id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
4908820|NCT04462731|12080703|P2|NOT COMPLETED|Overall Study||46
4908821|NCT04462731|12080704|P1|NOT COMPLETED|Overall Study||56
4908822|NCT04462731|12080703|P2|COMPLETED|Overall Study||51
4908823|NCT04462731|12080704|P1|COMPLETED|Overall Study||41
4908824|NCT04462731|12080703|P2|STARTED|Overall Study||97
4908825|NCT04462731|12080704|P1|STARTED|Overall Study||97
4908826|NCT04410159|12080714|P4|NOT COMPLETED|Overall Study||0
4908827|NCT04410159|12080715|P3|NOT COMPLETED|Overall Study||0
4908828|NCT04410159|12080716|P2|NOT COMPLETED|Overall Study||0
4908829|NCT04410159|12080717|P1|NOT COMPLETED|Overall Study||0
4908830|NCT04410159|12080714|P4|COMPLETED|Overall Study||5
4908831|NCT04410159|12080715|P3|COMPLETED|Overall Study||5
4908832|NCT04410159|12080716|P2|COMPLETED|Overall Study||5
4908833|NCT04410159|12080717|P1|COMPLETED|Overall Study||5
4908834|NCT04410159|12080714|P4|STARTED|Overall Study||5
4908835|NCT04410159|12080715|P3|STARTED|Overall Study||5
4908836|NCT04410159|12080716|P2|STARTED|Overall Study||5
4908837|NCT04410159|12080717|P1|STARTED|Overall Study||5
4908838|NCT04399161|12080746|P3|NOT COMPLETED|Overall Study||2
4908839|NCT04399161|12080747|P2|NOT COMPLETED|Overall Study||2
4908840|NCT04399161|12080748|P1|NOT COMPLETED|Overall Study||2
4908841|NCT04399161|12080746|P3|COMPLETED|Overall Study||18
4908842|NCT04399161|12080747|P2|COMPLETED|Overall Study||18
4908843|NCT04399161|12080748|P1|COMPLETED|Overall Study||18
4908844|NCT04399161|12080746|P3|STARTED|Overall Study||20
4908845|NCT04399161|12080747|P2|STARTED|Overall Study||20
4908846|NCT04399161|12080748|P1|STARTED|Overall Study||20
4908847|NCT04397094|12080758|P2|NOT COMPLETED|Overall Study||0
4908848|NCT04397094|12080759|P1|NOT COMPLETED|Overall Study||0
4908849|NCT04397094|12080758|P2|COMPLETED|Overall Study||30
4908850|NCT04397094|12080759|P1|COMPLETED|Overall Study||30
4908851|NCT04397094|12080758|P2|STARTED|Overall Study||30
4908852|NCT04397094|12080759|P1|STARTED|Overall Study||30
4908853|NCT04374500|12080767|P3|NOT COMPLETED|Overall Study||0
4908854|NCT04374500|12080768|P2|NOT COMPLETED|Overall Study||0
4908855|NCT04374500|12080769|P1|NOT COMPLETED|Overall Study||0
4908856|NCT04374500|12080767|P3|COMPLETED|Overall Study||83
4908857|NCT04374500|12080768|P2|COMPLETED|Overall Study||10
4908858|NCT04374500|12080769|P1|COMPLETED|Overall Study||10
4908859|NCT04374500|12080767|P3|STARTED|Overall Study||83
4908860|NCT04374500|12080768|P2|STARTED|Overall Study||10
4908861|NCT04374500|12080769|P1|STARTED|Overall Study||10
4908862|NCT04363879|12080788|P2|NOT COMPLETED|Overall Study||0
4908863|NCT04363879|12080789|P1|NOT COMPLETED|Overall Study||0
4908864|NCT04363879|12080788|P2|COMPLETED|Overall Study||92
4908865|NCT04363879|12080789|P1|COMPLETED|Overall Study||78
4908866|NCT04363879|12080788|P2|STARTED|Overall Study||92
4908867|NCT04363879|12080789|P1|STARTED|Overall Study||78
4908868|NCT04359771|12080803|P2|NOT COMPLETED|Overall Study||2
4908869|NCT04359771|12080804|P1|NOT COMPLETED|Overall Study||2
4908870|NCT04359771|12080803|P2|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
4908871|NCT04359771|12080804|P1|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
4908872|NCT04359771|12080803|P2|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
4908873|NCT04359771|12080804|P1|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
4908874|NCT04358991|12080812|P1|NOT COMPLETED|Overall Study||0
4908875|NCT04358991|12080812|P1|COMPLETED|Overall Study||20
4908876|NCT04358991|12080812|P1|STARTED|Overall Study||20
4908877|NCT04355663|12080819|P3|NOT COMPLETED|Overall Study||4
4908878|NCT04355663|12080820|P2|NOT COMPLETED|Overall Study||15
4908879|NCT04355663|12080821|P1|NOT COMPLETED|Overall Study||2
4908880|NCT04355663|12080819|P3|COMPLETED|Overall Study||17
4908881|NCT04355663|12080820|P2|COMPLETED|Overall Study||14
4908882|NCT04355663|12080821|P1|COMPLETED|Overall Study||40
4908883|NCT04355663|12080819|P3|STARTED|Overall Study||21
4908884|NCT04355663|12080820|P2|STARTED|Overall Study||29
4908885|NCT04355663|12080821|P1|STARTED|Overall Study||42
4908886|NCT04352660|12080843|P2|NOT COMPLETED|Overall Study||10
4908887|NCT04352660|12080844|P1|NOT COMPLETED|Overall Study||14
4908888|NCT04352660|12080843|P2|COMPLETED|Overall Study||40
4908889|NCT04352660|12080844|P1|COMPLETED|Overall Study||36
4908890|NCT04352660|12080843|P2|STARTED|Overall Study||50
4908891|NCT04352660|12080844|P1|STARTED|Overall Study||50
4908892|NCT04350307|12080864|P2|NOT COMPLETED|Overall Study||0
4908893|NCT04350307|12080865|P1|NOT COMPLETED|Overall Study||0
4908894|NCT04350307|12080864|P2|COMPLETED|Overall Study||78
4908895|NCT04350307|12080865|P1|COMPLETED|Overall Study||84
4908896|NCT04350307|12080864|P2|STARTED|Overall Study||78
4908897|NCT04350307|12080865|P1|STARTED|Overall Study||84
4908898|NCT04348851|12080877|P4|NOT COMPLETED|Post-Test 2||1
4908899|NCT04348851|12080878|P3|NOT COMPLETED|Post-Test 2||0
4908900|NCT04348851|12080879|P2|NOT COMPLETED|Post-Test 2||1
4908901|NCT04348851|12080880|P1|NOT COMPLETED|Post-Test 2||0
4908902|NCT04348851|12080877|P4|COMPLETED|Post-Test 2||13
4908903|NCT04348851|12080878|P3|COMPLETED|Post-Test 2||13
4908904|NCT04348851|12080879|P2|COMPLETED|Post-Test 2||10
4908905|NCT04348851|12080880|P1|COMPLETED|Post-Test 2||13
4908906|NCT04348851|12080877|P4|STARTED|Post-Test 2||14
4908907|NCT04348851|12080878|P3|STARTED|Post-Test 2||13
4908908|NCT04348851|12080879|P2|STARTED|Post-Test 2||11
4908909|NCT04348851|12080880|P1|STARTED|Post-Test 2||13
4908910|NCT04348851|12080877|P4|NOT COMPLETED|Post-Test 1||0
4908911|NCT04348851|12080878|P3|NOT COMPLETED|Post-Test 1||0
4908912|NCT04348851|12080879|P2|NOT COMPLETED|Post-Test 1||2
4908913|NCT04348851|12080880|P1|NOT COMPLETED|Post-Test 1||0
4908914|NCT04348851|12080877|P4|COMPLETED|Post-Test 1||14
4908915|NCT04348851|12080878|P3|COMPLETED|Post-Test 1||13
4908916|NCT04348851|12080879|P2|COMPLETED|Post-Test 1||11
4908917|NCT04348851|12080880|P1|COMPLETED|Post-Test 1||13
4908918|NCT04348851|12080877|P4|STARTED|Post-Test 1||14
4908919|NCT04348851|12080878|P3|STARTED|Post-Test 1||13
4908920|NCT04348851|12080879|P2|STARTED|Post-Test 1||13
4908921|NCT04348851|12080880|P1|STARTED|Post-Test 1||13
4908922|NCT04348357|12080960|P2|NOT COMPLETED|Overall Study||12
4908923|NCT04348357|12080961|P1|NOT COMPLETED|Overall Study||0
4908924|NCT04348357|12080960|P2|COMPLETED|Overall Study||16
4908925|NCT04348357|12080961|P1|COMPLETED|Overall Study||25
4908926|NCT04348357|12080960|P2|STARTED|Overall Study||28
4908927|NCT04348357|12080961|P1|STARTED|Overall Study||25
4908928|NCT04336475|12080989|P2|NOT COMPLETED|Overall Study||2
4908929|NCT04336475|12080990|P1|NOT COMPLETED|Overall Study||2
4908930|NCT04336475|12080989|P2|COMPLETED|Overall Study||28
4908931|NCT04336475|12080990|P1|COMPLETED|Overall Study||28
4908932|NCT04336475|12080989|P2|STARTED|Overall Study||30
4908933|NCT04336475|12080990|P1|STARTED|Overall Study||30
4908934|NCT04323592|12080998|P2|NOT COMPLETED|Overall Study||0
4908935|NCT04323592|12080999|P1|NOT COMPLETED|Overall Study||0
4908936|NCT04323592|12080998|P2|COMPLETED|Overall Study||90
4908937|NCT04323592|12080999|P1|COMPLETED|Overall Study||83
4908938|NCT04323592|12080998|P2|STARTED|Overall Study||90
4908939|NCT04323592|12080999|P1|STARTED|Overall Study||83
4908940|NCT04322526|12081017|P2|NOT COMPLETED|Second Intervention (1day)||0
4908941|NCT04322526|12081018|P1|NOT COMPLETED|Second Intervention (1day)||0
4908942|NCT04322526|12081017|P2|COMPLETED|Second Intervention (1day)||9
4908943|NCT04322526|12081018|P1|COMPLETED|Second Intervention (1day)||11
4908944|NCT04322526|12081017|P2|STARTED|Second Intervention (1day)||9
4908945|NCT04322526|12081018|P1|STARTED|Second Intervention (1day)||11
4908946|NCT04322526|12081017|P2|NOT COMPLETED|Washout (1 Week)||2
4908947|NCT04322526|12081018|P1|NOT COMPLETED|Washout (1 Week)||1
4908948|NCT04322526|12081017|P2|COMPLETED|Washout (1 Week)||9
4908949|NCT04322526|12081018|P1|COMPLETED|Washout (1 Week)||11
4908950|NCT04322526|12081017|P2|STARTED|Washout (1 Week)||11
4908951|NCT04322526|12081018|P1|STARTED|Washout (1 Week)||12
4908952|NCT04322526|12081017|P2|NOT COMPLETED|First Intervention (1 Day)||1
4908953|NCT04322526|12081018|P1|NOT COMPLETED|First Intervention (1 Day)||1
4908954|NCT04322526|12081017|P2|COMPLETED|First Intervention (1 Day)||11
4908955|NCT04322526|12081018|P1|COMPLETED|First Intervention (1 Day)||12
4908956|NCT04322526|12081017|P2|STARTED|First Intervention (1 Day)||12
4908957|NCT04322526|12081018|P1|STARTED|First Intervention (1 Day)||13
4908958|NCT04322500|12081026|P2|NOT COMPLETED|Overall Study||0
4908959|NCT04322500|12081027|P1|NOT COMPLETED|Overall Study||0
4908960|NCT04322500|12081026|P2|COMPLETED|Overall Study||13
4908961|NCT04322500|12081027|P1|COMPLETED|Overall Study||13
4908962|NCT04322500|12081026|P2|STARTED|Overall Study||13
4908963|NCT04322500|12081027|P1|STARTED|Overall Study||13
4908964|NCT04308239|12081037|P2|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
4908965|NCT04308239|12081038|P1|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
4908966|NCT04308239|12081037|P2|COMPLETED|Post-intervention Evaluation (1 Week)||10
4908967|NCT04308239|12081038|P1|COMPLETED|Post-intervention Evaluation (1 Week)||19
4908968|NCT04308239|12081037|P2|STARTED|Post-intervention Evaluation (1 Week)||14
4908969|NCT04308239|12081038|P1|STARTED|Post-intervention Evaluation (1 Week)||20
4908970|NCT04308239|12081037|P2|NOT COMPLETED|Intervention (2 Weeks)||0
4908971|NCT04308239|12081038|P1|NOT COMPLETED|Intervention (2 Weeks)||0
4908972|NCT04308239|12081037|P2|COMPLETED|Intervention (2 Weeks)||14
4908973|NCT04308239|12081038|P1|COMPLETED|Intervention (2 Weeks)||20
4908974|NCT04308239|12081037|P2|STARTED|Intervention (2 Weeks)||14
4908975|NCT04308239|12081038|P1|STARTED|Intervention (2 Weeks)||20
4908976|NCT04308239|12081037|P2|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
4908977|NCT04308239|12081038|P1|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
4908978|NCT04308239|12081037|P2|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
4908979|NCT04308239|12081038|P1|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
4908980|NCT04308239|12081037|P2|STARTED|Pre-intervention Evaluation (1 Week)||14
4908981|NCT04308239|12081038|P1|STARTED|Pre-intervention Evaluation (1 Week)||20
4908982|NCT04296227|12081060|P1|NOT COMPLETED|Overall Study||0
4908983|NCT04296227|12081060|P1|COMPLETED|Overall Study||85
4908984|NCT04296227|12081060|P1|STARTED|Overall Study||85
4908985|NCT04292639|12081064|P1|NOT COMPLETED|Overall Study||0
4908986|NCT04292639|12081064|P1|COMPLETED|Overall Study||20
4908987|NCT04292639|12081064|P1|STARTED|Overall Study||20
4908988|NCT04287517|12081070|P2|NOT COMPLETED|Overall Study||1
4908989|NCT04287517|12081071|P1|NOT COMPLETED|Overall Study||1
4908990|NCT04287517|12081070|P2|COMPLETED|Overall Study||18
4908991|NCT04287517|12081071|P1|COMPLETED|Overall Study||18
4908992|NCT04287517|12081070|P2|STARTED|Overall Study||19
4908993|NCT04287517|12081071|P1|STARTED|Overall Study||19
4908994|NCT04285411|12081085|P1|NOT COMPLETED|Overall Study||0
4908995|NCT04285411|12081085|P1|COMPLETED|Overall Study||10
4908996|NCT04285411|12081085|P1|STARTED|Overall Study||10
4908997|NCT04274556|12081090|P1|NOT COMPLETED|Overall Study||0
4908998|NCT04274556|12081090|P1|COMPLETED|Overall Study||86
4908999|NCT04274556|12081090|P1|STARTED|Overall Study||86
4909000|NCT04272775|12081098|P2|NOT COMPLETED|Overall Study||7
4909001|NCT04272775|12081099|P1|NOT COMPLETED|Overall Study||7
4909002|NCT04272775|12081098|P2|COMPLETED|Overall Study||0
4909003|NCT04272775|12081099|P1|COMPLETED|Overall Study||0
4909004|NCT04272775|12081098|P2|STARTED|Overall Study||7
4909005|NCT04272775|12081099|P1|STARTED|Overall Study||7
4909006|NCT04271020|12081119|P1|NOT COMPLETED|Overall Study||0
4909007|NCT04271020|12081119|P1|COMPLETED|Overall Study||12
4909008|NCT04271020|12081119|P1|STARTED|Overall Study||12
4909009|NCT04270292|12081125|P1|NOT COMPLETED|Overall Study||0
4909010|NCT04270292|12081125|P1|COMPLETED|Overall Study||164
4909011|NCT04270292|12081125|P1|STARTED|Overall Study||164
4909012|NCT04267770|12081134|P2|NOT COMPLETED|Overall Study||0
4909013|NCT04267770|12081135|P1|NOT COMPLETED|Overall Study||0
4909014|NCT04267770|12081134|P2|COMPLETED|Overall Study||8
4909015|NCT04267770|12081135|P1|COMPLETED|Overall Study||9
4909016|NCT04267770|12081134|P2|STARTED|Overall Study||8
4909017|NCT04267770|12081135|P1|STARTED|Overall Study||9
4909018|NCT04266925|12081143|P2|NOT COMPLETED|3 Referee Game (~1 Hour)||0
4909019|NCT04266925|12081144|P1|NOT COMPLETED|3 Referee Game (~1 Hour)||0
4909020|NCT04266925|12081143|P2|COMPLETED|3 Referee Game (~1 Hour)||26
4909021|NCT04266925|12081144|P1|COMPLETED|3 Referee Game (~1 Hour)||23
4909022|NCT04266925|12081143|P2|STARTED|3 Referee Game (~1 Hour)||26
4909023|NCT04266925|12081144|P1|STARTED|3 Referee Game (~1 Hour)||23
4909024|NCT04266925|12081143|P2|NOT COMPLETED|1 Referee Game (~1 Hour)||0
4909025|NCT04266925|12081144|P1|NOT COMPLETED|1 Referee Game (~1 Hour)||0
4909026|NCT04266925|12081143|P2|COMPLETED|1 Referee Game (~1 Hour)||26
4909027|NCT04266925|12081144|P1|COMPLETED|1 Referee Game (~1 Hour)||23
4909028|NCT04266925|12081143|P2|STARTED|1 Referee Game (~1 Hour)||26
4909029|NCT04266925|12081144|P1|STARTED|1 Referee Game (~1 Hour)||23
4909030|NCT04251884|12081152|P2|NOT COMPLETED|Overall Study||0
4909031|NCT04251884|12081153|P1|NOT COMPLETED|Overall Study||0
4909032|NCT04251884|12081152|P2|COMPLETED|Overall Study||26
4909033|NCT04251884|12081153|P1|COMPLETED|Overall Study||23
4909034|NCT04251884|12081152|P2|STARTED|Overall Study||26
4909035|NCT04251884|12081153|P1|STARTED|Overall Study||23
4909036|NCT04241146|12081169|P2|NOT COMPLETED|Overall Study||0
4909037|NCT04241146|12081170|P1|NOT COMPLETED|Overall Study||0
4909038|NCT04241146|12081169|P2|COMPLETED|Overall Study||28
4909039|NCT04241146|12081170|P1|COMPLETED|Overall Study||24
4909040|NCT04241146|12081169|P2|STARTED|Overall Study||28
4909041|NCT04241146|12081170|P1|STARTED|Overall Study||24
4909042|NCT04238429|12081180|P2|NOT COMPLETED|Overall Study||2
4909043|NCT04238429|12081181|P1|NOT COMPLETED|Overall Study||3
4909044|NCT04238429|12081180|P2|COMPLETED|Overall Study||41
4909045|NCT04238429|12081181|P1|COMPLETED|Overall Study||40
4909046|NCT04238429|12081180|P2|STARTED|Overall Study||43
4909047|NCT04238429|12081181|P1|STARTED|Overall Study||43
4909048|NCT04232137|12081199|P2|NOT COMPLETED|Overall Study||0
4909049|NCT04232137|12081200|P1|NOT COMPLETED|Overall Study||0
4909050|NCT04232137|12081199|P2|COMPLETED|Overall Study||185
4909051|NCT04232137|12081200|P1|COMPLETED|Overall Study||254
4909052|NCT04232137|12081199|P2|STARTED|Overall Study||185
4909053|NCT04232137|12081200|P1|STARTED|Overall Study||254
4909054|NCT04224753|12081206|P1|NOT COMPLETED|Overall Study||0
4909055|NCT04224753|12081206|P1|COMPLETED|Overall Study||51
4909056|NCT04224753|12081206|P1|STARTED|Overall Study||51
4909057|NCT04222699|12081210|P1|NOT COMPLETED|Overall Study||2
4909058|NCT04222699|12081210|P1|COMPLETED|Overall Study||26
4909059|NCT04222699|12081210|P1|STARTED|Overall Study||28
4909060|NCT04218799|12081217|P1|NOT COMPLETED|Overall Study||0
4909061|NCT04218799|12081217|P1|COMPLETED|Overall Study||7
4909062|NCT04218799|12081217|P1|STARTED|Overall Study||7
4909063|NCT04214080|12081226|P2|NOT COMPLETED|Overall Study||0
4909064|NCT04214080|12081227|P1|NOT COMPLETED|Overall Study||0
4909065|NCT04214080|12081226|P2|COMPLETED|Overall Study||20
4909066|NCT04214080|12081227|P1|COMPLETED|Overall Study||20
4909067|NCT04214080|12081226|P2|STARTED|Overall Study||20
4909068|NCT04214080|12081227|P1|STARTED|Overall Study||20
4909069|NCT04209335|12081245|P1|NOT COMPLETED|Overall Study||0
4909070|NCT04209335|12081245|P1|COMPLETED|Overall Study||48
4909071|NCT04209335|12081245|P1|STARTED|Overall Study||48
4909072|NCT04204200|12081255|P3|NOT COMPLETED|Overall Study||0
4909073|NCT04204200|12081256|P2|NOT COMPLETED|Overall Study||0
4909074|NCT04204200|12081257|P1|NOT COMPLETED|Overall Study||0
4909075|NCT04204200|12081255|P3|COMPLETED|Overall Study||22
4909076|NCT04204200|12081256|P2|COMPLETED|Overall Study||22
4909077|NCT04204200|12081257|P1|COMPLETED|Overall Study||22
4909078|NCT04204200|12081255|P3|STARTED|Overall Study||22
4909079|NCT04204200|12081256|P2|STARTED|Overall Study||22
4909080|NCT04204200|12081257|P1|STARTED|Overall Study||22
4909081|NCT04195880|12081276|P2|NOT COMPLETED|Overall Study||0
4909082|NCT04195880|12081277|P1|NOT COMPLETED|Overall Study||0
4909083|NCT04195880|12081276|P2|COMPLETED|Overall Study||3338
4909084|NCT04195880|12081277|P1|COMPLETED|Overall Study||3205
4909085|NCT04195880|12081276|P2|STARTED|Overall Study||3338
4909086|NCT04195880|12081277|P1|STARTED|Overall Study||3205
4909087|NCT04182217|12081285|P1|NOT COMPLETED|Overall Study||0
4909088|NCT04182217|12081285|P1|COMPLETED|Overall Study||91
4909089|NCT04182217|12081285|P1|STARTED|Overall Study||91
4909090|NCT04179838|12081298|P2|NOT COMPLETED|Second Intervention (1 Day)||1
4909091|NCT04179838|12081299|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4909092|NCT04179838|12081298|P2|COMPLETED|Second Intervention (1 Day)||12
4909093|NCT04179838|12081299|P1|COMPLETED|Second Intervention (1 Day)||13
4909094|NCT04179838|12081298|P2|STARTED|Second Intervention (1 Day)||13
4909095|NCT04179838|12081299|P1|STARTED|Second Intervention (1 Day)||13
4909096|NCT04179838|12081298|P2|NOT COMPLETED|Washout (4 Weeks)||0
4909097|NCT04179838|12081299|P1|NOT COMPLETED|Washout (4 Weeks)||0
4909098|NCT04179838|12081298|P2|COMPLETED|Washout (4 Weeks)||13
4909099|NCT04179838|12081299|P1|COMPLETED|Washout (4 Weeks)||13
4909100|NCT04179838|12081298|P2|STARTED|Washout (4 Weeks)||13
4909101|NCT04179838|12081299|P1|STARTED|Washout (4 Weeks)||13
4909102|NCT04179838|12081298|P2|NOT COMPLETED|First Intervention (1 Day)||3
4909103|NCT04179838|12081299|P1|NOT COMPLETED|First Intervention (1 Day)||0
4909104|NCT04179838|12081298|P2|COMPLETED|First Intervention (1 Day)||13
4909105|NCT04179838|12081299|P1|COMPLETED|First Intervention (1 Day)||13
4909106|NCT04179838|12081298|P2|STARTED|First Intervention (1 Day)||16
4909107|NCT04179838|12081299|P1|STARTED|First Intervention (1 Day)||13
4909108|NCT04178590|12081317|P1|NOT COMPLETED|Overall Study||2
4909109|NCT04178590|12081317|P1|COMPLETED|Overall Study||30
4909110|NCT04178590|12081317|P1|STARTED|Overall Study||32
4909111|NCT04171102|12081428|P3|NOT COMPLETED|Overall Study||0
4909112|NCT04171102|12081429|P2|NOT COMPLETED|Overall Study||0
4909113|NCT04171102|12081430|P1|NOT COMPLETED|Overall Study||0
4909114|NCT04171102|12081428|P3|COMPLETED|Overall Study||6
4909115|NCT04171102|12081429|P2|COMPLETED|Overall Study||5
4909116|NCT04171102|12081430|P1|COMPLETED|Overall Study||4
4909117|NCT04171102|12081428|P3|STARTED|Overall Study||6
4909118|NCT04171102|12081429|P2|STARTED|Overall Study||5
4909119|NCT04171102|12081430|P1|STARTED|Overall Study||4
4909120|NCT04150224|12081444|P6|NOT COMPLETED|Overall Study||0
4909121|NCT04150224|12081445|P5|NOT COMPLETED|Overall Study||0
4909122|NCT04150224|12081446|P4|NOT COMPLETED|Overall Study||0
4909123|NCT04150224|12081447|P3|NOT COMPLETED|Overall Study||0
4909124|NCT04150224|12081448|P2|NOT COMPLETED|Overall Study||0
4909125|NCT04150224|12081449|P1|NOT COMPLETED|Overall Study||0
4909126|NCT04150224|12081444|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
4909127|NCT04150224|12081445|P5|COMPLETED|Overall Study||10
4909128|NCT04150224|12081446|P4|COMPLETED|Overall Study||10
4909129|NCT04150224|12081447|P3|COMPLETED|Overall Study||10
4909130|NCT04150224|12081448|P2|COMPLETED|Overall Study||10
4909131|NCT04150224|12081449|P1|COMPLETED|Overall Study||10
4909132|NCT04150224|12081444|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
4909133|NCT04150224|12081445|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
4909134|NCT04150224|12081446|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
4909135|NCT04150224|12081447|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
4909136|NCT04150224|12081448|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
4909137|NCT04150224|12081449|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
4909138|NCT04149925|12081550|P2|NOT COMPLETED|Overall Study||0
4909139|NCT04149925|12081551|P1|NOT COMPLETED|Overall Study||0
4909140|NCT04149925|12081550|P2|COMPLETED|Overall Study||30
4909141|NCT04149925|12081551|P1|COMPLETED|Overall Study||30
4909142|NCT04149925|12081550|P2|STARTED|Overall Study||30
4909143|NCT04149925|12081551|P1|STARTED|Overall Study||30
4909144|NCT04149353|12081567|P1|NOT COMPLETED|Overall Study||1
4909145|NCT04149353|12081567|P1|COMPLETED|Overall Study||0
4909146|NCT04149353|12081567|P1|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
4909147|NCT04144088|12081575|P3|NOT COMPLETED|Overall Study||7
4909148|NCT04144088|12081576|P2|NOT COMPLETED|Overall Study||5
4909149|NCT04144088|12081577|P1|NOT COMPLETED|Overall Study||6
4909150|NCT04144088|12081575|P3|COMPLETED|Overall Study||13
4909151|NCT04144088|12081576|P2|COMPLETED|Overall Study||15
4909152|NCT04144088|12081577|P1|COMPLETED|Overall Study||14
4909153|NCT04144088|12081575|P3|STARTED|Overall Study||20
4909154|NCT04144088|12081576|P2|STARTED|Overall Study||20
4909155|NCT04144088|12081577|P1|STARTED|Overall Study||20
4909156|NCT04143373|12081585|P2|NOT COMPLETED|Overall Study||0
4909157|NCT04143373|12081586|P1|NOT COMPLETED|Overall Study||0
4909158|NCT04143373|12081585|P2|COMPLETED|Overall Study||20
4909159|NCT04143373|12081586|P1|COMPLETED|Overall Study||20
4909160|NCT04143373|12081585|P2|STARTED|Overall Study||20
4909161|NCT04143373|12081586|P1|STARTED|Overall Study||20
4909162|NCT04142216|12081595|P2|NOT COMPLETED|Overall Study||6
4909163|NCT04142216|12081596|P1|NOT COMPLETED|Overall Study||6
4909164|NCT04142216|12081595|P2|COMPLETED|Overall Study||22
4909165|NCT04142216|12081596|P1|COMPLETED|Overall Study||22
4909166|NCT04142216|12081595|P2|STARTED|Overall Study||28
4909167|NCT04142216|12081596|P1|STARTED|Overall Study||28
4909168|NCT04137627|12081618|P2|NOT COMPLETED|Overall Study||13
4909169|NCT04137627|12081619|P1|NOT COMPLETED|Overall Study||12
4909170|NCT04137627|12081618|P2|COMPLETED|Overall Study||12
4909171|NCT04137627|12081619|P1|COMPLETED|Overall Study||13
4909172|NCT04137627|12081618|P2|STARTED|Overall Study||25
4909173|NCT04137627|12081619|P1|STARTED|Overall Study||25
4909174|NCT04123665|12081635|P2|NOT COMPLETED|Overall Study||0
4909175|NCT04123665|12081636|P1|NOT COMPLETED|Overall Study||8
4909176|NCT04123665|12081635|P2|COMPLETED|Overall Study||48
4909177|NCT04123665|12081636|P1|COMPLETED|Overall Study||42
4909178|NCT04123665|12081635|P2|STARTED|Overall Study||48
4909179|NCT04123665|12081636|P1|STARTED|Overall Study||50
4909180|NCT04113785|12081658|P1|NOT COMPLETED|Overall Study||0
4909181|NCT04113785|12081658|P1|COMPLETED|Overall Study||21
4909182|NCT04113785|12081658|P1|STARTED|Overall Study||21
4909183|NCT04112160|12081667|P2|NOT COMPLETED|Overall Study||0
4909184|NCT04112160|12081668|P1|NOT COMPLETED|Overall Study||1
4909185|NCT04112160|12081667|P2|COMPLETED|Overall Study||62
4909186|NCT04112160|12081668|P1|COMPLETED|Overall Study||62
4909187|NCT04112160|12081667|P2|STARTED|Overall Study||62
4909188|NCT04112160|12081668|P1|STARTED|Overall Study||63
4909189|NCT04112069|12081684|P2|NOT COMPLETED|Overall Study||0
4909190|NCT04112069|12081685|P1|NOT COMPLETED|Overall Study||0
4909191|NCT04112069|12081684|P2|COMPLETED|Overall Study||10
4909192|NCT04112069|12081685|P1|COMPLETED|Overall Study||10
4909193|NCT04112069|12081684|P2|STARTED|Overall Study||10
4909194|NCT04112069|12081685|P1|STARTED|Overall Study||10
4909195|NCT04109703|12081707|P2|NOT COMPLETED|Overall Study||0
4909196|NCT04109703|12081708|P1|NOT COMPLETED|Overall Study||0
4909197|NCT04109703|12081707|P2|COMPLETED|Overall Study||51
4909198|NCT04109703|12081708|P1|COMPLETED|Overall Study||49
4909199|NCT04109703|12081707|P2|STARTED|Overall Study||51
4909200|NCT04109703|12081708|P1|STARTED|Overall Study||49
4909201|NCT04106817|12081719|P3|NOT COMPLETED|Overall Study||0
4909202|NCT04106817|12081720|P2|NOT COMPLETED|Overall Study||0
4909203|NCT04106817|12081721|P1|NOT COMPLETED|Overall Study||1
4909204|NCT04106817|12081719|P3|COMPLETED|Overall Study||12
4909205|NCT04106817|12081720|P2|COMPLETED|Overall Study||11
4909206|NCT04106817|12081721|P1|COMPLETED|Overall Study||11
4909207|NCT04106817|12081719|P3|STARTED|Overall Study||12
4909208|NCT04106817|12081720|P2|STARTED|Overall Study||11
4909209|NCT04106817|12081721|P1|STARTED|Overall Study||12
4909210|NCT04098809|12081737|P2|NOT COMPLETED|Overall Study||4
4909211|NCT04098809|12081738|P1|NOT COMPLETED|Overall Study||3
4909212|NCT04098809|12081737|P2|COMPLETED|Overall Study||21
4909213|NCT04098809|12081738|P1|COMPLETED|Overall Study||24
4909214|NCT04098809|12081737|P2|STARTED|Overall Study||25
4909215|NCT04098809|12081738|P1|STARTED|Overall Study||27
4909216|NCT04091659|12081766|P2|NOT COMPLETED|Overall Study||1
4909217|NCT04091659|12081767|P1|NOT COMPLETED|Overall Study||3
4909218|NCT04091659|12081766|P2|COMPLETED|Overall Study||57
4909219|NCT04091659|12081767|P1|COMPLETED|Overall Study||37
4909220|NCT04091659|12081766|P2|STARTED|Overall Study||58
4909221|NCT04091659|12081767|P1|STARTED|Overall Study||40
4909222|NCT04086433|12081777|P2|NOT COMPLETED|Overall Study||0
4909223|NCT04086433|12081778|P1|NOT COMPLETED|Overall Study||0
4909224|NCT04086433|12081777|P2|COMPLETED|Overall Study||18
4909225|NCT04086433|12081778|P1|COMPLETED|Overall Study||17
4909226|NCT04086433|12081777|P2|STARTED|Overall Study||18
4909227|NCT04086433|12081778|P1|STARTED|Overall Study||17
4909228|NCT04086407|12081784|P1|NOT COMPLETED|Overall Study||0
4909229|NCT04086407|12081784|P1|COMPLETED|Overall Study||8
4909230|NCT04086407|12081784|P1|STARTED|Overall Study||8
4909231|NCT04083404|12081791|P1|NOT COMPLETED|Overall Study||0
4909232|NCT04083404|12081791|P1|COMPLETED|Overall Study||202
4909233|NCT04083404|12081791|P1|STARTED|Overall Study||202
4909234|NCT04082819|12081799|P3|NOT COMPLETED|Overall Study||0
4909235|NCT04082819|12081800|P2|NOT COMPLETED|Overall Study||0
4909236|NCT04082819|12081801|P1|NOT COMPLETED|Overall Study||0
4909237|NCT04082819|12081799|P3|COMPLETED|Overall Study||3
4909238|NCT04082819|12081800|P2|COMPLETED|Overall Study||54
4909239|NCT04082819|12081801|P1|COMPLETED|Overall Study||37
4909240|NCT04082819|12081799|P3|STARTED|Overall Study||3
4909241|NCT04082819|12081800|P2|STARTED|Overall Study||54
4909242|NCT04082819|12081801|P1|STARTED|Overall Study||37
4909243|NCT04081961|12081815|P3|NOT COMPLETED|Overall Study||0
4909244|NCT04081961|12081816|P2|NOT COMPLETED|Overall Study||0
4909245|NCT04081961|12081817|P1|NOT COMPLETED|Overall Study||0
4909246|NCT04081961|12081815|P3|COMPLETED|Overall Study||9
4909247|NCT04081961|12081816|P2|COMPLETED|Overall Study||9
4909248|NCT04081961|12081817|P1|COMPLETED|Overall Study||9
4909249|NCT04081961|12081815|P3|STARTED|Overall Study||9
4909250|NCT04081961|12081816|P2|STARTED|Overall Study||9
4909251|NCT04081961|12081817|P1|STARTED|Overall Study||9
4909252|NCT04080297|12081833|P2|NOT COMPLETED|Overall Study||3
4909253|NCT04080297|12081834|P1|NOT COMPLETED|Overall Study||2
4909254|NCT04080297|12081833|P2|COMPLETED|Overall Study||8
4909255|NCT04080297|12081834|P1|COMPLETED|Overall Study||8
4909256|NCT04080297|12081833|P2|STARTED|Overall Study||11
4909257|NCT04080297|12081834|P1|STARTED|Overall Study||10
4909258|NCT04079127|12081852|P1|NOT COMPLETED|Overall Study||61
4909259|NCT04079127|12081852|P1|COMPLETED|Overall Study|89 cases have completed the study, and all 10 year data of 81 were available for analysis.|89
4909260|NCT04079127|12081852|P1|STARTED|Overall Study||150
4909261|NCT04079114|12081858|P1|NOT COMPLETED|Overall Study||166
4909262|NCT04079114|12081858|P1|COMPLETED|Overall Study|Study prematurely terminated.|0
4909263|NCT04079114|12081858|P1|STARTED|Overall Study||166
4909264|NCT04076787|12081868|P3|NOT COMPLETED|Overall Study||0
4909265|NCT04076787|12081869|P2|NOT COMPLETED|Overall Study||0
4909266|NCT04076787|12081870|P1|NOT COMPLETED|Overall Study||0
4909267|NCT04076787|12081868|P3|COMPLETED|Overall Study||420
4909268|NCT04076787|12081869|P2|COMPLETED|Overall Study||1031
4909269|NCT04076787|12081870|P1|COMPLETED|Overall Study||318
4909270|NCT04076787|12081868|P3|STARTED|Overall Study||420
4909271|NCT04076787|12081869|P2|STARTED|Overall Study||1031
4909272|NCT04076787|12081870|P1|STARTED|Overall Study||318
4909273|NCT04072432|12081896|P3|NOT COMPLETED|Overall Study||0
4909274|NCT04072432|12081897|P2|NOT COMPLETED|Overall Study||0
4909275|NCT04072432|12081898|P1|NOT COMPLETED|Overall Study||0
4909276|NCT04072432|12081896|P3|COMPLETED|Overall Study||6
4909277|NCT04072432|12081897|P2|COMPLETED|Overall Study||6
4909278|NCT04072432|12081898|P1|COMPLETED|Overall Study||6
4909279|NCT04072432|12081896|P3|STARTED|Overall Study||6
4909280|NCT04072432|12081897|P2|STARTED|Overall Study||6
4909281|NCT04072432|12081898|P1|STARTED|Overall Study||6
4909282|NCT04071392|12081908|P2|NOT COMPLETED|Overall Study||2
4909283|NCT04071392|12081909|P1|NOT COMPLETED|Overall Study||2
4909284|NCT04071392|12081908|P2|COMPLETED|Overall Study||10
4909285|NCT04071392|12081909|P1|COMPLETED|Overall Study||10
4909286|NCT04071392|12081908|P2|STARTED|Overall Study||12
4909287|NCT04071392|12081909|P1|STARTED|Overall Study||12
4909288|NCT04069221|12081919|P4|NOT COMPLETED|Overall Study||0
4909289|NCT04069221|12081920|P3|NOT COMPLETED|Overall Study||0
4909290|NCT04069221|12081921|P2|NOT COMPLETED|Overall Study||0
4909291|NCT04069221|12081922|P1|NOT COMPLETED|Overall Study||0
4909292|NCT04069221|12081919|P4|COMPLETED|Overall Study||6
4909293|NCT04069221|12081920|P3|COMPLETED|Overall Study||6
4909294|NCT04069221|12081921|P2|COMPLETED|Overall Study||6
4909295|NCT04069221|12081922|P1|COMPLETED|Overall Study||8
4909296|NCT04069221|12081919|P4|STARTED|Overall Study||6
4909297|NCT04069221|12081920|P3|STARTED|Overall Study||6
4909298|NCT04069221|12081921|P2|STARTED|Overall Study||6
4909299|NCT04069221|12081922|P1|STARTED|Overall Study||8
4909300|NCT04067401|12081943|P2|NOT COMPLETED|Overall Study||0
4909301|NCT04067401|12081944|P1|NOT COMPLETED|Overall Study||8
4909302|NCT04067401|12081943|P2|COMPLETED|Overall Study||737
4909303|NCT04067401|12081944|P1|COMPLETED|Overall Study||740
4909304|NCT04067401|12081943|P2|6 Month Survey Completion|Overall Study||618
4909305|NCT04067401|12081944|P1|6 Month Survey Completion|Overall Study||629
4909306|NCT04067401|12081943|P2|1 Month Survey Completion|Overall Study||694
4909307|NCT04067401|12081944|P1|1 Month Survey Completion|Overall Study||697
4909308|NCT04067401|12081943|P2|Baseline Survey Completion|Overall Study||735
4909309|NCT04067401|12081944|P1|Baseline Survey Completion|Overall Study||746
4909310|NCT04067401|12081943|P2|STARTED|Overall Study||737
4909311|NCT04067401|12081944|P1|STARTED|Overall Study||748
4909312|NCT04066647|12081964|P1|NOT COMPLETED|Overall Study||0
4909313|NCT04066647|12081964|P1|COMPLETED|Overall Study||7
4909314|NCT04066647|12081964|P1|STARTED|Overall Study||7
4909315|NCT04061694|12081970|P2|NOT COMPLETED|Overall Study||0
4909316|NCT04061694|12081971|P1|NOT COMPLETED|Overall Study||2
4909317|NCT04061694|12081970|P2|COMPLETED|Overall Study||25
4909318|NCT04061694|12081971|P1|COMPLETED|Overall Study||19
4909319|NCT04061694|12081970|P2|STARTED|Overall Study||25
4909320|NCT04061694|12081971|P1|STARTED|Overall Study||21
4909321|NCT04057235|12081985|P1|NOT COMPLETED|Overall Study||0
4909322|NCT04057235|12081985|P1|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
4909323|NCT04057235|12081985|P1|Had VAS Leg Data|Overall Study||45
4909324|NCT04057235|12081985|P1|Had VAS Back Data|Overall Study||45
4909325|NCT04057235|12081985|P1|Had ODI Data|Overall Study||43
4909326|NCT04057235|12081985|P1|Had Radiographic Data|Overall Study||58
4909327|NCT04057235|12081985|P1|STARTED|Overall Study||129
4909328|NCT04055675|12081994|P2|NOT COMPLETED|Overall Study||0
4909329|NCT04055675|12081995|P1|NOT COMPLETED|Overall Study||0
4909330|NCT04055675|12081994|P2|COMPLETED|Overall Study||104
4909331|NCT04055675|12081995|P1|COMPLETED|Overall Study||96
4909332|NCT04055675|12081994|P2|STARTED|Overall Study||104
4909333|NCT04055675|12081995|P1|STARTED|Overall Study||96
4909334|NCT04053465|12082003|P2|NOT COMPLETED|Overall Study||4
4909335|NCT04053465|12082004|P1|NOT COMPLETED|Overall Study||4
4909336|NCT04053465|12082003|P2|COMPLETED|Overall Study||8
4909337|NCT04053465|12082004|P1|COMPLETED|Overall Study||18
4909338|NCT04053465|12082003|P2|STARTED|Overall Study||12
4909339|NCT04053465|12082004|P1|STARTED|Overall Study||22
4909340|NCT04053270|12082014|P2|NOT COMPLETED|Overall Study||5
4909341|NCT04053270|12082015|P1|NOT COMPLETED|Overall Study||2
4909342|NCT04053270|12082014|P2|COMPLETED|Overall Study||46
4909343|NCT04053270|12082015|P1|COMPLETED|Overall Study||47
4909344|NCT04053270|12082014|P2|STARTED|Overall Study||51
4909345|NCT04053270|12082015|P1|STARTED|Overall Study||49
4909346|NCT04053023|12082033|P2|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
4909347|NCT04053023|12082034|P1|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
4909348|NCT04053023|12082033|P2|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
4909349|NCT04053023|12082034|P1|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
4909350|NCT04053023|12082033|P2|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
4909351|NCT04053023|12082034|P1|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
4909352|NCT04053023|12082033|P2|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
4909353|NCT04053023|12082034|P1|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
4909354|NCT04053023|12082033|P2|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
4909355|NCT04053023|12082034|P1|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
4909356|NCT04053023|12082033|P2|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
4909357|NCT04053023|12082034|P1|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
4909358|NCT04053023|12082033|P2|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
4909359|NCT04053023|12082034|P1|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
4909360|NCT04053023|12082033|P2|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
4909361|NCT04053023|12082034|P1|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
4909362|NCT04053023|12082033|P2|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
4909363|NCT04053023|12082034|P1|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
4909364|NCT04053023|12082033|P2|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
4909365|NCT04053023|12082034|P1|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
4909366|NCT04053023|12082033|P2|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
4909367|NCT04053023|12082034|P1|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
4909368|NCT04053023|12082033|P2|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
4909369|NCT04053023|12082034|P1|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
4909370|NCT04051684|12082198|P2|NOT COMPLETED|Overall Study||0
4909371|NCT04051684|12082199|P1|NOT COMPLETED|Overall Study||0
4909372|NCT04051684|12082198|P2|COMPLETED|Overall Study||11
4909373|NCT04051684|12082199|P1|COMPLETED|Overall Study||12
4909374|NCT04051684|12082198|P2|STARTED|Overall Study||11
4909375|NCT04051684|12082199|P1|STARTED|Overall Study||12
4909376|NCT04048681|12082211|P5|NOT COMPLETED|Overall Study||0
4909377|NCT04048681|12082212|P4|NOT COMPLETED|Overall Study||1
4909378|NCT04048681|12082213|P3|NOT COMPLETED|Overall Study||0
4909379|NCT04048681|12082214|P2|NOT COMPLETED|Overall Study||0
4909380|NCT04048681|12082215|P1|NOT COMPLETED|Overall Study||0
4909381|NCT04048681|12082211|P5|COMPLETED|Overall Study||1
4909382|NCT04048681|12082212|P4|COMPLETED|Overall Study||0
4909383|NCT04048681|12082213|P3|COMPLETED|Overall Study||1
4909384|NCT04048681|12082214|P2|COMPLETED|Overall Study||1
4909385|NCT04048681|12082215|P1|COMPLETED|Overall Study||1
4909386|NCT04048681|12082211|P5|STARTED|Overall Study||1
4909387|NCT04048681|12082212|P4|STARTED|Overall Study||1
4909388|NCT04048681|12082213|P3|STARTED|Overall Study||1
4909389|NCT04048681|12082214|P2|STARTED|Overall Study||1
4909390|NCT04048681|12082215|P1|STARTED|Overall Study||1
4909391|NCT04045964|12082228|P2|NOT COMPLETED|Overall Study||1
4909392|NCT04045964|12082229|P1|NOT COMPLETED|Overall Study||1
4909393|NCT04045964|12082228|P2|COMPLETED|Overall Study||15
4909394|NCT04045964|12082229|P1|COMPLETED|Overall Study||15
4909395|NCT04045964|12082228|P2|Follow up Visit 2|Overall Study||15
4909396|NCT04045964|12082229|P1|Follow up Visit 2|Overall Study||15
4909397|NCT04045964|12082228|P2|Follow up Visit 1|Overall Study||15
4909398|NCT04045964|12082229|P1|Follow up Visit 1|Overall Study||15
4909399|NCT04045964|12082228|P2|Intervention Visit(s)|Overall Study||16
4909400|NCT04045964|12082229|P1|Intervention Visit(s)|Overall Study||15
4909401|NCT04045964|12082228|P2|STARTED|Overall Study||16
4909402|NCT04045964|12082229|P1|STARTED|Overall Study||16
4909403|NCT04043416|12082260|P2|NOT COMPLETED|Campaign 2||0
4909404|NCT04043416|12082261|P1|NOT COMPLETED|Campaign 2||0
4909405|NCT04043416|12082260|P2|COMPLETED|Campaign 2||13
4909406|NCT04043416|12082261|P1|COMPLETED|Campaign 2||14
4909407|NCT04043416|12082260|P2|STARTED|Campaign 2||13
4909408|NCT04043416|12082261|P1|STARTED|Campaign 2||14
4909409|NCT04043416|12082260|P2|NOT COMPLETED|Washout||1
4909410|NCT04043416|12082261|P1|NOT COMPLETED|Washout||0
4909411|NCT04043416|12082260|P2|COMPLETED|Washout||13
4909412|NCT04043416|12082261|P1|COMPLETED|Washout||14
4909413|NCT04043416|12082260|P2|STARTED|Washout||14
4909414|NCT04043416|12082261|P1|STARTED|Washout||14
4909415|NCT04043416|12082260|P2|NOT COMPLETED|Campaign 1||0
4909416|NCT04043416|12082261|P1|NOT COMPLETED|Campaign 1||0
4909417|NCT04043416|12082260|P2|COMPLETED|Campaign 1||14
4909418|NCT04043416|12082261|P1|COMPLETED|Campaign 1||14
4909419|NCT04043416|12082260|P2|STARTED|Campaign 1||14
4909420|NCT04043416|12082261|P1|STARTED|Campaign 1||14
4909421|NCT04041453|12082299|P4|NOT COMPLETED|Overall Study||18
4909422|NCT04041453|12082300|P3|NOT COMPLETED|Overall Study||5
4909423|NCT04041453|12082301|P2|NOT COMPLETED|Overall Study||22
4909424|NCT04041453|12082302|P1|NOT COMPLETED|Overall Study||14
4909425|NCT04041453|12082299|P4|COMPLETED|Overall Study||40
4909426|NCT04041453|12082300|P3|COMPLETED|Overall Study||18
4909427|NCT04041453|12082301|P2|COMPLETED|Overall Study||35
4909428|NCT04041453|12082302|P1|COMPLETED|Overall Study||24
4909429|NCT04041453|12082299|P4|Safety Population|Overall Study||58
4909430|NCT04041453|12082300|P3|Safety Population|Overall Study||23
4909431|NCT04041453|12082301|P2|Safety Population|Overall Study||56
4909432|NCT04041453|12082302|P1|Safety Population|Overall Study||38
4909433|NCT04041453|12082299|P4|STARTED|Overall Study||58
4909434|NCT04041453|12082300|P3|STARTED|Overall Study||23
4909435|NCT04041453|12082301|P2|STARTED|Overall Study||57
4909436|NCT04041453|12082302|P1|STARTED|Overall Study||38
4909437|NCT04041037|12082316|P1|NOT COMPLETED|Overall Study||0
4909438|NCT04041037|12082316|P1|COMPLETED|Overall Study||2
4909439|NCT04041037|12082316|P1|STARTED|Overall Study||2
4909440|NCT04039867|12082323|P1|NOT COMPLETED|Overall Study||0
4909441|NCT04039867|12082323|P1|COMPLETED|Overall Study||17
4909442|NCT04039867|12082323|P1|STARTED|Overall Study||17
4909443|NCT04039412|12082332|P3|NOT COMPLETED|Overall Study||2
4909444|NCT04039412|12082333|P2|NOT COMPLETED|Overall Study||3
4909445|NCT04039412|12082334|P1|NOT COMPLETED|Overall Study||1
4909446|NCT04039412|12082332|P3|COMPLETED|Overall Study||108
4909447|NCT04039412|12082333|P2|COMPLETED|Overall Study||107
4909448|NCT04039412|12082334|P1|COMPLETED|Overall Study||109
4909449|NCT04039412|12082332|P3|STARTED|Overall Study||110
4909450|NCT04039412|12082333|P2|STARTED|Overall Study||110
4909451|NCT04039412|12082334|P1|STARTED|Overall Study||110
4909452|NCT04036838|12082348|P1|NOT COMPLETED|Overall Study||91
4909453|NCT04036838|12082348|P1|COMPLETED|Overall Study||324
4909454|NCT04036838|12082348|P1|STARTED|Overall Study||415
4909455|NCT04035564|12082354|P2|NOT COMPLETED|Overall Study||6
4909456|NCT04035564|12082355|P1|NOT COMPLETED|Overall Study||4
4909457|NCT04035564|12082354|P2|COMPLETED|Overall Study||19
4909458|NCT04035564|12082355|P1|COMPLETED|Overall Study||23
4909459|NCT04035564|12082354|P2|STARTED|Overall Study||25
4909460|NCT04035564|12082355|P1|STARTED|Overall Study||27
4909461|NCT04034043|12082377|P1|NOT COMPLETED|Overall Study||0
4909462|NCT04034043|12082377|P1|COMPLETED|Overall Study||68
4909463|NCT04034043|12082377|P1|STARTED|Overall Study||68
4909464|NCT04032652|12082386|P2|NOT COMPLETED|Overall Study||1
4909465|NCT04032652|12082387|P1|NOT COMPLETED|Overall Study||1
4909466|NCT04032652|12082386|P2|COMPLETED|Overall Study||0
4909467|NCT04032652|12082387|P1|COMPLETED|Overall Study||0
4909468|NCT04032652|12082386|P2|STARTED|Overall Study||1
4909469|NCT04032652|12082387|P1|STARTED|Overall Study||1
4909470|NCT04027803|12082397|P2|NOT COMPLETED|Overall Study||0
4909471|NCT04027803|12082398|P1|NOT COMPLETED|Overall Study||0
4909472|NCT04027803|12082397|P2|COMPLETED|Overall Study||39
4909473|NCT04027803|12082398|P1|COMPLETED|Overall Study||39
4909474|NCT04027803|12082397|P2|STARTED|Overall Study||39
4909475|NCT04027803|12082398|P1|STARTED|Overall Study||39
4909476|NCT04027218|12082436|P6|NOT COMPLETED|Overall Study||0
4909477|NCT04027218|12082437|P5|NOT COMPLETED|Overall Study||0
4909478|NCT04027218|12082438|P4|NOT COMPLETED|Overall Study||0
4909479|NCT04027218|12082439|P3|NOT COMPLETED|Overall Study||0
4909480|NCT04027218|12082440|P2|NOT COMPLETED|Overall Study||3
4909481|NCT04027218|12082441|P1|NOT COMPLETED|Overall Study||0
4909482|NCT04027218|12082436|P6|COMPLETED|Overall Study||11
4909483|NCT04027218|12082437|P5|COMPLETED|Overall Study||10
4909484|NCT04027218|12082438|P4|COMPLETED|Overall Study||11
4909485|NCT04027218|12082439|P3|COMPLETED|Overall Study||9
4909486|NCT04027218|12082440|P2|COMPLETED|Overall Study||8
4909487|NCT04027218|12082441|P1|COMPLETED|Overall Study||10
4909488|NCT04027218|12082436|P6|STARTED|Overall Study||11
4909489|NCT04027218|12082437|P5|STARTED|Overall Study||10
4909490|NCT04027218|12082438|P4|STARTED|Overall Study||11
4909491|NCT04027218|12082439|P3|STARTED|Overall Study||9
4909492|NCT04027218|12082440|P2|STARTED|Overall Study||11
4909493|NCT04027218|12082441|P1|STARTED|Overall Study||10
4909494|NCT04023695|12082473|P2|NOT COMPLETED|Overall Study||0
4909495|NCT04023695|12082474|P1|NOT COMPLETED|Overall Study||0
4909496|NCT04023695|12082473|P2|COMPLETED|Overall Study||53
4909497|NCT04023695|12082474|P1|COMPLETED|Overall Study||57
4909498|NCT04023695|12082473|P2|STARTED|Overall Study||53
4909499|NCT04023695|12082474|P1|STARTED|Overall Study||57
4909500|NCT04023578|12082482|P1|NOT COMPLETED|Overall Study||2
4909501|NCT04023578|12082482|P1|COMPLETED|Overall Study||13
4909502|NCT04023578|12082482|P1|STARTED|Overall Study||15
4909503|NCT04019990|12082487|P2|NOT COMPLETED|Overall Study||3
4909504|NCT04019990|12082488|P1|NOT COMPLETED|Overall Study||1
4909505|NCT04019990|12082487|P2|COMPLETED|Overall Study||12
4909506|NCT04019990|12082488|P1|COMPLETED|Overall Study||12
4909507|NCT04019990|12082487|P2|STARTED|Overall Study||15
4909508|NCT04019990|12082488|P1|STARTED|Overall Study||13
4909509|NCT04018001|12082497|P2|NOT COMPLETED|Overall Study||0
4909510|NCT04018001|12082498|P1|NOT COMPLETED|Overall Study||0
4909511|NCT04018001|12082497|P2|COMPLETED|Overall Study||379
4909512|NCT04018001|12082498|P1|COMPLETED|Overall Study||678
4909513|NCT04018001|12082497|P2|STARTED|Overall Study||379
4909514|NCT04018001|12082498|P1|STARTED|Overall Study||678
4909515|NCT04015232|12082530|P2|NOT COMPLETED|Overall Study||7
4909516|NCT04015232|12082531|P1|NOT COMPLETED|Overall Study||11
4909517|NCT04015232|12082530|P2|COMPLETED|Overall Study||93
4909518|NCT04015232|12082531|P1|COMPLETED|Overall Study||89
4909519|NCT04015232|12082530|P2|STARTED|Overall Study||100
4909520|NCT04015232|12082531|P1|STARTED|Overall Study||100
4909521|NCT04014062|12082603|P2|NOT COMPLETED|Period II: Crossover Dosing||0
4909522|NCT04014062|12082604|P1|NOT COMPLETED|Period II: Crossover Dosing||0
4909523|NCT04014062|12082603|P2|COMPLETED|Period II: Crossover Dosing||65
4909524|NCT04014062|12082604|P1|COMPLETED|Period II: Crossover Dosing||64
4909525|NCT04014062|12082603|P2|STARTED|Period II: Crossover Dosing||65
4909526|NCT04014062|12082604|P1|STARTED|Period II: Crossover Dosing||64
4909527|NCT04014062|12082603|P2|NOT COMPLETED|Period I: Dosing||6
4909528|NCT04014062|12082604|P1|NOT COMPLETED|Period I: Dosing||7
4909529|NCT04014062|12082603|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
4909530|NCT04014062|12082604|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
4909531|NCT04014062|12082603|P2|STARTED|Period I: Dosing||71
4909532|NCT04014062|12082604|P1|STARTED|Period I: Dosing||71
4909533|NCT04012970|12082644|P2|NOT COMPLETED|Control Session, 30 Minutes||0
4909534|NCT04012970|12082645|P1|NOT COMPLETED|Control Session, 30 Minutes||0
4909535|NCT04012970|12082644|P2|COMPLETED|Control Session, 30 Minutes||14
4909536|NCT04012970|12082645|P1|COMPLETED|Control Session, 30 Minutes||26
4909537|NCT04012970|12082644|P2|STARTED|Control Session, 30 Minutes||14
4909538|NCT04012970|12082645|P1|STARTED|Control Session, 30 Minutes||26
4909539|NCT04012970|12082644|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
4909540|NCT04012970|12082645|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
4909541|NCT04012970|12082644|P2|COMPLETED|Intervention Session, 30 Minutes||14
4909542|NCT04012970|12082645|P1|COMPLETED|Intervention Session, 30 Minutes||26
4909543|NCT04012970|12082644|P2|STARTED|Intervention Session, 30 Minutes||14
4909544|NCT04012970|12082645|P1|STARTED|Intervention Session, 30 Minutes||26
4909545|NCT04006366|12082657|P1|NOT COMPLETED|Overall Study||1
4909546|NCT04006366|12082657|P1|COMPLETED|Overall Study||5
4909547|NCT04006366|12082657|P1|STARTED|Overall Study||6
4909548|NCT04002648|12082665|P2|NOT COMPLETED|Overall Study||0
4909549|NCT04002648|12082666|P1|NOT COMPLETED|Overall Study||2
4909550|NCT04002648|12082665|P2|COMPLETED|Overall Study||104
4909551|NCT04002648|12082666|P1|COMPLETED|Overall Study||102
4909552|NCT04002648|12082665|P2|STARTED|Overall Study||104
4909553|NCT04002648|12082666|P1|STARTED|Overall Study||104
4909554|NCT04000815|12082677|P3|NOT COMPLETED|Overall Study||7
4909555|NCT04000815|12082678|P2|NOT COMPLETED|Overall Study||5
4909556|NCT04000815|12082679|P1|NOT COMPLETED|Overall Study||14
4909557|NCT04000815|12082677|P3|COMPLETED|Overall Study||15
4909558|NCT04000815|12082678|P2|COMPLETED|Overall Study||15
4909559|NCT04000815|12082679|P1|COMPLETED|Overall Study||15
4909560|NCT04000815|12082677|P3|STARTED|Overall Study||22
4909561|NCT04000815|12082678|P2|STARTED|Overall Study||20
4909562|NCT04000815|12082679|P1|STARTED|Overall Study||29
4909563|NCT04000373|12082693|P1|NOT COMPLETED|Overall Study||0
4909564|NCT04000373|12082693|P1|COMPLETED|Overall Study||5
4909565|NCT04000373|12082693|P1|STARTED|Overall Study||5
4909566|NCT03995680|12082701|P2|NOT COMPLETED|Overall Study||2
4909567|NCT03995680|12082702|P1|NOT COMPLETED|Overall Study||2
4909568|NCT03995680|12082701|P2|COMPLETED|Overall Study||196
4909569|NCT03995680|12082702|P1|COMPLETED|Overall Study||197
4909570|NCT03995680|12082701|P2|STARTED|Overall Study||198
4909571|NCT03995680|12082702|P1|STARTED|Overall Study||199
4909572|NCT03992482|12082726|P2|NOT COMPLETED|Overall Study||0
4909573|NCT03992482|12082727|P1|NOT COMPLETED|Overall Study||0
4909574|NCT03992482|12082726|P2|COMPLETED|Overall Study||14
4909575|NCT03992482|12082727|P1|COMPLETED|Overall Study||13
4909576|NCT03992482|12082726|P2|STARTED|Overall Study||14
4909577|NCT03992482|12082727|P1|STARTED|Overall Study||13
4909578|NCT03992014|12082737|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
4909579|NCT03992014|12082737|P1|COMPLETED|Treatment Period 2 (8 Days)||6
4909580|NCT03992014|12082737|P1|STARTED|Treatment Period 2 (8 Days)||6
4909581|NCT03992014|12082737|P1|NOT COMPLETED|Washout Period (7 Days)||0
4909582|NCT03992014|12082737|P1|COMPLETED|Washout Period (7 Days)||6
4909583|NCT03992014|12082737|P1|STARTED|Washout Period (7 Days)||6
4909584|NCT03992014|12082737|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
4909585|NCT03992014|12082737|P1|COMPLETED|Treatment Period 1 (8 Days)||6
4909586|NCT03992014|12082737|P1|STARTED|Treatment Period 1 (8 Days)||6
4909587|NCT03991715|12082796|P1|NOT COMPLETED|Overall Study||0
4909588|NCT03991715|12082796|P1|COMPLETED|Overall Study||5
4909589|NCT03991715|12082796|P1|STARTED|Overall Study||5
4909590|NCT03989570|12082808|P3|NOT COMPLETED|Overall Study||0
4909591|NCT03989570|12082809|P2|NOT COMPLETED|Overall Study||0
4909592|NCT03989570|12082810|P1|NOT COMPLETED|Overall Study||0
4909593|NCT03989570|12082808|P3|COMPLETED|Overall Study||31
4909594|NCT03989570|12082809|P2|COMPLETED|Overall Study||31
4909595|NCT03989570|12082810|P1|COMPLETED|Overall Study||31
4909596|NCT03989570|12082808|P3|STARTED|Overall Study||31
4909597|NCT03989570|12082809|P2|STARTED|Overall Study||31
4909598|NCT03989570|12082810|P1|STARTED|Overall Study||31
4909599|NCT03989427|12082826|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
4909600|NCT03989427|12082827|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4909601|NCT03989427|12082826|P2|COMPLETED|Second Intervention (2 Weeks)||15
4909602|NCT03989427|12082827|P1|COMPLETED|Second Intervention (2 Weeks)||15
4909603|NCT03989427|12082826|P2|STARTED|Second Intervention (2 Weeks)||15
4909604|NCT03989427|12082827|P1|STARTED|Second Intervention (2 Weeks)||15
4909605|NCT03989427|12082826|P2|NOT COMPLETED|Washout (1 Week)||0
4909606|NCT03989427|12082827|P1|NOT COMPLETED|Washout (1 Week)||0
4909607|NCT03989427|12082826|P2|COMPLETED|Washout (1 Week)||15
4909608|NCT03989427|12082827|P1|COMPLETED|Washout (1 Week)||15
4909609|NCT03989427|12082826|P2|STARTED|Washout (1 Week)||15
4909610|NCT03989427|12082827|P1|STARTED|Washout (1 Week)||15
4909611|NCT03989427|12082826|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
4909612|NCT03989427|12082827|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
4909613|NCT03989427|12082826|P2|COMPLETED|First Intervention (2 Weeks)||15
4909614|NCT03989427|12082827|P1|COMPLETED|First Intervention (2 Weeks)||15
4909615|NCT03989427|12082826|P2|STARTED|First Intervention (2 Weeks)||15
4909616|NCT03989427|12082827|P1|STARTED|First Intervention (2 Weeks)||15
4909617|NCT03988426|12082834|P1|NOT COMPLETED|Overall Study||1
4909618|NCT03988426|12082834|P1|COMPLETED|Overall Study||24
4909619|NCT03988426|12082834|P1|STARTED|Overall Study||25
4909620|NCT03984838|12082856|P1|NOT COMPLETED|Overall Study||0
4909621|NCT03984838|12082856|P1|COMPLETED|Overall Study||16
4909622|NCT03984838|12082856|P1|STARTED|Overall Study||16
4909623|NCT03982433|12082916|P1|NOT COMPLETED|Overall Study||1
4909624|NCT03982433|12082916|P1|COMPLETED|Overall Study||7
4909625|NCT03982433|12082916|P1|STARTED|Overall Study||8
4909626|NCT03979807|12082929|P2|NOT COMPLETED|Overall Study||0
4909627|NCT03979807|12082930|P1|NOT COMPLETED|Overall Study||0
4909628|NCT03979807|12082929|P2|COMPLETED|Overall Study||7420
4909629|NCT03979807|12082930|P1|COMPLETED|Overall Study||3876
4909630|NCT03979807|12082929|P2|STARTED|Overall Study||7420
4909631|NCT03979807|12082930|P1|STARTED|Overall Study||3876
4909632|NCT03975790|12082939|P3|NOT COMPLETED|Overall Study||0
4909633|NCT03975790|12082940|P2|NOT COMPLETED|Overall Study||0
4909634|NCT03975790|12082941|P1|NOT COMPLETED|Overall Study||0
4909635|NCT03975790|12082939|P3|COMPLETED|Overall Study||48
4909636|NCT03975790|12082940|P2|COMPLETED|Overall Study||94
4909637|NCT03975790|12082941|P1|COMPLETED|Overall Study||337
4909638|NCT03975790|12082939|P3|STARTED|Overall Study||48
4909639|NCT03975790|12082940|P2|STARTED|Overall Study||94
4909640|NCT03975790|12082941|P1|STARTED|Overall Study||337
4909641|NCT03973905|12083156|P2|NOT COMPLETED|Overall Study||0
4909642|NCT03973905|12083157|P1|NOT COMPLETED|Overall Study||0
4909643|NCT03973905|12083156|P2|COMPLETED|Overall Study||183
4909644|NCT03973905|12083157|P1|COMPLETED|Overall Study||107
4909645|NCT03973905|12083156|P2|STARTED|Overall Study||183
4909646|NCT03973905|12083157|P1|STARTED|Overall Study||107
4909647|NCT03972813|12083187|P18|NOT COMPLETED|Overall Study||2
4909648|NCT03972813|12083188|P17|NOT COMPLETED|Overall Study||3
4909649|NCT03972813|12083189|P16|NOT COMPLETED|Overall Study||6
4909650|NCT03972813|12083190|P15|NOT COMPLETED|Overall Study||2
4909651|NCT03972813|12083191|P14|NOT COMPLETED|Overall Study||3
4909652|NCT03972813|12083192|P13|NOT COMPLETED|Overall Study||3
4909653|NCT03972813|12083193|P12|NOT COMPLETED|Overall Study||4
4909654|NCT03972813|12083194|P11|NOT COMPLETED|Overall Study||5
4909655|NCT03972813|12083195|P10|NOT COMPLETED|Overall Study||2
4909656|NCT03972813|12083196|P9|NOT COMPLETED|Overall Study||5
4909657|NCT03972813|12083197|P8|NOT COMPLETED|Overall Study||3
4909658|NCT03972813|12083198|P7|NOT COMPLETED|Overall Study||4
4909659|NCT03972813|12083199|P6|NOT COMPLETED|Overall Study||2
4909660|NCT03972813|12083200|P5|NOT COMPLETED|Overall Study||4
4909661|NCT03972813|12083201|P4|NOT COMPLETED|Overall Study||4
4909662|NCT03972813|12083202|P3|NOT COMPLETED|Overall Study||6
4909663|NCT03972813|12083203|P2|NOT COMPLETED|Overall Study||4
4909664|NCT03972813|12083204|P1|NOT COMPLETED|Overall Study||6
4909665|NCT03972813|12083187|P18|COMPLETED|Overall Study||48
4909666|NCT03972813|12083188|P17|COMPLETED|Overall Study||48
4909667|NCT03972813|12083189|P16|COMPLETED|Overall Study||50
4909668|NCT03972813|12083190|P15|COMPLETED|Overall Study||56
4909669|NCT03972813|12083191|P14|COMPLETED|Overall Study||52
4909670|NCT03972813|12083192|P13|COMPLETED|Overall Study||55
4909671|NCT03972813|12083193|P12|COMPLETED|Overall Study||51
4909672|NCT03972813|12083194|P11|COMPLETED|Overall Study||57
4909673|NCT03972813|12083195|P10|COMPLETED|Overall Study||58
4909674|NCT03972813|12083196|P9|COMPLETED|Overall Study||53
4909675|NCT03972813|12083197|P8|COMPLETED|Overall Study||52
4909676|NCT03972813|12083198|P7|COMPLETED|Overall Study||49
4909677|NCT03972813|12083199|P6|COMPLETED|Overall Study||49
4909678|NCT03972813|12083200|P5|COMPLETED|Overall Study||48
4909679|NCT03972813|12083201|P4|COMPLETED|Overall Study||51
4909680|NCT03972813|12083202|P3|COMPLETED|Overall Study||52
4909681|NCT03972813|12083203|P2|COMPLETED|Overall Study||45
4909682|NCT03972813|12083204|P1|COMPLETED|Overall Study||79
4909683|NCT03972813|12083187|P18|STARTED|Overall Study||50
4909684|NCT03972813|12083188|P17|STARTED|Overall Study||51
4909685|NCT03972813|12083189|P16|STARTED|Overall Study||56
4909686|NCT03972813|12083190|P15|STARTED|Overall Study||58
4909687|NCT03972813|12083191|P14|STARTED|Overall Study||55
4909688|NCT03972813|12083192|P13|STARTED|Overall Study||58
4909689|NCT03972813|12083193|P12|STARTED|Overall Study||55
4909690|NCT03972813|12083194|P11|STARTED|Overall Study||62
4909691|NCT03972813|12083195|P10|STARTED|Overall Study||60
4909692|NCT03972813|12083196|P9|STARTED|Overall Study||58
4909693|NCT03972813|12083197|P8|STARTED|Overall Study||55
4909694|NCT03972813|12083198|P7|STARTED|Overall Study||53
4909695|NCT03972813|12083199|P6|STARTED|Overall Study||51
4909696|NCT03972813|12083200|P5|STARTED|Overall Study||52
4909697|NCT03972813|12083201|P4|STARTED|Overall Study||55
4909698|NCT03972813|12083202|P3|STARTED|Overall Study||58
4909699|NCT03972813|12083203|P2|STARTED|Overall Study||49
4909700|NCT03972813|12083204|P1|STARTED|Overall Study||85
4909701|NCT03966365|12083244|P2|NOT COMPLETED|Overall Study||0
4909702|NCT03966365|12083245|P1|NOT COMPLETED|Overall Study||1
4909703|NCT03966365|12083244|P2|COMPLETED|Overall Study||12
4909704|NCT03966365|12083245|P1|COMPLETED|Overall Study||11
4909705|NCT03966365|12083244|P2|STARTED|Overall Study||12
4909706|NCT03966365|12083245|P1|STARTED|Overall Study||12
4909707|NCT03965403|12083263|P1|NOT COMPLETED|Overall Study||1
4909708|NCT03965403|12083263|P1|COMPLETED|Overall Study||6
4909709|NCT03965403|12083263|P1|STARTED|Overall Study||7
4909710|NCT03965052|12083276|P2|NOT COMPLETED|Overall Study||0
4909711|NCT03965052|12083277|P1|NOT COMPLETED|Overall Study||1
4909712|NCT03965052|12083276|P2|COMPLETED|Overall Study||12
4909713|NCT03965052|12083277|P1|COMPLETED|Overall Study||11
4909714|NCT03965052|12083276|P2|STARTED|Overall Study||12
4909715|NCT03965052|12083277|P1|STARTED|Overall Study||12
4909716|NCT03961308|12083297|P2|NOT COMPLETED|Overall Study||2
4909717|NCT03961308|12083298|P1|NOT COMPLETED|Overall Study||2
4909718|NCT03961308|12083297|P2|COMPLETED|Overall Study||100
4909719|NCT03961308|12083298|P1|COMPLETED|Overall Study||100
4909720|NCT03961308|12083297|P2|STARTED|Overall Study||102
4909721|NCT03961308|12083298|P1|STARTED|Overall Study||102
4909722|NCT03961295|12083310|P2|NOT COMPLETED|Overall Study||0
4909723|NCT03961295|12083311|P1|NOT COMPLETED|Overall Study||0
4909724|NCT03961295|12083310|P2|COMPLETED|Overall Study||12
4909725|NCT03961295|12083311|P1|COMPLETED|Overall Study||12
4909726|NCT03961295|12083310|P2|STARTED|Overall Study||12
4909727|NCT03961295|12083311|P1|STARTED|Overall Study||12
4909728|NCT03959332|12083323|P2|NOT COMPLETED|Overall Study||0
4909729|NCT03959332|12083324|P1|NOT COMPLETED|Overall Study||0
4909730|NCT03959332|12083323|P2|COMPLETED|Overall Study||16
4909731|NCT03959332|12083324|P1|COMPLETED|Overall Study||16
4909732|NCT03959332|12083323|P2|STARTED|Overall Study||16
4909733|NCT03959332|12083324|P1|STARTED|Overall Study||16
4909734|NCT03954158|12083352|P4|NOT COMPLETED|Overall Study||0
4909735|NCT03954158|12083353|P3|NOT COMPLETED|Overall Study||0
4909736|NCT03954158|12083354|P2|NOT COMPLETED|Overall Study||0
4909737|NCT03954158|12083355|P1|NOT COMPLETED|Overall Study||0
4909738|NCT03954158|12083352|P4|COMPLETED|Overall Study||20
4909739|NCT03954158|12083353|P3|COMPLETED|Overall Study||20
4909740|NCT03954158|12083354|P2|COMPLETED|Overall Study||21
4909741|NCT03954158|12083355|P1|COMPLETED|Overall Study||20
4909742|NCT03954158|12083352|P4|STARTED|Overall Study||20
4909743|NCT03954158|12083353|P3|STARTED|Overall Study||20
4909744|NCT03954158|12083354|P2|STARTED|Overall Study||21
4909745|NCT03954158|12083355|P1|STARTED|Overall Study||20
4909746|NCT03951610|12083417|P2|NOT COMPLETED|Second Intervention||0
4909747|NCT03951610|12083418|P1|NOT COMPLETED|Second Intervention||0
4909748|NCT03951610|12083417|P2|COMPLETED|Second Intervention||25
4909749|NCT03951610|12083418|P1|COMPLETED|Second Intervention||27
4909750|NCT03951610|12083417|P2|STARTED|Second Intervention||25
4909751|NCT03951610|12083418|P1|STARTED|Second Intervention||27
4909752|NCT03951610|12083417|P2|NOT COMPLETED|First Intervention||0
4909753|NCT03951610|12083418|P1|NOT COMPLETED|First Intervention||0
4909754|NCT03951610|12083417|P2|COMPLETED|First Intervention||25
4909755|NCT03951610|12083418|P1|COMPLETED|First Intervention||27
4909756|NCT03951610|12083417|P2|STARTED|First Intervention||25
4909757|NCT03951610|12083418|P1|STARTED|First Intervention||27
4909758|NCT03950674|12083456|P2|NOT COMPLETED|Overall Study||15
4909759|NCT03950674|12083457|P1|NOT COMPLETED|Overall Study||25
4909760|NCT03950674|12083456|P2|COMPLETED|Overall Study||0
4909761|NCT03950674|12083457|P1|COMPLETED|Overall Study||0
4909762|NCT03950674|12083456|P2|Switched to Pembrolizumab|Overall Study||4
4909763|NCT03950674|12083457|P1|Switched to Pembrolizumab|Overall Study||0
4909764|NCT03950674|12083456|P2|Treated|Overall Study||15
4909765|NCT03950674|12083457|P1|Treated|Overall Study||25
4909766|NCT03950674|12083456|P2|STARTED|Overall Study||15
4909767|NCT03950674|12083457|P1|STARTED|Overall Study||25
4909768|NCT03949621|12083478|P2|NOT COMPLETED|Overall Study||0
4909769|NCT03949621|12083479|P1|NOT COMPLETED|Overall Study||0
4909770|NCT03949621|12083478|P2|COMPLETED|Overall Study||12
4909771|NCT03949621|12083479|P1|COMPLETED|Overall Study||12
4909772|NCT03949621|12083478|P2|STARTED|Overall Study||12
4909773|NCT03949621|12083479|P1|STARTED|Overall Study||12
4909774|NCT03948581|12083491|P2|NOT COMPLETED|Overall Study||1
4909775|NCT03948581|12083492|P1|NOT COMPLETED|Overall Study||0
4909776|NCT03948581|12083491|P2|COMPLETED|Overall Study||50
4909777|NCT03948581|12083492|P1|COMPLETED|Overall Study||51
4909778|NCT03948581|12083491|P2|STARTED|Overall Study||51
4909779|NCT03948581|12083492|P1|STARTED|Overall Study||51
4909780|NCT03946124|12083502|P1|NOT COMPLETED|Overall Study||19
4909781|NCT03946124|12083502|P1|COMPLETED|Overall Study||55
4909782|NCT03946124|12083502|P1|STARTED|Overall Study||74
4909783|NCT03933618|12083512|P6|NOT COMPLETED|Week 16 to Week 24||0
4909784|NCT03933618|12083513|P5|NOT COMPLETED|Week 16 to Week 24||0
4909785|NCT03933618|12083514|P4|NOT COMPLETED|Week 16 to Week 24||0
4909786|NCT03933618|12083515|P3|NOT COMPLETED|Week 16 to Week 24||0
4909787|NCT03933618|12083516|P2|NOT COMPLETED|Week 16 to Week 24||0
4909788|NCT03933618|12083517|P1|NOT COMPLETED|Week 16 to Week 24||0
4909789|NCT03933618|12083512|P6|COMPLETED|Week 16 to Week 24||4
4909790|NCT03933618|12083513|P5|COMPLETED|Week 16 to Week 24||4
4909791|NCT03933618|12083514|P4|COMPLETED|Week 16 to Week 24||4
4909792|NCT03933618|12083515|P3|COMPLETED|Week 16 to Week 24||4
4909793|NCT03933618|12083516|P2|COMPLETED|Week 16 to Week 24||4
4909794|NCT03933618|12083517|P1|COMPLETED|Week 16 to Week 24||4
4909795|NCT03933618|12083512|P6|STARTED|Week 16 to Week 24||4
4909796|NCT03933618|12083513|P5|STARTED|Week 16 to Week 24||4
4909797|NCT03933618|12083514|P4|STARTED|Week 16 to Week 24||4
4909798|NCT03933618|12083515|P3|STARTED|Week 16 to Week 24||4
4909799|NCT03933618|12083516|P2|STARTED|Week 16 to Week 24||4
4909800|NCT03933618|12083517|P1|STARTED|Week 16 to Week 24||4
4909801|NCT03933618|12083512|P6|NOT COMPLETED|Week 8 to Week 16||0
4909802|NCT03933618|12083513|P5|NOT COMPLETED|Week 8 to Week 16||0
4909803|NCT03933618|12083514|P4|NOT COMPLETED|Week 8 to Week 16||0
4909804|NCT03933618|12083515|P3|NOT COMPLETED|Week 8 to Week 16||0
4909805|NCT03933618|12083516|P2|NOT COMPLETED|Week 8 to Week 16||0
4909806|NCT03933618|12083517|P1|NOT COMPLETED|Week 8 to Week 16||0
4909807|NCT03933618|12083512|P6|COMPLETED|Week 8 to Week 16||4
4909808|NCT03933618|12083513|P5|COMPLETED|Week 8 to Week 16||4
4909809|NCT03933618|12083514|P4|COMPLETED|Week 8 to Week 16||4
4909810|NCT03933618|12083515|P3|COMPLETED|Week 8 to Week 16||4
4909811|NCT03933618|12083516|P2|COMPLETED|Week 8 to Week 16||4
4909812|NCT03933618|12083517|P1|COMPLETED|Week 8 to Week 16||4
4909813|NCT03933618|12083512|P6|STARTED|Week 8 to Week 16||4
4909814|NCT03933618|12083513|P5|STARTED|Week 8 to Week 16||4
4909815|NCT03933618|12083514|P4|STARTED|Week 8 to Week 16||4
4909816|NCT03933618|12083515|P3|STARTED|Week 8 to Week 16||4
4909817|NCT03933618|12083516|P2|STARTED|Week 8 to Week 16||4
4909818|NCT03933618|12083517|P1|STARTED|Week 8 to Week 16||4
4909819|NCT03933618|12083512|P6|NOT COMPLETED|Baseline to Week 8||0
4909820|NCT03933618|12083513|P5|NOT COMPLETED|Baseline to Week 8||0
4909821|NCT03933618|12083514|P4|NOT COMPLETED|Baseline to Week 8||0
4909822|NCT03933618|12083515|P3|NOT COMPLETED|Baseline to Week 8||0
4909823|NCT03933618|12083516|P2|NOT COMPLETED|Baseline to Week 8||0
4909824|NCT03933618|12083517|P1|NOT COMPLETED|Baseline to Week 8||0
4909825|NCT03933618|12083512|P6|COMPLETED|Baseline to Week 8||4
4909826|NCT03933618|12083513|P5|COMPLETED|Baseline to Week 8||4
4909827|NCT03933618|12083514|P4|COMPLETED|Baseline to Week 8||4
4909828|NCT03933618|12083515|P3|COMPLETED|Baseline to Week 8||4
4909829|NCT03933618|12083516|P2|COMPLETED|Baseline to Week 8||4
4909830|NCT03933618|12083517|P1|COMPLETED|Baseline to Week 8||4
4909831|NCT03933618|12083512|P6|STARTED|Baseline to Week 8||4
4909832|NCT03933618|12083513|P5|STARTED|Baseline to Week 8||4
4909833|NCT03933618|12083514|P4|STARTED|Baseline to Week 8||4
4909834|NCT03933618|12083515|P3|STARTED|Baseline to Week 8||4
4909835|NCT03933618|12083516|P2|STARTED|Baseline to Week 8||4
4909836|NCT03933618|12083517|P1|STARTED|Baseline to Week 8||4
4909837|NCT03933618|12083512|P6|NOT COMPLETED|Baseline||0
4909838|NCT03933618|12083513|P5|NOT COMPLETED|Baseline||0
4909839|NCT03933618|12083514|P4|NOT COMPLETED|Baseline||0
4909840|NCT03933618|12083515|P3|NOT COMPLETED|Baseline||0
4909841|NCT03933618|12083516|P2|NOT COMPLETED|Baseline||0
4909842|NCT03933618|12083517|P1|NOT COMPLETED|Baseline||0
4909843|NCT03933618|12083512|P6|COMPLETED|Baseline||4
4909844|NCT03933618|12083513|P5|COMPLETED|Baseline||4
4909845|NCT03933618|12083514|P4|COMPLETED|Baseline||4
4909846|NCT03933618|12083515|P3|COMPLETED|Baseline||4
4909847|NCT03933618|12083516|P2|COMPLETED|Baseline||4
4909848|NCT03933618|12083517|P1|COMPLETED|Baseline||4
4909849|NCT03933618|12083512|P6|STARTED|Baseline||4
4909850|NCT03933618|12083513|P5|STARTED|Baseline||4
4909851|NCT03933618|12083514|P4|STARTED|Baseline||4
4909852|NCT03933618|12083515|P3|STARTED|Baseline||4
4909853|NCT03933618|12083516|P2|STARTED|Baseline||4
4909854|NCT03933618|12083517|P1|STARTED|Baseline||4
4909855|NCT03933449|12083767|P2|NOT COMPLETED|Overall Study||61
4909856|NCT03933449|12083768|P1|NOT COMPLETED|Overall Study||62
4909857|NCT03933449|12083767|P2|COMPLETED|Overall Study||0
4909858|NCT03933449|12083768|P1|COMPLETED|Overall Study||0
4909859|NCT03933449|12083767|P2|Treated|Overall Study||59
4909860|NCT03933449|12083768|P1|Treated|Overall Study||62
4909861|NCT03933449|12083767|P2|STARTED|Overall Study||61
4909862|NCT03933449|12083768|P1|STARTED|Overall Study||62
4909863|NCT03927950|12083790|P1|NOT COMPLETED|Overall Study||9
4909864|NCT03927950|12083790|P1|COMPLETED|Overall Study||126
4909865|NCT03927950|12083790|P1|STARTED|Overall Study||135
4909866|NCT03923933|12083797|P2|NOT COMPLETED|Overall Study||1
4909867|NCT03923933|12083798|P1|NOT COMPLETED|Overall Study||1
4909868|NCT03923933|12083797|P2|COMPLETED|Overall Study||16
4909869|NCT03923933|12083798|P1|COMPLETED|Overall Study||16
4909870|NCT03923933|12083797|P2|STARTED|Overall Study||17
4909871|NCT03923933|12083798|P1|STARTED|Overall Study||17
4909872|NCT03923530|12083816|P1|NOT COMPLETED|Overall Study||4
4909873|NCT03923530|12083816|P1|COMPLETED|Overall Study||8
4909874|NCT03923530|12083816|P1|STARTED|Overall Study||12
4909875|NCT03921723|12083826|P1|NOT COMPLETED|Period 3 (4 Days)||1
4909876|NCT03921723|12083826|P1|COMPLETED|Period 3 (4 Days)||18
4909877|NCT03921723|12083826|P1|STARTED|Period 3 (4 Days)||19
4909878|NCT03921723|12083826|P1|NOT COMPLETED|Period 2 (4 Days)||3
4909879|NCT03921723|12083826|P1|COMPLETED|Period 2 (4 Days)||19
4909880|NCT03921723|12083826|P1|STARTED|Period 2 (4 Days)||22
4909881|NCT03921723|12083826|P1|NOT COMPLETED|Period 1 (4 Days)||0
4909882|NCT03921723|12083826|P1|COMPLETED|Period 1 (4 Days)||22
4909883|NCT03921723|12083826|P1|STARTED|Period 1 (4 Days)||22
4909884|NCT03914950|12083894|P1|NOT COMPLETED|Overall Study||54
4909885|NCT03914950|12083894|P1|COMPLETED|Overall Study||120
4909886|NCT03914950|12083894|P1|STARTED|Overall Study||174
4909887|NCT03911752|12083907|P3|NOT COMPLETED|Overall Study||0
4909888|NCT03911752|12083908|P2|NOT COMPLETED|Overall Study||0
4909889|NCT03911752|12083909|P1|NOT COMPLETED|Overall Study||0
4909890|NCT03911752|12083907|P3|COMPLETED|Overall Study||2
4909891|NCT03911752|12083908|P2|COMPLETED|Overall Study||2
4909892|NCT03911752|12083909|P1|COMPLETED|Overall Study||8
4909893|NCT03911752|12083907|P3|STARTED|Overall Study||2
4909894|NCT03911752|12083908|P2|STARTED|Overall Study||2
4909895|NCT03911752|12083909|P1|STARTED|Overall Study||8
4909896|NCT03909009|12083928|P2|NOT COMPLETED|Overall Study||0
4909897|NCT03909009|12083929|P1|NOT COMPLETED|Overall Study||0
4909898|NCT03909009|12083928|P2|COMPLETED|Overall Study||10
4909899|NCT03909009|12083929|P1|COMPLETED|Overall Study||10
4909900|NCT03909009|12083928|P2|STARTED|Overall Study||10
4909901|NCT03909009|12083929|P1|STARTED|Overall Study||10
4909902|NCT03905642|12083949|P1|NOT COMPLETED|Overall Study||8
4909903|NCT03905642|12083949|P1|COMPLETED|Overall Study||41
4909904|NCT03905642|12083949|P1|STARTED|Overall Study||49
4909905|NCT03902392|12083960|P2|NOT COMPLETED|Overall Study||7
4909906|NCT03902392|12083961|P1|NOT COMPLETED|Overall Study||7
4909907|NCT03902392|12083960|P2|COMPLETED|Overall Study||18
4909908|NCT03902392|12083961|P1|COMPLETED|Overall Study||18
4909909|NCT03902392|12083960|P2|STARTED|Overall Study||25
4909910|NCT03902392|12083961|P1|STARTED|Overall Study||25
4909911|NCT03901313|12083969|P6|NOT COMPLETED|Overall Study||0
4909912|NCT03901313|12083970|P5|NOT COMPLETED|Overall Study||0
4909913|NCT03901313|12083971|P4|NOT COMPLETED|Overall Study||0
4909914|NCT03901313|12083972|P3|NOT COMPLETED|Overall Study||0
4909915|NCT03901313|12083973|P2|NOT COMPLETED|Overall Study||0
4909916|NCT03901313|12083974|P1|NOT COMPLETED|Overall Study||0
4909917|NCT03901313|12083969|P6|COMPLETED|Overall Study||4
4909918|NCT03901313|12083970|P5|COMPLETED|Overall Study||4
4909919|NCT03901313|12083971|P4|COMPLETED|Overall Study||4
4909920|NCT03901313|12083972|P3|COMPLETED|Overall Study||4
4909921|NCT03901313|12083973|P2|COMPLETED|Overall Study||4
4909922|NCT03901313|12083974|P1|COMPLETED|Overall Study||4
4909923|NCT03901313|12083969|P6|STARTED|Overall Study||4
4909924|NCT03901313|12083970|P5|STARTED|Overall Study||4
4909925|NCT03901313|12083971|P4|STARTED|Overall Study||4
4909926|NCT03901313|12083972|P3|STARTED|Overall Study||4
4909927|NCT03901313|12083973|P2|STARTED|Overall Study||4
4909928|NCT03901313|12083974|P1|STARTED|Overall Study||4
4909929|NCT03900299|12083993|P2|NOT COMPLETED|Overall Study||0
4909930|NCT03900299|12083994|P1|NOT COMPLETED|Overall Study||0
4909931|NCT03900299|12083993|P2|COMPLETED|Overall Study||58
4909932|NCT03900299|12083994|P1|COMPLETED|Overall Study||56
4909933|NCT03900299|12083993|P2|STARTED|Overall Study||58
4909934|NCT03900299|12083994|P1|STARTED|Overall Study||56
4909935|NCT03899064|12084001|P1|NOT COMPLETED|Overall Study||7
4909936|NCT03899064|12084001|P1|COMPLETED|Overall Study||51
4909937|NCT03899064|12084001|P1|Control, Irradiation|Overall Study||58
4909938|NCT03899064|12084001|P1|MC2-01 Vehicle, no Irradiation|Overall Study||58
4909939|NCT03899064|12084001|P1|MC2-01 Vehicle, Irradiation|Overall Study||58
4909940|NCT03899064|12084001|P1|MC2-01 Cream, No Irradiation|Overall Study||58
4909941|NCT03899064|12084001|P1|MC2-01 Cream, Irradiation|Overall Study||58
4909942|NCT03899064|12084001|P1|STARTED|Overall Study||58
4909943|NCT03898349|12084009|P2|NOT COMPLETED|Overall Study||610
4909944|NCT03898349|12084010|P1|NOT COMPLETED|Overall Study||110
4909945|NCT03898349|12084009|P2|COMPLETED|Overall Study||15
4909946|NCT03898349|12084010|P1|COMPLETED|Overall Study||15
4909947|NCT03898349|12084009|P2|STARTED|Overall Study||625
4909948|NCT03898349|12084010|P1|STARTED|Overall Study||125
4909949|NCT03897179|12084016|P1|NOT COMPLETED|Overall Study||1
4909950|NCT03897179|12084016|P1|COMPLETED|Overall Study||26
4909951|NCT03897179|12084016|P1|STARTED|Overall Study||27
4909952|NCT03895307|12084024|P4|NOT COMPLETED|Overall Study||0
4909953|NCT03895307|12084025|P3|NOT COMPLETED|Overall Study||2
4909954|NCT03895307|12084026|P2|NOT COMPLETED|Overall Study||0
4909955|NCT03895307|12084027|P1|NOT COMPLETED|Overall Study||2
4909956|NCT03895307|12084024|P4|COMPLETED|Overall Study||21
4909957|NCT03895307|12084025|P3|COMPLETED|Overall Study||20
4909958|NCT03895307|12084026|P2|COMPLETED|Overall Study||20
4909959|NCT03895307|12084027|P1|COMPLETED|Overall Study||19
4909960|NCT03895307|12084024|P4|STARTED|Overall Study||21
4909961|NCT03895307|12084025|P3|STARTED|Overall Study||22
4909962|NCT03895307|12084026|P2|STARTED|Overall Study||20
4909963|NCT03895307|12084027|P1|STARTED|Overall Study||21
4909964|NCT03894449|12084118|P5|NOT COMPLETED|Overall Study||0
4909965|NCT03894449|12084119|P4|NOT COMPLETED|Overall Study||0
4909966|NCT03894449|12084120|P3|NOT COMPLETED|Overall Study||0
4909967|NCT03894449|12084121|P2|NOT COMPLETED|Overall Study||0
4909968|NCT03894449|12084122|P1|NOT COMPLETED|Overall Study||0
4909969|NCT03894449|12084118|P5|COMPLETED|Overall Study||15
4909970|NCT03894449|12084119|P4|COMPLETED|Overall Study||15
4909971|NCT03894449|12084120|P3|COMPLETED|Overall Study||15
4909972|NCT03894449|12084121|P2|COMPLETED|Overall Study||15
4909973|NCT03894449|12084122|P1|COMPLETED|Overall Study||15
4909974|NCT03894449|12084118|P5|STARTED|Overall Study||15
4909975|NCT03894449|12084119|P4|STARTED|Overall Study||15
4909976|NCT03894449|12084120|P3|STARTED|Overall Study||15
4909977|NCT03894449|12084121|P2|STARTED|Overall Study||15
4909978|NCT03894449|12084122|P1|STARTED|Overall Study||15
4909979|NCT03892564|12084234|P1|NOT COMPLETED|Overall Study||2
4909980|NCT03892564|12084234|P1|COMPLETED|Overall Study||33
4909981|NCT03892564|12084234|P1|Control Site|Overall Study||35
4909982|NCT03892564|12084234|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
4909983|NCT03892564|12084234|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
4909984|NCT03892564|12084234|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
4909985|NCT03892564|12084234|P1|MC2-01 Cream + Irridiation|Overall Study||35
4909986|NCT03892564|12084234|P1|STARTED|Overall Study||35
4909987|NCT03889444|12084240|P1|NOT COMPLETED|Overall Study||0
4909988|NCT03889444|12084240|P1|COMPLETED|Overall Study||141
4909989|NCT03889444|12084240|P1|STARTED|Overall Study||141
4909990|NCT03888755|12084250|P1|NOT COMPLETED|Overall Study||0
4909991|NCT03888755|12084250|P1|COMPLETED|Overall Study||8
4909992|NCT03888755|12084250|P1|STARTED|Overall Study||8
4909993|NCT03888482|12084273|P2|NOT COMPLETED|Second Wear (8 −1/+2 Days)||1
4909994|NCT03888482|12084274|P1|NOT COMPLETED|Second Wear (8 −1/+2 Days)||1
4909995|NCT03888482|12084273|P2|COMPLETED|Second Wear (8 −1/+2 Days)||74
4909996|NCT03888482|12084274|P1|COMPLETED|Second Wear (8 −1/+2 Days)||73
4909997|NCT03888482|12084273|P2|STARTED|Second Wear (8 −1/+2 Days)||75
4909998|NCT03888482|12084274|P1|STARTED|Second Wear (8 −1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
4909999|NCT03888482|12084273|P2|NOT COMPLETED|First Wear Period (8 −1/+2 Days)||0
4910000|NCT03888482|12084274|P1|NOT COMPLETED|First Wear Period (8 −1/+2 Days)||0
4910001|NCT03888482|12084273|P2|COMPLETED|First Wear Period (8 −1/+2 Days)||75
4910002|NCT03888482|12084274|P1|COMPLETED|First Wear Period (8 −1/+2 Days)||76
4910003|NCT03888482|12084273|P2|STARTED|First Wear Period (8 −1/+2 Days)||75
4910004|NCT03888482|12084274|P1|STARTED|First Wear Period (8 −1/+2 Days)||76
4910005|NCT03888469|12084284|P2|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
4910006|NCT03888469|12084285|P1|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
4910007|NCT03888469|12084284|P2|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
4910008|NCT03888469|12084285|P1|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
4910009|NCT03888469|12084284|P2|STARTED|Second Wear Period (8 -1/+2 Days)||46
4910010|NCT03888469|12084285|P1|STARTED|Second Wear Period (8 -1/+2 Days)||46
4910011|NCT03888469|12084284|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
4910012|NCT03888469|12084285|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
4910013|NCT03888469|12084284|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||46
4910014|NCT03888469|12084285|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||46
4910015|NCT03888469|12084284|P2|STARTED|First Wear Period (8 -1/+2 Days)||46
4910016|NCT03888469|12084285|P1|STARTED|First Wear Period (8 -1/+2 Days)||46
4910017|NCT03888391|12084293|P1|NOT COMPLETED|Overall Study||15
4910018|NCT03888391|12084293|P1|COMPLETED|Overall Study||3
4910019|NCT03888391|12084293|P1|STARTED|Overall Study||18
4910020|NCT03888274|12084303|P1|NOT COMPLETED|Overall Study||0
4910021|NCT03888274|12084303|P1|COMPLETED|Overall Study||30
4910022|NCT03888274|12084303|P1|STARTED|Overall Study||30
4910023|NCT03887429|12084313|P4|NOT COMPLETED|Overall Study||1
4910024|NCT03887429|12084314|P3|NOT COMPLETED|Overall Study||2
4910025|NCT03887429|12084315|P2|NOT COMPLETED|Overall Study||1
4910026|NCT03887429|12084316|P1|NOT COMPLETED|Overall Study||1
4910027|NCT03887429|12084313|P4|COMPLETED|Overall Study||7
4910028|NCT03887429|12084314|P3|COMPLETED|Overall Study||7
4910029|NCT03887429|12084315|P2|COMPLETED|Overall Study||8
4910030|NCT03887429|12084316|P1|COMPLETED|Overall Study||7
4910031|NCT03887429|12084313|P4|Completed Second Intervention (5 Days)|Overall Study||7
4910032|NCT03887429|12084314|P3|Completed Second Intervention (5 Days)|Overall Study||7
4910033|NCT03887429|12084315|P2|Completed Second Intervention (5 Days)|Overall Study||8
4910034|NCT03887429|12084316|P1|Completed Second Intervention (5 Days)|Overall Study||7
4910035|NCT03887429|12084313|P4|Completed Washout (9 Days)|Overall Study||7
4910036|NCT03887429|12084314|P3|Completed Washout (9 Days)|Overall Study||7
4910037|NCT03887429|12084315|P2|Completed Washout (9 Days)|Overall Study||8
4910038|NCT03887429|12084316|P1|Completed Washout (9 Days)|Overall Study||7
4910039|NCT03887429|12084313|P4|Completed First Intervention (5 Days)|Overall Study||7
4910040|NCT03887429|12084314|P3|Completed First Intervention (5 Days)|Overall Study||7
4910041|NCT03887429|12084315|P2|Completed First Intervention (5 Days)|Overall Study||8
4910042|NCT03887429|12084316|P1|Completed First Intervention (5 Days)|Overall Study||7
4910043|NCT03887429|12084313|P4|STARTED|Overall Study||8
4910044|NCT03887429|12084314|P3|STARTED|Overall Study||9
4910045|NCT03887429|12084315|P2|STARTED|Overall Study||9
4910046|NCT03887429|12084316|P1|STARTED|Overall Study||8
4910047|NCT03887286|12084340|P1|NOT COMPLETED|Overall Study||0
4910048|NCT03887286|12084340|P1|COMPLETED|Overall Study||47
4910049|NCT03887286|12084340|P1|STARTED|Overall Study||47
4910050|NCT03886701|12084345|P1|NOT COMPLETED|Period 2: Study Days 7-21||0
4910051|NCT03886701|12084345|P1|COMPLETED|Period 2: Study Days 7-21||11
4910052|NCT03886701|12084345|P1|STARTED|Period 2: Study Days 7-21||11
4910053|NCT03886701|12084345|P1|NOT COMPLETED|Period 1: Study Days 1-4||0
4910054|NCT03886701|12084345|P1|COMPLETED|Period 1: Study Days 1-4||11
4910055|NCT03886701|12084345|P1|STARTED|Period 1: Study Days 1-4||11
4910056|NCT03882424|12084360|P3|NOT COMPLETED|Overall Study||0
4910057|NCT03882424|12084361|P2|NOT COMPLETED|Overall Study||0
4910058|NCT03882424|12084362|P1|NOT COMPLETED|Overall Study||4
4910059|NCT03882424|12084360|P3|COMPLETED|Overall Study||38
4910060|NCT03882424|12084361|P2|COMPLETED|Overall Study||38
4910061|NCT03882424|12084362|P1|COMPLETED|Overall Study||34
4910062|NCT03882424|12084360|P3|STARTED|Overall Study||38
4910063|NCT03882424|12084361|P2|STARTED|Overall Study||38
4910064|NCT03882424|12084362|P1|STARTED|Overall Study||38
4910065|NCT03882047|12084385|P3|NOT COMPLETED|Overall Study||16
4910066|NCT03882047|12084386|P2|NOT COMPLETED|Overall Study||10
4910067|NCT03882047|12084387|P1|NOT COMPLETED|Overall Study||6
4910068|NCT03882047|12084385|P3|COMPLETED|Overall Study||88
4910069|NCT03882047|12084386|P2|COMPLETED|Overall Study||95
4910070|NCT03882047|12084387|P1|COMPLETED|Overall Study||98
4910071|NCT03882047|12084385|P3|Treated|Overall Study||103
4910072|NCT03882047|12084386|P2|Treated|Overall Study||104
4910073|NCT03882047|12084387|P1|Treated|Overall Study||104
4910074|NCT03882047|12084385|P3|STARTED|Overall Study||104
4910075|NCT03882047|12084386|P2|STARTED|Overall Study||105
4910076|NCT03882047|12084387|P1|STARTED|Overall Study||104
4910077|NCT03881670|12084427|P2|NOT COMPLETED|Overall Study||0
4910078|NCT03881670|12084428|P1|NOT COMPLETED|Overall Study||0
4910079|NCT03881670|12084427|P2|COMPLETED|Overall Study||12
4910080|NCT03881670|12084428|P1|COMPLETED|Overall Study||12
4910081|NCT03881670|12084427|P2|Completed Second Intervetion|Overall Study||12
4910082|NCT03881670|12084428|P1|Completed Second Intervetion|Overall Study||12
4910083|NCT03881670|12084427|P2|Completed First Intervention|Overall Study||12
4910084|NCT03881670|12084428|P1|Completed First Intervention|Overall Study||12
4910085|NCT03881670|12084427|P2|STARTED|Overall Study||12
4910086|NCT03881670|12084428|P1|STARTED|Overall Study||12
4910087|NCT03879772|12084443|P5|NOT COMPLETED|Overall Study||8
4910088|NCT03879772|12084444|P4|NOT COMPLETED|Overall Study||8
4910089|NCT03879772|12084445|P3|NOT COMPLETED|Overall Study||10
4910090|NCT03879772|12084446|P2|NOT COMPLETED|Overall Study||3
4910091|NCT03879772|12084447|P1|NOT COMPLETED|Overall Study||4
4910092|NCT03879772|12084443|P5|COMPLETED|Overall Study||128
4910093|NCT03879772|12084444|P4|COMPLETED|Overall Study||130
4910094|NCT03879772|12084445|P3|COMPLETED|Overall Study||123
4910095|NCT03879772|12084446|P2|COMPLETED|Overall Study||132
4910096|NCT03879772|12084447|P1|COMPLETED|Overall Study||133
4910097|NCT03879772|12084443|P5|STARTED|Overall Study||136
4910098|NCT03879772|12084444|P4|STARTED|Overall Study||138
4910099|NCT03879772|12084445|P3|STARTED|Overall Study||133
4910100|NCT03879772|12084446|P2|STARTED|Overall Study||135
4910101|NCT03879772|12084447|P1|STARTED|Overall Study||137
4910102|NCT03878758|12084484|P1|NOT COMPLETED|Overall Study||4
4910103|NCT03878758|12084484|P1|COMPLETED|Overall Study||154
4910104|NCT03878758|12084484|P1|STARTED|Overall Study||158
4910105|NCT03878745|12084507|P1|NOT COMPLETED|Overall Study||0
4910106|NCT03878745|12084507|P1|COMPLETED|Overall Study||55
4910107|NCT03878745|12084507|P1|STARTED|Overall Study||55
4910108|NCT03875664|12084523|P2|NOT COMPLETED|Overall Study||0
4910109|NCT03875664|12084524|P1|NOT COMPLETED|Overall Study||0
4910110|NCT03875664|12084523|P2|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
4910111|NCT03875664|12084524|P1|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
4910112|NCT03875664|12084523|P2|STARTED|Overall Study||35
4910113|NCT03875664|12084524|P1|STARTED|Overall Study||37
4910114|NCT03870997|12084554|P6|NOT COMPLETED|Overall Study||10531
4910115|NCT03870997|12084555|P5|NOT COMPLETED|Overall Study||10588
4910116|NCT03870997|12084556|P4|NOT COMPLETED|Overall Study||10947
4910117|NCT03870997|12084557|P3|NOT COMPLETED|Overall Study||10978
4910118|NCT03870997|12084558|P2|NOT COMPLETED|Overall Study||10431
4910119|NCT03870997|12084559|P1|NOT COMPLETED|Overall Study||10544
4910120|NCT03870997|12084554|P6|COMPLETED|Overall Study||5171
4910121|NCT03870997|12084555|P5|COMPLETED|Overall Study||5114
4910122|NCT03870997|12084556|P4|COMPLETED|Overall Study||4810
4910123|NCT03870997|12084557|P3|COMPLETED|Overall Study||4778
4910124|NCT03870997|12084558|P2|COMPLETED|Overall Study||5271
4910125|NCT03870997|12084559|P1|COMPLETED|Overall Study||5158
4910126|NCT03870997|12084554|P6|STARTED|Overall Study||15702
4910127|NCT03870997|12084555|P5|STARTED|Overall Study||15702
4910128|NCT03870997|12084556|P4|STARTED|Overall Study||15757
4910129|NCT03870997|12084557|P3|STARTED|Overall Study||15756
4910130|NCT03870997|12084558|P2|STARTED|Overall Study||15702
4910131|NCT03870997|12084559|P1|STARTED|Overall Study||15702
4910132|NCT03870737|12084568|P1|NOT COMPLETED|Overall Study||2
4910133|NCT03870737|12084568|P1|COMPLETED|Overall Study||20
4910134|NCT03870737|12084568|P1|STARTED|Overall Study||22
4910135|NCT03870555|12084581|P3|NOT COMPLETED|Period 3 (2 Days)||0
4910136|NCT03870555|12084582|P2|NOT COMPLETED|Period 3 (2 Days)||0
4910137|NCT03870555|12084583|P1|NOT COMPLETED|Period 3 (2 Days)||1
4910138|NCT03870555|12084581|P3|COMPLETED|Period 3 (2 Days)||2
4910139|NCT03870555|12084582|P2|COMPLETED|Period 3 (2 Days)||2
4910140|NCT03870555|12084583|P1|COMPLETED|Period 3 (2 Days)||1
4910141|NCT03870555|12084581|P3|STARTED|Period 3 (2 Days)||2
4910142|NCT03870555|12084582|P2|STARTED|Period 3 (2 Days)||2
4910143|NCT03870555|12084583|P1|STARTED|Period 3 (2 Days)||2
4910144|NCT03870555|12084581|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910145|NCT03870555|12084582|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910146|NCT03870555|12084583|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910147|NCT03870555|12084581|P3|COMPLETED|Washout Period (at Least 16 Days)||2
4910148|NCT03870555|12084582|P2|COMPLETED|Washout Period (at Least 16 Days)||2
4910149|NCT03870555|12084583|P1|COMPLETED|Washout Period (at Least 16 Days)||2
4910150|NCT03870555|12084581|P3|STARTED|Washout Period (at Least 16 Days)||2
4910151|NCT03870555|12084582|P2|STARTED|Washout Period (at Least 16 Days)||2
4910152|NCT03870555|12084583|P1|STARTED|Washout Period (at Least 16 Days)||2
4910153|NCT03870555|12084581|P3|NOT COMPLETED|Period 2 (2 Days)||0
4910154|NCT03870555|12084582|P2|NOT COMPLETED|Period 2 (2 Days)||0
4910155|NCT03870555|12084583|P1|NOT COMPLETED|Period 2 (2 Days)||0
4910156|NCT03870555|12084581|P3|COMPLETED|Period 2 (2 Days)||2
4910157|NCT03870555|12084582|P2|COMPLETED|Period 2 (2 Days)||2
4910158|NCT03870555|12084583|P1|COMPLETED|Period 2 (2 Days)||2
4910159|NCT03870555|12084581|P3|STARTED|Period 2 (2 Days)||2
4910160|NCT03870555|12084582|P2|STARTED|Period 2 (2 Days)||2
4910161|NCT03870555|12084583|P1|STARTED|Period 2 (2 Days)||2
4910162|NCT03870555|12084581|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910163|NCT03870555|12084582|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910164|NCT03870555|12084583|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
4910165|NCT03870555|12084581|P3|COMPLETED|Washout Period (at Least 16 Days)||2
4910166|NCT03870555|12084582|P2|COMPLETED|Washout Period (at Least 16 Days)||2
4910167|NCT03870555|12084583|P1|COMPLETED|Washout Period (at Least 16 Days)||2
4910168|NCT03870555|12084581|P3|STARTED|Washout Period (at Least 16 Days)||2
4910169|NCT03870555|12084582|P2|STARTED|Washout Period (at Least 16 Days)||2
4910170|NCT03870555|12084583|P1|STARTED|Washout Period (at Least 16 Days)||2
4910171|NCT03870555|12084581|P3|NOT COMPLETED|Period 1 (2 Days)||0
4910172|NCT03870555|12084582|P2|NOT COMPLETED|Period 1 (2 Days)||0
4910173|NCT03870555|12084583|P1|NOT COMPLETED|Period 1 (2 Days)||0
4910174|NCT03870555|12084581|P3|COMPLETED|Period 1 (2 Days)||2
4910175|NCT03870555|12084582|P2|COMPLETED|Period 1 (2 Days)||2
4910176|NCT03870555|12084583|P1|COMPLETED|Period 1 (2 Days)||2
4910177|NCT03870555|12084581|P3|STARTED|Period 1 (2 Days)||2
4910178|NCT03870555|12084582|P2|STARTED|Period 1 (2 Days)||2
4910179|NCT03870555|12084583|P1|STARTED|Period 1 (2 Days)||2
4910180|NCT03869450|12084651|P3|NOT COMPLETED|Overall Study||0
4910181|NCT03869450|12084652|P2|NOT COMPLETED|Overall Study||2
4910182|NCT03869450|12084653|P1|NOT COMPLETED|Overall Study||1
4910183|NCT03869450|12084651|P3|COMPLETED|Overall Study||34
4910184|NCT03869450|12084652|P2|COMPLETED|Overall Study||23
4910185|NCT03869450|12084653|P1|COMPLETED|Overall Study||30
4910186|NCT03869450|12084651|P3|STARTED|Overall Study||34
4910187|NCT03869450|12084652|P2|STARTED|Overall Study||25
4910188|NCT03869450|12084653|P1|STARTED|Overall Study||31
4910189|NCT03868631|12084669|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
4910190|NCT03868631|12084670|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
4910191|NCT03868631|12084669|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
4910192|NCT03868631|12084670|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
4910193|NCT03868631|12084669|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
4910194|NCT03868631|12084670|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
4910195|NCT03868631|12084669|P2|NOT COMPLETED|Baseline to Week 6||4
4910196|NCT03868631|12084670|P1|NOT COMPLETED|Baseline to Week 6||4
4910197|NCT03868631|12084669|P2|COMPLETED|Baseline to Week 6||27
4910198|NCT03868631|12084670|P1|COMPLETED|Baseline to Week 6||26
4910199|NCT03868631|12084669|P2|STARTED|Baseline to Week 6||31
4910200|NCT03868631|12084670|P1|STARTED|Baseline to Week 6||30
4910201|NCT03866434|12084682|P1|NOT COMPLETED|Overall Study||0
4910202|NCT03866434|12084682|P1|COMPLETED|Overall Study||20
4910203|NCT03866434|12084682|P1|STARTED|Overall Study||20
4910204|NCT03861559|12084700|P2|NOT COMPLETED|Overall Study||5
4910205|NCT03861559|12084701|P1|NOT COMPLETED|Overall Study||2
4910206|NCT03861559|12084700|P2|COMPLETED|Overall Study||95
4910207|NCT03861559|12084701|P1|COMPLETED|Overall Study||99
4910208|NCT03861559|12084700|P2|STARTED|Overall Study||100
4910209|NCT03861559|12084701|P1|STARTED|Overall Study||101
4910210|NCT03859622|12084747|P1|NOT COMPLETED|Overall Study||0
4910211|NCT03859622|12084747|P1|COMPLETED|Overall Study||289
4910212|NCT03859622|12084747|P1|STARTED|Overall Study||289
4910213|NCT03858335|12084757|P2|NOT COMPLETED|Overall Study||4
4910214|NCT03858335|12084758|P1|NOT COMPLETED|Overall Study||4
4910215|NCT03858335|12084757|P2|COMPLETED|Overall Study||12
4910216|NCT03858335|12084758|P1|COMPLETED|Overall Study||12
4910217|NCT03858335|12084757|P2|STARTED|Overall Study||16
4910218|NCT03858335|12084758|P1|STARTED|Overall Study||16
4910219|NCT03857750|12084778|P2|NOT COMPLETED|Overall Study||0
4910220|NCT03857750|12084779|P1|NOT COMPLETED|Overall Study||0
4910221|NCT03857750|12084778|P2|COMPLETED|Overall Study||16
4910222|NCT03857750|12084779|P1|COMPLETED|Overall Study||16
4910223|NCT03857750|12084778|P2|STARTED|Overall Study||16
4910224|NCT03857750|12084779|P1|STARTED|Overall Study||16
4910225|NCT03857243|12084791|P2|NOT COMPLETED|Overall Study||0
4910226|NCT03857243|12084792|P1|NOT COMPLETED|Overall Study||0
4910227|NCT03857243|12084791|P2|COMPLETED|Overall Study||1
4910228|NCT03857243|12084792|P1|COMPLETED|Overall Study||1
4910229|NCT03857243|12084791|P2|STARTED|Overall Study||1
4910230|NCT03857243|12084792|P1|STARTED|Overall Study||1
4910231|NCT03857230|12084804|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
4910232|NCT03857230|12084805|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
4910233|NCT03857230|12084804|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
4910234|NCT03857230|12084805|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
4910235|NCT03857230|12084804|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
4910236|NCT03857230|12084805|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
4910237|NCT03857230|12084804|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
4910238|NCT03857230|12084805|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
4910239|NCT03857230|12084804|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
4910240|NCT03857230|12084805|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
4910241|NCT03857230|12084804|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
4910242|NCT03857230|12084805|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
4910243|NCT03855228|12084823|P4|NOT COMPLETED|Overall Study||19
4910244|NCT03855228|12084824|P3|NOT COMPLETED|Overall Study||8
4910245|NCT03855228|12084825|P2|NOT COMPLETED|Overall Study||9
4910246|NCT03855228|12084826|P1|NOT COMPLETED|Overall Study||3
4910247|NCT03855228|12084823|P4|COMPLETED|Overall Study||158
4910248|NCT03855228|12084824|P3|COMPLETED|Overall Study||174
4910249|NCT03855228|12084825|P2|COMPLETED|Overall Study||167
4910250|NCT03855228|12084826|P1|COMPLETED|Overall Study||166
4910251|NCT03855228|12084823|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
4910252|NCT03855228|12084824|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
4910253|NCT03855228|12084825|P2|Treated|Overall Study||176
4910254|NCT03855228|12084826|P1|Treated|Overall Study||169
4910255|NCT03855228|12084823|P4|STARTED|Overall Study||177
4910256|NCT03855228|12084824|P3|STARTED|Overall Study||182
4910257|NCT03855228|12084825|P2|STARTED|Overall Study||176
4910258|NCT03855228|12084826|P1|STARTED|Overall Study||169
4910259|NCT03855189|12084875|P3|NOT COMPLETED|Overall Study||6
4910260|NCT03855189|12084876|P2|NOT COMPLETED|Overall Study||7
4910261|NCT03855189|12084877|P1|NOT COMPLETED|Overall Study||10
4910262|NCT03855189|12084875|P3|COMPLETED|Overall Study||110
4910263|NCT03855189|12084876|P2|COMPLETED|Overall Study||109
4910264|NCT03855189|12084877|P1|COMPLETED|Overall Study||103
4910265|NCT03855189|12084875|P3|Treated|Overall Study||116
4910266|NCT03855189|12084876|P2|Treated|Overall Study||116
4910267|NCT03855189|12084877|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
4910268|NCT03855189|12084875|P3|STARTED|Overall Study||116
4910269|NCT03855189|12084876|P2|STARTED|Overall Study||116
4910270|NCT03855189|12084877|P1|STARTED|Overall Study||113
4910271|NCT03854253|12084968|P2|NOT COMPLETED|Overall Study||0
4910272|NCT03854253|12084969|P1|NOT COMPLETED|Overall Study||1
4910273|NCT03854253|12084968|P2|COMPLETED|Overall Study||50
4910274|NCT03854253|12084969|P1|COMPLETED|Overall Study||49
4910275|NCT03854253|12084968|P2|STARTED|Overall Study||50
4910276|NCT03854253|12084969|P1|STARTED|Overall Study||50
4910277|NCT03851016|12084995|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
4910278|NCT03851016|12084996|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
4910279|NCT03851016|12084995|P2|COMPLETED|Second Intervention (3 Weeks)||10
4910280|NCT03851016|12084996|P1|COMPLETED|Second Intervention (3 Weeks)||11
4910281|NCT03851016|12084995|P2|STARTED|Second Intervention (3 Weeks)||10
4910282|NCT03851016|12084996|P1|STARTED|Second Intervention (3 Weeks)||11
4910283|NCT03851016|12084995|P2|NOT COMPLETED|Washout (1 Week)||0
4910284|NCT03851016|12084996|P1|NOT COMPLETED|Washout (1 Week)||0
4910285|NCT03851016|12084995|P2|COMPLETED|Washout (1 Week)||10
4910286|NCT03851016|12084996|P1|COMPLETED|Washout (1 Week)||11
4910287|NCT03851016|12084995|P2|STARTED|Washout (1 Week)||10
4910288|NCT03851016|12084996|P1|STARTED|Washout (1 Week)||11
4910289|NCT03851016|12084995|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
4910290|NCT03851016|12084996|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
4910291|NCT03851016|12084995|P2|COMPLETED|First Intervention (3 Weeks)||10
4910292|NCT03851016|12084996|P1|COMPLETED|First Intervention (3 Weeks)||11
4910293|NCT03851016|12084995|P2|STARTED|First Intervention (3 Weeks)||12
4910294|NCT03851016|12084996|P1|STARTED|First Intervention (3 Weeks)||12
4910295|NCT03850496|12085009|P3|NOT COMPLETED|Overall Study||4
4910296|NCT03850496|12085010|P2|NOT COMPLETED|Overall Study||1
4910297|NCT03850496|12085011|P1|NOT COMPLETED|Overall Study||1
4910298|NCT03850496|12085009|P3|COMPLETED|Overall Study||21
4910299|NCT03850496|12085010|P2|COMPLETED|Overall Study||24
4910300|NCT03850496|12085011|P1|COMPLETED|Overall Study||25
4910301|NCT03850496|12085009|P3|STARTED|Overall Study||25
4910302|NCT03850496|12085010|P2|STARTED|Overall Study||25
4910303|NCT03850496|12085011|P1|STARTED|Overall Study||26
4910304|NCT03850444|12085033|P2|NOT COMPLETED|Overall Study||134
4910305|NCT03850444|12085034|P1|NOT COMPLETED|Overall Study||128
4910306|NCT03850444|12085033|P2|COMPLETED|Overall Study||0
4910307|NCT03850444|12085034|P1|COMPLETED|Overall Study||0
4910308|NCT03850444|12085033|P2|STARTED|Overall Study||134
4910309|NCT03850444|12085034|P1|STARTED|Overall Study||128
4910310|NCT03850093|12085063|P3|NOT COMPLETED|Overall Study||2
4910311|NCT03850093|12085064|P2|NOT COMPLETED|Overall Study||0
4910312|NCT03850093|12085065|P1|NOT COMPLETED|Overall Study||1
4910313|NCT03850093|12085063|P3|COMPLETED|Overall Study||17
4910314|NCT03850093|12085064|P2|COMPLETED|Overall Study||22
4910315|NCT03850093|12085065|P1|COMPLETED|Overall Study||21
4910316|NCT03850093|12085063|P3|STARTED|Overall Study||19
4910317|NCT03850093|12085064|P2|STARTED|Overall Study||22
4910318|NCT03850093|12085065|P1|STARTED|Overall Study||22
4910319|NCT03849690|12085100|P1|NOT COMPLETED|Period 2 (6 Days)||0
4910320|NCT03849690|12085100|P1|COMPLETED|Period 2 (6 Days)||12
4910321|NCT03849690|12085100|P1|STARTED|Period 2 (6 Days)||12
4910322|NCT03849690|12085100|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
4910323|NCT03849690|12085100|P1|COMPLETED|Washout Period (at Least 4 Days)||12
4910324|NCT03849690|12085100|P1|STARTED|Washout Period (at Least 4 Days)||12
4910325|NCT03849690|12085100|P1|NOT COMPLETED|Period 1 (3 Days)||0
4910326|NCT03849690|12085100|P1|COMPLETED|Period 1 (3 Days)||12
4910327|NCT03849690|12085100|P1|STARTED|Period 1 (3 Days)||12
4910328|NCT03849300|12085127|P4|NOT COMPLETED|Overall Study||6
4910329|NCT03849300|12085128|P3|NOT COMPLETED|Overall Study||4
4910330|NCT03849300|12085129|P2|NOT COMPLETED|Overall Study||7
4910331|NCT03849300|12085130|P1|NOT COMPLETED|Overall Study||5
4910332|NCT03849300|12085127|P4|COMPLETED|Overall Study||25
4910333|NCT03849300|12085128|P3|COMPLETED|Overall Study||28
4910334|NCT03849300|12085129|P2|COMPLETED|Overall Study||35
4910335|NCT03849300|12085130|P1|COMPLETED|Overall Study||37
4910336|NCT03849300|12085127|P4|STARTED|Overall Study||31
4910337|NCT03849300|12085128|P3|STARTED|Overall Study||32
4910338|NCT03849300|12085129|P2|STARTED|Overall Study||42
4910339|NCT03849300|12085130|P1|STARTED|Overall Study||42
4910340|NCT03848910|12085184|P1|NOT COMPLETED|Overall Study||0
4910341|NCT03848910|12085184|P1|COMPLETED|Overall Study||11
4910342|NCT03848910|12085184|P1|STARTED|Overall Study||11
4910343|NCT03848455|12085204|P3|NOT COMPLETED|Overall Study||0
4910344|NCT03848455|12085205|P2|NOT COMPLETED|Overall Study||0
4910345|NCT03848455|12085206|P1|NOT COMPLETED|Overall Study||0
4910346|NCT03848455|12085204|P3|COMPLETED|Overall Study||23
4910347|NCT03848455|12085205|P2|COMPLETED|Overall Study||125
4910348|NCT03848455|12085206|P1|COMPLETED|Overall Study||90
4910349|NCT03848455|12085204|P3|STARTED|Overall Study||23
4910350|NCT03848455|12085205|P2|STARTED|Overall Study||125
4910351|NCT03848455|12085206|P1|STARTED|Overall Study||90
4910352|NCT03848416|12085223|P3|NOT COMPLETED|Overall Study||1
4910353|NCT03848416|12085224|P2|NOT COMPLETED|Overall Study||0
4910354|NCT03848416|12085225|P1|NOT COMPLETED|Overall Study||1
4910355|NCT03848416|12085223|P3|COMPLETED|Overall Study||32
4910356|NCT03848416|12085224|P2|COMPLETED|Overall Study||33
4910357|NCT03848416|12085225|P1|COMPLETED|Overall Study||32
4910358|NCT03848416|12085223|P3|Received at Least One Dose of Study Drug|Overall Study||33
4910359|NCT03848416|12085224|P2|Received at Least One Dose of Study Drug|Overall Study||33
4910360|NCT03848416|12085225|P1|Received at Least One Dose of Study Drug|Overall Study||33
4910361|NCT03848416|12085223|P3|STARTED|Overall Study||33
4910362|NCT03848416|12085224|P2|STARTED|Overall Study||33
4910363|NCT03848416|12085225|P1|STARTED|Overall Study||33
4910364|NCT03848403|12085239|P3|NOT COMPLETED|Period 3 (Day 15)||0
4910365|NCT03848403|12085240|P2|NOT COMPLETED|Period 3 (Day 15)||0
4910366|NCT03848403|12085241|P1|NOT COMPLETED|Period 3 (Day 15)||0
4910367|NCT03848403|12085239|P3|COMPLETED|Period 3 (Day 15)||15
4910368|NCT03848403|12085240|P2|COMPLETED|Period 3 (Day 15)||15
4910369|NCT03848403|12085241|P1|COMPLETED|Period 3 (Day 15)||15
4910370|NCT03848403|12085239|P3|STARTED|Period 3 (Day 15)||15
4910371|NCT03848403|12085240|P2|STARTED|Period 3 (Day 15)||15
4910372|NCT03848403|12085241|P1|STARTED|Period 3 (Day 15)||15
4910373|NCT03848403|12085239|P3|NOT COMPLETED|Period 2 (Day 8)||7
4910374|NCT03848403|12085240|P2|NOT COMPLETED|Period 2 (Day 8)||9
4910375|NCT03848403|12085241|P1|NOT COMPLETED|Period 2 (Day 8)||9
4910376|NCT03848403|12085239|P3|COMPLETED|Period 2 (Day 8)||15
4910377|NCT03848403|12085240|P2|COMPLETED|Period 2 (Day 8)||15
4910378|NCT03848403|12085241|P1|COMPLETED|Period 2 (Day 8)||15
4910379|NCT03848403|12085239|P3|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
4910380|NCT03848403|12085240|P2|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
4910381|NCT03848403|12085241|P1|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
4910382|NCT03848403|12085239|P3|STARTED|Period 2 (Day 8)||22
4910383|NCT03848403|12085240|P2|STARTED|Period 2 (Day 8)||24
4910384|NCT03848403|12085241|P1|STARTED|Period 2 (Day 8)||24
4910385|NCT03848403|12085239|P3|NOT COMPLETED|Period 1 (Day 1)||0
4910386|NCT03848403|12085240|P2|NOT COMPLETED|Period 1 (Day 1)||0
4910387|NCT03848403|12085241|P1|NOT COMPLETED|Period 1 (Day 1)||0
4910388|NCT03848403|12085239|P3|COMPLETED|Period 1 (Day 1)||22
4910389|NCT03848403|12085240|P2|COMPLETED|Period 1 (Day 1)||24
4910390|NCT03848403|12085241|P1|COMPLETED|Period 1 (Day 1)||24
4910391|NCT03848403|12085239|P3|Received Intervention|Period 1 (Day 1)||22
4910392|NCT03848403|12085240|P2|Received Intervention|Period 1 (Day 1)||24
4910393|NCT03848403|12085241|P1|Received Intervention|Period 1 (Day 1)||24
4910394|NCT03848403|12085239|P3|STARTED|Period 1 (Day 1)||22
4910395|NCT03848403|12085240|P2|STARTED|Period 1 (Day 1)||24
4910396|NCT03848403|12085241|P1|STARTED|Period 1 (Day 1)||24
4910397|NCT03848221|12085252|P3|NOT COMPLETED|Overall Study||0
4910398|NCT03848221|12085253|P2|NOT COMPLETED|Overall Study||0
4910399|NCT03848221|12085254|P1|NOT COMPLETED|Overall Study||0
4910400|NCT03848221|12085252|P3|COMPLETED|Overall Study||24
4910401|NCT03848221|12085253|P2|COMPLETED|Overall Study||24
4910402|NCT03848221|12085254|P1|COMPLETED|Overall Study||25
4910403|NCT03848221|12085252|P3|STARTED|Overall Study||24
4910404|NCT03848221|12085253|P2|STARTED|Overall Study||24
4910405|NCT03848221|12085254|P1|STARTED|Overall Study||25
4910406|NCT03847987|12085267|P2|NOT COMPLETED|Overall Study||0
4910407|NCT03847987|12085268|P1|NOT COMPLETED|Overall Study||3
4910408|NCT03847987|12085267|P2|COMPLETED|Overall Study||8
4910409|NCT03847987|12085268|P1|COMPLETED|Overall Study||13
4910410|NCT03847987|12085267|P2|STARTED|Overall Study||8
4910411|NCT03847987|12085268|P1|STARTED|Overall Study||16
4910412|NCT03845933|12085293|P2|NOT COMPLETED|Overall Study||0
4910413|NCT03845933|12085294|P1|NOT COMPLETED|Overall Study||0
4910414|NCT03845933|12085293|P2|COMPLETED|Overall Study||131
4910415|NCT03845933|12085294|P1|COMPLETED|Overall Study||131
4910416|NCT03845933|12085293|P2|STARTED|Overall Study||131
4910417|NCT03845933|12085294|P1|STARTED|Overall Study||131
4910418|NCT03842683|12085300|P1|NOT COMPLETED|Overall Study||0
4910419|NCT03842683|12085300|P1|COMPLETED|Overall Study||472
4910420|NCT03842683|12085300|P1|STARTED|Overall Study||472
4910421|NCT03840278|12085305|P2|NOT COMPLETED|Overall Study||0
4910422|NCT03840278|12085306|P1|NOT COMPLETED|Overall Study||0
4910423|NCT03840278|12085305|P2|COMPLETED|Overall Study||5
4910424|NCT03840278|12085306|P1|COMPLETED|Overall Study||5
4910425|NCT03840278|12085305|P2|STARTED|Overall Study||5
4910426|NCT03840278|12085306|P1|STARTED|Overall Study||5
4910427|NCT03840135|12085326|P2|NOT COMPLETED|Overall Study||1
4910428|NCT03840135|12085327|P1|NOT COMPLETED|Overall Study||7
4910429|NCT03840135|12085326|P2|COMPLETED|Overall Study||85
4910430|NCT03840135|12085327|P1|COMPLETED|Overall Study||79
4910431|NCT03840135|12085326|P2|STARTED|Overall Study||86
4910432|NCT03840135|12085327|P1|STARTED|Overall Study||86
4910433|NCT03836859|12085355|P2|NOT COMPLETED|Overall Study||0
4910434|NCT03836859|12085356|P1|NOT COMPLETED|Overall Study||0
4910435|NCT03836859|12085355|P2|COMPLETED|Overall Study||10
4910436|NCT03836859|12085356|P1|COMPLETED|Overall Study||20
4910437|NCT03836859|12085355|P2|STARTED|Overall Study||10
4910438|NCT03836859|12085356|P1|STARTED|Overall Study||20
4910439|NCT03836729|12085392|P1|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
4910440|NCT03836729|12085392|P1|COMPLETED|Treatment Period 2 (Up to Day 7)||15
4910441|NCT03836729|12085392|P1|STARTED|Treatment Period 2 (Up to Day 7)||16
4910442|NCT03836729|12085392|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
4910443|NCT03836729|12085392|P1|COMPLETED|Treatment Period 1 (Up to Day 14)||16
4910444|NCT03836729|12085392|P1|STARTED|Treatment Period 1 (Up to Day 14)||16
4910445|NCT03836664|12085506|P2|NOT COMPLETED|Overall Study||3
4910446|NCT03836664|12085507|P1|NOT COMPLETED|Overall Study||3
4910447|NCT03836664|12085506|P2|COMPLETED|Overall Study||8
4910448|NCT03836664|12085507|P1|COMPLETED|Overall Study||11
4910449|NCT03836664|12085506|P2|STARTED|Overall Study||11
4910450|NCT03836664|12085507|P1|STARTED|Overall Study||14
4910451|NCT03835546|12085520|P3|NOT COMPLETED|Overall Study||0
4910452|NCT03835546|12085521|P2|NOT COMPLETED|Overall Study||0
4910453|NCT03835546|12085522|P1|NOT COMPLETED|Overall Study||3
4910454|NCT03835546|12085520|P3|COMPLETED|Overall Study||15
4910455|NCT03835546|12085521|P2|COMPLETED|Overall Study||15
4910456|NCT03835546|12085522|P1|COMPLETED|Overall Study||12
4910457|NCT03835546|12085520|P3|STARTED|Overall Study||15
4910458|NCT03835546|12085521|P2|STARTED|Overall Study||15
4910459|NCT03835546|12085522|P1|STARTED|Overall Study||15
4910460|NCT03835221|12085548|P1|NOT COMPLETED|Fanfilcon A||0
4910461|NCT03835221|12085548|P1|COMPLETED|Fanfilcon A||42
4910462|NCT03835221|12085548|P1|STARTED|Fanfilcon A||42
4910463|NCT03835221|12085548|P1|NOT COMPLETED|Methafilcon A||1
4910464|NCT03835221|12085548|P1|COMPLETED|Methafilcon A||42
4910465|NCT03835221|12085548|P1|STARTED|Methafilcon A||43
4910466|NCT03835078|12085593|P1|NOT COMPLETED|Overall Study||0
4910467|NCT03835078|12085593|P1|COMPLETED|Overall Study||39
4910468|NCT03835078|12085593|P1|STARTED|Overall Study||39
4910469|NCT03832387|12085630|P2|NOT COMPLETED|Overall Study||7
4910470|NCT03832387|12085631|P1|NOT COMPLETED|Overall Study||5
4910471|NCT03832387|12085630|P2|COMPLETED|Overall Study||32
4910472|NCT03832387|12085631|P1|COMPLETED|Overall Study||33
4910473|NCT03832387|12085630|P2|STARTED|Overall Study||39
4910474|NCT03832387|12085631|P1|STARTED|Overall Study||38
4910475|NCT03832322|12085661|P2|NOT COMPLETED|Overall Study||1
4910476|NCT03832322|12085662|P1|NOT COMPLETED|Overall Study||3
4910477|NCT03832322|12085661|P2|COMPLETED|Overall Study||86
4910478|NCT03832322|12085662|P1|COMPLETED|Overall Study||86
4910479|NCT03832322|12085661|P2|STARTED|Overall Study||87
4910480|NCT03832322|12085662|P1|STARTED|Overall Study||89
4910481|NCT03831451|12085672|P2|NOT COMPLETED|Overall Study||0
4910482|NCT03831451|12085673|P1|NOT COMPLETED|Overall Study||0
4910483|NCT03831451|12085672|P2|COMPLETED|Overall Study||55
4910484|NCT03831451|12085673|P1|COMPLETED|Overall Study||74
4910485|NCT03831451|12085672|P2|STARTED|Overall Study||55
4910486|NCT03831451|12085673|P1|STARTED|Overall Study||74
4910487|NCT03831282|12085679|P1|NOT COMPLETED|Overall Study||1
4910488|NCT03831282|12085679|P1|COMPLETED|Overall Study||11
4910489|NCT03831282|12085679|P1|STARTED|Overall Study||12
4910490|NCT03830307|12085683|P1|NOT COMPLETED|Overall Study||0
4910491|NCT03830307|12085683|P1|COMPLETED|Overall Study||5
4910492|NCT03830307|12085683|P1|STARTED|Overall Study||5
4910493|NCT03828149|12085706|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
4910494|NCT03828149|12085707|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
4910495|NCT03828149|12085706|P2|COMPLETED|Second Intervention (Single Dose)||8
4910496|NCT03828149|12085707|P1|COMPLETED|Second Intervention (Single Dose)||9
4910497|NCT03828149|12085706|P2|STARTED|Second Intervention (Single Dose)||8
4910498|NCT03828149|12085707|P1|STARTED|Second Intervention (Single Dose)||9
4910499|NCT03828149|12085706|P2|NOT COMPLETED|Washout (6 Days)||0
4910500|NCT03828149|12085707|P1|NOT COMPLETED|Washout (6 Days)||0
4910501|NCT03828149|12085706|P2|COMPLETED|Washout (6 Days)||8
4910502|NCT03828149|12085707|P1|COMPLETED|Washout (6 Days)||9
4910503|NCT03828149|12085706|P2|STARTED|Washout (6 Days)||8
4910504|NCT03828149|12085707|P1|STARTED|Washout (6 Days)||9
4910505|NCT03828149|12085706|P2|NOT COMPLETED|First Intervention (Single Dose)||0
4910506|NCT03828149|12085707|P1|NOT COMPLETED|First Intervention (Single Dose)||0
4910507|NCT03828149|12085706|P2|COMPLETED|First Intervention (Single Dose)||8
4910508|NCT03828149|12085707|P1|COMPLETED|First Intervention (Single Dose)||9
4910509|NCT03828149|12085706|P2|STARTED|First Intervention (Single Dose)||8
4910510|NCT03828149|12085707|P1|STARTED|First Intervention (Single Dose)||9
4910511|NCT03827473|12085715|P2|NOT COMPLETED|Overall Study||0
4910512|NCT03827473|12085716|P1|NOT COMPLETED|Overall Study||1
4910513|NCT03827473|12085715|P2|COMPLETED|Overall Study||0
4910514|NCT03827473|12085716|P1|COMPLETED|Overall Study||0
4910515|NCT03827473|12085715|P2|STARTED|Overall Study||0
4910516|NCT03827473|12085716|P1|STARTED|Overall Study||1
4910517|NCT03825393|12085732|P2|NOT COMPLETED|Overall Study||0
4910518|NCT03825393|12085733|P1|NOT COMPLETED|Overall Study||0
4910519|NCT03825393|12085732|P2|COMPLETED|Overall Study||100
4910520|NCT03825393|12085733|P1|COMPLETED|Overall Study||100
4910521|NCT03825393|12085732|P2|STARTED|Overall Study||100
4910522|NCT03825393|12085733|P1|STARTED|Overall Study||100
4910523|NCT03825042|12085745|P2|NOT COMPLETED|Overall Study||0
4910524|NCT03825042|12085746|P1|NOT COMPLETED|Overall Study||2
4910525|NCT03825042|12085745|P2|COMPLETED|Overall Study||40
4910526|NCT03825042|12085746|P1|COMPLETED|Overall Study||38
4910527|NCT03825042|12085745|P2|STARTED|Overall Study||40
4910528|NCT03825042|12085746|P1|STARTED|Overall Study||40
4910529|NCT03824912|12085759|P3|NOT COMPLETED|Overall Study||68
4910530|NCT03824912|12085760|P2|NOT COMPLETED|Overall Study||134
4910531|NCT03824912|12085761|P1|NOT COMPLETED|Overall Study||140
4910532|NCT03824912|12085759|P3|COMPLETED|Overall Study||96
4910533|NCT03824912|12085760|P2|COMPLETED|Overall Study||201
4910534|NCT03824912|12085761|P1|COMPLETED|Overall Study||192
4910535|NCT03824912|12085759|P3|STARTED|Overall Study||164
4910536|NCT03824912|12085760|P2|STARTED|Overall Study||335
4910537|NCT03824912|12085761|P1|STARTED|Overall Study||332
4910538|NCT03824236|12085784|P3|NOT COMPLETED|Overall Study||1
4910539|NCT03824236|12085785|P2|NOT COMPLETED|Overall Study||0
4910540|NCT03824236|12085786|P1|NOT COMPLETED|Overall Study||0
4910541|NCT03824236|12085784|P3|COMPLETED|Overall Study||11
4910542|NCT03824236|12085785|P2|COMPLETED|Overall Study||24
4910543|NCT03824236|12085786|P1|COMPLETED|Overall Study||25
4910544|NCT03824236|12085784|P3|STARTED|Overall Study||12
4910545|NCT03824236|12085785|P2|STARTED|Overall Study||24
4910546|NCT03824236|12085786|P1|STARTED|Overall Study||25
4910547|NCT03823937|12085821|P2|NOT COMPLETED|Overall Study||0
4910548|NCT03823937|12085822|P1|NOT COMPLETED|Overall Study||0
4910549|NCT03823937|12085821|P2|COMPLETED|Overall Study||20
4910550|NCT03823937|12085822|P1|COMPLETED|Overall Study||30
4910551|NCT03823937|12085821|P2|STARTED|Overall Study||20
4910552|NCT03823937|12085822|P1|STARTED|Overall Study||30
4910553|NCT03822884|12085844|P6|NOT COMPLETED|Overall Study||0
4910554|NCT03822884|12085845|P5|NOT COMPLETED|Overall Study||1
4910555|NCT03822884|12085846|P4|NOT COMPLETED|Overall Study||0
4910556|NCT03822884|12085847|P3|NOT COMPLETED|Overall Study||0
4910557|NCT03822884|12085848|P2|NOT COMPLETED|Overall Study||0
4910558|NCT03822884|12085849|P1|NOT COMPLETED|Overall Study||0
4910559|NCT03822884|12085844|P6|COMPLETED|Overall Study||4
4910560|NCT03822884|12085845|P5|COMPLETED|Overall Study||3
4910561|NCT03822884|12085846|P4|COMPLETED|Overall Study||4
4910562|NCT03822884|12085847|P3|COMPLETED|Overall Study||4
4910563|NCT03822884|12085848|P2|COMPLETED|Overall Study||4
4910564|NCT03822884|12085849|P1|COMPLETED|Overall Study||4
4910565|NCT03822884|12085844|P6|STARTED|Overall Study||4
4910566|NCT03822884|12085845|P5|STARTED|Overall Study||4
4910567|NCT03822884|12085846|P4|STARTED|Overall Study||4
4910568|NCT03822884|12085847|P3|STARTED|Overall Study||4
4910569|NCT03822884|12085848|P2|STARTED|Overall Study||4
4910570|NCT03822884|12085849|P1|STARTED|Overall Study||4
4910571|NCT03822078|12085884|P6|NOT COMPLETED|Overall Study||0
4910572|NCT03822078|12085885|P5|NOT COMPLETED|Overall Study||1
4910573|NCT03822078|12085886|P4|NOT COMPLETED|Overall Study||2
4910574|NCT03822078|12085887|P3|NOT COMPLETED|Overall Study||0
4910575|NCT03822078|12085888|P2|NOT COMPLETED|Overall Study||0
4910576|NCT03822078|12085889|P1|NOT COMPLETED|Overall Study||2
4910577|NCT03822078|12085884|P6|COMPLETED|Overall Study||6
4910578|NCT03822078|12085885|P5|COMPLETED|Overall Study||6
4910579|NCT03822078|12085886|P4|COMPLETED|Overall Study||6
4910580|NCT03822078|12085887|P3|COMPLETED|Overall Study||6
4910581|NCT03822078|12085888|P2|COMPLETED|Overall Study||6
4910582|NCT03822078|12085889|P1|COMPLETED|Overall Study||10
4910583|NCT03822078|12085884|P6|Received Study Drug|Overall Study||6
4910584|NCT03822078|12085885|P5|Received Study Drug|Overall Study||6
4910585|NCT03822078|12085886|P4|Received Study Drug|Overall Study||6
4910586|NCT03822078|12085887|P3|Received Study Drug|Overall Study||6
4910587|NCT03822078|12085888|P2|Received Study Drug|Overall Study||6
4910588|NCT03822078|12085889|P1|Received Study Drug|Overall Study||10
4910589|NCT03822078|12085884|P6|STARTED|Overall Study||6
4910590|NCT03822078|12085885|P5|STARTED|Overall Study||7
4910591|NCT03822078|12085886|P4|STARTED|Overall Study||8
4910592|NCT03822078|12085887|P3|STARTED|Overall Study||6
4910593|NCT03822078|12085888|P2|STARTED|Overall Study||6
4910594|NCT03822078|12085889|P1|STARTED|Overall Study||12
4910595|NCT03821259|12085947|P1|NOT COMPLETED|Overall Study||0
4910596|NCT03821259|12085947|P1|COMPLETED|Overall Study||88
4910597|NCT03821259|12085947|P1|STARTED|Overall Study||88
4910598|NCT03820544|12085957|P2|NOT COMPLETED|Overall Study||0
4910599|NCT03820544|12085958|P1|NOT COMPLETED|Overall Study||0
4910600|NCT03820544|12085957|P2|COMPLETED|Overall Study||2
4910601|NCT03820544|12085958|P1|COMPLETED|Overall Study||2
4910602|NCT03820544|12085957|P2|STARTED|Overall Study||2
4910603|NCT03820544|12085958|P1|STARTED|Overall Study||2
4910604|NCT03819491|12085968|P2|NOT COMPLETED|After Randomization||0
4910605|NCT03819491|12085969|P1|NOT COMPLETED|After Randomization||0
4910606|NCT03819491|12085968|P2|COMPLETED|After Randomization||12
4910607|NCT03819491|12085969|P1|COMPLETED|After Randomization||12
4910608|NCT03819491|12085968|P2|STARTED|After Randomization||12
4910609|NCT03819491|12085969|P1|STARTED|After Randomization||12
4910610|NCT03819491|12085968|P2|NOT COMPLETED|Before Randomization||0
4910611|NCT03819491|12085969|P1|NOT COMPLETED|Before Randomization||0
4910612|NCT03819491|12085968|P2|COMPLETED|Before Randomization||0
4910613|NCT03819491|12085969|P1|COMPLETED|Before Randomization||24
4910614|NCT03819491|12085968|P2|STARTED|Before Randomization||0
4910615|NCT03819491|12085969|P1|STARTED|Before Randomization||24
4910616|NCT03817879|12085982|P2|NOT COMPLETED|Overall Study||13
4910617|NCT03817879|12085983|P1|NOT COMPLETED|Overall Study||5
4910618|NCT03817879|12085982|P2|COMPLETED|Overall Study||22
4910619|NCT03817879|12085983|P1|COMPLETED|Overall Study||30
4910620|NCT03817879|12085982|P2|STARTED|Overall Study||35
4910621|NCT03817879|12085983|P1|STARTED|Overall Study||35
4910622|NCT03817775|12085991|P2|NOT COMPLETED|Overall Study||0
4910623|NCT03817775|12085992|P1|NOT COMPLETED|Overall Study||0
4910624|NCT03817775|12085991|P2|COMPLETED|Overall Study||54
4910625|NCT03817775|12085992|P1|COMPLETED|Overall Study||22
4910626|NCT03817775|12085991|P2|STARTED|Overall Study||54
4910627|NCT03817775|12085992|P1|STARTED|Overall Study||22
4910628|NCT03816761|12086019|P6|NOT COMPLETED|Second Treatment Period (7 Days)||0
4910629|NCT03816761|12086020|P5|NOT COMPLETED|Second Treatment Period (7 Days)||0
4910630|NCT03816761|12086021|P4|NOT COMPLETED|Second Treatment Period (7 Days)||1
4910631|NCT03816761|12086022|P3|NOT COMPLETED|Second Treatment Period (7 Days)||0
4910632|NCT03816761|12086023|P2|NOT COMPLETED|Second Treatment Period (7 Days)||0
4910633|NCT03816761|12086024|P1|NOT COMPLETED|Second Treatment Period (7 Days)||0
4910634|NCT03816761|12086019|P6|COMPLETED|Second Treatment Period (7 Days)||3
4910635|NCT03816761|12086020|P5|COMPLETED|Second Treatment Period (7 Days)||4
4910636|NCT03816761|12086021|P4|COMPLETED|Second Treatment Period (7 Days)||3
4910637|NCT03816761|12086022|P3|COMPLETED|Second Treatment Period (7 Days)||4
4910638|NCT03816761|12086023|P2|COMPLETED|Second Treatment Period (7 Days)||4
4910639|NCT03816761|12086024|P1|COMPLETED|Second Treatment Period (7 Days)||4
4910640|NCT03816761|12086019|P6|STARTED|Second Treatment Period (7 Days)||3
4910641|NCT03816761|12086020|P5|STARTED|Second Treatment Period (7 Days)||4
4910642|NCT03816761|12086021|P4|STARTED|Second Treatment Period (7 Days)||4
4910643|NCT03816761|12086022|P3|STARTED|Second Treatment Period (7 Days)||4
4910644|NCT03816761|12086023|P2|STARTED|Second Treatment Period (7 Days)||4
4910645|NCT03816761|12086024|P1|STARTED|Second Treatment Period (7 Days)||4
4910646|NCT03816761|12086019|P6|NOT COMPLETED|First Treatment Period (7 Days)||1
4910647|NCT03816761|12086020|P5|NOT COMPLETED|First Treatment Period (7 Days)||0
4910648|NCT03816761|12086021|P4|NOT COMPLETED|First Treatment Period (7 Days)||0
4910649|NCT03816761|12086022|P3|NOT COMPLETED|First Treatment Period (7 Days)||0
4910650|NCT03816761|12086023|P2|NOT COMPLETED|First Treatment Period (7 Days)||0
4910651|NCT03816761|12086024|P1|NOT COMPLETED|First Treatment Period (7 Days)||0
4910652|NCT03816761|12086019|P6|COMPLETED|First Treatment Period (7 Days)||3
4910653|NCT03816761|12086020|P5|COMPLETED|First Treatment Period (7 Days)||4
4910654|NCT03816761|12086021|P4|COMPLETED|First Treatment Period (7 Days)||4
4910655|NCT03816761|12086022|P3|COMPLETED|First Treatment Period (7 Days)||4
4910656|NCT03816761|12086023|P2|COMPLETED|First Treatment Period (7 Days)||4
4910657|NCT03816761|12086024|P1|COMPLETED|First Treatment Period (7 Days)||4
4910658|NCT03816761|12086019|P6|STARTED|First Treatment Period (7 Days)||4
4910659|NCT03816761|12086020|P5|STARTED|First Treatment Period (7 Days)||4
4910660|NCT03816761|12086021|P4|STARTED|First Treatment Period (7 Days)||4
4910661|NCT03816761|12086022|P3|STARTED|First Treatment Period (7 Days)||4
4910662|NCT03816761|12086023|P2|STARTED|First Treatment Period (7 Days)||4
4910663|NCT03816761|12086024|P1|STARTED|First Treatment Period (7 Days)||4
4910664|NCT03816696|12086122|P1|NOT COMPLETED|Period 3 (Up to Day 11)||0
4910665|NCT03816696|12086122|P1|COMPLETED|Period 3 (Up to Day 11)||16
4910666|NCT03816696|12086122|P1|STARTED|Period 3 (Up to Day 11)||16
4910667|NCT03816696|12086122|P1|NOT COMPLETED|Period 2 (Up to Day 7)||0
4910668|NCT03816696|12086122|P1|COMPLETED|Period 2 (Up to Day 7)||16
4910669|NCT03816696|12086122|P1|STARTED|Period 2 (Up to Day 7)||16
4910670|NCT03816696|12086122|P1|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
4910671|NCT03816696|12086122|P1|COMPLETED|Wash Out Period (Days 6 to 9)||16
4910672|NCT03816696|12086122|P1|STARTED|Wash Out Period (Days 6 to 9)||16
4910673|NCT03816696|12086122|P1|NOT COMPLETED|Period 1 (Up to Day 5)||0
4910674|NCT03816696|12086122|P1|COMPLETED|Period 1 (Up to Day 5)||16
4910675|NCT03816696|12086122|P1|STARTED|Period 1 (Up to Day 5)||16
4910676|NCT03815240|12086267|P9|NOT COMPLETED|Intervention Optifoam Dressing||0
4910677|NCT03815240|12086268|P8|NOT COMPLETED|Intervention Optifoam Dressing||0
4910678|NCT03815240|12086269|P7|NOT COMPLETED|Intervention Optifoam Dressing||0
4910679|NCT03815240|12086270|P6|NOT COMPLETED|Intervention Optifoam Dressing||0
4910680|NCT03815240|12086271|P5|NOT COMPLETED|Intervention Optifoam Dressing||0
4910681|NCT03815240|12086272|P4|NOT COMPLETED|Intervention Optifoam Dressing||0
4910682|NCT03815240|12086273|P3|NOT COMPLETED|Intervention Optifoam Dressing||0
4910683|NCT03815240|12086274|P2|NOT COMPLETED|Intervention Optifoam Dressing||0
4910684|NCT03815240|12086275|P1|NOT COMPLETED|Intervention Optifoam Dressing||0
4910685|NCT03815240|12086267|P9|COMPLETED|Intervention Optifoam Dressing||1
4910686|NCT03815240|12086268|P8|COMPLETED|Intervention Optifoam Dressing||1
4910687|NCT03815240|12086269|P7|COMPLETED|Intervention Optifoam Dressing||1
4910688|NCT03815240|12086270|P6|COMPLETED|Intervention Optifoam Dressing||2
4910689|NCT03815240|12086271|P5|COMPLETED|Intervention Optifoam Dressing||1
4910690|NCT03815240|12086272|P4|COMPLETED|Intervention Optifoam Dressing||2
4910691|NCT03815240|12086273|P3|COMPLETED|Intervention Optifoam Dressing||1
4910692|NCT03815240|12086274|P2|COMPLETED|Intervention Optifoam Dressing||1
4910693|NCT03815240|12086275|P1|COMPLETED|Intervention Optifoam Dressing||2
4910694|NCT03815240|12086267|P9|STARTED|Intervention Optifoam Dressing||1
4910695|NCT03815240|12086268|P8|STARTED|Intervention Optifoam Dressing||1
4910696|NCT03815240|12086269|P7|STARTED|Intervention Optifoam Dressing||1
4910697|NCT03815240|12086270|P6|STARTED|Intervention Optifoam Dressing||2
4910698|NCT03815240|12086271|P5|STARTED|Intervention Optifoam Dressing||1
4910699|NCT03815240|12086272|P4|STARTED|Intervention Optifoam Dressing||2
4910700|NCT03815240|12086273|P3|STARTED|Intervention Optifoam Dressing||1
4910701|NCT03815240|12086274|P2|STARTED|Intervention Optifoam Dressing||1
4910702|NCT03815240|12086275|P1|STARTED|Intervention Optifoam Dressing||2
4910703|NCT03815240|12086267|P9|NOT COMPLETED|Intervention Allevyn Dressing||0
4910704|NCT03815240|12086268|P8|NOT COMPLETED|Intervention Allevyn Dressing||0
4910705|NCT03815240|12086269|P7|NOT COMPLETED|Intervention Allevyn Dressing||0
4910706|NCT03815240|12086270|P6|NOT COMPLETED|Intervention Allevyn Dressing||0
4910707|NCT03815240|12086271|P5|NOT COMPLETED|Intervention Allevyn Dressing||0
4910708|NCT03815240|12086272|P4|NOT COMPLETED|Intervention Allevyn Dressing||0
4910709|NCT03815240|12086273|P3|NOT COMPLETED|Intervention Allevyn Dressing||0
4910710|NCT03815240|12086274|P2|NOT COMPLETED|Intervention Allevyn Dressing||0
4910711|NCT03815240|12086275|P1|NOT COMPLETED|Intervention Allevyn Dressing||0
4910712|NCT03815240|12086267|P9|COMPLETED|Intervention Allevyn Dressing||1
4910713|NCT03815240|12086268|P8|COMPLETED|Intervention Allevyn Dressing||1
4910714|NCT03815240|12086269|P7|COMPLETED|Intervention Allevyn Dressing||1
4910715|NCT03815240|12086270|P6|COMPLETED|Intervention Allevyn Dressing||2
4910716|NCT03815240|12086271|P5|COMPLETED|Intervention Allevyn Dressing||1
4910717|NCT03815240|12086272|P4|COMPLETED|Intervention Allevyn Dressing||2
4910718|NCT03815240|12086273|P3|COMPLETED|Intervention Allevyn Dressing||1
4910719|NCT03815240|12086274|P2|COMPLETED|Intervention Allevyn Dressing||1
4910720|NCT03815240|12086275|P1|COMPLETED|Intervention Allevyn Dressing||2
4910721|NCT03815240|12086267|P9|STARTED|Intervention Allevyn Dressing||1
4910722|NCT03815240|12086268|P8|STARTED|Intervention Allevyn Dressing||1
4910723|NCT03815240|12086269|P7|STARTED|Intervention Allevyn Dressing||1
4910724|NCT03815240|12086270|P6|STARTED|Intervention Allevyn Dressing||2
4910725|NCT03815240|12086271|P5|STARTED|Intervention Allevyn Dressing||1
4910726|NCT03815240|12086272|P4|STARTED|Intervention Allevyn Dressing||2
4910727|NCT03815240|12086273|P3|STARTED|Intervention Allevyn Dressing||1
4910728|NCT03815240|12086274|P2|STARTED|Intervention Allevyn Dressing||1
4910729|NCT03815240|12086275|P1|STARTED|Intervention Allevyn Dressing||2
4910730|NCT03815240|12086267|P9|NOT COMPLETED|Intervention Mepilex Dressing||0
4910731|NCT03815240|12086268|P8|NOT COMPLETED|Intervention Mepilex Dressing||0
4910732|NCT03815240|12086269|P7|NOT COMPLETED|Intervention Mepilex Dressing||0
4910733|NCT03815240|12086270|P6|NOT COMPLETED|Intervention Mepilex Dressing||0
4910734|NCT03815240|12086271|P5|NOT COMPLETED|Intervention Mepilex Dressing||0
4910735|NCT03815240|12086272|P4|NOT COMPLETED|Intervention Mepilex Dressing||0
4910736|NCT03815240|12086273|P3|NOT COMPLETED|Intervention Mepilex Dressing||0
4910737|NCT03815240|12086274|P2|NOT COMPLETED|Intervention Mepilex Dressing||0
4910738|NCT03815240|12086275|P1|NOT COMPLETED|Intervention Mepilex Dressing||0
4910739|NCT03815240|12086267|P9|COMPLETED|Intervention Mepilex Dressing||1
4910740|NCT03815240|12086268|P8|COMPLETED|Intervention Mepilex Dressing||1
4910741|NCT03815240|12086269|P7|COMPLETED|Intervention Mepilex Dressing||1
4910742|NCT03815240|12086270|P6|COMPLETED|Intervention Mepilex Dressing||2
4910743|NCT03815240|12086271|P5|COMPLETED|Intervention Mepilex Dressing||1
4910744|NCT03815240|12086272|P4|COMPLETED|Intervention Mepilex Dressing||2
4910745|NCT03815240|12086273|P3|COMPLETED|Intervention Mepilex Dressing||1
4910746|NCT03815240|12086274|P2|COMPLETED|Intervention Mepilex Dressing||1
4910747|NCT03815240|12086275|P1|COMPLETED|Intervention Mepilex Dressing||2
4910748|NCT03815240|12086267|P9|STARTED|Intervention Mepilex Dressing||1
4910749|NCT03815240|12086268|P8|STARTED|Intervention Mepilex Dressing||1
4910750|NCT03815240|12086269|P7|STARTED|Intervention Mepilex Dressing||1
4910751|NCT03815240|12086270|P6|STARTED|Intervention Mepilex Dressing||2
4910752|NCT03815240|12086271|P5|STARTED|Intervention Mepilex Dressing||1
4910753|NCT03815240|12086272|P4|STARTED|Intervention Mepilex Dressing||2
4910754|NCT03815240|12086273|P3|STARTED|Intervention Mepilex Dressing||1
4910755|NCT03815240|12086274|P2|STARTED|Intervention Mepilex Dressing||1
4910756|NCT03815240|12086275|P1|STARTED|Intervention Mepilex Dressing||2
4910757|NCT03815240|12086267|P9|NOT COMPLETED|Intervention no Dressing||0
4910758|NCT03815240|12086268|P8|NOT COMPLETED|Intervention no Dressing||0
4910759|NCT03815240|12086269|P7|NOT COMPLETED|Intervention no Dressing||0
4910760|NCT03815240|12086270|P6|NOT COMPLETED|Intervention no Dressing||0
4910761|NCT03815240|12086271|P5|NOT COMPLETED|Intervention no Dressing||0
4910762|NCT03815240|12086272|P4|NOT COMPLETED|Intervention no Dressing||0
4910763|NCT03815240|12086273|P3|NOT COMPLETED|Intervention no Dressing||0
4910764|NCT03815240|12086274|P2|NOT COMPLETED|Intervention no Dressing||0
4910765|NCT03815240|12086275|P1|NOT COMPLETED|Intervention no Dressing||0
4910766|NCT03815240|12086267|P9|COMPLETED|Intervention no Dressing||1
4910767|NCT03815240|12086268|P8|COMPLETED|Intervention no Dressing||1
4910768|NCT03815240|12086269|P7|COMPLETED|Intervention no Dressing||1
4910769|NCT03815240|12086270|P6|COMPLETED|Intervention no Dressing||2
4910770|NCT03815240|12086271|P5|COMPLETED|Intervention no Dressing||1
4910771|NCT03815240|12086272|P4|COMPLETED|Intervention no Dressing||2
4910772|NCT03815240|12086273|P3|COMPLETED|Intervention no Dressing||1
4910773|NCT03815240|12086274|P2|COMPLETED|Intervention no Dressing||1
4910774|NCT03815240|12086275|P1|COMPLETED|Intervention no Dressing||2
4910775|NCT03815240|12086267|P9|STARTED|Intervention no Dressing||1
4910776|NCT03815240|12086268|P8|STARTED|Intervention no Dressing||1
4910777|NCT03815240|12086269|P7|STARTED|Intervention no Dressing||1
4910778|NCT03815240|12086270|P6|STARTED|Intervention no Dressing||2
4910779|NCT03815240|12086271|P5|STARTED|Intervention no Dressing||1
4910780|NCT03815240|12086272|P4|STARTED|Intervention no Dressing||2
4910781|NCT03815240|12086273|P3|STARTED|Intervention no Dressing||1
4910782|NCT03815240|12086274|P2|STARTED|Intervention no Dressing||1
4910783|NCT03815240|12086275|P1|STARTED|Intervention no Dressing||2
4910784|NCT03813719|12086321|P1|NOT COMPLETED|Overall Study||0
4910785|NCT03813719|12086321|P1|COMPLETED|Overall Study||250
4910786|NCT03813719|12086321|P1|STARTED|Overall Study||250
4910787|NCT03811093|12086329|P2|NOT COMPLETED|Overall Study||4
4910788|NCT03811093|12086330|P1|NOT COMPLETED|Overall Study||2
4910789|NCT03811093|12086329|P2|COMPLETED|Overall Study||15
4910790|NCT03811093|12086330|P1|COMPLETED|Overall Study||18
4910791|NCT03811093|12086329|P2|STARTED|Overall Study||19
4910792|NCT03811093|12086330|P1|STARTED|Overall Study||20
4910793|NCT03809104|12086340|P1|NOT COMPLETED|Overall Study||3
4910794|NCT03809104|12086340|P1|COMPLETED|Overall Study||40
4910795|NCT03809104|12086340|P1|STARTED|Overall Study||43
4910796|NCT03808493|12086353|P4|NOT COMPLETED|Overall Study||0
4910797|NCT03808493|12086354|P3|NOT COMPLETED|Overall Study||0
4910798|NCT03808493|12086355|P2|NOT COMPLETED|Overall Study||0
4910799|NCT03808493|12086356|P1|NOT COMPLETED|Overall Study||0
4910800|NCT03808493|12086353|P4|COMPLETED|Overall Study||12
4910801|NCT03808493|12086354|P3|COMPLETED|Overall Study||12
4910802|NCT03808493|12086355|P2|COMPLETED|Overall Study||12
4910803|NCT03808493|12086356|P1|COMPLETED|Overall Study||12
4910804|NCT03808493|12086353|P4|STARTED|Overall Study||12
4910805|NCT03808493|12086354|P3|STARTED|Overall Study||12
4910806|NCT03808493|12086355|P2|STARTED|Overall Study||12
4910807|NCT03808493|12086356|P1|STARTED|Overall Study||12
4910808|NCT03808298|12086386|P1|NOT COMPLETED|Overall Study||8
4910809|NCT03808298|12086386|P1|COMPLETED|Overall Study||49
4910810|NCT03808298|12086386|P1|STARTED|Overall Study||57
4910811|NCT03807700|12086461|P2|NOT COMPLETED|Overall Study||1
4910812|NCT03807700|12086462|P1|NOT COMPLETED|Overall Study||2
4910813|NCT03807700|12086461|P2|COMPLETED|Overall Study||58
4910814|NCT03807700|12086462|P1|COMPLETED|Overall Study||58
4910815|NCT03807700|12086461|P2|STARTED|Overall Study||59
4910816|NCT03807700|12086462|P1|STARTED|Overall Study||60
4910817|NCT03807544|12086485|P1|NOT COMPLETED|Overall Study||0
4910818|NCT03807544|12086485|P1|COMPLETED|Overall Study||17
4910819|NCT03807544|12086485|P1|STARTED|Overall Study||17
4910820|NCT03807089|12086492|P2|NOT COMPLETED|Overall Study||0
4910821|NCT03807089|12086493|P1|NOT COMPLETED|Overall Study||0
4910822|NCT03807089|12086492|P2|COMPLETED|Overall Study||93
4910823|NCT03807089|12086493|P1|COMPLETED|Overall Study||101
4910824|NCT03807089|12086492|P2|STARTED|Overall Study||93
4910825|NCT03807089|12086493|P1|STARTED|Overall Study||101
4910826|NCT03806270|12086510|P3|NOT COMPLETED|Overall Study||0
4910827|NCT03806270|12086511|P2|NOT COMPLETED|Overall Study||0
4910828|NCT03806270|12086512|P1|NOT COMPLETED|Overall Study||0
4910829|NCT03806270|12086510|P3|COMPLETED|Overall Study||15
4910830|NCT03806270|12086511|P2|COMPLETED|Overall Study||15
4910831|NCT03806270|12086512|P1|COMPLETED|Overall Study||15
4910832|NCT03806270|12086510|P3|STARTED|Overall Study||15
4910833|NCT03806270|12086511|P2|STARTED|Overall Study||15
4910834|NCT03806270|12086512|P1|STARTED|Overall Study||15
4910835|NCT03805971|12086538|P1|NOT COMPLETED|Overall Study||3
4910836|NCT03805971|12086538|P1|COMPLETED|Overall Study||62
4910837|NCT03805971|12086538|P1|STARTED|Overall Study||65
4910838|NCT03805672|12086553|P2|NOT COMPLETED|Overall Study||0
4910839|NCT03805672|12086554|P1|NOT COMPLETED|Overall Study||0
4910840|NCT03805672|12086553|P2|COMPLETED|Overall Study||2
4910841|NCT03805672|12086554|P1|COMPLETED|Overall Study||2
4910842|NCT03805672|12086553|P2|STARTED|Overall Study||2
4910843|NCT03805672|12086554|P1|STARTED|Overall Study||2
4910844|NCT03804710|12086562|P2|NOT COMPLETED|Overall Study||5
4910845|NCT03804710|12086563|P1|NOT COMPLETED|Overall Study||2
4910846|NCT03804710|12086562|P2|COMPLETED|Overall Study||69
4910847|NCT03804710|12086563|P1|COMPLETED|Overall Study||73
4910848|NCT03804710|12086562|P2|STARTED|Overall Study||74
4910849|NCT03804710|12086563|P1|STARTED|Overall Study||75
4910850|NCT03801148|12086622|P4|NOT COMPLETED|Follow-Up (12 Days)||0
4910851|NCT03801148|12086623|P3|NOT COMPLETED|Follow-Up (12 Days)||1
4910852|NCT03801148|12086624|P2|NOT COMPLETED|Follow-Up (12 Days)||1
4910853|NCT03801148|12086625|P1|NOT COMPLETED|Follow-Up (12 Days)||0
4910854|NCT03801148|12086622|P4|COMPLETED|Follow-Up (12 Days)||29
4910855|NCT03801148|12086623|P3|COMPLETED|Follow-Up (12 Days)||28
4910856|NCT03801148|12086624|P2|COMPLETED|Follow-Up (12 Days)||29
4910857|NCT03801148|12086625|P1|COMPLETED|Follow-Up (12 Days)||30
4910858|NCT03801148|12086622|P4|STARTED|Follow-Up (12 Days)||29
4910859|NCT03801148|12086623|P3|STARTED|Follow-Up (12 Days)||29
4910860|NCT03801148|12086624|P2|STARTED|Follow-Up (12 Days)||30
4910861|NCT03801148|12086625|P1|STARTED|Follow-Up (12 Days)||30
4910862|NCT03801148|12086622|P4|NOT COMPLETED|Period 2 (2 Days)||0
4910863|NCT03801148|12086623|P3|NOT COMPLETED|Period 2 (2 Days)||0
4910864|NCT03801148|12086624|P2|NOT COMPLETED|Period 2 (2 Days)||0
4910865|NCT03801148|12086625|P1|NOT COMPLETED|Period 2 (2 Days)||0
4910866|NCT03801148|12086622|P4|COMPLETED|Period 2 (2 Days)||29
4910867|NCT03801148|12086623|P3|COMPLETED|Period 2 (2 Days)||29
4910868|NCT03801148|12086624|P2|COMPLETED|Period 2 (2 Days)||30
4910869|NCT03801148|12086625|P1|COMPLETED|Period 2 (2 Days)||30
4910870|NCT03801148|12086622|P4|STARTED|Period 2 (2 Days)||29
4910871|NCT03801148|12086623|P3|STARTED|Period 2 (2 Days)||29
4910872|NCT03801148|12086624|P2|STARTED|Period 2 (2 Days)||30
4910873|NCT03801148|12086625|P1|STARTED|Period 2 (2 Days)||30
4910874|NCT03801148|12086622|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||1
4910875|NCT03801148|12086623|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||1
4910876|NCT03801148|12086624|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||0
4910877|NCT03801148|12086625|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||0
4910878|NCT03801148|12086622|P4|COMPLETED|Washout Period (at Least 5 Days)||29
4910879|NCT03801148|12086623|P3|COMPLETED|Washout Period (at Least 5 Days)||29
4910880|NCT03801148|12086624|P2|COMPLETED|Washout Period (at Least 5 Days)||30
4910881|NCT03801148|12086625|P1|COMPLETED|Washout Period (at Least 5 Days)||30
4910882|NCT03801148|12086622|P4|STARTED|Washout Period (at Least 5 Days)||30
4910883|NCT03801148|12086623|P3|STARTED|Washout Period (at Least 5 Days)||30
4910884|NCT03801148|12086624|P2|STARTED|Washout Period (at Least 5 Days)||30
4910885|NCT03801148|12086625|P1|STARTED|Washout Period (at Least 5 Days)||30
4910886|NCT03801148|12086622|P4|NOT COMPLETED|Period 1 (2 Days)||0
4910887|NCT03801148|12086623|P3|NOT COMPLETED|Period 1 (2 Days)||0
4910888|NCT03801148|12086624|P2|NOT COMPLETED|Period 1 (2 Days)||1
4910889|NCT03801148|12086625|P1|NOT COMPLETED|Period 1 (2 Days)||1
4910890|NCT03801148|12086622|P4|COMPLETED|Period 1 (2 Days)||30
4910891|NCT03801148|12086623|P3|COMPLETED|Period 1 (2 Days)||30
4910892|NCT03801148|12086624|P2|COMPLETED|Period 1 (2 Days)||30
4910893|NCT03801148|12086625|P1|COMPLETED|Period 1 (2 Days)||30
4910894|NCT03801148|12086622|P4|STARTED|Period 1 (2 Days)||30
4910895|NCT03801148|12086623|P3|STARTED|Period 1 (2 Days)||30
4910896|NCT03801148|12086624|P2|STARTED|Period 1 (2 Days)||31
4910897|NCT03801148|12086625|P1|STARTED|Period 1 (2 Days)||31
4910898|NCT03801044|12086647|P1|NOT COMPLETED|Overall Study||0
4910899|NCT03801044|12086647|P1|COMPLETED|Overall Study||21
4910900|NCT03801044|12086647|P1|STARTED|Overall Study||21
4910901|NCT03800030|12086666|P6|NOT COMPLETED|Third Intervention||0
4910902|NCT03800030|12086667|P5|NOT COMPLETED|Third Intervention||0
4910903|NCT03800030|12086668|P4|NOT COMPLETED|Third Intervention||0
4910904|NCT03800030|12086669|P3|NOT COMPLETED|Third Intervention||0
4910905|NCT03800030|12086670|P2|NOT COMPLETED|Third Intervention||0
4910906|NCT03800030|12086671|P1|NOT COMPLETED|Third Intervention||0
4910907|NCT03800030|12086666|P6|COMPLETED|Third Intervention||4
4910908|NCT03800030|12086667|P5|COMPLETED|Third Intervention||4
4910909|NCT03800030|12086668|P4|COMPLETED|Third Intervention||4
4910910|NCT03800030|12086669|P3|COMPLETED|Third Intervention||4
4910911|NCT03800030|12086670|P2|COMPLETED|Third Intervention||4
4910912|NCT03800030|12086671|P1|COMPLETED|Third Intervention||4
4910913|NCT03800030|12086666|P6|STARTED|Third Intervention||4
4910914|NCT03800030|12086667|P5|STARTED|Third Intervention||4
4910915|NCT03800030|12086668|P4|STARTED|Third Intervention||4
4910916|NCT03800030|12086669|P3|STARTED|Third Intervention||4
4910917|NCT03800030|12086670|P2|STARTED|Third Intervention||4
4910918|NCT03800030|12086671|P1|STARTED|Third Intervention||4
4910919|NCT03800030|12086666|P6|NOT COMPLETED|Second Washout (1 Week)||0
4910920|NCT03800030|12086667|P5|NOT COMPLETED|Second Washout (1 Week)||0
4910921|NCT03800030|12086668|P4|NOT COMPLETED|Second Washout (1 Week)||1
4910922|NCT03800030|12086669|P3|NOT COMPLETED|Second Washout (1 Week)||0
4910923|NCT03800030|12086670|P2|NOT COMPLETED|Second Washout (1 Week)||0
4910924|NCT03800030|12086671|P1|NOT COMPLETED|Second Washout (1 Week)||0
4910925|NCT03800030|12086666|P6|COMPLETED|Second Washout (1 Week)||4
4910926|NCT03800030|12086667|P5|COMPLETED|Second Washout (1 Week)||4
4910927|NCT03800030|12086668|P4|COMPLETED|Second Washout (1 Week)||4
4910928|NCT03800030|12086669|P3|COMPLETED|Second Washout (1 Week)||4
4910929|NCT03800030|12086670|P2|COMPLETED|Second Washout (1 Week)||4
4910930|NCT03800030|12086671|P1|COMPLETED|Second Washout (1 Week)||4
4910931|NCT03800030|12086666|P6|STARTED|Second Washout (1 Week)||4
4910932|NCT03800030|12086667|P5|STARTED|Second Washout (1 Week)||4
4910933|NCT03800030|12086668|P4|STARTED|Second Washout (1 Week)||5
4910934|NCT03800030|12086669|P3|STARTED|Second Washout (1 Week)||4
4910935|NCT03800030|12086670|P2|STARTED|Second Washout (1 Week)||4
4910936|NCT03800030|12086671|P1|STARTED|Second Washout (1 Week)||4
4910937|NCT03800030|12086666|P6|NOT COMPLETED|Second Intervention||0
4910938|NCT03800030|12086667|P5|NOT COMPLETED|Second Intervention||0
4910939|NCT03800030|12086668|P4|NOT COMPLETED|Second Intervention||1
4910940|NCT03800030|12086669|P3|NOT COMPLETED|Second Intervention||0
4910941|NCT03800030|12086670|P2|NOT COMPLETED|Second Intervention||0
4910942|NCT03800030|12086671|P1|NOT COMPLETED|Second Intervention||0
4910943|NCT03800030|12086666|P6|COMPLETED|Second Intervention||4
4910944|NCT03800030|12086667|P5|COMPLETED|Second Intervention||4
4910945|NCT03800030|12086668|P4|COMPLETED|Second Intervention||5
4910946|NCT03800030|12086669|P3|COMPLETED|Second Intervention||4
4910947|NCT03800030|12086670|P2|COMPLETED|Second Intervention||4
4910948|NCT03800030|12086671|P1|COMPLETED|Second Intervention||4
4910949|NCT03800030|12086666|P6|STARTED|Second Intervention||4
4910950|NCT03800030|12086667|P5|STARTED|Second Intervention||4
4910951|NCT03800030|12086668|P4|STARTED|Second Intervention||6
4910952|NCT03800030|12086669|P3|STARTED|Second Intervention||4
4910953|NCT03800030|12086670|P2|STARTED|Second Intervention||4
4910954|NCT03800030|12086671|P1|STARTED|Second Intervention||4
4910955|NCT03800030|12086666|P6|NOT COMPLETED|First Washout (1 Week)||0
4910956|NCT03800030|12086667|P5|NOT COMPLETED|First Washout (1 Week)||0
4910957|NCT03800030|12086668|P4|NOT COMPLETED|First Washout (1 Week)||0
4910958|NCT03800030|12086669|P3|NOT COMPLETED|First Washout (1 Week)||0
4910959|NCT03800030|12086670|P2|NOT COMPLETED|First Washout (1 Week)||0
4910960|NCT03800030|12086671|P1|NOT COMPLETED|First Washout (1 Week)||0
4910961|NCT03800030|12086666|P6|COMPLETED|First Washout (1 Week)||4
4910962|NCT03800030|12086667|P5|COMPLETED|First Washout (1 Week)||4
4910963|NCT03800030|12086668|P4|COMPLETED|First Washout (1 Week)||6
4910964|NCT03800030|12086669|P3|COMPLETED|First Washout (1 Week)||4
4910965|NCT03800030|12086670|P2|COMPLETED|First Washout (1 Week)||4
4910966|NCT03800030|12086671|P1|COMPLETED|First Washout (1 Week)||4
4910967|NCT03800030|12086666|P6|STARTED|First Washout (1 Week)||4
4910968|NCT03800030|12086667|P5|STARTED|First Washout (1 Week)||4
4910969|NCT03800030|12086668|P4|STARTED|First Washout (1 Week)||6
4910970|NCT03800030|12086669|P3|STARTED|First Washout (1 Week)||4
4910971|NCT03800030|12086670|P2|STARTED|First Washout (1 Week)||4
4910972|NCT03800030|12086671|P1|STARTED|First Washout (1 Week)||4
4910973|NCT03800030|12086666|P6|NOT COMPLETED|First Intervention||0
4910974|NCT03800030|12086667|P5|NOT COMPLETED|First Intervention||0
4910975|NCT03800030|12086668|P4|NOT COMPLETED|First Intervention||0
4910976|NCT03800030|12086669|P3|NOT COMPLETED|First Intervention||0
4910977|NCT03800030|12086670|P2|NOT COMPLETED|First Intervention||0
4910978|NCT03800030|12086671|P1|NOT COMPLETED|First Intervention||0
4910979|NCT03800030|12086666|P6|COMPLETED|First Intervention||4
4910980|NCT03800030|12086667|P5|COMPLETED|First Intervention||4
4910981|NCT03800030|12086668|P4|COMPLETED|First Intervention||6
4910982|NCT03800030|12086669|P3|COMPLETED|First Intervention||4
4910983|NCT03800030|12086670|P2|COMPLETED|First Intervention||4
4910984|NCT03800030|12086671|P1|COMPLETED|First Intervention||4
4910985|NCT03800030|12086666|P6|STARTED|First Intervention||4
4910986|NCT03800030|12086667|P5|STARTED|First Intervention||4
4910987|NCT03800030|12086668|P4|STARTED|First Intervention||6
4910988|NCT03800030|12086669|P3|STARTED|First Intervention||4
4910989|NCT03800030|12086670|P2|STARTED|First Intervention||4
4910990|NCT03800030|12086671|P1|STARTED|First Intervention||4
4910991|NCT03800030|12086666|P6|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910992|NCT03800030|12086667|P5|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910993|NCT03800030|12086668|P4|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910994|NCT03800030|12086669|P3|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910995|NCT03800030|12086670|P2|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910996|NCT03800030|12086671|P1|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
4910997|NCT03800030|12086666|P6|COMPLETED|Pre-Randomization Period (1 Week)||4
4910998|NCT03800030|12086667|P5|COMPLETED|Pre-Randomization Period (1 Week)||4
4910999|NCT03800030|12086668|P4|COMPLETED|Pre-Randomization Period (1 Week)||6
4911000|NCT03800030|12086669|P3|COMPLETED|Pre-Randomization Period (1 Week)||4
4911001|NCT03800030|12086670|P2|COMPLETED|Pre-Randomization Period (1 Week)||4
4911002|NCT03800030|12086671|P1|COMPLETED|Pre-Randomization Period (1 Week)||4
4911003|NCT03800030|12086666|P6|STARTED|Pre-Randomization Period (1 Week)||4
4911004|NCT03800030|12086667|P5|STARTED|Pre-Randomization Period (1 Week)||4
4911005|NCT03800030|12086668|P4|STARTED|Pre-Randomization Period (1 Week)||6
4911006|NCT03800030|12086669|P3|STARTED|Pre-Randomization Period (1 Week)||4
4911007|NCT03800030|12086670|P2|STARTED|Pre-Randomization Period (1 Week)||4
4911008|NCT03800030|12086671|P1|STARTED|Pre-Randomization Period (1 Week)||4
4911009|NCT03800030|12086666|P6|NOT COMPLETED|Baseline||0
4911010|NCT03800030|12086667|P5|NOT COMPLETED|Baseline||0
4911011|NCT03800030|12086668|P4|NOT COMPLETED|Baseline||0
4911012|NCT03800030|12086669|P3|NOT COMPLETED|Baseline||0
4911013|NCT03800030|12086670|P2|NOT COMPLETED|Baseline||0
4911014|NCT03800030|12086671|P1|NOT COMPLETED|Baseline||0
4911015|NCT03800030|12086666|P6|COMPLETED|Baseline||4
4911016|NCT03800030|12086667|P5|COMPLETED|Baseline||4
4911017|NCT03800030|12086668|P4|COMPLETED|Baseline||6
4911018|NCT03800030|12086669|P3|COMPLETED|Baseline||4
4911019|NCT03800030|12086670|P2|COMPLETED|Baseline||4
4911020|NCT03800030|12086671|P1|COMPLETED|Baseline||4
4911021|NCT03800030|12086666|P6|STARTED|Baseline||4
4911022|NCT03800030|12086667|P5|STARTED|Baseline||4
4911023|NCT03800030|12086668|P4|STARTED|Baseline||6
4911024|NCT03800030|12086669|P3|STARTED|Baseline||4
4911025|NCT03800030|12086670|P2|STARTED|Baseline||4
4911026|NCT03800030|12086671|P1|STARTED|Baseline||4
4911027|NCT03799484|12086694|P1|NOT COMPLETED|Overall Study||0
4911028|NCT03799484|12086694|P1|COMPLETED|Overall Study||14
4911029|NCT03799484|12086694|P1|STARTED|Overall Study||14
4911030|NCT03799211|12086724|P2|NOT COMPLETED|Overall Study||13
4911031|NCT03799211|12086725|P1|NOT COMPLETED|Overall Study||4
4911032|NCT03799211|12086724|P2|COMPLETED|Overall Study||27
4911033|NCT03799211|12086725|P1|COMPLETED|Overall Study||32
4911034|NCT03799211|12086724|P2|STARTED|Overall Study||40
4911035|NCT03799211|12086725|P1|STARTED|Overall Study||36
4911036|NCT03796260|12086743|P2|NOT COMPLETED|Period 2||0
4911037|NCT03796260|12086744|P1|NOT COMPLETED|Period 2||0
4911038|NCT03796260|12086743|P2|COMPLETED|Period 2||7
4911039|NCT03796260|12086744|P1|COMPLETED|Period 2||7
4911040|NCT03796260|12086743|P2|STARTED|Period 2||7
4911041|NCT03796260|12086744|P1|STARTED|Period 2||7
4911042|NCT03796260|12086743|P2|NOT COMPLETED|Period 1||0
4911043|NCT03796260|12086744|P1|NOT COMPLETED|Period 1||0
4911044|NCT03796260|12086743|P2|COMPLETED|Period 1||7
4911045|NCT03796260|12086744|P1|COMPLETED|Period 1||7
4911046|NCT03796260|12086743|P2|STARTED|Period 1||7
4911047|NCT03796260|12086744|P1|STARTED|Period 1||7
4911048|NCT03796182|12086756|P2|NOT COMPLETED|Period 2||0
4911049|NCT03796182|12086757|P1|NOT COMPLETED|Period 2||0
4911050|NCT03796182|12086756|P2|COMPLETED|Period 2||6
4911051|NCT03796182|12086757|P1|COMPLETED|Period 2||6
4911052|NCT03796182|12086756|P2|STARTED|Period 2||6
4911053|NCT03796182|12086757|P1|STARTED|Period 2||6
4911054|NCT03796182|12086756|P2|NOT COMPLETED|Washout Period||0
4911055|NCT03796182|12086757|P1|NOT COMPLETED|Washout Period||0
4911056|NCT03796182|12086756|P2|COMPLETED|Washout Period||6
4911057|NCT03796182|12086757|P1|COMPLETED|Washout Period||6
4911058|NCT03796182|12086756|P2|STARTED|Washout Period||6
4911059|NCT03796182|12086757|P1|STARTED|Washout Period||6
4911060|NCT03796182|12086756|P2|NOT COMPLETED|Period 1||0
4911061|NCT03796182|12086757|P1|NOT COMPLETED|Period 1||0
4911062|NCT03796182|12086756|P2|COMPLETED|Period 1||6
4911063|NCT03796182|12086757|P1|COMPLETED|Period 1||6
4911064|NCT03796182|12086756|P2|STARTED|Period 1||6
4911065|NCT03796182|12086757|P1|STARTED|Period 1||6
4911066|NCT03796013|12086791|P2|NOT COMPLETED|Period 2||0
4911067|NCT03796013|12086792|P1|NOT COMPLETED|Period 2||0
4911068|NCT03796013|12086791|P2|COMPLETED|Period 2||14
4911069|NCT03796013|12086792|P1|COMPLETED|Period 2||14
4911070|NCT03796013|12086791|P2|STARTED|Period 2||14
4911071|NCT03796013|12086792|P1|STARTED|Period 2||14
4911072|NCT03796013|12086791|P2|NOT COMPLETED|Period 1||0
4911073|NCT03796013|12086792|P1|NOT COMPLETED|Period 1||0
4911074|NCT03796013|12086791|P2|COMPLETED|Period 1||14
4911075|NCT03796013|12086792|P1|COMPLETED|Period 1||14
4911076|NCT03796013|12086791|P2|STARTED|Period 1||14
4911077|NCT03796013|12086792|P1|STARTED|Period 1||14
4911078|NCT03794024|12086804|P2|NOT COMPLETED|Overall Study||0
4911079|NCT03794024|12086805|P1|NOT COMPLETED|Overall Study||1
4911080|NCT03794024|12086804|P2|COMPLETED|Overall Study||0
4911081|NCT03794024|12086805|P1|COMPLETED|Overall Study||0
4911082|NCT03794024|12086804|P2|STARTED|Overall Study||0
4911083|NCT03794024|12086805|P1|STARTED|Overall Study||1
4911084|NCT03793751|12086813|P2|NOT COMPLETED|Overall Study||0
4911085|NCT03793751|12086814|P1|NOT COMPLETED|Overall Study||0
4911086|NCT03793751|12086813|P2|COMPLETED|Overall Study||60
4911087|NCT03793751|12086814|P1|COMPLETED|Overall Study||60
4911088|NCT03793751|12086813|P2|STARTED|Overall Study||60
4911089|NCT03793751|12086814|P1|STARTED|Overall Study||60
4911090|NCT03793556|12086830|P2|NOT COMPLETED|Overall Study||2
4911091|NCT03793556|12086831|P1|NOT COMPLETED|Overall Study||13
4911092|NCT03793556|12086830|P2|COMPLETED|Overall Study||34
4911093|NCT03793556|12086831|P1|COMPLETED|Overall Study||22
4911094|NCT03793556|12086830|P2|STARTED|Overall Study||36
4911095|NCT03793556|12086831|P1|STARTED|Overall Study||35
4911096|NCT03792672|12086873|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4911097|NCT03792672|12086874|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4911098|NCT03792672|12086875|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4911099|NCT03792672|12086876|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4911100|NCT03792672|12086877|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4911101|NCT03792672|12086878|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||1
4911102|NCT03792672|12086873|P6|COMPLETED|Treatment Period 4 (2 Days)||4
4911103|NCT03792672|12086874|P5|COMPLETED|Treatment Period 4 (2 Days)||4
4911104|NCT03792672|12086875|P4|COMPLETED|Treatment Period 4 (2 Days)||2
4911105|NCT03792672|12086876|P3|COMPLETED|Treatment Period 4 (2 Days)||3
4911106|NCT03792672|12086877|P2|COMPLETED|Treatment Period 4 (2 Days)||4
4911107|NCT03792672|12086878|P1|COMPLETED|Treatment Period 4 (2 Days)||2
4911108|NCT03792672|12086873|P6|STARTED|Treatment Period 4 (2 Days)||4
4911109|NCT03792672|12086874|P5|STARTED|Treatment Period 4 (2 Days)||4
4911110|NCT03792672|12086875|P4|STARTED|Treatment Period 4 (2 Days)||2
4911111|NCT03792672|12086876|P3|STARTED|Treatment Period 4 (2 Days)||3
4911112|NCT03792672|12086877|P2|STARTED|Treatment Period 4 (2 Days)||4
4911113|NCT03792672|12086878|P1|STARTED|Treatment Period 4 (2 Days)||3
4911114|NCT03792672|12086873|P6|NOT COMPLETED|Washout Period 3 (10 Days)||0
4911115|NCT03792672|12086874|P5|NOT COMPLETED|Washout Period 3 (10 Days)||0
4911116|NCT03792672|12086875|P4|NOT COMPLETED|Washout Period 3 (10 Days)||2
4911117|NCT03792672|12086876|P3|NOT COMPLETED|Washout Period 3 (10 Days)||1
4911118|NCT03792672|12086877|P2|NOT COMPLETED|Washout Period 3 (10 Days)||0
4911119|NCT03792672|12086878|P1|NOT COMPLETED|Washout Period 3 (10 Days)||1
4911120|NCT03792672|12086873|P6|COMPLETED|Washout Period 3 (10 Days)||4
4911121|NCT03792672|12086874|P5|COMPLETED|Washout Period 3 (10 Days)||4
4911122|NCT03792672|12086875|P4|COMPLETED|Washout Period 3 (10 Days)||2
4911123|NCT03792672|12086876|P3|COMPLETED|Washout Period 3 (10 Days)||3
4911124|NCT03792672|12086877|P2|COMPLETED|Washout Period 3 (10 Days)||4
4911125|NCT03792672|12086878|P1|COMPLETED|Washout Period 3 (10 Days)||3
4911126|NCT03792672|12086873|P6|STARTED|Washout Period 3 (10 Days)||4
4911127|NCT03792672|12086874|P5|STARTED|Washout Period 3 (10 Days)||4
4911128|NCT03792672|12086875|P4|STARTED|Washout Period 3 (10 Days)||4
4911129|NCT03792672|12086876|P3|STARTED|Washout Period 3 (10 Days)||4
4911130|NCT03792672|12086877|P2|STARTED|Washout Period 3 (10 Days)||4
4911131|NCT03792672|12086878|P1|STARTED|Washout Period 3 (10 Days)||4
4911132|NCT03792672|12086873|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911133|NCT03792672|12086874|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911134|NCT03792672|12086875|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911135|NCT03792672|12086876|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911136|NCT03792672|12086877|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911137|NCT03792672|12086878|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
4911138|NCT03792672|12086873|P6|COMPLETED|Treatment Period 3 (1 Day)||4
4911139|NCT03792672|12086874|P5|COMPLETED|Treatment Period 3 (1 Day)||4
4911140|NCT03792672|12086875|P4|COMPLETED|Treatment Period 3 (1 Day)||4
4911141|NCT03792672|12086876|P3|COMPLETED|Treatment Period 3 (1 Day)||4
4911142|NCT03792672|12086877|P2|COMPLETED|Treatment Period 3 (1 Day)||4
4911143|NCT03792672|12086878|P1|COMPLETED|Treatment Period 3 (1 Day)||4
4911144|NCT03792672|12086873|P6|STARTED|Treatment Period 3 (1 Day)||4
4911145|NCT03792672|12086874|P5|STARTED|Treatment Period 3 (1 Day)||4
4911146|NCT03792672|12086875|P4|STARTED|Treatment Period 3 (1 Day)||4
4911147|NCT03792672|12086876|P3|STARTED|Treatment Period 3 (1 Day)||4
4911148|NCT03792672|12086877|P2|STARTED|Treatment Period 3 (1 Day)||4
4911149|NCT03792672|12086878|P1|STARTED|Treatment Period 3 (1 Day)||4
4911150|NCT03792672|12086873|P6|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911151|NCT03792672|12086874|P5|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911152|NCT03792672|12086875|P4|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911153|NCT03792672|12086876|P3|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911154|NCT03792672|12086877|P2|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911155|NCT03792672|12086878|P1|NOT COMPLETED|Washout Period 2 (10 Days)||0
4911156|NCT03792672|12086873|P6|COMPLETED|Washout Period 2 (10 Days)||4
4911157|NCT03792672|12086874|P5|COMPLETED|Washout Period 2 (10 Days)||4
4911158|NCT03792672|12086875|P4|COMPLETED|Washout Period 2 (10 Days)||4
4911159|NCT03792672|12086876|P3|COMPLETED|Washout Period 2 (10 Days)||4
4911160|NCT03792672|12086877|P2|COMPLETED|Washout Period 2 (10 Days)||4
4911161|NCT03792672|12086878|P1|COMPLETED|Washout Period 2 (10 Days)||4
4911162|NCT03792672|12086873|P6|STARTED|Washout Period 2 (10 Days)||4
4911163|NCT03792672|12086874|P5|STARTED|Washout Period 2 (10 Days)||4
4911164|NCT03792672|12086875|P4|STARTED|Washout Period 2 (10 Days)||4
4911165|NCT03792672|12086876|P3|STARTED|Washout Period 2 (10 Days)||4
4911166|NCT03792672|12086877|P2|STARTED|Washout Period 2 (10 Days)||4
4911167|NCT03792672|12086878|P1|STARTED|Washout Period 2 (10 Days)||4
4911168|NCT03792672|12086873|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911169|NCT03792672|12086874|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911170|NCT03792672|12086875|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911171|NCT03792672|12086876|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911172|NCT03792672|12086877|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911173|NCT03792672|12086878|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
4911174|NCT03792672|12086873|P6|COMPLETED|Treatment Period 2 (1 Day)||4
4911175|NCT03792672|12086874|P5|COMPLETED|Treatment Period 2 (1 Day)||4
4911176|NCT03792672|12086875|P4|COMPLETED|Treatment Period 2 (1 Day)||4
4911177|NCT03792672|12086876|P3|COMPLETED|Treatment Period 2 (1 Day)||4
4911178|NCT03792672|12086877|P2|COMPLETED|Treatment Period 2 (1 Day)||4
4911179|NCT03792672|12086878|P1|COMPLETED|Treatment Period 2 (1 Day)||4
4911180|NCT03792672|12086873|P6|STARTED|Treatment Period 2 (1 Day)||4
4911181|NCT03792672|12086874|P5|STARTED|Treatment Period 2 (1 Day)||4
4911182|NCT03792672|12086875|P4|STARTED|Treatment Period 2 (1 Day)||4
4911183|NCT03792672|12086876|P3|STARTED|Treatment Period 2 (1 Day)||4
4911184|NCT03792672|12086877|P2|STARTED|Treatment Period 2 (1 Day)||4
4911185|NCT03792672|12086878|P1|STARTED|Treatment Period 2 (1 Day)||4
4911186|NCT03792672|12086873|P6|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911187|NCT03792672|12086874|P5|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911188|NCT03792672|12086875|P4|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911189|NCT03792672|12086876|P3|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911190|NCT03792672|12086877|P2|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911191|NCT03792672|12086878|P1|NOT COMPLETED|Washout Period 1 (10 Days)||0
4911192|NCT03792672|12086873|P6|COMPLETED|Washout Period 1 (10 Days)||4
4911193|NCT03792672|12086874|P5|COMPLETED|Washout Period 1 (10 Days)||4
4911194|NCT03792672|12086875|P4|COMPLETED|Washout Period 1 (10 Days)||4
4911195|NCT03792672|12086876|P3|COMPLETED|Washout Period 1 (10 Days)||4
4911196|NCT03792672|12086877|P2|COMPLETED|Washout Period 1 (10 Days)||4
4911197|NCT03792672|12086878|P1|COMPLETED|Washout Period 1 (10 Days)||4
4911198|NCT03792672|12086873|P6|STARTED|Washout Period 1 (10 Days)||4
4911199|NCT03792672|12086874|P5|STARTED|Washout Period 1 (10 Days)||4
4911200|NCT03792672|12086875|P4|STARTED|Washout Period 1 (10 Days)||4
4911201|NCT03792672|12086876|P3|STARTED|Washout Period 1 (10 Days)||4
4911202|NCT03792672|12086877|P2|STARTED|Washout Period 1 (10 Days)||4
4911203|NCT03792672|12086878|P1|STARTED|Washout Period 1 (10 Days)||4
4911204|NCT03792672|12086873|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911205|NCT03792672|12086874|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911206|NCT03792672|12086875|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911207|NCT03792672|12086876|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911208|NCT03792672|12086877|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911209|NCT03792672|12086878|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
4911210|NCT03792672|12086873|P6|COMPLETED|Treatment Period 1 (1 Day)||4
4911211|NCT03792672|12086874|P5|COMPLETED|Treatment Period 1 (1 Day)||4
4911212|NCT03792672|12086875|P4|COMPLETED|Treatment Period 1 (1 Day)||4
4911213|NCT03792672|12086876|P3|COMPLETED|Treatment Period 1 (1 Day)||4
4911214|NCT03792672|12086877|P2|COMPLETED|Treatment Period 1 (1 Day)||4
4911215|NCT03792672|12086878|P1|COMPLETED|Treatment Period 1 (1 Day)||4
4911216|NCT03792672|12086873|P6|STARTED|Treatment Period 1 (1 Day)||4
4911217|NCT03792672|12086874|P5|STARTED|Treatment Period 1 (1 Day)||4
4911218|NCT03792672|12086875|P4|STARTED|Treatment Period 1 (1 Day)||4
4911219|NCT03792672|12086876|P3|STARTED|Treatment Period 1 (1 Day)||4
4911220|NCT03792672|12086877|P2|STARTED|Treatment Period 1 (1 Day)||4
4911221|NCT03792672|12086878|P1|STARTED|Treatment Period 1 (1 Day)||4
4911222|NCT03791489|12086898|P1|NOT COMPLETED|90 Days (Primary Endpoint)||0
4911223|NCT03791489|12086898|P1|COMPLETED|90 Days (Primary Endpoint)||30
4911224|NCT03791489|12086898|P1|STARTED|90 Days (Primary Endpoint)||30
4911225|NCT03791489|12086898|P1|NOT COMPLETED|30 Days||0
4911226|NCT03791489|12086898|P1|COMPLETED|30 Days||30
4911227|NCT03791489|12086898|P1|STARTED|30 Days||30
4911228|NCT03790917|12086905|P1|NOT COMPLETED|Overall Study||1
4911229|NCT03790917|12086905|P1|COMPLETED|Overall Study||200
4911230|NCT03790917|12086905|P1|STARTED|Overall Study||201
4911231|NCT03790306|12086915|P1|NOT COMPLETED|Overall Study||0
4911232|NCT03790306|12086915|P1|COMPLETED|Overall Study||207
4911233|NCT03790306|12086915|P1|STARTED|Overall Study||207
4911234|NCT03787472|12086928|P2|NOT COMPLETED|Period 2||0
4911235|NCT03787472|12086929|P1|NOT COMPLETED|Period 2||0
4911236|NCT03787472|12086928|P2|COMPLETED|Period 2||22
4911237|NCT03787472|12086929|P1|COMPLETED|Period 2||23
4911238|NCT03787472|12086928|P2|STARTED|Period 2||22
4911239|NCT03787472|12086929|P1|STARTED|Period 2||23
4911240|NCT03787472|12086928|P2|NOT COMPLETED|Period 1||0
4911241|NCT03787472|12086929|P1|NOT COMPLETED|Period 1||0
4911242|NCT03787472|12086928|P2|COMPLETED|Period 1||22
4911243|NCT03787472|12086929|P1|COMPLETED|Period 1||23
4911244|NCT03787472|12086928|P2|STARTED|Period 1||22
4911245|NCT03787472|12086929|P1|STARTED|Period 1||23
4911246|NCT03787212|12086937|P2|NOT COMPLETED|Period 1||2
4911247|NCT03787212|12086938|P1|NOT COMPLETED|Period 1||2
4911248|NCT03787212|12086937|P2|COMPLETED|Period 1||0
4911249|NCT03787212|12086938|P1|COMPLETED|Period 1||0
4911250|NCT03787212|12086937|P2|STARTED|Period 1||2
4911251|NCT03787212|12086938|P1|STARTED|Period 1||2
4911252|NCT03787212|12086937|P2|NOT COMPLETED|Period 1||0
4911253|NCT03787212|12086938|P1|NOT COMPLETED|Period 1||0
4911254|NCT03787212|12086937|P2|COMPLETED|Period 1||2
4911255|NCT03787212|12086938|P1|COMPLETED|Period 1||2
4911256|NCT03787212|12086937|P2|STARTED|Period 1||2
4911257|NCT03787212|12086938|P1|STARTED|Period 1||2
4911258|NCT03786718|12086944|P1|NOT COMPLETED|Overall Study||7
4911259|NCT03786718|12086944|P1|COMPLETED|Overall Study||60
4911260|NCT03786718|12086944|P1|STARTED|Overall Study||67
4911261|NCT03784898|12086959|P1|NOT COMPLETED|Overall Study||0
4911262|NCT03784898|12086959|P1|COMPLETED|Overall Study||13
4911263|NCT03784898|12086959|P1|STARTED|Overall Study||13
4911264|NCT03784001|12086966|P3|NOT COMPLETED|Overall Study||1
4911265|NCT03784001|12086967|P2|NOT COMPLETED|Overall Study||0
4911266|NCT03784001|12086968|P1|NOT COMPLETED|Overall Study||2
4911267|NCT03784001|12086966|P3|COMPLETED|Overall Study||40
4911268|NCT03784001|12086967|P2|COMPLETED|Overall Study||38
4911269|NCT03784001|12086968|P1|COMPLETED|Overall Study||44
4911270|NCT03784001|12086966|P3|STARTED|Overall Study||41
4911271|NCT03784001|12086967|P2|STARTED|Overall Study||38
4911272|NCT03784001|12086968|P1|STARTED|Overall Study||46
4911273|NCT03783780|12087000|P1|NOT COMPLETED|Overall Study||1
4911274|NCT03783780|12087000|P1|COMPLETED|Overall Study||20
4911275|NCT03783780|12087000|P1|STARTED|Overall Study||21
4911276|NCT03782571|12087005|P4|NOT COMPLETED|Period 4||0
4911277|NCT03782571|12087006|P3|NOT COMPLETED|Period 4||0
4911278|NCT03782571|12087007|P2|NOT COMPLETED|Period 4||0
4911279|NCT03782571|12087008|P1|NOT COMPLETED|Period 4||0
4911280|NCT03782571|12087005|P4|COMPLETED|Period 4||7
4911281|NCT03782571|12087006|P3|COMPLETED|Period 4||6
4911282|NCT03782571|12087007|P2|COMPLETED|Period 4||6
4911283|NCT03782571|12087008|P1|COMPLETED|Period 4||3
4911284|NCT03782571|12087005|P4|STARTED|Period 4||7
4911285|NCT03782571|12087006|P3|STARTED|Period 4||6
4911286|NCT03782571|12087007|P2|STARTED|Period 4||6
4911287|NCT03782571|12087008|P1|STARTED|Period 4||3
4911288|NCT03782571|12087005|P4|NOT COMPLETED|Period 3||0
4911289|NCT03782571|12087006|P3|NOT COMPLETED|Period 3||0
4911290|NCT03782571|12087007|P2|NOT COMPLETED|Period 3||0
4911291|NCT03782571|12087008|P1|NOT COMPLETED|Period 3||2
4911292|NCT03782571|12087005|P4|COMPLETED|Period 3||7
4911293|NCT03782571|12087006|P3|COMPLETED|Period 3||6
4911294|NCT03782571|12087007|P2|COMPLETED|Period 3||6
4911295|NCT03782571|12087008|P1|COMPLETED|Period 3||3
4911296|NCT03782571|12087005|P4|STARTED|Period 3||7
4911297|NCT03782571|12087006|P3|STARTED|Period 3||6
4911298|NCT03782571|12087007|P2|STARTED|Period 3||6
4911299|NCT03782571|12087008|P1|STARTED|Period 3||5
4911300|NCT03782571|12087005|P4|NOT COMPLETED|Period 2||0
4911301|NCT03782571|12087006|P3|NOT COMPLETED|Period 2||0
4911302|NCT03782571|12087007|P2|NOT COMPLETED|Period 2||0
4911303|NCT03782571|12087008|P1|NOT COMPLETED|Period 2||0
4911304|NCT03782571|12087005|P4|COMPLETED|Period 2||7
4911305|NCT03782571|12087006|P3|COMPLETED|Period 2||6
4911306|NCT03782571|12087007|P2|COMPLETED|Period 2||6
4911307|NCT03782571|12087008|P1|COMPLETED|Period 2||5
4911308|NCT03782571|12087005|P4|STARTED|Period 2||7
4911309|NCT03782571|12087006|P3|STARTED|Period 2||6
4911310|NCT03782571|12087007|P2|STARTED|Period 2||6
4911311|NCT03782571|12087008|P1|STARTED|Period 2||5
4911312|NCT03782571|12087005|P4|NOT COMPLETED|Period 1||0
4911313|NCT03782571|12087006|P3|NOT COMPLETED|Period 1||0
4911314|NCT03782571|12087007|P2|NOT COMPLETED|Period 1||0
4911315|NCT03782571|12087008|P1|NOT COMPLETED|Period 1||1
4911316|NCT03782571|12087005|P4|COMPLETED|Period 1||7
4911317|NCT03782571|12087006|P3|COMPLETED|Period 1||6
4911318|NCT03782571|12087007|P2|COMPLETED|Period 1||6
4911319|NCT03782571|12087008|P1|COMPLETED|Period 1||5
4911320|NCT03782571|12087005|P4|STARTED|Period 1||7
4911321|NCT03782571|12087006|P3|STARTED|Period 1||6
4911322|NCT03782571|12087007|P2|STARTED|Period 1||6
4911323|NCT03782571|12087008|P1|STARTED|Period 1||6
4911324|NCT03782181|12087034|P2|NOT COMPLETED|Overall Study||0
4911325|NCT03782181|12087035|P1|NOT COMPLETED|Overall Study||0
4911326|NCT03782181|12087034|P2|COMPLETED|Overall Study||20
4911327|NCT03782181|12087035|P1|COMPLETED|Overall Study||20
4911328|NCT03782181|12087034|P2|STARTED|Overall Study||20
4911329|NCT03782181|12087035|P1|STARTED|Overall Study||20
4911330|NCT03781375|12087061|P2|NOT COMPLETED|Open-label Phase||3
4911331|NCT03781375|12087062|P1|NOT COMPLETED|Open-label Phase||3
4911332|NCT03781375|12087061|P2|COMPLETED|Open-label Phase||6
4911333|NCT03781375|12087062|P1|COMPLETED|Open-label Phase||8
4911334|NCT03781375|12087061|P2|Received Study Drug|Open-label Phase||9
4911335|NCT03781375|12087062|P1|Received Study Drug|Open-label Phase||10
4911336|NCT03781375|12087061|P2|STARTED|Open-label Phase||9
4911337|NCT03781375|12087062|P1|STARTED|Open-label Phase||11
4911338|NCT03781375|12087061|P2|NOT COMPLETED|Double-blind Phase||6
4911339|NCT03781375|12087062|P1|NOT COMPLETED|Double-blind Phase||7
4911340|NCT03781375|12087061|P2|COMPLETED|Double-blind Phase||7
4911341|NCT03781375|12087062|P1|COMPLETED|Double-blind Phase||5
4911342|NCT03781375|12087061|P2|Received Study Drug|Double-blind Phase||13
4911343|NCT03781375|12087062|P1|Received Study Drug|Double-blind Phase||12
4911344|NCT03781375|12087061|P2|STARTED|Double-blind Phase||13
4911345|NCT03781375|12087062|P1|STARTED|Double-blind Phase||12
4911346|NCT03780959|12087076|P3|NOT COMPLETED|Part 2||6
4911347|NCT03780959|12087077|P2|NOT COMPLETED|Part 2||19
4911348|NCT03780959|12087078|P1|NOT COMPLETED|Part 2||0
4911349|NCT03780959|12087076|P3|COMPLETED|Part 2||19
4911350|NCT03780959|12087077|P2|COMPLETED|Part 2||7
4911351|NCT03780959|12087078|P1|COMPLETED|Part 2||0
4911352|NCT03780959|12087076|P3|STARTED|Part 2||25
4911353|NCT03780959|12087077|P2|STARTED|Part 2||26
4911354|NCT03780959|12087078|P1|STARTED|Part 2||0
4911355|NCT03780959|12087076|P3|NOT COMPLETED|Part 1||0
4911356|NCT03780959|12087077|P2|NOT COMPLETED|Part 1||0
4911357|NCT03780959|12087078|P1|NOT COMPLETED|Part 1||5
4911358|NCT03780959|12087076|P3|COMPLETED|Part 1||0
4911359|NCT03780959|12087077|P2|COMPLETED|Part 1||0
4911360|NCT03780959|12087078|P1|COMPLETED|Part 1||64
4911361|NCT03780959|12087076|P3|STARTED|Part 1||0
4911362|NCT03780959|12087077|P2|STARTED|Part 1||0
4911363|NCT03780959|12087078|P1|STARTED|Part 1||69
4911364|NCT03780010|12087092|P2|NOT COMPLETED|Overall Study||0
4911365|NCT03780010|12087093|P1|NOT COMPLETED|Overall Study||0
4911366|NCT03780010|12087092|P2|COMPLETED|Overall Study||12
4911367|NCT03780010|12087093|P1|COMPLETED|Overall Study||3
4911368|NCT03780010|12087092|P2|STARTED|Overall Study||12
4911369|NCT03780010|12087093|P1|STARTED|Overall Study||3
4911370|NCT03779724|12087120|P2|NOT COMPLETED|Overall Study||4
4911371|NCT03779724|12087121|P1|NOT COMPLETED|Overall Study||6
4911372|NCT03779724|12087120|P2|COMPLETED|Overall Study||21
4911373|NCT03779724|12087121|P1|COMPLETED|Overall Study||19
4911374|NCT03779724|12087120|P2|STARTED|Overall Study||25
4911375|NCT03779724|12087121|P1|STARTED|Overall Study||25
4911376|NCT03777865|12087145|P1|NOT COMPLETED|Overall Study||0
4911377|NCT03777865|12087145|P1|COMPLETED|Overall Study||100
4911378|NCT03777865|12087145|P1|STARTED|Overall Study||100
4911379|NCT03774745|12087153|P2|NOT COMPLETED|Overall Study||4
4911380|NCT03774745|12087154|P1|NOT COMPLETED|Overall Study||2
4911381|NCT03774745|12087153|P2|COMPLETED|Overall Study||2
4911382|NCT03774745|12087154|P1|COMPLETED|Overall Study||4
4911383|NCT03774745|12087153|P2|Follow-up 2|Overall Study||2
4911384|NCT03774745|12087154|P1|Follow-up 2|Overall Study||4
4911385|NCT03774745|12087153|P2|Follow-Up 1|Overall Study||6
4911386|NCT03774745|12087154|P1|Follow-Up 1|Overall Study||5
4911387|NCT03774745|12087153|P2|STARTED|Overall Study||6
4911388|NCT03774745|12087154|P1|STARTED|Overall Study||6
4911389|NCT03774576|12087168|P1|NOT COMPLETED|Period 2||1
4911390|NCT03774576|12087168|P1|COMPLETED|Period 2||13
4911391|NCT03774576|12087168|P1|STARTED|Period 2||14
4911392|NCT03774576|12087168|P1|NOT COMPLETED|Period 1||0
4911393|NCT03774576|12087168|P1|COMPLETED|Period 1||14
4911394|NCT03774576|12087168|P1|STARTED|Period 1||14
4911395|NCT03772522|12087183|P2|NOT COMPLETED|Post-intervention Follow-up||0
4911396|NCT03772522|12087184|P1|NOT COMPLETED|Post-intervention Follow-up||1
4911397|NCT03772522|12087183|P2|COMPLETED|Post-intervention Follow-up||11
4911398|NCT03772522|12087184|P1|COMPLETED|Post-intervention Follow-up||7
4911399|NCT03772522|12087183|P2|STARTED|Post-intervention Follow-up||11
4911400|NCT03772522|12087184|P1|STARTED|Post-intervention Follow-up||8
4911401|NCT03772522|12087183|P2|NOT COMPLETED|Intervention||0
4911402|NCT03772522|12087184|P1|NOT COMPLETED|Intervention||1
4911403|NCT03772522|12087183|P2|COMPLETED|Intervention||11
4911404|NCT03772522|12087184|P1|COMPLETED|Intervention||8
4911405|NCT03772522|12087183|P2|STARTED|Intervention||11
4911406|NCT03772522|12087184|P1|STARTED|Intervention||9
4911407|NCT03772522|12087183|P2|NOT COMPLETED|Pre-intervention||4
4911408|NCT03772522|12087184|P1|NOT COMPLETED|Pre-intervention||3
4911409|NCT03772522|12087183|P2|COMPLETED|Pre-intervention||11
4911410|NCT03772522|12087184|P1|COMPLETED|Pre-intervention||9
4911411|NCT03772522|12087183|P2|STARTED|Pre-intervention||15
4911412|NCT03772522|12087184|P1|STARTED|Pre-intervention||12
4911413|NCT03772327|12087207|P2|NOT COMPLETED|Overall Study||7
4911414|NCT03772327|12087208|P1|NOT COMPLETED|Overall Study||5
4911415|NCT03772327|12087207|P2|COMPLETED|Overall Study||26
4911416|NCT03772327|12087208|P1|COMPLETED|Overall Study||25
4911417|NCT03772327|12087207|P2|Week 0 Visit|Overall Study||33
4911418|NCT03772327|12087208|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
4911419|NCT03772327|12087207|P2|STARTED|Overall Study||33
4911420|NCT03772327|12087208|P1|STARTED|Overall Study||30
4911421|NCT03771560|12087224|P1|NOT COMPLETED|Overall Study||6
4911422|NCT03771560|12087224|P1|COMPLETED|Overall Study||12
4911423|NCT03771560|12087224|P1|STARTED|Overall Study||18
4911424|NCT03768856|12087232|P1|NOT COMPLETED|Overall Study||0
4911425|NCT03768856|12087232|P1|COMPLETED|Overall Study||5
4911426|NCT03768856|12087232|P1|STARTED|Overall Study||5
4911427|NCT03767894|12087241|P1|NOT COMPLETED|Overall Study||1
4911428|NCT03767894|12087241|P1|COMPLETED|Overall Study||11
4911429|NCT03767894|12087241|P1|STARTED|Overall Study||12
4911430|NCT03767062|12087252|P2|NOT COMPLETED|Overall Study||4
4911431|NCT03767062|12087253|P1|NOT COMPLETED|Overall Study||8
4911432|NCT03767062|12087252|P2|COMPLETED|Overall Study||41
4911433|NCT03767062|12087253|P1|COMPLETED|Overall Study||37
4911434|NCT03767062|12087252|P2|STARTED|Overall Study||45
4911435|NCT03767062|12087253|P1|STARTED|Overall Study||45
4911436|NCT03766373|12087263|P2|NOT COMPLETED|Overall Study||0
4911437|NCT03766373|12087264|P1|NOT COMPLETED|Overall Study||0
4911438|NCT03766373|12087263|P2|COMPLETED|Overall Study||12
4911439|NCT03766373|12087264|P1|COMPLETED|Overall Study||12
4911440|NCT03766373|12087263|P2|STARTED|Overall Study||12
4911441|NCT03766373|12087264|P1|STARTED|Overall Study||12
4911442|NCT03765996|12087272|P2|NOT COMPLETED|Overall Study||0
4911443|NCT03765996|12087273|P1|NOT COMPLETED|Overall Study||4
4911444|NCT03765996|12087272|P2|COMPLETED|Overall Study||18
4911445|NCT03765996|12087273|P1|COMPLETED|Overall Study||14
4911446|NCT03765996|12087272|P2|STARTED|Overall Study||18
4911447|NCT03765996|12087273|P1|STARTED|Overall Study||18
4911448|NCT03765502|12087282|P5|NOT COMPLETED|Simulation 2||0
4911449|NCT03765502|12087283|P4|NOT COMPLETED|Simulation 2||0
4911450|NCT03765502|12087284|P3|NOT COMPLETED|Simulation 2||0
4911451|NCT03765502|12087285|P2|NOT COMPLETED|Simulation 2||0
4911452|NCT03765502|12087286|P1|NOT COMPLETED|Simulation 2||0
4911453|NCT03765502|12087282|P5|COMPLETED|Simulation 2||17
4911454|NCT03765502|12087283|P4|COMPLETED|Simulation 2||16
4911455|NCT03765502|12087284|P3|COMPLETED|Simulation 2||32
4911456|NCT03765502|12087285|P2|COMPLETED|Simulation 2||12
4911457|NCT03765502|12087286|P1|COMPLETED|Simulation 2||20
4911458|NCT03765502|12087282|P5|STARTED|Simulation 2||17
4911459|NCT03765502|12087283|P4|STARTED|Simulation 2||16
4911460|NCT03765502|12087284|P3|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
4911461|NCT03765502|12087285|P2|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
4911462|NCT03765502|12087286|P1|STARTED|Simulation 2||20
4911463|NCT03765502|12087282|P5|NOT COMPLETED|Simulation 1||0
4911464|NCT03765502|12087283|P4|NOT COMPLETED|Simulation 1||0
4911465|NCT03765502|12087284|P3|NOT COMPLETED|Simulation 1||0
4911466|NCT03765502|12087285|P2|NOT COMPLETED|Simulation 1||0
4911467|NCT03765502|12087286|P1|NOT COMPLETED|Simulation 1||0
4911468|NCT03765502|12087282|P5|COMPLETED|Simulation 1||17
4911469|NCT03765502|12087283|P4|COMPLETED|Simulation 1||16
4911470|NCT03765502|12087284|P3|COMPLETED|Simulation 1||33
4911471|NCT03765502|12087285|P2|COMPLETED|Simulation 1||13
4911472|NCT03765502|12087286|P1|COMPLETED|Simulation 1||20
4911473|NCT03765502|12087282|P5|STARTED|Simulation 1||17
4911474|NCT03765502|12087283|P4|STARTED|Simulation 1||16
4911475|NCT03765502|12087284|P3|STARTED|Simulation 1||33
4911476|NCT03765502|12087285|P2|STARTED|Simulation 1||13
4911477|NCT03765502|12087286|P1|STARTED|Simulation 1||20
4911478|NCT03765138|12087306|P1|NOT COMPLETED|Overall Study||1
4911479|NCT03765138|12087306|P1|COMPLETED|Overall Study||0
4911480|NCT03765138|12087306|P1|STARTED|Overall Study||1
4911481|NCT03764813|12087316|P4|NOT COMPLETED|From Enrollment to the Last HbF Test||0
4911482|NCT03764813|12087317|P3|NOT COMPLETED|From Enrollment to the Last HbF Test||0
4911483|NCT03764813|12087318|P2|NOT COMPLETED|From Enrollment to the Last HbF Test||0
4911484|NCT03764813|12087319|P1|NOT COMPLETED|From Enrollment to the Last HbF Test||0
4911485|NCT03764813|12087316|P4|COMPLETED|From Enrollment to the Last HbF Test||5
4911486|NCT03764813|12087317|P3|COMPLETED|From Enrollment to the Last HbF Test||4
4911487|NCT03764813|12087318|P2|COMPLETED|From Enrollment to the Last HbF Test||3
4911488|NCT03764813|12087319|P1|COMPLETED|From Enrollment to the Last HbF Test||13
4911489|NCT03764813|12087316|P4|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
4911490|NCT03764813|12087317|P3|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
4911491|NCT03764813|12087318|P2|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
4911492|NCT03764813|12087319|P1|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
4911493|NCT03764813|12087316|P4|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
4911494|NCT03764813|12087317|P3|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
4911495|NCT03764813|12087318|P2|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
4911496|NCT03764813|12087319|P1|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
4911497|NCT03764813|12087316|P4|COMPLETED|From Enrollment to the Age of 32 Weeks||4
4911498|NCT03764813|12087317|P3|COMPLETED|From Enrollment to the Age of 32 Weeks||3
4911499|NCT03764813|12087318|P2|COMPLETED|From Enrollment to the Age of 32 Weeks||2
4911500|NCT03764813|12087319|P1|COMPLETED|From Enrollment to the Age of 32 Weeks||14
4911501|NCT03764813|12087316|P4|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
4911502|NCT03764813|12087317|P3|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
4911503|NCT03764813|12087318|P2|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
4911504|NCT03764813|12087319|P1|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
4911505|NCT03764449|12087339|P2|NOT COMPLETED|Overall Study||0
4911506|NCT03764449|12087340|P1|NOT COMPLETED|Overall Study||0
4911507|NCT03764449|12087339|P2|COMPLETED|Overall Study||8
4911508|NCT03764449|12087340|P1|COMPLETED|Overall Study||8
4911509|NCT03764449|12087339|P2|STARTED|Overall Study||8
4911510|NCT03764449|12087340|P1|STARTED|Overall Study||8
4911511|NCT03763058|12087430|P1|NOT COMPLETED|Overall Study||2
4911512|NCT03763058|12087430|P1|COMPLETED|Overall Study||18
4911513|NCT03763058|12087430|P1|STARTED|Overall Study||20
4911514|NCT03762668|12087440|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
4911515|NCT03762668|12087441|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
4911516|NCT03762668|12087440|P2|COMPLETED|Period 2, Second Week of Wear||29
4911517|NCT03762668|12087441|P1|COMPLETED|Period 2, Second Week of Wear||30
4911518|NCT03762668|12087440|P2|STARTED|Period 2, Second Week of Wear||29
4911519|NCT03762668|12087441|P1|STARTED|Period 2, Second Week of Wear||30
4911520|NCT03762668|12087440|P2|NOT COMPLETED|Period 1, First Week of Wear||1
4911521|NCT03762668|12087441|P1|NOT COMPLETED|Period 1, First Week of Wear||0
4911522|NCT03762668|12087440|P2|COMPLETED|Period 1, First Week of Wear||29
4911523|NCT03762668|12087441|P1|COMPLETED|Period 1, First Week of Wear||30
4911524|NCT03762668|12087440|P2|STARTED|Period 1, First Week of Wear||30
4911525|NCT03762668|12087441|P1|STARTED|Period 1, First Week of Wear||30
4911526|NCT03760510|12087449|P2|NOT COMPLETED|Overall Study||97
4911527|NCT03760510|12087450|P1|NOT COMPLETED|Overall Study||105
4911528|NCT03760510|12087449|P2|COMPLETED|Overall Study||153
4911529|NCT03760510|12087450|P1|COMPLETED|Overall Study||145
4911530|NCT03760510|12087449|P2|STARTED|Overall Study||250
4911531|NCT03760510|12087450|P1|STARTED|Overall Study||250
4911532|NCT03759587|12087462|P1|NOT COMPLETED|Overall Study||19
4911533|NCT03759587|12087462|P1|COMPLETED|Overall Study||0
4911534|NCT03759587|12087462|P1|STARTED|Overall Study||19
4911535|NCT03758365|12087475|P1|NOT COMPLETED|Overall Study||0
4911536|NCT03758365|12087475|P1|COMPLETED|Overall Study||36
4911537|NCT03758365|12087475|P1|Vehicle Cream|Overall Study||36
4911538|NCT03758365|12087475|P1|Desonide 0.05% Cream|Overall Study||36
4911539|NCT03758365|12087475|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
4911540|NCT03758365|12087475|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
4911541|NCT03758365|12087475|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
4911542|NCT03758365|12087475|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
4911543|NCT03758365|12087475|P1|MC2-01 Cream|Overall Study||36
4911544|NCT03758365|12087475|P1|STARTED|Overall Study||36
4911545|NCT03757234|12087491|P5|NOT COMPLETED|Overall Study||4
4911546|NCT03757234|12087492|P4|NOT COMPLETED|Overall Study||1
4911547|NCT03757234|12087493|P3|NOT COMPLETED|Overall Study||0
4911548|NCT03757234|12087494|P2|NOT COMPLETED|Overall Study||2
4911549|NCT03757234|12087495|P1|NOT COMPLETED|Overall Study||3
4911550|NCT03757234|12087491|P5|COMPLETED|Overall Study||70
4911551|NCT03757234|12087492|P4|COMPLETED|Overall Study||16
4911552|NCT03757234|12087493|P3|COMPLETED|Overall Study||17
4911553|NCT03757234|12087494|P2|COMPLETED|Overall Study||16
4911554|NCT03757234|12087495|P1|COMPLETED|Overall Study||72
4911555|NCT03757234|12087491|P5|Completed PTE Visit|Overall Study||71
4911556|NCT03757234|12087492|P4|Completed PTE Visit|Overall Study||16
4911557|NCT03757234|12087493|P3|Completed PTE Visit|Overall Study||17
4911558|NCT03757234|12087494|P2|Completed PTE Visit|Overall Study||16
4911559|NCT03757234|12087495|P1|Completed PTE Visit|Overall Study||72
4911560|NCT03757234|12087491|P5|STARTED|Overall Study||74
4911561|NCT03757234|12087492|P4|STARTED|Overall Study||17
4911562|NCT03757234|12087493|P3|STARTED|Overall Study||17
4911563|NCT03757234|12087494|P2|STARTED|Overall Study||18
4911564|NCT03757234|12087495|P1|STARTED|Overall Study||75
4911565|NCT03757039|12087531|P2|NOT COMPLETED|Overall Study||0
4911566|NCT03757039|12087532|P1|NOT COMPLETED|Overall Study||0
4911567|NCT03757039|12087531|P2|COMPLETED|Overall Study||9
4911568|NCT03757039|12087532|P1|COMPLETED|Overall Study||32
4911569|NCT03757039|12087531|P2|DACP MF|Overall Study||0
4911570|NCT03757039|12087532|P1|DACP MF|Overall Study||10
4911571|NCT03757039|12087531|P2|DT1 MF|Overall Study||0
4911572|NCT03757039|12087532|P1|DT1 MF|Overall Study||11
4911573|NCT03757039|12087531|P2|AOHG MF|Overall Study||0
4911574|NCT03757039|12087532|P1|AOHG MF|Overall Study||11
4911575|NCT03757039|12087531|P2|STARTED|Overall Study||9
4911576|NCT03757039|12087532|P1|STARTED|Overall Study||32
4911577|NCT03756506|12087542|P2|NOT COMPLETED|Overall Study||0
4911578|NCT03756506|12087543|P1|NOT COMPLETED|Overall Study||1
4911579|NCT03756506|12087542|P2|COMPLETED|Overall Study||6
4911580|NCT03756506|12087543|P1|COMPLETED|Overall Study||6
4911581|NCT03756506|12087542|P2|STARTED|Overall Study||6
4911582|NCT03756506|12087543|P1|STARTED|Overall Study||7
4911583|NCT03756038|12087553|P2|NOT COMPLETED|Overall Study||0
4911584|NCT03756038|12087554|P1|NOT COMPLETED|Overall Study||0
4911585|NCT03756038|12087553|P2|COMPLETED|Overall Study||0
4911586|NCT03756038|12087554|P1|COMPLETED|Overall Study||1
4911587|NCT03756038|12087553|P2|STARTED|Overall Study||0
4911588|NCT03756038|12087554|P1|STARTED|Overall Study||1
4911589|NCT03755882|12087562|P2|NOT COMPLETED|Period 2||0
4911590|NCT03755882|12087563|P1|NOT COMPLETED|Period 2||0
4911591|NCT03755882|12087562|P2|COMPLETED|Period 2||22
4911592|NCT03755882|12087563|P1|COMPLETED|Period 2||19
4911593|NCT03755882|12087562|P2|STARTED|Period 2||22
4911594|NCT03755882|12087563|P1|STARTED|Period 2||19
4911595|NCT03755882|12087562|P2|NOT COMPLETED|Period 1||0
4911596|NCT03755882|12087563|P1|NOT COMPLETED|Period 1||4
4911597|NCT03755882|12087562|P2|COMPLETED|Period 1||22
4911598|NCT03755882|12087563|P1|COMPLETED|Period 1||19
4911599|NCT03755882|12087562|P2|STARTED|Period 1||22
4911600|NCT03755882|12087563|P1|STARTED|Period 1||23
4911601|NCT03753113|12087571|P2|NOT COMPLETED|Overall Study||0
4911602|NCT03753113|12087572|P1|NOT COMPLETED|Overall Study||0
4911603|NCT03753113|12087571|P2|COMPLETED|Overall Study||12
4911604|NCT03753113|12087572|P1|COMPLETED|Overall Study||12
4911605|NCT03753113|12087571|P2|STARTED|Overall Study||12
4911606|NCT03753113|12087572|P1|STARTED|Overall Study||12
4911607|NCT03752567|12087582|P1|NOT COMPLETED|Overall Study||0
4911608|NCT03752567|12087582|P1|COMPLETED|Overall Study||40
4911609|NCT03752567|12087582|P1|STARTED|Overall Study||40
4911610|NCT03752151|12087591|P1|NOT COMPLETED|Overall Study||2
4911611|NCT03752151|12087591|P1|COMPLETED|Overall Study||75
4911612|NCT03752151|12087591|P1|STARTED|Overall Study||77
4911613|NCT03748758|12087600|P3|NOT COMPLETED|Overall Study||1
4911614|NCT03748758|12087601|P2|NOT COMPLETED|Overall Study||0
4911615|NCT03748758|12087602|P1|NOT COMPLETED|Overall Study||0
4911616|NCT03748758|12087600|P3|COMPLETED|Overall Study||5
4911617|NCT03748758|12087601|P2|COMPLETED|Overall Study||12
4911618|NCT03748758|12087602|P1|COMPLETED|Overall Study||12
4911619|NCT03748758|12087600|P3|STARTED|Overall Study||6
4911620|NCT03748758|12087601|P2|STARTED|Overall Study||12
4911621|NCT03748758|12087602|P1|STARTED|Overall Study||12
4911622|NCT03745937|12087658|P4|NOT COMPLETED|Overall Study||2
4911623|NCT03745937|12087659|P3|NOT COMPLETED|Overall Study||0
4911624|NCT03745937|12087660|P2|NOT COMPLETED|Overall Study||1
4911625|NCT03745937|12087661|P1|NOT COMPLETED|Overall Study||0
4911626|NCT03745937|12087658|P4|COMPLETED|Overall Study||7
4911627|NCT03745937|12087659|P3|COMPLETED|Overall Study||3
4911628|NCT03745937|12087660|P2|COMPLETED|Overall Study||5
4911629|NCT03745937|12087661|P1|COMPLETED|Overall Study||2
4911630|NCT03745937|12087658|P4|STARTED|Overall Study||9
4911631|NCT03745937|12087659|P3|STARTED|Overall Study||3
4911632|NCT03745937|12087660|P2|STARTED|Overall Study||6
4911633|NCT03745937|12087661|P1|STARTED|Overall Study||2
4911634|NCT03745222|12087775|P3|NOT COMPLETED|Overall Study||0
4911635|NCT03745222|12087776|P2|NOT COMPLETED|Overall Study||1
4911636|NCT03745222|12087777|P1|NOT COMPLETED|Overall Study||0
4911637|NCT03745222|12087775|P3|COMPLETED|Overall Study||0
4911638|NCT03745222|12087776|P2|COMPLETED|Overall Study||0
4911639|NCT03745222|12087777|P1|COMPLETED|Overall Study||0
4911640|NCT03745222|12087775|P3|STARTED|Overall Study||0
4911641|NCT03745222|12087776|P2|STARTED|Overall Study||1
4911642|NCT03745222|12087777|P1|STARTED|Overall Study||0
4911643|NCT03745092|12087817|P2|NOT COMPLETED|Overall Study||0
4911644|NCT03745092|12087818|P1|NOT COMPLETED|Overall Study||0
4911645|NCT03745092|12087817|P2|COMPLETED|Overall Study||23
4911646|NCT03745092|12087818|P1|COMPLETED|Overall Study||26
4911647|NCT03745092|12087817|P2|STARTED|Overall Study||23
4911648|NCT03745092|12087818|P1|STARTED|Overall Study||26
4911649|NCT03744780|12087834|P1|NOT COMPLETED|Overall Study||0
4911650|NCT03744780|12087834|P1|COMPLETED|Overall Study||32
4911651|NCT03744780|12087834|P1|STARTED|Overall Study||32
4911652|NCT03742440|12087852|P1|NOT COMPLETED|Overall Study||0
4911653|NCT03742440|12087852|P1|COMPLETED|Overall Study||40
4911654|NCT03742440|12087852|P1|STARTED|Overall Study||40
4911655|NCT03742271|12087858|P1|NOT COMPLETED|Overall Study||12
4911656|NCT03742271|12087858|P1|COMPLETED|Overall Study||115
4911657|NCT03742271|12087858|P1|STARTED|Overall Study||127
4911658|NCT03741725|12087865|P3|NOT COMPLETED|Overall Study||0
4911659|NCT03741725|12087866|P2|NOT COMPLETED|Overall Study||0
4911660|NCT03741725|12087867|P1|NOT COMPLETED|Overall Study||0
4911661|NCT03741725|12087865|P3|COMPLETED|Overall Study||100
4911662|NCT03741725|12087866|P2|COMPLETED|Overall Study||100
4911663|NCT03741725|12087867|P1|COMPLETED|Overall Study||101
4911664|NCT03741725|12087865|P3|STARTED|Overall Study||100
4911665|NCT03741725|12087866|P2|STARTED|Overall Study||100
4911666|NCT03741725|12087867|P1|STARTED|Overall Study||101
4911667|NCT03740659|12087899|P3|NOT COMPLETED|Overall Study||0
4911668|NCT03740659|12087900|P2|NOT COMPLETED|Overall Study||0
4911669|NCT03740659|12087901|P1|NOT COMPLETED|Overall Study||0
4911670|NCT03740659|12087899|P3|COMPLETED|Overall Study||41
4911671|NCT03740659|12087900|P2|COMPLETED|Overall Study||42
4911672|NCT03740659|12087901|P1|COMPLETED|Overall Study||42
4911673|NCT03740659|12087899|P3|STARTED|Overall Study||41
4911674|NCT03740659|12087900|P2|STARTED|Overall Study||42
4911675|NCT03740659|12087901|P1|STARTED|Overall Study||42
4911676|NCT03739242|12087917|P2|NOT COMPLETED|Overall Study||2
4911677|NCT03739242|12087918|P1|NOT COMPLETED|Overall Study||1
4911678|NCT03739242|12087917|P2|COMPLETED|Overall Study||42
4911679|NCT03739242|12087918|P1|COMPLETED|Overall Study||43
4911680|NCT03739242|12087917|P2|STARTED|Overall Study||44
4911681|NCT03739242|12087918|P1|STARTED|Overall Study||44
4911682|NCT03738865|12087956|P2|NOT COMPLETED|Overall Study||4
4911683|NCT03738865|12087957|P1|NOT COMPLETED|Overall Study||5
4911684|NCT03738865|12087956|P2|COMPLETED|Overall Study||62
4911685|NCT03738865|12087957|P1|COMPLETED|Overall Study||61
4911686|NCT03738865|12087956|P2|STARTED|Overall Study||66
4911687|NCT03738865|12087957|P1|STARTED|Overall Study||66
4911688|NCT03738020|12087971|P1|NOT COMPLETED|Overall Study||1
4911689|NCT03738020|12087971|P1|COMPLETED|Overall Study||57
4911690|NCT03738020|12087971|P1|STARTED|Overall Study||58
4911691|NCT03735862|12087978|P1|NOT COMPLETED|Overall Study||0
4911692|NCT03735862|12087978|P1|COMPLETED|Overall Study||73
4911693|NCT03735862|12087978|P1|STARTED|Overall Study||73
4911694|NCT03734822|12087986|P1|NOT COMPLETED|Overall Study||0
4911695|NCT03734822|12087986|P1|COMPLETED|Overall Study||47
4911696|NCT03734822|12087986|P1|STARTED|Overall Study||47
4911697|NCT03733899|12087990|P6|NOT COMPLETED|Period 3||0
4911698|NCT03733899|12087991|P5|NOT COMPLETED|Period 3||0
4911699|NCT03733899|12087992|P4|NOT COMPLETED|Period 3||0
4911700|NCT03733899|12087993|P3|NOT COMPLETED|Period 3||0
4911701|NCT03733899|12087994|P2|NOT COMPLETED|Period 3||0
4911702|NCT03733899|12087995|P1|NOT COMPLETED|Period 3||1
4911703|NCT03733899|12087990|P6|COMPLETED|Period 3||2
4911704|NCT03733899|12087991|P5|COMPLETED|Period 3||4
4911705|NCT03733899|12087992|P4|COMPLETED|Period 3||4
4911706|NCT03733899|12087993|P3|COMPLETED|Period 3||3
4911707|NCT03733899|12087994|P2|COMPLETED|Period 3||2
4911708|NCT03733899|12087995|P1|COMPLETED|Period 3||2
4911709|NCT03733899|12087990|P6|STARTED|Period 3||2
4911710|NCT03733899|12087991|P5|STARTED|Period 3||4
4911711|NCT03733899|12087992|P4|STARTED|Period 3||4
4911712|NCT03733899|12087993|P3|STARTED|Period 3||3
4911713|NCT03733899|12087994|P2|STARTED|Period 3||2
4911714|NCT03733899|12087995|P1|STARTED|Period 3||3
4911715|NCT03733899|12087990|P6|NOT COMPLETED|Period 2||0
4911716|NCT03733899|12087991|P5|NOT COMPLETED|Period 2||0
4911717|NCT03733899|12087992|P4|NOT COMPLETED|Period 2||0
4911718|NCT03733899|12087993|P3|NOT COMPLETED|Period 2||0
4911719|NCT03733899|12087994|P2|NOT COMPLETED|Period 2||1
4911720|NCT03733899|12087995|P1|NOT COMPLETED|Period 2||0
4911721|NCT03733899|12087990|P6|COMPLETED|Period 2||2
4911722|NCT03733899|12087991|P5|COMPLETED|Period 2||4
4911723|NCT03733899|12087992|P4|COMPLETED|Period 2||4
4911724|NCT03733899|12087993|P3|COMPLETED|Period 2||3
4911725|NCT03733899|12087994|P2|COMPLETED|Period 2||2
4911726|NCT03733899|12087995|P1|COMPLETED|Period 2||3
4911727|NCT03733899|12087990|P6|STARTED|Period 2||2
4911728|NCT03733899|12087991|P5|STARTED|Period 2||4
4911729|NCT03733899|12087992|P4|STARTED|Period 2||4
4911730|NCT03733899|12087993|P3|STARTED|Period 2||3
4911731|NCT03733899|12087994|P2|STARTED|Period 2||3
4911732|NCT03733899|12087995|P1|STARTED|Period 2||3
4911733|NCT03733899|12087990|P6|NOT COMPLETED|Period 1||1
4911734|NCT03733899|12087991|P5|NOT COMPLETED|Period 1||0
4911735|NCT03733899|12087992|P4|NOT COMPLETED|Period 1||0
4911736|NCT03733899|12087993|P3|NOT COMPLETED|Period 1||0
4911737|NCT03733899|12087994|P2|NOT COMPLETED|Period 1||0
4911738|NCT03733899|12087995|P1|NOT COMPLETED|Period 1||0
4911739|NCT03733899|12087990|P6|COMPLETED|Period 1||2
4911740|NCT03733899|12087991|P5|COMPLETED|Period 1||4
4911741|NCT03733899|12087992|P4|COMPLETED|Period 1||4
4911742|NCT03733899|12087993|P3|COMPLETED|Period 1||3
4911743|NCT03733899|12087994|P2|COMPLETED|Period 1||3
4911744|NCT03733899|12087995|P1|COMPLETED|Period 1||3
4911745|NCT03733899|12087990|P6|STARTED|Period 1||3
4911746|NCT03733899|12087991|P5|STARTED|Period 1||4
4911747|NCT03733899|12087992|P4|STARTED|Period 1||4
4911748|NCT03733899|12087993|P3|STARTED|Period 1||3
4911749|NCT03733899|12087994|P2|STARTED|Period 1||3
4911750|NCT03733899|12087995|P1|STARTED|Period 1||3
4911751|NCT03733470|12088023|P2|NOT COMPLETED|Overall Study||1
4911752|NCT03733470|12088024|P1|NOT COMPLETED|Overall Study||1
4911753|NCT03733470|12088023|P2|COMPLETED|Overall Study||10
4911754|NCT03733470|12088024|P1|COMPLETED|Overall Study||7
4911755|NCT03733470|12088023|P2|STARTED|Overall Study||11
4911756|NCT03733470|12088024|P1|STARTED|Overall Study||8
4911757|NCT03729960|12088030|P1|NOT COMPLETED|Overall Study||0
4911758|NCT03729960|12088030|P1|COMPLETED|Overall Study||20
4911759|NCT03729960|12088030|P1|STARTED|Overall Study||20
4911760|NCT03728140|12088041|P2|NOT COMPLETED|Overall Study||7
4911761|NCT03728140|12088042|P1|NOT COMPLETED|Overall Study||10
4911762|NCT03728140|12088041|P2|COMPLETED|Overall Study||168
4911763|NCT03728140|12088042|P1|COMPLETED|Overall Study||150
4911764|NCT03728140|12088041|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
4911765|NCT03728140|12088042|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
4911766|NCT03727854|12088052|P2|NOT COMPLETED|Overall Study||0
4911767|NCT03727854|12088053|P1|NOT COMPLETED|Overall Study||0
4911768|NCT03727854|12088052|P2|COMPLETED|Overall Study||20
4911769|NCT03727854|12088053|P1|COMPLETED|Overall Study||20
4911770|NCT03727854|12088052|P2|STARTED|Overall Study||20
4911771|NCT03727854|12088053|P1|STARTED|Overall Study||20
4911772|NCT03727373|12088075|P1|NOT COMPLETED|Overall Study||0
4911773|NCT03727373|12088075|P1|COMPLETED|Overall Study||8
4911774|NCT03727373|12088075|P1|STARTED|Overall Study||8
4911775|NCT03725982|12088088|P2|NOT COMPLETED|Second Intervention||0
4911776|NCT03725982|12088089|P1|NOT COMPLETED|Second Intervention||0
4911777|NCT03725982|12088088|P2|COMPLETED|Second Intervention||17
4911778|NCT03725982|12088089|P1|COMPLETED|Second Intervention||19
4911779|NCT03725982|12088088|P2|STARTED|Second Intervention||17
4911780|NCT03725982|12088089|P1|STARTED|Second Intervention||19
4911781|NCT03725982|12088088|P2|NOT COMPLETED|First Intervention||2
4911782|NCT03725982|12088089|P1|NOT COMPLETED|First Intervention||1
4911783|NCT03725982|12088088|P2|COMPLETED|First Intervention||17
4911784|NCT03725982|12088089|P1|COMPLETED|First Intervention||19
4911785|NCT03725982|12088088|P2|STARTED|First Intervention||19
4911786|NCT03725982|12088089|P1|STARTED|First Intervention||20
4911787|NCT03725098|12088113|P2|NOT COMPLETED|Overall Study||0
4911788|NCT03725098|12088114|P1|NOT COMPLETED|Overall Study||0
4911789|NCT03725098|12088113|P2|COMPLETED|Overall Study||52
4911790|NCT03725098|12088114|P1|COMPLETED|Overall Study||53
4911791|NCT03725098|12088113|P2|STARTED|Overall Study||52
4911792|NCT03725098|12088114|P1|STARTED|Overall Study||53
4911793|NCT03725085|12088122|P1|NOT COMPLETED|Overall Study||2
4911794|NCT03725085|12088122|P1|COMPLETED|Overall Study||550
4911795|NCT03725085|12088122|P1|STARTED|Overall Study||552
4911796|NCT03724981|12088130|P2|NOT COMPLETED|Second Device||0
4911797|NCT03724981|12088131|P1|NOT COMPLETED|Second Device||0
4911798|NCT03724981|12088130|P2|COMPLETED|Second Device||155
4911799|NCT03724981|12088131|P1|COMPLETED|Second Device||155
4911800|NCT03724981|12088130|P2|STARTED|Second Device||155
4911801|NCT03724981|12088131|P1|STARTED|Second Device||155
4911802|NCT03724981|12088130|P2|NOT COMPLETED|First Device||1
4911803|NCT03724981|12088131|P1|NOT COMPLETED|First Device||1
4911804|NCT03724981|12088130|P2|COMPLETED|First Device||155
4911805|NCT03724981|12088131|P1|COMPLETED|First Device||155
4911806|NCT03724981|12088130|P2|STARTED|First Device||156
4911807|NCT03724981|12088131|P1|STARTED|First Device||156
4911808|NCT03724877|12088141|P2|NOT COMPLETED|Overall Study||0
4911809|NCT03724877|12088142|P1|NOT COMPLETED|Overall Study||0
4911810|NCT03724877|12088141|P2|COMPLETED|Overall Study||1932
4911811|NCT03724877|12088142|P1|COMPLETED|Overall Study||6921
4911812|NCT03724877|12088141|P2|STARTED|Overall Study||1932
4911813|NCT03724877|12088142|P1|STARTED|Overall Study||6921
4911814|NCT03723980|12088156|P2|NOT COMPLETED|Overall Study||5
4911815|NCT03723980|12088157|P1|NOT COMPLETED|Overall Study||7
4911816|NCT03723980|12088156|P2|COMPLETED|Overall Study||35
4911817|NCT03723980|12088157|P1|COMPLETED|Overall Study||33
4911818|NCT03723980|12088156|P2|STARTED|Overall Study||40
4911819|NCT03723980|12088157|P1|STARTED|Overall Study||40
4911820|NCT03723603|12088173|P1|NOT COMPLETED|Overall Study||3
4911821|NCT03723603|12088173|P1|COMPLETED|Overall Study||5
4911822|NCT03723603|12088173|P1|STARTED|Overall Study||8
4911823|NCT03722264|12088179|P1|NOT COMPLETED|Overall Study||3
4911824|NCT03722264|12088179|P1|COMPLETED|Overall Study||9
4911825|NCT03722264|12088179|P1|STARTED|Overall Study||12
4911826|NCT03721549|12088191|P2|NOT COMPLETED|Overall Study||0
4911827|NCT03721549|12088192|P1|NOT COMPLETED|Overall Study||1
4911828|NCT03721549|12088191|P2|COMPLETED|Overall Study||8
4911829|NCT03721549|12088192|P1|COMPLETED|Overall Study||7
4911830|NCT03721549|12088191|P2|STARTED|Overall Study||8
4911831|NCT03721549|12088192|P1|STARTED|Overall Study||8
4911832|NCT03720938|12088202|P2|NOT COMPLETED|Overall Study||623
4911833|NCT03720938|12088203|P1|NOT COMPLETED|Overall Study||189
4911834|NCT03720938|12088202|P2|COMPLETED|Overall Study||53
4911835|NCT03720938|12088203|P1|COMPLETED|Overall Study||53
4911836|NCT03720938|12088202|P2|STARTED|Overall Study||676
4911837|NCT03720938|12088203|P1|STARTED|Overall Study||242
4911838|NCT03720847|12088247|P2|NOT COMPLETED|Condition 2||0
4911839|NCT03720847|12088248|P1|NOT COMPLETED|Condition 2||0
4911840|NCT03720847|12088247|P2|COMPLETED|Condition 2||13
4911841|NCT03720847|12088248|P1|COMPLETED|Condition 2||14
4911842|NCT03720847|12088247|P2|STARTED|Condition 2||13
4911843|NCT03720847|12088248|P1|STARTED|Condition 2||14
4911844|NCT03720847|12088247|P2|NOT COMPLETED|Washout||2
4911845|NCT03720847|12088248|P1|NOT COMPLETED|Washout||1
4911846|NCT03720847|12088247|P2|COMPLETED|Washout||13
4911847|NCT03720847|12088248|P1|COMPLETED|Washout||14
4911848|NCT03720847|12088247|P2|STARTED|Washout||15
4911849|NCT03720847|12088248|P1|STARTED|Washout||15
4911850|NCT03720847|12088247|P2|NOT COMPLETED|Condition 1||0
4911851|NCT03720847|12088248|P1|NOT COMPLETED|Condition 1||0
4911852|NCT03720847|12088247|P2|COMPLETED|Condition 1||15
4911853|NCT03720847|12088248|P1|COMPLETED|Condition 1||15
4911854|NCT03720847|12088247|P2|STARTED|Condition 1||15
4911855|NCT03720847|12088248|P1|STARTED|Condition 1||15
4911856|NCT03720119|12088266|P1|NOT COMPLETED|Overall Study||9
4911857|NCT03720119|12088266|P1|COMPLETED|Overall Study||69
4911858|NCT03720119|12088266|P1|STARTED|Overall Study||78
4911859|NCT03718143|12088272|P3|NOT COMPLETED|Overall Study||1
4911860|NCT03718143|12088273|P2|NOT COMPLETED|Overall Study||2
4911861|NCT03718143|12088274|P1|NOT COMPLETED|Overall Study||3
4911862|NCT03718143|12088272|P3|COMPLETED|Overall Study||0
4911863|NCT03718143|12088273|P2|COMPLETED|Overall Study||0
4911864|NCT03718143|12088274|P1|COMPLETED|Overall Study||0
4911865|NCT03718143|12088272|P3|STARTED|Overall Study||1
4911866|NCT03718143|12088273|P2|STARTED|Overall Study||2
4911867|NCT03718143|12088274|P1|STARTED|Overall Study||3
4911868|NCT03718000|12088290|P2|NOT COMPLETED|Overall Study||5
4911869|NCT03718000|12088291|P1|NOT COMPLETED|Overall Study||2
4911870|NCT03718000|12088290|P2|COMPLETED|Overall Study||51
4911871|NCT03718000|12088291|P1|COMPLETED|Overall Study||53
4911872|NCT03718000|12088290|P2|STARTED|Overall Study||56
4911873|NCT03718000|12088291|P1|STARTED|Overall Study||55
4911874|NCT03717064|12088313|P1|NOT COMPLETED|Period 2||1
4911875|NCT03717064|12088313|P1|COMPLETED|Period 2||17
4911876|NCT03717064|12088313|P1|STARTED|Period 2||18
4911877|NCT03717064|12088313|P1|NOT COMPLETED|Period 1||0
4911878|NCT03717064|12088313|P1|COMPLETED|Period 1||18
4911879|NCT03717064|12088313|P1|STARTED|Period 1||18
4911880|NCT03716050|12088345|P8|NOT COMPLETED|Overall Study||2
4911881|NCT03716050|12088346|P7|NOT COMPLETED|Overall Study||0
4911882|NCT03716050|12088347|P6|NOT COMPLETED|Overall Study||0
4911883|NCT03716050|12088348|P5|NOT COMPLETED|Overall Study||0
4911884|NCT03716050|12088349|P4|NOT COMPLETED|Overall Study||2
4911885|NCT03716050|12088350|P3|NOT COMPLETED|Overall Study||1
4911886|NCT03716050|12088351|P2|NOT COMPLETED|Overall Study||0
4911887|NCT03716050|12088352|P1|NOT COMPLETED|Overall Study||0
4911888|NCT03716050|12088345|P8|COMPLETED|Overall Study||0
4911889|NCT03716050|12088346|P7|COMPLETED|Overall Study||4
4911890|NCT03716050|12088347|P6|COMPLETED|Overall Study||0
4911891|NCT03716050|12088348|P5|COMPLETED|Overall Study||1
4911892|NCT03716050|12088349|P4|COMPLETED|Overall Study||1
4911893|NCT03716050|12088350|P3|COMPLETED|Overall Study||0
4911894|NCT03716050|12088351|P2|COMPLETED|Overall Study||4
4911895|NCT03716050|12088352|P1|COMPLETED|Overall Study||2
4911896|NCT03716050|12088345|P8|STARTED|Overall Study||2
4911897|NCT03716050|12088346|P7|STARTED|Overall Study||4
4911898|NCT03716050|12088347|P6|STARTED|Overall Study||0
4911899|NCT03716050|12088348|P5|STARTED|Overall Study||1
4911900|NCT03716050|12088349|P4|STARTED|Overall Study||3
4911901|NCT03716050|12088350|P3|STARTED|Overall Study||1
4911902|NCT03716050|12088351|P2|STARTED|Overall Study||4
4911903|NCT03716050|12088352|P1|STARTED|Overall Study||2
4911904|NCT03715803|12088406|P2|NOT COMPLETED|Overall Study||0
4911905|NCT03715803|12088407|P1|NOT COMPLETED|Overall Study||0
4911906|NCT03715803|12088406|P2|COMPLETED|Overall Study||126
4911907|NCT03715803|12088407|P1|COMPLETED|Overall Study||91
4911908|NCT03715803|12088406|P2|STARTED|Overall Study||126
4911909|NCT03715803|12088407|P1|STARTED|Overall Study||91
4911910|NCT03715530|12088426|P3|NOT COMPLETED|Overall Study||2
4911911|NCT03715530|12088427|P2|NOT COMPLETED|Overall Study||1
4911912|NCT03715530|12088428|P1|NOT COMPLETED|Overall Study||3
4911913|NCT03715530|12088426|P3|COMPLETED|Overall Study||85
4911914|NCT03715530|12088427|P2|COMPLETED|Overall Study||41
4911915|NCT03715530|12088428|P1|COMPLETED|Overall Study||30
4911916|NCT03715530|12088426|P3|STARTED|Overall Study||87
4911917|NCT03715530|12088427|P2|STARTED|Overall Study||42
4911918|NCT03715530|12088428|P1|STARTED|Overall Study||33
4911919|NCT03715426|12088438|P2|NOT COMPLETED|Overall Study||25
4911920|NCT03715426|12088439|P1|NOT COMPLETED|Overall Study||21
4911921|NCT03715426|12088438|P2|COMPLETED|Overall Study||92
4911922|NCT03715426|12088439|P1|COMPLETED|Overall Study||112
4911923|NCT03715426|12088438|P2|4-Month Follow-Up Survey|Overall Study||92
4911924|NCT03715426|12088439|P1|4-Month Follow-Up Survey|Overall Study||112
4911925|NCT03715426|12088438|P2|1-Month Follow-Up Survey|Overall Study||97
4911926|NCT03715426|12088439|P1|1-Month Follow-Up Survey|Overall Study||113
4911927|NCT03715426|12088438|P2|STARTED|Overall Study||117
4911928|NCT03715426|12088439|P1|STARTED|Overall Study||133
4911929|NCT03714672|12088483|P4|NOT COMPLETED|Overall Study||1
4911930|NCT03714672|12088484|P3|NOT COMPLETED|Overall Study||4
4911931|NCT03714672|12088485|P2|NOT COMPLETED|Overall Study||4
4911932|NCT03714672|12088486|P1|NOT COMPLETED|Overall Study||2
4911933|NCT03714672|12088483|P4|COMPLETED|Overall Study||207
4911934|NCT03714672|12088484|P3|COMPLETED|Overall Study||202
4911935|NCT03714672|12088485|P2|COMPLETED|Overall Study||202
4911936|NCT03714672|12088486|P1|COMPLETED|Overall Study||207
4911937|NCT03714672|12088483|P4|Safety Set|Overall Study||207
4911938|NCT03714672|12088484|P3|Safety Set|Overall Study||206
4911939|NCT03714672|12088485|P2|Safety Set|Overall Study||205
4911940|NCT03714672|12088486|P1|Safety Set|Overall Study||208
4911941|NCT03714672|12088483|P4|STARTED|Overall Study||208
4911942|NCT03714672|12088484|P3|STARTED|Overall Study||206
4911943|NCT03714672|12088485|P2|STARTED|Overall Study||206
4911944|NCT03714672|12088486|P1|STARTED|Overall Study||209
4911945|NCT03714659|12088532|P1|NOT COMPLETED|Overall Study||1
4911946|NCT03714659|12088532|P1|COMPLETED|Overall Study||19
4911947|NCT03714659|12088532|P1|STARTED|Overall Study||20
4911948|NCT03712917|12088540|P3|NOT COMPLETED|Overall Study||9
4911949|NCT03712917|12088541|P2|NOT COMPLETED|Overall Study||8
4911950|NCT03712917|12088542|P1|NOT COMPLETED|Overall Study||9
4911951|NCT03712917|12088540|P3|COMPLETED|Overall Study||31
4911952|NCT03712917|12088541|P2|COMPLETED|Overall Study||32
4911953|NCT03712917|12088542|P1|COMPLETED|Overall Study||31
4911954|NCT03712917|12088540|P3|STARTED|Overall Study||40
4911955|NCT03712917|12088541|P2|STARTED|Overall Study||40
4911956|NCT03712917|12088542|P1|STARTED|Overall Study||40
4911957|NCT03709823|12088559|P6|NOT COMPLETED|Overall Study||0
4911958|NCT03709823|12088560|P5|NOT COMPLETED|Overall Study||1
4911959|NCT03709823|12088561|P4|NOT COMPLETED|Overall Study||2
4911960|NCT03709823|12088562|P3|NOT COMPLETED|Overall Study||3
4911961|NCT03709823|12088563|P2|NOT COMPLETED|Overall Study||5
4911962|NCT03709823|12088564|P1|NOT COMPLETED|Overall Study||3
4911963|NCT03709823|12088559|P6|COMPLETED|Overall Study||26
4911964|NCT03709823|12088560|P5|COMPLETED|Overall Study||49
4911965|NCT03709823|12088561|P4|COMPLETED|Overall Study||50
4911966|NCT03709823|12088562|P3|COMPLETED|Overall Study||22
4911967|NCT03709823|12088563|P2|COMPLETED|Overall Study||45
4911968|NCT03709823|12088564|P1|COMPLETED|Overall Study||48
4911969|NCT03709823|12088559|P6|STARTED|Overall Study||26
4911970|NCT03709823|12088560|P5|STARTED|Overall Study||50
4911971|NCT03709823|12088561|P4|STARTED|Overall Study||52
4911972|NCT03709823|12088562|P3|STARTED|Overall Study||25
4911973|NCT03709823|12088563|P2|STARTED|Overall Study||50
4911974|NCT03709823|12088564|P1|STARTED|Overall Study||51
4911975|NCT03709810|12088584|P2|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
4911976|NCT03709810|12088585|P1|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
4911977|NCT03709810|12088584|P2|COMPLETED|Treatment Period 2 (Visit 3)||24
4911978|NCT03709810|12088585|P1|COMPLETED|Treatment Period 2 (Visit 3)||24
4911979|NCT03709810|12088584|P2|STARTED|Treatment Period 2 (Visit 3)||24
4911980|NCT03709810|12088585|P1|STARTED|Treatment Period 2 (Visit 3)||24
4911981|NCT03709810|12088584|P2|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
4911982|NCT03709810|12088585|P1|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
4911983|NCT03709810|12088584|P2|COMPLETED|Treatment Period 1 (Visit 2)||24
4911984|NCT03709810|12088585|P1|COMPLETED|Treatment Period 1 (Visit 2)||24
4911985|NCT03709810|12088584|P2|STARTED|Treatment Period 1 (Visit 2)||24
4911986|NCT03709810|12088585|P1|STARTED|Treatment Period 1 (Visit 2)||24
4911987|NCT03708770|12088599|P1|NOT COMPLETED|Overall Study||10
4911988|NCT03708770|12088599|P1|COMPLETED|Overall Study||22
4911989|NCT03708770|12088599|P1|STARTED|Overall Study||32
4911990|NCT03708744|12088610|P4|NOT COMPLETED|Overall Study||0
4911991|NCT03708744|12088611|P3|NOT COMPLETED|Overall Study||1
4911992|NCT03708744|12088612|P2|NOT COMPLETED|Overall Study||0
4911993|NCT03708744|12088613|P1|NOT COMPLETED|Overall Study||0
4911994|NCT03708744|12088610|P4|COMPLETED|Overall Study||6
4911995|NCT03708744|12088611|P3|COMPLETED|Overall Study||4
4911996|NCT03708744|12088612|P2|COMPLETED|Overall Study||6
4911997|NCT03708744|12088613|P1|COMPLETED|Overall Study||7
4911998|NCT03708744|12088610|P4|STARTED|Overall Study||6
4911999|NCT03708744|12088611|P3|STARTED|Overall Study||5
4912000|NCT03708744|12088612|P2|STARTED|Overall Study||6
4912001|NCT03708744|12088613|P1|STARTED|Overall Study||7
4912002|NCT03708562|12088631|P1|NOT COMPLETED|Overall Study||12
4912003|NCT03708562|12088631|P1|COMPLETED|Overall Study||12
4912004|NCT03708562|12088631|P1|STARTED|Overall Study||24
4912005|NCT03707821|12088647|P2|NOT COMPLETED|Overall Study||1
4912006|NCT03707821|12088648|P1|NOT COMPLETED|Overall Study||2
4912007|NCT03707821|12088647|P2|COMPLETED|Overall Study||125
4912008|NCT03707821|12088648|P1|COMPLETED|Overall Study||123
4912009|NCT03707821|12088647|P2|STARTED|Overall Study||126
4912010|NCT03707821|12088648|P1|STARTED|Overall Study||125
4912011|NCT03707522|12088670|P4|NOT COMPLETED|Overall Study||36
4912012|NCT03707522|12088671|P3|NOT COMPLETED|Overall Study||41
4912013|NCT03707522|12088672|P2|NOT COMPLETED|Overall Study||27
4912014|NCT03707522|12088673|P1|NOT COMPLETED|Overall Study||24
4912015|NCT03707522|12088670|P4|COMPLETED|Overall Study||7
4912016|NCT03707522|12088671|P3|COMPLETED|Overall Study||11
4912017|NCT03707522|12088672|P2|COMPLETED|Overall Study||9
4912018|NCT03707522|12088673|P1|COMPLETED|Overall Study||7
4912019|NCT03707522|12088670|P4|STARTED|Overall Study||43
4912020|NCT03707522|12088671|P3|STARTED|Overall Study||52
4912021|NCT03707522|12088672|P2|STARTED|Overall Study||36
4912022|NCT03707522|12088673|P1|STARTED|Overall Study||31
4912023|NCT03706469|12088703|P4|NOT COMPLETED|Overall Study||0
4912024|NCT03706469|12088704|P3|NOT COMPLETED|Overall Study||0
4912025|NCT03706469|12088705|P2|NOT COMPLETED|Overall Study||0
4912026|NCT03706469|12088706|P1|NOT COMPLETED|Overall Study||0
4912027|NCT03706469|12088703|P4|COMPLETED|Overall Study||4
4912028|NCT03706469|12088704|P3|COMPLETED|Overall Study||4
4912029|NCT03706469|12088705|P2|COMPLETED|Overall Study||4
4912030|NCT03706469|12088706|P1|COMPLETED|Overall Study||4
4912031|NCT03706469|12088703|P4|STARTED|Overall Study||4
4912032|NCT03706469|12088704|P3|STARTED|Overall Study||4
4912033|NCT03706469|12088705|P2|STARTED|Overall Study||4
4912034|NCT03706469|12088706|P1|STARTED|Overall Study||4
4912035|NCT03705481|12088733|P1|NOT COMPLETED|Overall Study||0
4912036|NCT03705481|12088733|P1|COMPLETED|Overall Study||5
4912037|NCT03705481|12088733|P1|STARTED|Overall Study||5
4912038|NCT03704376|12088742|P2|NOT COMPLETED|Overall Study||4
4912039|NCT03704376|12088743|P1|NOT COMPLETED|Overall Study||4
4912040|NCT03704376|12088742|P2|COMPLETED|Overall Study||40
4912041|NCT03704376|12088743|P1|COMPLETED|Overall Study||38
4912042|NCT03704376|12088742|P2|STARTED|Overall Study||44
4912043|NCT03704376|12088743|P1|STARTED|Overall Study||42
4912044|NCT03704194|12088787|P2|NOT COMPLETED|Overall Study||1
4912045|NCT03704194|12088788|P1|NOT COMPLETED|Overall Study||0
4912046|NCT03704194|12088787|P2|COMPLETED|Overall Study||8
4912047|NCT03704194|12088788|P1|COMPLETED|Overall Study||8
4912048|NCT03704194|12088787|P2|STARTED|Overall Study||9
4912049|NCT03704194|12088788|P1|STARTED|Overall Study||8
4912050|NCT03701061|12088815|P2|NOT COMPLETED|Overall Study||0
4912051|NCT03701061|12088816|P1|NOT COMPLETED|Overall Study||0
4912052|NCT03701061|12088815|P2|COMPLETED|Overall Study||3
4912053|NCT03701061|12088816|P1|COMPLETED|Overall Study||9
4912054|NCT03701061|12088815|P2|STARTED|Overall Study||3
4912055|NCT03701061|12088816|P1|STARTED|Overall Study||9
4912056|NCT03700671|12088830|P2|NOT COMPLETED|Overall Study||2
4912057|NCT03700671|12088831|P1|NOT COMPLETED|Overall Study||1
4912058|NCT03700671|12088830|P2|COMPLETED|Overall Study||19
4912059|NCT03700671|12088831|P1|COMPLETED|Overall Study||20
4912060|NCT03700671|12088830|P2|STARTED|Overall Study||21
4912061|NCT03700671|12088831|P1|STARTED|Overall Study||21
4912062|NCT03698591|12088845|P2|NOT COMPLETED|Overall Study||5
4912063|NCT03698591|12088846|P1|NOT COMPLETED|Overall Study||5
4912064|NCT03698591|12088845|P2|COMPLETED|Overall Study||15
4912065|NCT03698591|12088846|P1|COMPLETED|Overall Study||15
4912066|NCT03698591|12088845|P2|STARTED|Overall Study||20
4912067|NCT03698591|12088846|P1|STARTED|Overall Study||20
4912068|NCT03698331|12088860|P2|NOT COMPLETED|Overall Study||6
4912069|NCT03698331|12088861|P1|NOT COMPLETED|Overall Study||4
4912070|NCT03698331|12088860|P2|COMPLETED|Overall Study||39
4912071|NCT03698331|12088861|P1|COMPLETED|Overall Study||40
4912072|NCT03698331|12088860|P2|Entered Withdrawal Period|Overall Study||39
4912073|NCT03698331|12088861|P1|Entered Withdrawal Period|Overall Study||42
4912074|NCT03698331|12088860|P2|STARTED|Overall Study||45
4912075|NCT03698331|12088861|P1|STARTED|Overall Study||44
4912076|NCT03698279|12088883|P6|NOT COMPLETED|Overall Study||0
4912077|NCT03698279|12088884|P5|NOT COMPLETED|Overall Study||0
4912078|NCT03698279|12088885|P4|NOT COMPLETED|Overall Study||6
4912079|NCT03698279|12088886|P3|NOT COMPLETED|Overall Study||7
4912080|NCT03698279|12088887|P2|NOT COMPLETED|Overall Study||2
4912081|NCT03698279|12088888|P1|NOT COMPLETED|Overall Study||5
4912082|NCT03698279|12088883|P6|COMPLETED|Overall Study||13
4912083|NCT03698279|12088884|P5|COMPLETED|Overall Study||13
4912084|NCT03698279|12088885|P4|COMPLETED|Overall Study||228
4912085|NCT03698279|12088886|P3|COMPLETED|Overall Study||152
4912086|NCT03698279|12088887|P2|COMPLETED|Overall Study||120
4912087|NCT03698279|12088888|P1|COMPLETED|Overall Study||119
4912088|NCT03698279|12088883|P6|Safety Analysis Set Population (SafAS)|Overall Study||13
4912089|NCT03698279|12088884|P5|Safety Analysis Set Population (SafAS)|Overall Study||13
4912090|NCT03698279|12088885|P4|Safety Analysis Set Population (SafAS)|Overall Study||234
4912091|NCT03698279|12088886|P3|Safety Analysis Set Population (SafAS)|Overall Study||158
4912092|NCT03698279|12088887|P2|Safety Analysis Set Population (SafAS)|Overall Study||121
4912093|NCT03698279|12088888|P1|Safety Analysis Set Population (SafAS)|Overall Study||122
4912094|NCT03698279|12088883|P6|STARTED|Overall Study||13
4912095|NCT03698279|12088884|P5|STARTED|Overall Study||13
4912096|NCT03698279|12088885|P4|STARTED|Overall Study||234
4912097|NCT03698279|12088886|P3|STARTED|Overall Study||159
4912098|NCT03698279|12088887|P2|STARTED|Overall Study||122
4912099|NCT03698279|12088888|P1|STARTED|Overall Study||124
4912100|NCT03697122|12088982|P1|NOT COMPLETED|Overall Study||0
4912101|NCT03697122|12088982|P1|COMPLETED|Overall Study||14
4912102|NCT03697122|12088982|P1|STARTED|Overall Study||14
4912103|NCT03697083|12088997|P3|NOT COMPLETED|Overall Study||0
4912104|NCT03697083|12088998|P2|NOT COMPLETED|Overall Study||10
4912105|NCT03697083|12088999|P1|NOT COMPLETED|Overall Study||0
4912106|NCT03697083|12088997|P3|COMPLETED|Overall Study||255
4912107|NCT03697083|12088998|P2|COMPLETED|Overall Study||250
4912108|NCT03697083|12088999|P1|COMPLETED|Overall Study||262
4912109|NCT03697083|12088997|P3|STARTED|Overall Study||255
4912110|NCT03697083|12088998|P2|STARTED|Overall Study||260
4912111|NCT03697083|12088999|P1|STARTED|Overall Study||262
4912112|NCT03695913|12089007|P1|NOT COMPLETED|Overall Study||0
4912113|NCT03695913|12089007|P1|COMPLETED|Overall Study||15
4912114|NCT03695913|12089007|P1|STARTED|Overall Study||15
4912115|NCT03695094|12089024|P2|NOT COMPLETED|Overall Study||1
4912116|NCT03695094|12089025|P1|NOT COMPLETED|Overall Study||2
4912117|NCT03695094|12089024|P2|COMPLETED|Overall Study||14
4912118|NCT03695094|12089025|P1|COMPLETED|Overall Study||14
4912119|NCT03695094|12089024|P2|STARTED|Overall Study||15
4912120|NCT03695094|12089025|P1|STARTED|Overall Study||16
4912121|NCT03694821|12089061|P3|NOT COMPLETED|Overall Study||4
4912122|NCT03694821|12089062|P2|NOT COMPLETED|Overall Study||8
4912123|NCT03694821|12089063|P1|NOT COMPLETED|Overall Study||4
4912124|NCT03694821|12089061|P3|COMPLETED|Overall Study||2
4912125|NCT03694821|12089062|P2|COMPLETED|Overall Study||0
4912126|NCT03694821|12089063|P1|COMPLETED|Overall Study||0
4912127|NCT03694821|12089061|P3|STARTED|Overall Study||6
4912128|NCT03694821|12089062|P2|STARTED|Overall Study||8
4912129|NCT03694821|12089063|P1|STARTED|Overall Study||4
4912130|NCT03693989|12089094|P2|NOT COMPLETED|Overall Study||4
4912131|NCT03693989|12089095|P1|NOT COMPLETED|Overall Study||3
4912132|NCT03693989|12089094|P2|COMPLETED|Overall Study||86
4912133|NCT03693989|12089095|P1|COMPLETED|Overall Study||85
4912134|NCT03693989|12089094|P2|STARTED|Overall Study||90
4912135|NCT03693989|12089095|P1|STARTED|Overall Study||88
4912136|NCT03693950|12089119|P2|NOT COMPLETED|Overall Study||0
4912137|NCT03693950|12089120|P1|NOT COMPLETED|Overall Study||1
4912138|NCT03693950|12089119|P2|COMPLETED|Overall Study||28
4912139|NCT03693950|12089120|P1|COMPLETED|Overall Study||28
4912140|NCT03693950|12089119|P2|STARTED|Overall Study||28
4912141|NCT03693950|12089120|P1|STARTED|Overall Study||29
4912142|NCT03693937|12089138|P1|NOT COMPLETED|Overall Study||0
4912143|NCT03693937|12089138|P1|COMPLETED|Overall Study||776
4912144|NCT03693937|12089138|P1|STARTED|Overall Study||776
4912145|NCT03688620|12089145|P3|NOT COMPLETED|Overall Study||8
4912146|NCT03688620|12089146|P2|NOT COMPLETED|Overall Study||1
4912147|NCT03688620|12089147|P1|NOT COMPLETED|Overall Study||16
4912148|NCT03688620|12089145|P3|COMPLETED|Overall Study||445
4912149|NCT03688620|12089146|P2|COMPLETED|Overall Study||277
4912150|NCT03688620|12089147|P1|COMPLETED|Overall Study||313
4912151|NCT03688620|12089145|P3|STARTED|Overall Study||453
4912152|NCT03688620|12089146|P2|STARTED|Overall Study||278
4912153|NCT03688620|12089147|P1|STARTED|Overall Study||329
4912154|NCT03687736|12089628|P1|NOT COMPLETED|Overall Study||10
4912155|NCT03687736|12089628|P1|COMPLETED|Overall Study||110
4912156|NCT03687736|12089628|P1|STARTED|Overall Study||120
4912157|NCT03687684|12089647|P9|NOT COMPLETED|Overall Study||0
4912158|NCT03687684|12089648|P8|NOT COMPLETED|Overall Study||0
4912159|NCT03687684|12089649|P7|NOT COMPLETED|Overall Study||0
4912160|NCT03687684|12089650|P6|NOT COMPLETED|Overall Study||0
4912161|NCT03687684|12089651|P5|NOT COMPLETED|Overall Study||0
4912162|NCT03687684|12089652|P4|NOT COMPLETED|Overall Study||0
4912163|NCT03687684|12089653|P3|NOT COMPLETED|Overall Study||0
4912164|NCT03687684|12089654|P2|NOT COMPLETED|Overall Study||0
4912165|NCT03687684|12089655|P1|NOT COMPLETED|Overall Study||0
4912166|NCT03687684|12089647|P9|COMPLETED|Overall Study||6
4912167|NCT03687684|12089648|P8|COMPLETED|Overall Study||2
4912168|NCT03687684|12089649|P7|COMPLETED|Overall Study||6
4912169|NCT03687684|12089650|P6|COMPLETED|Overall Study||6
4912170|NCT03687684|12089651|P5|COMPLETED|Overall Study||6
4912171|NCT03687684|12089652|P4|COMPLETED|Overall Study||6
4912172|NCT03687684|12089653|P3|COMPLETED|Overall Study||2
4912173|NCT03687684|12089654|P2|COMPLETED|Overall Study||2
4912174|NCT03687684|12089655|P1|COMPLETED|Overall Study||4
4912175|NCT03687684|12089647|P9|STARTED|Overall Study||6
4912176|NCT03687684|12089648|P8|STARTED|Overall Study||2
4912177|NCT03687684|12089649|P7|STARTED|Overall Study||6
4912178|NCT03687684|12089650|P6|STARTED|Overall Study||6
4912179|NCT03687684|12089651|P5|STARTED|Overall Study||6
4912180|NCT03687684|12089652|P4|STARTED|Overall Study||6
4912181|NCT03687684|12089653|P3|STARTED|Overall Study||2
4912182|NCT03687684|12089654|P2|STARTED|Overall Study||2
4912183|NCT03687684|12089655|P1|STARTED|Overall Study||4
4912184|NCT03687450|12089745|P2|NOT COMPLETED|Overall Study||2
4912185|NCT03687450|12089746|P1|NOT COMPLETED|Overall Study||12
4912186|NCT03687450|12089745|P2|COMPLETED|Overall Study||16
4912187|NCT03687450|12089746|P1|COMPLETED|Overall Study||26
4912188|NCT03687450|12089745|P2|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
4912189|NCT03687450|12089746|P1|Two-month Follow-up|Overall Study|2 lost to follow-up|26
4912190|NCT03687450|12089745|P2|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
4912191|NCT03687450|12089746|P1|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
4912192|NCT03687450|12089745|P2|STARTED|Overall Study||18
4912193|NCT03687450|12089746|P1|STARTED|Overall Study||38
4912194|NCT03686176|12089775|P3|NOT COMPLETED|Overall Study||0
4912195|NCT03686176|12089776|P2|NOT COMPLETED|Overall Study||0
4912196|NCT03686176|12089777|P1|NOT COMPLETED|Overall Study||2
4912197|NCT03686176|12089775|P3|COMPLETED|Overall Study||20
4912198|NCT03686176|12089776|P2|COMPLETED|Overall Study||25
4912199|NCT03686176|12089777|P1|COMPLETED|Overall Study||17
4912200|NCT03686176|12089775|P3|STARTED|Overall Study||20
4912201|NCT03686176|12089776|P2|STARTED|Overall Study||25
4912202|NCT03686176|12089777|P1|STARTED|Overall Study||19
4912203|NCT03685968|12089819|P3|NOT COMPLETED|Overall Study||0
4912204|NCT03685968|12089820|P2|NOT COMPLETED|Overall Study||0
4912205|NCT03685968|12089821|P1|NOT COMPLETED|Overall Study||0
4912206|NCT03685968|12089819|P3|COMPLETED|Overall Study||75
4912207|NCT03685968|12089820|P2|COMPLETED|Overall Study||75
4912208|NCT03685968|12089821|P1|COMPLETED|Overall Study||75
4912209|NCT03685968|12089819|P3|STARTED|Overall Study||75
4912210|NCT03685968|12089820|P2|STARTED|Overall Study||75
4912211|NCT03685968|12089821|P1|STARTED|Overall Study||75
4912212|NCT03685643|12089837|P2|NOT COMPLETED|Overall Study||22
4912213|NCT03685643|12089838|P1|NOT COMPLETED|Overall Study||14
4912214|NCT03685643|12089837|P2|COMPLETED|Overall Study||266
4912215|NCT03685643|12089838|P1|COMPLETED|Overall Study||276
4912216|NCT03685643|12089837|P2|STARTED|Overall Study||288
4912217|NCT03685643|12089838|P1|STARTED|Overall Study||290
4912218|NCT03685396|12089850|P2|NOT COMPLETED|Overall Study||0
4912219|NCT03685396|12089851|P1|NOT COMPLETED|Overall Study||0
4912220|NCT03685396|12089850|P2|COMPLETED|Overall Study||21
4912221|NCT03685396|12089851|P1|COMPLETED|Overall Study||21
4912222|NCT03685396|12089850|P2|STARTED|Overall Study||21
4912223|NCT03685396|12089851|P1|STARTED|Overall Study||21
4912224|NCT03684928|12089863|P2|NOT COMPLETED|Second Intervention||0
4912225|NCT03684928|12089864|P1|NOT COMPLETED|Second Intervention||1
4912226|NCT03684928|12089863|P2|COMPLETED|Second Intervention||19
4912227|NCT03684928|12089864|P1|COMPLETED|Second Intervention||20
4912228|NCT03684928|12089863|P2|STARTED|Second Intervention||19
4912229|NCT03684928|12089864|P1|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
4912230|NCT03684928|12089863|P2|NOT COMPLETED|First Intervention||3
4912231|NCT03684928|12089864|P1|NOT COMPLETED|First Intervention||0
4912232|NCT03684928|12089863|P2|COMPLETED|First Intervention||19
4912233|NCT03684928|12089864|P1|COMPLETED|First Intervention||23
4912234|NCT03684928|12089863|P2|STARTED|First Intervention||22
4912235|NCT03684928|12089864|P1|STARTED|First Intervention||23
4912236|NCT03684265|12089880|P2|NOT COMPLETED|Treatment Period 2||0
4912237|NCT03684265|12089881|P1|NOT COMPLETED|Treatment Period 2||0
4912238|NCT03684265|12089880|P2|COMPLETED|Treatment Period 2||13
4912239|NCT03684265|12089881|P1|COMPLETED|Treatment Period 2||13
4912240|NCT03684265|12089880|P2|STARTED|Treatment Period 2||13
4912241|NCT03684265|12089881|P1|STARTED|Treatment Period 2||13
4912242|NCT03684265|12089880|P2|NOT COMPLETED|Washout Period of 1 Week||0
4912243|NCT03684265|12089881|P1|NOT COMPLETED|Washout Period of 1 Week||0
4912244|NCT03684265|12089880|P2|COMPLETED|Washout Period of 1 Week||13
4912245|NCT03684265|12089881|P1|COMPLETED|Washout Period of 1 Week||13
4912246|NCT03684265|12089880|P2|STARTED|Washout Period of 1 Week||13
4912247|NCT03684265|12089881|P1|STARTED|Washout Period of 1 Week||13
4912248|NCT03684265|12089880|P2|NOT COMPLETED|Treatment Period 1||0
4912249|NCT03684265|12089881|P1|NOT COMPLETED|Treatment Period 1||0
4912250|NCT03684265|12089880|P2|COMPLETED|Treatment Period 1||13
4912251|NCT03684265|12089881|P1|COMPLETED|Treatment Period 1||13
4912252|NCT03684265|12089880|P2|STARTED|Treatment Period 1||13
4912253|NCT03684265|12089881|P1|STARTED|Treatment Period 1||13
4912254|NCT03683901|12089891|P1|NOT COMPLETED|Overall Study||0
4912255|NCT03683901|12089891|P1|COMPLETED|Overall Study||10
4912256|NCT03683901|12089891|P1|STARTED|Overall Study||10
4912257|NCT03683758|12089902|P2|NOT COMPLETED|Overall Study||3
4912258|NCT03683758|12089903|P1|NOT COMPLETED|Overall Study||3
4912259|NCT03683758|12089902|P2|COMPLETED|Overall Study||7
4912260|NCT03683758|12089903|P1|COMPLETED|Overall Study||8
4912261|NCT03683758|12089902|P2|STARTED|Overall Study||10
4912262|NCT03683758|12089903|P1|STARTED|Overall Study||11
4912263|NCT03682809|12089917|P2|NOT COMPLETED|Overall Study||0
4912264|NCT03682809|12089918|P1|NOT COMPLETED|Overall Study||0
4912265|NCT03682809|12089917|P2|COMPLETED|Overall Study||24
4912266|NCT03682809|12089918|P1|COMPLETED|Overall Study||22
4912267|NCT03682809|12089917|P2|STARTED|Overall Study||24
4912268|NCT03682809|12089918|P1|STARTED|Overall Study||22
4912269|NCT03681951|12089940|P8|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912270|NCT03681951|12089941|P7|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912271|NCT03681951|12089942|P6|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912272|NCT03681951|12089943|P5|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912273|NCT03681951|12089944|P4|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912274|NCT03681951|12089945|P3|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912275|NCT03681951|12089946|P2|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912276|NCT03681951|12089947|P1|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912277|NCT03681951|12089940|P8|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912278|NCT03681951|12089941|P7|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912279|NCT03681951|12089942|P6|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912280|NCT03681951|12089943|P5|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912281|NCT03681951|12089944|P4|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912282|NCT03681951|12089945|P3|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912283|NCT03681951|12089946|P2|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912284|NCT03681951|12089947|P1|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912285|NCT03681951|12089940|P8|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912286|NCT03681951|12089941|P7|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912287|NCT03681951|12089942|P6|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912288|NCT03681951|12089943|P5|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912289|NCT03681951|12089944|P4|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912290|NCT03681951|12089945|P3|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912291|NCT03681951|12089946|P2|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912292|NCT03681951|12089947|P1|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
4912293|NCT03681951|12089940|P8|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912294|NCT03681951|12089941|P7|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912295|NCT03681951|12089942|P6|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912296|NCT03681951|12089943|P5|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912297|NCT03681951|12089944|P4|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912298|NCT03681951|12089945|P3|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912299|NCT03681951|12089946|P2|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912300|NCT03681951|12089947|P1|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912301|NCT03681951|12089940|P8|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912302|NCT03681951|12089941|P7|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912303|NCT03681951|12089942|P6|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912304|NCT03681951|12089943|P5|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912305|NCT03681951|12089944|P4|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912306|NCT03681951|12089945|P3|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912307|NCT03681951|12089946|P2|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912308|NCT03681951|12089947|P1|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912309|NCT03681951|12089940|P8|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912310|NCT03681951|12089941|P7|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912311|NCT03681951|12089942|P6|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912312|NCT03681951|12089943|P5|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912313|NCT03681951|12089944|P4|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912314|NCT03681951|12089945|P3|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912315|NCT03681951|12089946|P2|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912316|NCT03681951|12089947|P1|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
4912317|NCT03681951|12089940|P8|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912318|NCT03681951|12089941|P7|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912319|NCT03681951|12089942|P6|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912320|NCT03681951|12089943|P5|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912321|NCT03681951|12089944|P4|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912322|NCT03681951|12089945|P3|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912323|NCT03681951|12089946|P2|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912324|NCT03681951|12089947|P1|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912325|NCT03681951|12089940|P8|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912326|NCT03681951|12089941|P7|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912327|NCT03681951|12089942|P6|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912328|NCT03681951|12089943|P5|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912329|NCT03681951|12089944|P4|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912330|NCT03681951|12089945|P3|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912331|NCT03681951|12089946|P2|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912332|NCT03681951|12089947|P1|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
4912333|NCT03681951|12089940|P8|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912334|NCT03681951|12089941|P7|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912335|NCT03681951|12089942|P6|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912336|NCT03681951|12089943|P5|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912337|NCT03681951|12089944|P4|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912338|NCT03681951|12089945|P3|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912339|NCT03681951|12089946|P2|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912340|NCT03681951|12089947|P1|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
4912341|NCT03681951|12089940|P8|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912342|NCT03681951|12089941|P7|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912343|NCT03681951|12089942|P6|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912344|NCT03681951|12089943|P5|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912345|NCT03681951|12089944|P4|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912346|NCT03681951|12089945|P3|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912347|NCT03681951|12089946|P2|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912348|NCT03681951|12089947|P1|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
4912349|NCT03681951|12089940|P8|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912350|NCT03681951|12089941|P7|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912351|NCT03681951|12089942|P6|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912352|NCT03681951|12089943|P5|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912353|NCT03681951|12089944|P4|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912354|NCT03681951|12089945|P3|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912355|NCT03681951|12089946|P2|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912356|NCT03681951|12089947|P1|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
4912357|NCT03681951|12089940|P8|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
4912358|NCT03681951|12089941|P7|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
4912359|NCT03681951|12089942|P6|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
4912360|NCT03681951|12089943|P5|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
4912361|NCT03681951|12089944|P4|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
4912362|NCT03681951|12089945|P3|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
4912363|NCT03681951|12089946|P2|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
4912364|NCT03681951|12089947|P1|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
4912365|NCT03681119|12090140|P2|NOT COMPLETED|Overall Study||0
4912366|NCT03681119|12090141|P1|NOT COMPLETED|Overall Study||6
4912367|NCT03681119|12090140|P2|COMPLETED|Overall Study||11
4912368|NCT03681119|12090141|P1|COMPLETED|Overall Study||66
4912369|NCT03681119|12090140|P2|STARTED|Overall Study||11
4912370|NCT03681119|12090141|P1|STARTED|Overall Study||72
4912371|NCT03680105|12090154|P9|NOT COMPLETED|Overall Study||0
4912372|NCT03680105|12090155|P8|NOT COMPLETED|Overall Study||0
4912373|NCT03680105|12090156|P7|NOT COMPLETED|Overall Study||0
4912374|NCT03680105|12090157|P6|NOT COMPLETED|Overall Study||0
4912375|NCT03680105|12090158|P5|NOT COMPLETED|Overall Study||0
4912376|NCT03680105|12090159|P4|NOT COMPLETED|Overall Study||0
4912377|NCT03680105|12090160|P3|NOT COMPLETED|Overall Study||0
4912378|NCT03680105|12090161|P2|NOT COMPLETED|Overall Study||0
4912379|NCT03680105|12090162|P1|NOT COMPLETED|Overall Study||0
4912380|NCT03680105|12090154|P9|COMPLETED|Overall Study||8
4912381|NCT03680105|12090155|P8|COMPLETED|Overall Study||8
4912382|NCT03680105|12090156|P7|COMPLETED|Overall Study||8
4912383|NCT03680105|12090157|P6|COMPLETED|Overall Study||12
4912384|NCT03680105|12090158|P5|COMPLETED|Overall Study||8
4912385|NCT03680105|12090159|P4|COMPLETED|Overall Study||8
4912386|NCT03680105|12090160|P3|COMPLETED|Overall Study||8
4912387|NCT03680105|12090161|P2|COMPLETED|Overall Study||8
4912388|NCT03680105|12090162|P1|COMPLETED|Overall Study||8
4912389|NCT03680105|12090154|P9|STARTED|Overall Study||8
4912390|NCT03680105|12090155|P8|STARTED|Overall Study||8
4912391|NCT03680105|12090156|P7|STARTED|Overall Study||8
4912392|NCT03680105|12090157|P6|STARTED|Overall Study||12
4912393|NCT03680105|12090158|P5|STARTED|Overall Study||8
4912394|NCT03680105|12090159|P4|STARTED|Overall Study||8
4912395|NCT03680105|12090160|P3|STARTED|Overall Study||8
4912396|NCT03680105|12090161|P2|STARTED|Overall Study||8
4912397|NCT03680105|12090162|P1|STARTED|Overall Study||8
4912398|NCT03679741|12090208|P2|NOT COMPLETED|Period 3||0
4912399|NCT03679741|12090209|P1|NOT COMPLETED|Period 3||0
4912400|NCT03679741|12090208|P2|COMPLETED|Period 3||56
4912401|NCT03679741|12090209|P1|COMPLETED|Period 3||54
4912402|NCT03679741|12090208|P2|STARTED|Period 3||56
4912403|NCT03679741|12090209|P1|STARTED|Period 3||54
4912404|NCT03679741|12090208|P2|NOT COMPLETED|Period 2||2
4912405|NCT03679741|12090209|P1|NOT COMPLETED|Period 2||3
4912406|NCT03679741|12090208|P2|COMPLETED|Period 2||56
4912407|NCT03679741|12090209|P1|COMPLETED|Period 2||54
4912408|NCT03679741|12090208|P2|STARTED|Period 2||58
4912409|NCT03679741|12090209|P1|STARTED|Period 2||57
4912410|NCT03679741|12090208|P2|NOT COMPLETED|Period 1||3
4912411|NCT03679741|12090209|P1|NOT COMPLETED|Period 1||2
4912412|NCT03679741|12090208|P2|COMPLETED|Period 1||58
4912413|NCT03679741|12090209|P1|COMPLETED|Period 1||57
4912414|NCT03679741|12090208|P2|STARTED|Period 1||61
4912415|NCT03679741|12090209|P1|STARTED|Period 1||59
4912416|NCT03679494|12090231|P2|NOT COMPLETED|Overall Study||0
4912417|NCT03679494|12090232|P1|NOT COMPLETED|Overall Study||0
4912418|NCT03679494|12090231|P2|COMPLETED|Overall Study||63
4912419|NCT03679494|12090232|P1|COMPLETED|Overall Study||67
4912420|NCT03679494|12090231|P2|STARTED|Overall Study||63
4912421|NCT03679494|12090232|P1|STARTED|Overall Study||67
4912422|NCT03678870|12090252|P2|NOT COMPLETED|Overall Study||8
4912423|NCT03678870|12090253|P1|NOT COMPLETED|Overall Study||13
4912424|NCT03678870|12090252|P2|COMPLETED|Overall Study||91
4912425|NCT03678870|12090253|P1|COMPLETED|Overall Study||84
4912426|NCT03678870|12090252|P2|STARTED|Overall Study||99
4912427|NCT03678870|12090253|P1|STARTED|Overall Study||97
4912428|NCT03678311|12090265|P1|NOT COMPLETED|Overall Study||0
4912429|NCT03678311|12090265|P1|COMPLETED|Overall Study||9
4912430|NCT03678311|12090265|P1|STARTED|Overall Study||9
4912431|NCT03677375|12090271|P1|NOT COMPLETED|Overall Study||12
4912432|NCT03677375|12090271|P1|COMPLETED|Overall Study||81
4912433|NCT03677375|12090271|P1|STARTED|Overall Study||93
4912434|NCT03677245|12090275|P1|NOT COMPLETED|Overall Study||0
4912435|NCT03677245|12090275|P1|COMPLETED|Overall Study||8
4912436|NCT03677245|12090275|P1|STARTED|Overall Study||8
4912437|NCT03677089|12090282|P1|NOT COMPLETED|Overall Study||34
4912438|NCT03677089|12090282|P1|COMPLETED|Overall Study||114
4912439|NCT03677089|12090282|P1|Follow-Up|Overall Study||114
4912440|NCT03677089|12090282|P1|Post-Intervention|Overall Study||117
4912441|NCT03677089|12090282|P1|Mid-Intervention|Overall Study||120
4912442|NCT03677089|12090282|P1|Baseline/Pre-Intervention|Overall Study||137
4912443|NCT03677089|12090282|P1|STARTED|Overall Study||148
4912444|NCT03676803|12090313|P2|NOT COMPLETED|Overall Study||0
4912445|NCT03676803|12090314|P1|NOT COMPLETED|Overall Study||0
4912446|NCT03676803|12090313|P2|COMPLETED|Overall Study||16
4912447|NCT03676803|12090314|P1|COMPLETED|Overall Study||15
4912448|NCT03676803|12090313|P2|STARTED|Overall Study||16
4912449|NCT03676803|12090314|P1|STARTED|Overall Study||15
4912450|NCT03675776|12090325|P3|NOT COMPLETED|Safety Follow-up Period||0
4912451|NCT03675776|12090326|P2|NOT COMPLETED|Safety Follow-up Period||0
4912452|NCT03675776|12090327|P1|NOT COMPLETED|Safety Follow-up Period||0
4912453|NCT03675776|12090325|P3|COMPLETED|Safety Follow-up Period||7
4912454|NCT03675776|12090326|P2|COMPLETED|Safety Follow-up Period||8
4912455|NCT03675776|12090327|P1|COMPLETED|Safety Follow-up Period||6
4912456|NCT03675776|12090325|P3|STARTED|Safety Follow-up Period||7
4912457|NCT03675776|12090326|P2|STARTED|Safety Follow-up Period||8
4912458|NCT03675776|12090327|P1|STARTED|Safety Follow-up Period||6
4912459|NCT03675776|12090325|P3|NOT COMPLETED|Double Blind Treatment Period||8
4912460|NCT03675776|12090326|P2|NOT COMPLETED|Double Blind Treatment Period||6
4912461|NCT03675776|12090327|P1|NOT COMPLETED|Double Blind Treatment Period||6
4912462|NCT03675776|12090325|P3|COMPLETED|Double Blind Treatment Period||10
4912463|NCT03675776|12090326|P2|COMPLETED|Double Blind Treatment Period||11
4912464|NCT03675776|12090327|P1|COMPLETED|Double Blind Treatment Period||9
4912465|NCT03675776|12090325|P3|STARTED|Double Blind Treatment Period||18
4912466|NCT03675776|12090326|P2|STARTED|Double Blind Treatment Period||17
4912467|NCT03675776|12090327|P1|STARTED|Double Blind Treatment Period||15
4912468|NCT03674177|12090342|P4|NOT COMPLETED|Overall Study||2
4912469|NCT03674177|12090343|P3|NOT COMPLETED|Overall Study||0
4912470|NCT03674177|12090344|P2|NOT COMPLETED|Overall Study||1
4912471|NCT03674177|12090345|P1|NOT COMPLETED|Overall Study||2
4912472|NCT03674177|12090342|P4|COMPLETED|Overall Study||124
4912473|NCT03674177|12090343|P3|COMPLETED|Overall Study||126
4912474|NCT03674177|12090344|P2|COMPLETED|Overall Study||125
4912475|NCT03674177|12090345|P1|COMPLETED|Overall Study||122
4912476|NCT03674177|12090342|P4|STARTED|Overall Study||126
4912477|NCT03674177|12090343|P3|STARTED|Overall Study||126
4912478|NCT03674177|12090344|P2|STARTED|Overall Study||126
4912479|NCT03674177|12090345|P1|STARTED|Overall Study||124
4912480|NCT03673670|12090409|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
4912481|NCT03673670|12090410|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
4912482|NCT03673670|12090411|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
4912483|NCT03673670|12090412|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
4912484|NCT03673670|12090413|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
4912485|NCT03673670|12090414|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
4912486|NCT03673670|12090409|P6|COMPLETED|Treatment Period 3 (3 Days)||11
4912487|NCT03673670|12090410|P5|COMPLETED|Treatment Period 3 (3 Days)||10
4912488|NCT03673670|12090411|P4|COMPLETED|Treatment Period 3 (3 Days)||12
4912489|NCT03673670|12090412|P3|COMPLETED|Treatment Period 3 (3 Days)||11
4912490|NCT03673670|12090413|P2|COMPLETED|Treatment Period 3 (3 Days)||14
4912491|NCT03673670|12090414|P1|COMPLETED|Treatment Period 3 (3 Days)||13
4912492|NCT03673670|12090409|P6|STARTED|Treatment Period 3 (3 Days)||11
4912493|NCT03673670|12090410|P5|STARTED|Treatment Period 3 (3 Days)||11
4912494|NCT03673670|12090411|P4|STARTED|Treatment Period 3 (3 Days)||12
4912495|NCT03673670|12090412|P3|STARTED|Treatment Period 3 (3 Days)||11
4912496|NCT03673670|12090413|P2|STARTED|Treatment Period 3 (3 Days)||14
4912497|NCT03673670|12090414|P1|STARTED|Treatment Period 3 (3 Days)||13
4912498|NCT03673670|12090409|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
4912499|NCT03673670|12090410|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
4912500|NCT03673670|12090411|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
4912501|NCT03673670|12090412|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
4912502|NCT03673670|12090413|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
4912503|NCT03673670|12090414|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
4912504|NCT03673670|12090409|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
4912505|NCT03673670|12090410|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
4912506|NCT03673670|12090411|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
4912507|NCT03673670|12090412|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
4912508|NCT03673670|12090413|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
4912509|NCT03673670|12090414|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
4912510|NCT03673670|12090409|P6|STARTED|Washout Period 2 (7-14 Days)||11
4912511|NCT03673670|12090410|P5|STARTED|Washout Period 2 (7-14 Days)||12
4912512|NCT03673670|12090411|P4|STARTED|Washout Period 2 (7-14 Days)||12
4912513|NCT03673670|12090412|P3|STARTED|Washout Period 2 (7-14 Days)||11
4912514|NCT03673670|12090413|P2|STARTED|Washout Period 2 (7-14 Days)||14
4912515|NCT03673670|12090414|P1|STARTED|Washout Period 2 (7-14 Days)||13
4912516|NCT03673670|12090409|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
4912517|NCT03673670|12090410|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
4912518|NCT03673670|12090411|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
4912519|NCT03673670|12090412|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
4912520|NCT03673670|12090413|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
4912521|NCT03673670|12090414|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
4912522|NCT03673670|12090409|P6|COMPLETED|Treatment Period 2 (3 Days)||11
4912523|NCT03673670|12090410|P5|COMPLETED|Treatment Period 2 (3 Days)||12
4912524|NCT03673670|12090411|P4|COMPLETED|Treatment Period 2 (3 Days)||12
4912525|NCT03673670|12090412|P3|COMPLETED|Treatment Period 2 (3 Days)||11
4912526|NCT03673670|12090413|P2|COMPLETED|Treatment Period 2 (3 Days)||14
4912527|NCT03673670|12090414|P1|COMPLETED|Treatment Period 2 (3 Days)||13
4912528|NCT03673670|12090409|P6|STARTED|Treatment Period 2 (3 Days)||11
4912529|NCT03673670|12090410|P5|STARTED|Treatment Period 2 (3 Days)||13
4912530|NCT03673670|12090411|P4|STARTED|Treatment Period 2 (3 Days)||12
4912531|NCT03673670|12090412|P3|STARTED|Treatment Period 2 (3 Days)||12
4912532|NCT03673670|12090413|P2|STARTED|Treatment Period 2 (3 Days)||14
4912533|NCT03673670|12090414|P1|STARTED|Treatment Period 2 (3 Days)||13
4912534|NCT03673670|12090409|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912535|NCT03673670|12090410|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912536|NCT03673670|12090411|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912537|NCT03673670|12090412|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912538|NCT03673670|12090413|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912539|NCT03673670|12090414|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
4912540|NCT03673670|12090409|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
4912541|NCT03673670|12090410|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
4912542|NCT03673670|12090411|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
4912543|NCT03673670|12090412|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
4912544|NCT03673670|12090413|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
4912545|NCT03673670|12090414|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
4912546|NCT03673670|12090409|P6|STARTED|Washout Period 1 (7-14 Days)||11
4912547|NCT03673670|12090410|P5|STARTED|Washout Period 1 (7-14 Days)||13
4912548|NCT03673670|12090411|P4|STARTED|Washout Period 1 (7-14 Days)||12
4912549|NCT03673670|12090412|P3|STARTED|Washout Period 1 (7-14 Days)||12
4912550|NCT03673670|12090413|P2|STARTED|Washout Period 1 (7-14 Days)||14
4912551|NCT03673670|12090414|P1|STARTED|Washout Period 1 (7-14 Days)||13
4912552|NCT03673670|12090409|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
4912553|NCT03673670|12090410|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
4912554|NCT03673670|12090411|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
4912555|NCT03673670|12090412|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
4912556|NCT03673670|12090413|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
4912557|NCT03673670|12090414|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
4912558|NCT03673670|12090409|P6|COMPLETED|Treatment Period 1 (3 Days)||11
4912559|NCT03673670|12090410|P5|COMPLETED|Treatment Period 1 (3 Days)||13
4912560|NCT03673670|12090411|P4|COMPLETED|Treatment Period 1 (3 Days)||12
4912561|NCT03673670|12090412|P3|COMPLETED|Treatment Period 1 (3 Days)||12
4912562|NCT03673670|12090413|P2|COMPLETED|Treatment Period 1 (3 Days)||14
4912563|NCT03673670|12090414|P1|COMPLETED|Treatment Period 1 (3 Days)||13
4912564|NCT03673670|12090409|P6|STARTED|Treatment Period 1 (3 Days)||13
4912565|NCT03673670|12090410|P5|STARTED|Treatment Period 1 (3 Days)||13
4912566|NCT03673670|12090411|P4|STARTED|Treatment Period 1 (3 Days)||12
4912567|NCT03673670|12090412|P3|STARTED|Treatment Period 1 (3 Days)||13
4912568|NCT03673670|12090413|P2|STARTED|Treatment Period 1 (3 Days)||14
4912569|NCT03673670|12090414|P1|STARTED|Treatment Period 1 (3 Days)||14
4912570|NCT03670537|12090461|P1|NOT COMPLETED|Overall Study||1
4912571|NCT03670537|12090461|P1|COMPLETED|Overall Study||101
4912572|NCT03670537|12090461|P1|STARTED|Overall Study||102
4912573|NCT03669081|12090467|P2|NOT COMPLETED|Overall Study||1
4912574|NCT03669081|12090468|P1|NOT COMPLETED|Overall Study||1
4912575|NCT03669081|12090467|P2|COMPLETED|Overall Study||29
4912576|NCT03669081|12090468|P1|COMPLETED|Overall Study||33
4912577|NCT03669081|12090467|P2|STARTED|Overall Study||30
4912578|NCT03669081|12090468|P1|STARTED|Overall Study||34
4912579|NCT03668600|12090484|P1|NOT COMPLETED|Overall Study||230
4912580|NCT03668600|12090484|P1|COMPLETED|Overall Study||0
4912581|NCT03668600|12090484|P1|STARTED|Overall Study||230
4912582|NCT03667547|12090488|P1|NOT COMPLETED|Overall Study||0
4912583|NCT03667547|12090488|P1|COMPLETED|Overall Study||12
4912584|NCT03667547|12090488|P1|STARTED|Overall Study||12
4912585|NCT03664544|12090504|P2|NOT COMPLETED|Overall Study||0
4912586|NCT03664544|12090505|P1|NOT COMPLETED|Overall Study||0
4912587|NCT03664544|12090504|P2|COMPLETED|Overall Study||6
4912588|NCT03664544|12090505|P1|COMPLETED|Overall Study||6
4912589|NCT03664544|12090504|P2|STARTED|Overall Study||6
4912590|NCT03664544|12090505|P1|STARTED|Overall Study||6
4912591|NCT03663179|12090537|P2|NOT COMPLETED|Overall Study||1
4912592|NCT03663179|12090538|P1|NOT COMPLETED|Overall Study||4
4912593|NCT03663179|12090537|P2|COMPLETED|Overall Study||13
4912594|NCT03663179|12090538|P1|COMPLETED|Overall Study||14
4912595|NCT03663179|12090537|P2|STARTED|Overall Study||14
4912596|NCT03663179|12090538|P1|STARTED|Overall Study||18
4912597|NCT03662334|12090548|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
4912598|NCT03662334|12090549|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
4912599|NCT03662334|12090548|P2|COMPLETED|Part 3: Treatment Period 2||0
4912600|NCT03662334|12090549|P1|COMPLETED|Part 3: Treatment Period 2||0
4912601|NCT03662334|12090548|P2|STARTED|Part 3: Treatment Period 2||0
4912602|NCT03662334|12090549|P1|STARTED|Part 3: Treatment Period 2||0
4912603|NCT03662334|12090548|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
4912604|NCT03662334|12090549|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
4912605|NCT03662334|12090548|P2|COMPLETED|Part 3: Treatment Period 1||0
4912606|NCT03662334|12090549|P1|COMPLETED|Part 3: Treatment Period 1||0
4912607|NCT03662334|12090548|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
4912608|NCT03662334|12090549|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
4912609|NCT03662334|12090548|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
4912610|NCT03662334|12090549|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
4912611|NCT03662334|12090548|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
4912612|NCT03662334|12090549|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
4912613|NCT03662334|12090548|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
4912614|NCT03662334|12090549|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
4912615|NCT03662334|12090548|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
4912616|NCT03662334|12090549|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
4912617|NCT03662334|12090548|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
4912618|NCT03662334|12090549|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
4912619|NCT03662334|12090548|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
4912620|NCT03662334|12090549|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
4912621|NCT03662334|12090548|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
4912622|NCT03662334|12090549|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
4912623|NCT03662334|12090548|P2|COMPLETED|Part 1: Treatment Period 2||0
4912624|NCT03662334|12090549|P1|COMPLETED|Part 1: Treatment Period 2||0
4912625|NCT03662334|12090548|P2|STARTED|Part 1: Treatment Period 2||0
4912626|NCT03662334|12090549|P1|STARTED|Part 1: Treatment Period 2||0
4912627|NCT03662334|12090548|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
4912628|NCT03662334|12090549|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
4912629|NCT03662334|12090548|P2|COMPLETED|Part 1: Treatment Period 1||0
4912630|NCT03662334|12090549|P1|COMPLETED|Part 1: Treatment Period 1||0
4912631|NCT03662334|12090548|P2|STARTED|Part 1: Treatment Period 1||0
4912632|NCT03662334|12090549|P1|STARTED|Part 1: Treatment Period 1||0
4912633|NCT03662282|12090585|P1|NOT COMPLETED|Overall Study||0
4912634|NCT03662282|12090585|P1|COMPLETED|Overall Study||2
4912635|NCT03662282|12090585|P1|STARTED|Overall Study||2
4912636|NCT03662139|12090595|P2|NOT COMPLETED|Overall Study||0
4912637|NCT03662139|12090596|P1|NOT COMPLETED|Overall Study||0
4912638|NCT03662139|12090595|P2|COMPLETED|Overall Study||16
4912639|NCT03662139|12090596|P1|COMPLETED|Overall Study||16
4912640|NCT03662139|12090595|P2|STARTED|Overall Study||16
4912641|NCT03662139|12090596|P1|STARTED|Overall Study||16
4912642|NCT03661697|12090610|P2|NOT COMPLETED|Overall Study||0
4912643|NCT03661697|12090611|P1|NOT COMPLETED|Overall Study||0
4912644|NCT03661697|12090610|P2|COMPLETED|Overall Study||7
4912645|NCT03661697|12090611|P1|COMPLETED|Overall Study||7
4912646|NCT03661697|12090610|P2|STARTED|Overall Study||7
4912647|NCT03661697|12090611|P1|STARTED|Overall Study||7
4912648|NCT03660787|12090623|P4|NOT COMPLETED|Overall Study||0
4912649|NCT03660787|12090624|P3|NOT COMPLETED|Overall Study||1
4912650|NCT03660787|12090625|P2|NOT COMPLETED|Overall Study||1
4912651|NCT03660787|12090626|P1|NOT COMPLETED|Overall Study||1
4912652|NCT03660787|12090623|P4|COMPLETED|Overall Study||26
4912653|NCT03660787|12090624|P3|COMPLETED|Overall Study||25
4912654|NCT03660787|12090625|P2|COMPLETED|Overall Study||25
4912655|NCT03660787|12090626|P1|COMPLETED|Overall Study||25
4912656|NCT03660787|12090623|P4|STARTED|Overall Study||26
4912657|NCT03660787|12090624|P3|STARTED|Overall Study||26
4912658|NCT03660787|12090625|P2|STARTED|Overall Study||26
4912659|NCT03660787|12090626|P1|STARTED|Overall Study||26
4912660|NCT03658889|12090662|P2|NOT COMPLETED|Overall Study||0
4912661|NCT03658889|12090663|P1|NOT COMPLETED|Overall Study||2
4912662|NCT03658889|12090662|P2|COMPLETED|Overall Study||69
4912663|NCT03658889|12090663|P1|COMPLETED|Overall Study|Analysis population|306
4912664|NCT03658889|12090662|P2|STARTED|Overall Study||69
4912665|NCT03658889|12090663|P1|STARTED|Overall Study|Enrolled population|308
4912666|NCT03658876|12090694|P2|NOT COMPLETED|Overall Study||12
4912667|NCT03658876|12090695|P1|NOT COMPLETED|Overall Study||12
4912668|NCT03658876|12090694|P2|COMPLETED|Overall Study||84
4912669|NCT03658876|12090695|P1|COMPLETED|Overall Study||76
4912670|NCT03658876|12090694|P2|STARTED|Overall Study||96
4912671|NCT03658876|12090695|P1|STARTED|Overall Study||88
4912672|NCT03658811|12090701|P1|NOT COMPLETED|Overall Study||3
4912673|NCT03658811|12090701|P1|COMPLETED|Overall Study||16
4912674|NCT03658811|12090701|P1|STARTED|Overall Study||19
4912675|NCT03657407|12090710|P2|NOT COMPLETED|Overall Study||0
4912676|NCT03657407|12090711|P1|NOT COMPLETED|Overall Study||0
4912677|NCT03657407|12090710|P2|COMPLETED|Overall Study||27
4912678|NCT03657407|12090711|P1|COMPLETED|Overall Study||29
4912679|NCT03657407|12090710|P2|STARTED|Overall Study||27
4912680|NCT03657407|12090711|P1|STARTED|Overall Study||29
4912681|NCT03657264|12090727|P4|NOT COMPLETED|Overall Study||0
4912682|NCT03657264|12090728|P3|NOT COMPLETED|Overall Study||0
4912683|NCT03657264|12090729|P2|NOT COMPLETED|Overall Study||0
4912684|NCT03657264|12090730|P1|NOT COMPLETED|Overall Study||0
4912685|NCT03657264|12090727|P4|COMPLETED|Overall Study||12
4912686|NCT03657264|12090728|P3|COMPLETED|Overall Study||12
4912687|NCT03657264|12090729|P2|COMPLETED|Overall Study||12
4912688|NCT03657264|12090730|P1|COMPLETED|Overall Study||12
4912689|NCT03657264|12090727|P4|STARTED|Overall Study||12
4912690|NCT03657264|12090728|P3|STARTED|Overall Study||12
4912691|NCT03657264|12090729|P2|STARTED|Overall Study||12
4912692|NCT03657264|12090730|P1|STARTED|Overall Study||12
4912693|NCT03655301|12090743|P1|NOT COMPLETED|Overall Study||0
4912694|NCT03655301|12090743|P1|COMPLETED|Overall Study||13
4912695|NCT03655301|12090743|P1|STARTED|Overall Study||13
4912696|NCT03655106|12090755|P2|NOT COMPLETED|Overall Study||4
4912697|NCT03655106|12090756|P1|NOT COMPLETED|Overall Study||9
4912698|NCT03655106|12090755|P2|COMPLETED|Overall Study||131
4912699|NCT03655106|12090756|P1|COMPLETED|Overall Study||126
4912700|NCT03655106|12090755|P2|STARTED|Overall Study||135
4912701|NCT03655106|12090756|P1|STARTED|Overall Study||135
4912702|NCT03654417|12090768|P2|NOT COMPLETED|Overall Study||0
4912703|NCT03654417|12090769|P1|NOT COMPLETED|Overall Study||0
4912704|NCT03654417|12090768|P2|COMPLETED|Overall Study||18
4912705|NCT03654417|12090769|P1|COMPLETED|Overall Study||19
4912706|NCT03654417|12090768|P2|STARTED|Overall Study||18
4912707|NCT03654417|12090769|P1|STARTED|Overall Study||19
4912708|NCT03653429|12090793|P2|NOT COMPLETED|Overall Study||10
4912709|NCT03653429|12090794|P1|NOT COMPLETED|Overall Study||4
4912710|NCT03653429|12090793|P2|COMPLETED|Overall Study||41
4912711|NCT03653429|12090794|P1|COMPLETED|Overall Study||45
4912712|NCT03653429|12090793|P2|STARTED|Overall Study||51
4912713|NCT03653429|12090794|P1|STARTED|Overall Study||49
4912714|NCT03651856|12090806|P1|NOT COMPLETED|Overall Study||0
4912715|NCT03651856|12090806|P1|COMPLETED|Overall Study||10
4912716|NCT03651856|12090806|P1|STARTED|Overall Study||10
4912717|NCT03651479|12090812|P2|NOT COMPLETED|Overall Study||0
4912718|NCT03651479|12090813|P1|NOT COMPLETED|Overall Study||0
4912719|NCT03651479|12090812|P2|COMPLETED|Overall Study||20
4912720|NCT03651479|12090813|P1|COMPLETED|Overall Study||20
4912721|NCT03651479|12090812|P2|STARTED|Overall Study||20
4912722|NCT03651479|12090813|P1|STARTED|Overall Study||20
4912723|NCT03650842|12090829|P1|NOT COMPLETED|Overall Study||0
4912724|NCT03650842|12090829|P1|COMPLETED|Overall Study||25
4912725|NCT03650842|12090829|P1|STARTED|Overall Study||25
4912726|NCT03650400|12090838|P2|NOT COMPLETED|Overall Study||5
4912727|NCT03650400|12090839|P1|NOT COMPLETED|Overall Study||0
4912728|NCT03650400|12090838|P2|COMPLETED|Overall Study||0
4912729|NCT03650400|12090839|P1|COMPLETED|Overall Study||6
4912730|NCT03650400|12090838|P2|STARTED|Overall Study||5
4912731|NCT03650400|12090839|P1|STARTED|Overall Study||6
4912732|NCT03649867|12090867|P1|NOT COMPLETED|Overall Study||0
4912733|NCT03649867|12090867|P1|COMPLETED|Overall Study||13
4912734|NCT03649867|12090867|P1|STARTED|Overall Study||13
4912735|NCT03649815|12090871|P1|NOT COMPLETED|Overall Study||0
4912736|NCT03649815|12090871|P1|COMPLETED|Overall Study||38
4912737|NCT03649815|12090871|P1|STARTED|Overall Study||38
4912738|NCT03649750|12090877|P2|NOT COMPLETED|Period 2||0
4912739|NCT03649750|12090878|P1|NOT COMPLETED|Period 2||0
4912740|NCT03649750|12090877|P2|COMPLETED|Period 2||24
4912741|NCT03649750|12090878|P1|COMPLETED|Period 2||12
4912742|NCT03649750|12090877|P2|STARTED|Period 2||24
4912743|NCT03649750|12090878|P1|STARTED|Period 2||12
4912744|NCT03649750|12090877|P2|NOT COMPLETED|Washout: 7 Days||0
4912745|NCT03649750|12090878|P1|NOT COMPLETED|Washout: 7 Days||0
4912746|NCT03649750|12090877|P2|COMPLETED|Washout: 7 Days||24
4912747|NCT03649750|12090878|P1|COMPLETED|Washout: 7 Days||12
4912748|NCT03649750|12090877|P2|STARTED|Washout: 7 Days||24
4912749|NCT03649750|12090878|P1|STARTED|Washout: 7 Days||12
4912750|NCT03649750|12090877|P2|NOT COMPLETED|Period 1||0
4912751|NCT03649750|12090878|P1|NOT COMPLETED|Period 1||0
4912752|NCT03649750|12090877|P2|COMPLETED|Period 1||24
4912753|NCT03649750|12090878|P1|COMPLETED|Period 1||12
4912754|NCT03649750|12090877|P2|STARTED|Period 1||24
4912755|NCT03649750|12090878|P1|STARTED|Period 1||12
4912756|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 6 (4days)||0
4912757|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 6 (4days)||0
4912758|NCT03649412|12090899|P2|COMPLETED|Part B, Period 6 (4days)||14
4912759|NCT03649412|12090900|P1|COMPLETED|Part B, Period 6 (4days)||0
4912760|NCT03649412|12090899|P2|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
4912761|NCT03649412|12090900|P1|STARTED|Part B, Period 6 (4days)||0
4912762|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
4912763|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
4912764|NCT03649412|12090899|P2|COMPLETED|Part B, Washout Period 5 (7 Days)||13
4912765|NCT03649412|12090900|P1|COMPLETED|Part B, Washout Period 5 (7 Days)||0
4912766|NCT03649412|12090899|P2|STARTED|Part B, Washout Period 5 (7 Days)||14
4912767|NCT03649412|12090900|P1|STARTED|Part B, Washout Period 5 (7 Days)||0
4912768|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 5 (4 Days)||0
4912769|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 5 (4 Days)||0
4912770|NCT03649412|12090899|P2|COMPLETED|Part B, Period 5 (4 Days)||14
4912771|NCT03649412|12090900|P1|COMPLETED|Part B, Period 5 (4 Days)||0
4912772|NCT03649412|12090899|P2|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
4912773|NCT03649412|12090900|P1|STARTED|Part B, Period 5 (4 Days)||0
4912774|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
4912775|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
4912776|NCT03649412|12090899|P2|COMPLETED|Part B, Washout Period 4 (7 Days)||15
4912777|NCT03649412|12090900|P1|COMPLETED|Part B, Washout Period 4 (7 Days)||0
4912778|NCT03649412|12090899|P2|STARTED|Part B, Washout Period 4 (7 Days)||15
4912779|NCT03649412|12090900|P1|STARTED|Part B, Washout Period 4 (7 Days)||0
4912780|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 4 (4 Days)||0
4912781|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 4 (4 Days)||0
4912782|NCT03649412|12090899|P2|COMPLETED|Part B, Period 4 (4 Days)||15
4912783|NCT03649412|12090900|P1|COMPLETED|Part B, Period 4 (4 Days)||0
4912784|NCT03649412|12090899|P2|STARTED|Part B, Period 4 (4 Days)||15
4912785|NCT03649412|12090900|P1|STARTED|Part B, Period 4 (4 Days)||0
4912786|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
4912787|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
4912788|NCT03649412|12090899|P2|COMPLETED|Part B, Washout Period 3 (7 Days)||15
4912789|NCT03649412|12090900|P1|COMPLETED|Part B, Washout Period 3 (7 Days)||0
4912790|NCT03649412|12090899|P2|STARTED|Part B, Washout Period 3 (7 Days)||15
4912791|NCT03649412|12090900|P1|STARTED|Part B, Washout Period 3 (7 Days)||0
4912792|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 3 (4 Days)||0
4912793|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 3 (4 Days)||0
4912794|NCT03649412|12090899|P2|COMPLETED|Part B, Period 3 (4 Days)||15
4912795|NCT03649412|12090900|P1|COMPLETED|Part B, Period 3 (4 Days)||0
4912796|NCT03649412|12090899|P2|STARTED|Part B, Period 3 (4 Days)||15
4912797|NCT03649412|12090900|P1|STARTED|Part B, Period 3 (4 Days)||0
4912798|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
4912799|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
4912800|NCT03649412|12090899|P2|COMPLETED|Part B, Washout Period 2 (7 Days)||15
4912801|NCT03649412|12090900|P1|COMPLETED|Part B, Washout Period 2 (7 Days)||0
4912802|NCT03649412|12090899|P2|STARTED|Part B, Washout Period 2 (7 Days)||15
4912803|NCT03649412|12090900|P1|STARTED|Part B, Washout Period 2 (7 Days)||0
4912804|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 2 (4 Days)||0
4912805|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 2 (4 Days)||0
4912806|NCT03649412|12090899|P2|COMPLETED|Part B, Period 2 (4 Days)||15
4912807|NCT03649412|12090900|P1|COMPLETED|Part B, Period 2 (4 Days)||0
4912808|NCT03649412|12090899|P2|STARTED|Part B, Period 2 (4 Days)||15
4912809|NCT03649412|12090900|P1|STARTED|Part B, Period 2 (4 Days)||0
4912810|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
4912811|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
4912812|NCT03649412|12090899|P2|COMPLETED|Part B, Washout Period 1 (7 Days)||15
4912813|NCT03649412|12090900|P1|COMPLETED|Part B, Washout Period 1 (7 Days)||0
4912814|NCT03649412|12090899|P2|STARTED|Part B, Washout Period 1 (7 Days)||16
4912815|NCT03649412|12090900|P1|STARTED|Part B, Washout Period 1 (7 Days)||0
4912816|NCT03649412|12090899|P2|NOT COMPLETED|Part B, Period 1 (4 Days)||0
4912817|NCT03649412|12090900|P1|NOT COMPLETED|Part B, Period 1 (4 Days)||0
4912818|NCT03649412|12090899|P2|COMPLETED|Part B, Period 1 (4 Days)||16
4912819|NCT03649412|12090900|P1|COMPLETED|Part B, Period 1 (4 Days)||0
4912820|NCT03649412|12090899|P2|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
4912821|NCT03649412|12090900|P1|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
4912822|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 6 (4 Days)||0
4912823|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 6 (4 Days)||0
4912824|NCT03649412|12090899|P2|COMPLETED|Part A, Period 6 (4 Days)||0
4912825|NCT03649412|12090900|P1|COMPLETED|Part A, Period 6 (4 Days)||12
4912826|NCT03649412|12090899|P2|STARTED|Part A, Period 6 (4 Days)||0
4912827|NCT03649412|12090900|P1|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
4912828|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
4912829|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
4912830|NCT03649412|12090899|P2|COMPLETED|Part A, Washout Period 5 (7 Days)||0
4912831|NCT03649412|12090900|P1|COMPLETED|Part A, Washout Period 5 (7 Days)||11
4912832|NCT03649412|12090899|P2|STARTED|Part A, Washout Period 5 (7 Days)||0
4912833|NCT03649412|12090900|P1|STARTED|Part A, Washout Period 5 (7 Days)||12
4912834|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 5 (4 Days)||0
4912835|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 5 (4 Days)||0
4912836|NCT03649412|12090899|P2|COMPLETED|Part A, Period 5 (4 Days)||0
4912837|NCT03649412|12090900|P1|COMPLETED|Part A, Period 5 (4 Days)||12
4912838|NCT03649412|12090899|P2|STARTED|Part A, Period 5 (4 Days)||0
4912839|NCT03649412|12090900|P1|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
4912840|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
4912841|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
4912842|NCT03649412|12090899|P2|COMPLETED|Part A, Washout Period 4 (7 Days)||0
4912843|NCT03649412|12090900|P1|COMPLETED|Part A, Washout Period 4 (7 Days)||14
4912844|NCT03649412|12090899|P2|STARTED|Part A, Washout Period 4 (7 Days)||0
4912845|NCT03649412|12090900|P1|STARTED|Part A, Washout Period 4 (7 Days)||16
4912846|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 4 (4 Days)||0
4912847|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 4 (4 Days)||0
4912848|NCT03649412|12090899|P2|COMPLETED|Part A, Period 4 (4 Days)||0
4912849|NCT03649412|12090900|P1|COMPLETED|Part A, Period 4 (4 Days)||16
4912850|NCT03649412|12090899|P2|STARTED|Part A, Period 4 (4 Days)||0
4912851|NCT03649412|12090900|P1|STARTED|Part A, Period 4 (4 Days)||16
4912852|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
4912853|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
4912854|NCT03649412|12090899|P2|COMPLETED|Part A, Washout Period 3 (7 Days)||0
4912855|NCT03649412|12090900|P1|COMPLETED|Part A, Washout Period 3 (7 Days)||16
4912856|NCT03649412|12090899|P2|STARTED|Part A, Washout Period 3 (7 Days)||0
4912857|NCT03649412|12090900|P1|STARTED|Part A, Washout Period 3 (7 Days)||16
4912858|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 3 (4 Days)||0
4912859|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 3 (4 Days)||0
4912860|NCT03649412|12090899|P2|COMPLETED|Part A, Period 3 (4 Days)||0
4912861|NCT03649412|12090900|P1|COMPLETED|Part A, Period 3 (4 Days)||16
4912862|NCT03649412|12090899|P2|STARTED|Part A, Period 3 (4 Days)||0
4912863|NCT03649412|12090900|P1|STARTED|Part A, Period 3 (4 Days)||16
4912864|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
4912865|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
4912866|NCT03649412|12090899|P2|COMPLETED|Part A, Washout Period 2 (7 Days)||0
4912867|NCT03649412|12090900|P1|COMPLETED|Part A, Washout Period 2 (7 Days)||16
4912868|NCT03649412|12090899|P2|STARTED|Part A, Washout Period 2 (7 Days)||0
4912869|NCT03649412|12090900|P1|STARTED|Part A, Washout Period 2 (7 Days)||16
4912870|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 2 (3 Days)||0
4912871|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 2 (3 Days)||0
4912872|NCT03649412|12090899|P2|COMPLETED|Part A, Period 2 (3 Days)||0
4912873|NCT03649412|12090900|P1|COMPLETED|Part A, Period 2 (3 Days)||16
4912874|NCT03649412|12090899|P2|STARTED|Part A, Period 2 (3 Days)||0
4912875|NCT03649412|12090900|P1|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
4912876|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
4912877|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
4912878|NCT03649412|12090899|P2|COMPLETED|Part A, Washout Period 1 (7 Days)||0
4912879|NCT03649412|12090900|P1|COMPLETED|Part A, Washout Period 1 (7 Days)||15
4912880|NCT03649412|12090899|P2|STARTED|Part A, Washout Period 1 (7 Days)||0
4912881|NCT03649412|12090900|P1|STARTED|Part A, Washout Period 1 (7 Days)||16
4912882|NCT03649412|12090899|P2|NOT COMPLETED|Part A, Period 1 (4 Days)||0
4912883|NCT03649412|12090900|P1|NOT COMPLETED|Part A, Period 1 (4 Days)||0
4912884|NCT03649412|12090899|P2|COMPLETED|Part A, Period 1 (4 Days)||0
4912885|NCT03649412|12090900|P1|COMPLETED|Part A, Period 1 (4 Days)||16
4912886|NCT03649412|12090899|P2|STARTED|Part A, Period 1 (4 Days)||0
4912887|NCT03649412|12090900|P1|STARTED|Part A, Period 1 (4 Days)||16
4912888|NCT03648983|12091058|P1|NOT COMPLETED|Overall Study||95
4912889|NCT03648983|12091058|P1|COMPLETED|Overall Study||0
4912890|NCT03648983|12091058|P1|STARTED|Overall Study||95
4912891|NCT03648853|12091064|P1|NOT COMPLETED|Overall Study||0
4912892|NCT03648853|12091064|P1|COMPLETED|Overall Study||12
4912893|NCT03648853|12091064|P1|STARTED|Overall Study||12
4912894|NCT03647709|12091068|P1|NOT COMPLETED|Overall Study||14
4912895|NCT03647709|12091068|P1|COMPLETED|Overall Study||386
4912896|NCT03647709|12091068|P1|STARTED|Overall Study||400
4912897|NCT03647046|12091084|P1|NOT COMPLETED|Overall Study||4
4912898|NCT03647046|12091084|P1|COMPLETED|Overall Study||8
4912899|NCT03647046|12091084|P1|STARTED|Overall Study||12
4912900|NCT03647033|12091090|P2|NOT COMPLETED|Overall Study||0
4912901|NCT03647033|12091091|P1|NOT COMPLETED|Overall Study||0
4912902|NCT03647033|12091090|P2|COMPLETED|Overall Study||16
4912903|NCT03647033|12091091|P1|COMPLETED|Overall Study||16
4912904|NCT03647033|12091090|P2|STARTED|Overall Study||16
4912905|NCT03647033|12091091|P1|STARTED|Overall Study||16
4912906|NCT03646656|12091101|P2|NOT COMPLETED|Overall Study||0
4912907|NCT03646656|12091102|P1|NOT COMPLETED|Overall Study||3
4912908|NCT03646656|12091101|P2|COMPLETED|Overall Study||3
4912909|NCT03646656|12091102|P1|COMPLETED|Overall Study||9
4912910|NCT03646656|12091101|P2|Attended 1st Group Session|Overall Study||3
4912911|NCT03646656|12091102|P1|Attended 1st Group Session|Overall Study||10
4912912|NCT03646656|12091101|P2|STARTED|Overall Study||3
4912913|NCT03646656|12091102|P1|STARTED|Overall Study||12
4912914|NCT03645811|12091122|P3|NOT COMPLETED|Overall Study||2
4912915|NCT03645811|12091123|P2|NOT COMPLETED|Overall Study||2
4912916|NCT03645811|12091124|P1|NOT COMPLETED|Overall Study||2
4912917|NCT03645811|12091122|P3|COMPLETED|Overall Study||30
4912918|NCT03645811|12091123|P2|COMPLETED|Overall Study||30
4912919|NCT03645811|12091124|P1|COMPLETED|Overall Study||30
4912920|NCT03645811|12091122|P3|STARTED|Overall Study||32
4912921|NCT03645811|12091123|P2|STARTED|Overall Study||32
4912922|NCT03645811|12091124|P1|STARTED|Overall Study||32
4912923|NCT03645421|12091136|P4|NOT COMPLETED|Overall Study||4
4912924|NCT03645421|12091137|P3|NOT COMPLETED|Overall Study||5
4912925|NCT03645421|12091138|P2|NOT COMPLETED|Overall Study||0
4912926|NCT03645421|12091139|P1|NOT COMPLETED|Overall Study||0
4912927|NCT03645421|12091136|P4|COMPLETED|Overall Study||11
4912928|NCT03645421|12091137|P3|COMPLETED|Overall Study||10
4912929|NCT03645421|12091138|P2|COMPLETED|Overall Study||15
4912930|NCT03645421|12091139|P1|COMPLETED|Overall Study||16
4912931|NCT03645421|12091136|P4|Received Investigational Product (IP)|Overall Study||15
4912932|NCT03645421|12091137|P3|Received Investigational Product (IP)|Overall Study||15
4912933|NCT03645421|12091138|P2|Received Investigational Product (IP)|Overall Study||15
4912934|NCT03645421|12091139|P1|Received Investigational Product (IP)|Overall Study||16
4912935|NCT03645421|12091136|P4|STARTED|Overall Study||15
4912936|NCT03645421|12091137|P3|STARTED|Overall Study||15
4912937|NCT03645421|12091138|P2|STARTED|Overall Study||15
4912938|NCT03645421|12091139|P1|STARTED|Overall Study||16
4912939|NCT03644212|12091205|P2|NOT COMPLETED|Overall Study||0
4912940|NCT03644212|12091206|P1|NOT COMPLETED|Overall Study||0
4912941|NCT03644212|12091205|P2|COMPLETED|Overall Study||16
4912942|NCT03644212|12091206|P1|COMPLETED|Overall Study||63
4912943|NCT03644212|12091205|P2|STARTED|Overall Study||16
4912944|NCT03644212|12091206|P1|STARTED|Overall Study||63
4912945|NCT03644108|12091212|P1|NOT COMPLETED|Overall Study||0
4912946|NCT03644108|12091212|P1|COMPLETED|Overall Study||30
4912947|NCT03644108|12091212|P1|STARTED|Overall Study||30
4912948|NCT03644095|12091223|P2|NOT COMPLETED|Period 2||0
4912949|NCT03644095|12091224|P1|NOT COMPLETED|Period 2||0
4912950|NCT03644095|12091223|P2|COMPLETED|Period 2||15
4912951|NCT03644095|12091224|P1|COMPLETED|Period 2||15
4912952|NCT03644095|12091223|P2|STARTED|Period 2||15
4912953|NCT03644095|12091224|P1|STARTED|Period 2||15
4912954|NCT03644095|12091223|P2|NOT COMPLETED|Washout (7 Days)||0
4912955|NCT03644095|12091224|P1|NOT COMPLETED|Washout (7 Days)||0
4912956|NCT03644095|12091223|P2|COMPLETED|Washout (7 Days)||15
4912957|NCT03644095|12091224|P1|COMPLETED|Washout (7 Days)||15
4912958|NCT03644095|12091223|P2|STARTED|Washout (7 Days)||15
4912959|NCT03644095|12091224|P1|STARTED|Washout (7 Days)||15
4912960|NCT03644095|12091223|P2|NOT COMPLETED|Period 1||0
4912961|NCT03644095|12091224|P1|NOT COMPLETED|Period 1||0
4912962|NCT03644095|12091223|P2|COMPLETED|Period 1||15
4912963|NCT03644095|12091224|P1|COMPLETED|Period 1||15
4912964|NCT03644095|12091223|P2|STARTED|Period 1||15
4912965|NCT03644095|12091224|P1|STARTED|Period 1||15
4912966|NCT03643575|12091244|P6|NOT COMPLETED|Period 3||0
4912967|NCT03643575|12091245|P5|NOT COMPLETED|Period 3||0
4912968|NCT03643575|12091246|P4|NOT COMPLETED|Period 3||0
4912969|NCT03643575|12091247|P3|NOT COMPLETED|Period 3||0
4912970|NCT03643575|12091248|P2|NOT COMPLETED|Period 3||0
4912971|NCT03643575|12091249|P1|NOT COMPLETED|Period 3||0
4912972|NCT03643575|12091244|P6|COMPLETED|Period 3||5
4912973|NCT03643575|12091245|P5|COMPLETED|Period 3||5
4912974|NCT03643575|12091246|P4|COMPLETED|Period 3||4
4912975|NCT03643575|12091247|P3|COMPLETED|Period 3||5
4912976|NCT03643575|12091248|P2|COMPLETED|Period 3||4
4912977|NCT03643575|12091249|P1|COMPLETED|Period 3||4
4912978|NCT03643575|12091244|P6|STARTED|Period 3||5
4912979|NCT03643575|12091245|P5|STARTED|Period 3||5
4912980|NCT03643575|12091246|P4|STARTED|Period 3||4
4912981|NCT03643575|12091247|P3|STARTED|Period 3||5
4912982|NCT03643575|12091248|P2|STARTED|Period 3||4
4912983|NCT03643575|12091249|P1|STARTED|Period 3||4
4912984|NCT03643575|12091244|P6|NOT COMPLETED|Washout: 7 Days||0
4912985|NCT03643575|12091245|P5|NOT COMPLETED|Washout: 7 Days||0
4912986|NCT03643575|12091246|P4|NOT COMPLETED|Washout: 7 Days||0
4912987|NCT03643575|12091247|P3|NOT COMPLETED|Washout: 7 Days||0
4912988|NCT03643575|12091248|P2|NOT COMPLETED|Washout: 7 Days||1
4912989|NCT03643575|12091249|P1|NOT COMPLETED|Washout: 7 Days||0
4912990|NCT03643575|12091244|P6|COMPLETED|Washout: 7 Days||5
4912991|NCT03643575|12091245|P5|COMPLETED|Washout: 7 Days||5
4912992|NCT03643575|12091246|P4|COMPLETED|Washout: 7 Days||4
4912993|NCT03643575|12091247|P3|COMPLETED|Washout: 7 Days||5
4912994|NCT03643575|12091248|P2|COMPLETED|Washout: 7 Days||4
4912995|NCT03643575|12091249|P1|COMPLETED|Washout: 7 Days||4
4912996|NCT03643575|12091244|P6|STARTED|Washout: 7 Days||5
4912997|NCT03643575|12091245|P5|STARTED|Washout: 7 Days||5
4912998|NCT03643575|12091246|P4|STARTED|Washout: 7 Days||4
4912999|NCT03643575|12091247|P3|STARTED|Washout: 7 Days||5
4913000|NCT03643575|12091248|P2|STARTED|Washout: 7 Days||5
4913001|NCT03643575|12091249|P1|STARTED|Washout: 7 Days||4
4913002|NCT03643575|12091244|P6|NOT COMPLETED|Period 2||0
4913003|NCT03643575|12091245|P5|NOT COMPLETED|Period 2||0
4913004|NCT03643575|12091246|P4|NOT COMPLETED|Period 2||0
4913005|NCT03643575|12091247|P3|NOT COMPLETED|Period 2||0
4913006|NCT03643575|12091248|P2|NOT COMPLETED|Period 2||0
4913007|NCT03643575|12091249|P1|NOT COMPLETED|Period 2||0
4913008|NCT03643575|12091244|P6|COMPLETED|Period 2||5
4913009|NCT03643575|12091245|P5|COMPLETED|Period 2||5
4913010|NCT03643575|12091246|P4|COMPLETED|Period 2||4
4913011|NCT03643575|12091247|P3|COMPLETED|Period 2||5
4913012|NCT03643575|12091248|P2|COMPLETED|Period 2||5
4913013|NCT03643575|12091249|P1|COMPLETED|Period 2||4
4913014|NCT03643575|12091244|P6|STARTED|Period 2||5
4913015|NCT03643575|12091245|P5|STARTED|Period 2||5
4913016|NCT03643575|12091246|P4|STARTED|Period 2||4
4913017|NCT03643575|12091247|P3|STARTED|Period 2||5
4913018|NCT03643575|12091248|P2|STARTED|Period 2||5
4913019|NCT03643575|12091249|P1|STARTED|Period 2||4
4913020|NCT03643575|12091244|P6|NOT COMPLETED|Washout: 7 Days||0
4913021|NCT03643575|12091245|P5|NOT COMPLETED|Washout: 7 Days||0
4913022|NCT03643575|12091246|P4|NOT COMPLETED|Washout: 7 Days||1
4913023|NCT03643575|12091247|P3|NOT COMPLETED|Washout: 7 Days||0
4913024|NCT03643575|12091248|P2|NOT COMPLETED|Washout: 7 Days||0
4913025|NCT03643575|12091249|P1|NOT COMPLETED|Washout: 7 Days||1
4913026|NCT03643575|12091244|P6|COMPLETED|Washout: 7 Days||5
4913027|NCT03643575|12091245|P5|COMPLETED|Washout: 7 Days||5
4913028|NCT03643575|12091246|P4|COMPLETED|Washout: 7 Days||4
4913029|NCT03643575|12091247|P3|COMPLETED|Washout: 7 Days||5
4913030|NCT03643575|12091248|P2|COMPLETED|Washout: 7 Days||5
4913031|NCT03643575|12091249|P1|COMPLETED|Washout: 7 Days||4
4913032|NCT03643575|12091244|P6|STARTED|Washout: 7 Days||5
4913033|NCT03643575|12091245|P5|STARTED|Washout: 7 Days||5
4913034|NCT03643575|12091246|P4|STARTED|Washout: 7 Days||5
4913035|NCT03643575|12091247|P3|STARTED|Washout: 7 Days||5
4913036|NCT03643575|12091248|P2|STARTED|Washout: 7 Days||5
4913037|NCT03643575|12091249|P1|STARTED|Washout: 7 Days||5
4913038|NCT03643575|12091244|P6|NOT COMPLETED|Period 1||0
4913039|NCT03643575|12091245|P5|NOT COMPLETED|Period 1||0
4913040|NCT03643575|12091246|P4|NOT COMPLETED|Period 1||0
4913041|NCT03643575|12091247|P3|NOT COMPLETED|Period 1||0
4913042|NCT03643575|12091248|P2|NOT COMPLETED|Period 1||0
4913043|NCT03643575|12091249|P1|NOT COMPLETED|Period 1||0
4913044|NCT03643575|12091244|P6|COMPLETED|Period 1||5
4913045|NCT03643575|12091245|P5|COMPLETED|Period 1||5
4913046|NCT03643575|12091246|P4|COMPLETED|Period 1||5
4913047|NCT03643575|12091247|P3|COMPLETED|Period 1||5
4913048|NCT03643575|12091248|P2|COMPLETED|Period 1||5
4913049|NCT03643575|12091249|P1|COMPLETED|Period 1||5
4913050|NCT03643575|12091244|P6|STARTED|Period 1||5
4913051|NCT03643575|12091245|P5|STARTED|Period 1||5
4913052|NCT03643575|12091246|P4|STARTED|Period 1||5
4913053|NCT03643575|12091247|P3|STARTED|Period 1||5
4913054|NCT03643575|12091248|P2|STARTED|Period 1||5
4913055|NCT03643575|12091249|P1|STARTED|Period 1||5
4913056|NCT03643432|12091307|P2|NOT COMPLETED|Overall Study||0
4913057|NCT03643432|12091308|P1|NOT COMPLETED|Overall Study||1
4913058|NCT03643432|12091307|P2|COMPLETED|Overall Study||21
4913059|NCT03643432|12091308|P1|COMPLETED|Overall Study||26
4913060|NCT03643432|12091307|P2|STARTED|Overall Study||21
4913061|NCT03643432|12091308|P1|STARTED|Overall Study||27
4913062|NCT03643159|12091332|P1|NOT COMPLETED|Overall Study||2
4913063|NCT03643159|12091332|P1|COMPLETED|Overall Study||0
4913064|NCT03643159|12091332|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
4913065|NCT03643159|12091332|P1|STARTED|Overall Study||2
4913066|NCT03642873|12091339|P6|NOT COMPLETED|Third Intervention (1 Day)||0
4913067|NCT03642873|12091340|P5|NOT COMPLETED|Third Intervention (1 Day)||1
4913068|NCT03642873|12091341|P4|NOT COMPLETED|Third Intervention (1 Day)||0
4913069|NCT03642873|12091342|P3|NOT COMPLETED|Third Intervention (1 Day)||0
4913070|NCT03642873|12091343|P2|NOT COMPLETED|Third Intervention (1 Day)||0
4913071|NCT03642873|12091344|P1|NOT COMPLETED|Third Intervention (1 Day)||0
4913072|NCT03642873|12091339|P6|COMPLETED|Third Intervention (1 Day)||4
4913073|NCT03642873|12091340|P5|COMPLETED|Third Intervention (1 Day)||3
4913074|NCT03642873|12091341|P4|COMPLETED|Third Intervention (1 Day)||4
4913075|NCT03642873|12091342|P3|COMPLETED|Third Intervention (1 Day)||4
4913076|NCT03642873|12091343|P2|COMPLETED|Third Intervention (1 Day)||4
4913077|NCT03642873|12091344|P1|COMPLETED|Third Intervention (1 Day)||4
4913078|NCT03642873|12091339|P6|STARTED|Third Intervention (1 Day)||4
4913079|NCT03642873|12091340|P5|STARTED|Third Intervention (1 Day)||4
4913080|NCT03642873|12091341|P4|STARTED|Third Intervention (1 Day)||4
4913081|NCT03642873|12091342|P3|STARTED|Third Intervention (1 Day)||4
4913082|NCT03642873|12091343|P2|STARTED|Third Intervention (1 Day)||4
4913083|NCT03642873|12091344|P1|STARTED|Third Intervention (1 Day)||4
4913084|NCT03642873|12091339|P6|NOT COMPLETED|Washout (7 Days)||0
4913085|NCT03642873|12091340|P5|NOT COMPLETED|Washout (7 Days)||0
4913086|NCT03642873|12091341|P4|NOT COMPLETED|Washout (7 Days)||0
4913087|NCT03642873|12091342|P3|NOT COMPLETED|Washout (7 Days)||0
4913088|NCT03642873|12091343|P2|NOT COMPLETED|Washout (7 Days)||0
4913089|NCT03642873|12091344|P1|NOT COMPLETED|Washout (7 Days)||0
4913090|NCT03642873|12091339|P6|COMPLETED|Washout (7 Days)||4
4913091|NCT03642873|12091340|P5|COMPLETED|Washout (7 Days)||4
4913092|NCT03642873|12091341|P4|COMPLETED|Washout (7 Days)||4
4913093|NCT03642873|12091342|P3|COMPLETED|Washout (7 Days)||4
4913094|NCT03642873|12091343|P2|COMPLETED|Washout (7 Days)||4
4913095|NCT03642873|12091344|P1|COMPLETED|Washout (7 Days)||4
4913096|NCT03642873|12091339|P6|STARTED|Washout (7 Days)||4
4913097|NCT03642873|12091340|P5|STARTED|Washout (7 Days)||4
4913098|NCT03642873|12091341|P4|STARTED|Washout (7 Days)||4
4913099|NCT03642873|12091342|P3|STARTED|Washout (7 Days)||4
4913100|NCT03642873|12091343|P2|STARTED|Washout (7 Days)||4
4913101|NCT03642873|12091344|P1|STARTED|Washout (7 Days)||4
4913102|NCT03642873|12091339|P6|NOT COMPLETED|Second Intervention (1 Day)||0
4913103|NCT03642873|12091340|P5|NOT COMPLETED|Second Intervention (1 Day)||0
4913104|NCT03642873|12091341|P4|NOT COMPLETED|Second Intervention (1 Day)||0
4913105|NCT03642873|12091342|P3|NOT COMPLETED|Second Intervention (1 Day)||0
4913106|NCT03642873|12091343|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4913107|NCT03642873|12091344|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4913108|NCT03642873|12091339|P6|COMPLETED|Second Intervention (1 Day)||4
4913109|NCT03642873|12091340|P5|COMPLETED|Second Intervention (1 Day)||4
4913110|NCT03642873|12091341|P4|COMPLETED|Second Intervention (1 Day)||4
4913111|NCT03642873|12091342|P3|COMPLETED|Second Intervention (1 Day)||4
4913112|NCT03642873|12091343|P2|COMPLETED|Second Intervention (1 Day)||4
4913113|NCT03642873|12091344|P1|COMPLETED|Second Intervention (1 Day)||4
4913114|NCT03642873|12091339|P6|STARTED|Second Intervention (1 Day)||4
4913115|NCT03642873|12091340|P5|STARTED|Second Intervention (1 Day)||4
4913116|NCT03642873|12091341|P4|STARTED|Second Intervention (1 Day)||4
4913117|NCT03642873|12091342|P3|STARTED|Second Intervention (1 Day)||4
4913118|NCT03642873|12091343|P2|STARTED|Second Intervention (1 Day)||4
4913119|NCT03642873|12091344|P1|STARTED|Second Intervention (1 Day)||4
4913120|NCT03642873|12091339|P6|NOT COMPLETED|Washout (7 Days)||0
4913121|NCT03642873|12091340|P5|NOT COMPLETED|Washout (7 Days)||0
4913122|NCT03642873|12091341|P4|NOT COMPLETED|Washout (7 Days)||0
4913123|NCT03642873|12091342|P3|NOT COMPLETED|Washout (7 Days)||0
4913124|NCT03642873|12091343|P2|NOT COMPLETED|Washout (7 Days)||0
4913125|NCT03642873|12091344|P1|NOT COMPLETED|Washout (7 Days)||0
4913126|NCT03642873|12091339|P6|COMPLETED|Washout (7 Days)||4
4913127|NCT03642873|12091340|P5|COMPLETED|Washout (7 Days)||4
4913128|NCT03642873|12091341|P4|COMPLETED|Washout (7 Days)||4
4913129|NCT03642873|12091342|P3|COMPLETED|Washout (7 Days)||4
4913130|NCT03642873|12091343|P2|COMPLETED|Washout (7 Days)||4
4913131|NCT03642873|12091344|P1|COMPLETED|Washout (7 Days)||4
4913132|NCT03642873|12091339|P6|STARTED|Washout (7 Days)||4
4913133|NCT03642873|12091340|P5|STARTED|Washout (7 Days)||4
4913134|NCT03642873|12091341|P4|STARTED|Washout (7 Days)||4
4913135|NCT03642873|12091342|P3|STARTED|Washout (7 Days)||4
4913136|NCT03642873|12091343|P2|STARTED|Washout (7 Days)||4
4913137|NCT03642873|12091344|P1|STARTED|Washout (7 Days)||4
4913138|NCT03642873|12091339|P6|NOT COMPLETED|First Intervention (1 Day)||0
4913139|NCT03642873|12091340|P5|NOT COMPLETED|First Intervention (1 Day)||0
4913140|NCT03642873|12091341|P4|NOT COMPLETED|First Intervention (1 Day)||0
4913141|NCT03642873|12091342|P3|NOT COMPLETED|First Intervention (1 Day)||0
4913142|NCT03642873|12091343|P2|NOT COMPLETED|First Intervention (1 Day)||0
4913143|NCT03642873|12091344|P1|NOT COMPLETED|First Intervention (1 Day)||0
4913144|NCT03642873|12091339|P6|COMPLETED|First Intervention (1 Day)||4
4913145|NCT03642873|12091340|P5|COMPLETED|First Intervention (1 Day)||4
4913146|NCT03642873|12091341|P4|COMPLETED|First Intervention (1 Day)||4
4913147|NCT03642873|12091342|P3|COMPLETED|First Intervention (1 Day)||4
4913148|NCT03642873|12091343|P2|COMPLETED|First Intervention (1 Day)||4
4913149|NCT03642873|12091344|P1|COMPLETED|First Intervention (1 Day)||4
4913150|NCT03642873|12091339|P6|STARTED|First Intervention (1 Day)||4
4913151|NCT03642873|12091340|P5|STARTED|First Intervention (1 Day)||4
4913152|NCT03642873|12091341|P4|STARTED|First Intervention (1 Day)||4
4913153|NCT03642873|12091342|P3|STARTED|First Intervention (1 Day)||4
4913154|NCT03642873|12091343|P2|STARTED|First Intervention (1 Day)||4
4913155|NCT03642873|12091344|P1|STARTED|First Intervention (1 Day)||4
4913156|NCT03642262|12091376|P2|NOT COMPLETED|Period 2||0
4913157|NCT03642262|12091377|P1|NOT COMPLETED|Period 2||0
4913158|NCT03642262|12091376|P2|COMPLETED|Period 2||16
4913159|NCT03642262|12091377|P1|COMPLETED|Period 2||11
4913160|NCT03642262|12091376|P2|STARTED|Period 2||16
4913161|NCT03642262|12091377|P1|STARTED|Period 2||11
4913162|NCT03642262|12091376|P2|NOT COMPLETED|Washout: 7 Days||0
4913163|NCT03642262|12091377|P1|NOT COMPLETED|Washout: 7 Days||0
4913164|NCT03642262|12091376|P2|COMPLETED|Washout: 7 Days||16
4913165|NCT03642262|12091377|P1|COMPLETED|Washout: 7 Days||11
4913166|NCT03642262|12091376|P2|STARTED|Washout: 7 Days||16
4913167|NCT03642262|12091377|P1|STARTED|Washout: 7 Days||11
4913168|NCT03642262|12091376|P2|NOT COMPLETED|Period 1||2
4913169|NCT03642262|12091377|P1|NOT COMPLETED|Period 1||1
4913170|NCT03642262|12091376|P2|COMPLETED|Period 1||16
4913171|NCT03642262|12091377|P1|COMPLETED|Period 1||11
4913172|NCT03642262|12091376|P2|STARTED|Period 1||18
4913173|NCT03642262|12091377|P1|STARTED|Period 1||12
4913174|NCT03641508|12091398|P2|NOT COMPLETED|Follow-up/Second Injection||0
4913175|NCT03641508|12091399|P1|NOT COMPLETED|Follow-up/Second Injection||0
4913176|NCT03641508|12091398|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
4913177|NCT03641508|12091399|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
4913178|NCT03641508|12091398|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
4913179|NCT03641508|12091399|P1|STARTED|Follow-up/Second Injection||2
4913180|NCT03641508|12091398|P2|NOT COMPLETED|First Injection||0
4913181|NCT03641508|12091399|P1|NOT COMPLETED|First Injection||2
4913182|NCT03641508|12091398|P2|COMPLETED|First Injection||32
4913183|NCT03641508|12091399|P1|COMPLETED|First Injection||35
4913184|NCT03641508|12091398|P2|STARTED|First Injection||32
4913185|NCT03641508|12091399|P1|STARTED|First Injection||37
4913186|NCT03640832|12091411|P2|NOT COMPLETED|Overall Study||0
4913187|NCT03640832|12091412|P1|NOT COMPLETED|Overall Study||0
4913188|NCT03640832|12091411|P2|COMPLETED|Overall Study||46
4913189|NCT03640832|12091412|P1|COMPLETED|Overall Study||44
4913190|NCT03640832|12091411|P2|STARTED|Overall Study||46
4913191|NCT03640832|12091412|P1|STARTED|Overall Study||44
4913192|NCT03640559|12091426|P2|NOT COMPLETED|Overall Study||1
4913193|NCT03640559|12091427|P1|NOT COMPLETED|Overall Study||2
4913194|NCT03640559|12091426|P2|COMPLETED|Overall Study||24
4913195|NCT03640559|12091427|P1|COMPLETED|Overall Study||23
4913196|NCT03640559|12091426|P2|STARTED|Overall Study||25
4913197|NCT03640559|12091427|P1|STARTED|Overall Study||25
4913198|NCT03640507|12091436|P3|NOT COMPLETED|Overall Study||1
4913199|NCT03640507|12091437|P2|NOT COMPLETED|Overall Study||0
4913200|NCT03640507|12091438|P1|NOT COMPLETED|Overall Study||0
4913201|NCT03640507|12091436|P3|COMPLETED|Overall Study||10
4913202|NCT03640507|12091437|P2|COMPLETED|Overall Study||9
4913203|NCT03640507|12091438|P1|COMPLETED|Overall Study||10
4913204|NCT03640507|12091436|P3|STARTED|Overall Study||11
4913205|NCT03640507|12091437|P2|STARTED|Overall Study||9
4913206|NCT03640507|12091438|P1|STARTED|Overall Study||10
4913207|NCT03640052|12091458|P5|NOT COMPLETED|Overall Study||0
4913208|NCT03640052|12091459|P4|NOT COMPLETED|Overall Study||0
4913209|NCT03640052|12091460|P3|NOT COMPLETED|Overall Study||0
4913210|NCT03640052|12091461|P2|NOT COMPLETED|Overall Study||1
4913211|NCT03640052|12091462|P1|NOT COMPLETED|Overall Study||0
4913212|NCT03640052|12091458|P5|COMPLETED|Overall Study||1
4913213|NCT03640052|12091459|P4|COMPLETED|Overall Study||1
4913214|NCT03640052|12091460|P3|COMPLETED|Overall Study||1
4913215|NCT03640052|12091461|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
4913216|NCT03640052|12091462|P1|COMPLETED|Overall Study||2
4913217|NCT03640052|12091458|P5|STARTED|Overall Study||1
4913218|NCT03640052|12091459|P4|STARTED|Overall Study||1
4913219|NCT03640052|12091460|P3|STARTED|Overall Study||1
4913220|NCT03640052|12091461|P2|STARTED|Overall Study||1
4913221|NCT03640052|12091462|P1|STARTED|Overall Study||2
4913222|NCT03639675|12091479|P1|NOT COMPLETED|Overall Study||1
4913223|NCT03639675|12091479|P1|COMPLETED|Overall Study||15
4913224|NCT03639675|12091479|P1|Received Treatment|Overall Study||16
4913225|NCT03639675|12091479|P1|STARTED|Overall Study||16
4913226|NCT03638908|12091484|P1|NOT COMPLETED|Overall Study||1
4913227|NCT03638908|12091484|P1|COMPLETED|Overall Study||7
4913228|NCT03638908|12091484|P1|STARTED|Overall Study||8
4913229|NCT03638635|12091501|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
4913230|NCT03638635|12091502|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
4913231|NCT03638635|12091501|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
4913232|NCT03638635|12091502|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
4913233|NCT03638635|12091501|P2|STARTED|Follow-Up (30 Days After Discharge)||22
4913234|NCT03638635|12091502|P1|STARTED|Follow-Up (30 Days After Discharge)||39
4913235|NCT03638635|12091501|P2|NOT COMPLETED|Initial Hospitalization||2
4913236|NCT03638635|12091502|P1|NOT COMPLETED|Initial Hospitalization||0
4913237|NCT03638635|12091501|P2|COMPLETED|Initial Hospitalization||22
4913238|NCT03638635|12091502|P1|COMPLETED|Initial Hospitalization||39
4913239|NCT03638635|12091501|P2|STARTED|Initial Hospitalization||24
4913240|NCT03638635|12091502|P1|STARTED|Initial Hospitalization||39
4913241|NCT03638323|12091532|P1|NOT COMPLETED|Overall Study||1
4913242|NCT03638323|12091532|P1|COMPLETED|Overall Study||37
4913243|NCT03638323|12091532|P1|STARTED|Overall Study||38
4913244|NCT03637517|12091556|P3|NOT COMPLETED|Overall Study||0
4913245|NCT03637517|12091557|P2|NOT COMPLETED|Overall Study||0
4913246|NCT03637517|12091558|P1|NOT COMPLETED|Overall Study||0
4913247|NCT03637517|12091556|P3|COMPLETED|Overall Study||14
4913248|NCT03637517|12091557|P2|COMPLETED|Overall Study||14
4913249|NCT03637517|12091558|P1|COMPLETED|Overall Study||14
4913250|NCT03637517|12091556|P3|STARTED|Overall Study||14
4913251|NCT03637517|12091557|P2|STARTED|Overall Study||14
4913252|NCT03637517|12091558|P1|STARTED|Overall Study||14
4913253|NCT03636893|12091586|P2|NOT COMPLETED|Overall Study||10
4913254|NCT03636893|12091587|P1|NOT COMPLETED|Overall Study||9
4913255|NCT03636893|12091586|P2|COMPLETED|Overall Study||24
4913256|NCT03636893|12091587|P1|COMPLETED|Overall Study||31
4913257|NCT03636893|12091586|P2|STARTED|Overall Study||34
4913258|NCT03636893|12091587|P1|STARTED|Overall Study||40
4913259|NCT03636386|12091595|P2|NOT COMPLETED|Overall Study||0
4913260|NCT03636386|12091596|P1|NOT COMPLETED|Overall Study||0
4913261|NCT03636386|12091595|P2|COMPLETED|Overall Study||24
4913262|NCT03636386|12091596|P1|COMPLETED|Overall Study||24
4913263|NCT03636386|12091595|P2|STARTED|Overall Study||24
4913264|NCT03636386|12091596|P1|STARTED|Overall Study||24
4913265|NCT03634579|12091604|P1|NOT COMPLETED|Overall Study||9
4913266|NCT03634579|12091604|P1|COMPLETED|Overall Study||0
4913267|NCT03634579|12091604|P1|STARTED|Overall Study||9
4913268|NCT03634306|12091615|P3|NOT COMPLETED|Overall Study||0
4913269|NCT03634306|12091616|P2|NOT COMPLETED|Overall Study||0
4913270|NCT03634306|12091617|P1|NOT COMPLETED|Overall Study||0
4913271|NCT03634306|12091615|P3|COMPLETED|Overall Study||5
4913272|NCT03634306|12091616|P2|COMPLETED|Overall Study||15
4913273|NCT03634306|12091617|P1|COMPLETED|Overall Study||15
4913274|NCT03634306|12091615|P3|STARTED|Overall Study||5
4913275|NCT03634306|12091616|P2|STARTED|Overall Study||15
4913276|NCT03634306|12091617|P1|STARTED|Overall Study||15
4913277|NCT03634085|12091702|P2|NOT COMPLETED|Overall Study||2
4913278|NCT03634085|12091703|P1|NOT COMPLETED|Overall Study||1
4913279|NCT03634085|12091702|P2|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
4913280|NCT03634085|12091703|P1|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
4913281|NCT03634085|12091702|P2|Period 4|Overall Study|this period is not applicable for Cohort B|0
4913282|NCT03634085|12091703|P1|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
4913283|NCT03634085|12091702|P2|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
4913284|NCT03634085|12091703|P1|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
4913285|NCT03634085|12091702|P2|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
4913286|NCT03634085|12091703|P1|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
4913287|NCT03634085|12091702|P2|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
4913288|NCT03634085|12091703|P1|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
4913289|NCT03634085|12091702|P2|STARTED|Overall Study||8
4913290|NCT03634085|12091703|P1|STARTED|Overall Study||8
4913291|NCT03633825|12091718|P2|NOT COMPLETED|Analysis||0
4913292|NCT03633825|12091719|P1|NOT COMPLETED|Analysis||0
4913293|NCT03633825|12091718|P2|COMPLETED|Analysis||325
4913294|NCT03633825|12091719|P1|COMPLETED|Analysis||327
4913295|NCT03633825|12091718|P2|STARTED|Analysis||325
4913296|NCT03633825|12091719|P1|STARTED|Analysis||327
4913297|NCT03633825|12091718|P2|NOT COMPLETED|Follow up||450
4913298|NCT03633825|12091719|P1|NOT COMPLETED|Follow up||478
4913299|NCT03633825|12091718|P2|COMPLETED|Follow up||325
4913300|NCT03633825|12091719|P1|COMPLETED|Follow up||327
4913301|NCT03633825|12091718|P2|STARTED|Follow up||775
4913302|NCT03633825|12091719|P1|STARTED|Follow up||805
4913303|NCT03633825|12091718|P2|NOT COMPLETED|Allocation||0
4913304|NCT03633825|12091719|P1|NOT COMPLETED|Allocation||0
4913305|NCT03633825|12091718|P2|COMPLETED|Allocation||775
4913306|NCT03633825|12091719|P1|COMPLETED|Allocation||805
4913307|NCT03633825|12091718|P2|STARTED|Allocation||775
4913308|NCT03633825|12091719|P1|STARTED|Allocation||805
4913309|NCT03633825|12091718|P2|NOT COMPLETED|Enrollment||18837
4913310|NCT03633825|12091719|P1|NOT COMPLETED|Enrollment||19033
4913311|NCT03633825|12091718|P2|COMPLETED|Enrollment||775
4913312|NCT03633825|12091719|P1|COMPLETED|Enrollment||805
4913313|NCT03633825|12091718|P2|STARTED|Enrollment||19612
4913314|NCT03633825|12091719|P1|STARTED|Enrollment||19838
4913315|NCT03633526|12091727|P1|NOT COMPLETED|Overall Study||0
4913316|NCT03633526|12091727|P1|COMPLETED|Overall Study||16
4913317|NCT03633526|12091727|P1|STARTED|Overall Study||16
4913318|NCT03633487|12091737|P1|NOT COMPLETED|Overall Study||0
4913319|NCT03633487|12091737|P1|COMPLETED|Overall Study||24
4913320|NCT03633487|12091737|P1|STARTED|Overall Study||24
4913321|NCT03633448|12091751|P2|NOT COMPLETED|Period 2 (1 Day)||0
4913322|NCT03633448|12091752|P1|NOT COMPLETED|Period 2 (1 Day)||0
4913323|NCT03633448|12091751|P2|COMPLETED|Period 2 (1 Day)||12
4913324|NCT03633448|12091752|P1|COMPLETED|Period 2 (1 Day)||12
4913325|NCT03633448|12091751|P2|STARTED|Period 2 (1 Day)||12
4913326|NCT03633448|12091752|P1|STARTED|Period 2 (1 Day)||12
4913327|NCT03633448|12091751|P2|NOT COMPLETED|Washout (7 Days)||0
4913328|NCT03633448|12091752|P1|NOT COMPLETED|Washout (7 Days)||0
4913329|NCT03633448|12091751|P2|COMPLETED|Washout (7 Days)||12
4913330|NCT03633448|12091752|P1|COMPLETED|Washout (7 Days)||12
4913331|NCT03633448|12091751|P2|STARTED|Washout (7 Days)||12
4913332|NCT03633448|12091752|P1|STARTED|Washout (7 Days)||12
4913333|NCT03633448|12091751|P2|NOT COMPLETED|Period 1 (1 Day)||0
4913334|NCT03633448|12091752|P1|NOT COMPLETED|Period 1 (1 Day)||0
4913335|NCT03633448|12091751|P2|COMPLETED|Period 1 (1 Day)||12
4913336|NCT03633448|12091752|P1|COMPLETED|Period 1 (1 Day)||12
4913337|NCT03633448|12091751|P2|STARTED|Period 1 (1 Day)||12
4913338|NCT03633448|12091752|P1|STARTED|Period 1 (1 Day)||12
4913339|NCT03633344|12091792|P2|NOT COMPLETED|Overall Study||0
4913340|NCT03633344|12091793|P1|NOT COMPLETED|Overall Study||0
4913341|NCT03633344|12091792|P2|COMPLETED|Overall Study||24
4913342|NCT03633344|12091793|P1|COMPLETED|Overall Study||120
4913343|NCT03633344|12091792|P2|STARTED|Overall Study||24
4913344|NCT03633344|12091793|P1|STARTED|Overall Study||120
4913345|NCT03630185|12091807|P2|NOT COMPLETED|Overall Study||4
4913346|NCT03630185|12091808|P1|NOT COMPLETED|Overall Study||4
4913347|NCT03630185|12091807|P2|COMPLETED|Overall Study||0
4913348|NCT03630185|12091808|P1|COMPLETED|Overall Study||0
4913349|NCT03630185|12091807|P2|6 Month Follow up|Overall Study||0
4913350|NCT03630185|12091808|P1|6 Month Follow up|Overall Study||0
4913351|NCT03630185|12091807|P2|90 Day Follow up|Overall Study||1
4913352|NCT03630185|12091808|P1|90 Day Follow up|Overall Study||0
4913353|NCT03630185|12091807|P2|30 Day Follow up|Overall Study||1
4913354|NCT03630185|12091808|P1|30 Day Follow up|Overall Study||1
4913355|NCT03630185|12091807|P2|STARTED|Overall Study||4
4913356|NCT03630185|12091808|P1|STARTED|Overall Study||4
4913357|NCT03630016|12091852|P1|NOT COMPLETED|Overall Study||1
4913358|NCT03630016|12091852|P1|COMPLETED|Overall Study||10
4913359|NCT03630016|12091852|P1|STARTED|Overall Study||11
4913360|NCT03629184|12091858|P2|NOT COMPLETED|Overall Study||1
4913361|NCT03629184|12091859|P1|NOT COMPLETED|Overall Study||3
4913362|NCT03629184|12091858|P2|COMPLETED|Overall Study||57
4913363|NCT03629184|12091859|P1|COMPLETED|Overall Study||112
4913364|NCT03629184|12091858|P2|STARTED|Overall Study||58
4913365|NCT03629184|12091859|P1|STARTED|Overall Study||115
4913366|NCT03629054|12091909|P2|NOT COMPLETED|Period 2 (4 Days)||1
4913367|NCT03629054|12091910|P1|NOT COMPLETED|Period 2 (4 Days)||0
4913368|NCT03629054|12091909|P2|COMPLETED|Period 2 (4 Days)||14
4913369|NCT03629054|12091910|P1|COMPLETED|Period 2 (4 Days)||15
4913370|NCT03629054|12091909|P2|Treated|Period 2 (4 Days)||14
4913371|NCT03629054|12091910|P1|Treated|Period 2 (4 Days)||15
4913372|NCT03629054|12091909|P2|STARTED|Period 2 (4 Days)|Started this period|15
4913373|NCT03629054|12091910|P1|STARTED|Period 2 (4 Days)|Started this period|15
4913374|NCT03629054|12091909|P2|NOT COMPLETED|Wasout Period (35 Days)||0
4913375|NCT03629054|12091910|P1|NOT COMPLETED|Wasout Period (35 Days)||0
4913376|NCT03629054|12091909|P2|COMPLETED|Wasout Period (35 Days)||15
4913377|NCT03629054|12091910|P1|COMPLETED|Wasout Period (35 Days)||15
4913378|NCT03629054|12091909|P2|STARTED|Wasout Period (35 Days)|Started this period|15
4913379|NCT03629054|12091910|P1|STARTED|Wasout Period (35 Days)|Started this period|15
4913380|NCT03629054|12091909|P2|NOT COMPLETED|Period 1 (4 Days)||0
4913381|NCT03629054|12091910|P1|NOT COMPLETED|Period 1 (4 Days)||0
4913382|NCT03629054|12091909|P2|COMPLETED|Period 1 (4 Days)||15
4913383|NCT03629054|12091910|P1|COMPLETED|Period 1 (4 Days)||15
4913384|NCT03629054|12091909|P2|STARTED|Period 1 (4 Days)|Started this period|15
4913385|NCT03629054|12091910|P1|STARTED|Period 1 (4 Days)|Started this period|15
4913386|NCT03629041|12091934|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
4913387|NCT03629041|12091935|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
4913388|NCT03629041|12091936|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
4913389|NCT03629041|12091937|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
4913390|NCT03629041|12091934|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913391|NCT03629041|12091935|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913392|NCT03629041|12091936|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
4913393|NCT03629041|12091937|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913394|NCT03629041|12091934|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913395|NCT03629041|12091935|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913396|NCT03629041|12091936|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913397|NCT03629041|12091937|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
4913398|NCT03629041|12091934|P4|NOT COMPLETED|Visit 1||0
4913399|NCT03629041|12091935|P3|NOT COMPLETED|Visit 1||0
4913400|NCT03629041|12091936|P2|NOT COMPLETED|Visit 1||0
4913401|NCT03629041|12091937|P1|NOT COMPLETED|Visit 1||0
4913402|NCT03629041|12091934|P4|COMPLETED|Visit 1||4
4913403|NCT03629041|12091935|P3|COMPLETED|Visit 1||4
4913404|NCT03629041|12091936|P2|COMPLETED|Visit 1||4
4913405|NCT03629041|12091937|P1|COMPLETED|Visit 1||4
4913406|NCT03629041|12091934|P4|STARTED|Visit 1||4
4913407|NCT03629041|12091935|P3|STARTED|Visit 1||4
4913408|NCT03629041|12091936|P2|STARTED|Visit 1||4
4913409|NCT03629041|12091937|P1|STARTED|Visit 1||4
4913410|NCT03629028|12091965|P2|NOT COMPLETED|Overall Study||25
4913411|NCT03629028|12091966|P1|NOT COMPLETED|Overall Study||32
4913412|NCT03629028|12091965|P2|COMPLETED|Overall Study||116
4913413|NCT03629028|12091966|P1|COMPLETED|Overall Study||109
4913414|NCT03629028|12091965|P2|STARTED|Overall Study||141
4913415|NCT03629028|12091966|P1|STARTED|Overall Study||141
4913416|NCT03628885|12091985|P3|NOT COMPLETED|Overall Study||60
4913417|NCT03628885|12091986|P2|NOT COMPLETED|Overall Study||47
4913418|NCT03628885|12091987|P1|NOT COMPLETED|Overall Study||39
4913419|NCT03628885|12091985|P3|COMPLETED|Overall Study||243
4913420|NCT03628885|12091986|P2|COMPLETED|Overall Study||252
4913421|NCT03628885|12091987|P1|COMPLETED|Overall Study||267
4913422|NCT03628885|12091985|P3|STARTED|Overall Study||303
4913423|NCT03628885|12091986|P2|STARTED|Overall Study||299
4913424|NCT03628885|12091987|P1|STARTED|Overall Study||306
4913425|NCT03628599|12091997|P2|NOT COMPLETED|Overall Study||1
4913426|NCT03628599|12091998|P1|NOT COMPLETED|Overall Study||0
4913427|NCT03628599|12091997|P2|COMPLETED|Overall Study||18
4913428|NCT03628599|12091998|P1|COMPLETED|Overall Study||18
4913429|NCT03628599|12091997|P2|STARTED|Overall Study||19
4913430|NCT03628599|12091998|P1|STARTED|Overall Study||18
4913431|NCT03628456|12092008|P1|NOT COMPLETED|Overall Study||0
4913432|NCT03628456|12092008|P1|COMPLETED|Overall Study||10
4913433|NCT03628456|12092008|P1|STARTED|Overall Study||10
4913434|NCT03628417|12092028|P2|NOT COMPLETED|Overall Study||1
4913435|NCT03628417|12092029|P1|NOT COMPLETED|Overall Study||1
4913436|NCT03628417|12092028|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
4913437|NCT03628417|12092029|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
4913438|NCT03628417|12092028|P2|Day 180|Overall Study||7
4913439|NCT03628417|12092029|P1|Day 180|Overall Study||7
4913440|NCT03628417|12092028|P2|Day 90|Overall Study||7
4913441|NCT03628417|12092029|P1|Day 90|Overall Study||7
4913442|NCT03628417|12092028|P2|Day 60|Overall Study||7
4913443|NCT03628417|12092029|P1|Day 60|Overall Study||7
4913444|NCT03628417|12092028|P2|Day 30|Overall Study||7
4913445|NCT03628417|12092029|P1|Day 30|Overall Study||7
4913446|NCT03628417|12092028|P2|Day 15|Overall Study||7
4913447|NCT03628417|12092029|P1|Day 15|Overall Study||7
4913448|NCT03628417|12092028|P2|Day 7|Overall Study||7
4913449|NCT03628417|12092029|P1|Day 7|Overall Study||7
4913450|NCT03628417|12092028|P2|Day 0|Overall Study||7
4913451|NCT03628417|12092029|P1|Day 0|Overall Study||7
4913452|NCT03628417|12092028|P2|STARTED|Overall Study||7
4913453|NCT03628417|12092029|P1|STARTED|Overall Study||7
4913454|NCT03627832|12092041|P2|NOT COMPLETED|Overall Study||1
4913455|NCT03627832|12092042|P1|NOT COMPLETED|Overall Study||10
4913456|NCT03627832|12092041|P2|COMPLETED|Overall Study||27
4913457|NCT03627832|12092042|P1|COMPLETED|Overall Study||18
4913458|NCT03627832|12092041|P2|STARTED|Overall Study||28
4913459|NCT03627832|12092042|P1|STARTED|Overall Study||28
4913460|NCT03627494|12092076|P12|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913461|NCT03627494|12092077|P11|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913462|NCT03627494|12092078|P10|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913463|NCT03627494|12092079|P9|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913464|NCT03627494|12092080|P8|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913465|NCT03627494|12092081|P7|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913466|NCT03627494|12092082|P6|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913467|NCT03627494|12092083|P5|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913468|NCT03627494|12092084|P4|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913469|NCT03627494|12092085|P3|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913470|NCT03627494|12092086|P2|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913471|NCT03627494|12092087|P1|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913472|NCT03627494|12092076|P12|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
4913473|NCT03627494|12092077|P11|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
4913474|NCT03627494|12092078|P10|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913475|NCT03627494|12092079|P9|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913476|NCT03627494|12092080|P8|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913477|NCT03627494|12092081|P7|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913478|NCT03627494|12092082|P6|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913479|NCT03627494|12092083|P5|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913480|NCT03627494|12092084|P4|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913481|NCT03627494|12092085|P3|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913482|NCT03627494|12092086|P2|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913483|NCT03627494|12092087|P1|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
4913484|NCT03627494|12092076|P12|STARTED|Part C Period2(4days)+Follow-up(14days)||5
4913485|NCT03627494|12092077|P11|STARTED|Part C Period2(4days)+Follow-up(14days)||5
4913486|NCT03627494|12092078|P10|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913487|NCT03627494|12092079|P9|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913488|NCT03627494|12092080|P8|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913489|NCT03627494|12092081|P7|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913490|NCT03627494|12092082|P6|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913491|NCT03627494|12092083|P5|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913492|NCT03627494|12092084|P4|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913493|NCT03627494|12092085|P3|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913494|NCT03627494|12092086|P2|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913495|NCT03627494|12092087|P1|STARTED|Part C Period2(4days)+Follow-up(14days)||0
4913496|NCT03627494|12092076|P12|NOT COMPLETED|Part C Washout 1 (7 Days)||1
4913497|NCT03627494|12092077|P11|NOT COMPLETED|Part C Washout 1 (7 Days)||1
4913498|NCT03627494|12092078|P10|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913499|NCT03627494|12092079|P9|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913500|NCT03627494|12092080|P8|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913501|NCT03627494|12092081|P7|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913502|NCT03627494|12092082|P6|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913503|NCT03627494|12092083|P5|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913504|NCT03627494|12092084|P4|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913505|NCT03627494|12092085|P3|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913506|NCT03627494|12092086|P2|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913507|NCT03627494|12092087|P1|NOT COMPLETED|Part C Washout 1 (7 Days)||0
4913508|NCT03627494|12092076|P12|COMPLETED|Part C Washout 1 (7 Days)||5
4913509|NCT03627494|12092077|P11|COMPLETED|Part C Washout 1 (7 Days)||5
4913510|NCT03627494|12092078|P10|COMPLETED|Part C Washout 1 (7 Days)||0
4913511|NCT03627494|12092079|P9|COMPLETED|Part C Washout 1 (7 Days)||0
4913512|NCT03627494|12092080|P8|COMPLETED|Part C Washout 1 (7 Days)||0
4913513|NCT03627494|12092081|P7|COMPLETED|Part C Washout 1 (7 Days)||0
4913514|NCT03627494|12092082|P6|COMPLETED|Part C Washout 1 (7 Days)||0
4913515|NCT03627494|12092083|P5|COMPLETED|Part C Washout 1 (7 Days)||0
4913516|NCT03627494|12092084|P4|COMPLETED|Part C Washout 1 (7 Days)||0
4913517|NCT03627494|12092085|P3|COMPLETED|Part C Washout 1 (7 Days)||0
4913518|NCT03627494|12092086|P2|COMPLETED|Part C Washout 1 (7 Days)||0
4913519|NCT03627494|12092087|P1|COMPLETED|Part C Washout 1 (7 Days)||0
4913520|NCT03627494|12092076|P12|STARTED|Part C Washout 1 (7 Days)||6
4913521|NCT03627494|12092077|P11|STARTED|Part C Washout 1 (7 Days)||6
4913522|NCT03627494|12092078|P10|STARTED|Part C Washout 1 (7 Days)||0
4913523|NCT03627494|12092079|P9|STARTED|Part C Washout 1 (7 Days)||0
4913524|NCT03627494|12092080|P8|STARTED|Part C Washout 1 (7 Days)||0
4913525|NCT03627494|12092081|P7|STARTED|Part C Washout 1 (7 Days)||0
4913526|NCT03627494|12092082|P6|STARTED|Part C Washout 1 (7 Days)||0
4913527|NCT03627494|12092083|P5|STARTED|Part C Washout 1 (7 Days)||0
4913528|NCT03627494|12092084|P4|STARTED|Part C Washout 1 (7 Days)||0
4913529|NCT03627494|12092085|P3|STARTED|Part C Washout 1 (7 Days)||0
4913530|NCT03627494|12092086|P2|STARTED|Part C Washout 1 (7 Days)||0
4913531|NCT03627494|12092087|P1|STARTED|Part C Washout 1 (7 Days)||0
4913532|NCT03627494|12092076|P12|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913533|NCT03627494|12092077|P11|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913534|NCT03627494|12092078|P10|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913535|NCT03627494|12092079|P9|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913536|NCT03627494|12092080|P8|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913537|NCT03627494|12092081|P7|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913538|NCT03627494|12092082|P6|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913539|NCT03627494|12092083|P5|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913540|NCT03627494|12092084|P4|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913541|NCT03627494|12092085|P3|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913542|NCT03627494|12092086|P2|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913543|NCT03627494|12092087|P1|NOT COMPLETED|Part C Period 1 (4 Days)||0
4913544|NCT03627494|12092076|P12|COMPLETED|Part C Period 1 (4 Days)||6
4913545|NCT03627494|12092077|P11|COMPLETED|Part C Period 1 (4 Days)||6
4913546|NCT03627494|12092078|P10|COMPLETED|Part C Period 1 (4 Days)||0
4913547|NCT03627494|12092079|P9|COMPLETED|Part C Period 1 (4 Days)||0
4913548|NCT03627494|12092080|P8|COMPLETED|Part C Period 1 (4 Days)||0
4913549|NCT03627494|12092081|P7|COMPLETED|Part C Period 1 (4 Days)||0
4913550|NCT03627494|12092082|P6|COMPLETED|Part C Period 1 (4 Days)||0
4913551|NCT03627494|12092083|P5|COMPLETED|Part C Period 1 (4 Days)||0
4913552|NCT03627494|12092084|P4|COMPLETED|Part C Period 1 (4 Days)||0
4913553|NCT03627494|12092085|P3|COMPLETED|Part C Period 1 (4 Days)||0
4913554|NCT03627494|12092086|P2|COMPLETED|Part C Period 1 (4 Days)||0
4913555|NCT03627494|12092087|P1|COMPLETED|Part C Period 1 (4 Days)||0
4913556|NCT03627494|12092076|P12|STARTED|Part C Period 1 (4 Days)||6
4913557|NCT03627494|12092077|P11|STARTED|Part C Period 1 (4 Days)||6
4913558|NCT03627494|12092078|P10|STARTED|Part C Period 1 (4 Days)||0
4913559|NCT03627494|12092079|P9|STARTED|Part C Period 1 (4 Days)||0
4913560|NCT03627494|12092080|P8|STARTED|Part C Period 1 (4 Days)||0
4913561|NCT03627494|12092081|P7|STARTED|Part C Period 1 (4 Days)||0
4913562|NCT03627494|12092082|P6|STARTED|Part C Period 1 (4 Days)||0
4913563|NCT03627494|12092083|P5|STARTED|Part C Period 1 (4 Days)||0
4913564|NCT03627494|12092084|P4|STARTED|Part C Period 1 (4 Days)||0
4913565|NCT03627494|12092085|P3|STARTED|Part C Period 1 (4 Days)||0
4913566|NCT03627494|12092086|P2|STARTED|Part C Period 1 (4 Days)||0
4913567|NCT03627494|12092087|P1|STARTED|Part C Period 1 (4 Days)||0
4913568|NCT03627494|12092076|P12|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913569|NCT03627494|12092077|P11|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913570|NCT03627494|12092078|P10|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913571|NCT03627494|12092079|P9|NOT COMPLETED|Part B (Maximum of 34 Days)||2
4913572|NCT03627494|12092080|P8|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913573|NCT03627494|12092081|P7|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913574|NCT03627494|12092082|P6|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913575|NCT03627494|12092083|P5|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913576|NCT03627494|12092084|P4|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913577|NCT03627494|12092085|P3|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913578|NCT03627494|12092086|P2|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913579|NCT03627494|12092087|P1|NOT COMPLETED|Part B (Maximum of 34 Days)||0
4913580|NCT03627494|12092076|P12|COMPLETED|Part B (Maximum of 34 Days)||0
4913581|NCT03627494|12092077|P11|COMPLETED|Part B (Maximum of 34 Days)||0
4913582|NCT03627494|12092078|P10|COMPLETED|Part B (Maximum of 34 Days)||9
4913583|NCT03627494|12092079|P9|COMPLETED|Part B (Maximum of 34 Days)||7
4913584|NCT03627494|12092080|P8|COMPLETED|Part B (Maximum of 34 Days)||9
4913585|NCT03627494|12092081|P7|COMPLETED|Part B (Maximum of 34 Days)||9
4913586|NCT03627494|12092082|P6|COMPLETED|Part B (Maximum of 34 Days)||0
4913587|NCT03627494|12092083|P5|COMPLETED|Part B (Maximum of 34 Days)||0
4913588|NCT03627494|12092084|P4|COMPLETED|Part B (Maximum of 34 Days)||0
4913589|NCT03627494|12092085|P3|COMPLETED|Part B (Maximum of 34 Days)||0
4913590|NCT03627494|12092086|P2|COMPLETED|Part B (Maximum of 34 Days)||0
4913591|NCT03627494|12092087|P1|COMPLETED|Part B (Maximum of 34 Days)||0
4913592|NCT03627494|12092076|P12|STARTED|Part B (Maximum of 34 Days)||0
4913593|NCT03627494|12092077|P11|STARTED|Part B (Maximum of 34 Days)||0
4913594|NCT03627494|12092078|P10|STARTED|Part B (Maximum of 34 Days)||9
4913595|NCT03627494|12092079|P9|STARTED|Part B (Maximum of 34 Days)||9
4913596|NCT03627494|12092080|P8|STARTED|Part B (Maximum of 34 Days)||9
4913597|NCT03627494|12092081|P7|STARTED|Part B (Maximum of 34 Days)||9
4913598|NCT03627494|12092082|P6|STARTED|Part B (Maximum of 34 Days)||0
4913599|NCT03627494|12092083|P5|STARTED|Part B (Maximum of 34 Days)||0
4913600|NCT03627494|12092084|P4|STARTED|Part B (Maximum of 34 Days)||0
4913601|NCT03627494|12092085|P3|STARTED|Part B (Maximum of 34 Days)||0
4913602|NCT03627494|12092086|P2|STARTED|Part B (Maximum of 34 Days)||0
4913603|NCT03627494|12092087|P1|STARTED|Part B (Maximum of 34 Days)||0
4913604|NCT03627494|12092076|P12|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913605|NCT03627494|12092077|P11|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913606|NCT03627494|12092078|P10|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913607|NCT03627494|12092079|P9|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913608|NCT03627494|12092080|P8|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913609|NCT03627494|12092081|P7|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913610|NCT03627494|12092082|P6|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913611|NCT03627494|12092083|P5|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913612|NCT03627494|12092084|P4|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913613|NCT03627494|12092085|P3|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913614|NCT03627494|12092086|P2|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913615|NCT03627494|12092087|P1|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913616|NCT03627494|12092076|P12|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913617|NCT03627494|12092077|P11|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913618|NCT03627494|12092078|P10|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913619|NCT03627494|12092079|P9|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913620|NCT03627494|12092080|P8|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913621|NCT03627494|12092081|P7|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
4913622|NCT03627494|12092082|P6|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
4913623|NCT03627494|12092083|P5|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
4913624|NCT03627494|12092084|P4|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
4913625|NCT03627494|12092085|P3|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
4913626|NCT03627494|12092086|P2|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
4913627|NCT03627494|12092087|P1|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
4913628|NCT03627494|12092076|P12|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913629|NCT03627494|12092077|P11|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913630|NCT03627494|12092078|P10|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913631|NCT03627494|12092079|P9|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913632|NCT03627494|12092080|P8|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913633|NCT03627494|12092081|P7|STARTED|Part A Period3(4days)+Follow-up(14days)||0
4913634|NCT03627494|12092082|P6|STARTED|Part A Period3(4days)+Follow-up(14days)||3
4913635|NCT03627494|12092083|P5|STARTED|Part A Period3(4days)+Follow-up(14days)||3
4913636|NCT03627494|12092084|P4|STARTED|Part A Period3(4days)+Follow-up(14days)||3
4913637|NCT03627494|12092085|P3|STARTED|Part A Period3(4days)+Follow-up(14days)||2
4913638|NCT03627494|12092086|P2|STARTED|Part A Period3(4days)+Follow-up(14days)||3
4913639|NCT03627494|12092087|P1|STARTED|Part A Period3(4days)+Follow-up(14days)||2
4913640|NCT03627494|12092076|P12|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913641|NCT03627494|12092077|P11|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913642|NCT03627494|12092078|P10|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913643|NCT03627494|12092079|P9|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913644|NCT03627494|12092080|P8|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913645|NCT03627494|12092081|P7|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913646|NCT03627494|12092082|P6|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913647|NCT03627494|12092083|P5|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913648|NCT03627494|12092084|P4|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913649|NCT03627494|12092085|P3|NOT COMPLETED|Part A Washout 2 (7 Days)||1
4913650|NCT03627494|12092086|P2|NOT COMPLETED|Part A Washout 2 (7 Days)||0
4913651|NCT03627494|12092087|P1|NOT COMPLETED|Part A Washout 2 (7 Days)||1
4913652|NCT03627494|12092076|P12|COMPLETED|Part A Washout 2 (7 Days)||0
4913653|NCT03627494|12092077|P11|COMPLETED|Part A Washout 2 (7 Days)||0
4913654|NCT03627494|12092078|P10|COMPLETED|Part A Washout 2 (7 Days)||0
4913655|NCT03627494|12092079|P9|COMPLETED|Part A Washout 2 (7 Days)||0
4913656|NCT03627494|12092080|P8|COMPLETED|Part A Washout 2 (7 Days)||0
4913657|NCT03627494|12092081|P7|COMPLETED|Part A Washout 2 (7 Days)||0
4913658|NCT03627494|12092082|P6|COMPLETED|Part A Washout 2 (7 Days)||3
4913659|NCT03627494|12092083|P5|COMPLETED|Part A Washout 2 (7 Days)||3
4913660|NCT03627494|12092084|P4|COMPLETED|Part A Washout 2 (7 Days)||3
4913661|NCT03627494|12092085|P3|COMPLETED|Part A Washout 2 (7 Days)||2
4913662|NCT03627494|12092086|P2|COMPLETED|Part A Washout 2 (7 Days)||3
4913663|NCT03627494|12092087|P1|COMPLETED|Part A Washout 2 (7 Days)||2
4913664|NCT03627494|12092076|P12|STARTED|Part A Washout 2 (7 Days)||0
4913665|NCT03627494|12092077|P11|STARTED|Part A Washout 2 (7 Days)||0
4913666|NCT03627494|12092078|P10|STARTED|Part A Washout 2 (7 Days)||0
4913667|NCT03627494|12092079|P9|STARTED|Part A Washout 2 (7 Days)||0
4913668|NCT03627494|12092080|P8|STARTED|Part A Washout 2 (7 Days)||0
4913669|NCT03627494|12092081|P7|STARTED|Part A Washout 2 (7 Days)||0
4913670|NCT03627494|12092082|P6|STARTED|Part A Washout 2 (7 Days)||3
4913671|NCT03627494|12092083|P5|STARTED|Part A Washout 2 (7 Days)||3
4913672|NCT03627494|12092084|P4|STARTED|Part A Washout 2 (7 Days)||3
4913673|NCT03627494|12092085|P3|STARTED|Part A Washout 2 (7 Days)||3
4913674|NCT03627494|12092086|P2|STARTED|Part A Washout 2 (7 Days)||3
4913675|NCT03627494|12092087|P1|STARTED|Part A Washout 2 (7 Days)||3
4913676|NCT03627494|12092076|P12|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913677|NCT03627494|12092077|P11|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913678|NCT03627494|12092078|P10|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913679|NCT03627494|12092079|P9|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913680|NCT03627494|12092080|P8|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913681|NCT03627494|12092081|P7|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913682|NCT03627494|12092082|P6|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913683|NCT03627494|12092083|P5|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913684|NCT03627494|12092084|P4|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913685|NCT03627494|12092085|P3|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913686|NCT03627494|12092086|P2|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913687|NCT03627494|12092087|P1|NOT COMPLETED|Part A Period 2 (4 Days)||0
4913688|NCT03627494|12092076|P12|COMPLETED|Part A Period 2 (4 Days)||0
4913689|NCT03627494|12092077|P11|COMPLETED|Part A Period 2 (4 Days)||0
4913690|NCT03627494|12092078|P10|COMPLETED|Part A Period 2 (4 Days)||0
4913691|NCT03627494|12092079|P9|COMPLETED|Part A Period 2 (4 Days)||0
4913692|NCT03627494|12092080|P8|COMPLETED|Part A Period 2 (4 Days)||0
4913693|NCT03627494|12092081|P7|COMPLETED|Part A Period 2 (4 Days)||0
4913694|NCT03627494|12092082|P6|COMPLETED|Part A Period 2 (4 Days)||3
4913695|NCT03627494|12092083|P5|COMPLETED|Part A Period 2 (4 Days)||3
4913696|NCT03627494|12092084|P4|COMPLETED|Part A Period 2 (4 Days)||3
4913697|NCT03627494|12092085|P3|COMPLETED|Part A Period 2 (4 Days)||3
4913698|NCT03627494|12092086|P2|COMPLETED|Part A Period 2 (4 Days)||3
4913699|NCT03627494|12092087|P1|COMPLETED|Part A Period 2 (4 Days)||3
4913700|NCT03627494|12092076|P12|STARTED|Part A Period 2 (4 Days)||0
4913701|NCT03627494|12092077|P11|STARTED|Part A Period 2 (4 Days)||0
4913702|NCT03627494|12092078|P10|STARTED|Part A Period 2 (4 Days)||0
4913703|NCT03627494|12092079|P9|STARTED|Part A Period 2 (4 Days)||0
4913704|NCT03627494|12092080|P8|STARTED|Part A Period 2 (4 Days)||0
4913705|NCT03627494|12092081|P7|STARTED|Part A Period 2 (4 Days)||0
4913706|NCT03627494|12092082|P6|STARTED|Part A Period 2 (4 Days)||3
4913707|NCT03627494|12092083|P5|STARTED|Part A Period 2 (4 Days)||3
4913708|NCT03627494|12092084|P4|STARTED|Part A Period 2 (4 Days)||3
4913709|NCT03627494|12092085|P3|STARTED|Part A Period 2 (4 Days)||3
4913710|NCT03627494|12092086|P2|STARTED|Part A Period 2 (4 Days)||3
4913711|NCT03627494|12092087|P1|STARTED|Part A Period 2 (4 Days)||3
4913712|NCT03627494|12092076|P12|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913713|NCT03627494|12092077|P11|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913714|NCT03627494|12092078|P10|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913715|NCT03627494|12092079|P9|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913716|NCT03627494|12092080|P8|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913717|NCT03627494|12092081|P7|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913718|NCT03627494|12092082|P6|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913719|NCT03627494|12092083|P5|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913720|NCT03627494|12092084|P4|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913721|NCT03627494|12092085|P3|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913722|NCT03627494|12092086|P2|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913723|NCT03627494|12092087|P1|NOT COMPLETED|Part A Washout 1 (7 Days)||0
4913724|NCT03627494|12092076|P12|COMPLETED|Part A Washout 1 (7 Days)||0
4913725|NCT03627494|12092077|P11|COMPLETED|Part A Washout 1 (7 Days)||0
4913726|NCT03627494|12092078|P10|COMPLETED|Part A Washout 1 (7 Days)||0
4913727|NCT03627494|12092079|P9|COMPLETED|Part A Washout 1 (7 Days)||0
4913728|NCT03627494|12092080|P8|COMPLETED|Part A Washout 1 (7 Days)||0
4913729|NCT03627494|12092081|P7|COMPLETED|Part A Washout 1 (7 Days)||0
4913730|NCT03627494|12092082|P6|COMPLETED|Part A Washout 1 (7 Days)||3
4913731|NCT03627494|12092083|P5|COMPLETED|Part A Washout 1 (7 Days)||3
4913732|NCT03627494|12092084|P4|COMPLETED|Part A Washout 1 (7 Days)||3
4913733|NCT03627494|12092085|P3|COMPLETED|Part A Washout 1 (7 Days)||3
4913734|NCT03627494|12092086|P2|COMPLETED|Part A Washout 1 (7 Days)||3
4913735|NCT03627494|12092087|P1|COMPLETED|Part A Washout 1 (7 Days)||3
4913736|NCT03627494|12092076|P12|STARTED|Part A Washout 1 (7 Days)||0
4913737|NCT03627494|12092077|P11|STARTED|Part A Washout 1 (7 Days)||0
4913738|NCT03627494|12092078|P10|STARTED|Part A Washout 1 (7 Days)||0
4913739|NCT03627494|12092079|P9|STARTED|Part A Washout 1 (7 Days)||0
4913740|NCT03627494|12092080|P8|STARTED|Part A Washout 1 (7 Days)||0
4913741|NCT03627494|12092081|P7|STARTED|Part A Washout 1 (7 Days)||0
4913742|NCT03627494|12092082|P6|STARTED|Part A Washout 1 (7 Days)||3
4913743|NCT03627494|12092083|P5|STARTED|Part A Washout 1 (7 Days)||3
4913744|NCT03627494|12092084|P4|STARTED|Part A Washout 1 (7 Days)||3
4913745|NCT03627494|12092085|P3|STARTED|Part A Washout 1 (7 Days)||3
4913746|NCT03627494|12092086|P2|STARTED|Part A Washout 1 (7 Days)||3
4913747|NCT03627494|12092087|P1|STARTED|Part A Washout 1 (7 Days)||3
4913748|NCT03627494|12092076|P12|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913749|NCT03627494|12092077|P11|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913750|NCT03627494|12092078|P10|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913751|NCT03627494|12092079|P9|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913752|NCT03627494|12092080|P8|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913753|NCT03627494|12092081|P7|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913754|NCT03627494|12092082|P6|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913755|NCT03627494|12092083|P5|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913756|NCT03627494|12092084|P4|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913757|NCT03627494|12092085|P3|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913758|NCT03627494|12092086|P2|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913759|NCT03627494|12092087|P1|NOT COMPLETED|Part A Period 1 (4 Days)||0
4913760|NCT03627494|12092076|P12|COMPLETED|Part A Period 1 (4 Days)||0
4913761|NCT03627494|12092077|P11|COMPLETED|Part A Period 1 (4 Days)||0
4913762|NCT03627494|12092078|P10|COMPLETED|Part A Period 1 (4 Days)||0
4913763|NCT03627494|12092079|P9|COMPLETED|Part A Period 1 (4 Days)||0
4913764|NCT03627494|12092080|P8|COMPLETED|Part A Period 1 (4 Days)||0
4913765|NCT03627494|12092081|P7|COMPLETED|Part A Period 1 (4 Days)||0
4913766|NCT03627494|12092082|P6|COMPLETED|Part A Period 1 (4 Days)||3
4913767|NCT03627494|12092083|P5|COMPLETED|Part A Period 1 (4 Days)||3
4913768|NCT03627494|12092084|P4|COMPLETED|Part A Period 1 (4 Days)||3
4913769|NCT03627494|12092085|P3|COMPLETED|Part A Period 1 (4 Days)||3
4913770|NCT03627494|12092086|P2|COMPLETED|Part A Period 1 (4 Days)||3
4913771|NCT03627494|12092087|P1|COMPLETED|Part A Period 1 (4 Days)||3
4913772|NCT03627494|12092076|P12|STARTED|Part A Period 1 (4 Days)||0
4913773|NCT03627494|12092077|P11|STARTED|Part A Period 1 (4 Days)||0
4913774|NCT03627494|12092078|P10|STARTED|Part A Period 1 (4 Days)||0
4913775|NCT03627494|12092079|P9|STARTED|Part A Period 1 (4 Days)||0
4913776|NCT03627494|12092080|P8|STARTED|Part A Period 1 (4 Days)||0
4913777|NCT03627494|12092081|P7|STARTED|Part A Period 1 (4 Days)||0
4913778|NCT03627494|12092082|P6|STARTED|Part A Period 1 (4 Days)||3
4913779|NCT03627494|12092083|P5|STARTED|Part A Period 1 (4 Days)||3
4913780|NCT03627494|12092084|P4|STARTED|Part A Period 1 (4 Days)||3
4913781|NCT03627494|12092085|P3|STARTED|Part A Period 1 (4 Days)||3
4913782|NCT03627494|12092086|P2|STARTED|Part A Period 1 (4 Days)||3
4913783|NCT03627494|12092087|P1|STARTED|Part A Period 1 (4 Days)||3
4913784|NCT03627195|12092289|P6|NOT COMPLETED|Overall Study||0
4913785|NCT03627195|12092290|P5|NOT COMPLETED|Overall Study||0
4913786|NCT03627195|12092291|P4|NOT COMPLETED|Overall Study||0
4913787|NCT03627195|12092292|P3|NOT COMPLETED|Overall Study||0
4913788|NCT03627195|12092293|P2|NOT COMPLETED|Overall Study||0
4913789|NCT03627195|12092294|P1|NOT COMPLETED|Overall Study||1
4913790|NCT03627195|12092289|P6|COMPLETED|Overall Study||10
4913791|NCT03627195|12092290|P5|COMPLETED|Overall Study||6
4913792|NCT03627195|12092291|P4|COMPLETED|Overall Study||6
4913793|NCT03627195|12092292|P3|COMPLETED|Overall Study||6
4913794|NCT03627195|12092293|P2|COMPLETED|Overall Study||6
4913795|NCT03627195|12092294|P1|COMPLETED|Overall Study||5
4913796|NCT03627195|12092289|P6|STARTED|Overall Study||10
4913797|NCT03627195|12092290|P5|STARTED|Overall Study||6
4913798|NCT03627195|12092291|P4|STARTED|Overall Study||6
4913799|NCT03627195|12092292|P3|STARTED|Overall Study||6
4913800|NCT03627195|12092293|P2|STARTED|Overall Study||6
4913801|NCT03627195|12092294|P1|STARTED|Overall Study||6
4913802|NCT03626714|12092320|P1|NOT COMPLETED|Overall Study||0
4913803|NCT03626714|12092320|P1|COMPLETED|Overall Study||8
4913804|NCT03626714|12092320|P1|STARTED|Overall Study||8
4913805|NCT03626415|12092332|P3|NOT COMPLETED|Overall Study||0
4913806|NCT03626415|12092333|P2|NOT COMPLETED|Overall Study||0
4913807|NCT03626415|12092334|P1|NOT COMPLETED|Overall Study||0
4913808|NCT03626415|12092332|P3|COMPLETED|Overall Study||8
4913809|NCT03626415|12092333|P2|COMPLETED|Overall Study||8
4913810|NCT03626415|12092334|P1|COMPLETED|Overall Study||8
4913811|NCT03626415|12092332|P3|STARTED|Overall Study||8
4913812|NCT03626415|12092333|P2|STARTED|Overall Study||8
4913813|NCT03626415|12092334|P1|STARTED|Overall Study||8
4913814|NCT03624946|12092365|P2|NOT COMPLETED|Overall Study||1
4913815|NCT03624946|12092366|P1|NOT COMPLETED|Overall Study||0
4913816|NCT03624946|12092365|P2|COMPLETED|Overall Study||10
4913817|NCT03624946|12092366|P1|COMPLETED|Overall Study||19
4913818|NCT03624946|12092365|P2|STARTED|Overall Study||11
4913819|NCT03624946|12092366|P1|STARTED|Overall Study||19
4913820|NCT03623035|12092386|P1|NOT COMPLETED|Overall Study||0
4913821|NCT03623035|12092386|P1|COMPLETED|Overall Study||10
4913822|NCT03623035|12092386|P1|STARTED|Overall Study||10
4913823|NCT03621878|12092395|P3|NOT COMPLETED|Overall Study||0
4913824|NCT03621878|12092396|P2|NOT COMPLETED|Overall Study||0
4913825|NCT03621878|12092397|P1|NOT COMPLETED|Overall Study||0
4913826|NCT03621878|12092395|P3|COMPLETED|Overall Study||17
4913827|NCT03621878|12092396|P2|COMPLETED|Overall Study||17
4913828|NCT03621878|12092397|P1|COMPLETED|Overall Study||17
4913829|NCT03621878|12092395|P3|STARTED|Overall Study||17
4913830|NCT03621878|12092396|P2|STARTED|Overall Study||17
4913831|NCT03621878|12092397|P1|STARTED|Overall Study||17
4913832|NCT03620708|12092420|P3|NOT COMPLETED|Overall Study||3
4913833|NCT03620708|12092421|P2|NOT COMPLETED|Overall Study||1
4913834|NCT03620708|12092422|P1|NOT COMPLETED|Overall Study||1
4913835|NCT03620708|12092420|P3|COMPLETED|Overall Study||17
4913836|NCT03620708|12092421|P2|COMPLETED|Overall Study||18
4913837|NCT03620708|12092422|P1|COMPLETED|Overall Study||18
4913838|NCT03620708|12092420|P3|STARTED|Overall Study||20
4913839|NCT03620708|12092421|P2|STARTED|Overall Study||19
4913840|NCT03620708|12092422|P1|STARTED|Overall Study||19
4913841|NCT03620383|12092444|P2|NOT COMPLETED|Overall Study||0
4913842|NCT03620383|12092445|P1|NOT COMPLETED|Overall Study||0
4913843|NCT03620383|12092444|P2|COMPLETED|Overall Study||15
4913844|NCT03620383|12092445|P1|COMPLETED|Overall Study||30
4913845|NCT03620383|12092444|P2|STARTED|Overall Study||15
4913846|NCT03620383|12092445|P1|STARTED|Overall Study||30
4913847|NCT03619889|12092453|P2|NOT COMPLETED|Overall Study||0
4913848|NCT03619889|12092454|P1|NOT COMPLETED|Overall Study||2
4913849|NCT03619889|12092453|P2|COMPLETED|Overall Study||37
4913850|NCT03619889|12092454|P1|COMPLETED|Overall Study||35
4913851|NCT03619889|12092453|P2|STARTED|Overall Study||37
4913852|NCT03619889|12092454|P1|STARTED|Overall Study||37
4913853|NCT03619590|12092484|P1|NOT COMPLETED|Overall Study||0
4913854|NCT03619590|12092484|P1|COMPLETED|Overall Study||103
4913855|NCT03619590|12092484|P1|STARTED|Overall Study||103
4913856|NCT03619135|12092494|P2|NOT COMPLETED|Overall Study||0
4913857|NCT03619135|12092495|P1|NOT COMPLETED|Overall Study||0
4913858|NCT03619135|12092494|P2|COMPLETED|Overall Study||50
4913859|NCT03619135|12092495|P1|COMPLETED|Overall Study||50
4913860|NCT03619135|12092494|P2|STARTED|Overall Study||50
4913861|NCT03619135|12092495|P1|STARTED|Overall Study||50
4913862|NCT03618628|12092503|P1|NOT COMPLETED|Overall Study||2
4913863|NCT03618628|12092503|P1|COMPLETED|Overall Study||1
4913864|NCT03618628|12092503|P1|STARTED|Overall Study||3
4913865|NCT03618147|12092507|P1|NOT COMPLETED|Overall Study||0
4913866|NCT03618147|12092507|P1|COMPLETED|Overall Study||314
4913867|NCT03618147|12092507|P1|STARTED|Overall Study||314
4913868|NCT03617861|12092514|P4|NOT COMPLETED|Second Intervention (1 Day)||0
4913869|NCT03617861|12092515|P3|NOT COMPLETED|Second Intervention (1 Day)||1
4913870|NCT03617861|12092516|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4913871|NCT03617861|12092517|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4913872|NCT03617861|12092514|P4|COMPLETED|Second Intervention (1 Day)||5
4913873|NCT03617861|12092515|P3|COMPLETED|Second Intervention (1 Day)||4
4913874|NCT03617861|12092516|P2|COMPLETED|Second Intervention (1 Day)||5
4913875|NCT03617861|12092517|P1|COMPLETED|Second Intervention (1 Day)||5
4913876|NCT03617861|12092514|P4|STARTED|Second Intervention (1 Day)||5
4913877|NCT03617861|12092515|P3|STARTED|Second Intervention (1 Day)||5
4913878|NCT03617861|12092516|P2|STARTED|Second Intervention (1 Day)||5
4913879|NCT03617861|12092517|P1|STARTED|Second Intervention (1 Day)||5
4913880|NCT03617861|12092514|P4|NOT COMPLETED|Washout (1 to 4 Weeks)||0
4913881|NCT03617861|12092515|P3|NOT COMPLETED|Washout (1 to 4 Weeks)||0
4913882|NCT03617861|12092516|P2|NOT COMPLETED|Washout (1 to 4 Weeks)||0
4913883|NCT03617861|12092517|P1|NOT COMPLETED|Washout (1 to 4 Weeks)||0
4913884|NCT03617861|12092514|P4|COMPLETED|Washout (1 to 4 Weeks)||5
4913885|NCT03617861|12092515|P3|COMPLETED|Washout (1 to 4 Weeks)||5
4913886|NCT03617861|12092516|P2|COMPLETED|Washout (1 to 4 Weeks)||5
4913887|NCT03617861|12092517|P1|COMPLETED|Washout (1 to 4 Weeks)||5
4913888|NCT03617861|12092514|P4|STARTED|Washout (1 to 4 Weeks)||5
4913889|NCT03617861|12092515|P3|STARTED|Washout (1 to 4 Weeks)||5
4913890|NCT03617861|12092516|P2|STARTED|Washout (1 to 4 Weeks)||5
4913891|NCT03617861|12092517|P1|STARTED|Washout (1 to 4 Weeks)||5
4913892|NCT03617861|12092514|P4|NOT COMPLETED|First Intervention (1 Day)||0
4913893|NCT03617861|12092515|P3|NOT COMPLETED|First Intervention (1 Day)||0
4913894|NCT03617861|12092516|P2|NOT COMPLETED|First Intervention (1 Day)||0
4913895|NCT03617861|12092517|P1|NOT COMPLETED|First Intervention (1 Day)||0
4913896|NCT03617861|12092514|P4|COMPLETED|First Intervention (1 Day)||5
4913897|NCT03617861|12092515|P3|COMPLETED|First Intervention (1 Day)||5
4913898|NCT03617861|12092516|P2|COMPLETED|First Intervention (1 Day)||5
4913899|NCT03617861|12092517|P1|COMPLETED|First Intervention (1 Day)||5
4913900|NCT03617861|12092514|P4|STARTED|First Intervention (1 Day)||5
4913901|NCT03617861|12092515|P3|STARTED|First Intervention (1 Day)||5
4913902|NCT03617861|12092516|P2|STARTED|First Intervention (1 Day)||5
4913903|NCT03617861|12092517|P1|STARTED|First Intervention (1 Day)||5
4913904|NCT03617588|12092549|P2|NOT COMPLETED|Overall Study||0
4913905|NCT03617588|12092550|P1|NOT COMPLETED|Overall Study||1
4913906|NCT03617588|12092549|P2|COMPLETED|Overall Study||29
4913907|NCT03617588|12092550|P1|COMPLETED|Overall Study||19
4913908|NCT03617588|12092549|P2|STARTED|Overall Study||29
4913909|NCT03617588|12092550|P1|STARTED|Overall Study||20
4913910|NCT03617523|12092567|P5|NOT COMPLETED|Overall Study||0
4913911|NCT03617523|12092568|P4|NOT COMPLETED|Overall Study||0
4913912|NCT03617523|12092569|P3|NOT COMPLETED|Overall Study||0
4913913|NCT03617523|12092570|P2|NOT COMPLETED|Overall Study||0
4913914|NCT03617523|12092571|P1|NOT COMPLETED|Overall Study||0
4913915|NCT03617523|12092567|P5|COMPLETED|Overall Study||60
4913916|NCT03617523|12092568|P4|COMPLETED|Overall Study||59
4913917|NCT03617523|12092569|P3|COMPLETED|Overall Study||61
4913918|NCT03617523|12092570|P2|COMPLETED|Overall Study||30
4913919|NCT03617523|12092571|P1|COMPLETED|Overall Study||30
4913920|NCT03617523|12092567|P5|STARTED|Overall Study||60
4913921|NCT03617523|12092568|P4|STARTED|Overall Study||59
4913922|NCT03617523|12092569|P3|STARTED|Overall Study||61
4913923|NCT03617523|12092570|P2|STARTED|Overall Study||30
4913924|NCT03617523|12092571|P1|STARTED|Overall Study||30
4913925|NCT03617419|12092603|P1|NOT COMPLETED|Part 2||0
4913926|NCT03617419|12092603|P1|COMPLETED|Part 2||14
4913927|NCT03617419|12092603|P1|STARTED|Part 2||14
4913928|NCT03617419|12092603|P1|NOT COMPLETED|Part 1||0
4913929|NCT03617419|12092603|P1|COMPLETED|Part 1||2
4913930|NCT03617419|12092603|P1|STARTED|Part 1||2
4913931|NCT03616977|12092611|P2|NOT COMPLETED|Period 4||0
4913932|NCT03616977|12092612|P1|NOT COMPLETED|Period 4||0
4913933|NCT03616977|12092611|P2|COMPLETED|Period 4||32
4913934|NCT03616977|12092612|P1|COMPLETED|Period 4||33
4913935|NCT03616977|12092611|P2|STARTED|Period 4||32
4913936|NCT03616977|12092612|P1|STARTED|Period 4||33
4913937|NCT03616977|12092611|P2|NOT COMPLETED|Period 3||1
4913938|NCT03616977|12092612|P1|NOT COMPLETED|Period 3||1
4913939|NCT03616977|12092611|P2|COMPLETED|Period 3||32
4913940|NCT03616977|12092612|P1|COMPLETED|Period 3||33
4913941|NCT03616977|12092611|P2|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
4913942|NCT03616977|12092612|P1|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
4913943|NCT03616977|12092611|P2|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
4913944|NCT03616977|12092612|P1|STARTED|Period 3||34
4913945|NCT03616977|12092611|P2|NOT COMPLETED|Period 2||0
4913946|NCT03616977|12092612|P1|NOT COMPLETED|Period 2||0
4913947|NCT03616977|12092611|P2|COMPLETED|Period 2||34
4913948|NCT03616977|12092612|P1|COMPLETED|Period 2||34
4913949|NCT03616977|12092611|P2|STARTED|Period 2||34
4913950|NCT03616977|12092612|P1|STARTED|Period 2||34
4913951|NCT03616977|12092611|P2|NOT COMPLETED|Period 1||1
4913952|NCT03616977|12092612|P1|NOT COMPLETED|Period 1||0
4913953|NCT03616977|12092611|P2|COMPLETED|Period 1||34
4913954|NCT03616977|12092612|P1|COMPLETED|Period 1||34
4913955|NCT03616977|12092611|P2|Received at Least One Dose of Study Drug|Period 1||34
4913956|NCT03616977|12092612|P1|Received at Least One Dose of Study Drug|Period 1||34
4913957|NCT03616977|12092611|P2|STARTED|Period 1||35
4913958|NCT03616977|12092612|P1|STARTED|Period 1||34
4913959|NCT03616600|12092622|P2|NOT COMPLETED|Overall Study||0
4913960|NCT03616600|12092623|P1|NOT COMPLETED|Overall Study||1
4913961|NCT03616600|12092622|P2|COMPLETED|Overall Study||15
4913962|NCT03616600|12092623|P1|COMPLETED|Overall Study||15
4913963|NCT03616600|12092622|P2|STARTED|Overall Study||15
4913964|NCT03616600|12092623|P1|STARTED|Overall Study||16
4913965|NCT03616171|12092641|P2|NOT COMPLETED|Overall Study||0
4913966|NCT03616171|12092642|P1|NOT COMPLETED|Overall Study||0
4913967|NCT03616171|12092641|P2|COMPLETED|Overall Study||2
4913968|NCT03616171|12092642|P1|COMPLETED|Overall Study||4
4913969|NCT03616171|12092641|P2|STARTED|Overall Study||2
4913970|NCT03616171|12092642|P1|STARTED|Overall Study||4
4913971|NCT03615807|12092657|P2|NOT COMPLETED|Overall Study||11
4913972|NCT03615807|12092658|P1|NOT COMPLETED|Overall Study||12
4913973|NCT03615807|12092657|P2|COMPLETED|Overall Study||80
4913974|NCT03615807|12092658|P1|COMPLETED|Overall Study||79
4913975|NCT03615807|12092657|P2|STARTED|Overall Study||91
4913976|NCT03615807|12092658|P1|STARTED|Overall Study||91
4913977|NCT03615534|12092670|P4|NOT COMPLETED|Overall Study||1
4913978|NCT03615534|12092671|P3|NOT COMPLETED|Overall Study||0
4913979|NCT03615534|12092672|P2|NOT COMPLETED|Overall Study||0
4913980|NCT03615534|12092673|P1|NOT COMPLETED|Overall Study||2
4913981|NCT03615534|12092670|P4|COMPLETED|Overall Study||13
4913982|NCT03615534|12092671|P3|COMPLETED|Overall Study||14
4913983|NCT03615534|12092672|P2|COMPLETED|Overall Study||15
4913984|NCT03615534|12092673|P1|COMPLETED|Overall Study||12
4913985|NCT03615534|12092670|P4|STARTED|Overall Study||14
4913986|NCT03615534|12092671|P3|STARTED|Overall Study||14
4913987|NCT03615534|12092672|P2|STARTED|Overall Study||15
4913988|NCT03615534|12092673|P1|STARTED|Overall Study||14
4913989|NCT03615482|12092717|P2|NOT COMPLETED|Overall Study||17
4913990|NCT03615482|12092718|P1|NOT COMPLETED|Overall Study||17
4913991|NCT03615482|12092717|P2|COMPLETED|Overall Study||583
4913992|NCT03615482|12092718|P1|COMPLETED|Overall Study||583
4913993|NCT03615482|12092717|P2|Vaccinated|Overall Study||598
4913994|NCT03615482|12092718|P1|Vaccinated|Overall Study||599
4913995|NCT03615482|12092717|P2|STARTED|Overall Study||600
4913996|NCT03615482|12092718|P1|STARTED|Overall Study||600
4913997|NCT03615001|12092748|P1|NOT COMPLETED|Overall Study||0
4913998|NCT03615001|12092748|P1|COMPLETED|Overall Study||20
4913999|NCT03615001|12092748|P1|STARTED|Overall Study||20
4914000|NCT03614975|12092755|P2|NOT COMPLETED|Overall Study||8
4914001|NCT03614975|12092756|P1|NOT COMPLETED|Overall Study||10
4914002|NCT03614975|12092755|P2|COMPLETED|Overall Study||73
4914003|NCT03614975|12092756|P1|COMPLETED|Overall Study||75
4914004|NCT03614975|12092755|P2|STARTED|Overall Study||81
4914005|NCT03614975|12092756|P1|STARTED|Overall Study||85
4914006|NCT03614078|12092769|P3|NOT COMPLETED|Overall Study||5
4914007|NCT03614078|12092770|P2|NOT COMPLETED|Overall Study||7
4914008|NCT03614078|12092771|P1|NOT COMPLETED|Overall Study||3
4914009|NCT03614078|12092769|P3|COMPLETED|Overall Study||26
4914010|NCT03614078|12092770|P2|COMPLETED|Overall Study||23
4914011|NCT03614078|12092771|P1|COMPLETED|Overall Study||28
4914012|NCT03614078|12092769|P3|STARTED|Overall Study||31
4914013|NCT03614078|12092770|P2|STARTED|Overall Study||30
4914014|NCT03614078|12092771|P1|STARTED|Overall Study||31
4914015|NCT03613649|12092800|P12|NOT COMPLETED|Fourth Treatment||0
4914016|NCT03613649|12092801|P11|NOT COMPLETED|Fourth Treatment||0
4914017|NCT03613649|12092802|P10|NOT COMPLETED|Fourth Treatment||0
4914018|NCT03613649|12092803|P9|NOT COMPLETED|Fourth Treatment||0
4914019|NCT03613649|12092804|P8|NOT COMPLETED|Fourth Treatment||0
4914020|NCT03613649|12092805|P7|NOT COMPLETED|Fourth Treatment||1
4914021|NCT03613649|12092806|P6|NOT COMPLETED|Fourth Treatment||0
4914022|NCT03613649|12092807|P5|NOT COMPLETED|Fourth Treatment||1
4914023|NCT03613649|12092808|P4|NOT COMPLETED|Fourth Treatment||0
4914024|NCT03613649|12092809|P3|NOT COMPLETED|Fourth Treatment||0
4914025|NCT03613649|12092810|P2|NOT COMPLETED|Fourth Treatment||0
4914026|NCT03613649|12092811|P1|NOT COMPLETED|Fourth Treatment||1
4914027|NCT03613649|12092800|P12|COMPLETED|Fourth Treatment||4
4914028|NCT03613649|12092801|P11|COMPLETED|Fourth Treatment||6
4914029|NCT03613649|12092802|P10|COMPLETED|Fourth Treatment||6
4914030|NCT03613649|12092803|P9|COMPLETED|Fourth Treatment||6
4914031|NCT03613649|12092804|P8|COMPLETED|Fourth Treatment||6
4914032|NCT03613649|12092805|P7|COMPLETED|Fourth Treatment||4
4914033|NCT03613649|12092806|P6|COMPLETED|Fourth Treatment||6
4914034|NCT03613649|12092807|P5|COMPLETED|Fourth Treatment||3
4914035|NCT03613649|12092808|P4|COMPLETED|Fourth Treatment||6
4914036|NCT03613649|12092809|P3|COMPLETED|Fourth Treatment||5
4914037|NCT03613649|12092810|P2|COMPLETED|Fourth Treatment||6
4914038|NCT03613649|12092811|P1|COMPLETED|Fourth Treatment||5
4914039|NCT03613649|12092800|P12|Received Treatment|Fourth Treatment||4
4914040|NCT03613649|12092801|P11|Received Treatment|Fourth Treatment||6
4914041|NCT03613649|12092802|P10|Received Treatment|Fourth Treatment||6
4914042|NCT03613649|12092803|P9|Received Treatment|Fourth Treatment||6
4914043|NCT03613649|12092804|P8|Received Treatment|Fourth Treatment||6
4914044|NCT03613649|12092805|P7|Received Treatment|Fourth Treatment||4
4914045|NCT03613649|12092806|P6|Received Treatment|Fourth Treatment||6
4914046|NCT03613649|12092807|P5|Received Treatment|Fourth Treatment||4
4914047|NCT03613649|12092808|P4|Received Treatment|Fourth Treatment||6
4914048|NCT03613649|12092809|P3|Received Treatment|Fourth Treatment||5
4914049|NCT03613649|12092810|P2|Received Treatment|Fourth Treatment||6
4914050|NCT03613649|12092811|P1|Received Treatment|Fourth Treatment||5
4914051|NCT03613649|12092800|P12|STARTED|Fourth Treatment||4
4914052|NCT03613649|12092801|P11|STARTED|Fourth Treatment||6
4914053|NCT03613649|12092802|P10|STARTED|Fourth Treatment||6
4914054|NCT03613649|12092803|P9|STARTED|Fourth Treatment||6
4914055|NCT03613649|12092804|P8|STARTED|Fourth Treatment||6
4914056|NCT03613649|12092805|P7|STARTED|Fourth Treatment||5
4914057|NCT03613649|12092806|P6|STARTED|Fourth Treatment||6
4914058|NCT03613649|12092807|P5|STARTED|Fourth Treatment||4
4914059|NCT03613649|12092808|P4|STARTED|Fourth Treatment||6
4914060|NCT03613649|12092809|P3|STARTED|Fourth Treatment||5
4914061|NCT03613649|12092810|P2|STARTED|Fourth Treatment||6
4914062|NCT03613649|12092811|P1|STARTED|Fourth Treatment||6
4914063|NCT03613649|12092800|P12|NOT COMPLETED|Third Treatment||2
4914064|NCT03613649|12092801|P11|NOT COMPLETED|Third Treatment||0
4914065|NCT03613649|12092802|P10|NOT COMPLETED|Third Treatment||0
4914066|NCT03613649|12092803|P9|NOT COMPLETED|Third Treatment||0
4914067|NCT03613649|12092804|P8|NOT COMPLETED|Third Treatment||0
4914068|NCT03613649|12092805|P7|NOT COMPLETED|Third Treatment||1
4914069|NCT03613649|12092806|P6|NOT COMPLETED|Third Treatment||0
4914070|NCT03613649|12092807|P5|NOT COMPLETED|Third Treatment||1
4914071|NCT03613649|12092808|P4|NOT COMPLETED|Third Treatment||0
4914072|NCT03613649|12092809|P3|NOT COMPLETED|Third Treatment||0
4914073|NCT03613649|12092810|P2|NOT COMPLETED|Third Treatment||0
4914074|NCT03613649|12092811|P1|NOT COMPLETED|Third Treatment||0
4914075|NCT03613649|12092800|P12|COMPLETED|Third Treatment||4
4914076|NCT03613649|12092801|P11|COMPLETED|Third Treatment||6
4914077|NCT03613649|12092802|P10|COMPLETED|Third Treatment||6
4914078|NCT03613649|12092803|P9|COMPLETED|Third Treatment||6
4914079|NCT03613649|12092804|P8|COMPLETED|Third Treatment||6
4914080|NCT03613649|12092805|P7|COMPLETED|Third Treatment||5
4914081|NCT03613649|12092806|P6|COMPLETED|Third Treatment||6
4914082|NCT03613649|12092807|P5|COMPLETED|Third Treatment||4
4914083|NCT03613649|12092808|P4|COMPLETED|Third Treatment||6
4914084|NCT03613649|12092809|P3|COMPLETED|Third Treatment||5
4914085|NCT03613649|12092810|P2|COMPLETED|Third Treatment||6
4914086|NCT03613649|12092811|P1|COMPLETED|Third Treatment||6
4914087|NCT03613649|12092800|P12|Received Treatment|Third Treatment||6
4914088|NCT03613649|12092801|P11|Received Treatment|Third Treatment||6
4914089|NCT03613649|12092802|P10|Received Treatment|Third Treatment||6
4914090|NCT03613649|12092803|P9|Received Treatment|Third Treatment||6
4914091|NCT03613649|12092804|P8|Received Treatment|Third Treatment||6
4914092|NCT03613649|12092805|P7|Received Treatment|Third Treatment||5
4914093|NCT03613649|12092806|P6|Received Treatment|Third Treatment||6
4914094|NCT03613649|12092807|P5|Received Treatment|Third Treatment||5
4914095|NCT03613649|12092808|P4|Received Treatment|Third Treatment||6
4914096|NCT03613649|12092809|P3|Received Treatment|Third Treatment||5
4914097|NCT03613649|12092810|P2|Received Treatment|Third Treatment||6
4914098|NCT03613649|12092811|P1|Received Treatment|Third Treatment||6
4914099|NCT03613649|12092800|P12|STARTED|Third Treatment||6
4914100|NCT03613649|12092801|P11|STARTED|Third Treatment||6
4914101|NCT03613649|12092802|P10|STARTED|Third Treatment||6
4914102|NCT03613649|12092803|P9|STARTED|Third Treatment||6
4914103|NCT03613649|12092804|P8|STARTED|Third Treatment||6
4914104|NCT03613649|12092805|P7|STARTED|Third Treatment||6
4914105|NCT03613649|12092806|P6|STARTED|Third Treatment||6
4914106|NCT03613649|12092807|P5|STARTED|Third Treatment||5
4914107|NCT03613649|12092808|P4|STARTED|Third Treatment||6
4914108|NCT03613649|12092809|P3|STARTED|Third Treatment||5
4914109|NCT03613649|12092810|P2|STARTED|Third Treatment||6
4914110|NCT03613649|12092811|P1|STARTED|Third Treatment||6
4914111|NCT03613649|12092800|P12|NOT COMPLETED|Second Treatment||0
4914112|NCT03613649|12092801|P11|NOT COMPLETED|Second Treatment||0
4914113|NCT03613649|12092802|P10|NOT COMPLETED|Second Treatment||0
4914114|NCT03613649|12092803|P9|NOT COMPLETED|Second Treatment||0
4914115|NCT03613649|12092804|P8|NOT COMPLETED|Second Treatment||0
4914116|NCT03613649|12092805|P7|NOT COMPLETED|Second Treatment||0
4914117|NCT03613649|12092806|P6|NOT COMPLETED|Second Treatment||0
4914118|NCT03613649|12092807|P5|NOT COMPLETED|Second Treatment||1
4914119|NCT03613649|12092808|P4|NOT COMPLETED|Second Treatment||0
4914120|NCT03613649|12092809|P3|NOT COMPLETED|Second Treatment||1
4914121|NCT03613649|12092810|P2|NOT COMPLETED|Second Treatment||0
4914122|NCT03613649|12092811|P1|NOT COMPLETED|Second Treatment||0
4914123|NCT03613649|12092800|P12|COMPLETED|Second Treatment||6
4914124|NCT03613649|12092801|P11|COMPLETED|Second Treatment||6
4914125|NCT03613649|12092802|P10|COMPLETED|Second Treatment||6
4914126|NCT03613649|12092803|P9|COMPLETED|Second Treatment||6
4914127|NCT03613649|12092804|P8|COMPLETED|Second Treatment||6
4914128|NCT03613649|12092805|P7|COMPLETED|Second Treatment||6
4914129|NCT03613649|12092806|P6|COMPLETED|Second Treatment||6
4914130|NCT03613649|12092807|P5|COMPLETED|Second Treatment||5
4914131|NCT03613649|12092808|P4|COMPLETED|Second Treatment||6
4914132|NCT03613649|12092809|P3|COMPLETED|Second Treatment||5
4914133|NCT03613649|12092810|P2|COMPLETED|Second Treatment||6
4914134|NCT03613649|12092811|P1|COMPLETED|Second Treatment||6
4914135|NCT03613649|12092800|P12|Received Treatment|Second Treatment||6
4914136|NCT03613649|12092801|P11|Received Treatment|Second Treatment||6
4914137|NCT03613649|12092802|P10|Received Treatment|Second Treatment||6
4914138|NCT03613649|12092803|P9|Received Treatment|Second Treatment||6
4914139|NCT03613649|12092804|P8|Received Treatment|Second Treatment||6
4914140|NCT03613649|12092805|P7|Received Treatment|Second Treatment||6
4914141|NCT03613649|12092806|P6|Received Treatment|Second Treatment||6
4914142|NCT03613649|12092807|P5|Received Treatment|Second Treatment||6
4914143|NCT03613649|12092808|P4|Received Treatment|Second Treatment||6
4914144|NCT03613649|12092809|P3|Received Treatment|Second Treatment||6
4914145|NCT03613649|12092810|P2|Received Treatment|Second Treatment||6
4914146|NCT03613649|12092811|P1|Received Treatment|Second Treatment||6
4914147|NCT03613649|12092800|P12|STARTED|Second Treatment||6
4914148|NCT03613649|12092801|P11|STARTED|Second Treatment||6
4914149|NCT03613649|12092802|P10|STARTED|Second Treatment||6
4914150|NCT03613649|12092803|P9|STARTED|Second Treatment||6
4914151|NCT03613649|12092804|P8|STARTED|Second Treatment||6
4914152|NCT03613649|12092805|P7|STARTED|Second Treatment||6
4914153|NCT03613649|12092806|P6|STARTED|Second Treatment||6
4914154|NCT03613649|12092807|P5|STARTED|Second Treatment||6
4914155|NCT03613649|12092808|P4|STARTED|Second Treatment||6
4914156|NCT03613649|12092809|P3|STARTED|Second Treatment||6
4914157|NCT03613649|12092810|P2|STARTED|Second Treatment||6
4914158|NCT03613649|12092811|P1|STARTED|Second Treatment||6
4914159|NCT03613649|12092800|P12|NOT COMPLETED|First Treatment||0
4914160|NCT03613649|12092801|P11|NOT COMPLETED|First Treatment||0
4914161|NCT03613649|12092802|P10|NOT COMPLETED|First Treatment||0
4914162|NCT03613649|12092803|P9|NOT COMPLETED|First Treatment||0
4914163|NCT03613649|12092804|P8|NOT COMPLETED|First Treatment||0
4914164|NCT03613649|12092805|P7|NOT COMPLETED|First Treatment||0
4914165|NCT03613649|12092806|P6|NOT COMPLETED|First Treatment||0
4914166|NCT03613649|12092807|P5|NOT COMPLETED|First Treatment||0
4914167|NCT03613649|12092808|P4|NOT COMPLETED|First Treatment||0
4914168|NCT03613649|12092809|P3|NOT COMPLETED|First Treatment||0
4914169|NCT03613649|12092810|P2|NOT COMPLETED|First Treatment||0
4914170|NCT03613649|12092811|P1|NOT COMPLETED|First Treatment||0
4914171|NCT03613649|12092800|P12|COMPLETED|First Treatment||6
4914172|NCT03613649|12092801|P11|COMPLETED|First Treatment||6
4914173|NCT03613649|12092802|P10|COMPLETED|First Treatment||6
4914174|NCT03613649|12092803|P9|COMPLETED|First Treatment||6
4914175|NCT03613649|12092804|P8|COMPLETED|First Treatment||6
4914176|NCT03613649|12092805|P7|COMPLETED|First Treatment||6
4914177|NCT03613649|12092806|P6|COMPLETED|First Treatment||6
4914178|NCT03613649|12092807|P5|COMPLETED|First Treatment||6
4914179|NCT03613649|12092808|P4|COMPLETED|First Treatment||6
4914180|NCT03613649|12092809|P3|COMPLETED|First Treatment||6
4914181|NCT03613649|12092810|P2|COMPLETED|First Treatment||6
4914182|NCT03613649|12092811|P1|COMPLETED|First Treatment||6
4914183|NCT03613649|12092800|P12|Received Treatment|First Treatment||6
4914184|NCT03613649|12092801|P11|Received Treatment|First Treatment||6
4914185|NCT03613649|12092802|P10|Received Treatment|First Treatment||6
4914186|NCT03613649|12092803|P9|Received Treatment|First Treatment||6
4914187|NCT03613649|12092804|P8|Received Treatment|First Treatment||6
4914188|NCT03613649|12092805|P7|Received Treatment|First Treatment||6
4914189|NCT03613649|12092806|P6|Received Treatment|First Treatment||6
4914190|NCT03613649|12092807|P5|Received Treatment|First Treatment||6
4914191|NCT03613649|12092808|P4|Received Treatment|First Treatment||6
4914192|NCT03613649|12092809|P3|Received Treatment|First Treatment||6
4914193|NCT03613649|12092810|P2|Received Treatment|First Treatment||6
4914194|NCT03613649|12092811|P1|Received Treatment|First Treatment||6
4914195|NCT03613649|12092800|P12|STARTED|First Treatment||6
4914196|NCT03613649|12092801|P11|STARTED|First Treatment||6
4914197|NCT03613649|12092802|P10|STARTED|First Treatment||6
4914198|NCT03613649|12092803|P9|STARTED|First Treatment||6
4914199|NCT03613649|12092804|P8|STARTED|First Treatment||6
4914200|NCT03613649|12092805|P7|STARTED|First Treatment||6
4914201|NCT03613649|12092806|P6|STARTED|First Treatment||6
4914202|NCT03613649|12092807|P5|STARTED|First Treatment||6
4914203|NCT03613649|12092808|P4|STARTED|First Treatment||6
4914204|NCT03613649|12092809|P3|STARTED|First Treatment||6
4914205|NCT03613649|12092810|P2|STARTED|First Treatment||6
4914206|NCT03613649|12092811|P1|STARTED|First Treatment||6
4914207|NCT03613493|12092940|P4|NOT COMPLETED|Overall Study||7
4914208|NCT03613493|12092941|P3|NOT COMPLETED|Overall Study||0
4914209|NCT03613493|12092942|P2|NOT COMPLETED|Overall Study||2
4914210|NCT03613493|12092943|P1|NOT COMPLETED|Overall Study||0
4914211|NCT03613493|12092940|P4|COMPLETED|Overall Study||83
4914212|NCT03613493|12092941|P3|COMPLETED|Overall Study||0
4914213|NCT03613493|12092942|P2|COMPLETED|Overall Study||73
4914214|NCT03613493|12092943|P1|COMPLETED|Overall Study||10
4914215|NCT03613493|12092940|P4|Enrollment Criteria Met|Overall Study||89
4914216|NCT03613493|12092941|P3|Enrollment Criteria Met|Overall Study||0
4914217|NCT03613493|12092942|P2|Enrollment Criteria Met|Overall Study||74
4914218|NCT03613493|12092943|P1|Enrollment Criteria Met|Overall Study||10
4914219|NCT03613493|12092940|P4|STARTED|Overall Study||90
4914220|NCT03613493|12092941|P3|STARTED|Overall Study||0
4914221|NCT03613493|12092942|P2|STARTED|Overall Study||75
4914222|NCT03613493|12092943|P1|STARTED|Overall Study||10
4914223|NCT03613129|12092956|P5|NOT COMPLETED|Post-treatment Assessment||0
4914224|NCT03613129|12092957|P4|NOT COMPLETED|Post-treatment Assessment||0
4914225|NCT03613129|12092958|P3|NOT COMPLETED|Post-treatment Assessment||0
4914226|NCT03613129|12092959|P2|NOT COMPLETED|Post-treatment Assessment||0
4914227|NCT03613129|12092960|P1|NOT COMPLETED|Post-treatment Assessment||0
4914228|NCT03613129|12092956|P5|COMPLETED|Post-treatment Assessment||2
4914229|NCT03613129|12092957|P4|COMPLETED|Post-treatment Assessment||2
4914230|NCT03613129|12092958|P3|COMPLETED|Post-treatment Assessment||7
4914231|NCT03613129|12092959|P2|COMPLETED|Post-treatment Assessment||3
4914232|NCT03613129|12092960|P1|COMPLETED|Post-treatment Assessment||0
4914233|NCT03613129|12092956|P5|STARTED|Post-treatment Assessment||2
4914234|NCT03613129|12092957|P4|STARTED|Post-treatment Assessment||2
4914235|NCT03613129|12092958|P3|STARTED|Post-treatment Assessment||7
4914236|NCT03613129|12092959|P2|STARTED|Post-treatment Assessment||3
4914237|NCT03613129|12092960|P1|STARTED|Post-treatment Assessment||0
4914238|NCT03613129|12092956|P5|NOT COMPLETED|Treatment||0
4914239|NCT03613129|12092957|P4|NOT COMPLETED|Treatment||0
4914240|NCT03613129|12092958|P3|NOT COMPLETED|Treatment||0
4914241|NCT03613129|12092959|P2|NOT COMPLETED|Treatment||0
4914242|NCT03613129|12092960|P1|NOT COMPLETED|Treatment||0
4914243|NCT03613129|12092956|P5|COMPLETED|Treatment||2
4914244|NCT03613129|12092957|P4|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
4914245|NCT03613129|12092958|P3|COMPLETED|Treatment||7
4914246|NCT03613129|12092959|P2|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
4914247|NCT03613129|12092960|P1|COMPLETED|Treatment||0
4914248|NCT03613129|12092956|P5|STARTED|Treatment||2
4914249|NCT03613129|12092957|P4|STARTED|Treatment||2
4914250|NCT03613129|12092958|P3|STARTED|Treatment||7
4914251|NCT03613129|12092959|P2|STARTED|Treatment||3
4914252|NCT03613129|12092960|P1|STARTED|Treatment||0
4914253|NCT03613129|12092956|P5|NOT COMPLETED|Pre-treatment Assessment||0
4914254|NCT03613129|12092957|P4|NOT COMPLETED|Pre-treatment Assessment||0
4914255|NCT03613129|12092958|P3|NOT COMPLETED|Pre-treatment Assessment||0
4914256|NCT03613129|12092959|P2|NOT COMPLETED|Pre-treatment Assessment||0
4914257|NCT03613129|12092960|P1|NOT COMPLETED|Pre-treatment Assessment||3
4914258|NCT03613129|12092956|P5|COMPLETED|Pre-treatment Assessment||2
4914259|NCT03613129|12092957|P4|COMPLETED|Pre-treatment Assessment||2
4914260|NCT03613129|12092958|P3|COMPLETED|Pre-treatment Assessment||7
4914261|NCT03613129|12092959|P2|COMPLETED|Pre-treatment Assessment||3
4914262|NCT03613129|12092960|P1|COMPLETED|Pre-treatment Assessment||0
4914263|NCT03613129|12092956|P5|STARTED|Pre-treatment Assessment||2
4914264|NCT03613129|12092957|P4|STARTED|Pre-treatment Assessment||2
4914265|NCT03613129|12092958|P3|STARTED|Pre-treatment Assessment||7
4914266|NCT03613129|12092959|P2|STARTED|Pre-treatment Assessment||3
4914267|NCT03613129|12092960|P1|STARTED|Pre-treatment Assessment||3
4914268|NCT03612856|12092985|P3|NOT COMPLETED|Post-dose Period||0
4914269|NCT03612856|12092986|P2|NOT COMPLETED|Post-dose Period||0
4914270|NCT03612856|12092987|P1|NOT COMPLETED|Post-dose Period||0
4914271|NCT03612856|12092985|P3|COMPLETED|Post-dose Period||8
4914272|NCT03612856|12092986|P2|COMPLETED|Post-dose Period||8
4914273|NCT03612856|12092987|P1|COMPLETED|Post-dose Period||8
4914274|NCT03612856|12092985|P3|STARTED|Post-dose Period||8
4914275|NCT03612856|12092986|P2|STARTED|Post-dose Period||8
4914276|NCT03612856|12092987|P1|STARTED|Post-dose Period||8
4914277|NCT03612856|12092985|P3|NOT COMPLETED|Pre-dose Period||1
4914278|NCT03612856|12092986|P2|NOT COMPLETED|Pre-dose Period||2
4914279|NCT03612856|12092987|P1|NOT COMPLETED|Pre-dose Period||0
4914280|NCT03612856|12092985|P3|COMPLETED|Pre-dose Period||8
4914281|NCT03612856|12092986|P2|COMPLETED|Pre-dose Period||8
4914282|NCT03612856|12092987|P1|COMPLETED|Pre-dose Period||8
4914283|NCT03612856|12092985|P3|STARTED|Pre-dose Period||9
4914284|NCT03612856|12092986|P2|STARTED|Pre-dose Period||10
4914285|NCT03612856|12092987|P1|STARTED|Pre-dose Period||8
4914286|NCT03611829|12093141|P2|NOT COMPLETED|Overall Study||25
4914287|NCT03611829|12093142|P1|NOT COMPLETED|Overall Study||22
4914288|NCT03611829|12093141|P2|COMPLETED|Overall Study||19
4914289|NCT03611829|12093142|P1|COMPLETED|Overall Study||21
4914290|NCT03611829|12093141|P2|STARTED|Overall Study||44
4914291|NCT03611829|12093142|P1|STARTED|Overall Study||43
4914292|NCT03610633|12093175|P2|NOT COMPLETED|Overall Study||1
4914293|NCT03610633|12093176|P1|NOT COMPLETED|Overall Study||0
4914294|NCT03610633|12093175|P2|COMPLETED|Overall Study||5
4914295|NCT03610633|12093176|P1|COMPLETED|Overall Study||5
4914296|NCT03610633|12093175|P2|STARTED|Overall Study||6
4914297|NCT03610633|12093176|P1|STARTED|Overall Study||5
4914298|NCT03610464|12093182|P1|NOT COMPLETED|Overall Study||0
4914299|NCT03610464|12093182|P1|COMPLETED|Overall Study||5
4914300|NCT03610464|12093182|P1|STARTED|Overall Study||5
4914301|NCT03610269|12093187|P1|NOT COMPLETED|Overall Study||16
4914302|NCT03610269|12093187|P1|COMPLETED|Overall Study||127
4914303|NCT03610269|12093187|P1|STARTED|Overall Study||143
4914304|NCT03609619|12093193|P2|NOT COMPLETED|Overall Study||6
4914305|NCT03609619|12093194|P1|NOT COMPLETED|Overall Study||10
4914306|NCT03609619|12093193|P2|COMPLETED|Overall Study||49
4914307|NCT03609619|12093194|P1|COMPLETED|Overall Study||44
4914308|NCT03609619|12093193|P2|STARTED|Overall Study||55
4914309|NCT03609619|12093194|P1|STARTED|Overall Study||54
4914310|NCT03608839|12093205|P3|NOT COMPLETED|Overall Study||0
4914311|NCT03608839|12093206|P2|NOT COMPLETED|Overall Study||0
4914312|NCT03608839|12093207|P1|NOT COMPLETED|Overall Study||0
4914313|NCT03608839|12093205|P3|COMPLETED|Overall Study||9
4914314|NCT03608839|12093206|P2|COMPLETED|Overall Study||9
4914315|NCT03608839|12093207|P1|COMPLETED|Overall Study||9
4914316|NCT03608839|12093205|P3|STARTED|Overall Study||9
4914317|NCT03608839|12093206|P2|STARTED|Overall Study||9
4914318|NCT03608839|12093207|P1|STARTED|Overall Study||9
4914319|NCT03608488|12093234|P4|NOT COMPLETED|Overall Study||5
4914320|NCT03608488|12093235|P3|NOT COMPLETED|Overall Study||2
4914321|NCT03608488|12093236|P2|NOT COMPLETED|Overall Study||3
4914322|NCT03608488|12093237|P1|NOT COMPLETED|Overall Study||1
4914323|NCT03608488|12093234|P4|COMPLETED|Overall Study||40
4914324|NCT03608488|12093235|P3|COMPLETED|Overall Study||20
4914325|NCT03608488|12093236|P2|COMPLETED|Overall Study||18
4914326|NCT03608488|12093237|P1|COMPLETED|Overall Study||21
4914327|NCT03608488|12093234|P4|STARTED|Overall Study||45
4914328|NCT03608488|12093235|P3|STARTED|Overall Study||22
4914329|NCT03608488|12093236|P2|STARTED|Overall Study||21
4914330|NCT03608488|12093237|P1|STARTED|Overall Study||22
4914331|NCT03606460|12093277|P2|NOT COMPLETED|Overall Study||8
4914332|NCT03606460|12093278|P1|NOT COMPLETED|Overall Study||1
4914333|NCT03606460|12093277|P2|COMPLETED|Overall Study||38
4914334|NCT03606460|12093278|P1|COMPLETED|Overall Study||94
4914335|NCT03606460|12093277|P2|STARTED|Overall Study||46
4914336|NCT03606460|12093278|P1|STARTED|Overall Study||95
4914337|NCT03605303|12093286|P2|NOT COMPLETED|Period 2||0
4914338|NCT03605303|12093287|P1|NOT COMPLETED|Period 2||0
4914339|NCT03605303|12093286|P2|COMPLETED|Period 2||0
4914340|NCT03605303|12093287|P1|COMPLETED|Period 2||0
4914341|NCT03605303|12093286|P2|STARTED|Period 2||0
4914342|NCT03605303|12093287|P1|STARTED|Period 2||0
4914343|NCT03605303|12093286|P2|NOT COMPLETED|Period 1||1
4914344|NCT03605303|12093287|P1|NOT COMPLETED|Period 1||2
4914345|NCT03605303|12093286|P2|COMPLETED|Period 1||0
4914346|NCT03605303|12093287|P1|COMPLETED|Period 1||0
4914347|NCT03605303|12093286|P2|STARTED|Period 1||1
4914348|NCT03605303|12093287|P1|STARTED|Period 1||2
4914349|NCT03604341|12093297|P2|NOT COMPLETED|Overall Study||2
4914350|NCT03604341|12093298|P1|NOT COMPLETED|Overall Study||2
4914351|NCT03604341|12093297|P2|COMPLETED|Overall Study||33
4914352|NCT03604341|12093298|P1|COMPLETED|Overall Study||33
4914353|NCT03604341|12093297|P2|STARTED|Overall Study||35
4914354|NCT03604341|12093298|P1|STARTED|Overall Study||35
4914355|NCT03604263|12093304|P1|NOT COMPLETED|Overall Study||2
4914356|NCT03604263|12093304|P1|COMPLETED|Overall Study||15
4914357|NCT03604263|12093304|P1|STARTED|Overall Study||17
4914358|NCT03603106|12093319|P11|NOT COMPLETED|Overall Study||0
4914359|NCT03603106|12093320|P10|NOT COMPLETED|Overall Study||0
4914360|NCT03603106|12093321|P9|NOT COMPLETED|Overall Study||0
4914361|NCT03603106|12093322|P8|NOT COMPLETED|Overall Study||0
4914362|NCT03603106|12093323|P7|NOT COMPLETED|Overall Study||0
4914363|NCT03603106|12093324|P6|NOT COMPLETED|Overall Study||0
4914364|NCT03603106|12093325|P5|NOT COMPLETED|Overall Study||0
4914365|NCT03603106|12093326|P4|NOT COMPLETED|Overall Study||0
4914366|NCT03603106|12093327|P3|NOT COMPLETED|Overall Study||0
4914367|NCT03603106|12093328|P2|NOT COMPLETED|Overall Study||0
4914368|NCT03603106|12093329|P1|NOT COMPLETED|Overall Study||0
4914369|NCT03603106|12093319|P11|COMPLETED|Overall Study||3
4914370|NCT03603106|12093320|P10|COMPLETED|Overall Study||3
4914371|NCT03603106|12093321|P9|COMPLETED|Overall Study||3
4914372|NCT03603106|12093322|P8|COMPLETED|Overall Study||3
4914373|NCT03603106|12093323|P7|COMPLETED|Overall Study||18
4914374|NCT03603106|12093324|P6|COMPLETED|Overall Study||6
4914375|NCT03603106|12093325|P5|COMPLETED|Overall Study||6
4914376|NCT03603106|12093326|P4|COMPLETED|Overall Study||6
4914377|NCT03603106|12093327|P3|COMPLETED|Overall Study||6
4914378|NCT03603106|12093328|P2|COMPLETED|Overall Study||6
4914379|NCT03603106|12093329|P1|COMPLETED|Overall Study||6
4914380|NCT03603106|12093319|P11|STARTED|Overall Study||3
4914381|NCT03603106|12093320|P10|STARTED|Overall Study||3
4914382|NCT03603106|12093321|P9|STARTED|Overall Study||3
4914383|NCT03603106|12093322|P8|STARTED|Overall Study||3
4914384|NCT03603106|12093323|P7|STARTED|Overall Study||18
4914385|NCT03603106|12093324|P6|STARTED|Overall Study||6
4914386|NCT03603106|12093325|P5|STARTED|Overall Study||6
4914387|NCT03603106|12093326|P4|STARTED|Overall Study||6
4914388|NCT03603106|12093327|P3|STARTED|Overall Study||6
4914389|NCT03603106|12093328|P2|STARTED|Overall Study||6
4914390|NCT03603106|12093329|P1|STARTED|Overall Study||6
4914391|NCT03603028|12093382|P1|NOT COMPLETED|Overall Study||1
4914392|NCT03603028|12093382|P1|COMPLETED|Overall Study||12
4914393|NCT03603028|12093382|P1|STARTED|Overall Study||13
4914394|NCT03601715|12093390|P3|NOT COMPLETED|Third Intervention||0
4914395|NCT03601715|12093391|P2|NOT COMPLETED|Third Intervention||0
4914396|NCT03601715|12093392|P1|NOT COMPLETED|Third Intervention||0
4914397|NCT03601715|12093390|P3|COMPLETED|Third Intervention||6
4914398|NCT03601715|12093391|P2|COMPLETED|Third Intervention||6
4914399|NCT03601715|12093392|P1|COMPLETED|Third Intervention||6
4914400|NCT03601715|12093390|P3|STARTED|Third Intervention||6
4914401|NCT03601715|12093391|P2|STARTED|Third Intervention||6
4914402|NCT03601715|12093392|P1|STARTED|Third Intervention||6
4914403|NCT03601715|12093390|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
4914404|NCT03601715|12093391|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
4914405|NCT03601715|12093392|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
4914406|NCT03601715|12093390|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
4914407|NCT03601715|12093391|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
4914408|NCT03601715|12093392|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
4914409|NCT03601715|12093390|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
4914410|NCT03601715|12093391|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
4914411|NCT03601715|12093392|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
4914412|NCT03601715|12093390|P3|NOT COMPLETED|Second Intervention||0
4914413|NCT03601715|12093391|P2|NOT COMPLETED|Second Intervention||1
4914414|NCT03601715|12093392|P1|NOT COMPLETED|Second Intervention||1
4914415|NCT03601715|12093390|P3|COMPLETED|Second Intervention||6
4914416|NCT03601715|12093391|P2|COMPLETED|Second Intervention||6
4914417|NCT03601715|12093392|P1|COMPLETED|Second Intervention||6
4914418|NCT03601715|12093390|P3|STARTED|Second Intervention||6
4914419|NCT03601715|12093391|P2|STARTED|Second Intervention||7
4914420|NCT03601715|12093392|P1|STARTED|Second Intervention||7
4914421|NCT03601715|12093390|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
4914422|NCT03601715|12093391|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
4914423|NCT03601715|12093392|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
4914424|NCT03601715|12093390|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
4914425|NCT03601715|12093391|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
4914426|NCT03601715|12093392|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
4914427|NCT03601715|12093390|P3|STARTED|Washout 1 (at Least 24 Hours)||6
4914428|NCT03601715|12093391|P2|STARTED|Washout 1 (at Least 24 Hours)||7
4914429|NCT03601715|12093392|P1|STARTED|Washout 1 (at Least 24 Hours)||7
4914430|NCT03601715|12093390|P3|NOT COMPLETED|First Intervention||0
4914431|NCT03601715|12093391|P2|NOT COMPLETED|First Intervention||0
4914432|NCT03601715|12093392|P1|NOT COMPLETED|First Intervention||0
4914433|NCT03601715|12093390|P3|COMPLETED|First Intervention||6
4914434|NCT03601715|12093391|P2|COMPLETED|First Intervention||7
4914435|NCT03601715|12093392|P1|COMPLETED|First Intervention||7
4914436|NCT03601715|12093390|P3|STARTED|First Intervention||6
4914437|NCT03601715|12093391|P2|STARTED|First Intervention||7
4914438|NCT03601715|12093392|P1|STARTED|First Intervention||7
4914439|NCT03599986|12093406|P1|NOT COMPLETED|Overall Study||32
4914440|NCT03599986|12093406|P1|COMPLETED|Overall Study||366
4914441|NCT03599986|12093406|P1|STARTED|Overall Study||398
4914442|NCT03599349|12093412|P1|NOT COMPLETED|Overall Study||1
4914443|NCT03599349|12093412|P1|COMPLETED|Overall Study||19
4914444|NCT03599349|12093412|P1|Treated|Overall Study||20
4914445|NCT03599349|12093412|P1|STARTED|Overall Study||20
4914446|NCT03597178|12093424|P1|NOT COMPLETED|Overall Study||0
4914447|NCT03597178|12093424|P1|COMPLETED|Overall Study||14
4914448|NCT03597178|12093424|P1|STARTED|Overall Study||14
4914449|NCT03596723|12093430|P2|NOT COMPLETED|Overall Study||0
4914450|NCT03596723|12093431|P1|NOT COMPLETED|Overall Study||0
4914451|NCT03596723|12093430|P2|COMPLETED|Overall Study||1
4914452|NCT03596723|12093431|P1|COMPLETED|Overall Study||1
4914453|NCT03596723|12093430|P2|STARTED|Overall Study||1
4914454|NCT03596723|12093431|P1|STARTED|Overall Study||1
4914455|NCT03595215|12093439|P1|NOT COMPLETED|Overall Study||8
4914456|NCT03595215|12093439|P1|COMPLETED|Overall Study||10
4914457|NCT03595215|12093439|P1|STARTED|Overall Study||18
4914458|NCT03592121|12093445|P2|NOT COMPLETED|Overall Study||0
4914459|NCT03592121|12093446|P1|NOT COMPLETED|Overall Study||0
4914460|NCT03592121|12093445|P2|COMPLETED|Overall Study||0
4914461|NCT03592121|12093446|P1|COMPLETED|Overall Study||3
4914462|NCT03592121|12093445|P2|STARTED|Overall Study||0
4914463|NCT03592121|12093446|P1|STARTED|Overall Study||3
4914464|NCT03591458|12093454|P2|NOT COMPLETED|Overall Study||0
4914465|NCT03591458|12093455|P1|NOT COMPLETED|Overall Study||0
4914466|NCT03591458|12093454|P2|COMPLETED|Overall Study||1
4914467|NCT03591458|12093455|P1|COMPLETED|Overall Study||1
4914468|NCT03591458|12093454|P2|STARTED|Overall Study||1
4914469|NCT03591458|12093455|P1|STARTED|Overall Study||1
4914470|NCT03591406|12093485|P2|NOT COMPLETED|Overall Study||9
4914471|NCT03591406|12093486|P1|NOT COMPLETED|Overall Study||7
4914472|NCT03591406|12093485|P2|COMPLETED|Overall Study||174
4914473|NCT03591406|12093486|P1|COMPLETED|Overall Study||181
4914474|NCT03591406|12093485|P2|STARTED|Overall Study||183
4914475|NCT03591406|12093486|P1|STARTED|Overall Study||188
4914476|NCT03590743|12093516|P2|NOT COMPLETED|Overall Study||1
4914477|NCT03590743|12093517|P1|NOT COMPLETED|Overall Study||0
4914478|NCT03590743|12093516|P2|COMPLETED|Overall Study||2
4914479|NCT03590743|12093517|P1|COMPLETED|Overall Study||2
4914480|NCT03590743|12093516|P2|STARTED|Overall Study||3
4914481|NCT03590743|12093517|P1|STARTED|Overall Study||2
4914482|NCT03590613|12093529|P4|NOT COMPLETED|Period 4, 4 Days||0
4914483|NCT03590613|12093530|P3|NOT COMPLETED|Period 4, 4 Days||0
4914484|NCT03590613|12093531|P2|NOT COMPLETED|Period 4, 4 Days||0
4914485|NCT03590613|12093532|P1|NOT COMPLETED|Period 4, 4 Days||0
4914486|NCT03590613|12093529|P4|COMPLETED|Period 4, 4 Days||3
4914487|NCT03590613|12093530|P3|COMPLETED|Period 4, 4 Days||3
4914488|NCT03590613|12093531|P2|COMPLETED|Period 4, 4 Days||3
4914489|NCT03590613|12093532|P1|COMPLETED|Period 4, 4 Days||3
4914490|NCT03590613|12093529|P4|STARTED|Period 4, 4 Days||3
4914491|NCT03590613|12093530|P3|STARTED|Period 4, 4 Days||3
4914492|NCT03590613|12093531|P2|STARTED|Period 4, 4 Days||3
4914493|NCT03590613|12093532|P1|STARTED|Period 4, 4 Days||3
4914494|NCT03590613|12093529|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
4914495|NCT03590613|12093530|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
4914496|NCT03590613|12093531|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
4914497|NCT03590613|12093532|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
4914498|NCT03590613|12093529|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
4914499|NCT03590613|12093530|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
4914500|NCT03590613|12093531|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
4914501|NCT03590613|12093532|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
4914502|NCT03590613|12093529|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
4914503|NCT03590613|12093530|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
4914504|NCT03590613|12093531|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
4914505|NCT03590613|12093532|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
4914506|NCT03590613|12093529|P4|NOT COMPLETED|Period 3, 4 Days||0
4914507|NCT03590613|12093530|P3|NOT COMPLETED|Period 3, 4 Days||0
4914508|NCT03590613|12093531|P2|NOT COMPLETED|Period 3, 4 Days||0
4914509|NCT03590613|12093532|P1|NOT COMPLETED|Period 3, 4 Days||0
4914510|NCT03590613|12093529|P4|COMPLETED|Period 3, 4 Days||3
4914511|NCT03590613|12093530|P3|COMPLETED|Period 3, 4 Days||3
4914512|NCT03590613|12093531|P2|COMPLETED|Period 3, 4 Days||3
4914513|NCT03590613|12093532|P1|COMPLETED|Period 3, 4 Days||3
4914514|NCT03590613|12093529|P4|STARTED|Period 3, 4 Days||3
4914515|NCT03590613|12093530|P3|STARTED|Period 3, 4 Days||3
4914516|NCT03590613|12093531|P2|STARTED|Period 3, 4 Days||3
4914517|NCT03590613|12093532|P1|STARTED|Period 3, 4 Days||3
4914518|NCT03590613|12093529|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
4914519|NCT03590613|12093530|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
4914520|NCT03590613|12093531|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
4914521|NCT03590613|12093532|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
4914522|NCT03590613|12093529|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
4914523|NCT03590613|12093530|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
4914524|NCT03590613|12093531|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
4914525|NCT03590613|12093532|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
4914526|NCT03590613|12093529|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
4914527|NCT03590613|12093530|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
4914528|NCT03590613|12093531|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
4914529|NCT03590613|12093532|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
4914530|NCT03590613|12093529|P4|NOT COMPLETED|Period 2, 4 Days||1
4914531|NCT03590613|12093530|P3|NOT COMPLETED|Period 2, 4 Days||0
4914532|NCT03590613|12093531|P2|NOT COMPLETED|Period 2, 4 Days||0
4914533|NCT03590613|12093532|P1|NOT COMPLETED|Period 2, 4 Days||0
4914534|NCT03590613|12093529|P4|COMPLETED|Period 2, 4 Days||3
4914535|NCT03590613|12093530|P3|COMPLETED|Period 2, 4 Days||3
4914536|NCT03590613|12093531|P2|COMPLETED|Period 2, 4 Days||3
4914537|NCT03590613|12093532|P1|COMPLETED|Period 2, 4 Days||3
4914538|NCT03590613|12093529|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
4914539|NCT03590613|12093530|P3|STARTED|Period 2, 4 Days||3
4914540|NCT03590613|12093531|P2|STARTED|Period 2, 4 Days||3
4914541|NCT03590613|12093532|P1|STARTED|Period 2, 4 Days||3
4914542|NCT03590613|12093529|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
4914543|NCT03590613|12093530|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
4914544|NCT03590613|12093531|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
4914545|NCT03590613|12093532|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
4914546|NCT03590613|12093529|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
4914547|NCT03590613|12093530|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
4914548|NCT03590613|12093531|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
4914549|NCT03590613|12093532|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
4914550|NCT03590613|12093529|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
4914551|NCT03590613|12093530|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
4914552|NCT03590613|12093531|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
4914553|NCT03590613|12093532|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
4914554|NCT03590613|12093529|P4|NOT COMPLETED|Period 1, 4 Days||0
4914555|NCT03590613|12093530|P3|NOT COMPLETED|Period 1, 4 Days||0
4914556|NCT03590613|12093531|P2|NOT COMPLETED|Period 1, 4 Days||0
4914557|NCT03590613|12093532|P1|NOT COMPLETED|Period 1, 4 Days||0
4914558|NCT03590613|12093529|P4|COMPLETED|Period 1, 4 Days||3
4914559|NCT03590613|12093530|P3|COMPLETED|Period 1, 4 Days||3
4914560|NCT03590613|12093531|P2|COMPLETED|Period 1, 4 Days||3
4914561|NCT03590613|12093532|P1|COMPLETED|Period 1, 4 Days||3
4914562|NCT03590613|12093529|P4|STARTED|Period 1, 4 Days||3
4914563|NCT03590613|12093530|P3|STARTED|Period 1, 4 Days||3
4914564|NCT03590613|12093531|P2|STARTED|Period 1, 4 Days||3
4914565|NCT03590613|12093532|P1|STARTED|Period 1, 4 Days||3
4914566|NCT03588806|12093650|P1|NOT COMPLETED|Overall Study||0
4914567|NCT03588806|12093650|P1|COMPLETED|Overall Study||11
4914568|NCT03588806|12093650|P1|STARTED|Overall Study||11
4914569|NCT03588741|12093661|P1|NOT COMPLETED|Overall Study||1
4914570|NCT03588741|12093661|P1|COMPLETED|Overall Study||0
4914571|NCT03588741|12093661|P1|STARTED|Overall Study||1
4914572|NCT03588572|12093668|P2|NOT COMPLETED|Visitation 3||2
4914573|NCT03588572|12093669|P1|NOT COMPLETED|Visitation 3||3
4914574|NCT03588572|12093668|P2|COMPLETED|Visitation 3||16
4914575|NCT03588572|12093669|P1|COMPLETED|Visitation 3||16
4914576|NCT03588572|12093668|P2|STARTED|Visitation 3||18
4914577|NCT03588572|12093669|P1|STARTED|Visitation 3||19
4914578|NCT03588572|12093668|P2|NOT COMPLETED|Visitation 2||2
4914579|NCT03588572|12093669|P1|NOT COMPLETED|Visitation 2||2
4914580|NCT03588572|12093668|P2|COMPLETED|Visitation 2||18
4914581|NCT03588572|12093669|P1|COMPLETED|Visitation 2||19
4914582|NCT03588572|12093668|P2|STARTED|Visitation 2||20
4914583|NCT03588572|12093669|P1|STARTED|Visitation 2||21
4914584|NCT03588572|12093668|P2|NOT COMPLETED|Visitation 1||1
4914585|NCT03588572|12093669|P1|NOT COMPLETED|Visitation 1||1
4914586|NCT03588572|12093668|P2|COMPLETED|Visitation 1||20
4914587|NCT03588572|12093669|P1|COMPLETED|Visitation 1||21
4914588|NCT03588572|12093668|P2|STARTED|Visitation 1||21
4914589|NCT03588572|12093669|P1|STARTED|Visitation 1||22
4914590|NCT03587974|12093687|P2|NOT COMPLETED|Overall Study||4
4914591|NCT03587974|12093688|P1|NOT COMPLETED|Overall Study||5
4914592|NCT03587974|12093687|P2|COMPLETED|Overall Study||26
4914593|NCT03587974|12093688|P1|COMPLETED|Overall Study||25
4914594|NCT03587974|12093687|P2|STARTED|Overall Study||30
4914595|NCT03587974|12093688|P1|STARTED|Overall Study||30
4914596|NCT03587428|12093698|P6|NOT COMPLETED|Period 3||0
4914597|NCT03587428|12093699|P5|NOT COMPLETED|Period 3||0
4914598|NCT03587428|12093700|P4|NOT COMPLETED|Period 3||0
4914599|NCT03587428|12093701|P3|NOT COMPLETED|Period 3||0
4914600|NCT03587428|12093702|P2|NOT COMPLETED|Period 3||0
4914601|NCT03587428|12093703|P1|NOT COMPLETED|Period 3||0
4914602|NCT03587428|12093698|P6|COMPLETED|Period 3||2
4914603|NCT03587428|12093699|P5|COMPLETED|Period 3||2
4914604|NCT03587428|12093700|P4|COMPLETED|Period 3||3
4914605|NCT03587428|12093701|P3|COMPLETED|Period 3||3
4914606|NCT03587428|12093702|P2|COMPLETED|Period 3||2
4914607|NCT03587428|12093703|P1|COMPLETED|Period 3||3
4914608|NCT03587428|12093698|P6|STARTED|Period 3||2
4914609|NCT03587428|12093699|P5|STARTED|Period 3||2
4914610|NCT03587428|12093700|P4|STARTED|Period 3||3
4914611|NCT03587428|12093701|P3|STARTED|Period 3||3
4914612|NCT03587428|12093702|P2|STARTED|Period 3||2
4914613|NCT03587428|12093703|P1|STARTED|Period 3||3
4914614|NCT03587428|12093698|P6|NOT COMPLETED|Period 2||0
4914615|NCT03587428|12093699|P5|NOT COMPLETED|Period 2||0
4914616|NCT03587428|12093700|P4|NOT COMPLETED|Period 2||0
4914617|NCT03587428|12093701|P3|NOT COMPLETED|Period 2||0
4914618|NCT03587428|12093702|P2|NOT COMPLETED|Period 2||0
4914619|NCT03587428|12093703|P1|NOT COMPLETED|Period 2||0
4914620|NCT03587428|12093698|P6|COMPLETED|Period 2||2
4914621|NCT03587428|12093699|P5|COMPLETED|Period 2||2
4914622|NCT03587428|12093700|P4|COMPLETED|Period 2||3
4914623|NCT03587428|12093701|P3|COMPLETED|Period 2||3
4914624|NCT03587428|12093702|P2|COMPLETED|Period 2||2
4914625|NCT03587428|12093703|P1|COMPLETED|Period 2||3
4914626|NCT03587428|12093698|P6|STARTED|Period 2||2
4914627|NCT03587428|12093699|P5|STARTED|Period 2||2
4914628|NCT03587428|12093700|P4|STARTED|Period 2||3
4914629|NCT03587428|12093701|P3|STARTED|Period 2||3
4914630|NCT03587428|12093702|P2|STARTED|Period 2||2
4914631|NCT03587428|12093703|P1|STARTED|Period 2||3
4914632|NCT03587428|12093698|P6|NOT COMPLETED|Period 1||0
4914633|NCT03587428|12093699|P5|NOT COMPLETED|Period 1||0
4914634|NCT03587428|12093700|P4|NOT COMPLETED|Period 1||0
4914635|NCT03587428|12093701|P3|NOT COMPLETED|Period 1||0
4914636|NCT03587428|12093702|P2|NOT COMPLETED|Period 1||0
4914637|NCT03587428|12093703|P1|NOT COMPLETED|Period 1||0
4914638|NCT03587428|12093698|P6|COMPLETED|Period 1||2
4914639|NCT03587428|12093699|P5|COMPLETED|Period 1||2
4914640|NCT03587428|12093700|P4|COMPLETED|Period 1||3
4914641|NCT03587428|12093701|P3|COMPLETED|Period 1||3
4914642|NCT03587428|12093702|P2|COMPLETED|Period 1||2
4914643|NCT03587428|12093703|P1|COMPLETED|Period 1||3
4914644|NCT03587428|12093698|P6|STARTED|Period 1||2
4914645|NCT03587428|12093699|P5|STARTED|Period 1||2
4914646|NCT03587428|12093700|P4|STARTED|Period 1||3
4914647|NCT03587428|12093701|P3|STARTED|Period 1||3
4914648|NCT03587428|12093702|P2|STARTED|Period 1||2
4914649|NCT03587428|12093703|P1|STARTED|Period 1||3
4914650|NCT03587207|12093725|P5|NOT COMPLETED|Overall Study||0
4914651|NCT03587207|12093726|P4|NOT COMPLETED|Overall Study||0
4914652|NCT03587207|12093727|P3|NOT COMPLETED|Overall Study||0
4914653|NCT03587207|12093728|P2|NOT COMPLETED|Overall Study||0
4914654|NCT03587207|12093729|P1|NOT COMPLETED|Overall Study||0
4914655|NCT03587207|12093725|P5|COMPLETED|Overall Study||102
4914656|NCT03587207|12093726|P4|COMPLETED|Overall Study||94
4914657|NCT03587207|12093727|P3|COMPLETED|Overall Study||100
4914658|NCT03587207|12093728|P2|COMPLETED|Overall Study||104
4914659|NCT03587207|12093729|P1|COMPLETED|Overall Study||100
4914660|NCT03587207|12093725|P5|STARTED|Overall Study||102
4914661|NCT03587207|12093726|P4|STARTED|Overall Study||94
4914662|NCT03587207|12093727|P3|STARTED|Overall Study||100
4914663|NCT03587207|12093728|P2|STARTED|Overall Study||104
4914664|NCT03587207|12093729|P1|STARTED|Overall Study||100
4914665|NCT03586830|12093804|P4|NOT COMPLETED|Overall Study||5
4914666|NCT03586830|12093805|P3|NOT COMPLETED|Overall Study||8
4914667|NCT03586830|12093806|P2|NOT COMPLETED|Overall Study||6
4914668|NCT03586830|12093807|P1|NOT COMPLETED|Overall Study||2
4914669|NCT03586830|12093804|P4|COMPLETED|Overall Study||44
4914670|NCT03586830|12093805|P3|COMPLETED|Overall Study||41
4914671|NCT03586830|12093806|P2|COMPLETED|Overall Study||42
4914672|NCT03586830|12093807|P1|COMPLETED|Overall Study||48
4914673|NCT03586830|12093804|P4|Treated|Overall Study||49
4914674|NCT03586830|12093805|P3|Treated|Overall Study||49
4914675|NCT03586830|12093806|P2|Treated|Overall Study||48
4914676|NCT03586830|12093807|P1|Treated|Overall Study||49
4914677|NCT03586830|12093804|P4|STARTED|Overall Study||49
4914678|NCT03586830|12093805|P3|STARTED|Overall Study||49
4914679|NCT03586830|12093806|P2|STARTED|Overall Study||48
4914680|NCT03586830|12093807|P1|STARTED|Overall Study||50
4914681|NCT03586726|12093829|P1|NOT COMPLETED|Overall Study||1
4914682|NCT03586726|12093829|P1|COMPLETED|Overall Study||15
4914683|NCT03586726|12093829|P1|STARTED|Overall Study||16
4914684|NCT03586648|12093846|P2|NOT COMPLETED|Period 2||0
4914685|NCT03586648|12093847|P1|NOT COMPLETED|Period 2||1
4914686|NCT03586648|12093846|P2|COMPLETED|Period 2||30
4914687|NCT03586648|12093847|P1|COMPLETED|Period 2||31
4914688|NCT03586648|12093846|P2|STARTED|Period 2||30
4914689|NCT03586648|12093847|P1|STARTED|Period 2||32
4914690|NCT03586648|12093846|P2|NOT COMPLETED|Period 1||4
4914691|NCT03586648|12093847|P1|NOT COMPLETED|Period 1||4
4914692|NCT03586648|12093846|P2|COMPLETED|Period 1||30
4914693|NCT03586648|12093847|P1|COMPLETED|Period 1||32
4914694|NCT03586648|12093846|P2|STARTED|Period 1||34
4914695|NCT03586648|12093847|P1|STARTED|Period 1||36
4914696|NCT03586583|12093855|P1|NOT COMPLETED|Overall Study||0
4914697|NCT03586583|12093855|P1|COMPLETED|Overall Study||600
4914698|NCT03586583|12093855|P1|STARTED|Overall Study||600
4914699|NCT03585959|12093860|P1|NOT COMPLETED|Overall Study||3
4914700|NCT03585959|12093860|P1|COMPLETED|Overall Study||47
4914701|NCT03585959|12093860|P1|STARTED|Overall Study||50
4914702|NCT03585790|12093882|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4914703|NCT03585790|12093883|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4914704|NCT03585790|12093882|P2|COMPLETED|Second Intervention (1 Week)||22
4914705|NCT03585790|12093883|P1|COMPLETED|Second Intervention (1 Week)||23
4914706|NCT03585790|12093882|P2|STARTED|Second Intervention (1 Week)||22
4914707|NCT03585790|12093883|P1|STARTED|Second Intervention (1 Week)||23
4914708|NCT03585790|12093882|P2|NOT COMPLETED|First Intervention (1 Week)||0
4914709|NCT03585790|12093883|P1|NOT COMPLETED|First Intervention (1 Week)||0
4914710|NCT03585790|12093882|P2|COMPLETED|First Intervention (1 Week)||22
4914711|NCT03585790|12093883|P1|COMPLETED|First Intervention (1 Week)||23
4914712|NCT03585790|12093882|P2|STARTED|First Intervention (1 Week)||22
4914713|NCT03585790|12093883|P1|STARTED|First Intervention (1 Week)||23
4914714|NCT03585543|12093890|P1|NOT COMPLETED|Overall Study||15
4914715|NCT03585543|12093890|P1|COMPLETED|Overall Study||15
4914716|NCT03585543|12093890|P1|3-month Post-intervention Follow-up (6 m|Overall Study||15
4914717|NCT03585543|12093890|P1|End-of-intervention Assessment (12 Weeks|Overall Study||22
4914718|NCT03585543|12093890|P1|Mid-intervention Assessment (6-weeks)|Overall Study||25
4914719|NCT03585543|12093890|P1|STARTED|Overall Study||30
4914720|NCT03585504|12093901|P2|NOT COMPLETED|Overall Study||29
4914721|NCT03585504|12093902|P1|NOT COMPLETED|Overall Study||26
4914722|NCT03585504|12093901|P2|COMPLETED|Overall Study||11
4914723|NCT03585504|12093902|P1|COMPLETED|Overall Study||15
4914724|NCT03585504|12093901|P2|STARTED|Overall Study||40
4914725|NCT03585504|12093902|P1|STARTED|Overall Study||41
4914726|NCT03585296|12093912|P1|NOT COMPLETED|Overall Study||5
4914727|NCT03585296|12093912|P1|COMPLETED|Overall Study||17
4914728|NCT03585296|12093912|P1|STARTED|Overall Study||22
4914729|NCT03583450|12093918|P2|NOT COMPLETED|Overall Study||0
4914730|NCT03583450|12093919|P1|NOT COMPLETED|Overall Study||1
4914731|NCT03583450|12093918|P2|COMPLETED|Overall Study||37
4914732|NCT03583450|12093919|P1|COMPLETED|Overall Study||33
4914733|NCT03583450|12093918|P2|STARTED|Overall Study||37
4914734|NCT03583450|12093919|P1|STARTED|Overall Study||34
4914735|NCT03583385|12093941|P2|NOT COMPLETED|Treatment Period 2||0
4914736|NCT03583385|12093942|P1|NOT COMPLETED|Treatment Period 2||1
4914737|NCT03583385|12093941|P2|COMPLETED|Treatment Period 2||23
4914738|NCT03583385|12093942|P1|COMPLETED|Treatment Period 2||21
4914739|NCT03583385|12093941|P2|STARTED|Treatment Period 2||23
4914740|NCT03583385|12093942|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn’t attend period2.|22
4914741|NCT03583385|12093941|P2|NOT COMPLETED|Treatment Period 1||1
4914742|NCT03583385|12093942|P1|NOT COMPLETED|Treatment Period 1||1
4914743|NCT03583385|12093941|P2|COMPLETED|Treatment Period 1||23
4914744|NCT03583385|12093942|P1|COMPLETED|Treatment Period 1||23
4914745|NCT03583385|12093941|P2|STARTED|Treatment Period 1||24
4914746|NCT03583385|12093942|P1|STARTED|Treatment Period 1||24
4914747|NCT03582943|12093960|P2|NOT COMPLETED|Analyzed||1
4914748|NCT03582943|12093961|P1|NOT COMPLETED|Analyzed||4
4914749|NCT03582943|12093960|P2|COMPLETED|Analyzed||36
4914750|NCT03582943|12093961|P1|COMPLETED|Analyzed||33
4914751|NCT03582943|12093960|P2|STARTED|Analyzed||37
4914752|NCT03582943|12093961|P1|STARTED|Analyzed||37
4914753|NCT03582943|12093960|P2|NOT COMPLETED|Intervention and Follow up||2
4914754|NCT03582943|12093961|P1|NOT COMPLETED|Intervention and Follow up||4
4914755|NCT03582943|12093960|P2|COMPLETED|Intervention and Follow up||37
4914756|NCT03582943|12093961|P1|COMPLETED|Intervention and Follow up||37
4914757|NCT03582943|12093960|P2|STARTED|Intervention and Follow up||39
4914758|NCT03582943|12093961|P1|STARTED|Intervention and Follow up||41
4914759|NCT03582943|12093960|P2|NOT COMPLETED|Allocated to Groups||1
4914760|NCT03582943|12093961|P1|NOT COMPLETED|Allocated to Groups||1
4914761|NCT03582943|12093960|P2|COMPLETED|Allocated to Groups||39
4914762|NCT03582943|12093961|P1|COMPLETED|Allocated to Groups||41
4914763|NCT03582943|12093960|P2|STARTED|Allocated to Groups||40
4914764|NCT03582943|12093961|P1|STARTED|Allocated to Groups||42
4914765|NCT03582813|12093969|P2|NOT COMPLETED|Overall Study||21
4914766|NCT03582813|12093970|P1|NOT COMPLETED|Overall Study||19
4914767|NCT03582813|12093969|P2|COMPLETED|Overall Study||81
4914768|NCT03582813|12093970|P1|COMPLETED|Overall Study||95
4914769|NCT03582813|12093969|P2|STARTED|Overall Study||102
4914770|NCT03582813|12093970|P1|STARTED|Overall Study||114
4914771|NCT03582553|12093994|P6|NOT COMPLETED|Intervention 3/Visit 3||0
4914772|NCT03582553|12093995|P5|NOT COMPLETED|Intervention 3/Visit 3||0
4914773|NCT03582553|12093996|P4|NOT COMPLETED|Intervention 3/Visit 3||0
4914774|NCT03582553|12093997|P3|NOT COMPLETED|Intervention 3/Visit 3||0
4914775|NCT03582553|12093998|P2|NOT COMPLETED|Intervention 3/Visit 3||0
4914776|NCT03582553|12093999|P1|NOT COMPLETED|Intervention 3/Visit 3||0
4914777|NCT03582553|12093994|P6|COMPLETED|Intervention 3/Visit 3||3
4914778|NCT03582553|12093995|P5|COMPLETED|Intervention 3/Visit 3||3
4914779|NCT03582553|12093996|P4|COMPLETED|Intervention 3/Visit 3||3
4914780|NCT03582553|12093997|P3|COMPLETED|Intervention 3/Visit 3||3
4914781|NCT03582553|12093998|P2|COMPLETED|Intervention 3/Visit 3||3
4914782|NCT03582553|12093999|P1|COMPLETED|Intervention 3/Visit 3||3
4914783|NCT03582553|12093994|P6|STARTED|Intervention 3/Visit 3||3
4914784|NCT03582553|12093995|P5|STARTED|Intervention 3/Visit 3||3
4914785|NCT03582553|12093996|P4|STARTED|Intervention 3/Visit 3||3
4914786|NCT03582553|12093997|P3|STARTED|Intervention 3/Visit 3||3
4914787|NCT03582553|12093998|P2|STARTED|Intervention 3/Visit 3||3
4914788|NCT03582553|12093999|P1|STARTED|Intervention 3/Visit 3||3
4914789|NCT03582553|12093994|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914790|NCT03582553|12093995|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914791|NCT03582553|12093996|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914792|NCT03582553|12093997|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914793|NCT03582553|12093998|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914794|NCT03582553|12093999|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
4914795|NCT03582553|12093994|P6|COMPLETED|Washout Period (At Least 1 Week)||3
4914796|NCT03582553|12093995|P5|COMPLETED|Washout Period (At Least 1 Week)||3
4914797|NCT03582553|12093996|P4|COMPLETED|Washout Period (At Least 1 Week)||3
4914798|NCT03582553|12093997|P3|COMPLETED|Washout Period (At Least 1 Week)||3
4914799|NCT03582553|12093998|P2|COMPLETED|Washout Period (At Least 1 Week)||3
4914800|NCT03582553|12093999|P1|COMPLETED|Washout Period (At Least 1 Week)||3
4914801|NCT03582553|12093994|P6|STARTED|Washout Period (At Least 1 Week)||3
4914802|NCT03582553|12093995|P5|STARTED|Washout Period (At Least 1 Week)||3
4914803|NCT03582553|12093996|P4|STARTED|Washout Period (At Least 1 Week)||3
4914804|NCT03582553|12093997|P3|STARTED|Washout Period (At Least 1 Week)||3
4914805|NCT03582553|12093998|P2|STARTED|Washout Period (At Least 1 Week)||3
4914806|NCT03582553|12093999|P1|STARTED|Washout Period (At Least 1 Week)||3
4914807|NCT03582553|12093994|P6|NOT COMPLETED|Intervention 2/Visit 2||0
4914808|NCT03582553|12093995|P5|NOT COMPLETED|Intervention 2/Visit 2||0
4914809|NCT03582553|12093996|P4|NOT COMPLETED|Intervention 2/Visit 2||0
4914810|NCT03582553|12093997|P3|NOT COMPLETED|Intervention 2/Visit 2||0
4914811|NCT03582553|12093998|P2|NOT COMPLETED|Intervention 2/Visit 2||0
4914812|NCT03582553|12093999|P1|NOT COMPLETED|Intervention 2/Visit 2||0
4914813|NCT03582553|12093994|P6|COMPLETED|Intervention 2/Visit 2||3
4914814|NCT03582553|12093995|P5|COMPLETED|Intervention 2/Visit 2||3
4914815|NCT03582553|12093996|P4|COMPLETED|Intervention 2/Visit 2||3
4914816|NCT03582553|12093997|P3|COMPLETED|Intervention 2/Visit 2||3
4914817|NCT03582553|12093998|P2|COMPLETED|Intervention 2/Visit 2||3
4914818|NCT03582553|12093999|P1|COMPLETED|Intervention 2/Visit 2||3
4914819|NCT03582553|12093994|P6|STARTED|Intervention 2/Visit 2||3
4914820|NCT03582553|12093995|P5|STARTED|Intervention 2/Visit 2||3
4914821|NCT03582553|12093996|P4|STARTED|Intervention 2/Visit 2||3
4914822|NCT03582553|12093997|P3|STARTED|Intervention 2/Visit 2||3
4914823|NCT03582553|12093998|P2|STARTED|Intervention 2/Visit 2||3
4914824|NCT03582553|12093999|P1|STARTED|Intervention 2/Visit 2||3
4914825|NCT03582553|12093994|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914826|NCT03582553|12093995|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914827|NCT03582553|12093996|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914828|NCT03582553|12093997|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914829|NCT03582553|12093998|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914830|NCT03582553|12093999|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
4914831|NCT03582553|12093994|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
4914832|NCT03582553|12093995|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
4914833|NCT03582553|12093996|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
4914834|NCT03582553|12093997|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
4914835|NCT03582553|12093998|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
4914836|NCT03582553|12093999|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
4914837|NCT03582553|12093994|P6|STARTED|Washout Period ( At Least 1 Week)||3
4914838|NCT03582553|12093995|P5|STARTED|Washout Period ( At Least 1 Week)||3
4914839|NCT03582553|12093996|P4|STARTED|Washout Period ( At Least 1 Week)||3
4914840|NCT03582553|12093997|P3|STARTED|Washout Period ( At Least 1 Week)||3
4914841|NCT03582553|12093998|P2|STARTED|Washout Period ( At Least 1 Week)||3
4914842|NCT03582553|12093999|P1|STARTED|Washout Period ( At Least 1 Week)||3
4914843|NCT03582553|12093994|P6|NOT COMPLETED|Intervention 1/Visit 1||0
4914844|NCT03582553|12093995|P5|NOT COMPLETED|Intervention 1/Visit 1||0
4914845|NCT03582553|12093996|P4|NOT COMPLETED|Intervention 1/Visit 1||0
4914846|NCT03582553|12093997|P3|NOT COMPLETED|Intervention 1/Visit 1||0
4914847|NCT03582553|12093998|P2|NOT COMPLETED|Intervention 1/Visit 1||0
4914848|NCT03582553|12093999|P1|NOT COMPLETED|Intervention 1/Visit 1||0
4914849|NCT03582553|12093994|P6|COMPLETED|Intervention 1/Visit 1||3
4914850|NCT03582553|12093995|P5|COMPLETED|Intervention 1/Visit 1||3
4914851|NCT03582553|12093996|P4|COMPLETED|Intervention 1/Visit 1||3
4914852|NCT03582553|12093997|P3|COMPLETED|Intervention 1/Visit 1||3
4914853|NCT03582553|12093998|P2|COMPLETED|Intervention 1/Visit 1||3
4914854|NCT03582553|12093999|P1|COMPLETED|Intervention 1/Visit 1||3
4914855|NCT03582553|12093994|P6|STARTED|Intervention 1/Visit 1||3
4914856|NCT03582553|12093995|P5|STARTED|Intervention 1/Visit 1||3
4914857|NCT03582553|12093996|P4|STARTED|Intervention 1/Visit 1||3
4914858|NCT03582553|12093997|P3|STARTED|Intervention 1/Visit 1||3
4914859|NCT03582553|12093998|P2|STARTED|Intervention 1/Visit 1||3
4914860|NCT03582553|12093999|P1|STARTED|Intervention 1/Visit 1||3
4914861|NCT03582215|12094037|P8|NOT COMPLETED|Overall Study||2
4914862|NCT03582215|12094038|P7|NOT COMPLETED|Overall Study||2
4914863|NCT03582215|12094039|P6|NOT COMPLETED|Overall Study||0
4914864|NCT03582215|12094040|P5|NOT COMPLETED|Overall Study||0
4914865|NCT03582215|12094041|P4|NOT COMPLETED|Overall Study||0
4914866|NCT03582215|12094042|P3|NOT COMPLETED|Overall Study||0
4914867|NCT03582215|12094043|P2|NOT COMPLETED|Overall Study||0
4914868|NCT03582215|12094044|P1|NOT COMPLETED|Overall Study||1
4914869|NCT03582215|12094037|P8|COMPLETED|Overall Study||10
4914870|NCT03582215|12094038|P7|COMPLETED|Overall Study||10
4914871|NCT03582215|12094039|P6|COMPLETED|Overall Study||12
4914872|NCT03582215|12094040|P5|COMPLETED|Overall Study||12
4914873|NCT03582215|12094041|P4|COMPLETED|Overall Study||6
4914874|NCT03582215|12094042|P3|COMPLETED|Overall Study||6
4914875|NCT03582215|12094043|P2|COMPLETED|Overall Study||6
4914876|NCT03582215|12094044|P1|COMPLETED|Overall Study||5
4914877|NCT03582215|12094037|P8|STARTED|Overall Study||12
4914878|NCT03582215|12094038|P7|STARTED|Overall Study||12
4914879|NCT03582215|12094039|P6|STARTED|Overall Study||12
4914880|NCT03582215|12094040|P5|STARTED|Overall Study||12
4914881|NCT03582215|12094041|P4|STARTED|Overall Study||6
4914882|NCT03582215|12094042|P3|STARTED|Overall Study||6
4914883|NCT03582215|12094043|P2|STARTED|Overall Study||6
4914884|NCT03582215|12094044|P1|STARTED|Overall Study||6
4914885|NCT03581825|12094085|P2|NOT COMPLETED|Period 2||1
4914886|NCT03581825|12094086|P1|NOT COMPLETED|Period 2||0
4914887|NCT03581825|12094085|P2|COMPLETED|Period 2||30
4914888|NCT03581825|12094086|P1|COMPLETED|Period 2||30
4914889|NCT03581825|12094085|P2|STARTED|Period 2||31
4914890|NCT03581825|12094086|P1|STARTED|Period 2||30
4914891|NCT03581825|12094085|P2|NOT COMPLETED|Period 1||0
4914892|NCT03581825|12094086|P1|NOT COMPLETED|Period 1||1
4914893|NCT03581825|12094085|P2|COMPLETED|Period 1||31
4914894|NCT03581825|12094086|P1|COMPLETED|Period 1||30
4914895|NCT03581825|12094085|P2|STARTED|Period 1||31
4914896|NCT03581825|12094086|P1|STARTED|Period 1||31
4914897|NCT03581474|12094093|P1|NOT COMPLETED|Overall Study||0
4914898|NCT03581474|12094093|P1|COMPLETED|Overall Study||12
4914899|NCT03581474|12094093|P1|STARTED|Overall Study||12
4914900|NCT03581097|12094099|P2|NOT COMPLETED|Overall Study||0
4914901|NCT03581097|12094100|P1|NOT COMPLETED|Overall Study||0
4914902|NCT03581097|12094099|P2|COMPLETED|Overall Study||47
4914903|NCT03581097|12094100|P1|COMPLETED|Overall Study||46
4914904|NCT03581097|12094099|P2|STARTED|Overall Study||47
4914905|NCT03581097|12094100|P1|STARTED|Overall Study||46
4914906|NCT03580382|12094122|P2|NOT COMPLETED|Overall Study||3
4914907|NCT03580382|12094123|P1|NOT COMPLETED|Overall Study||0
4914908|NCT03580382|12094122|P2|COMPLETED|Overall Study||0
4914909|NCT03580382|12094123|P1|COMPLETED|Overall Study||0
4914910|NCT03580382|12094122|P2|STARTED|Overall Study||3
4914911|NCT03580382|12094123|P1|STARTED|Overall Study||0
4914912|NCT03579940|12094141|P11|NOT COMPLETED|Period 3||0
4914913|NCT03579940|12094142|P10|NOT COMPLETED|Period 3||0
4914914|NCT03579940|12094143|P9|NOT COMPLETED|Period 3||0
4914915|NCT03579940|12094144|P8|NOT COMPLETED|Period 3||0
4914916|NCT03579940|12094145|P7|NOT COMPLETED|Period 3||0
4914917|NCT03579940|12094146|P6|NOT COMPLETED|Period 3||0
4914918|NCT03579940|12094147|P5|NOT COMPLETED|Period 3||0
4914919|NCT03579940|12094148|P4|NOT COMPLETED|Period 3||0
4914920|NCT03579940|12094149|P3|NOT COMPLETED|Period 3||0
4914921|NCT03579940|12094150|P2|NOT COMPLETED|Period 3||0
4914922|NCT03579940|12094151|P1|NOT COMPLETED|Period 3||0
4914923|NCT03579940|12094141|P11|COMPLETED|Period 3||3
4914924|NCT03579940|12094142|P10|COMPLETED|Period 3||2
4914925|NCT03579940|12094143|P9|COMPLETED|Period 3||3
4914926|NCT03579940|12094144|P8|COMPLETED|Period 3||3
4914927|NCT03579940|12094145|P7|COMPLETED|Period 3||3
4914928|NCT03579940|12094146|P6|COMPLETED|Period 3||2
4914929|NCT03579940|12094147|P5|COMPLETED|Period 3||2
4914930|NCT03579940|12094148|P4|COMPLETED|Period 3||2
4914931|NCT03579940|12094149|P3|COMPLETED|Period 3||1
4914932|NCT03579940|12094150|P2|COMPLETED|Period 3||2
4914933|NCT03579940|12094151|P1|COMPLETED|Period 3||3
4914934|NCT03579940|12094141|P11|STARTED|Period 3||3
4914935|NCT03579940|12094142|P10|STARTED|Period 3||2
4914936|NCT03579940|12094143|P9|STARTED|Period 3||3
4914937|NCT03579940|12094144|P8|STARTED|Period 3||3
4914938|NCT03579940|12094145|P7|STARTED|Period 3||3
4914939|NCT03579940|12094146|P6|STARTED|Period 3||2
4914940|NCT03579940|12094147|P5|STARTED|Period 3||2
4914941|NCT03579940|12094148|P4|STARTED|Period 3||2
4914942|NCT03579940|12094149|P3|STARTED|Period 3||1
4914943|NCT03579940|12094150|P2|STARTED|Period 3||2
4914944|NCT03579940|12094151|P1|STARTED|Period 3||3
4914945|NCT03579940|12094141|P11|NOT COMPLETED|Period 2||0
4914946|NCT03579940|12094142|P10|NOT COMPLETED|Period 2||0
4914947|NCT03579940|12094143|P9|NOT COMPLETED|Period 2||0
4914948|NCT03579940|12094144|P8|NOT COMPLETED|Period 2||0
4914949|NCT03579940|12094145|P7|NOT COMPLETED|Period 2||0
4914950|NCT03579940|12094146|P6|NOT COMPLETED|Period 2||0
4914951|NCT03579940|12094147|P5|NOT COMPLETED|Period 2||0
4914952|NCT03579940|12094148|P4|NOT COMPLETED|Period 2||0
4914953|NCT03579940|12094149|P3|NOT COMPLETED|Period 2||1
4914954|NCT03579940|12094150|P2|NOT COMPLETED|Period 2||0
4914955|NCT03579940|12094151|P1|NOT COMPLETED|Period 2||0
4914956|NCT03579940|12094141|P11|COMPLETED|Period 2||3
4914957|NCT03579940|12094142|P10|COMPLETED|Period 2||2
4914958|NCT03579940|12094143|P9|COMPLETED|Period 2||3
4914959|NCT03579940|12094144|P8|COMPLETED|Period 2||3
4914960|NCT03579940|12094145|P7|COMPLETED|Period 2||3
4914961|NCT03579940|12094146|P6|COMPLETED|Period 2||2
4914962|NCT03579940|12094147|P5|COMPLETED|Period 2||2
4914963|NCT03579940|12094148|P4|COMPLETED|Period 2||2
4914964|NCT03579940|12094149|P3|COMPLETED|Period 2||1
4914965|NCT03579940|12094150|P2|COMPLETED|Period 2||2
4914966|NCT03579940|12094151|P1|COMPLETED|Period 2||3
4914967|NCT03579940|12094141|P11|STARTED|Period 2||3
4914968|NCT03579940|12094142|P10|STARTED|Period 2||2
4914969|NCT03579940|12094143|P9|STARTED|Period 2||3
4914970|NCT03579940|12094144|P8|STARTED|Period 2||3
4914971|NCT03579940|12094145|P7|STARTED|Period 2||3
4914972|NCT03579940|12094146|P6|STARTED|Period 2||2
4914973|NCT03579940|12094147|P5|STARTED|Period 2||2
4914974|NCT03579940|12094148|P4|STARTED|Period 2||2
4914975|NCT03579940|12094149|P3|STARTED|Period 2||2
4914976|NCT03579940|12094150|P2|STARTED|Period 2||2
4914977|NCT03579940|12094151|P1|STARTED|Period 2||3
4914978|NCT03579940|12094141|P11|NOT COMPLETED|Period 1||0
4914979|NCT03579940|12094142|P10|NOT COMPLETED|Period 1||0
4914980|NCT03579940|12094143|P9|NOT COMPLETED|Period 1||0
4914981|NCT03579940|12094144|P8|NOT COMPLETED|Period 1||0
4914982|NCT03579940|12094145|P7|NOT COMPLETED|Period 1||0
4914983|NCT03579940|12094146|P6|NOT COMPLETED|Period 1||0
4914984|NCT03579940|12094147|P5|NOT COMPLETED|Period 1||0
4914985|NCT03579940|12094148|P4|NOT COMPLETED|Period 1||0
4914986|NCT03579940|12094149|P3|NOT COMPLETED|Period 1||0
4914987|NCT03579940|12094150|P2|NOT COMPLETED|Period 1||0
4914988|NCT03579940|12094151|P1|NOT COMPLETED|Period 1||0
4914989|NCT03579940|12094141|P11|COMPLETED|Period 1||3
4914990|NCT03579940|12094142|P10|COMPLETED|Period 1||2
4914991|NCT03579940|12094143|P9|COMPLETED|Period 1||3
4914992|NCT03579940|12094144|P8|COMPLETED|Period 1||3
4914993|NCT03579940|12094145|P7|COMPLETED|Period 1||3
4914994|NCT03579940|12094146|P6|COMPLETED|Period 1||2
4914995|NCT03579940|12094147|P5|COMPLETED|Period 1||2
4914996|NCT03579940|12094148|P4|COMPLETED|Period 1||2
4914997|NCT03579940|12094149|P3|COMPLETED|Period 1||2
4914998|NCT03579940|12094150|P2|COMPLETED|Period 1||2
4914999|NCT03579940|12094151|P1|COMPLETED|Period 1||3
4915000|NCT03579940|12094141|P11|Received at Least 1 Dose of Study Drug|Period 1||3
4915001|NCT03579940|12094142|P10|Received at Least 1 Dose of Study Drug|Period 1||2
4915002|NCT03579940|12094143|P9|Received at Least 1 Dose of Study Drug|Period 1||3
4915003|NCT03579940|12094144|P8|Received at Least 1 Dose of Study Drug|Period 1||3
4915004|NCT03579940|12094145|P7|Received at Least 1 Dose of Study Drug|Period 1||3
4915005|NCT03579940|12094146|P6|Received at Least 1 Dose of Study Drug|Period 1||2
4915006|NCT03579940|12094147|P5|Received at Least 1 Dose of Study Drug|Period 1||2
4915007|NCT03579940|12094148|P4|Received at Least 1 Dose of Study Drug|Period 1||2
4915008|NCT03579940|12094149|P3|Received at Least 1 Dose of Study Drug|Period 1||2
4915009|NCT03579940|12094150|P2|Received at Least 1 Dose of Study Drug|Period 1||2
4915010|NCT03579940|12094151|P1|Received at Least 1 Dose of Study Drug|Period 1||3
4915011|NCT03579940|12094141|P11|STARTED|Period 1||3
4915012|NCT03579940|12094142|P10|STARTED|Period 1||2
4915013|NCT03579940|12094143|P9|STARTED|Period 1||3
4915014|NCT03579940|12094144|P8|STARTED|Period 1||3
4915015|NCT03579940|12094145|P7|STARTED|Period 1||3
4915016|NCT03579940|12094146|P6|STARTED|Period 1||2
4915017|NCT03579940|12094147|P5|STARTED|Period 1||2
4915018|NCT03579940|12094148|P4|STARTED|Period 1||2
4915019|NCT03579940|12094149|P3|STARTED|Period 1||2
4915020|NCT03579940|12094150|P2|STARTED|Period 1||2
4915021|NCT03579940|12094151|P1|STARTED|Period 1||3
4915022|NCT03579719|12094191|P1|NOT COMPLETED|Overall Study||1
4915023|NCT03579719|12094191|P1|COMPLETED|Overall Study||14
4915024|NCT03579719|12094191|P1|STARTED|Overall Study||15
4915025|NCT03579433|12094208|P1|NOT COMPLETED|Overall Study||6
4915026|NCT03579433|12094208|P1|COMPLETED|Overall Study||98
4915027|NCT03579433|12094208|P1|Barrett Calculator|Overall Study||102
4915028|NCT03579433|12094208|P1|ORA With VerifEye+|Overall Study||96
4915029|NCT03579433|12094208|P1|STARTED|Overall Study||104
4915030|NCT03578926|12094216|P2|NOT COMPLETED|Second Intervention||0
4915031|NCT03578926|12094217|P1|NOT COMPLETED|Second Intervention||0
4915032|NCT03578926|12094216|P2|COMPLETED|Second Intervention||21
4915033|NCT03578926|12094217|P1|COMPLETED|Second Intervention||23
4915034|NCT03578926|12094216|P2|STARTED|Second Intervention||21
4915035|NCT03578926|12094217|P1|STARTED|Second Intervention||23
4915036|NCT03578926|12094216|P2|NOT COMPLETED|First Intervention||0
4915037|NCT03578926|12094217|P1|NOT COMPLETED|First Intervention||0
4915038|NCT03578926|12094216|P2|COMPLETED|First Intervention||23
4915039|NCT03578926|12094217|P1|COMPLETED|First Intervention||21
4915040|NCT03578926|12094216|P2|STARTED|First Intervention||23
4915041|NCT03578926|12094217|P1|STARTED|First Intervention||21
4915042|NCT03578146|12094243|P6|NOT COMPLETED|Overall Study||3
4915043|NCT03578146|12094244|P5|NOT COMPLETED|Overall Study||0
4915044|NCT03578146|12094245|P4|NOT COMPLETED|Overall Study||0
4915045|NCT03578146|12094246|P3|NOT COMPLETED|Overall Study||1
4915046|NCT03578146|12094247|P2|NOT COMPLETED|Overall Study||1
4915047|NCT03578146|12094248|P1|NOT COMPLETED|Overall Study||1
4915048|NCT03578146|12094243|P6|COMPLETED|Overall Study||5
4915049|NCT03578146|12094244|P5|COMPLETED|Overall Study||6
4915050|NCT03578146|12094245|P4|COMPLETED|Overall Study||6
4915051|NCT03578146|12094246|P3|COMPLETED|Overall Study||5
4915052|NCT03578146|12094247|P2|COMPLETED|Overall Study||5
4915053|NCT03578146|12094248|P1|COMPLETED|Overall Study||15
4915054|NCT03578146|12094243|P6|STARTED|Overall Study||8
4915055|NCT03578146|12094244|P5|STARTED|Overall Study||6
4915056|NCT03578146|12094245|P4|STARTED|Overall Study||6
4915057|NCT03578146|12094246|P3|STARTED|Overall Study||6
4915058|NCT03578146|12094247|P2|STARTED|Overall Study||6
4915059|NCT03578146|12094248|P1|STARTED|Overall Study||16
4915060|NCT03577275|12094310|P1|NOT COMPLETED|Overall Study||0
4915061|NCT03577275|12094310|P1|COMPLETED|Overall Study||32
4915062|NCT03577275|12094310|P1|NST-4016 2000mg|Overall Study||32
4915063|NCT03577275|12094310|P1|NST-4016 600mg|Overall Study||32
4915064|NCT03577275|12094310|P1|Moxifloxacin 400mg|Overall Study||32
4915065|NCT03577275|12094310|P1|Placebo|Overall Study||32
4915066|NCT03577275|12094310|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
4915067|NCT03576118|12094338|P2|NOT COMPLETED|Overall Study||4
4915068|NCT03576118|12094339|P1|NOT COMPLETED|Overall Study||3
4915069|NCT03576118|12094338|P2|COMPLETED|Overall Study||33
4915070|NCT03576118|12094339|P1|COMPLETED|Overall Study||34
4915071|NCT03576118|12094338|P2|STARTED|Overall Study||37
4915072|NCT03576118|12094339|P1|STARTED|Overall Study||37
4915073|NCT03575962|12094345|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4915074|NCT03575962|12094346|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4915075|NCT03575962|12094345|P2|COMPLETED|Treatment Period 2 (4 Days)||7
4915076|NCT03575962|12094346|P1|COMPLETED|Treatment Period 2 (4 Days)||7
4915077|NCT03575962|12094345|P2|STARTED|Treatment Period 2 (4 Days)||7
4915078|NCT03575962|12094346|P1|STARTED|Treatment Period 2 (4 Days)||7
4915079|NCT03575962|12094345|P2|NOT COMPLETED|Washout Period (7 Days)||0
4915080|NCT03575962|12094346|P1|NOT COMPLETED|Washout Period (7 Days)||0
4915081|NCT03575962|12094345|P2|COMPLETED|Washout Period (7 Days)||7
4915082|NCT03575962|12094346|P1|COMPLETED|Washout Period (7 Days)||7
4915083|NCT03575962|12094345|P2|STARTED|Washout Period (7 Days)||7
4915084|NCT03575962|12094346|P1|STARTED|Washout Period (7 Days)||7
4915085|NCT03575962|12094345|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4915086|NCT03575962|12094346|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4915087|NCT03575962|12094345|P2|COMPLETED|Treatment Period 1 (4 Days)||7
4915088|NCT03575962|12094346|P1|COMPLETED|Treatment Period 1 (4 Days)||7
4915089|NCT03575962|12094345|P2|STARTED|Treatment Period 1 (4 Days)||7
4915090|NCT03575962|12094346|P1|STARTED|Treatment Period 1 (4 Days)||7
4915091|NCT03575871|12094389|P3|NOT COMPLETED|Overall Study||26
4915092|NCT03575871|12094390|P2|NOT COMPLETED|Overall Study||14
4915093|NCT03575871|12094391|P1|NOT COMPLETED|Overall Study||21
4915094|NCT03575871|12094389|P3|COMPLETED|Overall Study||52
4915095|NCT03575871|12094390|P2|COMPLETED|Overall Study||141
4915096|NCT03575871|12094391|P1|COMPLETED|Overall Study||137
4915097|NCT03575871|12094389|P3|STARTED|Overall Study||78
4915098|NCT03575871|12094390|P2|STARTED|Overall Study||155
4915099|NCT03575871|12094391|P1|STARTED|Overall Study||158
4915100|NCT03575806|12094455|P2|NOT COMPLETED|Overall Study||4
4915101|NCT03575806|12094456|P1|NOT COMPLETED|Overall Study||0
4915102|NCT03575806|12094455|P2|COMPLETED|Overall Study||23
4915103|NCT03575806|12094456|P1|COMPLETED|Overall Study||25
4915104|NCT03575806|12094455|P2|STARTED|Overall Study||27
4915105|NCT03575806|12094456|P1|STARTED|Overall Study||25
4915106|NCT03575702|12094466|P2|NOT COMPLETED|Overall Study||4
4915107|NCT03575702|12094467|P1|NOT COMPLETED|Overall Study||6
4915108|NCT03575702|12094466|P2|COMPLETED|Overall Study||146
4915109|NCT03575702|12094467|P1|COMPLETED|Overall Study||143
4915110|NCT03575702|12094466|P2|STARTED|Overall Study||150
4915111|NCT03575702|12094467|P1|STARTED|Overall Study||149
4915112|NCT03574818|12094501|P1|NOT COMPLETED|Overall Study||0
4915113|NCT03574818|12094501|P1|COMPLETED|Overall Study||1
4915114|NCT03574818|12094501|P1|STARTED|Overall Study||1
4915115|NCT03574441|12094508|P3|NOT COMPLETED|Overall Study||0
4915116|NCT03574441|12094509|P2|NOT COMPLETED|Overall Study||0
4915117|NCT03574441|12094510|P1|NOT COMPLETED|Overall Study||0
4915118|NCT03574441|12094508|P3|COMPLETED|Overall Study||30
4915119|NCT03574441|12094509|P2|COMPLETED|Overall Study||30
4915120|NCT03574441|12094510|P1|COMPLETED|Overall Study||31
4915121|NCT03574441|12094508|P3|STARTED|Overall Study||30
4915122|NCT03574441|12094509|P2|STARTED|Overall Study||30
4915123|NCT03574441|12094510|P1|STARTED|Overall Study||31
4915124|NCT03573817|12094523|P2|NOT COMPLETED|Overall Study||4
4915125|NCT03573817|12094524|P1|NOT COMPLETED|Overall Study||1
4915126|NCT03573817|12094523|P2|COMPLETED|Overall Study||55
4915127|NCT03573817|12094524|P1|COMPLETED|Overall Study||62
4915128|NCT03573817|12094523|P2|Randomized and Treated With Study Drug|Overall Study||59
4915129|NCT03573817|12094524|P1|Randomized and Treated With Study Drug|Overall Study||63
4915130|NCT03573817|12094523|P2|STARTED|Overall Study||59
4915131|NCT03573817|12094524|P1|STARTED|Overall Study||63
4915132|NCT03573323|12094552|P2|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
4915133|NCT03573323|12094553|P1|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
4915134|NCT03573323|12094552|P2|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
4915135|NCT03573323|12094553|P1|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
4915136|NCT03573323|12094552|P2|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
4915137|NCT03573323|12094553|P1|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
4915138|NCT03573323|12094552|P2|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
4915139|NCT03573323|12094553|P1|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
4915140|NCT03573323|12094552|P2|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
4915141|NCT03573323|12094553|P1|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
4915142|NCT03573323|12094552|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
4915143|NCT03573323|12094553|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
4915144|NCT03573323|12094552|P2|STARTED|Blinded Treatment Period (Weeks 0-24)||507
4915145|NCT03573323|12094553|P1|STARTED|Blinded Treatment Period (Weeks 0-24)||520
4915146|NCT03573206|12094577|P1|NOT COMPLETED|Overall Study||0
4915147|NCT03573206|12094577|P1|COMPLETED|Overall Study||168
4915148|NCT03573206|12094577|P1|STARTED|Overall Study||168
4915149|NCT03572972|12094592|P5|NOT COMPLETED|Overall Study||0
4915150|NCT03572972|12094593|P4|NOT COMPLETED|Overall Study||0
4915151|NCT03572972|12094594|P3|NOT COMPLETED|Overall Study||0
4915152|NCT03572972|12094595|P2|NOT COMPLETED|Overall Study||0
4915153|NCT03572972|12094596|P1|NOT COMPLETED|Overall Study||0
4915154|NCT03572972|12094592|P5|COMPLETED|Overall Study||16295
4915155|NCT03572972|12094593|P4|COMPLETED|Overall Study||8648
4915156|NCT03572972|12094594|P3|COMPLETED|Overall Study||17779
4915157|NCT03572972|12094595|P2|COMPLETED|Overall Study||11414
4915158|NCT03572972|12094596|P1|COMPLETED|Overall Study||10548
4915159|NCT03572972|12094592|P5|STARTED|Overall Study||16295
4915160|NCT03572972|12094593|P4|STARTED|Overall Study||8648
4915161|NCT03572972|12094594|P3|STARTED|Overall Study||17779
4915162|NCT03572972|12094595|P2|STARTED|Overall Study||11414
4915163|NCT03572972|12094596|P1|STARTED|Overall Study||10548
4915164|NCT03572218|12094701|P2|NOT COMPLETED|Overall Study||5
4915165|NCT03572218|12094702|P1|NOT COMPLETED|Overall Study||6
4915166|NCT03572218|12094701|P2|COMPLETED|Overall Study||31
4915167|NCT03572218|12094702|P1|COMPLETED|Overall Study||30
4915168|NCT03572218|12094701|P2|Week 26|Overall Study||31
4915169|NCT03572218|12094702|P1|Week 26|Overall Study||30
4915170|NCT03572218|12094701|P2|Week 12|Overall Study||31
4915171|NCT03572218|12094702|P1|Week 12|Overall Study||30
4915172|NCT03572218|12094701|P2|STARTED|Overall Study||36
4915173|NCT03572218|12094702|P1|STARTED|Overall Study||36
4915174|NCT03571607|12094778|P2|NOT COMPLETED|Overall Study||0
4915175|NCT03571607|12094779|P1|NOT COMPLETED|Overall Study||0
4915176|NCT03571607|12094778|P2|COMPLETED|Overall Study||153
4915177|NCT03571607|12094779|P1|COMPLETED|Overall Study||53
4915178|NCT03571607|12094778|P2|Vaccinated|Overall Study||153
4915179|NCT03571607|12094779|P1|Vaccinated|Overall Study||53
4915180|NCT03571607|12094778|P2|STARTED|Overall Study||153
4915181|NCT03571607|12094779|P1|STARTED|Overall Study||53
4915182|NCT03571256|12094796|P3|NOT COMPLETED|Overall Study||4
4915183|NCT03571256|12094797|P2|NOT COMPLETED|Overall Study||3
4915184|NCT03571256|12094798|P1|NOT COMPLETED|Overall Study||6
4915185|NCT03571256|12094796|P3|COMPLETED|Overall Study||48
4915186|NCT03571256|12094797|P2|COMPLETED|Overall Study||51
4915187|NCT03571256|12094798|P1|COMPLETED|Overall Study||46
4915188|NCT03571256|12094796|P3|Modified ITT (mITT) Analysis Set|Overall Study||51
4915189|NCT03571256|12094797|P2|Modified ITT (mITT) Analysis Set|Overall Study||53
4915190|NCT03571256|12094798|P1|Modified ITT (mITT) Analysis Set|Overall Study||49
4915191|NCT03571256|12094796|P3|Safety Analysis Set|Overall Study||51
4915192|NCT03571256|12094797|P2|Safety Analysis Set|Overall Study||54
4915193|NCT03571256|12094798|P1|Safety Analysis Set|Overall Study||52
4915194|NCT03571256|12094796|P3|STARTED|Overall Study||52
4915195|NCT03571256|12094797|P2|STARTED|Overall Study||54
4915196|NCT03571256|12094798|P1|STARTED|Overall Study||52
4915197|NCT03570658|12094829|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
4915198|NCT03570658|12094830|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
4915199|NCT03570658|12094831|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
4915200|NCT03570658|12094832|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
4915201|NCT03570658|12094829|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
4915202|NCT03570658|12094830|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
4915203|NCT03570658|12094831|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
4915204|NCT03570658|12094832|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
4915205|NCT03570658|12094829|P4|STARTED|Multiple Ascending Dose (MAD)||10
4915206|NCT03570658|12094830|P3|STARTED|Multiple Ascending Dose (MAD)||10
4915207|NCT03570658|12094831|P2|STARTED|Multiple Ascending Dose (MAD)||0
4915208|NCT03570658|12094832|P1|STARTED|Multiple Ascending Dose (MAD)||4
4915209|NCT03570658|12094829|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
4915210|NCT03570658|12094830|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
4915211|NCT03570658|12094831|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
4915212|NCT03570658|12094832|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
4915213|NCT03570658|12094829|P4|COMPLETED|Single Ascending Dose (SAD)||10
4915214|NCT03570658|12094830|P3|COMPLETED|Single Ascending Dose (SAD)||10
4915215|NCT03570658|12094831|P2|COMPLETED|Single Ascending Dose (SAD)||2
4915216|NCT03570658|12094832|P1|COMPLETED|Single Ascending Dose (SAD)||6
4915217|NCT03570658|12094829|P4|STARTED|Single Ascending Dose (SAD)||10
4915218|NCT03570658|12094830|P3|STARTED|Single Ascending Dose (SAD)||10
4915219|NCT03570658|12094831|P2|STARTED|Single Ascending Dose (SAD)||2
4915220|NCT03570658|12094832|P1|STARTED|Single Ascending Dose (SAD)||6
4915221|NCT03570554|12094886|P4|NOT COMPLETED|Overall Study||1
4915222|NCT03570554|12094887|P3|NOT COMPLETED|Overall Study||1
4915223|NCT03570554|12094888|P2|NOT COMPLETED|Overall Study||0
4915224|NCT03570554|12094889|P1|NOT COMPLETED|Overall Study||0
4915225|NCT03570554|12094886|P4|COMPLETED|Overall Study||9
4915226|NCT03570554|12094887|P3|COMPLETED|Overall Study||10
4915227|NCT03570554|12094888|P2|COMPLETED|Overall Study||10
4915228|NCT03570554|12094889|P1|COMPLETED|Overall Study||10
4915229|NCT03570554|12094886|P4|STARTED|Overall Study||10
4915230|NCT03570554|12094887|P3|STARTED|Overall Study||11
4915231|NCT03570554|12094888|P2|STARTED|Overall Study||10
4915232|NCT03570554|12094889|P1|STARTED|Overall Study||10
4915233|NCT03570255|12094907|P1|NOT COMPLETED|Overall Study||0
4915234|NCT03570255|12094907|P1|COMPLETED|Overall Study||28
4915235|NCT03570255|12094907|P1|STARTED|Overall Study||28
4915236|NCT03570047|12094916|P5|NOT COMPLETED|Overall Study||0
4915237|NCT03570047|12094917|P4|NOT COMPLETED|Overall Study||0
4915238|NCT03570047|12094918|P3|NOT COMPLETED|Overall Study||0
4915239|NCT03570047|12094919|P2|NOT COMPLETED|Overall Study||0
4915240|NCT03570047|12094920|P1|NOT COMPLETED|Overall Study||0
4915241|NCT03570047|12094916|P5|COMPLETED|Overall Study||12262
4915242|NCT03570047|12094917|P4|COMPLETED|Overall Study||16564
4915243|NCT03570047|12094918|P3|COMPLETED|Overall Study||6925
4915244|NCT03570047|12094919|P2|COMPLETED|Overall Study||22336
4915245|NCT03570047|12094920|P1|COMPLETED|Overall Study||15902
4915246|NCT03570047|12094916|P5|STARTED|Overall Study||12262
4915247|NCT03570047|12094917|P4|STARTED|Overall Study||16564
4915248|NCT03570047|12094918|P3|STARTED|Overall Study||6925
4915249|NCT03570047|12094919|P2|STARTED|Overall Study||22336
4915250|NCT03570047|12094920|P1|STARTED|Overall Study||15902
4915251|NCT03569371|12094977|P1|NOT COMPLETED|Overall Study||3
4915252|NCT03569371|12094977|P1|COMPLETED|Overall Study||7
4915253|NCT03569371|12094977|P1|STARTED|Overall Study||10
4915254|NCT03569202|12094998|P2|NOT COMPLETED|Part 3||1
4915255|NCT03569202|12094999|P1|NOT COMPLETED|Part 3||2
4915256|NCT03569202|12094998|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
4915257|NCT03569202|12094999|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
4915258|NCT03569202|12094998|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
4915259|NCT03569202|12094999|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
4915260|NCT03569202|12094998|P2|NOT COMPLETED|Part 2||0
4915261|NCT03569202|12094999|P1|NOT COMPLETED|Part 2||0
4915262|NCT03569202|12094998|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
4915263|NCT03569202|12094999|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
4915347|NCT03566680|12095199|P1|STARTED|Overall Study||46
4915264|NCT03569202|12094998|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
4915265|NCT03569202|12094999|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
4915266|NCT03569202|12094998|P2|NOT COMPLETED|Part 1||0
4915267|NCT03569202|12094999|P1|NOT COMPLETED|Part 1||0
4915268|NCT03569202|12094998|P2|COMPLETED|Part 1||0
4915269|NCT03569202|12094999|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
4915270|NCT03569202|12094998|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
4915271|NCT03569202|12094999|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
4915272|NCT03569033|12095031|P2|NOT COMPLETED|Overall Study||0
4915273|NCT03569033|12095032|P1|NOT COMPLETED|Overall Study||0
4915274|NCT03569033|12095031|P2|COMPLETED|Overall Study||23
4915275|NCT03569033|12095032|P1|COMPLETED|Overall Study||23
4915276|NCT03569033|12095031|P2|STARTED|Overall Study||23
4915277|NCT03569033|12095032|P1|STARTED|Overall Study||23
4915278|NCT03568942|12095048|P1|NOT COMPLETED|Overall Study||2
4915279|NCT03568942|12095048|P1|COMPLETED|Overall Study||20
4915280|NCT03568942|12095048|P1|STARTED|Overall Study||22
4915281|NCT03568500|12095086|P3|NOT COMPLETED|Overall Study||4
4915282|NCT03568500|12095087|P2|NOT COMPLETED|Overall Study||6
4915283|NCT03568500|12095088|P1|NOT COMPLETED|Overall Study||10
4915284|NCT03568500|12095086|P3|COMPLETED|Overall Study||2
4915285|NCT03568500|12095087|P2|COMPLETED|Overall Study||14
4915286|NCT03568500|12095088|P1|COMPLETED|Overall Study||8
4915287|NCT03568500|12095086|P3|Received At Least 1 Dose of Study Drug|Overall Study||6
4915288|NCT03568500|12095087|P2|Received At Least 1 Dose of Study Drug|Overall Study||19
4915289|NCT03568500|12095088|P1|Received At Least 1 Dose of Study Drug|Overall Study||18
4915290|NCT03568500|12095086|P3|STARTED|Overall Study||6
4915291|NCT03568500|12095087|P2|STARTED|Overall Study||20
4915292|NCT03568500|12095088|P1|STARTED|Overall Study||18
4915293|NCT03567005|12095102|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
4915294|NCT03567005|12095103|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
4915295|NCT03567005|12095102|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
4915296|NCT03567005|12095103|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
4915297|NCT03567005|12095102|P2|STARTED|Period 2, Second 7 Days of Wear||31
4915298|NCT03567005|12095103|P1|STARTED|Period 2, Second 7 Days of Wear||29
4915299|NCT03567005|12095102|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
4915300|NCT03567005|12095103|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
4915301|NCT03567005|12095102|P2|COMPLETED|Period 1, First 7 Days of Wear||31
4915302|NCT03567005|12095103|P1|COMPLETED|Period 1, First 7 Days of Wear||29
4915303|NCT03567005|12095102|P2|STARTED|Period 1, First 7 Days of Wear||31
4915304|NCT03567005|12095103|P1|STARTED|Period 1, First 7 Days of Wear||29
4915305|NCT03566979|12095115|P4|NOT COMPLETED|Overall Study||6
4915306|NCT03566979|12095116|P3|NOT COMPLETED|Overall Study||10
4915307|NCT03566979|12095117|P2|NOT COMPLETED|Overall Study||7
4915308|NCT03566979|12095118|P1|NOT COMPLETED|Overall Study||5
4915309|NCT03566979|12095115|P4|COMPLETED|Overall Study||143
4915310|NCT03566979|12095116|P3|COMPLETED|Overall Study||132
4915311|NCT03566979|12095117|P2|COMPLETED|Overall Study||145
4915312|NCT03566979|12095118|P1|COMPLETED|Overall Study||53
4915313|NCT03566979|12095115|P4|STARTED|Overall Study||149
4915314|NCT03566979|12095116|P3|STARTED|Overall Study||142
4915315|NCT03566979|12095117|P2|STARTED|Overall Study||152
4915316|NCT03566979|12095118|P1|STARTED|Overall Study||58
4915317|NCT03566810|12095134|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4915318|NCT03566810|12095135|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4915319|NCT03566810|12095136|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4915320|NCT03566810|12095137|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4915321|NCT03566810|12095134|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
4915322|NCT03566810|12095135|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
4915323|NCT03566810|12095136|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
4915324|NCT03566810|12095137|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
4915325|NCT03566810|12095134|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
4915326|NCT03566810|12095135|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
4915327|NCT03566810|12095136|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
4915328|NCT03566810|12095137|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
4915329|NCT03566810|12095134|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4915330|NCT03566810|12095135|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4915331|NCT03566810|12095136|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
4915332|NCT03566810|12095137|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4915333|NCT03566810|12095134|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
4915334|NCT03566810|12095135|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
4915335|NCT03566810|12095136|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
4915336|NCT03566810|12095137|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
4915337|NCT03566810|12095134|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
4915338|NCT03566810|12095135|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
4915339|NCT03566810|12095136|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
4915340|NCT03566810|12095137|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
4915341|NCT03566810|12095134|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
4915342|NCT03566810|12095135|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
4915343|NCT03566810|12095136|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
4915344|NCT03566810|12095137|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
4915345|NCT03566680|12095199|P1|NOT COMPLETED|Overall Study||17
4915346|NCT03566680|12095199|P1|COMPLETED|Overall Study||29
4915348|NCT03565874|12095208|P1|NOT COMPLETED|Overall Study||2
4915349|NCT03565874|12095208|P1|COMPLETED|Overall Study||4
4915350|NCT03565874|12095208|P1|STARTED|Overall Study||6
4915351|NCT03565679|12095221|P1|NOT COMPLETED|Overall Study||0
4915352|NCT03565679|12095221|P1|COMPLETED|Overall Study||10
4915353|NCT03565679|12095221|P1|STARTED|Overall Study||10
4915354|NCT03565666|12095228|P3|NOT COMPLETED|Overall Study||1
4915355|NCT03565666|12095229|P2|NOT COMPLETED|Overall Study||0
4915356|NCT03565666|12095230|P1|NOT COMPLETED|Overall Study||0
4915357|NCT03565666|12095228|P3|COMPLETED|Overall Study||11
4915358|NCT03565666|12095229|P2|COMPLETED|Overall Study||12
4915359|NCT03565666|12095230|P1|COMPLETED|Overall Study||12
4915360|NCT03565666|12095228|P3|STARTED|Overall Study||12
4915361|NCT03565666|12095229|P2|STARTED|Overall Study||12
4915362|NCT03565666|12095230|P1|STARTED|Overall Study||12
4915363|NCT03564444|12095269|P2|NOT COMPLETED|Overall Study||0
4915364|NCT03564444|12095270|P1|NOT COMPLETED|Overall Study||0
4915365|NCT03564444|12095269|P2|COMPLETED|Overall Study||240
4915366|NCT03564444|12095270|P1|COMPLETED|Overall Study||60
4915367|NCT03564444|12095269|P2|STARTED|Overall Study||240
4915368|NCT03564444|12095270|P1|STARTED|Overall Study||60
4915369|NCT03563716|12095288|P2|NOT COMPLETED|Overall Study||67
4915370|NCT03563716|12095289|P1|NOT COMPLETED|Overall Study||68
4915371|NCT03563716|12095288|P2|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
4915372|NCT03563716|12095289|P1|COMPLETED|Overall Study||0
4915373|NCT03563716|12095288|P2|STARTED|Overall Study||67
4915374|NCT03563716|12095289|P1|STARTED|Overall Study||68
4915375|NCT03563313|12095299|P2|NOT COMPLETED|Overall Study||0
4915376|NCT03563313|12095300|P1|NOT COMPLETED|Overall Study||0
4915377|NCT03563313|12095299|P2|COMPLETED|Overall Study||56
4915378|NCT03563313|12095300|P1|COMPLETED|Overall Study||112
4915379|NCT03563313|12095299|P2|STARTED|Overall Study||56
4915380|NCT03563313|12095300|P1|STARTED|Overall Study||112
4915381|NCT03563209|12095408|P1|NOT COMPLETED|Overall Study||0
4915382|NCT03563209|12095408|P1|COMPLETED|Overall Study||60
4915383|NCT03563209|12095408|P1|STARTED|Overall Study||60
4915384|NCT03563183|12095414|P1|NOT COMPLETED|Overall Study||0
4915385|NCT03563183|12095414|P1|COMPLETED|Overall Study||26976
4915386|NCT03563183|12095414|P1|STARTED|Overall Study||26976
4915387|NCT03562559|12095515|P1|NOT COMPLETED|Overall Study||0
4915388|NCT03562559|12095515|P1|COMPLETED|Overall Study||40
4915389|NCT03562559|12095515|P1|STARTED|Overall Study||40
4915390|NCT03562481|12095521|P2|NOT COMPLETED|Second Intervention||0
4915391|NCT03562481|12095522|P1|NOT COMPLETED|Second Intervention||0
4915392|NCT03562481|12095521|P2|COMPLETED|Second Intervention||14
4915393|NCT03562481|12095522|P1|COMPLETED|Second Intervention||11
4915394|NCT03562481|12095521|P2|STARTED|Second Intervention||14
4915395|NCT03562481|12095522|P1|STARTED|Second Intervention||11
4915396|NCT03562481|12095521|P2|NOT COMPLETED|Washout||0
4915397|NCT03562481|12095522|P1|NOT COMPLETED|Washout||0
4915398|NCT03562481|12095521|P2|COMPLETED|Washout||14
4915399|NCT03562481|12095522|P1|COMPLETED|Washout||11
4915400|NCT03562481|12095521|P2|STARTED|Washout||14
4915401|NCT03562481|12095522|P1|STARTED|Washout||11
4915402|NCT03562481|12095521|P2|NOT COMPLETED|First Intervention||0
4915403|NCT03562481|12095522|P1|NOT COMPLETED|First Intervention||1
4915404|NCT03562481|12095521|P2|COMPLETED|First Intervention||14
4915405|NCT03562481|12095522|P1|COMPLETED|First Intervention||11
4915406|NCT03562481|12095521|P2|STARTED|First Intervention||14
4915407|NCT03562481|12095522|P1|STARTED|First Intervention||12
4915408|NCT03562117|12095547|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
4915409|NCT03562117|12095548|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
4915410|NCT03562117|12095549|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
4915411|NCT03562117|12095547|P3|COMPLETED|Part 2, Up to 3 Days||8
4915412|NCT03562117|12095548|P2|COMPLETED|Part 2, Up to 3 Days||0
4915413|NCT03562117|12095549|P1|COMPLETED|Part 2, Up to 3 Days||8
4915414|NCT03562117|12095547|P3|STARTED|Part 2, Up to 3 Days||8
4915415|NCT03562117|12095548|P2|STARTED|Part 2, Up to 3 Days||0
4915416|NCT03562117|12095549|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
4915417|NCT03562117|12095547|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
4915418|NCT03562117|12095548|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
4915419|NCT03562117|12095549|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
4915420|NCT03562117|12095547|P3|COMPLETED|Part 1, Up to 3 Days||0
4915421|NCT03562117|12095548|P2|COMPLETED|Part 1, Up to 3 Days||8
4915422|NCT03562117|12095549|P1|COMPLETED|Part 1, Up to 3 Days||7
4915423|NCT03562117|12095547|P3|STARTED|Part 1, Up to 3 Days||0
4915424|NCT03562117|12095548|P2|STARTED|Part 1, Up to 3 Days||8
4915425|NCT03562117|12095549|P1|STARTED|Part 1, Up to 3 Days||8
4915426|NCT03560128|12095637|P2|NOT COMPLETED|Overall Study||8
4915427|NCT03560128|12095638|P1|NOT COMPLETED|Overall Study||12
4915428|NCT03560128|12095637|P2|COMPLETED|Overall Study||298
4915429|NCT03560128|12095638|P1|COMPLETED|Overall Study||294
4915430|NCT03560128|12095637|P2|STARTED|Overall Study||306
4915431|NCT03560128|12095638|P1|STARTED|Overall Study||306
4915432|NCT03559829|12095658|P1|NOT COMPLETED|Overall Study||0
4915433|NCT03559829|12095658|P1|COMPLETED|Overall Study||20
4915434|NCT03559829|12095658|P1|STARTED|Overall Study||20
4915435|NCT03559257|12095673|P2|NOT COMPLETED|Open-label Treatment Period||7
4915436|NCT03559257|12095674|P1|NOT COMPLETED|Open-label Treatment Period||10
4915437|NCT03559257|12095673|P2|COMPLETED|Open-label Treatment Period||217
4915438|NCT03559257|12095674|P1|COMPLETED|Open-label Treatment Period||215
4915533|NCT03556579|12095886|P3|STARTED|Visit 1||14
4915439|NCT03559257|12095673|P2|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
4915440|NCT03559257|12095674|P1|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
4915441|NCT03559257|12095673|P2|NOT COMPLETED|Double Blind Treatment Period||8
4915442|NCT03559257|12095674|P1|NOT COMPLETED|Double Blind Treatment Period||4
4915443|NCT03559257|12095673|P2|COMPLETED|Double Blind Treatment Period||225
4915444|NCT03559257|12095674|P1|COMPLETED|Double Blind Treatment Period||226
4915445|NCT03559257|12095673|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
4915446|NCT03559257|12095674|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
4915447|NCT03559257|12095673|P2|STARTED|Double Blind Treatment Period||233
4915448|NCT03559257|12095674|P1|STARTED|Double Blind Treatment Period||230
4915449|NCT03559179|12095721|P3|NOT COMPLETED|Overall Study||0
4915450|NCT03559179|12095722|P2|NOT COMPLETED|Overall Study||1
4915451|NCT03559179|12095723|P1|NOT COMPLETED|Overall Study||0
4915452|NCT03559179|12095721|P3|COMPLETED|Overall Study||23
4915453|NCT03559179|12095722|P2|COMPLETED|Overall Study||23
4915454|NCT03559179|12095723|P1|COMPLETED|Overall Study||8
4915455|NCT03559179|12095721|P3|STARTED|Overall Study||23
4915456|NCT03559179|12095722|P2|STARTED|Overall Study||24
4915457|NCT03559179|12095723|P1|STARTED|Overall Study||8
4915458|NCT03559062|12095744|P3|NOT COMPLETED|Overall Study||0
4915459|NCT03559062|12095745|P2|NOT COMPLETED|Overall Study||1
4915460|NCT03559062|12095746|P1|NOT COMPLETED|Overall Study||0
4915461|NCT03559062|12095744|P3|COMPLETED|Overall Study||3
4915462|NCT03559062|12095745|P2|COMPLETED|Overall Study||53
4915463|NCT03559062|12095746|P1|COMPLETED|Overall Study||10
4915464|NCT03559062|12095744|P3|STARTED|Overall Study||3
4915465|NCT03559062|12095745|P2|STARTED|Overall Study||54
4915466|NCT03559062|12095746|P1|STARTED|Overall Study||10
4915467|NCT03558997|12095761|P4|NOT COMPLETED|Overall Study||2
4915468|NCT03558997|12095762|P3|NOT COMPLETED|Overall Study||8
4915469|NCT03558997|12095763|P2|NOT COMPLETED|Overall Study||2
4915470|NCT03558997|12095764|P1|NOT COMPLETED|Overall Study||1
4915471|NCT03558997|12095761|P4|COMPLETED|Overall Study||24
4915472|NCT03558997|12095762|P3|COMPLETED|Overall Study||18
4915473|NCT03558997|12095763|P2|COMPLETED|Overall Study||24
4915474|NCT03558997|12095764|P1|COMPLETED|Overall Study||24
4915475|NCT03558997|12095761|P4|STARTED|Overall Study||26
4915476|NCT03558997|12095762|P3|STARTED|Overall Study||26
4915477|NCT03558997|12095763|P2|STARTED|Overall Study||26
4915478|NCT03558997|12095764|P1|STARTED|Overall Study||25
4915479|NCT03558555|12095798|P2|NOT COMPLETED|Overall Study||1
4915480|NCT03558555|12095799|P1|NOT COMPLETED|Overall Study||2
4915481|NCT03558555|12095798|P2|COMPLETED|Overall Study||44
4915482|NCT03558555|12095799|P1|COMPLETED|Overall Study||56
4915483|NCT03558555|12095798|P2|STARTED|Overall Study||45
4915484|NCT03558555|12095799|P1|STARTED|Overall Study||58
4915485|NCT03558516|12095817|P2|NOT COMPLETED|Overall Study||2
4915486|NCT03558516|12095818|P1|NOT COMPLETED|Overall Study||2
4915487|NCT03558516|12095817|P2|COMPLETED|Overall Study||38
4915488|NCT03558516|12095818|P1|COMPLETED|Overall Study||38
4915489|NCT03558516|12095817|P2|STARTED|Overall Study||40
4915490|NCT03558516|12095818|P1|STARTED|Overall Study||40
4915491|NCT03558230|12095838|P2|NOT COMPLETED|Overall Study||0
4915492|NCT03558230|12095839|P1|NOT COMPLETED|Overall Study||0
4915493|NCT03558230|12095838|P2|COMPLETED|Overall Study||6
4915494|NCT03558230|12095839|P1|COMPLETED|Overall Study||7
4915495|NCT03558230|12095838|P2|STARTED|Overall Study||6
4915496|NCT03558230|12095839|P1|STARTED|Overall Study||7
4915497|NCT03557801|12095848|P3|NOT COMPLETED|Overall Study||3
4915498|NCT03557801|12095849|P2|NOT COMPLETED|Overall Study||1
4915499|NCT03557801|12095850|P1|NOT COMPLETED|Overall Study||2
4915500|NCT03557801|12095848|P3|COMPLETED|Overall Study||30
4915501|NCT03557801|12095849|P2|COMPLETED|Overall Study||32
4915502|NCT03557801|12095850|P1|COMPLETED|Overall Study||32
4915503|NCT03557801|12095848|P3|STARTED|Overall Study||33
4915504|NCT03557801|12095849|P2|STARTED|Overall Study||33
4915505|NCT03557801|12095850|P1|STARTED|Overall Study||34
4915506|NCT03557476|12095866|P2|NOT COMPLETED|Overall Study||0
4915507|NCT03557476|12095867|P1|NOT COMPLETED|Overall Study||0
4915508|NCT03557476|12095866|P2|COMPLETED|Overall Study||13
4915509|NCT03557476|12095867|P1|COMPLETED|Overall Study||13
4915510|NCT03557476|12095866|P2|STARTED|Overall Study||13
4915511|NCT03557476|12095867|P1|STARTED|Overall Study||13
4915512|NCT03556579|12095885|P4|NOT COMPLETED|Visit 2||0
4915513|NCT03556579|12095886|P3|NOT COMPLETED|Visit 2||0
4915514|NCT03556579|12095887|P2|NOT COMPLETED|Visit 2||0
4915515|NCT03556579|12095888|P1|NOT COMPLETED|Visit 2||0
4915516|NCT03556579|12095885|P4|COMPLETED|Visit 2||16
4915517|NCT03556579|12095886|P3|COMPLETED|Visit 2||14
4915518|NCT03556579|12095887|P2|COMPLETED|Visit 2||14
4915519|NCT03556579|12095888|P1|COMPLETED|Visit 2||16
4915520|NCT03556579|12095885|P4|STARTED|Visit 2||16
4915521|NCT03556579|12095886|P3|STARTED|Visit 2||14
4915522|NCT03556579|12095887|P2|STARTED|Visit 2||14
4915523|NCT03556579|12095888|P1|STARTED|Visit 2||16
4915524|NCT03556579|12095885|P4|NOT COMPLETED|Visit 1||0
4915525|NCT03556579|12095886|P3|NOT COMPLETED|Visit 1||0
4915526|NCT03556579|12095887|P2|NOT COMPLETED|Visit 1||0
4915527|NCT03556579|12095888|P1|NOT COMPLETED|Visit 1||0
4915528|NCT03556579|12095885|P4|COMPLETED|Visit 1||16
4915529|NCT03556579|12095886|P3|COMPLETED|Visit 1||14
4915530|NCT03556579|12095887|P2|COMPLETED|Visit 1||14
4915531|NCT03556579|12095888|P1|COMPLETED|Visit 1||16
4915532|NCT03556579|12095885|P4|STARTED|Visit 1||16
4915534|NCT03556579|12095887|P2|STARTED|Visit 1||14
4915535|NCT03556579|12095888|P1|STARTED|Visit 1||16
4915536|NCT03555890|12095916|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915537|NCT03555890|12095917|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915538|NCT03555890|12095918|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915539|NCT03555890|12095919|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915540|NCT03555890|12095916|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
4915541|NCT03555890|12095917|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
4915542|NCT03555890|12095918|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915543|NCT03555890|12095919|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
4915544|NCT03555890|12095916|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
4915545|NCT03555890|12095917|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
4915546|NCT03555890|12095918|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
4915547|NCT03555890|12095919|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
4915548|NCT03555890|12095916|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
4915549|NCT03555890|12095917|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
4915550|NCT03555890|12095918|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
4915551|NCT03555890|12095919|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
4915552|NCT03555890|12095916|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
4915553|NCT03555890|12095917|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
4915554|NCT03555890|12095918|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
4915555|NCT03555890|12095919|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
4915556|NCT03555890|12095916|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
4915557|NCT03555890|12095917|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
4915558|NCT03555890|12095918|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
4915559|NCT03555890|12095919|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
4915560|NCT03555890|12095916|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915561|NCT03555890|12095917|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915562|NCT03555890|12095918|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915563|NCT03555890|12095919|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915564|NCT03555890|12095916|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
4915565|NCT03555890|12095917|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
4915566|NCT03555890|12095918|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915567|NCT03555890|12095919|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
4915568|NCT03555890|12095916|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
4915569|NCT03555890|12095917|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
4915570|NCT03555890|12095918|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
4915571|NCT03555890|12095919|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
4915572|NCT03555890|12095916|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915573|NCT03555890|12095917|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915574|NCT03555890|12095918|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915575|NCT03555890|12095919|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915576|NCT03555890|12095916|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915577|NCT03555890|12095917|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
4915578|NCT03555890|12095918|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
4915579|NCT03555890|12095919|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
4915580|NCT03555890|12095916|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
4915581|NCT03555890|12095917|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
4915582|NCT03555890|12095918|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
4915583|NCT03555890|12095919|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
4915584|NCT03555890|12095916|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915585|NCT03555890|12095917|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915586|NCT03555890|12095918|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915587|NCT03555890|12095919|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915588|NCT03555890|12095916|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915589|NCT03555890|12095917|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
4915590|NCT03555890|12095918|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
4915591|NCT03555890|12095919|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
4915592|NCT03555890|12095916|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
4915593|NCT03555890|12095917|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
4915594|NCT03555890|12095918|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
4915595|NCT03555890|12095919|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
4915596|NCT03555890|12095916|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915597|NCT03555890|12095917|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915598|NCT03555890|12095918|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915599|NCT03555890|12095919|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915600|NCT03555890|12095916|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915601|NCT03555890|12095917|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
4915602|NCT03555890|12095918|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
4915603|NCT03555890|12095919|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
4915604|NCT03555890|12095916|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
4915605|NCT03555890|12095917|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
4915606|NCT03555890|12095918|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
4915607|NCT03555890|12095919|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
4915608|NCT03554954|12096053|P1|NOT COMPLETED|Overall Study||0
4915609|NCT03554954|12096053|P1|COMPLETED|Overall Study||108
4915610|NCT03554954|12096053|P1|STARTED|Overall Study||108
4915611|NCT03554746|12096106|P2|NOT COMPLETED|Overall Study||0
4915612|NCT03554746|12096107|P1|NOT COMPLETED|Overall Study||0
4915613|NCT03554746|12096106|P2|COMPLETED|Overall Study||24
4915614|NCT03554746|12096107|P1|COMPLETED|Overall Study||24
4915615|NCT03554746|12096106|P2|STARTED|Overall Study||24
4915616|NCT03554746|12096107|P1|STARTED|Overall Study||24
4915617|NCT03554005|12096129|P6|NOT COMPLETED|Overall Study||11
4915618|NCT03554005|12096130|P5|NOT COMPLETED|Overall Study||6
4915619|NCT03554005|12096131|P4|NOT COMPLETED|Overall Study||1
4915620|NCT03554005|12096132|P3|NOT COMPLETED|Overall Study||1
4915621|NCT03554005|12096133|P2|NOT COMPLETED|Overall Study||1
4915622|NCT03554005|12096134|P1|NOT COMPLETED|Overall Study||1
4915623|NCT03554005|12096129|P6|COMPLETED|Overall Study||0
4915624|NCT03554005|12096130|P5|COMPLETED|Overall Study||5
4915625|NCT03554005|12096131|P4|COMPLETED|Overall Study||1
4915626|NCT03554005|12096132|P3|COMPLETED|Overall Study||1
4915627|NCT03554005|12096133|P2|COMPLETED|Overall Study||1
4915628|NCT03554005|12096134|P1|COMPLETED|Overall Study||0
4915629|NCT03554005|12096129|P6|STARTED|Overall Study||11
4915630|NCT03554005|12096130|P5|STARTED|Overall Study||11
4915631|NCT03554005|12096131|P4|STARTED|Overall Study||2
4915632|NCT03554005|12096132|P3|STARTED|Overall Study||2
4915633|NCT03554005|12096133|P2|STARTED|Overall Study||2
4915634|NCT03554005|12096134|P1|STARTED|Overall Study||1
4915635|NCT03552549|12096162|P2|NOT COMPLETED|Overall Study||52
4915636|NCT03552549|12096163|P1|NOT COMPLETED|Overall Study||53
4915637|NCT03552549|12096162|P2|COMPLETED|Overall Study||11
4915638|NCT03552549|12096163|P1|COMPLETED|Overall Study||10
4915639|NCT03552549|12096162|P2|Treated|Overall Study||62
4915640|NCT03552549|12096163|P1|Treated|Overall Study||62
4915641|NCT03552549|12096162|P2|STARTED|Overall Study||63
4915642|NCT03552549|12096163|P1|STARTED|Overall Study||63
4915643|NCT03552536|12096174|P3|NOT COMPLETED|Overall Study||0
4915644|NCT03552536|12096175|P2|NOT COMPLETED|Overall Study||0
4915645|NCT03552536|12096176|P1|NOT COMPLETED|Overall Study||0
4915646|NCT03552536|12096174|P3|COMPLETED|Overall Study||0
4915647|NCT03552536|12096175|P2|COMPLETED|Overall Study||0
4915648|NCT03552536|12096176|P1|COMPLETED|Overall Study||5
4915649|NCT03552536|12096174|P3|STARTED|Overall Study||0
4915650|NCT03552536|12096175|P2|STARTED|Overall Study||0
4915651|NCT03552536|12096176|P1|STARTED|Overall Study||5
4915652|NCT03552523|12096201|P2|NOT COMPLETED|Overall Study||1
4915653|NCT03552523|12096202|P1|NOT COMPLETED|Overall Study||1
4915654|NCT03552523|12096201|P2|COMPLETED|Overall Study||1
4915655|NCT03552523|12096202|P1|COMPLETED|Overall Study||4
4915656|NCT03552523|12096201|P2|STARTED|Overall Study||2
4915657|NCT03552523|12096202|P1|STARTED|Overall Study||5
4915658|NCT03551821|12096210|P1|NOT COMPLETED|Overall Study||0
4915659|NCT03551821|12096210|P1|COMPLETED|Overall Study||1
4915660|NCT03551821|12096210|P1|STARTED|Overall Study||1
4915661|NCT03551743|12096219|P4|NOT COMPLETED|Overall Study||0
4915662|NCT03551743|12096220|P3|NOT COMPLETED|Overall Study||0
4915663|NCT03551743|12096221|P2|NOT COMPLETED|Overall Study||0
4915664|NCT03551743|12096222|P1|NOT COMPLETED|Overall Study||2
4915665|NCT03551743|12096219|P4|COMPLETED|Overall Study||6
4915666|NCT03551743|12096220|P3|COMPLETED|Overall Study||6
4915667|NCT03551743|12096221|P2|COMPLETED|Overall Study||6
4915668|NCT03551743|12096222|P1|COMPLETED|Overall Study||8
4915669|NCT03551743|12096219|P4|STARTED|Overall Study||6
4915670|NCT03551743|12096220|P3|STARTED|Overall Study||6
4915671|NCT03551743|12096221|P2|STARTED|Overall Study||6
4915672|NCT03551743|12096222|P1|STARTED|Overall Study||10
4915673|NCT03551730|12096268|P4|NOT COMPLETED|Overall Study||0
4915674|NCT03551730|12096269|P3|NOT COMPLETED|Overall Study||0
4915675|NCT03551730|12096270|P2|NOT COMPLETED|Overall Study||0
4915676|NCT03551730|12096271|P1|NOT COMPLETED|Overall Study||1
4915677|NCT03551730|12096268|P4|COMPLETED|Overall Study||6
4915678|NCT03551730|12096269|P3|COMPLETED|Overall Study||6
4915679|NCT03551730|12096270|P2|COMPLETED|Overall Study||6
4915680|NCT03551730|12096271|P1|COMPLETED|Overall Study||8
4915681|NCT03551730|12096268|P4|STARTED|Overall Study||6
4915682|NCT03551730|12096269|P3|STARTED|Overall Study||6
4915683|NCT03551730|12096270|P2|STARTED|Overall Study||6
4915684|NCT03551730|12096271|P1|STARTED|Overall Study||9
4915685|NCT03550989|12096313|P4|NOT COMPLETED|Overall Study||0
4915686|NCT03550989|12096314|P3|NOT COMPLETED|Overall Study||1
4915687|NCT03550989|12096315|P2|NOT COMPLETED|Overall Study||1
4915688|NCT03550989|12096316|P1|NOT COMPLETED|Overall Study||2
4915689|NCT03550989|12096313|P4|COMPLETED|Overall Study||60
4915690|NCT03550989|12096314|P3|COMPLETED|Overall Study||76
4915691|NCT03550989|12096315|P2|COMPLETED|Overall Study||73
4915692|NCT03550989|12096316|P1|COMPLETED|Overall Study||188
4915693|NCT03550989|12096313|P4|STARTED|Overall Study||60
4915694|NCT03550989|12096314|P3|STARTED|Overall Study||77
4915695|NCT03550989|12096315|P2|STARTED|Overall Study||74
4915696|NCT03550989|12096316|P1|STARTED|Overall Study||190
4915697|NCT03550378|12096393|P2|NOT COMPLETED|Overall Study||1
4915698|NCT03550378|12096394|P1|NOT COMPLETED|Overall Study||0
4915699|NCT03550378|12096393|P2|COMPLETED|Overall Study||20
4915700|NCT03550378|12096394|P1|COMPLETED|Overall Study||20
4915701|NCT03550378|12096393|P2|STARTED|Overall Study||21
4915702|NCT03550378|12096394|P1|STARTED|Overall Study||20
4915703|NCT03550066|12096434|P2|NOT COMPLETED|Overall Study||0
4915704|NCT03550066|12096435|P1|NOT COMPLETED|Overall Study||0
4915705|NCT03550066|12096434|P2|COMPLETED|Overall Study||41
4915706|NCT03550066|12096435|P1|COMPLETED|Overall Study||49
4915707|NCT03550066|12096434|P2|STARTED|Overall Study||41
4915708|NCT03550066|12096435|P1|STARTED|Overall Study||49
4915709|NCT03549429|12096447|P2|NOT COMPLETED|Overall Study||3
4915710|NCT03549429|12096448|P1|NOT COMPLETED|Overall Study||5
4915711|NCT03549429|12096447|P2|COMPLETED|Overall Study||75
4915712|NCT03549429|12096448|P1|COMPLETED|Overall Study||76
4915713|NCT03549429|12096447|P2|STARTED|Overall Study||78
4915714|NCT03549429|12096448|P1|STARTED|Overall Study||81
4915715|NCT03549338|12096461|P3|NOT COMPLETED|Overall Study||0
4915716|NCT03549338|12096462|P2|NOT COMPLETED|Overall Study||1
4915717|NCT03549338|12096463|P1|NOT COMPLETED|Overall Study||1
4915718|NCT03549338|12096461|P3|COMPLETED|Overall Study||0
4915719|NCT03549338|12096462|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
4915720|NCT03549338|12096463|P1|COMPLETED|Overall Study||0
4915721|NCT03549338|12096461|P3|STARTED|Overall Study||0
4915722|NCT03549338|12096462|P2|STARTED|Overall Study||1
4915723|NCT03549338|12096463|P1|STARTED|Overall Study||1
4915724|NCT03549234|12096471|P2|NOT COMPLETED|Overall Study||0
4915725|NCT03549234|12096472|P1|NOT COMPLETED|Overall Study||0
4915726|NCT03549234|12096471|P2|COMPLETED|Overall Study||50
4915727|NCT03549234|12096472|P1|COMPLETED|Overall Study||50
4915728|NCT03549234|12096471|P2|STARTED|Overall Study||50
4915729|NCT03549234|12096472|P1|STARTED|Overall Study||50
4915730|NCT03549130|12096490|P2|NOT COMPLETED|Overall Study||2
4915731|NCT03549130|12096491|P1|NOT COMPLETED|Overall Study||0
4915732|NCT03549130|12096490|P2|COMPLETED|Overall Study||64
4915733|NCT03549130|12096491|P1|COMPLETED|Overall Study||64
4915734|NCT03549130|12096490|P2|STARTED|Overall Study||66
4915735|NCT03549130|12096491|P1|STARTED|Overall Study||64
4915736|NCT03549117|12096509|P2|NOT COMPLETED|Overall Study||0
4915737|NCT03549117|12096510|P1|NOT COMPLETED|Overall Study||1
4915738|NCT03549117|12096509|P2|COMPLETED|Overall Study||70
4915739|NCT03549117|12096510|P1|COMPLETED|Overall Study||69
4915740|NCT03549117|12096509|P2|STARTED|Overall Study||70
4915741|NCT03549117|12096510|P1|STARTED|Overall Study||70
4915742|NCT03547635|12096539|P3|NOT COMPLETED|Overall Study||8
4915743|NCT03547635|12096540|P2|NOT COMPLETED|Overall Study||7
4915744|NCT03547635|12096541|P1|NOT COMPLETED|Overall Study||8
4915745|NCT03547635|12096539|P3|COMPLETED|Overall Study||29
4915746|NCT03547635|12096540|P2|COMPLETED|Overall Study||31
4915747|NCT03547635|12096541|P1|COMPLETED|Overall Study||33
4915748|NCT03547635|12096539|P3|STARTED|Overall Study||37
4915749|NCT03547635|12096540|P2|STARTED|Overall Study||38
4915750|NCT03547635|12096541|P1|STARTED|Overall Study||41
4915751|NCT03547531|12096551|P2|NOT COMPLETED|Overall Study||4
4915752|NCT03547531|12096552|P1|NOT COMPLETED|Overall Study||2
4915753|NCT03547531|12096551|P2|COMPLETED|Overall Study||58
4915754|NCT03547531|12096552|P1|COMPLETED|Overall Study||60
4915755|NCT03547531|12096551|P2|STARTED|Overall Study||62
4915756|NCT03547531|12096552|P1|STARTED|Overall Study||62
4915757|NCT03547154|12096566|P2|NOT COMPLETED|Overall Study||116
4915758|NCT03547154|12096567|P1|NOT COMPLETED|Overall Study||123
4915759|NCT03547154|12096566|P2|COMPLETED|Overall Study||55
4915760|NCT03547154|12096567|P1|COMPLETED|Overall Study||50
4915761|NCT03547154|12096566|P2|STARTED|Overall Study||171
4915762|NCT03547154|12096567|P1|STARTED|Overall Study||173
4915763|NCT03546842|12096579|P1|NOT COMPLETED|Overall Study||3
4915764|NCT03546842|12096579|P1|COMPLETED|Overall Study||198
4915765|NCT03546842|12096579|P1|Vaccination 3|Overall Study||198
4915766|NCT03546842|12096579|P1|Vaccination 2|Overall Study||200
4915767|NCT03546842|12096579|P1|Vaccination 1|Overall Study||200
4915768|NCT03546842|12096579|P1|STARTED|Overall Study||201
4915769|NCT03546621|12096592|P4|NOT COMPLETED|Overall Study||3
4915770|NCT03546621|12096593|P3|NOT COMPLETED|Overall Study||2
4915771|NCT03546621|12096594|P2|NOT COMPLETED|Overall Study||3
4915772|NCT03546621|12096595|P1|NOT COMPLETED|Overall Study||0
4915773|NCT03546621|12096592|P4|COMPLETED|Overall Study||25
4915774|NCT03546621|12096593|P3|COMPLETED|Overall Study||28
4915775|NCT03546621|12096594|P2|COMPLETED|Overall Study||29
4915776|NCT03546621|12096595|P1|COMPLETED|Overall Study||28
4915777|NCT03546621|12096592|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
4915778|NCT03546621|12096593|P3|STARTED|Overall Study||30
4915779|NCT03546621|12096594|P2|STARTED|Overall Study||32
4915780|NCT03546621|12096595|P1|STARTED|Overall Study||28
4915781|NCT03546491|12096633|P1|NOT COMPLETED|Overall Study||2
4915782|NCT03546491|12096633|P1|COMPLETED|Overall Study||30
4915783|NCT03546491|12096633|P1|Received Test Product 2|Overall Study||32
4915784|NCT03546491|12096633|P1|Recieved Test Product 1|Overall Study||32
4915785|NCT03546491|12096633|P1|STARTED|Overall Study||32
4915786|NCT03546270|12096647|P2|NOT COMPLETED|Overall Study||0
4915787|NCT03546270|12096648|P1|NOT COMPLETED|Overall Study||0
4915788|NCT03546270|12096647|P2|COMPLETED|Overall Study||48
4915789|NCT03546270|12096648|P1|COMPLETED|Overall Study||52
4915790|NCT03546270|12096647|P2|STARTED|Overall Study||48
4915791|NCT03546270|12096648|P1|STARTED|Overall Study||52
4915792|NCT03546192|12096666|P2|NOT COMPLETED|Overall Study||0
4915793|NCT03546192|12096667|P1|NOT COMPLETED|Overall Study||0
4915794|NCT03546192|12096666|P2|COMPLETED|Overall Study||60
4915795|NCT03546192|12096667|P1|COMPLETED|Overall Study||60
4915796|NCT03546192|12096666|P2|STARTED|Overall Study||60
4915797|NCT03546192|12096667|P1|STARTED|Overall Study||60
4915798|NCT03545984|12096685|P2|NOT COMPLETED|Overall Study||9
4915799|NCT03545984|12096686|P1|NOT COMPLETED|Overall Study||11
4915800|NCT03545984|12096685|P2|COMPLETED|Overall Study||15
4915801|NCT03545984|12096686|P1|COMPLETED|Overall Study||13
4915802|NCT03545984|12096685|P2|STARTED|Overall Study||24
4915803|NCT03545984|12096686|P1|STARTED|Overall Study||24
4915804|NCT03545893|12096694|P2|NOT COMPLETED|Overall Study||0
4915805|NCT03545893|12096695|P1|NOT COMPLETED|Overall Study||0
4915806|NCT03545893|12096694|P2|COMPLETED|Overall Study||35
4915807|NCT03545893|12096695|P1|COMPLETED|Overall Study||35
4915808|NCT03545893|12096694|P2|STARTED|Overall Study||35
4915809|NCT03545893|12096695|P1|STARTED|Overall Study||35
4915810|NCT03545412|12096701|P1|NOT COMPLETED|Overall Study||0
4915811|NCT03545412|12096701|P1|COMPLETED|Overall Study||25
4915812|NCT03545412|12096701|P1|STARTED|Overall Study||25
4915813|NCT03544879|12096713|P2|NOT COMPLETED|Overall Study||1
4915814|NCT03544879|12096714|P1|NOT COMPLETED|Overall Study||0
4915815|NCT03544879|12096713|P2|COMPLETED|Overall Study||23
4915816|NCT03544879|12096714|P1|COMPLETED|Overall Study||22
4915817|NCT03544879|12096713|P2|Completed Follow-up Physical Assessment|Overall Study||21
4915818|NCT03544879|12096714|P1|Completed Follow-up Physical Assessment|Overall Study||20
4915819|NCT03544879|12096713|P2|STARTED|Overall Study||24
4915820|NCT03544879|12096714|P1|STARTED|Overall Study||22
4915821|NCT03544307|12096742|P2|NOT COMPLETED|Overall Study||0
4915822|NCT03544307|12096743|P1|NOT COMPLETED|Overall Study||0
4915823|NCT03544307|12096742|P2|COMPLETED|Overall Study||10
4915824|NCT03544307|12096743|P1|COMPLETED|Overall Study||10
4915825|NCT03544307|12096742|P2|STARTED|Overall Study||10
4915826|NCT03544307|12096743|P1|STARTED|Overall Study||10
4915827|NCT03544216|12096763|P2|NOT COMPLETED|Overall Study||0
4915828|NCT03544216|12096764|P1|NOT COMPLETED|Overall Study||0
4915829|NCT03544216|12096763|P2|COMPLETED|Overall Study||42
4915830|NCT03544216|12096764|P1|COMPLETED|Overall Study||42
4915831|NCT03544216|12096763|P2|STARTED|Overall Study||42
4915832|NCT03544216|12096764|P1|STARTED|Overall Study||42
4915833|NCT03543137|12096771|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
4915834|NCT03543137|12096772|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
4915835|NCT03543137|12096771|P2|COMPLETED|Study Period 2: Up to Day 8||18
4915836|NCT03543137|12096772|P1|COMPLETED|Study Period 2: Up to Day 8||16
4915837|NCT03543137|12096771|P2|Treated|Study Period 2: Up to Day 8||18
4915838|NCT03543137|12096772|P1|Treated|Study Period 2: Up to Day 8||16
4915839|NCT03543137|12096771|P2|STARTED|Study Period 2: Up to Day 8||19
4915840|NCT03543137|12096772|P1|STARTED|Study Period 2: Up to Day 8||18
4915841|NCT03543137|12096771|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
4915842|NCT03543137|12096772|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
4915843|NCT03543137|12096771|P2|COMPLETED|Washout Period: 5 to 7 Days||19
4915844|NCT03543137|12096772|P1|COMPLETED|Washout Period: 5 to 7 Days||18
4915845|NCT03543137|12096771|P2|STARTED|Washout Period: 5 to 7 Days||19
4915846|NCT03543137|12096772|P1|STARTED|Washout Period: 5 to 7 Days||18
4915847|NCT03543137|12096771|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
4915848|NCT03543137|12096772|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
4915849|NCT03543137|12096771|P2|COMPLETED|Study Period 1: Up to Day 1||19
4915850|NCT03543137|12096772|P1|COMPLETED|Study Period 1: Up to Day 1||18
4915851|NCT03543137|12096771|P2|STARTED|Study Period 1: Up to Day 1||19
4915852|NCT03543137|12096772|P1|STARTED|Study Period 1: Up to Day 1||18
4915853|NCT03542474|12096792|P1|NOT COMPLETED|Overall Study||0
4915854|NCT03542474|12096792|P1|COMPLETED|Overall Study||8
4915855|NCT03542474|12096792|P1|STARTED|Overall Study||8
4915856|NCT03541044|12096797|P2|NOT COMPLETED|Study Period 2: Up to Day 8||0
4915857|NCT03541044|12096798|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
4915858|NCT03541044|12096797|P2|COMPLETED|Study Period 2: Up to Day 8||23
4915859|NCT03541044|12096798|P1|COMPLETED|Study Period 2: Up to Day 8||21
4915860|NCT03541044|12096797|P2|STARTED|Study Period 2: Up to Day 8||23
4915861|NCT03541044|12096798|P1|STARTED|Study Period 2: Up to Day 8||23
4915862|NCT03541044|12096797|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
4915863|NCT03541044|12096798|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
4915864|NCT03541044|12096797|P2|COMPLETED|Washout Period: 5 to 7 Days||23
4915865|NCT03541044|12096798|P1|COMPLETED|Washout Period: 5 to 7 Days||23
4915866|NCT03541044|12096797|P2|STARTED|Washout Period: 5 to 7 Days||23
4915867|NCT03541044|12096798|P1|STARTED|Washout Period: 5 to 7 Days||23
4915868|NCT03541044|12096797|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
4915869|NCT03541044|12096798|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
4915870|NCT03541044|12096797|P2|COMPLETED|Study Period 1: Up to Day 1||23
4915871|NCT03541044|12096798|P1|COMPLETED|Study Period 1: Up to Day 1||23
4915872|NCT03541044|12096797|P2|STARTED|Study Period 1: Up to Day 1||23
4915873|NCT03541044|12096798|P1|STARTED|Study Period 1: Up to Day 1||23
4915874|NCT03538743|12096827|P9|NOT COMPLETED|Overall Study||3
4915875|NCT03538743|12096828|P8|NOT COMPLETED|Overall Study||0
4915876|NCT03538743|12096829|P7|NOT COMPLETED|Overall Study||0
4915877|NCT03538743|12096830|P6|NOT COMPLETED|Overall Study||0
4915878|NCT03538743|12096831|P5|NOT COMPLETED|Overall Study||0
4915879|NCT03538743|12096832|P4|NOT COMPLETED|Overall Study||2
4915880|NCT03538743|12096833|P3|NOT COMPLETED|Overall Study||1
4915881|NCT03538743|12096834|P2|NOT COMPLETED|Overall Study||0
4915882|NCT03538743|12096835|P1|NOT COMPLETED|Overall Study||0
4915883|NCT03538743|12096827|P9|COMPLETED|Overall Study||7
4915884|NCT03538743|12096828|P8|COMPLETED|Overall Study||8
4915885|NCT03538743|12096829|P7|COMPLETED|Overall Study||9
4915886|NCT03538743|12096830|P6|COMPLETED|Overall Study||9
4915887|NCT03538743|12096831|P5|COMPLETED|Overall Study||9
4915888|NCT03538743|12096832|P4|COMPLETED|Overall Study||8
4915889|NCT03538743|12096833|P3|COMPLETED|Overall Study||8
4915890|NCT03538743|12096834|P2|COMPLETED|Overall Study||9
4915891|NCT03538743|12096835|P1|COMPLETED|Overall Study||25
4915892|NCT03538743|12096827|P9|Received Treatment|Overall Study||10
4915893|NCT03538743|12096828|P8|Received Treatment|Overall Study||8
4915894|NCT03538743|12096829|P7|Received Treatment|Overall Study||9
4915895|NCT03538743|12096830|P6|Received Treatment|Overall Study||9
4915896|NCT03538743|12096831|P5|Received Treatment|Overall Study||9
4915897|NCT03538743|12096832|P4|Received Treatment|Overall Study||10
4915898|NCT03538743|12096833|P3|Received Treatment|Overall Study||9
4915899|NCT03538743|12096834|P2|Received Treatment|Overall Study||9
4915900|NCT03538743|12096835|P1|Received Treatment|Overall Study||25
4915901|NCT03538743|12096827|P9|STARTED|Overall Study||10
4915902|NCT03538743|12096828|P8|STARTED|Overall Study||8
4915903|NCT03538743|12096829|P7|STARTED|Overall Study||9
4915904|NCT03538743|12096830|P6|STARTED|Overall Study||9
4915905|NCT03538743|12096831|P5|STARTED|Overall Study||9
4915906|NCT03538743|12096832|P4|STARTED|Overall Study||10
4915907|NCT03538743|12096833|P3|STARTED|Overall Study||9
4915908|NCT03538743|12096834|P2|STARTED|Overall Study||9
4915909|NCT03538743|12096835|P1|STARTED|Overall Study||25
4915910|NCT03538717|12096938|P1|NOT COMPLETED|Overall Study||0
4915911|NCT03538717|12096938|P1|COMPLETED|Overall Study||157
4915912|NCT03538717|12096938|P1|STARTED|Overall Study||157
4915913|NCT03537404|12096999|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
4915914|NCT03537404|12097000|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
4915915|NCT03537404|12096999|P2|COMPLETED|Third Intervention (A or B or C)||18
4915916|NCT03537404|12097000|P1|COMPLETED|Third Intervention (A or B or C)||18
4915917|NCT03537404|12096999|P2|STARTED|Third Intervention (A or B or C)||18
4915918|NCT03537404|12097000|P1|STARTED|Third Intervention (A or B or C)||18
4915919|NCT03537404|12096999|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
4915920|NCT03537404|12097000|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
4915921|NCT03537404|12096999|P2|COMPLETED|Second Washout Period (8 Days)||18
4915922|NCT03537404|12097000|P1|COMPLETED|Second Washout Period (8 Days)||18
4915923|NCT03537404|12096999|P2|STARTED|Second Washout Period (8 Days)||18
4915924|NCT03537404|12097000|P1|STARTED|Second Washout Period (8 Days)||18
4915925|NCT03537404|12096999|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
4915926|NCT03537404|12097000|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
4915927|NCT03537404|12096999|P2|COMPLETED|Second Intervention (A or B or C)||18
4915928|NCT03537404|12097000|P1|COMPLETED|Second Intervention (A or B or C)||18
4915929|NCT03537404|12096999|P2|STARTED|Second Intervention (A or B or C)||18
4915930|NCT03537404|12097000|P1|STARTED|Second Intervention (A or B or C)||18
4915931|NCT03537404|12096999|P2|NOT COMPLETED|First Washout Period (8 Days)||0
4915932|NCT03537404|12097000|P1|NOT COMPLETED|First Washout Period (8 Days)||0
4915933|NCT03537404|12096999|P2|COMPLETED|First Washout Period (8 Days)||18
4915934|NCT03537404|12097000|P1|COMPLETED|First Washout Period (8 Days)||18
4915935|NCT03537404|12096999|P2|STARTED|First Washout Period (8 Days)||18
4915936|NCT03537404|12097000|P1|STARTED|First Washout Period (8 Days)||18
4915937|NCT03537404|12096999|P2|NOT COMPLETED|First Intervention (A or B or C)||0
4915938|NCT03537404|12097000|P1|NOT COMPLETED|First Intervention (A or B or C)||0
4915939|NCT03537404|12096999|P2|COMPLETED|First Intervention (A or B or C)||18
4915940|NCT03537404|12097000|P1|COMPLETED|First Intervention (A or B or C)||18
4915941|NCT03537404|12096999|P2|STARTED|First Intervention (A or B or C)||18
4915942|NCT03537404|12097000|P1|STARTED|First Intervention (A or B or C)||18
4915943|NCT03537274|12097046|P4|NOT COMPLETED|Overall Study||76
4915944|NCT03537274|12097047|P3|NOT COMPLETED|Overall Study||76
4915945|NCT03537274|12097048|P2|NOT COMPLETED|Overall Study||69
4915946|NCT03537274|12097049|P1|NOT COMPLETED|Overall Study||60
4915947|NCT03537274|12097046|P4|COMPLETED|Overall Study||231
4915948|NCT03537274|12097047|P3|COMPLETED|Overall Study||228
4915949|NCT03537274|12097048|P2|COMPLETED|Overall Study||229
4915950|NCT03537274|12097049|P1|COMPLETED|Overall Study||255
4915951|NCT03537274|12097046|P4|Treated|Overall Study||303
4915952|NCT03537274|12097047|P3|Treated|Overall Study||304
4915953|NCT03537274|12097048|P2|Treated|Overall Study||297
4915954|NCT03537274|12097049|P1|Treated|Overall Study||315
4915955|NCT03537274|12097046|P4|STARTED|Overall Study||307
4915956|NCT03537274|12097047|P3|STARTED|Overall Study||304
4915957|NCT03537274|12097048|P2|STARTED|Overall Study||298
4915958|NCT03537274|12097049|P1|STARTED|Overall Study||315
4915959|NCT03537092|12097063|P1|NOT COMPLETED|Overall Study||0
4915960|NCT03537092|12097063|P1|COMPLETED|Overall Study||64
4915961|NCT03537092|12097063|P1|STARTED|Overall Study||64
4915962|NCT03536923|12097070|P1|NOT COMPLETED|Overall Study||0
4915963|NCT03536923|12097070|P1|COMPLETED|Overall Study||23
4915964|NCT03536923|12097070|P1|STARTED|Overall Study||23
4915965|NCT03535974|12097080|P3|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
4915966|NCT03535974|12097081|P2|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
4915967|NCT03535974|12097082|P1|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
4915968|NCT03535974|12097080|P3|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
4915969|NCT03535974|12097081|P2|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
4915970|NCT03535974|12097082|P1|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
4915971|NCT03535974|12097080|P3|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
4915972|NCT03535974|12097081|P2|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
4915973|NCT03535974|12097082|P1|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
4915974|NCT03535974|12097080|P3|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
4915975|NCT03535974|12097081|P2|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
4915976|NCT03535974|12097082|P1|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
4916072|NCT03530631|12097516|P1|STARTED|Placebo/Deception||4
4915977|NCT03535974|12097080|P3|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
4915978|NCT03535974|12097081|P2|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
4915979|NCT03535974|12097082|P1|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
4915980|NCT03535974|12097080|P3|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
4915981|NCT03535974|12097081|P2|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
4915982|NCT03535974|12097082|P1|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
4915983|NCT03535844|12097092|P2|NOT COMPLETED|Overall Study||1
4915984|NCT03535844|12097093|P1|NOT COMPLETED|Overall Study||0
4915985|NCT03535844|12097092|P2|COMPLETED|Overall Study||18
4915986|NCT03535844|12097093|P1|COMPLETED|Overall Study||22
4915987|NCT03535844|12097092|P2|STARTED|Overall Study||19
4915988|NCT03535844|12097093|P1|STARTED|Overall Study||22
4915989|NCT03535649|12097129|P1|NOT COMPLETED|Overall Study||0
4915990|NCT03535649|12097129|P1|COMPLETED|Overall Study||105
4915991|NCT03535649|12097129|P1|STARTED|Overall Study||105
4915992|NCT03535571|12097138|P1|NOT COMPLETED|Overall Study||1
4915993|NCT03535571|12097138|P1|COMPLETED|Overall Study||19
4915994|NCT03535571|12097138|P1|STARTED|Overall Study||20
4915995|NCT03534986|12097170|P3|NOT COMPLETED|Overall Study||2
4915996|NCT03534986|12097171|P2|NOT COMPLETED|Overall Study||0
4915997|NCT03534986|12097172|P1|NOT COMPLETED|Overall Study||0
4915998|NCT03534986|12097170|P3|COMPLETED|Overall Study||10
4915999|NCT03534986|12097171|P2|COMPLETED|Overall Study||10
4916000|NCT03534986|12097172|P1|COMPLETED|Overall Study||10
4916001|NCT03534986|12097170|P3|STARTED|Overall Study||12
4916002|NCT03534986|12097171|P2|STARTED|Overall Study||10
4916003|NCT03534986|12097172|P1|STARTED|Overall Study||10
4916004|NCT03534427|12097194|P2|NOT COMPLETED|Overall Study||0
4916005|NCT03534427|12097195|P1|NOT COMPLETED|Overall Study||0
4916006|NCT03534427|12097194|P2|COMPLETED|Overall Study||20
4916007|NCT03534427|12097195|P1|COMPLETED|Overall Study||20
4916008|NCT03534427|12097194|P2|STARTED|Overall Study||20
4916009|NCT03534427|12097195|P1|STARTED|Overall Study||20
4916010|NCT03534362|12097223|P2|NOT COMPLETED|Overall Study||0
4916011|NCT03534362|12097224|P1|NOT COMPLETED|Overall Study||0
4916012|NCT03534362|12097223|P2|COMPLETED|Overall Study||1
4916013|NCT03534362|12097224|P1|COMPLETED|Overall Study||0
4916014|NCT03534362|12097223|P2|STARTED|Overall Study||1
4916015|NCT03534362|12097224|P1|STARTED|Overall Study||0
4916016|NCT03533829|12097237|P3|NOT COMPLETED|Overall Study||0
4916017|NCT03533829|12097238|P2|NOT COMPLETED|Overall Study||0
4916018|NCT03533829|12097239|P1|NOT COMPLETED|Overall Study||0
4916019|NCT03533829|12097237|P3|COMPLETED|Overall Study||10
4916020|NCT03533829|12097238|P2|COMPLETED|Overall Study||10
4916021|NCT03533829|12097239|P1|COMPLETED|Overall Study||10
4916022|NCT03533829|12097237|P3|STARTED|Overall Study||10
4916023|NCT03533829|12097238|P2|STARTED|Overall Study||10
4916024|NCT03533829|12097239|P1|STARTED|Overall Study||10
4916025|NCT03533374|12097339|P2|NOT COMPLETED|Overall Study||0
4916026|NCT03533374|12097340|P1|NOT COMPLETED|Overall Study||0
4916027|NCT03533374|12097339|P2|COMPLETED|Overall Study||46
4916028|NCT03533374|12097340|P1|COMPLETED|Overall Study||54
4916029|NCT03533374|12097339|P2|STARTED|Overall Study||46
4916030|NCT03533374|12097340|P1|STARTED|Overall Study||54
4916031|NCT03533036|12097352|P2|NOT COMPLETED|Overall Study||0
4916032|NCT03533036|12097353|P1|NOT COMPLETED|Overall Study||0
4916033|NCT03533036|12097352|P2|COMPLETED|Overall Study||15
4916034|NCT03533036|12097353|P1|COMPLETED|Overall Study||15
4916035|NCT03533036|12097352|P2|STARTED|Overall Study||15
4916036|NCT03533036|12097353|P1|STARTED|Overall Study||15
4916037|NCT03531905|12097363|P3|NOT COMPLETED|Overall Study||3
4916038|NCT03531905|12097364|P2|NOT COMPLETED|Overall Study||5
4916039|NCT03531905|12097365|P1|NOT COMPLETED|Overall Study||7
4916040|NCT03531905|12097363|P3|COMPLETED|Overall Study||77
4916041|NCT03531905|12097364|P2|COMPLETED|Overall Study||76
4916042|NCT03531905|12097365|P1|COMPLETED|Overall Study||74
4916043|NCT03531905|12097363|P3|STARTED|Overall Study||80
4916044|NCT03531905|12097364|P2|STARTED|Overall Study||81
4916045|NCT03531905|12097365|P1|STARTED|Overall Study||81
4916046|NCT03530917|12097425|P8|NOT COMPLETED|Overall Study||0
4916047|NCT03530917|12097426|P7|NOT COMPLETED|Overall Study||0
4916048|NCT03530917|12097427|P6|NOT COMPLETED|Overall Study||0
4916049|NCT03530917|12097428|P5|NOT COMPLETED|Overall Study||0
4916050|NCT03530917|12097429|P4|NOT COMPLETED|Overall Study||0
4916051|NCT03530917|12097430|P3|NOT COMPLETED|Overall Study||0
4916052|NCT03530917|12097431|P2|NOT COMPLETED|Overall Study||0
4916053|NCT03530917|12097432|P1|NOT COMPLETED|Overall Study||0
4916054|NCT03530917|12097425|P8|COMPLETED|Overall Study||16
4916055|NCT03530917|12097426|P7|COMPLETED|Overall Study||8
4916056|NCT03530917|12097427|P6|COMPLETED|Overall Study||6
4916057|NCT03530917|12097428|P5|COMPLETED|Overall Study||8
4916058|NCT03530917|12097429|P4|COMPLETED|Overall Study||8
4916059|NCT03530917|12097430|P3|COMPLETED|Overall Study||8
4916060|NCT03530917|12097431|P2|COMPLETED|Overall Study||8
4916061|NCT03530917|12097432|P1|COMPLETED|Overall Study||8
4916062|NCT03530917|12097425|P8|STARTED|Overall Study||16
4916063|NCT03530917|12097426|P7|STARTED|Overall Study||8
4916064|NCT03530917|12097427|P6|STARTED|Overall Study||6
4916065|NCT03530917|12097428|P5|STARTED|Overall Study||8
4916066|NCT03530917|12097429|P4|STARTED|Overall Study||8
4916067|NCT03530917|12097430|P3|STARTED|Overall Study||8
4916068|NCT03530917|12097431|P2|STARTED|Overall Study||8
4916069|NCT03530917|12097432|P1|STARTED|Overall Study||8
4916070|NCT03530631|12097516|P1|NOT COMPLETED|Placebo/Deception||0
4916071|NCT03530631|12097516|P1|COMPLETED|Placebo/Deception||4
4916073|NCT03530631|12097516|P1|NOT COMPLETED|Adderall/Deception||0
4916074|NCT03530631|12097516|P1|COMPLETED|Adderall/Deception||4
4916075|NCT03530631|12097516|P1|STARTED|Adderall/Deception||4
4916076|NCT03530631|12097516|P1|NOT COMPLETED|Placebo/Truth||0
4916077|NCT03530631|12097516|P1|COMPLETED|Placebo/Truth||4
4916078|NCT03530631|12097516|P1|STARTED|Placebo/Truth||4
4916079|NCT03530631|12097516|P1|NOT COMPLETED|Adderall/Truth||0
4916080|NCT03530631|12097516|P1|COMPLETED|Adderall/Truth||4
4916081|NCT03530631|12097516|P1|STARTED|Adderall/Truth||4
4916082|NCT03529461|12097528|P2|NOT COMPLETED|Overall Study||0
4916083|NCT03529461|12097529|P1|NOT COMPLETED|Overall Study||0
4916084|NCT03529461|12097528|P2|COMPLETED|Overall Study||28
4916085|NCT03529461|12097529|P1|COMPLETED|Overall Study||28
4916086|NCT03529461|12097528|P2|STARTED|Overall Study||28
4916087|NCT03529461|12097529|P1|STARTED|Overall Study||28
4916088|NCT03528369|12097541|P3|NOT COMPLETED|Overall Study||0
4916089|NCT03528369|12097542|P2|NOT COMPLETED|Overall Study||1
4916090|NCT03528369|12097543|P1|NOT COMPLETED|Overall Study||3
4916091|NCT03528369|12097541|P3|COMPLETED|Overall Study||40
4916092|NCT03528369|12097542|P2|COMPLETED|Overall Study||41
4916093|NCT03528369|12097543|P1|COMPLETED|Overall Study||37
4916094|NCT03528369|12097541|P3|STARTED|Overall Study||40
4916095|NCT03528369|12097542|P2|STARTED|Overall Study||42
4916096|NCT03528369|12097543|P1|STARTED|Overall Study||40
4916097|NCT03528174|12097572|P1|NOT COMPLETED|Overall Study||2
4916098|NCT03528174|12097572|P1|COMPLETED|Overall Study||8
4916099|NCT03528174|12097572|P1|STARTED|Overall Study||10
4916100|NCT03527966|12097592|P2|NOT COMPLETED|Overall Study||0
4916101|NCT03527966|12097593|P1|NOT COMPLETED|Overall Study||3
4916102|NCT03527966|12097592|P2|COMPLETED|Overall Study||0
4916103|NCT03527966|12097593|P1|COMPLETED|Overall Study||0
4916104|NCT03527966|12097592|P2|STARTED|Overall Study||0
4916105|NCT03527966|12097593|P1|STARTED|Overall Study||3
4916106|NCT03527173|12097607|P2|NOT COMPLETED|Overall Study||7
4916107|NCT03527173|12097608|P1|NOT COMPLETED|Overall Study||7
4916108|NCT03527173|12097607|P2|COMPLETED|Overall Study||28
4916109|NCT03527173|12097608|P1|COMPLETED|Overall Study||29
4916110|NCT03527173|12097607|P2|STARTED|Overall Study||35
4916111|NCT03527173|12097608|P1|STARTED|Overall Study||36
4916112|NCT03526055|12097650|P2|NOT COMPLETED|Second Program||0
4916113|NCT03526055|12097651|P1|NOT COMPLETED|Second Program||0
4916114|NCT03526055|12097650|P2|COMPLETED|Second Program||5
4916115|NCT03526055|12097651|P1|COMPLETED|Second Program||5
4916116|NCT03526055|12097650|P2|STARTED|Second Program||5
4916117|NCT03526055|12097651|P1|STARTED|Second Program||5
4916118|NCT03526055|12097650|P2|NOT COMPLETED|Initial Program||0
4916119|NCT03526055|12097651|P1|NOT COMPLETED|Initial Program||0
4916120|NCT03526055|12097650|P2|COMPLETED|Initial Program||5
4916121|NCT03526055|12097651|P1|COMPLETED|Initial Program||5
4916122|NCT03526055|12097650|P2|STARTED|Initial Program||5
4916123|NCT03526055|12097651|P1|STARTED|Initial Program||5
4916124|NCT03525678|12097668|P3|NOT COMPLETED|Overall Study||25
4916125|NCT03525678|12097669|P2|NOT COMPLETED|Overall Study||99
4916126|NCT03525678|12097670|P1|NOT COMPLETED|Overall Study||97
4916127|NCT03525678|12097668|P3|COMPLETED|Overall Study||0
4916128|NCT03525678|12097669|P2|COMPLETED|Overall Study||0
4916129|NCT03525678|12097670|P1|COMPLETED|Overall Study||0
4916130|NCT03525678|12097668|P3|Received Study Treatment|Overall Study||24
4916131|NCT03525678|12097669|P2|Received Study Treatment|Overall Study||99
4916132|NCT03525678|12097670|P1|Received Study Treatment|Overall Study||95
4916133|NCT03525678|12097668|P3|STARTED|Overall Study||25
4916134|NCT03525678|12097669|P2|STARTED|Overall Study||99
4916135|NCT03525678|12097670|P1|STARTED|Overall Study||97
4916136|NCT03525548|12097855|P2|NOT COMPLETED|Overall Study||0
4916137|NCT03525548|12097856|P1|NOT COMPLETED|Overall Study||0
4916138|NCT03525548|12097855|P2|COMPLETED|Overall Study||55
4916139|NCT03525548|12097856|P1|COMPLETED|Overall Study||52
4916140|NCT03525548|12097855|P2|STARTED|Overall Study||55
4916141|NCT03525548|12097856|P1|STARTED|Overall Study||52
4916142|NCT03525444|12097872|P2|NOT COMPLETED|Overall Study||3
4916143|NCT03525444|12097873|P1|NOT COMPLETED|Overall Study||0
4916144|NCT03525444|12097872|P2|COMPLETED|Overall Study||197
4916145|NCT03525444|12097873|P1|COMPLETED|Overall Study||203
4916146|NCT03525444|12097872|P2|Safety Set|Overall Study||202
4916147|NCT03525444|12097873|P1|Safety Set|Overall Study||201
4916148|NCT03525444|12097872|P2|STARTED|Overall Study||200
4916149|NCT03525444|12097873|P1|STARTED|Overall Study||203
4916150|NCT03525119|12097905|P3|NOT COMPLETED|Overall Study||43
4916151|NCT03525119|12097906|P2|NOT COMPLETED|Overall Study||39
4916152|NCT03525119|12097907|P1|NOT COMPLETED|Overall Study||40
4916153|NCT03525119|12097905|P3|COMPLETED|Overall Study||257
4916154|NCT03525119|12097906|P2|COMPLETED|Overall Study||261
4916155|NCT03525119|12097907|P1|COMPLETED|Overall Study||260
4916156|NCT03525119|12097905|P3|Safety Population|Overall Study||298
4916157|NCT03525119|12097906|P2|Safety Population|Overall Study||300
4916158|NCT03525119|12097907|P1|Safety Population|Overall Study||299
4916159|NCT03525119|12097905|P3|STARTED|Overall Study||300
4916160|NCT03525119|12097906|P2|STARTED|Overall Study||300
4916161|NCT03525119|12097907|P1|STARTED|Overall Study||300
4916162|NCT03524157|12097942|P3|NOT COMPLETED|Overall Study||1
4916163|NCT03524157|12097943|P2|NOT COMPLETED|Overall Study||0
4916164|NCT03524157|12097944|P1|NOT COMPLETED|Overall Study||0
4916165|NCT03524157|12097942|P3|COMPLETED|Overall Study||9
4916166|NCT03524157|12097943|P2|COMPLETED|Overall Study||10
4916167|NCT03524157|12097944|P1|COMPLETED|Overall Study||10
4916168|NCT03524157|12097942|P3|STARTED|Overall Study||10
4916169|NCT03524157|12097943|P2|STARTED|Overall Study||10
4916170|NCT03524157|12097944|P1|STARTED|Overall Study||10
4916171|NCT03523988|12097982|P3|NOT COMPLETED|Overall Study||18
4916172|NCT03523988|12097983|P2|NOT COMPLETED|Overall Study||16
4916173|NCT03523988|12097984|P1|NOT COMPLETED|Overall Study||17
4916174|NCT03523988|12097982|P3|COMPLETED|Overall Study||7
4916175|NCT03523988|12097983|P2|COMPLETED|Overall Study||8
4916176|NCT03523988|12097984|P1|COMPLETED|Overall Study||7
4916177|NCT03523988|12097982|P3|STARTED|Overall Study||25
4916178|NCT03523988|12097983|P2|STARTED|Overall Study||24
4916179|NCT03523988|12097984|P1|STARTED|Overall Study||24
4916180|NCT03522675|12097998|P1|NOT COMPLETED|Overall Study||2
4916181|NCT03522675|12097998|P1|COMPLETED|Overall Study||20
4916182|NCT03522675|12097998|P1|STARTED|Overall Study||22
4916183|NCT03522506|12098016|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4916184|NCT03522506|12098017|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4916185|NCT03522506|12098018|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4916186|NCT03522506|12098019|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4916187|NCT03522506|12098016|P4|COMPLETED|Treatment Period 4 (2 Days)||3
4916188|NCT03522506|12098017|P3|COMPLETED|Treatment Period 4 (2 Days)||5
4916189|NCT03522506|12098018|P2|COMPLETED|Treatment Period 4 (2 Days)||5
4916190|NCT03522506|12098019|P1|COMPLETED|Treatment Period 4 (2 Days)||5
4916191|NCT03522506|12098016|P4|STARTED|Treatment Period 4 (2 Days)||3
4916192|NCT03522506|12098017|P3|STARTED|Treatment Period 4 (2 Days)||5
4916193|NCT03522506|12098018|P2|STARTED|Treatment Period 4 (2 Days)||5
4916194|NCT03522506|12098019|P1|STARTED|Treatment Period 4 (2 Days)||5
4916195|NCT03522506|12098016|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916196|NCT03522506|12098017|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916197|NCT03522506|12098018|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916198|NCT03522506|12098019|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916199|NCT03522506|12098016|P4|COMPLETED|Washout Period 3 (7 Days)||3
4916200|NCT03522506|12098017|P3|COMPLETED|Washout Period 3 (7 Days)||5
4916201|NCT03522506|12098018|P2|COMPLETED|Washout Period 3 (7 Days)||5
4916202|NCT03522506|12098019|P1|COMPLETED|Washout Period 3 (7 Days)||5
4916203|NCT03522506|12098016|P4|STARTED|Washout Period 3 (7 Days)||3
4916204|NCT03522506|12098017|P3|STARTED|Washout Period 3 (7 Days)||5
4916205|NCT03522506|12098018|P2|STARTED|Washout Period 3 (7 Days)||5
4916206|NCT03522506|12098019|P1|STARTED|Washout Period 3 (7 Days)||5
4916207|NCT03522506|12098016|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4916208|NCT03522506|12098017|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4916209|NCT03522506|12098018|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4916210|NCT03522506|12098019|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4916211|NCT03522506|12098016|P4|COMPLETED|Treatment Period 3 (2 Days)||3
4916212|NCT03522506|12098017|P3|COMPLETED|Treatment Period 3 (2 Days)||5
4916213|NCT03522506|12098018|P2|COMPLETED|Treatment Period 3 (2 Days)||5
4916214|NCT03522506|12098019|P1|COMPLETED|Treatment Period 3 (2 Days)||5
4916215|NCT03522506|12098016|P4|STARTED|Treatment Period 3 (2 Days)||3
4916216|NCT03522506|12098017|P3|STARTED|Treatment Period 3 (2 Days)||5
4916217|NCT03522506|12098018|P2|STARTED|Treatment Period 3 (2 Days)||5
4916218|NCT03522506|12098019|P1|STARTED|Treatment Period 3 (2 Days)||5
4916219|NCT03522506|12098016|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
4916220|NCT03522506|12098017|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916221|NCT03522506|12098018|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916222|NCT03522506|12098019|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916223|NCT03522506|12098016|P4|COMPLETED|Washout Period 2 (7 Days)||3
4916224|NCT03522506|12098017|P3|COMPLETED|Washout Period 2 (7 Days)||5
4916225|NCT03522506|12098018|P2|COMPLETED|Washout Period 2 (7 Days)||5
4916226|NCT03522506|12098019|P1|COMPLETED|Washout Period 2 (7 Days)||5
4916227|NCT03522506|12098016|P4|STARTED|Washout Period 2 (7 Days)||4
4916228|NCT03522506|12098017|P3|STARTED|Washout Period 2 (7 Days)||5
4916229|NCT03522506|12098018|P2|STARTED|Washout Period 2 (7 Days)||5
4916230|NCT03522506|12098019|P1|STARTED|Washout Period 2 (7 Days)||5
4916231|NCT03522506|12098016|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4916232|NCT03522506|12098017|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4916233|NCT03522506|12098018|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4916234|NCT03522506|12098019|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4916235|NCT03522506|12098016|P4|COMPLETED|Treatment Period 2 (2 Days)||4
4916236|NCT03522506|12098017|P3|COMPLETED|Treatment Period 2 (2 Days)||5
4916237|NCT03522506|12098018|P2|COMPLETED|Treatment Period 2 (2 Days)||5
4916238|NCT03522506|12098019|P1|COMPLETED|Treatment Period 2 (2 Days)||5
4916239|NCT03522506|12098016|P4|STARTED|Treatment Period 2 (2 Days)||4
4916240|NCT03522506|12098017|P3|STARTED|Treatment Period 2 (2 Days)||5
4916241|NCT03522506|12098018|P2|STARTED|Treatment Period 2 (2 Days)||5
4916242|NCT03522506|12098019|P1|STARTED|Treatment Period 2 (2 Days)||5
4916243|NCT03522506|12098016|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
4916244|NCT03522506|12098017|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916245|NCT03522506|12098018|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916246|NCT03522506|12098019|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916247|NCT03522506|12098016|P4|COMPLETED|Washout Period 1 (7 Days)||4
4916248|NCT03522506|12098017|P3|COMPLETED|Washout Period 1 (7 Days)||5
4916249|NCT03522506|12098018|P2|COMPLETED|Washout Period 1 (7 Days)||5
4916250|NCT03522506|12098019|P1|COMPLETED|Washout Period 1 (7 Days)||5
4916251|NCT03522506|12098016|P4|STARTED|Washout Period 1 (7 Days)||5
4916252|NCT03522506|12098017|P3|STARTED|Washout Period 1 (7 Days)||5
4916253|NCT03522506|12098018|P2|STARTED|Washout Period 1 (7 Days)||5
4916254|NCT03522506|12098019|P1|STARTED|Washout Period 1 (7 Days)||5
4916255|NCT03522506|12098016|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4916256|NCT03522506|12098017|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4916257|NCT03522506|12098018|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4916258|NCT03522506|12098019|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4916259|NCT03522506|12098016|P4|COMPLETED|Treatment Period 1 (2 Days)||5
4916260|NCT03522506|12098017|P3|COMPLETED|Treatment Period 1 (2 Days)||5
4916261|NCT03522506|12098018|P2|COMPLETED|Treatment Period 1 (2 Days)||5
4916262|NCT03522506|12098019|P1|COMPLETED|Treatment Period 1 (2 Days)||5
4916263|NCT03522506|12098016|P4|STARTED|Treatment Period 1 (2 Days)||5
4916264|NCT03522506|12098017|P3|STARTED|Treatment Period 1 (2 Days)||5
4916265|NCT03522506|12098018|P2|STARTED|Treatment Period 1 (2 Days)||5
4916266|NCT03522506|12098019|P1|STARTED|Treatment Period 1 (2 Days)||5
4916267|NCT03522350|12098067|P2|NOT COMPLETED|Overall Study||0
4916268|NCT03522350|12098068|P1|NOT COMPLETED|Overall Study||0
4916269|NCT03522350|12098067|P2|COMPLETED|Overall Study||18
4916270|NCT03522350|12098068|P1|COMPLETED|Overall Study||18
4916271|NCT03522350|12098067|P2|STARTED|Overall Study||18
4916272|NCT03522350|12098068|P1|STARTED|Overall Study||18
4916273|NCT03521817|12098081|P2|NOT COMPLETED|Overall Study||1
4916274|NCT03521817|12098082|P1|NOT COMPLETED|Overall Study||0
4916275|NCT03521817|12098081|P2|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
4916276|NCT03521817|12098082|P1|COMPLETED|Overall Study||7
4916277|NCT03521817|12098081|P2|STARTED|Overall Study||5
4916278|NCT03521817|12098082|P1|STARTED|Overall Study||7
4916279|NCT03521791|12098090|P2|NOT COMPLETED|Overall Study||17
4916280|NCT03521791|12098091|P1|NOT COMPLETED|Overall Study||7
4916281|NCT03521791|12098090|P2|COMPLETED|Overall Study||73
4916282|NCT03521791|12098091|P1|COMPLETED|Overall Study||69
4916283|NCT03521791|12098090|P2|STARTED|Overall Study||90
4916284|NCT03521791|12098091|P1|STARTED|Overall Study||76
4916285|NCT03521141|12098118|P3|NOT COMPLETED|Overall Study||1
4916286|NCT03521141|12098119|P2|NOT COMPLETED|Overall Study||0
4916287|NCT03521141|12098120|P1|NOT COMPLETED|Overall Study||1
4916288|NCT03521141|12098118|P3|COMPLETED|Overall Study||19
4916289|NCT03521141|12098119|P2|COMPLETED|Overall Study||19
4916290|NCT03521141|12098120|P1|COMPLETED|Overall Study||18
4916291|NCT03521141|12098118|P3|STARTED|Overall Study||20
4916292|NCT03521141|12098119|P2|STARTED|Overall Study||19
4916293|NCT03521141|12098120|P1|STARTED|Overall Study||19
4916294|NCT03521089|12098145|P2|NOT COMPLETED|Overall Study||0
4916295|NCT03521089|12098146|P1|NOT COMPLETED|Overall Study||0
4916296|NCT03521089|12098145|P2|COMPLETED|Overall Study||8
4916297|NCT03521089|12098146|P1|COMPLETED|Overall Study||8
4916298|NCT03521089|12098145|P2|STARTED|Overall Study||8
4916299|NCT03521089|12098146|P1|STARTED|Overall Study||8
4916300|NCT03520959|12098166|P2|NOT COMPLETED|Overall Study||1
4916301|NCT03520959|12098167|P1|NOT COMPLETED|Overall Study||0
4916302|NCT03520959|12098166|P2|COMPLETED|Overall Study||0
4916303|NCT03520959|12098167|P1|COMPLETED|Overall Study||0
4916304|NCT03520959|12098166|P2|STARTED|Overall Study||1
4916305|NCT03520959|12098167|P1|STARTED|Overall Study||0
4916306|NCT03520348|12098189|P2|NOT COMPLETED|Overall Study||0
4916307|NCT03520348|12098190|P1|NOT COMPLETED|Overall Study||0
4916308|NCT03520348|12098189|P2|COMPLETED|Overall Study||12
4916309|NCT03520348|12098190|P1|COMPLETED|Overall Study||12
4916310|NCT03520348|12098189|P2|STARTED|Overall Study||12
4916311|NCT03520348|12098190|P1|STARTED|Overall Study||12
4916312|NCT03519932|12098214|P2|NOT COMPLETED|Second Intervention||0
4916313|NCT03519932|12098215|P1|NOT COMPLETED|Second Intervention||0
4916314|NCT03519932|12098214|P2|COMPLETED|Second Intervention||23
4916315|NCT03519932|12098215|P1|COMPLETED|Second Intervention||22
4916316|NCT03519932|12098214|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
4916317|NCT03519932|12098215|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
4916318|NCT03519932|12098214|P2|NOT COMPLETED|First Intervention||3
4916319|NCT03519932|12098215|P1|NOT COMPLETED|First Intervention||1
4916320|NCT03519932|12098214|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
4916321|NCT03519932|12098215|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
4916322|NCT03519932|12098214|P2|STARTED|First Intervention||25
4916323|NCT03519932|12098215|P1|STARTED|First Intervention||24
4916324|NCT03519919|12098241|P1|NOT COMPLETED|Overall Study||3
4916325|NCT03519919|12098241|P1|COMPLETED|Overall Study||48
4916326|NCT03519919|12098241|P1|STARTED|Overall Study||51
4916327|NCT03519867|12098293|P10|NOT COMPLETED|Overall Study||0
4916328|NCT03519867|12098294|P9|NOT COMPLETED|Overall Study||1
4916329|NCT03519867|12098295|P8|NOT COMPLETED|Overall Study||1
4916330|NCT03519867|12098296|P7|NOT COMPLETED|Overall Study||1
4916331|NCT03519867|12098297|P6|NOT COMPLETED|Overall Study||3
4916332|NCT03519867|12098298|P5|NOT COMPLETED|Overall Study||0
4916333|NCT03519867|12098299|P4|NOT COMPLETED|Overall Study||1
4916334|NCT03519867|12098300|P3|NOT COMPLETED|Overall Study||1
4916335|NCT03519867|12098301|P2|NOT COMPLETED|Overall Study||3
4916336|NCT03519867|12098302|P1|NOT COMPLETED|Overall Study||3
4916337|NCT03519867|12098293|P10|COMPLETED|Overall Study||4
4916338|NCT03519867|12098294|P9|COMPLETED|Overall Study||3
4916339|NCT03519867|12098295|P8|COMPLETED|Overall Study||4
4916340|NCT03519867|12098296|P7|COMPLETED|Overall Study||3
4916341|NCT03519867|12098297|P6|COMPLETED|Overall Study||2
4916342|NCT03519867|12098298|P5|COMPLETED|Overall Study||5
4916343|NCT03519867|12098299|P4|COMPLETED|Overall Study||3
4916344|NCT03519867|12098300|P3|COMPLETED|Overall Study||5
4916345|NCT03519867|12098301|P2|COMPLETED|Overall Study||4
4916346|NCT03519867|12098302|P1|COMPLETED|Overall Study||3
4916347|NCT03519867|12098293|P10|Treated|Overall Study||4
4916348|NCT03519867|12098294|P9|Treated|Overall Study||3
4916349|NCT03519867|12098295|P8|Treated|Overall Study||4
4916350|NCT03519867|12098296|P7|Treated|Overall Study||4
4916351|NCT03519867|12098297|P6|Treated|Overall Study||4
4916352|NCT03519867|12098298|P5|Treated|Overall Study||5
4916353|NCT03519867|12098299|P4|Treated|Overall Study||3
4916354|NCT03519867|12098300|P3|Treated|Overall Study||5
4916355|NCT03519867|12098301|P2|Treated|Overall Study||6
4916356|NCT03519867|12098302|P1|Treated|Overall Study||5
4916357|NCT03519867|12098293|P10|STARTED|Overall Study||4
4916358|NCT03519867|12098294|P9|STARTED|Overall Study||4
4916359|NCT03519867|12098295|P8|STARTED|Overall Study||5
4916360|NCT03519867|12098296|P7|STARTED|Overall Study||4
4916361|NCT03519867|12098297|P6|STARTED|Overall Study||5
4916362|NCT03519867|12098298|P5|STARTED|Overall Study||5
4916363|NCT03519867|12098299|P4|STARTED|Overall Study||4
4916364|NCT03519867|12098300|P3|STARTED|Overall Study||6
4916365|NCT03519867|12098301|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
4916366|NCT03519867|12098302|P1|STARTED|Overall Study||6
4916367|NCT03519854|12098352|P18|NOT COMPLETED|Overall Study||0
4916368|NCT03519854|12098353|P17|NOT COMPLETED|Overall Study||0
4916369|NCT03519854|12098354|P16|NOT COMPLETED|Overall Study||0
4916370|NCT03519854|12098355|P15|NOT COMPLETED|Overall Study||0
4916371|NCT03519854|12098356|P14|NOT COMPLETED|Overall Study||0
4916372|NCT03519854|12098357|P13|NOT COMPLETED|Overall Study||0
4916373|NCT03519854|12098358|P12|NOT COMPLETED|Overall Study||0
4916374|NCT03519854|12098359|P11|NOT COMPLETED|Overall Study||0
4916375|NCT03519854|12098360|P10|NOT COMPLETED|Overall Study||0
4916376|NCT03519854|12098361|P9|NOT COMPLETED|Overall Study||0
4916377|NCT03519854|12098362|P8|NOT COMPLETED|Overall Study||0
4916378|NCT03519854|12098363|P7|NOT COMPLETED|Overall Study||0
4916379|NCT03519854|12098364|P6|NOT COMPLETED|Overall Study||0
4916380|NCT03519854|12098365|P5|NOT COMPLETED|Overall Study||0
4916381|NCT03519854|12098366|P4|NOT COMPLETED|Overall Study||0
4916382|NCT03519854|12098367|P3|NOT COMPLETED|Overall Study||1
4916383|NCT03519854|12098368|P2|NOT COMPLETED|Overall Study||0
4916384|NCT03519854|12098369|P1|NOT COMPLETED|Overall Study||0
4916385|NCT03519854|12098352|P18|COMPLETED|Overall Study||6
4916386|NCT03519854|12098353|P17|COMPLETED|Overall Study||6
4916387|NCT03519854|12098354|P16|COMPLETED|Overall Study||6
4916388|NCT03519854|12098355|P15|COMPLETED|Overall Study||6
4916389|NCT03519854|12098356|P14|COMPLETED|Overall Study||6
4916390|NCT03519854|12098357|P13|COMPLETED|Overall Study||3
4916391|NCT03519854|12098358|P12|COMPLETED|Overall Study||6
4916392|NCT03519854|12098359|P11|COMPLETED|Overall Study||6
4916393|NCT03519854|12098360|P10|COMPLETED|Overall Study||6
4916394|NCT03519854|12098361|P9|COMPLETED|Overall Study||6
4916395|NCT03519854|12098362|P8|COMPLETED|Overall Study||6
4916396|NCT03519854|12098363|P7|COMPLETED|Overall Study||3
4916397|NCT03519854|12098364|P6|COMPLETED|Overall Study||6
4916398|NCT03519854|12098365|P5|COMPLETED|Overall Study||6
4916399|NCT03519854|12098366|P4|COMPLETED|Overall Study||6
4916400|NCT03519854|12098367|P3|COMPLETED|Overall Study||4
4916401|NCT03519854|12098368|P2|COMPLETED|Overall Study||6
4916402|NCT03519854|12098369|P1|COMPLETED|Overall Study||4
4916403|NCT03519854|12098352|P18|Treated|Overall Study||6
4916404|NCT03519854|12098353|P17|Treated|Overall Study||6
4916405|NCT03519854|12098354|P16|Treated|Overall Study||6
4916406|NCT03519854|12098355|P15|Treated|Overall Study||6
4916407|NCT03519854|12098356|P14|Treated|Overall Study||6
4916408|NCT03519854|12098357|P13|Treated|Overall Study||3
4916409|NCT03519854|12098358|P12|Treated|Overall Study||6
4916410|NCT03519854|12098359|P11|Treated|Overall Study||6
4916411|NCT03519854|12098360|P10|Treated|Overall Study||6
4916412|NCT03519854|12098361|P9|Treated|Overall Study||6
4916413|NCT03519854|12098362|P8|Treated|Overall Study||6
4916414|NCT03519854|12098363|P7|Treated|Overall Study||3
4916415|NCT03519854|12098364|P6|Treated|Overall Study||6
4916416|NCT03519854|12098365|P5|Treated|Overall Study||6
4916417|NCT03519854|12098366|P4|Treated|Overall Study||6
4916418|NCT03519854|12098367|P3|Treated|Overall Study||4
4916419|NCT03519854|12098368|P2|Treated|Overall Study||6
4916420|NCT03519854|12098369|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
4916421|NCT03519854|12098352|P18|STARTED|Overall Study||6
4916422|NCT03519854|12098353|P17|STARTED|Overall Study||6
4916423|NCT03519854|12098354|P16|STARTED|Overall Study||6
4916424|NCT03519854|12098355|P15|STARTED|Overall Study||6
4916425|NCT03519854|12098356|P14|STARTED|Overall Study||6
4916426|NCT03519854|12098357|P13|STARTED|Overall Study||3
4916427|NCT03519854|12098358|P12|STARTED|Overall Study||6
4916428|NCT03519854|12098359|P11|STARTED|Overall Study||6
4916429|NCT03519854|12098360|P10|STARTED|Overall Study||6
4916430|NCT03519854|12098361|P9|STARTED|Overall Study||6
4916431|NCT03519854|12098362|P8|STARTED|Overall Study||6
4916432|NCT03519854|12098363|P7|STARTED|Overall Study||3
4916433|NCT03519854|12098364|P6|STARTED|Overall Study||6
4916434|NCT03519854|12098365|P5|STARTED|Overall Study||6
4916435|NCT03519854|12098366|P4|STARTED|Overall Study||6
4916436|NCT03519854|12098367|P3|STARTED|Overall Study||5
4916437|NCT03519854|12098368|P2|STARTED|Overall Study||6
4916438|NCT03519854|12098369|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
4916439|NCT03519516|12098535|P2|NOT COMPLETED|Overall Study||1
4916440|NCT03519516|12098536|P1|NOT COMPLETED|Overall Study||0
4916441|NCT03519516|12098535|P2|COMPLETED|Overall Study||14
4916442|NCT03519516|12098536|P1|COMPLETED|Overall Study||15
4916443|NCT03519516|12098535|P2|STARTED|Overall Study||15
4916444|NCT03519516|12098536|P1|STARTED|Overall Study||15
4916445|NCT03519282|12098560|P2|NOT COMPLETED|Second Intervention||0
4916446|NCT03519282|12098561|P1|NOT COMPLETED|Second Intervention||0
4916447|NCT03519282|12098560|P2|COMPLETED|Second Intervention||5
4916448|NCT03519282|12098561|P1|COMPLETED|Second Intervention||5
4916449|NCT03519282|12098560|P2|STARTED|Second Intervention||5
4916450|NCT03519282|12098561|P1|STARTED|Second Intervention||5
4916451|NCT03519282|12098560|P2|NOT COMPLETED|First Intervention||0
4916452|NCT03519282|12098561|P1|NOT COMPLETED|First Intervention||0
4916453|NCT03519282|12098560|P2|COMPLETED|First Intervention||5
4916454|NCT03519282|12098561|P1|COMPLETED|First Intervention||5
4916455|NCT03519282|12098560|P2|STARTED|First Intervention||5
4916456|NCT03519282|12098561|P1|STARTED|First Intervention||5
4916457|NCT03519243|12098576|P4|NOT COMPLETED|Overall Study||1
4916458|NCT03519243|12098577|P3|NOT COMPLETED|Overall Study||0
4916459|NCT03519243|12098578|P2|NOT COMPLETED|Overall Study||4
4916460|NCT03519243|12098579|P1|NOT COMPLETED|Overall Study||5
4916461|NCT03519243|12098576|P4|COMPLETED|Overall Study||24
4916462|NCT03519243|12098577|P3|COMPLETED|Overall Study||0
4916463|NCT03519243|12098578|P2|COMPLETED|Overall Study||21
4916464|NCT03519243|12098579|P1|COMPLETED|Overall Study||20
4916465|NCT03519243|12098576|P4|STARTED|Overall Study||25
4916466|NCT03519243|12098577|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
4916467|NCT03519243|12098578|P2|STARTED|Overall Study||25
4916468|NCT03519243|12098579|P1|STARTED|Overall Study||25
4916469|NCT03519204|12098610|P2|NOT COMPLETED|Overall Study||15
4916470|NCT03519204|12098611|P1|NOT COMPLETED|Overall Study||13
4916471|NCT03519204|12098610|P2|COMPLETED|Overall Study||118
4916472|NCT03519204|12098611|P1|COMPLETED|Overall Study||30
4916473|NCT03519204|12098610|P2|Safety Population|Overall Study||136
4916474|NCT03519204|12098611|P1|Safety Population|Overall Study||40
4916475|NCT03519204|12098610|P2|mITT Population|Overall Study||130
4916476|NCT03519204|12098611|P1|mITT Population|Overall Study||33
4916477|NCT03519204|12098610|P2|STARTED|Overall Study||133
4916478|NCT03519204|12098611|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
4916479|NCT03519087|12098630|P5|NOT COMPLETED|Laboratory Testing||6
4916480|NCT03519087|12098631|P4|NOT COMPLETED|Laboratory Testing||4
4916481|NCT03519087|12098632|P3|NOT COMPLETED|Laboratory Testing||2
4916482|NCT03519087|12098633|P2|NOT COMPLETED|Laboratory Testing||0
4916483|NCT03519087|12098634|P1|NOT COMPLETED|Laboratory Testing||0
4916484|NCT03519087|12098630|P5|COMPLETED|Laboratory Testing||1
4916485|NCT03519087|12098631|P4|COMPLETED|Laboratory Testing||2
4916486|NCT03519087|12098632|P3|COMPLETED|Laboratory Testing||4
4916487|NCT03519087|12098633|P2|COMPLETED|Laboratory Testing||0
4916488|NCT03519087|12098634|P1|COMPLETED|Laboratory Testing||0
4916489|NCT03519087|12098630|P5|Baseline Lab Testing|Laboratory Testing||3
4916490|NCT03519087|12098631|P4|Baseline Lab Testing|Laboratory Testing||4
4916491|NCT03519087|12098632|P3|Baseline Lab Testing|Laboratory Testing||5
4916492|NCT03519087|12098633|P2|Baseline Lab Testing|Laboratory Testing||0
4916493|NCT03519087|12098634|P1|Baseline Lab Testing|Laboratory Testing||0
4916494|NCT03519087|12098630|P5|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
4916495|NCT03519087|12098631|P4|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
4916496|NCT03519087|12098632|P3|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
4916497|NCT03519087|12098633|P2|STARTED|Laboratory Testing||0
4916498|NCT03519087|12098634|P1|STARTED|Laboratory Testing||0
4916499|NCT03519087|12098630|P5|NOT COMPLETED|Re-randomization for Treatment||0
4916500|NCT03519087|12098631|P4|NOT COMPLETED|Re-randomization for Treatment||0
4916501|NCT03519087|12098632|P3|NOT COMPLETED|Re-randomization for Treatment||0
4916502|NCT03519087|12098633|P2|NOT COMPLETED|Re-randomization for Treatment||32
4916503|NCT03519087|12098634|P1|NOT COMPLETED|Re-randomization for Treatment||27
4916504|NCT03519087|12098630|P5|COMPLETED|Re-randomization for Treatment||0
4916505|NCT03519087|12098631|P4|COMPLETED|Re-randomization for Treatment||0
4916506|NCT03519087|12098632|P3|COMPLETED|Re-randomization for Treatment||0
4916507|NCT03519087|12098633|P2|COMPLETED|Re-randomization for Treatment||7
4916508|NCT03519087|12098634|P1|COMPLETED|Re-randomization for Treatment||12
4916509|NCT03519087|12098630|P5|STARTED|Re-randomization for Treatment||0
4916510|NCT03519087|12098631|P4|STARTED|Re-randomization for Treatment||0
4916511|NCT03519087|12098632|P3|STARTED|Re-randomization for Treatment||0
4916512|NCT03519087|12098633|P2|STARTED|Re-randomization for Treatment||39
4916513|NCT03519087|12098634|P1|STARTED|Re-randomization for Treatment||39
4916514|NCT03519087|12098630|P5|NOT COMPLETED|Clinic Evaluation||0
4916515|NCT03519087|12098631|P4|NOT COMPLETED|Clinic Evaluation||0
4916516|NCT03519087|12098632|P3|NOT COMPLETED|Clinic Evaluation||0
4916517|NCT03519087|12098633|P2|NOT COMPLETED|Clinic Evaluation||18
4916518|NCT03519087|12098634|P1|NOT COMPLETED|Clinic Evaluation||16
4916519|NCT03519087|12098630|P5|COMPLETED|Clinic Evaluation||0
4916520|NCT03519087|12098631|P4|COMPLETED|Clinic Evaluation||0
4916521|NCT03519087|12098632|P3|COMPLETED|Clinic Evaluation||0
4916522|NCT03519087|12098633|P2|COMPLETED|Clinic Evaluation||39
4916523|NCT03519087|12098634|P1|COMPLETED|Clinic Evaluation||39
4916524|NCT03519087|12098630|P5|Confirmed Diagnosis by Physician|Clinic Evaluation||0
4916525|NCT03519087|12098631|P4|Confirmed Diagnosis by Physician|Clinic Evaluation||0
4916526|NCT03519087|12098632|P3|Confirmed Diagnosis by Physician|Clinic Evaluation||0
4916527|NCT03519087|12098633|P2|Confirmed Diagnosis by Physician|Clinic Evaluation||39
4916528|NCT03519087|12098634|P1|Confirmed Diagnosis by Physician|Clinic Evaluation||39
4916529|NCT03519087|12098630|P5|Received Assigned Intervention|Clinic Evaluation||0
4916530|NCT03519087|12098631|P4|Received Assigned Intervention|Clinic Evaluation||0
4916531|NCT03519087|12098632|P3|Received Assigned Intervention|Clinic Evaluation||0
4916532|NCT03519087|12098633|P2|Received Assigned Intervention|Clinic Evaluation||57
4916533|NCT03519087|12098634|P1|Received Assigned Intervention|Clinic Evaluation||54
4916534|NCT03519087|12098630|P5|STARTED|Clinic Evaluation||0
4916535|NCT03519087|12098631|P4|STARTED|Clinic Evaluation||0
4916536|NCT03519087|12098632|P3|STARTED|Clinic Evaluation||0
4916537|NCT03519087|12098633|P2|STARTED|Clinic Evaluation||57
4916538|NCT03519087|12098634|P1|STARTED|Clinic Evaluation||55
4916539|NCT03518125|12098676|P6|NOT COMPLETED|Overall Study||8
4916540|NCT03518125|12098677|P5|NOT COMPLETED|Overall Study||4
4916541|NCT03518125|12098678|P4|NOT COMPLETED|Overall Study||1
4916542|NCT03518125|12098679|P3|NOT COMPLETED|Overall Study||0
4916543|NCT03518125|12098680|P2|NOT COMPLETED|Overall Study||4
4916544|NCT03518125|12098681|P1|NOT COMPLETED|Overall Study||2
4916545|NCT03518125|12098676|P6|COMPLETED|Overall Study||44
4916546|NCT03518125|12098677|P5|COMPLETED|Overall Study||48
4916547|NCT03518125|12098678|P4|COMPLETED|Overall Study||51
4916548|NCT03518125|12098679|P3|COMPLETED|Overall Study||49
4916549|NCT03518125|12098680|P2|COMPLETED|Overall Study||46
4916550|NCT03518125|12098681|P1|COMPLETED|Overall Study||48
4916551|NCT03518125|12098676|P6|STARTED|Overall Study||52
4916552|NCT03518125|12098677|P5|STARTED|Overall Study||52
4916553|NCT03518125|12098678|P4|STARTED|Overall Study||52
4916554|NCT03518125|12098679|P3|STARTED|Overall Study||49
4916555|NCT03518125|12098680|P2|STARTED|Overall Study||50
4916556|NCT03518125|12098681|P1|STARTED|Overall Study||50
4916557|NCT03518008|12098779|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
4916558|NCT03518008|12098780|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
4916559|NCT03518008|12098779|P2|COMPLETED|Period 2, Second Week of Wear||10
4916560|NCT03518008|12098780|P1|COMPLETED|Period 2, Second Week of Wear||11
4916561|NCT03518008|12098779|P2|STARTED|Period 2, Second Week of Wear||11
4916562|NCT03518008|12098780|P1|STARTED|Period 2, Second Week of Wear||11
4916563|NCT03518008|12098779|P2|NOT COMPLETED|Period 1, First Week of Wear||0
4916564|NCT03518008|12098780|P1|NOT COMPLETED|Period 1, First Week of Wear||0
4916565|NCT03518008|12098779|P2|COMPLETED|Period 1, First Week of Wear||11
4916566|NCT03518008|12098780|P1|COMPLETED|Period 1, First Week of Wear||11
4916567|NCT03518008|12098779|P2|STARTED|Period 1, First Week of Wear||11
4916568|NCT03518008|12098780|P1|STARTED|Period 1, First Week of Wear||11
4916569|NCT03516227|12098788|P2|NOT COMPLETED|Overall Study||4
4916570|NCT03516227|12098789|P1|NOT COMPLETED|Overall Study||1
4916571|NCT03516227|12098788|P2|COMPLETED|Overall Study||16
4916572|NCT03516227|12098789|P1|COMPLETED|Overall Study||19
4916573|NCT03516227|12098788|P2|STARTED|Overall Study||20
4916574|NCT03516227|12098789|P1|STARTED|Overall Study||20
4916575|NCT03514966|12098805|P2|NOT COMPLETED|Overall Study||0
4916576|NCT03514966|12098806|P1|NOT COMPLETED|Overall Study||0
4916577|NCT03514966|12098805|P2|COMPLETED|Overall Study||43
4916578|NCT03514966|12098806|P1|COMPLETED|Overall Study||40
4916579|NCT03514966|12098805|P2|STARTED|Overall Study||43
4916580|NCT03514966|12098806|P1|STARTED|Overall Study||40
4916581|NCT03513848|12098818|P2|NOT COMPLETED|Overall Study||0
4916582|NCT03513848|12098819|P1|NOT COMPLETED|Overall Study||0
4916583|NCT03513848|12098818|P2|COMPLETED|Overall Study||6
4916584|NCT03513848|12098819|P1|COMPLETED|Overall Study||9
4916585|NCT03513848|12098818|P2|STARTED|Overall Study||6
4916586|NCT03513848|12098819|P1|STARTED|Overall Study||9
4916587|NCT03513757|12098829|P2|NOT COMPLETED|Overall Study||0
4916588|NCT03513757|12098830|P1|NOT COMPLETED|Overall Study||0
4916589|NCT03513757|12098829|P2|COMPLETED|Overall Study||18
4916590|NCT03513757|12098830|P1|COMPLETED|Overall Study||22
4916591|NCT03513757|12098829|P2|STARTED|Overall Study||18
4916592|NCT03513757|12098830|P1|STARTED|Overall Study||22
4916593|NCT03513588|12098863|P3|NOT COMPLETED|Overall Study||2
4916594|NCT03513588|12098864|P2|NOT COMPLETED|Overall Study||2
4916595|NCT03513588|12098865|P1|NOT COMPLETED|Overall Study||1
4916596|NCT03513588|12098863|P3|COMPLETED|Overall Study||13
4916597|NCT03513588|12098864|P2|COMPLETED|Overall Study||15
4916598|NCT03513588|12098865|P1|COMPLETED|Overall Study||15
4916599|NCT03513588|12098863|P3|STARTED|Overall Study||15
4916600|NCT03513588|12098864|P2|STARTED|Overall Study||17
4916601|NCT03513588|12098865|P1|STARTED|Overall Study||16
4916602|NCT03512457|12098899|P2|NOT COMPLETED|Overall Study||40
4916603|NCT03512457|12098900|P1|NOT COMPLETED|Overall Study||34
4916604|NCT03512457|12098899|P2|COMPLETED|Overall Study||185
4916605|NCT03512457|12098900|P1|COMPLETED|Overall Study||161
4916606|NCT03512457|12098899|P2|STARTED|Overall Study||225
4916607|NCT03512457|12098900|P1|STARTED|Overall Study||195
4916608|NCT03512067|12098908|P1|NOT COMPLETED|Overall Study||0
4916609|NCT03512067|12098908|P1|COMPLETED|Overall Study||1
4916610|NCT03512067|12098908|P1|STARTED|Overall Study||1
4916611|NCT03512041|12098917|P4|NOT COMPLETED|Overall Study||0
4916612|NCT03512041|12098918|P3|NOT COMPLETED|Overall Study||0
4916613|NCT03512041|12098919|P2|NOT COMPLETED|Overall Study||0
4916614|NCT03512041|12098920|P1|NOT COMPLETED|Overall Study||0
4916615|NCT03512041|12098917|P4|COMPLETED|Overall Study||9
4916616|NCT03512041|12098918|P3|COMPLETED|Overall Study||11
4916617|NCT03512041|12098919|P2|COMPLETED|Overall Study||10
4916618|NCT03512041|12098920|P1|COMPLETED|Overall Study||10
4916619|NCT03512041|12098917|P4|STARTED|Overall Study||9
4916620|NCT03512041|12098918|P3|STARTED|Overall Study||11
4916621|NCT03512041|12098919|P2|STARTED|Overall Study||10
4916622|NCT03512041|12098920|P1|STARTED|Overall Study||10
4916623|NCT03512028|12098940|P2|NOT COMPLETED|Overall Study||0
4916624|NCT03512028|12098941|P1|NOT COMPLETED|Overall Study||4
4916625|NCT03512028|12098940|P2|COMPLETED|Overall Study||15
4916626|NCT03512028|12098941|P1|COMPLETED|Overall Study||15
4916627|NCT03512028|12098940|P2|STARTED|Overall Study||15
4916628|NCT03512028|12098941|P1|STARTED|Overall Study||19
4916629|NCT03511105|12098949|P2|NOT COMPLETED|Overall Study||0
4916630|NCT03511105|12098950|P1|NOT COMPLETED|Overall Study||2
4916631|NCT03511105|12098949|P2|COMPLETED|Overall Study||22
4916632|NCT03511105|12098950|P1|COMPLETED|Overall Study||23
4916633|NCT03511105|12098949|P2|STARTED|Overall Study||22
4916634|NCT03511105|12098950|P1|STARTED|Overall Study||25
4916635|NCT03510273|12099004|P1|NOT COMPLETED|Overall Study||9
4916636|NCT03510273|12099004|P1|COMPLETED|Overall Study||310
4916637|NCT03510273|12099004|P1|Completed All One-year Follow up Visits|Overall Study||118
4916638|NCT03510273|12099004|P1|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
4916639|NCT03510273|12099004|P1|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
4916640|NCT03510273|12099004|P1|Treated With Thermal Coagulation|Overall Study||319
4916641|NCT03510273|12099004|P1|STARTED|Overall Study||319
4916642|NCT03510195|12099009|P1|NOT COMPLETED|Overall Study||166
4916643|NCT03510195|12099009|P1|COMPLETED|Overall Study||101
4916644|NCT03510195|12099009|P1|STARTED|Overall Study||267
4916645|NCT03509948|12099023|P2|NOT COMPLETED|Overall Study||1
4916646|NCT03509948|12099024|P1|NOT COMPLETED|Overall Study||0
4916647|NCT03509948|12099023|P2|COMPLETED|Overall Study||6
4916648|NCT03509948|12099024|P1|COMPLETED|Overall Study||6
4916649|NCT03509948|12099023|P2|STARTED|Overall Study||7
4916650|NCT03509948|12099024|P1|STARTED|Overall Study||6
4916651|NCT03509883|12099048|P2|NOT COMPLETED|Cross-over and Treatment||0
4916652|NCT03509883|12099049|P1|NOT COMPLETED|Cross-over and Treatment||0
4916653|NCT03509883|12099048|P2|COMPLETED|Cross-over and Treatment||15
4916654|NCT03509883|12099049|P1|COMPLETED|Cross-over and Treatment||15
4916655|NCT03509883|12099048|P2|STARTED|Cross-over and Treatment||15
4916656|NCT03509883|12099049|P1|STARTED|Cross-over and Treatment||15
4916657|NCT03509883|12099048|P2|NOT COMPLETED|Initial Treatment Washout||0
4916658|NCT03509883|12099049|P1|NOT COMPLETED|Initial Treatment Washout||0
4916659|NCT03509883|12099048|P2|COMPLETED|Initial Treatment Washout||15
4916660|NCT03509883|12099049|P1|COMPLETED|Initial Treatment Washout||15
4916661|NCT03509883|12099048|P2|STARTED|Initial Treatment Washout||15
4916662|NCT03509883|12099049|P1|STARTED|Initial Treatment Washout||15
4916663|NCT03509883|12099048|P2|NOT COMPLETED|Initial Treatment||0
4916664|NCT03509883|12099049|P1|NOT COMPLETED|Initial Treatment||0
4916665|NCT03509883|12099048|P2|COMPLETED|Initial Treatment||15
4916666|NCT03509883|12099049|P1|COMPLETED|Initial Treatment||15
4916667|NCT03509883|12099048|P2|STARTED|Initial Treatment||15
4916668|NCT03509883|12099049|P1|STARTED|Initial Treatment||15
4916669|NCT03509766|12099084|P1|NOT COMPLETED|Overall Study||0
4916670|NCT03509766|12099084|P1|COMPLETED|Overall Study||24
4916671|NCT03509766|12099084|P1|STARTED|Overall Study||24
4916672|NCT03509675|12099092|P2|NOT COMPLETED|Second Intervention )7 Days)||0
4916673|NCT03509675|12099093|P1|NOT COMPLETED|Second Intervention )7 Days)||2
4916674|NCT03509675|12099092|P2|COMPLETED|Second Intervention )7 Days)||8
4916675|NCT03509675|12099093|P1|COMPLETED|Second Intervention )7 Days)||4
4916676|NCT03509675|12099092|P2|STARTED|Second Intervention )7 Days)||8
4916677|NCT03509675|12099093|P1|STARTED|Second Intervention )7 Days)||6
4916678|NCT03509675|12099092|P2|NOT COMPLETED|Washout Period (7 Days)||0
4916679|NCT03509675|12099093|P1|NOT COMPLETED|Washout Period (7 Days)||0
4916680|NCT03509675|12099092|P2|COMPLETED|Washout Period (7 Days)||8
4916681|NCT03509675|12099093|P1|COMPLETED|Washout Period (7 Days)||6
4916682|NCT03509675|12099092|P2|STARTED|Washout Period (7 Days)||8
4916683|NCT03509675|12099093|P1|STARTED|Washout Period (7 Days)||6
4916684|NCT03509675|12099092|P2|NOT COMPLETED|First Intervention (7 Days)||4
4916685|NCT03509675|12099093|P1|NOT COMPLETED|First Intervention (7 Days)||5
4916686|NCT03509675|12099092|P2|COMPLETED|First Intervention (7 Days)||8
4916687|NCT03509675|12099093|P1|COMPLETED|First Intervention (7 Days)||6
4916688|NCT03509675|12099092|P2|STARTED|First Intervention (7 Days)||12
4916689|NCT03509675|12099093|P1|STARTED|First Intervention (7 Days)||11
4916690|NCT03509207|12099099|P1|NOT COMPLETED|Overall Study||2
4916691|NCT03509207|12099099|P1|COMPLETED|Overall Study||1
4916692|NCT03509207|12099099|P1|STARTED|Overall Study||3
4916693|NCT03508843|12099104|P1|NOT COMPLETED|Overall Study||3
4916694|NCT03508843|12099104|P1|COMPLETED|Overall Study||147
4916695|NCT03508843|12099104|P1|STARTED|Overall Study||150
4916696|NCT03508661|12099110|P1|NOT COMPLETED|Overall Study||0
4916697|NCT03508661|12099110|P1|COMPLETED|Overall Study||10
4916698|NCT03508661|12099110|P1|STARTED|Overall Study||10
4916699|NCT03508050|12099126|P2|NOT COMPLETED|Overall Study||2
4916700|NCT03508050|12099127|P1|NOT COMPLETED|Overall Study||5
4916701|NCT03508050|12099126|P2|COMPLETED|Overall Study||15
4916702|NCT03508050|12099127|P1|COMPLETED|Overall Study||15
4916703|NCT03508050|12099126|P2|STARTED|Overall Study||17
4916704|NCT03508050|12099127|P1|STARTED|Overall Study||20
4916705|NCT03507569|12099161|P4|NOT COMPLETED|Overall Study||0
4916706|NCT03507569|12099162|P3|NOT COMPLETED|Overall Study||0
4916707|NCT03507569|12099163|P2|NOT COMPLETED|Overall Study||0
4916708|NCT03507569|12099164|P1|NOT COMPLETED|Overall Study||0
4916709|NCT03507569|12099161|P4|COMPLETED|Overall Study||1
4916710|NCT03507569|12099162|P3|COMPLETED|Overall Study||2
4916711|NCT03507569|12099163|P2|COMPLETED|Overall Study||1
4916712|NCT03507569|12099164|P1|COMPLETED|Overall Study||2
4916713|NCT03507569|12099161|P4|STARTED|Overall Study||1
4916714|NCT03507569|12099162|P3|STARTED|Overall Study||2
4916715|NCT03507569|12099163|P2|STARTED|Overall Study||1
4916716|NCT03507569|12099164|P1|STARTED|Overall Study||2
4916717|NCT03506425|12099185|P3|NOT COMPLETED|Overall Study||1
4916718|NCT03506425|12099186|P2|NOT COMPLETED|Overall Study||3
4916719|NCT03506425|12099187|P1|NOT COMPLETED|Overall Study||2
4916720|NCT03506425|12099185|P3|COMPLETED|Overall Study||4
4916721|NCT03506425|12099186|P2|COMPLETED|Overall Study||2
4916722|NCT03506425|12099187|P1|COMPLETED|Overall Study||3
4916723|NCT03506425|12099185|P3|STARTED|Overall Study||5
4916724|NCT03506425|12099186|P2|STARTED|Overall Study||5
4916725|NCT03506425|12099187|P1|STARTED|Overall Study||5
4916726|NCT03506347|12099200|P2|NOT COMPLETED|Overall Study||0
4916727|NCT03506347|12099201|P1|NOT COMPLETED|Overall Study||0
4916728|NCT03506347|12099200|P2|COMPLETED|Overall Study||12
4916729|NCT03506347|12099201|P1|COMPLETED|Overall Study||12
4916730|NCT03506347|12099200|P2|STARTED|Overall Study||12
4916731|NCT03506347|12099201|P1|STARTED|Overall Study||12
4916732|NCT03506295|12099209|P1|NOT COMPLETED|Overall Study||0
4916733|NCT03506295|12099209|P1|COMPLETED|Overall Study||10
4916734|NCT03506295|12099209|P1|STARTED|Overall Study||10
4916735|NCT03505372|12099222|P1|NOT COMPLETED|Overall Study||0
4916736|NCT03505372|12099222|P1|COMPLETED|Overall Study||5
4916737|NCT03505372|12099222|P1|STARTED|Overall Study||5
4916738|NCT03504189|12099227|P1|NOT COMPLETED|Overall Study||4
4916739|NCT03504189|12099227|P1|COMPLETED|Overall Study||147
4916740|NCT03504189|12099227|P1|STARTED|Overall Study||151
4916741|NCT03503578|12099236|P1|NOT COMPLETED|Overall Study||0
4916742|NCT03503578|12099236|P1|COMPLETED|Overall Study||12
4916743|NCT03503578|12099236|P1|STARTED|Overall Study||12
4916744|NCT03503188|12099242|P2|NOT COMPLETED|Overall Study||1
4916745|NCT03503188|12099243|P1|NOT COMPLETED|Overall Study||0
4916746|NCT03503188|12099242|P2|COMPLETED|Overall Study||145
4916747|NCT03503188|12099243|P1|COMPLETED|Overall Study||128
4916748|NCT03503188|12099242|P2|Sub-study|Overall Study||44
4916749|NCT03503188|12099243|P1|Sub-study|Overall Study||29
4916750|NCT03503188|12099242|P2|Main Study|Overall Study||101
4916751|NCT03503188|12099243|P1|Main Study|Overall Study||99
4916752|NCT03503188|12099242|P2|Entered in the Entire Study|Overall Study||145
4916753|NCT03503188|12099243|P1|Entered in the Entire Study|Overall Study||128
4916754|NCT03503188|12099242|P2|STARTED|Overall Study||146
4916755|NCT03503188|12099243|P1|STARTED|Overall Study||128
4916756|NCT03502915|12099261|P2|NOT COMPLETED|Overall Study||0
4916757|NCT03502915|12099262|P1|NOT COMPLETED|Overall Study||0
4916758|NCT03502915|12099261|P2|COMPLETED|Overall Study||24
4916759|NCT03502915|12099262|P1|COMPLETED|Overall Study||24
4916760|NCT03502915|12099261|P2|STARTED|Overall Study||24
4916761|NCT03502915|12099262|P1|STARTED|Overall Study||24
4916762|NCT03502681|12099278|P2|NOT COMPLETED|Overall Study||2
4916763|NCT03502681|12099279|P1|NOT COMPLETED|Overall Study||3
4916764|NCT03502681|12099278|P2|COMPLETED|Overall Study||1
4916765|NCT03502681|12099279|P1|COMPLETED|Overall Study||0
4916766|NCT03502681|12099278|P2|STARTED|Overall Study||3
4916767|NCT03502681|12099279|P1|STARTED|Overall Study||3
4916768|NCT03502070|12099298|P1|NOT COMPLETED|Overall Study||2
4916769|NCT03502070|12099298|P1|COMPLETED|Overall Study||45
4916770|NCT03502070|12099298|P1|STARTED|Overall Study||47
4916771|NCT03501693|12099302|P2|NOT COMPLETED|Second Reading Session||0
4916772|NCT03501693|12099303|P1|NOT COMPLETED|Second Reading Session||0
4916773|NCT03501693|12099302|P2|COMPLETED|Second Reading Session||75
4916774|NCT03501693|12099303|P1|COMPLETED|Second Reading Session||75
4916775|NCT03501693|12099302|P2|STARTED|Second Reading Session||75
4916776|NCT03501693|12099303|P1|STARTED|Second Reading Session||75
4916777|NCT03501693|12099302|P2|NOT COMPLETED|4 Week Memory Washout Period||0
4916778|NCT03501693|12099303|P1|NOT COMPLETED|4 Week Memory Washout Period||0
4916779|NCT03501693|12099302|P2|COMPLETED|4 Week Memory Washout Period||75
4916780|NCT03501693|12099303|P1|COMPLETED|4 Week Memory Washout Period||75
4916781|NCT03501693|12099302|P2|STARTED|4 Week Memory Washout Period||75
4916782|NCT03501693|12099303|P1|STARTED|4 Week Memory Washout Period||75
4916783|NCT03501693|12099302|P2|NOT COMPLETED|First Reading Session||0
4916784|NCT03501693|12099303|P1|NOT COMPLETED|First Reading Session||0
4916785|NCT03501693|12099302|P2|COMPLETED|First Reading Session||75
4916786|NCT03501693|12099303|P1|COMPLETED|First Reading Session||75
4916787|NCT03501693|12099302|P2|STARTED|First Reading Session||75
4916788|NCT03501693|12099303|P1|STARTED|First Reading Session||75
4916789|NCT03501277|12099319|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
4916790|NCT03501277|12099320|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
4916791|NCT03501277|12099321|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
4916792|NCT03501277|12099322|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
4916793|NCT03501277|12099319|P4|COMPLETED|Intervention Period 4 (4 Days)||15
4916794|NCT03501277|12099320|P3|COMPLETED|Intervention Period 4 (4 Days)||17
4916795|NCT03501277|12099321|P2|COMPLETED|Intervention Period 4 (4 Days)||18
4916796|NCT03501277|12099322|P1|COMPLETED|Intervention Period 4 (4 Days)||18
4916797|NCT03501277|12099319|P4|STARTED|Intervention Period 4 (4 Days)||15
4916798|NCT03501277|12099320|P3|STARTED|Intervention Period 4 (4 Days)||17
4916799|NCT03501277|12099321|P2|STARTED|Intervention Period 4 (4 Days)||18
4916800|NCT03501277|12099322|P1|STARTED|Intervention Period 4 (4 Days)||18
4916801|NCT03501277|12099319|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916802|NCT03501277|12099320|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916803|NCT03501277|12099321|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916804|NCT03501277|12099322|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
4916805|NCT03501277|12099319|P4|COMPLETED|Washout Period 3 (7 Days)||15
4916806|NCT03501277|12099320|P3|COMPLETED|Washout Period 3 (7 Days)||17
4916807|NCT03501277|12099321|P2|COMPLETED|Washout Period 3 (7 Days)||18
4916808|NCT03501277|12099322|P1|COMPLETED|Washout Period 3 (7 Days)||18
4916809|NCT03501277|12099319|P4|STARTED|Washout Period 3 (7 Days)||15
4916810|NCT03501277|12099320|P3|STARTED|Washout Period 3 (7 Days)||17
4916811|NCT03501277|12099321|P2|STARTED|Washout Period 3 (7 Days)||18
4916812|NCT03501277|12099322|P1|STARTED|Washout Period 3 (7 Days)||18
4916813|NCT03501277|12099319|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
4916814|NCT03501277|12099320|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
4916815|NCT03501277|12099321|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
4916816|NCT03501277|12099322|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
4916817|NCT03501277|12099319|P4|COMPLETED|Intervention Period 3 (4 Days)||15
4916818|NCT03501277|12099320|P3|COMPLETED|Intervention Period 3 (4 Days)||17
4916819|NCT03501277|12099321|P2|COMPLETED|Intervention Period 3 (4 Days)||18
4916820|NCT03501277|12099322|P1|COMPLETED|Intervention Period 3 (4 Days)||18
4916821|NCT03501277|12099319|P4|STARTED|Intervention Period 3 (4 Days)||16
4916822|NCT03501277|12099320|P3|STARTED|Intervention Period 3 (4 Days)||17
4916823|NCT03501277|12099321|P2|STARTED|Intervention Period 3 (4 Days)||18
4916824|NCT03501277|12099322|P1|STARTED|Intervention Period 3 (4 Days)||18
4916825|NCT03501277|12099319|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916826|NCT03501277|12099320|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916827|NCT03501277|12099321|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916828|NCT03501277|12099322|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4916829|NCT03501277|12099319|P4|COMPLETED|Washout Period 2 (7 Days)||16
4916830|NCT03501277|12099320|P3|COMPLETED|Washout Period 2 (7 Days)||17
4916831|NCT03501277|12099321|P2|COMPLETED|Washout Period 2 (7 Days)||18
4916832|NCT03501277|12099322|P1|COMPLETED|Washout Period 2 (7 Days)||18
4916833|NCT03501277|12099319|P4|STARTED|Washout Period 2 (7 Days)||16
4916834|NCT03501277|12099320|P3|STARTED|Washout Period 2 (7 Days)||17
4916835|NCT03501277|12099321|P2|STARTED|Washout Period 2 (7 Days)||18
4916836|NCT03501277|12099322|P1|STARTED|Washout Period 2 (7 Days)||18
4916837|NCT03501277|12099319|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
4916838|NCT03501277|12099320|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
4916839|NCT03501277|12099321|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
4916840|NCT03501277|12099322|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
4916841|NCT03501277|12099319|P4|COMPLETED|Intervention Period 2 (4 Days)||16
4916842|NCT03501277|12099320|P3|COMPLETED|Intervention Period 2 (4 Days)||17
4916843|NCT03501277|12099321|P2|COMPLETED|Intervention Period 2 (4 Days)||18
4916844|NCT03501277|12099322|P1|COMPLETED|Intervention Period 2 (4 Days)||18
4916845|NCT03501277|12099319|P4|STARTED|Intervention Period 2 (4 Days)||17
4916846|NCT03501277|12099320|P3|STARTED|Intervention Period 2 (4 Days)||17
4916847|NCT03501277|12099321|P2|STARTED|Intervention Period 2 (4 Days)||18
4916848|NCT03501277|12099322|P1|STARTED|Intervention Period 2 (4 Days)||18
4916849|NCT03501277|12099319|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916850|NCT03501277|12099320|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916851|NCT03501277|12099321|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916852|NCT03501277|12099322|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4916853|NCT03501277|12099319|P4|COMPLETED|Washout Period 1 (7 Days)||17
4916854|NCT03501277|12099320|P3|COMPLETED|Washout Period 1 (7 Days)||17
4916855|NCT03501277|12099321|P2|COMPLETED|Washout Period 1 (7 Days)||18
4916856|NCT03501277|12099322|P1|COMPLETED|Washout Period 1 (7 Days)||18
4916857|NCT03501277|12099319|P4|STARTED|Washout Period 1 (7 Days)||17
4916858|NCT03501277|12099320|P3|STARTED|Washout Period 1 (7 Days)||17
4916859|NCT03501277|12099321|P2|STARTED|Washout Period 1 (7 Days)||18
4916860|NCT03501277|12099322|P1|STARTED|Washout Period 1 (7 Days)||18
4916861|NCT03501277|12099319|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
4916862|NCT03501277|12099320|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
4916863|NCT03501277|12099321|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
4916864|NCT03501277|12099322|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
4916865|NCT03501277|12099319|P4|COMPLETED|Intervention Period 1 (4 Days)||17
4916866|NCT03501277|12099320|P3|COMPLETED|Intervention Period 1 (4 Days)||17
4916867|NCT03501277|12099321|P2|COMPLETED|Intervention Period 1 (4 Days)||18
4916868|NCT03501277|12099322|P1|COMPLETED|Intervention Period 1 (4 Days)||18
4916869|NCT03501277|12099319|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
4916870|NCT03501277|12099320|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
4916871|NCT03501277|12099321|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
4916872|NCT03501277|12099322|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
4916873|NCT03501277|12099319|P4|STARTED|Intervention Period 1 (4 Days)||18
4916874|NCT03501277|12099320|P3|STARTED|Intervention Period 1 (4 Days)||18
4916875|NCT03501277|12099321|P2|STARTED|Intervention Period 1 (4 Days)||18
4916876|NCT03501277|12099322|P1|STARTED|Intervention Period 1 (4 Days)||18
4916877|NCT03501264|12099338|P2|NOT COMPLETED|Overall Study||0
4916878|NCT03501264|12099339|P1|NOT COMPLETED|Overall Study||0
4916879|NCT03501264|12099338|P2|COMPLETED|Overall Study||120
4916880|NCT03501264|12099339|P1|COMPLETED|Overall Study||120
4916881|NCT03501264|12099338|P2|STARTED|Overall Study||120
4916882|NCT03501264|12099339|P1|STARTED|Overall Study||120
4916883|NCT03501069|12099354|P9|NOT COMPLETED|Period B||0
4916884|NCT03501069|12099355|P8|NOT COMPLETED|Period B||0
4916885|NCT03501069|12099356|P7|NOT COMPLETED|Period B||0
4916886|NCT03501069|12099357|P6|NOT COMPLETED|Period B||0
4916887|NCT03501069|12099358|P5|NOT COMPLETED|Period B||0
4916888|NCT03501069|12099359|P4|NOT COMPLETED|Period B||0
4916889|NCT03501069|12099360|P3|NOT COMPLETED|Period B||0
4916890|NCT03501069|12099361|P2|NOT COMPLETED|Period B||0
4916891|NCT03501069|12099362|P1|NOT COMPLETED|Period B||0
4916892|NCT03501069|12099354|P9|COMPLETED|Period B||0
4916893|NCT03501069|12099355|P8|COMPLETED|Period B||0
4916894|NCT03501069|12099356|P7|COMPLETED|Period B||0
4916895|NCT03501069|12099357|P6|COMPLETED|Period B||0
4916896|NCT03501069|12099358|P5|COMPLETED|Period B||0
4916897|NCT03501069|12099359|P4|COMPLETED|Period B||0
4916898|NCT03501069|12099360|P3|COMPLETED|Period B||2
4916899|NCT03501069|12099361|P2|COMPLETED|Period B||4
4916900|NCT03501069|12099362|P1|COMPLETED|Period B||2
4916901|NCT03501069|12099354|P9|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916902|NCT03501069|12099355|P8|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916903|NCT03501069|12099356|P7|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916904|NCT03501069|12099357|P6|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916905|NCT03501069|12099358|P5|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916906|NCT03501069|12099359|P4|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916907|NCT03501069|12099360|P3|STARTED|Period B||2
4916908|NCT03501069|12099361|P2|STARTED|Period B||4
4916909|NCT03501069|12099362|P1|STARTED|Period B||2
4916910|NCT03501069|12099354|P9|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916911|NCT03501069|12099355|P8|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916912|NCT03501069|12099356|P7|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916913|NCT03501069|12099357|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916914|NCT03501069|12099358|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916915|NCT03501069|12099359|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916916|NCT03501069|12099360|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916917|NCT03501069|12099361|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916918|NCT03501069|12099362|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4916919|NCT03501069|12099354|P9|COMPLETED|Washout Period (at Least 14 Days)||0
4916920|NCT03501069|12099355|P8|COMPLETED|Washout Period (at Least 14 Days)||0
4916921|NCT03501069|12099356|P7|COMPLETED|Washout Period (at Least 14 Days)||0
4916922|NCT03501069|12099357|P6|COMPLETED|Washout Period (at Least 14 Days)||0
4916923|NCT03501069|12099358|P5|COMPLETED|Washout Period (at Least 14 Days)||0
4916924|NCT03501069|12099359|P4|COMPLETED|Washout Period (at Least 14 Days)||0
4916925|NCT03501069|12099360|P3|COMPLETED|Washout Period (at Least 14 Days)||2
4916926|NCT03501069|12099361|P2|COMPLETED|Washout Period (at Least 14 Days)||4
4916927|NCT03501069|12099362|P1|COMPLETED|Washout Period (at Least 14 Days)||2
4916928|NCT03501069|12099354|P9|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916929|NCT03501069|12099355|P8|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916930|NCT03501069|12099356|P7|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916931|NCT03501069|12099357|P6|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916932|NCT03501069|12099358|P5|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916933|NCT03501069|12099359|P4|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
4916934|NCT03501069|12099360|P3|STARTED|Washout Period (at Least 14 Days)||2
4916935|NCT03501069|12099361|P2|STARTED|Washout Period (at Least 14 Days)||4
4916936|NCT03501069|12099362|P1|STARTED|Washout Period (at Least 14 Days)||2
4916937|NCT03501069|12099354|P9|NOT COMPLETED|Period A||0
4916938|NCT03501069|12099355|P8|NOT COMPLETED|Period A||0
4916939|NCT03501069|12099356|P7|NOT COMPLETED|Period A||0
4916940|NCT03501069|12099357|P6|NOT COMPLETED|Period A||0
4916941|NCT03501069|12099358|P5|NOT COMPLETED|Period A||0
4916942|NCT03501069|12099359|P4|NOT COMPLETED|Period A||0
4916943|NCT03501069|12099360|P3|NOT COMPLETED|Period A||0
4916944|NCT03501069|12099361|P2|NOT COMPLETED|Period A||0
4916945|NCT03501069|12099362|P1|NOT COMPLETED|Period A||0
4916946|NCT03501069|12099354|P9|COMPLETED|Period A||3
4916947|NCT03501069|12099355|P8|COMPLETED|Period A||3
4916948|NCT03501069|12099356|P7|COMPLETED|Period A||6
4916949|NCT03501069|12099357|P6|COMPLETED|Period A||6
4916950|NCT03501069|12099358|P5|COMPLETED|Period A||1
4916951|NCT03501069|12099359|P4|COMPLETED|Period A||5
4916952|NCT03501069|12099360|P3|COMPLETED|Period A||2
4916953|NCT03501069|12099361|P2|COMPLETED|Period A||4
4916954|NCT03501069|12099362|P1|COMPLETED|Period A||2
4916955|NCT03501069|12099354|P9|STARTED|Period A||3
4916956|NCT03501069|12099355|P8|STARTED|Period A||3
4916957|NCT03501069|12099356|P7|STARTED|Period A||6
4916958|NCT03501069|12099357|P6|STARTED|Period A||6
4916959|NCT03501069|12099358|P5|STARTED|Period A||1
4916960|NCT03501069|12099359|P4|STARTED|Period A||5
4916961|NCT03501069|12099360|P3|STARTED|Period A||2
4916962|NCT03501069|12099361|P2|STARTED|Period A||4
4916963|NCT03501069|12099362|P1|STARTED|Period A||2
4916964|NCT03501043|12099432|P1|NOT COMPLETED|Overall Study||1
4916965|NCT03501043|12099432|P1|COMPLETED|Overall Study||10
4916966|NCT03501043|12099432|P1|STARTED|Overall Study||11
4916967|NCT03500679|12099449|P2|NOT COMPLETED|Overall Study||3
4916968|NCT03500679|12099450|P1|NOT COMPLETED|Overall Study||9
4916969|NCT03500679|12099449|P2|COMPLETED|Overall Study||22
4916970|NCT03500679|12099450|P1|COMPLETED|Overall Study||66
4916971|NCT03500679|12099449|P2|STARTED|Overall Study||25
4916972|NCT03500679|12099450|P1|STARTED|Overall Study||75
4916973|NCT03500406|12099498|P2|NOT COMPLETED|Overall Study||0
4916974|NCT03500406|12099499|P1|NOT COMPLETED|Overall Study||0
4916975|NCT03500406|12099498|P2|COMPLETED|Overall Study||20
4916976|NCT03500406|12099499|P1|COMPLETED|Overall Study||4
4916977|NCT03500406|12099498|P2|STARTED|Overall Study||20
4916978|NCT03500406|12099499|P1|STARTED|Overall Study||4
4916979|NCT03500302|12099517|P1|NOT COMPLETED|Overall Study||0
4916980|NCT03500302|12099517|P1|COMPLETED|Overall Study||19
4916981|NCT03500302|12099517|P1|STARTED|Overall Study||19
4916982|NCT03500224|12099522|P1|NOT COMPLETED|Overall Study||2
4916983|NCT03500224|12099522|P1|COMPLETED|Overall Study||4
4916984|NCT03500224|12099522|P1|STARTED|Overall Study||6
4916985|NCT03500211|12099561|P2|NOT COMPLETED|Overall Study||1
4916986|NCT03500211|12099562|P1|NOT COMPLETED|Overall Study||1
4916987|NCT03500211|12099561|P2|COMPLETED|Overall Study||24
4916988|NCT03500211|12099562|P1|COMPLETED|Overall Study||24
4916989|NCT03500211|12099561|P2|STARTED|Overall Study||25
4916990|NCT03500211|12099562|P1|STARTED|Overall Study||25
4916991|NCT03500198|12099578|P2|NOT COMPLETED|Overall Study||1
4916992|NCT03500198|12099579|P1|NOT COMPLETED|Overall Study||0
4916993|NCT03500198|12099578|P2|COMPLETED|Overall Study||107
4916994|NCT03500198|12099579|P1|COMPLETED|Overall Study||110
4916995|NCT03500198|12099578|P2|Second Eye|Overall Study||108
4916996|NCT03500198|12099579|P1|Second Eye|Overall Study||109
4916997|NCT03500198|12099578|P2|First Eye|Overall Study||108
4916998|NCT03500198|12099579|P1|First Eye|Overall Study||110
4916999|NCT03500198|12099578|P2|STARTED|Overall Study||108
4917000|NCT03500198|12099579|P1|STARTED|Overall Study||110
4917001|NCT03500159|12099595|P2|NOT COMPLETED|Overall Study||1
4917002|NCT03500159|12099596|P1|NOT COMPLETED|Overall Study||2
4917003|NCT03500159|12099595|P2|COMPLETED|Overall Study||0
4917004|NCT03500159|12099596|P1|COMPLETED|Overall Study||0
4917005|NCT03500159|12099595|P2|STARTED|Overall Study||1
4917006|NCT03500159|12099596|P1|STARTED|Overall Study||2
4917007|NCT03498300|12099604|P2|NOT COMPLETED|Overall Study||8
4917008|NCT03498300|12099605|P1|NOT COMPLETED|Overall Study||3
4917009|NCT03498300|12099604|P2|COMPLETED|Overall Study||13
4917010|NCT03498300|12099605|P1|COMPLETED|Overall Study||18
4917011|NCT03498300|12099604|P2|STARTED|Overall Study||21
4917012|NCT03498300|12099605|P1|STARTED|Overall Study||21
4917013|NCT03498287|12099614|P2|NOT COMPLETED|Overall Study||5
4917014|NCT03498287|12099615|P1|NOT COMPLETED|Overall Study||3
4917015|NCT03498287|12099614|P2|COMPLETED|Overall Study||38
4917016|NCT03498287|12099615|P1|COMPLETED|Overall Study||42
4917017|NCT03498287|12099614|P2|STARTED|Overall Study||43
4917018|NCT03498287|12099615|P1|STARTED|Overall Study||45
4917019|NCT03497845|12099635|P12|NOT COMPLETED|Overall Study||22
4917020|NCT03497845|12099636|P11|NOT COMPLETED|Overall Study||15
4917021|NCT03497845|12099637|P10|NOT COMPLETED|Overall Study||6
4917022|NCT03497845|12099638|P9|NOT COMPLETED|Overall Study||14
4917023|NCT03497845|12099639|P8|NOT COMPLETED|Overall Study||10
4917024|NCT03497845|12099640|P7|NOT COMPLETED|Overall Study||8
4917025|NCT03497845|12099641|P6|NOT COMPLETED|Overall Study||18
4917026|NCT03497845|12099642|P5|NOT COMPLETED|Overall Study||21
4917027|NCT03497845|12099643|P4|NOT COMPLETED|Overall Study||10
4917028|NCT03497845|12099644|P3|NOT COMPLETED|Overall Study||11
4917029|NCT03497845|12099645|P2|NOT COMPLETED|Overall Study||13
4917030|NCT03497845|12099646|P1|NOT COMPLETED|Overall Study||5
4917031|NCT03497845|12099635|P12|COMPLETED|Overall Study|Day 262|38
4917032|NCT03497845|12099636|P11|COMPLETED|Overall Study|Day 262|46
4917033|NCT03497845|12099637|P10|COMPLETED|Overall Study|Day 142|53
4917034|NCT03497845|12099638|P9|COMPLETED|Overall Study|Day 142|47
4917035|NCT03497845|12099639|P8|COMPLETED|Overall Study|Day 142|50
4917036|NCT03497845|12099640|P7|COMPLETED|Overall Study|Day 142|51
4917037|NCT03497845|12099641|P6|COMPLETED|Overall Study|Day 262|44
4917038|NCT03497845|12099642|P5|COMPLETED|Overall Study|Day 262|38
4917039|NCT03497845|12099643|P4|COMPLETED|Overall Study|Day 142|50
4917040|NCT03497845|12099644|P3|COMPLETED|Overall Study|Day 142|50
4917041|NCT03497845|12099645|P2|COMPLETED|Overall Study|Day 142|45
4917042|NCT03497845|12099646|P1|COMPLETED|Overall Study|Day 142|55
4917043|NCT03497845|12099635|P12|STARTED|Overall Study||60
4917044|NCT03497845|12099636|P11|STARTED|Overall Study||61
4917045|NCT03497845|12099637|P10|STARTED|Overall Study||59
4917046|NCT03497845|12099638|P9|STARTED|Overall Study||61
4917047|NCT03497845|12099639|P8|STARTED|Overall Study||60
4917048|NCT03497845|12099640|P7|STARTED|Overall Study||59
4917049|NCT03497845|12099641|P6|STARTED|Overall Study||62
4917050|NCT03497845|12099642|P5|STARTED|Overall Study||59
4917051|NCT03497845|12099643|P4|STARTED|Overall Study||60
4917052|NCT03497845|12099644|P3|STARTED|Overall Study||61
4917053|NCT03497845|12099645|P2|STARTED|Overall Study||58
4917054|NCT03497845|12099646|P1|STARTED|Overall Study||60
4917055|NCT03497130|12099702|P2|NOT COMPLETED|Overall Study||1
4917056|NCT03497130|12099703|P1|NOT COMPLETED|Overall Study||1
4917057|NCT03497130|12099702|P2|COMPLETED|Overall Study||13
4917058|NCT03497130|12099703|P1|COMPLETED|Overall Study||39
4917059|NCT03497130|12099702|P2|STARTED|Overall Study||14
4917060|NCT03497130|12099703|P1|STARTED|Overall Study||40
4917061|NCT03497039|12099715|P2|NOT COMPLETED|Overall Study||1
4917062|NCT03497039|12099716|P1|NOT COMPLETED|Overall Study||1
4917063|NCT03497039|12099715|P2|COMPLETED|Overall Study||16
4917064|NCT03497039|12099716|P1|COMPLETED|Overall Study||29
4917065|NCT03497039|12099715|P2|Treated|Overall Study||17
4917066|NCT03497039|12099716|P1|Treated|Overall Study||29
4917067|NCT03497039|12099715|P2|STARTED|Overall Study||17
4917068|NCT03497039|12099716|P1|STARTED|Overall Study||30
4917069|NCT03496987|12099730|P2|NOT COMPLETED|Overall Study||0
4917070|NCT03496987|12099731|P1|NOT COMPLETED|Overall Study||0
4917071|NCT03496987|12099730|P2|COMPLETED|Overall Study||51
4917072|NCT03496987|12099731|P1|COMPLETED|Overall Study||49
4917073|NCT03496987|12099730|P2|STARTED|Overall Study||51
4917074|NCT03496987|12099731|P1|STARTED|Overall Study||49
4917075|NCT03496974|12099751|P2|NOT COMPLETED|Overall Study||8
4917076|NCT03496974|12099752|P1|NOT COMPLETED|Overall Study||1
4917077|NCT03496974|12099751|P2|COMPLETED|Overall Study||20
4917078|NCT03496974|12099752|P1|COMPLETED|Overall Study||9
4917079|NCT03496974|12099751|P2|STARTED|Overall Study||28
4917080|NCT03496974|12099752|P1|STARTED|Overall Study||10
4917081|NCT03496428|12099786|P1|NOT COMPLETED|Overall Study||0
4917082|NCT03496428|12099786|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
4917083|NCT03496428|12099786|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
4917084|NCT03496324|12099791|P4|NOT COMPLETED|Period 7: Period 4||0
4917085|NCT03496324|12099792|P3|NOT COMPLETED|Period 7: Period 4||0
4917086|NCT03496324|12099793|P2|NOT COMPLETED|Period 7: Period 4||0
4917087|NCT03496324|12099794|P1|NOT COMPLETED|Period 7: Period 4||0
4917088|NCT03496324|12099791|P4|COMPLETED|Period 7: Period 4||6
4917089|NCT03496324|12099792|P3|COMPLETED|Period 7: Period 4||6
4917090|NCT03496324|12099793|P2|COMPLETED|Period 7: Period 4||6
4917091|NCT03496324|12099794|P1|COMPLETED|Period 7: Period 4||6
4917092|NCT03496324|12099791|P4|STARTED|Period 7: Period 4||6
4917093|NCT03496324|12099792|P3|STARTED|Period 7: Period 4||6
4917094|NCT03496324|12099793|P2|STARTED|Period 7: Period 4||6
4917095|NCT03496324|12099794|P1|STARTED|Period 7: Period 4||6
4917096|NCT03496324|12099791|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4917097|NCT03496324|12099792|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4917098|NCT03496324|12099793|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4917099|NCT03496324|12099794|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4917100|NCT03496324|12099791|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4917101|NCT03496324|12099792|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4917102|NCT03496324|12099793|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4917103|NCT03496324|12099794|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4917104|NCT03496324|12099791|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
4917105|NCT03496324|12099792|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
4917106|NCT03496324|12099793|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
4917107|NCT03496324|12099794|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
4917108|NCT03496324|12099791|P4|NOT COMPLETED|Period 3||0
4917109|NCT03496324|12099792|P3|NOT COMPLETED|Period 3||0
4917110|NCT03496324|12099793|P2|NOT COMPLETED|Period 3||0
4917111|NCT03496324|12099794|P1|NOT COMPLETED|Period 3||0
4917112|NCT03496324|12099791|P4|COMPLETED|Period 3||6
4917113|NCT03496324|12099792|P3|COMPLETED|Period 3||6
4917114|NCT03496324|12099793|P2|COMPLETED|Period 3||6
4917115|NCT03496324|12099794|P1|COMPLETED|Period 3||6
4917116|NCT03496324|12099791|P4|STARTED|Period 3||6
4917117|NCT03496324|12099792|P3|STARTED|Period 3||6
4917118|NCT03496324|12099793|P2|STARTED|Period 3||6
4917119|NCT03496324|12099794|P1|STARTED|Period 3||6
4917120|NCT03496324|12099791|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4917121|NCT03496324|12099792|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4917122|NCT03496324|12099793|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4917123|NCT03496324|12099794|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4917124|NCT03496324|12099791|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4917125|NCT03496324|12099792|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4917126|NCT03496324|12099793|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4917127|NCT03496324|12099794|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4917128|NCT03496324|12099791|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
4917129|NCT03496324|12099792|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
4917130|NCT03496324|12099793|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
4917131|NCT03496324|12099794|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
4917132|NCT03496324|12099791|P4|NOT COMPLETED|Period 2||0
4917133|NCT03496324|12099792|P3|NOT COMPLETED|Period 2||0
4917134|NCT03496324|12099793|P2|NOT COMPLETED|Period 2||0
4917135|NCT03496324|12099794|P1|NOT COMPLETED|Period 2||0
4917136|NCT03496324|12099791|P4|COMPLETED|Period 2||6
4917137|NCT03496324|12099792|P3|COMPLETED|Period 2||6
4917138|NCT03496324|12099793|P2|COMPLETED|Period 2||6
4917139|NCT03496324|12099794|P1|COMPLETED|Period 2||6
4917140|NCT03496324|12099791|P4|STARTED|Period 2||6
4917141|NCT03496324|12099792|P3|STARTED|Period 2||6
4917142|NCT03496324|12099793|P2|STARTED|Period 2||6
4917143|NCT03496324|12099794|P1|STARTED|Period 2||6
4917144|NCT03496324|12099791|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4917145|NCT03496324|12099792|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4917146|NCT03496324|12099793|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4917147|NCT03496324|12099794|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4917148|NCT03496324|12099791|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
4917149|NCT03496324|12099792|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
4917150|NCT03496324|12099793|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
4917151|NCT03496324|12099794|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
4917152|NCT03496324|12099791|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
4917153|NCT03496324|12099792|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
4917154|NCT03496324|12099793|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
4917155|NCT03496324|12099794|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
4917156|NCT03496324|12099791|P4|NOT COMPLETED|Period 1||0
4917157|NCT03496324|12099792|P3|NOT COMPLETED|Period 1||0
4917158|NCT03496324|12099793|P2|NOT COMPLETED|Period 1||0
4917159|NCT03496324|12099794|P1|NOT COMPLETED|Period 1||0
4917160|NCT03496324|12099791|P4|COMPLETED|Period 1||6
4917161|NCT03496324|12099792|P3|COMPLETED|Period 1||6
4917162|NCT03496324|12099793|P2|COMPLETED|Period 1||6
4917163|NCT03496324|12099794|P1|COMPLETED|Period 1||6
4917164|NCT03496324|12099791|P4|STARTED|Period 1||6
4917165|NCT03496324|12099792|P3|STARTED|Period 1||6
4917166|NCT03496324|12099793|P2|STARTED|Period 1||6
4917167|NCT03496324|12099794|P1|STARTED|Period 1||6
4917168|NCT03495856|12099832|P1|NOT COMPLETED|Overall Study||1
4917169|NCT03495856|12099832|P1|COMPLETED|Overall Study||22
4917170|NCT03495856|12099832|P1|STARTED|Overall Study||23
4917171|NCT03495102|12099853|P3|NOT COMPLETED|Overall Study||54
4917172|NCT03495102|12099854|P2|NOT COMPLETED|Overall Study||67
4917173|NCT03495102|12099855|P1|NOT COMPLETED|Overall Study||56
4917174|NCT03495102|12099853|P3|COMPLETED|Overall Study||560
4917175|NCT03495102|12099854|P2|COMPLETED|Overall Study||549
4917176|NCT03495102|12099855|P1|COMPLETED|Overall Study||556
4917177|NCT03495102|12099853|P3|Received at Least One Dose of Study Drug|Overall Study||614
4917178|NCT03495102|12099854|P2|Received at Least One Dose of Study Drug|Overall Study||616
4917179|NCT03495102|12099855|P1|Received at Least One Dose of Study Drug|Overall Study||612
4917180|NCT03495102|12099853|P3|STARTED|Overall Study||614
4917181|NCT03495102|12099854|P2|STARTED|Overall Study||616
4917182|NCT03495102|12099855|P1|STARTED|Overall Study||612
4917183|NCT03494985|12099885|P4|NOT COMPLETED|Overall Study||5
4917184|NCT03494985|12099886|P3|NOT COMPLETED|Overall Study||6
4917185|NCT03494985|12099887|P2|NOT COMPLETED|Overall Study||6
4917186|NCT03494985|12099888|P1|NOT COMPLETED|Overall Study||5
4917187|NCT03494985|12099885|P4|COMPLETED|Overall Study||94
4917188|NCT03494985|12099886|P3|COMPLETED|Overall Study||92
4917189|NCT03494985|12099887|P2|COMPLETED|Overall Study||92
4917190|NCT03494985|12099888|P1|COMPLETED|Overall Study||96
4917191|NCT03494985|12099885|P4|STARTED|Overall Study||99
4917192|NCT03494985|12099886|P3|STARTED|Overall Study||98
4917193|NCT03494985|12099887|P2|STARTED|Overall Study||98
4917194|NCT03494985|12099888|P1|STARTED|Overall Study||101
4917195|NCT03493854|12099924|P2|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
4917196|NCT03493854|12099925|P1|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
4917197|NCT03493854|12099924|P2|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
4917198|NCT03493854|12099925|P1|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
4917199|NCT03493854|12099924|P2|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
4917200|NCT03493854|12099925|P1|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
4917201|NCT03493854|12099924|P2|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
4917202|NCT03493854|12099925|P1|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
4917203|NCT03493854|12099924|P2|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
4917204|NCT03493854|12099925|P1|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
4917205|NCT03493854|12099924|P2|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
4917206|NCT03493854|12099925|P1|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
4917207|NCT03493854|12099924|P2|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
4917208|NCT03493854|12099925|P1|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
4917209|NCT03493854|12099924|P2|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
4917210|NCT03493854|12099925|P1|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
4917211|NCT03493854|12099924|P2|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
4917212|NCT03493854|12099925|P1|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
4917213|NCT03493854|12099924|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
4917214|NCT03493854|12099925|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
4917215|NCT03493854|12099924|P2|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
4917216|NCT03493854|12099925|P1|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
4917217|NCT03493828|12099946|P3|NOT COMPLETED|Overall Study||0
4917218|NCT03493828|12099947|P2|NOT COMPLETED|Overall Study||0
4917219|NCT03493828|12099948|P1|NOT COMPLETED|Overall Study||0
4917220|NCT03493828|12099946|P3|COMPLETED|Overall Study||20
4917221|NCT03493828|12099947|P2|COMPLETED|Overall Study||20
4917222|NCT03493828|12099948|P1|COMPLETED|Overall Study||20
4917223|NCT03493828|12099946|P3|STARTED|Overall Study||20
4917224|NCT03493828|12099947|P2|STARTED|Overall Study||20
4917225|NCT03493828|12099948|P1|STARTED|Overall Study||20
4917226|NCT03493815|12099958|P2|NOT COMPLETED|Overall Study||11
4917227|NCT03493815|12099959|P1|NOT COMPLETED|Overall Study||9
4917228|NCT03493815|12099958|P2|COMPLETED|Overall Study||32
4917229|NCT03493815|12099959|P1|COMPLETED|Overall Study||33
4917230|NCT03493815|12099958|P2|STARTED|Overall Study||43
4917231|NCT03493815|12099959|P1|STARTED|Overall Study||42
4917232|NCT03493542|12099973|P2|NOT COMPLETED|Overall Study||9
4917233|NCT03493542|12099974|P1|NOT COMPLETED|Overall Study||7
4917234|NCT03493542|12099973|P2|COMPLETED|Overall Study||374
4917235|NCT03493542|12099974|P1|COMPLETED|Overall Study||376
4917236|NCT03493542|12099973|P2|Vaccination 3|Overall Study||374
4917237|NCT03493542|12099974|P1|Vaccination 3|Overall Study||376
4917238|NCT03493542|12099973|P2|Vaccination 2|Overall Study||378
4917239|NCT03493542|12099974|P1|Vaccination 2|Overall Study||379
4917240|NCT03493542|12099973|P2|Vaccination 1|Overall Study||383
4917241|NCT03493542|12099974|P1|Vaccination 1|Overall Study||383
4917242|NCT03493542|12099973|P2|STARTED|Overall Study||383
4917243|NCT03493542|12099974|P1|STARTED|Overall Study||383
4917244|NCT03493386|12099998|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917245|NCT03493386|12099999|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917246|NCT03493386|12100000|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917247|NCT03493386|12100001|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917248|NCT03493386|12099998|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
4917249|NCT03493386|12099999|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
4917250|NCT03493386|12100000|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917251|NCT03493386|12100001|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
4917252|NCT03493386|12099998|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
4917253|NCT03493386|12099999|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
4917254|NCT03493386|12100000|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
4917255|NCT03493386|12100001|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
4917256|NCT03493386|12099998|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917257|NCT03493386|12099999|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917258|NCT03493386|12100000|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917259|NCT03493386|12100001|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917260|NCT03493386|12099998|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
4917261|NCT03493386|12099999|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
4917262|NCT03493386|12100000|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917263|NCT03493386|12100001|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
4917264|NCT03493386|12099998|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
4917265|NCT03493386|12099999|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
4917266|NCT03493386|12100000|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
4917267|NCT03493386|12100001|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
4917268|NCT03493386|12099998|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917269|NCT03493386|12099999|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917270|NCT03493386|12100000|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917271|NCT03493386|12100001|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917272|NCT03493386|12099998|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
4917273|NCT03493386|12099999|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
4917274|NCT03493386|12100000|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917275|NCT03493386|12100001|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
4917276|NCT03493386|12099998|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
4917277|NCT03493386|12099999|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
4917278|NCT03493386|12100000|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
4917279|NCT03493386|12100001|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
4917280|NCT03493386|12099998|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917281|NCT03493386|12099999|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917282|NCT03493386|12100000|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917283|NCT03493386|12100001|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917284|NCT03493386|12099998|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917285|NCT03493386|12099999|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
4917286|NCT03493386|12100000|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
4917287|NCT03493386|12100001|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
4917288|NCT03493386|12099998|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
4917289|NCT03493386|12099999|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
4917290|NCT03493386|12100000|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
4917291|NCT03493386|12100001|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
4917292|NCT03493386|12099998|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
4917293|NCT03493386|12099999|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
4917294|NCT03493386|12100000|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
4917295|NCT03493386|12100001|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
4917296|NCT03493386|12099998|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
4917297|NCT03493386|12099999|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
4917298|NCT03493386|12100000|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
4917299|NCT03493386|12100001|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
4917300|NCT03493386|12099998|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
4917301|NCT03493386|12099999|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
4917302|NCT03493386|12100000|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
4917303|NCT03493386|12100001|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
4917304|NCT03493386|12099998|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917305|NCT03493386|12099999|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917306|NCT03493386|12100000|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917307|NCT03493386|12100001|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917308|NCT03493386|12099998|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917309|NCT03493386|12099999|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
4917310|NCT03493386|12100000|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
4917311|NCT03493386|12100001|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
4917312|NCT03493386|12099998|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
4917313|NCT03493386|12099999|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
4917314|NCT03493386|12100000|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
4917315|NCT03493386|12100001|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
4917316|NCT03492554|12100121|P2|NOT COMPLETED|Overall Study||14
4917317|NCT03492554|12100122|P1|NOT COMPLETED|Overall Study||0
4917318|NCT03492554|12100121|P2|COMPLETED|Overall Study||287
4917319|NCT03492554|12100122|P1|COMPLETED|Overall Study||301
4917320|NCT03492554|12100121|P2|STARTED|Overall Study||301
4917321|NCT03492554|12100122|P1|STARTED|Overall Study||301
4917322|NCT03491917|12100134|P2|NOT COMPLETED|Second Reading Session||0
4917323|NCT03491917|12100135|P1|NOT COMPLETED|Second Reading Session||0
4917324|NCT03491917|12100134|P2|COMPLETED|Second Reading Session||50
4917325|NCT03491917|12100135|P1|COMPLETED|Second Reading Session||50
4917326|NCT03491917|12100134|P2|STARTED|Second Reading Session||50
4917327|NCT03491917|12100135|P1|STARTED|Second Reading Session||50
4917328|NCT03491917|12100134|P2|NOT COMPLETED|4 Week Memory Washout Period||0
4917329|NCT03491917|12100135|P1|NOT COMPLETED|4 Week Memory Washout Period||0
4917330|NCT03491917|12100134|P2|COMPLETED|4 Week Memory Washout Period||50
4917331|NCT03491917|12100135|P1|COMPLETED|4 Week Memory Washout Period||50
4917332|NCT03491917|12100134|P2|STARTED|4 Week Memory Washout Period||50
4917333|NCT03491917|12100135|P1|STARTED|4 Week Memory Washout Period||50
4917334|NCT03491917|12100134|P2|NOT COMPLETED|First Reading Session||0
4917335|NCT03491917|12100135|P1|NOT COMPLETED|First Reading Session||0
4917336|NCT03491917|12100134|P2|COMPLETED|First Reading Session||50
4917337|NCT03491917|12100135|P1|COMPLETED|First Reading Session||50
4917338|NCT03491917|12100134|P2|STARTED|First Reading Session||50
4917339|NCT03491917|12100135|P1|STARTED|First Reading Session||50
4917340|NCT03491891|12100143|P2|NOT COMPLETED|Overall Study||380
4917341|NCT03491891|12100144|P1|NOT COMPLETED|Overall Study||853
4917342|NCT03491891|12100143|P2|COMPLETED|Overall Study||2058
4917343|NCT03491891|12100144|P1|COMPLETED|Overall Study||5185
4917344|NCT03491891|12100143|P2|STARTED|Overall Study||2438
4917345|NCT03491891|12100144|P1|STARTED|Overall Study||6038
4917346|NCT03491553|12100156|P6|NOT COMPLETED|Overall Study||0
4917347|NCT03491553|12100157|P5|NOT COMPLETED|Overall Study||0
4917348|NCT03491553|12100158|P4|NOT COMPLETED|Overall Study||1
4917349|NCT03491553|12100159|P3|NOT COMPLETED|Overall Study||0
4917350|NCT03491553|12100160|P2|NOT COMPLETED|Overall Study||1
4917351|NCT03491553|12100161|P1|NOT COMPLETED|Overall Study||1
4917352|NCT03491553|12100156|P6|COMPLETED|Overall Study||4
4917353|NCT03491553|12100157|P5|COMPLETED|Overall Study||5
4917354|NCT03491553|12100158|P4|COMPLETED|Overall Study||9
4917355|NCT03491553|12100159|P3|COMPLETED|Overall Study||10
4917356|NCT03491553|12100160|P2|COMPLETED|Overall Study||9
4917357|NCT03491553|12100161|P1|COMPLETED|Overall Study||8
4917358|NCT03491553|12100156|P6|STARTED|Overall Study||4
4917359|NCT03491553|12100157|P5|STARTED|Overall Study||5
4917360|NCT03491553|12100158|P4|STARTED|Overall Study||10
4917361|NCT03491553|12100159|P3|STARTED|Overall Study||10
4917362|NCT03491553|12100160|P2|STARTED|Overall Study||10
4917363|NCT03491553|12100161|P1|STARTED|Overall Study||9
4917364|NCT03491228|12100268|P1|NOT COMPLETED|Overall Study||0
4917365|NCT03491228|12100268|P1|COMPLETED|Overall Study||107
4917366|NCT03491228|12100268|P1|STARTED|Overall Study||107
4917367|NCT03491150|12100276|P2|NOT COMPLETED|Overall Study||73
4917368|NCT03491150|12100277|P1|NOT COMPLETED|Overall Study||76
4917369|NCT03491150|12100276|P2|COMPLETED|Overall Study||0
4917370|NCT03491150|12100277|P1|COMPLETED|Overall Study||0
4917371|NCT03491150|12100276|P2|STARTED|Overall Study||73
4917372|NCT03491150|12100277|P1|STARTED|Overall Study||76
4917373|NCT03490916|12100287|P2|NOT COMPLETED|Overall Study||0
4917374|NCT03490916|12100288|P1|NOT COMPLETED|Overall Study||0
4917375|NCT03490916|12100287|P2|COMPLETED|Overall Study||0
4917376|NCT03490916|12100288|P1|COMPLETED|Overall Study||0
4917377|NCT03490916|12100287|P2|STARTED|Overall Study||0
4917378|NCT03490916|12100288|P1|STARTED|Overall Study||0
4917379|NCT03490110|12100298|P2|NOT COMPLETED|Overall Study||3
4917380|NCT03490110|12100299|P1|NOT COMPLETED|Overall Study||3
4917381|NCT03490110|12100298|P2|COMPLETED|Overall Study||6
4917382|NCT03490110|12100299|P1|COMPLETED|Overall Study||6
4917383|NCT03490110|12100298|P2|STARTED|Overall Study||9
4917384|NCT03490110|12100299|P1|STARTED|Overall Study||9
4917385|NCT03489720|12100315|P2|NOT COMPLETED|Overall Study||0
4917386|NCT03489720|12100316|P1|NOT COMPLETED|Overall Study||2
4917387|NCT03489720|12100315|P2|COMPLETED|Overall Study||22
4917388|NCT03489720|12100316|P1|COMPLETED|Overall Study||22
4917389|NCT03489720|12100315|P2|STARTED|Overall Study||22
4917390|NCT03489720|12100316|P1|STARTED|Overall Study||24
4917391|NCT03489551|12100341|P1|NOT COMPLETED|Overall Study||2
4917392|NCT03489551|12100341|P1|COMPLETED|Overall Study||15
4917393|NCT03489551|12100341|P1|STARTED|Overall Study||17
4917394|NCT03489304|12100345|P1|NOT COMPLETED|Overall Study||4
4917395|NCT03489304|12100345|P1|COMPLETED|Overall Study||16
4917396|NCT03489304|12100345|P1|STARTED|Overall Study||20
4917397|NCT03488108|12100353|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
4917398|NCT03488108|12100354|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
4917399|NCT03488108|12100353|P2|COMPLETED|Second Intervention (12 Weeks)||9
4917400|NCT03488108|12100354|P1|COMPLETED|Second Intervention (12 Weeks)||9
4917401|NCT03488108|12100353|P2|STARTED|Second Intervention (12 Weeks)||9
4917402|NCT03488108|12100354|P1|STARTED|Second Intervention (12 Weeks)||10
4917403|NCT03488108|12100353|P2|NOT COMPLETED|Washout (2 Months)||0
4917404|NCT03488108|12100354|P1|NOT COMPLETED|Washout (2 Months)||0
4917405|NCT03488108|12100353|P2|COMPLETED|Washout (2 Months)||9
4917406|NCT03488108|12100354|P1|COMPLETED|Washout (2 Months)||10
4917407|NCT03488108|12100353|P2|STARTED|Washout (2 Months)||9
4917408|NCT03488108|12100354|P1|STARTED|Washout (2 Months)||10
4917409|NCT03488108|12100353|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
4917410|NCT03488108|12100354|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
4917411|NCT03488108|12100353|P2|COMPLETED|First Intervention (12 Weeks)||9
4917412|NCT03488108|12100354|P1|COMPLETED|First Intervention (12 Weeks)||10
4917413|NCT03488108|12100353|P2|STARTED|First Intervention (12 Weeks)||10
4917414|NCT03488108|12100354|P1|STARTED|First Intervention (12 Weeks)||10
4917415|NCT03488030|12100372|P2|NOT COMPLETED|Overall Study||0
4917416|NCT03488030|12100373|P1|NOT COMPLETED|Overall Study||0
4917417|NCT03488030|12100372|P2|COMPLETED|Overall Study||145
4917418|NCT03488030|12100373|P1|COMPLETED|Overall Study||101
4917419|NCT03488030|12100372|P2|STARTED|Overall Study||145
4917420|NCT03488030|12100373|P1|STARTED|Overall Study||101
4917421|NCT03487588|12100421|P1|NOT COMPLETED|Overall Study||0
4917422|NCT03487588|12100421|P1|COMPLETED|Overall Study||41
4917423|NCT03487588|12100421|P1|STARTED|Overall Study||41
4917424|NCT03486990|12100436|P9|NOT COMPLETED|Overall Study||0
4917425|NCT03486990|12100437|P8|NOT COMPLETED|Overall Study||0
4917426|NCT03486990|12100438|P7|NOT COMPLETED|Overall Study||0
4917427|NCT03486990|12100439|P6|NOT COMPLETED|Overall Study||0
4917428|NCT03486990|12100440|P5|NOT COMPLETED|Overall Study||0
4917429|NCT03486990|12100441|P4|NOT COMPLETED|Overall Study||0
4917430|NCT03486990|12100442|P3|NOT COMPLETED|Overall Study||0
4917431|NCT03486990|12100443|P2|NOT COMPLETED|Overall Study||0
4917432|NCT03486990|12100444|P1|NOT COMPLETED|Overall Study||0
4917433|NCT03486990|12100436|P9|COMPLETED|Overall Study||2
4917434|NCT03486990|12100437|P8|COMPLETED|Overall Study||2
4917435|NCT03486990|12100438|P7|COMPLETED|Overall Study||2
4917436|NCT03486990|12100439|P6|COMPLETED|Overall Study||4
4917437|NCT03486990|12100440|P5|COMPLETED|Overall Study||3
4917438|NCT03486990|12100441|P4|COMPLETED|Overall Study||3
4917439|NCT03486990|12100442|P3|COMPLETED|Overall Study||3
4917440|NCT03486990|12100443|P2|COMPLETED|Overall Study||2
4917441|NCT03486990|12100444|P1|COMPLETED|Overall Study||2
4917442|NCT03486990|12100436|P9|STARTED|Overall Study||2
4917443|NCT03486990|12100437|P8|STARTED|Overall Study||2
4917444|NCT03486990|12100438|P7|STARTED|Overall Study||2
4917445|NCT03486990|12100439|P6|STARTED|Overall Study||4
4917446|NCT03486990|12100440|P5|STARTED|Overall Study||3
4917447|NCT03486990|12100441|P4|STARTED|Overall Study||3
4917448|NCT03486990|12100442|P3|STARTED|Overall Study||3
4917449|NCT03486990|12100443|P2|STARTED|Overall Study||2
4917450|NCT03486990|12100444|P1|STARTED|Overall Study||2
4917451|NCT03486392|12100623|P5|NOT COMPLETED|Overall Study||4
4917452|NCT03486392|12100624|P4|NOT COMPLETED|Overall Study||9
4917453|NCT03486392|12100625|P3|NOT COMPLETED|Overall Study||14
4917454|NCT03486392|12100626|P2|NOT COMPLETED|Overall Study||0
4917455|NCT03486392|12100627|P1|NOT COMPLETED|Overall Study||3
4917456|NCT03486392|12100623|P5|COMPLETED|Overall Study||115
4917457|NCT03486392|12100624|P4|COMPLETED|Overall Study||109
4917458|NCT03486392|12100625|P3|COMPLETED|Overall Study||104
4917459|NCT03486392|12100626|P2|COMPLETED|Overall Study||59
4917460|NCT03486392|12100627|P1|COMPLETED|Overall Study||57
4917461|NCT03486392|12100623|P5|STARTED|Overall Study||119
4917462|NCT03486392|12100624|P4|STARTED|Overall Study||118
4917463|NCT03486392|12100625|P3|STARTED|Overall Study||118
4917464|NCT03486392|12100626|P2|STARTED|Overall Study||59
4917465|NCT03486392|12100627|P1|STARTED|Overall Study||60
4917466|NCT03485976|12100659|P1|NOT COMPLETED|Overall Study||1
4917467|NCT03485976|12100659|P1|COMPLETED|Overall Study||11
4917468|NCT03485976|12100659|P1|STARTED|Overall Study||12
4917469|NCT03483896|12100667|P2|NOT COMPLETED|Overall Study||4
4917470|NCT03483896|12100668|P1|NOT COMPLETED|Overall Study||2
4917471|NCT03483896|12100667|P2|COMPLETED|Overall Study||46
4917472|NCT03483896|12100668|P1|COMPLETED|Overall Study||31
4917473|NCT03483896|12100667|P2|STARTED|Overall Study||50
4917474|NCT03483896|12100668|P1|STARTED|Overall Study||33
4917475|NCT03483623|12100676|P1|NOT COMPLETED|Overall Study||1
4917476|NCT03483623|12100676|P1|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
4917477|NCT03483623|12100676|P1|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
4917478|NCT03483623|12100676|P1|Started RAVEN FIS|Overall Study||44
4917479|NCT03483623|12100676|P1|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
4917480|NCT03483623|12100676|P1|Started RAVEN WELP|Overall Study||44
4917481|NCT03483623|12100676|P1|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
4917482|NCT03483623|12100676|P1|Started NATO FIS|Overall Study||44
4917483|NCT03483623|12100676|P1|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
4917484|NCT03483623|12100676|P1|Started NATO WELP|Overall Study||44
4917485|NCT03483623|12100676|P1|STARTED|Overall Study||44
4917486|NCT03483051|12100689|P2|NOT COMPLETED|Second Treatment, After Crossover||0
4917487|NCT03483051|12100690|P1|NOT COMPLETED|Second Treatment, After Crossover||0
4917488|NCT03483051|12100689|P2|COMPLETED|Second Treatment, After Crossover||1
4917489|NCT03483051|12100690|P1|COMPLETED|Second Treatment, After Crossover||2
4917490|NCT03483051|12100689|P2|STARTED|Second Treatment, After Crossover||1
4917491|NCT03483051|12100690|P1|STARTED|Second Treatment, After Crossover||2
4917492|NCT03483051|12100689|P2|NOT COMPLETED|First Treatment, Pre Crossover||0
4917493|NCT03483051|12100690|P1|NOT COMPLETED|First Treatment, Pre Crossover||0
4917494|NCT03483051|12100689|P2|COMPLETED|First Treatment, Pre Crossover||1
4917495|NCT03483051|12100690|P1|COMPLETED|First Treatment, Pre Crossover||2
4917496|NCT03483051|12100689|P2|STARTED|First Treatment, Pre Crossover||1
4917497|NCT03483051|12100690|P1|STARTED|First Treatment, Pre Crossover||2
4917498|NCT03482713|12100710|P2|NOT COMPLETED|Overall Study||0
4917499|NCT03482713|12100711|P1|NOT COMPLETED|Overall Study||0
4917500|NCT03482713|12100710|P2|COMPLETED|Overall Study||12
4917501|NCT03482713|12100711|P1|COMPLETED|Overall Study||11
4917502|NCT03482713|12100710|P2|STARTED|Overall Study||12
4917503|NCT03482713|12100711|P1|STARTED|Overall Study||11
4917504|NCT03482583|12100726|P3|NOT COMPLETED|Overall Study||21
4917505|NCT03482583|12100727|P2|NOT COMPLETED|Overall Study||9
4917506|NCT03482583|12100728|P1|NOT COMPLETED|Overall Study||25
4917507|NCT03482583|12100726|P3|COMPLETED|Overall Study||18
4917508|NCT03482583|12100727|P2|COMPLETED|Overall Study||5
4917509|NCT03482583|12100728|P1|COMPLETED|Overall Study||12
4917510|NCT03482583|12100726|P3|STARTED|Overall Study||39
4917511|NCT03482583|12100727|P2|STARTED|Overall Study||14
4917512|NCT03482583|12100728|P1|STARTED|Overall Study||37
4917513|NCT03482453|12100758|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917514|NCT03482453|12100759|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917515|NCT03482453|12100760|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917516|NCT03482453|12100761|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917517|NCT03482453|12100762|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917518|NCT03482453|12100763|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917519|NCT03482453|12100764|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917520|NCT03482453|12100765|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917521|NCT03482453|12100766|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917522|NCT03482453|12100767|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917523|NCT03482453|12100768|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917524|NCT03482453|12100769|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917525|NCT03482453|12100758|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
4917526|NCT03482453|12100759|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
4917527|NCT03482453|12100760|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
4917528|NCT03482453|12100761|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
4917529|NCT03482453|12100762|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
4917530|NCT03482453|12100763|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
4917531|NCT03482453|12100764|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917532|NCT03482453|12100765|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917533|NCT03482453|12100766|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917534|NCT03482453|12100767|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917535|NCT03482453|12100768|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917536|NCT03482453|12100769|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917537|NCT03482453|12100758|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
4917538|NCT03482453|12100759|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
4917539|NCT03482453|12100760|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
4917540|NCT03482453|12100761|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
4917541|NCT03482453|12100762|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
4917542|NCT03482453|12100763|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
4917543|NCT03482453|12100764|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917544|NCT03482453|12100765|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917545|NCT03482453|12100766|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917546|NCT03482453|12100767|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917547|NCT03482453|12100768|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917548|NCT03482453|12100769|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
4917549|NCT03482453|12100758|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917550|NCT03482453|12100759|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917551|NCT03482453|12100760|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917552|NCT03482453|12100761|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917553|NCT03482453|12100762|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917554|NCT03482453|12100763|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917555|NCT03482453|12100764|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917556|NCT03482453|12100765|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917557|NCT03482453|12100766|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917558|NCT03482453|12100767|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917559|NCT03482453|12100768|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917560|NCT03482453|12100769|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917561|NCT03482453|12100758|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
4917562|NCT03482453|12100759|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
4917563|NCT03482453|12100760|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
4917564|NCT03482453|12100761|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
4917565|NCT03482453|12100762|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
4917566|NCT03482453|12100763|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
4917567|NCT03482453|12100764|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917568|NCT03482453|12100765|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917569|NCT03482453|12100766|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917570|NCT03482453|12100767|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917571|NCT03482453|12100768|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917572|NCT03482453|12100769|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
4917573|NCT03482453|12100758|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
4917574|NCT03482453|12100759|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
4917575|NCT03482453|12100760|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
4917576|NCT03482453|12100761|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
4917577|NCT03482453|12100762|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
4917578|NCT03482453|12100763|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
4917579|NCT03482453|12100764|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917580|NCT03482453|12100765|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917581|NCT03482453|12100766|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917582|NCT03482453|12100767|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917583|NCT03482453|12100768|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917584|NCT03482453|12100769|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
4917585|NCT03482453|12100758|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917586|NCT03482453|12100759|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
4917587|NCT03482453|12100760|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917588|NCT03482453|12100761|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917589|NCT03482453|12100762|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917590|NCT03482453|12100763|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917591|NCT03482453|12100764|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917592|NCT03482453|12100765|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917593|NCT03482453|12100766|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917594|NCT03482453|12100767|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917595|NCT03482453|12100768|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917596|NCT03482453|12100769|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917597|NCT03482453|12100758|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
4917598|NCT03482453|12100759|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
4917599|NCT03482453|12100760|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
4917600|NCT03482453|12100761|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
4917601|NCT03482453|12100762|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
4917602|NCT03482453|12100763|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
4917603|NCT03482453|12100764|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917604|NCT03482453|12100765|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917605|NCT03482453|12100766|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917606|NCT03482453|12100767|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917607|NCT03482453|12100768|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917608|NCT03482453|12100769|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917609|NCT03482453|12100758|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
4917610|NCT03482453|12100759|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
4917611|NCT03482453|12100760|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
4917612|NCT03482453|12100761|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
4917613|NCT03482453|12100762|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
4917614|NCT03482453|12100763|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
4917615|NCT03482453|12100764|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917616|NCT03482453|12100765|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917617|NCT03482453|12100766|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917618|NCT03482453|12100767|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917619|NCT03482453|12100768|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917620|NCT03482453|12100769|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
4917621|NCT03482453|12100758|P12|NOT COMPLETED|Part 1 (1 Day)||0
4917622|NCT03482453|12100759|P11|NOT COMPLETED|Part 1 (1 Day)||0
4917623|NCT03482453|12100760|P10|NOT COMPLETED|Part 1 (1 Day)||0
4917624|NCT03482453|12100761|P9|NOT COMPLETED|Part 1 (1 Day)||0
4917625|NCT03482453|12100762|P8|NOT COMPLETED|Part 1 (1 Day)||0
4917626|NCT03482453|12100763|P7|NOT COMPLETED|Part 1 (1 Day)||0
4917627|NCT03482453|12100764|P6|NOT COMPLETED|Part 1 (1 Day)||0
4917628|NCT03482453|12100765|P5|NOT COMPLETED|Part 1 (1 Day)||0
4917629|NCT03482453|12100766|P4|NOT COMPLETED|Part 1 (1 Day)||0
4917630|NCT03482453|12100767|P3|NOT COMPLETED|Part 1 (1 Day)||0
4917631|NCT03482453|12100768|P2|NOT COMPLETED|Part 1 (1 Day)||0
4917632|NCT03482453|12100769|P1|NOT COMPLETED|Part 1 (1 Day)||0
4917633|NCT03482453|12100758|P12|COMPLETED|Part 1 (1 Day)||0
4917634|NCT03482453|12100759|P11|COMPLETED|Part 1 (1 Day)||0
4917635|NCT03482453|12100760|P10|COMPLETED|Part 1 (1 Day)||0
4917636|NCT03482453|12100761|P9|COMPLETED|Part 1 (1 Day)||0
4917637|NCT03482453|12100762|P8|COMPLETED|Part 1 (1 Day)||0
4917638|NCT03482453|12100763|P7|COMPLETED|Part 1 (1 Day)||0
4917639|NCT03482453|12100764|P6|COMPLETED|Part 1 (1 Day)||6
4917640|NCT03482453|12100765|P5|COMPLETED|Part 1 (1 Day)||6
4917641|NCT03482453|12100766|P4|COMPLETED|Part 1 (1 Day)||6
4917642|NCT03482453|12100767|P3|COMPLETED|Part 1 (1 Day)||6
4917643|NCT03482453|12100768|P2|COMPLETED|Part 1 (1 Day)||6
4917644|NCT03482453|12100769|P1|COMPLETED|Part 1 (1 Day)||10
4917645|NCT03482453|12100758|P12|STARTED|Part 1 (1 Day)||0
4917646|NCT03482453|12100759|P11|STARTED|Part 1 (1 Day)||0
4917647|NCT03482453|12100760|P10|STARTED|Part 1 (1 Day)||0
4917648|NCT03482453|12100761|P9|STARTED|Part 1 (1 Day)||0
4917649|NCT03482453|12100762|P8|STARTED|Part 1 (1 Day)||0
4917650|NCT03482453|12100763|P7|STARTED|Part 1 (1 Day)||0
4917651|NCT03482453|12100764|P6|STARTED|Part 1 (1 Day)||6
4917652|NCT03482453|12100765|P5|STARTED|Part 1 (1 Day)||6
4917653|NCT03482453|12100766|P4|STARTED|Part 1 (1 Day)||6
4917654|NCT03482453|12100767|P3|STARTED|Part 1 (1 Day)||6
4917655|NCT03482453|12100768|P2|STARTED|Part 1 (1 Day)||6
4917656|NCT03482453|12100769|P1|STARTED|Part 1 (1 Day)||10
4917657|NCT03481309|12100892|P6|NOT COMPLETED|Third Intervention (1 Day)||0
4917658|NCT03481309|12100893|P5|NOT COMPLETED|Third Intervention (1 Day)||0
4917659|NCT03481309|12100894|P4|NOT COMPLETED|Third Intervention (1 Day)||0
4917660|NCT03481309|12100895|P3|NOT COMPLETED|Third Intervention (1 Day)||0
4917661|NCT03481309|12100896|P2|NOT COMPLETED|Third Intervention (1 Day)||0
4917662|NCT03481309|12100897|P1|NOT COMPLETED|Third Intervention (1 Day)||0
4917663|NCT03481309|12100892|P6|COMPLETED|Third Intervention (1 Day)||3
4917664|NCT03481309|12100893|P5|COMPLETED|Third Intervention (1 Day)||3
4917665|NCT03481309|12100894|P4|COMPLETED|Third Intervention (1 Day)||3
4917666|NCT03481309|12100895|P3|COMPLETED|Third Intervention (1 Day)||3
4917667|NCT03481309|12100896|P2|COMPLETED|Third Intervention (1 Day)||3
4917668|NCT03481309|12100897|P1|COMPLETED|Third Intervention (1 Day)||3
4917669|NCT03481309|12100892|P6|STARTED|Third Intervention (1 Day)||3
4917670|NCT03481309|12100893|P5|STARTED|Third Intervention (1 Day)||3
4917671|NCT03481309|12100894|P4|STARTED|Third Intervention (1 Day)||3
4917672|NCT03481309|12100895|P3|STARTED|Third Intervention (1 Day)||3
4917673|NCT03481309|12100896|P2|STARTED|Third Intervention (1 Day)||3
4917674|NCT03481309|12100897|P1|STARTED|Third Intervention (1 Day)||3
4917675|NCT03481309|12100892|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
4917676|NCT03481309|12100893|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
4917677|NCT03481309|12100894|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
4917678|NCT03481309|12100895|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
4917679|NCT03481309|12100896|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
4917680|NCT03481309|12100897|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
4917681|NCT03481309|12100892|P6|COMPLETED|Washout (at Least 3 Days)||3
4917682|NCT03481309|12100893|P5|COMPLETED|Washout (at Least 3 Days)||3
4917683|NCT03481309|12100894|P4|COMPLETED|Washout (at Least 3 Days)||3
4917684|NCT03481309|12100895|P3|COMPLETED|Washout (at Least 3 Days)||3
4917685|NCT03481309|12100896|P2|COMPLETED|Washout (at Least 3 Days)||3
4917686|NCT03481309|12100897|P1|COMPLETED|Washout (at Least 3 Days)||3
4917687|NCT03481309|12100892|P6|STARTED|Washout (at Least 3 Days)||3
4917688|NCT03481309|12100893|P5|STARTED|Washout (at Least 3 Days)||3
4917689|NCT03481309|12100894|P4|STARTED|Washout (at Least 3 Days)||3
4917690|NCT03481309|12100895|P3|STARTED|Washout (at Least 3 Days)||3
4917691|NCT03481309|12100896|P2|STARTED|Washout (at Least 3 Days)||3
4917692|NCT03481309|12100897|P1|STARTED|Washout (at Least 3 Days)||3
4917693|NCT03481309|12100892|P6|NOT COMPLETED|Second Intervention (1 Day)||0
4917694|NCT03481309|12100893|P5|NOT COMPLETED|Second Intervention (1 Day)||0
4917695|NCT03481309|12100894|P4|NOT COMPLETED|Second Intervention (1 Day)||0
4917696|NCT03481309|12100895|P3|NOT COMPLETED|Second Intervention (1 Day)||0
4917697|NCT03481309|12100896|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4917698|NCT03481309|12100897|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4917699|NCT03481309|12100892|P6|COMPLETED|Second Intervention (1 Day)||3
4917700|NCT03481309|12100893|P5|COMPLETED|Second Intervention (1 Day)||3
4917701|NCT03481309|12100894|P4|COMPLETED|Second Intervention (1 Day)||3
4917702|NCT03481309|12100895|P3|COMPLETED|Second Intervention (1 Day)||3
4917703|NCT03481309|12100896|P2|COMPLETED|Second Intervention (1 Day)||3
4917704|NCT03481309|12100897|P1|COMPLETED|Second Intervention (1 Day)||3
4917705|NCT03481309|12100892|P6|STARTED|Second Intervention (1 Day)||3
4917706|NCT03481309|12100893|P5|STARTED|Second Intervention (1 Day)||3
4917707|NCT03481309|12100894|P4|STARTED|Second Intervention (1 Day)||3
4917708|NCT03481309|12100895|P3|STARTED|Second Intervention (1 Day)||3
4917709|NCT03481309|12100896|P2|STARTED|Second Intervention (1 Day)||3
4917710|NCT03481309|12100897|P1|STARTED|Second Intervention (1 Day)||3
4917711|NCT03481309|12100892|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
4917712|NCT03481309|12100893|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
4917713|NCT03481309|12100894|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
4917714|NCT03481309|12100895|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
4917715|NCT03481309|12100896|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
4917716|NCT03481309|12100897|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
4917717|NCT03481309|12100892|P6|COMPLETED|Washout (at Least 3 Days)||3
4917718|NCT03481309|12100893|P5|COMPLETED|Washout (at Least 3 Days)||3
4917719|NCT03481309|12100894|P4|COMPLETED|Washout (at Least 3 Days)||3
4917720|NCT03481309|12100895|P3|COMPLETED|Washout (at Least 3 Days)||3
4917721|NCT03481309|12100896|P2|COMPLETED|Washout (at Least 3 Days)||3
4917722|NCT03481309|12100897|P1|COMPLETED|Washout (at Least 3 Days)||3
4917723|NCT03481309|12100892|P6|STARTED|Washout (at Least 3 Days)||3
4917724|NCT03481309|12100893|P5|STARTED|Washout (at Least 3 Days)||3
4917725|NCT03481309|12100894|P4|STARTED|Washout (at Least 3 Days)||3
4917726|NCT03481309|12100895|P3|STARTED|Washout (at Least 3 Days)||3
4917727|NCT03481309|12100896|P2|STARTED|Washout (at Least 3 Days)||3
4917728|NCT03481309|12100897|P1|STARTED|Washout (at Least 3 Days)||4
4917729|NCT03481309|12100892|P6|NOT COMPLETED|First Intervention (1 Day)||0
4917730|NCT03481309|12100893|P5|NOT COMPLETED|First Intervention (1 Day)||0
4917731|NCT03481309|12100894|P4|NOT COMPLETED|First Intervention (1 Day)||0
4917732|NCT03481309|12100895|P3|NOT COMPLETED|First Intervention (1 Day)||0
4917733|NCT03481309|12100896|P2|NOT COMPLETED|First Intervention (1 Day)||0
4917734|NCT03481309|12100897|P1|NOT COMPLETED|First Intervention (1 Day)||0
4917735|NCT03481309|12100892|P6|COMPLETED|First Intervention (1 Day)||3
4917736|NCT03481309|12100893|P5|COMPLETED|First Intervention (1 Day)||3
4917737|NCT03481309|12100894|P4|COMPLETED|First Intervention (1 Day)||3
4917738|NCT03481309|12100895|P3|COMPLETED|First Intervention (1 Day)||3
4917739|NCT03481309|12100896|P2|COMPLETED|First Intervention (1 Day)||3
4917740|NCT03481309|12100897|P1|COMPLETED|First Intervention (1 Day)||4
4917741|NCT03481309|12100892|P6|STARTED|First Intervention (1 Day)||3
4917742|NCT03481309|12100893|P5|STARTED|First Intervention (1 Day)||3
4917743|NCT03481309|12100894|P4|STARTED|First Intervention (1 Day)||3
4917744|NCT03481309|12100895|P3|STARTED|First Intervention (1 Day)||3
4917745|NCT03481309|12100896|P2|STARTED|First Intervention (1 Day)||3
4917746|NCT03481309|12100897|P1|STARTED|First Intervention (1 Day)||4
4917747|NCT03481270|12100913|P2|NOT COMPLETED|Overall Study||0
4917748|NCT03481270|12100914|P1|NOT COMPLETED|Overall Study||0
4917749|NCT03481270|12100913|P2|COMPLETED|Overall Study||313
4917750|NCT03481270|12100914|P1|COMPLETED|Overall Study||324
4917751|NCT03481270|12100913|P2|STARTED|Overall Study||313
4917752|NCT03481270|12100914|P1|STARTED|Overall Study||324
4917753|NCT03480919|12100923|P3|NOT COMPLETED|Overall Study||0
4917754|NCT03480919|12100924|P2|NOT COMPLETED|Overall Study||0
4917755|NCT03480919|12100925|P1|NOT COMPLETED|Overall Study||0
4917756|NCT03480919|12100923|P3|COMPLETED|Overall Study||1
4917757|NCT03480919|12100924|P2|COMPLETED|Overall Study||2
4917758|NCT03480919|12100925|P1|COMPLETED|Overall Study||1
4917759|NCT03480919|12100923|P3|STARTED|Overall Study||1
4917760|NCT03480919|12100924|P2|STARTED|Overall Study||2
4917761|NCT03480919|12100925|P1|STARTED|Overall Study||1
4917762|NCT03480841|12100939|P1|NOT COMPLETED|Overall Study||2
4917763|NCT03480841|12100939|P1|COMPLETED|Overall Study||8
4917764|NCT03480841|12100939|P1|Time 2 Data Collection (T2)|Overall Study||8
4917765|NCT03480841|12100939|P1|LENA Time 5|Overall Study||8
4917766|NCT03480841|12100939|P1|LENA Time 4|Overall Study||9
4917767|NCT03480841|12100939|P1|LENA Time 3|Overall Study||10
4917768|NCT03480841|12100939|P1|LENA Time 2|Overall Study||10
4917769|NCT03480841|12100939|P1|LENA Time 1|Overall Study||10
4917770|NCT03480841|12100939|P1|LENA Baseline|Overall Study||10
4917771|NCT03480841|12100939|P1|Time 1 Data Collection (T1)|Overall Study||10
4917772|NCT03480841|12100939|P1|STARTED|Overall Study||10
4917773|NCT03480425|12100948|P1|NOT COMPLETED|Overall Study||1
4917774|NCT03480425|12100948|P1|COMPLETED|Overall Study||10
4917775|NCT03480425|12100948|P1|STARTED|Overall Study||11
4917776|NCT03480152|12100954|P3|NOT COMPLETED|Phase II||0
4917777|NCT03480152|12100955|P2|NOT COMPLETED|Phase II||0
4917778|NCT03480152|12100956|P1|NOT COMPLETED|Phase II||0
4917779|NCT03480152|12100954|P3|COMPLETED|Phase II||0
4917780|NCT03480152|12100955|P2|COMPLETED|Phase II||0
4917781|NCT03480152|12100956|P1|COMPLETED|Phase II||0
4917782|NCT03480152|12100954|P3|STARTED|Phase II||0
4917783|NCT03480152|12100955|P2|STARTED|Phase II||0
4917784|NCT03480152|12100956|P1|STARTED|Phase II||0
4917785|NCT03480152|12100954|P3|NOT COMPLETED|Phase I||0
4917786|NCT03480152|12100955|P2|NOT COMPLETED|Phase I||0
4917787|NCT03480152|12100956|P1|NOT COMPLETED|Phase I||1
4917788|NCT03480152|12100954|P3|COMPLETED|Phase I||0
4917789|NCT03480152|12100955|P2|COMPLETED|Phase I||2
4917790|NCT03480152|12100956|P1|COMPLETED|Phase I||2
4917791|NCT03480152|12100954|P3|Received Intervention|Phase I||0
4917792|NCT03480152|12100955|P2|Received Intervention|Phase I||2
4917793|NCT03480152|12100956|P1|Received Intervention|Phase I||2
4917794|NCT03480152|12100954|P3|STARTED|Phase I||0
4917795|NCT03480152|12100955|P2|STARTED|Phase I||2
4917796|NCT03480152|12100956|P1|STARTED|Phase I||3
4917797|NCT03480048|12100973|P2|NOT COMPLETED|Overall Study||8
4917798|NCT03480048|12100974|P1|NOT COMPLETED|Overall Study||10
4917799|NCT03480048|12100973|P2|COMPLETED|Overall Study||17
4917800|NCT03480048|12100974|P1|COMPLETED|Overall Study||18
4917801|NCT03480048|12100973|P2|STARTED|Overall Study||25
4917802|NCT03480048|12100974|P1|STARTED|Overall Study||28
4917803|NCT03479944|12100982|P1|NOT COMPLETED|Overall Study||0
4917804|NCT03479944|12100982|P1|COMPLETED|Overall Study||55
4917805|NCT03479944|12100982|P1|Full Analysis Set|Overall Study||53
4917806|NCT03479944|12100982|P1|Conventional|Overall Study||55
4917807|NCT03479944|12100982|P1|FLACS|Overall Study||55
4917808|NCT03479944|12100982|P1|STARTED|Overall Study||55
4917809|NCT03479216|12100995|P2|NOT COMPLETED|Overall Study||5
4917810|NCT03479216|12100996|P1|NOT COMPLETED|Overall Study||5
4917811|NCT03479216|12100995|P2|COMPLETED|Overall Study||26
4917812|NCT03479216|12100996|P1|COMPLETED|Overall Study||26
4917813|NCT03479216|12100995|P2|STARTED|Overall Study||31
4917814|NCT03479216|12100996|P1|STARTED|Overall Study||31
4917815|NCT03478891|12101017|P3|NOT COMPLETED|Overall Study||3
4917816|NCT03478891|12101018|P2|NOT COMPLETED|Overall Study||0
4917817|NCT03478891|12101019|P1|NOT COMPLETED|Overall Study||1
4917818|NCT03478891|12101017|P3|COMPLETED|Overall Study||8
4917819|NCT03478891|12101018|P2|COMPLETED|Overall Study||5
4917820|NCT03478891|12101019|P1|COMPLETED|Overall Study||2
4917915|NCT03474081|12101297|P2|STARTED|Overall Study||400
4917821|NCT03478891|12101017|P3|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
4917822|NCT03478891|12101018|P2|Received MAb114|Overall Study||5
4917823|NCT03478891|12101019|P1|Received MAb114|Overall Study||3
4917824|NCT03478891|12101017|P3|STARTED|Overall Study||11
4917825|NCT03478891|12101018|P2|STARTED|Overall Study||5
4917826|NCT03478891|12101019|P1|STARTED|Overall Study||3
4917827|NCT03478696|12101070|P2|NOT COMPLETED|Overall Study||12
4917828|NCT03478696|12101071|P1|NOT COMPLETED|Overall Study||17
4917829|NCT03478696|12101070|P2|COMPLETED|Overall Study||354
4917830|NCT03478696|12101071|P1|COMPLETED|Overall Study||349
4917831|NCT03478696|12101070|P2|STARTED|Overall Study||366
4917832|NCT03478696|12101071|P1|STARTED|Overall Study||366
4917833|NCT03478683|12101085|P2|NOT COMPLETED|Overall Study||18
4917834|NCT03478683|12101086|P1|NOT COMPLETED|Overall Study||13
4917835|NCT03478683|12101085|P2|COMPLETED|Overall Study||347
4917836|NCT03478683|12101086|P1|COMPLETED|Overall Study||350
4917837|NCT03478683|12101085|P2|STARTED|Overall Study||365
4917838|NCT03478683|12101086|P1|STARTED|Overall Study||363
4917839|NCT03478657|12101100|P2|NOT COMPLETED|Overall Study||1
4917840|NCT03478657|12101101|P1|NOT COMPLETED|Overall Study||0
4917841|NCT03478657|12101100|P2|COMPLETED|Overall Study||133
4917842|NCT03478657|12101101|P1|COMPLETED|Overall Study||88
4917843|NCT03478657|12101100|P2|STARTED|Overall Study||134
4917844|NCT03478657|12101101|P1|STARTED|Overall Study||88
4917845|NCT03478644|12101116|P2|NOT COMPLETED|Phase 2||1
4917846|NCT03478644|12101117|P1|NOT COMPLETED|Phase 2||3
4917847|NCT03478644|12101116|P2|COMPLETED|Phase 2||75
4917848|NCT03478644|12101117|P1|COMPLETED|Phase 2||73
4917849|NCT03478644|12101116|P2|STARTED|Phase 2||76
4917850|NCT03478644|12101117|P1|STARTED|Phase 2||76
4917851|NCT03478644|12101116|P2|NOT COMPLETED|Phase 1||0
4917852|NCT03478644|12101117|P1|NOT COMPLETED|Phase 1||0
4917853|NCT03478644|12101116|P2|COMPLETED|Phase 1||0
4917854|NCT03478644|12101117|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
4917855|NCT03478644|12101116|P2|STARTED|Phase 1||0
4917856|NCT03478644|12101117|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
4917857|NCT03478371|12101129|P1|NOT COMPLETED|Overall Study||5
4917858|NCT03478371|12101129|P1|COMPLETED|Overall Study||89
4917859|NCT03478371|12101129|P1|Received Tampon V|Overall Study||91
4917860|NCT03478371|12101129|P1|Recived Tampon T|Overall Study||90
4917861|NCT03478371|12101129|P1|Received Tampon M|Overall Study||92
4917862|NCT03478371|12101129|P1|Received Tampon D|Overall Study||91
4917863|NCT03478371|12101129|P1|STARTED|Overall Study||94
4917864|NCT03477903|12101151|P1|NOT COMPLETED|Overall Study||1
4917865|NCT03477903|12101151|P1|COMPLETED|Overall Study||0
4917866|NCT03477903|12101151|P1|STARTED|Overall Study||1
4917867|NCT03476850|12101164|P2|NOT COMPLETED|Overall Study||0
4917868|NCT03476850|12101165|P1|NOT COMPLETED|Overall Study||0
4917869|NCT03476850|12101164|P2|COMPLETED|Overall Study||24
4917870|NCT03476850|12101165|P1|COMPLETED|Overall Study||24
4917871|NCT03476850|12101164|P2|STARTED|Overall Study||24
4917872|NCT03476850|12101165|P1|STARTED|Overall Study||24
4917873|NCT03476278|12101181|P1|NOT COMPLETED|Overall Study||0
4917874|NCT03476278|12101181|P1|COMPLETED|Overall Study||300
4917875|NCT03476278|12101181|P1|STARTED|Overall Study||300
4917876|NCT03476135|12101229|P2|NOT COMPLETED|Overall Study||0
4917877|NCT03476135|12101230|P1|NOT COMPLETED|Overall Study||0
4917878|NCT03476135|12101229|P2|COMPLETED|Overall Study||49
4917879|NCT03476135|12101230|P1|COMPLETED|Overall Study||42
4917880|NCT03476135|12101229|P2|STARTED|Overall Study||49
4917881|NCT03476135|12101230|P1|STARTED|Overall Study||42
4917882|NCT03475875|12101258|P2|NOT COMPLETED|Period 3||0
4917883|NCT03475875|12101259|P1|NOT COMPLETED|Period 3||0
4917884|NCT03475875|12101258|P2|COMPLETED|Period 3||43
4917885|NCT03475875|12101259|P1|COMPLETED|Period 3||40
4917886|NCT03475875|12101258|P2|STARTED|Period 3||43
4917887|NCT03475875|12101259|P1|STARTED|Period 3||40
4917888|NCT03475875|12101258|P2|NOT COMPLETED|Period 2||1
4917889|NCT03475875|12101259|P1|NOT COMPLETED|Period 2||3
4917890|NCT03475875|12101258|P2|COMPLETED|Period 2||43
4917891|NCT03475875|12101259|P1|COMPLETED|Period 2||40
4917892|NCT03475875|12101258|P2|STARTED|Period 2||44
4917893|NCT03475875|12101259|P1|STARTED|Period 2||43
4917894|NCT03475875|12101258|P2|NOT COMPLETED|Period 1||1
4917895|NCT03475875|12101259|P1|NOT COMPLETED|Period 1||3
4917896|NCT03475875|12101258|P2|COMPLETED|Period 1||44
4917897|NCT03475875|12101259|P1|COMPLETED|Period 1||43
4917898|NCT03475875|12101258|P2|STARTED|Period 1||45
4917899|NCT03475875|12101259|P1|STARTED|Period 1||46
4917900|NCT03474874|12101267|P1|NOT COMPLETED|Overall Study||14
4917901|NCT03474874|12101267|P1|COMPLETED|Overall Study||54
4917902|NCT03474874|12101267|P1|STARTED|Overall Study||68
4917903|NCT03474172|12101278|P2|NOT COMPLETED|Overall Study||0
4917904|NCT03474172|12101279|P1|NOT COMPLETED|Overall Study||0
4917905|NCT03474172|12101278|P2|COMPLETED|Overall Study||30
4917906|NCT03474172|12101279|P1|COMPLETED|Overall Study||30
4917907|NCT03474172|12101278|P2|STARTED|Overall Study||30
4917908|NCT03474172|12101279|P1|STARTED|Overall Study||30
4917909|NCT03474081|12101297|P2|NOT COMPLETED|Overall Study||13
4917910|NCT03474081|12101298|P1|NOT COMPLETED|Overall Study||17
4917911|NCT03474081|12101297|P2|COMPLETED|Overall Study||387
4917912|NCT03474081|12101298|P1|COMPLETED|Overall Study||383
4917913|NCT03474081|12101297|P2|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
4917914|NCT03474081|12101298|P1|Received Study Treatment|Overall Study||400
4917916|NCT03474081|12101298|P1|STARTED|Overall Study||400
4917917|NCT03473886|12101314|P1|NOT COMPLETED|Overall Study||1
4917918|NCT03473886|12101314|P1|COMPLETED|Overall Study||7
4917919|NCT03473886|12101314|P1|STARTED|Overall Study||8
4917920|NCT03473808|12101339|P1|NOT COMPLETED|Overall Study||1
4917921|NCT03473808|12101339|P1|COMPLETED|Overall Study||4
4917922|NCT03473808|12101339|P1|STARTED|Overall Study||5
4917923|NCT03473236|12101356|P10|NOT COMPLETED|Overall Study||0
4917924|NCT03473236|12101357|P9|NOT COMPLETED|Overall Study||1
4917925|NCT03473236|12101358|P8|NOT COMPLETED|Overall Study||0
4917926|NCT03473236|12101359|P7|NOT COMPLETED|Overall Study||0
4917927|NCT03473236|12101360|P6|NOT COMPLETED|Overall Study||1
4917928|NCT03473236|12101361|P5|NOT COMPLETED|Overall Study||0
4917929|NCT03473236|12101362|P4|NOT COMPLETED|Overall Study||0
4917930|NCT03473236|12101363|P3|NOT COMPLETED|Overall Study||0
4917931|NCT03473236|12101364|P2|NOT COMPLETED|Overall Study||0
4917932|NCT03473236|12101365|P1|NOT COMPLETED|Overall Study||0
4917933|NCT03473236|12101356|P10|COMPLETED|Overall Study||6
4917934|NCT03473236|12101357|P9|COMPLETED|Overall Study||6
4917935|NCT03473236|12101358|P8|COMPLETED|Overall Study||6
4917936|NCT03473236|12101359|P7|COMPLETED|Overall Study||6
4917937|NCT03473236|12101360|P6|COMPLETED|Overall Study||6
4917938|NCT03473236|12101361|P5|COMPLETED|Overall Study||6
4917939|NCT03473236|12101362|P4|COMPLETED|Overall Study||6
4917940|NCT03473236|12101363|P3|COMPLETED|Overall Study||6
4917941|NCT03473236|12101364|P2|COMPLETED|Overall Study||6
4917942|NCT03473236|12101365|P1|COMPLETED|Overall Study||10
4917943|NCT03473236|12101356|P10|STARTED|Overall Study||6
4917944|NCT03473236|12101357|P9|STARTED|Overall Study||7
4917945|NCT03473236|12101358|P8|STARTED|Overall Study||6
4917946|NCT03473236|12101359|P7|STARTED|Overall Study||6
4917947|NCT03473236|12101360|P6|STARTED|Overall Study||7
4917948|NCT03473236|12101361|P5|STARTED|Overall Study||6
4917949|NCT03473236|12101362|P4|STARTED|Overall Study||6
4917950|NCT03473236|12101363|P3|STARTED|Overall Study||6
4917951|NCT03473236|12101364|P2|STARTED|Overall Study||6
4917952|NCT03473236|12101365|P1|STARTED|Overall Study||10
4917953|NCT03473197|12101532|P1|NOT COMPLETED|Overall Study||10
4917954|NCT03473197|12101532|P1|COMPLETED|Overall Study||51
4917955|NCT03473197|12101532|P1|Untreated Irradiated|Overall Study||51
4917956|NCT03473197|12101532|P1|Vehicle Ointment Non-irradiated|Overall Study||51
4917957|NCT03473197|12101532|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
4917958|NCT03473197|12101532|P1|Vehicle Ointment Irradiated|Overall Study||51
4917959|NCT03473197|12101532|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
4917960|NCT03473197|12101532|P1|STARTED|Overall Study||61
4917961|NCT03473184|12101536|P1|NOT COMPLETED|Overall Study||0
4917962|NCT03473184|12101536|P1|COMPLETED|Overall Study||34
4917963|NCT03473184|12101536|P1|Untreated Irradiated|Overall Study||34
4917964|NCT03473184|12101536|P1|Vehicle Ointment Non-irradiated|Overall Study||34
4917965|NCT03473184|12101536|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
4917966|NCT03473184|12101536|P1|Vehicle Ointment Irradiated|Overall Study||34
4917967|NCT03473184|12101536|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
4917968|NCT03473184|12101536|P1|STARTED|Overall Study||34
4917969|NCT03473171|12101540|P1|NOT COMPLETED|Overall Study||0
4917970|NCT03473171|12101540|P1|COMPLETED|Overall Study||5
4917971|NCT03473171|12101540|P1|STARTED|Overall Study||5
4917972|NCT03472547|12101544|P1|NOT COMPLETED|Overall Study||30
4917973|NCT03472547|12101544|P1|COMPLETED|Overall Study||204
4917974|NCT03472547|12101544|P1|STARTED|Overall Study||234
4917975|NCT03472534|12101548|P1|NOT COMPLETED|Overall Study||11
4917976|NCT03472534|12101548|P1|COMPLETED|Overall Study||35
4917977|NCT03472534|12101548|P1|0.9% Saline|Overall Study||46
4917978|NCT03472534|12101548|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
4917979|NCT03472534|12101548|P1|Vehicle Ointment|Overall Study||46
4917980|NCT03472534|12101548|P1|Diacerein 1% Ointment|Overall Study||46
4917981|NCT03472534|12101548|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
4917982|NCT03472287|12101554|P2|NOT COMPLETED|Overall Study||0
4917983|NCT03472287|12101555|P1|NOT COMPLETED|Overall Study||0
4917984|NCT03472287|12101554|P2|COMPLETED|Overall Study||3
4917985|NCT03472287|12101555|P1|COMPLETED|Overall Study||8
4917986|NCT03472287|12101554|P2|STARTED|Overall Study||3
4917987|NCT03472287|12101555|P1|STARTED|Overall Study||8
4917988|NCT03471975|12101563|P2|NOT COMPLETED|Overall Study||0
4917989|NCT03471975|12101564|P1|NOT COMPLETED|Overall Study||0
4917990|NCT03471975|12101563|P2|COMPLETED|Overall Study||20
4917991|NCT03471975|12101564|P1|COMPLETED|Overall Study||17
4917992|NCT03471975|12101563|P2|STARTED|Overall Study||20
4917993|NCT03471975|12101564|P1|STARTED|Overall Study||17
4917994|NCT03471871|12101574|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
4917995|NCT03471871|12101575|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
4917996|NCT03471871|12101576|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
4917997|NCT03471871|12101577|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
4917998|NCT03471871|12101578|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
4917999|NCT03471871|12101574|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
4918000|NCT03471871|12101575|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
4918001|NCT03471871|12101576|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
4918002|NCT03471871|12101577|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
4918003|NCT03471871|12101578|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
4918004|NCT03471871|12101574|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
4918005|NCT03471871|12101575|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
4918006|NCT03471871|12101576|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
4918007|NCT03471871|12101577|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
4918008|NCT03471871|12101578|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
4918009|NCT03471871|12101574|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918010|NCT03471871|12101575|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918011|NCT03471871|12101576|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918012|NCT03471871|12101577|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918013|NCT03471871|12101578|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918014|NCT03471871|12101574|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918015|NCT03471871|12101575|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
4918016|NCT03471871|12101576|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
4918017|NCT03471871|12101577|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
4918018|NCT03471871|12101578|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
4918019|NCT03471871|12101574|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
4918020|NCT03471871|12101575|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
4918021|NCT03471871|12101576|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
4918022|NCT03471871|12101577|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
4918023|NCT03471871|12101578|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
4918024|NCT03471871|12101574|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
4918025|NCT03471871|12101575|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
4918026|NCT03471871|12101576|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
4918027|NCT03471871|12101577|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
4918028|NCT03471871|12101578|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
4918029|NCT03471871|12101574|P5|COMPLETED|Washout Period 2 (14 Days)||0
4918030|NCT03471871|12101575|P4|COMPLETED|Washout Period 2 (14 Days)||0
4918031|NCT03471871|12101576|P3|COMPLETED|Washout Period 2 (14 Days)||5
4918032|NCT03471871|12101577|P2|COMPLETED|Washout Period 2 (14 Days)||5
4918033|NCT03471871|12101578|P1|COMPLETED|Washout Period 2 (14 Days)||6
4918034|NCT03471871|12101574|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
4918035|NCT03471871|12101575|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
4918036|NCT03471871|12101576|P3|STARTED|Washout Period 2 (14 Days)||5
4918037|NCT03471871|12101577|P2|STARTED|Washout Period 2 (14 Days)||5
4918038|NCT03471871|12101578|P1|STARTED|Washout Period 2 (14 Days)||6
4918039|NCT03471871|12101574|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
4918040|NCT03471871|12101575|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
4918041|NCT03471871|12101576|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
4918042|NCT03471871|12101577|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
4918043|NCT03471871|12101578|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
4918044|NCT03471871|12101574|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
4918045|NCT03471871|12101575|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
4918046|NCT03471871|12101576|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
4918047|NCT03471871|12101577|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
4918048|NCT03471871|12101578|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
4918049|NCT03471871|12101574|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
4918050|NCT03471871|12101575|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
4918051|NCT03471871|12101576|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
4918052|NCT03471871|12101577|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
4918053|NCT03471871|12101578|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
4918054|NCT03471871|12101574|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
4918055|NCT03471871|12101575|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
4918056|NCT03471871|12101576|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
4918057|NCT03471871|12101577|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
4918058|NCT03471871|12101578|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
4918059|NCT03471871|12101574|P5|COMPLETED|Washout Period 1 (14 Days)||19
4918060|NCT03471871|12101575|P4|COMPLETED|Washout Period 1 (14 Days)||18
4918061|NCT03471871|12101576|P3|COMPLETED|Washout Period 1 (14 Days)||5
4918062|NCT03471871|12101577|P2|COMPLETED|Washout Period 1 (14 Days)||5
4918063|NCT03471871|12101578|P1|COMPLETED|Washout Period 1 (14 Days)||6
4918064|NCT03471871|12101574|P5|STARTED|Washout Period 1 (14 Days)||19
4918065|NCT03471871|12101575|P4|STARTED|Washout Period 1 (14 Days)||18
4918066|NCT03471871|12101576|P3|STARTED|Washout Period 1 (14 Days)||5
4918067|NCT03471871|12101577|P2|STARTED|Washout Period 1 (14 Days)||5
4918068|NCT03471871|12101578|P1|STARTED|Washout Period 1 (14 Days)||6
4918069|NCT03471871|12101574|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
4918070|NCT03471871|12101575|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
4918071|NCT03471871|12101576|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
4918072|NCT03471871|12101577|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
4918073|NCT03471871|12101578|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
4918074|NCT03471871|12101574|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
4918075|NCT03471871|12101575|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
4918076|NCT03471871|12101576|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
4918077|NCT03471871|12101577|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
4918078|NCT03471871|12101578|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
4918079|NCT03471871|12101574|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
4918080|NCT03471871|12101575|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
4918081|NCT03471871|12101576|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
4918082|NCT03471871|12101577|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
4918083|NCT03471871|12101578|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
4918084|NCT03471871|12101574|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
4918085|NCT03471871|12101575|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
4918086|NCT03471871|12101576|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
4918087|NCT03471871|12101577|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
4918088|NCT03471871|12101578|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
4918089|NCT03471832|12101607|P2|NOT COMPLETED|Overall Study||0
4918090|NCT03471832|12101608|P1|NOT COMPLETED|Overall Study||0
4918091|NCT03471832|12101607|P2|COMPLETED|Overall Study||40
4918092|NCT03471832|12101608|P1|COMPLETED|Overall Study||40
4918093|NCT03471832|12101607|P2|STARTED|Overall Study||40
4918094|NCT03471832|12101608|P1|STARTED|Overall Study||40
4918095|NCT03470740|12101667|P2|NOT COMPLETED|Overall Study||6
4918096|NCT03470740|12101668|P1|NOT COMPLETED|Overall Study||4
4918097|NCT03470740|12101667|P2|COMPLETED|Overall Study||106
4918098|NCT03470740|12101668|P1|COMPLETED|Overall Study||108
4918099|NCT03470740|12101667|P2|STARTED|Overall Study||112
4918100|NCT03470740|12101668|P1|STARTED|Overall Study||112
4918101|NCT03470012|12101686|P1|NOT COMPLETED|Overall Study||0
4918102|NCT03470012|12101686|P1|COMPLETED|Overall Study||24
4918103|NCT03470012|12101686|P1|STARTED|Overall Study||24
4918104|NCT03469336|12101690|P1|NOT COMPLETED|Overall Study||1
4918105|NCT03469336|12101690|P1|COMPLETED|Overall Study||17
4918106|NCT03469336|12101690|P1|STARTED|Overall Study||18
4918107|NCT03468920|12101715|P2|NOT COMPLETED|Overall Study||0
4918108|NCT03468920|12101716|P1|NOT COMPLETED|Overall Study||0
4918109|NCT03468920|12101715|P2|COMPLETED|Overall Study||60
4918110|NCT03468920|12101716|P1|COMPLETED|Overall Study||60
4918111|NCT03468920|12101715|P2|STARTED|Overall Study||60
4918112|NCT03468920|12101716|P1|STARTED|Overall Study||60
4918113|NCT03468816|12101732|P2|NOT COMPLETED|Overall Study||0
4918114|NCT03468816|12101733|P1|NOT COMPLETED|Overall Study||0
4918115|NCT03468816|12101732|P2|COMPLETED|Overall Study||3
4918116|NCT03468816|12101733|P1|COMPLETED|Overall Study||2
4918117|NCT03468816|12101732|P2|STARTED|Overall Study||3
4918118|NCT03468816|12101733|P1|STARTED|Overall Study||2
4918119|NCT03468543|12101750|P1|NOT COMPLETED|Overall Study||3
4918120|NCT03468543|12101750|P1|COMPLETED|Overall Study||0
4918121|NCT03468543|12101750|P1|STARTED|Overall Study||3
4918122|NCT03468179|12101754|P1|NOT COMPLETED|Overall Study||0
4918123|NCT03468179|12101754|P1|COMPLETED|Overall Study||10
4918124|NCT03468179|12101754|P1|STARTED|Overall Study||10
4918125|NCT03467971|12101762|P2|NOT COMPLETED|Treatment Period 2||1
4918126|NCT03467971|12101763|P1|NOT COMPLETED|Treatment Period 2||0
4918127|NCT03467971|12101762|P2|COMPLETED|Treatment Period 2||10
4918128|NCT03467971|12101763|P1|COMPLETED|Treatment Period 2||10
4918129|NCT03467971|12101762|P2|STARTED|Treatment Period 2||11
4918130|NCT03467971|12101763|P1|STARTED|Treatment Period 2||10
4918131|NCT03467971|12101762|P2|NOT COMPLETED|Treatment Period 1||0
4918132|NCT03467971|12101763|P1|NOT COMPLETED|Treatment Period 1||0
4918133|NCT03467971|12101762|P2|COMPLETED|Treatment Period 1||11
4918134|NCT03467971|12101763|P1|COMPLETED|Treatment Period 1||10
4918135|NCT03467971|12101762|P2|STARTED|Treatment Period 1||11
4918136|NCT03467971|12101763|P1|STARTED|Treatment Period 1||10
4918137|NCT03467945|12101787|P4|NOT COMPLETED|Treatment Period 4||0
4918138|NCT03467945|12101788|P3|NOT COMPLETED|Treatment Period 4||0
4918139|NCT03467945|12101789|P2|NOT COMPLETED|Treatment Period 4||0
4918140|NCT03467945|12101790|P1|NOT COMPLETED|Treatment Period 4||0
4918141|NCT03467945|12101787|P4|COMPLETED|Treatment Period 4||9
4918142|NCT03467945|12101788|P3|COMPLETED|Treatment Period 4||8
4918143|NCT03467945|12101789|P2|COMPLETED|Treatment Period 4||9
4918144|NCT03467945|12101790|P1|COMPLETED|Treatment Period 4||9
4918145|NCT03467945|12101787|P4|STARTED|Treatment Period 4||9
4918146|NCT03467945|12101788|P3|STARTED|Treatment Period 4||8
4918147|NCT03467945|12101789|P2|STARTED|Treatment Period 4||9
4918148|NCT03467945|12101790|P1|STARTED|Treatment Period 4||9
4918149|NCT03467945|12101787|P4|NOT COMPLETED|Treatment Period 3||1
4918150|NCT03467945|12101788|P3|NOT COMPLETED|Treatment Period 3||2
4918151|NCT03467945|12101789|P2|NOT COMPLETED|Treatment Period 3||0
4918152|NCT03467945|12101790|P1|NOT COMPLETED|Treatment Period 3||1
4918153|NCT03467945|12101787|P4|COMPLETED|Treatment Period 3||9
4918154|NCT03467945|12101788|P3|COMPLETED|Treatment Period 3||8
4918155|NCT03467945|12101789|P2|COMPLETED|Treatment Period 3||9
4918156|NCT03467945|12101790|P1|COMPLETED|Treatment Period 3||9
4918157|NCT03467945|12101787|P4|STARTED|Treatment Period 3||10
4918158|NCT03467945|12101788|P3|STARTED|Treatment Period 3||10
4918159|NCT03467945|12101789|P2|STARTED|Treatment Period 3||9
4918160|NCT03467945|12101790|P1|STARTED|Treatment Period 3||10
4918161|NCT03467945|12101787|P4|NOT COMPLETED|Treatment Period 2||0
4918162|NCT03467945|12101788|P3|NOT COMPLETED|Treatment Period 2||0
4918163|NCT03467945|12101789|P2|NOT COMPLETED|Treatment Period 2||1
4918164|NCT03467945|12101790|P1|NOT COMPLETED|Treatment Period 2||0
4918165|NCT03467945|12101787|P4|COMPLETED|Treatment Period 2||10
4918166|NCT03467945|12101788|P3|COMPLETED|Treatment Period 2||10
4918167|NCT03467945|12101789|P2|COMPLETED|Treatment Period 2||9
4918168|NCT03467945|12101790|P1|COMPLETED|Treatment Period 2||10
4918169|NCT03467945|12101787|P4|STARTED|Treatment Period 2||10
4918170|NCT03467945|12101788|P3|STARTED|Treatment Period 2||10
4918171|NCT03467945|12101789|P2|STARTED|Treatment Period 2||10
4918172|NCT03467945|12101790|P1|STARTED|Treatment Period 2||10
4918173|NCT03467945|12101787|P4|NOT COMPLETED|Treatment Period 1||0
4918174|NCT03467945|12101788|P3|NOT COMPLETED|Treatment Period 1||0
4918175|NCT03467945|12101789|P2|NOT COMPLETED|Treatment Period 1||0
4918176|NCT03467945|12101790|P1|NOT COMPLETED|Treatment Period 1||0
4918177|NCT03467945|12101787|P4|COMPLETED|Treatment Period 1||10
4918178|NCT03467945|12101788|P3|COMPLETED|Treatment Period 1||10
4918179|NCT03467945|12101789|P2|COMPLETED|Treatment Period 1||10
4918180|NCT03467945|12101790|P1|COMPLETED|Treatment Period 1||10
4918181|NCT03467945|12101787|P4|STARTED|Treatment Period 1||10
4918182|NCT03467945|12101788|P3|STARTED|Treatment Period 1||10
4918183|NCT03467945|12101789|P2|STARTED|Treatment Period 1||10
4918184|NCT03467945|12101790|P1|STARTED|Treatment Period 1||10
4918185|NCT03467048|12101844|P2|NOT COMPLETED|Overall Study||1
4918186|NCT03467048|12101845|P1|NOT COMPLETED|Overall Study||0
4918187|NCT03467048|12101844|P2|COMPLETED|Overall Study||63
4918188|NCT03467048|12101845|P1|COMPLETED|Overall Study||66
4918189|NCT03467048|12101844|P2|STARTED|Overall Study||64
4918190|NCT03467048|12101845|P1|STARTED|Overall Study||66
4918191|NCT03466918|12101855|P1|NOT COMPLETED|Overall Study||0
4918192|NCT03466918|12101855|P1|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
4918193|NCT03466918|12101855|P1|STARTED|Overall Study||58
4918194|NCT03466658|12101862|P1|NOT COMPLETED|Overall Study||3
4918195|NCT03466658|12101862|P1|COMPLETED|Overall Study||14
4918196|NCT03466658|12101862|P1|STARTED|Overall Study||17
4918197|NCT03466086|12101868|P2|NOT COMPLETED|Period 2||0
4918198|NCT03466086|12101869|P1|NOT COMPLETED|Period 2||0
4918199|NCT03466086|12101868|P2|COMPLETED|Period 2||27
4918200|NCT03466086|12101869|P1|COMPLETED|Period 2||26
4918201|NCT03466086|12101868|P2|STARTED|Period 2||27
4918202|NCT03466086|12101869|P1|STARTED|Period 2||26
4918203|NCT03466086|12101868|P2|NOT COMPLETED|Period 1||0
4918204|NCT03466086|12101869|P1|NOT COMPLETED|Period 1||2
4918205|NCT03466086|12101868|P2|COMPLETED|Period 1||27
4918206|NCT03466086|12101869|P1|COMPLETED|Period 1||26
4918207|NCT03466086|12101868|P2|STARTED|Period 1||27
4918208|NCT03466086|12101869|P1|STARTED|Period 1||28
4918209|NCT03466073|12101883|P6|NOT COMPLETED|Overall Study||1
4918210|NCT03466073|12101884|P5|NOT COMPLETED|Overall Study||0
4918211|NCT03466073|12101885|P4|NOT COMPLETED|Overall Study||0
4918212|NCT03466073|12101886|P3|NOT COMPLETED|Overall Study||0
4918213|NCT03466073|12101887|P2|NOT COMPLETED|Overall Study||0
4918214|NCT03466073|12101888|P1|NOT COMPLETED|Overall Study||1
4918215|NCT03466073|12101883|P6|COMPLETED|Overall Study||6
4918216|NCT03466073|12101884|P5|COMPLETED|Overall Study||6
4918217|NCT03466073|12101885|P4|COMPLETED|Overall Study||6
4918218|NCT03466073|12101886|P3|COMPLETED|Overall Study||6
4918219|NCT03466073|12101887|P2|COMPLETED|Overall Study||2
4918220|NCT03466073|12101888|P1|COMPLETED|Overall Study||5
4918221|NCT03466073|12101883|P6|STARTED|Overall Study||7
4918222|NCT03466073|12101884|P5|STARTED|Overall Study||6
4918223|NCT03466073|12101885|P4|STARTED|Overall Study||6
4918224|NCT03466073|12101886|P3|STARTED|Overall Study||6
4918225|NCT03466073|12101887|P2|STARTED|Overall Study||2
4918226|NCT03466073|12101888|P1|STARTED|Overall Study||6
4918227|NCT03466060|12101921|P6|NOT COMPLETED|Period 2||0
4918228|NCT03466060|12101922|P5|NOT COMPLETED|Period 2||0
4918229|NCT03466060|12101923|P4|NOT COMPLETED|Period 2||0
4918230|NCT03466060|12101924|P3|NOT COMPLETED|Period 2||1
4918231|NCT03466060|12101925|P2|NOT COMPLETED|Period 2||0
4918232|NCT03466060|12101926|P1|NOT COMPLETED|Period 2||0
4918233|NCT03466060|12101921|P6|COMPLETED|Period 2||18
4918234|NCT03466060|12101922|P5|COMPLETED|Period 2||20
4918235|NCT03466060|12101923|P4|COMPLETED|Period 2||17
4918236|NCT03466060|12101924|P3|COMPLETED|Period 2||16
4918237|NCT03466060|12101925|P2|COMPLETED|Period 2||16
4918238|NCT03466060|12101926|P1|COMPLETED|Period 2||19
4918239|NCT03466060|12101921|P6|STARTED|Period 2||18
4918240|NCT03466060|12101922|P5|STARTED|Period 2||20
4918241|NCT03466060|12101923|P4|STARTED|Period 2||17
4918242|NCT03466060|12101924|P3|STARTED|Period 2||17
4918243|NCT03466060|12101925|P2|STARTED|Period 2||16
4918244|NCT03466060|12101926|P1|STARTED|Period 2||19
4918245|NCT03466060|12101921|P6|NOT COMPLETED|Period 1||0
4918246|NCT03466060|12101922|P5|NOT COMPLETED|Period 1||0
4918247|NCT03466060|12101923|P4|NOT COMPLETED|Period 1||1
4918248|NCT03466060|12101924|P3|NOT COMPLETED|Period 1||3
4918249|NCT03466060|12101925|P2|NOT COMPLETED|Period 1||2
4918250|NCT03466060|12101926|P1|NOT COMPLETED|Period 1||0
4918251|NCT03466060|12101921|P6|COMPLETED|Period 1||18
4918252|NCT03466060|12101922|P5|COMPLETED|Period 1||20
4918253|NCT03466060|12101923|P4|COMPLETED|Period 1||17
4918254|NCT03466060|12101924|P3|COMPLETED|Period 1||17
4918255|NCT03466060|12101925|P2|COMPLETED|Period 1||16
4918256|NCT03466060|12101926|P1|COMPLETED|Period 1||19
4918257|NCT03466060|12101921|P6|STARTED|Period 1||18
4918258|NCT03466060|12101922|P5|STARTED|Period 1||20
4918259|NCT03466060|12101923|P4|STARTED|Period 1||18
4918260|NCT03466060|12101924|P3|STARTED|Period 1||20
4918261|NCT03466060|12101925|P2|STARTED|Period 1||18
4918262|NCT03466060|12101926|P1|STARTED|Period 1||19
4918263|NCT03465904|12101942|P2|NOT COMPLETED|Overall Study||66
4918264|NCT03465904|12101943|P1|NOT COMPLETED|Overall Study||89
4918265|NCT03465904|12101942|P2|COMPLETED|Overall Study||237
4918266|NCT03465904|12101943|P1|COMPLETED|Overall Study||209
4918267|NCT03465904|12101942|P2|STARTED|Overall Study||303
4918268|NCT03465904|12101943|P1|STARTED|Overall Study||298
4918269|NCT03465878|12101963|P4|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
4918270|NCT03465878|12101964|P3|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
4918271|NCT03465878|12101965|P2|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
4918272|NCT03465878|12101966|P1|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
4918273|NCT03465878|12101963|P4|COMPLETED|Period2-Part B Second Intervention Day 1||17
4918274|NCT03465878|12101964|P3|COMPLETED|Period2-Part B Second Intervention Day 1||20
4918275|NCT03465878|12101965|P2|COMPLETED|Period2-Part B Second Intervention Day 1||0
4918276|NCT03465878|12101966|P1|COMPLETED|Period2-Part B Second Intervention Day 1||0
4918277|NCT03465878|12101963|P4|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
4918278|NCT03465878|12101964|P3|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
4918279|NCT03465878|12101965|P2|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
4918280|NCT03465878|12101966|P1|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
4918281|NCT03465878|12101963|P4|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
4918282|NCT03465878|12101964|P3|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
4918283|NCT03465878|12101965|P2|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
4918284|NCT03465878|12101966|P1|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
4918285|NCT03465878|12101963|P4|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
4918286|NCT03465878|12101964|P3|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
4918287|NCT03465878|12101965|P2|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
4918288|NCT03465878|12101966|P1|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
4918289|NCT03465878|12101963|P4|STARTED|Period2-Part B Second Intervention Day 1||17
4918290|NCT03465878|12101964|P3|STARTED|Period2-Part B Second Intervention Day 1||20
4918291|NCT03465878|12101965|P2|STARTED|Period2-Part B Second Intervention Day 1||0
4918292|NCT03465878|12101966|P1|STARTED|Period2-Part B Second Intervention Day 1||0
4918293|NCT03465878|12101963|P4|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
4918294|NCT03465878|12101964|P3|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
4918295|NCT03465878|12101965|P2|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
4918296|NCT03465878|12101966|P1|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
4918297|NCT03465878|12101963|P4|COMPLETED|Period 1-Part B First Intervention Day 1||17
4918298|NCT03465878|12101964|P3|COMPLETED|Period 1-Part B First Intervention Day 1||20
4918299|NCT03465878|12101965|P2|COMPLETED|Period 1-Part B First Intervention Day 1||0
4918300|NCT03465878|12101966|P1|COMPLETED|Period 1-Part B First Intervention Day 1||0
4918301|NCT03465878|12101963|P4|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
4918302|NCT03465878|12101964|P3|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
4918303|NCT03465878|12101965|P2|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
4918304|NCT03465878|12101966|P1|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
4918305|NCT03465878|12101963|P4|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
4918306|NCT03465878|12101964|P3|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
4918307|NCT03465878|12101965|P2|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
4918308|NCT03465878|12101966|P1|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
4918309|NCT03465878|12101963|P4|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
4918310|NCT03465878|12101964|P3|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
4918311|NCT03465878|12101965|P2|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
4918312|NCT03465878|12101966|P1|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
4918313|NCT03465878|12101963|P4|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
4918314|NCT03465878|12101964|P3|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
4918315|NCT03465878|12101965|P2|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
4918316|NCT03465878|12101966|P1|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
4918317|NCT03465878|12101963|P4|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
4918318|NCT03465878|12101964|P3|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
4918319|NCT03465878|12101965|P2|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
4918320|NCT03465878|12101966|P1|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
4918321|NCT03465878|12101963|P4|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
4918322|NCT03465878|12101964|P3|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
4918323|NCT03465878|12101965|P2|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
4918324|NCT03465878|12101966|P1|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
4918325|NCT03465878|12101963|P4|COMPLETED|Period2-Part A Second Intervention Day 1||0
4918326|NCT03465878|12101964|P3|COMPLETED|Period2-Part A Second Intervention Day 1||0
4918327|NCT03465878|12101965|P2|COMPLETED|Period2-Part A Second Intervention Day 1||20
4918328|NCT03465878|12101966|P1|COMPLETED|Period2-Part A Second Intervention Day 1||21
4918329|NCT03465878|12101963|P4|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
4918330|NCT03465878|12101964|P3|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
4918331|NCT03465878|12101965|P2|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
4918332|NCT03465878|12101966|P1|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
4918333|NCT03465878|12101963|P4|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
4918334|NCT03465878|12101964|P3|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
4918335|NCT03465878|12101965|P2|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
4918336|NCT03465878|12101966|P1|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
4918337|NCT03465878|12101963|P4|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
4918338|NCT03465878|12101964|P3|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
4918339|NCT03465878|12101965|P2|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
4918340|NCT03465878|12101966|P1|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
4918341|NCT03465878|12101963|P4|STARTED|Period2-Part A Second Intervention Day 1||0
4918342|NCT03465878|12101964|P3|STARTED|Period2-Part A Second Intervention Day 1||0
4918343|NCT03465878|12101965|P2|STARTED|Period2-Part A Second Intervention Day 1||20
4918344|NCT03465878|12101966|P1|STARTED|Period2-Part A Second Intervention Day 1||21
4918345|NCT03465878|12101963|P4|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
4918346|NCT03465878|12101964|P3|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
4918347|NCT03465878|12101965|P2|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
4918348|NCT03465878|12101966|P1|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
4918349|NCT03465878|12101963|P4|COMPLETED|Period 1-Part A First Intervention Day 1||0
4918350|NCT03465878|12101964|P3|COMPLETED|Period 1-Part A First Intervention Day 1||0
4918351|NCT03465878|12101965|P2|COMPLETED|Period 1-Part A First Intervention Day 1||20
4918352|NCT03465878|12101966|P1|COMPLETED|Period 1-Part A First Intervention Day 1||21
4918353|NCT03465878|12101963|P4|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
4918354|NCT03465878|12101964|P3|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
4918355|NCT03465878|12101965|P2|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
4918356|NCT03465878|12101966|P1|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
4918357|NCT03465878|12101963|P4|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
4918358|NCT03465878|12101964|P3|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
4918359|NCT03465878|12101965|P2|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
4918360|NCT03465878|12101966|P1|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
4918361|NCT03465878|12101963|P4|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
4918362|NCT03465878|12101964|P3|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
4918363|NCT03465878|12101965|P2|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
4918364|NCT03465878|12101966|P1|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
4918365|NCT03465878|12101963|P4|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
4918366|NCT03465878|12101964|P3|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
4918367|NCT03465878|12101965|P2|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
4918368|NCT03465878|12101966|P1|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
4918369|NCT03465878|12101963|P4|STARTED|Period 1-Part A First Intervention Day 1||0
4918370|NCT03465878|12101964|P3|STARTED|Period 1-Part A First Intervention Day 1||0
4918371|NCT03465878|12101965|P2|STARTED|Period 1-Part A First Intervention Day 1||21
4918372|NCT03465878|12101966|P1|STARTED|Period 1-Part A First Intervention Day 1||21
4918373|NCT03465436|12102008|P4|NOT COMPLETED|Period 4||0
4918374|NCT03465436|12102009|P3|NOT COMPLETED|Period 4||1
4918375|NCT03465436|12102010|P2|NOT COMPLETED|Period 4||0
4918376|NCT03465436|12102011|P1|NOT COMPLETED|Period 4||0
4918377|NCT03465436|12102008|P4|COMPLETED|Period 4||14
4918378|NCT03465436|12102009|P3|COMPLETED|Period 4||12
4918379|NCT03465436|12102010|P2|COMPLETED|Period 4||12
4918380|NCT03465436|12102011|P1|COMPLETED|Period 4||13
4918381|NCT03465436|12102008|P4|Received at Least 1 Dose of Study Drug|Period 4||14
4918382|NCT03465436|12102009|P3|Received at Least 1 Dose of Study Drug|Period 4||13
4918383|NCT03465436|12102010|P2|Received at Least 1 Dose of Study Drug|Period 4||12
4918384|NCT03465436|12102011|P1|Received at Least 1 Dose of Study Drug|Period 4||13
4918385|NCT03465436|12102008|P4|STARTED|Period 4||14
4918386|NCT03465436|12102009|P3|STARTED|Period 4||13
4918387|NCT03465436|12102010|P2|STARTED|Period 4||12
4918388|NCT03465436|12102011|P1|STARTED|Period 4||13
4918389|NCT03465436|12102008|P4|NOT COMPLETED|Period 3||0
4918390|NCT03465436|12102009|P3|NOT COMPLETED|Period 3||0
4918391|NCT03465436|12102010|P2|NOT COMPLETED|Period 3||1
4918392|NCT03465436|12102011|P1|NOT COMPLETED|Period 3||1
4918393|NCT03465436|12102008|P4|COMPLETED|Period 3||14
4918394|NCT03465436|12102009|P3|COMPLETED|Period 3||13
4918395|NCT03465436|12102010|P2|COMPLETED|Period 3||12
4918396|NCT03465436|12102011|P1|COMPLETED|Period 3||13
4918397|NCT03465436|12102008|P4|Received at Least One Dose of Study Drug|Period 3||14
4918398|NCT03465436|12102009|P3|Received at Least One Dose of Study Drug|Period 3||13
4918399|NCT03465436|12102010|P2|Received at Least One Dose of Study Drug|Period 3||12
4918400|NCT03465436|12102011|P1|Received at Least One Dose of Study Drug|Period 3||13
4918401|NCT03465436|12102008|P4|STARTED|Period 3||14
4918402|NCT03465436|12102009|P3|STARTED|Period 3||13
4918403|NCT03465436|12102010|P2|STARTED|Period 3||13
4918404|NCT03465436|12102011|P1|STARTED|Period 3||14
4918405|NCT03465436|12102008|P4|NOT COMPLETED|Period 2||0
4918406|NCT03465436|12102009|P3|NOT COMPLETED|Period 2||0
4918407|NCT03465436|12102010|P2|NOT COMPLETED|Period 2||1
4918408|NCT03465436|12102011|P1|NOT COMPLETED|Period 2||0
4918409|NCT03465436|12102008|P4|COMPLETED|Period 2||14
4918410|NCT03465436|12102009|P3|COMPLETED|Period 2||13
4918411|NCT03465436|12102010|P2|COMPLETED|Period 2||13
4918412|NCT03465436|12102011|P1|COMPLETED|Period 2||14
4918413|NCT03465436|12102008|P4|Received at Least 1 Dose of Study Drug|Period 2||14
4918414|NCT03465436|12102009|P3|Received at Least 1 Dose of Study Drug|Period 2||13
4918415|NCT03465436|12102010|P2|Received at Least 1 Dose of Study Drug|Period 2||13
4918416|NCT03465436|12102011|P1|Received at Least 1 Dose of Study Drug|Period 2||14
4918417|NCT03465436|12102008|P4|STARTED|Period 2||14
4918418|NCT03465436|12102009|P3|STARTED|Period 2||13
4918419|NCT03465436|12102010|P2|STARTED|Period 2||14
4918420|NCT03465436|12102011|P1|STARTED|Period 2||14
4918421|NCT03465436|12102008|P4|NOT COMPLETED|Period 1||0
4918422|NCT03465436|12102009|P3|NOT COMPLETED|Period 1||1
4918423|NCT03465436|12102010|P2|NOT COMPLETED|Period 1||0
4918424|NCT03465436|12102011|P1|NOT COMPLETED|Period 1||0
4918425|NCT03465436|12102008|P4|COMPLETED|Period 1||14
4918426|NCT03465436|12102009|P3|COMPLETED|Period 1||13
4918427|NCT03465436|12102010|P2|COMPLETED|Period 1||14
4918428|NCT03465436|12102011|P1|COMPLETED|Period 1||14
4918429|NCT03465436|12102008|P4|Received at Least 1 Dose of Study Drug|Period 1||14
4918430|NCT03465436|12102009|P3|Received at Least 1 Dose of Study Drug|Period 1||14
4918431|NCT03465436|12102010|P2|Received at Least 1 Dose of Study Drug|Period 1||14
4918432|NCT03465436|12102011|P1|Received at Least 1 Dose of Study Drug|Period 1||14
4918433|NCT03465436|12102008|P4|STARTED|Period 1||14
4918434|NCT03465436|12102009|P3|STARTED|Period 1||14
4918435|NCT03465436|12102010|P2|STARTED|Period 1||14
4918436|NCT03465436|12102011|P1|STARTED|Period 1||14
4918437|NCT03463512|12102047|P2|NOT COMPLETED|Overall Study||0
4918438|NCT03463512|12102048|P1|NOT COMPLETED|Overall Study||0
4918439|NCT03463512|12102047|P2|COMPLETED|Overall Study||62
4918440|NCT03463512|12102048|P1|COMPLETED|Overall Study||62
4918441|NCT03463512|12102047|P2|STARTED|Overall Study||62
4918442|NCT03463512|12102048|P1|STARTED|Overall Study||62
4918443|NCT03463161|12102058|P1|NOT COMPLETED|Overall Study||0
4918444|NCT03463161|12102058|P1|COMPLETED|Overall Study||2
4918445|NCT03463161|12102058|P1|STARTED|Overall Study||2
4918446|NCT03463031|12102067|P2|NOT COMPLETED|Overall Study||5
4918447|NCT03463031|12102068|P1|NOT COMPLETED|Overall Study||10
4918448|NCT03463031|12102067|P2|COMPLETED|Overall Study||216
4918449|NCT03463031|12102068|P1|COMPLETED|Overall Study||215
4918450|NCT03463031|12102067|P2|STARTED|Overall Study||221
4918451|NCT03463031|12102068|P1|STARTED|Overall Study||225
4918452|NCT03462927|12102082|P2|NOT COMPLETED|Overall Study||2
4918453|NCT03462927|12102083|P1|NOT COMPLETED|Overall Study||6
4918454|NCT03462927|12102082|P2|COMPLETED|Overall Study||29
4918455|NCT03462927|12102083|P1|COMPLETED|Overall Study||26
4918456|NCT03462927|12102082|P2|STARTED|Overall Study||31
4918457|NCT03462927|12102083|P1|STARTED|Overall Study||32
4918458|NCT03462745|12102109|P2|NOT COMPLETED|Overall Study||0
4918459|NCT03462745|12102110|P1|NOT COMPLETED|Overall Study||0
4918460|NCT03462745|12102109|P2|COMPLETED|Overall Study||92
4918461|NCT03462745|12102110|P1|COMPLETED|Overall Study||92
4918462|NCT03462745|12102109|P2|STARTED|Overall Study||92
4918463|NCT03462745|12102110|P1|STARTED|Overall Study||92
4918464|NCT03461757|12102118|P2|NOT COMPLETED|Overall Study||45
4918465|NCT03461757|12102119|P1|NOT COMPLETED|Overall Study||53
4918466|NCT03461757|12102118|P2|COMPLETED|Overall Study||689
4918467|NCT03461757|12102119|P1|COMPLETED|Overall Study||679
4918468|NCT03461757|12102118|P2|Treated|Overall Study||693
4918469|NCT03461757|12102119|P1|Treated|Overall Study||682
4918470|NCT03461757|12102118|P2|STARTED|Overall Study||734
4918471|NCT03461757|12102119|P1|STARTED|Overall Study||732
4918472|NCT03461705|12102169|P1|NOT COMPLETED|Overall Study||0
4918473|NCT03461705|12102169|P1|COMPLETED|Overall Study||5
4918474|NCT03461705|12102169|P1|STARTED|Overall Study||5
4918475|NCT03460990|12102182|P2|NOT COMPLETED|Overall Study||0
4918476|NCT03460990|12102183|P1|NOT COMPLETED|Overall Study||0
4918477|NCT03460990|12102182|P2|COMPLETED|Overall Study||54
4918478|NCT03460990|12102183|P1|COMPLETED|Overall Study||57
4918479|NCT03460990|12102182|P2|STARTED|Overall Study||54
4918480|NCT03460990|12102183|P1|STARTED|Overall Study||57
4918481|NCT03460899|12102197|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
4918482|NCT03460899|12102197|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
4918483|NCT03460899|12102197|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
4918484|NCT03460899|12102197|P1|NOT COMPLETED|Euglycaemic Clamp||0
4918485|NCT03460899|12102197|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
4918486|NCT03460899|12102197|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
4918487|NCT03459794|12102206|P2|NOT COMPLETED|Overall Study||0
4918488|NCT03459794|12102207|P1|NOT COMPLETED|Overall Study||0
4918489|NCT03459794|12102206|P2|COMPLETED|Overall Study||4
4918490|NCT03459794|12102207|P1|COMPLETED|Overall Study||8
4918491|NCT03459794|12102206|P2|STARTED|Overall Study||4
4918492|NCT03459794|12102207|P1|STARTED|Overall Study||8
4918493|NCT03459612|12102227|P4|NOT COMPLETED|Period 4||0
4918494|NCT03459612|12102228|P3|NOT COMPLETED|Period 4||0
4918495|NCT03459612|12102229|P2|NOT COMPLETED|Period 4||0
4918496|NCT03459612|12102230|P1|NOT COMPLETED|Period 4||0
4918497|NCT03459612|12102227|P4|COMPLETED|Period 4||17
4918498|NCT03459612|12102228|P3|COMPLETED|Period 4||16
4918499|NCT03459612|12102229|P2|COMPLETED|Period 4||17
4918500|NCT03459612|12102230|P1|COMPLETED|Period 4||17
4918501|NCT03459612|12102227|P4|Received at Least 1 Dose of Study Drug|Period 4||17
4918502|NCT03459612|12102228|P3|Received at Least 1 Dose of Study Drug|Period 4||16
4918503|NCT03459612|12102229|P2|Received at Least 1 Dose of Study Drug|Period 4||17
4918504|NCT03459612|12102230|P1|Received at Least 1 Dose of Study Drug|Period 4||17
4918505|NCT03459612|12102227|P4|STARTED|Period 4||17
4918506|NCT03459612|12102228|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
4918507|NCT03459612|12102229|P2|STARTED|Period 4||17
4918508|NCT03459612|12102230|P1|STARTED|Period 4||17
4918509|NCT03459612|12102227|P4|NOT COMPLETED|Period 3||0
4918510|NCT03459612|12102228|P3|NOT COMPLETED|Period 3||0
4918511|NCT03459612|12102229|P2|NOT COMPLETED|Period 3||0
4918512|NCT03459612|12102230|P1|NOT COMPLETED|Period 3||0
4918513|NCT03459612|12102227|P4|COMPLETED|Period 3||17
4918514|NCT03459612|12102228|P3|COMPLETED|Period 3||17
4918515|NCT03459612|12102229|P2|COMPLETED|Period 3||17
4918516|NCT03459612|12102230|P1|COMPLETED|Period 3||17
4918517|NCT03459612|12102227|P4|Received at Least 1 Dose of Study Drug|Period 3||17
4918518|NCT03459612|12102228|P3|Received at Least 1 Dose of Study Drug|Period 3||17
4918519|NCT03459612|12102229|P2|Received at Least 1 Dose of Study Drug|Period 3||17
4918520|NCT03459612|12102230|P1|Received at Least 1 Dose of Study Drug|Period 3||17
4918521|NCT03459612|12102227|P4|STARTED|Period 3||17
4918522|NCT03459612|12102228|P3|STARTED|Period 3||17
4918523|NCT03459612|12102229|P2|STARTED|Period 3||17
4918524|NCT03459612|12102230|P1|STARTED|Period 3||17
4918525|NCT03459612|12102227|P4|NOT COMPLETED|Period 2||0
4918526|NCT03459612|12102228|P3|NOT COMPLETED|Period 2||0
4918527|NCT03459612|12102229|P2|NOT COMPLETED|Period 2||0
4918528|NCT03459612|12102230|P1|NOT COMPLETED|Period 2||0
4918529|NCT03459612|12102227|P4|COMPLETED|Period 2||17
4918530|NCT03459612|12102228|P3|COMPLETED|Period 2||17
4918531|NCT03459612|12102229|P2|COMPLETED|Period 2||17
4918532|NCT03459612|12102230|P1|COMPLETED|Period 2||17
4918533|NCT03459612|12102227|P4|Received at Least 1 Dose of Study Drug|Period 2||17
4918534|NCT03459612|12102228|P3|Received at Least 1 Dose of Study Drug|Period 2||17
4918535|NCT03459612|12102229|P2|Received at Least 1 Dose of Study Drug|Period 2||17
4918536|NCT03459612|12102230|P1|Received at Least 1 Dose of Study Drug|Period 2||17
4918537|NCT03459612|12102227|P4|STARTED|Period 2||17
4918538|NCT03459612|12102228|P3|STARTED|Period 2||17
4918539|NCT03459612|12102229|P2|STARTED|Period 2||17
4918540|NCT03459612|12102230|P1|STARTED|Period 2||17
4918541|NCT03459612|12102227|P4|NOT COMPLETED|Period 1||0
4918542|NCT03459612|12102228|P3|NOT COMPLETED|Period 1||0
4918543|NCT03459612|12102229|P2|NOT COMPLETED|Period 1||0
4918544|NCT03459612|12102230|P1|NOT COMPLETED|Period 1||0
4918545|NCT03459612|12102227|P4|COMPLETED|Period 1||17
4918546|NCT03459612|12102228|P3|COMPLETED|Period 1||17
4918547|NCT03459612|12102229|P2|COMPLETED|Period 1||17
4918548|NCT03459612|12102230|P1|COMPLETED|Period 1||17
4918549|NCT03459612|12102227|P4|Received at Least 1 Dose of Study Drug|Period 1||17
4918550|NCT03459612|12102228|P3|Received at Least 1 Dose of Study Drug|Period 1||17
4918551|NCT03459612|12102229|P2|Received at Least 1 Dose of Study Drug|Period 1||17
4918552|NCT03459612|12102230|P1|Received at Least 1 Dose of Study Drug|Period 1||17
4918553|NCT03459612|12102227|P4|STARTED|Period 1||17
4918554|NCT03459612|12102228|P3|STARTED|Period 1||17
4918555|NCT03459612|12102229|P2|STARTED|Period 1||17
4918556|NCT03459612|12102230|P1|STARTED|Period 1||17
4918557|NCT03459196|12102288|P1|NOT COMPLETED|Overall Study||2
4918558|NCT03459196|12102288|P1|COMPLETED|Overall Study||52
4918559|NCT03459196|12102288|P1|STARTED|Overall Study||54
4918560|NCT03459131|12102293|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
4918561|NCT03459131|12102294|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
4918562|NCT03459131|12102293|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
4918563|NCT03459131|12102294|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
4918564|NCT03459131|12102293|P2|STARTED|Period 2, Second 7 Days of Wear||8
4918565|NCT03459131|12102294|P1|STARTED|Period 2, Second 7 Days of Wear||7
4918566|NCT03459131|12102293|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
4918567|NCT03459131|12102294|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
4918568|NCT03459131|12102293|P2|COMPLETED|Period 1, First 7 Days of Wear||8
4918569|NCT03459131|12102294|P1|COMPLETED|Period 1, First 7 Days of Wear||7
4918570|NCT03459131|12102293|P2|STARTED|Period 1, First 7 Days of Wear||8
4918571|NCT03459131|12102294|P1|STARTED|Period 1, First 7 Days of Wear||7
4918572|NCT03458871|12102302|P1|NOT COMPLETED|Overall Study||0
4918573|NCT03458871|12102302|P1|COMPLETED|Overall Study||16
4918574|NCT03458871|12102302|P1|STARTED|Overall Study||16
4918575|NCT03458702|12102332|P2|NOT COMPLETED|Picture Rating/Body Composition||0
4918576|NCT03458702|12102333|P1|NOT COMPLETED|Picture Rating/Body Composition||0
4918577|NCT03458702|12102332|P2|COMPLETED|Picture Rating/Body Composition||20
4918578|NCT03458702|12102333|P1|COMPLETED|Picture Rating/Body Composition||20
4918579|NCT03458702|12102332|P2|STARTED|Picture Rating/Body Composition||20
4918580|NCT03458702|12102333|P1|STARTED|Picture Rating/Body Composition||20
4918581|NCT03458702|12102332|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
4918582|NCT03458702|12102333|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
4918583|NCT03458702|12102332|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
4918584|NCT03458702|12102333|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
4918585|NCT03458702|12102332|P2|STARTED|Study Condition B (Yoga or Rest)||22
4918586|NCT03458702|12102333|P1|STARTED|Study Condition B (Yoga or Rest)||24
4918587|NCT03458702|12102332|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
4918588|NCT03458702|12102333|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
4918589|NCT03458702|12102332|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
4918590|NCT03458702|12102333|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
4918591|NCT03458702|12102332|P2|STARTED|Study Condition A (Yoga or Rest)||28
4918592|NCT03458702|12102333|P1|STARTED|Study Condition A (Yoga or Rest)||28
4918593|NCT03457909|12102349|P1|NOT COMPLETED|Overall Study||0
4918594|NCT03457909|12102349|P1|COMPLETED|Overall Study||25
4918595|NCT03457909|12102349|P1|STARTED|Overall Study||25
4918596|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
4918597|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
4918598|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
4918599|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
4918600|NCT03457727|12102362|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
4918601|NCT03457727|12102363|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
4918602|NCT03457727|12102364|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
4918603|NCT03457727|12102365|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
4918604|NCT03457727|12102362|P4|STARTED|Part 2, Period 4 (1 Day)||0
4918605|NCT03457727|12102363|P3|STARTED|Part 2, Period 4 (1 Day)||12
4918606|NCT03457727|12102364|P2|STARTED|Part 2, Period 4 (1 Day)||0
4918607|NCT03457727|12102365|P1|STARTED|Part 2, Period 4 (1 Day)||0
4918608|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918609|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918610|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918611|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918612|NCT03457727|12102362|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
4918613|NCT03457727|12102363|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
4918614|NCT03457727|12102364|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918615|NCT03457727|12102365|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
4918616|NCT03457727|12102362|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
4918617|NCT03457727|12102363|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
4918618|NCT03457727|12102364|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
4918619|NCT03457727|12102365|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
4918620|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
4918621|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
4918622|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
4918623|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
4918624|NCT03457727|12102362|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
4918625|NCT03457727|12102363|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
4918626|NCT03457727|12102364|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
4918627|NCT03457727|12102365|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
4918628|NCT03457727|12102362|P4|STARTED|Part 2, Period 3 (1 Day)||11
4918629|NCT03457727|12102363|P3|STARTED|Part 2, Period 3 (1 Day)||12
4918630|NCT03457727|12102364|P2|STARTED|Part 2, Period 3 (1 Day)||0
4918631|NCT03457727|12102365|P1|STARTED|Part 2, Period 3 (1 Day)||0
4918632|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918633|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918634|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918635|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918636|NCT03457727|12102362|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
4918637|NCT03457727|12102363|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
4918638|NCT03457727|12102364|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918639|NCT03457727|12102365|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
4918640|NCT03457727|12102362|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
4918641|NCT03457727|12102363|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
4918642|NCT03457727|12102364|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
4918643|NCT03457727|12102365|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
4918644|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4918645|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4918646|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4918647|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4918648|NCT03457727|12102362|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
4918649|NCT03457727|12102363|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
4918650|NCT03457727|12102364|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
4918651|NCT03457727|12102365|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
4918652|NCT03457727|12102362|P4|STARTED|Part 2, Period 2 (1 Day)||11
4918653|NCT03457727|12102363|P3|STARTED|Part 2, Period 2 (1 Day)||12
4918654|NCT03457727|12102364|P2|STARTED|Part 2, Period 2 (1 Day)||0
4918655|NCT03457727|12102365|P1|STARTED|Part 2, Period 2 (1 Day)||0
4918656|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
4918657|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
4918658|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
4918659|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
4918660|NCT03457727|12102362|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
4918661|NCT03457727|12102363|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
4918662|NCT03457727|12102364|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
4918663|NCT03457727|12102365|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
4918664|NCT03457727|12102362|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
4918665|NCT03457727|12102363|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
4918666|NCT03457727|12102364|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
4918667|NCT03457727|12102365|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
4918668|NCT03457727|12102362|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4918669|NCT03457727|12102363|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4918670|NCT03457727|12102364|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4918671|NCT03457727|12102365|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4918672|NCT03457727|12102362|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
4918673|NCT03457727|12102363|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
4918674|NCT03457727|12102364|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
4918675|NCT03457727|12102365|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
4918676|NCT03457727|12102362|P4|STARTED|Part 2, Period 1 (1 Day)||12
4918677|NCT03457727|12102363|P3|STARTED|Part 2, Period 1 (1 Day)||12
4918678|NCT03457727|12102364|P2|STARTED|Part 2, Period 1 (1 Day)||0
4918679|NCT03457727|12102365|P1|STARTED|Part 2, Period 1 (1 Day)||0
4918680|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
4918681|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
4918682|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
4918683|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
4918684|NCT03457727|12102362|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
4918685|NCT03457727|12102363|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
4918686|NCT03457727|12102364|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
4918687|NCT03457727|12102365|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
4918688|NCT03457727|12102362|P4|STARTED|Part 1, Period 4 (1 Day)||0
4918689|NCT03457727|12102363|P3|STARTED|Part 1, Period 4 (1 Day)||0
4918690|NCT03457727|12102364|P2|STARTED|Part 1, Period 4 (1 Day)||8
4918691|NCT03457727|12102365|P1|STARTED|Part 1, Period 4 (1 Day)||8
4918692|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918693|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918694|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918695|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918696|NCT03457727|12102362|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918697|NCT03457727|12102363|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
4918698|NCT03457727|12102364|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
4918699|NCT03457727|12102365|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
4918700|NCT03457727|12102362|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
4918701|NCT03457727|12102363|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
4918702|NCT03457727|12102364|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
4918703|NCT03457727|12102365|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
4918704|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
4918705|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
4918706|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
4918707|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
4918708|NCT03457727|12102362|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
4918709|NCT03457727|12102363|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
4918710|NCT03457727|12102364|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
4918711|NCT03457727|12102365|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
4918712|NCT03457727|12102362|P4|STARTED|Part 1, Period 3 (1 Day)||0
4918713|NCT03457727|12102363|P3|STARTED|Part 1, Period 3 (1 Day)||0
4918714|NCT03457727|12102364|P2|STARTED|Part 1, Period 3 (1 Day)||8
4918715|NCT03457727|12102365|P1|STARTED|Part 1, Period 3 (1 Day)||8
4918716|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918717|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918718|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918719|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918720|NCT03457727|12102362|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918721|NCT03457727|12102363|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
4918722|NCT03457727|12102364|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
4918723|NCT03457727|12102365|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
4918724|NCT03457727|12102362|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
4918725|NCT03457727|12102363|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
4918726|NCT03457727|12102364|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
4918727|NCT03457727|12102365|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
4918728|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4918729|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4918730|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4918731|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4918732|NCT03457727|12102362|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
4918733|NCT03457727|12102363|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
4918734|NCT03457727|12102364|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
4918735|NCT03457727|12102365|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
4918736|NCT03457727|12102362|P4|STARTED|Part 1, Period 2 (1 Day)||0
4918737|NCT03457727|12102363|P3|STARTED|Part 1, Period 2 (1 Day)||0
4918738|NCT03457727|12102364|P2|STARTED|Part 1, Period 2 (1 Day)||8
4918739|NCT03457727|12102365|P1|STARTED|Part 1, Period 2 (1 Day)||8
4918740|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918741|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918742|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918743|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918744|NCT03457727|12102362|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918745|NCT03457727|12102363|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
4918746|NCT03457727|12102364|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
4918747|NCT03457727|12102365|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
4918748|NCT03457727|12102362|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
4918749|NCT03457727|12102363|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
4918750|NCT03457727|12102364|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
4918751|NCT03457727|12102365|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
4918752|NCT03457727|12102362|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4918753|NCT03457727|12102363|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4918754|NCT03457727|12102364|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4918755|NCT03457727|12102365|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4918756|NCT03457727|12102362|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
4918757|NCT03457727|12102363|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
4918758|NCT03457727|12102364|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
4918759|NCT03457727|12102365|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
4918760|NCT03457727|12102362|P4|STARTED|Part 1, Period 1 (1 Day)||0
4918761|NCT03457727|12102363|P3|STARTED|Part 1, Period 1 (1 Day)||0
4918762|NCT03457727|12102364|P2|STARTED|Part 1, Period 1 (1 Day)||8
4918763|NCT03457727|12102365|P1|STARTED|Part 1, Period 1 (1 Day)||8
4918764|NCT03457636|12102562|P1|NOT COMPLETED|Overall Study||2
4918765|NCT03457636|12102562|P1|COMPLETED|Overall Study||20
4918766|NCT03457636|12102562|P1|STARTED|Overall Study||22
4918767|NCT03456960|12102575|P6|NOT COMPLETED|Period 2 (1 Day)||0
4918768|NCT03456960|12102576|P5|NOT COMPLETED|Period 2 (1 Day)||0
4918769|NCT03456960|12102577|P4|NOT COMPLETED|Period 2 (1 Day)||1
4918770|NCT03456960|12102578|P3|NOT COMPLETED|Period 2 (1 Day)||0
4918771|NCT03456960|12102579|P2|NOT COMPLETED|Period 2 (1 Day)||0
4918772|NCT03456960|12102580|P1|NOT COMPLETED|Period 2 (1 Day)||1
4918773|NCT03456960|12102575|P6|COMPLETED|Period 2 (1 Day)||6
4918774|NCT03456960|12102576|P5|COMPLETED|Period 2 (1 Day)||6
4918775|NCT03456960|12102577|P4|COMPLETED|Period 2 (1 Day)||117
4918776|NCT03456960|12102578|P3|COMPLETED|Period 2 (1 Day)||119
4918777|NCT03456960|12102579|P2|COMPLETED|Period 2 (1 Day)||12
4918778|NCT03456960|12102580|P1|COMPLETED|Period 2 (1 Day)||11
4918779|NCT03456960|12102575|P6|STARTED|Period 2 (1 Day)||6
4918780|NCT03456960|12102576|P5|STARTED|Period 2 (1 Day)||6
4918781|NCT03456960|12102577|P4|STARTED|Period 2 (1 Day)||118
4918782|NCT03456960|12102578|P3|STARTED|Period 2 (1 Day)||119
4918783|NCT03456960|12102579|P2|STARTED|Period 2 (1 Day)||12
4918784|NCT03456960|12102580|P1|STARTED|Period 2 (1 Day)||12
4918785|NCT03456960|12102575|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4918786|NCT03456960|12102576|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4918787|NCT03456960|12102577|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
4918788|NCT03456960|12102578|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
4918789|NCT03456960|12102579|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4918790|NCT03456960|12102580|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4918791|NCT03456960|12102575|P6|COMPLETED|Washout Period (at Least 14 Days)||6
4918792|NCT03456960|12102576|P5|COMPLETED|Washout Period (at Least 14 Days)||6
4918793|NCT03456960|12102577|P4|COMPLETED|Washout Period (at Least 14 Days)||118
4918794|NCT03456960|12102578|P3|COMPLETED|Washout Period (at Least 14 Days)||119
4918795|NCT03456960|12102579|P2|COMPLETED|Washout Period (at Least 14 Days)||12
4918796|NCT03456960|12102580|P1|COMPLETED|Washout Period (at Least 14 Days)||12
4918797|NCT03456960|12102575|P6|STARTED|Washout Period (at Least 14 Days)||6
4918798|NCT03456960|12102576|P5|STARTED|Washout Period (at Least 14 Days)||6
4918799|NCT03456960|12102577|P4|STARTED|Washout Period (at Least 14 Days)||120
4918800|NCT03456960|12102578|P3|STARTED|Washout Period (at Least 14 Days)||120
4918801|NCT03456960|12102579|P2|STARTED|Washout Period (at Least 14 Days)||12
4918802|NCT03456960|12102580|P1|STARTED|Washout Period (at Least 14 Days)||12
4918803|NCT03456960|12102575|P6|NOT COMPLETED|Period 1 (1 Day)||0
4918804|NCT03456960|12102576|P5|NOT COMPLETED|Period 1 (1 Day)||0
4918805|NCT03456960|12102577|P4|NOT COMPLETED|Period 1 (1 Day)||0
4918806|NCT03456960|12102578|P3|NOT COMPLETED|Period 1 (1 Day)||0
4918807|NCT03456960|12102579|P2|NOT COMPLETED|Period 1 (1 Day)||0
4918808|NCT03456960|12102580|P1|NOT COMPLETED|Period 1 (1 Day)||0
4918809|NCT03456960|12102575|P6|COMPLETED|Period 1 (1 Day)||6
4918810|NCT03456960|12102576|P5|COMPLETED|Period 1 (1 Day)||6
4918811|NCT03456960|12102577|P4|COMPLETED|Period 1 (1 Day)||120
4918812|NCT03456960|12102578|P3|COMPLETED|Period 1 (1 Day)||120
4918813|NCT03456960|12102579|P2|COMPLETED|Period 1 (1 Day)||12
4918814|NCT03456960|12102580|P1|COMPLETED|Period 1 (1 Day)||12
4918815|NCT03456960|12102575|P6|STARTED|Period 1 (1 Day)||6
4918816|NCT03456960|12102576|P5|STARTED|Period 1 (1 Day)||6
4918817|NCT03456960|12102577|P4|STARTED|Period 1 (1 Day)||120
4918818|NCT03456960|12102578|P3|STARTED|Period 1 (1 Day)||120
4918819|NCT03456960|12102579|P2|STARTED|Period 1 (1 Day)||12
4918820|NCT03456960|12102580|P1|STARTED|Period 1 (1 Day)||12
4918821|NCT03456856|12102672|P1|NOT COMPLETED|Overall Study||3
4918822|NCT03456856|12102672|P1|COMPLETED|Overall Study||27
4918823|NCT03456856|12102672|P1|STARTED|Overall Study||30
4918824|NCT03456700|12102676|P1|NOT COMPLETED|Overall Study||1
4918825|NCT03456700|12102676|P1|COMPLETED|Overall Study||21
4918826|NCT03456700|12102676|P1|STARTED|Overall Study||22
4918827|NCT03456427|12102684|P1|NOT COMPLETED|Overall Study||3
4918828|NCT03456427|12102684|P1|COMPLETED|Overall Study||33
4918829|NCT03456427|12102684|P1|STARTED|Overall Study||36
4918830|NCT03456245|12102693|P1|NOT COMPLETED|Overall Study||15
4918831|NCT03456245|12102693|P1|COMPLETED|Overall Study||190
4918832|NCT03456245|12102693|P1|STARTED|Overall Study||205
4918833|NCT03455556|12102697|P1|NOT COMPLETED|Overall Study||0
4918834|NCT03455556|12102697|P1|COMPLETED|Overall Study||1
4918835|NCT03455556|12102697|P1|STARTED|Overall Study||1
4918836|NCT03455543|12102708|P3|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
4918837|NCT03455543|12102709|P2|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
4918838|NCT03455543|12102710|P1|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
4918839|NCT03455543|12102708|P3|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
4918840|NCT03455543|12102709|P2|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
4918841|NCT03455543|12102710|P1|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
4918842|NCT03455543|12102708|P3|STARTED|Part B: Open-label Extension (24 Weeks)||152
4918843|NCT03455543|12102709|P2|STARTED|Part B: Open-label Extension (24 Weeks)||0
4918844|NCT03455543|12102710|P1|STARTED|Part B: Open-label Extension (24 Weeks)||0
4918845|NCT03455543|12102708|P3|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
4918846|NCT03455543|12102709|P2|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
4918847|NCT03455543|12102710|P1|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
4918848|NCT03455543|12102708|P3|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
4918849|NCT03455543|12102709|P2|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
4918850|NCT03455543|12102710|P1|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
4918851|NCT03455543|12102708|P3|STARTED|Part A: Randomized Treatment (17 Weeks)||0
4918852|NCT03455543|12102709|P2|STARTED|Part A: Randomized Treatment (17 Weeks)||90
4918853|NCT03455543|12102710|P1|STARTED|Part A: Randomized Treatment (17 Weeks)||92
4918854|NCT03455491|12102751|P3|NOT COMPLETED|Overall Study||0
4918855|NCT03455491|12102752|P2|NOT COMPLETED|Overall Study||0
4918856|NCT03455491|12102753|P1|NOT COMPLETED|Overall Study||0
4918857|NCT03455491|12102751|P3|COMPLETED|Overall Study||40
4918858|NCT03455491|12102752|P2|COMPLETED|Overall Study||40
4918859|NCT03455491|12102753|P1|COMPLETED|Overall Study||40
4918860|NCT03455491|12102751|P3|STARTED|Overall Study||40
4918861|NCT03455491|12102752|P2|STARTED|Overall Study||40
4918862|NCT03455491|12102753|P1|STARTED|Overall Study||40
4918863|NCT03454581|12102773|P3|NOT COMPLETED|Overall Study||3
4918864|NCT03454581|12102774|P2|NOT COMPLETED|Overall Study||3
4918865|NCT03454581|12102775|P1|NOT COMPLETED|Overall Study||4
4918866|NCT03454581|12102773|P3|COMPLETED|Overall Study||14
4918867|NCT03454581|12102774|P2|COMPLETED|Overall Study||13
4918868|NCT03454581|12102775|P1|COMPLETED|Overall Study||14
4918869|NCT03454581|12102773|P3|STARTED|Overall Study||17
4918870|NCT03454581|12102774|P2|STARTED|Overall Study||16
4918871|NCT03454581|12102775|P1|STARTED|Overall Study||18
4918872|NCT03454048|12102808|P4|NOT COMPLETED|Overall Study||0
4918873|NCT03454048|12102809|P3|NOT COMPLETED|Overall Study||0
4918874|NCT03454048|12102810|P2|NOT COMPLETED|Overall Study||0
4918875|NCT03454048|12102811|P1|NOT COMPLETED|Overall Study||0
4918876|NCT03454048|12102808|P4|COMPLETED|Overall Study||6
4918877|NCT03454048|12102809|P3|COMPLETED|Overall Study||6
4918878|NCT03454048|12102810|P2|COMPLETED|Overall Study||6
4918879|NCT03454048|12102811|P1|COMPLETED|Overall Study||6
4918880|NCT03454048|12102808|P4|STARTED|Overall Study||6
4918881|NCT03454048|12102809|P3|STARTED|Overall Study||6
4918882|NCT03454048|12102810|P2|STARTED|Overall Study||6
4918883|NCT03454048|12102811|P1|STARTED|Overall Study||6
4918884|NCT03453151|12102841|P1|NOT COMPLETED|Overall Study||4
4918885|NCT03453151|12102841|P1|COMPLETED|Overall Study||15
4918886|NCT03453151|12102841|P1|STARTED|Overall Study||19
4918887|NCT03453060|12102855|P5|NOT COMPLETED|Overall Study||0
4918888|NCT03453060|12102856|P4|NOT COMPLETED|Overall Study||0
4918889|NCT03453060|12102857|P3|NOT COMPLETED|Overall Study||0
4918890|NCT03453060|12102858|P2|NOT COMPLETED|Overall Study||0
4918891|NCT03453060|12102859|P1|NOT COMPLETED|Overall Study||0
4918892|NCT03453060|12102855|P5|COMPLETED|Overall Study||5
4918893|NCT03453060|12102856|P4|COMPLETED|Overall Study||4
4918894|NCT03453060|12102857|P3|COMPLETED|Overall Study||4
4918895|NCT03453060|12102858|P2|COMPLETED|Overall Study||4
4918896|NCT03453060|12102859|P1|COMPLETED|Overall Study||4
4918897|NCT03453060|12102855|P5|STARTED|Overall Study||5
4918898|NCT03453060|12102856|P4|STARTED|Overall Study||4
4918899|NCT03453060|12102857|P3|STARTED|Overall Study||4
4918900|NCT03453060|12102858|P2|STARTED|Overall Study||4
4918901|NCT03453060|12102859|P1|STARTED|Overall Study||4
4918902|NCT03452943|12103078|P2|NOT COMPLETED|Maintenance Period (5 Weeks)||0
4918903|NCT03452943|12103079|P1|NOT COMPLETED|Maintenance Period (5 Weeks)||3
4918904|NCT03452943|12103078|P2|COMPLETED|Maintenance Period (5 Weeks)||56
4918905|NCT03452943|12103079|P1|COMPLETED|Maintenance Period (5 Weeks)||51
4918906|NCT03452943|12103078|P2|STARTED|Maintenance Period (5 Weeks)||56
4918907|NCT03452943|12103079|P1|STARTED|Maintenance Period (5 Weeks)||54
4918908|NCT03452943|12103078|P2|NOT COMPLETED|Titration Period (7 Weeks)||4
4918909|NCT03452943|12103079|P1|NOT COMPLETED|Titration Period (7 Weeks)||5
4918910|NCT03452943|12103078|P2|COMPLETED|Titration Period (7 Weeks)||56
4918911|NCT03452943|12103079|P1|COMPLETED|Titration Period (7 Weeks)||54
4918912|NCT03452943|12103078|P2|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
4918913|NCT03452943|12103079|P1|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
4918914|NCT03452943|12103078|P2|Safety Analysis Set|Titration Period (7 Weeks)||59
4918915|NCT03452943|12103079|P1|Safety Analysis Set|Titration Period (7 Weeks)||58
4918916|NCT03452943|12103078|P2|STARTED|Titration Period (7 Weeks)||60
4918917|NCT03452943|12103079|P1|STARTED|Titration Period (7 Weeks)||59
4918918|NCT03452371|12103095|P2|NOT COMPLETED|Overall Study||0
4918919|NCT03452371|12103096|P1|NOT COMPLETED|Overall Study||0
4918920|NCT03452371|12103095|P2|COMPLETED|Overall Study||23
4918921|NCT03452371|12103096|P1|COMPLETED|Overall Study||21
4918922|NCT03452371|12103095|P2|STARTED|Overall Study||23
4918923|NCT03452371|12103096|P1|STARTED|Overall Study||21
4918924|NCT03452176|12103114|P2|NOT COMPLETED|Overall Study||0
4918925|NCT03452176|12103115|P1|NOT COMPLETED|Overall Study||0
4918926|NCT03452176|12103114|P2|COMPLETED|Overall Study||11
4918927|NCT03452176|12103115|P1|COMPLETED|Overall Study||11
4918928|NCT03452176|12103114|P2|STARTED|Overall Study||11
4918929|NCT03452176|12103115|P1|STARTED|Overall Study||11
4918930|NCT03451721|12103131|P1|NOT COMPLETED|Overall Study||1
4918931|NCT03451721|12103131|P1|COMPLETED|Overall Study||19
4918932|NCT03451721|12103131|P1|STARTED|Overall Study||20
4918933|NCT03450070|12103140|P1|NOT COMPLETED|Overall Study||8
4918934|NCT03450070|12103140|P1|COMPLETED|Overall Study||110
4918935|NCT03450070|12103140|P1|STARTED|Overall Study||118
4918936|NCT03449979|12103148|P4|NOT COMPLETED|Overall Study||1
4918937|NCT03449979|12103149|P3|NOT COMPLETED|Overall Study||0
4918938|NCT03449979|12103150|P2|NOT COMPLETED|Overall Study||0
4918939|NCT03449979|12103151|P1|NOT COMPLETED|Overall Study||0
4918940|NCT03449979|12103148|P4|COMPLETED|Overall Study||21
4918941|NCT03449979|12103149|P3|COMPLETED|Overall Study||21
4918942|NCT03449979|12103150|P2|COMPLETED|Overall Study||20
4918943|NCT03449979|12103151|P1|COMPLETED|Overall Study||21
4918944|NCT03449979|12103148|P4|STARTED|Overall Study||22
4918945|NCT03449979|12103149|P3|STARTED|Overall Study||21
4918946|NCT03449979|12103150|P2|STARTED|Overall Study||20
4918947|NCT03449979|12103151|P1|STARTED|Overall Study||21
4918948|NCT03449433|12103163|P5|NOT COMPLETED|Period 4||0
4918949|NCT03449433|12103164|P4|NOT COMPLETED|Period 4||0
4918950|NCT03449433|12103165|P3|NOT COMPLETED|Period 4||0
4918951|NCT03449433|12103166|P2|NOT COMPLETED|Period 4||0
4918952|NCT03449433|12103167|P1|NOT COMPLETED|Period 4||0
4918953|NCT03449433|12103163|P5|COMPLETED|Period 4||12
4918954|NCT03449433|12103164|P4|COMPLETED|Period 4||17
4918955|NCT03449433|12103165|P3|COMPLETED|Period 4||18
4918956|NCT03449433|12103166|P2|COMPLETED|Period 4||15
4918957|NCT03449433|12103167|P1|COMPLETED|Period 4||17
4918958|NCT03449433|12103163|P5|Received at Least 1 Dose of Study Drug|Period 4||0
4918959|NCT03449433|12103164|P4|Received at Least 1 Dose of Study Drug|Period 4||17
4918960|NCT03449433|12103165|P3|Received at Least 1 Dose of Study Drug|Period 4||18
4918961|NCT03449433|12103166|P2|Received at Least 1 Dose of Study Drug|Period 4||15
4918962|NCT03449433|12103167|P1|Received at Least 1 Dose of Study Drug|Period 4||17
4918963|NCT03449433|12103163|P5|STARTED|Period 4||12
4918964|NCT03449433|12103164|P4|STARTED|Period 4||17
4918965|NCT03449433|12103165|P3|STARTED|Period 4||18
4918966|NCT03449433|12103166|P2|STARTED|Period 4||15
4918967|NCT03449433|12103167|P1|STARTED|Period 4||17
4918968|NCT03449433|12103163|P5|NOT COMPLETED|Period 3||0
4918969|NCT03449433|12103164|P4|NOT COMPLETED|Period 3||0
4918970|NCT03449433|12103165|P3|NOT COMPLETED|Period 3||0
4918971|NCT03449433|12103166|P2|NOT COMPLETED|Period 3||1
4918972|NCT03449433|12103167|P1|NOT COMPLETED|Period 3||0
4918973|NCT03449433|12103163|P5|COMPLETED|Period 3||12
4918974|NCT03449433|12103164|P4|COMPLETED|Period 3||17
4918975|NCT03449433|12103165|P3|COMPLETED|Period 3||18
4918976|NCT03449433|12103166|P2|COMPLETED|Period 3||15
4918977|NCT03449433|12103167|P1|COMPLETED|Period 3||17
4918978|NCT03449433|12103163|P5|Received at Least 1 Dose of Study Drug|Period 3||0
4918979|NCT03449433|12103164|P4|Received at Least 1 Dose of Study Drug|Period 3||17
4918980|NCT03449433|12103165|P3|Received at Least 1 Dose of Study Drug|Period 3||18
4918981|NCT03449433|12103166|P2|Received at Least 1 Dose of Study Drug|Period 3||15
4918982|NCT03449433|12103167|P1|Received at Least 1 Dose of Study Drug|Period 3||17
4918983|NCT03449433|12103163|P5|STARTED|Period 3||12
4918984|NCT03449433|12103164|P4|STARTED|Period 3||17
4918985|NCT03449433|12103165|P3|STARTED|Period 3||18
4918986|NCT03449433|12103166|P2|STARTED|Period 3||16
4918987|NCT03449433|12103167|P1|STARTED|Period 3||17
4918988|NCT03449433|12103163|P5|NOT COMPLETED|Period 2||0
4918989|NCT03449433|12103164|P4|NOT COMPLETED|Period 2||0
4918990|NCT03449433|12103165|P3|NOT COMPLETED|Period 2||0
4918991|NCT03449433|12103166|P2|NOT COMPLETED|Period 2||0
4918992|NCT03449433|12103167|P1|NOT COMPLETED|Period 2||0
4918993|NCT03449433|12103163|P5|COMPLETED|Period 2||12
4918994|NCT03449433|12103164|P4|COMPLETED|Period 2||17
4918995|NCT03449433|12103165|P3|COMPLETED|Period 2||18
4918996|NCT03449433|12103166|P2|COMPLETED|Period 2||16
4918997|NCT03449433|12103167|P1|COMPLETED|Period 2||17
4918998|NCT03449433|12103163|P5|Received at Least 1 Dose of Study Drug|Period 2||0
4918999|NCT03449433|12103164|P4|Received at Least 1 Dose of Study Drug|Period 2||17
4919000|NCT03449433|12103165|P3|Received at Least 1 Dose of Study Drug|Period 2||18
4919001|NCT03449433|12103166|P2|Received at Least 1 Dose of Study Drug|Period 2||16
4919002|NCT03449433|12103167|P1|Received at Least 1 Dose of Study Drug|Period 2||17
4919003|NCT03449433|12103163|P5|STARTED|Period 2||12
4919004|NCT03449433|12103164|P4|STARTED|Period 2||17
4919005|NCT03449433|12103165|P3|STARTED|Period 2||18
4919006|NCT03449433|12103166|P2|STARTED|Period 2||16
4919007|NCT03449433|12103167|P1|STARTED|Period 2||17
4919008|NCT03449433|12103163|P5|NOT COMPLETED|Period 1||0
4919009|NCT03449433|12103164|P4|NOT COMPLETED|Period 1||0
4919010|NCT03449433|12103165|P3|NOT COMPLETED|Period 1||0
4919011|NCT03449433|12103166|P2|NOT COMPLETED|Period 1||0
4919012|NCT03449433|12103167|P1|NOT COMPLETED|Period 1||0
4919013|NCT03449433|12103163|P5|COMPLETED|Period 1||12
4919014|NCT03449433|12103164|P4|COMPLETED|Period 1||17
4919015|NCT03449433|12103165|P3|COMPLETED|Period 1||18
4919016|NCT03449433|12103166|P2|COMPLETED|Period 1||16
4919017|NCT03449433|12103167|P1|COMPLETED|Period 1||17
4919018|NCT03449433|12103163|P5|Received at Least 1 Dose of Study Drug|Period 1||0
4919019|NCT03449433|12103164|P4|Received at Least 1 Dose of Study Drug|Period 1||17
4919020|NCT03449433|12103165|P3|Received at Least 1 Dose of Study Drug|Period 1||18
4919021|NCT03449433|12103166|P2|Received at Least 1 Dose of Study Drug|Period 1||16
4919022|NCT03449433|12103167|P1|Received at Least 1 Dose of Study Drug|Period 1||17
4919023|NCT03449433|12103163|P5|STARTED|Period 1||12
4919024|NCT03449433|12103164|P4|STARTED|Period 1||17
4919025|NCT03449433|12103165|P3|STARTED|Period 1||18
4919026|NCT03449433|12103166|P2|STARTED|Period 1||16
4919027|NCT03449433|12103167|P1|STARTED|Period 1||17
4919028|NCT03449342|12103185|P2|NOT COMPLETED|Overall Study||0
4919029|NCT03449342|12103186|P1|NOT COMPLETED|Overall Study||0
4919030|NCT03449342|12103185|P2|COMPLETED|Overall Study||50
4919031|NCT03449342|12103186|P1|COMPLETED|Overall Study||10
4919032|NCT03449342|12103185|P2|STARTED|Overall Study||50
4919033|NCT03449342|12103186|P1|STARTED|Overall Study||10
4919034|NCT03448536|12103202|P2|NOT COMPLETED|Overall Study||4
4919035|NCT03448536|12103203|P1|NOT COMPLETED|Overall Study||12
4919036|NCT03448536|12103202|P2|COMPLETED|Overall Study||97
4919037|NCT03448536|12103203|P1|COMPLETED|Overall Study||88
4919038|NCT03448536|12103202|P2|Completed Second Intervention|Overall Study||87
4919039|NCT03448536|12103203|P1|Completed Second Intervention|Overall Study||82
4919040|NCT03448536|12103202|P2|Completed First Intervention|Overall Study||97
4919041|NCT03448536|12103203|P1|Completed First Intervention|Overall Study||95
4919042|NCT03448536|12103202|P2|Completed First Intervention|Overall Study||78
4919043|NCT03448536|12103203|P1|Completed First Intervention|Overall Study||83
4919044|NCT03448536|12103202|P2|STARTED|Overall Study||101
4919045|NCT03448536|12103203|P1|STARTED|Overall Study||100
4919046|NCT03447821|12103230|P3|NOT COMPLETED|Overall Study||1
4919047|NCT03447821|12103231|P2|NOT COMPLETED|Overall Study||1
4919048|NCT03447821|12103232|P1|NOT COMPLETED|Overall Study||1
4919049|NCT03447821|12103230|P3|COMPLETED|Overall Study||12
4919050|NCT03447821|12103231|P2|COMPLETED|Overall Study||12
4919051|NCT03447821|12103232|P1|COMPLETED|Overall Study||13
4919052|NCT03447821|12103230|P3|STARTED|Overall Study||13
4919053|NCT03447821|12103231|P2|STARTED|Overall Study||13
4919054|NCT03447821|12103232|P1|STARTED|Overall Study||14
4919055|NCT03447639|12103257|P2|NOT COMPLETED|Overall Study||2
4919056|NCT03447639|12103258|P1|NOT COMPLETED|Overall Study||0
4919057|NCT03447639|12103257|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
4919058|NCT03447639|12103258|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
4919059|NCT03447639|12103257|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
4919060|NCT03447639|12103258|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
4919061|NCT03447353|12103268|P1|NOT COMPLETED|Overall Study||10
4919062|NCT03447353|12103268|P1|COMPLETED|Overall Study||8
4919063|NCT03447353|12103268|P1|STARTED|Overall Study||18
4919064|NCT03447249|12103284|P2|NOT COMPLETED|Overall Study||0
4919065|NCT03447249|12103285|P1|NOT COMPLETED|Overall Study||5
4919066|NCT03447249|12103284|P2|COMPLETED|Overall Study||192
4919067|NCT03447249|12103285|P1|COMPLETED|Overall Study||185
4919068|NCT03447249|12103284|P2|Safety Set|Overall Study||193
4919069|NCT03447249|12103285|P1|Safety Set|Overall Study||189
4919070|NCT03447249|12103284|P2|STARTED|Overall Study||192
4919071|NCT03447249|12103285|P1|STARTED|Overall Study||190
4919072|NCT03447015|12103316|P2|NOT COMPLETED|Overall Study||44
4919073|NCT03447015|12103317|P1|NOT COMPLETED|Overall Study||45
4919074|NCT03447015|12103316|P2|COMPLETED|Overall Study||106
4919075|NCT03447015|12103317|P1|COMPLETED|Overall Study||95
4919076|NCT03447015|12103316|P2|STARTED|Overall Study||150
4919077|NCT03447015|12103317|P1|STARTED|Overall Study||140
4919078|NCT03446690|12103335|P2|NOT COMPLETED|Overall Study||0
4919079|NCT03446690|12103336|P1|NOT COMPLETED|Overall Study||7
4919080|NCT03446690|12103335|P2|COMPLETED|Overall Study||29
4919081|NCT03446690|12103336|P1|COMPLETED|Overall Study||26
4919082|NCT03446690|12103335|P2|STARTED|Overall Study||29
4919083|NCT03446690|12103336|P1|STARTED|Overall Study||33
4919084|NCT03446573|12103344|P2|NOT COMPLETED|Overall Study||372
4919085|NCT03446573|12103345|P1|NOT COMPLETED|Overall Study||369
4919086|NCT03446573|12103344|P2|COMPLETED|Overall Study||0
4919087|NCT03446573|12103345|P1|COMPLETED|Overall Study||0
4919088|NCT03446573|12103344|P2|STARTED|Overall Study||372
4919089|NCT03446573|12103345|P1|STARTED|Overall Study||369
4919090|NCT03445390|12103417|P2|NOT COMPLETED|Second Intervention||1
4919091|NCT03445390|12103418|P1|NOT COMPLETED|Second Intervention||2
4919092|NCT03445390|12103417|P2|COMPLETED|Second Intervention||10
4919093|NCT03445390|12103418|P1|COMPLETED|Second Intervention||10
4919094|NCT03445390|12103417|P2|STARTED|Second Intervention||11
4919095|NCT03445390|12103418|P1|STARTED|Second Intervention||12
4919096|NCT03445390|12103417|P2|NOT COMPLETED|First Intervention||2
4919097|NCT03445390|12103418|P1|NOT COMPLETED|First Intervention||2
4919098|NCT03445390|12103417|P2|COMPLETED|First Intervention||11
4919099|NCT03445390|12103418|P1|COMPLETED|First Intervention||12
4919100|NCT03445390|12103417|P2|STARTED|First Intervention||13
4919101|NCT03445390|12103418|P1|STARTED|First Intervention||14
4919102|NCT03445195|12103430|P2|NOT COMPLETED|Overall Study||0
4919103|NCT03445195|12103431|P1|NOT COMPLETED|Overall Study||2
4919104|NCT03445195|12103430|P2|COMPLETED|Overall Study||27
4919105|NCT03445195|12103431|P1|COMPLETED|Overall Study||51
4919106|NCT03445195|12103430|P2|STARTED|Overall Study||27
4919107|NCT03445195|12103431|P1|STARTED|Overall Study||53
4919108|NCT03445156|12103446|P3|NOT COMPLETED|Experiment Proper||0
4919109|NCT03445156|12103447|P2|NOT COMPLETED|Experiment Proper||0
4919110|NCT03445156|12103448|P1|NOT COMPLETED|Experiment Proper||0
4919111|NCT03445156|12103446|P3|COMPLETED|Experiment Proper||59
4919112|NCT03445156|12103447|P2|COMPLETED|Experiment Proper||115
4919113|NCT03445156|12103448|P1|COMPLETED|Experiment Proper||113
4919114|NCT03445156|12103446|P3|STARTED|Experiment Proper||59
4919115|NCT03445156|12103447|P2|STARTED|Experiment Proper||115
4919116|NCT03445156|12103448|P1|STARTED|Experiment Proper||113
4919117|NCT03445156|12103446|P3|NOT COMPLETED|Pilot Study||0
4919118|NCT03445156|12103447|P2|NOT COMPLETED|Pilot Study||0
4919119|NCT03445156|12103448|P1|NOT COMPLETED|Pilot Study||0
4919120|NCT03445156|12103446|P3|COMPLETED|Pilot Study||0
4919121|NCT03445156|12103447|P2|COMPLETED|Pilot Study||20
4919122|NCT03445156|12103448|P1|COMPLETED|Pilot Study||20
4919123|NCT03445156|12103446|P3|STARTED|Pilot Study||0
4919124|NCT03445156|12103447|P2|STARTED|Pilot Study||20
4919125|NCT03445156|12103448|P1|STARTED|Pilot Study||20
4919126|NCT03444584|12103467|P2|NOT COMPLETED|Overall Study||2
4919127|NCT03444584|12103468|P1|NOT COMPLETED|Overall Study||0
4919128|NCT03444584|12103467|P2|COMPLETED|Overall Study||23
4919129|NCT03444584|12103468|P1|COMPLETED|Overall Study||24
4919130|NCT03444584|12103467|P2|STARTED|Overall Study||25
4919131|NCT03444584|12103468|P1|STARTED|Overall Study||24
4919132|NCT03444090|12103526|P2|NOT COMPLETED|Overall Study||4
4919133|NCT03444090|12103527|P1|NOT COMPLETED|Overall Study||3
4919134|NCT03444090|12103526|P2|COMPLETED|Overall Study||210
4919135|NCT03444090|12103527|P1|COMPLETED|Overall Study||211
4919136|NCT03444090|12103526|P2|STARTED|Overall Study||214
4919137|NCT03444090|12103527|P1|STARTED|Overall Study||214
4919138|NCT03443713|12103538|P3|NOT COMPLETED|Close-out Visit (30 Minutes)||0
4919139|NCT03443713|12103539|P2|NOT COMPLETED|Close-out Visit (30 Minutes)||0
4919140|NCT03443713|12103540|P1|NOT COMPLETED|Close-out Visit (30 Minutes)||0
4919141|NCT03443713|12103538|P3|COMPLETED|Close-out Visit (30 Minutes)||8
4919142|NCT03443713|12103539|P2|COMPLETED|Close-out Visit (30 Minutes)||8
4919143|NCT03443713|12103540|P1|COMPLETED|Close-out Visit (30 Minutes)||8
4919144|NCT03443713|12103538|P3|STARTED|Close-out Visit (30 Minutes)||8
4919145|NCT03443713|12103539|P2|STARTED|Close-out Visit (30 Minutes)||8
4919146|NCT03443713|12103540|P1|STARTED|Close-out Visit (30 Minutes)||8
4919147|NCT03443713|12103538|P3|NOT COMPLETED|Third at Home Period (8-12 Days)||0
4919148|NCT03443713|12103539|P2|NOT COMPLETED|Third at Home Period (8-12 Days)||0
4919149|NCT03443713|12103540|P1|NOT COMPLETED|Third at Home Period (8-12 Days)||0
4919150|NCT03443713|12103538|P3|COMPLETED|Third at Home Period (8-12 Days)||8
4919151|NCT03443713|12103539|P2|COMPLETED|Third at Home Period (8-12 Days)||8
4919152|NCT03443713|12103540|P1|COMPLETED|Third at Home Period (8-12 Days)||8
4919153|NCT03443713|12103538|P3|STARTED|Third at Home Period (8-12 Days)||8
4919154|NCT03443713|12103539|P2|STARTED|Third at Home Period (8-12 Days)||8
4919155|NCT03443713|12103540|P1|STARTED|Third at Home Period (8-12 Days)||8
4919156|NCT03443713|12103538|P3|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
4919157|NCT03443713|12103539|P2|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
4919158|NCT03443713|12103540|P1|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
4919159|NCT03443713|12103538|P3|COMPLETED|Second Exercise Visit (1 Hour)||8
4919160|NCT03443713|12103539|P2|COMPLETED|Second Exercise Visit (1 Hour)||8
4919161|NCT03443713|12103540|P1|COMPLETED|Second Exercise Visit (1 Hour)||8
4919162|NCT03443713|12103538|P3|STARTED|Second Exercise Visit (1 Hour)||8
4919163|NCT03443713|12103539|P2|STARTED|Second Exercise Visit (1 Hour)||8
4919164|NCT03443713|12103540|P1|STARTED|Second Exercise Visit (1 Hour)||8
4919165|NCT03443713|12103538|P3|NOT COMPLETED|Second at Home Period (2-11 Days)||0
4919166|NCT03443713|12103539|P2|NOT COMPLETED|Second at Home Period (2-11 Days)||0
4919167|NCT03443713|12103540|P1|NOT COMPLETED|Second at Home Period (2-11 Days)||0
4919168|NCT03443713|12103538|P3|COMPLETED|Second at Home Period (2-11 Days)||8
4919169|NCT03443713|12103539|P2|COMPLETED|Second at Home Period (2-11 Days)||8
4919170|NCT03443713|12103540|P1|COMPLETED|Second at Home Period (2-11 Days)||8
4919171|NCT03443713|12103538|P3|STARTED|Second at Home Period (2-11 Days)||8
4919172|NCT03443713|12103539|P2|STARTED|Second at Home Period (2-11 Days)||8
4919173|NCT03443713|12103540|P1|STARTED|Second at Home Period (2-11 Days)||8
4919174|NCT03443713|12103538|P3|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
4919175|NCT03443713|12103539|P2|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
4919176|NCT03443713|12103540|P1|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
4919177|NCT03443713|12103538|P3|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
4919178|NCT03443713|12103539|P2|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
4919179|NCT03443713|12103540|P1|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
4919180|NCT03443713|12103538|P3|STARTED|Dexcom Insertion Visit (30 Minutes)||8
4919181|NCT03443713|12103539|P2|STARTED|Dexcom Insertion Visit (30 Minutes)||8
4919182|NCT03443713|12103540|P1|STARTED|Dexcom Insertion Visit (30 Minutes)||8
4919183|NCT03443713|12103538|P3|NOT COMPLETED|First Exercise Visit (1 Hour)||0
4919184|NCT03443713|12103539|P2|NOT COMPLETED|First Exercise Visit (1 Hour)||0
4919185|NCT03443713|12103540|P1|NOT COMPLETED|First Exercise Visit (1 Hour)||0
4919186|NCT03443713|12103538|P3|COMPLETED|First Exercise Visit (1 Hour)||8
4919187|NCT03443713|12103539|P2|COMPLETED|First Exercise Visit (1 Hour)||8
4919188|NCT03443713|12103540|P1|COMPLETED|First Exercise Visit (1 Hour)||8
4919189|NCT03443713|12103538|P3|STARTED|First Exercise Visit (1 Hour)||8
4919190|NCT03443713|12103539|P2|STARTED|First Exercise Visit (1 Hour)||8
4919191|NCT03443713|12103540|P1|STARTED|First Exercise Visit (1 Hour)||8
4919192|NCT03443713|12103538|P3|NOT COMPLETED|First at Home Period (9-14 Days)||1
4919193|NCT03443713|12103539|P2|NOT COMPLETED|First at Home Period (9-14 Days)||0
4919194|NCT03443713|12103540|P1|NOT COMPLETED|First at Home Period (9-14 Days)||0
4919195|NCT03443713|12103538|P3|COMPLETED|First at Home Period (9-14 Days)||8
4919196|NCT03443713|12103539|P2|COMPLETED|First at Home Period (9-14 Days)||8
4919197|NCT03443713|12103540|P1|COMPLETED|First at Home Period (9-14 Days)||8
4919198|NCT03443713|12103538|P3|STARTED|First at Home Period (9-14 Days)||9
4919199|NCT03443713|12103539|P2|STARTED|First at Home Period (9-14 Days)||8
4919200|NCT03443713|12103540|P1|STARTED|First at Home Period (9-14 Days)||8
4919201|NCT03443713|12103538|P3|NOT COMPLETED|Start up Visit (2 Hours)||0
4919202|NCT03443713|12103539|P2|NOT COMPLETED|Start up Visit (2 Hours)||0
4919203|NCT03443713|12103540|P1|NOT COMPLETED|Start up Visit (2 Hours)||0
4919204|NCT03443713|12103538|P3|COMPLETED|Start up Visit (2 Hours)||9
4919205|NCT03443713|12103539|P2|COMPLETED|Start up Visit (2 Hours)||8
4919206|NCT03443713|12103540|P1|COMPLETED|Start up Visit (2 Hours)||8
4919207|NCT03443713|12103538|P3|STARTED|Start up Visit (2 Hours)||9
4919208|NCT03443713|12103539|P2|STARTED|Start up Visit (2 Hours)||8
4919209|NCT03443713|12103540|P1|STARTED|Start up Visit (2 Hours)||8
4919210|NCT03443414|12103574|P5|NOT COMPLETED|Overall Study||5
4919211|NCT03443414|12103575|P4|NOT COMPLETED|Overall Study||5
4919212|NCT03443414|12103576|P3|NOT COMPLETED|Overall Study||6
4919213|NCT03443414|12103577|P2|NOT COMPLETED|Overall Study||3
4919214|NCT03443414|12103578|P1|NOT COMPLETED|Overall Study||11
4919215|NCT03443414|12103574|P5|COMPLETED|Overall Study||75
4919216|NCT03443414|12103575|P4|COMPLETED|Overall Study||75
4919217|NCT03443414|12103576|P3|COMPLETED|Overall Study||76
4919218|NCT03443414|12103577|P2|COMPLETED|Overall Study||78
4919219|NCT03443414|12103578|P1|COMPLETED|Overall Study||71
4919220|NCT03443414|12103574|P5|Received Treatment|Overall Study||79
4919221|NCT03443414|12103575|P4|Received Treatment|Overall Study||80
4919222|NCT03443414|12103576|P3|Received Treatment|Overall Study||82
4919223|NCT03443414|12103577|P2|Received Treatment|Overall Study||81
4919224|NCT03443414|12103578|P1|Received Treatment|Overall Study||81
4919225|NCT03443414|12103574|P5|STARTED|Overall Study||80
4919226|NCT03443414|12103575|P4|STARTED|Overall Study||80
4919227|NCT03443414|12103576|P3|STARTED|Overall Study||82
4919228|NCT03443414|12103577|P2|STARTED|Overall Study||81
4919229|NCT03443414|12103578|P1|STARTED|Overall Study||82
4919230|NCT03443063|12103617|P2|NOT COMPLETED|Overall Study||0
4919231|NCT03443063|12103618|P1|NOT COMPLETED|Overall Study||0
4919232|NCT03443063|12103617|P2|COMPLETED|Overall Study||8
4919233|NCT03443063|12103618|P1|COMPLETED|Overall Study||8
4919234|NCT03443063|12103617|P2|STARTED|Overall Study||8
4919235|NCT03443063|12103618|P1|STARTED|Overall Study||8
4919236|NCT03442933|12103668|P2|NOT COMPLETED|Overall Study||0
4919237|NCT03442933|12103669|P1|NOT COMPLETED|Overall Study||0
4919238|NCT03442933|12103668|P2|COMPLETED|Overall Study||20
4919239|NCT03442933|12103669|P1|COMPLETED|Overall Study||20
4919240|NCT03442933|12103668|P2|STARTED|Overall Study||20
4919241|NCT03442933|12103669|P1|STARTED|Overall Study||20
4919242|NCT03442725|12103682|P2|NOT COMPLETED|Overall Study||0
4919243|NCT03442725|12103683|P1|NOT COMPLETED|Overall Study||0
4919244|NCT03442725|12103682|P2|COMPLETED|Overall Study||8
4919245|NCT03442725|12103683|P1|COMPLETED|Overall Study||8
4919246|NCT03442725|12103682|P2|STARTED|Overall Study||8
4919247|NCT03442725|12103683|P1|STARTED|Overall Study||8
4919248|NCT03442699|12103715|P1|NOT COMPLETED|Overall Study||0
4919249|NCT03442699|12103715|P1|COMPLETED|Overall Study||6
4919250|NCT03442699|12103715|P1|STARTED|Overall Study||6
4919251|NCT03442036|12103725|P2|NOT COMPLETED|Overall Study||0
4919252|NCT03442036|12103726|P1|NOT COMPLETED|Overall Study||0
4919253|NCT03442036|12103725|P2|COMPLETED|Overall Study||35
4919254|NCT03442036|12103726|P1|COMPLETED|Overall Study||35
4919255|NCT03442036|12103725|P2|STARTED|Overall Study||35
4919256|NCT03442036|12103726|P1|STARTED|Overall Study||35
4919257|NCT03441984|12103738|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919258|NCT03441984|12103739|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919259|NCT03441984|12103740|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919260|NCT03441984|12103741|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919261|NCT03441984|12103742|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919262|NCT03441984|12103743|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919263|NCT03441984|12103744|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919264|NCT03441984|12103745|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919265|NCT03441984|12103746|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919266|NCT03441984|12103747|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919267|NCT03441984|12103748|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919268|NCT03441984|12103749|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919269|NCT03441984|12103738|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919270|NCT03441984|12103739|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919271|NCT03441984|12103740|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919272|NCT03441984|12103741|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919273|NCT03441984|12103742|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919274|NCT03441984|12103743|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
4919275|NCT03441984|12103744|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919276|NCT03441984|12103745|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919277|NCT03441984|12103746|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919278|NCT03441984|12103747|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919279|NCT03441984|12103748|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919280|NCT03441984|12103749|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
4919281|NCT03441984|12103738|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919282|NCT03441984|12103739|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919283|NCT03441984|12103740|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919284|NCT03441984|12103741|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919285|NCT03441984|12103742|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919286|NCT03441984|12103743|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
4919287|NCT03441984|12103744|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919288|NCT03441984|12103745|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919289|NCT03441984|12103746|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919290|NCT03441984|12103747|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919291|NCT03441984|12103748|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919292|NCT03441984|12103749|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
4919293|NCT03441984|12103738|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919294|NCT03441984|12103739|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919295|NCT03441984|12103740|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919296|NCT03441984|12103741|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919297|NCT03441984|12103742|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919298|NCT03441984|12103743|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919299|NCT03441984|12103744|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919300|NCT03441984|12103745|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919301|NCT03441984|12103746|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919302|NCT03441984|12103747|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919303|NCT03441984|12103748|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919304|NCT03441984|12103749|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919305|NCT03441984|12103738|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919306|NCT03441984|12103739|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919307|NCT03441984|12103740|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919308|NCT03441984|12103741|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919309|NCT03441984|12103742|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919310|NCT03441984|12103743|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919311|NCT03441984|12103744|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919312|NCT03441984|12103745|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919313|NCT03441984|12103746|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919314|NCT03441984|12103747|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919315|NCT03441984|12103748|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919316|NCT03441984|12103749|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919317|NCT03441984|12103738|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919318|NCT03441984|12103739|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919319|NCT03441984|12103740|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919320|NCT03441984|12103741|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919321|NCT03441984|12103742|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919322|NCT03441984|12103743|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
4919323|NCT03441984|12103744|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919324|NCT03441984|12103745|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919325|NCT03441984|12103746|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919326|NCT03441984|12103747|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919327|NCT03441984|12103748|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919328|NCT03441984|12103749|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
4919329|NCT03441984|12103738|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919330|NCT03441984|12103739|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919331|NCT03441984|12103740|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919332|NCT03441984|12103741|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919333|NCT03441984|12103742|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919334|NCT03441984|12103743|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919335|NCT03441984|12103744|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919336|NCT03441984|12103745|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919337|NCT03441984|12103746|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919338|NCT03441984|12103747|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919339|NCT03441984|12103748|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919340|NCT03441984|12103749|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919341|NCT03441984|12103738|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919342|NCT03441984|12103739|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919343|NCT03441984|12103740|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919344|NCT03441984|12103741|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919345|NCT03441984|12103742|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919346|NCT03441984|12103743|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
4919347|NCT03441984|12103744|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919348|NCT03441984|12103745|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919349|NCT03441984|12103746|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919350|NCT03441984|12103747|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919351|NCT03441984|12103748|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919352|NCT03441984|12103749|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
4919353|NCT03441984|12103738|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919354|NCT03441984|12103739|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919355|NCT03441984|12103740|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919356|NCT03441984|12103741|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919357|NCT03441984|12103742|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919358|NCT03441984|12103743|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
4919359|NCT03441984|12103744|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919360|NCT03441984|12103745|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919361|NCT03441984|12103746|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919362|NCT03441984|12103747|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919363|NCT03441984|12103748|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919364|NCT03441984|12103749|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
4919365|NCT03441984|12103738|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919366|NCT03441984|12103739|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919367|NCT03441984|12103740|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919368|NCT03441984|12103741|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919369|NCT03441984|12103742|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919370|NCT03441984|12103743|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919371|NCT03441984|12103744|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919372|NCT03441984|12103745|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919373|NCT03441984|12103746|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919374|NCT03441984|12103747|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919375|NCT03441984|12103748|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919376|NCT03441984|12103749|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919377|NCT03441984|12103738|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919378|NCT03441984|12103739|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919379|NCT03441984|12103740|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919380|NCT03441984|12103741|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919381|NCT03441984|12103742|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919382|NCT03441984|12103743|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919383|NCT03441984|12103744|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919384|NCT03441984|12103745|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919385|NCT03441984|12103746|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919386|NCT03441984|12103747|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919387|NCT03441984|12103748|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919388|NCT03441984|12103749|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919389|NCT03441984|12103738|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919390|NCT03441984|12103739|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919391|NCT03441984|12103740|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919392|NCT03441984|12103741|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919393|NCT03441984|12103742|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919394|NCT03441984|12103743|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
4919395|NCT03441984|12103744|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919396|NCT03441984|12103745|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919397|NCT03441984|12103746|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919398|NCT03441984|12103747|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919399|NCT03441984|12103748|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919400|NCT03441984|12103749|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
4919401|NCT03441984|12103738|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919402|NCT03441984|12103739|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919403|NCT03441984|12103740|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919404|NCT03441984|12103741|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919405|NCT03441984|12103742|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919406|NCT03441984|12103743|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919407|NCT03441984|12103744|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919408|NCT03441984|12103745|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919409|NCT03441984|12103746|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919410|NCT03441984|12103747|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919411|NCT03441984|12103748|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919412|NCT03441984|12103749|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919413|NCT03441984|12103738|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919414|NCT03441984|12103739|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919415|NCT03441984|12103740|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919416|NCT03441984|12103741|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919417|NCT03441984|12103742|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919418|NCT03441984|12103743|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
4919419|NCT03441984|12103744|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919420|NCT03441984|12103745|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919421|NCT03441984|12103746|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919422|NCT03441984|12103747|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919423|NCT03441984|12103748|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919424|NCT03441984|12103749|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
4919425|NCT03441984|12103738|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
4919426|NCT03441984|12103739|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
4919427|NCT03441984|12103740|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
4919428|NCT03441984|12103741|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
4919429|NCT03441984|12103742|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
4919430|NCT03441984|12103743|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
4919431|NCT03441984|12103744|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
4919432|NCT03441984|12103745|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
4919433|NCT03441984|12103746|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
4919434|NCT03441984|12103747|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
4919435|NCT03441984|12103748|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
4919436|NCT03441984|12103749|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
4919437|NCT03441984|12103738|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919438|NCT03441984|12103739|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919439|NCT03441984|12103740|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919440|NCT03441984|12103741|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919441|NCT03441984|12103742|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919442|NCT03441984|12103743|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919443|NCT03441984|12103744|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919444|NCT03441984|12103745|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919445|NCT03441984|12103746|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919446|NCT03441984|12103747|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919447|NCT03441984|12103748|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919448|NCT03441984|12103749|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919449|NCT03441984|12103738|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919450|NCT03441984|12103739|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919451|NCT03441984|12103740|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919452|NCT03441984|12103741|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919453|NCT03441984|12103742|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919454|NCT03441984|12103743|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
4919455|NCT03441984|12103744|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
4919456|NCT03441984|12103745|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
4919457|NCT03441984|12103746|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
4919458|NCT03441984|12103747|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
4919459|NCT03441984|12103748|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
4919460|NCT03441984|12103749|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
4919461|NCT03441984|12103738|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919462|NCT03441984|12103739|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919463|NCT03441984|12103740|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919464|NCT03441984|12103741|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919465|NCT03441984|12103742|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919466|NCT03441984|12103743|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
4919467|NCT03441984|12103744|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
4919468|NCT03441984|12103745|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
4919469|NCT03441984|12103746|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
4919470|NCT03441984|12103747|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
4919471|NCT03441984|12103748|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
4919472|NCT03441984|12103749|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
4919473|NCT03441984|12103738|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919474|NCT03441984|12103739|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919475|NCT03441984|12103740|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919476|NCT03441984|12103741|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919477|NCT03441984|12103742|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919478|NCT03441984|12103743|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919479|NCT03441984|12103744|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919480|NCT03441984|12103745|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919481|NCT03441984|12103746|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919482|NCT03441984|12103747|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919483|NCT03441984|12103748|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919484|NCT03441984|12103749|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919485|NCT03441984|12103738|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919486|NCT03441984|12103739|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919487|NCT03441984|12103740|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919488|NCT03441984|12103741|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919489|NCT03441984|12103742|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919490|NCT03441984|12103743|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919491|NCT03441984|12103744|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919492|NCT03441984|12103745|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919493|NCT03441984|12103746|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919494|NCT03441984|12103747|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
4919495|NCT03441984|12103748|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919496|NCT03441984|12103749|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919497|NCT03441984|12103738|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919498|NCT03441984|12103739|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919499|NCT03441984|12103740|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919500|NCT03441984|12103741|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919501|NCT03441984|12103742|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919502|NCT03441984|12103743|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
4919503|NCT03441984|12103744|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919504|NCT03441984|12103745|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919505|NCT03441984|12103746|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919506|NCT03441984|12103747|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
4919507|NCT03441984|12103748|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919508|NCT03441984|12103749|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
4919509|NCT03441984|12103738|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919510|NCT03441984|12103739|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919511|NCT03441984|12103740|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919512|NCT03441984|12103741|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919513|NCT03441984|12103742|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919514|NCT03441984|12103743|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919515|NCT03441984|12103744|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919516|NCT03441984|12103745|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919517|NCT03441984|12103746|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919518|NCT03441984|12103747|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
4919519|NCT03441984|12103748|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919520|NCT03441984|12103749|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919521|NCT03441984|12103738|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919522|NCT03441984|12103739|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919523|NCT03441984|12103740|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919524|NCT03441984|12103741|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919525|NCT03441984|12103742|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919526|NCT03441984|12103743|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
4919527|NCT03441984|12103744|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
4919528|NCT03441984|12103745|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
4919529|NCT03441984|12103746|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
4919530|NCT03441984|12103747|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
4919531|NCT03441984|12103748|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
4919532|NCT03441984|12103749|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
4919533|NCT03441984|12103738|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919534|NCT03441984|12103739|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919535|NCT03441984|12103740|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919536|NCT03441984|12103741|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919537|NCT03441984|12103742|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919538|NCT03441984|12103743|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
4919539|NCT03441984|12103744|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919540|NCT03441984|12103745|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919541|NCT03441984|12103746|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919542|NCT03441984|12103747|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919543|NCT03441984|12103748|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919544|NCT03441984|12103749|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
4919545|NCT03441984|12103738|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919546|NCT03441984|12103739|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919547|NCT03441984|12103740|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919548|NCT03441984|12103741|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919549|NCT03441984|12103742|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919550|NCT03441984|12103743|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919551|NCT03441984|12103744|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919552|NCT03441984|12103745|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919553|NCT03441984|12103746|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919554|NCT03441984|12103747|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919555|NCT03441984|12103748|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919556|NCT03441984|12103749|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919557|NCT03441984|12103738|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919558|NCT03441984|12103739|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919559|NCT03441984|12103740|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919560|NCT03441984|12103741|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919561|NCT03441984|12103742|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919562|NCT03441984|12103743|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919563|NCT03441984|12103744|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919564|NCT03441984|12103745|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919565|NCT03441984|12103746|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919566|NCT03441984|12103747|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919567|NCT03441984|12103748|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919568|NCT03441984|12103749|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919569|NCT03441984|12103738|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919570|NCT03441984|12103739|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919571|NCT03441984|12103740|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919572|NCT03441984|12103741|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919573|NCT03441984|12103742|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919574|NCT03441984|12103743|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
4919575|NCT03441984|12103744|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919576|NCT03441984|12103745|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919577|NCT03441984|12103746|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919578|NCT03441984|12103747|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919579|NCT03441984|12103748|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919580|NCT03441984|12103749|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
4919581|NCT03441984|12103738|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919582|NCT03441984|12103739|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919583|NCT03441984|12103740|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919584|NCT03441984|12103741|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919585|NCT03441984|12103742|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919586|NCT03441984|12103743|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919587|NCT03441984|12103744|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919588|NCT03441984|12103745|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919589|NCT03441984|12103746|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919590|NCT03441984|12103747|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919591|NCT03441984|12103748|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919592|NCT03441984|12103749|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919593|NCT03441984|12103738|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919594|NCT03441984|12103739|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919595|NCT03441984|12103740|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919596|NCT03441984|12103741|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919597|NCT03441984|12103742|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919598|NCT03441984|12103743|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
4919599|NCT03441984|12103744|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919600|NCT03441984|12103745|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919601|NCT03441984|12103746|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919602|NCT03441984|12103747|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919603|NCT03441984|12103748|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919604|NCT03441984|12103749|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
4919605|NCT03441984|12103738|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919606|NCT03441984|12103739|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919607|NCT03441984|12103740|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919608|NCT03441984|12103741|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919609|NCT03441984|12103742|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919610|NCT03441984|12103743|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
4919611|NCT03441984|12103744|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919612|NCT03441984|12103745|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919613|NCT03441984|12103746|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919614|NCT03441984|12103747|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919615|NCT03441984|12103748|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919616|NCT03441984|12103749|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
4919617|NCT03441789|12104110|P2|NOT COMPLETED|Overall Study||4
4919618|NCT03441789|12104111|P1|NOT COMPLETED|Overall Study||1
4919619|NCT03441789|12104110|P2|COMPLETED|Overall Study||10
4919620|NCT03441789|12104111|P1|COMPLETED|Overall Study||13
4919621|NCT03441789|12104110|P2|STARTED|Overall Study||14
4919622|NCT03441789|12104111|P1|STARTED|Overall Study||14
4919623|NCT03441633|12104137|P10|NOT COMPLETED|Overall Study||0
4919624|NCT03441633|12104138|P9|NOT COMPLETED|Overall Study||0
4919625|NCT03441633|12104139|P8|NOT COMPLETED|Overall Study||0
4919626|NCT03441633|12104140|P7|NOT COMPLETED|Overall Study||0
4919627|NCT03441633|12104141|P6|NOT COMPLETED|Overall Study||0
4919628|NCT03441633|12104142|P5|NOT COMPLETED|Overall Study||0
4919629|NCT03441633|12104143|P4|NOT COMPLETED|Overall Study||0
4919630|NCT03441633|12104144|P3|NOT COMPLETED|Overall Study||0
4919631|NCT03441633|12104145|P2|NOT COMPLETED|Overall Study||0
4919632|NCT03441633|12104146|P1|NOT COMPLETED|Overall Study||0
4919633|NCT03441633|12104137|P10|COMPLETED|Overall Study||1562
4919634|NCT03441633|12104138|P9|COMPLETED|Overall Study||5132
4919635|NCT03441633|12104139|P8|COMPLETED|Overall Study||953
4919636|NCT03441633|12104140|P7|COMPLETED|Overall Study||2855
4919637|NCT03441633|12104141|P6|COMPLETED|Overall Study||363
4919638|NCT03441633|12104142|P5|COMPLETED|Overall Study||2286
4919639|NCT03441633|12104143|P4|COMPLETED|Overall Study||192
4919640|NCT03441633|12104144|P3|COMPLETED|Overall Study||32212
4919641|NCT03441633|12104145|P2|COMPLETED|Overall Study||1423
4919642|NCT03441633|12104146|P1|COMPLETED|Overall Study||4712
4919643|NCT03441633|12104137|P10|STARTED|Overall Study||1562
4919644|NCT03441633|12104138|P9|STARTED|Overall Study||5132
4919645|NCT03441633|12104139|P8|STARTED|Overall Study||953
4919646|NCT03441633|12104140|P7|STARTED|Overall Study||2855
4919647|NCT03441633|12104141|P6|STARTED|Overall Study||363
4919648|NCT03441633|12104142|P5|STARTED|Overall Study||2286
4919649|NCT03441633|12104143|P4|STARTED|Overall Study||192
4919650|NCT03441633|12104144|P3|STARTED|Overall Study||32212
4919651|NCT03441633|12104145|P2|STARTED|Overall Study||1423
4919652|NCT03441633|12104146|P1|STARTED|Overall Study||4712
4919653|NCT03441594|12104286|P1|NOT COMPLETED|Overall Study||0
4919654|NCT03441594|12104286|P1|COMPLETED|Overall Study||56
4919655|NCT03441594|12104286|P1|STARTED|Overall Study||56
4919656|NCT03441269|12104294|P3|NOT COMPLETED|Overall Study||1
4919657|NCT03441269|12104295|P2|NOT COMPLETED|Overall Study||1
4919658|NCT03441269|12104296|P1|NOT COMPLETED|Overall Study||0
4919659|NCT03441269|12104294|P3|COMPLETED|Overall Study||74
4919660|NCT03441269|12104295|P2|COMPLETED|Overall Study||74
4919661|NCT03441269|12104296|P1|COMPLETED|Overall Study||75
4919662|NCT03441269|12104294|P3|STARTED|Overall Study||75
4919663|NCT03441269|12104295|P2|STARTED|Overall Study||75
4919664|NCT03441269|12104296|P1|STARTED|Overall Study||75
4919665|NCT03440918|12104312|P2|NOT COMPLETED|Overall Study||16
4919666|NCT03440918|12104313|P1|NOT COMPLETED|Overall Study||0
4919667|NCT03440918|12104312|P2|COMPLETED|Overall Study||122
4919668|NCT03440918|12104313|P1|COMPLETED|Overall Study||133
4919669|NCT03440918|12104312|P2|STARTED|Overall Study||138
4919670|NCT03440918|12104313|P1|STARTED|Overall Study||133
4919671|NCT03440619|12104341|P1|NOT COMPLETED|Overall Study||0
4919672|NCT03440619|12104341|P1|COMPLETED|Overall Study||28
4919673|NCT03440619|12104341|P1|STARTED|Overall Study||28
4919674|NCT03440424|12104348|P3|NOT COMPLETED|Overall Study||0
4919675|NCT03440424|12104349|P2|NOT COMPLETED|Overall Study||0
4919676|NCT03440424|12104350|P1|NOT COMPLETED|Overall Study||0
4919677|NCT03440424|12104348|P3|COMPLETED|Overall Study||8
4919678|NCT03440424|12104349|P2|COMPLETED|Overall Study||8
4919679|NCT03440424|12104350|P1|COMPLETED|Overall Study||8
4919680|NCT03440424|12104348|P3|STARTED|Overall Study||8
4919681|NCT03440424|12104349|P2|STARTED|Overall Study||8
4919682|NCT03440424|12104350|P1|STARTED|Overall Study||8
4919683|NCT03439072|12104409|P2|NOT COMPLETED|Overall Study||4
4919684|NCT03439072|12104410|P1|NOT COMPLETED|Overall Study||2
4919685|NCT03439072|12104409|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
4919686|NCT03439072|12104410|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
4919687|NCT03439072|12104409|P2|STARTED|Overall Study||40
4919688|NCT03439072|12104410|P1|STARTED|Overall Study||41
4919689|NCT03438539|12104448|P6|NOT COMPLETED|Overall Study||8
4919690|NCT03438539|12104449|P5|NOT COMPLETED|Overall Study||3
4919691|NCT03438539|12104450|P4|NOT COMPLETED|Overall Study||9
4919692|NCT03438539|12104451|P3|NOT COMPLETED|Overall Study||10
4919693|NCT03438539|12104452|P2|NOT COMPLETED|Overall Study||4
4919694|NCT03438539|12104453|P1|NOT COMPLETED|Overall Study||8
4919695|NCT03438539|12104448|P6|COMPLETED|Overall Study||66
4919696|NCT03438539|12104449|P5|COMPLETED|Overall Study||70
4919697|NCT03438539|12104450|P4|COMPLETED|Overall Study||64
4919698|NCT03438539|12104451|P3|COMPLETED|Overall Study||66
4919699|NCT03438539|12104452|P2|COMPLETED|Overall Study||68
4919700|NCT03438539|12104453|P1|COMPLETED|Overall Study||68
4919701|NCT03438539|12104448|P6|STARTED|Overall Study||74
4919702|NCT03438539|12104449|P5|STARTED|Overall Study||73
4919703|NCT03438539|12104450|P4|STARTED|Overall Study||73
4919704|NCT03438539|12104451|P3|STARTED|Overall Study||76
4919705|NCT03438539|12104452|P2|STARTED|Overall Study||72
4919706|NCT03438539|12104453|P1|STARTED|Overall Study||76
4919707|NCT03438383|12104481|P2|NOT COMPLETED|Overall Study||3
4919708|NCT03438383|12104482|P1|NOT COMPLETED|Overall Study||9
4919709|NCT03438383|12104481|P2|COMPLETED|Overall Study||21
4919710|NCT03438383|12104482|P1|COMPLETED|Overall Study||14
4919711|NCT03438383|12104481|P2|STARTED|Overall Study||24
4919712|NCT03438383|12104482|P1|STARTED|Overall Study||23
4919713|NCT03438266|12104502|P1|NOT COMPLETED|Overall Study||0
4919714|NCT03438266|12104502|P1|COMPLETED|Overall Study||60
4919715|NCT03438266|12104502|P1|STARTED|Overall Study||60
4919716|NCT03437733|12104513|P2|NOT COMPLETED|Overall Study||3
4919717|NCT03437733|12104514|P1|NOT COMPLETED|Overall Study||0
4919718|NCT03437733|12104513|P2|COMPLETED|Overall Study||87
4919719|NCT03437733|12104514|P1|COMPLETED|Overall Study||8
4919720|NCT03437733|12104513|P2|Safety|Overall Study||87
4919721|NCT03437733|12104514|P1|Safety|Overall Study||8
4919722|NCT03437733|12104513|P2|STARTED|Overall Study||90
4919723|NCT03437733|12104514|P1|STARTED|Overall Study||8
4919724|NCT03437564|12104522|P2|NOT COMPLETED|Overall Study||0
4919725|NCT03437564|12104523|P1|NOT COMPLETED|Overall Study||0
4919726|NCT03437564|12104522|P2|COMPLETED|Overall Study||14
4919727|NCT03437564|12104523|P1|COMPLETED|Overall Study||14
4919728|NCT03437564|12104522|P2|STARTED|Overall Study||14
4919729|NCT03437564|12104523|P1|STARTED|Overall Study||14
4919730|NCT03437447|12104554|P3|NOT COMPLETED|Treatment Period 3||0
4919731|NCT03437447|12104555|P2|NOT COMPLETED|Treatment Period 3||0
4919732|NCT03437447|12104556|P1|NOT COMPLETED|Treatment Period 3||0
4919733|NCT03437447|12104554|P3|COMPLETED|Treatment Period 3||19
4919734|NCT03437447|12104555|P2|COMPLETED|Treatment Period 3||20
4919735|NCT03437447|12104556|P1|COMPLETED|Treatment Period 3||20
4919736|NCT03437447|12104554|P3|STARTED|Treatment Period 3||19
4919737|NCT03437447|12104555|P2|STARTED|Treatment Period 3||20
4919738|NCT03437447|12104556|P1|STARTED|Treatment Period 3||20
4919739|NCT03437447|12104554|P3|NOT COMPLETED|Treatment Period 2||0
4919740|NCT03437447|12104555|P2|NOT COMPLETED|Treatment Period 2||0
4919741|NCT03437447|12104556|P1|NOT COMPLETED|Treatment Period 2||0
4919742|NCT03437447|12104554|P3|COMPLETED|Treatment Period 2||19
4919743|NCT03437447|12104555|P2|COMPLETED|Treatment Period 2||20
4919744|NCT03437447|12104556|P1|COMPLETED|Treatment Period 2||20
4919745|NCT03437447|12104554|P3|STARTED|Treatment Period 2||19
4919746|NCT03437447|12104555|P2|STARTED|Treatment Period 2||20
4919747|NCT03437447|12104556|P1|STARTED|Treatment Period 2||20
4919748|NCT03437447|12104554|P3|NOT COMPLETED|Treatment Period 1||1
4919749|NCT03437447|12104555|P2|NOT COMPLETED|Treatment Period 1||0
4919750|NCT03437447|12104556|P1|NOT COMPLETED|Treatment Period 1||0
4919751|NCT03437447|12104554|P3|COMPLETED|Treatment Period 1||19
4919752|NCT03437447|12104555|P2|COMPLETED|Treatment Period 1||20
4919753|NCT03437447|12104556|P1|COMPLETED|Treatment Period 1||20
4919754|NCT03437447|12104554|P3|STARTED|Treatment Period 1||20
4919755|NCT03437447|12104555|P2|STARTED|Treatment Period 1||20
4919756|NCT03437447|12104556|P1|STARTED|Treatment Period 1||20
4919757|NCT03436732|12104611|P2|NOT COMPLETED|Overall Study||1
4919758|NCT03436732|12104612|P1|NOT COMPLETED|Overall Study||4
4919759|NCT03436732|12104611|P2|COMPLETED|Overall Study||0
4919760|NCT03436732|12104612|P1|COMPLETED|Overall Study||0
4919761|NCT03436732|12104611|P2|STARTED|Overall Study||1
4919762|NCT03436732|12104612|P1|STARTED|Overall Study||4
4919763|NCT03435783|12104627|P2|NOT COMPLETED|Overall Study||1
4919764|NCT03435783|12104628|P1|NOT COMPLETED|Overall Study||0
4919765|NCT03435783|12104627|P2|COMPLETED|Overall Study||19
4919766|NCT03435783|12104628|P1|COMPLETED|Overall Study||20
4919767|NCT03435783|12104627|P2|STARTED|Overall Study||20
4919768|NCT03435783|12104628|P1|STARTED|Overall Study||20
4919769|NCT03435497|12104644|P2|NOT COMPLETED|Overall Study||6
4919770|NCT03435497|12104645|P1|NOT COMPLETED|Overall Study||2
4919771|NCT03435497|12104644|P2|COMPLETED|Overall Study||41
4919772|NCT03435497|12104645|P1|COMPLETED|Overall Study||49
4919773|NCT03435497|12104644|P2|STARTED|Overall Study||47
4919774|NCT03435497|12104645|P1|STARTED|Overall Study||51
4919775|NCT03435185|12104661|P2|NOT COMPLETED|Overall Study||15
4919776|NCT03435185|12104662|P1|NOT COMPLETED|Overall Study||1
4919777|NCT03435185|12104661|P2|COMPLETED|Overall Study||28
4919778|NCT03435185|12104662|P1|COMPLETED|Overall Study||43
4919779|NCT03435185|12104661|P2|STARTED|Overall Study||43
4919780|NCT03435185|12104662|P1|STARTED|Overall Study||44
4919781|NCT03434977|12104672|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4919782|NCT03434977|12104673|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4919783|NCT03434977|12104672|P2|COMPLETED|Intervention Period 2 (6 Days)||5
4919784|NCT03434977|12104673|P1|COMPLETED|Intervention Period 2 (6 Days)||6
4919785|NCT03434977|12104672|P2|STARTED|Intervention Period 2 (6 Days)||5
4919786|NCT03434977|12104673|P1|STARTED|Intervention Period 2 (6 Days)||6
4919880|NCT03430856|12104889|P2|STARTED|Overall Study||30
4919787|NCT03434977|12104672|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
4919788|NCT03434977|12104673|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
4919789|NCT03434977|12104672|P2|COMPLETED|Washout Period (at Least 6 Days)||5
4919790|NCT03434977|12104673|P1|COMPLETED|Washout Period (at Least 6 Days)||6
4919791|NCT03434977|12104672|P2|STARTED|Washout Period (at Least 6 Days)||6
4919792|NCT03434977|12104673|P1|STARTED|Washout Period (at Least 6 Days)||6
4919793|NCT03434977|12104672|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4919794|NCT03434977|12104673|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4919795|NCT03434977|12104672|P2|COMPLETED|Intervention Period 1 (6 Days)||6
4919796|NCT03434977|12104673|P1|COMPLETED|Intervention Period 1 (6 Days)||6
4919797|NCT03434977|12104672|P2|STARTED|Intervention Period 1 (6 Days)||6
4919798|NCT03434977|12104673|P1|STARTED|Intervention Period 1 (6 Days)||6
4919799|NCT03434457|12104707|P1|NOT COMPLETED|Overall Study||0
4919800|NCT03434457|12104707|P1|COMPLETED|Overall Study||630
4919801|NCT03434457|12104707|P1|STARTED|Overall Study||630
4919802|NCT03434249|12104740|P2|NOT COMPLETED|Overall Study||3
4919803|NCT03434249|12104741|P1|NOT COMPLETED|Overall Study||5
4919804|NCT03434249|12104740|P2|COMPLETED|Overall Study||37
4919805|NCT03434249|12104741|P1|COMPLETED|Overall Study||35
4919806|NCT03434249|12104740|P2|STARTED|Overall Study||40
4919807|NCT03434249|12104741|P1|STARTED|Overall Study||40
4919808|NCT03434119|12104775|P2|NOT COMPLETED|Overall Study||113
4919809|NCT03434119|12104776|P1|NOT COMPLETED|Overall Study||107
4919810|NCT03434119|12104775|P2|COMPLETED|Overall Study||12
4919811|NCT03434119|12104776|P1|COMPLETED|Overall Study||9
4919812|NCT03434119|12104775|P2|Treated|Overall Study||125
4919813|NCT03434119|12104776|P1|Treated|Overall Study||115
4919814|NCT03434119|12104775|P2|STARTED|Overall Study||125
4919815|NCT03434119|12104776|P1|STARTED|Overall Study||116
4919816|NCT03433703|12104794|P1|NOT COMPLETED|Overall Study||2
4919817|NCT03433703|12104794|P1|COMPLETED|Overall Study||0
4919818|NCT03433703|12104794|P1|STARTED|Overall Study||2
4919819|NCT03433677|12104803|P2|NOT COMPLETED|Period 2||1
4919820|NCT03433677|12104804|P1|NOT COMPLETED|Period 2||1
4919821|NCT03433677|12104803|P2|COMPLETED|Period 2||24
4919822|NCT03433677|12104804|P1|COMPLETED|Period 2||22
4919823|NCT03433677|12104803|P2|Received at Least 1 Dose of Study Drug|Period 2||25
4919824|NCT03433677|12104804|P1|Received at Least 1 Dose of Study Drug|Period 2||23
4919825|NCT03433677|12104803|P2|STARTED|Period 2||25
4919826|NCT03433677|12104804|P1|STARTED|Period 2||23
4919827|NCT03433677|12104803|P2|NOT COMPLETED|Period 1||0
4919828|NCT03433677|12104804|P1|NOT COMPLETED|Period 1||1
4919829|NCT03433677|12104803|P2|COMPLETED|Period 1||25
4919830|NCT03433677|12104804|P1|COMPLETED|Period 1||23
4919831|NCT03433677|12104803|P2|Received at Least 1 Dose of Study Drug|Period 1||25
4919832|NCT03433677|12104804|P1|Received at Least 1 Dose of Study Drug|Period 1||24
4919833|NCT03433677|12104803|P2|STARTED|Period 1||25
4919834|NCT03433677|12104804|P1|STARTED|Period 1||24
4919835|NCT03432533|12104824|P2|NOT COMPLETED|Overall Study||11
4919836|NCT03432533|12104825|P1|NOT COMPLETED|Overall Study||15
4919837|NCT03432533|12104824|P2|COMPLETED|Overall Study||131
4919838|NCT03432533|12104825|P1|COMPLETED|Overall Study||126
4919839|NCT03432533|12104824|P2|Completed 6-Month Treatment Period|Overall Study||137
4919840|NCT03432533|12104825|P1|Completed 6-Month Treatment Period|Overall Study||136
4919841|NCT03432533|12104824|P2|STARTED|Overall Study||142
4919842|NCT03432533|12104825|P1|STARTED|Overall Study||141
4919843|NCT03432390|12104841|P2|NOT COMPLETED|Recovery Period||0
4919844|NCT03432390|12104842|P1|NOT COMPLETED|Recovery Period||0
4919845|NCT03432390|12104841|P2|COMPLETED|Recovery Period||34
4919846|NCT03432390|12104842|P1|COMPLETED|Recovery Period||34
4919847|NCT03432390|12104841|P2|STARTED|Recovery Period||34
4919848|NCT03432390|12104842|P1|STARTED|Recovery Period||34
4919849|NCT03432390|12104841|P2|NOT COMPLETED|Apnea Period||2
4919850|NCT03432390|12104842|P1|NOT COMPLETED|Apnea Period||2
4919851|NCT03432390|12104841|P2|COMPLETED|Apnea Period||34
4919852|NCT03432390|12104842|P1|COMPLETED|Apnea Period||34
4919853|NCT03432390|12104841|P2|STARTED|Apnea Period||36
4919854|NCT03432390|12104842|P1|STARTED|Apnea Period||36
4919855|NCT03431441|12104852|P1|NOT COMPLETED|Overall Study||5
4919856|NCT03431441|12104852|P1|COMPLETED|Overall Study||19
4919857|NCT03431441|12104852|P1|STARTED|Overall Study||24
4919858|NCT03431012|12104860|P4|NOT COMPLETED|Overall Study||0
4919859|NCT03431012|12104861|P3|NOT COMPLETED|Overall Study||0
4919860|NCT03431012|12104862|P2|NOT COMPLETED|Overall Study||0
4919861|NCT03431012|12104863|P1|NOT COMPLETED|Overall Study||0
4919862|NCT03431012|12104860|P4|COMPLETED|Overall Study||53
4919863|NCT03431012|12104861|P3|COMPLETED|Overall Study||56
4919864|NCT03431012|12104862|P2|COMPLETED|Overall Study||60
4919865|NCT03431012|12104863|P1|COMPLETED|Overall Study||47
4919866|NCT03431012|12104860|P4|STARTED|Overall Study||53
4919867|NCT03431012|12104861|P3|STARTED|Overall Study||56
4919868|NCT03431012|12104862|P2|STARTED|Overall Study||60
4919869|NCT03431012|12104863|P1|STARTED|Overall Study||47
4919870|NCT03430856|12104888|P3|NOT COMPLETED|Overall Study||1
4919871|NCT03430856|12104889|P2|NOT COMPLETED|Overall Study||3
4919872|NCT03430856|12104890|P1|NOT COMPLETED|Overall Study||2
4919873|NCT03430856|12104888|P3|COMPLETED|Overall Study||29
4919874|NCT03430856|12104889|P2|COMPLETED|Overall Study||27
4919875|NCT03430856|12104890|P1|COMPLETED|Overall Study||29
4919876|NCT03430856|12104888|P3|Exposed|Overall Study||30
4919877|NCT03430856|12104889|P2|Exposed|Overall Study||30
4919878|NCT03430856|12104890|P1|Exposed|Overall Study||31
4919879|NCT03430856|12104888|P3|STARTED|Overall Study||30
4919881|NCT03430856|12104890|P1|STARTED|Overall Study||31
4919882|NCT03430245|12104928|P1|NOT COMPLETED|Overall Study||7
4919883|NCT03430245|12104928|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
4919884|NCT03430245|12104928|P1|STARTED|Overall Study||16
4919885|NCT03430050|12104937|P2|NOT COMPLETED|Overall Study||0
4919886|NCT03430050|12104938|P1|NOT COMPLETED|Overall Study||0
4919887|NCT03430050|12104937|P2|COMPLETED|Overall Study||5
4919888|NCT03430050|12104938|P1|COMPLETED|Overall Study||3
4919889|NCT03430050|12104937|P2|STARTED|Overall Study||5
4919890|NCT03430050|12104938|P1|STARTED|Overall Study||3
4919891|NCT03429712|12104946|P1|NOT COMPLETED|Overall Study||9
4919892|NCT03429712|12104946|P1|COMPLETED|Overall Study||10
4919893|NCT03429712|12104946|P1|STARTED|Overall Study||19
4919894|NCT03429556|12104954|P4|NOT COMPLETED|Overall Study||0
4919895|NCT03429556|12104955|P3|NOT COMPLETED|Overall Study||0
4919896|NCT03429556|12104956|P2|NOT COMPLETED|Overall Study||1
4919897|NCT03429556|12104957|P1|NOT COMPLETED|Overall Study||0
4919898|NCT03429556|12104954|P4|COMPLETED|Overall Study||3
4919899|NCT03429556|12104955|P3|COMPLETED|Overall Study||4
4919900|NCT03429556|12104956|P2|COMPLETED|Overall Study||3
4919901|NCT03429556|12104957|P1|COMPLETED|Overall Study||12
4919902|NCT03429556|12104954|P4|STARTED|Overall Study||3
4919903|NCT03429556|12104955|P3|STARTED|Overall Study||4
4919904|NCT03429556|12104956|P2|STARTED|Overall Study||4
4919905|NCT03429556|12104957|P1|STARTED|Overall Study||12
4919906|NCT03429270|12105003|P1|NOT COMPLETED|Overall Study||0
4919907|NCT03429270|12105003|P1|COMPLETED|Overall Study||28
4919908|NCT03429270|12105003|P1|STARTED|Overall Study||28
4919909|NCT03428997|12105008|P1|NOT COMPLETED|Overall Study||8
4919910|NCT03428997|12105008|P1|COMPLETED|Overall Study||16
4919911|NCT03428997|12105008|P1|STARTED|Overall Study||24
4919912|NCT03428152|12105016|P2|NOT COMPLETED|Overall Study||11
4919913|NCT03428152|12105017|P1|NOT COMPLETED|Overall Study||7
4919914|NCT03428152|12105016|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
4919915|NCT03428152|12105017|P1|COMPLETED|Overall Study||30
4919916|NCT03428152|12105016|P2|STARTED|Overall Study||41
4919917|NCT03428152|12105017|P1|STARTED|Overall Study||37
4919918|NCT03427892|12105033|P1|NOT COMPLETED|Overall Study||2
4919919|NCT03427892|12105033|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
4919920|NCT03427892|12105033|P1|STARTED|Overall Study||21
4919921|NCT03427073|12105057|P8|NOT COMPLETED|Overall Study||4
4919922|NCT03427073|12105058|P7|NOT COMPLETED|Overall Study||3
4919923|NCT03427073|12105059|P6|NOT COMPLETED|Overall Study||4
4919924|NCT03427073|12105060|P5|NOT COMPLETED|Overall Study||3
4919925|NCT03427073|12105061|P4|NOT COMPLETED|Overall Study||3
4919926|NCT03427073|12105062|P3|NOT COMPLETED|Overall Study||1
4919927|NCT03427073|12105063|P2|NOT COMPLETED|Overall Study||1
4919928|NCT03427073|12105064|P1|NOT COMPLETED|Overall Study||1
4919929|NCT03427073|12105057|P8|COMPLETED|Overall Study||0
4919930|NCT03427073|12105058|P7|COMPLETED|Overall Study||0
4919931|NCT03427073|12105059|P6|COMPLETED|Overall Study||0
4919932|NCT03427073|12105060|P5|COMPLETED|Overall Study||0
4919933|NCT03427073|12105061|P4|COMPLETED|Overall Study||0
4919934|NCT03427073|12105062|P3|COMPLETED|Overall Study||0
4919935|NCT03427073|12105063|P2|COMPLETED|Overall Study||0
4919936|NCT03427073|12105064|P1|COMPLETED|Overall Study||0
4919937|NCT03427073|12105057|P8|STARTED|Overall Study||4
4919938|NCT03427073|12105058|P7|STARTED|Overall Study||3
4919939|NCT03427073|12105059|P6|STARTED|Overall Study||4
4919940|NCT03427073|12105060|P5|STARTED|Overall Study||3
4919941|NCT03427073|12105061|P4|STARTED|Overall Study||3
4919942|NCT03427073|12105062|P3|STARTED|Overall Study||1
4919943|NCT03427073|12105063|P2|STARTED|Overall Study||1
4919944|NCT03427073|12105064|P1|STARTED|Overall Study||1
4919945|NCT03426787|12105114|P1|NOT COMPLETED|Overall Study||14
4919946|NCT03426787|12105114|P1|COMPLETED|Overall Study||56
4919947|NCT03426787|12105114|P1|STARTED|Overall Study||70
4919948|NCT03426631|12105124|P2|NOT COMPLETED|Overall Study||1
4919949|NCT03426631|12105125|P1|NOT COMPLETED|Overall Study||0
4919950|NCT03426631|12105124|P2|COMPLETED|Overall Study||5
4919951|NCT03426631|12105125|P1|COMPLETED|Overall Study||7
4919952|NCT03426631|12105124|P2|STARTED|Overall Study||6
4919953|NCT03426631|12105125|P1|STARTED|Overall Study||7
4919954|NCT03426566|12105131|P1|NOT COMPLETED|Overall Study||0
4919955|NCT03426566|12105131|P1|COMPLETED|Overall Study||974
4919956|NCT03426566|12105131|P1|STARTED|Overall Study||974
4919957|NCT03426436|12105137|P1|NOT COMPLETED|Overall Study||19
4919958|NCT03426436|12105137|P1|COMPLETED|Overall Study||295
4919959|NCT03426436|12105137|P1|STARTED|Overall Study||314
4919960|NCT03426137|12105145|P3|NOT COMPLETED|Overall Study||0
4919961|NCT03426137|12105146|P2|NOT COMPLETED|Overall Study||0
4919962|NCT03426137|12105147|P1|NOT COMPLETED|Overall Study||3
4919963|NCT03426137|12105145|P3|COMPLETED|Overall Study||0
4919964|NCT03426137|12105146|P2|COMPLETED|Overall Study||0
4919965|NCT03426137|12105147|P1|COMPLETED|Overall Study||0
4919966|NCT03426137|12105145|P3|STARTED|Overall Study||0
4919967|NCT03426137|12105146|P2|STARTED|Overall Study||0
4919968|NCT03426137|12105147|P1|STARTED|Overall Study||3
4919969|NCT03425396|12105160|P5|NOT COMPLETED|Overall Study||1
4919970|NCT03425396|12105161|P4|NOT COMPLETED|Overall Study||1
4919971|NCT03425396|12105162|P3|NOT COMPLETED|Overall Study||3
4919972|NCT03425396|12105163|P2|NOT COMPLETED|Overall Study||7
4919973|NCT03425396|12105164|P1|NOT COMPLETED|Overall Study||2
4919974|NCT03425396|12105160|P5|COMPLETED|Overall Study||53
4919975|NCT03425396|12105161|P4|COMPLETED|Overall Study||7
4919976|NCT03425396|12105162|P3|COMPLETED|Overall Study||51
4919977|NCT03425396|12105163|P2|COMPLETED|Overall Study||47
4919978|NCT03425396|12105164|P1|COMPLETED|Overall Study||53
4919979|NCT03425396|12105160|P5|Completed Final Follow-up Visit|Overall Study||53
4919980|NCT03425396|12105161|P4|Completed Final Follow-up Visit|Overall Study||7
4919981|NCT03425396|12105162|P3|Completed Final Follow-up Visit|Overall Study||51
4919982|NCT03425396|12105163|P2|Completed Final Follow-up Visit|Overall Study||47
4919983|NCT03425396|12105164|P1|Completed Final Follow-up Visit|Overall Study||53
4919984|NCT03425396|12105160|P5|Completed Post-therapy Evaluation Visit|Overall Study||54
4919985|NCT03425396|12105161|P4|Completed Post-therapy Evaluation Visit|Overall Study||7
4919986|NCT03425396|12105162|P3|Completed Post-therapy Evaluation Visit|Overall Study||51
4919987|NCT03425396|12105163|P2|Completed Post-therapy Evaluation Visit|Overall Study||49
4919988|NCT03425396|12105164|P1|Completed Post-therapy Evaluation Visit|Overall Study||53
4919989|NCT03425396|12105160|P5|Completed End of Treatment Visit|Overall Study||53
4919990|NCT03425396|12105161|P4|Completed End of Treatment Visit|Overall Study||7
4919991|NCT03425396|12105162|P3|Completed End of Treatment Visit|Overall Study||51
4919992|NCT03425396|12105163|P2|Completed End of Treatment Visit|Overall Study||52
4919993|NCT03425396|12105164|P1|Completed End of Treatment Visit|Overall Study||53
4919994|NCT03425396|12105160|P5|STARTED|Overall Study||54
4919995|NCT03425396|12105161|P4|STARTED|Overall Study||8
4919996|NCT03425396|12105162|P3|STARTED|Overall Study||54
4919997|NCT03425396|12105163|P2|STARTED|Overall Study||54
4919998|NCT03425396|12105164|P1|STARTED|Overall Study||55
4919999|NCT03424681|12105248|P2|NOT COMPLETED|Overall Study||1
4920000|NCT03424681|12105249|P1|NOT COMPLETED|Overall Study||0
4920001|NCT03424681|12105248|P2|COMPLETED|Overall Study||5
4920002|NCT03424681|12105249|P1|COMPLETED|Overall Study||6
4920003|NCT03424681|12105248|P2|STARTED|Overall Study||6
4920004|NCT03424681|12105249|P1|STARTED|Overall Study||6
4920005|NCT03424044|12105261|P9|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920006|NCT03424044|12105262|P8|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920007|NCT03424044|12105263|P7|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920008|NCT03424044|12105264|P6|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920009|NCT03424044|12105265|P5|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920010|NCT03424044|12105266|P4|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920011|NCT03424044|12105267|P3|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920012|NCT03424044|12105268|P2|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920013|NCT03424044|12105269|P1|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920014|NCT03424044|12105261|P9|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
4920015|NCT03424044|12105262|P8|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
4920016|NCT03424044|12105263|P7|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920017|NCT03424044|12105264|P6|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920018|NCT03424044|12105265|P5|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920019|NCT03424044|12105266|P4|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920020|NCT03424044|12105267|P3|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920021|NCT03424044|12105268|P2|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920022|NCT03424044|12105269|P1|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
4920023|NCT03424044|12105261|P9|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
4920024|NCT03424044|12105262|P8|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
4920025|NCT03424044|12105263|P7|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920026|NCT03424044|12105264|P6|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920027|NCT03424044|12105265|P5|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920028|NCT03424044|12105266|P4|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920029|NCT03424044|12105267|P3|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920030|NCT03424044|12105268|P2|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920031|NCT03424044|12105269|P1|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
4920032|NCT03424044|12105261|P9|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920033|NCT03424044|12105262|P8|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920034|NCT03424044|12105263|P7|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920035|NCT03424044|12105264|P6|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920036|NCT03424044|12105265|P5|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920037|NCT03424044|12105266|P4|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920038|NCT03424044|12105267|P3|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920039|NCT03424044|12105268|P2|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920040|NCT03424044|12105269|P1|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920041|NCT03424044|12105261|P9|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
4920042|NCT03424044|12105262|P8|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
4920043|NCT03424044|12105263|P7|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920044|NCT03424044|12105264|P6|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920045|NCT03424044|12105265|P5|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920046|NCT03424044|12105266|P4|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920047|NCT03424044|12105267|P3|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920048|NCT03424044|12105268|P2|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920049|NCT03424044|12105269|P1|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
4920050|NCT03424044|12105261|P9|STARTED|Optional Fourth Rest Period (7-45 Days)||1
4920051|NCT03424044|12105262|P8|STARTED|Optional Fourth Rest Period (7-45 Days)||1
4920052|NCT03424044|12105263|P7|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920053|NCT03424044|12105264|P6|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920054|NCT03424044|12105265|P5|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920055|NCT03424044|12105266|P4|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920056|NCT03424044|12105267|P3|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920057|NCT03424044|12105268|P2|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920058|NCT03424044|12105269|P1|STARTED|Optional Fourth Rest Period (7-45 Days)||0
4920059|NCT03424044|12105261|P9|NOT COMPLETED|Third Intervention (76 Hours)||0
4920060|NCT03424044|12105262|P8|NOT COMPLETED|Third Intervention (76 Hours)||0
4920061|NCT03424044|12105263|P7|NOT COMPLETED|Third Intervention (76 Hours)||1
4920062|NCT03424044|12105264|P6|NOT COMPLETED|Third Intervention (76 Hours)||0
4920063|NCT03424044|12105265|P5|NOT COMPLETED|Third Intervention (76 Hours)||0
4920064|NCT03424044|12105266|P4|NOT COMPLETED|Third Intervention (76 Hours)||1
4920065|NCT03424044|12105267|P3|NOT COMPLETED|Third Intervention (76 Hours)||0
4920066|NCT03424044|12105268|P2|NOT COMPLETED|Third Intervention (76 Hours)||0
4920067|NCT03424044|12105269|P1|NOT COMPLETED|Third Intervention (76 Hours)||1
4920068|NCT03424044|12105261|P9|COMPLETED|Third Intervention (76 Hours)||1
4920069|NCT03424044|12105262|P8|COMPLETED|Third Intervention (76 Hours)||1
4920070|NCT03424044|12105263|P7|COMPLETED|Third Intervention (76 Hours)||0
4920071|NCT03424044|12105264|P6|COMPLETED|Third Intervention (76 Hours)||4
4920072|NCT03424044|12105265|P5|COMPLETED|Third Intervention (76 Hours)||2
4920073|NCT03424044|12105266|P4|COMPLETED|Third Intervention (76 Hours)||2
4920074|NCT03424044|12105267|P3|COMPLETED|Third Intervention (76 Hours)||2
4920075|NCT03424044|12105268|P2|COMPLETED|Third Intervention (76 Hours)||3
4920076|NCT03424044|12105269|P1|COMPLETED|Third Intervention (76 Hours)||3
4920077|NCT03424044|12105261|P9|STARTED|Third Intervention (76 Hours)||1
4920078|NCT03424044|12105262|P8|STARTED|Third Intervention (76 Hours)||1
4920079|NCT03424044|12105263|P7|STARTED|Third Intervention (76 Hours)||1
4920080|NCT03424044|12105264|P6|STARTED|Third Intervention (76 Hours)||4
4920081|NCT03424044|12105265|P5|STARTED|Third Intervention (76 Hours)||2
4920082|NCT03424044|12105266|P4|STARTED|Third Intervention (76 Hours)||3
4920083|NCT03424044|12105267|P3|STARTED|Third Intervention (76 Hours)||2
4920084|NCT03424044|12105268|P2|STARTED|Third Intervention (76 Hours)||3
4920085|NCT03424044|12105269|P1|STARTED|Third Intervention (76 Hours)||4
4920086|NCT03424044|12105261|P9|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920087|NCT03424044|12105262|P8|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920088|NCT03424044|12105263|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920089|NCT03424044|12105264|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920090|NCT03424044|12105265|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920091|NCT03424044|12105266|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920092|NCT03424044|12105267|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920093|NCT03424044|12105268|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920094|NCT03424044|12105269|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4920095|NCT03424044|12105261|P9|COMPLETED|Third Rest Period (7-45 Days)||1
4920096|NCT03424044|12105262|P8|COMPLETED|Third Rest Period (7-45 Days)||1
4920097|NCT03424044|12105263|P7|COMPLETED|Third Rest Period (7-45 Days)||1
4920098|NCT03424044|12105264|P6|COMPLETED|Third Rest Period (7-45 Days)||4
4920099|NCT03424044|12105265|P5|COMPLETED|Third Rest Period (7-45 Days)||2
4920100|NCT03424044|12105266|P4|COMPLETED|Third Rest Period (7-45 Days)||3
4920101|NCT03424044|12105267|P3|COMPLETED|Third Rest Period (7-45 Days)||2
4920102|NCT03424044|12105268|P2|COMPLETED|Third Rest Period (7-45 Days)||3
4920103|NCT03424044|12105269|P1|COMPLETED|Third Rest Period (7-45 Days)||4
4920104|NCT03424044|12105261|P9|STARTED|Third Rest Period (7-45 Days)||1
4920105|NCT03424044|12105262|P8|STARTED|Third Rest Period (7-45 Days)||1
4920106|NCT03424044|12105263|P7|STARTED|Third Rest Period (7-45 Days)||1
4920107|NCT03424044|12105264|P6|STARTED|Third Rest Period (7-45 Days)||4
4920108|NCT03424044|12105265|P5|STARTED|Third Rest Period (7-45 Days)||2
4920109|NCT03424044|12105266|P4|STARTED|Third Rest Period (7-45 Days)||3
4920110|NCT03424044|12105267|P3|STARTED|Third Rest Period (7-45 Days)||2
4920111|NCT03424044|12105268|P2|STARTED|Third Rest Period (7-45 Days)||3
4920112|NCT03424044|12105269|P1|STARTED|Third Rest Period (7-45 Days)||4
4920113|NCT03424044|12105261|P9|NOT COMPLETED|Second Intervention (76 Hours)||0
4920114|NCT03424044|12105262|P8|NOT COMPLETED|Second Intervention (76 Hours)||0
4920115|NCT03424044|12105263|P7|NOT COMPLETED|Second Intervention (76 Hours)||0
4920116|NCT03424044|12105264|P6|NOT COMPLETED|Second Intervention (76 Hours)||0
4920117|NCT03424044|12105265|P5|NOT COMPLETED|Second Intervention (76 Hours)||0
4920118|NCT03424044|12105266|P4|NOT COMPLETED|Second Intervention (76 Hours)||0
4920119|NCT03424044|12105267|P3|NOT COMPLETED|Second Intervention (76 Hours)||0
4920120|NCT03424044|12105268|P2|NOT COMPLETED|Second Intervention (76 Hours)||0
4920121|NCT03424044|12105269|P1|NOT COMPLETED|Second Intervention (76 Hours)||0
4920122|NCT03424044|12105261|P9|COMPLETED|Second Intervention (76 Hours)||1
4920123|NCT03424044|12105262|P8|COMPLETED|Second Intervention (76 Hours)||1
4920124|NCT03424044|12105263|P7|COMPLETED|Second Intervention (76 Hours)||1
4920125|NCT03424044|12105264|P6|COMPLETED|Second Intervention (76 Hours)||4
4920126|NCT03424044|12105265|P5|COMPLETED|Second Intervention (76 Hours)||2
4920127|NCT03424044|12105266|P4|COMPLETED|Second Intervention (76 Hours)||3
4920128|NCT03424044|12105267|P3|COMPLETED|Second Intervention (76 Hours)||2
4920129|NCT03424044|12105268|P2|COMPLETED|Second Intervention (76 Hours)||3
4920130|NCT03424044|12105269|P1|COMPLETED|Second Intervention (76 Hours)||4
4920131|NCT03424044|12105261|P9|STARTED|Second Intervention (76 Hours)||1
4920132|NCT03424044|12105262|P8|STARTED|Second Intervention (76 Hours)||1
4920133|NCT03424044|12105263|P7|STARTED|Second Intervention (76 Hours)||1
4920134|NCT03424044|12105264|P6|STARTED|Second Intervention (76 Hours)||4
4920135|NCT03424044|12105265|P5|STARTED|Second Intervention (76 Hours)||2
4920136|NCT03424044|12105266|P4|STARTED|Second Intervention (76 Hours)||3
4920137|NCT03424044|12105267|P3|STARTED|Second Intervention (76 Hours)||2
4920138|NCT03424044|12105268|P2|STARTED|Second Intervention (76 Hours)||3
4920139|NCT03424044|12105269|P1|STARTED|Second Intervention (76 Hours)||4
4920140|NCT03424044|12105261|P9|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920141|NCT03424044|12105262|P8|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920142|NCT03424044|12105263|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920143|NCT03424044|12105264|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920144|NCT03424044|12105265|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920145|NCT03424044|12105266|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920146|NCT03424044|12105267|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920147|NCT03424044|12105268|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920148|NCT03424044|12105269|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4920149|NCT03424044|12105261|P9|COMPLETED|Second Rest Period (7-45 Days)||1
4920150|NCT03424044|12105262|P8|COMPLETED|Second Rest Period (7-45 Days)||1
4920151|NCT03424044|12105263|P7|COMPLETED|Second Rest Period (7-45 Days)||1
4920152|NCT03424044|12105264|P6|COMPLETED|Second Rest Period (7-45 Days)||4
4920153|NCT03424044|12105265|P5|COMPLETED|Second Rest Period (7-45 Days)||2
4920154|NCT03424044|12105266|P4|COMPLETED|Second Rest Period (7-45 Days)||3
4920155|NCT03424044|12105267|P3|COMPLETED|Second Rest Period (7-45 Days)||2
4920156|NCT03424044|12105268|P2|COMPLETED|Second Rest Period (7-45 Days)||3
4920157|NCT03424044|12105269|P1|COMPLETED|Second Rest Period (7-45 Days)||4
4920158|NCT03424044|12105261|P9|STARTED|Second Rest Period (7-45 Days)||1
4920159|NCT03424044|12105262|P8|STARTED|Second Rest Period (7-45 Days)||1
4920160|NCT03424044|12105263|P7|STARTED|Second Rest Period (7-45 Days)||1
4920161|NCT03424044|12105264|P6|STARTED|Second Rest Period (7-45 Days)||4
4920162|NCT03424044|12105265|P5|STARTED|Second Rest Period (7-45 Days)||2
4920163|NCT03424044|12105266|P4|STARTED|Second Rest Period (7-45 Days)||3
4920164|NCT03424044|12105267|P3|STARTED|Second Rest Period (7-45 Days)||2
4920165|NCT03424044|12105268|P2|STARTED|Second Rest Period (7-45 Days)||3
4920166|NCT03424044|12105269|P1|STARTED|Second Rest Period (7-45 Days)||4
4920167|NCT03424044|12105261|P9|NOT COMPLETED|First Intervention (76 Hours)||1
4920168|NCT03424044|12105262|P8|NOT COMPLETED|First Intervention (76 Hours)||1
4920169|NCT03424044|12105263|P7|NOT COMPLETED|First Intervention (76 Hours)||1
4920170|NCT03424044|12105264|P6|NOT COMPLETED|First Intervention (76 Hours)||0
4920171|NCT03424044|12105265|P5|NOT COMPLETED|First Intervention (76 Hours)||1
4920172|NCT03424044|12105266|P4|NOT COMPLETED|First Intervention (76 Hours)||0
4920173|NCT03424044|12105267|P3|NOT COMPLETED|First Intervention (76 Hours)||0
4920174|NCT03424044|12105268|P2|NOT COMPLETED|First Intervention (76 Hours)||0
4920175|NCT03424044|12105269|P1|NOT COMPLETED|First Intervention (76 Hours)||0
4920176|NCT03424044|12105261|P9|COMPLETED|First Intervention (76 Hours)||0
4920177|NCT03424044|12105262|P8|COMPLETED|First Intervention (76 Hours)||0
4920178|NCT03424044|12105263|P7|COMPLETED|First Intervention (76 Hours)||0
4920179|NCT03424044|12105264|P6|COMPLETED|First Intervention (76 Hours)||4
4920180|NCT03424044|12105265|P5|COMPLETED|First Intervention (76 Hours)||2
4920181|NCT03424044|12105266|P4|COMPLETED|First Intervention (76 Hours)||3
4920182|NCT03424044|12105267|P3|COMPLETED|First Intervention (76 Hours)||2
4920183|NCT03424044|12105268|P2|COMPLETED|First Intervention (76 Hours)||3
4920184|NCT03424044|12105269|P1|COMPLETED|First Intervention (76 Hours)||4
4920185|NCT03424044|12105261|P9|STARTED|First Intervention (76 Hours)||1
4920186|NCT03424044|12105262|P8|STARTED|First Intervention (76 Hours)||1
4920187|NCT03424044|12105263|P7|STARTED|First Intervention (76 Hours)||1
4920188|NCT03424044|12105264|P6|STARTED|First Intervention (76 Hours)||4
4920189|NCT03424044|12105265|P5|STARTED|First Intervention (76 Hours)||3
4920190|NCT03424044|12105266|P4|STARTED|First Intervention (76 Hours)||3
4920191|NCT03424044|12105267|P3|STARTED|First Intervention (76 Hours)||2
4920192|NCT03424044|12105268|P2|STARTED|First Intervention (76 Hours)||3
4920193|NCT03424044|12105269|P1|STARTED|First Intervention (76 Hours)||4
4920194|NCT03424044|12105261|P9|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920195|NCT03424044|12105262|P8|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920196|NCT03424044|12105263|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920197|NCT03424044|12105264|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920198|NCT03424044|12105265|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920199|NCT03424044|12105266|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920200|NCT03424044|12105267|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
4920201|NCT03424044|12105268|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920202|NCT03424044|12105269|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4920203|NCT03424044|12105261|P9|COMPLETED|First Rest Period (1-12 Weeks)||1
4920204|NCT03424044|12105262|P8|COMPLETED|First Rest Period (1-12 Weeks)||1
4920205|NCT03424044|12105263|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
4920206|NCT03424044|12105264|P6|COMPLETED|First Rest Period (1-12 Weeks)||4
4920207|NCT03424044|12105265|P5|COMPLETED|First Rest Period (1-12 Weeks)||3
4920208|NCT03424044|12105266|P4|COMPLETED|First Rest Period (1-12 Weeks)||3
4920209|NCT03424044|12105267|P3|COMPLETED|First Rest Period (1-12 Weeks)||2
4920210|NCT03424044|12105268|P2|COMPLETED|First Rest Period (1-12 Weeks)||3
4920211|NCT03424044|12105269|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
4920212|NCT03424044|12105261|P9|STARTED|First Rest Period (1-12 Weeks)||1
4920213|NCT03424044|12105262|P8|STARTED|First Rest Period (1-12 Weeks)||1
4920214|NCT03424044|12105263|P7|STARTED|First Rest Period (1-12 Weeks)||1
4920215|NCT03424044|12105264|P6|STARTED|First Rest Period (1-12 Weeks)||4
4920216|NCT03424044|12105265|P5|STARTED|First Rest Period (1-12 Weeks)||3
4920217|NCT03424044|12105266|P4|STARTED|First Rest Period (1-12 Weeks)||3
4920218|NCT03424044|12105267|P3|STARTED|First Rest Period (1-12 Weeks)||3
4920219|NCT03424044|12105268|P2|STARTED|First Rest Period (1-12 Weeks)||3
4920220|NCT03424044|12105269|P1|STARTED|First Rest Period (1-12 Weeks)||4
4920221|NCT03424044|12105261|P9|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920222|NCT03424044|12105262|P8|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920223|NCT03424044|12105263|P7|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920224|NCT03424044|12105264|P6|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920225|NCT03424044|12105265|P5|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920226|NCT03424044|12105266|P4|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920227|NCT03424044|12105267|P3|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920228|NCT03424044|12105268|P2|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920229|NCT03424044|12105269|P1|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
4920230|NCT03424044|12105261|P9|COMPLETED|Dexcom Training Visit (1 Week)||1
4920231|NCT03424044|12105262|P8|COMPLETED|Dexcom Training Visit (1 Week)||1
4920232|NCT03424044|12105263|P7|COMPLETED|Dexcom Training Visit (1 Week)||1
4920233|NCT03424044|12105264|P6|COMPLETED|Dexcom Training Visit (1 Week)||4
4920234|NCT03424044|12105265|P5|COMPLETED|Dexcom Training Visit (1 Week)||3
4920235|NCT03424044|12105266|P4|COMPLETED|Dexcom Training Visit (1 Week)||3
4920236|NCT03424044|12105267|P3|COMPLETED|Dexcom Training Visit (1 Week)||3
4920237|NCT03424044|12105268|P2|COMPLETED|Dexcom Training Visit (1 Week)||3
4920238|NCT03424044|12105269|P1|COMPLETED|Dexcom Training Visit (1 Week)||4
4920239|NCT03424044|12105261|P9|STARTED|Dexcom Training Visit (1 Week)||1
4920240|NCT03424044|12105262|P8|STARTED|Dexcom Training Visit (1 Week)||1
4920241|NCT03424044|12105263|P7|STARTED|Dexcom Training Visit (1 Week)||1
4920242|NCT03424044|12105264|P6|STARTED|Dexcom Training Visit (1 Week)||4
4920243|NCT03424044|12105265|P5|STARTED|Dexcom Training Visit (1 Week)||3
4920244|NCT03424044|12105266|P4|STARTED|Dexcom Training Visit (1 Week)||3
4920245|NCT03424044|12105267|P3|STARTED|Dexcom Training Visit (1 Week)||3
4920246|NCT03424044|12105268|P2|STARTED|Dexcom Training Visit (1 Week)||3
4920247|NCT03424044|12105269|P1|STARTED|Dexcom Training Visit (1 Week)||4
4920248|NCT03423654|12105296|P2|NOT COMPLETED|Overall Study||0
4920249|NCT03423654|12105297|P1|NOT COMPLETED|Overall Study||0
4920250|NCT03423654|12105296|P2|COMPLETED|Overall Study||3
4920251|NCT03423654|12105297|P1|COMPLETED|Overall Study||3
4920252|NCT03423654|12105296|P2|STARTED|Overall Study||3
4920253|NCT03423654|12105297|P1|STARTED|Overall Study||3
4920254|NCT03423641|12105305|P2|NOT COMPLETED|Overall Study||8074
4920255|NCT03423641|12105306|P1|NOT COMPLETED|Overall Study||331
4920256|NCT03423641|12105305|P2|COMPLETED|Overall Study||10210
4920257|NCT03423641|12105306|P1|COMPLETED|Overall Study||15193
4920258|NCT03423641|12105305|P2|STARTED|Overall Study||18284
4920259|NCT03423641|12105306|P1|STARTED|Overall Study||15524
4920260|NCT03421730|12105337|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920261|NCT03421730|12105338|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920262|NCT03421730|12105339|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920263|NCT03421730|12105340|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920264|NCT03421730|12105341|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920265|NCT03421730|12105342|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920266|NCT03421730|12105343|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920267|NCT03421730|12105344|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920268|NCT03421730|12105345|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920269|NCT03421730|12105346|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920270|NCT03421730|12105347|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920271|NCT03421730|12105348|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4920272|NCT03421730|12105337|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920273|NCT03421730|12105338|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920274|NCT03421730|12105339|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
4920275|NCT03421730|12105340|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920276|NCT03421730|12105341|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920277|NCT03421730|12105342|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920278|NCT03421730|12105343|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920279|NCT03421730|12105344|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920280|NCT03421730|12105345|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920281|NCT03421730|12105346|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920282|NCT03421730|12105347|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920283|NCT03421730|12105348|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4920284|NCT03421730|12105337|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920285|NCT03421730|12105338|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920286|NCT03421730|12105339|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
4920287|NCT03421730|12105340|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920288|NCT03421730|12105341|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920289|NCT03421730|12105342|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920290|NCT03421730|12105343|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920291|NCT03421730|12105344|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920292|NCT03421730|12105345|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920293|NCT03421730|12105346|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920294|NCT03421730|12105347|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920295|NCT03421730|12105348|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4920296|NCT03421730|12105337|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
4920297|NCT03421730|12105338|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
4920298|NCT03421730|12105339|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
4920299|NCT03421730|12105340|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
4920300|NCT03421730|12105341|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
4920301|NCT03421730|12105342|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
4920302|NCT03421730|12105343|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
4920303|NCT03421730|12105344|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
4920304|NCT03421730|12105345|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
4920305|NCT03421730|12105346|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
4920306|NCT03421730|12105347|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
4920307|NCT03421730|12105348|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
4920308|NCT03421730|12105337|P12|COMPLETED|Washout (Days 4 to 10)||1
4920309|NCT03421730|12105338|P11|COMPLETED|Washout (Days 4 to 10)||1
4920310|NCT03421730|12105339|P10|COMPLETED|Washout (Days 4 to 10)||2
4920311|NCT03421730|12105340|P9|COMPLETED|Washout (Days 4 to 10)||1
4920312|NCT03421730|12105341|P8|COMPLETED|Washout (Days 4 to 10)||1
4920313|NCT03421730|12105342|P7|COMPLETED|Washout (Days 4 to 10)||1
4920314|NCT03421730|12105343|P6|COMPLETED|Washout (Days 4 to 10)||1
4920315|NCT03421730|12105344|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
4920316|NCT03421730|12105345|P4|COMPLETED|Washout (Days 4 to 10)||1
4920317|NCT03421730|12105346|P3|COMPLETED|Washout (Days 4 to 10)||1
4920318|NCT03421730|12105347|P2|COMPLETED|Washout (Days 4 to 10)||1
4920319|NCT03421730|12105348|P1|COMPLETED|Washout (Days 4 to 10)||1
4920320|NCT03421730|12105337|P12|STARTED|Washout (Days 4 to 10)||1
4920321|NCT03421730|12105338|P11|STARTED|Washout (Days 4 to 10)||1
4920322|NCT03421730|12105339|P10|STARTED|Washout (Days 4 to 10)||2
4920323|NCT03421730|12105340|P9|STARTED|Washout (Days 4 to 10)||1
4920324|NCT03421730|12105341|P8|STARTED|Washout (Days 4 to 10)||1
4920325|NCT03421730|12105342|P7|STARTED|Washout (Days 4 to 10)||1
4920326|NCT03421730|12105343|P6|STARTED|Washout (Days 4 to 10)||1
4920327|NCT03421730|12105344|P5|STARTED|Washout (Days 4 to 10)||3
4920328|NCT03421730|12105345|P4|STARTED|Washout (Days 4 to 10)||1
4920329|NCT03421730|12105346|P3|STARTED|Washout (Days 4 to 10)||1
4920330|NCT03421730|12105347|P2|STARTED|Washout (Days 4 to 10)||1
4920331|NCT03421730|12105348|P1|STARTED|Washout (Days 4 to 10)||1
4920332|NCT03421730|12105337|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920333|NCT03421730|12105338|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920334|NCT03421730|12105339|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920335|NCT03421730|12105340|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920336|NCT03421730|12105341|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920337|NCT03421730|12105342|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920338|NCT03421730|12105343|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920339|NCT03421730|12105344|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920340|NCT03421730|12105345|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920341|NCT03421730|12105346|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920342|NCT03421730|12105347|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
4920343|NCT03421730|12105348|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4920344|NCT03421730|12105337|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920345|NCT03421730|12105338|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920346|NCT03421730|12105339|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
4920347|NCT03421730|12105340|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920348|NCT03421730|12105341|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920349|NCT03421730|12105342|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920350|NCT03421730|12105343|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920351|NCT03421730|12105344|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
4920352|NCT03421730|12105345|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920353|NCT03421730|12105346|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920354|NCT03421730|12105347|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
4920355|NCT03421730|12105348|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
4920356|NCT03421730|12105337|P12|STARTED|First Intervention (Day 1, Visit 2)||1
4920357|NCT03421730|12105338|P11|STARTED|First Intervention (Day 1, Visit 2)||1
4920358|NCT03421730|12105339|P10|STARTED|First Intervention (Day 1, Visit 2)||2
4920359|NCT03421730|12105340|P9|STARTED|First Intervention (Day 1, Visit 2)||1
4920360|NCT03421730|12105341|P8|STARTED|First Intervention (Day 1, Visit 2)||1
4920361|NCT03421730|12105342|P7|STARTED|First Intervention (Day 1, Visit 2)||1
4920362|NCT03421730|12105343|P6|STARTED|First Intervention (Day 1, Visit 2)||1
4920363|NCT03421730|12105344|P5|STARTED|First Intervention (Day 1, Visit 2)||3
4920364|NCT03421730|12105345|P4|STARTED|First Intervention (Day 1, Visit 2)||1
4920365|NCT03421730|12105346|P3|STARTED|First Intervention (Day 1, Visit 2)||1
4920366|NCT03421730|12105347|P2|STARTED|First Intervention (Day 1, Visit 2)||3
4920367|NCT03421730|12105348|P1|STARTED|First Intervention (Day 1, Visit 2)||1
4920368|NCT03421379|12105421|P2|NOT COMPLETED|Period 2||0
4920369|NCT03421379|12105422|P1|NOT COMPLETED|Period 2||0
4920370|NCT03421379|12105421|P2|COMPLETED|Period 2||37
4920371|NCT03421379|12105422|P1|COMPLETED|Period 2||32
4920372|NCT03421379|12105421|P2|STARTED|Period 2||37
4920373|NCT03421379|12105422|P1|STARTED|Period 2||32
4920374|NCT03421379|12105421|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
4920375|NCT03421379|12105422|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
4920376|NCT03421379|12105421|P2|COMPLETED|Washout Period (3 to 14 Days)||37
4920377|NCT03421379|12105422|P1|COMPLETED|Washout Period (3 to 14 Days)||32
4920378|NCT03421379|12105421|P2|STARTED|Washout Period (3 to 14 Days)||37
4920379|NCT03421379|12105422|P1|STARTED|Washout Period (3 to 14 Days)||32
4920380|NCT03421379|12105421|P2|NOT COMPLETED|Period 1||4
4920381|NCT03421379|12105422|P1|NOT COMPLETED|Period 1||2
4920382|NCT03421379|12105421|P2|COMPLETED|Period 1||37
4920383|NCT03421379|12105422|P1|COMPLETED|Period 1||32
4920384|NCT03421379|12105421|P2|Received at Least One Dose of Study Drug|Period 1||39
4920385|NCT03421379|12105422|P1|Received at Least One Dose of Study Drug|Period 1||33
4920386|NCT03421379|12105421|P2|STARTED|Period 1||41
4920387|NCT03421379|12105422|P1|STARTED|Period 1||34
4920388|NCT03420625|12105438|P1|NOT COMPLETED|Overall Study||0
4920389|NCT03420625|12105438|P1|COMPLETED|Overall Study||10
4920390|NCT03420625|12105438|P1|Calf NMES|Overall Study||10
4920391|NCT03420625|12105438|P1|Slow Calf IPC|Overall Study||10
4920392|NCT03420625|12105438|P1|Rapid Calf IPC|Overall Study||10
4920393|NCT03420625|12105438|P1|Foot IPC|Overall Study||10
4920394|NCT03420625|12105438|P1|Baseline|Overall Study||10
4920395|NCT03420625|12105438|P1|STARTED|Overall Study||10
4920396|NCT03420300|12105468|P1|NOT COMPLETED|Overall Study||2
4920397|NCT03420300|12105468|P1|COMPLETED|Overall Study||38
4920398|NCT03420300|12105468|P1|STARTED|Overall Study||40
4920399|NCT03419962|12105477|P1|NOT COMPLETED|Overall Study||37
4920400|NCT03419962|12105477|P1|COMPLETED|Overall Study||1322
4920401|NCT03419962|12105477|P1|STARTED|Overall Study||1359
4920402|NCT03419078|12105490|P3|NOT COMPLETED|Overall Study||0
4920403|NCT03419078|12105491|P2|NOT COMPLETED|Overall Study||0
4920404|NCT03419078|12105492|P1|NOT COMPLETED|Overall Study||0
4920405|NCT03419078|12105490|P3|COMPLETED|Overall Study||91
4920406|NCT03419078|12105491|P2|COMPLETED|Overall Study||148
4920407|NCT03419078|12105492|P1|COMPLETED|Overall Study||245
4920408|NCT03419078|12105490|P3|STARTED|Overall Study||91
4920409|NCT03419078|12105491|P2|STARTED|Overall Study||148
4920410|NCT03419078|12105492|P1|STARTED|Overall Study||245
4920411|NCT03418662|12105511|P2|NOT COMPLETED|Overall Study||4
4920412|NCT03418662|12105512|P1|NOT COMPLETED|Overall Study||3
4920413|NCT03418662|12105511|P2|COMPLETED|Overall Study||278
4920414|NCT03418662|12105512|P1|COMPLETED|Overall Study||284
4920415|NCT03418662|12105511|P2|STARTED|Overall Study||282
4920416|NCT03418662|12105512|P1|STARTED|Overall Study||287
4920417|NCT03418571|12105536|P2|NOT COMPLETED|Overall Study||0
4920418|NCT03418571|12105537|P1|NOT COMPLETED|Overall Study||1
4920419|NCT03418571|12105536|P2|COMPLETED|Overall Study||3
4920420|NCT03418571|12105537|P1|COMPLETED|Overall Study||11
4920421|NCT03418571|12105536|P2|STARTED|Overall Study||3
4920422|NCT03418571|12105537|P1|STARTED|Overall Study||12
4920423|NCT03418376|12105549|P4|NOT COMPLETED|Overall Study||1
4920424|NCT03418376|12105550|P3|NOT COMPLETED|Overall Study||3
4920425|NCT03418376|12105551|P2|NOT COMPLETED|Overall Study||5
4920426|NCT03418376|12105552|P1|NOT COMPLETED|Overall Study||1
4920427|NCT03418376|12105549|P4|COMPLETED|Overall Study||10
4920428|NCT03418376|12105550|P3|COMPLETED|Overall Study||8
4920429|NCT03418376|12105551|P2|COMPLETED|Overall Study||6
4920430|NCT03418376|12105552|P1|COMPLETED|Overall Study||11
4920431|NCT03418376|12105549|P4|STARTED|Overall Study||11
4920432|NCT03418376|12105550|P3|STARTED|Overall Study||11
4920433|NCT03418376|12105551|P2|STARTED|Overall Study||11
4920434|NCT03418376|12105552|P1|STARTED|Overall Study||12
4920435|NCT03418064|12105578|P2|NOT COMPLETED|Second Intervention (1 Month)||0
4920436|NCT03418064|12105579|P1|NOT COMPLETED|Second Intervention (1 Month)||0
4920437|NCT03418064|12105578|P2|COMPLETED|Second Intervention (1 Month)||21
4920438|NCT03418064|12105579|P1|COMPLETED|Second Intervention (1 Month)||21
4920439|NCT03418064|12105578|P2|STARTED|Second Intervention (1 Month)||21
4920440|NCT03418064|12105579|P1|STARTED|Second Intervention (1 Month)||21
4920441|NCT03418064|12105578|P2|NOT COMPLETED|First Intervention (1 Month)||0
4920442|NCT03418064|12105579|P1|NOT COMPLETED|First Intervention (1 Month)||0
4920443|NCT03418064|12105578|P2|COMPLETED|First Intervention (1 Month)||21
4920444|NCT03418064|12105579|P1|COMPLETED|First Intervention (1 Month)||21
4920445|NCT03418064|12105578|P2|STARTED|First Intervention (1 Month)||21
4920446|NCT03418064|12105579|P1|STARTED|First Intervention (1 Month)||21
4920447|NCT03417830|12105610|P2|NOT COMPLETED|Part B (up to 26 Days)||0
4920448|NCT03417830|12105611|P1|NOT COMPLETED|Part B (up to 26 Days)||0
4920449|NCT03417830|12105610|P2|COMPLETED|Part B (up to 26 Days)||0
4920450|NCT03417830|12105611|P1|COMPLETED|Part B (up to 26 Days)||0
4920451|NCT03417830|12105610|P2|STARTED|Part B (up to 26 Days)||0
4920452|NCT03417830|12105611|P1|STARTED|Part B (up to 26 Days)||0
4920453|NCT03417830|12105610|P2|NOT COMPLETED|Part A (up to 26 Days)||0
4920454|NCT03417830|12105611|P1|NOT COMPLETED|Part A (up to 26 Days)||1
4920455|NCT03417830|12105610|P2|COMPLETED|Part A (up to 26 Days)||0
4920456|NCT03417830|12105611|P1|COMPLETED|Part A (up to 26 Days)||1
4920457|NCT03417830|12105610|P2|STARTED|Part A (up to 26 Days)||0
4920458|NCT03417830|12105611|P1|STARTED|Part A (up to 26 Days)||2
4920459|NCT03417713|12105705|P1|NOT COMPLETED|Overall Study||3
4920460|NCT03417713|12105705|P1|COMPLETED|Overall Study||30
4920461|NCT03417713|12105705|P1|STARTED|Overall Study||33
4920462|NCT03417557|12105710|P2|NOT COMPLETED|2nd Intervention (3 Hours)||0
4920463|NCT03417557|12105711|P1|NOT COMPLETED|2nd Intervention (3 Hours)||0
4920464|NCT03417557|12105710|P2|COMPLETED|2nd Intervention (3 Hours)||8
4920465|NCT03417557|12105711|P1|COMPLETED|2nd Intervention (3 Hours)||9
4920466|NCT03417557|12105710|P2|STARTED|2nd Intervention (3 Hours)||8
4920467|NCT03417557|12105711|P1|STARTED|2nd Intervention (3 Hours)||9
4920468|NCT03417557|12105710|P2|NOT COMPLETED|1st Intervention (3 Hours)||0
4920469|NCT03417557|12105711|P1|NOT COMPLETED|1st Intervention (3 Hours)||0
4920470|NCT03417557|12105710|P2|COMPLETED|1st Intervention (3 Hours)||9
4920471|NCT03417557|12105711|P1|COMPLETED|1st Intervention (3 Hours)||8
4920472|NCT03417557|12105710|P2|STARTED|1st Intervention (3 Hours)||9
4920473|NCT03417557|12105711|P1|STARTED|1st Intervention (3 Hours)||8
4920474|NCT03417505|12105723|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
4920475|NCT03417505|12105724|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
4920476|NCT03417505|12105723|P2|COMPLETED|Second Lens Type (30 Days)||11
4920477|NCT03417505|12105724|P1|COMPLETED|Second Lens Type (30 Days)||8
4920478|NCT03417505|12105723|P2|STARTED|Second Lens Type (30 Days)||11
4920479|NCT03417505|12105724|P1|STARTED|Second Lens Type (30 Days)||8
4920480|NCT03417505|12105723|P2|NOT COMPLETED|Washout Period (7 Days)||0
4920481|NCT03417505|12105724|P1|NOT COMPLETED|Washout Period (7 Days)||0
4920482|NCT03417505|12105723|P2|COMPLETED|Washout Period (7 Days)||11
4920483|NCT03417505|12105724|P1|COMPLETED|Washout Period (7 Days)||8
4920484|NCT03417505|12105723|P2|STARTED|Washout Period (7 Days)||11
4920485|NCT03417505|12105724|P1|STARTED|Washout Period (7 Days)||8
4920486|NCT03417505|12105723|P2|NOT COMPLETED|First Lens Type (30 Days)||1
4920487|NCT03417505|12105724|P1|NOT COMPLETED|First Lens Type (30 Days)||1
4920488|NCT03417505|12105723|P2|COMPLETED|First Lens Type (30 Days)||11
4920489|NCT03417505|12105724|P1|COMPLETED|First Lens Type (30 Days)||8
4920490|NCT03417505|12105723|P2|STARTED|First Lens Type (30 Days)||12
4920491|NCT03417505|12105724|P1|STARTED|First Lens Type (30 Days)||9
4920492|NCT03417466|12105746|P1|NOT COMPLETED|Overall Study||0
4920493|NCT03417466|12105746|P1|COMPLETED|Overall Study||66
4920494|NCT03417466|12105746|P1|STARTED|Overall Study||66
4920495|NCT03417219|12105755|P2|NOT COMPLETED|Overall Study||3
4920496|NCT03417219|12105756|P1|NOT COMPLETED|Overall Study||0
4920497|NCT03417219|12105755|P2|COMPLETED|Overall Study||5
4920498|NCT03417219|12105756|P1|COMPLETED|Overall Study||8
4920499|NCT03417219|12105755|P2|STARTED|Overall Study||8
4920500|NCT03417219|12105756|P1|STARTED|Overall Study||8
4920501|NCT03417141|12105766|P1|NOT COMPLETED|Overall Study||4
4920502|NCT03417141|12105766|P1|COMPLETED|Overall Study||8
4920503|NCT03417141|12105766|P1|STARTED|Overall Study||12
4920504|NCT03417024|12105773|P1|NOT COMPLETED|Overall Study||13
4920505|NCT03417024|12105773|P1|COMPLETED|Overall Study||0
4920506|NCT03417024|12105773|P1|STARTED|Overall Study||13
4920507|NCT03416985|12105782|P3|NOT COMPLETED|Overall Study||6
4920508|NCT03416985|12105783|P2|NOT COMPLETED|Overall Study||0
4920509|NCT03416985|12105784|P1|NOT COMPLETED|Overall Study||2
4920510|NCT03416985|12105782|P3|COMPLETED|Overall Study||24
4920511|NCT03416985|12105783|P2|COMPLETED|Overall Study||30
4920512|NCT03416985|12105784|P1|COMPLETED|Overall Study||28
4920513|NCT03416985|12105782|P3|STARTED|Overall Study||30
4920514|NCT03416985|12105783|P2|STARTED|Overall Study||30
4920515|NCT03416985|12105784|P1|STARTED|Overall Study||30
4920516|NCT03415243|12105797|P2|NOT COMPLETED|Overall Study||0
4920517|NCT03415243|12105798|P1|NOT COMPLETED|Overall Study||0
4920518|NCT03415243|12105797|P2|COMPLETED|Overall Study||14
4920519|NCT03415243|12105798|P1|COMPLETED|Overall Study||14
4920520|NCT03415243|12105797|P2|STARTED|Overall Study||14
4920521|NCT03415243|12105798|P1|STARTED|Overall Study||14
4920522|NCT03415178|12105862|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
4920523|NCT03415178|12105863|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
4920524|NCT03415178|12105862|P2|COMPLETED|Single Arm Period (up to Week 16)||65
4920525|NCT03415178|12105863|P1|COMPLETED|Single Arm Period (up to Week 16)||0
4920526|NCT03415178|12105862|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
4920527|NCT03415178|12105863|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
4920528|NCT03415178|12105862|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
4920529|NCT03415178|12105863|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
4920530|NCT03415178|12105862|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
4920531|NCT03415178|12105863|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
4920532|NCT03415178|12105862|P2|Treated|Parallel-Arm Period (up to Week 4)||33
4920533|NCT03415178|12105863|P1|Treated|Parallel-Arm Period (up to Week 4)||34
4920534|NCT03415178|12105862|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
4920535|NCT03415178|12105863|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
4920536|NCT03414359|12105900|P2|NOT COMPLETED|Overall Study||2
4920537|NCT03414359|12105901|P1|NOT COMPLETED|Overall Study||1
4920538|NCT03414359|12105900|P2|COMPLETED|Overall Study||33
4920539|NCT03414359|12105901|P1|COMPLETED|Overall Study||34
4920540|NCT03414359|12105900|P2|STARTED|Overall Study||35
4920541|NCT03414359|12105901|P1|STARTED|Overall Study||35
4920542|NCT03414047|12105913|P4|NOT COMPLETED|Overall Study||3
4920543|NCT03414047|12105914|P3|NOT COMPLETED|Overall Study||0
4920544|NCT03414047|12105915|P2|NOT COMPLETED|Overall Study||0
4920545|NCT03414047|12105916|P1|NOT COMPLETED|Overall Study||1
4920546|NCT03414047|12105913|P4|COMPLETED|Overall Study||28
4920547|NCT03414047|12105914|P3|COMPLETED|Overall Study||40
4920548|NCT03414047|12105915|P2|COMPLETED|Overall Study||44
4920549|NCT03414047|12105916|P1|COMPLETED|Overall Study||53
4920550|NCT03414047|12105913|P4|STARTED|Overall Study||31
4920551|NCT03414047|12105914|P3|STARTED|Overall Study||40
4920552|NCT03414047|12105915|P2|STARTED|Overall Study||44
4920553|NCT03414047|12105916|P1|STARTED|Overall Study||54
4920554|NCT03413618|12105949|P2|NOT COMPLETED|Overall Study||0
4920555|NCT03413618|12105950|P1|NOT COMPLETED|Overall Study||0
4920556|NCT03413618|12105949|P2|COMPLETED|Overall Study||45
4920557|NCT03413618|12105950|P1|COMPLETED|Overall Study||45
4920558|NCT03413618|12105949|P2|STARTED|Overall Study||45
4920559|NCT03413618|12105950|P1|STARTED|Overall Study||45
4920560|NCT03412929|12105976|P1|NOT COMPLETED|Overall Study||3
4920561|NCT03412929|12105976|P1|COMPLETED|Overall Study||5
4920562|NCT03412929|12105976|P1|STARTED|Overall Study||8
4920563|NCT03412019|12105987|P2|NOT COMPLETED|Overall Study||1
4920564|NCT03412019|12105988|P1|NOT COMPLETED|Overall Study||1
4920565|NCT03412019|12105987|P2|COMPLETED|Overall Study||10
4920566|NCT03412019|12105988|P1|COMPLETED|Overall Study||10
4920567|NCT03412019|12105987|P2|STARTED|Overall Study||11
4920568|NCT03412019|12105988|P1|STARTED|Overall Study||11
4920569|NCT03410628|12105998|P1|NOT COMPLETED|Overall Study||6
4920570|NCT03410628|12105998|P1|COMPLETED|Overall Study||15
4920571|NCT03410628|12105998|P1|STARTED|Overall Study||21
4920572|NCT03409731|12106003|P1|NOT COMPLETED|Overall Study||0
4920573|NCT03409731|12106003|P1|COMPLETED|Overall Study||135
4920574|NCT03409731|12106003|P1|STARTED|Overall Study||135
4920575|NCT03408639|12106037|P2|NOT COMPLETED|Overall Study||22
4920576|NCT03408639|12106038|P1|NOT COMPLETED|Overall Study||11
4920577|NCT03408639|12106037|P2|COMPLETED|Overall Study||56
4920578|NCT03408639|12106038|P1|COMPLETED|Overall Study||67
4920579|NCT03408639|12106037|P2|STARTED|Overall Study||78
4920580|NCT03408639|12106038|P1|STARTED|Overall Study||78
4920581|NCT03408392|12106066|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
4920582|NCT03408392|12106067|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
4920583|NCT03408392|12106066|P2|COMPLETED|Treatment Period 2 (16 Days)||14
4920584|NCT03408392|12106067|P1|COMPLETED|Treatment Period 2 (16 Days)||14
4920585|NCT03408392|12106066|P2|STARTED|Treatment Period 2 (16 Days)||14
4920586|NCT03408392|12106067|P1|STARTED|Treatment Period 2 (16 Days)||14
4920587|NCT03408392|12106066|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
4920588|NCT03408392|12106067|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
4920589|NCT03408392|12106066|P2|COMPLETED|Wash-out Period (14 Days)||14
4920590|NCT03408392|12106067|P1|COMPLETED|Wash-out Period (14 Days)||14
4920591|NCT03408392|12106066|P2|STARTED|Wash-out Period (14 Days)||14
4920592|NCT03408392|12106067|P1|STARTED|Wash-out Period (14 Days)||14
4920593|NCT03408392|12106066|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
4920594|NCT03408392|12106067|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
4920595|NCT03408392|12106066|P2|COMPLETED|Treatment Period 1 (16 Days)||14
4920596|NCT03408392|12106067|P1|COMPLETED|Treatment Period 1 (16 Days)||14
4920597|NCT03408392|12106066|P2|STARTED|Treatment Period 1 (16 Days)||14
4920598|NCT03408392|12106067|P1|STARTED|Treatment Period 1 (16 Days)||14
4920599|NCT03408171|12106121|P2|NOT COMPLETED|Overall Study||0
4920600|NCT03408171|12106122|P1|NOT COMPLETED|Overall Study||0
4920601|NCT03408171|12106121|P2|COMPLETED|Overall Study||20
4920602|NCT03408171|12106122|P1|COMPLETED|Overall Study||20
4920603|NCT03408171|12106121|P2|STARTED|Overall Study||20
4920604|NCT03408171|12106122|P1|STARTED|Overall Study||20
4920605|NCT03407612|12106150|P2|NOT COMPLETED|Overall Study||0
4920606|NCT03407612|12106151|P1|NOT COMPLETED|Overall Study||0
4920607|NCT03407612|12106150|P2|COMPLETED|Overall Study||23
4920608|NCT03407612|12106151|P1|COMPLETED|Overall Study||19
4920609|NCT03407612|12106150|P2|STARTED|Overall Study||23
4920610|NCT03407612|12106151|P1|STARTED|Overall Study||19
4920611|NCT03407430|12106163|P2|NOT COMPLETED|Second Intervention||0
4920612|NCT03407430|12106164|P1|NOT COMPLETED|Second Intervention||0
4920613|NCT03407430|12106163|P2|COMPLETED|Second Intervention||3
4920614|NCT03407430|12106164|P1|COMPLETED|Second Intervention||4
4920615|NCT03407430|12106163|P2|STARTED|Second Intervention||3
4920616|NCT03407430|12106164|P1|STARTED|Second Intervention||4
4920617|NCT03407430|12106163|P2|NOT COMPLETED|Washout||0
4920618|NCT03407430|12106164|P1|NOT COMPLETED|Washout||1
4920619|NCT03407430|12106163|P2|COMPLETED|Washout||3
4920620|NCT03407430|12106164|P1|COMPLETED|Washout||4
4920621|NCT03407430|12106163|P2|STARTED|Washout||3
4920622|NCT03407430|12106164|P1|STARTED|Washout||5
4920623|NCT03407430|12106163|P2|NOT COMPLETED|First Intervention||0
4920624|NCT03407430|12106164|P1|NOT COMPLETED|First Intervention||0
4920625|NCT03407430|12106163|P2|COMPLETED|First Intervention||3
4920626|NCT03407430|12106164|P1|COMPLETED|First Intervention||5
4920627|NCT03407430|12106163|P2|STARTED|First Intervention||3
4920628|NCT03407430|12106164|P1|STARTED|First Intervention||5
4920629|NCT03407170|12106196|P1|NOT COMPLETED|Overall Study||1
4920630|NCT03407170|12106196|P1|COMPLETED|Overall Study||0
4920631|NCT03407170|12106196|P1|STARTED|Overall Study||1
4920632|NCT03407118|12106209|P2|NOT COMPLETED|Period 2||0
4920633|NCT03407118|12106210|P1|NOT COMPLETED|Period 2||1
4920634|NCT03407118|12106209|P2|COMPLETED|Period 2||17
4920635|NCT03407118|12106210|P1|COMPLETED|Period 2||13
4920636|NCT03407118|12106209|P2|Received at Least 1 Dose of Study Drug|Period 2||17
4920637|NCT03407118|12106210|P1|Received at Least 1 Dose of Study Drug|Period 2||13
4920638|NCT03407118|12106209|P2|STARTED|Period 2||17
4920639|NCT03407118|12106210|P1|STARTED|Period 2||14
4920640|NCT03407118|12106209|P2|NOT COMPLETED|Period 1||0
4920641|NCT03407118|12106210|P1|NOT COMPLETED|Period 1||0
4920642|NCT03407118|12106209|P2|COMPLETED|Period 1||17
4920643|NCT03407118|12106210|P1|COMPLETED|Period 1||14
4920644|NCT03407118|12106209|P2|Received at Least 1 Dose of Study Drug|Period 1||17
4920645|NCT03407118|12106210|P1|Received at Least 1 Dose of Study Drug|Period 1||14
4920646|NCT03407118|12106209|P2|STARTED|Period 1||17
4920647|NCT03407118|12106210|P1|STARTED|Period 1||14
4920648|NCT03406325|12106226|P8|NOT COMPLETED|Overall Study||0
4920649|NCT03406325|12106227|P7|NOT COMPLETED|Overall Study||0
4920650|NCT03406325|12106228|P6|NOT COMPLETED|Overall Study||0
4920651|NCT03406325|12106229|P5|NOT COMPLETED|Overall Study||0
4920652|NCT03406325|12106230|P4|NOT COMPLETED|Overall Study||0
4920653|NCT03406325|12106231|P3|NOT COMPLETED|Overall Study||0
4920654|NCT03406325|12106232|P2|NOT COMPLETED|Overall Study||0
4920655|NCT03406325|12106233|P1|NOT COMPLETED|Overall Study||0
4920656|NCT03406325|12106226|P8|COMPLETED|Overall Study||1
4920657|NCT03406325|12106227|P7|COMPLETED|Overall Study||1
4920658|NCT03406325|12106228|P6|COMPLETED|Overall Study||1
4920659|NCT03406325|12106229|P5|COMPLETED|Overall Study||1
4920660|NCT03406325|12106230|P4|COMPLETED|Overall Study||1
4920661|NCT03406325|12106231|P3|COMPLETED|Overall Study||1
4920662|NCT03406325|12106232|P2|COMPLETED|Overall Study||1
4920663|NCT03406325|12106233|P1|COMPLETED|Overall Study||12
4920664|NCT03406325|12106226|P8|STARTED|Overall Study||1
4920665|NCT03406325|12106227|P7|STARTED|Overall Study||1
4920666|NCT03406325|12106228|P6|STARTED|Overall Study||1
4920667|NCT03406325|12106229|P5|STARTED|Overall Study||1
4920668|NCT03406325|12106230|P4|STARTED|Overall Study||1
4920669|NCT03406325|12106231|P3|STARTED|Overall Study||1
4920670|NCT03406325|12106232|P2|STARTED|Overall Study||1
4920671|NCT03406325|12106233|P1|STARTED|Overall Study||12
4920672|NCT03406260|12106287|P6|NOT COMPLETED|Period 3||0
4920673|NCT03406260|12106288|P5|NOT COMPLETED|Period 3||0
4920674|NCT03406260|12106289|P4|NOT COMPLETED|Period 3||0
4920675|NCT03406260|12106290|P3|NOT COMPLETED|Period 3||0
4920676|NCT03406260|12106291|P2|NOT COMPLETED|Period 3||0
4920677|NCT03406260|12106292|P1|NOT COMPLETED|Period 3||0
4920678|NCT03406260|12106287|P6|COMPLETED|Period 3||6
4920679|NCT03406260|12106288|P5|COMPLETED|Period 3||5
4920680|NCT03406260|12106289|P4|COMPLETED|Period 3||6
4920681|NCT03406260|12106290|P3|COMPLETED|Period 3||6
4920682|NCT03406260|12106291|P2|COMPLETED|Period 3||6
4920683|NCT03406260|12106292|P1|COMPLETED|Period 3||6
4920684|NCT03406260|12106287|P6|STARTED|Period 3||6
4920685|NCT03406260|12106288|P5|STARTED|Period 3||5
4920686|NCT03406260|12106289|P4|STARTED|Period 3||6
4920687|NCT03406260|12106290|P3|STARTED|Period 3||6
4920688|NCT03406260|12106291|P2|STARTED|Period 3||6
4920689|NCT03406260|12106292|P1|STARTED|Period 3||6
4920690|NCT03406260|12106287|P6|NOT COMPLETED|Period 2||0
4920691|NCT03406260|12106288|P5|NOT COMPLETED|Period 2||0
4920692|NCT03406260|12106289|P4|NOT COMPLETED|Period 2||0
4920693|NCT03406260|12106290|P3|NOT COMPLETED|Period 2||0
4920694|NCT03406260|12106291|P2|NOT COMPLETED|Period 2||0
4920695|NCT03406260|12106292|P1|NOT COMPLETED|Period 2||0
4920696|NCT03406260|12106287|P6|COMPLETED|Period 2||6
4920697|NCT03406260|12106288|P5|COMPLETED|Period 2||5
4920698|NCT03406260|12106289|P4|COMPLETED|Period 2||6
4920699|NCT03406260|12106290|P3|COMPLETED|Period 2||6
4920700|NCT03406260|12106291|P2|COMPLETED|Period 2||6
4920701|NCT03406260|12106292|P1|COMPLETED|Period 2||6
4920702|NCT03406260|12106287|P6|STARTED|Period 2||6
4920703|NCT03406260|12106288|P5|STARTED|Period 2||5
4920704|NCT03406260|12106289|P4|STARTED|Period 2||6
4920705|NCT03406260|12106290|P3|STARTED|Period 2||6
4920706|NCT03406260|12106291|P2|STARTED|Period 2||6
4920707|NCT03406260|12106292|P1|STARTED|Period 2||6
4920708|NCT03406260|12106287|P6|NOT COMPLETED|Period 1||0
4920709|NCT03406260|12106288|P5|NOT COMPLETED|Period 1||1
4920710|NCT03406260|12106289|P4|NOT COMPLETED|Period 1||0
4920711|NCT03406260|12106290|P3|NOT COMPLETED|Period 1||0
4920712|NCT03406260|12106291|P2|NOT COMPLETED|Period 1||0
4920713|NCT03406260|12106292|P1|NOT COMPLETED|Period 1||0
4920714|NCT03406260|12106287|P6|COMPLETED|Period 1||6
4920715|NCT03406260|12106288|P5|COMPLETED|Period 1||5
4920716|NCT03406260|12106289|P4|COMPLETED|Period 1||6
4920717|NCT03406260|12106290|P3|COMPLETED|Period 1||6
4920718|NCT03406260|12106291|P2|COMPLETED|Period 1||6
4920719|NCT03406260|12106292|P1|COMPLETED|Period 1||6
4920720|NCT03406260|12106287|P6|Received at Least 1 Dose of Study Drug|Period 1||6
4920721|NCT03406260|12106288|P5|Received at Least 1 Dose of Study Drug|Period 1||6
4920722|NCT03406260|12106289|P4|Received at Least 1 Dose of Study Drug|Period 1||6
4920723|NCT03406260|12106290|P3|Received at Least 1 Dose of Study Drug|Period 1||6
4920724|NCT03406260|12106291|P2|Received at Least 1 Dose of Study Drug|Period 1||6
4920725|NCT03406260|12106292|P1|Received at Least 1 Dose of Study Drug|Period 1||6
4920726|NCT03406260|12106287|P6|STARTED|Period 1||6
4920727|NCT03406260|12106288|P5|STARTED|Period 1||6
4920728|NCT03406260|12106289|P4|STARTED|Period 1||6
4920729|NCT03406260|12106290|P3|STARTED|Period 1||6
4920730|NCT03406260|12106291|P2|STARTED|Period 1||6
4920731|NCT03406260|12106292|P1|STARTED|Period 1||6
4920732|NCT03405935|12106304|P1|NOT COMPLETED|Overall Study||86
4920733|NCT03405935|12106304|P1|COMPLETED|Overall Study||0
4920734|NCT03405935|12106304|P1|STARTED|Overall Study||86
4920735|NCT03405818|12106315|P1|NOT COMPLETED|Overall Study||8
4920736|NCT03405818|12106315|P1|COMPLETED|Overall Study||47
4920737|NCT03405818|12106315|P1|STARTED|Overall Study||55
4920738|NCT03405259|12106358|P2|NOT COMPLETED|Overall Study||0
4920739|NCT03405259|12106359|P1|NOT COMPLETED|Overall Study||0
4920740|NCT03405259|12106358|P2|COMPLETED|Overall Study||11
4920741|NCT03405259|12106359|P1|COMPLETED|Overall Study||11
4920742|NCT03405259|12106358|P2|STARTED|Overall Study||11
4920743|NCT03405259|12106359|P1|STARTED|Overall Study||11
4920744|NCT03404843|12106369|P2|NOT COMPLETED|Overall Study||1
4920745|NCT03404843|12106370|P1|NOT COMPLETED|Overall Study||4
4920746|NCT03404843|12106369|P2|COMPLETED|Overall Study||13
4920747|NCT03404843|12106370|P1|COMPLETED|Overall Study||13
4920748|NCT03404843|12106369|P2|STARTED|Overall Study||14
4920749|NCT03404843|12106370|P1|STARTED|Overall Study||17
4920750|NCT03404206|12106399|P3|NOT COMPLETED|Overall Study||0
4920751|NCT03404206|12106400|P2|NOT COMPLETED|Overall Study||2
4920752|NCT03404206|12106401|P1|NOT COMPLETED|Overall Study||4
4920753|NCT03404206|12106399|P3|COMPLETED|Overall Study||55
4920754|NCT03404206|12106400|P2|COMPLETED|Overall Study||164
4920755|NCT03404206|12106401|P1|COMPLETED|Overall Study||162
4920756|NCT03404206|12106399|P3|STARTED|Overall Study||55
4920757|NCT03404206|12106400|P2|STARTED|Overall Study||166
4920758|NCT03404206|12106401|P1|STARTED|Overall Study||166
4920759|NCT03404167|12106415|P1|NOT COMPLETED|Overall Study||0
4920760|NCT03404167|12106415|P1|COMPLETED|Overall Study||8
4920761|NCT03404167|12106415|P1|STARTED|Overall Study||8
4920762|NCT03403712|12106452|P2|NOT COMPLETED|Overall Study||100
4920763|NCT03403712|12106453|P1|NOT COMPLETED|Overall Study||105
4920764|NCT03403712|12106452|P2|COMPLETED|Overall Study||102
4920765|NCT03403712|12106453|P1|COMPLETED|Overall Study||95
4920766|NCT03403712|12106452|P2|STARTED|Overall Study||202
4920767|NCT03403712|12106453|P1|STARTED|Overall Study||200
4920768|NCT03403504|12106475|P2|NOT COMPLETED|Period 2||0
4920769|NCT03403504|12106476|P1|NOT COMPLETED|Period 2||0
4920770|NCT03403504|12106475|P2|COMPLETED|Period 2||11
4920771|NCT03403504|12106476|P1|COMPLETED|Period 2||12
4920772|NCT03403504|12106475|P2|STARTED|Period 2||11
4920773|NCT03403504|12106476|P1|STARTED|Period 2||12
4920774|NCT03403504|12106475|P2|NOT COMPLETED|Period 1||1
4920775|NCT03403504|12106476|P1|NOT COMPLETED|Period 1||0
4920776|NCT03403504|12106475|P2|COMPLETED|Period 1||11
4920777|NCT03403504|12106476|P1|COMPLETED|Period 1||12
4920778|NCT03403504|12106475|P2|STARTED|Period 1||12
4920779|NCT03403504|12106476|P1|STARTED|Period 1||12
4920780|NCT03403491|12106496|P2|NOT COMPLETED|Overall Study||5
4920781|NCT03403491|12106497|P1|NOT COMPLETED|Overall Study||3
4920782|NCT03403491|12106496|P2|COMPLETED|Overall Study||18
4920783|NCT03403491|12106497|P1|COMPLETED|Overall Study||17
4920784|NCT03403491|12106496|P2|STARTED|Overall Study||23
4920785|NCT03403491|12106497|P1|STARTED|Overall Study||20
4920786|NCT03403413|12106529|P1|NOT COMPLETED|Overall Study||2
4920787|NCT03403413|12106529|P1|COMPLETED|Overall Study||3
4920788|NCT03403413|12106529|P1|STARTED|Overall Study||5
4920789|NCT03403400|12106547|P3|NOT COMPLETED|Overall Study||2
4920790|NCT03403400|12106548|P2|NOT COMPLETED|Overall Study||0
4920791|NCT03403400|12106549|P1|NOT COMPLETED|Overall Study||2
4920792|NCT03403400|12106547|P3|COMPLETED|Overall Study||4
4920793|NCT03403400|12106548|P2|COMPLETED|Overall Study||6
4920794|NCT03403400|12106549|P1|COMPLETED|Overall Study||3
4920795|NCT03403400|12106547|P3|STARTED|Overall Study||6
4920796|NCT03403400|12106548|P2|STARTED|Overall Study||6
4920797|NCT03403400|12106549|P1|STARTED|Overall Study||5
4920798|NCT03403036|12106581|P1|NOT COMPLETED|Overall Study||5
4920799|NCT03403036|12106581|P1|COMPLETED|Overall Study||34
4920800|NCT03403036|12106581|P1|STARTED|Overall Study||39
4920801|NCT03402932|12106591|P4|NOT COMPLETED|Overall Study||0
4920802|NCT03402932|12106592|P3|NOT COMPLETED|Overall Study||0
4920803|NCT03402932|12106593|P2|NOT COMPLETED|Overall Study||0
4920804|NCT03402932|12106594|P1|NOT COMPLETED|Overall Study||0
4920805|NCT03402932|12106591|P4|COMPLETED|Overall Study||8
4920806|NCT03402932|12106592|P3|COMPLETED|Overall Study||8
4920807|NCT03402932|12106593|P2|COMPLETED|Overall Study||8
4920808|NCT03402932|12106594|P1|COMPLETED|Overall Study||13
4920809|NCT03402932|12106591|P4|STARTED|Overall Study||8
4920810|NCT03402932|12106592|P3|STARTED|Overall Study||8
4920811|NCT03402932|12106593|P2|STARTED|Overall Study||8
4920812|NCT03402932|12106594|P1|STARTED|Overall Study||13
4920813|NCT03402893|12106608|P1|NOT COMPLETED|Overall Study||1
4920814|NCT03402893|12106608|P1|COMPLETED|Overall Study||20
4920815|NCT03402893|12106608|P1|STARTED|Overall Study||21
4920816|NCT03402750|12106619|P2|NOT COMPLETED|Overall Study||1
4920817|NCT03402750|12106620|P1|NOT COMPLETED|Overall Study||2
4920818|NCT03402750|12106619|P2|COMPLETED|Overall Study||19
4920819|NCT03402750|12106620|P1|COMPLETED|Overall Study||18
4920820|NCT03402750|12106619|P2|STARTED|Overall Study||20
4920821|NCT03402750|12106620|P1|STARTED|Overall Study||20
4920822|NCT03401671|12106636|P2|NOT COMPLETED|Overall Study||0
4920823|NCT03401671|12106637|P1|NOT COMPLETED|Overall Study||0
4920824|NCT03401671|12106636|P2|COMPLETED|Overall Study||16
4920825|NCT03401671|12106637|P1|COMPLETED|Overall Study||16
4920826|NCT03401671|12106636|P2|STARTED|Overall Study||16
4920827|NCT03401671|12106637|P1|STARTED|Overall Study||16
4920828|NCT03400787|12106679|P2|NOT COMPLETED|Overall Study||8
4920829|NCT03400787|12106680|P1|NOT COMPLETED|Overall Study||2
4920830|NCT03400787|12106679|P2|COMPLETED|Overall Study||63
4920831|NCT03400787|12106680|P1|COMPLETED|Overall Study||64
4920832|NCT03400787|12106679|P2|3-Month Follow-up|Overall Study||63
4920833|NCT03400787|12106680|P1|3-Month Follow-up|Overall Study||64
4920834|NCT03400787|12106679|P2|STARTED|Overall Study||71
4920835|NCT03400787|12106680|P1|STARTED|Overall Study||66
4920836|NCT03400475|12106688|P2|NOT COMPLETED|Overall Study||0
4920837|NCT03400475|12106689|P1|NOT COMPLETED|Overall Study||0
4920838|NCT03400475|12106688|P2|COMPLETED|Overall Study||22
4920839|NCT03400475|12106689|P1|COMPLETED|Overall Study||24
4920840|NCT03400475|12106688|P2|STARTED|Overall Study||22
4920841|NCT03400475|12106689|P1|STARTED|Overall Study||24
4920842|NCT03400449|12106731|P2|NOT COMPLETED|Overall Study||0
4920843|NCT03400449|12106732|P1|NOT COMPLETED|Overall Study||1
4920844|NCT03400449|12106731|P2|COMPLETED|Overall Study||119
4920845|NCT03400449|12106732|P1|COMPLETED|Overall Study||120
4920846|NCT03400449|12106731|P2|STARTED|Overall Study||119
4920847|NCT03400449|12106732|P1|STARTED|Overall Study||121
4920848|NCT03400163|12106744|P2|NOT COMPLETED|Follow-up Period||0
4920849|NCT03400163|12106745|P1|NOT COMPLETED|Follow-up Period||0
4920850|NCT03400163|12106744|P2|COMPLETED|Follow-up Period||2
4920851|NCT03400163|12106745|P1|COMPLETED|Follow-up Period||1
4920852|NCT03400163|12106744|P2|STARTED|Follow-up Period||2
4920853|NCT03400163|12106745|P1|STARTED|Follow-up Period||1
4920854|NCT03400163|12106744|P2|NOT COMPLETED|Treatment Period||0
4920855|NCT03400163|12106745|P1|NOT COMPLETED|Treatment Period||0
4920856|NCT03400163|12106744|P2|COMPLETED|Treatment Period||2
4920857|NCT03400163|12106745|P1|COMPLETED|Treatment Period||1
4920858|NCT03400163|12106744|P2|STARTED|Treatment Period||2
4920859|NCT03400163|12106745|P1|STARTED|Treatment Period||1
4920860|NCT03398798|12106781|P4|NOT COMPLETED|Overall Study||0
4920861|NCT03398798|12106782|P3|NOT COMPLETED|Overall Study||0
4920862|NCT03398798|12106783|P2|NOT COMPLETED|Overall Study||0
4920863|NCT03398798|12106784|P1|NOT COMPLETED|Overall Study||0
4920864|NCT03398798|12106781|P4|COMPLETED|Overall Study||9
4920865|NCT03398798|12106782|P3|COMPLETED|Overall Study||9
4920866|NCT03398798|12106783|P2|COMPLETED|Overall Study||9
4920867|NCT03398798|12106784|P1|COMPLETED|Overall Study||9
4920868|NCT03398798|12106781|P4|STARTED|Overall Study||9
4920869|NCT03398798|12106782|P3|STARTED|Overall Study||9
4920870|NCT03398798|12106783|P2|STARTED|Overall Study||9
4920871|NCT03398798|12106784|P1|STARTED|Overall Study||9
4920872|NCT03398421|12106818|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4920873|NCT03398421|12106819|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4920874|NCT03398421|12106818|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
4920875|NCT03398421|12106819|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4920876|NCT03398421|12106818|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
4920877|NCT03398421|12106819|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
4920878|NCT03398421|12106818|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4920879|NCT03398421|12106819|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4920880|NCT03398421|12106818|P2|COMPLETED|Washout Period (Up to 14 Days)||0
4920881|NCT03398421|12106819|P1|COMPLETED|Washout Period (Up to 14 Days)||20
4920882|NCT03398421|12106818|P2|STARTED|Washout Period (Up to 14 Days)||0
4920883|NCT03398421|12106819|P1|STARTED|Washout Period (Up to 14 Days)||20
4920884|NCT03398421|12106818|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4920885|NCT03398421|12106819|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4920886|NCT03398421|12106818|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4920887|NCT03398421|12106819|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
4920888|NCT03398421|12106818|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
4920889|NCT03398421|12106819|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
4920890|NCT03398330|12106882|P2|NOT COMPLETED|Period 2||0
4920891|NCT03398330|12106883|P1|NOT COMPLETED|Period 2||1
4920892|NCT03398330|12106882|P2|COMPLETED|Period 2||17
4920893|NCT03398330|12106883|P1|COMPLETED|Period 2||19
4920894|NCT03398330|12106882|P2|STARTED|Period 2||17
4920895|NCT03398330|12106883|P1|STARTED|Period 2||20
4920896|NCT03398330|12106882|P2|NOT COMPLETED|Period 1||4
4920897|NCT03398330|12106883|P1|NOT COMPLETED|Period 1||1
4920898|NCT03398330|12106882|P2|COMPLETED|Period 1||17
4920899|NCT03398330|12106883|P1|COMPLETED|Period 1||20
4920900|NCT03398330|12106882|P2|STARTED|Period 1||21
4920901|NCT03398330|12106883|P1|STARTED|Period 1||21
4920902|NCT03398278|12106905|P2|NOT COMPLETED|Period 2||2
4920903|NCT03398278|12106906|P1|NOT COMPLETED|Period 2||2
4920904|NCT03398278|12106905|P2|COMPLETED|Period 2||17
4920905|NCT03398278|12106906|P1|COMPLETED|Period 2||16
4920906|NCT03398278|12106905|P2|STARTED|Period 2||19
4920907|NCT03398278|12106906|P1|STARTED|Period 2||18
4920908|NCT03398278|12106905|P2|NOT COMPLETED|Period 1||0
4920909|NCT03398278|12106906|P1|NOT COMPLETED|Period 1||1
4920910|NCT03398278|12106905|P2|COMPLETED|Period 1||19
4920911|NCT03398278|12106906|P1|COMPLETED|Period 1||18
4920912|NCT03398278|12106905|P2|STARTED|Period 1||19
4920913|NCT03398278|12106906|P1|STARTED|Period 1||19
4920914|NCT03397771|12106928|P2|NOT COMPLETED|Overall Study||7
4920915|NCT03397771|12106929|P1|NOT COMPLETED|Overall Study||8
4920916|NCT03397771|12106928|P2|COMPLETED|Overall Study||22
4920917|NCT03397771|12106929|P1|COMPLETED|Overall Study||45
4920918|NCT03397771|12106928|P2|STARTED|Overall Study||29
4920919|NCT03397771|12106929|P1|STARTED|Overall Study||53
4920920|NCT03396835|12106937|P1|NOT COMPLETED|Overall Study||2
4920921|NCT03396835|12106937|P1|COMPLETED|Overall Study||14
4920922|NCT03396835|12106937|P1|STARTED|Overall Study||16
4920923|NCT03395990|12106943|P2|NOT COMPLETED|Overall Study||0
4920924|NCT03395990|12106944|P1|NOT COMPLETED|Overall Study||0
4920925|NCT03395990|12106943|P2|COMPLETED|Overall Study||8
4920926|NCT03395990|12106944|P1|COMPLETED|Overall Study||8
4920927|NCT03395990|12106943|P2|STARTED|Overall Study||8
4920928|NCT03395990|12106944|P1|STARTED|Overall Study||8
4920929|NCT03395886|12106952|P2|NOT COMPLETED|Overall Study||38
4920930|NCT03395886|12106953|P1|NOT COMPLETED|Overall Study||52
4920931|NCT03395886|12106952|P2|COMPLETED|Overall Study||0
4920932|NCT03395886|12106953|P1|COMPLETED|Overall Study||0
4920933|NCT03395886|12106952|P2|STARTED|Overall Study||38
4920934|NCT03395886|12106953|P1|STARTED|Overall Study||52
4920935|NCT03394391|12106963|P2|NOT COMPLETED|Overall Study||2
4920936|NCT03394391|12106964|P1|NOT COMPLETED|Overall Study||1
4920937|NCT03394391|12106963|P2|COMPLETED|Overall Study||104
4920938|NCT03394391|12106964|P1|COMPLETED|Overall Study||105
4920939|NCT03394391|12106963|P2|STARTED|Overall Study||106
4920940|NCT03394391|12106964|P1|STARTED|Overall Study||106
4920941|NCT03393754|12106982|P2|NOT COMPLETED|Overall Study||38
4920942|NCT03393754|12106983|P1|NOT COMPLETED|Overall Study||26
4920943|NCT03393754|12106982|P2|COMPLETED|Overall Study||758
4920944|NCT03393754|12106983|P1|COMPLETED|Overall Study||785
4920945|NCT03393754|12106982|P2|STARTED|Overall Study||796
4920946|NCT03393754|12106983|P1|STARTED|Overall Study||811
4920947|NCT03393208|12106997|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4920948|NCT03393208|12106998|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4920949|NCT03393208|12106999|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4920950|NCT03393208|12107000|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4920951|NCT03393208|12106997|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
4920952|NCT03393208|12106998|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
4920953|NCT03393208|12106999|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
4920954|NCT03393208|12107000|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
4920955|NCT03393208|12106997|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
4920956|NCT03393208|12106998|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
4920957|NCT03393208|12106999|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
4920958|NCT03393208|12107000|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
4920959|NCT03393208|12106997|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4920960|NCT03393208|12106998|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4920961|NCT03393208|12106999|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4920962|NCT03393208|12107000|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4920963|NCT03393208|12106997|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
4920964|NCT03393208|12106998|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
4920965|NCT03393208|12106999|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
4920966|NCT03393208|12107000|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
4920967|NCT03393208|12106997|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
4920968|NCT03393208|12106998|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
4920969|NCT03393208|12106999|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
4920970|NCT03393208|12107000|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
4920971|NCT03392532|12107054|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
4920972|NCT03392532|12107055|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
4920973|NCT03392532|12107054|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
4920974|NCT03392532|12107055|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
4920975|NCT03392532|12107054|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
4920976|NCT03392532|12107055|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
4920977|NCT03392532|12107054|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
4920978|NCT03392532|12107055|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
4920979|NCT03392532|12107054|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
4920980|NCT03392532|12107055|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
4920981|NCT03392532|12107054|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
4920982|NCT03392532|12107055|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
4920983|NCT03392194|12107063|P2|NOT COMPLETED|Overall Study||2
4920984|NCT03392194|12107064|P1|NOT COMPLETED|Overall Study||2
4920985|NCT03392194|12107063|P2|COMPLETED|Overall Study||15
4920986|NCT03392194|12107064|P1|COMPLETED|Overall Study||14
4920987|NCT03392194|12107063|P2|STARTED|Overall Study||17
4920988|NCT03392194|12107064|P1|STARTED|Overall Study||16
4920989|NCT03391986|12107073|P3|NOT COMPLETED|Overall Study||0
4920990|NCT03391986|12107074|P2|NOT COMPLETED|Overall Study||0
4920991|NCT03391986|12107075|P1|NOT COMPLETED|Overall Study||0
4920992|NCT03391986|12107073|P3|COMPLETED|Overall Study||50
4920993|NCT03391986|12107074|P2|COMPLETED|Overall Study||50
4920994|NCT03391986|12107075|P1|COMPLETED|Overall Study||53
4920995|NCT03391986|12107073|P3|STARTED|Overall Study||50
4920996|NCT03391986|12107074|P2|STARTED|Overall Study||50
4920997|NCT03391986|12107075|P1|STARTED|Overall Study||53
4920998|NCT03391115|12107088|P2|NOT COMPLETED|Overall Study||0
4920999|NCT03391115|12107089|P1|NOT COMPLETED|Overall Study||0
4921000|NCT03391115|12107088|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
4921001|NCT03391115|12107089|P1|COMPLETED|Overall Study||20
4921002|NCT03391115|12107088|P2|STARTED|Overall Study||18
4921003|NCT03391115|12107089|P1|STARTED|Overall Study||20
4921004|NCT03390426|12107099|P2|NOT COMPLETED|Overall Study||1
4921005|NCT03390426|12107100|P1|NOT COMPLETED|Overall Study||0
4921006|NCT03390426|12107099|P2|COMPLETED|Overall Study||15
4921007|NCT03390426|12107100|P1|COMPLETED|Overall Study||15
4921008|NCT03390426|12107099|P2|STARTED|Overall Study||16
4921009|NCT03390426|12107100|P1|STARTED|Overall Study||15
4921010|NCT03390166|12107114|P2|NOT COMPLETED|Overall Study||10
4921011|NCT03390166|12107115|P1|NOT COMPLETED|Overall Study||12
4921012|NCT03390166|12107114|P2|COMPLETED|Overall Study||305
4921013|NCT03390166|12107115|P1|COMPLETED|Overall Study||618
4921014|NCT03390166|12107114|P2|STARTED|Overall Study||315
4921015|NCT03390166|12107115|P1|STARTED|Overall Study||630
4921016|NCT03387683|12107129|P2|NOT COMPLETED|Overall Study||0
4921017|NCT03387683|12107130|P1|NOT COMPLETED|Overall Study||2
4921018|NCT03387683|12107129|P2|COMPLETED|Overall Study||26
4921019|NCT03387683|12107130|P1|COMPLETED|Overall Study||25
4921020|NCT03387683|12107129|P2|STARTED|Overall Study||26
4921021|NCT03387683|12107130|P1|STARTED|Overall Study||27
4921022|NCT03387462|12107138|P1|NOT COMPLETED|Overall Study||1
4921023|NCT03387462|12107138|P1|COMPLETED|Overall Study||19
4921024|NCT03387462|12107138|P1|8 Weeks|Overall Study||19
4921025|NCT03387462|12107138|P1|4 Weeks|Overall Study||20
4921026|NCT03387462|12107138|P1|STARTED|Overall Study||20
4921027|NCT03387319|12107147|P2|NOT COMPLETED|Overall Study||0
4921028|NCT03387319|12107148|P1|NOT COMPLETED|Overall Study||0
4921029|NCT03387319|12107147|P2|COMPLETED|Overall Study||25
4921030|NCT03387319|12107148|P1|COMPLETED|Overall Study||25
4921031|NCT03387319|12107147|P2|STARTED|Overall Study||25
4921032|NCT03387319|12107148|P1|STARTED|Overall Study||25
4921033|NCT03387059|12107168|P2|NOT COMPLETED|Overall Study||4
4921034|NCT03387059|12107169|P1|NOT COMPLETED|Overall Study||5
4921035|NCT03387059|12107168|P2|COMPLETED|Overall Study||0
4921036|NCT03387059|12107169|P1|COMPLETED|Overall Study||0
4921037|NCT03387059|12107168|P2|STARTED|Overall Study||4
4921038|NCT03387059|12107169|P1|STARTED|Overall Study||5
4921039|NCT03387046|12107183|P2|NOT COMPLETED|Overall Study||1
4921040|NCT03387046|12107184|P1|NOT COMPLETED|Overall Study||1
4921041|NCT03387046|12107183|P2|COMPLETED|Overall Study||1
4921042|NCT03387046|12107184|P1|COMPLETED|Overall Study||4
4921043|NCT03387046|12107183|P2|STARTED|Overall Study||2
4921044|NCT03387046|12107184|P1|STARTED|Overall Study||5
4921045|NCT03386474|12107210|P2|NOT COMPLETED|Overall Study||1
4921046|NCT03386474|12107211|P1|NOT COMPLETED|Overall Study||1
4921047|NCT03386474|12107210|P2|COMPLETED|Overall Study||42
4921048|NCT03386474|12107211|P1|COMPLETED|Overall Study||106
4921049|NCT03386474|12107210|P2|STARTED|Overall Study||43
4921050|NCT03386474|12107211|P1|STARTED|Overall Study||107
4921051|NCT03386448|12107233|P2|NOT COMPLETED|Overall Study||2
4921052|NCT03386448|12107234|P1|NOT COMPLETED|Overall Study||0
4921053|NCT03386448|12107233|P2|COMPLETED|Overall Study||6
4921054|NCT03386448|12107234|P1|COMPLETED|Overall Study||6
4921055|NCT03386448|12107233|P2|STARTED|Overall Study||8
4921056|NCT03386448|12107234|P1|STARTED|Overall Study||6
4921057|NCT03386435|12107242|P2|NOT COMPLETED|Overall Study||7
4921058|NCT03386435|12107243|P1|NOT COMPLETED|Overall Study||5
4921059|NCT03386435|12107242|P2|COMPLETED|Overall Study||73
4921060|NCT03386435|12107243|P1|COMPLETED|Overall Study||75
4921061|NCT03386435|12107242|P2|STARTED|Overall Study||80
4921062|NCT03386435|12107243|P1|STARTED|Overall Study||80
4921063|NCT03384953|12107257|P2|NOT COMPLETED|Overall Study||8
4921064|NCT03384953|12107258|P1|NOT COMPLETED|Overall Study||40
4921065|NCT03384953|12107257|P2|COMPLETED|Overall Study||4
4921066|NCT03384953|12107258|P1|COMPLETED|Overall Study||51
4921067|NCT03384953|12107257|P2|Completed Treatment|Overall Study||6
4921068|NCT03384953|12107258|P1|Completed Treatment|Overall Study||68
4921069|NCT03384953|12107257|P2|STARTED|Overall Study||12
4921070|NCT03384953|12107258|P1|STARTED|Overall Study||91
4921071|NCT03384316|12107266|P2|NOT COMPLETED|Overall Study||1
4921072|NCT03384316|12107267|P1|NOT COMPLETED|Overall Study||0
4921073|NCT03384316|12107266|P2|COMPLETED|Overall Study||4
4921074|NCT03384316|12107267|P1|COMPLETED|Overall Study||6
4921075|NCT03384316|12107266|P2|STARTED|Overall Study||5
4921076|NCT03384316|12107267|P1|STARTED|Overall Study||6
4921077|NCT03383887|12107290|P2|NOT COMPLETED|Overall Study||1
4921078|NCT03383887|12107291|P1|NOT COMPLETED|Overall Study||0
4921079|NCT03383887|12107290|P2|COMPLETED|Overall Study||5
4921080|NCT03383887|12107291|P1|COMPLETED|Overall Study||5
4921081|NCT03383887|12107290|P2|STARTED|Overall Study||6
4921082|NCT03383887|12107291|P1|STARTED|Overall Study||5
4921083|NCT03383783|12107299|P1|NOT COMPLETED|Overall Study||2
4921084|NCT03383783|12107299|P1|COMPLETED|Overall Study||25
4921085|NCT03383783|12107299|P1|STARTED|Overall Study||27
4921086|NCT03383627|12107363|P1|NOT COMPLETED|Overall Study||0
4921087|NCT03383627|12107363|P1|COMPLETED|Overall Study||80
4921088|NCT03383627|12107363|P1|STARTED|Overall Study||80
4921089|NCT03383614|12107377|P4|NOT COMPLETED|Overall Study||0
4921090|NCT03383614|12107378|P3|NOT COMPLETED|Overall Study||0
4921091|NCT03383614|12107379|P2|NOT COMPLETED|Overall Study||1
4921092|NCT03383614|12107380|P1|NOT COMPLETED|Overall Study||0
4921093|NCT03383614|12107377|P4|COMPLETED|Overall Study||6
4921094|NCT03383614|12107378|P3|COMPLETED|Overall Study||6
4921095|NCT03383614|12107379|P2|COMPLETED|Overall Study||5
4921096|NCT03383614|12107380|P1|COMPLETED|Overall Study||6
4921097|NCT03383614|12107377|P4|STARTED|Overall Study||6
4921098|NCT03383614|12107378|P3|STARTED|Overall Study||6
4921099|NCT03383614|12107379|P2|STARTED|Overall Study||6
4921100|NCT03383614|12107380|P1|STARTED|Overall Study||6
4921101|NCT03383588|12107547|P3|NOT COMPLETED|Overall Study||0
4921102|NCT03383588|12107548|P2|NOT COMPLETED|Overall Study||0
4921103|NCT03383588|12107549|P1|NOT COMPLETED|Overall Study||0
4921104|NCT03383588|12107547|P3|COMPLETED|Overall Study||9
4921105|NCT03383588|12107548|P2|COMPLETED|Overall Study||9
4921106|NCT03383588|12107549|P1|COMPLETED|Overall Study||8
4921107|NCT03383588|12107547|P3|STARTED|Overall Study||9
4921108|NCT03383588|12107548|P2|STARTED|Overall Study||9
4921109|NCT03383588|12107549|P1|STARTED|Overall Study||8
4921110|NCT03383523|12107564|P7|NOT COMPLETED|Overall Study||0
4921111|NCT03383523|12107565|P6|NOT COMPLETED|Overall Study||0
4921112|NCT03383523|12107566|P5|NOT COMPLETED|Overall Study||0
4921113|NCT03383523|12107567|P4|NOT COMPLETED|Overall Study||0
4921114|NCT03383523|12107568|P3|NOT COMPLETED|Overall Study||1
4921115|NCT03383523|12107569|P2|NOT COMPLETED|Overall Study||0
4921116|NCT03383523|12107570|P1|NOT COMPLETED|Overall Study||1
4921117|NCT03383523|12107564|P7|COMPLETED|Overall Study||10
4921118|NCT03383523|12107565|P6|COMPLETED|Overall Study||12
4921119|NCT03383523|12107566|P5|COMPLETED|Overall Study||11
4921120|NCT03383523|12107567|P4|COMPLETED|Overall Study||12
4921121|NCT03383523|12107568|P3|COMPLETED|Overall Study||9
4921122|NCT03383523|12107569|P2|COMPLETED|Overall Study||11
4921123|NCT03383523|12107570|P1|COMPLETED|Overall Study||10
4921124|NCT03383523|12107564|P7|STARTED|Overall Study||10
4921125|NCT03383523|12107565|P6|STARTED|Overall Study||12
4921126|NCT03383523|12107566|P5|STARTED|Overall Study||11
4921127|NCT03383523|12107567|P4|STARTED|Overall Study||12
4921128|NCT03383523|12107568|P3|STARTED|Overall Study||10
4921129|NCT03383523|12107569|P2|STARTED|Overall Study||11
4921130|NCT03383523|12107570|P1|STARTED|Overall Study||11
4921131|NCT03382834|12107637|P2|NOT COMPLETED|Overall Study||1
4921132|NCT03382834|12107638|P1|NOT COMPLETED|Overall Study||1
4921133|NCT03382834|12107637|P2|COMPLETED|Overall Study||9
4921134|NCT03382834|12107638|P1|COMPLETED|Overall Study||20
4921135|NCT03382834|12107637|P2|STARTED|Overall Study||10
4921136|NCT03382834|12107638|P1|STARTED|Overall Study||21
4921137|NCT03382262|12107654|P4|NOT COMPLETED|Overall Study||1
4921138|NCT03382262|12107655|P3|NOT COMPLETED|Overall Study||1
4921139|NCT03382262|12107656|P2|NOT COMPLETED|Overall Study||0
4921140|NCT03382262|12107657|P1|NOT COMPLETED|Overall Study||0
4921141|NCT03382262|12107654|P4|COMPLETED|Overall Study||14
4921142|NCT03382262|12107655|P3|COMPLETED|Overall Study||14
4921143|NCT03382262|12107656|P2|COMPLETED|Overall Study||13
4921144|NCT03382262|12107657|P1|COMPLETED|Overall Study||12
4921145|NCT03382262|12107654|P4|STARTED|Overall Study||15
4921146|NCT03382262|12107655|P3|STARTED|Overall Study||15
4921147|NCT03382262|12107656|P2|STARTED|Overall Study||13
4921148|NCT03382262|12107657|P1|STARTED|Overall Study||12
4921149|NCT03381989|12107671|P1|NOT COMPLETED|Overall Study||8
4921150|NCT03381989|12107671|P1|COMPLETED|Overall Study||22
4921151|NCT03381989|12107671|P1|STARTED|Overall Study||30
4921152|NCT03381742|12107680|P4|NOT COMPLETED|Overall Study||0
4921153|NCT03381742|12107681|P3|NOT COMPLETED|Overall Study||0
4921154|NCT03381742|12107682|P2|NOT COMPLETED|Overall Study||0
4921155|NCT03381742|12107683|P1|NOT COMPLETED|Overall Study||0
4921156|NCT03381742|12107680|P4|COMPLETED|Overall Study||506
4921157|NCT03381742|12107681|P3|COMPLETED|Overall Study||1511
4921158|NCT03381742|12107682|P2|COMPLETED|Overall Study||501
4921159|NCT03381742|12107683|P1|COMPLETED|Overall Study||525
4921160|NCT03381742|12107680|P4|STARTED|Overall Study||506
4921161|NCT03381742|12107681|P3|STARTED|Overall Study||1511
4921162|NCT03381742|12107682|P2|STARTED|Overall Study||501
4921163|NCT03381742|12107683|P1|STARTED|Overall Study||525
4921164|NCT03381248|12107715|P2|NOT COMPLETED|Overall Study||6
4921165|NCT03381248|12107716|P1|NOT COMPLETED|Overall Study||13
4921166|NCT03381248|12107715|P2|COMPLETED|Overall Study||82
4921167|NCT03381248|12107716|P1|COMPLETED|Overall Study||76
4921168|NCT03381248|12107715|P2|STARTED|Overall Study||88
4921169|NCT03381248|12107716|P1|STARTED|Overall Study||89
4921170|NCT03380845|12107730|P1|NOT COMPLETED|Overall Study||0
4921171|NCT03380845|12107730|P1|COMPLETED|Overall Study||4
4921172|NCT03380845|12107730|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
4921173|NCT03380780|12107740|P1|NOT COMPLETED|Overall Study||0
4921174|NCT03380780|12107740|P1|COMPLETED|Overall Study||16
4921175|NCT03380780|12107740|P1|STARTED|Overall Study||16
4921176|NCT03380572|12107809|P2|NOT COMPLETED|Overall Study||0
4921177|NCT03380572|12107810|P1|NOT COMPLETED|Overall Study||0
4921178|NCT03380572|12107809|P2|COMPLETED|Overall Study||20
4921179|NCT03380572|12107810|P1|COMPLETED|Overall Study||20
4921180|NCT03380572|12107809|P2|STARTED|Overall Study||20
4921181|NCT03380572|12107810|P1|STARTED|Overall Study||20
4921182|NCT03380429|12107823|P5|NOT COMPLETED|Overall Study||5
4921183|NCT03380429|12107824|P4|NOT COMPLETED|Overall Study||10
4921184|NCT03380429|12107825|P3|NOT COMPLETED|Overall Study||11
4921185|NCT03380429|12107826|P2|NOT COMPLETED|Overall Study||7
4921186|NCT03380429|12107827|P1|NOT COMPLETED|Overall Study||5
4921187|NCT03380429|12107823|P5|COMPLETED|Overall Study||81
4921188|NCT03380429|12107824|P4|COMPLETED|Overall Study||78
4921189|NCT03380429|12107825|P3|COMPLETED|Overall Study||77
4921190|NCT03380429|12107826|P2|COMPLETED|Overall Study||81
4921191|NCT03380429|12107827|P1|COMPLETED|Overall Study||82
4921192|NCT03380429|12107823|P5|STARTED|Overall Study||86
4921193|NCT03380429|12107824|P4|STARTED|Overall Study||88
4921194|NCT03380429|12107825|P3|STARTED|Overall Study||88
4921195|NCT03380429|12107826|P2|STARTED|Overall Study||88
4921196|NCT03380429|12107827|P1|STARTED|Overall Study||87
4921197|NCT03380390|12107880|P1|NOT COMPLETED|Overall Study||3
4921198|NCT03380390|12107880|P1|COMPLETED|Overall Study||43
4921199|NCT03380390|12107880|P1|STARTED|Overall Study||46
4921200|NCT03379740|12107888|P2|NOT COMPLETED|Overall Study||0
4921201|NCT03379740|12107889|P1|NOT COMPLETED|Overall Study||0
4921202|NCT03379740|12107888|P2|COMPLETED|Overall Study||7
4921203|NCT03379740|12107889|P1|COMPLETED|Overall Study||8
4921204|NCT03379740|12107888|P2|STARTED|Overall Study||7
4921205|NCT03379740|12107889|P1|STARTED|Overall Study||8
4921206|NCT03379545|12107967|P1|NOT COMPLETED|Overall Study||0
4921207|NCT03379545|12107967|P1|COMPLETED|Overall Study||29
4921208|NCT03379545|12107967|P1|STARTED|Overall Study||29
4921209|NCT03379376|12107972|P1|NOT COMPLETED|Overall Study||5
4921210|NCT03379376|12107972|P1|COMPLETED|Overall Study||5
4921211|NCT03379376|12107972|P1|STARTED|Overall Study||10
4921212|NCT03379233|12107982|P2|NOT COMPLETED|Overall Study||6
4921213|NCT03379233|12107983|P1|NOT COMPLETED|Overall Study||1
4921214|NCT03379233|12107982|P2|COMPLETED|Overall Study||0
4921215|NCT03379233|12107983|P1|COMPLETED|Overall Study||0
4921216|NCT03379233|12107982|P2|STARTED|Overall Study||6
4921217|NCT03379233|12107983|P1|STARTED|Overall Study||1
4921218|NCT03378973|12107997|P2|NOT COMPLETED|Overall Study||0
4921219|NCT03378973|12107998|P1|NOT COMPLETED|Overall Study||0
4921220|NCT03378973|12107997|P2|COMPLETED|Overall Study||3
4921221|NCT03378973|12107998|P1|COMPLETED|Overall Study||4
4921222|NCT03378973|12107997|P2|STARTED|Overall Study||3
4921223|NCT03378973|12107998|P1|STARTED|Overall Study||4
4921224|NCT03378076|12108006|P2|NOT COMPLETED|Overall Study||0
4921225|NCT03378076|12108007|P1|NOT COMPLETED|Overall Study||0
4921226|NCT03378076|12108006|P2|COMPLETED|Overall Study||12
4921227|NCT03378076|12108007|P1|COMPLETED|Overall Study||12
4921228|NCT03378076|12108006|P2|STARTED|Overall Study||12
4921229|NCT03378076|12108007|P1|STARTED|Overall Study||12
4921230|NCT03376516|12108015|P1|NOT COMPLETED|Overall Study||2
4921231|NCT03376516|12108015|P1|COMPLETED|Overall Study||9
4921232|NCT03376516|12108015|P1|SURG Population|Overall Study||2
4921233|NCT03376516|12108015|P1|PP Population|Overall Study||9
4921234|NCT03376516|12108015|P1|PK Population|Overall Study||10
4921235|NCT03376516|12108015|P1|FAS Population|Overall Study||10
4921236|NCT03376516|12108015|P1|SAF Population|Overall Study||10
4921237|NCT03376516|12108015|P1|Received Treatment|Overall Study||10
4921238|NCT03376516|12108015|P1|STARTED|Overall Study||11
4921239|NCT03376295|12108047|P2|NOT COMPLETED|Overall Study||0
4921240|NCT03376295|12108048|P1|NOT COMPLETED|Overall Study||0
4921241|NCT03376295|12108047|P2|COMPLETED|Overall Study||1977
4921242|NCT03376295|12108048|P1|COMPLETED|Overall Study||1977
4921243|NCT03376295|12108047|P2|STARTED|Overall Study||1977
4921244|NCT03376295|12108048|P1|STARTED|Overall Study||1977
4921245|NCT03376061|12108060|P2|NOT COMPLETED|Overall Study||0
4921246|NCT03376061|12108061|P1|NOT COMPLETED|Overall Study||0
4921247|NCT03376061|12108060|P2|COMPLETED|Overall Study||48
4921248|NCT03376061|12108061|P1|COMPLETED|Overall Study||49
4921249|NCT03376061|12108060|P2|STARTED|Overall Study||48
4921250|NCT03376061|12108061|P1|STARTED|Overall Study||49
4921251|NCT03375294|12108079|P1|NOT COMPLETED|Overall Study||0
4921252|NCT03375294|12108079|P1|COMPLETED|Overall Study||3
4921253|NCT03375294|12108079|P1|STARTED|Overall Study||3
4921254|NCT03374995|12108085|P2|NOT COMPLETED|Overall Study||1
4921255|NCT03374995|12108086|P1|NOT COMPLETED|Overall Study||0
4921256|NCT03374995|12108085|P2|COMPLETED|Overall Study||11
4921257|NCT03374995|12108086|P1|COMPLETED|Overall Study||13
4921258|NCT03374995|12108085|P2|STARTED|Overall Study||12
4921259|NCT03374995|12108086|P1|STARTED|Overall Study||13
4921260|NCT03374488|12108100|P2|NOT COMPLETED|Overall Study||37
4921261|NCT03374488|12108101|P1|NOT COMPLETED|Overall Study||41
4921262|NCT03374488|12108100|P2|COMPLETED|Overall Study||5
4921263|NCT03374488|12108101|P1|COMPLETED|Overall Study||1
4921264|NCT03374488|12108100|P2|All Participants as Treated (APaT)|Overall Study||41
4921265|NCT03374488|12108101|P1|All Participants as Treated (APaT)|Overall Study||42
4921266|NCT03374488|12108100|P2|Intention-to-Treat (ITT)|Overall Study||42
4921267|NCT03374488|12108101|P1|Intention-to-Treat (ITT)|Overall Study||42
4921268|NCT03374488|12108100|P2|STARTED|Overall Study||42
4921269|NCT03374488|12108101|P1|STARTED|Overall Study||42
4921270|NCT03374189|12108113|P2|NOT COMPLETED|Overall Study||0
4921271|NCT03374189|12108114|P1|NOT COMPLETED|Overall Study||1
4921272|NCT03374189|12108113|P2|COMPLETED|Overall Study||39
4921273|NCT03374189|12108114|P1|COMPLETED|Overall Study||39
4921274|NCT03374189|12108113|P2|STARTED|Overall Study||39
4921275|NCT03374189|12108114|P1|STARTED|Overall Study||40
4921276|NCT03374176|12108134|P2|NOT COMPLETED|Overall Study||0
4921277|NCT03374176|12108135|P1|NOT COMPLETED|Overall Study||0
4921278|NCT03374176|12108134|P2|COMPLETED|Overall Study||21
4921279|NCT03374176|12108135|P1|COMPLETED|Overall Study||21
4921280|NCT03374176|12108134|P2|STARTED|Overall Study||21
4921281|NCT03374176|12108135|P1|STARTED|Overall Study||21
4921282|NCT03373890|12108149|P2|NOT COMPLETED|Overall Study||0
4921283|NCT03373890|12108150|P1|NOT COMPLETED|Overall Study||0
4921284|NCT03373890|12108149|P2|COMPLETED|Overall Study||6
4921285|NCT03373890|12108150|P1|COMPLETED|Overall Study||6
4921286|NCT03373890|12108149|P2|STARTED|Overall Study||6
4921287|NCT03373890|12108150|P1|STARTED|Overall Study||6
4921288|NCT03373591|12108173|P3|NOT COMPLETED|Overall Study||0
4921289|NCT03373591|12108174|P2|NOT COMPLETED|Overall Study||0
4921290|NCT03373591|12108175|P1|NOT COMPLETED|Overall Study||0
4921291|NCT03373591|12108173|P3|COMPLETED|Overall Study||73
4921292|NCT03373591|12108174|P2|COMPLETED|Overall Study||71
4921293|NCT03373591|12108175|P1|COMPLETED|Overall Study||75
4921294|NCT03373591|12108173|P3|STARTED|Overall Study||73
4921295|NCT03373591|12108174|P2|STARTED|Overall Study||71
4921296|NCT03373591|12108175|P1|STARTED|Overall Study||75
4921297|NCT03373162|12108204|P1|NOT COMPLETED|Overall Study||0
4921298|NCT03373162|12108204|P1|COMPLETED|Overall Study||10
4921299|NCT03373162|12108204|P1|STARTED|Overall Study||10
4921300|NCT03373006|12108210|P1|NOT COMPLETED|Overall Study||0
4921301|NCT03373006|12108210|P1|COMPLETED|Overall Study||20
4921302|NCT03373006|12108210|P1|STARTED|Overall Study||20
4921303|NCT03372603|12108214|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
4921304|NCT03372603|12108215|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
4921305|NCT03372603|12108214|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
4921306|NCT03372603|12108215|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
4921307|NCT03372603|12108214|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
4921308|NCT03372603|12108215|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
4921309|NCT03372603|12108214|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
4921310|NCT03372603|12108215|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
4921311|NCT03372603|12108214|P2|COMPLETED|Wash-out Period (14-21 Days)||8
4921312|NCT03372603|12108215|P1|COMPLETED|Wash-out Period (14-21 Days)||8
4921313|NCT03372603|12108214|P2|STARTED|Wash-out Period (14-21 Days)||8
4921314|NCT03372603|12108215|P1|STARTED|Wash-out Period (14-21 Days)||9
4921315|NCT03372603|12108214|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
4921316|NCT03372603|12108215|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
4921317|NCT03372603|12108214|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
4921318|NCT03372603|12108215|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
4921319|NCT03372603|12108214|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
4921320|NCT03372603|12108215|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
4921321|NCT03372551|12108257|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4921322|NCT03372551|12108258|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4921323|NCT03372551|12108257|P2|COMPLETED|Second Intervention (1 Week)||16
4921324|NCT03372551|12108258|P1|COMPLETED|Second Intervention (1 Week)||16
4921325|NCT03372551|12108257|P2|STARTED|Second Intervention (1 Week)||16
4921326|NCT03372551|12108258|P1|STARTED|Second Intervention (1 Week)||16
4921327|NCT03372551|12108257|P2|NOT COMPLETED|First Intervention (1 Week)||0
4921328|NCT03372551|12108258|P1|NOT COMPLETED|First Intervention (1 Week)||1
4921329|NCT03372551|12108257|P2|COMPLETED|First Intervention (1 Week)||16
4921330|NCT03372551|12108258|P1|COMPLETED|First Intervention (1 Week)||16
4921331|NCT03372551|12108257|P2|STARTED|First Intervention (1 Week)||16
4921332|NCT03372551|12108258|P1|STARTED|First Intervention (1 Week)||17
4921333|NCT03372382|12108277|P2|NOT COMPLETED|Overall Study||4
4921334|NCT03372382|12108278|P1|NOT COMPLETED|Overall Study||9
4921335|NCT03372382|12108277|P2|COMPLETED|Overall Study||81
4921336|NCT03372382|12108278|P1|COMPLETED|Overall Study||76
4921337|NCT03372382|12108277|P2|STARTED|Overall Study||85
4921338|NCT03372382|12108278|P1|STARTED|Overall Study||85
4921339|NCT03372369|12108288|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
4921340|NCT03372369|12108289|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
4921341|NCT03372369|12108288|P2|COMPLETED|Intervention and Follow-Up Period||470
4921342|NCT03372369|12108289|P1|COMPLETED|Intervention and Follow-Up Period||466
4921343|NCT03372369|12108288|P2|STARTED|Intervention and Follow-Up Period||473
4921344|NCT03372369|12108289|P1|STARTED|Intervention and Follow-Up Period||469
4921345|NCT03372369|12108288|P2|NOT COMPLETED|Qualification Period||22
4921346|NCT03372369|12108289|P1|NOT COMPLETED|Qualification Period||26
4921347|NCT03372369|12108288|P2|COMPLETED|Qualification Period||473
4921348|NCT03372369|12108289|P1|COMPLETED|Qualification Period||469
4921349|NCT03372369|12108288|P2|STARTED|Qualification Period||495
4921350|NCT03372369|12108289|P1|STARTED|Qualification Period||495
4921351|NCT03371459|12108301|P2|NOT COMPLETED|Period 2||0
4921352|NCT03371459|12108302|P1|NOT COMPLETED|Period 2||0
4921353|NCT03371459|12108301|P2|COMPLETED|Period 2||22
4921354|NCT03371459|12108302|P1|COMPLETED|Period 2||23
4921355|NCT03371459|12108301|P2|STARTED|Period 2||22
4921356|NCT03371459|12108302|P1|STARTED|Period 2||23
4921357|NCT03371459|12108301|P2|NOT COMPLETED|Washout||1
4921358|NCT03371459|12108302|P1|NOT COMPLETED|Washout||0
4921359|NCT03371459|12108301|P2|COMPLETED|Washout||22
4921360|NCT03371459|12108302|P1|COMPLETED|Washout||23
4921361|NCT03371459|12108301|P2|STARTED|Washout||23
4921362|NCT03371459|12108302|P1|STARTED|Washout||23
4921363|NCT03371459|12108301|P2|NOT COMPLETED|Period 1||0
4921364|NCT03371459|12108302|P1|NOT COMPLETED|Period 1||0
4921365|NCT03371459|12108301|P2|COMPLETED|Period 1||23
4921366|NCT03371459|12108302|P1|COMPLETED|Period 1||23
4921367|NCT03371459|12108301|P2|STARTED|Period 1||23
4921368|NCT03371459|12108302|P1|STARTED|Period 1||23
4921369|NCT03371381|12108310|P1|NOT COMPLETED|Overall Study||12
4921370|NCT03371381|12108310|P1|COMPLETED|Overall Study||0
4921371|NCT03371381|12108310|P1|STARTED|Overall Study||12
4921372|NCT03370536|12108322|P1|NOT COMPLETED|Overall Study||1
4921373|NCT03370536|12108322|P1|COMPLETED|Overall Study||0
4921374|NCT03370536|12108322|P1|STARTED|Overall Study||1
4921375|NCT03370419|12108331|P1|NOT COMPLETED|Overall Study||16
4921376|NCT03370419|12108331|P1|COMPLETED|Overall Study||24
4921377|NCT03370419|12108331|P1|STARTED|Overall Study||40
4921378|NCT03370289|12108335|P1|NOT COMPLETED|Overall Study||5
4921379|NCT03370289|12108335|P1|COMPLETED|Overall Study||50
4921380|NCT03370289|12108335|P1|STARTED|Overall Study||55
4921381|NCT03370042|12108354|P2|NOT COMPLETED|Overall Study||0
4921382|NCT03370042|12108355|P1|NOT COMPLETED|Overall Study||0
4921383|NCT03370042|12108354|P2|COMPLETED|Overall Study||10
4921384|NCT03370042|12108355|P1|COMPLETED|Overall Study||10
4921385|NCT03370042|12108354|P2|STARTED|Overall Study||10
4921386|NCT03370042|12108355|P1|STARTED|Overall Study||10
4921387|NCT03369704|12108371|P2|NOT COMPLETED|Follow-up Epoch||0
4921388|NCT03369704|12108372|P1|NOT COMPLETED|Follow-up Epoch||1
4921389|NCT03369704|12108371|P2|COMPLETED|Follow-up Epoch||174
4921390|NCT03369704|12108372|P1|COMPLETED|Follow-up Epoch||160
4921391|NCT03369704|12108371|P2|STARTED|Follow-up Epoch||174
4921392|NCT03369704|12108372|P1|STARTED|Follow-up Epoch||161
4921393|NCT03369704|12108371|P2|NOT COMPLETED|Treatment Epoch||3
4921394|NCT03369704|12108372|P1|NOT COMPLETED|Treatment Epoch||4
4921395|NCT03369704|12108371|P2|COMPLETED|Treatment Epoch||172
4921396|NCT03369704|12108372|P1|COMPLETED|Treatment Epoch||158
4921397|NCT03369704|12108371|P2|STARTED|Treatment Epoch||175
4921398|NCT03369704|12108372|P1|STARTED|Treatment Epoch||162
4921399|NCT03369340|12108405|P6|NOT COMPLETED|Day 4||0
4921400|NCT03369340|12108406|P5|NOT COMPLETED|Day 4||0
4921401|NCT03369340|12108407|P4|NOT COMPLETED|Day 4||0
4921402|NCT03369340|12108408|P3|NOT COMPLETED|Day 4||0
4921403|NCT03369340|12108409|P2|NOT COMPLETED|Day 4||0
4921404|NCT03369340|12108410|P1|NOT COMPLETED|Day 4||0
4921405|NCT03369340|12108405|P6|COMPLETED|Day 4||3
4921406|NCT03369340|12108406|P5|COMPLETED|Day 4||3
4921407|NCT03369340|12108407|P4|COMPLETED|Day 4||3
4921408|NCT03369340|12108408|P3|COMPLETED|Day 4||3
4921409|NCT03369340|12108409|P2|COMPLETED|Day 4||3
4921410|NCT03369340|12108410|P1|COMPLETED|Day 4||3
4921411|NCT03369340|12108405|P6|STARTED|Day 4||3
4921412|NCT03369340|12108406|P5|STARTED|Day 4||3
4921413|NCT03369340|12108407|P4|STARTED|Day 4||3
4921414|NCT03369340|12108408|P3|STARTED|Day 4||3
4921415|NCT03369340|12108409|P2|STARTED|Day 4||3
4921416|NCT03369340|12108410|P1|STARTED|Day 4||3
4921417|NCT03369340|12108405|P6|NOT COMPLETED|Day 3||0
4921418|NCT03369340|12108406|P5|NOT COMPLETED|Day 3||0
4921419|NCT03369340|12108407|P4|NOT COMPLETED|Day 3||0
4921420|NCT03369340|12108408|P3|NOT COMPLETED|Day 3||0
4921421|NCT03369340|12108409|P2|NOT COMPLETED|Day 3||0
4921422|NCT03369340|12108410|P1|NOT COMPLETED|Day 3||0
4921423|NCT03369340|12108405|P6|COMPLETED|Day 3||3
4921424|NCT03369340|12108406|P5|COMPLETED|Day 3||3
4921425|NCT03369340|12108407|P4|COMPLETED|Day 3||3
4921426|NCT03369340|12108408|P3|COMPLETED|Day 3||3
4921427|NCT03369340|12108409|P2|COMPLETED|Day 3||3
4921428|NCT03369340|12108410|P1|COMPLETED|Day 3||3
4921429|NCT03369340|12108405|P6|STARTED|Day 3||3
4921430|NCT03369340|12108406|P5|STARTED|Day 3||3
4921431|NCT03369340|12108407|P4|STARTED|Day 3||3
4921432|NCT03369340|12108408|P3|STARTED|Day 3||3
4921433|NCT03369340|12108409|P2|STARTED|Day 3||3
4921434|NCT03369340|12108410|P1|STARTED|Day 3||3
4921435|NCT03369340|12108405|P6|NOT COMPLETED|Day 2||0
4921436|NCT03369340|12108406|P5|NOT COMPLETED|Day 2||0
4921437|NCT03369340|12108407|P4|NOT COMPLETED|Day 2||0
4921438|NCT03369340|12108408|P3|NOT COMPLETED|Day 2||0
4921439|NCT03369340|12108409|P2|NOT COMPLETED|Day 2||0
4921440|NCT03369340|12108410|P1|NOT COMPLETED|Day 2||0
4921441|NCT03369340|12108405|P6|COMPLETED|Day 2||3
4921442|NCT03369340|12108406|P5|COMPLETED|Day 2||3
4921443|NCT03369340|12108407|P4|COMPLETED|Day 2||3
4921444|NCT03369340|12108408|P3|COMPLETED|Day 2||3
4921445|NCT03369340|12108409|P2|COMPLETED|Day 2||3
4921446|NCT03369340|12108410|P1|COMPLETED|Day 2||3
4921447|NCT03369340|12108405|P6|STARTED|Day 2||3
4921448|NCT03369340|12108406|P5|STARTED|Day 2||3
4921449|NCT03369340|12108407|P4|STARTED|Day 2||3
4921450|NCT03369340|12108408|P3|STARTED|Day 2||3
4921451|NCT03369340|12108409|P2|STARTED|Day 2||3
4921452|NCT03369340|12108410|P1|STARTED|Day 2||3
4921453|NCT03368937|12108488|P1|NOT COMPLETED|Overall Study||0
4921454|NCT03368937|12108488|P1|COMPLETED|Overall Study||5
4921455|NCT03368937|12108488|P1|STARTED|Overall Study||5
4921456|NCT03368807|12108492|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
4921457|NCT03368807|12108492|P1|COMPLETED|Period 2 (Unblinded CGM)||73
4921458|NCT03368807|12108492|P1|STARTED|Period 2 (Unblinded CGM)||73
4921459|NCT03368807|12108492|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
4921460|NCT03368807|12108492|P1|COMPLETED|Period 1 (Blinded CGM)||73
4921461|NCT03368807|12108492|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
4921462|NCT03368807|12108492|P1|STARTED|Period 1 (Blinded CGM)||79
4921463|NCT03368170|12108508|P2|NOT COMPLETED|Overall Study||1
4921464|NCT03368170|12108509|P1|NOT COMPLETED|Overall Study||2
4921465|NCT03368170|12108508|P2|COMPLETED|Overall Study||35
4921466|NCT03368170|12108509|P1|COMPLETED|Overall Study||37
4921467|NCT03368170|12108508|P2|STARTED|Overall Study||36
4921468|NCT03368170|12108509|P1|STARTED|Overall Study||39
4921469|NCT03368053|12108521|P1|NOT COMPLETED|Overall Study||0
4921470|NCT03368053|12108521|P1|COMPLETED|Overall Study||36
4921471|NCT03368053|12108521|P1|STARTED|Overall Study||36
4921472|NCT03366207|12108536|P1|NOT COMPLETED|Overall Study||8
4921473|NCT03366207|12108536|P1|COMPLETED|Overall Study||242
4921474|NCT03366207|12108536|P1|STARTED|Overall Study||250
4921475|NCT03365934|12108541|P1|NOT COMPLETED|Overall Study||2
4921476|NCT03365934|12108541|P1|COMPLETED|Overall Study||33
4921477|NCT03365934|12108541|P1|STARTED|Overall Study||35
4921478|NCT03365778|12108817|P3|NOT COMPLETED|Overall Study||0
4921479|NCT03365778|12108818|P2|NOT COMPLETED|Overall Study||0
4921480|NCT03365778|12108819|P1|NOT COMPLETED|Overall Study||0
4921481|NCT03365778|12108817|P3|COMPLETED|Overall Study||53
4921482|NCT03365778|12108818|P2|COMPLETED|Overall Study||17
4921483|NCT03365778|12108819|P1|COMPLETED|Overall Study||16
4921484|NCT03365778|12108817|P3|STARTED|Overall Study||53
4921485|NCT03365778|12108818|P2|STARTED|Overall Study||17
4921486|NCT03365778|12108819|P1|STARTED|Overall Study||16
4921487|NCT03365011|12108831|P2|NOT COMPLETED|Overall Study||2
4921488|NCT03365011|12108832|P1|NOT COMPLETED|Overall Study||1
4921489|NCT03365011|12108831|P2|COMPLETED|Overall Study||18
4921490|NCT03365011|12108832|P1|COMPLETED|Overall Study||19
4921491|NCT03365011|12108831|P2|STARTED|Overall Study||20
4921492|NCT03365011|12108832|P1|STARTED|Overall Study||20
4921493|NCT03364608|12108842|P1|NOT COMPLETED|Overall Study||8
4921494|NCT03364608|12108842|P1|COMPLETED|Overall Study||78
4921495|NCT03364608|12108842|P1|Proventil 180 µg|Overall Study||79
4921496|NCT03364608|12108842|P1|Proventil 90 µg|Overall Study||82
4921497|NCT03364608|12108842|P1|AS MDI 180 µg|Overall Study||81
4921498|NCT03364608|12108842|P1|AS MDI 90 µg|Overall Study||81
4921499|NCT03364608|12108842|P1|Placebo MDI|Overall Study||82
4921500|NCT03364608|12108842|P1|STARTED|Overall Study||86
4921501|NCT03364335|12108869|P5|NOT COMPLETED|Overall Study||11
4921502|NCT03364335|12108870|P4|NOT COMPLETED|Overall Study||13
4921503|NCT03364335|12108871|P3|NOT COMPLETED|Overall Study||11
4921504|NCT03364335|12108872|P2|NOT COMPLETED|Overall Study||11
4921505|NCT03364335|12108873|P1|NOT COMPLETED|Overall Study||10
4921506|NCT03364335|12108869|P5|COMPLETED|Overall Study||41
4921507|NCT03364335|12108870|P4|COMPLETED|Overall Study||37
4921508|NCT03364335|12108871|P3|COMPLETED|Overall Study||42
4921509|NCT03364335|12108872|P2|COMPLETED|Overall Study||40
4921510|NCT03364335|12108873|P1|COMPLETED|Overall Study||42
4921511|NCT03364335|12108869|P5|STARTED|Overall Study||52
4921512|NCT03364335|12108870|P4|STARTED|Overall Study||50
4921513|NCT03364335|12108871|P3|STARTED|Overall Study||53
4921514|NCT03364335|12108872|P2|STARTED|Overall Study||51
4921515|NCT03364335|12108873|P1|STARTED|Overall Study||52
4921516|NCT03363906|12108945|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
4921517|NCT03363906|12108946|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
4921518|NCT03363906|12108945|P2|COMPLETED|Period 2 (Test or Reference)||9
4921519|NCT03363906|12108946|P1|COMPLETED|Period 2 (Test or Reference)||10
4921520|NCT03363906|12108945|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
4921521|NCT03363906|12108946|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
4921522|NCT03363906|12108945|P2|STARTED|Period 2 (Test or Reference)||10
4921523|NCT03363906|12108946|P1|STARTED|Period 2 (Test or Reference)||14
4921524|NCT03363906|12108945|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
4921525|NCT03363906|12108946|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
4921526|NCT03363906|12108945|P2|COMPLETED|Period 1 (Reference or Test)||10
4921527|NCT03363906|12108946|P1|COMPLETED|Period 1 (Reference or Test)||14
4921528|NCT03363906|12108945|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
4921529|NCT03363906|12108946|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
4921530|NCT03363906|12108945|P2|STARTED|Period 1 (Reference or Test)||12
4921531|NCT03363906|12108946|P1|STARTED|Period 1 (Reference or Test)||15
4921532|NCT03363633|12108954|P1|NOT COMPLETED|Overall Study||12
4921533|NCT03363633|12108954|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
4921534|NCT03363633|12108954|P1|STARTED|Overall Study||12
4921535|NCT03362944|12108962|P2|NOT COMPLETED|Second Intervention||0
4921536|NCT03362944|12108963|P1|NOT COMPLETED|Second Intervention||0
4921537|NCT03362944|12108962|P2|COMPLETED|Second Intervention||8
4921538|NCT03362944|12108963|P1|COMPLETED|Second Intervention||8
4921539|NCT03362944|12108962|P2|STARTED|Second Intervention||8
4921540|NCT03362944|12108963|P1|STARTED|Second Intervention||8
4921541|NCT03362944|12108962|P2|NOT COMPLETED|Single Week Washout Period||0
4921542|NCT03362944|12108963|P1|NOT COMPLETED|Single Week Washout Period||0
4921543|NCT03362944|12108962|P2|COMPLETED|Single Week Washout Period||8
4921544|NCT03362944|12108963|P1|COMPLETED|Single Week Washout Period||8
4921545|NCT03362944|12108962|P2|STARTED|Single Week Washout Period||8
4921546|NCT03362944|12108963|P1|STARTED|Single Week Washout Period||8
4921547|NCT03362944|12108962|P2|NOT COMPLETED|First Intervention||0
4921548|NCT03362944|12108963|P1|NOT COMPLETED|First Intervention||0
4921549|NCT03362944|12108962|P2|COMPLETED|First Intervention||8
4921550|NCT03362944|12108963|P1|COMPLETED|First Intervention||8
4921551|NCT03362944|12108962|P2|STARTED|First Intervention||8
4921552|NCT03362944|12108963|P1|STARTED|First Intervention||8
4921553|NCT03362879|12108979|P1|NOT COMPLETED|Overall Study||0
4921554|NCT03362879|12108979|P1|COMPLETED|Overall Study||409
4921555|NCT03362879|12108979|P1|STARTED|Overall Study||409
4921556|NCT03361917|12108997|P2|NOT COMPLETED|Overall Study||0
4921557|NCT03361917|12108998|P1|NOT COMPLETED|Overall Study||0
4921558|NCT03361917|12108997|P2|COMPLETED|Overall Study||101
4921559|NCT03361917|12108998|P1|COMPLETED|Overall Study||99
4921560|NCT03361917|12108997|P2|STARTED|Overall Study||101
4921561|NCT03361917|12108998|P1|STARTED|Overall Study||99
4921562|NCT03361865|12109016|P2|NOT COMPLETED|Overall Study||49
4921563|NCT03361865|12109017|P1|NOT COMPLETED|Overall Study||43
4921564|NCT03361865|12109016|P2|COMPLETED|Overall Study||0
4921565|NCT03361865|12109017|P1|COMPLETED|Overall Study||1
4921566|NCT03361865|12109016|P2|All Participants as Treated (APaT)|Overall Study||49
4921567|NCT03361865|12109017|P1|All Participants as Treated (APaT)|Overall Study||43
4921568|NCT03361865|12109016|P2|Intention-to-Treat (ITT)|Overall Study||49
4921569|NCT03361865|12109017|P1|Intention-to-Treat (ITT)|Overall Study||44
4921570|NCT03361865|12109016|P2|STARTED|Overall Study||49
4921571|NCT03361865|12109017|P1|STARTED|Overall Study||44
4921572|NCT03361228|12109029|P2|NOT COMPLETED|Overall Study||1
4921573|NCT03361228|12109030|P1|NOT COMPLETED|Overall Study||4
4921574|NCT03361228|12109029|P2|COMPLETED|Overall Study||0
4921575|NCT03361228|12109030|P1|COMPLETED|Overall Study||0
4921576|NCT03361228|12109029|P2|STARTED|Overall Study||1
4921577|NCT03361228|12109030|P1|STARTED|Overall Study||4
4921578|NCT03361176|12109052|P2|NOT COMPLETED|Overall Study||5
4921579|NCT03361176|12109053|P1|NOT COMPLETED|Overall Study||1
4921580|NCT03361176|12109052|P2|COMPLETED|Overall Study||15
4921581|NCT03361176|12109053|P1|COMPLETED|Overall Study||9
4921582|NCT03361176|12109052|P2|STARTED|Overall Study||20
4921583|NCT03361176|12109053|P1|STARTED|Overall Study||10
4921584|NCT03360903|12109065|P2|NOT COMPLETED|Second Intervention||0
4921585|NCT03360903|12109066|P1|NOT COMPLETED|Second Intervention||0
4921586|NCT03360903|12109065|P2|COMPLETED|Second Intervention||4
4921587|NCT03360903|12109066|P1|COMPLETED|Second Intervention||4
4921588|NCT03360903|12109065|P2|STARTED|Second Intervention||4
4921589|NCT03360903|12109066|P1|STARTED|Second Intervention||4
4921590|NCT03360903|12109065|P2|NOT COMPLETED|Washout (2 Weeks)||0
4921591|NCT03360903|12109066|P1|NOT COMPLETED|Washout (2 Weeks)||0
4921592|NCT03360903|12109065|P2|COMPLETED|Washout (2 Weeks)||4
4921593|NCT03360903|12109066|P1|COMPLETED|Washout (2 Weeks)||4
4921594|NCT03360903|12109065|P2|STARTED|Washout (2 Weeks)||4
4921595|NCT03360903|12109066|P1|STARTED|Washout (2 Weeks)||4
4921596|NCT03360903|12109065|P2|NOT COMPLETED|First Intervention||0
4921597|NCT03360903|12109066|P1|NOT COMPLETED|First Intervention||0
4921598|NCT03360903|12109065|P2|COMPLETED|First Intervention||4
4921599|NCT03360903|12109066|P1|COMPLETED|First Intervention||4
4921600|NCT03360903|12109065|P2|STARTED|First Intervention||4
4921601|NCT03360903|12109066|P1|STARTED|First Intervention||4
4921602|NCT03360071|12109086|P2|NOT COMPLETED|Overall Study||0
4921603|NCT03360071|12109087|P1|NOT COMPLETED|Overall Study||1
4921604|NCT03360071|12109086|P2|COMPLETED|Overall Study||14
4921605|NCT03360071|12109087|P1|COMPLETED|Overall Study||16
4921606|NCT03360071|12109086|P2|STARTED|Overall Study||14
4921607|NCT03360071|12109087|P1|STARTED|Overall Study||17
4921608|NCT03359629|12109101|P2|NOT COMPLETED|Overall Study||0
4921609|NCT03359629|12109102|P1|NOT COMPLETED|Overall Study||0
4921610|NCT03359629|12109101|P2|COMPLETED|Overall Study||10
4921611|NCT03359629|12109102|P1|COMPLETED|Overall Study||200
4921612|NCT03359629|12109101|P2|STARTED|Overall Study||10
4921613|NCT03359629|12109102|P1|STARTED|Overall Study||200
4921614|NCT03359473|12109112|P4|NOT COMPLETED|Overall Study||5
4921615|NCT03359473|12109113|P3|NOT COMPLETED|Overall Study||6
4921616|NCT03359473|12109114|P2|NOT COMPLETED|Overall Study||6
4921617|NCT03359473|12109115|P1|NOT COMPLETED|Overall Study||2
4921618|NCT03359473|12109112|P4|COMPLETED|Overall Study||20
4921619|NCT03359473|12109113|P3|COMPLETED|Overall Study||18
4921620|NCT03359473|12109114|P2|COMPLETED|Overall Study||18
4921621|NCT03359473|12109115|P1|COMPLETED|Overall Study||21
4921622|NCT03359473|12109112|P4|STARTED|Overall Study||25
4921623|NCT03359473|12109113|P3|STARTED|Overall Study||24
4921624|NCT03359473|12109114|P2|STARTED|Overall Study||24
4921625|NCT03359473|12109115|P1|STARTED|Overall Study||23
4921626|NCT03358472|12109328|P3|NOT COMPLETED|Overall Study||16
4921627|NCT03358472|12109329|P2|NOT COMPLETED|Overall Study||10
4921628|NCT03358472|12109330|P1|NOT COMPLETED|Overall Study||15
4921629|NCT03358472|12109328|P3|COMPLETED|Overall Study||19
4921630|NCT03358472|12109329|P2|COMPLETED|Overall Study||9
4921631|NCT03358472|12109330|P1|COMPLETED|Overall Study||20
4921632|NCT03358472|12109328|P3|All Participants as Treated (APaT)|Overall Study||34
4921633|NCT03358472|12109329|P2|All Participants as Treated (APaT)|Overall Study||19
4921634|NCT03358472|12109330|P1|All Participants as Treated (APaT)|Overall Study||34
4921635|NCT03358472|12109328|P3|Intention-to-Treat (ITT)|Overall Study||35
4921636|NCT03358472|12109329|P2|Intention-to-Treat (ITT)|Overall Study||19
4921637|NCT03358472|12109330|P1|Intention-to-Treat (ITT)|Overall Study||35
4921638|NCT03358472|12109328|P3|STARTED|Overall Study||35
4921639|NCT03358472|12109329|P2|STARTED|Overall Study||19
4921640|NCT03358472|12109330|P1|STARTED|Overall Study||35
4921641|NCT03358407|12109354|P10|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921642|NCT03358407|12109355|P9|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921643|NCT03358407|12109356|P8|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921644|NCT03358407|12109357|P7|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921645|NCT03358407|12109358|P6|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921646|NCT03358407|12109359|P5|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921647|NCT03358407|12109360|P4|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921648|NCT03358407|12109361|P3|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921649|NCT03358407|12109362|P2|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921650|NCT03358407|12109363|P1|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
4921651|NCT03358407|12109354|P10|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921652|NCT03358407|12109355|P9|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921653|NCT03358407|12109356|P8|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921654|NCT03358407|12109357|P7|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921655|NCT03358407|12109358|P6|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921656|NCT03358407|12109359|P5|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921657|NCT03358407|12109360|P4|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921658|NCT03358407|12109361|P3|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921659|NCT03358407|12109362|P2|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921660|NCT03358407|12109363|P1|COMPLETED|Part B: Overall Period (11 Weeks)||0
4921661|NCT03358407|12109354|P10|STARTED|Part B: Overall Period (11 Weeks)||0
4921662|NCT03358407|12109355|P9|STARTED|Part B: Overall Period (11 Weeks)||0
4921663|NCT03358407|12109356|P8|STARTED|Part B: Overall Period (11 Weeks)||0
4921664|NCT03358407|12109357|P7|STARTED|Part B: Overall Period (11 Weeks)||0
4921665|NCT03358407|12109358|P6|STARTED|Part B: Overall Period (11 Weeks)||0
4921666|NCT03358407|12109359|P5|STARTED|Part B: Overall Period (11 Weeks)||0
4921667|NCT03358407|12109360|P4|STARTED|Part B: Overall Period (11 Weeks)||0
4921668|NCT03358407|12109361|P3|STARTED|Part B: Overall Period (11 Weeks)||0
4921669|NCT03358407|12109362|P2|STARTED|Part B: Overall Period (11 Weeks)||0
4921670|NCT03358407|12109363|P1|STARTED|Part B: Overall Period (11 Weeks)||0
4921671|NCT03358407|12109354|P10|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921672|NCT03358407|12109355|P9|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921673|NCT03358407|12109356|P8|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
4921674|NCT03358407|12109357|P7|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
4921675|NCT03358407|12109358|P6|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
4921676|NCT03358407|12109359|P5|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921677|NCT03358407|12109360|P4|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921678|NCT03358407|12109361|P3|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921679|NCT03358407|12109362|P2|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921680|NCT03358407|12109363|P1|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921681|NCT03358407|12109354|P10|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921682|NCT03358407|12109355|P9|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921683|NCT03358407|12109356|P8|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921684|NCT03358407|12109357|P7|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921685|NCT03358407|12109358|P6|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921686|NCT03358407|12109359|P5|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921687|NCT03358407|12109360|P4|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921688|NCT03358407|12109361|P3|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921689|NCT03358407|12109362|P2|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921690|NCT03358407|12109363|P1|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921691|NCT03358407|12109354|P10|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921692|NCT03358407|12109355|P9|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921693|NCT03358407|12109356|P8|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
4921694|NCT03358407|12109357|P7|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
4921695|NCT03358407|12109358|P6|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
4921696|NCT03358407|12109359|P5|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921697|NCT03358407|12109360|P4|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921698|NCT03358407|12109361|P3|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921699|NCT03358407|12109362|P2|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921700|NCT03358407|12109363|P1|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
4921701|NCT03358407|12109354|P10|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921702|NCT03358407|12109355|P9|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921703|NCT03358407|12109356|P8|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
4921704|NCT03358407|12109357|P7|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
4921705|NCT03358407|12109358|P6|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
4921706|NCT03358407|12109359|P5|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921707|NCT03358407|12109360|P4|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921708|NCT03358407|12109361|P3|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921709|NCT03358407|12109362|P2|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921710|NCT03358407|12109363|P1|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921711|NCT03358407|12109354|P10|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921712|NCT03358407|12109355|P9|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921713|NCT03358407|12109356|P8|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
4921714|NCT03358407|12109357|P7|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
4921715|NCT03358407|12109358|P6|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921716|NCT03358407|12109359|P5|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921717|NCT03358407|12109360|P4|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921718|NCT03358407|12109361|P3|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921719|NCT03358407|12109362|P2|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921720|NCT03358407|12109363|P1|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921721|NCT03358407|12109354|P10|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921722|NCT03358407|12109355|P9|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921723|NCT03358407|12109356|P8|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
4921724|NCT03358407|12109357|P7|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
4921725|NCT03358407|12109358|P6|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
4921726|NCT03358407|12109359|P5|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921727|NCT03358407|12109360|P4|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921728|NCT03358407|12109361|P3|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921729|NCT03358407|12109362|P2|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921730|NCT03358407|12109363|P1|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
4921731|NCT03358407|12109354|P10|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921732|NCT03358407|12109355|P9|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921733|NCT03358407|12109356|P8|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921734|NCT03358407|12109357|P7|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921735|NCT03358407|12109358|P6|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921736|NCT03358407|12109359|P5|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921737|NCT03358407|12109360|P4|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921738|NCT03358407|12109361|P3|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921739|NCT03358407|12109362|P2|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921740|NCT03358407|12109363|P1|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921741|NCT03358407|12109354|P10|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921742|NCT03358407|12109355|P9|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921743|NCT03358407|12109356|P8|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921744|NCT03358407|12109357|P7|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921745|NCT03358407|12109358|P6|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921746|NCT03358407|12109359|P5|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921747|NCT03358407|12109360|P4|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921748|NCT03358407|12109361|P3|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921749|NCT03358407|12109362|P2|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921750|NCT03358407|12109363|P1|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921751|NCT03358407|12109354|P10|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921752|NCT03358407|12109355|P9|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921753|NCT03358407|12109356|P8|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921754|NCT03358407|12109357|P7|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921755|NCT03358407|12109358|P6|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
4921756|NCT03358407|12109359|P5|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
4921757|NCT03358407|12109360|P4|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921758|NCT03358407|12109361|P3|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921759|NCT03358407|12109362|P2|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921760|NCT03358407|12109363|P1|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
4921761|NCT03358407|12109354|P10|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921762|NCT03358407|12109355|P9|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921763|NCT03358407|12109356|P8|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921764|NCT03358407|12109357|P7|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921765|NCT03358407|12109358|P6|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921766|NCT03358407|12109359|P5|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
4921767|NCT03358407|12109360|P4|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921768|NCT03358407|12109361|P3|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921769|NCT03358407|12109362|P2|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921770|NCT03358407|12109363|P1|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921771|NCT03358407|12109354|P10|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921772|NCT03358407|12109355|P9|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921773|NCT03358407|12109356|P8|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921774|NCT03358407|12109357|P7|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921775|NCT03358407|12109358|P6|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921776|NCT03358407|12109359|P5|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
4921777|NCT03358407|12109360|P4|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921778|NCT03358407|12109361|P3|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921779|NCT03358407|12109362|P2|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921780|NCT03358407|12109363|P1|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921781|NCT03358407|12109354|P10|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921782|NCT03358407|12109355|P9|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921783|NCT03358407|12109356|P8|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921784|NCT03358407|12109357|P7|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921785|NCT03358407|12109358|P6|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
4921786|NCT03358407|12109359|P5|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921787|NCT03358407|12109360|P4|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921788|NCT03358407|12109361|P3|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921789|NCT03358407|12109362|P2|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921790|NCT03358407|12109363|P1|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
4921791|NCT03358407|12109354|P10|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921792|NCT03358407|12109355|P9|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921793|NCT03358407|12109356|P8|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921794|NCT03358407|12109357|P7|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921795|NCT03358407|12109358|P6|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921796|NCT03358407|12109359|P5|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921797|NCT03358407|12109360|P4|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921798|NCT03358407|12109361|P3|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921799|NCT03358407|12109362|P2|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921800|NCT03358407|12109363|P1|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921801|NCT03358407|12109354|P10|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921802|NCT03358407|12109355|P9|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921803|NCT03358407|12109356|P8|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921804|NCT03358407|12109357|P7|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921805|NCT03358407|12109358|P6|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921806|NCT03358407|12109359|P5|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921807|NCT03358407|12109360|P4|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921808|NCT03358407|12109361|P3|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921809|NCT03358407|12109362|P2|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921810|NCT03358407|12109363|P1|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921811|NCT03358407|12109354|P10|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921812|NCT03358407|12109355|P9|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921813|NCT03358407|12109356|P8|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921814|NCT03358407|12109357|P7|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921815|NCT03358407|12109358|P6|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
4921816|NCT03358407|12109359|P5|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921817|NCT03358407|12109360|P4|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921818|NCT03358407|12109361|P3|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
4921819|NCT03358407|12109362|P2|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921820|NCT03358407|12109363|P1|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
4921821|NCT03358407|12109354|P10|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921822|NCT03358407|12109355|P9|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921823|NCT03358407|12109356|P8|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921824|NCT03358407|12109357|P7|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921825|NCT03358407|12109358|P6|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921826|NCT03358407|12109359|P5|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921827|NCT03358407|12109360|P4|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921828|NCT03358407|12109361|P3|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
4921829|NCT03358407|12109362|P2|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921830|NCT03358407|12109363|P1|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921831|NCT03358407|12109354|P10|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921832|NCT03358407|12109355|P9|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921833|NCT03358407|12109356|P8|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921834|NCT03358407|12109357|P7|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921835|NCT03358407|12109358|P6|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921836|NCT03358407|12109359|P5|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921837|NCT03358407|12109360|P4|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921838|NCT03358407|12109361|P3|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
4921839|NCT03358407|12109362|P2|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921840|NCT03358407|12109363|P1|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921841|NCT03358407|12109354|P10|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921842|NCT03358407|12109355|P9|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921843|NCT03358407|12109356|P8|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921844|NCT03358407|12109357|P7|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921845|NCT03358407|12109358|P6|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
4921846|NCT03358407|12109359|P5|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921847|NCT03358407|12109360|P4|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921848|NCT03358407|12109361|P3|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921849|NCT03358407|12109362|P2|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921850|NCT03358407|12109363|P1|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
4921851|NCT03358407|12109354|P10|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921852|NCT03358407|12109355|P9|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921853|NCT03358407|12109356|P8|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921854|NCT03358407|12109357|P7|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921855|NCT03358407|12109358|P6|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921856|NCT03358407|12109359|P5|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921857|NCT03358407|12109360|P4|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921858|NCT03358407|12109361|P3|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921859|NCT03358407|12109362|P2|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921860|NCT03358407|12109363|P1|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921861|NCT03358407|12109354|P10|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921862|NCT03358407|12109355|P9|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921863|NCT03358407|12109356|P8|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921864|NCT03358407|12109357|P7|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921865|NCT03358407|12109358|P6|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921866|NCT03358407|12109359|P5|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921867|NCT03358407|12109360|P4|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921868|NCT03358407|12109361|P3|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921869|NCT03358407|12109362|P2|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921870|NCT03358407|12109363|P1|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921871|NCT03358407|12109354|P10|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921872|NCT03358407|12109355|P9|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921873|NCT03358407|12109356|P8|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921874|NCT03358407|12109357|P7|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921875|NCT03358407|12109358|P6|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
4921876|NCT03358407|12109359|P5|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921877|NCT03358407|12109360|P4|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921878|NCT03358407|12109361|P3|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921879|NCT03358407|12109362|P2|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921880|NCT03358407|12109363|P1|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
4921881|NCT03358355|12109625|P1|NOT COMPLETED|Overall Study||0
4921882|NCT03358355|12109625|P1|COMPLETED|Overall Study||9
4921883|NCT03358355|12109625|P1|STARTED|Overall Study||9
4921884|NCT03358329|12109640|P1|NOT COMPLETED|Overall Study||4
4921885|NCT03358329|12109640|P1|COMPLETED|Overall Study||46
4921886|NCT03358329|12109640|P1|STARTED|Overall Study||50
4921887|NCT03358238|12109648|P2|NOT COMPLETED|Overall Study||1
4921888|NCT03358238|12109649|P1|NOT COMPLETED|Overall Study||0
4921889|NCT03358238|12109648|P2|COMPLETED|Overall Study||24
4921890|NCT03358238|12109649|P1|COMPLETED|Overall Study||23
4921891|NCT03358238|12109648|P2|STARTED|Overall Study||25
4921892|NCT03358238|12109649|P1|STARTED|Overall Study||23
4921893|NCT03357952|12109666|P2|NOT COMPLETED|Overall Study||1
4921894|NCT03357952|12109667|P1|NOT COMPLETED|Overall Study||9
4921895|NCT03357952|12109666|P2|COMPLETED|Overall Study||0
4921896|NCT03357952|12109667|P1|COMPLETED|Overall Study||0
4921897|NCT03357952|12109666|P2|STARTED|Overall Study||1
4921898|NCT03357952|12109667|P1|STARTED|Overall Study||9
4921899|NCT03357731|12109674|P6|NOT COMPLETED|Overall Study||1
4921900|NCT03357731|12109675|P5|NOT COMPLETED|Overall Study||1
4921901|NCT03357731|12109676|P4|NOT COMPLETED|Overall Study||3
4921902|NCT03357731|12109677|P3|NOT COMPLETED|Overall Study||1
4921903|NCT03357731|12109678|P2|NOT COMPLETED|Overall Study||0
4921904|NCT03357731|12109679|P1|NOT COMPLETED|Overall Study||0
4921905|NCT03357731|12109674|P6|COMPLETED|Overall Study||7
4921906|NCT03357731|12109675|P5|COMPLETED|Overall Study||7
4921907|NCT03357731|12109676|P4|COMPLETED|Overall Study||4
4921908|NCT03357731|12109677|P3|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
4921909|NCT03357731|12109678|P2|COMPLETED|Overall Study||7
4921910|NCT03357731|12109679|P1|COMPLETED|Overall Study||8
4921911|NCT03357731|12109674|P6|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
4921912|NCT03357731|12109675|P5|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
4921913|NCT03357731|12109676|P4|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
4921914|NCT03357731|12109677|P3|Completed Period 2 (P2)|Overall Study||7
4921915|NCT03357731|12109678|P2|Completed Period 2 (P2)|Overall Study||7
4921916|NCT03357731|12109679|P1|Completed Period 2 (P2)|Overall Study||8
4921917|NCT03357731|12109674|P6|Completed Period 1 (P1)|Overall Study||8
4921918|NCT03357731|12109675|P5|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
4921919|NCT03357731|12109676|P4|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
4921920|NCT03357731|12109677|P3|Completed Period 1 (P1)|Overall Study||7
4921921|NCT03357731|12109678|P2|Completed Period 1 (P1)|Overall Study||7
4921922|NCT03357731|12109679|P1|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
4921923|NCT03357731|12109674|P6|STARTED|Overall Study||8
4921924|NCT03357731|12109675|P5|STARTED|Overall Study||8
4921925|NCT03357731|12109676|P4|STARTED|Overall Study||7
4921926|NCT03357731|12109677|P3|STARTED|Overall Study||7
4921927|NCT03357731|12109678|P2|STARTED|Overall Study||7
4921928|NCT03357731|12109679|P1|STARTED|Overall Study||8
4921929|NCT03357471|12109707|P2|NOT COMPLETED|Overall Study||0
4921930|NCT03357471|12109708|P1|NOT COMPLETED|Overall Study||2
4921931|NCT03357471|12109707|P2|COMPLETED|Overall Study||32
4921932|NCT03357471|12109708|P1|COMPLETED|Overall Study||33
4921933|NCT03357471|12109707|P2|STARTED|Overall Study||32
4921934|NCT03357471|12109708|P1|STARTED|Overall Study||35
4921935|NCT03356977|12109732|P1|NOT COMPLETED|Overall Study||5
4921936|NCT03356977|12109732|P1|COMPLETED|Overall Study||132
4921937|NCT03356977|12109732|P1|STARTED|Overall Study||137
4921938|NCT03355820|12109744|P1|NOT COMPLETED|Overall Study||0
4921939|NCT03355820|12109744|P1|COMPLETED|Overall Study||227
4921940|NCT03355820|12109744|P1|STARTED|Overall Study||227
4921941|NCT03354754|12109757|P2|NOT COMPLETED|Overall Study||0
4921942|NCT03354754|12109758|P1|NOT COMPLETED|Overall Study||0
4921943|NCT03354754|12109757|P2|COMPLETED|Overall Study||1
4921944|NCT03354754|12109758|P1|COMPLETED|Overall Study||2
4921945|NCT03354754|12109757|P2|STARTED|Overall Study||1
4921946|NCT03354754|12109758|P1|STARTED|Overall Study||2
4921947|NCT03354663|12109780|P1|NOT COMPLETED|Completed 30-day Visit||2
4921948|NCT03354663|12109780|P1|COMPLETED|Completed 30-day Visit||149
4921949|NCT03354663|12109780|P1|STARTED|Completed 30-day Visit||151
4921950|NCT03354663|12109780|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
4921951|NCT03354663|12109780|P1|COMPLETED|Enrollment to Catheter Insertion||151
4921952|NCT03354663|12109780|P1|STARTED|Enrollment to Catheter Insertion||156
4921953|NCT03354637|12109799|P3|NOT COMPLETED|Open Label Extension||28
4921954|NCT03354637|12109800|P2|NOT COMPLETED|Open Label Extension||0
4921955|NCT03354637|12109801|P1|NOT COMPLETED|Open Label Extension||0
4921956|NCT03354637|12109799|P3|COMPLETED|Open Label Extension||33
4921957|NCT03354637|12109800|P2|COMPLETED|Open Label Extension||0
4921958|NCT03354637|12109801|P1|COMPLETED|Open Label Extension||0
4921959|NCT03354637|12109799|P3|STARTED|Open Label Extension||61
4921960|NCT03354637|12109800|P2|STARTED|Open Label Extension||0
4921961|NCT03354637|12109801|P1|STARTED|Open Label Extension||0
4921962|NCT03354637|12109799|P3|NOT COMPLETED|Double-blind Period||7
4921963|NCT03354637|12109800|P2|NOT COMPLETED|Double-blind Period||13
4921964|NCT03354637|12109801|P1|NOT COMPLETED|Double-blind Period||17
4921965|NCT03354637|12109799|P3|COMPLETED|Double-blind Period||35
4921966|NCT03354637|12109800|P2|COMPLETED|Double-blind Period||31
4921967|NCT03354637|12109801|P1|COMPLETED|Double-blind Period||26
4921968|NCT03354637|12109799|P3|STARTED|Double-blind Period||42
4921969|NCT03354637|12109800|P2|STARTED|Double-blind Period||44
4921970|NCT03354637|12109801|P1|STARTED|Double-blind Period||43
4921971|NCT03354325|12109860|P2|NOT COMPLETED|Overall Study||15
4921972|NCT03354325|12109861|P1|NOT COMPLETED|Overall Study||20
4921973|NCT03354325|12109860|P2|COMPLETED|Overall Study||138
4921974|NCT03354325|12109861|P1|COMPLETED|Overall Study||131
4921975|NCT03354325|12109860|P2|STARTED|Overall Study||153
4921976|NCT03354325|12109861|P1|STARTED|Overall Study||151
4921977|NCT03353246|12109891|P1|NOT COMPLETED|Overall Study||0
4921978|NCT03353246|12109891|P1|COMPLETED|Overall Study||500
4921979|NCT03353246|12109891|P1|STARTED|Overall Study||500
4921980|NCT03352882|12109908|P1|NOT COMPLETED|Overall Study||0
4921981|NCT03352882|12109908|P1|COMPLETED|Overall Study||1
4921982|NCT03352882|12109908|P1|STARTED|Overall Study||1
4921983|NCT03352713|12109916|P1|NOT COMPLETED|Overall Study||26
4921984|NCT03352713|12109916|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
4921985|NCT03352713|12109916|P1|STARTED|Overall Study||185
4921986|NCT03352609|12109924|P2|NOT COMPLETED|Overall Study||0
4921987|NCT03352609|12109925|P1|NOT COMPLETED|Overall Study||0
4921988|NCT03352609|12109924|P2|COMPLETED|Overall Study||3
4921989|NCT03352609|12109925|P1|COMPLETED|Overall Study||2
4921990|NCT03352609|12109924|P2|STARTED|Overall Study||3
4921991|NCT03352609|12109925|P1|STARTED|Overall Study||2
4921992|NCT03351933|12109935|P1|NOT COMPLETED|Overall Study||2
4921993|NCT03351933|12109935|P1|COMPLETED|Overall Study||26
4921994|NCT03351933|12109935|P1|STARTED|Overall Study||28
4921995|NCT03351738|12109945|P6|NOT COMPLETED|Overall Study||0
4921996|NCT03351738|12109946|P5|NOT COMPLETED|Overall Study||0
4921997|NCT03351738|12109947|P4|NOT COMPLETED|Overall Study||1
4921998|NCT03351738|12109948|P3|NOT COMPLETED|Overall Study||0
4921999|NCT03351738|12109949|P2|NOT COMPLETED|Overall Study||1
4922000|NCT03351738|12109950|P1|NOT COMPLETED|Overall Study||0
4922001|NCT03351738|12109945|P6|COMPLETED|Overall Study||22
4922002|NCT03351738|12109946|P5|COMPLETED|Overall Study||21
4922003|NCT03351738|12109947|P4|COMPLETED|Overall Study||21
4922004|NCT03351738|12109948|P3|COMPLETED|Overall Study||24
4922005|NCT03351738|12109949|P2|COMPLETED|Overall Study||19
4922006|NCT03351738|12109950|P1|COMPLETED|Overall Study||23
4922007|NCT03351738|12109945|P6|STARTED|Overall Study||22
4922008|NCT03351738|12109946|P5|STARTED|Overall Study||21
4922009|NCT03351738|12109947|P4|STARTED|Overall Study||22
4922010|NCT03351738|12109948|P3|STARTED|Overall Study||24
4922011|NCT03351738|12109949|P2|STARTED|Overall Study||20
4922012|NCT03351738|12109950|P1|STARTED|Overall Study||23
4922013|NCT03351699|12110026|P5|NOT COMPLETED|Overall Study||0
4922014|NCT03351699|12110027|P4|NOT COMPLETED|Overall Study||0
4922015|NCT03351699|12110028|P3|NOT COMPLETED|Overall Study||0
4922016|NCT03351699|12110029|P2|NOT COMPLETED|Overall Study||0
4922017|NCT03351699|12110030|P1|NOT COMPLETED|Overall Study||0
4922018|NCT03351699|12110026|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
4922019|NCT03351699|12110027|P4|COMPLETED|Overall Study||6
4922020|NCT03351699|12110028|P3|COMPLETED|Overall Study||6
4922021|NCT03351699|12110029|P2|COMPLETED|Overall Study||6
4922022|NCT03351699|12110030|P1|COMPLETED|Overall Study||6
4922023|NCT03351699|12110026|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
4922024|NCT03351699|12110027|P4|STARTED|Overall Study||6
4922025|NCT03351699|12110028|P3|STARTED|Overall Study||6
4922026|NCT03351699|12110029|P2|STARTED|Overall Study||6
4922027|NCT03351699|12110030|P1|STARTED|Overall Study||6
4922028|NCT03351335|12110102|P3|NOT COMPLETED|Overall Study||4
4922029|NCT03351335|12110103|P2|NOT COMPLETED|Overall Study||0
4922030|NCT03351335|12110104|P1|NOT COMPLETED|Overall Study||0
4922031|NCT03351335|12110102|P3|COMPLETED|Overall Study||16
4922032|NCT03351335|12110103|P2|COMPLETED|Overall Study||19
4922033|NCT03351335|12110104|P1|COMPLETED|Overall Study||21
4922034|NCT03351335|12110102|P3|STARTED|Overall Study||20
4922035|NCT03351335|12110103|P2|STARTED|Overall Study||19
4922036|NCT03351335|12110104|P1|STARTED|Overall Study||21
4922037|NCT03351231|12110124|P1|NOT COMPLETED|Safety Follow-Up Period||3
4922038|NCT03351231|12110124|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
4922039|NCT03351231|12110124|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
4922040|NCT03351231|12110124|P1|NOT COMPLETED|Combination Therapy Period||5
4922041|NCT03351231|12110124|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
4922042|NCT03351231|12110124|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
4922043|NCT03350984|12110148|P2|NOT COMPLETED|Overall Study||8
4922044|NCT03350984|12110149|P1|NOT COMPLETED|Overall Study||8
4922045|NCT03350984|12110148|P2|COMPLETED|Overall Study||28
4922046|NCT03350984|12110149|P1|COMPLETED|Overall Study||31
4922047|NCT03350984|12110148|P2|STARTED|Overall Study||36
4922048|NCT03350984|12110149|P1|STARTED|Overall Study||39
4922049|NCT03350724|12110161|P2|NOT COMPLETED|Overall Study||0
4922050|NCT03350724|12110162|P1|NOT COMPLETED|Overall Study||0
4922051|NCT03350724|12110161|P2|COMPLETED|Overall Study||17
4922052|NCT03350724|12110162|P1|COMPLETED|Overall Study||17
4922053|NCT03350724|12110161|P2|STARTED|Overall Study||17
4922054|NCT03350724|12110162|P1|STARTED|Overall Study||17
4922055|NCT03350503|12110216|P1|NOT COMPLETED|Overall Study||5
4922056|NCT03350503|12110216|P1|COMPLETED|Overall Study||116
4922057|NCT03350503|12110216|P1|STARTED|Overall Study||121
4922058|NCT03350256|12110220|P1|NOT COMPLETED|Overall Study||36
4922059|NCT03350256|12110220|P1|COMPLETED|Overall Study||24
4922060|NCT03350256|12110220|P1|6 Month Follow up|Overall Study||24
4922061|NCT03350256|12110220|P1|3 Month Follow up|Overall Study||27
4922062|NCT03350256|12110220|P1|1 Month Follow up|Overall Study||30
4922063|NCT03350256|12110220|P1|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
4922064|NCT03350256|12110220|P1|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
4922065|NCT03350256|12110220|P1|STARTED|Overall Study||60
4922066|NCT03350217|12110242|P2|NOT COMPLETED|Overall Study||0
4922067|NCT03350217|12110243|P1|NOT COMPLETED|Overall Study||2
4922068|NCT03350217|12110242|P2|COMPLETED|Overall Study||81
4922069|NCT03350217|12110243|P1|COMPLETED|Overall Study||77
4922070|NCT03350217|12110242|P2|STARTED|Overall Study||81
4922071|NCT03350217|12110243|P1|STARTED|Overall Study||79
4922072|NCT03349632|12110273|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
4922073|NCT03349632|12110274|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
4922074|NCT03349632|12110275|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
4922075|NCT03349632|12110276|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
4922076|NCT03349632|12110277|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
4922077|NCT03349632|12110278|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
4922078|NCT03349632|12110273|P6|COMPLETED|Period 2, Second Week of Wear||11
4922079|NCT03349632|12110274|P5|COMPLETED|Period 2, Second Week of Wear||11
4922080|NCT03349632|12110275|P4|COMPLETED|Period 2, Second Week of Wear||11
4922081|NCT03349632|12110276|P3|COMPLETED|Period 2, Second Week of Wear||11
4922082|NCT03349632|12110277|P2|COMPLETED|Period 2, Second Week of Wear||11
4922083|NCT03349632|12110278|P1|COMPLETED|Period 2, Second Week of Wear||11
4922084|NCT03349632|12110273|P6|STARTED|Period 2, Second Week of Wear||11
4922085|NCT03349632|12110274|P5|STARTED|Period 2, Second Week of Wear||11
4922086|NCT03349632|12110275|P4|STARTED|Period 2, Second Week of Wear||11
4922087|NCT03349632|12110276|P3|STARTED|Period 2, Second Week of Wear||11
4922088|NCT03349632|12110277|P2|STARTED|Period 2, Second Week of Wear||11
4922089|NCT03349632|12110278|P1|STARTED|Period 2, Second Week of Wear||11
4922090|NCT03349632|12110273|P6|NOT COMPLETED|Period 1, First Week of Wear||0
4922091|NCT03349632|12110274|P5|NOT COMPLETED|Period 1, First Week of Wear||0
4922092|NCT03349632|12110275|P4|NOT COMPLETED|Period 1, First Week of Wear||0
4922093|NCT03349632|12110276|P3|NOT COMPLETED|Period 1, First Week of Wear||0
4922094|NCT03349632|12110277|P2|NOT COMPLETED|Period 1, First Week of Wear||0
4922095|NCT03349632|12110278|P1|NOT COMPLETED|Period 1, First Week of Wear||0
4922096|NCT03349632|12110273|P6|COMPLETED|Period 1, First Week of Wear||11
4922097|NCT03349632|12110274|P5|COMPLETED|Period 1, First Week of Wear||11
4922098|NCT03349632|12110275|P4|COMPLETED|Period 1, First Week of Wear||11
4922099|NCT03349632|12110276|P3|COMPLETED|Period 1, First Week of Wear||11
4922100|NCT03349632|12110277|P2|COMPLETED|Period 1, First Week of Wear||11
4922101|NCT03349632|12110278|P1|COMPLETED|Period 1, First Week of Wear||11
4922102|NCT03349632|12110273|P6|STARTED|Period 1, First Week of Wear||11
4922103|NCT03349632|12110274|P5|STARTED|Period 1, First Week of Wear||11
4922104|NCT03349632|12110275|P4|STARTED|Period 1, First Week of Wear||11
4922105|NCT03349632|12110276|P3|STARTED|Period 1, First Week of Wear||11
4922106|NCT03349632|12110277|P2|STARTED|Period 1, First Week of Wear||11
4922107|NCT03349632|12110278|P1|STARTED|Period 1, First Week of Wear||11
4922108|NCT03349515|12110294|P2|NOT COMPLETED|Overall Study||1
4922109|NCT03349515|12110295|P1|NOT COMPLETED|Overall Study||5
4922110|NCT03349515|12110294|P2|COMPLETED|Overall Study||50
4922111|NCT03349515|12110295|P1|COMPLETED|Overall Study||50
4922112|NCT03349515|12110294|P2|STARTED|Overall Study||51
4922113|NCT03349515|12110295|P1|STARTED|Overall Study||55
4922114|NCT03349437|12110301|P3|NOT COMPLETED|Intervention||0
4922115|NCT03349437|12110302|P2|NOT COMPLETED|Intervention||0
4922116|NCT03349437|12110303|P1|NOT COMPLETED|Intervention||0
4922117|NCT03349437|12110301|P3|COMPLETED|Intervention||10
4922118|NCT03349437|12110302|P2|COMPLETED|Intervention||10
4922119|NCT03349437|12110303|P1|COMPLETED|Intervention||0
4922120|NCT03349437|12110301|P3|STARTED|Intervention||10
4922121|NCT03349437|12110302|P2|STARTED|Intervention||10
4922122|NCT03349437|12110303|P1|STARTED|Intervention||0
4922123|NCT03349437|12110301|P3|NOT COMPLETED|Screening||0
4922124|NCT03349437|12110302|P2|NOT COMPLETED|Screening||0
4922125|NCT03349437|12110303|P1|NOT COMPLETED|Screening||5
4922126|NCT03349437|12110301|P3|COMPLETED|Screening||0
4922127|NCT03349437|12110302|P2|COMPLETED|Screening||0
4922128|NCT03349437|12110303|P1|COMPLETED|Screening||20
4922129|NCT03349437|12110301|P3|STARTED|Screening||0
4922130|NCT03349437|12110302|P2|STARTED|Screening||0
4922131|NCT03349437|12110303|P1|STARTED|Screening||25
4922132|NCT03349333|12110310|P1|NOT COMPLETED|Overall Study||71
4922133|NCT03349333|12110310|P1|COMPLETED|Overall Study||0
4922134|NCT03349333|12110310|P1|STARTED|Overall Study||71
4922135|NCT03349099|12110333|P2|NOT COMPLETED|Overall Study||4
4922136|NCT03349099|12110334|P1|NOT COMPLETED|Overall Study||4
4922137|NCT03349099|12110333|P2|COMPLETED|Overall Study||43
4922138|NCT03349099|12110334|P1|COMPLETED|Overall Study||44
4922139|NCT03349099|12110333|P2|STARTED|Overall Study||47
4922140|NCT03349099|12110334|P1|STARTED|Overall Study||48
4922141|NCT03349060|12110347|P3|NOT COMPLETED|Overall Study||16
4922142|NCT03349060|12110348|P2|NOT COMPLETED|Overall Study||17
4922143|NCT03349060|12110349|P1|NOT COMPLETED|Overall Study||21
4922144|NCT03349060|12110347|P3|COMPLETED|Overall Study||61
4922145|NCT03349060|12110348|P2|COMPLETED|Overall Study||137
4922146|NCT03349060|12110349|P1|COMPLETED|Overall Study||135
4922147|NCT03349060|12110347|P3|STARTED|Overall Study||77
4922148|NCT03349060|12110348|P2|STARTED|Overall Study||154
4922149|NCT03349060|12110349|P1|STARTED|Overall Study||156
4922150|NCT03348904|12110491|P3|NOT COMPLETED|Overall Study||0
4922151|NCT03348904|12110492|P2|NOT COMPLETED|Overall Study||1
4922152|NCT03348904|12110493|P1|NOT COMPLETED|Overall Study||0
4922153|NCT03348904|12110491|P3|COMPLETED|Overall Study||0
4922154|NCT03348904|12110492|P2|COMPLETED|Overall Study||1
4922155|NCT03348904|12110493|P1|COMPLETED|Overall Study||0
4922156|NCT03348904|12110491|P3|STARTED|Overall Study||0
4922157|NCT03348904|12110492|P2|STARTED|Overall Study||2
4922158|NCT03348904|12110493|P1|STARTED|Overall Study||0
4922159|NCT03348683|12110512|P2|NOT COMPLETED|Overall Study||0
4922160|NCT03348683|12110513|P1|NOT COMPLETED|Overall Study||0
4922161|NCT03348683|12110512|P2|COMPLETED|Overall Study||119
4922162|NCT03348683|12110513|P1|COMPLETED|Overall Study||121
4922163|NCT03348683|12110512|P2|STARTED|Overall Study||119
4922164|NCT03348683|12110513|P1|STARTED|Overall Study||121
4922165|NCT03346902|12110537|P2|NOT COMPLETED|Overall Study||0
4922166|NCT03346902|12110538|P1|NOT COMPLETED|Overall Study||0
4922167|NCT03346902|12110537|P2|COMPLETED|Overall Study||8
4922168|NCT03346902|12110538|P1|COMPLETED|Overall Study||4
4922169|NCT03346902|12110537|P2|STARTED|Overall Study||8
4922170|NCT03346902|12110538|P1|STARTED|Overall Study||4
4922171|NCT03346850|12110546|P2|NOT COMPLETED|Overall Study||3
4922172|NCT03346850|12110547|P1|NOT COMPLETED|Overall Study||2
4922173|NCT03346850|12110546|P2|COMPLETED|Overall Study||17
4922174|NCT03346850|12110547|P1|COMPLETED|Overall Study||18
4922175|NCT03346850|12110546|P2|STARTED|Overall Study||20
4922176|NCT03346850|12110547|P1|STARTED|Overall Study||20
4922177|NCT03346759|12110569|P2|NOT COMPLETED|Third Menstrual Cycle||0
4922178|NCT03346759|12110570|P1|NOT COMPLETED|Third Menstrual Cycle||0
4922179|NCT03346759|12110569|P2|COMPLETED|Third Menstrual Cycle||10
4922180|NCT03346759|12110570|P1|COMPLETED|Third Menstrual Cycle||11
4922181|NCT03346759|12110569|P2|STARTED|Third Menstrual Cycle||10
4922182|NCT03346759|12110570|P1|STARTED|Third Menstrual Cycle||11
4922183|NCT03346759|12110569|P2|NOT COMPLETED|Second Menstrual Cycle||0
4922184|NCT03346759|12110570|P1|NOT COMPLETED|Second Menstrual Cycle||1
4922185|NCT03346759|12110569|P2|COMPLETED|Second Menstrual Cycle||10
4922186|NCT03346759|12110570|P1|COMPLETED|Second Menstrual Cycle||11
4922187|NCT03346759|12110569|P2|STARTED|Second Menstrual Cycle||10
4922188|NCT03346759|12110570|P1|STARTED|Second Menstrual Cycle||12
4922189|NCT03346759|12110569|P2|NOT COMPLETED|First Menstrual Cycle||0
4922190|NCT03346759|12110570|P1|NOT COMPLETED|First Menstrual Cycle||1
4922191|NCT03346759|12110569|P2|COMPLETED|First Menstrual Cycle||10
4922192|NCT03346759|12110570|P1|COMPLETED|First Menstrual Cycle||12
4922193|NCT03346759|12110569|P2|STARTED|First Menstrual Cycle||10
4922194|NCT03346759|12110570|P1|STARTED|First Menstrual Cycle||13
4922195|NCT03346759|12110569|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
4922196|NCT03346759|12110570|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
4922197|NCT03346759|12110569|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
4922198|NCT03346759|12110570|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
4922199|NCT03346759|12110569|P2|STARTED|Enrollment to Baseline Data Collected||13
4922200|NCT03346759|12110570|P1|STARTED|Enrollment to Baseline Data Collected||15
4922201|NCT03346161|12110581|P2|NOT COMPLETED|Overall Study||0
4922202|NCT03346161|12110582|P1|NOT COMPLETED|Overall Study||0
4922203|NCT03346161|12110581|P2|COMPLETED|Overall Study||60
4922204|NCT03346161|12110582|P1|COMPLETED|Overall Study||60
4922205|NCT03346161|12110581|P2|STARTED|Overall Study||60
4922206|NCT03346161|12110582|P1|STARTED|Overall Study||60
4922207|NCT03346070|12110615|P5|NOT COMPLETED|Overall Study||5
4922208|NCT03346070|12110616|P4|NOT COMPLETED|Overall Study||6
4922209|NCT03346070|12110617|P3|NOT COMPLETED|Overall Study||4
4922210|NCT03346070|12110618|P2|NOT COMPLETED|Overall Study||4
4922211|NCT03346070|12110619|P1|NOT COMPLETED|Overall Study||3
4922212|NCT03346070|12110615|P5|COMPLETED|Overall Study||37
4922213|NCT03346070|12110616|P4|COMPLETED|Overall Study||36
4922214|NCT03346070|12110617|P3|COMPLETED|Overall Study||37
4922215|NCT03346070|12110618|P2|COMPLETED|Overall Study||37
4922216|NCT03346070|12110619|P1|COMPLETED|Overall Study||38
4922217|NCT03346070|12110615|P5|Treated|Overall Study||38
4922218|NCT03346070|12110616|P4|Treated|Overall Study||36
4922219|NCT03346070|12110617|P3|Treated|Overall Study||38
4922220|NCT03346070|12110618|P2|Treated|Overall Study||38
4922221|NCT03346070|12110619|P1|Treated|Overall Study||38
4922222|NCT03346070|12110615|P5|STARTED|Overall Study||42
4922223|NCT03346070|12110616|P4|STARTED|Overall Study||42
4922224|NCT03346070|12110617|P3|STARTED|Overall Study||41
4922225|NCT03346070|12110618|P2|STARTED|Overall Study||41
4922226|NCT03346070|12110619|P1|STARTED|Overall Study||41
4922227|NCT03345472|12110703|P1|NOT COMPLETED|3 Months to 12 Months||8
4922228|NCT03345472|12110703|P1|COMPLETED|3 Months to 12 Months||91
4922229|NCT03345472|12110703|P1|STARTED|3 Months to 12 Months||99
4922230|NCT03345472|12110703|P1|NOT COMPLETED|Implant to 3 Months||4
4922231|NCT03345472|12110703|P1|COMPLETED|Implant to 3 Months||99
4922232|NCT03345472|12110703|P1|STARTED|Implant to 3 Months||103
4922233|NCT03345407|12110717|P7|NOT COMPLETED|Overall Study||45
4922234|NCT03345407|12110718|P6|NOT COMPLETED|Overall Study||16
4922235|NCT03345407|12110719|P5|NOT COMPLETED|Overall Study||15
4922236|NCT03345407|12110720|P4|NOT COMPLETED|Overall Study||11
4922237|NCT03345407|12110721|P3|NOT COMPLETED|Overall Study||12
4922238|NCT03345407|12110722|P2|NOT COMPLETED|Overall Study||3
4922239|NCT03345407|12110723|P1|NOT COMPLETED|Overall Study||32
4922240|NCT03345407|12110717|P7|COMPLETED|Overall Study||233
4922241|NCT03345407|12110718|P6|COMPLETED|Overall Study||73
4922242|NCT03345407|12110719|P5|COMPLETED|Overall Study||75
4922243|NCT03345407|12110720|P4|COMPLETED|Overall Study||81
4922244|NCT03345407|12110721|P3|COMPLETED|Overall Study||79
4922245|NCT03345407|12110722|P2|COMPLETED|Overall Study||19
4922246|NCT03345407|12110723|P1|COMPLETED|Overall Study||244
4922247|NCT03345407|12110717|P7|STARTED|Overall Study||278
4922248|NCT03345407|12110718|P6|STARTED|Overall Study||89
4922249|NCT03345407|12110719|P5|STARTED|Overall Study||90
4922250|NCT03345407|12110720|P4|STARTED|Overall Study||92
4922251|NCT03345407|12110721|P3|STARTED|Overall Study||91
4922252|NCT03345407|12110722|P2|STARTED|Overall Study||22
4922253|NCT03345407|12110723|P1|STARTED|Overall Study||276
4922254|NCT03345108|12110908|P6|NOT COMPLETED|Period-3||0
4922255|NCT03345108|12110909|P5|NOT COMPLETED|Period-3||0
4922256|NCT03345108|12110910|P4|NOT COMPLETED|Period-3||0
4922257|NCT03345108|12110911|P3|NOT COMPLETED|Period-3||0
4922258|NCT03345108|12110912|P2|NOT COMPLETED|Period-3||0
4922259|NCT03345108|12110913|P1|NOT COMPLETED|Period-3||0
4922260|NCT03345108|12110908|P6|COMPLETED|Period-3||8
4922261|NCT03345108|12110909|P5|COMPLETED|Period-3||8
4922262|NCT03345108|12110910|P4|COMPLETED|Period-3||8
4922263|NCT03345108|12110911|P3|COMPLETED|Period-3||8
4922264|NCT03345108|12110912|P2|COMPLETED|Period-3||8
4922265|NCT03345108|12110913|P1|COMPLETED|Period-3||7
4922266|NCT03345108|12110908|P6|STARTED|Period-3||8
4922267|NCT03345108|12110909|P5|STARTED|Period-3||8
4922268|NCT03345108|12110910|P4|STARTED|Period-3||8
4922269|NCT03345108|12110911|P3|STARTED|Period-3||8
4922270|NCT03345108|12110912|P2|STARTED|Period-3||8
4922271|NCT03345108|12110913|P1|STARTED|Period-3||7
4922272|NCT03345108|12110908|P6|NOT COMPLETED|Period-2||0
4922273|NCT03345108|12110909|P5|NOT COMPLETED|Period-2||0
4922274|NCT03345108|12110910|P4|NOT COMPLETED|Period-2||0
4922275|NCT03345108|12110911|P3|NOT COMPLETED|Period-2||0
4922276|NCT03345108|12110912|P2|NOT COMPLETED|Period-2||0
4922277|NCT03345108|12110913|P1|NOT COMPLETED|Period-2||0
4922278|NCT03345108|12110908|P6|COMPLETED|Period-2||8
4922279|NCT03345108|12110909|P5|COMPLETED|Period-2||8
4922280|NCT03345108|12110910|P4|COMPLETED|Period-2||8
4922281|NCT03345108|12110911|P3|COMPLETED|Period-2||8
4922282|NCT03345108|12110912|P2|COMPLETED|Period-2||8
4922283|NCT03345108|12110913|P1|COMPLETED|Period-2||8
4922284|NCT03345108|12110908|P6|STARTED|Period-2||8
4922285|NCT03345108|12110909|P5|STARTED|Period-2||8
4922286|NCT03345108|12110910|P4|STARTED|Period-2||8
4922287|NCT03345108|12110911|P3|STARTED|Period-2||8
4922288|NCT03345108|12110912|P2|STARTED|Period-2||8
4922289|NCT03345108|12110913|P1|STARTED|Period-2||8
4922290|NCT03345108|12110908|P6|NOT COMPLETED|Period-1||0
4922291|NCT03345108|12110909|P5|NOT COMPLETED|Period-1||0
4922292|NCT03345108|12110910|P4|NOT COMPLETED|Period-1||0
4922293|NCT03345108|12110911|P3|NOT COMPLETED|Period-1||0
4922294|NCT03345108|12110912|P2|NOT COMPLETED|Period-1||0
4922295|NCT03345108|12110913|P1|NOT COMPLETED|Period-1||0
4922296|NCT03345108|12110908|P6|COMPLETED|Period-1||8
4922297|NCT03345108|12110909|P5|COMPLETED|Period-1||8
4922298|NCT03345108|12110910|P4|COMPLETED|Period-1||8
4922299|NCT03345108|12110911|P3|COMPLETED|Period-1||8
4922300|NCT03345108|12110912|P2|COMPLETED|Period-1||8
4922301|NCT03345108|12110913|P1|COMPLETED|Period-1||8
4922302|NCT03345108|12110908|P6|STARTED|Period-1||8
4922303|NCT03345108|12110909|P5|STARTED|Period-1||8
4922304|NCT03345108|12110910|P4|STARTED|Period-1||8
4922305|NCT03345108|12110911|P3|STARTED|Period-1||8
4922306|NCT03345108|12110912|P2|STARTED|Period-1||8
4922307|NCT03345108|12110913|P1|STARTED|Period-1||8
4922308|NCT03344861|12110921|P1|NOT COMPLETED|Overall Study||0
4922309|NCT03344861|12110921|P1|COMPLETED|Overall Study||10
4922310|NCT03344861|12110921|P1|STARTED|Overall Study||10
4922311|NCT03344510|12110950|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
4922312|NCT03344510|12110951|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
4922313|NCT03344510|12110950|P2|COMPLETED|Second Injection (5 Minutes)||26
4922314|NCT03344510|12110951|P1|COMPLETED|Second Injection (5 Minutes)||21
4922315|NCT03344510|12110950|P2|Received Injection|Second Injection (5 Minutes)||26
4922316|NCT03344510|12110951|P1|Received Injection|Second Injection (5 Minutes)||21
4922317|NCT03344510|12110950|P2|STARTED|Second Injection (5 Minutes)||26
4922318|NCT03344510|12110951|P1|STARTED|Second Injection (5 Minutes)||21
4922319|NCT03344510|12110950|P2|NOT COMPLETED|Wash Out (10 Minutes||0
4922320|NCT03344510|12110951|P1|NOT COMPLETED|Wash Out (10 Minutes||0
4922321|NCT03344510|12110950|P2|COMPLETED|Wash Out (10 Minutes||26
4922322|NCT03344510|12110951|P1|COMPLETED|Wash Out (10 Minutes||21
4922323|NCT03344510|12110950|P2|STARTED|Wash Out (10 Minutes||26
4922324|NCT03344510|12110951|P1|STARTED|Wash Out (10 Minutes||21
4922325|NCT03344510|12110950|P2|NOT COMPLETED|First Injection (5 Minutes)||0
4922326|NCT03344510|12110951|P1|NOT COMPLETED|First Injection (5 Minutes)||0
4922327|NCT03344510|12110950|P2|COMPLETED|First Injection (5 Minutes)||26
4922328|NCT03344510|12110951|P1|COMPLETED|First Injection (5 Minutes)||21
4922329|NCT03344510|12110950|P2|Received Injection|First Injection (5 Minutes)||26
4922330|NCT03344510|12110951|P1|Received Injection|First Injection (5 Minutes)||21
4922331|NCT03344510|12110950|P2|STARTED|First Injection (5 Minutes)||26
4922332|NCT03344510|12110951|P1|STARTED|First Injection (5 Minutes)||21
4922333|NCT03344172|12110960|P2|NOT COMPLETED|Overall Study||0
4922334|NCT03344172|12110961|P1|NOT COMPLETED|Overall Study||1
4922335|NCT03344172|12110960|P2|COMPLETED|Overall Study||16
4922336|NCT03344172|12110961|P1|COMPLETED|Overall Study||15
4922337|NCT03344172|12110960|P2|STARTED|Overall Study||16
4922338|NCT03344172|12110961|P1|STARTED|Overall Study||16
4922339|NCT03343639|12110979|P2|NOT COMPLETED|Overall Study||12
4922340|NCT03343639|12110980|P1|NOT COMPLETED|Overall Study||14
4922341|NCT03343639|12110979|P2|COMPLETED|Overall Study||90
4922342|NCT03343639|12110980|P1|COMPLETED|Overall Study||88
4922343|NCT03343639|12110979|P2|STARTED|Overall Study||102
4922344|NCT03343639|12110980|P1|STARTED|Overall Study||102
4922345|NCT03343080|12110994|P2|NOT COMPLETED|Overall Study||0
4922346|NCT03343080|12110995|P1|NOT COMPLETED|Overall Study||0
4922347|NCT03343080|12110994|P2|COMPLETED|Overall Study||18
4922348|NCT03343080|12110995|P1|COMPLETED|Overall Study||14
4922349|NCT03343080|12110994|P2|STARTED|Overall Study||18
4922350|NCT03343080|12110995|P1|STARTED|Overall Study||14
4922351|NCT03343067|12111008|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
4922352|NCT03343067|12111009|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
4922353|NCT03343067|12111010|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
4922354|NCT03343067|12111008|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
4922355|NCT03343067|12111009|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
4922356|NCT03343067|12111010|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
4922357|NCT03343067|12111008|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
4922358|NCT03343067|12111009|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
4922359|NCT03343067|12111010|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
4922360|NCT03343067|12111008|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
4922361|NCT03343067|12111009|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
4922362|NCT03343067|12111010|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
4922363|NCT03343067|12111008|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
4922364|NCT03343067|12111009|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
4922365|NCT03343067|12111010|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
4922366|NCT03343067|12111008|P3|STARTED|Open Label Period: Day 1 to Month 3||1
4922367|NCT03343067|12111009|P2|STARTED|Open Label Period: Day 1 to Month 3||3
4922368|NCT03343067|12111010|P1|STARTED|Open Label Period: Day 1 to Month 3||7
4922369|NCT03342560|12111135|P1|NOT COMPLETED|Overall Study||2
4922370|NCT03342560|12111135|P1|COMPLETED|Overall Study||28
4922371|NCT03342560|12111135|P1|STARTED|Overall Study||30
4922372|NCT03341923|12111143|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
4922373|NCT03341923|12111144|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
4922374|NCT03341923|12111143|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
4922375|NCT03341923|12111144|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
4922376|NCT03341923|12111143|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
4922377|NCT03341923|12111144|P1|STARTED|Period 2, Second 14 Days of Wear||67
4922378|NCT03341923|12111143|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
4922379|NCT03341923|12111144|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
4922380|NCT03341923|12111143|P2|COMPLETED|Period 1, First 14 Days of Wear||67
4922381|NCT03341923|12111144|P1|COMPLETED|Period 1, First 14 Days of Wear||67
4922382|NCT03341923|12111143|P2|STARTED|Period 1, First 14 Days of Wear||67
4922383|NCT03341923|12111144|P1|STARTED|Period 1, First 14 Days of Wear||67
4922384|NCT03341728|12111152|P2|NOT COMPLETED|Session 2||0
4922385|NCT03341728|12111153|P1|NOT COMPLETED|Session 2||0
4922386|NCT03341728|12111152|P2|COMPLETED|Session 2||7
4922387|NCT03341728|12111153|P1|COMPLETED|Session 2||7
4922388|NCT03341728|12111152|P2|STARTED|Session 2||7
4922389|NCT03341728|12111153|P1|STARTED|Session 2||7
4922390|NCT03341728|12111152|P2|NOT COMPLETED|Washout (1 Week)||0
4922391|NCT03341728|12111153|P1|NOT COMPLETED|Washout (1 Week)||0
4922392|NCT03341728|12111152|P2|COMPLETED|Washout (1 Week)||7
4922393|NCT03341728|12111153|P1|COMPLETED|Washout (1 Week)||7
4922394|NCT03341728|12111152|P2|STARTED|Washout (1 Week)||7
4922395|NCT03341728|12111153|P1|STARTED|Washout (1 Week)||7
4922396|NCT03341728|12111152|P2|NOT COMPLETED|Session 1||0
4922397|NCT03341728|12111153|P1|NOT COMPLETED|Session 1||0
4922398|NCT03341728|12111152|P2|COMPLETED|Session 1||7
4922399|NCT03341728|12111153|P1|COMPLETED|Session 1||7
4922400|NCT03341728|12111152|P2|STARTED|Session 1||7
4922401|NCT03341728|12111153|P1|STARTED|Session 1||7
4922402|NCT03341637|12111171|P2|NOT COMPLETED|Overall Study||4
4922403|NCT03341637|12111172|P1|NOT COMPLETED|Overall Study||5
4922404|NCT03341637|12111171|P2|COMPLETED|Overall Study||296
4922405|NCT03341637|12111172|P1|COMPLETED|Overall Study||95
4922406|NCT03341637|12111171|P2|STARTED|Overall Study||300
4922407|NCT03341637|12111172|P1|STARTED|Overall Study||100
4922408|NCT03341546|12111194|P1|NOT COMPLETED|Overall Study||0
4922409|NCT03341546|12111194|P1|COMPLETED|Overall Study||20
4922410|NCT03341546|12111194|P1|STARTED|Overall Study||20
4922411|NCT03341533|12111200|P2|NOT COMPLETED|Overall Study||2
4922412|NCT03341533|12111201|P1|NOT COMPLETED|Overall Study||3
4922413|NCT03341533|12111200|P2|COMPLETED|Overall Study||68
4922414|NCT03341533|12111201|P1|COMPLETED|Overall Study||69
4922415|NCT03341533|12111200|P2|STARTED|Overall Study||70
4922416|NCT03341533|12111201|P1|STARTED|Overall Study||72
4922417|NCT03341312|12111213|P4|NOT COMPLETED|Period 4||0
4922418|NCT03341312|12111214|P3|NOT COMPLETED|Period 4||0
4922419|NCT03341312|12111215|P2|NOT COMPLETED|Period 4||0
4922420|NCT03341312|12111216|P1|NOT COMPLETED|Period 4||0
4922421|NCT03341312|12111213|P4|COMPLETED|Period 4||8
4922422|NCT03341312|12111214|P3|COMPLETED|Period 4||9
4922423|NCT03341312|12111215|P2|COMPLETED|Period 4||9
4922424|NCT03341312|12111216|P1|COMPLETED|Period 4||9
4922425|NCT03341312|12111213|P4|STARTED|Period 4||8
4922426|NCT03341312|12111214|P3|STARTED|Period 4||9
4922427|NCT03341312|12111215|P2|STARTED|Period 4||9
4922428|NCT03341312|12111216|P1|STARTED|Period 4||9
4922429|NCT03341312|12111213|P4|NOT COMPLETED|Period 3||0
4922430|NCT03341312|12111214|P3|NOT COMPLETED|Period 3||0
4922431|NCT03341312|12111215|P2|NOT COMPLETED|Period 3||0
4922432|NCT03341312|12111216|P1|NOT COMPLETED|Period 3||0
4922433|NCT03341312|12111213|P4|COMPLETED|Period 3||8
4922434|NCT03341312|12111214|P3|COMPLETED|Period 3||9
4922435|NCT03341312|12111215|P2|COMPLETED|Period 3||9
4922436|NCT03341312|12111216|P1|COMPLETED|Period 3||9
4922437|NCT03341312|12111213|P4|STARTED|Period 3||8
4922438|NCT03341312|12111214|P3|STARTED|Period 3||9
4922439|NCT03341312|12111215|P2|STARTED|Period 3||9
4922440|NCT03341312|12111216|P1|STARTED|Period 3||9
4922441|NCT03341312|12111213|P4|NOT COMPLETED|Period 2||0
4922442|NCT03341312|12111214|P3|NOT COMPLETED|Period 2||0
4922443|NCT03341312|12111215|P2|NOT COMPLETED|Period 2||0
4922444|NCT03341312|12111216|P1|NOT COMPLETED|Period 2||0
4922445|NCT03341312|12111213|P4|COMPLETED|Period 2||8
4922446|NCT03341312|12111214|P3|COMPLETED|Period 2||9
4922447|NCT03341312|12111215|P2|COMPLETED|Period 2||9
4922448|NCT03341312|12111216|P1|COMPLETED|Period 2||9
4922449|NCT03341312|12111213|P4|STARTED|Period 2||8
4922450|NCT03341312|12111214|P3|STARTED|Period 2||9
4922451|NCT03341312|12111215|P2|STARTED|Period 2||9
4922452|NCT03341312|12111216|P1|STARTED|Period 2||9
4922453|NCT03341312|12111213|P4|NOT COMPLETED|Period 1||0
4922454|NCT03341312|12111214|P3|NOT COMPLETED|Period 1||0
4922455|NCT03341312|12111215|P2|NOT COMPLETED|Period 1||1
4922456|NCT03341312|12111216|P1|NOT COMPLETED|Period 1||0
4922457|NCT03341312|12111213|P4|COMPLETED|Period 1||8
4922458|NCT03341312|12111214|P3|COMPLETED|Period 1||9
4922459|NCT03341312|12111215|P2|COMPLETED|Period 1||9
4922460|NCT03341312|12111216|P1|COMPLETED|Period 1||9
4922461|NCT03341312|12111213|P4|Received at Least One Dose of Study Drug|Period 1||8
4922462|NCT03341312|12111214|P3|Received at Least One Dose of Study Drug|Period 1||9
4922463|NCT03341312|12111215|P2|Received at Least One Dose of Study Drug|Period 1||10
4922464|NCT03341312|12111216|P1|Received at Least One Dose of Study Drug|Period 1||9
4922465|NCT03341312|12111213|P4|STARTED|Period 1||8
4922466|NCT03341312|12111214|P3|STARTED|Period 1||9
4922467|NCT03341312|12111215|P2|STARTED|Period 1||10
4922468|NCT03341312|12111216|P1|STARTED|Period 1||9
4922469|NCT03341299|12111228|P4|NOT COMPLETED|Period 4||0
4922470|NCT03341299|12111229|P3|NOT COMPLETED|Period 4||0
4922471|NCT03341299|12111230|P2|NOT COMPLETED|Period 4||0
4922472|NCT03341299|12111231|P1|NOT COMPLETED|Period 4||0
4922473|NCT03341299|12111228|P4|COMPLETED|Period 4||9
4922474|NCT03341299|12111229|P3|COMPLETED|Period 4||8
4922475|NCT03341299|12111230|P2|COMPLETED|Period 4||9
4922476|NCT03341299|12111231|P1|COMPLETED|Period 4||9
4922477|NCT03341299|12111228|P4|STARTED|Period 4||9
4922478|NCT03341299|12111229|P3|STARTED|Period 4||8
4922479|NCT03341299|12111230|P2|STARTED|Period 4||9
4922480|NCT03341299|12111231|P1|STARTED|Period 4||9
4922481|NCT03341299|12111228|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922482|NCT03341299|12111229|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922483|NCT03341299|12111230|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922484|NCT03341299|12111231|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922485|NCT03341299|12111228|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922486|NCT03341299|12111229|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
4922487|NCT03341299|12111230|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922488|NCT03341299|12111231|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922489|NCT03341299|12111228|P4|STARTED|Washout (A Minimum of 21 Hours)||9
4922490|NCT03341299|12111229|P3|STARTED|Washout (A Minimum of 21 Hours)||8
4922491|NCT03341299|12111230|P2|STARTED|Washout (A Minimum of 21 Hours)||9
4922492|NCT03341299|12111231|P1|STARTED|Washout (A Minimum of 21 Hours)||9
4922493|NCT03341299|12111228|P4|NOT COMPLETED|Period 3||0
4922494|NCT03341299|12111229|P3|NOT COMPLETED|Period 3||0
4922495|NCT03341299|12111230|P2|NOT COMPLETED|Period 3||0
4922496|NCT03341299|12111231|P1|NOT COMPLETED|Period 3||0
4922497|NCT03341299|12111228|P4|COMPLETED|Period 3||9
4922498|NCT03341299|12111229|P3|COMPLETED|Period 3||8
4922499|NCT03341299|12111230|P2|COMPLETED|Period 3||9
4922500|NCT03341299|12111231|P1|COMPLETED|Period 3||9
4922501|NCT03341299|12111228|P4|STARTED|Period 3||9
4922502|NCT03341299|12111229|P3|STARTED|Period 3||8
4922503|NCT03341299|12111230|P2|STARTED|Period 3||9
4922504|NCT03341299|12111231|P1|STARTED|Period 3||9
4922505|NCT03341299|12111228|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922506|NCT03341299|12111229|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922507|NCT03341299|12111230|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922508|NCT03341299|12111231|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922509|NCT03341299|12111228|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922510|NCT03341299|12111229|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
4922511|NCT03341299|12111230|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922512|NCT03341299|12111231|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922513|NCT03341299|12111228|P4|STARTED|Washout (A Minimum of 21 Hours)||9
4922514|NCT03341299|12111229|P3|STARTED|Washout (A Minimum of 21 Hours)||8
4922515|NCT03341299|12111230|P2|STARTED|Washout (A Minimum of 21 Hours)||9
4922516|NCT03341299|12111231|P1|STARTED|Washout (A Minimum of 21 Hours)||9
4922517|NCT03341299|12111228|P4|NOT COMPLETED|Period 2||0
4922518|NCT03341299|12111229|P3|NOT COMPLETED|Period 2||0
4922519|NCT03341299|12111230|P2|NOT COMPLETED|Period 2||0
4922520|NCT03341299|12111231|P1|NOT COMPLETED|Period 2||0
4922521|NCT03341299|12111228|P4|COMPLETED|Period 2||9
4922522|NCT03341299|12111229|P3|COMPLETED|Period 2||8
4922523|NCT03341299|12111230|P2|COMPLETED|Period 2||9
4922524|NCT03341299|12111231|P1|COMPLETED|Period 2||9
4922525|NCT03341299|12111228|P4|STARTED|Period 2||9
4922526|NCT03341299|12111229|P3|STARTED|Period 2||8
4922527|NCT03341299|12111230|P2|STARTED|Period 2||9
4922528|NCT03341299|12111231|P1|STARTED|Period 2||9
4922529|NCT03341299|12111228|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922530|NCT03341299|12111229|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
4922531|NCT03341299|12111230|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922532|NCT03341299|12111231|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
4922533|NCT03341299|12111228|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922534|NCT03341299|12111229|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
4922535|NCT03341299|12111230|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922536|NCT03341299|12111231|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
4922537|NCT03341299|12111228|P4|STARTED|Washout (A Minimum of 21 Hours)||9
4922538|NCT03341299|12111229|P3|STARTED|Washout (A Minimum of 21 Hours)||9
4922539|NCT03341299|12111230|P2|STARTED|Washout (A Minimum of 21 Hours)||9
4922540|NCT03341299|12111231|P1|STARTED|Washout (A Minimum of 21 Hours)||9
4922541|NCT03341299|12111228|P4|NOT COMPLETED|Period 1||0
4922542|NCT03341299|12111229|P3|NOT COMPLETED|Period 1||0
4922543|NCT03341299|12111230|P2|NOT COMPLETED|Period 1||0
4922544|NCT03341299|12111231|P1|NOT COMPLETED|Period 1||0
4922545|NCT03341299|12111228|P4|COMPLETED|Period 1||9
4922546|NCT03341299|12111229|P3|COMPLETED|Period 1||9
4922547|NCT03341299|12111230|P2|COMPLETED|Period 1||9
4922548|NCT03341299|12111231|P1|COMPLETED|Period 1||9
4922549|NCT03341299|12111228|P4|STARTED|Period 1||9
4922550|NCT03341299|12111229|P3|STARTED|Period 1||9
4922551|NCT03341299|12111230|P2|STARTED|Period 1||9
4922552|NCT03341299|12111231|P1|STARTED|Period 1||9
4922553|NCT03340961|12111247|P4|NOT COMPLETED|Overall Study||18
4922554|NCT03340961|12111248|P3|NOT COMPLETED|Overall Study||9
4922555|NCT03340961|12111249|P2|NOT COMPLETED|Overall Study||12
4922556|NCT03340961|12111250|P1|NOT COMPLETED|Overall Study||6
4922557|NCT03340961|12111247|P4|COMPLETED|Overall Study||35
4922558|NCT03340961|12111248|P3|COMPLETED|Overall Study||40
4922559|NCT03340961|12111249|P2|COMPLETED|Overall Study||38
4922560|NCT03340961|12111250|P1|COMPLETED|Overall Study||47
4922561|NCT03340961|12111247|P4|STARTED|Overall Study||53
4922562|NCT03340961|12111248|P3|STARTED|Overall Study||49
4922563|NCT03340961|12111249|P2|STARTED|Overall Study||50
4922564|NCT03340961|12111250|P1|STARTED|Overall Study||53
4922565|NCT03340805|12111270|P2|NOT COMPLETED|Overall Study||0
4922566|NCT03340805|12111271|P1|NOT COMPLETED|Overall Study||0
4922567|NCT03340805|12111270|P2|COMPLETED|Overall Study||26
4922568|NCT03340805|12111271|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
4922569|NCT03340805|12111270|P2|STARTED|Overall Study||26
4922570|NCT03340805|12111271|P1|STARTED|Overall Study||24
4922571|NCT03340610|12111291|P1|NOT COMPLETED|Overall Study||3
4922572|NCT03340610|12111291|P1|COMPLETED|Overall Study||27
4922573|NCT03340610|12111291|P1|STARTED|Overall Study||30
4922574|NCT03340350|12111295|P1|NOT COMPLETED|Overall Study||6
4922575|NCT03340350|12111295|P1|COMPLETED|Overall Study||4
4922576|NCT03340350|12111295|P1|STARTED|Overall Study||10
4922577|NCT03339726|12111310|P3|NOT COMPLETED|Overall Study||0
4922578|NCT03339726|12111311|P2|NOT COMPLETED|Overall Study||1
4922579|NCT03339726|12111312|P1|NOT COMPLETED|Overall Study||1
4922580|NCT03339726|12111310|P3|COMPLETED|Overall Study||63
4922581|NCT03339726|12111311|P2|COMPLETED|Overall Study||65
4922582|NCT03339726|12111312|P1|COMPLETED|Overall Study||63
4922583|NCT03339726|12111310|P3|STARTED|Overall Study||63
4922584|NCT03339726|12111311|P2|STARTED|Overall Study||66
4922585|NCT03339726|12111312|P1|STARTED|Overall Study||64
4922586|NCT03339583|12111370|P2|NOT COMPLETED|Follow-up (14 Days)||3
4922587|NCT03339583|12111371|P1|NOT COMPLETED|Follow-up (14 Days)||6
4922588|NCT03339583|12111370|P2|COMPLETED|Follow-up (14 Days)||18
4922589|NCT03339583|12111371|P1|COMPLETED|Follow-up (14 Days)||12
4922590|NCT03339583|12111370|P2|STARTED|Follow-up (14 Days)||21
4922591|NCT03339583|12111371|P1|STARTED|Follow-up (14 Days)||18
4922592|NCT03339583|12111370|P2|NOT COMPLETED|Second Intervention (14 Days)||2
4922593|NCT03339583|12111371|P1|NOT COMPLETED|Second Intervention (14 Days)||0
4922594|NCT03339583|12111370|P2|COMPLETED|Second Intervention (14 Days)||21
4922595|NCT03339583|12111371|P1|COMPLETED|Second Intervention (14 Days)||18
4922596|NCT03339583|12111370|P2|STARTED|Second Intervention (14 Days)||23
4922597|NCT03339583|12111371|P1|STARTED|Second Intervention (14 Days)||18
4922598|NCT03339583|12111370|P2|NOT COMPLETED|Washout (14 Days)||0
4922599|NCT03339583|12111371|P1|NOT COMPLETED|Washout (14 Days)||0
4922600|NCT03339583|12111370|P2|COMPLETED|Washout (14 Days)||23
4922601|NCT03339583|12111371|P1|COMPLETED|Washout (14 Days)||18
4922602|NCT03339583|12111370|P2|STARTED|Washout (14 Days)||23
4922603|NCT03339583|12111371|P1|STARTED|Washout (14 Days)||18
4922604|NCT03339583|12111370|P2|NOT COMPLETED|First Intervention (14 Days)||0
4922605|NCT03339583|12111371|P1|NOT COMPLETED|First Intervention (14 Days)||1
4922606|NCT03339583|12111370|P2|COMPLETED|First Intervention (14 Days)||23
4922607|NCT03339583|12111371|P1|COMPLETED|First Intervention (14 Days)||18
4922608|NCT03339583|12111370|P2|STARTED|First Intervention (14 Days)||23
4922609|NCT03339583|12111371|P1|STARTED|First Intervention (14 Days)||19
4922610|NCT03339453|12111409|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
4922611|NCT03339453|12111410|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
4922612|NCT03339453|12111409|P2|COMPLETED|Second Visit for Alternate Glucagon||34
4922613|NCT03339453|12111410|P1|COMPLETED|Second Visit for Alternate Glucagon||35
4922614|NCT03339453|12111409|P2|STARTED|Second Visit for Alternate Glucagon||34
4922615|NCT03339453|12111410|P1|STARTED|Second Visit for Alternate Glucagon||35
4922616|NCT03339453|12111409|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
4922617|NCT03339453|12111410|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
4922618|NCT03339453|12111409|P2|COMPLETED|First Visit of Glucagon Treatment||34
4922619|NCT03339453|12111410|P1|COMPLETED|First Visit of Glucagon Treatment||35
4922620|NCT03339453|12111409|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
4922621|NCT03339453|12111410|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
4922622|NCT03339453|12111409|P2|STARTED|First Visit of Glucagon Treatment||35
4922623|NCT03339453|12111410|P1|STARTED|First Visit of Glucagon Treatment||35
4922624|NCT03338816|12111428|P2|NOT COMPLETED|Open-Label Extension Period||47
4922625|NCT03338816|12111429|P1|NOT COMPLETED|Open-Label Extension Period||46
4922626|NCT03338816|12111428|P2|COMPLETED|Open-Label Extension Period||0
4922627|NCT03338816|12111429|P1|COMPLETED|Open-Label Extension Period||0
4922628|NCT03338816|12111428|P2|STARTED|Open-Label Extension Period||47
4922629|NCT03338816|12111429|P1|STARTED|Open-Label Extension Period||46
4922630|NCT03338816|12111428|P2|NOT COMPLETED|6-Month Double-blind Period||1
4922631|NCT03338816|12111429|P1|NOT COMPLETED|6-Month Double-blind Period||0
4922632|NCT03338816|12111428|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
4922633|NCT03338816|12111429|P1|COMPLETED|6-Month Double-blind Period||46
4922634|NCT03338816|12111428|P2|STARTED|6-Month Double-blind Period||48
4922635|NCT03338816|12111429|P1|STARTED|6-Month Double-blind Period||46
4922636|NCT03338803|12111457|P1|NOT COMPLETED|Overall Study||0
4922637|NCT03338803|12111457|P1|COMPLETED|Overall Study||11001
4922638|NCT03338803|12111457|P1|STARTED|Overall Study||11001
4922639|NCT03338556|12111468|P4|NOT COMPLETED|Overall Study||2
4922640|NCT03338556|12111469|P3|NOT COMPLETED|Overall Study||2
4922641|NCT03338556|12111470|P2|NOT COMPLETED|Overall Study||4
4922642|NCT03338556|12111471|P1|NOT COMPLETED|Overall Study||2
4922643|NCT03338556|12111468|P4|COMPLETED|Overall Study||24
4922644|NCT03338556|12111469|P3|COMPLETED|Overall Study||22
4922645|NCT03338556|12111470|P2|COMPLETED|Overall Study||23
4922646|NCT03338556|12111471|P1|COMPLETED|Overall Study||23
4922647|NCT03338556|12111468|P4|STARTED|Overall Study||26
4922648|NCT03338556|12111469|P3|STARTED|Overall Study||24
4922649|NCT03338556|12111470|P2|STARTED|Overall Study||27
4922650|NCT03338556|12111471|P1|STARTED|Overall Study||25
4922651|NCT03338400|12111491|P2|NOT COMPLETED|Overall Study||2
4922652|NCT03338400|12111492|P1|NOT COMPLETED|Overall Study||1
4922653|NCT03338400|12111491|P2|COMPLETED|Overall Study||24
4922654|NCT03338400|12111492|P1|COMPLETED|Overall Study||24
4922655|NCT03338400|12111491|P2|STARTED|Overall Study||26
4922656|NCT03338400|12111492|P1|STARTED|Overall Study||25
4922657|NCT03338036|12111502|P4|NOT COMPLETED|Overall Study||0
4922658|NCT03338036|12111503|P3|NOT COMPLETED|Overall Study||3
4922659|NCT03338036|12111504|P2|NOT COMPLETED|Overall Study||4
4922660|NCT03338036|12111505|P1|NOT COMPLETED|Overall Study||0
4922661|NCT03338036|12111502|P4|COMPLETED|Overall Study||8
4922662|NCT03338036|12111503|P3|COMPLETED|Overall Study||9
4922663|NCT03338036|12111504|P2|COMPLETED|Overall Study||7
4922664|NCT03338036|12111505|P1|COMPLETED|Overall Study||0
4922665|NCT03338036|12111502|P4|STARTED|Overall Study||8
4922666|NCT03338036|12111503|P3|STARTED|Overall Study||12
4922667|NCT03338036|12111504|P2|STARTED|Overall Study||11
4922668|NCT03338036|12111505|P1|STARTED|Overall Study||0
4922669|NCT03337477|12111527|P2|NOT COMPLETED|Overall Study||13
4922670|NCT03337477|12111528|P1|NOT COMPLETED|Overall Study||11
4922671|NCT03337477|12111527|P2|COMPLETED|Overall Study||24
4922672|NCT03337477|12111528|P1|COMPLETED|Overall Study||22
4922673|NCT03337477|12111527|P2|STARTED|Overall Study||37
4922674|NCT03337477|12111528|P1|STARTED|Overall Study||33
4922675|NCT03337308|12111552|P4|NOT COMPLETED|Overall Study||2
4922676|NCT03337308|12111553|P3|NOT COMPLETED|Overall Study||5
4922677|NCT03337308|12111554|P2|NOT COMPLETED|Overall Study||7
4922678|NCT03337308|12111555|P1|NOT COMPLETED|Overall Study||5
4922679|NCT03337308|12111552|P4|COMPLETED|Overall Study||53
4922680|NCT03337308|12111553|P3|COMPLETED|Overall Study||104
4922681|NCT03337308|12111554|P2|COMPLETED|Overall Study||103
4922682|NCT03337308|12111555|P1|COMPLETED|Overall Study||103
4922683|NCT03337308|12111552|P4|STARTED|Overall Study||55
4922684|NCT03337308|12111553|P3|STARTED|Overall Study||109
4922685|NCT03337308|12111554|P2|STARTED|Overall Study||110
4922686|NCT03337308|12111555|P1|STARTED|Overall Study||108
4922687|NCT03336853|12111591|P2|NOT COMPLETED|Overall Study||0
4922688|NCT03336853|12111592|P1|NOT COMPLETED|Overall Study||0
4922689|NCT03336853|12111591|P2|COMPLETED|Overall Study||30
4922690|NCT03336853|12111592|P1|COMPLETED|Overall Study||30
4922691|NCT03336853|12111591|P2|STARTED|Overall Study||30
4922692|NCT03336853|12111592|P1|STARTED|Overall Study||30
4922693|NCT03336645|12111598|P1|NOT COMPLETED|Overall Study||0
4922694|NCT03336645|12111598|P1|COMPLETED|Overall Study||25
4922695|NCT03336645|12111598|P1|STARTED|Overall Study||25
4922696|NCT03336502|12111622|P2|NOT COMPLETED|Overall Study||9
4922697|NCT03336502|12111623|P1|NOT COMPLETED|Overall Study||4
4922698|NCT03336502|12111622|P2|COMPLETED|Overall Study||31
4922699|NCT03336502|12111623|P1|COMPLETED|Overall Study||26
4922700|NCT03336502|12111622|P2|STARTED|Overall Study||40
4922701|NCT03336502|12111623|P1|STARTED|Overall Study||30
4922702|NCT03335800|12111650|P1|NOT COMPLETED|Overall Study||419531
4922703|NCT03335800|12111650|P1|COMPLETED|Overall Study||396
4922704|NCT03335800|12111650|P1|Attended Second Study Visit|Overall Study||396
4922705|NCT03335800|12111650|P1|ECG Patch Returned for Analysis|Overall Study||450
4922706|NCT03335800|12111650|P1|ECG Patch Shipped|Overall Study||658
4922707|NCT03335800|12111650|P1|Attended First Study Visit|Overall Study||945
4922708|NCT03335800|12111650|P1|Received Irregular Pulse Notification|Overall Study||2161
4922709|NCT03335800|12111650|P1|STARTED|Overall Study||419927
4922710|NCT03335566|12111659|P2|NOT COMPLETED|Overall Study||3
4922711|NCT03335566|12111660|P1|NOT COMPLETED|Overall Study||4
4922712|NCT03335566|12111659|P2|COMPLETED|Overall Study||203
4922713|NCT03335566|12111660|P1|COMPLETED|Overall Study||214
4922714|NCT03335566|12111659|P2|STARTED|Overall Study||206
4922715|NCT03335566|12111660|P1|STARTED|Overall Study||218
4922716|NCT03335254|12111692|P20|NOT COMPLETED|Period 3, Day 26-30||0
4922717|NCT03335254|12111693|P19|NOT COMPLETED|Period 3, Day 26-30||0
4922718|NCT03335254|12111694|P18|NOT COMPLETED|Period 3, Day 26-30||0
4922719|NCT03335254|12111695|P17|NOT COMPLETED|Period 3, Day 26-30||0
4922720|NCT03335254|12111696|P16|NOT COMPLETED|Period 3, Day 26-30||0
4922721|NCT03335254|12111697|P15|NOT COMPLETED|Period 3, Day 26-30||0
4922722|NCT03335254|12111698|P14|NOT COMPLETED|Period 3, Day 26-30||0
4922723|NCT03335254|12111699|P13|NOT COMPLETED|Period 3, Day 26-30||0
4922724|NCT03335254|12111700|P12|NOT COMPLETED|Period 3, Day 26-30||0
4922725|NCT03335254|12111701|P11|NOT COMPLETED|Period 3, Day 26-30||0
4922726|NCT03335254|12111702|P10|NOT COMPLETED|Period 3, Day 26-30||0
4922727|NCT03335254|12111703|P9|NOT COMPLETED|Period 3, Day 26-30||0
4922728|NCT03335254|12111704|P8|NOT COMPLETED|Period 3, Day 26-30||0
4922729|NCT03335254|12111705|P7|NOT COMPLETED|Period 3, Day 26-30||0
4922730|NCT03335254|12111706|P6|NOT COMPLETED|Period 3, Day 26-30||0
4922731|NCT03335254|12111707|P5|NOT COMPLETED|Period 3, Day 26-30||0
4922732|NCT03335254|12111708|P4|NOT COMPLETED|Period 3, Day 26-30||0
4922733|NCT03335254|12111709|P3|NOT COMPLETED|Period 3, Day 26-30||0
4922734|NCT03335254|12111710|P2|NOT COMPLETED|Period 3, Day 26-30||0
4922735|NCT03335254|12111711|P1|NOT COMPLETED|Period 3, Day 26-30||0
4922736|NCT03335254|12111692|P20|COMPLETED|Period 3, Day 26-30||0
4922737|NCT03335254|12111693|P19|COMPLETED|Period 3, Day 26-30||0
4922738|NCT03335254|12111694|P18|COMPLETED|Period 3, Day 26-30||0
4922739|NCT03335254|12111695|P17|COMPLETED|Period 3, Day 26-30||0
4922740|NCT03335254|12111696|P16|COMPLETED|Period 3, Day 26-30||0
4922741|NCT03335254|12111697|P15|COMPLETED|Period 3, Day 26-30||0
4922742|NCT03335254|12111698|P14|COMPLETED|Period 3, Day 26-30||0
4922743|NCT03335254|12111699|P13|COMPLETED|Period 3, Day 26-30||0
4922744|NCT03335254|12111700|P12|COMPLETED|Period 3, Day 26-30||0
4922745|NCT03335254|12111701|P11|COMPLETED|Period 3, Day 26-30||0
4922746|NCT03335254|12111702|P10|COMPLETED|Period 3, Day 26-30||0
4922747|NCT03335254|12111703|P9|COMPLETED|Period 3, Day 26-30||0
4922748|NCT03335254|12111704|P8|COMPLETED|Period 3, Day 26-30||0
4922749|NCT03335254|12111705|P7|COMPLETED|Period 3, Day 26-30||0
4922750|NCT03335254|12111706|P6|COMPLETED|Period 3, Day 26-30||0
4922751|NCT03335254|12111707|P5|COMPLETED|Period 3, Day 26-30||0
4922752|NCT03335254|12111708|P4|COMPLETED|Period 3, Day 26-30||0
4922753|NCT03335254|12111709|P3|COMPLETED|Period 3, Day 26-30||0
4922754|NCT03335254|12111710|P2|COMPLETED|Period 3, Day 26-30||0
4922755|NCT03335254|12111711|P1|COMPLETED|Period 3, Day 26-30||9
4922756|NCT03335254|12111692|P20|STARTED|Period 3, Day 26-30||0
4922757|NCT03335254|12111693|P19|STARTED|Period 3, Day 26-30||0
4922758|NCT03335254|12111694|P18|STARTED|Period 3, Day 26-30||0
4922759|NCT03335254|12111695|P17|STARTED|Period 3, Day 26-30||0
4922760|NCT03335254|12111696|P16|STARTED|Period 3, Day 26-30||0
4922761|NCT03335254|12111697|P15|STARTED|Period 3, Day 26-30||0
4922762|NCT03335254|12111698|P14|STARTED|Period 3, Day 26-30||0
4922763|NCT03335254|12111699|P13|STARTED|Period 3, Day 26-30||0
4922764|NCT03335254|12111700|P12|STARTED|Period 3, Day 26-30||0
4922765|NCT03335254|12111701|P11|STARTED|Period 3, Day 26-30||0
4922766|NCT03335254|12111702|P10|STARTED|Period 3, Day 26-30||0
4922767|NCT03335254|12111703|P9|STARTED|Period 3, Day 26-30||0
4922768|NCT03335254|12111704|P8|STARTED|Period 3, Day 26-30||0
4922769|NCT03335254|12111705|P7|STARTED|Period 3, Day 26-30||0
4922770|NCT03335254|12111706|P6|STARTED|Period 3, Day 26-30||0
4922771|NCT03335254|12111707|P5|STARTED|Period 3, Day 26-30||0
4922772|NCT03335254|12111708|P4|STARTED|Period 3, Day 26-30||0
4922773|NCT03335254|12111709|P3|STARTED|Period 3, Day 26-30||0
4922774|NCT03335254|12111710|P2|STARTED|Period 3, Day 26-30||0
4922775|NCT03335254|12111711|P1|STARTED|Period 3, Day 26-30||9
4922776|NCT03335254|12111692|P20|NOT COMPLETED|Period 3, Day 16-25||0
4922777|NCT03335254|12111693|P19|NOT COMPLETED|Period 3, Day 16-25||0
4922778|NCT03335254|12111694|P18|NOT COMPLETED|Period 3, Day 16-25||0
4922779|NCT03335254|12111695|P17|NOT COMPLETED|Period 3, Day 16-25||0
4922780|NCT03335254|12111696|P16|NOT COMPLETED|Period 3, Day 16-25||0
4922781|NCT03335254|12111697|P15|NOT COMPLETED|Period 3, Day 16-25||0
4922782|NCT03335254|12111698|P14|NOT COMPLETED|Period 3, Day 16-25||0
4922783|NCT03335254|12111699|P13|NOT COMPLETED|Period 3, Day 16-25||0
4922784|NCT03335254|12111700|P12|NOT COMPLETED|Period 3, Day 16-25||0
4922785|NCT03335254|12111701|P11|NOT COMPLETED|Period 3, Day 16-25||0
4922786|NCT03335254|12111702|P10|NOT COMPLETED|Period 3, Day 16-25||0
4922787|NCT03335254|12111703|P9|NOT COMPLETED|Period 3, Day 16-25||0
4922788|NCT03335254|12111704|P8|NOT COMPLETED|Period 3, Day 16-25||0
4922789|NCT03335254|12111705|P7|NOT COMPLETED|Period 3, Day 16-25||0
4922790|NCT03335254|12111706|P6|NOT COMPLETED|Period 3, Day 16-25||0
4922791|NCT03335254|12111707|P5|NOT COMPLETED|Period 3, Day 16-25||0
4922792|NCT03335254|12111708|P4|NOT COMPLETED|Period 3, Day 16-25||0
4922793|NCT03335254|12111709|P3|NOT COMPLETED|Period 3, Day 16-25||0
4922794|NCT03335254|12111710|P2|NOT COMPLETED|Period 3, Day 16-25||0
4922795|NCT03335254|12111711|P1|NOT COMPLETED|Period 3, Day 16-25||0
4922796|NCT03335254|12111692|P20|COMPLETED|Period 3, Day 16-25||0
4922797|NCT03335254|12111693|P19|COMPLETED|Period 3, Day 16-25||0
4922798|NCT03335254|12111694|P18|COMPLETED|Period 3, Day 16-25||0
4922799|NCT03335254|12111695|P17|COMPLETED|Period 3, Day 16-25||0
4922800|NCT03335254|12111696|P16|COMPLETED|Period 3, Day 16-25||0
4922801|NCT03335254|12111697|P15|COMPLETED|Period 3, Day 16-25||0
4922802|NCT03335254|12111698|P14|COMPLETED|Period 3, Day 16-25||0
4922803|NCT03335254|12111699|P13|COMPLETED|Period 3, Day 16-25||0
4922804|NCT03335254|12111700|P12|COMPLETED|Period 3, Day 16-25||0
4922805|NCT03335254|12111701|P11|COMPLETED|Period 3, Day 16-25||0
4922806|NCT03335254|12111702|P10|COMPLETED|Period 3, Day 16-25||0
4922807|NCT03335254|12111703|P9|COMPLETED|Period 3, Day 16-25||0
4922808|NCT03335254|12111704|P8|COMPLETED|Period 3, Day 16-25||0
4922809|NCT03335254|12111705|P7|COMPLETED|Period 3, Day 16-25||0
4922810|NCT03335254|12111706|P6|COMPLETED|Period 3, Day 16-25||0
4922811|NCT03335254|12111707|P5|COMPLETED|Period 3, Day 16-25||0
4922812|NCT03335254|12111708|P4|COMPLETED|Period 3, Day 16-25||0
4922813|NCT03335254|12111709|P3|COMPLETED|Period 3, Day 16-25||0
4922814|NCT03335254|12111710|P2|COMPLETED|Period 3, Day 16-25||0
4922815|NCT03335254|12111711|P1|COMPLETED|Period 3, Day 16-25||9
4922816|NCT03335254|12111692|P20|STARTED|Period 3, Day 16-25||0
4922817|NCT03335254|12111693|P19|STARTED|Period 3, Day 16-25||0
4922818|NCT03335254|12111694|P18|STARTED|Period 3, Day 16-25||0
4922819|NCT03335254|12111695|P17|STARTED|Period 3, Day 16-25||0
4922820|NCT03335254|12111696|P16|STARTED|Period 3, Day 16-25||0
4922821|NCT03335254|12111697|P15|STARTED|Period 3, Day 16-25||0
4922822|NCT03335254|12111698|P14|STARTED|Period 3, Day 16-25||0
4922823|NCT03335254|12111699|P13|STARTED|Period 3, Day 16-25||0
4922824|NCT03335254|12111700|P12|STARTED|Period 3, Day 16-25||0
4922825|NCT03335254|12111701|P11|STARTED|Period 3, Day 16-25||0
4922826|NCT03335254|12111702|P10|STARTED|Period 3, Day 16-25||0
4922827|NCT03335254|12111703|P9|STARTED|Period 3, Day 16-25||0
4922828|NCT03335254|12111704|P8|STARTED|Period 3, Day 16-25||0
4922829|NCT03335254|12111705|P7|STARTED|Period 3, Day 16-25||0
4922830|NCT03335254|12111706|P6|STARTED|Period 3, Day 16-25||0
4922831|NCT03335254|12111707|P5|STARTED|Period 3, Day 16-25||0
4922832|NCT03335254|12111708|P4|STARTED|Period 3, Day 16-25||0
4922833|NCT03335254|12111709|P3|STARTED|Period 3, Day 16-25||0
4922834|NCT03335254|12111710|P2|STARTED|Period 3, Day 16-25||0
4922835|NCT03335254|12111711|P1|STARTED|Period 3, Day 16-25||9
4922836|NCT03335254|12111692|P20|NOT COMPLETED|Period 2, Day 1-15||0
4922837|NCT03335254|12111693|P19|NOT COMPLETED|Period 2, Day 1-15||0
4922838|NCT03335254|12111694|P18|NOT COMPLETED|Period 2, Day 1-15||0
4922839|NCT03335254|12111695|P17|NOT COMPLETED|Period 2, Day 1-15||0
4922840|NCT03335254|12111696|P16|NOT COMPLETED|Period 2, Day 1-15||0
4922841|NCT03335254|12111697|P15|NOT COMPLETED|Period 2, Day 1-15||0
4922842|NCT03335254|12111698|P14|NOT COMPLETED|Period 2, Day 1-15||0
4922843|NCT03335254|12111699|P13|NOT COMPLETED|Period 2, Day 1-15||0
4922844|NCT03335254|12111700|P12|NOT COMPLETED|Period 2, Day 1-15||0
4922845|NCT03335254|12111701|P11|NOT COMPLETED|Period 2, Day 1-15||0
4922846|NCT03335254|12111702|P10|NOT COMPLETED|Period 2, Day 1-15||0
4922847|NCT03335254|12111703|P9|NOT COMPLETED|Period 2, Day 1-15||0
4922848|NCT03335254|12111704|P8|NOT COMPLETED|Period 2, Day 1-15||0
4922849|NCT03335254|12111705|P7|NOT COMPLETED|Period 2, Day 1-15||0
4922850|NCT03335254|12111706|P6|NOT COMPLETED|Period 2, Day 1-15||0
4922851|NCT03335254|12111707|P5|NOT COMPLETED|Period 2, Day 1-15||0
4922852|NCT03335254|12111708|P4|NOT COMPLETED|Period 2, Day 1-15||0
4922853|NCT03335254|12111709|P3|NOT COMPLETED|Period 2, Day 1-15||0
4922854|NCT03335254|12111710|P2|NOT COMPLETED|Period 2, Day 1-15||0
4922855|NCT03335254|12111711|P1|NOT COMPLETED|Period 2, Day 1-15||0
4922856|NCT03335254|12111692|P20|COMPLETED|Period 2, Day 1-15||0
4922857|NCT03335254|12111693|P19|COMPLETED|Period 2, Day 1-15||0
4922858|NCT03335254|12111694|P18|COMPLETED|Period 2, Day 1-15||0
4922859|NCT03335254|12111695|P17|COMPLETED|Period 2, Day 1-15||0
4922860|NCT03335254|12111696|P16|COMPLETED|Period 2, Day 1-15||0
4922861|NCT03335254|12111697|P15|COMPLETED|Period 2, Day 1-15||0
4922862|NCT03335254|12111698|P14|COMPLETED|Period 2, Day 1-15||0
4922863|NCT03335254|12111699|P13|COMPLETED|Period 2, Day 1-15||0
4922864|NCT03335254|12111700|P12|COMPLETED|Period 2, Day 1-15||0
4922865|NCT03335254|12111701|P11|COMPLETED|Period 2, Day 1-15||0
4922866|NCT03335254|12111702|P10|COMPLETED|Period 2, Day 1-15||0
4922867|NCT03335254|12111703|P9|COMPLETED|Period 2, Day 1-15||0
4922868|NCT03335254|12111704|P8|COMPLETED|Period 2, Day 1-15||0
4922869|NCT03335254|12111705|P7|COMPLETED|Period 2, Day 1-15||0
4922870|NCT03335254|12111706|P6|COMPLETED|Period 2, Day 1-15||0
4922871|NCT03335254|12111707|P5|COMPLETED|Period 2, Day 1-15||0
4922872|NCT03335254|12111708|P4|COMPLETED|Period 2, Day 1-15||0
4922873|NCT03335254|12111709|P3|COMPLETED|Period 2, Day 1-15||0
4922874|NCT03335254|12111710|P2|COMPLETED|Period 2, Day 1-15||0
4922875|NCT03335254|12111711|P1|COMPLETED|Period 2, Day 1-15||9
4922876|NCT03335254|12111692|P20|STARTED|Period 2, Day 1-15||0
4922877|NCT03335254|12111693|P19|STARTED|Period 2, Day 1-15||0
4922878|NCT03335254|12111694|P18|STARTED|Period 2, Day 1-15||0
4922879|NCT03335254|12111695|P17|STARTED|Period 2, Day 1-15||0
4922880|NCT03335254|12111696|P16|STARTED|Period 2, Day 1-15||0
4922881|NCT03335254|12111697|P15|STARTED|Period 2, Day 1-15||0
4922882|NCT03335254|12111698|P14|STARTED|Period 2, Day 1-15||0
4922883|NCT03335254|12111699|P13|STARTED|Period 2, Day 1-15||0
4922884|NCT03335254|12111700|P12|STARTED|Period 2, Day 1-15||0
4922885|NCT03335254|12111701|P11|STARTED|Period 2, Day 1-15||0
4922886|NCT03335254|12111702|P10|STARTED|Period 2, Day 1-15||0
4922887|NCT03335254|12111703|P9|STARTED|Period 2, Day 1-15||0
4922888|NCT03335254|12111704|P8|STARTED|Period 2, Day 1-15||0
4922889|NCT03335254|12111705|P7|STARTED|Period 2, Day 1-15||0
4922890|NCT03335254|12111706|P6|STARTED|Period 2, Day 1-15||0
4922891|NCT03335254|12111707|P5|STARTED|Period 2, Day 1-15||0
4922892|NCT03335254|12111708|P4|STARTED|Period 2, Day 1-15||0
4922893|NCT03335254|12111709|P3|STARTED|Period 2, Day 1-15||0
4922894|NCT03335254|12111710|P2|STARTED|Period 2, Day 1-15||0
4922895|NCT03335254|12111711|P1|STARTED|Period 2, Day 1-15||9
4922896|NCT03335254|12111692|P20|NOT COMPLETED|Period 1||0
4922897|NCT03335254|12111693|P19|NOT COMPLETED|Period 1||0
4922898|NCT03335254|12111694|P18|NOT COMPLETED|Period 1||0
4922899|NCT03335254|12111695|P17|NOT COMPLETED|Period 1||0
4922900|NCT03335254|12111696|P16|NOT COMPLETED|Period 1||0
4922901|NCT03335254|12111697|P15|NOT COMPLETED|Period 1||0
4922902|NCT03335254|12111698|P14|NOT COMPLETED|Period 1||0
4922903|NCT03335254|12111699|P13|NOT COMPLETED|Period 1||0
4922904|NCT03335254|12111700|P12|NOT COMPLETED|Period 1||0
4922905|NCT03335254|12111701|P11|NOT COMPLETED|Period 1||0
4922906|NCT03335254|12111702|P10|NOT COMPLETED|Period 1||0
4922907|NCT03335254|12111703|P9|NOT COMPLETED|Period 1||0
4922908|NCT03335254|12111704|P8|NOT COMPLETED|Period 1||0
4922909|NCT03335254|12111705|P7|NOT COMPLETED|Period 1||0
4922910|NCT03335254|12111706|P6|NOT COMPLETED|Period 1||0
4922911|NCT03335254|12111707|P5|NOT COMPLETED|Period 1||0
4922912|NCT03335254|12111708|P4|NOT COMPLETED|Period 1||0
4922913|NCT03335254|12111709|P3|NOT COMPLETED|Period 1||0
4922914|NCT03335254|12111710|P2|NOT COMPLETED|Period 1||0
4922915|NCT03335254|12111711|P1|NOT COMPLETED|Period 1||0
4922916|NCT03335254|12111692|P20|COMPLETED|Period 1||0
4922917|NCT03335254|12111693|P19|COMPLETED|Period 1||0
4922918|NCT03335254|12111694|P18|COMPLETED|Period 1||0
4922919|NCT03335254|12111695|P17|COMPLETED|Period 1||0
4922920|NCT03335254|12111696|P16|COMPLETED|Period 1||0
4922921|NCT03335254|12111697|P15|COMPLETED|Period 1||0
4922922|NCT03335254|12111698|P14|COMPLETED|Period 1||0
4922923|NCT03335254|12111699|P13|COMPLETED|Period 1||0
4922924|NCT03335254|12111700|P12|COMPLETED|Period 1||0
4922925|NCT03335254|12111701|P11|COMPLETED|Period 1||0
4922926|NCT03335254|12111702|P10|COMPLETED|Period 1||0
4922927|NCT03335254|12111703|P9|COMPLETED|Period 1||0
4922928|NCT03335254|12111704|P8|COMPLETED|Period 1||0
4922929|NCT03335254|12111705|P7|COMPLETED|Period 1||0
4922930|NCT03335254|12111706|P6|COMPLETED|Period 1||0
4922931|NCT03335254|12111707|P5|COMPLETED|Period 1||0
4922932|NCT03335254|12111708|P4|COMPLETED|Period 1||0
4922933|NCT03335254|12111709|P3|COMPLETED|Period 1||0
4922934|NCT03335254|12111710|P2|COMPLETED|Period 1||0
4922935|NCT03335254|12111711|P1|COMPLETED|Period 1||9
4922936|NCT03335254|12111692|P20|STARTED|Period 1||0
4922937|NCT03335254|12111693|P19|STARTED|Period 1||0
4922938|NCT03335254|12111694|P18|STARTED|Period 1||0
4922939|NCT03335254|12111695|P17|STARTED|Period 1||0
4922940|NCT03335254|12111696|P16|STARTED|Period 1||0
4922941|NCT03335254|12111697|P15|STARTED|Period 1||0
4922942|NCT03335254|12111698|P14|STARTED|Period 1||0
4922943|NCT03335254|12111699|P13|STARTED|Period 1||0
4922944|NCT03335254|12111700|P12|STARTED|Period 1||0
4922945|NCT03335254|12111701|P11|STARTED|Period 1||0
4922946|NCT03335254|12111702|P10|STARTED|Period 1||0
4922947|NCT03335254|12111703|P9|STARTED|Period 1||0
4922948|NCT03335254|12111704|P8|STARTED|Period 1||0
4922949|NCT03335254|12111705|P7|STARTED|Period 1||0
4922950|NCT03335254|12111706|P6|STARTED|Period 1||0
4922951|NCT03335254|12111707|P5|STARTED|Period 1||0
4922952|NCT03335254|12111708|P4|STARTED|Period 1||0
4922953|NCT03335254|12111709|P3|STARTED|Period 1||0
4922954|NCT03335254|12111710|P2|STARTED|Period 1||0
4922955|NCT03335254|12111711|P1|STARTED|Period 1||9
4922956|NCT03335150|12111742|P2|NOT COMPLETED|Overall Study||5
4922957|NCT03335150|12111743|P1|NOT COMPLETED|Overall Study||10
4922958|NCT03335150|12111742|P2|COMPLETED|Overall Study||50
4922959|NCT03335150|12111743|P1|COMPLETED|Overall Study||45
4922960|NCT03335150|12111742|P2|POST Testing Session|Overall Study||50
4922961|NCT03335150|12111743|P1|POST Testing Session|Overall Study||45
4922962|NCT03335150|12111742|P2|Commenced Group|Overall Study||52
4922963|NCT03335150|12111743|P1|Commenced Group|Overall Study||47
4922964|NCT03335150|12111742|P2|PRE Testing Session|Overall Study||55
4922965|NCT03335150|12111743|P1|PRE Testing Session|Overall Study||53
4922966|NCT03335150|12111742|P2|Enrolled + Assigned Group|Overall Study||55
4922967|NCT03335150|12111743|P1|Enrolled + Assigned Group|Overall Study||54
4922968|NCT03335150|12111742|P2|STARTED|Overall Study||55
4922969|NCT03335150|12111743|P1|STARTED|Overall Study||55
4922970|NCT03334825|12111767|P2|NOT COMPLETED|Overall Study||4
4922971|NCT03334825|12111768|P1|NOT COMPLETED|Overall Study||7
4922972|NCT03334825|12111767|P2|COMPLETED|Overall Study||113
4922973|NCT03334825|12111768|P1|COMPLETED|Overall Study||112
4922974|NCT03334825|12111767|P2|STARTED|Overall Study||117
4922975|NCT03334825|12111768|P1|STARTED|Overall Study||119
4922976|NCT03334812|12111780|P4|NOT COMPLETED|Overall Study||0
4922977|NCT03334812|12111781|P3|NOT COMPLETED|Overall Study||0
4922978|NCT03334812|12111782|P2|NOT COMPLETED|Overall Study||0
4922979|NCT03334812|12111783|P1|NOT COMPLETED|Overall Study||0
4922980|NCT03334812|12111780|P4|COMPLETED|Overall Study||0
4922981|NCT03334812|12111781|P3|COMPLETED|Overall Study||0
4922982|NCT03334812|12111782|P2|COMPLETED|Overall Study||5
4922983|NCT03334812|12111783|P1|COMPLETED|Overall Study||9
4922984|NCT03334812|12111780|P4|STARTED|Overall Study||0
4922985|NCT03334812|12111781|P3|STARTED|Overall Study||0
4922986|NCT03334812|12111782|P2|STARTED|Overall Study||5
4922987|NCT03334812|12111783|P1|STARTED|Overall Study||9
4922988|NCT03334734|12111809|P4|NOT COMPLETED|Overall Study||0
4922989|NCT03334734|12111810|P3|NOT COMPLETED|Overall Study||2
4922990|NCT03334734|12111811|P2|NOT COMPLETED|Overall Study||0
4922991|NCT03334734|12111812|P1|NOT COMPLETED|Overall Study||0
4922992|NCT03334734|12111809|P4|COMPLETED|Overall Study||1
4922993|NCT03334734|12111810|P3|COMPLETED|Overall Study||5
4922994|NCT03334734|12111811|P2|COMPLETED|Overall Study||4
4922995|NCT03334734|12111812|P1|COMPLETED|Overall Study||4
4922996|NCT03334734|12111809|P4|STARTED|Overall Study||1
4922997|NCT03334734|12111810|P3|STARTED|Overall Study||7
4922998|NCT03334734|12111811|P2|STARTED|Overall Study||4
4922999|NCT03334734|12111812|P1|STARTED|Overall Study||4
4923000|NCT03334448|12111905|P4|NOT COMPLETED|Period 4||0
4923001|NCT03334448|12111906|P3|NOT COMPLETED|Period 4||0
4923002|NCT03334448|12111907|P2|NOT COMPLETED|Period 4||0
4923003|NCT03334448|12111908|P1|NOT COMPLETED|Period 4||0
4923004|NCT03334448|12111905|P4|COMPLETED|Period 4||11
4923005|NCT03334448|12111906|P3|COMPLETED|Period 4||13
4923006|NCT03334448|12111907|P2|COMPLETED|Period 4||11
4923007|NCT03334448|12111908|P1|COMPLETED|Period 4||12
4923008|NCT03334448|12111905|P4|Received at Least 1 Dose of Study Drug|Period 4||11
4923009|NCT03334448|12111906|P3|Received at Least 1 Dose of Study Drug|Period 4||13
4923010|NCT03334448|12111907|P2|Received at Least 1 Dose of Study Drug|Period 4||11
4923011|NCT03334448|12111908|P1|Received at Least 1 Dose of Study Drug|Period 4||12
4923012|NCT03334448|12111905|P4|STARTED|Period 4||11
4923013|NCT03334448|12111906|P3|STARTED|Period 4||13
4923014|NCT03334448|12111907|P2|STARTED|Period 4||11
4923015|NCT03334448|12111908|P1|STARTED|Period 4||12
4923016|NCT03334448|12111905|P4|NOT COMPLETED|Washout||1
4923017|NCT03334448|12111906|P3|NOT COMPLETED|Washout||0
4923018|NCT03334448|12111907|P2|NOT COMPLETED|Washout||0
4923019|NCT03334448|12111908|P1|NOT COMPLETED|Washout||0
4923020|NCT03334448|12111905|P4|COMPLETED|Washout||11
4923021|NCT03334448|12111906|P3|COMPLETED|Washout||13
4923022|NCT03334448|12111907|P2|COMPLETED|Washout||11
4923023|NCT03334448|12111908|P1|COMPLETED|Washout||12
4923024|NCT03334448|12111905|P4|STARTED|Washout||12
4923025|NCT03334448|12111906|P3|STARTED|Washout||13
4923026|NCT03334448|12111907|P2|STARTED|Washout||11
4923027|NCT03334448|12111908|P1|STARTED|Washout||12
4923028|NCT03334448|12111905|P4|NOT COMPLETED|Period 3||0
4923029|NCT03334448|12111906|P3|NOT COMPLETED|Period 3||0
4923030|NCT03334448|12111907|P2|NOT COMPLETED|Period 3||0
4923031|NCT03334448|12111908|P1|NOT COMPLETED|Period 3||0
4923032|NCT03334448|12111905|P4|COMPLETED|Period 3||12
4923033|NCT03334448|12111906|P3|COMPLETED|Period 3||13
4923034|NCT03334448|12111907|P2|COMPLETED|Period 3||11
4923035|NCT03334448|12111908|P1|COMPLETED|Period 3||12
4923036|NCT03334448|12111905|P4|Received at Least 1 Dose of Study Drug|Period 3||12
4923037|NCT03334448|12111906|P3|Received at Least 1 Dose of Study Drug|Period 3||13
4923038|NCT03334448|12111907|P2|Received at Least 1 Dose of Study Drug|Period 3||11
4923039|NCT03334448|12111908|P1|Received at Least 1 Dose of Study Drug|Period 3||12
4923040|NCT03334448|12111905|P4|STARTED|Period 3||12
4923041|NCT03334448|12111906|P3|STARTED|Period 3||13
4923042|NCT03334448|12111907|P2|STARTED|Period 3||11
4923043|NCT03334448|12111908|P1|STARTED|Period 3||12
4923044|NCT03334448|12111905|P4|NOT COMPLETED|Washout||0
4923045|NCT03334448|12111906|P3|NOT COMPLETED|Washout||0
4923046|NCT03334448|12111907|P2|NOT COMPLETED|Washout||1
4923047|NCT03334448|12111908|P1|NOT COMPLETED|Washout||0
4923048|NCT03334448|12111905|P4|COMPLETED|Washout||12
4923049|NCT03334448|12111906|P3|COMPLETED|Washout||13
4923050|NCT03334448|12111907|P2|COMPLETED|Washout||11
4923051|NCT03334448|12111908|P1|COMPLETED|Washout||12
4923052|NCT03334448|12111905|P4|STARTED|Washout||12
4923053|NCT03334448|12111906|P3|STARTED|Washout||13
4923054|NCT03334448|12111907|P2|STARTED|Washout||12
4923055|NCT03334448|12111908|P1|STARTED|Washout||12
4923056|NCT03334448|12111905|P4|NOT COMPLETED|Period 2||0
4923057|NCT03334448|12111906|P3|NOT COMPLETED|Period 2||0
4923058|NCT03334448|12111907|P2|NOT COMPLETED|Period 2||0
4923059|NCT03334448|12111908|P1|NOT COMPLETED|Period 2||0
4923060|NCT03334448|12111905|P4|COMPLETED|Period 2||12
4923061|NCT03334448|12111906|P3|COMPLETED|Period 2||13
4923062|NCT03334448|12111907|P2|COMPLETED|Period 2||12
4923063|NCT03334448|12111908|P1|COMPLETED|Period 2||12
4923064|NCT03334448|12111905|P4|Received at Least 1 Dose of Study Drug|Period 2||12
4923065|NCT03334448|12111906|P3|Received at Least 1 Dose of Study Drug|Period 2||13
4923066|NCT03334448|12111907|P2|Received at Least 1 Dose of Study Drug|Period 2||12
4923067|NCT03334448|12111908|P1|Received at Least 1 Dose of Study Drug|Period 2||12
4923068|NCT03334448|12111905|P4|STARTED|Period 2||12
4923069|NCT03334448|12111906|P3|STARTED|Period 2||13
4923070|NCT03334448|12111907|P2|STARTED|Period 2||12
4923071|NCT03334448|12111908|P1|STARTED|Period 2||12
4923072|NCT03334448|12111905|P4|NOT COMPLETED|Washout||0
4923073|NCT03334448|12111906|P3|NOT COMPLETED|Washout||0
4923074|NCT03334448|12111907|P2|NOT COMPLETED|Washout||0
4923075|NCT03334448|12111908|P1|NOT COMPLETED|Washout||0
4923076|NCT03334448|12111905|P4|COMPLETED|Washout||12
4923077|NCT03334448|12111906|P3|COMPLETED|Washout||13
4923078|NCT03334448|12111907|P2|COMPLETED|Washout||12
4923079|NCT03334448|12111908|P1|COMPLETED|Washout||12
4923080|NCT03334448|12111905|P4|STARTED|Washout||12
4923081|NCT03334448|12111906|P3|STARTED|Washout||13
4923082|NCT03334448|12111907|P2|STARTED|Washout||12
4923083|NCT03334448|12111908|P1|STARTED|Washout||12
4923084|NCT03334448|12111905|P4|NOT COMPLETED|Period 1||0
4923085|NCT03334448|12111906|P3|NOT COMPLETED|Period 1||0
4923086|NCT03334448|12111907|P2|NOT COMPLETED|Period 1||0
4923087|NCT03334448|12111908|P1|NOT COMPLETED|Period 1||0
4923088|NCT03334448|12111905|P4|COMPLETED|Period 1||12
4923089|NCT03334448|12111906|P3|COMPLETED|Period 1||13
4923090|NCT03334448|12111907|P2|COMPLETED|Period 1||12
4923091|NCT03334448|12111908|P1|COMPLETED|Period 1||12
4923092|NCT03334448|12111905|P4|Received at Least 1 Dose of Study Drug|Period 1||12
4923093|NCT03334448|12111906|P3|Received at Least 1 Dose of Study Drug|Period 1||13
4923094|NCT03334448|12111907|P2|Received at Least 1 Dose of Study Drug|Period 1||12
4923095|NCT03334448|12111908|P1|Received at Least 1 Dose of Study Drug|Period 1||12
4923096|NCT03334448|12111905|P4|STARTED|Period 1||12
4923097|NCT03334448|12111906|P3|STARTED|Period 1||13
4923098|NCT03334448|12111907|P2|STARTED|Period 1||12
4923099|NCT03334448|12111908|P1|STARTED|Period 1||12
4923100|NCT03334422|12111920|P4|NOT COMPLETED|Overall Study||6
4923101|NCT03334422|12111921|P3|NOT COMPLETED|Overall Study||10
4923102|NCT03334422|12111922|P2|NOT COMPLETED|Overall Study||10
4923103|NCT03334422|12111923|P1|NOT COMPLETED|Overall Study||19
4923104|NCT03334422|12111920|P4|COMPLETED|Overall Study||117
4923105|NCT03334422|12111921|P3|COMPLETED|Overall Study||113
4923106|NCT03334422|12111922|P2|COMPLETED|Overall Study||115
4923107|NCT03334422|12111923|P1|COMPLETED|Overall Study||225
4923108|NCT03334422|12111920|P4|Received at Least One Dose of Study Drug|Overall Study||123
4923109|NCT03334422|12111921|P3|Received at Least One Dose of Study Drug|Overall Study||123
4923110|NCT03334422|12111922|P2|Received at Least One Dose of Study Drug|Overall Study||124
4923111|NCT03334422|12111923|P1|Received at Least One Dose of Study Drug|Overall Study||244
4923112|NCT03334422|12111920|P4|STARTED|Overall Study||123
4923113|NCT03334422|12111921|P3|STARTED|Overall Study||123
4923114|NCT03334422|12111922|P2|STARTED|Overall Study||125
4923115|NCT03334422|12111923|P1|STARTED|Overall Study||244
4923116|NCT03334396|12112026|P4|NOT COMPLETED|Overall Study||5
4923117|NCT03334396|12112027|P3|NOT COMPLETED|Overall Study||10
4923118|NCT03334396|12112028|P2|NOT COMPLETED|Overall Study||11
4923119|NCT03334396|12112029|P1|NOT COMPLETED|Overall Study||23
4923120|NCT03334396|12112026|P4|COMPLETED|Overall Study||120
4923121|NCT03334396|12112027|P3|COMPLETED|Overall Study||113
4923122|NCT03334396|12112028|P2|COMPLETED|Overall Study||116
4923123|NCT03334396|12112029|P1|COMPLETED|Overall Study||226
4923124|NCT03334396|12112026|P4|Received at Least One Dose of Study Drug|Overall Study||125
4923125|NCT03334396|12112027|P3|Received at Least One Dose of Study Drug|Overall Study||123
4923126|NCT03334396|12112028|P2|Received at Least One Dose of Study Drug|Overall Study||127
4923127|NCT03334396|12112029|P1|Received at Least One Dose of Study Drug|Overall Study||249
4923128|NCT03334396|12112026|P4|STARTED|Overall Study||125
4923129|NCT03334396|12112027|P3|STARTED|Overall Study||123
4923130|NCT03334396|12112028|P2|STARTED|Overall Study||127
4923131|NCT03334396|12112029|P1|STARTED|Overall Study||249
4923132|NCT03334214|12112130|P2|NOT COMPLETED|Overall Study||2
4923133|NCT03334214|12112131|P1|NOT COMPLETED|Overall Study||1
4923134|NCT03334214|12112130|P2|COMPLETED|Overall Study||27
4923135|NCT03334214|12112131|P1|COMPLETED|Overall Study||14
4923136|NCT03334214|12112130|P2|STARTED|Overall Study||29
4923137|NCT03334214|12112131|P1|STARTED|Overall Study||15
4923138|NCT03333876|12112157|P1|NOT COMPLETED|Positional Therapy||0
4923139|NCT03333876|12112157|P1|COMPLETED|Positional Therapy||54
4923140|NCT03333876|12112157|P1|STARTED|Positional Therapy||54
4923141|NCT03333876|12112157|P1|NOT COMPLETED|Mandibular Advancement||4
4923142|NCT03333876|12112157|P1|COMPLETED|Mandibular Advancement||50
4923143|NCT03333876|12112157|P1|STARTED|Mandibular Advancement||54
4923144|NCT03333876|12112157|P1|NOT COMPLETED|Nasal Dilator||6
4923145|NCT03333876|12112157|P1|COMPLETED|Nasal Dilator||48
4923146|NCT03333876|12112157|P1|STARTED|Nasal Dilator||54
4923147|NCT03333876|12112157|P1|NOT COMPLETED|Screening Period||4
4923148|NCT03333876|12112157|P1|COMPLETED|Screening Period||54
4923149|NCT03333876|12112157|P1|STARTED|Screening Period||58
4923150|NCT03333746|12112178|P1|NOT COMPLETED|Overall Study||1
4923151|NCT03333746|12112178|P1|COMPLETED|Overall Study||0
4923152|NCT03333746|12112178|P1|STARTED|Overall Study||1
4923153|NCT03333577|12112189|P1|NOT COMPLETED|Overall Study||7
4923154|NCT03333577|12112189|P1|COMPLETED|Overall Study||25
4923155|NCT03333577|12112189|P1|STARTED|Overall Study||32
4923156|NCT03333317|12112197|P3|NOT COMPLETED|Overall Study||0
4923157|NCT03333317|12112198|P2|NOT COMPLETED|Overall Study||0
4923158|NCT03333317|12112199|P1|NOT COMPLETED|Overall Study||0
4923159|NCT03333317|12112197|P3|COMPLETED|Overall Study||3
4923160|NCT03333317|12112198|P2|COMPLETED|Overall Study||1
4923161|NCT03333317|12112199|P1|COMPLETED|Overall Study||3
4923162|NCT03333317|12112197|P3|STARTED|Overall Study||3
4923163|NCT03333317|12112198|P2|STARTED|Overall Study||1
4923164|NCT03333317|12112199|P1|STARTED|Overall Study||3
4923165|NCT03331965|12112319|P2|NOT COMPLETED|Overall Study||4
4923166|NCT03331965|12112320|P1|NOT COMPLETED|Overall Study||10
4923167|NCT03331965|12112319|P2|COMPLETED|Overall Study||51
4923168|NCT03331965|12112320|P1|COMPLETED|Overall Study||45
4923169|NCT03331965|12112319|P2|STARTED|Overall Study||55
4923170|NCT03331965|12112320|P1|STARTED|Overall Study||55
4923171|NCT03331835|12112336|P2|NOT COMPLETED|Overall Study||47
4923172|NCT03331835|12112337|P1|NOT COMPLETED|Overall Study||14
4923173|NCT03331835|12112336|P2|COMPLETED|Overall Study||58
4923174|NCT03331835|12112337|P1|COMPLETED|Overall Study||91
4923175|NCT03331835|12112336|P2|STARTED|Overall Study||105
4923176|NCT03331835|12112337|P1|STARTED|Overall Study||105
4923177|NCT03331315|12112371|P2|NOT COMPLETED|Overall Study||14
4923178|NCT03331315|12112372|P1|NOT COMPLETED|Overall Study||18
4923179|NCT03331315|12112371|P2|COMPLETED|Overall Study||68
4923180|NCT03331315|12112372|P1|COMPLETED|Overall Study||70
4923181|NCT03331315|12112371|P2|STARTED|Overall Study||82
4923182|NCT03331315|12112372|P1|STARTED|Overall Study||88
4923183|NCT03331185|12112394|P2|NOT COMPLETED|Overall Study||0
4923184|NCT03331185|12112395|P1|NOT COMPLETED|Overall Study||0
4923185|NCT03331185|12112394|P2|COMPLETED|Overall Study||12
4923186|NCT03331185|12112395|P1|COMPLETED|Overall Study||14
4923187|NCT03331185|12112394|P2|STARTED|Overall Study||12
4923188|NCT03331185|12112395|P1|STARTED|Overall Study||14
4923189|NCT03331042|12112409|P4|NOT COMPLETED|Overall Study||1
4923190|NCT03331042|12112410|P3|NOT COMPLETED|Overall Study||1
4923191|NCT03331042|12112411|P2|NOT COMPLETED|Overall Study||0
4923192|NCT03331042|12112412|P1|NOT COMPLETED|Overall Study||1
4923193|NCT03331042|12112409|P4|COMPLETED|Overall Study||20
4923194|NCT03331042|12112410|P3|COMPLETED|Overall Study||20
4923195|NCT03331042|12112411|P2|COMPLETED|Overall Study||21
4923196|NCT03331042|12112412|P1|COMPLETED|Overall Study||21
4923197|NCT03331042|12112409|P4|STARTED|Overall Study||21
4923198|NCT03331042|12112410|P3|STARTED|Overall Study||21
4923199|NCT03331042|12112411|P2|STARTED|Overall Study||21
4923200|NCT03331042|12112412|P1|STARTED|Overall Study||22
4923201|NCT03330834|12112458|P1|NOT COMPLETED|Overall Study||0
4923202|NCT03330834|12112458|P1|COMPLETED|Overall Study||1
4923203|NCT03330834|12112458|P1|STARTED|Overall Study||1
4923204|NCT03330275|12112464|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923205|NCT03330275|12112465|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923206|NCT03330275|12112466|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923207|NCT03330275|12112467|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923208|NCT03330275|12112468|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923209|NCT03330275|12112469|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923210|NCT03330275|12112470|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923211|NCT03330275|12112471|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923212|NCT03330275|12112472|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923213|NCT03330275|12112473|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923214|NCT03330275|12112464|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923215|NCT03330275|12112465|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923216|NCT03330275|12112466|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923217|NCT03330275|12112467|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923218|NCT03330275|12112468|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923219|NCT03330275|12112469|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
4923220|NCT03330275|12112470|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923221|NCT03330275|12112471|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923222|NCT03330275|12112472|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923223|NCT03330275|12112473|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
4923224|NCT03330275|12112464|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
4923225|NCT03330275|12112465|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
4923226|NCT03330275|12112466|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
4923227|NCT03330275|12112467|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
4923228|NCT03330275|12112468|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
4923229|NCT03330275|12112469|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
4923230|NCT03330275|12112470|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
4923231|NCT03330275|12112471|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
4923232|NCT03330275|12112472|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
4923233|NCT03330275|12112473|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
4923234|NCT03330275|12112464|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923235|NCT03330275|12112465|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923236|NCT03330275|12112466|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923237|NCT03330275|12112467|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923238|NCT03330275|12112468|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923239|NCT03330275|12112469|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923240|NCT03330275|12112470|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923241|NCT03330275|12112471|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923242|NCT03330275|12112472|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923243|NCT03330275|12112473|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923244|NCT03330275|12112464|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923245|NCT03330275|12112465|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923246|NCT03330275|12112466|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923247|NCT03330275|12112467|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923248|NCT03330275|12112468|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923249|NCT03330275|12112469|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
4923250|NCT03330275|12112470|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923251|NCT03330275|12112471|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923252|NCT03330275|12112472|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923253|NCT03330275|12112473|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
4923254|NCT03330275|12112464|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
4923255|NCT03330275|12112465|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
4923256|NCT03330275|12112466|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
4923257|NCT03330275|12112467|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
4923258|NCT03330275|12112468|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
4923259|NCT03330275|12112469|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
4923260|NCT03330275|12112470|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
4923261|NCT03330275|12112471|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
4923262|NCT03330275|12112472|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
4923263|NCT03330275|12112473|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
4923264|NCT03330275|12112464|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923265|NCT03330275|12112465|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923266|NCT03330275|12112466|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923267|NCT03330275|12112467|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923268|NCT03330275|12112468|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923269|NCT03330275|12112469|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923270|NCT03330275|12112470|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923271|NCT03330275|12112471|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923272|NCT03330275|12112472|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923273|NCT03330275|12112473|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923274|NCT03330275|12112464|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923275|NCT03330275|12112465|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923276|NCT03330275|12112466|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923277|NCT03330275|12112467|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923278|NCT03330275|12112468|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923279|NCT03330275|12112469|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
4923280|NCT03330275|12112470|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923281|NCT03330275|12112471|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923282|NCT03330275|12112472|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923283|NCT03330275|12112473|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
4923284|NCT03330275|12112464|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
4923285|NCT03330275|12112465|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
4923286|NCT03330275|12112466|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
4923287|NCT03330275|12112467|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
4923288|NCT03330275|12112468|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
4923289|NCT03330275|12112469|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
4923290|NCT03330275|12112470|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
4923291|NCT03330275|12112471|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
4923292|NCT03330275|12112472|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
4923293|NCT03330275|12112473|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
4923294|NCT03330275|12112464|P10|NOT COMPLETED|Visit 1 - Period 2||0
4923295|NCT03330275|12112465|P9|NOT COMPLETED|Visit 1 - Period 2||0
4923296|NCT03330275|12112466|P8|NOT COMPLETED|Visit 1 - Period 2||0
4923297|NCT03330275|12112467|P7|NOT COMPLETED|Visit 1 - Period 2||0
4923298|NCT03330275|12112468|P6|NOT COMPLETED|Visit 1 - Period 2||0
4923299|NCT03330275|12112469|P5|NOT COMPLETED|Visit 1 - Period 2||0
4923300|NCT03330275|12112470|P4|NOT COMPLETED|Visit 1 - Period 2||0
4923301|NCT03330275|12112471|P3|NOT COMPLETED|Visit 1 - Period 2||0
4923302|NCT03330275|12112472|P2|NOT COMPLETED|Visit 1 - Period 2||0
4923303|NCT03330275|12112473|P1|NOT COMPLETED|Visit 1 - Period 2||0
4923304|NCT03330275|12112464|P10|COMPLETED|Visit 1 - Period 2||0
4923305|NCT03330275|12112465|P9|COMPLETED|Visit 1 - Period 2||0
4923306|NCT03330275|12112466|P8|COMPLETED|Visit 1 - Period 2||0
4923307|NCT03330275|12112467|P7|COMPLETED|Visit 1 - Period 2||0
4923308|NCT03330275|12112468|P6|COMPLETED|Visit 1 - Period 2||0
4923309|NCT03330275|12112469|P5|COMPLETED|Visit 1 - Period 2||0
4923310|NCT03330275|12112470|P4|COMPLETED|Visit 1 - Period 2||6
4923311|NCT03330275|12112471|P3|COMPLETED|Visit 1 - Period 2||6
4923312|NCT03330275|12112472|P2|COMPLETED|Visit 1 - Period 2||6
4923313|NCT03330275|12112473|P1|COMPLETED|Visit 1 - Period 2||6
4923314|NCT03330275|12112464|P10|STARTED|Visit 1 - Period 2||0
4923315|NCT03330275|12112465|P9|STARTED|Visit 1 - Period 2||0
4923316|NCT03330275|12112466|P8|STARTED|Visit 1 - Period 2||0
4923317|NCT03330275|12112467|P7|STARTED|Visit 1 - Period 2||0
4923318|NCT03330275|12112468|P6|STARTED|Visit 1 - Period 2||0
4923319|NCT03330275|12112469|P5|STARTED|Visit 1 - Period 2||0
4923320|NCT03330275|12112470|P4|STARTED|Visit 1 - Period 2||6
4923321|NCT03330275|12112471|P3|STARTED|Visit 1 - Period 2||6
4923322|NCT03330275|12112472|P2|STARTED|Visit 1 - Period 2||6
4923323|NCT03330275|12112473|P1|STARTED|Visit 1 - Period 2||6
4923324|NCT03330275|12112464|P10|NOT COMPLETED|Visit 1 - Period 1||0
4923325|NCT03330275|12112465|P9|NOT COMPLETED|Visit 1 - Period 1||0
4923326|NCT03330275|12112466|P8|NOT COMPLETED|Visit 1 - Period 1||0
4923327|NCT03330275|12112467|P7|NOT COMPLETED|Visit 1 - Period 1||0
4923328|NCT03330275|12112468|P6|NOT COMPLETED|Visit 1 - Period 1||0
4923329|NCT03330275|12112469|P5|NOT COMPLETED|Visit 1 - Period 1||0
4923330|NCT03330275|12112470|P4|NOT COMPLETED|Visit 1 - Period 1||0
4923331|NCT03330275|12112471|P3|NOT COMPLETED|Visit 1 - Period 1||0
4923332|NCT03330275|12112472|P2|NOT COMPLETED|Visit 1 - Period 1||0
4923333|NCT03330275|12112473|P1|NOT COMPLETED|Visit 1 - Period 1||0
4923334|NCT03330275|12112464|P10|COMPLETED|Visit 1 - Period 1||0
4923335|NCT03330275|12112465|P9|COMPLETED|Visit 1 - Period 1||0
4923336|NCT03330275|12112466|P8|COMPLETED|Visit 1 - Period 1||0
4923337|NCT03330275|12112467|P7|COMPLETED|Visit 1 - Period 1||0
4923338|NCT03330275|12112468|P6|COMPLETED|Visit 1 - Period 1||0
4923339|NCT03330275|12112469|P5|COMPLETED|Visit 1 - Period 1||0
4923340|NCT03330275|12112470|P4|COMPLETED|Visit 1 - Period 1||6
4923341|NCT03330275|12112471|P3|COMPLETED|Visit 1 - Period 1||6
4923342|NCT03330275|12112472|P2|COMPLETED|Visit 1 - Period 1||6
4923343|NCT03330275|12112473|P1|COMPLETED|Visit 1 - Period 1||6
4923344|NCT03330275|12112464|P10|STARTED|Visit 1 - Period 1||0
4923345|NCT03330275|12112465|P9|STARTED|Visit 1 - Period 1||0
4923346|NCT03330275|12112466|P8|STARTED|Visit 1 - Period 1||0
4923347|NCT03330275|12112467|P7|STARTED|Visit 1 - Period 1||0
4923348|NCT03330275|12112468|P6|STARTED|Visit 1 - Period 1||0
4923349|NCT03330275|12112469|P5|STARTED|Visit 1 - Period 1||0
4923350|NCT03330275|12112470|P4|STARTED|Visit 1 - Period 1||6
4923351|NCT03330275|12112471|P3|STARTED|Visit 1 - Period 1||6
4923352|NCT03330275|12112472|P2|STARTED|Visit 1 - Period 1||6
4923353|NCT03330275|12112473|P1|STARTED|Visit 1 - Period 1||6
4923354|NCT03330041|12112499|P1|NOT COMPLETED|Overall Study||2
4923355|NCT03330041|12112499|P1|COMPLETED|Overall Study||48
4923356|NCT03330041|12112499|P1|STARTED|Overall Study||50
4923357|NCT03329885|12112515|P9|NOT COMPLETED|Overall Study||0
4923358|NCT03329885|12112516|P8|NOT COMPLETED|Overall Study||1
4923359|NCT03329885|12112517|P7|NOT COMPLETED|Overall Study||1
4923360|NCT03329885|12112518|P6|NOT COMPLETED|Overall Study||0
4923361|NCT03329885|12112519|P5|NOT COMPLETED|Overall Study||0
4923362|NCT03329885|12112520|P4|NOT COMPLETED|Overall Study||0
4923363|NCT03329885|12112521|P3|NOT COMPLETED|Overall Study||0
4923364|NCT03329885|12112522|P2|NOT COMPLETED|Overall Study||0
4923365|NCT03329885|12112523|P1|NOT COMPLETED|Overall Study||0
4923366|NCT03329885|12112515|P9|COMPLETED|Overall Study||0
4923367|NCT03329885|12112516|P8|COMPLETED|Overall Study||0
4923368|NCT03329885|12112517|P7|COMPLETED|Overall Study||0
4923369|NCT03329885|12112518|P6|COMPLETED|Overall Study||3
4923370|NCT03329885|12112519|P5|COMPLETED|Overall Study||6
4923371|NCT03329885|12112520|P4|COMPLETED|Overall Study||6
4923372|NCT03329885|12112521|P3|COMPLETED|Overall Study||6
4923373|NCT03329885|12112522|P2|COMPLETED|Overall Study||6
4923374|NCT03329885|12112523|P1|COMPLETED|Overall Study||9
4923375|NCT03329885|12112515|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
4923376|NCT03329885|12112516|P8|STARTED|Overall Study||1
4923377|NCT03329885|12112517|P7|STARTED|Overall Study||1
4923378|NCT03329885|12112518|P6|STARTED|Overall Study||3
4923379|NCT03329885|12112519|P5|STARTED|Overall Study||6
4923380|NCT03329885|12112520|P4|STARTED|Overall Study||6
4923381|NCT03329885|12112521|P3|STARTED|Overall Study||6
4923382|NCT03329885|12112522|P2|STARTED|Overall Study||6
4923383|NCT03329885|12112523|P1|STARTED|Overall Study||9
4923384|NCT03329573|12112691|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
4923385|NCT03329573|12112692|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
4923386|NCT03329573|12112693|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
4923387|NCT03329573|12112694|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
4923388|NCT03329573|12112691|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
4923389|NCT03329573|12112692|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
4923390|NCT03329573|12112693|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
4923391|NCT03329573|12112694|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
4923392|NCT03329573|12112691|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
4923393|NCT03329573|12112692|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
4923394|NCT03329573|12112693|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
4923395|NCT03329573|12112694|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
4923396|NCT03329573|12112691|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
4923397|NCT03329573|12112692|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
4923398|NCT03329573|12112693|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
4923399|NCT03329573|12112694|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
4923400|NCT03329573|12112691|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
4923401|NCT03329573|12112692|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
4923402|NCT03329573|12112693|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
4923403|NCT03329573|12112694|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
4923404|NCT03329573|12112691|P4|STARTED|Washout Period (Day 6 to Day 11)||19
4923405|NCT03329573|12112692|P3|STARTED|Washout Period (Day 6 to Day 11)||19
4923406|NCT03329573|12112693|P2|STARTED|Washout Period (Day 6 to Day 11)||21
4923407|NCT03329573|12112694|P1|STARTED|Washout Period (Day 6 to Day 11)||22
4923408|NCT03329573|12112691|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
4923409|NCT03329573|12112692|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
4923410|NCT03329573|12112693|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
4923411|NCT03329573|12112694|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
4923412|NCT03329573|12112691|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
4923413|NCT03329573|12112692|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
4923414|NCT03329573|12112693|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
4923415|NCT03329573|12112694|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
4923416|NCT03329573|12112691|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
4923417|NCT03329573|12112692|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
4923418|NCT03329573|12112693|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
4923419|NCT03329573|12112694|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
4923420|NCT03329209|12112760|P1|NOT COMPLETED|Overall Study||0
4923421|NCT03329209|12112760|P1|COMPLETED|Overall Study||16
4923422|NCT03329209|12112760|P1|STARTED|Overall Study||16
4923423|NCT03328949|12112768|P1|NOT COMPLETED|Overall Study||0
4923424|NCT03328949|12112768|P1|COMPLETED|Overall Study||120
4923425|NCT03328949|12112768|P1|STARTED|Overall Study||120
4923426|NCT03328624|12112775|P1|NOT COMPLETED|Overall Study||0
4923427|NCT03328624|12112775|P1|COMPLETED|Overall Study||36
4923428|NCT03328624|12112775|P1|STARTED|Overall Study||36
4923429|NCT03328208|12112781|P2|NOT COMPLETED|Overall Study||0
4923430|NCT03328208|12112782|P1|NOT COMPLETED|Overall Study||0
4923431|NCT03328208|12112781|P2|COMPLETED|Overall Study||35
4923432|NCT03328208|12112782|P1|COMPLETED|Overall Study||37
4923433|NCT03328208|12112781|P2|STARTED|Overall Study||35
4923434|NCT03328208|12112782|P1|STARTED|Overall Study||37
4923435|NCT03328182|12112808|P1|NOT COMPLETED|Overall Study||4
4923436|NCT03328182|12112808|P1|COMPLETED|Overall Study||30
4923437|NCT03328182|12112808|P1|STARTED|Overall Study||34
4923438|NCT03327402|12112813|P1|NOT COMPLETED|Overall Study||2
4923439|NCT03327402|12112813|P1|COMPLETED|Overall Study||22
4923440|NCT03327402|12112813|P1|Sparse PK Sampling Group|Overall Study||12
4923441|NCT03327402|12112813|P1|Rich PK Sampling Group|Overall Study||12
4923442|NCT03327402|12112813|P1|STARTED|Overall Study||24
4923443|NCT03327051|12112848|P2|NOT COMPLETED|Overall Study||5
4923444|NCT03327051|12112849|P1|NOT COMPLETED|Overall Study||5
4923445|NCT03327051|12112848|P2|COMPLETED|Overall Study||15
4923446|NCT03327051|12112849|P1|COMPLETED|Overall Study||14
4923447|NCT03327051|12112848|P2|Attended Visit 2 (Week 0)|Overall Study||15
4923448|NCT03327051|12112849|P1|Attended Visit 2 (Week 0)|Overall Study||15
4923449|NCT03327051|12112848|P2|Received Treatment|Overall Study||16
4923450|NCT03327051|12112849|P1|Received Treatment|Overall Study||16
4923451|NCT03327051|12112848|P2|STARTED|Overall Study||20
4923452|NCT03327051|12112849|P1|STARTED|Overall Study||19
4923453|NCT03326986|12112864|P3|NOT COMPLETED|Overall Study||0
4923454|NCT03326986|12112865|P2|NOT COMPLETED|Overall Study||0
4923455|NCT03326986|12112866|P1|NOT COMPLETED|Overall Study||0
4923456|NCT03326986|12112864|P3|COMPLETED|Overall Study||8
4923457|NCT03326986|12112865|P2|COMPLETED|Overall Study||8
4923458|NCT03326986|12112866|P1|COMPLETED|Overall Study||8
4923459|NCT03326986|12112864|P3|STARTED|Overall Study||8
4923460|NCT03326986|12112865|P2|STARTED|Overall Study||8
4923461|NCT03326986|12112866|P1|STARTED|Overall Study||8
4923462|NCT03326843|12113106|P1|NOT COMPLETED|Overall Study||0
4923463|NCT03326843|12113106|P1|COMPLETED|Overall Study||4
4923464|NCT03326843|12113106|P1|STARTED|Overall Study||4
4923465|NCT03326323|12113111|P1|NOT COMPLETED|Overall Study||3
4923466|NCT03326323|12113111|P1|COMPLETED|Overall Study||40
4923467|NCT03326323|12113111|P1|STARTED|Overall Study||43
4923468|NCT03325894|12113118|P2|NOT COMPLETED|Overall Study||77
4923469|NCT03325894|12113119|P1|NOT COMPLETED|Overall Study||64
4923470|NCT03325894|12113118|P2|COMPLETED|Overall Study||0
4923471|NCT03325894|12113119|P1|COMPLETED|Overall Study||0
4923472|NCT03325894|12113118|P2|STARTED|Overall Study||77
4923473|NCT03325894|12113119|P1|STARTED|Overall Study||64
4923474|NCT03325881|12113187|P2|NOT COMPLETED|Overall Study||3
4923475|NCT03325881|12113188|P1|NOT COMPLETED|Overall Study||3
4923476|NCT03325881|12113187|P2|COMPLETED|Overall Study||42
4923477|NCT03325881|12113188|P1|COMPLETED|Overall Study||41
4923478|NCT03325881|12113187|P2|Treated|Overall Study||45
4923479|NCT03325881|12113188|P1|Treated|Overall Study||43
4923480|NCT03325881|12113187|P2|STARTED|Overall Study||45
4923481|NCT03325881|12113188|P1|STARTED|Overall Study||44
4923482|NCT03325673|12113216|P2|NOT COMPLETED|Overall Study||0
4923483|NCT03325673|12113217|P1|NOT COMPLETED|Overall Study||4
4923484|NCT03325673|12113216|P2|COMPLETED|Overall Study||42
4923485|NCT03325673|12113217|P1|COMPLETED|Overall Study||38
4923486|NCT03325673|12113216|P2|STARTED|Overall Study||42
4923487|NCT03325673|12113217|P1|STARTED|Overall Study||42
4923488|NCT03323736|12113232|P3|NOT COMPLETED|Overall Study||2
4923489|NCT03323736|12113233|P2|NOT COMPLETED|Overall Study||12
4923490|NCT03323736|12113234|P1|NOT COMPLETED|Overall Study||19
4923491|NCT03323736|12113232|P3|COMPLETED|Overall Study||68
4923492|NCT03323736|12113233|P2|COMPLETED|Overall Study||47
4923493|NCT03323736|12113234|P1|COMPLETED|Overall Study||222
4923494|NCT03323736|12113232|P3|Treated|Overall Study||68
4923495|NCT03323736|12113233|P2|Treated|Overall Study||47
4923496|NCT03323736|12113234|P1|Treated|Overall Study||222
4923497|NCT03323736|12113232|P3|STARTED|Overall Study||70
4923498|NCT03323736|12113233|P2|STARTED|Overall Study||59
4923499|NCT03323736|12113234|P1|STARTED|Overall Study||241
4923500|NCT03323723|12113245|P1|NOT COMPLETED|Treatment Phase||9
4923501|NCT03323723|12113245|P1|COMPLETED|Treatment Phase||51
4923502|NCT03323723|12113245|P1|STARTED|Treatment Phase||60
4923503|NCT03323723|12113245|P1|NOT COMPLETED|Baseline Phase||4
4923504|NCT03323723|12113245|P1|COMPLETED|Baseline Phase||60
4923505|NCT03323723|12113245|P1|STARTED|Baseline Phase||64
4923506|NCT03323723|12113245|P1|NOT COMPLETED|Screening||9
4923507|NCT03323723|12113245|P1|COMPLETED|Screening||64
4923508|NCT03323723|12113245|P1|STARTED|Screening||73
4923509|NCT03323307|12113252|P1|NOT COMPLETED|Overall Study||0
4923510|NCT03323307|12113252|P1|COMPLETED|Overall Study||70
4923511|NCT03323307|12113252|P1|STARTED|Overall Study||70
4923512|NCT03323086|12113261|P2|NOT COMPLETED|Overall Study||2
4923513|NCT03323086|12113262|P1|NOT COMPLETED|Overall Study||3
4923514|NCT03323086|12113261|P2|COMPLETED|Overall Study||20
4923515|NCT03323086|12113262|P1|COMPLETED|Overall Study||23
4923516|NCT03323086|12113261|P2|STARTED|Overall Study||22
4923517|NCT03323086|12113262|P1|STARTED|Overall Study||26
4923518|NCT03322930|12113280|P2|NOT COMPLETED|Overall Study||0
4923519|NCT03322930|12113281|P1|NOT COMPLETED|Overall Study||0
4923520|NCT03322930|12113280|P2|COMPLETED|Overall Study||20
4923521|NCT03322930|12113281|P1|COMPLETED|Overall Study||20
4923522|NCT03322930|12113280|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
4923523|NCT03322930|12113281|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
4923524|NCT03322566|12113290|P3|NOT COMPLETED|Overall Study||55
4923525|NCT03322566|12113291|P2|NOT COMPLETED|Overall Study||87
4923526|NCT03322566|12113292|P1|NOT COMPLETED|Overall Study||91
4923527|NCT03322566|12113290|P3|COMPLETED|Overall Study||0
4923528|NCT03322566|12113291|P2|COMPLETED|Overall Study||0
4923529|NCT03322566|12113292|P1|COMPLETED|Overall Study||0
4923530|NCT03322566|12113290|P3|STARTED|Overall Study||55
4923531|NCT03322566|12113291|P2|STARTED|Overall Study||87
4923532|NCT03322566|12113292|P1|STARTED|Overall Study||91
4923533|NCT03322540|12113311|P2|NOT COMPLETED|Overall Study||77
4923534|NCT03322540|12113312|P1|NOT COMPLETED|Overall Study||77
4923535|NCT03322540|12113311|P2|COMPLETED|Overall Study||0
4923536|NCT03322540|12113312|P1|COMPLETED|Overall Study||0
4923537|NCT03322540|12113311|P2|STARTED|Overall Study||77
4923538|NCT03322540|12113312|P1|STARTED|Overall Study||77
4923539|NCT03322514|12113320|P2|NOT COMPLETED|Overall Study||1
4923540|NCT03322514|12113321|P1|NOT COMPLETED|Overall Study||1
4923541|NCT03322514|12113320|P2|COMPLETED|Overall Study||5
4923542|NCT03322514|12113321|P1|COMPLETED|Overall Study||5
4923543|NCT03322514|12113320|P2|STARTED|Overall Study||6
4923544|NCT03322514|12113321|P1|STARTED|Overall Study||6
4923545|NCT03322423|12113331|P2|NOT COMPLETED|Period 2||2
4923546|NCT03322423|12113332|P1|NOT COMPLETED|Period 2||1
4923547|NCT03322423|12113331|P2|COMPLETED|Period 2||36
4923548|NCT03322423|12113332|P1|COMPLETED|Period 2||35
4923549|NCT03322423|12113331|P2|STARTED|Period 2||38
4923550|NCT03322423|12113332|P1|STARTED|Period 2||36
4923551|NCT03322423|12113331|P2|NOT COMPLETED|Period 1||2
4923552|NCT03322423|12113332|P1|NOT COMPLETED|Period 1||2
4923553|NCT03322423|12113331|P2|COMPLETED|Period 1||38
4923554|NCT03322423|12113332|P1|COMPLETED|Period 1||36
4923555|NCT03322423|12113331|P2|STARTED|Period 1||40
4923556|NCT03322423|12113332|P1|STARTED|Period 1||38
4923557|NCT03322293|12113345|P3|NOT COMPLETED|Overall Study||1
4923558|NCT03322293|12113346|P2|NOT COMPLETED|Overall Study||0
4923559|NCT03322293|12113347|P1|NOT COMPLETED|Overall Study||0
4923560|NCT03322293|12113345|P3|COMPLETED|Overall Study||7
4923561|NCT03322293|12113346|P2|COMPLETED|Overall Study||8
4923562|NCT03322293|12113347|P1|COMPLETED|Overall Study||8
4923563|NCT03322293|12113345|P3|STARTED|Overall Study||8
4923564|NCT03322293|12113346|P2|STARTED|Overall Study||8
4923565|NCT03322293|12113347|P1|STARTED|Overall Study||8
4923566|NCT03321396|12113367|P1|NOT COMPLETED|Overall Study||1
4923567|NCT03321396|12113367|P1|COMPLETED|Overall Study||12
4923568|NCT03321396|12113367|P1|STARTED|Overall Study||13
4923569|NCT03321253|12113373|P1|NOT COMPLETED|Overall Study||0
4923570|NCT03321253|12113373|P1|COMPLETED|Overall Study||38
4923571|NCT03321253|12113373|P1|STARTED|Overall Study||38
4923572|NCT03321097|12113383|P2|NOT COMPLETED|Overall Study||0
4923573|NCT03321097|12113384|P1|NOT COMPLETED|Overall Study||0
4923574|NCT03321097|12113383|P2|COMPLETED|Overall Study||18
4923575|NCT03321097|12113384|P1|COMPLETED|Overall Study||18
4923576|NCT03321097|12113383|P2|STARTED|Overall Study||18
4923577|NCT03321097|12113384|P1|STARTED|Overall Study||18
4923578|NCT03320941|12113405|P5|NOT COMPLETED|Overall Study||0
4923579|NCT03320941|12113406|P4|NOT COMPLETED|Overall Study||1
4923580|NCT03320941|12113407|P3|NOT COMPLETED|Overall Study||0
4923581|NCT03320941|12113408|P2|NOT COMPLETED|Overall Study||0
4923582|NCT03320941|12113409|P1|NOT COMPLETED|Overall Study||0
4923583|NCT03320941|12113405|P5|COMPLETED|Overall Study||29
4923584|NCT03320941|12113406|P4|COMPLETED|Overall Study||30
4923585|NCT03320941|12113407|P3|COMPLETED|Overall Study||28
4923586|NCT03320941|12113408|P2|COMPLETED|Overall Study||19
4923587|NCT03320941|12113409|P1|COMPLETED|Overall Study||19
4923588|NCT03320941|12113405|P5|STARTED|Overall Study||29
4923589|NCT03320941|12113406|P4|STARTED|Overall Study||31
4923590|NCT03320941|12113407|P3|STARTED|Overall Study||28
4923591|NCT03320941|12113408|P2|STARTED|Overall Study||19
4923592|NCT03320941|12113409|P1|STARTED|Overall Study||19
4923593|NCT03320824|12113512|P2|NOT COMPLETED|Overall Study||4
4923594|NCT03320824|12113513|P1|NOT COMPLETED|Overall Study||18
4923595|NCT03320824|12113512|P2|COMPLETED|Overall Study||85
4923596|NCT03320824|12113513|P1|COMPLETED|Overall Study||166
4923597|NCT03320824|12113512|P2|STARTED|Overall Study||89
4923598|NCT03320824|12113513|P1|STARTED|Overall Study||184
4923599|NCT03320564|12113529|P1|NOT COMPLETED|Overall Study||1
4923600|NCT03320564|12113529|P1|COMPLETED|Overall Study||1
4923601|NCT03320564|12113529|P1|STARTED|Overall Study||2
4923602|NCT03320096|12113533|P1|NOT COMPLETED|Overall Study||0
4923603|NCT03320096|12113533|P1|COMPLETED|Overall Study||20
4923604|NCT03320096|12113533|P1|STARTED|Overall Study||20
4923605|NCT03319810|12113540|P1|NOT COMPLETED|Overall Study||0
4923606|NCT03319810|12113540|P1|COMPLETED|Overall Study||5
4923607|NCT03319810|12113540|P1|STARTED|Overall Study||5
4923608|NCT03319719|12113545|P1|NOT COMPLETED|Overall Study||1
4923609|NCT03319719|12113545|P1|COMPLETED|Overall Study||51
4923610|NCT03319719|12113545|P1|STARTED|Overall Study||52
4923611|NCT03319407|12113559|P1|NOT COMPLETED|Overall Study||21
4923612|NCT03319407|12113559|P1|COMPLETED|Overall Study||0
4923613|NCT03319407|12113559|P1|STARTED|Overall Study||21
4923614|NCT03319277|12113565|P2|NOT COMPLETED|Overall Study||0
4923615|NCT03319277|12113566|P1|NOT COMPLETED|Overall Study||0
4923616|NCT03319277|12113565|P2|COMPLETED|Overall Study||59
4923617|NCT03319277|12113566|P1|COMPLETED|Overall Study||59
4923618|NCT03319277|12113565|P2|STARTED|Overall Study||59
4923619|NCT03319277|12113566|P1|STARTED|Overall Study||59
4923620|NCT03319212|12113578|P2|NOT COMPLETED|Overall Study||5
4923621|NCT03319212|12113579|P1|NOT COMPLETED|Overall Study||3
4923622|NCT03319212|12113578|P2|COMPLETED|Overall Study||47
4923623|NCT03319212|12113579|P1|COMPLETED|Overall Study||26
4923624|NCT03319212|12113578|P2|STARTED|Overall Study||52
4923625|NCT03319212|12113579|P1|STARTED|Overall Study||29
4923626|NCT03319173|12113606|P2|NOT COMPLETED|Overall Study||0
4923627|NCT03319173|12113607|P1|NOT COMPLETED|Overall Study||0
4923628|NCT03319173|12113606|P2|COMPLETED|Overall Study||50
4923629|NCT03319173|12113607|P1|COMPLETED|Overall Study||48
4923630|NCT03319173|12113606|P2|STARTED|Overall Study||50
4923631|NCT03319173|12113607|P1|STARTED|Overall Study||48
4923632|NCT03318861|12113648|P5|NOT COMPLETED|Overall Study||3
4923633|NCT03318861|12113649|P4|NOT COMPLETED|Overall Study||4
4923634|NCT03318861|12113650|P3|NOT COMPLETED|Overall Study||3
4923635|NCT03318861|12113651|P2|NOT COMPLETED|Overall Study||4
4923636|NCT03318861|12113652|P1|NOT COMPLETED|Overall Study||3
4923637|NCT03318861|12113648|P5|COMPLETED|Overall Study||0
4923638|NCT03318861|12113649|P4|COMPLETED|Overall Study||0
4923639|NCT03318861|12113650|P3|COMPLETED|Overall Study||0
4923640|NCT03318861|12113651|P2|COMPLETED|Overall Study||0
4923641|NCT03318861|12113652|P1|COMPLETED|Overall Study||0
4923642|NCT03318861|12113648|P5|STARTED|Overall Study||3
4923643|NCT03318861|12113649|P4|STARTED|Overall Study||4
4923644|NCT03318861|12113650|P3|STARTED|Overall Study||3
4923645|NCT03318861|12113651|P2|STARTED|Overall Study||4
4923646|NCT03318861|12113652|P1|STARTED|Overall Study||3
4923647|NCT03318341|12113700|P2|NOT COMPLETED|Month 2||0
4923648|NCT03318341|12113701|P1|NOT COMPLETED|Month 2||0
4923649|NCT03318341|12113700|P2|COMPLETED|Month 2||12
4923650|NCT03318341|12113701|P1|COMPLETED|Month 2||13
4923651|NCT03318341|12113700|P2|STARTED|Month 2||12
4923652|NCT03318341|12113701|P1|STARTED|Month 2||13
4923653|NCT03318341|12113700|P2|NOT COMPLETED|Month 1||1
4923654|NCT03318341|12113701|P1|NOT COMPLETED|Month 1||0
4923655|NCT03318341|12113700|P2|COMPLETED|Month 1||12
4923656|NCT03318341|12113701|P1|COMPLETED|Month 1||13
4923657|NCT03318341|12113700|P2|STARTED|Month 1||13
4923658|NCT03318341|12113701|P1|STARTED|Month 1||13
4923659|NCT03317431|12113711|P1|NOT COMPLETED|Overall Study||0
4923660|NCT03317431|12113711|P1|COMPLETED|Overall Study||46
4923661|NCT03317431|12113711|P1|STARTED|Overall Study||46
4923662|NCT03316976|12113721|P2|NOT COMPLETED|Overall Study||0
4923663|NCT03316976|12113722|P1|NOT COMPLETED|Overall Study||0
4923664|NCT03316976|12113721|P2|COMPLETED|Overall Study||20
4923665|NCT03316976|12113722|P1|COMPLETED|Overall Study||20
4923666|NCT03316976|12113721|P2|STARTED|Overall Study||20
4923667|NCT03316976|12113722|P1|STARTED|Overall Study||20
4923668|NCT03316911|12113734|P2|NOT COMPLETED|Overall Study||29
4923669|NCT03316911|12113735|P1|NOT COMPLETED|Overall Study||33
4923670|NCT03316911|12113734|P2|COMPLETED|Overall Study||110
4923671|NCT03316911|12113735|P1|COMPLETED|Overall Study||89
4923672|NCT03316911|12113734|P2|5-Month Follow-up Survey|Overall Study||110
4923673|NCT03316911|12113735|P1|5-Month Follow-up Survey|Overall Study||89
4923674|NCT03316911|12113734|P2|3-Month Follow-up Survey|Overall Study||112
4923675|NCT03316911|12113735|P1|3-Month Follow-up Survey|Overall Study||93
4923676|NCT03316911|12113734|P2|STARTED|Overall Study|3 did not complete baseline survey|139
4923677|NCT03316911|12113735|P1|STARTED|Overall Study|2 did not complete baseline survey|122
4923678|NCT03316378|12113769|P2|NOT COMPLETED|Overall Study||0
4923679|NCT03316378|12113770|P1|NOT COMPLETED|Overall Study||0
4923680|NCT03316378|12113769|P2|COMPLETED|Overall Study||23
4923681|NCT03316378|12113770|P1|COMPLETED|Overall Study||23
4923682|NCT03316378|12113769|P2|STARTED|Overall Study||23
4923683|NCT03316378|12113770|P1|STARTED|Overall Study||23
4923684|NCT03316131|12113780|P2|NOT COMPLETED|Treatment Period 2||0
4923685|NCT03316131|12113781|P1|NOT COMPLETED|Treatment Period 2||1
4923686|NCT03316131|12113780|P2|COMPLETED|Treatment Period 2||18
4923687|NCT03316131|12113781|P1|COMPLETED|Treatment Period 2||17
4923688|NCT03316131|12113780|P2|STARTED|Treatment Period 2||18
4923689|NCT03316131|12113781|P1|STARTED|Treatment Period 2||18
4923690|NCT03316131|12113780|P2|NOT COMPLETED|Treatment Period 1||0
4923691|NCT03316131|12113781|P1|NOT COMPLETED|Treatment Period 1||0
4923692|NCT03316131|12113780|P2|COMPLETED|Treatment Period 1||18
4923693|NCT03316131|12113781|P1|COMPLETED|Treatment Period 1||18
4923694|NCT03316131|12113780|P2|STARTED|Treatment Period 1||18
4923695|NCT03316131|12113781|P1|STARTED|Treatment Period 1||18
4923696|NCT03316105|12113801|P2|NOT COMPLETED|Overall Study||0
4923697|NCT03316105|12113802|P1|NOT COMPLETED|Overall Study||0
4923698|NCT03316105|12113801|P2|COMPLETED|Overall Study||7
4923699|NCT03316105|12113802|P1|COMPLETED|Overall Study||9
4923700|NCT03316105|12113801|P2|STARTED|Overall Study||7
4923701|NCT03316105|12113802|P1|STARTED|Overall Study||9
4923702|NCT03315780|12113808|P2|NOT COMPLETED|Period 2||0
4923703|NCT03315780|12113809|P1|NOT COMPLETED|Period 2||0
4923704|NCT03315780|12113808|P2|COMPLETED|Period 2||6
4923705|NCT03315780|12113809|P1|COMPLETED|Period 2||6
4923706|NCT03315780|12113808|P2|STARTED|Period 2||6
4923707|NCT03315780|12113809|P1|STARTED|Period 2||6
4923708|NCT03315780|12113808|P2|NOT COMPLETED|Period 1||0
4923709|NCT03315780|12113809|P1|NOT COMPLETED|Period 1||0
4923710|NCT03315780|12113808|P2|COMPLETED|Period 1||6
4923711|NCT03315780|12113809|P1|COMPLETED|Period 1||6
4923712|NCT03315780|12113808|P2|Received One Dose of Study Drug|Period 1||6
4923713|NCT03315780|12113809|P1|Received One Dose of Study Drug|Period 1||6
4923714|NCT03315780|12113808|P2|STARTED|Period 1||6
4923715|NCT03315780|12113809|P1|STARTED|Period 1||6
4923716|NCT03315702|12113829|P1|NOT COMPLETED|Overall Study||0
4923717|NCT03315702|12113829|P1|COMPLETED|Overall Study||52
4923718|NCT03315702|12113829|P1|STARTED|Overall Study||52
4923719|NCT03315689|12113838|P2|NOT COMPLETED|Open Label Extension = 52 Weeks||3
4923720|NCT03315689|12113839|P1|NOT COMPLETED|Open Label Extension = 52 Weeks||0
4923721|NCT03315689|12113838|P2|COMPLETED|Open Label Extension = 52 Weeks||7
4923722|NCT03315689|12113839|P1|COMPLETED|Open Label Extension = 52 Weeks||0
4923723|NCT03315689|12113838|P2|STARTED|Open Label Extension = 52 Weeks||10
4923724|NCT03315689|12113839|P1|STARTED|Open Label Extension = 52 Weeks||0
4923725|NCT03315689|12113838|P2|NOT COMPLETED|Double-blind Period = 28 Days||0
4923726|NCT03315689|12113839|P1|NOT COMPLETED|Double-blind Period = 28 Days||1
4923727|NCT03315689|12113838|P2|COMPLETED|Double-blind Period = 28 Days||7
4923728|NCT03315689|12113839|P1|COMPLETED|Double-blind Period = 28 Days||3
4923729|NCT03315689|12113838|P2|STARTED|Double-blind Period = 28 Days||7
4923730|NCT03315689|12113839|P1|STARTED|Double-blind Period = 28 Days||4
4923731|NCT03315572|12113869|P2|NOT COMPLETED|Overall Study||0
4923732|NCT03315572|12113870|P1|NOT COMPLETED|Overall Study||0
4923733|NCT03315572|12113869|P2|COMPLETED|Overall Study||14
4923734|NCT03315572|12113870|P1|COMPLETED|Overall Study||14
4923735|NCT03315572|12113869|P2|STARTED|Overall Study||14
4923736|NCT03315572|12113870|P1|STARTED|Overall Study||14
4923737|NCT03315559|12113893|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
4923738|NCT03315559|12113893|P1|COMPLETED|Treatment Period 2 (15 Days)||6
4923739|NCT03315559|12113893|P1|STARTED|Treatment Period 2 (15 Days)||6
4923740|NCT03315559|12113893|P1|NOT COMPLETED|Washout Period (14 Days)||0
4923741|NCT03315559|12113893|P1|COMPLETED|Washout Period (14 Days)||6
4923742|NCT03315559|12113893|P1|STARTED|Washout Period (14 Days)||6
4923743|NCT03315559|12113893|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
4923744|NCT03315559|12113893|P1|COMPLETED|Treatment Period 1 (8 Days)||6
4923745|NCT03315559|12113893|P1|STARTED|Treatment Period 1 (8 Days)||6
4923746|NCT03315286|12113933|P2|NOT COMPLETED|Overall Study||4
4923747|NCT03315286|12113934|P1|NOT COMPLETED|Overall Study||1
4923748|NCT03315286|12113933|P2|COMPLETED|Overall Study||43
4923749|NCT03315286|12113934|P1|COMPLETED|Overall Study||49
4923750|NCT03315286|12113933|P2|STARTED|Overall Study||47
4923751|NCT03315286|12113934|P1|STARTED|Overall Study||50
4923752|NCT03314857|12113950|P1|NOT COMPLETED|Overall Study||5
4923753|NCT03314857|12113950|P1|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
4923754|NCT03314857|12113950|P1|STARTED|Overall Study||67
4923755|NCT03314753|12113958|P2|NOT COMPLETED|Overall Study||0
4923756|NCT03314753|12113959|P1|NOT COMPLETED|Overall Study||0
4923757|NCT03314753|12113958|P2|COMPLETED|Overall Study||36
4923758|NCT03314753|12113959|P1|COMPLETED|Overall Study||53
4923759|NCT03314753|12113958|P2|STARTED|Overall Study||36
4923760|NCT03314753|12113959|P1|STARTED|Overall Study||53
4923761|NCT03314662|12113984|P3|NOT COMPLETED|Overall Study||5
4923762|NCT03314662|12113985|P2|NOT COMPLETED|Overall Study||5
4923763|NCT03314662|12113986|P1|NOT COMPLETED|Overall Study||8
4923764|NCT03314662|12113984|P3|COMPLETED|Overall Study||439
4923765|NCT03314662|12113985|P2|COMPLETED|Overall Study||440
4923766|NCT03314662|12113986|P1|COMPLETED|Overall Study||881
4923767|NCT03314662|12113984|P3|Treated|Overall Study||444
4923768|NCT03314662|12113985|P2|Treated|Overall Study||444
4923769|NCT03314662|12113986|P1|Treated|Overall Study||888
4923770|NCT03314662|12113984|P3|STARTED|Overall Study||444
4923771|NCT03314662|12113985|P2|STARTED|Overall Study||445
4923772|NCT03314662|12113986|P1|STARTED|Overall Study||889
4923773|NCT03314519|12114031|P2|NOT COMPLETED|Overall Study||2
4923774|NCT03314519|12114032|P1|NOT COMPLETED|Overall Study||3
4923775|NCT03314519|12114031|P2|COMPLETED|Overall Study||98
4923776|NCT03314519|12114032|P1|COMPLETED|Overall Study||97
4923777|NCT03314519|12114031|P2|STARTED|Overall Study||100
4923778|NCT03314519|12114032|P1|STARTED|Overall Study||100
4923779|NCT03314233|12114042|P1|NOT COMPLETED|Overall Study||1
4923780|NCT03314233|12114042|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
4923781|NCT03314233|12114042|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
4923782|NCT03313050|12114057|P4|NOT COMPLETED|Stage 2: 12 Months||20
4923783|NCT03313050|12114058|P3|NOT COMPLETED|Stage 2: 12 Months||11
4923784|NCT03313050|12114059|P2|NOT COMPLETED|Stage 2: 12 Months||0
4923785|NCT03313050|12114060|P1|NOT COMPLETED|Stage 2: 12 Months||0
4923786|NCT03313050|12114057|P4|COMPLETED|Stage 2: 12 Months||204
4923787|NCT03313050|12114058|P3|COMPLETED|Stage 2: 12 Months||210
4923788|NCT03313050|12114059|P2|COMPLETED|Stage 2: 12 Months||0
4923789|NCT03313050|12114060|P1|COMPLETED|Stage 2: 12 Months||0
4923790|NCT03313050|12114057|P4|Vaccinated|Stage 2: 12 Months||223
4923791|NCT03313050|12114058|P3|Vaccinated|Stage 2: 12 Months||221
4923792|NCT03313050|12114059|P2|Vaccinated|Stage 2: 12 Months||0
4923793|NCT03313050|12114060|P1|Vaccinated|Stage 2: 12 Months||0
4923794|NCT03313050|12114057|P4|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
4923795|NCT03313050|12114058|P3|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
4923796|NCT03313050|12114059|P2|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
4923797|NCT03313050|12114060|P1|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
4923798|NCT03313050|12114057|P4|NOT COMPLETED|Stage 1: 6 Months||0
4923799|NCT03313050|12114058|P3|NOT COMPLETED|Stage 1: 6 Months||0
4923800|NCT03313050|12114059|P2|NOT COMPLETED|Stage 1: 6 Months||0
4923801|NCT03313050|12114060|P1|NOT COMPLETED|Stage 1: 6 Months||0
4923802|NCT03313050|12114057|P4|COMPLETED|Stage 1: 6 Months||0
4923803|NCT03313050|12114058|P3|COMPLETED|Stage 1: 6 Months||0
4923804|NCT03313050|12114059|P2|COMPLETED|Stage 1: 6 Months||32
4923805|NCT03313050|12114060|P1|COMPLETED|Stage 1: 6 Months||34
4923806|NCT03313050|12114057|P4|Vaccinated|Stage 1: 6 Months||0
4923807|NCT03313050|12114058|P3|Vaccinated|Stage 1: 6 Months||0
4923808|NCT03313050|12114059|P2|Vaccinated|Stage 1: 6 Months||32
4923809|NCT03313050|12114060|P1|Vaccinated|Stage 1: 6 Months||34
4923810|NCT03313050|12114057|P4|STARTED|Stage 1: 6 Months||0
4923811|NCT03313050|12114058|P3|STARTED|Stage 1: 6 Months||0
4923812|NCT03313050|12114059|P2|STARTED|Stage 1: 6 Months||32
4923813|NCT03313050|12114060|P1|STARTED|Stage 1: 6 Months||34
4923814|NCT03313037|12114100|P2|NOT COMPLETED|Overall Study||20
4923815|NCT03313037|12114101|P1|NOT COMPLETED|Overall Study||20
4923816|NCT03313037|12114100|P2|COMPLETED|Overall Study||202
4923817|NCT03313037|12114101|P1|COMPLETED|Overall Study||202
4923818|NCT03313037|12114100|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
4923819|NCT03313037|12114101|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
4923820|NCT03313037|12114100|P2|Safety Population|Overall Study||222
4923821|NCT03313037|12114101|P1|Safety Population|Overall Study||221
4923822|NCT03313037|12114100|P2|STARTED|Overall Study||222
4923823|NCT03313037|12114101|P1|STARTED|Overall Study||222
4923824|NCT03312933|12114123|P1|NOT COMPLETED|Overall Study||54
4923825|NCT03312933|12114123|P1|COMPLETED|Overall Study||46
4923826|NCT03312933|12114123|P1|STARTED|Overall Study||100
4923827|NCT03312543|12114129|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
4923828|NCT03312543|12114130|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
4923829|NCT03312543|12114129|P2|COMPLETED|Regression (Week 12 to Week 24)||52
4923830|NCT03312543|12114130|P1|COMPLETED|Regression (Week 12 to Week 24)||55
4923831|NCT03312543|12114129|P2|STARTED|Regression (Week 12 to Week 24)||54
4923832|NCT03312543|12114130|P1|STARTED|Regression (Week 12 to Week 24)||56
4923833|NCT03312543|12114129|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
4923834|NCT03312543|12114130|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
4923835|NCT03312543|12114129|P2|COMPLETED|Treatment (Baseline to Week 12)||54
4923836|NCT03312543|12114130|P1|COMPLETED|Treatment (Baseline to Week 12)||56
4923837|NCT03312543|12114129|P2|STARTED|Treatment (Baseline to Week 12)||59
4923838|NCT03312543|12114130|P1|STARTED|Treatment (Baseline to Week 12)||60
4923839|NCT03312543|12114129|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
4923840|NCT03312543|12114130|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
4923841|NCT03312543|12114129|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
4923842|NCT03312543|12114130|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
4923843|NCT03312543|12114129|P2|STARTED|Before Treatment (Screening to Baseline)||63
4923844|NCT03312543|12114130|P1|STARTED|Before Treatment (Screening to Baseline)||61
4923845|NCT03312517|12114204|P6|NOT COMPLETED|Overall Study||0
4923846|NCT03312517|12114205|P5|NOT COMPLETED|Overall Study||0
4923847|NCT03312517|12114206|P4|NOT COMPLETED|Overall Study||0
4923848|NCT03312517|12114207|P3|NOT COMPLETED|Overall Study||0
4923849|NCT03312517|12114208|P2|NOT COMPLETED|Overall Study||0
4923850|NCT03312517|12114209|P1|NOT COMPLETED|Overall Study||0
4923851|NCT03312517|12114204|P6|COMPLETED|Overall Study||2
4923852|NCT03312517|12114205|P5|COMPLETED|Overall Study||2
4923853|NCT03312517|12114206|P4|COMPLETED|Overall Study||2
4923854|NCT03312517|12114207|P3|COMPLETED|Overall Study||2
4923855|NCT03312517|12114208|P2|COMPLETED|Overall Study||2
4923856|NCT03312517|12114209|P1|COMPLETED|Overall Study||2
4923857|NCT03312517|12114204|P6|STARTED|Overall Study||2
4923858|NCT03312517|12114205|P5|STARTED|Overall Study||2
4923859|NCT03312517|12114206|P4|STARTED|Overall Study||2
4923860|NCT03312517|12114207|P3|STARTED|Overall Study||2
4923861|NCT03312517|12114208|P2|STARTED|Overall Study||2
4923862|NCT03312517|12114209|P1|STARTED|Overall Study||2
4923863|NCT03312348|12114217|P1|NOT COMPLETED|Overall Study||0
4923864|NCT03312348|12114217|P1|COMPLETED|Overall Study||30
4923865|NCT03312348|12114217|P1|STARTED|Overall Study||30
4923866|NCT03311841|12114226|P5|NOT COMPLETED|Period 2||0
4923867|NCT03311841|12114227|P4|NOT COMPLETED|Period 2||0
4923868|NCT03311841|12114228|P3|NOT COMPLETED|Period 2||0
4923869|NCT03311841|12114229|P2|NOT COMPLETED|Period 2||0
4923870|NCT03311841|12114230|P1|NOT COMPLETED|Period 2||0
4923871|NCT03311841|12114226|P5|COMPLETED|Period 2||6
4923872|NCT03311841|12114227|P4|COMPLETED|Period 2||6
4923873|NCT03311841|12114228|P3|COMPLETED|Period 2||6
4923874|NCT03311841|12114229|P2|COMPLETED|Period 2||6
4923875|NCT03311841|12114230|P1|COMPLETED|Period 2||6
4923876|NCT03311841|12114226|P5|STARTED|Period 2||6
4923877|NCT03311841|12114227|P4|STARTED|Period 2||6
4923878|NCT03311841|12114228|P3|STARTED|Period 2||6
4923879|NCT03311841|12114229|P2|STARTED|Period 2||6
4923880|NCT03311841|12114230|P1|STARTED|Period 2||6
4923881|NCT03311841|12114226|P5|NOT COMPLETED|14-day Wash-out||0
4923882|NCT03311841|12114227|P4|NOT COMPLETED|14-day Wash-out||1
4923883|NCT03311841|12114228|P3|NOT COMPLETED|14-day Wash-out||0
4923884|NCT03311841|12114229|P2|NOT COMPLETED|14-day Wash-out||1
4923885|NCT03311841|12114230|P1|NOT COMPLETED|14-day Wash-out||0
4923886|NCT03311841|12114226|P5|COMPLETED|14-day Wash-out||6
4923887|NCT03311841|12114227|P4|COMPLETED|14-day Wash-out||6
4923888|NCT03311841|12114228|P3|COMPLETED|14-day Wash-out||6
4923889|NCT03311841|12114229|P2|COMPLETED|14-day Wash-out||6
4923890|NCT03311841|12114230|P1|COMPLETED|14-day Wash-out||6
4923891|NCT03311841|12114226|P5|STARTED|14-day Wash-out||6
4923892|NCT03311841|12114227|P4|STARTED|14-day Wash-out||7
4923893|NCT03311841|12114228|P3|STARTED|14-day Wash-out||6
4923894|NCT03311841|12114229|P2|STARTED|14-day Wash-out||7
4923895|NCT03311841|12114230|P1|STARTED|14-day Wash-out||6
4923896|NCT03311841|12114226|P5|NOT COMPLETED|Period 1||0
4923897|NCT03311841|12114227|P4|NOT COMPLETED|Period 1||0
4923898|NCT03311841|12114228|P3|NOT COMPLETED|Period 1||0
4923899|NCT03311841|12114229|P2|NOT COMPLETED|Period 1||0
4923900|NCT03311841|12114230|P1|NOT COMPLETED|Period 1||0
4923901|NCT03311841|12114226|P5|COMPLETED|Period 1||6
4923902|NCT03311841|12114227|P4|COMPLETED|Period 1||7
4923903|NCT03311841|12114228|P3|COMPLETED|Period 1||6
4923904|NCT03311841|12114229|P2|COMPLETED|Period 1||7
4923905|NCT03311841|12114230|P1|COMPLETED|Period 1||6
4923906|NCT03311841|12114226|P5|STARTED|Period 1||6
4923907|NCT03311841|12114227|P4|STARTED|Period 1||7
4923908|NCT03311841|12114228|P3|STARTED|Period 1||6
4923909|NCT03311841|12114229|P2|STARTED|Period 1||7
4923910|NCT03311841|12114230|P1|STARTED|Period 1||6
4923911|NCT03311659|12114331|P1|NOT COMPLETED|Overall Study||1
4923912|NCT03311659|12114331|P1|COMPLETED|Overall Study||446
4923913|NCT03311659|12114331|P1|STARTED|Overall Study||447
4923914|NCT03311646|12114346|P1|NOT COMPLETED|Overall Study||15
4923915|NCT03311646|12114346|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
4923916|NCT03311646|12114346|P1|STARTED|Overall Study|Number who were eligible and consented.|31
4923917|NCT03311373|12114353|P1|NOT COMPLETED|Overall Study||9
4923918|NCT03311373|12114353|P1|COMPLETED|Overall Study||47
4923919|NCT03311373|12114353|P1|STARTED|Overall Study||56
4923920|NCT03311230|12114411|P4|NOT COMPLETED|Overall Study||7
4923921|NCT03311230|12114412|P3|NOT COMPLETED|Overall Study||2
4923922|NCT03311230|12114413|P2|NOT COMPLETED|Overall Study||5
4923923|NCT03311230|12114414|P1|NOT COMPLETED|Overall Study||1
4923924|NCT03311230|12114411|P4|COMPLETED|Overall Study||143
4923925|NCT03311230|12114412|P3|COMPLETED|Overall Study||148
4923926|NCT03311230|12114413|P2|COMPLETED|Overall Study||146
4923927|NCT03311230|12114414|P1|COMPLETED|Overall Study||150
4923928|NCT03311230|12114411|P4|STARTED|Overall Study||150
4923929|NCT03311230|12114412|P3|STARTED|Overall Study||150
4923930|NCT03311230|12114413|P2|STARTED|Overall Study||151
4923931|NCT03311230|12114414|P1|STARTED|Overall Study||151
4923932|NCT03310580|12114439|P3|NOT COMPLETED|Overall Study||0
4923933|NCT03310580|12114440|P2|NOT COMPLETED|Overall Study||1
4923934|NCT03310580|12114441|P1|NOT COMPLETED|Overall Study||0
4923935|NCT03310580|12114439|P3|COMPLETED|Overall Study||12
4923936|NCT03310580|12114440|P2|COMPLETED|Overall Study||14
4923937|NCT03310580|12114441|P1|COMPLETED|Overall Study||15
4923938|NCT03310580|12114439|P3|STARTED|Overall Study||12
4923939|NCT03310580|12114440|P2|STARTED|Overall Study||15
4923940|NCT03310580|12114441|P1|STARTED|Overall Study||15
4923941|NCT03310450|12114455|P3|NOT COMPLETED|Overall Study||0
4923942|NCT03310450|12114456|P2|NOT COMPLETED|Overall Study||4
4923943|NCT03310450|12114457|P1|NOT COMPLETED|Overall Study||2
4923944|NCT03310450|12114455|P3|COMPLETED|Overall Study||28
4923945|NCT03310450|12114456|P2|COMPLETED|Overall Study||30
4923946|NCT03310450|12114457|P1|COMPLETED|Overall Study||30
4923947|NCT03310450|12114455|P3|STARTED|Overall Study||28
4923948|NCT03310450|12114456|P2|STARTED|Overall Study||34
4923949|NCT03310450|12114457|P1|STARTED|Overall Study||32
4923950|NCT03310411|12114474|P4|NOT COMPLETED|Period Title: Period 4||0
4923951|NCT03310411|12114475|P3|NOT COMPLETED|Period Title: Period 4||0
4923952|NCT03310411|12114476|P2|NOT COMPLETED|Period Title: Period 4||0
4923953|NCT03310411|12114477|P1|NOT COMPLETED|Period Title: Period 4||0
4923954|NCT03310411|12114474|P4|COMPLETED|Period Title: Period 4||9
4923955|NCT03310411|12114475|P3|COMPLETED|Period Title: Period 4||10
4923956|NCT03310411|12114476|P2|COMPLETED|Period Title: Period 4||10
4923957|NCT03310411|12114477|P1|COMPLETED|Period Title: Period 4||10
4923958|NCT03310411|12114474|P4|STARTED|Period Title: Period 4||9
4923959|NCT03310411|12114475|P3|STARTED|Period Title: Period 4||10
4923960|NCT03310411|12114476|P2|STARTED|Period Title: Period 4||10
4923961|NCT03310411|12114477|P1|STARTED|Period Title: Period 4||10
4923962|NCT03310411|12114474|P4|NOT COMPLETED|Period 3||0
4923963|NCT03310411|12114475|P3|NOT COMPLETED|Period 3||0
4923964|NCT03310411|12114476|P2|NOT COMPLETED|Period 3||0
4923965|NCT03310411|12114477|P1|NOT COMPLETED|Period 3||0
4923966|NCT03310411|12114474|P4|COMPLETED|Period 3||9
4923967|NCT03310411|12114475|P3|COMPLETED|Period 3||10
4923968|NCT03310411|12114476|P2|COMPLETED|Period 3||10
4923969|NCT03310411|12114477|P1|COMPLETED|Period 3||10
4923970|NCT03310411|12114474|P4|STARTED|Period 3||9
4923971|NCT03310411|12114475|P3|STARTED|Period 3||10
4923972|NCT03310411|12114476|P2|STARTED|Period 3||10
4923973|NCT03310411|12114477|P1|STARTED|Period 3||10
4923974|NCT03310411|12114474|P4|NOT COMPLETED|Period 2||0
4923975|NCT03310411|12114475|P3|NOT COMPLETED|Period 2||0
4923976|NCT03310411|12114476|P2|NOT COMPLETED|Period 2||0
4923977|NCT03310411|12114477|P1|NOT COMPLETED|Period 2||0
4923978|NCT03310411|12114474|P4|COMPLETED|Period 2||9
4923979|NCT03310411|12114475|P3|COMPLETED|Period 2||10
4923980|NCT03310411|12114476|P2|COMPLETED|Period 2||10
4923981|NCT03310411|12114477|P1|COMPLETED|Period 2||10
4923982|NCT03310411|12114474|P4|STARTED|Period 2||9
4923983|NCT03310411|12114475|P3|STARTED|Period 2||10
4923984|NCT03310411|12114476|P2|STARTED|Period 2||10
4923985|NCT03310411|12114477|P1|STARTED|Period 2||10
4923986|NCT03310411|12114474|P4|NOT COMPLETED|Period 1||1
4923987|NCT03310411|12114475|P3|NOT COMPLETED|Period 1||0
4923988|NCT03310411|12114476|P2|NOT COMPLETED|Period 1||0
4923989|NCT03310411|12114477|P1|NOT COMPLETED|Period 1||0
4923990|NCT03310411|12114474|P4|COMPLETED|Period 1||9
4923991|NCT03310411|12114475|P3|COMPLETED|Period 1||10
4923992|NCT03310411|12114476|P2|COMPLETED|Period 1||10
4923993|NCT03310411|12114477|P1|COMPLETED|Period 1||10
4923994|NCT03310411|12114474|P4|Received at Least 1 Dose of Study Drug|Period 1||10
4923995|NCT03310411|12114475|P3|Received at Least 1 Dose of Study Drug|Period 1||10
4923996|NCT03310411|12114476|P2|Received at Least 1 Dose of Study Drug|Period 1||10
4923997|NCT03310411|12114477|P1|Received at Least 1 Dose of Study Drug|Period 1||10
4923998|NCT03310411|12114474|P4|STARTED|Period 1||10
4923999|NCT03310411|12114475|P3|STARTED|Period 1||10
4924000|NCT03310411|12114476|P2|STARTED|Period 1||10
4924001|NCT03310411|12114477|P1|STARTED|Period 1||10
4924002|NCT03310268|12114498|P3|NOT COMPLETED|Overall Study||0
4924003|NCT03310268|12114499|P2|NOT COMPLETED|Overall Study||5
4924004|NCT03310268|12114500|P1|NOT COMPLETED|Overall Study||1
4924005|NCT03310268|12114498|P3|COMPLETED|Overall Study||61
4924006|NCT03310268|12114499|P2|COMPLETED|Overall Study||57
4924007|NCT03310268|12114500|P1|COMPLETED|Overall Study||61
4924008|NCT03310268|12114498|P3|STARTED|Overall Study||61
4924009|NCT03310268|12114499|P2|STARTED|Overall Study||62
4924010|NCT03310268|12114500|P1|STARTED|Overall Study||62
4924011|NCT03309787|12114514|P3|NOT COMPLETED|Overall Study||2
4924012|NCT03309787|12114515|P2|NOT COMPLETED|Overall Study||6
4924013|NCT03309787|12114516|P1|NOT COMPLETED|Overall Study||2
4924014|NCT03309787|12114514|P3|COMPLETED|Overall Study||7
4924015|NCT03309787|12114515|P2|COMPLETED|Overall Study||14
4924016|NCT03309787|12114516|P1|COMPLETED|Overall Study||6
4924017|NCT03309787|12114514|P3|STARTED|Overall Study||9
4924018|NCT03309787|12114515|P2|STARTED|Overall Study||20
4924019|NCT03309787|12114516|P1|STARTED|Overall Study||8
4924020|NCT03309202|12114550|P4|NOT COMPLETED|Overall Study||0
4924021|NCT03309202|12114551|P3|NOT COMPLETED|Overall Study||0
4924022|NCT03309202|12114552|P2|NOT COMPLETED|Overall Study||0
4924023|NCT03309202|12114553|P1|NOT COMPLETED|Overall Study||1
4924024|NCT03309202|12114550|P4|COMPLETED|Overall Study||6
4924025|NCT03309202|12114551|P3|COMPLETED|Overall Study||6
4924026|NCT03309202|12114552|P2|COMPLETED|Overall Study||6
4924027|NCT03309202|12114553|P1|COMPLETED|Overall Study||5
4924028|NCT03309202|12114550|P4|STARTED|Overall Study||6
4924029|NCT03309202|12114551|P3|STARTED|Overall Study||6
4924030|NCT03309202|12114552|P2|STARTED|Overall Study||6
4924031|NCT03309202|12114553|P1|STARTED|Overall Study||6
4924032|NCT03308968|12114638|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
4924033|NCT03308968|12114639|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
4924034|NCT03308968|12114640|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
4924035|NCT03308968|12114638|P3|COMPLETED|Open-Label Period (12 Weeks)||260
4924036|NCT03308968|12114639|P2|COMPLETED|Open-Label Period (12 Weeks)||259
4924037|NCT03308968|12114640|P1|COMPLETED|Open-Label Period (12 Weeks)||253
4924038|NCT03308968|12114638|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
4924039|NCT03308968|12114639|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
4924040|NCT03308968|12114640|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
4924041|NCT03308968|12114638|P3|STARTED|Open-Label Period (12 Weeks)||272
4924042|NCT03308968|12114639|P2|STARTED|Open-Label Period (12 Weeks)||271
4924043|NCT03308968|12114640|P1|STARTED|Open-Label Period (12 Weeks)||264
4924044|NCT03308968|12114638|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
4924045|NCT03308968|12114639|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
4924046|NCT03308968|12114640|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
4924047|NCT03308968|12114638|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
4924048|NCT03308968|12114639|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
4924049|NCT03308968|12114640|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
4924050|NCT03308968|12114638|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
4924051|NCT03308968|12114639|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
4924052|NCT03308968|12114640|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
4924053|NCT03308968|12114638|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
4924054|NCT03308968|12114639|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
4924055|NCT03308968|12114640|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
4924056|NCT03308968|12114638|P3|STARTED|Double-Blind Period (12 Weeks)||283
4924057|NCT03308968|12114639|P2|STARTED|Double-Blind Period (12 Weeks)||276
4924058|NCT03308968|12114640|P1|STARTED|Double-Blind Period (12 Weeks)||279
4924059|NCT03308825|12114718|P4|NOT COMPLETED|Overall Study||0
4924060|NCT03308825|12114719|P3|NOT COMPLETED|Overall Study||1
4924061|NCT03308825|12114720|P2|NOT COMPLETED|Overall Study||4
4924062|NCT03308825|12114721|P1|NOT COMPLETED|Overall Study||2
4924063|NCT03308825|12114718|P4|COMPLETED|Overall Study||60
4924064|NCT03308825|12114719|P3|COMPLETED|Overall Study||59
4924065|NCT03308825|12114720|P2|COMPLETED|Overall Study||57
4924066|NCT03308825|12114721|P1|COMPLETED|Overall Study||57
4924067|NCT03308825|12114718|P4|STARTED|Overall Study||60
4924068|NCT03308825|12114719|P3|STARTED|Overall Study||60
4924069|NCT03308825|12114720|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
4924070|NCT03308825|12114721|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
4924071|NCT03308799|12114750|P3|NOT COMPLETED|Overall Study||21
4924072|NCT03308799|12114751|P2|NOT COMPLETED|Overall Study||28
4924073|NCT03308799|12114752|P1|NOT COMPLETED|Overall Study||22
4924074|NCT03308799|12114750|P3|COMPLETED|Overall Study||94
4924075|NCT03308799|12114751|P2|COMPLETED|Overall Study||309
4924076|NCT03308799|12114752|P1|COMPLETED|Overall Study||320
4924077|NCT03308799|12114750|P3|STARTED|Overall Study||115
4924078|NCT03308799|12114751|P2|STARTED|Overall Study||337
4924079|NCT03308799|12114752|P1|STARTED|Overall Study||342
4924080|NCT03308669|12114768|P2|NOT COMPLETED|Overall Study||0
4924081|NCT03308669|12114769|P1|NOT COMPLETED|Overall Study||0
4924082|NCT03308669|12114768|P2|COMPLETED|Overall Study||20
4924083|NCT03308669|12114769|P1|COMPLETED|Overall Study||10
4924084|NCT03308669|12114768|P2|Received at Least One Dose of Study Drug|Overall Study||20
4924085|NCT03308669|12114769|P1|Received at Least One Dose of Study Drug|Overall Study||10
4924086|NCT03308669|12114768|P2|STARTED|Overall Study||20
4924087|NCT03308669|12114769|P1|STARTED|Overall Study||10
4924088|NCT03308058|12114791|P2|NOT COMPLETED|Overall Study||0
4924089|NCT03308058|12114792|P1|NOT COMPLETED|Overall Study||0
4924090|NCT03308058|12114791|P2|COMPLETED|Overall Study||23
4924091|NCT03308058|12114792|P1|COMPLETED|Overall Study||23
4924092|NCT03308058|12114791|P2|STARTED|Overall Study||23
4924093|NCT03308058|12114792|P1|STARTED|Overall Study||23
4924094|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Period 4||0
4924095|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Period 4||0
4924096|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Period 4||0
4924097|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Period 4||0
4924098|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Period 4||0
4924099|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Period 4||0
4924100|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Period 4||0
4924101|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Period 4||0
4924102|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Period 4||0
4924103|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Period 4||0
4924104|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Period 4||0
4924105|NCT03307252|12114809|P11|COMPLETED|Part 3, Period 4||3
4924106|NCT03307252|12114810|P10|COMPLETED|Part 3, Period 4||4
4924107|NCT03307252|12114811|P9|COMPLETED|Part 3, Period 4||4
4924108|NCT03307252|12114812|P8|COMPLETED|Part 3, Period 4||4
4924109|NCT03307252|12114813|P7|COMPLETED|Part 3, Period 4||0
4924110|NCT03307252|12114814|P6|COMPLETED|Part 3, Period 4||0
4924111|NCT03307252|12114815|P5|COMPLETED|Part 3, Period 4||0
4924112|NCT03307252|12114816|P4|COMPLETED|Part 3, Period 4||0
4924113|NCT03307252|12114817|P3|COMPLETED|Part 3, Period 4||0
4924114|NCT03307252|12114818|P2|COMPLETED|Part 3, Period 4||0
4924115|NCT03307252|12114819|P1|COMPLETED|Part 3, Period 4||0
4924116|NCT03307252|12114809|P11|STARTED|Part 3, Period 4||3
4924117|NCT03307252|12114810|P10|STARTED|Part 3, Period 4||4
4924118|NCT03307252|12114811|P9|STARTED|Part 3, Period 4||4
4924119|NCT03307252|12114812|P8|STARTED|Part 3, Period 4||4
4924120|NCT03307252|12114813|P7|STARTED|Part 3, Period 4||0
4924121|NCT03307252|12114814|P6|STARTED|Part 3, Period 4||0
4924122|NCT03307252|12114815|P5|STARTED|Part 3, Period 4||0
4924123|NCT03307252|12114816|P4|STARTED|Part 3, Period 4||0
4924124|NCT03307252|12114817|P3|STARTED|Part 3, Period 4||0
4924125|NCT03307252|12114818|P2|STARTED|Part 3, Period 4||0
4924126|NCT03307252|12114819|P1|STARTED|Part 3, Period 4||0
4924127|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
4924128|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924129|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924130|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924131|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924132|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924133|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924134|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924135|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924136|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924137|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924138|NCT03307252|12114809|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
4924139|NCT03307252|12114810|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
4924140|NCT03307252|12114811|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
4924141|NCT03307252|12114812|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
4924142|NCT03307252|12114813|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924143|NCT03307252|12114814|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924144|NCT03307252|12114815|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924145|NCT03307252|12114816|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924146|NCT03307252|12114817|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924147|NCT03307252|12114818|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924148|NCT03307252|12114819|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
4924149|NCT03307252|12114809|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
4924150|NCT03307252|12114810|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
4924151|NCT03307252|12114811|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
4924152|NCT03307252|12114812|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
4924153|NCT03307252|12114813|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924154|NCT03307252|12114814|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924155|NCT03307252|12114815|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924156|NCT03307252|12114816|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924157|NCT03307252|12114817|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924158|NCT03307252|12114818|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924159|NCT03307252|12114819|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
4924160|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Period 3||0
4924161|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Period 3||0
4924162|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Period 3||0
4924163|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Period 3||0
4924164|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Period 3||0
4924165|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Period 3||0
4924166|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Period 3||0
4924167|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Period 3||0
4924168|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Period 3||0
4924169|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Period 3||0
4924170|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Period 3||0
4924171|NCT03307252|12114809|P11|COMPLETED|Part 3, Period 3||4
4924172|NCT03307252|12114810|P10|COMPLETED|Part 3, Period 3||4
4924173|NCT03307252|12114811|P9|COMPLETED|Part 3, Period 3||4
4924174|NCT03307252|12114812|P8|COMPLETED|Part 3, Period 3||4
4924175|NCT03307252|12114813|P7|COMPLETED|Part 3, Period 3||0
4924176|NCT03307252|12114814|P6|COMPLETED|Part 3, Period 3||0
4924177|NCT03307252|12114815|P5|COMPLETED|Part 3, Period 3||0
4924178|NCT03307252|12114816|P4|COMPLETED|Part 3, Period 3||0
4924179|NCT03307252|12114817|P3|COMPLETED|Part 3, Period 3||0
4924180|NCT03307252|12114818|P2|COMPLETED|Part 3, Period 3||0
4924181|NCT03307252|12114819|P1|COMPLETED|Part 3, Period 3||0
4924182|NCT03307252|12114809|P11|STARTED|Part 3, Period 3||4
4924183|NCT03307252|12114810|P10|STARTED|Part 3, Period 3||4
4924184|NCT03307252|12114811|P9|STARTED|Part 3, Period 3||4
4924185|NCT03307252|12114812|P8|STARTED|Part 3, Period 3||4
4924186|NCT03307252|12114813|P7|STARTED|Part 3, Period 3||0
4924187|NCT03307252|12114814|P6|STARTED|Part 3, Period 3||0
4924188|NCT03307252|12114815|P5|STARTED|Part 3, Period 3||0
4924189|NCT03307252|12114816|P4|STARTED|Part 3, Period 3||0
4924190|NCT03307252|12114817|P3|STARTED|Part 3, Period 3||0
4924191|NCT03307252|12114818|P2|STARTED|Part 3, Period 3||0
4924192|NCT03307252|12114819|P1|STARTED|Part 3, Period 3||0
4924193|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924194|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924195|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924196|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924197|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924198|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924199|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924200|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924201|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924202|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924203|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924204|NCT03307252|12114809|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
4924205|NCT03307252|12114810|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
4924206|NCT03307252|12114811|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
4924207|NCT03307252|12114812|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
4924208|NCT03307252|12114813|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924209|NCT03307252|12114814|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924210|NCT03307252|12114815|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924211|NCT03307252|12114816|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924212|NCT03307252|12114817|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924213|NCT03307252|12114818|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924214|NCT03307252|12114819|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
4924215|NCT03307252|12114809|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
4924216|NCT03307252|12114810|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
4924217|NCT03307252|12114811|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
4924218|NCT03307252|12114812|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
4924219|NCT03307252|12114813|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924220|NCT03307252|12114814|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924221|NCT03307252|12114815|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924222|NCT03307252|12114816|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924223|NCT03307252|12114817|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924224|NCT03307252|12114818|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924225|NCT03307252|12114819|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
4924226|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Period 2||0
4924227|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Period 2||0
4924228|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Period 2||0
4924229|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Period 2||0
4924230|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Period 2||0
4924231|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Period 2||0
4924232|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Period 2||0
4924233|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Period 2||0
4924234|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Period 2||0
4924235|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Period 2||0
4924236|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Period 2||0
4924237|NCT03307252|12114809|P11|COMPLETED|Part 3, Period 2||4
4924238|NCT03307252|12114810|P10|COMPLETED|Part 3, Period 2||4
4924239|NCT03307252|12114811|P9|COMPLETED|Part 3, Period 2||4
4924240|NCT03307252|12114812|P8|COMPLETED|Part 3, Period 2||4
4924241|NCT03307252|12114813|P7|COMPLETED|Part 3, Period 2||0
4924242|NCT03307252|12114814|P6|COMPLETED|Part 3, Period 2||0
4924243|NCT03307252|12114815|P5|COMPLETED|Part 3, Period 2||0
4924244|NCT03307252|12114816|P4|COMPLETED|Part 3, Period 2||0
4924245|NCT03307252|12114817|P3|COMPLETED|Part 3, Period 2||0
4924246|NCT03307252|12114818|P2|COMPLETED|Part 3, Period 2||0
4924247|NCT03307252|12114819|P1|COMPLETED|Part 3, Period 2||0
4924248|NCT03307252|12114809|P11|STARTED|Part 3, Period 2||4
4924249|NCT03307252|12114810|P10|STARTED|Part 3, Period 2||4
4924250|NCT03307252|12114811|P9|STARTED|Part 3, Period 2||4
4924251|NCT03307252|12114812|P8|STARTED|Part 3, Period 2||4
4924252|NCT03307252|12114813|P7|STARTED|Part 3, Period 2||0
4924253|NCT03307252|12114814|P6|STARTED|Part 3, Period 2||0
4924254|NCT03307252|12114815|P5|STARTED|Part 3, Period 2||0
4924255|NCT03307252|12114816|P4|STARTED|Part 3, Period 2||0
4924256|NCT03307252|12114817|P3|STARTED|Part 3, Period 2||0
4924257|NCT03307252|12114818|P2|STARTED|Part 3, Period 2||0
4924258|NCT03307252|12114819|P1|STARTED|Part 3, Period 2||0
4924259|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924260|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924261|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924262|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924263|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924264|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924265|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924266|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924267|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924268|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924269|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924270|NCT03307252|12114809|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
4924271|NCT03307252|12114810|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
4924272|NCT03307252|12114811|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
4924273|NCT03307252|12114812|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
4924274|NCT03307252|12114813|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924275|NCT03307252|12114814|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924276|NCT03307252|12114815|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924277|NCT03307252|12114816|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924278|NCT03307252|12114817|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924279|NCT03307252|12114818|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924280|NCT03307252|12114819|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
4924281|NCT03307252|12114809|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
4924282|NCT03307252|12114810|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
4924283|NCT03307252|12114811|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
4924284|NCT03307252|12114812|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
4924285|NCT03307252|12114813|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924286|NCT03307252|12114814|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924287|NCT03307252|12114815|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924288|NCT03307252|12114816|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924289|NCT03307252|12114817|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924290|NCT03307252|12114818|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924291|NCT03307252|12114819|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
4924292|NCT03307252|12114809|P11|NOT COMPLETED|Part 3, Period 1||0
4924293|NCT03307252|12114810|P10|NOT COMPLETED|Part 3, Period 1||0
4924294|NCT03307252|12114811|P9|NOT COMPLETED|Part 3, Period 1||0
4924295|NCT03307252|12114812|P8|NOT COMPLETED|Part 3, Period 1||0
4924296|NCT03307252|12114813|P7|NOT COMPLETED|Part 3, Period 1||0
4924297|NCT03307252|12114814|P6|NOT COMPLETED|Part 3, Period 1||0
4924298|NCT03307252|12114815|P5|NOT COMPLETED|Part 3, Period 1||0
4924299|NCT03307252|12114816|P4|NOT COMPLETED|Part 3, Period 1||0
4924300|NCT03307252|12114817|P3|NOT COMPLETED|Part 3, Period 1||0
4924301|NCT03307252|12114818|P2|NOT COMPLETED|Part 3, Period 1||0
4924302|NCT03307252|12114819|P1|NOT COMPLETED|Part 3, Period 1||0
4924303|NCT03307252|12114809|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
4924304|NCT03307252|12114810|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
4924305|NCT03307252|12114811|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
4924306|NCT03307252|12114812|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
4924307|NCT03307252|12114813|P7|COMPLETED|Part 3, Period 1||0
4924308|NCT03307252|12114814|P6|COMPLETED|Part 3, Period 1||0
4924309|NCT03307252|12114815|P5|COMPLETED|Part 3, Period 1||0
4924310|NCT03307252|12114816|P4|COMPLETED|Part 3, Period 1||0
4924311|NCT03307252|12114817|P3|COMPLETED|Part 3, Period 1||0
4924312|NCT03307252|12114818|P2|COMPLETED|Part 3, Period 1||0
4924313|NCT03307252|12114819|P1|COMPLETED|Part 3, Period 1||0
4924314|NCT03307252|12114809|P11|STARTED|Part 3, Period 1||4
4924315|NCT03307252|12114810|P10|STARTED|Part 3, Period 1||4
4924316|NCT03307252|12114811|P9|STARTED|Part 3, Period 1||4
4924317|NCT03307252|12114812|P8|STARTED|Part 3, Period 1||4
4924318|NCT03307252|12114813|P7|STARTED|Part 3, Period 1||0
4924319|NCT03307252|12114814|P6|STARTED|Part 3, Period 1||0
4924320|NCT03307252|12114815|P5|STARTED|Part 3, Period 1||0
4924321|NCT03307252|12114816|P4|STARTED|Part 3, Period 1||0
4924322|NCT03307252|12114817|P3|STARTED|Part 3, Period 1||0
4924323|NCT03307252|12114818|P2|STARTED|Part 3, Period 1||0
4924324|NCT03307252|12114819|P1|STARTED|Part 3, Period 1||0
4924325|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Period 4||0
4924326|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Period 4||0
4924327|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Period 4||0
4924328|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Period 4||0
4924329|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Period 4||1
4924330|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Period 4||0
4924331|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Period 4||0
4924332|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Period 4||0
4924333|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Period 4||0
4924334|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Period 4||0
4924335|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Period 4||0
4924336|NCT03307252|12114809|P11|COMPLETED|Part 2, Period 4||0
4924337|NCT03307252|12114810|P10|COMPLETED|Part 2, Period 4||0
4924338|NCT03307252|12114811|P9|COMPLETED|Part 2, Period 4||0
4924339|NCT03307252|12114812|P8|COMPLETED|Part 2, Period 4||0
4924340|NCT03307252|12114813|P7|COMPLETED|Part 2, Period 4||4
4924341|NCT03307252|12114814|P6|COMPLETED|Part 2, Period 4||3
4924342|NCT03307252|12114815|P5|COMPLETED|Part 2, Period 4||3
4924343|NCT03307252|12114816|P4|COMPLETED|Part 2, Period 4||4
4924344|NCT03307252|12114817|P3|COMPLETED|Part 2, Period 4||0
4924345|NCT03307252|12114818|P2|COMPLETED|Part 2, Period 4||0
4924346|NCT03307252|12114819|P1|COMPLETED|Part 2, Period 4||0
4924347|NCT03307252|12114809|P11|STARTED|Part 2, Period 4||0
4924348|NCT03307252|12114810|P10|STARTED|Part 2, Period 4||0
4924349|NCT03307252|12114811|P9|STARTED|Part 2, Period 4||0
4924350|NCT03307252|12114812|P8|STARTED|Part 2, Period 4||0
4924351|NCT03307252|12114813|P7|STARTED|Part 2, Period 4||5
4924352|NCT03307252|12114814|P6|STARTED|Part 2, Period 4||3
4924353|NCT03307252|12114815|P5|STARTED|Part 2, Period 4||3
4924354|NCT03307252|12114816|P4|STARTED|Part 2, Period 4||4
4924355|NCT03307252|12114817|P3|STARTED|Part 2, Period 4||0
4924356|NCT03307252|12114818|P2|STARTED|Part 2, Period 4||0
4924357|NCT03307252|12114819|P1|STARTED|Part 2, Period 4||0
4924358|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924359|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924360|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924361|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924362|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
4924363|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924364|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924365|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924366|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924367|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924368|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924369|NCT03307252|12114809|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924370|NCT03307252|12114810|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924371|NCT03307252|12114811|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924372|NCT03307252|12114812|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924373|NCT03307252|12114813|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
4924374|NCT03307252|12114814|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
4924375|NCT03307252|12114815|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
4924376|NCT03307252|12114816|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
4924377|NCT03307252|12114817|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924378|NCT03307252|12114818|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924379|NCT03307252|12114819|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
4924380|NCT03307252|12114809|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924381|NCT03307252|12114810|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924382|NCT03307252|12114811|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924383|NCT03307252|12114812|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924384|NCT03307252|12114813|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
4924385|NCT03307252|12114814|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
4924386|NCT03307252|12114815|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
4924387|NCT03307252|12114816|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
4924388|NCT03307252|12114817|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924389|NCT03307252|12114818|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924390|NCT03307252|12114819|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
4924391|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Period 3||0
4924392|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Period 3||0
4924393|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Period 3||0
4924394|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Period 3||0
4924395|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Period 3||0
4924396|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Period 3||0
4924397|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Period 3||1
4924398|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Period 3||0
4924399|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Period 3||0
4924400|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Period 3||0
4924401|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Period 3||0
4924402|NCT03307252|12114809|P11|COMPLETED|Part 2, Period 3||0
4924403|NCT03307252|12114810|P10|COMPLETED|Part 2, Period 3||0
4924404|NCT03307252|12114811|P9|COMPLETED|Part 2, Period 3||0
4924405|NCT03307252|12114812|P8|COMPLETED|Part 2, Period 3||0
4924406|NCT03307252|12114813|P7|COMPLETED|Part 2, Period 3||5
4924407|NCT03307252|12114814|P6|COMPLETED|Part 2, Period 3||3
4924408|NCT03307252|12114815|P5|COMPLETED|Part 2, Period 3||3
4924409|NCT03307252|12114816|P4|COMPLETED|Part 2, Period 3||4
4924410|NCT03307252|12114817|P3|COMPLETED|Part 2, Period 3||0
4924411|NCT03307252|12114818|P2|COMPLETED|Part 2, Period 3||0
4924412|NCT03307252|12114819|P1|COMPLETED|Part 2, Period 3||0
4924413|NCT03307252|12114809|P11|STARTED|Part 2, Period 3||0
4924414|NCT03307252|12114810|P10|STARTED|Part 2, Period 3||0
4924415|NCT03307252|12114811|P9|STARTED|Part 2, Period 3||0
4924416|NCT03307252|12114812|P8|STARTED|Part 2, Period 3||0
4924417|NCT03307252|12114813|P7|STARTED|Part 2, Period 3||5
4924418|NCT03307252|12114814|P6|STARTED|Part 2, Period 3||3
4924419|NCT03307252|12114815|P5|STARTED|Part 2, Period 3||4
4924420|NCT03307252|12114816|P4|STARTED|Part 2, Period 3||4
4924421|NCT03307252|12114817|P3|STARTED|Part 2, Period 3||0
4924422|NCT03307252|12114818|P2|STARTED|Part 2, Period 3||0
4924423|NCT03307252|12114819|P1|STARTED|Part 2, Period 3||0
4924424|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924425|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924426|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924427|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924428|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924513|NCT03307252|12114810|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924429|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924430|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924431|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924432|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924433|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924434|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924435|NCT03307252|12114809|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924436|NCT03307252|12114810|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924437|NCT03307252|12114811|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924438|NCT03307252|12114812|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924439|NCT03307252|12114813|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
4924440|NCT03307252|12114814|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
4924441|NCT03307252|12114815|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
4924442|NCT03307252|12114816|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
4924443|NCT03307252|12114817|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924444|NCT03307252|12114818|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924445|NCT03307252|12114819|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
4924446|NCT03307252|12114809|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924447|NCT03307252|12114810|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924448|NCT03307252|12114811|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924449|NCT03307252|12114812|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924450|NCT03307252|12114813|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
4924451|NCT03307252|12114814|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
4924452|NCT03307252|12114815|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
4924453|NCT03307252|12114816|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
4924454|NCT03307252|12114817|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924455|NCT03307252|12114818|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924456|NCT03307252|12114819|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
4924457|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Period 2||0
4924458|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Period 2||0
4924459|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Period 2||0
4924460|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Period 2||0
4924461|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Period 2||0
4924462|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Period 2||0
4924463|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Period 2||0
4924464|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Period 2||0
4924465|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Period 2||0
4924466|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Period 2||0
4924467|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Period 2||0
4924468|NCT03307252|12114809|P11|COMPLETED|Part 2, Period 2||0
4924469|NCT03307252|12114810|P10|COMPLETED|Part 2, Period 2||0
4924470|NCT03307252|12114811|P9|COMPLETED|Part 2, Period 2||0
4924471|NCT03307252|12114812|P8|COMPLETED|Part 2, Period 2||0
4924472|NCT03307252|12114813|P7|COMPLETED|Part 2, Period 2||5
4924473|NCT03307252|12114814|P6|COMPLETED|Part 2, Period 2||3
4924474|NCT03307252|12114815|P5|COMPLETED|Part 2, Period 2||4
4924475|NCT03307252|12114816|P4|COMPLETED|Part 2, Period 2||4
4924476|NCT03307252|12114817|P3|COMPLETED|Part 2, Period 2||0
4924477|NCT03307252|12114818|P2|COMPLETED|Part 2, Period 2||0
4924478|NCT03307252|12114819|P1|COMPLETED|Part 2, Period 2||0
4924479|NCT03307252|12114809|P11|STARTED|Part 2, Period 2||0
4924480|NCT03307252|12114810|P10|STARTED|Part 2, Period 2||0
4924481|NCT03307252|12114811|P9|STARTED|Part 2, Period 2||0
4924482|NCT03307252|12114812|P8|STARTED|Part 2, Period 2||0
4924483|NCT03307252|12114813|P7|STARTED|Part 2, Period 2||5
4924484|NCT03307252|12114814|P6|STARTED|Part 2, Period 2||3
4924485|NCT03307252|12114815|P5|STARTED|Part 2, Period 2||4
4924486|NCT03307252|12114816|P4|STARTED|Part 2, Period 2||4
4924487|NCT03307252|12114817|P3|STARTED|Part 2, Period 2||0
4924488|NCT03307252|12114818|P2|STARTED|Part 2, Period 2||0
4924489|NCT03307252|12114819|P1|STARTED|Part 2, Period 2||0
4924490|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924491|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924492|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924493|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924494|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924495|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924496|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924497|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924498|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924499|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924500|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924501|NCT03307252|12114809|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924502|NCT03307252|12114810|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924503|NCT03307252|12114811|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924504|NCT03307252|12114812|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924505|NCT03307252|12114813|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
4924506|NCT03307252|12114814|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
4924507|NCT03307252|12114815|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
4924508|NCT03307252|12114816|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
4924509|NCT03307252|12114817|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924510|NCT03307252|12114818|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924511|NCT03307252|12114819|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4924512|NCT03307252|12114809|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924514|NCT03307252|12114811|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924515|NCT03307252|12114812|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924516|NCT03307252|12114813|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
4924517|NCT03307252|12114814|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
4924518|NCT03307252|12114815|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
4924519|NCT03307252|12114816|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
4924520|NCT03307252|12114817|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924521|NCT03307252|12114818|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924522|NCT03307252|12114819|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
4924523|NCT03307252|12114809|P11|NOT COMPLETED|Part 2, Period 1||0
4924524|NCT03307252|12114810|P10|NOT COMPLETED|Part 2, Period 1||0
4924525|NCT03307252|12114811|P9|NOT COMPLETED|Part 2, Period 1||0
4924526|NCT03307252|12114812|P8|NOT COMPLETED|Part 2, Period 1||0
4924527|NCT03307252|12114813|P7|NOT COMPLETED|Part 2, Period 1||0
4924528|NCT03307252|12114814|P6|NOT COMPLETED|Part 2, Period 1||1
4924529|NCT03307252|12114815|P5|NOT COMPLETED|Part 2, Period 1||0
4924530|NCT03307252|12114816|P4|NOT COMPLETED|Part 2, Period 1||0
4924531|NCT03307252|12114817|P3|NOT COMPLETED|Part 2, Period 1||0
4924532|NCT03307252|12114818|P2|NOT COMPLETED|Part 2, Period 1||0
4924533|NCT03307252|12114819|P1|NOT COMPLETED|Part 2, Period 1||0
4924534|NCT03307252|12114809|P11|COMPLETED|Part 2, Period 1||0
4924535|NCT03307252|12114810|P10|COMPLETED|Part 2, Period 1||0
4924536|NCT03307252|12114811|P9|COMPLETED|Part 2, Period 1||0
4924537|NCT03307252|12114812|P8|COMPLETED|Part 2, Period 1||0
4924538|NCT03307252|12114813|P7|COMPLETED|Part 2, Period 1||5
4924539|NCT03307252|12114814|P6|COMPLETED|Part 2, Period 1||3
4924540|NCT03307252|12114815|P5|COMPLETED|Part 2, Period 1||4
4924541|NCT03307252|12114816|P4|COMPLETED|Part 2, Period 1||4
4924542|NCT03307252|12114817|P3|COMPLETED|Part 2, Period 1||0
4924543|NCT03307252|12114818|P2|COMPLETED|Part 2, Period 1||0
4924544|NCT03307252|12114819|P1|COMPLETED|Part 2, Period 1||0
4924545|NCT03307252|12114809|P11|STARTED|Part 2, Period 1||0
4924546|NCT03307252|12114810|P10|STARTED|Part 2, Period 1||0
4924547|NCT03307252|12114811|P9|STARTED|Part 2, Period 1||0
4924548|NCT03307252|12114812|P8|STARTED|Part 2, Period 1||0
4924549|NCT03307252|12114813|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
4924550|NCT03307252|12114814|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
4924551|NCT03307252|12114815|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
4924552|NCT03307252|12114816|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
4924553|NCT03307252|12114817|P3|STARTED|Part 2, Period 1||0
4924554|NCT03307252|12114818|P2|STARTED|Part 2, Period 1||0
4924555|NCT03307252|12114819|P1|STARTED|Part 2, Period 1||0
4924556|NCT03307252|12114809|P11|NOT COMPLETED|Part 1, Period 3||0
4924557|NCT03307252|12114810|P10|NOT COMPLETED|Part 1, Period 3||0
4924558|NCT03307252|12114811|P9|NOT COMPLETED|Part 1, Period 3||0
4924559|NCT03307252|12114812|P8|NOT COMPLETED|Part 1, Period 3||0
4924560|NCT03307252|12114813|P7|NOT COMPLETED|Part 1, Period 3||0
4924561|NCT03307252|12114814|P6|NOT COMPLETED|Part 1, Period 3||0
4924562|NCT03307252|12114815|P5|NOT COMPLETED|Part 1, Period 3||0
4924563|NCT03307252|12114816|P4|NOT COMPLETED|Part 1, Period 3||0
4924564|NCT03307252|12114817|P3|NOT COMPLETED|Part 1, Period 3||0
4924565|NCT03307252|12114818|P2|NOT COMPLETED|Part 1, Period 3||0
4924566|NCT03307252|12114819|P1|NOT COMPLETED|Part 1, Period 3||0
4924567|NCT03307252|12114809|P11|COMPLETED|Part 1, Period 3||0
4924568|NCT03307252|12114810|P10|COMPLETED|Part 1, Period 3||0
4924569|NCT03307252|12114811|P9|COMPLETED|Part 1, Period 3||0
4924570|NCT03307252|12114812|P8|COMPLETED|Part 1, Period 3||0
4924571|NCT03307252|12114813|P7|COMPLETED|Part 1, Period 3||0
4924572|NCT03307252|12114814|P6|COMPLETED|Part 1, Period 3||0
4924573|NCT03307252|12114815|P5|COMPLETED|Part 1, Period 3||0
4924574|NCT03307252|12114816|P4|COMPLETED|Part 1, Period 3||0
4924575|NCT03307252|12114817|P3|COMPLETED|Part 1, Period 3||4
4924576|NCT03307252|12114818|P2|COMPLETED|Part 1, Period 3||4
4924577|NCT03307252|12114819|P1|COMPLETED|Part 1, Period 3||4
4924578|NCT03307252|12114809|P11|STARTED|Part 1, Period 3||0
4924579|NCT03307252|12114810|P10|STARTED|Part 1, Period 3||0
4924580|NCT03307252|12114811|P9|STARTED|Part 1, Period 3||0
4924581|NCT03307252|12114812|P8|STARTED|Part 1, Period 3||0
4924582|NCT03307252|12114813|P7|STARTED|Part 1, Period 3||0
4924583|NCT03307252|12114814|P6|STARTED|Part 1, Period 3||0
4924584|NCT03307252|12114815|P5|STARTED|Part 1, Period 3||0
4924585|NCT03307252|12114816|P4|STARTED|Part 1, Period 3||0
4924586|NCT03307252|12114817|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
4924587|NCT03307252|12114818|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
4924588|NCT03307252|12114819|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
4924589|NCT03307252|12114809|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924590|NCT03307252|12114810|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924591|NCT03307252|12114811|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924592|NCT03307252|12114812|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924593|NCT03307252|12114813|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924594|NCT03307252|12114814|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924595|NCT03307252|12114815|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924596|NCT03307252|12114816|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924597|NCT03307252|12114817|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924598|NCT03307252|12114818|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924599|NCT03307252|12114819|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924600|NCT03307252|12114809|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924601|NCT03307252|12114810|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924602|NCT03307252|12114811|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924603|NCT03307252|12114812|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924604|NCT03307252|12114813|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924605|NCT03307252|12114814|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924606|NCT03307252|12114815|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924607|NCT03307252|12114816|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
4924608|NCT03307252|12114817|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
4924609|NCT03307252|12114818|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
4924610|NCT03307252|12114819|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
4924611|NCT03307252|12114809|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924612|NCT03307252|12114810|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924613|NCT03307252|12114811|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924614|NCT03307252|12114812|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924615|NCT03307252|12114813|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924616|NCT03307252|12114814|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924617|NCT03307252|12114815|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924618|NCT03307252|12114816|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
4924619|NCT03307252|12114817|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
4924620|NCT03307252|12114818|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
4924621|NCT03307252|12114819|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
4924622|NCT03307252|12114809|P11|NOT COMPLETED|Part 1, Period 2||0
4924623|NCT03307252|12114810|P10|NOT COMPLETED|Part 1, Period 2||0
4924624|NCT03307252|12114811|P9|NOT COMPLETED|Part 1, Period 2||0
4924625|NCT03307252|12114812|P8|NOT COMPLETED|Part 1, Period 2||0
4924626|NCT03307252|12114813|P7|NOT COMPLETED|Part 1, Period 2||0
4924627|NCT03307252|12114814|P6|NOT COMPLETED|Part 1, Period 2||0
4924628|NCT03307252|12114815|P5|NOT COMPLETED|Part 1, Period 2||0
4924629|NCT03307252|12114816|P4|NOT COMPLETED|Part 1, Period 2||0
4924630|NCT03307252|12114817|P3|NOT COMPLETED|Part 1, Period 2||0
4924631|NCT03307252|12114818|P2|NOT COMPLETED|Part 1, Period 2||0
4924632|NCT03307252|12114819|P1|NOT COMPLETED|Part 1, Period 2||0
4924633|NCT03307252|12114809|P11|COMPLETED|Part 1, Period 2||0
4924634|NCT03307252|12114810|P10|COMPLETED|Part 1, Period 2||0
4924635|NCT03307252|12114811|P9|COMPLETED|Part 1, Period 2||0
4924636|NCT03307252|12114812|P8|COMPLETED|Part 1, Period 2||0
4924637|NCT03307252|12114813|P7|COMPLETED|Part 1, Period 2||0
4924638|NCT03307252|12114814|P6|COMPLETED|Part 1, Period 2||0
4924639|NCT03307252|12114815|P5|COMPLETED|Part 1, Period 2||0
4924640|NCT03307252|12114816|P4|COMPLETED|Part 1, Period 2||0
4924641|NCT03307252|12114817|P3|COMPLETED|Part 1, Period 2||4
4924642|NCT03307252|12114818|P2|COMPLETED|Part 1, Period 2||4
4924643|NCT03307252|12114819|P1|COMPLETED|Part 1, Period 2||4
4924644|NCT03307252|12114809|P11|STARTED|Part 1, Period 2||0
4924645|NCT03307252|12114810|P10|STARTED|Part 1, Period 2||0
4924646|NCT03307252|12114811|P9|STARTED|Part 1, Period 2||0
4924647|NCT03307252|12114812|P8|STARTED|Part 1, Period 2||0
4924648|NCT03307252|12114813|P7|STARTED|Part 1, Period 2||0
4924649|NCT03307252|12114814|P6|STARTED|Part 1, Period 2||0
4924650|NCT03307252|12114815|P5|STARTED|Part 1, Period 2||0
4924651|NCT03307252|12114816|P4|STARTED|Part 1, Period 2||0
4924652|NCT03307252|12114817|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
4924653|NCT03307252|12114818|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
4924654|NCT03307252|12114819|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
4924655|NCT03307252|12114809|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924656|NCT03307252|12114810|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924657|NCT03307252|12114811|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924658|NCT03307252|12114812|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924659|NCT03307252|12114813|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924660|NCT03307252|12114814|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924661|NCT03307252|12114815|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924662|NCT03307252|12114816|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924663|NCT03307252|12114817|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924664|NCT03307252|12114818|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924665|NCT03307252|12114819|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924666|NCT03307252|12114809|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924667|NCT03307252|12114810|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924668|NCT03307252|12114811|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924669|NCT03307252|12114812|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924670|NCT03307252|12114813|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924671|NCT03307252|12114814|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924672|NCT03307252|12114815|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924673|NCT03307252|12114816|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
4924674|NCT03307252|12114817|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
4924675|NCT03307252|12114818|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
4924676|NCT03307252|12114819|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
4924677|NCT03307252|12114809|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924678|NCT03307252|12114810|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924679|NCT03307252|12114811|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924680|NCT03307252|12114812|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924681|NCT03307252|12114813|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924682|NCT03307252|12114814|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924683|NCT03307252|12114815|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924684|NCT03307252|12114816|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
4924685|NCT03307252|12114817|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
4924686|NCT03307252|12114818|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
4924687|NCT03307252|12114819|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
4924688|NCT03307252|12114809|P11|NOT COMPLETED|Part 1, Period 1||0
4924689|NCT03307252|12114810|P10|NOT COMPLETED|Part 1, Period 1||0
4924690|NCT03307252|12114811|P9|NOT COMPLETED|Part 1, Period 1||0
4924691|NCT03307252|12114812|P8|NOT COMPLETED|Part 1, Period 1||0
4924692|NCT03307252|12114813|P7|NOT COMPLETED|Part 1, Period 1||0
4924693|NCT03307252|12114814|P6|NOT COMPLETED|Part 1, Period 1||0
4924694|NCT03307252|12114815|P5|NOT COMPLETED|Part 1, Period 1||0
4924695|NCT03307252|12114816|P4|NOT COMPLETED|Part 1, Period 1||0
4924696|NCT03307252|12114817|P3|NOT COMPLETED|Part 1, Period 1||0
4924697|NCT03307252|12114818|P2|NOT COMPLETED|Part 1, Period 1||0
4924698|NCT03307252|12114819|P1|NOT COMPLETED|Part 1, Period 1||0
4924699|NCT03307252|12114809|P11|COMPLETED|Part 1, Period 1||0
4924700|NCT03307252|12114810|P10|COMPLETED|Part 1, Period 1||0
4924701|NCT03307252|12114811|P9|COMPLETED|Part 1, Period 1||0
4924702|NCT03307252|12114812|P8|COMPLETED|Part 1, Period 1||0
4924703|NCT03307252|12114813|P7|COMPLETED|Part 1, Period 1||0
4924704|NCT03307252|12114814|P6|COMPLETED|Part 1, Period 1||0
4924705|NCT03307252|12114815|P5|COMPLETED|Part 1, Period 1||0
4924706|NCT03307252|12114816|P4|COMPLETED|Part 1, Period 1||0
4924707|NCT03307252|12114817|P3|COMPLETED|Part 1, Period 1||4
4924708|NCT03307252|12114818|P2|COMPLETED|Part 1, Period 1||4
4924709|NCT03307252|12114819|P1|COMPLETED|Part 1, Period 1||4
4924710|NCT03307252|12114809|P11|STARTED|Part 1, Period 1||0
4924711|NCT03307252|12114810|P10|STARTED|Part 1, Period 1||0
4924712|NCT03307252|12114811|P9|STARTED|Part 1, Period 1||0
4924713|NCT03307252|12114812|P8|STARTED|Part 1, Period 1||0
4924714|NCT03307252|12114813|P7|STARTED|Part 1, Period 1||0
4924715|NCT03307252|12114814|P6|STARTED|Part 1, Period 1||0
4924716|NCT03307252|12114815|P5|STARTED|Part 1, Period 1||0
4924717|NCT03307252|12114816|P4|STARTED|Part 1, Period 1||0
4924718|NCT03307252|12114817|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
4924719|NCT03307252|12114818|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
4924720|NCT03307252|12114819|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
4924721|NCT03307174|12114856|P2|NOT COMPLETED|Overall Study||7
4924722|NCT03307174|12114857|P1|NOT COMPLETED|Overall Study||14
4924723|NCT03307174|12114856|P2|COMPLETED|Overall Study||53
4924724|NCT03307174|12114857|P1|COMPLETED|Overall Study||46
4924725|NCT03307174|12114856|P2|STARTED|Overall Study||60
4924726|NCT03307174|12114857|P1|STARTED|Overall Study||60
4924727|NCT03307005|12114877|P2|NOT COMPLETED|Overall Study||0
4924728|NCT03307005|12114878|P1|NOT COMPLETED|Overall Study||0
4924729|NCT03307005|12114877|P2|COMPLETED|Overall Study||2
4924730|NCT03307005|12114878|P1|COMPLETED|Overall Study||3
4924731|NCT03307005|12114877|P2|STARTED|Overall Study||2
4924732|NCT03307005|12114878|P1|STARTED|Overall Study||3
4924733|NCT03306589|12114902|P6|NOT COMPLETED|Part 2 (69 Days)||0
4924734|NCT03306589|12114903|P5|NOT COMPLETED|Part 2 (69 Days)||0
4924735|NCT03306589|12114904|P4|NOT COMPLETED|Part 2 (69 Days)||0
4924736|NCT03306589|12114905|P3|NOT COMPLETED|Part 2 (69 Days)||0
4924737|NCT03306589|12114906|P2|NOT COMPLETED|Part 2 (69 Days)||0
4924738|NCT03306589|12114907|P1|NOT COMPLETED|Part 2 (69 Days)||0
4924739|NCT03306589|12114902|P6|COMPLETED|Part 2 (69 Days)||0
4924740|NCT03306589|12114903|P5|COMPLETED|Part 2 (69 Days)||0
4924741|NCT03306589|12114904|P4|COMPLETED|Part 2 (69 Days)||0
4924742|NCT03306589|12114905|P3|COMPLETED|Part 2 (69 Days)||0
4924743|NCT03306589|12114906|P2|COMPLETED|Part 2 (69 Days)||0
4924744|NCT03306589|12114907|P1|COMPLETED|Part 2 (69 Days)||0
4924745|NCT03306589|12114902|P6|STARTED|Part 2 (69 Days)||0
4924746|NCT03306589|12114903|P5|STARTED|Part 2 (69 Days)||0
4924747|NCT03306589|12114904|P4|STARTED|Part 2 (69 Days)||0
4924748|NCT03306589|12114905|P3|STARTED|Part 2 (69 Days)||0
4924749|NCT03306589|12114906|P2|STARTED|Part 2 (69 Days)||0
4924750|NCT03306589|12114907|P1|STARTED|Part 2 (69 Days)||0
4924751|NCT03306589|12114902|P6|NOT COMPLETED|Part 1 (69 Days)||0
4924752|NCT03306589|12114903|P5|NOT COMPLETED|Part 1 (69 Days)||0
4924753|NCT03306589|12114904|P4|NOT COMPLETED|Part 1 (69 Days)||0
4924754|NCT03306589|12114905|P3|NOT COMPLETED|Part 1 (69 Days)||0
4924755|NCT03306589|12114906|P2|NOT COMPLETED|Part 1 (69 Days)||0
4924756|NCT03306589|12114907|P1|NOT COMPLETED|Part 1 (69 Days)||0
4924757|NCT03306589|12114902|P6|COMPLETED|Part 1 (69 Days)||0
4924758|NCT03306589|12114903|P5|COMPLETED|Part 1 (69 Days)||0
4924759|NCT03306589|12114904|P4|COMPLETED|Part 1 (69 Days)||4
4924760|NCT03306589|12114905|P3|COMPLETED|Part 1 (69 Days)||2
4924761|NCT03306589|12114906|P2|COMPLETED|Part 1 (69 Days)||4
4924762|NCT03306589|12114907|P1|COMPLETED|Part 1 (69 Days)||2
4924763|NCT03306589|12114902|P6|STARTED|Part 1 (69 Days)||0
4924764|NCT03306589|12114903|P5|STARTED|Part 1 (69 Days)||0
4924765|NCT03306589|12114904|P4|STARTED|Part 1 (69 Days)||4
4924766|NCT03306589|12114905|P3|STARTED|Part 1 (69 Days)||2
4924767|NCT03306589|12114906|P2|STARTED|Part 1 (69 Days)||4
4924768|NCT03306589|12114907|P1|STARTED|Part 1 (69 Days)||2
4924769|NCT03306420|12115013|P5|NOT COMPLETED|Overall Study||0
4924770|NCT03306420|12115014|P4|NOT COMPLETED|Overall Study||0
4924771|NCT03306420|12115015|P3|NOT COMPLETED|Overall Study||0
4924772|NCT03306420|12115016|P2|NOT COMPLETED|Overall Study||0
4924773|NCT03306420|12115017|P1|NOT COMPLETED|Overall Study||0
4924774|NCT03306420|12115013|P5|COMPLETED|Overall Study||3
4924775|NCT03306420|12115014|P4|COMPLETED|Overall Study||3
4924776|NCT03306420|12115015|P3|COMPLETED|Overall Study||3
4924777|NCT03306420|12115016|P2|COMPLETED|Overall Study||3
4924778|NCT03306420|12115017|P1|COMPLETED|Overall Study||3
4924779|NCT03306420|12115013|P5|STARTED|Overall Study||3
4924780|NCT03306420|12115014|P4|STARTED|Overall Study||3
4924781|NCT03306420|12115015|P3|STARTED|Overall Study||3
4924782|NCT03306420|12115016|P2|STARTED|Overall Study||3
4924783|NCT03306420|12115017|P1|STARTED|Overall Study||3
4924784|NCT03306277|12115129|P1|NOT COMPLETED|Overall Study||3
4924785|NCT03306277|12115129|P1|COMPLETED|Overall Study||19
4924786|NCT03306277|12115129|P1|STARTED|Overall Study||22
4924787|NCT03306199|12115136|P1|NOT COMPLETED|Overall Study||15
4924788|NCT03306199|12115136|P1|COMPLETED|Overall Study||67
4924789|NCT03306199|12115136|P1|STARTED|Overall Study||82
4924790|NCT03306043|12115140|P1|NOT COMPLETED|Overall Study||4
4924791|NCT03306043|12115140|P1|COMPLETED|Overall Study||98
4924792|NCT03306043|12115140|P1|STARTED|Overall Study||102
4924793|NCT03305887|12115148|P2|NOT COMPLETED|Overall Study||10
4924794|NCT03305887|12115149|P1|NOT COMPLETED|Overall Study||11
4924795|NCT03305887|12115148|P2|COMPLETED|Overall Study||83
4924796|NCT03305887|12115149|P1|COMPLETED|Overall Study||80
4924797|NCT03305887|12115148|P2|STARTED|Overall Study||93
4924798|NCT03305887|12115149|P1|STARTED|Overall Study||91
4924799|NCT03305822|12115155|P2|NOT COMPLETED|Period 2||0
4924800|NCT03305822|12115156|P1|NOT COMPLETED|Period 2||0
4924801|NCT03305822|12115155|P2|COMPLETED|Period 2||18
4924802|NCT03305822|12115156|P1|COMPLETED|Period 2||20
4924803|NCT03305822|12115155|P2|Received at Least 1 Dose of Study Drug|Period 2||18
4924804|NCT03305822|12115156|P1|Received at Least 1 Dose of Study Drug|Period 2||20
4924805|NCT03305822|12115155|P2|STARTED|Period 2||18
4924806|NCT03305822|12115156|P1|STARTED|Period 2||20
4924807|NCT03305822|12115155|P2|NOT COMPLETED|Washout||0
4924808|NCT03305822|12115156|P1|NOT COMPLETED|Washout||0
4924809|NCT03305822|12115155|P2|COMPLETED|Washout||18
4924810|NCT03305822|12115156|P1|COMPLETED|Washout||20
4924811|NCT03305822|12115155|P2|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
4924812|NCT03305822|12115156|P1|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
4924813|NCT03305822|12115155|P2|NOT COMPLETED|Period 1||0
4924814|NCT03305822|12115156|P1|NOT COMPLETED|Period 1||0
4924815|NCT03305822|12115155|P2|COMPLETED|Period 1||18
4924816|NCT03305822|12115156|P1|COMPLETED|Period 1||20
4924817|NCT03305822|12115155|P2|Received at Least 1 Dose of Study Drug|Period 1||18
4924818|NCT03305822|12115156|P1|Received at Least 1 Dose of Study Drug|Period 1||20
4924819|NCT03305822|12115155|P2|STARTED|Period 1||18
4924820|NCT03305822|12115156|P1|STARTED|Period 1||20
4924821|NCT03305770|12115166|P2|NOT COMPLETED|Overall Study||1
4924822|NCT03305770|12115167|P1|NOT COMPLETED|Overall Study||1
4924823|NCT03305770|12115166|P2|COMPLETED|Overall Study||36
4924824|NCT03305770|12115167|P1|COMPLETED|Overall Study||69
4924825|NCT03305770|12115166|P2|Completed Analysis Set|Overall Study||36
4924826|NCT03305770|12115167|P1|Completed Analysis Set|Overall Study||69
4924827|NCT03305770|12115166|P2|Enrolled Dispensed Analysis Set|Overall Study||36
4924828|NCT03305770|12115167|P1|Enrolled Dispensed Analysis Set|Overall Study||70
4924829|NCT03305770|12115166|P2|STARTED|Overall Study||37
4924830|NCT03305770|12115167|P1|STARTED|Overall Study||70
4924831|NCT03305731|12115175|P1|NOT COMPLETED|Overall Study||1
4924832|NCT03305731|12115175|P1|COMPLETED|Overall Study||20
4924833|NCT03305731|12115175|P1|Week 11|Overall Study||20
4924834|NCT03305731|12115175|P1|Week 6|Overall Study||20
4924835|NCT03305731|12115175|P1|STARTED|Overall Study||21
4924836|NCT03305419|12115192|P8|NOT COMPLETED|Part B (14 Days)||0
4924837|NCT03305419|12115193|P7|NOT COMPLETED|Part B (14 Days)||5
4924838|NCT03305419|12115194|P6|NOT COMPLETED|Part B (14 Days)||10
4924839|NCT03305419|12115195|P5|NOT COMPLETED|Part B (14 Days)||3
4924840|NCT03305419|12115196|P4|NOT COMPLETED|Part B (14 Days)||0
4924841|NCT03305419|12115197|P3|NOT COMPLETED|Part B (14 Days)||0
4924842|NCT03305419|12115198|P2|NOT COMPLETED|Part B (14 Days)||0
4924843|NCT03305419|12115199|P1|NOT COMPLETED|Part B (14 Days)||0
4924844|NCT03305419|12115192|P8|COMPLETED|Part B (14 Days)||0
4924845|NCT03305419|12115193|P7|COMPLETED|Part B (14 Days)||8
4924846|NCT03305419|12115194|P6|COMPLETED|Part B (14 Days)||10
4924847|NCT03305419|12115195|P5|COMPLETED|Part B (14 Days)||11
4924848|NCT03305419|12115196|P4|COMPLETED|Part B (14 Days)||0
4924849|NCT03305419|12115197|P3|COMPLETED|Part B (14 Days)||0
4924850|NCT03305419|12115198|P2|COMPLETED|Part B (14 Days)||0
4924851|NCT03305419|12115199|P1|COMPLETED|Part B (14 Days)||0
4924852|NCT03305419|12115192|P8|STARTED|Part B (14 Days)||0
4924853|NCT03305419|12115193|P7|STARTED|Part B (14 Days)||13
4924854|NCT03305419|12115194|P6|STARTED|Part B (14 Days)||20
4924855|NCT03305419|12115195|P5|STARTED|Part B (14 Days)||14
4924856|NCT03305419|12115196|P4|STARTED|Part B (14 Days)||0
4924857|NCT03305419|12115197|P3|STARTED|Part B (14 Days)||0
4924858|NCT03305419|12115198|P2|STARTED|Part B (14 Days)||0
4924859|NCT03305419|12115199|P1|STARTED|Part B (14 Days)||0
4924860|NCT03305419|12115192|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924861|NCT03305419|12115193|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924862|NCT03305419|12115194|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924863|NCT03305419|12115195|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924864|NCT03305419|12115196|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924865|NCT03305419|12115197|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924866|NCT03305419|12115198|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924867|NCT03305419|12115199|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924868|NCT03305419|12115192|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924869|NCT03305419|12115193|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924870|NCT03305419|12115194|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924871|NCT03305419|12115195|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
4924872|NCT03305419|12115196|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
4924873|NCT03305419|12115197|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
4924874|NCT03305419|12115198|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
4924875|NCT03305419|12115199|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
4924876|NCT03305419|12115192|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
4924877|NCT03305419|12115193|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
4924878|NCT03305419|12115194|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
4924879|NCT03305419|12115195|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
4924880|NCT03305419|12115196|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
4924881|NCT03305419|12115197|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
4924882|NCT03305419|12115198|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
4924883|NCT03305419|12115199|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
4924884|NCT03305419|12115192|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924885|NCT03305419|12115193|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924886|NCT03305419|12115194|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924887|NCT03305419|12115195|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924888|NCT03305419|12115196|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924889|NCT03305419|12115197|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924890|NCT03305419|12115198|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924891|NCT03305419|12115199|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
4924892|NCT03305419|12115192|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924893|NCT03305419|12115193|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924894|NCT03305419|12115194|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924895|NCT03305419|12115195|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
4924896|NCT03305419|12115196|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
4924897|NCT03305419|12115197|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
4924898|NCT03305419|12115198|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
4924899|NCT03305419|12115199|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
4924900|NCT03305419|12115192|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
4924901|NCT03305419|12115193|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
4924902|NCT03305419|12115194|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
4924903|NCT03305419|12115195|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
4924904|NCT03305419|12115196|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
4924905|NCT03305419|12115197|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
4924906|NCT03305419|12115198|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
4924907|NCT03305419|12115199|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
4924908|NCT03305419|12115192|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924909|NCT03305419|12115193|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924910|NCT03305419|12115194|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924911|NCT03305419|12115195|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924912|NCT03305419|12115196|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924913|NCT03305419|12115197|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924914|NCT03305419|12115198|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
4924915|NCT03305419|12115199|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924916|NCT03305419|12115192|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924917|NCT03305419|12115193|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924918|NCT03305419|12115194|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924919|NCT03305419|12115195|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
4924920|NCT03305419|12115196|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
4924921|NCT03305419|12115197|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
4924922|NCT03305419|12115198|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
4924923|NCT03305419|12115199|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
4924924|NCT03305419|12115192|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
4924925|NCT03305419|12115193|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
4924926|NCT03305419|12115194|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
4924927|NCT03305419|12115195|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
4924928|NCT03305419|12115196|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
4924929|NCT03305419|12115197|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
4924930|NCT03305419|12115198|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
4924931|NCT03305419|12115199|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
4924932|NCT03305159|12115331|P2|NOT COMPLETED|Overall Study||8
4924933|NCT03305159|12115332|P1|NOT COMPLETED|Overall Study||3
4924934|NCT03305159|12115331|P2|COMPLETED|Overall Study||60
4924935|NCT03305159|12115332|P1|COMPLETED|Overall Study||63
4924936|NCT03305159|12115331|P2|STARTED|Overall Study||68
4924937|NCT03305159|12115332|P1|STARTED|Overall Study||66
4924938|NCT03305055|12115340|P2|NOT COMPLETED|Overall Study||2
4924939|NCT03305055|12115341|P1|NOT COMPLETED|Overall Study||1
4924940|NCT03305055|12115340|P2|COMPLETED|Overall Study||0
4924941|NCT03305055|12115341|P1|COMPLETED|Overall Study||1
4924942|NCT03305055|12115340|P2|STARTED|Overall Study||2
4924943|NCT03305055|12115341|P1|STARTED|Overall Study||2
4924944|NCT03304873|12115359|P2|NOT COMPLETED|Overall Study||8
4924945|NCT03304873|12115360|P1|NOT COMPLETED|Overall Study||1
4924946|NCT03304873|12115359|P2|COMPLETED|Overall Study||16
4924947|NCT03304873|12115360|P1|COMPLETED|Overall Study||22
4924948|NCT03304873|12115359|P2|STARTED|Overall Study||24
4924949|NCT03304873|12115360|P1|STARTED|Overall Study||23
4924950|NCT03304119|12115370|P2|NOT COMPLETED|Overall Study||0
4924951|NCT03304119|12115371|P1|NOT COMPLETED|Overall Study||0
4924952|NCT03304119|12115370|P2|COMPLETED|Overall Study||55
4924953|NCT03304119|12115371|P1|COMPLETED|Overall Study||37
4924954|NCT03304119|12115370|P2|STARTED|Overall Study||55
4924955|NCT03304119|12115371|P1|STARTED|Overall Study||37
4924956|NCT03303950|12115381|P1|NOT COMPLETED|Overall Study||0
4924957|NCT03303950|12115381|P1|COMPLETED|Overall Study||6
4924958|NCT03303950|12115381|P1|STARTED|Overall Study||6
4924959|NCT03303911|12115387|P2|NOT COMPLETED|Overall Study||0
4924960|NCT03303911|12115388|P1|NOT COMPLETED|Overall Study||0
4924961|NCT03303911|12115387|P2|COMPLETED|Overall Study||13
4924962|NCT03303911|12115388|P1|COMPLETED|Overall Study||13
4924963|NCT03303911|12115387|P2|STARTED|Overall Study||13
4924964|NCT03303911|12115388|P1|STARTED|Overall Study||13
4924965|NCT03303794|12115444|P2|NOT COMPLETED|Overall Study||0
4924966|NCT03303794|12115445|P1|NOT COMPLETED|Overall Study||0
4924967|NCT03303794|12115444|P2|COMPLETED|Overall Study||12
4924968|NCT03303794|12115445|P1|COMPLETED|Overall Study||13
4924969|NCT03303794|12115444|P2|STARTED|Overall Study||12
4924970|NCT03303794|12115445|P1|STARTED|Overall Study||13
4924971|NCT03303521|12115457|P2|NOT COMPLETED|Overall Study||3
4924972|NCT03303521|12115458|P1|NOT COMPLETED|Overall Study||5
4924973|NCT03303521|12115457|P2|COMPLETED|Overall Study||96
4924974|NCT03303521|12115458|P1|COMPLETED|Overall Study||92
4924975|NCT03303521|12115457|P2|STARTED|Overall Study||99
4924976|NCT03303521|12115458|P1|STARTED|Overall Study||97
4924977|NCT03303417|12115468|P2|NOT COMPLETED|Overall Study||1
4924978|NCT03303417|12115469|P1|NOT COMPLETED|Overall Study||1
4924979|NCT03303417|12115468|P2|COMPLETED|Overall Study||7
4924980|NCT03303417|12115469|P1|COMPLETED|Overall Study||7
4924981|NCT03303417|12115468|P2|STARTED|Overall Study||8
4924982|NCT03303417|12115469|P1|STARTED|Overall Study||8
4924983|NCT03302975|12115483|P1|NOT COMPLETED|Overall Study||4
4924984|NCT03302975|12115483|P1|COMPLETED|Overall Study||12
4924985|NCT03302975|12115483|P1|STARTED|Overall Study||16
4924986|NCT03302936|12115491|P2|NOT COMPLETED|Overall Study||4
4924987|NCT03302936|12115492|P1|NOT COMPLETED|Overall Study||3
4924988|NCT03302936|12115491|P2|COMPLETED|Overall Study||45
4924989|NCT03302936|12115492|P1|COMPLETED|Overall Study||46
4924990|NCT03302936|12115491|P2|STARTED|Overall Study||49
4924991|NCT03302936|12115492|P1|STARTED|Overall Study||49
4924992|NCT03302793|12115502|P2|NOT COMPLETED|Overall Study||2
4924993|NCT03302793|12115503|P1|NOT COMPLETED|Overall Study||0
4924994|NCT03302793|12115502|P2|COMPLETED|Overall Study||4
4924995|NCT03302793|12115503|P1|COMPLETED|Overall Study||6
4924996|NCT03302793|12115502|P2|STARTED|Overall Study||6
4924997|NCT03302793|12115503|P1|STARTED|Overall Study||6
4924998|NCT03302559|12115513|P1|NOT COMPLETED|Overall Study||6
4924999|NCT03302559|12115513|P1|COMPLETED|Overall Study||23
4925000|NCT03302559|12115513|P1|STARTED|Overall Study||29
4925001|NCT03301844|12115529|P2|NOT COMPLETED|Overall Study||1
4925002|NCT03301844|12115530|P1|NOT COMPLETED|Overall Study||1
4925003|NCT03301844|12115529|P2|COMPLETED|Overall Study||18
4925004|NCT03301844|12115530|P1|COMPLETED|Overall Study||18
4925005|NCT03301844|12115529|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
4925006|NCT03301844|12115530|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
4925007|NCT03301779|12115544|P2|NOT COMPLETED|Overall Study||7
4925008|NCT03301779|12115545|P1|NOT COMPLETED|Overall Study||8
4925009|NCT03301779|12115544|P2|COMPLETED|Overall Study||45
4925010|NCT03301779|12115545|P1|COMPLETED|Overall Study||40
4925011|NCT03301779|12115544|P2|STARTED|Overall Study||52
4925012|NCT03301779|12115545|P1|STARTED|Overall Study||48
4925013|NCT03301740|12115557|P2|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
4925014|NCT03301740|12115558|P1|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
4925015|NCT03301740|12115557|P2|COMPLETED|Phase 4 Intervention (3 Weeks)||16
4925016|NCT03301740|12115558|P1|COMPLETED|Phase 4 Intervention (3 Weeks)||16
4925017|NCT03301740|12115557|P2|STARTED|Phase 4 Intervention (3 Weeks)||16
4925018|NCT03301740|12115558|P1|STARTED|Phase 4 Intervention (3 Weeks)||17
4925019|NCT03301740|12115557|P2|NOT COMPLETED|Third Washout (1 Week)||0
4925020|NCT03301740|12115558|P1|NOT COMPLETED|Third Washout (1 Week)||0
4925021|NCT03301740|12115557|P2|COMPLETED|Third Washout (1 Week)||16
4925022|NCT03301740|12115558|P1|COMPLETED|Third Washout (1 Week)||17
4925023|NCT03301740|12115557|P2|STARTED|Third Washout (1 Week)||16
4925024|NCT03301740|12115558|P1|STARTED|Third Washout (1 Week)||17
4925025|NCT03301740|12115557|P2|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
4925026|NCT03301740|12115558|P1|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
4925027|NCT03301740|12115557|P2|COMPLETED|Phase 3 Intervention (3 Weeks)||16
4925028|NCT03301740|12115558|P1|COMPLETED|Phase 3 Intervention (3 Weeks)||17
4925029|NCT03301740|12115557|P2|STARTED|Phase 3 Intervention (3 Weeks)||16
4925030|NCT03301740|12115558|P1|STARTED|Phase 3 Intervention (3 Weeks)||17
4925031|NCT03301740|12115557|P2|NOT COMPLETED|Second Washout (1 Week)||0
4925032|NCT03301740|12115558|P1|NOT COMPLETED|Second Washout (1 Week)||0
4925033|NCT03301740|12115557|P2|COMPLETED|Second Washout (1 Week)||16
4925034|NCT03301740|12115558|P1|COMPLETED|Second Washout (1 Week)||17
4925035|NCT03301740|12115557|P2|STARTED|Second Washout (1 Week)||16
4925036|NCT03301740|12115558|P1|STARTED|Second Washout (1 Week)||17
4925037|NCT03301740|12115557|P2|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
4925038|NCT03301740|12115558|P1|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
4925039|NCT03301740|12115557|P2|COMPLETED|Phase 2 Intervention (3 Weeks)||16
4925040|NCT03301740|12115558|P1|COMPLETED|Phase 2 Intervention (3 Weeks)||17
4925041|NCT03301740|12115557|P2|STARTED|Phase 2 Intervention (3 Weeks)||16
4925042|NCT03301740|12115558|P1|STARTED|Phase 2 Intervention (3 Weeks)||18
4925043|NCT03301740|12115557|P2|NOT COMPLETED|First Washout (1 Week)||0
4925044|NCT03301740|12115558|P1|NOT COMPLETED|First Washout (1 Week)||0
4925045|NCT03301740|12115557|P2|COMPLETED|First Washout (1 Week)||16
4925046|NCT03301740|12115558|P1|COMPLETED|First Washout (1 Week)||18
4925047|NCT03301740|12115557|P2|STARTED|First Washout (1 Week)||16
4925048|NCT03301740|12115558|P1|STARTED|First Washout (1 Week)||18
4925049|NCT03301740|12115557|P2|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
4925050|NCT03301740|12115558|P1|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
4925051|NCT03301740|12115557|P2|COMPLETED|Phase 1 Intervention (3 Weeks)||16
4925052|NCT03301740|12115558|P1|COMPLETED|Phase 1 Intervention (3 Weeks)||18
4925053|NCT03301740|12115557|P2|STARTED|Phase 1 Intervention (3 Weeks)||16
4925054|NCT03301740|12115558|P1|STARTED|Phase 1 Intervention (3 Weeks)||18
4925055|NCT03301714|12115601|P3|NOT COMPLETED|Overall Study||7
4925056|NCT03301714|12115602|P2|NOT COMPLETED|Overall Study||6
4925057|NCT03301714|12115603|P1|NOT COMPLETED|Overall Study||10
4925058|NCT03301714|12115601|P3|COMPLETED|Overall Study||53
4925059|NCT03301714|12115602|P2|COMPLETED|Overall Study||54
4925060|NCT03301714|12115603|P1|COMPLETED|Overall Study||50
4925061|NCT03301714|12115601|P3|STARTED|Overall Study||60
4925062|NCT03301714|12115602|P2|STARTED|Overall Study||60
4925063|NCT03301714|12115603|P1|STARTED|Overall Study||60
4925064|NCT03301649|12115620|P3|NOT COMPLETED|Overall Study||85
4925065|NCT03301649|12115621|P2|NOT COMPLETED|Overall Study||44
4925066|NCT03301649|12115622|P1|NOT COMPLETED|Overall Study||43
4925067|NCT03301649|12115620|P3|COMPLETED|Overall Study||27
4925068|NCT03301649|12115621|P2|COMPLETED|Overall Study||356
4925069|NCT03301649|12115622|P1|COMPLETED|Overall Study||356
4925070|NCT03301649|12115620|P3|Per-protocol (PP) Population|Overall Study||103
4925071|NCT03301649|12115621|P2|Per-protocol (PP) Population|Overall Study||354
4925072|NCT03301649|12115622|P1|Per-protocol (PP) Population|Overall Study||345
4925073|NCT03301649|12115620|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
4925074|NCT03301649|12115621|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
4925075|NCT03301649|12115622|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
4925076|NCT03301649|12115620|P3|Safety Population|Overall Study||112
4925077|NCT03301649|12115621|P2|Safety Population|Overall Study||400
4925078|NCT03301649|12115622|P1|Safety Population|Overall Study||399
4925079|NCT03301649|12115620|P3|STARTED|Overall Study||112
4925080|NCT03301649|12115621|P2|STARTED|Overall Study||400
4925081|NCT03301649|12115622|P1|STARTED|Overall Study||399
4925082|NCT03301298|12115644|P7|NOT COMPLETED|Fed Conditions||0
4925083|NCT03301298|12115645|P6|NOT COMPLETED|Fed Conditions||0
4925084|NCT03301298|12115646|P5|NOT COMPLETED|Fed Conditions||0
4925085|NCT03301298|12115647|P4|NOT COMPLETED|Fed Conditions||0
4925086|NCT03301298|12115648|P3|NOT COMPLETED|Fed Conditions||0
4925087|NCT03301298|12115649|P2|NOT COMPLETED|Fed Conditions||0
4925088|NCT03301298|12115650|P1|NOT COMPLETED|Fed Conditions||0
4925089|NCT03301298|12115644|P7|COMPLETED|Fed Conditions||2
4925090|NCT03301298|12115645|P6|COMPLETED|Fed Conditions||0
4925091|NCT03301298|12115646|P5|COMPLETED|Fed Conditions||5
4925092|NCT03301298|12115647|P4|COMPLETED|Fed Conditions||0
4925093|NCT03301298|12115648|P3|COMPLETED|Fed Conditions||0
4925094|NCT03301298|12115649|P2|COMPLETED|Fed Conditions||0
4925095|NCT03301298|12115650|P1|COMPLETED|Fed Conditions||0
4925096|NCT03301298|12115644|P7|STARTED|Fed Conditions||2
4925097|NCT03301298|12115645|P6|STARTED|Fed Conditions||0
4925098|NCT03301298|12115646|P5|STARTED|Fed Conditions||5
4925099|NCT03301298|12115647|P4|STARTED|Fed Conditions||0
4925100|NCT03301298|12115648|P3|STARTED|Fed Conditions||0
4925101|NCT03301298|12115649|P2|STARTED|Fed Conditions||0
4925102|NCT03301298|12115650|P1|STARTED|Fed Conditions||0
4925103|NCT03301298|12115644|P7|NOT COMPLETED|Unfed Conditions||0
4925104|NCT03301298|12115645|P6|NOT COMPLETED|Unfed Conditions||0
4925105|NCT03301298|12115646|P5|NOT COMPLETED|Unfed Conditions||0
4925106|NCT03301298|12115647|P4|NOT COMPLETED|Unfed Conditions||0
4925107|NCT03301298|12115648|P3|NOT COMPLETED|Unfed Conditions||0
4925108|NCT03301298|12115649|P2|NOT COMPLETED|Unfed Conditions||0
4925109|NCT03301298|12115650|P1|NOT COMPLETED|Unfed Conditions||0
4925110|NCT03301298|12115644|P7|COMPLETED|Unfed Conditions||12
4925111|NCT03301298|12115645|P6|COMPLETED|Unfed Conditions||6
4925112|NCT03301298|12115646|P5|COMPLETED|Unfed Conditions||6
4925113|NCT03301298|12115647|P4|COMPLETED|Unfed Conditions||6
4925114|NCT03301298|12115648|P3|COMPLETED|Unfed Conditions||6
4925115|NCT03301298|12115649|P2|COMPLETED|Unfed Conditions||6
4925116|NCT03301298|12115650|P1|COMPLETED|Unfed Conditions||6
4925117|NCT03301298|12115644|P7|STARTED|Unfed Conditions||12
4925118|NCT03301298|12115645|P6|STARTED|Unfed Conditions||6
4925119|NCT03301298|12115646|P5|STARTED|Unfed Conditions||6
4925120|NCT03301298|12115647|P4|STARTED|Unfed Conditions||6
4925121|NCT03301298|12115648|P3|STARTED|Unfed Conditions||6
4925122|NCT03301298|12115649|P2|STARTED|Unfed Conditions||6
4925123|NCT03301298|12115650|P1|STARTED|Unfed Conditions||6
4925124|NCT03301155|12115688|P2|NOT COMPLETED|Overall Study||7
4925125|NCT03301155|12115689|P1|NOT COMPLETED|Overall Study||8
4925126|NCT03301155|12115688|P2|COMPLETED|Overall Study||501
4925127|NCT03301155|12115689|P1|COMPLETED|Overall Study||520
4925128|NCT03301155|12115688|P2|STARTED|Overall Study||508
4925129|NCT03301155|12115689|P1|STARTED|Overall Study||528
4925130|NCT03300843|12115703|P1|NOT COMPLETED|Overall Study||0
4925131|NCT03300843|12115703|P1|COMPLETED|Overall Study||1
4925132|NCT03300843|12115703|P1|STARTED|Overall Study||1
4925133|NCT03300674|12115711|P2|NOT COMPLETED|Overall Study||0
4925134|NCT03300674|12115712|P1|NOT COMPLETED|Overall Study||0
4925135|NCT03300674|12115711|P2|COMPLETED|Overall Study||77
4925136|NCT03300674|12115712|P1|COMPLETED|Overall Study||77
4925137|NCT03300674|12115711|P2|STARTED|Overall Study||77
4925138|NCT03300674|12115712|P1|STARTED|Overall Study||77
4925139|NCT03300570|12115724|P2|NOT COMPLETED|Overall Study||1
4925140|NCT03300570|12115725|P1|NOT COMPLETED|Overall Study||2
4925141|NCT03300570|12115724|P2|COMPLETED|Overall Study||13
4925142|NCT03300570|12115725|P1|COMPLETED|Overall Study||11
4925143|NCT03300570|12115724|P2|STARTED|Overall Study||14
4925144|NCT03300570|12115725|P1|STARTED|Overall Study||13
4925145|NCT03300466|12115737|P2|NOT COMPLETED|Overall Study||0
4925146|NCT03300466|12115738|P1|NOT COMPLETED|Overall Study||1
4925147|NCT03300466|12115737|P2|COMPLETED|Overall Study||10
4925148|NCT03300466|12115738|P1|COMPLETED|Overall Study||9
4925149|NCT03300466|12115737|P2|STARTED|Overall Study||10
4925150|NCT03300466|12115738|P1|STARTED|Overall Study||10
4925151|NCT03300024|12115748|P2|NOT COMPLETED|Overall Study||6
4925152|NCT03300024|12115749|P1|NOT COMPLETED|Overall Study||4
4925153|NCT03300024|12115748|P2|COMPLETED|Overall Study||0
4925154|NCT03300024|12115749|P1|COMPLETED|Overall Study||0
4925155|NCT03300024|12115748|P2|STARTED|Overall Study||6
4925156|NCT03300024|12115749|P1|STARTED|Overall Study||4
4925157|NCT03299049|12115803|P2|NOT COMPLETED|Overall Study||523
4925158|NCT03299049|12115804|P1|NOT COMPLETED|Overall Study||522
4925159|NCT03299049|12115803|P2|COMPLETED|Overall Study||0
4925160|NCT03299049|12115804|P1|COMPLETED|Overall Study||0
4925161|NCT03299049|12115803|P2|STARTED|Overall Study||523
4925162|NCT03299049|12115804|P1|STARTED|Overall Study||522
4925163|NCT03298867|12115903|P2|NOT COMPLETED|Overall Study||2
4925164|NCT03298867|12115904|P1|NOT COMPLETED|Overall Study||2
4925165|NCT03298867|12115903|P2|COMPLETED|Overall Study||39
4925166|NCT03298867|12115904|P1|COMPLETED|Overall Study||40
4925167|NCT03298867|12115903|P2|STARTED|Overall Study||41
4925168|NCT03298867|12115904|P1|STARTED|Overall Study||42
4925169|NCT03298113|12115922|P2|NOT COMPLETED|Overall Study||0
4925170|NCT03298113|12115923|P1|NOT COMPLETED|Overall Study||0
4925171|NCT03298113|12115922|P2|COMPLETED|Overall Study||10
4925172|NCT03298113|12115923|P1|COMPLETED|Overall Study||10
4925173|NCT03298113|12115922|P2|IAD 2A|Overall Study||6
4925174|NCT03298113|12115923|P1|IAD 2A|Overall Study||7
4925175|NCT03298113|12115922|P2|IAD 1A|Overall Study||4
4925176|NCT03298113|12115923|P1|IAD 1A|Overall Study||3
4925177|NCT03298113|12115922|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
4925178|NCT03298113|12115923|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
4925179|NCT03298048|12115962|P3|NOT COMPLETED|Overall Study||0
4925180|NCT03298048|12115963|P2|NOT COMPLETED|Overall Study||0
4925181|NCT03298048|12115964|P1|NOT COMPLETED|Overall Study||0
4925182|NCT03298048|12115962|P3|COMPLETED|Overall Study||8
4925183|NCT03298048|12115963|P2|COMPLETED|Overall Study||3
4925184|NCT03298048|12115964|P1|COMPLETED|Overall Study||4
4925185|NCT03298048|12115962|P3|STARTED|Overall Study||8
4925186|NCT03298048|12115963|P2|STARTED|Overall Study||3
4925187|NCT03298048|12115964|P1|STARTED|Overall Study||4
4925188|NCT03298035|12115989|P2|NOT COMPLETED|Overall Study||2
4925189|NCT03298035|12115990|P1|NOT COMPLETED|Overall Study||1
4925190|NCT03298035|12115989|P2|COMPLETED|Overall Study||7
4925191|NCT03298035|12115990|P1|COMPLETED|Overall Study||9
4925192|NCT03298035|12115989|P2|Received Intervention|Overall Study||7
4925193|NCT03298035|12115990|P1|Received Intervention|Overall Study||9
4925194|NCT03298035|12115989|P2|STARTED|Overall Study||9
4925195|NCT03298035|12115990|P1|STARTED|Overall Study||10
4925196|NCT03297944|12116012|P1|NOT COMPLETED|Overall Study||0
4925197|NCT03297944|12116012|P1|COMPLETED|Overall Study||15
4925198|NCT03297944|12116012|P1|PLC/ALP|Overall Study||15
4925199|NCT03297944|12116012|P1|PLC/PLC|Overall Study||15
4925200|NCT03297944|12116012|P1|ZOL/PLC|Overall Study||15
4925201|NCT03297944|12116012|P1|0.5ALP/PLC|Overall Study||15
4925202|NCT03297944|12116012|P1|1ALP/PLC|Overall Study||15
4925203|NCT03297944|12116012|P1|2ALP/PLC|Overall Study||15
4925204|NCT03297944|12116012|P1|STARTED|Overall Study||15
4925205|NCT03297294|12116023|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4925206|NCT03297294|12116024|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
4925207|NCT03297294|12116025|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4925208|NCT03297294|12116026|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4925209|NCT03297294|12116027|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4925210|NCT03297294|12116023|P5|COMPLETED|Treatment Withdrawal Period (TW)||27
4925211|NCT03297294|12116024|P4|COMPLETED|Treatment Withdrawal Period (TW)||11
4925212|NCT03297294|12116025|P3|COMPLETED|Treatment Withdrawal Period (TW)||14
4925213|NCT03297294|12116026|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
4925214|NCT03297294|12116027|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
4925215|NCT03297294|12116023|P5|STARTED|Treatment Withdrawal Period (TW)||27
4925216|NCT03297294|12116024|P4|STARTED|Treatment Withdrawal Period (TW)||12
4925217|NCT03297294|12116025|P3|STARTED|Treatment Withdrawal Period (TW)||14
4925218|NCT03297294|12116026|P2|STARTED|Treatment Withdrawal Period (TW)||0
4925219|NCT03297294|12116027|P1|STARTED|Treatment Withdrawal Period (TW)||0
4925220|NCT03297294|12116023|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4925221|NCT03297294|12116024|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4925222|NCT03297294|12116025|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4925223|NCT03297294|12116026|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
4925224|NCT03297294|12116027|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
4925225|NCT03297294|12116023|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
4925226|NCT03297294|12116024|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
4925227|NCT03297294|12116025|P3|COMPLETED|Double-Blind Treatment Period (DB)||0
4925228|NCT03297294|12116026|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
4925229|NCT03297294|12116027|P1|COMPLETED|Double-Blind Treatment Period (DB)||32
4925230|NCT03297294|12116023|P5|STARTED|Double-Blind Treatment Period (DB)||0
4925231|NCT03297294|12116024|P4|STARTED|Double-Blind Treatment Period (DB)||0
4925232|NCT03297294|12116025|P3|STARTED|Double-Blind Treatment Period (DB)||0
4925233|NCT03297294|12116026|P2|STARTED|Double-Blind Treatment Period (DB)||67
4925234|NCT03297294|12116027|P1|STARTED|Double-Blind Treatment Period (DB)||70
4925235|NCT03297112|12116061|P1|NOT COMPLETED|Overall Study||0
4925236|NCT03297112|12116061|P1|COMPLETED|Overall Study||12
4925237|NCT03297112|12116061|P1|STARTED|Overall Study||12
4925238|NCT03297021|12116069|P3|NOT COMPLETED|Overall Study||4
4925239|NCT03297021|12116070|P2|NOT COMPLETED|Overall Study||4
4925240|NCT03297021|12116071|P1|NOT COMPLETED|Overall Study||5
4925241|NCT03297021|12116069|P3|COMPLETED|Overall Study||43
4925242|NCT03297021|12116070|P2|COMPLETED|Overall Study||42
4925243|NCT03297021|12116071|P1|COMPLETED|Overall Study||43
4925244|NCT03297021|12116069|P3|STARTED|Overall Study||47
4925245|NCT03297021|12116070|P2|STARTED|Overall Study||46
4925246|NCT03297021|12116071|P1|STARTED|Overall Study||48
4925247|NCT03296566|12116093|P2|NOT COMPLETED|Overall Study||49
4925248|NCT03296566|12116094|P1|NOT COMPLETED|Overall Study||19
4925249|NCT03296566|12116093|P2|COMPLETED|Overall Study||103
4925250|NCT03296566|12116094|P1|COMPLETED|Overall Study||126
4925251|NCT03296566|12116093|P2|STARTED|Overall Study||152
4925252|NCT03296566|12116094|P1|STARTED|Overall Study||145
4925253|NCT03296280|12116110|P2|NOT COMPLETED|Overall Study||7
4925254|NCT03296280|12116111|P1|NOT COMPLETED|Overall Study||6
4925255|NCT03296280|12116110|P2|COMPLETED|Overall Study||36
4925256|NCT03296280|12116111|P1|COMPLETED|Overall Study||67
4925257|NCT03296280|12116110|P2|STARTED|Overall Study||43
4925258|NCT03296280|12116111|P1|STARTED|Overall Study||73
4925259|NCT03296072|12116131|P6|NOT COMPLETED|Treament Period 3||0
4925260|NCT03296072|12116132|P5|NOT COMPLETED|Treament Period 3||0
4925261|NCT03296072|12116133|P4|NOT COMPLETED|Treament Period 3||0
4925262|NCT03296072|12116134|P3|NOT COMPLETED|Treament Period 3||0
4925263|NCT03296072|12116135|P2|NOT COMPLETED|Treament Period 3||0
4925264|NCT03296072|12116136|P1|NOT COMPLETED|Treament Period 3||0
4925265|NCT03296072|12116131|P6|COMPLETED|Treament Period 3||11
4925266|NCT03296072|12116132|P5|COMPLETED|Treament Period 3||10
4925267|NCT03296072|12116133|P4|COMPLETED|Treament Period 3||10
4925268|NCT03296072|12116134|P3|COMPLETED|Treament Period 3||10
4925269|NCT03296072|12116135|P2|COMPLETED|Treament Period 3||11
4925270|NCT03296072|12116136|P1|COMPLETED|Treament Period 3||10
4925271|NCT03296072|12116131|P6|STARTED|Treament Period 3||11
4925272|NCT03296072|12116132|P5|STARTED|Treament Period 3||10
4925273|NCT03296072|12116133|P4|STARTED|Treament Period 3||10
4925274|NCT03296072|12116134|P3|STARTED|Treament Period 3||10
4925275|NCT03296072|12116135|P2|STARTED|Treament Period 3||11
4925276|NCT03296072|12116136|P1|STARTED|Treament Period 3||10
4925277|NCT03296072|12116131|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925278|NCT03296072|12116132|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925279|NCT03296072|12116133|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925280|NCT03296072|12116134|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925281|NCT03296072|12116135|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925282|NCT03296072|12116136|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
4925283|NCT03296072|12116131|P6|COMPLETED|Treament Period 2: Wash Out Period||11
4925284|NCT03296072|12116132|P5|COMPLETED|Treament Period 2: Wash Out Period||10
4925285|NCT03296072|12116133|P4|COMPLETED|Treament Period 2: Wash Out Period||10
4925286|NCT03296072|12116134|P3|COMPLETED|Treament Period 2: Wash Out Period||10
4925287|NCT03296072|12116135|P2|COMPLETED|Treament Period 2: Wash Out Period||11
4925288|NCT03296072|12116136|P1|COMPLETED|Treament Period 2: Wash Out Period||10
4925289|NCT03296072|12116131|P6|STARTED|Treament Period 2: Wash Out Period||11
4925290|NCT03296072|12116132|P5|STARTED|Treament Period 2: Wash Out Period||10
4925291|NCT03296072|12116133|P4|STARTED|Treament Period 2: Wash Out Period||10
4925292|NCT03296072|12116134|P3|STARTED|Treament Period 2: Wash Out Period||10
4925293|NCT03296072|12116135|P2|STARTED|Treament Period 2: Wash Out Period||11
4925294|NCT03296072|12116136|P1|STARTED|Treament Period 2: Wash Out Period||10
4925295|NCT03296072|12116131|P6|NOT COMPLETED|Treament Period 2||0
4925296|NCT03296072|12116132|P5|NOT COMPLETED|Treament Period 2||0
4925297|NCT03296072|12116133|P4|NOT COMPLETED|Treament Period 2||0
4925298|NCT03296072|12116134|P3|NOT COMPLETED|Treament Period 2||0
4925299|NCT03296072|12116135|P2|NOT COMPLETED|Treament Period 2||0
4925300|NCT03296072|12116136|P1|NOT COMPLETED|Treament Period 2||0
4925301|NCT03296072|12116131|P6|COMPLETED|Treament Period 2||11
4925302|NCT03296072|12116132|P5|COMPLETED|Treament Period 2||10
4925303|NCT03296072|12116133|P4|COMPLETED|Treament Period 2||10
4925304|NCT03296072|12116134|P3|COMPLETED|Treament Period 2||10
4925305|NCT03296072|12116135|P2|COMPLETED|Treament Period 2||11
4925306|NCT03296072|12116136|P1|COMPLETED|Treament Period 2||10
4925307|NCT03296072|12116131|P6|STARTED|Treament Period 2||11
4925308|NCT03296072|12116132|P5|STARTED|Treament Period 2||10
4925309|NCT03296072|12116133|P4|STARTED|Treament Period 2||10
4925310|NCT03296072|12116134|P3|STARTED|Treament Period 2||10
4925311|NCT03296072|12116135|P2|STARTED|Treament Period 2||11
4925312|NCT03296072|12116136|P1|STARTED|Treament Period 2||10
4925313|NCT03296072|12116131|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925314|NCT03296072|12116132|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925315|NCT03296072|12116133|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925316|NCT03296072|12116134|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925317|NCT03296072|12116135|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925318|NCT03296072|12116136|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
4925319|NCT03296072|12116131|P6|COMPLETED|Treament Period 1: Wash Out Period||11
4925320|NCT03296072|12116132|P5|COMPLETED|Treament Period 1: Wash Out Period||10
4925321|NCT03296072|12116133|P4|COMPLETED|Treament Period 1: Wash Out Period||10
4925322|NCT03296072|12116134|P3|COMPLETED|Treament Period 1: Wash Out Period||10
4925323|NCT03296072|12116135|P2|COMPLETED|Treament Period 1: Wash Out Period||11
4925324|NCT03296072|12116136|P1|COMPLETED|Treament Period 1: Wash Out Period||10
4925325|NCT03296072|12116131|P6|STARTED|Treament Period 1: Wash Out Period||11
4925326|NCT03296072|12116132|P5|STARTED|Treament Period 1: Wash Out Period||10
4925327|NCT03296072|12116133|P4|STARTED|Treament Period 1: Wash Out Period||10
4925328|NCT03296072|12116134|P3|STARTED|Treament Period 1: Wash Out Period||10
4925329|NCT03296072|12116135|P2|STARTED|Treament Period 1: Wash Out Period||11
4925330|NCT03296072|12116136|P1|STARTED|Treament Period 1: Wash Out Period||10
4925331|NCT03296072|12116131|P6|NOT COMPLETED|Treatment Period 1||0
4925332|NCT03296072|12116132|P5|NOT COMPLETED|Treatment Period 1||0
4925333|NCT03296072|12116133|P4|NOT COMPLETED|Treatment Period 1||0
4925334|NCT03296072|12116134|P3|NOT COMPLETED|Treatment Period 1||0
4925335|NCT03296072|12116135|P2|NOT COMPLETED|Treatment Period 1||0
4925336|NCT03296072|12116136|P1|NOT COMPLETED|Treatment Period 1||0
4925337|NCT03296072|12116131|P6|COMPLETED|Treatment Period 1||11
4925338|NCT03296072|12116132|P5|COMPLETED|Treatment Period 1||10
4925339|NCT03296072|12116133|P4|COMPLETED|Treatment Period 1||10
4925340|NCT03296072|12116134|P3|COMPLETED|Treatment Period 1||10
4925341|NCT03296072|12116135|P2|COMPLETED|Treatment Period 1||11
4925342|NCT03296072|12116136|P1|COMPLETED|Treatment Period 1||10
4925343|NCT03296072|12116131|P6|STARTED|Treatment Period 1||11
4925344|NCT03296072|12116132|P5|STARTED|Treatment Period 1||10
4925345|NCT03296072|12116133|P4|STARTED|Treatment Period 1||10
4925346|NCT03296072|12116134|P3|STARTED|Treatment Period 1||10
4925347|NCT03296072|12116135|P2|STARTED|Treatment Period 1||11
4925348|NCT03296072|12116136|P1|STARTED|Treatment Period 1||10
4925349|NCT03295630|12116153|P1|NOT COMPLETED|Overall Study||0
4925350|NCT03295630|12116153|P1|COMPLETED|Overall Study||20
4925351|NCT03295630|12116153|P1|STARTED|Overall Study||20
4925352|NCT03295266|12116160|P2|NOT COMPLETED|Overall Study||0
4925353|NCT03295266|12116161|P1|NOT COMPLETED|Overall Study||0
4925354|NCT03295266|12116160|P2|COMPLETED|Overall Study||4
4925355|NCT03295266|12116161|P1|COMPLETED|Overall Study||5
4925356|NCT03295266|12116160|P2|STARTED|Overall Study||4
4925357|NCT03295266|12116161|P1|STARTED|Overall Study||5
4925358|NCT03295201|12116191|P2|NOT COMPLETED|Overall Study||2
4925359|NCT03295201|12116192|P1|NOT COMPLETED|Overall Study||1
4925360|NCT03295201|12116191|P2|COMPLETED|Overall Study||9
4925361|NCT03295201|12116192|P1|COMPLETED|Overall Study||10
4925362|NCT03295201|12116191|P2|STARTED|Overall Study||11
4925363|NCT03295201|12116192|P1|STARTED|Overall Study||11
4925364|NCT03294681|12116244|P1|NOT COMPLETED|Overall Study||1
4925365|NCT03294681|12116244|P1|COMPLETED|Overall Study||152
4925366|NCT03294681|12116244|P1|STARTED|Overall Study||153
4925367|NCT03294629|12116250|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
4925368|NCT03294629|12116251|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
4925369|NCT03294629|12116250|P2|COMPLETED|Second Intervention (2 Weeks)||13
4925370|NCT03294629|12116251|P1|COMPLETED|Second Intervention (2 Weeks)||12
4925371|NCT03294629|12116250|P2|STARTED|Second Intervention (2 Weeks)||15
4925372|NCT03294629|12116251|P1|STARTED|Second Intervention (2 Weeks)||14
4925373|NCT03294629|12116250|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
4925374|NCT03294629|12116251|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
4925375|NCT03294629|12116250|P2|COMPLETED|First Intervention (2 Weeks)||15
4925376|NCT03294629|12116251|P1|COMPLETED|First Intervention (2 Weeks)||14
4925377|NCT03294629|12116250|P2|STARTED|First Intervention (2 Weeks)||19
4925378|NCT03294629|12116251|P1|STARTED|First Intervention (2 Weeks)||16
4925379|NCT03294538|12116282|P3|NOT COMPLETED|Overall Study||2
4925380|NCT03294538|12116283|P2|NOT COMPLETED|Overall Study||5
4925381|NCT03294538|12116284|P1|NOT COMPLETED|Overall Study||5
4925382|NCT03294538|12116282|P3|COMPLETED|Overall Study||131
4925383|NCT03294538|12116283|P2|COMPLETED|Overall Study||257
4925384|NCT03294538|12116284|P1|COMPLETED|Overall Study||263
4925385|NCT03294538|12116282|P3|PP Population|Overall Study||126
4925386|NCT03294538|12116283|P2|PP Population|Overall Study||227
4925387|NCT03294538|12116284|P1|PP Population|Overall Study||244
4925388|NCT03294538|12116282|P3|mITT Population|Overall Study||132
4925389|NCT03294538|12116283|P2|mITT Population|Overall Study||262
4925390|NCT03294538|12116284|P1|mITT Population|Overall Study||267
4925391|NCT03294538|12116282|P3|Safety Population|Overall Study||132
4925392|NCT03294538|12116283|P2|Safety Population|Overall Study||262
4925393|NCT03294538|12116284|P1|Safety Population|Overall Study||267
4925394|NCT03294538|12116282|P3|STARTED|Overall Study||133
4925395|NCT03294538|12116283|P2|STARTED|Overall Study||262
4925396|NCT03294538|12116284|P1|STARTED|Overall Study||268
4925397|NCT03293654|12116302|P3|NOT COMPLETED|Overall Study||0
4925398|NCT03293654|12116303|P2|NOT COMPLETED|Overall Study||1
4925399|NCT03293654|12116304|P1|NOT COMPLETED|Overall Study||0
4925400|NCT03293654|12116302|P3|COMPLETED|Overall Study||38
4925401|NCT03293654|12116303|P2|COMPLETED|Overall Study||37
4925402|NCT03293654|12116304|P1|COMPLETED|Overall Study||38
4925403|NCT03293654|12116302|P3|STARTED|Overall Study||38
4925404|NCT03293654|12116303|P2|STARTED|Overall Study||38
4925405|NCT03293654|12116304|P1|STARTED|Overall Study||38
4925406|NCT03293485|12116342|P1|NOT COMPLETED|Overall Study||5
4925407|NCT03293485|12116342|P1|COMPLETED|Overall Study||78
4925408|NCT03293485|12116342|P1|Treated|Overall Study||81
4925409|NCT03293485|12116342|P1|STARTED|Overall Study||83
4925410|NCT03293394|12116353|P2|NOT COMPLETED|Follow-up (6 Months)||2
4925411|NCT03293394|12116354|P1|NOT COMPLETED|Follow-up (6 Months)||4
4925412|NCT03293394|12116353|P2|COMPLETED|Follow-up (6 Months)||8
4925413|NCT03293394|12116354|P1|COMPLETED|Follow-up (6 Months)||16
4925414|NCT03293394|12116353|P2|STARTED|Follow-up (6 Months)||10
4925415|NCT03293394|12116354|P1|STARTED|Follow-up (6 Months)||20
4925416|NCT03293394|12116353|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
4925417|NCT03293394|12116354|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
4925418|NCT03293394|12116353|P2|COMPLETED|First Intervention (2 Weeks)||10
4925419|NCT03293394|12116354|P1|COMPLETED|First Intervention (2 Weeks)||20
4925420|NCT03293394|12116353|P2|STARTED|First Intervention (2 Weeks)||10
4925421|NCT03293394|12116354|P1|STARTED|First Intervention (2 Weeks)||20
4925422|NCT03293238|12116378|P4|NOT COMPLETED|Overall Study||0
4925423|NCT03293238|12116379|P3|NOT COMPLETED|Overall Study||0
4925424|NCT03293238|12116380|P2|NOT COMPLETED|Overall Study||0
4925425|NCT03293238|12116381|P1|NOT COMPLETED|Overall Study||0
4925426|NCT03293238|12116378|P4|COMPLETED|Overall Study||14
4925427|NCT03293238|12116379|P3|COMPLETED|Overall Study||14
4925428|NCT03293238|12116380|P2|COMPLETED|Overall Study||16
4925429|NCT03293238|12116381|P1|COMPLETED|Overall Study||19
4925430|NCT03293238|12116378|P4|STARTED|Overall Study||14
4925431|NCT03293238|12116379|P3|STARTED|Overall Study||14
4925432|NCT03293238|12116380|P2|STARTED|Overall Study||16
4925433|NCT03293238|12116381|P1|STARTED|Overall Study||19
4925434|NCT03292692|12116401|P2|NOT COMPLETED|Overall Study||38
4925435|NCT03292692|12116402|P1|NOT COMPLETED|Overall Study||38
4925436|NCT03292692|12116401|P2|COMPLETED|Overall Study||260
4925437|NCT03292692|12116402|P1|COMPLETED|Overall Study||264
4925438|NCT03292692|12116401|P2|STARTED|Overall Study||298
4925439|NCT03292692|12116402|P1|STARTED|Overall Study||302
4925440|NCT03292640|12116416|P2|NOT COMPLETED|Overall Study||42
4925441|NCT03292640|12116417|P1|NOT COMPLETED|Overall Study||61
4925442|NCT03292640|12116416|P2|COMPLETED|Overall Study||230
4925443|NCT03292640|12116417|P1|COMPLETED|Overall Study||214
4925444|NCT03292640|12116416|P2|STARTED|Overall Study||272
4925445|NCT03292640|12116417|P1|STARTED|Overall Study||275
4925446|NCT03292614|12116427|P1|NOT COMPLETED|Overall Study||0
4925447|NCT03292614|12116427|P1|COMPLETED|Overall Study||25
4925448|NCT03292614|12116427|P1|STARTED|Overall Study||25
4925449|NCT03292562|12116433|P2|NOT COMPLETED|Overall Study||1
4925450|NCT03292562|12116434|P1|NOT COMPLETED|Overall Study||6
4925451|NCT03292562|12116433|P2|COMPLETED|Overall Study||30
4925452|NCT03292562|12116434|P1|COMPLETED|Overall Study||29
4925453|NCT03292562|12116433|P2|STARTED|Overall Study||31
4925454|NCT03292562|12116434|P1|STARTED|Overall Study||35
4925455|NCT03291613|12116454|P1|NOT COMPLETED|Overall Study||1
4925456|NCT03291613|12116454|P1|COMPLETED|Overall Study||12
4925457|NCT03291613|12116454|P1|STARTED|Overall Study||13
4925458|NCT03291288|12116458|P2|NOT COMPLETED|Pexidartinib Only||25
4925459|NCT03291288|12116459|P1|NOT COMPLETED|Pexidartinib Only||0
4925460|NCT03291288|12116458|P2|COMPLETED|Pexidartinib Only||0
4925461|NCT03291288|12116459|P1|COMPLETED|Pexidartinib Only||0
4925462|NCT03291288|12116458|P2|STARTED|Pexidartinib Only|1 participant completed Part 1 but did not enter Part 2.|25
4925463|NCT03291288|12116459|P1|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
4925464|NCT03291288|12116458|P2|NOT COMPLETED|Drug-drug Interaction Phase||0
4925465|NCT03291288|12116459|P1|NOT COMPLETED|Drug-drug Interaction Phase||7
4925466|NCT03291288|12116458|P2|COMPLETED|Drug-drug Interaction Phase||0
4925467|NCT03291288|12116459|P1|COMPLETED|Drug-drug Interaction Phase||25
4925468|NCT03291288|12116458|P2|Ongoing|Drug-drug Interaction Phase||0
4925469|NCT03291288|12116459|P1|Ongoing|Drug-drug Interaction Phase||1
4925470|NCT03291288|12116458|P2|STARTED|Drug-drug Interaction Phase||0
4925471|NCT03291288|12116459|P1|STARTED|Drug-drug Interaction Phase||32
4925472|NCT03291197|12116501|P1|NOT COMPLETED|Overall Study||0
4925473|NCT03291197|12116501|P1|COMPLETED|Overall Study||5
4925474|NCT03291197|12116501|P1|STARTED|Overall Study||5
4925475|NCT03290768|12116509|P1|NOT COMPLETED|Overall Study||165
4925476|NCT03290768|12116509|P1|COMPLETED|Overall Study||193
4925477|NCT03290768|12116509|P1|STARTED|Overall Study||358
4925478|NCT03290378|12116523|P3|NOT COMPLETED|Overall Study||16
4925479|NCT03290378|12116524|P2|NOT COMPLETED|Overall Study||10
4925480|NCT03290378|12116525|P1|NOT COMPLETED|Overall Study||3
4925481|NCT03290378|12116523|P3|COMPLETED|Overall Study||120
4925482|NCT03290378|12116524|P2|COMPLETED|Overall Study||123
4925483|NCT03290378|12116525|P1|COMPLETED|Overall Study||137
4925484|NCT03290378|12116523|P3|STARTED|Overall Study||136
4925485|NCT03290378|12116524|P2|STARTED|Overall Study||133
4925486|NCT03290378|12116525|P1|STARTED|Overall Study||140
4925487|NCT03290300|12116533|P1|NOT COMPLETED|Overall Study||3
4925488|NCT03290300|12116533|P1|COMPLETED|Overall Study||36
4925489|NCT03290300|12116533|P1|STARTED|Overall Study||39
4925490|NCT03290027|12116544|P2|NOT COMPLETED|Overall Study||45
4925491|NCT03290027|12116545|P1|NOT COMPLETED|Overall Study||58
4925492|NCT03290027|12116544|P2|COMPLETED|Overall Study||228
4925493|NCT03290027|12116545|P1|COMPLETED|Overall Study||219
4925494|NCT03290027|12116544|P2|STARTED|Overall Study||273
4925495|NCT03290027|12116545|P1|STARTED|Overall Study||277
4925496|NCT03289858|12116557|P2|NOT COMPLETED|Overall Study||0
4925497|NCT03289858|12116558|P1|NOT COMPLETED|Overall Study||2
4925498|NCT03289858|12116557|P2|COMPLETED|Overall Study||28
4925499|NCT03289858|12116558|P1|COMPLETED|Overall Study||25
4925500|NCT03289858|12116557|P2|STARTED|Overall Study||28
4925501|NCT03289858|12116558|P1|STARTED|Overall Study||27
4925502|NCT03289676|12116566|P2|NOT COMPLETED|Overall Study||1
4925503|NCT03289676|12116567|P1|NOT COMPLETED|Overall Study||4
4925504|NCT03289676|12116566|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
4925505|NCT03289676|12116567|P1|COMPLETED|Overall Study||23
4925506|NCT03289676|12116566|P2|STARTED|Overall Study||26
4925507|NCT03289676|12116567|P1|STARTED|Overall Study||27
4925508|NCT03289481|12116579|P2|NOT COMPLETED|Overall Study||2
4925509|NCT03289481|12116580|P1|NOT COMPLETED|Overall Study||2
4925510|NCT03289481|12116579|P2|COMPLETED|Overall Study||5
4925511|NCT03289481|12116580|P1|COMPLETED|Overall Study||4
4925512|NCT03289481|12116579|P2|STARTED|Overall Study||7
4925513|NCT03289481|12116580|P1|STARTED|Overall Study||6
4925514|NCT03289234|12116595|P3|NOT COMPLETED|Overall Study||0
4925515|NCT03289234|12116596|P2|NOT COMPLETED|Overall Study||0
4925516|NCT03289234|12116597|P1|NOT COMPLETED|Overall Study||0
4925517|NCT03289234|12116595|P3|COMPLETED|Overall Study||8
4925518|NCT03289234|12116596|P2|COMPLETED|Overall Study||6
4925519|NCT03289234|12116597|P1|COMPLETED|Overall Study||8
4925520|NCT03289234|12116595|P3|STARTED|Overall Study||8
4925521|NCT03289234|12116596|P2|STARTED|Overall Study||6
4925522|NCT03289234|12116597|P1|STARTED|Overall Study||8
4925523|NCT03289208|12116617|P3|NOT COMPLETED|Overall Study||0
4925524|NCT03289208|12116618|P2|NOT COMPLETED|Overall Study||0
4925525|NCT03289208|12116619|P1|NOT COMPLETED|Overall Study||1
4925526|NCT03289208|12116617|P3|COMPLETED|Overall Study||11
4925527|NCT03289208|12116618|P2|COMPLETED|Overall Study||8
4925528|NCT03289208|12116619|P1|COMPLETED|Overall Study||10
4925529|NCT03289208|12116617|P3|STARTED|Overall Study||11
4925530|NCT03289208|12116618|P2|STARTED|Overall Study||8
4925531|NCT03289208|12116619|P1|STARTED|Overall Study||11
4925532|NCT03288779|12116636|P1|NOT COMPLETED|Overall Study||3
4925533|NCT03288779|12116636|P1|COMPLETED|Overall Study||3
4925534|NCT03288779|12116636|P1|STARTED|Overall Study||6
4925535|NCT03287843|12116643|P2|NOT COMPLETED|Overall Study||8
4925536|NCT03287843|12116644|P1|NOT COMPLETED|Overall Study||15
4925537|NCT03287843|12116643|P2|COMPLETED|Overall Study||167
4925538|NCT03287843|12116644|P1|COMPLETED|Overall Study||160
4925539|NCT03287843|12116643|P2|Lost to Follow up|Overall Study||0
4925540|NCT03287843|12116644|P1|Lost to Follow up|Overall Study||3
4925541|NCT03287843|12116643|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
4925542|NCT03287843|12116644|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
4925543|NCT03287843|12116643|P2|STARTED|Overall Study||175
4925544|NCT03287843|12116644|P1|STARTED|Overall Study||175
4925545|NCT03287791|12116659|P3|NOT COMPLETED|Overall Study||36
4925546|NCT03287791|12116660|P2|NOT COMPLETED|Overall Study||36
4925547|NCT03287791|12116661|P1|NOT COMPLETED|Overall Study||32
4925548|NCT03287791|12116659|P3|COMPLETED|Overall Study||264
4925549|NCT03287791|12116660|P2|COMPLETED|Overall Study||276
4925550|NCT03287791|12116661|P1|COMPLETED|Overall Study||280
4925551|NCT03287791|12116659|P3|PP Population|Overall Study||245
4925552|NCT03287791|12116660|P2|PP Population|Overall Study||259
4925553|NCT03287791|12116661|P1|PP Population|Overall Study||262
4925554|NCT03287791|12116659|P3|mITT Population|Overall Study||283
4925555|NCT03287791|12116660|P2|mITT Population|Overall Study||291
4925556|NCT03287791|12116661|P1|mITT Population|Overall Study||291
4925557|NCT03287791|12116659|P3|Safety Population|Overall Study||291
4925558|NCT03287791|12116660|P2|Safety Population|Overall Study||297
4925559|NCT03287791|12116661|P1|Safety Population|Overall Study||306
4925560|NCT03287791|12116659|P3|STARTED|Overall Study||300
4925561|NCT03287791|12116660|P2|STARTED|Overall Study||312
4925562|NCT03287791|12116661|P1|STARTED|Overall Study||312
4925563|NCT03287089|12116674|P2|NOT COMPLETED|Overall Study||6
4925564|NCT03287089|12116675|P1|NOT COMPLETED|Overall Study||0
4925565|NCT03287089|12116674|P2|COMPLETED|Overall Study||76
4925566|NCT03287089|12116675|P1|COMPLETED|Overall Study||82
4925567|NCT03287089|12116674|P2|STARTED|Overall Study||82
4925568|NCT03287089|12116675|P1|STARTED|Overall Study||82
4925569|NCT03286829|12116689|P4|NOT COMPLETED|Overall Study||0
4925570|NCT03286829|12116690|P3|NOT COMPLETED|Overall Study||0
4925571|NCT03286829|12116691|P2|NOT COMPLETED|Overall Study||0
4925572|NCT03286829|12116692|P1|NOT COMPLETED|Overall Study||0
4925573|NCT03286829|12116689|P4|COMPLETED|Overall Study||15
4925574|NCT03286829|12116690|P3|COMPLETED|Overall Study||15
4925575|NCT03286829|12116691|P2|COMPLETED|Overall Study||15
4925576|NCT03286829|12116692|P1|COMPLETED|Overall Study||15
4925577|NCT03286829|12116689|P4|STARTED|Overall Study||15
4925578|NCT03286829|12116690|P3|STARTED|Overall Study||15
4925579|NCT03286829|12116691|P2|STARTED|Overall Study||15
4925580|NCT03286829|12116692|P1|STARTED|Overall Study||15
4925581|NCT03286751|12116710|P6|NOT COMPLETED|Period 6||0
4925582|NCT03286751|12116711|P5|NOT COMPLETED|Period 6||0
4925583|NCT03286751|12116712|P4|NOT COMPLETED|Period 6||0
4925584|NCT03286751|12116713|P3|NOT COMPLETED|Period 6||0
4925585|NCT03286751|12116714|P2|NOT COMPLETED|Period 6||0
4925586|NCT03286751|12116715|P1|NOT COMPLETED|Period 6||0
4925587|NCT03286751|12116710|P6|COMPLETED|Period 6||7
4925588|NCT03286751|12116711|P5|COMPLETED|Period 6||5
4925589|NCT03286751|12116712|P4|COMPLETED|Period 6||7
4925590|NCT03286751|12116713|P3|COMPLETED|Period 6||7
4925591|NCT03286751|12116714|P2|COMPLETED|Period 6||6
4925592|NCT03286751|12116715|P1|COMPLETED|Period 6||7
4925593|NCT03286751|12116710|P6|STARTED|Period 6||7
4925594|NCT03286751|12116711|P5|STARTED|Period 6||5
4925595|NCT03286751|12116712|P4|STARTED|Period 6||7
4925596|NCT03286751|12116713|P3|STARTED|Period 6||7
4925597|NCT03286751|12116714|P2|STARTED|Period 6||6
4925598|NCT03286751|12116715|P1|STARTED|Period 6||7
4925599|NCT03286751|12116710|P6|NOT COMPLETED|Washout Period 5||0
4925600|NCT03286751|12116711|P5|NOT COMPLETED|Washout Period 5||1
4925601|NCT03286751|12116712|P4|NOT COMPLETED|Washout Period 5||0
4925602|NCT03286751|12116713|P3|NOT COMPLETED|Washout Period 5||0
4925603|NCT03286751|12116714|P2|NOT COMPLETED|Washout Period 5||0
4925604|NCT03286751|12116715|P1|NOT COMPLETED|Washout Period 5||0
4925605|NCT03286751|12116710|P6|COMPLETED|Washout Period 5||7
4925606|NCT03286751|12116711|P5|COMPLETED|Washout Period 5||5
4925607|NCT03286751|12116712|P4|COMPLETED|Washout Period 5||7
4925608|NCT03286751|12116713|P3|COMPLETED|Washout Period 5||7
4925609|NCT03286751|12116714|P2|COMPLETED|Washout Period 5||6
4925610|NCT03286751|12116715|P1|COMPLETED|Washout Period 5||7
4925611|NCT03286751|12116710|P6|STARTED|Washout Period 5||7
4925612|NCT03286751|12116711|P5|STARTED|Washout Period 5||6
4925613|NCT03286751|12116712|P4|STARTED|Washout Period 5||7
4925614|NCT03286751|12116713|P3|STARTED|Washout Period 5||7
4925615|NCT03286751|12116714|P2|STARTED|Washout Period 5||6
4925616|NCT03286751|12116715|P1|STARTED|Washout Period 5||7
4925617|NCT03286751|12116710|P6|NOT COMPLETED|Period 5||0
4925618|NCT03286751|12116711|P5|NOT COMPLETED|Period 5||0
4925619|NCT03286751|12116712|P4|NOT COMPLETED|Period 5||0
4925620|NCT03286751|12116713|P3|NOT COMPLETED|Period 5||0
4925621|NCT03286751|12116714|P2|NOT COMPLETED|Period 5||0
4925622|NCT03286751|12116715|P1|NOT COMPLETED|Period 5||0
4925623|NCT03286751|12116710|P6|COMPLETED|Period 5||7
4925624|NCT03286751|12116711|P5|COMPLETED|Period 5||6
4925625|NCT03286751|12116712|P4|COMPLETED|Period 5||7
4925626|NCT03286751|12116713|P3|COMPLETED|Period 5||7
4925627|NCT03286751|12116714|P2|COMPLETED|Period 5||6
4925628|NCT03286751|12116715|P1|COMPLETED|Period 5||7
4925629|NCT03286751|12116710|P6|STARTED|Period 5||7
4925630|NCT03286751|12116711|P5|STARTED|Period 5||6
4925631|NCT03286751|12116712|P4|STARTED|Period 5||7
4925632|NCT03286751|12116713|P3|STARTED|Period 5||7
4925633|NCT03286751|12116714|P2|STARTED|Period 5||6
4925634|NCT03286751|12116715|P1|STARTED|Period 5||7
4925635|NCT03286751|12116710|P6|NOT COMPLETED|Washout Period 4||0
4925636|NCT03286751|12116711|P5|NOT COMPLETED|Washout Period 4||0
4925637|NCT03286751|12116712|P4|NOT COMPLETED|Washout Period 4||0
4925638|NCT03286751|12116713|P3|NOT COMPLETED|Washout Period 4||0
4925639|NCT03286751|12116714|P2|NOT COMPLETED|Washout Period 4||0
4925640|NCT03286751|12116715|P1|NOT COMPLETED|Washout Period 4||0
4925641|NCT03286751|12116710|P6|COMPLETED|Washout Period 4||7
4925642|NCT03286751|12116711|P5|COMPLETED|Washout Period 4||6
4925643|NCT03286751|12116712|P4|COMPLETED|Washout Period 4||7
4925644|NCT03286751|12116713|P3|COMPLETED|Washout Period 4||7
4925645|NCT03286751|12116714|P2|COMPLETED|Washout Period 4||6
4925646|NCT03286751|12116715|P1|COMPLETED|Washout Period 4||7
4925647|NCT03286751|12116710|P6|STARTED|Washout Period 4||7
4925648|NCT03286751|12116711|P5|STARTED|Washout Period 4||6
4925649|NCT03286751|12116712|P4|STARTED|Washout Period 4||7
4925650|NCT03286751|12116713|P3|STARTED|Washout Period 4||7
4925651|NCT03286751|12116714|P2|STARTED|Washout Period 4||6
4925652|NCT03286751|12116715|P1|STARTED|Washout Period 4||7
4925653|NCT03286751|12116710|P6|NOT COMPLETED|Period 4||0
4925654|NCT03286751|12116711|P5|NOT COMPLETED|Period 4||0
4925655|NCT03286751|12116712|P4|NOT COMPLETED|Period 4||0
4925656|NCT03286751|12116713|P3|NOT COMPLETED|Period 4||0
4925657|NCT03286751|12116714|P2|NOT COMPLETED|Period 4||0
4925658|NCT03286751|12116715|P1|NOT COMPLETED|Period 4||0
4925659|NCT03286751|12116710|P6|COMPLETED|Period 4||7
4925660|NCT03286751|12116711|P5|COMPLETED|Period 4||6
4925661|NCT03286751|12116712|P4|COMPLETED|Period 4||7
4925662|NCT03286751|12116713|P3|COMPLETED|Period 4||7
4925663|NCT03286751|12116714|P2|COMPLETED|Period 4||6
4925664|NCT03286751|12116715|P1|COMPLETED|Period 4||7
4925665|NCT03286751|12116710|P6|STARTED|Period 4||7
4925666|NCT03286751|12116711|P5|STARTED|Period 4||6
4925667|NCT03286751|12116712|P4|STARTED|Period 4||7
4925668|NCT03286751|12116713|P3|STARTED|Period 4||7
4925669|NCT03286751|12116714|P2|STARTED|Period 4||6
4925670|NCT03286751|12116715|P1|STARTED|Period 4||7
4925671|NCT03286751|12116710|P6|NOT COMPLETED|Washout Period 3||0
4925672|NCT03286751|12116711|P5|NOT COMPLETED|Washout Period 3||0
4925673|NCT03286751|12116712|P4|NOT COMPLETED|Washout Period 3||0
4925674|NCT03286751|12116713|P3|NOT COMPLETED|Washout Period 3||0
4925675|NCT03286751|12116714|P2|NOT COMPLETED|Washout Period 3||0
4925676|NCT03286751|12116715|P1|NOT COMPLETED|Washout Period 3||0
4925677|NCT03286751|12116710|P6|COMPLETED|Washout Period 3||7
4925678|NCT03286751|12116711|P5|COMPLETED|Washout Period 3||6
4925679|NCT03286751|12116712|P4|COMPLETED|Washout Period 3||7
4925680|NCT03286751|12116713|P3|COMPLETED|Washout Period 3||7
4925681|NCT03286751|12116714|P2|COMPLETED|Washout Period 3||6
4925682|NCT03286751|12116715|P1|COMPLETED|Washout Period 3||7
4925683|NCT03286751|12116710|P6|STARTED|Washout Period 3||7
4925684|NCT03286751|12116711|P5|STARTED|Washout Period 3||6
4925685|NCT03286751|12116712|P4|STARTED|Washout Period 3||7
4925686|NCT03286751|12116713|P3|STARTED|Washout Period 3||7
4925687|NCT03286751|12116714|P2|STARTED|Washout Period 3||6
4925688|NCT03286751|12116715|P1|STARTED|Washout Period 3||7
4925689|NCT03286751|12116710|P6|NOT COMPLETED|Period 3||0
4925690|NCT03286751|12116711|P5|NOT COMPLETED|Period 3||0
4925691|NCT03286751|12116712|P4|NOT COMPLETED|Period 3||0
4925692|NCT03286751|12116713|P3|NOT COMPLETED|Period 3||0
4925693|NCT03286751|12116714|P2|NOT COMPLETED|Period 3||0
4925694|NCT03286751|12116715|P1|NOT COMPLETED|Period 3||0
4925695|NCT03286751|12116710|P6|COMPLETED|Period 3||7
4925696|NCT03286751|12116711|P5|COMPLETED|Period 3||6
4925697|NCT03286751|12116712|P4|COMPLETED|Period 3||7
4925698|NCT03286751|12116713|P3|COMPLETED|Period 3||7
4925699|NCT03286751|12116714|P2|COMPLETED|Period 3||6
4925700|NCT03286751|12116715|P1|COMPLETED|Period 3||7
4925701|NCT03286751|12116710|P6|STARTED|Period 3||7
4925702|NCT03286751|12116711|P5|STARTED|Period 3||6
4925703|NCT03286751|12116712|P4|STARTED|Period 3||7
4925704|NCT03286751|12116713|P3|STARTED|Period 3||7
4925705|NCT03286751|12116714|P2|STARTED|Period 3||6
4925706|NCT03286751|12116715|P1|STARTED|Period 3||7
4925707|NCT03286751|12116710|P6|NOT COMPLETED|Washout Period 2||0
4925708|NCT03286751|12116711|P5|NOT COMPLETED|Washout Period 2||0
4925709|NCT03286751|12116712|P4|NOT COMPLETED|Washout Period 2||0
4925710|NCT03286751|12116713|P3|NOT COMPLETED|Washout Period 2||0
4925711|NCT03286751|12116714|P2|NOT COMPLETED|Washout Period 2||1
4925712|NCT03286751|12116715|P1|NOT COMPLETED|Washout Period 2||0
4925713|NCT03286751|12116710|P6|COMPLETED|Washout Period 2||7
4925714|NCT03286751|12116711|P5|COMPLETED|Washout Period 2||6
4925715|NCT03286751|12116712|P4|COMPLETED|Washout Period 2||7
4925716|NCT03286751|12116713|P3|COMPLETED|Washout Period 2||7
4925717|NCT03286751|12116714|P2|COMPLETED|Washout Period 2||6
4925718|NCT03286751|12116715|P1|COMPLETED|Washout Period 2||7
4925719|NCT03286751|12116710|P6|STARTED|Washout Period 2||7
4925720|NCT03286751|12116711|P5|STARTED|Washout Period 2||6
4925721|NCT03286751|12116712|P4|STARTED|Washout Period 2||7
4925722|NCT03286751|12116713|P3|STARTED|Washout Period 2||7
4925723|NCT03286751|12116714|P2|STARTED|Washout Period 2||7
4925724|NCT03286751|12116715|P1|STARTED|Washout Period 2||7
4925725|NCT03286751|12116710|P6|NOT COMPLETED|Period 2||0
4925726|NCT03286751|12116711|P5|NOT COMPLETED|Period 2||0
4925727|NCT03286751|12116712|P4|NOT COMPLETED|Period 2||0
4925728|NCT03286751|12116713|P3|NOT COMPLETED|Period 2||0
4925729|NCT03286751|12116714|P2|NOT COMPLETED|Period 2||0
4925730|NCT03286751|12116715|P1|NOT COMPLETED|Period 2||0
4925731|NCT03286751|12116710|P6|COMPLETED|Period 2||7
4925732|NCT03286751|12116711|P5|COMPLETED|Period 2||6
4925733|NCT03286751|12116712|P4|COMPLETED|Period 2||7
4925734|NCT03286751|12116713|P3|COMPLETED|Period 2||7
4925735|NCT03286751|12116714|P2|COMPLETED|Period 2||7
4925736|NCT03286751|12116715|P1|COMPLETED|Period 2||7
4925737|NCT03286751|12116710|P6|STARTED|Period 2||7
4925738|NCT03286751|12116711|P5|STARTED|Period 2||6
4925739|NCT03286751|12116712|P4|STARTED|Period 2||7
4925740|NCT03286751|12116713|P3|STARTED|Period 2||7
4925741|NCT03286751|12116714|P2|STARTED|Period 2||7
4925742|NCT03286751|12116715|P1|STARTED|Period 2||7
4925743|NCT03286751|12116710|P6|NOT COMPLETED|Washout Period 1||0
4925744|NCT03286751|12116711|P5|NOT COMPLETED|Washout Period 1||1
4925745|NCT03286751|12116712|P4|NOT COMPLETED|Washout Period 1||0
4925746|NCT03286751|12116713|P3|NOT COMPLETED|Washout Period 1||0
4925747|NCT03286751|12116714|P2|NOT COMPLETED|Washout Period 1||0
4925748|NCT03286751|12116715|P1|NOT COMPLETED|Washout Period 1||0
4925749|NCT03286751|12116710|P6|COMPLETED|Washout Period 1||7
4925750|NCT03286751|12116711|P5|COMPLETED|Washout Period 1||6
4925751|NCT03286751|12116712|P4|COMPLETED|Washout Period 1||7
4925752|NCT03286751|12116713|P3|COMPLETED|Washout Period 1||7
4925753|NCT03286751|12116714|P2|COMPLETED|Washout Period 1||7
4925754|NCT03286751|12116715|P1|COMPLETED|Washout Period 1||7
4925755|NCT03286751|12116710|P6|STARTED|Washout Period 1||7
4925756|NCT03286751|12116711|P5|STARTED|Washout Period 1||7
4925757|NCT03286751|12116712|P4|STARTED|Washout Period 1||7
4925758|NCT03286751|12116713|P3|STARTED|Washout Period 1||7
4925759|NCT03286751|12116714|P2|STARTED|Washout Period 1||7
4925760|NCT03286751|12116715|P1|STARTED|Washout Period 1||7
4925761|NCT03286751|12116710|P6|NOT COMPLETED|Period 1||0
4925762|NCT03286751|12116711|P5|NOT COMPLETED|Period 1||0
4925763|NCT03286751|12116712|P4|NOT COMPLETED|Period 1||0
4925764|NCT03286751|12116713|P3|NOT COMPLETED|Period 1||0
4925765|NCT03286751|12116714|P2|NOT COMPLETED|Period 1||0
4925766|NCT03286751|12116715|P1|NOT COMPLETED|Period 1||0
4925767|NCT03286751|12116710|P6|COMPLETED|Period 1||7
4925768|NCT03286751|12116711|P5|COMPLETED|Period 1||7
4925769|NCT03286751|12116712|P4|COMPLETED|Period 1||7
4925770|NCT03286751|12116713|P3|COMPLETED|Period 1||7
4925771|NCT03286751|12116714|P2|COMPLETED|Period 1||7
4925772|NCT03286751|12116715|P1|COMPLETED|Period 1||7
4925773|NCT03286751|12116710|P6|Received at Least One Dose of Study Drug|Period 1||7
4925774|NCT03286751|12116711|P5|Received at Least One Dose of Study Drug|Period 1||7
4925775|NCT03286751|12116712|P4|Received at Least One Dose of Study Drug|Period 1||7
4925776|NCT03286751|12116713|P3|Received at Least One Dose of Study Drug|Period 1||7
4925777|NCT03286751|12116714|P2|Received at Least One Dose of Study Drug|Period 1||7
4925778|NCT03286751|12116715|P1|Received at Least One Dose of Study Drug|Period 1||7
4925779|NCT03286751|12116710|P6|STARTED|Period 1||7
4925780|NCT03286751|12116711|P5|STARTED|Period 1||7
4925781|NCT03286751|12116712|P4|STARTED|Period 1||7
4925782|NCT03286751|12116713|P3|STARTED|Period 1||7
4925783|NCT03286751|12116714|P2|STARTED|Period 1||7
4925784|NCT03286751|12116715|P1|STARTED|Period 1||7
4925785|NCT03286283|12116735|P1|NOT COMPLETED|Overall Study||0
4925786|NCT03286283|12116735|P1|COMPLETED|Overall Study||55
4925787|NCT03286283|12116735|P1|STARTED|Overall Study||55
4925788|NCT03286218|12116751|P12|NOT COMPLETED|Treatment Phase Period 5||0
4925789|NCT03286218|12116752|P11|NOT COMPLETED|Treatment Phase Period 5||0
4925790|NCT03286218|12116753|P10|NOT COMPLETED|Treatment Phase Period 5||0
4925791|NCT03286218|12116754|P9|NOT COMPLETED|Treatment Phase Period 5||0
4925792|NCT03286218|12116755|P8|NOT COMPLETED|Treatment Phase Period 5||0
4925793|NCT03286218|12116756|P7|NOT COMPLETED|Treatment Phase Period 5||0
4925794|NCT03286218|12116757|P6|NOT COMPLETED|Treatment Phase Period 5||0
4925795|NCT03286218|12116758|P5|NOT COMPLETED|Treatment Phase Period 5||0
4925796|NCT03286218|12116759|P4|NOT COMPLETED|Treatment Phase Period 5||0
4925797|NCT03286218|12116760|P3|NOT COMPLETED|Treatment Phase Period 5||0
4925798|NCT03286218|12116761|P2|NOT COMPLETED|Treatment Phase Period 5||0
4925799|NCT03286218|12116762|P1|NOT COMPLETED|Treatment Phase Period 5||0
4925800|NCT03286218|12116751|P12|COMPLETED|Treatment Phase Period 5||4
4925801|NCT03286218|12116752|P11|COMPLETED|Treatment Phase Period 5||5
4925802|NCT03286218|12116753|P10|COMPLETED|Treatment Phase Period 5||6
4925803|NCT03286218|12116754|P9|COMPLETED|Treatment Phase Period 5||6
4925804|NCT03286218|12116755|P8|COMPLETED|Treatment Phase Period 5||6
4925805|NCT03286218|12116756|P7|COMPLETED|Treatment Phase Period 5||6
4925806|NCT03286218|12116757|P6|COMPLETED|Treatment Phase Period 5||5
4925807|NCT03286218|12116758|P5|COMPLETED|Treatment Phase Period 5||5
4925808|NCT03286218|12116759|P4|COMPLETED|Treatment Phase Period 5||5
4925809|NCT03286218|12116760|P3|COMPLETED|Treatment Phase Period 5||5
4925810|NCT03286218|12116761|P2|COMPLETED|Treatment Phase Period 5||0
4925811|NCT03286218|12116762|P1|COMPLETED|Treatment Phase Period 5||0
4925812|NCT03286218|12116751|P12|STARTED|Treatment Phase Period 5||4
4925813|NCT03286218|12116752|P11|STARTED|Treatment Phase Period 5||5
4925814|NCT03286218|12116753|P10|STARTED|Treatment Phase Period 5||6
4925815|NCT03286218|12116754|P9|STARTED|Treatment Phase Period 5||6
4925816|NCT03286218|12116755|P8|STARTED|Treatment Phase Period 5||6
4925817|NCT03286218|12116756|P7|STARTED|Treatment Phase Period 5||6
4925818|NCT03286218|12116757|P6|STARTED|Treatment Phase Period 5||5
4925819|NCT03286218|12116758|P5|STARTED|Treatment Phase Period 5||5
4925820|NCT03286218|12116759|P4|STARTED|Treatment Phase Period 5||5
4925821|NCT03286218|12116760|P3|STARTED|Treatment Phase Period 5||5
4925822|NCT03286218|12116761|P2|STARTED|Treatment Phase Period 5||0
4925823|NCT03286218|12116762|P1|STARTED|Treatment Phase Period 5||0
4925824|NCT03286218|12116751|P12|NOT COMPLETED|Treatment Phase Period 4||1
4925825|NCT03286218|12116752|P11|NOT COMPLETED|Treatment Phase Period 4||0
4925826|NCT03286218|12116753|P10|NOT COMPLETED|Treatment Phase Period 4||0
4925827|NCT03286218|12116754|P9|NOT COMPLETED|Treatment Phase Period 4||0
4925828|NCT03286218|12116755|P8|NOT COMPLETED|Treatment Phase Period 4||0
4925829|NCT03286218|12116756|P7|NOT COMPLETED|Treatment Phase Period 4||0
4925830|NCT03286218|12116757|P6|NOT COMPLETED|Treatment Phase Period 4||0
4925831|NCT03286218|12116758|P5|NOT COMPLETED|Treatment Phase Period 4||0
4925832|NCT03286218|12116759|P4|NOT COMPLETED|Treatment Phase Period 4||0
4925833|NCT03286218|12116760|P3|NOT COMPLETED|Treatment Phase Period 4||0
4925834|NCT03286218|12116761|P2|NOT COMPLETED|Treatment Phase Period 4||0
4925835|NCT03286218|12116762|P1|NOT COMPLETED|Treatment Phase Period 4||0
4925836|NCT03286218|12116751|P12|COMPLETED|Treatment Phase Period 4||4
4925837|NCT03286218|12116752|P11|COMPLETED|Treatment Phase Period 4||5
4925838|NCT03286218|12116753|P10|COMPLETED|Treatment Phase Period 4||6
4925839|NCT03286218|12116754|P9|COMPLETED|Treatment Phase Period 4||6
4925840|NCT03286218|12116755|P8|COMPLETED|Treatment Phase Period 4||6
4925841|NCT03286218|12116756|P7|COMPLETED|Treatment Phase Period 4||6
4925842|NCT03286218|12116757|P6|COMPLETED|Treatment Phase Period 4||5
4925843|NCT03286218|12116758|P5|COMPLETED|Treatment Phase Period 4||5
4925844|NCT03286218|12116759|P4|COMPLETED|Treatment Phase Period 4||5
4925845|NCT03286218|12116760|P3|COMPLETED|Treatment Phase Period 4||5
4925846|NCT03286218|12116761|P2|COMPLETED|Treatment Phase Period 4||0
4925847|NCT03286218|12116762|P1|COMPLETED|Treatment Phase Period 4||0
4925848|NCT03286218|12116751|P12|STARTED|Treatment Phase Period 4||5
4925849|NCT03286218|12116752|P11|STARTED|Treatment Phase Period 4||5
4925850|NCT03286218|12116753|P10|STARTED|Treatment Phase Period 4||6
4925851|NCT03286218|12116754|P9|STARTED|Treatment Phase Period 4||6
4925852|NCT03286218|12116755|P8|STARTED|Treatment Phase Period 4||6
4925853|NCT03286218|12116756|P7|STARTED|Treatment Phase Period 4||6
4925854|NCT03286218|12116757|P6|STARTED|Treatment Phase Period 4||5
4925855|NCT03286218|12116758|P5|STARTED|Treatment Phase Period 4||5
4925856|NCT03286218|12116759|P4|STARTED|Treatment Phase Period 4||5
4925857|NCT03286218|12116760|P3|STARTED|Treatment Phase Period 4||5
4925858|NCT03286218|12116761|P2|STARTED|Treatment Phase Period 4||0
4925859|NCT03286218|12116762|P1|STARTED|Treatment Phase Period 4||0
4925860|NCT03286218|12116751|P12|NOT COMPLETED|Treatment Phase Period 3||0
4925861|NCT03286218|12116752|P11|NOT COMPLETED|Treatment Phase Period 3||0
4925862|NCT03286218|12116753|P10|NOT COMPLETED|Treatment Phase Period 3||0
4925863|NCT03286218|12116754|P9|NOT COMPLETED|Treatment Phase Period 3||0
4925864|NCT03286218|12116755|P8|NOT COMPLETED|Treatment Phase Period 3||0
4925865|NCT03286218|12116756|P7|NOT COMPLETED|Treatment Phase Period 3||0
4925866|NCT03286218|12116757|P6|NOT COMPLETED|Treatment Phase Period 3||0
4925867|NCT03286218|12116758|P5|NOT COMPLETED|Treatment Phase Period 3||0
4925868|NCT03286218|12116759|P4|NOT COMPLETED|Treatment Phase Period 3||0
4925869|NCT03286218|12116760|P3|NOT COMPLETED|Treatment Phase Period 3||0
4925870|NCT03286218|12116761|P2|NOT COMPLETED|Treatment Phase Period 3||0
4925871|NCT03286218|12116762|P1|NOT COMPLETED|Treatment Phase Period 3||0
4925872|NCT03286218|12116751|P12|COMPLETED|Treatment Phase Period 3||5
4925873|NCT03286218|12116752|P11|COMPLETED|Treatment Phase Period 3||5
4925874|NCT03286218|12116753|P10|COMPLETED|Treatment Phase Period 3||6
4925875|NCT03286218|12116754|P9|COMPLETED|Treatment Phase Period 3||6
4925876|NCT03286218|12116755|P8|COMPLETED|Treatment Phase Period 3||6
4925877|NCT03286218|12116756|P7|COMPLETED|Treatment Phase Period 3||6
4925878|NCT03286218|12116757|P6|COMPLETED|Treatment Phase Period 3||5
4925879|NCT03286218|12116758|P5|COMPLETED|Treatment Phase Period 3||5
4925880|NCT03286218|12116759|P4|COMPLETED|Treatment Phase Period 3||5
4925881|NCT03286218|12116760|P3|COMPLETED|Treatment Phase Period 3||5
4925882|NCT03286218|12116761|P2|COMPLETED|Treatment Phase Period 3||0
4925883|NCT03286218|12116762|P1|COMPLETED|Treatment Phase Period 3||0
4925884|NCT03286218|12116751|P12|STARTED|Treatment Phase Period 3||5
4925885|NCT03286218|12116752|P11|STARTED|Treatment Phase Period 3||5
4925886|NCT03286218|12116753|P10|STARTED|Treatment Phase Period 3||6
4925887|NCT03286218|12116754|P9|STARTED|Treatment Phase Period 3||6
4925888|NCT03286218|12116755|P8|STARTED|Treatment Phase Period 3||6
4925889|NCT03286218|12116756|P7|STARTED|Treatment Phase Period 3||6
4925890|NCT03286218|12116757|P6|STARTED|Treatment Phase Period 3||5
4925891|NCT03286218|12116758|P5|STARTED|Treatment Phase Period 3||5
4925892|NCT03286218|12116759|P4|STARTED|Treatment Phase Period 3||5
4925893|NCT03286218|12116760|P3|STARTED|Treatment Phase Period 3||5
4925894|NCT03286218|12116761|P2|STARTED|Treatment Phase Period 3||0
4925895|NCT03286218|12116762|P1|STARTED|Treatment Phase Period 3||0
4925896|NCT03286218|12116751|P12|NOT COMPLETED|Treatment Phase Period 2||0
4925897|NCT03286218|12116752|P11|NOT COMPLETED|Treatment Phase Period 2||0
4925898|NCT03286218|12116753|P10|NOT COMPLETED|Treatment Phase Period 2||0
4925899|NCT03286218|12116754|P9|NOT COMPLETED|Treatment Phase Period 2||0
4925900|NCT03286218|12116755|P8|NOT COMPLETED|Treatment Phase Period 2||0
4925901|NCT03286218|12116756|P7|NOT COMPLETED|Treatment Phase Period 2||0
4925902|NCT03286218|12116757|P6|NOT COMPLETED|Treatment Phase Period 2||0
4925903|NCT03286218|12116758|P5|NOT COMPLETED|Treatment Phase Period 2||0
4925904|NCT03286218|12116759|P4|NOT COMPLETED|Treatment Phase Period 2||0
4925905|NCT03286218|12116760|P3|NOT COMPLETED|Treatment Phase Period 2||0
4925906|NCT03286218|12116761|P2|NOT COMPLETED|Treatment Phase Period 2||0
4925907|NCT03286218|12116762|P1|NOT COMPLETED|Treatment Phase Period 2||0
4925908|NCT03286218|12116751|P12|COMPLETED|Treatment Phase Period 2||5
4925909|NCT03286218|12116752|P11|COMPLETED|Treatment Phase Period 2||5
4925910|NCT03286218|12116753|P10|COMPLETED|Treatment Phase Period 2||6
4925911|NCT03286218|12116754|P9|COMPLETED|Treatment Phase Period 2||6
4925912|NCT03286218|12116755|P8|COMPLETED|Treatment Phase Period 2||6
4925913|NCT03286218|12116756|P7|COMPLETED|Treatment Phase Period 2||6
4925914|NCT03286218|12116757|P6|COMPLETED|Treatment Phase Period 2||5
4925915|NCT03286218|12116758|P5|COMPLETED|Treatment Phase Period 2||5
4925916|NCT03286218|12116759|P4|COMPLETED|Treatment Phase Period 2||5
4925917|NCT03286218|12116760|P3|COMPLETED|Treatment Phase Period 2||5
4925918|NCT03286218|12116761|P2|COMPLETED|Treatment Phase Period 2||0
4925919|NCT03286218|12116762|P1|COMPLETED|Treatment Phase Period 2||0
4925920|NCT03286218|12116751|P12|STARTED|Treatment Phase Period 2||5
4925921|NCT03286218|12116752|P11|STARTED|Treatment Phase Period 2||5
4925922|NCT03286218|12116753|P10|STARTED|Treatment Phase Period 2||6
4925923|NCT03286218|12116754|P9|STARTED|Treatment Phase Period 2||6
4925924|NCT03286218|12116755|P8|STARTED|Treatment Phase Period 2||6
4925925|NCT03286218|12116756|P7|STARTED|Treatment Phase Period 2||6
4925926|NCT03286218|12116757|P6|STARTED|Treatment Phase Period 2||5
4925927|NCT03286218|12116758|P5|STARTED|Treatment Phase Period 2||5
4925928|NCT03286218|12116759|P4|STARTED|Treatment Phase Period 2||5
4925929|NCT03286218|12116760|P3|STARTED|Treatment Phase Period 2||5
4925930|NCT03286218|12116761|P2|STARTED|Treatment Phase Period 2||0
4925931|NCT03286218|12116762|P1|STARTED|Treatment Phase Period 2||0
4925932|NCT03286218|12116751|P12|NOT COMPLETED|Treatment Phase Period 1||1
4925933|NCT03286218|12116752|P11|NOT COMPLETED|Treatment Phase Period 1||0
4925934|NCT03286218|12116753|P10|NOT COMPLETED|Treatment Phase Period 1||0
4925935|NCT03286218|12116754|P9|NOT COMPLETED|Treatment Phase Period 1||0
4925936|NCT03286218|12116755|P8|NOT COMPLETED|Treatment Phase Period 1||0
4925937|NCT03286218|12116756|P7|NOT COMPLETED|Treatment Phase Period 1||0
4925938|NCT03286218|12116757|P6|NOT COMPLETED|Treatment Phase Period 1||1
4925939|NCT03286218|12116758|P5|NOT COMPLETED|Treatment Phase Period 1||0
4925940|NCT03286218|12116759|P4|NOT COMPLETED|Treatment Phase Period 1||1
4925941|NCT03286218|12116760|P3|NOT COMPLETED|Treatment Phase Period 1||1
4925942|NCT03286218|12116761|P2|NOT COMPLETED|Treatment Phase Period 1||0
4925943|NCT03286218|12116762|P1|NOT COMPLETED|Treatment Phase Period 1||0
4925944|NCT03286218|12116751|P12|COMPLETED|Treatment Phase Period 1||5
4925945|NCT03286218|12116752|P11|COMPLETED|Treatment Phase Period 1||5
4925946|NCT03286218|12116753|P10|COMPLETED|Treatment Phase Period 1||6
4925947|NCT03286218|12116754|P9|COMPLETED|Treatment Phase Period 1||6
4925948|NCT03286218|12116755|P8|COMPLETED|Treatment Phase Period 1||6
4925949|NCT03286218|12116756|P7|COMPLETED|Treatment Phase Period 1||6
4925950|NCT03286218|12116757|P6|COMPLETED|Treatment Phase Period 1||5
4925951|NCT03286218|12116758|P5|COMPLETED|Treatment Phase Period 1||5
4925952|NCT03286218|12116759|P4|COMPLETED|Treatment Phase Period 1||5
4925953|NCT03286218|12116760|P3|COMPLETED|Treatment Phase Period 1||5
4925954|NCT03286218|12116761|P2|COMPLETED|Treatment Phase Period 1||0
4925955|NCT03286218|12116762|P1|COMPLETED|Treatment Phase Period 1||0
4925956|NCT03286218|12116751|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925957|NCT03286218|12116752|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
4925958|NCT03286218|12116753|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925959|NCT03286218|12116754|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925960|NCT03286218|12116755|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925961|NCT03286218|12116756|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925962|NCT03286218|12116757|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925963|NCT03286218|12116758|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
4925964|NCT03286218|12116759|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925965|NCT03286218|12116760|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
4925966|NCT03286218|12116761|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
4925967|NCT03286218|12116762|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
4925968|NCT03286218|12116751|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925969|NCT03286218|12116752|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
4925970|NCT03286218|12116753|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925971|NCT03286218|12116754|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925972|NCT03286218|12116755|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925973|NCT03286218|12116756|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925974|NCT03286218|12116757|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925975|NCT03286218|12116758|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
4925976|NCT03286218|12116759|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925977|NCT03286218|12116760|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
4925978|NCT03286218|12116761|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
4925979|NCT03286218|12116762|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
4925980|NCT03286218|12116751|P12|NOT COMPLETED|Qualification Phase Period 2||0
4925981|NCT03286218|12116752|P11|NOT COMPLETED|Qualification Phase Period 2||0
4925982|NCT03286218|12116753|P10|NOT COMPLETED|Qualification Phase Period 2||0
4925983|NCT03286218|12116754|P9|NOT COMPLETED|Qualification Phase Period 2||0
4925984|NCT03286218|12116755|P8|NOT COMPLETED|Qualification Phase Period 2||0
4925985|NCT03286218|12116756|P7|NOT COMPLETED|Qualification Phase Period 2||0
4925986|NCT03286218|12116757|P6|NOT COMPLETED|Qualification Phase Period 2||0
4925987|NCT03286218|12116758|P5|NOT COMPLETED|Qualification Phase Period 2||0
4925988|NCT03286218|12116759|P4|NOT COMPLETED|Qualification Phase Period 2||0
4925989|NCT03286218|12116760|P3|NOT COMPLETED|Qualification Phase Period 2||0
4925990|NCT03286218|12116761|P2|NOT COMPLETED|Qualification Phase Period 2||19
4925991|NCT03286218|12116762|P1|NOT COMPLETED|Qualification Phase Period 2||17
4925992|NCT03286218|12116751|P12|COMPLETED|Qualification Phase Period 2||0
4925993|NCT03286218|12116752|P11|COMPLETED|Qualification Phase Period 2||0
4925994|NCT03286218|12116753|P10|COMPLETED|Qualification Phase Period 2||0
4925995|NCT03286218|12116754|P9|COMPLETED|Qualification Phase Period 2||0
4925996|NCT03286218|12116755|P8|COMPLETED|Qualification Phase Period 2||0
4925997|NCT03286218|12116756|P7|COMPLETED|Qualification Phase Period 2||0
4925998|NCT03286218|12116757|P6|COMPLETED|Qualification Phase Period 2||0
4925999|NCT03286218|12116758|P5|COMPLETED|Qualification Phase Period 2||0
4926000|NCT03286218|12116759|P4|COMPLETED|Qualification Phase Period 2||0
4926001|NCT03286218|12116760|P3|COMPLETED|Qualification Phase Period 2||0
4926002|NCT03286218|12116761|P2|COMPLETED|Qualification Phase Period 2||28
4926003|NCT03286218|12116762|P1|COMPLETED|Qualification Phase Period 2||30
4926004|NCT03286218|12116751|P12|STARTED|Qualification Phase Period 2||0
4926005|NCT03286218|12116752|P11|STARTED|Qualification Phase Period 2||0
4926006|NCT03286218|12116753|P10|STARTED|Qualification Phase Period 2||0
4926007|NCT03286218|12116754|P9|STARTED|Qualification Phase Period 2||0
4926008|NCT03286218|12116755|P8|STARTED|Qualification Phase Period 2||0
4926009|NCT03286218|12116756|P7|STARTED|Qualification Phase Period 2||0
4926010|NCT03286218|12116757|P6|STARTED|Qualification Phase Period 2||0
4926011|NCT03286218|12116758|P5|STARTED|Qualification Phase Period 2||0
4926012|NCT03286218|12116759|P4|STARTED|Qualification Phase Period 2||0
4926013|NCT03286218|12116760|P3|STARTED|Qualification Phase Period 2||0
4926014|NCT03286218|12116761|P2|STARTED|Qualification Phase Period 2||47
4926015|NCT03286218|12116762|P1|STARTED|Qualification Phase Period 2||47
4926016|NCT03286218|12116751|P12|NOT COMPLETED|Qualification Phase Period 1||0
4926017|NCT03286218|12116752|P11|NOT COMPLETED|Qualification Phase Period 1||0
4926018|NCT03286218|12116753|P10|NOT COMPLETED|Qualification Phase Period 1||0
4926019|NCT03286218|12116754|P9|NOT COMPLETED|Qualification Phase Period 1||0
4926020|NCT03286218|12116755|P8|NOT COMPLETED|Qualification Phase Period 1||0
4926021|NCT03286218|12116756|P7|NOT COMPLETED|Qualification Phase Period 1||0
4926022|NCT03286218|12116757|P6|NOT COMPLETED|Qualification Phase Period 1||0
4926023|NCT03286218|12116758|P5|NOT COMPLETED|Qualification Phase Period 1||0
4926024|NCT03286218|12116759|P4|NOT COMPLETED|Qualification Phase Period 1||0
4926025|NCT03286218|12116760|P3|NOT COMPLETED|Qualification Phase Period 1||0
4926026|NCT03286218|12116761|P2|NOT COMPLETED|Qualification Phase Period 1||1
4926027|NCT03286218|12116762|P1|NOT COMPLETED|Qualification Phase Period 1||1
4926028|NCT03286218|12116751|P12|COMPLETED|Qualification Phase Period 1||0
4926029|NCT03286218|12116752|P11|COMPLETED|Qualification Phase Period 1||0
4926030|NCT03286218|12116753|P10|COMPLETED|Qualification Phase Period 1||0
4926031|NCT03286218|12116754|P9|COMPLETED|Qualification Phase Period 1||0
4926032|NCT03286218|12116755|P8|COMPLETED|Qualification Phase Period 1||0
4926033|NCT03286218|12116756|P7|COMPLETED|Qualification Phase Period 1||0
4926034|NCT03286218|12116757|P6|COMPLETED|Qualification Phase Period 1||0
4926035|NCT03286218|12116758|P5|COMPLETED|Qualification Phase Period 1||0
4926036|NCT03286218|12116759|P4|COMPLETED|Qualification Phase Period 1||0
4926037|NCT03286218|12116760|P3|COMPLETED|Qualification Phase Period 1||0
4926038|NCT03286218|12116761|P2|COMPLETED|Qualification Phase Period 1||47
4926039|NCT03286218|12116762|P1|COMPLETED|Qualification Phase Period 1||47
4926040|NCT03286218|12116751|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926041|NCT03286218|12116752|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926042|NCT03286218|12116753|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926043|NCT03286218|12116754|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926044|NCT03286218|12116755|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926045|NCT03286218|12116756|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926046|NCT03286218|12116757|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926047|NCT03286218|12116758|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926048|NCT03286218|12116759|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926049|NCT03286218|12116760|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
4926050|NCT03286218|12116761|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
4926051|NCT03286218|12116762|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
4926052|NCT03286218|12116751|P12|STARTED|Qualification Phase Period 1||0
4926053|NCT03286218|12116752|P11|STARTED|Qualification Phase Period 1||0
4926054|NCT03286218|12116753|P10|STARTED|Qualification Phase Period 1||0
4926055|NCT03286218|12116754|P9|STARTED|Qualification Phase Period 1||0
4926056|NCT03286218|12116755|P8|STARTED|Qualification Phase Period 1||0
4926057|NCT03286218|12116756|P7|STARTED|Qualification Phase Period 1||0
4926058|NCT03286218|12116757|P6|STARTED|Qualification Phase Period 1||0
4926059|NCT03286218|12116758|P5|STARTED|Qualification Phase Period 1||0
4926060|NCT03286218|12116759|P4|STARTED|Qualification Phase Period 1||0
4926061|NCT03286218|12116760|P3|STARTED|Qualification Phase Period 1||0
4926062|NCT03286218|12116761|P2|STARTED|Qualification Phase Period 1||48
4926063|NCT03286218|12116762|P1|STARTED|Qualification Phase Period 1||48
4926064|NCT03285984|12116804|P1|NOT COMPLETED|Overall Study||0
4926065|NCT03285984|12116804|P1|COMPLETED|Overall Study||56
4926066|NCT03285984|12116804|P1|Received Test Product 4|Overall Study||56
4926067|NCT03285984|12116804|P1|Received Test Product 3|Overall Study||56
4926068|NCT03285984|12116804|P1|Received Test Product 2|Overall Study||56
4926069|NCT03285984|12116804|P1|Received Test Product 1|Overall Study||56
4926070|NCT03285984|12116804|P1|STARTED|Overall Study||56
4926071|NCT03285724|12116816|P1|NOT COMPLETED|Overall Study||0
4926072|NCT03285724|12116816|P1|COMPLETED|Overall Study||1
4926073|NCT03285724|12116816|P1|STARTED|Overall Study||1
4926074|NCT03285711|12116825|P4|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
4926075|NCT03285711|12116826|P3|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
4926076|NCT03285711|12116827|P2|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
4926077|NCT03285711|12116828|P1|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
4926078|NCT03285711|12116825|P4|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
4926079|NCT03285711|12116826|P3|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
4926080|NCT03285711|12116827|P2|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
4926081|NCT03285711|12116828|P1|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
4926082|NCT03285711|12116825|P4|STARTED|Extended Blinded Phase (Week 32 to 52)||1
4926083|NCT03285711|12116826|P3|STARTED|Extended Blinded Phase (Week 32 to 52)||0
4926084|NCT03285711|12116827|P2|STARTED|Extended Blinded Phase (Week 32 to 52)||3
4926085|NCT03285711|12116828|P1|STARTED|Extended Blinded Phase (Week 32 to 52)||0
4926086|NCT03285711|12116825|P4|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
4926087|NCT03285711|12116826|P3|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
4926088|NCT03285711|12116827|P2|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
4926089|NCT03285711|12116828|P1|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
4926090|NCT03285711|12116825|P4|COMPLETED|Blinded Phase (Week 16 to 32)||1
4926091|NCT03285711|12116826|P3|COMPLETED|Blinded Phase (Week 16 to 32)||0
4926092|NCT03285711|12116827|P2|COMPLETED|Blinded Phase (Week 16 to 32)||3
4926093|NCT03285711|12116828|P1|COMPLETED|Blinded Phase (Week 16 to 32)||0
4926094|NCT03285711|12116825|P4|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
4926095|NCT03285711|12116826|P3|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
4926096|NCT03285711|12116827|P2|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
4926097|NCT03285711|12116828|P1|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
4926098|NCT03285711|12116825|P4|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
4926099|NCT03285711|12116826|P3|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
4926100|NCT03285711|12116827|P2|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
4926101|NCT03285711|12116828|P1|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
4926102|NCT03285711|12116825|P4|COMPLETED|Blinded Phase (Up to Week 16)||0
4926103|NCT03285711|12116826|P3|COMPLETED|Blinded Phase (Up to Week 16)||0
4926104|NCT03285711|12116827|P2|COMPLETED|Blinded Phase (Up to Week 16)||4
4926105|NCT03285711|12116828|P1|COMPLETED|Blinded Phase (Up to Week 16)||1
4926106|NCT03285711|12116825|P4|STARTED|Blinded Phase (Up to Week 16)||0
4926107|NCT03285711|12116826|P3|STARTED|Blinded Phase (Up to Week 16)||0
4926108|NCT03285711|12116827|P2|STARTED|Blinded Phase (Up to Week 16)||5
4926109|NCT03285711|12116828|P1|STARTED|Blinded Phase (Up to Week 16)||4
4926110|NCT03285373|12116848|P4|NOT COMPLETED|Overall Study||0
4926111|NCT03285373|12116849|P3|NOT COMPLETED|Overall Study||0
4926112|NCT03285373|12116850|P2|NOT COMPLETED|Overall Study||0
4926113|NCT03285373|12116851|P1|NOT COMPLETED|Overall Study||0
4926114|NCT03285373|12116848|P4|COMPLETED|Overall Study||130
4926115|NCT03285373|12116849|P3|COMPLETED|Overall Study||266
4926116|NCT03285373|12116850|P2|COMPLETED|Overall Study||253
4926117|NCT03285373|12116851|P1|COMPLETED|Overall Study||314
4926118|NCT03285373|12116848|P4|STARTED|Overall Study||130
4926119|NCT03285373|12116849|P3|STARTED|Overall Study||266
4926120|NCT03285373|12116850|P2|STARTED|Overall Study||253
4926121|NCT03285373|12116851|P1|STARTED|Overall Study||314
4926122|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
4926123|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
4926124|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
4926125|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
4926126|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
4926127|NCT03285295|12116901|P5|COMPLETED|Alinity s Chagas Follow-Up||0
4926128|NCT03285295|12116902|P4|COMPLETED|Alinity s Chagas Follow-Up||0
4926129|NCT03285295|12116903|P3|COMPLETED|Alinity s Chagas Follow-Up||0
4926130|NCT03285295|12116904|P2|COMPLETED|Alinity s Chagas Follow-Up||0
4926131|NCT03285295|12116905|P1|COMPLETED|Alinity s Chagas Follow-Up||1
4926132|NCT03285295|12116901|P5|STARTED|Alinity s Chagas Follow-Up||0
4926133|NCT03285295|12116902|P4|STARTED|Alinity s Chagas Follow-Up||0
4926134|NCT03285295|12116903|P3|STARTED|Alinity s Chagas Follow-Up||0
4926135|NCT03285295|12116904|P2|STARTED|Alinity s Chagas Follow-Up||0
4926136|NCT03285295|12116905|P1|STARTED|Alinity s Chagas Follow-Up||14
4926137|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Chagas||0
4926138|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Chagas||0
4926139|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Chagas||0
4926140|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Chagas||0
4926141|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Chagas||219
4926142|NCT03285295|12116901|P5|COMPLETED|Alinity s Chagas||0
4926143|NCT03285295|12116902|P4|COMPLETED|Alinity s Chagas||615
4926144|NCT03285295|12116903|P3|COMPLETED|Alinity s Chagas||0
4926145|NCT03285295|12116904|P2|COMPLETED|Alinity s Chagas||320
4926146|NCT03285295|12116905|P1|COMPLETED|Alinity s Chagas||15804
4926147|NCT03285295|12116901|P5|STARTED|Alinity s Chagas||0
4926148|NCT03285295|12116902|P4|STARTED|Alinity s Chagas||615
4926149|NCT03285295|12116903|P3|STARTED|Alinity s Chagas||0
4926150|NCT03285295|12116904|P2|STARTED|Alinity s Chagas||320
4926151|NCT03285295|12116905|P1|STARTED|Alinity s Chagas||16023
4926152|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926153|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926154|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926155|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926156|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
4926157|NCT03285295|12116901|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926158|NCT03285295|12116902|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926159|NCT03285295|12116903|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926160|NCT03285295|12116904|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
4926161|NCT03285295|12116905|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
4926162|NCT03285295|12116901|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
4926163|NCT03285295|12116902|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
4926164|NCT03285295|12116903|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
4926165|NCT03285295|12116904|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
4926166|NCT03285295|12116905|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
4926167|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Anti-HBc||0
4926168|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Anti-HBc||0
4926169|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Anti-HBc||0
4926170|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Anti-HBc||1
4926171|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Anti-HBc||91
4926172|NCT03285295|12116901|P5|COMPLETED|Alinity s Anti-HBc||0
4926173|NCT03285295|12116902|P4|COMPLETED|Alinity s Anti-HBc||0
4926174|NCT03285295|12116903|P3|COMPLETED|Alinity s Anti-HBc||403
4926175|NCT03285295|12116904|P2|COMPLETED|Alinity s Anti-HBc||404
4926176|NCT03285295|12116905|P1|COMPLETED|Alinity s Anti-HBc||15877
4926177|NCT03285295|12116901|P5|STARTED|Alinity s Anti-HBc||0
4926178|NCT03285295|12116902|P4|STARTED|Alinity s Anti-HBc||0
4926179|NCT03285295|12116903|P3|STARTED|Alinity s Anti-HBc||403
4926180|NCT03285295|12116904|P2|STARTED|Alinity s Anti-HBc||405
4926181|NCT03285295|12116905|P1|STARTED|Alinity s Anti-HBc||15968
4926182|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926183|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926184|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926185|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926186|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
4926187|NCT03285295|12116901|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926188|NCT03285295|12116902|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926189|NCT03285295|12116903|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926190|NCT03285295|12116904|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926191|NCT03285295|12116905|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
4926192|NCT03285295|12116901|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926193|NCT03285295|12116902|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926194|NCT03285295|12116903|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926195|NCT03285295|12116904|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
4926196|NCT03285295|12116905|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
4926197|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
4926198|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
4926199|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
4926200|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
4926201|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
4926202|NCT03285295|12116901|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
4926203|NCT03285295|12116902|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
4926204|NCT03285295|12116903|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
4926205|NCT03285295|12116904|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
4926206|NCT03285295|12116905|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
4926207|NCT03285295|12116901|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
4926208|NCT03285295|12116902|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
4926209|NCT03285295|12116903|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
4926210|NCT03285295|12116904|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
4926211|NCT03285295|12116905|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
4926212|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926213|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926214|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926215|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926216|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
4926217|NCT03285295|12116901|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926218|NCT03285295|12116902|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926219|NCT03285295|12116903|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926220|NCT03285295|12116904|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
4926221|NCT03285295|12116905|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
4926222|NCT03285295|12116901|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
4926223|NCT03285295|12116902|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
4926224|NCT03285295|12116903|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
4926225|NCT03285295|12116904|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
4926226|NCT03285295|12116905|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
4926227|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s Anti-HCV||0
4926228|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s Anti-HCV||0
4926229|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s Anti-HCV||0
4926230|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s Anti-HCV||0
4926231|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s Anti-HCV||96
4926232|NCT03285295|12116901|P5|COMPLETED|Alinity s Anti-HCV||0
4926233|NCT03285295|12116902|P4|COMPLETED|Alinity s Anti-HCV||0
4926234|NCT03285295|12116903|P3|COMPLETED|Alinity s Anti-HCV||407
4926235|NCT03285295|12116904|P2|COMPLETED|Alinity s Anti-HCV||402
4926236|NCT03285295|12116905|P1|COMPLETED|Alinity s Anti-HCV||16999
4926237|NCT03285295|12116901|P5|STARTED|Alinity s Anti-HCV||0
4926238|NCT03285295|12116902|P4|STARTED|Alinity s Anti-HCV||0
4926239|NCT03285295|12116903|P3|STARTED|Alinity s Anti-HCV||407
4926240|NCT03285295|12116904|P2|STARTED|Alinity s Anti-HCV||402
4926241|NCT03285295|12116905|P1|STARTED|Alinity s Anti-HCV||17095
4926242|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926243|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926244|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926245|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926246|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
4926247|NCT03285295|12116901|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926248|NCT03285295|12116902|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926249|NCT03285295|12116903|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926250|NCT03285295|12116904|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
4926251|NCT03285295|12116905|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
4926252|NCT03285295|12116901|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
4926253|NCT03285295|12116902|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
4926254|NCT03285295|12116903|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
4926255|NCT03285295|12116904|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
4926256|NCT03285295|12116905|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
4926257|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HTLV I/II||0
4926258|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HTLV I/II||0
4926259|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HTLV I/II||0
4926260|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HTLV I/II||0
4926261|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HTLV I/II||91
4926262|NCT03285295|12116901|P5|COMPLETED|Alinity s HTLV I/II||0
4926263|NCT03285295|12116902|P4|COMPLETED|Alinity s HTLV I/II||509
4926264|NCT03285295|12116903|P3|COMPLETED|Alinity s HTLV I/II||502
4926265|NCT03285295|12116904|P2|COMPLETED|Alinity s HTLV I/II||706
4926266|NCT03285295|12116905|P1|COMPLETED|Alinity s HTLV I/II||15877
4926267|NCT03285295|12116901|P5|STARTED|Alinity s HTLV I/II||0
4926268|NCT03285295|12116902|P4|STARTED|Alinity s HTLV I/II||509
4926269|NCT03285295|12116903|P3|STARTED|Alinity s HTLV I/II||502
4926270|NCT03285295|12116904|P2|STARTED|Alinity s HTLV I/II||706
4926271|NCT03285295|12116905|P1|STARTED|Alinity s HTLV I/II||15968
4926272|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
4926273|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
4926274|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
4926275|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
4926276|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
4926277|NCT03285295|12116901|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
4926278|NCT03285295|12116902|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
4926279|NCT03285295|12116903|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
4926280|NCT03285295|12116904|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
4926281|NCT03285295|12116905|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
4926282|NCT03285295|12116901|P5|STARTED|Alinity s HBsAg Follow-Up||0
4926283|NCT03285295|12116902|P4|STARTED|Alinity s HBsAg Follow-Up||0
4926284|NCT03285295|12116903|P3|STARTED|Alinity s HBsAg Follow-Up||0
4926285|NCT03285295|12116904|P2|STARTED|Alinity s HBsAg Follow-Up||0
4926286|NCT03285295|12116905|P1|STARTED|Alinity s HBsAg Follow-Up||0
4926287|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
4926288|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
4926289|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
4926290|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
4926291|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
4926292|NCT03285295|12116901|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
4926293|NCT03285295|12116902|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
4926294|NCT03285295|12116903|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
4926295|NCT03285295|12116904|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
4926296|NCT03285295|12116905|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
4926297|NCT03285295|12116901|P5|STARTED|Alinity s HBsAg Confirmatory||0
4926298|NCT03285295|12116902|P4|STARTED|Alinity s HBsAg Confirmatory||0
4926299|NCT03285295|12116903|P3|STARTED|Alinity s HBsAg Confirmatory||3
4926300|NCT03285295|12116904|P2|STARTED|Alinity s HBsAg Confirmatory||432
4926301|NCT03285295|12116905|P1|STARTED|Alinity s HBsAg Confirmatory||8
4926302|NCT03285295|12116901|P5|NOT COMPLETED|Alinity s HBsAg||0
4926303|NCT03285295|12116902|P4|NOT COMPLETED|Alinity s HBsAg||0
4926304|NCT03285295|12116903|P3|NOT COMPLETED|Alinity s HBsAg||0
4926305|NCT03285295|12116904|P2|NOT COMPLETED|Alinity s HBsAg||6
4926306|NCT03285295|12116905|P1|NOT COMPLETED|Alinity s HBsAg||102
4926307|NCT03285295|12116901|P5|COMPLETED|Alinity s HBsAg||51
4926308|NCT03285295|12116902|P4|COMPLETED|Alinity s HBsAg||0
4926309|NCT03285295|12116903|P3|COMPLETED|Alinity s HBsAg||403
4926310|NCT03285295|12116904|P2|COMPLETED|Alinity s HBsAg||432
4926311|NCT03285295|12116905|P1|COMPLETED|Alinity s HBsAg||16993
4926312|NCT03285295|12116901|P5|STARTED|Alinity s HBsAg||51
4926313|NCT03285295|12116902|P4|STARTED|Alinity s HBsAg||0
4926314|NCT03285295|12116903|P3|STARTED|Alinity s HBsAg||403
4926315|NCT03285295|12116904|P2|STARTED|Alinity s HBsAg||438
4926316|NCT03285295|12116905|P1|STARTED|Alinity s HBsAg||17095
4926317|NCT03284411|12116934|P1|NOT COMPLETED|Overall Study||0
4926318|NCT03284411|12116934|P1|COMPLETED|Overall Study||30
4926319|NCT03284411|12116934|P1|STARTED|Overall Study||30
4926320|NCT03283709|12116941|P2|NOT COMPLETED|Overall Study||1
4926321|NCT03283709|12116942|P1|NOT COMPLETED|Overall Study||0
4926322|NCT03283709|12116941|P2|COMPLETED|Overall Study||0
4926323|NCT03283709|12116942|P1|COMPLETED|Overall Study||0
4926324|NCT03283709|12116941|P2|STARTED|Overall Study||1
4926325|NCT03283709|12116942|P1|STARTED|Overall Study||0
4926326|NCT03283319|12116978|P6|NOT COMPLETED|Overall Study||4
4926327|NCT03283319|12116979|P5|NOT COMPLETED|Overall Study||4
4926328|NCT03283319|12116980|P4|NOT COMPLETED|Overall Study||7
4926329|NCT03283319|12116981|P3|NOT COMPLETED|Overall Study||7
4926330|NCT03283319|12116982|P2|NOT COMPLETED|Overall Study||6
4926331|NCT03283319|12116983|P1|NOT COMPLETED|Overall Study||7
4926332|NCT03283319|12116978|P6|COMPLETED|Overall Study||57
4926333|NCT03283319|12116979|P5|COMPLETED|Overall Study||56
4926334|NCT03283319|12116980|P4|COMPLETED|Overall Study||54
4926335|NCT03283319|12116981|P3|COMPLETED|Overall Study||55
4926336|NCT03283319|12116982|P2|COMPLETED|Overall Study||54
4926337|NCT03283319|12116983|P1|COMPLETED|Overall Study||55
4926338|NCT03283319|12116978|P6|STARTED|Overall Study||61
4926339|NCT03283319|12116979|P5|STARTED|Overall Study||60
4926340|NCT03283319|12116980|P4|STARTED|Overall Study||61
4926341|NCT03283319|12116981|P3|STARTED|Overall Study||62
4926342|NCT03283319|12116982|P2|STARTED|Overall Study||60
4926343|NCT03283319|12116983|P1|STARTED|Overall Study||62
4926344|NCT03283098|12117125|P2|NOT COMPLETED|Overall Study||1
4926345|NCT03283098|12117126|P1|NOT COMPLETED|Overall Study||0
4926346|NCT03283098|12117125|P2|COMPLETED|Overall Study||24
4926347|NCT03283098|12117126|P1|COMPLETED|Overall Study||8
4926348|NCT03283098|12117125|P2|STARTED|Overall Study||25
4926349|NCT03283098|12117126|P1|STARTED|Overall Study||8
4926350|NCT03282682|12117165|P3|NOT COMPLETED|Overall Study||0
4926351|NCT03282682|12117166|P2|NOT COMPLETED|Overall Study||0
4926352|NCT03282682|12117167|P1|NOT COMPLETED|Overall Study||0
4926353|NCT03282682|12117165|P3|COMPLETED|Overall Study||8
4926354|NCT03282682|12117166|P2|COMPLETED|Overall Study||8
4926355|NCT03282682|12117167|P1|COMPLETED|Overall Study||6
4926356|NCT03282682|12117165|P3|STARTED|Overall Study||8
4926357|NCT03282682|12117166|P2|STARTED|Overall Study||8
4926358|NCT03282682|12117167|P1|STARTED|Overall Study||6
4926359|NCT03282591|12117228|P2|NOT COMPLETED|Overall Study||4
4926360|NCT03282591|12117229|P1|NOT COMPLETED|Overall Study||4
4926361|NCT03282591|12117228|P2|COMPLETED|Overall Study||89
4926362|NCT03282591|12117229|P1|COMPLETED|Overall Study||88
4926363|NCT03282591|12117228|P2|STARTED|Overall Study||93
4926364|NCT03282591|12117229|P1|STARTED|Overall Study||92
4926365|NCT03282240|12117246|P3|NOT COMPLETED|Overall Study||3
4926366|NCT03282240|12117247|P2|NOT COMPLETED|Overall Study||3
4926367|NCT03282240|12117248|P1|NOT COMPLETED|Overall Study||10
4926368|NCT03282240|12117246|P3|COMPLETED|Overall Study||447
4926369|NCT03282240|12117247|P2|COMPLETED|Overall Study||440
4926370|NCT03282240|12117248|P1|COMPLETED|Overall Study||1767
4926371|NCT03282240|12117246|P3|STARTED|Overall Study||450
4926372|NCT03282240|12117247|P2|STARTED|Overall Study||443
4926373|NCT03282240|12117248|P1|STARTED|Overall Study||1777
4926374|NCT03281668|12117300|P1|NOT COMPLETED|Overall Study||8
4926375|NCT03281668|12117300|P1|COMPLETED|Overall Study||21
4926376|NCT03281668|12117300|P1|STARTED|Overall Study||29
4926377|NCT03281577|12117328|P4|NOT COMPLETED|Overall Study||1
4926378|NCT03281577|12117329|P3|NOT COMPLETED|Overall Study||0
4926379|NCT03281577|12117330|P2|NOT COMPLETED|Overall Study||0
4926380|NCT03281577|12117331|P1|NOT COMPLETED|Overall Study||1
4926381|NCT03281577|12117328|P4|COMPLETED|Overall Study||6
4926382|NCT03281577|12117329|P3|COMPLETED|Overall Study||9
4926383|NCT03281577|12117330|P2|COMPLETED|Overall Study||10
4926384|NCT03281577|12117331|P1|COMPLETED|Overall Study||9
4926385|NCT03281577|12117328|P4|STARTED|Overall Study||7
4926386|NCT03281577|12117329|P3|STARTED|Overall Study||9
4926387|NCT03281577|12117330|P2|STARTED|Overall Study||10
4926388|NCT03281577|12117331|P1|STARTED|Overall Study||10
4926389|NCT03281200|12117362|P1|NOT COMPLETED|Overall Study||0
4926390|NCT03281200|12117362|P1|COMPLETED|Overall Study||172
4926391|NCT03281200|12117362|P1|STARTED|Overall Study||172
4926392|NCT03280615|12117386|P2|NOT COMPLETED|Overall Study||5
4926393|NCT03280615|12117387|P1|NOT COMPLETED|Overall Study||4
4926394|NCT03280615|12117386|P2|COMPLETED|Overall Study||45
4926395|NCT03280615|12117387|P1|COMPLETED|Overall Study||46
4926396|NCT03280615|12117386|P2|STARTED|Overall Study||50
4926397|NCT03280615|12117387|P1|STARTED|Overall Study||50
4926398|NCT03280550|12117399|P2|NOT COMPLETED|Overall Study||3
4926399|NCT03280550|12117400|P1|NOT COMPLETED|Overall Study||2
4926400|NCT03280550|12117399|P2|COMPLETED|Overall Study||69
4926401|NCT03280550|12117400|P1|COMPLETED|Overall Study||64
4926402|NCT03280550|12117399|P2|STARTED|Overall Study||72
4926403|NCT03280550|12117400|P1|STARTED|Overall Study||66
4926404|NCT03280537|12117452|P2|NOT COMPLETED|Overall Study||4
4926405|NCT03280537|12117453|P1|NOT COMPLETED|Overall Study||2
4926406|NCT03280537|12117452|P2|COMPLETED|Overall Study||58
4926407|NCT03280537|12117453|P1|COMPLETED|Overall Study||63
4926408|NCT03280537|12117452|P2|STARTED|Overall Study||62
4926409|NCT03280537|12117453|P1|STARTED|Overall Study||65
4926410|NCT03280381|12117505|P2|NOT COMPLETED|Overall Study||2
4926411|NCT03280381|12117506|P1|NOT COMPLETED|Overall Study||0
4926412|NCT03280381|12117505|P2|COMPLETED|Overall Study||97
4926413|NCT03280381|12117506|P1|COMPLETED|Overall Study||101
4926414|NCT03280381|12117505|P2|STARTED|Overall Study||99
4926415|NCT03280381|12117506|P1|STARTED|Overall Study||101
4926416|NCT03280108|12117516|P2|NOT COMPLETED|Overall Study||0
4926417|NCT03280108|12117517|P1|NOT COMPLETED|Overall Study||2
4926418|NCT03280108|12117516|P2|COMPLETED|Overall Study||114
4926419|NCT03280108|12117517|P1|COMPLETED|Overall Study||127
4926420|NCT03280108|12117516|P2|STARTED|Overall Study||114
4926421|NCT03280108|12117517|P1|STARTED|Overall Study||129
4926422|NCT03279458|12117548|P1|NOT COMPLETED|Overall Study||0
4926423|NCT03279458|12117548|P1|COMPLETED|Overall Study||40
4926424|NCT03279458|12117548|P1|STARTED|Overall Study||40
4926425|NCT03279237|12117554|P1|NOT COMPLETED|Overall Study||5
4926426|NCT03279237|12117554|P1|COMPLETED|Overall Study||20
4926427|NCT03279237|12117554|P1|Surgical Resection|Overall Study||20
4926428|NCT03279237|12117554|P1|Chemo-radiation|Overall Study||23
4926429|NCT03279237|12117554|P1|STARTED|Overall Study||25
4926430|NCT03278106|12117561|P1|NOT COMPLETED|Overall Study||1
4926431|NCT03278106|12117561|P1|COMPLETED|Overall Study||27
4926432|NCT03278106|12117561|P1|STARTED|Overall Study||28
4926433|NCT03278067|12117572|P3|NOT COMPLETED|Overall Study||0
4926434|NCT03278067|12117573|P2|NOT COMPLETED|Overall Study||0
4926435|NCT03278067|12117574|P1|NOT COMPLETED|Overall Study||0
4926436|NCT03278067|12117572|P3|COMPLETED|Overall Study||4196
4926437|NCT03278067|12117573|P2|COMPLETED|Overall Study||3310
4926438|NCT03278067|12117574|P1|COMPLETED|Overall Study||16433
4926439|NCT03278067|12117572|P3|STARTED|Overall Study||4196
4926440|NCT03278067|12117573|P2|STARTED|Overall Study||3310
4926441|NCT03278067|12117574|P1|STARTED|Overall Study||16433
4926442|NCT03278028|12117977|P2|NOT COMPLETED|Overall Study||2
4926443|NCT03278028|12117978|P1|NOT COMPLETED|Overall Study||4
4926444|NCT03278028|12117977|P2|COMPLETED|Overall Study||76
4926445|NCT03278028|12117978|P1|COMPLETED|Overall Study||77
4926446|NCT03278028|12117977|P2|STARTED|Overall Study||78
4926447|NCT03278028|12117978|P1|STARTED|Overall Study||81
4926448|NCT03277846|12117986|P2|NOT COMPLETED|Overall Study||11
4926449|NCT03277846|12117987|P1|NOT COMPLETED|Overall Study||12
4926450|NCT03277846|12117986|P2|COMPLETED|Overall Study||40
4926451|NCT03277846|12117987|P1|COMPLETED|Overall Study||38
4926452|NCT03277846|12117986|P2|STARTED|Overall Study||51
4926453|NCT03277846|12117987|P1|STARTED|Overall Study||50
4926454|NCT03277274|12117996|P3|NOT COMPLETED|Overall Study||0
4926455|NCT03277274|12117997|P2|NOT COMPLETED|Overall Study||0
4926456|NCT03277274|12117998|P1|NOT COMPLETED|Overall Study||0
4926457|NCT03277274|12117996|P3|COMPLETED|Overall Study||7
4926458|NCT03277274|12117997|P2|COMPLETED|Overall Study||10
4926459|NCT03277274|12117998|P1|COMPLETED|Overall Study||8
4926460|NCT03277274|12117996|P3|STARTED|Overall Study||7
4926461|NCT03277274|12117997|P2|STARTED|Overall Study||10
4926462|NCT03277274|12117998|P1|STARTED|Overall Study||8
4926463|NCT03277105|12118029|P2|NOT COMPLETED|Overall Study||263
4926464|NCT03277105|12118030|P1|NOT COMPLETED|Overall Study||259
4926465|NCT03277105|12118029|P2|COMPLETED|Overall Study||0
4926466|NCT03277105|12118030|P1|COMPLETED|Overall Study||0
4926467|NCT03277105|12118029|P2|Safety Analysis Set|Overall Study||260
4926468|NCT03277105|12118030|P1|Safety Analysis Set|Overall Study||258
4926469|NCT03277105|12118029|P2|STARTED|Overall Study||263
4926470|NCT03277105|12118030|P1|STARTED|Overall Study||259
4926471|NCT03276871|12118062|P2|NOT COMPLETED|Overall Study||0
4926472|NCT03276871|12118063|P1|NOT COMPLETED|Overall Study||0
4926473|NCT03276871|12118062|P2|COMPLETED|Overall Study||19
4926474|NCT03276871|12118063|P1|COMPLETED|Overall Study||21
4926475|NCT03276871|12118062|P2|STARTED|Overall Study||19
4926476|NCT03276871|12118063|P1|STARTED|Overall Study||21
4926477|NCT03276494|12118075|P1|NOT COMPLETED|Overall Study||1
4926478|NCT03276494|12118075|P1|COMPLETED|Overall Study||5
4926479|NCT03276494|12118075|P1|STARTED|Overall Study||6
4926480|NCT03276078|12118080|P1|NOT COMPLETED|Overall Study||1
4926481|NCT03276078|12118080|P1|COMPLETED|Overall Study||19
4926482|NCT03276078|12118080|P1|STARTED|Overall Study||20
4926483|NCT03276026|12118109|P2|NOT COMPLETED|Overall Study||0
4926484|NCT03276026|12118110|P1|NOT COMPLETED|Overall Study||1
4926485|NCT03276026|12118109|P2|COMPLETED|Overall Study||33
4926486|NCT03276026|12118110|P1|COMPLETED|Overall Study||34
4926487|NCT03276026|12118109|P2|STARTED|Overall Study||33
4926488|NCT03276026|12118110|P1|STARTED|Overall Study||35
4926489|NCT03275870|12118120|P1|NOT COMPLETED|Overall Study||14
4926490|NCT03275870|12118120|P1|COMPLETED|Overall Study||3
4926491|NCT03275870|12118120|P1|STARTED|Overall Study||17
4926492|NCT03275623|12118127|P2|NOT COMPLETED|Overall Study||2
4926493|NCT03275623|12118128|P1|NOT COMPLETED|Overall Study||5
4926494|NCT03275623|12118127|P2|COMPLETED|Overall Study||28
4926495|NCT03275623|12118128|P1|COMPLETED|Overall Study||25
4926496|NCT03275623|12118127|P2|STARTED|Overall Study||30
4926497|NCT03275623|12118128|P1|STARTED|Overall Study||30
4926498|NCT03274986|12118138|P2|NOT COMPLETED|Overall Study||2
4926499|NCT03274986|12118139|P1|NOT COMPLETED|Overall Study||0
4926500|NCT03274986|12118138|P2|COMPLETED|Overall Study||111
4926501|NCT03274986|12118139|P1|COMPLETED|Overall Study||107
4926502|NCT03274986|12118138|P2|Successful Implantation, as Treated|Overall Study||113
4926503|NCT03274986|12118139|P1|Successful Implantation, as Treated|Overall Study||107
4926504|NCT03274986|12118138|P2|STARTED|Overall Study||113
4926505|NCT03274986|12118139|P1|STARTED|Overall Study||107
4926506|NCT03274856|12118172|P2|NOT COMPLETED|Overall Study||0
4926507|NCT03274856|12118173|P1|NOT COMPLETED|Overall Study||0
4926508|NCT03274856|12118172|P2|COMPLETED|Overall Study||9
4926509|NCT03274856|12118173|P1|COMPLETED|Overall Study||10
4926510|NCT03274856|12118172|P2|STARTED|Overall Study||9
4926511|NCT03274856|12118173|P1|STARTED|Overall Study||10
4926512|NCT03274518|12118189|P2|NOT COMPLETED|Second Intervention||0
4926513|NCT03274518|12118190|P1|NOT COMPLETED|Second Intervention||0
4926514|NCT03274518|12118189|P2|COMPLETED|Second Intervention||8
4926515|NCT03274518|12118190|P1|COMPLETED|Second Intervention||8
4926516|NCT03274518|12118189|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
4926517|NCT03274518|12118190|P1|STARTED|Second Intervention||8
4926518|NCT03274518|12118189|P2|NOT COMPLETED|Washout Period||0
4926519|NCT03274518|12118190|P1|NOT COMPLETED|Washout Period||0
4926520|NCT03274518|12118189|P2|COMPLETED|Washout Period||8
4926521|NCT03274518|12118190|P1|COMPLETED|Washout Period||8
4926522|NCT03274518|12118189|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
4926523|NCT03274518|12118190|P1|STARTED|Washout Period||8
4926524|NCT03274518|12118189|P2|NOT COMPLETED|First Intervention||0
4926525|NCT03274518|12118190|P1|NOT COMPLETED|First Intervention||0
4926526|NCT03274518|12118189|P2|COMPLETED|First Intervention||8
4926527|NCT03274518|12118190|P1|COMPLETED|First Intervention||8
4926528|NCT03274518|12118189|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
4926529|NCT03274518|12118190|P1|STARTED|First Intervention||8
4926530|NCT03274453|12118206|P4|NOT COMPLETED|Overall Study||4
4926531|NCT03274453|12118207|P3|NOT COMPLETED|Overall Study||4
4926532|NCT03274453|12118208|P2|NOT COMPLETED|Overall Study||6
4926533|NCT03274453|12118209|P1|NOT COMPLETED|Overall Study||4
4926534|NCT03274453|12118206|P4|COMPLETED|Overall Study||25
4926535|NCT03274453|12118207|P3|COMPLETED|Overall Study||28
4926536|NCT03274453|12118208|P2|COMPLETED|Overall Study||24
4926537|NCT03274453|12118209|P1|COMPLETED|Overall Study||34
4926538|NCT03274453|12118206|P4|STARTED|Overall Study||29
4926539|NCT03274453|12118207|P3|STARTED|Overall Study||32
4926540|NCT03274453|12118208|P2|STARTED|Overall Study||30
4926541|NCT03274453|12118209|P1|STARTED|Overall Study||38
4926542|NCT03274440|12118219|P6|NOT COMPLETED|Overall Study||0
4926543|NCT03274440|12118220|P5|NOT COMPLETED|Overall Study||0
4926544|NCT03274440|12118221|P4|NOT COMPLETED|Overall Study||1
4926545|NCT03274440|12118222|P3|NOT COMPLETED|Overall Study||0
4926546|NCT03274440|12118223|P2|NOT COMPLETED|Overall Study||0
4926547|NCT03274440|12118224|P1|NOT COMPLETED|Overall Study||1
4926548|NCT03274440|12118219|P6|COMPLETED|Overall Study||3
4926549|NCT03274440|12118220|P5|COMPLETED|Overall Study||1
4926550|NCT03274440|12118221|P4|COMPLETED|Overall Study||0
4926551|NCT03274440|12118222|P3|COMPLETED|Overall Study||4
4926552|NCT03274440|12118223|P2|COMPLETED|Overall Study||2
4926553|NCT03274440|12118224|P1|COMPLETED|Overall Study||2
4926554|NCT03274440|12118219|P6|STARTED|Overall Study||3
4926555|NCT03274440|12118220|P5|STARTED|Overall Study||1
4926556|NCT03274440|12118221|P4|STARTED|Overall Study||1
4926557|NCT03274440|12118222|P3|STARTED|Overall Study||4
4926558|NCT03274440|12118223|P2|STARTED|Overall Study||2
4926559|NCT03274440|12118224|P1|STARTED|Overall Study||3
4926560|NCT03274076|12118237|P4|NOT COMPLETED|24 Weeks Open Label||1
4926561|NCT03274076|12118238|P3|NOT COMPLETED|24 Weeks Open Label||2
4926562|NCT03274076|12118239|P2|NOT COMPLETED|24 Weeks Open Label||0
4926563|NCT03274076|12118240|P1|NOT COMPLETED|24 Weeks Open Label||0
4926564|NCT03274076|12118237|P4|COMPLETED|24 Weeks Open Label||3
4926565|NCT03274076|12118238|P3|COMPLETED|24 Weeks Open Label||8
4926566|NCT03274076|12118239|P2|COMPLETED|24 Weeks Open Label||0
4926567|NCT03274076|12118240|P1|COMPLETED|24 Weeks Open Label||0
4926568|NCT03274076|12118237|P4|STARTED|24 Weeks Open Label||4
4926569|NCT03274076|12118238|P3|STARTED|24 Weeks Open Label||10
4926570|NCT03274076|12118239|P2|STARTED|24 Weeks Open Label||0
4926571|NCT03274076|12118240|P1|STARTED|24 Weeks Open Label||0
4926572|NCT03274076|12118237|P4|NOT COMPLETED|24 Weeks Double Blind||0
4926573|NCT03274076|12118238|P3|NOT COMPLETED|24 Weeks Double Blind||0
4926574|NCT03274076|12118239|P2|NOT COMPLETED|24 Weeks Double Blind||1
4926575|NCT03274076|12118240|P1|NOT COMPLETED|24 Weeks Double Blind||0
4926576|NCT03274076|12118237|P4|COMPLETED|24 Weeks Double Blind||0
4926577|NCT03274076|12118238|P3|COMPLETED|24 Weeks Double Blind||0
4926578|NCT03274076|12118239|P2|COMPLETED|24 Weeks Double Blind||4
4926579|NCT03274076|12118240|P1|COMPLETED|24 Weeks Double Blind||10
4926580|NCT03274076|12118237|P4|STARTED|24 Weeks Double Blind||0
4926581|NCT03274076|12118238|P3|STARTED|24 Weeks Double Blind||0
4926582|NCT03274076|12118239|P2|STARTED|24 Weeks Double Blind||5
4926583|NCT03274076|12118240|P1|STARTED|24 Weeks Double Blind||10
4926584|NCT03273946|12118268|P1|NOT COMPLETED|Overall Study||9
4926585|NCT03273946|12118268|P1|COMPLETED|Overall Study||149
4926586|NCT03273946|12118268|P1|STARTED|Overall Study||158
4926587|NCT03273426|12118276|P2|NOT COMPLETED|Overall Study||0
4926588|NCT03273426|12118277|P1|NOT COMPLETED|Overall Study||0
4926589|NCT03273426|12118276|P2|COMPLETED|Overall Study||20
4926590|NCT03273426|12118277|P1|COMPLETED|Overall Study||20
4926591|NCT03273426|12118276|P2|STARTED|Overall Study||20
4926592|NCT03273426|12118277|P1|STARTED|Overall Study||20
4926593|NCT03273387|12118288|P2|NOT COMPLETED|Overall Study||3
4926594|NCT03273387|12118289|P1|NOT COMPLETED|Overall Study||3
4926595|NCT03273387|12118288|P2|COMPLETED|Overall Study||10
4926596|NCT03273387|12118289|P1|COMPLETED|Overall Study||10
4926597|NCT03273387|12118288|P2|STARTED|Overall Study||13
4926598|NCT03273387|12118289|P1|STARTED|Overall Study||13
4926599|NCT03273283|12118301|P2|NOT COMPLETED|Overall Study||20
4926600|NCT03273283|12118302|P1|NOT COMPLETED|Overall Study||27
4926601|NCT03273283|12118301|P2|COMPLETED|Overall Study||81
4926602|NCT03273283|12118302|P1|COMPLETED|Overall Study||72
4926603|NCT03273283|12118301|P2|STARTED|Overall Study||101
4926604|NCT03273283|12118302|P1|STARTED|Overall Study||99
4926605|NCT03273153|12118312|P2|NOT COMPLETED|Overall Study||222
4926606|NCT03273153|12118313|P1|NOT COMPLETED|Overall Study||224
4926607|NCT03273153|12118312|P2|COMPLETED|Overall Study||0
4926608|NCT03273153|12118313|P1|COMPLETED|Overall Study||0
4926609|NCT03273153|12118312|P2|STARTED|Overall Study||222
4926610|NCT03273153|12118313|P1|STARTED|Overall Study||224
4926611|NCT03272711|12118335|P2|NOT COMPLETED|Overall Study||8
4926612|NCT03272711|12118336|P1|NOT COMPLETED|Overall Study||7
4926613|NCT03272711|12118335|P2|COMPLETED|Overall Study||41
4926614|NCT03272711|12118336|P1|COMPLETED|Overall Study||44
4926615|NCT03272711|12118335|P2|STARTED|Overall Study||49
4926616|NCT03272711|12118336|P1|STARTED|Overall Study||51
4926617|NCT03272139|12118348|P2|NOT COMPLETED|Overall Study||0
4926618|NCT03272139|12118349|P1|NOT COMPLETED|Overall Study||0
4926619|NCT03272139|12118348|P2|COMPLETED|Overall Study||63
4926620|NCT03272139|12118349|P1|COMPLETED|Overall Study||63
4926621|NCT03272139|12118348|P2|STARTED|Overall Study||63
4926622|NCT03272139|12118349|P1|STARTED|Overall Study||63
4926623|NCT03271424|12118362|P3|NOT COMPLETED|April-May 2016||0
4926624|NCT03271424|12118363|P2|NOT COMPLETED|April-May 2016||0
4926625|NCT03271424|12118364|P1|NOT COMPLETED|April-May 2016||0
4926626|NCT03271424|12118362|P3|COMPLETED|April-May 2016||40
4926627|NCT03271424|12118363|P2|COMPLETED|April-May 2016||0
4926628|NCT03271424|12118364|P1|COMPLETED|April-May 2016||0
4926629|NCT03271424|12118362|P3|STARTED|April-May 2016||40
4926630|NCT03271424|12118363|P2|STARTED|April-May 2016||0
4926631|NCT03271424|12118364|P1|STARTED|April-May 2016||0
4926632|NCT03271424|12118362|P3|NOT COMPLETED|December 2015||0
4926633|NCT03271424|12118363|P2|NOT COMPLETED|December 2015||0
4926634|NCT03271424|12118364|P1|NOT COMPLETED|December 2015||0
4926635|NCT03271424|12118362|P3|COMPLETED|December 2015||0
4926636|NCT03271424|12118363|P2|COMPLETED|December 2015||35
4926637|NCT03271424|12118364|P1|COMPLETED|December 2015||0
4926638|NCT03271424|12118362|P3|STARTED|December 2015||0
4926639|NCT03271424|12118363|P2|STARTED|December 2015||35
4926640|NCT03271424|12118364|P1|STARTED|December 2015||0
4926641|NCT03271424|12118362|P3|NOT COMPLETED|November 2015||0
4926642|NCT03271424|12118363|P2|NOT COMPLETED|November 2015||0
4926643|NCT03271424|12118364|P1|NOT COMPLETED|November 2015||0
4926644|NCT03271424|12118362|P3|COMPLETED|November 2015||0
4926645|NCT03271424|12118363|P2|COMPLETED|November 2015||0
4926646|NCT03271424|12118364|P1|COMPLETED|November 2015||20
4926647|NCT03271424|12118362|P3|STARTED|November 2015||0
4926648|NCT03271424|12118363|P2|STARTED|November 2015||0
4926649|NCT03271424|12118364|P1|STARTED|November 2015||20
4926650|NCT03271021|12118376|P2|NOT COMPLETED|Overall Study||106
4926651|NCT03271021|12118377|P1|NOT COMPLETED|Overall Study||89
4926652|NCT03271021|12118376|P2|COMPLETED|Overall Study||644
4926653|NCT03271021|12118377|P1|COMPLETED|Overall Study||649
4926654|NCT03271021|12118376|P2|STARTED|Overall Study||750
4926655|NCT03271021|12118377|P1|STARTED|Overall Study||738
4926656|NCT03270657|12118395|P1|NOT COMPLETED|Overall Study||1
4926657|NCT03270657|12118395|P1|COMPLETED|Overall Study||4
4926658|NCT03270657|12118395|P1|STARTED|Overall Study||5
4926659|NCT03270644|12118401|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
4926660|NCT03270644|12118401|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
4926661|NCT03270644|12118401|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
4926662|NCT03270644|12118401|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
4926663|NCT03270644|12118401|P1|STARTED|Day 4 - 10 Propranolol Reference||43
4926664|NCT03270644|12118401|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
4926665|NCT03270644|12118401|P1|COMPLETED|Day 1 Lasmiditan Reference||43
4926666|NCT03270644|12118401|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
4926667|NCT03270644|12118401|P1|STARTED|Day 1 Lasmiditan Reference||44
4926668|NCT03270085|12118424|P2|NOT COMPLETED|Overall Study||0
4926669|NCT03270085|12118425|P1|NOT COMPLETED|Overall Study||1
4926670|NCT03270085|12118424|P2|COMPLETED|Overall Study||15
4926671|NCT03270085|12118425|P1|COMPLETED|Overall Study||14
4926672|NCT03270085|12118424|P2|STARTED|Overall Study||15
4926673|NCT03270085|12118425|P1|STARTED|Overall Study||15
4926674|NCT03269552|12118435|P1|NOT COMPLETED|Overall Study||2
4926675|NCT03269552|12118435|P1|COMPLETED|Overall Study||2
4926676|NCT03269552|12118435|P1|STARTED|Overall Study||4
4926677|NCT03268941|12118446|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926678|NCT03268941|12118447|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926679|NCT03268941|12118448|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926680|NCT03268941|12118449|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926681|NCT03268941|12118450|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926682|NCT03268941|12118451|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926683|NCT03268941|12118452|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926684|NCT03268941|12118446|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926685|NCT03268941|12118447|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
4926686|NCT03268941|12118448|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926687|NCT03268941|12118449|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926688|NCT03268941|12118450|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926689|NCT03268941|12118451|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926690|NCT03268941|12118452|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
4926691|NCT03268941|12118446|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926692|NCT03268941|12118447|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
4926693|NCT03268941|12118448|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926694|NCT03268941|12118449|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926695|NCT03268941|12118450|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926696|NCT03268941|12118451|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926697|NCT03268941|12118452|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
4926698|NCT03268941|12118446|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
4926699|NCT03268941|12118447|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
4926700|NCT03268941|12118448|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
4926701|NCT03268941|12118449|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
4926702|NCT03268941|12118450|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
4926703|NCT03268941|12118451|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
4926704|NCT03268941|12118452|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
4926705|NCT03268941|12118446|P7|COMPLETED|Part 2: Days 17 to 25||13
4926706|NCT03268941|12118447|P6|COMPLETED|Part 2: Days 17 to 25||0
4926707|NCT03268941|12118448|P5|COMPLETED|Part 2: Days 17 to 25||6
4926708|NCT03268941|12118449|P4|COMPLETED|Part 2: Days 17 to 25||0
4926709|NCT03268941|12118450|P3|COMPLETED|Part 2: Days 17 to 25||0
4926710|NCT03268941|12118451|P2|COMPLETED|Part 2: Days 17 to 25||0
4926711|NCT03268941|12118452|P1|COMPLETED|Part 2: Days 17 to 25||0
4926712|NCT03268941|12118446|P7|Treated|Part 2: Days 17 to 25||13
4926713|NCT03268941|12118447|P6|Treated|Part 2: Days 17 to 25||0
4926714|NCT03268941|12118448|P5|Treated|Part 2: Days 17 to 25||6
4926715|NCT03268941|12118449|P4|Treated|Part 2: Days 17 to 25||0
4926716|NCT03268941|12118450|P3|Treated|Part 2: Days 17 to 25||0
4926717|NCT03268941|12118451|P2|Treated|Part 2: Days 17 to 25||0
4926718|NCT03268941|12118452|P1|Treated|Part 2: Days 17 to 25||0
4926719|NCT03268941|12118446|P7|STARTED|Part 2: Days 17 to 25||15
4926720|NCT03268941|12118447|P6|STARTED|Part 2: Days 17 to 25||0
4926721|NCT03268941|12118448|P5|STARTED|Part 2: Days 17 to 25||6
4926722|NCT03268941|12118449|P4|STARTED|Part 2: Days 17 to 25||0
4926723|NCT03268941|12118450|P3|STARTED|Part 2: Days 17 to 25||0
4926724|NCT03268941|12118451|P2|STARTED|Part 2: Days 17 to 25||0
4926725|NCT03268941|12118452|P1|STARTED|Part 2: Days 17 to 25||0
4926726|NCT03268941|12118446|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
4926727|NCT03268941|12118447|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
4926728|NCT03268941|12118448|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
4926729|NCT03268941|12118449|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
4926730|NCT03268941|12118450|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
4926731|NCT03268941|12118451|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
4926732|NCT03268941|12118452|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
4926733|NCT03268941|12118446|P7|COMPLETED|Part 1 (Days 1 to 9)||0
4926734|NCT03268941|12118447|P6|COMPLETED|Part 1 (Days 1 to 9)||0
4926735|NCT03268941|12118448|P5|COMPLETED|Part 1 (Days 1 to 9)||0
4926736|NCT03268941|12118449|P4|COMPLETED|Part 1 (Days 1 to 9)||11
4926737|NCT03268941|12118450|P3|COMPLETED|Part 1 (Days 1 to 9)||12
4926738|NCT03268941|12118451|P2|COMPLETED|Part 1 (Days 1 to 9)||14
4926739|NCT03268941|12118452|P1|COMPLETED|Part 1 (Days 1 to 9)||11
4926740|NCT03268941|12118446|P7|STARTED|Part 1 (Days 1 to 9)||0
4926741|NCT03268941|12118447|P6|STARTED|Part 1 (Days 1 to 9)||0
4926742|NCT03268941|12118448|P5|STARTED|Part 1 (Days 1 to 9)||0
4926743|NCT03268941|12118449|P4|STARTED|Part 1 (Days 1 to 9)||13
4926744|NCT03268941|12118450|P3|STARTED|Part 1 (Days 1 to 9)||12
4926745|NCT03268941|12118451|P2|STARTED|Part 1 (Days 1 to 9)||14
4926746|NCT03268941|12118452|P1|STARTED|Part 1 (Days 1 to 9)||12
4926747|NCT03268746|12118514|P1|NOT COMPLETED|Overall Study||1
4926748|NCT03268746|12118514|P1|COMPLETED|Overall Study||44
4926749|NCT03268746|12118514|P1|STARTED|Overall Study||45
4926750|NCT03268590|12118536|P1|NOT COMPLETED|Overall Study||1
4926751|NCT03268590|12118536|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
4926752|NCT03268590|12118536|P1|STARTED|Overall Study||33
4926753|NCT03268343|12118543|P2|NOT COMPLETED|Overall Study||0
4926754|NCT03268343|12118544|P1|NOT COMPLETED|Overall Study||0
4926755|NCT03268343|12118543|P2|COMPLETED|Overall Study||12
4926756|NCT03268343|12118544|P1|COMPLETED|Overall Study||12
4926757|NCT03268343|12118543|P2|STARTED|Overall Study||12
4926758|NCT03268343|12118544|P1|STARTED|Overall Study||12
4926759|NCT03268005|12118571|P2|NOT COMPLETED|Overall Study||14
4926760|NCT03268005|12118572|P1|NOT COMPLETED|Overall Study||15
4926761|NCT03268005|12118571|P2|COMPLETED|Overall Study||531
4926762|NCT03268005|12118572|P1|COMPLETED|Overall Study||531
4926763|NCT03268005|12118571|P2|Safety Analysis Set|Overall Study||544
4926764|NCT03268005|12118572|P1|Safety Analysis Set|Overall Study||544
4926765|NCT03268005|12118571|P2|Full Analysis Set|Overall Study||545
4926766|NCT03268005|12118572|P1|Full Analysis Set|Overall Study||546
4926767|NCT03268005|12118571|P2|STARTED|Overall Study||545
4926768|NCT03268005|12118572|P1|STARTED|Overall Study||546
4926769|NCT03267940|12118686|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
4926770|NCT03267940|12118687|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
4926771|NCT03267940|12118688|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
4926772|NCT03267940|12118689|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
4926773|NCT03267940|12118690|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926774|NCT03267940|12118691|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926775|NCT03267940|12118686|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926776|NCT03267940|12118687|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
4926777|NCT03267940|12118688|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926778|NCT03267940|12118689|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
4926779|NCT03267940|12118690|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926780|NCT03267940|12118691|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
4926781|NCT03267940|12118686|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
4926782|NCT03267940|12118687|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
4926783|NCT03267940|12118688|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
4926784|NCT03267940|12118689|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
4926785|NCT03267940|12118690|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
4926786|NCT03267940|12118691|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
4926787|NCT03267940|12118686|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
4926788|NCT03267940|12118687|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
4926789|NCT03267940|12118688|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
4926790|NCT03267940|12118689|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
4926791|NCT03267940|12118690|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
4926792|NCT03267940|12118691|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
4926793|NCT03267940|12118686|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926794|NCT03267940|12118687|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926795|NCT03267940|12118688|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926796|NCT03267940|12118689|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926797|NCT03267940|12118690|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
4926798|NCT03267940|12118691|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
4926799|NCT03267940|12118686|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926800|NCT03267940|12118687|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926801|NCT03267940|12118688|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926802|NCT03267940|12118689|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
4926803|NCT03267940|12118690|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
4926804|NCT03267940|12118691|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
4926805|NCT03267940|12118686|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
4926806|NCT03267940|12118687|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
4926807|NCT03267940|12118688|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
4926808|NCT03267940|12118689|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
4926809|NCT03267940|12118690|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
4926810|NCT03267940|12118691|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
4926811|NCT03267940|12118686|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
4926812|NCT03267940|12118687|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
4926813|NCT03267940|12118688|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
4926814|NCT03267940|12118689|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
4926815|NCT03267940|12118690|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
4926816|NCT03267940|12118691|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
4926817|NCT03267576|12118793|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
4926818|NCT03267576|12118794|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
4926819|NCT03267576|12118793|P2|COMPLETED|Period 2: Day 44 to 71||30
4926820|NCT03267576|12118794|P1|COMPLETED|Period 2: Day 44 to 71||30
4926821|NCT03267576|12118793|P2|STARTED|Period 2: Day 44 to 71||32
4926822|NCT03267576|12118794|P1|STARTED|Period 2: Day 44 to 71||31
4926823|NCT03267576|12118793|P2|NOT COMPLETED|Washout Period: 16 Days||0
4926824|NCT03267576|12118794|P1|NOT COMPLETED|Washout Period: 16 Days||0
4926825|NCT03267576|12118793|P2|COMPLETED|Washout Period: 16 Days||32
4926826|NCT03267576|12118794|P1|COMPLETED|Washout Period: 16 Days||31
4926827|NCT03267576|12118793|P2|STARTED|Washout Period: 16 Days||32
4926828|NCT03267576|12118794|P1|STARTED|Washout Period: 16 Days||31
4926829|NCT03267576|12118793|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
4926830|NCT03267576|12118794|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
4926831|NCT03267576|12118793|P2|COMPLETED|Period 1: Day 0 to 27||32
4926832|NCT03267576|12118794|P1|COMPLETED|Period 1: Day 0 to 27||31
4926833|NCT03267576|12118793|P2|STARTED|Period 1: Day 0 to 27||32
4926834|NCT03267576|12118794|P1|STARTED|Period 1: Day 0 to 27||31
4926835|NCT03267511|12118832|P4|NOT COMPLETED|Overall Study||1
4926836|NCT03267511|12118833|P3|NOT COMPLETED|Overall Study||0
4926837|NCT03267511|12118834|P2|NOT COMPLETED|Overall Study||0
4926838|NCT03267511|12118835|P1|NOT COMPLETED|Overall Study||0
4926839|NCT03267511|12118832|P4|COMPLETED|Overall Study||30
4926840|NCT03267511|12118833|P3|COMPLETED|Overall Study||30
4926841|NCT03267511|12118834|P2|COMPLETED|Overall Study||31
4926842|NCT03267511|12118835|P1|COMPLETED|Overall Study||31
4926843|NCT03267511|12118832|P4|STARTED|Overall Study||31
4926844|NCT03267511|12118833|P3|STARTED|Overall Study||30
4926845|NCT03267511|12118834|P2|STARTED|Overall Study||31
4926846|NCT03267511|12118835|P1|STARTED|Overall Study||31
4926847|NCT03267264|12118851|P4|NOT COMPLETED|Overall Study||4
4926848|NCT03267264|12118852|P3|NOT COMPLETED|Overall Study||2
4926849|NCT03267264|12118853|P2|NOT COMPLETED|Overall Study||0
4926850|NCT03267264|12118854|P1|NOT COMPLETED|Overall Study||1
4926851|NCT03267264|12118851|P4|COMPLETED|Overall Study||61
4926852|NCT03267264|12118852|P3|COMPLETED|Overall Study||66
4926853|NCT03267264|12118853|P2|COMPLETED|Overall Study||49
4926854|NCT03267264|12118854|P1|COMPLETED|Overall Study||65
4926855|NCT03267264|12118851|P4|Sequence B(Comparator)|Overall Study||32
4926856|NCT03267264|12118852|P3|Sequence B(Comparator)|Overall Study||33
4926857|NCT03267264|12118853|P2|Sequence B(Comparator)|Overall Study||24
4926858|NCT03267264|12118854|P1|Sequence B(Comparator)|Overall Study||32
4926859|NCT03267264|12118851|P4|Sequence A(Nucleus)|Overall Study||33
4926860|NCT03267264|12118852|P3|Sequence A(Nucleus)|Overall Study||33
4926861|NCT03267264|12118853|P2|Sequence A(Nucleus)|Overall Study||25
4926862|NCT03267264|12118854|P1|Sequence A(Nucleus)|Overall Study||34
4926863|NCT03267264|12118851|P4|STARTED|Overall Study||65
4926864|NCT03267264|12118852|P3|STARTED|Overall Study||68
4926865|NCT03267264|12118853|P2|STARTED|Overall Study||49
4926866|NCT03267264|12118854|P1|STARTED|Overall Study||66
4926867|NCT03267212|12118871|P2|NOT COMPLETED|Second Intervention||0
4926868|NCT03267212|12118872|P1|NOT COMPLETED|Second Intervention||0
4926869|NCT03267212|12118871|P2|COMPLETED|Second Intervention||6
4926870|NCT03267212|12118872|P1|COMPLETED|Second Intervention||4
4926871|NCT03267212|12118871|P2|STARTED|Second Intervention||6
4926872|NCT03267212|12118872|P1|STARTED|Second Intervention||4
4926873|NCT03267212|12118871|P2|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
4926874|NCT03267212|12118872|P1|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
4926875|NCT03267212|12118871|P2|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
4926876|NCT03267212|12118872|P1|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
4926877|NCT03267212|12118871|P2|STARTED|Washout (Min 2 Days / Max 7 Days)||6
4926878|NCT03267212|12118872|P1|STARTED|Washout (Min 2 Days / Max 7 Days)||5
4926879|NCT03267212|12118871|P2|NOT COMPLETED|First Intervention||3
4926880|NCT03267212|12118872|P1|NOT COMPLETED|First Intervention||1
4926881|NCT03267212|12118871|P2|COMPLETED|First Intervention||6
4926882|NCT03267212|12118872|P1|COMPLETED|First Intervention||5
4926883|NCT03267212|12118871|P2|Low SCI|First Intervention||4
4926884|NCT03267212|12118872|P1|Low SCI|First Intervention||4
4926885|NCT03267212|12118871|P2|High SCI|First Intervention||5
4926886|NCT03267212|12118872|P1|High SCI|First Intervention||2
4926887|NCT03267212|12118871|P2|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
4926888|NCT03267212|12118872|P1|STARTED|First Intervention|Non-invasive ventilation|6
4926889|NCT03266588|12118887|P3|NOT COMPLETED|Long-term Treatment Period||65
4926890|NCT03266588|12118888|P2|NOT COMPLETED|Long-term Treatment Period||240
4926891|NCT03266588|12118889|P1|NOT COMPLETED|Long-term Treatment Period||406
4926892|NCT03266588|12118887|P3|COMPLETED|Long-term Treatment Period||243
4926893|NCT03266588|12118888|P2|COMPLETED|Long-term Treatment Period||271
4926894|NCT03266588|12118889|P1|COMPLETED|Long-term Treatment Period||683
4926895|NCT03266588|12118887|P3|Treated|Long-term Treatment Period||286
4926896|NCT03266588|12118888|P2|Treated|Long-term Treatment Period||481
4926897|NCT03266588|12118889|P1|Treated|Long-term Treatment Period||1033
4926898|NCT03266588|12118887|P3|STARTED|Long-term Treatment Period||308
4926899|NCT03266588|12118888|P2|STARTED|Long-term Treatment Period||511
4926900|NCT03266588|12118889|P1|STARTED|Long-term Treatment Period||1089
4926901|NCT03266588|12118887|P3|NOT COMPLETED|Observational Period||168
4926902|NCT03266588|12118888|P2|NOT COMPLETED|Observational Period||275
4926903|NCT03266588|12118889|P1|NOT COMPLETED|Observational Period||516
4926904|NCT03266588|12118887|P3|COMPLETED|Observational Period||308
4926905|NCT03266588|12118888|P2|COMPLETED|Observational Period||511
4926906|NCT03266588|12118889|P1|COMPLETED|Observational Period||1089
4926907|NCT03266588|12118887|P3|STARTED|Observational Period||476
4926908|NCT03266588|12118888|P2|STARTED|Observational Period||786
4926909|NCT03266588|12118889|P1|STARTED|Observational Period||1605
4926910|NCT03266419|12118908|P2|NOT COMPLETED|Overall Study||0
4926911|NCT03266419|12118909|P1|NOT COMPLETED|Overall Study||0
4926912|NCT03266419|12118908|P2|COMPLETED|Overall Study||49
4926913|NCT03266419|12118909|P1|COMPLETED|Overall Study||51
4926914|NCT03266419|12118908|P2|STARTED|Overall Study||49
4926915|NCT03266419|12118909|P1|STARTED|Overall Study||51
4926916|NCT03266172|12118920|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
4926917|NCT03266172|12118921|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
4926918|NCT03266172|12118922|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
4926919|NCT03266172|12118920|P3|COMPLETED|Part C Period 6(2 Days)||14
4926920|NCT03266172|12118921|P2|COMPLETED|Part C Period 6(2 Days)||0
4926921|NCT03266172|12118922|P1|COMPLETED|Part C Period 6(2 Days)||0
4926922|NCT03266172|12118920|P3|STARTED|Part C Period 6(2 Days)||14
4926923|NCT03266172|12118921|P2|STARTED|Part C Period 6(2 Days)||0
4926924|NCT03266172|12118922|P1|STARTED|Part C Period 6(2 Days)||0
4926925|NCT03266172|12118920|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
4926926|NCT03266172|12118921|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926927|NCT03266172|12118922|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926928|NCT03266172|12118920|P3|COMPLETED|Part C Washout Period (7 Days)||14
4926929|NCT03266172|12118921|P2|COMPLETED|Part C Washout Period (7 Days)||0
4926930|NCT03266172|12118922|P1|COMPLETED|Part C Washout Period (7 Days)||0
4926931|NCT03266172|12118920|P3|STARTED|Part C Washout Period (7 Days)||15
4926932|NCT03266172|12118921|P2|STARTED|Part C Washout Period (7 Days)||0
4926933|NCT03266172|12118922|P1|STARTED|Part C Washout Period (7 Days)||0
4926934|NCT03266172|12118920|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
4926935|NCT03266172|12118921|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
4926936|NCT03266172|12118922|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
4926937|NCT03266172|12118920|P3|COMPLETED|Part C Period 5(2 Days)||15
4926938|NCT03266172|12118921|P2|COMPLETED|Part C Period 5(2 Days)||0
4926939|NCT03266172|12118922|P1|COMPLETED|Part C Period 5(2 Days)||0
4926940|NCT03266172|12118920|P3|STARTED|Part C Period 5(2 Days)||15
4926941|NCT03266172|12118921|P2|STARTED|Part C Period 5(2 Days)||0
4926942|NCT03266172|12118922|P1|STARTED|Part C Period 5(2 Days)||0
4926943|NCT03266172|12118920|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
4926944|NCT03266172|12118921|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926945|NCT03266172|12118922|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926946|NCT03266172|12118920|P3|COMPLETED|Part C Washout Period (7 Days)||15
4926947|NCT03266172|12118921|P2|COMPLETED|Part C Washout Period (7 Days)||0
4926948|NCT03266172|12118922|P1|COMPLETED|Part C Washout Period (7 Days)||0
4926949|NCT03266172|12118920|P3|STARTED|Part C Washout Period (7 Days)||16
4926950|NCT03266172|12118921|P2|STARTED|Part C Washout Period (7 Days)||0
4926951|NCT03266172|12118922|P1|STARTED|Part C Washout Period (7 Days)||0
4926952|NCT03266172|12118920|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
4926953|NCT03266172|12118921|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
4926954|NCT03266172|12118922|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
4926955|NCT03266172|12118920|P3|COMPLETED|Part C Period 4(2 Days)||16
4926956|NCT03266172|12118921|P2|COMPLETED|Part C Period 4(2 Days)||0
4926957|NCT03266172|12118922|P1|COMPLETED|Part C Period 4(2 Days)||0
4926958|NCT03266172|12118920|P3|STARTED|Part C Period 4(2 Days)||16
4926959|NCT03266172|12118921|P2|STARTED|Part C Period 4(2 Days)||0
4926960|NCT03266172|12118922|P1|STARTED|Part C Period 4(2 Days)||0
4926961|NCT03266172|12118920|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926962|NCT03266172|12118921|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926963|NCT03266172|12118922|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926964|NCT03266172|12118920|P3|COMPLETED|Part C Washout Period (7 Days)||16
4926965|NCT03266172|12118921|P2|COMPLETED|Part C Washout Period (7 Days)||0
4926966|NCT03266172|12118922|P1|COMPLETED|Part C Washout Period (7 Days)||0
4926967|NCT03266172|12118920|P3|STARTED|Part C Washout Period (7 Days)||16
4926968|NCT03266172|12118921|P2|STARTED|Part C Washout Period (7 Days)||0
4926969|NCT03266172|12118922|P1|STARTED|Part C Washout Period (7 Days)||0
4926970|NCT03266172|12118920|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
4926971|NCT03266172|12118921|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
4926972|NCT03266172|12118922|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
4926973|NCT03266172|12118920|P3|COMPLETED|Part C Period 3(2 Days)||16
4926974|NCT03266172|12118921|P2|COMPLETED|Part C Period 3(2 Days)||0
4926975|NCT03266172|12118922|P1|COMPLETED|Part C Period 3(2 Days)||0
4926976|NCT03266172|12118920|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
4926977|NCT03266172|12118921|P2|STARTED|Part C Period 3(2 Days)||0
4926978|NCT03266172|12118922|P1|STARTED|Part C Period 3(2 Days)||0
4926979|NCT03266172|12118920|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926980|NCT03266172|12118921|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926981|NCT03266172|12118922|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926982|NCT03266172|12118920|P3|COMPLETED|Part C Washout Period (7 Days)||15
4926983|NCT03266172|12118921|P2|COMPLETED|Part C Washout Period (7 Days)||0
4926984|NCT03266172|12118922|P1|COMPLETED|Part C Washout Period (7 Days)||0
4926985|NCT03266172|12118920|P3|STARTED|Part C Washout Period (7 Days)||15
4926986|NCT03266172|12118921|P2|STARTED|Part C Washout Period (7 Days)||0
4926987|NCT03266172|12118922|P1|STARTED|Part C Washout Period (7 Days)||0
4926988|NCT03266172|12118920|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
4926989|NCT03266172|12118921|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
4926990|NCT03266172|12118922|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
4926991|NCT03266172|12118920|P3|COMPLETED|Part C Period 2(2 Days)||15
4926992|NCT03266172|12118921|P2|COMPLETED|Part C Period 2(2 Days)||0
4926993|NCT03266172|12118922|P1|COMPLETED|Part C Period 2(2 Days)||0
4926994|NCT03266172|12118920|P3|STARTED|Part C Period 2(2 Days)||15
4926995|NCT03266172|12118921|P2|STARTED|Part C Period 2(2 Days)||0
4926996|NCT03266172|12118922|P1|STARTED|Part C Period 2(2 Days)||0
4926997|NCT03266172|12118920|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926998|NCT03266172|12118921|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
4926999|NCT03266172|12118922|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
4927000|NCT03266172|12118920|P3|COMPLETED|Part C Washout Period (7 Days)||15
4927001|NCT03266172|12118921|P2|COMPLETED|Part C Washout Period (7 Days)||0
4927002|NCT03266172|12118922|P1|COMPLETED|Part C Washout Period (7 Days)||0
4927003|NCT03266172|12118920|P3|STARTED|Part C Washout Period (7 Days)||15
4927004|NCT03266172|12118921|P2|STARTED|Part C Washout Period (7 Days)||0
4927005|NCT03266172|12118922|P1|STARTED|Part C Washout Period (7 Days)||0
4927006|NCT03266172|12118920|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
4927007|NCT03266172|12118921|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
4927008|NCT03266172|12118922|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
4927009|NCT03266172|12118920|P3|COMPLETED|Part C: Period 1(2 Days)||15
4927010|NCT03266172|12118921|P2|COMPLETED|Part C: Period 1(2 Days)||0
4927011|NCT03266172|12118922|P1|COMPLETED|Part C: Period 1(2 Days)||0
4927012|NCT03266172|12118920|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
4927013|NCT03266172|12118921|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
4927014|NCT03266172|12118922|P1|STARTED|Part C: Period 1(2 Days)||0
4927015|NCT03266172|12118920|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
4927016|NCT03266172|12118921|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
4927017|NCT03266172|12118922|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
4927018|NCT03266172|12118920|P3|COMPLETED|Part B: Period 3 (4 Days)||0
4927019|NCT03266172|12118921|P2|COMPLETED|Part B: Period 3 (4 Days)||6
4927020|NCT03266172|12118922|P1|COMPLETED|Part B: Period 3 (4 Days)||0
4927021|NCT03266172|12118920|P3|STARTED|Part B: Period 3 (4 Days)||0
4927022|NCT03266172|12118921|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
4927023|NCT03266172|12118922|P1|STARTED|Part B: Period 3 (4 Days)||0
4927024|NCT03266172|12118920|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
4927025|NCT03266172|12118921|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
4927026|NCT03266172|12118922|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
4927027|NCT03266172|12118920|P3|COMPLETED|Part B: Washout (7 Days)||0
4927028|NCT03266172|12118921|P2|COMPLETED|Part B: Washout (7 Days)||8
4927029|NCT03266172|12118922|P1|COMPLETED|Part B: Washout (7 Days)||0
4927030|NCT03266172|12118920|P3|STARTED|Part B: Washout (7 Days)||0
4927031|NCT03266172|12118921|P2|STARTED|Part B: Washout (7 Days)||10
4927032|NCT03266172|12118922|P1|STARTED|Part B: Washout (7 Days)||0
4927033|NCT03266172|12118920|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
4927034|NCT03266172|12118921|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
4927035|NCT03266172|12118922|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
4927036|NCT03266172|12118920|P3|COMPLETED|Part B: Period 2 (4 Days)||0
4927037|NCT03266172|12118921|P2|COMPLETED|Part B: Period 2 (4 Days)||10
4927038|NCT03266172|12118922|P1|COMPLETED|Part B: Period 2 (4 Days)||0
4927039|NCT03266172|12118920|P3|STARTED|Part B: Period 2 (4 Days)||0
4927040|NCT03266172|12118921|P2|STARTED|Part B: Period 2 (4 Days)||10
4927041|NCT03266172|12118922|P1|STARTED|Part B: Period 2 (4 Days)||0
4927042|NCT03266172|12118920|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
4927043|NCT03266172|12118921|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
4927044|NCT03266172|12118922|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
4927045|NCT03266172|12118920|P3|COMPLETED|Part B: Washout (7 Days)||0
4927046|NCT03266172|12118921|P2|COMPLETED|Part B: Washout (7 Days)||10
4927047|NCT03266172|12118922|P1|COMPLETED|Part B: Washout (7 Days)||0
4927048|NCT03266172|12118920|P3|STARTED|Part B: Washout (7 Days)||0
4927049|NCT03266172|12118921|P2|STARTED|Part B: Washout (7 Days)||10
4927050|NCT03266172|12118922|P1|STARTED|Part B: Washout (7 Days)||0
4927051|NCT03266172|12118920|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
4927052|NCT03266172|12118921|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
4927053|NCT03266172|12118922|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
4927054|NCT03266172|12118920|P3|COMPLETED|Part B: Period 1 (4 Days)||0
4927055|NCT03266172|12118921|P2|COMPLETED|Part B: Period 1 (4 Days)||10
4927056|NCT03266172|12118922|P1|COMPLETED|Part B: Period 1 (4 Days)||0
4927057|NCT03266172|12118920|P3|STARTED|Part B: Period 1 (4 Days)||0
4927058|NCT03266172|12118921|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
4927059|NCT03266172|12118922|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
4927060|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
4927061|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
4927062|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
4927063|NCT03266172|12118920|P3|COMPLETED|Part A: Period 4 (2 Days)||0
4927064|NCT03266172|12118921|P2|COMPLETED|Part A: Period 4 (2 Days)||0
4927065|NCT03266172|12118922|P1|COMPLETED|Part A: Period 4 (2 Days)||16
4927066|NCT03266172|12118920|P3|STARTED|Part A: Period 4 (2 Days)||0
4927067|NCT03266172|12118921|P2|STARTED|Part A: Period 4 (2 Days)||0
4927068|NCT03266172|12118922|P1|STARTED|Part A: Period 4 (2 Days)||16
4927069|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
4927070|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
4927071|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
4927072|NCT03266172|12118920|P3|COMPLETED|Part A: Washout (7 Days)||0
4927073|NCT03266172|12118921|P2|COMPLETED|Part A: Washout (7 Days)||0
4927074|NCT03266172|12118922|P1|COMPLETED|Part A: Washout (7 Days)||16
4927075|NCT03266172|12118920|P3|STARTED|Part A: Washout (7 Days)||0
4927076|NCT03266172|12118921|P2|STARTED|Part A: Washout (7 Days)||0
4927077|NCT03266172|12118922|P1|STARTED|Part A: Washout (7 Days)||16
4927078|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
4927079|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
4927080|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
4927081|NCT03266172|12118920|P3|COMPLETED|Part A: Period 3 (2 Days)||0
4927082|NCT03266172|12118921|P2|COMPLETED|Part A: Period 3 (2 Days)||0
4927083|NCT03266172|12118922|P1|COMPLETED|Part A: Period 3 (2 Days)||16
4927084|NCT03266172|12118920|P3|STARTED|Part A: Period 3 (2 Days)||0
4927085|NCT03266172|12118921|P2|STARTED|Part A: Period 3 (2 Days)||0
4927086|NCT03266172|12118922|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
4927087|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
4927088|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
4927089|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
4927090|NCT03266172|12118920|P3|COMPLETED|Part A: Washout (7 Days)||0
4927091|NCT03266172|12118921|P2|COMPLETED|Part A: Washout (7 Days)||0
4927092|NCT03266172|12118922|P1|COMPLETED|Part A: Washout (7 Days)||13
4927093|NCT03266172|12118920|P3|STARTED|Part A: Washout (7 Days)||0
4927094|NCT03266172|12118921|P2|STARTED|Part A: Washout (7 Days)||0
4927095|NCT03266172|12118922|P1|STARTED|Part A: Washout (7 Days)||13
4927096|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
4927097|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
4927098|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
4927099|NCT03266172|12118920|P3|COMPLETED|Part A: Period 2 (2 Days)||0
4927100|NCT03266172|12118921|P2|COMPLETED|Part A: Period 2 (2 Days)||0
4927101|NCT03266172|12118922|P1|COMPLETED|Part A: Period 2 (2 Days)||13
4927102|NCT03266172|12118920|P3|STARTED|Part A: Period 2 (2 Days)||0
4927103|NCT03266172|12118921|P2|STARTED|Part A: Period 2 (2 Days)||0
4927104|NCT03266172|12118922|P1|STARTED|Part A: Period 2 (2 Days)||13
4927105|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
4927106|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
4927107|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
4927108|NCT03266172|12118920|P3|COMPLETED|Part A: Washout Period (7 Days)||0
4927109|NCT03266172|12118921|P2|COMPLETED|Part A: Washout Period (7 Days)||0
4927110|NCT03266172|12118922|P1|COMPLETED|Part A: Washout Period (7 Days)||13
4927111|NCT03266172|12118920|P3|STARTED|Part A: Washout Period (7 Days)||0
4927112|NCT03266172|12118921|P2|STARTED|Part A: Washout Period (7 Days)||0
4927113|NCT03266172|12118922|P1|STARTED|Part A: Washout Period (7 Days)||15
4927114|NCT03266172|12118920|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
4927115|NCT03266172|12118921|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
4927116|NCT03266172|12118922|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
4927117|NCT03266172|12118920|P3|COMPLETED|Part A: Period 1(2 Days)||0
4927118|NCT03266172|12118921|P2|COMPLETED|Part A: Period 1(2 Days)||0
4927119|NCT03266172|12118922|P1|COMPLETED|Part A: Period 1(2 Days)||15
4927120|NCT03266172|12118920|P3|STARTED|Part A: Period 1(2 Days)||0
4927121|NCT03266172|12118921|P2|STARTED|Part A: Period 1(2 Days)||0
4927122|NCT03266172|12118922|P1|STARTED|Part A: Period 1(2 Days)||16
4927123|NCT03266094|12119167|P1|NOT COMPLETED|Overall Study||2
4927124|NCT03266094|12119167|P1|COMPLETED|Overall Study||58
4927125|NCT03266094|12119167|P1|STARTED|Overall Study||60
4927126|NCT03265938|12119185|P1|NOT COMPLETED|Overall Study||8
4927127|NCT03265938|12119185|P1|COMPLETED|Overall Study||92
4927128|NCT03265938|12119185|P1|STARTED|Overall Study||100
4927129|NCT03265600|12119198|P2|NOT COMPLETED|Overall Study||12
4927130|NCT03265600|12119199|P1|NOT COMPLETED|Overall Study||24
4927131|NCT03265600|12119198|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
4927132|NCT03265600|12119199|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
4927133|NCT03265600|12119198|P2|STARTED|Overall Study||44
4927134|NCT03265600|12119199|P1|STARTED|Overall Study||92
4927135|NCT03265132|12119225|P2|NOT COMPLETED|Overall Study||6
4927136|NCT03265132|12119226|P1|NOT COMPLETED|Overall Study||0
4927137|NCT03265132|12119225|P2|COMPLETED|Overall Study||0
4927138|NCT03265132|12119226|P1|COMPLETED|Overall Study||6
4927139|NCT03265132|12119225|P2|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
4927140|NCT03265132|12119226|P1|STARTED|Overall Study||6
4927141|NCT03265119|12119324|P2|NOT COMPLETED|Overall Study||7
4927142|NCT03265119|12119325|P1|NOT COMPLETED|Overall Study||10
4927143|NCT03265119|12119324|P2|COMPLETED|Overall Study||28
4927144|NCT03265119|12119325|P1|COMPLETED|Overall Study||24
4927145|NCT03265119|12119324|P2|STARTED|Overall Study||35
4927146|NCT03265119|12119325|P1|STARTED|Overall Study||34
4927147|NCT03264456|12119333|P1|NOT COMPLETED|Overall Study||4
4927148|NCT03264456|12119333|P1|COMPLETED|Overall Study||14
4927149|NCT03264456|12119333|P1|STARTED|Overall Study||18
4927150|NCT03264248|12119340|P1|NOT COMPLETED|Overall Study||0
4927151|NCT03264248|12119340|P1|COMPLETED|Overall Study||9
4927152|NCT03264248|12119340|P1|STARTED|Overall Study||9
4927153|NCT03264157|12119349|P2|NOT COMPLETED|Overall Study||7
4927154|NCT03264157|12119350|P1|NOT COMPLETED|Overall Study||13
4927155|NCT03264157|12119349|P2|COMPLETED|Overall Study||74
4927156|NCT03264157|12119350|P1|COMPLETED|Overall Study||68
4927157|NCT03264157|12119349|P2|STARTED|Overall Study||81
4927158|NCT03264157|12119350|P1|STARTED|Overall Study||81
4927159|NCT03263806|12119368|P2|NOT COMPLETED|Overall Study||7
4927160|NCT03263806|12119369|P1|NOT COMPLETED|Overall Study||6
4927161|NCT03263806|12119368|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
4927162|NCT03263806|12119369|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
4927163|NCT03263806|12119368|P2|STARTED|Overall Study||7
4927164|NCT03263806|12119369|P1|STARTED|Overall Study||6
4927165|NCT03263702|12119383|P2|NOT COMPLETED|Overall Study||4
4927166|NCT03263702|12119384|P1|NOT COMPLETED|Overall Study||3
4927167|NCT03263702|12119383|P2|COMPLETED|Overall Study||22
4927168|NCT03263702|12119384|P1|COMPLETED|Overall Study||35
4927169|NCT03263702|12119383|P2|STARTED|Overall Study||26
4927170|NCT03263702|12119384|P1|STARTED|Overall Study||38
4927171|NCT03262233|12119414|P4|NOT COMPLETED|Overall Study||29
4927172|NCT03262233|12119415|P3|NOT COMPLETED|Overall Study||25
4927173|NCT03262233|12119416|P2|NOT COMPLETED|Overall Study||21
4927174|NCT03262233|12119417|P1|NOT COMPLETED|Overall Study||18
4927175|NCT03262233|12119414|P4|COMPLETED|Overall Study||32
4927176|NCT03262233|12119415|P3|COMPLETED|Overall Study||34
4927177|NCT03262233|12119416|P2|COMPLETED|Overall Study||32
4927178|NCT03262233|12119417|P1|COMPLETED|Overall Study||35
4927179|NCT03262233|12119414|P4|STARTED|Overall Study||61
4927180|NCT03262233|12119415|P3|STARTED|Overall Study||59
4927181|NCT03262233|12119416|P2|STARTED|Overall Study||53
4927182|NCT03262233|12119417|P1|STARTED|Overall Study||53
4927183|NCT03262012|12119443|P4|NOT COMPLETED|Overall Study||15
4927184|NCT03262012|12119444|P3|NOT COMPLETED|Overall Study||14
4927185|NCT03262012|12119445|P2|NOT COMPLETED|Overall Study||36
4927186|NCT03262012|12119446|P1|NOT COMPLETED|Overall Study||27
4927187|NCT03262012|12119443|P4|COMPLETED|Overall Study||54
4927188|NCT03262012|12119444|P3|COMPLETED|Overall Study||56
4927189|NCT03262012|12119445|P2|COMPLETED|Overall Study||102
4927190|NCT03262012|12119446|P1|COMPLETED|Overall Study||112
4927191|NCT03262012|12119443|P4|STARTED|Overall Study||69
4927192|NCT03262012|12119444|P3|STARTED|Overall Study||70
4927193|NCT03262012|12119445|P2|STARTED|Overall Study||138
4927194|NCT03262012|12119446|P1|STARTED|Overall Study||139
4927195|NCT03261999|12119464|P1|NOT COMPLETED|Overall Study||15
4927196|NCT03261999|12119464|P1|COMPLETED|Overall Study||129
4927197|NCT03261999|12119464|P1|PP|Overall Study||132
4927198|NCT03261999|12119464|P1|ITT|Overall Study||144
4927199|NCT03261999|12119464|P1|STARTED|Overall Study||144
4927200|NCT03261531|12119469|P1|NOT COMPLETED|Overall Study||4
4927201|NCT03261531|12119469|P1|COMPLETED|Overall Study||3
4927202|NCT03261531|12119469|P1|STARTED|Overall Study||7
4927203|NCT03261167|12119487|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
4927204|NCT03261167|12119488|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
4927205|NCT03261167|12119487|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
4927206|NCT03261167|12119488|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
4927207|NCT03261167|12119487|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
4927208|NCT03261167|12119488|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
4927209|NCT03261167|12119487|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
4927210|NCT03261167|12119488|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
4927211|NCT03261167|12119487|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
4927212|NCT03261167|12119488|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
4927213|NCT03261167|12119487|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
4927214|NCT03261167|12119488|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
4927215|NCT03261167|12119487|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
4927216|NCT03261167|12119488|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
4927217|NCT03261167|12119487|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
4927218|NCT03261167|12119488|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
4927219|NCT03261167|12119487|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
4927220|NCT03261167|12119488|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
4927221|NCT03261167|12119487|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
4927222|NCT03261167|12119488|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
4927223|NCT03261167|12119487|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
4927224|NCT03261167|12119488|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
4927225|NCT03261167|12119487|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
4927226|NCT03261167|12119488|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
4927227|NCT03260894|12119526|P2|NOT COMPLETED|Overall Study||50
4927228|NCT03260894|12119527|P1|NOT COMPLETED|Overall Study||46
4927229|NCT03260894|12119526|P2|COMPLETED|Overall Study||15
4927230|NCT03260894|12119527|P1|COMPLETED|Overall Study||18
4927231|NCT03260894|12119526|P2|All Subjects as Treated (ASaT)|Overall Study||63
4927232|NCT03260894|12119527|P1|All Subjects as Treated (ASaT)|Overall Study||64
4927233|NCT03260894|12119526|P2|Intention-to-Treat (ITT)|Overall Study||65
4927234|NCT03260894|12119527|P1|Intention-to-Treat (ITT)|Overall Study||64
4927235|NCT03260894|12119526|P2|STARTED|Overall Study||65
4927236|NCT03260894|12119527|P1|STARTED|Overall Study||64
4927237|NCT03260868|12119539|P2|NOT COMPLETED|Overall Study||3
4927238|NCT03260868|12119540|P1|NOT COMPLETED|Overall Study||3
4927239|NCT03260868|12119539|P2|COMPLETED|Overall Study||4
4927240|NCT03260868|12119540|P1|COMPLETED|Overall Study||5
4927241|NCT03260868|12119539|P2|Safety Population|Overall Study||6
4927242|NCT03260868|12119540|P1|Safety Population|Overall Study||8
4927243|NCT03260868|12119539|P2|STARTED|Overall Study||7
4927244|NCT03260868|12119540|P1|STARTED|Overall Study||8
4927245|NCT03260699|12119580|P2|NOT COMPLETED|Overall Study||2
4927246|NCT03260699|12119581|P1|NOT COMPLETED|Overall Study||0
4927247|NCT03260699|12119580|P2|COMPLETED|Overall Study||2
4927248|NCT03260699|12119581|P1|COMPLETED|Overall Study||5
4927249|NCT03260699|12119580|P2|STARTED|Overall Study||4
4927250|NCT03260699|12119581|P1|STARTED|Overall Study||5
4927251|NCT03260595|12119610|P3|NOT COMPLETED|Overall Study||0
4927252|NCT03260595|12119611|P2|NOT COMPLETED|Overall Study||0
4927253|NCT03260595|12119612|P1|NOT COMPLETED|Overall Study||0
4927254|NCT03260595|12119610|P3|COMPLETED|Overall Study||2
4927255|NCT03260595|12119611|P2|COMPLETED|Overall Study||10
4927256|NCT03260595|12119612|P1|COMPLETED|Overall Study||20
4927257|NCT03260595|12119610|P3|STARTED|Overall Study||2
4927258|NCT03260595|12119611|P2|STARTED|Overall Study||10
4927259|NCT03260595|12119612|P1|STARTED|Overall Study||20
4927260|NCT03260426|12119636|P2|NOT COMPLETED|Overall Study||0
4927261|NCT03260426|12119637|P1|NOT COMPLETED|Overall Study||0
4927262|NCT03260426|12119636|P2|COMPLETED|Overall Study||50
4927263|NCT03260426|12119637|P1|COMPLETED|Overall Study||50
4927264|NCT03260426|12119636|P2|STARTED|Overall Study||50
4927265|NCT03260426|12119637|P1|STARTED|Overall Study||50
4927266|NCT03260205|12119662|P5|NOT COMPLETED|Overall Study||14
4927267|NCT03260205|12119663|P4|NOT COMPLETED|Overall Study||7
4927268|NCT03260205|12119664|P3|NOT COMPLETED|Overall Study||11
4927269|NCT03260205|12119665|P2|NOT COMPLETED|Overall Study||8
4927270|NCT03260205|12119666|P1|NOT COMPLETED|Overall Study||9
4927271|NCT03260205|12119662|P5|COMPLETED|Overall Study||25
4927272|NCT03260205|12119663|P4|COMPLETED|Overall Study||30
4927273|NCT03260205|12119664|P3|COMPLETED|Overall Study||26
4927274|NCT03260205|12119665|P2|COMPLETED|Overall Study||32
4927275|NCT03260205|12119666|P1|COMPLETED|Overall Study||37
4927276|NCT03260205|12119662|P5|Received Treatment|Overall Study||38
4927277|NCT03260205|12119663|P4|Received Treatment|Overall Study||34
4927278|NCT03260205|12119664|P3|Received Treatment|Overall Study||35
4927279|NCT03260205|12119665|P2|Received Treatment|Overall Study||39
4927280|NCT03260205|12119666|P1|Received Treatment|Overall Study||45
4927281|NCT03260205|12119662|P5|STARTED|Overall Study||39
4927282|NCT03260205|12119663|P4|STARTED|Overall Study||37
4927283|NCT03260205|12119664|P3|STARTED|Overall Study||37
4927284|NCT03260205|12119665|P2|STARTED|Overall Study||40
4927285|NCT03260205|12119666|P1|STARTED|Overall Study||46
4927286|NCT03259555|12119729|P2|NOT COMPLETED|Overall Study||30
4927287|NCT03259555|12119730|P1|NOT COMPLETED|Overall Study||34
4927288|NCT03259555|12119729|P2|COMPLETED|Overall Study||134
4927289|NCT03259555|12119730|P1|COMPLETED|Overall Study||124
4927290|NCT03259555|12119729|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
4927291|NCT03259555|12119730|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
4927292|NCT03259555|12119729|P2|STARTED|Overall Study||164
4927293|NCT03259555|12119730|P1|STARTED|Overall Study||158
4927294|NCT03259490|12119740|P2|NOT COMPLETED|Period 2||0
4927295|NCT03259490|12119741|P1|NOT COMPLETED|Period 2||1
4927296|NCT03259490|12119740|P2|COMPLETED|Period 2||14
4927297|NCT03259490|12119741|P1|COMPLETED|Period 2||14
4927298|NCT03259490|12119740|P2|STARTED|Period 2||14
4927299|NCT03259490|12119741|P1|STARTED|Period 2||15
4927300|NCT03259490|12119740|P2|NOT COMPLETED|Period 1||1
4927301|NCT03259490|12119741|P1|NOT COMPLETED|Period 1||0
4927302|NCT03259490|12119740|P2|COMPLETED|Period 1||14
4927303|NCT03259490|12119741|P1|COMPLETED|Period 1||15
4927304|NCT03259490|12119740|P2|STARTED|Period 1||15
4927305|NCT03259490|12119741|P1|STARTED|Period 1||15
4927306|NCT03259425|12119763|P1|NOT COMPLETED|Overall Study||1
4927307|NCT03259425|12119763|P1|COMPLETED|Overall Study||6
4927308|NCT03259425|12119763|P1|Surgery|Overall Study||6
4927309|NCT03259425|12119763|P1|STARTED|Overall Study||7
4927310|NCT03259139|12119773|P6|NOT COMPLETED|Overall Study||6
4927311|NCT03259139|12119774|P5|NOT COMPLETED|Overall Study||6
4927312|NCT03259139|12119775|P4|NOT COMPLETED|Overall Study||5
4927313|NCT03259139|12119776|P3|NOT COMPLETED|Overall Study||5
4927314|NCT03259139|12119777|P2|NOT COMPLETED|Overall Study||4
4927315|NCT03259139|12119778|P1|NOT COMPLETED|Overall Study||4
4927316|NCT03259139|12119773|P6|COMPLETED|Overall Study||35
4927317|NCT03259139|12119774|P5|COMPLETED|Overall Study||35
4927318|NCT03259139|12119775|P4|COMPLETED|Overall Study||37
4927319|NCT03259139|12119776|P3|COMPLETED|Overall Study||37
4927320|NCT03259139|12119777|P2|COMPLETED|Overall Study||38
4927321|NCT03259139|12119778|P1|COMPLETED|Overall Study||38
4927322|NCT03259139|12119773|P6|Found Handgun|Overall Study||35
4927323|NCT03259139|12119774|P5|Found Handgun|Overall Study||35
4927324|NCT03259139|12119775|P4|Found Handgun|Overall Study||37
4927325|NCT03259139|12119776|P3|Found Handgun|Overall Study||37
4927326|NCT03259139|12119777|P2|Found Handgun|Overall Study||38
4927327|NCT03259139|12119778|P1|Found Handgun|Overall Study||38
4927328|NCT03259139|12119773|P6|Outlier Elimination|Overall Study||39
4927329|NCT03259139|12119774|P5|Outlier Elimination|Overall Study||39
4927330|NCT03259139|12119775|P4|Outlier Elimination|Overall Study||41
4927331|NCT03259139|12119776|P3|Outlier Elimination|Overall Study||41
4927332|NCT03259139|12119777|P2|Outlier Elimination|Overall Study||41
4927333|NCT03259139|12119778|P1|Outlier Elimination|Overall Study||41
4927334|NCT03259139|12119773|P6|Eligible|Overall Study||41
4927335|NCT03259139|12119774|P5|Eligible|Overall Study||41
4927336|NCT03259139|12119775|P4|Eligible|Overall Study||41
4927337|NCT03259139|12119776|P3|Eligible|Overall Study||41
4927338|NCT03259139|12119777|P2|Eligible|Overall Study||41
4927339|NCT03259139|12119778|P1|Eligible|Overall Study||41
4927340|NCT03259139|12119773|P6|STARTED|Overall Study||41
4927341|NCT03259139|12119774|P5|STARTED|Overall Study||41
4927342|NCT03259139|12119775|P4|STARTED|Overall Study||42
4927343|NCT03259139|12119776|P3|STARTED|Overall Study||42
4927344|NCT03259139|12119777|P2|STARTED|Overall Study||42
4927345|NCT03259139|12119778|P1|STARTED|Overall Study||42
4927346|NCT03259087|12119809|P5|NOT COMPLETED|Period 2 of Part 2||1
4927347|NCT03259087|12119810|P4|NOT COMPLETED|Period 2 of Part 2||0
4927348|NCT03259087|12119811|P3|NOT COMPLETED|Period 2 of Part 2||0
4927349|NCT03259087|12119812|P2|NOT COMPLETED|Period 2 of Part 2||0
4927350|NCT03259087|12119813|P1|NOT COMPLETED|Period 2 of Part 2||0
4927351|NCT03259087|12119809|P5|COMPLETED|Period 2 of Part 2||6
4927352|NCT03259087|12119810|P4|COMPLETED|Period 2 of Part 2||0
4927353|NCT03259087|12119811|P3|COMPLETED|Period 2 of Part 2||0
4927354|NCT03259087|12119812|P2|COMPLETED|Period 2 of Part 2||0
4927355|NCT03259087|12119813|P1|COMPLETED|Period 2 of Part 2||0
4927356|NCT03259087|12119809|P5|STARTED|Period 2 of Part 2||7
4927357|NCT03259087|12119810|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
4927358|NCT03259087|12119811|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
4927359|NCT03259087|12119812|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
4927360|NCT03259087|12119813|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
4927361|NCT03259087|12119809|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
4927362|NCT03259087|12119810|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
4927363|NCT03259087|12119811|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
4927364|NCT03259087|12119812|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
4927365|NCT03259087|12119813|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
4927366|NCT03259087|12119809|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
4927367|NCT03259087|12119810|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
4927368|NCT03259087|12119811|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
4927369|NCT03259087|12119812|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
4927370|NCT03259087|12119813|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
4927371|NCT03259087|12119809|P5|STARTED|Part 1 and Period 1 of Part 2||8
4927372|NCT03259087|12119810|P4|STARTED|Part 1 and Period 1 of Part 2||10
4927373|NCT03259087|12119811|P3|STARTED|Part 1 and Period 1 of Part 2||8
4927374|NCT03259087|12119812|P2|STARTED|Part 1 and Period 1 of Part 2||8
4927375|NCT03259087|12119813|P1|STARTED|Part 1 and Period 1 of Part 2||8
4927376|NCT03258814|12119941|P3|NOT COMPLETED|Overall Study||10
4927377|NCT03258814|12119942|P2|NOT COMPLETED|Overall Study||3
4927378|NCT03258814|12119943|P1|NOT COMPLETED|Overall Study||4
4927379|NCT03258814|12119941|P3|COMPLETED|Overall Study||0
4927380|NCT03258814|12119942|P2|COMPLETED|Overall Study||0
4927381|NCT03258814|12119943|P1|COMPLETED|Overall Study||0
4927382|NCT03258814|12119941|P3|STARTED|Overall Study||10
4927383|NCT03258814|12119942|P2|STARTED|Overall Study||3
4927384|NCT03258814|12119943|P1|STARTED|Overall Study||4
4927385|NCT03258762|12119998|P2|NOT COMPLETED|Overall Study||1
4927386|NCT03258762|12119999|P1|NOT COMPLETED|Overall Study||0
4927387|NCT03258762|12119998|P2|COMPLETED|Overall Study||6
4927388|NCT03258762|12119999|P1|COMPLETED|Overall Study||7
4927389|NCT03258762|12119998|P2|STARTED|Overall Study||7
4927390|NCT03258762|12119999|P1|STARTED|Overall Study||7
4927391|NCT03258710|12120059|P1|NOT COMPLETED|Overall Study||2
4927392|NCT03258710|12120059|P1|COMPLETED|Overall Study||73
4927393|NCT03258710|12120059|P1|STARTED|Overall Study||75
4927394|NCT03258645|12120097|P1|NOT COMPLETED|Overall Study||0
4927395|NCT03258645|12120097|P1|COMPLETED|Overall Study||1489
4927396|NCT03258645|12120097|P1|STARTED|Overall Study||1489
4927397|NCT03257995|12120152|P6|NOT COMPLETED|Overall Study||2
4927398|NCT03257995|12120153|P5|NOT COMPLETED|Overall Study||0
4927399|NCT03257995|12120154|P4|NOT COMPLETED|Overall Study||0
4927400|NCT03257995|12120155|P3|NOT COMPLETED|Overall Study||0
4927401|NCT03257995|12120156|P2|NOT COMPLETED|Overall Study||1
4927402|NCT03257995|12120157|P1|NOT COMPLETED|Overall Study||0
4927403|NCT03257995|12120152|P6|COMPLETED|Overall Study||7
4927404|NCT03257995|12120153|P5|COMPLETED|Overall Study||9
4927405|NCT03257995|12120154|P4|COMPLETED|Overall Study||9
4927406|NCT03257995|12120155|P3|COMPLETED|Overall Study||9
4927407|NCT03257995|12120156|P2|COMPLETED|Overall Study||8
4927408|NCT03257995|12120157|P1|COMPLETED|Overall Study||9
4927409|NCT03257995|12120152|P6|STARTED|Overall Study||9
4927410|NCT03257995|12120153|P5|STARTED|Overall Study||9
4927411|NCT03257995|12120154|P4|STARTED|Overall Study||9
4927412|NCT03257995|12120155|P3|STARTED|Overall Study||9
4927413|NCT03257995|12120156|P2|STARTED|Overall Study||9
4927414|NCT03257995|12120157|P1|STARTED|Overall Study||9
4927415|NCT03257865|12120207|P2|NOT COMPLETED|Overall Study||35
4927416|NCT03257865|12120208|P1|NOT COMPLETED|Overall Study||35
4927417|NCT03257865|12120207|P2|COMPLETED|Overall Study||135
4927418|NCT03257865|12120208|P1|COMPLETED|Overall Study||128
4927419|NCT03257865|12120207|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
4927420|NCT03257865|12120208|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
4927421|NCT03257865|12120207|P2|STARTED|Overall Study||170
4927422|NCT03257865|12120208|P1|STARTED|Overall Study||163
4927423|NCT03257813|12120218|P2|NOT COMPLETED|Overall Study||3
4927424|NCT03257813|12120219|P1|NOT COMPLETED|Overall Study||6
4927425|NCT03257813|12120218|P2|COMPLETED|Overall Study||27
4927426|NCT03257813|12120219|P1|COMPLETED|Overall Study||24
4927427|NCT03257813|12120218|P2|STARTED|Overall Study||30
4927428|NCT03257813|12120219|P1|STARTED|Overall Study||30
4927429|NCT03257657|12120241|P2|NOT COMPLETED|Overall Study||5
4927430|NCT03257657|12120242|P1|NOT COMPLETED|Overall Study||0
4927431|NCT03257657|12120241|P2|COMPLETED|Overall Study||15
4927432|NCT03257657|12120242|P1|COMPLETED|Overall Study||22
4927433|NCT03257657|12120241|P2|STARTED|Overall Study||20
4927434|NCT03257657|12120242|P1|STARTED|Overall Study||22
4927435|NCT03257631|12120273|P4|NOT COMPLETED|Overall Study||10
4927436|NCT03257631|12120274|P3|NOT COMPLETED|Overall Study||23
4927437|NCT03257631|12120275|P2|NOT COMPLETED|Overall Study||9
4927438|NCT03257631|12120276|P1|NOT COMPLETED|Overall Study||11
4927439|NCT03257631|12120273|P4|COMPLETED|Overall Study||0
4927440|NCT03257631|12120274|P3|COMPLETED|Overall Study||0
4927441|NCT03257631|12120275|P2|COMPLETED|Overall Study||0
4927442|NCT03257631|12120276|P1|COMPLETED|Overall Study||0
4927443|NCT03257631|12120273|P4|Received Study Drug|Overall Study||10
4927444|NCT03257631|12120274|P3|Received Study Drug|Overall Study||22
4927445|NCT03257631|12120275|P2|Received Study Drug|Overall Study||9
4927446|NCT03257631|12120276|P1|Received Study Drug|Overall Study||11
4927447|NCT03257631|12120273|P4|STARTED|Overall Study||10
4927448|NCT03257631|12120274|P3|STARTED|Overall Study||23
4927449|NCT03257631|12120275|P2|STARTED|Overall Study||9
4927450|NCT03257631|12120276|P1|STARTED|Overall Study||11
4927451|NCT03257358|12120312|P2|NOT COMPLETED|Overall Study||34
4927452|NCT03257358|12120313|P1|NOT COMPLETED|Overall Study||71
4927453|NCT03257358|12120312|P2|COMPLETED|Overall Study||183
4927454|NCT03257358|12120313|P1|COMPLETED|Overall Study||94
4927455|NCT03257358|12120312|P2|Never Received Treatment|Overall Study||0
4927456|NCT03257358|12120313|P1|Never Received Treatment|Overall Study||2
4927457|NCT03257358|12120312|P2|STARTED|Overall Study||217
4927458|NCT03257358|12120313|P1|STARTED|Overall Study||165
4927459|NCT03257202|12120413|P1|NOT COMPLETED|Overall Study||0
4927460|NCT03257202|12120413|P1|COMPLETED|Overall Study||12
4927461|NCT03257202|12120413|P1|STARTED|Overall Study||12
4927462|NCT03257189|12120423|P1|NOT COMPLETED|Overall Study||0
4927463|NCT03257189|12120423|P1|COMPLETED|Overall Study||30
4927464|NCT03257189|12120423|P1|STARTED|Overall Study||30
4927465|NCT03256968|12120435|P1|NOT COMPLETED|Overall Study||0
4927466|NCT03256968|12120435|P1|COMPLETED|Overall Study||1
4927467|NCT03256968|12120435|P1|STARTED|Overall Study||1
4927468|NCT03256851|12120441|P2|NOT COMPLETED|Overall Study||0
4927469|NCT03256851|12120442|P1|NOT COMPLETED|Overall Study||1
4927470|NCT03256851|12120441|P2|COMPLETED|Overall Study||10
4927471|NCT03256851|12120442|P1|COMPLETED|Overall Study||9
4927472|NCT03256851|12120441|P2|STARTED|Overall Study||10
4927473|NCT03256851|12120442|P1|STARTED|Overall Study||10
4927474|NCT03256799|12120450|P1|NOT COMPLETED|Overall Study||0
4927475|NCT03256799|12120450|P1|COMPLETED|Overall Study||1
4927476|NCT03256799|12120450|P1|STARTED|Overall Study||1
4927477|NCT03256695|12120454|P1|NOT COMPLETED|Overall Study||39
4927478|NCT03256695|12120454|P1|COMPLETED|Overall Study||366
4927479|NCT03256695|12120454|P1|Used ABS eMDPI at Least Once|Overall Study||390
4927480|NCT03256695|12120454|P1|STARTED|Overall Study||405
4927481|NCT03256552|12120462|P1|NOT COMPLETED|Overall Study||5
4927482|NCT03256552|12120462|P1|COMPLETED|Overall Study||61
4927483|NCT03256552|12120462|P1|Placebo MDI|Overall Study||65
4927484|NCT03256552|12120462|P1|GP MDI 7.2 µg|Overall Study||62
4927485|NCT03256552|12120462|P1|GP MDI 14.4 µg|Overall Study||63
4927486|NCT03256552|12120462|P1|GP MDI 28.8 µg|Overall Study||61
4927487|NCT03256552|12120462|P1|STARTED|Overall Study||66
4927488|NCT03256526|12120487|P3|NOT COMPLETED|Overall Study||3
4927489|NCT03256526|12120488|P2|NOT COMPLETED|Overall Study||0
4927490|NCT03256526|12120489|P1|NOT COMPLETED|Overall Study||2
4927491|NCT03256526|12120487|P3|COMPLETED|Overall Study||14
4927492|NCT03256526|12120488|P2|COMPLETED|Overall Study||17
4927493|NCT03256526|12120489|P1|COMPLETED|Overall Study||17
4927494|NCT03256526|12120487|P3|STARTED|Overall Study||17
4927495|NCT03256526|12120488|P2|STARTED|Overall Study||17
4927496|NCT03256526|12120489|P1|STARTED|Overall Study||19
4927497|NCT03256162|12120511|P2|NOT COMPLETED|Overall Study||4
4927498|NCT03256162|12120512|P1|NOT COMPLETED|Overall Study||5
4927499|NCT03256162|12120511|P2|COMPLETED|Overall Study||8
4927500|NCT03256162|12120512|P1|COMPLETED|Overall Study||8
4927501|NCT03256162|12120511|P2|STARTED|Overall Study||12
4927502|NCT03256162|12120512|P1|STARTED|Overall Study||13
4927503|NCT03255902|12120530|P1|NOT COMPLETED|Overall Study||2
4927504|NCT03255902|12120530|P1|COMPLETED|Overall Study||5
4927505|NCT03255902|12120530|P1|STARTED|Overall Study||7
4927506|NCT03255824|12120537|P2|NOT COMPLETED|Overall Study||1
4927507|NCT03255824|12120538|P1|NOT COMPLETED|Overall Study||2
4927508|NCT03255824|12120537|P2|COMPLETED|Overall Study||74
4927509|NCT03255824|12120538|P1|COMPLETED|Overall Study||67
4927510|NCT03255824|12120537|P2|STARTED|Overall Study||75
4927511|NCT03255824|12120538|P1|STARTED|Overall Study||69
4927512|NCT03255733|12120566|P1|NOT COMPLETED|Overall Study||4
4927513|NCT03255733|12120566|P1|COMPLETED|Overall Study||25
4927514|NCT03255733|12120566|P1|STARTED|Overall Study||29
4927515|NCT03255655|12120573|P2|NOT COMPLETED|Overall Study||4
4927516|NCT03255655|12120574|P1|NOT COMPLETED|Overall Study||7
4927517|NCT03255655|12120573|P2|COMPLETED|Overall Study||8
4927518|NCT03255655|12120574|P1|COMPLETED|Overall Study||22
4927519|NCT03255655|12120573|P2|STARTED|Overall Study||12
4927520|NCT03255655|12120574|P1|STARTED|Overall Study||29
4927521|NCT03255382|12120584|P2|NOT COMPLETED|Overall Study||0
4927522|NCT03255382|12120585|P1|NOT COMPLETED|Overall Study||13
4927523|NCT03255382|12120584|P2|COMPLETED|Overall Study||60
4927524|NCT03255382|12120585|P1|COMPLETED|Overall Study||47
4927525|NCT03255382|12120584|P2|STARTED|Overall Study||60
4927526|NCT03255382|12120585|P1|STARTED|Overall Study||60
4927527|NCT03255291|12120759|P6|NOT COMPLETED|Overall Study||10
4927528|NCT03255291|12120760|P5|NOT COMPLETED|Overall Study||7
4927529|NCT03255291|12120761|P4|NOT COMPLETED|Overall Study||6
4927530|NCT03255291|12120762|P3|NOT COMPLETED|Overall Study||6
4927531|NCT03255291|12120763|P2|NOT COMPLETED|Overall Study||12
4927532|NCT03255291|12120764|P1|NOT COMPLETED|Overall Study||13
4927533|NCT03255291|12120759|P6|COMPLETED|Overall Study||85
4927534|NCT03255291|12120760|P5|COMPLETED|Overall Study||88
4927535|NCT03255291|12120761|P4|COMPLETED|Overall Study||84
4927536|NCT03255291|12120762|P3|COMPLETED|Overall Study||85
4927537|NCT03255291|12120763|P2|COMPLETED|Overall Study||78
4927538|NCT03255291|12120764|P1|COMPLETED|Overall Study||80
4927539|NCT03255291|12120759|P6|STARTED|Overall Study||95
4927540|NCT03255291|12120760|P5|STARTED|Overall Study||95
4927541|NCT03255291|12120761|P4|STARTED|Overall Study||90
4927542|NCT03255291|12120762|P3|STARTED|Overall Study||91
4927543|NCT03255291|12120763|P2|STARTED|Overall Study||90
4927544|NCT03255291|12120764|P1|STARTED|Overall Study||93
4927545|NCT03255187|12120797|P2|NOT COMPLETED|Period at Fourth Follow-up||0
4927546|NCT03255187|12120798|P1|NOT COMPLETED|Period at Fourth Follow-up||0
4927547|NCT03255187|12120797|P2|COMPLETED|Period at Fourth Follow-up||31
4927548|NCT03255187|12120798|P1|COMPLETED|Period at Fourth Follow-up||34
4927549|NCT03255187|12120797|P2|STARTED|Period at Fourth Follow-up||31
4927550|NCT03255187|12120798|P1|STARTED|Period at Fourth Follow-up||34
4927551|NCT03255187|12120797|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
4927552|NCT03255187|12120798|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
4927553|NCT03255187|12120797|P2|COMPLETED|Period From Third to Fourth Follow-up||31
4927554|NCT03255187|12120798|P1|COMPLETED|Period From Third to Fourth Follow-up||34
4927555|NCT03255187|12120797|P2|STARTED|Period From Third to Fourth Follow-up||31
4927556|NCT03255187|12120798|P1|STARTED|Period From Third to Fourth Follow-up||34
4927557|NCT03255187|12120797|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
4927558|NCT03255187|12120798|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
4927559|NCT03255187|12120797|P2|COMPLETED|Period From Second to Third Follow-up||31
4927560|NCT03255187|12120798|P1|COMPLETED|Period From Second to Third Follow-up||34
4927561|NCT03255187|12120797|P2|STARTED|Period From Second to Third Follow-up||31
4927562|NCT03255187|12120798|P1|STARTED|Period From Second to Third Follow-up||34
4927563|NCT03255187|12120797|P2|NOT COMPLETED|Period From First to Second Follow-up||1
4927564|NCT03255187|12120798|P1|NOT COMPLETED|Period From First to Second Follow-up||0
4927565|NCT03255187|12120797|P2|COMPLETED|Period From First to Second Follow-up||31
4927566|NCT03255187|12120798|P1|COMPLETED|Period From First to Second Follow-up||34
4927567|NCT03255187|12120797|P2|STARTED|Period From First to Second Follow-up||32
4927568|NCT03255187|12120798|P1|STARTED|Period From First to Second Follow-up||34
4927569|NCT03255187|12120797|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
4927570|NCT03255187|12120798|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
4927571|NCT03255187|12120797|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
4927572|NCT03255187|12120798|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
4927573|NCT03255187|12120797|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
4927574|NCT03255187|12120798|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
4927575|NCT03254719|12120838|P1|NOT COMPLETED|Overall Study||0
4927576|NCT03254719|12120838|P1|COMPLETED|Overall Study||40
4927577|NCT03254719|12120838|P1|STARTED|Overall Study||40
4927578|NCT03254602|12120857|P1|NOT COMPLETED|Overall Study||4
4927579|NCT03254602|12120857|P1|COMPLETED|Overall Study||29
4927580|NCT03254602|12120857|P1|STARTED|Overall Study||33
4927581|NCT03254459|12120865|P2|NOT COMPLETED|Overall Study||23
4927582|NCT03254459|12120866|P1|NOT COMPLETED|Overall Study||10
4927583|NCT03254459|12120865|P2|COMPLETED|Overall Study||27
4927584|NCT03254459|12120866|P1|COMPLETED|Overall Study||40
4927585|NCT03254459|12120865|P2|STARTED|Overall Study||50
4927586|NCT03254459|12120866|P1|STARTED|Overall Study||50
4927587|NCT03254147|12120884|P1|NOT COMPLETED|Overall Study||0
4927588|NCT03254147|12120884|P1|COMPLETED|Overall Study||53969
4927589|NCT03254147|12120884|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
4927590|NCT03254134|12120891|P2|NOT COMPLETED|Overall Study||3630
4927591|NCT03254134|12120892|P1|NOT COMPLETED|Overall Study||599
4927592|NCT03254134|12120891|P2|COMPLETED|Overall Study||13115
4927593|NCT03254134|12120892|P1|COMPLETED|Overall Study||5146
4927594|NCT03254134|12120891|P2|STARTED|Overall Study||16745
4927595|NCT03254134|12120892|P1|STARTED|Overall Study||5745
4927596|NCT03252964|12120900|P1|NOT COMPLETED|Overall Study||32
4927597|NCT03252964|12120900|P1|COMPLETED|Overall Study||20
4927598|NCT03252964|12120900|P1|STARTED|Overall Study||52
4927599|NCT03252015|12120918|P4|NOT COMPLETED|Overall Study||1
4927600|NCT03252015|12120919|P3|NOT COMPLETED|Overall Study||1
4927601|NCT03252015|12120920|P2|NOT COMPLETED|Overall Study||1
4927602|NCT03252015|12120921|P1|NOT COMPLETED|Overall Study||1
4927603|NCT03252015|12120918|P4|COMPLETED|Overall Study||14
4927604|NCT03252015|12120919|P3|COMPLETED|Overall Study||14
4927605|NCT03252015|12120920|P2|COMPLETED|Overall Study||27
4927606|NCT03252015|12120921|P1|COMPLETED|Overall Study||11
4927607|NCT03252015|12120918|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
4927608|NCT03252015|12120919|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
4927609|NCT03252015|12120920|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
4927610|NCT03252015|12120921|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
4927611|NCT03252015|12120918|P4|STARTED|Overall Study||15
4927612|NCT03252015|12120919|P3|STARTED|Overall Study||15
4927613|NCT03252015|12120920|P2|STARTED|Overall Study||28
4927614|NCT03252015|12120921|P1|STARTED|Overall Study||12
4927615|NCT03251963|12120959|P2|NOT COMPLETED|Overall Study||5
4927616|NCT03251963|12120960|P1|NOT COMPLETED|Overall Study||9
4927617|NCT03251963|12120959|P2|COMPLETED|Overall Study||61
4927618|NCT03251963|12120960|P1|COMPLETED|Overall Study||56
4927619|NCT03251963|12120959|P2|STARTED|Overall Study||66
4927620|NCT03251963|12120960|P1|STARTED|Overall Study||65
4927621|NCT03251937|12120970|P1|NOT COMPLETED|Overall Study||3
4927622|NCT03251937|12120970|P1|COMPLETED|Overall Study||37
4927623|NCT03251937|12120970|P1|STARTED|Overall Study||40
4927624|NCT03251482|12120979|P5|NOT COMPLETED|Overall Study||0
4927625|NCT03251482|12120980|P4|NOT COMPLETED|Overall Study||0
4927626|NCT03251482|12120981|P3|NOT COMPLETED|Overall Study||0
4927627|NCT03251482|12120982|P2|NOT COMPLETED|Overall Study||1
4927628|NCT03251482|12120983|P1|NOT COMPLETED|Overall Study||0
4927629|NCT03251482|12120979|P5|COMPLETED|Overall Study||63
4927630|NCT03251482|12120980|P4|COMPLETED|Overall Study||122
4927631|NCT03251482|12120981|P3|COMPLETED|Overall Study||43
4927632|NCT03251482|12120982|P2|COMPLETED|Overall Study||40
4927633|NCT03251482|12120983|P1|COMPLETED|Overall Study||39
4927634|NCT03251482|12120979|P5|Treated|Overall Study||63
4927635|NCT03251482|12120980|P4|Treated|Overall Study||122
4927636|NCT03251482|12120981|P3|Treated|Overall Study||42
4927637|NCT03251482|12120982|P2|Treated|Overall Study||40
4927638|NCT03251482|12120983|P1|Treated|Overall Study||38
4927639|NCT03251482|12120979|P5|STARTED|Overall Study||63
4927640|NCT03251482|12120980|P4|STARTED|Overall Study||122
4927641|NCT03251482|12120981|P3|STARTED|Overall Study||43
4927642|NCT03251482|12120982|P2|STARTED|Overall Study||41
4927643|NCT03251482|12120983|P1|STARTED|Overall Study||39
4927644|NCT03250845|12121055|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
4927645|NCT03250845|12121055|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
4927646|NCT03250845|12121055|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
4927647|NCT03250845|12121055|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
4927648|NCT03250845|12121055|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
4927649|NCT03250845|12121055|P1|STARTED|Multigam 5% Infusion (Baseline)||30
4927650|NCT03250689|12121066|P2|NOT COMPLETED|Overall Study||0
4927651|NCT03250689|12121067|P1|NOT COMPLETED|Overall Study||0
4927652|NCT03250689|12121066|P2|COMPLETED|Overall Study||14
4927653|NCT03250689|12121067|P1|COMPLETED|Overall Study||5
4927654|NCT03250689|12121066|P2|STARTED|Overall Study||14
4927655|NCT03250689|12121067|P1|STARTED|Overall Study||5
4927656|NCT03250182|12121127|P1|NOT COMPLETED|Overall Study||1
4927657|NCT03250182|12121127|P1|COMPLETED|Overall Study||29
4927658|NCT03250182|12121127|P1|STARTED|Overall Study||30
4927659|NCT03249935|12121151|P1|NOT COMPLETED|Overall Study||45
4927660|NCT03249935|12121151|P1|COMPLETED|Overall Study||55
4927661|NCT03249935|12121151|P1|STARTED|Overall Study||100
4927662|NCT03249779|12121157|P1|NOT COMPLETED|Overall Study||0
4927663|NCT03249779|12121157|P1|COMPLETED|Overall Study||8
4927664|NCT03249779|12121157|P1|STARTED|Overall Study||8
4927665|NCT03249584|12121162|P1|NOT COMPLETED|Overall Study||98
4927666|NCT03249584|12121162|P1|COMPLETED|Overall Study||2
4927667|NCT03249584|12121162|P1|Month 3 Primary Objective|Overall Study|Included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3|42
4927668|NCT03249584|12121162|P1|Month 3|Overall Study||46
4927669|NCT03249584|12121162|P1|STARTED|Overall Study|87 subjects in Thoracic/Lumbar and 13 subjects in Periacetabulum, Iliac Crest, and/or Sacrum|100
4927670|NCT03249454|12121166|P11|NOT COMPLETED|Overall Study||1
4927671|NCT03249454|12121167|P10|NOT COMPLETED|Overall Study||1
4927672|NCT03249454|12121168|P9|NOT COMPLETED|Overall Study||0
4927673|NCT03249454|12121169|P8|NOT COMPLETED|Overall Study||0
4927674|NCT03249454|12121170|P7|NOT COMPLETED|Overall Study||0
4927675|NCT03249454|12121171|P6|NOT COMPLETED|Overall Study||0
4927676|NCT03249454|12121172|P5|NOT COMPLETED|Overall Study||0
4927677|NCT03249454|12121173|P4|NOT COMPLETED|Overall Study||0
4927678|NCT03249454|12121174|P3|NOT COMPLETED|Overall Study||0
4927679|NCT03249454|12121175|P2|NOT COMPLETED|Overall Study||0
4927680|NCT03249454|12121176|P1|NOT COMPLETED|Overall Study||0
4927681|NCT03249454|12121166|P11|COMPLETED|Overall Study||0
4927682|NCT03249454|12121167|P10|COMPLETED|Overall Study||0
4927683|NCT03249454|12121168|P9|COMPLETED|Overall Study||1
4927684|NCT03249454|12121169|P8|COMPLETED|Overall Study||1
4927685|NCT03249454|12121170|P7|COMPLETED|Overall Study||1
4927686|NCT03249454|12121171|P6|COMPLETED|Overall Study||2
4927687|NCT03249454|12121172|P5|COMPLETED|Overall Study||1
4927688|NCT03249454|12121173|P4|COMPLETED|Overall Study||1
4927689|NCT03249454|12121174|P3|COMPLETED|Overall Study||2
4927690|NCT03249454|12121175|P2|COMPLETED|Overall Study||1
4927691|NCT03249454|12121176|P1|COMPLETED|Overall Study||1
4927692|NCT03249454|12121166|P11|Fifth Intervention (1 Day)|Overall Study||0
4927693|NCT03249454|12121167|P10|Fifth Intervention (1 Day)|Overall Study||0
4927694|NCT03249454|12121168|P9|Fifth Intervention (1 Day)|Overall Study||1
4927695|NCT03249454|12121169|P8|Fifth Intervention (1 Day)|Overall Study||1
4927696|NCT03249454|12121170|P7|Fifth Intervention (1 Day)|Overall Study||1
4927697|NCT03249454|12121171|P6|Fifth Intervention (1 Day)|Overall Study||2
4927698|NCT03249454|12121172|P5|Fifth Intervention (1 Day)|Overall Study||1
4927699|NCT03249454|12121173|P4|Fifth Intervention (1 Day)|Overall Study||1
4927700|NCT03249454|12121174|P3|Fifth Intervention (1 Day)|Overall Study||2
4927701|NCT03249454|12121175|P2|Fifth Intervention (1 Day)|Overall Study||1
4927702|NCT03249454|12121176|P1|Fifth Intervention (1 Day)|Overall Study||1
4927703|NCT03249454|12121166|P11|Washout (1 Week)|Overall Study||0
4927704|NCT03249454|12121167|P10|Washout (1 Week)|Overall Study||0
4927705|NCT03249454|12121168|P9|Washout (1 Week)|Overall Study||1
4927706|NCT03249454|12121169|P8|Washout (1 Week)|Overall Study||1
4927707|NCT03249454|12121170|P7|Washout (1 Week)|Overall Study||1
4927708|NCT03249454|12121171|P6|Washout (1 Week)|Overall Study||2
4927709|NCT03249454|12121172|P5|Washout (1 Week)|Overall Study||1
4927710|NCT03249454|12121173|P4|Washout (1 Week)|Overall Study||1
4927711|NCT03249454|12121174|P3|Washout (1 Week)|Overall Study||2
4927712|NCT03249454|12121175|P2|Washout (1 Week)|Overall Study||1
4927713|NCT03249454|12121176|P1|Washout (1 Week)|Overall Study||1
4927714|NCT03249454|12121166|P11|Fourth Intervention (1 Day)|Overall Study||0
4927715|NCT03249454|12121167|P10|Fourth Intervention (1 Day)|Overall Study||0
4927716|NCT03249454|12121168|P9|Fourth Intervention (1 Day)|Overall Study||1
4927717|NCT03249454|12121169|P8|Fourth Intervention (1 Day)|Overall Study||1
4927718|NCT03249454|12121170|P7|Fourth Intervention (1 Day)|Overall Study||1
4927719|NCT03249454|12121171|P6|Fourth Intervention (1 Day)|Overall Study||2
4927720|NCT03249454|12121172|P5|Fourth Intervention (1 Day)|Overall Study||1
4927721|NCT03249454|12121173|P4|Fourth Intervention (1 Day)|Overall Study||1
4927722|NCT03249454|12121174|P3|Fourth Intervention (1 Day)|Overall Study||2
4927723|NCT03249454|12121175|P2|Fourth Intervention (1 Day)|Overall Study||1
4927724|NCT03249454|12121176|P1|Fourth Intervention (1 Day)|Overall Study||1
4927725|NCT03249454|12121166|P11|Washout (1 Week)|Overall Study||0
4927726|NCT03249454|12121167|P10|Washout (1 Week)|Overall Study||0
4927727|NCT03249454|12121168|P9|Washout (1 Week)|Overall Study||1
4927728|NCT03249454|12121169|P8|Washout (1 Week)|Overall Study||1
4927729|NCT03249454|12121170|P7|Washout (1 Week)|Overall Study||1
4927730|NCT03249454|12121171|P6|Washout (1 Week)|Overall Study||2
4927731|NCT03249454|12121172|P5|Washout (1 Week)|Overall Study||1
4927732|NCT03249454|12121173|P4|Washout (1 Week)|Overall Study||1
4927733|NCT03249454|12121174|P3|Washout (1 Week)|Overall Study||2
4927734|NCT03249454|12121175|P2|Washout (1 Week)|Overall Study||1
4927735|NCT03249454|12121176|P1|Washout (1 Week)|Overall Study||1
4927736|NCT03249454|12121166|P11|Third Intervention (1 Day)|Overall Study||0
4927737|NCT03249454|12121167|P10|Third Intervention (1 Day)|Overall Study||0
4927738|NCT03249454|12121168|P9|Third Intervention (1 Day)|Overall Study||1
4927739|NCT03249454|12121169|P8|Third Intervention (1 Day)|Overall Study||1
4927740|NCT03249454|12121170|P7|Third Intervention (1 Day)|Overall Study||1
4927741|NCT03249454|12121171|P6|Third Intervention (1 Day)|Overall Study||2
4927742|NCT03249454|12121172|P5|Third Intervention (1 Day)|Overall Study||1
4927743|NCT03249454|12121173|P4|Third Intervention (1 Day)|Overall Study||1
4927744|NCT03249454|12121174|P3|Third Intervention (1 Day)|Overall Study||2
4927745|NCT03249454|12121175|P2|Third Intervention (1 Day)|Overall Study||1
4927746|NCT03249454|12121176|P1|Third Intervention (1 Day)|Overall Study||1
4927747|NCT03249454|12121166|P11|Washout (1 Week)|Overall Study||0
4927748|NCT03249454|12121167|P10|Washout (1 Week)|Overall Study||0
4927749|NCT03249454|12121168|P9|Washout (1 Week)|Overall Study||1
4927750|NCT03249454|12121169|P8|Washout (1 Week)|Overall Study||1
4927751|NCT03249454|12121170|P7|Washout (1 Week)|Overall Study||1
4927752|NCT03249454|12121171|P6|Washout (1 Week)|Overall Study||2
4927753|NCT03249454|12121172|P5|Washout (1 Week)|Overall Study||1
4927754|NCT03249454|12121173|P4|Washout (1 Week)|Overall Study||1
4927755|NCT03249454|12121174|P3|Washout (1 Week)|Overall Study||2
4927756|NCT03249454|12121175|P2|Washout (1 Week)|Overall Study||1
4927757|NCT03249454|12121176|P1|Washout (1 Week)|Overall Study||1
4927758|NCT03249454|12121166|P11|Second Intervention (1 Day)|Overall Study||0
4927759|NCT03249454|12121167|P10|Second Intervention (1 Day)|Overall Study||0
4927760|NCT03249454|12121168|P9|Second Intervention (1 Day)|Overall Study||1
4927761|NCT03249454|12121169|P8|Second Intervention (1 Day)|Overall Study||1
4927762|NCT03249454|12121170|P7|Second Intervention (1 Day)|Overall Study||1
4927763|NCT03249454|12121171|P6|Second Intervention (1 Day)|Overall Study||2
4927764|NCT03249454|12121172|P5|Second Intervention (1 Day)|Overall Study||1
4927765|NCT03249454|12121173|P4|Second Intervention (1 Day)|Overall Study||1
4927766|NCT03249454|12121174|P3|Second Intervention (1 Day)|Overall Study||2
4927767|NCT03249454|12121175|P2|Second Intervention (1 Day)|Overall Study||1
4927768|NCT03249454|12121176|P1|Second Intervention (1 Day)|Overall Study||1
4927769|NCT03249454|12121166|P11|Washout (1 Week)|Overall Study||0
4927770|NCT03249454|12121167|P10|Washout (1 Week)|Overall Study||0
4927771|NCT03249454|12121168|P9|Washout (1 Week)|Overall Study||1
4927772|NCT03249454|12121169|P8|Washout (1 Week)|Overall Study||1
4927773|NCT03249454|12121170|P7|Washout (1 Week)|Overall Study||1
4927774|NCT03249454|12121171|P6|Washout (1 Week)|Overall Study||2
4927775|NCT03249454|12121172|P5|Washout (1 Week)|Overall Study||1
4927776|NCT03249454|12121173|P4|Washout (1 Week)|Overall Study||1
4927777|NCT03249454|12121174|P3|Washout (1 Week)|Overall Study||2
4927778|NCT03249454|12121175|P2|Washout (1 Week)|Overall Study||1
4927779|NCT03249454|12121176|P1|Washout (1 Week)|Overall Study||1
4927780|NCT03249454|12121166|P11|First Intervention (1 Day)|Overall Study||0
4927781|NCT03249454|12121167|P10|First Intervention (1 Day)|Overall Study||0
4927782|NCT03249454|12121168|P9|First Intervention (1 Day)|Overall Study||1
4927783|NCT03249454|12121169|P8|First Intervention (1 Day)|Overall Study||1
4927784|NCT03249454|12121170|P7|First Intervention (1 Day)|Overall Study||1
4927785|NCT03249454|12121171|P6|First Intervention (1 Day)|Overall Study||2
4927786|NCT03249454|12121172|P5|First Intervention (1 Day)|Overall Study||1
4927787|NCT03249454|12121173|P4|First Intervention (1 Day)|Overall Study||1
4927788|NCT03249454|12121174|P3|First Intervention (1 Day)|Overall Study||2
4927789|NCT03249454|12121175|P2|First Intervention (1 Day)|Overall Study||1
4927790|NCT03249454|12121176|P1|First Intervention (1 Day)|Overall Study||1
4927791|NCT03249454|12121166|P11|STARTED|Overall Study||1
4927792|NCT03249454|12121167|P10|STARTED|Overall Study||1
4927793|NCT03249454|12121168|P9|STARTED|Overall Study||1
4927794|NCT03249454|12121169|P8|STARTED|Overall Study||1
4927795|NCT03249454|12121170|P7|STARTED|Overall Study||1
4927796|NCT03249454|12121171|P6|STARTED|Overall Study||2
4927797|NCT03249454|12121172|P5|STARTED|Overall Study||1
4927798|NCT03249454|12121173|P4|STARTED|Overall Study||1
4927799|NCT03249454|12121174|P3|STARTED|Overall Study||2
4927800|NCT03249454|12121175|P2|STARTED|Overall Study||1
4927801|NCT03249454|12121176|P1|STARTED|Overall Study||1
4927802|NCT03248882|12121201|P5|NOT COMPLETED|Overall Study||13
4927803|NCT03248882|12121202|P4|NOT COMPLETED|Overall Study||10
4927804|NCT03248882|12121203|P3|NOT COMPLETED|Overall Study||7
4927805|NCT03248882|12121204|P2|NOT COMPLETED|Overall Study||5
4927806|NCT03248882|12121205|P1|NOT COMPLETED|Overall Study||7
4927807|NCT03248882|12121201|P5|COMPLETED|Overall Study||48
4927808|NCT03248882|12121202|P4|COMPLETED|Overall Study||48
4927809|NCT03248882|12121203|P3|COMPLETED|Overall Study||55
4927810|NCT03248882|12121204|P2|COMPLETED|Overall Study||58
4927811|NCT03248882|12121205|P1|COMPLETED|Overall Study||54
4927812|NCT03248882|12121201|P5|Received Treatment|Overall Study||61
4927813|NCT03248882|12121202|P4|Received Treatment|Overall Study||58
4927814|NCT03248882|12121203|P3|Received Treatment|Overall Study||62
4927815|NCT03248882|12121204|P2|Received Treatment|Overall Study||63
4927816|NCT03248882|12121205|P1|Received Treatment|Overall Study||61
4927817|NCT03248882|12121201|P5|STARTED|Overall Study||61
4927818|NCT03248882|12121202|P4|STARTED|Overall Study||58
4927819|NCT03248882|12121203|P3|STARTED|Overall Study||62
4927820|NCT03248882|12121204|P2|STARTED|Overall Study||63
4927821|NCT03248882|12121205|P1|STARTED|Overall Study||61
4927822|NCT03248492|12121247|P5|NOT COMPLETED|Overall Study||4
4927823|NCT03248492|12121248|P4|NOT COMPLETED|Overall Study||130
4927824|NCT03248492|12121249|P3|NOT COMPLETED|Overall Study||21
4927825|NCT03248492|12121250|P2|NOT COMPLETED|Overall Study||48
4927826|NCT03248492|12121251|P1|NOT COMPLETED|Overall Study||50
4927827|NCT03248492|12121247|P5|COMPLETED|Overall Study||0
4927828|NCT03248492|12121248|P4|COMPLETED|Overall Study||0
4927829|NCT03248492|12121249|P3|COMPLETED|Overall Study||0
4927830|NCT03248492|12121250|P2|COMPLETED|Overall Study||0
4927831|NCT03248492|12121251|P1|COMPLETED|Overall Study||0
4927832|NCT03248492|12121247|P5|STARTED|Overall Study||4
4927833|NCT03248492|12121248|P4|STARTED|Overall Study||130
4927834|NCT03248492|12121249|P3|STARTED|Overall Study||21
4927835|NCT03248492|12121250|P2|STARTED|Overall Study||48
4927836|NCT03248492|12121251|P1|STARTED|Overall Study||50
4927837|NCT03248141|12121291|P2|NOT COMPLETED|Overall Study||0
4927838|NCT03248141|12121292|P1|NOT COMPLETED|Overall Study||0
4927839|NCT03248141|12121291|P2|COMPLETED|Overall Study||0
4927840|NCT03248141|12121292|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
4927841|NCT03248141|12121291|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
4927842|NCT03248141|12121292|P1|STARTED|Overall Study||11
4927843|NCT03247985|12121302|P2|NOT COMPLETED|Overall Study||0
4927844|NCT03247985|12121303|P1|NOT COMPLETED|Overall Study||0
4927845|NCT03247985|12121302|P2|COMPLETED|Overall Study||19
4927846|NCT03247985|12121303|P1|COMPLETED|Overall Study||19
4927847|NCT03247985|12121302|P2|STARTED|Overall Study||19
4927848|NCT03247985|12121303|P1|STARTED|Overall Study||19
4927849|NCT03247790|12121317|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
4927850|NCT03247790|12121317|P1|COMPLETED|Period 2: Inter-ictal Period||16
4927851|NCT03247790|12121317|P1|STARTED|Period 2: Inter-ictal Period||16
4927852|NCT03247790|12121317|P1|NOT COMPLETED|Period 1: Migraine Attack||0
4927853|NCT03247790|12121317|P1|COMPLETED|Period 1: Migraine Attack||16
4927854|NCT03247790|12121317|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
4927855|NCT03247790|12121317|P1|STARTED|Period 1: Migraine Attack||16
4927856|NCT03247738|12121331|P2|NOT COMPLETED|Overall Study||0
4927857|NCT03247738|12121332|P1|NOT COMPLETED|Overall Study||0
4927858|NCT03247738|12121331|P2|COMPLETED|Overall Study||25
4927859|NCT03247738|12121332|P1|COMPLETED|Overall Study||25
4927860|NCT03247738|12121331|P2|STARTED|Overall Study||25
4927861|NCT03247738|12121332|P1|STARTED|Overall Study||25
4927862|NCT03247673|12121343|P3|NOT COMPLETED|Overall Study||4
4927863|NCT03247673|12121344|P2|NOT COMPLETED|Overall Study||0
4927864|NCT03247673|12121345|P1|NOT COMPLETED|Overall Study||1
4927865|NCT03247673|12121343|P3|COMPLETED|Overall Study||44
4927866|NCT03247673|12121344|P2|COMPLETED|Overall Study||47
4927867|NCT03247673|12121345|P1|COMPLETED|Overall Study||45
4927868|NCT03247673|12121343|P3|STARTED|Overall Study||48
4927869|NCT03247673|12121344|P2|STARTED|Overall Study||47
4927870|NCT03247673|12121345|P1|STARTED|Overall Study||46
4927871|NCT03246672|12121365|P1|NOT COMPLETED|Overall Study||2
4927872|NCT03246672|12121365|P1|COMPLETED|Overall Study||28
4927873|NCT03246672|12121365|P1|Completed First Phone Call|Overall Study||29
4927874|NCT03246672|12121365|P1|STARTED|Overall Study||30
4927875|NCT03246152|12121371|P1|NOT COMPLETED|Overall Study||3
4927876|NCT03246152|12121371|P1|COMPLETED|Overall Study||28
4927877|NCT03246152|12121371|P1|STARTED|Overall Study||31
4927878|NCT03245762|12121379|P2|NOT COMPLETED|Overall Study||0
4927879|NCT03245762|12121380|P1|NOT COMPLETED|Overall Study||0
4927880|NCT03245762|12121379|P2|COMPLETED|Overall Study||5
4927881|NCT03245762|12121380|P1|COMPLETED|Overall Study||10
4927882|NCT03245762|12121379|P2|STARTED|Overall Study||5
4927883|NCT03245762|12121380|P1|STARTED|Overall Study||10
4927884|NCT03245619|12121403|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
4927885|NCT03245619|12121404|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
4927886|NCT03245619|12121405|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
4927887|NCT03245619|12121406|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
4927888|NCT03245619|12121407|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
4927889|NCT03245619|12121408|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
4927890|NCT03245619|12121409|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
4927891|NCT03245619|12121410|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
4927892|NCT03245619|12121411|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
4927893|NCT03245619|12121412|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
4927894|NCT03245619|12121413|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
4927895|NCT03245619|12121414|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
4927896|NCT03245619|12121415|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
4927897|NCT03245619|12121416|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
4927898|NCT03245619|12121417|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
4927899|NCT03245619|12121418|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
4927900|NCT03245619|12121419|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
4927901|NCT03245619|12121403|P17|COMPLETED|Part C (Up to 34 Days)||0
4927902|NCT03245619|12121404|P16|COMPLETED|Part C (Up to 34 Days)||0
4927903|NCT03245619|12121405|P15|COMPLETED|Part C (Up to 34 Days)||0
4927904|NCT03245619|12121406|P14|COMPLETED|Part C (Up to 34 Days)||0
4927905|NCT03245619|12121407|P13|COMPLETED|Part C (Up to 34 Days)||0
4927906|NCT03245619|12121408|P12|COMPLETED|Part C (Up to 34 Days)||0
4927907|NCT03245619|12121409|P11|COMPLETED|Part C (Up to 34 Days)||0
4927908|NCT03245619|12121410|P10|COMPLETED|Part C (Up to 34 Days)||0
4927909|NCT03245619|12121411|P9|COMPLETED|Part C (Up to 34 Days)||0
4927910|NCT03245619|12121412|P8|COMPLETED|Part C (Up to 34 Days)||0
4927911|NCT03245619|12121413|P7|COMPLETED|Part C (Up to 34 Days)||0
4927912|NCT03245619|12121414|P6|COMPLETED|Part C (Up to 34 Days)||0
4927913|NCT03245619|12121415|P5|COMPLETED|Part C (Up to 34 Days)||0
4927914|NCT03245619|12121416|P4|COMPLETED|Part C (Up to 34 Days)||0
4927915|NCT03245619|12121417|P3|COMPLETED|Part C (Up to 34 Days)||0
4927916|NCT03245619|12121418|P2|COMPLETED|Part C (Up to 34 Days)||0
4927917|NCT03245619|12121419|P1|COMPLETED|Part C (Up to 34 Days)||0
4927918|NCT03245619|12121403|P17|STARTED|Part C (Up to 34 Days)||0
4927919|NCT03245619|12121404|P16|STARTED|Part C (Up to 34 Days)||0
4927920|NCT03245619|12121405|P15|STARTED|Part C (Up to 34 Days)||0
4927921|NCT03245619|12121406|P14|STARTED|Part C (Up to 34 Days)||0
4927922|NCT03245619|12121407|P13|STARTED|Part C (Up to 34 Days)||0
4927923|NCT03245619|12121408|P12|STARTED|Part C (Up to 34 Days)||0
4927924|NCT03245619|12121409|P11|STARTED|Part C (Up to 34 Days)||0
4927925|NCT03245619|12121410|P10|STARTED|Part C (Up to 34 Days)||0
4927926|NCT03245619|12121411|P9|STARTED|Part C (Up to 34 Days)||0
4927927|NCT03245619|12121412|P8|STARTED|Part C (Up to 34 Days)||0
4927928|NCT03245619|12121413|P7|STARTED|Part C (Up to 34 Days)||0
4927929|NCT03245619|12121414|P6|STARTED|Part C (Up to 34 Days)||0
4927930|NCT03245619|12121415|P5|STARTED|Part C (Up to 34 Days)||0
4927931|NCT03245619|12121416|P4|STARTED|Part C (Up to 34 Days)||0
4927932|NCT03245619|12121417|P3|STARTED|Part C (Up to 34 Days)||0
4927933|NCT03245619|12121418|P2|STARTED|Part C (Up to 34 Days)||0
4927934|NCT03245619|12121419|P1|STARTED|Part C (Up to 34 Days)||0
4927935|NCT03245619|12121403|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
4927936|NCT03245619|12121404|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
4927937|NCT03245619|12121405|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
4927938|NCT03245619|12121406|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
4927939|NCT03245619|12121407|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
4927940|NCT03245619|12121408|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
4927941|NCT03245619|12121409|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
4927942|NCT03245619|12121410|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
4927943|NCT03245619|12121411|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
4927944|NCT03245619|12121412|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
4927945|NCT03245619|12121413|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
4927946|NCT03245619|12121414|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
4927947|NCT03245619|12121415|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
4927948|NCT03245619|12121416|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
4927949|NCT03245619|12121417|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
4927950|NCT03245619|12121418|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
4927951|NCT03245619|12121419|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
4927952|NCT03245619|12121403|P17|COMPLETED|Part B (Up to 34 Days)||0
4927953|NCT03245619|12121404|P16|COMPLETED|Part B (Up to 34 Days)||0
4927954|NCT03245619|12121405|P15|COMPLETED|Part B (Up to 34 Days)||0
4927955|NCT03245619|12121406|P14|COMPLETED|Part B (Up to 34 Days)||0
4927956|NCT03245619|12121407|P13|COMPLETED|Part B (Up to 34 Days)||0
4927957|NCT03245619|12121408|P12|COMPLETED|Part B (Up to 34 Days)||0
4927958|NCT03245619|12121409|P11|COMPLETED|Part B (Up to 34 Days)||0
4927959|NCT03245619|12121410|P10|COMPLETED|Part B (Up to 34 Days)||0
4927960|NCT03245619|12121411|P9|COMPLETED|Part B (Up to 34 Days)||0
4927961|NCT03245619|12121412|P8|COMPLETED|Part B (Up to 34 Days)||0
4927962|NCT03245619|12121413|P7|COMPLETED|Part B (Up to 34 Days)||0
4927963|NCT03245619|12121414|P6|COMPLETED|Part B (Up to 34 Days)||0
4927964|NCT03245619|12121415|P5|COMPLETED|Part B (Up to 34 Days)||0
4927965|NCT03245619|12121416|P4|COMPLETED|Part B (Up to 34 Days)||0
4927966|NCT03245619|12121417|P3|COMPLETED|Part B (Up to 34 Days)||0
4927967|NCT03245619|12121418|P2|COMPLETED|Part B (Up to 34 Days)||0
4927968|NCT03245619|12121419|P1|COMPLETED|Part B (Up to 34 Days)||0
4927969|NCT03245619|12121403|P17|STARTED|Part B (Up to 34 Days)||0
4927970|NCT03245619|12121404|P16|STARTED|Part B (Up to 34 Days)||0
4927971|NCT03245619|12121405|P15|STARTED|Part B (Up to 34 Days)||0
4927972|NCT03245619|12121406|P14|STARTED|Part B (Up to 34 Days)||0
4927973|NCT03245619|12121407|P13|STARTED|Part B (Up to 34 Days)||0
4927974|NCT03245619|12121408|P12|STARTED|Part B (Up to 34 Days)||0
4927975|NCT03245619|12121409|P11|STARTED|Part B (Up to 34 Days)||0
4927976|NCT03245619|12121410|P10|STARTED|Part B (Up to 34 Days)||0
4927977|NCT03245619|12121411|P9|STARTED|Part B (Up to 34 Days)||0
4927978|NCT03245619|12121412|P8|STARTED|Part B (Up to 34 Days)||0
4927979|NCT03245619|12121413|P7|STARTED|Part B (Up to 34 Days)||0
4927980|NCT03245619|12121414|P6|STARTED|Part B (Up to 34 Days)||0
4927981|NCT03245619|12121415|P5|STARTED|Part B (Up to 34 Days)||0
4927982|NCT03245619|12121416|P4|STARTED|Part B (Up to 34 Days)||0
4927983|NCT03245619|12121417|P3|STARTED|Part B (Up to 34 Days)||0
4927984|NCT03245619|12121418|P2|STARTED|Part B (Up to 34 Days)||0
4927985|NCT03245619|12121419|P1|STARTED|Part B (Up to 34 Days)||0
4927986|NCT03245619|12121403|P17|NOT COMPLETED|Part A (Up to Day 22)||0
4927987|NCT03245619|12121404|P16|NOT COMPLETED|Part A (Up to Day 22)||0
4927988|NCT03245619|12121405|P15|NOT COMPLETED|Part A (Up to Day 22)||0
4927989|NCT03245619|12121406|P14|NOT COMPLETED|Part A (Up to Day 22)||0
4927990|NCT03245619|12121407|P13|NOT COMPLETED|Part A (Up to Day 22)||0
4927991|NCT03245619|12121408|P12|NOT COMPLETED|Part A (Up to Day 22)||0
4927992|NCT03245619|12121409|P11|NOT COMPLETED|Part A (Up to Day 22)||0
4927993|NCT03245619|12121410|P10|NOT COMPLETED|Part A (Up to Day 22)||0
4927994|NCT03245619|12121411|P9|NOT COMPLETED|Part A (Up to Day 22)||0
4927995|NCT03245619|12121412|P8|NOT COMPLETED|Part A (Up to Day 22)||0
4927996|NCT03245619|12121413|P7|NOT COMPLETED|Part A (Up to Day 22)||0
4927997|NCT03245619|12121414|P6|NOT COMPLETED|Part A (Up to Day 22)||0
4927998|NCT03245619|12121415|P5|NOT COMPLETED|Part A (Up to Day 22)||0
4927999|NCT03245619|12121416|P4|NOT COMPLETED|Part A (Up to Day 22)||0
4928000|NCT03245619|12121417|P3|NOT COMPLETED|Part A (Up to Day 22)||6
4928001|NCT03245619|12121418|P2|NOT COMPLETED|Part A (Up to Day 22)||6
4928002|NCT03245619|12121419|P1|NOT COMPLETED|Part A (Up to Day 22)||4
4928003|NCT03245619|12121403|P17|COMPLETED|Part A (Up to Day 22)||0
4928004|NCT03245619|12121404|P16|COMPLETED|Part A (Up to Day 22)||0
4928005|NCT03245619|12121405|P15|COMPLETED|Part A (Up to Day 22)||0
4928006|NCT03245619|12121406|P14|COMPLETED|Part A (Up to Day 22)||0
4928007|NCT03245619|12121407|P13|COMPLETED|Part A (Up to Day 22)||0
4928008|NCT03245619|12121408|P12|COMPLETED|Part A (Up to Day 22)||0
4928009|NCT03245619|12121409|P11|COMPLETED|Part A (Up to Day 22)||0
4928010|NCT03245619|12121410|P10|COMPLETED|Part A (Up to Day 22)||0
4928011|NCT03245619|12121411|P9|COMPLETED|Part A (Up to Day 22)||0
4928012|NCT03245619|12121412|P8|COMPLETED|Part A (Up to Day 22)||0
4928013|NCT03245619|12121413|P7|COMPLETED|Part A (Up to Day 22)||0
4928014|NCT03245619|12121414|P6|COMPLETED|Part A (Up to Day 22)||0
4928015|NCT03245619|12121415|P5|COMPLETED|Part A (Up to Day 22)||0
4928016|NCT03245619|12121416|P4|COMPLETED|Part A (Up to Day 22)||1
4928017|NCT03245619|12121417|P3|COMPLETED|Part A (Up to Day 22)||0
4928018|NCT03245619|12121418|P2|COMPLETED|Part A (Up to Day 22)||0
4928019|NCT03245619|12121419|P1|COMPLETED|Part A (Up to Day 22)||1
4928020|NCT03245619|12121403|P17|STARTED|Part A (Up to Day 22)||0
4928021|NCT03245619|12121404|P16|STARTED|Part A (Up to Day 22)||0
4928022|NCT03245619|12121405|P15|STARTED|Part A (Up to Day 22)||0
4928023|NCT03245619|12121406|P14|STARTED|Part A (Up to Day 22)||0
4928024|NCT03245619|12121407|P13|STARTED|Part A (Up to Day 22)||0
4928025|NCT03245619|12121408|P12|STARTED|Part A (Up to Day 22)||0
4928026|NCT03245619|12121409|P11|STARTED|Part A (Up to Day 22)||0
4928027|NCT03245619|12121410|P10|STARTED|Part A (Up to Day 22)||0
4928028|NCT03245619|12121411|P9|STARTED|Part A (Up to Day 22)||0
4928029|NCT03245619|12121412|P8|STARTED|Part A (Up to Day 22)||0
4928030|NCT03245619|12121413|P7|STARTED|Part A (Up to Day 22)||0
4928031|NCT03245619|12121414|P6|STARTED|Part A (Up to Day 22)||0
4928032|NCT03245619|12121415|P5|STARTED|Part A (Up to Day 22)||0
4928033|NCT03245619|12121416|P4|STARTED|Part A (Up to Day 22)||1
4928034|NCT03245619|12121417|P3|STARTED|Part A (Up to Day 22)||6
4928035|NCT03245619|12121418|P2|STARTED|Part A (Up to Day 22)||6
4928036|NCT03245619|12121419|P1|STARTED|Part A (Up to Day 22)||5
4928037|NCT03245463|12121674|P2|NOT COMPLETED|Overall Study||0
4928038|NCT03245463|12121675|P1|NOT COMPLETED|Overall Study||0
4928039|NCT03245463|12121674|P2|COMPLETED|Overall Study||12
4928040|NCT03245463|12121675|P1|COMPLETED|Overall Study||12
4928041|NCT03245463|12121674|P2|STARTED|Overall Study||12
4928042|NCT03245463|12121675|P1|STARTED|Overall Study||12
4928043|NCT03245398|12121693|P2|NOT COMPLETED|Overall Study||0
4928044|NCT03245398|12121694|P1|NOT COMPLETED|Overall Study||1
4928045|NCT03245398|12121693|P2|COMPLETED|Overall Study||93
4928046|NCT03245398|12121694|P1|COMPLETED|Overall Study||92
4928047|NCT03245398|12121693|P2|STARTED|Overall Study||93
4928048|NCT03245398|12121694|P1|STARTED|Overall Study||93
4928049|NCT03244865|12121716|P1|NOT COMPLETED|Overall Study||0
4928050|NCT03244865|12121716|P1|COMPLETED|Overall Study||35
4928051|NCT03244865|12121716|P1|STARTED|Overall Study||35
4928052|NCT03244800|12121724|P4|NOT COMPLETED|Overall Study||2
4928053|NCT03244800|12121725|P3|NOT COMPLETED|Overall Study||0
4928054|NCT03244800|12121726|P2|NOT COMPLETED|Overall Study||1
4928055|NCT03244800|12121727|P1|NOT COMPLETED|Overall Study||0
4928056|NCT03244800|12121724|P4|COMPLETED|Overall Study||18
4928057|NCT03244800|12121725|P3|COMPLETED|Overall Study||6
4928058|NCT03244800|12121726|P2|COMPLETED|Overall Study||25
4928059|NCT03244800|12121727|P1|COMPLETED|Overall Study||13
4928060|NCT03244800|12121724|P4|STARTED|Overall Study||20
4928061|NCT03244800|12121725|P3|STARTED|Overall Study||6
4928062|NCT03244800|12121726|P2|STARTED|Overall Study||26
4928063|NCT03244800|12121727|P1|STARTED|Overall Study||13
4928064|NCT03243981|12121785|P1|NOT COMPLETED|Overall Study||0
4928065|NCT03243981|12121785|P1|COMPLETED|Overall Study||5
4928066|NCT03243981|12121785|P1|STARTED|Overall Study||5
4928067|NCT03243305|12121804|P1|NOT COMPLETED|Overall Study||935
4928068|NCT03243305|12121804|P1|COMPLETED|Overall Study||449
4928069|NCT03243305|12121804|P1|STARTED|Overall Study||1384
4928070|NCT03243084|12121811|P2|NOT COMPLETED|Session 2||0
4928071|NCT03243084|12121812|P1|NOT COMPLETED|Session 2||0
4928072|NCT03243084|12121811|P2|COMPLETED|Session 2||10
4928073|NCT03243084|12121812|P1|COMPLETED|Session 2||10
4928074|NCT03243084|12121811|P2|STARTED|Session 2||10
4928075|NCT03243084|12121812|P1|STARTED|Session 2||10
4928076|NCT03243084|12121811|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
4928077|NCT03243084|12121812|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
4928078|NCT03243084|12121811|P2|COMPLETED|Washout (1-3 Weeks)||10
4928079|NCT03243084|12121812|P1|COMPLETED|Washout (1-3 Weeks)||10
4928080|NCT03243084|12121811|P2|STARTED|Washout (1-3 Weeks)||10
4928081|NCT03243084|12121812|P1|STARTED|Washout (1-3 Weeks)||11
4928082|NCT03243084|12121811|P2|NOT COMPLETED|Session 1||0
4928083|NCT03243084|12121812|P1|NOT COMPLETED|Session 1||0
4928084|NCT03243084|12121811|P2|COMPLETED|Session 1||10
4928085|NCT03243084|12121812|P1|COMPLETED|Session 1||11
4928086|NCT03243084|12121811|P2|STARTED|Session 1||10
4928087|NCT03243084|12121812|P1|STARTED|Session 1||11
4928088|NCT03242941|12121822|P1|NOT COMPLETED|Overall Study||2
4928089|NCT03242941|12121822|P1|COMPLETED|Overall Study||14
4928090|NCT03242941|12121822|P1|STARTED|Overall Study||16
4928091|NCT03242863|12121828|P6|NOT COMPLETED|Study Week 3||0
4928092|NCT03242863|12121829|P5|NOT COMPLETED|Study Week 3||0
4928093|NCT03242863|12121830|P4|NOT COMPLETED|Study Week 3||0
4928094|NCT03242863|12121831|P3|NOT COMPLETED|Study Week 3||0
4928095|NCT03242863|12121832|P2|NOT COMPLETED|Study Week 3||0
4928096|NCT03242863|12121833|P1|NOT COMPLETED|Study Week 3||0
4928097|NCT03242863|12121828|P6|COMPLETED|Study Week 3||5
4928098|NCT03242863|12121829|P5|COMPLETED|Study Week 3||12
4928099|NCT03242863|12121830|P4|COMPLETED|Study Week 3||4
4928100|NCT03242863|12121831|P3|COMPLETED|Study Week 3||4
4928101|NCT03242863|12121832|P2|COMPLETED|Study Week 3||15
4928102|NCT03242863|12121833|P1|COMPLETED|Study Week 3||13
4928103|NCT03242863|12121828|P6|STARTED|Study Week 3||5
4928104|NCT03242863|12121829|P5|STARTED|Study Week 3||12
4928105|NCT03242863|12121830|P4|STARTED|Study Week 3||4
4928106|NCT03242863|12121831|P3|STARTED|Study Week 3||4
4928107|NCT03242863|12121832|P2|STARTED|Study Week 3||15
4928108|NCT03242863|12121833|P1|STARTED|Study Week 3||13
4928109|NCT03242863|12121828|P6|NOT COMPLETED|Study Week 2||0
4928110|NCT03242863|12121829|P5|NOT COMPLETED|Study Week 2||0
4928111|NCT03242863|12121830|P4|NOT COMPLETED|Study Week 2||0
4928112|NCT03242863|12121831|P3|NOT COMPLETED|Study Week 2||0
4928113|NCT03242863|12121832|P2|NOT COMPLETED|Study Week 2||0
4928114|NCT03242863|12121833|P1|NOT COMPLETED|Study Week 2||0
4928115|NCT03242863|12121828|P6|COMPLETED|Study Week 2||5
4928116|NCT03242863|12121829|P5|COMPLETED|Study Week 2||12
4928117|NCT03242863|12121830|P4|COMPLETED|Study Week 2||4
4928118|NCT03242863|12121831|P3|COMPLETED|Study Week 2||4
4928119|NCT03242863|12121832|P2|COMPLETED|Study Week 2||15
4928120|NCT03242863|12121833|P1|COMPLETED|Study Week 2||13
4928121|NCT03242863|12121828|P6|STARTED|Study Week 2||5
4928122|NCT03242863|12121829|P5|STARTED|Study Week 2||12
4928123|NCT03242863|12121830|P4|STARTED|Study Week 2||4
4928124|NCT03242863|12121831|P3|STARTED|Study Week 2||4
4928125|NCT03242863|12121832|P2|STARTED|Study Week 2||15
4928126|NCT03242863|12121833|P1|STARTED|Study Week 2||13
4928127|NCT03242863|12121828|P6|NOT COMPLETED|Study Week 1||0
4928128|NCT03242863|12121829|P5|NOT COMPLETED|Study Week 1||3
4928129|NCT03242863|12121830|P4|NOT COMPLETED|Study Week 1||0
4928130|NCT03242863|12121831|P3|NOT COMPLETED|Study Week 1||0
4928131|NCT03242863|12121832|P2|NOT COMPLETED|Study Week 1||1
4928132|NCT03242863|12121833|P1|NOT COMPLETED|Study Week 1||0
4928133|NCT03242863|12121828|P6|COMPLETED|Study Week 1||5
4928134|NCT03242863|12121829|P5|COMPLETED|Study Week 1||12
4928135|NCT03242863|12121830|P4|COMPLETED|Study Week 1||4
4928136|NCT03242863|12121831|P3|COMPLETED|Study Week 1||4
4928137|NCT03242863|12121832|P2|COMPLETED|Study Week 1||15
4928138|NCT03242863|12121833|P1|COMPLETED|Study Week 1||13
4928139|NCT03242863|12121828|P6|STARTED|Study Week 1||5
4928140|NCT03242863|12121829|P5|STARTED|Study Week 1||15
4928141|NCT03242863|12121830|P4|STARTED|Study Week 1||4
4928142|NCT03242863|12121831|P3|STARTED|Study Week 1||4
4928143|NCT03242863|12121832|P2|STARTED|Study Week 1||16
4928144|NCT03242863|12121833|P1|STARTED|Study Week 1||13
4928145|NCT03242590|12121850|P1|NOT COMPLETED|Overall Study||0
4928146|NCT03242590|12121850|P1|COMPLETED|Overall Study||95
4928147|NCT03242590|12121850|P1|STARTED|Overall Study||95
4928148|NCT03242434|12121856|P2|NOT COMPLETED|Overall Study||2
4928149|NCT03242434|12121857|P1|NOT COMPLETED|Overall Study||0
4928150|NCT03242434|12121856|P2|COMPLETED|Overall Study||1
4928151|NCT03242434|12121857|P1|COMPLETED|Overall Study||15
4928152|NCT03242434|12121856|P2|STARTED|Overall Study||3
4928153|NCT03242434|12121857|P1|STARTED|Overall Study||15
4928154|NCT03242408|12121865|P1|NOT COMPLETED|Overall Study||2
4928155|NCT03242408|12121865|P1|COMPLETED|Overall Study||98
4928156|NCT03242408|12121865|P1|STARTED|Overall Study||100
4928157|NCT03241368|12121869|P1|NOT COMPLETED|Overall Study||39
4928158|NCT03241368|12121869|P1|COMPLETED|Overall Study||119
4928159|NCT03241368|12121869|P1|STARTED|Overall Study||158
4928160|NCT03240575|12121880|P4|NOT COMPLETED|Overall Study||2
4928161|NCT03240575|12121881|P3|NOT COMPLETED|Overall Study||0
4928162|NCT03240575|12121882|P2|NOT COMPLETED|Overall Study||14
4928163|NCT03240575|12121883|P1|NOT COMPLETED|Overall Study||2
4928164|NCT03240575|12121880|P4|COMPLETED|Overall Study||3
4928165|NCT03240575|12121881|P3|COMPLETED|Overall Study||6
4928166|NCT03240575|12121882|P2|COMPLETED|Overall Study||131
4928167|NCT03240575|12121883|P1|COMPLETED|Overall Study||144
4928168|NCT03240575|12121880|P4|STARTED|Overall Study||5
4928169|NCT03240575|12121881|P3|STARTED|Overall Study||6
4928170|NCT03240575|12121882|P2|STARTED|Overall Study||145
4928171|NCT03240575|12121883|P1|STARTED|Overall Study||146
4928172|NCT03239873|12121905|P2|NOT COMPLETED|Overall Study||27
4928173|NCT03239873|12121906|P1|NOT COMPLETED|Overall Study||32
4928174|NCT03239873|12121905|P2|COMPLETED|Overall Study||273
4928175|NCT03239873|12121906|P1|COMPLETED|Overall Study||268
4928176|NCT03239873|12121905|P2|Vaccination 2|Overall Study||282
4928177|NCT03239873|12121906|P1|Vaccination 2|Overall Study||276
4928178|NCT03239873|12121905|P2|Vaccination 1|Overall Study||300
4928179|NCT03239873|12121906|P1|Vaccination 1|Overall Study||299
4928180|NCT03239873|12121905|P2|STARTED|Overall Study||300
4928181|NCT03239873|12121906|P1|STARTED|Overall Study||300
4928182|NCT03239665|12121952|P2|NOT COMPLETED|Overall Study||20
4928183|NCT03239665|12121953|P1|NOT COMPLETED|Overall Study||28
4928184|NCT03239665|12121952|P2|COMPLETED|Overall Study||140
4928185|NCT03239665|12121953|P1|COMPLETED|Overall Study||147
4928186|NCT03239665|12121952|P2|Submitted Survey Data|Overall Study||140
4928187|NCT03239665|12121953|P1|Submitted Survey Data|Overall Study||147
4928188|NCT03239665|12121952|P2|Met Inclusion Criteria|Overall Study||144
4928189|NCT03239665|12121953|P1|Met Inclusion Criteria|Overall Study||150
4928190|NCT03239665|12121952|P2|STARTED|Overall Study||160
4928191|NCT03239665|12121953|P1|STARTED|Overall Study||175
4928192|NCT03239522|12121973|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
4928193|NCT03239522|12121973|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
4928194|NCT03239522|12121973|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
4928195|NCT03239522|12121973|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
4928196|NCT03239522|12121973|P1|COMPLETED|Washout Period (Up to 7 Days)||6
4928197|NCT03239522|12121973|P1|STARTED|Washout Period (Up to 7 Days)||6
4928198|NCT03239522|12121973|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
4928199|NCT03239522|12121973|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
4928200|NCT03239522|12121973|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
4928201|NCT03239483|12122065|P2|NOT COMPLETED|Overall Study||0
4928202|NCT03239483|12122066|P1|NOT COMPLETED|Overall Study||2
4928203|NCT03239483|12122065|P2|COMPLETED|Overall Study||9
4928204|NCT03239483|12122066|P1|COMPLETED|Overall Study||17
4928205|NCT03239483|12122065|P2|STARTED|Overall Study||9
4928206|NCT03239483|12122066|P1|STARTED|Overall Study||19
4928207|NCT03239106|12122080|P1|NOT COMPLETED|Overall Study||7
4928208|NCT03239106|12122080|P1|COMPLETED|Overall Study||3
4928209|NCT03239106|12122080|P1|STARTED|Overall Study||10
4928210|NCT03238924|12122087|P2|NOT COMPLETED|Overall Study||2
4928211|NCT03238924|12122088|P1|NOT COMPLETED|Overall Study||2
4928212|NCT03238924|12122087|P2|COMPLETED|Overall Study||7
4928213|NCT03238924|12122088|P1|COMPLETED|Overall Study||6
4928214|NCT03238924|12122087|P2|STARTED|Overall Study||9
4928215|NCT03238924|12122088|P1|STARTED|Overall Study||8
4928216|NCT03238911|12122100|P2|NOT COMPLETED|Overall Study||3
4928217|NCT03238911|12122101|P1|NOT COMPLETED|Overall Study||3
4928218|NCT03238911|12122100|P2|COMPLETED|Overall Study||58
4928219|NCT03238911|12122101|P1|COMPLETED|Overall Study||59
4928220|NCT03238911|12122100|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
4928221|NCT03238911|12122101|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
4928222|NCT03238911|12122100|P2|STARTED|Overall Study||61
4928223|NCT03238911|12122101|P1|STARTED|Overall Study||62
4928224|NCT03238781|12122144|P3|NOT COMPLETED|Overall Study||20
4928225|NCT03238781|12122145|P2|NOT COMPLETED|Overall Study||17
4928226|NCT03238781|12122146|P1|NOT COMPLETED|Overall Study||26
4928227|NCT03238781|12122144|P3|COMPLETED|Overall Study||82
4928228|NCT03238781|12122145|P2|COMPLETED|Overall Study||87
4928229|NCT03238781|12122146|P1|COMPLETED|Overall Study||111
4928230|NCT03238781|12122144|P3|STARTED|Overall Study||102
4928231|NCT03238781|12122145|P2|STARTED|Overall Study||104
4928232|NCT03238781|12122146|P1|STARTED|Overall Study||137
4928233|NCT03238352|12122196|P3|NOT COMPLETED|Overall Study||1
4928234|NCT03238352|12122197|P2|NOT COMPLETED|Overall Study||3
4928235|NCT03238352|12122198|P1|NOT COMPLETED|Overall Study||0
4928236|NCT03238352|12122196|P3|COMPLETED|Overall Study||22
4928237|NCT03238352|12122197|P2|COMPLETED|Overall Study||20
4928238|NCT03238352|12122198|P1|COMPLETED|Overall Study||43
4928239|NCT03238352|12122196|P3|STARTED|Overall Study||23
4928240|NCT03238352|12122197|P2|STARTED|Overall Study||23
4928241|NCT03238352|12122198|P1|STARTED|Overall Study||43
4928242|NCT03238001|12122209|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
4928243|NCT03238001|12122209|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
4928244|NCT03238001|12122209|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
4928245|NCT03238001|12122209|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
4928246|NCT03238001|12122209|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
4928247|NCT03238001|12122209|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
4928248|NCT03237871|12122232|P1|NOT COMPLETED|Overall Study||6
4928249|NCT03237871|12122232|P1|COMPLETED|Overall Study||11
4928250|NCT03237871|12122232|P1|STARTED|Overall Study||17
4928251|NCT03237156|12122242|P4|NOT COMPLETED|Overall Study||0
4928252|NCT03237156|12122243|P3|NOT COMPLETED|Overall Study||0
4928253|NCT03237156|12122244|P2|NOT COMPLETED|Overall Study||0
4928254|NCT03237156|12122245|P1|NOT COMPLETED|Overall Study||0
4928255|NCT03237156|12122242|P4|COMPLETED|Overall Study||6
4928256|NCT03237156|12122243|P3|COMPLETED|Overall Study||6
4928257|NCT03237156|12122244|P2|COMPLETED|Overall Study||6
4928258|NCT03237156|12122245|P1|COMPLETED|Overall Study||6
4928259|NCT03237156|12122242|P4|STARTED|Overall Study||6
4928260|NCT03237156|12122243|P3|STARTED|Overall Study||6
4928261|NCT03237156|12122244|P2|STARTED|Overall Study||6
4928262|NCT03237156|12122245|P1|STARTED|Overall Study||6
4928263|NCT03237065|12122338|P2|NOT COMPLETED|Overall Study||4
4928264|NCT03237065|12122339|P1|NOT COMPLETED|Overall Study||4
4928265|NCT03237065|12122338|P2|COMPLETED|Overall Study||57
4928266|NCT03237065|12122339|P1|COMPLETED|Overall Study||57
4928267|NCT03237065|12122338|P2|Safety Analysis Set|Overall Study||57
4928268|NCT03237065|12122339|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
4928269|NCT03237065|12122338|P2|STARTED|Overall Study||61
4928270|NCT03237065|12122339|P1|STARTED|Overall Study||61
4928271|NCT03237013|12122382|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
4928272|NCT03237013|12122383|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
4928273|NCT03237013|12122384|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
4928274|NCT03237013|12122382|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
4928275|NCT03237013|12122383|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
4928276|NCT03237013|12122384|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
4928277|NCT03237013|12122382|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
4928278|NCT03237013|12122383|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
4928279|NCT03237013|12122384|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
4928280|NCT03237013|12122382|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
4928281|NCT03237013|12122383|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
4928282|NCT03237013|12122384|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
4928283|NCT03237013|12122382|P3|COMPLETED|Baseline to Immediate Post-treatment||73
4928284|NCT03237013|12122383|P2|COMPLETED|Baseline to Immediate Post-treatment||73
4928285|NCT03237013|12122384|P1|COMPLETED|Baseline to Immediate Post-treatment||73
4928286|NCT03237013|12122382|P3|STARTED|Baseline to Immediate Post-treatment||73
4928287|NCT03237013|12122383|P2|STARTED|Baseline to Immediate Post-treatment||73
4928288|NCT03237013|12122384|P1|STARTED|Baseline to Immediate Post-treatment||73
4928289|NCT03236311|12122433|P2|NOT COMPLETED|Overall Study||3
4928290|NCT03236311|12122434|P1|NOT COMPLETED|Overall Study||0
4928291|NCT03236311|12122433|P2|COMPLETED|Overall Study||2
4928292|NCT03236311|12122434|P1|COMPLETED|Overall Study||5
4928293|NCT03236311|12122433|P2|STARTED|Overall Study||5
4928294|NCT03236311|12122434|P1|STARTED|Overall Study||5
4928295|NCT03236168|12122444|P1|NOT COMPLETED|Overall Study||11
4928296|NCT03236168|12122444|P1|COMPLETED|Overall Study||107
4928297|NCT03236168|12122444|P1|STARTED|Overall Study||118
4928298|NCT03235817|12122451|P3|NOT COMPLETED|Overall Study||2
4928299|NCT03235817|12122452|P2|NOT COMPLETED|Overall Study||1
4928300|NCT03235817|12122453|P1|NOT COMPLETED|Overall Study||3
4928301|NCT03235817|12122451|P3|COMPLETED|Overall Study||11
4928302|NCT03235817|12122452|P2|COMPLETED|Overall Study||12
4928303|NCT03235817|12122453|P1|COMPLETED|Overall Study||10
4928304|NCT03235817|12122451|P3|STARTED|Overall Study||13
4928305|NCT03235817|12122452|P2|STARTED|Overall Study||13
4928306|NCT03235817|12122453|P1|STARTED|Overall Study||13
4928307|NCT03235726|12122478|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928308|NCT03235726|12122479|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928309|NCT03235726|12122480|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928310|NCT03235726|12122481|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928311|NCT03235726|12122482|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928312|NCT03235726|12122483|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928313|NCT03235726|12122484|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928314|NCT03235726|12122485|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928315|NCT03235726|12122486|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928316|NCT03235726|12122487|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928317|NCT03235726|12122478|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
4928318|NCT03235726|12122479|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928319|NCT03235726|12122480|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928320|NCT03235726|12122481|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928321|NCT03235726|12122482|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928322|NCT03235726|12122483|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928323|NCT03235726|12122484|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928324|NCT03235726|12122485|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928325|NCT03235726|12122486|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928326|NCT03235726|12122487|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
4928327|NCT03235726|12122478|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
4928328|NCT03235726|12122479|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928329|NCT03235726|12122480|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928330|NCT03235726|12122481|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928331|NCT03235726|12122482|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928332|NCT03235726|12122483|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928333|NCT03235726|12122484|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928334|NCT03235726|12122485|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928335|NCT03235726|12122486|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928336|NCT03235726|12122487|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
4928337|NCT03235726|12122478|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928338|NCT03235726|12122479|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928339|NCT03235726|12122480|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928340|NCT03235726|12122481|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928341|NCT03235726|12122482|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928342|NCT03235726|12122483|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928343|NCT03235726|12122484|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928344|NCT03235726|12122485|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928345|NCT03235726|12122486|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928346|NCT03235726|12122487|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
4928347|NCT03235726|12122478|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928348|NCT03235726|12122479|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
4928349|NCT03235726|12122480|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
4928350|NCT03235726|12122481|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928351|NCT03235726|12122482|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928352|NCT03235726|12122483|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928353|NCT03235726|12122484|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928354|NCT03235726|12122485|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928355|NCT03235726|12122486|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928356|NCT03235726|12122487|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
4928357|NCT03235726|12122478|P10|STARTED|Part 2 (Cohort A - Day 1)||0
4928358|NCT03235726|12122479|P9|STARTED|Part 2 (Cohort A - Day 1)||2
4928359|NCT03235726|12122480|P8|STARTED|Part 2 (Cohort A - Day 1)||6
4928360|NCT03235726|12122481|P7|STARTED|Part 2 (Cohort A - Day 1)||0
4928361|NCT03235726|12122482|P6|STARTED|Part 2 (Cohort A - Day 1)||0
4928362|NCT03235726|12122483|P5|STARTED|Part 2 (Cohort A - Day 1)||0
4928363|NCT03235726|12122484|P4|STARTED|Part 2 (Cohort A - Day 1)||0
4928364|NCT03235726|12122485|P3|STARTED|Part 2 (Cohort A - Day 1)||0
4928365|NCT03235726|12122486|P2|STARTED|Part 2 (Cohort A - Day 1)||0
4928366|NCT03235726|12122487|P1|STARTED|Part 2 (Cohort A - Day 1)||0
4928367|NCT03235726|12122478|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928368|NCT03235726|12122479|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928369|NCT03235726|12122480|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928370|NCT03235726|12122481|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928371|NCT03235726|12122482|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928372|NCT03235726|12122483|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
4928373|NCT03235726|12122484|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928374|NCT03235726|12122485|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928375|NCT03235726|12122486|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928376|NCT03235726|12122487|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928377|NCT03235726|12122478|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928378|NCT03235726|12122479|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928379|NCT03235726|12122480|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928380|NCT03235726|12122481|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
4928381|NCT03235726|12122482|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
4928382|NCT03235726|12122483|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
4928383|NCT03235726|12122484|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928384|NCT03235726|12122485|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928385|NCT03235726|12122486|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928386|NCT03235726|12122487|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928387|NCT03235726|12122478|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928388|NCT03235726|12122479|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928389|NCT03235726|12122480|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928390|NCT03235726|12122481|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
4928391|NCT03235726|12122482|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
4928392|NCT03235726|12122483|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
4928393|NCT03235726|12122484|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928394|NCT03235726|12122485|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928395|NCT03235726|12122486|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928396|NCT03235726|12122487|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
4928397|NCT03235726|12122478|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928398|NCT03235726|12122479|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928399|NCT03235726|12122480|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928400|NCT03235726|12122481|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928401|NCT03235726|12122482|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928402|NCT03235726|12122483|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928403|NCT03235726|12122484|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928404|NCT03235726|12122485|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928405|NCT03235726|12122486|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928406|NCT03235726|12122487|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928407|NCT03235726|12122478|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928408|NCT03235726|12122479|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928409|NCT03235726|12122480|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928410|NCT03235726|12122481|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928411|NCT03235726|12122482|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928412|NCT03235726|12122483|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928413|NCT03235726|12122484|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
4928414|NCT03235726|12122485|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
4928415|NCT03235726|12122486|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928416|NCT03235726|12122487|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928417|NCT03235726|12122478|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928418|NCT03235726|12122479|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928419|NCT03235726|12122480|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928420|NCT03235726|12122481|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928421|NCT03235726|12122482|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928422|NCT03235726|12122483|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928423|NCT03235726|12122484|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
4928424|NCT03235726|12122485|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
4928425|NCT03235726|12122486|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928426|NCT03235726|12122487|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
4928427|NCT03235726|12122478|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928428|NCT03235726|12122479|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928429|NCT03235726|12122480|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928430|NCT03235726|12122481|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928431|NCT03235726|12122482|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928432|NCT03235726|12122483|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928433|NCT03235726|12122484|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928434|NCT03235726|12122485|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928435|NCT03235726|12122486|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928436|NCT03235726|12122487|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928437|NCT03235726|12122478|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928438|NCT03235726|12122479|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928439|NCT03235726|12122480|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928440|NCT03235726|12122481|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928441|NCT03235726|12122482|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928442|NCT03235726|12122483|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928443|NCT03235726|12122484|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
4928444|NCT03235726|12122485|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928445|NCT03235726|12122486|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
4928446|NCT03235726|12122487|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
4928447|NCT03235726|12122478|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928448|NCT03235726|12122479|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928449|NCT03235726|12122480|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928450|NCT03235726|12122481|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928451|NCT03235726|12122482|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928452|NCT03235726|12122483|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928453|NCT03235726|12122484|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
4928454|NCT03235726|12122485|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928455|NCT03235726|12122486|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
4928456|NCT03235726|12122487|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
4928457|NCT03235726|12122478|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928458|NCT03235726|12122479|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928459|NCT03235726|12122480|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928460|NCT03235726|12122481|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928461|NCT03235726|12122482|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928462|NCT03235726|12122483|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928463|NCT03235726|12122484|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928464|NCT03235726|12122485|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928465|NCT03235726|12122486|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928466|NCT03235726|12122487|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928467|NCT03235726|12122478|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928468|NCT03235726|12122479|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928469|NCT03235726|12122480|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928470|NCT03235726|12122481|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928471|NCT03235726|12122482|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928472|NCT03235726|12122483|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928473|NCT03235726|12122484|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
4928474|NCT03235726|12122485|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928475|NCT03235726|12122486|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
4928476|NCT03235726|12122487|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
4928477|NCT03235726|12122478|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928478|NCT03235726|12122479|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928479|NCT03235726|12122480|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928480|NCT03235726|12122481|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928481|NCT03235726|12122482|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928482|NCT03235726|12122483|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928483|NCT03235726|12122484|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
4928484|NCT03235726|12122485|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928485|NCT03235726|12122486|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
4928486|NCT03235726|12122487|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
4928487|NCT03235349|12122639|P1|NOT COMPLETED|Overall Study||2
4928488|NCT03235349|12122639|P1|COMPLETED|Overall Study||158
4928489|NCT03235349|12122639|P1|STARTED|Overall Study||160
4928490|NCT03235284|12122649|P3|NOT COMPLETED|Overall Study||1
4928491|NCT03235284|12122650|P2|NOT COMPLETED|Overall Study||2
4928492|NCT03235284|12122651|P1|NOT COMPLETED|Overall Study||1
4928493|NCT03235284|12122649|P3|COMPLETED|Overall Study||14
4928494|NCT03235284|12122650|P2|COMPLETED|Overall Study||13
4928495|NCT03235284|12122651|P1|COMPLETED|Overall Study||14
4928496|NCT03235284|12122649|P3|STARTED|Overall Study||15
4928497|NCT03235284|12122650|P2|STARTED|Overall Study||15
4928498|NCT03235284|12122651|P1|STARTED|Overall Study||15
4928499|NCT03235115|12122668|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928500|NCT03235115|12122669|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928501|NCT03235115|12122670|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928502|NCT03235115|12122671|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928503|NCT03235115|12122672|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928504|NCT03235115|12122673|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
4928505|NCT03235115|12122668|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
4928506|NCT03235115|12122669|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
4928507|NCT03235115|12122670|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
4928508|NCT03235115|12122671|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
4928509|NCT03235115|12122672|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
4928510|NCT03235115|12122673|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
4928511|NCT03235115|12122668|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
4928512|NCT03235115|12122669|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
4928513|NCT03235115|12122670|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
4928514|NCT03235115|12122671|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
4928515|NCT03235115|12122672|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
4928516|NCT03235115|12122673|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
4928517|NCT03235115|12122668|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928518|NCT03235115|12122669|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928519|NCT03235115|12122670|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928520|NCT03235115|12122671|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928521|NCT03235115|12122672|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928522|NCT03235115|12122673|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
4928523|NCT03235115|12122668|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
4928524|NCT03235115|12122669|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
4928525|NCT03235115|12122670|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
4928526|NCT03235115|12122671|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
4928527|NCT03235115|12122672|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
4928528|NCT03235115|12122673|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
4928529|NCT03235115|12122668|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
4928530|NCT03235115|12122669|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
4928531|NCT03235115|12122670|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
4928532|NCT03235115|12122671|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
4928533|NCT03235115|12122672|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
4928534|NCT03235115|12122673|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
4928535|NCT03235115|12122668|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
4928536|NCT03235115|12122669|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
4928537|NCT03235115|12122670|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
4928538|NCT03235115|12122671|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
4928539|NCT03235115|12122672|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
4928540|NCT03235115|12122673|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
4928541|NCT03235115|12122668|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
4928542|NCT03235115|12122669|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
4928543|NCT03235115|12122670|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
4928544|NCT03235115|12122671|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
4928545|NCT03235115|12122672|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
4928546|NCT03235115|12122673|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
4928547|NCT03235115|12122668|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
4928548|NCT03235115|12122669|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
4928549|NCT03235115|12122670|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
4928550|NCT03235115|12122671|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
4928551|NCT03235115|12122672|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
4928552|NCT03235115|12122673|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
4928553|NCT03235050|12122698|P5|NOT COMPLETED|Overall Study||11
4928554|NCT03235050|12122699|P4|NOT COMPLETED|Overall Study||14
4928555|NCT03235050|12122700|P3|NOT COMPLETED|Overall Study||4
4928556|NCT03235050|12122701|P2|NOT COMPLETED|Overall Study||5
4928557|NCT03235050|12122702|P1|NOT COMPLETED|Overall Study||4
4928558|NCT03235050|12122698|P5|COMPLETED|Overall Study||245
4928559|NCT03235050|12122699|P4|COMPLETED|Overall Study||242
4928560|NCT03235050|12122700|P3|COMPLETED|Overall Study||96
4928561|NCT03235050|12122701|P2|COMPLETED|Overall Study||105
4928562|NCT03235050|12122702|P1|COMPLETED|Overall Study||108
4928563|NCT03235050|12122698|P5|STARTED|Overall Study||256
4928564|NCT03235050|12122699|P4|STARTED|Overall Study||256
4928565|NCT03235050|12122700|P3|STARTED|Overall Study||100
4928566|NCT03235050|12122701|P2|STARTED|Overall Study||110
4928567|NCT03235050|12122702|P1|STARTED|Overall Study||112
4928568|NCT03234036|12122764|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
4928569|NCT03234036|12122765|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
4928570|NCT03234036|12122766|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
4928571|NCT03234036|12122767|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
4928572|NCT03234036|12122764|P4|COMPLETED|Part 2 (Up to 25 Days)||7
4928573|NCT03234036|12122765|P3|COMPLETED|Part 2 (Up to 25 Days)||3
4928574|NCT03234036|12122766|P2|COMPLETED|Part 2 (Up to 25 Days)||0
4928575|NCT03234036|12122767|P1|COMPLETED|Part 2 (Up to 25 Days)||0
4928576|NCT03234036|12122764|P4|STARTED|Part 2 (Up to 25 Days)||7
4928577|NCT03234036|12122765|P3|STARTED|Part 2 (Up to 25 Days)||3
4928578|NCT03234036|12122766|P2|STARTED|Part 2 (Up to 25 Days)||0
4928579|NCT03234036|12122767|P1|STARTED|Part 2 (Up to 25 Days)||0
4928580|NCT03234036|12122764|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928581|NCT03234036|12122765|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928582|NCT03234036|12122766|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928583|NCT03234036|12122767|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928584|NCT03234036|12122764|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928585|NCT03234036|12122765|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928586|NCT03234036|12122766|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
4928587|NCT03234036|12122767|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
4928588|NCT03234036|12122764|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928589|NCT03234036|12122765|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
4928590|NCT03234036|12122766|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
4928591|NCT03234036|12122767|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
4928592|NCT03234036|12122764|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928593|NCT03234036|12122765|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928594|NCT03234036|12122766|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928595|NCT03234036|12122767|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928596|NCT03234036|12122764|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928597|NCT03234036|12122765|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928598|NCT03234036|12122766|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
4928599|NCT03234036|12122767|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
4928600|NCT03234036|12122764|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928601|NCT03234036|12122765|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
4928602|NCT03234036|12122766|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
4928603|NCT03234036|12122767|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
4928604|NCT03234036|12122764|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928605|NCT03234036|12122765|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928606|NCT03234036|12122766|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928607|NCT03234036|12122767|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928608|NCT03234036|12122764|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928609|NCT03234036|12122765|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928610|NCT03234036|12122766|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
4928611|NCT03234036|12122767|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
4928612|NCT03234036|12122764|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928613|NCT03234036|12122765|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
4928614|NCT03234036|12122766|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
4928615|NCT03234036|12122767|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
4928616|NCT03234036|12122764|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928617|NCT03234036|12122765|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928618|NCT03234036|12122766|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
4928619|NCT03234036|12122767|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
4928620|NCT03234036|12122764|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928621|NCT03234036|12122765|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928622|NCT03234036|12122766|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
4928623|NCT03234036|12122767|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
4928624|NCT03234036|12122764|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928625|NCT03234036|12122765|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
4928626|NCT03234036|12122766|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
4928627|NCT03234036|12122767|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
4928628|NCT03234036|12122764|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928629|NCT03234036|12122765|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928630|NCT03234036|12122766|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928631|NCT03234036|12122767|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928632|NCT03234036|12122764|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928633|NCT03234036|12122765|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928634|NCT03234036|12122766|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
4928635|NCT03234036|12122767|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
4928636|NCT03234036|12122764|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928637|NCT03234036|12122765|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
4928638|NCT03234036|12122766|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
4928639|NCT03234036|12122767|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
4928640|NCT03233737|12122874|P5|NOT COMPLETED|Overall Study||0
4928641|NCT03233737|12122875|P4|NOT COMPLETED|Overall Study||0
4928642|NCT03233737|12122876|P3|NOT COMPLETED|Overall Study||0
4928643|NCT03233737|12122877|P2|NOT COMPLETED|Overall Study||0
4928644|NCT03233737|12122878|P1|NOT COMPLETED|Overall Study||0
4928645|NCT03233737|12122874|P5|COMPLETED|Overall Study||26
4928646|NCT03233737|12122875|P4|COMPLETED|Overall Study||24
4928647|NCT03233737|12122876|P3|COMPLETED|Overall Study||5
4928648|NCT03233737|12122877|P2|COMPLETED|Overall Study||10
4928649|NCT03233737|12122878|P1|COMPLETED|Overall Study||10
4928650|NCT03233737|12122874|P5|STARTED|Overall Study||26
4928651|NCT03233737|12122875|P4|STARTED|Overall Study||24
4928652|NCT03233737|12122876|P3|STARTED|Overall Study||5
4928653|NCT03233737|12122877|P2|STARTED|Overall Study||10
4928654|NCT03233737|12122878|P1|STARTED|Overall Study||10
4928655|NCT03233529|12122938|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
4928656|NCT03233529|12122938|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
4928657|NCT03233529|12122938|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
4928658|NCT03233529|12122938|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
4928659|NCT03233529|12122938|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
4928660|NCT03233529|12122938|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
4928661|NCT03233438|12122982|P2|NOT COMPLETED|Overall Study||11
4928662|NCT03233438|12122983|P1|NOT COMPLETED|Overall Study||6
4928663|NCT03233438|12122982|P2|COMPLETED|Overall Study||32
4928664|NCT03233438|12122983|P1|COMPLETED|Overall Study||42
4928665|NCT03233438|12122982|P2|STARTED|Overall Study||43
4928666|NCT03233438|12122983|P1|STARTED|Overall Study||48
4928667|NCT03233308|12123049|P1|NOT COMPLETED|Overall Study||2
4928668|NCT03233308|12123049|P1|COMPLETED|Overall Study||18
4928669|NCT03233308|12123049|P1|STARTED|Overall Study||20
4928670|NCT03233217|12123066|P5|NOT COMPLETED|Overall Study||0
4928671|NCT03233217|12123067|P4|NOT COMPLETED|Overall Study||0
4928672|NCT03233217|12123068|P3|NOT COMPLETED|Overall Study||0
4928673|NCT03233217|12123069|P2|NOT COMPLETED|Overall Study||0
4928674|NCT03233217|12123070|P1|NOT COMPLETED|Overall Study||0
4928675|NCT03233217|12123066|P5|COMPLETED|Overall Study||55
4928676|NCT03233217|12123067|P4|COMPLETED|Overall Study||55
4928677|NCT03233217|12123068|P3|COMPLETED|Overall Study||55
4928678|NCT03233217|12123069|P2|COMPLETED|Overall Study||5
4928679|NCT03233217|12123070|P1|COMPLETED|Overall Study||5
4928680|NCT03233217|12123066|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
4928681|NCT03233217|12123067|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
4928682|NCT03233217|12123068|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
4928683|NCT03233217|12123069|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
4928684|NCT03233217|12123070|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
4928685|NCT03233217|12123066|P5|Safety Analysis Set (SafAS)|Overall Study||55
4928686|NCT03233217|12123067|P4|Safety Analysis Set (SafAS)|Overall Study||55
4928687|NCT03233217|12123068|P3|Safety Analysis Set (SafAS)|Overall Study||55
4928688|NCT03233217|12123069|P2|Safety Analysis Set (SafAS)|Overall Study||5
4928689|NCT03233217|12123070|P1|Safety Analysis Set (SafAS)|Overall Study||5
4928690|NCT03233217|12123066|P5|STARTED|Overall Study||55
4928691|NCT03233217|12123067|P4|STARTED|Overall Study||55
4928692|NCT03233217|12123068|P3|STARTED|Overall Study||55
4928693|NCT03233217|12123069|P2|STARTED|Overall Study||5
4928694|NCT03233217|12123070|P1|STARTED|Overall Study||5
4928695|NCT03233009|12123099|P1|NOT COMPLETED|Overall Study||1
4928696|NCT03233009|12123099|P1|COMPLETED|Overall Study||39
4928697|NCT03233009|12123099|P1|Reference Product|Overall Study||39
4928698|NCT03233009|12123099|P1|Test Product 4|Overall Study||39
4928699|NCT03233009|12123099|P1|Test Product 3|Overall Study||39
4928700|NCT03233009|12123099|P1|Test Product 2|Overall Study||39
4928701|NCT03233009|12123099|P1|Test Product 1|Overall Study||39
4928702|NCT03233009|12123099|P1|STARTED|Overall Study||40
4928703|NCT03232983|12123142|P4|NOT COMPLETED|Period 4||0
4928704|NCT03232983|12123143|P3|NOT COMPLETED|Period 4||0
4928705|NCT03232983|12123144|P2|NOT COMPLETED|Period 4||0
4928706|NCT03232983|12123145|P1|NOT COMPLETED|Period 4||1
4928707|NCT03232983|12123142|P4|COMPLETED|Period 4||6
4928708|NCT03232983|12123143|P3|COMPLETED|Period 4||5
4928709|NCT03232983|12123144|P2|COMPLETED|Period 4||7
4928710|NCT03232983|12123145|P1|COMPLETED|Period 4||6
4928711|NCT03232983|12123142|P4|STARTED|Period 4||6
4928712|NCT03232983|12123143|P3|STARTED|Period 4||5
4928713|NCT03232983|12123144|P2|STARTED|Period 4||7
4928714|NCT03232983|12123145|P1|STARTED|Period 4||7
4928715|NCT03232983|12123142|P4|NOT COMPLETED|Washout Period 3||0
4928716|NCT03232983|12123143|P3|NOT COMPLETED|Washout Period 3||0
4928717|NCT03232983|12123144|P2|NOT COMPLETED|Washout Period 3||0
4928718|NCT03232983|12123145|P1|NOT COMPLETED|Washout Period 3||0
4928719|NCT03232983|12123142|P4|COMPLETED|Washout Period 3||6
4928720|NCT03232983|12123143|P3|COMPLETED|Washout Period 3||5
4928721|NCT03232983|12123144|P2|COMPLETED|Washout Period 3||7
4928722|NCT03232983|12123145|P1|COMPLETED|Washout Period 3||7
4928723|NCT03232983|12123142|P4|STARTED|Washout Period 3||6
4928724|NCT03232983|12123143|P3|STARTED|Washout Period 3||5
4928725|NCT03232983|12123144|P2|STARTED|Washout Period 3||7
4928726|NCT03232983|12123145|P1|STARTED|Washout Period 3||7
4928727|NCT03232983|12123142|P4|NOT COMPLETED|Period 3||0
4928728|NCT03232983|12123143|P3|NOT COMPLETED|Period 3||0
4928729|NCT03232983|12123144|P2|NOT COMPLETED|Period 3||0
4928730|NCT03232983|12123145|P1|NOT COMPLETED|Period 3||0
4928731|NCT03232983|12123142|P4|COMPLETED|Period 3||6
4928732|NCT03232983|12123143|P3|COMPLETED|Period 3||5
4928733|NCT03232983|12123144|P2|COMPLETED|Period 3||7
4928734|NCT03232983|12123145|P1|COMPLETED|Period 3||7
4928735|NCT03232983|12123142|P4|STARTED|Period 3||6
4928736|NCT03232983|12123143|P3|STARTED|Period 3||5
4928737|NCT03232983|12123144|P2|STARTED|Period 3||7
4928738|NCT03232983|12123145|P1|STARTED|Period 3||7
4928739|NCT03232983|12123142|P4|NOT COMPLETED|Washout Period 2||1
4928740|NCT03232983|12123143|P3|NOT COMPLETED|Washout Period 2||1
4928741|NCT03232983|12123144|P2|NOT COMPLETED|Washout Period 2||0
4928742|NCT03232983|12123145|P1|NOT COMPLETED|Washout Period 2||0
4928743|NCT03232983|12123142|P4|COMPLETED|Washout Period 2||6
4928744|NCT03232983|12123143|P3|COMPLETED|Washout Period 2||5
4928745|NCT03232983|12123144|P2|COMPLETED|Washout Period 2||7
4928746|NCT03232983|12123145|P1|COMPLETED|Washout Period 2||7
4928747|NCT03232983|12123142|P4|STARTED|Washout Period 2||7
4928748|NCT03232983|12123143|P3|STARTED|Washout Period 2||6
4928749|NCT03232983|12123144|P2|STARTED|Washout Period 2||7
4928750|NCT03232983|12123145|P1|STARTED|Washout Period 2||7
4928751|NCT03232983|12123142|P4|NOT COMPLETED|Period 2||0
4928752|NCT03232983|12123143|P3|NOT COMPLETED|Period 2||0
4928753|NCT03232983|12123144|P2|NOT COMPLETED|Period 2||0
4928754|NCT03232983|12123145|P1|NOT COMPLETED|Period 2||0
4928755|NCT03232983|12123142|P4|COMPLETED|Period 2||7
4928756|NCT03232983|12123143|P3|COMPLETED|Period 2||6
4928757|NCT03232983|12123144|P2|COMPLETED|Period 2||7
4928758|NCT03232983|12123145|P1|COMPLETED|Period 2||7
4928759|NCT03232983|12123142|P4|STARTED|Period 2||7
4928760|NCT03232983|12123143|P3|STARTED|Period 2||6
4928761|NCT03232983|12123144|P2|STARTED|Period 2||7
4928762|NCT03232983|12123145|P1|STARTED|Period 2||7
4928763|NCT03232983|12123142|P4|NOT COMPLETED|Washout Period 1||0
4928764|NCT03232983|12123143|P3|NOT COMPLETED|Washout Period 1||0
4928765|NCT03232983|12123144|P2|NOT COMPLETED|Washout Period 1||0
4928766|NCT03232983|12123145|P1|NOT COMPLETED|Washout Period 1||0
4928767|NCT03232983|12123142|P4|COMPLETED|Washout Period 1||7
4928768|NCT03232983|12123143|P3|COMPLETED|Washout Period 1||6
4928769|NCT03232983|12123144|P2|COMPLETED|Washout Period 1||7
4928770|NCT03232983|12123145|P1|COMPLETED|Washout Period 1||7
4928771|NCT03232983|12123142|P4|STARTED|Washout Period 1||7
4928772|NCT03232983|12123143|P3|STARTED|Washout Period 1||6
4928773|NCT03232983|12123144|P2|STARTED|Washout Period 1||7
4928774|NCT03232983|12123145|P1|STARTED|Washout Period 1||7
4928775|NCT03232983|12123142|P4|NOT COMPLETED|Period 1||0
4928776|NCT03232983|12123143|P3|NOT COMPLETED|Period 1||1
4928777|NCT03232983|12123144|P2|NOT COMPLETED|Period 1||0
4928778|NCT03232983|12123145|P1|NOT COMPLETED|Period 1||0
4928779|NCT03232983|12123142|P4|COMPLETED|Period 1||7
4928780|NCT03232983|12123143|P3|COMPLETED|Period 1||6
4928781|NCT03232983|12123144|P2|COMPLETED|Period 1||7
4928782|NCT03232983|12123145|P1|COMPLETED|Period 1||7
4928783|NCT03232983|12123142|P4|Received at Least One Dose of Study Drug|Period 1||7
4928784|NCT03232983|12123143|P3|Received at Least One Dose of Study Drug|Period 1||7
4928785|NCT03232983|12123144|P2|Received at Least One Dose of Study Drug|Period 1||7
4928786|NCT03232983|12123145|P1|Received at Least One Dose of Study Drug|Period 1||7
4928787|NCT03232983|12123142|P4|STARTED|Period 1||7
4928788|NCT03232983|12123143|P3|STARTED|Period 1||7
4928789|NCT03232983|12123144|P2|STARTED|Period 1||7
4928790|NCT03232983|12123145|P1|STARTED|Period 1||7
4928791|NCT03232892|12123158|P1|NOT COMPLETED|Overall Study||0
4928792|NCT03232892|12123158|P1|COMPLETED|Overall Study||1
4928793|NCT03232892|12123158|P1|STARTED|Overall Study||1
4928794|NCT03232827|12123166|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
4928795|NCT03232827|12123166|P1|COMPLETED|Flavored-very Low Sweetened||66
4928796|NCT03232827|12123166|P1|STARTED|Flavored-very Low Sweetened||66
4928797|NCT03232827|12123166|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
4928798|NCT03232827|12123166|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
4928799|NCT03232827|12123166|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
4928800|NCT03232827|12123166|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
4928801|NCT03232827|12123166|P1|COMPLETED|Unflavored-sweetened (US)||86
4928802|NCT03232827|12123166|P1|STARTED|Unflavored-sweetened (US)||86
4928803|NCT03232827|12123166|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
4928804|NCT03232827|12123166|P1|COMPLETED|Flavored-sweetened (FS)||80
4928805|NCT03232827|12123166|P1|STARTED|Flavored-sweetened (FS)||80
4928806|NCT03232580|12123180|P1|NOT COMPLETED|Overall Study||0
4928807|NCT03232580|12123180|P1|COMPLETED|Overall Study||5
4928808|NCT03232580|12123180|P1|STARTED|Overall Study||5
4928809|NCT03232567|12123189|P4|NOT COMPLETED|Overall Study||0
4928810|NCT03232567|12123190|P3|NOT COMPLETED|Overall Study||0
4928811|NCT03232567|12123191|P2|NOT COMPLETED|Overall Study||1
4928812|NCT03232567|12123192|P1|NOT COMPLETED|Overall Study||0
4928813|NCT03232567|12123189|P4|COMPLETED|Overall Study||15
4928814|NCT03232567|12123190|P3|COMPLETED|Overall Study||15
4928815|NCT03232567|12123191|P2|COMPLETED|Overall Study||14
4928816|NCT03232567|12123192|P1|COMPLETED|Overall Study||15
4928817|NCT03232567|12123189|P4|STARTED|Overall Study||15
4928818|NCT03232567|12123190|P3|STARTED|Overall Study||15
4928819|NCT03232567|12123191|P2|STARTED|Overall Study||15
4928820|NCT03232567|12123192|P1|STARTED|Overall Study||15
4928821|NCT03232333|12123214|P1|NOT COMPLETED|Overall Study||15
4928822|NCT03232333|12123214|P1|COMPLETED|Overall Study||38
4928823|NCT03232333|12123214|P1|STARTED|Overall Study||53
4928824|NCT03231943|12123231|P13|NOT COMPLETED|Part 2||0
4928825|NCT03231943|12123232|P12|NOT COMPLETED|Part 2||1
4928826|NCT03231943|12123233|P11|NOT COMPLETED|Part 2||1
4928827|NCT03231943|12123234|P10|NOT COMPLETED|Part 2||0
4928828|NCT03231943|12123235|P9|NOT COMPLETED|Part 2||0
4928829|NCT03231943|12123236|P8|NOT COMPLETED|Part 2||0
4928830|NCT03231943|12123237|P7|NOT COMPLETED|Part 2||0
4928831|NCT03231943|12123238|P6|NOT COMPLETED|Part 2||0
4928832|NCT03231943|12123239|P5|NOT COMPLETED|Part 2||0
4928833|NCT03231943|12123240|P4|NOT COMPLETED|Part 2||0
4928834|NCT03231943|12123241|P3|NOT COMPLETED|Part 2||0
4928835|NCT03231943|12123242|P2|NOT COMPLETED|Part 2||0
4928836|NCT03231943|12123243|P1|NOT COMPLETED|Part 2||0
4928837|NCT03231943|12123231|P13|COMPLETED|Part 2||14
4928838|NCT03231943|12123232|P12|COMPLETED|Part 2||6
4928839|NCT03231943|12123233|P11|COMPLETED|Part 2||24
4928840|NCT03231943|12123234|P10|COMPLETED|Part 2||6
4928841|NCT03231943|12123235|P9|COMPLETED|Part 2||6
4928842|NCT03231943|12123236|P8|COMPLETED|Part 2||0
4928843|NCT03231943|12123237|P7|COMPLETED|Part 2||0
4928844|NCT03231943|12123238|P6|COMPLETED|Part 2||0
4928845|NCT03231943|12123239|P5|COMPLETED|Part 2||0
4928846|NCT03231943|12123240|P4|COMPLETED|Part 2||0
4928847|NCT03231943|12123241|P3|COMPLETED|Part 2||0
4928848|NCT03231943|12123242|P2|COMPLETED|Part 2||0
4928849|NCT03231943|12123243|P1|COMPLETED|Part 2||0
4928850|NCT03231943|12123231|P13|STARTED|Part 2||14
4928851|NCT03231943|12123232|P12|STARTED|Part 2||7
4928852|NCT03231943|12123233|P11|STARTED|Part 2||25
4928853|NCT03231943|12123234|P10|STARTED|Part 2||6
4928854|NCT03231943|12123235|P9|STARTED|Part 2||6
4928855|NCT03231943|12123236|P8|STARTED|Part 2||0
4928856|NCT03231943|12123237|P7|STARTED|Part 2||0
4928857|NCT03231943|12123238|P6|STARTED|Part 2||0
4928858|NCT03231943|12123239|P5|STARTED|Part 2||0
4928859|NCT03231943|12123240|P4|STARTED|Part 2||0
4928860|NCT03231943|12123241|P3|STARTED|Part 2||0
4928861|NCT03231943|12123242|P2|STARTED|Part 2||0
4928862|NCT03231943|12123243|P1|STARTED|Part 2||0
4928863|NCT03231943|12123231|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928864|NCT03231943|12123232|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928865|NCT03231943|12123233|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928866|NCT03231943|12123234|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928867|NCT03231943|12123235|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928868|NCT03231943|12123236|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928869|NCT03231943|12123237|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928870|NCT03231943|12123238|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928871|NCT03231943|12123239|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928872|NCT03231943|12123240|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928873|NCT03231943|12123241|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928874|NCT03231943|12123242|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928875|NCT03231943|12123243|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928876|NCT03231943|12123231|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928877|NCT03231943|12123232|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928878|NCT03231943|12123233|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928879|NCT03231943|12123234|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928880|NCT03231943|12123235|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
4928881|NCT03231943|12123236|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928882|NCT03231943|12123237|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928883|NCT03231943|12123238|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928884|NCT03231943|12123239|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928885|NCT03231943|12123240|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928886|NCT03231943|12123241|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928887|NCT03231943|12123242|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928888|NCT03231943|12123243|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
4928889|NCT03231943|12123231|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
4928890|NCT03231943|12123232|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
4928891|NCT03231943|12123233|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
4928892|NCT03231943|12123234|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
4928893|NCT03231943|12123235|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
4928894|NCT03231943|12123236|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
4928895|NCT03231943|12123237|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
4928896|NCT03231943|12123238|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
4928897|NCT03231943|12123239|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
4928898|NCT03231943|12123240|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
4928899|NCT03231943|12123241|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
4928900|NCT03231943|12123242|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
4928901|NCT03231943|12123243|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
4928902|NCT03231943|12123231|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928903|NCT03231943|12123232|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928904|NCT03231943|12123233|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928905|NCT03231943|12123234|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928906|NCT03231943|12123235|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928907|NCT03231943|12123236|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928908|NCT03231943|12123237|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928909|NCT03231943|12123238|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928910|NCT03231943|12123239|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928911|NCT03231943|12123240|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928912|NCT03231943|12123241|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928913|NCT03231943|12123242|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928914|NCT03231943|12123243|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
4928915|NCT03231943|12123231|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928916|NCT03231943|12123232|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928917|NCT03231943|12123233|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928918|NCT03231943|12123234|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928919|NCT03231943|12123235|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
4928920|NCT03231943|12123236|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928921|NCT03231943|12123237|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928922|NCT03231943|12123238|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928923|NCT03231943|12123239|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928924|NCT03231943|12123240|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928925|NCT03231943|12123241|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928926|NCT03231943|12123242|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
4928927|NCT03231943|12123243|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
4928928|NCT03231943|12123231|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
4928929|NCT03231943|12123232|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
4928930|NCT03231943|12123233|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
4928931|NCT03231943|12123234|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
4928932|NCT03231943|12123235|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
4928933|NCT03231943|12123236|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
4928934|NCT03231943|12123237|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
4928935|NCT03231943|12123238|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
4928936|NCT03231943|12123239|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
4928937|NCT03231943|12123240|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
4928938|NCT03231943|12123241|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
4928939|NCT03231943|12123242|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
4928940|NCT03231943|12123243|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
4928941|NCT03231943|12123231|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928942|NCT03231943|12123232|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928943|NCT03231943|12123233|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928944|NCT03231943|12123234|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928945|NCT03231943|12123235|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928946|NCT03231943|12123236|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928947|NCT03231943|12123237|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928948|NCT03231943|12123238|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928949|NCT03231943|12123239|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928950|NCT03231943|12123240|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928951|NCT03231943|12123241|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
4928952|NCT03231943|12123242|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928953|NCT03231943|12123243|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928954|NCT03231943|12123231|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928955|NCT03231943|12123232|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928956|NCT03231943|12123233|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928957|NCT03231943|12123234|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928958|NCT03231943|12123235|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
4928959|NCT03231943|12123236|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928960|NCT03231943|12123237|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928961|NCT03231943|12123238|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928962|NCT03231943|12123239|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928963|NCT03231943|12123240|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928964|NCT03231943|12123241|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
4928965|NCT03231943|12123242|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
4928966|NCT03231943|12123243|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
4928967|NCT03231943|12123231|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
4928968|NCT03231943|12123232|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
4928969|NCT03231943|12123233|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
4928970|NCT03231943|12123234|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
4928971|NCT03231943|12123235|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
4928972|NCT03231943|12123236|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
4928973|NCT03231943|12123237|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
4928974|NCT03231943|12123238|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
4928975|NCT03231943|12123239|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
4928976|NCT03231943|12123240|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
4928977|NCT03231943|12123241|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
4928978|NCT03231943|12123242|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
4928979|NCT03231943|12123243|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
4928980|NCT03231943|12123231|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928981|NCT03231943|12123232|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928982|NCT03231943|12123233|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928983|NCT03231943|12123234|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928984|NCT03231943|12123235|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928985|NCT03231943|12123236|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928986|NCT03231943|12123237|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928987|NCT03231943|12123238|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928988|NCT03231943|12123239|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928989|NCT03231943|12123240|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928990|NCT03231943|12123241|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928991|NCT03231943|12123242|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928992|NCT03231943|12123243|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928993|NCT03231943|12123231|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928994|NCT03231943|12123232|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928995|NCT03231943|12123233|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928996|NCT03231943|12123234|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928997|NCT03231943|12123235|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
4928998|NCT03231943|12123236|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4928999|NCT03231943|12123237|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929000|NCT03231943|12123238|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929001|NCT03231943|12123239|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929002|NCT03231943|12123240|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929003|NCT03231943|12123241|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929004|NCT03231943|12123242|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929005|NCT03231943|12123243|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
4929006|NCT03231943|12123231|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
4929007|NCT03231943|12123232|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
4929008|NCT03231943|12123233|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
4929009|NCT03231943|12123234|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
4929010|NCT03231943|12123235|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
4929011|NCT03231943|12123236|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
4929012|NCT03231943|12123237|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
4929013|NCT03231943|12123238|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
4929014|NCT03231943|12123239|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
4929015|NCT03231943|12123240|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
4929016|NCT03231943|12123241|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
4929017|NCT03231943|12123242|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
4929018|NCT03231943|12123243|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
4929019|NCT03231917|12123693|P2|NOT COMPLETED|Overall Study||0
4929020|NCT03231917|12123694|P1|NOT COMPLETED|Overall Study||0
4929021|NCT03231917|12123693|P2|COMPLETED|Overall Study||61
4929022|NCT03231917|12123694|P1|COMPLETED|Overall Study||60
4929023|NCT03231917|12123693|P2|STARTED|Overall Study||61
4929024|NCT03231917|12123694|P1|STARTED|Overall Study||60
4929025|NCT03231800|12123706|P2|NOT COMPLETED|Overall Study||3
4929026|NCT03231800|12123707|P1|NOT COMPLETED|Overall Study||3
4929027|NCT03231800|12123706|P2|COMPLETED|Overall Study||44
4929028|NCT03231800|12123707|P1|COMPLETED|Overall Study||45
4929029|NCT03231800|12123706|P2|Safety Population|Overall Study||47
4929030|NCT03231800|12123707|P1|Safety Population|Overall Study||47
4929031|NCT03231800|12123706|P2|STARTED|Overall Study||47
4929032|NCT03231800|12123707|P1|STARTED|Overall Study||48
4929033|NCT03231709|12123723|P2|NOT COMPLETED|Treatment Period 2||1
4929034|NCT03231709|12123724|P1|NOT COMPLETED|Treatment Period 2||0
4929035|NCT03231709|12123723|P2|COMPLETED|Treatment Period 2||28
4929036|NCT03231709|12123724|P1|COMPLETED|Treatment Period 2||30
4929037|NCT03231709|12123723|P2|STARTED|Treatment Period 2||29
4929038|NCT03231709|12123724|P1|STARTED|Treatment Period 2||30
4929039|NCT03231709|12123723|P2|NOT COMPLETED|Treatment Period 1||1
4929040|NCT03231709|12123724|P1|NOT COMPLETED|Treatment Period 1||0
4929041|NCT03231709|12123723|P2|COMPLETED|Treatment Period 1||29
4929042|NCT03231709|12123724|P1|COMPLETED|Treatment Period 1||30
4929043|NCT03231709|12123723|P2|STARTED|Treatment Period 1||30
4929044|NCT03231709|12123724|P1|STARTED|Treatment Period 1||30
4929045|NCT03231371|12123742|P1|NOT COMPLETED|Overall Study||13
4929046|NCT03231371|12123742|P1|COMPLETED|Overall Study||9
4929047|NCT03231371|12123742|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
4929048|NCT03231371|12123742|P1|STARTED|Overall Study||22
4929049|NCT03231345|12123747|P1|NOT COMPLETED|Overall Study||0
4929050|NCT03231345|12123747|P1|COMPLETED|Overall Study||35
4929051|NCT03231345|12123747|P1|STARTED|Overall Study||35
4929052|NCT03231228|12123755|P2|NOT COMPLETED|Overall Study||0
4929053|NCT03231228|12123756|P1|NOT COMPLETED|Overall Study||3
4929054|NCT03231228|12123755|P2|COMPLETED|Overall Study||28
4929055|NCT03231228|12123756|P1|COMPLETED|Overall Study||30
4929056|NCT03231228|12123755|P2|STARTED|Overall Study||28
4929057|NCT03231228|12123756|P1|STARTED|Overall Study||33
4929058|NCT03230864|12123767|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
4929059|NCT03230864|12123768|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
4929060|NCT03230864|12123769|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
4929061|NCT03230864|12123770|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
4929062|NCT03230864|12123767|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
4929063|NCT03230864|12123768|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
4929064|NCT03230864|12123769|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
4929065|NCT03230864|12123770|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
4929066|NCT03230864|12123767|P4|STARTED|Double Blind Treatment (DBT) Period||33
4929067|NCT03230864|12123768|P3|STARTED|Double Blind Treatment (DBT) Period||35
4929068|NCT03230864|12123769|P2|STARTED|Double Blind Treatment (DBT) Period||0
4929069|NCT03230864|12123770|P1|STARTED|Double Blind Treatment (DBT) Period||0
4929070|NCT03230864|12123767|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
4929071|NCT03230864|12123768|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
4929072|NCT03230864|12123769|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
4929073|NCT03230864|12123770|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
4929074|NCT03230864|12123767|P4|COMPLETED|Prospective Confirmation (PC) Period||0
4929075|NCT03230864|12123768|P3|COMPLETED|Prospective Confirmation (PC) Period||0
4929076|NCT03230864|12123769|P2|COMPLETED|Prospective Confirmation (PC) Period||32
4929077|NCT03230864|12123770|P1|COMPLETED|Prospective Confirmation (PC) Period||36
4929078|NCT03230864|12123767|P4|STARTED|Prospective Confirmation (PC) Period||0
4929079|NCT03230864|12123768|P3|STARTED|Prospective Confirmation (PC) Period||0
4929080|NCT03230864|12123769|P2|STARTED|Prospective Confirmation (PC) Period||51
4929081|NCT03230864|12123770|P1|STARTED|Prospective Confirmation (PC) Period||68
4929082|NCT03229486|12123788|P2|NOT COMPLETED|Overall Study||1
4929083|NCT03229486|12123789|P1|NOT COMPLETED|Overall Study||0
4929084|NCT03229486|12123788|P2|COMPLETED|Overall Study||19
4929085|NCT03229486|12123789|P1|COMPLETED|Overall Study||20
4929086|NCT03229486|12123788|P2|STARTED|Overall Study||20
4929087|NCT03229486|12123789|P1|STARTED|Overall Study||20
4929088|NCT03229252|12123810|P3|NOT COMPLETED|Overall Study||6
4929089|NCT03229252|12123811|P2|NOT COMPLETED|Overall Study||0
4929090|NCT03229252|12123812|P1|NOT COMPLETED|Overall Study||2
4929091|NCT03229252|12123810|P3|COMPLETED|Overall Study||39
4929092|NCT03229252|12123811|P2|COMPLETED|Overall Study||15
4929093|NCT03229252|12123812|P1|COMPLETED|Overall Study||29
4929094|NCT03229252|12123810|P3|STARTED|Overall Study||45
4929095|NCT03229252|12123811|P2|STARTED|Overall Study||15
4929096|NCT03229252|12123812|P1|STARTED|Overall Study||31
4929097|NCT03229109|12123830|P4|NOT COMPLETED|Overall Study||1
4929098|NCT03229109|12123831|P3|NOT COMPLETED|Overall Study||0
4929099|NCT03229109|12123832|P2|NOT COMPLETED|Overall Study||0
4929100|NCT03229109|12123833|P1|NOT COMPLETED|Overall Study||0
4929101|NCT03229109|12123830|P4|COMPLETED|Overall Study||50
4929102|NCT03229109|12123831|P3|COMPLETED|Overall Study||50
4929103|NCT03229109|12123832|P2|COMPLETED|Overall Study||50
4929104|NCT03229109|12123833|P1|COMPLETED|Overall Study||50
4929105|NCT03229109|12123830|P4|STARTED|Overall Study||51
4929106|NCT03229109|12123831|P3|STARTED|Overall Study||50
4929107|NCT03229109|12123832|P2|STARTED|Overall Study||50
4929108|NCT03229109|12123833|P1|STARTED|Overall Study||50
4929109|NCT03228433|12123849|P6|NOT COMPLETED|Overall Study||0
4929110|NCT03228433|12123850|P5|NOT COMPLETED|Overall Study||0
4929111|NCT03228433|12123851|P4|NOT COMPLETED|Overall Study||1
4929112|NCT03228433|12123852|P3|NOT COMPLETED|Overall Study||0
4929113|NCT03228433|12123853|P2|NOT COMPLETED|Overall Study||0
4929114|NCT03228433|12123854|P1|NOT COMPLETED|Overall Study||1
4929115|NCT03228433|12123849|P6|COMPLETED|Overall Study||6
4929116|NCT03228433|12123850|P5|COMPLETED|Overall Study||6
4929117|NCT03228433|12123851|P4|COMPLETED|Overall Study||5
4929118|NCT03228433|12123852|P3|COMPLETED|Overall Study||6
4929119|NCT03228433|12123853|P2|COMPLETED|Overall Study||6
4929120|NCT03228433|12123854|P1|COMPLETED|Overall Study||9
4929121|NCT03228433|12123849|P6|STARTED|Overall Study||6
4929122|NCT03228433|12123850|P5|STARTED|Overall Study||6
4929123|NCT03228433|12123851|P4|STARTED|Overall Study||6
4929124|NCT03228433|12123852|P3|STARTED|Overall Study||6
4929125|NCT03228433|12123853|P2|STARTED|Overall Study||6
4929126|NCT03228433|12123854|P1|STARTED|Overall Study||10
4929127|NCT03228212|12123929|P2|NOT COMPLETED|Period 3||0
4929128|NCT03228212|12123930|P1|NOT COMPLETED|Period 3||0
4929129|NCT03228212|12123929|P2|COMPLETED|Period 3||64
4929130|NCT03228212|12123930|P1|COMPLETED|Period 3||63
4929131|NCT03228212|12123929|P2|STARTED|Period 3||64
4929132|NCT03228212|12123930|P1|STARTED|Period 3||63
4929133|NCT03228212|12123929|P2|NOT COMPLETED|Period 2||0
4929134|NCT03228212|12123930|P1|NOT COMPLETED|Period 2||1
4929135|NCT03228212|12123929|P2|COMPLETED|Period 2||64
4929136|NCT03228212|12123930|P1|COMPLETED|Period 2||63
4929137|NCT03228212|12123929|P2|STARTED|Period 2||64
4929138|NCT03228212|12123930|P1|STARTED|Period 2||64
4929139|NCT03228212|12123929|P2|NOT COMPLETED|Period 1||1
4929140|NCT03228212|12123930|P1|NOT COMPLETED|Period 1||1
4929141|NCT03228212|12123929|P2|COMPLETED|Period 1||64
4929142|NCT03228212|12123930|P1|COMPLETED|Period 1||64
4929143|NCT03228212|12123929|P2|STARTED|Period 1||65
4929144|NCT03228212|12123930|P1|STARTED|Period 1||65
4929145|NCT03227861|12123946|P1|NOT COMPLETED|Overall Study||12
4929146|NCT03227861|12123946|P1|COMPLETED|Overall Study||97
4929147|NCT03227861|12123946|P1|STARTED|Overall Study||109
4929148|NCT03227692|12123973|P2|NOT COMPLETED|Overall Study||5
4929149|NCT03227692|12123974|P1|NOT COMPLETED|Overall Study||5
4929150|NCT03227692|12123973|P2|COMPLETED|Overall Study||41
4929151|NCT03227692|12123974|P1|COMPLETED|Overall Study||42
4929152|NCT03227692|12123973|P2|STARTED|Overall Study||46
4929153|NCT03227692|12123974|P1|STARTED|Overall Study||47
4929154|NCT03227445|12124002|P4|NOT COMPLETED|Period 2 (28 Days)||3
4929155|NCT03227445|12124003|P3|NOT COMPLETED|Period 2 (28 Days)||2
4929156|NCT03227445|12124004|P2|NOT COMPLETED|Period 2 (28 Days)||1
4929157|NCT03227445|12124005|P1|NOT COMPLETED|Period 2 (28 Days)||1
4929158|NCT03227445|12124002|P4|COMPLETED|Period 2 (28 Days)||55
4929159|NCT03227445|12124003|P3|COMPLETED|Period 2 (28 Days)||57
4929160|NCT03227445|12124004|P2|COMPLETED|Period 2 (28 Days)||56
4929161|NCT03227445|12124005|P1|COMPLETED|Period 2 (28 Days)||57
4929162|NCT03227445|12124002|P4|STARTED|Period 2 (28 Days)||58
4929163|NCT03227445|12124003|P3|STARTED|Period 2 (28 Days)||59
4929164|NCT03227445|12124004|P2|STARTED|Period 2 (28 Days)||57
4929165|NCT03227445|12124005|P1|STARTED|Period 2 (28 Days)||58
4929166|NCT03227445|12124002|P4|NOT COMPLETED|Period 1 (28 Days)||2
4929167|NCT03227445|12124003|P3|NOT COMPLETED|Period 1 (28 Days)||1
4929168|NCT03227445|12124004|P2|NOT COMPLETED|Period 1 (28 Days)||2
4929169|NCT03227445|12124005|P1|NOT COMPLETED|Period 1 (28 Days)||2
4929170|NCT03227445|12124002|P4|COMPLETED|Period 1 (28 Days)||58
4929171|NCT03227445|12124003|P3|COMPLETED|Period 1 (28 Days)||59
4929172|NCT03227445|12124004|P2|COMPLETED|Period 1 (28 Days)||57
4929173|NCT03227445|12124005|P1|COMPLETED|Period 1 (28 Days)||58
4929174|NCT03227445|12124002|P4|STARTED|Period 1 (28 Days)||60
4929175|NCT03227445|12124003|P3|STARTED|Period 1 (28 Days)||60
4929176|NCT03227445|12124004|P2|STARTED|Period 1 (28 Days)||59
4929177|NCT03227445|12124005|P1|STARTED|Period 1 (28 Days)||60
4929178|NCT03226691|12124029|P1|NOT COMPLETED|Overall Study||0
4929179|NCT03226691|12124029|P1|COMPLETED|Overall Study||15
4929180|NCT03226691|12124029|P1|STARTED|Overall Study||15
4929181|NCT03226392|12124035|P2|NOT COMPLETED|Overall Study||8
4929182|NCT03226392|12124036|P1|NOT COMPLETED|Overall Study||11
4929183|NCT03226392|12124035|P2|COMPLETED|Overall Study||344
4929184|NCT03226392|12124036|P1|COMPLETED|Overall Study||341
4929185|NCT03226392|12124035|P2|FAS|Overall Study|2 patients in the placebo were mis-randomized, not treated, not included due to “technical problems|350
4929186|NCT03226392|12124036|P1|FAS|Overall Study||352
4929187|NCT03226392|12124035|P2|STARTED|Overall Study||352
4929188|NCT03226392|12124036|P1|STARTED|Overall Study||352
4929189|NCT03226366|12124052|P4|NOT COMPLETED|Overall Study||0
4929190|NCT03226366|12124053|P3|NOT COMPLETED|Overall Study||0
4929191|NCT03226366|12124054|P2|NOT COMPLETED|Overall Study||0
4929192|NCT03226366|12124055|P1|NOT COMPLETED|Overall Study||0
4929193|NCT03226366|12124052|P4|COMPLETED|Overall Study||641
4929194|NCT03226366|12124053|P3|COMPLETED|Overall Study||1183
4929195|NCT03226366|12124054|P2|COMPLETED|Overall Study||495
4929196|NCT03226366|12124055|P1|COMPLETED|Overall Study||911
4929197|NCT03226366|12124052|P4|STARTED|Overall Study||641
4929198|NCT03226366|12124053|P3|STARTED|Overall Study||1183
4929199|NCT03226366|12124054|P2|STARTED|Overall Study||495
4929200|NCT03226366|12124055|P1|STARTED|Overall Study||911
4929201|NCT03226353|12124077|P1|NOT COMPLETED|Overall Study||6
4929202|NCT03226353|12124077|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
4929203|NCT03226353|12124077|P1|Other Habitual Lens Types|Overall Study||75
4929204|NCT03226353|12124077|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
4929205|NCT03226353|12124077|P1|STARTED|Overall Study||77
4929206|NCT03226275|12124101|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
4929207|NCT03226275|12124102|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
4929208|NCT03226275|12124103|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
4929209|NCT03226275|12124104|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
4929210|NCT03226275|12124101|P4|COMPLETED|Treatment Period 2 (8 Days)||7
4929211|NCT03226275|12124102|P3|COMPLETED|Treatment Period 2 (8 Days)||7
4929212|NCT03226275|12124103|P2|COMPLETED|Treatment Period 2 (8 Days)||8
4929213|NCT03226275|12124104|P1|COMPLETED|Treatment Period 2 (8 Days)||8
4929214|NCT03226275|12124101|P4|STARTED|Treatment Period 2 (8 Days)||7
4929215|NCT03226275|12124102|P3|STARTED|Treatment Period 2 (8 Days)||7
4929216|NCT03226275|12124103|P2|STARTED|Treatment Period 2 (8 Days)||8
4929217|NCT03226275|12124104|P1|STARTED|Treatment Period 2 (8 Days)||8
4929218|NCT03226275|12124101|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
4929219|NCT03226275|12124102|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
4929220|NCT03226275|12124103|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
4929221|NCT03226275|12124104|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
4929222|NCT03226275|12124101|P4|COMPLETED|Treatment Period 1 (8 Days)||7
4929223|NCT03226275|12124102|P3|COMPLETED|Treatment Period 1 (8 Days)||7
4929224|NCT03226275|12124103|P2|COMPLETED|Treatment Period 1 (8 Days)||8
4929225|NCT03226275|12124104|P1|COMPLETED|Treatment Period 1 (8 Days)||8
4929226|NCT03226275|12124101|P4|STARTED|Treatment Period 1 (8 Days)||8
4929227|NCT03226275|12124102|P3|STARTED|Treatment Period 1 (8 Days)||8
4929228|NCT03226275|12124103|P2|STARTED|Treatment Period 1 (8 Days)||8
4929229|NCT03226275|12124104|P1|STARTED|Treatment Period 1 (8 Days)||8
4929230|NCT03226249|12124150|P1|NOT COMPLETED|Survival Follow-up||30
4929231|NCT03226249|12124150|P1|COMPLETED|Survival Follow-up||0
4929232|NCT03226249|12124150|P1|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
4929233|NCT03226249|12124150|P1|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
4929234|NCT03226249|12124150|P1|COMPLETED|PEM Consolidation (1-2 Years)||0
4929235|NCT03226249|12124150|P1|STARTED|PEM Consolidation (1-2 Years)||29
4929236|NCT03226249|12124150|P1|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
4929237|NCT03226249|12124150|P1|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
4929238|NCT03226249|12124150|P1|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
4929239|NCT03226249|12124150|P1|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
4929240|NCT03226249|12124150|P1|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
4929241|NCT03226249|12124150|P1|NOT COMPLETED|2 Cycles of AVD + PET#3||0
4929242|NCT03226249|12124150|P1|COMPLETED|2 Cycles of AVD + PET#3||30
4929243|NCT03226249|12124150|P1|PET#3|2 Cycles of AVD + PET#3||30
4929244|NCT03226249|12124150|P1|AVD Cycle 2|2 Cycles of AVD + PET#3||30
4929245|NCT03226249|12124150|P1|AVD Cycle 1|2 Cycles of AVD + PET#3||30
4929246|NCT03226249|12124150|P1|STARTED|2 Cycles of AVD + PET#3||30
4929247|NCT03226249|12124150|P1|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
4929248|NCT03226249|12124150|P1|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
4929249|NCT03226249|12124150|P1|PET#2|PEM Induction Cycles 1-3, and PET#2||30
4929250|NCT03226249|12124150|P1|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
4929251|NCT03226249|12124150|P1|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
4929252|NCT03226249|12124150|P1|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
4929253|NCT03226249|12124150|P1|STARTED|PEM Induction Cycles 1-3, and PET#2||30
4929254|NCT03225599|12124156|P1|NOT COMPLETED|Overall Study||2
4929255|NCT03225599|12124156|P1|COMPLETED|Overall Study||7
4929256|NCT03225599|12124156|P1|STARTED|Overall Study||9
4929257|NCT03225573|12124160|P1|NOT COMPLETED|Overall Study||0
4929258|NCT03225573|12124160|P1|COMPLETED|Overall Study||60
4929259|NCT03225573|12124160|P1|STARTED|Overall Study||60
4929260|NCT03225313|12124167|P3|NOT COMPLETED|Overall Study||0
4929261|NCT03225313|12124168|P2|NOT COMPLETED|Overall Study||0
4929262|NCT03225313|12124169|P1|NOT COMPLETED|Overall Study||0
4929263|NCT03225313|12124167|P3|COMPLETED|Overall Study|25 Patients|25
4929264|NCT03225313|12124168|P2|COMPLETED|Overall Study|25 Patients|25
4929265|NCT03225313|12124169|P1|COMPLETED|Overall Study|25 Patients|25
4929266|NCT03225313|12124167|P3|STARTED|Overall Study|25 Patients|25
4929267|NCT03225313|12124168|P2|STARTED|Overall Study|25 Patients|25
4929268|NCT03225313|12124169|P1|STARTED|Overall Study|25 Patients|25
4929269|NCT03225001|12124201|P1|NOT COMPLETED|Overall Study||9
4929270|NCT03225001|12124201|P1|COMPLETED|Overall Study||188
4929271|NCT03225001|12124201|P1|Valve-Implanted|Overall Study||195
4929272|NCT03225001|12124201|P1|STARTED|Overall Study||197
4929273|NCT03224598|12124209|P3|NOT COMPLETED|Overall Study||0
4929274|NCT03224598|12124210|P2|NOT COMPLETED|Overall Study||3
4929275|NCT03224598|12124211|P1|NOT COMPLETED|Overall Study||0
4929276|NCT03224598|12124209|P3|COMPLETED|Overall Study||13
4929277|NCT03224598|12124210|P2|COMPLETED|Overall Study||14
4929278|NCT03224598|12124211|P1|COMPLETED|Overall Study||9
4929279|NCT03224598|12124209|P3|STARTED|Overall Study||13
4929280|NCT03224598|12124210|P2|STARTED|Overall Study||17
4929281|NCT03224598|12124211|P1|STARTED|Overall Study||9
4929282|NCT03224390|12124221|P2|NOT COMPLETED|Overall Study||35
4929283|NCT03224390|12124222|P1|NOT COMPLETED|Overall Study||27
4929284|NCT03224390|12124221|P2|COMPLETED|Overall Study||21
4929285|NCT03224390|12124222|P1|COMPLETED|Overall Study||29
4929286|NCT03224390|12124221|P2|STARTED|Overall Study||56
4929287|NCT03224390|12124222|P1|STARTED|Overall Study||56
4929288|NCT03224325|12124237|P7|NOT COMPLETED|Overall Study||1
4929289|NCT03224325|12124238|P6|NOT COMPLETED|Overall Study||0
4929290|NCT03224325|12124239|P5|NOT COMPLETED|Overall Study||0
4929291|NCT03224325|12124240|P4|NOT COMPLETED|Overall Study||1
4929292|NCT03224325|12124241|P3|NOT COMPLETED|Overall Study||0
4929293|NCT03224325|12124242|P2|NOT COMPLETED|Overall Study||0
4929294|NCT03224325|12124243|P1|NOT COMPLETED|Overall Study||1
4929295|NCT03224325|12124237|P7|COMPLETED|Overall Study||6
4929296|NCT03224325|12124238|P6|COMPLETED|Overall Study||6
4929297|NCT03224325|12124239|P5|COMPLETED|Overall Study||6
4929298|NCT03224325|12124240|P4|COMPLETED|Overall Study||5
4929299|NCT03224325|12124241|P3|COMPLETED|Overall Study||6
4929300|NCT03224325|12124242|P2|COMPLETED|Overall Study||6
4929301|NCT03224325|12124243|P1|COMPLETED|Overall Study||12
4929302|NCT03224325|12124237|P7|STARTED|Overall Study||7
4929303|NCT03224325|12124238|P6|STARTED|Overall Study||6
4929304|NCT03224325|12124239|P5|STARTED|Overall Study||6
4929305|NCT03224325|12124240|P4|STARTED|Overall Study||6
4929306|NCT03224325|12124241|P3|STARTED|Overall Study||6
4929307|NCT03224325|12124242|P2|STARTED|Overall Study||6
4929308|NCT03224325|12124243|P1|STARTED|Overall Study||13
4929309|NCT03224130|12124306|P2|NOT COMPLETED|Overall Study||1
4929310|NCT03224130|12124307|P1|NOT COMPLETED|Overall Study||0
4929311|NCT03224130|12124306|P2|COMPLETED|Overall Study||482
4929312|NCT03224130|12124307|P1|COMPLETED|Overall Study||483
4929313|NCT03224130|12124306|P2|STARTED|Overall Study||483
4929314|NCT03224130|12124307|P1|STARTED|Overall Study||483
4929315|NCT03223909|12124328|P3|NOT COMPLETED|Overall Study||16
4929316|NCT03223909|12124329|P2|NOT COMPLETED|Overall Study||45
4929317|NCT03223909|12124330|P1|NOT COMPLETED|Overall Study||48
4929318|NCT03223909|12124328|P3|COMPLETED|Overall Study||81
4929319|NCT03223909|12124329|P2|COMPLETED|Overall Study||64
4929320|NCT03223909|12124330|P1|COMPLETED|Overall Study||72
4929321|NCT03223909|12124328|P3|STARTED|Overall Study||97
4929322|NCT03223909|12124329|P2|STARTED|Overall Study||109
4929323|NCT03223909|12124330|P1|STARTED|Overall Study||120
4929324|NCT03223662|12124359|P1|NOT COMPLETED|Overall Study||2
4929325|NCT03223662|12124359|P1|COMPLETED|Overall Study||0
4929326|NCT03223662|12124359|P1|STARTED|Overall Study||2
4929327|NCT03223337|12124373|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
4929328|NCT03223337|12124374|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
4929329|NCT03223337|12124375|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
4929330|NCT03223337|12124376|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
4929331|NCT03223337|12124373|P4|COMPLETED|Part 2 (Up to 16 Days)||9
4929332|NCT03223337|12124374|P3|COMPLETED|Part 2 (Up to 16 Days)||12
4929333|NCT03223337|12124375|P2|COMPLETED|Part 2 (Up to 16 Days)||0
4929334|NCT03223337|12124376|P1|COMPLETED|Part 2 (Up to 16 Days)||0
4929335|NCT03223337|12124373|P4|STARTED|Part 2 (Up to 16 Days)||9
4929336|NCT03223337|12124374|P3|STARTED|Part 2 (Up to 16 Days)||12
4929337|NCT03223337|12124375|P2|STARTED|Part 2 (Up to 16 Days)||0
4929338|NCT03223337|12124376|P1|STARTED|Part 2 (Up to 16 Days)||0
4929339|NCT03223337|12124373|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
4929340|NCT03223337|12124374|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
4929341|NCT03223337|12124375|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
4929342|NCT03223337|12124376|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
4929343|NCT03223337|12124373|P4|COMPLETED|Part 1 (Up to 16 Days)||0
4929344|NCT03223337|12124374|P3|COMPLETED|Part 1 (Up to 16 Days)||0
4929345|NCT03223337|12124375|P2|COMPLETED|Part 1 (Up to 16 Days)||8
4929346|NCT03223337|12124376|P1|COMPLETED|Part 1 (Up to 16 Days)||8
4929347|NCT03223337|12124373|P4|STARTED|Part 1 (Up to 16 Days)||0
4929348|NCT03223337|12124374|P3|STARTED|Part 1 (Up to 16 Days)||0
4929349|NCT03223337|12124375|P2|STARTED|Part 1 (Up to 16 Days)||8
4929350|NCT03223337|12124376|P1|STARTED|Part 1 (Up to 16 Days)||8
4929351|NCT03222583|12124444|P2|NOT COMPLETED|Overall Study||6
4929352|NCT03222583|12124445|P1|NOT COMPLETED|Overall Study||5
4929353|NCT03222583|12124444|P2|COMPLETED|Overall Study||177
4929354|NCT03222583|12124445|P1|COMPLETED|Overall Study||358
4929355|NCT03222583|12124444|P2|Completed Open-label Period|Overall Study||181
4929356|NCT03222583|12124445|P1|Completed Open-label Period|Overall Study||0
4929357|NCT03222583|12124444|P2|Entered Open-label Period|Overall Study||182
4929358|NCT03222583|12124445|P1|Entered Open-label Period|Overall Study||0
4929359|NCT03222583|12124444|P2|Completed Double-blind Period|Overall Study||183
4929360|NCT03222583|12124445|P1|Completed Double-blind Period|Overall Study||360
4929361|NCT03222583|12124444|P2|Received Double-blind Treatment|Overall Study||183
4929362|NCT03222583|12124445|P1|Received Double-blind Treatment|Overall Study||362
4929363|NCT03222583|12124444|P2|STARTED|Overall Study||183
4929364|NCT03222583|12124445|P1|STARTED|Overall Study||363
4929365|NCT03222505|12124458|P2|NOT COMPLETED|Overall Study||0
4929366|NCT03222505|12124459|P1|NOT COMPLETED|Overall Study||0
4929367|NCT03222505|12124458|P2|COMPLETED|Overall Study||7
4929368|NCT03222505|12124459|P1|COMPLETED|Overall Study||5
4929369|NCT03222505|12124458|P2|STARTED|Overall Study||7
4929370|NCT03222505|12124459|P1|STARTED|Overall Study||5
4929371|NCT03222427|12124469|P1|NOT COMPLETED|Overall Study||0
4929372|NCT03222427|12124469|P1|COMPLETED|Overall Study||8
4929373|NCT03222427|12124469|P1|Received One Dose of Study Drug|Overall Study||8
4929374|NCT03222427|12124469|P1|STARTED|Overall Study||8
4929375|NCT03222414|12124478|P2|NOT COMPLETED|Overall Study||0
4929376|NCT03222414|12124479|P1|NOT COMPLETED|Overall Study||0
4929377|NCT03222414|12124478|P2|COMPLETED|Overall Study||1
4929378|NCT03222414|12124479|P1|COMPLETED|Overall Study||0
4929379|NCT03222414|12124478|P2|STARTED|Overall Study||1
4929380|NCT03222414|12124479|P1|STARTED|Overall Study||0
4929381|NCT03222141|12124495|P1|NOT COMPLETED|Overall Study||18
4929382|NCT03222141|12124495|P1|COMPLETED|Overall Study||565
4929383|NCT03222141|12124495|P1|STARTED|Overall Study||583
4929384|NCT03222128|12124501|P1|NOT COMPLETED|Overall Study||106
4929385|NCT03222128|12124501|P1|COMPLETED|Overall Study||968
4929386|NCT03222128|12124501|P1|Valve-Implanted|Overall Study||1069
4929387|NCT03222128|12124501|P1|STARTED|Overall Study||1074
4929388|NCT03222037|12124506|P2|NOT COMPLETED|Period 2||0
4929389|NCT03222037|12124507|P1|NOT COMPLETED|Period 2||0
4929390|NCT03222037|12124506|P2|COMPLETED|Period 2||22
4929391|NCT03222037|12124507|P1|COMPLETED|Period 2||21
4929392|NCT03222037|12124506|P2|STARTED|Period 2||22
4929393|NCT03222037|12124507|P1|STARTED|Period 2||21
4929394|NCT03222037|12124506|P2|NOT COMPLETED|Period 1||0
4929395|NCT03222037|12124507|P1|NOT COMPLETED|Period 1||0
4929396|NCT03222037|12124506|P2|COMPLETED|Period 1||22
4929397|NCT03222037|12124507|P1|COMPLETED|Period 1||21
4929398|NCT03222037|12124506|P2|STARTED|Period 1||22
4929399|NCT03222037|12124507|P1|STARTED|Period 1||21
4929400|NCT03221764|12124515|P1|NOT COMPLETED|Overall Study||0
4929401|NCT03221764|12124515|P1|COMPLETED|Overall Study||20
4929402|NCT03221764|12124515|P1|STARTED|Overall Study||20
4929403|NCT03221738|12124521|P1|NOT COMPLETED|Overall Study||0
4929404|NCT03221738|12124521|P1|COMPLETED|Overall Study||10
4929405|NCT03221738|12124521|P1|STARTED|Overall Study||10
4929406|NCT03221192|12124527|P1|NOT COMPLETED|Overall Study||0
4929407|NCT03221192|12124527|P1|COMPLETED|Overall Study||27
4929408|NCT03221192|12124527|P1|STARTED|Overall Study||27
4929409|NCT03220412|12124568|P2|NOT COMPLETED|Overall Study||0
4929410|NCT03220412|12124569|P1|NOT COMPLETED|Overall Study||0
4929411|NCT03220412|12124568|P2|COMPLETED|Overall Study||50
4929412|NCT03220412|12124569|P1|COMPLETED|Overall Study||54
4929413|NCT03220412|12124568|P2|STARTED|Overall Study||50
4929414|NCT03220412|12124569|P1|STARTED|Overall Study||54
4929415|NCT03220230|12124577|P1|NOT COMPLETED|Overall Study||0
4929416|NCT03220230|12124577|P1|COMPLETED|Overall Study||4240
4929417|NCT03220230|12124577|P1|STARTED|Overall Study||4240
4929418|NCT03220204|12124590|P3|NOT COMPLETED|Overall Study||3
4929419|NCT03220204|12124591|P2|NOT COMPLETED|Overall Study||2
4929420|NCT03220204|12124592|P1|NOT COMPLETED|Overall Study||1
4929421|NCT03220204|12124590|P3|COMPLETED|Overall Study||12
4929422|NCT03220204|12124591|P2|COMPLETED|Overall Study||13
4929423|NCT03220204|12124592|P1|COMPLETED|Overall Study||14
4929424|NCT03220204|12124590|P3|STARTED|Overall Study||15
4929425|NCT03220204|12124591|P2|STARTED|Overall Study||15
4929426|NCT03220204|12124592|P1|STARTED|Overall Study||15
4929427|NCT03220048|12124642|P3|NOT COMPLETED|Overall Study||1
4929428|NCT03220048|12124643|P2|NOT COMPLETED|Overall Study||2
4929429|NCT03220048|12124644|P1|NOT COMPLETED|Overall Study||0
4929430|NCT03220048|12124642|P3|COMPLETED|Overall Study||27
4929431|NCT03220048|12124643|P2|COMPLETED|Overall Study||25
4929432|NCT03220048|12124644|P1|COMPLETED|Overall Study||11
4929433|NCT03220048|12124642|P3|STARTED|Overall Study||28
4929434|NCT03220048|12124643|P2|STARTED|Overall Study||27
4929435|NCT03220048|12124644|P1|STARTED|Overall Study||11
4929436|NCT03219723|12124667|P1|NOT COMPLETED|Overall Study||10
4929437|NCT03219723|12124667|P1|COMPLETED|Overall Study||550
4929438|NCT03219723|12124667|P1|STARTED|Overall Study||560
4929439|NCT03219320|12124676|P4|NOT COMPLETED|Overall Study||3
4929440|NCT03219320|12124677|P3|NOT COMPLETED|Overall Study||5
4929441|NCT03219320|12124678|P2|NOT COMPLETED|Overall Study||3
4929442|NCT03219320|12124679|P1|NOT COMPLETED|Overall Study||2
4929443|NCT03219320|12124676|P4|COMPLETED|Overall Study||69
4929444|NCT03219320|12124677|P3|COMPLETED|Overall Study||72
4929445|NCT03219320|12124678|P2|COMPLETED|Overall Study||74
4929446|NCT03219320|12124679|P1|COMPLETED|Overall Study||73
4929447|NCT03219320|12124676|P4|STARTED|Overall Study||72
4929448|NCT03219320|12124677|P3|STARTED|Overall Study||77
4929449|NCT03219320|12124678|P2|STARTED|Overall Study||77
4929450|NCT03219320|12124679|P1|STARTED|Overall Study||75
4929451|NCT03219294|12124699|P2|NOT COMPLETED|Overall Study||0
4929452|NCT03219294|12124700|P1|NOT COMPLETED|Overall Study||0
4929453|NCT03219294|12124699|P2|COMPLETED|Overall Study||58
4929454|NCT03219294|12124700|P1|COMPLETED|Overall Study||58
4929455|NCT03219294|12124699|P2|STARTED|Overall Study||58
4929456|NCT03219294|12124700|P1|STARTED|Overall Study||58
4929457|NCT03219216|12124710|P2|NOT COMPLETED|Overall Study||1
4929458|NCT03219216|12124711|P1|NOT COMPLETED|Overall Study||0
4929459|NCT03219216|12124710|P2|COMPLETED|Overall Study||24
4929460|NCT03219216|12124711|P1|COMPLETED|Overall Study||75
4929461|NCT03219216|12124710|P2|STARTED|Overall Study||25
4929462|NCT03219216|12124711|P1|STARTED|Overall Study||75
4929463|NCT03218592|12124720|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
4929464|NCT03218592|12124721|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
4929465|NCT03218592|12124722|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
4929466|NCT03218592|12124720|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
4929467|NCT03218592|12124721|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
4929468|NCT03218592|12124722|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
4929469|NCT03218592|12124720|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
4929470|NCT03218592|12124721|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
4929471|NCT03218592|12124722|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
4929472|NCT03218592|12124720|P3|STARTED|Phase 3: 3 Doses Per Week||4
4929473|NCT03218592|12124721|P2|STARTED|Phase 3: 3 Doses Per Week||4
4929474|NCT03218592|12124722|P1|STARTED|Phase 3: 3 Doses Per Week||4
4929475|NCT03218592|12124720|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
4929476|NCT03218592|12124721|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
4929477|NCT03218592|12124722|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
4929478|NCT03218592|12124720|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
4929479|NCT03218592|12124721|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
4929480|NCT03218592|12124722|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
4929481|NCT03218592|12124720|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
4929482|NCT03218592|12124721|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
4929483|NCT03218592|12124722|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
4929484|NCT03218592|12124720|P3|STARTED|Phase 3: 1 Dose Per Period||4
4929485|NCT03218592|12124721|P2|STARTED|Phase 3: 1 Dose Per Period||4
4929486|NCT03218592|12124722|P1|STARTED|Phase 3: 1 Dose Per Period||4
4929487|NCT03218592|12124720|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
4929488|NCT03218592|12124721|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
4929489|NCT03218592|12124722|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
4929490|NCT03218592|12124720|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
4929491|NCT03218592|12124721|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
4929492|NCT03218592|12124722|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
4929493|NCT03218592|12124720|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
4929494|NCT03218592|12124721|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
4929495|NCT03218592|12124722|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
4929496|NCT03218592|12124720|P3|STARTED|Phase 3: 0 Doses Per Week||4
4929497|NCT03218592|12124721|P2|STARTED|Phase 3: 0 Doses Per Week||4
4929498|NCT03218592|12124722|P1|STARTED|Phase 3: 0 Doses Per Week||4
4929499|NCT03218592|12124720|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
4929500|NCT03218592|12124721|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
4929501|NCT03218592|12124722|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
4929502|NCT03218592|12124720|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
4929503|NCT03218592|12124721|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
4929504|NCT03218592|12124722|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
4929505|NCT03218592|12124720|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
4929506|NCT03218592|12124721|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
4929507|NCT03218592|12124722|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
4929508|NCT03218592|12124720|P3|NOT COMPLETED|Phase 1: 1 Dose||0
4929509|NCT03218592|12124721|P2|NOT COMPLETED|Phase 1: 1 Dose||0
4929510|NCT03218592|12124722|P1|NOT COMPLETED|Phase 1: 1 Dose||0
4929511|NCT03218592|12124720|P3|COMPLETED|Phase 1: 1 Dose||12
4929512|NCT03218592|12124721|P2|COMPLETED|Phase 1: 1 Dose||12
4929513|NCT03218592|12124722|P1|COMPLETED|Phase 1: 1 Dose||12
4929514|NCT03218592|12124720|P3|STARTED|Phase 1: 1 Dose||12
4929515|NCT03218592|12124721|P2|STARTED|Phase 1: 1 Dose||12
4929516|NCT03218592|12124722|P1|STARTED|Phase 1: 1 Dose||12
4929517|NCT03218397|12124744|P2|NOT COMPLETED|Overall Study||29
4929518|NCT03218397|12124745|P1|NOT COMPLETED|Overall Study||23
4929519|NCT03218397|12124744|P2|COMPLETED|Overall Study||222
4929520|NCT03218397|12124745|P1|COMPLETED|Overall Study||226
4929521|NCT03218397|12124744|P2|STARTED|Overall Study||251
4929522|NCT03218397|12124745|P1|STARTED|Overall Study||249
4929523|NCT03218163|12124773|P1|NOT COMPLETED|Overall Study||0
4929524|NCT03218163|12124773|P1|COMPLETED|Overall Study||0
4929525|NCT03218163|12124773|P1|STARTED|Overall Study||0
4929526|NCT03217968|12124777|P1|NOT COMPLETED|Overall Study||11
4929527|NCT03217968|12124777|P1|COMPLETED|Overall Study||48
4929528|NCT03217968|12124777|P1|STARTED|Overall Study||59
4929529|NCT03217175|12124786|P2|NOT COMPLETED|Overall Study||1
4929530|NCT03217175|12124787|P1|NOT COMPLETED|Overall Study||4
4929531|NCT03217175|12124786|P2|COMPLETED|Overall Study||0
4929532|NCT03217175|12124787|P1|COMPLETED|Overall Study||0
4929533|NCT03217175|12124786|P2|STARTED|Overall Study||1
4929534|NCT03217175|12124787|P1|STARTED|Overall Study||4
4929535|NCT03216850|12124801|P1|NOT COMPLETED|Overall Study||6
4929536|NCT03216850|12124801|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
4929537|NCT03216850|12124801|P1|STARTED|Overall Study||15
4929538|NCT03216746|12124809|P4|NOT COMPLETED|Overall Study||6
4929539|NCT03216746|12124810|P3|NOT COMPLETED|Overall Study||5
4929540|NCT03216746|12124811|P2|NOT COMPLETED|Overall Study||8
4929541|NCT03216746|12124812|P1|NOT COMPLETED|Overall Study||6
4929542|NCT03216746|12124809|P4|COMPLETED|Overall Study||63
4929543|NCT03216746|12124810|P3|COMPLETED|Overall Study||63
4929544|NCT03216746|12124811|P2|COMPLETED|Overall Study||71
4929545|NCT03216746|12124812|P1|COMPLETED|Overall Study||66
4929546|NCT03216746|12124809|P4|STARTED|Overall Study||69
4929547|NCT03216746|12124810|P3|STARTED|Overall Study||68
4929548|NCT03216746|12124811|P2|STARTED|Overall Study||79
4929549|NCT03216746|12124812|P1|STARTED|Overall Study||72
4929550|NCT03216512|12124824|P2|NOT COMPLETED|Overall Study||1
4929551|NCT03216512|12124825|P1|NOT COMPLETED|Overall Study||0
4929552|NCT03216512|12124824|P2|COMPLETED|Overall Study||13
4929553|NCT03216512|12124825|P1|COMPLETED|Overall Study||17
4929554|NCT03216512|12124824|P2|STARTED|Overall Study||14
4929555|NCT03216512|12124825|P1|STARTED|Overall Study||17
4929556|NCT03216265|12124846|P3|NOT COMPLETED|Overall Study||3
4929557|NCT03216265|12124847|P2|NOT COMPLETED|Overall Study||1
4929558|NCT03216265|12124848|P1|NOT COMPLETED|Overall Study||2
4929559|NCT03216265|12124846|P3|COMPLETED|Overall Study||19
4929560|NCT03216265|12124847|P2|COMPLETED|Overall Study||21
4929561|NCT03216265|12124848|P1|COMPLETED|Overall Study||20
4929562|NCT03216265|12124846|P3|STARTED|Overall Study||22
4929563|NCT03216265|12124847|P2|STARTED|Overall Study||22
4929564|NCT03216265|12124848|P1|STARTED|Overall Study||22
4929565|NCT03216200|12124898|P1|NOT COMPLETED|Overall Study||0
4929566|NCT03216200|12124898|P1|COMPLETED|Overall Study||5
4929567|NCT03216200|12124898|P1|STARTED|Overall Study||5
4929568|NCT03215901|12124906|P3|NOT COMPLETED|Overall Study||0
4929569|NCT03215901|12124907|P2|NOT COMPLETED|Overall Study||0
4929570|NCT03215901|12124908|P1|NOT COMPLETED|Overall Study||0
4929571|NCT03215901|12124906|P3|COMPLETED|Overall Study||116
4929572|NCT03215901|12124907|P2|COMPLETED|Overall Study||112
4929573|NCT03215901|12124908|P1|COMPLETED|Overall Study||199
4929574|NCT03215901|12124906|P3|STARTED|Overall Study||116
4929575|NCT03215901|12124907|P2|STARTED|Overall Study||112
4929576|NCT03215901|12124908|P1|STARTED|Overall Study||199
4929577|NCT03215758|12124939|P2|NOT COMPLETED|Overall Study||8
4929578|NCT03215758|12124940|P1|NOT COMPLETED|Overall Study||5
4929579|NCT03215758|12124939|P2|COMPLETED|Overall Study||328
4929580|NCT03215758|12124940|P1|COMPLETED|Overall Study||334
4929581|NCT03215758|12124939|P2|STARTED|Overall Study||336
4929582|NCT03215758|12124940|P1|STARTED|Overall Study||339
4929583|NCT03214952|12124952|P1|NOT COMPLETED|Overall Study||58
4929584|NCT03214952|12124952|P1|COMPLETED|Overall Study||3125
4929585|NCT03214952|12124952|P1|STARTED|Overall Study||3183
4929586|NCT03214588|12124967|P3|NOT COMPLETED|Overall Study||2
4929587|NCT03214588|12124968|P2|NOT COMPLETED|Overall Study||1
4929588|NCT03214588|12124969|P1|NOT COMPLETED|Overall Study||1
4929589|NCT03214588|12124967|P3|COMPLETED|Overall Study||24
4929590|NCT03214588|12124968|P2|COMPLETED|Overall Study||13
4929591|NCT03214588|12124969|P1|COMPLETED|Overall Study||26
4929592|NCT03214588|12124967|P3|STARTED|Overall Study||26
4929593|NCT03214588|12124968|P2|STARTED|Overall Study||14
4929594|NCT03214588|12124969|P1|STARTED|Overall Study||27
4929595|NCT03214406|12125036|P2|NOT COMPLETED|Overall Study||15
4929596|NCT03214406|12125037|P1|NOT COMPLETED|Overall Study||10
4929597|NCT03214406|12125036|P2|COMPLETED|Overall Study||78
4929598|NCT03214406|12125037|P1|COMPLETED|Overall Study||78
4929599|NCT03214406|12125036|P2|STARTED|Overall Study||93
4929600|NCT03214406|12125037|P1|STARTED|Overall Study||88
4929601|NCT03214380|12125051|P6|NOT COMPLETED|Treatment Period||11
4929602|NCT03214380|12125052|P5|NOT COMPLETED|Treatment Period||9
4929603|NCT03214380|12125053|P4|NOT COMPLETED|Treatment Period||0
4929604|NCT03214380|12125054|P3|NOT COMPLETED|Treatment Period||16
4929605|NCT03214380|12125055|P2|NOT COMPLETED|Treatment Period||18
4929606|NCT03214380|12125056|P1|NOT COMPLETED|Treatment Period||0
4929607|NCT03214380|12125051|P6|COMPLETED|Treatment Period||71
4929608|NCT03214380|12125052|P5|COMPLETED|Treatment Period||73
4929609|NCT03214380|12125053|P4|COMPLETED|Treatment Period||0
4929610|NCT03214380|12125054|P3|COMPLETED|Treatment Period||320
4929611|NCT03214380|12125055|P2|COMPLETED|Treatment Period||319
4929612|NCT03214380|12125056|P1|COMPLETED|Treatment Period||0
4929613|NCT03214380|12125051|P6|Received at Least 1 Dose of Study Drug|Treatment Period||82
4929614|NCT03214380|12125052|P5|Received at Least 1 Dose of Study Drug|Treatment Period||82
4929615|NCT03214380|12125053|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
4929616|NCT03214380|12125054|P3|Received at Least 1 Dose of Study Drug|Treatment Period||336
4929617|NCT03214380|12125055|P2|Received at Least 1 Dose of Study Drug|Treatment Period||337
4929618|NCT03214380|12125056|P1|Received at Least 1 Dose of Study Drug|Treatment Period||0
4929619|NCT03214380|12125051|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
4929620|NCT03214380|12125052|P5|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
4929621|NCT03214380|12125053|P4|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
4929622|NCT03214380|12125054|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
4929623|NCT03214380|12125055|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
4929624|NCT03214380|12125056|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
4929625|NCT03214380|12125051|P6|NOT COMPLETED|Lead-in||0
4929626|NCT03214380|12125052|P5|NOT COMPLETED|Lead-in||0
4929627|NCT03214380|12125053|P4|NOT COMPLETED|Lead-in||19
4929628|NCT03214380|12125054|P3|NOT COMPLETED|Lead-in||0
4929629|NCT03214380|12125055|P2|NOT COMPLETED|Lead-in||0
4929630|NCT03214380|12125056|P1|NOT COMPLETED|Lead-in||77
4929631|NCT03214380|12125051|P6|COMPLETED|Lead-in||0
4929632|NCT03214380|12125052|P5|COMPLETED|Lead-in||0
4929633|NCT03214380|12125053|P4|COMPLETED|Lead-in||164
4929634|NCT03214380|12125054|P3|COMPLETED|Lead-in||0
4929635|NCT03214380|12125055|P2|COMPLETED|Lead-in||0
4929636|NCT03214380|12125056|P1|COMPLETED|Lead-in||673
4929637|NCT03214380|12125051|P6|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
4929638|NCT03214380|12125052|P5|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
4929639|NCT03214380|12125053|P4|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
4929640|NCT03214380|12125054|P3|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
4929641|NCT03214380|12125055|P2|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
4929642|NCT03214380|12125056|P1|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
4929643|NCT03214380|12125051|P6|STARTED|Lead-in||0
4929644|NCT03214380|12125052|P5|STARTED|Lead-in||0
4929645|NCT03214380|12125053|P4|STARTED|Lead-in||183
4929646|NCT03214380|12125054|P3|STARTED|Lead-in||0
4929647|NCT03214380|12125055|P2|STARTED|Lead-in||0
4929648|NCT03214380|12125056|P1|STARTED|Lead-in||750
4929649|NCT03214367|12125092|P8|NOT COMPLETED|Treatment Period||1
4929650|NCT03214367|12125093|P7|NOT COMPLETED|Treatment Period||2
4929651|NCT03214367|12125094|P6|NOT COMPLETED|Treatment Period||3
4929652|NCT03214367|12125095|P5|NOT COMPLETED|Treatment Period||0
4929653|NCT03214367|12125096|P4|NOT COMPLETED|Treatment Period||19
4929654|NCT03214367|12125097|P3|NOT COMPLETED|Treatment Period||33
4929655|NCT03214367|12125098|P2|NOT COMPLETED|Treatment Period||34
4929656|NCT03214367|12125099|P1|NOT COMPLETED|Treatment Period||0
4929657|NCT03214367|12125092|P8|COMPLETED|Treatment Period||21
4929658|NCT03214367|12125093|P7|COMPLETED|Treatment Period||19
4929659|NCT03214367|12125094|P6|COMPLETED|Treatment Period||28
4929660|NCT03214367|12125095|P5|COMPLETED|Treatment Period||0
4929661|NCT03214367|12125096|P4|COMPLETED|Treatment Period||310
4929662|NCT03214367|12125097|P3|COMPLETED|Treatment Period||418
4929663|NCT03214367|12125098|P2|COMPLETED|Treatment Period||408
4929664|NCT03214367|12125099|P1|COMPLETED|Treatment Period||0
4929665|NCT03214367|12125092|P8|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
4929666|NCT03214367|12125093|P7|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
4929667|NCT03214367|12125094|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
4929668|NCT03214367|12125095|P5|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
4929669|NCT03214367|12125096|P4|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
4929670|NCT03214367|12125097|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
4929671|NCT03214367|12125098|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
4929672|NCT03214367|12125099|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
4929673|NCT03214367|12125092|P8|NOT COMPLETED|Lead-in Period||0
4929674|NCT03214367|12125093|P7|NOT COMPLETED|Lead-in Period||0
4929675|NCT03214367|12125094|P6|NOT COMPLETED|Lead-in Period||0
4929676|NCT03214367|12125095|P5|NOT COMPLETED|Lead-in Period||2
4929677|NCT03214367|12125096|P4|NOT COMPLETED|Lead-in Period||0
4929678|NCT03214367|12125097|P3|NOT COMPLETED|Lead-in Period||0
4929679|NCT03214367|12125098|P2|NOT COMPLETED|Lead-in Period||0
4929680|NCT03214367|12125099|P1|NOT COMPLETED|Lead-in Period||94
4929681|NCT03214367|12125092|P8|COMPLETED|Lead-in Period||0
4929682|NCT03214367|12125093|P7|COMPLETED|Lead-in Period||0
4929683|NCT03214367|12125094|P6|COMPLETED|Lead-in Period||0
4929684|NCT03214367|12125095|P5|COMPLETED|Lead-in Period||74
4929685|NCT03214367|12125096|P4|COMPLETED|Lead-in Period||0
4929686|NCT03214367|12125097|P3|COMPLETED|Lead-in Period||0
4929687|NCT03214367|12125098|P2|COMPLETED|Lead-in Period||0
4929688|NCT03214367|12125099|P1|COMPLETED|Lead-in Period||1222
4929689|NCT03214367|12125092|P8|STARTED|Lead-in Period||0
4929690|NCT03214367|12125093|P7|STARTED|Lead-in Period||0
4929691|NCT03214367|12125094|P6|STARTED|Lead-in Period||0
4929692|NCT03214367|12125095|P5|STARTED|Lead-in Period||76
4929693|NCT03214367|12125096|P4|STARTED|Lead-in Period||0
4929694|NCT03214367|12125097|P3|STARTED|Lead-in Period||0
4929695|NCT03214367|12125098|P2|STARTED|Lead-in Period||0
4929696|NCT03214367|12125099|P1|STARTED|Lead-in Period||1316
4929697|NCT03214224|12125147|P3|NOT COMPLETED|Longitudinal PFT Study||0
4929698|NCT03214224|12125148|P2|NOT COMPLETED|Longitudinal PFT Study||0
4929699|NCT03214224|12125149|P1|NOT COMPLETED|Longitudinal PFT Study||0
4929700|NCT03214224|12125147|P3|COMPLETED|Longitudinal PFT Study||0
4929701|NCT03214224|12125148|P2|COMPLETED|Longitudinal PFT Study||0
4929702|NCT03214224|12125149|P1|COMPLETED|Longitudinal PFT Study||0
4929703|NCT03214224|12125147|P3|STARTED|Longitudinal PFT Study||0
4929704|NCT03214224|12125148|P2|STARTED|Longitudinal PFT Study||0
4929705|NCT03214224|12125149|P1|STARTED|Longitudinal PFT Study||0
4929706|NCT03214224|12125147|P3|NOT COMPLETED|Validation Study||9
4929707|NCT03214224|12125148|P2|NOT COMPLETED|Validation Study||0
4929708|NCT03214224|12125149|P1|NOT COMPLETED|Validation Study||0
4929709|NCT03214224|12125147|P3|COMPLETED|Validation Study|3 therapists enrolled. 3 controls enrolled but not included in analysis set. 3 patients also.|40
4929710|NCT03214224|12125148|P2|COMPLETED|Validation Study||0
4929711|NCT03214224|12125149|P1|COMPLETED|Validation Study||0
4929712|NCT03214224|12125147|P3|STARTED|Validation Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
4929713|NCT03214224|12125148|P2|STARTED|Validation Study||0
4929714|NCT03214224|12125149|P1|STARTED|Validation Study||0
4929715|NCT03214094|12125158|P1|NOT COMPLETED|Overall Study||60
4929716|NCT03214094|12125158|P1|COMPLETED|Overall Study||1059
4929717|NCT03214094|12125158|P1|STARTED|Overall Study||1119
4929718|NCT03214081|12125166|P1|NOT COMPLETED|Overall Study||63
4929719|NCT03214081|12125166|P1|COMPLETED|Overall Study||1174
4929720|NCT03214081|12125166|P1|STARTED|Overall Study||1237
4929721|NCT03213509|12125183|P2|NOT COMPLETED|Overall Study||5
4929722|NCT03213509|12125184|P1|NOT COMPLETED|Overall Study||4
4929723|NCT03213509|12125183|P2|COMPLETED|Overall Study||85
4929724|NCT03213509|12125184|P1|COMPLETED|Overall Study||76
4929725|NCT03213509|12125183|P2|STARTED|Overall Study||90
4929726|NCT03213509|12125184|P1|STARTED|Overall Study||80
4929727|NCT03213366|12125197|P2|NOT COMPLETED|Overall Study||4
4929728|NCT03213366|12125198|P1|NOT COMPLETED|Overall Study||9
4929729|NCT03213366|12125197|P2|COMPLETED|Overall Study||67
4929730|NCT03213366|12125198|P1|COMPLETED|Overall Study||72
4929731|NCT03213366|12125197|P2|STARTED|Overall Study||71
4929732|NCT03213366|12125198|P1|STARTED|Overall Study||81
4929733|NCT03212690|12125224|P1|NOT COMPLETED|Overall Study||1
4929734|NCT03212690|12125224|P1|COMPLETED|Overall Study||56
4929735|NCT03212690|12125224|P1|STARTED|Overall Study||57
4929736|NCT03212638|12125246|P5|NOT COMPLETED|Period 5||0
4929737|NCT03212638|12125247|P4|NOT COMPLETED|Period 5||0
4929738|NCT03212638|12125248|P3|NOT COMPLETED|Period 5||0
4929739|NCT03212638|12125249|P2|NOT COMPLETED|Period 5||0
4929740|NCT03212638|12125250|P1|NOT COMPLETED|Period 5||0
4929741|NCT03212638|12125246|P5|COMPLETED|Period 5||9
4929742|NCT03212638|12125247|P4|COMPLETED|Period 5||9
4929743|NCT03212638|12125248|P3|COMPLETED|Period 5||0
4929744|NCT03212638|12125249|P2|COMPLETED|Period 5||0
4929745|NCT03212638|12125250|P1|COMPLETED|Period 5||0
4929746|NCT03212638|12125246|P5|Received at Least 1 Dose of Study Drug|Period 5||9
4929747|NCT03212638|12125247|P4|Received at Least 1 Dose of Study Drug|Period 5||9
4929748|NCT03212638|12125248|P3|Received at Least 1 Dose of Study Drug|Period 5||0
4929749|NCT03212638|12125249|P2|Received at Least 1 Dose of Study Drug|Period 5||0
4929750|NCT03212638|12125250|P1|Received at Least 1 Dose of Study Drug|Period 5||0
4929751|NCT03212638|12125246|P5|STARTED|Period 5||9
4929752|NCT03212638|12125247|P4|STARTED|Period 5||9
4929753|NCT03212638|12125248|P3|STARTED|Period 5||0
4929754|NCT03212638|12125249|P2|STARTED|Period 5||0
4929755|NCT03212638|12125250|P1|STARTED|Period 5||0
4929756|NCT03212638|12125246|P5|NOT COMPLETED|Period 4||0
4929757|NCT03212638|12125247|P4|NOT COMPLETED|Period 4||0
4929758|NCT03212638|12125248|P3|NOT COMPLETED|Period 4||0
4929759|NCT03212638|12125249|P2|NOT COMPLETED|Period 4||0
4929760|NCT03212638|12125250|P1|NOT COMPLETED|Period 4||0
4929761|NCT03212638|12125246|P5|COMPLETED|Period 4||9
4929762|NCT03212638|12125247|P4|COMPLETED|Period 4||9
4929763|NCT03212638|12125248|P3|COMPLETED|Period 4||0
4929764|NCT03212638|12125249|P2|COMPLETED|Period 4||0
4929765|NCT03212638|12125250|P1|COMPLETED|Period 4||0
4929766|NCT03212638|12125246|P5|Received at Least 1 Dose of Study Drug|Period 4||9
4929767|NCT03212638|12125247|P4|Received at Least 1 Dose of Study Drug|Period 4||9
4929768|NCT03212638|12125248|P3|Received at Least 1 Dose of Study Drug|Period 4||0
4929769|NCT03212638|12125249|P2|Received at Least 1 Dose of Study Drug|Period 4||0
4929770|NCT03212638|12125250|P1|Received at Least 1 Dose of Study Drug|Period 4||0
4929771|NCT03212638|12125246|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
4929772|NCT03212638|12125247|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
4929773|NCT03212638|12125248|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
4929774|NCT03212638|12125249|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
4929775|NCT03212638|12125250|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
4929776|NCT03212638|12125246|P5|NOT COMPLETED|Period 3||0
4929777|NCT03212638|12125247|P4|NOT COMPLETED|Period 3||0
4929778|NCT03212638|12125248|P3|NOT COMPLETED|Period 3||0
4929779|NCT03212638|12125249|P2|NOT COMPLETED|Period 3||0
4929780|NCT03212638|12125250|P1|NOT COMPLETED|Period 3||0
4929781|NCT03212638|12125246|P5|COMPLETED|Period 3||0
4929782|NCT03212638|12125247|P4|COMPLETED|Period 3||0
4929783|NCT03212638|12125248|P3|COMPLETED|Period 3||8
4929784|NCT03212638|12125249|P2|COMPLETED|Period 3||8
4929785|NCT03212638|12125250|P1|COMPLETED|Period 3||8
4929786|NCT03212638|12125246|P5|Received at Least 1 Dose of Study Drug|Period 3||0
4929787|NCT03212638|12125247|P4|Received at Least 1 Dose of Study Drug|Period 3||0
4929788|NCT03212638|12125248|P3|Received at Least 1 Dose of Study Drug|Period 3||8
4929789|NCT03212638|12125249|P2|Received at Least 1 Dose of Study Drug|Period 3||8
4929790|NCT03212638|12125250|P1|Received at Least 1 Dose of Study Drug|Period 3||8
4929791|NCT03212638|12125246|P5|STARTED|Period 3||0
4929792|NCT03212638|12125247|P4|STARTED|Period 3||0
4929793|NCT03212638|12125248|P3|STARTED|Period 3||8
4929794|NCT03212638|12125249|P2|STARTED|Period 3||8
4929795|NCT03212638|12125250|P1|STARTED|Period 3||8
4929796|NCT03212638|12125246|P5|NOT COMPLETED|Period 2||0
4929797|NCT03212638|12125247|P4|NOT COMPLETED|Period 2||0
4929798|NCT03212638|12125248|P3|NOT COMPLETED|Period 2||0
4929799|NCT03212638|12125249|P2|NOT COMPLETED|Period 2||0
4929800|NCT03212638|12125250|P1|NOT COMPLETED|Period 2||0
4929801|NCT03212638|12125246|P5|COMPLETED|Period 2||0
4929802|NCT03212638|12125247|P4|COMPLETED|Period 2||0
4929803|NCT03212638|12125248|P3|COMPLETED|Period 2||8
4929804|NCT03212638|12125249|P2|COMPLETED|Period 2||8
4929805|NCT03212638|12125250|P1|COMPLETED|Period 2||8
4929806|NCT03212638|12125246|P5|Received at Least 1 Dose of Study Drug|Period 2||0
4929807|NCT03212638|12125247|P4|Received at Least 1 Dose of Study Drug|Period 2||0
4929808|NCT03212638|12125248|P3|Received at Least 1 Dose of Study Drug|Period 2||8
4929809|NCT03212638|12125249|P2|Received at Least 1 Dose of Study Drug|Period 2||8
4929810|NCT03212638|12125250|P1|Received at Least 1 Dose of Study Drug|Period 2||8
4929811|NCT03212638|12125246|P5|STARTED|Period 2||0
4929812|NCT03212638|12125247|P4|STARTED|Period 2||0
4929813|NCT03212638|12125248|P3|STARTED|Period 2||8
4929814|NCT03212638|12125249|P2|STARTED|Period 2||8
4929815|NCT03212638|12125250|P1|STARTED|Period 2||8
4929816|NCT03212638|12125246|P5|NOT COMPLETED|Period 1||0
4929817|NCT03212638|12125247|P4|NOT COMPLETED|Period 1||0
4929818|NCT03212638|12125248|P3|NOT COMPLETED|Period 1||0
4929819|NCT03212638|12125249|P2|NOT COMPLETED|Period 1||0
4929820|NCT03212638|12125250|P1|NOT COMPLETED|Period 1||0
4929821|NCT03212638|12125246|P5|COMPLETED|Period 1||0
4929822|NCT03212638|12125247|P4|COMPLETED|Period 1||0
4929823|NCT03212638|12125248|P3|COMPLETED|Period 1||8
4929824|NCT03212638|12125249|P2|COMPLETED|Period 1||8
4929825|NCT03212638|12125250|P1|COMPLETED|Period 1||8
4929826|NCT03212638|12125246|P5|Received at Least 1 Dose of Study Drug|Period 1||0
4929827|NCT03212638|12125247|P4|Received at Least 1 Dose of Study Drug|Period 1||0
4929828|NCT03212638|12125248|P3|Received at Least 1 Dose of Study Drug|Period 1||8
4929829|NCT03212638|12125249|P2|Received at Least 1 Dose of Study Drug|Period 1||8
4929830|NCT03212638|12125250|P1|Received at Least 1 Dose of Study Drug|Period 1||8
4929831|NCT03212638|12125246|P5|STARTED|Period 1||0
4929832|NCT03212638|12125247|P4|STARTED|Period 1||0
4929833|NCT03212638|12125248|P3|STARTED|Period 1||8
4929834|NCT03212638|12125249|P2|STARTED|Period 1||8
4929835|NCT03212638|12125250|P1|STARTED|Period 1||8
4929836|NCT03212521|12125272|P1|NOT COMPLETED|Overall Study||7
4929837|NCT03212521|12125272|P1|COMPLETED|Overall Study||223
4929838|NCT03212521|12125272|P1|STARTED|Overall Study||230
4929839|NCT03212326|12125279|P1|NOT COMPLETED|Overall Study||4
4929840|NCT03212326|12125279|P1|COMPLETED|Overall Study||20
4929841|NCT03212326|12125279|P1|STARTED|Overall Study||24
4929842|NCT03212261|12125284|P1|NOT COMPLETED|Overall Study||16
4929843|NCT03212261|12125284|P1|COMPLETED|Overall Study||21
4929844|NCT03212261|12125284|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
4929845|NCT03212261|12125284|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
4929846|NCT03212261|12125284|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
4929847|NCT03212261|12125284|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
4929848|NCT03212261|12125284|P1|Remained Eligible|Overall Study||35
4929849|NCT03212261|12125284|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
4929850|NCT03212144|12125292|P2|NOT COMPLETED|Second Sequence (4 Weeks)||1
4929851|NCT03212144|12125293|P1|NOT COMPLETED|Second Sequence (4 Weeks)||1
4929852|NCT03212144|12125292|P2|COMPLETED|Second Sequence (4 Weeks)||0
4929853|NCT03212144|12125293|P1|COMPLETED|Second Sequence (4 Weeks)||0
4929854|NCT03212144|12125292|P2|STARTED|Second Sequence (4 Weeks)||1
4929855|NCT03212144|12125293|P1|STARTED|Second Sequence (4 Weeks)||1
4929856|NCT03212144|12125292|P2|NOT COMPLETED|Washout (4 Weeks)||0
4929857|NCT03212144|12125293|P1|NOT COMPLETED|Washout (4 Weeks)||0
4929858|NCT03212144|12125292|P2|COMPLETED|Washout (4 Weeks)||1
4929859|NCT03212144|12125293|P1|COMPLETED|Washout (4 Weeks)||1
4929860|NCT03212144|12125292|P2|STARTED|Washout (4 Weeks)||1
4929861|NCT03212144|12125293|P1|STARTED|Washout (4 Weeks)||1
4929862|NCT03212144|12125292|P2|NOT COMPLETED|First Sequence (4 Weeks)||0
4929863|NCT03212144|12125293|P1|NOT COMPLETED|First Sequence (4 Weeks)||1
4929864|NCT03212144|12125292|P2|COMPLETED|First Sequence (4 Weeks)||1
4929865|NCT03212144|12125293|P1|COMPLETED|First Sequence (4 Weeks)||1
4929866|NCT03212144|12125292|P2|STARTED|First Sequence (4 Weeks)||1
4929867|NCT03212144|12125293|P1|STARTED|First Sequence (4 Weeks)||2
4929868|NCT03211858|12125301|P2|NOT COMPLETED|Overall Study||33
4929869|NCT03211858|12125302|P1|NOT COMPLETED|Overall Study||37
4929870|NCT03211858|12125301|P2|COMPLETED|Overall Study||263
4929871|NCT03211858|12125302|P1|COMPLETED|Overall Study||264
4929872|NCT03211858|12125301|P2|Treated|Overall Study||296
4929873|NCT03211858|12125302|P1|Treated|Overall Study||301
4929874|NCT03211858|12125301|P2|STARTED|Overall Study||296
4929875|NCT03211858|12125302|P1|STARTED|Overall Study||301
4929876|NCT03211117|12125330|P2|NOT COMPLETED|Overall Study||0
4929877|NCT03211117|12125331|P1|NOT COMPLETED|Overall Study||0
4929878|NCT03211117|12125330|P2|COMPLETED|Overall Study||3
4929879|NCT03211117|12125331|P1|COMPLETED|Overall Study||0
4929880|NCT03211117|12125330|P2|STARTED|Overall Study||3
4929881|NCT03211117|12125331|P1|STARTED|Overall Study||0
4929882|NCT03210961|12125353|P15|NOT COMPLETED|Overall Study||2
4929883|NCT03210961|12125354|P14|NOT COMPLETED|Overall Study||4
4929884|NCT03210961|12125355|P13|NOT COMPLETED|Overall Study||2
4929885|NCT03210961|12125356|P12|NOT COMPLETED|Overall Study||0
4929886|NCT03210961|12125357|P11|NOT COMPLETED|Overall Study||1
4929887|NCT03210961|12125358|P10|NOT COMPLETED|Overall Study||0
4929888|NCT03210961|12125359|P9|NOT COMPLETED|Overall Study||0
4929889|NCT03210961|12125360|P8|NOT COMPLETED|Overall Study||0
4929890|NCT03210961|12125361|P7|NOT COMPLETED|Overall Study||1
4929891|NCT03210961|12125362|P6|NOT COMPLETED|Overall Study||0
4929892|NCT03210961|12125363|P5|NOT COMPLETED|Overall Study||0
4929893|NCT03210961|12125364|P4|NOT COMPLETED|Overall Study||1
4929894|NCT03210961|12125365|P3|NOT COMPLETED|Overall Study||0
4929895|NCT03210961|12125366|P2|NOT COMPLETED|Overall Study||0
4929896|NCT03210961|12125367|P1|NOT COMPLETED|Overall Study||0
4929897|NCT03210961|12125353|P15|COMPLETED|Overall Study||9
4929898|NCT03210961|12125354|P14|COMPLETED|Overall Study||11
4929899|NCT03210961|12125355|P13|COMPLETED|Overall Study||12
4929900|NCT03210961|12125356|P12|COMPLETED|Overall Study||5
4929901|NCT03210961|12125357|P11|COMPLETED|Overall Study||6
4929902|NCT03210961|12125358|P10|COMPLETED|Overall Study||6
4929903|NCT03210961|12125359|P9|COMPLETED|Overall Study||8
4929904|NCT03210961|12125360|P8|COMPLETED|Overall Study||7
4929905|NCT03210961|12125361|P7|COMPLETED|Overall Study||7
4929906|NCT03210961|12125362|P6|COMPLETED|Overall Study||6
4929907|NCT03210961|12125363|P5|COMPLETED|Overall Study||6
4929908|NCT03210961|12125364|P4|COMPLETED|Overall Study||1
4929909|NCT03210961|12125365|P3|COMPLETED|Overall Study||1
4929910|NCT03210961|12125366|P2|COMPLETED|Overall Study||9
4929911|NCT03210961|12125367|P1|COMPLETED|Overall Study||4
4929912|NCT03210961|12125353|P15|STARTED|Overall Study||11
4929913|NCT03210961|12125354|P14|STARTED|Overall Study||15
4929914|NCT03210961|12125355|P13|STARTED|Overall Study||14
4929915|NCT03210961|12125356|P12|STARTED|Overall Study||5
4929916|NCT03210961|12125357|P11|STARTED|Overall Study||7
4929917|NCT03210961|12125358|P10|STARTED|Overall Study||6
4929918|NCT03210961|12125359|P9|STARTED|Overall Study||8
4929919|NCT03210961|12125360|P8|STARTED|Overall Study||7
4929920|NCT03210961|12125361|P7|STARTED|Overall Study||8
4929921|NCT03210961|12125362|P6|STARTED|Overall Study||6
4929922|NCT03210961|12125363|P5|STARTED|Overall Study||6
4929923|NCT03210961|12125364|P4|STARTED|Overall Study||2
4929924|NCT03210961|12125365|P3|STARTED|Overall Study||1
4929925|NCT03210961|12125366|P2|STARTED|Overall Study||9
4929926|NCT03210961|12125367|P1|STARTED|Overall Study||4
4929927|NCT03210701|12125716|P1|NOT COMPLETED|Overall Study||0
4929928|NCT03210701|12125716|P1|COMPLETED|Overall Study||123
4929929|NCT03210701|12125716|P1|STARTED|Overall Study||123
4929930|NCT03210519|12125726|P2|NOT COMPLETED|Overall Study||0
4929931|NCT03210519|12125727|P1|NOT COMPLETED|Overall Study||2
4929932|NCT03210519|12125726|P2|COMPLETED|Overall Study||10
4929933|NCT03210519|12125727|P1|COMPLETED|Overall Study||9
4929934|NCT03210519|12125726|P2|STARTED|Overall Study||10
4929935|NCT03210519|12125727|P1|STARTED|Overall Study||11
4929936|NCT03210376|12125753|P2|NOT COMPLETED|Overall Study||0
4929937|NCT03210376|12125754|P1|NOT COMPLETED|Overall Study||0
4929938|NCT03210376|12125753|P2|COMPLETED|Overall Study||50
4929939|NCT03210376|12125754|P1|COMPLETED|Overall Study||50
4929940|NCT03210376|12125753|P2|STARTED|Overall Study||50
4929941|NCT03210376|12125754|P1|STARTED|Overall Study||50
4929942|NCT03210337|12125774|P2|NOT COMPLETED|Overall Study||5
4929943|NCT03210337|12125775|P1|NOT COMPLETED|Overall Study||8
4929944|NCT03210337|12125774|P2|COMPLETED|Overall Study||74
4929945|NCT03210337|12125775|P1|COMPLETED|Overall Study||70
4929946|NCT03210337|12125774|P2|STARTED|Overall Study||79
4929947|NCT03210337|12125775|P1|STARTED|Overall Study||78
4929948|NCT03210220|12125783|P2|NOT COMPLETED|Overall Study||0
4929949|NCT03210220|12125784|P1|NOT COMPLETED|Overall Study||1
4929950|NCT03210220|12125783|P2|COMPLETED|Overall Study||20
4929951|NCT03210220|12125784|P1|COMPLETED|Overall Study||19
4929952|NCT03210220|12125783|P2|STARTED|Overall Study||20
4929953|NCT03210220|12125784|P1|STARTED|Overall Study||20
4929954|NCT03209570|12125792|P2|NOT COMPLETED|Overall Study||13
4929955|NCT03209570|12125793|P1|NOT COMPLETED|Overall Study||10
4929956|NCT03209570|12125792|P2|COMPLETED|Overall Study||12
4929957|NCT03209570|12125793|P1|COMPLETED|Overall Study||14
4929958|NCT03209570|12125792|P2|STARTED|Overall Study||25
4929959|NCT03209570|12125793|P1|STARTED|Overall Study||24
4929960|NCT03209518|12125803|P1|NOT COMPLETED|Overall Study||2
4929961|NCT03209518|12125803|P1|COMPLETED|Overall Study||310
4929962|NCT03209518|12125803|P1|STARTED|Overall Study||312
4929963|NCT03209492|12125808|P1|NOT COMPLETED|Overall Study||5
4929964|NCT03209492|12125808|P1|COMPLETED|Overall Study||328
4929965|NCT03209492|12125808|P1|STARTED|Overall Study||333
4929966|NCT03208673|12125813|P1|NOT COMPLETED|Overall Study||0
4929967|NCT03208673|12125813|P1|COMPLETED|Overall Study||32
4929968|NCT03208673|12125813|P1|STARTED|Overall Study||32
4929969|NCT03208166|12125821|P2|NOT COMPLETED|Overall Study||0
4929970|NCT03208166|12125822|P1|NOT COMPLETED|Overall Study||0
4929971|NCT03208166|12125821|P2|COMPLETED|Overall Study||1
4929972|NCT03208166|12125822|P1|COMPLETED|Overall Study||1
4929973|NCT03208166|12125821|P2|STARTED|Overall Study||1
4929974|NCT03208166|12125822|P1|STARTED|Overall Study||1
4929975|NCT03207776|12125832|P2|NOT COMPLETED|Overall Study||0
4929976|NCT03207776|12125833|P1|NOT COMPLETED|Overall Study||0
4929977|NCT03207776|12125832|P2|COMPLETED|Overall Study||2353
4929978|NCT03207776|12125833|P1|COMPLETED|Overall Study||2479
4929979|NCT03207776|12125832|P2|STARTED|Overall Study||2353
4929980|NCT03207776|12125833|P1|STARTED|Overall Study||2479
4929981|NCT03207750|12125847|P2|NOT COMPLETED|Overall Study||66
4929982|NCT03207750|12125848|P1|NOT COMPLETED|Overall Study||58
4929983|NCT03207750|12125847|P2|COMPLETED|Overall Study||574
4929984|NCT03207750|12125848|P1|COMPLETED|Overall Study||574
4929985|NCT03207750|12125847|P2|STARTED|Overall Study||640
4929986|NCT03207750|12125848|P1|STARTED|Overall Study||632
4929987|NCT03207438|12125894|P4|NOT COMPLETED|Overall Study||112
4929988|NCT03207438|12125895|P3|NOT COMPLETED|Overall Study||232
4929989|NCT03207438|12125896|P2|NOT COMPLETED|Overall Study||21
4929990|NCT03207438|12125897|P1|NOT COMPLETED|Overall Study||19
4929991|NCT03207438|12125894|P4|COMPLETED|Overall Study||470
4929992|NCT03207438|12125895|P3|COMPLETED|Overall Study||643
4929993|NCT03207438|12125896|P2|COMPLETED|Overall Study||145
4929994|NCT03207438|12125897|P1|COMPLETED|Overall Study||148
4929995|NCT03207438|12125894|P4|STARTED|Overall Study||582
4929996|NCT03207438|12125895|P3|STARTED|Overall Study||875
4929997|NCT03207438|12125896|P2|STARTED|Overall Study||166
4929998|NCT03207438|12125897|P1|STARTED|Overall Study||167
4929999|NCT03207399|12125914|P1|NOT COMPLETED|Overall Study||0
4930000|NCT03207399|12125914|P1|COMPLETED|Overall Study||1
4930001|NCT03207399|12125914|P1|STARTED|Overall Study||1
4930002|NCT03207243|12125928|P2|NOT COMPLETED|Overall Study||44
4930003|NCT03207243|12125929|P1|NOT COMPLETED|Overall Study||59
4930004|NCT03207243|12125928|P2|COMPLETED|Overall Study||39
4930005|NCT03207243|12125929|P1|COMPLETED|Overall Study||23
4930006|NCT03207243|12125928|P2|STARTED|Overall Study||83
4930007|NCT03207243|12125929|P1|STARTED|Overall Study||82
4930008|NCT03207074|12126036|P1|NOT COMPLETED|Overall Study||0
4930009|NCT03207074|12126036|P1|COMPLETED|Overall Study||150
4930010|NCT03207074|12126036|P1|STARTED|Overall Study||150
4930011|NCT03206970|12126040|P1|NOT COMPLETED|Overall Study||26
4930012|NCT03206970|12126040|P1|COMPLETED|Overall Study||60
4930013|NCT03206970|12126040|P1|STARTED|Overall Study||86
4930014|NCT03206216|12126046|P2|NOT COMPLETED|Overall Study||1
4930015|NCT03206216|12126047|P1|NOT COMPLETED|Overall Study||0
4930016|NCT03206216|12126046|P2|COMPLETED|Overall Study||0
4930017|NCT03206216|12126047|P1|COMPLETED|Overall Study||0
4930018|NCT03206216|12126046|P2|STARTED|Overall Study||1
4930019|NCT03206216|12126047|P1|STARTED|Overall Study||0
4930020|NCT03205488|12126058|P3|NOT COMPLETED|Overall Study||5
4930021|NCT03205488|12126059|P2|NOT COMPLETED|Overall Study||2
4930022|NCT03205488|12126060|P1|NOT COMPLETED|Overall Study||1
4930023|NCT03205488|12126058|P3|COMPLETED|Overall Study||21
4930024|NCT03205488|12126059|P2|COMPLETED|Overall Study||23
4930025|NCT03205488|12126060|P1|COMPLETED|Overall Study||24
4930026|NCT03205488|12126058|P3|STARTED|Overall Study||26
4930027|NCT03205488|12126059|P2|STARTED|Overall Study||25
4930028|NCT03205488|12126060|P1|STARTED|Overall Study||25
4930029|NCT03205371|12126086|P12|NOT COMPLETED|Overall Study||1
4930030|NCT03205371|12126087|P11|NOT COMPLETED|Overall Study||0
4930031|NCT03205371|12126088|P10|NOT COMPLETED|Overall Study||0
4930032|NCT03205371|12126089|P9|NOT COMPLETED|Overall Study||5
4930033|NCT03205371|12126090|P8|NOT COMPLETED|Overall Study||3
4930034|NCT03205371|12126091|P7|NOT COMPLETED|Overall Study||10
4930035|NCT03205371|12126092|P6|NOT COMPLETED|Overall Study||0
4930036|NCT03205371|12126093|P5|NOT COMPLETED|Overall Study||0
4930037|NCT03205371|12126094|P4|NOT COMPLETED|Overall Study||0
4930038|NCT03205371|12126095|P3|NOT COMPLETED|Overall Study||0
4930039|NCT03205371|12126096|P2|NOT COMPLETED|Overall Study||1
4930040|NCT03205371|12126097|P1|NOT COMPLETED|Overall Study||4
4930041|NCT03205371|12126086|P12|COMPLETED|Overall Study||99
4930042|NCT03205371|12126087|P11|COMPLETED|Overall Study||100
4930043|NCT03205371|12126088|P10|COMPLETED|Overall Study||200
4930044|NCT03205371|12126089|P9|COMPLETED|Overall Study||95
4930045|NCT03205371|12126090|P8|COMPLETED|Overall Study||97
4930046|NCT03205371|12126091|P7|COMPLETED|Overall Study||190
4930047|NCT03205371|12126092|P6|COMPLETED|Overall Study||42
4930048|NCT03205371|12126093|P5|COMPLETED|Overall Study||42
4930049|NCT03205371|12126094|P4|COMPLETED|Overall Study||86
4930050|NCT03205371|12126095|P3|COMPLETED|Overall Study||53
4930051|NCT03205371|12126096|P2|COMPLETED|Overall Study||52
4930052|NCT03205371|12126097|P1|COMPLETED|Overall Study||103
4930053|NCT03205371|12126086|P12|Per-protocol Analysis Set (PPAS)|Overall Study||92
4930054|NCT03205371|12126087|P11|Per-protocol Analysis Set (PPAS)|Overall Study||96
4930055|NCT03205371|12126088|P10|Per-protocol Analysis Set (PPAS)|Overall Study||196
4930056|NCT03205371|12126089|P9|Per-protocol Analysis Set (PPAS)|Overall Study||68
4930057|NCT03205371|12126090|P8|Per-protocol Analysis Set (PPAS)|Overall Study||79
4930058|NCT03205371|12126091|P7|Per-protocol Analysis Set (PPAS)|Overall Study||155
4930059|NCT03205371|12126092|P6|Per-protocol Analysis Set (PPAS)|Overall Study||42
4930060|NCT03205371|12126093|P5|Per-protocol Analysis Set (PPAS)|Overall Study||42
4930061|NCT03205371|12126094|P4|Per-protocol Analysis Set (PPAS)|Overall Study||85
4930062|NCT03205371|12126095|P3|Per-protocol Analysis Set (PPAS)|Overall Study||50
4930063|NCT03205371|12126096|P2|Per-protocol Analysis Set (PPAS)|Overall Study||45
4930064|NCT03205371|12126097|P1|Per-protocol Analysis Set (PPAS)|Overall Study||92
4930065|NCT03205371|12126086|P12|Safety Analysis Set (SafAS)|Overall Study||99
4930066|NCT03205371|12126087|P11|Safety Analysis Set (SafAS)|Overall Study||100
4930067|NCT03205371|12126088|P10|Safety Analysis Set (SafAS)|Overall Study||200
4930068|NCT03205371|12126089|P9|Safety Analysis Set (SafAS)|Overall Study||100
4930069|NCT03205371|12126090|P8|Safety Analysis Set (SafAS)|Overall Study||100
4930070|NCT03205371|12126091|P7|Safety Analysis Set (SafAS)|Overall Study||200
4930071|NCT03205371|12126092|P6|Safety Analysis Set (SafAS)|Overall Study||42
4930072|NCT03205371|12126093|P5|Safety Analysis Set (SafAS)|Overall Study||42
4930073|NCT03205371|12126094|P4|Safety Analysis Set (SafAS)|Overall Study||86
4930074|NCT03205371|12126095|P3|Safety Analysis Set (SafAS)|Overall Study||53
4930075|NCT03205371|12126096|P2|Safety Analysis Set (SafAS)|Overall Study||52
4930076|NCT03205371|12126097|P1|Safety Analysis Set (SafAS)|Overall Study||103
4930077|NCT03205371|12126086|P12|STARTED|Overall Study||100
4930078|NCT03205371|12126087|P11|STARTED|Overall Study||100
4930079|NCT03205371|12126088|P10|STARTED|Overall Study||200
4930080|NCT03205371|12126089|P9|STARTED|Overall Study||100
4930081|NCT03205371|12126090|P8|STARTED|Overall Study||100
4930082|NCT03205371|12126091|P7|STARTED|Overall Study||200
4930083|NCT03205371|12126092|P6|STARTED|Overall Study||42
4930084|NCT03205371|12126093|P5|STARTED|Overall Study||42
4930085|NCT03205371|12126094|P4|STARTED|Overall Study||86
4930086|NCT03205371|12126095|P3|STARTED|Overall Study||53
4930087|NCT03205371|12126096|P2|STARTED|Overall Study||53
4930088|NCT03205371|12126097|P1|STARTED|Overall Study||107
4930089|NCT03205358|12126177|P2|NOT COMPLETED|Overall Study||0
4930090|NCT03205358|12126178|P1|NOT COMPLETED|Overall Study||0
4930091|NCT03205358|12126177|P2|COMPLETED|Overall Study||94
4930092|NCT03205358|12126178|P1|COMPLETED|Overall Study||94
4930093|NCT03205358|12126177|P2|STARTED|Overall Study||94
4930094|NCT03205358|12126178|P1|STARTED|Overall Study||94
4930095|NCT03205163|12126186|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
4930096|NCT03205163|12126187|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
4930097|NCT03205163|12126186|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
4930098|NCT03205163|12126187|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
4930099|NCT03205163|12126186|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
4930100|NCT03205163|12126187|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
4930101|NCT03205163|12126186|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
4930102|NCT03205163|12126187|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
4930103|NCT03205163|12126186|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
4930104|NCT03205163|12126187|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
4930105|NCT03205163|12126186|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
4930106|NCT03205163|12126187|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
4930107|NCT03205163|12126186|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
4930108|NCT03205163|12126187|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
4930109|NCT03205163|12126186|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
4930110|NCT03205163|12126187|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
4930111|NCT03204942|12126238|P3|NOT COMPLETED|Overall Study||0
4930112|NCT03204942|12126239|P2|NOT COMPLETED|Overall Study||0
4930113|NCT03204942|12126240|P1|NOT COMPLETED|Overall Study||0
4930114|NCT03204942|12126238|P3|COMPLETED|Overall Study||23
4930115|NCT03204942|12126239|P2|COMPLETED|Overall Study||23
4930116|NCT03204942|12126240|P1|COMPLETED|Overall Study||23
4930117|NCT03204942|12126238|P3|STARTED|Overall Study||23
4930118|NCT03204942|12126239|P2|STARTED|Overall Study||23
4930119|NCT03204942|12126240|P1|STARTED|Overall Study||23
4930120|NCT03204643|12126268|P2|NOT COMPLETED|Overall Study||0
4930121|NCT03204643|12126269|P1|NOT COMPLETED|Overall Study||0
4930122|NCT03204643|12126268|P2|COMPLETED|Overall Study||314
4930123|NCT03204643|12126269|P1|COMPLETED|Overall Study||323
4930124|NCT03204643|12126268|P2|STARTED|Overall Study||314
4930125|NCT03204643|12126269|P1|STARTED|Overall Study||323
4930126|NCT03204539|12126283|P2|NOT COMPLETED|Overall Study||1
4930127|NCT03204539|12126284|P1|NOT COMPLETED|Overall Study||0
4930128|NCT03204539|12126283|P2|COMPLETED|Overall Study||0
4930129|NCT03204539|12126284|P1|COMPLETED|Overall Study||0
4930130|NCT03204539|12126283|P2|STARTED|Overall Study||1
4930131|NCT03204539|12126284|P1|STARTED|Overall Study||0
4930132|NCT03203564|12126310|P4|NOT COMPLETED|Overall Study||0
4930133|NCT03203564|12126311|P3|NOT COMPLETED|Overall Study||0
4930134|NCT03203564|12126312|P2|NOT COMPLETED|Overall Study||0
4930135|NCT03203564|12126313|P1|NOT COMPLETED|Overall Study||0
4930136|NCT03203564|12126310|P4|COMPLETED|Overall Study||9
4930137|NCT03203564|12126311|P3|COMPLETED|Overall Study||8
4930138|NCT03203564|12126312|P2|COMPLETED|Overall Study||8
4930139|NCT03203564|12126313|P1|COMPLETED|Overall Study||8
4930140|NCT03203564|12126310|P4|STARTED|Overall Study||9
4930141|NCT03203564|12126311|P3|STARTED|Overall Study||8
4930142|NCT03203564|12126312|P2|STARTED|Overall Study||8
4930143|NCT03203564|12126313|P1|STARTED|Overall Study||8
4930144|NCT03203291|12126422|P1|NOT COMPLETED|Overall Study||1
4930145|NCT03203291|12126422|P1|COMPLETED|Overall Study||11
4930146|NCT03203291|12126422|P1|STARTED|Overall Study||12
4930147|NCT03202550|12126434|P2|NOT COMPLETED|Overall Study||0
4930148|NCT03202550|12126435|P1|NOT COMPLETED|Overall Study||0
4930149|NCT03202550|12126434|P2|COMPLETED|Overall Study||11
4930150|NCT03202550|12126435|P1|COMPLETED|Overall Study||13
4930151|NCT03202550|12126434|P2|STARTED|Overall Study||11
4930152|NCT03202550|12126435|P1|STARTED|Overall Study||13
4930153|NCT03202472|12126457|P1|NOT COMPLETED|Overall Study||0
4930154|NCT03202472|12126457|P1|COMPLETED|Overall Study||50
4930155|NCT03202472|12126457|P1|STARTED|Overall Study||50
4930156|NCT03201900|12126470|P1|NOT COMPLETED|Extension Phase (Up to 124 Weeks)||46
4930157|NCT03201900|12126470|P1|COMPLETED|Extension Phase (Up to 124 Weeks)||0
4930158|NCT03201900|12126470|P1|STARTED|Extension Phase (Up to 124 Weeks)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
4930159|NCT03201900|12126470|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
4930160|NCT03201900|12126470|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
4930161|NCT03201900|12126470|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
4930162|NCT03201900|12126470|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
4930163|NCT03200925|12126478|P2|NOT COMPLETED|Overall Study||0
4930164|NCT03200925|12126479|P1|NOT COMPLETED|Overall Study||0
4930165|NCT03200925|12126478|P2|COMPLETED|Overall Study||120
4930166|NCT03200925|12126479|P1|COMPLETED|Overall Study||120
4930167|NCT03200925|12126478|P2|STARTED|Overall Study||120
4930168|NCT03200925|12126479|P1|STARTED|Overall Study||120
4930169|NCT03200912|12126492|P3|NOT COMPLETED|Overall Study||4
4930170|NCT03200912|12126493|P2|NOT COMPLETED|Overall Study||3
4930171|NCT03200912|12126494|P1|NOT COMPLETED|Overall Study||4
4930172|NCT03200912|12126492|P3|COMPLETED|Overall Study||164
4930173|NCT03200912|12126493|P2|COMPLETED|Overall Study||166
4930174|NCT03200912|12126494|P1|COMPLETED|Overall Study||166
4930175|NCT03200912|12126492|P3|STARTED|Overall Study||168
4930176|NCT03200912|12126493|P2|STARTED|Overall Study||169
4930177|NCT03200912|12126494|P1|STARTED|Overall Study||170
4930178|NCT03200860|12126504|P2|NOT COMPLETED|Overall Study||0
4930179|NCT03200860|12126505|P1|NOT COMPLETED|Overall Study||1
4930180|NCT03200860|12126504|P2|COMPLETED|Overall Study||39
4930181|NCT03200860|12126505|P1|COMPLETED|Overall Study||40
4930182|NCT03200860|12126504|P2|STARTED|Overall Study||39
4930183|NCT03200860|12126505|P1|STARTED|Overall Study||41
4930184|NCT03200535|12126529|P4|NOT COMPLETED|Overall Study||0
4930185|NCT03200535|12126530|P3|NOT COMPLETED|Overall Study||0
4930186|NCT03200535|12126531|P2|NOT COMPLETED|Overall Study||0
4930187|NCT03200535|12126532|P1|NOT COMPLETED|Overall Study||0
4930188|NCT03200535|12126529|P4|COMPLETED|Overall Study||1000
4930189|NCT03200535|12126530|P3|COMPLETED|Overall Study||1862
4930190|NCT03200535|12126531|P2|COMPLETED|Overall Study||1863
4930191|NCT03200535|12126532|P1|COMPLETED|Overall Study||1863
4930192|NCT03200535|12126529|P4|STARTED|Overall Study||1000
4930193|NCT03200535|12126530|P3|STARTED|Overall Study||1862
4930194|NCT03200535|12126531|P2|STARTED|Overall Study||1863
4930195|NCT03200535|12126532|P1|STARTED|Overall Study||1863
4930196|NCT03199911|12126548|P2|NOT COMPLETED|Overall Study||6
4930197|NCT03199911|12126549|P1|NOT COMPLETED|Overall Study||7
4930198|NCT03199911|12126548|P2|COMPLETED|Overall Study||187
4930199|NCT03199911|12126549|P1|COMPLETED|Overall Study||201
4930200|NCT03199911|12126548|P2|Primary Outcome Analyzed|Overall Study||187
4930201|NCT03199911|12126549|P1|Primary Outcome Analyzed|Overall Study||201
4930202|NCT03199911|12126548|P2|Lost to Follow-up|Overall Study||5
4930203|NCT03199911|12126549|P1|Lost to Follow-up|Overall Study||5
4930204|NCT03199911|12126548|P2|Received Allocated Treatment|Overall Study||192
4930205|NCT03199911|12126549|P1|Received Allocated Treatment|Overall Study||206
4930206|NCT03199911|12126548|P2|Did Not Proceed With Surgery|Overall Study||1
4930207|NCT03199911|12126549|P1|Did Not Proceed With Surgery|Overall Study||2
4930208|NCT03199911|12126548|P2|STARTED|Overall Study||193
4930209|NCT03199911|12126549|P1|STARTED|Overall Study||208
4930210|NCT03199872|12126561|P1|NOT COMPLETED|Overall Study||0
4930211|NCT03199872|12126561|P1|COMPLETED|Overall Study||22
4930212|NCT03199872|12126561|P1|STARTED|Overall Study||22
4930213|NCT03199079|12126568|P2|NOT COMPLETED|Overall Study||0
4930214|NCT03199079|12126569|P1|NOT COMPLETED|Overall Study||0
4930215|NCT03199079|12126568|P2|COMPLETED|Overall Study||10
4930216|NCT03199079|12126569|P1|COMPLETED|Overall Study||10
4930217|NCT03199079|12126568|P2|STARTED|Overall Study||10
4930218|NCT03199079|12126569|P1|STARTED|Overall Study||10
4930219|NCT03198884|12126577|P1|NOT COMPLETED|Overall Study||0
4930220|NCT03198884|12126577|P1|COMPLETED|Overall Study||20
4930221|NCT03198884|12126577|P1|STARTED|Overall Study||20
4930222|NCT03198767|12126600|P7|NOT COMPLETED|Overall Study||0
4930223|NCT03198767|12126601|P6|NOT COMPLETED|Overall Study||0
4930224|NCT03198767|12126602|P5|NOT COMPLETED|Overall Study||0
4930225|NCT03198767|12126603|P4|NOT COMPLETED|Overall Study||6
4930226|NCT03198767|12126604|P3|NOT COMPLETED|Overall Study||0
4930227|NCT03198767|12126605|P2|NOT COMPLETED|Overall Study||0
4930228|NCT03198767|12126606|P1|NOT COMPLETED|Overall Study||0
4930229|NCT03198767|12126600|P7|COMPLETED|Overall Study||8
4930230|NCT03198767|12126601|P6|COMPLETED|Overall Study||8
4930231|NCT03198767|12126602|P5|COMPLETED|Overall Study||8
4930232|NCT03198767|12126603|P4|COMPLETED|Overall Study||0
4930233|NCT03198767|12126604|P3|COMPLETED|Overall Study||8
4930234|NCT03198767|12126605|P2|COMPLETED|Overall Study||8
4930235|NCT03198767|12126606|P1|COMPLETED|Overall Study||8
4930236|NCT03198767|12126600|P7|STARTED|Overall Study||8
4930237|NCT03198767|12126601|P6|STARTED|Overall Study||8
4930238|NCT03198767|12126602|P5|STARTED|Overall Study||8
4930239|NCT03198767|12126603|P4|STARTED|Overall Study||6
4930240|NCT03198767|12126604|P3|STARTED|Overall Study||8
4930241|NCT03198767|12126605|P2|STARTED|Overall Study||8
4930242|NCT03198767|12126606|P1|STARTED|Overall Study||8
4930243|NCT03198507|12126647|P2|NOT COMPLETED|Overall Study||0
4930244|NCT03198507|12126648|P1|NOT COMPLETED|Overall Study||1
4930245|NCT03198507|12126647|P2|COMPLETED|Overall Study||227
4930246|NCT03198507|12126648|P1|COMPLETED|Overall Study||227
4930247|NCT03198507|12126647|P2|STARTED|Overall Study||227
4930248|NCT03198507|12126648|P1|STARTED|Overall Study||228
4930249|NCT03198000|12126663|P3|NOT COMPLETED|Overall Study||0
4930250|NCT03198000|12126664|P2|NOT COMPLETED|Overall Study||0
4930251|NCT03198000|12126665|P1|NOT COMPLETED|Overall Study||0
4930252|NCT03198000|12126663|P3|COMPLETED|Overall Study||41
4930253|NCT03198000|12126664|P2|COMPLETED|Overall Study||38
4930254|NCT03198000|12126665|P1|COMPLETED|Overall Study||41
4930255|NCT03198000|12126663|P3|STARTED|Overall Study||41
4930256|NCT03198000|12126664|P2|STARTED|Overall Study||38
4930257|NCT03198000|12126665|P1|STARTED|Overall Study||41
4930258|NCT03197883|12126774|P2|NOT COMPLETED|Overall Study||6
4930259|NCT03197883|12126775|P1|NOT COMPLETED|Overall Study||3
4930260|NCT03197883|12126774|P2|COMPLETED|Overall Study||44
4930261|NCT03197883|12126775|P1|COMPLETED|Overall Study||47
4930262|NCT03197883|12126774|P2|STARTED|Overall Study||50
4930263|NCT03197883|12126775|P1|STARTED|Overall Study||50
4930264|NCT03197558|12126805|P1|NOT COMPLETED|Overall Study||1
4930265|NCT03197558|12126805|P1|COMPLETED|Overall Study||29
4930266|NCT03197558|12126805|P1|STARTED|Overall Study||30
4930267|NCT03197376|12126813|P4|NOT COMPLETED|Immune Persistence Phase||5
4930268|NCT03197376|12126814|P3|NOT COMPLETED|Immune Persistence Phase||5
4930269|NCT03197376|12126815|P2|NOT COMPLETED|Immune Persistence Phase||4
4930270|NCT03197376|12126816|P1|NOT COMPLETED|Immune Persistence Phase||5
4930271|NCT03197376|12126813|P4|COMPLETED|Immune Persistence Phase||190
4930272|NCT03197376|12126814|P3|COMPLETED|Immune Persistence Phase||123
4930273|NCT03197376|12126815|P2|COMPLETED|Immune Persistence Phase||129
4930274|NCT03197376|12126816|P1|COMPLETED|Immune Persistence Phase||127
4930275|NCT03197376|12126813|P4|STARTED|Immune Persistence Phase||195
4930276|NCT03197376|12126814|P3|STARTED|Immune Persistence Phase||128
4930277|NCT03197376|12126815|P2|STARTED|Immune Persistence Phase||133
4930278|NCT03197376|12126816|P1|STARTED|Immune Persistence Phase||132
4930279|NCT03197376|12126813|P4|NOT COMPLETED|Primary and Booster Phase||25
4930280|NCT03197376|12126814|P3|NOT COMPLETED|Primary and Booster Phase||20
4930281|NCT03197376|12126815|P2|NOT COMPLETED|Primary and Booster Phase||13
4930282|NCT03197376|12126816|P1|NOT COMPLETED|Primary and Booster Phase||15
4930283|NCT03197376|12126813|P4|COMPLETED|Primary and Booster Phase||722
4930284|NCT03197376|12126814|P3|COMPLETED|Primary and Booster Phase||480
4930285|NCT03197376|12126815|P2|COMPLETED|Primary and Booster Phase||488
4930286|NCT03197376|12126816|P1|COMPLETED|Primary and Booster Phase||487
4930287|NCT03197376|12126813|P4|Received Booster Vaccine|Primary and Booster Phase||213
4930288|NCT03197376|12126814|P3|Received Booster Vaccine|Primary and Booster Phase||139
4930289|NCT03197376|12126815|P2|Received Booster Vaccine|Primary and Booster Phase||144
4930290|NCT03197376|12126816|P1|Received Booster Vaccine|Primary and Booster Phase||145
4930291|NCT03197376|12126813|P4|Booster Cohort|Primary and Booster Phase||224
4930292|NCT03197376|12126814|P3|Booster Cohort|Primary and Booster Phase||150
4930293|NCT03197376|12126815|P2|Booster Cohort|Primary and Booster Phase||151
4930294|NCT03197376|12126816|P1|Booster Cohort|Primary and Booster Phase||150
4930295|NCT03197376|12126813|P4|Primary Reactogenicity Cohort|Primary and Booster Phase||364
4930296|NCT03197376|12126814|P3|Primary Reactogenicity Cohort|Primary and Booster Phase||257
4930297|NCT03197376|12126815|P2|Primary Reactogenicity Cohort|Primary and Booster Phase||243
4930298|NCT03197376|12126816|P1|Primary Reactogenicity Cohort|Primary and Booster Phase||251
4930299|NCT03197376|12126813|P4|Vaccinated-Dose 3|Primary and Booster Phase||731
4930300|NCT03197376|12126814|P3|Vaccinated-Dose 3|Primary and Booster Phase||490
4930301|NCT03197376|12126815|P2|Vaccinated-Dose 3|Primary and Booster Phase||493
4930302|NCT03197376|12126816|P1|Vaccinated-Dose 3|Primary and Booster Phase||492
4930303|NCT03197376|12126813|P4|Vaccinated-Dose 2|Primary and Booster Phase||738
4930304|NCT03197376|12126814|P3|Vaccinated-Dose 2|Primary and Booster Phase||491
4930305|NCT03197376|12126815|P2|Vaccinated-Dose 2|Primary and Booster Phase||495
4930306|NCT03197376|12126816|P1|Vaccinated-Dose 2|Primary and Booster Phase||495
4930307|NCT03197376|12126813|P4|Vaccinated-Dose 1|Primary and Booster Phase||747
4930308|NCT03197376|12126814|P3|Vaccinated-Dose 1|Primary and Booster Phase||500
4930309|NCT03197376|12126815|P2|Vaccinated-Dose 1|Primary and Booster Phase||501
4930310|NCT03197376|12126816|P1|Vaccinated-Dose 1|Primary and Booster Phase||502
4930311|NCT03197376|12126813|P4|STARTED|Primary and Booster Phase||747
4930312|NCT03197376|12126814|P3|STARTED|Primary and Booster Phase||500
4930313|NCT03197376|12126815|P2|STARTED|Primary and Booster Phase||501
4930314|NCT03197376|12126816|P1|STARTED|Primary and Booster Phase||502
4930315|NCT03197025|12126883|P1|NOT COMPLETED|Overall Study||0
4930316|NCT03197025|12126883|P1|COMPLETED|Overall Study||1
4930317|NCT03197025|12126883|P1|STARTED|Overall Study||1
4930318|NCT03196635|12126890|P1|NOT COMPLETED|Overall Study||1
4930319|NCT03196635|12126890|P1|COMPLETED|Overall Study||30
4930320|NCT03196635|12126890|P1|STARTED|Overall Study||31
4930321|NCT03196349|12126911|P3|NOT COMPLETED|Overall Study||13
4930322|NCT03196349|12126912|P2|NOT COMPLETED|Overall Study||14
4930323|NCT03196349|12126913|P1|NOT COMPLETED|Overall Study||17
4930324|NCT03196349|12126911|P3|COMPLETED|Overall Study||0
4930325|NCT03196349|12126912|P2|COMPLETED|Overall Study||0
4930326|NCT03196349|12126913|P1|COMPLETED|Overall Study||0
4930327|NCT03196349|12126911|P3|STARTED|Overall Study||13
4930328|NCT03196349|12126912|P2|STARTED|Overall Study||14
4930329|NCT03196349|12126913|P1|STARTED|Overall Study||17
4930330|NCT03196232|12126939|P1|NOT COMPLETED|Overall Study||0
4930331|NCT03196232|12126939|P1|COMPLETED|Overall Study||3
4930332|NCT03196232|12126939|P1|STARTED|Overall Study||3
4930333|NCT03195517|12126948|P1|NOT COMPLETED|Overall Study||0
4930334|NCT03195517|12126948|P1|COMPLETED|Overall Study||33
4930335|NCT03195517|12126948|P1|STARTED|Overall Study||33
4930336|NCT03195010|12126963|P2|NOT COMPLETED|Overall Study||0
4930337|NCT03195010|12126964|P1|NOT COMPLETED|Overall Study||0
4930338|NCT03195010|12126963|P2|COMPLETED|Overall Study||2
4930339|NCT03195010|12126964|P1|COMPLETED|Overall Study||2
4930340|NCT03195010|12126963|P2|STARTED|Overall Study||2
4930341|NCT03195010|12126964|P1|STARTED|Overall Study||2
4930342|NCT03194776|12126991|P2|NOT COMPLETED|Overall Study||0
4930343|NCT03194776|12126992|P1|NOT COMPLETED|Overall Study||0
4930344|NCT03194776|12126991|P2|COMPLETED|Overall Study||23
4930345|NCT03194776|12126992|P1|COMPLETED|Overall Study||23
4930346|NCT03194776|12126991|P2|STARTED|Overall Study||23
4930347|NCT03194776|12126992|P1|STARTED|Overall Study||23
4930348|NCT03194698|12127010|P2|NOT COMPLETED|Overall Study||0
4930349|NCT03194698|12127011|P1|NOT COMPLETED|Overall Study||0
4930350|NCT03194698|12127010|P2|COMPLETED|Overall Study||10
4930351|NCT03194698|12127011|P1|COMPLETED|Overall Study||10
4930352|NCT03194698|12127010|P2|STARTED|Overall Study||10
4930353|NCT03194698|12127011|P1|STARTED|Overall Study||10
4930354|NCT03194503|12127023|P2|NOT COMPLETED|Overall Study||0
4930355|NCT03194503|12127024|P1|NOT COMPLETED|Overall Study||0
4930356|NCT03194503|12127023|P2|COMPLETED|Overall Study||1054
4930357|NCT03194503|12127024|P1|COMPLETED|Overall Study||458
4930358|NCT03194503|12127023|P2|STARTED|Overall Study||1054
4930359|NCT03194503|12127024|P1|STARTED|Overall Study||458
4930360|NCT03194490|12127034|P2|NOT COMPLETED|Overall Study||3
4930361|NCT03194490|12127035|P1|NOT COMPLETED|Overall Study||2
4930362|NCT03194490|12127034|P2|COMPLETED|Overall Study||20
4930363|NCT03194490|12127035|P1|COMPLETED|Overall Study||18
4930364|NCT03194490|12127034|P2|STARTED|Overall Study||23
4930365|NCT03194490|12127035|P1|STARTED|Overall Study||20
4930366|NCT03194464|12127077|P1|NOT COMPLETED|Overall Study||2
4930367|NCT03194464|12127077|P1|COMPLETED|Overall Study||13
4930368|NCT03194464|12127077|P1|STARTED|Overall Study||15
4930369|NCT03194373|12127084|P1|NOT COMPLETED|Overall Study||2
4930370|NCT03194373|12127084|P1|COMPLETED|Overall Study||18
4930371|NCT03194373|12127084|P1|STARTED|Overall Study||20
4930372|NCT03194334|12127091|P3|NOT COMPLETED|3-6 Months||0
4930373|NCT03194334|12127092|P2|NOT COMPLETED|3-6 Months||0
4930374|NCT03194334|12127093|P1|NOT COMPLETED|3-6 Months||0
4930375|NCT03194334|12127091|P3|COMPLETED|3-6 Months||14
4930376|NCT03194334|12127092|P2|COMPLETED|3-6 Months||15
4930377|NCT03194334|12127093|P1|COMPLETED|3-6 Months||10
4930378|NCT03194334|12127091|P3|STARTED|3-6 Months||14
4930379|NCT03194334|12127092|P2|STARTED|3-6 Months||15
4930380|NCT03194334|12127093|P1|STARTED|3-6 Months||10
4930381|NCT03194334|12127091|P3|NOT COMPLETED|0-3 Months||1
4930382|NCT03194334|12127092|P2|NOT COMPLETED|0-3 Months||0
4930383|NCT03194334|12127093|P1|NOT COMPLETED|0-3 Months||0
4930384|NCT03194334|12127091|P3|COMPLETED|0-3 Months||14
4930385|NCT03194334|12127092|P2|COMPLETED|0-3 Months||15
4930386|NCT03194334|12127093|P1|COMPLETED|0-3 Months||10
4930387|NCT03194334|12127091|P3|STARTED|0-3 Months||15
4930388|NCT03194334|12127092|P2|STARTED|0-3 Months||15
4930389|NCT03194334|12127093|P1|STARTED|0-3 Months||10
4930390|NCT03193593|12127171|P7|NOT COMPLETED|Overall Study||4
4930391|NCT03193593|12127172|P6|NOT COMPLETED|Overall Study||3
4930392|NCT03193593|12127173|P5|NOT COMPLETED|Overall Study||1
4930393|NCT03193593|12127174|P4|NOT COMPLETED|Overall Study||0
4930394|NCT03193593|12127175|P3|NOT COMPLETED|Overall Study||1
4930395|NCT03193593|12127176|P2|NOT COMPLETED|Overall Study||1
4930396|NCT03193593|12127177|P1|NOT COMPLETED|Overall Study||4
4930397|NCT03193593|12127171|P7|COMPLETED|Overall Study||8
4930398|NCT03193593|12127172|P6|COMPLETED|Overall Study||13
4930399|NCT03193593|12127173|P5|COMPLETED|Overall Study||7
4930400|NCT03193593|12127174|P4|COMPLETED|Overall Study||4
4930401|NCT03193593|12127175|P3|COMPLETED|Overall Study||3
4930402|NCT03193593|12127176|P2|COMPLETED|Overall Study||3
4930403|NCT03193593|12127177|P1|COMPLETED|Overall Study||14
4930404|NCT03193593|12127171|P7|STARTED|Overall Study||12
4930405|NCT03193593|12127172|P6|STARTED|Overall Study||16
4930406|NCT03193593|12127173|P5|STARTED|Overall Study||8
4930407|NCT03193593|12127174|P4|STARTED|Overall Study||4
4930408|NCT03193593|12127175|P3|STARTED|Overall Study||4
4930409|NCT03193593|12127176|P2|STARTED|Overall Study||4
4930410|NCT03193593|12127177|P1|STARTED|Overall Study||18
4930411|NCT03193047|12127195|P2|NOT COMPLETED|Overall Study||0
4930412|NCT03193047|12127196|P1|NOT COMPLETED|Overall Study||2
4930413|NCT03193047|12127195|P2|COMPLETED|Overall Study||28
4930414|NCT03193047|12127196|P1|COMPLETED|Overall Study||29
4930415|NCT03193047|12127195|P2|STARTED|Overall Study||28
4930416|NCT03193047|12127196|P1|STARTED|Overall Study||31
4930417|NCT03193021|12127216|P2|NOT COMPLETED|Overall Study||1
4930418|NCT03193021|12127217|P1|NOT COMPLETED|Overall Study||1
4930419|NCT03193021|12127216|P2|COMPLETED|Overall Study||103
4930420|NCT03193021|12127217|P1|COMPLETED|Overall Study||99
4930421|NCT03193021|12127216|P2|STARTED|Overall Study||104
4930422|NCT03193021|12127217|P1|STARTED|Overall Study||100
4930423|NCT03192904|12127242|P2|NOT COMPLETED|Overall Study||2
4930424|NCT03192904|12127243|P1|NOT COMPLETED|Overall Study||3
4930425|NCT03192904|12127242|P2|COMPLETED|Overall Study||33
4930426|NCT03192904|12127243|P1|COMPLETED|Overall Study||32
4930427|NCT03192904|12127242|P2|STARTED|Overall Study||35
4930428|NCT03192904|12127243|P1|STARTED|Overall Study||35
4930429|NCT03192826|12127280|P3|NOT COMPLETED|Overall Study||0
4930430|NCT03192826|12127281|P2|NOT COMPLETED|Overall Study||0
4930431|NCT03192826|12127282|P1|NOT COMPLETED|Overall Study||0
4930432|NCT03192826|12127280|P3|COMPLETED|Overall Study||25
4930433|NCT03192826|12127281|P2|COMPLETED|Overall Study||27
4930434|NCT03192826|12127282|P1|COMPLETED|Overall Study||27
4930435|NCT03192826|12127280|P3|STARTED|Overall Study||25
4930436|NCT03192826|12127281|P2|STARTED|Overall Study||27
4930437|NCT03192826|12127282|P1|STARTED|Overall Study||27
4930438|NCT03192488|12127299|P6|NOT COMPLETED|Third Intervention (d1)||0
4930439|NCT03192488|12127300|P5|NOT COMPLETED|Third Intervention (d1)||1
4930440|NCT03192488|12127301|P4|NOT COMPLETED|Third Intervention (d1)||0
4930441|NCT03192488|12127302|P3|NOT COMPLETED|Third Intervention (d1)||0
4930442|NCT03192488|12127303|P2|NOT COMPLETED|Third Intervention (d1)||0
4930443|NCT03192488|12127304|P1|NOT COMPLETED|Third Intervention (d1)||0
4930444|NCT03192488|12127299|P6|COMPLETED|Third Intervention (d1)||0
4930445|NCT03192488|12127300|P5|COMPLETED|Third Intervention (d1)||0
4930446|NCT03192488|12127301|P4|COMPLETED|Third Intervention (d1)||1
4930447|NCT03192488|12127302|P3|COMPLETED|Third Intervention (d1)||1
4930448|NCT03192488|12127303|P2|COMPLETED|Third Intervention (d1)||5
4930449|NCT03192488|12127304|P1|COMPLETED|Third Intervention (d1)||1
4930450|NCT03192488|12127299|P6|STARTED|Third Intervention (d1)||0
4930451|NCT03192488|12127300|P5|STARTED|Third Intervention (d1)||1
4930452|NCT03192488|12127301|P4|STARTED|Third Intervention (d1)||1
4930453|NCT03192488|12127302|P3|STARTED|Third Intervention (d1)||1
4930454|NCT03192488|12127303|P2|STARTED|Third Intervention (d1)||5
4930455|NCT03192488|12127304|P1|STARTED|Third Intervention (d1)||1
4930456|NCT03192488|12127299|P6|NOT COMPLETED|Second Washout (>6d)||0
4930457|NCT03192488|12127300|P5|NOT COMPLETED|Second Washout (>6d)||0
4930458|NCT03192488|12127301|P4|NOT COMPLETED|Second Washout (>6d)||0
4930459|NCT03192488|12127302|P3|NOT COMPLETED|Second Washout (>6d)||0
4930460|NCT03192488|12127303|P2|NOT COMPLETED|Second Washout (>6d)||0
4930461|NCT03192488|12127304|P1|NOT COMPLETED|Second Washout (>6d)||0
4930462|NCT03192488|12127299|P6|COMPLETED|Second Washout (>6d)||0
4930463|NCT03192488|12127300|P5|COMPLETED|Second Washout (>6d)||1
4930464|NCT03192488|12127301|P4|COMPLETED|Second Washout (>6d)||1
4930465|NCT03192488|12127302|P3|COMPLETED|Second Washout (>6d)||1
4930466|NCT03192488|12127303|P2|COMPLETED|Second Washout (>6d)||5
4930467|NCT03192488|12127304|P1|COMPLETED|Second Washout (>6d)||1
4930468|NCT03192488|12127299|P6|STARTED|Second Washout (>6d)||0
4930469|NCT03192488|12127300|P5|STARTED|Second Washout (>6d)||1
4930470|NCT03192488|12127301|P4|STARTED|Second Washout (>6d)||1
4930471|NCT03192488|12127302|P3|STARTED|Second Washout (>6d)||1
4930472|NCT03192488|12127303|P2|STARTED|Second Washout (>6d)||5
4930473|NCT03192488|12127304|P1|STARTED|Second Washout (>6d)||1
4930474|NCT03192488|12127299|P6|NOT COMPLETED|Second Intervention (d1)||0
4930475|NCT03192488|12127300|P5|NOT COMPLETED|Second Intervention (d1)||0
4930476|NCT03192488|12127301|P4|NOT COMPLETED|Second Intervention (d1)||0
4930477|NCT03192488|12127302|P3|NOT COMPLETED|Second Intervention (d1)||0
4930478|NCT03192488|12127303|P2|NOT COMPLETED|Second Intervention (d1)||0
4930479|NCT03192488|12127304|P1|NOT COMPLETED|Second Intervention (d1)||0
4930480|NCT03192488|12127299|P6|COMPLETED|Second Intervention (d1)||0
4930481|NCT03192488|12127300|P5|COMPLETED|Second Intervention (d1)||1
4930482|NCT03192488|12127301|P4|COMPLETED|Second Intervention (d1)||1
4930483|NCT03192488|12127302|P3|COMPLETED|Second Intervention (d1)||1
4930484|NCT03192488|12127303|P2|COMPLETED|Second Intervention (d1)||5
4930485|NCT03192488|12127304|P1|COMPLETED|Second Intervention (d1)||1
4930486|NCT03192488|12127299|P6|STARTED|Second Intervention (d1)||0
4930487|NCT03192488|12127300|P5|STARTED|Second Intervention (d1)||1
4930488|NCT03192488|12127301|P4|STARTED|Second Intervention (d1)||1
4930489|NCT03192488|12127302|P3|STARTED|Second Intervention (d1)||1
4930490|NCT03192488|12127303|P2|STARTED|Second Intervention (d1)||5
4930491|NCT03192488|12127304|P1|STARTED|Second Intervention (d1)||1
4930492|NCT03192488|12127299|P6|NOT COMPLETED|First Washout (>6d)||1
4930493|NCT03192488|12127300|P5|NOT COMPLETED|First Washout (>6d)||0
4930494|NCT03192488|12127301|P4|NOT COMPLETED|First Washout (>6d)||0
4930495|NCT03192488|12127302|P3|NOT COMPLETED|First Washout (>6d)||1
4930496|NCT03192488|12127303|P2|NOT COMPLETED|First Washout (>6d)||0
4930497|NCT03192488|12127304|P1|NOT COMPLETED|First Washout (>6d)||0
4930498|NCT03192488|12127299|P6|COMPLETED|First Washout (>6d)||0
4930499|NCT03192488|12127300|P5|COMPLETED|First Washout (>6d)||1
4930500|NCT03192488|12127301|P4|COMPLETED|First Washout (>6d)||1
4930501|NCT03192488|12127302|P3|COMPLETED|First Washout (>6d)||1
4930502|NCT03192488|12127303|P2|COMPLETED|First Washout (>6d)||5
4930503|NCT03192488|12127304|P1|COMPLETED|First Washout (>6d)||1
4930504|NCT03192488|12127299|P6|STARTED|First Washout (>6d)||1
4930505|NCT03192488|12127300|P5|STARTED|First Washout (>6d)||1
4930506|NCT03192488|12127301|P4|STARTED|First Washout (>6d)||1
4930507|NCT03192488|12127302|P3|STARTED|First Washout (>6d)||2
4930508|NCT03192488|12127303|P2|STARTED|First Washout (>6d)||5
4930509|NCT03192488|12127304|P1|STARTED|First Washout (>6d)||1
4930510|NCT03192488|12127299|P6|NOT COMPLETED|First Intervention (d1)||0
4930511|NCT03192488|12127300|P5|NOT COMPLETED|First Intervention (d1)||0
4930512|NCT03192488|12127301|P4|NOT COMPLETED|First Intervention (d1)||0
4930513|NCT03192488|12127302|P3|NOT COMPLETED|First Intervention (d1)||0
4930514|NCT03192488|12127303|P2|NOT COMPLETED|First Intervention (d1)||0
4930515|NCT03192488|12127304|P1|NOT COMPLETED|First Intervention (d1)||0
4930516|NCT03192488|12127299|P6|COMPLETED|First Intervention (d1)||1
4930517|NCT03192488|12127300|P5|COMPLETED|First Intervention (d1)||1
4930518|NCT03192488|12127301|P4|COMPLETED|First Intervention (d1)||1
4930519|NCT03192488|12127302|P3|COMPLETED|First Intervention (d1)||2
4930520|NCT03192488|12127303|P2|COMPLETED|First Intervention (d1)||5
4930521|NCT03192488|12127304|P1|COMPLETED|First Intervention (d1)||1
4930522|NCT03192488|12127299|P6|STARTED|First Intervention (d1)||1
4930523|NCT03192488|12127300|P5|STARTED|First Intervention (d1)||1
4930524|NCT03192488|12127301|P4|STARTED|First Intervention (d1)||1
4930525|NCT03192488|12127302|P3|STARTED|First Intervention (d1)||2
4930526|NCT03192488|12127303|P2|STARTED|First Intervention (d1)||5
4930527|NCT03192488|12127304|P1|STARTED|First Intervention (d1)||1
4930528|NCT03192475|12127320|P2|NOT COMPLETED|Overall Study||9
4930529|NCT03192475|12127321|P1|NOT COMPLETED|Overall Study||13
4930530|NCT03192475|12127320|P2|COMPLETED|Overall Study||151
4930531|NCT03192475|12127321|P1|COMPLETED|Overall Study||149
4930532|NCT03192475|12127320|P2|STARTED|Overall Study||160
4930533|NCT03192475|12127321|P1|STARTED|Overall Study||162
4930534|NCT03192306|12127357|P2|NOT COMPLETED|Overall Study||145
4930535|NCT03192306|12127358|P1|NOT COMPLETED|Overall Study||152
4930536|NCT03192306|12127357|P2|COMPLETED|Overall Study||79
4930537|NCT03192306|12127358|P1|COMPLETED|Overall Study||75
4930538|NCT03192306|12127357|P2|Modified Intent to Treat (MITT)|Overall Study||80
4930539|NCT03192306|12127358|P1|Modified Intent to Treat (MITT)|Overall Study||76
4930540|NCT03192306|12127357|P2|STARTED|Overall Study||224
4930541|NCT03192306|12127358|P1|STARTED|Overall Study||227
4930542|NCT03192137|12127378|P2|NOT COMPLETED|Overall Study||58
4930543|NCT03192137|12127379|P1|NOT COMPLETED|Overall Study||50
4930544|NCT03192137|12127378|P2|COMPLETED|Overall Study||29
4930545|NCT03192137|12127379|P1|COMPLETED|Overall Study||123
4930546|NCT03192137|12127378|P2|STARTED|Overall Study||87
4930547|NCT03192137|12127379|P1|STARTED|Overall Study||173
4930548|NCT03191552|12127390|P3|NOT COMPLETED|Overall Study||0
4930549|NCT03191552|12127391|P2|NOT COMPLETED|Overall Study||1
4930550|NCT03191552|12127392|P1|NOT COMPLETED|Overall Study||1
4930551|NCT03191552|12127390|P3|COMPLETED|Overall Study||8
4930552|NCT03191552|12127391|P2|COMPLETED|Overall Study||8
4930553|NCT03191552|12127392|P1|COMPLETED|Overall Study||8
4930554|NCT03191552|12127390|P3|STARTED|Overall Study||8
4930555|NCT03191552|12127391|P2|STARTED|Overall Study||9
4930556|NCT03191552|12127392|P1|STARTED|Overall Study||9
4930557|NCT03191396|12127445|P2|NOT COMPLETED|Overall Study||5
4930558|NCT03191396|12127446|P1|NOT COMPLETED|Overall Study||3
4930559|NCT03191396|12127445|P2|COMPLETED|Overall Study||282
4930560|NCT03191396|12127446|P1|COMPLETED|Overall Study||287
4930561|NCT03191396|12127445|P2|STARTED|Overall Study||287
4930562|NCT03191396|12127446|P1|STARTED|Overall Study||290
4930563|NCT03190993|12127534|P2|NOT COMPLETED|Overall Study||0
4930564|NCT03190993|12127535|P1|NOT COMPLETED|Overall Study||0
4930565|NCT03190993|12127534|P2|COMPLETED|Overall Study||10
4930566|NCT03190993|12127535|P1|COMPLETED|Overall Study||10
4930567|NCT03190993|12127534|P2|STARTED|Overall Study||10
4930568|NCT03190993|12127535|P1|STARTED|Overall Study||10
4930569|NCT03190369|12127543|P2|NOT COMPLETED|Overall Study||8
4930570|NCT03190369|12127544|P1|NOT COMPLETED|Overall Study||1
4930571|NCT03190369|12127543|P2|COMPLETED|Overall Study||212
4930572|NCT03190369|12127544|P1|COMPLETED|Overall Study||219
4930573|NCT03190369|12127543|P2|Treated|Overall Study||218
4930574|NCT03190369|12127544|P1|Treated|Overall Study||220
4930575|NCT03190369|12127543|P2|STARTED|Overall Study||220
4930576|NCT03190369|12127544|P1|STARTED|Overall Study||220
4930577|NCT03190213|12127562|P1|NOT COMPLETED|Overall Study||0
4930578|NCT03190213|12127562|P1|COMPLETED|Overall Study||6
4930579|NCT03190213|12127562|P1|STARTED|Overall Study||6
4930580|NCT03190083|12127570|P1|NOT COMPLETED|Overall Study||0
4930581|NCT03190083|12127570|P1|COMPLETED|Overall Study||16
4930582|NCT03190083|12127570|P1|STARTED|Overall Study||16
4930583|NCT03190005|12127581|P7|NOT COMPLETED|Overall Study||0
4930584|NCT03190005|12127582|P6|NOT COMPLETED|Overall Study||0
4930585|NCT03190005|12127583|P5|NOT COMPLETED|Overall Study||0
4930586|NCT03190005|12127584|P4|NOT COMPLETED|Overall Study||0
4930587|NCT03190005|12127585|P3|NOT COMPLETED|Overall Study||0
4930588|NCT03190005|12127586|P2|NOT COMPLETED|Overall Study||0
4930589|NCT03190005|12127587|P1|NOT COMPLETED|Overall Study||0
4930590|NCT03190005|12127581|P7|COMPLETED|Overall Study||5
4930591|NCT03190005|12127582|P6|COMPLETED|Overall Study||5
4930592|NCT03190005|12127583|P5|COMPLETED|Overall Study||5
4930593|NCT03190005|12127584|P4|COMPLETED|Overall Study||5
4930594|NCT03190005|12127585|P3|COMPLETED|Overall Study||5
4930595|NCT03190005|12127586|P2|COMPLETED|Overall Study||5
4930596|NCT03190005|12127587|P1|COMPLETED|Overall Study||5
4930597|NCT03190005|12127581|P7|STARTED|Overall Study||5
4930598|NCT03190005|12127582|P6|STARTED|Overall Study||5
4930599|NCT03190005|12127583|P5|STARTED|Overall Study||5
4930600|NCT03190005|12127584|P4|STARTED|Overall Study||5
4930601|NCT03190005|12127585|P3|STARTED|Overall Study||5
4930602|NCT03190005|12127586|P2|STARTED|Overall Study||5
4930603|NCT03190005|12127587|P1|STARTED|Overall Study||5
4930604|NCT03189589|12127605|P2|NOT COMPLETED|Overall Study||0
4930605|NCT03189589|12127606|P1|NOT COMPLETED|Overall Study||0
4930606|NCT03189589|12127605|P2|COMPLETED|Overall Study||6
4930607|NCT03189589|12127606|P1|COMPLETED|Overall Study||6
4930608|NCT03189589|12127605|P2|STARTED|Overall Study||6
4930609|NCT03189589|12127606|P1|STARTED|Overall Study||6
4930610|NCT03189134|12127630|P1|NOT COMPLETED|Overall Study||0
4930611|NCT03189134|12127630|P1|COMPLETED|Overall Study||6
4930612|NCT03189134|12127630|P1|STARTED|Overall Study||6
4930613|NCT03188523|12127638|P4|NOT COMPLETED|Overall Study||0
4930614|NCT03188523|12127639|P3|NOT COMPLETED|Overall Study||0
4930615|NCT03188523|12127640|P2|NOT COMPLETED|Overall Study||0
4930616|NCT03188523|12127641|P1|NOT COMPLETED|Overall Study||0
4930617|NCT03188523|12127638|P4|COMPLETED|Overall Study||0
4930618|NCT03188523|12127639|P3|COMPLETED|Overall Study||0
4930619|NCT03188523|12127640|P2|COMPLETED|Overall Study||6
4930620|NCT03188523|12127641|P1|COMPLETED|Overall Study||6
4930621|NCT03188523|12127638|P4|STARTED|Overall Study||0
4930622|NCT03188523|12127639|P3|STARTED|Overall Study||0
4930623|NCT03188523|12127640|P2|STARTED|Overall Study||6
4930624|NCT03188523|12127641|P1|STARTED|Overall Study||6
4930625|NCT03188120|12127691|P1|NOT COMPLETED|Overall Study||47
4930626|NCT03188120|12127691|P1|COMPLETED|Overall Study||146
4930627|NCT03188120|12127691|P1|STARTED|Overall Study||193
4930628|NCT03187756|12127696|P1|NOT COMPLETED|Overall Study||4
4930629|NCT03187756|12127696|P1|COMPLETED|Overall Study||2
4930630|NCT03187756|12127696|P1|STARTED|Overall Study||6
4930631|NCT03187678|12127706|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
4930632|NCT03187678|12127706|P1|COMPLETED|Period 3 (Oral Selexipag)||20
4930633|NCT03187678|12127706|P1|STARTED|Period 3 (Oral Selexipag)||20
4930634|NCT03187678|12127706|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
4930635|NCT03187678|12127706|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
4930636|NCT03187678|12127706|P1|STARTED|Period 2 (Intravenous Selexipag)||20
4930637|NCT03187678|12127706|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
4930638|NCT03187678|12127706|P1|COMPLETED|Period 1 (Oral Selexipag)||20
4930639|NCT03187678|12127706|P1|STARTED|Period 1 (Oral Selexipag)||20
4930640|NCT03187197|12127717|P3|NOT COMPLETED|Overall Study||23
4930641|NCT03187197|12127718|P2|NOT COMPLETED|Overall Study||393
4930642|NCT03187197|12127719|P1|NOT COMPLETED|Overall Study||46
4930643|NCT03187197|12127717|P3|COMPLETED|Overall Study||32
4930644|NCT03187197|12127718|P2|COMPLETED|Overall Study||704
4930645|NCT03187197|12127719|P1|COMPLETED|Overall Study||107
4930646|NCT03187197|12127717|P3|Started (Eligible Participants as FAS)|Overall Study||54
4930647|NCT03187197|12127718|P2|Started (Eligible Participants as FAS)|Overall Study||1052
4930648|NCT03187197|12127719|P1|Started (Eligible Participants as FAS)|Overall Study||139
4930649|NCT03187197|12127717|P3|STARTED|Overall Study||55
4930650|NCT03187197|12127718|P2|STARTED|Overall Study||1097
4930651|NCT03187197|12127719|P1|STARTED|Overall Study||153
4930652|NCT03185481|12127730|P1|NOT COMPLETED|Overall Study||5
4930653|NCT03185481|12127730|P1|COMPLETED|Overall Study||0
4930654|NCT03185481|12127730|P1|STARTED|Overall Study||5
4930655|NCT03185455|12127749|P2|NOT COMPLETED|Overall Study||0
4930656|NCT03185455|12127750|P1|NOT COMPLETED|Overall Study||0
4930657|NCT03185455|12127749|P2|COMPLETED|Overall Study||103
4930658|NCT03185455|12127750|P1|COMPLETED|Overall Study||103
4930659|NCT03185455|12127749|P2|STARTED|Overall Study||103
4930660|NCT03185455|12127750|P1|STARTED|Overall Study||103
4930661|NCT03185182|12127764|P1|NOT COMPLETED|Overall Study||0
4930662|NCT03185182|12127764|P1|COMPLETED|Overall Study||5
4930663|NCT03185182|12127764|P1|STARTED|Overall Study||5
4930664|NCT03184987|12127772|P3|NOT COMPLETED|Overall Study||4
4930665|NCT03184987|12127773|P2|NOT COMPLETED|Overall Study||1
4930666|NCT03184987|12127774|P1|NOT COMPLETED|Overall Study||1
4930667|NCT03184987|12127772|P3|COMPLETED|Overall Study||51
4930668|NCT03184987|12127773|P2|COMPLETED|Overall Study||8
4930669|NCT03184987|12127774|P1|COMPLETED|Overall Study||46
4930670|NCT03184987|12127772|P3|STARTED|Overall Study||55
4930671|NCT03184987|12127773|P2|STARTED|Overall Study||9
4930672|NCT03184987|12127774|P1|STARTED|Overall Study||47
4930673|NCT03184701|12127839|P1|NOT COMPLETED|Overall Study||17
4930674|NCT03184701|12127839|P1|COMPLETED|Overall Study||28
4930675|NCT03184701|12127839|P1|STARTED|Overall Study||45
4930676|NCT03184519|12127843|P1|NOT COMPLETED|Overall Study||27
4930677|NCT03184519|12127843|P1|COMPLETED|Overall Study||129
4930678|NCT03184519|12127843|P1|STARTED|Overall Study||156
4930679|NCT03184441|12127847|P1|NOT COMPLETED|Overall Study||1
4930680|NCT03184441|12127847|P1|COMPLETED|Overall Study|Last subject completed study|10
4930681|NCT03184441|12127847|P1|STARTED|Overall Study||11
4930682|NCT03184428|12127855|P1|NOT COMPLETED|Overall Study||822
4930683|NCT03184428|12127855|P1|COMPLETED|Overall Study||2963
4930684|NCT03184428|12127855|P1|STARTED|Overall Study||3785
4930685|NCT03184077|12127873|P2|NOT COMPLETED|Overall Study||21
4930686|NCT03184077|12127874|P1|NOT COMPLETED|Overall Study||21
4930687|NCT03184077|12127873|P2|COMPLETED|Overall Study||131
4930688|NCT03184077|12127874|P1|COMPLETED|Overall Study||145
4930689|NCT03184077|12127873|P2|STARTED|Overall Study||152
4930690|NCT03184077|12127874|P1|STARTED|Overall Study||166
4930691|NCT03183869|12127886|P2|NOT COMPLETED|Overall Study||5
4930692|NCT03183869|12127887|P1|NOT COMPLETED|Overall Study||4
4930693|NCT03183869|12127886|P2|COMPLETED|Overall Study||2
4930694|NCT03183869|12127887|P1|COMPLETED|Overall Study||0
4930695|NCT03183869|12127886|P2|STARTED|Overall Study||7
4930696|NCT03183869|12127887|P1|STARTED|Overall Study||4
4930697|NCT03183518|12127893|P1|NOT COMPLETED|Overall Study||3
4930698|NCT03183518|12127893|P1|COMPLETED|Overall Study||33
4930699|NCT03183518|12127893|P1|Negative Control|Overall Study||36
4930700|NCT03183518|12127893|P1|Test Product|Overall Study||36
4930701|NCT03183518|12127893|P1|STARTED|Overall Study||36
4930702|NCT03183063|12127927|P3|NOT COMPLETED|Overall Study||4
4930703|NCT03183063|12127928|P2|NOT COMPLETED|Overall Study||4
4930704|NCT03183063|12127929|P1|NOT COMPLETED|Overall Study||5
4930705|NCT03183063|12127927|P3|COMPLETED|Overall Study||111
4930706|NCT03183063|12127928|P2|COMPLETED|Overall Study||0
4930707|NCT03183063|12127929|P1|COMPLETED|Overall Study||15
4930708|NCT03183063|12127927|P3|STARTED|Overall Study||115
4930709|NCT03183063|12127928|P2|STARTED|Overall Study||4
4930710|NCT03183063|12127929|P1|STARTED|Overall Study||20
4930711|NCT03182933|12127954|P2|NOT COMPLETED|Overall Study||0
4930712|NCT03182933|12127955|P1|NOT COMPLETED|Overall Study||1
4930713|NCT03182933|12127954|P2|COMPLETED|Overall Study||32
4930714|NCT03182933|12127955|P1|COMPLETED|Overall Study||31
4930715|NCT03182933|12127954|P2|STARTED|Overall Study||32
4930716|NCT03182933|12127955|P1|STARTED|Overall Study||32
4930717|NCT03182920|12127971|P3|NOT COMPLETED|Period 2||0
4930718|NCT03182920|12127972|P2|NOT COMPLETED|Period 2||0
4930719|NCT03182920|12127973|P1|NOT COMPLETED|Period 2||0
4930720|NCT03182920|12127971|P3|COMPLETED|Period 2||0
4930721|NCT03182920|12127972|P2|COMPLETED|Period 2||9
4930722|NCT03182920|12127973|P1|COMPLETED|Period 2||9
4930723|NCT03182920|12127971|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
4930724|NCT03182920|12127972|P2|STARTED|Period 2||9
4930725|NCT03182920|12127973|P1|STARTED|Period 2||9
4930726|NCT03182920|12127971|P3|NOT COMPLETED|Washout Period||0
4930727|NCT03182920|12127972|P2|NOT COMPLETED|Washout Period||0
4930728|NCT03182920|12127973|P1|NOT COMPLETED|Washout Period||0
4930729|NCT03182920|12127971|P3|COMPLETED|Washout Period||0
4930730|NCT03182920|12127972|P2|COMPLETED|Washout Period||9
4930731|NCT03182920|12127973|P1|COMPLETED|Washout Period||9
4930732|NCT03182920|12127971|P3|STARTED|Washout Period||0
4930733|NCT03182920|12127972|P2|STARTED|Washout Period||9
4930734|NCT03182920|12127973|P1|STARTED|Washout Period||9
4930735|NCT03182920|12127971|P3|NOT COMPLETED|Period 1||0
4930736|NCT03182920|12127972|P2|NOT COMPLETED|Period 1||0
4930737|NCT03182920|12127973|P1|NOT COMPLETED|Period 1||0
4930738|NCT03182920|12127971|P3|COMPLETED|Period 1||17
4930739|NCT03182920|12127972|P2|COMPLETED|Period 1||9
4930740|NCT03182920|12127973|P1|COMPLETED|Period 1||9
4930741|NCT03182920|12127971|P3|STARTED|Period 1||17
4930742|NCT03182920|12127972|P2|STARTED|Period 1||9
4930743|NCT03182920|12127973|P1|STARTED|Period 1||9
4930744|NCT03182738|12127984|P2|NOT COMPLETED|Overall Study||5
4930745|NCT03182738|12127985|P1|NOT COMPLETED|Overall Study||9
4930746|NCT03182738|12127984|P2|COMPLETED|Overall Study||45
4930747|NCT03182738|12127985|P1|COMPLETED|Overall Study||41
4930748|NCT03182738|12127984|P2|STARTED|Overall Study||50
4930749|NCT03182738|12127985|P1|STARTED|Overall Study||50
4930750|NCT03182582|12127999|P2|NOT COMPLETED|Treatment 2||0
4930751|NCT03182582|12128000|P1|NOT COMPLETED|Treatment 2||0
4930752|NCT03182582|12127999|P2|COMPLETED|Treatment 2||10
4930753|NCT03182582|12128000|P1|COMPLETED|Treatment 2||12
4930754|NCT03182582|12127999|P2|STARTED|Treatment 2||10
4930755|NCT03182582|12128000|P1|STARTED|Treatment 2||12
4930756|NCT03182582|12127999|P2|NOT COMPLETED|Treatment 1||0
4930757|NCT03182582|12128000|P1|NOT COMPLETED|Treatment 1||0
4930758|NCT03182582|12127999|P2|COMPLETED|Treatment 1||10
4930759|NCT03182582|12128000|P1|COMPLETED|Treatment 1||12
4930760|NCT03182582|12127999|P2|STARTED|Treatment 1||10
4930761|NCT03182582|12128000|P1|STARTED|Treatment 1||12
4930762|NCT03181724|12128017|P2|NOT COMPLETED|Overall Study||0
4930763|NCT03181724|12128018|P1|NOT COMPLETED|Overall Study||0
4930764|NCT03181724|12128017|P2|COMPLETED|Overall Study||45
4930765|NCT03181724|12128018|P1|COMPLETED|Overall Study||45
4930766|NCT03181724|12128017|P2|STARTED|Overall Study||45
4930767|NCT03181724|12128018|P1|STARTED|Overall Study||45
4930768|NCT03181594|12128034|P1|NOT COMPLETED|Overall Study||2
4930769|NCT03181594|12128034|P1|COMPLETED|Overall Study||98
4930770|NCT03181594|12128034|P1|90-day Follow-up|Overall Study||98
4930771|NCT03181594|12128034|P1|30-day Follow-up|Overall Study||99
4930772|NCT03181594|12128034|P1|STARTED|Overall Study||100
4930773|NCT03181503|12128042|P2|NOT COMPLETED|Overall Study||3
4930774|NCT03181503|12128043|P1|NOT COMPLETED|Overall Study||7
4930775|NCT03181503|12128042|P2|COMPLETED|Overall Study||31
4930776|NCT03181503|12128043|P1|COMPLETED|Overall Study||29
4930777|NCT03181503|12128042|P2|Treated|Overall Study||34
4930778|NCT03181503|12128043|P1|Treated|Overall Study||36
4930779|NCT03181503|12128042|P2|STARTED|Overall Study||34
4930780|NCT03181503|12128043|P1|STARTED|Overall Study||36
4930781|NCT03181451|12128082|P3|NOT COMPLETED|Overall Study||0
4930782|NCT03181451|12128083|P2|NOT COMPLETED|Overall Study||2
4930783|NCT03181451|12128084|P1|NOT COMPLETED|Overall Study||0
4930784|NCT03181451|12128082|P3|COMPLETED|Overall Study||12
4930785|NCT03181451|12128083|P2|COMPLETED|Overall Study||11
4930786|NCT03181451|12128084|P1|COMPLETED|Overall Study||12
4930787|NCT03181451|12128082|P3|STARTED|Overall Study||12
4930788|NCT03181451|12128083|P2|STARTED|Overall Study||13
4930789|NCT03181451|12128084|P1|STARTED|Overall Study||12
4930790|NCT03181308|12128244|P2|NOT COMPLETED|Overall Study||0
4930791|NCT03181308|12128245|P1|NOT COMPLETED|Overall Study||0
4930792|NCT03181308|12128244|P2|COMPLETED|Overall Study||8
4930793|NCT03181308|12128245|P1|COMPLETED|Overall Study||3
4930794|NCT03181308|12128244|P2|STARTED|Overall Study||8
4930795|NCT03181308|12128245|P1|STARTED|Overall Study||3
4930796|NCT03181009|12128261|P2|NOT COMPLETED|Overall Study||2
4930797|NCT03181009|12128262|P1|NOT COMPLETED|Overall Study||0
4930798|NCT03181009|12128261|P2|COMPLETED|Overall Study||28
4930799|NCT03181009|12128262|P1|COMPLETED|Overall Study||30
4930800|NCT03181009|12128261|P2|STARTED|Overall Study||30
4930801|NCT03181009|12128262|P1|STARTED|Overall Study||30
4930802|NCT03180801|12128271|P3|NOT COMPLETED|Overall Study||10
4930803|NCT03180801|12128272|P2|NOT COMPLETED|Overall Study||12
4930804|NCT03180801|12128273|P1|NOT COMPLETED|Overall Study||8
4930805|NCT03180801|12128271|P3|COMPLETED|Overall Study||41
4930806|NCT03180801|12128272|P2|COMPLETED|Overall Study||40
4930807|NCT03180801|12128273|P1|COMPLETED|Overall Study||42
4930808|NCT03180801|12128271|P3|Intention to Treat|Overall Study||41
4930809|NCT03180801|12128272|P2|Intention to Treat|Overall Study||40
4930810|NCT03180801|12128273|P1|Intention to Treat|Overall Study||42
4930811|NCT03180801|12128271|P3|Safety Population|Overall Study||51
4930812|NCT03180801|12128272|P2|Safety Population|Overall Study||52
4930813|NCT03180801|12128273|P1|Safety Population|Overall Study||50
4930814|NCT03180801|12128271|P3|STARTED|Overall Study||51
4930815|NCT03180801|12128272|P2|STARTED|Overall Study||52
4930816|NCT03180801|12128273|P1|STARTED|Overall Study||50
4930817|NCT03180645|12128314|P3|NOT COMPLETED|Overall Study||2
4930818|NCT03180645|12128315|P2|NOT COMPLETED|Overall Study||1
4930819|NCT03180645|12128316|P1|NOT COMPLETED|Overall Study||0
4930820|NCT03180645|12128314|P3|COMPLETED|Overall Study||22
4930821|NCT03180645|12128315|P2|COMPLETED|Overall Study||23
4930822|NCT03180645|12128316|P1|COMPLETED|Overall Study||24
4930823|NCT03180645|12128314|P3|STARTED|Overall Study||24
4930824|NCT03180645|12128315|P2|STARTED|Overall Study||24
4930825|NCT03180645|12128316|P1|STARTED|Overall Study||24
4930826|NCT03180619|12128358|P3|NOT COMPLETED|Overall Study||31
4930827|NCT03180619|12128359|P2|NOT COMPLETED|Overall Study||15
4930828|NCT03180619|12128360|P1|NOT COMPLETED|Overall Study||78
4930829|NCT03180619|12128358|P3|COMPLETED|Overall Study||0
4930830|NCT03180619|12128359|P2|COMPLETED|Overall Study||0
4930831|NCT03180619|12128360|P1|COMPLETED|Overall Study||0
4930832|NCT03180619|12128358|P3|STARTED|Overall Study||31
4930833|NCT03180619|12128359|P2|STARTED|Overall Study||15
4930834|NCT03180619|12128360|P1|STARTED|Overall Study||78
4930835|NCT03180515|12128411|P1|NOT COMPLETED|Aim 3||0
4930836|NCT03180515|12128411|P1|COMPLETED|Aim 3||1
4930837|NCT03180515|12128411|P1|STARTED|Aim 3||1
4930838|NCT03180515|12128411|P1|NOT COMPLETED|Aim 2||0
4930839|NCT03180515|12128411|P1|COMPLETED|Aim 2||12
4930840|NCT03180515|12128411|P1|STARTED|Aim 2||12
4930841|NCT03180515|12128411|P1|NOT COMPLETED|Aim 1||0
4930842|NCT03180515|12128411|P1|COMPLETED|Aim 1||12
4930843|NCT03180515|12128411|P1|STARTED|Aim 1||12
4930844|NCT03180489|12128456|P2|NOT COMPLETED|Overall Study||4
4930845|NCT03180489|12128457|P1|NOT COMPLETED|Overall Study||8
4930846|NCT03180489|12128456|P2|COMPLETED|Overall Study||25
4930847|NCT03180489|12128457|P1|COMPLETED|Overall Study||25
4930848|NCT03180489|12128456|P2|STARTED|Overall Study||29
4930849|NCT03180489|12128457|P1|STARTED|Overall Study||33
4930850|NCT03180385|12128489|P2|NOT COMPLETED|Overall Study||0
4930851|NCT03180385|12128490|P1|NOT COMPLETED|Overall Study||0
4930852|NCT03180385|12128489|P2|COMPLETED|Overall Study||2
4930853|NCT03180385|12128490|P1|COMPLETED|Overall Study||0
4930854|NCT03180385|12128489|P2|STARTED|Overall Study||2
4930855|NCT03180385|12128490|P1|STARTED|Overall Study||0
4930856|NCT03180138|12128517|P3|NOT COMPLETED|Overall Study||24
4930857|NCT03180138|12128518|P2|NOT COMPLETED|Overall Study||13
4930858|NCT03180138|12128519|P1|NOT COMPLETED|Overall Study||22
4930859|NCT03180138|12128517|P3|COMPLETED|Overall Study||179
4930860|NCT03180138|12128518|P2|COMPLETED|Overall Study||188
4930861|NCT03180138|12128519|P1|COMPLETED|Overall Study||182
4930862|NCT03180138|12128517|P3|STARTED|Overall Study||203
4930863|NCT03180138|12128518|P2|STARTED|Overall Study||201
4930864|NCT03180138|12128519|P1|STARTED|Overall Study||204
4930865|NCT03179345|12128534|P4|NOT COMPLETED|Overall Study||2
4930866|NCT03179345|12128535|P3|NOT COMPLETED|Overall Study||1
4930867|NCT03179345|12128536|P2|NOT COMPLETED|Overall Study||1
4930868|NCT03179345|12128537|P1|NOT COMPLETED|Overall Study||0
4930869|NCT03179345|12128534|P4|COMPLETED|Overall Study||6
4930870|NCT03179345|12128535|P3|COMPLETED|Overall Study||7
4930871|NCT03179345|12128536|P2|COMPLETED|Overall Study||7
4930872|NCT03179345|12128537|P1|COMPLETED|Overall Study||8
4930873|NCT03179345|12128534|P4|Received Placebo|Overall Study||8
4930874|NCT03179345|12128535|P3|Received Placebo|Overall Study||7
4930875|NCT03179345|12128536|P2|Received Placebo|Overall Study||7
4930876|NCT03179345|12128537|P1|Received Placebo|Overall Study||8
4930877|NCT03179345|12128534|P4|Received Lyrica®|Overall Study||8
4930878|NCT03179345|12128535|P3|Received Lyrica®|Overall Study||8
4930879|NCT03179345|12128536|P2|Received Lyrica®|Overall Study||7
4930880|NCT03179345|12128537|P1|Received Lyrica®|Overall Study||8
4930881|NCT03179345|12128534|P4|Received Neurontin®|Overall Study||8
4930882|NCT03179345|12128535|P3|Received Neurontin®|Overall Study||7
4930883|NCT03179345|12128536|P2|Received Neurontin®|Overall Study||8
4930884|NCT03179345|12128537|P1|Received Neurontin®|Overall Study||8
4930885|NCT03179345|12128534|P4|Received Gralise®|Overall Study||6
4930886|NCT03179345|12128535|P3|Received Gralise®|Overall Study||7
4930887|NCT03179345|12128536|P2|Received Gralise®|Overall Study||7
4930888|NCT03179345|12128537|P1|Received Gralise®|Overall Study||8
4930889|NCT03179345|12128534|P4|STARTED|Overall Study||8
4930890|NCT03179345|12128535|P3|STARTED|Overall Study||8
4930891|NCT03179345|12128536|P2|STARTED|Overall Study||8
4930892|NCT03179345|12128537|P1|STARTED|Overall Study||8
4930893|NCT03178942|12128589|P2|NOT COMPLETED|Overall Study||2
4930894|NCT03178942|12128590|P1|NOT COMPLETED|Overall Study||3
4930895|NCT03178942|12128589|P2|COMPLETED|Overall Study||123
4930896|NCT03178942|12128590|P1|COMPLETED|Overall Study||126
4930897|NCT03178942|12128589|P2|STARTED|Overall Study||125
4930898|NCT03178942|12128590|P1|STARTED|Overall Study||129
4930899|NCT03178851|12128605|P3|NOT COMPLETED|Overall Study||52
4930900|NCT03178851|12128606|P2|NOT COMPLETED|Overall Study||11
4930901|NCT03178851|12128607|P1|NOT COMPLETED|Overall Study||92
4930902|NCT03178851|12128605|P3|COMPLETED|Overall Study||0
4930903|NCT03178851|12128606|P2|COMPLETED|Overall Study||0
4930904|NCT03178851|12128607|P1|COMPLETED|Overall Study||0
4930905|NCT03178851|12128605|P3|STARTED|Overall Study||52
4930906|NCT03178851|12128606|P2|STARTED|Overall Study||11
4930907|NCT03178851|12128607|P1|STARTED|Overall Study||92
4930908|NCT03178344|12128637|P2|NOT COMPLETED|Second Session||0
4930909|NCT03178344|12128638|P1|NOT COMPLETED|Second Session||0
4930910|NCT03178344|12128637|P2|COMPLETED|Second Session||10
4930911|NCT03178344|12128638|P1|COMPLETED|Second Session||10
4930912|NCT03178344|12128637|P2|STARTED|Second Session||10
4930913|NCT03178344|12128638|P1|STARTED|Second Session||10
4930914|NCT03178344|12128637|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
4930915|NCT03178344|12128638|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
4930916|NCT03178344|12128637|P2|COMPLETED|Washout Period (5-9 Days)||10
4930917|NCT03178344|12128638|P1|COMPLETED|Washout Period (5-9 Days)||10
4930918|NCT03178344|12128637|P2|STARTED|Washout Period (5-9 Days)||10
4930919|NCT03178344|12128638|P1|STARTED|Washout Period (5-9 Days)||10
4930920|NCT03178344|12128637|P2|NOT COMPLETED|First Session||0
4930921|NCT03178344|12128638|P1|NOT COMPLETED|First Session||0
4930922|NCT03178344|12128637|P2|COMPLETED|First Session||10
4930923|NCT03178344|12128638|P1|COMPLETED|First Session||10
4930924|NCT03178344|12128637|P2|STARTED|First Session||10
4930925|NCT03178344|12128638|P1|STARTED|First Session||10
4930926|NCT03178266|12128654|P2|NOT COMPLETED|Overall Study||4
4930927|NCT03178266|12128655|P1|NOT COMPLETED|Overall Study||0
4930928|NCT03178266|12128654|P2|COMPLETED|Overall Study||16
4930929|NCT03178266|12128655|P1|COMPLETED|Overall Study||21
4930930|NCT03178266|12128654|P2|STARTED|Overall Study||20
4930931|NCT03178266|12128655|P1|STARTED|Overall Study||21
4930932|NCT03177798|12128665|P2|NOT COMPLETED|Overall Study||0
4930933|NCT03177798|12128666|P1|NOT COMPLETED|Overall Study||0
4930934|NCT03177798|12128665|P2|COMPLETED|Overall Study||6
4930935|NCT03177798|12128666|P1|COMPLETED|Overall Study||5
4930936|NCT03177798|12128665|P2|Intervention 2|Overall Study||6
4930937|NCT03177798|12128666|P1|Intervention 2|Overall Study||5
4930938|NCT03177798|12128665|P2|Washout|Overall Study||6
4930939|NCT03177798|12128666|P1|Washout|Overall Study||5
4930940|NCT03177798|12128665|P2|Intervention 1|Overall Study||6
4930941|NCT03177798|12128666|P1|Intervention 1|Overall Study||5
4930942|NCT03177798|12128665|P2|STARTED|Overall Study||6
4930943|NCT03177798|12128666|P1|STARTED|Overall Study||5
4930944|NCT03177603|12128678|P4|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930945|NCT03177603|12128679|P3|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930946|NCT03177603|12128680|P2|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930947|NCT03177603|12128681|P1|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930948|NCT03177603|12128678|P4|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
4930949|NCT03177603|12128679|P3|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930950|NCT03177603|12128680|P2|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930951|NCT03177603|12128681|P1|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930952|NCT03177603|12128678|P4|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
4930953|NCT03177603|12128679|P3|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930954|NCT03177603|12128680|P2|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930955|NCT03177603|12128681|P1|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
4930956|NCT03177603|12128678|P4|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930957|NCT03177603|12128679|P3|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930958|NCT03177603|12128680|P2|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930959|NCT03177603|12128681|P1|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930960|NCT03177603|12128678|P4|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930961|NCT03177603|12128679|P3|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
4930962|NCT03177603|12128680|P2|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930963|NCT03177603|12128681|P1|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930964|NCT03177603|12128678|P4|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930965|NCT03177603|12128679|P3|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
4930966|NCT03177603|12128680|P2|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930967|NCT03177603|12128681|P1|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
4930968|NCT03177603|12128678|P4|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4931149|NCT03170609|12129572|P3|Vaccinated|Overall Study||52
4930969|NCT03177603|12128679|P3|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930970|NCT03177603|12128680|P2|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930971|NCT03177603|12128681|P1|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930972|NCT03177603|12128678|P4|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930973|NCT03177603|12128679|P3|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930974|NCT03177603|12128680|P2|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
4930975|NCT03177603|12128681|P1|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930976|NCT03177603|12128678|P4|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930977|NCT03177603|12128679|P3|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930978|NCT03177603|12128680|P2|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
4930979|NCT03177603|12128681|P1|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
4930980|NCT03177603|12128678|P4|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930981|NCT03177603|12128679|P3|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930982|NCT03177603|12128680|P2|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930983|NCT03177603|12128681|P1|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930984|NCT03177603|12128678|P4|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930985|NCT03177603|12128679|P3|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930986|NCT03177603|12128680|P2|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930987|NCT03177603|12128681|P1|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
4930988|NCT03177603|12128678|P4|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930989|NCT03177603|12128679|P3|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930990|NCT03177603|12128680|P2|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
4930991|NCT03177603|12128681|P1|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
4930992|NCT03177395|12128851|P4|NOT COMPLETED|Overall Study||0
4930993|NCT03177395|12128852|P3|NOT COMPLETED|Overall Study||0
4930994|NCT03177395|12128853|P2|NOT COMPLETED|Overall Study||0
4930995|NCT03177395|12128854|P1|NOT COMPLETED|Overall Study||0
4930996|NCT03177395|12128851|P4|COMPLETED|Overall Study||6
4930997|NCT03177395|12128852|P3|COMPLETED|Overall Study||6
4930998|NCT03177395|12128853|P2|COMPLETED|Overall Study||6
4930999|NCT03177395|12128854|P1|COMPLETED|Overall Study||6
4931000|NCT03177395|12128851|P4|STARTED|Overall Study||6
4931001|NCT03177395|12128852|P3|STARTED|Overall Study||6
4931002|NCT03177395|12128853|P2|STARTED|Overall Study||6
4931003|NCT03177395|12128854|P1|STARTED|Overall Study||6
4931004|NCT03176654|12128958|P2|NOT COMPLETED|Overall Study||0
4931005|NCT03176654|12128959|P1|NOT COMPLETED|Overall Study||0
4931006|NCT03176654|12128958|P2|COMPLETED|Overall Study||15
4931007|NCT03176654|12128959|P1|COMPLETED|Overall Study||13
4931008|NCT03176654|12128958|P2|STARTED|Overall Study||15
4931009|NCT03176654|12128959|P1|STARTED|Overall Study||13
4931010|NCT03176407|12128979|P1|NOT COMPLETED|Overall Study||3
4931011|NCT03176407|12128979|P1|COMPLETED|Overall Study||27
4931012|NCT03176407|12128979|P1|STARTED|Overall Study||30
4931013|NCT03176238|12128989|P2|NOT COMPLETED|Overall Study||36
4931014|NCT03176238|12128990|P1|NOT COMPLETED|Overall Study||199
4931015|NCT03176238|12128989|P2|COMPLETED|Overall Study||0
4931016|NCT03176238|12128990|P1|COMPLETED|Overall Study||0
4931017|NCT03176238|12128989|P2|STARTED|Overall Study||36
4931018|NCT03176238|12128990|P1|STARTED|Overall Study||199
4931019|NCT03175562|12129009|P1|NOT COMPLETED|Overall Study||16
4931020|NCT03175562|12129009|P1|COMPLETED|Overall Study||224
4931021|NCT03175562|12129009|P1|Negative Control|Overall Study||240
4931022|NCT03175562|12129009|P1|Test Product|Overall Study||240
4931023|NCT03175562|12129009|P1|STARTED|Overall Study||240
4931024|NCT03175172|12129034|P1|NOT COMPLETED|Overall Study||10
4931025|NCT03175172|12129034|P1|COMPLETED|Overall Study||0
4931026|NCT03175172|12129034|P1|STARTED|Overall Study||10
4931027|NCT03175120|12129044|P2|NOT COMPLETED|Overall Study||12
4931028|NCT03175120|12129045|P1|NOT COMPLETED|Overall Study||12
4931029|NCT03175120|12129044|P2|COMPLETED|Overall Study||139
4931030|NCT03175120|12129045|P1|COMPLETED|Overall Study||290
4931031|NCT03175120|12129044|P2|Safety Analysis Set (SAS)|Overall Study||151
4931032|NCT03175120|12129045|P1|Safety Analysis Set (SAS)|Overall Study||301
4931033|NCT03175120|12129044|P2|Full Analysis Set (FAS)|Overall Study||151
4931034|NCT03175120|12129045|P1|Full Analysis Set (FAS)|Overall Study||302
4931035|NCT03175120|12129044|P2|Treated|Overall Study||151
4931036|NCT03175120|12129045|P1|Treated|Overall Study||301
4931037|NCT03175120|12129044|P2|STARTED|Overall Study||151
4931038|NCT03175120|12129045|P1|STARTED|Overall Study||302
4931039|NCT03174366|12129167|P1|NOT COMPLETED|Overall Study||0
4931040|NCT03174366|12129167|P1|COMPLETED|Overall Study||7
4931041|NCT03174366|12129167|P1|STARTED|Overall Study||7
4931042|NCT03174158|12129176|P4|NOT COMPLETED|Overall Study||1
4931043|NCT03174158|12129177|P3|NOT COMPLETED|Overall Study||2
4931044|NCT03174158|12129178|P2|NOT COMPLETED|Overall Study||2
4931045|NCT03174158|12129179|P1|NOT COMPLETED|Overall Study||4
4931046|NCT03174158|12129176|P4|COMPLETED|Overall Study||38
4931047|NCT03174158|12129177|P3|COMPLETED|Overall Study||34
4931048|NCT03174158|12129178|P2|COMPLETED|Overall Study||37
4931049|NCT03174158|12129179|P1|COMPLETED|Overall Study||35
4931050|NCT03174158|12129176|P4|STARTED|Overall Study||39
4931051|NCT03174158|12129177|P3|STARTED|Overall Study||36
4931052|NCT03174158|12129178|P2|STARTED|Overall Study||39
4931053|NCT03174158|12129179|P1|STARTED|Overall Study||39
4931054|NCT03174132|12129215|P1|NOT COMPLETED|Overall Study||0
4931055|NCT03174132|12129215|P1|COMPLETED|Overall Study||70
4931056|NCT03174132|12129215|P1|STARTED|Overall Study||70
4931057|NCT03173170|12129220|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
4931058|NCT03173170|12129220|P1|COMPLETED|Intervention Period 2 (9 Days)||10
4931059|NCT03173170|12129220|P1|STARTED|Intervention Period 2 (9 Days)||10
4931060|NCT03173170|12129220|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
4931061|NCT03173170|12129220|P1|COMPLETED|Washout Period (at Least 7 Days)||10
4931062|NCT03173170|12129220|P1|STARTED|Washout Period (at Least 7 Days)||10
4931063|NCT03173170|12129220|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
4931064|NCT03173170|12129220|P1|COMPLETED|First Intervention Period (6 Days)||10
4931065|NCT03173170|12129220|P1|STARTED|First Intervention Period (6 Days)||10
4931066|NCT03172702|12129229|P1|NOT COMPLETED|Overall Study||28
4931067|NCT03172702|12129229|P1|COMPLETED|Overall Study||122
4931068|NCT03172702|12129229|P1|Received Treatment in MP|Overall Study||150
4931069|NCT03172702|12129229|P1|Received Treatment in CP|Overall Study||150
4931070|NCT03172702|12129229|P1|STARTED|Overall Study||150
4931071|NCT03172520|12129250|P1|NOT COMPLETED|Overall Study||10
4931072|NCT03172520|12129250|P1|COMPLETED|Overall Study||0
4931073|NCT03172520|12129250|P1|STARTED|Overall Study||10
4931074|NCT03172494|12129257|P3|NOT COMPLETED|Overall Study||29
4931075|NCT03172494|12129258|P2|NOT COMPLETED|Overall Study||12
4931076|NCT03172494|12129259|P1|NOT COMPLETED|Overall Study||20
4931077|NCT03172494|12129257|P3|COMPLETED|Overall Study||151
4931078|NCT03172494|12129258|P2|COMPLETED|Overall Study||167
4931079|NCT03172494|12129259|P1|COMPLETED|Overall Study||341
4931080|NCT03172494|12129257|P3|Exposed|Overall Study||180
4931081|NCT03172494|12129258|P2|Exposed|Overall Study||175
4931082|NCT03172494|12129259|P1|Exposed|Overall Study||358
4931083|NCT03172494|12129257|P3|Safety Analysis Set (SAS)|Overall Study||180
4931084|NCT03172494|12129258|P2|Safety Analysis Set (SAS)|Overall Study||175
4931085|NCT03172494|12129259|P1|Safety Analysis Set (SAS)|Overall Study||358
4931086|NCT03172494|12129257|P3|Full Analysis Set (FAS)|Overall Study||180
4931087|NCT03172494|12129258|P2|Full Analysis Set (FAS)|Overall Study||179
4931088|NCT03172494|12129259|P1|Full Analysis Set (FAS)|Overall Study||361
4931089|NCT03172494|12129257|P3|STARTED|Overall Study||180
4931090|NCT03172494|12129258|P2|STARTED|Overall Study||179
4931091|NCT03172494|12129259|P1|STARTED|Overall Study||361
4931092|NCT03172481|12129442|P2|NOT COMPLETED|Double-blind||0
4931093|NCT03172481|12129443|P1|NOT COMPLETED|Double-blind||1
4931094|NCT03172481|12129442|P2|COMPLETED|Double-blind||73
4931095|NCT03172481|12129443|P1|COMPLETED|Double-blind||74
4931096|NCT03172481|12129442|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
4931097|NCT03172481|12129443|P1|STARTED|Double-blind||75
4931098|NCT03172481|12129442|P2|NOT COMPLETED|Open-label||0
4931099|NCT03172481|12129443|P1|NOT COMPLETED|Open-label||8
4931100|NCT03172481|12129442|P2|COMPLETED|Open-label||0
4931101|NCT03172481|12129443|P1|COMPLETED|Open-label||148
4931102|NCT03172481|12129442|P2|STARTED|Open-label||0
4931103|NCT03172481|12129443|P1|STARTED|Open-label||156
4931104|NCT03172364|12129451|P2|NOT COMPLETED|Overall Study||1
4931105|NCT03172364|12129452|P1|NOT COMPLETED|Overall Study||2
4931106|NCT03172364|12129451|P2|COMPLETED|Overall Study||57
4931107|NCT03172364|12129452|P1|COMPLETED|Overall Study||53
4931108|NCT03172364|12129451|P2|STARTED|Overall Study||58
4931109|NCT03172364|12129452|P1|STARTED|Overall Study||55
4931110|NCT03172130|12129470|P2|NOT COMPLETED|Overall Study||1
4931111|NCT03172130|12129471|P1|NOT COMPLETED|Overall Study||3
4931112|NCT03172130|12129470|P2|COMPLETED|Overall Study||9
4931113|NCT03172130|12129471|P1|COMPLETED|Overall Study||9
4931114|NCT03172130|12129470|P2|STARTED|Overall Study||10
4931115|NCT03172130|12129471|P1|STARTED|Overall Study||12
4931116|NCT03171415|12129496|P5|NOT COMPLETED|Overall Study||2
4931117|NCT03171415|12129497|P4|NOT COMPLETED|Overall Study||0
4931118|NCT03171415|12129498|P3|NOT COMPLETED|Overall Study||0
4931119|NCT03171415|12129499|P2|NOT COMPLETED|Overall Study||0
4931120|NCT03171415|12129500|P1|NOT COMPLETED|Overall Study||0
4931121|NCT03171415|12129496|P5|COMPLETED|Overall Study||7
4931122|NCT03171415|12129497|P4|COMPLETED|Overall Study||6
4931123|NCT03171415|12129498|P3|COMPLETED|Overall Study||6
4931124|NCT03171415|12129499|P2|COMPLETED|Overall Study||6
4931125|NCT03171415|12129500|P1|COMPLETED|Overall Study||6
4931126|NCT03171415|12129496|P5|STARTED|Overall Study||9
4931127|NCT03171415|12129497|P4|STARTED|Overall Study||6
4931128|NCT03171415|12129498|P3|STARTED|Overall Study||6
4931129|NCT03171415|12129499|P2|STARTED|Overall Study||6
4931130|NCT03171415|12129500|P1|STARTED|Overall Study||6
4931131|NCT03170609|12129568|P7|NOT COMPLETED|Overall Study||1
4931132|NCT03170609|12129569|P6|NOT COMPLETED|Overall Study||2
4931133|NCT03170609|12129570|P5|NOT COMPLETED|Overall Study||1
4931134|NCT03170609|12129571|P4|NOT COMPLETED|Overall Study||2
4931135|NCT03170609|12129572|P3|NOT COMPLETED|Overall Study||6
4931136|NCT03170609|12129573|P2|NOT COMPLETED|Overall Study||2
4931137|NCT03170609|12129574|P1|NOT COMPLETED|Overall Study||3
4931138|NCT03170609|12129568|P7|COMPLETED|Overall Study||51
4931139|NCT03170609|12129569|P6|COMPLETED|Overall Study||50
4931140|NCT03170609|12129570|P5|COMPLETED|Overall Study||51
4931141|NCT03170609|12129571|P4|COMPLETED|Overall Study||50
4931142|NCT03170609|12129572|P3|COMPLETED|Overall Study||46
4931143|NCT03170609|12129573|P2|COMPLETED|Overall Study||50
4931144|NCT03170609|12129574|P1|COMPLETED|Overall Study||50
4931145|NCT03170609|12129568|P7|Vaccinated|Overall Study||52
4931146|NCT03170609|12129569|P6|Vaccinated|Overall Study||52
4931147|NCT03170609|12129570|P5|Vaccinated|Overall Study||52
4931148|NCT03170609|12129571|P4|Vaccinated|Overall Study||52
4931150|NCT03170609|12129573|P2|Vaccinated|Overall Study||52
4931151|NCT03170609|12129574|P1|Vaccinated|Overall Study||52
4931152|NCT03170609|12129568|P7|STARTED|Overall Study||52
4931153|NCT03170609|12129569|P6|STARTED|Overall Study||52
4931154|NCT03170609|12129570|P5|STARTED|Overall Study||52
4931155|NCT03170609|12129571|P4|STARTED|Overall Study||52
4931156|NCT03170609|12129572|P3|STARTED|Overall Study||52
4931157|NCT03170609|12129573|P2|STARTED|Overall Study||52
4931158|NCT03170609|12129574|P1|STARTED|Overall Study||53
4931159|NCT03170544|12129644|P12|NOT COMPLETED|Part 4||0
4931160|NCT03170544|12129645|P11|NOT COMPLETED|Part 4||0
4931161|NCT03170544|12129646|P10|NOT COMPLETED|Part 4||0
4931162|NCT03170544|12129647|P9|NOT COMPLETED|Part 4||0
4931163|NCT03170544|12129648|P8|NOT COMPLETED|Part 4||0
4931164|NCT03170544|12129649|P7|NOT COMPLETED|Part 4||0
4931165|NCT03170544|12129650|P6|NOT COMPLETED|Part 4||0
4931166|NCT03170544|12129651|P5|NOT COMPLETED|Part 4||0
4931167|NCT03170544|12129652|P4|NOT COMPLETED|Part 4||0
4931168|NCT03170544|12129653|P3|NOT COMPLETED|Part 4||0
4931169|NCT03170544|12129654|P2|NOT COMPLETED|Part 4||0
4931170|NCT03170544|12129655|P1|NOT COMPLETED|Part 4||0
4931171|NCT03170544|12129644|P12|COMPLETED|Part 4||6
4931172|NCT03170544|12129645|P11|COMPLETED|Part 4||3
4931173|NCT03170544|12129646|P10|COMPLETED|Part 4||0
4931174|NCT03170544|12129647|P9|COMPLETED|Part 4||0
4931175|NCT03170544|12129648|P8|COMPLETED|Part 4||0
4931176|NCT03170544|12129649|P7|COMPLETED|Part 4||0
4931177|NCT03170544|12129650|P6|COMPLETED|Part 4||0
4931178|NCT03170544|12129651|P5|COMPLETED|Part 4||0
4931179|NCT03170544|12129652|P4|COMPLETED|Part 4||0
4931180|NCT03170544|12129653|P3|COMPLETED|Part 4||0
4931181|NCT03170544|12129654|P2|COMPLETED|Part 4||0
4931182|NCT03170544|12129655|P1|COMPLETED|Part 4||0
4931183|NCT03170544|12129644|P12|STARTED|Part 4||6
4931184|NCT03170544|12129645|P11|STARTED|Part 4||3
4931185|NCT03170544|12129646|P10|STARTED|Part 4||0
4931186|NCT03170544|12129647|P9|STARTED|Part 4||0
4931187|NCT03170544|12129648|P8|STARTED|Part 4||0
4931188|NCT03170544|12129649|P7|STARTED|Part 4||0
4931189|NCT03170544|12129650|P6|STARTED|Part 4||0
4931190|NCT03170544|12129651|P5|STARTED|Part 4||0
4931191|NCT03170544|12129652|P4|STARTED|Part 4||0
4931192|NCT03170544|12129653|P3|STARTED|Part 4||0
4931193|NCT03170544|12129654|P2|STARTED|Part 4||0
4931194|NCT03170544|12129655|P1|STARTED|Part 4||0
4931195|NCT03170544|12129644|P12|NOT COMPLETED|Part 3||0
4931196|NCT03170544|12129645|P11|NOT COMPLETED|Part 3||0
4931197|NCT03170544|12129646|P10|NOT COMPLETED|Part 3||0
4931198|NCT03170544|12129647|P9|NOT COMPLETED|Part 3||0
4931199|NCT03170544|12129648|P8|NOT COMPLETED|Part 3||0
4931200|NCT03170544|12129649|P7|NOT COMPLETED|Part 3||0
4931201|NCT03170544|12129650|P6|NOT COMPLETED|Part 3||0
4931202|NCT03170544|12129651|P5|NOT COMPLETED|Part 3||0
4931203|NCT03170544|12129652|P4|NOT COMPLETED|Part 3||0
4931204|NCT03170544|12129653|P3|NOT COMPLETED|Part 3||0
4931205|NCT03170544|12129654|P2|NOT COMPLETED|Part 3||0
4931206|NCT03170544|12129655|P1|NOT COMPLETED|Part 3||0
4931207|NCT03170544|12129644|P12|COMPLETED|Part 3||0
4931208|NCT03170544|12129645|P11|COMPLETED|Part 3||0
4931209|NCT03170544|12129646|P10|COMPLETED|Part 3||6
4931210|NCT03170544|12129647|P9|COMPLETED|Part 3||6
4931211|NCT03170544|12129648|P8|COMPLETED|Part 3||4
4931212|NCT03170544|12129649|P7|COMPLETED|Part 3||0
4931213|NCT03170544|12129650|P6|COMPLETED|Part 3||0
4931214|NCT03170544|12129651|P5|COMPLETED|Part 3||0
4931215|NCT03170544|12129652|P4|COMPLETED|Part 3||0
4931216|NCT03170544|12129653|P3|COMPLETED|Part 3||0
4931217|NCT03170544|12129654|P2|COMPLETED|Part 3||0
4931218|NCT03170544|12129655|P1|COMPLETED|Part 3||0
4931219|NCT03170544|12129644|P12|STARTED|Part 3||0
4931220|NCT03170544|12129645|P11|STARTED|Part 3||0
4931221|NCT03170544|12129646|P10|STARTED|Part 3||6
4931222|NCT03170544|12129647|P9|STARTED|Part 3||6
4931223|NCT03170544|12129648|P8|STARTED|Part 3||4
4931224|NCT03170544|12129649|P7|STARTED|Part 3||0
4931225|NCT03170544|12129650|P6|STARTED|Part 3||0
4931226|NCT03170544|12129651|P5|STARTED|Part 3||0
4931227|NCT03170544|12129652|P4|STARTED|Part 3||0
4931228|NCT03170544|12129653|P3|STARTED|Part 3||0
4931229|NCT03170544|12129654|P2|STARTED|Part 3||0
4931230|NCT03170544|12129655|P1|STARTED|Part 3||0
4931231|NCT03170544|12129644|P12|NOT COMPLETED|Part 2||0
4931232|NCT03170544|12129645|P11|NOT COMPLETED|Part 2||0
4931233|NCT03170544|12129646|P10|NOT COMPLETED|Part 2||0
4931234|NCT03170544|12129647|P9|NOT COMPLETED|Part 2||0
4931235|NCT03170544|12129648|P8|NOT COMPLETED|Part 2||0
4931236|NCT03170544|12129649|P7|NOT COMPLETED|Part 2||0
4931237|NCT03170544|12129650|P6|NOT COMPLETED|Part 2||0
4931238|NCT03170544|12129651|P5|NOT COMPLETED|Part 2||0
4931239|NCT03170544|12129652|P4|NOT COMPLETED|Part 2||0
4931240|NCT03170544|12129653|P3|NOT COMPLETED|Part 2||0
4931241|NCT03170544|12129654|P2|NOT COMPLETED|Part 2||0
4931242|NCT03170544|12129655|P1|NOT COMPLETED|Part 2||0
4931243|NCT03170544|12129644|P12|COMPLETED|Part 2||0
4931244|NCT03170544|12129645|P11|COMPLETED|Part 2||0
4931245|NCT03170544|12129646|P10|COMPLETED|Part 2||0
4931246|NCT03170544|12129647|P9|COMPLETED|Part 2||0
4931247|NCT03170544|12129648|P8|COMPLETED|Part 2||0
4931248|NCT03170544|12129649|P7|COMPLETED|Part 2||4
4931249|NCT03170544|12129650|P6|COMPLETED|Part 2||0
4931250|NCT03170544|12129651|P5|COMPLETED|Part 2||0
4931251|NCT03170544|12129652|P4|COMPLETED|Part 2||0
4931252|NCT03170544|12129653|P3|COMPLETED|Part 2||0
4931253|NCT03170544|12129654|P2|COMPLETED|Part 2||0
4931254|NCT03170544|12129655|P1|COMPLETED|Part 2||0
4931255|NCT03170544|12129644|P12|STARTED|Part 2||0
4931256|NCT03170544|12129645|P11|STARTED|Part 2||0
4931257|NCT03170544|12129646|P10|STARTED|Part 2||0
4931258|NCT03170544|12129647|P9|STARTED|Part 2||0
4931259|NCT03170544|12129648|P8|STARTED|Part 2||0
4931260|NCT03170544|12129649|P7|STARTED|Part 2||4
4931261|NCT03170544|12129650|P6|STARTED|Part 2||0
4931262|NCT03170544|12129651|P5|STARTED|Part 2||0
4931263|NCT03170544|12129652|P4|STARTED|Part 2||0
4931264|NCT03170544|12129653|P3|STARTED|Part 2||0
4931265|NCT03170544|12129654|P2|STARTED|Part 2||0
4931266|NCT03170544|12129655|P1|STARTED|Part 2||0
4931267|NCT03170544|12129644|P12|NOT COMPLETED|Part 1||0
4931268|NCT03170544|12129645|P11|NOT COMPLETED|Part 1||0
4931269|NCT03170544|12129646|P10|NOT COMPLETED|Part 1||0
4931270|NCT03170544|12129647|P9|NOT COMPLETED|Part 1||0
4931271|NCT03170544|12129648|P8|NOT COMPLETED|Part 1||0
4931272|NCT03170544|12129649|P7|NOT COMPLETED|Part 1||0
4931273|NCT03170544|12129650|P6|NOT COMPLETED|Part 1||0
4931274|NCT03170544|12129651|P5|NOT COMPLETED|Part 1||0
4931275|NCT03170544|12129652|P4|NOT COMPLETED|Part 1||1
4931276|NCT03170544|12129653|P3|NOT COMPLETED|Part 1||0
4931277|NCT03170544|12129654|P2|NOT COMPLETED|Part 1||0
4931278|NCT03170544|12129655|P1|NOT COMPLETED|Part 1||1
4931279|NCT03170544|12129644|P12|COMPLETED|Part 1||0
4931280|NCT03170544|12129645|P11|COMPLETED|Part 1||0
4931281|NCT03170544|12129646|P10|COMPLETED|Part 1||0
4931282|NCT03170544|12129647|P9|COMPLETED|Part 1||0
4931283|NCT03170544|12129648|P8|COMPLETED|Part 1||0
4931284|NCT03170544|12129649|P7|COMPLETED|Part 1||0
4931285|NCT03170544|12129650|P6|COMPLETED|Part 1||6
4931286|NCT03170544|12129651|P5|COMPLETED|Part 1||6
4931287|NCT03170544|12129652|P4|COMPLETED|Part 1||6
4931288|NCT03170544|12129653|P3|COMPLETED|Part 1||6
4931289|NCT03170544|12129654|P2|COMPLETED|Part 1||6
4931290|NCT03170544|12129655|P1|COMPLETED|Part 1||9
4931291|NCT03170544|12129644|P12|STARTED|Part 1||0
4931292|NCT03170544|12129645|P11|STARTED|Part 1||0
4931293|NCT03170544|12129646|P10|STARTED|Part 1||0
4931294|NCT03170544|12129647|P9|STARTED|Part 1||0
4931295|NCT03170544|12129648|P8|STARTED|Part 1||0
4931296|NCT03170544|12129649|P7|STARTED|Part 1||0
4931297|NCT03170544|12129650|P6|STARTED|Part 1||6
4931298|NCT03170544|12129651|P5|STARTED|Part 1||6
4931299|NCT03170544|12129652|P4|STARTED|Part 1||7
4931300|NCT03170544|12129653|P3|STARTED|Part 1||6
4931301|NCT03170544|12129654|P2|STARTED|Part 1||6
4931302|NCT03170544|12129655|P1|STARTED|Part 1||10
4931303|NCT03170232|12129819|P2|NOT COMPLETED|Overall Study||27
4931304|NCT03170232|12129820|P1|NOT COMPLETED|Overall Study||27
4931305|NCT03170232|12129819|P2|COMPLETED|Overall Study||0
4931306|NCT03170232|12129820|P1|COMPLETED|Overall Study||0
4931307|NCT03170232|12129819|P2|STARTED|Overall Study||27
4931308|NCT03170232|12129820|P1|STARTED|Overall Study||27
4931309|NCT03170219|12129866|P2|NOT COMPLETED|Overall Study||0
4931310|NCT03170219|12129867|P1|NOT COMPLETED|Overall Study||0
4931311|NCT03170219|12129866|P2|COMPLETED|Overall Study||4
4931312|NCT03170219|12129867|P1|COMPLETED|Overall Study||7
4931313|NCT03170219|12129866|P2|STARTED|Overall Study||4
4931314|NCT03170219|12129867|P1|STARTED|Overall Study||7
4931315|NCT03170193|12129898|P7|NOT COMPLETED|Overall Study||0
4931316|NCT03170193|12129899|P6|NOT COMPLETED|Overall Study||0
4931317|NCT03170193|12129900|P5|NOT COMPLETED|Overall Study||0
4931318|NCT03170193|12129901|P4|NOT COMPLETED|Overall Study||1
4931319|NCT03170193|12129902|P3|NOT COMPLETED|Overall Study||0
4931320|NCT03170193|12129903|P2|NOT COMPLETED|Overall Study||1
4931321|NCT03170193|12129904|P1|NOT COMPLETED|Overall Study||1
4931322|NCT03170193|12129898|P7|COMPLETED|Overall Study||6
4931323|NCT03170193|12129899|P6|COMPLETED|Overall Study||6
4931324|NCT03170193|12129900|P5|COMPLETED|Overall Study||6
4931325|NCT03170193|12129901|P4|COMPLETED|Overall Study||5
4931326|NCT03170193|12129902|P3|COMPLETED|Overall Study||6
4931327|NCT03170193|12129903|P2|COMPLETED|Overall Study||5
4931328|NCT03170193|12129904|P1|COMPLETED|Overall Study||11
4931329|NCT03170193|12129898|P7|STARTED|Overall Study||6
4931330|NCT03170193|12129899|P6|STARTED|Overall Study||6
4931331|NCT03170193|12129900|P5|STARTED|Overall Study||6
4931332|NCT03170193|12129901|P4|STARTED|Overall Study||6
4931333|NCT03170193|12129902|P3|STARTED|Overall Study||6
4931334|NCT03170193|12129903|P2|STARTED|Overall Study||6
4931335|NCT03170193|12129904|P1|STARTED|Overall Study||12
4931336|NCT03170154|12129973|P1|NOT COMPLETED|Overall Study||8
4931337|NCT03170154|12129973|P1|COMPLETED|Overall Study||342
4931338|NCT03170154|12129973|P1|Rotational Stability Sub-study|Overall Study||141
4931339|NCT03170154|12129973|P1|STARTED|Overall Study||350
4931340|NCT03169530|12129988|P2|NOT COMPLETED|Overall Study||17
4931341|NCT03169530|12129989|P1|NOT COMPLETED|Overall Study||15
4931342|NCT03169530|12129988|P2|COMPLETED|Overall Study||0
4931343|NCT03169530|12129989|P1|COMPLETED|Overall Study||0
4931344|NCT03169530|12129988|P2|STARTED|Overall Study||17
4931345|NCT03169530|12129989|P1|STARTED|Overall Study||15
4931346|NCT03169153|12130007|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
4931347|NCT03169153|12130008|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
4931348|NCT03169153|12130007|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
4931349|NCT03169153|12130008|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
4931442|NCT03166735|12130155|P5|NOT COMPLETED|Overall Study||4
4931350|NCT03169153|12130007|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
4931351|NCT03169153|12130008|P1|STARTED|Period 2, Second 30 Days of Wear||39
4931352|NCT03169153|12130007|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
4931353|NCT03169153|12130008|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
4931354|NCT03169153|12130007|P2|COMPLETED|Period 1, First 30 Days of Wear||35
4931355|NCT03169153|12130008|P1|COMPLETED|Period 1, First 30 Days of Wear||39
4931356|NCT03169153|12130007|P2|STARTED|Period 1, First 30 Days of Wear||39
4931357|NCT03169153|12130008|P1|STARTED|Period 1, First 30 Days of Wear||42
4931358|NCT03169062|12130014|P1|NOT COMPLETED|Overall Study||0
4931359|NCT03169062|12130014|P1|COMPLETED|Overall Study||10
4931360|NCT03169062|12130014|P1|STARTED|Overall Study||10
4931361|NCT03168919|12130019|P1|NOT COMPLETED|Overall Study||2
4931362|NCT03168919|12130019|P1|COMPLETED|Overall Study||3
4931363|NCT03168919|12130019|P1|STARTED|Overall Study||5
4931364|NCT03168906|12130029|P2|NOT COMPLETED|Overall Study||6
4931365|NCT03168906|12130030|P1|NOT COMPLETED|Overall Study||6
4931366|NCT03168906|12130029|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
4931367|NCT03168906|12130030|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
4931368|NCT03168906|12130029|P2|STARTED|Overall Study||6
4931369|NCT03168906|12130030|P1|STARTED|Overall Study||6
4931370|NCT03168841|12130038|P1|NOT COMPLETED|Overall Study||4
4931371|NCT03168841|12130038|P1|COMPLETED|Overall Study||36
4931372|NCT03168841|12130038|P1|STARTED|Overall Study||40
4931373|NCT03168542|12130043|P3|NOT COMPLETED|Overall Study||0
4931374|NCT03168542|12130044|P2|NOT COMPLETED|Overall Study||0
4931375|NCT03168542|12130045|P1|NOT COMPLETED|Overall Study||0
4931376|NCT03168542|12130043|P3|COMPLETED|Overall Study||9
4931377|NCT03168542|12130044|P2|COMPLETED|Overall Study||5
4931378|NCT03168542|12130045|P1|COMPLETED|Overall Study||7
4931379|NCT03168542|12130043|P3|STARTED|Overall Study||9
4931380|NCT03168542|12130044|P2|STARTED|Overall Study||5
4931381|NCT03168542|12130045|P1|STARTED|Overall Study||7
4931382|NCT03168425|12130062|P2|NOT COMPLETED|Overall Study||11
4931383|NCT03168425|12130063|P1|NOT COMPLETED|Overall Study||7
4931384|NCT03168425|12130062|P2|COMPLETED|Overall Study||85
4931385|NCT03168425|12130063|P1|COMPLETED|Overall Study||87
4931386|NCT03168425|12130062|P2|STARTED|Overall Study||96
4931387|NCT03168425|12130063|P1|STARTED|Overall Study||94
4931388|NCT03168308|12130073|P2|NOT COMPLETED|Overall Study||0
4931389|NCT03168308|12130074|P1|NOT COMPLETED|Overall Study||0
4931390|NCT03168308|12130073|P2|COMPLETED|Overall Study||44
4931391|NCT03168308|12130074|P1|COMPLETED|Overall Study||48
4931392|NCT03168308|12130073|P2|STARTED|Overall Study||44
4931393|NCT03168308|12130074|P1|STARTED|Overall Study||48
4931394|NCT03168295|12130087|P5|NOT COMPLETED|Overall Study||0
4931395|NCT03168295|12130088|P4|NOT COMPLETED|Overall Study||0
4931396|NCT03168295|12130089|P3|NOT COMPLETED|Overall Study||0
4931397|NCT03168295|12130090|P2|NOT COMPLETED|Overall Study||0
4931398|NCT03168295|12130091|P1|NOT COMPLETED|Overall Study||0
4931399|NCT03168295|12130087|P5|COMPLETED|Overall Study||20
4931400|NCT03168295|12130088|P4|COMPLETED|Overall Study||4
4931401|NCT03168295|12130089|P3|COMPLETED|Overall Study||4
4931402|NCT03168295|12130090|P2|COMPLETED|Overall Study||3
4931403|NCT03168295|12130091|P1|COMPLETED|Overall Study||3
4931404|NCT03168295|12130087|P5|STARTED|Overall Study||20
4931405|NCT03168295|12130088|P4|STARTED|Overall Study||4
4931406|NCT03168295|12130089|P3|STARTED|Overall Study||4
4931407|NCT03168295|12130090|P2|STARTED|Overall Study||3
4931408|NCT03168295|12130091|P1|STARTED|Overall Study||3
4931409|NCT03168022|12130105|P2|NOT COMPLETED|Overall Study||1
4931410|NCT03168022|12130106|P1|NOT COMPLETED|Overall Study||0
4931411|NCT03168022|12130105|P2|COMPLETED|Overall Study||21
4931412|NCT03168022|12130106|P1|COMPLETED|Overall Study||21
4931413|NCT03168022|12130105|P2|STARTED|Overall Study||22
4931414|NCT03168022|12130106|P1|STARTED|Overall Study||21
4931415|NCT03167541|12130114|P2|NOT COMPLETED|Second Intervention||0
4931416|NCT03167541|12130115|P1|NOT COMPLETED|Second Intervention||0
4931417|NCT03167541|12130114|P2|COMPLETED|Second Intervention||9
4931418|NCT03167541|12130115|P1|COMPLETED|Second Intervention||9
4931419|NCT03167541|12130114|P2|STARTED|Second Intervention||9
4931420|NCT03167541|12130115|P1|STARTED|Second Intervention||9
4931421|NCT03167541|12130114|P2|NOT COMPLETED|Washout: 5-8 Days||0
4931422|NCT03167541|12130115|P1|NOT COMPLETED|Washout: 5-8 Days||0
4931423|NCT03167541|12130114|P2|COMPLETED|Washout: 5-8 Days||9
4931424|NCT03167541|12130115|P1|COMPLETED|Washout: 5-8 Days||9
4931425|NCT03167541|12130114|P2|STARTED|Washout: 5-8 Days||9
4931426|NCT03167541|12130115|P1|STARTED|Washout: 5-8 Days||9
4931427|NCT03167541|12130114|P2|NOT COMPLETED|First Intervention||0
4931428|NCT03167541|12130115|P1|NOT COMPLETED|First Intervention||0
4931429|NCT03167541|12130114|P2|COMPLETED|First Intervention||9
4931430|NCT03167541|12130115|P1|COMPLETED|First Intervention||9
4931431|NCT03167541|12130114|P2|STARTED|First Intervention||9
4931432|NCT03167541|12130115|P1|STARTED|First Intervention||9
4931433|NCT03167151|12130140|P3|NOT COMPLETED|Overall Study||1
4931434|NCT03167151|12130141|P2|NOT COMPLETED|Overall Study||1
4931435|NCT03167151|12130142|P1|NOT COMPLETED|Overall Study||1
4931436|NCT03167151|12130140|P3|COMPLETED|Overall Study||2
4931437|NCT03167151|12130141|P2|COMPLETED|Overall Study||2
4931438|NCT03167151|12130142|P1|COMPLETED|Overall Study||2
4931439|NCT03167151|12130140|P3|STARTED|Overall Study||3
4931440|NCT03167151|12130141|P2|STARTED|Overall Study||3
4931441|NCT03167151|12130142|P1|STARTED|Overall Study||3
4931443|NCT03166735|12130156|P4|NOT COMPLETED|Overall Study||1
4931444|NCT03166735|12130157|P3|NOT COMPLETED|Overall Study||3
4931445|NCT03166735|12130158|P2|NOT COMPLETED|Overall Study||3
4931446|NCT03166735|12130159|P1|NOT COMPLETED|Overall Study||1
4931447|NCT03166735|12130155|P5|COMPLETED|Overall Study||28
4931448|NCT03166735|12130156|P4|COMPLETED|Overall Study||16
4931449|NCT03166735|12130157|P3|COMPLETED|Overall Study||13
4931450|NCT03166735|12130158|P2|COMPLETED|Overall Study||13
4931451|NCT03166735|12130159|P1|COMPLETED|Overall Study||32
4931452|NCT03166735|12130155|P5|Treated|Overall Study||32
4931453|NCT03166735|12130156|P4|Treated|Overall Study||17
4931454|NCT03166735|12130157|P3|Treated|Overall Study||16
4931455|NCT03166735|12130158|P2|Treated|Overall Study||16
4931456|NCT03166735|12130159|P1|Treated|Overall Study||32
4931457|NCT03166735|12130155|P5|STARTED|Overall Study||32
4931458|NCT03166735|12130156|P4|STARTED|Overall Study||17
4931459|NCT03166735|12130157|P3|STARTED|Overall Study||16
4931460|NCT03166735|12130158|P2|STARTED|Overall Study||16
4931461|NCT03166735|12130159|P1|STARTED|Overall Study||33
4931462|NCT03166618|12130209|P2|NOT COMPLETED|Overall Study||1
4931463|NCT03166618|12130210|P1|NOT COMPLETED|Overall Study||0
4931464|NCT03166618|12130209|P2|COMPLETED|Overall Study||0
4931465|NCT03166618|12130210|P1|COMPLETED|Overall Study||0
4931466|NCT03166618|12130209|P2|STARTED|Overall Study||1
4931467|NCT03166618|12130210|P1|STARTED|Overall Study||0
4931468|NCT03166215|12130222|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
4931469|NCT03166215|12130223|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931470|NCT03166215|12130224|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931471|NCT03166215|12130222|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
4931472|NCT03166215|12130223|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931473|NCT03166215|12130224|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931474|NCT03166215|12130222|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
4931475|NCT03166215|12130223|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931476|NCT03166215|12130224|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
4931477|NCT03166215|12130222|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
4931478|NCT03166215|12130223|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
4931479|NCT03166215|12130224|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
4931480|NCT03166215|12130222|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
4931481|NCT03166215|12130223|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
4931482|NCT03166215|12130224|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
4931483|NCT03166215|12130222|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
4931484|NCT03166215|12130223|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
4931485|NCT03166215|12130224|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
4931486|NCT03166124|12130264|P4|NOT COMPLETED|Treatment Period 2||0
4931487|NCT03166124|12130265|P3|NOT COMPLETED|Treatment Period 2||0
4931488|NCT03166124|12130266|P2|NOT COMPLETED|Treatment Period 2||0
4931489|NCT03166124|12130267|P1|NOT COMPLETED|Treatment Period 2||0
4931490|NCT03166124|12130264|P4|COMPLETED|Treatment Period 2||20
4931491|NCT03166124|12130265|P3|COMPLETED|Treatment Period 2||17
4931492|NCT03166124|12130266|P2|COMPLETED|Treatment Period 2||18
4931493|NCT03166124|12130267|P1|COMPLETED|Treatment Period 2||20
4931494|NCT03166124|12130264|P4|STARTED|Treatment Period 2||20
4931495|NCT03166124|12130265|P3|STARTED|Treatment Period 2||17
4931496|NCT03166124|12130266|P2|STARTED|Treatment Period 2||18
4931497|NCT03166124|12130267|P1|STARTED|Treatment Period 2||20
4931498|NCT03166124|12130264|P4|NOT COMPLETED|Wash-out Period||1
4931499|NCT03166124|12130265|P3|NOT COMPLETED|Wash-out Period||1
4931500|NCT03166124|12130266|P2|NOT COMPLETED|Wash-out Period||2
4931501|NCT03166124|12130267|P1|NOT COMPLETED|Wash-out Period||0
4931502|NCT03166124|12130264|P4|COMPLETED|Wash-out Period||20
4931503|NCT03166124|12130265|P3|COMPLETED|Wash-out Period||17
4931504|NCT03166124|12130266|P2|COMPLETED|Wash-out Period||18
4931505|NCT03166124|12130267|P1|COMPLETED|Wash-out Period||20
4931506|NCT03166124|12130264|P4|STARTED|Wash-out Period||21
4931507|NCT03166124|12130265|P3|STARTED|Wash-out Period||18
4931508|NCT03166124|12130266|P2|STARTED|Wash-out Period||20
4931509|NCT03166124|12130267|P1|STARTED|Wash-out Period||20
4931510|NCT03166124|12130264|P4|NOT COMPLETED|Treatment Period 1||0
4931511|NCT03166124|12130265|P3|NOT COMPLETED|Treatment Period 1||1
4931512|NCT03166124|12130266|P2|NOT COMPLETED|Treatment Period 1||0
4931513|NCT03166124|12130267|P1|NOT COMPLETED|Treatment Period 1||0
4931514|NCT03166124|12130264|P4|COMPLETED|Treatment Period 1||21
4931515|NCT03166124|12130265|P3|COMPLETED|Treatment Period 1||18
4931516|NCT03166124|12130266|P2|COMPLETED|Treatment Period 1||20
4931517|NCT03166124|12130267|P1|COMPLETED|Treatment Period 1||20
4931518|NCT03166124|12130264|P4|Received at Least One Dose of Study Drug|Treatment Period 1||21
4931519|NCT03166124|12130265|P3|Received at Least One Dose of Study Drug|Treatment Period 1||18
4931520|NCT03166124|12130266|P2|Received at Least One Dose of Study Drug|Treatment Period 1||20
4931521|NCT03166124|12130267|P1|Received at Least One Dose of Study Drug|Treatment Period 1||20
4931522|NCT03166124|12130264|P4|STARTED|Treatment Period 1||21
4931523|NCT03166124|12130265|P3|STARTED|Treatment Period 1||19
4931524|NCT03166124|12130266|P2|STARTED|Treatment Period 1||20
4931525|NCT03166124|12130267|P1|STARTED|Treatment Period 1||20
4931526|NCT03165981|12130283|P2|NOT COMPLETED|Overall Study||4
4931527|NCT03165981|12130284|P1|NOT COMPLETED|Overall Study||11
4931528|NCT03165981|12130283|P2|COMPLETED|Overall Study||107
4931529|NCT03165981|12130284|P1|COMPLETED|Overall Study||99
4931530|NCT03165981|12130283|P2|Per Protocol Population|Overall Study||107
4931531|NCT03165981|12130284|P1|Per Protocol Population|Overall Study||99
4931532|NCT03165981|12130283|P2|STARTED|Overall Study||111
4931533|NCT03165981|12130284|P1|STARTED|Overall Study||110
4931534|NCT03165955|12130312|P1|NOT COMPLETED|Treatment||8
4931535|NCT03165955|12130312|P1|COMPLETED|Treatment||20
4931536|NCT03165955|12130312|P1|STARTED|Treatment||28
4931537|NCT03165955|12130312|P1|NOT COMPLETED|Screening/Baseline||3
4931538|NCT03165955|12130312|P1|COMPLETED|Screening/Baseline||28
4931539|NCT03165955|12130312|P1|STARTED|Screening/Baseline||31
4931540|NCT03165916|12130331|P2|NOT COMPLETED|Overall Study||0
4931541|NCT03165916|12130332|P1|NOT COMPLETED|Overall Study||0
4931542|NCT03165916|12130331|P2|COMPLETED|Overall Study||57
4931543|NCT03165916|12130332|P1|COMPLETED|Overall Study||58
4931544|NCT03165916|12130331|P2|Reconstruction Interventions|Overall Study||57
4931545|NCT03165916|12130332|P1|Reconstruction Interventions|Overall Study||59
4931546|NCT03165916|12130331|P2|STARTED|Overall Study||57
4931547|NCT03165916|12130332|P1|STARTED|Overall Study||58
4931548|NCT03165747|12130340|P2|NOT COMPLETED|Overall Study||0
4931549|NCT03165747|12130341|P1|NOT COMPLETED|Overall Study||0
4931550|NCT03165747|12130340|P2|COMPLETED|Overall Study||0
4931551|NCT03165747|12130341|P1|COMPLETED|Overall Study||0
4931552|NCT03165747|12130340|P2|STARTED|Overall Study||0
4931553|NCT03165747|12130341|P1|STARTED|Overall Study||0
4931554|NCT03165175|12130369|P2|NOT COMPLETED|Baseline to 3-month||0
4931555|NCT03165175|12130370|P1|NOT COMPLETED|Baseline to 3-month||4
4931556|NCT03165175|12130369|P2|COMPLETED|Baseline to 3-month||39
4931557|NCT03165175|12130370|P1|COMPLETED|Baseline to 3-month||31
4931558|NCT03165175|12130369|P2|STARTED|Baseline to 3-month||39
4931559|NCT03165175|12130370|P1|STARTED|Baseline to 3-month||35
4931560|NCT03165175|12130369|P2|NOT COMPLETED|1-month to 3-month||0
4931561|NCT03165175|12130370|P1|NOT COMPLETED|1-month to 3-month||6
4931562|NCT03165175|12130369|P2|COMPLETED|1-month to 3-month||39
4931563|NCT03165175|12130370|P1|COMPLETED|1-month to 3-month||35
4931564|NCT03165175|12130369|P2|STARTED|1-month to 3-month||39
4931565|NCT03165175|12130370|P1|STARTED|1-month to 3-month||41
4931566|NCT03165110|12130384|P1|NOT COMPLETED|Overall Study||1
4931567|NCT03165110|12130384|P1|COMPLETED|Overall Study||46
4931568|NCT03165110|12130384|P1|STARTED|Overall Study||47
4931569|NCT03165058|12130398|P2|NOT COMPLETED|Overall Study||0
4931570|NCT03165058|12130399|P1|NOT COMPLETED|Overall Study||0
4931571|NCT03165058|12130398|P2|COMPLETED|Overall Study||11
4931572|NCT03165058|12130399|P1|COMPLETED|Overall Study||21
4931573|NCT03165058|12130398|P2|STARTED|Overall Study||11
4931574|NCT03165058|12130399|P1|STARTED|Overall Study||21
4931575|NCT03165045|12130406|P1|NOT COMPLETED|Visit 2||182
4931576|NCT03165045|12130406|P1|COMPLETED|Visit 2||1140
4931577|NCT03165045|12130406|P1|STARTED|Visit 2||1322
4931578|NCT03165045|12130406|P1|NOT COMPLETED|Visit 1||29
4931579|NCT03165045|12130406|P1|COMPLETED|Visit 1||1322
4931580|NCT03165045|12130406|P1|STARTED|Visit 1||1351
4931581|NCT03164629|12130417|P2|NOT COMPLETED|Overall Study||0
4931582|NCT03164629|12130418|P1|NOT COMPLETED|Overall Study||0
4931583|NCT03164629|12130417|P2|COMPLETED|Overall Study||25
4931584|NCT03164629|12130418|P1|COMPLETED|Overall Study||25
4931585|NCT03164629|12130417|P2|STARTED|Overall Study||25
4931586|NCT03164629|12130418|P1|STARTED|Overall Study||25
4931587|NCT03163758|12130426|P2|NOT COMPLETED|Overall Study||7
4931588|NCT03163758|12130427|P1|NOT COMPLETED|Overall Study||8
4931589|NCT03163758|12130426|P2|COMPLETED|Overall Study||14
4931590|NCT03163758|12130427|P1|COMPLETED|Overall Study||13
4931591|NCT03163758|12130426|P2|STARTED|Overall Study||21
4931592|NCT03163758|12130427|P1|STARTED|Overall Study||21
4931593|NCT03163342|12130439|P1|NOT COMPLETED|Overall Study||0
4931594|NCT03163342|12130439|P1|COMPLETED|Overall Study||20
4931595|NCT03163342|12130439|P1|STARTED|Overall Study||20
4931596|NCT03163134|12130448|P2|NOT COMPLETED|Overall Study||0
4931597|NCT03163134|12130449|P1|NOT COMPLETED|Overall Study||0
4931598|NCT03163134|12130448|P2|COMPLETED|Overall Study||85
4931599|NCT03163134|12130449|P1|COMPLETED|Overall Study||85
4931600|NCT03163134|12130448|P2|STARTED|Overall Study||85
4931601|NCT03163134|12130449|P1|STARTED|Overall Study||85
4931602|NCT03163017|12130457|P1|NOT COMPLETED|Overall Study||0
4931603|NCT03163017|12130457|P1|COMPLETED|Overall Study||30
4931604|NCT03163017|12130457|P1|STARTED|Overall Study||30
4931605|NCT03162614|12130479|P6|NOT COMPLETED|Overall Study||0
4931606|NCT03162614|12130480|P5|NOT COMPLETED|Overall Study||5
4931607|NCT03162614|12130481|P4|NOT COMPLETED|Overall Study||7
4931608|NCT03162614|12130482|P3|NOT COMPLETED|Overall Study||4
4931609|NCT03162614|12130483|P2|NOT COMPLETED|Overall Study||5
4931610|NCT03162614|12130484|P1|NOT COMPLETED|Overall Study||6
4931611|NCT03162614|12130479|P6|COMPLETED|Overall Study||24
4931612|NCT03162614|12130480|P5|COMPLETED|Overall Study||21
4931613|NCT03162614|12130481|P4|COMPLETED|Overall Study||19
4931614|NCT03162614|12130482|P3|COMPLETED|Overall Study||22
4931615|NCT03162614|12130483|P2|COMPLETED|Overall Study||21
4931616|NCT03162614|12130484|P1|COMPLETED|Overall Study||20
4931617|NCT03162614|12130479|P6|STARTED|Overall Study||24
4931618|NCT03162614|12130480|P5|STARTED|Overall Study||26
4931619|NCT03162614|12130481|P4|STARTED|Overall Study||26
4931620|NCT03162614|12130482|P3|STARTED|Overall Study||26
4931621|NCT03162614|12130483|P2|STARTED|Overall Study||26
4931622|NCT03162614|12130484|P1|STARTED|Overall Study||26
4931623|NCT03162458|12130578|P2|NOT COMPLETED|Overall Study||0
4931624|NCT03162458|12130579|P1|NOT COMPLETED|Overall Study||0
4931625|NCT03162458|12130578|P2|COMPLETED|Overall Study||71
4931626|NCT03162458|12130579|P1|COMPLETED|Overall Study||71
4931627|NCT03162458|12130578|P2|STARTED|Overall Study||71
4931628|NCT03162458|12130579|P1|STARTED|Overall Study||71
4931629|NCT03162328|12130603|P3|NOT COMPLETED|Study Period||1
4931630|NCT03162328|12130604|P2|NOT COMPLETED|Study Period||0
4931631|NCT03162328|12130605|P1|NOT COMPLETED|Study Period||0
4931632|NCT03162328|12130603|P3|COMPLETED|Study Period||31
4931633|NCT03162328|12130604|P2|COMPLETED|Study Period||30
4931634|NCT03162328|12130605|P1|COMPLETED|Study Period||0
4931635|NCT03162328|12130603|P3|STARTED|Study Period||32
4931636|NCT03162328|12130604|P2|STARTED|Study Period||30
4931637|NCT03162328|12130605|P1|STARTED|Study Period||0
4931638|NCT03162328|12130603|P3|NOT COMPLETED|Screening Period||0
4931639|NCT03162328|12130604|P2|NOT COMPLETED|Screening Period||0
4931640|NCT03162328|12130605|P1|NOT COMPLETED|Screening Period||22
4931641|NCT03162328|12130603|P3|COMPLETED|Screening Period||0
4931642|NCT03162328|12130604|P2|COMPLETED|Screening Period||0
4931643|NCT03162328|12130605|P1|COMPLETED|Screening Period||62
4931644|NCT03162328|12130603|P3|STARTED|Screening Period||0
4931645|NCT03162328|12130604|P2|STARTED|Screening Period||0
4931646|NCT03162328|12130605|P1|STARTED|Screening Period||84
4931647|NCT03162055|12130634|P2|NOT COMPLETED|Overall Study||43
4931648|NCT03162055|12130635|P1|NOT COMPLETED|Overall Study||62
4931649|NCT03162055|12130634|P2|COMPLETED|Overall Study||517
4931650|NCT03162055|12130635|P1|COMPLETED|Overall Study||497
4931651|NCT03162055|12130634|P2|Per Protocol (PP) Analysis Set|Overall Study||510
4931652|NCT03162055|12130635|P1|Per Protocol (PP) Analysis Set|Overall Study||506
4931653|NCT03162055|12130634|P2|Full Analysis Set (FAS)|Overall Study||552
4931654|NCT03162055|12130635|P1|Full Analysis Set (FAS)|Overall Study||552
4931655|NCT03162055|12130634|P2|Safety Analysis Set|Overall Study||552
4931656|NCT03162055|12130635|P1|Safety Analysis Set|Overall Study||552
4931657|NCT03162055|12130634|P2|Received Treatment|Overall Study||560
4931658|NCT03162055|12130635|P1|Received Treatment|Overall Study||557
4931659|NCT03162055|12130634|P2|STARTED|Overall Study||560
4931660|NCT03162055|12130635|P1|STARTED|Overall Study||559
4931661|NCT03161938|12130661|P2|NOT COMPLETED|Overall Study||0
4931662|NCT03161938|12130662|P1|NOT COMPLETED|Overall Study||0
4931663|NCT03161938|12130661|P2|COMPLETED|Overall Study||32
4931664|NCT03161938|12130662|P1|COMPLETED|Overall Study||32
4931665|NCT03161938|12130661|P2|STARTED|Overall Study||32
4931666|NCT03161938|12130662|P1|STARTED|Overall Study||32
4931667|NCT03161405|12130688|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
4931668|NCT03161405|12130688|P1|COMPLETED|Second Intervention Period (6 Days)||11
4931669|NCT03161405|12130688|P1|STARTED|Second Intervention Period (6 Days)||12
4931670|NCT03161405|12130688|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
4931671|NCT03161405|12130688|P1|COMPLETED|Washout Period (at Least 4 Days)||12
4931672|NCT03161405|12130688|P1|STARTED|Washout Period (at Least 4 Days)||12
4931673|NCT03161405|12130688|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
4931674|NCT03161405|12130688|P1|COMPLETED|First Intervention Period (3 Days)||12
4931675|NCT03161405|12130688|P1|STARTED|First Intervention Period (3 Days)||12
4931676|NCT03161327|12130699|P1|NOT COMPLETED|Overall Study||0
4931677|NCT03161327|12130699|P1|COMPLETED|Overall Study||238
4931678|NCT03161327|12130699|P1|STARTED|Overall Study||238
4931679|NCT03160716|12130704|P1|NOT COMPLETED|Overall Study||1
4931680|NCT03160716|12130704|P1|COMPLETED|Overall Study||59
4931681|NCT03160716|12130704|P1|STARTED|Overall Study||60
4931682|NCT03160703|12130715|P4|NOT COMPLETED|Overall Study||1
4931683|NCT03160703|12130716|P3|NOT COMPLETED|Overall Study||0
4931684|NCT03160703|12130717|P2|NOT COMPLETED|Overall Study||0
4931685|NCT03160703|12130718|P1|NOT COMPLETED|Overall Study||0
4931686|NCT03160703|12130715|P4|COMPLETED|Overall Study||54
4931687|NCT03160703|12130716|P3|COMPLETED|Overall Study||55
4931688|NCT03160703|12130717|P2|COMPLETED|Overall Study||55
4931689|NCT03160703|12130718|P1|COMPLETED|Overall Study||55
4931690|NCT03160703|12130715|P4|STARTED|Overall Study||55
4931691|NCT03160703|12130716|P3|STARTED|Overall Study||55
4931692|NCT03160703|12130717|P2|STARTED|Overall Study||55
4931693|NCT03160703|12130718|P1|STARTED|Overall Study||55
4931694|NCT03160170|12130730|P2|NOT COMPLETED|Overall Study||0
4931695|NCT03160170|12130731|P1|NOT COMPLETED|Overall Study||0
4931696|NCT03160170|12130730|P2|COMPLETED|Overall Study||10
4931697|NCT03160170|12130731|P1|COMPLETED|Overall Study||10
4931698|NCT03160170|12130730|P2|STARTED|Overall Study||10
4931699|NCT03160170|12130731|P1|STARTED|Overall Study||10
4931700|NCT03160027|12130745|P4|NOT COMPLETED|Overall Study||0
4931701|NCT03160027|12130746|P3|NOT COMPLETED|Overall Study||0
4931702|NCT03160027|12130747|P2|NOT COMPLETED|Overall Study||0
4931703|NCT03160027|12130748|P1|NOT COMPLETED|Overall Study||0
4931704|NCT03160027|12130745|P4|COMPLETED|Overall Study||4
4931705|NCT03160027|12130746|P3|COMPLETED|Overall Study||6
4931706|NCT03160027|12130747|P2|COMPLETED|Overall Study||4
4931707|NCT03160027|12130748|P1|COMPLETED|Overall Study||6
4931708|NCT03160027|12130745|P4|STARTED|Overall Study||4
4931709|NCT03160027|12130746|P3|STARTED|Overall Study||6
4931710|NCT03160027|12130747|P2|STARTED|Overall Study||4
4931711|NCT03160027|12130748|P1|STARTED|Overall Study||6
4931712|NCT03159624|12130783|P2|NOT COMPLETED|Overall Study||1
4931713|NCT03159624|12130784|P1|NOT COMPLETED|Overall Study||0
4931714|NCT03159624|12130783|P2|COMPLETED|Overall Study||25
4931715|NCT03159624|12130784|P1|COMPLETED|Overall Study||21
4931716|NCT03159624|12130783|P2|STARTED|Overall Study||26
4931717|NCT03159624|12130784|P1|STARTED|Overall Study||21
4931718|NCT03159611|12130796|P2|NOT COMPLETED|Overall Study||15
4931719|NCT03159611|12130797|P1|NOT COMPLETED|Overall Study||23
4931720|NCT03159611|12130796|P2|COMPLETED|Overall Study||72
4931721|NCT03159611|12130797|P1|COMPLETED|Overall Study||72
4931722|NCT03159611|12130796|P2|STARTED|Overall Study||87
4931723|NCT03159611|12130797|P1|STARTED|Overall Study||95
4931724|NCT03159468|12130817|P6|NOT COMPLETED|Overall Study||0
4931725|NCT03159468|12130818|P5|NOT COMPLETED|Overall Study||0
4931726|NCT03159468|12130819|P4|NOT COMPLETED|Overall Study||0
4931727|NCT03159468|12130820|P3|NOT COMPLETED|Overall Study||3
4931728|NCT03159468|12130821|P2|NOT COMPLETED|Overall Study||0
4931729|NCT03159468|12130822|P1|NOT COMPLETED|Overall Study||0
4931730|NCT03159468|12130817|P6|COMPLETED|Overall Study||34
4931731|NCT03159468|12130818|P5|COMPLETED|Overall Study||34
4931732|NCT03159468|12130819|P4|COMPLETED|Overall Study||34
4931733|NCT03159468|12130820|P3|COMPLETED|Overall Study||34
4931734|NCT03159468|12130821|P2|COMPLETED|Overall Study||35
4931735|NCT03159468|12130822|P1|COMPLETED|Overall Study||35
4931736|NCT03159468|12130817|P6|STARTED|Overall Study||34
4931737|NCT03159468|12130818|P5|STARTED|Overall Study||34
4931738|NCT03159468|12130819|P4|STARTED|Overall Study||34
4931739|NCT03159468|12130820|P3|STARTED|Overall Study||37
4931740|NCT03159468|12130821|P2|STARTED|Overall Study||35
4931741|NCT03159468|12130822|P1|STARTED|Overall Study||35
4931742|NCT03159299|12130838|P2|NOT COMPLETED|Overall Study||1
4931743|NCT03159299|12130839|P1|NOT COMPLETED|Overall Study||2
4931744|NCT03159299|12130838|P2|COMPLETED|Overall Study||20
4931745|NCT03159299|12130839|P1|COMPLETED|Overall Study||24
4931746|NCT03159299|12130838|P2|STARTED|Overall Study||21
4931747|NCT03159299|12130839|P1|STARTED|Overall Study||26
4931748|NCT03159260|12130847|P2|NOT COMPLETED|Overall Study||4
4931749|NCT03159260|12130848|P1|NOT COMPLETED|Overall Study||3
4931750|NCT03159260|12130847|P2|COMPLETED|Overall Study||25
4931751|NCT03159260|12130848|P1|COMPLETED|Overall Study||25
4931752|NCT03159260|12130847|P2|STARTED|Overall Study||29
4931753|NCT03159260|12130848|P1|STARTED|Overall Study||28
4931754|NCT03159143|12130862|P1|NOT COMPLETED|Overall Study||0
4931755|NCT03159143|12130862|P1|COMPLETED|Overall Study||22
4931756|NCT03159143|12130862|P1|STARTED|Overall Study||22
4931757|NCT03158220|12130871|P2|NOT COMPLETED|Overall Study||16
4931758|NCT03158220|12130872|P1|NOT COMPLETED|Overall Study||17
4931759|NCT03158220|12130871|P2|COMPLETED|Overall Study||626
4931760|NCT03158220|12130872|P1|COMPLETED|Overall Study||553
4931761|NCT03158220|12130871|P2|Vaccination 3|Overall Study||629
4931762|NCT03158220|12130872|P1|Vaccination 3|Overall Study||556
4931763|NCT03158220|12130871|P2|Vaccination 2|Overall Study||635
4931764|NCT03158220|12130872|P1|Vaccination 2|Overall Study||563
4931765|NCT03158220|12130871|P2|Vaccination 1|Overall Study||640
4931766|NCT03158220|12130872|P1|Vaccination 1|Overall Study||570
4931767|NCT03158220|12130871|P2|STARTED|Overall Study||642
4931768|NCT03158220|12130872|P1|STARTED|Overall Study||570
4931769|NCT03158038|12130892|P2|NOT COMPLETED|Overall Study||0
4931770|NCT03158038|12130893|P1|NOT COMPLETED|Overall Study||0
4931771|NCT03158038|12130892|P2|COMPLETED|Overall Study||60
4931772|NCT03158038|12130893|P1|COMPLETED|Overall Study||240
4931773|NCT03158038|12130892|P2|STARTED|Overall Study||60
4931774|NCT03158038|12130893|P1|STARTED|Overall Study||240
4931775|NCT03158012|12130909|P2|NOT COMPLETED|Overall Study||1
4931776|NCT03158012|12130910|P1|NOT COMPLETED|Overall Study||0
4931777|NCT03158012|12130909|P2|COMPLETED|Overall Study||6
4931778|NCT03158012|12130910|P1|COMPLETED|Overall Study||8
4931779|NCT03158012|12130909|P2|STARTED|Overall Study||7
4931780|NCT03158012|12130910|P1|STARTED|Overall Study||8
4931781|NCT03157583|12130916|P1|NOT COMPLETED|Overall Study||1
4931782|NCT03157583|12130916|P1|COMPLETED|Overall Study||7
4931783|NCT03157583|12130916|P1|STARTED|Overall Study||8
4931784|NCT03157531|12130934|P1|NOT COMPLETED|Overall Study||6
4931785|NCT03157531|12130934|P1|COMPLETED|Overall Study||91
4931786|NCT03157531|12130934|P1|Analyzed at 30 Days For MAEs|Overall Study||93
4931787|NCT03157531|12130934|P1|STARTED|Overall Study||97
4931788|NCT03157232|12130949|P1|NOT COMPLETED|Overall Study||0
4931789|NCT03157232|12130949|P1|COMPLETED|Overall Study||18
4931790|NCT03157232|12130949|P1|STARTED|Overall Study||18
4931791|NCT03155269|12130955|P2|NOT COMPLETED|Overall Study||7
4931792|NCT03155269|12130956|P1|NOT COMPLETED|Overall Study||5
4931793|NCT03155269|12130955|P2|COMPLETED|Overall Study||50
4931794|NCT03155269|12130956|P1|COMPLETED|Overall Study||52
4931795|NCT03155269|12130955|P2|STARTED|Overall Study||57
4931796|NCT03155269|12130956|P1|STARTED|Overall Study||57
4931797|NCT03155178|12131002|P4|NOT COMPLETED|Overall Study||7
4931798|NCT03155178|12131003|P3|NOT COMPLETED|Overall Study||7
4931799|NCT03155178|12131004|P2|NOT COMPLETED|Overall Study||7
4931800|NCT03155178|12131005|P1|NOT COMPLETED|Overall Study||7
4931801|NCT03155178|12131002|P4|COMPLETED|Overall Study||62
4931802|NCT03155178|12131003|P3|COMPLETED|Overall Study||62
4931803|NCT03155178|12131004|P2|COMPLETED|Overall Study||62
4931804|NCT03155178|12131005|P1|COMPLETED|Overall Study||62
4931805|NCT03155178|12131002|P4|STARTED|Overall Study||69
4931806|NCT03155178|12131003|P3|STARTED|Overall Study||69
4931807|NCT03155178|12131004|P2|STARTED|Overall Study||69
4931808|NCT03155178|12131005|P1|STARTED|Overall Study||69
4931809|NCT03154333|12131025|P2|NOT COMPLETED|Overall Study||5
4931810|NCT03154333|12131026|P1|NOT COMPLETED|Overall Study||7
4931811|NCT03154333|12131025|P2|COMPLETED|Overall Study||21
4931812|NCT03154333|12131026|P1|COMPLETED|Overall Study||21
4931813|NCT03154333|12131025|P2|STARTED|Overall Study||26
4931814|NCT03154333|12131026|P1|STARTED|Overall Study||28
4931815|NCT03154086|12131049|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
4931816|NCT03154086|12131050|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
4931817|NCT03154086|12131051|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
4931818|NCT03154086|12131052|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
4931819|NCT03154086|12131053|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
4931820|NCT03154086|12131054|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
4931821|NCT03154086|12131055|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
4931822|NCT03154086|12131056|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
4931823|NCT03154086|12131057|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
4931824|NCT03154086|12131058|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
4931825|NCT03154086|12131059|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
4931826|NCT03154086|12131060|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
4931827|NCT03154086|12131061|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
4931828|NCT03154086|12131062|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
4931829|NCT03154086|12131063|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
4931830|NCT03154086|12131049|P15|COMPLETED|Part B (Up to 25 Days)||6
4931831|NCT03154086|12131050|P14|COMPLETED|Part B (Up to 25 Days)||6
4931832|NCT03154086|12131051|P13|COMPLETED|Part B (Up to 25 Days)||6
4931833|NCT03154086|12131052|P12|COMPLETED|Part B (Up to 25 Days)||6
4931834|NCT03154086|12131053|P11|COMPLETED|Part B (Up to 25 Days)||5
4931835|NCT03154086|12131054|P10|COMPLETED|Part B (Up to 25 Days)||10
4931836|NCT03154086|12131055|P9|COMPLETED|Part B (Up to 25 Days)||0
4931837|NCT03154086|12131056|P8|COMPLETED|Part B (Up to 25 Days)||0
4931838|NCT03154086|12131057|P7|COMPLETED|Part B (Up to 25 Days)||0
4931839|NCT03154086|12131058|P6|COMPLETED|Part B (Up to 25 Days)||0
4931840|NCT03154086|12131059|P5|COMPLETED|Part B (Up to 25 Days)||0
4931841|NCT03154086|12131060|P4|COMPLETED|Part B (Up to 25 Days)||0
4931842|NCT03154086|12131061|P3|COMPLETED|Part B (Up to 25 Days)||0
4931843|NCT03154086|12131062|P2|COMPLETED|Part B (Up to 25 Days)||0
4931844|NCT03154086|12131063|P1|COMPLETED|Part B (Up to 25 Days)||0
4931845|NCT03154086|12131049|P15|STARTED|Part B (Up to 25 Days)||6
4931846|NCT03154086|12131050|P14|STARTED|Part B (Up to 25 Days)||6
4931847|NCT03154086|12131051|P13|STARTED|Part B (Up to 25 Days)||6
4931848|NCT03154086|12131052|P12|STARTED|Part B (Up to 25 Days)||6
4931849|NCT03154086|12131053|P11|STARTED|Part B (Up to 25 Days)||6
4931850|NCT03154086|12131054|P10|STARTED|Part B (Up to 25 Days)||10
4931851|NCT03154086|12131055|P9|STARTED|Part B (Up to 25 Days)||0
4931852|NCT03154086|12131056|P8|STARTED|Part B (Up to 25 Days)||0
4931853|NCT03154086|12131057|P7|STARTED|Part B (Up to 25 Days)||0
4931854|NCT03154086|12131058|P6|STARTED|Part B (Up to 25 Days)||0
4931855|NCT03154086|12131059|P5|STARTED|Part B (Up to 25 Days)||0
4931856|NCT03154086|12131060|P4|STARTED|Part B (Up to 25 Days)||0
4931857|NCT03154086|12131061|P3|STARTED|Part B (Up to 25 Days)||0
4931858|NCT03154086|12131062|P2|STARTED|Part B (Up to 25 Days)||0
4931859|NCT03154086|12131063|P1|STARTED|Part B (Up to 25 Days)||0
4931860|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931861|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931862|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931863|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931864|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931865|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931866|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
4931867|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
4931868|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931869|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931870|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931871|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931872|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931873|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931874|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931875|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931876|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931877|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931878|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931879|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931880|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931881|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
4931882|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
4931883|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
4931884|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931885|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931886|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931887|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931888|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931889|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931890|NCT03154086|12131049|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931891|NCT03154086|12131050|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931892|NCT03154086|12131051|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931893|NCT03154086|12131052|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931894|NCT03154086|12131053|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931895|NCT03154086|12131054|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931896|NCT03154086|12131055|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
4931897|NCT03154086|12131056|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
4931898|NCT03154086|12131057|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
4931899|NCT03154086|12131058|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931900|NCT03154086|12131059|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931901|NCT03154086|12131060|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931902|NCT03154086|12131061|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931903|NCT03154086|12131062|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931904|NCT03154086|12131063|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
4931905|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931906|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931907|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931908|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931909|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931910|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931911|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931912|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931913|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931914|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931915|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931916|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931917|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931918|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931919|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931920|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931921|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931922|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931923|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931924|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931925|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931926|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
4931927|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
4931928|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
4931929|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931930|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931931|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931932|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931933|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931934|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931935|NCT03154086|12131049|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931936|NCT03154086|12131050|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931937|NCT03154086|12131051|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931938|NCT03154086|12131052|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931939|NCT03154086|12131053|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931940|NCT03154086|12131054|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931941|NCT03154086|12131055|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
4931942|NCT03154086|12131056|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
4931943|NCT03154086|12131057|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
4931944|NCT03154086|12131058|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931945|NCT03154086|12131059|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931946|NCT03154086|12131060|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931947|NCT03154086|12131061|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931948|NCT03154086|12131062|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931949|NCT03154086|12131063|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
4931950|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931951|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931952|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931953|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931954|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931955|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931956|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931957|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931958|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931959|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931960|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931961|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931962|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931963|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931964|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931965|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931966|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931967|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931968|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931969|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931970|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931971|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
4931972|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
4931973|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
4931974|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931975|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931976|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931977|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931978|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931979|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931980|NCT03154086|12131049|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931981|NCT03154086|12131050|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931982|NCT03154086|12131051|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931983|NCT03154086|12131052|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931984|NCT03154086|12131053|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931985|NCT03154086|12131054|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931986|NCT03154086|12131055|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
4931987|NCT03154086|12131056|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
4931988|NCT03154086|12131057|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
4931989|NCT03154086|12131058|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931990|NCT03154086|12131059|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931991|NCT03154086|12131060|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931992|NCT03154086|12131061|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931993|NCT03154086|12131062|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931994|NCT03154086|12131063|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
4931995|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4931996|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4931997|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4931998|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4931999|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932000|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932001|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932002|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932003|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932004|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932005|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932006|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932007|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932008|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932009|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932010|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932011|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932012|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932013|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932014|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932015|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932016|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932017|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932018|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932019|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
4932020|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
4932021|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932022|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932023|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932024|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932025|NCT03154086|12131049|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932026|NCT03154086|12131050|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932027|NCT03154086|12131051|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932028|NCT03154086|12131052|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932029|NCT03154086|12131053|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932030|NCT03154086|12131054|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932031|NCT03154086|12131055|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932032|NCT03154086|12131056|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932033|NCT03154086|12131057|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932034|NCT03154086|12131058|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
4932035|NCT03154086|12131059|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
4932036|NCT03154086|12131060|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932037|NCT03154086|12131061|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932038|NCT03154086|12131062|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932039|NCT03154086|12131063|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
4932040|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932041|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932042|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932043|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932044|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932045|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932046|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932047|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932048|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932049|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932050|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932051|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932052|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932053|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932054|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932055|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932056|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932057|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932058|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932059|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932060|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932061|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932062|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932063|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932064|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
4932065|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
4932066|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932067|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932068|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932069|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932070|NCT03154086|12131049|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932071|NCT03154086|12131050|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932072|NCT03154086|12131051|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932073|NCT03154086|12131052|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932074|NCT03154086|12131053|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932075|NCT03154086|12131054|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932076|NCT03154086|12131055|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932077|NCT03154086|12131056|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932078|NCT03154086|12131057|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932079|NCT03154086|12131058|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
4932080|NCT03154086|12131059|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
4932081|NCT03154086|12131060|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932082|NCT03154086|12131061|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932083|NCT03154086|12131062|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932084|NCT03154086|12131063|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
4932085|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932086|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932087|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932088|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932089|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932090|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932091|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932092|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932093|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932094|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932095|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932096|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932097|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932098|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932099|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932100|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932101|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932102|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932103|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932104|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932105|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932106|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932107|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932108|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932109|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
4932110|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
4932111|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932112|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932113|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932114|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932115|NCT03154086|12131049|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932116|NCT03154086|12131050|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932117|NCT03154086|12131051|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932118|NCT03154086|12131052|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932119|NCT03154086|12131053|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932120|NCT03154086|12131054|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932121|NCT03154086|12131055|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932122|NCT03154086|12131056|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932123|NCT03154086|12131057|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932124|NCT03154086|12131058|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
4932125|NCT03154086|12131059|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
4932126|NCT03154086|12131060|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932127|NCT03154086|12131061|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932128|NCT03154086|12131062|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932129|NCT03154086|12131063|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
4932130|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932131|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932132|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932133|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932134|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932135|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932136|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932137|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932138|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932139|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932140|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932141|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932142|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932143|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932144|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
4932145|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932146|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932147|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932148|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932149|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932150|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932151|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932152|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932153|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932154|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932155|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932156|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
4932157|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
4932158|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
4932159|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
4932160|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932161|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932162|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932163|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932164|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932165|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932166|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932167|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932168|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932169|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932170|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
4932171|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
4932172|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
4932173|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
4932174|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
4932175|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932176|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932177|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932178|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932179|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932180|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932181|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932182|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932183|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932184|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932185|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932186|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932187|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
4932188|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932189|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932190|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932191|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932192|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932193|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932194|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932195|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932196|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932197|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932198|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932199|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932200|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932201|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932202|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
4932203|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932204|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932205|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932206|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932207|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932208|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932209|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932210|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932211|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932212|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932213|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932214|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932215|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
4932216|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932217|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932218|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932219|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
4932220|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932221|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932222|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932223|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932224|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932225|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932226|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932227|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932228|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932229|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932230|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932231|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932232|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932233|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932234|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932235|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932236|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932237|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932238|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932239|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932240|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932241|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932242|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932243|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932244|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932245|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932246|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932247|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932248|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932249|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932250|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932251|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932252|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932253|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932254|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932255|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932256|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932257|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932258|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932259|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932260|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
4932261|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932262|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932263|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
4932264|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
4932265|NCT03154086|12131049|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932266|NCT03154086|12131050|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932267|NCT03154086|12131051|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932268|NCT03154086|12131052|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932269|NCT03154086|12131053|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932270|NCT03154086|12131054|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932271|NCT03154086|12131055|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932272|NCT03154086|12131056|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932273|NCT03154086|12131057|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932274|NCT03154086|12131058|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932275|NCT03154086|12131059|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932276|NCT03154086|12131060|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932277|NCT03154086|12131061|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932278|NCT03154086|12131062|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
4932279|NCT03154086|12131063|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932280|NCT03154086|12131049|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932281|NCT03154086|12131050|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932282|NCT03154086|12131051|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932283|NCT03154086|12131052|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932284|NCT03154086|12131053|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932285|NCT03154086|12131054|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932286|NCT03154086|12131055|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932287|NCT03154086|12131056|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932288|NCT03154086|12131057|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932289|NCT03154086|12131058|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932290|NCT03154086|12131059|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932291|NCT03154086|12131060|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932292|NCT03154086|12131061|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932293|NCT03154086|12131062|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
4932294|NCT03154086|12131063|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932295|NCT03154086|12131049|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932296|NCT03154086|12131050|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932297|NCT03154086|12131051|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932298|NCT03154086|12131052|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932299|NCT03154086|12131053|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932300|NCT03154086|12131054|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932301|NCT03154086|12131055|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932302|NCT03154086|12131056|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932303|NCT03154086|12131057|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932304|NCT03154086|12131058|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932305|NCT03154086|12131059|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
4932306|NCT03154086|12131060|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932307|NCT03154086|12131061|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932308|NCT03154086|12131062|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932309|NCT03154086|12131063|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
4932310|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932311|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932312|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932313|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932314|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932315|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932316|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932317|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932318|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932319|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932320|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932321|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932322|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932323|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932324|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932325|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932326|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932327|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932328|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932329|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932330|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932331|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932332|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932333|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932334|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932335|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932336|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932337|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932338|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932339|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932340|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932341|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932342|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932343|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932344|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932345|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932346|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932347|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932348|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932349|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932350|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
4932351|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
4932352|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932353|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932354|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
4932355|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932356|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932357|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932358|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932359|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932360|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932361|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932362|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932363|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932364|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932365|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932366|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
4932367|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932368|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932369|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932370|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932371|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932372|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932373|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932374|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932375|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932376|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932377|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932378|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932379|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932380|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932381|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
4932382|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932383|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932384|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932385|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932386|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932387|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932388|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932389|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932390|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932391|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932392|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932393|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932394|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932395|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
4932396|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932397|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932398|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932399|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
4932400|NCT03154086|12131049|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932401|NCT03154086|12131050|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932402|NCT03154086|12131051|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932403|NCT03154086|12131052|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932404|NCT03154086|12131053|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932405|NCT03154086|12131054|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932406|NCT03154086|12131055|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932407|NCT03154086|12131056|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932408|NCT03154086|12131057|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932409|NCT03154086|12131058|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932410|NCT03154086|12131059|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932411|NCT03154086|12131060|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932412|NCT03154086|12131061|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932413|NCT03154086|12131062|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932414|NCT03154086|12131063|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932415|NCT03154086|12131049|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932416|NCT03154086|12131050|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932417|NCT03154086|12131051|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932418|NCT03154086|12131052|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932419|NCT03154086|12131053|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932420|NCT03154086|12131054|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932421|NCT03154086|12131055|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932422|NCT03154086|12131056|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932423|NCT03154086|12131057|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932424|NCT03154086|12131058|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932425|NCT03154086|12131059|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932426|NCT03154086|12131060|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932427|NCT03154086|12131061|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932428|NCT03154086|12131062|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932429|NCT03154086|12131063|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932430|NCT03154086|12131049|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932431|NCT03154086|12131050|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932432|NCT03154086|12131051|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932433|NCT03154086|12131052|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932434|NCT03154086|12131053|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932435|NCT03154086|12131054|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932436|NCT03154086|12131055|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932437|NCT03154086|12131056|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932438|NCT03154086|12131057|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932439|NCT03154086|12131058|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932440|NCT03154086|12131059|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
4932441|NCT03154086|12131060|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932442|NCT03154086|12131061|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932443|NCT03154086|12131062|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932444|NCT03154086|12131063|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
4932445|NCT03154047|12131463|P1|NOT COMPLETED|Overall Study||80
4932446|NCT03154047|12131463|P1|COMPLETED|Overall Study||0
4932447|NCT03154047|12131463|P1|Number of Patients Dosed|Overall Study||80
4932448|NCT03154047|12131463|P1|STARTED|Overall Study||80
4932449|NCT03153956|12131469|P2|NOT COMPLETED|Overall Study||0
4932450|NCT03153956|12131470|P1|NOT COMPLETED|Overall Study||0
4932451|NCT03153956|12131469|P2|COMPLETED|Overall Study||38
4932452|NCT03153956|12131470|P1|COMPLETED|Overall Study||39
4932453|NCT03153956|12131469|P2|STARTED|Overall Study||38
4932454|NCT03153956|12131470|P1|STARTED|Overall Study||39
4932455|NCT03152591|12131482|P2|NOT COMPLETED|Overall Study||0
4932456|NCT03152591|12131483|P1|NOT COMPLETED|Overall Study||0
4932457|NCT03152591|12131482|P2|COMPLETED|Overall Study||14
4932458|NCT03152591|12131483|P1|COMPLETED|Overall Study||15
4932459|NCT03152591|12131482|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
4932460|NCT03152591|12131483|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
4932461|NCT03152591|12131482|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
4932462|NCT03152591|12131483|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
4932463|NCT03152591|12131482|P2|STARTED|Overall Study||14
4932464|NCT03152591|12131483|P1|STARTED|Overall Study||15
4932465|NCT03152552|12131510|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
4932466|NCT03152552|12131511|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
4932467|NCT03152552|12131512|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
4932468|NCT03152552|12131513|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
4932469|NCT03152552|12131514|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
4932470|NCT03152552|12131510|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
4932471|NCT03152552|12131511|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
4932472|NCT03152552|12131512|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
4932473|NCT03152552|12131513|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
4932474|NCT03152552|12131514|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
4932475|NCT03152552|12131510|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
4932476|NCT03152552|12131511|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
4932477|NCT03152552|12131512|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
4932478|NCT03152552|12131513|P2|STARTED|Treatment Period 2 (24 Weeks)||5
4932479|NCT03152552|12131514|P1|STARTED|Treatment Period 2 (24 Weeks)||7
4932480|NCT03152552|12131510|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
4932481|NCT03152552|12131511|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
4932482|NCT03152552|12131512|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
4932483|NCT03152552|12131513|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
4932484|NCT03152552|12131514|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
4932485|NCT03152552|12131510|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
4932486|NCT03152552|12131511|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
4932487|NCT03152552|12131512|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
4932488|NCT03152552|12131513|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
4932489|NCT03152552|12131514|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
4932490|NCT03152552|12131510|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
4932491|NCT03152552|12131511|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
4932492|NCT03152552|12131512|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
4932493|NCT03152552|12131513|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
4932494|NCT03152552|12131514|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
4932495|NCT03152552|12131510|P5|STARTED|Treatment Period 1 (12 Weeks)||33
4932496|NCT03152552|12131511|P4|STARTED|Treatment Period 1 (12 Weeks)||30
4932497|NCT03152552|12131512|P3|STARTED|Treatment Period 1 (12 Weeks)||31
4932498|NCT03152552|12131513|P2|STARTED|Treatment Period 1 (12 Weeks)||16
4932499|NCT03152552|12131514|P1|STARTED|Treatment Period 1 (12 Weeks)||15
4932500|NCT03152526|12131647|P2|NOT COMPLETED|Overall Study||1
4932501|NCT03152526|12131648|P1|NOT COMPLETED|Overall Study||0
4932502|NCT03152526|12131647|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
4932503|NCT03152526|12131648|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
4932504|NCT03152526|12131647|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
4932505|NCT03152526|12131648|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
4932506|NCT03152136|12131659|P3|NOT COMPLETED|Overall Study||1
4932507|NCT03152136|12131660|P2|NOT COMPLETED|Overall Study||0
4932508|NCT03152136|12131661|P1|NOT COMPLETED|Overall Study||3
4932509|NCT03152136|12131659|P3|COMPLETED|Overall Study||14
4932510|NCT03152136|12131660|P2|COMPLETED|Overall Study||15
4932511|NCT03152136|12131661|P1|COMPLETED|Overall Study||29
4932512|NCT03152136|12131659|P3|STARTED|Overall Study||15
4932513|NCT03152136|12131660|P2|STARTED|Overall Study||15
4932514|NCT03152136|12131661|P1|STARTED|Overall Study||32
4932515|NCT03152019|12131670|P2|NOT COMPLETED|Overall Study||1
4932516|NCT03152019|12131671|P1|NOT COMPLETED|Overall Study||0
4932517|NCT03152019|12131670|P2|COMPLETED|Overall Study||24
4932518|NCT03152019|12131671|P1|COMPLETED|Overall Study||25
4932519|NCT03152019|12131670|P2|STARTED|Overall Study||25
4932520|NCT03152019|12131671|P1|STARTED|Overall Study||25
4932521|NCT03151551|12131679|P2|NOT COMPLETED|Overall Study||276
4932522|NCT03151551|12131680|P1|NOT COMPLETED|Overall Study||275
4932523|NCT03151551|12131679|P2|COMPLETED|Overall Study||7
4932524|NCT03151551|12131680|P1|COMPLETED|Overall Study||8
4932525|NCT03151551|12131679|P2|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study||219
4932526|NCT03151551|12131680|P1|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
4932527|NCT03151551|12131679|P2|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study||64
4932528|NCT03151551|12131680|P1|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
4932529|NCT03151551|12131679|P2|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study|Row represents Ixekizumab data only.|0
4932530|NCT03151551|12131680|P1|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study||218
4932531|NCT03151551|12131679|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study|Row represents Ixekizumab data only.|0
4932532|NCT03151551|12131680|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study||65
4932533|NCT03151551|12131679|P2|Received at Least One Dose of Study Drug|Overall Study||283
4932534|NCT03151551|12131680|P1|Received at Least One Dose of Study Drug|Overall Study||283
4932535|NCT03151551|12131679|P2|STARTED|Overall Study||283
4932536|NCT03151551|12131680|P1|STARTED|Overall Study||283
4932537|NCT03151265|12131692|P2|NOT COMPLETED|Overall Study||0
4932538|NCT03151265|12131693|P1|NOT COMPLETED|Overall Study||0
4932539|NCT03151265|12131692|P2|COMPLETED|Overall Study||20
4932540|NCT03151265|12131693|P1|COMPLETED|Overall Study||20
4932541|NCT03151265|12131692|P2|STARTED|Overall Study||20
4932542|NCT03151265|12131693|P1|STARTED|Overall Study||20
4932543|NCT03151226|12131715|P1|NOT COMPLETED|Overall Study||3
4932544|NCT03151226|12131715|P1|COMPLETED|Overall Study||0
4932545|NCT03151226|12131715|P1|STARTED|Overall Study||3
4932546|NCT03151148|12131721|P2|NOT COMPLETED|Overall Study||0
4932547|NCT03151148|12131722|P1|NOT COMPLETED|Overall Study||2
4932548|NCT03151148|12131721|P2|COMPLETED|Overall Study||18
4932549|NCT03151148|12131722|P1|COMPLETED|Overall Study||34
4932550|NCT03151148|12131721|P2|STARTED|Overall Study||18
4932551|NCT03151148|12131722|P1|STARTED|Overall Study||36
4932552|NCT03150758|12131766|P1|NOT COMPLETED|Overall Study||0
4932553|NCT03150758|12131766|P1|COMPLETED|Overall Study||6
4932554|NCT03150758|12131766|P1|STARTED|Overall Study||6
4932555|NCT03150719|12131772|P2|NOT COMPLETED|Overall Study||2
4932556|NCT03150719|12131773|P1|NOT COMPLETED|Overall Study||1
4932557|NCT03150719|12131772|P2|COMPLETED|Overall Study||48
4932558|NCT03150719|12131773|P1|COMPLETED|Overall Study||46
4932559|NCT03150719|12131772|P2|STARTED|Overall Study||50
4932560|NCT03150719|12131773|P1|STARTED|Overall Study||47
4932561|NCT03150485|12131789|P6|NOT COMPLETED|Overall Study||0
4932562|NCT03150485|12131790|P5|NOT COMPLETED|Overall Study||0
4932563|NCT03150485|12131791|P4|NOT COMPLETED|Overall Study||0
4932564|NCT03150485|12131792|P3|NOT COMPLETED|Overall Study||0
4932565|NCT03150485|12131793|P2|NOT COMPLETED|Overall Study||1
4932566|NCT03150485|12131794|P1|NOT COMPLETED|Overall Study||0
4932567|NCT03150485|12131789|P6|COMPLETED|Overall Study||1
4932568|NCT03150485|12131790|P5|COMPLETED|Overall Study||2
4932569|NCT03150485|12131791|P4|COMPLETED|Overall Study||5
4932570|NCT03150485|12131792|P3|COMPLETED|Overall Study||4
4932571|NCT03150485|12131793|P2|COMPLETED|Overall Study||8
4932572|NCT03150485|12131794|P1|COMPLETED|Overall Study||2
4932573|NCT03150485|12131789|P6|STARTED|Overall Study||1
4932574|NCT03150485|12131790|P5|STARTED|Overall Study||2
4932575|NCT03150485|12131791|P4|STARTED|Overall Study||5
4932576|NCT03150485|12131792|P3|STARTED|Overall Study||4
4932577|NCT03150485|12131793|P2|STARTED|Overall Study||9
4932578|NCT03150485|12131794|P1|STARTED|Overall Study||2
4932579|NCT03150199|12131811|P2|NOT COMPLETED|Overall Study||0
4932580|NCT03150199|12131812|P1|NOT COMPLETED|Overall Study||0
4932581|NCT03150199|12131811|P2|COMPLETED|Overall Study||30
4932582|NCT03150199|12131812|P1|COMPLETED|Overall Study||30
4932583|NCT03150199|12131811|P2|STARTED|Overall Study||30
4932584|NCT03150199|12131812|P1|STARTED|Overall Study||30
4932585|NCT03150160|12131863|P2|NOT COMPLETED|Overall Study||0
4932586|NCT03150160|12131864|P1|NOT COMPLETED|Overall Study||0
4932587|NCT03150160|12131863|P2|COMPLETED|Overall Study||1
4932588|NCT03150160|12131864|P1|COMPLETED|Overall Study||0
4932589|NCT03150160|12131863|P2|STARTED|Overall Study||1
4932590|NCT03150160|12131864|P1|STARTED|Overall Study||0
4932591|NCT03150108|12131880|P2|NOT COMPLETED|Overall Study||0
4932592|NCT03150108|12131881|P1|NOT COMPLETED|Overall Study||0
4932593|NCT03150108|12131880|P2|COMPLETED|Overall Study||12
4932594|NCT03150108|12131881|P1|COMPLETED|Overall Study||12
4932595|NCT03150108|12131880|P2|STARTED|Overall Study||12
4932596|NCT03150108|12131881|P1|STARTED|Overall Study||12
4932597|NCT03150082|12131971|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
4932598|NCT03150082|12131972|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
4932599|NCT03150082|12131971|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
4932600|NCT03150082|12131972|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
4932601|NCT03150082|12131971|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
4932602|NCT03150082|12131972|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
4932603|NCT03150082|12131971|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
4932604|NCT03150082|12131972|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
4932605|NCT03150082|12131971|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
4932606|NCT03150082|12131972|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
4932607|NCT03150082|12131971|P2|STARTED|Washout Period (Up to 4 Weeks)||13
4932608|NCT03150082|12131972|P1|STARTED|Washout Period (Up to 4 Weeks)||12
4932609|NCT03150082|12131971|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
4932610|NCT03150082|12131972|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
4932611|NCT03150082|12131971|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
4932612|NCT03150082|12131972|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
4932613|NCT03150082|12131971|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
4932614|NCT03150082|12131972|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
4932615|NCT03149991|12132028|P2|NOT COMPLETED|Overall Study||2
4932616|NCT03149991|12132029|P1|NOT COMPLETED|Overall Study||4
4932617|NCT03149991|12132028|P2|COMPLETED|Overall Study||24
4932618|NCT03149991|12132029|P1|COMPLETED|Overall Study||21
4932619|NCT03149991|12132028|P2|Exited|Overall Study||2
4932620|NCT03149991|12132029|P1|Exited|Overall Study||4
4932621|NCT03149991|12132028|P2|Completed Primary Endpoint (Day 14)|Overall Study||24
4932622|NCT03149991|12132029|P1|Completed Primary Endpoint (Day 14)|Overall Study||25
4932623|NCT03149991|12132028|P2|STARTED|Overall Study||26
4932624|NCT03149991|12132029|P1|STARTED|Overall Study||25
4932625|NCT03149887|12132057|P2|NOT COMPLETED|Overall Study||0
4932626|NCT03149887|12132058|P1|NOT COMPLETED|Overall Study||0
4932627|NCT03149887|12132057|P2|COMPLETED|Overall Study||27
4932628|NCT03149887|12132058|P1|COMPLETED|Overall Study||27
4932629|NCT03149887|12132057|P2|STARTED|Overall Study||27
4932630|NCT03149887|12132058|P1|STARTED|Overall Study||27
4932631|NCT03149848|12132078|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
4932632|NCT03149848|12132078|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
4932633|NCT03149848|12132078|P1|STARTED|Period 2 (Day 15 to Day 28)||14
4932634|NCT03149848|12132078|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
4932635|NCT03149848|12132078|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
4932636|NCT03149848|12132078|P1|STARTED|Period 1 (Day 1 to Day 14)||15
4932637|NCT03149042|12132115|P1|NOT COMPLETED|Overall Study||23
4932638|NCT03149042|12132115|P1|COMPLETED|Overall Study||52
4932639|NCT03149042|12132115|P1|STARTED|Overall Study||75
4932640|NCT03148756|12132129|P2|NOT COMPLETED|Overall Study||1
4932641|NCT03148756|12132130|P1|NOT COMPLETED|Overall Study||0
4932642|NCT03148756|12132129|P2|COMPLETED|Overall Study||1
4932643|NCT03148756|12132130|P1|COMPLETED|Overall Study||0
4932644|NCT03148756|12132129|P2|STARTED|Overall Study||2
4932645|NCT03148756|12132130|P1|STARTED|Overall Study||0
4932646|NCT03148691|12132163|P3|NOT COMPLETED|Overall Study||8
4932647|NCT03148691|12132164|P2|NOT COMPLETED|Overall Study||2
4932648|NCT03148691|12132165|P1|NOT COMPLETED|Overall Study||3
4932649|NCT03148691|12132163|P3|COMPLETED|Overall Study||92
4932650|NCT03148691|12132164|P2|COMPLETED|Overall Study||101
4932651|NCT03148691|12132165|P1|COMPLETED|Overall Study||47
4932652|NCT03148691|12132163|P3|STARTED|Overall Study||100
4932653|NCT03148691|12132164|P2|STARTED|Overall Study||103
4932654|NCT03148691|12132165|P1|STARTED|Overall Study||50
4932655|NCT03148470|12132175|P2|NOT COMPLETED|Overall Study||0
4932656|NCT03148470|12132176|P1|NOT COMPLETED|Overall Study||1
4932657|NCT03148470|12132175|P2|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
4932658|NCT03148470|12132176|P1|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
4932659|NCT03148470|12132175|P2|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
4932660|NCT03148470|12132176|P1|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
4932661|NCT03148262|12132192|P2|NOT COMPLETED|Overall Study||1
4932662|NCT03148262|12132193|P1|NOT COMPLETED|Overall Study||3
4932663|NCT03148262|12132192|P2|COMPLETED|Overall Study||31
4932664|NCT03148262|12132193|P1|COMPLETED|Overall Study||28
4932665|NCT03148262|12132192|P2|STARTED|Overall Study||32
4932666|NCT03148262|12132193|P1|STARTED|Overall Study||31
4932667|NCT03148236|12132201|P2|NOT COMPLETED|Overall Study||0
4932668|NCT03148236|12132202|P1|NOT COMPLETED|Overall Study||0
4932669|NCT03148236|12132201|P2|COMPLETED|Overall Study||10
4932670|NCT03148236|12132202|P1|COMPLETED|Overall Study||10
4932671|NCT03148236|12132201|P2|STARTED|Overall Study||10
4932672|NCT03148236|12132202|P1|STARTED|Overall Study||10
4932673|NCT03148067|12132228|P1|NOT COMPLETED|Overall Study||4
4932674|NCT03148067|12132228|P1|COMPLETED|Overall Study||221
4932675|NCT03148067|12132228|P1|STARTED|Overall Study||225
4932676|NCT03147248|12132239|P6|NOT COMPLETED|Overall Study||31
4932677|NCT03147248|12132240|P5|NOT COMPLETED|Overall Study||26
4932678|NCT03147248|12132241|P4|NOT COMPLETED|Overall Study||2
4932679|NCT03147248|12132242|P3|NOT COMPLETED|Overall Study||2
4932680|NCT03147248|12132243|P2|NOT COMPLETED|Overall Study||2
4932681|NCT03147248|12132244|P1|NOT COMPLETED|Overall Study||1
4932682|NCT03147248|12132239|P6|COMPLETED|Overall Study||145
4932683|NCT03147248|12132240|P5|COMPLETED|Overall Study||141
4932684|NCT03147248|12132241|P4|COMPLETED|Overall Study||10
4932685|NCT03147248|12132242|P3|COMPLETED|Overall Study||10
4932686|NCT03147248|12132243|P2|COMPLETED|Overall Study||9
4932687|NCT03147248|12132244|P1|COMPLETED|Overall Study||12
4932688|NCT03147248|12132239|P6|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
4932689|NCT03147248|12132240|P5|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
4932690|NCT03147248|12132241|P4|STARTED|Overall Study|This cohort is only for Part 1.|12
4932691|NCT03147248|12132242|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
4932692|NCT03147248|12132243|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
4932693|NCT03147248|12132244|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
4932694|NCT03146741|12132266|P1|NOT COMPLETED|Overall Study||10
4932695|NCT03146741|12132266|P1|COMPLETED|Overall Study||10
4932696|NCT03146741|12132266|P1|STARTED|Overall Study||20
4932697|NCT03146585|12132274|P3|NOT COMPLETED|Overall Study||0
4932698|NCT03146585|12132275|P2|NOT COMPLETED|Overall Study||0
4932699|NCT03146585|12132276|P1|NOT COMPLETED|Overall Study||0
4932700|NCT03146585|12132274|P3|COMPLETED|Overall Study||5
4932701|NCT03146585|12132275|P2|COMPLETED|Overall Study||10
4932702|NCT03146585|12132276|P1|COMPLETED|Overall Study||25
4932703|NCT03146585|12132274|P3|STARTED|Overall Study||5
4932704|NCT03146585|12132275|P2|STARTED|Overall Study||10
4932705|NCT03146585|12132276|P1|STARTED|Overall Study||25
4932706|NCT03146403|12132286|P2|NOT COMPLETED|Overall Study||3
4932707|NCT03146403|12132287|P1|NOT COMPLETED|Overall Study||2
4932708|NCT03146403|12132286|P2|COMPLETED|Overall Study||14
4932709|NCT03146403|12132287|P1|COMPLETED|Overall Study||14
4932710|NCT03146403|12132286|P2|STARTED|Overall Study||17
4932711|NCT03146403|12132287|P1|STARTED|Overall Study||16
4932712|NCT03145259|12132301|P1|NOT COMPLETED|Overall Study||0
4932713|NCT03145259|12132301|P1|COMPLETED|Overall Study||12
4932714|NCT03145259|12132301|P1|STARTED|Overall Study||12
4932715|NCT03145207|12132308|P1|NOT COMPLETED|Overall Study||2
4932716|NCT03145207|12132308|P1|COMPLETED|Overall Study||12
4932717|NCT03145207|12132308|P1|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
4932718|NCT03144635|12132323|P1|NOT COMPLETED|Overall Study||80
4932719|NCT03144635|12132323|P1|COMPLETED|Overall Study||0
4932720|NCT03144635|12132323|P1|STARTED|Overall Study||80
4932721|NCT03144518|12132335|P2|NOT COMPLETED|16 Week Post-Vaccination||2
4932722|NCT03144518|12132336|P1|NOT COMPLETED|16 Week Post-Vaccination||3
4932723|NCT03144518|12132335|P2|COMPLETED|16 Week Post-Vaccination||49
4932724|NCT03144518|12132336|P1|COMPLETED|16 Week Post-Vaccination||49
4932725|NCT03144518|12132335|P2|STARTED|16 Week Post-Vaccination||51
4932726|NCT03144518|12132336|P1|STARTED|16 Week Post-Vaccination||52
4932727|NCT03144518|12132335|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
4932728|NCT03144518|12132336|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
4932729|NCT03144518|12132335|P2|COMPLETED|4 Weeks Post-Vaccination||51
4932730|NCT03144518|12132336|P1|COMPLETED|4 Weeks Post-Vaccination||51
4932731|NCT03144518|12132335|P2|STARTED|4 Weeks Post-Vaccination||51
4932732|NCT03144518|12132336|P1|STARTED|4 Weeks Post-Vaccination||52
4932733|NCT03144518|12132335|P2|NOT COMPLETED|Primary Outcome (Mood)||0
4932734|NCT03144518|12132336|P1|NOT COMPLETED|Primary Outcome (Mood)||0
4932735|NCT03144518|12132335|P2|COMPLETED|Primary Outcome (Mood)||51
4932736|NCT03144518|12132336|P1|COMPLETED|Primary Outcome (Mood)||52
4932737|NCT03144518|12132335|P2|STARTED|Primary Outcome (Mood)||51
4932738|NCT03144518|12132336|P1|STARTED|Primary Outcome (Mood)||52
4932739|NCT03144180|12132353|P2|NOT COMPLETED|Overall Study||6
4932740|NCT03144180|12132354|P1|NOT COMPLETED|Overall Study||2
4932741|NCT03144180|12132353|P2|COMPLETED|Overall Study||10
4932742|NCT03144180|12132354|P1|COMPLETED|Overall Study||14
4932743|NCT03144180|12132353|P2|STARTED|Overall Study||16
4932744|NCT03144180|12132354|P1|STARTED|Overall Study||16
4932745|NCT03143569|12132366|P2|NOT COMPLETED|Overall Study||2
4932746|NCT03143569|12132367|P1|NOT COMPLETED|Overall Study||0
4932747|NCT03143569|12132366|P2|COMPLETED|Overall Study||8
4932748|NCT03143569|12132367|P1|COMPLETED|Overall Study||10
4932749|NCT03143569|12132366|P2|STARTED|Overall Study||10
4932750|NCT03143569|12132367|P1|STARTED|Overall Study||10
4932751|NCT03143166|12132389|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
4932752|NCT03143166|12132389|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
4932753|NCT03143166|12132389|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
4932754|NCT03143166|12132389|P1|NOT COMPLETED|Period 1||0
4932755|NCT03143166|12132389|P1|COMPLETED|Period 1||36
4932756|NCT03143166|12132389|P1|STARTED|Period 1||36
4932757|NCT03143101|12132408|P3|NOT COMPLETED|Overall Study||0
4932758|NCT03143101|12132409|P2|NOT COMPLETED|Overall Study||3
4932759|NCT03143101|12132410|P1|NOT COMPLETED|Overall Study||2
4932760|NCT03143101|12132408|P3|COMPLETED|Overall Study||67
4932761|NCT03143101|12132409|P2|COMPLETED|Overall Study||63
4932762|NCT03143101|12132410|P1|COMPLETED|Overall Study||65
4932763|NCT03143101|12132408|P3|STARTED|Overall Study||67
4932764|NCT03143101|12132409|P2|STARTED|Overall Study||66
4932765|NCT03143101|12132410|P1|STARTED|Overall Study||67
4932766|NCT03142932|12132465|P2|NOT COMPLETED|Overall Study||11
4932767|NCT03142932|12132466|P1|NOT COMPLETED|Overall Study||2
4932768|NCT03142932|12132465|P2|COMPLETED|Overall Study||39
4932769|NCT03142932|12132466|P1|COMPLETED|Overall Study||50
4932770|NCT03142932|12132465|P2|STARTED|Overall Study||50
4932771|NCT03142932|12132466|P1|STARTED|Overall Study||52
4932772|NCT03142750|12132482|P2|NOT COMPLETED|Overall Study||1
4932773|NCT03142750|12132483|P1|NOT COMPLETED|Overall Study||4
4932774|NCT03142750|12132482|P2|COMPLETED|Overall Study||9
4932775|NCT03142750|12132483|P1|COMPLETED|Overall Study||10
4932776|NCT03142750|12132482|P2|STARTED|Overall Study||10
4932777|NCT03142750|12132483|P1|STARTED|Overall Study||14
4932778|NCT03141931|12132496|P2|NOT COMPLETED|Overall Study||6
4932779|NCT03141931|12132497|P1|NOT COMPLETED|Overall Study||12
4932780|NCT03141931|12132496|P2|COMPLETED|Overall Study||52
4932781|NCT03141931|12132497|P1|COMPLETED|Overall Study||49
4932782|NCT03141931|12132496|P2|STARTED|Overall Study||58
4932783|NCT03141931|12132497|P1|STARTED|Overall Study||61
4932784|NCT03141528|12132519|P2|NOT COMPLETED|Overall Study||41
4932785|NCT03141528|12132520|P1|NOT COMPLETED|Overall Study||47
4932786|NCT03141528|12132519|P2|COMPLETED|Overall Study||77
4932787|NCT03141528|12132520|P1|COMPLETED|Overall Study||75
4932788|NCT03141528|12132519|P2|STARTED|Overall Study||118
4932789|NCT03141528|12132520|P1|STARTED|Overall Study||122
4932790|NCT03141372|12132562|P2|NOT COMPLETED|Overall Study||2
4932791|NCT03141372|12132563|P1|NOT COMPLETED|Overall Study||0
4932792|NCT03141372|12132562|P2|COMPLETED|Overall Study||40
4932793|NCT03141372|12132563|P1|COMPLETED|Overall Study||42
4932794|NCT03141372|12132562|P2|STARTED|Overall Study||42
4932795|NCT03141372|12132563|P1|STARTED|Overall Study||42
4932796|NCT03141307|12132583|P2|NOT COMPLETED|Follow-Up||54
4932797|NCT03141307|12132584|P1|NOT COMPLETED|Follow-Up||97
4932798|NCT03141307|12132583|P2|COMPLETED|Follow-Up||184
4932799|NCT03141307|12132584|P1|COMPLETED|Follow-Up||370
4932800|NCT03141307|12132583|P2|STARTED|Follow-Up||238
4932801|NCT03141307|12132584|P1|STARTED|Follow-Up||467
4932802|NCT03141307|12132583|P2|NOT COMPLETED|In-Hospital||2
4932803|NCT03141307|12132584|P1|NOT COMPLETED|In-Hospital||4
4932804|NCT03141307|12132583|P2|COMPLETED|In-Hospital||238
4932805|NCT03141307|12132584|P1|COMPLETED|In-Hospital||467
4932806|NCT03141307|12132583|P2|STARTED|In-Hospital||240
4932807|NCT03141307|12132584|P1|STARTED|In-Hospital||471
4932808|NCT03141151|12132602|P2|NOT COMPLETED|Overall Study||4
4932809|NCT03141151|12132603|P1|NOT COMPLETED|Overall Study||6
4932810|NCT03141151|12132602|P2|COMPLETED|Overall Study||54
4932811|NCT03141151|12132603|P1|COMPLETED|Overall Study||53
4932812|NCT03141151|12132602|P2|STARTED|Overall Study||58
4932813|NCT03141151|12132603|P1|STARTED|Overall Study||59
4932814|NCT03141086|12132621|P2|NOT COMPLETED|Overall Study||5
4932815|NCT03141086|12132622|P1|NOT COMPLETED|Overall Study||1
4932816|NCT03141086|12132621|P2|COMPLETED|Overall Study||12
4932817|NCT03141086|12132622|P1|COMPLETED|Overall Study||6
4932818|NCT03141086|12132621|P2|STARTED|Overall Study||17
4932819|NCT03141086|12132622|P1|STARTED|Overall Study||7
4932820|NCT03140631|12132651|P2|NOT COMPLETED|Overall Study||0
4932821|NCT03140631|12132652|P1|NOT COMPLETED|Overall Study||0
4932822|NCT03140631|12132651|P2|COMPLETED|Overall Study||77
4932823|NCT03140631|12132652|P1|COMPLETED|Overall Study||73
4932824|NCT03140631|12132651|P2|STARTED|Overall Study||77
4932825|NCT03140631|12132652|P1|STARTED|Overall Study||73
4932826|NCT03139604|12132662|P2|NOT COMPLETED|Overall Study||220
4932827|NCT03139604|12132663|P1|NOT COMPLETED|Overall Study||219
4932828|NCT03139604|12132662|P2|COMPLETED|Overall Study||0
4932829|NCT03139604|12132663|P1|COMPLETED|Overall Study||0
4932830|NCT03139604|12132662|P2|STARTED|Overall Study||220
4932831|NCT03139604|12132663|P1|STARTED|Overall Study||219
4932832|NCT03139578|12132675|P4|NOT COMPLETED|Period 2||0
4932833|NCT03139578|12132676|P3|NOT COMPLETED|Period 2||0
4932834|NCT03139578|12132677|P2|NOT COMPLETED|Period 2||0
4932835|NCT03139578|12132678|P1|NOT COMPLETED|Period 2||0
4932836|NCT03139578|12132675|P4|COMPLETED|Period 2||13
4932837|NCT03139578|12132676|P3|COMPLETED|Period 2||12
4932838|NCT03139578|12132677|P2|COMPLETED|Period 2||13
4932839|NCT03139578|12132678|P1|COMPLETED|Period 2||12
4932840|NCT03139578|12132675|P4|Discontinued|Period 2||0
4932841|NCT03139578|12132676|P3|Discontinued|Period 2||0
4932842|NCT03139578|12132677|P2|Discontinued|Period 2||0
4932843|NCT03139578|12132678|P1|Discontinued|Period 2||0
4932844|NCT03139578|12132675|P4|STARTED|Period 2||13
4932845|NCT03139578|12132676|P3|STARTED|Period 2||12
4932846|NCT03139578|12132677|P2|STARTED|Period 2||13
4932847|NCT03139578|12132678|P1|STARTED|Period 2||12
4932848|NCT03139578|12132675|P4|NOT COMPLETED|Period 1||0
4932849|NCT03139578|12132676|P3|NOT COMPLETED|Period 1||0
4932850|NCT03139578|12132677|P2|NOT COMPLETED|Period 1||0
4932851|NCT03139578|12132678|P1|NOT COMPLETED|Period 1||0
4932852|NCT03139578|12132675|P4|COMPLETED|Period 1||13
4932853|NCT03139578|12132676|P3|COMPLETED|Period 1||12
4932854|NCT03139578|12132677|P2|COMPLETED|Period 1||13
4932855|NCT03139578|12132678|P1|COMPLETED|Period 1||12
4932856|NCT03139578|12132675|P4|Discontinued|Period 1||0
4932857|NCT03139578|12132676|P3|Discontinued|Period 1||0
4932858|NCT03139578|12132677|P2|Discontinued|Period 1||0
4932859|NCT03139578|12132678|P1|Discontinued|Period 1||0
4932860|NCT03139578|12132675|P4|STARTED|Period 1||13
4932861|NCT03139578|12132676|P3|STARTED|Period 1||12
4932862|NCT03139578|12132677|P2|STARTED|Period 1||13
4932863|NCT03139578|12132678|P1|STARTED|Period 1||12
4932864|NCT03139552|12132712|P1|NOT COMPLETED|Overall Study||3
4932865|NCT03139552|12132712|P1|COMPLETED|Overall Study||147
4932866|NCT03139552|12132712|P1|STARTED|Overall Study||150
4932867|NCT03139448|12132755|P2|NOT COMPLETED|Overall Study||26
4932868|NCT03139448|12132756|P1|NOT COMPLETED|Overall Study||12
4932869|NCT03139448|12132755|P2|COMPLETED|Overall Study||63
4932870|NCT03139448|12132756|P1|COMPLETED|Overall Study||73
4932871|NCT03139448|12132755|P2|Intervention Started|Overall Study||70
4932872|NCT03139448|12132756|P1|Intervention Started|Overall Study||79
4932873|NCT03139448|12132755|P2|STARTED|Overall Study||89
4932874|NCT03139448|12132756|P1|STARTED|Overall Study||85
4932875|NCT03139279|12132780|P2|NOT COMPLETED|Overall Study||6
4932876|NCT03139279|12132781|P1|NOT COMPLETED|Overall Study||7
4932877|NCT03139279|12132780|P2|COMPLETED|Overall Study||50
4932878|NCT03139279|12132781|P1|COMPLETED|Overall Study||51
4932879|NCT03139279|12132780|P2|STARTED|Overall Study||56
4932880|NCT03139279|12132781|P1|STARTED|Overall Study||58
4932881|NCT03139240|12132799|P4|NOT COMPLETED|Overall Study||0
4932882|NCT03139240|12132800|P3|NOT COMPLETED|Overall Study||1
4932883|NCT03139240|12132801|P2|NOT COMPLETED|Overall Study||1
4932884|NCT03139240|12132802|P1|NOT COMPLETED|Overall Study||0
4932885|NCT03139240|12132799|P4|COMPLETED|Overall Study||38
4932886|NCT03139240|12132800|P3|COMPLETED|Overall Study||37
4932887|NCT03139240|12132801|P2|COMPLETED|Overall Study||47
4932888|NCT03139240|12132802|P1|COMPLETED|Overall Study||48
4932889|NCT03139240|12132799|P4|STARTED|Overall Study||38
4932890|NCT03139240|12132800|P3|STARTED|Overall Study||38
4932891|NCT03139240|12132801|P2|STARTED|Overall Study||48
4932892|NCT03139240|12132802|P1|STARTED|Overall Study||48
4932893|NCT03138967|12132814|P2|NOT COMPLETED|Overall Study||4
4932894|NCT03138967|12132815|P1|NOT COMPLETED|Overall Study||1
4932895|NCT03138967|12132814|P2|COMPLETED|Overall Study||24
4932896|NCT03138967|12132815|P1|COMPLETED|Overall Study||25
4932897|NCT03138967|12132814|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
4932898|NCT03138967|12132815|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
4932899|NCT03138967|12132814|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
4932900|NCT03138967|12132815|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
4932901|NCT03138967|12132814|P2|STARTED|Overall Study||28
4932902|NCT03138967|12132815|P1|STARTED|Overall Study||26
4932903|NCT03138876|12132825|P1|NOT COMPLETED|Overall Study||0
4932904|NCT03138876|12132825|P1|COMPLETED|Overall Study||20
4932905|NCT03138876|12132825|P1|STARTED|Overall Study||20
4932906|NCT03138798|12132834|P2|NOT COMPLETED|Overall Study||4
4932907|NCT03138798|12132835|P1|NOT COMPLETED|Overall Study||6
4932908|NCT03138798|12132834|P2|COMPLETED|Overall Study||171
4932909|NCT03138798|12132835|P1|COMPLETED|Overall Study||167
4932910|NCT03138798|12132834|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
4932911|NCT03138798|12132835|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
4932912|NCT03138798|12132834|P2|STARTED|Overall Study||175
4932913|NCT03138798|12132835|P1|STARTED|Overall Study||173
4932914|NCT03138577|12132865|P7|NOT COMPLETED|Overall Study||0
4932915|NCT03138577|12132866|P6|NOT COMPLETED|Overall Study||0
4932916|NCT03138577|12132867|P5|NOT COMPLETED|Overall Study||0
4932917|NCT03138577|12132868|P4|NOT COMPLETED|Overall Study||0
4932918|NCT03138577|12132869|P3|NOT COMPLETED|Overall Study||0
4932919|NCT03138577|12132870|P2|NOT COMPLETED|Overall Study||0
4932920|NCT03138577|12132871|P1|NOT COMPLETED|Overall Study||0
4932921|NCT03138577|12132865|P7|COMPLETED|Overall Study||3
4932922|NCT03138577|12132866|P6|COMPLETED|Overall Study||3
4932923|NCT03138577|12132867|P5|COMPLETED|Overall Study||3
4932924|NCT03138577|12132868|P4|COMPLETED|Overall Study||3
4932925|NCT03138577|12132869|P3|COMPLETED|Overall Study||3
4932926|NCT03138577|12132870|P2|COMPLETED|Overall Study||3
4932927|NCT03138577|12132871|P1|COMPLETED|Overall Study||3
4932928|NCT03138577|12132865|P7|STARTED|Overall Study||3
4932929|NCT03138577|12132866|P6|STARTED|Overall Study||3
4932930|NCT03138577|12132867|P5|STARTED|Overall Study||3
4932931|NCT03138577|12132868|P4|STARTED|Overall Study||3
4932932|NCT03138577|12132869|P3|STARTED|Overall Study||3
4932933|NCT03138577|12132870|P2|STARTED|Overall Study||3
4932934|NCT03138577|12132871|P1|STARTED|Overall Study||3
4932935|NCT03138382|12132916|P2|NOT COMPLETED|Overall Study||0
4932936|NCT03138382|12132917|P1|NOT COMPLETED|Overall Study||0
4932937|NCT03138382|12132916|P2|COMPLETED|Overall Study||10
4932938|NCT03138382|12132917|P1|COMPLETED|Overall Study||10
4932939|NCT03138382|12132916|P2|STARTED|Overall Study||10
4932940|NCT03138382|12132917|P1|STARTED|Overall Study||10
4932941|NCT03138330|12132925|P1|NOT COMPLETED|Overall Study||4
4932942|NCT03138330|12132925|P1|COMPLETED|Overall Study||91
4932943|NCT03138330|12132925|P1|STARTED|Overall Study||95
4932944|NCT03137784|12132930|P6|NOT COMPLETED|Overall Study||0
4932945|NCT03137784|12132931|P5|NOT COMPLETED|Overall Study||1
4932946|NCT03137784|12132932|P4|NOT COMPLETED|Overall Study||0
4932947|NCT03137784|12132933|P3|NOT COMPLETED|Overall Study||0
4932948|NCT03137784|12132934|P2|NOT COMPLETED|Overall Study||1
4932949|NCT03137784|12132935|P1|NOT COMPLETED|Overall Study||2
4932950|NCT03137784|12132930|P6|COMPLETED|Overall Study||25
4932951|NCT03137784|12132931|P5|COMPLETED|Overall Study||24
4932952|NCT03137784|12132932|P4|COMPLETED|Overall Study||24
4932953|NCT03137784|12132933|P3|COMPLETED|Overall Study||25
4932954|NCT03137784|12132934|P2|COMPLETED|Overall Study||24
4932955|NCT03137784|12132935|P1|COMPLETED|Overall Study||22
4932956|NCT03137784|12132930|P6|STARTED|Overall Study||25
4932957|NCT03137784|12132931|P5|STARTED|Overall Study||25
4932958|NCT03137784|12132932|P4|STARTED|Overall Study||24
4932959|NCT03137784|12132933|P3|STARTED|Overall Study||25
4932960|NCT03137784|12132934|P2|STARTED|Overall Study||25
4932961|NCT03137784|12132935|P1|STARTED|Overall Study||24
4932962|NCT03137225|12132972|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
4932963|NCT03137225|12132973|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
4932964|NCT03137225|12132972|P2|COMPLETED|Second 4 Hour Measurement Period||0
4932965|NCT03137225|12132973|P1|COMPLETED|Second 4 Hour Measurement Period||1
4932966|NCT03137225|12132972|P2|STARTED|Second 4 Hour Measurement Period||0
4932967|NCT03137225|12132973|P1|STARTED|Second 4 Hour Measurement Period||1
4932968|NCT03137225|12132972|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
4932969|NCT03137225|12132973|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
4932970|NCT03137225|12132972|P2|COMPLETED|First 4 Hour Measurement Period||0
4932971|NCT03137225|12132973|P1|COMPLETED|First 4 Hour Measurement Period||1
4932972|NCT03137225|12132972|P2|STARTED|First 4 Hour Measurement Period||0
4932973|NCT03137225|12132973|P1|STARTED|First 4 Hour Measurement Period||1
4932974|NCT03137173|12132987|P2|NOT COMPLETED|Overall Study||36
4932975|NCT03137173|12132988|P1|NOT COMPLETED|Overall Study||26
4932976|NCT03137173|12132987|P2|COMPLETED|Overall Study||308
4932977|NCT03137173|12132988|P1|COMPLETED|Overall Study||309
4932978|NCT03137173|12132987|P2|STARTED|Overall Study||344
4932979|NCT03137173|12132988|P1|STARTED|Overall Study||335
4932980|NCT03136861|12133005|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
4932981|NCT03136861|12133006|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4932982|NCT03136861|12133007|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
4932983|NCT03136861|12133008|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
4932984|NCT03136861|12133009|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
4932985|NCT03136861|12133010|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4932986|NCT03136861|12133011|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4932987|NCT03136861|12133005|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
4932988|NCT03136861|12133006|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
4932989|NCT03136861|12133007|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
4932990|NCT03136861|12133008|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
4932991|NCT03136861|12133009|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
4932992|NCT03136861|12133010|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4932993|NCT03136861|12133011|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4932994|NCT03136861|12133005|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
4932995|NCT03136861|12133006|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
4932996|NCT03136861|12133007|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
4932997|NCT03136861|12133008|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
4932998|NCT03136861|12133009|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
4932999|NCT03136861|12133010|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4933000|NCT03136861|12133011|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
4933001|NCT03136861|12133005|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933002|NCT03136861|12133006|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933003|NCT03136861|12133007|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933004|NCT03136861|12133008|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933005|NCT03136861|12133009|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933006|NCT03136861|12133010|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
4933007|NCT03136861|12133011|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
4933008|NCT03136861|12133005|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933009|NCT03136861|12133006|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933010|NCT03136861|12133007|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933011|NCT03136861|12133008|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933012|NCT03136861|12133009|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933013|NCT03136861|12133010|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
4933014|NCT03136861|12133011|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
4933015|NCT03136861|12133005|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933016|NCT03136861|12133006|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933017|NCT03136861|12133007|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933018|NCT03136861|12133008|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933019|NCT03136861|12133009|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
4933020|NCT03136861|12133010|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
4933021|NCT03136861|12133011|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
4933022|NCT03136484|12133026|P2|NOT COMPLETED|Overall Study||22
4933023|NCT03136484|12133027|P1|NOT COMPLETED|Overall Study||27
4933024|NCT03136484|12133026|P2|COMPLETED|Overall Study||372
4933025|NCT03136484|12133027|P1|COMPLETED|Overall Study||367
4933026|NCT03136484|12133026|P2|Exposed|Overall Study||394
4933027|NCT03136484|12133027|P1|Exposed|Overall Study||392
4933028|NCT03136484|12133026|P2|STARTED|Overall Study||394
4933029|NCT03136484|12133027|P1|STARTED|Overall Study||394
4933030|NCT03136380|12133155|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4933031|NCT03136380|12133156|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4933032|NCT03136380|12133157|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4933033|NCT03136380|12133158|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4933034|NCT03136380|12133159|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4933035|NCT03136380|12133155|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
4933036|NCT03136380|12133156|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
4933037|NCT03136380|12133157|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
4933038|NCT03136380|12133158|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
4933039|NCT03136380|12133159|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
4933040|NCT03136380|12133155|P5|STARTED|Part 2, Period 2 (3 Days)||8
4933041|NCT03136380|12133156|P4|STARTED|Part 2, Period 2 (3 Days)||8
4933042|NCT03136380|12133157|P3|STARTED|Part 2, Period 2 (3 Days)||0
4933043|NCT03136380|12133158|P2|STARTED|Part 2, Period 2 (3 Days)||0
4933044|NCT03136380|12133159|P1|STARTED|Part 2, Period 2 (3 Days)||0
4933045|NCT03136380|12133155|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933046|NCT03136380|12133156|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933047|NCT03136380|12133157|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933048|NCT03136380|12133158|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933049|NCT03136380|12133159|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933050|NCT03136380|12133155|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
4933051|NCT03136380|12133156|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
4933052|NCT03136380|12133157|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933053|NCT03136380|12133158|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933054|NCT03136380|12133159|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
4933055|NCT03136380|12133155|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
4933056|NCT03136380|12133156|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
4933057|NCT03136380|12133157|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
4933058|NCT03136380|12133158|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
4933059|NCT03136380|12133159|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
4933060|NCT03136380|12133155|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4933061|NCT03136380|12133156|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4933062|NCT03136380|12133157|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4933063|NCT03136380|12133158|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4933064|NCT03136380|12133159|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4933065|NCT03136380|12133155|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
4933066|NCT03136380|12133156|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
4933067|NCT03136380|12133157|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
4933068|NCT03136380|12133158|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
4933069|NCT03136380|12133159|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
4933070|NCT03136380|12133155|P5|STARTED|Part 2, Period 1 (3 Days)||8
4933071|NCT03136380|12133156|P4|STARTED|Part 2, Period 1 (3 Days)||8
4933072|NCT03136380|12133157|P3|STARTED|Part 2, Period 1 (3 Days)||0
4933073|NCT03136380|12133158|P2|STARTED|Part 2, Period 1 (3 Days)||0
4933074|NCT03136380|12133159|P1|STARTED|Part 2, Period 1 (3 Days)||0
4933075|NCT03136380|12133155|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
4933076|NCT03136380|12133156|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
4933077|NCT03136380|12133157|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
4933078|NCT03136380|12133158|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
4933079|NCT03136380|12133159|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
4933080|NCT03136380|12133155|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
4933081|NCT03136380|12133156|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
4933082|NCT03136380|12133157|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
4933083|NCT03136380|12133158|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
4933084|NCT03136380|12133159|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
4933085|NCT03136380|12133155|P5|STARTED|Part 1, Period 3 (4 Days)||0
4933086|NCT03136380|12133156|P4|STARTED|Part 1, Period 3 (4 Days)||0
4933087|NCT03136380|12133157|P3|STARTED|Part 1, Period 3 (4 Days)||6
4933088|NCT03136380|12133158|P2|STARTED|Part 1, Period 3 (4 Days)||5
4933089|NCT03136380|12133159|P1|STARTED|Part 1, Period 3 (4 Days)||6
4933090|NCT03136380|12133155|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933091|NCT03136380|12133156|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933092|NCT03136380|12133157|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933093|NCT03136380|12133158|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
4933094|NCT03136380|12133159|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933095|NCT03136380|12133155|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933096|NCT03136380|12133156|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4933097|NCT03136380|12133157|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
4933098|NCT03136380|12133158|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
4933099|NCT03136380|12133159|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
4933100|NCT03136380|12133155|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
4933101|NCT03136380|12133156|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
4933102|NCT03136380|12133157|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
4933103|NCT03136380|12133158|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
4933104|NCT03136380|12133159|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
4933105|NCT03136380|12133155|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
4933106|NCT03136380|12133156|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
4933107|NCT03136380|12133157|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
4933108|NCT03136380|12133158|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
4933109|NCT03136380|12133159|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
4933110|NCT03136380|12133155|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
4933111|NCT03136380|12133156|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
4933112|NCT03136380|12133157|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
4933113|NCT03136380|12133158|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
4933114|NCT03136380|12133159|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
4933115|NCT03136380|12133155|P5|STARTED|Part 1, Period 2 (3 Days)||0
4933116|NCT03136380|12133156|P4|STARTED|Part 1, Period 2 (3 Days)||0
4933117|NCT03136380|12133157|P3|STARTED|Part 1, Period 2 (3 Days)||6
4933118|NCT03136380|12133158|P2|STARTED|Part 1, Period 2 (3 Days)||6
4933119|NCT03136380|12133159|P1|STARTED|Part 1, Period 2 (3 Days)||6
4933120|NCT03136380|12133155|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933121|NCT03136380|12133156|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933122|NCT03136380|12133157|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933123|NCT03136380|12133158|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933124|NCT03136380|12133159|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933125|NCT03136380|12133155|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933126|NCT03136380|12133156|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4933127|NCT03136380|12133157|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
4933128|NCT03136380|12133158|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
4933129|NCT03136380|12133159|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
4933130|NCT03136380|12133155|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
4933131|NCT03136380|12133156|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
4933132|NCT03136380|12133157|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
4933133|NCT03136380|12133158|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
4933134|NCT03136380|12133159|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
4933135|NCT03136380|12133155|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
4933136|NCT03136380|12133156|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
4933137|NCT03136380|12133157|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
4933138|NCT03136380|12133158|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
4933139|NCT03136380|12133159|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
4933140|NCT03136380|12133155|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
4933141|NCT03136380|12133156|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
4933142|NCT03136380|12133157|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
4933143|NCT03136380|12133158|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
4933144|NCT03136380|12133159|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
4933145|NCT03136380|12133155|P5|STARTED|Part 1, Period 1 (3 Days)||0
4933146|NCT03136380|12133156|P4|STARTED|Part 1, Period 1 (3 Days)||0
4933147|NCT03136380|12133157|P3|STARTED|Part 1, Period 1 (3 Days)||6
4933148|NCT03136380|12133158|P2|STARTED|Part 1, Period 1 (3 Days)||6
4933149|NCT03136380|12133159|P1|STARTED|Part 1, Period 1 (3 Days)||6
4933150|NCT03136328|12133332|P1|NOT COMPLETED|Overall Study||0
4933151|NCT03136328|12133332|P1|COMPLETED|Overall Study||11
4933152|NCT03136328|12133332|P1|STARTED|Overall Study||11
4933153|NCT03136198|12133340|P2|NOT COMPLETED|Overall Study||1
4933154|NCT03136198|12133341|P1|NOT COMPLETED|Overall Study||0
4933155|NCT03136198|12133340|P2|COMPLETED|Overall Study||63
4933156|NCT03136198|12133341|P1|COMPLETED|Overall Study||66
4933157|NCT03136198|12133340|P2|STARTED|Overall Study||64
4933158|NCT03136198|12133341|P1|STARTED|Overall Study||66
4933159|NCT03136107|12133347|P1|NOT COMPLETED|Overall Study||1
4933160|NCT03136107|12133347|P1|COMPLETED|Overall Study||25
4933161|NCT03136107|12133347|P1|Negative Control|Overall Study||26
4933162|NCT03136107|12133347|P1|Reference Product|Overall Study||26
4933163|NCT03136107|12133347|P1|Test Product|Overall Study||26
4933164|NCT03136107|12133347|P1|STARTED|Overall Study||26
4933165|NCT03136068|12133357|P2|NOT COMPLETED|Overall Study||1
4933166|NCT03136068|12133358|P1|NOT COMPLETED|Overall Study||2
4933167|NCT03136068|12133357|P2|COMPLETED|Overall Study||89
4933168|NCT03136068|12133358|P1|COMPLETED|Overall Study||86
4933169|NCT03136068|12133357|P2|STARTED|Overall Study||90
4933170|NCT03136068|12133358|P1|STARTED|Overall Study||88
4933171|NCT03135899|12133380|P8|NOT COMPLETED|Overall Study||0
4933172|NCT03135899|12133381|P7|NOT COMPLETED|Overall Study||1
4933173|NCT03135899|12133382|P6|NOT COMPLETED|Overall Study||2
4933174|NCT03135899|12133383|P5|NOT COMPLETED|Overall Study||0
4933175|NCT03135899|12133384|P4|NOT COMPLETED|Overall Study||0
4933176|NCT03135899|12133385|P3|NOT COMPLETED|Overall Study||0
4933177|NCT03135899|12133386|P2|NOT COMPLETED|Overall Study||0
4933178|NCT03135899|12133387|P1|NOT COMPLETED|Overall Study||0
4933179|NCT03135899|12133380|P8|COMPLETED|Overall Study||8
4933180|NCT03135899|12133381|P7|COMPLETED|Overall Study||7
4933181|NCT03135899|12133382|P6|COMPLETED|Overall Study||7
4933182|NCT03135899|12133383|P5|COMPLETED|Overall Study||8
4933183|NCT03135899|12133384|P4|COMPLETED|Overall Study||1
4933184|NCT03135899|12133385|P3|COMPLETED|Overall Study||1
4933185|NCT03135899|12133386|P2|COMPLETED|Overall Study||1
4933186|NCT03135899|12133387|P1|COMPLETED|Overall Study||1
4933187|NCT03135899|12133380|P8|STARTED|Overall Study||8
4933188|NCT03135899|12133381|P7|STARTED|Overall Study||8
4933189|NCT03135899|12133382|P6|STARTED|Overall Study||9
4933190|NCT03135899|12133383|P5|STARTED|Overall Study||8
4933191|NCT03135899|12133384|P4|STARTED|Overall Study||1
4933192|NCT03135899|12133385|P3|STARTED|Overall Study||1
4933193|NCT03135899|12133386|P2|STARTED|Overall Study||1
4933194|NCT03135899|12133387|P1|STARTED|Overall Study||1
4933195|NCT03135548|12133420|P3|NOT COMPLETED|Overall Study||3
4933196|NCT03135548|12133421|P2|NOT COMPLETED|Overall Study||4
4933197|NCT03135548|12133422|P1|NOT COMPLETED|Overall Study||5
4933198|NCT03135548|12133420|P3|COMPLETED|Overall Study||18
4933199|NCT03135548|12133421|P2|COMPLETED|Overall Study||15
4933200|NCT03135548|12133422|P1|COMPLETED|Overall Study||14
4933201|NCT03135548|12133420|P3|STARTED|Overall Study||21
4933202|NCT03135548|12133421|P2|STARTED|Overall Study||19
4933203|NCT03135548|12133422|P1|STARTED|Overall Study||19
4933204|NCT03135535|12133442|P1|NOT COMPLETED|Overall Study||0
4933205|NCT03135535|12133442|P1|COMPLETED|Overall Study||30
4933206|NCT03135535|12133442|P1|STARTED|Overall Study||30
4933207|NCT03135431|12133452|P2|NOT COMPLETED|Overall Study||0
4933208|NCT03135431|12133453|P1|NOT COMPLETED|Overall Study||2
4933209|NCT03135431|12133452|P2|COMPLETED|Overall Study||20
4933210|NCT03135431|12133453|P1|COMPLETED|Overall Study||18
4933211|NCT03135431|12133452|P2|STARTED|Overall Study||20
4933212|NCT03135431|12133453|P1|STARTED|Overall Study||20
4933213|NCT03135379|12133465|P2|NOT COMPLETED|Overall Study||3
4933214|NCT03135379|12133466|P1|NOT COMPLETED|Overall Study||1
4933215|NCT03135379|12133465|P2|COMPLETED|Overall Study||59
4933216|NCT03135379|12133466|P1|COMPLETED|Overall Study||61
4933217|NCT03135379|12133465|P2|STARTED|Overall Study||62
4933218|NCT03135379|12133466|P1|STARTED|Overall Study||62
4933219|NCT03135028|12133474|P1|NOT COMPLETED|Overall Study||9
4933220|NCT03135028|12133474|P1|COMPLETED|Overall Study||0
4933221|NCT03135028|12133474|P1|STARTED|Overall Study||9
4933222|NCT03135015|12133482|P2|NOT COMPLETED|Overall Study||0
4933223|NCT03135015|12133483|P1|NOT COMPLETED|Overall Study||2
4933224|NCT03135015|12133482|P2|COMPLETED|Overall Study||11
4933225|NCT03135015|12133483|P1|COMPLETED|Overall Study||9
4933226|NCT03135015|12133482|P2|4g Tablets|Overall Study||11
4933227|NCT03135015|12133483|P1|4g Tablets|Overall Study||9
4933228|NCT03135015|12133482|P2|2g Tablets|Overall Study||11
4933229|NCT03135015|12133483|P1|2g Tablets|Overall Study||9
4933230|NCT03135015|12133482|P2|4g Capsules|Overall Study||11
4933231|NCT03135015|12133483|P1|4g Capsules|Overall Study||9
4933232|NCT03135015|12133482|P2|2g Capsules|Overall Study||11
4933233|NCT03135015|12133483|P1|2g Capsules|Overall Study||9
4933234|NCT03135015|12133482|P2|Placebo Capsules|Overall Study||11
4933235|NCT03135015|12133483|P1|Placebo Capsules|Overall Study||9
4933236|NCT03135015|12133482|P2|Water Control|Overall Study||11
4933237|NCT03135015|12133483|P1|Water Control|Overall Study||9
4933238|NCT03135015|12133482|P2|STARTED|Overall Study||11
4933239|NCT03135015|12133483|P1|STARTED|Overall Study||11
4933240|NCT03134911|12133591|P1|NOT COMPLETED|Overall Study||34
4933241|NCT03134911|12133591|P1|COMPLETED|Overall Study||501
4933242|NCT03134911|12133591|P1|STARTED|Overall Study||535
4933243|NCT03134768|12133618|P1|NOT COMPLETED|Overall Study||0
4933244|NCT03134768|12133618|P1|COMPLETED|Overall Study||50
4933245|NCT03134768|12133618|P1|STARTED|Overall Study||50
4933246|NCT03134703|12133626|P2|NOT COMPLETED|Overall Study||2
4933247|NCT03134703|12133627|P1|NOT COMPLETED|Overall Study||6
4933248|NCT03134703|12133626|P2|COMPLETED|Overall Study||3
4933249|NCT03134703|12133627|P1|COMPLETED|Overall Study||0
4933250|NCT03134703|12133626|P2|STARTED|Overall Study||5
4933251|NCT03134703|12133627|P1|STARTED|Overall Study||6
4933252|NCT03134599|12133653|P6|NOT COMPLETED|Week 3||1
4933253|NCT03134599|12133654|P5|NOT COMPLETED|Week 3||0
4933254|NCT03134599|12133655|P4|NOT COMPLETED|Week 3||1
4933255|NCT03134599|12133656|P3|NOT COMPLETED|Week 3||0
4933256|NCT03134599|12133657|P2|NOT COMPLETED|Week 3||0
4933257|NCT03134599|12133658|P1|NOT COMPLETED|Week 3||0
4933258|NCT03134599|12133653|P6|COMPLETED|Week 3||8
4933259|NCT03134599|12133654|P5|COMPLETED|Week 3||8
4933260|NCT03134599|12133655|P4|COMPLETED|Week 3||9
4933261|NCT03134599|12133656|P3|COMPLETED|Week 3||10
4933262|NCT03134599|12133657|P2|COMPLETED|Week 3||10
4933263|NCT03134599|12133658|P1|COMPLETED|Week 3||9
4933264|NCT03134599|12133653|P6|STARTED|Week 3||9
4933265|NCT03134599|12133654|P5|STARTED|Week 3||8
4933266|NCT03134599|12133655|P4|STARTED|Week 3||10
4933267|NCT03134599|12133656|P3|STARTED|Week 3||10
4933268|NCT03134599|12133657|P2|STARTED|Week 3||10
4933269|NCT03134599|12133658|P1|STARTED|Week 3||9
4933270|NCT03134599|12133653|P6|NOT COMPLETED|Week 2||0
4933271|NCT03134599|12133654|P5|NOT COMPLETED|Week 2||1
4933272|NCT03134599|12133655|P4|NOT COMPLETED|Week 2||1
4933273|NCT03134599|12133656|P3|NOT COMPLETED|Week 2||0
4933274|NCT03134599|12133657|P2|NOT COMPLETED|Week 2||0
4933275|NCT03134599|12133658|P1|NOT COMPLETED|Week 2||1
4933276|NCT03134599|12133653|P6|COMPLETED|Week 2||9
4933277|NCT03134599|12133654|P5|COMPLETED|Week 2||8
4933278|NCT03134599|12133655|P4|COMPLETED|Week 2||10
4933279|NCT03134599|12133656|P3|COMPLETED|Week 2||10
4933280|NCT03134599|12133657|P2|COMPLETED|Week 2||10
4933281|NCT03134599|12133658|P1|COMPLETED|Week 2||9
4933282|NCT03134599|12133653|P6|STARTED|Week 2||9
4933283|NCT03134599|12133654|P5|STARTED|Week 2||9
4933284|NCT03134599|12133655|P4|STARTED|Week 2||11
4933285|NCT03134599|12133656|P3|STARTED|Week 2||10
4933286|NCT03134599|12133657|P2|STARTED|Week 2||10
4933287|NCT03134599|12133658|P1|STARTED|Week 2||10
4933288|NCT03134599|12133653|P6|NOT COMPLETED|Week 1||0
4933289|NCT03134599|12133654|P5|NOT COMPLETED|Week 1||1
4933290|NCT03134599|12133655|P4|NOT COMPLETED|Week 1||0
4933291|NCT03134599|12133656|P3|NOT COMPLETED|Week 1||0
4933292|NCT03134599|12133657|P2|NOT COMPLETED|Week 1||0
4933293|NCT03134599|12133658|P1|NOT COMPLETED|Week 1||0
4933294|NCT03134599|12133653|P6|COMPLETED|Week 1||9
4933295|NCT03134599|12133654|P5|COMPLETED|Week 1||9
4933296|NCT03134599|12133655|P4|COMPLETED|Week 1||11
4933297|NCT03134599|12133656|P3|COMPLETED|Week 1||10
4933298|NCT03134599|12133657|P2|COMPLETED|Week 1||10
4933299|NCT03134599|12133658|P1|COMPLETED|Week 1||10
4933300|NCT03134599|12133653|P6|STARTED|Week 1||9
4933301|NCT03134599|12133654|P5|STARTED|Week 1||10
4933302|NCT03134599|12133655|P4|STARTED|Week 1||11
4933303|NCT03134599|12133656|P3|STARTED|Week 1||10
4933304|NCT03134599|12133657|P2|STARTED|Week 1||10
4933305|NCT03134599|12133658|P1|STARTED|Week 1||10
4933306|NCT03134326|12133666|P1|NOT COMPLETED|Overall Study||0
4933307|NCT03134326|12133666|P1|COMPLETED|Overall Study||21
4933308|NCT03134326|12133666|P1|STARTED|Overall Study||21
4933309|NCT03134313|12133670|P1|NOT COMPLETED|Overall Study||0
4933310|NCT03134313|12133670|P1|COMPLETED|Overall Study||25
4933311|NCT03134313|12133670|P1|STARTED|Overall Study||25
4933312|NCT03134248|12133674|P6|NOT COMPLETED|Week 3||0
4933313|NCT03134248|12133675|P5|NOT COMPLETED|Week 3||0
4933314|NCT03134248|12133676|P4|NOT COMPLETED|Week 3||0
4933315|NCT03134248|12133677|P3|NOT COMPLETED|Week 3||0
4933316|NCT03134248|12133678|P2|NOT COMPLETED|Week 3||0
4933317|NCT03134248|12133679|P1|NOT COMPLETED|Week 3||0
4933318|NCT03134248|12133674|P6|COMPLETED|Week 3||9
4933319|NCT03134248|12133675|P5|COMPLETED|Week 3||9
4933320|NCT03134248|12133676|P4|COMPLETED|Week 3||7
4933321|NCT03134248|12133677|P3|COMPLETED|Week 3||9
4933322|NCT03134248|12133678|P2|COMPLETED|Week 3||8
4933323|NCT03134248|12133679|P1|COMPLETED|Week 3||7
4933324|NCT03134248|12133674|P6|STARTED|Week 3||9
4933325|NCT03134248|12133675|P5|STARTED|Week 3||9
4933326|NCT03134248|12133676|P4|STARTED|Week 3||7
4933327|NCT03134248|12133677|P3|STARTED|Week 3||9
4933328|NCT03134248|12133678|P2|STARTED|Week 3||8
4933329|NCT03134248|12133679|P1|STARTED|Week 3||7
4933330|NCT03134248|12133674|P6|NOT COMPLETED|Week 2||0
4933331|NCT03134248|12133675|P5|NOT COMPLETED|Week 2||0
4933332|NCT03134248|12133676|P4|NOT COMPLETED|Week 2||0
4933333|NCT03134248|12133677|P3|NOT COMPLETED|Week 2||0
4933334|NCT03134248|12133678|P2|NOT COMPLETED|Week 2||0
4933335|NCT03134248|12133679|P1|NOT COMPLETED|Week 2||0
4933336|NCT03134248|12133674|P6|COMPLETED|Week 2||9
4933337|NCT03134248|12133675|P5|COMPLETED|Week 2||9
4933338|NCT03134248|12133676|P4|COMPLETED|Week 2||7
4933339|NCT03134248|12133677|P3|COMPLETED|Week 2||9
4933340|NCT03134248|12133678|P2|COMPLETED|Week 2||8
4933341|NCT03134248|12133679|P1|COMPLETED|Week 2||7
4933342|NCT03134248|12133674|P6|STARTED|Week 2||9
4933343|NCT03134248|12133675|P5|STARTED|Week 2||9
4933344|NCT03134248|12133676|P4|STARTED|Week 2||7
4933345|NCT03134248|12133677|P3|STARTED|Week 2||9
4933346|NCT03134248|12133678|P2|STARTED|Week 2||8
4933347|NCT03134248|12133679|P1|STARTED|Week 2||7
4933348|NCT03134248|12133674|P6|NOT COMPLETED|Week 1||0
4933349|NCT03134248|12133675|P5|NOT COMPLETED|Week 1||0
4933350|NCT03134248|12133676|P4|NOT COMPLETED|Week 1||0
4933351|NCT03134248|12133677|P3|NOT COMPLETED|Week 1||0
4933352|NCT03134248|12133678|P2|NOT COMPLETED|Week 1||0
4933353|NCT03134248|12133679|P1|NOT COMPLETED|Week 1||0
4933354|NCT03134248|12133674|P6|COMPLETED|Week 1||9
4933355|NCT03134248|12133675|P5|COMPLETED|Week 1||9
4933356|NCT03134248|12133676|P4|COMPLETED|Week 1||7
4933357|NCT03134248|12133677|P3|COMPLETED|Week 1||9
4933358|NCT03134248|12133678|P2|COMPLETED|Week 1||8
4933359|NCT03134248|12133679|P1|COMPLETED|Week 1||7
4933360|NCT03134248|12133674|P6|STARTED|Week 1||9
4933361|NCT03134248|12133675|P5|STARTED|Week 1||9
4933362|NCT03134248|12133676|P4|STARTED|Week 1||7
4933363|NCT03134248|12133677|P3|STARTED|Week 1||9
4933364|NCT03134248|12133678|P2|STARTED|Week 1||8
4933365|NCT03134248|12133679|P1|STARTED|Week 1||7
4933366|NCT03134222|12133698|P5|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
4933367|NCT03134222|12133699|P4|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
4933368|NCT03134222|12133700|P3|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
4933369|NCT03134222|12133701|P2|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
4933370|NCT03134222|12133702|P1|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
4933371|NCT03134222|12133698|P5|COMPLETED|Treatment Period (Week 12 to 48)||3
4933372|NCT03134222|12133699|P4|COMPLETED|Treatment Period (Week 12 to 48)||3
4933373|NCT03134222|12133700|P3|COMPLETED|Treatment Period (Week 12 to 48)||0
4933374|NCT03134222|12133701|P2|COMPLETED|Treatment Period (Week 12 to 48)||11
4933375|NCT03134222|12133702|P1|COMPLETED|Treatment Period (Week 12 to 48)||12
4933376|NCT03134222|12133698|P5|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
4933377|NCT03134222|12133699|P4|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
4933378|NCT03134222|12133700|P3|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
4933379|NCT03134222|12133701|P2|STARTED|Treatment Period (Week 12 to 48)||14
4933380|NCT03134222|12133702|P1|STARTED|Treatment Period (Week 12 to 48)||14
4933381|NCT03134222|12133698|P5|NOT COMPLETED|Treatment Period (Up to Week 12)||0
4933382|NCT03134222|12133699|P4|NOT COMPLETED|Treatment Period (Up to Week 12)||0
4933383|NCT03134222|12133700|P3|NOT COMPLETED|Treatment Period (Up to Week 12)||2
4933384|NCT03134222|12133701|P2|NOT COMPLETED|Treatment Period (Up to Week 12)||4
4933385|NCT03134222|12133702|P1|NOT COMPLETED|Treatment Period (Up to Week 12)||5
4933386|NCT03134222|12133698|P5|COMPLETED|Treatment Period (Up to Week 12)||0
4933387|NCT03134222|12133699|P4|COMPLETED|Treatment Period (Up to Week 12)||0
4933388|NCT03134222|12133700|P3|COMPLETED|Treatment Period (Up to Week 12)||8
4933389|NCT03134222|12133701|P2|COMPLETED|Treatment Period (Up to Week 12)||14
4933390|NCT03134222|12133702|P1|COMPLETED|Treatment Period (Up to Week 12)||14
4933391|NCT03134222|12133698|P5|STARTED|Treatment Period (Up to Week 12)||0
4933392|NCT03134222|12133699|P4|STARTED|Treatment Period (Up to Week 12)||0
4933393|NCT03134222|12133700|P3|STARTED|Treatment Period (Up to Week 12)||10
4933394|NCT03134222|12133701|P2|STARTED|Treatment Period (Up to Week 12)||18
4933395|NCT03134222|12133702|P1|STARTED|Treatment Period (Up to Week 12)||19
4933396|NCT03134183|12133724|P2|NOT COMPLETED|Overall Study||1
4933397|NCT03134183|12133725|P1|NOT COMPLETED|Overall Study||1
4933398|NCT03134183|12133724|P2|COMPLETED|Overall Study||33
4933399|NCT03134183|12133725|P1|COMPLETED|Overall Study||35
4933400|NCT03134183|12133724|P2|STARTED|Overall Study||34
4933401|NCT03134183|12133725|P1|STARTED|Overall Study||36
4933402|NCT03134144|12133735|P2|NOT COMPLETED|Overall Study||0
4933403|NCT03134144|12133736|P1|NOT COMPLETED|Overall Study||0
4933404|NCT03134144|12133735|P2|COMPLETED|Overall Study||30
4933405|NCT03134144|12133736|P1|COMPLETED|Overall Study||15
4933406|NCT03134144|12133735|P2|STARTED|Overall Study||30
4933407|NCT03134144|12133736|P1|STARTED|Overall Study||15
4933408|NCT03133767|12133752|P2|NOT COMPLETED|Overall Study||25
4933409|NCT03133767|12133753|P1|NOT COMPLETED|Overall Study||38
4933410|NCT03133767|12133752|P2|COMPLETED|Overall Study||53
4933411|NCT03133767|12133753|P1|COMPLETED|Overall Study||41
4933412|NCT03133767|12133752|P2|STARTED|Overall Study||78
4933413|NCT03133767|12133753|P1|STARTED|Overall Study||79
4933414|NCT03133481|12133769|P2|NOT COMPLETED|Overall Study||4
4933415|NCT03133481|12133770|P1|NOT COMPLETED|Overall Study||0
4933416|NCT03133481|12133769|P2|COMPLETED|Overall Study||45
4933417|NCT03133481|12133770|P1|COMPLETED|Overall Study||45
4933418|NCT03133481|12133769|P2|STARTED|Overall Study||49
4933419|NCT03133481|12133770|P1|STARTED|Overall Study||45
4933420|NCT03132571|12133800|P2|NOT COMPLETED|Overall Study||0
4933421|NCT03132571|12133801|P1|NOT COMPLETED|Overall Study||0
4933422|NCT03132571|12133800|P2|COMPLETED|Overall Study||2
4933423|NCT03132571|12133801|P1|COMPLETED|Overall Study||3
4933424|NCT03132571|12133800|P2|STARTED|Overall Study||2
4933425|NCT03132571|12133801|P1|STARTED|Overall Study||3
4933426|NCT03132298|12133815|P2|NOT COMPLETED|Overall Study||13
4933427|NCT03132298|12133816|P1|NOT COMPLETED|Overall Study||12
4933428|NCT03132298|12133815|P2|COMPLETED|Overall Study||35
4933429|NCT03132298|12133816|P1|COMPLETED|Overall Study||36
4933430|NCT03132298|12133815|P2|STARTED|Overall Study||48
4933431|NCT03132298|12133816|P1|STARTED|Overall Study||48
4933432|NCT03132246|12133846|P1|NOT COMPLETED|Overall Study||104
4933433|NCT03132246|12133846|P1|COMPLETED|Overall Study||156
4933434|NCT03132246|12133846|P1|STARTED|Overall Study||260
4933435|NCT03132220|12133857|P2|NOT COMPLETED|Overall Study||12
4933436|NCT03132220|12133858|P1|NOT COMPLETED|Overall Study||18
4933437|NCT03132220|12133857|P2|COMPLETED|Overall Study||54
4933438|NCT03132220|12133858|P1|COMPLETED|Overall Study||47
4933439|NCT03132220|12133857|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
4933440|NCT03132220|12133858|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
4933441|NCT03132220|12133857|P2|STARTED|Overall Study||66
4933442|NCT03132220|12133858|P1|STARTED|Overall Study||65
4933443|NCT03131999|12133886|P2|NOT COMPLETED|Overall Study||1
4933444|NCT03131999|12133887|P1|NOT COMPLETED|Overall Study||0
4933445|NCT03131999|12133886|P2|COMPLETED|Overall Study||7
4933446|NCT03131999|12133887|P1|COMPLETED|Overall Study||8
4933447|NCT03131999|12133886|P2|STARTED|Overall Study||8
4933448|NCT03131999|12133887|P1|STARTED|Overall Study||8
4933449|NCT03131895|12133899|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
4933450|NCT03131895|12133900|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
4933451|NCT03131895|12133901|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
4933452|NCT03131895|12133902|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
4933453|NCT03131895|12133899|P4|COMPLETED|Intervention Period 2 (2 Days)||25
4933454|NCT03131895|12133900|P3|COMPLETED|Intervention Period 2 (2 Days)||26
4933455|NCT03131895|12133901|P2|COMPLETED|Intervention Period 2 (2 Days)||22
4933456|NCT03131895|12133902|P1|COMPLETED|Intervention Period 2 (2 Days)||26
4933457|NCT03131895|12133899|P4|STARTED|Intervention Period 2 (2 Days)||25
4933458|NCT03131895|12133900|P3|STARTED|Intervention Period 2 (2 Days)||26
4933459|NCT03131895|12133901|P2|STARTED|Intervention Period 2 (2 Days)||23
4933460|NCT03131895|12133902|P1|STARTED|Intervention Period 2 (2 Days)||27
4933461|NCT03131895|12133899|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
4933462|NCT03131895|12133900|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
4933463|NCT03131895|12133901|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
4933464|NCT03131895|12133902|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
4933465|NCT03131895|12133899|P4|COMPLETED|Washout Period (at Least 5 Days)||25
4933466|NCT03131895|12133900|P3|COMPLETED|Washout Period (at Least 5 Days)||26
4933467|NCT03131895|12133901|P2|COMPLETED|Washout Period (at Least 5 Days)||23
4933468|NCT03131895|12133902|P1|COMPLETED|Washout Period (at Least 5 Days)||27
4933469|NCT03131895|12133899|P4|STARTED|Washout Period (at Least 5 Days)||30
4933470|NCT03131895|12133900|P3|STARTED|Washout Period (at Least 5 Days)||30
4933471|NCT03131895|12133901|P2|STARTED|Washout Period (at Least 5 Days)||28
4933472|NCT03131895|12133902|P1|STARTED|Washout Period (at Least 5 Days)||28
4933473|NCT03131895|12133899|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
4933474|NCT03131895|12133900|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
4933475|NCT03131895|12133901|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
4933476|NCT03131895|12133902|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
4933477|NCT03131895|12133899|P4|COMPLETED|Intervention Period 1 (2 Days)||30
4933478|NCT03131895|12133900|P3|COMPLETED|Intervention Period 1 (2 Days)||30
4933479|NCT03131895|12133901|P2|COMPLETED|Intervention Period 1 (2 Days)||28
4933480|NCT03131895|12133902|P1|COMPLETED|Intervention Period 1 (2 Days)||28
4933481|NCT03131895|12133899|P4|STARTED|Intervention Period 1 (2 Days)||30
4933482|NCT03131895|12133900|P3|STARTED|Intervention Period 1 (2 Days)||30
4933483|NCT03131895|12133901|P2|STARTED|Intervention Period 1 (2 Days)||28
4933484|NCT03131895|12133902|P1|STARTED|Intervention Period 1 (2 Days)||28
4933485|NCT03131713|12133922|P2|NOT COMPLETED|Overall Study||0
4933486|NCT03131713|12133923|P1|NOT COMPLETED|Overall Study||5
4933487|NCT03131713|12133922|P2|COMPLETED|Overall Study||51
4933488|NCT03131713|12133923|P1|COMPLETED|Overall Study||45
4933489|NCT03131713|12133922|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
4933490|NCT03131713|12133923|P1|STARTED|Overall Study||50
4933491|NCT03131687|12133947|P6|NOT COMPLETED|Overall Study||5
4933492|NCT03131687|12133948|P5|NOT COMPLETED|Overall Study||8
4933493|NCT03131687|12133949|P4|NOT COMPLETED|Overall Study||4
4933494|NCT03131687|12133950|P3|NOT COMPLETED|Overall Study||3
4933495|NCT03131687|12133951|P2|NOT COMPLETED|Overall Study||9
4933496|NCT03131687|12133952|P1|NOT COMPLETED|Overall Study||6
4933497|NCT03131687|12133947|P6|COMPLETED|Overall Study||49
4933498|NCT03131687|12133948|P5|COMPLETED|Overall Study||45
4933499|NCT03131687|12133949|P4|COMPLETED|Overall Study||48
4933500|NCT03131687|12133950|P3|COMPLETED|Overall Study||52
4933501|NCT03131687|12133951|P2|COMPLETED|Overall Study||44
4933502|NCT03131687|12133952|P1|COMPLETED|Overall Study||45
4933503|NCT03131687|12133947|P6|Received at Least One Dose of Study Drug|Overall Study||54
4933504|NCT03131687|12133948|P5|Received at Least One Dose of Study Drug|Overall Study||53
4933505|NCT03131687|12133949|P4|Received at Least One Dose of Study Drug|Overall Study||51
4933506|NCT03131687|12133950|P3|Received at Least One Dose of Study Drug|Overall Study||55
4933507|NCT03131687|12133951|P2|Received at Least One Dose of Study Drug|Overall Study||52
4933508|NCT03131687|12133952|P1|Received at Least One Dose of Study Drug|Overall Study||51
4933509|NCT03131687|12133947|P6|STARTED|Overall Study||54
4933510|NCT03131687|12133948|P5|STARTED|Overall Study||53
4933511|NCT03131687|12133949|P4|STARTED|Overall Study||52
4933512|NCT03131687|12133950|P3|STARTED|Overall Study||55
4933513|NCT03131687|12133951|P2|STARTED|Overall Study||53
4933514|NCT03131687|12133952|P1|STARTED|Overall Study||51
4933515|NCT03131596|12134062|P2|NOT COMPLETED|Overall Study||3
4933516|NCT03131596|12134063|P1|NOT COMPLETED|Overall Study||6
4933517|NCT03131596|12134062|P2|COMPLETED|Overall Study||97
4933518|NCT03131596|12134063|P1|COMPLETED|Overall Study||94
4933519|NCT03131596|12134062|P2|STARTED|Overall Study||100
4933520|NCT03131596|12134063|P1|STARTED|Overall Study||100
4933521|NCT03131479|12134080|P5|NOT COMPLETED|Overall Study||0
4933522|NCT03131479|12134081|P4|NOT COMPLETED|Overall Study||2
4933523|NCT03131479|12134082|P3|NOT COMPLETED|Overall Study||1
4933524|NCT03131479|12134083|P2|NOT COMPLETED|Overall Study||0
4933525|NCT03131479|12134084|P1|NOT COMPLETED|Overall Study||0
4933526|NCT03131479|12134080|P5|COMPLETED|Overall Study||10
4933527|NCT03131479|12134081|P4|COMPLETED|Overall Study||10
4933528|NCT03131479|12134082|P3|COMPLETED|Overall Study||10
4933529|NCT03131479|12134083|P2|COMPLETED|Overall Study||10
4933530|NCT03131479|12134084|P1|COMPLETED|Overall Study||10
4933531|NCT03131479|12134080|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
4933532|NCT03131479|12134081|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
4933533|NCT03131479|12134082|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
4933534|NCT03131479|12134083|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
4933535|NCT03131479|12134084|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
4933536|NCT03131479|12134080|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
4933537|NCT03131479|12134081|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
4933538|NCT03131479|12134082|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
4933539|NCT03131479|12134083|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
4933540|NCT03131479|12134084|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
4933541|NCT03131479|12134080|P5|Safety Analysis Set (SS)|Overall Study||10
4933542|NCT03131479|12134081|P4|Safety Analysis Set (SS)|Overall Study||12
4933543|NCT03131479|12134082|P3|Safety Analysis Set (SS)|Overall Study||11
4933544|NCT03131479|12134083|P2|Safety Analysis Set (SS)|Overall Study||10
4933545|NCT03131479|12134084|P1|Safety Analysis Set (SS)|Overall Study||10
4933546|NCT03131479|12134080|P5|STARTED|Overall Study||10
4933547|NCT03131479|12134081|P4|STARTED|Overall Study||12
4933548|NCT03131479|12134082|P3|STARTED|Overall Study||11
4933549|NCT03131479|12134083|P2|STARTED|Overall Study||10
4933550|NCT03131479|12134084|P1|STARTED|Overall Study||10
4933551|NCT03131206|12134145|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933552|NCT03131206|12134146|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933553|NCT03131206|12134147|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933554|NCT03131206|12134148|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933555|NCT03131206|12134145|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933556|NCT03131206|12134146|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933557|NCT03131206|12134147|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933558|NCT03131206|12134148|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933559|NCT03131206|12134145|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933560|NCT03131206|12134146|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933561|NCT03131206|12134147|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933562|NCT03131206|12134148|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
4933563|NCT03131206|12134145|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933564|NCT03131206|12134146|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933565|NCT03131206|12134147|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933566|NCT03131206|12134148|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933567|NCT03131206|12134145|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933568|NCT03131206|12134146|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933569|NCT03131206|12134147|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933570|NCT03131206|12134148|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
4933571|NCT03131206|12134145|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933572|NCT03131206|12134146|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933573|NCT03131206|12134147|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
4933574|NCT03131206|12134148|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
4933575|NCT03131167|12134179|P13|NOT COMPLETED|Overall Study||0
4933576|NCT03131167|12134180|P12|NOT COMPLETED|Overall Study||0
4933577|NCT03131167|12134181|P11|NOT COMPLETED|Overall Study||0
4933578|NCT03131167|12134182|P10|NOT COMPLETED|Overall Study||0
4933579|NCT03131167|12134183|P9|NOT COMPLETED|Overall Study||0
4933580|NCT03131167|12134184|P8|NOT COMPLETED|Overall Study||0
4933581|NCT03131167|12134185|P7|NOT COMPLETED|Overall Study||0
4933582|NCT03131167|12134186|P6|NOT COMPLETED|Overall Study||1
4933583|NCT03131167|12134187|P5|NOT COMPLETED|Overall Study||0
4933584|NCT03131167|12134188|P4|NOT COMPLETED|Overall Study||0
4933585|NCT03131167|12134189|P3|NOT COMPLETED|Overall Study||0
4933586|NCT03131167|12134190|P2|NOT COMPLETED|Overall Study||0
4933587|NCT03131167|12134191|P1|NOT COMPLETED|Overall Study||0
4933588|NCT03131167|12134179|P13|COMPLETED|Overall Study||5
4933589|NCT03131167|12134180|P12|COMPLETED|Overall Study||5
4933590|NCT03131167|12134181|P11|COMPLETED|Overall Study||4
4933591|NCT03131167|12134182|P10|COMPLETED|Overall Study||5
4933592|NCT03131167|12134183|P9|COMPLETED|Overall Study||2
4933593|NCT03131167|12134184|P8|COMPLETED|Overall Study||5
4933594|NCT03131167|12134185|P7|COMPLETED|Overall Study||5
4933595|NCT03131167|12134186|P6|COMPLETED|Overall Study||4
4933596|NCT03131167|12134187|P5|COMPLETED|Overall Study||6
4933597|NCT03131167|12134188|P4|COMPLETED|Overall Study||5
4933598|NCT03131167|12134189|P3|COMPLETED|Overall Study||5
4933599|NCT03131167|12134190|P2|COMPLETED|Overall Study||5
4933600|NCT03131167|12134191|P1|COMPLETED|Overall Study||6
4933601|NCT03131167|12134179|P13|STARTED|Overall Study||5
4933602|NCT03131167|12134180|P12|STARTED|Overall Study||5
4933603|NCT03131167|12134181|P11|STARTED|Overall Study||4
4933604|NCT03131167|12134182|P10|STARTED|Overall Study||5
4933605|NCT03131167|12134183|P9|STARTED|Overall Study||2
4933606|NCT03131167|12134184|P8|STARTED|Overall Study||5
4933607|NCT03131167|12134185|P7|STARTED|Overall Study||5
4933608|NCT03131167|12134186|P6|STARTED|Overall Study||5
4933609|NCT03131167|12134187|P5|STARTED|Overall Study||6
4933610|NCT03131167|12134188|P4|STARTED|Overall Study||5
4933611|NCT03131167|12134189|P3|STARTED|Overall Study||5
4933612|NCT03131167|12134190|P2|STARTED|Overall Study||5
4933613|NCT03131167|12134191|P1|STARTED|Overall Study||6
4933614|NCT03130738|12134235|P3|NOT COMPLETED|Overall Study||6
4933615|NCT03130738|12134236|P2|NOT COMPLETED|Overall Study||2
4933616|NCT03130738|12134237|P1|NOT COMPLETED|Overall Study||3
4933617|NCT03130738|12134235|P3|COMPLETED|Overall Study||14
4933618|NCT03130738|12134236|P2|COMPLETED|Overall Study||20
4933619|NCT03130738|12134237|P1|COMPLETED|Overall Study||20
4933620|NCT03130738|12134235|P3|STARTED|Overall Study||20
4933621|NCT03130738|12134236|P2|STARTED|Overall Study||22
4933622|NCT03130738|12134237|P1|STARTED|Overall Study||23
4933623|NCT03129321|12134251|P3|NOT COMPLETED|Overall Study||55
4933624|NCT03129321|12134252|P2|NOT COMPLETED|Overall Study||109
4933625|NCT03129321|12134253|P1|NOT COMPLETED|Overall Study||98
4933626|NCT03129321|12134251|P3|COMPLETED|Overall Study||120
4933627|NCT03129321|12134252|P2|COMPLETED|Overall Study||241
4933628|NCT03129321|12134253|P1|COMPLETED|Overall Study||253
4933629|NCT03129321|12134251|P3|STARTED|Overall Study||175
4933630|NCT03129321|12134252|P2|STARTED|Overall Study||350
4933631|NCT03129321|12134253|P1|STARTED|Overall Study||351
4933632|NCT03129178|12134275|P2|NOT COMPLETED|Overall Study||2
4933633|NCT03129178|12134276|P1|NOT COMPLETED|Overall Study||1
4933634|NCT03129178|12134275|P2|COMPLETED|Overall Study||11
4933635|NCT03129178|12134276|P1|COMPLETED|Overall Study||12
4933636|NCT03129178|12134275|P2|STARTED|Overall Study||13
4933637|NCT03129178|12134276|P1|STARTED|Overall Study||13
4933638|NCT03128931|12134294|P1|NOT COMPLETED|Overall Study||4
4933639|NCT03128931|12134294|P1|COMPLETED|Overall Study||41
4933640|NCT03128931|12134294|P1|STARTED|Overall Study||45
4933641|NCT03128892|12134298|P1|NOT COMPLETED|Overall Study||3
4933642|NCT03128892|12134298|P1|COMPLETED|Overall Study||31
4933643|NCT03128892|12134298|P1|STARTED|Overall Study||34
4933644|NCT03128723|12134304|P1|NOT COMPLETED|Overall Study||2
4933645|NCT03128723|12134304|P1|COMPLETED|Overall Study||43
4933646|NCT03128723|12134304|P1|STARTED|Overall Study||45
4933647|NCT03128372|12134319|P1|NOT COMPLETED|Overall Study||0
4933648|NCT03128372|12134319|P1|COMPLETED|Overall Study||32
4933649|NCT03128372|12134319|P1|STARTED|Overall Study||32
4933650|NCT03128307|12134323|P1|NOT COMPLETED|Overall Study||34
4933651|NCT03128307|12134323|P1|COMPLETED|Overall Study||570
4933652|NCT03128307|12134323|P1|STARTED|Overall Study||604
4933653|NCT03128099|12134331|P3|NOT COMPLETED|Overall Study||1
4933654|NCT03128099|12134332|P2|NOT COMPLETED|Overall Study||4
4933655|NCT03128099|12134333|P1|NOT COMPLETED|Overall Study||2
4933656|NCT03128099|12134331|P3|COMPLETED|Overall Study||21
4933657|NCT03128099|12134332|P2|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
4933658|NCT03128099|12134333|P1|COMPLETED|Overall Study||19
4933659|NCT03128099|12134331|P3|Hour 2 (High Dose) Completed|Overall Study||0
4933660|NCT03128099|12134332|P2|Hour 2 (High Dose) Completed|Overall Study||0
4933661|NCT03128099|12134333|P1|Hour 2 (High Dose) Completed|Overall Study||0
4933662|NCT03128099|12134331|P3|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
4933663|NCT03128099|12134332|P2|Hour 2 (High Dose)Started|Overall Study||4
4933664|NCT03128099|12134333|P1|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
4933665|NCT03128099|12134331|P3|Hour 1 (Low Dose) Completed|Overall Study||21
4933666|NCT03128099|12134332|P2|Hour 1 (Low Dose) Completed|Overall Study||4
4933667|NCT03128099|12134333|P1|Hour 1 (Low Dose) Completed|Overall Study||19
4933668|NCT03128099|12134331|P3|Hour 1 (Low Dose) Started|Overall Study||22
4933669|NCT03128099|12134332|P2|Hour 1 (Low Dose) Started|Overall Study||4
4933670|NCT03128099|12134333|P1|Hour 1 (Low Dose) Started|Overall Study||21
4933671|NCT03128099|12134331|P3|STARTED|Overall Study||22
4933672|NCT03128099|12134332|P2|STARTED|Overall Study||4
4933673|NCT03128099|12134333|P1|STARTED|Overall Study||21
4933674|NCT03128086|12134341|P2|NOT COMPLETED|Overall Study||0
4933675|NCT03128086|12134342|P1|NOT COMPLETED|Overall Study||0
4933676|NCT03128086|12134341|P2|COMPLETED|Overall Study||44
4933677|NCT03128086|12134342|P1|COMPLETED|Overall Study||50
4933678|NCT03128086|12134341|P2|STARTED|Overall Study||44
4933679|NCT03128086|12134342|P1|STARTED|Overall Study||50
4933680|NCT03128008|12134362|P1|NOT COMPLETED|Overall Study||9
4933681|NCT03128008|12134362|P1|COMPLETED|Overall Study|9 participants are in follow up|1
4933682|NCT03128008|12134362|P1|STARTED|Overall Study||10
4933683|NCT03127956|12134367|P1|NOT COMPLETED|Overall Study||317
4933684|NCT03127956|12134367|P1|COMPLETED|Overall Study||431
4933685|NCT03127956|12134367|P1|STARTED|Overall Study||748
4933686|NCT03127943|12134371|P2|NOT COMPLETED|Second Intervention||0
4933687|NCT03127943|12134372|P1|NOT COMPLETED|Second Intervention||0
4933688|NCT03127943|12134371|P2|COMPLETED|Second Intervention||12
4933689|NCT03127943|12134372|P1|COMPLETED|Second Intervention||12
4933690|NCT03127943|12134371|P2|STARTED|Second Intervention||12
4933691|NCT03127943|12134372|P1|STARTED|Second Intervention||12
4933692|NCT03127943|12134371|P2|NOT COMPLETED|Washout (1 Week)||0
4933693|NCT03127943|12134372|P1|NOT COMPLETED|Washout (1 Week)||0
4933694|NCT03127943|12134371|P2|COMPLETED|Washout (1 Week)||12
4933695|NCT03127943|12134372|P1|COMPLETED|Washout (1 Week)||12
4933696|NCT03127943|12134371|P2|STARTED|Washout (1 Week)||12
4933697|NCT03127943|12134372|P1|STARTED|Washout (1 Week)||12
4933698|NCT03127943|12134371|P2|NOT COMPLETED|First Intervention||0
4933699|NCT03127943|12134372|P1|NOT COMPLETED|First Intervention||0
4933700|NCT03127943|12134371|P2|COMPLETED|First Intervention||12
4933701|NCT03127943|12134372|P1|COMPLETED|First Intervention||12
4933702|NCT03127943|12134371|P2|STARTED|First Intervention||12
4933703|NCT03127943|12134372|P1|STARTED|First Intervention||12
4933704|NCT03127644|12134383|P3|NOT COMPLETED|Overall Study||2
4933705|NCT03127644|12134384|P2|NOT COMPLETED|Overall Study||0
4933706|NCT03127644|12134385|P1|NOT COMPLETED|Overall Study||0
4933707|NCT03127644|12134383|P3|COMPLETED|Overall Study||31
4933708|NCT03127644|12134384|P2|COMPLETED|Overall Study||36
4933709|NCT03127644|12134385|P1|COMPLETED|Overall Study||34
4933710|NCT03127644|12134383|P3|STARTED|Overall Study||33
4933711|NCT03127644|12134384|P2|STARTED|Overall Study||36
4933712|NCT03127644|12134385|P1|STARTED|Overall Study||34
4933713|NCT03127384|12134417|P1|NOT COMPLETED|Overall Study||6
4933714|NCT03127384|12134417|P1|COMPLETED|Overall Study||43
4933715|NCT03127384|12134417|P1|Completed 3 Month Visit|Overall Study||47
4933716|NCT03127384|12134417|P1|STARTED|Overall Study||49
4933717|NCT03127228|12134425|P2|NOT COMPLETED|Overall Study||0
4933718|NCT03127228|12134426|P1|NOT COMPLETED|Overall Study||0
4933719|NCT03127228|12134425|P2|COMPLETED|Overall Study||12
4933720|NCT03127228|12134426|P1|COMPLETED|Overall Study||12
4933721|NCT03127228|12134425|P2|STARTED|Overall Study||12
4933722|NCT03127228|12134426|P1|STARTED|Overall Study||12
4933723|NCT03126682|12134440|P2|NOT COMPLETED|Overall Study||0
4933724|NCT03126682|12134441|P1|NOT COMPLETED|Overall Study||0
4933725|NCT03126682|12134440|P2|COMPLETED|Overall Study||5
4933726|NCT03126682|12134441|P1|COMPLETED|Overall Study||5
4933727|NCT03126682|12134440|P2|STARTED|Overall Study||5
4933728|NCT03126682|12134441|P1|STARTED|Overall Study||5
4933729|NCT03126539|12134453|P5|NOT COMPLETED|Overall Study||0
4933730|NCT03126539|12134454|P4|NOT COMPLETED|Overall Study||0
4933731|NCT03126539|12134455|P3|NOT COMPLETED|Overall Study||1
4933732|NCT03126539|12134456|P2|NOT COMPLETED|Overall Study||1
4933733|NCT03126539|12134457|P1|NOT COMPLETED|Overall Study||1
4933734|NCT03126539|12134453|P5|COMPLETED|Overall Study||0
4933735|NCT03126539|12134454|P4|COMPLETED|Overall Study||0
4933736|NCT03126539|12134455|P3|COMPLETED|Overall Study||8
4933737|NCT03126539|12134456|P2|COMPLETED|Overall Study||8
4933738|NCT03126539|12134457|P1|COMPLETED|Overall Study||8
4933739|NCT03126539|12134453|P5|STARTED|Overall Study||0
4933740|NCT03126539|12134454|P4|STARTED|Overall Study|Group B was not done|0
4933741|NCT03126539|12134455|P3|STARTED|Overall Study||9
4933742|NCT03126539|12134456|P2|STARTED|Overall Study||9
4933743|NCT03126539|12134457|P1|STARTED|Overall Study||9
4933744|NCT03126448|12134473|P3|NOT COMPLETED|Overall Study||10
4933745|NCT03126448|12134474|P2|NOT COMPLETED|Overall Study||8
4933746|NCT03126448|12134475|P1|NOT COMPLETED|Overall Study||13
4933747|NCT03126448|12134473|P3|COMPLETED|Overall Study||27
4933748|NCT03126448|12134474|P2|COMPLETED|Overall Study||41
4933749|NCT03126448|12134475|P1|COMPLETED|Overall Study||43
4933750|NCT03126448|12134473|P3|STARTED|Overall Study||37
4933751|NCT03126448|12134474|P2|STARTED|Overall Study||49
4933752|NCT03126448|12134475|P1|STARTED|Overall Study||56
4933753|NCT03125941|12134485|P2|NOT COMPLETED|Overall Study||2
4933754|NCT03125941|12134486|P1|NOT COMPLETED|Overall Study||1
4933755|NCT03125941|12134485|P2|COMPLETED|Overall Study||63
4933756|NCT03125941|12134486|P1|COMPLETED|Overall Study||64
4933757|NCT03125941|12134485|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
4933758|NCT03125941|12134486|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
4933759|NCT03125941|12134485|P2|STARTED|Overall Study||65
4933760|NCT03125941|12134486|P1|STARTED|Overall Study||65
4933761|NCT03125915|12134522|P4|NOT COMPLETED|6 Month Follow-up||3
4933762|NCT03125915|12134523|P3|NOT COMPLETED|6 Month Follow-up||6
4933763|NCT03125915|12134524|P2|NOT COMPLETED|6 Month Follow-up||3
4933764|NCT03125915|12134525|P1|NOT COMPLETED|6 Month Follow-up||7
4933765|NCT03125915|12134522|P4|COMPLETED|6 Month Follow-up||31
4933766|NCT03125915|12134523|P3|COMPLETED|6 Month Follow-up||28
4933767|NCT03125915|12134524|P2|COMPLETED|6 Month Follow-up||37
4933768|NCT03125915|12134525|P1|COMPLETED|6 Month Follow-up||25
4933769|NCT03125915|12134522|P4|STARTED|6 Month Follow-up||34
4933770|NCT03125915|12134523|P3|STARTED|6 Month Follow-up||34
4933771|NCT03125915|12134524|P2|STARTED|6 Month Follow-up||40
4933772|NCT03125915|12134525|P1|STARTED|6 Month Follow-up||32
4933773|NCT03125915|12134522|P4|NOT COMPLETED|3 Month Follow-up||2
4933774|NCT03125915|12134523|P3|NOT COMPLETED|3 Month Follow-up||4
4933775|NCT03125915|12134524|P2|NOT COMPLETED|3 Month Follow-up||4
4933776|NCT03125915|12134525|P1|NOT COMPLETED|3 Month Follow-up||6
4933777|NCT03125915|12134522|P4|COMPLETED|3 Month Follow-up||32
4933778|NCT03125915|12134523|P3|COMPLETED|3 Month Follow-up||30
4933779|NCT03125915|12134524|P2|COMPLETED|3 Month Follow-up||36
4933780|NCT03125915|12134525|P1|COMPLETED|3 Month Follow-up||26
4933781|NCT03125915|12134522|P4|STARTED|3 Month Follow-up||34
4933782|NCT03125915|12134523|P3|STARTED|3 Month Follow-up||34
4933783|NCT03125915|12134524|P2|STARTED|3 Month Follow-up||40
4933784|NCT03125915|12134525|P1|STARTED|3 Month Follow-up||32
4933785|NCT03125915|12134522|P4|NOT COMPLETED|1 Month Follow up||3
4933786|NCT03125915|12134523|P3|NOT COMPLETED|1 Month Follow up||2
4933787|NCT03125915|12134524|P2|NOT COMPLETED|1 Month Follow up||3
4933788|NCT03125915|12134525|P1|NOT COMPLETED|1 Month Follow up||3
4933789|NCT03125915|12134522|P4|COMPLETED|1 Month Follow up||31
4933790|NCT03125915|12134523|P3|COMPLETED|1 Month Follow up||32
4933791|NCT03125915|12134524|P2|COMPLETED|1 Month Follow up||37
4933792|NCT03125915|12134525|P1|COMPLETED|1 Month Follow up||29
4933793|NCT03125915|12134522|P4|STARTED|1 Month Follow up||34
4933794|NCT03125915|12134523|P3|STARTED|1 Month Follow up||34
4933795|NCT03125915|12134524|P2|STARTED|1 Month Follow up||40
4933796|NCT03125915|12134525|P1|STARTED|1 Month Follow up||32
4933797|NCT03125915|12134522|P4|NOT COMPLETED|Baseline and Intervention||0
4933798|NCT03125915|12134523|P3|NOT COMPLETED|Baseline and Intervention||0
4933799|NCT03125915|12134524|P2|NOT COMPLETED|Baseline and Intervention||0
4933800|NCT03125915|12134525|P1|NOT COMPLETED|Baseline and Intervention||0
4933801|NCT03125915|12134522|P4|COMPLETED|Baseline and Intervention||34
4933802|NCT03125915|12134523|P3|COMPLETED|Baseline and Intervention||34
4933803|NCT03125915|12134524|P2|COMPLETED|Baseline and Intervention||40
4933804|NCT03125915|12134525|P1|COMPLETED|Baseline and Intervention||32
4933805|NCT03125915|12134522|P4|STARTED|Baseline and Intervention||34
4933806|NCT03125915|12134523|P3|STARTED|Baseline and Intervention||34
4933807|NCT03125915|12134524|P2|STARTED|Baseline and Intervention||40
4933808|NCT03125915|12134525|P1|STARTED|Baseline and Intervention||32
4933809|NCT03125200|12134550|P7|NOT COMPLETED|Overall Study||3
4933810|NCT03125200|12134551|P6|NOT COMPLETED|Overall Study||3
4933811|NCT03125200|12134552|P5|NOT COMPLETED|Overall Study||4
4933812|NCT03125200|12134553|P4|NOT COMPLETED|Overall Study||5
4933813|NCT03125200|12134554|P3|NOT COMPLETED|Overall Study||2
4933814|NCT03125200|12134555|P2|NOT COMPLETED|Overall Study||2
4933815|NCT03125200|12134556|P1|NOT COMPLETED|Overall Study||2
4933816|NCT03125200|12134550|P7|COMPLETED|Overall Study||0
4933817|NCT03125200|12134551|P6|COMPLETED|Overall Study||0
4933818|NCT03125200|12134552|P5|COMPLETED|Overall Study||0
4933819|NCT03125200|12134553|P4|COMPLETED|Overall Study||0
4933820|NCT03125200|12134554|P3|COMPLETED|Overall Study||0
4933821|NCT03125200|12134555|P2|COMPLETED|Overall Study||0
4933822|NCT03125200|12134556|P1|COMPLETED|Overall Study||0
4933823|NCT03125200|12134550|P7|STARTED|Overall Study||3
4933824|NCT03125200|12134551|P6|STARTED|Overall Study||3
4933825|NCT03125200|12134552|P5|STARTED|Overall Study||4
4933826|NCT03125200|12134553|P4|STARTED|Overall Study||5
4933827|NCT03125200|12134554|P3|STARTED|Overall Study||2
4933828|NCT03125200|12134555|P2|STARTED|Overall Study||2
4933829|NCT03125200|12134556|P1|STARTED|Overall Study||2
4933830|NCT03125031|12134754|P2|NOT COMPLETED|Overall Study||0
4933831|NCT03125031|12134755|P1|NOT COMPLETED|Overall Study||0
4933832|NCT03125031|12134754|P2|COMPLETED|Overall Study||44
4933833|NCT03125031|12134755|P1|COMPLETED|Overall Study||44
4933834|NCT03125031|12134754|P2|STARTED|Overall Study||44
4933835|NCT03125031|12134755|P1|STARTED|Overall Study||44
4933836|NCT03125018|12134760|P1|NOT COMPLETED|Overall Study||0
4933837|NCT03125018|12134760|P1|COMPLETED|Overall Study||13
4933838|NCT03125018|12134760|P1|STARTED|Overall Study||13
4933839|NCT03125005|12134764|P1|NOT COMPLETED|Overall Study||0
4933840|NCT03125005|12134764|P1|COMPLETED|Overall Study||51
4933841|NCT03125005|12134764|P1|STARTED|Overall Study||51
4933842|NCT03124979|12134768|P1|NOT COMPLETED|Overall Study||0
4933843|NCT03124979|12134768|P1|COMPLETED|Overall Study||13
4933844|NCT03124979|12134768|P1|STARTED|Overall Study||13
4933845|NCT03124966|12134772|P1|NOT COMPLETED|Overall Study||0
4933846|NCT03124966|12134772|P1|COMPLETED|Overall Study||118
4933847|NCT03124966|12134772|P1|STARTED|Overall Study||118
4933848|NCT03124927|12134776|P1|NOT COMPLETED|Overall Study||0
4933849|NCT03124927|12134776|P1|COMPLETED|Overall Study||25
4933850|NCT03124927|12134776|P1|STARTED|Overall Study||25
4933851|NCT03124901|12134780|P1|NOT COMPLETED|Overall Study||0
4933852|NCT03124901|12134780|P1|COMPLETED|Overall Study||147
4933853|NCT03124901|12134780|P1|STARTED|Overall Study||147
4933854|NCT03124836|12134784|P1|NOT COMPLETED|Overall Study||0
4933855|NCT03124836|12134784|P1|COMPLETED|Overall Study||28
4933856|NCT03124836|12134784|P1|STARTED|Overall Study||28
4933857|NCT03124823|12134788|P1|NOT COMPLETED|Overall Study||0
4933858|NCT03124823|12134788|P1|COMPLETED|Overall Study||11
4933859|NCT03124823|12134788|P1|STARTED|Overall Study||11
4933860|NCT03124797|12134792|P1|NOT COMPLETED|Overall Study||0
4933861|NCT03124797|12134792|P1|COMPLETED|Overall Study||18
4933862|NCT03124797|12134792|P1|STARTED|Overall Study||18
4933863|NCT03124784|12134796|P1|NOT COMPLETED|Overall Study||2
4933864|NCT03124784|12134796|P1|COMPLETED|Overall Study||25
4933865|NCT03124784|12134796|P1|STARTED|Overall Study||27
4933866|NCT03124771|12134800|P1|NOT COMPLETED|Overall Study||0
4933867|NCT03124771|12134800|P1|COMPLETED|Overall Study||132
4933868|NCT03124771|12134800|P1|STARTED|Overall Study||132
4933869|NCT03124758|12134804|P1|NOT COMPLETED|Overall Study||0
4933870|NCT03124758|12134804|P1|COMPLETED|Overall Study||354
4933871|NCT03124758|12134804|P1|STARTED|Overall Study||354
4933872|NCT03124693|12134808|P1|NOT COMPLETED|Overall Study||0
4933873|NCT03124693|12134808|P1|COMPLETED|Overall Study||90
4933874|NCT03124693|12134808|P1|STARTED|Overall Study||90
4933875|NCT03124602|12134812|P1|NOT COMPLETED|Overall Study||10
4933876|NCT03124602|12134812|P1|COMPLETED|Overall Study||25
4933877|NCT03124602|12134812|P1|STARTED|Overall Study||35
4933878|NCT03124563|12134818|P2|NOT COMPLETED|Overall Study||2
4933879|NCT03124563|12134819|P1|NOT COMPLETED|Overall Study||2
4933880|NCT03124563|12134818|P2|COMPLETED|Overall Study||29
4933881|NCT03124563|12134819|P1|COMPLETED|Overall Study||30
4933882|NCT03124563|12134818|P2|Pre-test|Overall Study||30
4933883|NCT03124563|12134819|P1|Pre-test|Overall Study||30
4933884|NCT03124563|12134818|P2|STARTED|Overall Study||31
4933885|NCT03124563|12134819|P1|STARTED|Overall Study||32
4933886|NCT03124407|12134839|P4|NOT COMPLETED|Overall Study||0
4933887|NCT03124407|12134840|P3|NOT COMPLETED|Overall Study||1
4933888|NCT03124407|12134841|P2|NOT COMPLETED|Overall Study||0
4933889|NCT03124407|12134842|P1|NOT COMPLETED|Overall Study||1
4933890|NCT03124407|12134839|P4|COMPLETED|Overall Study||20
4933891|NCT03124407|12134840|P3|COMPLETED|Overall Study||39
4933892|NCT03124407|12134841|P2|COMPLETED|Overall Study||20
4933893|NCT03124407|12134842|P1|COMPLETED|Overall Study||39
4933894|NCT03124407|12134839|P4|STARTED|Overall Study||20
4933895|NCT03124407|12134840|P3|STARTED|Overall Study||40
4933896|NCT03124407|12134841|P2|STARTED|Overall Study||20
4933897|NCT03124407|12134842|P1|STARTED|Overall Study||40
4933898|NCT03124381|12134862|P2|NOT COMPLETED|Overall Study||6
4933899|NCT03124381|12134863|P1|NOT COMPLETED|Overall Study||9
4933900|NCT03124381|12134862|P2|COMPLETED|Overall Study||55
4933901|NCT03124381|12134863|P1|COMPLETED|Overall Study||56
4933902|NCT03124381|12134862|P2|STARTED|Overall Study||61
4933903|NCT03124381|12134863|P1|STARTED|Overall Study||65
4933904|NCT03124342|12134955|P2|NOT COMPLETED|Overall Study||0
4933905|NCT03124342|12134956|P1|NOT COMPLETED|Overall Study||0
4933906|NCT03124342|12134955|P2|COMPLETED|Overall Study||121
4933907|NCT03124342|12134956|P1|COMPLETED|Overall Study||111
4933908|NCT03124342|12134955|P2|STARTED|Overall Study||121
4933909|NCT03124342|12134956|P1|STARTED|Overall Study||111
4933910|NCT03124199|12134970|P1|NOT COMPLETED|Overall Study||4
4933911|NCT03124199|12134970|P1|COMPLETED|Overall Study||36
4933912|NCT03124199|12134970|P1|STARTED|Overall Study||40
4933913|NCT03124108|12134979|P3|NOT COMPLETED|Overall Study||0
4933914|NCT03124108|12134980|P2|NOT COMPLETED|Overall Study||1
4933915|NCT03124108|12134981|P1|NOT COMPLETED|Overall Study||0
4933916|NCT03124108|12134979|P3|COMPLETED|Overall Study||15
4933917|NCT03124108|12134980|P2|COMPLETED|Overall Study||14
4933918|NCT03124108|12134981|P1|COMPLETED|Overall Study||15
4933919|NCT03124108|12134979|P3|STARTED|Overall Study||15
4933920|NCT03124108|12134980|P2|STARTED|Overall Study||15
4933921|NCT03124108|12134981|P1|STARTED|Overall Study||15
4933922|NCT03123874|12135114|P2|NOT COMPLETED|Overall Study||0
4933923|NCT03123874|12135115|P1|NOT COMPLETED|Overall Study||0
4933924|NCT03123874|12135114|P2|COMPLETED|Overall Study||25
4933925|NCT03123874|12135115|P1|COMPLETED|Overall Study||27
4933926|NCT03123874|12135114|P2|STARTED|Overall Study||25
4933927|NCT03123874|12135115|P1|STARTED|Overall Study||27
4933928|NCT03123848|12135125|P1|NOT COMPLETED|Overall Study||0
4933929|NCT03123848|12135125|P1|COMPLETED|Overall Study||8
4933930|NCT03123848|12135125|P1|STARTED|Overall Study||8
4933931|NCT03123471|12135149|P2|NOT COMPLETED|Apremilast Extension Phase||25
4933932|NCT03123471|12135150|P1|NOT COMPLETED|Apremilast Extension Phase||8
4933933|NCT03123471|12135149|P2|COMPLETED|Apremilast Extension Phase||140
4933934|NCT03123471|12135150|P1|COMPLETED|Apremilast Extension Phase||76
4933935|NCT03123471|12135149|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
4933936|NCT03123471|12135150|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
4933937|NCT03123471|12135149|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
4933938|NCT03123471|12135150|P1|STARTED|Apremilast Extension Phase||84
4933939|NCT03123471|12135149|P2|NOT COMPLETED|Placebo-controlled Phase||33
4933940|NCT03123471|12135150|P1|NOT COMPLETED|Placebo-controlled Phase||18
4933941|NCT03123471|12135149|P2|COMPLETED|Placebo-controlled Phase||168
4933942|NCT03123471|12135150|P1|COMPLETED|Placebo-controlled Phase||84
4933943|NCT03123471|12135149|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
4933944|NCT03123471|12135150|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
4933945|NCT03123471|12135149|P2|STARTED|Placebo-controlled Phase||201
4933946|NCT03123471|12135150|P1|STARTED|Placebo-controlled Phase||102
4933947|NCT03123354|12135175|P1|NOT COMPLETED|Overall Study||6
4933948|NCT03123354|12135175|P1|COMPLETED|Overall Study||38
4933949|NCT03123354|12135175|P1|STARTED|Overall Study||44
4933950|NCT03123263|12135179|P1|NOT COMPLETED|Overall Study||0
4933951|NCT03123263|12135179|P1|COMPLETED|Overall Study||60
4933952|NCT03123263|12135179|P1|STARTED|Overall Study||60
4933953|NCT03123055|12135186|P1|NOT COMPLETED|Overall Study||0
4933954|NCT03123055|12135186|P1|COMPLETED|Overall Study||28
4933955|NCT03123055|12135186|P1|STARTED|Overall Study||28
4933956|NCT03122886|12135200|P2|NOT COMPLETED|Overall Study||2
4933957|NCT03122886|12135201|P1|NOT COMPLETED|Overall Study||1
4933958|NCT03122886|12135200|P2|COMPLETED|Overall Study||7
4933959|NCT03122886|12135201|P1|COMPLETED|Overall Study||9
4933960|NCT03122886|12135200|P2|STARTED|Overall Study||9
4933961|NCT03122886|12135201|P1|STARTED|Overall Study||10
4933962|NCT03122587|12135210|P3|NOT COMPLETED|Overall Study||1
4933963|NCT03122587|12135211|P2|NOT COMPLETED|Overall Study||2
4933964|NCT03122587|12135212|P1|NOT COMPLETED|Overall Study||2
4933965|NCT03122587|12135210|P3|COMPLETED|Overall Study||12
4933966|NCT03122587|12135211|P2|COMPLETED|Overall Study||10
4933967|NCT03122587|12135212|P1|COMPLETED|Overall Study||11
4933968|NCT03122587|12135210|P3|STARTED|Overall Study||13
4933969|NCT03122587|12135211|P2|STARTED|Overall Study||12
4933970|NCT03122587|12135212|P1|STARTED|Overall Study||13
4933971|NCT03122548|12135223|P1|NOT COMPLETED|Overall Study||5
4933972|NCT03122548|12135223|P1|COMPLETED|Overall Study||0
4933973|NCT03122548|12135223|P1|STARTED|Overall Study||5
4933974|NCT03122184|12135233|P2|NOT COMPLETED|Overall Study||6
4933975|NCT03122184|12135234|P1|NOT COMPLETED|Overall Study||8
4933976|NCT03122184|12135233|P2|COMPLETED|Overall Study||17
4933977|NCT03122184|12135234|P1|COMPLETED|Overall Study||16
4933978|NCT03122184|12135233|P2|STARTED|Overall Study||23
4933979|NCT03122184|12135234|P1|STARTED|Overall Study||24
4933980|NCT03122145|12135273|P2|NOT COMPLETED|Overall Study||0
4933981|NCT03122145|12135274|P1|NOT COMPLETED|Overall Study||3
4933982|NCT03122145|12135273|P2|COMPLETED|Overall Study||12
4933983|NCT03122145|12135274|P1|COMPLETED|Overall Study||34
4933984|NCT03122145|12135273|P2|STARTED|Overall Study||12
4933985|NCT03122145|12135274|P1|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
4933986|NCT03121950|12135284|P2|NOT COMPLETED|Overall Study||2
4933987|NCT03121950|12135285|P1|NOT COMPLETED|Overall Study||10
4933988|NCT03121950|12135284|P2|COMPLETED|Overall Study||1
4933989|NCT03121950|12135285|P1|COMPLETED|Overall Study||7
4933990|NCT03121950|12135284|P2|STARTED|Overall Study||3
4933991|NCT03121950|12135285|P1|STARTED|Overall Study||17
4933992|NCT03121820|12135297|P2|NOT COMPLETED|Second Period (After Washout)||0
4933993|NCT03121820|12135298|P1|NOT COMPLETED|Second Period (After Washout)||0
4933994|NCT03121820|12135297|P2|COMPLETED|Second Period (After Washout)||9
4933995|NCT03121820|12135298|P1|COMPLETED|Second Period (After Washout)||9
4933996|NCT03121820|12135297|P2|STARTED|Second Period (After Washout)||9
4933997|NCT03121820|12135298|P1|STARTED|Second Period (After Washout)||9
4933998|NCT03121820|12135297|P2|NOT COMPLETED|First Period||0
4933999|NCT03121820|12135298|P1|NOT COMPLETED|First Period||0
4934000|NCT03121820|12135297|P2|COMPLETED|First Period||9
4934001|NCT03121820|12135298|P1|COMPLETED|First Period||9
4934002|NCT03121820|12135297|P2|STARTED|First Period||9
4934003|NCT03121820|12135298|P1|STARTED|First Period||9
4934004|NCT03121612|12135308|P2|NOT COMPLETED|Overall Study||0
4934005|NCT03121612|12135309|P1|NOT COMPLETED|Overall Study||0
4934006|NCT03121612|12135308|P2|COMPLETED|Overall Study||25
4934007|NCT03121612|12135309|P1|COMPLETED|Overall Study||26
4934008|NCT03121612|12135308|P2|STARTED|Overall Study||25
4934009|NCT03121612|12135309|P1|STARTED|Overall Study||26
4934010|NCT03121365|12135353|P2|NOT COMPLETED|12 Months||8
4934011|NCT03121365|12135354|P1|NOT COMPLETED|12 Months||11
4934012|NCT03121365|12135353|P2|COMPLETED|12 Months||37
4934013|NCT03121365|12135354|P1|COMPLETED|12 Months||43
4934014|NCT03121365|12135353|P2|STARTED|12 Months||45
4934015|NCT03121365|12135354|P1|STARTED|12 Months||54
4934016|NCT03121365|12135353|P2|NOT COMPLETED|9 Months||1
4934017|NCT03121365|12135354|P1|NOT COMPLETED|9 Months||3
4934018|NCT03121365|12135353|P2|COMPLETED|9 Months||44
4934019|NCT03121365|12135354|P1|COMPLETED|9 Months||52
4934020|NCT03121365|12135353|P2|STARTED|9 Months||45
4934021|NCT03121365|12135354|P1|STARTED|9 Months||55
4934022|NCT03121365|12135353|P2|NOT COMPLETED|6 Months||1
4934023|NCT03121365|12135354|P1|NOT COMPLETED|6 Months||2
4934024|NCT03121365|12135353|P2|COMPLETED|6 Months||45
4934025|NCT03121365|12135354|P1|COMPLETED|6 Months||53
4934026|NCT03121365|12135353|P2|STARTED|6 Months||46
4934027|NCT03121365|12135354|P1|STARTED|6 Months||55
4934028|NCT03121365|12135353|P2|NOT COMPLETED|Baseline||1
4934029|NCT03121365|12135354|P1|NOT COMPLETED|Baseline||0
4934030|NCT03121365|12135353|P2|COMPLETED|Baseline||48
4934031|NCT03121365|12135354|P1|COMPLETED|Baseline||55
4934032|NCT03121365|12135353|P2|STARTED|Baseline||49
4934033|NCT03121365|12135354|P1|STARTED|Baseline||55
4934034|NCT03121144|12135362|P1|NOT COMPLETED|Overall Study||0
4934035|NCT03121144|12135362|P1|COMPLETED|Overall Study||34
4934036|NCT03121144|12135362|P1|STARTED|Overall Study||34
4934037|NCT03120676|12135366|P1|NOT COMPLETED|Overall Study||1
4934038|NCT03120676|12135366|P1|COMPLETED|Overall Study||2
4934039|NCT03120676|12135366|P1|STARTED|Overall Study||3
4934040|NCT03120520|12135374|P4|NOT COMPLETED|Overall Study||3
4934041|NCT03120520|12135375|P3|NOT COMPLETED|Overall Study||4
4934042|NCT03120520|12135376|P2|NOT COMPLETED|Overall Study||4
4934043|NCT03120520|12135377|P1|NOT COMPLETED|Overall Study||4
4934044|NCT03120520|12135374|P4|COMPLETED|Overall Study||29
4934045|NCT03120520|12135375|P3|COMPLETED|Overall Study||26
4934046|NCT03120520|12135376|P2|COMPLETED|Overall Study||27
4934047|NCT03120520|12135377|P1|COMPLETED|Overall Study||27
4934048|NCT03120520|12135374|P4|STARTED|Overall Study||32
4934049|NCT03120520|12135375|P3|STARTED|Overall Study||30
4934050|NCT03120520|12135376|P2|STARTED|Overall Study||31
4934051|NCT03120520|12135377|P1|STARTED|Overall Study||31
4934052|NCT03120351|12135401|P2|NOT COMPLETED|Overall Study||1
4934053|NCT03120351|12135402|P1|NOT COMPLETED|Overall Study||1
4934054|NCT03120351|12135401|P2|COMPLETED|Overall Study||39
4934055|NCT03120351|12135402|P1|COMPLETED|Overall Study||39
4934056|NCT03120351|12135401|P2|STARTED|Overall Study||40
4934057|NCT03120351|12135402|P1|STARTED|Overall Study||40
4934058|NCT03120013|12135408|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
4934059|NCT03120013|12135409|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4934060|NCT03120013|12135408|P2|COMPLETED|Second Intervention (2 Weeks)||10
4934061|NCT03120013|12135409|P1|COMPLETED|Second Intervention (2 Weeks)||10
4934062|NCT03120013|12135408|P2|STARTED|Second Intervention (2 Weeks)||10
4934063|NCT03120013|12135409|P1|STARTED|Second Intervention (2 Weeks)||10
4934064|NCT03120013|12135408|P2|NOT COMPLETED|Washout (6 Months)||0
4934065|NCT03120013|12135409|P1|NOT COMPLETED|Washout (6 Months)||0
4934066|NCT03120013|12135408|P2|COMPLETED|Washout (6 Months)||10
4934067|NCT03120013|12135409|P1|COMPLETED|Washout (6 Months)||10
4934068|NCT03120013|12135408|P2|STARTED|Washout (6 Months)||10
4934069|NCT03120013|12135409|P1|STARTED|Washout (6 Months)||10
4934070|NCT03120013|12135408|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
4934071|NCT03120013|12135409|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
4934072|NCT03120013|12135408|P2|COMPLETED|First Intervention (2 Weeks)||10
4934073|NCT03120013|12135409|P1|COMPLETED|First Intervention (2 Weeks)||10
4934074|NCT03120013|12135408|P2|Received Intervention|First Intervention (2 Weeks)||11
4934075|NCT03120013|12135409|P1|Received Intervention|First Intervention (2 Weeks)||10
4934076|NCT03120013|12135408|P2|STARTED|First Intervention (2 Weeks)||11
4934077|NCT03120013|12135409|P1|STARTED|First Intervention (2 Weeks)||10
4934078|NCT03119831|12135432|P3|NOT COMPLETED|Overall Study||0
4934079|NCT03119831|12135433|P2|NOT COMPLETED|Overall Study||0
4934080|NCT03119831|12135434|P1|NOT COMPLETED|Overall Study||0
4934081|NCT03119831|12135432|P3|COMPLETED|Overall Study||14
4934082|NCT03119831|12135433|P2|COMPLETED|Overall Study||14
4934083|NCT03119831|12135434|P1|COMPLETED|Overall Study||14
4934084|NCT03119831|12135432|P3|STARTED|Overall Study||14
4934085|NCT03119831|12135433|P2|STARTED|Overall Study||14
4934086|NCT03119831|12135434|P1|STARTED|Overall Study||14
4934087|NCT03119688|12135451|P1|NOT COMPLETED|Overall Study||4
4934088|NCT03119688|12135451|P1|COMPLETED|Overall Study||44
4934089|NCT03119688|12135451|P1|STARTED|Overall Study||48
4934090|NCT03119662|12135484|P2|NOT COMPLETED|Overall Study||1
4934091|NCT03119662|12135485|P1|NOT COMPLETED|Overall Study||0
4934092|NCT03119662|12135484|P2|COMPLETED|Overall Study||1
4934093|NCT03119662|12135485|P1|COMPLETED|Overall Study||2
4934094|NCT03119662|12135484|P2|STARTED|Overall Study||2
4934095|NCT03119662|12135485|P1|STARTED|Overall Study||2
4934096|NCT03119649|12135506|P5|NOT COMPLETED|Overall Study||0
4934097|NCT03119649|12135507|P4|NOT COMPLETED|Overall Study||0
4934098|NCT03119649|12135508|P3|NOT COMPLETED|Overall Study||0
4934099|NCT03119649|12135509|P2|NOT COMPLETED|Overall Study||0
4934100|NCT03119649|12135510|P1|NOT COMPLETED|Overall Study||0
4934101|NCT03119649|12135506|P5|COMPLETED|Overall Study||14
4934102|NCT03119649|12135507|P4|COMPLETED|Overall Study||14
4934103|NCT03119649|12135508|P3|COMPLETED|Overall Study||10
4934104|NCT03119649|12135509|P2|COMPLETED|Overall Study||10
4934105|NCT03119649|12135510|P1|COMPLETED|Overall Study||11
4934106|NCT03119649|12135506|P5|STARTED|Overall Study||14
4934107|NCT03119649|12135507|P4|STARTED|Overall Study||14
4934108|NCT03119649|12135508|P3|STARTED|Overall Study||10
4934109|NCT03119649|12135509|P2|STARTED|Overall Study||10
4934110|NCT03119649|12135510|P1|STARTED|Overall Study||11
4934111|NCT03119389|12135555|P2|NOT COMPLETED|Overall Study||0
4934112|NCT03119389|12135556|P1|NOT COMPLETED|Overall Study||0
4934113|NCT03119389|12135555|P2|COMPLETED|Overall Study||7627
4934114|NCT03119389|12135556|P1|COMPLETED|Overall Study||6791
4934115|NCT03119389|12135555|P2|STARTED|Overall Study||7627
4934116|NCT03119389|12135556|P1|STARTED|Overall Study||6791
4934117|NCT03119181|12135572|P2|NOT COMPLETED|Overall Study||0
4934118|NCT03119181|12135573|P1|NOT COMPLETED|Overall Study||0
4934119|NCT03119181|12135572|P2|COMPLETED|Overall Study||21
4934120|NCT03119181|12135573|P1|COMPLETED|Overall Study||19
4934121|NCT03119181|12135572|P2|STARTED|Overall Study||21
4934122|NCT03119181|12135573|P1|STARTED|Overall Study||19
4934123|NCT03119168|12135581|P2|NOT COMPLETED|Overall Study||0
4934124|NCT03119168|12135582|P1|NOT COMPLETED|Overall Study||0
4934125|NCT03119168|12135581|P2|COMPLETED|Overall Study||139
4934126|NCT03119168|12135582|P1|COMPLETED|Overall Study||129
4934127|NCT03119168|12135581|P2|STARTED|Overall Study||139
4934128|NCT03119168|12135582|P1|STARTED|Overall Study||129
4934129|NCT03119025|12135594|P1|NOT COMPLETED|Overall Study||0
4934130|NCT03119025|12135594|P1|COMPLETED|Overall Study||10
4934131|NCT03119025|12135594|P1|STARTED|Overall Study||10
4934132|NCT03118947|12135601|P1|NOT COMPLETED|Overall Study||29
4934133|NCT03118947|12135601|P1|COMPLETED|Overall Study||49
4934134|NCT03118947|12135601|P1|STARTED|Overall Study||78
4934135|NCT03118934|12135608|P6|NOT COMPLETED|Overall Study||2
4934136|NCT03118934|12135609|P5|NOT COMPLETED|Overall Study||2
4934137|NCT03118934|12135610|P4|NOT COMPLETED|Overall Study||1
4934138|NCT03118934|12135611|P3|NOT COMPLETED|Overall Study||1
4934139|NCT03118934|12135612|P2|NOT COMPLETED|Overall Study||1
4934140|NCT03118934|12135613|P1|NOT COMPLETED|Overall Study||0
4934141|NCT03118934|12135608|P6|COMPLETED|Overall Study||23
4934142|NCT03118934|12135609|P5|COMPLETED|Overall Study||27
4934143|NCT03118934|12135610|P4|COMPLETED|Overall Study||28
4934144|NCT03118934|12135611|P3|COMPLETED|Overall Study||33
4934145|NCT03118934|12135612|P2|COMPLETED|Overall Study||30
4934146|NCT03118934|12135613|P1|COMPLETED|Overall Study||34
4934147|NCT03118934|12135608|P6|Safety Analysis Set|Overall Study||25
4934148|NCT03118934|12135609|P5|Safety Analysis Set|Overall Study||26
4934149|NCT03118934|12135610|P4|Safety Analysis Set|Overall Study||29
4934150|NCT03118934|12135611|P3|Safety Analysis Set|Overall Study||34
4934151|NCT03118934|12135612|P2|Safety Analysis Set|Overall Study||29
4934152|NCT03118934|12135613|P1|Safety Analysis Set|Overall Study||34
4934153|NCT03118934|12135608|P6|STARTED|Overall Study||25
4934154|NCT03118934|12135609|P5|STARTED|Overall Study||29
4934155|NCT03118934|12135610|P4|STARTED|Overall Study||29
4934156|NCT03118934|12135611|P3|STARTED|Overall Study||34
4934157|NCT03118934|12135612|P2|STARTED|Overall Study||31
4934158|NCT03118934|12135613|P1|STARTED|Overall Study||34
4934159|NCT03118843|12135623|P1|NOT COMPLETED|Overall Study||0
4934160|NCT03118843|12135623|P1|COMPLETED|Overall Study||31
4934161|NCT03118843|12135623|P1|STARTED|Overall Study||31
4934162|NCT03118765|12135637|P5|NOT COMPLETED|Overall Study||2
4934163|NCT03118765|12135638|P4|NOT COMPLETED|Overall Study||3
4934164|NCT03118765|12135639|P3|NOT COMPLETED|Overall Study||5
4934165|NCT03118765|12135640|P2|NOT COMPLETED|Overall Study||2
4934166|NCT03118765|12135641|P1|NOT COMPLETED|Overall Study||4
4934167|NCT03118765|12135637|P5|COMPLETED|Overall Study||28
4934168|NCT03118765|12135638|P4|COMPLETED|Overall Study||29
4934169|NCT03118765|12135639|P3|COMPLETED|Overall Study||26
4934170|NCT03118765|12135640|P2|COMPLETED|Overall Study||30
4934171|NCT03118765|12135641|P1|COMPLETED|Overall Study||26
4934172|NCT03118765|12135637|P5|STARTED|Overall Study||30
4934173|NCT03118765|12135638|P4|STARTED|Overall Study||32
4934174|NCT03118765|12135639|P3|STARTED|Overall Study||31
4934175|NCT03118765|12135640|P2|STARTED|Overall Study||32
4934176|NCT03118765|12135641|P1|STARTED|Overall Study||30
4934177|NCT03118739|12135737|P2|NOT COMPLETED|Overall Study||4
4934178|NCT03118739|12135738|P1|NOT COMPLETED|Overall Study||7
4934179|NCT03118739|12135737|P2|COMPLETED|Overall Study||24
4934180|NCT03118739|12135738|P1|COMPLETED|Overall Study||25
4934181|NCT03118739|12135737|P2|Completed 24 Weeks of Treatment|Overall Study||25
4934182|NCT03118739|12135738|P1|Completed 24 Weeks of Treatment|Overall Study||24
4934183|NCT03118739|12135737|P2|Completed 12 Weeks of Treatment|Overall Study||25
4934184|NCT03118739|12135738|P1|Completed 12 Weeks of Treatment|Overall Study||26
4934185|NCT03118739|12135737|P2|STARTED|Overall Study||28
4934186|NCT03118739|12135738|P1|STARTED|Overall Study||32
4934187|NCT03118596|12135830|P2|NOT COMPLETED|Overall Study||4
4934188|NCT03118596|12135831|P1|NOT COMPLETED|Overall Study||0
4934189|NCT03118596|12135830|P2|COMPLETED|Overall Study||86
4934190|NCT03118596|12135831|P1|COMPLETED|Overall Study||90
4934191|NCT03118596|12135830|P2|Failed|Overall Study||4
4934192|NCT03118596|12135831|P1|Failed|Overall Study||0
4934193|NCT03118596|12135830|P2|Treated|Overall Study||0
4934194|NCT03118596|12135831|P1|Treated|Overall Study||2
4934195|NCT03118596|12135830|P2|STARTED|Overall Study||90
4934196|NCT03118596|12135831|P1|STARTED|Overall Study||90
4934197|NCT03118297|12135851|P2|NOT COMPLETED|Overall Study||2
4934198|NCT03118297|12135852|P1|NOT COMPLETED|Overall Study||0
4934199|NCT03118297|12135851|P2|COMPLETED|Overall Study||31
4934200|NCT03118297|12135852|P1|COMPLETED|Overall Study||32
4934201|NCT03118297|12135851|P2|STARTED|Overall Study||33
4934202|NCT03118297|12135852|P1|STARTED|Overall Study||32
4934203|NCT03117569|12135868|P2|NOT COMPLETED|Overall Study||12
4934204|NCT03117569|12135869|P1|NOT COMPLETED|Overall Study||4
4934205|NCT03117569|12135868|P2|COMPLETED|Overall Study||241
4934206|NCT03117569|12135869|P1|COMPLETED|Overall Study||123
4934207|NCT03117569|12135868|P2|STARTED|Overall Study||253
4934208|NCT03117569|12135869|P1|STARTED|Overall Study||127
4934209|NCT03117517|12135893|P2|NOT COMPLETED|Overall Study||4
4934210|NCT03117517|12135894|P1|NOT COMPLETED|Overall Study||5
4934211|NCT03117517|12135893|P2|COMPLETED|Overall Study||49
4934212|NCT03117517|12135894|P1|COMPLETED|Overall Study||48
4934213|NCT03117517|12135893|P2|STARTED|Overall Study||53
4934214|NCT03117517|12135894|P1|STARTED|Overall Study||53
4934215|NCT03117140|12135908|P4|NOT COMPLETED|Overall Study||0
4934216|NCT03117140|12135909|P3|NOT COMPLETED|Overall Study||0
4934217|NCT03117140|12135910|P2|NOT COMPLETED|Overall Study||0
4934218|NCT03117140|12135911|P1|NOT COMPLETED|Overall Study||0
4934219|NCT03117140|12135908|P4|COMPLETED|Overall Study||40
4934220|NCT03117140|12135909|P3|COMPLETED|Overall Study||40
4934221|NCT03117140|12135910|P2|COMPLETED|Overall Study||40
4934222|NCT03117140|12135911|P1|COMPLETED|Overall Study||40
4934223|NCT03117140|12135908|P4|STARTED|Overall Study||40
4934224|NCT03117140|12135909|P3|STARTED|Overall Study||40
4934225|NCT03117140|12135910|P2|STARTED|Overall Study||40
4934226|NCT03117140|12135911|P1|STARTED|Overall Study||40
4934227|NCT03116841|12135977|P1|NOT COMPLETED|Overall Study||0
4934228|NCT03116841|12135977|P1|COMPLETED|Overall Study||3
4934229|NCT03116841|12135977|P1|STARTED|Overall Study||3
4934230|NCT03116828|12135996|P2|NOT COMPLETED|Overall Study||21
4934231|NCT03116828|12135997|P1|NOT COMPLETED|Overall Study||8
4934232|NCT03116828|12135996|P2|COMPLETED|Overall Study||37
4934233|NCT03116828|12135997|P1|COMPLETED|Overall Study||36
4934234|NCT03116828|12135996|P2|STARTED|Overall Study||58
4934235|NCT03116828|12135997|P1|STARTED|Overall Study||44
4934236|NCT03116698|12136007|P4|NOT COMPLETED|Overall Study||2
4934237|NCT03116698|12136008|P3|NOT COMPLETED|Overall Study||8
4934238|NCT03116698|12136009|P2|NOT COMPLETED|Overall Study||6
4934239|NCT03116698|12136010|P1|NOT COMPLETED|Overall Study||6
4934240|NCT03116698|12136007|P4|COMPLETED|Overall Study||55
4934241|NCT03116698|12136008|P3|COMPLETED|Overall Study||54
4934242|NCT03116698|12136009|P2|COMPLETED|Overall Study||51
4934243|NCT03116698|12136010|P1|COMPLETED|Overall Study||56
4934244|NCT03116698|12136007|P4|STARTED|Overall Study||57
4934245|NCT03116698|12136008|P3|STARTED|Overall Study||62
4934246|NCT03116698|12136009|P2|STARTED|Overall Study||57
4934247|NCT03116698|12136010|P1|STARTED|Overall Study||62
4934248|NCT03115853|12136024|P1|NOT COMPLETED|Overall Study||0
4934249|NCT03115853|12136024|P1|COMPLETED|Overall Study||31
4934250|NCT03115853|12136024|P1|STARTED|Overall Study||31
4934251|NCT03115827|12136042|P1|NOT COMPLETED|Overall Study||3
4934252|NCT03115827|12136042|P1|COMPLETED|Overall Study||12
4934253|NCT03115827|12136042|P1|STARTED|Overall Study||15
4934254|NCT03115580|12136052|P2|NOT COMPLETED|Overall Study||0
4934255|NCT03115580|12136053|P1|NOT COMPLETED|Overall Study||0
4934256|NCT03115580|12136052|P2|COMPLETED|Overall Study||36
4934257|NCT03115580|12136053|P1|COMPLETED|Overall Study||35
4934258|NCT03115580|12136052|P2|STARTED|Overall Study||36
4934259|NCT03115580|12136053|P1|STARTED|Overall Study||35
4934260|NCT03115476|12136072|P3|NOT COMPLETED|LP0084-1369||162
4934261|NCT03115476|12136073|P2|NOT COMPLETED|LP0084-1369||210
4934262|NCT03115476|12136074|P1|NOT COMPLETED|LP0084-1369||191
4934263|NCT03115476|12136072|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
4934264|NCT03115476|12136073|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
4934265|NCT03115476|12136074|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
4934266|NCT03115476|12136072|P3|STARTED|LP0084-1369||162
4934267|NCT03115476|12136073|P2|STARTED|LP0084-1369||210
4934268|NCT03115476|12136074|P1|STARTED|LP0084-1369||191
4934269|NCT03115476|12136072|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
4934270|NCT03115476|12136073|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
4934271|NCT03115476|12136074|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
4934272|NCT03115476|12136072|P3|COMPLETED|Main Trials (LP0084-119x)||409
4934273|NCT03115476|12136073|P2|COMPLETED|Main Trials (LP0084-119x)||418
4934274|NCT03115476|12136074|P1|COMPLETED|Main Trials (LP0084-119x)||407
4934275|NCT03115476|12136072|P3|STARTED|Main Trials (LP0084-119x)||409
4934276|NCT03115476|12136073|P2|STARTED|Main Trials (LP0084-119x)||418
4934277|NCT03115476|12136074|P1|STARTED|Main Trials (LP0084-119x)||407
4934278|NCT03115411|12136085|P1|NOT COMPLETED|Overall Study||0
4934279|NCT03115411|12136085|P1|COMPLETED|Overall Study||23
4934280|NCT03115411|12136085|P1|STARTED|Overall Study||23
4934281|NCT03115177|12136091|P2|NOT COMPLETED|Overall Study||0
4934282|NCT03115177|12136092|P1|NOT COMPLETED|Overall Study||0
4934283|NCT03115177|12136091|P2|COMPLETED|Overall Study||29
4934284|NCT03115177|12136092|P1|COMPLETED|Overall Study||27
4934285|NCT03115177|12136091|P2|STARTED|Overall Study||29
4934286|NCT03115177|12136092|P1|STARTED|Overall Study||27
4934287|NCT03114995|12136101|P3|NOT COMPLETED|Overall Study||0
4934288|NCT03114995|12136102|P2|NOT COMPLETED|Overall Study||1
4934289|NCT03114995|12136103|P1|NOT COMPLETED|Overall Study||1
4934290|NCT03114995|12136101|P3|COMPLETED|Overall Study||78
4934291|NCT03114995|12136102|P2|COMPLETED|Overall Study||30
4934292|NCT03114995|12136103|P1|COMPLETED|Overall Study||30
4934293|NCT03114995|12136101|P3|STARTED|Overall Study||78
4934294|NCT03114995|12136102|P2|STARTED|Overall Study||31
4934295|NCT03114995|12136103|P1|STARTED|Overall Study||31
4934296|NCT03114969|12136123|P9|NOT COMPLETED|Overall Study||2
4934297|NCT03114969|12136124|P8|NOT COMPLETED|Overall Study||0
4934298|NCT03114969|12136125|P7|NOT COMPLETED|Overall Study||1
4934299|NCT03114969|12136126|P6|NOT COMPLETED|Overall Study||1
4934300|NCT03114969|12136127|P5|NOT COMPLETED|Overall Study||0
4934301|NCT03114969|12136128|P4|NOT COMPLETED|Overall Study||2
4934302|NCT03114969|12136129|P3|NOT COMPLETED|Overall Study||4
4934303|NCT03114969|12136130|P2|NOT COMPLETED|Overall Study||0
4934304|NCT03114969|12136131|P1|NOT COMPLETED|Overall Study||0
4934305|NCT03114969|12136123|P9|COMPLETED|Overall Study||48
4934306|NCT03114969|12136124|P8|COMPLETED|Overall Study||50
4934307|NCT03114969|12136125|P7|COMPLETED|Overall Study||49
4934308|NCT03114969|12136126|P6|COMPLETED|Overall Study||48
4934309|NCT03114969|12136127|P5|COMPLETED|Overall Study||51
4934310|NCT03114969|12136128|P4|COMPLETED|Overall Study||48
4934311|NCT03114969|12136129|P3|COMPLETED|Overall Study||46
4934312|NCT03114969|12136130|P2|COMPLETED|Overall Study||50
4934313|NCT03114969|12136131|P1|COMPLETED|Overall Study||50
4934314|NCT03114969|12136123|P9|STARTED|Overall Study||50
4934315|NCT03114969|12136124|P8|STARTED|Overall Study||50
4934316|NCT03114969|12136125|P7|STARTED|Overall Study||50
4934317|NCT03114969|12136126|P6|STARTED|Overall Study||49
4934318|NCT03114969|12136127|P5|STARTED|Overall Study||51
4934319|NCT03114969|12136128|P4|STARTED|Overall Study||50
4934320|NCT03114969|12136129|P3|STARTED|Overall Study||50
4934321|NCT03114969|12136130|P2|STARTED|Overall Study||50
4934322|NCT03114969|12136131|P1|STARTED|Overall Study||50
4934323|NCT03114657|12136228|P2|NOT COMPLETED|Overall Study||407
4934324|NCT03114657|12136229|P1|NOT COMPLETED|Overall Study||399
4934325|NCT03114657|12136228|P2|COMPLETED|Overall Study||0
4934326|NCT03114657|12136229|P1|COMPLETED|Overall Study||0
4934327|NCT03114657|12136228|P2|STARTED|Overall Study||407
4934328|NCT03114657|12136229|P1|STARTED|Overall Study||399
4934329|NCT03114488|12136274|P2|NOT COMPLETED|Time Period 2||3
4934330|NCT03114488|12136275|P1|NOT COMPLETED|Time Period 2||1
4934331|NCT03114488|12136274|P2|COMPLETED|Time Period 2||19
4934332|NCT03114488|12136275|P1|COMPLETED|Time Period 2||18
4934333|NCT03114488|12136274|P2|STARTED|Time Period 2||22
4934334|NCT03114488|12136275|P1|STARTED|Time Period 2||19
4934335|NCT03114488|12136274|P2|NOT COMPLETED|Time Period 1||0
4934336|NCT03114488|12136275|P1|NOT COMPLETED|Time Period 1||0
4934337|NCT03114488|12136274|P2|COMPLETED|Time Period 1||22
4934338|NCT03114488|12136275|P1|COMPLETED|Time Period 1||19
4934339|NCT03114488|12136274|P2|STARTED|Time Period 1||22
4934340|NCT03114488|12136275|P1|STARTED|Time Period 1||19
4934341|NCT03113656|12136287|P2|NOT COMPLETED|Overall Study||0
4934342|NCT03113656|12136288|P1|NOT COMPLETED|Overall Study||0
4934343|NCT03113656|12136287|P2|COMPLETED|Overall Study||7
4934344|NCT03113656|12136288|P1|COMPLETED|Overall Study||9
4934345|NCT03113656|12136287|P2|STARTED|Overall Study||7
4934346|NCT03113656|12136288|P1|STARTED|Overall Study||9
4934347|NCT03112993|12136296|P2|NOT COMPLETED|Overall Study||0
4934348|NCT03112993|12136297|P1|NOT COMPLETED|Overall Study||0
4934349|NCT03112993|12136296|P2|COMPLETED|Overall Study||21
4934350|NCT03112993|12136297|P1|COMPLETED|Overall Study||19
4934351|NCT03112993|12136296|P2|STARTED|Overall Study||21
4934352|NCT03112993|12136297|P1|STARTED|Overall Study||19
4934353|NCT03111316|12136315|P4|NOT COMPLETED|Overall Study||0
4934354|NCT03111316|12136316|P3|NOT COMPLETED|Overall Study||0
4934355|NCT03111316|12136317|P2|NOT COMPLETED|Overall Study||0
4934356|NCT03111316|12136318|P1|NOT COMPLETED|Overall Study||0
4934357|NCT03111316|12136315|P4|COMPLETED|Overall Study||25
4934358|NCT03111316|12136316|P3|COMPLETED|Overall Study||25
4934359|NCT03111316|12136317|P2|COMPLETED|Overall Study||24
4934360|NCT03111316|12136318|P1|COMPLETED|Overall Study||26
4934361|NCT03111316|12136315|P4|STARTED|Overall Study||25
4934362|NCT03111316|12136316|P3|STARTED|Overall Study||25
4934363|NCT03111316|12136317|P2|STARTED|Overall Study||24
4934364|NCT03111316|12136318|P1|STARTED|Overall Study||26
4934365|NCT03111108|12136334|P2|NOT COMPLETED|Overall Study||1
4934366|NCT03111108|12136335|P1|NOT COMPLETED|Overall Study||1
4934367|NCT03111108|12136334|P2|COMPLETED|Overall Study||63
4934368|NCT03111108|12136335|P1|COMPLETED|Overall Study||52
4934369|NCT03111108|12136334|P2|STARTED|Overall Study||64
4934370|NCT03111108|12136335|P1|STARTED|Overall Study||53
4934371|NCT03110900|12136353|P2|NOT COMPLETED|Overall Study||1
4934372|NCT03110900|12136354|P1|NOT COMPLETED|Overall Study||1
4934373|NCT03110900|12136353|P2|COMPLETED|Overall Study||0
4934374|NCT03110900|12136354|P1|COMPLETED|Overall Study||0
4934375|NCT03110900|12136353|P2|STARTED|Overall Study||1
4934376|NCT03110900|12136354|P1|STARTED|Overall Study||1
4934377|NCT03110692|12136362|P2|NOT COMPLETED|Overall Study||0
4934378|NCT03110692|12136363|P1|NOT COMPLETED|Overall Study||0
4934379|NCT03110692|12136362|P2|COMPLETED|Overall Study||509
4934380|NCT03110692|12136363|P1|COMPLETED|Overall Study||679
4934381|NCT03110692|12136362|P2|STARTED|Overall Study||509
4934382|NCT03110692|12136363|P1|STARTED|Overall Study||679
4934383|NCT03110601|12136369|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
4934384|NCT03110601|12136369|P1|COMPLETED|Stimgenics SCS Parameters||20
4934385|NCT03110601|12136369|P1|STARTED|Stimgenics SCS Parameters||23
4934386|NCT03110601|12136369|P1|NOT COMPLETED|Washout Period||1
4934387|NCT03110601|12136369|P1|COMPLETED|Washout Period||23
4934388|NCT03110601|12136369|P1|STARTED|Washout Period||24
4934389|NCT03110601|12136369|P1|NOT COMPLETED|Conventional SCS Parameters||1
4934390|NCT03110601|12136369|P1|COMPLETED|Conventional SCS Parameters||24
4934391|NCT03110601|12136369|P1|STARTED|Conventional SCS Parameters||25
4934392|NCT03110471|12136378|P2|NOT COMPLETED|Overall Study||0
4934393|NCT03110471|12136379|P1|NOT COMPLETED|Overall Study||0
4934394|NCT03110471|12136378|P2|COMPLETED|Overall Study||30
4934395|NCT03110471|12136379|P1|COMPLETED|Overall Study||30
4934396|NCT03110471|12136378|P2|STARTED|Overall Study||30
4934397|NCT03110471|12136379|P1|STARTED|Overall Study||30
4934398|NCT03110380|12136390|P2|NOT COMPLETED|Overall Study||283
4934399|NCT03110380|12136391|P1|NOT COMPLETED|Overall Study||284
4934400|NCT03110380|12136390|P2|COMPLETED|Overall Study||0
4934401|NCT03110380|12136391|P1|COMPLETED|Overall Study||0
4934402|NCT03110380|12136390|P2|STARTED|Overall Study||283
4934403|NCT03110380|12136391|P1|STARTED|Overall Study||284
4934404|NCT03110185|12136403|P2|NOT COMPLETED|Overall Study||31
4934405|NCT03110185|12136404|P1|NOT COMPLETED|Overall Study||10
4934406|NCT03110185|12136403|P2|COMPLETED|Overall Study||33
4934407|NCT03110185|12136404|P1|COMPLETED|Overall Study||17
4934408|NCT03110185|12136403|P2|STARTED|Overall Study||64
4934409|NCT03110185|12136404|P1|STARTED|Overall Study||27
4934410|NCT03110159|12136414|P1|NOT COMPLETED|Overall Study||1
4934411|NCT03110159|12136414|P1|COMPLETED|Overall Study||0
4934412|NCT03110159|12136414|P1|STARTED|Overall Study||1
4934413|NCT03110029|12136425|P2|NOT COMPLETED|Overall Study||1
4934414|NCT03110029|12136426|P1|NOT COMPLETED|Overall Study||1
4934415|NCT03110029|12136425|P2|COMPLETED|Overall Study||5
4934416|NCT03110029|12136426|P1|COMPLETED|Overall Study||6
4934417|NCT03110029|12136425|P2|STARTED|Overall Study||6
4934418|NCT03110029|12136426|P1|STARTED|Overall Study||7
4934419|NCT03110003|12136436|P2|NOT COMPLETED|Overall Study||0
4934420|NCT03110003|12136437|P1|NOT COMPLETED|Overall Study||0
4934421|NCT03110003|12136436|P2|COMPLETED|Overall Study||24
4934422|NCT03110003|12136437|P1|COMPLETED|Overall Study||21
4934423|NCT03110003|12136436|P2|STARTED|Overall Study||24
4934424|NCT03110003|12136437|P1|STARTED|Overall Study||21
4934425|NCT03109951|12136453|P1|NOT COMPLETED|Overall Study||0
4934426|NCT03109951|12136453|P1|COMPLETED|Overall Study||187
4934427|NCT03109951|12136453|P1|STARTED|Overall Study||187
4934428|NCT03109873|12136461|P2|NOT COMPLETED|Overall Study||0
4934429|NCT03109873|12136462|P1|NOT COMPLETED|Overall Study||0
4934430|NCT03109873|12136461|P2|COMPLETED|Overall Study||4
4934431|NCT03109873|12136462|P1|COMPLETED|Overall Study||5
4934432|NCT03109873|12136461|P2|STARTED|Overall Study||4
4934433|NCT03109873|12136462|P1|STARTED|Overall Study||5
4934434|NCT03109769|12136478|P2|NOT COMPLETED|Overall Study||0
4934435|NCT03109769|12136479|P1|NOT COMPLETED|Overall Study||0
4934436|NCT03109769|12136478|P2|COMPLETED|Overall Study||22
4934437|NCT03109769|12136479|P1|COMPLETED|Overall Study||22
4934438|NCT03109769|12136478|P2|STARTED|Overall Study||22
4934439|NCT03109769|12136479|P1|STARTED|Overall Study||22
4934440|NCT03109418|12136489|P2|NOT COMPLETED|Overall Study||1
4934441|NCT03109418|12136490|P1|NOT COMPLETED|Overall Study||0
4934442|NCT03109418|12136489|P2|COMPLETED|Overall Study||3
4934443|NCT03109418|12136490|P1|COMPLETED|Overall Study||2
4934444|NCT03109418|12136489|P2|STARTED|Overall Study||4
4934445|NCT03109418|12136490|P1|STARTED|Overall Study||2
4934446|NCT03109184|12136500|P2|NOT COMPLETED|Overall Study||7
4934447|NCT03109184|12136501|P1|NOT COMPLETED|Overall Study||7
4934448|NCT03109184|12136500|P2|COMPLETED|Overall Study||52
4934449|NCT03109184|12136501|P1|COMPLETED|Overall Study||53
4934450|NCT03109184|12136500|P2|STARTED|Overall Study||59
4934451|NCT03109184|12136501|P1|STARTED|Overall Study||60
4934452|NCT03108924|12136523|P4|NOT COMPLETED|Overall Study||0
4934453|NCT03108924|12136524|P3|NOT COMPLETED|Overall Study||0
4934454|NCT03108924|12136525|P2|NOT COMPLETED|Overall Study||0
4934455|NCT03108924|12136526|P1|NOT COMPLETED|Overall Study||0
4934456|NCT03108924|12136523|P4|COMPLETED|Overall Study||6
4934457|NCT03108924|12136524|P3|COMPLETED|Overall Study||6
4934458|NCT03108924|12136525|P2|COMPLETED|Overall Study||6
4934459|NCT03108924|12136526|P1|COMPLETED|Overall Study||6
4934460|NCT03108924|12136523|P4|STARTED|Overall Study||6
4934461|NCT03108924|12136524|P3|STARTED|Overall Study||6
4934462|NCT03108924|12136525|P2|STARTED|Overall Study||6
4934463|NCT03108924|12136526|P1|STARTED|Overall Study||6
4934464|NCT03108521|12136622|P2|NOT COMPLETED|Overall Study||0
4934465|NCT03108521|12136623|P1|NOT COMPLETED|Overall Study||12
4934466|NCT03108521|12136622|P2|COMPLETED|Overall Study||36
4934467|NCT03108521|12136623|P1|COMPLETED|Overall Study||71
4934468|NCT03108521|12136622|P2|STARTED|Overall Study||36
4934469|NCT03108521|12136623|P1|STARTED|Overall Study||83
4934470|NCT03108482|12136637|P4|NOT COMPLETED|Overall Study||3
4934471|NCT03108482|12136638|P3|NOT COMPLETED|Overall Study||2
4934472|NCT03108482|12136639|P2|NOT COMPLETED|Overall Study||4
4934473|NCT03108482|12136640|P1|NOT COMPLETED|Overall Study||0
4934474|NCT03108482|12136637|P4|COMPLETED|Overall Study||86
4934475|NCT03108482|12136638|P3|COMPLETED|Overall Study||180
4934476|NCT03108482|12136639|P2|COMPLETED|Overall Study||179
4934477|NCT03108482|12136640|P1|COMPLETED|Overall Study||183
4934478|NCT03108482|12136637|P4|STARTED|Overall Study||89
4934479|NCT03108482|12136638|P3|STARTED|Overall Study||182
4934480|NCT03108482|12136639|P2|STARTED|Overall Study||183
4934481|NCT03108482|12136640|P1|STARTED|Overall Study||183
4934482|NCT03108469|12136652|P2|NOT COMPLETED|Overall Study||4
4934483|NCT03108469|12136653|P1|NOT COMPLETED|Overall Study||4
4934484|NCT03108469|12136652|P2|COMPLETED|Overall Study||11
4934485|NCT03108469|12136653|P1|COMPLETED|Overall Study||11
4934486|NCT03108469|12136652|P2|STARTED|Overall Study||15
4934487|NCT03108469|12136653|P1|STARTED|Overall Study||15
4934488|NCT03108157|12136675|P2|NOT COMPLETED|Overall Study||4
4934489|NCT03108157|12136676|P1|NOT COMPLETED|Overall Study||15
4934490|NCT03108157|12136675|P2|COMPLETED|Overall Study||172
4934491|NCT03108157|12136676|P1|COMPLETED|Overall Study||161
4934492|NCT03108157|12136675|P2|STARTED|Overall Study||176
4934493|NCT03108157|12136676|P1|STARTED|Overall Study||176
4934494|NCT03108027|12136686|P6|NOT COMPLETED|Period 3||0
4934495|NCT03108027|12136687|P5|NOT COMPLETED|Period 3||0
4934496|NCT03108027|12136688|P4|NOT COMPLETED|Period 3||0
4934497|NCT03108027|12136689|P3|NOT COMPLETED|Period 3||0
4934498|NCT03108027|12136690|P2|NOT COMPLETED|Period 3||1
4934499|NCT03108027|12136691|P1|NOT COMPLETED|Period 3||0
4934500|NCT03108027|12136686|P6|COMPLETED|Period 3||6
4934501|NCT03108027|12136687|P5|COMPLETED|Period 3||6
4934502|NCT03108027|12136688|P4|COMPLETED|Period 3||4
4934503|NCT03108027|12136689|P3|COMPLETED|Period 3||6
4934504|NCT03108027|12136690|P2|COMPLETED|Period 3||5
4934505|NCT03108027|12136691|P1|COMPLETED|Period 3||7
4934506|NCT03108027|12136686|P6|STARTED|Period 3||6
4934507|NCT03108027|12136687|P5|STARTED|Period 3||6
4934508|NCT03108027|12136688|P4|STARTED|Period 3||4
4934509|NCT03108027|12136689|P3|STARTED|Period 3||6
4934510|NCT03108027|12136690|P2|STARTED|Period 3||6
4934511|NCT03108027|12136691|P1|STARTED|Period 3||7
4934512|NCT03108027|12136686|P6|NOT COMPLETED|Period 2||0
4934513|NCT03108027|12136687|P5|NOT COMPLETED|Period 2||0
4934514|NCT03108027|12136688|P4|NOT COMPLETED|Period 2||0
4934515|NCT03108027|12136689|P3|NOT COMPLETED|Period 2||0
4934516|NCT03108027|12136690|P2|NOT COMPLETED|Period 2||0
4934517|NCT03108027|12136691|P1|NOT COMPLETED|Period 2||0
4934518|NCT03108027|12136686|P6|COMPLETED|Period 2||6
4934519|NCT03108027|12136687|P5|COMPLETED|Period 2||6
4934520|NCT03108027|12136688|P4|COMPLETED|Period 2||4
4934521|NCT03108027|12136689|P3|COMPLETED|Period 2||6
4934522|NCT03108027|12136690|P2|COMPLETED|Period 2||6
4934523|NCT03108027|12136691|P1|COMPLETED|Period 2||7
4934524|NCT03108027|12136686|P6|STARTED|Period 2||6
4934525|NCT03108027|12136687|P5|STARTED|Period 2||6
4934526|NCT03108027|12136688|P4|STARTED|Period 2||4
4934527|NCT03108027|12136689|P3|STARTED|Period 2||6
4934528|NCT03108027|12136690|P2|STARTED|Period 2||6
4934529|NCT03108027|12136691|P1|STARTED|Period 2||7
4934530|NCT03108027|12136686|P6|NOT COMPLETED|Period 1||0
4934531|NCT03108027|12136687|P5|NOT COMPLETED|Period 1||0
4934532|NCT03108027|12136688|P4|NOT COMPLETED|Period 1||2
4934533|NCT03108027|12136689|P3|NOT COMPLETED|Period 1||0
4934534|NCT03108027|12136690|P2|NOT COMPLETED|Period 1||0
4934535|NCT03108027|12136691|P1|NOT COMPLETED|Period 1||0
4934536|NCT03108027|12136686|P6|COMPLETED|Period 1||6
4934537|NCT03108027|12136687|P5|COMPLETED|Period 1||6
4934538|NCT03108027|12136688|P4|COMPLETED|Period 1||4
4934539|NCT03108027|12136689|P3|COMPLETED|Period 1||6
4934540|NCT03108027|12136690|P2|COMPLETED|Period 1||6
4934541|NCT03108027|12136691|P1|COMPLETED|Period 1||7
4934542|NCT03108027|12136686|P6|STARTED|Period 1||6
4934543|NCT03108027|12136687|P5|STARTED|Period 1||6
4934544|NCT03108027|12136688|P4|STARTED|Period 1||6
4934545|NCT03108027|12136689|P3|STARTED|Period 1||6
4934546|NCT03108027|12136690|P2|STARTED|Period 1||6
4934547|NCT03108027|12136691|P1|STARTED|Period 1||7
4934548|NCT03107754|12136707|P2|NOT COMPLETED|Overall Study||0
4934549|NCT03107754|12136708|P1|NOT COMPLETED|Overall Study||0
4934550|NCT03107754|12136707|P2|COMPLETED|Overall Study||50
4934551|NCT03107754|12136708|P1|COMPLETED|Overall Study||48
4934552|NCT03107754|12136707|P2|STARTED|Overall Study||50
4934553|NCT03107754|12136708|P1|STARTED|Overall Study||48
4934554|NCT03107715|12136718|P2|NOT COMPLETED|Overall Study||7
4934555|NCT03107715|12136719|P1|NOT COMPLETED|Overall Study||4
4934556|NCT03107715|12136718|P2|COMPLETED|Overall Study||104
4934557|NCT03107715|12136719|P1|COMPLETED|Overall Study||128
4934558|NCT03107715|12136718|P2|STARTED|Overall Study||111
4934559|NCT03107715|12136719|P1|STARTED|Overall Study||132
4934560|NCT03107611|12136734|P3|NOT COMPLETED|Overall Study||9
4934561|NCT03107611|12136735|P2|NOT COMPLETED|Overall Study||4
4934562|NCT03107611|12136736|P1|NOT COMPLETED|Overall Study||7
4934563|NCT03107611|12136734|P3|COMPLETED|Overall Study||212
4934564|NCT03107611|12136735|P2|COMPLETED|Overall Study||212
4934565|NCT03107611|12136736|P1|COMPLETED|Overall Study||210
4934566|NCT03107611|12136734|P3|Dosed|Overall Study||220
4934567|NCT03107611|12136735|P2|Dosed|Overall Study||214
4934568|NCT03107611|12136736|P1|Dosed|Overall Study||215
4934569|NCT03107611|12136734|P3|STARTED|Overall Study||221
4934570|NCT03107611|12136735|P2|STARTED|Overall Study||216
4934571|NCT03107611|12136736|P1|STARTED|Overall Study||217
4934572|NCT03107052|12136756|P3|NOT COMPLETED|Overall Study||41
4934573|NCT03107052|12136757|P2|NOT COMPLETED|Overall Study||46
4934574|NCT03107052|12136758|P1|NOT COMPLETED|Overall Study||119
4934575|NCT03107052|12136756|P3|COMPLETED|Overall Study||29
4934576|NCT03107052|12136757|P2|COMPLETED|Overall Study||14
4934577|NCT03107052|12136758|P1|COMPLETED|Overall Study||26
4934578|NCT03107052|12136756|P3|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
4934579|NCT03107052|12136757|P2|Safety Analysis Set|Overall Study||60
4934580|NCT03107052|12136758|P1|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
4934581|NCT03107052|12136756|P3|STARTED|Overall Study||70
4934582|NCT03107052|12136757|P2|STARTED|Overall Study||60
4934583|NCT03107052|12136758|P1|STARTED|Overall Study||145
4934584|NCT03107026|12136802|P3|NOT COMPLETED|Overall Study||56
4934585|NCT03107026|12136803|P2|NOT COMPLETED|Overall Study||38
4934586|NCT03107026|12136804|P1|NOT COMPLETED|Overall Study||32
4934587|NCT03107026|12136802|P3|COMPLETED|Overall Study||106
4934588|NCT03107026|12136803|P2|COMPLETED|Overall Study||123
4934589|NCT03107026|12136804|P1|COMPLETED|Overall Study||131
4934590|NCT03107026|12136802|P3|STARTED|Overall Study||162
4934591|NCT03107026|12136803|P2|STARTED|Overall Study||161
4934592|NCT03107026|12136804|P1|STARTED|Overall Study||163
4934593|NCT03106870|12136853|P2|NOT COMPLETED|Overall Study||0
4934594|NCT03106870|12136854|P1|NOT COMPLETED|Overall Study||0
4934595|NCT03106870|12136853|P2|COMPLETED|Overall Study||31
4934596|NCT03106870|12136854|P1|COMPLETED|Overall Study||31
4934597|NCT03106870|12136853|P2|STARTED|Overall Study||31
4934598|NCT03106870|12136854|P1|STARTED|Overall Study||31
4934599|NCT03106636|12136866|P2|NOT COMPLETED|Overall Study||26
4934600|NCT03106636|12136867|P1|NOT COMPLETED|Overall Study||44
4934601|NCT03106636|12136866|P2|COMPLETED|Overall Study||164
4934602|NCT03106636|12136867|P1|COMPLETED|Overall Study||182
4934603|NCT03106636|12136866|P2|STARTED|Overall Study||190
4934604|NCT03106636|12136867|P1|STARTED|Overall Study||226
4934605|NCT03106337|12136903|P1|NOT COMPLETED|Overall Study||0
4934606|NCT03106337|12136903|P1|COMPLETED|Overall Study||35
4934607|NCT03106337|12136903|P1|STARTED|Overall Study||35
4934608|NCT03105518|12136908|P1|NOT COMPLETED|Overall Study||0
4934609|NCT03105518|12136908|P1|COMPLETED|Overall Study||100
4934610|NCT03105518|12136908|P1|STARTED|Overall Study||100
4934611|NCT03105479|12136913|P7|NOT COMPLETED|Overall Study||0
4934612|NCT03105479|12136914|P6|NOT COMPLETED|Overall Study||0
4934613|NCT03105479|12136915|P5|NOT COMPLETED|Overall Study||0
4934614|NCT03105479|12136916|P4|NOT COMPLETED|Overall Study||0
4934615|NCT03105479|12136917|P3|NOT COMPLETED|Overall Study||0
4934616|NCT03105479|12136918|P2|NOT COMPLETED|Overall Study||0
4934617|NCT03105479|12136919|P1|NOT COMPLETED|Overall Study||0
4934618|NCT03105479|12136913|P7|COMPLETED|Overall Study||0
4934619|NCT03105479|12136914|P6|COMPLETED|Overall Study||0
4934620|NCT03105479|12136915|P5|COMPLETED|Overall Study||0
4934621|NCT03105479|12136916|P4|COMPLETED|Overall Study||0
4934622|NCT03105479|12136917|P3|COMPLETED|Overall Study||0
4934623|NCT03105479|12136918|P2|COMPLETED|Overall Study||0
4934624|NCT03105479|12136919|P1|COMPLETED|Overall Study||1
4934625|NCT03105479|12136913|P7|STARTED|Overall Study||0
4934626|NCT03105479|12136914|P6|STARTED|Overall Study||0
4934627|NCT03105479|12136915|P5|STARTED|Overall Study||0
4934628|NCT03105479|12136916|P4|STARTED|Overall Study||0
4934629|NCT03105479|12136917|P3|STARTED|Overall Study||0
4934630|NCT03105479|12136918|P2|STARTED|Overall Study||0
4934631|NCT03105479|12136919|P1|STARTED|Overall Study||1
4934632|NCT03105362|12136942|P1|NOT COMPLETED|Overall Study||2
4934633|NCT03105362|12136942|P1|COMPLETED|Overall Study||2
4934634|NCT03105362|12136942|P1|Completed 2 Week Questionaire|Overall Study||2
4934635|NCT03105362|12136942|P1|Completed 2 Weeks of Study|Overall Study||3
4934636|NCT03105362|12136942|P1|Completed 1 Week of Study|Overall Study||4
4934637|NCT03105362|12136942|P1|STARTED|Overall Study||4
4934638|NCT03105297|12136949|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
4934639|NCT03105297|12136949|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
4934640|NCT03105297|12136949|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
4934641|NCT03105297|12136949|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
4934642|NCT03105297|12136949|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
4934643|NCT03105297|12136949|P1|COMPLETED|Active Phase (Day 2-29)||70
4934644|NCT03105297|12136949|P1|STARTED|Active Phase (Day 2-29)||70
4934645|NCT03105297|12136949|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
4934646|NCT03105297|12136949|P1|COMPLETED|Baseline Phase (Day 1)||70
4934647|NCT03105297|12136949|P1|STARTED|Baseline Phase (Day 1)||91
4934648|NCT03104985|12136983|P2|NOT COMPLETED|Overall Study||0
4934649|NCT03104985|12136984|P1|NOT COMPLETED|Overall Study||0
4934650|NCT03104985|12136983|P2|COMPLETED|Overall Study||34
4934651|NCT03104985|12136984|P1|COMPLETED|Overall Study||34
4934652|NCT03104985|12136983|P2|STARTED|Overall Study||34
4934653|NCT03104985|12136984|P1|STARTED|Overall Study||34
4934654|NCT03104816|12136993|P3|NOT COMPLETED|Overall Study||2
4934655|NCT03104816|12136994|P2|NOT COMPLETED|Overall Study||2
4934656|NCT03104816|12136995|P1|NOT COMPLETED|Overall Study||2
4934657|NCT03104816|12136993|P3|COMPLETED|Overall Study||4
4934658|NCT03104816|12136994|P2|COMPLETED|Overall Study||9
4934659|NCT03104816|12136995|P1|COMPLETED|Overall Study||9
4934660|NCT03104816|12136993|P3|STARTED|Overall Study||6
4934661|NCT03104816|12136994|P2|STARTED|Overall Study||11
4934662|NCT03104816|12136995|P1|STARTED|Overall Study||11
4934663|NCT03104738|12137005|P2|NOT COMPLETED|Overall Study||0
4934664|NCT03104738|12137006|P1|NOT COMPLETED|Overall Study||0
4934665|NCT03104738|12137005|P2|COMPLETED|Overall Study||20
4934666|NCT03104738|12137006|P1|COMPLETED|Overall Study||20
4934667|NCT03104738|12137005|P2|STARTED|Overall Study||20
4934668|NCT03104738|12137006|P1|STARTED|Overall Study||20
4934669|NCT03104647|12137032|P1|NOT COMPLETED|Overall Study||0
4934670|NCT03104647|12137032|P1|COMPLETED|Overall Study||20
4934671|NCT03104647|12137032|P1|STARTED|Overall Study||20
4934672|NCT03104322|12137037|P1|NOT COMPLETED|Overall Study||1
4934673|NCT03104322|12137037|P1|COMPLETED|Overall Study||6
4934674|NCT03104322|12137037|P1|STARTED|Overall Study||7
4934675|NCT03104192|12137049|P4|NOT COMPLETED|Overall Study||3
4934676|NCT03104192|12137050|P3|NOT COMPLETED|Overall Study||2
4934677|NCT03104192|12137051|P2|NOT COMPLETED|Overall Study||4
4934678|NCT03104192|12137052|P1|NOT COMPLETED|Overall Study||0
4934679|NCT03104192|12137049|P4|COMPLETED|Overall Study||14
4934680|NCT03104192|12137050|P3|COMPLETED|Overall Study||14
4934681|NCT03104192|12137051|P2|COMPLETED|Overall Study||23
4934682|NCT03104192|12137052|P1|COMPLETED|Overall Study||9
4934683|NCT03104192|12137049|P4|STARTED|Overall Study||17
4934684|NCT03104192|12137050|P3|STARTED|Overall Study||16
4934685|NCT03104192|12137051|P2|STARTED|Overall Study||27
4934686|NCT03104192|12137052|P1|STARTED|Overall Study||9
4934687|NCT03103919|12137103|P2|NOT COMPLETED|Overall Study||2
4934688|NCT03103919|12137104|P1|NOT COMPLETED|Overall Study||2
4934689|NCT03103919|12137103|P2|COMPLETED|Overall Study||17
4934690|NCT03103919|12137104|P1|COMPLETED|Overall Study||18
4934691|NCT03103919|12137103|P2|STARTED|Overall Study||19
4934692|NCT03103919|12137104|P1|STARTED|Overall Study||20
4934693|NCT03103906|12137140|P2|NOT COMPLETED|Overall Study||3
4934694|NCT03103906|12137141|P1|NOT COMPLETED|Overall Study||4
4934695|NCT03103906|12137140|P2|COMPLETED|Overall Study||39
4934696|NCT03103906|12137141|P1|COMPLETED|Overall Study||36
4934697|NCT03103906|12137140|P2|STARTED|Overall Study||42
4934698|NCT03103906|12137141|P1|STARTED|Overall Study||40
4934699|NCT03103763|12137164|P3|NOT COMPLETED|Overall Study||7
4934700|NCT03103763|12137165|P2|NOT COMPLETED|Overall Study||8
4934701|NCT03103763|12137166|P1|NOT COMPLETED|Overall Study||15
4934702|NCT03103763|12137164|P3|COMPLETED|Overall Study||37
4934703|NCT03103763|12137165|P2|COMPLETED|Overall Study||36
4934704|NCT03103763|12137166|P1|COMPLETED|Overall Study||29
4934705|NCT03103763|12137164|P3|STARTED|Overall Study||44
4934706|NCT03103763|12137165|P2|STARTED|Overall Study||44
4934707|NCT03103763|12137166|P1|STARTED|Overall Study||44
4934708|NCT03103061|12137195|P1|NOT COMPLETED|Overall Study||0
4934709|NCT03103061|12137195|P1|COMPLETED|Overall Study||24
4934710|NCT03103061|12137195|P1|STARTED|Overall Study||24
4934711|NCT03102918|12137202|P2|NOT COMPLETED|Overall Study||0
4934712|NCT03102918|12137203|P1|NOT COMPLETED|Overall Study||1
4934713|NCT03102918|12137202|P2|COMPLETED|Overall Study||5
4934714|NCT03102918|12137203|P1|COMPLETED|Overall Study||4
4934715|NCT03102918|12137202|P2|STARTED|Overall Study||5
4934716|NCT03102918|12137203|P1|STARTED|Overall Study||5
4934717|NCT03102879|12137211|P2|NOT COMPLETED|Overall Study||0
4934718|NCT03102879|12137212|P1|NOT COMPLETED|Overall Study||0
4934719|NCT03102879|12137211|P2|COMPLETED|Overall Study||18
4934720|NCT03102879|12137212|P1|COMPLETED|Overall Study||18
4934721|NCT03102879|12137211|P2|STARTED|Overall Study||18
4934722|NCT03102879|12137212|P1|STARTED|Overall Study||18
4934723|NCT03102762|12137229|P2|NOT COMPLETED|Overall Study||0
4934724|NCT03102762|12137230|P1|NOT COMPLETED|Overall Study||1
4934725|NCT03102762|12137229|P2|COMPLETED|Overall Study||35
4934726|NCT03102762|12137230|P1|COMPLETED|Overall Study||34
4934727|NCT03102762|12137229|P2|STARTED|Overall Study||35
4934728|NCT03102762|12137230|P1|STARTED|Overall Study||35
4934729|NCT03102736|12137258|P2|NOT COMPLETED|Overall Study||0
4934730|NCT03102736|12137259|P1|NOT COMPLETED|Overall Study||0
4934731|NCT03102736|12137258|P2|COMPLETED|Overall Study||9
4934732|NCT03102736|12137259|P1|COMPLETED|Overall Study||7
4934733|NCT03102736|12137258|P2|STARTED|Overall Study||9
4934734|NCT03102736|12137259|P1|STARTED|Overall Study||7
4934735|NCT03102710|12137274|P3|NOT COMPLETED|Overall Study||0
4934736|NCT03102710|12137275|P2|NOT COMPLETED|Overall Study||3
4934737|NCT03102710|12137276|P1|NOT COMPLETED|Overall Study||1
4934738|NCT03102710|12137274|P3|COMPLETED|Overall Study||27
4934739|NCT03102710|12137275|P2|COMPLETED|Overall Study||27
4934740|NCT03102710|12137276|P1|COMPLETED|Overall Study||27
4934741|NCT03102710|12137274|P3|STARTED|Overall Study||27
4934742|NCT03102710|12137275|P2|STARTED|Overall Study||30
4934743|NCT03102710|12137276|P1|STARTED|Overall Study||28
4934744|NCT03102411|12137290|P1|NOT COMPLETED|Overall Study||163
4934745|NCT03102411|12137290|P1|COMPLETED|Overall Study||1718
4934746|NCT03102411|12137290|P1|STARTED|Overall Study||1881
4934747|NCT03102190|12137295|P1|NOT COMPLETED|Overall Study||0
4934748|NCT03102190|12137295|P1|COMPLETED|Overall Study||6
4934749|NCT03102190|12137295|P1|STARTED|Overall Study||6
4934750|NCT03102034|12137301|P2|NOT COMPLETED|Overall Study||0
4934751|NCT03102034|12137302|P1|NOT COMPLETED|Overall Study||1
4934752|NCT03102034|12137301|P2|COMPLETED|Overall Study||11
4934753|NCT03102034|12137302|P1|COMPLETED|Overall Study||20
4934754|NCT03102034|12137301|P2|STARTED|Overall Study||11
4934755|NCT03102034|12137302|P1|STARTED|Overall Study||21
4934756|NCT03101462|12137330|P2|NOT COMPLETED|Overall Study||1
4934757|NCT03101462|12137331|P1|NOT COMPLETED|Overall Study||1
4934758|NCT03101462|12137330|P2|COMPLETED|Overall Study||18
4934759|NCT03101462|12137331|P1|COMPLETED|Overall Study||18
4934760|NCT03101462|12137330|P2|STARTED|Overall Study||19
4934761|NCT03101462|12137331|P1|STARTED|Overall Study||19
4934762|NCT03101371|12137347|P2|NOT COMPLETED|Overall Study||6
4934763|NCT03101371|12137348|P1|NOT COMPLETED|Overall Study||3
4934764|NCT03101371|12137347|P2|COMPLETED|Overall Study||45
4934765|NCT03101371|12137348|P1|COMPLETED|Overall Study||45
4934766|NCT03101371|12137347|P2|STARTED|Overall Study||51
4934767|NCT03101371|12137348|P1|STARTED|Overall Study||48
4934768|NCT03101293|12137368|P2|NOT COMPLETED|Intervention Period 2||0
4934769|NCT03101293|12137369|P1|NOT COMPLETED|Intervention Period 2||0
4934770|NCT03101293|12137368|P2|COMPLETED|Intervention Period 2||8
4934771|NCT03101293|12137369|P1|COMPLETED|Intervention Period 2||6
4934772|NCT03101293|12137368|P2|STARTED|Intervention Period 2||8
4934773|NCT03101293|12137369|P1|STARTED|Intervention Period 2||6
4934774|NCT03101293|12137368|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
4934775|NCT03101293|12137369|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
4934776|NCT03101293|12137368|P2|COMPLETED|Washout Period (at Least 7 Days)||8
4934777|NCT03101293|12137369|P1|COMPLETED|Washout Period (at Least 7 Days)||6
4934778|NCT03101293|12137368|P2|STARTED|Washout Period (at Least 7 Days)||8
4934779|NCT03101293|12137369|P1|STARTED|Washout Period (at Least 7 Days)||7
4934780|NCT03101293|12137368|P2|NOT COMPLETED|Intervention Period 1||0
4934781|NCT03101293|12137369|P1|NOT COMPLETED|Intervention Period 1||0
4934782|NCT03101293|12137368|P2|COMPLETED|Intervention Period 1||8
4934783|NCT03101293|12137369|P1|COMPLETED|Intervention Period 1||7
4934784|NCT03101293|12137368|P2|STARTED|Intervention Period 1||8
4934785|NCT03101293|12137369|P1|STARTED|Intervention Period 1||7
4934786|NCT03101267|12137384|P3|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
4934787|NCT03101267|12137385|P2|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
4934788|NCT03101267|12137386|P1|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
4934789|NCT03101267|12137384|P3|COMPLETED|Pollinosis Symptoms Survey Period||47
4934790|NCT03101267|12137385|P2|COMPLETED|Pollinosis Symptoms Survey Period||48
4934791|NCT03101267|12137386|P1|COMPLETED|Pollinosis Symptoms Survey Period||47
4934792|NCT03101267|12137384|P3|STARTED|Pollinosis Symptoms Survey Period||47
4934793|NCT03101267|12137385|P2|STARTED|Pollinosis Symptoms Survey Period||48
4934794|NCT03101267|12137386|P1|STARTED|Pollinosis Symptoms Survey Period||47
4934795|NCT03101267|12137384|P3|NOT COMPLETED|Primary Study Period||3
4934796|NCT03101267|12137385|P2|NOT COMPLETED|Primary Study Period||2
4934797|NCT03101267|12137386|P1|NOT COMPLETED|Primary Study Period||3
4934798|NCT03101267|12137384|P3|COMPLETED|Primary Study Period||47
4934799|NCT03101267|12137385|P2|COMPLETED|Primary Study Period||48
4934800|NCT03101267|12137386|P1|COMPLETED|Primary Study Period||47
4934801|NCT03101267|12137384|P3|STARTED|Primary Study Period||50
4934802|NCT03101267|12137385|P2|STARTED|Primary Study Period||50
4934803|NCT03101267|12137386|P1|STARTED|Primary Study Period||50
4934804|NCT03101150|12137441|P2|NOT COMPLETED|Overall Study||10
4934805|NCT03101150|12137442|P1|NOT COMPLETED|Overall Study||5
4934806|NCT03101150|12137441|P2|COMPLETED|Overall Study||83
4934807|NCT03101150|12137442|P1|COMPLETED|Overall Study||81
4934808|NCT03101150|12137441|P2|STARTED|Overall Study||93
4934809|NCT03101150|12137442|P1|STARTED|Overall Study||86
4934810|NCT03101033|12137454|P2|NOT COMPLETED|Overall Study||9
4934811|NCT03101033|12137455|P1|NOT COMPLETED|Overall Study||5
4934812|NCT03101033|12137454|P2|COMPLETED|Overall Study||51
4934813|NCT03101033|12137455|P1|COMPLETED|Overall Study||27
4934814|NCT03101033|12137454|P2|STARTED|Overall Study||60
4934815|NCT03101033|12137455|P1|STARTED|Overall Study||32
4934816|NCT03101020|12137477|P2|NOT COMPLETED|Overall Study||3
4934817|NCT03101020|12137478|P1|NOT COMPLETED|Overall Study||1
4934818|NCT03101020|12137477|P2|COMPLETED|Overall Study||7
4934819|NCT03101020|12137478|P1|COMPLETED|Overall Study||9
4934820|NCT03101020|12137477|P2|STARTED|Overall Study||10
4934821|NCT03101020|12137478|P1|STARTED|Overall Study||10
4934822|NCT03100968|12137492|P2|NOT COMPLETED|Overall Study||0
4934823|NCT03100968|12137493|P1|NOT COMPLETED|Overall Study||0
4934824|NCT03100968|12137492|P2|COMPLETED|Overall Study||75
4934825|NCT03100968|12137493|P1|COMPLETED|Overall Study||75
4934826|NCT03100968|12137492|P2|STARTED|Overall Study||75
4934827|NCT03100968|12137493|P1|STARTED|Overall Study||75
4934828|NCT03100942|12137513|P4|NOT COMPLETED|Overall Study||23
4934829|NCT03100942|12137514|P3|NOT COMPLETED|Overall Study||26
4934830|NCT03100942|12137515|P2|NOT COMPLETED|Overall Study||27
4934831|NCT03100942|12137516|P1|NOT COMPLETED|Overall Study||29
4934832|NCT03100942|12137513|P4|COMPLETED|Overall Study||14
4934833|NCT03100942|12137514|P3|COMPLETED|Overall Study||13
4934834|NCT03100942|12137515|P2|COMPLETED|Overall Study||11
4934835|NCT03100942|12137516|P1|COMPLETED|Overall Study||9
4934836|NCT03100942|12137513|P4|Study Completed up to Week 24|Overall Study|32 participants were rerandomized at Week 24.|32
4934837|NCT03100942|12137514|P3|Study Completed up to Week 24|Overall Study||37
4934838|NCT03100942|12137515|P2|Study Completed up to Week 24|Overall Study||30
4934839|NCT03100942|12137516|P1|Study Completed up to Week 24|Overall Study||35
4934840|NCT03100942|12137513|P4|STARTED|Overall Study||37
4934841|NCT03100942|12137514|P3|STARTED|Overall Study||39
4934842|NCT03100942|12137515|P2|STARTED|Overall Study||38
4934843|NCT03100942|12137516|P1|STARTED|Overall Study||38
4934844|NCT03100838|12137542|P4|NOT COMPLETED|Overall Study||1
4934845|NCT03100838|12137543|P3|NOT COMPLETED|Overall Study||2
4934846|NCT03100838|12137544|P2|NOT COMPLETED|Overall Study||2
4934847|NCT03100838|12137545|P1|NOT COMPLETED|Overall Study||2
4934848|NCT03100838|12137542|P4|COMPLETED|Overall Study||15
4934849|NCT03100838|12137543|P3|COMPLETED|Overall Study||14
4934850|NCT03100838|12137544|P2|COMPLETED|Overall Study||14
4934851|NCT03100838|12137545|P1|COMPLETED|Overall Study||14
4934852|NCT03100838|12137542|P4|STARTED|Overall Study||16
4934853|NCT03100838|12137543|P3|STARTED|Overall Study||16
4934854|NCT03100838|12137544|P2|STARTED|Overall Study||16
4934855|NCT03100838|12137545|P1|STARTED|Overall Study||16
4934856|NCT03100825|12137571|P1|NOT COMPLETED|Overall Study||8
4934857|NCT03100825|12137571|P1|COMPLETED|Overall Study||86
4934858|NCT03100825|12137571|P1|STARTED|Overall Study||94
4934859|NCT03100617|12137581|P1|NOT COMPLETED|Overall Study||0
4934860|NCT03100617|12137581|P1|COMPLETED|Overall Study||6
4934861|NCT03100617|12137581|P1|STARTED|Overall Study||6
4934862|NCT03100500|12137585|P1|NOT COMPLETED|Overall Study||0
4934863|NCT03100500|12137585|P1|COMPLETED|Overall Study||51
4934864|NCT03100500|12137585|P1|STARTED|Overall Study||51
4934865|NCT03100344|12137598|P4|NOT COMPLETED|Overall Study||12
4934866|NCT03100344|12137599|P3|NOT COMPLETED|Overall Study||7
4934867|NCT03100344|12137600|P2|NOT COMPLETED|Overall Study||11
4934868|NCT03100344|12137601|P1|NOT COMPLETED|Overall Study||14
4934869|NCT03100344|12137598|P4|COMPLETED|Overall Study||45
4934870|NCT03100344|12137599|P3|COMPLETED|Overall Study||50
4934871|NCT03100344|12137600|P2|COMPLETED|Overall Study||44
4934872|NCT03100344|12137601|P1|COMPLETED|Overall Study||43
4934873|NCT03100344|12137598|P4|STARTED|Overall Study||57
4934874|NCT03100344|12137599|P3|STARTED|Overall Study||57
4934875|NCT03100344|12137600|P2|STARTED|Overall Study||55
4934876|NCT03100344|12137601|P1|STARTED|Overall Study||57
4934877|NCT03100123|12137681|P2|NOT COMPLETED|Overall Study||0
4934878|NCT03100123|12137682|P1|NOT COMPLETED|Overall Study||0
4934879|NCT03100123|12137681|P2|COMPLETED|Overall Study||1
4934880|NCT03100123|12137682|P1|COMPLETED|Overall Study||0
4934881|NCT03100123|12137681|P2|STARTED|Overall Study||1
4934882|NCT03100123|12137682|P1|STARTED|Overall Study||0
4934883|NCT03100058|12137704|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
4934884|NCT03100058|12137705|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
4934885|NCT03100058|12137706|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
4934886|NCT03100058|12137707|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
4934887|NCT03100058|12137708|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934888|NCT03100058|12137709|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934889|NCT03100058|12137710|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934890|NCT03100058|12137711|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934891|NCT03100058|12137712|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934892|NCT03100058|12137713|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934893|NCT03100058|12137714|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934894|NCT03100058|12137715|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934895|NCT03100058|12137716|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934896|NCT03100058|12137704|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
4934897|NCT03100058|12137705|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
4934898|NCT03100058|12137706|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
4934899|NCT03100058|12137707|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
4934900|NCT03100058|12137708|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934901|NCT03100058|12137709|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934902|NCT03100058|12137710|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934903|NCT03100058|12137711|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934904|NCT03100058|12137712|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934905|NCT03100058|12137713|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934906|NCT03100058|12137714|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934907|NCT03100058|12137715|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934908|NCT03100058|12137716|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
4934909|NCT03100058|12137704|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
4934910|NCT03100058|12137705|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
4934911|NCT03100058|12137706|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
4934912|NCT03100058|12137707|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
4934913|NCT03100058|12137708|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934914|NCT03100058|12137709|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934915|NCT03100058|12137710|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934916|NCT03100058|12137711|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934917|NCT03100058|12137712|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934918|NCT03100058|12137713|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934919|NCT03100058|12137714|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934920|NCT03100058|12137715|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934921|NCT03100058|12137716|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
4934922|NCT03100058|12137704|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934923|NCT03100058|12137705|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934924|NCT03100058|12137706|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934925|NCT03100058|12137707|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934926|NCT03100058|12137708|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
4934927|NCT03100058|12137709|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
4934928|NCT03100058|12137710|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
4934929|NCT03100058|12137711|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
4934930|NCT03100058|12137712|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
4934931|NCT03100058|12137713|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
4934932|NCT03100058|12137714|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
4934933|NCT03100058|12137715|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
4934934|NCT03100058|12137716|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
4934935|NCT03100058|12137704|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934936|NCT03100058|12137705|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934937|NCT03100058|12137706|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934938|NCT03100058|12137707|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
4934939|NCT03100058|12137708|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
4934940|NCT03100058|12137709|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
4934941|NCT03100058|12137710|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
4934942|NCT03100058|12137711|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
4934943|NCT03100058|12137712|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
4934944|NCT03100058|12137713|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
4934945|NCT03100058|12137714|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
4934946|NCT03100058|12137715|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
4934947|NCT03100058|12137716|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
4934948|NCT03100058|12137704|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
4934949|NCT03100058|12137705|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
4934950|NCT03100058|12137706|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
4934951|NCT03100058|12137707|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
4934952|NCT03100058|12137708|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
4934953|NCT03100058|12137709|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
4934954|NCT03100058|12137710|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
4934955|NCT03100058|12137711|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
4934956|NCT03100058|12137712|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
4934957|NCT03100058|12137713|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
4934958|NCT03100058|12137714|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
4934959|NCT03100058|12137715|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
4934960|NCT03100058|12137716|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
4934961|NCT03099694|12137923|P2|NOT COMPLETED|Overall Study||18
4934962|NCT03099694|12137924|P1|NOT COMPLETED|Overall Study||20
4934963|NCT03099694|12137923|P2|COMPLETED|Overall Study||152
4934964|NCT03099694|12137924|P1|COMPLETED|Overall Study||150
4934965|NCT03099694|12137923|P2|STARTED|Overall Study||170
4934966|NCT03099694|12137924|P1|STARTED|Overall Study||170
4934967|NCT03099655|12137952|P1|NOT COMPLETED|Overall Study||61
4934968|NCT03099655|12137952|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
4934969|NCT03099655|12137952|P1|STARTED|Overall Study||440
4934970|NCT03099538|12137963|P1|NOT COMPLETED|Overall Study||3
4934971|NCT03099538|12137963|P1|COMPLETED|Overall Study||1
4934972|NCT03099538|12137963|P1|STARTED|Overall Study||4
4934973|NCT03099369|12137975|P2|NOT COMPLETED|Overall Study||4
4934974|NCT03099369|12137976|P1|NOT COMPLETED|Overall Study||6
4934975|NCT03099369|12137975|P2|COMPLETED|Overall Study||5
4934976|NCT03099369|12137976|P1|COMPLETED|Overall Study||5
4934977|NCT03099369|12137975|P2|STARTED|Overall Study||9
4934978|NCT03099369|12137976|P1|STARTED|Overall Study||11
4934979|NCT03099187|12137988|P2|NOT COMPLETED|Overall Study||34
4934980|NCT03099187|12137989|P1|NOT COMPLETED|Overall Study||43
4934981|NCT03099187|12137988|P2|COMPLETED|Overall Study||92
4934982|NCT03099187|12137989|P1|COMPLETED|Overall Study||84
4934983|NCT03099187|12137988|P2|STARTED|Overall Study||126
4934984|NCT03099187|12137989|P1|STARTED|Overall Study||127
4934985|NCT03099161|12138038|P3|NOT COMPLETED|Overall Study||3
4934986|NCT03099161|12138039|P2|NOT COMPLETED|Overall Study||4
4934987|NCT03099161|12138040|P1|NOT COMPLETED|Overall Study||3
4934988|NCT03099161|12138038|P3|COMPLETED|Overall Study||0
4934989|NCT03099161|12138039|P2|COMPLETED|Overall Study||0
4934990|NCT03099161|12138040|P1|COMPLETED|Overall Study||0
4934991|NCT03099161|12138038|P3|STARTED|Overall Study||3
4934992|NCT03099161|12138039|P2|STARTED|Overall Study||4
4934993|NCT03099161|12138040|P1|STARTED|Overall Study||3
4934994|NCT03099096|12138057|P1|NOT COMPLETED|Overall Study||2
4934995|NCT03099096|12138057|P1|COMPLETED|Overall Study||157
4934996|NCT03099096|12138057|P1|STARTED|Overall Study||159
4934997|NCT03098979|12138070|P6|NOT COMPLETED|Overall Study||4
4934998|NCT03098979|12138071|P5|NOT COMPLETED|Overall Study||9
4934999|NCT03098979|12138072|P4|NOT COMPLETED|Overall Study||5
4935000|NCT03098979|12138073|P3|NOT COMPLETED|Overall Study||4
4935001|NCT03098979|12138074|P2|NOT COMPLETED|Overall Study||2
4935002|NCT03098979|12138075|P1|NOT COMPLETED|Overall Study||6
4935003|NCT03098979|12138070|P6|COMPLETED|Overall Study||47
4935004|NCT03098979|12138071|P5|COMPLETED|Overall Study||41
4935005|NCT03098979|12138072|P4|COMPLETED|Overall Study||46
4935006|NCT03098979|12138073|P3|COMPLETED|Overall Study||46
4935007|NCT03098979|12138074|P2|COMPLETED|Overall Study||25
4935008|NCT03098979|12138075|P1|COMPLETED|Overall Study||70
4935009|NCT03098979|12138070|P6|STARTED|Overall Study||51
4935010|NCT03098979|12138071|P5|STARTED|Overall Study||50
4935011|NCT03098979|12138072|P4|STARTED|Overall Study||51
4935012|NCT03098979|12138073|P3|STARTED|Overall Study||50
4935013|NCT03098979|12138074|P2|STARTED|Overall Study||27
4935014|NCT03098979|12138075|P1|STARTED|Overall Study||76
4935015|NCT03098966|12138113|P1|NOT COMPLETED|Overall Study||0
4935016|NCT03098966|12138113|P1|COMPLETED|Overall Study||368
4935017|NCT03098966|12138113|P1|STARTED|Overall Study||368
4935018|NCT03098745|12138119|P6|NOT COMPLETED|Day 3||0
4935019|NCT03098745|12138120|P5|NOT COMPLETED|Day 3||0
4935020|NCT03098745|12138121|P4|NOT COMPLETED|Day 3||0
4935021|NCT03098745|12138122|P3|NOT COMPLETED|Day 3||0
4935022|NCT03098745|12138123|P2|NOT COMPLETED|Day 3||0
4935023|NCT03098745|12138124|P1|NOT COMPLETED|Day 3||0
4935024|NCT03098745|12138119|P6|COMPLETED|Day 3||4
4935025|NCT03098745|12138120|P5|COMPLETED|Day 3||10
4935026|NCT03098745|12138121|P4|COMPLETED|Day 3||8
4935027|NCT03098745|12138122|P3|COMPLETED|Day 3||8
4935028|NCT03098745|12138123|P2|COMPLETED|Day 3||3
4935029|NCT03098745|12138124|P1|COMPLETED|Day 3||7
4935030|NCT03098745|12138119|P6|STARTED|Day 3||4
4935031|NCT03098745|12138120|P5|STARTED|Day 3||10
4935032|NCT03098745|12138121|P4|STARTED|Day 3||8
4935033|NCT03098745|12138122|P3|STARTED|Day 3||8
4935034|NCT03098745|12138123|P2|STARTED|Day 3||3
4935035|NCT03098745|12138124|P1|STARTED|Day 3||7
4935036|NCT03098745|12138119|P6|NOT COMPLETED|Day 2||0
4935037|NCT03098745|12138120|P5|NOT COMPLETED|Day 2||0
4935038|NCT03098745|12138121|P4|NOT COMPLETED|Day 2||0
4935039|NCT03098745|12138122|P3|NOT COMPLETED|Day 2||0
4935040|NCT03098745|12138123|P2|NOT COMPLETED|Day 2||0
4935041|NCT03098745|12138124|P1|NOT COMPLETED|Day 2||0
4935042|NCT03098745|12138119|P6|COMPLETED|Day 2||4
4935043|NCT03098745|12138120|P5|COMPLETED|Day 2||10
4935044|NCT03098745|12138121|P4|COMPLETED|Day 2||8
4935045|NCT03098745|12138122|P3|COMPLETED|Day 2||8
4935046|NCT03098745|12138123|P2|COMPLETED|Day 2||3
4935047|NCT03098745|12138124|P1|COMPLETED|Day 2||7
4935048|NCT03098745|12138119|P6|STARTED|Day 2||4
4935049|NCT03098745|12138120|P5|STARTED|Day 2||10
4935050|NCT03098745|12138121|P4|STARTED|Day 2||8
4935051|NCT03098745|12138122|P3|STARTED|Day 2||8
4935052|NCT03098745|12138123|P2|STARTED|Day 2||3
4935053|NCT03098745|12138124|P1|STARTED|Day 2||7
4935054|NCT03098745|12138119|P6|NOT COMPLETED|Day 1||0
4935055|NCT03098745|12138120|P5|NOT COMPLETED|Day 1||0
4935056|NCT03098745|12138121|P4|NOT COMPLETED|Day 1||0
4935057|NCT03098745|12138122|P3|NOT COMPLETED|Day 1||0
4935058|NCT03098745|12138123|P2|NOT COMPLETED|Day 1||0
4935059|NCT03098745|12138124|P1|NOT COMPLETED|Day 1||0
4935060|NCT03098745|12138119|P6|COMPLETED|Day 1||4
4935061|NCT03098745|12138120|P5|COMPLETED|Day 1||10
4935062|NCT03098745|12138121|P4|COMPLETED|Day 1||8
4935063|NCT03098745|12138122|P3|COMPLETED|Day 1||8
4935064|NCT03098745|12138123|P2|COMPLETED|Day 1||3
4935065|NCT03098745|12138124|P1|COMPLETED|Day 1||7
4935066|NCT03098745|12138119|P6|STARTED|Day 1||4
4935067|NCT03098745|12138120|P5|STARTED|Day 1||10
4935068|NCT03098745|12138121|P4|STARTED|Day 1||8
4935069|NCT03098745|12138122|P3|STARTED|Day 1||8
4935070|NCT03098745|12138123|P2|STARTED|Day 1||3
4935071|NCT03098745|12138124|P1|STARTED|Day 1||7
4935072|NCT03098641|12138160|P1|NOT COMPLETED|Overall Study||52
4935073|NCT03098641|12138160|P1|COMPLETED|Overall Study||220
4935074|NCT03098641|12138160|P1|STARTED|Overall Study||272
4935075|NCT03098615|12138178|P1|NOT COMPLETED|Overall Study||2
4935076|NCT03098615|12138178|P1|COMPLETED|Overall Study||17
4935077|NCT03098615|12138178|P1|STARTED|Overall Study||19
4935078|NCT03098173|12138185|P2|NOT COMPLETED|Overall Study||2
4935079|NCT03098173|12138186|P1|NOT COMPLETED|Overall Study||1
4935080|NCT03098173|12138185|P2|COMPLETED|Overall Study||79
4935081|NCT03098173|12138186|P1|COMPLETED|Overall Study||80
4935082|NCT03098173|12138185|P2|STARTED|Overall Study||81
4935083|NCT03098173|12138186|P1|STARTED|Overall Study||81
4935084|NCT03097861|12138217|P3|NOT COMPLETED|Overall Study||9
4935085|NCT03097861|12138218|P2|NOT COMPLETED|Overall Study||22
4935086|NCT03097861|12138219|P1|NOT COMPLETED|Overall Study||7
4935087|NCT03097861|12138217|P3|COMPLETED|Overall Study||122
4935088|NCT03097861|12138218|P2|COMPLETED|Overall Study||254
4935089|NCT03097861|12138219|P1|COMPLETED|Overall Study||138
4935090|NCT03097861|12138217|P3|Per-protocol Population (PP)|Overall Study||113
4935091|NCT03097861|12138218|P2|Per-protocol Population (PP)|Overall Study||234
4935092|NCT03097861|12138219|P1|Per-protocol Population (PP)|Overall Study||126
4935093|NCT03097861|12138217|P3|Completers|Overall Study||121
4935094|NCT03097861|12138218|P2|Completers|Overall Study||255
4935095|NCT03097861|12138219|P1|Completers|Overall Study||129
4935096|NCT03097861|12138217|P3|Modified Intent to Treat|Overall Study||130
4935097|NCT03097861|12138218|P2|Modified Intent to Treat|Overall Study||275
4935098|NCT03097861|12138219|P1|Modified Intent to Treat|Overall Study||143
4935099|NCT03097861|12138217|P3|Safety Population|Overall Study||130
4935100|NCT03097861|12138218|P2|Safety Population|Overall Study||275
4935101|NCT03097861|12138219|P1|Safety Population|Overall Study||143
4935102|NCT03097861|12138217|P3|STARTED|Overall Study||131
4935103|NCT03097861|12138218|P2|STARTED|Overall Study||276
4935104|NCT03097861|12138219|P1|STARTED|Overall Study||145
4935105|NCT03097614|12138236|P1|NOT COMPLETED|Overall Study||3
4935106|NCT03097614|12138236|P1|COMPLETED|Overall Study||54
4935107|NCT03097614|12138236|P1|STARTED|Overall Study||57
4935108|NCT03097484|12138242|P2|NOT COMPLETED|Overall Study||0
4935109|NCT03097484|12138243|P1|NOT COMPLETED|Overall Study||0
4935110|NCT03097484|12138242|P2|COMPLETED|Overall Study||19
4935111|NCT03097484|12138243|P1|COMPLETED|Overall Study||19
4935112|NCT03097484|12138242|P2|STARTED|Overall Study||19
4935113|NCT03097484|12138243|P1|STARTED|Overall Study||19
4935114|NCT03097341|12138256|P5|NOT COMPLETED|Overall Study||0
4935115|NCT03097341|12138257|P4|NOT COMPLETED|Overall Study||0
4935116|NCT03097341|12138258|P3|NOT COMPLETED|Overall Study||0
4935117|NCT03097341|12138259|P2|NOT COMPLETED|Overall Study||0
4935118|NCT03097341|12138260|P1|NOT COMPLETED|Overall Study||0
4935119|NCT03097341|12138256|P5|COMPLETED|Overall Study||5
4935120|NCT03097341|12138257|P4|COMPLETED|Overall Study||4
4935121|NCT03097341|12138258|P3|COMPLETED|Overall Study||4
4935122|NCT03097341|12138259|P2|COMPLETED|Overall Study||4
4935123|NCT03097341|12138260|P1|COMPLETED|Overall Study||4
4935124|NCT03097341|12138256|P5|STARTED|Overall Study||5
4935125|NCT03097341|12138257|P4|STARTED|Overall Study||4
4935126|NCT03097341|12138258|P3|STARTED|Overall Study||4
4935127|NCT03097341|12138259|P2|STARTED|Overall Study||4
4935128|NCT03097341|12138260|P1|STARTED|Overall Study||4
4935129|NCT03097289|12138338|P1|NOT COMPLETED|Overall Study||6
4935130|NCT03097289|12138338|P1|COMPLETED|Overall Study||26
4935131|NCT03097289|12138338|P1|STARTED|Overall Study||32
4935132|NCT03097029|12138345|P1|NOT COMPLETED|Overall Study||1
4935133|NCT03097029|12138345|P1|COMPLETED|Overall Study||14
4935134|NCT03097029|12138345|P1|STARTED|Overall Study||15
4935135|NCT03096873|12138352|P2|NOT COMPLETED|Overall Study||0
4935136|NCT03096873|12138353|P1|NOT COMPLETED|Overall Study||0
4935137|NCT03096873|12138352|P2|COMPLETED|Overall Study||20
4935138|NCT03096873|12138353|P1|COMPLETED|Overall Study||20
4935139|NCT03096873|12138352|P2|STARTED|Overall Study||20
4935140|NCT03096873|12138353|P1|STARTED|Overall Study||20
4935141|NCT03096483|12138389|P1|NOT COMPLETED|Overall Study||1
4935142|NCT03096483|12138389|P1|COMPLETED|Overall Study||11
4935143|NCT03096483|12138389|P1|STARTED|Overall Study||12
4935144|NCT03096444|12138394|P1|NOT COMPLETED|Overall Study||0
4935145|NCT03096444|12138394|P1|COMPLETED|Overall Study||13
4935146|NCT03096444|12138394|P1|STARTED|Overall Study||13
4935147|NCT03096314|12138418|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
4935148|NCT03096314|12138419|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
4935149|NCT03096314|12138418|P2|COMPLETED|Confirmed Vitamin D Deficient||528
4935150|NCT03096314|12138419|P1|COMPLETED|Confirmed Vitamin D Deficient||531
4935151|NCT03096314|12138418|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
4935152|NCT03096314|12138419|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
4935153|NCT03096314|12138418|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
4935154|NCT03096314|12138419|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
4935155|NCT03096314|12138418|P2|COMPLETED|Screened Vitamin D Deficient||656
4935156|NCT03096314|12138419|P1|COMPLETED|Screened Vitamin D Deficient||681
4935157|NCT03096314|12138418|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
4935158|NCT03096314|12138419|P1|STARTED|Screened Vitamin D Deficient||690
4935159|NCT03095885|12138467|P1|NOT COMPLETED|Overall Study||0
4935160|NCT03095885|12138467|P1|COMPLETED|Overall Study||22
4935161|NCT03095885|12138467|P1|STARTED|Overall Study||22
4935162|NCT03095651|12138481|P8|NOT COMPLETED|Overall Study||0
4935163|NCT03095651|12138482|P7|NOT COMPLETED|Overall Study||0
4935164|NCT03095651|12138483|P6|NOT COMPLETED|Overall Study||1
4935165|NCT03095651|12138484|P5|NOT COMPLETED|Overall Study||0
4935166|NCT03095651|12138485|P4|NOT COMPLETED|Overall Study||1
4935167|NCT03095651|12138486|P3|NOT COMPLETED|Overall Study||0
4935168|NCT03095651|12138487|P2|NOT COMPLETED|Overall Study||1
4935169|NCT03095651|12138488|P1|NOT COMPLETED|Overall Study||1
4935170|NCT03095651|12138481|P8|COMPLETED|Overall Study||4
4935171|NCT03095651|12138482|P7|COMPLETED|Overall Study||6
4935172|NCT03095651|12138483|P6|COMPLETED|Overall Study||6
4935173|NCT03095651|12138484|P5|COMPLETED|Overall Study||0
4935174|NCT03095651|12138485|P4|COMPLETED|Overall Study||3
4935175|NCT03095651|12138486|P3|COMPLETED|Overall Study||0
4935176|NCT03095651|12138487|P2|COMPLETED|Overall Study||5
4935177|NCT03095651|12138488|P1|COMPLETED|Overall Study||5
4935178|NCT03095651|12138481|P8|STARTED|Overall Study||4
4935179|NCT03095651|12138482|P7|STARTED|Overall Study||6
4935180|NCT03095651|12138483|P6|STARTED|Overall Study||7
4935181|NCT03095651|12138484|P5|STARTED|Overall Study||0
4935182|NCT03095651|12138485|P4|STARTED|Overall Study||4
4935183|NCT03095651|12138486|P3|STARTED|Overall Study||0
4935184|NCT03095651|12138487|P2|STARTED|Overall Study||6
4935185|NCT03095651|12138488|P1|STARTED|Overall Study||6
4935186|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935187|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935188|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935189|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935190|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935191|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935192|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935193|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935194|NCT03095638|12138612|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935195|NCT03095638|12138613|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935196|NCT03095638|12138614|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935197|NCT03095638|12138615|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935198|NCT03095638|12138616|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935199|NCT03095638|12138617|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
4935200|NCT03095638|12138618|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935201|NCT03095638|12138619|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
4935202|NCT03095638|12138612|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935203|NCT03095638|12138613|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935204|NCT03095638|12138614|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935205|NCT03095638|12138615|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935206|NCT03095638|12138616|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935207|NCT03095638|12138617|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
4935208|NCT03095638|12138618|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
4935209|NCT03095638|12138619|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
4935210|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935211|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935212|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935213|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935214|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935215|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935216|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935217|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
4935218|NCT03095638|12138612|P8|COMPLETED|P2: Period 3 (4 Days)||4
4935219|NCT03095638|12138613|P7|COMPLETED|P2: Period 3 (4 Days)||4
4935220|NCT03095638|12138614|P6|COMPLETED|P2: Period 3 (4 Days)||4
4935221|NCT03095638|12138615|P5|COMPLETED|P2: Period 3 (4 Days)||4
4935222|NCT03095638|12138616|P4|COMPLETED|P2: Period 3 (4 Days)||4
4935223|NCT03095638|12138617|P3|COMPLETED|P2: Period 3 (4 Days)||4
4935224|NCT03095638|12138618|P2|COMPLETED|P2: Period 3 (4 Days)||0
4935225|NCT03095638|12138619|P1|COMPLETED|P2: Period 3 (4 Days)||0
4935226|NCT03095638|12138612|P8|STARTED|P2: Period 3 (4 Days)||4
4935227|NCT03095638|12138613|P7|STARTED|P2: Period 3 (4 Days)||4
4935228|NCT03095638|12138614|P6|STARTED|P2: Period 3 (4 Days)||4
4935229|NCT03095638|12138615|P5|STARTED|P2: Period 3 (4 Days)||4
4935230|NCT03095638|12138616|P4|STARTED|P2: Period 3 (4 Days)||4
4935231|NCT03095638|12138617|P3|STARTED|P2: Period 3 (4 Days)||4
4935232|NCT03095638|12138618|P2|STARTED|P2: Period 3 (4 Days)||0
4935233|NCT03095638|12138619|P1|STARTED|P2: Period 3 (4 Days)||0
4935234|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935235|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935236|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935237|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935238|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935239|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935240|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935241|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935242|NCT03095638|12138612|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935243|NCT03095638|12138613|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935244|NCT03095638|12138614|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935245|NCT03095638|12138615|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935246|NCT03095638|12138616|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935247|NCT03095638|12138617|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
4935248|NCT03095638|12138618|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935249|NCT03095638|12138619|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
4935250|NCT03095638|12138612|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935251|NCT03095638|12138613|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935252|NCT03095638|12138614|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935253|NCT03095638|12138615|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935254|NCT03095638|12138616|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935255|NCT03095638|12138617|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
4935256|NCT03095638|12138618|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
4935257|NCT03095638|12138619|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
4935258|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935259|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935260|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935261|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935262|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935263|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935264|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935265|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
4935266|NCT03095638|12138612|P8|COMPLETED|P2: Period 2 (4 Days)||4
4935267|NCT03095638|12138613|P7|COMPLETED|P2: Period 2 (4 Days)||4
4935268|NCT03095638|12138614|P6|COMPLETED|P2: Period 2 (4 Days)||4
4935269|NCT03095638|12138615|P5|COMPLETED|P2: Period 2 (4 Days)||4
4935270|NCT03095638|12138616|P4|COMPLETED|P2: Period 2 (4 Days)||4
4935271|NCT03095638|12138617|P3|COMPLETED|P2: Period 2 (4 Days)||4
4935272|NCT03095638|12138618|P2|COMPLETED|P2: Period 2 (4 Days)||0
4935273|NCT03095638|12138619|P1|COMPLETED|P2: Period 2 (4 Days)||0
4935274|NCT03095638|12138612|P8|STARTED|P2: Period 2 (4 Days)||4
4935275|NCT03095638|12138613|P7|STARTED|P2: Period 2 (4 Days)||4
4935276|NCT03095638|12138614|P6|STARTED|P2: Period 2 (4 Days)||4
4935277|NCT03095638|12138615|P5|STARTED|P2: Period 2 (4 Days)||4
4935278|NCT03095638|12138616|P4|STARTED|P2: Period 2 (4 Days)||4
4935279|NCT03095638|12138617|P3|STARTED|P2: Period 2 (4 Days)||4
4935280|NCT03095638|12138618|P2|STARTED|P2: Period 2 (4 Days)||0
4935281|NCT03095638|12138619|P1|STARTED|P2: Period 2 (4 Days)||0
4935282|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935283|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935284|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935285|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935286|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935287|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935288|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935289|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935290|NCT03095638|12138612|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935291|NCT03095638|12138613|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935292|NCT03095638|12138614|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935293|NCT03095638|12138615|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935294|NCT03095638|12138616|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935295|NCT03095638|12138617|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
4935296|NCT03095638|12138618|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935297|NCT03095638|12138619|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
4935298|NCT03095638|12138612|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935299|NCT03095638|12138613|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935300|NCT03095638|12138614|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935301|NCT03095638|12138615|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935302|NCT03095638|12138616|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935303|NCT03095638|12138617|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
4935304|NCT03095638|12138618|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
4935305|NCT03095638|12138619|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
4935306|NCT03095638|12138612|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935307|NCT03095638|12138613|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935308|NCT03095638|12138614|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935309|NCT03095638|12138615|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935310|NCT03095638|12138616|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935311|NCT03095638|12138617|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935312|NCT03095638|12138618|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935313|NCT03095638|12138619|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
4935314|NCT03095638|12138612|P8|COMPLETED|P2: Period 1 (4 Days)||4
4935315|NCT03095638|12138613|P7|COMPLETED|P2: Period 1 (4 Days)||4
4935316|NCT03095638|12138614|P6|COMPLETED|P2: Period 1 (4 Days)||4
4935317|NCT03095638|12138615|P5|COMPLETED|P2: Period 1 (4 Days)||4
4935318|NCT03095638|12138616|P4|COMPLETED|P2: Period 1 (4 Days)||4
4935319|NCT03095638|12138617|P3|COMPLETED|P2: Period 1 (4 Days)||4
4935320|NCT03095638|12138618|P2|COMPLETED|P2: Period 1 (4 Days)||0
4935321|NCT03095638|12138619|P1|COMPLETED|P2: Period 1 (4 Days)||0
4935322|NCT03095638|12138612|P8|STARTED|P2: Period 1 (4 Days)||4
4935323|NCT03095638|12138613|P7|STARTED|P2: Period 1 (4 Days)||4
4935324|NCT03095638|12138614|P6|STARTED|P2: Period 1 (4 Days)||4
4935325|NCT03095638|12138615|P5|STARTED|P2: Period 1 (4 Days)||4
4935326|NCT03095638|12138616|P4|STARTED|P2: Period 1 (4 Days)||4
4935327|NCT03095638|12138617|P3|STARTED|P2: Period 1 (4 Days)||4
4935328|NCT03095638|12138618|P2|STARTED|P2: Period 1 (4 Days)||0
4935329|NCT03095638|12138619|P1|STARTED|P2: Period 1 (4 Days)||0
4935330|NCT03095638|12138612|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935331|NCT03095638|12138613|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935332|NCT03095638|12138614|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935333|NCT03095638|12138615|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935334|NCT03095638|12138616|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935335|NCT03095638|12138617|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935336|NCT03095638|12138618|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935337|NCT03095638|12138619|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935338|NCT03095638|12138612|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935339|NCT03095638|12138613|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935340|NCT03095638|12138614|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935341|NCT03095638|12138615|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935342|NCT03095638|12138616|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935343|NCT03095638|12138617|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
4935344|NCT03095638|12138618|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
4935345|NCT03095638|12138619|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
4935346|NCT03095638|12138612|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935347|NCT03095638|12138613|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935348|NCT03095638|12138614|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935349|NCT03095638|12138615|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935350|NCT03095638|12138616|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935351|NCT03095638|12138617|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
4935352|NCT03095638|12138618|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
4935353|NCT03095638|12138619|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
4935354|NCT03095638|12138612|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935355|NCT03095638|12138613|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935356|NCT03095638|12138614|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935357|NCT03095638|12138615|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935358|NCT03095638|12138616|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935359|NCT03095638|12138617|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935360|NCT03095638|12138618|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935361|NCT03095638|12138619|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
4935362|NCT03095638|12138612|P8|COMPLETED|P1: Period 2 (4 Days)||0
4935363|NCT03095638|12138613|P7|COMPLETED|P1: Period 2 (4 Days)||0
4935364|NCT03095638|12138614|P6|COMPLETED|P1: Period 2 (4 Days)||0
4935365|NCT03095638|12138615|P5|COMPLETED|P1: Period 2 (4 Days)||0
4935366|NCT03095638|12138616|P4|COMPLETED|P1: Period 2 (4 Days)||0
4935367|NCT03095638|12138617|P3|COMPLETED|P1: Period 2 (4 Days)||0
4935368|NCT03095638|12138618|P2|COMPLETED|P1: Period 2 (4 Days)||7
4935369|NCT03095638|12138619|P1|COMPLETED|P1: Period 2 (4 Days)||7
4935370|NCT03095638|12138612|P8|STARTED|P1: Period 2 (4 Days)||0
4935371|NCT03095638|12138613|P7|STARTED|P1: Period 2 (4 Days)||0
4935372|NCT03095638|12138614|P6|STARTED|P1: Period 2 (4 Days)||0
4935373|NCT03095638|12138615|P5|STARTED|P1: Period 2 (4 Days)||0
4935374|NCT03095638|12138616|P4|STARTED|P1: Period 2 (4 Days)||0
4935375|NCT03095638|12138617|P3|STARTED|P1: Period 2 (4 Days)||0
4935376|NCT03095638|12138618|P2|STARTED|P1: Period 2 (4 Days)||7
4935377|NCT03095638|12138619|P1|STARTED|P1: Period 2 (4 Days)||7
4935378|NCT03095638|12138612|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935379|NCT03095638|12138613|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935380|NCT03095638|12138614|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935381|NCT03095638|12138615|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935382|NCT03095638|12138616|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935383|NCT03095638|12138617|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935384|NCT03095638|12138618|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935385|NCT03095638|12138619|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935386|NCT03095638|12138612|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935387|NCT03095638|12138613|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935388|NCT03095638|12138614|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935389|NCT03095638|12138615|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935390|NCT03095638|12138616|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935391|NCT03095638|12138617|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
4935392|NCT03095638|12138618|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
4935393|NCT03095638|12138619|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
4935394|NCT03095638|12138612|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935395|NCT03095638|12138613|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935396|NCT03095638|12138614|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935397|NCT03095638|12138615|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935398|NCT03095638|12138616|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935399|NCT03095638|12138617|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
4935400|NCT03095638|12138618|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
4935401|NCT03095638|12138619|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
4935402|NCT03095638|12138612|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935403|NCT03095638|12138613|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935404|NCT03095638|12138614|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935405|NCT03095638|12138615|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935406|NCT03095638|12138616|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935407|NCT03095638|12138617|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935408|NCT03095638|12138618|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935409|NCT03095638|12138619|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
4935410|NCT03095638|12138612|P8|COMPLETED|P1: Period 1 (4 Days)||0
4935411|NCT03095638|12138613|P7|COMPLETED|P1: Period 1 (4 Days)||0
4935412|NCT03095638|12138614|P6|COMPLETED|P1: Period 1 (4 Days)||0
4935413|NCT03095638|12138615|P5|COMPLETED|P1: Period 1 (4 Days)||0
4935414|NCT03095638|12138616|P4|COMPLETED|P1: Period 1 (4 Days)||0
4935415|NCT03095638|12138617|P3|COMPLETED|P1: Period 1 (4 Days)||0
4935416|NCT03095638|12138618|P2|COMPLETED|P1: Period 1 (4 Days)||7
4935417|NCT03095638|12138619|P1|COMPLETED|P1: Period 1 (4 Days)||7
4935418|NCT03095638|12138612|P8|STARTED|P1: Period 1 (4 Days)||0
4935419|NCT03095638|12138613|P7|STARTED|P1: Period 1 (4 Days)||0
4935420|NCT03095638|12138614|P6|STARTED|P1: Period 1 (4 Days)||0
4935421|NCT03095638|12138615|P5|STARTED|P1: Period 1 (4 Days)||0
4935422|NCT03095638|12138616|P4|STARTED|P1: Period 1 (4 Days)||0
4935423|NCT03095638|12138617|P3|STARTED|P1: Period 1 (4 Days)||0
4935424|NCT03095638|12138618|P2|STARTED|P1: Period 1 (4 Days)||7
4935425|NCT03095638|12138619|P1|STARTED|P1: Period 1 (4 Days)||7
4935426|NCT03095599|12138767|P2|NOT COMPLETED|Overall Study||0
4935427|NCT03095599|12138768|P1|NOT COMPLETED|Overall Study||3
4935428|NCT03095599|12138767|P2|COMPLETED|Overall Study||148
4935429|NCT03095599|12138768|P1|COMPLETED|Overall Study||738
4935430|NCT03095599|12138767|P2|Vaccinated|Overall Study||148
4935431|NCT03095599|12138768|P1|Vaccinated|Overall Study||740
4935432|NCT03095599|12138767|P2|Withdrawal Before Vaccination|Overall Study||0
4935433|NCT03095599|12138768|P1|Withdrawal Before Vaccination|Overall Study||1
4935434|NCT03095599|12138767|P2|STARTED|Overall Study||148
4935435|NCT03095599|12138768|P1|STARTED|Overall Study||741
4935436|NCT03095521|12138804|P2|NOT COMPLETED|Overall Study||2
4935437|NCT03095521|12138805|P1|NOT COMPLETED|Overall Study||0
4935438|NCT03095521|12138804|P2|COMPLETED|Overall Study||111
4935439|NCT03095521|12138805|P1|COMPLETED|Overall Study||115
4935440|NCT03095521|12138804|P2|Safety Population|Overall Study||113
4935441|NCT03095521|12138805|P1|Safety Population|Overall Study||115
4935442|NCT03095521|12138804|P2|Per Protocol Population PP|Overall Study||107
4935443|NCT03095521|12138805|P1|Per Protocol Population PP|Overall Study||113
4935444|NCT03095521|12138804|P2|Intent to Treat Population ITT|Overall Study||113
4935445|NCT03095521|12138805|P1|Intent to Treat Population ITT|Overall Study||115
4935446|NCT03095521|12138804|P2|STARTED|Overall Study||113
4935447|NCT03095521|12138805|P1|STARTED|Overall Study||115
4935448|NCT03095508|12138823|P2|NOT COMPLETED|Overall Study||1
4935449|NCT03095508|12138824|P1|NOT COMPLETED|Overall Study||0
4935450|NCT03095508|12138823|P2|COMPLETED|Overall Study||114
4935451|NCT03095508|12138824|P1|COMPLETED|Overall Study||114
4935452|NCT03095508|12138823|P2|ITT Population|Overall Study||115
4935453|NCT03095508|12138824|P1|ITT Population|Overall Study||114
4935454|NCT03095508|12138823|P2|Safety Population|Overall Study||115
4935455|NCT03095508|12138824|P1|Safety Population|Overall Study||114
4935456|NCT03095508|12138823|P2|Per Protocol Population|Overall Study||111
4935457|NCT03095508|12138824|P1|Per Protocol Population|Overall Study||112
4935458|NCT03095508|12138823|P2|STARTED|Overall Study||115
4935459|NCT03095508|12138824|P1|STARTED|Overall Study||114
4935460|NCT03095456|12138842|P2|NOT COMPLETED|Overall Study||8
4935461|NCT03095456|12138843|P1|NOT COMPLETED|Overall Study||4
4935462|NCT03095456|12138842|P2|COMPLETED|Overall Study||96
4935463|NCT03095456|12138843|P1|COMPLETED|Overall Study||99
4935464|NCT03095456|12138842|P2|STARTED|Overall Study||104
4935465|NCT03095456|12138843|P1|STARTED|Overall Study||103
4935466|NCT03095053|12138861|P2|NOT COMPLETED|Overall Study||0
4935467|NCT03095053|12138862|P1|NOT COMPLETED|Overall Study||29
4935468|NCT03095053|12138861|P2|COMPLETED|Overall Study||111
4935469|NCT03095053|12138862|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
4935470|NCT03095053|12138861|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
4935471|NCT03095053|12138862|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
4935472|NCT03095027|12138872|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
4935473|NCT03095027|12138873|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
4935474|NCT03095027|12138872|P2|COMPLETED|Period 2, Second Week of Wear||24
4935475|NCT03095027|12138873|P1|COMPLETED|Period 2, Second Week of Wear||26
4935476|NCT03095027|12138872|P2|STARTED|Period 2, Second Week of Wear||24
4935477|NCT03095027|12138873|P1|STARTED|Period 2, Second Week of Wear||27
4935478|NCT03095027|12138872|P2|NOT COMPLETED|Period 1, First Week of Wear||0
4935479|NCT03095027|12138873|P1|NOT COMPLETED|Period 1, First Week of Wear||0
4935480|NCT03095027|12138872|P2|COMPLETED|Period 1, First Week of Wear||24
4935481|NCT03095027|12138873|P1|COMPLETED|Period 1, First Week of Wear||27
4935482|NCT03095027|12138872|P2|STARTED|Period 1, First Week of Wear||24
4935483|NCT03095027|12138873|P1|STARTED|Period 1, First Week of Wear||27
4935484|NCT03094806|12138881|P2|NOT COMPLETED|Overall Study||0
4935485|NCT03094806|12138882|P1|NOT COMPLETED|Overall Study||0
4935486|NCT03094806|12138881|P2|COMPLETED|Overall Study||47
4935487|NCT03094806|12138882|P1|COMPLETED|Overall Study||44
4935488|NCT03094806|12138881|P2|STARTED|Overall Study||47
4935489|NCT03094806|12138882|P1|STARTED|Overall Study||44
4935490|NCT03094325|12138900|P1|NOT COMPLETED|Overall Study||0
4935491|NCT03094325|12138900|P1|COMPLETED|Overall Study||10
4935492|NCT03094325|12138900|P1|OPIE After Cardiopulmonary Bypass|Overall Study||10
4935493|NCT03094325|12138900|P1|TEE After Cardiopulmonary Bypass|Overall Study||10
4935494|NCT03094325|12138900|P1|OPIE Before Cardiopulmonary Bypass|Overall Study||10
4935495|NCT03094325|12138900|P1|TEE Before Cardiopulmonary Bypass|Overall Study||10
4935496|NCT03094325|12138900|P1|STARTED|Overall Study||10
4935497|NCT03094195|12138909|P8|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935498|NCT03094195|12138910|P7|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935499|NCT03094195|12138911|P6|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935500|NCT03094195|12138912|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935501|NCT03094195|12138913|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935502|NCT03094195|12138914|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935503|NCT03094195|12138915|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935504|NCT03094195|12138916|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
4935505|NCT03094195|12138909|P8|COMPLETED|Treatment Withdrawal Period (TW)||26
4935506|NCT03094195|12138910|P7|COMPLETED|Treatment Withdrawal Period (TW)||13
4935507|NCT03094195|12138911|P6|COMPLETED|Treatment Withdrawal Period (TW)||15
4935508|NCT03094195|12138912|P5|COMPLETED|Treatment Withdrawal Period (TW)||13
4935509|NCT03094195|12138913|P4|COMPLETED|Treatment Withdrawal Period (TW)||13
4935510|NCT03094195|12138914|P3|COMPLETED|Treatment Withdrawal Period (TW)||0
4935511|NCT03094195|12138915|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
4935512|NCT03094195|12138916|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
4935513|NCT03094195|12138909|P8|STARTED|Treatment Withdrawal Period (TW)||26
4935514|NCT03094195|12138910|P7|STARTED|Treatment Withdrawal Period (TW)||13
4935515|NCT03094195|12138911|P6|STARTED|Treatment Withdrawal Period (TW)||15
4935516|NCT03094195|12138912|P5|STARTED|Treatment Withdrawal Period (TW)||13
4935517|NCT03094195|12138913|P4|STARTED|Treatment Withdrawal Period (TW)||13
4935518|NCT03094195|12138914|P3|STARTED|Treatment Withdrawal Period (TW)||0
4935519|NCT03094195|12138915|P2|STARTED|Treatment Withdrawal Period (TW)||0
4935520|NCT03094195|12138916|P1|STARTED|Treatment Withdrawal Period (TW)||0
4935521|NCT03094195|12138909|P8|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4935522|NCT03094195|12138910|P7|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4935523|NCT03094195|12138911|P6|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4935524|NCT03094195|12138912|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4935525|NCT03094195|12138913|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
4935526|NCT03094195|12138914|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
4935527|NCT03094195|12138915|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
4935528|NCT03094195|12138916|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
4935529|NCT03094195|12138909|P8|COMPLETED|Double-Blind Treatment Period (DB)||0
4935530|NCT03094195|12138910|P7|COMPLETED|Double-Blind Treatment Period (DB)||0
4935531|NCT03094195|12138911|P6|COMPLETED|Double-Blind Treatment Period (DB)||0
4935532|NCT03094195|12138912|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
4935533|NCT03094195|12138913|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
4935534|NCT03094195|12138914|P3|COMPLETED|Double-Blind Treatment Period (DB)||29
4935535|NCT03094195|12138915|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
4935536|NCT03094195|12138916|P1|COMPLETED|Double-Blind Treatment Period (DB)||28
4935537|NCT03094195|12138909|P8|STARTED|Double-Blind Treatment Period (DB)||0
4935538|NCT03094195|12138910|P7|STARTED|Double-Blind Treatment Period (DB)||0
4935539|NCT03094195|12138911|P6|STARTED|Double-Blind Treatment Period (DB)||0
4935540|NCT03094195|12138912|P5|STARTED|Double-Blind Treatment Period (DB)||0
4935541|NCT03094195|12138913|P4|STARTED|Double-Blind Treatment Period (DB)||0
4935542|NCT03094195|12138914|P3|STARTED|Double-Blind Treatment Period (DB)||43
4935543|NCT03094195|12138915|P2|STARTED|Double-Blind Treatment Period (DB)||43
4935544|NCT03094195|12138916|P1|STARTED|Double-Blind Treatment Period (DB)||43
4935545|NCT03093350|12138962|P1|NOT COMPLETED|Overall Study||2
4935546|NCT03093350|12138962|P1|COMPLETED|Overall Study||10
4935547|NCT03093350|12138962|P1|Started Treatment|Overall Study||10
4935548|NCT03093350|12138962|P1|STARTED|Overall Study||12
4935549|NCT03093324|12138970|P2|NOT COMPLETED|Overall Study||19
4935550|NCT03093324|12138971|P1|NOT COMPLETED|Overall Study||9
4935551|NCT03093324|12138970|P2|COMPLETED|Overall Study||233
4935552|NCT03093324|12138971|P1|COMPLETED|Overall Study||245
4935553|NCT03093324|12138970|P2|Safety Population|Overall Study||251
4935554|NCT03093324|12138971|P1|Safety Population|Overall Study||253
4935555|NCT03093324|12138970|P2|STARTED|Overall Study||252
4935556|NCT03093324|12138971|P1|STARTED|Overall Study||254
4935557|NCT03093272|12138993|P1|NOT COMPLETED|Overall Study||0
4935558|NCT03093272|12138993|P1|COMPLETED|Overall Study||9
4935559|NCT03093272|12138993|P1|STARTED|Overall Study||9
4935560|NCT03093181|12139005|P3|NOT COMPLETED|Overall Study||3
4935561|NCT03093181|12139006|P2|NOT COMPLETED|Overall Study||2
4935562|NCT03093181|12139007|P1|NOT COMPLETED|Overall Study||3
4935563|NCT03093181|12139005|P3|COMPLETED|Overall Study||41
4935564|NCT03093181|12139006|P2|COMPLETED|Overall Study||42
4935565|NCT03093181|12139007|P1|COMPLETED|Overall Study||41
4935566|NCT03093181|12139005|P3|STARTED|Overall Study||44
4935567|NCT03093181|12139006|P2|STARTED|Overall Study||44
4935568|NCT03093181|12139007|P1|STARTED|Overall Study||44
4935569|NCT03093025|12139036|P3|NOT COMPLETED|Overall Study||2
4935570|NCT03093025|12139037|P2|NOT COMPLETED|Overall Study||2
4935571|NCT03093025|12139038|P1|NOT COMPLETED|Overall Study||4
4935572|NCT03093025|12139036|P3|COMPLETED|Overall Study||16
4935573|NCT03093025|12139037|P2|COMPLETED|Overall Study||15
4935574|NCT03093025|12139038|P1|COMPLETED|Overall Study||12
4935575|NCT03093025|12139036|P3|STARTED|Overall Study||18
4935576|NCT03093025|12139037|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
4935577|NCT03093025|12139038|P1|STARTED|Overall Study||16
4935578|NCT03092791|12139069|P8|NOT COMPLETED|Overall Study||60
4935579|NCT03092791|12139070|P7|NOT COMPLETED|Overall Study||60
4935580|NCT03092791|12139071|P6|NOT COMPLETED|Overall Study||60
4935581|NCT03092791|12139072|P5|NOT COMPLETED|Overall Study||60
4935582|NCT03092791|12139073|P4|NOT COMPLETED|Overall Study||0
4935583|NCT03092791|12139074|P3|NOT COMPLETED|Overall Study||0
4935584|NCT03092791|12139075|P2|NOT COMPLETED|Overall Study||0
4935585|NCT03092791|12139076|P1|NOT COMPLETED|Overall Study||0
4935586|NCT03092791|12139069|P8|COMPLETED|Overall Study||0
4935587|NCT03092791|12139070|P7|COMPLETED|Overall Study||0
4935588|NCT03092791|12139071|P6|COMPLETED|Overall Study||0
4935589|NCT03092791|12139072|P5|COMPLETED|Overall Study||0
4935590|NCT03092791|12139073|P4|COMPLETED|Overall Study||30
4935591|NCT03092791|12139074|P3|COMPLETED|Overall Study||30
4935592|NCT03092791|12139075|P2|COMPLETED|Overall Study||20
4935593|NCT03092791|12139076|P1|COMPLETED|Overall Study||20
4935594|NCT03092791|12139069|P8|STARTED|Overall Study||60
4935595|NCT03092791|12139070|P7|STARTED|Overall Study||60
4935596|NCT03092791|12139071|P6|STARTED|Overall Study||60
4935597|NCT03092791|12139072|P5|STARTED|Overall Study||60
4935598|NCT03092791|12139073|P4|STARTED|Overall Study||30
4935599|NCT03092791|12139074|P3|STARTED|Overall Study||30
4935600|NCT03092791|12139075|P2|STARTED|Overall Study||20
4935601|NCT03092791|12139076|P1|STARTED|Overall Study||20
4935602|NCT03092752|12139191|P1|NOT COMPLETED|Overall Study||361469
4935603|NCT03092752|12139191|P1|COMPLETED|Overall Study||162116
4935604|NCT03092752|12139191|P1|STARTED|Overall Study||523585
4935605|NCT03092726|12139256|P2|NOT COMPLETED|Overall Study||14
4935606|NCT03092726|12139257|P1|NOT COMPLETED|Overall Study||9
4935607|NCT03092726|12139256|P2|COMPLETED|Overall Study||81
4935608|NCT03092726|12139257|P1|COMPLETED|Overall Study||79
4935609|NCT03092726|12139256|P2|Treated|Overall Study||95
4935610|NCT03092726|12139257|P1|Treated|Overall Study||88
4935611|NCT03092726|12139256|P2|STARTED|Overall Study||95
4935612|NCT03092726|12139257|P1|STARTED|Overall Study||88
4935613|NCT03092479|12139283|P2|NOT COMPLETED|Overall Study||2
4935614|NCT03092479|12139284|P1|NOT COMPLETED|Overall Study||7
4935615|NCT03092479|12139283|P2|COMPLETED|Overall Study||24
4935616|NCT03092479|12139284|P1|COMPLETED|Overall Study||17
4935617|NCT03092479|12139283|P2|STARTED|Overall Study||26
4935618|NCT03092479|12139284|P1|STARTED|Overall Study||24
4935619|NCT03092375|12139306|P4|NOT COMPLETED|Overall Study||0
4935620|NCT03092375|12139307|P3|NOT COMPLETED|Overall Study||1
4935621|NCT03092375|12139308|P2|NOT COMPLETED|Overall Study||1
4935622|NCT03092375|12139309|P1|NOT COMPLETED|Overall Study||0
4935623|NCT03092375|12139306|P4|COMPLETED|Overall Study||29
4935624|NCT03092375|12139307|P3|COMPLETED|Overall Study||20
4935625|NCT03092375|12139308|P2|COMPLETED|Overall Study||48
4935626|NCT03092375|12139309|P1|COMPLETED|Overall Study||78
4935627|NCT03092375|12139306|P4|STARTED|Overall Study||29
4935628|NCT03092375|12139307|P3|STARTED|Overall Study||21
4935629|NCT03092375|12139308|P2|STARTED|Overall Study||49
4935630|NCT03092375|12139309|P1|STARTED|Overall Study||78
4935631|NCT03092219|12139337|P2|NOT COMPLETED|Overall Study||4
4935632|NCT03092219|12139338|P1|NOT COMPLETED|Overall Study||7
4935633|NCT03092219|12139337|P2|COMPLETED|Overall Study||48
4935634|NCT03092219|12139338|P1|COMPLETED|Overall Study||143
4935635|NCT03092219|12139337|P2|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
4935636|NCT03092219|12139338|P1|Pooled SAFT Population|Overall Study||150
4935637|NCT03092219|12139337|P2|Primary Analysis Endpoint|Overall Study||51
4935638|NCT03092219|12139338|P1|Primary Analysis Endpoint|Overall Study||150
4935639|NCT03092219|12139337|P2|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
4935640|NCT03092219|12139338|P1|Baseline / ITT Population|Overall Study||150
4935641|NCT03092219|12139337|P2|STARTED|Overall Study||52
4935642|NCT03092219|12139338|P1|STARTED|Overall Study||150
4935643|NCT03091777|12139382|P3|NOT COMPLETED|Overall Study||37
4935644|NCT03091777|12139383|P2|NOT COMPLETED|Overall Study||33
4935645|NCT03091777|12139384|P1|NOT COMPLETED|Overall Study||32
4935646|NCT03091777|12139382|P3|COMPLETED|Overall Study||257
4935647|NCT03091777|12139383|P2|COMPLETED|Overall Study||255
4935648|NCT03091777|12139384|P1|COMPLETED|Overall Study||257
4935649|NCT03091777|12139382|P3|STARTED|Overall Study||294
4935650|NCT03091777|12139383|P2|STARTED|Overall Study||288
4935651|NCT03091777|12139384|P1|STARTED|Overall Study||289
4935652|NCT03091751|12139392|P1|NOT COMPLETED|Overall Study||0
4935653|NCT03091751|12139392|P1|COMPLETED|Overall Study||22
4935654|NCT03091751|12139392|P1|STARTED|Overall Study||22
4935655|NCT03091673|12139403|P2|NOT COMPLETED|Second Dose||0
4935656|NCT03091673|12139404|P1|NOT COMPLETED|Second Dose||0
4935657|NCT03091673|12139403|P2|COMPLETED|Second Dose||11
4935658|NCT03091673|12139404|P1|COMPLETED|Second Dose||0
4935659|NCT03091673|12139403|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
4935660|NCT03091673|12139404|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
4935661|NCT03091673|12139403|P2|NOT COMPLETED|First Dose||0
4935662|NCT03091673|12139404|P1|NOT COMPLETED|First Dose||0
4935663|NCT03091673|12139403|P2|COMPLETED|First Dose||0
4935664|NCT03091673|12139404|P1|COMPLETED|First Dose||31
4935665|NCT03091673|12139403|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
4935666|NCT03091673|12139404|P1|STARTED|First Dose||31
4935667|NCT03091439|12139426|P2|NOT COMPLETED|Overall Study||0
4935668|NCT03091439|12139427|P1|NOT COMPLETED|Overall Study||1
4935669|NCT03091439|12139426|P2|COMPLETED|Overall Study||0
4935670|NCT03091439|12139427|P1|COMPLETED|Overall Study||0
4935671|NCT03091439|12139426|P2|STARTED|Overall Study||0
4935672|NCT03091439|12139427|P1|STARTED|Overall Study||1
4935673|NCT03091400|12139451|P2|NOT COMPLETED|Phase 2 - 6 Weeks||0
4935674|NCT03091400|12139452|P1|NOT COMPLETED|Phase 2 - 6 Weeks||0
4935675|NCT03091400|12139451|P2|COMPLETED|Phase 2 - 6 Weeks||6
4935676|NCT03091400|12139452|P1|COMPLETED|Phase 2 - 6 Weeks||4
4935677|NCT03091400|12139451|P2|STARTED|Phase 2 - 6 Weeks||6
4935678|NCT03091400|12139452|P1|STARTED|Phase 2 - 6 Weeks||4
4935679|NCT03091400|12139451|P2|NOT COMPLETED|Washout - 2 Weeks||0
4935680|NCT03091400|12139452|P1|NOT COMPLETED|Washout - 2 Weeks||1
4935681|NCT03091400|12139451|P2|COMPLETED|Washout - 2 Weeks||6
4935682|NCT03091400|12139452|P1|COMPLETED|Washout - 2 Weeks||4
4935683|NCT03091400|12139451|P2|STARTED|Washout - 2 Weeks||6
4935684|NCT03091400|12139452|P1|STARTED|Washout - 2 Weeks||5
4935685|NCT03091400|12139451|P2|NOT COMPLETED|Phase 1 - 6 Weeks||0
4935686|NCT03091400|12139452|P1|NOT COMPLETED|Phase 1 - 6 Weeks||0
4935687|NCT03091400|12139451|P2|COMPLETED|Phase 1 - 6 Weeks||6
4935688|NCT03091400|12139452|P1|COMPLETED|Phase 1 - 6 Weeks||5
4935689|NCT03091400|12139451|P2|STARTED|Phase 1 - 6 Weeks||6
4935690|NCT03091400|12139452|P1|STARTED|Phase 1 - 6 Weeks||5
4935691|NCT03091361|12139468|P1|NOT COMPLETED|Overall Study||0
4935692|NCT03091361|12139468|P1|COMPLETED|Overall Study||30
4935693|NCT03091361|12139468|P1|STARTED|Overall Study||30
4935694|NCT03091348|12139474|P2|NOT COMPLETED|Overall Study||1
4935695|NCT03091348|12139475|P1|NOT COMPLETED|Overall Study||2
4935696|NCT03091348|12139474|P2|COMPLETED|Overall Study||1
4935697|NCT03091348|12139475|P1|COMPLETED|Overall Study||0
4935698|NCT03091348|12139474|P2|STARTED|Overall Study||2
4935699|NCT03091348|12139475|P1|STARTED|Overall Study||2
4935700|NCT03091192|12139501|P2|NOT COMPLETED|Overall Study||27
4935701|NCT03091192|12139502|P1|NOT COMPLETED|Overall Study||33
4935702|NCT03091192|12139501|P2|COMPLETED|Overall Study||0
4935703|NCT03091192|12139502|P1|COMPLETED|Overall Study||0
4935704|NCT03091192|12139501|P2|STARTED|Overall Study||27
4935705|NCT03091192|12139502|P1|STARTED|Overall Study||33
4935706|NCT03091179|12139520|P2|NOT COMPLETED|Overall Study||0
4935707|NCT03091179|12139521|P1|NOT COMPLETED|Overall Study||0
4935708|NCT03091179|12139520|P2|COMPLETED|Overall Study||10
4935709|NCT03091179|12139521|P1|COMPLETED|Overall Study||10
4935710|NCT03091179|12139520|P2|STARTED|Overall Study||10
4935711|NCT03091179|12139521|P1|STARTED|Overall Study||10
4935712|NCT03090958|12139547|P1|NOT COMPLETED|Overall Study||0
4935713|NCT03090958|12139547|P1|COMPLETED|Overall Study||20
4935714|NCT03090958|12139547|P1|STARTED|Overall Study||20
4935715|NCT03090256|12139559|P1|NOT COMPLETED|Overall Study||0
4935716|NCT03090256|12139559|P1|COMPLETED|Overall Study||68
4935717|NCT03090256|12139559|P1|STARTED|Overall Study||68
4935718|NCT03090100|12139570|P2|NOT COMPLETED|Overall Study||48
4935719|NCT03090100|12139571|P1|NOT COMPLETED|Overall Study||27
4935720|NCT03090100|12139570|P2|COMPLETED|Overall Study||466
4935721|NCT03090100|12139571|P1|COMPLETED|Overall Study||507
4935722|NCT03090100|12139570|P2|Treated|Overall Study||511
4935723|NCT03090100|12139571|P1|Treated|Overall Study||534
4935724|NCT03090100|12139570|P2|STARTED|Overall Study||514
4935725|NCT03090100|12139571|P1|STARTED|Overall Study||534
4935726|NCT03089944|12139611|P1|NOT COMPLETED|Overall Study||12
4935727|NCT03089944|12139611|P1|COMPLETED|Overall Study||331
4935728|NCT03089944|12139611|P1|STARTED|Overall Study||343
4935729|NCT03089879|12139625|P3|NOT COMPLETED|Overall Study||0
4935730|NCT03089879|12139626|P2|NOT COMPLETED|Overall Study||0
4935731|NCT03089879|12139627|P1|NOT COMPLETED|Overall Study||0
4935732|NCT03089879|12139625|P3|COMPLETED|Overall Study||26
4935733|NCT03089879|12139626|P2|COMPLETED|Overall Study||2
4935734|NCT03089879|12139627|P1|COMPLETED|Overall Study||7
4935735|NCT03089879|12139625|P3|STARTED|Overall Study||26
4935736|NCT03089879|12139626|P2|STARTED|Overall Study||2
4935737|NCT03089879|12139627|P1|STARTED|Overall Study||7
4935738|NCT03089580|12139656|P1|NOT COMPLETED|Overall Study||2
4935739|NCT03089580|12139656|P1|COMPLETED|Overall Study||12
4935740|NCT03089580|12139656|P1|STARTED|Overall Study||14
4935741|NCT03089216|12139667|P4|NOT COMPLETED|Overall Study||1
4935742|NCT03089216|12139668|P3|NOT COMPLETED|Overall Study||0
4935743|NCT03089216|12139669|P2|NOT COMPLETED|Overall Study||0
4935744|NCT03089216|12139670|P1|NOT COMPLETED|Overall Study||0
4935745|NCT03089216|12139667|P4|COMPLETED|Overall Study||26
4935746|NCT03089216|12139668|P3|COMPLETED|Overall Study||27
4935747|NCT03089216|12139669|P2|COMPLETED|Overall Study||27
4935748|NCT03089216|12139670|P1|COMPLETED|Overall Study||27
4935749|NCT03089216|12139667|P4|STARTED|Overall Study||27
4935750|NCT03089216|12139668|P3|STARTED|Overall Study||27
4935751|NCT03089216|12139669|P2|STARTED|Overall Study||27
4935752|NCT03089216|12139670|P1|STARTED|Overall Study||27
4935753|NCT03088917|12139684|P1|NOT COMPLETED|Overall Study||96
4935754|NCT03088917|12139684|P1|COMPLETED|Overall Study||10
4935755|NCT03088917|12139684|P1|STARTED|Overall Study||106
4935756|NCT03088345|12139694|P2|NOT COMPLETED|Overall Study||0
4935757|NCT03088345|12139695|P1|NOT COMPLETED|Overall Study||0
4935758|NCT03088345|12139694|P2|COMPLETED|Overall Study||10
4935759|NCT03088345|12139695|P1|COMPLETED|Overall Study||10
4935760|NCT03088345|12139694|P2|STARTED|Overall Study||10
4935761|NCT03088345|12139695|P1|STARTED|Overall Study||10
4935762|NCT03088267|12139711|P2|NOT COMPLETED|Overall Study||0
4935763|NCT03088267|12139712|P1|NOT COMPLETED|Overall Study||0
4935764|NCT03088267|12139711|P2|COMPLETED|Overall Study||9
4935765|NCT03088267|12139712|P1|COMPLETED|Overall Study||9
4935766|NCT03088267|12139711|P2|STARTED|Overall Study||9
4935767|NCT03088267|12139712|P1|STARTED|Overall Study||9
4935768|NCT03088137|12139723|P2|NOT COMPLETED|Overall Study||0
4935769|NCT03088137|12139724|P1|NOT COMPLETED|Overall Study||0
4935770|NCT03088137|12139723|P2|COMPLETED|Overall Study||55
4935771|NCT03088137|12139724|P1|COMPLETED|Overall Study||55
4935772|NCT03088137|12139723|P2|STARTED|Overall Study||55
4935773|NCT03088137|12139724|P1|STARTED|Overall Study||55
4935774|NCT03087643|12139754|P2|NOT COMPLETED|Overall Study||6
4935775|NCT03087643|12139755|P1|NOT COMPLETED|Overall Study||4
4935776|NCT03087643|12139754|P2|COMPLETED|Overall Study||19
4935777|NCT03087643|12139755|P1|COMPLETED|Overall Study||22
4935778|NCT03087643|12139754|P2|STARTED|Overall Study||25
4935779|NCT03087643|12139755|P1|STARTED|Overall Study||26
4935780|NCT03087604|12139771|P2|NOT COMPLETED|Overall Study||0
4935781|NCT03087604|12139772|P1|NOT COMPLETED|Overall Study||0
4935782|NCT03087604|12139771|P2|COMPLETED|Overall Study||50
4935783|NCT03087604|12139772|P1|COMPLETED|Overall Study||50
4935784|NCT03087604|12139771|P2|STARTED|Overall Study||50
4935785|NCT03087604|12139772|P1|STARTED|Overall Study||50
4935786|NCT03087513|12139782|P1|NOT COMPLETED|Second Intervention After 3 hr Washout||2
4935787|NCT03087513|12139782|P1|COMPLETED|Second Intervention After 3 hr Washout||38
4935788|NCT03087513|12139782|P1|STARTED|Second Intervention After 3 hr Washout||40
4935789|NCT03087513|12139782|P1|NOT COMPLETED|First Intervention||0
4935790|NCT03087513|12139782|P1|COMPLETED|First Intervention||40
4935791|NCT03087513|12139782|P1|STARTED|First Intervention||40
4935792|NCT03086551|12139798|P2|NOT COMPLETED|Second Intervention||0
4935793|NCT03086551|12139799|P1|NOT COMPLETED|Second Intervention||0
4935794|NCT03086551|12139798|P2|COMPLETED|Second Intervention||1
4935795|NCT03086551|12139799|P1|COMPLETED|Second Intervention||1
4935796|NCT03086551|12139798|P2|STARTED|Second Intervention||1
4935797|NCT03086551|12139799|P1|STARTED|Second Intervention||1
4935798|NCT03086551|12139798|P2|NOT COMPLETED|Washout||3
4935799|NCT03086551|12139799|P1|NOT COMPLETED|Washout||3
4935800|NCT03086551|12139798|P2|COMPLETED|Washout||1
4935801|NCT03086551|12139799|P1|COMPLETED|Washout||1
4935802|NCT03086551|12139798|P2|STARTED|Washout||4
4935803|NCT03086551|12139799|P1|STARTED|Washout||4
4935804|NCT03086551|12139798|P2|NOT COMPLETED|First Intervention||1
4935805|NCT03086551|12139799|P1|NOT COMPLETED|First Intervention||1
4935806|NCT03086551|12139798|P2|COMPLETED|First Intervention||4
4935807|NCT03086551|12139799|P1|COMPLETED|First Intervention||4
4935808|NCT03086551|12139798|P2|STARTED|First Intervention||5
4935809|NCT03086551|12139799|P1|STARTED|First Intervention||5
4935810|NCT03086447|12139815|P2|NOT COMPLETED|Overall Study||20
4935811|NCT03086447|12139816|P1|NOT COMPLETED|Overall Study||11
4935812|NCT03086447|12139815|P2|COMPLETED|Overall Study||110
4935813|NCT03086447|12139816|P1|COMPLETED|Overall Study||121
4935814|NCT03086447|12139815|P2|STARTED|Overall Study||130
4935815|NCT03086447|12139816|P1|STARTED|Overall Study||132
4935816|NCT03086408|12139838|P2|NOT COMPLETED|Overall Study||0
4935817|NCT03086408|12139839|P1|NOT COMPLETED|Overall Study||0
4935818|NCT03086408|12139838|P2|COMPLETED|Overall Study||10
4935819|NCT03086408|12139839|P1|COMPLETED|Overall Study||10
4935820|NCT03086408|12139838|P2|STARTED|Overall Study||10
4935821|NCT03086408|12139839|P1|STARTED|Overall Study||10
4935822|NCT03086356|12139863|P1|NOT COMPLETED|Overall Study||0
4935823|NCT03086356|12139863|P1|COMPLETED|Overall Study||12
4935824|NCT03086356|12139863|P1|STARTED|Overall Study||12
4935825|NCT03086343|12139874|P2|NOT COMPLETED|Overall Study||25
4935826|NCT03086343|12139875|P1|NOT COMPLETED|Overall Study||32
4935827|NCT03086343|12139874|P2|COMPLETED|Overall Study||278
4935828|NCT03086343|12139875|P1|COMPLETED|Overall Study||277
4935829|NCT03086343|12139874|P2|STARTED|Overall Study||303
4935830|NCT03086343|12139875|P1|STARTED|Overall Study||309
4935831|NCT03086330|12139887|P2|NOT COMPLETED|Overall Study||4
4935832|NCT03086330|12139888|P1|NOT COMPLETED|Overall Study||4
4935833|NCT03086330|12139887|P2|COMPLETED|Overall Study||147
4935834|NCT03086330|12139888|P1|COMPLETED|Overall Study||147
4935835|NCT03086330|12139887|P2|Exposed|Overall Study||151
4935836|NCT03086330|12139888|P1|Exposed|Overall Study||150
4935837|NCT03086330|12139887|P2|STARTED|Overall Study||151
4935838|NCT03086330|12139888|P1|STARTED|Overall Study||151
4935839|NCT03086265|12140010|P2|NOT COMPLETED|Overall Study||0
4935840|NCT03086265|12140011|P1|NOT COMPLETED|Overall Study||0
4935841|NCT03086265|12140010|P2|COMPLETED|Overall Study||10
4935842|NCT03086265|12140011|P1|COMPLETED|Overall Study||10
4935843|NCT03086265|12140010|P2|STARTED|Overall Study||10
4935844|NCT03086265|12140011|P1|STARTED|Overall Study||10
4935845|NCT03086213|12140068|P2|NOT COMPLETED|Overall Study||0
4935846|NCT03086213|12140069|P1|NOT COMPLETED|Overall Study||0
4935847|NCT03086213|12140068|P2|COMPLETED|Overall Study||24
4935848|NCT03086213|12140069|P1|COMPLETED|Overall Study||24
4935849|NCT03086213|12140068|P2|STARTED|Overall Study||24
4935850|NCT03086213|12140069|P1|STARTED|Overall Study||24
4935851|NCT03086135|12140085|P1|NOT COMPLETED|Overall Study||3
4935852|NCT03086135|12140085|P1|COMPLETED|Overall Study||48
4935853|NCT03086135|12140085|P1|STARTED|Overall Study||51
4935854|NCT03086018|12140112|P1|NOT COMPLETED|Final Testing for End of Trial||2
4935855|NCT03086018|12140112|P1|COMPLETED|Final Testing for End of Trial||28
4935856|NCT03086018|12140112|P1|STARTED|Final Testing for End of Trial||30
4935857|NCT03086018|12140112|P1|NOT COMPLETED|Field Testing||0
4935858|NCT03086018|12140112|P1|COMPLETED|Field Testing||30
4935859|NCT03086018|12140112|P1|STARTED|Field Testing||30
4935860|NCT03085914|12140127|P7|NOT COMPLETED|Overall Study||11
4935861|NCT03085914|12140128|P6|NOT COMPLETED|Overall Study||8
4935862|NCT03085914|12140129|P5|NOT COMPLETED|Overall Study||13
4935863|NCT03085914|12140130|P4|NOT COMPLETED|Overall Study||9
4935864|NCT03085914|12140131|P3|NOT COMPLETED|Overall Study||11
4935865|NCT03085914|12140132|P2|NOT COMPLETED|Overall Study||9
4935866|NCT03085914|12140133|P1|NOT COMPLETED|Overall Study||9
4935867|NCT03085914|12140127|P7|COMPLETED|Overall Study||0
4935868|NCT03085914|12140128|P6|COMPLETED|Overall Study||0
4935869|NCT03085914|12140129|P5|COMPLETED|Overall Study||0
4935870|NCT03085914|12140130|P4|COMPLETED|Overall Study||0
4935871|NCT03085914|12140131|P3|COMPLETED|Overall Study||0
4935872|NCT03085914|12140132|P2|COMPLETED|Overall Study||0
4935873|NCT03085914|12140133|P1|COMPLETED|Overall Study||0
4935874|NCT03085914|12140127|P7|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
4935875|NCT03085914|12140128|P6|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
4935876|NCT03085914|12140129|P5|Phase 2 Mandatory Biopsy Cohort|Overall Study||6
4935877|NCT03085914|12140130|P4|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
4935878|NCT03085914|12140131|P3|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
4935879|NCT03085914|12140132|P2|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
4935880|NCT03085914|12140133|P1|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
4935881|NCT03085914|12140127|P7|STARTED|Overall Study||11
4935882|NCT03085914|12140128|P6|STARTED|Overall Study||8
4935883|NCT03085914|12140129|P5|STARTED|Overall Study||13
4935884|NCT03085914|12140130|P4|STARTED|Overall Study||9
4935885|NCT03085914|12140131|P3|STARTED|Overall Study||11
4935886|NCT03085914|12140132|P2|STARTED|Overall Study||9
4935887|NCT03085914|12140133|P1|STARTED|Overall Study||9
4935888|NCT03085836|12140166|P3|NOT COMPLETED|Overall Study||0
4935889|NCT03085836|12140167|P2|NOT COMPLETED|Overall Study||0
4935890|NCT03085836|12140168|P1|NOT COMPLETED|Overall Study||0
4935891|NCT03085836|12140166|P3|COMPLETED|Overall Study||10
4935892|NCT03085836|12140167|P2|COMPLETED|Overall Study||11
4935893|NCT03085836|12140168|P1|COMPLETED|Overall Study||12
4935894|NCT03085836|12140166|P3|STARTED|Overall Study||10
4935895|NCT03085836|12140167|P2|STARTED|Overall Study||11
4935896|NCT03085836|12140168|P1|STARTED|Overall Study||12
4935897|NCT03085238|12140215|P1|NOT COMPLETED|Overall Study||4
4935898|NCT03085238|12140215|P1|COMPLETED|Overall Study||19
4935899|NCT03085238|12140215|P1|18 Months|Overall Study||7
4935900|NCT03085238|12140215|P1|15 Months|Overall Study||11
4935901|NCT03085238|12140215|P1|12 Months|Overall Study||14
4935902|NCT03085238|12140215|P1|9 Months|Overall Study||16
4935903|NCT03085238|12140215|P1|6 Months|Overall Study||19
4935904|NCT03085238|12140215|P1|3 Months|Overall Study||22
4935905|NCT03085238|12140215|P1|1 Month|Overall Study||23
4935906|NCT03085238|12140215|P1|STARTED|Overall Study||23
4935907|NCT03084315|12140242|P2|NOT COMPLETED|Overall Study||9
4935908|NCT03084315|12140243|P1|NOT COMPLETED|Overall Study||10
4935909|NCT03084315|12140242|P2|COMPLETED|Overall Study||109
4935910|NCT03084315|12140243|P1|COMPLETED|Overall Study||106
4935911|NCT03084315|12140242|P2|STARTED|Overall Study||118
4935912|NCT03084315|12140243|P1|STARTED|Overall Study||116
4935913|NCT03083847|12140261|P10|NOT COMPLETED|Overall Study||0
4935914|NCT03083847|12140262|P9|NOT COMPLETED|Overall Study||0
4935915|NCT03083847|12140263|P8|NOT COMPLETED|Overall Study||0
4935916|NCT03083847|12140264|P7|NOT COMPLETED|Overall Study||0
4935917|NCT03083847|12140265|P6|NOT COMPLETED|Overall Study||0
4935918|NCT03083847|12140266|P5|NOT COMPLETED|Overall Study||0
4935919|NCT03083847|12140267|P4|NOT COMPLETED|Overall Study||0
4935920|NCT03083847|12140268|P3|NOT COMPLETED|Overall Study||4
4935921|NCT03083847|12140269|P2|NOT COMPLETED|Overall Study||1
4935922|NCT03083847|12140270|P1|NOT COMPLETED|Overall Study||1
4935923|NCT03083847|12140261|P10|COMPLETED|Overall Study||4
4935924|NCT03083847|12140262|P9|COMPLETED|Overall Study||2
4935925|NCT03083847|12140263|P8|COMPLETED|Overall Study||4
4935926|NCT03083847|12140264|P7|COMPLETED|Overall Study||2
4935927|NCT03083847|12140265|P6|COMPLETED|Overall Study||2
4935928|NCT03083847|12140266|P5|COMPLETED|Overall Study||8
4935929|NCT03083847|12140267|P4|COMPLETED|Overall Study||4
4935930|NCT03083847|12140268|P3|COMPLETED|Overall Study||6
4935931|NCT03083847|12140269|P2|COMPLETED|Overall Study||9
4935932|NCT03083847|12140270|P1|COMPLETED|Overall Study||8
4935933|NCT03083847|12140261|P10|STARTED|Overall Study||4
4935934|NCT03083847|12140262|P9|STARTED|Overall Study||2
4935935|NCT03083847|12140263|P8|STARTED|Overall Study||4
4935936|NCT03083847|12140264|P7|STARTED|Overall Study||2
4935937|NCT03083847|12140265|P6|STARTED|Overall Study||2
4935938|NCT03083847|12140266|P5|STARTED|Overall Study||8
4935939|NCT03083847|12140267|P4|STARTED|Overall Study||4
4935940|NCT03083847|12140268|P3|STARTED|Overall Study||10
4935941|NCT03083847|12140269|P2|STARTED|Overall Study||10
4935942|NCT03083847|12140270|P1|STARTED|Overall Study||9
4935943|NCT03083769|12140292|P2|NOT COMPLETED|Overall Study||32
4935944|NCT03083769|12140293|P1|NOT COMPLETED|Overall Study||20
4935945|NCT03083769|12140292|P2|COMPLETED|Overall Study||631
4935946|NCT03083769|12140293|P1|COMPLETED|Overall Study||819
4935947|NCT03083769|12140292|P2|STARTED|Overall Study||663
4935948|NCT03083769|12140293|P1|STARTED|Overall Study||839
4935949|NCT03083639|12140305|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
4935950|NCT03083639|12140306|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
4935951|NCT03083639|12140305|P2|COMPLETED|Intervention Period 2 (1 Day)||25
4935952|NCT03083639|12140306|P1|COMPLETED|Intervention Period 2 (1 Day)||25
4935953|NCT03083639|12140305|P2|STARTED|Intervention Period 2 (1 Day)||25
4935954|NCT03083639|12140306|P1|STARTED|Intervention Period 2 (1 Day)||25
4935955|NCT03083639|12140305|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
4935956|NCT03083639|12140306|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
4935957|NCT03083639|12140305|P2|COMPLETED|Washout Period (at Least 6 Days)||25
4935958|NCT03083639|12140306|P1|COMPLETED|Washout Period (at Least 6 Days)||25
4935959|NCT03083639|12140305|P2|STARTED|Washout Period (at Least 6 Days)||26
4935960|NCT03083639|12140306|P1|STARTED|Washout Period (at Least 6 Days)||26
4935961|NCT03083639|12140305|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4935962|NCT03083639|12140306|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4935963|NCT03083639|12140305|P2|COMPLETED|Intervention Period 1 (1 Day)||26
4935964|NCT03083639|12140306|P1|COMPLETED|Intervention Period 1 (1 Day)||26
4935965|NCT03083639|12140305|P2|STARTED|Intervention Period 1 (1 Day)||26
4935966|NCT03083639|12140306|P1|STARTED|Intervention Period 1 (1 Day)||26
4935967|NCT03083483|12140319|P3|NOT COMPLETED|Overall Study||3
4935968|NCT03083483|12140320|P2|NOT COMPLETED|Overall Study||2
4935969|NCT03083483|12140321|P1|NOT COMPLETED|Overall Study||4
4935970|NCT03083483|12140319|P3|COMPLETED|Overall Study||20
4935971|NCT03083483|12140320|P2|COMPLETED|Overall Study||20
4935972|NCT03083483|12140321|P1|COMPLETED|Overall Study||20
4935973|NCT03083483|12140319|P3|STARTED|Overall Study||23
4935974|NCT03083483|12140320|P2|STARTED|Overall Study||22
4935975|NCT03083483|12140321|P1|STARTED|Overall Study||24
4935976|NCT03083470|12140340|P5|NOT COMPLETED|Overall Study||2
4935977|NCT03083470|12140341|P4|NOT COMPLETED|Overall Study||0
4935978|NCT03083470|12140342|P3|NOT COMPLETED|Overall Study||0
4935979|NCT03083470|12140343|P2|NOT COMPLETED|Overall Study||0
4935980|NCT03083470|12140344|P1|NOT COMPLETED|Overall Study||0
4935981|NCT03083470|12140340|P5|COMPLETED|Overall Study||7
4935982|NCT03083470|12140341|P4|COMPLETED|Overall Study||6
4935983|NCT03083470|12140342|P3|COMPLETED|Overall Study||6
4935984|NCT03083470|12140343|P2|COMPLETED|Overall Study||6
4935985|NCT03083470|12140344|P1|COMPLETED|Overall Study||6
4935986|NCT03083470|12140340|P5|STARTED|Overall Study||9
4935987|NCT03083470|12140341|P4|STARTED|Overall Study||6
4935988|NCT03083470|12140342|P3|STARTED|Overall Study||6
4935989|NCT03083470|12140343|P2|STARTED|Overall Study||6
4935990|NCT03083470|12140344|P1|STARTED|Overall Study||6
4935991|NCT03083379|12140383|P2|NOT COMPLETED|Overall Study||0
4935992|NCT03083379|12140384|P1|NOT COMPLETED|Overall Study||0
4935993|NCT03083379|12140383|P2|COMPLETED|Overall Study||15
4935994|NCT03083379|12140384|P1|COMPLETED|Overall Study||15
4935995|NCT03083379|12140383|P2|STARTED|Overall Study||15
4935996|NCT03083379|12140384|P1|STARTED|Overall Study||15
4935997|NCT03082599|12140392|P2|NOT COMPLETED|Overall Study||0
4935998|NCT03082599|12140393|P1|NOT COMPLETED|Overall Study||1
4935999|NCT03082599|12140392|P2|COMPLETED|Overall Study||39
4936000|NCT03082599|12140393|P1|COMPLETED|Overall Study||39
4936001|NCT03082599|12140392|P2|STARTED|Overall Study||39
4936002|NCT03082599|12140393|P1|STARTED|Overall Study||40
4936003|NCT03082586|12140425|P6|NOT COMPLETED|Overall Study||0
4936004|NCT03082586|12140426|P5|NOT COMPLETED|Overall Study||0
4936005|NCT03082586|12140427|P4|NOT COMPLETED|Overall Study||0
4936006|NCT03082586|12140428|P3|NOT COMPLETED|Overall Study||0
4936007|NCT03082586|12140429|P2|NOT COMPLETED|Overall Study||0
4936008|NCT03082586|12140430|P1|NOT COMPLETED|Overall Study||0
4936009|NCT03082586|12140425|P6|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
4936010|NCT03082586|12140426|P5|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
4936011|NCT03082586|12140427|P4|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
4936012|NCT03082586|12140428|P3|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
4936013|NCT03082586|12140429|P2|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
4936014|NCT03082586|12140430|P1|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
4936015|NCT03082586|12140425|P6|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
4936016|NCT03082586|12140426|P5|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
4936017|NCT03082586|12140427|P4|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
4936018|NCT03082586|12140428|P3|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
4936019|NCT03082586|12140429|P2|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
4936020|NCT03082586|12140430|P1|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
4936021|NCT03080961|12140444|P1|NOT COMPLETED|Overall Study||3
4936022|NCT03080961|12140444|P1|COMPLETED|Overall Study||43
4936023|NCT03080961|12140444|P1|STARTED|Overall Study||46
4936024|NCT03080493|12140455|P2|NOT COMPLETED|Overall Study||2
4936025|NCT03080493|12140456|P1|NOT COMPLETED|Overall Study||1
4936026|NCT03080493|12140455|P2|COMPLETED|Overall Study||58
4936027|NCT03080493|12140456|P1|COMPLETED|Overall Study||60
4936028|NCT03080493|12140455|P2|STARTED|Overall Study||60
4936029|NCT03080493|12140456|P1|STARTED|Overall Study||61
4936030|NCT03080454|12140472|P1|NOT COMPLETED|Anodal FU (7 Days)||4
4936031|NCT03080454|12140472|P1|COMPLETED|Anodal FU (7 Days)||19
4936032|NCT03080454|12140472|P1|STARTED|Anodal FU (7 Days)||23
4936033|NCT03080454|12140472|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
4936034|NCT03080454|12140472|P1|COMPLETED|Anodal Doublestim (5 Days)||23
4936035|NCT03080454|12140472|P1|STARTED|Anodal Doublestim (5 Days)||24
4936036|NCT03080454|12140472|P1|NOT COMPLETED|Sham FU (7days)||0
4936037|NCT03080454|12140472|P1|COMPLETED|Sham FU (7days)||24
4936038|NCT03080454|12140472|P1|STARTED|Sham FU (7days)||24
4936039|NCT03080454|12140472|P1|NOT COMPLETED|Sham Doublestim (5days)||0
4936040|NCT03080454|12140472|P1|COMPLETED|Sham Doublestim (5days)||24
4936041|NCT03080454|12140472|P1|STARTED|Sham Doublestim (5days)||24
4936042|NCT03080454|12140472|P1|NOT COMPLETED|Baseline||2
4936043|NCT03080454|12140472|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
4936044|NCT03080454|12140472|P1|STARTED|Baseline||26
4936045|NCT03079531|12140481|P1|NOT COMPLETED|Overall Study||7
4936046|NCT03079531|12140481|P1|COMPLETED|Overall Study||17
4936047|NCT03079531|12140481|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
4936048|NCT03079531|12140481|P1|STARTED|Overall Study||24
4936049|NCT03079375|12140494|P3|NOT COMPLETED|Overall Study||21
4936050|NCT03079375|12140495|P2|NOT COMPLETED|Overall Study||6
4936051|NCT03079375|12140496|P1|NOT COMPLETED|Overall Study||5
4936052|NCT03079375|12140494|P3|COMPLETED|Overall Study||476
4936053|NCT03079375|12140495|P2|COMPLETED|Overall Study||493
4936054|NCT03079375|12140496|P1|COMPLETED|Overall Study||498
4936055|NCT03079375|12140494|P3|STARTED|Overall Study||497
4936056|NCT03079375|12140495|P2|STARTED|Overall Study||499
4936057|NCT03079375|12140496|P1|STARTED|Overall Study||503
4936058|NCT03078647|12140531|P3|NOT COMPLETED|Overall Study||0
4936059|NCT03078647|12140532|P2|NOT COMPLETED|Overall Study||1
4936060|NCT03078647|12140533|P1|NOT COMPLETED|Overall Study||0
4936061|NCT03078647|12140531|P3|COMPLETED|Overall Study||3
4936062|NCT03078647|12140532|P2|COMPLETED|Overall Study||10
4936063|NCT03078647|12140533|P1|COMPLETED|Overall Study||17
4936064|NCT03078647|12140531|P3|STARTED|Overall Study||3
4936065|NCT03078647|12140532|P2|STARTED|Overall Study||11
4936066|NCT03078647|12140533|P1|STARTED|Overall Study||17
4936067|NCT03078595|12140552|P2|NOT COMPLETED|Overall Study||0
4936068|NCT03078595|12140553|P1|NOT COMPLETED|Overall Study||0
4936069|NCT03078595|12140552|P2|COMPLETED|Overall Study||24
4936070|NCT03078595|12140553|P1|COMPLETED|Overall Study||24
4936071|NCT03078595|12140552|P2|STARTED|Overall Study||24
4936072|NCT03078595|12140553|P1|STARTED|Overall Study||24
4936073|NCT03078582|12140563|P2|NOT COMPLETED|Overall Study||8
4936074|NCT03078582|12140564|P1|NOT COMPLETED|Overall Study||0
4936075|NCT03078582|12140563|P2|COMPLETED|Overall Study||8
4936076|NCT03078582|12140564|P1|COMPLETED|Overall Study||10
4936077|NCT03078582|12140563|P2|STARTED|Overall Study||16
4936078|NCT03078582|12140564|P1|STARTED|Overall Study||10
4936079|NCT03078556|12140584|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
4936080|NCT03078556|12140585|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
4936081|NCT03078556|12140586|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
4936082|NCT03078556|12140587|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
4936083|NCT03078556|12140584|P4|COMPLETED|Treatment Period 3 (4 Days)||9
4936084|NCT03078556|12140585|P3|COMPLETED|Treatment Period 3 (4 Days)||7
4936085|NCT03078556|12140586|P2|COMPLETED|Treatment Period 3 (4 Days)||7
4936086|NCT03078556|12140587|P1|COMPLETED|Treatment Period 3 (4 Days)||9
4936087|NCT03078556|12140584|P4|STARTED|Treatment Period 3 (4 Days)||9
4936088|NCT03078556|12140585|P3|STARTED|Treatment Period 3 (4 Days)||7
4936089|NCT03078556|12140586|P2|STARTED|Treatment Period 3 (4 Days)||7
4936090|NCT03078556|12140587|P1|STARTED|Treatment Period 3 (4 Days)||9
4936091|NCT03078556|12140584|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4936092|NCT03078556|12140585|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4936093|NCT03078556|12140586|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4936094|NCT03078556|12140587|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4936095|NCT03078556|12140584|P4|COMPLETED|Washout Period 2 (7 Days)||9
4936096|NCT03078556|12140585|P3|COMPLETED|Washout Period 2 (7 Days)||7
4936097|NCT03078556|12140586|P2|COMPLETED|Washout Period 2 (7 Days)||7
4936098|NCT03078556|12140587|P1|COMPLETED|Washout Period 2 (7 Days)||9
4936099|NCT03078556|12140584|P4|STARTED|Washout Period 2 (7 Days)||9
4936100|NCT03078556|12140585|P3|STARTED|Washout Period 2 (7 Days)||7
4936101|NCT03078556|12140586|P2|STARTED|Washout Period 2 (7 Days)||7
4936102|NCT03078556|12140587|P1|STARTED|Washout Period 2 (7 Days)||9
4936103|NCT03078556|12140584|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4936104|NCT03078556|12140585|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4936105|NCT03078556|12140586|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4936106|NCT03078556|12140587|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4936107|NCT03078556|12140584|P4|COMPLETED|Treatment Period 2 (4 Days)||37
4936108|NCT03078556|12140585|P3|COMPLETED|Treatment Period 2 (4 Days)||37
4936109|NCT03078556|12140586|P2|COMPLETED|Treatment Period 2 (4 Days)||36
4936110|NCT03078556|12140587|P1|COMPLETED|Treatment Period 2 (4 Days)||37
4936111|NCT03078556|12140584|P4|STARTED|Treatment Period 2 (4 Days)||37
4936112|NCT03078556|12140585|P3|STARTED|Treatment Period 2 (4 Days)||37
4936113|NCT03078556|12140586|P2|STARTED|Treatment Period 2 (4 Days)||36
4936114|NCT03078556|12140587|P1|STARTED|Treatment Period 2 (4 Days)||37
4936115|NCT03078556|12140584|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
4936116|NCT03078556|12140585|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
4936117|NCT03078556|12140586|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
4936118|NCT03078556|12140587|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
4936119|NCT03078556|12140584|P4|COMPLETED|Washout Period 1 (7 Days)||37
4936120|NCT03078556|12140585|P3|COMPLETED|Washout Period 1 (7 Days)||37
4936121|NCT03078556|12140586|P2|COMPLETED|Washout Period 1 (7 Days)||36
4936122|NCT03078556|12140587|P1|COMPLETED|Washout Period 1 (7 Days)||37
4936123|NCT03078556|12140584|P4|STARTED|Washout Period 1 (7 Days)||38
4936124|NCT03078556|12140585|P3|STARTED|Washout Period 1 (7 Days)||38
4936125|NCT03078556|12140586|P2|STARTED|Washout Period 1 (7 Days)||38
4936126|NCT03078556|12140587|P1|STARTED|Washout Period 1 (7 Days)||39
4936127|NCT03078556|12140584|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4936128|NCT03078556|12140585|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4936129|NCT03078556|12140586|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
4936130|NCT03078556|12140587|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4936131|NCT03078556|12140584|P4|COMPLETED|Treatment Period 1 (4 Days)||38
4936132|NCT03078556|12140585|P3|COMPLETED|Treatment Period 1 (4 Days)||38
4936133|NCT03078556|12140586|P2|COMPLETED|Treatment Period 1 (4 Days)||38
4936134|NCT03078556|12140587|P1|COMPLETED|Treatment Period 1 (4 Days)||39
4936135|NCT03078556|12140584|P4|STARTED|Treatment Period 1 (4 Days)||38
4936136|NCT03078556|12140585|P3|STARTED|Treatment Period 1 (4 Days)||38
4936137|NCT03078556|12140586|P2|STARTED|Treatment Period 1 (4 Days)||39
4936138|NCT03078556|12140587|P1|STARTED|Treatment Period 1 (4 Days)||39
4936139|NCT03078504|12140725|P1|NOT COMPLETED|Overall Study||0
4936140|NCT03078504|12140725|P1|COMPLETED|Overall Study||6
4936141|NCT03078504|12140725|P1|STARTED|Overall Study||6
4936142|NCT03078478|12140731|P2|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
4936143|NCT03078478|12140732|P1|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
4936144|NCT03078478|12140731|P2|COMPLETED|Maintencance Period 2 (36 Weeks)||734
4936145|NCT03078478|12140732|P1|COMPLETED|Maintencance Period 2 (36 Weeks)||733
4936146|NCT03078478|12140731|P2|STARTED|Maintencance Period 2 (36 Weeks)||761
4936147|NCT03078478|12140732|P1|STARTED|Maintencance Period 2 (36 Weeks)||758
4936148|NCT03078478|12140731|P2|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
4936149|NCT03078478|12140732|P1|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
4936150|NCT03078478|12140731|P2|COMPLETED|Maintenance Period 1 (36 Weeks)||761
4936151|NCT03078478|12140732|P1|COMPLETED|Maintenance Period 1 (36 Weeks)||758
4936152|NCT03078478|12140731|P2|STARTED|Maintenance Period 1 (36 Weeks)||804
4936153|NCT03078478|12140732|P1|STARTED|Maintenance Period 1 (36 Weeks)||805
4936154|NCT03078478|12140731|P2|NOT COMPLETED|Titration Period (16 Weeks)||0
4936155|NCT03078478|12140732|P1|NOT COMPLETED|Titration Period (16 Weeks)||0
4936156|NCT03078478|12140731|P2|COMPLETED|Titration Period (16 Weeks)||804
4936157|NCT03078478|12140732|P1|COMPLETED|Titration Period (16 Weeks)||805
4936158|NCT03078478|12140731|P2|Safety Analysis Set|Titration Period (16 Weeks)||798
4936159|NCT03078478|12140732|P1|Safety Analysis Set|Titration Period (16 Weeks)||802
4936160|NCT03078478|12140731|P2|Full Analysis Set|Titration Period (16 Weeks)||804
4936161|NCT03078478|12140732|P1|Full Analysis Set|Titration Period (16 Weeks)||805
4936162|NCT03078478|12140731|P2|STARTED|Titration Period (16 Weeks)||804
4936163|NCT03078478|12140732|P1|STARTED|Titration Period (16 Weeks)||805
4936164|NCT03078270|12140770|P2|NOT COMPLETED|Overall Study||0
4936165|NCT03078270|12140771|P1|NOT COMPLETED|Overall Study||4
4936166|NCT03078270|12140770|P2|COMPLETED|Overall Study||0
4936167|NCT03078270|12140771|P1|COMPLETED|Overall Study||0
4936168|NCT03078270|12140770|P2|STARTED|Overall Study||0
4936169|NCT03078270|12140771|P1|STARTED|Overall Study||4
4936170|NCT03078127|12140780|P3|NOT COMPLETED|Third Intervention||0
4936171|NCT03078127|12140781|P2|NOT COMPLETED|Third Intervention||0
4936172|NCT03078127|12140782|P1|NOT COMPLETED|Third Intervention||0
4936173|NCT03078127|12140780|P3|COMPLETED|Third Intervention||3
4936174|NCT03078127|12140781|P2|COMPLETED|Third Intervention||3
4936175|NCT03078127|12140782|P1|COMPLETED|Third Intervention||4
4936176|NCT03078127|12140780|P3|STARTED|Third Intervention||3
4936177|NCT03078127|12140781|P2|STARTED|Third Intervention||3
4936178|NCT03078127|12140782|P1|STARTED|Third Intervention||4
4936179|NCT03078127|12140780|P3|NOT COMPLETED|Washout (3-21 Days)||0
4936180|NCT03078127|12140781|P2|NOT COMPLETED|Washout (3-21 Days)||0
4936181|NCT03078127|12140782|P1|NOT COMPLETED|Washout (3-21 Days)||0
4936182|NCT03078127|12140780|P3|COMPLETED|Washout (3-21 Days)||3
4936183|NCT03078127|12140781|P2|COMPLETED|Washout (3-21 Days)||3
4936184|NCT03078127|12140782|P1|COMPLETED|Washout (3-21 Days)||4
4936185|NCT03078127|12140780|P3|STARTED|Washout (3-21 Days)||3
4936186|NCT03078127|12140781|P2|STARTED|Washout (3-21 Days)||3
4936187|NCT03078127|12140782|P1|STARTED|Washout (3-21 Days)||4
4936188|NCT03078127|12140780|P3|NOT COMPLETED|Second Intervention||0
4936189|NCT03078127|12140781|P2|NOT COMPLETED|Second Intervention||0
4936190|NCT03078127|12140782|P1|NOT COMPLETED|Second Intervention||0
4936191|NCT03078127|12140780|P3|COMPLETED|Second Intervention||3
4936192|NCT03078127|12140781|P2|COMPLETED|Second Intervention||3
4936193|NCT03078127|12140782|P1|COMPLETED|Second Intervention||4
4936194|NCT03078127|12140780|P3|STARTED|Second Intervention||3
4936195|NCT03078127|12140781|P2|STARTED|Second Intervention||3
4936196|NCT03078127|12140782|P1|STARTED|Second Intervention||4
4936197|NCT03078127|12140780|P3|NOT COMPLETED|Washout (3-21 Days)||0
4936198|NCT03078127|12140781|P2|NOT COMPLETED|Washout (3-21 Days)||0
4936199|NCT03078127|12140782|P1|NOT COMPLETED|Washout (3-21 Days)||0
4936200|NCT03078127|12140780|P3|COMPLETED|Washout (3-21 Days)||3
4936201|NCT03078127|12140781|P2|COMPLETED|Washout (3-21 Days)||3
4936202|NCT03078127|12140782|P1|COMPLETED|Washout (3-21 Days)||4
4936203|NCT03078127|12140780|P3|STARTED|Washout (3-21 Days)||3
4936204|NCT03078127|12140781|P2|STARTED|Washout (3-21 Days)||3
4936205|NCT03078127|12140782|P1|STARTED|Washout (3-21 Days)||4
4936206|NCT03078127|12140780|P3|NOT COMPLETED|First Intervention||0
4936207|NCT03078127|12140781|P2|NOT COMPLETED|First Intervention||0
4936208|NCT03078127|12140782|P1|NOT COMPLETED|First Intervention||0
4936209|NCT03078127|12140780|P3|COMPLETED|First Intervention||3
4936210|NCT03078127|12140781|P2|COMPLETED|First Intervention||3
4936211|NCT03078127|12140782|P1|COMPLETED|First Intervention||4
4936212|NCT03078127|12140780|P3|STARTED|First Intervention||3
4936213|NCT03078127|12140781|P2|STARTED|First Intervention||3
4936214|NCT03078127|12140782|P1|STARTED|First Intervention||4
4936215|NCT03077919|12140818|P2|NOT COMPLETED|Overall Study||1
4936216|NCT03077919|12140819|P1|NOT COMPLETED|Overall Study||4
4936217|NCT03077919|12140818|P2|COMPLETED|Overall Study||38
4936218|NCT03077919|12140819|P1|COMPLETED|Overall Study||70
4936219|NCT03077919|12140818|P2|Final CAPS|Overall Study||38
4936220|NCT03077919|12140819|P1|Final CAPS|Overall Study||70
4936221|NCT03077919|12140818|P2|Week 8 Visit|Overall Study||38
4936222|NCT03077919|12140819|P1|Week 8 Visit|Overall Study||71
4936223|NCT03077919|12140818|P2|Week 6 Visit|Overall Study||38
4936224|NCT03077919|12140819|P1|Week 6 Visit|Overall Study||73
4936225|NCT03077919|12140818|P2|Week 4 Visit|Overall Study||38
4936226|NCT03077919|12140819|P1|Week 4 Visit|Overall Study||73
4936227|NCT03077919|12140818|P2|Week 2 Visit|Overall Study||39
4936228|NCT03077919|12140819|P1|Week 2 Visit|Overall Study||74
4936229|NCT03077919|12140818|P2|STARTED|Overall Study||39
4936230|NCT03077919|12140819|P1|STARTED|Overall Study||74
4936231|NCT03077893|12140849|P2|NOT COMPLETED|Overall Study||3
4936232|NCT03077893|12140850|P1|NOT COMPLETED|Overall Study||4
4936233|NCT03077893|12140849|P2|COMPLETED|Overall Study||16
4936234|NCT03077893|12140850|P1|COMPLETED|Overall Study||14
4936235|NCT03077893|12140849|P2|STARTED|Overall Study||19
4936236|NCT03077893|12140850|P1|STARTED|Overall Study||18
4936237|NCT03077724|12140879|P2|NOT COMPLETED|Overall Study||2
4936238|NCT03077724|12140880|P1|NOT COMPLETED|Overall Study||8
4936239|NCT03077724|12140879|P2|COMPLETED|Overall Study||12
4936240|NCT03077724|12140880|P1|COMPLETED|Overall Study||6
4936241|NCT03077724|12140879|P2|STARTED|Overall Study||14
4936242|NCT03077724|12140880|P1|STARTED|Overall Study||14
4936243|NCT03077711|12140892|P2|NOT COMPLETED|Overall Study||2
4936244|NCT03077711|12140893|P1|NOT COMPLETED|Overall Study||4
4936245|NCT03077711|12140892|P2|COMPLETED|Overall Study||43
4936246|NCT03077711|12140893|P1|COMPLETED|Overall Study||43
4936247|NCT03077711|12140892|P2|STARTED|Overall Study||45
4936248|NCT03077711|12140893|P1|STARTED|Overall Study||47
4936249|NCT03077659|12140912|P3|NOT COMPLETED|Overall Study||1
4936250|NCT03077659|12140913|P2|NOT COMPLETED|Overall Study||0
4936251|NCT03077659|12140914|P1|NOT COMPLETED|Overall Study||0
4936252|NCT03077659|12140912|P3|COMPLETED|Overall Study||9
4936253|NCT03077659|12140913|P2|COMPLETED|Overall Study||3
4936254|NCT03077659|12140914|P1|COMPLETED|Overall Study||3
4936255|NCT03077659|12140912|P3|STARTED|Overall Study||10
4936256|NCT03077659|12140913|P2|STARTED|Overall Study||3
4936257|NCT03077659|12140914|P1|STARTED|Overall Study||3
4936258|NCT03077607|12140945|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
4936259|NCT03077607|12140946|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
4936260|NCT03077607|12140945|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
4936261|NCT03077607|12140946|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
4936262|NCT03077607|12140945|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
4936263|NCT03077607|12140946|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
4936264|NCT03077607|12140945|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
4936265|NCT03077607|12140946|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
4936266|NCT03077607|12140945|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
4936267|NCT03077607|12140946|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
4936268|NCT03077607|12140945|P2|NOT COMPLETED|Period 1 (15 Days)||0
4936269|NCT03077607|12140946|P1|NOT COMPLETED|Period 1 (15 Days)||2
4936270|NCT03077607|12140945|P2|COMPLETED|Period 1 (15 Days)||17
4936271|NCT03077607|12140946|P1|COMPLETED|Period 1 (15 Days)||17
4936272|NCT03077607|12140945|P2|Received Talazoparib|Period 1 (15 Days)||17
4936273|NCT03077607|12140946|P1|Received Talazoparib|Period 1 (15 Days)||19
4936274|NCT03077607|12140945|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
4936275|NCT03077607|12140946|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
4936276|NCT03077607|12140945|P2|STARTED|Period 1 (15 Days)||17
4936277|NCT03077607|12140946|P1|STARTED|Period 1 (15 Days)||19
4936278|NCT03077438|12141014|P2|NOT COMPLETED|Overall Study||14
4936279|NCT03077438|12141015|P1|NOT COMPLETED|Overall Study||12
4936280|NCT03077438|12141014|P2|COMPLETED|Overall Study||487
4936281|NCT03077438|12141015|P1|COMPLETED|Overall Study||487
4936282|NCT03077438|12141014|P2|Safety Analysis Set (SafAS)|Overall Study||494
4936283|NCT03077438|12141015|P1|Safety Analysis Set (SafAS)|Overall Study||498
4936284|NCT03077438|12141014|P2|STARTED|Overall Study||501
4936285|NCT03077438|12141015|P1|STARTED|Overall Study||499
4936286|NCT03076996|12141031|P1|NOT COMPLETED|Overall Study||6
4936287|NCT03076996|12141031|P1|COMPLETED|Overall Study||35
4936288|NCT03076996|12141031|P1|STARTED|Overall Study||41
4936289|NCT03076983|12141040|P2|NOT COMPLETED|Overall Study||0
4936290|NCT03076983|12141041|P1|NOT COMPLETED|Overall Study||0
4936291|NCT03076983|12141040|P2|COMPLETED|Overall Study||25
4936292|NCT03076983|12141041|P1|COMPLETED|Overall Study||55
4936293|NCT03076983|12141040|P2|STARTED|Overall Study||25
4936294|NCT03076983|12141041|P1|STARTED|Overall Study||55
4936295|NCT03076970|12141057|P6|NOT COMPLETED|Washout Period 3||0
4936296|NCT03076970|12141058|P5|NOT COMPLETED|Washout Period 3||0
4936297|NCT03076970|12141059|P4|NOT COMPLETED|Washout Period 3||0
4936298|NCT03076970|12141060|P3|NOT COMPLETED|Washout Period 3||0
4936299|NCT03076970|12141061|P2|NOT COMPLETED|Washout Period 3||0
4936300|NCT03076970|12141062|P1|NOT COMPLETED|Washout Period 3||0
4936301|NCT03076970|12141057|P6|COMPLETED|Washout Period 3||6
4936302|NCT03076970|12141058|P5|COMPLETED|Washout Period 3||5
4936303|NCT03076970|12141059|P4|COMPLETED|Washout Period 3||7
4936304|NCT03076970|12141060|P3|COMPLETED|Washout Period 3||7
4936305|NCT03076970|12141061|P2|COMPLETED|Washout Period 3||7
4936306|NCT03076970|12141062|P1|COMPLETED|Washout Period 3||7
4936307|NCT03076970|12141057|P6|STARTED|Washout Period 3||6
4936308|NCT03076970|12141058|P5|STARTED|Washout Period 3||5
4936309|NCT03076970|12141059|P4|STARTED|Washout Period 3||7
4936310|NCT03076970|12141060|P3|STARTED|Washout Period 3||7
4936311|NCT03076970|12141061|P2|STARTED|Washout Period 3||7
4936312|NCT03076970|12141062|P1|STARTED|Washout Period 3||7
4936313|NCT03076970|12141057|P6|NOT COMPLETED|Period 3||1
4936314|NCT03076970|12141058|P5|NOT COMPLETED|Period 3||1
4936315|NCT03076970|12141059|P4|NOT COMPLETED|Period 3||0
4936316|NCT03076970|12141060|P3|NOT COMPLETED|Period 3||0
4936317|NCT03076970|12141061|P2|NOT COMPLETED|Period 3||0
4936318|NCT03076970|12141062|P1|NOT COMPLETED|Period 3||0
4936319|NCT03076970|12141057|P6|COMPLETED|Period 3||6
4936320|NCT03076970|12141058|P5|COMPLETED|Period 3||5
4936321|NCT03076970|12141059|P4|COMPLETED|Period 3||7
4936322|NCT03076970|12141060|P3|COMPLETED|Period 3||7
4936323|NCT03076970|12141061|P2|COMPLETED|Period 3||7
4936324|NCT03076970|12141062|P1|COMPLETED|Period 3||7
4936325|NCT03076970|12141057|P6|STARTED|Period 3||7
4936326|NCT03076970|12141058|P5|STARTED|Period 3||6
4936327|NCT03076970|12141059|P4|STARTED|Period 3||7
4936328|NCT03076970|12141060|P3|STARTED|Period 3||7
4936329|NCT03076970|12141061|P2|STARTED|Period 3||7
4936330|NCT03076970|12141062|P1|STARTED|Period 3||7
4936331|NCT03076970|12141057|P6|NOT COMPLETED|Washout Period 2||0
4936332|NCT03076970|12141058|P5|NOT COMPLETED|Washout Period 2||1
4936333|NCT03076970|12141059|P4|NOT COMPLETED|Washout Period 2||0
4936334|NCT03076970|12141060|P3|NOT COMPLETED|Washout Period 2||0
4936335|NCT03076970|12141061|P2|NOT COMPLETED|Washout Period 2||0
4936336|NCT03076970|12141062|P1|NOT COMPLETED|Washout Period 2||0
4936337|NCT03076970|12141057|P6|COMPLETED|Washout Period 2||7
4936338|NCT03076970|12141058|P5|COMPLETED|Washout Period 2||6
4936339|NCT03076970|12141059|P4|COMPLETED|Washout Period 2||7
4936340|NCT03076970|12141060|P3|COMPLETED|Washout Period 2||7
4936341|NCT03076970|12141061|P2|COMPLETED|Washout Period 2||7
4936342|NCT03076970|12141062|P1|COMPLETED|Washout Period 2||7
4936343|NCT03076970|12141057|P6|STARTED|Washout Period 2||7
4936344|NCT03076970|12141058|P5|STARTED|Washout Period 2||7
4936345|NCT03076970|12141059|P4|STARTED|Washout Period 2||7
4936346|NCT03076970|12141060|P3|STARTED|Washout Period 2||7
4936347|NCT03076970|12141061|P2|STARTED|Washout Period 2||7
4936348|NCT03076970|12141062|P1|STARTED|Washout Period 2||7
4936349|NCT03076970|12141057|P6|NOT COMPLETED|Period 2||0
4936350|NCT03076970|12141058|P5|NOT COMPLETED|Period 2||0
4936351|NCT03076970|12141059|P4|NOT COMPLETED|Period 2||0
4936352|NCT03076970|12141060|P3|NOT COMPLETED|Period 2||0
4936353|NCT03076970|12141061|P2|NOT COMPLETED|Period 2||0
4936354|NCT03076970|12141062|P1|NOT COMPLETED|Period 2||0
4936355|NCT03076970|12141057|P6|COMPLETED|Period 2||7
4936356|NCT03076970|12141058|P5|COMPLETED|Period 2||7
4936357|NCT03076970|12141059|P4|COMPLETED|Period 2||7
4936358|NCT03076970|12141060|P3|COMPLETED|Period 2||7
4936359|NCT03076970|12141061|P2|COMPLETED|Period 2||7
4936360|NCT03076970|12141062|P1|COMPLETED|Period 2||7
4936361|NCT03076970|12141057|P6|STARTED|Period 2||7
4936362|NCT03076970|12141058|P5|STARTED|Period 2||7
4936363|NCT03076970|12141059|P4|STARTED|Period 2||7
4936364|NCT03076970|12141060|P3|STARTED|Period 2||7
4936365|NCT03076970|12141061|P2|STARTED|Period 2||7
4936366|NCT03076970|12141062|P1|STARTED|Period 2||7
4936367|NCT03076970|12141057|P6|NOT COMPLETED|Washout Period 1||0
4936368|NCT03076970|12141058|P5|NOT COMPLETED|Washout Period 1||0
4936369|NCT03076970|12141059|P4|NOT COMPLETED|Washout Period 1||0
4936370|NCT03076970|12141060|P3|NOT COMPLETED|Washout Period 1||0
4936371|NCT03076970|12141061|P2|NOT COMPLETED|Washout Period 1||0
4936372|NCT03076970|12141062|P1|NOT COMPLETED|Washout Period 1||0
4936373|NCT03076970|12141057|P6|COMPLETED|Washout Period 1||7
4936374|NCT03076970|12141058|P5|COMPLETED|Washout Period 1||7
4936375|NCT03076970|12141059|P4|COMPLETED|Washout Period 1||7
4936376|NCT03076970|12141060|P3|COMPLETED|Washout Period 1||7
4936377|NCT03076970|12141061|P2|COMPLETED|Washout Period 1||7
4936378|NCT03076970|12141062|P1|COMPLETED|Washout Period 1||7
4936379|NCT03076970|12141057|P6|STARTED|Washout Period 1||7
4936380|NCT03076970|12141058|P5|STARTED|Washout Period 1||7
4936381|NCT03076970|12141059|P4|STARTED|Washout Period 1||7
4936382|NCT03076970|12141060|P3|STARTED|Washout Period 1||7
4936383|NCT03076970|12141061|P2|STARTED|Washout Period 1||7
4936384|NCT03076970|12141062|P1|STARTED|Washout Period 1||7
4936385|NCT03076970|12141057|P6|NOT COMPLETED|Period 1||0
4936386|NCT03076970|12141058|P5|NOT COMPLETED|Period 1||0
4936387|NCT03076970|12141059|P4|NOT COMPLETED|Period 1||0
4936388|NCT03076970|12141060|P3|NOT COMPLETED|Period 1||0
4936389|NCT03076970|12141061|P2|NOT COMPLETED|Period 1||0
4936390|NCT03076970|12141062|P1|NOT COMPLETED|Period 1||0
4936391|NCT03076970|12141057|P6|COMPLETED|Period 1||7
4936392|NCT03076970|12141058|P5|COMPLETED|Period 1||7
4936393|NCT03076970|12141059|P4|COMPLETED|Period 1||7
4936394|NCT03076970|12141060|P3|COMPLETED|Period 1||7
4936395|NCT03076970|12141061|P2|COMPLETED|Period 1||7
4936396|NCT03076970|12141062|P1|COMPLETED|Period 1||7
4936397|NCT03076970|12141057|P6|Received at Least 1 Dose of Study Drug|Period 1||7
4936398|NCT03076970|12141058|P5|Received at Least 1 Dose of Study Drug|Period 1||7
4936399|NCT03076970|12141059|P4|Received at Least 1 Dose of Study Drug|Period 1||7
4936400|NCT03076970|12141060|P3|Received at Least 1 Dose of Study Drug|Period 1||7
4936401|NCT03076970|12141061|P2|Received at Least 1 Dose of Study Drug|Period 1||7
4936402|NCT03076970|12141062|P1|Received at Least 1 Dose of Study Drug|Period 1||7
4936403|NCT03076970|12141057|P6|STARTED|Period 1||7
4936404|NCT03076970|12141058|P5|STARTED|Period 1||7
4936405|NCT03076970|12141059|P4|STARTED|Period 1||7
4936406|NCT03076970|12141060|P3|STARTED|Period 1||7
4936407|NCT03076970|12141061|P2|STARTED|Period 1||7
4936408|NCT03076970|12141062|P1|STARTED|Period 1||7
4936409|NCT03076190|12141114|P2|NOT COMPLETED|Overall Study||41
4936410|NCT03076190|12141115|P1|NOT COMPLETED|Overall Study||18
4936411|NCT03076190|12141114|P2|COMPLETED|Overall Study||36
4936412|NCT03076190|12141115|P1|COMPLETED|Overall Study||32
4936413|NCT03076190|12141114|P2|STARTED|Overall Study||77
4936414|NCT03076190|12141115|P1|STARTED|Overall Study||50
4936415|NCT03075904|12141128|P1|NOT COMPLETED|Overall Study||4
4936416|NCT03075904|12141128|P1|COMPLETED|Overall Study||4
4936417|NCT03075904|12141128|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
4936418|NCT03075904|12141128|P1|STARTED|Overall Study||8
4936419|NCT03075891|12141138|P2|NOT COMPLETED|Overall Study||13
4936420|NCT03075891|12141139|P1|NOT COMPLETED|Overall Study||9
4936421|NCT03075891|12141138|P2|COMPLETED|Overall Study||125
4936422|NCT03075891|12141139|P1|COMPLETED|Overall Study||126
4936423|NCT03075891|12141138|P2|STARTED|Overall Study||138
4936424|NCT03075891|12141139|P1|STARTED|Overall Study||135
4936425|NCT03075878|12141145|P1|NOT COMPLETED|Overall Study||1
4936426|NCT03075878|12141145|P1|COMPLETED|Overall Study||7
4936427|NCT03075878|12141145|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
4936428|NCT03075878|12141145|P1|STARTED|Overall Study||8
4936429|NCT03075839|12141153|P1|NOT COMPLETED|Overall Study||4
4936430|NCT03075839|12141153|P1|COMPLETED|Overall Study||29
4936431|NCT03075839|12141153|P1|STARTED|Overall Study||33
4936432|NCT03075553|12141159|P1|NOT COMPLETED|Overall Study||0
4936433|NCT03075553|12141159|P1|COMPLETED|Overall Study||12
4936434|NCT03075553|12141159|P1|STARTED|Overall Study||12
4936435|NCT03075527|12141168|P1|NOT COMPLETED|Overall Study||2
4936436|NCT03075527|12141168|P1|COMPLETED|Overall Study||17
4936437|NCT03075527|12141168|P1|STARTED|Overall Study||19
4936438|NCT03075449|12141172|P1|NOT COMPLETED|Overall Study||0
4936439|NCT03075449|12141172|P1|COMPLETED|Overall Study||170
4936440|NCT03075449|12141172|P1|STARTED|Overall Study||170
4936441|NCT03075410|12141192|P9|NOT COMPLETED|Part B (up to 28 Days)||0
4936442|NCT03075410|12141193|P8|NOT COMPLETED|Part B (up to 28 Days)||0
4936443|NCT03075410|12141194|P7|NOT COMPLETED|Part B (up to 28 Days)||0
4936444|NCT03075410|12141195|P6|NOT COMPLETED|Part B (up to 28 Days)||0
4936445|NCT03075410|12141196|P5|NOT COMPLETED|Part B (up to 28 Days)||0
4936446|NCT03075410|12141197|P4|NOT COMPLETED|Part B (up to 28 Days)||0
4936447|NCT03075410|12141198|P3|NOT COMPLETED|Part B (up to 28 Days)||0
4936448|NCT03075410|12141199|P2|NOT COMPLETED|Part B (up to 28 Days)||0
4936449|NCT03075410|12141200|P1|NOT COMPLETED|Part B (up to 28 Days)||0
4936450|NCT03075410|12141192|P9|COMPLETED|Part B (up to 28 Days)||8
4936451|NCT03075410|12141193|P8|COMPLETED|Part B (up to 28 Days)||7
4936452|NCT03075410|12141194|P7|COMPLETED|Part B (up to 28 Days)||4
4936453|NCT03075410|12141195|P6|COMPLETED|Part B (up to 28 Days)||0
4936454|NCT03075410|12141196|P5|COMPLETED|Part B (up to 28 Days)||0
4936455|NCT03075410|12141197|P4|COMPLETED|Part B (up to 28 Days)||0
4936456|NCT03075410|12141198|P3|COMPLETED|Part B (up to 28 Days)||0
4936457|NCT03075410|12141199|P2|COMPLETED|Part B (up to 28 Days)||0
4936458|NCT03075410|12141200|P1|COMPLETED|Part B (up to 28 Days)||0
4936459|NCT03075410|12141192|P9|STARTED|Part B (up to 28 Days)||8
4936460|NCT03075410|12141193|P8|STARTED|Part B (up to 28 Days)||7
4936461|NCT03075410|12141194|P7|STARTED|Part B (up to 28 Days)||4
4936462|NCT03075410|12141195|P6|STARTED|Part B (up to 28 Days)||0
4936463|NCT03075410|12141196|P5|STARTED|Part B (up to 28 Days)||0
4936464|NCT03075410|12141197|P4|STARTED|Part B (up to 28 Days)||0
4936465|NCT03075410|12141198|P3|STARTED|Part B (up to 28 Days)||0
4936466|NCT03075410|12141199|P2|STARTED|Part B (up to 28 Days)||0
4936467|NCT03075410|12141200|P1|STARTED|Part B (up to 28 Days)||0
4936468|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936469|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936470|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936471|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936472|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936473|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936474|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936475|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936476|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
4936477|NCT03075410|12141192|P9|COMPLETED|Part A-Period 4 (14 Days)||0
4936478|NCT03075410|12141193|P8|COMPLETED|Part A-Period 4 (14 Days)||0
4936479|NCT03075410|12141194|P7|COMPLETED|Part A-Period 4 (14 Days)||0
4936480|NCT03075410|12141195|P6|COMPLETED|Part A-Period 4 (14 Days)||1
4936481|NCT03075410|12141196|P5|COMPLETED|Part A-Period 4 (14 Days)||2
4936482|NCT03075410|12141197|P4|COMPLETED|Part A-Period 4 (14 Days)||1
4936483|NCT03075410|12141198|P3|COMPLETED|Part A-Period 4 (14 Days)||2
4936484|NCT03075410|12141199|P2|COMPLETED|Part A-Period 4 (14 Days)||1
4936485|NCT03075410|12141200|P1|COMPLETED|Part A-Period 4 (14 Days)||1
4936486|NCT03075410|12141192|P9|STARTED|Part A-Period 4 (14 Days)||0
4936487|NCT03075410|12141193|P8|STARTED|Part A-Period 4 (14 Days)||0
4936488|NCT03075410|12141194|P7|STARTED|Part A-Period 4 (14 Days)||0
4936489|NCT03075410|12141195|P6|STARTED|Part A-Period 4 (14 Days)||1
4936490|NCT03075410|12141196|P5|STARTED|Part A-Period 4 (14 Days)||2
4936491|NCT03075410|12141197|P4|STARTED|Part A-Period 4 (14 Days)||1
4936492|NCT03075410|12141198|P3|STARTED|Part A-Period 4 (14 Days)||2
4936493|NCT03075410|12141199|P2|STARTED|Part A-Period 4 (14 Days)||1
4936494|NCT03075410|12141200|P1|STARTED|Part A-Period 4 (14 Days)||1
4936495|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936496|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936497|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936498|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936499|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936500|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936501|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936502|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936503|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936504|NCT03075410|12141192|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936505|NCT03075410|12141193|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936506|NCT03075410|12141194|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
4936507|NCT03075410|12141195|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
4936508|NCT03075410|12141196|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
4936509|NCT03075410|12141197|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
4936510|NCT03075410|12141198|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
4936511|NCT03075410|12141199|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
4936512|NCT03075410|12141200|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
4936513|NCT03075410|12141192|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
4936514|NCT03075410|12141193|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
4936515|NCT03075410|12141194|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
4936516|NCT03075410|12141195|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
4936517|NCT03075410|12141196|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
4936518|NCT03075410|12141197|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
4936519|NCT03075410|12141198|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
4936520|NCT03075410|12141199|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
4936521|NCT03075410|12141200|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
4936522|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936523|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936524|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936525|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936526|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936527|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936528|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936529|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
4936530|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
4936531|NCT03075410|12141192|P9|COMPLETED|Part A-Period 3 (14 Days)||0
4936532|NCT03075410|12141193|P8|COMPLETED|Part A-Period 3 (14 Days)||0
4936533|NCT03075410|12141194|P7|COMPLETED|Part A-Period 3 (14 Days)||0
4936534|NCT03075410|12141195|P6|COMPLETED|Part A-Period 3 (14 Days)||1
4936535|NCT03075410|12141196|P5|COMPLETED|Part A-Period 3 (14 Days)||2
4936536|NCT03075410|12141197|P4|COMPLETED|Part A-Period 3 (14 Days)||1
4936537|NCT03075410|12141198|P3|COMPLETED|Part A-Period 3 (14 Days)||2
4936538|NCT03075410|12141199|P2|COMPLETED|Part A-Period 3 (14 Days)||1
4936539|NCT03075410|12141200|P1|COMPLETED|Part A-Period 3 (14 Days)||1
4936540|NCT03075410|12141192|P9|STARTED|Part A-Period 3 (14 Days)||0
4936541|NCT03075410|12141193|P8|STARTED|Part A-Period 3 (14 Days)||0
4936542|NCT03075410|12141194|P7|STARTED|Part A-Period 3 (14 Days)||0
4936543|NCT03075410|12141195|P6|STARTED|Part A-Period 3 (14 Days)||1
4936544|NCT03075410|12141196|P5|STARTED|Part A-Period 3 (14 Days)||2
4936545|NCT03075410|12141197|P4|STARTED|Part A-Period 3 (14 Days)||1
4936546|NCT03075410|12141198|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
4936547|NCT03075410|12141199|P2|STARTED|Part A-Period 3 (14 Days)||1
4936548|NCT03075410|12141200|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
4936549|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936550|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936551|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936552|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936553|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936554|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936555|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936556|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936557|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936558|NCT03075410|12141192|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936559|NCT03075410|12141193|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936560|NCT03075410|12141194|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
4936561|NCT03075410|12141195|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
4936562|NCT03075410|12141196|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
4936563|NCT03075410|12141197|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
4936564|NCT03075410|12141198|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
4936565|NCT03075410|12141199|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
4936566|NCT03075410|12141200|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
4936567|NCT03075410|12141192|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
4936568|NCT03075410|12141193|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
4936569|NCT03075410|12141194|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
4936570|NCT03075410|12141195|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
4936571|NCT03075410|12141196|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
4936572|NCT03075410|12141197|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
4936573|NCT03075410|12141198|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
4936574|NCT03075410|12141199|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
4936575|NCT03075410|12141200|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
4936576|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936577|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936578|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936579|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936580|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936581|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936582|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
4936583|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
4936584|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
4936585|NCT03075410|12141192|P9|COMPLETED|Part A-Period 2 (14 Days)||0
4936586|NCT03075410|12141193|P8|COMPLETED|Part A-Period 2 (14 Days)||0
4936587|NCT03075410|12141194|P7|COMPLETED|Part A-Period 2 (14 Days)||0
4936588|NCT03075410|12141195|P6|COMPLETED|Part A-Period 2 (14 Days)||1
4936589|NCT03075410|12141196|P5|COMPLETED|Part A-Period 2 (14 Days)||2
4936590|NCT03075410|12141197|P4|COMPLETED|Part A-Period 2 (14 Days)||1
4936591|NCT03075410|12141198|P3|COMPLETED|Part A-Period 2 (14 Days)||1
4936592|NCT03075410|12141199|P2|COMPLETED|Part A-Period 2 (14 Days)||1
4936593|NCT03075410|12141200|P1|COMPLETED|Part A-Period 2 (14 Days)||1
4936594|NCT03075410|12141192|P9|STARTED|Part A-Period 2 (14 Days)||0
4936595|NCT03075410|12141193|P8|STARTED|Part A-Period 2 (14 Days)||0
4936596|NCT03075410|12141194|P7|STARTED|Part A-Period 2 (14 Days)||0
4936597|NCT03075410|12141195|P6|STARTED|Part A-Period 2 (14 Days)||1
4936598|NCT03075410|12141196|P5|STARTED|Part A-Period 2 (14 Days)||2
4936599|NCT03075410|12141197|P4|STARTED|Part A-Period 2 (14 Days)||1
4936600|NCT03075410|12141198|P3|STARTED|Part A-Period 2 (14 Days)||2
4936601|NCT03075410|12141199|P2|STARTED|Part A-Period 2 (14 Days)||1
4936602|NCT03075410|12141200|P1|STARTED|Part A-Period 2 (14 Days)||2
4936603|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936604|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936605|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936606|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936607|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936608|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936609|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936610|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936611|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936612|NCT03075410|12141192|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936613|NCT03075410|12141193|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936614|NCT03075410|12141194|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
4936615|NCT03075410|12141195|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
4936616|NCT03075410|12141196|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
4936617|NCT03075410|12141197|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
4936618|NCT03075410|12141198|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
4936619|NCT03075410|12141199|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
4936620|NCT03075410|12141200|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
4936621|NCT03075410|12141192|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
4936622|NCT03075410|12141193|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
4936623|NCT03075410|12141194|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
4936624|NCT03075410|12141195|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
4936625|NCT03075410|12141196|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
4936626|NCT03075410|12141197|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
4936627|NCT03075410|12141198|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
4936628|NCT03075410|12141199|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
4936629|NCT03075410|12141200|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
4936630|NCT03075410|12141192|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936631|NCT03075410|12141193|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936632|NCT03075410|12141194|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936633|NCT03075410|12141195|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936634|NCT03075410|12141196|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936635|NCT03075410|12141197|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936636|NCT03075410|12141198|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936637|NCT03075410|12141199|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936638|NCT03075410|12141200|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
4936639|NCT03075410|12141192|P9|COMPLETED|Part A-Period 1 (14 Days)||0
4936640|NCT03075410|12141193|P8|COMPLETED|Part A-Period 1 (14 Days)||0
4936641|NCT03075410|12141194|P7|COMPLETED|Part A-Period 1 (14 Days)||0
4936642|NCT03075410|12141195|P6|COMPLETED|Part A-Period 1 (14 Days)||1
4936643|NCT03075410|12141196|P5|COMPLETED|Part A-Period 1 (14 Days)||2
4936644|NCT03075410|12141197|P4|COMPLETED|Part A-Period 1 (14 Days)||1
4936645|NCT03075410|12141198|P3|COMPLETED|Part A-Period 1 (14 Days)||2
4936646|NCT03075410|12141199|P2|COMPLETED|Part A-Period 1 (14 Days)||1
4936647|NCT03075410|12141200|P1|COMPLETED|Part A-Period 1 (14 Days)||2
4936648|NCT03075410|12141192|P9|STARTED|Part A-Period 1 (14 Days)||0
4936649|NCT03075410|12141193|P8|STARTED|Part A-Period 1 (14 Days)||0
4936650|NCT03075410|12141194|P7|STARTED|Part A-Period 1 (14 Days)||0
4936651|NCT03075410|12141195|P6|STARTED|Part A-Period 1 (14 Days)||1
4936652|NCT03075410|12141196|P5|STARTED|Part A-Period 1 (14 Days)||2
4936653|NCT03075410|12141197|P4|STARTED|Part A-Period 1 (14 Days)||1
4936654|NCT03075410|12141198|P3|STARTED|Part A-Period 1 (14 Days)||2
4936655|NCT03075410|12141199|P2|STARTED|Part A-Period 1 (14 Days)||1
4936656|NCT03075410|12141200|P1|STARTED|Part A-Period 1 (14 Days)||2
4936657|NCT03075163|12141366|P2|NOT COMPLETED|Overall Study||138
4936658|NCT03075163|12141367|P1|NOT COMPLETED|Overall Study||138
4936659|NCT03075163|12141366|P2|COMPLETED|Overall Study||12
4936660|NCT03075163|12141367|P1|COMPLETED|Overall Study||12
4936661|NCT03075163|12141366|P2|STARTED|Overall Study||150
4936662|NCT03075163|12141367|P1|STARTED|Overall Study||150
4936663|NCT03074682|12141376|P3|NOT COMPLETED|Overall Study||0
4936664|NCT03074682|12141377|P2|NOT COMPLETED|Overall Study||0
4936665|NCT03074682|12141378|P1|NOT COMPLETED|Overall Study||0
4936666|NCT03074682|12141376|P3|COMPLETED|Overall Study||18
4936667|NCT03074682|12141377|P2|COMPLETED|Overall Study||18
4936668|NCT03074682|12141378|P1|COMPLETED|Overall Study||18
4936669|NCT03074682|12141376|P3|STARTED|Overall Study||18
4936670|NCT03074682|12141377|P2|STARTED|Overall Study||18
4936671|NCT03074682|12141378|P1|STARTED|Overall Study||18
4936672|NCT03074500|12141398|P3|NOT COMPLETED|Overall Study||1
4936673|NCT03074500|12141399|P2|NOT COMPLETED|Overall Study||1
4936674|NCT03074500|12141400|P1|NOT COMPLETED|Overall Study||1
4936675|NCT03074500|12141398|P3|COMPLETED|Overall Study||10
4936676|NCT03074500|12141399|P2|COMPLETED|Overall Study||10
4936677|NCT03074500|12141400|P1|COMPLETED|Overall Study||10
4936678|NCT03074500|12141398|P3|STARTED|Overall Study||11
4936679|NCT03074500|12141399|P2|STARTED|Overall Study||11
4936680|NCT03074500|12141400|P1|STARTED|Overall Study||11
4936681|NCT03074409|12141428|P2|NOT COMPLETED|Overall Study||4
4936682|NCT03074409|12141429|P1|NOT COMPLETED|Overall Study||4
4936683|NCT03074409|12141428|P2|COMPLETED|Overall Study||38
4936684|NCT03074409|12141429|P1|COMPLETED|Overall Study||37
4936685|NCT03074409|12141428|P2|STARTED|Overall Study||42
4936686|NCT03074409|12141429|P1|STARTED|Overall Study||41
4936687|NCT03074331|12141437|P1|NOT COMPLETED|Overall Study||7
4936688|NCT03074331|12141437|P1|COMPLETED|Overall Study||123
4936689|NCT03074331|12141437|P1|STARTED|Overall Study||130
4936690|NCT03074162|12141449|P6|NOT COMPLETED|Period 3||0
4936691|NCT03074162|12141450|P5|NOT COMPLETED|Period 3||1
4936692|NCT03074162|12141451|P4|NOT COMPLETED|Period 3||0
4936693|NCT03074162|12141452|P3|NOT COMPLETED|Period 3||0
4936694|NCT03074162|12141453|P2|NOT COMPLETED|Period 3||0
4936695|NCT03074162|12141454|P1|NOT COMPLETED|Period 3||1
4936696|NCT03074162|12141449|P6|COMPLETED|Period 3||7
4936697|NCT03074162|12141450|P5|COMPLETED|Period 3||7
4936698|NCT03074162|12141451|P4|COMPLETED|Period 3||8
4936699|NCT03074162|12141452|P3|COMPLETED|Period 3||6
4936700|NCT03074162|12141453|P2|COMPLETED|Period 3||8
4936701|NCT03074162|12141454|P1|COMPLETED|Period 3||7
4936702|NCT03074162|12141449|P6|STARTED|Period 3||7
4936703|NCT03074162|12141450|P5|STARTED|Period 3||8
4936704|NCT03074162|12141451|P4|STARTED|Period 3||8
4936705|NCT03074162|12141452|P3|STARTED|Period 3||6
4936706|NCT03074162|12141453|P2|STARTED|Period 3||8
4936707|NCT03074162|12141454|P1|STARTED|Period 3||8
4936708|NCT03074162|12141449|P6|NOT COMPLETED|Period 2 Including Washout 2||1
4936709|NCT03074162|12141450|P5|NOT COMPLETED|Period 2 Including Washout 2||0
4936710|NCT03074162|12141451|P4|NOT COMPLETED|Period 2 Including Washout 2||0
4936711|NCT03074162|12141452|P3|NOT COMPLETED|Period 2 Including Washout 2||1
4936712|NCT03074162|12141453|P2|NOT COMPLETED|Period 2 Including Washout 2||0
4936713|NCT03074162|12141454|P1|NOT COMPLETED|Period 2 Including Washout 2||0
4936714|NCT03074162|12141449|P6|COMPLETED|Period 2 Including Washout 2||7
4936715|NCT03074162|12141450|P5|COMPLETED|Period 2 Including Washout 2||8
4936716|NCT03074162|12141451|P4|COMPLETED|Period 2 Including Washout 2||8
4936717|NCT03074162|12141452|P3|COMPLETED|Period 2 Including Washout 2||6
4936718|NCT03074162|12141453|P2|COMPLETED|Period 2 Including Washout 2||8
4936719|NCT03074162|12141454|P1|COMPLETED|Period 2 Including Washout 2||8
4936720|NCT03074162|12141449|P6|STARTED|Period 2 Including Washout 2||8
4936721|NCT03074162|12141450|P5|STARTED|Period 2 Including Washout 2||8
4936722|NCT03074162|12141451|P4|STARTED|Period 2 Including Washout 2||8
4936723|NCT03074162|12141452|P3|STARTED|Period 2 Including Washout 2||7
4936724|NCT03074162|12141453|P2|STARTED|Period 2 Including Washout 2||8
4936725|NCT03074162|12141454|P1|STARTED|Period 2 Including Washout 2||8
4936726|NCT03074162|12141449|P6|NOT COMPLETED|Period 1 Including Washout 1||0
4936727|NCT03074162|12141450|P5|NOT COMPLETED|Period 1 Including Washout 1||0
4936728|NCT03074162|12141451|P4|NOT COMPLETED|Period 1 Including Washout 1||0
4936729|NCT03074162|12141452|P3|NOT COMPLETED|Period 1 Including Washout 1||1
4936730|NCT03074162|12141453|P2|NOT COMPLETED|Period 1 Including Washout 1||0
4936731|NCT03074162|12141454|P1|NOT COMPLETED|Period 1 Including Washout 1||0
4936732|NCT03074162|12141449|P6|COMPLETED|Period 1 Including Washout 1||8
4936733|NCT03074162|12141450|P5|COMPLETED|Period 1 Including Washout 1||8
4936734|NCT03074162|12141451|P4|COMPLETED|Period 1 Including Washout 1||8
4936735|NCT03074162|12141452|P3|COMPLETED|Period 1 Including Washout 1||7
4936736|NCT03074162|12141453|P2|COMPLETED|Period 1 Including Washout 1||8
4936737|NCT03074162|12141454|P1|COMPLETED|Period 1 Including Washout 1||8
4936738|NCT03074162|12141449|P6|STARTED|Period 1 Including Washout 1||8
4936739|NCT03074162|12141450|P5|STARTED|Period 1 Including Washout 1||8
4936740|NCT03074162|12141451|P4|STARTED|Period 1 Including Washout 1||8
4936741|NCT03074162|12141452|P3|STARTED|Period 1 Including Washout 1||8
4936742|NCT03074162|12141453|P2|STARTED|Period 1 Including Washout 1||8
4936743|NCT03074162|12141454|P1|STARTED|Period 1 Including Washout 1||8
4936744|NCT03073876|12141476|P2|NOT COMPLETED|Overall Study||0
4936745|NCT03073876|12141477|P1|NOT COMPLETED|Overall Study||0
4936746|NCT03073876|12141476|P2|COMPLETED|Overall Study||11
4936747|NCT03073876|12141477|P1|COMPLETED|Overall Study||12
4936748|NCT03073876|12141476|P2|STARTED|Overall Study||11
4936749|NCT03073876|12141477|P1|STARTED|Overall Study||12
4936750|NCT03073798|12141516|P1|NOT COMPLETED|Overall Study||2
4936751|NCT03073798|12141516|P1|COMPLETED|Overall Study||10
4936752|NCT03073798|12141516|P1|STARTED|Overall Study||12
4936753|NCT03073486|12141529|P2|NOT COMPLETED|Overall Study||44
4936754|NCT03073486|12141530|P1|NOT COMPLETED|Overall Study||88
4936755|NCT03073486|12141529|P2|COMPLETED|Overall Study||207
4936756|NCT03073486|12141530|P1|COMPLETED|Overall Study||405
4936757|NCT03073486|12141529|P2|STARTED|Overall Study||251
4936758|NCT03073486|12141530|P1|STARTED|Overall Study||493
4936759|NCT03073213|12141543|P3|NOT COMPLETED|Multiple Dose Period||1
4936760|NCT03073213|12141544|P2|NOT COMPLETED|Multiple Dose Period||0
4936761|NCT03073213|12141545|P1|NOT COMPLETED|Multiple Dose Period||0
4936762|NCT03073213|12141543|P3|COMPLETED|Multiple Dose Period||14
4936763|NCT03073213|12141544|P2|COMPLETED|Multiple Dose Period||14
4936764|NCT03073213|12141545|P1|COMPLETED|Multiple Dose Period||0
4936765|NCT03073213|12141543|P3|Participants Enrolled From Single Dose|Multiple Dose Period||2
4936766|NCT03073213|12141544|P2|Participants Enrolled From Single Dose|Multiple Dose Period||7
4936767|NCT03073213|12141545|P1|Participants Enrolled From Single Dose|Multiple Dose Period||0
4936768|NCT03073213|12141543|P3|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
4936769|NCT03073213|12141544|P2|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
4936770|NCT03073213|12141545|P1|STARTED|Multiple Dose Period||0
4936771|NCT03073213|12141543|P3|NOT COMPLETED|Single Dose Period||0
4936772|NCT03073213|12141544|P2|NOT COMPLETED|Single Dose Period||0
4936773|NCT03073213|12141545|P1|NOT COMPLETED|Single Dose Period||0
4936774|NCT03073213|12141543|P3|COMPLETED|Single Dose Period||0
4936775|NCT03073213|12141544|P2|COMPLETED|Single Dose Period||0
4936776|NCT03073213|12141545|P1|COMPLETED|Single Dose Period||12
4936777|NCT03073213|12141543|P3|STARTED|Single Dose Period||0
4936778|NCT03073213|12141544|P2|STARTED|Single Dose Period||0
4936779|NCT03073213|12141545|P1|STARTED|Single Dose Period||12
4936780|NCT03073200|12141560|P3|NOT COMPLETED|Overall Study||30
4936781|NCT03073200|12141561|P2|NOT COMPLETED|Overall Study||115
4936782|NCT03073200|12141562|P1|NOT COMPLETED|Overall Study||55
4936783|NCT03073200|12141560|P3|COMPLETED|Overall Study||0
4936784|NCT03073200|12141561|P2|COMPLETED|Overall Study||0
4936785|NCT03073200|12141562|P1|COMPLETED|Overall Study||1
4936786|NCT03073200|12141560|P3|Pts in Etanercept Approved Countries|Overall Study||30
4936787|NCT03073200|12141561|P2|Pts in Etanercept Approved Countries|Overall Study||38
4936788|NCT03073200|12141562|P1|Pts in Etanercept Approved Countries|Overall Study||19
4936789|NCT03073200|12141560|P3|STARTED|Overall Study||30
4936790|NCT03073200|12141561|P2|STARTED|Overall Study||115
4936791|NCT03073200|12141562|P1|STARTED|Overall Study||56
4936792|NCT03072875|12141598|P1|NOT COMPLETED|Overall Study||1
4936793|NCT03072875|12141598|P1|COMPLETED|Overall Study||25
4936794|NCT03072875|12141598|P1|STARTED|Overall Study||26
4936795|NCT03072719|12141605|P2|NOT COMPLETED|Overall Study||1
4936796|NCT03072719|12141606|P1|NOT COMPLETED|Overall Study||1
4936797|NCT03072719|12141605|P2|COMPLETED|Overall Study||59
4936798|NCT03072719|12141606|P1|COMPLETED|Overall Study||59
4936799|NCT03072719|12141605|P2|STARTED|Overall Study||60
4936800|NCT03072719|12141606|P1|STARTED|Overall Study||60
4936801|NCT03072550|12141616|P1|NOT COMPLETED|Overall Study||2
4936802|NCT03072550|12141616|P1|COMPLETED|Overall Study||24
4936803|NCT03072550|12141616|P1|STARTED|Overall Study||26
4936804|NCT03071887|12141620|P1|NOT COMPLETED|Overall Study||6
4936805|NCT03071887|12141620|P1|COMPLETED|Overall Study||7
4936806|NCT03071887|12141620|P1|STARTED|Overall Study||13
4936807|NCT03071744|12141625|P1|NOT COMPLETED|Overall Study||2
4936808|NCT03071744|12141625|P1|COMPLETED|Overall Study||4
4936809|NCT03071744|12141625|P1|STARTED|Overall Study||6
4936810|NCT03071276|12141631|P1|NOT COMPLETED|Overall Study||15
4936811|NCT03071276|12141631|P1|COMPLETED|Overall Study||22
4936812|NCT03071276|12141631|P1|STARTED|Overall Study||37
4936813|NCT03071263|12141639|P2|NOT COMPLETED|Overall Study||7
4936814|NCT03071263|12141640|P1|NOT COMPLETED|Overall Study||3
4936815|NCT03071263|12141639|P2|COMPLETED|Overall Study||141
4936816|NCT03071263|12141640|P1|COMPLETED|Overall Study||144
4936817|NCT03071263|12141639|P2|STARTED|Overall Study||148
4936818|NCT03071263|12141640|P1|STARTED|Overall Study||147
4936819|NCT03070730|12141667|P3|NOT COMPLETED|Overall Study||0
4936820|NCT03070730|12141668|P2|NOT COMPLETED|Overall Study||0
4936821|NCT03070730|12141669|P1|NOT COMPLETED|Overall Study||0
4936822|NCT03070730|12141667|P3|COMPLETED|Overall Study||0
4936823|NCT03070730|12141668|P2|COMPLETED|Overall Study||0
4936824|NCT03070730|12141669|P1|COMPLETED|Overall Study||0
4936825|NCT03070730|12141667|P3|STARTED|Overall Study||0
4936826|NCT03070730|12141668|P2|STARTED|Overall Study||0
4936827|NCT03070730|12141669|P1|STARTED|Overall Study||0
4936828|NCT03070548|12141800|P1|NOT COMPLETED|Overall Study||0
4936829|NCT03070548|12141800|P1|COMPLETED|Overall Study||6
4936830|NCT03070548|12141800|P1|STARTED|Overall Study||6
4936831|NCT03070483|12141836|P1|NOT COMPLETED|Overall Study||2
4936832|NCT03070483|12141836|P1|COMPLETED|Overall Study||3
4936833|NCT03070483|12141836|P1|STARTED|Overall Study||5
4936834|NCT03070470|12141851|P6|NOT COMPLETED|Overall Study||2
4936835|NCT03070470|12141852|P5|NOT COMPLETED|Overall Study||0
4936836|NCT03070470|12141853|P4|NOT COMPLETED|Overall Study||0
4936837|NCT03070470|12141854|P3|NOT COMPLETED|Overall Study||0
4936838|NCT03070470|12141855|P2|NOT COMPLETED|Overall Study||1
4936839|NCT03070470|12141856|P1|NOT COMPLETED|Overall Study||0
4936840|NCT03070470|12141851|P6|COMPLETED|Overall Study||8
4936841|NCT03070470|12141852|P5|COMPLETED|Overall Study||10
4936842|NCT03070470|12141853|P4|COMPLETED|Overall Study||10
4936843|NCT03070470|12141854|P3|COMPLETED|Overall Study||10
4936844|NCT03070470|12141855|P2|COMPLETED|Overall Study||9
4936845|NCT03070470|12141856|P1|COMPLETED|Overall Study||10
4936846|NCT03070470|12141851|P6|STARTED|Overall Study||10
4936847|NCT03070470|12141852|P5|STARTED|Overall Study||10
4936848|NCT03070470|12141853|P4|STARTED|Overall Study||10
4936849|NCT03070470|12141854|P3|STARTED|Overall Study||10
4936850|NCT03070470|12141855|P2|STARTED|Overall Study||10
4936851|NCT03070470|12141856|P1|STARTED|Overall Study||10
4936852|NCT03070431|12141883|P1|NOT COMPLETED|Overall Study||4
4936853|NCT03070431|12141883|P1|COMPLETED|Overall Study||40
4936854|NCT03070431|12141883|P1|STARTED|Overall Study||44
4936855|NCT03070236|12141898|P1|NOT COMPLETED|Overall Study||0
4936856|NCT03070236|12141898|P1|COMPLETED|Overall Study||912
4936857|NCT03070236|12141898|P1|Active Surveillance (AS) Arm|Overall Study||374
4936858|NCT03070236|12141898|P1|Guideline Concordant Care (GCC) Arm|Overall Study||538
4936859|NCT03070236|12141898|P1|STARTED|Overall Study||912
4936860|NCT03070171|12141905|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
4936861|NCT03070171|12141906|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
4936862|NCT03070171|12141905|P2|COMPLETED|Treatment Period 4 + Washout||78
4936863|NCT03070171|12141906|P1|COMPLETED|Treatment Period 4 + Washout||80
4936864|NCT03070171|12141905|P2|STARTED|Treatment Period 4 + Washout||79
4936865|NCT03070171|12141906|P1|STARTED|Treatment Period 4 + Washout||80
4936866|NCT03070171|12141905|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
4936867|NCT03070171|12141906|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
4936868|NCT03070171|12141905|P2|COMPLETED|Treatment Period 3 + Washout||79
4936869|NCT03070171|12141906|P1|COMPLETED|Treatment Period 3 + Washout||80
4936870|NCT03070171|12141905|P2|STARTED|Treatment Period 3 + Washout||79
4936871|NCT03070171|12141906|P1|STARTED|Treatment Period 3 + Washout||80
4936872|NCT03070171|12141905|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
4936873|NCT03070171|12141906|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
4936874|NCT03070171|12141905|P2|COMPLETED|Treatment Period 2 + Washout||79
4936875|NCT03070171|12141906|P1|COMPLETED|Treatment Period 2 + Washout||80
4936876|NCT03070171|12141905|P2|STARTED|Treatment Period 2 + Washout||80
4936877|NCT03070171|12141906|P1|STARTED|Treatment Period 2 + Washout||80
4936878|NCT03070171|12141905|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
4936879|NCT03070171|12141906|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
4936880|NCT03070171|12141905|P2|COMPLETED|Treatment Period 1 + Washout||80
4936881|NCT03070171|12141906|P1|COMPLETED|Treatment Period 1 + Washout||80
4936882|NCT03070171|12141905|P2|STARTED|Treatment Period 1 + Washout||80
4936883|NCT03070171|12141906|P1|STARTED|Treatment Period 1 + Washout||80
4936884|NCT03070002|12141922|P1|NOT COMPLETED|Follow up for 2 Years||1
4936885|NCT03070002|12141922|P1|COMPLETED|Follow up for 2 Years||0
4936886|NCT03070002|12141922|P1|STARTED|Follow up for 2 Years||1
4936887|NCT03070002|12141922|P1|NOT COMPLETED|3 Cycles of Treatment||0
4936888|NCT03070002|12141922|P1|COMPLETED|3 Cycles of Treatment||1
4936889|NCT03070002|12141922|P1|STARTED|3 Cycles of Treatment||1
4936890|NCT03069989|12141930|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
4936891|NCT03069989|12141931|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
4936892|NCT03069989|12141930|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
4936893|NCT03069989|12141931|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
4936894|NCT03069989|12141930|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
4936895|NCT03069989|12141931|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
4936896|NCT03069989|12141930|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
4936897|NCT03069989|12141931|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
4936898|NCT03069989|12141930|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
4936899|NCT03069989|12141931|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
4936900|NCT03069989|12141930|P2|STARTED|Wash Out Period (Up to 28 Days))||5
4936901|NCT03069989|12141931|P1|STARTED|Wash Out Period (Up to 28 Days))||3
4936902|NCT03069989|12141930|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
4936903|NCT03069989|12141931|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
4936904|NCT03069989|12141930|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
4936905|NCT03069989|12141931|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
4936906|NCT03069989|12141930|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
4936907|NCT03069989|12141931|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
4936908|NCT03069677|12142019|P2|NOT COMPLETED|Overall Study||3
4936909|NCT03069677|12142020|P1|NOT COMPLETED|Overall Study||3
4936910|NCT03069677|12142019|P2|COMPLETED|Overall Study||77
4936911|NCT03069677|12142020|P1|COMPLETED|Overall Study||77
4936912|NCT03069677|12142019|P2|STARTED|Overall Study||80
4936913|NCT03069677|12142020|P1|STARTED|Overall Study||80
4936914|NCT03069482|12142038|P2|NOT COMPLETED|Overall Study||1
4936915|NCT03069482|12142039|P1|NOT COMPLETED|Overall Study||1
4936916|NCT03069482|12142038|P2|COMPLETED|Overall Study||28
4936917|NCT03069482|12142039|P1|COMPLETED|Overall Study||33
4936918|NCT03069482|12142038|P2|STARTED|Overall Study||29
4936919|NCT03069482|12142039|P1|STARTED|Overall Study||34
4936920|NCT03069365|12142149|P1|NOT COMPLETED|Overall Study||1
4936921|NCT03069365|12142149|P1|COMPLETED|Overall Study||100
4936922|NCT03069365|12142149|P1|STARTED|Overall Study||101
4936923|NCT03069352|12142157|P2|NOT COMPLETED|Overall Study||40
4936924|NCT03069352|12142158|P1|NOT COMPLETED|Overall Study||12
4936925|NCT03069352|12142157|P2|COMPLETED|Overall Study||103
4936926|NCT03069352|12142158|P1|COMPLETED|Overall Study||56
4936927|NCT03069352|12142157|P2|Received Treatment|Overall Study||142
4936928|NCT03069352|12142158|P1|Received Treatment|Overall Study||68
4936929|NCT03069352|12142157|P2|STARTED|Overall Study||143
4936930|NCT03069352|12142158|P1|STARTED|Overall Study||68
4936931|NCT03069313|12142200|P1|NOT COMPLETED|Overall Study||5
4936932|NCT03069313|12142200|P1|COMPLETED|Overall Study||36
4936933|NCT03069313|12142200|P1|STARTED|Overall Study||41
4936934|NCT03068767|12142209|P2|NOT COMPLETED|Overall Study||3
4936935|NCT03068767|12142210|P1|NOT COMPLETED|Overall Study||10
4936936|NCT03068767|12142209|P2|COMPLETED|Overall Study|December 2018|71
4936937|NCT03068767|12142210|P1|COMPLETED|Overall Study|December 2018|65
4936938|NCT03068767|12142209|P2|STARTED|Overall Study|from August 2017 to September 2018|74
4936939|NCT03068767|12142210|P1|STARTED|Overall Study|from August 2017 to September 2018|75
4936940|NCT03068611|12142220|P2|NOT COMPLETED|Overall Study||25
4936941|NCT03068611|12142221|P1|NOT COMPLETED|Overall Study||31
4936942|NCT03068611|12142220|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
4936943|NCT03068611|12142221|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
4936944|NCT03068611|12142220|P2|STARTED|Overall Study||58
4936945|NCT03068611|12142221|P1|STARTED|Overall Study||61
4936946|NCT03068312|12142235|P2|NOT COMPLETED|Overall Study||0
4936947|NCT03068312|12142236|P1|NOT COMPLETED|Overall Study||0
4936948|NCT03068312|12142235|P2|COMPLETED|Overall Study||19
4936949|NCT03068312|12142236|P1|COMPLETED|Overall Study||19
4936950|NCT03068312|12142235|P2|STARTED|Overall Study||19
4936951|NCT03068312|12142236|P1|STARTED|Overall Study||19
4936952|NCT03068091|12142242|P1|NOT COMPLETED|Overall Study||1
4936953|NCT03068091|12142242|P1|COMPLETED|Overall Study||24
4936954|NCT03068091|12142242|P1|STARTED|Overall Study||25
4936955|NCT03067987|12142249|P2|NOT COMPLETED|Overall Study||13
4936956|NCT03067987|12142250|P1|NOT COMPLETED|Overall Study||10
4936957|NCT03067987|12142249|P2|COMPLETED|Overall Study||40
4936958|NCT03067987|12142250|P1|COMPLETED|Overall Study||40
4936959|NCT03067987|12142249|P2|STARTED|Overall Study||53
4936960|NCT03067987|12142250|P1|STARTED|Overall Study||50
4936961|NCT03067948|12142262|P1|NOT COMPLETED|Overall Study||0
4936962|NCT03067948|12142262|P1|COMPLETED|Overall Study||32
4936963|NCT03067948|12142262|P1|STARTED|Overall Study||32
4936964|NCT03067506|12142267|P1|NOT COMPLETED|Overall Study||0
4936965|NCT03067506|12142267|P1|COMPLETED|Overall Study||30
4936966|NCT03067506|12142267|P1|STARTED|Overall Study||30
4936967|NCT03066999|12142276|P2|NOT COMPLETED|Overall Study||2
4936968|NCT03066999|12142277|P1|NOT COMPLETED|Overall Study||0
4936969|NCT03066999|12142276|P2|COMPLETED|Overall Study||1
4936970|NCT03066999|12142277|P1|COMPLETED|Overall Study||2
4936971|NCT03066999|12142276|P2|STARTED|Overall Study||3
4936972|NCT03066999|12142277|P1|STARTED|Overall Study||2
4936973|NCT03066622|12142297|P2|NOT COMPLETED|Overall Study||26
4936974|NCT03066622|12142298|P1|NOT COMPLETED|Overall Study||26
4936975|NCT03066622|12142297|P2|COMPLETED|Overall Study||35
4936976|NCT03066622|12142298|P1|COMPLETED|Overall Study||35
4936977|NCT03066622|12142297|P2|STARTED|Overall Study||61
4936978|NCT03066622|12142298|P1|STARTED|Overall Study||61
4936979|NCT03066609|12142311|P4|NOT COMPLETED|OVERALL STUDY||5
4936980|NCT03066609|12142312|P3|NOT COMPLETED|OVERALL STUDY||4
4936981|NCT03066609|12142313|P2|NOT COMPLETED|OVERALL STUDY||8
4936982|NCT03066609|12142314|P1|NOT COMPLETED|OVERALL STUDY||10
4936983|NCT03066609|12142311|P4|COMPLETED|OVERALL STUDY||124
4936984|NCT03066609|12142312|P3|COMPLETED|OVERALL STUDY||2
4936985|NCT03066609|12142313|P2|COMPLETED|OVERALL STUDY||264
4936986|NCT03066609|12142314|P1|COMPLETED|OVERALL STUDY||126
4936987|NCT03066609|12142311|P4|STARTED|OVERALL STUDY||129
4936988|NCT03066609|12142312|P3|STARTED|OVERALL STUDY||6
4936989|NCT03066609|12142313|P2|STARTED|OVERALL STUDY||272
4936990|NCT03066609|12142314|P1|STARTED|OVERALL STUDY||136
4936991|NCT03066609|12142311|P4|NOT COMPLETED|MAINTENANCE||3
4936992|NCT03066609|12142312|P3|NOT COMPLETED|MAINTENANCE||2
4936993|NCT03066609|12142313|P2|NOT COMPLETED|MAINTENANCE||4
4936994|NCT03066609|12142314|P1|NOT COMPLETED|MAINTENANCE||7
4936995|NCT03066609|12142311|P4|COMPLETED|MAINTENANCE||126
4936996|NCT03066609|12142312|P3|COMPLETED|MAINTENANCE||2
4936997|NCT03066609|12142313|P2|COMPLETED|MAINTENANCE||266
4936998|NCT03066609|12142314|P1|COMPLETED|MAINTENANCE||127
4936999|NCT03066609|12142311|P4|STARTED|MAINTENANCE||129
4937000|NCT03066609|12142312|P3|STARTED|MAINTENANCE||4
4937001|NCT03066609|12142313|P2|STARTED|MAINTENANCE||270
4937002|NCT03066609|12142314|P1|STARTED|MAINTENANCE||134
4937003|NCT03066609|12142311|P4|NOT COMPLETED|INDUCTION||0
4937004|NCT03066609|12142312|P3|NOT COMPLETED|INDUCTION||2
4937005|NCT03066609|12142313|P2|NOT COMPLETED|INDUCTION||2
4937006|NCT03066609|12142314|P1|NOT COMPLETED|INDUCTION||2
4937007|NCT03066609|12142311|P4|COMPLETED|INDUCTION||0
4937008|NCT03066609|12142312|P3|COMPLETED|INDUCTION||133
4937009|NCT03066609|12142313|P2|COMPLETED|INDUCTION||270
4937010|NCT03066609|12142314|P1|COMPLETED|INDUCTION||134
4937011|NCT03066609|12142311|P4|STARTED|INDUCTION||0
4937012|NCT03066609|12142312|P3|STARTED|INDUCTION||135
4937013|NCT03066609|12142313|P2|STARTED|INDUCTION||272
4937014|NCT03066609|12142314|P1|STARTED|INDUCTION||136
4937015|NCT03066193|12142344|P1|NOT COMPLETED|Overall Study||1
4937016|NCT03066193|12142344|P1|COMPLETED|Overall Study||16
4937017|NCT03066193|12142344|P1|STARTED|Overall Study||17
4937018|NCT03066102|12142348|P1|NOT COMPLETED|Overall Study||0
4937019|NCT03066102|12142348|P1|COMPLETED|Overall Study||30
4937020|NCT03066102|12142348|P1|STARTED|Overall Study||30
4937021|NCT03065933|12142357|P1|NOT COMPLETED|Overall Study||5
4937022|NCT03065933|12142357|P1|COMPLETED|Overall Study||0
4937023|NCT03065933|12142357|P1|STARTED|Overall Study||5
4937024|NCT03065530|12142365|P4|NOT COMPLETED|Overall Study||2
4937025|NCT03065530|12142366|P3|NOT COMPLETED|Overall Study||1
4937026|NCT03065530|12142367|P2|NOT COMPLETED|Overall Study||1
4937027|NCT03065530|12142368|P1|NOT COMPLETED|Overall Study||2
4937028|NCT03065530|12142365|P4|COMPLETED|Overall Study||28
4937029|NCT03065530|12142366|P3|COMPLETED|Overall Study||29
4937030|NCT03065530|12142367|P2|COMPLETED|Overall Study||29
4937031|NCT03065530|12142368|P1|COMPLETED|Overall Study||28
4937032|NCT03065530|12142365|P4|STARTED|Overall Study||30
4937033|NCT03065530|12142366|P3|STARTED|Overall Study||30
4937034|NCT03065530|12142367|P2|STARTED|Overall Study||30
4937035|NCT03065530|12142368|P1|STARTED|Overall Study||30
4937036|NCT03065283|12142447|P2|NOT COMPLETED|Overall Study||0
4937037|NCT03065283|12142448|P1|NOT COMPLETED|Overall Study||0
4937038|NCT03065283|12142447|P2|COMPLETED|Overall Study||25
4937039|NCT03065283|12142448|P1|COMPLETED|Overall Study||50
4937040|NCT03065283|12142447|P2|STARTED|Overall Study||25
4937041|NCT03065283|12142448|P1|STARTED|Overall Study||50
4937042|NCT03065205|12142454|P1|NOT COMPLETED|Overall Study||12
4937043|NCT03065205|12142454|P1|COMPLETED|Overall Study||53
4937044|NCT03065205|12142454|P1|STARTED|Overall Study||65
4937045|NCT03065075|12142463|P2|NOT COMPLETED|Overall Study||0
4937046|NCT03065075|12142464|P1|NOT COMPLETED|Overall Study||0
4937047|NCT03065075|12142463|P2|COMPLETED|Overall Study||76
4937048|NCT03065075|12142464|P1|COMPLETED|Overall Study||76
4937049|NCT03065075|12142463|P2|As-treated Analysis|Overall Study||77
4937050|NCT03065075|12142464|P1|As-treated Analysis|Overall Study||69
4937051|NCT03065075|12142463|P2|Intent-to-treat Analysis|Overall Study||74
4937052|NCT03065075|12142464|P1|Intent-to-treat Analysis|Overall Study||72
4937053|NCT03065075|12142463|P2|STARTED|Overall Study||76
4937054|NCT03065075|12142464|P1|STARTED|Overall Study||76
4937055|NCT03065023|12142476|P5|NOT COMPLETED|Overall Study||0
4937056|NCT03065023|12142477|P4|NOT COMPLETED|Overall Study||3
4937057|NCT03065023|12142478|P3|NOT COMPLETED|Overall Study||1
4937058|NCT03065023|12142479|P2|NOT COMPLETED|Overall Study||2
4937059|NCT03065023|12142480|P1|NOT COMPLETED|Overall Study||2
4937060|NCT03065023|12142476|P5|COMPLETED|Overall Study||0
4937061|NCT03065023|12142477|P4|COMPLETED|Overall Study||3
4937062|NCT03065023|12142478|P3|COMPLETED|Overall Study||2
4937063|NCT03065023|12142479|P2|COMPLETED|Overall Study||1
4937064|NCT03065023|12142480|P1|COMPLETED|Overall Study||1
4937065|NCT03065023|12142476|P5|STARTED|Overall Study|Group B not started for business reasons.|0
4937066|NCT03065023|12142477|P4|STARTED|Overall Study||6
4937067|NCT03065023|12142478|P3|STARTED|Overall Study||3
4937068|NCT03065023|12142479|P2|STARTED|Overall Study||3
4937069|NCT03065023|12142480|P1|STARTED|Overall Study||3
4937070|NCT03064841|12142546|P1|NOT COMPLETED|Overall Study||17
4937071|NCT03064841|12142546|P1|COMPLETED|Overall Study||1520
4937072|NCT03064841|12142546|P1|STARTED|Overall Study||1537
4937073|NCT03064451|12142561|P1|NOT COMPLETED|Overall Study||14
4937074|NCT03064451|12142561|P1|COMPLETED|Overall Study||46
4937075|NCT03064451|12142561|P1|Safety Population|Overall Study||52
4937076|NCT03064451|12142561|P1|STARTED|Overall Study||60
4937077|NCT03064126|12142579|P4|NOT COMPLETED|Overall Study||1
4937078|NCT03064126|12142580|P3|NOT COMPLETED|Overall Study||3
4937079|NCT03064126|12142581|P2|NOT COMPLETED|Overall Study||7
4937080|NCT03064126|12142582|P1|NOT COMPLETED|Overall Study||26
4937081|NCT03064126|12142579|P4|COMPLETED|Overall Study||11
4937082|NCT03064126|12142580|P3|COMPLETED|Overall Study||49
4937083|NCT03064126|12142581|P2|COMPLETED|Overall Study||91
4937084|NCT03064126|12142582|P1|COMPLETED|Overall Study||252
4937085|NCT03064126|12142579|P4|STARTED|Overall Study||12
4937086|NCT03064126|12142580|P3|STARTED|Overall Study||52
4937087|NCT03064126|12142581|P2|STARTED|Overall Study||98
4937088|NCT03064126|12142582|P1|STARTED|Overall Study||278
4937089|NCT03064113|12142631|P4|NOT COMPLETED|Washout (7 Days)||0
4937090|NCT03064113|12142632|P3|NOT COMPLETED|Washout (7 Days)||0
4937091|NCT03064113|12142633|P2|NOT COMPLETED|Washout (7 Days)||0
4937092|NCT03064113|12142634|P1|NOT COMPLETED|Washout (7 Days)||0
4937093|NCT03064113|12142631|P4|COMPLETED|Washout (7 Days)||8
4937094|NCT03064113|12142632|P3|COMPLETED|Washout (7 Days)||8
4937095|NCT03064113|12142633|P2|COMPLETED|Washout (7 Days)||8
4937096|NCT03064113|12142634|P1|COMPLETED|Washout (7 Days)||8
4937097|NCT03064113|12142631|P4|STARTED|Washout (7 Days)||8
4937098|NCT03064113|12142632|P3|STARTED|Washout (7 Days)||8
4937099|NCT03064113|12142633|P2|STARTED|Washout (7 Days)||8
4937100|NCT03064113|12142634|P1|STARTED|Washout (7 Days)||8
4937101|NCT03064113|12142631|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
4937102|NCT03064113|12142632|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
4937103|NCT03064113|12142633|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
4937104|NCT03064113|12142634|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
4937105|NCT03064113|12142631|P4|COMPLETED|Intervention 4 (2 Days)||8
4937106|NCT03064113|12142632|P3|COMPLETED|Intervention 4 (2 Days)||8
4937107|NCT03064113|12142633|P2|COMPLETED|Intervention 4 (2 Days)||8
4937108|NCT03064113|12142634|P1|COMPLETED|Intervention 4 (2 Days)||8
4937109|NCT03064113|12142631|P4|STARTED|Intervention 4 (2 Days)||8
4937110|NCT03064113|12142632|P3|STARTED|Intervention 4 (2 Days)||8
4937111|NCT03064113|12142633|P2|STARTED|Intervention 4 (2 Days)||8
4937112|NCT03064113|12142634|P1|STARTED|Intervention 4 (2 Days)||8
4937113|NCT03064113|12142631|P4|NOT COMPLETED|Washout (7 Days)||0
4937114|NCT03064113|12142632|P3|NOT COMPLETED|Washout (7 Days)||0
4937115|NCT03064113|12142633|P2|NOT COMPLETED|Washout (7 Days)||0
4937116|NCT03064113|12142634|P1|NOT COMPLETED|Washout (7 Days)||0
4937117|NCT03064113|12142631|P4|COMPLETED|Washout (7 Days)||8
4937118|NCT03064113|12142632|P3|COMPLETED|Washout (7 Days)||8
4937119|NCT03064113|12142633|P2|COMPLETED|Washout (7 Days)||8
4937120|NCT03064113|12142634|P1|COMPLETED|Washout (7 Days)||8
4937121|NCT03064113|12142631|P4|STARTED|Washout (7 Days)||8
4937122|NCT03064113|12142632|P3|STARTED|Washout (7 Days)||8
4937123|NCT03064113|12142633|P2|STARTED|Washout (7 Days)||8
4937124|NCT03064113|12142634|P1|STARTED|Washout (7 Days)||8
4937125|NCT03064113|12142631|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
4937126|NCT03064113|12142632|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
4937127|NCT03064113|12142633|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
4937128|NCT03064113|12142634|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
4937129|NCT03064113|12142631|P4|COMPLETED|Intervention 3 (2 Days)||8
4937130|NCT03064113|12142632|P3|COMPLETED|Intervention 3 (2 Days)||8
4937131|NCT03064113|12142633|P2|COMPLETED|Intervention 3 (2 Days)||8
4937132|NCT03064113|12142634|P1|COMPLETED|Intervention 3 (2 Days)||8
4937133|NCT03064113|12142631|P4|STARTED|Intervention 3 (2 Days)||8
4937134|NCT03064113|12142632|P3|STARTED|Intervention 3 (2 Days)||8
4937135|NCT03064113|12142633|P2|STARTED|Intervention 3 (2 Days)||8
4937136|NCT03064113|12142634|P1|STARTED|Intervention 3 (2 Days)||8
4937137|NCT03064113|12142631|P4|NOT COMPLETED|Washout (7 Days)||0
4937138|NCT03064113|12142632|P3|NOT COMPLETED|Washout (7 Days)||0
4937139|NCT03064113|12142633|P2|NOT COMPLETED|Washout (7 Days)||0
4937140|NCT03064113|12142634|P1|NOT COMPLETED|Washout (7 Days)||0
4937141|NCT03064113|12142631|P4|COMPLETED|Washout (7 Days)||8
4937142|NCT03064113|12142632|P3|COMPLETED|Washout (7 Days)||8
4937143|NCT03064113|12142633|P2|COMPLETED|Washout (7 Days)||8
4937144|NCT03064113|12142634|P1|COMPLETED|Washout (7 Days)||8
4937145|NCT03064113|12142631|P4|STARTED|Washout (7 Days)||8
4937146|NCT03064113|12142632|P3|STARTED|Washout (7 Days)||8
4937147|NCT03064113|12142633|P2|STARTED|Washout (7 Days)||8
4937148|NCT03064113|12142634|P1|STARTED|Washout (7 Days)||8
4937149|NCT03064113|12142631|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
4937150|NCT03064113|12142632|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
4937151|NCT03064113|12142633|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
4937152|NCT03064113|12142634|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
4937153|NCT03064113|12142631|P4|COMPLETED|Intervention 2 (2 Days)||8
4937154|NCT03064113|12142632|P3|COMPLETED|Intervention 2 (2 Days)||8
4937155|NCT03064113|12142633|P2|COMPLETED|Intervention 2 (2 Days)||8
4937156|NCT03064113|12142634|P1|COMPLETED|Intervention 2 (2 Days)||8
4937157|NCT03064113|12142631|P4|STARTED|Intervention 2 (2 Days)||8
4937158|NCT03064113|12142632|P3|STARTED|Intervention 2 (2 Days)||8
4937159|NCT03064113|12142633|P2|STARTED|Intervention 2 (2 Days)||8
4937160|NCT03064113|12142634|P1|STARTED|Intervention 2 (2 Days)||8
4937161|NCT03064113|12142631|P4|NOT COMPLETED|Washout (7 Days)||0
4937162|NCT03064113|12142632|P3|NOT COMPLETED|Washout (7 Days)||0
4937163|NCT03064113|12142633|P2|NOT COMPLETED|Washout (7 Days)||0
4937164|NCT03064113|12142634|P1|NOT COMPLETED|Washout (7 Days)||0
4937165|NCT03064113|12142631|P4|COMPLETED|Washout (7 Days)||8
4937166|NCT03064113|12142632|P3|COMPLETED|Washout (7 Days)||8
4937167|NCT03064113|12142633|P2|COMPLETED|Washout (7 Days)||8
4937168|NCT03064113|12142634|P1|COMPLETED|Washout (7 Days)||8
4937169|NCT03064113|12142631|P4|STARTED|Washout (7 Days)||8
4937170|NCT03064113|12142632|P3|STARTED|Washout (7 Days)||8
4937171|NCT03064113|12142633|P2|STARTED|Washout (7 Days)||8
4937172|NCT03064113|12142634|P1|STARTED|Washout (7 Days)||8
4937173|NCT03064113|12142631|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
4937174|NCT03064113|12142632|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
4937175|NCT03064113|12142633|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
4937176|NCT03064113|12142634|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
4937177|NCT03064113|12142631|P4|COMPLETED|Intervention 1 (2 Days)||8
4937178|NCT03064113|12142632|P3|COMPLETED|Intervention 1 (2 Days)||8
4937179|NCT03064113|12142633|P2|COMPLETED|Intervention 1 (2 Days)||8
4937180|NCT03064113|12142634|P1|COMPLETED|Intervention 1 (2 Days)||8
4937181|NCT03064113|12142631|P4|STARTED|Intervention 1 (2 Days)||8
4937182|NCT03064113|12142632|P3|STARTED|Intervention 1 (2 Days)||8
4937183|NCT03064113|12142633|P2|STARTED|Intervention 1 (2 Days)||8
4937184|NCT03064113|12142634|P1|STARTED|Intervention 1 (2 Days)||8
4937185|NCT03063476|12142668|P1|NOT COMPLETED|Overall Study||0
4937186|NCT03063476|12142668|P1|COMPLETED|Overall Study||2
4937187|NCT03063476|12142668|P1|STARTED|Overall Study||2
4937188|NCT03063437|12142675|P2|NOT COMPLETED|Overall Study||0
4937189|NCT03063437|12142676|P1|NOT COMPLETED|Overall Study||0
4937190|NCT03063437|12142675|P2|COMPLETED|Overall Study||5
4937191|NCT03063437|12142676|P1|COMPLETED|Overall Study||4
4937192|NCT03063437|12142675|P2|STARTED|Overall Study||5
4937193|NCT03063437|12142676|P1|STARTED|Overall Study||4
4937194|NCT03063385|12142704|P2|NOT COMPLETED|Overall Study||76
4937195|NCT03063385|12142705|P1|NOT COMPLETED|Overall Study||87
4937196|NCT03063385|12142704|P2|COMPLETED|Overall Study||254
4937197|NCT03063385|12142705|P1|COMPLETED|Overall Study||243
4937198|NCT03063385|12142704|P2|12-month Follow-up|Overall Study||254
4937199|NCT03063385|12142705|P1|12-month Follow-up|Overall Study||243
4937200|NCT03063385|12142704|P2|6-month Follow-up|Overall Study||259
4937201|NCT03063385|12142705|P1|6-month Follow-up|Overall Study||265
4937202|NCT03063385|12142704|P2|3-month Follow-up|Overall Study||259
4937203|NCT03063385|12142705|P1|3-month Follow-up|Overall Study||257
4937204|NCT03063385|12142704|P2|STARTED|Overall Study||330
4937205|NCT03063385|12142705|P1|STARTED|Overall Study||330
4937206|NCT03063086|12142715|P6|NOT COMPLETED|Overall Study||1
4937207|NCT03063086|12142716|P5|NOT COMPLETED|Overall Study||0
4937208|NCT03063086|12142717|P4|NOT COMPLETED|Overall Study||3
4937209|NCT03063086|12142718|P3|NOT COMPLETED|Overall Study||1
4937210|NCT03063086|12142719|P2|NOT COMPLETED|Overall Study||1
4937211|NCT03063086|12142720|P1|NOT COMPLETED|Overall Study||3
4937212|NCT03063086|12142715|P6|COMPLETED|Overall Study||18
4937213|NCT03063086|12142716|P5|COMPLETED|Overall Study||20
4937214|NCT03063086|12142717|P4|COMPLETED|Overall Study||17
4937215|NCT03063086|12142718|P3|COMPLETED|Overall Study||17
4937216|NCT03063086|12142719|P2|COMPLETED|Overall Study||19
4937217|NCT03063086|12142720|P1|COMPLETED|Overall Study||16
4937218|NCT03063086|12142715|P6|STARTED|Overall Study||19
4937219|NCT03063086|12142716|P5|STARTED|Overall Study||20
4937220|NCT03063086|12142717|P4|STARTED|Overall Study||20
4937221|NCT03063086|12142718|P3|STARTED|Overall Study||18
4937222|NCT03063086|12142719|P2|STARTED|Overall Study||20
4937223|NCT03063086|12142720|P1|STARTED|Overall Study||19
4937224|NCT03062917|12142748|P5|NOT COMPLETED|Overall Study||0
4937225|NCT03062917|12142749|P4|NOT COMPLETED|Overall Study||0
4937226|NCT03062917|12142750|P3|NOT COMPLETED|Overall Study||0
4937227|NCT03062917|12142751|P2|NOT COMPLETED|Overall Study||0
4937228|NCT03062917|12142752|P1|NOT COMPLETED|Overall Study||0
4937229|NCT03062917|12142748|P5|COMPLETED|Overall Study||0
4937230|NCT03062917|12142749|P4|COMPLETED|Overall Study||20
4937231|NCT03062917|12142750|P3|COMPLETED|Overall Study||49
4937232|NCT03062917|12142751|P2|COMPLETED|Overall Study||51
4937233|NCT03062917|12142752|P1|COMPLETED|Overall Study||32
4937234|NCT03062917|12142748|P5|STARTED|Overall Study||0
4937235|NCT03062917|12142749|P4|STARTED|Overall Study||20
4937236|NCT03062917|12142750|P3|STARTED|Overall Study||49
4937237|NCT03062917|12142751|P2|STARTED|Overall Study||51
4937238|NCT03062917|12142752|P1|STARTED|Overall Study||32
4937239|NCT03062891|12142766|P2|NOT COMPLETED|Overall Study||38
4937240|NCT03062891|12142767|P1|NOT COMPLETED|Overall Study||52
4937241|NCT03062891|12142766|P2|COMPLETED|Overall Study||62
4937242|NCT03062891|12142767|P1|COMPLETED|Overall Study||47
4937243|NCT03062891|12142766|P2|Followup|Overall Study||62
4937244|NCT03062891|12142767|P1|Followup|Overall Study||47
4937245|NCT03062891|12142766|P2|End of Intervention|Overall Study||78
4937246|NCT03062891|12142767|P1|End of Intervention|Overall Study||67
4937247|NCT03062891|12142766|P2|Mid-intervention|Overall Study||74
4937248|NCT03062891|12142767|P1|Mid-intervention|Overall Study||68
4937249|NCT03062891|12142766|P2|STARTED|Overall Study||100
4937250|NCT03062891|12142767|P1|STARTED|Overall Study||99
4937251|NCT03062605|12142812|P2|NOT COMPLETED|Overall Study||10
4937252|NCT03062605|12142813|P1|NOT COMPLETED|Overall Study||11
4937253|NCT03062605|12142812|P2|COMPLETED|Overall Study||13
4937254|NCT03062605|12142813|P1|COMPLETED|Overall Study||14
4937255|NCT03062605|12142812|P2|STARTED|Overall Study||23
4937256|NCT03062605|12142813|P1|STARTED|Overall Study||25
4937257|NCT03062488|12142822|P3|NOT COMPLETED|Overall Study||0
4937258|NCT03062488|12142823|P2|NOT COMPLETED|Overall Study||0
4937259|NCT03062488|12142824|P1|NOT COMPLETED|Overall Study||0
4937260|NCT03062488|12142822|P3|COMPLETED|Overall Study||41
4937261|NCT03062488|12142823|P2|COMPLETED|Overall Study||51
4937262|NCT03062488|12142824|P1|COMPLETED|Overall Study||51
4937263|NCT03062488|12142822|P3|STARTED|Overall Study||41
4937264|NCT03062488|12142823|P2|STARTED|Overall Study||51
4937265|NCT03062488|12142824|P1|STARTED|Overall Study||51
4937266|NCT03062228|12142838|P1|NOT COMPLETED|Overall Study||0
4937267|NCT03062228|12142838|P1|COMPLETED|Overall Study||162
4937268|NCT03062228|12142838|P1|STARTED|Overall Study||162
4937269|NCT03061513|12142851|P2|NOT COMPLETED|Overall Study||1
4937270|NCT03061513|12142852|P1|NOT COMPLETED|Overall Study||0
4937271|NCT03061513|12142851|P2|COMPLETED|Overall Study||4
4937272|NCT03061513|12142852|P1|COMPLETED|Overall Study||6
4937273|NCT03061513|12142851|P2|STARTED|Overall Study||5
4937274|NCT03061513|12142852|P1|STARTED|Overall Study||6
4937275|NCT03061331|12142862|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4937276|NCT03061331|12142863|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4937277|NCT03061331|12142862|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
4937278|NCT03061331|12142863|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
4937279|NCT03061331|12142862|P2|STARTED|Treatment Period 2 (8 Weeks)||9
4937280|NCT03061331|12142863|P1|STARTED|Treatment Period 2 (8 Weeks)||8
4937281|NCT03061331|12142862|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
4937282|NCT03061331|12142863|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
4937283|NCT03061331|12142862|P2|COMPLETED|Washout Period (8 Weeks)||9
4937284|NCT03061331|12142863|P1|COMPLETED|Washout Period (8 Weeks)||8
4937285|NCT03061331|12142862|P2|STARTED|Washout Period (8 Weeks)||10
4937286|NCT03061331|12142863|P1|STARTED|Washout Period (8 Weeks)||10
4937287|NCT03061331|12142862|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
4937288|NCT03061331|12142863|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
4937289|NCT03061331|12142862|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
4937290|NCT03061331|12142863|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
4937291|NCT03061331|12142862|P2|STARTED|Treatment Period 1 (8 Weeks)||10
4937292|NCT03061331|12142863|P1|STARTED|Treatment Period 1 (8 Weeks)||10
4937293|NCT03061279|12142871|P2|NOT COMPLETED|Overall Study||1
4937294|NCT03061279|12142872|P1|NOT COMPLETED|Overall Study||0
4937295|NCT03061279|12142871|P2|COMPLETED|Overall Study||0
4937296|NCT03061279|12142872|P1|COMPLETED|Overall Study||0
4937297|NCT03061279|12142871|P2|STARTED|Overall Study||1
4937298|NCT03061279|12142872|P1|STARTED|Overall Study||0
4937299|NCT03061214|12142893|P3|NOT COMPLETED|Overall Study||10
4937300|NCT03061214|12142894|P2|NOT COMPLETED|Overall Study||28
4937301|NCT03061214|12142895|P1|NOT COMPLETED|Overall Study||25
4937302|NCT03061214|12142893|P3|COMPLETED|Overall Study||280
4937303|NCT03061214|12142894|P2|COMPLETED|Overall Study||262
4937304|NCT03061214|12142895|P1|COMPLETED|Overall Study||263
4937305|NCT03061214|12142893|P3|Safety Analysis Set (SAS)|Overall Study||290
4937306|NCT03061214|12142894|P2|Safety Analysis Set (SAS)|Overall Study||290
4937307|NCT03061214|12142895|P1|Safety Analysis Set (SAS)|Overall Study||287
4937308|NCT03061214|12142893|P3|Full Analysis Set (FAS)|Overall Study||290
4937309|NCT03061214|12142894|P2|Full Analysis Set (FAS)|Overall Study||290
4937310|NCT03061214|12142895|P1|Full Analysis Set (FAS)|Overall Study||288
4937311|NCT03061214|12142893|P3|Exposed|Overall Study||290
4937312|NCT03061214|12142894|P2|Exposed|Overall Study||290
4937313|NCT03061214|12142895|P1|Exposed|Overall Study||287
4937314|NCT03061214|12142893|P3|STARTED|Overall Study||290
4937315|NCT03061214|12142894|P2|STARTED|Overall Study||290
4937316|NCT03061214|12142895|P1|STARTED|Overall Study||288
4937317|NCT03061175|12143119|P2|NOT COMPLETED|Followup 2 at 6 Months||7
4937318|NCT03061175|12143120|P1|NOT COMPLETED|Followup 2 at 6 Months||4
4937319|NCT03061175|12143119|P2|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
4937320|NCT03061175|12143120|P1|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
4937321|NCT03061175|12143119|P2|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
4937322|NCT03061175|12143120|P1|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
4937323|NCT03061175|12143119|P2|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
4937324|NCT03061175|12143120|P1|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
4937325|NCT03061175|12143119|P2|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
4937326|NCT03061175|12143120|P1|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
4937327|NCT03061175|12143119|P2|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
4937328|NCT03061175|12143120|P1|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
4937329|NCT03061175|12143119|P2|NOT COMPLETED|Baseline||0
4937330|NCT03061175|12143120|P1|NOT COMPLETED|Baseline||1
4937331|NCT03061175|12143119|P2|COMPLETED|Baseline||47
4937332|NCT03061175|12143120|P1|COMPLETED|Baseline||46
4937333|NCT03061175|12143119|P2|STARTED|Baseline||47
4937334|NCT03061175|12143120|P1|STARTED|Baseline||47
4937335|NCT03060759|12143144|P2|NOT COMPLETED|Overall Study||3
4937336|NCT03060759|12143145|P1|NOT COMPLETED|Overall Study||5
4937337|NCT03060759|12143144|P2|COMPLETED|Overall Study||12
4937338|NCT03060759|12143145|P1|COMPLETED|Overall Study||15
4937339|NCT03060759|12143144|P2|STARTED|Overall Study||15
4937340|NCT03060759|12143145|P1|STARTED|Overall Study||20
4937341|NCT03060512|12143153|P2|NOT COMPLETED|Overall Study||9
4937342|NCT03060512|12143154|P1|NOT COMPLETED|Overall Study||7
4937343|NCT03060512|12143153|P2|COMPLETED|Overall Study||130
4937344|NCT03060512|12143154|P1|COMPLETED|Overall Study||130
4937345|NCT03060512|12143153|P2|Treated With PEG 3350|Overall Study||138
4937346|NCT03060512|12143154|P1|Treated With PEG 3350|Overall Study||130
4937347|NCT03060512|12143153|P2|Treated With Movantik|Overall Study||135
4937348|NCT03060512|12143154|P1|Treated With Movantik|Overall Study||136
4937349|NCT03060512|12143153|P2|STARTED|Overall Study||139
4937350|NCT03060512|12143154|P1|STARTED|Overall Study||137
4937351|NCT03060486|12143171|P1|NOT COMPLETED|Overall Study||0
4937352|NCT03060486|12143171|P1|COMPLETED|Overall Study||15
4937353|NCT03060486|12143171|P1|STARTED|Overall Study||15
4937354|NCT03059901|12143177|P2|NOT COMPLETED|Overall Study||2
4937355|NCT03059901|12143178|P1|NOT COMPLETED|Overall Study||4
4937356|NCT03059901|12143177|P2|COMPLETED|Overall Study||28
4937357|NCT03059901|12143178|P1|COMPLETED|Overall Study||26
4937358|NCT03059901|12143177|P2|STARTED|Overall Study||30
4937359|NCT03059901|12143178|P1|STARTED|Overall Study||30
4937360|NCT03059810|12143184|P1|NOT COMPLETED|Overall Study||0
4937361|NCT03059810|12143184|P1|COMPLETED|Overall Study||63
4937362|NCT03059810|12143184|P1|STARTED|Overall Study||63
4937363|NCT03058991|12143191|P3|NOT COMPLETED|Overall Study||12
4937364|NCT03058991|12143192|P2|NOT COMPLETED|Overall Study||12
4937365|NCT03058991|12143193|P1|NOT COMPLETED|Overall Study||18
4937366|NCT03058991|12143191|P3|COMPLETED|Overall Study||25
4937367|NCT03058991|12143192|P2|COMPLETED|Overall Study||20
4937368|NCT03058991|12143193|P1|COMPLETED|Overall Study||21
4937369|NCT03058991|12143191|P3|1-Week Follow Up|Overall Study||28
4937370|NCT03058991|12143192|P2|1-Week Follow Up|Overall Study||27
4937371|NCT03058991|12143193|P1|1-Week Follow Up|Overall Study||23
4937372|NCT03058991|12143191|P3|STARTED|Overall Study||37
4937373|NCT03058991|12143192|P2|STARTED|Overall Study||32
4937374|NCT03058991|12143193|P1|STARTED|Overall Study||39
4937375|NCT03058705|12143219|P1|NOT COMPLETED|Overall Study||4
4937376|NCT03058705|12143219|P1|COMPLETED|Overall Study||6
4937377|NCT03058705|12143219|P1|STARTED|Overall Study||10
4937378|NCT03058692|12143225|P2|NOT COMPLETED|Overall Study||2
4937379|NCT03058692|12143226|P1|NOT COMPLETED|Overall Study||3
4937380|NCT03058692|12143225|P2|COMPLETED|Overall Study||57
4937381|NCT03058692|12143226|P1|COMPLETED|Overall Study||58
4937382|NCT03058692|12143225|P2|STARTED|Overall Study||59
4937383|NCT03058692|12143226|P1|STARTED|Overall Study||61
4937384|NCT03057704|12143340|P2|NOT COMPLETED|Overall Study||0
4937385|NCT03057704|12143341|P1|NOT COMPLETED|Overall Study||0
4937386|NCT03057704|12143340|P2|COMPLETED|Overall Study||25
4937387|NCT03057704|12143341|P1|COMPLETED|Overall Study||25
4937388|NCT03057704|12143340|P2|STARTED|Overall Study||25
4937389|NCT03057704|12143341|P1|STARTED|Overall Study||25
4937390|NCT03057366|12143351|P3|NOT COMPLETED|Part B||0
4937391|NCT03057366|12143352|P2|NOT COMPLETED|Part B||0
4937392|NCT03057366|12143353|P1|NOT COMPLETED|Part B||0
4937393|NCT03057366|12143351|P3|COMPLETED|Part B||2
4937394|NCT03057366|12143352|P2|COMPLETED|Part B||5
4937395|NCT03057366|12143353|P1|COMPLETED|Part B||0
4937396|NCT03057366|12143351|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
4937397|NCT03057366|12143352|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
4937398|NCT03057366|12143353|P1|STARTED|Part B||0
4937399|NCT03057366|12143351|P3|NOT COMPLETED|Part A||0
4937400|NCT03057366|12143352|P2|NOT COMPLETED|Part A||0
4937401|NCT03057366|12143353|P1|NOT COMPLETED|Part A||0
4937402|NCT03057366|12143351|P3|COMPLETED|Part A||0
4937403|NCT03057366|12143352|P2|COMPLETED|Part A||0
4937404|NCT03057366|12143353|P1|COMPLETED|Part A||8
4937405|NCT03057366|12143351|P3|STARTED|Part A||0
4937406|NCT03057366|12143352|P2|STARTED|Part A||0
4937407|NCT03057366|12143353|P1|STARTED|Part A||8
4937408|NCT03057132|12143376|P1|NOT COMPLETED|Overall Study||0
4937409|NCT03057132|12143376|P1|COMPLETED|Overall Study||1
4937410|NCT03057132|12143376|P1|STARTED|Overall Study||1
4937411|NCT03056573|12143383|P2|NOT COMPLETED|Overall Study||5
4937412|NCT03056573|12143384|P1|NOT COMPLETED|Overall Study||5
4937413|NCT03056573|12143383|P2|COMPLETED|Overall Study||14
4937414|NCT03056573|12143384|P1|COMPLETED|Overall Study||40
4937415|NCT03056573|12143383|P2|STARTED|Overall Study||19
4937416|NCT03056573|12143384|P1|STARTED|Overall Study||45
4937417|NCT03056456|12143428|P4|NOT COMPLETED|Period 4||0
4937418|NCT03056456|12143429|P3|NOT COMPLETED|Period 4||0
4937419|NCT03056456|12143430|P2|NOT COMPLETED|Period 4||0
4937420|NCT03056456|12143431|P1|NOT COMPLETED|Period 4||0
4937421|NCT03056456|12143428|P4|COMPLETED|Period 4||5
4937422|NCT03056456|12143429|P3|COMPLETED|Period 4||6
4937423|NCT03056456|12143430|P2|COMPLETED|Period 4||6
4937424|NCT03056456|12143431|P1|COMPLETED|Period 4||6
4937425|NCT03056456|12143428|P4|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
4937426|NCT03056456|12143429|P3|STARTED|Period 4||6
4937427|NCT03056456|12143430|P2|STARTED|Period 4||6
4937428|NCT03056456|12143431|P1|STARTED|Period 4||6
4937429|NCT03056456|12143428|P4|NOT COMPLETED|Period 3||0
4937430|NCT03056456|12143429|P3|NOT COMPLETED|Period 3||0
4937431|NCT03056456|12143430|P2|NOT COMPLETED|Period 3||0
4937432|NCT03056456|12143431|P1|NOT COMPLETED|Period 3||0
4937433|NCT03056456|12143428|P4|COMPLETED|Period 3||6
4937434|NCT03056456|12143429|P3|COMPLETED|Period 3||6
4937435|NCT03056456|12143430|P2|COMPLETED|Period 3||6
4937436|NCT03056456|12143431|P1|COMPLETED|Period 3||6
4937437|NCT03056456|12143428|P4|STARTED|Period 3||6
4937438|NCT03056456|12143429|P3|STARTED|Period 3||6
4937439|NCT03056456|12143430|P2|STARTED|Period 3||6
4937440|NCT03056456|12143431|P1|STARTED|Period 3||6
4937441|NCT03056456|12143428|P4|NOT COMPLETED|Period 2||0
4937442|NCT03056456|12143429|P3|NOT COMPLETED|Period 2||0
4937443|NCT03056456|12143430|P2|NOT COMPLETED|Period 2||0
4937444|NCT03056456|12143431|P1|NOT COMPLETED|Period 2||0
4937445|NCT03056456|12143428|P4|COMPLETED|Period 2||6
4937446|NCT03056456|12143429|P3|COMPLETED|Period 2||6
4937447|NCT03056456|12143430|P2|COMPLETED|Period 2||6
4937448|NCT03056456|12143431|P1|COMPLETED|Period 2||6
4937449|NCT03056456|12143428|P4|STARTED|Period 2||6
4937450|NCT03056456|12143429|P3|STARTED|Period 2||6
4937451|NCT03056456|12143430|P2|STARTED|Period 2||6
4937452|NCT03056456|12143431|P1|STARTED|Period 2||6
4937453|NCT03056456|12143428|P4|NOT COMPLETED|Period 1||0
4937454|NCT03056456|12143429|P3|NOT COMPLETED|Period 1||0
4937455|NCT03056456|12143430|P2|NOT COMPLETED|Period 1||0
4937456|NCT03056456|12143431|P1|NOT COMPLETED|Period 1||0
4937457|NCT03056456|12143428|P4|COMPLETED|Period 1||6
4937458|NCT03056456|12143429|P3|COMPLETED|Period 1||6
4937459|NCT03056456|12143430|P2|COMPLETED|Period 1||6
4937460|NCT03056456|12143431|P1|COMPLETED|Period 1||6
4937461|NCT03056456|12143428|P4|Received One Dose of Study Drug|Period 1||6
4937462|NCT03056456|12143429|P3|Received One Dose of Study Drug|Period 1||6
4937463|NCT03056456|12143430|P2|Received One Dose of Study Drug|Period 1||6
4937464|NCT03056456|12143431|P1|Received One Dose of Study Drug|Period 1||6
4937465|NCT03056456|12143428|P4|STARTED|Period 1||6
4937466|NCT03056456|12143429|P3|STARTED|Period 1||6
4937467|NCT03056456|12143430|P2|STARTED|Period 1||6
4937468|NCT03056456|12143431|P1|STARTED|Period 1||6
4937469|NCT03056352|12143444|P1|NOT COMPLETED|Overall Study||1
4937470|NCT03056352|12143444|P1|COMPLETED|Overall Study||20
4937471|NCT03056352|12143444|P1|STARTED|Overall Study||21
4937472|NCT03056300|12143450|P1|NOT COMPLETED|Overall Study||3
4937473|NCT03056300|12143450|P1|COMPLETED|Overall Study||47
4937474|NCT03056300|12143450|P1|STARTED|Overall Study||50
4937475|NCT03056144|12143455|P1|NOT COMPLETED|Overall Study||0
4937476|NCT03056144|12143455|P1|COMPLETED|Overall Study||1
4937477|NCT03056144|12143455|P1|STARTED|Overall Study||1
4937478|NCT03056040|12143467|P2|NOT COMPLETED|Extension Period||95
4937479|NCT03056040|12143468|P1|NOT COMPLETED|Extension Period||96
4937480|NCT03056040|12143467|P2|COMPLETED|Extension Period||0
4937481|NCT03056040|12143468|P1|COMPLETED|Extension Period||0
4937482|NCT03056040|12143467|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
4937483|NCT03056040|12143468|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
4937484|NCT03056040|12143467|P2|STARTED|Extension Period||95
4937485|NCT03056040|12143468|P1|STARTED|Extension Period||96
4937486|NCT03056040|12143467|P2|NOT COMPLETED|Primary Evaluation Period||3
4937487|NCT03056040|12143468|P1|NOT COMPLETED|Primary Evaluation Period||1
4937488|NCT03056040|12143467|P2|COMPLETED|Primary Evaluation Period||95
4937489|NCT03056040|12143468|P1|COMPLETED|Primary Evaluation Period||96
4937490|NCT03056040|12143467|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
4937491|NCT03056040|12143468|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
4937492|NCT03056040|12143467|P2|STARTED|Primary Evaluation Period||98
4937493|NCT03056040|12143468|P1|STARTED|Primary Evaluation Period||97
4937494|NCT03055988|12143482|P2|NOT COMPLETED|Period 2||2
4937495|NCT03055988|12143483|P1|NOT COMPLETED|Period 2||1
4937496|NCT03055988|12143482|P2|COMPLETED|Period 2||31
4937497|NCT03055988|12143483|P1|COMPLETED|Period 2||36
4937498|NCT03055988|12143482|P2|STARTED|Period 2||33
4937499|NCT03055988|12143483|P1|STARTED|Period 2||37
4937500|NCT03055988|12143482|P2|NOT COMPLETED|Period 1||5
4937501|NCT03055988|12143483|P1|NOT COMPLETED|Period 1||1
4937502|NCT03055988|12143482|P2|COMPLETED|Period 1||33
4937503|NCT03055988|12143483|P1|COMPLETED|Period 1||37
4937504|NCT03055988|12143482|P2|STARTED|Period 1||38
4937505|NCT03055988|12143483|P1|STARTED|Period 1||38
4937506|NCT03055832|12143507|P2|NOT COMPLETED|Week 4||0
4937507|NCT03055832|12143508|P1|NOT COMPLETED|Week 4||0
4937508|NCT03055832|12143507|P2|COMPLETED|Week 4||71
4937509|NCT03055832|12143508|P1|COMPLETED|Week 4||70
4937510|NCT03055832|12143507|P2|STARTED|Week 4||71
4937511|NCT03055832|12143508|P1|STARTED|Week 4||70
4937512|NCT03055832|12143507|P2|NOT COMPLETED|Week 2||0
4937513|NCT03055832|12143508|P1|NOT COMPLETED|Week 2||1
4937514|NCT03055832|12143507|P2|COMPLETED|Week 2||71
4937515|NCT03055832|12143508|P1|COMPLETED|Week 2||70
4937516|NCT03055832|12143507|P2|STARTED|Week 2||71
4937517|NCT03055832|12143508|P1|STARTED|Week 2||71
4937518|NCT03055832|12143507|P2|NOT COMPLETED|Day 1||0
4937519|NCT03055832|12143508|P1|NOT COMPLETED|Day 1||0
4937520|NCT03055832|12143507|P2|COMPLETED|Day 1||71
4937521|NCT03055832|12143508|P1|COMPLETED|Day 1||71
4937522|NCT03055832|12143507|P2|STARTED|Day 1||71
4937523|NCT03055832|12143508|P1|STARTED|Day 1||71
4937524|NCT03055832|12143507|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
4937525|NCT03055832|12143508|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
4937526|NCT03055832|12143507|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
4937527|NCT03055832|12143508|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
4937528|NCT03055832|12143507|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
4937529|NCT03055832|12143508|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
4937530|NCT03055832|12143507|P2|NOT COMPLETED|Baseline||0
4937531|NCT03055832|12143508|P1|NOT COMPLETED|Baseline||0
4937532|NCT03055832|12143507|P2|COMPLETED|Baseline||71
4937533|NCT03055832|12143508|P1|COMPLETED|Baseline||71
4937534|NCT03055832|12143507|P2|STARTED|Baseline||71
4937535|NCT03055832|12143508|P1|STARTED|Baseline||71
4937536|NCT03055806|12143568|P4|NOT COMPLETED|Overall Study||15
4937537|NCT03055806|12143569|P3|NOT COMPLETED|Overall Study||13
4937538|NCT03055806|12143570|P2|NOT COMPLETED|Overall Study||7
4937539|NCT03055806|12143571|P1|NOT COMPLETED|Overall Study||6
4937540|NCT03055806|12143568|P4|COMPLETED|Overall Study||57
4937541|NCT03055806|12143569|P3|COMPLETED|Overall Study||58
4937542|NCT03055806|12143570|P2|COMPLETED|Overall Study||41
4937543|NCT03055806|12143571|P1|COMPLETED|Overall Study||42
4937544|NCT03055806|12143568|P4|STARTED|Overall Study||72
4937545|NCT03055806|12143569|P3|STARTED|Overall Study||71
4937546|NCT03055806|12143570|P2|STARTED|Overall Study||48
4937547|NCT03055806|12143571|P1|STARTED|Overall Study||48
4937548|NCT03055624|12143613|P1|NOT COMPLETED|Overall Study||9
4937549|NCT03055624|12143613|P1|COMPLETED|Overall Study||0
4937550|NCT03055624|12143613|P1|STARTED|Overall Study||9
4937551|NCT03055494|12143624|P2|NOT COMPLETED|Overall Study||1
4937552|NCT03055494|12143625|P1|NOT COMPLETED|Overall Study||10
4937553|NCT03055494|12143624|P2|COMPLETED|Overall Study||27
4937554|NCT03055494|12143625|P1|COMPLETED|Overall Study||44
4937555|NCT03055494|12143624|P2|STARTED|Overall Study||28
4937556|NCT03055494|12143625|P1|STARTED|Overall Study||54
4937557|NCT03055338|12143656|P3|NOT COMPLETED|Overall Study||12
4937558|NCT03055338|12143657|P2|NOT COMPLETED|Overall Study||11
4937559|NCT03055338|12143658|P1|NOT COMPLETED|Overall Study||18
4937560|NCT03055338|12143656|P3|COMPLETED|Overall Study||77
4937561|NCT03055338|12143657|P2|COMPLETED|Overall Study||34
4937562|NCT03055338|12143658|P1|COMPLETED|Overall Study||72
4937563|NCT03055338|12143656|P3|STARTED|Overall Study||89
4937564|NCT03055338|12143657|P2|STARTED|Overall Study||45
4937565|NCT03055338|12143658|P1|STARTED|Overall Study||90
4937566|NCT03055260|12143677|P2|NOT COMPLETED|Overall Study||0
4937567|NCT03055260|12143678|P1|NOT COMPLETED|Overall Study||1
4937568|NCT03055260|12143677|P2|COMPLETED|Overall Study||0
4937569|NCT03055260|12143678|P1|COMPLETED|Overall Study||7
4937570|NCT03055260|12143677|P2|STARTED|Overall Study||0
4937571|NCT03055260|12143678|P1|STARTED|Overall Study||8
4937572|NCT03055221|12143686|P1|NOT COMPLETED|Overall Study||16
4937573|NCT03055221|12143686|P1|COMPLETED|Overall Study||0
4937574|NCT03055221|12143686|P1|STARTED|Overall Study||16
4937575|NCT03055195|12143693|P2|NOT COMPLETED|Overall Study||14
4937576|NCT03055195|12143694|P1|NOT COMPLETED|Overall Study||12
4937577|NCT03055195|12143693|P2|COMPLETED|Overall Study||4
4937578|NCT03055195|12143694|P1|COMPLETED|Overall Study||4
4937579|NCT03055195|12143693|P2|STARTED|Overall Study||18
4937580|NCT03055195|12143694|P1|STARTED|Overall Study||16
4937581|NCT03054922|12143749|P3|NOT COMPLETED|Overall Study||0
4937582|NCT03054922|12143750|P2|NOT COMPLETED|Overall Study||0
4937583|NCT03054922|12143751|P1|NOT COMPLETED|Overall Study||0
4937584|NCT03054922|12143749|P3|COMPLETED|Overall Study||20
4937585|NCT03054922|12143750|P2|COMPLETED|Overall Study||19
4937586|NCT03054922|12143751|P1|COMPLETED|Overall Study||20
4937587|NCT03054922|12143749|P3|STARTED|Overall Study||20
4937588|NCT03054922|12143750|P2|STARTED|Overall Study||19
4937589|NCT03054922|12143751|P1|STARTED|Overall Study||20
4937590|NCT03054857|12143773|P2|NOT COMPLETED|Overall Study||0
4937591|NCT03054857|12143774|P1|NOT COMPLETED|Overall Study||1
4937592|NCT03054857|12143773|P2|COMPLETED|Overall Study||50
4937593|NCT03054857|12143774|P1|COMPLETED|Overall Study||49
4937594|NCT03054857|12143773|P2|STARTED|Overall Study||50
4937595|NCT03054857|12143774|P1|STARTED|Overall Study||50
4937596|NCT03054844|12143790|P2|NOT COMPLETED|Overall Study||1
4937597|NCT03054844|12143791|P1|NOT COMPLETED|Overall Study||3
4937598|NCT03054844|12143790|P2|COMPLETED|Overall Study||26
4937599|NCT03054844|12143791|P1|COMPLETED|Overall Study||25
4937600|NCT03054844|12143790|P2|STARTED|Overall Study||27
4937601|NCT03054844|12143791|P1|STARTED|Overall Study||28
4937602|NCT03054805|12143810|P3|NOT COMPLETED|Overall Study||2
4937603|NCT03054805|12143811|P2|NOT COMPLETED|Overall Study||10
4937604|NCT03054805|12143812|P1|NOT COMPLETED|Overall Study||16
4937605|NCT03054805|12143810|P3|COMPLETED|Overall Study||42
4937606|NCT03054805|12143811|P2|COMPLETED|Overall Study||41
4937607|NCT03054805|12143812|P1|COMPLETED|Overall Study||42
4937608|NCT03054805|12143810|P3|STARTED|Overall Study||44
4937609|NCT03054805|12143811|P2|STARTED|Overall Study||51
4937610|NCT03054805|12143812|P1|STARTED|Overall Study||58
4937611|NCT03054740|12143822|P2|NOT COMPLETED|Overall Study||0
4937612|NCT03054740|12143823|P1|NOT COMPLETED|Overall Study||0
4937613|NCT03054740|12143822|P2|COMPLETED|Overall Study||15
4937614|NCT03054740|12143823|P1|COMPLETED|Overall Study||15
4937615|NCT03054740|12143822|P2|STARTED|Overall Study||15
4937616|NCT03054740|12143823|P1|STARTED|Overall Study||15
4937617|NCT03054649|12143837|P2|NOT COMPLETED|Overall Study||0
4937618|NCT03054649|12143838|P1|NOT COMPLETED|Overall Study||0
4937619|NCT03054649|12143837|P2|COMPLETED|Overall Study||27
4937620|NCT03054649|12143838|P1|COMPLETED|Overall Study||27
4937621|NCT03054649|12143837|P2|STARTED|Overall Study||27
4937622|NCT03054649|12143838|P1|STARTED|Overall Study||27
4937623|NCT03054506|12143895|P3|NOT COMPLETED|Overall Study||0
4937624|NCT03054506|12143896|P2|NOT COMPLETED|Overall Study||0
4937625|NCT03054506|12143897|P1|NOT COMPLETED|Overall Study||1
4937626|NCT03054506|12143895|P3|COMPLETED|Overall Study||9
4937627|NCT03054506|12143896|P2|COMPLETED|Overall Study||11
4937628|NCT03054506|12143897|P1|COMPLETED|Overall Study||19
4937629|NCT03054506|12143895|P3|STARTED|Overall Study||9
4937630|NCT03054506|12143896|P2|STARTED|Overall Study||11
4937631|NCT03054506|12143897|P1|STARTED|Overall Study||20
4937632|NCT03054428|12143941|P3|NOT COMPLETED|Overall Study||79
4937633|NCT03054428|12143942|P2|NOT COMPLETED|Overall Study||80
4937634|NCT03054428|12143943|P1|NOT COMPLETED|Overall Study||83
4937635|NCT03054428|12143941|P3|COMPLETED|Overall Study||3
4937636|NCT03054428|12143942|P2|COMPLETED|Overall Study||4
4937637|NCT03054428|12143943|P1|COMPLETED|Overall Study||2
4937638|NCT03054428|12143941|P3|Completed Week 28 (End of Study)|Overall Study||3
4937639|NCT03054428|12143942|P2|Completed Week 28 (End of Study)|Overall Study||4
4937640|NCT03054428|12143943|P1|Completed Week 28 (End of Study)|Overall Study||2
4937641|NCT03054428|12143941|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
4937642|NCT03054428|12143942|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
4937643|NCT03054428|12143943|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
4937644|NCT03054428|12143941|P3|STARTED|Overall Study||82
4937645|NCT03054428|12143942|P2|STARTED|Overall Study||84
4937646|NCT03054428|12143943|P1|STARTED|Overall Study||85
4937647|NCT03054103|12144011|P3|NOT COMPLETED|Overall Study||0
4937648|NCT03054103|12144012|P2|NOT COMPLETED|Overall Study||0
4937649|NCT03054103|12144013|P1|NOT COMPLETED|Overall Study||0
4937650|NCT03054103|12144011|P3|COMPLETED|Overall Study||35
4937651|NCT03054103|12144012|P2|COMPLETED|Overall Study||29
4937652|NCT03054103|12144013|P1|COMPLETED|Overall Study||41
4937653|NCT03054103|12144011|P3|STARTED|Overall Study||35
4937654|NCT03054103|12144012|P2|STARTED|Overall Study||29
4937655|NCT03054103|12144013|P1|STARTED|Overall Study||41
4937656|NCT03054077|12144032|P2|NOT COMPLETED|Overall Study||0
4937657|NCT03054077|12144033|P1|NOT COMPLETED|Overall Study||0
4937658|NCT03054077|12144032|P2|COMPLETED|Overall Study||12
4937659|NCT03054077|12144033|P1|COMPLETED|Overall Study||12
4937660|NCT03054077|12144032|P2|STARTED|Overall Study||12
4937661|NCT03054077|12144033|P1|STARTED|Overall Study||12
4937662|NCT03054064|12144039|P1|NOT COMPLETED|Overall Study||6
4937663|NCT03054064|12144039|P1|COMPLETED|Overall Study||42
4937664|NCT03054064|12144039|P1|Screen Failure|Overall Study||2
4937665|NCT03054064|12144039|P1|STARTED|Overall Study||48
4937666|NCT03054051|12144049|P2|NOT COMPLETED|Overall Study||0
4937667|NCT03054051|12144050|P1|NOT COMPLETED|Overall Study||0
4937668|NCT03054051|12144049|P2|COMPLETED|Overall Study||30
4937669|NCT03054051|12144050|P1|COMPLETED|Overall Study||30
4937670|NCT03054051|12144049|P2|STARTED|Overall Study||30
4937671|NCT03054051|12144050|P1|STARTED|Overall Study||30
4937672|NCT03053960|12144079|P1|NOT COMPLETED|Overall Study||0
4937673|NCT03053960|12144079|P1|COMPLETED|Overall Study||8
4937674|NCT03053960|12144079|P1|STARTED|Overall Study||8
4937675|NCT03053427|12144086|P2|NOT COMPLETED|Overall Study||16
4937676|NCT03053427|12144087|P1|NOT COMPLETED|Overall Study||13
4937677|NCT03053427|12144086|P2|COMPLETED|Overall Study||173
4937678|NCT03053427|12144087|P1|COMPLETED|Overall Study||173
4937679|NCT03053427|12144086|P2|STARTED|Overall Study||189
4937680|NCT03053427|12144087|P1|STARTED|Overall Study||186
4937681|NCT03053180|12144109|P1|NOT COMPLETED|Overall Study||1
4937682|NCT03053180|12144109|P1|COMPLETED|Overall Study||59
4937683|NCT03053180|12144109|P1|STARTED|Overall Study||60
4937684|NCT03053063|12144121|P4|NOT COMPLETED|Open-Label Phase||23
4937685|NCT03053063|12144122|P3|NOT COMPLETED|Open-Label Phase||0
4937686|NCT03053063|12144123|P2|NOT COMPLETED|Open-Label Phase||0
4937687|NCT03053063|12144124|P1|NOT COMPLETED|Open-Label Phase||0
4937688|NCT03053063|12144121|P4|COMPLETED|Open-Label Phase||0
4937689|NCT03053063|12144122|P3|COMPLETED|Open-Label Phase||0
4937690|NCT03053063|12144123|P2|COMPLETED|Open-Label Phase||0
4937691|NCT03053063|12144124|P1|COMPLETED|Open-Label Phase||0
4937692|NCT03053063|12144121|P4|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
4937693|NCT03053063|12144122|P3|STARTED|Open-Label Phase||0
4937694|NCT03053063|12144123|P2|STARTED|Open-Label Phase||0
4937695|NCT03053063|12144124|P1|STARTED|Open-Label Phase||0
4937696|NCT03053063|12144121|P4|NOT COMPLETED|Randomized Phase||0
4937697|NCT03053063|12144122|P3|NOT COMPLETED|Randomized Phase||174
4937698|NCT03053063|12144123|P2|NOT COMPLETED|Randomized Phase||354
4937699|NCT03053063|12144124|P1|NOT COMPLETED|Randomized Phase||355
4937700|NCT03053063|12144121|P4|COMPLETED|Randomized Phase||0
4937701|NCT03053063|12144122|P3|COMPLETED|Randomized Phase||0
4937702|NCT03053063|12144123|P2|COMPLETED|Randomized Phase||0
4937703|NCT03053063|12144124|P1|COMPLETED|Randomized Phase||0
4937704|NCT03053063|12144121|P4|STARTED|Randomized Phase||0
4937705|NCT03053063|12144122|P3|STARTED|Randomized Phase||174
4937706|NCT03053063|12144123|P2|STARTED|Randomized Phase||354
4937707|NCT03053063|12144124|P1|STARTED|Randomized Phase||355
4937708|NCT03053050|12144154|P4|NOT COMPLETED|Open-label Phase||99
4937709|NCT03053050|12144155|P3|NOT COMPLETED|Open-label Phase||0
4937710|NCT03053050|12144156|P2|NOT COMPLETED|Open-label Phase||0
4937711|NCT03053050|12144157|P1|NOT COMPLETED|Open-label Phase||0
4937712|NCT03053050|12144154|P4|COMPLETED|Open-label Phase||0
4937713|NCT03053050|12144155|P3|COMPLETED|Open-label Phase||0
4937714|NCT03053050|12144156|P2|COMPLETED|Open-label Phase||0
4937715|NCT03053050|12144157|P1|COMPLETED|Open-label Phase||0
4937716|NCT03053050|12144154|P4|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
4937717|NCT03053050|12144155|P3|STARTED|Open-label Phase||0
4937718|NCT03053050|12144156|P2|STARTED|Open-label Phase||0
4937719|NCT03053050|12144157|P1|STARTED|Open-label Phase||0
4937720|NCT03053050|12144154|P4|NOT COMPLETED|Randomized Phase||0
4937721|NCT03053050|12144155|P3|NOT COMPLETED|Randomized Phase||161
4937722|NCT03053050|12144156|P2|NOT COMPLETED|Randomized Phase||323
4937723|NCT03053050|12144157|P1|NOT COMPLETED|Randomized Phase||324
4937724|NCT03053050|12144154|P4|COMPLETED|Randomized Phase||0
4937725|NCT03053050|12144155|P3|COMPLETED|Randomized Phase||0
4937726|NCT03053050|12144156|P2|COMPLETED|Randomized Phase||0
4937727|NCT03053050|12144157|P1|COMPLETED|Randomized Phase||0
4937728|NCT03053050|12144154|P4|STARTED|Randomized Phase||0
4937729|NCT03053050|12144155|P3|STARTED|Randomized Phase||161
4937730|NCT03053050|12144156|P2|STARTED|Randomized Phase||323
4937731|NCT03053050|12144157|P1|STARTED|Randomized Phase||324
4937732|NCT03052764|12144189|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
4937733|NCT03052764|12144190|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
4937734|NCT03052764|12144189|P2|COMPLETED|Open-Label Re-Treatment Period||33
4937735|NCT03052764|12144190|P1|COMPLETED|Open-Label Re-Treatment Period||58
4937736|NCT03052764|12144189|P2|STARTED|Open-Label Re-Treatment Period||33
4937737|NCT03052764|12144190|P1|STARTED|Open-Label Re-Treatment Period||58
4937738|NCT03052764|12144189|P2|NOT COMPLETED|Double-Blind Treatment Period||3
4937739|NCT03052764|12144190|P1|NOT COMPLETED|Double-Blind Treatment Period||10
4937740|NCT03052764|12144189|P2|COMPLETED|Double-Blind Treatment Period||37
4937741|NCT03052764|12144190|P1|COMPLETED|Double-Blind Treatment Period||70
4937742|NCT03052764|12144189|P2|mITT|Double-Blind Treatment Period||39
4937743|NCT03052764|12144190|P1|mITT|Double-Blind Treatment Period||78
4937744|NCT03052764|12144189|P2|STARTED|Double-Blind Treatment Period||40
4937745|NCT03052764|12144190|P1|STARTED|Double-Blind Treatment Period||80
4937746|NCT03052725|12144210|P2|NOT COMPLETED|Overall Study||150
4937747|NCT03052725|12144211|P1|NOT COMPLETED|Overall Study||148
4937748|NCT03052725|12144210|P2|COMPLETED|Overall Study||47
4937749|NCT03052725|12144211|P1|COMPLETED|Overall Study||46
4937750|NCT03052725|12144210|P2|Safety Analysis Set|Overall Study||196
4937751|NCT03052725|12144211|P1|Safety Analysis Set|Overall Study||194
4937752|NCT03052725|12144210|P2|STARTED|Overall Study||197
4937753|NCT03052725|12144211|P1|STARTED|Overall Study||194
4937754|NCT03052530|12144248|P1|NOT COMPLETED|Overall Study||0
4937755|NCT03052530|12144248|P1|COMPLETED|Overall Study||61
4937756|NCT03052530|12144248|P1|STARTED|Overall Study||61
4937757|NCT03052426|12144258|P3|NOT COMPLETED|Overall Study||1
4937758|NCT03052426|12144259|P2|NOT COMPLETED|Overall Study||1
4937759|NCT03052426|12144260|P1|NOT COMPLETED|Overall Study||2
4937760|NCT03052426|12144258|P3|COMPLETED|Overall Study||5
4937761|NCT03052426|12144259|P2|COMPLETED|Overall Study||5
4937762|NCT03052426|12144260|P1|COMPLETED|Overall Study||4
4937763|NCT03052426|12144258|P3|STARTED|Overall Study||6
4937764|NCT03052426|12144259|P2|STARTED|Overall Study||6
4937765|NCT03052426|12144260|P1|STARTED|Overall Study||6
4937766|NCT03052322|12144275|P2|NOT COMPLETED|Overall Study||32
4937767|NCT03052322|12144276|P1|NOT COMPLETED|Overall Study||21
4937768|NCT03052322|12144275|P2|COMPLETED|Overall Study||113
4937769|NCT03052322|12144276|P1|COMPLETED|Overall Study||122
4937770|NCT03052322|12144275|P2|STARTED|Overall Study||145
4937771|NCT03052322|12144276|P1|STARTED|Overall Study||143
4937772|NCT03051646|12144328|P2|NOT COMPLETED|Overall Study||0
4937773|NCT03051646|12144329|P1|NOT COMPLETED|Overall Study||0
4937774|NCT03051646|12144328|P2|COMPLETED|Overall Study||6
4937775|NCT03051646|12144329|P1|COMPLETED|Overall Study||6
4937776|NCT03051646|12144328|P2|STARTED|Overall Study||6
4937777|NCT03051646|12144329|P1|STARTED|Overall Study||6
4937778|NCT03051607|12144337|P1|NOT COMPLETED|Overall Study||66
4937779|NCT03051607|12144337|P1|COMPLETED|Overall Study||0
4937780|NCT03051607|12144337|P1|STARTED|Overall Study||66
4937781|NCT03051217|12144347|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
4937782|NCT03051217|12144348|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
4937783|NCT03051217|12144349|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
4937784|NCT03051217|12144350|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
4937785|NCT03051217|12144351|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937786|NCT03051217|12144352|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937787|NCT03051217|12144353|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937788|NCT03051217|12144347|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
4937789|NCT03051217|12144348|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
4937790|NCT03051217|12144349|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
4937791|NCT03051217|12144350|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
4937792|NCT03051217|12144351|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937793|NCT03051217|12144352|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937794|NCT03051217|12144353|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
4937795|NCT03051217|12144347|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
4937796|NCT03051217|12144348|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
4937797|NCT03051217|12144349|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
4937798|NCT03051217|12144350|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
4937799|NCT03051217|12144351|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
4937800|NCT03051217|12144352|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
4937801|NCT03051217|12144353|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
4937802|NCT03051217|12144347|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
4937803|NCT03051217|12144348|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
4937804|NCT03051217|12144349|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
4937805|NCT03051217|12144350|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
4937806|NCT03051217|12144351|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
4937807|NCT03051217|12144352|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
4937808|NCT03051217|12144353|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
4937809|NCT03051217|12144347|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
4937810|NCT03051217|12144348|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
4937811|NCT03051217|12144349|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
4937812|NCT03051217|12144350|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
4937813|NCT03051217|12144351|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
4937814|NCT03051217|12144352|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
4937815|NCT03051217|12144353|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
4937816|NCT03051217|12144347|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
4937817|NCT03051217|12144348|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
4937818|NCT03051217|12144349|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
4937819|NCT03051217|12144350|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
4937820|NCT03051217|12144351|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
4937821|NCT03051217|12144352|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
4937822|NCT03051217|12144353|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
4937823|NCT03051217|12144347|P7|STARTED|Initial Period (Week 0 to Week 16)||0
4937824|NCT03051217|12144348|P6|STARTED|Initial Period (Week 0 to Week 16)||0
4937825|NCT03051217|12144349|P5|STARTED|Initial Period (Week 0 to Week 16)||0
4937826|NCT03051217|12144350|P4|STARTED|Initial Period (Week 0 to Week 16)||0
4937827|NCT03051217|12144351|P3|STARTED|Initial Period (Week 0 to Week 16)||53
4937828|NCT03051217|12144352|P2|STARTED|Initial Period (Week 0 to Week 16)||48
4937829|NCT03051217|12144353|P1|STARTED|Initial Period (Week 0 to Week 16)||26
4937830|NCT03051165|12144382|P1|NOT COMPLETED|Overall Study||13
4937831|NCT03051165|12144382|P1|COMPLETED|Overall Study||0
4937832|NCT03051165|12144382|P1|Completed Some Day 137 Assessments|Overall Study||0
4937833|NCT03051165|12144382|P1|Began HGNS Treatment Withdrawal|Overall Study||0
4937834|NCT03051165|12144382|P1|Completed Some Day 105 Assessments|Overall Study||1
4937835|NCT03051165|12144382|P1|Completed Some Baseline Assessments|Overall Study||1
4937836|NCT03051165|12144382|P1|STARTED|Overall Study||13
4937837|NCT03051100|12144396|P2|NOT COMPLETED|Overall Study||0
4937838|NCT03051100|12144397|P1|NOT COMPLETED|Overall Study||1
4937839|NCT03051100|12144396|P2|COMPLETED|Overall Study||43
4937840|NCT03051100|12144397|P1|COMPLETED|Overall Study||19
4937841|NCT03051100|12144396|P2|STARTED|Overall Study||43
4937842|NCT03051100|12144397|P1|STARTED|Overall Study||20
4937843|NCT03050918|12144413|P2|NOT COMPLETED|Overall Study||0
4937844|NCT03050918|12144414|P1|NOT COMPLETED|Overall Study||0
4937845|NCT03050918|12144413|P2|COMPLETED|Overall Study||1520
4937846|NCT03050918|12144414|P1|COMPLETED|Overall Study||1534
4937847|NCT03050918|12144413|P2|STARTED|Overall Study||1520
4937848|NCT03050918|12144414|P1|STARTED|Overall Study||1534
4937849|NCT03050775|12144436|P2|NOT COMPLETED|Overall Study||0
4937850|NCT03050775|12144437|P1|NOT COMPLETED|Overall Study||0
4937851|NCT03050775|12144436|P2|COMPLETED|Overall Study||35
4937852|NCT03050775|12144437|P1|COMPLETED|Overall Study||35
4937853|NCT03050775|12144436|P2|STARTED|Overall Study||35
4937854|NCT03050775|12144437|P1|STARTED|Overall Study||35
4937855|NCT03050697|12144455|P1|NOT COMPLETED|Overall Study||0
4937856|NCT03050697|12144455|P1|COMPLETED|Overall Study||12
4937857|NCT03050697|12144455|P1|STARTED|Overall Study||12
4937858|NCT03050619|12144492|P6|NOT COMPLETED|Overall Study||0
4937859|NCT03050619|12144493|P5|NOT COMPLETED|Overall Study||0
4937860|NCT03050619|12144494|P4|NOT COMPLETED|Overall Study||0
4937861|NCT03050619|12144495|P3|NOT COMPLETED|Overall Study||0
4937862|NCT03050619|12144496|P2|NOT COMPLETED|Overall Study||0
4937863|NCT03050619|12144497|P1|NOT COMPLETED|Overall Study||0
4937864|NCT03050619|12144492|P6|COMPLETED|Overall Study||1351
4937865|NCT03050619|12144493|P5|COMPLETED|Overall Study||6079
4937866|NCT03050619|12144494|P4|COMPLETED|Overall Study||14007
4937867|NCT03050619|12144495|P3|COMPLETED|Overall Study||6416
4937868|NCT03050619|12144496|P2|COMPLETED|Overall Study||3926
4937869|NCT03050619|12144497|P1|COMPLETED|Overall Study||129
4937870|NCT03050619|12144492|P6|STARTED|Overall Study||1351
4937871|NCT03050619|12144493|P5|STARTED|Overall Study||6079
4937872|NCT03050619|12144494|P4|STARTED|Overall Study||14007
4937873|NCT03050619|12144495|P3|STARTED|Overall Study||6416
4937874|NCT03050619|12144496|P2|STARTED|Overall Study||3926
4937875|NCT03050619|12144497|P1|STARTED|Overall Study||129
4937876|NCT03050541|12144634|P3|NOT COMPLETED|Overall Study||8
4937877|NCT03050541|12144635|P2|NOT COMPLETED|Overall Study||8
4937878|NCT03050541|12144636|P1|NOT COMPLETED|Overall Study||8
4937879|NCT03050541|12144634|P3|COMPLETED|Overall Study||20
4937880|NCT03050541|12144635|P2|COMPLETED|Overall Study||20
4937881|NCT03050541|12144636|P1|COMPLETED|Overall Study||20
4937882|NCT03050541|12144634|P3|STARTED|Overall Study||28
4937883|NCT03050541|12144635|P2|STARTED|Overall Study||28
4937884|NCT03050541|12144636|P1|STARTED|Overall Study||28
4937885|NCT03050398|12144647|P1|NOT COMPLETED|Overall Study||8
4937886|NCT03050398|12144647|P1|COMPLETED|Overall Study||0
4937887|NCT03050398|12144647|P1|STARTED|Overall Study||8
4937888|NCT03050372|12144652|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
4937889|NCT03050372|12144653|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
4937890|NCT03050372|12144652|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
4937891|NCT03050372|12144653|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
4937892|NCT03050372|12144652|P2|STARTED|Second Intervention (Nights #4 and #5)||6
4937893|NCT03050372|12144653|P1|STARTED|Second Intervention (Nights #4 and #5)||5
4937894|NCT03050372|12144652|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
4937895|NCT03050372|12144653|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
4937896|NCT03050372|12144652|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
4937897|NCT03050372|12144653|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
4937898|NCT03050372|12144652|P2|STARTED|First Intervention (Nights #2 and #3)||6
4937899|NCT03050372|12144653|P1|STARTED|First Intervention (Nights #2 and #3)||5
4937900|NCT03050372|12144652|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
4937901|NCT03050372|12144653|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
4937902|NCT03050372|12144652|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
4937903|NCT03050372|12144653|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
4937904|NCT03050372|12144652|P2|STARTED|Adaptation Night (Night #1 PSG)||6
4937905|NCT03050372|12144653|P1|STARTED|Adaptation Night (Night #1 PSG)||6
4937906|NCT03050359|12144676|P2|NOT COMPLETED|Overall Study||20
4937907|NCT03050359|12144677|P1|NOT COMPLETED|Overall Study||17
4937908|NCT03050359|12144676|P2|COMPLETED|Overall Study||248
4937909|NCT03050359|12144677|P1|COMPLETED|Overall Study||248
4937910|NCT03050359|12144676|P2|STARTED|Overall Study||268
4937911|NCT03050359|12144677|P1|STARTED|Overall Study||265
4937912|NCT03050320|12144691|P2|NOT COMPLETED|Overall Study||1
4937913|NCT03050320|12144692|P1|NOT COMPLETED|Overall Study||1
4937914|NCT03050320|12144691|P2|COMPLETED|Overall Study||21
4937915|NCT03050320|12144692|P1|COMPLETED|Overall Study||20
4937916|NCT03050320|12144691|P2|STARTED|Overall Study||22
4937917|NCT03050320|12144692|P1|STARTED|Overall Study||21
4937918|NCT03050294|12144726|P4|NOT COMPLETED|Overall Study||0
4937919|NCT03050294|12144727|P3|NOT COMPLETED|Overall Study||0
4937920|NCT03050294|12144728|P2|NOT COMPLETED|Overall Study||0
4937921|NCT03050294|12144729|P1|NOT COMPLETED|Overall Study||0
4937922|NCT03050294|12144726|P4|COMPLETED|Overall Study||6
4937923|NCT03050294|12144727|P3|COMPLETED|Overall Study||6
4937924|NCT03050294|12144728|P2|COMPLETED|Overall Study||6
4937925|NCT03050294|12144729|P1|COMPLETED|Overall Study||6
4937926|NCT03050294|12144726|P4|STARTED|Overall Study||6
4937927|NCT03050294|12144727|P3|STARTED|Overall Study||6
4937928|NCT03050294|12144728|P2|STARTED|Overall Study||6
4937929|NCT03050294|12144729|P1|STARTED|Overall Study||6
4937930|NCT03050203|12144753|P2|NOT COMPLETED|Overall Study||0
4937931|NCT03050203|12144754|P1|NOT COMPLETED|Overall Study||0
4937932|NCT03050203|12144753|P2|COMPLETED|Overall Study||18
4937933|NCT03050203|12144754|P1|COMPLETED|Overall Study||19
4937934|NCT03050203|12144753|P2|STARTED|Overall Study||18
4937935|NCT03050203|12144754|P1|STARTED|Overall Study||19
4937936|NCT03049852|12144763|P3|NOT COMPLETED|Overall Study||0
4937937|NCT03049852|12144764|P2|NOT COMPLETED|Overall Study||1
4937938|NCT03049852|12144765|P1|NOT COMPLETED|Overall Study||0
4937939|NCT03049852|12144763|P3|COMPLETED|Overall Study||26
4937940|NCT03049852|12144764|P2|COMPLETED|Overall Study||24
4937941|NCT03049852|12144765|P1|COMPLETED|Overall Study||24
4937942|NCT03049852|12144763|P3|STARTED|Overall Study||26
4937943|NCT03049852|12144764|P2|STARTED|Overall Study||25
4937944|NCT03049852|12144765|P1|STARTED|Overall Study||24
4937945|NCT03049748|12144777|P2|NOT COMPLETED|Overall Study||6
4937946|NCT03049748|12144778|P1|NOT COMPLETED|Overall Study||4
4937947|NCT03049748|12144777|P2|COMPLETED|Overall Study||14
4937948|NCT03049748|12144778|P1|COMPLETED|Overall Study||16
4937949|NCT03049748|12144777|P2|STARTED|Overall Study||20
4937950|NCT03049748|12144778|P1|STARTED|Overall Study||20
4937951|NCT03049501|12144796|P2|NOT COMPLETED|Overall Study||29
4937952|NCT03049501|12144797|P1|NOT COMPLETED|Overall Study||22
4937953|NCT03049501|12144796|P2|COMPLETED|Overall Study||92
4937954|NCT03049501|12144797|P1|COMPLETED|Overall Study||101
4937955|NCT03049501|12144796|P2|12 Month Follow up|Overall Study||92
4937956|NCT03049501|12144797|P1|12 Month Follow up|Overall Study||101
4937957|NCT03049501|12144796|P2|6 Month Follow up|Overall Study||91
4937958|NCT03049501|12144797|P1|6 Month Follow up|Overall Study||107
4937959|NCT03049501|12144796|P2|STARTED|Overall Study||121
4937960|NCT03049501|12144797|P1|STARTED|Overall Study||123
4937961|NCT03048383|12144816|P3|NOT COMPLETED|Overall Study||12
4937962|NCT03048383|12144817|P2|NOT COMPLETED|Overall Study||8
4937963|NCT03048383|12144818|P1|NOT COMPLETED|Overall Study||13
4937964|NCT03048383|12144816|P3|COMPLETED|Overall Study||10
4937965|NCT03048383|12144817|P2|COMPLETED|Overall Study||13
4937966|NCT03048383|12144818|P1|COMPLETED|Overall Study||15
4937967|NCT03048383|12144816|P3|STARTED|Overall Study||22
4937968|NCT03048383|12144817|P2|STARTED|Overall Study||21
4937969|NCT03048383|12144818|P1|STARTED|Overall Study||28
4937970|NCT03048058|12144831|P2|NOT COMPLETED|Overall Study||4
4937971|NCT03048058|12144832|P1|NOT COMPLETED|Overall Study||4
4937972|NCT03048058|12144831|P2|COMPLETED|Overall Study||6
4937973|NCT03048058|12144832|P1|COMPLETED|Overall Study||6
4937974|NCT03048058|12144831|P2|STARTED|Overall Study||10
4937975|NCT03048058|12144832|P1|STARTED|Overall Study||10
4937976|NCT03048006|12144850|P1|NOT COMPLETED|Overall Study||0
4937977|NCT03048006|12144850|P1|COMPLETED|Overall Study||44456
4937978|NCT03048006|12144850|P1|STARTED|Overall Study||44456
4937979|NCT03047551|12144858|P2|NOT COMPLETED|Overall Study||3
4937980|NCT03047551|12144859|P1|NOT COMPLETED|Overall Study||2
4937981|NCT03047551|12144858|P2|COMPLETED|Overall Study||312
4937982|NCT03047551|12144859|P1|COMPLETED|Overall Study||317
4937983|NCT03047551|12144858|P2|STARTED|Overall Study||315
4937984|NCT03047551|12144859|P1|STARTED|Overall Study||319
4937985|NCT03047447|12144870|P3|NOT COMPLETED|Overall Study||0
4937986|NCT03047447|12144871|P2|NOT COMPLETED|Overall Study||0
4937987|NCT03047447|12144872|P1|NOT COMPLETED|Overall Study||0
4937988|NCT03047447|12144870|P3|COMPLETED|Overall Study||10
4937989|NCT03047447|12144871|P2|COMPLETED|Overall Study||10
4937990|NCT03047447|12144872|P1|COMPLETED|Overall Study||10
4937991|NCT03047447|12144870|P3|STARTED|Overall Study||10
4937992|NCT03047447|12144871|P2|STARTED|Overall Study||10
4937993|NCT03047447|12144872|P1|STARTED|Overall Study||10
4937994|NCT03047174|12144894|P2|NOT COMPLETED|Overall Study||2
4937995|NCT03047174|12144895|P1|NOT COMPLETED|Overall Study||19
4937996|NCT03047174|12144894|P2|COMPLETED|Overall Study||27
4937997|NCT03047174|12144895|P1|COMPLETED|Overall Study||9
4937998|NCT03047174|12144894|P2|STARTED|Overall Study||29
4937999|NCT03047174|12144895|P1|STARTED|Overall Study||28
4938000|NCT03046472|12144925|P2|NOT COMPLETED|Overall Study||0
4938001|NCT03046472|12144926|P1|NOT COMPLETED|Overall Study||0
4938002|NCT03046472|12144925|P2|COMPLETED|Overall Study||17
4938003|NCT03046472|12144926|P1|COMPLETED|Overall Study||33
4938004|NCT03046472|12144925|P2|STARTED|Overall Study||17
4938005|NCT03046472|12144926|P1|STARTED|Overall Study||33
4938006|NCT03046446|12144936|P1|NOT COMPLETED|Overall Study||59
4938007|NCT03046446|12144936|P1|COMPLETED|Overall Study||149
4938008|NCT03046446|12144936|P1|Completed at Week 52|Overall Study||133
4938009|NCT03046446|12144936|P1|Completed at Week 24|Overall Study||6
4938010|NCT03046446|12144936|P1|Completed at Week 12|Overall Study||10
4938011|NCT03046446|12144936|P1|Second Injection|Overall Study||179
4938012|NCT03046446|12144936|P1|STARTED|Overall Study||208
4938013|NCT03046225|12144946|P2|NOT COMPLETED|Overall Study||0
4938014|NCT03046225|12144947|P1|NOT COMPLETED|Overall Study||0
4938015|NCT03046225|12144946|P2|COMPLETED|Overall Study||13
4938016|NCT03046225|12144947|P1|COMPLETED|Overall Study||13
4938017|NCT03046225|12144946|P2|STARTED|Overall Study||13
4938018|NCT03046225|12144947|P1|STARTED|Overall Study||13
4938019|NCT03046212|12144959|P2|NOT COMPLETED|Overall Study||0
4938020|NCT03046212|12144960|P1|NOT COMPLETED|Overall Study||0
4938021|NCT03046212|12144959|P2|COMPLETED|Overall Study||15
4938022|NCT03046212|12144960|P1|COMPLETED|Overall Study||15
4938023|NCT03046212|12144959|P2|STARTED|Overall Study||15
4938024|NCT03046212|12144960|P1|STARTED|Overall Study||15
4938025|NCT03045926|12144970|P1|NOT COMPLETED|Overall Study||0
4938026|NCT03045926|12144970|P1|COMPLETED|Overall Study||35
4938027|NCT03045926|12144970|P1|STARTED|Overall Study||35
4938028|NCT03045887|12144999|P10|NOT COMPLETED|Part B (14 Days)||0
4938029|NCT03045887|12145000|P9|NOT COMPLETED|Part B (14 Days)||0
4938030|NCT03045887|12145001|P8|NOT COMPLETED|Part B (14 Days)||0
4938031|NCT03045887|12145002|P7|NOT COMPLETED|Part B (14 Days)||0
4938032|NCT03045887|12145003|P6|NOT COMPLETED|Part B (14 Days)||0
4938033|NCT03045887|12145004|P5|NOT COMPLETED|Part B (14 Days)||0
4938034|NCT03045887|12145005|P4|NOT COMPLETED|Part B (14 Days)||0
4938035|NCT03045887|12145006|P3|NOT COMPLETED|Part B (14 Days)||0
4938036|NCT03045887|12145007|P2|NOT COMPLETED|Part B (14 Days)||0
4938037|NCT03045887|12145008|P1|NOT COMPLETED|Part B (14 Days)||0
4938038|NCT03045887|12144999|P10|COMPLETED|Part B (14 Days)||9
4938039|NCT03045887|12145000|P9|COMPLETED|Part B (14 Days)||3
4938040|NCT03045887|12145001|P8|COMPLETED|Part B (14 Days)||0
4938041|NCT03045887|12145002|P7|COMPLETED|Part B (14 Days)||0
4938042|NCT03045887|12145003|P6|COMPLETED|Part B (14 Days)||0
4938043|NCT03045887|12145004|P5|COMPLETED|Part B (14 Days)||0
4938044|NCT03045887|12145005|P4|COMPLETED|Part B (14 Days)||0
4938045|NCT03045887|12145006|P3|COMPLETED|Part B (14 Days)||0
4938046|NCT03045887|12145007|P2|COMPLETED|Part B (14 Days)||0
4938047|NCT03045887|12145008|P1|COMPLETED|Part B (14 Days)||0
4938048|NCT03045887|12144999|P10|STARTED|Part B (14 Days)||9
4938049|NCT03045887|12145000|P9|STARTED|Part B (14 Days)||3
4938050|NCT03045887|12145001|P8|STARTED|Part B (14 Days)||0
4938051|NCT03045887|12145002|P7|STARTED|Part B (14 Days)||0
4938052|NCT03045887|12145003|P6|STARTED|Part B (14 Days)||0
4938053|NCT03045887|12145004|P5|STARTED|Part B (14 Days)||0
4938054|NCT03045887|12145005|P4|STARTED|Part B (14 Days)||0
4938055|NCT03045887|12145006|P3|STARTED|Part B (14 Days)||0
4938056|NCT03045887|12145007|P2|STARTED|Part B (14 Days)||0
4938057|NCT03045887|12145008|P1|STARTED|Part B (14 Days)||0
4938058|NCT03045887|12144999|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938059|NCT03045887|12145000|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938060|NCT03045887|12145001|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938061|NCT03045887|12145002|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938062|NCT03045887|12145003|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938063|NCT03045887|12145004|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938064|NCT03045887|12145005|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938065|NCT03045887|12145006|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938066|NCT03045887|12145007|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938067|NCT03045887|12145008|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
4938068|NCT03045887|12144999|P10|COMPLETED|Part A, Period 3 (1 Day)||0
4938069|NCT03045887|12145000|P9|COMPLETED|Part A, Period 3 (1 Day)||0
4938070|NCT03045887|12145001|P8|COMPLETED|Part A, Period 3 (1 Day)||4
4938071|NCT03045887|12145002|P7|COMPLETED|Part A, Period 3 (1 Day)||4
4938072|NCT03045887|12145003|P6|COMPLETED|Part A, Period 3 (1 Day)||4
4938073|NCT03045887|12145004|P5|COMPLETED|Part A, Period 3 (1 Day)||4
4938074|NCT03045887|12145005|P4|COMPLETED|Part A, Period 3 (1 Day)||2
4938075|NCT03045887|12145006|P3|COMPLETED|Part A, Period 3 (1 Day)||4
4938076|NCT03045887|12145007|P2|COMPLETED|Part A, Period 3 (1 Day)||4
4938077|NCT03045887|12145008|P1|COMPLETED|Part A, Period 3 (1 Day)||3
4938078|NCT03045887|12144999|P10|STARTED|Part A, Period 3 (1 Day)||0
4938079|NCT03045887|12145000|P9|STARTED|Part A, Period 3 (1 Day)||0
4938080|NCT03045887|12145001|P8|STARTED|Part A, Period 3 (1 Day)||4
4938081|NCT03045887|12145002|P7|STARTED|Part A, Period 3 (1 Day)||4
4938082|NCT03045887|12145003|P6|STARTED|Part A, Period 3 (1 Day)||4
4938083|NCT03045887|12145004|P5|STARTED|Part A, Period 3 (1 Day)||4
4938084|NCT03045887|12145005|P4|STARTED|Part A, Period 3 (1 Day)||2
4938085|NCT03045887|12145006|P3|STARTED|Part A, Period 3 (1 Day)||4
4938086|NCT03045887|12145007|P2|STARTED|Part A, Period 3 (1 Day)||4
4938087|NCT03045887|12145008|P1|STARTED|Part A, Period 3 (1 Day)||3
4938088|NCT03045887|12144999|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938089|NCT03045887|12145000|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938090|NCT03045887|12145001|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938091|NCT03045887|12145002|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938092|NCT03045887|12145003|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938093|NCT03045887|12145004|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938094|NCT03045887|12145005|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
4938095|NCT03045887|12145006|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
4938096|NCT03045887|12145007|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938097|NCT03045887|12145008|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938098|NCT03045887|12144999|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938099|NCT03045887|12145000|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
4938100|NCT03045887|12145001|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938101|NCT03045887|12145002|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938102|NCT03045887|12145003|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938103|NCT03045887|12145004|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938104|NCT03045887|12145005|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
4938105|NCT03045887|12145006|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938106|NCT03045887|12145007|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
4938107|NCT03045887|12145008|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
4938108|NCT03045887|12144999|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
4938109|NCT03045887|12145000|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
4938110|NCT03045887|12145001|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938111|NCT03045887|12145002|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938112|NCT03045887|12145003|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938113|NCT03045887|12145004|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938114|NCT03045887|12145005|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938115|NCT03045887|12145006|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
4938116|NCT03045887|12145007|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
4938117|NCT03045887|12145008|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
4938118|NCT03045887|12144999|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938119|NCT03045887|12145000|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938120|NCT03045887|12145001|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938121|NCT03045887|12145002|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938122|NCT03045887|12145003|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938123|NCT03045887|12145004|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938124|NCT03045887|12145005|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938125|NCT03045887|12145006|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938126|NCT03045887|12145007|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
4938127|NCT03045887|12145008|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
4938128|NCT03045887|12144999|P10|COMPLETED|Part A, Period 2 (1 Day)||0
4938129|NCT03045887|12145000|P9|COMPLETED|Part A, Period 2 (1 Day)||0
4938130|NCT03045887|12145001|P8|COMPLETED|Part A, Period 2 (1 Day)||4
4938131|NCT03045887|12145002|P7|COMPLETED|Part A, Period 2 (1 Day)||4
4938132|NCT03045887|12145003|P6|COMPLETED|Part A, Period 2 (1 Day)||4
4938133|NCT03045887|12145004|P5|COMPLETED|Part A, Period 2 (1 Day)||4
4938134|NCT03045887|12145005|P4|COMPLETED|Part A, Period 2 (1 Day)||4
4938135|NCT03045887|12145006|P3|COMPLETED|Part A, Period 2 (1 Day)||5
4938136|NCT03045887|12145007|P2|COMPLETED|Part A, Period 2 (1 Day)||4
4938137|NCT03045887|12145008|P1|COMPLETED|Part A, Period 2 (1 Day)||3
4938138|NCT03045887|12144999|P10|STARTED|Part A, Period 2 (1 Day)||0
4938139|NCT03045887|12145000|P9|STARTED|Part A, Period 2 (1 Day)||0
4938140|NCT03045887|12145001|P8|STARTED|Part A, Period 2 (1 Day)||4
4938141|NCT03045887|12145002|P7|STARTED|Part A, Period 2 (1 Day)||4
4938142|NCT03045887|12145003|P6|STARTED|Part A, Period 2 (1 Day)||4
4938143|NCT03045887|12145004|P5|STARTED|Part A, Period 2 (1 Day)||4
4938144|NCT03045887|12145005|P4|STARTED|Part A, Period 2 (1 Day)||4
4938145|NCT03045887|12145006|P3|STARTED|Part A, Period 2 (1 Day)||5
4938146|NCT03045887|12145007|P2|STARTED|Part A, Period 2 (1 Day)||4
4938147|NCT03045887|12145008|P1|STARTED|Part A, Period 2 (1 Day)||4
4938148|NCT03045887|12144999|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938149|NCT03045887|12145000|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938150|NCT03045887|12145001|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938151|NCT03045887|12145002|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938152|NCT03045887|12145003|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938153|NCT03045887|12145004|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938154|NCT03045887|12145005|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
4938155|NCT03045887|12145006|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938156|NCT03045887|12145007|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938157|NCT03045887|12145008|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
4938158|NCT03045887|12144999|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938159|NCT03045887|12145000|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
4938160|NCT03045887|12145001|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938161|NCT03045887|12145002|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938162|NCT03045887|12145003|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938163|NCT03045887|12145004|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938164|NCT03045887|12145005|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938165|NCT03045887|12145006|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
4938166|NCT03045887|12145007|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938167|NCT03045887|12145008|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
4938168|NCT03045887|12144999|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
4938169|NCT03045887|12145000|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
4938170|NCT03045887|12145001|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
4938171|NCT03045887|12145002|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
4938172|NCT03045887|12145003|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
4938173|NCT03045887|12145004|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
4938174|NCT03045887|12145005|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
4938175|NCT03045887|12145006|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
4938176|NCT03045887|12145007|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
4938177|NCT03045887|12145008|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
4938178|NCT03045887|12144999|P10|NOT COMPLETED|Part A, Period (1 Day)||0
4938179|NCT03045887|12145000|P9|NOT COMPLETED|Part A, Period (1 Day)||0
4938180|NCT03045887|12145001|P8|NOT COMPLETED|Part A, Period (1 Day)||0
4938181|NCT03045887|12145002|P7|NOT COMPLETED|Part A, Period (1 Day)||0
4938182|NCT03045887|12145003|P6|NOT COMPLETED|Part A, Period (1 Day)||0
4938183|NCT03045887|12145004|P5|NOT COMPLETED|Part A, Period (1 Day)||0
4938184|NCT03045887|12145005|P4|NOT COMPLETED|Part A, Period (1 Day)||0
4938185|NCT03045887|12145006|P3|NOT COMPLETED|Part A, Period (1 Day)||0
4938186|NCT03045887|12145007|P2|NOT COMPLETED|Part A, Period (1 Day)||0
4938187|NCT03045887|12145008|P1|NOT COMPLETED|Part A, Period (1 Day)||0
4938188|NCT03045887|12144999|P10|COMPLETED|Part A, Period (1 Day)||0
4938189|NCT03045887|12145000|P9|COMPLETED|Part A, Period (1 Day)||0
4938190|NCT03045887|12145001|P8|COMPLETED|Part A, Period (1 Day)||4
4938191|NCT03045887|12145002|P7|COMPLETED|Part A, Period (1 Day)||4
4938192|NCT03045887|12145003|P6|COMPLETED|Part A, Period (1 Day)||4
4938193|NCT03045887|12145004|P5|COMPLETED|Part A, Period (1 Day)||4
4938194|NCT03045887|12145005|P4|COMPLETED|Part A, Period (1 Day)||5
4938195|NCT03045887|12145006|P3|COMPLETED|Part A, Period (1 Day)||5
4938196|NCT03045887|12145007|P2|COMPLETED|Part A, Period (1 Day)||4
4938197|NCT03045887|12145008|P1|COMPLETED|Part A, Period (1 Day)||7
4938198|NCT03045887|12144999|P10|STARTED|Part A, Period (1 Day)||0
4938199|NCT03045887|12145000|P9|STARTED|Part A, Period (1 Day)||0
4938200|NCT03045887|12145001|P8|STARTED|Part A, Period (1 Day)||4
4938201|NCT03045887|12145002|P7|STARTED|Part A, Period (1 Day)||4
4938202|NCT03045887|12145003|P6|STARTED|Part A, Period (1 Day)||4
4938203|NCT03045887|12145004|P5|STARTED|Part A, Period (1 Day)||4
4938204|NCT03045887|12145005|P4|STARTED|Part A, Period (1 Day)||5
4938205|NCT03045887|12145006|P3|STARTED|Part A, Period (1 Day)||5
4938206|NCT03045887|12145007|P2|STARTED|Part A, Period (1 Day)||4
4938207|NCT03045887|12145008|P1|STARTED|Part A, Period (1 Day)||7
4938208|NCT03045861|12145150|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
4938209|NCT03045861|12145151|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
4938210|NCT03045861|12145152|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
4938211|NCT03045861|12145153|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
4938212|NCT03045861|12145150|P4|COMPLETED|Part B (Up to 10 Days)||8
4938213|NCT03045861|12145151|P3|COMPLETED|Part B (Up to 10 Days)||0
4938214|NCT03045861|12145152|P2|COMPLETED|Part B (Up to 10 Days)||8
4938215|NCT03045861|12145153|P1|COMPLETED|Part B (Up to 10 Days)||7
4938216|NCT03045861|12145150|P4|STARTED|Part B (Up to 10 Days)||8
4938217|NCT03045861|12145151|P3|STARTED|Part B (Up to 10 Days)||0
4938218|NCT03045861|12145152|P2|STARTED|Part B (Up to 10 Days)||8
4938219|NCT03045861|12145153|P1|STARTED|Part B (Up to 10 Days)||7
4938220|NCT03045861|12145150|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
4938221|NCT03045861|12145151|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
4938222|NCT03045861|12145152|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
4938223|NCT03045861|12145153|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
4938224|NCT03045861|12145150|P4|COMPLETED|Part A (Up to 10 Days)||0
4938225|NCT03045861|12145151|P3|COMPLETED|Part A (Up to 10 Days)||10
4938226|NCT03045861|12145152|P2|COMPLETED|Part A (Up to 10 Days)||0
4938227|NCT03045861|12145153|P1|COMPLETED|Part A (Up to 10 Days)||0
4938228|NCT03045861|12145150|P4|STARTED|Part A (Up to 10 Days)||0
4938229|NCT03045861|12145151|P3|STARTED|Part A (Up to 10 Days)||10
4938230|NCT03045861|12145152|P2|STARTED|Part A (Up to 10 Days)||0
4938231|NCT03045861|12145153|P1|STARTED|Part A (Up to 10 Days)||0
4938232|NCT03045809|12145279|P1|NOT COMPLETED|Overall Study||0
4938233|NCT03045809|12145279|P1|COMPLETED|Overall Study||705
4938234|NCT03045809|12145279|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
4938235|NCT03045809|12145279|P1|STARTED|Overall Study||705
4938236|NCT03045653|12145286|P1|NOT COMPLETED|Overall Study||0
4938237|NCT03045653|12145286|P1|COMPLETED|Overall Study||30
4938238|NCT03045653|12145286|P1|STARTED|Overall Study||30
4938239|NCT03045302|12145290|P1|NOT COMPLETED|Overall Study||1
4938240|NCT03045302|12145290|P1|COMPLETED|Overall Study||3
4938241|NCT03045302|12145290|P1|STARTED|Overall Study||4
4938242|NCT03045081|12145296|P2|NOT COMPLETED|Overall Study||11
4938243|NCT03045081|12145297|P1|NOT COMPLETED|Overall Study||6
4938244|NCT03045081|12145296|P2|COMPLETED|Overall Study||37
4938245|NCT03045081|12145297|P1|COMPLETED|Overall Study||45
4938246|NCT03045081|12145296|P2|STARTED|Overall Study||48
4938247|NCT03045081|12145297|P1|STARTED|Overall Study||51
4938248|NCT03044886|12145316|P3|NOT COMPLETED|Overall Study||12
4938249|NCT03044886|12145317|P2|NOT COMPLETED|Overall Study||10
4938250|NCT03044886|12145318|P1|NOT COMPLETED|Overall Study||15
4938251|NCT03044886|12145316|P3|COMPLETED|Overall Study||108
4938252|NCT03044886|12145317|P2|COMPLETED|Overall Study||110
4938253|NCT03044886|12145318|P1|COMPLETED|Overall Study||105
4938254|NCT03044886|12145316|P3|STARTED|Overall Study||120
4938255|NCT03044886|12145317|P2|STARTED|Overall Study||120
4938256|NCT03044886|12145318|P1|STARTED|Overall Study||120
4938257|NCT03044730|12145359|P1|NOT COMPLETED|On Follow-up for 2 Years||25
4938258|NCT03044730|12145359|P1|COMPLETED|On Follow-up for 2 Years||4
4938259|NCT03044730|12145359|P1|STARTED|On Follow-up for 2 Years||29
4938260|NCT03044730|12145359|P1|NOT COMPLETED|Cycles 4 and Beyond||10
4938261|NCT03044730|12145359|P1|COMPLETED|Cycles 4 and Beyond||16
4938262|NCT03044730|12145359|P1|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
4938263|NCT03044730|12145359|P1|Started Cycle 4|Cycles 4 and Beyond||20
4938264|NCT03044730|12145359|P1|Assessed for Cycle 4|Cycles 4 and Beyond||26
4938265|NCT03044730|12145359|P1|STARTED|Cycles 4 and Beyond||26
4938266|NCT03044730|12145359|P1|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
4938267|NCT03044730|12145359|P1|COMPLETED|3 Cycles of Pembro + Capecitab||26
4938268|NCT03044730|12145359|P1|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
4938269|NCT03044730|12145359|P1|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
4938270|NCT03044730|12145359|P1|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
4938271|NCT03044730|12145359|P1|STARTED|3 Cycles of Pembro + Capecitab||30
4938272|NCT03044691|12145370|P2|NOT COMPLETED|Overall Study||0
4938273|NCT03044691|12145371|P1|NOT COMPLETED|Overall Study||0
4938274|NCT03044691|12145370|P2|COMPLETED|Overall Study||84
4938275|NCT03044691|12145371|P1|COMPLETED|Overall Study||0
4938276|NCT03044691|12145370|P2|STARTED|Overall Study||84
4938277|NCT03044691|12145371|P1|STARTED|Overall Study||0
4938278|NCT03044574|12145379|P2|NOT COMPLETED|Overall Study||45
4938279|NCT03044574|12145380|P1|NOT COMPLETED|Overall Study||37
4938280|NCT03044574|12145379|P2|COMPLETED|Overall Study||158
4938281|NCT03044574|12145380|P1|COMPLETED|Overall Study||167
4938282|NCT03044574|12145379|P2|180 Days After Surgery|Overall Study||158
4938283|NCT03044574|12145380|P1|180 Days After Surgery|Overall Study||167
4938284|NCT03044574|12145379|P2|30 Days After Surgery|Overall Study||194
4938285|NCT03044574|12145380|P1|30 Days After Surgery|Overall Study||193
4938286|NCT03044574|12145379|P2|Inpatient Period|Overall Study||203
4938287|NCT03044574|12145380|P1|Inpatient Period|Overall Study||204
4938288|NCT03044574|12145379|P2|STARTED|Overall Study||203
4938289|NCT03044574|12145380|P1|STARTED|Overall Study||204
4938290|NCT03044431|12145406|P1|NOT COMPLETED|Overall Study||59
4938291|NCT03044431|12145406|P1|COMPLETED|Overall Study||148
4938292|NCT03044431|12145406|P1|STARTED|Overall Study||207
4938293|NCT03044353|12145419|P3|NOT COMPLETED|Overall Study||0
4938294|NCT03044353|12145420|P2|NOT COMPLETED|Overall Study||1
4938295|NCT03044353|12145421|P1|NOT COMPLETED|Overall Study||0
4938296|NCT03044353|12145419|P3|COMPLETED|Overall Study||0
4938297|NCT03044353|12145420|P2|COMPLETED|Overall Study||0
4938298|NCT03044353|12145421|P1|COMPLETED|Overall Study||6
4938299|NCT03044353|12145419|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
4938300|NCT03044353|12145420|P2|STARTED|Overall Study||1
4938301|NCT03044353|12145421|P1|STARTED|Overall Study||6
4938302|NCT03044197|12145504|P2|NOT COMPLETED|Overall Study||1
4938303|NCT03044197|12145505|P1|NOT COMPLETED|Overall Study||3
4938304|NCT03044197|12145504|P2|COMPLETED|Overall Study||11
4938305|NCT03044197|12145505|P1|COMPLETED|Overall Study||9
4938306|NCT03044197|12145504|P2|STARTED|Overall Study||12
4938307|NCT03044197|12145505|P1|STARTED|Overall Study||12
4938308|NCT03044106|12145515|P2|NOT COMPLETED|Visit 2||0
4938309|NCT03044106|12145516|P1|NOT COMPLETED|Visit 2||0
4938310|NCT03044106|12145515|P2|COMPLETED|Visit 2||20
4938311|NCT03044106|12145516|P1|COMPLETED|Visit 2||22
4938312|NCT03044106|12145515|P2|STARTED|Visit 2||20
4938313|NCT03044106|12145516|P1|STARTED|Visit 2||22
4938314|NCT03044106|12145515|P2|NOT COMPLETED|Washout (1 Week)||2
4938315|NCT03044106|12145516|P1|NOT COMPLETED|Washout (1 Week)||0
4938316|NCT03044106|12145515|P2|COMPLETED|Washout (1 Week)||20
4938317|NCT03044106|12145516|P1|COMPLETED|Washout (1 Week)||22
4938318|NCT03044106|12145515|P2|STARTED|Washout (1 Week)||22
4938319|NCT03044106|12145516|P1|STARTED|Washout (1 Week)||22
4938320|NCT03044106|12145515|P2|NOT COMPLETED|Visit 1||0
4938321|NCT03044106|12145516|P1|NOT COMPLETED|Visit 1||0
4938322|NCT03044106|12145515|P2|COMPLETED|Visit 1||22
4938323|NCT03044106|12145516|P1|COMPLETED|Visit 1||22
4938324|NCT03044106|12145515|P2|STARTED|Visit 1||22
4938325|NCT03044106|12145516|P1|STARTED|Visit 1||22
4938326|NCT03044028|12145533|P3|NOT COMPLETED|Overall Study||0
4938327|NCT03044028|12145534|P2|NOT COMPLETED|Overall Study||10
4938328|NCT03044028|12145535|P1|NOT COMPLETED|Overall Study||10
4938329|NCT03044028|12145533|P3|COMPLETED|Overall Study||22
4938330|NCT03044028|12145534|P2|COMPLETED|Overall Study||12
4938331|NCT03044028|12145535|P1|COMPLETED|Overall Study||12
4938332|NCT03044028|12145533|P3|STARTED|Overall Study||22
4938333|NCT03044028|12145534|P2|STARTED|Overall Study||22
4938334|NCT03044028|12145535|P1|STARTED|Overall Study||22
4938335|NCT03043885|12145571|P4|NOT COMPLETED|Overall Study||0
4938336|NCT03043885|12145572|P3|NOT COMPLETED|Overall Study||0
4938337|NCT03043885|12145573|P2|NOT COMPLETED|Overall Study||0
4938338|NCT03043885|12145574|P1|NOT COMPLETED|Overall Study||0
4938339|NCT03043885|12145571|P4|COMPLETED|Overall Study||10
4938340|NCT03043885|12145572|P3|COMPLETED|Overall Study||10
4938341|NCT03043885|12145573|P2|COMPLETED|Overall Study||10
4938342|NCT03043885|12145574|P1|COMPLETED|Overall Study||10
4938343|NCT03043885|12145571|P4|STARTED|Overall Study||10
4938344|NCT03043885|12145572|P3|STARTED|Overall Study||10
4938345|NCT03043885|12145573|P2|STARTED|Overall Study||10
4938346|NCT03043885|12145574|P1|STARTED|Overall Study||10
4938347|NCT03043599|12145588|P1|NOT COMPLETED|Overall Study||0
4938348|NCT03043599|12145588|P1|COMPLETED|Overall Study||21
4938349|NCT03043599|12145588|P1|STARTED|Overall Study||21
4938350|NCT03043534|12145596|P2|NOT COMPLETED|Overall Study||0
4938351|NCT03043534|12145597|P1|NOT COMPLETED|Overall Study||0
4938352|NCT03043534|12145596|P2|COMPLETED|Overall Study||14
4938353|NCT03043534|12145597|P1|COMPLETED|Overall Study||15
4938354|NCT03043534|12145596|P2|STARTED|Overall Study||14
4938355|NCT03043534|12145597|P1|STARTED|Overall Study||15
4938356|NCT03043274|12145613|P2|NOT COMPLETED|Overall Study||1
4938357|NCT03043274|12145614|P1|NOT COMPLETED|Overall Study||0
4938358|NCT03043274|12145613|P2|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
4938359|NCT03043274|12145614|P1|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
4938360|NCT03043274|12145613|P2|STARTED|Overall Study||10
4938361|NCT03043274|12145614|P1|STARTED|Overall Study||13
4938362|NCT03043105|12145630|P1|NOT COMPLETED|Overall Study||0
4938363|NCT03043105|12145630|P1|COMPLETED|Overall Study||25
4938364|NCT03043105|12145630|P1|STARTED|Overall Study||25
4938365|NCT03043079|12145642|P3|NOT COMPLETED|Overall Study||0
4938366|NCT03043079|12145643|P2|NOT COMPLETED|Overall Study||0
4938367|NCT03043079|12145644|P1|NOT COMPLETED|Overall Study||0
4938368|NCT03043079|12145642|P3|COMPLETED|Overall Study||10
4938369|NCT03043079|12145643|P2|COMPLETED|Overall Study||14
4938370|NCT03043079|12145644|P1|COMPLETED|Overall Study||21
4938371|NCT03043079|12145642|P3|STARTED|Overall Study||10
4938372|NCT03043079|12145643|P2|STARTED|Overall Study||14
4938373|NCT03043079|12145644|P1|STARTED|Overall Study||21
4938374|NCT03042910|12145654|P1|NOT COMPLETED|Overall Study||7
4938375|NCT03042910|12145654|P1|COMPLETED|Overall Study||31
4938376|NCT03042910|12145654|P1|Treated|Overall Study||37
4938377|NCT03042910|12145654|P1|STARTED|Overall Study||38
4938378|NCT03042780|12145677|P1|NOT COMPLETED|Overall Study||0
4938379|NCT03042780|12145677|P1|COMPLETED|Overall Study||2
4938380|NCT03042780|12145677|P1|STARTED|Overall Study||2
4938381|NCT03042715|12145683|P1|NOT COMPLETED|Overall Study||1
4938382|NCT03042715|12145683|P1|COMPLETED|Overall Study||5
4938383|NCT03042715|12145683|P1|STARTED|Overall Study||6
4938384|NCT03042702|12145687|P1|NOT COMPLETED|Overall Study||0
4938385|NCT03042702|12145687|P1|COMPLETED|Overall Study||2
4938386|NCT03042702|12145687|P1|STARTED|Overall Study||2
4938387|NCT03042559|12145698|P2|NOT COMPLETED|Overall Study||1
4938388|NCT03042559|12145699|P1|NOT COMPLETED|Overall Study||1
4938389|NCT03042559|12145698|P2|COMPLETED|Overall Study||20
4938390|NCT03042559|12145699|P1|COMPLETED|Overall Study||21
4938391|NCT03042559|12145698|P2|STARTED|Overall Study||21
4938392|NCT03042559|12145699|P1|STARTED|Overall Study||22
4938393|NCT03042299|12145761|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4938394|NCT03042299|12145762|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4938395|NCT03042299|12145761|P2|COMPLETED|Intervention Period 2 (6 Days)||7
4938396|NCT03042299|12145762|P1|COMPLETED|Intervention Period 2 (6 Days)||7
4938397|NCT03042299|12145761|P2|STARTED|Intervention Period 2 (6 Days)||7
4938398|NCT03042299|12145762|P1|STARTED|Intervention Period 2 (6 Days)||7
4938399|NCT03042299|12145761|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
4938400|NCT03042299|12145762|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
4938401|NCT03042299|12145761|P2|COMPLETED|Washout Period (at Least 6 Days)||7
4938402|NCT03042299|12145762|P1|COMPLETED|Washout Period (at Least 6 Days)||7
4938403|NCT03042299|12145761|P2|STARTED|Washout Period (at Least 6 Days)||7
4938404|NCT03042299|12145762|P1|STARTED|Washout Period (at Least 6 Days)||7
4938405|NCT03042299|12145761|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4938406|NCT03042299|12145762|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4938407|NCT03042299|12145761|P2|COMPLETED|Intervention Period 1 (6 Days)||7
4938408|NCT03042299|12145762|P1|COMPLETED|Intervention Period 1 (6 Days)||7
4938409|NCT03042299|12145761|P2|STARTED|Intervention Period 1 (6 Days)||7
4938410|NCT03042299|12145762|P1|STARTED|Intervention Period 1 (6 Days)||7
4938411|NCT03041909|12145791|P3|NOT COMPLETED|Overall Study||0
4938412|NCT03041909|12145792|P2|NOT COMPLETED|Overall Study||0
4938413|NCT03041909|12145793|P1|NOT COMPLETED|Overall Study||0
4938414|NCT03041909|12145791|P3|COMPLETED|Overall Study||1
4938415|NCT03041909|12145792|P2|COMPLETED|Overall Study||1
4938416|NCT03041909|12145793|P1|COMPLETED|Overall Study||3
4938417|NCT03041909|12145791|P3|STARTED|Overall Study||1
4938418|NCT03041909|12145792|P2|STARTED|Overall Study||1
4938419|NCT03041909|12145793|P1|STARTED|Overall Study||3
4938420|NCT03041896|12145814|P4|NOT COMPLETED|Overall Study||3
4938421|NCT03041896|12145815|P3|NOT COMPLETED|Overall Study||63
4938422|NCT03041896|12145816|P2|NOT COMPLETED|Overall Study||0
4938423|NCT03041896|12145817|P1|NOT COMPLETED|Overall Study||0
4938424|NCT03041896|12145814|P4|COMPLETED|Overall Study||253
4938425|NCT03041896|12145815|P3|COMPLETED|Overall Study||2236
4938426|NCT03041896|12145816|P2|COMPLETED|Overall Study||1009
4938427|NCT03041896|12145817|P1|COMPLETED|Overall Study||1486
4938428|NCT03041896|12145814|P4|STARTED|Overall Study||256
4938429|NCT03041896|12145815|P3|STARTED|Overall Study||2299
4938430|NCT03041896|12145816|P2|STARTED|Overall Study||1009
4938431|NCT03041896|12145817|P1|STARTED|Overall Study||1486
4938432|NCT03041792|12145834|P2|NOT COMPLETED|Overall Study||3
4938433|NCT03041792|12145835|P1|NOT COMPLETED|Overall Study||4
4938434|NCT03041792|12145834|P2|COMPLETED|Overall Study||26
4938435|NCT03041792|12145835|P1|COMPLETED|Overall Study||28
4938436|NCT03041792|12145834|P2|Received Treatment|Overall Study||28
4938437|NCT03041792|12145835|P1|Received Treatment|Overall Study||32
4938438|NCT03041792|12145834|P2|STARTED|Overall Study||29
4938439|NCT03041792|12145835|P1|STARTED|Overall Study||32
4938440|NCT03041467|12145859|P2|NOT COMPLETED|Overall Study||160
4938441|NCT03041467|12145860|P1|NOT COMPLETED|Overall Study||170
4938442|NCT03041467|12145859|P2|COMPLETED|Overall Study||0
4938443|NCT03041467|12145860|P1|COMPLETED|Overall Study||0
4938444|NCT03041467|12145859|P2|STARTED|Overall Study||160
4938445|NCT03041467|12145860|P1|STARTED|Overall Study||170
4938446|NCT03041441|12145890|P1|NOT COMPLETED|Overall Study||2
4938447|NCT03041441|12145890|P1|COMPLETED|Overall Study||3
4938448|NCT03041441|12145890|P1|STARTED|Overall Study||5
4938449|NCT03041298|12145898|P1|NOT COMPLETED|Overall Study||0
4938450|NCT03041298|12145898|P1|COMPLETED|Overall Study||1537
4938451|NCT03041298|12145898|P1|STARTED|Overall Study||1537
4938452|NCT03041181|12145908|P2|NOT COMPLETED|Overall Study||2
4938453|NCT03041181|12145909|P1|NOT COMPLETED|Overall Study||1
4938454|NCT03041181|12145908|P2|COMPLETED|Overall Study||0
4938455|NCT03041181|12145909|P1|COMPLETED|Overall Study||0
4938456|NCT03041181|12145908|P2|STARTED|Overall Study||2
4938457|NCT03041181|12145909|P1|STARTED|Overall Study||1
4938458|NCT03041090|12145925|P2|NOT COMPLETED|Overall Study||3
4938459|NCT03041090|12145926|P1|NOT COMPLETED|Overall Study||0
4938460|NCT03041090|12145925|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
4938461|NCT03041090|12145926|P1|COMPLETED|Overall Study||109
4938462|NCT03041090|12145925|P2|STARTED|Overall Study||24
4938463|NCT03041090|12145926|P1|STARTED|Overall Study||109
4938464|NCT03040687|12145939|P3|NOT COMPLETED|Overall Study||0
4938465|NCT03040687|12145940|P2|NOT COMPLETED|Overall Study||0
4938466|NCT03040687|12145941|P1|NOT COMPLETED|Overall Study||1
4938467|NCT03040687|12145939|P3|COMPLETED|Overall Study||20
4938468|NCT03040687|12145940|P2|COMPLETED|Overall Study||20
4938469|NCT03040687|12145941|P1|COMPLETED|Overall Study||19
4938470|NCT03040687|12145939|P3|STARTED|Overall Study||20
4938471|NCT03040687|12145940|P2|STARTED|Overall Study||20
4938472|NCT03040687|12145941|P1|STARTED|Overall Study||20
4938473|NCT03040479|12145955|P3|NOT COMPLETED|Overall Study||0
4938474|NCT03040479|12145956|P2|NOT COMPLETED|Overall Study||0
4938475|NCT03040479|12145957|P1|NOT COMPLETED|Overall Study||0
4938476|NCT03040479|12145955|P3|COMPLETED|Overall Study||8
4938477|NCT03040479|12145956|P2|COMPLETED|Overall Study||8
4938478|NCT03040479|12145957|P1|COMPLETED|Overall Study||8
4938479|NCT03040479|12145955|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
4938480|NCT03040479|12145956|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
4938481|NCT03040479|12145957|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
4938482|NCT03040479|12145955|P3|STARTED|Overall Study||8
4938483|NCT03040479|12145956|P2|STARTED|Overall Study||8
4938484|NCT03040479|12145957|P1|STARTED|Overall Study||8
4938485|NCT03040362|12145983|P1|NOT COMPLETED|Overall Study||0
4938486|NCT03040362|12145983|P1|COMPLETED|Overall Study||8
4938487|NCT03040362|12145983|P1|Received at Least 1dose of Study Drug|Overall Study||8
4938488|NCT03040362|12145983|P1|STARTED|Overall Study||8
4938489|NCT03040336|12145997|P2|NOT COMPLETED|Overall Study||3
4938490|NCT03040336|12145998|P1|NOT COMPLETED|Overall Study||3
4938491|NCT03040336|12145997|P2|COMPLETED|Overall Study||4
4938492|NCT03040336|12145998|P1|COMPLETED|Overall Study||7
4938493|NCT03040336|12145997|P2|STARTED|Overall Study||7
4938494|NCT03040336|12145998|P1|STARTED|Overall Study||10
4938495|NCT03040323|12146030|P2|NOT COMPLETED|Overall Study||0
4938496|NCT03040323|12146031|P1|NOT COMPLETED|Overall Study||0
4938497|NCT03040323|12146030|P2|COMPLETED|Overall Study||0
4938498|NCT03040323|12146031|P1|COMPLETED|Overall Study||0
4938499|NCT03040323|12146030|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
4938500|NCT03040323|12146031|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
4938501|NCT03040011|12146042|P3|NOT COMPLETED|Primary Outcome Follow Up||1
4938502|NCT03040011|12146043|P2|NOT COMPLETED|Primary Outcome Follow Up||1
4938503|NCT03040011|12146044|P1|NOT COMPLETED|Primary Outcome Follow Up||4
4938504|NCT03040011|12146042|P3|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
4938505|NCT03040011|12146043|P2|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
4938506|NCT03040011|12146044|P1|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
4938507|NCT03040011|12146042|P3|STARTED|Primary Outcome Follow Up||25
4938508|NCT03040011|12146043|P2|STARTED|Primary Outcome Follow Up||25
4938509|NCT03040011|12146044|P1|STARTED|Primary Outcome Follow Up||25
4938510|NCT03040011|12146042|P3|NOT COMPLETED|Received Randomized Study Intervention||0
4938511|NCT03040011|12146043|P2|NOT COMPLETED|Received Randomized Study Intervention||0
4938512|NCT03040011|12146044|P1|NOT COMPLETED|Received Randomized Study Intervention||0
4938513|NCT03040011|12146042|P3|COMPLETED|Received Randomized Study Intervention||25
4938514|NCT03040011|12146043|P2|COMPLETED|Received Randomized Study Intervention||25
4938515|NCT03040011|12146044|P1|COMPLETED|Received Randomized Study Intervention||25
4938516|NCT03040011|12146042|P3|STARTED|Received Randomized Study Intervention||25
4938517|NCT03040011|12146043|P2|STARTED|Received Randomized Study Intervention||25
4938518|NCT03040011|12146044|P1|STARTED|Received Randomized Study Intervention||25
4938519|NCT03039738|12146111|P2|NOT COMPLETED|Overall Study||0
4938520|NCT03039738|12146112|P1|NOT COMPLETED|Overall Study||54
4938521|NCT03039738|12146111|P2|COMPLETED|Overall Study||0
4938522|NCT03039738|12146112|P1|COMPLETED|Overall Study||152
4938523|NCT03039738|12146111|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
4938524|NCT03039738|12146112|P1|STARTED|Overall Study||206
4938525|NCT03039621|12146134|P2|NOT COMPLETED|Overall Study||16
4938526|NCT03039621|12146135|P1|NOT COMPLETED|Overall Study||12
4938527|NCT03039621|12146134|P2|COMPLETED|Overall Study||128
4938528|NCT03039621|12146135|P1|COMPLETED|Overall Study||131
4938529|NCT03039621|12146134|P2|STARTED|Overall Study||144
4938530|NCT03039621|12146135|P1|STARTED|Overall Study||143
4938531|NCT03039569|12146159|P2|NOT COMPLETED|Overall Study||4
4938532|NCT03039569|12146160|P1|NOT COMPLETED|Overall Study||5
4938533|NCT03039569|12146159|P2|COMPLETED|Overall Study||35
4938534|NCT03039569|12146160|P1|COMPLETED|Overall Study||35
4938535|NCT03039569|12146159|P2|STARTED|Overall Study||39
4938536|NCT03039569|12146160|P1|STARTED|Overall Study||40
4938537|NCT03039543|12146190|P2|NOT COMPLETED|Overall Study||3
4938538|NCT03039543|12146191|P1|NOT COMPLETED|Overall Study||1
4938539|NCT03039543|12146190|P2|COMPLETED|Overall Study||51
4938540|NCT03039543|12146191|P1|COMPLETED|Overall Study||53
4938541|NCT03039543|12146190|P2|STARTED|Overall Study||54
4938542|NCT03039543|12146191|P1|STARTED|Overall Study||54
4938543|NCT03039283|12146205|P1|NOT COMPLETED|Overall Study||2
4938544|NCT03039283|12146205|P1|COMPLETED|Overall Study||160
4938545|NCT03039283|12146205|P1|STARTED|Overall Study||162
4938546|NCT03039179|12146216|P2|NOT COMPLETED|Overall Study||0
4938547|NCT03039179|12146217|P1|NOT COMPLETED|Overall Study||0
4938548|NCT03039179|12146216|P2|COMPLETED|Overall Study||42
4938549|NCT03039179|12146217|P1|COMPLETED|Overall Study||38
4938550|NCT03039179|12146216|P2|STARTED|Overall Study||42
4938551|NCT03039179|12146217|P1|STARTED|Overall Study||38
4938552|NCT03039088|12146227|P2|NOT COMPLETED|Overall Study||0
4938553|NCT03039088|12146228|P1|NOT COMPLETED|Overall Study||0
4938554|NCT03039088|12146227|P2|COMPLETED|Overall Study||316
4938555|NCT03039088|12146228|P1|COMPLETED|Overall Study||192
4938556|NCT03039088|12146227|P2|STARTED|Overall Study||316
4938557|NCT03039088|12146228|P1|STARTED|Overall Study||192
4938558|NCT03038867|12146236|P2|NOT COMPLETED|Overall Study||0
4938559|NCT03038867|12146237|P1|NOT COMPLETED|Overall Study||0
4938560|NCT03038867|12146236|P2|COMPLETED|Overall Study||32
4938561|NCT03038867|12146237|P1|COMPLETED|Overall Study||37
4938562|NCT03038867|12146236|P2|STARTED|Overall Study||32
4938563|NCT03038867|12146237|P1|STARTED|Overall Study||37
4938564|NCT03038815|12146353|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
4938565|NCT03038815|12146354|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
4938566|NCT03038815|12146353|P2|COMPLETED|Intervention 2, 1 Hour||10
4938567|NCT03038815|12146354|P1|COMPLETED|Intervention 2, 1 Hour||10
4938568|NCT03038815|12146353|P2|STARTED|Intervention 2, 1 Hour||10
4938569|NCT03038815|12146354|P1|STARTED|Intervention 2, 1 Hour||10
4938570|NCT03038815|12146353|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
4938571|NCT03038815|12146354|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
4938572|NCT03038815|12146353|P2|COMPLETED|Intervention 1, 1 Hour||10
4938573|NCT03038815|12146354|P1|COMPLETED|Intervention 1, 1 Hour||10
4938574|NCT03038815|12146353|P2|STARTED|Intervention 1, 1 Hour||10
4938575|NCT03038815|12146354|P1|STARTED|Intervention 1, 1 Hour||10
4938576|NCT03038815|12146353|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
4938577|NCT03038815|12146354|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
4938578|NCT03038815|12146353|P2|COMPLETED|Controll Condition, 1 Hour||10
4938579|NCT03038815|12146354|P1|COMPLETED|Controll Condition, 1 Hour||10
4938580|NCT03038815|12146353|P2|STARTED|Controll Condition, 1 Hour||10
4938581|NCT03038815|12146354|P1|STARTED|Controll Condition, 1 Hour||10
4938582|NCT03038126|12146366|P2|NOT COMPLETED|Overall Study||4
4938583|NCT03038126|12146367|P1|NOT COMPLETED|Overall Study||9
4938584|NCT03038126|12146366|P2|COMPLETED|Overall Study||51
4938585|NCT03038126|12146367|P1|COMPLETED|Overall Study||54
4938586|NCT03038126|12146366|P2|STARTED|Overall Study||55
4938587|NCT03038126|12146367|P1|STARTED|Overall Study||63
4938588|NCT03037905|12146379|P2|NOT COMPLETED|Overall Study||0
4938589|NCT03037905|12146380|P1|NOT COMPLETED|Overall Study||0
4938590|NCT03037905|12146379|P2|COMPLETED|Overall Study||50
4938591|NCT03037905|12146380|P1|COMPLETED|Overall Study||50
4938592|NCT03037905|12146379|P2|STARTED|Overall Study||50
4938593|NCT03037905|12146380|P1|STARTED|Overall Study||50
4938594|NCT03037619|12146394|P2|NOT COMPLETED|Overall Study||1
4938595|NCT03037619|12146395|P1|NOT COMPLETED|Overall Study||0
4938596|NCT03037619|12146394|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
4938597|NCT03037619|12146395|P1|COMPLETED|Overall Study||8
4938598|NCT03037619|12146394|P2|STARTED|Overall Study|8 participants and 7 buddies|15
4938599|NCT03037619|12146395|P1|STARTED|Overall Study||8
4938600|NCT03037541|12146409|P2|NOT COMPLETED|Overall Study||0
4938601|NCT03037541|12146410|P1|NOT COMPLETED|Overall Study||0
4938602|NCT03037541|12146409|P2|COMPLETED|Overall Study||30
4938603|NCT03037541|12146410|P1|COMPLETED|Overall Study||30
4938604|NCT03037541|12146409|P2|STARTED|Overall Study||30
4938605|NCT03037541|12146410|P1|STARTED|Overall Study||30
4938606|NCT03037489|12146420|P2|NOT COMPLETED|Overall Study||0
4938607|NCT03037489|12146421|P1|NOT COMPLETED|Overall Study||7
4938608|NCT03037489|12146420|P2|COMPLETED|Overall Study||4
4938609|NCT03037489|12146421|P1|COMPLETED|Overall Study||39
4938610|NCT03037489|12146420|P2|STARTED|Overall Study||4
4938611|NCT03037489|12146421|P1|STARTED|Overall Study||46
4938612|NCT03037307|12146427|P6|NOT COMPLETED|Period 3||0
4938613|NCT03037307|12146428|P5|NOT COMPLETED|Period 3||0
4938614|NCT03037307|12146429|P4|NOT COMPLETED|Period 3||0
4938615|NCT03037307|12146430|P3|NOT COMPLETED|Period 3||0
4938616|NCT03037307|12146431|P2|NOT COMPLETED|Period 3||0
4938617|NCT03037307|12146432|P1|NOT COMPLETED|Period 3||0
4938618|NCT03037307|12146427|P6|COMPLETED|Period 3||8
4938619|NCT03037307|12146428|P5|COMPLETED|Period 3||7
4938620|NCT03037307|12146429|P4|COMPLETED|Period 3||6
4938621|NCT03037307|12146430|P3|COMPLETED|Period 3||8
4938622|NCT03037307|12146431|P2|COMPLETED|Period 3||7
4938623|NCT03037307|12146432|P1|COMPLETED|Period 3||7
4938624|NCT03037307|12146427|P6|STARTED|Period 3||8
4938625|NCT03037307|12146428|P5|STARTED|Period 3||7
4938626|NCT03037307|12146429|P4|STARTED|Period 3||6
4938627|NCT03037307|12146430|P3|STARTED|Period 3||8
4938628|NCT03037307|12146431|P2|STARTED|Period 3||7
4938629|NCT03037307|12146432|P1|STARTED|Period 3||7
4938630|NCT03037307|12146427|P6|NOT COMPLETED|Wash Out Period 2||0
4938631|NCT03037307|12146428|P5|NOT COMPLETED|Wash Out Period 2||0
4938632|NCT03037307|12146429|P4|NOT COMPLETED|Wash Out Period 2||0
4938633|NCT03037307|12146430|P3|NOT COMPLETED|Wash Out Period 2||0
4938634|NCT03037307|12146431|P2|NOT COMPLETED|Wash Out Period 2||0
4938635|NCT03037307|12146432|P1|NOT COMPLETED|Wash Out Period 2||0
4938636|NCT03037307|12146427|P6|COMPLETED|Wash Out Period 2||8
4938637|NCT03037307|12146428|P5|COMPLETED|Wash Out Period 2||7
4938638|NCT03037307|12146429|P4|COMPLETED|Wash Out Period 2||6
4938639|NCT03037307|12146430|P3|COMPLETED|Wash Out Period 2||8
4938640|NCT03037307|12146431|P2|COMPLETED|Wash Out Period 2||7
4938641|NCT03037307|12146432|P1|COMPLETED|Wash Out Period 2||7
4938642|NCT03037307|12146427|P6|STARTED|Wash Out Period 2||8
4938643|NCT03037307|12146428|P5|STARTED|Wash Out Period 2||7
4938644|NCT03037307|12146429|P4|STARTED|Wash Out Period 2||6
4938645|NCT03037307|12146430|P3|STARTED|Wash Out Period 2||8
4938646|NCT03037307|12146431|P2|STARTED|Wash Out Period 2||7
4938647|NCT03037307|12146432|P1|STARTED|Wash Out Period 2||7
4938648|NCT03037307|12146427|P6|NOT COMPLETED|Period 2||0
4938649|NCT03037307|12146428|P5|NOT COMPLETED|Period 2||0
4938650|NCT03037307|12146429|P4|NOT COMPLETED|Period 2||0
4938651|NCT03037307|12146430|P3|NOT COMPLETED|Period 2||0
4938652|NCT03037307|12146431|P2|NOT COMPLETED|Period 2||0
4938653|NCT03037307|12146432|P1|NOT COMPLETED|Period 2||0
4938654|NCT03037307|12146427|P6|COMPLETED|Period 2||8
4938655|NCT03037307|12146428|P5|COMPLETED|Period 2||7
4938656|NCT03037307|12146429|P4|COMPLETED|Period 2||6
4938657|NCT03037307|12146430|P3|COMPLETED|Period 2||8
4938658|NCT03037307|12146431|P2|COMPLETED|Period 2||7
4938659|NCT03037307|12146432|P1|COMPLETED|Period 2||7
4938660|NCT03037307|12146427|P6|STARTED|Period 2||8
4938661|NCT03037307|12146428|P5|STARTED|Period 2||7
4938662|NCT03037307|12146429|P4|STARTED|Period 2||6
4938663|NCT03037307|12146430|P3|STARTED|Period 2||8
4938664|NCT03037307|12146431|P2|STARTED|Period 2||7
4938665|NCT03037307|12146432|P1|STARTED|Period 2||7
4938666|NCT03037307|12146427|P6|NOT COMPLETED|Wash Out Period 1||0
4938667|NCT03037307|12146428|P5|NOT COMPLETED|Wash Out Period 1||0
4938668|NCT03037307|12146429|P4|NOT COMPLETED|Wash Out Period 1||0
4938669|NCT03037307|12146430|P3|NOT COMPLETED|Wash Out Period 1||0
4938670|NCT03037307|12146431|P2|NOT COMPLETED|Wash Out Period 1||0
4938671|NCT03037307|12146432|P1|NOT COMPLETED|Wash Out Period 1||0
4938672|NCT03037307|12146427|P6|COMPLETED|Wash Out Period 1||8
4938673|NCT03037307|12146428|P5|COMPLETED|Wash Out Period 1||7
4938674|NCT03037307|12146429|P4|COMPLETED|Wash Out Period 1||6
4938675|NCT03037307|12146430|P3|COMPLETED|Wash Out Period 1||8
4938676|NCT03037307|12146431|P2|COMPLETED|Wash Out Period 1||7
4938677|NCT03037307|12146432|P1|COMPLETED|Wash Out Period 1||7
4938678|NCT03037307|12146427|P6|STARTED|Wash Out Period 1||8
4938679|NCT03037307|12146428|P5|STARTED|Wash Out Period 1||7
4938680|NCT03037307|12146429|P4|STARTED|Wash Out Period 1||6
4938681|NCT03037307|12146430|P3|STARTED|Wash Out Period 1||8
4938682|NCT03037307|12146431|P2|STARTED|Wash Out Period 1||7
4938683|NCT03037307|12146432|P1|STARTED|Wash Out Period 1||7
4938684|NCT03037307|12146427|P6|NOT COMPLETED|Period 1||0
4938685|NCT03037307|12146428|P5|NOT COMPLETED|Period 1||0
4938686|NCT03037307|12146429|P4|NOT COMPLETED|Period 1||1
4938687|NCT03037307|12146430|P3|NOT COMPLETED|Period 1||0
4938688|NCT03037307|12146431|P2|NOT COMPLETED|Period 1||0
4938689|NCT03037307|12146432|P1|NOT COMPLETED|Period 1||0
4938690|NCT03037307|12146427|P6|COMPLETED|Period 1||8
4938691|NCT03037307|12146428|P5|COMPLETED|Period 1||7
4938692|NCT03037307|12146429|P4|COMPLETED|Period 1||6
4938693|NCT03037307|12146430|P3|COMPLETED|Period 1||8
4938694|NCT03037307|12146431|P2|COMPLETED|Period 1||7
4938695|NCT03037307|12146432|P1|COMPLETED|Period 1||7
4938696|NCT03037307|12146427|P6|STARTED|Period 1||8
4938697|NCT03037307|12146428|P5|STARTED|Period 1||7
4938698|NCT03037307|12146429|P4|STARTED|Period 1||7
4938699|NCT03037307|12146430|P3|STARTED|Period 1||8
4938700|NCT03037307|12146431|P2|STARTED|Period 1||7
4938701|NCT03037307|12146432|P1|STARTED|Period 1||7
4938702|NCT03037203|12146445|P3|NOT COMPLETED|Overall Study||1
4938703|NCT03037203|12146446|P2|NOT COMPLETED|Overall Study||2
4938704|NCT03037203|12146447|P1|NOT COMPLETED|Overall Study||1
4938705|NCT03037203|12146445|P3|COMPLETED|Overall Study||9
4938706|NCT03037203|12146446|P2|COMPLETED|Overall Study||26
4938707|NCT03037203|12146447|P1|COMPLETED|Overall Study||27
4938708|NCT03037203|12146445|P3|STARTED|Overall Study||10
4938709|NCT03037203|12146446|P2|STARTED|Overall Study||28
4938710|NCT03037203|12146447|P1|STARTED|Overall Study||28
4938711|NCT03036852|12146471|P1|NOT COMPLETED|Overall Study||6
4938712|NCT03036852|12146471|P1|COMPLETED|Overall Study||53
4938713|NCT03036852|12146471|P1|STARTED|Overall Study||59
4938714|NCT03036839|12146528|P3|NOT COMPLETED|Overall Study||5
4938715|NCT03036839|12146529|P2|NOT COMPLETED|Overall Study||0
4938716|NCT03036839|12146530|P1|NOT COMPLETED|Overall Study||3
4938717|NCT03036839|12146528|P3|COMPLETED|Overall Study||14
4938718|NCT03036839|12146529|P2|COMPLETED|Overall Study||31
4938719|NCT03036839|12146530|P1|COMPLETED|Overall Study||42
4938720|NCT03036839|12146528|P3|STARTED|Overall Study||19
4938721|NCT03036839|12146529|P2|STARTED|Overall Study||31
4938722|NCT03036839|12146530|P1|STARTED|Overall Study||45
4938723|NCT03036735|12146580|P1|NOT COMPLETED|Overall Study||10
4938724|NCT03036735|12146580|P1|COMPLETED|Overall Study||0
4938725|NCT03036735|12146580|P1|STARTED|Overall Study||10
4938726|NCT03036384|12146588|P10|NOT COMPLETED|Overall Study||0
4938727|NCT03036384|12146589|P9|NOT COMPLETED|Overall Study||0
4938728|NCT03036384|12146590|P8|NOT COMPLETED|Overall Study||0
4938729|NCT03036384|12146591|P7|NOT COMPLETED|Overall Study||0
4938730|NCT03036384|12146592|P6|NOT COMPLETED|Overall Study||0
4938731|NCT03036384|12146593|P5|NOT COMPLETED|Overall Study||0
4938732|NCT03036384|12146594|P4|NOT COMPLETED|Overall Study||0
4938733|NCT03036384|12146595|P3|NOT COMPLETED|Overall Study||0
4938734|NCT03036384|12146596|P2|NOT COMPLETED|Overall Study||0
4938735|NCT03036384|12146597|P1|NOT COMPLETED|Overall Study||0
4938736|NCT03036384|12146588|P10|COMPLETED|Overall Study||4
4938737|NCT03036384|12146589|P9|COMPLETED|Overall Study||4
4938738|NCT03036384|12146590|P8|COMPLETED|Overall Study||4
4938739|NCT03036384|12146591|P7|COMPLETED|Overall Study||4
4938740|NCT03036384|12146592|P6|COMPLETED|Overall Study||4
4938741|NCT03036384|12146593|P5|COMPLETED|Overall Study||4
4938742|NCT03036384|12146594|P4|COMPLETED|Overall Study||4
4938743|NCT03036384|12146595|P3|COMPLETED|Overall Study||4
4938744|NCT03036384|12146596|P2|COMPLETED|Overall Study||4
4938745|NCT03036384|12146597|P1|COMPLETED|Overall Study||4
4938746|NCT03036384|12146588|P10|STARTED|Overall Study||4
4938747|NCT03036384|12146589|P9|STARTED|Overall Study||4
4938748|NCT03036384|12146590|P8|STARTED|Overall Study||4
4938749|NCT03036384|12146591|P7|STARTED|Overall Study||4
4938750|NCT03036384|12146592|P6|STARTED|Overall Study||4
4938751|NCT03036384|12146593|P5|STARTED|Overall Study||4
4938752|NCT03036384|12146594|P4|STARTED|Overall Study||4
4938753|NCT03036384|12146595|P3|STARTED|Overall Study||4
4938754|NCT03036384|12146596|P2|STARTED|Overall Study||4
4938755|NCT03036384|12146597|P1|STARTED|Overall Study||4
4938756|NCT03036215|12146641|P2|NOT COMPLETED|Overall Study||3
4938757|NCT03036215|12146642|P1|NOT COMPLETED|Overall Study||2
4938758|NCT03036215|12146641|P2|COMPLETED|Overall Study||36
4938759|NCT03036215|12146642|P1|COMPLETED|Overall Study||39
4938760|NCT03036215|12146641|P2|STARTED|Overall Study||39
4938761|NCT03036215|12146642|P1|STARTED|Overall Study||41
4938762|NCT03036163|12146659|P7|NOT COMPLETED|Overall Study||0
4938763|NCT03036163|12146660|P6|NOT COMPLETED|Overall Study||0
4938764|NCT03036163|12146661|P5|NOT COMPLETED|Overall Study||0
4938765|NCT03036163|12146662|P4|NOT COMPLETED|Overall Study||0
4938766|NCT03036163|12146663|P3|NOT COMPLETED|Overall Study||0
4938767|NCT03036163|12146664|P2|NOT COMPLETED|Overall Study||0
4938768|NCT03036163|12146665|P1|NOT COMPLETED|Overall Study||0
4938769|NCT03036163|12146659|P7|COMPLETED|Overall Study||5
4938770|NCT03036163|12146660|P6|COMPLETED|Overall Study||5
4938771|NCT03036163|12146661|P5|COMPLETED|Overall Study||6
4938772|NCT03036163|12146662|P4|COMPLETED|Overall Study||6
4938773|NCT03036163|12146663|P3|COMPLETED|Overall Study||6
4938774|NCT03036163|12146664|P2|COMPLETED|Overall Study||6
4938775|NCT03036163|12146665|P1|COMPLETED|Overall Study||6
4938776|NCT03036163|12146659|P7|STARTED|Overall Study||5
4938777|NCT03036163|12146660|P6|STARTED|Overall Study||5
4938778|NCT03036163|12146661|P5|STARTED|Overall Study||6
4938779|NCT03036163|12146662|P4|STARTED|Overall Study||6
4938780|NCT03036163|12146663|P3|STARTED|Overall Study||6
4938781|NCT03036163|12146664|P2|STARTED|Overall Study||6
4938782|NCT03036163|12146665|P1|STARTED|Overall Study||6
4938783|NCT03036072|12146756|P2|NOT COMPLETED|Overall Study||3
4938784|NCT03036072|12146757|P1|NOT COMPLETED|Overall Study||0
4938785|NCT03036072|12146756|P2|COMPLETED|Overall Study||10
4938786|NCT03036072|12146757|P1|COMPLETED|Overall Study||12
4938787|NCT03036072|12146756|P2|STARTED|Overall Study||13
4938788|NCT03036072|12146757|P1|STARTED|Overall Study||12
4938789|NCT03035955|12146767|P2|NOT COMPLETED|Overall Study||1
4938790|NCT03035955|12146768|P1|NOT COMPLETED|Overall Study||1
4938791|NCT03035955|12146767|P2|COMPLETED|Overall Study||9
4938792|NCT03035955|12146768|P1|COMPLETED|Overall Study||9
4938793|NCT03035955|12146767|P2|STARTED|Overall Study||10
4938794|NCT03035955|12146768|P1|STARTED|Overall Study||10
4938795|NCT03035942|12146777|P3|NOT COMPLETED|Overall Study||5
4938796|NCT03035942|12146778|P2|NOT COMPLETED|Overall Study||4
4938797|NCT03035942|12146779|P1|NOT COMPLETED|Overall Study||8
4938798|NCT03035942|12146777|P3|COMPLETED|Overall Study||40
4938799|NCT03035942|12146778|P2|COMPLETED|Overall Study||41
4938800|NCT03035942|12146779|P1|COMPLETED|Overall Study||37
4938801|NCT03035942|12146777|P3|STARTED|Overall Study||45
4938802|NCT03035942|12146778|P2|STARTED|Overall Study||45
4938803|NCT03035942|12146779|P1|STARTED|Overall Study||45
4938804|NCT03035929|12146796|P1|NOT COMPLETED|Overall Study||0
4938805|NCT03035929|12146796|P1|COMPLETED|Overall Study||10
4938806|NCT03035929|12146796|P1|STARTED|Overall Study||10
4938807|NCT03035916|12146808|P3|NOT COMPLETED|Overall Study||0
4938808|NCT03035916|12146809|P2|NOT COMPLETED|Overall Study||2
4938809|NCT03035916|12146810|P1|NOT COMPLETED|Overall Study||0
4938810|NCT03035916|12146808|P3|COMPLETED|Overall Study||31
4938811|NCT03035916|12146809|P2|COMPLETED|Overall Study||28
4938812|NCT03035916|12146810|P1|COMPLETED|Overall Study||30
4938813|NCT03035916|12146808|P3|STARTED|Overall Study||31
4938814|NCT03035916|12146809|P2|STARTED|Overall Study||30
4938815|NCT03035916|12146810|P1|STARTED|Overall Study||30
4938816|NCT03035864|12146859|P2|NOT COMPLETED|Follow-up Period||4
4938817|NCT03035864|12146860|P1|NOT COMPLETED|Follow-up Period||11
4938818|NCT03035864|12146859|P2|COMPLETED|Follow-up Period||55
4938819|NCT03035864|12146860|P1|COMPLETED|Follow-up Period||105
4938820|NCT03035864|12146859|P2|STARTED|Follow-up Period||59
4938821|NCT03035864|12146860|P1|STARTED|Follow-up Period||116
4938822|NCT03035864|12146859|P2|NOT COMPLETED|Treatment Period||1
4938823|NCT03035864|12146860|P1|NOT COMPLETED|Treatment Period||4
4938824|NCT03035864|12146859|P2|COMPLETED|Treatment Period||59
4938825|NCT03035864|12146860|P1|COMPLETED|Treatment Period||116
4938826|NCT03035864|12146859|P2|STARTED|Treatment Period||60
4938827|NCT03035864|12146860|P1|STARTED|Treatment Period||120
4938828|NCT03035760|12146881|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
4938829|NCT03035760|12146882|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
4938830|NCT03035760|12146883|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
4938831|NCT03035760|12146884|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
4938832|NCT03035760|12146885|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
4938833|NCT03035760|12146881|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
4938834|NCT03035760|12146882|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
4938835|NCT03035760|12146883|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
4938836|NCT03035760|12146884|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
4938837|NCT03035760|12146885|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
4938838|NCT03035760|12146881|P5|STARTED|Second Intervention - 7 Days Follow-up||6
4938839|NCT03035760|12146882|P4|STARTED|Second Intervention - 7 Days Follow-up||6
4938840|NCT03035760|12146883|P3|STARTED|Second Intervention - 7 Days Follow-up||0
4938841|NCT03035760|12146884|P2|STARTED|Second Intervention - 7 Days Follow-up||0
4938842|NCT03035760|12146885|P1|STARTED|Second Intervention - 7 Days Follow-up||0
4938843|NCT03035760|12146881|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
4938844|NCT03035760|12146882|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
4938845|NCT03035760|12146883|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
4938846|NCT03035760|12146884|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
4938847|NCT03035760|12146885|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
4938848|NCT03035760|12146881|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
4938849|NCT03035760|12146882|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
4938850|NCT03035760|12146883|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
4938851|NCT03035760|12146884|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
4938852|NCT03035760|12146885|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
4938853|NCT03035760|12146881|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
4938854|NCT03035760|12146882|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
4938855|NCT03035760|12146883|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
4938856|NCT03035760|12146884|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
4938857|NCT03035760|12146885|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
4938858|NCT03035708|12146915|P2|NOT COMPLETED|Overall Study||11
4938859|NCT03035708|12146916|P1|NOT COMPLETED|Overall Study||4
4938860|NCT03035708|12146915|P2|COMPLETED|Overall Study||13
4938861|NCT03035708|12146916|P1|COMPLETED|Overall Study||19
4938862|NCT03035708|12146915|P2|STARTED|Overall Study||24
4938863|NCT03035708|12146916|P1|STARTED|Overall Study||23
4938864|NCT03035487|12146930|P1|NOT COMPLETED|Overall Study||0
4938865|NCT03035487|12146930|P1|COMPLETED|Overall Study||9
4938866|NCT03035487|12146930|P1|STARTED|Overall Study||9
4938867|NCT03034967|12146940|P6|NOT COMPLETED|Overall Study||15
4938868|NCT03034967|12146941|P5|NOT COMPLETED|Overall Study||14
4938869|NCT03034967|12146942|P4|NOT COMPLETED|Overall Study||11
4938870|NCT03034967|12146943|P3|NOT COMPLETED|Overall Study||13
4938871|NCT03034967|12146944|P2|NOT COMPLETED|Overall Study||5
4938872|NCT03034967|12146945|P1|NOT COMPLETED|Overall Study||14
4938873|NCT03034967|12146940|P6|COMPLETED|Overall Study||87
4938874|NCT03034967|12146941|P5|COMPLETED|Overall Study||88
4938875|NCT03034967|12146942|P4|COMPLETED|Overall Study||92
4938876|NCT03034967|12146943|P3|COMPLETED|Overall Study||90
4938877|NCT03034967|12146944|P2|COMPLETED|Overall Study||97
4938878|NCT03034967|12146945|P1|COMPLETED|Overall Study||88
4938879|NCT03034967|12146940|P6|STARTED|Overall Study||102
4938880|NCT03034967|12146941|P5|STARTED|Overall Study||102
4938881|NCT03034967|12146942|P4|STARTED|Overall Study||103
4938882|NCT03034967|12146943|P3|STARTED|Overall Study||103
4938883|NCT03034967|12146944|P2|STARTED|Overall Study||102
4938884|NCT03034967|12146945|P1|STARTED|Overall Study||102
4938885|NCT03034954|12147143|P2|NOT COMPLETED|Overall Study||0
4938886|NCT03034954|12147144|P1|NOT COMPLETED|Overall Study||1
4938887|NCT03034954|12147143|P2|COMPLETED|Overall Study||21
4938888|NCT03034954|12147144|P1|COMPLETED|Overall Study||20
4938889|NCT03034954|12147143|P2|STARTED|Overall Study||21
4938890|NCT03034954|12147144|P1|STARTED|Overall Study||21
4938891|NCT03034928|12147196|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
4938892|NCT03034928|12147197|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
4938893|NCT03034928|12147198|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
4938894|NCT03034928|12147199|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
4938895|NCT03034928|12147196|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
4938896|NCT03034928|12147197|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
4938897|NCT03034928|12147198|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
4938898|NCT03034928|12147199|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
4938899|NCT03034928|12147196|P4|STARTED|Period 2, Second 2 Hours of Wear||8
4938900|NCT03034928|12147197|P3|STARTED|Period 2, Second 2 Hours of Wear||9
4938901|NCT03034928|12147198|P2|STARTED|Period 2, Second 2 Hours of Wear||8
4938902|NCT03034928|12147199|P1|STARTED|Period 2, Second 2 Hours of Wear||8
4938903|NCT03034928|12147196|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
4938904|NCT03034928|12147197|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
4938905|NCT03034928|12147198|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
4938906|NCT03034928|12147199|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
4938907|NCT03034928|12147196|P4|COMPLETED|Washout Period Between Lens Wear||8
4938908|NCT03034928|12147197|P3|COMPLETED|Washout Period Between Lens Wear||9
4938909|NCT03034928|12147198|P2|COMPLETED|Washout Period Between Lens Wear||8
4938910|NCT03034928|12147199|P1|COMPLETED|Washout Period Between Lens Wear||8
4938911|NCT03034928|12147196|P4|STARTED|Washout Period Between Lens Wear||8
4938912|NCT03034928|12147197|P3|STARTED|Washout Period Between Lens Wear||9
4938913|NCT03034928|12147198|P2|STARTED|Washout Period Between Lens Wear||8
4938914|NCT03034928|12147199|P1|STARTED|Washout Period Between Lens Wear||8
4938915|NCT03034928|12147196|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
4938916|NCT03034928|12147197|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
4938917|NCT03034928|12147198|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
4938918|NCT03034928|12147199|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
4938919|NCT03034928|12147196|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
4938920|NCT03034928|12147197|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
4938921|NCT03034928|12147198|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
4938922|NCT03034928|12147199|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
4938923|NCT03034928|12147196|P4|STARTED|Period 1, First 2 Hours of Wear||8
4938924|NCT03034928|12147197|P3|STARTED|Period 1, First 2 Hours of Wear||9
4938925|NCT03034928|12147198|P2|STARTED|Period 1, First 2 Hours of Wear||8
4938926|NCT03034928|12147199|P1|STARTED|Period 1, First 2 Hours of Wear||8
4938927|NCT03034915|12147211|P3|NOT COMPLETED|Overall Study||126
4938928|NCT03034915|12147212|P2|NOT COMPLETED|Overall Study||154
4938929|NCT03034915|12147213|P1|NOT COMPLETED|Overall Study||95
4938930|NCT03034915|12147211|P3|COMPLETED|Overall Study||683
4938931|NCT03034915|12147212|P2|COMPLETED|Overall Study||650
4938932|NCT03034915|12147213|P1|COMPLETED|Overall Study||717
4938933|NCT03034915|12147211|P3|STARTED|Overall Study||809
4938934|NCT03034915|12147212|P2|STARTED|Overall Study||804
4938935|NCT03034915|12147213|P1|STARTED|Overall Study||812
4938936|NCT03034772|12147253|P2|NOT COMPLETED|Overall Study||2
4938937|NCT03034772|12147254|P1|NOT COMPLETED|Overall Study||0
4938938|NCT03034772|12147253|P2|COMPLETED|Overall Study||23
4938939|NCT03034772|12147254|P1|COMPLETED|Overall Study||27
4938940|NCT03034772|12147253|P2|STARTED|Overall Study||25
4938941|NCT03034772|12147254|P1|STARTED|Overall Study||27
4938942|NCT03034577|12147270|P2|NOT COMPLETED|Overall Study||35
4938943|NCT03034577|12147271|P1|NOT COMPLETED|Overall Study||31
4938944|NCT03034577|12147270|P2|COMPLETED|Overall Study||140
4938945|NCT03034577|12147271|P1|COMPLETED|Overall Study||144
4938946|NCT03034577|12147270|P2|STARTED|Overall Study||175
4938947|NCT03034577|12147271|P1|STARTED|Overall Study||175
4938948|NCT03034057|12147287|P1|NOT COMPLETED|Overall Study||55
4938949|NCT03034057|12147287|P1|COMPLETED|Overall Study||114
4938950|NCT03034057|12147287|P1|STARTED|Overall Study||169
4938951|NCT03034044|12147293|P1|NOT COMPLETED|Overall Study||1
4938952|NCT03034044|12147293|P1|COMPLETED|Overall Study||105
4938953|NCT03034044|12147293|P1|Received Xyntha|Overall Study||105
4938954|NCT03034044|12147293|P1|STARTED|Overall Study||106
4938955|NCT03033745|12147316|P3|NOT COMPLETED|Overall Study||2
4938956|NCT03033745|12147317|P2|NOT COMPLETED|Overall Study||1
4938957|NCT03033745|12147318|P1|NOT COMPLETED|Overall Study||1
4938958|NCT03033745|12147316|P3|COMPLETED|Overall Study||14
4938959|NCT03033745|12147317|P2|COMPLETED|Overall Study||17
4938960|NCT03033745|12147318|P1|COMPLETED|Overall Study||14
4938961|NCT03033745|12147316|P3|STARTED|Overall Study||16
4938962|NCT03033745|12147317|P2|STARTED|Overall Study||18
4938963|NCT03033745|12147318|P1|STARTED|Overall Study||15
4938964|NCT03033134|12147353|P2|NOT COMPLETED|Overall Study||12
4938965|NCT03033134|12147354|P1|NOT COMPLETED|Overall Study||42
4938966|NCT03033134|12147353|P2|COMPLETED|Overall Study||0
4938967|NCT03033134|12147354|P1|COMPLETED|Overall Study||0
4938968|NCT03033134|12147353|P2|6-month Primary Endpoints|Overall Study||12
4938969|NCT03033134|12147354|P1|6-month Primary Endpoints|Overall Study||42
4938970|NCT03033134|12147353|P2|STARTED|Overall Study||12
4938971|NCT03033134|12147354|P1|STARTED|Overall Study||42
4938972|NCT03032965|12147376|P2|NOT COMPLETED|Overall Study||0
4938973|NCT03032965|12147377|P1|NOT COMPLETED|Overall Study||0
4938974|NCT03032965|12147376|P2|COMPLETED|Overall Study||68
4938975|NCT03032965|12147377|P1|COMPLETED|Overall Study||61
4938976|NCT03032965|12147376|P2|STARTED|Overall Study||68
4938977|NCT03032965|12147377|P1|STARTED|Overall Study||61
4938978|NCT03032523|12147401|P2|NOT COMPLETED|Overall Study||2
4938979|NCT03032523|12147402|P1|NOT COMPLETED|Overall Study||3
4938980|NCT03032523|12147401|P2|COMPLETED|Overall Study||4
4938981|NCT03032523|12147402|P1|COMPLETED|Overall Study||12
4938982|NCT03032523|12147401|P2|STARTED|Overall Study||6
4938983|NCT03032523|12147402|P1|STARTED|Overall Study||15
4938984|NCT03032510|12147414|P2|NOT COMPLETED|Overall Study||18
4938985|NCT03032510|12147415|P1|NOT COMPLETED|Overall Study||27
4938986|NCT03032510|12147414|P2|COMPLETED|Overall Study||584
4938987|NCT03032510|12147415|P1|COMPLETED|Overall Study||576
4938988|NCT03032510|12147414|P2|STARTED|Overall Study||602
4938989|NCT03032510|12147415|P1|STARTED|Overall Study||603
4938990|NCT03032263|12147427|P2|NOT COMPLETED|Overall Study||0
4938991|NCT03032263|12147428|P1|NOT COMPLETED|Overall Study||0
4938992|NCT03032263|12147427|P2|COMPLETED|Overall Study||6
4938993|NCT03032263|12147428|P1|COMPLETED|Overall Study||6
4938994|NCT03032263|12147427|P2|STARTED|Overall Study||6
4938995|NCT03032263|12147428|P1|STARTED|Overall Study||6
4938996|NCT03031899|12147442|P1|NOT COMPLETED|Overall Study||2
4938997|NCT03031899|12147442|P1|COMPLETED|Overall Study||25
4938998|NCT03031899|12147442|P1|STARTED|Overall Study||27
4938999|NCT03031795|12147452|P2|NOT COMPLETED|Overall Study||1
4939000|NCT03031795|12147453|P1|NOT COMPLETED|Overall Study||0
4939001|NCT03031795|12147452|P2|COMPLETED|Overall Study||35
4939002|NCT03031795|12147453|P1|COMPLETED|Overall Study||35
4939003|NCT03031795|12147452|P2|STARTED|Overall Study||36
4939004|NCT03031795|12147453|P1|STARTED|Overall Study||35
4939005|NCT03031496|12147459|P2|NOT COMPLETED|Period 2||0
4939006|NCT03031496|12147460|P1|NOT COMPLETED|Period 2||0
4939007|NCT03031496|12147459|P2|COMPLETED|Period 2||19
4939008|NCT03031496|12147460|P1|COMPLETED|Period 2||19
4939009|NCT03031496|12147459|P2|STARTED|Period 2||19
4939010|NCT03031496|12147460|P1|STARTED|Period 2||19
4939011|NCT03031496|12147459|P2|NOT COMPLETED|Period 1||2
4939012|NCT03031496|12147460|P1|NOT COMPLETED|Period 1||2
4939013|NCT03031496|12147459|P2|COMPLETED|Period 1||19
4939014|NCT03031496|12147460|P1|COMPLETED|Period 1||19
4939015|NCT03031496|12147459|P2|STARTED|Period 1||21
4939016|NCT03031496|12147460|P1|STARTED|Period 1||21
4939017|NCT03031431|12147496|P1|NOT COMPLETED|Overall Study||1
4939018|NCT03031431|12147496|P1|COMPLETED|Overall Study||129
4939019|NCT03031431|12147496|P1|STARTED|Overall Study||130
4939020|NCT03031340|12147505|P2|NOT COMPLETED|Overall Study||1
4939021|NCT03031340|12147506|P1|NOT COMPLETED|Overall Study||2
4939022|NCT03031340|12147505|P2|COMPLETED|Overall Study||0
4939023|NCT03031340|12147506|P1|COMPLETED|Overall Study||0
4939024|NCT03031340|12147505|P2|STARTED|Overall Study||1
4939025|NCT03031340|12147506|P1|STARTED|Overall Study||2
4939026|NCT03030638|12147530|P8|NOT COMPLETED|Overall Study||0
4939027|NCT03030638|12147531|P7|NOT COMPLETED|Overall Study||0
4939028|NCT03030638|12147532|P6|NOT COMPLETED|Overall Study||0
4939029|NCT03030638|12147533|P5|NOT COMPLETED|Overall Study||0
4939030|NCT03030638|12147534|P4|NOT COMPLETED|Overall Study||0
4939031|NCT03030638|12147535|P3|NOT COMPLETED|Overall Study||0
4939032|NCT03030638|12147536|P2|NOT COMPLETED|Overall Study||0
4939033|NCT03030638|12147537|P1|NOT COMPLETED|Overall Study||0
4939034|NCT03030638|12147530|P8|COMPLETED|Overall Study||127
4939035|NCT03030638|12147531|P7|COMPLETED|Overall Study||364
4939036|NCT03030638|12147532|P6|COMPLETED|Overall Study||1592
4939037|NCT03030638|12147533|P5|COMPLETED|Overall Study||696
4939038|NCT03030638|12147534|P4|COMPLETED|Overall Study||6406
4939039|NCT03030638|12147535|P3|COMPLETED|Overall Study||1712
4939040|NCT03030638|12147536|P2|COMPLETED|Overall Study||1841
4939041|NCT03030638|12147537|P1|COMPLETED|Overall Study||1386
4939042|NCT03030638|12147530|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939043|NCT03030638|12147531|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939044|NCT03030638|12147532|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939045|NCT03030638|12147533|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939046|NCT03030638|12147534|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939047|NCT03030638|12147535|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
4939048|NCT03030638|12147536|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
4939049|NCT03030638|12147537|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
4939050|NCT03030638|12147530|P8|STARTED|Overall Study||127
4939051|NCT03030638|12147531|P7|STARTED|Overall Study||364
4939052|NCT03030638|12147532|P6|STARTED|Overall Study||1592
4939053|NCT03030638|12147533|P5|STARTED|Overall Study||696
4939054|NCT03030638|12147534|P4|STARTED|Overall Study||6406
4939055|NCT03030638|12147535|P3|STARTED|Overall Study||1712
4939056|NCT03030638|12147536|P2|STARTED|Overall Study||1841
4939057|NCT03030638|12147537|P1|STARTED|Overall Study||1386
4939058|NCT03030183|12147567|P1|NOT COMPLETED|Overall Study||0
4939059|NCT03030183|12147567|P1|COMPLETED|Overall Study||3
4939060|NCT03030183|12147567|P1|STARTED|Overall Study||3
4939061|NCT03029988|12147577|P1|NOT COMPLETED|Overall Study||0
4939062|NCT03029988|12147577|P1|COMPLETED|Overall Study||3
4939063|NCT03029988|12147577|P1|STARTED|Overall Study||3
4939064|NCT03029832|12147584|P2|NOT COMPLETED|Overall Study||1
4939065|NCT03029832|12147585|P1|NOT COMPLETED|Overall Study||4
4939066|NCT03029832|12147584|P2|COMPLETED|Overall Study||0
4939067|NCT03029832|12147585|P1|COMPLETED|Overall Study||0
4939068|NCT03029832|12147584|P2|STARTED|Overall Study||1
4939069|NCT03029832|12147585|P1|STARTED|Overall Study||4
4939070|NCT03029819|12147615|P2|NOT COMPLETED|Overall Study||6
4939071|NCT03029819|12147616|P1|NOT COMPLETED|Overall Study||3
4939072|NCT03029819|12147615|P2|COMPLETED|Overall Study||33
4939073|NCT03029819|12147616|P1|COMPLETED|Overall Study||30
4939074|NCT03029819|12147615|P2|STARTED|Overall Study||39
4939075|NCT03029819|12147616|P1|STARTED|Overall Study||33
4939076|NCT03029780|12147630|P2|NOT COMPLETED|Overall Study||11
4939077|NCT03029780|12147631|P1|NOT COMPLETED|Overall Study||6
4939078|NCT03029780|12147630|P2|COMPLETED|Overall Study||41
4939079|NCT03029780|12147631|P1|COMPLETED|Overall Study||46
4939080|NCT03029780|12147630|P2|STARTED|Overall Study||52
4939081|NCT03029780|12147631|P1|STARTED|Overall Study||52
4939082|NCT03029650|12147643|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
4939083|NCT03029650|12147644|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
4939084|NCT03029650|12147643|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
4939085|NCT03029650|12147644|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
4939086|NCT03029650|12147643|P2|STARTED|2nd Intervention (3 - 6 Days)||10
4939087|NCT03029650|12147644|P1|STARTED|2nd Intervention (3 - 6 Days)||13
4939088|NCT03029650|12147643|P2|NOT COMPLETED|Washout (1 Week)||2
4939089|NCT03029650|12147644|P1|NOT COMPLETED|Washout (1 Week)||1
4939090|NCT03029650|12147643|P2|COMPLETED|Washout (1 Week)||10
4939091|NCT03029650|12147644|P1|COMPLETED|Washout (1 Week)||13
4939092|NCT03029650|12147643|P2|STARTED|Washout (1 Week)||12
4939093|NCT03029650|12147644|P1|STARTED|Washout (1 Week)||14
4939094|NCT03029650|12147643|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
4939095|NCT03029650|12147644|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
4939096|NCT03029650|12147643|P2|COMPLETED|First Intervention (3 - 6 Days)||12
4939097|NCT03029650|12147644|P1|COMPLETED|First Intervention (3 - 6 Days)||14
4939098|NCT03029650|12147643|P2|STARTED|First Intervention (3 - 6 Days)||12
4939099|NCT03029650|12147644|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
4939100|NCT03029234|12147659|P1|NOT COMPLETED|Overall Study||67
4939101|NCT03029234|12147659|P1|COMPLETED|Overall Study||59
4939102|NCT03029234|12147659|P1|Received Carfilzomib|Overall Study||123
4939103|NCT03029234|12147659|P1|STARTED|Overall Study||126
4939104|NCT03029000|12147684|P1|NOT COMPLETED|Overall Study||0
4939105|NCT03029000|12147684|P1|COMPLETED|Overall Study||1
4939106|NCT03029000|12147684|P1|STARTED|Overall Study||1
4939107|NCT03028987|12147697|P2|NOT COMPLETED|Overall Study||0
4939108|NCT03028987|12147698|P1|NOT COMPLETED|Overall Study||0
4939109|NCT03028987|12147697|P2|COMPLETED|Overall Study||5
4939110|NCT03028987|12147698|P1|COMPLETED|Overall Study||5
4939111|NCT03028987|12147697|P2|STARTED|Overall Study||5
4939112|NCT03028987|12147698|P1|STARTED|Overall Study||5
4939113|NCT03028974|12147711|P7|NOT COMPLETED|2017-2018||0
4939114|NCT03028974|12147712|P6|NOT COMPLETED|2017-2018||0
4939115|NCT03028974|12147713|P5|NOT COMPLETED|2017-2018||0
4939116|NCT03028974|12147714|P4|NOT COMPLETED|2017-2018||0
4939117|NCT03028974|12147715|P3|NOT COMPLETED|2017-2018||0
4939118|NCT03028974|12147716|P2|NOT COMPLETED|2017-2018||0
4939119|NCT03028974|12147717|P1|NOT COMPLETED|2017-2018||0
4939120|NCT03028974|12147711|P7|COMPLETED|2017-2018||5
4939121|NCT03028974|12147712|P6|COMPLETED|2017-2018||0
4939122|NCT03028974|12147713|P5|COMPLETED|2017-2018||0
4939123|NCT03028974|12147714|P4|COMPLETED|2017-2018||5
4939124|NCT03028974|12147715|P3|COMPLETED|2017-2018||0
4939125|NCT03028974|12147716|P2|COMPLETED|2017-2018||0
4939126|NCT03028974|12147717|P1|COMPLETED|2017-2018||0
4939127|NCT03028974|12147711|P7|STARTED|2017-2018|5 new participants were enrolled.|5
4939128|NCT03028974|12147712|P6|STARTED|2017-2018||0
4939129|NCT03028974|12147713|P5|STARTED|2017-2018||0
4939130|NCT03028974|12147714|P4|STARTED|2017-2018||5
4939131|NCT03028974|12147715|P3|STARTED|2017-2018||0
4939132|NCT03028974|12147716|P2|STARTED|2017-2018||0
4939133|NCT03028974|12147717|P1|STARTED|2017-2018||0
4939134|NCT03028974|12147711|P7|NOT COMPLETED|2016-2017||0
4939135|NCT03028974|12147712|P6|NOT COMPLETED|2016-2017||0
4939136|NCT03028974|12147713|P5|NOT COMPLETED|2016-2017||0
4939137|NCT03028974|12147714|P4|NOT COMPLETED|2016-2017||0
4939138|NCT03028974|12147715|P3|NOT COMPLETED|2016-2017||0
4939139|NCT03028974|12147716|P2|NOT COMPLETED|2016-2017||0
4939140|NCT03028974|12147717|P1|NOT COMPLETED|2016-2017||0
4939141|NCT03028974|12147711|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
4939142|NCT03028974|12147712|P6|COMPLETED|2016-2017||0
4939143|NCT03028974|12147713|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
4939144|NCT03028974|12147714|P4|COMPLETED|2016-2017||4
4939145|NCT03028974|12147715|P3|COMPLETED|2016-2017||0
4939146|NCT03028974|12147716|P2|COMPLETED|2016-2017||0
4939147|NCT03028974|12147717|P1|COMPLETED|2016-2017||0
4939148|NCT03028974|12147711|P7|STARTED|2016-2017|18 new participants were enrolled.|18
4939149|NCT03028974|12147712|P6|STARTED|2016-2017||0
4939150|NCT03028974|12147713|P5|STARTED|2016-2017|2 new participants were enrolled.|2
4939151|NCT03028974|12147714|P4|STARTED|2016-2017|1 new participant was enrolled.|4
4939152|NCT03028974|12147715|P3|STARTED|2016-2017||0
4939153|NCT03028974|12147716|P2|STARTED|2016-2017||0
4939154|NCT03028974|12147717|P1|STARTED|2016-2017||0
4939155|NCT03028974|12147711|P7|NOT COMPLETED|2015-2016||0
4939156|NCT03028974|12147712|P6|NOT COMPLETED|2015-2016||0
4939157|NCT03028974|12147713|P5|NOT COMPLETED|2015-2016||0
4939158|NCT03028974|12147714|P4|NOT COMPLETED|2015-2016||0
4939159|NCT03028974|12147715|P3|NOT COMPLETED|2015-2016||0
4939160|NCT03028974|12147716|P2|NOT COMPLETED|2015-2016||0
4939161|NCT03028974|12147717|P1|NOT COMPLETED|2015-2016||0
4939162|NCT03028974|12147711|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
4939163|NCT03028974|12147712|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
4939164|NCT03028974|12147713|P5|COMPLETED|2015-2016||0
4939165|NCT03028974|12147714|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
4939166|NCT03028974|12147715|P3|COMPLETED|2015-2016||0
4939167|NCT03028974|12147716|P2|COMPLETED|2015-2016||0
4939168|NCT03028974|12147717|P1|COMPLETED|2015-2016||0
4939169|NCT03028974|12147711|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
4939170|NCT03028974|12147712|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
4939171|NCT03028974|12147713|P5|STARTED|2015-2016||0
4939172|NCT03028974|12147714|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
4939173|NCT03028974|12147715|P3|STARTED|2015-2016||0
4939174|NCT03028974|12147716|P2|STARTED|2015-2016||0
4939175|NCT03028974|12147717|P1|STARTED|2015-2016||0
4939176|NCT03028974|12147711|P7|NOT COMPLETED|2014-2015||0
4939177|NCT03028974|12147712|P6|NOT COMPLETED|2014-2015||0
4939178|NCT03028974|12147713|P5|NOT COMPLETED|2014-2015||0
4939179|NCT03028974|12147714|P4|NOT COMPLETED|2014-2015||0
4939180|NCT03028974|12147715|P3|NOT COMPLETED|2014-2015||0
4939181|NCT03028974|12147716|P2|NOT COMPLETED|2014-2015||0
4939182|NCT03028974|12147717|P1|NOT COMPLETED|2014-2015||0
4939183|NCT03028974|12147711|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
4939184|NCT03028974|12147712|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
4939185|NCT03028974|12147713|P5|COMPLETED|2014-2015||0
4939186|NCT03028974|12147714|P4|COMPLETED|2014-2015||3
4939187|NCT03028974|12147715|P3|COMPLETED|2014-2015||0
4939188|NCT03028974|12147716|P2|COMPLETED|2014-2015||0
4939189|NCT03028974|12147717|P1|COMPLETED|2014-2015||1
4939190|NCT03028974|12147711|P7|STARTED|2014-2015||13
4939191|NCT03028974|12147712|P6|STARTED|2014-2015||11
4939192|NCT03028974|12147713|P5|STARTED|2014-2015||0
4939193|NCT03028974|12147714|P4|STARTED|2014-2015||3
4939194|NCT03028974|12147715|P3|STARTED|2014-2015||0
4939195|NCT03028974|12147716|P2|STARTED|2014-2015||0
4939196|NCT03028974|12147717|P1|STARTED|2014-2015||1
4939197|NCT03028896|12147736|P2|NOT COMPLETED|Overall Study||0
4939198|NCT03028896|12147737|P1|NOT COMPLETED|Overall Study||3
4939199|NCT03028896|12147736|P2|COMPLETED|Overall Study||66
4939200|NCT03028896|12147737|P1|COMPLETED|Overall Study||63
4939201|NCT03028896|12147736|P2|STARTED|Overall Study||66
4939202|NCT03028896|12147737|P1|STARTED|Overall Study||66
4939203|NCT03028870|12147753|P4|NOT COMPLETED|Overall Study||9
4939204|NCT03028870|12147754|P3|NOT COMPLETED|Overall Study||16
4939205|NCT03028870|12147755|P2|NOT COMPLETED|Overall Study||10
4939206|NCT03028870|12147756|P1|NOT COMPLETED|Overall Study||17
4939207|NCT03028870|12147753|P4|COMPLETED|Overall Study||65
4939208|NCT03028870|12147754|P3|COMPLETED|Overall Study||60
4939209|NCT03028870|12147755|P2|COMPLETED|Overall Study||57
4939210|NCT03028870|12147756|P1|COMPLETED|Overall Study||57
4939211|NCT03028870|12147753|P4|STARTED|Overall Study||74
4939212|NCT03028870|12147754|P3|STARTED|Overall Study||76
4939213|NCT03028870|12147755|P2|STARTED|Overall Study||67
4939214|NCT03028870|12147756|P1|STARTED|Overall Study||74
4939215|NCT03028636|12147834|P1|NOT COMPLETED|Overall Study||6
4939216|NCT03028636|12147834|P1|COMPLETED|Overall Study||11
4939217|NCT03028636|12147834|P1|STARTED|Overall Study||17
4939218|NCT03028467|12147847|P4|NOT COMPLETED|Overall Study||0
4939219|NCT03028467|12147848|P3|NOT COMPLETED|Overall Study||0
4939220|NCT03028467|12147849|P2|NOT COMPLETED|Overall Study||0
4939221|NCT03028467|12147850|P1|NOT COMPLETED|Overall Study||0
4939222|NCT03028467|12147847|P4|COMPLETED|Overall Study||4
4939223|NCT03028467|12147848|P3|COMPLETED|Overall Study||4
4939224|NCT03028467|12147849|P2|COMPLETED|Overall Study||3
4939225|NCT03028467|12147850|P1|COMPLETED|Overall Study||4
4939226|NCT03028467|12147847|P4|STARTED|Overall Study||4
4939227|NCT03028467|12147848|P3|STARTED|Overall Study||4
4939228|NCT03028467|12147849|P2|STARTED|Overall Study||3
4939229|NCT03028467|12147850|P1|STARTED|Overall Study||4
4939230|NCT03028363|12147914|P2|NOT COMPLETED|Overall Study||33
4939231|NCT03028363|12147915|P1|NOT COMPLETED|Overall Study||78
4939232|NCT03028363|12147914|P2|COMPLETED|Overall Study||228
4939233|NCT03028363|12147915|P1|COMPLETED|Overall Study||420
4939234|NCT03028363|12147914|P2|STARTED|Overall Study||261
4939235|NCT03028363|12147915|P1|STARTED|Overall Study||498
4939236|NCT03028324|12147925|P1|NOT COMPLETED|Overall Study||0
4939237|NCT03028324|12147925|P1|COMPLETED|Overall Study||4
4939238|NCT03028324|12147925|P1|STARTED|Overall Study||4
4939239|NCT03028220|12147932|P2|NOT COMPLETED|Overall Study||0
4939240|NCT03028220|12147933|P1|NOT COMPLETED|Overall Study||0
4939241|NCT03028220|12147932|P2|COMPLETED|Overall Study||20
4939242|NCT03028220|12147933|P1|COMPLETED|Overall Study||20
4939243|NCT03028220|12147932|P2|STARTED|Overall Study||20
4939244|NCT03028220|12147933|P1|STARTED|Overall Study||20
4939245|NCT03028142|12147961|P6|NOT COMPLETED|Overall Study||1
4939246|NCT03028142|12147962|P5|NOT COMPLETED|Overall Study||1
4939247|NCT03028142|12147963|P4|NOT COMPLETED|Overall Study||0
4939248|NCT03028142|12147964|P3|NOT COMPLETED|Overall Study||0
4939249|NCT03028142|12147965|P2|NOT COMPLETED|Overall Study||1
4939250|NCT03028142|12147966|P1|NOT COMPLETED|Overall Study||1
4939251|NCT03028142|12147961|P6|COMPLETED|Overall Study||3
4939252|NCT03028142|12147962|P5|COMPLETED|Overall Study||5
4939253|NCT03028142|12147963|P4|COMPLETED|Overall Study||4
4939254|NCT03028142|12147964|P3|COMPLETED|Overall Study||6
4939255|NCT03028142|12147965|P2|COMPLETED|Overall Study||4
4939256|NCT03028142|12147966|P1|COMPLETED|Overall Study||4
4939257|NCT03028142|12147961|P6|STARTED|Overall Study||4
4939258|NCT03028142|12147962|P5|STARTED|Overall Study||6
4939259|NCT03028142|12147963|P4|STARTED|Overall Study||4
4939260|NCT03028142|12147964|P3|STARTED|Overall Study||6
4939261|NCT03028142|12147965|P2|STARTED|Overall Study||5
4939262|NCT03028142|12147966|P1|STARTED|Overall Study||5
4939263|NCT03028129|12147985|P2|NOT COMPLETED|Overall Study||87
4939264|NCT03028129|12147986|P1|NOT COMPLETED|Overall Study||126
4939265|NCT03028129|12147985|P2|COMPLETED|Overall Study||122
4939266|NCT03028129|12147986|P1|COMPLETED|Overall Study||132
4939267|NCT03028129|12147985|P2|STARTED|Overall Study||209
4939268|NCT03028129|12147986|P1|STARTED|Overall Study||258
4939269|NCT03028025|12147994|P2|NOT COMPLETED|Overall Study||1
4939270|NCT03028025|12147995|P1|NOT COMPLETED|Overall Study||3
4939271|NCT03028025|12147994|P2|COMPLETED|Overall Study||93
4939272|NCT03028025|12147995|P1|COMPLETED|Overall Study||87
4939273|NCT03028025|12147994|P2|STARTED|Overall Study||94
4939274|NCT03028025|12147995|P1|STARTED|Overall Study||90
4939275|NCT03027661|12148005|P2|NOT COMPLETED|Overall Study||0
4939276|NCT03027661|12148006|P1|NOT COMPLETED|Overall Study||0
4939277|NCT03027661|12148005|P2|COMPLETED|Overall Study||21
4939278|NCT03027661|12148006|P1|COMPLETED|Overall Study||20
4939279|NCT03027661|12148005|P2|STARTED|Overall Study||21
4939280|NCT03027661|12148006|P1|STARTED|Overall Study||20
4939281|NCT03026803|12148014|P1|NOT COMPLETED|Overall Study||0
4939282|NCT03026803|12148014|P1|COMPLETED|Overall Study||4
4939283|NCT03026803|12148014|P1|STARTED|Overall Study||4
4939284|NCT03026556|12148021|P3|NOT COMPLETED|Overall Study||0
4939285|NCT03026556|12148022|P2|NOT COMPLETED|Overall Study||0
4939286|NCT03026556|12148023|P1|NOT COMPLETED|Overall Study||0
4939287|NCT03026556|12148021|P3|COMPLETED|Overall Study||12594
4939288|NCT03026556|12148022|P2|COMPLETED|Overall Study||17177
4939289|NCT03026556|12148023|P1|COMPLETED|Overall Study||12763
4939290|NCT03026556|12148021|P3|STARTED|Overall Study||12594
4939291|NCT03026556|12148022|P2|STARTED|Overall Study||17177
4939292|NCT03026556|12148023|P1|STARTED|Overall Study||12763
4939293|NCT03026530|12148082|P2|NOT COMPLETED|Overall Study||29
4939294|NCT03026530|12148083|P1|NOT COMPLETED|Overall Study||21
4939295|NCT03026530|12148082|P2|COMPLETED|Overall Study||71
4939296|NCT03026530|12148083|P1|COMPLETED|Overall Study||79
4939297|NCT03026530|12148082|P2|STARTED|Overall Study||100
4939298|NCT03026530|12148083|P1|STARTED|Overall Study||100
4939299|NCT03026283|12148091|P8|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939300|NCT03026283|12148092|P7|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939301|NCT03026283|12148093|P6|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939302|NCT03026283|12148094|P5|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939303|NCT03026283|12148095|P4|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939304|NCT03026283|12148096|P3|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939305|NCT03026283|12148097|P2|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939306|NCT03026283|12148098|P1|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939307|NCT03026283|12148091|P8|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939308|NCT03026283|12148092|P7|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
4939309|NCT03026283|12148093|P6|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939310|NCT03026283|12148094|P5|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939311|NCT03026283|12148095|P4|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939312|NCT03026283|12148096|P3|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939313|NCT03026283|12148097|P2|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939314|NCT03026283|12148098|P1|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
4939315|NCT03026283|12148091|P8|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939316|NCT03026283|12148092|P7|STARTED|Optimal Care/ICA Diagnostic Cath||21
4939317|NCT03026283|12148093|P6|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939318|NCT03026283|12148094|P5|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939319|NCT03026283|12148095|P4|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939320|NCT03026283|12148096|P3|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939321|NCT03026283|12148097|P2|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939322|NCT03026283|12148098|P1|STARTED|Optimal Care/ICA Diagnostic Cath||0
4939323|NCT03026283|12148091|P8|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
4939324|NCT03026283|12148092|P7|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
4939325|NCT03026283|12148093|P6|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
4939326|NCT03026283|12148094|P5|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
4939327|NCT03026283|12148095|P4|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
4939328|NCT03026283|12148096|P3|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
4939329|NCT03026283|12148097|P2|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
4939330|NCT03026283|12148098|P1|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
4939331|NCT03026283|12148091|P8|COMPLETED|Optimal Care/Stress Test/ICA||0
4939332|NCT03026283|12148092|P7|COMPLETED|Optimal Care/Stress Test/ICA||0
4939333|NCT03026283|12148093|P6|COMPLETED|Optimal Care/Stress Test/ICA||73
4939334|NCT03026283|12148094|P5|COMPLETED|Optimal Care/Stress Test/ICA||14
4939335|NCT03026283|12148095|P4|COMPLETED|Optimal Care/Stress Test/ICA||108
4939336|NCT03026283|12148096|P3|COMPLETED|Optimal Care/Stress Test/ICA||0
4939337|NCT03026283|12148097|P2|COMPLETED|Optimal Care/Stress Test/ICA||0
4939338|NCT03026283|12148098|P1|COMPLETED|Optimal Care/Stress Test/ICA||0
4939339|NCT03026283|12148091|P8|STARTED|Optimal Care/Stress Test/ICA||0
4939340|NCT03026283|12148092|P7|STARTED|Optimal Care/Stress Test/ICA||0
4939341|NCT03026283|12148093|P6|STARTED|Optimal Care/Stress Test/ICA||101
4939342|NCT03026283|12148094|P5|STARTED|Optimal Care/Stress Test/ICA||52
4939343|NCT03026283|12148095|P4|STARTED|Optimal Care/Stress Test/ICA||128
4939344|NCT03026283|12148096|P3|STARTED|Optimal Care/Stress Test/ICA||0
4939345|NCT03026283|12148097|P2|STARTED|Optimal Care/Stress Test/ICA||0
4939346|NCT03026283|12148098|P1|STARTED|Optimal Care/Stress Test/ICA||0
4939347|NCT03026283|12148091|P8|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939348|NCT03026283|12148092|P7|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939349|NCT03026283|12148093|P6|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939350|NCT03026283|12148094|P5|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939351|NCT03026283|12148095|P4|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939352|NCT03026283|12148096|P3|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
4939353|NCT03026283|12148097|P2|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
4939354|NCT03026283|12148098|P1|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939355|NCT03026283|12148091|P8|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939356|NCT03026283|12148092|P7|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939357|NCT03026283|12148093|P6|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939358|NCT03026283|12148094|P5|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939359|NCT03026283|12148095|P4|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939360|NCT03026283|12148096|P3|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
4939361|NCT03026283|12148097|P2|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
4939362|NCT03026283|12148098|P1|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
4939363|NCT03026283|12148091|P8|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939364|NCT03026283|12148092|P7|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939365|NCT03026283|12148093|P6|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939366|NCT03026283|12148094|P5|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939367|NCT03026283|12148095|P4|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939368|NCT03026283|12148096|P3|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
4939369|NCT03026283|12148097|P2|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
4939370|NCT03026283|12148098|P1|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
4939371|NCT03026283|12148091|P8|NOT COMPLETED|CCTA Diagnosis||0
4939372|NCT03026283|12148092|P7|NOT COMPLETED|CCTA Diagnosis||0
4939373|NCT03026283|12148093|P6|NOT COMPLETED|CCTA Diagnosis||0
4939374|NCT03026283|12148094|P5|NOT COMPLETED|CCTA Diagnosis||0
4939375|NCT03026283|12148095|P4|NOT COMPLETED|CCTA Diagnosis||0
4939376|NCT03026283|12148096|P3|NOT COMPLETED|CCTA Diagnosis||0
4939377|NCT03026283|12148097|P2|NOT COMPLETED|CCTA Diagnosis||0
4939378|NCT03026283|12148098|P1|NOT COMPLETED|CCTA Diagnosis||14
4939379|NCT03026283|12148091|P8|COMPLETED|CCTA Diagnosis||0
4939380|NCT03026283|12148092|P7|COMPLETED|CCTA Diagnosis||0
4939381|NCT03026283|12148093|P6|COMPLETED|CCTA Diagnosis||0
4939382|NCT03026283|12148094|P5|COMPLETED|CCTA Diagnosis||0
4939383|NCT03026283|12148095|P4|COMPLETED|CCTA Diagnosis||0
4939384|NCT03026283|12148096|P3|COMPLETED|CCTA Diagnosis||0
4939385|NCT03026283|12148097|P2|COMPLETED|CCTA Diagnosis||0
4939386|NCT03026283|12148098|P1|COMPLETED|CCTA Diagnosis||572
4939387|NCT03026283|12148091|P8|STARTED|CCTA Diagnosis||0
4939388|NCT03026283|12148092|P7|STARTED|CCTA Diagnosis||0
4939389|NCT03026283|12148093|P6|STARTED|CCTA Diagnosis||0
4939390|NCT03026283|12148094|P5|STARTED|CCTA Diagnosis||0
4939391|NCT03026283|12148095|P4|STARTED|CCTA Diagnosis||0
4939392|NCT03026283|12148096|P3|STARTED|CCTA Diagnosis||0
4939393|NCT03026283|12148097|P2|STARTED|CCTA Diagnosis||0
4939394|NCT03026283|12148098|P1|STARTED|CCTA Diagnosis||586
4939395|NCT03026257|12148119|P6|NOT COMPLETED|Overall Study||0
4939396|NCT03026257|12148120|P5|NOT COMPLETED|Overall Study||1
4939397|NCT03026257|12148121|P4|NOT COMPLETED|Overall Study||1
4939398|NCT03026257|12148122|P3|NOT COMPLETED|Overall Study||0
4939399|NCT03026257|12148123|P2|NOT COMPLETED|Overall Study||1
4939400|NCT03026257|12148124|P1|NOT COMPLETED|Overall Study||6
4939401|NCT03026257|12148119|P6|COMPLETED|Overall Study||46
4939402|NCT03026257|12148120|P5|COMPLETED|Overall Study||22
4939403|NCT03026257|12148121|P4|COMPLETED|Overall Study||24
4939404|NCT03026257|12148122|P3|COMPLETED|Overall Study||34
4939405|NCT03026257|12148123|P2|COMPLETED|Overall Study||63
4939406|NCT03026257|12148124|P1|COMPLETED|Overall Study||54
4939407|NCT03026257|12148119|P6|Treated|Overall Study||47
4939408|NCT03026257|12148120|P5|Treated|Overall Study||23
4939409|NCT03026257|12148121|P4|Treated|Overall Study||24
4939410|NCT03026257|12148122|P3|Treated|Overall Study||35
4939411|NCT03026257|12148123|P2|Treated|Overall Study||65
4939412|NCT03026257|12148124|P1|Treated|Overall Study||58
4939413|NCT03026257|12148119|P6|STARTED|Overall Study||46
4939414|NCT03026257|12148120|P5|STARTED|Overall Study||23
4939415|NCT03026257|12148121|P4|STARTED|Overall Study||25
4939416|NCT03026257|12148122|P3|STARTED|Overall Study||34
4939417|NCT03026257|12148123|P2|STARTED|Overall Study||64
4939418|NCT03026257|12148124|P1|STARTED|Overall Study||60
4939419|NCT03026166|12148140|P2|NOT COMPLETED|Overall Study||12
4939420|NCT03026166|12148141|P1|NOT COMPLETED|Overall Study||30
4939421|NCT03026166|12148140|P2|COMPLETED|Overall Study||0
4939422|NCT03026166|12148141|P1|COMPLETED|Overall Study||0
4939423|NCT03026166|12148140|P2|STARTED|Overall Study||12
4939424|NCT03026166|12148141|P1|STARTED|Overall Study||30
4939425|NCT03026088|12148157|P1|NOT COMPLETED|Overall Study||20
4939426|NCT03026088|12148157|P1|COMPLETED|Overall Study||0
4939427|NCT03026088|12148157|P1|STARTED|Overall Study||20
4939428|NCT03026075|12148181|P1|NOT COMPLETED|Overall Study||1
4939429|NCT03026075|12148181|P1|COMPLETED|Overall Study||46
4939430|NCT03026075|12148181|P1|STARTED|Overall Study||47
4939431|NCT03025945|12148187|P2|NOT COMPLETED|Overall Study||0
4939432|NCT03025945|12148188|P1|NOT COMPLETED|Overall Study||0
4939433|NCT03025945|12148187|P2|COMPLETED|Overall Study||331
4939434|NCT03025945|12148188|P1|COMPLETED|Overall Study||331
4939435|NCT03025945|12148187|P2|STARTED|Overall Study||331
4939436|NCT03025945|12148188|P1|STARTED|Overall Study||331
4939437|NCT03025217|12148194|P1|NOT COMPLETED|Overall Study||4
4939438|NCT03025217|12148194|P1|COMPLETED|Overall Study||27
4939439|NCT03025217|12148194|P1|STARTED|Overall Study||31
4939440|NCT03024970|12148199|P2|NOT COMPLETED|Second Intervention||0
4939441|NCT03024970|12148200|P1|NOT COMPLETED|Second Intervention||1
4939442|NCT03024970|12148199|P2|COMPLETED|Second Intervention||38
4939443|NCT03024970|12148200|P1|COMPLETED|Second Intervention||32
4939444|NCT03024970|12148199|P2|STARTED|Second Intervention||38
4939445|NCT03024970|12148200|P1|STARTED|Second Intervention||33
4939446|NCT03024970|12148199|P2|NOT COMPLETED|First Intervention||0
4939447|NCT03024970|12148200|P1|NOT COMPLETED|First Intervention||1
4939448|NCT03024970|12148199|P2|COMPLETED|First Intervention||38
4939449|NCT03024970|12148200|P1|COMPLETED|First Intervention||33
4939450|NCT03024970|12148199|P2|STARTED|First Intervention||38
4939451|NCT03024970|12148200|P1|STARTED|First Intervention||34
4939452|NCT03024606|12148278|P2|NOT COMPLETED|Overall Study||10
4939453|NCT03024606|12148279|P1|NOT COMPLETED|Overall Study||9
4939454|NCT03024606|12148278|P2|COMPLETED|Overall Study||16
4939455|NCT03024606|12148279|P1|COMPLETED|Overall Study||14
4939456|NCT03024606|12148278|P2|STARTED|Overall Study||26
4939457|NCT03024606|12148279|P1|STARTED|Overall Study||23
4939458|NCT03024112|12148287|P2|NOT COMPLETED|Overall Study||0
4939459|NCT03024112|12148288|P1|NOT COMPLETED|Overall Study||7
4939460|NCT03024112|12148287|P2|COMPLETED|Overall Study||26
4939461|NCT03024112|12148288|P1|COMPLETED|Overall Study||18
4939462|NCT03024112|12148287|P2|STARTED|Overall Study||26
4939463|NCT03024112|12148288|P1|STARTED|Overall Study||25
4939464|NCT03023891|12148300|P1|NOT COMPLETED|Overall Study||0
4939465|NCT03023891|12148300|P1|COMPLETED|Overall Study||18
4939466|NCT03023891|12148300|P1|STARTED|Overall Study||18
4939467|NCT03023878|12148307|P1|NOT COMPLETED|Long Term Follow-Up (as of 22-10-2019)||22
4939468|NCT03023878|12148307|P1|COMPLETED|Long Term Follow-Up (as of 22-10-2019)||6
4939469|NCT03023878|12148307|P1|STARTED|Long Term Follow-Up (as of 22-10-2019)||28
4939470|NCT03023878|12148307|P1|NOT COMPLETED|Treatment Period||3
4939471|NCT03023878|12148307|P1|COMPLETED|Treatment Period||25
4939472|NCT03023878|12148307|P1|Started Cycle 2|Treatment Period||11
4939473|NCT03023878|12148307|P1|Started Cycle 1|Treatment Period||28
4939474|NCT03023878|12148307|P1|STARTED|Treatment Period||28
4939475|NCT03023878|12148307|P1|NOT COMPLETED|Between Run-In and Treatment Periods||2
4939476|NCT03023878|12148307|P1|COMPLETED|Between Run-In and Treatment Periods||28
4939477|NCT03023878|12148307|P1|STARTED|Between Run-In and Treatment Periods||30
4939478|NCT03023878|12148307|P1|NOT COMPLETED|Pre-Study Run-In Period||17
4939479|NCT03023878|12148307|P1|COMPLETED|Pre-Study Run-In Period||30
4939480|NCT03023878|12148307|P1|STARTED|Pre-Study Run-In Period||47
4939481|NCT03023709|12148322|P2|NOT COMPLETED|Overall Study||0
4939482|NCT03023709|12148323|P1|NOT COMPLETED|Overall Study||0
4939483|NCT03023709|12148322|P2|COMPLETED|Overall Study||0
4939484|NCT03023709|12148323|P1|COMPLETED|Overall Study||3
4939485|NCT03023709|12148322|P2|STARTED|Overall Study||0
4939486|NCT03023709|12148323|P1|STARTED|Overall Study||3
4939487|NCT03023683|12148333|P2|NOT COMPLETED|Overall Study||1
4939488|NCT03023683|12148334|P1|NOT COMPLETED|Overall Study||0
4939489|NCT03023683|12148333|P2|COMPLETED|Overall Study||17
4939490|NCT03023683|12148334|P1|COMPLETED|Overall Study||0
4939491|NCT03023683|12148333|P2|STARTED|Overall Study||18
4939492|NCT03023683|12148334|P1|STARTED|Overall Study||0
4939493|NCT03023553|12148344|P2|NOT COMPLETED|Overall Study||1
4939494|NCT03023553|12148345|P1|NOT COMPLETED|Overall Study||0
4939495|NCT03023553|12148344|P2|COMPLETED|Overall Study||8
4939496|NCT03023553|12148345|P1|COMPLETED|Overall Study||4
4939497|NCT03023553|12148344|P2|STARTED|Overall Study||9
4939498|NCT03023553|12148345|P1|STARTED|Overall Study||4
4939499|NCT03023488|12148353|P1|NOT COMPLETED|Overall Study||0
4939500|NCT03023488|12148353|P1|COMPLETED|Overall Study||46
4939501|NCT03023488|12148353|P1|STARTED|Overall Study||46
4939502|NCT03023423|12148369|P3|NOT COMPLETED|Overall Study||46
4939503|NCT03023423|12148370|P2|NOT COMPLETED|Overall Study||46
4939504|NCT03023423|12148371|P1|NOT COMPLETED|Overall Study||7
4939505|NCT03023423|12148369|P3|COMPLETED|Overall Study||0
4939506|NCT03023423|12148370|P2|COMPLETED|Overall Study||0
4939507|NCT03023423|12148371|P1|COMPLETED|Overall Study||0
4939508|NCT03023423|12148369|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
4939509|NCT03023423|12148370|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
4939510|NCT03023423|12148371|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
4939511|NCT03023423|12148369|P3|Treated|Overall Study||44
4939512|NCT03023423|12148370|P2|Treated|Overall Study||44
4939513|NCT03023423|12148371|P1|Treated|Overall Study||7
4939514|NCT03023423|12148369|P3|STARTED|Overall Study||46
4939515|NCT03023423|12148370|P2|STARTED|Overall Study||46
4939516|NCT03023423|12148371|P1|STARTED|Overall Study||7
4939517|NCT03023176|12148401|P1|NOT COMPLETED|Overall Study||0
4939518|NCT03023176|12148401|P1|COMPLETED|Overall Study||20
4939519|NCT03023176|12148401|P1|STARTED|Overall Study||20
4939520|NCT03023137|12148408|P2|NOT COMPLETED|Overall Study||9
4939521|NCT03023137|12148409|P1|NOT COMPLETED|Overall Study||4
4939522|NCT03023137|12148408|P2|COMPLETED|Overall Study||162
4939523|NCT03023137|12148409|P1|COMPLETED|Overall Study||174
4939524|NCT03023137|12148408|P2|STARTED|Overall Study||171
4939525|NCT03023137|12148409|P1|STARTED|Overall Study||178
4939526|NCT03022916|12148435|P4|NOT COMPLETED|Overall Study||0
4939527|NCT03022916|12148436|P3|NOT COMPLETED|Overall Study||0
4939528|NCT03022916|12148437|P2|NOT COMPLETED|Overall Study||0
4939529|NCT03022916|12148438|P1|NOT COMPLETED|Overall Study||0
4939530|NCT03022916|12148435|P4|COMPLETED|Overall Study||5
4939531|NCT03022916|12148436|P3|COMPLETED|Overall Study||5
4939532|NCT03022916|12148437|P2|COMPLETED|Overall Study||5
4939533|NCT03022916|12148438|P1|COMPLETED|Overall Study||5
4939534|NCT03022916|12148435|P4|Nail Polish, Top Coat|Overall Study||5
4939535|NCT03022916|12148436|P3|Nail Polish, Top Coat|Overall Study||5
4939536|NCT03022916|12148437|P2|Nail Polish, Top Coat|Overall Study||5
4939537|NCT03022916|12148438|P1|Nail Polish, Top Coat|Overall Study||5
4939538|NCT03022916|12148435|P4|Nail Polish, Base Coat|Overall Study||5
4939539|NCT03022916|12148436|P3|Nail Polish, Base Coat|Overall Study||5
4939540|NCT03022916|12148437|P2|Nail Polish, Base Coat|Overall Study||5
4939541|NCT03022916|12148438|P1|Nail Polish, Base Coat|Overall Study||5
4939542|NCT03022916|12148435|P4|Nail Polish|Overall Study||5
4939543|NCT03022916|12148436|P3|Nail Polish|Overall Study||5
4939544|NCT03022916|12148437|P2|Nail Polish|Overall Study||5
4939545|NCT03022916|12148438|P1|Nail Polish|Overall Study||5
4939546|NCT03022916|12148435|P4|STARTED|Overall Study||5
4939547|NCT03022916|12148436|P3|STARTED|Overall Study||5
4939548|NCT03022916|12148437|P2|STARTED|Overall Study||5
4939549|NCT03022916|12148438|P1|STARTED|Overall Study||5
4939550|NCT03022799|12148458|P13|NOT COMPLETED|Overall Study||0
4939551|NCT03022799|12148459|P12|NOT COMPLETED|Overall Study||0
4939552|NCT03022799|12148460|P11|NOT COMPLETED|Overall Study||1
4939553|NCT03022799|12148461|P10|NOT COMPLETED|Overall Study||1
4939554|NCT03022799|12148462|P9|NOT COMPLETED|Overall Study||0
4939555|NCT03022799|12148463|P8|NOT COMPLETED|Overall Study||0
4939556|NCT03022799|12148464|P7|NOT COMPLETED|Overall Study||0
4939557|NCT03022799|12148465|P6|NOT COMPLETED|Overall Study||0
4939558|NCT03022799|12148466|P5|NOT COMPLETED|Overall Study||0
4939559|NCT03022799|12148467|P4|NOT COMPLETED|Overall Study||0
4939560|NCT03022799|12148468|P3|NOT COMPLETED|Overall Study||0
4939561|NCT03022799|12148469|P2|NOT COMPLETED|Overall Study||0
4939562|NCT03022799|12148470|P1|NOT COMPLETED|Overall Study||0
4939563|NCT03022799|12148458|P13|COMPLETED|Overall Study||10
4939564|NCT03022799|12148459|P12|COMPLETED|Overall Study||6
4939565|NCT03022799|12148460|P11|COMPLETED|Overall Study||5
4939566|NCT03022799|12148461|P10|COMPLETED|Overall Study||5
4939567|NCT03022799|12148462|P9|COMPLETED|Overall Study||6
4939568|NCT03022799|12148463|P8|COMPLETED|Overall Study||6
4939569|NCT03022799|12148464|P7|COMPLETED|Overall Study||12
4939570|NCT03022799|12148465|P6|COMPLETED|Overall Study||6
4939571|NCT03022799|12148466|P5|COMPLETED|Overall Study||6
4939572|NCT03022799|12148467|P4|COMPLETED|Overall Study||6
4939573|NCT03022799|12148468|P3|COMPLETED|Overall Study||6
4939574|NCT03022799|12148469|P2|COMPLETED|Overall Study||6
4939575|NCT03022799|12148470|P1|COMPLETED|Overall Study||6
4939576|NCT03022799|12148458|P13|STARTED|Overall Study||10
4939577|NCT03022799|12148459|P12|STARTED|Overall Study||6
4939578|NCT03022799|12148460|P11|STARTED|Overall Study||6
4939579|NCT03022799|12148461|P10|STARTED|Overall Study||6
4939580|NCT03022799|12148462|P9|STARTED|Overall Study||6
4939581|NCT03022799|12148463|P8|STARTED|Overall Study||6
4939582|NCT03022799|12148464|P7|STARTED|Overall Study||12
4939583|NCT03022799|12148465|P6|STARTED|Overall Study||6
4939584|NCT03022799|12148466|P5|STARTED|Overall Study||6
4939585|NCT03022799|12148467|P4|STARTED|Overall Study||6
4939586|NCT03022799|12148468|P3|STARTED|Overall Study||6
4939587|NCT03022799|12148469|P2|STARTED|Overall Study||6
4939588|NCT03022799|12148470|P1|STARTED|Overall Study||6
4939589|NCT03022630|12148667|P2|NOT COMPLETED|Overall Study||12
4939590|NCT03022630|12148668|P1|NOT COMPLETED|Overall Study||9
4939591|NCT03022630|12148667|P2|COMPLETED|Overall Study||20
4939592|NCT03022630|12148668|P1|COMPLETED|Overall Study||22
4939593|NCT03022630|12148667|P2|STARTED|Overall Study||32
4939594|NCT03022630|12148668|P1|STARTED|Overall Study||31
4939595|NCT03022435|12148721|P5|NOT COMPLETED|Overall Study||0
4939596|NCT03022435|12148722|P4|NOT COMPLETED|Overall Study||0
4939597|NCT03022435|12148723|P3|NOT COMPLETED|Overall Study||0
4939598|NCT03022435|12148724|P2|NOT COMPLETED|Overall Study||0
4939599|NCT03022435|12148725|P1|NOT COMPLETED|Overall Study||0
4939600|NCT03022435|12148721|P5|COMPLETED|Overall Study||3
4939601|NCT03022435|12148722|P4|COMPLETED|Overall Study||3
4939602|NCT03022435|12148723|P3|COMPLETED|Overall Study||6
4939603|NCT03022435|12148724|P2|COMPLETED|Overall Study||5
4939604|NCT03022435|12148725|P1|COMPLETED|Overall Study||5
4939605|NCT03022435|12148721|P5|STARTED|Overall Study||3
4939606|NCT03022435|12148722|P4|STARTED|Overall Study||3
4939607|NCT03022435|12148723|P3|STARTED|Overall Study||6
4939608|NCT03022435|12148724|P2|STARTED|Overall Study||5
4939609|NCT03022435|12148725|P1|STARTED|Overall Study||5
4939610|NCT03022422|12148748|P6|NOT COMPLETED|Overall Study||0
4939611|NCT03022422|12148749|P5|NOT COMPLETED|Overall Study||0
4939612|NCT03022422|12148750|P4|NOT COMPLETED|Overall Study||0
4939613|NCT03022422|12148751|P3|NOT COMPLETED|Overall Study||3
4939614|NCT03022422|12148752|P2|NOT COMPLETED|Overall Study||0
4939615|NCT03022422|12148753|P1|NOT COMPLETED|Overall Study||0
4939616|NCT03022422|12148748|P6|COMPLETED|Overall Study||5
4939617|NCT03022422|12148749|P5|COMPLETED|Overall Study||5
4939618|NCT03022422|12148750|P4|COMPLETED|Overall Study||12
4939619|NCT03022422|12148751|P3|COMPLETED|Overall Study||20
4939620|NCT03022422|12148752|P2|COMPLETED|Overall Study||10
4939621|NCT03022422|12148753|P1|COMPLETED|Overall Study||8
4939622|NCT03022422|12148748|P6|STARTED|Overall Study||5
4939623|NCT03022422|12148749|P5|STARTED|Overall Study||5
4939624|NCT03022422|12148750|P4|STARTED|Overall Study||12
4939625|NCT03022422|12148751|P3|STARTED|Overall Study||23
4939626|NCT03022422|12148752|P2|STARTED|Overall Study||10
4939627|NCT03022422|12148753|P1|STARTED|Overall Study||8
4939628|NCT03022396|12148779|P6|NOT COMPLETED|Overall Study||0
4939629|NCT03022396|12148780|P5|NOT COMPLETED|Overall Study||0
4939630|NCT03022396|12148781|P4|NOT COMPLETED|Overall Study||0
4939631|NCT03022396|12148782|P3|NOT COMPLETED|Overall Study||0
4939632|NCT03022396|12148783|P2|NOT COMPLETED|Overall Study||0
4939633|NCT03022396|12148784|P1|NOT COMPLETED|Overall Study||0
4939634|NCT03022396|12148779|P6|COMPLETED|Overall Study||8
4939635|NCT03022396|12148780|P5|COMPLETED|Overall Study||14
4939636|NCT03022396|12148781|P4|COMPLETED|Overall Study||20
4939637|NCT03022396|12148782|P3|COMPLETED|Overall Study||10
4939638|NCT03022396|12148783|P2|COMPLETED|Overall Study||14
4939639|NCT03022396|12148784|P1|COMPLETED|Overall Study||16
4939640|NCT03022396|12148779|P6|STARTED|Overall Study||8
4939641|NCT03022396|12148780|P5|STARTED|Overall Study||14
4939642|NCT03022396|12148781|P4|STARTED|Overall Study||20
4939643|NCT03022396|12148782|P3|STARTED|Overall Study||10
4939644|NCT03022396|12148783|P2|STARTED|Overall Study||14
4939645|NCT03022396|12148784|P1|STARTED|Overall Study||16
4939646|NCT03022370|12148808|P2|NOT COMPLETED|Overall Study||121
4939647|NCT03022370|12148809|P1|NOT COMPLETED|Overall Study||180
4939648|NCT03022370|12148808|P2|COMPLETED|Overall Study||553
4939649|NCT03022370|12148809|P1|COMPLETED|Overall Study||497
4939650|NCT03022370|12148808|P2|STARTED|Overall Study||674
4939651|NCT03022370|12148809|P1|STARTED|Overall Study||677
4939652|NCT03022084|12148885|P2|NOT COMPLETED|Overall Study||3
4939653|NCT03022084|12148886|P1|NOT COMPLETED|Overall Study||2
4939654|NCT03022084|12148885|P2|COMPLETED|Overall Study||29
4939655|NCT03022084|12148886|P1|COMPLETED|Overall Study||27
4939656|NCT03022084|12148885|P2|STARTED|Overall Study||32
4939657|NCT03022084|12148886|P1|STARTED|Overall Study||29
4939658|NCT03022045|12148894|P2|NOT COMPLETED|Overall Study||2
4939659|NCT03022045|12148895|P1|NOT COMPLETED|Overall Study||1
4939660|NCT03022045|12148894|P2|COMPLETED|Overall Study||6
4939661|NCT03022045|12148895|P1|COMPLETED|Overall Study||8
4939662|NCT03022045|12148894|P2|STARTED|Overall Study||8
4939663|NCT03022045|12148895|P1|STARTED|Overall Study||9
4939664|NCT03021759|12148912|P3|NOT COMPLETED|Overall Study||0
4939665|NCT03021759|12148913|P2|NOT COMPLETED|Overall Study||0
4939666|NCT03021759|12148914|P1|NOT COMPLETED|Overall Study||0
4939667|NCT03021759|12148912|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
4939668|NCT03021759|12148913|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
4939669|NCT03021759|12148914|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
4939670|NCT03021759|12148912|P3|STARTED|Overall Study||1465
4939671|NCT03021759|12148913|P2|STARTED|Overall Study||1743
4939672|NCT03021759|12148914|P1|STARTED|Overall Study||1566
4939673|NCT03021668|12148924|P2|NOT COMPLETED|Overall Study||1
4939674|NCT03021668|12148925|P1|NOT COMPLETED|Overall Study||0
4939675|NCT03021668|12148924|P2|COMPLETED|Overall Study||61
4939676|NCT03021668|12148925|P1|COMPLETED|Overall Study||62
4939677|NCT03021668|12148924|P2|STARTED|Overall Study||62
4939678|NCT03021668|12148925|P1|STARTED|Overall Study||62
4939679|NCT03021642|12148937|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
4939680|NCT03021642|12148938|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
4939681|NCT03021642|12148937|P2|COMPLETED|Treatment Period 2 (Day 22)||11
4939682|NCT03021642|12148938|P1|COMPLETED|Treatment Period 2 (Day 22)||11
4939683|NCT03021642|12148937|P2|STARTED|Treatment Period 2 (Day 22)||11
4939684|NCT03021642|12148938|P1|STARTED|Treatment Period 2 (Day 22)||11
4939685|NCT03021642|12148937|P2|NOT COMPLETED|Washout Period (21 Days)||1
4939686|NCT03021642|12148938|P1|NOT COMPLETED|Washout Period (21 Days)||1
4939687|NCT03021642|12148937|P2|COMPLETED|Washout Period (21 Days)||11
4939688|NCT03021642|12148938|P1|COMPLETED|Washout Period (21 Days)||11
4939689|NCT03021642|12148937|P2|STARTED|Washout Period (21 Days)||12
4939690|NCT03021642|12148938|P1|STARTED|Washout Period (21 Days)||12
4939691|NCT03021642|12148937|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
4939692|NCT03021642|12148938|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
4939693|NCT03021642|12148937|P2|COMPLETED|Treatment Period 1 (Day 1)||12
4939694|NCT03021642|12148938|P1|COMPLETED|Treatment Period 1 (Day 1)||12
4939695|NCT03021642|12148937|P2|STARTED|Treatment Period 1 (Day 1)||12
4939696|NCT03021642|12148938|P1|STARTED|Treatment Period 1 (Day 1)||12
4939697|NCT03021538|12148978|P2|NOT COMPLETED|Overall Study||0
4939698|NCT03021538|12148979|P1|NOT COMPLETED|Overall Study||0
4939699|NCT03021538|12148978|P2|COMPLETED|Overall Study||7
4939700|NCT03021538|12148979|P1|COMPLETED|Overall Study||6
4939701|NCT03021538|12148978|P2|STARTED|Overall Study||7
4939702|NCT03021538|12148979|P1|STARTED|Overall Study||6
4939703|NCT03021343|12148987|P2|NOT COMPLETED|Overall Study||7
4939704|NCT03021343|12148988|P1|NOT COMPLETED|Overall Study||5
4939705|NCT03021343|12148987|P2|COMPLETED|Overall Study||174
4939706|NCT03021343|12148988|P1|COMPLETED|Overall Study||174
4939707|NCT03021343|12148987|P2|STARTED|Overall Study||181
4939708|NCT03021343|12148988|P1|STARTED|Overall Study||179
4939709|NCT03021304|12148996|P1|NOT COMPLETED|Overall Study||1
4939710|NCT03021304|12148996|P1|COMPLETED|Overall Study||55
4939711|NCT03021304|12148996|P1|STARTED|Overall Study||56
4939712|NCT03021265|12149001|P1|NOT COMPLETED|Overall Study||122
4939713|NCT03021265|12149001|P1|COMPLETED|Overall Study||554
4939714|NCT03021265|12149001|P1|STARTED|Overall Study||676
4939715|NCT03021187|12149011|P4|NOT COMPLETED|Overall Study||9
4939716|NCT03021187|12149012|P3|NOT COMPLETED|Overall Study||6
4939717|NCT03021187|12149013|P2|NOT COMPLETED|Overall Study||9
4939718|NCT03021187|12149014|P1|NOT COMPLETED|Overall Study||10
4939719|NCT03021187|12149011|P4|COMPLETED|Overall Study||175
4939720|NCT03021187|12149012|P3|COMPLETED|Overall Study||175
4939721|NCT03021187|12149013|P2|COMPLETED|Overall Study||173
4939722|NCT03021187|12149014|P1|COMPLETED|Overall Study||174
4939723|NCT03021187|12149011|P4|Safety Analysis Set (SAS)|Overall Study||184
4939724|NCT03021187|12149012|P3|Safety Analysis Set (SAS)|Overall Study||181
4939725|NCT03021187|12149013|P2|Safety Analysis Set (SAS)|Overall Study||181
4939726|NCT03021187|12149014|P1|Safety Analysis Set (SAS)|Overall Study||184
4939727|NCT03021187|12149011|P4|Full Analysis Set (FAS)|Overall Study||184
4939728|NCT03021187|12149012|P3|Full Analysis Set (FAS)|Overall Study||181
4939729|NCT03021187|12149013|P2|Full Analysis Set (FAS)|Overall Study||182
4939730|NCT03021187|12149014|P1|Full Analysis Set (FAS)|Overall Study||184
4939731|NCT03021187|12149011|P4|Exposed|Overall Study||184
4939732|NCT03021187|12149012|P3|Exposed|Overall Study||181
4939733|NCT03021187|12149013|P2|Exposed|Overall Study||181
4939734|NCT03021187|12149014|P1|Exposed|Overall Study||184
4939735|NCT03021187|12149011|P4|STARTED|Overall Study||184
4939736|NCT03021187|12149012|P3|STARTED|Overall Study||181
4939737|NCT03021187|12149013|P2|STARTED|Overall Study||182
4939738|NCT03021187|12149014|P1|STARTED|Overall Study||184
4939739|NCT03021018|12149170|P3|NOT COMPLETED|Overall Study||0
4939740|NCT03021018|12149171|P2|NOT COMPLETED|Overall Study||0
4939741|NCT03021018|12149172|P1|NOT COMPLETED|Overall Study||2
4939742|NCT03021018|12149170|P3|COMPLETED|Overall Study||15
4939743|NCT03021018|12149171|P2|COMPLETED|Overall Study||15
4939744|NCT03021018|12149172|P1|COMPLETED|Overall Study||14
4939745|NCT03021018|12149170|P3|STARTED|Overall Study||15
4939746|NCT03021018|12149171|P2|STARTED|Overall Study||15
4939747|NCT03021018|12149172|P1|STARTED|Overall Study||16
4939748|NCT03021005|12149203|P2|NOT COMPLETED|Overall Study||26
4939749|NCT03021005|12149204|P1|NOT COMPLETED|Overall Study||39
4939750|NCT03021005|12149203|P2|COMPLETED|Overall Study||72
4939751|NCT03021005|12149204|P1|COMPLETED|Overall Study||63
4939752|NCT03021005|12149203|P2|STARTED|Overall Study||98
4939753|NCT03021005|12149204|P1|STARTED|Overall Study||102
4939754|NCT03020745|12149218|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939755|NCT03020745|12149219|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
4939756|NCT03020745|12149220|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
4939757|NCT03020745|12149221|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939758|NCT03020745|12149222|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939759|NCT03020745|12149223|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939760|NCT03020745|12149224|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939761|NCT03020745|12149225|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939762|NCT03020745|12149226|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939763|NCT03020745|12149227|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
4939764|NCT03020745|12149218|P10|COMPLETED|Part 2 (Up to 169 Days)||15
4939765|NCT03020745|12149219|P9|COMPLETED|Part 2 (Up to 169 Days)||14
4939766|NCT03020745|12149220|P8|COMPLETED|Part 2 (Up to 169 Days)||19
4939767|NCT03020745|12149221|P7|COMPLETED|Part 2 (Up to 169 Days)||6
4939768|NCT03020745|12149222|P6|COMPLETED|Part 2 (Up to 169 Days)||10
4939769|NCT03020745|12149223|P5|COMPLETED|Part 2 (Up to 169 Days)||0
4939770|NCT03020745|12149224|P4|COMPLETED|Part 2 (Up to 169 Days)||0
4939771|NCT03020745|12149225|P3|COMPLETED|Part 2 (Up to 169 Days)||0
4939772|NCT03020745|12149226|P2|COMPLETED|Part 2 (Up to 169 Days)||0
4939773|NCT03020745|12149227|P1|COMPLETED|Part 2 (Up to 169 Days)||0
4939774|NCT03020745|12149218|P10|STARTED|Part 2 (Up to 169 Days)||15
4939775|NCT03020745|12149219|P9|STARTED|Part 2 (Up to 169 Days)||15
4939776|NCT03020745|12149220|P8|STARTED|Part 2 (Up to 169 Days)||20
4939777|NCT03020745|12149221|P7|STARTED|Part 2 (Up to 169 Days)||6
4939778|NCT03020745|12149222|P6|STARTED|Part 2 (Up to 169 Days)||10
4939779|NCT03020745|12149223|P5|STARTED|Part 2 (Up to 169 Days)||0
4939780|NCT03020745|12149224|P4|STARTED|Part 2 (Up to 169 Days)||0
4939781|NCT03020745|12149225|P3|STARTED|Part 2 (Up to 169 Days)||0
4939782|NCT03020745|12149226|P2|STARTED|Part 2 (Up to 169 Days)||0
4939783|NCT03020745|12149227|P1|STARTED|Part 2 (Up to 169 Days)||0
4939784|NCT03020745|12149218|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939785|NCT03020745|12149219|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939786|NCT03020745|12149220|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939787|NCT03020745|12149221|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939788|NCT03020745|12149222|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939789|NCT03020745|12149223|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939790|NCT03020745|12149224|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939791|NCT03020745|12149225|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939792|NCT03020745|12149226|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939793|NCT03020745|12149227|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
4939794|NCT03020745|12149218|P10|COMPLETED|Part 1 (Up to 60 Days)||0
4939795|NCT03020745|12149219|P9|COMPLETED|Part 1 (Up to 60 Days)||0
4939796|NCT03020745|12149220|P8|COMPLETED|Part 1 (Up to 60 Days)||0
4939797|NCT03020745|12149221|P7|COMPLETED|Part 1 (Up to 60 Days)||0
4939798|NCT03020745|12149222|P6|COMPLETED|Part 1 (Up to 60 Days)||0
4939799|NCT03020745|12149223|P5|COMPLETED|Part 1 (Up to 60 Days)||0
4939800|NCT03020745|12149224|P4|COMPLETED|Part 1 (Up to 60 Days)||6
4939801|NCT03020745|12149225|P3|COMPLETED|Part 1 (Up to 60 Days)||0
4939802|NCT03020745|12149226|P2|COMPLETED|Part 1 (Up to 60 Days)||3
4939803|NCT03020745|12149227|P1|COMPLETED|Part 1 (Up to 60 Days)||3
4939804|NCT03020745|12149218|P10|STARTED|Part 1 (Up to 60 Days)||0
4939805|NCT03020745|12149219|P9|STARTED|Part 1 (Up to 60 Days)||0
4939806|NCT03020745|12149220|P8|STARTED|Part 1 (Up to 60 Days)||0
4939807|NCT03020745|12149221|P7|STARTED|Part 1 (Up to 60 Days)||0
4939808|NCT03020745|12149222|P6|STARTED|Part 1 (Up to 60 Days)||0
4939809|NCT03020745|12149223|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
4939810|NCT03020745|12149224|P4|STARTED|Part 1 (Up to 60 Days)||6
4939811|NCT03020745|12149225|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
4939812|NCT03020745|12149226|P2|STARTED|Part 1 (Up to 60 Days)||3
4939813|NCT03020745|12149227|P1|STARTED|Part 1 (Up to 60 Days)||3
4939814|NCT03020719|12149467|P2|NOT COMPLETED|Overall Study||2
4939815|NCT03020719|12149468|P1|NOT COMPLETED|Overall Study||0
4939816|NCT03020719|12149467|P2|COMPLETED|Overall Study||28
4939817|NCT03020719|12149468|P1|COMPLETED|Overall Study||30
4939818|NCT03020719|12149467|P2|STARTED|Overall Study||30
4939819|NCT03020719|12149468|P1|STARTED|Overall Study||30
4939820|NCT03020576|12149488|P2|NOT COMPLETED|Overall Study||2
4939821|NCT03020576|12149489|P1|NOT COMPLETED|Overall Study||1
4939822|NCT03020576|12149488|P2|COMPLETED|Overall Study||14
4939823|NCT03020576|12149489|P1|COMPLETED|Overall Study||14
4939824|NCT03020576|12149488|P2|STARTED|Overall Study||16
4939825|NCT03020576|12149489|P1|STARTED|Overall Study||15
4939826|NCT03020537|12149511|P2|NOT COMPLETED|Overall Study||0
4939827|NCT03020537|12149512|P1|NOT COMPLETED|Overall Study||0
4939828|NCT03020537|12149511|P2|COMPLETED|Overall Study||7
4939829|NCT03020537|12149512|P1|COMPLETED|Overall Study||1
4939830|NCT03020537|12149511|P2|STARTED|Overall Study||7
4939831|NCT03020537|12149512|P1|STARTED|Overall Study||1
4939832|NCT03020498|12149523|P3|NOT COMPLETED|Overall Study||0
4939833|NCT03020498|12149524|P2|NOT COMPLETED|Overall Study||3
4939834|NCT03020498|12149525|P1|NOT COMPLETED|Overall Study||0
4939835|NCT03020498|12149523|P3|COMPLETED|Overall Study||36
4939836|NCT03020498|12149524|P2|COMPLETED|Overall Study||38
4939837|NCT03020498|12149525|P1|COMPLETED|Overall Study||14
4939838|NCT03020498|12149523|P3|STARTED|Overall Study||36
4939839|NCT03020498|12149524|P2|STARTED|Overall Study||41
4939840|NCT03020498|12149525|P1|STARTED|Overall Study||14
4939841|NCT03020472|12149536|P1|NOT COMPLETED|Overall Study||0
4939842|NCT03020472|12149536|P1|COMPLETED|Overall Study||6
4939843|NCT03020472|12149536|P1|STARTED|Overall Study||6
4939844|NCT03020160|12149544|P2|NOT COMPLETED|Overall Study||41
4939845|NCT03020160|12149545|P1|NOT COMPLETED|Overall Study||7
4939846|NCT03020160|12149544|P2|COMPLETED|Overall Study||0
4939847|NCT03020160|12149545|P1|COMPLETED|Overall Study||0
4939848|NCT03020160|12149544|P2|Completed 24 Weeks in the Study|Overall Study||41
4939849|NCT03020160|12149545|P1|Completed 24 Weeks in the Study|Overall Study||7
4939850|NCT03020160|12149544|P2|STARTED|Overall Study||41
4939851|NCT03020160|12149545|P1|STARTED|Overall Study||7
4939852|NCT03020069|12149600|P2|NOT COMPLETED|Overall Study||1
4939853|NCT03020069|12149601|P1|NOT COMPLETED|Overall Study||0
4939854|NCT03020069|12149600|P2|COMPLETED|Overall Study||3
4939855|NCT03020069|12149601|P1|COMPLETED|Overall Study||9
4939856|NCT03020069|12149600|P2|STARTED|Overall Study||4
4939857|NCT03020069|12149601|P1|STARTED|Overall Study||9
4939858|NCT03020004|12149613|P1|NOT COMPLETED|Overall Study||1
4939859|NCT03020004|12149613|P1|COMPLETED|Overall Study||69
4939860|NCT03020004|12149613|P1|STARTED|Overall Study||70
4939861|NCT03019783|12149619|P2|NOT COMPLETED|Overall Study||0
4939862|NCT03019783|12149620|P1|NOT COMPLETED|Overall Study||0
4939863|NCT03019783|12149619|P2|COMPLETED|Overall Study||31
4939864|NCT03019783|12149620|P1|COMPLETED|Overall Study||29
4939865|NCT03019783|12149619|P2|STARTED|Overall Study||31
4939866|NCT03019783|12149620|P1|STARTED|Overall Study||29
4939867|NCT03019744|12149630|P2|NOT COMPLETED|Overall Study||8
4939868|NCT03019744|12149631|P1|NOT COMPLETED|Overall Study||6
4939869|NCT03019744|12149630|P2|COMPLETED|Overall Study||36
4939870|NCT03019744|12149631|P1|COMPLETED|Overall Study||32
4939871|NCT03019744|12149630|P2|STARTED|Overall Study||44
4939872|NCT03019744|12149631|P1|STARTED|Overall Study||38
4939873|NCT03019627|12149647|P2|NOT COMPLETED|Overall Study||8
4939874|NCT03019627|12149648|P1|NOT COMPLETED|Overall Study||15
4939875|NCT03019627|12149647|P2|COMPLETED|Overall Study||42
4939876|NCT03019627|12149648|P1|COMPLETED|Overall Study||85
4939877|NCT03019627|12149647|P2|STARTED|Overall Study||50
4939878|NCT03019627|12149648|P1|STARTED|Overall Study||100
4939879|NCT03019549|12149664|P1|NOT COMPLETED|Period 2||5
4939880|NCT03019549|12149664|P1|COMPLETED|Period 2||26
4939881|NCT03019549|12149664|P1|Received at Least 1 Dose of Study Drug|Period 2||29
4939882|NCT03019549|12149664|P1|STARTED|Period 2||31
4939883|NCT03019549|12149664|P1|NOT COMPLETED|Washout||11
4939884|NCT03019549|12149664|P1|COMPLETED|Washout||31
4939885|NCT03019549|12149664|P1|STARTED|Washout||42
4939886|NCT03019549|12149664|P1|NOT COMPLETED|Period 1||0
4939887|NCT03019549|12149664|P1|COMPLETED|Period 1||42
4939888|NCT03019549|12149664|P1|Received 1 Dose of Study Drug|Period 1||42
4939889|NCT03019549|12149664|P1|STARTED|Period 1||42
4939890|NCT03019458|12149677|P2|NOT COMPLETED|Overall Study||1
4939891|NCT03019458|12149678|P1|NOT COMPLETED|Overall Study||0
4939892|NCT03019458|12149677|P2|COMPLETED|Overall Study||25
4939893|NCT03019458|12149678|P1|COMPLETED|Overall Study||24
4939894|NCT03019458|12149677|P2|STARTED|Overall Study||26
4939895|NCT03019458|12149678|P1|STARTED|Overall Study||24
4939896|NCT03018938|12149692|P2|NOT COMPLETED|Overall Study||85
4939897|NCT03018938|12149693|P1|NOT COMPLETED|Overall Study||66
4939898|NCT03018938|12149692|P2|COMPLETED|Overall Study||325
4939899|NCT03018938|12149693|P1|COMPLETED|Overall Study||338
4939900|NCT03018938|12149692|P2|Received at Least 1 Dose of Study Drug|Overall Study||410
4939901|NCT03018938|12149693|P1|Received at Least 1 Dose of Study Drug|Overall Study||404
4939902|NCT03018938|12149692|P2|STARTED|Overall Study||410
4939903|NCT03018938|12149693|P1|STARTED|Overall Study||404
4939904|NCT03018691|12149732|P3|NOT COMPLETED|Overall Study||7
4939905|NCT03018691|12149733|P2|NOT COMPLETED|Overall Study||1
4939906|NCT03018691|12149734|P1|NOT COMPLETED|Overall Study||2
4939907|NCT03018691|12149732|P3|COMPLETED|Overall Study||17
4939908|NCT03018691|12149733|P2|COMPLETED|Overall Study||24
4939909|NCT03018691|12149734|P1|COMPLETED|Overall Study||22
4939910|NCT03018691|12149732|P3|STARTED|Overall Study||24
4939911|NCT03018691|12149733|P2|STARTED|Overall Study||25
4939912|NCT03018691|12149734|P1|STARTED|Overall Study||24
4939913|NCT03018340|12149770|P2|NOT COMPLETED|Overall Study||30
4939914|NCT03018340|12149771|P1|NOT COMPLETED|Overall Study||8
4939915|NCT03018340|12149770|P2|COMPLETED|Overall Study||125
4939916|NCT03018340|12149771|P1|COMPLETED|Overall Study||44
4939917|NCT03018340|12149770|P2|STARTED|Overall Study||155
4939918|NCT03018340|12149771|P1|STARTED|Overall Study||52
4939919|NCT03018223|12149821|P1|NOT COMPLETED|Overall Study||0
4939920|NCT03018223|12149821|P1|COMPLETED|Overall Study||32
4939921|NCT03018223|12149821|P1|STARTED|Overall Study||32
4939922|NCT03018106|12149830|P2|NOT COMPLETED|Overall Study||1
4939923|NCT03018106|12149831|P1|NOT COMPLETED|Overall Study||0
4939924|NCT03018106|12149830|P2|COMPLETED|Overall Study||0
4939925|NCT03018106|12149831|P1|COMPLETED|Overall Study||0
4939926|NCT03018106|12149830|P2|STARTED|Overall Study||1
4939927|NCT03018106|12149831|P1|STARTED|Overall Study||0
4939928|NCT03018028|12149844|P5|NOT COMPLETED|Overall Study||0
4939929|NCT03018028|12149845|P4|NOT COMPLETED|Overall Study||2
4939930|NCT03018028|12149846|P3|NOT COMPLETED|Overall Study||1
4939931|NCT03018028|12149847|P2|NOT COMPLETED|Overall Study||0
4939932|NCT03018028|12149848|P1|NOT COMPLETED|Overall Study||3
4939933|NCT03018028|12149844|P5|COMPLETED|Overall Study||49
4939934|NCT03018028|12149845|P4|COMPLETED|Overall Study||46
4939935|NCT03018028|12149846|P3|COMPLETED|Overall Study||47
4939936|NCT03018028|12149847|P2|COMPLETED|Overall Study||49
4939937|NCT03018028|12149848|P1|COMPLETED|Overall Study||46
4939938|NCT03018028|12149844|P5|Safety Analysis Set (SAS)|Overall Study||49
4939939|NCT03018028|12149845|P4|Safety Analysis Set (SAS)|Overall Study||48
4939940|NCT03018028|12149846|P3|Safety Analysis Set (SAS)|Overall Study||48
4939941|NCT03018028|12149847|P2|Safety Analysis Set (SAS)|Overall Study||49
4939942|NCT03018028|12149848|P1|Safety Analysis Set (SAS)|Overall Study||49
4939943|NCT03018028|12149844|P5|Full Analysis Set (FAS)|Overall Study||49
4939944|NCT03018028|12149845|P4|Full Analysis Set (FAS)|Overall Study||48
4939945|NCT03018028|12149846|P3|Full Analysis Set (FAS)|Overall Study||48
4939946|NCT03018028|12149847|P2|Full Analysis Set (FAS)|Overall Study||49
4939947|NCT03018028|12149848|P1|Full Analysis Set (FAS)|Overall Study||49
4939948|NCT03018028|12149844|P5|STARTED|Overall Study||49
4939949|NCT03018028|12149845|P4|STARTED|Overall Study||48
4939950|NCT03018028|12149846|P3|STARTED|Overall Study||48
4939951|NCT03018028|12149847|P2|STARTED|Overall Study||49
4939952|NCT03018028|12149848|P1|STARTED|Overall Study||49
4939953|NCT03017846|12150093|P1|NOT COMPLETED|Overall Study||5
4939954|NCT03017846|12150093|P1|COMPLETED|Overall Study||25
4939955|NCT03017846|12150093|P1|STARTED|Overall Study||30
4939956|NCT03017612|12150101|P1|NOT COMPLETED|Overall Study||2
4939957|NCT03017612|12150101|P1|COMPLETED|Overall Study||11
4939958|NCT03017612|12150101|P1|STARTED|Overall Study||13
4939959|NCT03017261|12150109|P1|NOT COMPLETED|12 Month Follow up||47
4939960|NCT03017261|12150109|P1|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
4939961|NCT03017261|12150109|P1|STARTED|12 Month Follow up||106
4939962|NCT03017261|12150109|P1|NOT COMPLETED|6 Month Follow up||9
4939963|NCT03017261|12150109|P1|COMPLETED|6 Month Follow up||106
4939964|NCT03017261|12150109|P1|STARTED|6 Month Follow up||115
4939965|NCT03017261|12150109|P1|NOT COMPLETED|3 Month Follow up||0
4939966|NCT03017261|12150109|P1|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
4939967|NCT03017261|12150109|P1|STARTED|3 Month Follow up||115
4939968|NCT03017261|12150109|P1|NOT COMPLETED|6 Week Follow up||0
4939969|NCT03017261|12150109|P1|COMPLETED|6 Week Follow up||115
4939970|NCT03017261|12150109|P1|STARTED|6 Week Follow up||115
4939971|NCT03017235|12150146|P2|NOT COMPLETED|Overall Study||14
4939972|NCT03017235|12150147|P1|NOT COMPLETED|Overall Study||12
4939973|NCT03017235|12150146|P2|COMPLETED|Overall Study||447
4939974|NCT03017235|12150147|P1|COMPLETED|Overall Study||444
4939975|NCT03017235|12150146|P2|STARTED|Overall Study||461
4939976|NCT03017235|12150147|P1|STARTED|Overall Study||456
4939977|NCT03017040|12150197|P2|NOT COMPLETED|Overall Study||1
4939978|NCT03017040|12150198|P1|NOT COMPLETED|Overall Study||1
4939979|NCT03017040|12150197|P2|COMPLETED|Overall Study||0
4939980|NCT03017040|12150198|P1|COMPLETED|Overall Study||0
4939981|NCT03017040|12150197|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
4939982|NCT03017040|12150198|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
4939983|NCT03016078|12150208|P1|NOT COMPLETED|Overall Study||2
4939984|NCT03016078|12150208|P1|COMPLETED|Overall Study||19
4939985|NCT03016078|12150208|P1|STARTED|Overall Study||21
4939986|NCT03015649|12150219|P1|NOT COMPLETED|Overall Study||0
4939987|NCT03015649|12150219|P1|COMPLETED|Overall Study||34
4939988|NCT03015649|12150219|P1|STARTED|Overall Study||34
4939989|NCT03015220|12150227|P4|NOT COMPLETED|Overall Study||2
4939990|NCT03015220|12150228|P3|NOT COMPLETED|Overall Study||3
4939991|NCT03015220|12150229|P2|NOT COMPLETED|Overall Study||2
4939992|NCT03015220|12150230|P1|NOT COMPLETED|Overall Study||3
4939993|NCT03015220|12150227|P4|COMPLETED|Overall Study||63
4939994|NCT03015220|12150228|P3|COMPLETED|Overall Study||127
4939995|NCT03015220|12150229|P2|COMPLETED|Overall Study||130
4939996|NCT03015220|12150230|P1|COMPLETED|Overall Study||128
4939997|NCT03015220|12150227|P4|Safety Analysis Set (SAS)|Overall Study||65
4939998|NCT03015220|12150228|P3|Safety Analysis Set (SAS)|Overall Study||130
4939999|NCT03015220|12150229|P2|Safety Analysis Set (SAS)|Overall Study||132
4940000|NCT03015220|12150230|P1|Safety Analysis Set (SAS)|Overall Study||131
4940001|NCT03015220|12150227|P4|Full Analysis Set (FAS)|Overall Study||65
4940002|NCT03015220|12150228|P3|Full Analysis Set (FAS)|Overall Study||130
4940003|NCT03015220|12150229|P2|Full Analysis Set (FAS)|Overall Study||132
4940004|NCT03015220|12150230|P1|Full Analysis Set (FAS)|Overall Study||131
4940005|NCT03015220|12150227|P4|STARTED|Overall Study||65
4940006|NCT03015220|12150228|P3|STARTED|Overall Study||130
4940007|NCT03015220|12150229|P2|STARTED|Overall Study||132
4940008|NCT03015220|12150230|P1|STARTED|Overall Study||131
4940009|NCT03015181|12150375|P7|NOT COMPLETED|Overall Study||1
4940010|NCT03015181|12150376|P6|NOT COMPLETED|Overall Study||1
4940011|NCT03015181|12150377|P5|NOT COMPLETED|Overall Study||0
4940012|NCT03015181|12150378|P4|NOT COMPLETED|Overall Study||0
4940013|NCT03015181|12150379|P3|NOT COMPLETED|Overall Study||0
4940014|NCT03015181|12150380|P2|NOT COMPLETED|Overall Study||0
4940015|NCT03015181|12150381|P1|NOT COMPLETED|Overall Study||1
4940016|NCT03015181|12150375|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
4940017|NCT03015181|12150376|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
4940018|NCT03015181|12150377|P5|COMPLETED|Overall Study||3
4940019|NCT03015181|12150378|P4|COMPLETED|Overall Study||3
4940020|NCT03015181|12150379|P3|COMPLETED|Overall Study||3
4940021|NCT03015181|12150380|P2|COMPLETED|Overall Study||3
4940022|NCT03015181|12150381|P1|COMPLETED|Overall Study||3
4940023|NCT03015181|12150375|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
4940024|NCT03015181|12150376|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
4940025|NCT03015181|12150377|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
4940026|NCT03015181|12150378|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
4940027|NCT03015181|12150379|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
4940028|NCT03015181|12150380|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
4940029|NCT03015181|12150381|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
4940030|NCT03015181|12150375|P7|Received VRC07-523LS Per Protocol|Overall Study||4
4940031|NCT03015181|12150376|P6|Received VRC07-523LS Per Protocol|Overall Study||4
4940032|NCT03015181|12150377|P5|Received VRC07-523LS Per Protocol|Overall Study||3
4940033|NCT03015181|12150378|P4|Received VRC07-523LS Per Protocol|Overall Study||3
4940034|NCT03015181|12150379|P3|Received VRC07-523LS Per Protocol|Overall Study||3
4940035|NCT03015181|12150380|P2|Received VRC07-523LS Per Protocol|Overall Study||3
4940036|NCT03015181|12150381|P1|Received VRC07-523LS Per Protocol|Overall Study||3
4940037|NCT03015181|12150375|P7|STARTED|Overall Study||5
4940038|NCT03015181|12150376|P6|STARTED|Overall Study||5
4940039|NCT03015181|12150377|P5|STARTED|Overall Study||3
4940040|NCT03015181|12150378|P4|STARTED|Overall Study||3
4940041|NCT03015181|12150379|P3|STARTED|Overall Study||3
4940042|NCT03015181|12150380|P2|STARTED|Overall Study||3
4940043|NCT03015181|12150381|P1|STARTED|Overall Study||4
4940044|NCT03015142|12150492|P1|NOT COMPLETED|Overall Study||1
4940045|NCT03015142|12150492|P1|COMPLETED|Overall Study||20
4940046|NCT03015142|12150492|P1|STARTED|Overall Study||21
4940047|NCT03014700|12150507|P2|NOT COMPLETED|Overall Study||1
4940048|NCT03014700|12150508|P1|NOT COMPLETED|Overall Study||5
4940049|NCT03014700|12150507|P2|COMPLETED|Overall Study||29
4940050|NCT03014700|12150508|P1|COMPLETED|Overall Study||25
4940051|NCT03014700|12150507|P2|STARTED|Overall Study||30
4940052|NCT03014700|12150508|P1|STARTED|Overall Study||30
4940053|NCT03014674|12150527|P3|NOT COMPLETED|Overall Study||0
4940054|NCT03014674|12150528|P2|NOT COMPLETED|Overall Study||0
4940055|NCT03014674|12150529|P1|NOT COMPLETED|Overall Study||1
4940056|NCT03014674|12150527|P3|COMPLETED|Overall Study||80
4940057|NCT03014674|12150528|P2|COMPLETED|Overall Study||79
4940058|NCT03014674|12150529|P1|COMPLETED|Overall Study||84
4940059|NCT03014674|12150527|P3|STARTED|Overall Study||80
4940060|NCT03014674|12150528|P2|STARTED|Overall Study||79
4940061|NCT03014674|12150529|P1|STARTED|Overall Study||85
4940062|NCT03014479|12150593|P2|NOT COMPLETED|Overall Study||4
4940063|NCT03014479|12150594|P1|NOT COMPLETED|Overall Study||0
4940064|NCT03014479|12150593|P2|COMPLETED|Overall Study||105
4940065|NCT03014479|12150594|P1|COMPLETED|Overall Study||110
4940066|NCT03014479|12150593|P2|STARTED|Overall Study||109
4940067|NCT03014479|12150594|P1|STARTED|Overall Study||110
4940068|NCT03014453|12150640|P1|NOT COMPLETED|Overall Study||71
4940069|NCT03014453|12150640|P1|COMPLETED|Overall Study||116
4940070|NCT03014453|12150640|P1|STARTED|Overall Study||187
4940071|NCT03014206|12150644|P1|NOT COMPLETED|Overall Study||12
4940072|NCT03014206|12150644|P1|COMPLETED|Overall Study||684
4940073|NCT03014206|12150644|P1|STARTED|Overall Study||696
4940074|NCT03014180|12150648|P1|NOT COMPLETED|Overall Study||2
4940075|NCT03014180|12150648|P1|COMPLETED|Overall Study||58
4940076|NCT03014180|12150648|P1|STARTED|Overall Study||60
4940077|NCT03014011|12150657|P2|NOT COMPLETED|Second Intervention||0
4940078|NCT03014011|12150658|P1|NOT COMPLETED|Second Intervention||0
4940079|NCT03014011|12150657|P2|COMPLETED|Second Intervention||13
4940080|NCT03014011|12150658|P1|COMPLETED|Second Intervention||12
4940081|NCT03014011|12150657|P2|STARTED|Second Intervention||13
4940082|NCT03014011|12150658|P1|STARTED|Second Intervention||12
4940083|NCT03014011|12150657|P2|NOT COMPLETED|Washout||0
4940084|NCT03014011|12150658|P1|NOT COMPLETED|Washout||1
4940085|NCT03014011|12150657|P2|COMPLETED|Washout||13
4940086|NCT03014011|12150658|P1|COMPLETED|Washout||12
4940087|NCT03014011|12150657|P2|STARTED|Washout||13
4940088|NCT03014011|12150658|P1|STARTED|Washout||13
4940089|NCT03014011|12150657|P2|NOT COMPLETED|First Intervention||0
4940090|NCT03014011|12150658|P1|NOT COMPLETED|First Intervention||1
4940091|NCT03014011|12150657|P2|COMPLETED|First Intervention||13
4940092|NCT03014011|12150658|P1|COMPLETED|First Intervention||13
4940093|NCT03014011|12150657|P2|STARTED|First Intervention||13
4940094|NCT03014011|12150658|P1|STARTED|First Intervention||14
4940095|NCT03013985|12150666|P2|NOT COMPLETED|Overall Study||19
4940096|NCT03013985|12150667|P1|NOT COMPLETED|Overall Study||16
4940097|NCT03013985|12150666|P2|COMPLETED|Overall Study||84
4940098|NCT03013985|12150667|P1|COMPLETED|Overall Study||92
4940099|NCT03013985|12150666|P2|STARTED|Overall Study||103
4940100|NCT03013985|12150667|P1|STARTED|Overall Study||108
4940101|NCT03012828|12150705|P6|NOT COMPLETED|Overall Study||2
4940102|NCT03012828|12150706|P5|NOT COMPLETED|Overall Study||2
4940103|NCT03012828|12150707|P4|NOT COMPLETED|Overall Study||0
4940104|NCT03012828|12150708|P3|NOT COMPLETED|Overall Study||2
4940105|NCT03012828|12150709|P2|NOT COMPLETED|Overall Study||0
4940106|NCT03012828|12150710|P1|NOT COMPLETED|Overall Study||1
4940107|NCT03012828|12150705|P6|COMPLETED|Overall Study||8
4940108|NCT03012828|12150706|P5|COMPLETED|Overall Study||8
4940109|NCT03012828|12150707|P4|COMPLETED|Overall Study||10
4940110|NCT03012828|12150708|P3|COMPLETED|Overall Study||8
4940111|NCT03012828|12150709|P2|COMPLETED|Overall Study||10
4940112|NCT03012828|12150710|P1|COMPLETED|Overall Study||9
4940113|NCT03012828|12150705|P6|STARTED|Overall Study||10
4940114|NCT03012828|12150706|P5|STARTED|Overall Study||10
4940115|NCT03012828|12150707|P4|STARTED|Overall Study||10
4940116|NCT03012828|12150708|P3|STARTED|Overall Study||10
4940117|NCT03012828|12150709|P2|STARTED|Overall Study||10
4940118|NCT03012828|12150710|P1|STARTED|Overall Study||10
4940119|NCT03012334|12150753|P10|NOT COMPLETED|Period 5||0
4940120|NCT03012334|12150754|P9|NOT COMPLETED|Period 5||0
4940121|NCT03012334|12150755|P8|NOT COMPLETED|Period 5||0
4940122|NCT03012334|12150756|P7|NOT COMPLETED|Period 5||0
4940123|NCT03012334|12150757|P6|NOT COMPLETED|Period 5||0
4940124|NCT03012334|12150758|P5|NOT COMPLETED|Period 5||0
4940125|NCT03012334|12150759|P4|NOT COMPLETED|Period 5||0
4940126|NCT03012334|12150760|P3|NOT COMPLETED|Period 5||0
4940127|NCT03012334|12150761|P2|NOT COMPLETED|Period 5||0
4940128|NCT03012334|12150762|P1|NOT COMPLETED|Period 5||0
4940129|NCT03012334|12150753|P10|COMPLETED|Period 5||8
4940130|NCT03012334|12150754|P9|COMPLETED|Period 5||8
4940131|NCT03012334|12150755|P8|COMPLETED|Period 5||8
4940132|NCT03012334|12150756|P7|COMPLETED|Period 5||8
4940133|NCT03012334|12150757|P6|COMPLETED|Period 5||9
4940134|NCT03012334|12150758|P5|COMPLETED|Period 5||9
4940135|NCT03012334|12150759|P4|COMPLETED|Period 5||9
4940136|NCT03012334|12150760|P3|COMPLETED|Period 5||8
4940137|NCT03012334|12150761|P2|COMPLETED|Period 5||8
4940138|NCT03012334|12150762|P1|COMPLETED|Period 5||9
4940139|NCT03012334|12150753|P10|STARTED|Period 5||8
4940140|NCT03012334|12150754|P9|STARTED|Period 5||8
4940141|NCT03012334|12150755|P8|STARTED|Period 5||8
4940142|NCT03012334|12150756|P7|STARTED|Period 5||8
4940143|NCT03012334|12150757|P6|STARTED|Period 5||9
4940144|NCT03012334|12150758|P5|STARTED|Period 5||9
4940145|NCT03012334|12150759|P4|STARTED|Period 5||9
4940146|NCT03012334|12150760|P3|STARTED|Period 5||8
4940147|NCT03012334|12150761|P2|STARTED|Period 5||8
4940148|NCT03012334|12150762|P1|STARTED|Period 5||9
4940149|NCT03012334|12150753|P10|NOT COMPLETED|Period 4||0
4940150|NCT03012334|12150754|P9|NOT COMPLETED|Period 4||1
4940151|NCT03012334|12150755|P8|NOT COMPLETED|Period 4||0
4940152|NCT03012334|12150756|P7|NOT COMPLETED|Period 4||1
4940153|NCT03012334|12150757|P6|NOT COMPLETED|Period 4||0
4940154|NCT03012334|12150758|P5|NOT COMPLETED|Period 4||0
4940155|NCT03012334|12150759|P4|NOT COMPLETED|Period 4||0
4940156|NCT03012334|12150760|P3|NOT COMPLETED|Period 4||0
4940157|NCT03012334|12150761|P2|NOT COMPLETED|Period 4||0
4940158|NCT03012334|12150762|P1|NOT COMPLETED|Period 4||0
4940159|NCT03012334|12150753|P10|COMPLETED|Period 4||8
4940160|NCT03012334|12150754|P9|COMPLETED|Period 4||8
4940161|NCT03012334|12150755|P8|COMPLETED|Period 4||8
4940162|NCT03012334|12150756|P7|COMPLETED|Period 4||8
4940163|NCT03012334|12150757|P6|COMPLETED|Period 4||9
4940164|NCT03012334|12150758|P5|COMPLETED|Period 4||9
4940165|NCT03012334|12150759|P4|COMPLETED|Period 4||9
4940166|NCT03012334|12150760|P3|COMPLETED|Period 4||8
4940167|NCT03012334|12150761|P2|COMPLETED|Period 4||8
4940168|NCT03012334|12150762|P1|COMPLETED|Period 4||9
4940169|NCT03012334|12150753|P10|STARTED|Period 4||8
4940170|NCT03012334|12150754|P9|STARTED|Period 4||9
4940171|NCT03012334|12150755|P8|STARTED|Period 4||8
4940172|NCT03012334|12150756|P7|STARTED|Period 4||9
4940173|NCT03012334|12150757|P6|STARTED|Period 4||9
4940174|NCT03012334|12150758|P5|STARTED|Period 4||9
4940175|NCT03012334|12150759|P4|STARTED|Period 4||9
4940176|NCT03012334|12150760|P3|STARTED|Period 4||8
4940177|NCT03012334|12150761|P2|STARTED|Period 4||8
4940178|NCT03012334|12150762|P1|STARTED|Period 4||9
4940179|NCT03012334|12150753|P10|NOT COMPLETED|Period 3||0
4940180|NCT03012334|12150754|P9|NOT COMPLETED|Period 3||0
4940181|NCT03012334|12150755|P8|NOT COMPLETED|Period 3||0
4940182|NCT03012334|12150756|P7|NOT COMPLETED|Period 3||0
4940183|NCT03012334|12150757|P6|NOT COMPLETED|Period 3||0
4940184|NCT03012334|12150758|P5|NOT COMPLETED|Period 3||0
4940185|NCT03012334|12150759|P4|NOT COMPLETED|Period 3||0
4940186|NCT03012334|12150760|P3|NOT COMPLETED|Period 3||0
4940187|NCT03012334|12150761|P2|NOT COMPLETED|Period 3||0
4940188|NCT03012334|12150762|P1|NOT COMPLETED|Period 3||0
4940189|NCT03012334|12150753|P10|COMPLETED|Period 3||8
4940190|NCT03012334|12150754|P9|COMPLETED|Period 3||9
4940191|NCT03012334|12150755|P8|COMPLETED|Period 3||8
4940192|NCT03012334|12150756|P7|COMPLETED|Period 3||9
4940193|NCT03012334|12150757|P6|COMPLETED|Period 3||9
4940194|NCT03012334|12150758|P5|COMPLETED|Period 3||9
4940195|NCT03012334|12150759|P4|COMPLETED|Period 3||9
4940196|NCT03012334|12150760|P3|COMPLETED|Period 3||8
4940197|NCT03012334|12150761|P2|COMPLETED|Period 3||8
4940198|NCT03012334|12150762|P1|COMPLETED|Period 3||9
4940199|NCT03012334|12150753|P10|STARTED|Period 3||8
4940200|NCT03012334|12150754|P9|STARTED|Period 3||9
4940201|NCT03012334|12150755|P8|STARTED|Period 3||8
4940202|NCT03012334|12150756|P7|STARTED|Period 3||9
4940203|NCT03012334|12150757|P6|STARTED|Period 3||9
4940204|NCT03012334|12150758|P5|STARTED|Period 3||9
4940205|NCT03012334|12150759|P4|STARTED|Period 3||9
4940206|NCT03012334|12150760|P3|STARTED|Period 3||8
4940207|NCT03012334|12150761|P2|STARTED|Period 3||8
4940208|NCT03012334|12150762|P1|STARTED|Period 3||9
4940209|NCT03012334|12150753|P10|NOT COMPLETED|Period 2||0
4940210|NCT03012334|12150754|P9|NOT COMPLETED|Period 2||0
4940211|NCT03012334|12150755|P8|NOT COMPLETED|Period 2||1
4940212|NCT03012334|12150756|P7|NOT COMPLETED|Period 2||0
4940213|NCT03012334|12150757|P6|NOT COMPLETED|Period 2||0
4940214|NCT03012334|12150758|P5|NOT COMPLETED|Period 2||0
4940215|NCT03012334|12150759|P4|NOT COMPLETED|Period 2||0
4940216|NCT03012334|12150760|P3|NOT COMPLETED|Period 2||1
4940217|NCT03012334|12150761|P2|NOT COMPLETED|Period 2||1
4940218|NCT03012334|12150762|P1|NOT COMPLETED|Period 2||0
4940219|NCT03012334|12150753|P10|COMPLETED|Period 2||8
4940220|NCT03012334|12150754|P9|COMPLETED|Period 2||9
4940221|NCT03012334|12150755|P8|COMPLETED|Period 2||8
4940222|NCT03012334|12150756|P7|COMPLETED|Period 2||9
4940223|NCT03012334|12150757|P6|COMPLETED|Period 2||9
4940224|NCT03012334|12150758|P5|COMPLETED|Period 2||9
4940225|NCT03012334|12150759|P4|COMPLETED|Period 2||9
4940226|NCT03012334|12150760|P3|COMPLETED|Period 2||8
4940227|NCT03012334|12150761|P2|COMPLETED|Period 2||8
4940228|NCT03012334|12150762|P1|COMPLETED|Period 2||9
4940229|NCT03012334|12150753|P10|STARTED|Period 2||8
4940230|NCT03012334|12150754|P9|STARTED|Period 2||9
4940231|NCT03012334|12150755|P8|STARTED|Period 2||9
4940232|NCT03012334|12150756|P7|STARTED|Period 2||9
4940233|NCT03012334|12150757|P6|STARTED|Period 2||9
4940234|NCT03012334|12150758|P5|STARTED|Period 2||9
4940235|NCT03012334|12150759|P4|STARTED|Period 2||9
4940236|NCT03012334|12150760|P3|STARTED|Period 2||9
4940237|NCT03012334|12150761|P2|STARTED|Period 2||9
4940238|NCT03012334|12150762|P1|STARTED|Period 2||9
4940239|NCT03012334|12150753|P10|NOT COMPLETED|Period 1||1
4940240|NCT03012334|12150754|P9|NOT COMPLETED|Period 1||0
4940241|NCT03012334|12150755|P8|NOT COMPLETED|Period 1||0
4940242|NCT03012334|12150756|P7|NOT COMPLETED|Period 1||0
4940243|NCT03012334|12150757|P6|NOT COMPLETED|Period 1||0
4940244|NCT03012334|12150758|P5|NOT COMPLETED|Period 1||0
4940245|NCT03012334|12150759|P4|NOT COMPLETED|Period 1||0
4940246|NCT03012334|12150760|P3|NOT COMPLETED|Period 1||0
4940247|NCT03012334|12150761|P2|NOT COMPLETED|Period 1||0
4940248|NCT03012334|12150762|P1|NOT COMPLETED|Period 1||0
4940249|NCT03012334|12150753|P10|COMPLETED|Period 1||8
4940250|NCT03012334|12150754|P9|COMPLETED|Period 1||9
4940251|NCT03012334|12150755|P8|COMPLETED|Period 1||9
4940252|NCT03012334|12150756|P7|COMPLETED|Period 1||9
4940253|NCT03012334|12150757|P6|COMPLETED|Period 1||9
4940254|NCT03012334|12150758|P5|COMPLETED|Period 1||9
4940255|NCT03012334|12150759|P4|COMPLETED|Period 1||9
4940256|NCT03012334|12150760|P3|COMPLETED|Period 1||9
4940257|NCT03012334|12150761|P2|COMPLETED|Period 1||9
4940258|NCT03012334|12150762|P1|COMPLETED|Period 1||9
4940259|NCT03012334|12150753|P10|STARTED|Period 1||9
4940260|NCT03012334|12150754|P9|STARTED|Period 1||9
4940261|NCT03012334|12150755|P8|STARTED|Period 1||9
4940262|NCT03012334|12150756|P7|STARTED|Period 1||9
4940263|NCT03012334|12150757|P6|STARTED|Period 1||9
4940264|NCT03012334|12150758|P5|STARTED|Period 1||9
4940265|NCT03012334|12150759|P4|STARTED|Period 1||9
4940266|NCT03012334|12150760|P3|STARTED|Period 1||9
4940267|NCT03012334|12150761|P2|STARTED|Period 1||9
4940268|NCT03012334|12150762|P1|STARTED|Period 1||9
4940269|NCT03012191|12150812|P3|NOT COMPLETED|Overall Study||0
4940270|NCT03012191|12150813|P2|NOT COMPLETED|Overall Study||0
4940271|NCT03012191|12150814|P1|NOT COMPLETED|Overall Study||0
4940272|NCT03012191|12150812|P3|COMPLETED|Overall Study||2
4940273|NCT03012191|12150813|P2|COMPLETED|Overall Study||2
4940274|NCT03012191|12150814|P1|COMPLETED|Overall Study||2
4940275|NCT03012191|12150812|P3|STARTED|Overall Study||2
4940276|NCT03012191|12150813|P2|STARTED|Overall Study||2
4940277|NCT03012191|12150814|P1|STARTED|Overall Study||2
4940278|NCT03012061|12150832|P3|NOT COMPLETED|Overall Study||8
4940279|NCT03012061|12150833|P2|NOT COMPLETED|Overall Study||9
4940280|NCT03012061|12150834|P1|NOT COMPLETED|Overall Study||6
4940281|NCT03012061|12150832|P3|COMPLETED|Overall Study||131
4940282|NCT03012061|12150833|P2|COMPLETED|Overall Study||130
4940283|NCT03012061|12150834|P1|COMPLETED|Overall Study||137
4940284|NCT03012061|12150832|P3|STARTED|Overall Study||139
4940285|NCT03012061|12150833|P2|STARTED|Overall Study||139
4940286|NCT03012061|12150834|P1|STARTED|Overall Study||143
4940287|NCT03011840|12150859|P2|NOT COMPLETED|Overall Study||21
4940288|NCT03011840|12150860|P1|NOT COMPLETED|Overall Study||0
4940289|NCT03011840|12150859|P2|COMPLETED|Overall Study||196
4940290|NCT03011840|12150860|P1|COMPLETED|Overall Study||232
4940291|NCT03011840|12150859|P2|STARTED|Overall Study||217
4940292|NCT03011840|12150860|P1|STARTED|Overall Study||232
4940293|NCT03011099|12150870|P2|NOT COMPLETED|Overall Study||2
4940294|NCT03011099|12150871|P1|NOT COMPLETED|Overall Study||0
4940295|NCT03011099|12150870|P2|COMPLETED|Overall Study||3
4940296|NCT03011099|12150871|P1|COMPLETED|Overall Study||6
4940297|NCT03011099|12150870|P2|STARTED|Overall Study||5
4940298|NCT03011099|12150871|P1|STARTED|Overall Study||6
4940299|NCT03011034|12150897|P2|NOT COMPLETED|Overall Study||0
4940300|NCT03011034|12150898|P1|NOT COMPLETED|Overall Study||1
4940301|NCT03011034|12150897|P2|COMPLETED|Overall Study||33
4940302|NCT03011034|12150898|P1|COMPLETED|Overall Study||0
4940303|NCT03011034|12150897|P2|STARTED|Overall Study||33
4940304|NCT03011034|12150898|P1|STARTED|Overall Study||1
4940305|NCT03010800|12150928|P2|NOT COMPLETED|Cross Over||0
4940306|NCT03010800|12150929|P1|NOT COMPLETED|Cross Over||0
4940307|NCT03010800|12150928|P2|COMPLETED|Cross Over||4
4940308|NCT03010800|12150929|P1|COMPLETED|Cross Over||4
4940309|NCT03010800|12150928|P2|STARTED|Cross Over||4
4940310|NCT03010800|12150929|P1|STARTED|Cross Over||4
4940311|NCT03010800|12150928|P2|NOT COMPLETED|Initial Assignment||0
4940312|NCT03010800|12150929|P1|NOT COMPLETED|Initial Assignment||0
4940313|NCT03010800|12150928|P2|COMPLETED|Initial Assignment||4
4940314|NCT03010800|12150929|P1|COMPLETED|Initial Assignment||4
4940315|NCT03010800|12150928|P2|STARTED|Initial Assignment||4
4940316|NCT03010800|12150929|P1|STARTED|Initial Assignment||4
4940317|NCT03010631|12150939|P4|NOT COMPLETED|Cohort 2||0
4940318|NCT03010631|12150940|P3|NOT COMPLETED|Cohort 2||0
4940319|NCT03010631|12150941|P2|NOT COMPLETED|Cohort 2||0
4940320|NCT03010631|12150942|P1|NOT COMPLETED|Cohort 2||0
4940321|NCT03010631|12150939|P4|COMPLETED|Cohort 2||7
4940322|NCT03010631|12150940|P3|COMPLETED|Cohort 2||7
4940323|NCT03010631|12150941|P2|COMPLETED|Cohort 2||0
4940324|NCT03010631|12150942|P1|COMPLETED|Cohort 2||0
4940325|NCT03010631|12150939|P4|STARTED|Cohort 2||7
4940326|NCT03010631|12150940|P3|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
4940327|NCT03010631|12150941|P2|STARTED|Cohort 2||0
4940328|NCT03010631|12150942|P1|STARTED|Cohort 2||0
4940329|NCT03010631|12150939|P4|NOT COMPLETED|Cohort 1||0
4940330|NCT03010631|12150940|P3|NOT COMPLETED|Cohort 1||0
4940331|NCT03010631|12150941|P2|NOT COMPLETED|Cohort 1||0
4940332|NCT03010631|12150942|P1|NOT COMPLETED|Cohort 1||4
4940333|NCT03010631|12150939|P4|COMPLETED|Cohort 1||0
4940334|NCT03010631|12150940|P3|COMPLETED|Cohort 1||0
4940335|NCT03010631|12150941|P2|COMPLETED|Cohort 1||17
4940336|NCT03010631|12150942|P1|COMPLETED|Cohort 1||14
4940337|NCT03010631|12150939|P4|STARTED|Cohort 1||0
4940338|NCT03010631|12150940|P3|STARTED|Cohort 1||0
4940339|NCT03010631|12150941|P2|STARTED|Cohort 1||17
4940340|NCT03010631|12150942|P1|STARTED|Cohort 1||18
4940341|NCT03010501|12150960|P6|NOT COMPLETED|Study Week 3||0
4940342|NCT03010501|12150961|P5|NOT COMPLETED|Study Week 3||0
4940343|NCT03010501|12150962|P4|NOT COMPLETED|Study Week 3||1
4940344|NCT03010501|12150963|P3|NOT COMPLETED|Study Week 3||0
4940345|NCT03010501|12150964|P2|NOT COMPLETED|Study Week 3||0
4940346|NCT03010501|12150965|P1|NOT COMPLETED|Study Week 3||0
4940347|NCT03010501|12150960|P6|COMPLETED|Study Week 3||11
4940348|NCT03010501|12150961|P5|COMPLETED|Study Week 3||7
4940349|NCT03010501|12150962|P4|COMPLETED|Study Week 3||4
4940350|NCT03010501|12150963|P3|COMPLETED|Study Week 3||7
4940351|NCT03010501|12150964|P2|COMPLETED|Study Week 3||14
4940352|NCT03010501|12150965|P1|COMPLETED|Study Week 3||7
4940353|NCT03010501|12150960|P6|STARTED|Study Week 3||11
4940354|NCT03010501|12150961|P5|STARTED|Study Week 3||7
4940355|NCT03010501|12150962|P4|STARTED|Study Week 3||5
4940356|NCT03010501|12150963|P3|STARTED|Study Week 3||7
4940357|NCT03010501|12150964|P2|STARTED|Study Week 3||14
4940358|NCT03010501|12150965|P1|STARTED|Study Week 3||7
4940359|NCT03010501|12150960|P6|NOT COMPLETED|Study Week 2||0
4940360|NCT03010501|12150961|P5|NOT COMPLETED|Study Week 2||0
4940361|NCT03010501|12150962|P4|NOT COMPLETED|Study Week 2||0
4940362|NCT03010501|12150963|P3|NOT COMPLETED|Study Week 2||0
4940363|NCT03010501|12150964|P2|NOT COMPLETED|Study Week 2||0
4940364|NCT03010501|12150965|P1|NOT COMPLETED|Study Week 2||0
4940365|NCT03010501|12150960|P6|COMPLETED|Study Week 2||11
4940366|NCT03010501|12150961|P5|COMPLETED|Study Week 2||7
4940367|NCT03010501|12150962|P4|COMPLETED|Study Week 2||5
4940368|NCT03010501|12150963|P3|COMPLETED|Study Week 2||7
4940369|NCT03010501|12150964|P2|COMPLETED|Study Week 2||14
4940370|NCT03010501|12150965|P1|COMPLETED|Study Week 2||7
4940371|NCT03010501|12150960|P6|STARTED|Study Week 2||11
4940372|NCT03010501|12150961|P5|STARTED|Study Week 2||7
4940373|NCT03010501|12150962|P4|STARTED|Study Week 2||5
4940374|NCT03010501|12150963|P3|STARTED|Study Week 2||7
4940375|NCT03010501|12150964|P2|STARTED|Study Week 2||14
4940376|NCT03010501|12150965|P1|STARTED|Study Week 2||7
4940377|NCT03010501|12150960|P6|NOT COMPLETED|Study Week 1||0
4940378|NCT03010501|12150961|P5|NOT COMPLETED|Study Week 1||0
4940379|NCT03010501|12150962|P4|NOT COMPLETED|Study Week 1||2
4940380|NCT03010501|12150963|P3|NOT COMPLETED|Study Week 1||0
4940381|NCT03010501|12150964|P2|NOT COMPLETED|Study Week 1||1
4940382|NCT03010501|12150965|P1|NOT COMPLETED|Study Week 1||2
4940383|NCT03010501|12150960|P6|COMPLETED|Study Week 1||11
4940384|NCT03010501|12150961|P5|COMPLETED|Study Week 1||7
4940385|NCT03010501|12150962|P4|COMPLETED|Study Week 1||5
4940386|NCT03010501|12150963|P3|COMPLETED|Study Week 1||7
4940387|NCT03010501|12150964|P2|COMPLETED|Study Week 1||14
4940388|NCT03010501|12150965|P1|COMPLETED|Study Week 1||7
4940389|NCT03010501|12150960|P6|STARTED|Study Week 1||11
4940390|NCT03010501|12150961|P5|STARTED|Study Week 1||7
4940391|NCT03010501|12150962|P4|STARTED|Study Week 1||7
4940392|NCT03010501|12150963|P3|STARTED|Study Week 1||7
4940393|NCT03010501|12150964|P2|STARTED|Study Week 1||15
4940394|NCT03010501|12150965|P1|STARTED|Study Week 1||9
4940395|NCT03010423|12150979|P1|NOT COMPLETED|Overall Study||8
4940396|NCT03010423|12150979|P1|COMPLETED|Overall Study||0
4940397|NCT03010423|12150979|P1|STARTED|Overall Study||8
4940398|NCT03010254|12150992|P2|NOT COMPLETED|Overall Study||5
4940399|NCT03010254|12150993|P1|NOT COMPLETED|Overall Study||7
4940400|NCT03010254|12150992|P2|COMPLETED|Overall Study||118
4940401|NCT03010254|12150993|P1|COMPLETED|Overall Study||152
4940402|NCT03010254|12150992|P2|Successful Implantation|Overall Study||120
4940403|NCT03010254|12150993|P1|Successful Implantation|Overall Study||156
4940404|NCT03010254|12150992|P2|Attempted Implantation|Overall Study||120
4940405|NCT03010254|12150993|P1|Attempted Implantation|Overall Study||156
4940406|NCT03010254|12150992|P2|STARTED|Overall Study||123
4940407|NCT03010254|12150993|P1|STARTED|Overall Study||159
4940408|NCT03010137|12151020|P2|NOT COMPLETED|Overall Study||0
4940409|NCT03010137|12151021|P1|NOT COMPLETED|Overall Study||0
4940410|NCT03010137|12151020|P2|COMPLETED|Overall Study||15
4940411|NCT03010137|12151021|P1|COMPLETED|Overall Study||15
4940412|NCT03010137|12151020|P2|STARTED|Overall Study||15
4940413|NCT03010137|12151021|P1|STARTED|Overall Study||15
4940414|NCT03009162|12151037|P2|NOT COMPLETED|Overall Study||0
4940415|NCT03009162|12151038|P1|NOT COMPLETED|Overall Study||0
4940416|NCT03009162|12151037|P2|COMPLETED|Overall Study||8
4940417|NCT03009162|12151038|P1|COMPLETED|Overall Study||8
4940418|NCT03009162|12151037|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
4940419|NCT03009162|12151038|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
4940420|NCT03009162|12151037|P2|STARTED|Overall Study||8
4940421|NCT03009162|12151038|P1|STARTED|Overall Study||8
4940422|NCT03008837|12151060|P2|NOT COMPLETED|Overall Study||4
4940423|NCT03008837|12151061|P1|NOT COMPLETED|Overall Study||3
4940424|NCT03008837|12151060|P2|COMPLETED|Overall Study||5
4940425|NCT03008837|12151061|P1|COMPLETED|Overall Study||9
4940426|NCT03008837|12151060|P2|STARTED|Overall Study||9
4940427|NCT03008837|12151061|P1|STARTED|Overall Study||12
4940428|NCT03008707|12151079|P2|NOT COMPLETED|Overall Study||0
4940429|NCT03008707|12151080|P1|NOT COMPLETED|Overall Study||0
4940430|NCT03008707|12151079|P2|COMPLETED|Overall Study||38
4940431|NCT03008707|12151080|P1|COMPLETED|Overall Study||28
4940432|NCT03008707|12151079|P2|STARTED|Overall Study||38
4940433|NCT03008707|12151080|P1|STARTED|Overall Study||28
4940434|NCT03008213|12151100|P1|NOT COMPLETED|Overall Study||0
4940435|NCT03008213|12151100|P1|COMPLETED|Overall Study||1
4940436|NCT03008213|12151100|P1|STARTED|Overall Study||1
4940437|NCT03008174|12151106|P2|NOT COMPLETED|Overall Study||4
4940438|NCT03008174|12151107|P1|NOT COMPLETED|Overall Study||3
4940439|NCT03008174|12151106|P2|COMPLETED|Overall Study||6
4940440|NCT03008174|12151107|P1|COMPLETED|Overall Study||7
4940441|NCT03008174|12151106|P2|STARTED|Overall Study||10
4940442|NCT03008174|12151107|P1|STARTED|Overall Study||10
4940443|NCT03007966|12151135|P2|NOT COMPLETED|Overall Study||0
4940444|NCT03007966|12151136|P1|NOT COMPLETED|Overall Study||1
4940445|NCT03007966|12151135|P2|COMPLETED|Overall Study||30
4940446|NCT03007966|12151136|P1|COMPLETED|Overall Study||29
4940447|NCT03007966|12151135|P2|STARTED|Overall Study||30
4940448|NCT03007966|12151136|P1|STARTED|Overall Study||30
4940449|NCT03007719|12151168|P2|NOT COMPLETED|Overall Study||0
4940450|NCT03007719|12151169|P1|NOT COMPLETED|Overall Study||0
4940451|NCT03007719|12151168|P2|COMPLETED|Overall Study||4
4940452|NCT03007719|12151169|P1|COMPLETED|Overall Study||0
4940453|NCT03007719|12151168|P2|STARTED|Overall Study||4
4940454|NCT03007719|12151169|P1|STARTED|Overall Study||0
4940455|NCT03007394|12151179|P2|NOT COMPLETED|Overall Study||63
4940456|NCT03007394|12151180|P1|NOT COMPLETED|Overall Study||27
4940457|NCT03007394|12151179|P2|COMPLETED|Overall Study||91
4940458|NCT03007394|12151180|P1|COMPLETED|Overall Study||91
4940459|NCT03007394|12151179|P2|STARTED|Overall Study||154
4940460|NCT03007394|12151180|P1|STARTED|Overall Study||118
4940461|NCT03006562|12151190|P2|NOT COMPLETED|Overall Study||1
4940462|NCT03006562|12151191|P1|NOT COMPLETED|Overall Study||0
4940463|NCT03006562|12151190|P2|COMPLETED|Overall Study||249
4940464|NCT03006562|12151191|P1|COMPLETED|Overall Study||251
4940465|NCT03006562|12151190|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
4940466|NCT03006562|12151191|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
4940467|NCT03006562|12151190|P2|STARTED|Overall Study||250
4940468|NCT03006562|12151191|P1|STARTED|Overall Study||251
4940469|NCT03006458|12151209|P2|NOT COMPLETED|Second Intervention||0
4940470|NCT03006458|12151210|P1|NOT COMPLETED|Second Intervention||0
4940471|NCT03006458|12151209|P2|COMPLETED|Second Intervention||10
4940472|NCT03006458|12151210|P1|COMPLETED|Second Intervention||14
4940473|NCT03006458|12151209|P2|STARTED|Second Intervention||10
4940474|NCT03006458|12151210|P1|STARTED|Second Intervention||14
4940475|NCT03006458|12151209|P2|NOT COMPLETED|First Intervention||3
4940476|NCT03006458|12151210|P1|NOT COMPLETED|First Intervention||0
4940477|NCT03006458|12151209|P2|COMPLETED|First Intervention||7
4940478|NCT03006458|12151210|P1|COMPLETED|First Intervention||14
4940479|NCT03006458|12151209|P2|STARTED|First Intervention||10
4940480|NCT03006458|12151210|P1|STARTED|First Intervention||14
4940481|NCT03006341|12151252|P4|NOT COMPLETED|Overall Study||10685
4940482|NCT03006341|12151253|P3|NOT COMPLETED|Overall Study||30993
4940483|NCT03006341|12151254|P2|NOT COMPLETED|Overall Study||67505
4940484|NCT03006341|12151255|P1|NOT COMPLETED|Overall Study||25069
4940485|NCT03006341|12151252|P4|COMPLETED|Overall Study||637
4940486|NCT03006341|12151253|P3|COMPLETED|Overall Study||1602
4940487|NCT03006341|12151254|P2|COMPLETED|Overall Study||2566
4940488|NCT03006341|12151255|P1|COMPLETED|Overall Study||1130
4940489|NCT03006341|12151252|P4|STARTED|Overall Study||11322
4940490|NCT03006341|12151253|P3|STARTED|Overall Study||32595
4940491|NCT03006341|12151254|P2|STARTED|Overall Study||70071
4940492|NCT03006341|12151255|P1|STARTED|Overall Study||26199
4940493|NCT03005288|12151299|P2|NOT COMPLETED|Overall Study||8
4940494|NCT03005288|12151300|P1|NOT COMPLETED|Overall Study||12
4940495|NCT03005288|12151299|P2|COMPLETED|Overall Study||31
4940496|NCT03005288|12151300|P1|COMPLETED|Overall Study||27
4940497|NCT03005288|12151299|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
4940498|NCT03005288|12151300|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
4940499|NCT03005288|12151299|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
4940500|NCT03005288|12151300|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
4940501|NCT03005288|12151299|P2|Safety Analysis Set|Overall Study||38
4940502|NCT03005288|12151300|P1|Safety Analysis Set|Overall Study||37
4940503|NCT03005288|12151299|P2|STARTED|Overall Study||39
4940504|NCT03005288|12151300|P1|STARTED|Overall Study||39
4940505|NCT03005067|12151332|P2|NOT COMPLETED|Overall Study||7
4940506|NCT03005067|12151333|P1|NOT COMPLETED|Overall Study||10
4940507|NCT03005067|12151332|P2|COMPLETED|Overall Study||74
4940508|NCT03005067|12151333|P1|COMPLETED|Overall Study||80
4940509|NCT03005067|12151332|P2|STARTED|Overall Study||81
4940510|NCT03005067|12151333|P1|STARTED|Overall Study||90
4940511|NCT03005041|12151345|P2|NOT COMPLETED|Period 2||0
4940512|NCT03005041|12151346|P1|NOT COMPLETED|Period 2||0
4940513|NCT03005041|12151345|P2|COMPLETED|Period 2||27
4940514|NCT03005041|12151346|P1|COMPLETED|Period 2||28
4940515|NCT03005041|12151345|P2|STARTED|Period 2||27
4940516|NCT03005041|12151346|P1|STARTED|Period 2||28
4940517|NCT03005041|12151345|P2|NOT COMPLETED|Washout Period 1||0
4940518|NCT03005041|12151346|P1|NOT COMPLETED|Washout Period 1||0
4940519|NCT03005041|12151345|P2|COMPLETED|Washout Period 1||27
4940520|NCT03005041|12151346|P1|COMPLETED|Washout Period 1||28
4940521|NCT03005041|12151345|P2|STARTED|Washout Period 1||27
4940522|NCT03005041|12151346|P1|STARTED|Washout Period 1||28
4940523|NCT03005041|12151345|P2|NOT COMPLETED|Period 1||0
4940524|NCT03005041|12151346|P1|NOT COMPLETED|Period 1||0
4940525|NCT03005041|12151345|P2|COMPLETED|Period 1||27
4940526|NCT03005041|12151346|P1|COMPLETED|Period 1||28
4940527|NCT03005041|12151345|P2|STARTED|Period 1||27
4940528|NCT03005041|12151346|P1|STARTED|Period 1||28
4940529|NCT03004924|12151361|P3|NOT COMPLETED|Overall Study||28
4940530|NCT03004924|12151362|P2|NOT COMPLETED|Overall Study||14
4940531|NCT03004924|12151363|P1|NOT COMPLETED|Overall Study||27
4940532|NCT03004924|12151361|P3|COMPLETED|Overall Study||293
4940533|NCT03004924|12151362|P2|COMPLETED|Overall Study||94
4940534|NCT03004924|12151363|P1|COMPLETED|Overall Study||297
4940535|NCT03004924|12151361|P3|STARTED|Overall Study||321
4940536|NCT03004924|12151362|P2|STARTED|Overall Study||108
4940537|NCT03004924|12151363|P1|STARTED|Overall Study||324
4940538|NCT03004911|12151415|P2|NOT COMPLETED|Overall Study||3
4940539|NCT03004911|12151416|P1|NOT COMPLETED|Overall Study||1
4940540|NCT03004911|12151415|P2|COMPLETED|Overall Study||17
4940541|NCT03004911|12151416|P1|COMPLETED|Overall Study||19
4940542|NCT03004911|12151415|P2|STARTED|Overall Study||20
4940543|NCT03004911|12151416|P1|STARTED|Overall Study||20
4940544|NCT03004846|12151434|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
4940545|NCT03004846|12151435|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
4940546|NCT03004846|12151436|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
4940547|NCT03004846|12151434|P3|COMPLETED|Part B (Up to 14 Weeks)||0
4940548|NCT03004846|12151435|P2|COMPLETED|Part B (Up to 14 Weeks)||0
4940549|NCT03004846|12151436|P1|COMPLETED|Part B (Up to 14 Weeks)||0
4940550|NCT03004846|12151434|P3|STARTED|Part B (Up to 14 Weeks)||0
4940551|NCT03004846|12151435|P2|STARTED|Part B (Up to 14 Weeks)||0
4940552|NCT03004846|12151436|P1|STARTED|Part B (Up to 14 Weeks)||0
4940553|NCT03004846|12151434|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
4940554|NCT03004846|12151435|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
4940555|NCT03004846|12151436|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
4940556|NCT03004846|12151434|P3|COMPLETED|Part A (Up to 14 Weeks)||0
4940557|NCT03004846|12151435|P2|COMPLETED|Part A (Up to 14 Weeks)||0
4940558|NCT03004846|12151436|P1|COMPLETED|Part A (Up to 14 Weeks)||8
4940559|NCT03004846|12151434|P3|STARTED|Part A (Up to 14 Weeks)||0
4940560|NCT03004846|12151435|P2|STARTED|Part A (Up to 14 Weeks)||0
4940561|NCT03004846|12151436|P1|STARTED|Part A (Up to 14 Weeks)||8
4940562|NCT03004638|12151488|P6|NOT COMPLETED|Overall Study||0
4940563|NCT03004638|12151489|P5|NOT COMPLETED|Overall Study||0
4940564|NCT03004638|12151490|P4|NOT COMPLETED|Overall Study||0
4940565|NCT03004638|12151491|P3|NOT COMPLETED|Overall Study||0
4940566|NCT03004638|12151492|P2|NOT COMPLETED|Overall Study||0
4940567|NCT03004638|12151493|P1|NOT COMPLETED|Overall Study||0
4940568|NCT03004638|12151488|P6|COMPLETED|Overall Study||7
4940569|NCT03004638|12151489|P5|COMPLETED|Overall Study||1
4940570|NCT03004638|12151490|P4|COMPLETED|Overall Study||6
4940571|NCT03004638|12151491|P3|COMPLETED|Overall Study||6
4940572|NCT03004638|12151492|P2|COMPLETED|Overall Study||6
4940573|NCT03004638|12151493|P1|COMPLETED|Overall Study||6
4940574|NCT03004638|12151488|P6|STARTED|Overall Study||7
4940575|NCT03004638|12151489|P5|STARTED|Overall Study||1
4940576|NCT03004638|12151490|P4|STARTED|Overall Study||6
4940577|NCT03004638|12151491|P3|STARTED|Overall Study||6
4940578|NCT03004638|12151492|P2|STARTED|Overall Study||6
4940579|NCT03004638|12151493|P1|STARTED|Overall Study||6
4940580|NCT03004534|12151599|P1|NOT COMPLETED|Overall Study||0
4940581|NCT03004534|12151599|P1|COMPLETED|Overall Study||36
4940582|NCT03004534|12151599|P1|STARTED|Overall Study||36
4940583|NCT03004469|12151607|P3|NOT COMPLETED|Overall Study||25
4940584|NCT03004469|12151608|P2|NOT COMPLETED|Overall Study||49
4940585|NCT03004469|12151609|P1|NOT COMPLETED|Overall Study||61
4940586|NCT03004469|12151607|P3|COMPLETED|Overall Study||60
4940587|NCT03004469|12151608|P2|COMPLETED|Overall Study||135
4940588|NCT03004469|12151609|P1|COMPLETED|Overall Study||128
4940589|NCT03004469|12151607|P3|STARTED|Overall Study||85
4940590|NCT03004469|12151608|P2|STARTED|Overall Study||184
4940591|NCT03004469|12151609|P1|STARTED|Overall Study||189
4940592|NCT03003793|12151643|P2|NOT COMPLETED|Overall Study||0
4940593|NCT03003793|12151644|P1|NOT COMPLETED|Overall Study||0
4940594|NCT03003793|12151643|P2|COMPLETED|Overall Study||16
4940595|NCT03003793|12151644|P1|COMPLETED|Overall Study||16
4940596|NCT03003793|12151643|P2|STARTED|Overall Study||16
4940597|NCT03003793|12151644|P1|STARTED|Overall Study||16
4940598|NCT03003520|12151652|P2|NOT COMPLETED|Follow-up||3
4940599|NCT03003520|12151653|P1|NOT COMPLETED|Follow-up||14
4940600|NCT03003520|12151652|P2|COMPLETED|Follow-up||0
4940601|NCT03003520|12151653|P1|COMPLETED|Follow-up||0
4940602|NCT03003520|12151652|P2|STARTED|Follow-up||3
4940603|NCT03003520|12151653|P1|STARTED|Follow-up||14
4940604|NCT03003520|12151652|P2|NOT COMPLETED|Consolidation||1
4940605|NCT03003520|12151653|P1|NOT COMPLETED|Consolidation||24
4940606|NCT03003520|12151652|P2|COMPLETED|Consolidation||2
4940607|NCT03003520|12151653|P1|COMPLETED|Consolidation||1
4940608|NCT03003520|12151652|P2|STARTED|Consolidation||3
4940609|NCT03003520|12151653|P1|STARTED|Consolidation||25
4940610|NCT03003520|12151652|P2|NOT COMPLETED|Induction||0
4940611|NCT03003520|12151653|P1|NOT COMPLETED|Induction||13
4940612|NCT03003520|12151652|P2|COMPLETED|Induction||3
4940613|NCT03003520|12151653|P1|COMPLETED|Induction||30
4940614|NCT03003520|12151652|P2|Efficacy Evaluable Population|Induction||3
4940615|NCT03003520|12151653|P1|Efficacy Evaluable Population|Induction||37
4940616|NCT03003520|12151652|P2|Safety Population|Induction||3
4940617|NCT03003520|12151653|P1|Safety Population|Induction||43
4940618|NCT03003520|12151652|P2|STARTED|Induction||3
4940619|NCT03003520|12151653|P1|STARTED|Induction||43
4940620|NCT03003494|12151671|P1|NOT COMPLETED|Overall Study||28
4940621|NCT03003494|12151671|P1|COMPLETED|Overall Study||278
4940622|NCT03003494|12151671|P1|STARTED|Overall Study||306
4940623|NCT03003390|12151682|P2|NOT COMPLETED|Overall Study||0
4940624|NCT03003390|12151683|P1|NOT COMPLETED|Overall Study||4
4940625|NCT03003390|12151682|P2|COMPLETED|Overall Study||24
4940626|NCT03003390|12151683|P1|COMPLETED|Overall Study||23
4940627|NCT03003390|12151682|P2|STARTED|Overall Study||24
4940628|NCT03003390|12151683|P1|STARTED|Overall Study||27
4940629|NCT03003000|12151711|P3|NOT COMPLETED|Overall Study||5
4940630|NCT03003000|12151712|P2|NOT COMPLETED|Overall Study||4
4940631|NCT03003000|12151713|P1|NOT COMPLETED|Overall Study||5
4940632|NCT03003000|12151711|P3|COMPLETED|Overall Study||251
4940633|NCT03003000|12151712|P2|COMPLETED|Overall Study||249
4940634|NCT03003000|12151713|P1|COMPLETED|Overall Study||121
4940635|NCT03003000|12151711|P3|STARTED|Overall Study||256
4940636|NCT03003000|12151712|P2|STARTED|Overall Study||253
4940637|NCT03003000|12151713|P1|STARTED|Overall Study||126
4940638|NCT03002974|12151742|P3|NOT COMPLETED|Overall Study||18
4940639|NCT03002974|12151743|P2|NOT COMPLETED|Overall Study||16
4940640|NCT03002974|12151744|P1|NOT COMPLETED|Overall Study||20
4940641|NCT03002974|12151742|P3|COMPLETED|Overall Study||36
4940642|NCT03002974|12151743|P2|COMPLETED|Overall Study||40
4940643|NCT03002974|12151744|P1|COMPLETED|Overall Study||35
4940644|NCT03002974|12151742|P3|Safety Population|Overall Study||52
4940645|NCT03002974|12151743|P2|Safety Population|Overall Study||55
4940646|NCT03002974|12151744|P1|Safety Population|Overall Study||54
4940647|NCT03002974|12151742|P3|Intention To Treat Populatio|Overall Study||54
4940648|NCT03002974|12151743|P2|Intention To Treat Populatio|Overall Study||56
4940649|NCT03002974|12151744|P1|Intention To Treat Populatio|Overall Study||55
4940650|NCT03002974|12151742|P3|STARTED|Overall Study||54
4940651|NCT03002974|12151743|P2|STARTED|Overall Study||56
4940652|NCT03002974|12151744|P1|STARTED|Overall Study||55
4940653|NCT03002818|12151815|P1|NOT COMPLETED|Overall Study||1
4940654|NCT03002818|12151815|P1|COMPLETED|Overall Study||40
4940655|NCT03002818|12151815|P1|STARTED|Overall Study||41
4940656|NCT03002753|12151829|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
4940657|NCT03002753|12151830|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
4940658|NCT03002753|12151831|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
4940659|NCT03002753|12151829|P3|COMPLETED|Second Randomization (Re-randomization)||0
4940660|NCT03002753|12151830|P2|COMPLETED|Second Randomization (Re-randomization)||9
4940661|NCT03002753|12151831|P1|COMPLETED|Second Randomization (Re-randomization)||11
4940662|NCT03002753|12151829|P3|STARTED|Second Randomization (Re-randomization)||0
4940663|NCT03002753|12151830|P2|STARTED|Second Randomization (Re-randomization)||10
4940664|NCT03002753|12151831|P1|STARTED|Second Randomization (Re-randomization)||11
4940665|NCT03002753|12151829|P3|NOT COMPLETED|First Randomization||0
4940666|NCT03002753|12151830|P2|NOT COMPLETED|First Randomization||1
4940667|NCT03002753|12151831|P1|NOT COMPLETED|First Randomization||1
4940668|NCT03002753|12151829|P3|COMPLETED|First Randomization||21
4940669|NCT03002753|12151830|P2|COMPLETED|First Randomization||11
4940670|NCT03002753|12151831|P1|COMPLETED|First Randomization||9
4940671|NCT03002753|12151829|P3|STARTED|First Randomization||21
4940672|NCT03002753|12151830|P2|STARTED|First Randomization||12
4940673|NCT03002753|12151831|P1|STARTED|First Randomization||10
4940674|NCT03002623|12151841|P2|NOT COMPLETED|Overall Study||1
4940675|NCT03002623|12151842|P1|NOT COMPLETED|Overall Study||2
4940676|NCT03002623|12151841|P2|COMPLETED|Overall Study||2
4940677|NCT03002623|12151842|P1|COMPLETED|Overall Study||2
4940678|NCT03002623|12151841|P2|STARTED|Overall Study||3
4940679|NCT03002623|12151842|P1|STARTED|Overall Study||4
4940680|NCT03002610|12151859|P3|NOT COMPLETED|Overall Study||13
4940681|NCT03002610|12151860|P2|NOT COMPLETED|Overall Study||25
4940682|NCT03002610|12151861|P1|NOT COMPLETED|Overall Study||6
4940683|NCT03002610|12151859|P3|COMPLETED|Overall Study||21
4940684|NCT03002610|12151860|P2|COMPLETED|Overall Study||25
4940685|NCT03002610|12151861|P1|COMPLETED|Overall Study||18
4940686|NCT03002610|12151859|P3|STARTED|Overall Study||34
4940687|NCT03002610|12151860|P2|STARTED|Overall Study||50
4940688|NCT03002610|12151861|P1|STARTED|Overall Study||24
4940689|NCT03002454|12151878|P1|NOT COMPLETED|Overall Study||0
4940690|NCT03002454|12151878|P1|COMPLETED|Overall Study||4
4940691|NCT03002454|12151878|P1|STARTED|Overall Study||4
4940692|NCT03002194|12151883|P1|NOT COMPLETED|Overall Study||10
4940693|NCT03002194|12151883|P1|COMPLETED|Overall Study||38
4940694|NCT03002194|12151883|P1|STARTED|Overall Study||48
4940695|NCT03002077|12151889|P1|NOT COMPLETED|Overall Study||438
4940696|NCT03002077|12151889|P1|COMPLETED|Overall Study||179
4940697|NCT03002077|12151889|P1|STARTED|Overall Study||617
4940698|NCT03002012|12151897|P2|NOT COMPLETED|Overall Study||0
4940699|NCT03002012|12151898|P1|NOT COMPLETED|Overall Study||0
4940700|NCT03002012|12151897|P2|COMPLETED|Overall Study||11
4940701|NCT03002012|12151898|P1|COMPLETED|Overall Study||11
4940702|NCT03002012|12151897|P2|STARTED|Overall Study||11
4940703|NCT03002012|12151898|P1|STARTED|Overall Study||11
4940704|NCT03001778|12151920|P2|NOT COMPLETED|Overall Study||0
4940705|NCT03001778|12151921|P1|NOT COMPLETED|Overall Study||0
4940706|NCT03001778|12151920|P2|COMPLETED|Overall Study||46
4940707|NCT03001778|12151921|P1|COMPLETED|Overall Study||21
4940708|NCT03001778|12151920|P2|STARTED|Overall Study||46
4940709|NCT03001778|12151921|P1|STARTED|Overall Study||21
4940710|NCT03001674|12151929|P2|NOT COMPLETED|Overall Study||0
4940711|NCT03001674|12151930|P1|NOT COMPLETED|Overall Study||0
4940712|NCT03001674|12151929|P2|COMPLETED|Overall Study||5
4940713|NCT03001674|12151930|P1|COMPLETED|Overall Study||10
4940714|NCT03001674|12151929|P2|STARTED|Overall Study||5
4940715|NCT03001674|12151930|P1|STARTED|Overall Study||10
4940716|NCT03001557|12151941|P5|NOT COMPLETED|Overall Study||0
4940717|NCT03001557|12151942|P4|NOT COMPLETED|Overall Study||0
4940718|NCT03001557|12151943|P3|NOT COMPLETED|Overall Study||1
4940719|NCT03001557|12151944|P2|NOT COMPLETED|Overall Study||0
4940720|NCT03001557|12151945|P1|NOT COMPLETED|Overall Study||0
4940721|NCT03001557|12151941|P5|COMPLETED|Overall Study||12
4940722|NCT03001557|12151942|P4|COMPLETED|Overall Study||13
4940723|NCT03001557|12151943|P3|COMPLETED|Overall Study||13
4940724|NCT03001557|12151944|P2|COMPLETED|Overall Study||12
4940725|NCT03001557|12151945|P1|COMPLETED|Overall Study||12
4940726|NCT03001557|12151941|P5|Treated|Overall Study||12
4940727|NCT03001557|12151942|P4|Treated|Overall Study||13
4940728|NCT03001557|12151943|P3|Treated|Overall Study||13
4940729|NCT03001557|12151944|P2|Treated|Overall Study||12
4940730|NCT03001557|12151945|P1|Treated|Overall Study||12
4940731|NCT03001557|12151941|P5|STARTED|Overall Study||12
4940732|NCT03001557|12151942|P4|STARTED|Overall Study||13
4940733|NCT03001557|12151943|P3|STARTED|Overall Study||14
4940734|NCT03001557|12151944|P2|STARTED|Overall Study||12
4940735|NCT03001557|12151945|P1|STARTED|Overall Study||12
4940736|NCT03001453|12152214|P2|NOT COMPLETED|Overall Study||0
4940737|NCT03001453|12152215|P1|NOT COMPLETED|Overall Study||0
4940738|NCT03001453|12152214|P2|COMPLETED|Overall Study||57
4940739|NCT03001453|12152215|P1|COMPLETED|Overall Study||50
4940740|NCT03001453|12152214|P2|STARTED|Overall Study||57
4940741|NCT03001453|12152215|P1|STARTED|Overall Study||50
4940742|NCT03001258|12152232|P3|NOT COMPLETED|Overall Study||0
4940743|NCT03001258|12152233|P2|NOT COMPLETED|Overall Study||0
4940744|NCT03001258|12152234|P1|NOT COMPLETED|Overall Study||0
4940745|NCT03001258|12152232|P3|COMPLETED|Overall Study||485
4940746|NCT03001258|12152233|P2|COMPLETED|Overall Study||751
4940747|NCT03001258|12152234|P1|COMPLETED|Overall Study||765
4940748|NCT03001258|12152232|P3|STARTED|Overall Study||485
4940749|NCT03001258|12152233|P2|STARTED|Overall Study||751
4940750|NCT03001258|12152234|P1|STARTED|Overall Study||765
4940751|NCT03001219|12152244|P2|NOT COMPLETED|Extension Period Analysis||45
4940752|NCT03001219|12152245|P1|NOT COMPLETED|Extension Period Analysis||5
4940753|NCT03001219|12152244|P2|COMPLETED|Extension Period Analysis||52
4940754|NCT03001219|12152245|P1|COMPLETED|Extension Period Analysis||4
4940755|NCT03001219|12152244|P2|STARTED|Extension Period Analysis||97
4940756|NCT03001219|12152245|P1|STARTED|Extension Period Analysis||9
4940757|NCT03001219|12152244|P2|NOT COMPLETED|Proof of Concept||7
4940758|NCT03001219|12152245|P1|NOT COMPLETED|Proof of Concept||2
4940759|NCT03001219|12152244|P2|COMPLETED|Proof of Concept||65
4940760|NCT03001219|12152245|P1|COMPLETED|Proof of Concept||35
4940761|NCT03001219|12152244|P2|STARTED|Proof of Concept||72
4940762|NCT03001219|12152245|P1|STARTED|Proof of Concept||37
4940763|NCT03001076|12152306|P2|NOT COMPLETED|Overall Study||5
4940764|NCT03001076|12152307|P1|NOT COMPLETED|Overall Study||7
4940765|NCT03001076|12152306|P2|COMPLETED|Overall Study||176
4940766|NCT03001076|12152307|P1|COMPLETED|Overall Study||81
4940767|NCT03001076|12152306|P2|STARTED|Overall Study||181
4940768|NCT03001076|12152307|P1|STARTED|Overall Study||88
4940769|NCT03001011|12152341|P2|NOT COMPLETED|Overall Study||21
4940770|NCT03001011|12152342|P1|NOT COMPLETED|Overall Study||27
4940771|NCT03001011|12152341|P2|COMPLETED|Overall Study||80
4940772|NCT03001011|12152342|P1|COMPLETED|Overall Study||74
4940773|NCT03001011|12152341|P2|STARTED|Overall Study||101
4940774|NCT03001011|12152342|P1|STARTED|Overall Study||101
4940775|NCT03000686|12152376|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4940776|NCT03000686|12152377|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4940777|NCT03000686|12152378|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4940778|NCT03000686|12152379|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
4940779|NCT03000686|12152376|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
4940780|NCT03000686|12152377|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
4940781|NCT03000686|12152378|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
4940782|NCT03000686|12152379|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
4940783|NCT03000686|12152376|P4|STARTED|Part 2, Period 2 (1 Day)||3
4940784|NCT03000686|12152377|P3|STARTED|Part 2, Period 2 (1 Day)||3
4940785|NCT03000686|12152378|P2|STARTED|Part 2, Period 2 (1 Day)||0
4940786|NCT03000686|12152379|P1|STARTED|Part 2, Period 2 (1 Day)||0
4940787|NCT03000686|12152376|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940788|NCT03000686|12152377|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940789|NCT03000686|12152378|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940790|NCT03000686|12152379|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940791|NCT03000686|12152376|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
4940792|NCT03000686|12152377|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
4940793|NCT03000686|12152378|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940794|NCT03000686|12152379|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
4940795|NCT03000686|12152376|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
4940796|NCT03000686|12152377|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
4940797|NCT03000686|12152378|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
4940798|NCT03000686|12152379|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
4940799|NCT03000686|12152376|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4940800|NCT03000686|12152377|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4940801|NCT03000686|12152378|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4940802|NCT03000686|12152379|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
4940803|NCT03000686|12152376|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
4940804|NCT03000686|12152377|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
4940805|NCT03000686|12152378|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
4940806|NCT03000686|12152379|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
4940807|NCT03000686|12152376|P4|STARTED|Part 2, Period 1 (1 Day)||3
4940808|NCT03000686|12152377|P3|STARTED|Part 2, Period 1 (1 Day)||3
4940809|NCT03000686|12152378|P2|STARTED|Part 2, Period 1 (1 Day)||0
4940810|NCT03000686|12152379|P1|STARTED|Part 2, Period 1 (1 Day)||0
4940811|NCT03000686|12152376|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4940812|NCT03000686|12152377|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4940813|NCT03000686|12152378|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4940814|NCT03000686|12152379|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
4940815|NCT03000686|12152376|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
4940816|NCT03000686|12152377|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
4940817|NCT03000686|12152378|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
4940818|NCT03000686|12152379|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
4940819|NCT03000686|12152376|P4|STARTED|Part 1, Period 2 (1 Day)||0
4940820|NCT03000686|12152377|P3|STARTED|Part 1, Period 2 (1 Day)||0
4940821|NCT03000686|12152378|P2|STARTED|Part 1, Period 2 (1 Day)||5
4940822|NCT03000686|12152379|P1|STARTED|Part 1, Period 2 (1 Day)||5
4940823|NCT03000686|12152376|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940824|NCT03000686|12152377|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940825|NCT03000686|12152378|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940826|NCT03000686|12152379|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940827|NCT03000686|12152376|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940828|NCT03000686|12152377|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
4940829|NCT03000686|12152378|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
4940830|NCT03000686|12152379|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
4940831|NCT03000686|12152376|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
4940832|NCT03000686|12152377|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
4940833|NCT03000686|12152378|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
4940834|NCT03000686|12152379|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
4940835|NCT03000686|12152376|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4940836|NCT03000686|12152377|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4940837|NCT03000686|12152378|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
4940838|NCT03000686|12152379|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
4940839|NCT03000686|12152376|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
4940840|NCT03000686|12152377|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
4940841|NCT03000686|12152378|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
4940842|NCT03000686|12152379|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
4940843|NCT03000686|12152376|P4|STARTED|Part 1, Period 1 (1 Day)||0
4940844|NCT03000686|12152377|P3|STARTED|Part 1, Period 1 (1 Day)||0
4940845|NCT03000686|12152378|P2|STARTED|Part 1, Period 1 (1 Day)||6
4940846|NCT03000686|12152379|P1|STARTED|Part 1, Period 1 (1 Day)||5
4940847|NCT03000608|12152447|P2|NOT COMPLETED|Overall Study||4
4940848|NCT03000608|12152448|P1|NOT COMPLETED|Overall Study||6
4940849|NCT03000608|12152447|P2|COMPLETED|Overall Study||19
4940850|NCT03000608|12152448|P1|COMPLETED|Overall Study||40
4940851|NCT03000608|12152447|P2|STARTED|Overall Study||23
4940852|NCT03000608|12152448|P1|STARTED|Overall Study||46
4940853|NCT03000452|12152456|P1|NOT COMPLETED|Follow-Up Period||7
4940854|NCT03000452|12152456|P1|COMPLETED|Follow-Up Period||10
4940855|NCT03000452|12152456|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
4940856|NCT03000452|12152456|P1|NOT COMPLETED|Treatment Period||18
4940857|NCT03000452|12152456|P1|COMPLETED|Treatment Period||0
4940858|NCT03000452|12152456|P1|STARTED|Treatment Period||18
4940859|NCT03000309|12152472|P1|NOT COMPLETED|Overall Study||1
4940860|NCT03000309|12152472|P1|COMPLETED|Overall Study||19
4940861|NCT03000309|12152472|P1|STARTED|Overall Study||20
4940862|NCT03000283|12152492|P1|NOT COMPLETED|Overall Study||0
4940863|NCT03000283|12152492|P1|COMPLETED|Overall Study||7
4940864|NCT03000283|12152492|P1|STARTED|Overall Study||7
4940865|NCT03000088|12152503|P2|NOT COMPLETED|Overall Study||0
4940866|NCT03000088|12152504|P1|NOT COMPLETED|Overall Study||0
4940867|NCT03000088|12152503|P2|COMPLETED|Overall Study||70
4940868|NCT03000088|12152504|P1|COMPLETED|Overall Study||70
4940869|NCT03000088|12152503|P2|STARTED|Overall Study||70
4940870|NCT03000088|12152504|P1|STARTED|Overall Study||70
4940871|NCT03000075|12152513|P7|NOT COMPLETED|Part B||1
4940872|NCT03000075|12152514|P6|NOT COMPLETED|Part B||2
4940873|NCT03000075|12152515|P5|NOT COMPLETED|Part B||1
4940874|NCT03000075|12152516|P4|NOT COMPLETED|Part B||0
4940875|NCT03000075|12152517|P3|NOT COMPLETED|Part B||0
4940876|NCT03000075|12152518|P2|NOT COMPLETED|Part B||0
4940877|NCT03000075|12152519|P1|NOT COMPLETED|Part B||0
4940878|NCT03000075|12152513|P7|COMPLETED|Part B||54
4940879|NCT03000075|12152514|P6|COMPLETED|Part B||56
4940880|NCT03000075|12152515|P5|COMPLETED|Part B||26
4940881|NCT03000075|12152516|P4|COMPLETED|Part B||27
4940882|NCT03000075|12152517|P3|COMPLETED|Part B||0
4940883|NCT03000075|12152518|P2|COMPLETED|Part B||0
4940884|NCT03000075|12152519|P1|COMPLETED|Part B||0
4940885|NCT03000075|12152513|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
4940886|NCT03000075|12152514|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
4940887|NCT03000075|12152515|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
4940888|NCT03000075|12152516|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
4940889|NCT03000075|12152517|P3|STARTED|Part B||0
4940890|NCT03000075|12152518|P2|STARTED|Part B||0
4940891|NCT03000075|12152519|P1|STARTED|Part B||0
4940892|NCT03000075|12152513|P7|NOT COMPLETED|Part A||0
4940893|NCT03000075|12152514|P6|NOT COMPLETED|Part A||0
4940894|NCT03000075|12152515|P5|NOT COMPLETED|Part A||0
4940895|NCT03000075|12152516|P4|NOT COMPLETED|Part A||0
4940896|NCT03000075|12152517|P3|NOT COMPLETED|Part A||0
4940897|NCT03000075|12152518|P2|NOT COMPLETED|Part A||0
4940898|NCT03000075|12152519|P1|NOT COMPLETED|Part A||4
4940899|NCT03000075|12152513|P7|COMPLETED|Part A||0
4940900|NCT03000075|12152514|P6|COMPLETED|Part A||0
4940901|NCT03000075|12152515|P5|COMPLETED|Part A||0
4940902|NCT03000075|12152516|P4|COMPLETED|Part A||0
4940903|NCT03000075|12152517|P3|COMPLETED|Part A||55
4940904|NCT03000075|12152518|P2|COMPLETED|Part A||58
4940905|NCT03000075|12152519|P1|COMPLETED|Part A||54
4940906|NCT03000075|12152513|P7|STARTED|Part A||0
4940907|NCT03000075|12152514|P6|STARTED|Part A||0
4940908|NCT03000075|12152515|P5|STARTED|Part A||0
4940909|NCT03000075|12152516|P4|STARTED|Part A||0
4940910|NCT03000075|12152517|P3|STARTED|Part A||55
4940911|NCT03000075|12152518|P2|STARTED|Part A||58
4940912|NCT03000075|12152519|P1|STARTED|Part A||58
4940913|NCT02999763|12152563|P1|NOT COMPLETED|Overall Study||12
4940914|NCT02999763|12152563|P1|COMPLETED|Overall Study||58
4940915|NCT02999763|12152563|P1|STARTED|Overall Study||70
4940916|NCT02999672|12152572|P2|NOT COMPLETED|Overall Study||7
4940917|NCT02999672|12152573|P1|NOT COMPLETED|Overall Study||13
4940918|NCT02999672|12152572|P2|COMPLETED|Overall Study||0
4940919|NCT02999672|12152573|P1|COMPLETED|Overall Study||0
4940920|NCT02999672|12152572|P2|STARTED|Overall Study||7
4940921|NCT02999672|12152573|P1|STARTED|Overall Study||13
4940922|NCT02999633|12152589|P1|NOT COMPLETED|Overall Study||14
4940923|NCT02999633|12152589|P1|COMPLETED|Overall Study||0
4940924|NCT02999633|12152589|P1|STARTED|Overall Study||14
4940925|NCT02999178|12152599|P2|NOT COMPLETED|Overall Study||100
4940926|NCT02999178|12152600|P1|NOT COMPLETED|Overall Study||114
4940927|NCT02999178|12152599|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
4940928|NCT02999178|12152600|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
4940929|NCT02999178|12152599|P2|STARTED|Overall Study||331
4940930|NCT02999178|12152600|P1|STARTED|Overall Study||332
4940931|NCT02999100|12152650|P6|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940932|NCT02999100|12152651|P5|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940933|NCT02999100|12152652|P4|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940934|NCT02999100|12152653|P3|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940935|NCT02999100|12152654|P2|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940936|NCT02999100|12152655|P1|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940937|NCT02999100|12152650|P6|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
4940938|NCT02999100|12152651|P5|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
4940939|NCT02999100|12152652|P4|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
4940940|NCT02999100|12152653|P3|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
4940941|NCT02999100|12152654|P2|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940942|NCT02999100|12152655|P1|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
4940943|NCT02999100|12152650|P6|STARTED|Part 2 (Day 14): Dosing Session 2||2
4940944|NCT02999100|12152651|P5|STARTED|Part 2 (Day 14): Dosing Session 2||3
4940945|NCT02999100|12152652|P4|STARTED|Part 2 (Day 14): Dosing Session 2||3
4940946|NCT02999100|12152653|P3|STARTED|Part 2 (Day 14): Dosing Session 2||4
4940947|NCT02999100|12152654|P2|STARTED|Part 2 (Day 14): Dosing Session 2||0
4940948|NCT02999100|12152655|P1|STARTED|Part 2 (Day 14): Dosing Session 2||0
4940949|NCT02999100|12152650|P6|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
4940950|NCT02999100|12152651|P5|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940951|NCT02999100|12152652|P4|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940952|NCT02999100|12152653|P3|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
4940953|NCT02999100|12152654|P2|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940954|NCT02999100|12152655|P1|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940955|NCT02999100|12152650|P6|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
4940956|NCT02999100|12152651|P5|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
4940957|NCT02999100|12152652|P4|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
4940958|NCT02999100|12152653|P3|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
4940959|NCT02999100|12152654|P2|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940960|NCT02999100|12152655|P1|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
4940961|NCT02999100|12152650|P6|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
4940962|NCT02999100|12152651|P5|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
4940963|NCT02999100|12152652|P4|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
4940964|NCT02999100|12152653|P3|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
4940965|NCT02999100|12152654|P2|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
4940966|NCT02999100|12152655|P1|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
4940967|NCT02999100|12152650|P6|NOT COMPLETED|Part 1 (up to 15 Days)||0
4940968|NCT02999100|12152651|P5|NOT COMPLETED|Part 1 (up to 15 Days)||0
4940969|NCT02999100|12152652|P4|NOT COMPLETED|Part 1 (up to 15 Days)||0
4940970|NCT02999100|12152653|P3|NOT COMPLETED|Part 1 (up to 15 Days)||0
4940971|NCT02999100|12152654|P2|NOT COMPLETED|Part 1 (up to 15 Days)||1
4940972|NCT02999100|12152655|P1|NOT COMPLETED|Part 1 (up to 15 Days)||0
4940973|NCT02999100|12152650|P6|COMPLETED|Part 1 (up to 15 Days)||0
4940974|NCT02999100|12152651|P5|COMPLETED|Part 1 (up to 15 Days)||0
4940975|NCT02999100|12152652|P4|COMPLETED|Part 1 (up to 15 Days)||0
4940976|NCT02999100|12152653|P3|COMPLETED|Part 1 (up to 15 Days)||0
4940977|NCT02999100|12152654|P2|COMPLETED|Part 1 (up to 15 Days)||7
4940978|NCT02999100|12152655|P1|COMPLETED|Part 1 (up to 15 Days)||9
4940979|NCT02999100|12152650|P6|STARTED|Part 1 (up to 15 Days)||0
4940980|NCT02999100|12152651|P5|STARTED|Part 1 (up to 15 Days)||0
4940981|NCT02999100|12152652|P4|STARTED|Part 1 (up to 15 Days)||0
4940982|NCT02999100|12152653|P3|STARTED|Part 1 (up to 15 Days)||0
4940983|NCT02999100|12152654|P2|STARTED|Part 1 (up to 15 Days)||8
4940984|NCT02999100|12152655|P1|STARTED|Part 1 (up to 15 Days)||9
4940985|NCT02998996|12152823|P6|NOT COMPLETED|Overall Study||0
4940986|NCT02998996|12152824|P5|NOT COMPLETED|Overall Study||1
4940987|NCT02998996|12152825|P4|NOT COMPLETED|Overall Study||0
4940988|NCT02998996|12152826|P3|NOT COMPLETED|Overall Study||1
4940989|NCT02998996|12152827|P2|NOT COMPLETED|Overall Study||1
4940990|NCT02998996|12152828|P1|NOT COMPLETED|Overall Study||0
4940991|NCT02998996|12152823|P6|COMPLETED|Overall Study||19
4940992|NCT02998996|12152824|P5|COMPLETED|Overall Study||17
4940993|NCT02998996|12152825|P4|COMPLETED|Overall Study||18
4940994|NCT02998996|12152826|P3|COMPLETED|Overall Study||35
4940995|NCT02998996|12152827|P2|COMPLETED|Overall Study||34
4940996|NCT02998996|12152828|P1|COMPLETED|Overall Study||36
4940997|NCT02998996|12152823|P6|STARTED|Overall Study||19
4940998|NCT02998996|12152824|P5|STARTED|Overall Study||18
4940999|NCT02998996|12152825|P4|STARTED|Overall Study||18
4941000|NCT02998996|12152826|P3|STARTED|Overall Study||36
4941001|NCT02998996|12152827|P2|STARTED|Overall Study||35
4941002|NCT02998996|12152828|P1|STARTED|Overall Study||36
4941003|NCT02998684|12152848|P2|NOT COMPLETED|Overall Study||1
4941004|NCT02998684|12152849|P1|NOT COMPLETED|Overall Study||3
4941005|NCT02998684|12152848|P2|COMPLETED|Overall Study||6
4941006|NCT02998684|12152849|P1|COMPLETED|Overall Study||4
4941007|NCT02998684|12152848|P2|STARTED|Overall Study||7
4941008|NCT02998684|12152849|P1|STARTED|Overall Study||7
4941009|NCT02998671|12152862|P5|NOT COMPLETED|Period 2||0
4941010|NCT02998671|12152863|P4|NOT COMPLETED|Period 2||4
4941011|NCT02998671|12152864|P3|NOT COMPLETED|Period 2||1
4941012|NCT02998671|12152865|P2|NOT COMPLETED|Period 2||7
4941013|NCT02998671|12152866|P1|NOT COMPLETED|Period 2||3
4941014|NCT02998671|12152862|P5|COMPLETED|Period 2||0
4941015|NCT02998671|12152863|P4|COMPLETED|Period 2||4
4941016|NCT02998671|12152864|P3|COMPLETED|Period 2||5
4941017|NCT02998671|12152865|P2|COMPLETED|Period 2||3
4941018|NCT02998671|12152866|P1|COMPLETED|Period 2||14
4941019|NCT02998671|12152862|P5|STARTED|Period 2||0
4941020|NCT02998671|12152863|P4|STARTED|Period 2||8
4941021|NCT02998671|12152864|P3|STARTED|Period 2||6
4941022|NCT02998671|12152865|P2|STARTED|Period 2||10
4941023|NCT02998671|12152866|P1|STARTED|Period 2||17
4941024|NCT02998671|12152862|P5|NOT COMPLETED|Period 1||4
4941025|NCT02998671|12152863|P4|NOT COMPLETED|Period 1||0
4941026|NCT02998671|12152864|P3|NOT COMPLETED|Period 1||0
4941027|NCT02998671|12152865|P2|NOT COMPLETED|Period 1||3
4941028|NCT02998671|12152866|P1|NOT COMPLETED|Period 1||4
4941029|NCT02998671|12152862|P5|COMPLETED|Period 1||0
4941030|NCT02998671|12152863|P4|COMPLETED|Period 1||8
4941031|NCT02998671|12152864|P3|COMPLETED|Period 1||6
4941032|NCT02998671|12152865|P2|COMPLETED|Period 1||10
4941033|NCT02998671|12152866|P1|COMPLETED|Period 1||17
4941034|NCT02998671|12152862|P5|STARTED|Period 1||4
4941035|NCT02998671|12152863|P4|STARTED|Period 1||8
4941036|NCT02998671|12152864|P3|STARTED|Period 1||6
4941037|NCT02998671|12152865|P2|STARTED|Period 1||13
4941038|NCT02998671|12152866|P1|STARTED|Period 1||21
4941039|NCT02998554|12152911|P2|NOT COMPLETED|Overall Study||11
4941040|NCT02998554|12152912|P1|NOT COMPLETED|Overall Study||11
4941041|NCT02998554|12152911|P2|COMPLETED|Overall Study||66
4941042|NCT02998554|12152912|P1|COMPLETED|Overall Study||68
4941043|NCT02998554|12152911|P2|STARTED|Overall Study||77
4941044|NCT02998554|12152912|P1|STARTED|Overall Study||79
4941045|NCT02998541|12152943|P3|NOT COMPLETED|Overall Study||6
4941046|NCT02998541|12152944|P2|NOT COMPLETED|Overall Study||9
4941047|NCT02998541|12152945|P1|NOT COMPLETED|Overall Study||8
4941048|NCT02998541|12152943|P3|COMPLETED|Overall Study||37
4941049|NCT02998541|12152944|P2|COMPLETED|Overall Study||81
4941050|NCT02998541|12152945|P1|COMPLETED|Overall Study||78
4941051|NCT02998541|12152943|P3|STARTED|Overall Study||43
4941052|NCT02998541|12152944|P2|STARTED|Overall Study||90
4941053|NCT02998541|12152945|P1|STARTED|Overall Study||86
4941054|NCT02998476|12153000|P2|NOT COMPLETED|Overall Study||5
4941055|NCT02998476|12153001|P1|NOT COMPLETED|Overall Study||55
4941056|NCT02998476|12153000|P2|COMPLETED|Overall Study||0
4941057|NCT02998476|12153001|P1|COMPLETED|Overall Study||0
4941058|NCT02998476|12153000|P2|STARTED|Overall Study||5
4941059|NCT02998476|12153001|P1|STARTED|Overall Study||55
4941060|NCT02998021|12153011|P2|NOT COMPLETED|Overall Study||2
4941061|NCT02998021|12153012|P1|NOT COMPLETED|Overall Study||3
4941062|NCT02998021|12153011|P2|COMPLETED|Overall Study||0
4941063|NCT02998021|12153012|P1|COMPLETED|Overall Study||5
4941064|NCT02998021|12153011|P2|STARTED|Overall Study||2
4941065|NCT02998021|12153012|P1|STARTED|Overall Study||8
4941066|NCT02997904|12153038|P2|NOT COMPLETED|Overall Study||0
4941067|NCT02997904|12153039|P1|NOT COMPLETED|Overall Study||0
4941068|NCT02997904|12153038|P2|COMPLETED|Overall Study||49
4941069|NCT02997904|12153039|P1|COMPLETED|Overall Study||51
4941070|NCT02997904|12153038|P2|STARTED|Overall Study||49
4941071|NCT02997904|12153039|P1|STARTED|Overall Study||51
4941072|NCT02997735|12153051|P2|NOT COMPLETED|Overall Study||0
4941073|NCT02997735|12153052|P1|NOT COMPLETED|Overall Study||0
4941074|NCT02997735|12153051|P2|COMPLETED|Overall Study||251
4941075|NCT02997735|12153052|P1|COMPLETED|Overall Study||233
4941076|NCT02997735|12153051|P2|STARTED|Overall Study||251
4941077|NCT02997735|12153052|P1|STARTED|Overall Study||233
4941078|NCT02997722|12153076|P2|NOT COMPLETED|Overall Study||0
4941079|NCT02997722|12153077|P1|NOT COMPLETED|Overall Study||0
4941080|NCT02997722|12153076|P2|COMPLETED|Overall Study||1
4941081|NCT02997722|12153077|P1|COMPLETED|Overall Study||3
4941082|NCT02997722|12153076|P2|STARTED|Overall Study||1
4941083|NCT02997722|12153077|P1|STARTED|Overall Study||3
4941084|NCT02997163|12153087|P4|NOT COMPLETED|Overall Study||1
4941085|NCT02997163|12153088|P3|NOT COMPLETED|Overall Study||0
4941086|NCT02997163|12153089|P2|NOT COMPLETED|Overall Study||0
4941087|NCT02997163|12153090|P1|NOT COMPLETED|Overall Study||1
4941088|NCT02997163|12153087|P4|COMPLETED|Overall Study||7
4941089|NCT02997163|12153088|P3|COMPLETED|Overall Study||8
4941090|NCT02997163|12153089|P2|COMPLETED|Overall Study||9
4941091|NCT02997163|12153090|P1|COMPLETED|Overall Study||8
4941092|NCT02997163|12153087|P4|STARTED|Overall Study||8
4941093|NCT02997163|12153088|P3|STARTED|Overall Study||8
4941094|NCT02997163|12153089|P2|STARTED|Overall Study||9
4941095|NCT02997163|12153090|P1|STARTED|Overall Study||9
4941096|NCT02996968|12153222|P2|NOT COMPLETED|Overall Study||0
4941097|NCT02996968|12153223|P1|NOT COMPLETED|Overall Study||1
4941098|NCT02996968|12153222|P2|COMPLETED|Overall Study||79
4941099|NCT02996968|12153223|P1|COMPLETED|Overall Study||78
4941100|NCT02996968|12153222|P2|STARTED|Overall Study||79
4941101|NCT02996968|12153223|P1|STARTED|Overall Study||79
4941102|NCT02996682|12153231|P2|NOT COMPLETED|Overall Study||3
4941103|NCT02996682|12153232|P1|NOT COMPLETED|Overall Study||0
4941104|NCT02996682|12153231|P2|COMPLETED|Overall Study||48
4941105|NCT02996682|12153232|P1|COMPLETED|Overall Study||51
4941106|NCT02996682|12153231|P2|STARTED|Overall Study||51
4941107|NCT02996682|12153232|P1|STARTED|Overall Study||51
4941108|NCT02996591|12153256|P2|NOT COMPLETED|Overall Study||0
4941109|NCT02996591|12153257|P1|NOT COMPLETED|Overall Study||0
4941110|NCT02996591|12153256|P2|COMPLETED|Overall Study||18
4941111|NCT02996591|12153257|P1|COMPLETED|Overall Study||18
4941112|NCT02996591|12153256|P2|STARTED|Overall Study||18
4941113|NCT02996591|12153257|P1|STARTED|Overall Study||18
4941114|NCT02996500|12153311|P6|NOT COMPLETED|Overall Study||4
4941115|NCT02996500|12153312|P5|NOT COMPLETED|Overall Study||5
4941116|NCT02996500|12153313|P4|NOT COMPLETED|Overall Study||4
4941117|NCT02996500|12153314|P3|NOT COMPLETED|Overall Study||10
4941118|NCT02996500|12153315|P2|NOT COMPLETED|Overall Study||1
4941119|NCT02996500|12153316|P1|NOT COMPLETED|Overall Study||8
4941120|NCT02996500|12153311|P6|COMPLETED|Overall Study||44
4941121|NCT02996500|12153312|P5|COMPLETED|Overall Study||45
4941122|NCT02996500|12153313|P4|COMPLETED|Overall Study||46
4941123|NCT02996500|12153314|P3|COMPLETED|Overall Study||29
4941124|NCT02996500|12153315|P2|COMPLETED|Overall Study||42
4941125|NCT02996500|12153316|P1|COMPLETED|Overall Study||31
4941126|NCT02996500|12153311|P6|STARTED|Overall Study||48
4941127|NCT02996500|12153312|P5|STARTED|Overall Study||50
4941128|NCT02996500|12153313|P4|STARTED|Overall Study||50
4941129|NCT02996500|12153314|P3|STARTED|Overall Study||39
4941130|NCT02996500|12153315|P2|STARTED|Overall Study||43
4941131|NCT02996500|12153316|P1|STARTED|Overall Study||39
4941132|NCT02996474|12153499|P1|NOT COMPLETED|Overall Study||5
4941133|NCT02996474|12153499|P1|COMPLETED|Overall Study||5
4941134|NCT02996474|12153499|P1|STARTED|Overall Study||10
4941135|NCT02996448|12153503|P1|NOT COMPLETED|Overall Study||3
4941136|NCT02996448|12153503|P1|COMPLETED|Overall Study||0
4941137|NCT02996448|12153503|P1|STARTED|Overall Study||3
4941138|NCT02996097|12153509|P2|NOT COMPLETED|Overall Study||11
4941139|NCT02996097|12153510|P1|NOT COMPLETED|Overall Study||11
4941140|NCT02996097|12153509|P2|COMPLETED|Overall Study||19
4941141|NCT02996097|12153510|P1|COMPLETED|Overall Study||19
4941142|NCT02996097|12153509|P2|Per Protocol Population|Overall Study||22
4941143|NCT02996097|12153510|P1|Per Protocol Population|Overall Study||22
4941144|NCT02996097|12153509|P2|STARTED|Overall Study||30
4941145|NCT02996097|12153510|P1|STARTED|Overall Study||30
4941146|NCT02995980|12153517|P1|NOT COMPLETED|Overall Study||14
4941147|NCT02995980|12153517|P1|COMPLETED|Overall Study||114
4941148|NCT02995980|12153517|P1|STARTED|Overall Study||128
4941149|NCT02995967|12153528|P2|NOT COMPLETED|Overall Study||0
4941150|NCT02995967|12153529|P1|NOT COMPLETED|Overall Study||0
4941151|NCT02995967|12153528|P2|COMPLETED|Overall Study||2
4941152|NCT02995967|12153529|P1|COMPLETED|Overall Study||1
4941153|NCT02995967|12153528|P2|STARTED|Overall Study||2
4941154|NCT02995967|12153529|P1|STARTED|Overall Study||1
4941155|NCT02994979|12153555|P2|NOT COMPLETED|Overall Study||0
4941156|NCT02994979|12153556|P1|NOT COMPLETED|Overall Study||0
4941157|NCT02994979|12153555|P2|COMPLETED|Overall Study||105
4941158|NCT02994979|12153556|P1|COMPLETED|Overall Study||114
4941159|NCT02994979|12153555|P2|STARTED|Overall Study||105
4941160|NCT02994979|12153556|P1|STARTED|Overall Study||114
4941161|NCT02994732|12153568|P1|NOT COMPLETED|Overall Study||0
4941162|NCT02994732|12153568|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
4941163|NCT02994732|12153568|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
4941164|NCT02994251|12153582|P1|NOT COMPLETED|Overall Study||0
4941165|NCT02994251|12153582|P1|COMPLETED|Overall Study||0
4941166|NCT02994251|12153582|P1|STARTED|Overall Study||0
4941167|NCT02994108|12153594|P2|NOT COMPLETED|Phase 2 Assessment||7
4941168|NCT02994108|12153595|P1|NOT COMPLETED|Phase 2 Assessment||9
4941169|NCT02994108|12153594|P2|COMPLETED|Phase 2 Assessment||69
4941170|NCT02994108|12153595|P1|COMPLETED|Phase 2 Assessment||63
4941171|NCT02994108|12153594|P2|STARTED|Phase 2 Assessment||76
4941172|NCT02994108|12153595|P1|STARTED|Phase 2 Assessment||72
4941173|NCT02994108|12153594|P2|NOT COMPLETED|Phase 1 Assessment||3
4941174|NCT02994108|12153595|P1|NOT COMPLETED|Phase 1 Assessment||5
4941175|NCT02994108|12153594|P2|COMPLETED|Phase 1 Assessment||73
4941176|NCT02994108|12153595|P1|COMPLETED|Phase 1 Assessment||67
4941177|NCT02994108|12153594|P2|STARTED|Phase 1 Assessment||76
4941178|NCT02994108|12153595|P1|STARTED|Phase 1 Assessment||72
4941179|NCT02994108|12153594|P2|NOT COMPLETED|Intervention Messages||0
4941180|NCT02994108|12153595|P1|NOT COMPLETED|Intervention Messages||2
4941181|NCT02994108|12153594|P2|COMPLETED|Intervention Messages||76
4941182|NCT02994108|12153595|P1|COMPLETED|Intervention Messages||72
4941183|NCT02994108|12153594|P2|STARTED|Intervention Messages||76
4941184|NCT02994108|12153595|P1|STARTED|Intervention Messages||74
4941185|NCT02994056|12153627|P1|NOT COMPLETED|Overall Study||9
4941186|NCT02994056|12153627|P1|COMPLETED|Overall Study||23
4941187|NCT02994056|12153627|P1|STARTED|Overall Study||32
4941188|NCT02993926|12153661|P3|NOT COMPLETED|Follow-Up Phase||0
4941189|NCT02993926|12153662|P2|NOT COMPLETED|Follow-Up Phase||0
4941190|NCT02993926|12153663|P1|NOT COMPLETED|Follow-Up Phase||0
4941191|NCT02993926|12153661|P3|COMPLETED|Follow-Up Phase||26
4941192|NCT02993926|12153662|P2|COMPLETED|Follow-Up Phase||44
4941193|NCT02993926|12153663|P1|COMPLETED|Follow-Up Phase||0
4941194|NCT02993926|12153661|P3|STARTED|Follow-Up Phase||26
4941195|NCT02993926|12153662|P2|STARTED|Follow-Up Phase||44
4941196|NCT02993926|12153663|P1|STARTED|Follow-Up Phase||0
4941197|NCT02993926|12153661|P3|NOT COMPLETED|Enantone Treatment Phase||0
4941198|NCT02993926|12153662|P2|NOT COMPLETED|Enantone Treatment Phase||0
4941199|NCT02993926|12153663|P1|NOT COMPLETED|Enantone Treatment Phase||32
4941200|NCT02993926|12153661|P3|COMPLETED|Enantone Treatment Phase||0
4941201|NCT02993926|12153662|P2|COMPLETED|Enantone Treatment Phase||0
4941202|NCT02993926|12153663|P1|COMPLETED|Enantone Treatment Phase||76
4941203|NCT02993926|12153661|P3|STARTED|Enantone Treatment Phase||0
4941204|NCT02993926|12153662|P2|STARTED|Enantone Treatment Phase||0
4941205|NCT02993926|12153663|P1|STARTED|Enantone Treatment Phase||108
4941206|NCT02993783|12153695|P2|NOT COMPLETED|Overall Study||9
4941207|NCT02993783|12153696|P1|NOT COMPLETED|Overall Study||6
4941208|NCT02993783|12153695|P2|COMPLETED|Overall Study||0
4941209|NCT02993783|12153696|P1|COMPLETED|Overall Study||2
4941210|NCT02993783|12153695|P2|STARTED|Overall Study||9
4941211|NCT02993783|12153696|P1|STARTED|Overall Study||8
4941212|NCT02993757|12153728|P2|NOT COMPLETED|Overall Study||178
4941213|NCT02993757|12153729|P1|NOT COMPLETED|Overall Study||164
4941214|NCT02993757|12153728|P2|COMPLETED|Overall Study||84
4941215|NCT02993757|12153729|P1|COMPLETED|Overall Study||102
4941216|NCT02993757|12153728|P2|Safety Analysis Set (SafAS)|Overall Study||260
4941217|NCT02993757|12153729|P1|Safety Analysis Set (SafAS)|Overall Study||263
4941218|NCT02993757|12153728|P2|STARTED|Overall Study||262
4941219|NCT02993757|12153729|P1|STARTED|Overall Study||266
4941220|NCT02993471|12153761|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
4941221|NCT02993471|12153761|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
4941222|NCT02993471|12153761|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
4941223|NCT02993471|12153761|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
4941224|NCT02993471|12153761|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
4941225|NCT02993471|12153761|P1|COMPLETED|Period 1 (Drug Cocktail)||28
4941226|NCT02993471|12153761|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
4941227|NCT02993471|12153761|P1|STARTED|Period 1 (Drug Cocktail)||28
4941228|NCT02993302|12153797|P2|NOT COMPLETED|Overall Study||0
4941229|NCT02993302|12153798|P1|NOT COMPLETED|Overall Study||0
4941230|NCT02993302|12153797|P2|COMPLETED|Overall Study||12
4941231|NCT02993302|12153798|P1|COMPLETED|Overall Study||13
4941232|NCT02993302|12153797|P2|STARTED|Overall Study||12
4941233|NCT02993302|12153798|P1|STARTED|Overall Study||13
4941234|NCT02993250|12153812|P2|NOT COMPLETED|Overall Study||1
4941235|NCT02993250|12153813|P1|NOT COMPLETED|Overall Study||0
4941236|NCT02993250|12153812|P2|COMPLETED|Overall Study||10
4941237|NCT02993250|12153813|P1|COMPLETED|Overall Study||22
4941238|NCT02993250|12153812|P2|STARTED|Overall Study||11
4941239|NCT02993250|12153813|P1|STARTED|Overall Study||22
4941240|NCT02992691|12153833|P1|NOT COMPLETED|Overall Study||3
4941241|NCT02992691|12153833|P1|COMPLETED|Overall Study||53
4941242|NCT02992691|12153833|P1|Received Negative Control|Overall Study||55
4941243|NCT02992691|12153833|P1|Received Positive Control|Overall Study||55
4941244|NCT02992691|12153833|P1|Received Test Product 3|Overall Study||52
4941245|NCT02992691|12153833|P1|Received Test Product 2|Overall Study||55
4941246|NCT02992691|12153833|P1|Received Test Product 1|Overall Study||55
4941247|NCT02992691|12153833|P1|STARTED|Overall Study||56
4941248|NCT02992288|12153856|P6|NOT COMPLETED|Overall Study||13
4941249|NCT02992288|12153857|P5|NOT COMPLETED|Overall Study||8
4941250|NCT02992288|12153858|P4|NOT COMPLETED|Overall Study||9
4941251|NCT02992288|12153859|P3|NOT COMPLETED|Overall Study||7
4941252|NCT02992288|12153860|P2|NOT COMPLETED|Overall Study||5
4941253|NCT02992288|12153861|P1|NOT COMPLETED|Overall Study||17
4941254|NCT02992288|12153856|P6|COMPLETED|Overall Study||59
4941255|NCT02992288|12153857|P5|COMPLETED|Overall Study||61
4941256|NCT02992288|12153858|P4|COMPLETED|Overall Study||64
4941257|NCT02992288|12153859|P3|COMPLETED|Overall Study||63
4941258|NCT02992288|12153860|P2|COMPLETED|Overall Study||32
4941259|NCT02992288|12153861|P1|COMPLETED|Overall Study||89
4941260|NCT02992288|12153856|P6|Treated|Overall Study||72
4941261|NCT02992288|12153857|P5|Treated|Overall Study||69
4941262|NCT02992288|12153858|P4|Treated|Overall Study||72
4941263|NCT02992288|12153859|P3|Treated|Overall Study||70
4941264|NCT02992288|12153860|P2|Treated|Overall Study||37
4941265|NCT02992288|12153861|P1|Treated|Overall Study||106
4941266|NCT02992288|12153856|P6|STARTED|Overall Study||72
4941267|NCT02992288|12153857|P5|STARTED|Overall Study||69
4941268|NCT02992288|12153858|P4|STARTED|Overall Study||73
4941269|NCT02992288|12153859|P3|STARTED|Overall Study||70
4941270|NCT02992288|12153860|P2|STARTED|Overall Study||37
4941271|NCT02992288|12153861|P1|STARTED|Overall Study||106
4941272|NCT02992236|12153919|P2|NOT COMPLETED|Overall Study||0
4941273|NCT02992236|12153920|P1|NOT COMPLETED|Overall Study||0
4941274|NCT02992236|12153919|P2|COMPLETED|Overall Study||8
4941275|NCT02992236|12153920|P1|COMPLETED|Overall Study||8
4941276|NCT02992236|12153919|P2|STARTED|Overall Study||8
4941277|NCT02992236|12153920|P1|STARTED|Overall Study||8
4941278|NCT02992197|12153932|P2|NOT COMPLETED|Overall Study||7
4941279|NCT02992197|12153933|P1|NOT COMPLETED|Overall Study||11
4941280|NCT02992197|12153932|P2|COMPLETED|Overall Study||103
4941281|NCT02992197|12153933|P1|COMPLETED|Overall Study||99
4941282|NCT02992197|12153932|P2|STARTED|Overall Study||110
4941283|NCT02992197|12153933|P1|STARTED|Overall Study||110
4941284|NCT02992132|12153946|P3|NOT COMPLETED|Overall Study||7
4941285|NCT02992132|12153947|P2|NOT COMPLETED|Overall Study||8
4941286|NCT02992132|12153948|P1|NOT COMPLETED|Overall Study||13
4941287|NCT02992132|12153946|P3|COMPLETED|Overall Study||29
4941288|NCT02992132|12153947|P2|COMPLETED|Overall Study||27
4941289|NCT02992132|12153948|P1|COMPLETED|Overall Study||27
4941290|NCT02992132|12153946|P3|STARTED|Overall Study||36
4941291|NCT02992132|12153947|P2|STARTED|Overall Study||35
4941292|NCT02992132|12153948|P1|STARTED|Overall Study||40
4941293|NCT02992119|12153966|P7|NOT COMPLETED|Overall Study||3
4941294|NCT02992119|12153967|P6|NOT COMPLETED|Overall Study||0
4941295|NCT02992119|12153968|P5|NOT COMPLETED|Overall Study||0
4941296|NCT02992119|12153969|P4|NOT COMPLETED|Overall Study||0
4941297|NCT02992119|12153970|P3|NOT COMPLETED|Overall Study||1
4941298|NCT02992119|12153971|P2|NOT COMPLETED|Overall Study||1
4941299|NCT02992119|12153972|P1|NOT COMPLETED|Overall Study||2
4941300|NCT02992119|12153966|P7|COMPLETED|Overall Study||28
4941301|NCT02992119|12153967|P6|COMPLETED|Overall Study||30
4941302|NCT02992119|12153968|P5|COMPLETED|Overall Study||30
4941303|NCT02992119|12153969|P4|COMPLETED|Overall Study||30
4941304|NCT02992119|12153970|P3|COMPLETED|Overall Study||29
4941305|NCT02992119|12153971|P2|COMPLETED|Overall Study||20
4941306|NCT02992119|12153972|P1|COMPLETED|Overall Study||19
4941307|NCT02992119|12153966|P7|STARTED|Overall Study||31
4941308|NCT02992119|12153967|P6|STARTED|Overall Study||30
4941309|NCT02992119|12153968|P5|STARTED|Overall Study||30
4941310|NCT02992119|12153969|P4|STARTED|Overall Study||30
4941311|NCT02992119|12153970|P3|STARTED|Overall Study||30
4941312|NCT02992119|12153971|P2|STARTED|Overall Study||21
4941313|NCT02992119|12153972|P1|STARTED|Overall Study||21
4941314|NCT02992067|12154023|P1|NOT COMPLETED|Overall Study||0
4941315|NCT02992067|12154023|P1|COMPLETED|Overall Study||359
4941316|NCT02992067|12154023|P1|STARTED|Overall Study||359
4941317|NCT02991898|12154027|P1|NOT COMPLETED|Overall Study||0
4941318|NCT02991898|12154027|P1|COMPLETED|Overall Study||3
4941319|NCT02991898|12154027|P1|STARTED|Overall Study||3
4941320|NCT02991859|12154061|P17|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941321|NCT02991859|12154062|P16|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941322|NCT02991859|12154063|P15|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941323|NCT02991859|12154064|P14|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941324|NCT02991859|12154065|P13|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941325|NCT02991859|12154066|P12|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941326|NCT02991859|12154067|P11|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941327|NCT02991859|12154068|P10|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941328|NCT02991859|12154069|P9|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941329|NCT02991859|12154070|P8|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941330|NCT02991859|12154071|P7|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941331|NCT02991859|12154072|P6|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941332|NCT02991859|12154073|P5|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941333|NCT02991859|12154074|P4|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941334|NCT02991859|12154075|P3|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941335|NCT02991859|12154076|P2|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941336|NCT02991859|12154077|P1|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941337|NCT02991859|12154061|P17|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941338|NCT02991859|12154062|P16|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941339|NCT02991859|12154063|P15|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941340|NCT02991859|12154064|P14|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941341|NCT02991859|12154065|P13|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
4941342|NCT02991859|12154066|P12|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941343|NCT02991859|12154067|P11|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941344|NCT02991859|12154068|P10|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941345|NCT02991859|12154069|P9|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
4941346|NCT02991859|12154070|P8|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941347|NCT02991859|12154071|P7|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941348|NCT02991859|12154072|P6|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
4941349|NCT02991859|12154073|P5|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941350|NCT02991859|12154074|P4|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941351|NCT02991859|12154075|P3|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941352|NCT02991859|12154076|P2|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941353|NCT02991859|12154077|P1|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
4941354|NCT02991859|12154061|P17|STARTED|Period2,Escalation Phase5,Upto Day 112||0
4941355|NCT02991859|12154062|P16|STARTED|Period2,Escalation Phase5,Upto Day 112||0
4941356|NCT02991859|12154063|P15|STARTED|Period2,Escalation Phase5,Upto Day 112||0
4941357|NCT02991859|12154064|P14|STARTED|Period2,Escalation Phase5,Upto Day 112||0
4941358|NCT02991859|12154065|P13|STARTED|Period2,Escalation Phase5,Upto Day 112||0
4941359|NCT02991859|12154066|P12|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941360|NCT02991859|12154067|P11|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941361|NCT02991859|12154068|P10|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941362|NCT02991859|12154069|P9|STARTED|Period2,Escalation Phase5,Upto Day 112||1
4941363|NCT02991859|12154070|P8|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941364|NCT02991859|12154071|P7|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941365|NCT02991859|12154072|P6|STARTED|Period2,Escalation Phase5,Upto Day 112||1
4941366|NCT02991859|12154073|P5|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941367|NCT02991859|12154074|P4|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941368|NCT02991859|12154075|P3|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941369|NCT02991859|12154076|P2|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941370|NCT02991859|12154077|P1|STARTED|Period2,Escalation Phase5,Upto Day 112||2
4941371|NCT02991859|12154061|P17|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941372|NCT02991859|12154062|P16|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941373|NCT02991859|12154063|P15|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941374|NCT02991859|12154064|P14|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941375|NCT02991859|12154065|P13|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941376|NCT02991859|12154066|P12|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941377|NCT02991859|12154067|P11|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941378|NCT02991859|12154068|P10|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941379|NCT02991859|12154069|P9|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
4941380|NCT02991859|12154070|P8|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941381|NCT02991859|12154071|P7|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941382|NCT02991859|12154072|P6|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941383|NCT02991859|12154073|P5|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941384|NCT02991859|12154074|P4|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941385|NCT02991859|12154075|P3|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941386|NCT02991859|12154076|P2|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941387|NCT02991859|12154077|P1|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941388|NCT02991859|12154061|P17|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941389|NCT02991859|12154062|P16|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941390|NCT02991859|12154063|P15|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941391|NCT02991859|12154064|P14|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941392|NCT02991859|12154065|P13|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
4941393|NCT02991859|12154066|P12|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941394|NCT02991859|12154067|P11|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941395|NCT02991859|12154068|P10|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941396|NCT02991859|12154069|P9|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
4941397|NCT02991859|12154070|P8|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941398|NCT02991859|12154071|P7|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941399|NCT02991859|12154072|P6|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
4941400|NCT02991859|12154073|P5|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941401|NCT02991859|12154074|P4|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941402|NCT02991859|12154075|P3|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941403|NCT02991859|12154076|P2|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941404|NCT02991859|12154077|P1|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
4941405|NCT02991859|12154061|P17|STARTED|Period2, Escalation Phase4, Upto Day 105||0
4941406|NCT02991859|12154062|P16|STARTED|Period2, Escalation Phase4, Upto Day 105||0
4941407|NCT02991859|12154063|P15|STARTED|Period2, Escalation Phase4, Upto Day 105||0
4941408|NCT02991859|12154064|P14|STARTED|Period2, Escalation Phase4, Upto Day 105||0
4941409|NCT02991859|12154065|P13|STARTED|Period2, Escalation Phase4, Upto Day 105||0
4941410|NCT02991859|12154066|P12|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941411|NCT02991859|12154067|P11|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941412|NCT02991859|12154068|P10|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941413|NCT02991859|12154069|P9|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941414|NCT02991859|12154070|P8|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941415|NCT02991859|12154071|P7|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941416|NCT02991859|12154072|P6|STARTED|Period2, Escalation Phase4, Upto Day 105||1
4941417|NCT02991859|12154073|P5|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941418|NCT02991859|12154074|P4|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941419|NCT02991859|12154075|P3|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941420|NCT02991859|12154076|P2|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941421|NCT02991859|12154077|P1|STARTED|Period2, Escalation Phase4, Upto Day 105||2
4941422|NCT02991859|12154061|P17|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941423|NCT02991859|12154062|P16|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941424|NCT02991859|12154063|P15|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941425|NCT02991859|12154064|P14|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941426|NCT02991859|12154065|P13|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941427|NCT02991859|12154066|P12|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941428|NCT02991859|12154067|P11|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941429|NCT02991859|12154068|P10|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941430|NCT02991859|12154069|P9|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941431|NCT02991859|12154070|P8|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941432|NCT02991859|12154071|P7|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941433|NCT02991859|12154072|P6|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941434|NCT02991859|12154073|P5|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941435|NCT02991859|12154074|P4|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941436|NCT02991859|12154075|P3|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941437|NCT02991859|12154076|P2|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941438|NCT02991859|12154077|P1|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941439|NCT02991859|12154061|P17|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941440|NCT02991859|12154062|P16|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941441|NCT02991859|12154063|P15|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941442|NCT02991859|12154064|P14|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941443|NCT02991859|12154065|P13|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
4941444|NCT02991859|12154066|P12|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941445|NCT02991859|12154067|P11|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941446|NCT02991859|12154068|P10|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941447|NCT02991859|12154069|P9|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941448|NCT02991859|12154070|P8|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941449|NCT02991859|12154071|P7|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941450|NCT02991859|12154072|P6|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
4941451|NCT02991859|12154073|P5|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941452|NCT02991859|12154074|P4|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941453|NCT02991859|12154075|P3|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941454|NCT02991859|12154076|P2|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941455|NCT02991859|12154077|P1|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
4941456|NCT02991859|12154061|P17|STARTED|Period2, Escalation Phase3, Upto Day 98||0
4941457|NCT02991859|12154062|P16|STARTED|Period2, Escalation Phase3, Upto Day 98||0
4941458|NCT02991859|12154063|P15|STARTED|Period2, Escalation Phase3, Upto Day 98||0
4941459|NCT02991859|12154064|P14|STARTED|Period2, Escalation Phase3, Upto Day 98||0
4941460|NCT02991859|12154065|P13|STARTED|Period2, Escalation Phase3, Upto Day 98||0
4941461|NCT02991859|12154066|P12|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941462|NCT02991859|12154067|P11|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941463|NCT02991859|12154068|P10|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941464|NCT02991859|12154069|P9|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941465|NCT02991859|12154070|P8|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941466|NCT02991859|12154071|P7|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941467|NCT02991859|12154072|P6|STARTED|Period2, Escalation Phase3, Upto Day 98||1
4941468|NCT02991859|12154073|P5|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941469|NCT02991859|12154074|P4|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941470|NCT02991859|12154075|P3|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941471|NCT02991859|12154076|P2|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941472|NCT02991859|12154077|P1|STARTED|Period2, Escalation Phase3, Upto Day 98||2
4941473|NCT02991859|12154061|P17|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941474|NCT02991859|12154062|P16|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941475|NCT02991859|12154063|P15|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941476|NCT02991859|12154064|P14|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941477|NCT02991859|12154065|P13|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941478|NCT02991859|12154066|P12|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941479|NCT02991859|12154067|P11|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941480|NCT02991859|12154068|P10|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941481|NCT02991859|12154069|P9|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941482|NCT02991859|12154070|P8|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941483|NCT02991859|12154071|P7|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941484|NCT02991859|12154072|P6|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941485|NCT02991859|12154073|P5|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941486|NCT02991859|12154074|P4|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941487|NCT02991859|12154075|P3|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941488|NCT02991859|12154076|P2|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941489|NCT02991859|12154077|P1|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941490|NCT02991859|12154061|P17|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941491|NCT02991859|12154062|P16|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941492|NCT02991859|12154063|P15|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941493|NCT02991859|12154064|P14|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941494|NCT02991859|12154065|P13|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
4941495|NCT02991859|12154066|P12|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941496|NCT02991859|12154067|P11|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941497|NCT02991859|12154068|P10|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941498|NCT02991859|12154069|P9|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941499|NCT02991859|12154070|P8|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941500|NCT02991859|12154071|P7|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941501|NCT02991859|12154072|P6|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
4941502|NCT02991859|12154073|P5|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941503|NCT02991859|12154074|P4|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941504|NCT02991859|12154075|P3|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941505|NCT02991859|12154076|P2|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941506|NCT02991859|12154077|P1|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
4941507|NCT02991859|12154061|P17|STARTED|Period2, Escalation Phase2, Upto Day 91||0
4941508|NCT02991859|12154062|P16|STARTED|Period2, Escalation Phase2, Upto Day 91||0
4941509|NCT02991859|12154063|P15|STARTED|Period2, Escalation Phase2, Upto Day 91||0
4941510|NCT02991859|12154064|P14|STARTED|Period2, Escalation Phase2, Upto Day 91||0
4941511|NCT02991859|12154065|P13|STARTED|Period2, Escalation Phase2, Upto Day 91||0
4941512|NCT02991859|12154066|P12|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941513|NCT02991859|12154067|P11|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941514|NCT02991859|12154068|P10|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941515|NCT02991859|12154069|P9|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941516|NCT02991859|12154070|P8|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941517|NCT02991859|12154071|P7|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941518|NCT02991859|12154072|P6|STARTED|Period2, Escalation Phase2, Upto Day 91||1
4941519|NCT02991859|12154073|P5|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941520|NCT02991859|12154074|P4|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941521|NCT02991859|12154075|P3|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941522|NCT02991859|12154076|P2|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941523|NCT02991859|12154077|P1|STARTED|Period2, Escalation Phase2, Upto Day 91||2
4941524|NCT02991859|12154061|P17|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941525|NCT02991859|12154062|P16|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941526|NCT02991859|12154063|P15|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941527|NCT02991859|12154064|P14|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941528|NCT02991859|12154065|P13|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941529|NCT02991859|12154066|P12|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941530|NCT02991859|12154067|P11|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941531|NCT02991859|12154068|P10|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941532|NCT02991859|12154069|P9|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941533|NCT02991859|12154070|P8|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941534|NCT02991859|12154071|P7|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941535|NCT02991859|12154072|P6|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941536|NCT02991859|12154073|P5|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941537|NCT02991859|12154074|P4|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941538|NCT02991859|12154075|P3|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941539|NCT02991859|12154076|P2|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941540|NCT02991859|12154077|P1|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941541|NCT02991859|12154061|P17|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941542|NCT02991859|12154062|P16|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941543|NCT02991859|12154063|P15|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941544|NCT02991859|12154064|P14|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941545|NCT02991859|12154065|P13|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
4941546|NCT02991859|12154066|P12|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941547|NCT02991859|12154067|P11|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941548|NCT02991859|12154068|P10|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941549|NCT02991859|12154069|P9|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941550|NCT02991859|12154070|P8|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941551|NCT02991859|12154071|P7|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941552|NCT02991859|12154072|P6|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
4941553|NCT02991859|12154073|P5|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941554|NCT02991859|12154074|P4|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941555|NCT02991859|12154075|P3|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941556|NCT02991859|12154076|P2|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941557|NCT02991859|12154077|P1|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
4941558|NCT02991859|12154061|P17|STARTED|Period2, Escalation Phase1, Upto Day 84||0
4941559|NCT02991859|12154062|P16|STARTED|Period2, Escalation Phase1, Upto Day 84||0
4941560|NCT02991859|12154063|P15|STARTED|Period2, Escalation Phase1, Upto Day 84||0
4941561|NCT02991859|12154064|P14|STARTED|Period2, Escalation Phase1, Upto Day 84||0
4941562|NCT02991859|12154065|P13|STARTED|Period2, Escalation Phase1, Upto Day 84||0
4941563|NCT02991859|12154066|P12|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941564|NCT02991859|12154067|P11|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
4941565|NCT02991859|12154068|P10|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
4941566|NCT02991859|12154069|P9|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941567|NCT02991859|12154070|P8|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941568|NCT02991859|12154071|P7|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941569|NCT02991859|12154072|P6|STARTED|Period2, Escalation Phase1, Upto Day 84||1
4941570|NCT02991859|12154073|P5|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941571|NCT02991859|12154074|P4|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941572|NCT02991859|12154075|P3|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941573|NCT02991859|12154076|P2|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941574|NCT02991859|12154077|P1|STARTED|Period2, Escalation Phase1, Upto Day 84||2
4941575|NCT02991859|12154061|P17|NOT COMPLETED|Wash Out, Up to Day 77||0
4941576|NCT02991859|12154062|P16|NOT COMPLETED|Wash Out, Up to Day 77||0
4941577|NCT02991859|12154063|P15|NOT COMPLETED|Wash Out, Up to Day 77||0
4941578|NCT02991859|12154064|P14|NOT COMPLETED|Wash Out, Up to Day 77||0
4941579|NCT02991859|12154065|P13|NOT COMPLETED|Wash Out, Up to Day 77||0
4941580|NCT02991859|12154066|P12|NOT COMPLETED|Wash Out, Up to Day 77||0
4941581|NCT02991859|12154067|P11|NOT COMPLETED|Wash Out, Up to Day 77||0
4941582|NCT02991859|12154068|P10|NOT COMPLETED|Wash Out, Up to Day 77||1
4941583|NCT02991859|12154069|P9|NOT COMPLETED|Wash Out, Up to Day 77||0
4941584|NCT02991859|12154070|P8|NOT COMPLETED|Wash Out, Up to Day 77||0
4941585|NCT02991859|12154071|P7|NOT COMPLETED|Wash Out, Up to Day 77||0
4941586|NCT02991859|12154072|P6|NOT COMPLETED|Wash Out, Up to Day 77||1
4941587|NCT02991859|12154073|P5|NOT COMPLETED|Wash Out, Up to Day 77||0
4941588|NCT02991859|12154074|P4|NOT COMPLETED|Wash Out, Up to Day 77||0
4941589|NCT02991859|12154075|P3|NOT COMPLETED|Wash Out, Up to Day 77||0
4941590|NCT02991859|12154076|P2|NOT COMPLETED|Wash Out, Up to Day 77||0
4941591|NCT02991859|12154077|P1|NOT COMPLETED|Wash Out, Up to Day 77||0
4941592|NCT02991859|12154061|P17|COMPLETED|Wash Out, Up to Day 77||0
4941593|NCT02991859|12154062|P16|COMPLETED|Wash Out, Up to Day 77||0
4941594|NCT02991859|12154063|P15|COMPLETED|Wash Out, Up to Day 77||0
4941595|NCT02991859|12154064|P14|COMPLETED|Wash Out, Up to Day 77||0
4941596|NCT02991859|12154065|P13|COMPLETED|Wash Out, Up to Day 77||0
4941597|NCT02991859|12154066|P12|COMPLETED|Wash Out, Up to Day 77||2
4941598|NCT02991859|12154067|P11|COMPLETED|Wash Out, Up to Day 77||1
4941599|NCT02991859|12154068|P10|COMPLETED|Wash Out, Up to Day 77||1
4941600|NCT02991859|12154069|P9|COMPLETED|Wash Out, Up to Day 77||2
4941601|NCT02991859|12154070|P8|COMPLETED|Wash Out, Up to Day 77||2
4941602|NCT02991859|12154071|P7|COMPLETED|Wash Out, Up to Day 77||2
4941603|NCT02991859|12154072|P6|COMPLETED|Wash Out, Up to Day 77||1
4941604|NCT02991859|12154073|P5|COMPLETED|Wash Out, Up to Day 77||2
4941605|NCT02991859|12154074|P4|COMPLETED|Wash Out, Up to Day 77||2
4941606|NCT02991859|12154075|P3|COMPLETED|Wash Out, Up to Day 77||2
4941607|NCT02991859|12154076|P2|COMPLETED|Wash Out, Up to Day 77||2
4941608|NCT02991859|12154077|P1|COMPLETED|Wash Out, Up to Day 77||2
4941609|NCT02991859|12154061|P17|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
4941610|NCT02991859|12154062|P16|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
4941611|NCT02991859|12154063|P15|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
4941612|NCT02991859|12154064|P14|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
4941613|NCT02991859|12154065|P13|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
4941614|NCT02991859|12154066|P12|STARTED|Wash Out, Up to Day 77||2
4941615|NCT02991859|12154067|P11|STARTED|Wash Out, Up to Day 77||1
4941616|NCT02991859|12154068|P10|STARTED|Wash Out, Up to Day 77||2
4941617|NCT02991859|12154069|P9|STARTED|Wash Out, Up to Day 77||2
4941618|NCT02991859|12154070|P8|STARTED|Wash Out, Up to Day 77||2
4941619|NCT02991859|12154071|P7|STARTED|Wash Out, Up to Day 77||2
4941620|NCT02991859|12154072|P6|STARTED|Wash Out, Up to Day 77||2
4941621|NCT02991859|12154073|P5|STARTED|Wash Out, Up to Day 77||2
4941622|NCT02991859|12154074|P4|STARTED|Wash Out, Up to Day 77||2
4941623|NCT02991859|12154075|P3|STARTED|Wash Out, Up to Day 77||2
4941624|NCT02991859|12154076|P2|STARTED|Wash Out, Up to Day 77||2
4941625|NCT02991859|12154077|P1|STARTED|Wash Out, Up to Day 77||2
4941626|NCT02991859|12154061|P17|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941627|NCT02991859|12154062|P16|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941628|NCT02991859|12154063|P15|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941629|NCT02991859|12154064|P14|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941630|NCT02991859|12154065|P13|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941631|NCT02991859|12154066|P12|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941632|NCT02991859|12154067|P11|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941633|NCT02991859|12154068|P10|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941634|NCT02991859|12154069|P9|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941635|NCT02991859|12154070|P8|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941636|NCT02991859|12154071|P7|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941637|NCT02991859|12154072|P6|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941638|NCT02991859|12154073|P5|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941639|NCT02991859|12154074|P4|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941640|NCT02991859|12154075|P3|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941641|NCT02991859|12154076|P2|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941642|NCT02991859|12154077|P1|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
4941643|NCT02991859|12154061|P17|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
4941644|NCT02991859|12154062|P16|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
4941645|NCT02991859|12154063|P15|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
4941646|NCT02991859|12154064|P14|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
4941647|NCT02991859|12154065|P13|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
4941648|NCT02991859|12154066|P12|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941649|NCT02991859|12154067|P11|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
4941650|NCT02991859|12154068|P10|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941651|NCT02991859|12154069|P9|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941652|NCT02991859|12154070|P8|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941653|NCT02991859|12154071|P7|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941654|NCT02991859|12154072|P6|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941655|NCT02991859|12154073|P5|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941656|NCT02991859|12154074|P4|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941657|NCT02991859|12154075|P3|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941658|NCT02991859|12154076|P2|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941659|NCT02991859|12154077|P1|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
4941660|NCT02991859|12154061|P17|STARTED|Period1, Escalation Phase5, Upto Day35||3
4941661|NCT02991859|12154062|P16|STARTED|Period1, Escalation Phase5, Upto Day35||3
4941662|NCT02991859|12154063|P15|STARTED|Period1, Escalation Phase5, Upto Day35||6
4941663|NCT02991859|12154064|P14|STARTED|Period1, Escalation Phase5, Upto Day35||6
4941664|NCT02991859|12154065|P13|STARTED|Period1, Escalation Phase5, Upto Day35||6
4941665|NCT02991859|12154066|P12|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941666|NCT02991859|12154067|P11|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
4941667|NCT02991859|12154068|P10|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941668|NCT02991859|12154069|P9|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941669|NCT02991859|12154070|P8|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941670|NCT02991859|12154071|P7|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941671|NCT02991859|12154072|P6|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941672|NCT02991859|12154073|P5|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941673|NCT02991859|12154074|P4|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941674|NCT02991859|12154075|P3|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941675|NCT02991859|12154076|P2|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941676|NCT02991859|12154077|P1|STARTED|Period1, Escalation Phase5, Upto Day35||2
4941677|NCT02991859|12154061|P17|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941678|NCT02991859|12154062|P16|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941679|NCT02991859|12154063|P15|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941680|NCT02991859|12154064|P14|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941681|NCT02991859|12154065|P13|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941682|NCT02991859|12154066|P12|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941683|NCT02991859|12154067|P11|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941684|NCT02991859|12154068|P10|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941685|NCT02991859|12154069|P9|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941686|NCT02991859|12154070|P8|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941687|NCT02991859|12154071|P7|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941688|NCT02991859|12154072|P6|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941689|NCT02991859|12154073|P5|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941690|NCT02991859|12154074|P4|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941691|NCT02991859|12154075|P3|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941692|NCT02991859|12154076|P2|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941693|NCT02991859|12154077|P1|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
4941694|NCT02991859|12154061|P17|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
4941695|NCT02991859|12154062|P16|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
4941696|NCT02991859|12154063|P15|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
4941697|NCT02991859|12154064|P14|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
4941698|NCT02991859|12154065|P13|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
4941699|NCT02991859|12154066|P12|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941700|NCT02991859|12154067|P11|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941701|NCT02991859|12154068|P10|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941702|NCT02991859|12154069|P9|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941703|NCT02991859|12154070|P8|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941704|NCT02991859|12154071|P7|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941705|NCT02991859|12154072|P6|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941706|NCT02991859|12154073|P5|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941707|NCT02991859|12154074|P4|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941708|NCT02991859|12154075|P3|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941709|NCT02991859|12154076|P2|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941710|NCT02991859|12154077|P1|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
4941711|NCT02991859|12154061|P17|STARTED|Period1, Escalation Phase4, Upto Day28||3
4941712|NCT02991859|12154062|P16|STARTED|Period1, Escalation Phase4, Upto Day28||3
4941713|NCT02991859|12154063|P15|STARTED|Period1, Escalation Phase4, Upto Day28||6
4941714|NCT02991859|12154064|P14|STARTED|Period1, Escalation Phase4, Upto Day28||6
4941715|NCT02991859|12154065|P13|STARTED|Period1, Escalation Phase4, Upto Day28||6
4941716|NCT02991859|12154066|P12|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941717|NCT02991859|12154067|P11|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941718|NCT02991859|12154068|P10|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941719|NCT02991859|12154069|P9|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941720|NCT02991859|12154070|P8|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941721|NCT02991859|12154071|P7|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941722|NCT02991859|12154072|P6|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
4941723|NCT02991859|12154073|P5|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941724|NCT02991859|12154074|P4|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941725|NCT02991859|12154075|P3|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941726|NCT02991859|12154076|P2|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941727|NCT02991859|12154077|P1|STARTED|Period1, Escalation Phase4, Upto Day28||2
4941728|NCT02991859|12154061|P17|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941729|NCT02991859|12154062|P16|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941730|NCT02991859|12154063|P15|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941731|NCT02991859|12154064|P14|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
4941732|NCT02991859|12154065|P13|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
4941733|NCT02991859|12154066|P12|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941734|NCT02991859|12154067|P11|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941735|NCT02991859|12154068|P10|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941736|NCT02991859|12154069|P9|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941737|NCT02991859|12154070|P8|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941738|NCT02991859|12154071|P7|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941739|NCT02991859|12154072|P6|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941740|NCT02991859|12154073|P5|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941741|NCT02991859|12154074|P4|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941742|NCT02991859|12154075|P3|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941743|NCT02991859|12154076|P2|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941744|NCT02991859|12154077|P1|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
4941745|NCT02991859|12154061|P17|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
4941746|NCT02991859|12154062|P16|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
4941747|NCT02991859|12154063|P15|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
4941748|NCT02991859|12154064|P14|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
4941749|NCT02991859|12154065|P13|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
4941750|NCT02991859|12154066|P12|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941751|NCT02991859|12154067|P11|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941752|NCT02991859|12154068|P10|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941753|NCT02991859|12154069|P9|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941754|NCT02991859|12154070|P8|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941755|NCT02991859|12154071|P7|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941756|NCT02991859|12154072|P6|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
4941757|NCT02991859|12154073|P5|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941758|NCT02991859|12154074|P4|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941759|NCT02991859|12154075|P3|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941760|NCT02991859|12154076|P2|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941761|NCT02991859|12154077|P1|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
4941762|NCT02991859|12154061|P17|STARTED|Period1, Escalation Phase3, Upto Day21||3
4941763|NCT02991859|12154062|P16|STARTED|Period1, Escalation Phase3, Upto Day21||3
4941764|NCT02991859|12154063|P15|STARTED|Period1, Escalation Phase3, Upto Day21||6
4941765|NCT02991859|12154064|P14|STARTED|Period1, Escalation Phase3, Upto Day21||7
4941766|NCT02991859|12154065|P13|STARTED|Period1, Escalation Phase3, Upto Day21||7
4941767|NCT02991859|12154066|P12|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941768|NCT02991859|12154067|P11|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941769|NCT02991859|12154068|P10|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941770|NCT02991859|12154069|P9|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941771|NCT02991859|12154070|P8|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941772|NCT02991859|12154071|P7|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941773|NCT02991859|12154072|P6|STARTED|Period1, Escalation Phase3, Upto Day21||3
4941774|NCT02991859|12154073|P5|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941775|NCT02991859|12154074|P4|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941776|NCT02991859|12154075|P3|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941777|NCT02991859|12154076|P2|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941778|NCT02991859|12154077|P1|STARTED|Period1, Escalation Phase3, Upto Day21||2
4941779|NCT02991859|12154061|P17|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941780|NCT02991859|12154062|P16|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941781|NCT02991859|12154063|P15|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941782|NCT02991859|12154064|P14|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941783|NCT02991859|12154065|P13|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941784|NCT02991859|12154066|P12|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941785|NCT02991859|12154067|P11|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941786|NCT02991859|12154068|P10|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941787|NCT02991859|12154069|P9|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941788|NCT02991859|12154070|P8|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941789|NCT02991859|12154071|P7|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941790|NCT02991859|12154072|P6|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941791|NCT02991859|12154073|P5|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941792|NCT02991859|12154074|P4|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941793|NCT02991859|12154075|P3|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941794|NCT02991859|12154076|P2|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941795|NCT02991859|12154077|P1|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
4941796|NCT02991859|12154061|P17|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
4941797|NCT02991859|12154062|P16|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
4941798|NCT02991859|12154063|P15|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
4941799|NCT02991859|12154064|P14|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
4941800|NCT02991859|12154065|P13|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
4941801|NCT02991859|12154066|P12|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941802|NCT02991859|12154067|P11|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941803|NCT02991859|12154068|P10|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941804|NCT02991859|12154069|P9|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941805|NCT02991859|12154070|P8|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941806|NCT02991859|12154071|P7|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941807|NCT02991859|12154072|P6|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
4941808|NCT02991859|12154073|P5|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941809|NCT02991859|12154074|P4|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941810|NCT02991859|12154075|P3|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941811|NCT02991859|12154076|P2|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941812|NCT02991859|12154077|P1|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
4941813|NCT02991859|12154061|P17|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
4941814|NCT02991859|12154062|P16|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
4941815|NCT02991859|12154063|P15|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
4941816|NCT02991859|12154064|P14|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
4941817|NCT02991859|12154065|P13|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
4941818|NCT02991859|12154066|P12|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941819|NCT02991859|12154067|P11|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941820|NCT02991859|12154068|P10|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941821|NCT02991859|12154069|P9|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941822|NCT02991859|12154070|P8|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941823|NCT02991859|12154071|P7|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941824|NCT02991859|12154072|P6|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
4941825|NCT02991859|12154073|P5|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941826|NCT02991859|12154074|P4|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941827|NCT02991859|12154075|P3|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941828|NCT02991859|12154076|P2|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941829|NCT02991859|12154077|P1|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
4941830|NCT02991859|12154061|P17|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941831|NCT02991859|12154062|P16|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941832|NCT02991859|12154063|P15|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941833|NCT02991859|12154064|P14|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941834|NCT02991859|12154065|P13|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941835|NCT02991859|12154066|P12|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941836|NCT02991859|12154067|P11|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941837|NCT02991859|12154068|P10|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941838|NCT02991859|12154069|P9|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941839|NCT02991859|12154070|P8|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941840|NCT02991859|12154071|P7|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941841|NCT02991859|12154072|P6|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941842|NCT02991859|12154073|P5|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
4941843|NCT02991859|12154074|P4|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941844|NCT02991859|12154075|P3|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941845|NCT02991859|12154076|P2|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
4941846|NCT02991859|12154077|P1|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
4941847|NCT02991859|12154061|P17|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
4941848|NCT02991859|12154062|P16|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
4941849|NCT02991859|12154063|P15|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
4941850|NCT02991859|12154064|P14|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
4941851|NCT02991859|12154065|P13|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
4941852|NCT02991859|12154066|P12|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941853|NCT02991859|12154067|P11|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941854|NCT02991859|12154068|P10|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941855|NCT02991859|12154069|P9|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941856|NCT02991859|12154070|P8|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941857|NCT02991859|12154071|P7|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941858|NCT02991859|12154072|P6|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
4941859|NCT02991859|12154073|P5|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941860|NCT02991859|12154074|P4|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941861|NCT02991859|12154075|P3|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941862|NCT02991859|12154076|P2|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941863|NCT02991859|12154077|P1|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
4941864|NCT02991859|12154061|P17|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
4941865|NCT02991859|12154062|P16|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
4941866|NCT02991859|12154063|P15|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
4941867|NCT02991859|12154064|P14|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
4941868|NCT02991859|12154065|P13|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
4941869|NCT02991859|12154066|P12|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941870|NCT02991859|12154067|P11|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941871|NCT02991859|12154068|P10|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941872|NCT02991859|12154069|P9|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941873|NCT02991859|12154070|P8|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941874|NCT02991859|12154071|P7|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941875|NCT02991859|12154072|P6|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
4941876|NCT02991859|12154073|P5|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
4941877|NCT02991859|12154074|P4|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941878|NCT02991859|12154075|P3|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941879|NCT02991859|12154076|P2|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
4941880|NCT02991859|12154077|P1|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
4941881|NCT02991820|12154322|P2|NOT COMPLETED|Overall Study||0
4941882|NCT02991820|12154323|P1|NOT COMPLETED|Overall Study||0
4941883|NCT02991820|12154322|P2|COMPLETED|Overall Study||31
4941884|NCT02991820|12154323|P1|COMPLETED|Overall Study||12
4941885|NCT02991820|12154322|P2|STARTED|Overall Study||31
4941886|NCT02991820|12154323|P1|STARTED|Overall Study||12
4941887|NCT02991729|12154333|P2|NOT COMPLETED|Overall Study||0
4941888|NCT02991729|12154334|P1|NOT COMPLETED|Overall Study||0
4941889|NCT02991729|12154333|P2|COMPLETED|Overall Study||92
4941890|NCT02991729|12154334|P1|COMPLETED|Overall Study||105
4941891|NCT02991729|12154333|P2|STARTED|Overall Study||92
4941892|NCT02991729|12154334|P1|STARTED|Overall Study||105
4941893|NCT02991599|12154348|P2|NOT COMPLETED|Overall Study||37
4941894|NCT02991599|12154349|P1|NOT COMPLETED|Overall Study||38
4941895|NCT02991599|12154348|P2|COMPLETED|Overall Study||61
4941896|NCT02991599|12154349|P1|COMPLETED|Overall Study||60
4941897|NCT02991599|12154348|P2|STARTED|Overall Study||98
4941898|NCT02991599|12154349|P1|STARTED|Overall Study||98
4941899|NCT02991430|12154372|P3|NOT COMPLETED|Post-treatment Observation Period||5
4941900|NCT02991430|12154373|P2|NOT COMPLETED|Post-treatment Observation Period||6
4941901|NCT02991430|12154374|P1|NOT COMPLETED|Post-treatment Observation Period||3
4941902|NCT02991430|12154372|P3|COMPLETED|Post-treatment Observation Period||5
4941903|NCT02991430|12154373|P2|COMPLETED|Post-treatment Observation Period||2
4941904|NCT02991430|12154374|P1|COMPLETED|Post-treatment Observation Period||4
4941905|NCT02991430|12154372|P3|STARTED|Post-treatment Observation Period||10
4941906|NCT02991430|12154373|P2|STARTED|Post-treatment Observation Period||8
4941907|NCT02991430|12154374|P1|STARTED|Post-treatment Observation Period||7
4941908|NCT02991430|12154372|P3|NOT COMPLETED|Treatment Period 2||4
4941909|NCT02991430|12154373|P2|NOT COMPLETED|Treatment Period 2||3
4941910|NCT02991430|12154374|P1|NOT COMPLETED|Treatment Period 2||6
4941911|NCT02991430|12154372|P3|COMPLETED|Treatment Period 2||10
4941912|NCT02991430|12154373|P2|COMPLETED|Treatment Period 2||8
4941913|NCT02991430|12154374|P1|COMPLETED|Treatment Period 2||7
4941914|NCT02991430|12154372|P3|STARTED|Treatment Period 2||14
4941915|NCT02991430|12154373|P2|STARTED|Treatment Period 2||11
4941916|NCT02991430|12154374|P1|STARTED|Treatment Period 2||13
4941917|NCT02991430|12154372|P3|NOT COMPLETED|Treatment Period 1||2
4941918|NCT02991430|12154373|P2|NOT COMPLETED|Treatment Period 1||4
4941919|NCT02991430|12154374|P1|NOT COMPLETED|Treatment Period 1||1
4941920|NCT02991430|12154372|P3|COMPLETED|Treatment Period 1||14
4941921|NCT02991430|12154373|P2|COMPLETED|Treatment Period 1||11
4941922|NCT02991430|12154374|P1|COMPLETED|Treatment Period 1||13
4941923|NCT02991430|12154372|P3|STARTED|Treatment Period 1||16
4941924|NCT02991430|12154373|P2|STARTED|Treatment Period 1||15
4941925|NCT02991430|12154374|P1|STARTED|Treatment Period 1||14
4941926|NCT02991118|12154411|P2|NOT COMPLETED|Overall Study||32
4941927|NCT02991118|12154412|P1|NOT COMPLETED|Overall Study||7
4941928|NCT02991118|12154411|P2|COMPLETED|Overall Study||490
4941929|NCT02991118|12154412|P1|COMPLETED|Overall Study||250
4941930|NCT02991118|12154411|P2|STARTED|Overall Study||522
4941931|NCT02991118|12154412|P1|STARTED|Overall Study||257
4941932|NCT02991040|12154456|P1|NOT COMPLETED|Overall Study||4
4941933|NCT02991040|12154456|P1|COMPLETED|Overall Study||96
4941934|NCT02991040|12154456|P1|STARTED|Overall Study||100
4941935|NCT02990910|12154471|P2|NOT COMPLETED|Overall Study||10
4941936|NCT02990910|12154472|P1|NOT COMPLETED|Overall Study||6
4941937|NCT02990910|12154471|P2|COMPLETED|Overall Study||130
4941938|NCT02990910|12154472|P1|COMPLETED|Overall Study||134
4941939|NCT02990910|12154471|P2|STARTED|Overall Study||140
4941940|NCT02990910|12154472|P1|STARTED|Overall Study||140
4941941|NCT02990338|12154482|P2|NOT COMPLETED|Overall Study||89
4941942|NCT02990338|12154483|P1|NOT COMPLETED|Overall Study||118
4941943|NCT02990338|12154482|P2|COMPLETED|Overall Study||65
4941944|NCT02990338|12154483|P1|COMPLETED|Overall Study||35
4941945|NCT02990338|12154482|P2|Ongoing|Overall Study||65
4941946|NCT02990338|12154483|P1|Ongoing|Overall Study||35
4941947|NCT02990338|12154482|P2|Treated|Overall Study||152
4941948|NCT02990338|12154483|P1|Treated|Overall Study||149
4941949|NCT02990338|12154482|P2|STARTED|Overall Study||154
4941950|NCT02990338|12154483|P1|STARTED|Overall Study||153
4941951|NCT02990000|12154531|P2|NOT COMPLETED|Overall Study||34
4941952|NCT02990000|12154532|P1|NOT COMPLETED|Overall Study||36
4941953|NCT02990000|12154531|P2|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
4941954|NCT02990000|12154532|P1|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
4941955|NCT02990000|12154531|P2|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
4941956|NCT02990000|12154532|P1|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
4941957|NCT02990000|12154531|P2|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
4941958|NCT02990000|12154532|P1|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
4941959|NCT02989805|12154552|P2|NOT COMPLETED|Overall Study||4
4941960|NCT02989805|12154553|P1|NOT COMPLETED|Overall Study||6
4941961|NCT02989805|12154552|P2|COMPLETED|Overall Study||162
4941962|NCT02989805|12154553|P1|COMPLETED|Overall Study||154
4941963|NCT02989805|12154552|P2|STARTED|Overall Study||166
4941964|NCT02989805|12154553|P1|STARTED|Overall Study||160
4941965|NCT02989727|12154569|P4|NOT COMPLETED|Overall Study||0
4941966|NCT02989727|12154570|P3|NOT COMPLETED|Overall Study||0
4941967|NCT02989727|12154571|P2|NOT COMPLETED|Overall Study||0
4941968|NCT02989727|12154572|P1|NOT COMPLETED|Overall Study||0
4941969|NCT02989727|12154569|P4|COMPLETED|Overall Study||30
4941970|NCT02989727|12154570|P3|COMPLETED|Overall Study||30
4941971|NCT02989727|12154571|P2|COMPLETED|Overall Study||44
4941972|NCT02989727|12154572|P1|COMPLETED|Overall Study||46
4941973|NCT02989727|12154569|P4|STARTED|Overall Study||30
4941974|NCT02989727|12154570|P3|STARTED|Overall Study||30
4941975|NCT02989727|12154571|P2|STARTED|Overall Study||44
4941976|NCT02989727|12154572|P1|STARTED|Overall Study||46
4941977|NCT02989714|12154648|P1|NOT COMPLETED|Overall Study||1
4941978|NCT02989714|12154648|P1|COMPLETED|Overall Study||12
4941979|NCT02989714|12154648|P1|Started Nivolumab|Overall Study||12
4941980|NCT02989714|12154648|P1|STARTED|Overall Study||13
4941981|NCT02989649|12154654|P1|NOT COMPLETED|Overall Study||420
4941982|NCT02989649|12154654|P1|COMPLETED|Overall Study||173
4941983|NCT02989649|12154654|P1|Eligible to Enter Into Treatment Period|Overall Study||509
4941984|NCT02989649|12154654|P1|Started But Not Treated|Overall Study||84
4941985|NCT02989649|12154654|P1|STARTED|Overall Study||593
4941986|NCT02989545|12154666|P1|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
4941987|NCT02989545|12154666|P1|COMPLETED|Treatment Period - Anal Tape Provided||20
4941988|NCT02989545|12154666|P1|STARTED|Treatment Period - Anal Tape Provided||20
4941989|NCT02989545|12154666|P1|NOT COMPLETED|Control Period - no Intervention||0
4941990|NCT02989545|12154666|P1|COMPLETED|Control Period - no Intervention||20
4941991|NCT02989545|12154666|P1|STARTED|Control Period - no Intervention||20
4941992|NCT02989389|12154690|P10|NOT COMPLETED|Period 3||0
4941993|NCT02989389|12154691|P9|NOT COMPLETED|Period 3||0
4941994|NCT02989389|12154692|P8|NOT COMPLETED|Period 3||0
4941995|NCT02989389|12154693|P7|NOT COMPLETED|Period 3||0
4941996|NCT02989389|12154694|P6|NOT COMPLETED|Period 3||0
4941997|NCT02989389|12154695|P5|NOT COMPLETED|Period 3||0
4941998|NCT02989389|12154696|P4|NOT COMPLETED|Period 3||0
4941999|NCT02989389|12154697|P3|NOT COMPLETED|Period 3||0
4942000|NCT02989389|12154698|P2|NOT COMPLETED|Period 3||0
4942001|NCT02989389|12154699|P1|NOT COMPLETED|Period 3||0
4942002|NCT02989389|12154690|P10|COMPLETED|Period 3||0
4942003|NCT02989389|12154691|P9|COMPLETED|Period 3||0
4942004|NCT02989389|12154692|P8|COMPLETED|Period 3||0
4942005|NCT02989389|12154693|P7|COMPLETED|Period 3||0
4942006|NCT02989389|12154694|P6|COMPLETED|Period 3||3
4942007|NCT02989389|12154695|P5|COMPLETED|Period 3||3
4942008|NCT02989389|12154696|P4|COMPLETED|Period 3||3
4942009|NCT02989389|12154697|P3|COMPLETED|Period 3||3
4942010|NCT02989389|12154698|P2|COMPLETED|Period 3||3
4942011|NCT02989389|12154699|P1|COMPLETED|Period 3||3
4942012|NCT02989389|12154690|P10|STARTED|Period 3||0
4942013|NCT02989389|12154691|P9|STARTED|Period 3||0
4942014|NCT02989389|12154692|P8|STARTED|Period 3||0
4942015|NCT02989389|12154693|P7|STARTED|Period 3||0
4942016|NCT02989389|12154694|P6|STARTED|Period 3||3
4942017|NCT02989389|12154695|P5|STARTED|Period 3||3
4942018|NCT02989389|12154696|P4|STARTED|Period 3||3
4942019|NCT02989389|12154697|P3|STARTED|Period 3||3
4942020|NCT02989389|12154698|P2|STARTED|Period 3||3
4942021|NCT02989389|12154699|P1|STARTED|Period 3||3
4942022|NCT02989389|12154690|P10|NOT COMPLETED|Period 2||0
4942023|NCT02989389|12154691|P9|NOT COMPLETED|Period 2||0
4942024|NCT02989389|12154692|P8|NOT COMPLETED|Period 2||0
4942025|NCT02989389|12154693|P7|NOT COMPLETED|Period 2||0
4942026|NCT02989389|12154694|P6|NOT COMPLETED|Period 2||0
4942027|NCT02989389|12154695|P5|NOT COMPLETED|Period 2||0
4942028|NCT02989389|12154696|P4|NOT COMPLETED|Period 2||0
4942029|NCT02989389|12154697|P3|NOT COMPLETED|Period 2||0
4942030|NCT02989389|12154698|P2|NOT COMPLETED|Period 2||0
4942031|NCT02989389|12154699|P1|NOT COMPLETED|Period 2||0
4942032|NCT02989389|12154690|P10|COMPLETED|Period 2||0
4942033|NCT02989389|12154691|P9|COMPLETED|Period 2||0
4942034|NCT02989389|12154692|P8|COMPLETED|Period 2||0
4942035|NCT02989389|12154693|P7|COMPLETED|Period 2||0
4942036|NCT02989389|12154694|P6|COMPLETED|Period 2||3
4942037|NCT02989389|12154695|P5|COMPLETED|Period 2||3
4942038|NCT02989389|12154696|P4|COMPLETED|Period 2||3
4942039|NCT02989389|12154697|P3|COMPLETED|Period 2||3
4942040|NCT02989389|12154698|P2|COMPLETED|Period 2||3
4942041|NCT02989389|12154699|P1|COMPLETED|Period 2||3
4942042|NCT02989389|12154690|P10|STARTED|Period 2|Part B was planned as a single period study.|0
4942043|NCT02989389|12154691|P9|STARTED|Period 2|Part B was planned as a single period study.|0
4942044|NCT02989389|12154692|P8|STARTED|Period 2|Part B was planned as a single period study.|0
4942045|NCT02989389|12154693|P7|STARTED|Period 2|Part B was planned as a single period study.|0
4942046|NCT02989389|12154694|P6|STARTED|Period 2||3
4942047|NCT02989389|12154695|P5|STARTED|Period 2||3
4942048|NCT02989389|12154696|P4|STARTED|Period 2||3
4942049|NCT02989389|12154697|P3|STARTED|Period 2||3
4942050|NCT02989389|12154698|P2|STARTED|Period 2||3
4942051|NCT02989389|12154699|P1|STARTED|Period 2||3
4942052|NCT02989389|12154690|P10|NOT COMPLETED|Period 1||0
4942053|NCT02989389|12154691|P9|NOT COMPLETED|Period 1||1
4942054|NCT02989389|12154692|P8|NOT COMPLETED|Period 1||0
4942055|NCT02989389|12154693|P7|NOT COMPLETED|Period 1||0
4942056|NCT02989389|12154694|P6|NOT COMPLETED|Period 1||0
4942057|NCT02989389|12154695|P5|NOT COMPLETED|Period 1||0
4942058|NCT02989389|12154696|P4|NOT COMPLETED|Period 1||0
4942059|NCT02989389|12154697|P3|NOT COMPLETED|Period 1||0
4942060|NCT02989389|12154698|P2|NOT COMPLETED|Period 1||1
4942061|NCT02989389|12154699|P1|NOT COMPLETED|Period 1||0
4942062|NCT02989389|12154690|P10|COMPLETED|Period 1||6
4942063|NCT02989389|12154691|P9|COMPLETED|Period 1||5
4942064|NCT02989389|12154692|P8|COMPLETED|Period 1||5
4942065|NCT02989389|12154693|P7|COMPLETED|Period 1||6
4942066|NCT02989389|12154694|P6|COMPLETED|Period 1||3
4942067|NCT02989389|12154695|P5|COMPLETED|Period 1||3
4942068|NCT02989389|12154696|P4|COMPLETED|Period 1||3
4942069|NCT02989389|12154697|P3|COMPLETED|Period 1||3
4942070|NCT02989389|12154698|P2|COMPLETED|Period 1||3
4942071|NCT02989389|12154699|P1|COMPLETED|Period 1||3
4942072|NCT02989389|12154690|P10|Received at Least 1 Dose of Study Drug|Period 1||6
4942073|NCT02989389|12154691|P9|Received at Least 1 Dose of Study Drug|Period 1||6
4942074|NCT02989389|12154692|P8|Received at Least 1 Dose of Study Drug|Period 1||5
4942075|NCT02989389|12154693|P7|Received at Least 1 Dose of Study Drug|Period 1||6
4942076|NCT02989389|12154694|P6|Received at Least 1 Dose of Study Drug|Period 1||3
4942077|NCT02989389|12154695|P5|Received at Least 1 Dose of Study Drug|Period 1||3
4942078|NCT02989389|12154696|P4|Received at Least 1 Dose of Study Drug|Period 1||3
4942079|NCT02989389|12154697|P3|Received at Least 1 Dose of Study Drug|Period 1||3
4942080|NCT02989389|12154698|P2|Received at Least 1 Dose of Study Drug|Period 1||4
4942081|NCT02989389|12154699|P1|Received at Least 1 Dose of Study Drug|Period 1||3
4942082|NCT02989389|12154690|P10|STARTED|Period 1||6
4942083|NCT02989389|12154691|P9|STARTED|Period 1||6
4942084|NCT02989389|12154692|P8|STARTED|Period 1||5
4942085|NCT02989389|12154693|P7|STARTED|Period 1||6
4942086|NCT02989389|12154694|P6|STARTED|Period 1||3
4942087|NCT02989389|12154695|P5|STARTED|Period 1||3
4942088|NCT02989389|12154696|P4|STARTED|Period 1||3
4942089|NCT02989389|12154697|P3|STARTED|Period 1||3
4942090|NCT02989389|12154698|P2|STARTED|Period 1||4
4942091|NCT02989389|12154699|P1|STARTED|Period 1||3
4942092|NCT02988882|12154765|P2|NOT COMPLETED|Overall Study||2
4942093|NCT02988882|12154766|P1|NOT COMPLETED|Overall Study||3
4942094|NCT02988882|12154765|P2|COMPLETED|Overall Study||40
4942095|NCT02988882|12154766|P1|COMPLETED|Overall Study||41
4942096|NCT02988882|12154765|P2|STARTED|Overall Study||42
4942097|NCT02988882|12154766|P1|STARTED|Overall Study||44
4942098|NCT02988622|12154776|P1|NOT COMPLETED|Overall Study||17
4942099|NCT02988622|12154776|P1|COMPLETED|Overall Study||83
4942100|NCT02988622|12154776|P1|STARTED|Overall Study||100
4942101|NCT02988349|12154800|P2|NOT COMPLETED|Overall Study||0
4942102|NCT02988349|12154801|P1|NOT COMPLETED|Overall Study||0
4942103|NCT02988349|12154800|P2|COMPLETED|Overall Study||21
4942104|NCT02988349|12154801|P1|COMPLETED|Overall Study||21
4942105|NCT02988349|12154800|P2|STARTED|Overall Study||21
4942106|NCT02988349|12154801|P1|STARTED|Overall Study||21
4942107|NCT02988219|12154811|P2|NOT COMPLETED|Overall Study||3
4942108|NCT02988219|12154812|P1|NOT COMPLETED|Overall Study||1
4942109|NCT02988219|12154811|P2|COMPLETED|Overall Study||22
4942110|NCT02988219|12154812|P1|COMPLETED|Overall Study||24
4942111|NCT02988219|12154811|P2|STARTED|Overall Study||25
4942112|NCT02988219|12154812|P1|STARTED|Overall Study||25
4942113|NCT02988193|12154822|P2|NOT COMPLETED|Overall Study||0
4942114|NCT02988193|12154823|P1|NOT COMPLETED|Overall Study||0
4942115|NCT02988193|12154822|P2|COMPLETED|Overall Study||16
4942116|NCT02988193|12154823|P1|COMPLETED|Overall Study||12
4942117|NCT02988193|12154822|P2|STARTED|Overall Study||16
4942118|NCT02988193|12154823|P1|STARTED|Overall Study||12
4942119|NCT02988115|12154831|P2|NOT COMPLETED|Overall Study||4
4942120|NCT02988115|12154832|P1|NOT COMPLETED|Overall Study||14
4942121|NCT02988115|12154831|P2|COMPLETED|Overall Study||107
4942122|NCT02988115|12154832|P1|COMPLETED|Overall Study||220
4942123|NCT02988115|12154831|P2|STARTED|Overall Study||111
4942124|NCT02988115|12154832|P1|STARTED|Overall Study||234
4942125|NCT02987972|12154849|P3|NOT COMPLETED|Overall Study||42
4942126|NCT02987972|12154850|P2|NOT COMPLETED|Overall Study||45
4942127|NCT02987972|12154851|P1|NOT COMPLETED|Overall Study||43
4942128|NCT02987972|12154849|P3|COMPLETED|Overall Study||308
4942129|NCT02987972|12154850|P2|COMPLETED|Overall Study||305
4942130|NCT02987972|12154851|P1|COMPLETED|Overall Study||308
4942131|NCT02987972|12154849|P3|Vaccination 4|Overall Study||311
4942132|NCT02987972|12154850|P2|Vaccination 4|Overall Study||306
4942133|NCT02987972|12154851|P1|Vaccination 4|Overall Study||310
4942134|NCT02987972|12154849|P3|Vaccination 3|Overall Study||332
4942135|NCT02987972|12154850|P2|Vaccination 3|Overall Study||331
4942136|NCT02987972|12154851|P1|Vaccination 3|Overall Study||330
4942137|NCT02987972|12154849|P3|Vaccination 2|Overall Study||335
4942138|NCT02987972|12154850|P2|Vaccination 2|Overall Study||335
4942139|NCT02987972|12154851|P1|Vaccination 2|Overall Study||333
4942140|NCT02987972|12154849|P3|Vaccination 1|Overall Study||347
4942141|NCT02987972|12154850|P2|Vaccination 1|Overall Study||347
4942142|NCT02987972|12154851|P1|Vaccination 1|Overall Study||350
4942143|NCT02987972|12154849|P3|STARTED|Overall Study||350
4942144|NCT02987972|12154850|P2|STARTED|Overall Study||350
4942145|NCT02987972|12154851|P1|STARTED|Overall Study||351
4942146|NCT02987868|12154880|P2|NOT COMPLETED|Second Intervention||0
4942147|NCT02987868|12154881|P1|NOT COMPLETED|Second Intervention||0
4942148|NCT02987868|12154880|P2|COMPLETED|Second Intervention||8
4942149|NCT02987868|12154881|P1|COMPLETED|Second Intervention||8
4942150|NCT02987868|12154880|P2|STARTED|Second Intervention||8
4942151|NCT02987868|12154881|P1|STARTED|Second Intervention||8
4942152|NCT02987868|12154880|P2|NOT COMPLETED|Wash Out Period 1 Week||0
4942153|NCT02987868|12154881|P1|NOT COMPLETED|Wash Out Period 1 Week||0
4942154|NCT02987868|12154880|P2|COMPLETED|Wash Out Period 1 Week||8
4942155|NCT02987868|12154881|P1|COMPLETED|Wash Out Period 1 Week||8
4942156|NCT02987868|12154880|P2|STARTED|Wash Out Period 1 Week||8
4942157|NCT02987868|12154881|P1|STARTED|Wash Out Period 1 Week||8
4942158|NCT02987868|12154880|P2|NOT COMPLETED|First Intervention||0
4942159|NCT02987868|12154881|P1|NOT COMPLETED|First Intervention||0
4942160|NCT02987868|12154880|P2|COMPLETED|First Intervention||8
4942161|NCT02987868|12154881|P1|COMPLETED|First Intervention||8
4942162|NCT02987868|12154880|P2|STARTED|First Intervention||8
4942163|NCT02987868|12154881|P1|STARTED|First Intervention||8
4942164|NCT02987660|12154889|P2|NOT COMPLETED|Overall Study||10
4942165|NCT02987660|12154890|P1|NOT COMPLETED|Overall Study||10
4942166|NCT02987660|12154889|P2|COMPLETED|Overall Study||0
4942167|NCT02987660|12154890|P1|COMPLETED|Overall Study||0
4942168|NCT02987660|12154889|P2|STARTED|Overall Study||10
4942169|NCT02987660|12154890|P1|STARTED|Overall Study||10
4942170|NCT02987621|12154900|P2|NOT COMPLETED|Overall Study||0
4942171|NCT02987621|12154901|P1|NOT COMPLETED|Overall Study||0
4942172|NCT02987621|12154900|P2|COMPLETED|Overall Study||7
4942173|NCT02987621|12154901|P1|COMPLETED|Overall Study||7
4942174|NCT02987621|12154900|P2|STARTED|Overall Study||7
4942175|NCT02987621|12154901|P1|STARTED|Overall Study||7
4942176|NCT02987374|12154910|P1|NOT COMPLETED|Overall Study||0
4942177|NCT02987374|12154910|P1|COMPLETED|Overall Study||10
4942178|NCT02987374|12154910|P1|STARTED|Overall Study||10
4942179|NCT02987231|12154917|P2|NOT COMPLETED|Overall Study||0
4942180|NCT02987231|12154918|P1|NOT COMPLETED|Overall Study||0
4942181|NCT02987231|12154917|P2|COMPLETED|Overall Study||30
4942182|NCT02987231|12154918|P1|COMPLETED|Overall Study||30
4942183|NCT02987231|12154917|P2|STARTED|Overall Study||30
4942184|NCT02987231|12154918|P1|STARTED|Overall Study||30
4942185|NCT02987205|12154926|P1|NOT COMPLETED|Overall Study||4
4942186|NCT02987205|12154926|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
4942187|NCT02987205|12154926|P1|Treated - Bilateral NLF Injection|Overall Study||163
4942188|NCT02987205|12154926|P1|STARTED|Overall Study||163
4942189|NCT02986958|12154936|P2|NOT COMPLETED|Overall Study||0
4942190|NCT02986958|12154937|P1|NOT COMPLETED|Overall Study||0
4942191|NCT02986958|12154936|P2|COMPLETED|Overall Study||44
4942192|NCT02986958|12154937|P1|COMPLETED|Overall Study||49
4942193|NCT02986958|12154936|P2|STARTED|Overall Study||44
4942194|NCT02986958|12154937|P1|STARTED|Overall Study||49
4942195|NCT02986854|12154960|P3|NOT COMPLETED|Overall Study||3
4942196|NCT02986854|12154961|P2|NOT COMPLETED|Overall Study||12
4942197|NCT02986854|12154962|P1|NOT COMPLETED|Overall Study||3
4942198|NCT02986854|12154960|P3|COMPLETED|Overall Study||97
4942199|NCT02986854|12154961|P2|COMPLETED|Overall Study||288
4942200|NCT02986854|12154962|P1|COMPLETED|Overall Study||298
4942201|NCT02986854|12154960|P3|STARTED|Overall Study||100
4942202|NCT02986854|12154961|P2|STARTED|Overall Study||300
4942203|NCT02986854|12154962|P1|STARTED|Overall Study||301
4942204|NCT02986711|12155037|P2|NOT COMPLETED|Overall Study||10
4942205|NCT02986711|12155038|P1|NOT COMPLETED|Overall Study||8
4942206|NCT02986711|12155037|P2|COMPLETED|Overall Study||70
4942207|NCT02986711|12155038|P1|COMPLETED|Overall Study||70
4942208|NCT02986711|12155037|P2|STARTED|Overall Study||80
4942209|NCT02986711|12155038|P1|STARTED|Overall Study||78
4942210|NCT02986373|12155046|P1|NOT COMPLETED|Overall Study||39
4942211|NCT02986373|12155046|P1|COMPLETED|Overall Study||106
4942212|NCT02986373|12155046|P1|STARTED|Overall Study||145
4942213|NCT02986282|12155081|P1|NOT COMPLETED|Overall Study||16
4942214|NCT02986282|12155081|P1|COMPLETED|Overall Study||99
4942215|NCT02986282|12155081|P1|STARTED|Overall Study||115
4942216|NCT02986139|12155088|P2|NOT COMPLETED|Overall Study||4
4942217|NCT02986139|12155089|P1|NOT COMPLETED|Overall Study||1
4942218|NCT02986139|12155088|P2|COMPLETED|Overall Study||51
4942219|NCT02986139|12155089|P1|COMPLETED|Overall Study||55
4942220|NCT02986139|12155088|P2|Received Etanercept|Overall Study||53
4942221|NCT02986139|12155089|P1|Received Etanercept|Overall Study||56
4942222|NCT02986139|12155088|P2|STARTED|Overall Study||55
4942223|NCT02986139|12155089|P1|STARTED|Overall Study||56
4942224|NCT02985996|12155106|P5|NOT COMPLETED|Overall Study||0
4942225|NCT02985996|12155107|P4|NOT COMPLETED|Overall Study||0
4942226|NCT02985996|12155108|P3|NOT COMPLETED|Overall Study||1
4942227|NCT02985996|12155109|P2|NOT COMPLETED|Overall Study||1
4942228|NCT02985996|12155110|P1|NOT COMPLETED|Overall Study||0
4942229|NCT02985996|12155106|P5|COMPLETED|Overall Study||9
4942230|NCT02985996|12155107|P4|COMPLETED|Overall Study||7
4942231|NCT02985996|12155108|P3|COMPLETED|Overall Study||9
4942232|NCT02985996|12155109|P2|COMPLETED|Overall Study||7
4942233|NCT02985996|12155110|P1|COMPLETED|Overall Study||5
4942234|NCT02985996|12155106|P5|STARTED|Overall Study||9
4942235|NCT02985996|12155107|P4|STARTED|Overall Study||7
4942236|NCT02985996|12155108|P3|STARTED|Overall Study||10
4942237|NCT02985996|12155109|P2|STARTED|Overall Study||8
4942238|NCT02985996|12155110|P1|STARTED|Overall Study||5
4942239|NCT02985840|12155224|P2|NOT COMPLETED|Overall Study||0
4942240|NCT02985840|12155225|P1|NOT COMPLETED|Overall Study||0
4942241|NCT02985840|12155224|P2|COMPLETED|Overall Study||63
4942242|NCT02985840|12155225|P1|COMPLETED|Overall Study||64
4942243|NCT02985840|12155224|P2|STARTED|Overall Study||63
4942244|NCT02985840|12155225|P1|STARTED|Overall Study||64
4942245|NCT02985827|12155235|P2|NOT COMPLETED|Overall Study||0
4942246|NCT02985827|12155236|P1|NOT COMPLETED|Overall Study||0
4942247|NCT02985827|12155235|P2|COMPLETED|Overall Study||15
4942248|NCT02985827|12155236|P1|COMPLETED|Overall Study||33
4942249|NCT02985827|12155235|P2|STARTED|Overall Study||15
4942250|NCT02985827|12155236|P1|STARTED|Overall Study||33
4942251|NCT02985684|12155244|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
4942252|NCT02985684|12155244|P1|COMPLETED|6-Month Closure Success Evaluation||112
4942253|NCT02985684|12155244|P1|STARTED|6-Month Closure Success Evaluation||120
4942254|NCT02985684|12155244|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
4942255|NCT02985684|12155244|P1|COMPLETED|6-Month Clinical Success Evaluation||120
4942256|NCT02985684|12155244|P1|STARTED|6-Month Clinical Success Evaluation||125
4942257|NCT02985398|12155255|P1|NOT COMPLETED|Overall Study||22
4942258|NCT02985398|12155255|P1|COMPLETED|Overall Study||106
4942259|NCT02985398|12155255|P1|Participants Treated|Overall Study||128
4942260|NCT02985398|12155255|P1|STARTED|Overall Study||128
4942261|NCT02984995|12155273|P2|NOT COMPLETED|Overall Study||3
4942262|NCT02984995|12155274|P1|NOT COMPLETED|Overall Study||25
4942263|NCT02984995|12155273|P2|COMPLETED|Overall Study||0
4942264|NCT02984995|12155274|P1|COMPLETED|Overall Study||9
4942265|NCT02984995|12155273|P2|STARTED|Overall Study||3
4942266|NCT02984995|12155274|P1|STARTED|Overall Study||34
4942267|NCT02984982|12155321|P2|NOT COMPLETED|Overall Study||10
4942268|NCT02984982|12155322|P1|NOT COMPLETED|Overall Study||8
4942269|NCT02984982|12155321|P2|COMPLETED|Overall Study||94
4942270|NCT02984982|12155322|P1|COMPLETED|Overall Study||94
4942271|NCT02984982|12155321|P2|Treated|Overall Study||103
4942272|NCT02984982|12155322|P1|Treated|Overall Study||102
4942273|NCT02984982|12155321|P2|STARTED|Overall Study||104
4942274|NCT02984982|12155322|P1|STARTED|Overall Study||102
4942275|NCT02984943|12155374|P1|NOT COMPLETED|Overall Study||4
4942276|NCT02984943|12155374|P1|COMPLETED|Overall Study||10
4942277|NCT02984943|12155374|P1|STARTED|Overall Study||14
4942278|NCT02984878|12155419|P2|NOT COMPLETED|Overall Study||0
4942279|NCT02984878|12155420|P1|NOT COMPLETED|Overall Study||0
4942280|NCT02984878|12155419|P2|COMPLETED|Overall Study||41
4942281|NCT02984878|12155420|P1|COMPLETED|Overall Study||30
4942282|NCT02984878|12155419|P2|STARTED|Overall Study||41
4942283|NCT02984878|12155420|P1|STARTED|Overall Study||30
4942284|NCT02984709|12155432|P2|NOT COMPLETED|Overall Study||0
4942285|NCT02984709|12155433|P1|NOT COMPLETED|Overall Study||0
4942286|NCT02984709|12155432|P2|COMPLETED|Overall Study||24
4942287|NCT02984709|12155433|P1|COMPLETED|Overall Study||24
4942288|NCT02984709|12155432|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
4942289|NCT02984709|12155433|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
4942290|NCT02984644|12155457|P2|NOT COMPLETED|Overall Study||0
4942291|NCT02984644|12155458|P1|NOT COMPLETED|Overall Study||0
4942292|NCT02984644|12155457|P2|COMPLETED|Overall Study||10
4942293|NCT02984644|12155458|P1|COMPLETED|Overall Study||20
4942294|NCT02984644|12155457|P2|STARTED|Overall Study||10
4942295|NCT02984644|12155458|P1|STARTED|Overall Study||20
4942296|NCT02984267|12155488|P2|NOT COMPLETED|Overall Study||1
4942297|NCT02984267|12155489|P1|NOT COMPLETED|Overall Study||1
4942298|NCT02984267|12155488|P2|COMPLETED|Overall Study||9
4942299|NCT02984267|12155489|P1|COMPLETED|Overall Study||7
4942300|NCT02984267|12155488|P2|STARTED|Overall Study||10
4942301|NCT02984267|12155489|P1|STARTED|Overall Study||8
4942302|NCT02983981|12155513|P1|NOT COMPLETED|Overall Study||0
4942303|NCT02983981|12155513|P1|COMPLETED|Overall Study||20
4942304|NCT02983981|12155513|P1|STARTED|Overall Study||20
4942305|NCT02983877|12155520|P1|NOT COMPLETED|Overall Study||0
4942306|NCT02983877|12155520|P1|COMPLETED|Overall Study||38
4942307|NCT02983877|12155520|P1|STARTED|Overall Study||38
4942308|NCT02983825|12155527|P1|NOT COMPLETED|Overall Study||3
4942309|NCT02983825|12155527|P1|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
4942310|NCT02983825|12155527|P1|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
4942311|NCT02983617|12155534|P2|NOT COMPLETED|Overall Study||30
4942312|NCT02983617|12155535|P1|NOT COMPLETED|Overall Study||6
4942313|NCT02983617|12155534|P2|COMPLETED|Overall Study||0
4942314|NCT02983617|12155535|P1|COMPLETED|Overall Study||0
4942315|NCT02983617|12155534|P2|STARTED|Overall Study||30
4942316|NCT02983617|12155535|P1|STARTED|Overall Study||6
4942317|NCT02983604|12155553|P4|NOT COMPLETED|Overall Study||0
4942318|NCT02983604|12155554|P3|NOT COMPLETED|Overall Study||1
4942319|NCT02983604|12155555|P2|NOT COMPLETED|Overall Study||0
4942320|NCT02983604|12155556|P1|NOT COMPLETED|Overall Study||0
4942321|NCT02983604|12155553|P4|COMPLETED|Overall Study||3
4942322|NCT02983604|12155554|P3|COMPLETED|Overall Study||3
4942323|NCT02983604|12155555|P2|COMPLETED|Overall Study||3
4942324|NCT02983604|12155556|P1|COMPLETED|Overall Study||4
4942325|NCT02983604|12155553|P4|STARTED|Overall Study||3
4942326|NCT02983604|12155554|P3|STARTED|Overall Study||4
4942327|NCT02983604|12155555|P2|STARTED|Overall Study||3
4942328|NCT02983604|12155556|P1|STARTED|Overall Study||4
4942329|NCT02983448|12155594|P2|NOT COMPLETED|Overall Study||0
4942330|NCT02983448|12155595|P1|NOT COMPLETED|Overall Study||0
4942331|NCT02983448|12155594|P2|COMPLETED|Overall Study||12
4942332|NCT02983448|12155595|P1|COMPLETED|Overall Study||12
4942333|NCT02983448|12155594|P2|STARTED|Overall Study||12
4942334|NCT02983448|12155595|P1|STARTED|Overall Study||12
4942335|NCT02983305|12155605|P2|NOT COMPLETED|Overall Study||0
4942336|NCT02983305|12155606|P1|NOT COMPLETED|Overall Study||2
4942337|NCT02983305|12155605|P2|COMPLETED|Overall Study||10
4942338|NCT02983305|12155606|P1|COMPLETED|Overall Study||10
4942339|NCT02983305|12155605|P2|STARTED|Overall Study||10
4942340|NCT02983305|12155606|P1|STARTED|Overall Study||12
4942341|NCT02983058|12155616|P2|NOT COMPLETED|Overall Study||3
4942342|NCT02983058|12155617|P1|NOT COMPLETED|Overall Study||5
4942343|NCT02983058|12155616|P2|COMPLETED|Overall Study||2
4942344|NCT02983058|12155617|P1|COMPLETED|Overall Study||2
4942345|NCT02983058|12155616|P2|STARTED|Overall Study||5
4942346|NCT02983058|12155617|P1|STARTED|Overall Study||7
4942347|NCT02982928|12155627|P1|NOT COMPLETED|Overall Study||0
4942348|NCT02982928|12155627|P1|COMPLETED|Overall Study||11
4942349|NCT02982928|12155627|P1|STARTED|Overall Study||11
4942350|NCT02982863|12155636|P5|NOT COMPLETED|Overall Study||492
4942351|NCT02982863|12155637|P4|NOT COMPLETED|Overall Study||1400
4942352|NCT02982863|12155638|P3|NOT COMPLETED|Overall Study||1852
4942353|NCT02982863|12155639|P2|NOT COMPLETED|Overall Study||4261
4942354|NCT02982863|12155640|P1|NOT COMPLETED|Overall Study||809
4942355|NCT02982863|12155636|P5|COMPLETED|Overall Study||2268
4942356|NCT02982863|12155637|P4|COMPLETED|Overall Study||8758
4942357|NCT02982863|12155638|P3|COMPLETED|Overall Study||11386
4942358|NCT02982863|12155639|P2|COMPLETED|Overall Study||12484
4942359|NCT02982863|12155640|P1|COMPLETED|Overall Study||4936
4942360|NCT02982863|12155636|P5|STARTED|Overall Study||2760
4942361|NCT02982863|12155637|P4|STARTED|Overall Study||10158
4942362|NCT02982863|12155638|P3|STARTED|Overall Study||13238
4942363|NCT02982863|12155639|P2|STARTED|Overall Study||16745
4942364|NCT02982863|12155640|P1|STARTED|Overall Study||5745
4942365|NCT02982720|12155697|P1|NOT COMPLETED|Overall Study||4
4942366|NCT02982720|12155697|P1|COMPLETED|Overall Study||0
4942367|NCT02982720|12155697|P1|STARTED|Overall Study||4
4942368|NCT02982239|12155707|P2|NOT COMPLETED|Overall Study||2
4942369|NCT02982239|12155708|P1|NOT COMPLETED|Overall Study||3
4942370|NCT02982239|12155707|P2|COMPLETED|Overall Study||18
4942371|NCT02982239|12155708|P1|COMPLETED|Overall Study||17
4942372|NCT02982239|12155707|P2|STARTED|Overall Study||20
4942373|NCT02982239|12155708|P1|STARTED|Overall Study||20
4942374|NCT02982187|12155724|P8|NOT COMPLETED|Overall Study||0
4942375|NCT02982187|12155725|P7|NOT COMPLETED|Overall Study||1
4942376|NCT02982187|12155726|P6|NOT COMPLETED|Overall Study||0
4942377|NCT02982187|12155727|P5|NOT COMPLETED|Overall Study||0
4942378|NCT02982187|12155728|P4|NOT COMPLETED|Overall Study||0
4942379|NCT02982187|12155729|P3|NOT COMPLETED|Overall Study||0
4942380|NCT02982187|12155730|P2|NOT COMPLETED|Overall Study||0
4942381|NCT02982187|12155731|P1|NOT COMPLETED|Overall Study||0
4942382|NCT02982187|12155724|P8|COMPLETED|Overall Study||20
4942383|NCT02982187|12155725|P7|COMPLETED|Overall Study||19
4942384|NCT02982187|12155726|P6|COMPLETED|Overall Study||20
4942385|NCT02982187|12155727|P5|COMPLETED|Overall Study||20
4942386|NCT02982187|12155728|P4|COMPLETED|Overall Study||20
4942387|NCT02982187|12155729|P3|COMPLETED|Overall Study||20
4942388|NCT02982187|12155730|P2|COMPLETED|Overall Study||20
4942389|NCT02982187|12155731|P1|COMPLETED|Overall Study||20
4942390|NCT02982187|12155724|P8|STARTED|Overall Study||20
4942391|NCT02982187|12155725|P7|STARTED|Overall Study||20
4942392|NCT02982187|12155726|P6|STARTED|Overall Study||20
4942393|NCT02982187|12155727|P5|STARTED|Overall Study||20
4942394|NCT02982187|12155728|P4|STARTED|Overall Study||20
4942395|NCT02982187|12155729|P3|STARTED|Overall Study||20
4942396|NCT02982187|12155730|P2|STARTED|Overall Study||20
4942397|NCT02982187|12155731|P1|STARTED|Overall Study||20
4942398|NCT02982018|12155781|P2|NOT COMPLETED|Overall Study||3
4942399|NCT02982018|12155782|P1|NOT COMPLETED|Overall Study||5
4942400|NCT02982018|12155781|P2|COMPLETED|Overall Study||61
4942401|NCT02982018|12155782|P1|COMPLETED|Overall Study||62
4942402|NCT02982018|12155781|P2|STARTED|Overall Study||64
4942403|NCT02982018|12155782|P1|STARTED|Overall Study||67
4942404|NCT02981524|12155796|P1|NOT COMPLETED|Overall Study||17
4942405|NCT02981524|12155796|P1|COMPLETED|Overall Study||0
4942406|NCT02981524|12155796|P1|STARTED|Overall Study||17
4942407|NCT02981342|12155808|P4|NOT COMPLETED|Overall Study||14
4942408|NCT02981342|12155809|P3|NOT COMPLETED|Overall Study||13
4942409|NCT02981342|12155810|P2|NOT COMPLETED|Overall Study||11
4942410|NCT02981342|12155811|P1|NOT COMPLETED|Overall Study||0
4942411|NCT02981342|12155808|P4|COMPLETED|Overall Study||19
4942412|NCT02981342|12155809|P3|COMPLETED|Overall Study||20
4942413|NCT02981342|12155810|P2|COMPLETED|Overall Study||22
4942414|NCT02981342|12155811|P1|COMPLETED|Overall Study||7
4942415|NCT02981342|12155808|P4|Received at Least One Dose of Study Drug|Overall Study||26
4942416|NCT02981342|12155809|P3|Received at Least One Dose of Study Drug|Overall Study||33
4942417|NCT02981342|12155810|P2|Received at Least One Dose of Study Drug|Overall Study||32
4942418|NCT02981342|12155811|P1|Received at Least One Dose of Study Drug|Overall Study||7
4942419|NCT02981342|12155808|P4|STARTED|Overall Study||33
4942420|NCT02981342|12155809|P3|STARTED|Overall Study||33
4942421|NCT02981342|12155810|P2|STARTED|Overall Study||33
4942422|NCT02981342|12155811|P1|STARTED|Overall Study||7
4942423|NCT02980978|12155854|P2|NOT COMPLETED|Overall Study||8
4942424|NCT02980978|12155855|P1|NOT COMPLETED|Overall Study||6
4942425|NCT02980978|12155854|P2|COMPLETED|Overall Study||50
4942426|NCT02980978|12155855|P1|COMPLETED|Overall Study||54
4942427|NCT02980978|12155854|P2|STARTED|Overall Study||58
4942428|NCT02980978|12155855|P1|STARTED|Overall Study||60
4942429|NCT02980783|12155869|P1|NOT COMPLETED|Overall Study||1
4942430|NCT02980783|12155869|P1|COMPLETED|Overall Study||52
4942431|NCT02980783|12155869|P1|STARTED|Overall Study||53
4942432|NCT02980601|12155882|P2|NOT COMPLETED|Overall Study||3
4942433|NCT02980601|12155883|P1|NOT COMPLETED|Overall Study||5
4942434|NCT02980601|12155882|P2|COMPLETED|Overall Study||1
4942435|NCT02980601|12155883|P1|COMPLETED|Overall Study||1
4942436|NCT02980601|12155882|P2|STARTED|Overall Study||4
4942437|NCT02980601|12155883|P1|STARTED|Overall Study||6
4942438|NCT02980523|12155976|P5|NOT COMPLETED|Overall Study||10
4942439|NCT02980523|12155977|P4|NOT COMPLETED|Overall Study||9
4942440|NCT02980523|12155978|P3|NOT COMPLETED|Overall Study||6
4942441|NCT02980523|12155979|P2|NOT COMPLETED|Overall Study||11
4942442|NCT02980523|12155980|P1|NOT COMPLETED|Overall Study||3
4942443|NCT02980523|12155976|P5|COMPLETED|Overall Study||20
4942444|NCT02980523|12155977|P4|COMPLETED|Overall Study||21
4942445|NCT02980523|12155978|P3|COMPLETED|Overall Study||24
4942446|NCT02980523|12155979|P2|COMPLETED|Overall Study||19
4942447|NCT02980523|12155980|P1|COMPLETED|Overall Study||27
4942448|NCT02980523|12155976|P5|STARTED|Overall Study||30
4942449|NCT02980523|12155977|P4|STARTED|Overall Study||30
4942450|NCT02980523|12155978|P3|STARTED|Overall Study||30
4942451|NCT02980523|12155979|P2|STARTED|Overall Study||30
4942452|NCT02980523|12155980|P1|STARTED|Overall Study||30
4942453|NCT02980224|12156024|P2|NOT COMPLETED|Overall Study||3
4942454|NCT02980224|12156025|P1|NOT COMPLETED|Overall Study||4
4942455|NCT02980224|12156024|P2|COMPLETED|Overall Study||88
4942456|NCT02980224|12156025|P1|COMPLETED|Overall Study||85
4942457|NCT02980224|12156024|P2|STARTED|Overall Study||91
4942458|NCT02980224|12156025|P1|STARTED|Overall Study||89
4942459|NCT02980211|12156035|P1|NOT COMPLETED|Overall Study||0
4942460|NCT02980211|12156035|P1|COMPLETED|Overall Study||17
4942461|NCT02980211|12156035|P1|STARTED|Overall Study||17
4942462|NCT02980133|12156043|P4|NOT COMPLETED|Overall Study||6
4942463|NCT02980133|12156044|P3|NOT COMPLETED|Overall Study||7
4942464|NCT02980133|12156045|P2|NOT COMPLETED|Overall Study||5
4942465|NCT02980133|12156046|P1|NOT COMPLETED|Overall Study||7
4942466|NCT02980133|12156043|P4|COMPLETED|Overall Study||205
4942467|NCT02980133|12156044|P3|COMPLETED|Overall Study||203
4942468|NCT02980133|12156045|P2|COMPLETED|Overall Study||206
4942469|NCT02980133|12156046|P1|COMPLETED|Overall Study||202
4942470|NCT02980133|12156043|P4|Received at Least 1 Dose of Study Drug|Overall Study||211
4942471|NCT02980133|12156044|P3|Received at Least 1 Dose of Study Drug|Overall Study||208
4942472|NCT02980133|12156045|P2|Received at Least 1 Dose of Study Drug|Overall Study||211
4942473|NCT02980133|12156046|P1|Received at Least 1 Dose of Study Drug|Overall Study||209
4942474|NCT02980133|12156043|P4|STARTED|Overall Study||211
4942475|NCT02980133|12156044|P3|STARTED|Overall Study||210
4942476|NCT02980133|12156045|P2|STARTED|Overall Study||211
4942477|NCT02980133|12156046|P1|STARTED|Overall Study||209
4942478|NCT02980107|12156084|P2|NOT COMPLETED|Overall Study||62
4942479|NCT02980107|12156085|P1|NOT COMPLETED|Overall Study||51
4942480|NCT02980107|12156084|P2|COMPLETED|Overall Study||45
4942481|NCT02980107|12156085|P1|COMPLETED|Overall Study||54
4942482|NCT02980107|12156084|P2|STARTED|Overall Study||107
4942483|NCT02980107|12156085|P1|STARTED|Overall Study||105
4942484|NCT02980042|12156099|P2|NOT COMPLETED|Overall Study||0
4942485|NCT02980042|12156100|P1|NOT COMPLETED|Overall Study||7
4942486|NCT02980042|12156099|P2|COMPLETED|Overall Study||100
4942487|NCT02980042|12156100|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
4942488|NCT02980042|12156099|P2|STARTED|Overall Study||100
4942489|NCT02980042|12156100|P1|STARTED|Overall Study||100
4942490|NCT02979899|12156119|P2|NOT COMPLETED|Overall Study||0
4942491|NCT02979899|12156120|P1|NOT COMPLETED|Overall Study||0
4942492|NCT02979899|12156119|P2|COMPLETED|Overall Study||64
4942493|NCT02979899|12156120|P1|COMPLETED|Overall Study||64
4942494|NCT02979899|12156119|P2|STARTED|Overall Study||64
4942495|NCT02979899|12156120|P1|STARTED|Overall Study||64
4942496|NCT02979639|12156132|P1|NOT COMPLETED|Overall Study||14
4942497|NCT02979639|12156132|P1|COMPLETED|Overall Study||387
4942498|NCT02979639|12156132|P1|STARTED|Overall Study||401
4942499|NCT02979613|12156164|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||227
4942500|NCT02979613|12156165|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||223
4942501|NCT02979613|12156164|P2|COMPLETED|Open-Label Extension (OLE) Phase||10
4942502|NCT02979613|12156165|P1|COMPLETED|Open-Label Extension (OLE) Phase||12
4942503|NCT02979613|12156164|P2|STARTED|Open-Label Extension (OLE) Phase||237
4942504|NCT02979613|12156165|P1|STARTED|Open-Label Extension (OLE) Phase||235
4942505|NCT02979613|12156164|P2|NOT COMPLETED|Double-Blind Phase||8
4942506|NCT02979613|12156165|P1|NOT COMPLETED|Double-Blind Phase||10
4942507|NCT02979613|12156164|P2|COMPLETED|Double-Blind Phase||237
4942508|NCT02979613|12156165|P1|COMPLETED|Double-Blind Phase||235
4942509|NCT02979613|12156164|P2|STARTED|Double-Blind Phase||245
4942510|NCT02979613|12156165|P1|STARTED|Double-Blind Phase||245
4942511|NCT02979535|12156199|P2|NOT COMPLETED|Overall Study||101
4942512|NCT02979535|12156200|P1|NOT COMPLETED|Overall Study||95
4942513|NCT02979535|12156199|P2|COMPLETED|Overall Study||140
4942514|NCT02979535|12156200|P1|COMPLETED|Overall Study||144
4942515|NCT02979535|12156199|P2|Safety Analysis Set|Overall Study||241
4942516|NCT02979535|12156200|P1|Safety Analysis Set|Overall Study||237
4942517|NCT02979535|12156199|P2|STARTED|Overall Study||241
4942518|NCT02979535|12156200|P1|STARTED|Overall Study||239
4942519|NCT02979444|12156237|P3|NOT COMPLETED|Overall Study||10
4942520|NCT02979444|12156238|P2|NOT COMPLETED|Overall Study||17
4942521|NCT02979444|12156239|P1|NOT COMPLETED|Overall Study||23
4942522|NCT02979444|12156237|P3|COMPLETED|Overall Study||149
4942523|NCT02979444|12156238|P2|COMPLETED|Overall Study||293
4942524|NCT02979444|12156239|P1|COMPLETED|Overall Study||382
4942525|NCT02979444|12156237|P3|STARTED|Overall Study||159
4942526|NCT02979444|12156238|P2|STARTED|Overall Study||310
4942527|NCT02979444|12156239|P1|STARTED|Overall Study||405
4942528|NCT02979431|12156263|P4|NOT COMPLETED|Overall Study||1
4942529|NCT02979431|12156264|P3|NOT COMPLETED|Overall Study||2
4942530|NCT02979431|12156265|P2|NOT COMPLETED|Overall Study||2
4942531|NCT02979431|12156266|P1|NOT COMPLETED|Overall Study||4
4942532|NCT02979431|12156263|P4|COMPLETED|Overall Study||44
4942533|NCT02979431|12156264|P3|COMPLETED|Overall Study||43
4942534|NCT02979431|12156265|P2|COMPLETED|Overall Study||44
4942535|NCT02979431|12156266|P1|COMPLETED|Overall Study||40
4942536|NCT02979431|12156263|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
4942537|NCT02979431|12156264|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
4942538|NCT02979431|12156265|P2|Included in the Safety Population|Overall Study||45
4942539|NCT02979431|12156266|P1|Included in the Safety Population|Overall Study||40
4942540|NCT02979431|12156263|P4|Included in the mITT Population|Overall Study||45
4942541|NCT02979431|12156264|P3|Included in the mITT Population|Overall Study||43
4942542|NCT02979431|12156265|P2|Included in the mITT Population|Overall Study||45
4942543|NCT02979431|12156266|P1|Included in the mITT Population|Overall Study||42
4942544|NCT02979431|12156263|P4|STARTED|Overall Study||45
4942545|NCT02979431|12156264|P3|STARTED|Overall Study||45
4942546|NCT02979431|12156265|P2|STARTED|Overall Study||46
4942547|NCT02979431|12156266|P1|STARTED|Overall Study||44
4942548|NCT02979301|12156318|P2|NOT COMPLETED|Overall Study||0
4942549|NCT02979301|12156319|P1|NOT COMPLETED|Overall Study||1
4942550|NCT02979301|12156318|P2|COMPLETED|Overall Study||11
4942551|NCT02979301|12156319|P1|COMPLETED|Overall Study||10
4942552|NCT02979301|12156318|P2|STARTED|Overall Study||11
4942553|NCT02979301|12156319|P1|STARTED|Overall Study||11
4942554|NCT02979262|12156327|P2|NOT COMPLETED|Overall Study||9
4942555|NCT02979262|12156328|P1|NOT COMPLETED|Overall Study||12
4942556|NCT02979262|12156327|P2|COMPLETED|Overall Study||20
4942557|NCT02979262|12156328|P1|COMPLETED|Overall Study||21
4942558|NCT02979262|12156327|P2|Received Allocated Intervention|Overall Study||27
4942559|NCT02979262|12156328|P1|Received Allocated Intervention|Overall Study||30
4942560|NCT02979262|12156327|P2|STARTED|Overall Study||29
4942561|NCT02979262|12156328|P1|STARTED|Overall Study||33
4942562|NCT02979197|12156347|P3|NOT COMPLETED|Overall Study||0
4942563|NCT02979197|12156348|P2|NOT COMPLETED|Overall Study||4
4942564|NCT02979197|12156349|P1|NOT COMPLETED|Overall Study||4
4942565|NCT02979197|12156347|P3|COMPLETED|Overall Study||8
4942566|NCT02979197|12156348|P2|COMPLETED|Overall Study||45
4942567|NCT02979197|12156349|P1|COMPLETED|Overall Study||44
4942568|NCT02979197|12156347|P3|STARTED|Overall Study||8
4942569|NCT02979197|12156348|P2|STARTED|Overall Study||49
4942570|NCT02979197|12156349|P1|STARTED|Overall Study||48
4942571|NCT02979054|12156377|P2|NOT COMPLETED|Overall Study||0
4942572|NCT02979054|12156378|P1|NOT COMPLETED|Overall Study||0
4942573|NCT02979054|12156377|P2|COMPLETED|Overall Study||64
4942574|NCT02979054|12156378|P1|COMPLETED|Overall Study||71
4942575|NCT02979054|12156377|P2|STARTED|Overall Study||64
4942576|NCT02979054|12156378|P1|STARTED|Overall Study||71
4942577|NCT02978833|12156392|P2|NOT COMPLETED|Overall Study||1
4942578|NCT02978833|12156393|P1|NOT COMPLETED|Overall Study||1
4942579|NCT02978833|12156392|P2|COMPLETED|Overall Study||0
4942580|NCT02978833|12156393|P1|COMPLETED|Overall Study||0
4942581|NCT02978833|12156392|P2|STARTED|Overall Study||1
4942582|NCT02978833|12156393|P1|STARTED|Overall Study||1
4942583|NCT02978417|12156411|P2|NOT COMPLETED|Overall Study||2
4942584|NCT02978417|12156412|P1|NOT COMPLETED|Overall Study||2
4942585|NCT02978417|12156411|P2|COMPLETED|Overall Study||3
4942586|NCT02978417|12156412|P1|COMPLETED|Overall Study||3
4942587|NCT02978417|12156411|P2|STARTED|Overall Study||5
4942588|NCT02978417|12156412|P1|STARTED|Overall Study||5
4942589|NCT02978339|12156446|P1|NOT COMPLETED|Overall Study||0
4942590|NCT02978339|12156446|P1|COMPLETED|Overall Study||15
4942591|NCT02978339|12156446|P1|STARTED|Overall Study||15
4942592|NCT02978157|12156458|P2|NOT COMPLETED|Overall Study||0
4942593|NCT02978157|12156459|P1|NOT COMPLETED|Overall Study||0
4942594|NCT02978157|12156458|P2|COMPLETED|Overall Study||50
4942595|NCT02978157|12156459|P1|COMPLETED|Overall Study||52
4942596|NCT02978157|12156458|P2|STARTED|Overall Study||50
4942597|NCT02978157|12156459|P1|STARTED|Overall Study||52
4942598|NCT02977572|12156467|P2|NOT COMPLETED|Overall Study||2
4942599|NCT02977572|12156468|P1|NOT COMPLETED|Overall Study||2
4942600|NCT02977572|12156467|P2|COMPLETED|Overall Study||54
4942601|NCT02977572|12156468|P1|COMPLETED|Overall Study||56
4942602|NCT02977572|12156467|P2|STARTED|Overall Study||56
4942603|NCT02977572|12156468|P1|STARTED|Overall Study||58
4942604|NCT02977507|12156490|P2|NOT COMPLETED|Overall Study||0
4942605|NCT02977507|12156491|P1|NOT COMPLETED|Overall Study||2
4942606|NCT02977507|12156490|P2|COMPLETED|Overall Study||10
4942607|NCT02977507|12156491|P1|COMPLETED|Overall Study||6
4942608|NCT02977507|12156490|P2|STARTED|Overall Study||10
4942609|NCT02977507|12156491|P1|STARTED|Overall Study||8
4942610|NCT02976519|12156521|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
4942611|NCT02976519|12156522|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942612|NCT02976519|12156523|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942613|NCT02976519|12156524|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942614|NCT02976519|12156525|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942615|NCT02976519|12156526|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942616|NCT02976519|12156527|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942617|NCT02976519|12156521|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
4942618|NCT02976519|12156522|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
4942619|NCT02976519|12156523|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942620|NCT02976519|12156524|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942621|NCT02976519|12156525|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942622|NCT02976519|12156526|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942623|NCT02976519|12156527|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
4942624|NCT02976519|12156521|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
4942625|NCT02976519|12156522|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
4942626|NCT02976519|12156523|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
4942627|NCT02976519|12156524|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
4942628|NCT02976519|12156525|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
4942629|NCT02976519|12156526|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
4942630|NCT02976519|12156527|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
4942631|NCT02976519|12156521|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
4942632|NCT02976519|12156522|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942633|NCT02976519|12156523|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942634|NCT02976519|12156524|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942635|NCT02976519|12156525|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942636|NCT02976519|12156526|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942637|NCT02976519|12156527|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
4942638|NCT02976519|12156521|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
4942639|NCT02976519|12156522|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
4942640|NCT02976519|12156523|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
4942641|NCT02976519|12156524|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
4942642|NCT02976519|12156525|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
4942643|NCT02976519|12156526|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
4942644|NCT02976519|12156527|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
4942645|NCT02976519|12156521|P7|STARTED|Wash-out Period (Part 2 Only)||12
4942646|NCT02976519|12156522|P6|STARTED|Wash-out Period (Part 2 Only)||12
4942647|NCT02976519|12156523|P5|STARTED|Wash-out Period (Part 2 Only)||0
4942648|NCT02976519|12156524|P4|STARTED|Wash-out Period (Part 2 Only)||0
4942649|NCT02976519|12156525|P3|STARTED|Wash-out Period (Part 2 Only)||0
4942650|NCT02976519|12156526|P2|STARTED|Wash-out Period (Part 2 Only)||0
4942651|NCT02976519|12156527|P1|STARTED|Wash-out Period (Part 2 Only)||0
4942652|NCT02976519|12156521|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
4942827|NCT02972658|12157316|P4|NOT COMPLETED|Overall Study||131
4942653|NCT02976519|12156522|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
4942654|NCT02976519|12156523|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
4942655|NCT02976519|12156524|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
4942656|NCT02976519|12156525|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
4942657|NCT02976519|12156526|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
4942658|NCT02976519|12156527|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
4942659|NCT02976519|12156521|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
4942660|NCT02976519|12156522|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
4942661|NCT02976519|12156523|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
4942662|NCT02976519|12156524|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
4942663|NCT02976519|12156525|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
4942664|NCT02976519|12156526|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
4942665|NCT02976519|12156527|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
4942666|NCT02976519|12156521|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
4942667|NCT02976519|12156522|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
4942668|NCT02976519|12156523|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
4942669|NCT02976519|12156524|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
4942670|NCT02976519|12156525|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
4942671|NCT02976519|12156526|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
4942672|NCT02976519|12156527|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
4942673|NCT02976181|12156551|P1|NOT COMPLETED|Overall Study||1
4942674|NCT02976181|12156551|P1|COMPLETED|Overall Study||112
4942675|NCT02976181|12156551|P1|STARTED|Overall Study||113
4942676|NCT02976103|12156558|P2|NOT COMPLETED|Overall Study||8
4942677|NCT02976103|12156559|P1|NOT COMPLETED|Overall Study||13
4942678|NCT02976103|12156558|P2|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
4942679|NCT02976103|12156559|P1|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
4942680|NCT02976103|12156558|P2|STARTED|Overall Study||72
4942681|NCT02976103|12156559|P1|STARTED|Overall Study||67
4942682|NCT02975804|12156612|P2|NOT COMPLETED|Overall Study||0
4942683|NCT02975804|12156613|P1|NOT COMPLETED|Overall Study||0
4942684|NCT02975804|12156612|P2|COMPLETED|Overall Study||9
4942685|NCT02975804|12156613|P1|COMPLETED|Overall Study||9
4942686|NCT02975804|12156612|P2|STARTED|Overall Study||9
4942687|NCT02975804|12156613|P1|STARTED|Overall Study||9
4942688|NCT02975700|12156651|P1|NOT COMPLETED|Overall Study||6
4942689|NCT02975700|12156651|P1|COMPLETED|Overall Study||0
4942690|NCT02975700|12156651|P1|STARTED|Overall Study||6
4942691|NCT02975557|12156672|P3|NOT COMPLETED|Overall Study||1
4942692|NCT02975557|12156673|P2|NOT COMPLETED|Overall Study||3
4942693|NCT02975557|12156674|P1|NOT COMPLETED|Overall Study||1
4942694|NCT02975557|12156672|P3|COMPLETED|Overall Study||5
4942695|NCT02975557|12156673|P2|COMPLETED|Overall Study||2
4942696|NCT02975557|12156674|P1|COMPLETED|Overall Study||3
4942697|NCT02975557|12156672|P3|STARTED|Overall Study||6
4942698|NCT02975557|12156673|P2|STARTED|Overall Study||5
4942699|NCT02975557|12156674|P1|STARTED|Overall Study||4
4942700|NCT02975206|12156685|P3|NOT COMPLETED|Overall Study||17
4942701|NCT02975206|12156686|P2|NOT COMPLETED|Overall Study||17
4942702|NCT02975206|12156687|P1|NOT COMPLETED|Overall Study||27
4942703|NCT02975206|12156685|P3|COMPLETED|Overall Study||145
4942704|NCT02975206|12156686|P2|COMPLETED|Overall Study||144
4942705|NCT02975206|12156687|P1|COMPLETED|Overall Study||134
4942706|NCT02975206|12156685|P3|STARTED|Overall Study||162
4942707|NCT02975206|12156686|P2|STARTED|Overall Study||161
4942708|NCT02975206|12156687|P1|STARTED|Overall Study||161
4942709|NCT02974868|12156704|P4|NOT COMPLETED|Cross-Over Extension (COE) Period||0
4942710|NCT02974868|12156705|P3|NOT COMPLETED|Cross-Over Extension (COE) Period||3
4942711|NCT02974868|12156706|P2|NOT COMPLETED|Cross-Over Extension (COE) Period||1
4942712|NCT02974868|12156707|P1|NOT COMPLETED|Cross-Over Extension (COE) Period||2
4942713|NCT02974868|12156704|P4|COMPLETED|Cross-Over Extension (COE) Period||3
4942714|NCT02974868|12156705|P3|COMPLETED|Cross-Over Extension (COE) Period||8
4942715|NCT02974868|12156706|P2|COMPLETED|Cross-Over Extension (COE) Period||1
4942716|NCT02974868|12156707|P1|COMPLETED|Cross-Over Extension (COE) Period||5
4942717|NCT02974868|12156704|P4|STARTED|Cross-Over Extension (COE) Period||3
4942718|NCT02974868|12156705|P3|STARTED|Cross-Over Extension (COE) Period||11
4942719|NCT02974868|12156706|P2|STARTED|Cross-Over Extension (COE) Period||2
4942720|NCT02974868|12156707|P1|STARTED|Cross-Over Extension (COE) Period||7
4942721|NCT02974868|12156704|P4|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
4942722|NCT02974868|12156705|P3|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
4942723|NCT02974868|12156706|P2|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
4942724|NCT02974868|12156707|P1|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
4942725|NCT02974868|12156704|P4|COMPLETED|Single-Blind Extension (SBE) Period||23
4942726|NCT02974868|12156705|P3|COMPLETED|Single-Blind Extension (SBE) Period||27
4942727|NCT02974868|12156706|P2|COMPLETED|Single-Blind Extension (SBE) Period||11
4942728|NCT02974868|12156707|P1|COMPLETED|Single-Blind Extension (SBE) Period||15
4942729|NCT02974868|12156704|P4|STARTED|Single-Blind Extension (SBE) Period||29
4942730|NCT02974868|12156705|P3|STARTED|Single-Blind Extension (SBE) Period||38
4942731|NCT02974868|12156706|P2|STARTED|Single-Blind Extension (SBE) Period||12
4942732|NCT02974868|12156707|P1|STARTED|Single-Blind Extension (SBE) Period||17
4942733|NCT02974868|12156704|P4|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
4942734|NCT02974868|12156705|P3|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
4942735|NCT02974868|12156706|P2|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
4942736|NCT02974868|12156707|P1|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
4942737|NCT02974868|12156704|P4|COMPLETED|Initial 24-Week Treatment Period (TP)||35
4942738|NCT02974868|12156705|P3|COMPLETED|Initial 24-Week Treatment Period (TP)||45
4942739|NCT02974868|12156706|P2|COMPLETED|Initial 24-Week Treatment Period (TP)||14
4942740|NCT02974868|12156707|P1|COMPLETED|Initial 24-Week Treatment Period (TP)||20
4942741|NCT02974868|12156704|P4|STARTED|Initial 24-Week Treatment Period (TP)||47
4942742|NCT02974868|12156705|P3|STARTED|Initial 24-Week Treatment Period (TP)||48
4942743|NCT02974868|12156706|P2|STARTED|Initial 24-Week Treatment Period (TP)||23
4942744|NCT02974868|12156707|P1|STARTED|Initial 24-Week Treatment Period (TP)||24
4942745|NCT02974855|12156829|P4|NOT COMPLETED|Overall Study||1
4942746|NCT02974855|12156830|P3|NOT COMPLETED|Overall Study||0
4942747|NCT02974855|12156831|P2|NOT COMPLETED|Overall Study||1
4942748|NCT02974855|12156832|P1|NOT COMPLETED|Overall Study||0
4942749|NCT02974855|12156829|P4|COMPLETED|Overall Study||6
4942750|NCT02974855|12156830|P3|COMPLETED|Overall Study||6
4942751|NCT02974855|12156831|P2|COMPLETED|Overall Study||5
4942752|NCT02974855|12156832|P1|COMPLETED|Overall Study||7
4942753|NCT02974855|12156829|P4|STARTED|Overall Study||7
4942754|NCT02974855|12156830|P3|STARTED|Overall Study||6
4942755|NCT02974855|12156831|P2|STARTED|Overall Study||6
4942756|NCT02974855|12156832|P1|STARTED|Overall Study||7
4942757|NCT02974842|12157018|P1|NOT COMPLETED|Overall Study||8
4942758|NCT02974842|12157018|P1|COMPLETED|Overall Study||42
4942759|NCT02974842|12157018|P1|STARTED|Overall Study|Participants|50
4942760|NCT02974543|12157024|P2|NOT COMPLETED|Overall Study||0
4942761|NCT02974543|12157025|P1|NOT COMPLETED|Overall Study||1
4942762|NCT02974543|12157024|P2|COMPLETED|Overall Study||10
4942763|NCT02974543|12157025|P1|COMPLETED|Overall Study||10
4942764|NCT02974543|12157024|P2|Began Crossover Assignment|Overall Study||10
4942765|NCT02974543|12157025|P1|Began Crossover Assignment|Overall Study||10
4942766|NCT02974543|12157024|P2|Began Washout Period|Overall Study||10
4942767|NCT02974543|12157025|P1|Began Washout Period|Overall Study||10
4942768|NCT02974543|12157024|P2|STARTED|Overall Study||10
4942769|NCT02974543|12157025|P1|STARTED|Overall Study||11
4942770|NCT02974153|12157048|P3|NOT COMPLETED|Overall Study||50
4942771|NCT02974153|12157049|P2|NOT COMPLETED|Overall Study||48
4942772|NCT02974153|12157050|P1|NOT COMPLETED|Overall Study||52
4942773|NCT02974153|12157048|P3|COMPLETED|Overall Study||325
4942774|NCT02974153|12157049|P2|COMPLETED|Overall Study||324
4942775|NCT02974153|12157050|P1|COMPLETED|Overall Study||322
4942776|NCT02974153|12157048|P3|Participants Treated|Overall Study||366
4942777|NCT02974153|12157049|P2|Participants Treated|Overall Study||356
4942778|NCT02974153|12157050|P1|Participants Treated|Overall Study||350
4942779|NCT02974153|12157048|P3|STARTED|Overall Study||375
4942780|NCT02974153|12157049|P2|STARTED|Overall Study||372
4942781|NCT02974153|12157050|P1|STARTED|Overall Study||374
4942782|NCT02974140|12157136|P1|NOT COMPLETED|Overall Study||39
4942783|NCT02974140|12157136|P1|COMPLETED|Overall Study||0
4942784|NCT02974140|12157136|P1|Manual (Fellow Eye)|Overall Study||38
4942785|NCT02974140|12157136|P1|CRS (Left or Right Eye)|Overall Study||38
4942786|NCT02974140|12157136|P1|STARTED|Overall Study||39
4942787|NCT02974114|12157152|P3|NOT COMPLETED|Overall Study||2
4942788|NCT02974114|12157153|P2|NOT COMPLETED|Overall Study||1
4942789|NCT02974114|12157154|P1|NOT COMPLETED|Overall Study||0
4942790|NCT02974114|12157152|P3|COMPLETED|Overall Study||6
4942791|NCT02974114|12157153|P2|COMPLETED|Overall Study||6
4942792|NCT02974114|12157154|P1|COMPLETED|Overall Study||6
4942793|NCT02974114|12157152|P3|STARTED|Overall Study||8
4942794|NCT02974114|12157153|P2|STARTED|Overall Study||7
4942795|NCT02974114|12157154|P1|STARTED|Overall Study||6
4942796|NCT02974088|12157197|P2|NOT COMPLETED|Overall Study||3
4942797|NCT02974088|12157198|P1|NOT COMPLETED|Overall Study||0
4942798|NCT02974088|12157197|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
4942799|NCT02974088|12157198|P1|COMPLETED|Overall Study||23
4942800|NCT02974088|12157197|P2|STARTED|Overall Study||24
4942801|NCT02974088|12157198|P1|STARTED|Overall Study||23
4942802|NCT02973802|12157204|P1|NOT COMPLETED|Overall Study||2
4942803|NCT02973802|12157204|P1|COMPLETED|Overall Study||10
4942804|NCT02973802|12157204|P1|STARTED|Overall Study||12
4942805|NCT02973100|12157222|P4|NOT COMPLETED|Overall Study||7
4942806|NCT02973100|12157223|P3|NOT COMPLETED|Overall Study||4
4942807|NCT02973100|12157224|P2|NOT COMPLETED|Overall Study||8
4942808|NCT02973100|12157225|P1|NOT COMPLETED|Overall Study||7
4942809|NCT02973100|12157222|P4|COMPLETED|Overall Study||69
4942810|NCT02973100|12157223|P3|COMPLETED|Overall Study||75
4942811|NCT02973100|12157224|P2|COMPLETED|Overall Study||73
4942812|NCT02973100|12157225|P1|COMPLETED|Overall Study||75
4942813|NCT02973100|12157222|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
4942814|NCT02973100|12157223|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
4942815|NCT02973100|12157224|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
4942816|NCT02973100|12157225|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
4942817|NCT02973100|12157222|P4|STARTED|Overall Study||76
4942818|NCT02973100|12157223|P3|STARTED|Overall Study||79
4942819|NCT02973100|12157224|P2|STARTED|Overall Study||81
4942820|NCT02973100|12157225|P1|STARTED|Overall Study||82
4942821|NCT02973048|12157263|P2|NOT COMPLETED|Overall Study||3
4942822|NCT02973048|12157264|P1|NOT COMPLETED|Overall Study||1
4942823|NCT02973048|12157263|P2|COMPLETED|Overall Study||17
4942824|NCT02973048|12157264|P1|COMPLETED|Overall Study||19
4942825|NCT02973048|12157263|P2|STARTED|Overall Study||20
4942826|NCT02973048|12157264|P1|STARTED|Overall Study||20
4942828|NCT02972658|12157317|P3|NOT COMPLETED|Overall Study||75
4942829|NCT02972658|12157318|P2|NOT COMPLETED|Overall Study||138
4942830|NCT02972658|12157319|P1|NOT COMPLETED|Overall Study||76
4942831|NCT02972658|12157316|P4|COMPLETED|Overall Study||0
4942832|NCT02972658|12157317|P3|COMPLETED|Overall Study||0
4942833|NCT02972658|12157318|P2|COMPLETED|Overall Study|1 participant was incorrectly marked as “Completed” rather than study terminated by Sponsor.|1
4942834|NCT02972658|12157319|P1|COMPLETED|Overall Study||0
4942835|NCT02972658|12157316|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
4942836|NCT02972658|12157317|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
4942837|NCT02972658|12157318|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
4942838|NCT02972658|12157319|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
4942839|NCT02972658|12157316|P4|STARTED|Overall Study||131
4942840|NCT02972658|12157317|P3|STARTED|Overall Study||75
4942841|NCT02972658|12157318|P2|STARTED|Overall Study||139
4942842|NCT02972658|12157319|P1|STARTED|Overall Study||76
4942843|NCT02972632|12157349|P1|NOT COMPLETED|Overall Study||17
4942844|NCT02972632|12157349|P1|COMPLETED|Overall Study||106
4942845|NCT02972632|12157349|P1|Safety Analysis Set|Overall Study||122
4942846|NCT02972632|12157349|P1|STARTED|Overall Study||123
4942847|NCT02972554|12157362|P2|NOT COMPLETED|Overall Study||0
4942848|NCT02972554|12157363|P1|NOT COMPLETED|Overall Study||0
4942849|NCT02972554|12157362|P2|COMPLETED|Overall Study||48
4942850|NCT02972554|12157363|P1|COMPLETED|Overall Study||44
4942851|NCT02972554|12157362|P2|STARTED|Overall Study||48
4942852|NCT02972554|12157363|P1|STARTED|Overall Study||44
4942853|NCT02972515|12157379|P1|NOT COMPLETED|Overall Study||78
4942854|NCT02972515|12157379|P1|COMPLETED|Overall Study||88
4942855|NCT02972515|12157379|P1|STARTED|Overall Study||166
4942856|NCT02972502|12157388|P2|NOT COMPLETED|Overall Study||2
4942857|NCT02972502|12157389|P1|NOT COMPLETED|Overall Study||4
4942858|NCT02972502|12157388|P2|COMPLETED|Overall Study||29
4942859|NCT02972502|12157389|P1|COMPLETED|Overall Study||31
4942860|NCT02972502|12157388|P2|STARTED|Overall Study||31
4942861|NCT02972502|12157389|P1|STARTED|Overall Study||35
4942862|NCT02972359|12157399|P1|NOT COMPLETED|Overall Study||71
4942863|NCT02972359|12157399|P1|COMPLETED|Overall Study||247
4942864|NCT02972359|12157399|P1|STARTED|Overall Study||318
4942865|NCT02972242|12157412|P2|NOT COMPLETED|Overall Study||0
4942866|NCT02972242|12157413|P1|NOT COMPLETED|Overall Study||1
4942867|NCT02972242|12157412|P2|COMPLETED|Overall Study||93
4942868|NCT02972242|12157413|P1|COMPLETED|Overall Study||81
4942869|NCT02972242|12157412|P2|STARTED|Overall Study||93
4942870|NCT02972242|12157413|P1|STARTED|Overall Study||82
4942871|NCT02971670|12157439|P4|NOT COMPLETED|Overall Study||2
4942872|NCT02971670|12157440|P3|NOT COMPLETED|Overall Study||1
4942873|NCT02971670|12157441|P2|NOT COMPLETED|Overall Study||1
4942874|NCT02971670|12157442|P1|NOT COMPLETED|Overall Study||4
4942875|NCT02971670|12157439|P4|COMPLETED|Overall Study||1
4942876|NCT02971670|12157440|P3|COMPLETED|Overall Study||4
4942877|NCT02971670|12157441|P2|COMPLETED|Overall Study||1
4942878|NCT02971670|12157442|P1|COMPLETED|Overall Study||9
4942879|NCT02971670|12157439|P4|STARTED|Overall Study||3
4942880|NCT02971670|12157440|P3|STARTED|Overall Study||5
4942881|NCT02971670|12157441|P2|STARTED|Overall Study||2
4942882|NCT02971670|12157442|P1|STARTED|Overall Study||13
4942883|NCT02971631|12157460|P2|NOT COMPLETED|Second Intervention - One Day||0
4942884|NCT02971631|12157461|P1|NOT COMPLETED|Second Intervention - One Day||0
4942885|NCT02971631|12157460|P2|COMPLETED|Second Intervention - One Day||2
4942886|NCT02971631|12157461|P1|COMPLETED|Second Intervention - One Day||3
4942887|NCT02971631|12157460|P2|STARTED|Second Intervention - One Day||2
4942888|NCT02971631|12157461|P1|STARTED|Second Intervention - One Day||3
4942889|NCT02971631|12157460|P2|NOT COMPLETED|First Intervention - One Day||0
4942890|NCT02971631|12157461|P1|NOT COMPLETED|First Intervention - One Day||0
4942891|NCT02971631|12157460|P2|COMPLETED|First Intervention - One Day||2
4942892|NCT02971631|12157461|P1|COMPLETED|First Intervention - One Day||3
4942893|NCT02971631|12157460|P2|STARTED|First Intervention - One Day||2
4942894|NCT02971631|12157461|P1|STARTED|First Intervention - One Day||3
4942895|NCT02971605|12157481|P1|NOT COMPLETED|Overall Study||1
4942896|NCT02971605|12157481|P1|COMPLETED|Overall Study||12
4942897|NCT02971605|12157481|P1|STARTED|Overall Study||13
4942898|NCT02971488|12157496|P1|NOT COMPLETED|Overall Study||0
4942899|NCT02971488|12157496|P1|COMPLETED|Overall Study||529
4942900|NCT02971488|12157496|P1|STARTED|Overall Study||529
4942901|NCT02971293|12157506|P1|NOT COMPLETED|Overall Study||11
4942902|NCT02971293|12157506|P1|COMPLETED|Overall Study||31
4942903|NCT02971293|12157506|P1|STARTED|Overall Study||42
4942904|NCT02971202|12157595|P3|NOT COMPLETED|Overall Study||1
4942905|NCT02971202|12157596|P2|NOT COMPLETED|Overall Study||0
4942906|NCT02971202|12157597|P1|NOT COMPLETED|Overall Study||2
4942907|NCT02971202|12157595|P3|COMPLETED|Overall Study||10
4942908|NCT02971202|12157596|P2|COMPLETED|Overall Study||10
4942909|NCT02971202|12157597|P1|COMPLETED|Overall Study||10
4942910|NCT02971202|12157595|P3|Started Study|Overall Study||10
4942911|NCT02971202|12157596|P2|Started Study|Overall Study||10
4942912|NCT02971202|12157597|P1|Started Study|Overall Study||11
4942913|NCT02971202|12157595|P3|STARTED|Overall Study||11
4942914|NCT02971202|12157596|P2|STARTED|Overall Study||10
4942915|NCT02971202|12157597|P1|STARTED|Overall Study||12
4942916|NCT02971163|12157613|P2|NOT COMPLETED|Overall Study||2
4942917|NCT02971163|12157614|P1|NOT COMPLETED|Overall Study||4
4942918|NCT02971163|12157613|P2|COMPLETED|Overall Study||24
4942919|NCT02971163|12157614|P1|COMPLETED|Overall Study||20
4942920|NCT02971163|12157613|P2|STARTED|Overall Study||26
4942921|NCT02971163|12157614|P1|STARTED|Overall Study||24
4942922|NCT02971007|12157637|P3|NOT COMPLETED|Overall Study||1
4942923|NCT02971007|12157638|P2|NOT COMPLETED|Overall Study||3
4942924|NCT02971007|12157639|P1|NOT COMPLETED|Overall Study||2
4942925|NCT02971007|12157637|P3|COMPLETED|Overall Study||45
4942926|NCT02971007|12157638|P2|COMPLETED|Overall Study||42
4942927|NCT02971007|12157639|P1|COMPLETED|Overall Study||44
4942928|NCT02971007|12157637|P3|STARTED|Overall Study||46
4942929|NCT02971007|12157638|P2|STARTED|Overall Study||45
4942930|NCT02971007|12157639|P1|STARTED|Overall Study||46
4942931|NCT02970981|12157656|P1|NOT COMPLETED|Overall Study||0
4942932|NCT02970981|12157656|P1|COMPLETED|Overall Study||16
4942933|NCT02970981|12157656|P1|STARTED|Overall Study||16
4942934|NCT02970812|12157662|P2|NOT COMPLETED|Overall Study||2
4942935|NCT02970812|12157663|P1|NOT COMPLETED|Overall Study||8
4942936|NCT02970812|12157662|P2|COMPLETED|Overall Study||28
4942937|NCT02970812|12157663|P1|COMPLETED|Overall Study||22
4942938|NCT02970812|12157662|P2|STARTED|Overall Study||30
4942939|NCT02970812|12157663|P1|STARTED|Overall Study||30
4942940|NCT02970669|12157671|P2|NOT COMPLETED|Open-label Period||2
4942941|NCT02970669|12157672|P1|NOT COMPLETED|Open-label Period||4
4942942|NCT02970669|12157671|P2|COMPLETED|Open-label Period||62
4942943|NCT02970669|12157672|P1|COMPLETED|Open-label Period||58
4942944|NCT02970669|12157671|P2|STARTED|Open-label Period||64
4942945|NCT02970669|12157672|P1|STARTED|Open-label Period||62
4942946|NCT02970669|12157671|P2|NOT COMPLETED|Double-blind Period||6
4942947|NCT02970669|12157672|P1|NOT COMPLETED|Double-blind Period||8
4942948|NCT02970669|12157671|P2|COMPLETED|Double-blind Period||64
4942949|NCT02970669|12157672|P1|COMPLETED|Double-blind Period||62
4942950|NCT02970669|12157671|P2|STARTED|Double-blind Period||70
4942951|NCT02970669|12157672|P1|STARTED|Double-blind Period||70
4942952|NCT02970552|12157692|P2|NOT COMPLETED|Overall Study||3
4942953|NCT02970552|12157693|P1|NOT COMPLETED|Overall Study||3
4942954|NCT02970552|12157692|P2|COMPLETED|Overall Study||67
4942955|NCT02970552|12157693|P1|COMPLETED|Overall Study||67
4942956|NCT02970552|12157692|P2|STARTED|Overall Study||70
4942957|NCT02970552|12157693|P1|STARTED|Overall Study||70
4942958|NCT02970292|12157723|P2|NOT COMPLETED|Overall Study||8
4942959|NCT02970292|12157724|P1|NOT COMPLETED|Overall Study||24
4942960|NCT02970292|12157723|P2|COMPLETED|Overall Study||190
4942961|NCT02970292|12157724|P1|COMPLETED|Overall Study||174
4942962|NCT02970292|12157723|P2|STARTED|Overall Study||198
4942963|NCT02970292|12157724|P1|STARTED|Overall Study||198
4942964|NCT02970162|12157748|P2|NOT COMPLETED|Overall Study||0
4942965|NCT02970162|12157749|P1|NOT COMPLETED|Overall Study||0
4942966|NCT02970162|12157748|P2|COMPLETED|Overall Study||13
4942967|NCT02970162|12157749|P1|COMPLETED|Overall Study||13
4942968|NCT02970162|12157748|P2|STARTED|Overall Study||13
4942969|NCT02970162|12157749|P1|STARTED|Overall Study||13
4942970|NCT02970032|12157761|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
4942971|NCT02970032|12157761|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
4942972|NCT02970032|12157761|P1|STARTED|Real Time Heparin Dose Adjustment||20
4942973|NCT02970032|12157761|P1|NOT COMPLETED|Standard Heparin Dose||0
4942974|NCT02970032|12157761|P1|COMPLETED|Standard Heparin Dose||20
4942975|NCT02970032|12157761|P1|STARTED|Standard Heparin Dose||20
4942976|NCT02969876|12157767|P1|NOT COMPLETED|Overall Study||0
4942977|NCT02969876|12157767|P1|COMPLETED|Overall Study||2
4942978|NCT02969876|12157767|P1|STARTED|Overall Study||2
4942979|NCT02969863|12157773|P6|NOT COMPLETED|Overall Study||0
4942980|NCT02969863|12157774|P5|NOT COMPLETED|Overall Study||0
4942981|NCT02969863|12157775|P4|NOT COMPLETED|Overall Study||0
4942982|NCT02969863|12157776|P3|NOT COMPLETED|Overall Study||0
4942983|NCT02969863|12157777|P2|NOT COMPLETED|Overall Study||0
4942984|NCT02969863|12157778|P1|NOT COMPLETED|Overall Study||1
4942985|NCT02969863|12157773|P6|COMPLETED|Overall Study||4
4942986|NCT02969863|12157774|P5|COMPLETED|Overall Study||4
4942987|NCT02969863|12157775|P4|COMPLETED|Overall Study||4
4942988|NCT02969863|12157776|P3|COMPLETED|Overall Study||4
4942989|NCT02969863|12157777|P2|COMPLETED|Overall Study||4
4942990|NCT02969863|12157778|P1|COMPLETED|Overall Study||3
4942991|NCT02969863|12157773|P6|STARTED|Overall Study||4
4942992|NCT02969863|12157774|P5|STARTED|Overall Study||4
4942993|NCT02969863|12157775|P4|STARTED|Overall Study||4
4942994|NCT02969863|12157776|P3|STARTED|Overall Study||4
4942995|NCT02969863|12157777|P2|STARTED|Overall Study||4
4942996|NCT02969863|12157778|P1|STARTED|Overall Study||4
4942997|NCT02969655|12157794|P2|NOT COMPLETED|Overall Study||15
4942998|NCT02969655|12157795|P1|NOT COMPLETED|Overall Study||21
4942999|NCT02969655|12157794|P2|COMPLETED|Overall Study||120
4943000|NCT02969655|12157795|P1|COMPLETED|Overall Study||115
4943001|NCT02969655|12157794|P2|STARTED|Overall Study||135
4943002|NCT02969655|12157795|P1|STARTED|Overall Study||136
4943003|NCT02969590|12157830|P3|NOT COMPLETED|Treatment Period 2||0
4943004|NCT02969590|12157831|P2|NOT COMPLETED|Treatment Period 2||0
4943005|NCT02969590|12157832|P1|NOT COMPLETED|Treatment Period 2||0
4943006|NCT02969590|12157830|P3|COMPLETED|Treatment Period 2||2
4943007|NCT02969590|12157831|P2|COMPLETED|Treatment Period 2||2
4943008|NCT02969590|12157832|P1|COMPLETED|Treatment Period 2||0
4943009|NCT02969590|12157830|P3|STARTED|Treatment Period 2||2
4943010|NCT02969590|12157831|P2|STARTED|Treatment Period 2||2
4943011|NCT02969590|12157832|P1|STARTED|Treatment Period 2||0
4943012|NCT02969590|12157830|P3|NOT COMPLETED|Treatment Period 1||0
4943013|NCT02969590|12157831|P2|NOT COMPLETED|Treatment Period 1||0
4943014|NCT02969590|12157832|P1|NOT COMPLETED|Treatment Period 1||0
4943015|NCT02969590|12157830|P3|COMPLETED|Treatment Period 1||2
4943016|NCT02969590|12157831|P2|COMPLETED|Treatment Period 1||2
4943017|NCT02969590|12157832|P1|COMPLETED|Treatment Period 1||0
4943018|NCT02969590|12157830|P3|STARTED|Treatment Period 1||2
4943019|NCT02969590|12157831|P2|STARTED|Treatment Period 1||2
4943020|NCT02969590|12157832|P1|STARTED|Treatment Period 1||0
4943021|NCT02969590|12157830|P3|NOT COMPLETED|Screening Period||0
4943022|NCT02969590|12157831|P2|NOT COMPLETED|Screening Period||0
4943023|NCT02969590|12157832|P1|NOT COMPLETED|Screening Period||1
4943024|NCT02969590|12157830|P3|COMPLETED|Screening Period||0
4943025|NCT02969590|12157831|P2|COMPLETED|Screening Period||0
4943026|NCT02969590|12157832|P1|COMPLETED|Screening Period||4
4943027|NCT02969590|12157830|P3|STARTED|Screening Period||0
4943028|NCT02969590|12157831|P2|STARTED|Screening Period||0
4943029|NCT02969590|12157832|P1|STARTED|Screening Period||5
4943030|NCT02969421|12157852|P2|NOT COMPLETED|Overall Study||0
4943031|NCT02969421|12157853|P1|NOT COMPLETED|Overall Study||0
4943032|NCT02969421|12157852|P2|COMPLETED|Overall Study||33
4943033|NCT02969421|12157853|P1|COMPLETED|Overall Study||33
4943034|NCT02969421|12157852|P2|STARTED|Overall Study||33
4943035|NCT02969421|12157853|P1|STARTED|Overall Study||33
4943036|NCT02969408|12157863|P1|NOT COMPLETED|Overall Study||16
4943037|NCT02969408|12157863|P1|COMPLETED|Overall Study||381
4943038|NCT02969408|12157863|P1|Used ABS eMDPI at Least Once|Overall Study||370
4943039|NCT02969408|12157863|P1|STARTED|Overall Study||397
4943040|NCT02969356|12157871|P1|NOT COMPLETED|Overall Study||23
4943041|NCT02969356|12157871|P1|COMPLETED|Overall Study||134
4943042|NCT02969356|12157871|P1|Intent-to-Treat (ITT) Population|Overall Study||153
4943043|NCT02969356|12157871|P1|STARTED|Overall Study||157
4943044|NCT02969317|12157889|P1|NOT COMPLETED|Overall Study||0
4943045|NCT02969317|12157889|P1|COMPLETED|Overall Study||12
4943046|NCT02969317|12157889|P1|STARTED|Overall Study||12
4943047|NCT02969187|12157914|P2|NOT COMPLETED|Overall Study||13
4943048|NCT02969187|12157915|P1|NOT COMPLETED|Overall Study||12
4943049|NCT02969187|12157914|P2|COMPLETED|Overall Study||50
4943050|NCT02969187|12157915|P1|COMPLETED|Overall Study||51
4943051|NCT02969187|12157914|P2|STARTED|Overall Study||63
4943052|NCT02969187|12157915|P1|STARTED|Overall Study||63
4943053|NCT02969044|12157927|P2|NOT COMPLETED|Overall Study||6
4943054|NCT02969044|12157928|P1|NOT COMPLETED|Overall Study||5
4943055|NCT02969044|12157927|P2|COMPLETED|Overall Study||22
4943056|NCT02969044|12157928|P1|COMPLETED|Overall Study||37
4943057|NCT02969044|12157927|P2|STARTED|Overall Study||28
4943058|NCT02969044|12157928|P1|STARTED|Overall Study||42
4943059|NCT02969031|12157970|P2|NOT COMPLETED|Completed and Analyzed||0
4943060|NCT02969031|12157971|P1|NOT COMPLETED|Completed and Analyzed||0
4943061|NCT02969031|12157970|P2|COMPLETED|Completed and Analyzed||12
4943062|NCT02969031|12157971|P1|COMPLETED|Completed and Analyzed||15
4943063|NCT02969031|12157970|P2|STARTED|Completed and Analyzed||12
4943064|NCT02969031|12157971|P1|STARTED|Completed and Analyzed||15
4943065|NCT02969031|12157970|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
4943066|NCT02969031|12157971|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
4943067|NCT02969031|12157970|P2|COMPLETED|Collection of Follow-Up Recordings||12
4943068|NCT02969031|12157971|P1|COMPLETED|Collection of Follow-Up Recordings||15
4943069|NCT02969031|12157970|P2|STARTED|Collection of Follow-Up Recordings||12
4943070|NCT02969031|12157971|P1|STARTED|Collection of Follow-Up Recordings||15
4943071|NCT02969031|12157970|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
4943072|NCT02969031|12157971|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
4943073|NCT02969031|12157970|P2|COMPLETED|Collection of Follow-Up Surveys||12
4943074|NCT02969031|12157971|P1|COMPLETED|Collection of Follow-Up Surveys||15
4943075|NCT02969031|12157970|P2|STARTED|Collection of Follow-Up Surveys||14
4943076|NCT02969031|12157971|P1|STARTED|Collection of Follow-Up Surveys||15
4943077|NCT02969031|12157970|P2|NOT COMPLETED|Completed Intervention||4
4943078|NCT02969031|12157971|P1|NOT COMPLETED|Completed Intervention||7
4943079|NCT02969031|12157970|P2|COMPLETED|Completed Intervention||14
4943080|NCT02969031|12157971|P1|COMPLETED|Completed Intervention||15
4943081|NCT02969031|12157970|P2|STARTED|Completed Intervention||18
4943082|NCT02969031|12157971|P1|STARTED|Completed Intervention||22
4943083|NCT02969031|12157970|P2|NOT COMPLETED|Collection of Baseline Recordings||5
4943084|NCT02969031|12157971|P1|NOT COMPLETED|Collection of Baseline Recordings||12
4943085|NCT02969031|12157970|P2|COMPLETED|Collection of Baseline Recordings||18
4943086|NCT02969031|12157971|P1|COMPLETED|Collection of Baseline Recordings||22
4943087|NCT02969031|12157970|P2|STARTED|Collection of Baseline Recordings||23
4943088|NCT02969031|12157971|P1|STARTED|Collection of Baseline Recordings||34
4943089|NCT02969031|12157970|P2|NOT COMPLETED|Collection of Baseline Surveys||52
4943090|NCT02969031|12157971|P1|NOT COMPLETED|Collection of Baseline Surveys||39
4943091|NCT02969031|12157970|P2|COMPLETED|Collection of Baseline Surveys||23
4943092|NCT02969031|12157971|P1|COMPLETED|Collection of Baseline Surveys||34
4943093|NCT02969031|12157970|P2|STARTED|Collection of Baseline Surveys||75
4943094|NCT02969031|12157971|P1|STARTED|Collection of Baseline Surveys||73
4943095|NCT02969031|12157970|P2|NOT COMPLETED|Enrolled and Randomized||0
4943096|NCT02969031|12157971|P1|NOT COMPLETED|Enrolled and Randomized||0
4943097|NCT02969031|12157970|P2|COMPLETED|Enrolled and Randomized||75
4943098|NCT02969031|12157971|P1|COMPLETED|Enrolled and Randomized||73
4943099|NCT02969031|12157970|P2|STARTED|Enrolled and Randomized||75
4943100|NCT02969031|12157971|P1|STARTED|Enrolled and Randomized||73
4943101|NCT02969018|12157987|P8|NOT COMPLETED|Overall Study||7
4943102|NCT02969018|12157988|P7|NOT COMPLETED|Overall Study||8
4943103|NCT02969018|12157989|P6|NOT COMPLETED|Overall Study||8
4943104|NCT02969018|12157990|P5|NOT COMPLETED|Overall Study||2
4943105|NCT02969018|12157991|P4|NOT COMPLETED|Overall Study||5
4943106|NCT02969018|12157992|P3|NOT COMPLETED|Overall Study||6
4943107|NCT02969018|12157993|P2|NOT COMPLETED|Overall Study||8
4943108|NCT02969018|12157994|P1|NOT COMPLETED|Overall Study||4
4943109|NCT02969018|12157987|P8|COMPLETED|Overall Study||16
4943110|NCT02969018|12157988|P7|COMPLETED|Overall Study||22
4943111|NCT02969018|12157989|P6|COMPLETED|Overall Study||17
4943112|NCT02969018|12157990|P5|COMPLETED|Overall Study||27
4943113|NCT02969018|12157991|P4|COMPLETED|Overall Study||20
4943114|NCT02969018|12157992|P3|COMPLETED|Overall Study||20
4943115|NCT02969018|12157993|P2|COMPLETED|Overall Study||21
4943116|NCT02969018|12157994|P1|COMPLETED|Overall Study||21
4943117|NCT02969018|12157987|P8|STARTED|Overall Study||23
4943118|NCT02969018|12157988|P7|STARTED|Overall Study||30
4943119|NCT02969018|12157989|P6|STARTED|Overall Study||25
4943120|NCT02969018|12157990|P5|STARTED|Overall Study||29
4943121|NCT02969018|12157991|P4|STARTED|Overall Study||25
4943122|NCT02969018|12157992|P3|STARTED|Overall Study||26
4943123|NCT02969018|12157993|P2|STARTED|Overall Study||29
4943124|NCT02969018|12157994|P1|STARTED|Overall Study||25
4943125|NCT02968992|12158113|P2|NOT COMPLETED|Overall Study||1
4943126|NCT02968992|12158114|P1|NOT COMPLETED|Overall Study||0
4943127|NCT02968992|12158113|P2|COMPLETED|Overall Study||17
4943128|NCT02968992|12158114|P1|COMPLETED|Overall Study||18
4943129|NCT02968992|12158113|P2|STARTED|Overall Study||18
4943130|NCT02968992|12158114|P1|STARTED|Overall Study||18
4943131|NCT02968979|12158134|P1|NOT COMPLETED|Overall Study||8
4943132|NCT02968979|12158134|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
4943133|NCT02968979|12158134|P1|STARTED|Overall Study||539
4943134|NCT02968914|12158222|P2|NOT COMPLETED|Overall Study||0
4943135|NCT02968914|12158223|P1|NOT COMPLETED|Overall Study||0
4943136|NCT02968914|12158222|P2|COMPLETED|Overall Study||90
4943137|NCT02968914|12158223|P1|COMPLETED|Overall Study||90
4943138|NCT02968914|12158222|P2|STARTED|Overall Study||90
4943139|NCT02968914|12158223|P1|STARTED|Overall Study||90
4943140|NCT02968758|12158247|P2|NOT COMPLETED|Overall Study||0
4943141|NCT02968758|12158248|P1|NOT COMPLETED|Overall Study||0
4943142|NCT02968758|12158247|P2|COMPLETED|Overall Study||1664
4943143|NCT02968758|12158248|P1|COMPLETED|Overall Study||797
4943144|NCT02968758|12158247|P2|STARTED|Overall Study||1664
4943145|NCT02968758|12158248|P1|STARTED|Overall Study||797
4943146|NCT02968576|12158259|P2|NOT COMPLETED|Overall Study||1
4943147|NCT02968576|12158260|P1|NOT COMPLETED|Overall Study||0
4943148|NCT02968576|12158259|P2|COMPLETED|Overall Study||13
4943149|NCT02968576|12158260|P1|COMPLETED|Overall Study||11
4943150|NCT02968576|12158259|P2|STARTED|Overall Study||14
4943151|NCT02968576|12158260|P1|STARTED|Overall Study||11
4943152|NCT02968563|12158267|P2|NOT COMPLETED|Overall Study||23
4943153|NCT02968563|12158268|P1|NOT COMPLETED|Overall Study||1
4943154|NCT02968563|12158267|P2|COMPLETED|Overall Study||7
4943155|NCT02968563|12158268|P1|COMPLETED|Overall Study||4
4943156|NCT02968563|12158267|P2|STARTED|Overall Study||30
4943157|NCT02968563|12158268|P1|STARTED|Overall Study||5
4943158|NCT02968368|12158284|P2|NOT COMPLETED|Open Label Phase||14
4943159|NCT02968368|12158285|P1|NOT COMPLETED|Open Label Phase||19
4943160|NCT02968368|12158284|P2|COMPLETED|Open Label Phase||25
4943161|NCT02968368|12158285|P1|COMPLETED|Open Label Phase||67
4943162|NCT02968368|12158284|P2|STARTED|Open Label Phase||39
4943163|NCT02968368|12158285|P1|STARTED|Open Label Phase||86
4943164|NCT02968368|12158284|P2|NOT COMPLETED|Double Blind Phase||17
4943165|NCT02968368|12158285|P1|NOT COMPLETED|Double Blind Phase||21
4943166|NCT02968368|12158284|P2|COMPLETED|Double Blind Phase||39
4943167|NCT02968368|12158285|P1|COMPLETED|Double Blind Phase||90
4943168|NCT02968368|12158284|P2|STARTED|Double Blind Phase||56
4943169|NCT02968368|12158285|P1|STARTED|Double Blind Phase||111
4943170|NCT02968277|12158318|P3|NOT COMPLETED|Overall Study||0
4943171|NCT02968277|12158319|P2|NOT COMPLETED|Overall Study||0
4943172|NCT02968277|12158320|P1|NOT COMPLETED|Overall Study||0
4943173|NCT02968277|12158318|P3|COMPLETED|Overall Study||13
4943174|NCT02968277|12158319|P2|COMPLETED|Overall Study||7
4943175|NCT02968277|12158320|P1|COMPLETED|Overall Study||10
4943176|NCT02968277|12158318|P3|STARTED|Overall Study||13
4943177|NCT02968277|12158319|P2|STARTED|Overall Study||7
4943178|NCT02968277|12158320|P1|STARTED|Overall Study||10
4943179|NCT02968173|12158346|P1|NOT COMPLETED|Overall Study||1
4943180|NCT02968173|12158346|P1|COMPLETED|Overall Study||49
4943181|NCT02968173|12158346|P1|STARTED|Overall Study||50
4943182|NCT02968134|12158358|P1|NOT COMPLETED|Overall Study||0
4943183|NCT02968134|12158358|P1|COMPLETED|Overall Study||8
4943184|NCT02968134|12158358|P1|STARTED|Overall Study||8
4943185|NCT02967991|12158363|P2|NOT COMPLETED|Overall Study||0
4943186|NCT02967991|12158364|P1|NOT COMPLETED|Overall Study||0
4943187|NCT02967991|12158363|P2|COMPLETED|Overall Study||10
4943188|NCT02967991|12158364|P1|COMPLETED|Overall Study||10
4943189|NCT02967991|12158363|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
4943190|NCT02967991|12158364|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
4943191|NCT02967510|12158387|P4|NOT COMPLETED|Overall Study||8
4943192|NCT02967510|12158388|P3|NOT COMPLETED|Overall Study||7
4943193|NCT02967510|12158389|P2|NOT COMPLETED|Overall Study||3
4943194|NCT02967510|12158390|P1|NOT COMPLETED|Overall Study||4
4943195|NCT02967510|12158387|P4|COMPLETED|Overall Study||63
4943196|NCT02967510|12158388|P3|COMPLETED|Overall Study||65
4943197|NCT02967510|12158389|P2|COMPLETED|Overall Study||67
4943198|NCT02967510|12158390|P1|COMPLETED|Overall Study||66
4943199|NCT02967510|12158387|P4|STARTED|Overall Study||71
4943200|NCT02967510|12158388|P3|STARTED|Overall Study||72
4943201|NCT02967510|12158389|P2|STARTED|Overall Study||70
4943202|NCT02967510|12158390|P1|STARTED|Overall Study||70
4943203|NCT02967458|12158516|P1|NOT COMPLETED|Overall Study||0
4943204|NCT02967458|12158516|P1|COMPLETED|Overall Study||55
4943205|NCT02967458|12158516|P1|STARTED|Overall Study||55
4943206|NCT02967393|12158524|P2|NOT COMPLETED|Overall Study||0
4943207|NCT02967393|12158525|P1|NOT COMPLETED|Overall Study||0
4943208|NCT02967393|12158524|P2|COMPLETED|Overall Study||20
4943209|NCT02967393|12158525|P1|COMPLETED|Overall Study||20
4943210|NCT02967393|12158524|P2|STARTED|Overall Study||20
4943211|NCT02967393|12158525|P1|STARTED|Overall Study||20
4943212|NCT02967367|12158550|P1|NOT COMPLETED|Overall Study||14
4943213|NCT02967367|12158550|P1|COMPLETED|Overall Study||22
4943214|NCT02967367|12158550|P1|STARTED|Overall Study||36
4943215|NCT02967354|12158563|P5|NOT COMPLETED|Overall Study||0
4943216|NCT02967354|12158564|P4|NOT COMPLETED|Overall Study||0
4943217|NCT02967354|12158565|P3|NOT COMPLETED|Overall Study||0
4943218|NCT02967354|12158566|P2|NOT COMPLETED|Overall Study||0
4943219|NCT02967354|12158567|P1|NOT COMPLETED|Overall Study||0
4943220|NCT02967354|12158563|P5|COMPLETED|Overall Study||8
4943221|NCT02967354|12158564|P4|COMPLETED|Overall Study||7
4943222|NCT02967354|12158565|P3|COMPLETED|Overall Study||9
4943223|NCT02967354|12158566|P2|COMPLETED|Overall Study||7
4943224|NCT02967354|12158567|P1|COMPLETED|Overall Study||8
4943225|NCT02967354|12158563|P5|STARTED|Overall Study||8
4943226|NCT02967354|12158564|P4|STARTED|Overall Study||7
4943227|NCT02967354|12158565|P3|STARTED|Overall Study||9
4943228|NCT02967354|12158566|P2|STARTED|Overall Study||7
4943229|NCT02967354|12158567|P1|STARTED|Overall Study||8
4943230|NCT02967016|12158601|P2|NOT COMPLETED|Overall Study||0
4943231|NCT02967016|12158602|P1|NOT COMPLETED|Overall Study||0
4943232|NCT02967016|12158601|P2|COMPLETED|Overall Study||25
4943233|NCT02967016|12158602|P1|COMPLETED|Overall Study||25
4943234|NCT02967016|12158601|P2|STARTED|Overall Study||25
4943235|NCT02967016|12158602|P1|STARTED|Overall Study||25
4943236|NCT02966795|12158614|P2|NOT COMPLETED|Overall Study||1
4943237|NCT02966795|12158615|P1|NOT COMPLETED|Overall Study||0
4943238|NCT02966795|12158614|P2|COMPLETED|Overall Study||60
4943239|NCT02966795|12158615|P1|COMPLETED|Overall Study||23
4943240|NCT02966795|12158614|P2|STARTED|Overall Study||61
4943241|NCT02966795|12158615|P1|STARTED|Overall Study||23
4943242|NCT02966509|12158626|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
4943243|NCT02966509|12158627|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
4943244|NCT02966509|12158626|P2|COMPLETED|End of Life Utilization and Cost 15month||60
4943245|NCT02966509|12158627|P1|COMPLETED|End of Life Utilization and Cost 15month||60
4943246|NCT02966509|12158626|P2|STARTED|End of Life Utilization and Cost 15month||108
4943247|NCT02966509|12158627|P1|STARTED|End of Life Utilization and Cost 15month||105
4943248|NCT02966509|12158626|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
4943249|NCT02966509|12158627|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
4943250|NCT02966509|12158626|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
4943251|NCT02966509|12158627|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
4943252|NCT02966509|12158626|P2|STARTED|End of Life Utilization and Cost 6 Month||108
4943253|NCT02966509|12158627|P1|STARTED|End of Life Utilization and Cost 6 Month||105
4943254|NCT02966509|12158626|P2|NOT COMPLETED|15-Month Utilization and Cost||0
4943255|NCT02966509|12158627|P1|NOT COMPLETED|15-Month Utilization and Cost||0
4943256|NCT02966509|12158626|P2|COMPLETED|15-Month Utilization and Cost||108
4943257|NCT02966509|12158627|P1|COMPLETED|15-Month Utilization and Cost||105
4943258|NCT02966509|12158626|P2|STARTED|15-Month Utilization and Cost||108
4943259|NCT02966509|12158627|P1|STARTED|15-Month Utilization and Cost||105
4943260|NCT02966509|12158626|P2|NOT COMPLETED|6-Month Utilization and Cost||0
4943261|NCT02966509|12158627|P1|NOT COMPLETED|6-Month Utilization and Cost||0
4943262|NCT02966509|12158626|P2|COMPLETED|6-Month Utilization and Cost||108
4943263|NCT02966509|12158627|P1|COMPLETED|6-Month Utilization and Cost||105
4943264|NCT02966509|12158626|P2|STARTED|6-Month Utilization and Cost||108
4943265|NCT02966509|12158627|P1|STARTED|6-Month Utilization and Cost||105
4943266|NCT02966509|12158626|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
4943267|NCT02966509|12158627|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
4943268|NCT02966509|12158626|P2|COMPLETED|6 Month Satisfaction Survey||60
4943269|NCT02966509|12158627|P1|COMPLETED|6 Month Satisfaction Survey||58
4943270|NCT02966509|12158626|P2|STARTED|6 Month Satisfaction Survey||108
4943271|NCT02966509|12158627|P1|STARTED|6 Month Satisfaction Survey||105
4943272|NCT02966509|12158626|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
4943273|NCT02966509|12158627|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
4943274|NCT02966509|12158626|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
4943275|NCT02966509|12158627|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
4943276|NCT02966509|12158626|P2|STARTED|6 Month Satisfaction Decision Survey||108
4943277|NCT02966509|12158627|P1|STARTED|6 Month Satisfaction Decision Survey||105
4943278|NCT02966509|12158626|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
4943279|NCT02966509|12158627|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
4943280|NCT02966509|12158626|P2|COMPLETED|Baseline Satisfaction Survey||101
4943281|NCT02966509|12158627|P1|COMPLETED|Baseline Satisfaction Survey||101
4943282|NCT02966509|12158626|P2|STARTED|Baseline Satisfaction Survey||108
4943283|NCT02966509|12158627|P1|STARTED|Baseline Satisfaction Survey||105
4943284|NCT02966353|12158651|P1|NOT COMPLETED|Overall Study||22
4943285|NCT02966353|12158651|P1|COMPLETED|Overall Study||29
4943286|NCT02966353|12158651|P1|Completed After Data Cutoff|Overall Study||1
4943287|NCT02966353|12158651|P1|STARTED|Overall Study||51
4943288|NCT02966340|12158660|P2|NOT COMPLETED|Overall Study||3
4943289|NCT02966340|12158661|P1|NOT COMPLETED|Overall Study||3
4943290|NCT02966340|12158660|P2|COMPLETED|Overall Study||30
4943291|NCT02966340|12158661|P1|COMPLETED|Overall Study||34
4943292|NCT02966340|12158660|P2|STARTED|Overall Study||33
4943293|NCT02966340|12158661|P1|STARTED|Overall Study||37
4943294|NCT02966275|12158669|P1|NOT COMPLETED|Overall Study||0
4943295|NCT02966275|12158669|P1|COMPLETED|Overall Study||10
4943296|NCT02966275|12158669|P1|STARTED|Overall Study||10
4943297|NCT02966015|12158706|P2|NOT COMPLETED|Test Period||0
4943298|NCT02966015|12158707|P1|NOT COMPLETED|Test Period||0
4943299|NCT02966015|12158706|P2|COMPLETED|Test Period||55
4943300|NCT02966015|12158707|P1|COMPLETED|Test Period||87
4943301|NCT02966015|12158706|P2|STARTED|Test Period||55
4943302|NCT02966015|12158707|P1|STARTED|Test Period||87
4943303|NCT02966015|12158706|P2|NOT COMPLETED|Inclusion Visit||3
4943304|NCT02966015|12158707|P1|NOT COMPLETED|Inclusion Visit||8
4943305|NCT02966015|12158706|P2|COMPLETED|Inclusion Visit||55
4943306|NCT02966015|12158707|P1|COMPLETED|Inclusion Visit||87
4943307|NCT02966015|12158706|P2|STARTED|Inclusion Visit||58
4943308|NCT02966015|12158707|P1|STARTED|Inclusion Visit||95
4943309|NCT02966002|12158713|P1|NOT COMPLETED|Overall Study||4
4943310|NCT02966002|12158713|P1|COMPLETED|Overall Study||5
4943311|NCT02966002|12158713|P1|STARTED|Overall Study||9
4943312|NCT02965924|12158720|P1|NOT COMPLETED|Overall Study||0
4943313|NCT02965924|12158720|P1|COMPLETED|Overall Study||20
4943314|NCT02965924|12158720|P1|STARTED|Overall Study||20
4943315|NCT02965846|12158728|P3|NOT COMPLETED|Overall Study||33
4943316|NCT02965846|12158729|P2|NOT COMPLETED|Overall Study||5
4943317|NCT02965846|12158730|P1|NOT COMPLETED|Overall Study||5
4943318|NCT02965846|12158728|P3|COMPLETED|Overall Study||0
4943319|NCT02965846|12158729|P2|COMPLETED|Overall Study||0
4943320|NCT02965846|12158730|P1|COMPLETED|Overall Study||0
4943321|NCT02965846|12158728|P3|STARTED|Overall Study||33
4943322|NCT02965846|12158729|P2|STARTED|Overall Study||5
4943323|NCT02965846|12158730|P1|STARTED|Overall Study||5
4943324|NCT02965833|12158738|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
4943325|NCT02965833|12158739|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
4943326|NCT02965833|12158738|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
4943327|NCT02965833|12158739|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
4943328|NCT02965833|12158738|P2|STARTED|Period 2, Second 30 Days of Wear||52
4943329|NCT02965833|12158739|P1|STARTED|Period 2, Second 30 Days of Wear||64
4943330|NCT02965833|12158738|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
4943331|NCT02965833|12158739|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
4943332|NCT02965833|12158738|P2|COMPLETED|Period 1, First 30 Days of Wear||52
4943333|NCT02965833|12158739|P1|COMPLETED|Period 1, First 30 Days of Wear||64
4943334|NCT02965833|12158738|P2|STARTED|Period 1, First 30 Days of Wear||54
4943335|NCT02965833|12158739|P1|STARTED|Period 1, First 30 Days of Wear||67
4943336|NCT02965820|12158745|P2|NOT COMPLETED|Period 2, Second 30 Days||1
4943337|NCT02965820|12158746|P1|NOT COMPLETED|Period 2, Second 30 Days||1
4943338|NCT02965820|12158745|P2|COMPLETED|Period 2, Second 30 Days||61
4943339|NCT02965820|12158746|P1|COMPLETED|Period 2, Second 30 Days||57
4943340|NCT02965820|12158745|P2|STARTED|Period 2, Second 30 Days||62
4943341|NCT02965820|12158746|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
4943342|NCT02965820|12158745|P2|NOT COMPLETED|Period 1, First 30 Days||0
4943343|NCT02965820|12158746|P1|NOT COMPLETED|Period 1, First 30 Days||0
4943344|NCT02965820|12158745|P2|COMPLETED|Period 1, First 30 Days||62
4943345|NCT02965820|12158746|P1|COMPLETED|Period 1, First 30 Days||59
4943346|NCT02965820|12158745|P2|STARTED|Period 1, First 30 Days||62
4943347|NCT02965820|12158746|P1|STARTED|Period 1, First 30 Days||59
4943348|NCT02965729|12158755|P3|NOT COMPLETED|Overall Study||11
4943349|NCT02965729|12158756|P2|NOT COMPLETED|Overall Study||3
4943350|NCT02965729|12158757|P1|NOT COMPLETED|Overall Study||7
4943351|NCT02965729|12158755|P3|COMPLETED|Overall Study||45
4943352|NCT02965729|12158756|P2|COMPLETED|Overall Study||22
4943353|NCT02965729|12158757|P1|COMPLETED|Overall Study||17
4943354|NCT02965729|12158755|P3|STARTED|Overall Study||56
4943355|NCT02965729|12158756|P2|STARTED|Overall Study||25
4943356|NCT02965729|12158757|P1|STARTED|Overall Study||24
4943357|NCT02965599|12158785|P2|NOT COMPLETED|Overall Study||0
4943358|NCT02965599|12158786|P1|NOT COMPLETED|Overall Study||1
4943359|NCT02965599|12158785|P2|COMPLETED|Overall Study||1
4943360|NCT02965599|12158786|P1|COMPLETED|Overall Study||1
4943361|NCT02965599|12158785|P2|STARTED|Overall Study||1
4943362|NCT02965599|12158786|P1|STARTED|Overall Study||2
4943363|NCT02965534|12158848|P2|NOT COMPLETED|Overall Study||0
4943364|NCT02965534|12158849|P1|NOT COMPLETED|Overall Study||0
4943365|NCT02965534|12158848|P2|COMPLETED|Overall Study||55
4943366|NCT02965534|12158849|P1|COMPLETED|Overall Study||45
4943367|NCT02965534|12158848|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
4943368|NCT02965534|12158849|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
4943369|NCT02965456|12158865|P2|NOT COMPLETED|Overall Study||43
4943370|NCT02965456|12158866|P1|NOT COMPLETED|Overall Study||71
4943371|NCT02965456|12158865|P2|COMPLETED|Overall Study||364
4943372|NCT02965456|12158866|P1|COMPLETED|Overall Study||342
4943373|NCT02965456|12158865|P2|Safety Population|Overall Study||398
4943374|NCT02965456|12158866|P1|Safety Population|Overall Study||389
4943375|NCT02965456|12158865|P2|Intent-to-treat (ITT) Population|Overall Study||407
4943376|NCT02965456|12158866|P1|Intent-to-treat (ITT) Population|Overall Study||413
4943377|NCT02965456|12158865|P2|STARTED|Overall Study||407
4943378|NCT02965456|12158866|P1|STARTED|Overall Study||413
4943379|NCT02965144|12158880|P1|NOT COMPLETED|Overall Study||0
4943380|NCT02965144|12158880|P1|COMPLETED|Overall Study||13
4943381|NCT02965144|12158880|P1|STARTED|Overall Study||13
4943382|NCT02964910|12158890|P2|NOT COMPLETED|Overall Study||44
4943383|NCT02964910|12158891|P1|NOT COMPLETED|Overall Study||43
4943384|NCT02964910|12158890|P2|COMPLETED|Overall Study||196
4943385|NCT02964910|12158891|P1|COMPLETED|Overall Study||192
4943386|NCT02964910|12158890|P2|STARTED|Overall Study||240
4943387|NCT02964910|12158891|P1|STARTED|Overall Study||235
4943388|NCT02964767|12158917|P2|NOT COMPLETED|Overall Study||0
4943389|NCT02964767|12158918|P1|NOT COMPLETED|Overall Study||0
4943390|NCT02964767|12158917|P2|COMPLETED|Overall Study||48
4943391|NCT02964767|12158918|P1|COMPLETED|Overall Study||171
4943392|NCT02964767|12158917|P2|STARTED|Overall Study||48
4943393|NCT02964767|12158918|P1|STARTED|Overall Study||171
4943394|NCT02964338|12158928|P3|NOT COMPLETED|Overall Study||19
4943395|NCT02964338|12158929|P2|NOT COMPLETED|Overall Study||24
4943396|NCT02964338|12158930|P1|NOT COMPLETED|Overall Study||17
4943397|NCT02964338|12158928|P3|COMPLETED|Overall Study||68
4943398|NCT02964338|12158929|P2|COMPLETED|Overall Study||64
4943399|NCT02964338|12158930|P1|COMPLETED|Overall Study||67
4943400|NCT02964338|12158928|P3|Full Analysis Set|Overall Study||87
4943401|NCT02964338|12158929|P2|Full Analysis Set|Overall Study||86
4943402|NCT02964338|12158930|P1|Full Analysis Set|Overall Study||81
4943403|NCT02964338|12158928|P3|Safety Analysis Set|Overall Study||87
4943404|NCT02964338|12158929|P2|Safety Analysis Set|Overall Study||88
4943405|NCT02964338|12158930|P1|Safety Analysis Set|Overall Study||83
4943406|NCT02964338|12158928|P3|STARTED|Overall Study||87
4943407|NCT02964338|12158929|P2|STARTED|Overall Study||88
4943408|NCT02964338|12158930|P1|STARTED|Overall Study||84
4943409|NCT02964312|12158974|P1|NOT COMPLETED|Overall Study||27
4943410|NCT02964312|12158974|P1|COMPLETED|Overall Study||139
4943411|NCT02964312|12158974|P1|12-Month Follow-up|Overall Study||139
4943412|NCT02964312|12158974|P1|6-Month Follow-up|Overall Study||152
4943413|NCT02964312|12158974|P1|3-Month Follow-up|Overall Study||159
4943414|NCT02964312|12158974|P1|1-Month Follow-up|Overall Study||164
4943415|NCT02964312|12158974|P1|STARTED|Overall Study||166
4943416|NCT02964247|12158982|P2|NOT COMPLETED|Overall Study||2
4943417|NCT02964247|12158983|P1|NOT COMPLETED|Overall Study||3
4943418|NCT02964247|12158982|P2|COMPLETED|Overall Study||98
4943419|NCT02964247|12158983|P1|COMPLETED|Overall Study||200
4943420|NCT02964247|12158982|P2|Exposed to Trial Product|Overall Study||100
4943421|NCT02964247|12158983|P1|Exposed to Trial Product|Overall Study||202
4943422|NCT02964247|12158982|P2|STARTED|Overall Study||100
4943423|NCT02964247|12158983|P1|STARTED|Overall Study||203
4943424|NCT02964234|12159041|P2|NOT COMPLETED|Overall Study||13
4943425|NCT02964234|12159042|P1|NOT COMPLETED|Overall Study||22
4943426|NCT02964234|12159041|P2|COMPLETED|Overall Study||56
4943427|NCT02964234|12159042|P1|COMPLETED|Overall Study||54
4943428|NCT02964234|12159041|P2|STARTED|Overall Study||69
4943429|NCT02964234|12159042|P1|STARTED|Overall Study||76
4943430|NCT02964078|12159052|P1|NOT COMPLETED|Overall Study||0
4943431|NCT02964078|12159052|P1|COMPLETED|Overall Study||27
4943432|NCT02964078|12159052|P1|STARTED|Overall Study||27
4943433|NCT02963987|12159058|P2|NOT COMPLETED|Second Intervention Period||0
4943434|NCT02963987|12159059|P1|NOT COMPLETED|Second Intervention Period||0
4943435|NCT02963987|12159058|P2|COMPLETED|Second Intervention Period||19
4943436|NCT02963987|12159059|P1|COMPLETED|Second Intervention Period||31
4943437|NCT02963987|12159058|P2|STARTED|Second Intervention Period||19
4943438|NCT02963987|12159059|P1|STARTED|Second Intervention Period||31
4943439|NCT02963987|12159058|P2|NOT COMPLETED|First Intervention Period||0
4943440|NCT02963987|12159059|P1|NOT COMPLETED|First Intervention Period||0
4943441|NCT02963987|12159058|P2|COMPLETED|First Intervention Period||19
4943442|NCT02963987|12159059|P1|COMPLETED|First Intervention Period||31
4943443|NCT02963987|12159058|P2|STARTED|First Intervention Period||19
4943444|NCT02963987|12159059|P1|STARTED|First Intervention Period||31
4943445|NCT02963935|12159071|P2|NOT COMPLETED|Overall Study||37
4943446|NCT02963935|12159072|P1|NOT COMPLETED|Overall Study||28
4943447|NCT02963935|12159071|P2|COMPLETED|Overall Study||103
4943448|NCT02963935|12159072|P1|COMPLETED|Overall Study||114
4943449|NCT02963935|12159071|P2|STARTED|Overall Study||140
4943450|NCT02963935|12159072|P1|STARTED|Overall Study||142
4943451|NCT02963922|12159180|P2|NOT COMPLETED|Overall Study||30
4943452|NCT02963922|12159181|P1|NOT COMPLETED|Overall Study||32
4943453|NCT02963922|12159180|P2|COMPLETED|Overall Study||168
4943454|NCT02963922|12159181|P1|COMPLETED|Overall Study||166
4943455|NCT02963922|12159180|P2|STARTED|Overall Study||198
4943456|NCT02963922|12159181|P1|STARTED|Overall Study||198
4943457|NCT02963701|12159279|P2|NOT COMPLETED|Period 2 (2 Days)||0
4943458|NCT02963701|12159280|P1|NOT COMPLETED|Period 2 (2 Days)||0
4943459|NCT02963701|12159279|P2|COMPLETED|Period 2 (2 Days)||28
4943460|NCT02963701|12159280|P1|COMPLETED|Period 2 (2 Days)||27
4943461|NCT02963701|12159279|P2|STARTED|Period 2 (2 Days)||28
4943462|NCT02963701|12159280|P1|STARTED|Period 2 (2 Days)||27
4943463|NCT02963701|12159279|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
4943464|NCT02963701|12159280|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
4943465|NCT02963701|12159279|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
4943466|NCT02963701|12159280|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
4943467|NCT02963701|12159279|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
4943468|NCT02963701|12159280|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
4943469|NCT02963597|12159312|P2|NOT COMPLETED|Overall Study||0
4943470|NCT02963597|12159313|P1|NOT COMPLETED|Overall Study||0
4943471|NCT02963597|12159312|P2|COMPLETED|Overall Study||11
4943472|NCT02963597|12159313|P1|COMPLETED|Overall Study||10
4943473|NCT02963597|12159312|P2|STARTED|Overall Study||11
4943474|NCT02963597|12159313|P1|STARTED|Overall Study||10
4943475|NCT02963311|12159335|P1|NOT COMPLETED|Overall Study||5
4943476|NCT02963311|12159335|P1|COMPLETED|Overall Study||4
4943477|NCT02963311|12159335|P1|STARTED|Overall Study||9
4943478|NCT02962960|12159362|P3|NOT COMPLETED|Overall Study||0
4943479|NCT02962960|12159363|P2|NOT COMPLETED|Overall Study||2
4943480|NCT02962960|12159364|P1|NOT COMPLETED|Overall Study||3
4943481|NCT02962960|12159362|P3|COMPLETED|Overall Study||9
4943482|NCT02962960|12159363|P2|COMPLETED|Overall Study||11
4943483|NCT02962960|12159364|P1|COMPLETED|Overall Study||11
4943484|NCT02962960|12159362|P3|STARTED|Overall Study||9
4943485|NCT02962960|12159363|P2|STARTED|Overall Study||13
4943486|NCT02962960|12159364|P1|STARTED|Overall Study||14
4943487|NCT02962934|12159437|P2|NOT COMPLETED|Overall Study||0
4943488|NCT02962934|12159438|P1|NOT COMPLETED|Overall Study||0
4943489|NCT02962934|12159437|P2|COMPLETED|Overall Study||6
4943490|NCT02962934|12159438|P1|COMPLETED|Overall Study||12
4943491|NCT02962934|12159437|P2|STARTED|Overall Study||6
4943492|NCT02962934|12159438|P1|STARTED|Overall Study||12
4943493|NCT02962908|12159448|P4|NOT COMPLETED|Overall Study||3
4943494|NCT02962908|12159449|P3|NOT COMPLETED|Overall Study||0
4943495|NCT02962908|12159450|P2|NOT COMPLETED|Overall Study||8
4943496|NCT02962908|12159451|P1|NOT COMPLETED|Overall Study||0
4943497|NCT02962908|12159448|P4|COMPLETED|Overall Study||24
4943498|NCT02962908|12159449|P3|COMPLETED|Overall Study||32
4943499|NCT02962908|12159450|P2|COMPLETED|Overall Study||50
4943500|NCT02962908|12159451|P1|COMPLETED|Overall Study||58
4943501|NCT02962908|12159448|P4|STARTED|Overall Study||27
4943502|NCT02962908|12159449|P3|STARTED|Overall Study||32
4943503|NCT02962908|12159450|P2|STARTED|Overall Study||58
4943504|NCT02962908|12159451|P1|STARTED|Overall Study||58
4943505|NCT02962882|12159493|P1|NOT COMPLETED|Overall Study||36
4943506|NCT02962882|12159493|P1|COMPLETED|Overall Study||14
4943507|NCT02962882|12159493|P1|STARTED|Overall Study||50
4943508|NCT02962687|12159504|P2|NOT COMPLETED|Overall Study||8
4943509|NCT02962687|12159505|P1|NOT COMPLETED|Overall Study||10
4943510|NCT02962687|12159504|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
4943511|NCT02962687|12159505|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
4943512|NCT02962687|12159504|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
4943513|NCT02962687|12159505|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
4943514|NCT02962648|12159529|P1|NOT COMPLETED|Overall Study||9
4943515|NCT02962648|12159529|P1|COMPLETED|Overall Study||94
4943516|NCT02962648|12159529|P1|STARTED|Overall Study||103
4943517|NCT02962609|12159543|P2|NOT COMPLETED|Overall Study||0
4943518|NCT02962609|12159544|P1|NOT COMPLETED|Overall Study||0
4943519|NCT02962609|12159543|P2|COMPLETED|Overall Study||42
4943520|NCT02962609|12159544|P1|COMPLETED|Overall Study||38
4943521|NCT02962609|12159543|P2|STARTED|Overall Study||42
4943522|NCT02962609|12159544|P1|STARTED|Overall Study||38
4943523|NCT02962427|12159556|P2|NOT COMPLETED|Overall Study||0
4943524|NCT02962427|12159557|P1|NOT COMPLETED|Overall Study||0
4943525|NCT02962427|12159556|P2|COMPLETED|Overall Study||1
4943526|NCT02962427|12159557|P1|COMPLETED|Overall Study||3
4943527|NCT02962427|12159556|P2|STARTED|Overall Study||1
4943528|NCT02962427|12159557|P1|STARTED|Overall Study||3
4943529|NCT02962284|12159567|P2|NOT COMPLETED|Overall Study||3
4943530|NCT02962284|12159568|P1|NOT COMPLETED|Overall Study||5
4943531|NCT02962284|12159567|P2|COMPLETED|Overall Study||8
4943532|NCT02962284|12159568|P1|COMPLETED|Overall Study||4
4943533|NCT02962284|12159567|P2|STARTED|Overall Study||11
4943534|NCT02962284|12159568|P1|STARTED|Overall Study||9
4943535|NCT02961946|12159587|P3|NOT COMPLETED|Overall Study||0
4943536|NCT02961946|12159588|P2|NOT COMPLETED|Overall Study||0
4943537|NCT02961946|12159589|P1|NOT COMPLETED|Overall Study||0
4943538|NCT02961946|12159587|P3|COMPLETED|Overall Study||66
4943539|NCT02961946|12159588|P2|COMPLETED|Overall Study||66
4943540|NCT02961946|12159589|P1|COMPLETED|Overall Study||66
4943541|NCT02961946|12159587|P3|STARTED|Overall Study||66
4943542|NCT02961946|12159588|P2|STARTED|Overall Study||66
4943543|NCT02961946|12159589|P1|STARTED|Overall Study||66
4943544|NCT02961920|12159599|P2|NOT COMPLETED|Overall Study||1
4943545|NCT02961920|12159600|P1|NOT COMPLETED|Overall Study||1
4943546|NCT02961920|12159599|P2|COMPLETED|Overall Study||24
4943547|NCT02961920|12159600|P1|COMPLETED|Overall Study||24
4943548|NCT02961920|12159599|P2|STARTED|Overall Study||25
4943549|NCT02961920|12159600|P1|STARTED|Overall Study||25
4943550|NCT02961790|12159610|P4|NOT COMPLETED|Overall Study||5
4943551|NCT02961790|12159611|P3|NOT COMPLETED|Overall Study||6
4943552|NCT02961790|12159612|P2|NOT COMPLETED|Overall Study||11
4943553|NCT02961790|12159613|P1|NOT COMPLETED|Overall Study||15
4943554|NCT02961790|12159610|P4|COMPLETED|Overall Study||20
4943555|NCT02961790|12159611|P3|COMPLETED|Overall Study||18
4943556|NCT02961790|12159612|P2|COMPLETED|Overall Study||40
4943557|NCT02961790|12159613|P1|COMPLETED|Overall Study||35
4943558|NCT02961790|12159610|P4|STARTED|Overall Study||25
4943559|NCT02961790|12159611|P3|STARTED|Overall Study||24
4943560|NCT02961790|12159612|P2|STARTED|Overall Study||51
4943561|NCT02961790|12159613|P1|STARTED|Overall Study||50
4943562|NCT02961764|12159636|P2|NOT COMPLETED|Overall Study||25
4943563|NCT02961764|12159637|P1|NOT COMPLETED|Overall Study||39
4943564|NCT02961764|12159636|P2|COMPLETED|Overall Study||128
4943565|NCT02961764|12159637|P1|COMPLETED|Overall Study||121
4943566|NCT02961764|12159636|P2|STARTED|Overall Study||153
4943567|NCT02961764|12159637|P1|STARTED|Overall Study||160
4943568|NCT02961751|12159711|P1|NOT COMPLETED|Overall Study||15
4943569|NCT02961751|12159711|P1|COMPLETED|Overall Study||196
4943570|NCT02961751|12159711|P1|STARTED|Overall Study||211
4943571|NCT02961244|12159724|P2|NOT COMPLETED|Overall Study||9
4943572|NCT02961244|12159725|P1|NOT COMPLETED|Overall Study||1
4943573|NCT02961244|12159724|P2|COMPLETED|Overall Study||55
4943574|NCT02961244|12159725|P1|COMPLETED|Overall Study||63
4943575|NCT02961244|12159724|P2|Patients Excluded During Randomization|Overall Study||1
4943576|NCT02961244|12159725|P1|Patients Excluded During Randomization|Overall Study||0
4943577|NCT02961244|12159724|P2|STARTED|Overall Study||64
4943578|NCT02961244|12159725|P1|STARTED|Overall Study||64
4943579|NCT02961062|12159735|P2|NOT COMPLETED|Overall Study||0
4943580|NCT02961062|12159736|P1|NOT COMPLETED|Overall Study||0
4943581|NCT02961062|12159735|P2|COMPLETED|Overall Study||20
4943582|NCT02961062|12159736|P1|COMPLETED|Overall Study||20
4943583|NCT02961062|12159735|P2|STARTED|Overall Study||20
4943584|NCT02961062|12159736|P1|STARTED|Overall Study||20
4943585|NCT02960997|12159752|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
4943586|NCT02960997|12159753|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
4943587|NCT02960997|12159752|P2|COMPLETED|Follow-up Period, 4 Weeks||4
4943588|NCT02960997|12159753|P1|COMPLETED|Follow-up Period, 4 Weeks||4
4943589|NCT02960997|12159752|P2|STARTED|Follow-up Period, 4 Weeks||4
4943590|NCT02960997|12159753|P1|STARTED|Follow-up Period, 4 Weeks||4
4943591|NCT02960997|12159752|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
4943592|NCT02960997|12159753|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
4943593|NCT02960997|12159752|P2|COMPLETED|Second Treatment, 12 Weeks||4
4943594|NCT02960997|12159753|P1|COMPLETED|Second Treatment, 12 Weeks||4
4943595|NCT02960997|12159752|P2|STARTED|Second Treatment, 12 Weeks||4
4943596|NCT02960997|12159753|P1|STARTED|Second Treatment, 12 Weeks||4
4943597|NCT02960997|12159752|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
4943598|NCT02960997|12159753|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
4943599|NCT02960997|12159752|P2|COMPLETED|Washout Period, 4 Weeks||4
4943600|NCT02960997|12159753|P1|COMPLETED|Washout Period, 4 Weeks||4
4943601|NCT02960997|12159752|P2|STARTED|Washout Period, 4 Weeks||4
4943602|NCT02960997|12159753|P1|STARTED|Washout Period, 4 Weeks||4
4943603|NCT02960997|12159752|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
4943604|NCT02960997|12159753|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
4943605|NCT02960997|12159752|P2|COMPLETED|First Intervention, 12 Weeks||4
4943606|NCT02960997|12159753|P1|COMPLETED|First Intervention, 12 Weeks||4
4943607|NCT02960997|12159752|P2|STARTED|First Intervention, 12 Weeks||4
4943608|NCT02960997|12159753|P1|STARTED|First Intervention, 12 Weeks||4
4943609|NCT02960854|12159778|P2|NOT COMPLETED|Overall Study||9
4943610|NCT02960854|12159779|P1|NOT COMPLETED|Overall Study||7
4943611|NCT02960854|12159778|P2|COMPLETED|Overall Study||7
4943612|NCT02960854|12159779|P1|COMPLETED|Overall Study||8
4943613|NCT02960854|12159778|P2|STARTED|Overall Study||16
4943614|NCT02960854|12159779|P1|STARTED|Overall Study||15
4943615|NCT02960295|12159809|P1|NOT COMPLETED|Overall Study||0
4943616|NCT02960295|12159809|P1|COMPLETED|Overall Study||10
4943617|NCT02960295|12159809|P1|STARTED|Overall Study||10
4943618|NCT02960217|12159818|P2|NOT COMPLETED|Open-Label Extension Phase||13
4943619|NCT02960217|12159819|P1|NOT COMPLETED|Open-Label Extension Phase||20
4943620|NCT02960217|12159818|P2|COMPLETED|Open-Label Extension Phase||0
4943621|NCT02960217|12159819|P1|COMPLETED|Open-Label Extension Phase||0
4943622|NCT02960217|12159818|P2|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
4943623|NCT02960217|12159819|P1|STARTED|Open-Label Extension Phase||20
4943624|NCT02960217|12159818|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
4943625|NCT02960217|12159819|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
4943626|NCT02960217|12159818|P2|COMPLETED|Maintenance Phase: Treatment Period 2||18
4943627|NCT02960217|12159819|P1|COMPLETED|Maintenance Phase: Treatment Period 2||20
4943628|NCT02960217|12159818|P2|STARTED|Maintenance Phase: Treatment Period 2||21
4943629|NCT02960217|12159819|P1|STARTED|Maintenance Phase: Treatment Period 2||21
4943630|NCT02960217|12159818|P2|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
4943631|NCT02960217|12159819|P1|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
4943632|NCT02960217|12159818|P2|COMPLETED|Maintenance Phase: Crossover Washout||21
4943633|NCT02960217|12159819|P1|COMPLETED|Maintenance Phase: Crossover Washout||21
4943634|NCT02960217|12159818|P2|STARTED|Maintenance Phase: Crossover Washout||21
4943635|NCT02960217|12159819|P1|STARTED|Maintenance Phase: Crossover Washout||21
4943636|NCT02960217|12159818|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
4943637|NCT02960217|12159819|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
4943638|NCT02960217|12159818|P2|COMPLETED|Maintenance Phase: Treatment Period 1||21
4943639|NCT02960217|12159819|P1|COMPLETED|Maintenance Phase: Treatment Period 1||21
4943640|NCT02960217|12159818|P2|STARTED|Maintenance Phase: Treatment Period 1||21
4943641|NCT02960217|12159819|P1|STARTED|Maintenance Phase: Treatment Period 1||22
4943642|NCT02959996|12159873|P2|NOT COMPLETED|Overall Study||0
4943643|NCT02959996|12159874|P1|NOT COMPLETED|Overall Study||0
4943644|NCT02959996|12159873|P2|COMPLETED|Overall Study||39
4943645|NCT02959996|12159874|P1|COMPLETED|Overall Study||40
4943646|NCT02959996|12159873|P2|STARTED|Overall Study||39
4943647|NCT02959996|12159874|P1|STARTED|Overall Study||40
4943648|NCT02959983|12159898|P2|NOT COMPLETED|Overall Study||25
4943649|NCT02959983|12159899|P1|NOT COMPLETED|Overall Study||26
4943650|NCT02959983|12159898|P2|COMPLETED|Overall Study||149
4943651|NCT02959983|12159899|P1|COMPLETED|Overall Study||146
4943652|NCT02959983|12159898|P2|STARTED|Overall Study||174
4943653|NCT02959983|12159899|P1|STARTED|Overall Study||172
4943654|NCT02959970|12159913|P2|NOT COMPLETED|Overall Study||7
4943655|NCT02959970|12159914|P1|NOT COMPLETED|Overall Study||2
4943656|NCT02959970|12159913|P2|COMPLETED|Overall Study||76
4943657|NCT02959970|12159914|P1|COMPLETED|Overall Study||15
4943658|NCT02959970|12159913|P2|STARTED|Overall Study||83
4943659|NCT02959970|12159914|P1|STARTED|Overall Study||17
4943660|NCT02959892|12159948|P2|NOT COMPLETED|Overall Study||1
4943661|NCT02959892|12159949|P1|NOT COMPLETED|Overall Study||1
4943662|NCT02959892|12159948|P2|COMPLETED|Overall Study||5
4943663|NCT02959892|12159949|P1|COMPLETED|Overall Study||5
4943664|NCT02959892|12159948|P2|STARTED|Overall Study||6
4943665|NCT02959892|12159949|P1|STARTED|Overall Study||6
4943666|NCT02959866|12159957|P1|NOT COMPLETED|Overall Study||1
4943667|NCT02959866|12159957|P1|COMPLETED|Overall Study||58
4943668|NCT02959866|12159957|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
4943669|NCT02959866|12159957|P1|STARTED|Overall Study||59
4943670|NCT02959853|12159964|P2|NOT COMPLETED|Overall Study||2
4943671|NCT02959853|12159965|P1|NOT COMPLETED|Overall Study||4
4943672|NCT02959853|12159964|P2|COMPLETED|Overall Study||10
4943673|NCT02959853|12159965|P1|COMPLETED|Overall Study||7
4943674|NCT02959853|12159964|P2|STARTED|Overall Study||12
4943675|NCT02959853|12159965|P1|STARTED|Overall Study||11
4943676|NCT02959840|12159984|P3|NOT COMPLETED|Overall Study||0
4943677|NCT02959840|12159985|P2|NOT COMPLETED|Overall Study||0
4943678|NCT02959840|12159986|P1|NOT COMPLETED|Overall Study||0
4943679|NCT02959840|12159984|P3|COMPLETED|Overall Study||60
4943680|NCT02959840|12159985|P2|COMPLETED|Overall Study||60
4943681|NCT02959840|12159986|P1|COMPLETED|Overall Study||60
4943682|NCT02959840|12159984|P3|STARTED|Overall Study||60
4943683|NCT02959840|12159985|P2|STARTED|Overall Study||60
4943684|NCT02959840|12159986|P1|STARTED|Overall Study||60
4943685|NCT02959827|12160027|P1|NOT COMPLETED|Overall Study||0
4943686|NCT02959827|12160027|P1|COMPLETED|Overall Study||2320
4943687|NCT02959827|12160027|P1|STARTED|Overall Study||2320
4943688|NCT02959814|12160046|P1|NOT COMPLETED|Overall Study||57
4943689|NCT02959814|12160046|P1|COMPLETED|Overall Study|17-10-2017|272
4943690|NCT02959814|12160046|P1|STARTED|Overall Study|22-02-2017|329
4943691|NCT02959437|12160069|P4|NOT COMPLETED|Overall Study||0
4943692|NCT02959437|12160070|P3|NOT COMPLETED|Overall Study||0
4943693|NCT02959437|12160071|P2|NOT COMPLETED|Overall Study||8
4943694|NCT02959437|12160072|P1|NOT COMPLETED|Overall Study||62
4943695|NCT02959437|12160069|P4|COMPLETED|Overall Study||0
4943696|NCT02959437|12160070|P3|COMPLETED|Overall Study||0
4943697|NCT02959437|12160071|P2|COMPLETED|Overall Study||0
4943698|NCT02959437|12160072|P1|COMPLETED|Overall Study||0
4943699|NCT02959437|12160069|P4|STARTED|Overall Study||0
4943700|NCT02959437|12160070|P3|STARTED|Overall Study||0
4943701|NCT02959437|12160071|P2|STARTED|Overall Study||8
4943702|NCT02959437|12160072|P1|STARTED|Overall Study||62
4943703|NCT02959177|12160087|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
4943704|NCT02959177|12160088|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
4943705|NCT02959177|12160089|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
4943706|NCT02959177|12160087|P3|COMPLETED|Follow-up Post Treatment Phase||98
4943707|NCT02959177|12160088|P2|COMPLETED|Follow-up Post Treatment Phase||51
4943708|NCT02959177|12160089|P1|COMPLETED|Follow-up Post Treatment Phase||51
4943709|NCT02959177|12160087|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
4943710|NCT02959177|12160088|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
4943711|NCT02959177|12160089|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
4943712|NCT02959177|12160087|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
4943713|NCT02959177|12160088|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
4943714|NCT02959177|12160089|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
4943715|NCT02959177|12160087|P3|COMPLETED|Double-Blind Treatment Phase||225
4943716|NCT02959177|12160088|P2|COMPLETED|Double-Blind Treatment Phase||111
4943717|NCT02959177|12160089|P1|COMPLETED|Double-Blind Treatment Phase||104
4943718|NCT02959177|12160087|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
4943719|NCT02959177|12160088|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
4943720|NCT02959177|12160089|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
4943721|NCT02959177|12160087|P3|STARTED|Double-Blind Treatment Phase||230
4943722|NCT02959177|12160088|P2|STARTED|Double-Blind Treatment Phase||114
4943723|NCT02959177|12160089|P1|STARTED|Double-Blind Treatment Phase||115
4943724|NCT02959138|12160144|P3|NOT COMPLETED|Overall Study||0
4943725|NCT02959138|12160145|P2|NOT COMPLETED|Overall Study||1
4943726|NCT02959138|12160146|P1|NOT COMPLETED|Overall Study||0
4943727|NCT02959138|12160144|P3|COMPLETED|Overall Study||16
4943728|NCT02959138|12160145|P2|COMPLETED|Overall Study||9
4943729|NCT02959138|12160146|P1|COMPLETED|Overall Study||10
4943730|NCT02959138|12160144|P3|STARTED|Overall Study||16
4943731|NCT02959138|12160145|P2|STARTED|Overall Study||10
4943732|NCT02959138|12160146|P1|STARTED|Overall Study||10
4943733|NCT02958995|12160171|P2|NOT COMPLETED|Overall Study||0
4943734|NCT02958995|12160172|P1|NOT COMPLETED|Overall Study||0
4943735|NCT02958995|12160171|P2|COMPLETED|Overall Study||107495
4943736|NCT02958995|12160172|P1|COMPLETED|Overall Study||2630666
4943737|NCT02958995|12160171|P2|STARTED|Overall Study||107495
4943738|NCT02958995|12160172|P1|STARTED|Overall Study||2630666
4943739|NCT02958982|12160191|P11|NOT COMPLETED|Proof of Concept Study||0
4943740|NCT02958982|12160192|P10|NOT COMPLETED|Proof of Concept Study||0
4943741|NCT02958982|12160193|P9|NOT COMPLETED|Proof of Concept Study||0
4943742|NCT02958982|12160194|P8|NOT COMPLETED|Proof of Concept Study||0
4943743|NCT02958982|12160195|P7|NOT COMPLETED|Proof of Concept Study||0
4943744|NCT02958982|12160196|P6|NOT COMPLETED|Proof of Concept Study||0
4943745|NCT02958982|12160197|P5|NOT COMPLETED|Proof of Concept Study||0
4943746|NCT02958982|12160198|P4|NOT COMPLETED|Proof of Concept Study||0
4943747|NCT02958982|12160199|P3|NOT COMPLETED|Proof of Concept Study||0
4943748|NCT02958982|12160200|P2|NOT COMPLETED|Proof of Concept Study||0
4943749|NCT02958982|12160201|P1|NOT COMPLETED|Proof of Concept Study||0
4943750|NCT02958982|12160191|P11|COMPLETED|Proof of Concept Study||1
4943751|NCT02958982|12160192|P10|COMPLETED|Proof of Concept Study||0
4943752|NCT02958982|12160193|P9|COMPLETED|Proof of Concept Study||0
4943753|NCT02958982|12160194|P8|COMPLETED|Proof of Concept Study||0
4943754|NCT02958982|12160195|P7|COMPLETED|Proof of Concept Study||0
4943755|NCT02958982|12160196|P6|COMPLETED|Proof of Concept Study||0
4943756|NCT02958982|12160197|P5|COMPLETED|Proof of Concept Study||0
4943757|NCT02958982|12160198|P4|COMPLETED|Proof of Concept Study||0
4943758|NCT02958982|12160199|P3|COMPLETED|Proof of Concept Study||0
4943759|NCT02958982|12160200|P2|COMPLETED|Proof of Concept Study||0
4943760|NCT02958982|12160201|P1|COMPLETED|Proof of Concept Study||0
4943761|NCT02958982|12160191|P11|STARTED|Proof of Concept Study||1
4943762|NCT02958982|12160192|P10|STARTED|Proof of Concept Study||0
4943763|NCT02958982|12160193|P9|STARTED|Proof of Concept Study||0
4943764|NCT02958982|12160194|P8|STARTED|Proof of Concept Study||0
4943765|NCT02958982|12160195|P7|STARTED|Proof of Concept Study||0
4943766|NCT02958982|12160196|P6|STARTED|Proof of Concept Study||0
4943767|NCT02958982|12160197|P5|STARTED|Proof of Concept Study||0
4943768|NCT02958982|12160198|P4|STARTED|Proof of Concept Study||0
4943769|NCT02958982|12160199|P3|STARTED|Proof of Concept Study||0
4943770|NCT02958982|12160200|P2|STARTED|Proof of Concept Study||0
4943771|NCT02958982|12160201|P1|STARTED|Proof of Concept Study||0
4943772|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943773|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943774|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943775|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943776|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943777|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943778|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943779|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943780|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943781|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943782|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943783|NCT02958982|12160191|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943784|NCT02958982|12160192|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
4943785|NCT02958982|12160193|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943786|NCT02958982|12160194|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943787|NCT02958982|12160195|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
4943788|NCT02958982|12160196|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943789|NCT02958982|12160197|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943790|NCT02958982|12160198|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943791|NCT02958982|12160199|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943792|NCT02958982|12160200|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943793|NCT02958982|12160201|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
4943794|NCT02958982|12160191|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
4943795|NCT02958982|12160192|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
4943796|NCT02958982|12160193|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
4943797|NCT02958982|12160194|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
4943798|NCT02958982|12160195|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
4943799|NCT02958982|12160196|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
4943800|NCT02958982|12160197|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
4943801|NCT02958982|12160198|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
4943802|NCT02958982|12160199|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
4943803|NCT02958982|12160200|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
4943804|NCT02958982|12160201|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
4943805|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943806|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943807|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943808|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943809|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943810|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943811|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943812|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943813|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943814|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943815|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943816|NCT02958982|12160191|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943817|NCT02958982|12160192|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943818|NCT02958982|12160193|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
4943819|NCT02958982|12160194|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943820|NCT02958982|12160195|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
4943821|NCT02958982|12160196|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943822|NCT02958982|12160197|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943823|NCT02958982|12160198|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943824|NCT02958982|12160199|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943825|NCT02958982|12160200|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943826|NCT02958982|12160201|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
4943827|NCT02958982|12160191|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
4943828|NCT02958982|12160192|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
4943829|NCT02958982|12160193|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
4943830|NCT02958982|12160194|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
4943831|NCT02958982|12160195|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
4943832|NCT02958982|12160196|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
4943833|NCT02958982|12160197|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
4943834|NCT02958982|12160198|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
4943835|NCT02958982|12160199|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
4943836|NCT02958982|12160200|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
4943837|NCT02958982|12160201|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
4943838|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943839|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943840|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943841|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943842|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943843|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943844|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943845|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943846|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943847|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943848|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943849|NCT02958982|12160191|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943850|NCT02958982|12160192|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943851|NCT02958982|12160193|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943852|NCT02958982|12160194|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
4943853|NCT02958982|12160195|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
4943854|NCT02958982|12160196|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943855|NCT02958982|12160197|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943856|NCT02958982|12160198|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943857|NCT02958982|12160199|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943858|NCT02958982|12160200|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943859|NCT02958982|12160201|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
4943860|NCT02958982|12160191|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943861|NCT02958982|12160192|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943862|NCT02958982|12160193|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943863|NCT02958982|12160194|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
4943864|NCT02958982|12160195|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
4943865|NCT02958982|12160196|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943866|NCT02958982|12160197|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943867|NCT02958982|12160198|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943868|NCT02958982|12160199|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943869|NCT02958982|12160200|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943870|NCT02958982|12160201|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
4943871|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943872|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943873|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943874|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943875|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943876|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943877|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943878|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943879|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943880|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943881|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943882|NCT02958982|12160191|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943883|NCT02958982|12160192|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943884|NCT02958982|12160193|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943885|NCT02958982|12160194|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943886|NCT02958982|12160195|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943887|NCT02958982|12160196|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
4943888|NCT02958982|12160197|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943889|NCT02958982|12160198|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943890|NCT02958982|12160199|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943891|NCT02958982|12160200|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
4943892|NCT02958982|12160201|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
4943893|NCT02958982|12160191|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
4943894|NCT02958982|12160192|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
4943895|NCT02958982|12160193|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
4943896|NCT02958982|12160194|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
4943897|NCT02958982|12160195|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
4943898|NCT02958982|12160196|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
4943899|NCT02958982|12160197|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
4943900|NCT02958982|12160198|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
4943901|NCT02958982|12160199|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
4943902|NCT02958982|12160200|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
4943903|NCT02958982|12160201|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
4943904|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943905|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943906|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943907|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943908|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943909|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943910|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943911|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943912|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943913|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943914|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943915|NCT02958982|12160191|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943916|NCT02958982|12160192|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943917|NCT02958982|12160193|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943918|NCT02958982|12160194|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943919|NCT02958982|12160195|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943920|NCT02958982|12160196|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943921|NCT02958982|12160197|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
4943922|NCT02958982|12160198|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943923|NCT02958982|12160199|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943924|NCT02958982|12160200|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
4943925|NCT02958982|12160201|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
4943926|NCT02958982|12160191|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
4943927|NCT02958982|12160192|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
4943928|NCT02958982|12160193|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
4943929|NCT02958982|12160194|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
4943930|NCT02958982|12160195|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
4943931|NCT02958982|12160196|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
4943932|NCT02958982|12160197|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
4943933|NCT02958982|12160198|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
4943934|NCT02958982|12160199|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
4943935|NCT02958982|12160200|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
4943936|NCT02958982|12160201|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
4943937|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943938|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943939|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943940|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943941|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943942|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943943|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943944|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943945|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943946|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943947|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943948|NCT02958982|12160191|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943949|NCT02958982|12160192|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943950|NCT02958982|12160193|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943951|NCT02958982|12160194|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943952|NCT02958982|12160195|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943953|NCT02958982|12160196|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943954|NCT02958982|12160197|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943955|NCT02958982|12160198|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
4943956|NCT02958982|12160199|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943957|NCT02958982|12160200|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
4943958|NCT02958982|12160201|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
4943959|NCT02958982|12160191|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
4943960|NCT02958982|12160192|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
4943961|NCT02958982|12160193|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
4943962|NCT02958982|12160194|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
4943963|NCT02958982|12160195|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
4943964|NCT02958982|12160196|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
4943965|NCT02958982|12160197|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
4943966|NCT02958982|12160198|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
4943967|NCT02958982|12160199|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
4943968|NCT02958982|12160200|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
4943969|NCT02958982|12160201|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
4943970|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943971|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943972|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943973|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943974|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943975|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943976|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943977|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943978|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943979|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943980|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943981|NCT02958982|12160191|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943982|NCT02958982|12160192|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943983|NCT02958982|12160193|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943984|NCT02958982|12160194|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943985|NCT02958982|12160195|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943986|NCT02958982|12160196|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943987|NCT02958982|12160197|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943988|NCT02958982|12160198|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943989|NCT02958982|12160199|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
4943990|NCT02958982|12160200|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
4943991|NCT02958982|12160201|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
4943992|NCT02958982|12160191|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
4943993|NCT02958982|12160192|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
4943994|NCT02958982|12160193|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
4943995|NCT02958982|12160194|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
4943996|NCT02958982|12160195|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
4943997|NCT02958982|12160196|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
4943998|NCT02958982|12160197|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
4943999|NCT02958982|12160198|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
4944000|NCT02958982|12160199|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
4944001|NCT02958982|12160200|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
4944002|NCT02958982|12160201|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
4944003|NCT02958982|12160191|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944004|NCT02958982|12160192|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944005|NCT02958982|12160193|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944006|NCT02958982|12160194|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944007|NCT02958982|12160195|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944008|NCT02958982|12160196|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944009|NCT02958982|12160197|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944010|NCT02958982|12160198|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944011|NCT02958982|12160199|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944012|NCT02958982|12160200|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944013|NCT02958982|12160201|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944014|NCT02958982|12160191|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944015|NCT02958982|12160192|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944016|NCT02958982|12160193|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944017|NCT02958982|12160194|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944018|NCT02958982|12160195|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944019|NCT02958982|12160196|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944020|NCT02958982|12160197|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944021|NCT02958982|12160198|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944022|NCT02958982|12160199|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
4944023|NCT02958982|12160200|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
4944024|NCT02958982|12160201|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
4944025|NCT02958982|12160191|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
4944026|NCT02958982|12160192|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
4944027|NCT02958982|12160193|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
4944028|NCT02958982|12160194|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
4944029|NCT02958982|12160195|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
4944030|NCT02958982|12160196|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
4944031|NCT02958982|12160197|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
4944032|NCT02958982|12160198|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
4944033|NCT02958982|12160199|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
4944034|NCT02958982|12160200|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
4944035|NCT02958982|12160201|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
4944036|NCT02958969|12160247|P1|NOT COMPLETED|Overall Study||0
4944037|NCT02958969|12160247|P1|COMPLETED|Overall Study||50
4944038|NCT02958969|12160247|P1|STARTED|Overall Study||50
4944039|NCT02958956|12160256|P2|NOT COMPLETED|Overall Study||0
4944040|NCT02958956|12160257|P1|NOT COMPLETED|Overall Study||0
4944041|NCT02958956|12160256|P2|COMPLETED|Overall Study||198317
4944042|NCT02958956|12160257|P1|COMPLETED|Overall Study||38190
4944043|NCT02958956|12160256|P2|STARTED|Overall Study||198317
4944044|NCT02958956|12160257|P1|STARTED|Overall Study||38190
4944045|NCT02958826|12160272|P2|NOT COMPLETED|Overall Study||0
4944046|NCT02958826|12160273|P1|NOT COMPLETED|Overall Study||0
4944047|NCT02958826|12160272|P2|COMPLETED|Overall Study||80
4944048|NCT02958826|12160273|P1|COMPLETED|Overall Study||80
4944049|NCT02958826|12160272|P2|STARTED|Overall Study||80
4944050|NCT02958826|12160273|P1|STARTED|Overall Study||80
4944051|NCT02958787|12160283|P1|NOT COMPLETED|Overall Study||0
4944052|NCT02958787|12160283|P1|COMPLETED|Overall Study||135
4944053|NCT02958787|12160283|P1|STARTED|Overall Study||135
4944054|NCT02958553|12160287|P1|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
4944055|NCT02958553|12160287|P1|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
4944056|NCT02958553|12160287|P1|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
4944057|NCT02958553|12160287|P1|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
4944058|NCT02958553|12160287|P1|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
4944059|NCT02958553|12160287|P1|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
4944060|NCT02958553|12160287|P1|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
4944061|NCT02958553|12160287|P1|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
4944062|NCT02958553|12160287|P1|STARTED|Phase II, 5th Visit -Crossover Visit||4
4944063|NCT02958553|12160287|P1|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
4944064|NCT02958553|12160287|P1|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
4944065|NCT02958553|12160287|P1|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
4944066|NCT02958553|12160287|P1|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
4944067|NCT02958553|12160287|P1|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
4944068|NCT02958553|12160287|P1|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
4944069|NCT02958553|12160287|P1|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
4944070|NCT02958553|12160287|P1|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
4944071|NCT02958553|12160287|P1|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
4944072|NCT02958553|12160287|P1|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
4944073|NCT02958553|12160287|P1|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
4944074|NCT02958553|12160287|P1|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
4944075|NCT02958345|12160310|P2|NOT COMPLETED|Overall Study||1
4944076|NCT02958345|12160311|P1|NOT COMPLETED|Overall Study||1
4944077|NCT02958345|12160310|P2|COMPLETED|Overall Study||13
4944078|NCT02958345|12160311|P1|COMPLETED|Overall Study||13
4944079|NCT02958345|12160310|P2|STARTED|Overall Study||14
4944080|NCT02958345|12160311|P1|STARTED|Overall Study||14
4944081|NCT02958267|12160321|P2|NOT COMPLETED|Follow-up Visits||1
4944082|NCT02958267|12160322|P1|NOT COMPLETED|Follow-up Visits||2
4944083|NCT02958267|12160321|P2|COMPLETED|Follow-up Visits||14
4944084|NCT02958267|12160322|P1|COMPLETED|Follow-up Visits||13
4944085|NCT02958267|12160321|P2|12 Month Follow-up|Follow-up Visits||14
4944086|NCT02958267|12160322|P1|12 Month Follow-up|Follow-up Visits||13
4944087|NCT02958267|12160321|P2|6 Month Follow-up|Follow-up Visits||14
4944088|NCT02958267|12160322|P1|6 Month Follow-up|Follow-up Visits||14
4944089|NCT02958267|12160321|P2|3 Month Follow-up|Follow-up Visits||15
4944090|NCT02958267|12160322|P1|3 Month Follow-up|Follow-up Visits||15
4944091|NCT02958267|12160321|P2|STARTED|Follow-up Visits||15
4944092|NCT02958267|12160322|P1|STARTED|Follow-up Visits||15
4944093|NCT02958267|12160321|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
4944094|NCT02958267|12160322|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
4944095|NCT02958267|12160321|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
4944096|NCT02958267|12160322|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
4944097|NCT02958267|12160321|P2|STARTED|Enrollment to Actual Treatment Complete||15
4944098|NCT02958267|12160322|P1|STARTED|Enrollment to Actual Treatment Complete||17
4944099|NCT02958267|12160321|P2|NOT COMPLETED|Enrollment||0
4944100|NCT02958267|12160322|P1|NOT COMPLETED|Enrollment||0
4944101|NCT02958267|12160321|P2|COMPLETED|Enrollment||15
4944102|NCT02958267|12160322|P1|COMPLETED|Enrollment||17
4944103|NCT02958267|12160321|P2|STARTED|Enrollment||15
4944104|NCT02958267|12160322|P1|STARTED|Enrollment||17
4944105|NCT02957747|12160334|P2|NOT COMPLETED|Overall Study||8
4944106|NCT02957747|12160335|P1|NOT COMPLETED|Overall Study||10
4944107|NCT02957747|12160334|P2|COMPLETED|Overall Study||69
4944108|NCT02957747|12160335|P1|COMPLETED|Overall Study||66
4944109|NCT02957747|12160334|P2|STARTED|Overall Study||77
4944110|NCT02957747|12160335|P1|STARTED|Overall Study||76
4944111|NCT02957331|12160363|P2|NOT COMPLETED|Overall Study||0
4944112|NCT02957331|12160364|P1|NOT COMPLETED|Overall Study||1
4944113|NCT02957331|12160363|P2|COMPLETED|Overall Study||12
4944114|NCT02957331|12160364|P1|COMPLETED|Overall Study||13
4944115|NCT02957331|12160363|P2|STARTED|Overall Study||12
4944116|NCT02957331|12160364|P1|STARTED|Overall Study||14
4944117|NCT02956967|12160372|P1|NOT COMPLETED|Overall Study||48
4944118|NCT02956967|12160372|P1|COMPLETED|Overall Study||123
4944119|NCT02956967|12160372|P1|STARTED|Overall Study||171
4944120|NCT02956837|12160399|P4|NOT COMPLETED|Overall Study||3
4944121|NCT02956837|12160400|P3|NOT COMPLETED|Overall Study||2
4944122|NCT02956837|12160401|P2|NOT COMPLETED|Overall Study||3
4944123|NCT02956837|12160402|P1|NOT COMPLETED|Overall Study||0
4944124|NCT02956837|12160399|P4|COMPLETED|Overall Study||99
4944125|NCT02956837|12160400|P3|COMPLETED|Overall Study||97
4944126|NCT02956837|12160401|P2|COMPLETED|Overall Study||96
4944127|NCT02956837|12160402|P1|COMPLETED|Overall Study||100
4944128|NCT02956837|12160399|P4|STARTED|Overall Study||102
4944129|NCT02956837|12160400|P3|STARTED|Overall Study||99
4944130|NCT02956837|12160401|P2|STARTED|Overall Study||99
4944131|NCT02956837|12160402|P1|STARTED|Overall Study||100
4944132|NCT02956746|12160496|P4|NOT COMPLETED|Overall Study||4
4944133|NCT02956746|12160497|P3|NOT COMPLETED|Overall Study||6
4944134|NCT02956746|12160498|P2|NOT COMPLETED|Overall Study||3
4944135|NCT02956746|12160499|P1|NOT COMPLETED|Overall Study||2
4944136|NCT02956746|12160496|P4|COMPLETED|Overall Study||38
4944137|NCT02956746|12160497|P3|COMPLETED|Overall Study||36
4944138|NCT02956746|12160498|P2|COMPLETED|Overall Study||37
4944139|NCT02956746|12160499|P1|COMPLETED|Overall Study||38
4944140|NCT02956746|12160496|P4|STARTED|Overall Study||42
4944141|NCT02956746|12160497|P3|STARTED|Overall Study||42
4944142|NCT02956746|12160498|P2|STARTED|Overall Study||40
4944143|NCT02956746|12160499|P1|STARTED|Overall Study||40
4944144|NCT02956629|12160537|P6|NOT COMPLETED|Overall Study||1
4944145|NCT02956629|12160538|P5|NOT COMPLETED|Overall Study||0
4944146|NCT02956629|12160539|P4|NOT COMPLETED|Overall Study||1
4944147|NCT02956629|12160540|P3|NOT COMPLETED|Overall Study||4
4944148|NCT02956629|12160541|P2|NOT COMPLETED|Overall Study||6
4944149|NCT02956629|12160542|P1|NOT COMPLETED|Overall Study||5
4944150|NCT02956629|12160537|P6|COMPLETED|Overall Study||21
4944151|NCT02956629|12160538|P5|COMPLETED|Overall Study||18
4944152|NCT02956629|12160539|P4|COMPLETED|Overall Study||55
4944153|NCT02956629|12160540|P3|COMPLETED|Overall Study||57
4944154|NCT02956629|12160541|P2|COMPLETED|Overall Study||41
4944155|NCT02956629|12160542|P1|COMPLETED|Overall Study||73
4944156|NCT02956629|12160537|P6|STARTED|Overall Study||22
4944157|NCT02956629|12160538|P5|STARTED|Overall Study||18
4944158|NCT02956629|12160539|P4|STARTED|Overall Study||56
4944159|NCT02956629|12160540|P3|STARTED|Overall Study||61
4944160|NCT02956629|12160541|P2|STARTED|Overall Study||47
4944161|NCT02956629|12160542|P1|STARTED|Overall Study||78
4944162|NCT02956616|12160606|P2|NOT COMPLETED|Overall Study||0
4944163|NCT02956616|12160607|P1|NOT COMPLETED|Overall Study||0
4944164|NCT02956616|12160606|P2|COMPLETED|Overall Study||60
4944165|NCT02956616|12160607|P1|COMPLETED|Overall Study||58
4944166|NCT02956616|12160606|P2|STARTED|Overall Study||60
4944167|NCT02956616|12160607|P1|STARTED|Overall Study||58
4944168|NCT02956460|12160621|P2|NOT COMPLETED|Lens 2||0
4944169|NCT02956460|12160622|P1|NOT COMPLETED|Lens 2||0
4944170|NCT02956460|12160621|P2|COMPLETED|Lens 2||34
4944171|NCT02956460|12160622|P1|COMPLETED|Lens 2||29
4944172|NCT02956460|12160621|P2|STARTED|Lens 2||34
4944173|NCT02956460|12160622|P1|STARTED|Lens 2||29
4944174|NCT02956460|12160621|P2|NOT COMPLETED|Lens 1||0
4944175|NCT02956460|12160622|P1|NOT COMPLETED|Lens 1||1
4944176|NCT02956460|12160621|P2|COMPLETED|Lens 1||34
4944177|NCT02956460|12160622|P1|COMPLETED|Lens 1||29
4944178|NCT02956460|12160621|P2|STARTED|Lens 1||34
4944179|NCT02956460|12160622|P1|STARTED|Lens 1||30
4944180|NCT02956278|12160651|P3|NOT COMPLETED|Overall Study||0
4944181|NCT02956278|12160652|P2|NOT COMPLETED|Overall Study||2
4944182|NCT02956278|12160653|P1|NOT COMPLETED|Overall Study||6
4944183|NCT02956278|12160651|P3|COMPLETED|Overall Study||3
4944184|NCT02956278|12160652|P2|COMPLETED|Overall Study||7
4944185|NCT02956278|12160653|P1|COMPLETED|Overall Study||9
4944186|NCT02956278|12160651|P3|STARTED|Overall Study||3
4944187|NCT02956278|12160652|P2|STARTED|Overall Study||9
4944188|NCT02956278|12160653|P1|STARTED|Overall Study||15
4944189|NCT02956122|12160667|P1|NOT COMPLETED|Overall Study||0
4944190|NCT02956122|12160667|P1|COMPLETED|Overall Study||1
4944191|NCT02956122|12160667|P1|STARTED|Overall Study||1
4944192|NCT02956005|12160718|P1|NOT COMPLETED|Overall Study||16
4944193|NCT02956005|12160718|P1|COMPLETED|Overall Study||2
4944194|NCT02956005|12160718|P1|STARTED|Overall Study||18
4944195|NCT02955797|12160727|P4|NOT COMPLETED|Overall Study||2
4944196|NCT02955797|12160728|P3|NOT COMPLETED|Overall Study||0
4944197|NCT02955797|12160729|P2|NOT COMPLETED|Overall Study||3
4944198|NCT02955797|12160730|P1|NOT COMPLETED|Overall Study||3
4944199|NCT02955797|12160727|P4|COMPLETED|Overall Study||101
4944200|NCT02955797|12160728|P3|COMPLETED|Overall Study||203
4944201|NCT02955797|12160729|P2|COMPLETED|Overall Study||303
4944202|NCT02955797|12160730|P1|COMPLETED|Overall Study||303
4944203|NCT02955797|12160727|P4|Per Protocol Analysis Set (PPAS)|Overall Study||99
4944204|NCT02955797|12160728|P3|Per Protocol Analysis Set (PPAS)|Overall Study||198
4944205|NCT02955797|12160729|P2|Per Protocol Analysis Set (PPAS)|Overall Study||296
4944206|NCT02955797|12160730|P1|Per Protocol Analysis Set (PPAS)|Overall Study||293
4944207|NCT02955797|12160727|P4|Safety Analysis Set (SafAS)|Overall Study||102
4944208|NCT02955797|12160728|P3|Safety Analysis Set (SafAS)|Overall Study||203
4944209|NCT02955797|12160729|P2|Safety Analysis Set (SafAS)|Overall Study||306
4944210|NCT02955797|12160730|P1|Safety Analysis Set (SafAS)|Overall Study||303
4944211|NCT02955797|12160727|P4|STARTED|Overall Study||103
4944212|NCT02955797|12160728|P3|STARTED|Overall Study||203
4944213|NCT02955797|12160729|P2|STARTED|Overall Study||306
4944214|NCT02955797|12160730|P1|STARTED|Overall Study||306
4944215|NCT02955147|12160746|P1|NOT COMPLETED|Overall Study||0
4944216|NCT02955147|12160746|P1|COMPLETED|Overall Study||13
4944217|NCT02955147|12160746|P1|STARTED|Overall Study||13
4944218|NCT02954952|12160756|P3|NOT COMPLETED|Overall Study||0
4944219|NCT02954952|12160757|P2|NOT COMPLETED|Overall Study||1
4944220|NCT02954952|12160758|P1|NOT COMPLETED|Overall Study||1
4944221|NCT02954952|12160756|P3|COMPLETED|Overall Study||3
4944222|NCT02954952|12160757|P2|COMPLETED|Overall Study||4
4944223|NCT02954952|12160758|P1|COMPLETED|Overall Study||35
4944224|NCT02954952|12160756|P3|STARTED|Overall Study||3
4944225|NCT02954952|12160757|P2|STARTED|Overall Study||5
4944226|NCT02954952|12160758|P1|STARTED|Overall Study||36
4944227|NCT02954887|12160766|P1|NOT COMPLETED|Overall Study||7
4944228|NCT02954887|12160766|P1|COMPLETED|Overall Study||2
4944229|NCT02954887|12160766|P1|STARTED|Overall Study||9
4944230|NCT02954848|12160795|P2|NOT COMPLETED|Overall Study||5
4944231|NCT02954848|12160796|P1|NOT COMPLETED|Overall Study||2
4944232|NCT02954848|12160795|P2|COMPLETED|Overall Study||234
4944233|NCT02954848|12160796|P1|COMPLETED|Overall Study||243
4944234|NCT02954848|12160795|P2|Treated|Overall Study||238
4944235|NCT02954848|12160796|P1|Treated|Overall Study||245
4944236|NCT02954848|12160795|P2|STARTED|Overall Study||239
4944237|NCT02954848|12160796|P1|STARTED|Overall Study||245
4944238|NCT02954653|12160856|P9|NOT COMPLETED|Overall Study||0
4944239|NCT02954653|12160857|P8|NOT COMPLETED|Overall Study||0
4944240|NCT02954653|12160858|P7|NOT COMPLETED|Overall Study||0
4944241|NCT02954653|12160859|P6|NOT COMPLETED|Overall Study||0
4944242|NCT02954653|12160860|P5|NOT COMPLETED|Overall Study||0
4944243|NCT02954653|12160861|P4|NOT COMPLETED|Overall Study||0
4944244|NCT02954653|12160862|P3|NOT COMPLETED|Overall Study||0
4944245|NCT02954653|12160863|P2|NOT COMPLETED|Overall Study||3
4944246|NCT02954653|12160864|P1|NOT COMPLETED|Overall Study||4
4944247|NCT02954653|12160856|P9|COMPLETED|Overall Study||0
4944248|NCT02954653|12160857|P8|COMPLETED|Overall Study||0
4944249|NCT02954653|12160858|P7|COMPLETED|Overall Study||0
4944250|NCT02954653|12160859|P6|COMPLETED|Overall Study||0
4944251|NCT02954653|12160860|P5|COMPLETED|Overall Study||0
4944252|NCT02954653|12160861|P4|COMPLETED|Overall Study||0
4944253|NCT02954653|12160862|P3|COMPLETED|Overall Study||0
4944254|NCT02954653|12160863|P2|COMPLETED|Overall Study||1
4944255|NCT02954653|12160864|P1|COMPLETED|Overall Study||0
4944256|NCT02954653|12160856|P9|Received Treatment|Overall Study||0
4944257|NCT02954653|12160857|P8|Received Treatment|Overall Study||0
4944258|NCT02954653|12160858|P7|Received Treatment|Overall Study||0
4944259|NCT02954653|12160859|P6|Received Treatment|Overall Study||0
4944260|NCT02954653|12160860|P5|Received Treatment|Overall Study||0
4944261|NCT02954653|12160861|P4|Received Treatment|Overall Study||0
4944262|NCT02954653|12160862|P3|Received Treatment|Overall Study||0
4944263|NCT02954653|12160863|P2|Received Treatment|Overall Study||4
4944264|NCT02954653|12160864|P1|Received Treatment|Overall Study||3
4944265|NCT02954653|12160856|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944266|NCT02954653|12160857|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944267|NCT02954653|12160858|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944268|NCT02954653|12160859|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944269|NCT02954653|12160860|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944270|NCT02954653|12160861|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944271|NCT02954653|12160862|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
4944272|NCT02954653|12160863|P2|STARTED|Overall Study||4
4944273|NCT02954653|12160864|P1|STARTED|Overall Study||4
4944274|NCT02954601|12160983|P4|NOT COMPLETED|Third Intervention (Five Days)||0
4944275|NCT02954601|12160984|P3|NOT COMPLETED|Third Intervention (Five Days)||0
4944276|NCT02954601|12160985|P2|NOT COMPLETED|Third Intervention (Five Days)||0
4944277|NCT02954601|12160986|P1|NOT COMPLETED|Third Intervention (Five Days)||0
4944278|NCT02954601|12160983|P4|COMPLETED|Third Intervention (Five Days)||8
4944279|NCT02954601|12160984|P3|COMPLETED|Third Intervention (Five Days)||6
4944280|NCT02954601|12160985|P2|COMPLETED|Third Intervention (Five Days)||8
4944281|NCT02954601|12160986|P1|COMPLETED|Third Intervention (Five Days)||9
4944282|NCT02954601|12160983|P4|STARTED|Third Intervention (Five Days)||8
4944283|NCT02954601|12160984|P3|STARTED|Third Intervention (Five Days)||6
4944284|NCT02954601|12160985|P2|STARTED|Third Intervention (Five Days)||8
4944285|NCT02954601|12160986|P1|STARTED|Third Intervention (Five Days)||9
4944286|NCT02954601|12160983|P4|NOT COMPLETED|Second Intervention (Five Days)||0
4944287|NCT02954601|12160984|P3|NOT COMPLETED|Second Intervention (Five Days)||0
4944288|NCT02954601|12160985|P2|NOT COMPLETED|Second Intervention (Five Days)||0
4944289|NCT02954601|12160986|P1|NOT COMPLETED|Second Intervention (Five Days)||0
4944290|NCT02954601|12160983|P4|COMPLETED|Second Intervention (Five Days)||6
4944291|NCT02954601|12160984|P3|COMPLETED|Second Intervention (Five Days)||8
4944292|NCT02954601|12160985|P2|COMPLETED|Second Intervention (Five Days)||6
4944293|NCT02954601|12160986|P1|COMPLETED|Second Intervention (Five Days)||11
4944294|NCT02954601|12160983|P4|STARTED|Second Intervention (Five Days)||6
4944295|NCT02954601|12160984|P3|STARTED|Second Intervention (Five Days)||8
4944296|NCT02954601|12160985|P2|STARTED|Second Intervention (Five Days)||6
4944297|NCT02954601|12160986|P1|STARTED|Second Intervention (Five Days)||11
4944298|NCT02954601|12160983|P4|NOT COMPLETED|First Intervention (Five Days)||0
4944299|NCT02954601|12160984|P3|NOT COMPLETED|First Intervention (Five Days)||1
4944300|NCT02954601|12160985|P2|NOT COMPLETED|First Intervention (Five Days)||0
4944301|NCT02954601|12160986|P1|NOT COMPLETED|First Intervention (Five Days)||0
4944302|NCT02954601|12160983|P4|COMPLETED|First Intervention (Five Days)||7
4944303|NCT02954601|12160984|P3|COMPLETED|First Intervention (Five Days)||7
4944304|NCT02954601|12160985|P2|COMPLETED|First Intervention (Five Days)||6
4944305|NCT02954601|12160986|P1|COMPLETED|First Intervention (Five Days)||11
4944306|NCT02954601|12160983|P4|STARTED|First Intervention (Five Days)||7
4944307|NCT02954601|12160984|P3|STARTED|First Intervention (Five Days)||8
4944308|NCT02954601|12160985|P2|STARTED|First Intervention (Five Days)||6
4944309|NCT02954601|12160986|P1|STARTED|First Intervention (Five Days)||11
4944310|NCT02954575|12161008|P1|NOT COMPLETED|Overall Study||3
4944311|NCT02954575|12161008|P1|COMPLETED|Overall Study||54
4944312|NCT02954575|12161008|P1|SURG Population|Overall Study||1
4944313|NCT02954575|12161008|P1|PK Population|Overall Study||21
4944314|NCT02954575|12161008|P1|PP Population|Overall Study||52
4944315|NCT02954575|12161008|P1|FAS Population|Overall Study||55
4944316|NCT02954575|12161008|P1|SAF Population|Overall Study||55
4944317|NCT02954575|12161008|P1|Received Treatment|Overall Study||55
4944318|NCT02954575|12161008|P1|STARTED|Overall Study||57
4944319|NCT02954354|12161028|P3|NOT COMPLETED|Overall Study||16
4944320|NCT02954354|12161029|P2|NOT COMPLETED|Overall Study||20
4944321|NCT02954354|12161030|P1|NOT COMPLETED|Overall Study||34
4944322|NCT02954354|12161028|P3|COMPLETED|Overall Study||498
4944323|NCT02954354|12161029|P2|COMPLETED|Overall Study||290
4944324|NCT02954354|12161030|P1|COMPLETED|Overall Study||578
4944325|NCT02954354|12161028|P3|Intention to Treat Infected Population|Overall Study||377
4944326|NCT02954354|12161029|P2|Intention to Treat Infected Population|Overall Study||231
4944327|NCT02954354|12161030|P1|Intention to Treat Infected Population|Overall Study||456
4944328|NCT02954354|12161028|P3|Received Study Drug|Overall Study||513
4944329|NCT02954354|12161029|P2|Received Study Drug|Overall Study||309
4944330|NCT02954354|12161030|P1|Received Study Drug|Overall Study||610
4944331|NCT02954354|12161028|P3|STARTED|Overall Study||514
4944332|NCT02954354|12161029|P2|STARTED|Overall Study||310
4944333|NCT02954354|12161030|P1|STARTED|Overall Study||612
4944334|NCT02954198|12161116|P2|NOT COMPLETED|Overall Study||0
4944335|NCT02954198|12161117|P1|NOT COMPLETED|Overall Study||0
4944336|NCT02954198|12161116|P2|COMPLETED|Overall Study||20
4944337|NCT02954198|12161117|P1|COMPLETED|Overall Study||20
4944338|NCT02954198|12161116|P2|STARTED|Overall Study||20
4944339|NCT02954198|12161117|P1|STARTED|Overall Study||20
4944340|NCT02953938|12161131|P2|NOT COMPLETED|Overall Study||2
4944341|NCT02953938|12161132|P1|NOT COMPLETED|Overall Study||1
4944342|NCT02953938|12161131|P2|COMPLETED|Overall Study||28
4944343|NCT02953938|12161132|P1|COMPLETED|Overall Study||28
4944344|NCT02953938|12161131|P2|STARTED|Overall Study||30
4944345|NCT02953938|12161132|P1|STARTED|Overall Study||29
4944346|NCT02953886|12161147|P1|NOT COMPLETED|Overall Study||0
4944347|NCT02953886|12161147|P1|COMPLETED|Overall Study||20
4944348|NCT02953886|12161147|P1|STARTED|Overall Study||20
4944349|NCT02953873|12161153|P1|NOT COMPLETED|Overall Study||0
4944350|NCT02953873|12161153|P1|COMPLETED|Overall Study||25
4944351|NCT02953873|12161153|P1|STARTED|Overall Study||25
4944352|NCT02953678|12161161|P1|NOT COMPLETED|Overall Study||60
4944353|NCT02953678|12161161|P1|COMPLETED|Overall Study||11
4944354|NCT02953678|12161161|P1|Participants Continuing in Study|Overall Study||19
4944355|NCT02953678|12161161|P1|Participants Discontinued From Study|Overall Study||41
4944356|NCT02953678|12161161|P1|STARTED|Overall Study||71
4944357|NCT02953548|12161170|P2|NOT COMPLETED|Overall Study||0
4944358|NCT02953548|12161171|P1|NOT COMPLETED|Overall Study||0
4944359|NCT02953548|12161170|P2|COMPLETED|Overall Study||4
4944360|NCT02953548|12161171|P1|COMPLETED|Overall Study||5
4944361|NCT02953548|12161170|P2|STARTED|Overall Study||4
4944362|NCT02953548|12161171|P1|STARTED|Overall Study||5
4944363|NCT02953314|12161195|P2|NOT COMPLETED|Overall Study||3
4944364|NCT02953314|12161196|P1|NOT COMPLETED|Overall Study||0
4944365|NCT02953314|12161195|P2|COMPLETED|Overall Study||67
4944366|NCT02953314|12161196|P1|COMPLETED|Overall Study||13
4944367|NCT02953314|12161195|P2|STARTED|Overall Study||70
4944368|NCT02953314|12161196|P1|STARTED|Overall Study||13
4944369|NCT02952898|12161222|P3|NOT COMPLETED|Overall Study||15
4944370|NCT02952898|12161223|P2|NOT COMPLETED|Overall Study||19
4944371|NCT02952898|12161224|P1|NOT COMPLETED|Overall Study||22
4944372|NCT02952898|12161222|P3|COMPLETED|Overall Study||209
4944373|NCT02952898|12161223|P2|COMPLETED|Overall Study||202
4944374|NCT02952898|12161224|P1|COMPLETED|Overall Study||198
4944375|NCT02952898|12161222|P3|STARTED|Overall Study||224
4944376|NCT02952898|12161223|P2|STARTED|Overall Study||221
4944377|NCT02952898|12161224|P1|STARTED|Overall Study||220
4944378|NCT02952872|12161248|P16|NOT COMPLETED|Overall Study||0
4944379|NCT02952872|12161249|P15|NOT COMPLETED|Overall Study||0
4944380|NCT02952872|12161250|P14|NOT COMPLETED|Overall Study||0
4944381|NCT02952872|12161251|P13|NOT COMPLETED|Overall Study||0
4944382|NCT02952872|12161252|P12|NOT COMPLETED|Overall Study||0
4944383|NCT02952872|12161253|P11|NOT COMPLETED|Overall Study||0
4944384|NCT02952872|12161254|P10|NOT COMPLETED|Overall Study||0
4944385|NCT02952872|12161255|P9|NOT COMPLETED|Overall Study||0
4944386|NCT02952872|12161256|P8|NOT COMPLETED|Overall Study||0
4944387|NCT02952872|12161257|P7|NOT COMPLETED|Overall Study||0
4944388|NCT02952872|12161258|P6|NOT COMPLETED|Overall Study||0
4944389|NCT02952872|12161259|P5|NOT COMPLETED|Overall Study||0
4944390|NCT02952872|12161260|P4|NOT COMPLETED|Overall Study||0
4944391|NCT02952872|12161261|P3|NOT COMPLETED|Overall Study||0
4944392|NCT02952872|12161262|P2|NOT COMPLETED|Overall Study||0
4944393|NCT02952872|12161263|P1|NOT COMPLETED|Overall Study||0
4944394|NCT02952872|12161248|P16|COMPLETED|Overall Study||23
4944395|NCT02952872|12161249|P15|COMPLETED|Overall Study||22
4944396|NCT02952872|12161250|P14|COMPLETED|Overall Study||22
4944397|NCT02952872|12161251|P13|COMPLETED|Overall Study||22
4944398|NCT02952872|12161252|P12|COMPLETED|Overall Study||22
4944399|NCT02952872|12161253|P11|COMPLETED|Overall Study||23
4944400|NCT02952872|12161254|P10|COMPLETED|Overall Study||22
4944401|NCT02952872|12161255|P9|COMPLETED|Overall Study||22
4944402|NCT02952872|12161256|P8|COMPLETED|Overall Study||21
4944403|NCT02952872|12161257|P7|COMPLETED|Overall Study||22
4944404|NCT02952872|12161258|P6|COMPLETED|Overall Study||21
4944405|NCT02952872|12161259|P5|COMPLETED|Overall Study||22
4944406|NCT02952872|12161260|P4|COMPLETED|Overall Study||22
4944407|NCT02952872|12161261|P3|COMPLETED|Overall Study||22
4944408|NCT02952872|12161262|P2|COMPLETED|Overall Study||22
4944409|NCT02952872|12161263|P1|COMPLETED|Overall Study||22
4944410|NCT02952872|12161248|P16|STARTED|Overall Study||23
4944411|NCT02952872|12161249|P15|STARTED|Overall Study||22
4944412|NCT02952872|12161250|P14|STARTED|Overall Study||22
4944413|NCT02952872|12161251|P13|STARTED|Overall Study||22
4944414|NCT02952872|12161252|P12|STARTED|Overall Study||22
4944415|NCT02952872|12161253|P11|STARTED|Overall Study||23
4944416|NCT02952872|12161254|P10|STARTED|Overall Study||22
4944417|NCT02952872|12161255|P9|STARTED|Overall Study||22
4944418|NCT02952872|12161256|P8|STARTED|Overall Study||21
4944419|NCT02952872|12161257|P7|STARTED|Overall Study||22
4944420|NCT02952872|12161258|P6|STARTED|Overall Study||21
4944421|NCT02952872|12161259|P5|STARTED|Overall Study||22
4944422|NCT02952872|12161260|P4|STARTED|Overall Study||22
4944423|NCT02952872|12161261|P3|STARTED|Overall Study||22
4944424|NCT02952872|12161262|P2|STARTED|Overall Study||22
4944425|NCT02952872|12161263|P1|STARTED|Overall Study||22
4944426|NCT02952820|12161348|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
4944427|NCT02952820|12161349|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
4944428|NCT02952820|12161350|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
4944429|NCT02952820|12161348|P3|COMPLETED|Active Treatment Period (6 Months)||321
4944430|NCT02952820|12161349|P2|COMPLETED|Active Treatment Period (6 Months)||346
4944431|NCT02952820|12161350|P1|COMPLETED|Active Treatment Period (6 Months)||0
4944432|NCT02952820|12161348|P3|STARTED|Active Treatment Period (6 Months)||352
4944433|NCT02952820|12161349|P2|STARTED|Active Treatment Period (6 Months)||384
4944434|NCT02952820|12161350|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
4944435|NCT02952820|12161348|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
4944436|NCT02952820|12161349|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
4944437|NCT02952820|12161350|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
4944438|NCT02952820|12161348|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
4944439|NCT02952820|12161349|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
4944440|NCT02952820|12161350|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
4944441|NCT02952820|12161348|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
4944442|NCT02952820|12161349|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
4944443|NCT02952820|12161350|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
4944444|NCT02952820|12161348|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
4944445|NCT02952820|12161349|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
4944446|NCT02952820|12161350|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
4944447|NCT02952820|12161348|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
4944448|NCT02952820|12161349|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
4944449|NCT02952820|12161350|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
4944450|NCT02952313|12161410|P1|NOT COMPLETED|Overall Study||7
4944451|NCT02952313|12161410|P1|COMPLETED|Overall Study||106
4944452|NCT02952313|12161410|P1|6 Months|Overall Study||106
4944453|NCT02952313|12161410|P1|STARTED|Overall Study||113
4944454|NCT02952261|12161418|P2|NOT COMPLETED|Overall Study||5
4944455|NCT02952261|12161419|P1|NOT COMPLETED|Overall Study||5
4944456|NCT02952261|12161418|P2|COMPLETED|Overall Study||95
4944457|NCT02952261|12161419|P1|COMPLETED|Overall Study||95
4944458|NCT02952261|12161418|P2|STARTED|Overall Study||100
4944459|NCT02952261|12161419|P1|STARTED|Overall Study||100
4944460|NCT02951988|12161434|P4|NOT COMPLETED|Double-Blind Treatment Period||115
4944461|NCT02951988|12161435|P3|NOT COMPLETED|Double-Blind Treatment Period||101
4944462|NCT02951988|12161436|P2|NOT COMPLETED|Double-Blind Treatment Period||101
4944463|NCT02951988|12161437|P1|NOT COMPLETED|Double-Blind Treatment Period||0
4944464|NCT02951988|12161434|P4|COMPLETED|Double-Blind Treatment Period||85
4944465|NCT02951988|12161435|P3|COMPLETED|Double-Blind Treatment Period||101
4944466|NCT02951988|12161436|P2|COMPLETED|Double-Blind Treatment Period||101
4944467|NCT02951988|12161437|P1|COMPLETED|Double-Blind Treatment Period||0
4944468|NCT02951988|12161434|P4|STARTED|Double-Blind Treatment Period||200
4944469|NCT02951988|12161435|P3|STARTED|Double-Blind Treatment Period||202
4944470|NCT02951988|12161436|P2|STARTED|Double-Blind Treatment Period||202
4944471|NCT02951988|12161437|P1|STARTED|Double-Blind Treatment Period||0
4944472|NCT02951988|12161434|P4|NOT COMPLETED|Open-Label Treatment Period||0
4944473|NCT02951988|12161435|P3|NOT COMPLETED|Open-Label Treatment Period||0
4944474|NCT02951988|12161436|P2|NOT COMPLETED|Open-Label Treatment Period||0
4944475|NCT02951988|12161437|P1|NOT COMPLETED|Open-Label Treatment Period||248
4944476|NCT02951988|12161434|P4|COMPLETED|Open-Label Treatment Period||0
4944477|NCT02951988|12161435|P3|COMPLETED|Open-Label Treatment Period||0
4944478|NCT02951988|12161436|P2|COMPLETED|Open-Label Treatment Period||0
4944479|NCT02951988|12161437|P1|COMPLETED|Open-Label Treatment Period||1056
4944480|NCT02951988|12161434|P4|STARTED|Open-Label Treatment Period||0
4944481|NCT02951988|12161435|P3|STARTED|Open-Label Treatment Period||0
4944482|NCT02951988|12161436|P2|STARTED|Open-Label Treatment Period||0
4944483|NCT02951988|12161437|P1|STARTED|Open-Label Treatment Period||1304
4944484|NCT02951884|12161455|P3|NOT COMPLETED|Overall Study||0
4944485|NCT02951884|12161456|P2|NOT COMPLETED|Overall Study||0
4944486|NCT02951884|12161457|P1|NOT COMPLETED|Overall Study||0
4944487|NCT02951884|12161455|P3|COMPLETED|Overall Study||1
4944488|NCT02951884|12161456|P2|COMPLETED|Overall Study||1
4944489|NCT02951884|12161457|P1|COMPLETED|Overall Study||0
4944490|NCT02951884|12161455|P3|STARTED|Overall Study||1
4944491|NCT02951884|12161456|P2|STARTED|Overall Study||1
4944492|NCT02951884|12161457|P1|STARTED|Overall Study||0
4944493|NCT02951819|12161470|P2|NOT COMPLETED|Overall Study||14
4944494|NCT02951819|12161471|P1|NOT COMPLETED|Overall Study||87
4944495|NCT02951819|12161470|P2|COMPLETED|Overall Study||0
4944496|NCT02951819|12161471|P1|COMPLETED|Overall Study||0
4944497|NCT02951819|12161470|P2|Treated|Overall Study||14
4944498|NCT02951819|12161471|P1|Treated|Overall Study||86
4944499|NCT02951819|12161470|P2|STARTED|Overall Study||14
4944500|NCT02951819|12161471|P1|STARTED|Overall Study||87
4944501|NCT02951780|12161502|P9|NOT COMPLETED|Period 3||0
4944502|NCT02951780|12161503|P8|NOT COMPLETED|Period 3||0
4944503|NCT02951780|12161504|P7|NOT COMPLETED|Period 3||0
4944504|NCT02951780|12161505|P6|NOT COMPLETED|Period 3||0
4944505|NCT02951780|12161506|P5|NOT COMPLETED|Period 3||0
4944506|NCT02951780|12161507|P4|NOT COMPLETED|Period 3||0
4944507|NCT02951780|12161508|P3|NOT COMPLETED|Period 3||0
4944508|NCT02951780|12161509|P2|NOT COMPLETED|Period 3||0
4944509|NCT02951780|12161510|P1|NOT COMPLETED|Period 3||0
4944510|NCT02951780|12161502|P9|COMPLETED|Period 3||2
4944511|NCT02951780|12161503|P8|COMPLETED|Period 3||1
4944512|NCT02951780|12161504|P7|COMPLETED|Period 3||2
4944513|NCT02951780|12161505|P6|COMPLETED|Period 3||3
4944514|NCT02951780|12161506|P5|COMPLETED|Period 3||2
4944515|NCT02951780|12161507|P4|COMPLETED|Period 3||2
4944516|NCT02951780|12161508|P3|COMPLETED|Period 3||3
4944517|NCT02951780|12161509|P2|COMPLETED|Period 3||2
4944518|NCT02951780|12161510|P1|COMPLETED|Period 3||3
4944519|NCT02951780|12161502|P9|STARTED|Period 3||2
4944520|NCT02951780|12161503|P8|STARTED|Period 3||1
4944521|NCT02951780|12161504|P7|STARTED|Period 3||2
4944522|NCT02951780|12161505|P6|STARTED|Period 3||3
4944523|NCT02951780|12161506|P5|STARTED|Period 3||2
4944524|NCT02951780|12161507|P4|STARTED|Period 3||2
4944525|NCT02951780|12161508|P3|STARTED|Period 3||3
4944526|NCT02951780|12161509|P2|STARTED|Period 3||2
4944527|NCT02951780|12161510|P1|STARTED|Period 3||3
4944528|NCT02951780|12161502|P9|NOT COMPLETED|Period 2||0
4944529|NCT02951780|12161503|P8|NOT COMPLETED|Period 2||1
4944530|NCT02951780|12161504|P7|NOT COMPLETED|Period 2||0
4944531|NCT02951780|12161505|P6|NOT COMPLETED|Period 2||0
4944532|NCT02951780|12161506|P5|NOT COMPLETED|Period 2||0
4944533|NCT02951780|12161507|P4|NOT COMPLETED|Period 2||0
4944534|NCT02951780|12161508|P3|NOT COMPLETED|Period 2||0
4944535|NCT02951780|12161509|P2|NOT COMPLETED|Period 2||0
4944536|NCT02951780|12161510|P1|NOT COMPLETED|Period 2||0
4944537|NCT02951780|12161502|P9|COMPLETED|Period 2||2
4944538|NCT02951780|12161503|P8|COMPLETED|Period 2||1
4944539|NCT02951780|12161504|P7|COMPLETED|Period 2||2
4944540|NCT02951780|12161505|P6|COMPLETED|Period 2||3
4944541|NCT02951780|12161506|P5|COMPLETED|Period 2||2
4944542|NCT02951780|12161507|P4|COMPLETED|Period 2||2
4944543|NCT02951780|12161508|P3|COMPLETED|Period 2||3
4944544|NCT02951780|12161509|P2|COMPLETED|Period 2||2
4944545|NCT02951780|12161510|P1|COMPLETED|Period 2||3
4944546|NCT02951780|12161502|P9|STARTED|Period 2||2
4944547|NCT02951780|12161503|P8|STARTED|Period 2||2
4944548|NCT02951780|12161504|P7|STARTED|Period 2||2
4944549|NCT02951780|12161505|P6|STARTED|Period 2||3
4944550|NCT02951780|12161506|P5|STARTED|Period 2||2
4944551|NCT02951780|12161507|P4|STARTED|Period 2||2
4944552|NCT02951780|12161508|P3|STARTED|Period 2||3
4944553|NCT02951780|12161509|P2|STARTED|Period 2||2
4944554|NCT02951780|12161510|P1|STARTED|Period 2||3
4944555|NCT02951780|12161502|P9|NOT COMPLETED|Period 1||0
4944556|NCT02951780|12161503|P8|NOT COMPLETED|Period 1||1
4944557|NCT02951780|12161504|P7|NOT COMPLETED|Period 1||0
4944558|NCT02951780|12161505|P6|NOT COMPLETED|Period 1||0
4944559|NCT02951780|12161506|P5|NOT COMPLETED|Period 1||0
4944560|NCT02951780|12161507|P4|NOT COMPLETED|Period 1||1
4944561|NCT02951780|12161508|P3|NOT COMPLETED|Period 1||0
4944562|NCT02951780|12161509|P2|NOT COMPLETED|Period 1||0
4944563|NCT02951780|12161510|P1|NOT COMPLETED|Period 1||0
4944564|NCT02951780|12161502|P9|COMPLETED|Period 1||2
4944565|NCT02951780|12161503|P8|COMPLETED|Period 1||2
4944566|NCT02951780|12161504|P7|COMPLETED|Period 1||2
4944567|NCT02951780|12161505|P6|COMPLETED|Period 1||3
4944568|NCT02951780|12161506|P5|COMPLETED|Period 1||2
4944569|NCT02951780|12161507|P4|COMPLETED|Period 1||2
4944570|NCT02951780|12161508|P3|COMPLETED|Period 1||3
4944571|NCT02951780|12161509|P2|COMPLETED|Period 1||2
4944572|NCT02951780|12161510|P1|COMPLETED|Period 1||3
4944573|NCT02951780|12161502|P9|STARTED|Period 1||2
4944574|NCT02951780|12161503|P8|STARTED|Period 1||3
4944575|NCT02951780|12161504|P7|STARTED|Period 1||2
4944576|NCT02951780|12161505|P6|STARTED|Period 1||3
4944577|NCT02951780|12161506|P5|STARTED|Period 1||2
4944578|NCT02951780|12161507|P4|STARTED|Period 1||3
4944579|NCT02951780|12161508|P3|STARTED|Period 1||3
4944580|NCT02951780|12161509|P2|STARTED|Period 1||2
4944581|NCT02951780|12161510|P1|STARTED|Period 1||3
4944582|NCT02951767|12161575|P1|NOT COMPLETED|Overall Study||119
4944583|NCT02951767|12161575|P1|COMPLETED|Overall Study||0
4944584|NCT02951767|12161575|P1|STARTED|Overall Study||119
4944585|NCT02951702|12161594|P2|NOT COMPLETED|Overall Study||0
4944586|NCT02951702|12161595|P1|NOT COMPLETED|Overall Study||0
4944587|NCT02951702|12161594|P2|COMPLETED|Overall Study||17
4944588|NCT02951702|12161595|P1|COMPLETED|Overall Study||34
4944589|NCT02951702|12161594|P2|STARTED|Overall Study||17
4944590|NCT02951702|12161595|P1|STARTED|Overall Study||34
4944591|NCT02951533|12161607|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
4944592|NCT02951533|12161608|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
4944593|NCT02951533|12161609|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
4944594|NCT02951533|12161607|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
4944595|NCT02951533|12161608|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
4944596|NCT02951533|12161609|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
4944597|NCT02951533|12161607|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
4944598|NCT02951533|12161608|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
4944599|NCT02951533|12161609|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
4944600|NCT02951533|12161607|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
4944601|NCT02951533|12161608|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
4944602|NCT02951533|12161609|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
4944603|NCT02951533|12161607|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
4944604|NCT02951533|12161608|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
4944605|NCT02951533|12161609|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
4944606|NCT02951533|12161607|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
4944607|NCT02951533|12161608|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
4944608|NCT02951533|12161609|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
4944609|NCT02951533|12161607|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
4944610|NCT02951533|12161608|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
4944611|NCT02951533|12161609|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
4944612|NCT02951533|12161607|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
4944613|NCT02951533|12161608|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
4944614|NCT02951533|12161609|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
4944615|NCT02951533|12161607|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
4944616|NCT02951533|12161608|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
4944617|NCT02951533|12161609|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
4944618|NCT02951533|12161607|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
4944619|NCT02951533|12161608|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
4944620|NCT02951533|12161609|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
4944621|NCT02951533|12161607|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
4944622|NCT02951533|12161608|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
4944623|NCT02951533|12161609|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
4944624|NCT02951533|12161607|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
4944625|NCT02951533|12161608|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
4944626|NCT02951533|12161609|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
4944627|NCT02951533|12161607|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
4944628|NCT02951533|12161608|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
4944629|NCT02951533|12161609|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
4944630|NCT02951533|12161607|P3|Treated|Part I (Week 0 Through Week 24)||0
4944631|NCT02951533|12161608|P2|Treated|Part I (Week 0 Through Week 24)||58
4944632|NCT02951533|12161609|P1|Treated|Part I (Week 0 Through Week 24)||60
4944633|NCT02951533|12161607|P3|STARTED|Part I (Week 0 Through Week 24)||0
4944634|NCT02951533|12161608|P2|STARTED|Part I (Week 0 Through Week 24)||59
4944635|NCT02951533|12161609|P1|STARTED|Part I (Week 0 Through Week 24)||60
4944636|NCT02951351|12161708|P2|NOT COMPLETED|Overall Study||0
4944637|NCT02951351|12161709|P1|NOT COMPLETED|Overall Study||0
4944638|NCT02951351|12161708|P2|COMPLETED|Overall Study||17
4944639|NCT02951351|12161709|P1|COMPLETED|Overall Study||19
4944640|NCT02951351|12161708|P2|STARTED|Overall Study||17
4944641|NCT02951351|12161709|P1|STARTED|Overall Study||19
4944642|NCT02951312|12161733|P4|NOT COMPLETED|Study Part 2||0
4944643|NCT02951312|12161734|P3|NOT COMPLETED|Study Part 2||0
4944644|NCT02951312|12161735|P2|NOT COMPLETED|Study Part 2||0
4944645|NCT02951312|12161736|P1|NOT COMPLETED|Study Part 2||0
4944646|NCT02951312|12161733|P4|COMPLETED|Study Part 2||6
4944647|NCT02951312|12161734|P3|COMPLETED|Study Part 2||6
4944648|NCT02951312|12161735|P2|COMPLETED|Study Part 2||0
4944649|NCT02951312|12161736|P1|COMPLETED|Study Part 2||0
4944650|NCT02951312|12161733|P4|STARTED|Study Part 2||6
4944651|NCT02951312|12161734|P3|STARTED|Study Part 2||6
4944652|NCT02951312|12161735|P2|STARTED|Study Part 2||0
4944653|NCT02951312|12161736|P1|STARTED|Study Part 2||0
4944654|NCT02951312|12161733|P4|NOT COMPLETED|Study Part 1||0
4944655|NCT02951312|12161734|P3|NOT COMPLETED|Study Part 1||0
4944656|NCT02951312|12161735|P2|NOT COMPLETED|Study Part 1||0
4944657|NCT02951312|12161736|P1|NOT COMPLETED|Study Part 1||0
4944658|NCT02951312|12161733|P4|COMPLETED|Study Part 1||0
4944659|NCT02951312|12161734|P3|COMPLETED|Study Part 1||0
4944660|NCT02951312|12161735|P2|COMPLETED|Study Part 1||6
4944661|NCT02951312|12161736|P1|COMPLETED|Study Part 1||6
4944662|NCT02951312|12161733|P4|STARTED|Study Part 1||0
4944663|NCT02951312|12161734|P3|STARTED|Study Part 1||0
4944664|NCT02951312|12161735|P2|STARTED|Study Part 1||6
4944665|NCT02951312|12161736|P1|STARTED|Study Part 1||6
4944666|NCT02951273|12161856|P1|NOT COMPLETED|Overall Study||3
4944667|NCT02951273|12161856|P1|COMPLETED|Overall Study||27
4944668|NCT02951273|12161856|P1|STARTED|Overall Study||30
4944669|NCT02951052|12161873|P2|NOT COMPLETED|Overall Study||18
4944670|NCT02951052|12161874|P1|NOT COMPLETED|Overall Study||27
4944671|NCT02951052|12161873|P2|COMPLETED|Overall Study||290
4944672|NCT02951052|12161874|P1|COMPLETED|Overall Study||281
4944673|NCT02951052|12161873|P2|STARTED|Overall Study||308
4944674|NCT02951052|12161874|P1|STARTED|Overall Study||308
4944675|NCT02950896|12162038|P1|NOT COMPLETED|Overall Study||0
4944676|NCT02950896|12162038|P1|COMPLETED|Overall Study||4
4944677|NCT02950896|12162038|P1|STARTED|Overall Study||4
4944678|NCT02950831|12162042|P1|NOT COMPLETED|Overall Study||9
4944679|NCT02950831|12162042|P1|COMPLETED|Overall Study||18
4944680|NCT02950831|12162042|P1|8 Weeks Follow up|Overall Study||19
4944681|NCT02950831|12162042|P1|4 Week Follow up|Overall Study||20
4944682|NCT02950831|12162042|P1|Permanent Implant|Overall Study||20
4944683|NCT02950831|12162042|P1|Complete Trial|Overall Study||26
4944684|NCT02950831|12162042|P1|STARTED|Overall Study||27
4944685|NCT02950753|12162067|P2|NOT COMPLETED|Overall Study||0
4944686|NCT02950753|12162068|P1|NOT COMPLETED|Overall Study||0
4944687|NCT02950753|12162067|P2|COMPLETED|Overall Study||15
4944688|NCT02950753|12162068|P1|COMPLETED|Overall Study||15
4944689|NCT02950753|12162067|P2|STARTED|Overall Study||15
4944690|NCT02950753|12162068|P1|STARTED|Overall Study||15
4944691|NCT02950545|12162084|P6|NOT COMPLETED|Session 3 (70 Minutes)||1
4944692|NCT02950545|12162085|P5|NOT COMPLETED|Session 3 (70 Minutes)||0
4944693|NCT02950545|12162086|P4|NOT COMPLETED|Session 3 (70 Minutes)||0
4944694|NCT02950545|12162087|P3|NOT COMPLETED|Session 3 (70 Minutes)||0
4944695|NCT02950545|12162088|P2|NOT COMPLETED|Session 3 (70 Minutes)||0
4944696|NCT02950545|12162089|P1|NOT COMPLETED|Session 3 (70 Minutes)||0
4944697|NCT02950545|12162084|P6|COMPLETED|Session 3 (70 Minutes)||7
4944698|NCT02950545|12162085|P5|COMPLETED|Session 3 (70 Minutes)||7
4944699|NCT02950545|12162086|P4|COMPLETED|Session 3 (70 Minutes)||7
4944700|NCT02950545|12162087|P3|COMPLETED|Session 3 (70 Minutes)||7
4944701|NCT02950545|12162088|P2|COMPLETED|Session 3 (70 Minutes)||9
4944702|NCT02950545|12162089|P1|COMPLETED|Session 3 (70 Minutes)||7
4944703|NCT02950545|12162084|P6|STARTED|Session 3 (70 Minutes)||8
4944704|NCT02950545|12162085|P5|STARTED|Session 3 (70 Minutes)||7
4944705|NCT02950545|12162086|P4|STARTED|Session 3 (70 Minutes)||7
4944706|NCT02950545|12162087|P3|STARTED|Session 3 (70 Minutes)||7
4944707|NCT02950545|12162088|P2|STARTED|Session 3 (70 Minutes)||9
4944708|NCT02950545|12162089|P1|STARTED|Session 3 (70 Minutes)||7
4944709|NCT02950545|12162084|P6|NOT COMPLETED|Washout 2 (5 Minutes)||0
4944710|NCT02950545|12162085|P5|NOT COMPLETED|Washout 2 (5 Minutes)||0
4944711|NCT02950545|12162086|P4|NOT COMPLETED|Washout 2 (5 Minutes)||0
4944712|NCT02950545|12162087|P3|NOT COMPLETED|Washout 2 (5 Minutes)||0
4944713|NCT02950545|12162088|P2|NOT COMPLETED|Washout 2 (5 Minutes)||0
4944714|NCT02950545|12162089|P1|NOT COMPLETED|Washout 2 (5 Minutes)||1
4944715|NCT02950545|12162084|P6|COMPLETED|Washout 2 (5 Minutes)||8
4944716|NCT02950545|12162085|P5|COMPLETED|Washout 2 (5 Minutes)||7
4944717|NCT02950545|12162086|P4|COMPLETED|Washout 2 (5 Minutes)||7
4944718|NCT02950545|12162087|P3|COMPLETED|Washout 2 (5 Minutes)||7
4944719|NCT02950545|12162088|P2|COMPLETED|Washout 2 (5 Minutes)||9
4944720|NCT02950545|12162089|P1|COMPLETED|Washout 2 (5 Minutes)||7
4944721|NCT02950545|12162084|P6|STARTED|Washout 2 (5 Minutes)||8
4944722|NCT02950545|12162085|P5|STARTED|Washout 2 (5 Minutes)||7
4944723|NCT02950545|12162086|P4|STARTED|Washout 2 (5 Minutes)||7
4944724|NCT02950545|12162087|P3|STARTED|Washout 2 (5 Minutes)||7
4944725|NCT02950545|12162088|P2|STARTED|Washout 2 (5 Minutes)||9
4944726|NCT02950545|12162089|P1|STARTED|Washout 2 (5 Minutes)||8
4944727|NCT02950545|12162084|P6|NOT COMPLETED|Session 2 (70 Minutes)||0
4944728|NCT02950545|12162085|P5|NOT COMPLETED|Session 2 (70 Minutes)||1
4944729|NCT02950545|12162086|P4|NOT COMPLETED|Session 2 (70 Minutes)||0
4944730|NCT02950545|12162087|P3|NOT COMPLETED|Session 2 (70 Minutes)||0
4944731|NCT02950545|12162088|P2|NOT COMPLETED|Session 2 (70 Minutes)||0
4944732|NCT02950545|12162089|P1|NOT COMPLETED|Session 2 (70 Minutes)||0
4944733|NCT02950545|12162084|P6|COMPLETED|Session 2 (70 Minutes)||8
4944734|NCT02950545|12162085|P5|COMPLETED|Session 2 (70 Minutes)||7
4944735|NCT02950545|12162086|P4|COMPLETED|Session 2 (70 Minutes)||7
4944736|NCT02950545|12162087|P3|COMPLETED|Session 2 (70 Minutes)||7
4944737|NCT02950545|12162088|P2|COMPLETED|Session 2 (70 Minutes)||9
4944738|NCT02950545|12162089|P1|COMPLETED|Session 2 (70 Minutes)||8
4944739|NCT02950545|12162084|P6|STARTED|Session 2 (70 Minutes)||8
4944740|NCT02950545|12162085|P5|STARTED|Session 2 (70 Minutes)||8
4944741|NCT02950545|12162086|P4|STARTED|Session 2 (70 Minutes)||7
4944742|NCT02950545|12162087|P3|STARTED|Session 2 (70 Minutes)||7
4944743|NCT02950545|12162088|P2|STARTED|Session 2 (70 Minutes)||9
4944744|NCT02950545|12162089|P1|STARTED|Session 2 (70 Minutes)||8
4944745|NCT02950545|12162084|P6|NOT COMPLETED|Washout 1 (5 Minutes)||1
4944746|NCT02950545|12162085|P5|NOT COMPLETED|Washout 1 (5 Minutes)||0
4944747|NCT02950545|12162086|P4|NOT COMPLETED|Washout 1 (5 Minutes)||1
4944748|NCT02950545|12162087|P3|NOT COMPLETED|Washout 1 (5 Minutes)||0
4944749|NCT02950545|12162088|P2|NOT COMPLETED|Washout 1 (5 Minutes)||0
4944750|NCT02950545|12162089|P1|NOT COMPLETED|Washout 1 (5 Minutes)||1
4944751|NCT02950545|12162084|P6|COMPLETED|Washout 1 (5 Minutes)||8
4944752|NCT02950545|12162085|P5|COMPLETED|Washout 1 (5 Minutes)||8
4944753|NCT02950545|12162086|P4|COMPLETED|Washout 1 (5 Minutes)||7
4944754|NCT02950545|12162087|P3|COMPLETED|Washout 1 (5 Minutes)||7
4944755|NCT02950545|12162088|P2|COMPLETED|Washout 1 (5 Minutes)||9
4944756|NCT02950545|12162089|P1|COMPLETED|Washout 1 (5 Minutes)||8
4944757|NCT02950545|12162084|P6|STARTED|Washout 1 (5 Minutes)||9
4944758|NCT02950545|12162085|P5|STARTED|Washout 1 (5 Minutes)||8
4944759|NCT02950545|12162086|P4|STARTED|Washout 1 (5 Minutes)||8
4944760|NCT02950545|12162087|P3|STARTED|Washout 1 (5 Minutes)||7
4944761|NCT02950545|12162088|P2|STARTED|Washout 1 (5 Minutes)||9
4944762|NCT02950545|12162089|P1|STARTED|Washout 1 (5 Minutes)||9
4944763|NCT02950545|12162084|P6|NOT COMPLETED|Session 1 (70 Minutes)||1
4944764|NCT02950545|12162085|P5|NOT COMPLETED|Session 1 (70 Minutes)||0
4944765|NCT02950545|12162086|P4|NOT COMPLETED|Session 1 (70 Minutes)||0
4944766|NCT02950545|12162087|P3|NOT COMPLETED|Session 1 (70 Minutes)||0
4944767|NCT02950545|12162088|P2|NOT COMPLETED|Session 1 (70 Minutes)||0
4944768|NCT02950545|12162089|P1|NOT COMPLETED|Session 1 (70 Minutes)||0
4944769|NCT02950545|12162084|P6|COMPLETED|Session 1 (70 Minutes)||9
4944770|NCT02950545|12162085|P5|COMPLETED|Session 1 (70 Minutes)||8
4944771|NCT02950545|12162086|P4|COMPLETED|Session 1 (70 Minutes)||8
4944772|NCT02950545|12162087|P3|COMPLETED|Session 1 (70 Minutes)||7
4944773|NCT02950545|12162088|P2|COMPLETED|Session 1 (70 Minutes)||9
4944774|NCT02950545|12162089|P1|COMPLETED|Session 1 (70 Minutes)||9
4944775|NCT02950545|12162084|P6|STARTED|Session 1 (70 Minutes)||10
4944776|NCT02950545|12162085|P5|STARTED|Session 1 (70 Minutes)||8
4944777|NCT02950545|12162086|P4|STARTED|Session 1 (70 Minutes)||8
4944778|NCT02950545|12162087|P3|STARTED|Session 1 (70 Minutes)||7
4944779|NCT02950545|12162088|P2|STARTED|Session 1 (70 Minutes)||9
4944780|NCT02950545|12162089|P1|STARTED|Session 1 (70 Minutes)||9
4944781|NCT02950480|12162098|P2|NOT COMPLETED|Overall Study||0
4944782|NCT02950480|12162099|P1|NOT COMPLETED|Overall Study||1
4944783|NCT02950480|12162098|P2|COMPLETED|Overall Study||2
4944784|NCT02950480|12162099|P1|COMPLETED|Overall Study||1
4944785|NCT02950480|12162098|P2|STARTED|Overall Study||2
4944786|NCT02950480|12162099|P1|STARTED|Overall Study||2
4944787|NCT02950025|12162111|P2|NOT COMPLETED|Overall Study||0
4944788|NCT02950025|12162112|P1|NOT COMPLETED|Overall Study||0
4944789|NCT02950025|12162111|P2|COMPLETED|Overall Study||3
4944790|NCT02950025|12162112|P1|COMPLETED|Overall Study||2
4944791|NCT02950025|12162111|P2|STARTED|Overall Study||3
4944792|NCT02950025|12162112|P1|STARTED|Overall Study||2
4944793|NCT02949947|12162132|P2|NOT COMPLETED|Overall Study||1
4944794|NCT02949947|12162133|P1|NOT COMPLETED|Overall Study||1
4944795|NCT02949947|12162132|P2|COMPLETED|Overall Study||1
4944796|NCT02949947|12162133|P1|COMPLETED|Overall Study||0
4944797|NCT02949947|12162132|P2|STARTED|Overall Study||2
4944798|NCT02949947|12162133|P1|STARTED|Overall Study||1
4944799|NCT02949921|12162141|P2|NOT COMPLETED|Overall Study||0
4944800|NCT02949921|12162142|P1|NOT COMPLETED|Overall Study||0
4944801|NCT02949921|12162141|P2|COMPLETED|Overall Study||10
4944802|NCT02949921|12162142|P1|COMPLETED|Overall Study||10
4944803|NCT02949921|12162141|P2|STARTED|Overall Study||10
4944804|NCT02949921|12162142|P1|STARTED|Overall Study||10
4944805|NCT02949908|12162166|P1|NOT COMPLETED|Overall Study||2
4944806|NCT02949908|12162166|P1|COMPLETED|Overall Study||0
4944807|NCT02949908|12162166|P1|STARTED|Overall Study||2
4944808|NCT02949674|12162189|P3|NOT COMPLETED|Overall Study||0
4944809|NCT02949674|12162190|P2|NOT COMPLETED|Overall Study||0
4944810|NCT02949674|12162191|P1|NOT COMPLETED|Overall Study||0
4944811|NCT02949674|12162189|P3|COMPLETED|Overall Study||31
4944812|NCT02949674|12162190|P2|COMPLETED|Overall Study||31
4944813|NCT02949674|12162191|P1|COMPLETED|Overall Study||31
4944814|NCT02949674|12162189|P3|STARTED|Overall Study||31
4944815|NCT02949674|12162190|P2|STARTED|Overall Study||31
4944816|NCT02949674|12162191|P1|STARTED|Overall Study||31
4944817|NCT02949518|12162201|P2|NOT COMPLETED|Overall Study||2
4944818|NCT02949518|12162202|P1|NOT COMPLETED|Overall Study||3
4944819|NCT02949518|12162201|P2|COMPLETED|Overall Study||26
4944820|NCT02949518|12162202|P1|COMPLETED|Overall Study||25
4944821|NCT02949518|12162201|P2|STARTED|Overall Study||28
4944822|NCT02949518|12162202|P1|STARTED|Overall Study||28
4944823|NCT02949271|12162230|P2|NOT COMPLETED|Overall Study||30
4944824|NCT02949271|12162231|P1|NOT COMPLETED|Overall Study||29
4944825|NCT02949271|12162230|P2|COMPLETED|Overall Study||59
4944826|NCT02949271|12162231|P1|COMPLETED|Overall Study||61
4944827|NCT02949271|12162230|P2|STARTED|Overall Study||89
4944828|NCT02949271|12162231|P1|STARTED|Overall Study||90
4944829|NCT02949219|12162257|P1|NOT COMPLETED|Overall Study||1
4944830|NCT02949219|12162257|P1|COMPLETED|Overall Study||40
4944831|NCT02949219|12162257|P1|STARTED|Overall Study||41
4944832|NCT02949141|12162264|P1|NOT COMPLETED|Overall Study||0
4944833|NCT02949141|12162264|P1|COMPLETED|Overall Study||62
4944834|NCT02949141|12162264|P1|STARTED|Overall Study||62
4944835|NCT02949128|12162271|P1|NOT COMPLETED|Extension Period||2
4944836|NCT02949128|12162271|P1|COMPLETED|Extension Period||47
4944837|NCT02949128|12162271|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
4944838|NCT02949128|12162271|P1|STARTED|Extension Period||49
4944839|NCT02949128|12162271|P1|NOT COMPLETED|Initial Evaluation Period||9
4944840|NCT02949128|12162271|P1|COMPLETED|Initial Evaluation Period||49
4944841|NCT02949128|12162271|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
4944842|NCT02949128|12162271|P1|STARTED|Initial Evaluation Period||58
4944843|NCT02949011|12162288|P3|NOT COMPLETED|Overall Study||42
4944844|NCT02949011|12162289|P2|NOT COMPLETED|Overall Study||34
4944845|NCT02949011|12162290|P1|NOT COMPLETED|Overall Study||33
4944846|NCT02949011|12162288|P3|COMPLETED|Overall Study||683
4944847|NCT02949011|12162289|P2|COMPLETED|Overall Study||695
4944848|NCT02949011|12162290|P1|COMPLETED|Overall Study||697
4944849|NCT02949011|12162288|P3|Intention to Treat Infected Population|Overall Study||389
4944850|NCT02949011|12162289|P2|Intention to Treat Infected Population|Overall Study||386
4944851|NCT02949011|12162290|P1|Intention to Treat Infected Population|Overall Study||388
4944852|NCT02949011|12162288|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
4944853|NCT02949011|12162289|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
4944854|NCT02949011|12162290|P1|Received Study Drug|Overall Study||728
4944855|NCT02949011|12162288|P3|STARTED|Overall Study||725
4944856|NCT02949011|12162289|P2|STARTED|Overall Study||729
4944857|NCT02949011|12162290|P1|STARTED|Overall Study||730
4944858|NCT02948634|12162360|P2|NOT COMPLETED|Overall Study||2
4944859|NCT02948634|12162361|P1|NOT COMPLETED|Overall Study||10
4944860|NCT02948634|12162360|P2|COMPLETED|Overall Study||9
4944861|NCT02948634|12162361|P1|COMPLETED|Overall Study||7
4944862|NCT02948634|12162360|P2|STARTED|Overall Study||11
4944863|NCT02948634|12162361|P1|STARTED|Overall Study||17
4944864|NCT02948582|12162371|P6|NOT COMPLETED|Wshout Period 6||0
4944865|NCT02948582|12162372|P5|NOT COMPLETED|Wshout Period 6||0
4944866|NCT02948582|12162373|P4|NOT COMPLETED|Wshout Period 6||0
4944867|NCT02948582|12162374|P3|NOT COMPLETED|Wshout Period 6||0
4944868|NCT02948582|12162375|P2|NOT COMPLETED|Wshout Period 6||0
4944869|NCT02948582|12162376|P1|NOT COMPLETED|Wshout Period 6||0
4944870|NCT02948582|12162371|P6|COMPLETED|Wshout Period 6||6
4944871|NCT02948582|12162372|P5|COMPLETED|Wshout Period 6||7
4944872|NCT02948582|12162373|P4|COMPLETED|Wshout Period 6||6
4944873|NCT02948582|12162374|P3|COMPLETED|Wshout Period 6||6
4944874|NCT02948582|12162375|P2|COMPLETED|Wshout Period 6||4
4944875|NCT02948582|12162376|P1|COMPLETED|Wshout Period 6||6
4944876|NCT02948582|12162371|P6|STARTED|Wshout Period 6||6
4944877|NCT02948582|12162372|P5|STARTED|Wshout Period 6||7
4944878|NCT02948582|12162373|P4|STARTED|Wshout Period 6||6
4944879|NCT02948582|12162374|P3|STARTED|Wshout Period 6||6
4944880|NCT02948582|12162375|P2|STARTED|Wshout Period 6||4
4944881|NCT02948582|12162376|P1|STARTED|Wshout Period 6||6
4944882|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 6||0
4944883|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 6||0
4944884|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 6||0
4944885|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 6||0
4944886|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 6||0
4944887|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 6||0
4944888|NCT02948582|12162371|P6|COMPLETED|Treatment Period 6||6
4944889|NCT02948582|12162372|P5|COMPLETED|Treatment Period 6||7
4944890|NCT02948582|12162373|P4|COMPLETED|Treatment Period 6||6
4944891|NCT02948582|12162374|P3|COMPLETED|Treatment Period 6||6
4944892|NCT02948582|12162375|P2|COMPLETED|Treatment Period 6||4
4944893|NCT02948582|12162376|P1|COMPLETED|Treatment Period 6||6
4944894|NCT02948582|12162371|P6|STARTED|Treatment Period 6||6
4944895|NCT02948582|12162372|P5|STARTED|Treatment Period 6||7
4944896|NCT02948582|12162373|P4|STARTED|Treatment Period 6||6
4944897|NCT02948582|12162374|P3|STARTED|Treatment Period 6||6
4944898|NCT02948582|12162375|P2|STARTED|Treatment Period 6||4
4944899|NCT02948582|12162376|P1|STARTED|Treatment Period 6||6
4944900|NCT02948582|12162371|P6|NOT COMPLETED|Washout Period 5||0
4944901|NCT02948582|12162372|P5|NOT COMPLETED|Washout Period 5||0
4944902|NCT02948582|12162373|P4|NOT COMPLETED|Washout Period 5||0
4944903|NCT02948582|12162374|P3|NOT COMPLETED|Washout Period 5||0
4944904|NCT02948582|12162375|P2|NOT COMPLETED|Washout Period 5||0
4944905|NCT02948582|12162376|P1|NOT COMPLETED|Washout Period 5||0
4944906|NCT02948582|12162371|P6|COMPLETED|Washout Period 5||6
4944907|NCT02948582|12162372|P5|COMPLETED|Washout Period 5||7
4944908|NCT02948582|12162373|P4|COMPLETED|Washout Period 5||6
4944909|NCT02948582|12162374|P3|COMPLETED|Washout Period 5||6
4944910|NCT02948582|12162375|P2|COMPLETED|Washout Period 5||4
4944911|NCT02948582|12162376|P1|COMPLETED|Washout Period 5||6
4944912|NCT02948582|12162371|P6|STARTED|Washout Period 5||6
4944913|NCT02948582|12162372|P5|STARTED|Washout Period 5||7
4944914|NCT02948582|12162373|P4|STARTED|Washout Period 5||6
4944915|NCT02948582|12162374|P3|STARTED|Washout Period 5||6
4944916|NCT02948582|12162375|P2|STARTED|Washout Period 5||4
4944917|NCT02948582|12162376|P1|STARTED|Washout Period 5||6
4944918|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 5||0
4944919|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 5||0
4944920|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 5||0
4944921|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 5||0
4944922|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 5||0
4944923|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 5||0
4944924|NCT02948582|12162371|P6|COMPLETED|Treatment Period 5||6
4944925|NCT02948582|12162372|P5|COMPLETED|Treatment Period 5||7
4944926|NCT02948582|12162373|P4|COMPLETED|Treatment Period 5||6
4944927|NCT02948582|12162374|P3|COMPLETED|Treatment Period 5||6
4944928|NCT02948582|12162375|P2|COMPLETED|Treatment Period 5||4
4944929|NCT02948582|12162376|P1|COMPLETED|Treatment Period 5||6
4944930|NCT02948582|12162371|P6|STARTED|Treatment Period 5||6
4944931|NCT02948582|12162372|P5|STARTED|Treatment Period 5||7
4944932|NCT02948582|12162373|P4|STARTED|Treatment Period 5||6
4944933|NCT02948582|12162374|P3|STARTED|Treatment Period 5||6
4944934|NCT02948582|12162375|P2|STARTED|Treatment Period 5||4
4944935|NCT02948582|12162376|P1|STARTED|Treatment Period 5||6
4944936|NCT02948582|12162371|P6|NOT COMPLETED|Washout Period 4||0
4944937|NCT02948582|12162372|P5|NOT COMPLETED|Washout Period 4||0
4944938|NCT02948582|12162373|P4|NOT COMPLETED|Washout Period 4||0
4944939|NCT02948582|12162374|P3|NOT COMPLETED|Washout Period 4||1
4944940|NCT02948582|12162375|P2|NOT COMPLETED|Washout Period 4||0
4944941|NCT02948582|12162376|P1|NOT COMPLETED|Washout Period 4||1
4944942|NCT02948582|12162371|P6|COMPLETED|Washout Period 4||6
4944943|NCT02948582|12162372|P5|COMPLETED|Washout Period 4||7
4944944|NCT02948582|12162373|P4|COMPLETED|Washout Period 4||6
4944945|NCT02948582|12162374|P3|COMPLETED|Washout Period 4||6
4944946|NCT02948582|12162375|P2|COMPLETED|Washout Period 4||4
4944947|NCT02948582|12162376|P1|COMPLETED|Washout Period 4||6
4944948|NCT02948582|12162371|P6|STARTED|Washout Period 4||6
4944949|NCT02948582|12162372|P5|STARTED|Washout Period 4||7
4944950|NCT02948582|12162373|P4|STARTED|Washout Period 4||6
4944951|NCT02948582|12162374|P3|STARTED|Washout Period 4||7
4944952|NCT02948582|12162375|P2|STARTED|Washout Period 4||4
4944953|NCT02948582|12162376|P1|STARTED|Washout Period 4||7
4944954|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 4||0
4944955|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 4||0
4944956|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 4||0
4944957|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 4||0
4944958|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 4||0
4944959|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 4||0
4944960|NCT02948582|12162371|P6|COMPLETED|Treatment Period 4||6
4944961|NCT02948582|12162372|P5|COMPLETED|Treatment Period 4||7
4944962|NCT02948582|12162373|P4|COMPLETED|Treatment Period 4||6
4944963|NCT02948582|12162374|P3|COMPLETED|Treatment Period 4||7
4944964|NCT02948582|12162375|P2|COMPLETED|Treatment Period 4||4
4944965|NCT02948582|12162376|P1|COMPLETED|Treatment Period 4||7
4944966|NCT02948582|12162371|P6|STARTED|Treatment Period 4||6
4944967|NCT02948582|12162372|P5|STARTED|Treatment Period 4||7
4944968|NCT02948582|12162373|P4|STARTED|Treatment Period 4||6
4944969|NCT02948582|12162374|P3|STARTED|Treatment Period 4||7
4944970|NCT02948582|12162375|P2|STARTED|Treatment Period 4||4
4944971|NCT02948582|12162376|P1|STARTED|Treatment Period 4||7
4944972|NCT02948582|12162371|P6|NOT COMPLETED|Washout Period 3||0
4944973|NCT02948582|12162372|P5|NOT COMPLETED|Washout Period 3||0
4944974|NCT02948582|12162373|P4|NOT COMPLETED|Washout Period 3||0
4944975|NCT02948582|12162374|P3|NOT COMPLETED|Washout Period 3||0
4944976|NCT02948582|12162375|P2|NOT COMPLETED|Washout Period 3||0
4944977|NCT02948582|12162376|P1|NOT COMPLETED|Washout Period 3||0
4944978|NCT02948582|12162371|P6|COMPLETED|Washout Period 3||6
4944979|NCT02948582|12162372|P5|COMPLETED|Washout Period 3||7
4944980|NCT02948582|12162373|P4|COMPLETED|Washout Period 3||6
4944981|NCT02948582|12162374|P3|COMPLETED|Washout Period 3||7
4944982|NCT02948582|12162375|P2|COMPLETED|Washout Period 3||4
4944983|NCT02948582|12162376|P1|COMPLETED|Washout Period 3||7
4944984|NCT02948582|12162371|P6|STARTED|Washout Period 3||6
4944985|NCT02948582|12162372|P5|STARTED|Washout Period 3||7
4944986|NCT02948582|12162373|P4|STARTED|Washout Period 3||6
4944987|NCT02948582|12162374|P3|STARTED|Washout Period 3||7
4944988|NCT02948582|12162375|P2|STARTED|Washout Period 3||4
4944989|NCT02948582|12162376|P1|STARTED|Washout Period 3||7
4944990|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 3||0
4944991|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 3||0
4944992|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 3||0
4944993|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 3||0
4944994|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 3||0
4944995|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 3||0
4944996|NCT02948582|12162371|P6|COMPLETED|Treatment Period 3||6
4944997|NCT02948582|12162372|P5|COMPLETED|Treatment Period 3||7
4944998|NCT02948582|12162373|P4|COMPLETED|Treatment Period 3||6
4944999|NCT02948582|12162374|P3|COMPLETED|Treatment Period 3||7
4945000|NCT02948582|12162375|P2|COMPLETED|Treatment Period 3||4
4945001|NCT02948582|12162376|P1|COMPLETED|Treatment Period 3||7
4945002|NCT02948582|12162371|P6|STARTED|Treatment Period 3||6
4945003|NCT02948582|12162372|P5|STARTED|Treatment Period 3||7
4945004|NCT02948582|12162373|P4|STARTED|Treatment Period 3||6
4945005|NCT02948582|12162374|P3|STARTED|Treatment Period 3||7
4945006|NCT02948582|12162375|P2|STARTED|Treatment Period 3||4
4945007|NCT02948582|12162376|P1|STARTED|Treatment Period 3||7
4945008|NCT02948582|12162371|P6|NOT COMPLETED|Washout Period 2||0
4945009|NCT02948582|12162372|P5|NOT COMPLETED|Washout Period 2||0
4945010|NCT02948582|12162373|P4|NOT COMPLETED|Washout Period 2||1
4945011|NCT02948582|12162374|P3|NOT COMPLETED|Washout Period 2||0
4945012|NCT02948582|12162375|P2|NOT COMPLETED|Washout Period 2||1
4945013|NCT02948582|12162376|P1|NOT COMPLETED|Washout Period 2||0
4945014|NCT02948582|12162371|P6|COMPLETED|Washout Period 2||6
4945015|NCT02948582|12162372|P5|COMPLETED|Washout Period 2||7
4945016|NCT02948582|12162373|P4|COMPLETED|Washout Period 2||6
4945017|NCT02948582|12162374|P3|COMPLETED|Washout Period 2||7
4945018|NCT02948582|12162375|P2|COMPLETED|Washout Period 2||4
4945019|NCT02948582|12162376|P1|COMPLETED|Washout Period 2||7
4945020|NCT02948582|12162371|P6|STARTED|Washout Period 2||6
4945021|NCT02948582|12162372|P5|STARTED|Washout Period 2||7
4945022|NCT02948582|12162373|P4|STARTED|Washout Period 2||7
4945023|NCT02948582|12162374|P3|STARTED|Washout Period 2||7
4945024|NCT02948582|12162375|P2|STARTED|Washout Period 2||5
4945025|NCT02948582|12162376|P1|STARTED|Washout Period 2||7
4945026|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 2||0
4945027|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 2||0
4945028|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 2||0
4945029|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 2||0
4945030|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 2||0
4945031|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 2||0
4945032|NCT02948582|12162371|P6|COMPLETED|Treatment Period 2||6
4945033|NCT02948582|12162372|P5|COMPLETED|Treatment Period 2||7
4945034|NCT02948582|12162373|P4|COMPLETED|Treatment Period 2||7
4945035|NCT02948582|12162374|P3|COMPLETED|Treatment Period 2||7
4945036|NCT02948582|12162375|P2|COMPLETED|Treatment Period 2||5
4945037|NCT02948582|12162376|P1|COMPLETED|Treatment Period 2||7
4945038|NCT02948582|12162371|P6|STARTED|Treatment Period 2||6
4945039|NCT02948582|12162372|P5|STARTED|Treatment Period 2||7
4945040|NCT02948582|12162373|P4|STARTED|Treatment Period 2||7
4945041|NCT02948582|12162374|P3|STARTED|Treatment Period 2||7
4945042|NCT02948582|12162375|P2|STARTED|Treatment Period 2||5
4945043|NCT02948582|12162376|P1|STARTED|Treatment Period 2||7
4945044|NCT02948582|12162371|P6|NOT COMPLETED|Washout Period 1||1
4945045|NCT02948582|12162372|P5|NOT COMPLETED|Washout Period 1||0
4945046|NCT02948582|12162373|P4|NOT COMPLETED|Washout Period 1||0
4945047|NCT02948582|12162374|P3|NOT COMPLETED|Washout Period 1||0
4945048|NCT02948582|12162375|P2|NOT COMPLETED|Washout Period 1||2
4945049|NCT02948582|12162376|P1|NOT COMPLETED|Washout Period 1||0
4945050|NCT02948582|12162371|P6|COMPLETED|Washout Period 1||6
4945051|NCT02948582|12162372|P5|COMPLETED|Washout Period 1||7
4945052|NCT02948582|12162373|P4|COMPLETED|Washout Period 1||7
4945053|NCT02948582|12162374|P3|COMPLETED|Washout Period 1||7
4945054|NCT02948582|12162375|P2|COMPLETED|Washout Period 1||5
4945055|NCT02948582|12162376|P1|COMPLETED|Washout Period 1||7
4945056|NCT02948582|12162371|P6|STARTED|Washout Period 1||7
4945057|NCT02948582|12162372|P5|STARTED|Washout Period 1||7
4945058|NCT02948582|12162373|P4|STARTED|Washout Period 1||7
4945059|NCT02948582|12162374|P3|STARTED|Washout Period 1||7
4945060|NCT02948582|12162375|P2|STARTED|Washout Period 1||7
4945061|NCT02948582|12162376|P1|STARTED|Washout Period 1||7
4945062|NCT02948582|12162371|P6|NOT COMPLETED|Treatment Period 1||0
4945063|NCT02948582|12162372|P5|NOT COMPLETED|Treatment Period 1||0
4945064|NCT02948582|12162373|P4|NOT COMPLETED|Treatment Period 1||0
4945065|NCT02948582|12162374|P3|NOT COMPLETED|Treatment Period 1||0
4945066|NCT02948582|12162375|P2|NOT COMPLETED|Treatment Period 1||0
4945067|NCT02948582|12162376|P1|NOT COMPLETED|Treatment Period 1||0
4945068|NCT02948582|12162371|P6|COMPLETED|Treatment Period 1||7
4945069|NCT02948582|12162372|P5|COMPLETED|Treatment Period 1||7
4945070|NCT02948582|12162373|P4|COMPLETED|Treatment Period 1||7
4945071|NCT02948582|12162374|P3|COMPLETED|Treatment Period 1||7
4945072|NCT02948582|12162375|P2|COMPLETED|Treatment Period 1||7
4945073|NCT02948582|12162376|P1|COMPLETED|Treatment Period 1||7
4945074|NCT02948582|12162371|P6|STARTED|Treatment Period 1||7
4945075|NCT02948582|12162372|P5|STARTED|Treatment Period 1||7
4945076|NCT02948582|12162373|P4|STARTED|Treatment Period 1||7
4945077|NCT02948582|12162374|P3|STARTED|Treatment Period 1||7
4945078|NCT02948582|12162375|P2|STARTED|Treatment Period 1||7
4945079|NCT02948582|12162376|P1|STARTED|Treatment Period 1||7
4945080|NCT02948257|12162469|P1|NOT COMPLETED|Overall Study||0
4945081|NCT02948257|12162469|P1|COMPLETED|Overall Study||52
4945082|NCT02948257|12162469|P1|STARTED|Overall Study||52
4945083|NCT02947997|12162479|P1|NOT COMPLETED|Overall Study||0
4945084|NCT02947997|12162479|P1|COMPLETED|Overall Study||4
4945085|NCT02947997|12162479|P1|STARTED|Overall Study||4
4945086|NCT02947984|12162485|P2|NOT COMPLETED|Overall Study||0
4945087|NCT02947984|12162486|P1|NOT COMPLETED|Overall Study||0
4945088|NCT02947984|12162485|P2|COMPLETED|Overall Study||22
4945089|NCT02947984|12162486|P1|COMPLETED|Overall Study||22
4945090|NCT02947984|12162485|P2|STARTED|Overall Study||22
4945091|NCT02947984|12162486|P1|STARTED|Overall Study||22
4945092|NCT02947022|12162498|P1|NOT COMPLETED|Overall Study||1
4945093|NCT02947022|12162498|P1|COMPLETED|Overall Study||0
4945094|NCT02947022|12162498|P1|STARTED|Overall Study||1
4945095|NCT02946580|12162519|P2|NOT COMPLETED|Overall Study||5
4945096|NCT02946580|12162520|P1|NOT COMPLETED|Overall Study||1
4945097|NCT02946580|12162519|P2|COMPLETED|Overall Study||20
4945098|NCT02946580|12162520|P1|COMPLETED|Overall Study||27
4945099|NCT02946580|12162519|P2|STARTED|Overall Study||25
4945100|NCT02946580|12162520|P1|STARTED|Overall Study||28
4945101|NCT02946515|12162538|P2|NOT COMPLETED|Overall Study||1
4945102|NCT02946515|12162539|P1|NOT COMPLETED|Overall Study||2
4945103|NCT02946515|12162538|P2|COMPLETED|Overall Study||21
4945104|NCT02946515|12162539|P1|COMPLETED|Overall Study||20
4945105|NCT02946515|12162538|P2|STARTED|Overall Study||22
4945106|NCT02946515|12162539|P1|STARTED|Overall Study||22
4945107|NCT02946489|12162545|P1|NOT COMPLETED|Overall Study||0
4945108|NCT02946489|12162545|P1|COMPLETED|Overall Study||8
4945109|NCT02946489|12162545|P1|STARTED|Overall Study||8
4945110|NCT02946463|12162552|P2|NOT COMPLETED|Extension Period||119
4945111|NCT02946463|12162553|P1|NOT COMPLETED|Extension Period||124
4945112|NCT02946463|12162552|P2|COMPLETED|Extension Period||0
4945113|NCT02946463|12162553|P1|COMPLETED|Extension Period||0
4945114|NCT02946463|12162552|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
4945115|NCT02946463|12162553|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
4945116|NCT02946463|12162552|P2|STARTED|Extension Period||119
4945117|NCT02946463|12162553|P1|STARTED|Extension Period||124
4945118|NCT02946463|12162552|P2|NOT COMPLETED|Primary Evaluation Period||2
4945119|NCT02946463|12162553|P1|NOT COMPLETED|Primary Evaluation Period||0
4945120|NCT02946463|12162552|P2|COMPLETED|Primary Evaluation Period||119
4945121|NCT02946463|12162553|P1|COMPLETED|Primary Evaluation Period||125
4945122|NCT02946463|12162552|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
4945123|NCT02946463|12162553|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
4945124|NCT02946463|12162552|P2|STARTED|Primary Evaluation Period||121
4945125|NCT02946463|12162553|P1|STARTED|Primary Evaluation Period||125
4945126|NCT02946385|12162575|P6|NOT COMPLETED|Overall Study||1
4945127|NCT02946385|12162576|P5|NOT COMPLETED|Overall Study||2
4945128|NCT02946385|12162577|P4|NOT COMPLETED|Overall Study||0
4945129|NCT02946385|12162578|P3|NOT COMPLETED|Overall Study||3
4945130|NCT02946385|12162579|P2|NOT COMPLETED|Overall Study||0
4945131|NCT02946385|12162580|P1|NOT COMPLETED|Overall Study||0
4945132|NCT02946385|12162575|P6|COMPLETED|Overall Study||76
4945133|NCT02946385|12162576|P5|COMPLETED|Overall Study||99
4945134|NCT02946385|12162577|P4|COMPLETED|Overall Study||74
4945135|NCT02946385|12162578|P3|COMPLETED|Overall Study||96
4945136|NCT02946385|12162579|P2|COMPLETED|Overall Study||127
4945137|NCT02946385|12162580|P1|COMPLETED|Overall Study||126
4945138|NCT02946385|12162575|P6|STARTED|Overall Study||77
4945139|NCT02946385|12162576|P5|STARTED|Overall Study||101
4945140|NCT02946385|12162577|P4|STARTED|Overall Study||74
4945141|NCT02946385|12162578|P3|STARTED|Overall Study||99
4945142|NCT02946385|12162579|P2|STARTED|Overall Study||127
4945143|NCT02946385|12162580|P1|STARTED|Overall Study||126
4945144|NCT02946229|12162664|P1|NOT COMPLETED|Overall Study||0
4945145|NCT02946229|12162664|P1|COMPLETED|Overall Study||142
4945146|NCT02946229|12162664|P1|STARTED|Overall Study||142
4945147|NCT02946021|12162670|P2|NOT COMPLETED|Overall Study||0
4945148|NCT02946021|12162671|P1|NOT COMPLETED|Overall Study||0
4945149|NCT02946021|12162670|P2|COMPLETED|Overall Study||5
4945150|NCT02946021|12162671|P1|COMPLETED|Overall Study||6
4945151|NCT02946021|12162670|P2|STARTED|Overall Study||5
4945152|NCT02946021|12162671|P1|STARTED|Overall Study||6
4945153|NCT02945657|12162683|P1|NOT COMPLETED|Overall Study||4
4945154|NCT02945657|12162683|P1|COMPLETED|Overall Study||28
4945155|NCT02945657|12162683|P1|STARTED|Overall Study||32
4945156|NCT02945410|12162706|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
4945157|NCT02945410|12162707|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
4945158|NCT02945410|12162708|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
4945159|NCT02945410|12162709|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
4945160|NCT02945410|12162710|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
4945161|NCT02945410|12162711|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
4945162|NCT02945410|12162706|P6|COMPLETED|Intervention 3 (5 Days)||0
4945163|NCT02945410|12162707|P5|COMPLETED|Intervention 3 (5 Days)||1
4945164|NCT02945410|12162708|P4|COMPLETED|Intervention 3 (5 Days)||3
4945165|NCT02945410|12162709|P3|COMPLETED|Intervention 3 (5 Days)||0
4945166|NCT02945410|12162710|P2|COMPLETED|Intervention 3 (5 Days)||1
4945167|NCT02945410|12162711|P1|COMPLETED|Intervention 3 (5 Days)||2
4945168|NCT02945410|12162706|P6|STARTED|Intervention 3 (5 Days)||0
4945169|NCT02945410|12162707|P5|STARTED|Intervention 3 (5 Days)||1
4945170|NCT02945410|12162708|P4|STARTED|Intervention 3 (5 Days)||3
4945171|NCT02945410|12162709|P3|STARTED|Intervention 3 (5 Days)||0
4945172|NCT02945410|12162710|P2|STARTED|Intervention 3 (5 Days)||1
4945173|NCT02945410|12162711|P1|STARTED|Intervention 3 (5 Days)||2
4945174|NCT02945410|12162706|P6|NOT COMPLETED|Washout 2 (14 Days)||0
4945175|NCT02945410|12162707|P5|NOT COMPLETED|Washout 2 (14 Days)||0
4945176|NCT02945410|12162708|P4|NOT COMPLETED|Washout 2 (14 Days)||0
4945177|NCT02945410|12162709|P3|NOT COMPLETED|Washout 2 (14 Days)||0
4945178|NCT02945410|12162710|P2|NOT COMPLETED|Washout 2 (14 Days)||0
4945179|NCT02945410|12162711|P1|NOT COMPLETED|Washout 2 (14 Days)||0
4945180|NCT02945410|12162706|P6|COMPLETED|Washout 2 (14 Days)||0
4945181|NCT02945410|12162707|P5|COMPLETED|Washout 2 (14 Days)||1
4945182|NCT02945410|12162708|P4|COMPLETED|Washout 2 (14 Days)||3
4945183|NCT02945410|12162709|P3|COMPLETED|Washout 2 (14 Days)||0
4945184|NCT02945410|12162710|P2|COMPLETED|Washout 2 (14 Days)||1
4945185|NCT02945410|12162711|P1|COMPLETED|Washout 2 (14 Days)||2
4945186|NCT02945410|12162706|P6|STARTED|Washout 2 (14 Days)||0
4945187|NCT02945410|12162707|P5|STARTED|Washout 2 (14 Days)||1
4945188|NCT02945410|12162708|P4|STARTED|Washout 2 (14 Days)||3
4945189|NCT02945410|12162709|P3|STARTED|Washout 2 (14 Days)||0
4945190|NCT02945410|12162710|P2|STARTED|Washout 2 (14 Days)||1
4945191|NCT02945410|12162711|P1|STARTED|Washout 2 (14 Days)||2
4945192|NCT02945410|12162706|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
4945193|NCT02945410|12162707|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
4945194|NCT02945410|12162708|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
4945195|NCT02945410|12162709|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
4945196|NCT02945410|12162710|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
4945197|NCT02945410|12162711|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
4945198|NCT02945410|12162706|P6|COMPLETED|Intervention 2 (5 Days)||0
4945199|NCT02945410|12162707|P5|COMPLETED|Intervention 2 (5 Days)||1
4945200|NCT02945410|12162708|P4|COMPLETED|Intervention 2 (5 Days)||3
4945201|NCT02945410|12162709|P3|COMPLETED|Intervention 2 (5 Days)||0
4945202|NCT02945410|12162710|P2|COMPLETED|Intervention 2 (5 Days)||1
4945203|NCT02945410|12162711|P1|COMPLETED|Intervention 2 (5 Days)||2
4945204|NCT02945410|12162706|P6|STARTED|Intervention 2 (5 Days)||0
4945205|NCT02945410|12162707|P5|STARTED|Intervention 2 (5 Days)||1
4945206|NCT02945410|12162708|P4|STARTED|Intervention 2 (5 Days)||3
4945207|NCT02945410|12162709|P3|STARTED|Intervention 2 (5 Days)||0
4945208|NCT02945410|12162710|P2|STARTED|Intervention 2 (5 Days)||1
4945209|NCT02945410|12162711|P1|STARTED|Intervention 2 (5 Days)||2
4945210|NCT02945410|12162706|P6|NOT COMPLETED|Washout 1 (14 Days)||0
4945211|NCT02945410|12162707|P5|NOT COMPLETED|Washout 1 (14 Days)||1
4945212|NCT02945410|12162708|P4|NOT COMPLETED|Washout 1 (14 Days)||0
4945213|NCT02945410|12162709|P3|NOT COMPLETED|Washout 1 (14 Days)||2
4945214|NCT02945410|12162710|P2|NOT COMPLETED|Washout 1 (14 Days)||0
4945215|NCT02945410|12162711|P1|NOT COMPLETED|Washout 1 (14 Days)||0
4945216|NCT02945410|12162706|P6|COMPLETED|Washout 1 (14 Days)||0
4945217|NCT02945410|12162707|P5|COMPLETED|Washout 1 (14 Days)||1
4945218|NCT02945410|12162708|P4|COMPLETED|Washout 1 (14 Days)||3
4945219|NCT02945410|12162709|P3|COMPLETED|Washout 1 (14 Days)||0
4945220|NCT02945410|12162710|P2|COMPLETED|Washout 1 (14 Days)||1
4945221|NCT02945410|12162711|P1|COMPLETED|Washout 1 (14 Days)||2
4945222|NCT02945410|12162706|P6|STARTED|Washout 1 (14 Days)||0
4945223|NCT02945410|12162707|P5|STARTED|Washout 1 (14 Days)||2
4945224|NCT02945410|12162708|P4|STARTED|Washout 1 (14 Days)||3
4945225|NCT02945410|12162709|P3|STARTED|Washout 1 (14 Days)||2
4945226|NCT02945410|12162710|P2|STARTED|Washout 1 (14 Days)||1
4945227|NCT02945410|12162711|P1|STARTED|Washout 1 (14 Days)||2
4945228|NCT02945410|12162706|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
4945229|NCT02945410|12162707|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
4945230|NCT02945410|12162708|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
4945231|NCT02945410|12162709|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
4945232|NCT02945410|12162710|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
4945233|NCT02945410|12162711|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
4945234|NCT02945410|12162706|P6|COMPLETED|Intervention 1 (5 Days)||0
4945235|NCT02945410|12162707|P5|COMPLETED|Intervention 1 (5 Days)||2
4945236|NCT02945410|12162708|P4|COMPLETED|Intervention 1 (5 Days)||3
4945237|NCT02945410|12162709|P3|COMPLETED|Intervention 1 (5 Days)||2
4945238|NCT02945410|12162710|P2|COMPLETED|Intervention 1 (5 Days)||1
4945239|NCT02945410|12162711|P1|COMPLETED|Intervention 1 (5 Days)||2
4945240|NCT02945410|12162706|P6|STARTED|Intervention 1 (5 Days)||1
4945241|NCT02945410|12162707|P5|STARTED|Intervention 1 (5 Days)||2
4945242|NCT02945410|12162708|P4|STARTED|Intervention 1 (5 Days)||3
4945243|NCT02945410|12162709|P3|STARTED|Intervention 1 (5 Days)||2
4945244|NCT02945410|12162710|P2|STARTED|Intervention 1 (5 Days)||4
4945245|NCT02945410|12162711|P1|STARTED|Intervention 1 (5 Days)||3
4945246|NCT02945254|12162742|P2|NOT COMPLETED|Overall Study||0
4945247|NCT02945254|12162743|P1|NOT COMPLETED|Overall Study||2
4945248|NCT02945254|12162742|P2|COMPLETED|Overall Study||10
4945249|NCT02945254|12162743|P1|COMPLETED|Overall Study||8
4945250|NCT02945254|12162742|P2|STARTED|Overall Study||10
4945251|NCT02945254|12162743|P1|STARTED|Overall Study||10
4945252|NCT02945150|12162751|P1|NOT COMPLETED|Overall Study||0
4945253|NCT02945150|12162751|P1|COMPLETED|Overall Study||8
4945254|NCT02945150|12162751|P1|SVR12|Overall Study||8
4945255|NCT02945150|12162751|P1|STARTED|Overall Study||8
4945256|NCT02945046|12162759|P3|NOT COMPLETED|Overall Study||15
4945257|NCT02945046|12162760|P2|NOT COMPLETED|Overall Study||13
4945258|NCT02945046|12162761|P1|NOT COMPLETED|Overall Study||13
4945259|NCT02945046|12162759|P3|COMPLETED|Overall Study||40
4945260|NCT02945046|12162760|P2|COMPLETED|Overall Study||42
4945261|NCT02945046|12162761|P1|COMPLETED|Overall Study||46
4945262|NCT02945046|12162759|P3|Full Analysis Set|Overall Study||55
4945263|NCT02945046|12162760|P2|Full Analysis Set|Overall Study||53
4945264|NCT02945046|12162761|P1|Full Analysis Set|Overall Study||57
4945265|NCT02945046|12162759|P3|Safety Analysis Set|Overall Study||55
4945266|NCT02945046|12162760|P2|Safety Analysis Set|Overall Study||55
4945267|NCT02945046|12162761|P1|Safety Analysis Set|Overall Study||59
4945268|NCT02945046|12162759|P3|STARTED|Overall Study||55
4945269|NCT02945046|12162760|P2|STARTED|Overall Study||55
4945270|NCT02945046|12162761|P1|STARTED|Overall Study||59
4945271|NCT02944968|12162814|P1|NOT COMPLETED|Overall Study||3
4945272|NCT02944968|12162814|P1|COMPLETED|Overall Study||48
4945273|NCT02944968|12162814|P1|STARTED|Overall Study||51
4945274|NCT02944656|12162821|P2|NOT COMPLETED|Overall Study||10
4945275|NCT02944656|12162822|P1|NOT COMPLETED|Overall Study||10
4945276|NCT02944656|12162821|P2|COMPLETED|Overall Study||47
4945277|NCT02944656|12162822|P1|COMPLETED|Overall Study||47
4945278|NCT02944656|12162821|P2|Completed Day 1 Follow up|Overall Study||47
4945279|NCT02944656|12162822|P1|Completed Day 1 Follow up|Overall Study||47
4945280|NCT02944656|12162821|P2|Completed Procedure Day|Overall Study||57
4945281|NCT02944656|12162822|P1|Completed Procedure Day|Overall Study||54
4945282|NCT02944656|12162821|P2|STARTED|Overall Study||57
4945283|NCT02944656|12162822|P1|STARTED|Overall Study||57
4945284|NCT02944565|12162850|P1|NOT COMPLETED|Overall Study||0
4945285|NCT02944565|12162850|P1|COMPLETED|Overall Study||28
4945286|NCT02944565|12162850|P1|STARTED|Overall Study||28
4945287|NCT02944513|12162858|P2|NOT COMPLETED|Overall Study||1
4945288|NCT02944513|12162859|P1|NOT COMPLETED|Overall Study||4
4945289|NCT02944513|12162858|P2|COMPLETED|Overall Study||32
4945290|NCT02944513|12162859|P1|COMPLETED|Overall Study||31
4945291|NCT02944513|12162858|P2|STARTED|Overall Study||33
4945292|NCT02944513|12162859|P1|STARTED|Overall Study||35
4945293|NCT02944461|12162875|P1|NOT COMPLETED|Overall Study||5
4945294|NCT02944461|12162875|P1|COMPLETED|Overall Study||15
4945295|NCT02944461|12162875|P1|STARTED|Overall Study||20
4945296|NCT02944383|12162885|P3|NOT COMPLETED|Overall Study||1
4945297|NCT02944383|12162886|P2|NOT COMPLETED|Overall Study||0
4945298|NCT02944383|12162887|P1|NOT COMPLETED|Overall Study||1
4945299|NCT02944383|12162885|P3|COMPLETED|Overall Study||30
4945300|NCT02944383|12162886|P2|COMPLETED|Overall Study||30
4945301|NCT02944383|12162887|P1|COMPLETED|Overall Study||29
4945302|NCT02944383|12162885|P3|STARTED|Overall Study||31
4945303|NCT02944383|12162886|P2|STARTED|Overall Study||30
4945304|NCT02944383|12162887|P1|STARTED|Overall Study||30
4945305|NCT02943941|12163042|P1|NOT COMPLETED|Overall Study||0
4945306|NCT02943941|12163042|P1|COMPLETED|Overall Study||16
4945307|NCT02943941|12163042|P1|STARTED|Overall Study||16
4945308|NCT02943668|12163048|P1|NOT COMPLETED|Overall Study||1
4945309|NCT02943668|12163048|P1|COMPLETED|Overall Study||1
4945310|NCT02943668|12163048|P1|STARTED|Overall Study||2
4945311|NCT02943577|12163059|P2|NOT COMPLETED|Overall Study||5
4945312|NCT02943577|12163060|P1|NOT COMPLETED|Overall Study||5
4945313|NCT02943577|12163059|P2|COMPLETED|Overall Study||201
4945314|NCT02943577|12163060|P1|COMPLETED|Overall Study||204
4945315|NCT02943577|12163059|P2|STARTED|Overall Study||206
4945316|NCT02943577|12163060|P1|STARTED|Overall Study||209
4945317|NCT02943564|12163075|P3|NOT COMPLETED|Overall Study||9
4945318|NCT02943564|12163076|P2|NOT COMPLETED|Overall Study||13
4945319|NCT02943564|12163077|P1|NOT COMPLETED|Overall Study||10
4945320|NCT02943564|12163075|P3|COMPLETED|Overall Study||201
4945321|NCT02943564|12163076|P2|COMPLETED|Overall Study||198
4945322|NCT02943564|12163077|P1|COMPLETED|Overall Study||207
4945323|NCT02943564|12163075|P3|Non-Responder|Overall Study||133
4945324|NCT02943564|12163076|P2|Non-Responder|Overall Study||134
4945325|NCT02943564|12163077|P1|Non-Responder|Overall Study||134
4945326|NCT02943564|12163075|P3|Responder|Overall Study||77
4945327|NCT02943564|12163076|P2|Responder|Overall Study||77
4945328|NCT02943564|12163077|P1|Responder|Overall Study||83
4945329|NCT02943564|12163075|P3|STARTED|Overall Study||210
4945330|NCT02943564|12163076|P2|STARTED|Overall Study||211
4945331|NCT02943564|12163077|P1|STARTED|Overall Study||217
4945332|NCT02943499|12163090|P2|NOT COMPLETED|Overall Study||5
4945333|NCT02943499|12163091|P1|NOT COMPLETED|Overall Study||7
4945334|NCT02943499|12163090|P2|COMPLETED|Overall Study||34
4945335|NCT02943499|12163091|P1|COMPLETED|Overall Study||34
4945336|NCT02943499|12163090|P2|STARTED|Overall Study||39
4945337|NCT02943499|12163091|P1|STARTED|Overall Study||41
4945338|NCT02943460|12163100|P3|NOT COMPLETED|Open Label Extension (OLE)||9
4945339|NCT02943460|12163101|P2|NOT COMPLETED|Open Label Extension (OLE)||18
4945340|NCT02943460|12163102|P1|NOT COMPLETED|Open Label Extension (OLE)||19
4945341|NCT02943460|12163100|P3|COMPLETED|Open Label Extension (OLE)||0
4945342|NCT02943460|12163101|P2|COMPLETED|Open Label Extension (OLE)||0
4945343|NCT02943460|12163102|P1|COMPLETED|Open Label Extension (OLE)||0
4945344|NCT02943460|12163100|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
4945345|NCT02943460|12163101|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
4945346|NCT02943460|12163102|P1|STARTED|Open Label Extension (OLE)||19
4945347|NCT02943460|12163100|P3|NOT COMPLETED|Blinded Study||0
4945348|NCT02943460|12163101|P2|NOT COMPLETED|Blinded Study||1
4945349|NCT02943460|12163102|P1|NOT COMPLETED|Blinded Study||3
4945350|NCT02943460|12163100|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
4945351|NCT02943460|12163101|P2|COMPLETED|Blinded Study||19
4945352|NCT02943460|12163102|P1|COMPLETED|Blinded Study||19
4945353|NCT02943460|12163100|P3|STARTED|Blinded Study||10
4945354|NCT02943460|12163101|P2|STARTED|Blinded Study||20
4945355|NCT02943460|12163102|P1|STARTED|Blinded Study||22
4945356|NCT02943447|12163120|P3|NOT COMPLETED|Overall Study||13
4945357|NCT02943447|12163121|P2|NOT COMPLETED|Overall Study||30
4945358|NCT02943447|12163122|P1|NOT COMPLETED|Overall Study||28
4945359|NCT02943447|12163120|P3|COMPLETED|Overall Study||0
4945360|NCT02943447|12163121|P2|COMPLETED|Overall Study||0
4945361|NCT02943447|12163122|P1|COMPLETED|Overall Study||0
4945362|NCT02943447|12163120|P3|STARTED|Overall Study||13
4945363|NCT02943447|12163121|P2|STARTED|Overall Study||30
4945364|NCT02943447|12163122|P1|STARTED|Overall Study||28
4945365|NCT02943226|12163144|P2|NOT COMPLETED|Overall Study||0
4945366|NCT02943226|12163145|P1|NOT COMPLETED|Overall Study||0
4945367|NCT02943226|12163144|P2|COMPLETED|Overall Study||30
4945368|NCT02943226|12163145|P1|COMPLETED|Overall Study||31
4945369|NCT02943226|12163144|P2|STARTED|Overall Study||30
4945370|NCT02943226|12163145|P1|STARTED|Overall Study||31
4945371|NCT02943213|12163161|P1|NOT COMPLETED|Treatment Period 2||0
4945372|NCT02943213|12163161|P1|COMPLETED|Treatment Period 2||20
4945373|NCT02943213|12163161|P1|STARTED|Treatment Period 2||20
4945374|NCT02943213|12163161|P1|NOT COMPLETED|Treatment Period 1||0
4945375|NCT02943213|12163161|P1|COMPLETED|Treatment Period 1||20
4945376|NCT02943213|12163161|P1|STARTED|Treatment Period 1||20
4945377|NCT02943096|12163191|P2|NOT COMPLETED|Overall Study||1
4945378|NCT02943096|12163192|P1|NOT COMPLETED|Overall Study||0
4945379|NCT02943096|12163191|P2|COMPLETED|Overall Study||2
4945380|NCT02943096|12163192|P1|COMPLETED|Overall Study||3
4945381|NCT02943096|12163191|P2|STARTED|Overall Study||3
4945382|NCT02943096|12163192|P1|STARTED|Overall Study||3
4945383|NCT02942771|12163211|P5|NOT COMPLETED|Overall Study||4
4945384|NCT02942771|12163212|P4|NOT COMPLETED|Overall Study||0
4945385|NCT02942771|12163213|P3|NOT COMPLETED|Overall Study||0
4945386|NCT02942771|12163214|P2|NOT COMPLETED|Overall Study||0
4945387|NCT02942771|12163215|P1|NOT COMPLETED|Overall Study||3
4945388|NCT02942771|12163211|P5|COMPLETED|Overall Study||4
4945389|NCT02942771|12163212|P4|COMPLETED|Overall Study||6
4945390|NCT02942771|12163213|P3|COMPLETED|Overall Study||6
4945391|NCT02942771|12163214|P2|COMPLETED|Overall Study||6
4945392|NCT02942771|12163215|P1|COMPLETED|Overall Study||6
4945393|NCT02942771|12163211|P5|STARTED|Overall Study||8
4945394|NCT02942771|12163212|P4|STARTED|Overall Study||6
4945395|NCT02942771|12163213|P3|STARTED|Overall Study||6
4945396|NCT02942771|12163214|P2|STARTED|Overall Study||6
4945397|NCT02942771|12163215|P1|STARTED|Overall Study||9
4945398|NCT02942654|12163257|P2|NOT COMPLETED|Period 2||0
4945399|NCT02942654|12163258|P1|NOT COMPLETED|Period 2||0
4945400|NCT02942654|12163257|P2|COMPLETED|Period 2||16
4945401|NCT02942654|12163258|P1|COMPLETED|Period 2||16
4945402|NCT02942654|12163257|P2|STARTED|Period 2||16
4945403|NCT02942654|12163258|P1|STARTED|Period 2||16
4945404|NCT02942654|12163257|P2|NOT COMPLETED|Washout||0
4945405|NCT02942654|12163258|P1|NOT COMPLETED|Washout||0
4945406|NCT02942654|12163257|P2|COMPLETED|Washout||16
4945407|NCT02942654|12163258|P1|COMPLETED|Washout||16
4945408|NCT02942654|12163257|P2|STARTED|Washout||16
4945409|NCT02942654|12163258|P1|STARTED|Washout||16
4945410|NCT02942654|12163257|P2|NOT COMPLETED|Period 1||0
4945411|NCT02942654|12163258|P1|NOT COMPLETED|Period 1||0
4945412|NCT02942654|12163257|P2|COMPLETED|Period 1||16
4945413|NCT02942654|12163258|P1|COMPLETED|Period 1||16
4945414|NCT02942654|12163257|P2|Received at Least 1 Dose of Study Drug|Period 1||16
4945415|NCT02942654|12163258|P1|Received at Least 1 Dose of Study Drug|Period 1||16
4945416|NCT02942654|12163257|P2|STARTED|Period 1||16
4945417|NCT02942654|12163258|P1|STARTED|Period 1||16
4945418|NCT02942576|12163268|P2|NOT COMPLETED|Overall Study||23
4945419|NCT02942576|12163269|P1|NOT COMPLETED|Overall Study||46
4945420|NCT02942576|12163268|P2|COMPLETED|Overall Study||174
4945421|NCT02942576|12163269|P1|COMPLETED|Overall Study||359
4945422|NCT02942576|12163268|P2|STARTED|Overall Study||197
4945423|NCT02942576|12163269|P1|STARTED|Overall Study||405
4945424|NCT02942017|12163283|P2|NOT COMPLETED|Overall Study||6
4945425|NCT02942017|12163284|P1|NOT COMPLETED|Overall Study||2
4945426|NCT02942017|12163283|P2|COMPLETED|Overall Study||48
4945427|NCT02942017|12163284|P1|COMPLETED|Overall Study||52
4945428|NCT02942017|12163283|P2|Treated|Overall Study||51
4945429|NCT02942017|12163284|P1|Treated|Overall Study||53
4945430|NCT02942017|12163283|P2|STARTED|Overall Study||54
4945431|NCT02942017|12163284|P1|STARTED|Overall Study||54
4945432|NCT02942004|12163315|P3|NOT COMPLETED|Overall Study||9
4945433|NCT02942004|12163316|P2|NOT COMPLETED|Overall Study||12
4945434|NCT02942004|12163317|P1|NOT COMPLETED|Overall Study||4
4945435|NCT02942004|12163315|P3|COMPLETED|Overall Study||36
4945436|NCT02942004|12163316|P2|COMPLETED|Overall Study||35
4945437|NCT02942004|12163317|P1|COMPLETED|Overall Study||42
4945438|NCT02942004|12163315|P3|Participants Who Received Study Drug|Overall Study||41
4945439|NCT02942004|12163316|P2|Participants Who Received Study Drug|Overall Study||38
4945440|NCT02942004|12163317|P1|Participants Who Received Study Drug|Overall Study||43
4945441|NCT02942004|12163315|P3|STARTED|Overall Study||45
4945442|NCT02942004|12163316|P2|STARTED|Overall Study||47
4945443|NCT02942004|12163317|P1|STARTED|Overall Study||46
4945444|NCT02941692|12163360|P2|NOT COMPLETED|Overall Study||0
4945445|NCT02941692|12163361|P1|NOT COMPLETED|Overall Study||0
4945446|NCT02941692|12163360|P2|COMPLETED|Overall Study||34
4945447|NCT02941692|12163361|P1|COMPLETED|Overall Study||32
4945448|NCT02941692|12163360|P2|STARTED|Overall Study||34
4945449|NCT02941692|12163361|P1|STARTED|Overall Study||32
4945450|NCT02941640|12163373|P4|NOT COMPLETED|Overall Study||0
4945451|NCT02941640|12163374|P3|NOT COMPLETED|Overall Study||0
4945452|NCT02941640|12163375|P2|NOT COMPLETED|Overall Study||0
4945453|NCT02941640|12163376|P1|NOT COMPLETED|Overall Study||0
4945454|NCT02941640|12163373|P4|COMPLETED|Overall Study||30
4945455|NCT02941640|12163374|P3|COMPLETED|Overall Study||30
4945456|NCT02941640|12163375|P2|COMPLETED|Overall Study||30
4945457|NCT02941640|12163376|P1|COMPLETED|Overall Study||30
4945458|NCT02941640|12163373|P4|STARTED|Overall Study||30
4945459|NCT02941640|12163374|P3|STARTED|Overall Study||30
4945460|NCT02941640|12163375|P2|STARTED|Overall Study||30
4945461|NCT02941640|12163376|P1|STARTED|Overall Study||30
4945462|NCT02941614|12163408|P2|NOT COMPLETED|Overall Study||246
4945463|NCT02941614|12163409|P1|NOT COMPLETED|Overall Study||141
4945464|NCT02941614|12163408|P2|COMPLETED|Overall Study||446
4945465|NCT02941614|12163409|P1|COMPLETED|Overall Study||603
4945466|NCT02941614|12163408|P2|STARTED|Overall Study||692
4945467|NCT02941614|12163409|P1|STARTED|Overall Study||744
4945468|NCT02940886|12163431|P2|NOT COMPLETED|Overall Study||54
4945469|NCT02940886|12163432|P1|NOT COMPLETED|Overall Study||102
4945470|NCT02940886|12163431|P2|COMPLETED|Overall Study||449
4945471|NCT02940886|12163432|P1|COMPLETED|Overall Study||907
4945472|NCT02940886|12163431|P2|Safety Analysis Set|Overall Study||494
4945473|NCT02940886|12163432|P1|Safety Analysis Set|Overall Study||989
4945474|NCT02940886|12163431|P2|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
4945475|NCT02940886|12163432|P1|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
4945476|NCT02940860|12163478|P2|NOT COMPLETED|Overall Study||35
4945477|NCT02940860|12163479|P1|NOT COMPLETED|Overall Study||56
4945478|NCT02940860|12163478|P2|COMPLETED|Overall Study||476
4945479|NCT02940860|12163479|P1|COMPLETED|Overall Study||971
4945480|NCT02940860|12163478|P2|STARTED|Overall Study||511
4945481|NCT02940860|12163479|P1|STARTED|Overall Study||1027
4945482|NCT02940691|12163523|P1|NOT COMPLETED|Overall Study||6
4945483|NCT02940691|12163523|P1|COMPLETED|Overall Study||26
4945484|NCT02940691|12163523|P1|STARTED|Overall Study||32
4945485|NCT02940626|12163532|P2|NOT COMPLETED|Overall Study||35
4945486|NCT02940626|12163533|P1|NOT COMPLETED|Overall Study||47
4945487|NCT02940626|12163532|P2|COMPLETED|Overall Study||43
4945488|NCT02940626|12163533|P1|COMPLETED|Overall Study||30
4945489|NCT02940626|12163532|P2|Completed Through Study Day 22|Overall Study||49
4945490|NCT02940626|12163533|P1|Completed Through Study Day 22|Overall Study||42
4945491|NCT02940626|12163532|P2|Received Study Treatment|Overall Study||77
4945492|NCT02940626|12163533|P1|Received Study Treatment|Overall Study||77
4945493|NCT02940626|12163532|P2|Randomized Into Treatment Sub-study|Overall Study||1
4945494|NCT02940626|12163533|P1|Randomized Into Treatment Sub-study|Overall Study||0
4945495|NCT02940626|12163532|P2|Randomized Into Primary Prevention Study|Overall Study||77
4945496|NCT02940626|12163533|P1|Randomized Into Primary Prevention Study|Overall Study||77
4945497|NCT02940626|12163532|P2|STARTED|Overall Study||78
4945498|NCT02940626|12163533|P1|STARTED|Overall Study||77
4945499|NCT02940574|12163555|P2|NOT COMPLETED|1-year Follow-up||4
4945500|NCT02940574|12163556|P1|NOT COMPLETED|1-year Follow-up||3
4945501|NCT02940574|12163555|P2|COMPLETED|1-year Follow-up||14
4945502|NCT02940574|12163556|P1|COMPLETED|1-year Follow-up||18
4945503|NCT02940574|12163555|P2|STARTED|1-year Follow-up||18
4945504|NCT02940574|12163556|P1|STARTED|1-year Follow-up||21
4945505|NCT02940574|12163555|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
4945506|NCT02940574|12163556|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
4945599|NCT02939079|12163816|P1|COMPLETED|Overall Study||21
4945507|NCT02940574|12163555|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
4945508|NCT02940574|12163556|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
4945509|NCT02940574|12163555|P2|STARTED|From Study Start to 1-month Follow-up||18
4945510|NCT02940574|12163556|P1|STARTED|From Study Start to 1-month Follow-up||22
4945511|NCT02940522|12163594|P2|NOT COMPLETED|Overall Study||2
4945512|NCT02940522|12163595|P1|NOT COMPLETED|Overall Study||2
4945513|NCT02940522|12163594|P2|COMPLETED|Overall Study||59
4945514|NCT02940522|12163595|P1|COMPLETED|Overall Study||57
4945515|NCT02940522|12163594|P2|STARTED|Overall Study||61
4945516|NCT02940522|12163595|P1|STARTED|Overall Study||59
4945517|NCT02940327|12163611|P1|NOT COMPLETED|Overall Study||0
4945518|NCT02940327|12163611|P1|COMPLETED|Overall Study||24
4945519|NCT02940327|12163611|P1|STARTED|Overall Study||24
4945520|NCT02940249|12163674|P1|NOT COMPLETED|Overall Study||4
4945521|NCT02940249|12163674|P1|COMPLETED|Overall Study||30
4945522|NCT02940249|12163674|P1|STARTED|Overall Study||34
4945523|NCT02939950|12163686|P2|NOT COMPLETED|Overall Study||81
4945524|NCT02939950|12163687|P1|NOT COMPLETED|Overall Study||66
4945525|NCT02939950|12163686|P2|COMPLETED|Overall Study||329
4945526|NCT02939950|12163687|P1|COMPLETED|Overall Study||340
4945527|NCT02939950|12163686|P2|Eligible at Baseline|Overall Study||402
4945528|NCT02939950|12163687|P1|Eligible at Baseline|Overall Study||403
4945529|NCT02939950|12163686|P2|Dispensed the Assigned Lenses|Overall Study||410
4945530|NCT02939950|12163687|P1|Dispensed the Assigned Lenses|Overall Study||405
4945531|NCT02939950|12163686|P2|STARTED|Overall Study||410
4945532|NCT02939950|12163687|P1|STARTED|Overall Study||406
4945533|NCT02939937|12163697|P2|NOT COMPLETED|Overall Study||3
4945534|NCT02939937|12163698|P1|NOT COMPLETED|Overall Study||6
4945535|NCT02939937|12163697|P2|COMPLETED|Overall Study||47
4945536|NCT02939937|12163698|P1|COMPLETED|Overall Study||15
4945537|NCT02939937|12163697|P2|STARTED|Overall Study|3 patients excluded from study|50
4945538|NCT02939937|12163698|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
4945539|NCT02939716|12163712|P6|NOT COMPLETED|Overall Study||1
4945540|NCT02939716|12163713|P5|NOT COMPLETED|Overall Study||1
4945541|NCT02939716|12163714|P4|NOT COMPLETED|Overall Study||1
4945542|NCT02939716|12163715|P3|NOT COMPLETED|Overall Study||0
4945543|NCT02939716|12163716|P2|NOT COMPLETED|Overall Study||0
4945544|NCT02939716|12163717|P1|NOT COMPLETED|Overall Study||0
4945545|NCT02939716|12163712|P6|COMPLETED|Overall Study||2
4945546|NCT02939716|12163713|P5|COMPLETED|Overall Study||2
4945547|NCT02939716|12163714|P4|COMPLETED|Overall Study||2
4945548|NCT02939716|12163715|P3|COMPLETED|Overall Study||3
4945549|NCT02939716|12163716|P2|COMPLETED|Overall Study||3
4945550|NCT02939716|12163717|P1|COMPLETED|Overall Study||3
4945551|NCT02939716|12163712|P6|STARTED|Overall Study||3
4945552|NCT02939716|12163713|P5|STARTED|Overall Study||3
4945553|NCT02939716|12163714|P4|STARTED|Overall Study||3
4945554|NCT02939716|12163715|P3|STARTED|Overall Study||3
4945555|NCT02939716|12163716|P2|STARTED|Overall Study||3
4945556|NCT02939716|12163717|P1|STARTED|Overall Study||3
4945557|NCT02939599|12163742|P2|NOT COMPLETED|Overall Study||2
4945558|NCT02939599|12163743|P1|NOT COMPLETED|Overall Study||3
4945559|NCT02939599|12163742|P2|COMPLETED|Overall Study||0
4945560|NCT02939599|12163743|P1|COMPLETED|Overall Study||0
4945561|NCT02939599|12163742|P2|STARTED|Overall Study||2
4945562|NCT02939599|12163743|P1|STARTED|Overall Study||3
4945563|NCT02939560|12163757|P1|NOT COMPLETED|Overall Study||3
4945564|NCT02939560|12163757|P1|COMPLETED|Overall Study||10
4945565|NCT02939560|12163757|P1|STARTED|Overall Study||13
4945566|NCT02939326|12163774|P8|NOT COMPLETED|Overall Study||0
4945567|NCT02939326|12163775|P7|NOT COMPLETED|Overall Study||0
4945568|NCT02939326|12163776|P6|NOT COMPLETED|Overall Study||0
4945569|NCT02939326|12163777|P5|NOT COMPLETED|Overall Study||0
4945570|NCT02939326|12163778|P4|NOT COMPLETED|Overall Study||0
4945571|NCT02939326|12163779|P3|NOT COMPLETED|Overall Study||0
4945572|NCT02939326|12163780|P2|NOT COMPLETED|Overall Study||0
4945573|NCT02939326|12163781|P1|NOT COMPLETED|Overall Study||0
4945574|NCT02939326|12163774|P8|COMPLETED|Overall Study||5
4945575|NCT02939326|12163775|P7|COMPLETED|Overall Study||5
4945576|NCT02939326|12163776|P6|COMPLETED|Overall Study||5
4945577|NCT02939326|12163777|P5|COMPLETED|Overall Study||5
4945578|NCT02939326|12163778|P4|COMPLETED|Overall Study||5
4945579|NCT02939326|12163779|P3|COMPLETED|Overall Study||5
4945580|NCT02939326|12163780|P2|COMPLETED|Overall Study||5
4945581|NCT02939326|12163781|P1|COMPLETED|Overall Study||7
4945582|NCT02939326|12163774|P8|STARTED|Overall Study||5
4945583|NCT02939326|12163775|P7|STARTED|Overall Study||5
4945584|NCT02939326|12163776|P6|STARTED|Overall Study||5
4945585|NCT02939326|12163777|P5|STARTED|Overall Study||5
4945586|NCT02939326|12163778|P4|STARTED|Overall Study||5
4945587|NCT02939326|12163779|P3|STARTED|Overall Study||5
4945588|NCT02939326|12163780|P2|STARTED|Overall Study||5
4945589|NCT02939326|12163781|P1|STARTED|Overall Study||7
4945590|NCT02939170|12163801|P2|NOT COMPLETED|Overall Study||0
4945591|NCT02939170|12163802|P1|NOT COMPLETED|Overall Study||0
4945592|NCT02939170|12163801|P2|COMPLETED|Overall Study||40
4945593|NCT02939170|12163802|P1|COMPLETED|Overall Study||40
4945594|NCT02939170|12163801|P2|STARTED|Overall Study||40
4945595|NCT02939170|12163802|P1|STARTED|Overall Study||40
4945596|NCT02939079|12163815|P2|NOT COMPLETED|Overall Study||5
4945597|NCT02939079|12163816|P1|NOT COMPLETED|Overall Study||4
4945598|NCT02939079|12163815|P2|COMPLETED|Overall Study||20
4945600|NCT02939079|12163815|P2|STARTED|Overall Study||25
4945601|NCT02939079|12163816|P1|STARTED|Overall Study||25
4945602|NCT02939014|12163846|P2|NOT COMPLETED|Overall Study||9
4945603|NCT02939014|12163847|P1|NOT COMPLETED|Overall Study||30
4945604|NCT02939014|12163846|P2|COMPLETED|Overall Study||0
4945605|NCT02939014|12163847|P1|COMPLETED|Overall Study||0
4945606|NCT02939014|12163846|P2|STARTED|Overall Study||9
4945607|NCT02939014|12163847|P1|STARTED|Overall Study||30
4945608|NCT02938949|12163876|P2|NOT COMPLETED|Overall Study||0
4945609|NCT02938949|12163877|P1|NOT COMPLETED|Overall Study||0
4945610|NCT02938949|12163876|P2|COMPLETED|Overall Study||10
4945611|NCT02938949|12163877|P1|COMPLETED|Overall Study||10
4945612|NCT02938949|12163876|P2|STARTED|Overall Study||10
4945613|NCT02938949|12163877|P1|STARTED|Overall Study||10
4945614|NCT02938585|12163891|P4|NOT COMPLETED|Overall Study||5
4945615|NCT02938585|12163892|P3|NOT COMPLETED|Overall Study||0
4945616|NCT02938585|12163893|P2|NOT COMPLETED|Overall Study||1
4945617|NCT02938585|12163894|P1|NOT COMPLETED|Overall Study||0
4945618|NCT02938585|12163891|P4|COMPLETED|Overall Study||10
4945619|NCT02938585|12163892|P3|COMPLETED|Overall Study||11
4945620|NCT02938585|12163893|P2|COMPLETED|Overall Study||32
4945621|NCT02938585|12163894|P1|COMPLETED|Overall Study||9
4945622|NCT02938585|12163891|P4|Exposed to On-demand Regimen|Overall Study||8
4945623|NCT02938585|12163892|P3|Exposed to On-demand Regimen|Overall Study||1
4945624|NCT02938585|12163893|P2|Exposed to On-demand Regimen|Overall Study||7
4945625|NCT02938585|12163894|P1|Exposed to On-demand Regimen|Overall Study||1
4945626|NCT02938585|12163891|P4|Exposed to Prophylaxis Regimen|Overall Study||12
4945627|NCT02938585|12163892|P3|Exposed to Prophylaxis Regimen|Overall Study||11
4945628|NCT02938585|12163893|P2|Exposed to Prophylaxis Regimen|Overall Study||31
4945629|NCT02938585|12163894|P1|Exposed to Prophylaxis Regimen|Overall Study||9
4945630|NCT02938585|12163891|P4|STARTED|Overall Study||15
4945631|NCT02938585|12163892|P3|STARTED|Overall Study||11
4945632|NCT02938585|12163893|P2|STARTED|Overall Study||33
4945633|NCT02938585|12163894|P1|STARTED|Overall Study||9
4945634|NCT02938520|12164058|P2|NOT COMPLETED|Overall Study||283
4945635|NCT02938520|12164059|P1|NOT COMPLETED|Overall Study||283
4945636|NCT02938520|12164058|P2|COMPLETED|Overall Study||0
4945637|NCT02938520|12164059|P1|COMPLETED|Overall Study||0
4945638|NCT02938520|12164058|P2|STARTED|Overall Study||283
4945639|NCT02938520|12164059|P1|STARTED|Overall Study||283
4945640|NCT02938052|12164184|P1|NOT COMPLETED|Overall Study||0
4945641|NCT02938052|12164184|P1|COMPLETED|Overall Study||10
4945642|NCT02938052|12164184|P1|STARTED|Overall Study||10
4945643|NCT02937870|12164204|P1|NOT COMPLETED|Overall Study||3
4945644|NCT02937870|12164204|P1|COMPLETED|Overall Study||20
4945645|NCT02937870|12164204|P1|Received no Adhesive|Overall Study||20
4945646|NCT02937870|12164204|P1|Received Positive Control Adhesive|Overall Study||21
4945647|NCT02937870|12164204|P1|Received Test Adhesive 2|Overall Study||22
4945648|NCT02937870|12164204|P1|Received Test Adhesive 1|Overall Study||21
4945649|NCT02937870|12164204|P1|STARTED|Overall Study||23
4945650|NCT02937766|12164222|P2|NOT COMPLETED|Overall Study||0
4945651|NCT02937766|12164223|P1|NOT COMPLETED|Overall Study||7
4945652|NCT02937766|12164222|P2|COMPLETED|Overall Study||30
4945653|NCT02937766|12164223|P1|COMPLETED|Overall Study||23
4945654|NCT02937766|12164222|P2|STARTED|Overall Study||30
4945655|NCT02937766|12164223|P1|STARTED|Overall Study||30
4945656|NCT02937740|12164235|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
4945657|NCT02937740|12164236|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
4945658|NCT02937740|12164235|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
4945659|NCT02937740|12164236|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
4945660|NCT02937740|12164235|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
4945661|NCT02937740|12164236|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
4945662|NCT02937740|12164235|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
4945663|NCT02937740|12164236|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
4945664|NCT02937740|12164235|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
4945665|NCT02937740|12164236|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
4945666|NCT02937740|12164235|P2|STARTED|BID for 90 Days, 22 mg/Day||93
4945667|NCT02937740|12164236|P1|STARTED|BID for 90 Days, 22 mg/Day||24
4945668|NCT02937701|12164252|P5|NOT COMPLETED|Week 22 to Week 50||9
4945669|NCT02937701|12164253|P4|NOT COMPLETED|Week 22 to Week 50||8
4945670|NCT02937701|12164254|P3|NOT COMPLETED|Week 22 to Week 50||32
4945671|NCT02937701|12164255|P2|NOT COMPLETED|Week 22 to Week 50||0
4945672|NCT02937701|12164256|P1|NOT COMPLETED|Week 22 to Week 50||0
4945673|NCT02937701|12164252|P5|COMPLETED|Week 22 to Week 50||110
4945674|NCT02937701|12164253|P4|COMPLETED|Week 22 to Week 50||113
4945675|NCT02937701|12164254|P3|COMPLETED|Week 22 to Week 50||212
4945676|NCT02937701|12164255|P2|COMPLETED|Week 22 to Week 50||0
4945677|NCT02937701|12164256|P1|COMPLETED|Week 22 to Week 50||0
4945678|NCT02937701|12164252|P5|STARTED|Week 22 to Week 50||119
4945679|NCT02937701|12164253|P4|STARTED|Week 22 to Week 50||121
4945680|NCT02937701|12164254|P3|STARTED|Week 22 to Week 50||244
4945681|NCT02937701|12164255|P2|STARTED|Week 22 to Week 50||0
4945682|NCT02937701|12164256|P1|STARTED|Week 22 to Week 50||0
4945683|NCT02937701|12164252|P5|NOT COMPLETED|Day 1 to Week 22||0
4945684|NCT02937701|12164253|P4|NOT COMPLETED|Day 1 to Week 22||0
4945685|NCT02937701|12164254|P3|NOT COMPLETED|Day 1 to Week 22||0
4945686|NCT02937701|12164255|P2|NOT COMPLETED|Day 1 to Week 22||39
4945687|NCT02937701|12164256|P1|NOT COMPLETED|Day 1 to Week 22||35
4945688|NCT02937701|12164252|P5|COMPLETED|Day 1 to Week 22||0
4945689|NCT02937701|12164253|P4|COMPLETED|Day 1 to Week 22||0
4945690|NCT02937701|12164254|P3|COMPLETED|Day 1 to Week 22||0
4945691|NCT02937701|12164255|P2|COMPLETED|Day 1 to Week 22||240
4945692|NCT02937701|12164256|P1|COMPLETED|Day 1 to Week 22||244
4945693|NCT02937701|12164252|P5|Received Treatment|Day 1 to Week 22||0
4945694|NCT02937701|12164253|P4|Received Treatment|Day 1 to Week 22||0
4945695|NCT02937701|12164254|P3|Received Treatment|Day 1 to Week 22||0
4945696|NCT02937701|12164255|P2|Received Treatment|Day 1 to Week 22||278
4945697|NCT02937701|12164256|P1|Received Treatment|Day 1 to Week 22||278
4945698|NCT02937701|12164252|P5|STARTED|Day 1 to Week 22||0
4945699|NCT02937701|12164253|P4|STARTED|Day 1 to Week 22||0
4945700|NCT02937701|12164254|P3|STARTED|Day 1 to Week 22||0
4945701|NCT02937701|12164255|P2|STARTED|Day 1 to Week 22||279
4945702|NCT02937701|12164256|P1|STARTED|Day 1 to Week 22||279
4945703|NCT02937636|12164287|P2|NOT COMPLETED|Overall Study||2
4945704|NCT02937636|12164288|P1|NOT COMPLETED|Overall Study||3
4945705|NCT02937636|12164287|P2|COMPLETED|Overall Study||63
4945706|NCT02937636|12164288|P1|COMPLETED|Overall Study||60
4945707|NCT02937636|12164287|P2|STARTED|Overall Study||65
4945708|NCT02937636|12164288|P1|STARTED|Overall Study||63
4945709|NCT02937623|12164302|P2|NOT COMPLETED|Overall Study||0
4945710|NCT02937623|12164303|P1|NOT COMPLETED|Overall Study||0
4945711|NCT02937623|12164302|P2|COMPLETED|Overall Study||60
4945712|NCT02937623|12164303|P1|COMPLETED|Overall Study||60
4945713|NCT02937623|12164302|P2|STARTED|Overall Study||60
4945714|NCT02937623|12164303|P1|STARTED|Overall Study||60
4945715|NCT02937584|12164315|P2|NOT COMPLETED|Period 2||0
4945716|NCT02937584|12164316|P1|NOT COMPLETED|Period 2||0
4945717|NCT02937584|12164315|P2|COMPLETED|Period 2||9
4945718|NCT02937584|12164316|P1|COMPLETED|Period 2||10
4945719|NCT02937584|12164315|P2|STARTED|Period 2||9
4945720|NCT02937584|12164316|P1|STARTED|Period 2||10
4945721|NCT02937584|12164315|P2|NOT COMPLETED|Washout||1
4945722|NCT02937584|12164316|P1|NOT COMPLETED|Washout||0
4945723|NCT02937584|12164315|P2|COMPLETED|Washout||9
4945724|NCT02937584|12164316|P1|COMPLETED|Washout||10
4945725|NCT02937584|12164315|P2|STARTED|Washout||10
4945726|NCT02937584|12164316|P1|STARTED|Washout||10
4945727|NCT02937584|12164315|P2|NOT COMPLETED|Period 1||2
4945728|NCT02937584|12164316|P1|NOT COMPLETED|Period 1||1
4945729|NCT02937584|12164315|P2|COMPLETED|Period 1||10
4945730|NCT02937584|12164316|P1|COMPLETED|Period 1||10
4945731|NCT02937584|12164315|P2|STARTED|Period 1||12
4945732|NCT02937584|12164316|P1|STARTED|Period 1||11
4945733|NCT02937558|12164334|P2|NOT COMPLETED|Open-label Phase||0
4945734|NCT02937558|12164335|P1|NOT COMPLETED|Open-label Phase||0
4945735|NCT02937558|12164334|P2|COMPLETED|Open-label Phase||0
4945736|NCT02937558|12164335|P1|COMPLETED|Open-label Phase||5
4945737|NCT02937558|12164334|P2|STARTED|Open-label Phase||0
4945738|NCT02937558|12164335|P1|STARTED|Open-label Phase||5
4945739|NCT02937558|12164334|P2|NOT COMPLETED|Double-blind Phase||0
4945740|NCT02937558|12164335|P1|NOT COMPLETED|Double-blind Phase||0
4945741|NCT02937558|12164334|P2|COMPLETED|Double-blind Phase||2
4945742|NCT02937558|12164335|P1|COMPLETED|Double-blind Phase||3
4945743|NCT02937558|12164334|P2|STARTED|Double-blind Phase||2
4945744|NCT02937558|12164335|P1|STARTED|Double-blind Phase||3
4945745|NCT02937506|12164350|P2|NOT COMPLETED|Overall Study||0
4945746|NCT02937506|12164351|P1|NOT COMPLETED|Overall Study||0
4945747|NCT02937506|12164350|P2|COMPLETED|Overall Study||300
4945748|NCT02937506|12164351|P1|COMPLETED|Overall Study||300
4945749|NCT02937506|12164350|P2|STARTED|Overall Study||300
4945750|NCT02937506|12164351|P1|STARTED|Overall Study||300
4945751|NCT02937168|12164357|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945752|NCT02937168|12164358|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945753|NCT02937168|12164359|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945754|NCT02937168|12164357|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945755|NCT02937168|12164358|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945756|NCT02937168|12164359|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
4945757|NCT02937168|12164357|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
4945758|NCT02937168|12164358|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
4945759|NCT02937168|12164359|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
4945760|NCT02937168|12164357|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
4945761|NCT02937168|12164358|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
4945762|NCT02937168|12164359|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
4945763|NCT02937168|12164357|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
4945764|NCT02937168|12164358|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
4945765|NCT02937168|12164359|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
4945766|NCT02937168|12164357|P3|STARTED|PET/CT Screening Period (21 Days)||0
4945767|NCT02937168|12164358|P2|STARTED|PET/CT Screening Period (21 Days)||0
4945768|NCT02937168|12164359|P1|STARTED|PET/CT Screening Period (21 Days)||5
4945769|NCT02936869|12164379|P2|NOT COMPLETED|Overall Study||5
4945770|NCT02936869|12164380|P1|NOT COMPLETED|Overall Study||2
4945771|NCT02936869|12164379|P2|COMPLETED|Overall Study||98
4945772|NCT02936869|12164380|P1|COMPLETED|Overall Study||102
4945773|NCT02936869|12164379|P2|STARTED|Overall Study||103
4945774|NCT02936869|12164380|P1|STARTED|Overall Study||104
4945775|NCT02936648|12164388|P1|NOT COMPLETED|Overall Study||0
4945776|NCT02936648|12164388|P1|COMPLETED|Overall Study||2209
4945777|NCT02936648|12164388|P1|STARTED|Overall Study||2209
4945778|NCT02936479|12164392|P1|NOT COMPLETED|Overall Study||0
4945779|NCT02936479|12164392|P1|COMPLETED|Overall Study||1
4945780|NCT02936479|12164392|P1|STARTED|Overall Study||1
4945781|NCT02936076|12164398|P2|NOT COMPLETED|Overall Study||4
4945782|NCT02936076|12164399|P1|NOT COMPLETED|Overall Study||6
4945783|NCT02936076|12164398|P2|COMPLETED|Overall Study||20
4945784|NCT02936076|12164399|P1|COMPLETED|Overall Study||19
4945785|NCT02936076|12164398|P2|STARTED|Overall Study||24
4945786|NCT02936076|12164399|P1|STARTED|Overall Study||25
4945787|NCT02935894|12164411|P1|NOT COMPLETED|Overall Study||1
4945788|NCT02935894|12164411|P1|COMPLETED|Overall Study||13
4945789|NCT02935894|12164411|P1|STARTED|Overall Study||14
4945790|NCT02935842|12164426|P4|NOT COMPLETED|Testing and Therapy Period 3||1
4945791|NCT02935842|12164427|P3|NOT COMPLETED|Testing and Therapy Period 3||5
4945792|NCT02935842|12164428|P2|NOT COMPLETED|Testing and Therapy Period 3||4
4945793|NCT02935842|12164429|P1|NOT COMPLETED|Testing and Therapy Period 3||3
4945794|NCT02935842|12164426|P4|COMPLETED|Testing and Therapy Period 3||17
4945795|NCT02935842|12164427|P3|COMPLETED|Testing and Therapy Period 3||1
4945796|NCT02935842|12164428|P2|COMPLETED|Testing and Therapy Period 3||2
4945797|NCT02935842|12164429|P1|COMPLETED|Testing and Therapy Period 3||3
4945798|NCT02935842|12164426|P4|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
4945799|NCT02935842|12164427|P3|STARTED|Testing and Therapy Period 3||6
4945800|NCT02935842|12164428|P2|STARTED|Testing and Therapy Period 3||6
4945801|NCT02935842|12164429|P1|STARTED|Testing and Therapy Period 3||6
4945802|NCT02935842|12164426|P4|NOT COMPLETED|Testing and Therapy Period 2||0
4945803|NCT02935842|12164427|P3|NOT COMPLETED|Testing and Therapy Period 2||0
4945804|NCT02935842|12164428|P2|NOT COMPLETED|Testing and Therapy Period 2||0
4945805|NCT02935842|12164429|P1|NOT COMPLETED|Testing and Therapy Period 2||2
4945806|NCT02935842|12164426|P4|COMPLETED|Testing and Therapy Period 2||0
4945807|NCT02935842|12164427|P3|COMPLETED|Testing and Therapy Period 2||6
4945808|NCT02935842|12164428|P2|COMPLETED|Testing and Therapy Period 2||6
4945809|NCT02935842|12164429|P1|COMPLETED|Testing and Therapy Period 2||6
4945810|NCT02935842|12164426|P4|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
4945811|NCT02935842|12164427|P3|STARTED|Testing and Therapy Period 2||6
4945812|NCT02935842|12164428|P2|STARTED|Testing and Therapy Period 2||6
4945813|NCT02935842|12164429|P1|STARTED|Testing and Therapy Period 2||8
4945814|NCT02935842|12164426|P4|NOT COMPLETED|Testing and Therapy Period 1||0
4945815|NCT02935842|12164427|P3|NOT COMPLETED|Testing and Therapy Period 1||0
4945816|NCT02935842|12164428|P2|NOT COMPLETED|Testing and Therapy Period 1||0
4945817|NCT02935842|12164429|P1|NOT COMPLETED|Testing and Therapy Period 1||0
4945818|NCT02935842|12164426|P4|COMPLETED|Testing and Therapy Period 1||0
4945819|NCT02935842|12164427|P3|COMPLETED|Testing and Therapy Period 1||6
4945820|NCT02935842|12164428|P2|COMPLETED|Testing and Therapy Period 1||6
4945821|NCT02935842|12164429|P1|COMPLETED|Testing and Therapy Period 1||8
4945822|NCT02935842|12164426|P4|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
4945823|NCT02935842|12164427|P3|STARTED|Testing and Therapy Period 1||6
4945824|NCT02935842|12164428|P2|STARTED|Testing and Therapy Period 1||6
4945825|NCT02935842|12164429|P1|STARTED|Testing and Therapy Period 1||8
4945826|NCT02935699|12164465|P2|NOT COMPLETED|Overall Study||0
4945827|NCT02935699|12164466|P1|NOT COMPLETED|Overall Study||0
4945828|NCT02935699|12164465|P2|COMPLETED|Overall Study||135
4945829|NCT02935699|12164466|P1|COMPLETED|Overall Study||127
4945830|NCT02935699|12164465|P2|STARTED|Overall Study||135
4945831|NCT02935699|12164466|P1|STARTED|Overall Study||127
4945832|NCT02935673|12164481|P3|NOT COMPLETED|Overall Study||0
4945833|NCT02935673|12164482|P2|NOT COMPLETED|Overall Study||3
4945834|NCT02935673|12164483|P1|NOT COMPLETED|Overall Study||1
4945835|NCT02935673|12164481|P3|COMPLETED|Overall Study||6
4945836|NCT02935673|12164482|P2|COMPLETED|Overall Study||24
4945837|NCT02935673|12164483|P1|COMPLETED|Overall Study||15
4945838|NCT02935673|12164481|P3|STARTED|Overall Study||6
4945839|NCT02935673|12164482|P2|STARTED|Overall Study||27
4945840|NCT02935673|12164483|P1|STARTED|Overall Study||16
4945841|NCT02935543|12164605|P1|NOT COMPLETED|Overall Study||0
4945842|NCT02935543|12164605|P1|COMPLETED|Overall Study||1
4945843|NCT02935543|12164605|P1|STARTED|Overall Study||1
4945844|NCT02935192|12164617|P2|NOT COMPLETED|Overall Study||4
4945845|NCT02935192|12164618|P1|NOT COMPLETED|Overall Study||8
4945846|NCT02935192|12164617|P2|COMPLETED|Overall Study||156
4945847|NCT02935192|12164618|P1|COMPLETED|Overall Study||312
4945848|NCT02935192|12164617|P2|Received Vaccine/Placebo|Overall Study||156
4945849|NCT02935192|12164618|P1|Received Vaccine/Placebo|Overall Study||312
4945850|NCT02935192|12164617|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
4945851|NCT02935192|12164618|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
4945852|NCT02935179|12164642|P2|NOT COMPLETED|Overall Study||1
4945853|NCT02935179|12164643|P1|NOT COMPLETED|Overall Study||1
4945854|NCT02935179|12164642|P2|COMPLETED|Overall Study||29
4945855|NCT02935179|12164643|P1|COMPLETED|Overall Study||29
4945856|NCT02935179|12164642|P2|STARTED|Overall Study||30
4945857|NCT02935179|12164643|P1|STARTED|Overall Study||30
4945858|NCT02935088|12164651|P1|NOT COMPLETED|Overall Study||102
4945859|NCT02935088|12164651|P1|COMPLETED|Overall Study||2115
4945860|NCT02935088|12164651|P1|STARTED|Overall Study||2217
4945861|NCT02935062|12164666|P3|NOT COMPLETED|Overall Study||0
4945862|NCT02935062|12164667|P2|NOT COMPLETED|Overall Study||0
4945863|NCT02935062|12164668|P1|NOT COMPLETED|Overall Study||0
4945864|NCT02935062|12164666|P3|COMPLETED|Overall Study||8
4945865|NCT02935062|12164667|P2|COMPLETED|Overall Study||8
4945866|NCT02935062|12164668|P1|COMPLETED|Overall Study||8
4945867|NCT02935062|12164666|P3|STARTED|Overall Study||8
4945868|NCT02935062|12164667|P2|STARTED|Overall Study||8
4945869|NCT02935062|12164668|P1|STARTED|Overall Study||8
4945870|NCT02935036|12164681|P2|NOT COMPLETED|Overall Study||11
4945871|NCT02935036|12164682|P1|NOT COMPLETED|Overall Study||10
4945872|NCT02935036|12164681|P2|COMPLETED|Overall Study||136
4945873|NCT02935036|12164682|P1|COMPLETED|Overall Study||137
4945874|NCT02935036|12164681|P2|STARTED|Overall Study||147
4945875|NCT02935036|12164682|P1|STARTED|Overall Study||147
4945876|NCT02934932|12164692|P1|NOT COMPLETED|Overall Study||3
4945877|NCT02934932|12164692|P1|COMPLETED|Overall Study||6
4945878|NCT02934932|12164692|P1|STARTED|Overall Study||9
4945879|NCT02934698|12164701|P1|NOT COMPLETED|Overall Study||0
4945880|NCT02934698|12164701|P1|COMPLETED|Overall Study||2
4945881|NCT02934698|12164701|P1|STARTED|Overall Study||2
4945882|NCT02934347|12164709|P2|NOT COMPLETED|Overall Study||0
4945883|NCT02934347|12164710|P1|NOT COMPLETED|Overall Study||0
4945884|NCT02934347|12164709|P2|COMPLETED|Overall Study||407
4945885|NCT02934347|12164710|P1|COMPLETED|Overall Study||374
4945886|NCT02934347|12164709|P2|STARTED|Overall Study||407
4945887|NCT02934347|12164710|P1|STARTED|Overall Study||374
4945888|NCT02934191|12164724|P2|NOT COMPLETED|Overall Study||0
4945889|NCT02934191|12164725|P1|NOT COMPLETED|Overall Study||0
4945890|NCT02934191|12164724|P2|COMPLETED|Overall Study||85
4945891|NCT02934191|12164725|P1|COMPLETED|Overall Study||87
4945892|NCT02934191|12164724|P2|STARTED|Overall Study||85
4945893|NCT02934191|12164725|P1|STARTED|Overall Study||87
4945894|NCT02934178|12164735|P2|NOT COMPLETED|Received Vaccination 3||0
4945895|NCT02934178|12164736|P1|NOT COMPLETED|Received Vaccination 3||1
4945896|NCT02934178|12164735|P2|COMPLETED|Received Vaccination 3||3
4945897|NCT02934178|12164736|P1|COMPLETED|Received Vaccination 3||11
4945898|NCT02934178|12164735|P2|STARTED|Received Vaccination 3||3
4945899|NCT02934178|12164736|P1|STARTED|Received Vaccination 3||12
4945900|NCT02934178|12164735|P2|NOT COMPLETED|Received Vaccination 2||1
4945901|NCT02934178|12164736|P1|NOT COMPLETED|Received Vaccination 2||0
4945902|NCT02934178|12164735|P2|COMPLETED|Received Vaccination 2||3
4945903|NCT02934178|12164736|P1|COMPLETED|Received Vaccination 2||12
4945904|NCT02934178|12164735|P2|STARTED|Received Vaccination 2||4
4945905|NCT02934178|12164736|P1|STARTED|Received Vaccination 2||12
4945906|NCT02934178|12164735|P2|NOT COMPLETED|Received Vaccination 1||0
4945907|NCT02934178|12164736|P1|NOT COMPLETED|Received Vaccination 1||0
4945908|NCT02934178|12164735|P2|COMPLETED|Received Vaccination 1||4
4945909|NCT02934178|12164736|P1|COMPLETED|Received Vaccination 1||12
4945910|NCT02934178|12164735|P2|STARTED|Received Vaccination 1||4
4945911|NCT02934178|12164736|P1|STARTED|Received Vaccination 1||12
4945912|NCT02933879|12164831|P3|NOT COMPLETED|Overall Study||17
4945913|NCT02933879|12164832|P2|NOT COMPLETED|Overall Study||14
4945914|NCT02933879|12164833|P1|NOT COMPLETED|Overall Study||16
4945915|NCT02933879|12164831|P3|COMPLETED|Overall Study||41
4945916|NCT02933879|12164832|P2|COMPLETED|Overall Study||48
4945917|NCT02933879|12164833|P1|COMPLETED|Overall Study||48
4945918|NCT02933879|12164831|P3|STARTED|Overall Study||58
4945919|NCT02933879|12164832|P2|STARTED|Overall Study||62
4945920|NCT02933879|12164833|P1|STARTED|Overall Study||64
4945921|NCT02933866|12164869|P2|NOT COMPLETED|Overall Study||9
4945922|NCT02933866|12164870|P1|NOT COMPLETED|Overall Study||12
4945923|NCT02933866|12164869|P2|COMPLETED|Overall Study||176
4945924|NCT02933866|12164870|P1|COMPLETED|Overall Study||174
4945925|NCT02933866|12164869|P2|STARTED|Overall Study||185
4945926|NCT02933866|12164870|P1|STARTED|Overall Study||186
4945927|NCT02933528|12164876|P1|NOT COMPLETED|Overall Study||2
4945928|NCT02933528|12164876|P1|COMPLETED|Overall Study||22
4945929|NCT02933528|12164876|P1|STARTED|Overall Study||24
4945930|NCT02933502|12164880|P1|NOT COMPLETED|Overall Study||0
4945931|NCT02933502|12164880|P1|COMPLETED|Overall Study||3
4945932|NCT02933502|12164880|P1|STARTED|Overall Study||3
4945933|NCT02933476|12164884|P1|NOT COMPLETED|Overall Study||0
4945934|NCT02933476|12164884|P1|COMPLETED|Overall Study||5
4945935|NCT02933476|12164884|P1|STARTED|Overall Study||5
4945936|NCT02933450|12164893|P2|NOT COMPLETED|Overall Study||8
4945937|NCT02933450|12164894|P1|NOT COMPLETED|Overall Study||5
4945938|NCT02933450|12164893|P2|COMPLETED|Overall Study||15
4945939|NCT02933450|12164894|P1|COMPLETED|Overall Study||15
4945940|NCT02933450|12164893|P2|STARTED|Overall Study||23
4945941|NCT02933450|12164894|P1|STARTED|Overall Study||20
4945942|NCT02933060|12164904|P2|NOT COMPLETED|Overall Study||1
4945943|NCT02933060|12164905|P1|NOT COMPLETED|Overall Study||0
4945944|NCT02933060|12164904|P2|COMPLETED|Overall Study||24
4945945|NCT02933060|12164905|P1|COMPLETED|Overall Study||25
4945946|NCT02933060|12164904|P2|STARTED|Overall Study||25
4945947|NCT02933060|12164905|P1|STARTED|Overall Study||25
4945948|NCT02933034|12164929|P1|NOT COMPLETED|Overall Study||9
4945949|NCT02933034|12164929|P1|COMPLETED|Overall Study||24
4945950|NCT02933034|12164929|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
4945951|NCT02933034|12164929|P1|STARTED|Overall Study||33
4945952|NCT02932943|12164946|P2|NOT COMPLETED|Overall Study||7
4945953|NCT02932943|12164947|P1|NOT COMPLETED|Overall Study||5
4945954|NCT02932943|12164946|P2|COMPLETED|Overall Study||224
4945955|NCT02932943|12164947|P1|COMPLETED|Overall Study||222
4945956|NCT02932943|12164946|P2|STARTED|Overall Study||231
4945957|NCT02932943|12164947|P1|STARTED|Overall Study||227
4945958|NCT02932904|12164963|P4|NOT COMPLETED|Overall Study||14
4945959|NCT02932904|12164964|P3|NOT COMPLETED|Overall Study||23
4945960|NCT02932904|12164965|P2|NOT COMPLETED|Overall Study||18
4945961|NCT02932904|12164966|P1|NOT COMPLETED|Overall Study||16
4945962|NCT02932904|12164963|P4|COMPLETED|Overall Study||79
4945963|NCT02932904|12164964|P3|COMPLETED|Overall Study||68
4945964|NCT02932904|12164965|P2|COMPLETED|Overall Study||67
4945965|NCT02932904|12164966|P1|COMPLETED|Overall Study||76
4945966|NCT02932904|12164963|P4|Treated|Overall Study||91
4945967|NCT02932904|12164964|P3|Treated|Overall Study||91
4945968|NCT02932904|12164965|P2|Treated|Overall Study||84
4945969|NCT02932904|12164966|P1|Treated|Overall Study||91
4945970|NCT02932904|12164963|P4|STARTED|Overall Study||93
4945971|NCT02932904|12164964|P3|STARTED|Overall Study||91
4945972|NCT02932904|12164965|P2|STARTED|Overall Study||85
4945973|NCT02932904|12164966|P1|STARTED|Overall Study||92
4945974|NCT02932891|12165001|P1|NOT COMPLETED|Overall Study||4
4945975|NCT02932891|12165001|P1|COMPLETED|Overall Study||24
4945976|NCT02932891|12165001|P1|STARTED|Overall Study||28
4945977|NCT02932878|12165007|P2|NOT COMPLETED|Overall Study||1
4945978|NCT02932878|12165008|P1|NOT COMPLETED|Overall Study||2
4945979|NCT02932878|12165007|P2|COMPLETED|Overall Study||0
4945980|NCT02932878|12165008|P1|COMPLETED|Overall Study||13
4945981|NCT02932878|12165007|P2|STARTED|Overall Study||1
4945982|NCT02932878|12165008|P1|STARTED|Overall Study||15
4945983|NCT02932787|12165016|P2|NOT COMPLETED|Overall Study||0
4945984|NCT02932787|12165017|P1|NOT COMPLETED|Overall Study||0
4945985|NCT02932787|12165016|P2|COMPLETED|Overall Study||9
4945986|NCT02932787|12165017|P1|COMPLETED|Overall Study||22
4945987|NCT02932787|12165016|P2|STARTED|Overall Study||9
4945988|NCT02932787|12165017|P1|STARTED|Overall Study||22
4945989|NCT02932462|12165029|P2|NOT COMPLETED|Overall Study||13
4945990|NCT02932462|12165030|P1|NOT COMPLETED|Overall Study||7
4945991|NCT02932462|12165029|P2|COMPLETED|Overall Study||176
4945992|NCT02932462|12165030|P1|COMPLETED|Overall Study||177
4945993|NCT02932462|12165029|P2|STARTED|Overall Study||189
4945994|NCT02932462|12165030|P1|STARTED|Overall Study||184
4945995|NCT02932306|12165042|P2|NOT COMPLETED|Overall Study||77
4945996|NCT02932306|12165043|P1|NOT COMPLETED|Overall Study||68
4945997|NCT02932306|12165042|P2|COMPLETED|Overall Study||337
4945998|NCT02932306|12165043|P1|COMPLETED|Overall Study||338
4945999|NCT02932306|12165042|P2|Safety Population|Overall Study||385
4946000|NCT02932306|12165043|P1|Safety Population|Overall Study||378
4946001|NCT02932306|12165042|P2|Intent-to-treat (ITT) Population|Overall Study||414
4946002|NCT02932306|12165043|P1|Intent-to-treat (ITT) Population|Overall Study||406
4946003|NCT02932306|12165042|P2|STARTED|Overall Study||414
4946004|NCT02932306|12165043|P1|STARTED|Overall Study||406
4946005|NCT02932267|12165057|P1|NOT COMPLETED|Overall Study||8
4946006|NCT02932267|12165057|P1|COMPLETED|Overall Study||42
4946007|NCT02932267|12165057|P1|STARTED|Overall Study||50
4946008|NCT02932228|12165063|P2|NOT COMPLETED|Overall Study||28
4946009|NCT02932228|12165064|P1|NOT COMPLETED|Overall Study||10
4946010|NCT02932228|12165063|P2|COMPLETED|Overall Study||405
4946011|NCT02932228|12165064|P1|COMPLETED|Overall Study||140
4946012|NCT02932228|12165063|P2|STARTED|Overall Study||433
4946013|NCT02932228|12165064|P1|STARTED|Overall Study||150
4946014|NCT02931396|12165085|P2|NOT COMPLETED|Overall Study||0
4946015|NCT02931396|12165086|P1|NOT COMPLETED|Overall Study||5
4946016|NCT02931396|12165085|P2|COMPLETED|Overall Study||10
4946017|NCT02931396|12165086|P1|COMPLETED|Overall Study||5
4946018|NCT02931396|12165085|P2|STARTED|Overall Study||10
4946019|NCT02931396|12165086|P1|STARTED|Overall Study||10
4946020|NCT02931253|12165098|P2|NOT COMPLETED|Overall Study||0
4946021|NCT02931253|12165099|P1|NOT COMPLETED|Overall Study||0
4946022|NCT02931253|12165098|P2|COMPLETED|Overall Study||4
4946023|NCT02931253|12165099|P1|COMPLETED|Overall Study||2
4946024|NCT02931253|12165098|P2|STARTED|Overall Study||4
4946025|NCT02931253|12165099|P1|STARTED|Overall Study||2
4946026|NCT02930980|12165119|P1|NOT COMPLETED|Overall Study||0
4946027|NCT02930980|12165119|P1|COMPLETED|Overall Study||43
4946028|NCT02930980|12165119|P1|STARTED|Overall Study||43
4946029|NCT02930837|12165123|P1|NOT COMPLETED|Overall Study||12
4946030|NCT02930837|12165123|P1|COMPLETED|Overall Study|Completed the trial|108
4946031|NCT02930837|12165123|P1|STARTED|Overall Study|Started are treated patients|120
4946032|NCT02930590|12165133|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
4946033|NCT02930590|12165134|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
4946034|NCT02930590|12165135|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
4946035|NCT02930590|12165136|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
4946036|NCT02930590|12165137|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
4946037|NCT02930590|12165138|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
4946038|NCT02930590|12165133|P6|COMPLETED|Third Intervention (2 Hours)||2
4946039|NCT02930590|12165134|P5|COMPLETED|Third Intervention (2 Hours)||2
4946040|NCT02930590|12165135|P4|COMPLETED|Third Intervention (2 Hours)||2
4946041|NCT02930590|12165136|P3|COMPLETED|Third Intervention (2 Hours)||3
4946042|NCT02930590|12165137|P2|COMPLETED|Third Intervention (2 Hours)||3
4946043|NCT02930590|12165138|P1|COMPLETED|Third Intervention (2 Hours)||3
4946044|NCT02930590|12165133|P6|STARTED|Third Intervention (2 Hours)||2
4946045|NCT02930590|12165134|P5|STARTED|Third Intervention (2 Hours)||2
4946046|NCT02930590|12165135|P4|STARTED|Third Intervention (2 Hours)||2
4946047|NCT02930590|12165136|P3|STARTED|Third Intervention (2 Hours)||3
4946048|NCT02930590|12165137|P2|STARTED|Third Intervention (2 Hours)||3
4946049|NCT02930590|12165138|P1|STARTED|Third Intervention (2 Hours)||3
4946050|NCT02930590|12165133|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
4946051|NCT02930590|12165134|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
4946052|NCT02930590|12165135|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
4946053|NCT02930590|12165136|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
4946054|NCT02930590|12165137|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
4946055|NCT02930590|12165138|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
4946056|NCT02930590|12165133|P6|COMPLETED|Second Intervention (2 Hours)||2
4946057|NCT02930590|12165134|P5|COMPLETED|Second Intervention (2 Hours)||2
4946058|NCT02930590|12165135|P4|COMPLETED|Second Intervention (2 Hours)||2
4946059|NCT02930590|12165136|P3|COMPLETED|Second Intervention (2 Hours)||3
4946060|NCT02930590|12165137|P2|COMPLETED|Second Intervention (2 Hours)||3
4946061|NCT02930590|12165138|P1|COMPLETED|Second Intervention (2 Hours)||3
4946062|NCT02930590|12165133|P6|STARTED|Second Intervention (2 Hours)||2
4946063|NCT02930590|12165134|P5|STARTED|Second Intervention (2 Hours)||2
4946064|NCT02930590|12165135|P4|STARTED|Second Intervention (2 Hours)||2
4946065|NCT02930590|12165136|P3|STARTED|Second Intervention (2 Hours)||3
4946066|NCT02930590|12165137|P2|STARTED|Second Intervention (2 Hours)||3
4946067|NCT02930590|12165138|P1|STARTED|Second Intervention (2 Hours)||3
4946068|NCT02930590|12165133|P6|NOT COMPLETED|First Intervention (2 Hours)||0
4946069|NCT02930590|12165134|P5|NOT COMPLETED|First Intervention (2 Hours)||0
4946070|NCT02930590|12165135|P4|NOT COMPLETED|First Intervention (2 Hours)||0
4946071|NCT02930590|12165136|P3|NOT COMPLETED|First Intervention (2 Hours)||0
4946072|NCT02930590|12165137|P2|NOT COMPLETED|First Intervention (2 Hours)||0
4946073|NCT02930590|12165138|P1|NOT COMPLETED|First Intervention (2 Hours)||0
4946074|NCT02930590|12165133|P6|COMPLETED|First Intervention (2 Hours)||2
4946075|NCT02930590|12165134|P5|COMPLETED|First Intervention (2 Hours)||2
4946076|NCT02930590|12165135|P4|COMPLETED|First Intervention (2 Hours)||2
4946077|NCT02930590|12165136|P3|COMPLETED|First Intervention (2 Hours)||3
4946078|NCT02930590|12165137|P2|COMPLETED|First Intervention (2 Hours)||3
4946079|NCT02930590|12165138|P1|COMPLETED|First Intervention (2 Hours)||3
4946080|NCT02930590|12165133|P6|STARTED|First Intervention (2 Hours)||2
4946081|NCT02930590|12165134|P5|STARTED|First Intervention (2 Hours)||2
4946082|NCT02930590|12165135|P4|STARTED|First Intervention (2 Hours)||2
4946083|NCT02930590|12165136|P3|STARTED|First Intervention (2 Hours)||3
4946084|NCT02930590|12165137|P2|STARTED|First Intervention (2 Hours)||3
4946085|NCT02930590|12165138|P1|STARTED|First Intervention (2 Hours)||3
4946086|NCT02930226|12165419|P6|NOT COMPLETED|Overall Study||0
4946087|NCT02930226|12165420|P5|NOT COMPLETED|Overall Study||1
4946088|NCT02930226|12165421|P4|NOT COMPLETED|Overall Study||0
4946089|NCT02930226|12165422|P3|NOT COMPLETED|Overall Study||0
4946090|NCT02930226|12165423|P2|NOT COMPLETED|Overall Study||0
4946091|NCT02930226|12165424|P1|NOT COMPLETED|Overall Study||0
4946092|NCT02930226|12165419|P6|COMPLETED|Overall Study||4
4946093|NCT02930226|12165420|P5|COMPLETED|Overall Study||3
4946094|NCT02930226|12165421|P4|COMPLETED|Overall Study||4
4946095|NCT02930226|12165422|P3|COMPLETED|Overall Study||4
4946096|NCT02930226|12165423|P2|COMPLETED|Overall Study||4
4946097|NCT02930226|12165424|P1|COMPLETED|Overall Study||4
4946098|NCT02930226|12165419|P6|STARTED|Overall Study||4
4946099|NCT02930226|12165420|P5|STARTED|Overall Study||4
4946100|NCT02930226|12165421|P4|STARTED|Overall Study||4
4946101|NCT02930226|12165422|P3|STARTED|Overall Study||4
4946102|NCT02930226|12165423|P2|STARTED|Overall Study||4
4946103|NCT02930226|12165424|P1|STARTED|Overall Study||4
4946104|NCT02930174|12165460|P2|NOT COMPLETED|Overall Study||0
4946105|NCT02930174|12165461|P1|NOT COMPLETED|Overall Study||0
4946106|NCT02930174|12165460|P2|COMPLETED|Overall Study||8
4946107|NCT02930174|12165461|P1|COMPLETED|Overall Study||12
4946108|NCT02930174|12165460|P2|STARTED|Overall Study||8
4946109|NCT02930174|12165461|P1|STARTED|Overall Study||12
4946110|NCT02930005|12165478|P2|NOT COMPLETED|Overall Study||5
4946111|NCT02930005|12165479|P1|NOT COMPLETED|Overall Study||1
4946112|NCT02930005|12165478|P2|COMPLETED|Overall Study||1
4946113|NCT02930005|12165479|P1|COMPLETED|Overall Study||1
4946114|NCT02930005|12165478|P2|Completed 2 Weeks|Overall Study||2
4946115|NCT02930005|12165479|P1|Completed 2 Weeks|Overall Study||2
4946116|NCT02930005|12165478|P2|STARTED|Overall Study||6
4946117|NCT02930005|12165479|P1|STARTED|Overall Study||2
4946118|NCT02929823|12165490|P3|NOT COMPLETED|Overall Study||4
4946119|NCT02929823|12165491|P2|NOT COMPLETED|Overall Study||6
4946120|NCT02929823|12165492|P1|NOT COMPLETED|Overall Study||3
4946121|NCT02929823|12165490|P3|COMPLETED|Overall Study||38
4946122|NCT02929823|12165491|P2|COMPLETED|Overall Study||40
4946123|NCT02929823|12165492|P1|COMPLETED|Overall Study||39
4946124|NCT02929823|12165490|P3|STARTED|Overall Study||42
4946125|NCT02929823|12165491|P2|STARTED|Overall Study||46
4946126|NCT02929823|12165492|P1|STARTED|Overall Study||42
4946127|NCT02929667|12165502|P2|NOT COMPLETED|Overall Study||0
4946128|NCT02929667|12165503|P1|NOT COMPLETED|Overall Study||0
4946129|NCT02929667|12165502|P2|COMPLETED|Overall Study||11
4946130|NCT02929667|12165503|P1|COMPLETED|Overall Study||11
4946131|NCT02929667|12165502|P2|STARTED|Overall Study||11
4946132|NCT02929667|12165503|P1|STARTED|Overall Study||11
4946133|NCT02929498|12165519|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946134|NCT02929498|12165520|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946135|NCT02929498|12165521|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946136|NCT02929498|12165519|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946137|NCT02929498|12165520|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946138|NCT02929498|12165521|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946139|NCT02929498|12165519|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946140|NCT02929498|12165520|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946141|NCT02929498|12165521|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
4946142|NCT02929498|12165519|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946143|NCT02929498|12165520|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946144|NCT02929498|12165521|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
4946145|NCT02929498|12165519|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946146|NCT02929498|12165520|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946147|NCT02929498|12165521|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946148|NCT02929498|12165519|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946149|NCT02929498|12165520|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
4946150|NCT02929498|12165521|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
4946151|NCT02929407|12165615|P1|NOT COMPLETED|Overall Study||1
4946152|NCT02929407|12165615|P1|COMPLETED|Overall Study||3
4946153|NCT02929407|12165615|P1|STARTED|Overall Study||4
4946154|NCT02928770|12165630|P1|NOT COMPLETED|Overall Study||2
4946155|NCT02928770|12165630|P1|COMPLETED|Overall Study||30
4946156|NCT02928770|12165630|P1|STARTED|Overall Study||32
4946157|NCT02928536|12165634|P1|NOT COMPLETED|Overall Study||0
4946158|NCT02928536|12165634|P1|COMPLETED|Overall Study||11902
4946159|NCT02928536|12165634|P1|STARTED|Overall Study||11902
4946160|NCT02928380|12165641|P6|NOT COMPLETED|Period 3||0
4946161|NCT02928380|12165642|P5|NOT COMPLETED|Period 3||0
4946162|NCT02928380|12165643|P4|NOT COMPLETED|Period 3||0
4946163|NCT02928380|12165644|P3|NOT COMPLETED|Period 3||0
4946164|NCT02928380|12165645|P2|NOT COMPLETED|Period 3||0
4946165|NCT02928380|12165646|P1|NOT COMPLETED|Period 3||0
4946166|NCT02928380|12165641|P6|COMPLETED|Period 3||14
4946167|NCT02928380|12165642|P5|COMPLETED|Period 3||14
4946168|NCT02928380|12165643|P4|COMPLETED|Period 3||14
4946169|NCT02928380|12165644|P3|COMPLETED|Period 3||14
4946170|NCT02928380|12165645|P2|COMPLETED|Period 3||14
4946171|NCT02928380|12165646|P1|COMPLETED|Period 3||13
4946172|NCT02928380|12165641|P6|STARTED|Period 3||14
4946173|NCT02928380|12165642|P5|STARTED|Period 3||14
4946174|NCT02928380|12165643|P4|STARTED|Period 3||14
4946175|NCT02928380|12165644|P3|STARTED|Period 3||14
4946176|NCT02928380|12165645|P2|STARTED|Period 3||14
4946177|NCT02928380|12165646|P1|STARTED|Period 3||13
4946178|NCT02928380|12165641|P6|NOT COMPLETED|Wash Out Period 2||0
4946179|NCT02928380|12165642|P5|NOT COMPLETED|Wash Out Period 2||0
4946180|NCT02928380|12165643|P4|NOT COMPLETED|Wash Out Period 2||0
4946181|NCT02928380|12165644|P3|NOT COMPLETED|Wash Out Period 2||0
4946182|NCT02928380|12165645|P2|NOT COMPLETED|Wash Out Period 2||0
4946183|NCT02928380|12165646|P1|NOT COMPLETED|Wash Out Period 2||0
4946184|NCT02928380|12165641|P6|COMPLETED|Wash Out Period 2||14
4946185|NCT02928380|12165642|P5|COMPLETED|Wash Out Period 2||14
4946186|NCT02928380|12165643|P4|COMPLETED|Wash Out Period 2||14
4946187|NCT02928380|12165644|P3|COMPLETED|Wash Out Period 2||14
4946188|NCT02928380|12165645|P2|COMPLETED|Wash Out Period 2||14
4946189|NCT02928380|12165646|P1|COMPLETED|Wash Out Period 2||13
4946190|NCT02928380|12165641|P6|STARTED|Wash Out Period 2||14
4946191|NCT02928380|12165642|P5|STARTED|Wash Out Period 2||14
4946192|NCT02928380|12165643|P4|STARTED|Wash Out Period 2||14
4946193|NCT02928380|12165644|P3|STARTED|Wash Out Period 2||14
4946194|NCT02928380|12165645|P2|STARTED|Wash Out Period 2||14
4946195|NCT02928380|12165646|P1|STARTED|Wash Out Period 2||13
4946196|NCT02928380|12165641|P6|NOT COMPLETED|Period 2||0
4946197|NCT02928380|12165642|P5|NOT COMPLETED|Period 2||0
4946198|NCT02928380|12165643|P4|NOT COMPLETED|Period 2||0
4946199|NCT02928380|12165644|P3|NOT COMPLETED|Period 2||0
4946200|NCT02928380|12165645|P2|NOT COMPLETED|Period 2||0
4946201|NCT02928380|12165646|P1|NOT COMPLETED|Period 2||0
4946202|NCT02928380|12165641|P6|COMPLETED|Period 2||14
4946203|NCT02928380|12165642|P5|COMPLETED|Period 2||14
4946204|NCT02928380|12165643|P4|COMPLETED|Period 2||14
4946205|NCT02928380|12165644|P3|COMPLETED|Period 2||14
4946206|NCT02928380|12165645|P2|COMPLETED|Period 2||14
4946207|NCT02928380|12165646|P1|COMPLETED|Period 2||13
4946208|NCT02928380|12165641|P6|STARTED|Period 2||14
4946209|NCT02928380|12165642|P5|STARTED|Period 2||14
4946210|NCT02928380|12165643|P4|STARTED|Period 2||14
4946211|NCT02928380|12165644|P3|STARTED|Period 2||14
4946212|NCT02928380|12165645|P2|STARTED|Period 2||14
4946213|NCT02928380|12165646|P1|STARTED|Period 2||13
4946214|NCT02928380|12165641|P6|NOT COMPLETED|Wash Out Period 1||0
4946215|NCT02928380|12165642|P5|NOT COMPLETED|Wash Out Period 1||0
4946216|NCT02928380|12165643|P4|NOT COMPLETED|Wash Out Period 1||0
4946217|NCT02928380|12165644|P3|NOT COMPLETED|Wash Out Period 1||0
4946218|NCT02928380|12165645|P2|NOT COMPLETED|Wash Out Period 1||0
4946219|NCT02928380|12165646|P1|NOT COMPLETED|Wash Out Period 1||0
4946220|NCT02928380|12165641|P6|COMPLETED|Wash Out Period 1||14
4946221|NCT02928380|12165642|P5|COMPLETED|Wash Out Period 1||14
4946222|NCT02928380|12165643|P4|COMPLETED|Wash Out Period 1||14
4946223|NCT02928380|12165644|P3|COMPLETED|Wash Out Period 1||14
4946224|NCT02928380|12165645|P2|COMPLETED|Wash Out Period 1||14
4946225|NCT02928380|12165646|P1|COMPLETED|Wash Out Period 1||13
4946226|NCT02928380|12165641|P6|STARTED|Wash Out Period 1||14
4946227|NCT02928380|12165642|P5|STARTED|Wash Out Period 1||14
4946228|NCT02928380|12165643|P4|STARTED|Wash Out Period 1||14
4946229|NCT02928380|12165644|P3|STARTED|Wash Out Period 1||14
4946230|NCT02928380|12165645|P2|STARTED|Wash Out Period 1||14
4946231|NCT02928380|12165646|P1|STARTED|Wash Out Period 1||13
4946232|NCT02928380|12165641|P6|NOT COMPLETED|Period 1||0
4946233|NCT02928380|12165642|P5|NOT COMPLETED|Period 1||0
4946234|NCT02928380|12165643|P4|NOT COMPLETED|Period 1||0
4946235|NCT02928380|12165644|P3|NOT COMPLETED|Period 1||0
4946236|NCT02928380|12165645|P2|NOT COMPLETED|Period 1||0
4946237|NCT02928380|12165646|P1|NOT COMPLETED|Period 1||0
4946238|NCT02928380|12165641|P6|COMPLETED|Period 1||14
4946239|NCT02928380|12165642|P5|COMPLETED|Period 1||14
4946240|NCT02928380|12165643|P4|COMPLETED|Period 1||14
4946241|NCT02928380|12165644|P3|COMPLETED|Period 1||14
4946242|NCT02928380|12165645|P2|COMPLETED|Period 1||14
4946243|NCT02928380|12165646|P1|COMPLETED|Period 1||13
4946244|NCT02928380|12165641|P6|STARTED|Period 1||14
4946245|NCT02928380|12165642|P5|STARTED|Period 1||14
4946246|NCT02928380|12165643|P4|STARTED|Period 1||14
4946247|NCT02928380|12165644|P3|STARTED|Period 1||14
4946248|NCT02928380|12165645|P2|STARTED|Period 1||14
4946249|NCT02928380|12165646|P1|STARTED|Period 1||13
4946250|NCT02928224|12165670|P4|NOT COMPLETED|Overall Study||221
4946251|NCT02928224|12165671|P3|NOT COMPLETED|Overall Study||220
4946252|NCT02928224|12165672|P2|NOT COMPLETED|Overall Study||224
4946253|NCT02928224|12165673|P1|NOT COMPLETED|Overall Study||37
4946254|NCT02928224|12165670|P4|COMPLETED|Overall Study||0
4946255|NCT02928224|12165671|P3|COMPLETED|Overall Study||0
4946256|NCT02928224|12165672|P2|COMPLETED|Overall Study||0
4946257|NCT02928224|12165673|P1|COMPLETED|Overall Study||0
4946258|NCT02928224|12165670|P4|STARTED|Overall Study||221
4946259|NCT02928224|12165671|P3|STARTED|Overall Study||220
4946260|NCT02928224|12165672|P2|STARTED|Overall Study||224
4946261|NCT02928224|12165673|P1|STARTED|Overall Study||37
4946262|NCT02928029|12165777|P2|NOT COMPLETED|Overall Study||4
4946263|NCT02928029|12165778|P1|NOT COMPLETED|Overall Study||3
4946264|NCT02928029|12165777|P2|COMPLETED|Overall Study||0
4946265|NCT02928029|12165778|P1|COMPLETED|Overall Study||0
4946266|NCT02928029|12165777|P2|STARTED|Overall Study||4
4946267|NCT02928029|12165778|P1|STARTED|Overall Study||3
4946268|NCT02927938|12165792|P4|NOT COMPLETED|Overall Study||7
4946269|NCT02927938|12165793|P3|NOT COMPLETED|Overall Study||4
4946270|NCT02927938|12165794|P2|NOT COMPLETED|Overall Study||6
4946271|NCT02927938|12165795|P1|NOT COMPLETED|Overall Study||1
4946272|NCT02927938|12165792|P4|COMPLETED|Overall Study||0
4946273|NCT02927938|12165793|P3|COMPLETED|Overall Study||0
4946274|NCT02927938|12165794|P2|COMPLETED|Overall Study||0
4946275|NCT02927938|12165795|P1|COMPLETED|Overall Study||0
4946276|NCT02927938|12165792|P4|STARTED|Overall Study||7
4946277|NCT02927938|12165793|P3|STARTED|Overall Study||4
4946278|NCT02927938|12165794|P2|STARTED|Overall Study||6
4946279|NCT02927938|12165795|P1|STARTED|Overall Study||1
4946280|NCT02927795|12165803|P1|NOT COMPLETED|Overall Study||23
4946281|NCT02927795|12165803|P1|COMPLETED|Overall Study||234
4946282|NCT02927795|12165803|P1|Treated|Overall Study||253
4946283|NCT02927795|12165803|P1|STARTED|Overall Study||257
4946284|NCT02927457|12165814|P2|NOT COMPLETED|Overall Study||0
4946285|NCT02927457|12165815|P1|NOT COMPLETED|Overall Study||0
4946286|NCT02927457|12165814|P2|COMPLETED|Overall Study||11
4946287|NCT02927457|12165815|P1|COMPLETED|Overall Study||0
4946288|NCT02927457|12165814|P2|STARTED|Overall Study||11
4946289|NCT02927457|12165815|P1|STARTED|Overall Study||0
4946290|NCT02927431|12165850|P3|NOT COMPLETED|Overall Study||1
4946291|NCT02927431|12165851|P2|NOT COMPLETED|Overall Study||0
4946292|NCT02927431|12165852|P1|NOT COMPLETED|Overall Study||0
4946293|NCT02927431|12165850|P3|COMPLETED|Overall Study||3
4946294|NCT02927431|12165851|P2|COMPLETED|Overall Study||4
4946295|NCT02927431|12165852|P1|COMPLETED|Overall Study||2
4946296|NCT02927431|12165850|P3|STARTED|Overall Study||4
4946297|NCT02927431|12165851|P2|STARTED|Overall Study||4
4946298|NCT02927431|12165852|P1|STARTED|Overall Study||2
4946299|NCT02927366|12165930|P2|NOT COMPLETED|Overall Study||0
4946300|NCT02927366|12165931|P1|NOT COMPLETED|Overall Study||2
4946301|NCT02927366|12165930|P2|COMPLETED|Overall Study||2
4946302|NCT02927366|12165931|P1|COMPLETED|Overall Study||4
4946303|NCT02927366|12165930|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
4946304|NCT02927366|12165931|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
4946305|NCT02927366|12165930|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
4946306|NCT02927366|12165931|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
4946307|NCT02927366|12165930|P2|STARTED|Overall Study||2
4946308|NCT02927366|12165931|P1|STARTED|Overall Study||6
4946309|NCT02927327|12165965|P2|NOT COMPLETED|Overall Study||0
4946310|NCT02927327|12165966|P1|NOT COMPLETED|Overall Study||0
4946311|NCT02927327|12165965|P2|COMPLETED|Overall Study||31
4946312|NCT02927327|12165966|P1|COMPLETED|Overall Study||30
4946313|NCT02927327|12165965|P2|STARTED|Overall Study||31
4946314|NCT02927327|12165966|P1|STARTED|Overall Study||30
4946315|NCT02927223|12165978|P1|NOT COMPLETED|Overall Study||0
4946316|NCT02927223|12165978|P1|COMPLETED|Overall Study||6
4946317|NCT02927223|12165978|P1|STARTED|Overall Study||6
4946318|NCT02927171|12165986|P2|NOT COMPLETED|Overall Study||1
4946319|NCT02927171|12165987|P1|NOT COMPLETED|Overall Study||0
4946320|NCT02927171|12165986|P2|COMPLETED|Overall Study||50
4946321|NCT02927171|12165987|P1|COMPLETED|Overall Study||53
4946322|NCT02927171|12165986|P2|STARTED|Overall Study||51
4946323|NCT02927171|12165987|P1|STARTED|Overall Study||53
4946324|NCT02926833|12166001|P4|NOT COMPLETED|Overall Study||23
4946325|NCT02926833|12166002|P3|NOT COMPLETED|Overall Study||7
4946326|NCT02926833|12166003|P2|NOT COMPLETED|Overall Study||4
4946327|NCT02926833|12166004|P1|NOT COMPLETED|Overall Study||3
4946328|NCT02926833|12166001|P4|COMPLETED|Overall Study||0
4946329|NCT02926833|12166002|P3|COMPLETED|Overall Study||0
4946330|NCT02926833|12166003|P2|COMPLETED|Overall Study||0
4946331|NCT02926833|12166004|P1|COMPLETED|Overall Study||0
4946332|NCT02926833|12166001|P4|STARTED|Overall Study||23
4946333|NCT02926833|12166002|P3|STARTED|Overall Study||7
4946334|NCT02926833|12166003|P2|STARTED|Overall Study||4
4946335|NCT02926833|12166004|P1|STARTED|Overall Study||3
4946336|NCT02926638|12166060|P2|NOT COMPLETED|Overall Study||5
4946337|NCT02926638|12166061|P1|NOT COMPLETED|Overall Study||4
4946338|NCT02926638|12166060|P2|COMPLETED|Overall Study||0
4946339|NCT02926638|12166061|P1|COMPLETED|Overall Study||0
4946340|NCT02926638|12166060|P2|Eligible|Overall Study||5
4946341|NCT02926638|12166061|P1|Eligible|Overall Study||3
4946342|NCT02926638|12166060|P2|STARTED|Overall Study||5
4946343|NCT02926638|12166061|P1|STARTED|Overall Study||4
4946344|NCT02926573|12166075|P2|NOT COMPLETED|Overall Study||9
4946345|NCT02926573|12166076|P1|NOT COMPLETED|Overall Study||11
4946346|NCT02926573|12166075|P2|COMPLETED|Overall Study||46
4946347|NCT02926573|12166076|P1|COMPLETED|Overall Study||44
4946348|NCT02926573|12166075|P2|STARTED|Overall Study||55
4946349|NCT02926573|12166076|P1|STARTED|Overall Study||55
4946350|NCT02926209|12166094|P2|NOT COMPLETED|Training Cohort - First Patients||0
4946351|NCT02926209|12166095|P1|NOT COMPLETED|Training Cohort - First Patients||0
4946352|NCT02926209|12166094|P2|COMPLETED|Training Cohort - First Patients||0
4946353|NCT02926209|12166095|P1|COMPLETED|Training Cohort - First Patients||20
4946354|NCT02926209|12166094|P2|STARTED|Training Cohort - First Patients||0
4946355|NCT02926209|12166095|P1|STARTED|Training Cohort - First Patients||20
4946356|NCT02926209|12166094|P2|NOT COMPLETED|Study Cohort||0
4946357|NCT02926209|12166095|P1|NOT COMPLETED|Study Cohort||1
4946358|NCT02926209|12166094|P2|COMPLETED|Study Cohort||37
4946359|NCT02926209|12166095|P1|COMPLETED|Study Cohort||41
4946360|NCT02926209|12166094|P2|STARTED|Study Cohort||37
4946361|NCT02926209|12166095|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
4946362|NCT02925923|12166108|P2|NOT COMPLETED|Overall Study||2
4946363|NCT02925923|12166109|P1|NOT COMPLETED|Overall Study||0
4946364|NCT02925923|12166108|P2|COMPLETED|Overall Study||48
4946365|NCT02925923|12166109|P1|COMPLETED|Overall Study||50
4946366|NCT02925923|12166108|P2|STARTED|Overall Study||50
4946367|NCT02925923|12166109|P1|STARTED|Overall Study||50
4946368|NCT02925858|12166139|P2|NOT COMPLETED|Overall Study||0
4946369|NCT02925858|12166140|P1|NOT COMPLETED|Overall Study||0
4946370|NCT02925858|12166139|P2|COMPLETED|Overall Study||38
4946371|NCT02925858|12166140|P1|COMPLETED|Overall Study||42
4946372|NCT02925858|12166139|P2|STARTED|Overall Study||38
4946373|NCT02925858|12166140|P1|STARTED|Overall Study||42
4946374|NCT02925741|12166166|P2|NOT COMPLETED|Overall Study||0
4946375|NCT02925741|12166167|P1|NOT COMPLETED|Overall Study||0
4946376|NCT02925741|12166166|P2|COMPLETED|Overall Study||1706
4946377|NCT02925741|12166167|P1|COMPLETED|Overall Study||1626
4946378|NCT02925741|12166166|P2|STARTED|Overall Study||1706
4946379|NCT02925741|12166167|P1|STARTED|Overall Study|1637 participants were allocated to synthetic sheets, but 11 participants refused.|1626
4946380|NCT02925611|12166179|P2|NOT COMPLETED|Overall Study||0
4946381|NCT02925611|12166180|P1|NOT COMPLETED|Overall Study||0
4946382|NCT02925611|12166179|P2|COMPLETED|Overall Study||30
4946383|NCT02925611|12166180|P1|COMPLETED|Overall Study||30
4946384|NCT02925611|12166179|P2|STARTED|Overall Study||30
4946385|NCT02925611|12166180|P1|STARTED|Overall Study||30
4946386|NCT02925494|12166200|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||50
4946387|NCT02925494|12166201|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||24
4946388|NCT02925494|12166202|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||10
4946389|NCT02925494|12166203|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||14
4946390|NCT02925494|12166200|P4|COMPLETED|Post-Treatment Follow-Up Period||134
4946391|NCT02925494|12166201|P3|COMPLETED|Post-Treatment Follow-Up Period||64
4946392|NCT02925494|12166202|P2|COMPLETED|Post-Treatment Follow-Up Period||37
4946393|NCT02925494|12166203|P1|COMPLETED|Post-Treatment Follow-Up Period||40
4946394|NCT02925494|12166200|P4|STARTED|Post-Treatment Follow-Up Period||184
4946395|NCT02925494|12166201|P3|STARTED|Post-Treatment Follow-Up Period||88
4946396|NCT02925494|12166202|P2|STARTED|Post-Treatment Follow-Up Period||47
4946397|NCT02925494|12166203|P1|STARTED|Post-Treatment Follow-Up Period||54
4946398|NCT02925494|12166200|P4|NOT COMPLETED|Treatment Period||36
4946399|NCT02925494|12166201|P3|NOT COMPLETED|Treatment Period||19
4946400|NCT02925494|12166202|P2|NOT COMPLETED|Treatment Period||15
4946401|NCT02925494|12166203|P1|NOT COMPLETED|Treatment Period||9
4946402|NCT02925494|12166200|P4|COMPLETED|Treatment Period||182
4946403|NCT02925494|12166201|P3|COMPLETED|Treatment Period||79
4946404|NCT02925494|12166202|P2|COMPLETED|Treatment Period||43
4946405|NCT02925494|12166203|P1|COMPLETED|Treatment Period||50
4946406|NCT02925494|12166200|P4|STARTED|Treatment Period||218
4946407|NCT02925494|12166201|P3|STARTED|Treatment Period||98
4946408|NCT02925494|12166202|P2|STARTED|Treatment Period||58
4946409|NCT02925494|12166203|P1|STARTED|Treatment Period||59
4946410|NCT02925403|12166231|P2|NOT COMPLETED|Overall Study||1
4946411|NCT02925403|12166232|P1|NOT COMPLETED|Overall Study||0
4946412|NCT02925403|12166231|P2|COMPLETED|Overall Study||4
4946413|NCT02925403|12166232|P1|COMPLETED|Overall Study||8
4946414|NCT02925403|12166231|P2|STARTED|Overall Study||5
4946415|NCT02925403|12166232|P1|STARTED|Overall Study||8
4946416|NCT02925312|12166246|P2|NOT COMPLETED|Overall Study||0
4946417|NCT02925312|12166247|P1|NOT COMPLETED|Overall Study||27
4946418|NCT02925312|12166246|P2|COMPLETED|Overall Study||294
4946419|NCT02925312|12166247|P1|COMPLETED|Overall Study||98
4946420|NCT02925312|12166246|P2|STARTED|Overall Study||294
4946421|NCT02925312|12166247|P1|STARTED|Overall Study||125
4946422|NCT02925117|12166263|P12|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
4946423|NCT02925117|12166264|P11|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
4946424|NCT02925117|12166265|P10|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
4946425|NCT02925117|12166266|P9|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
4946426|NCT02925117|12166267|P8|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
4946427|NCT02925117|12166268|P7|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
4946428|NCT02925117|12166269|P6|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
4946429|NCT02925117|12166270|P5|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
4946430|NCT02925117|12166271|P4|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
4946431|NCT02925117|12166272|P3|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
4946432|NCT02925117|12166273|P2|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
4946433|NCT02925117|12166274|P1|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
4946434|NCT02925117|12166263|P12|COMPLETED|Period 2 (Weeks 16 - 88)||14
4946435|NCT02925117|12166264|P11|COMPLETED|Period 2 (Weeks 16 - 88)||11
4946436|NCT02925117|12166265|P10|COMPLETED|Period 2 (Weeks 16 - 88)||12
4946437|NCT02925117|12166266|P9|COMPLETED|Period 2 (Weeks 16 - 88)||13
4946438|NCT02925117|12166267|P8|COMPLETED|Period 2 (Weeks 16 - 88)||11
4946439|NCT02925117|12166268|P7|COMPLETED|Period 2 (Weeks 16 - 88)||9
4946440|NCT02925117|12166269|P6|COMPLETED|Period 2 (Weeks 16 - 88)||5
4946441|NCT02925117|12166270|P5|COMPLETED|Period 2 (Weeks 16 - 88)||8
4946442|NCT02925117|12166271|P4|COMPLETED|Period 2 (Weeks 16 - 88)||0
4946443|NCT02925117|12166272|P3|COMPLETED|Period 2 (Weeks 16 - 88)||0
4946444|NCT02925117|12166273|P2|COMPLETED|Period 2 (Weeks 16 - 88)||0
4946445|NCT02925117|12166274|P1|COMPLETED|Period 2 (Weeks 16 - 88)||0
4946446|NCT02925117|12166263|P12|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
4946447|NCT02925117|12166264|P11|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
4946448|NCT02925117|12166265|P10|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
4946449|NCT02925117|12166266|P9|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
4946450|NCT02925117|12166267|P8|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
4946451|NCT02925117|12166268|P7|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
4946452|NCT02925117|12166269|P6|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
4946453|NCT02925117|12166270|P5|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
4946454|NCT02925117|12166271|P4|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
4946455|NCT02925117|12166272|P3|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
4946456|NCT02925117|12166273|P2|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
4946457|NCT02925117|12166274|P1|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
4946458|NCT02925117|12166263|P12|STARTED|Period 2 (Weeks 16 - 88)||19
4946459|NCT02925117|12166264|P11|STARTED|Period 2 (Weeks 16 - 88)||19
4946460|NCT02925117|12166265|P10|STARTED|Period 2 (Weeks 16 - 88)||18
4946461|NCT02925117|12166266|P9|STARTED|Period 2 (Weeks 16 - 88)||19
4946462|NCT02925117|12166267|P8|STARTED|Period 2 (Weeks 16 - 88)||16
4946463|NCT02925117|12166268|P7|STARTED|Period 2 (Weeks 16 - 88)||15
4946464|NCT02925117|12166269|P6|STARTED|Period 2 (Weeks 16 - 88)||10
4946465|NCT02925117|12166270|P5|STARTED|Period 2 (Weeks 16 - 88)||10
4946466|NCT02925117|12166271|P4|STARTED|Period 2 (Weeks 16 - 88)||0
4946467|NCT02925117|12166272|P3|STARTED|Period 2 (Weeks 16 - 88)||0
4946468|NCT02925117|12166273|P2|STARTED|Period 2 (Weeks 16 - 88)||0
4946469|NCT02925117|12166274|P1|STARTED|Period 2 (Weeks 16 - 88)||0
4946470|NCT02925117|12166263|P12|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946471|NCT02925117|12166264|P11|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946472|NCT02925117|12166265|P10|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946473|NCT02925117|12166266|P9|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946474|NCT02925117|12166267|P8|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946475|NCT02925117|12166268|P7|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946476|NCT02925117|12166269|P6|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946477|NCT02925117|12166270|P5|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
4946478|NCT02925117|12166271|P4|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
4946479|NCT02925117|12166272|P3|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
4946480|NCT02925117|12166273|P2|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
4946481|NCT02925117|12166274|P1|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
4946482|NCT02925117|12166263|P12|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946483|NCT02925117|12166264|P11|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946484|NCT02925117|12166265|P10|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946485|NCT02925117|12166266|P9|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946486|NCT02925117|12166267|P8|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946487|NCT02925117|12166268|P7|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946488|NCT02925117|12166269|P6|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946489|NCT02925117|12166270|P5|COMPLETED|Period 1 (Weeks 0 - 16)||0
4946490|NCT02925117|12166271|P4|COMPLETED|Period 1 (Weeks 0 - 16)||39
4946491|NCT02925117|12166272|P3|COMPLETED|Period 1 (Weeks 0 - 16)||37
4946492|NCT02925117|12166273|P2|COMPLETED|Period 1 (Weeks 0 - 16)||31
4946493|NCT02925117|12166274|P1|COMPLETED|Period 1 (Weeks 0 - 16)||23
4946494|NCT02925117|12166263|P12|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946495|NCT02925117|12166264|P11|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946496|NCT02925117|12166265|P10|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946497|NCT02925117|12166266|P9|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946498|NCT02925117|12166267|P8|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946499|NCT02925117|12166268|P7|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946500|NCT02925117|12166269|P6|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946501|NCT02925117|12166270|P5|Received Treatment|Period 1 (Weeks 0 - 16)||0
4946502|NCT02925117|12166271|P4|Received Treatment|Period 1 (Weeks 0 - 16)||42
4946503|NCT02925117|12166272|P3|Received Treatment|Period 1 (Weeks 0 - 16)||42
4946504|NCT02925117|12166273|P2|Received Treatment|Period 1 (Weeks 0 - 16)||42
4946505|NCT02925117|12166274|P1|Received Treatment|Period 1 (Weeks 0 - 16)||40
4946506|NCT02925117|12166263|P12|STARTED|Period 1 (Weeks 0 - 16)||0
4946507|NCT02925117|12166264|P11|STARTED|Period 1 (Weeks 0 - 16)||0
4946508|NCT02925117|12166265|P10|STARTED|Period 1 (Weeks 0 - 16)||0
4946509|NCT02925117|12166266|P9|STARTED|Period 1 (Weeks 0 - 16)||0
4946510|NCT02925117|12166267|P8|STARTED|Period 1 (Weeks 0 - 16)||0
4946511|NCT02925117|12166268|P7|STARTED|Period 1 (Weeks 0 - 16)||0
4946512|NCT02925117|12166269|P6|STARTED|Period 1 (Weeks 0 - 16)||0
4946513|NCT02925117|12166270|P5|STARTED|Period 1 (Weeks 0 - 16)||0
4946514|NCT02925117|12166271|P4|STARTED|Period 1 (Weeks 0 - 16)||42
4946515|NCT02925117|12166272|P3|STARTED|Period 1 (Weeks 0 - 16)||42
4946516|NCT02925117|12166273|P2|STARTED|Period 1 (Weeks 0 - 16)||42
4946517|NCT02925117|12166274|P1|STARTED|Period 1 (Weeks 0 - 16)||41
4946518|NCT02924883|12166374|P2|NOT COMPLETED|Overall Study||133
4946519|NCT02924883|12166375|P1|NOT COMPLETED|Overall Study||69
4946520|NCT02924883|12166374|P2|COMPLETED|Overall Study||0
4946521|NCT02924883|12166375|P1|COMPLETED|Overall Study||0
4946522|NCT02924883|12166374|P2|STARTED|Overall Study||133
4946523|NCT02924883|12166375|P1|STARTED|Overall Study||69
4946524|NCT02924688|12166400|P6|NOT COMPLETED|Overall Study||24
4946525|NCT02924688|12166401|P5|NOT COMPLETED|Overall Study||23
4946526|NCT02924688|12166402|P4|NOT COMPLETED|Overall Study||28
4946527|NCT02924688|12166403|P3|NOT COMPLETED|Overall Study||23
4946528|NCT02924688|12166404|P2|NOT COMPLETED|Overall Study||31
4946529|NCT02924688|12166405|P1|NOT COMPLETED|Overall Study||33
4946530|NCT02924688|12166400|P6|COMPLETED|Overall Study||384
4946531|NCT02924688|12166401|P5|COMPLETED|Overall Study||381
4946532|NCT02924688|12166402|P4|COMPLETED|Overall Study||378
4946533|NCT02924688|12166403|P3|COMPLETED|Overall Study||383
4946534|NCT02924688|12166404|P2|COMPLETED|Overall Study||374
4946535|NCT02924688|12166405|P1|COMPLETED|Overall Study||374
4946536|NCT02924688|12166400|P6|STARTED|Overall Study||408
4946537|NCT02924688|12166401|P5|STARTED|Overall Study||404
4946538|NCT02924688|12166402|P4|STARTED|Overall Study||406
4946539|NCT02924688|12166403|P3|STARTED|Overall Study||406
4946540|NCT02924688|12166404|P2|STARTED|Overall Study||405
4946541|NCT02924688|12166405|P1|STARTED|Overall Study||407
4946542|NCT02924350|12166475|P2|NOT COMPLETED|Overall Study||2
4946543|NCT02924350|12166476|P1|NOT COMPLETED|Overall Study||0
4946544|NCT02924350|12166475|P2|COMPLETED|Overall Study||100
4946545|NCT02924350|12166476|P1|COMPLETED|Overall Study||102
4946546|NCT02924350|12166475|P2|STARTED|Overall Study||102
4946547|NCT02924350|12166476|P1|STARTED|Overall Study||102
4946548|NCT02924051|12166488|P2|NOT COMPLETED|Overall Study||9
4946549|NCT02924051|12166489|P1|NOT COMPLETED|Overall Study||1
4946550|NCT02924051|12166488|P2|COMPLETED|Overall Study||97
4946551|NCT02924051|12166489|P1|COMPLETED|Overall Study||81
4946552|NCT02924051|12166488|P2|STARTED|Overall Study||106
4946553|NCT02924051|12166489|P1|STARTED|Overall Study||82
4946554|NCT02923895|12166501|P2|NOT COMPLETED|Overall Study||0
4946555|NCT02923895|12166502|P1|NOT COMPLETED|Overall Study||0
4946556|NCT02923895|12166501|P2|COMPLETED|Overall Study||95
4946557|NCT02923895|12166502|P1|COMPLETED|Overall Study||97
4946558|NCT02923895|12166501|P2|STARTED|Overall Study||95
4946559|NCT02923895|12166502|P1|STARTED|Overall Study||97
4946560|NCT02923830|12166516|P2|NOT COMPLETED|Overall Study||15
4946561|NCT02923830|12166517|P1|NOT COMPLETED|Overall Study||13
4946562|NCT02923830|12166516|P2|COMPLETED|Overall Study|Study terminated|0
4946563|NCT02923830|12166517|P1|COMPLETED|Overall Study|Study terminated|0
4946564|NCT02923830|12166516|P2|STARTED|Overall Study||15
4946565|NCT02923830|12166517|P1|STARTED|Overall Study||13
4946566|NCT02923349|12166542|P7|NOT COMPLETED|Overall Study||3
4946567|NCT02923349|12166543|P6|NOT COMPLETED|Overall Study||7
4946568|NCT02923349|12166544|P5|NOT COMPLETED|Overall Study||19
4946569|NCT02923349|12166545|P4|NOT COMPLETED|Overall Study||16
4946570|NCT02923349|12166546|P3|NOT COMPLETED|Overall Study||17
4946571|NCT02923349|12166547|P2|NOT COMPLETED|Overall Study||4
4946572|NCT02923349|12166548|P1|NOT COMPLETED|Overall Study||4
4946573|NCT02923349|12166542|P7|COMPLETED|Overall Study||1
4946574|NCT02923349|12166543|P6|COMPLETED|Overall Study||5
4946575|NCT02923349|12166544|P5|COMPLETED|Overall Study||4
4946576|NCT02923349|12166545|P4|COMPLETED|Overall Study||2
4946577|NCT02923349|12166546|P3|COMPLETED|Overall Study||5
4946578|NCT02923349|12166547|P2|COMPLETED|Overall Study||0
4946579|NCT02923349|12166548|P1|COMPLETED|Overall Study||0
4946580|NCT02923349|12166542|P7|STARTED|Overall Study||4
4946581|NCT02923349|12166543|P6|STARTED|Overall Study||12
4946582|NCT02923349|12166544|P5|STARTED|Overall Study||23
4946583|NCT02923349|12166545|P4|STARTED|Overall Study||18
4946584|NCT02923349|12166546|P3|STARTED|Overall Study||22
4946585|NCT02923349|12166547|P2|STARTED|Overall Study||4
4946586|NCT02923349|12166548|P1|STARTED|Overall Study||4
4946587|NCT02923271|12166622|P2|NOT COMPLETED|Overall Study||2
4946588|NCT02923271|12166623|P1|NOT COMPLETED|Overall Study||8
4946589|NCT02923271|12166622|P2|COMPLETED|Overall Study||14
4946590|NCT02923271|12166623|P1|COMPLETED|Overall Study||10
4946591|NCT02923271|12166622|P2|STARTED|Overall Study||16
4946592|NCT02923271|12166623|P1|STARTED|Overall Study||18
4946593|NCT02923245|12166633|P2|NOT COMPLETED|Overall Study||1
4946594|NCT02923245|12166634|P1|NOT COMPLETED|Overall Study||2
4946595|NCT02923245|12166633|P2|COMPLETED|Overall Study||59
4946596|NCT02923245|12166634|P1|COMPLETED|Overall Study||58
4946597|NCT02923245|12166633|P2|STARTED|Overall Study||60
4946598|NCT02923245|12166634|P1|STARTED|Overall Study||60
4946599|NCT02923115|12166657|P6|NOT COMPLETED|Overall Study||0
4946600|NCT02923115|12166658|P5|NOT COMPLETED|Overall Study||5
4946601|NCT02923115|12166659|P4|NOT COMPLETED|Overall Study||2
4946602|NCT02923115|12166660|P3|NOT COMPLETED|Overall Study||3
4946603|NCT02923115|12166661|P2|NOT COMPLETED|Overall Study||1
4946604|NCT02923115|12166662|P1|NOT COMPLETED|Overall Study||0
4946605|NCT02923115|12166657|P6|COMPLETED|Overall Study||38
4946606|NCT02923115|12166658|P5|COMPLETED|Overall Study||17
4946607|NCT02923115|12166659|P4|COMPLETED|Overall Study||21
4946608|NCT02923115|12166660|P3|COMPLETED|Overall Study||20
4946609|NCT02923115|12166661|P2|COMPLETED|Overall Study||15
4946610|NCT02923115|12166662|P1|COMPLETED|Overall Study||12
4946611|NCT02923115|12166657|P6|Treated|Overall Study||38
4946612|NCT02923115|12166658|P5|Treated|Overall Study||17
4946613|NCT02923115|12166659|P4|Treated|Overall Study||22
4946614|NCT02923115|12166660|P3|Treated|Overall Study||20
4946615|NCT02923115|12166661|P2|Treated|Overall Study||16
4946616|NCT02923115|12166662|P1|Treated|Overall Study||12
4946617|NCT02923115|12166657|P6|STARTED|Overall Study||38
4946618|NCT02923115|12166658|P5|STARTED|Overall Study||22
4946619|NCT02923115|12166659|P4|STARTED|Overall Study||23
4946620|NCT02923115|12166660|P3|STARTED|Overall Study||23
4946621|NCT02923115|12166661|P2|STARTED|Overall Study||16
4946622|NCT02923115|12166662|P1|STARTED|Overall Study||12
4946623|NCT02922985|12166705|P2|NOT COMPLETED|Overall Study||0
4946624|NCT02922985|12166706|P1|NOT COMPLETED|Overall Study||0
4946625|NCT02922985|12166705|P2|COMPLETED|Overall Study||60
4946626|NCT02922985|12166706|P1|COMPLETED|Overall Study||60
4946627|NCT02922985|12166705|P2|STARTED|Overall Study||60
4946628|NCT02922985|12166706|P1|STARTED|Overall Study||60
4946629|NCT02922959|12166732|P2|NOT COMPLETED|Overall Study||17
4946630|NCT02922959|12166733|P1|NOT COMPLETED|Overall Study||19
4946631|NCT02922959|12166732|P2|COMPLETED|Overall Study||23
4946632|NCT02922959|12166733|P1|COMPLETED|Overall Study||21
4946633|NCT02922959|12166732|P2|12 Months|Overall Study|n=23 (57.5%)|23
4946634|NCT02922959|12166733|P1|12 Months|Overall Study|n=21 (52.5%)|21
4946635|NCT02922959|12166732|P2|6 Months|Overall Study|n=30 (75.0%)|30
4946636|NCT02922959|12166733|P1|6 Months|Overall Study|n=28 (70.0%)|28
4946637|NCT02922959|12166732|P2|3 Months|Overall Study|n=31 (77.5%)|31
4946638|NCT02922959|12166733|P1|3 Months|Overall Study|n=35 (87.5%)|35
4946639|NCT02922959|12166732|P2|3 Weeks|Overall Study|n=36 (90.0%)|36
4946640|NCT02922959|12166733|P1|3 Weeks|Overall Study|n=38 (95.0%)|38
4946641|NCT02922959|12166732|P2|STARTED|Overall Study||40
4946642|NCT02922959|12166733|P1|STARTED|Overall Study||40
4946643|NCT02922868|12166747|P2|NOT COMPLETED|Overall Study||0
4946644|NCT02922868|12166748|P1|NOT COMPLETED|Overall Study||0
4946645|NCT02922868|12166747|P2|COMPLETED|Overall Study||30
4946646|NCT02922868|12166748|P1|COMPLETED|Overall Study||30
4946647|NCT02922868|12166747|P2|STARTED|Overall Study||30
4946648|NCT02922868|12166748|P1|STARTED|Overall Study||30
4946649|NCT02922738|12166768|P2|NOT COMPLETED|Overall Study||0
4946650|NCT02922738|12166769|P1|NOT COMPLETED|Overall Study||0
4946651|NCT02922738|12166768|P2|COMPLETED|Overall Study||290
4946652|NCT02922738|12166769|P1|COMPLETED|Overall Study||175
4946653|NCT02922738|12166768|P2|STARTED|Overall Study|275 patients and 15 providers|290
4946654|NCT02922738|12166769|P1|STARTED|Overall Study|158 patients and 17 providers|175
4946655|NCT02921841|12166779|P2|NOT COMPLETED|Overall Study||13
4946656|NCT02921841|12166780|P1|NOT COMPLETED|Overall Study||16
4946657|NCT02921841|12166779|P2|COMPLETED|Overall Study||44
4946658|NCT02921841|12166780|P1|COMPLETED|Overall Study||52
4946659|NCT02921841|12166779|P2|STARTED|Overall Study||57
4946660|NCT02921841|12166780|P1|STARTED|Overall Study||68
4946661|NCT02921490|12166812|P1|NOT COMPLETED|Overall Study||0
4946662|NCT02921490|12166812|P1|COMPLETED|Overall Study||10
4946663|NCT02921490|12166812|P1|STARTED|Overall Study||10
4946664|NCT02921425|12166823|P1|NOT COMPLETED|Overall Study||9
4946665|NCT02921425|12166823|P1|COMPLETED|Overall Study||38
4946666|NCT02921425|12166823|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
4946667|NCT02921425|12166823|P1|STARTED|Overall Study||47
4946668|NCT02921412|12166837|P1|NOT COMPLETED|Overall Study||0
4946669|NCT02921412|12166837|P1|COMPLETED|Overall Study||36
4946670|NCT02921412|12166837|P1|STARTED|Overall Study||36
4946671|NCT02921386|12166860|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
4946672|NCT02921386|12166860|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
4946673|NCT02921386|12166860|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
4946674|NCT02921386|12166860|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
4946675|NCT02921386|12166860|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
4946676|NCT02921386|12166860|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
4946677|NCT02921386|12166860|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
4946678|NCT02921386|12166860|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
4946679|NCT02921386|12166860|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
4946680|NCT02921386|12166860|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
4946681|NCT02921386|12166860|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
4946682|NCT02921386|12166860|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
4946683|NCT02921386|12166860|P1|NOT COMPLETED|Sequence A: Fasting||0
4946684|NCT02921386|12166860|P1|COMPLETED|Sequence A: Fasting||18
4946685|NCT02921386|12166860|P1|STARTED|Sequence A: Fasting||18
4946686|NCT02921295|12166883|P1|NOT COMPLETED|Conventional Prostheses||0
4946687|NCT02921295|12166883|P1|COMPLETED|Conventional Prostheses||1
4946688|NCT02921295|12166883|P1|STARTED|Conventional Prostheses||1
4946689|NCT02921295|12166883|P1|NOT COMPLETED|Sidekicks||0
4946690|NCT02921295|12166883|P1|COMPLETED|Sidekicks||1
4946691|NCT02921295|12166883|P1|STARTED|Sidekicks||1
4946692|NCT02921087|12166895|P2|NOT COMPLETED|Overall Study||1
4946693|NCT02921087|12166896|P1|NOT COMPLETED|Overall Study||0
4946694|NCT02921087|12166895|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
4946695|NCT02921087|12166896|P1|COMPLETED|Overall Study||12
4946696|NCT02921087|12166895|P2|STARTED|Overall Study||11
4946697|NCT02921087|12166896|P1|STARTED|Overall Study||12
4946698|NCT02921061|12166916|P1|NOT COMPLETED|Overall Study||0
4946699|NCT02921061|12166916|P1|COMPLETED|Overall Study||28
4946700|NCT02921061|12166916|P1|STARTED|Overall Study||28
4946701|NCT02920983|12166925|P6|NOT COMPLETED|Dispense 3||0
4946702|NCT02920983|12166926|P5|NOT COMPLETED|Dispense 3||1
4946703|NCT02920983|12166927|P4|NOT COMPLETED|Dispense 3||0
4946704|NCT02920983|12166928|P3|NOT COMPLETED|Dispense 3||0
4946705|NCT02920983|12166929|P2|NOT COMPLETED|Dispense 3||1
4946706|NCT02920983|12166930|P1|NOT COMPLETED|Dispense 3||1
4946707|NCT02920983|12166925|P6|COMPLETED|Dispense 3||7
4946708|NCT02920983|12166926|P5|COMPLETED|Dispense 3||12
4946709|NCT02920983|12166927|P4|COMPLETED|Dispense 3||6
4946710|NCT02920983|12166928|P3|COMPLETED|Dispense 3||7
4946711|NCT02920983|12166929|P2|COMPLETED|Dispense 3||9
4946712|NCT02920983|12166930|P1|COMPLETED|Dispense 3||7
4946713|NCT02920983|12166925|P6|STARTED|Dispense 3||7
4946714|NCT02920983|12166926|P5|STARTED|Dispense 3||13
4946715|NCT02920983|12166927|P4|STARTED|Dispense 3||6
4946716|NCT02920983|12166928|P3|STARTED|Dispense 3||7
4946717|NCT02920983|12166929|P2|STARTED|Dispense 3||10
4946718|NCT02920983|12166930|P1|STARTED|Dispense 3||8
4946719|NCT02920983|12166925|P6|NOT COMPLETED|Dispense 2||0
4946720|NCT02920983|12166926|P5|NOT COMPLETED|Dispense 2||1
4946721|NCT02920983|12166927|P4|NOT COMPLETED|Dispense 2||0
4946722|NCT02920983|12166928|P3|NOT COMPLETED|Dispense 2||0
4946723|NCT02920983|12166929|P2|NOT COMPLETED|Dispense 2||0
4946724|NCT02920983|12166930|P1|NOT COMPLETED|Dispense 2||1
4946725|NCT02920983|12166925|P6|COMPLETED|Dispense 2||7
4946726|NCT02920983|12166926|P5|COMPLETED|Dispense 2||12
4946727|NCT02920983|12166927|P4|COMPLETED|Dispense 2||6
4946728|NCT02920983|12166928|P3|COMPLETED|Dispense 2||7
4946729|NCT02920983|12166929|P2|COMPLETED|Dispense 2||10
4946730|NCT02920983|12166930|P1|COMPLETED|Dispense 2||7
4946731|NCT02920983|12166925|P6|STARTED|Dispense 2||7
4946732|NCT02920983|12166926|P5|STARTED|Dispense 2||13
4946733|NCT02920983|12166927|P4|STARTED|Dispense 2||6
4946734|NCT02920983|12166928|P3|STARTED|Dispense 2||7
4946735|NCT02920983|12166929|P2|STARTED|Dispense 2||10
4946736|NCT02920983|12166930|P1|STARTED|Dispense 2||8
4946737|NCT02920983|12166925|P6|NOT COMPLETED|Dispense 1||0
4946738|NCT02920983|12166926|P5|NOT COMPLETED|Dispense 1||1
4946739|NCT02920983|12166927|P4|NOT COMPLETED|Dispense 1||0
4946740|NCT02920983|12166928|P3|NOT COMPLETED|Dispense 1||0
4946741|NCT02920983|12166929|P2|NOT COMPLETED|Dispense 1||0
4946742|NCT02920983|12166930|P1|NOT COMPLETED|Dispense 1||0
4946743|NCT02920983|12166925|P6|COMPLETED|Dispense 1||7
4946744|NCT02920983|12166926|P5|COMPLETED|Dispense 1||12
4946745|NCT02920983|12166927|P4|COMPLETED|Dispense 1||6
4946746|NCT02920983|12166928|P3|COMPLETED|Dispense 1||7
4946747|NCT02920983|12166929|P2|COMPLETED|Dispense 1||10
4946748|NCT02920983|12166930|P1|COMPLETED|Dispense 1||8
4946749|NCT02920983|12166925|P6|STARTED|Dispense 1||7
4946750|NCT02920983|12166926|P5|STARTED|Dispense 1||13
4946751|NCT02920983|12166927|P4|STARTED|Dispense 1||6
4946752|NCT02920983|12166928|P3|STARTED|Dispense 1||7
4946753|NCT02920983|12166929|P2|STARTED|Dispense 1||10
4946754|NCT02920983|12166930|P1|STARTED|Dispense 1||8
4946755|NCT02920970|12166959|P2|NOT COMPLETED|Second Intervention||0
4946756|NCT02920970|12166960|P1|NOT COMPLETED|Second Intervention||1
4946757|NCT02920970|12166959|P2|COMPLETED|Second Intervention||30
4946758|NCT02920970|12166960|P1|COMPLETED|Second Intervention||37
4946759|NCT02920970|12166959|P2|STARTED|Second Intervention||30
4946760|NCT02920970|12166960|P1|STARTED|Second Intervention||38
4946761|NCT02920970|12166959|P2|NOT COMPLETED|First Intervention||2
4946762|NCT02920970|12166960|P1|NOT COMPLETED|First Intervention||0
4946763|NCT02920970|12166959|P2|COMPLETED|First Intervention||30
4946764|NCT02920970|12166960|P1|COMPLETED|First Intervention||38
4946765|NCT02920970|12166959|P2|STARTED|First Intervention||32
4946766|NCT02920970|12166960|P1|STARTED|First Intervention||38
4946767|NCT02920957|12166986|P2|NOT COMPLETED|Second Intervention: 1 Month||1
4946768|NCT02920957|12166987|P1|NOT COMPLETED|Second Intervention: 1 Month||0
4946769|NCT02920957|12166986|P2|COMPLETED|Second Intervention: 1 Month||40
4946770|NCT02920957|12166987|P1|COMPLETED|Second Intervention: 1 Month||42
4946771|NCT02920957|12166986|P2|STARTED|Second Intervention: 1 Month||41
4946772|NCT02920957|12166987|P1|STARTED|Second Intervention: 1 Month||42
4946773|NCT02920957|12166986|P2|NOT COMPLETED|First Intervention : 1 Month||0
4946774|NCT02920957|12166987|P1|NOT COMPLETED|First Intervention : 1 Month||4
4946775|NCT02920957|12166986|P2|COMPLETED|First Intervention : 1 Month||41
4946776|NCT02920957|12166987|P1|COMPLETED|First Intervention : 1 Month||42
4946777|NCT02920957|12166986|P2|STARTED|First Intervention : 1 Month||41
4946778|NCT02920957|12166987|P1|STARTED|First Intervention : 1 Month||46
4946779|NCT02920918|12167041|P2|NOT COMPLETED|Overall Study||0
4946780|NCT02920918|12167042|P1|NOT COMPLETED|Overall Study||0
4946781|NCT02920918|12167041|P2|COMPLETED|Overall Study||19
4946782|NCT02920918|12167042|P1|COMPLETED|Overall Study||17
4946783|NCT02920918|12167041|P2|STARTED|Overall Study||19
4946784|NCT02920918|12167042|P1|STARTED|Overall Study||17
4946785|NCT02920749|12167054|P4|NOT COMPLETED|Overall Study||0
4946786|NCT02920749|12167055|P3|NOT COMPLETED|Overall Study||0
4946787|NCT02920749|12167056|P2|NOT COMPLETED|Overall Study||0
4946788|NCT02920749|12167057|P1|NOT COMPLETED|Overall Study||0
4946789|NCT02920749|12167054|P4|COMPLETED|Overall Study||30
4946790|NCT02920749|12167055|P3|COMPLETED|Overall Study||30
4946791|NCT02920749|12167056|P2|COMPLETED|Overall Study||30
4946792|NCT02920749|12167057|P1|COMPLETED|Overall Study||30
4946793|NCT02920749|12167054|P4|STARTED|Overall Study||30
4946794|NCT02920749|12167055|P3|STARTED|Overall Study||30
4946795|NCT02920749|12167056|P2|STARTED|Overall Study||30
4946796|NCT02920749|12167057|P1|STARTED|Overall Study||30
4946797|NCT02920476|12167071|P1|NOT COMPLETED|Overall Study||1
4946798|NCT02920476|12167071|P1|COMPLETED|Overall Study||3
4946799|NCT02920476|12167071|P1|STARTED|Overall Study||4
4946800|NCT02920450|12167076|P4|NOT COMPLETED|Overall Study||0
4946801|NCT02920450|12167077|P3|NOT COMPLETED|Overall Study||0
4946802|NCT02920450|12167078|P2|NOT COMPLETED|Overall Study||0
4946803|NCT02920450|12167079|P1|NOT COMPLETED|Overall Study||2
4946804|NCT02920450|12167076|P4|COMPLETED|Overall Study||0
4946805|NCT02920450|12167077|P3|COMPLETED|Overall Study||0
4946806|NCT02920450|12167078|P2|COMPLETED|Overall Study||0
4946807|NCT02920450|12167079|P1|COMPLETED|Overall Study||1
4946808|NCT02920450|12167076|P4|STARTED|Overall Study||0
4946809|NCT02920450|12167077|P3|STARTED|Overall Study||0
4946810|NCT02920450|12167078|P2|STARTED|Overall Study||0
4946811|NCT02920450|12167079|P1|STARTED|Overall Study||3
4946812|NCT02920242|12167090|P3|NOT COMPLETED|Overall Study||1
4946813|NCT02920242|12167091|P2|NOT COMPLETED|Overall Study||0
4946814|NCT02920242|12167092|P1|NOT COMPLETED|Overall Study||2
4946815|NCT02920242|12167090|P3|COMPLETED|Overall Study||3
4946816|NCT02920242|12167091|P2|COMPLETED|Overall Study||11
4946817|NCT02920242|12167092|P1|COMPLETED|Overall Study||11
4946818|NCT02920242|12167090|P3|Safety Set|Overall Study||4
4946819|NCT02920242|12167091|P2|Safety Set|Overall Study||11
4946820|NCT02920242|12167092|P1|Safety Set|Overall Study||12
4946821|NCT02920242|12167090|P3|STARTED|Overall Study||4
4946822|NCT02920242|12167091|P2|STARTED|Overall Study||11
4946823|NCT02920242|12167092|P1|STARTED|Overall Study||13
4946824|NCT02920177|12167120|P2|NOT COMPLETED|Overall Study||2
4946825|NCT02920177|12167121|P1|NOT COMPLETED|Overall Study||2
4946826|NCT02920177|12167120|P2|COMPLETED|Overall Study||0
4946827|NCT02920177|12167121|P1|COMPLETED|Overall Study||0
4946828|NCT02920177|12167120|P2|STARTED|Overall Study||2
4946829|NCT02920177|12167121|P1|STARTED|Overall Study||2
4946830|NCT02919995|12167141|P6|NOT COMPLETED|Overall Study||1
4946831|NCT02919995|12167142|P5|NOT COMPLETED|Overall Study||0
4946832|NCT02919995|12167143|P4|NOT COMPLETED|Overall Study||0
4946833|NCT02919995|12167144|P3|NOT COMPLETED|Overall Study||0
4946834|NCT02919995|12167145|P2|NOT COMPLETED|Overall Study||0
4946835|NCT02919995|12167146|P1|NOT COMPLETED|Overall Study||0
4946836|NCT02919995|12167141|P6|COMPLETED|Overall Study||1
4946837|NCT02919995|12167142|P5|COMPLETED|Overall Study||1
4946838|NCT02919995|12167143|P4|COMPLETED|Overall Study||2
4946839|NCT02919995|12167144|P3|COMPLETED|Overall Study||2
4946840|NCT02919995|12167145|P2|COMPLETED|Overall Study||2
4946841|NCT02919995|12167146|P1|COMPLETED|Overall Study||1
4946842|NCT02919995|12167141|P6|STARTED|Overall Study||2
4946843|NCT02919995|12167142|P5|STARTED|Overall Study||1
4946844|NCT02919995|12167143|P4|STARTED|Overall Study||2
4946845|NCT02919995|12167144|P3|STARTED|Overall Study||2
4946846|NCT02919995|12167145|P2|STARTED|Overall Study||2
4946847|NCT02919995|12167146|P1|STARTED|Overall Study||1
4946848|NCT02919826|12167173|P2|NOT COMPLETED|Overall Study||2
4946849|NCT02919826|12167174|P1|NOT COMPLETED|Overall Study||0
4946850|NCT02919826|12167173|P2|COMPLETED|Overall Study||8
4946851|NCT02919826|12167174|P1|COMPLETED|Overall Study||10
4946852|NCT02919826|12167173|P2|STARTED|Overall Study||10
4946853|NCT02919826|12167174|P1|STARTED|Overall Study||10
4946854|NCT02919813|12167190|P2|NOT COMPLETED|Overall Study||0
4946855|NCT02919813|12167191|P1|NOT COMPLETED|Overall Study||0
4946856|NCT02919813|12167190|P2|COMPLETED|Overall Study||17
4946857|NCT02919813|12167191|P1|COMPLETED|Overall Study||14
4946858|NCT02919813|12167190|P2|STARTED|Overall Study||17
4946859|NCT02919813|12167191|P1|STARTED|Overall Study||14
4946860|NCT02919761|12167209|P3|NOT COMPLETED|Part 2: Double-blind||21
4946861|NCT02919761|12167210|P2|NOT COMPLETED|Part 2: Double-blind||6
4946862|NCT02919761|12167211|P1|NOT COMPLETED|Part 2: Double-blind||0
4946863|NCT02919761|12167209|P3|COMPLETED|Part 2: Double-blind||56
4946864|NCT02919761|12167210|P2|COMPLETED|Part 2: Double-blind||71
4946865|NCT02919761|12167211|P1|COMPLETED|Part 2: Double-blind||0
4946866|NCT02919761|12167209|P3|Per Protocol Population|Part 2: Double-blind||73
4946867|NCT02919761|12167210|P2|Per Protocol Population|Part 2: Double-blind||76
4946868|NCT02919761|12167211|P1|Per Protocol Population|Part 2: Double-blind||0
4946869|NCT02919761|12167209|P3|mITT Population|Part 2: Double-blind||76
4946870|NCT02919761|12167210|P2|mITT Population|Part 2: Double-blind||77
4946871|NCT02919761|12167211|P1|mITT Population|Part 2: Double-blind||0
4946872|NCT02919761|12167209|P3|Safety Population|Part 2: Double-blind||77
4946873|NCT02919761|12167210|P2|Safety Population|Part 2: Double-blind||77
4946874|NCT02919761|12167211|P1|Safety Population|Part 2: Double-blind||0
4946875|NCT02919761|12167209|P3|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
4946876|NCT02919761|12167210|P2|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
4946877|NCT02919761|12167211|P1|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
4946878|NCT02919761|12167209|P3|NOT COMPLETED|Part 1: Open Label||0
4946879|NCT02919761|12167210|P2|NOT COMPLETED|Part 1: Open Label||0
4946880|NCT02919761|12167211|P1|NOT COMPLETED|Part 1: Open Label||24
4946881|NCT02919761|12167209|P3|COMPLETED|Part 1: Open Label||0
4946882|NCT02919761|12167210|P2|COMPLETED|Part 1: Open Label||0
4946883|NCT02919761|12167211|P1|COMPLETED|Part 1: Open Label||235
4946884|NCT02919761|12167209|P3|Per Protocol Population|Part 1: Open Label||0
4946885|NCT02919761|12167210|P2|Per Protocol Population|Part 1: Open Label||0
4946886|NCT02919761|12167211|P1|Per Protocol Population|Part 1: Open Label||236
4946887|NCT02919761|12167209|P3|Safety Population|Part 1: Open Label||0
4946888|NCT02919761|12167210|P2|Safety Population|Part 1: Open Label||0
4946889|NCT02919761|12167211|P1|Safety Population|Part 1: Open Label||259
4946890|NCT02919761|12167209|P3|mITT Population|Part 1: Open Label||0
4946891|NCT02919761|12167210|P2|mITT Population|Part 1: Open Label||0
4946892|NCT02919761|12167211|P1|mITT Population|Part 1: Open Label||259
4946893|NCT02919761|12167209|P3|STARTED|Part 1: Open Label||0
4946894|NCT02919761|12167210|P2|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
4946895|NCT02919761|12167211|P1|STARTED|Part 1: Open Label||259
4946896|NCT02919683|12167239|P2|NOT COMPLETED|Post-Surgery Follow-Up||2
4946897|NCT02919683|12167240|P1|NOT COMPLETED|Post-Surgery Follow-Up||3
4946898|NCT02919683|12167239|P2|COMPLETED|Post-Surgery Follow-Up||13
4946899|NCT02919683|12167240|P1|COMPLETED|Post-Surgery Follow-Up||12
4946900|NCT02919683|12167239|P2|STARTED|Post-Surgery Follow-Up||15
4946901|NCT02919683|12167240|P1|STARTED|Post-Surgery Follow-Up||15
4946902|NCT02919683|12167239|P2|NOT COMPLETED|Pre-Surgery Intervention||0
4946903|NCT02919683|12167240|P1|NOT COMPLETED|Pre-Surgery Intervention||0
4946904|NCT02919683|12167239|P2|COMPLETED|Pre-Surgery Intervention||15
4946905|NCT02919683|12167240|P1|COMPLETED|Pre-Surgery Intervention||15
4946906|NCT02919683|12167239|P2|STARTED|Pre-Surgery Intervention||15
4946907|NCT02919683|12167240|P1|STARTED|Pre-Surgery Intervention||15
4946908|NCT02919657|12167246|P2|NOT COMPLETED|Overall Study||0
4946909|NCT02919657|12167247|P1|NOT COMPLETED|Overall Study||0
4946910|NCT02919657|12167246|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
4946911|NCT02919657|12167247|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
4946912|NCT02919657|12167246|P2|STARTED|Overall Study|10 Participants|10
4946913|NCT02919657|12167247|P1|STARTED|Overall Study|10 Participants|10
4946914|NCT02919618|12167253|P1|NOT COMPLETED|Overall Study||1
4946915|NCT02919618|12167253|P1|COMPLETED|Overall Study||18
4946916|NCT02919618|12167253|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
4946917|NCT02919618|12167253|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
4946918|NCT02919618|12167253|P1|STARTED|Overall Study||19
4946919|NCT02919423|12167272|P2|NOT COMPLETED|Overall Study||9
4946920|NCT02919423|12167273|P1|NOT COMPLETED|Overall Study||2
4946921|NCT02919423|12167272|P2|COMPLETED|Overall Study||16
4946922|NCT02919423|12167273|P1|COMPLETED|Overall Study||4
4946923|NCT02919423|12167272|P2|STARTED|Overall Study||25
4946924|NCT02919423|12167273|P1|STARTED|Overall Study||6
4946925|NCT02919267|12167283|P4|NOT COMPLETED|Overall Study||4
4946926|NCT02919267|12167284|P3|NOT COMPLETED|Overall Study||3
4946927|NCT02919267|12167285|P2|NOT COMPLETED|Overall Study||3
4946928|NCT02919267|12167286|P1|NOT COMPLETED|Overall Study||0
4946929|NCT02919267|12167283|P4|COMPLETED|Overall Study||10
4946930|NCT02919267|12167284|P3|COMPLETED|Overall Study||10
4946931|NCT02919267|12167285|P2|COMPLETED|Overall Study||9
4946932|NCT02919267|12167286|P1|COMPLETED|Overall Study||10
4946933|NCT02919267|12167283|P4|STARTED|Overall Study||14
4946934|NCT02919267|12167284|P3|STARTED|Overall Study||13
4946935|NCT02919267|12167285|P2|STARTED|Overall Study||12
4946936|NCT02919267|12167286|P1|STARTED|Overall Study||10
4946937|NCT02919007|12167296|P1|NOT COMPLETED|Overall Study||0
4946938|NCT02919007|12167296|P1|COMPLETED|Overall Study||25
4946939|NCT02919007|12167296|P1|STARTED|Overall Study||25
4946940|NCT02918773|12167302|P2|NOT COMPLETED|Overall Study||0
4946941|NCT02918773|12167303|P1|NOT COMPLETED|Overall Study||0
4946942|NCT02918773|12167302|P2|COMPLETED|Overall Study||11
4946943|NCT02918773|12167303|P1|COMPLETED|Overall Study||11
4946944|NCT02918773|12167302|P2|STARTED|Overall Study||11
4946945|NCT02918773|12167303|P1|STARTED|Overall Study||11
4946946|NCT02918669|12167314|P1|NOT COMPLETED|Overall Study||4
4946947|NCT02918669|12167314|P1|COMPLETED|Overall Study||8
4946948|NCT02918669|12167314|P1|STARTED|Overall Study||12
4946949|NCT02918656|12167324|P3|NOT COMPLETED|Overall Study||0
4946950|NCT02918656|12167325|P2|NOT COMPLETED|Overall Study||0
4946951|NCT02918656|12167326|P1|NOT COMPLETED|Overall Study||0
4946952|NCT02918656|12167324|P3|COMPLETED|Overall Study||57
4946953|NCT02918656|12167325|P2|COMPLETED|Overall Study||60
4946954|NCT02918656|12167326|P1|COMPLETED|Overall Study||54
4946955|NCT02918656|12167324|P3|STARTED|Overall Study||57
4946956|NCT02918656|12167325|P2|STARTED|Overall Study||60
4946957|NCT02918656|12167326|P1|STARTED|Overall Study||54
4946958|NCT02918630|12167345|P2|NOT COMPLETED|Overall Study||0
4946959|NCT02918630|12167346|P1|NOT COMPLETED|Overall Study||0
4946960|NCT02918630|12167345|P2|COMPLETED|Overall Study||3
4946961|NCT02918630|12167346|P1|COMPLETED|Overall Study||4
4946962|NCT02918630|12167345|P2|STARTED|Overall Study||3
4946963|NCT02918630|12167346|P1|STARTED|Overall Study||4
4946964|NCT02918617|12167369|P9|NOT COMPLETED|Overall Study||0
4946965|NCT02918617|12167370|P8|NOT COMPLETED|Overall Study||1
4946966|NCT02918617|12167371|P7|NOT COMPLETED|Overall Study||0
4946967|NCT02918617|12167372|P6|NOT COMPLETED|Overall Study||0
4946968|NCT02918617|12167373|P5|NOT COMPLETED|Overall Study||0
4946969|NCT02918617|12167374|P4|NOT COMPLETED|Overall Study||0
4946970|NCT02918617|12167375|P3|NOT COMPLETED|Overall Study||3
4946971|NCT02918617|12167376|P2|NOT COMPLETED|Overall Study||0
4946972|NCT02918617|12167377|P1|NOT COMPLETED|Overall Study||1
4946973|NCT02918617|12167369|P9|COMPLETED|Overall Study||26
4946974|NCT02918617|12167370|P8|COMPLETED|Overall Study||25
4946975|NCT02918617|12167371|P7|COMPLETED|Overall Study||22
4946976|NCT02918617|12167372|P6|COMPLETED|Overall Study||20
4946977|NCT02918617|12167373|P5|COMPLETED|Overall Study||24
4946978|NCT02918617|12167374|P4|COMPLETED|Overall Study||22
4946979|NCT02918617|12167375|P3|COMPLETED|Overall Study||19
4946980|NCT02918617|12167376|P2|COMPLETED|Overall Study||20
4946981|NCT02918617|12167377|P1|COMPLETED|Overall Study||20
4946982|NCT02918617|12167369|P9|STARTED|Overall Study||26
4946983|NCT02918617|12167370|P8|STARTED|Overall Study||26
4946984|NCT02918617|12167371|P7|STARTED|Overall Study||22
4946985|NCT02918617|12167372|P6|STARTED|Overall Study||20
4946986|NCT02918617|12167373|P5|STARTED|Overall Study||24
4946987|NCT02918617|12167374|P4|STARTED|Overall Study||22
4946988|NCT02918617|12167375|P3|STARTED|Overall Study||22
4946989|NCT02918617|12167376|P2|STARTED|Overall Study||20
4946990|NCT02918617|12167377|P1|STARTED|Overall Study||21
4946991|NCT02918552|12167426|P2|NOT COMPLETED|Overall Study||2
4946992|NCT02918552|12167427|P1|NOT COMPLETED|Overall Study||1
4946993|NCT02918552|12167426|P2|COMPLETED|Overall Study||6
4946994|NCT02918552|12167427|P1|COMPLETED|Overall Study||6
4946995|NCT02918552|12167426|P2|STARTED|Overall Study||8
4946996|NCT02918552|12167427|P1|STARTED|Overall Study||7
4946997|NCT02918396|12167464|P3|NOT COMPLETED|Overall Study||0
4946998|NCT02918396|12167465|P2|NOT COMPLETED|Overall Study||0
4946999|NCT02918396|12167466|P1|NOT COMPLETED|Overall Study||0
4947000|NCT02918396|12167464|P3|COMPLETED|Overall Study||2
4947001|NCT02918396|12167465|P2|COMPLETED|Overall Study||1
4947002|NCT02918396|12167466|P1|COMPLETED|Overall Study||2
4947003|NCT02918396|12167464|P3|STARTED|Overall Study||2
4947004|NCT02918396|12167465|P2|STARTED|Overall Study||1
4947005|NCT02918396|12167466|P1|STARTED|Overall Study||2
4947006|NCT02918357|12167474|P1|NOT COMPLETED|Overall Study||0
4947007|NCT02918357|12167474|P1|COMPLETED|Overall Study||385
4947008|NCT02918357|12167474|P1|PET/CT Scan|Overall Study||385
4947009|NCT02918357|12167474|P1|Investigational Drug Administration|Overall Study||385
4947010|NCT02918357|12167474|P1|STARTED|Overall Study||385
4947011|NCT02918279|12167501|P2|NOT COMPLETED|Overall Study||23
4947012|NCT02918279|12167502|P1|NOT COMPLETED|Overall Study||13
4947013|NCT02918279|12167501|P2|COMPLETED|Overall Study||103
4947014|NCT02918279|12167502|P1|COMPLETED|Overall Study||112
4947015|NCT02918279|12167501|P2|Safety Analysis Set|Overall Study||126
4947016|NCT02918279|12167502|P1|Safety Analysis Set|Overall Study||125
4947017|NCT02918279|12167501|P2|Full Analysis Set|Overall Study||126
4947018|NCT02918279|12167502|P1|Full Analysis Set|Overall Study||125
4947019|NCT02918279|12167501|P2|STARTED|Overall Study||126
4947020|NCT02918279|12167502|P1|STARTED|Overall Study||125
4947021|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947022|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947023|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947024|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947025|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947026|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947027|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947028|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947029|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947030|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947031|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947032|NCT02918266|12167638|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947033|NCT02918266|12167639|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947034|NCT02918266|12167640|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947035|NCT02918266|12167641|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947036|NCT02918266|12167642|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947037|NCT02918266|12167643|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947038|NCT02918266|12167644|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947039|NCT02918266|12167645|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947040|NCT02918266|12167646|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947041|NCT02918266|12167647|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947042|NCT02918266|12167648|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
4947043|NCT02918266|12167638|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947044|NCT02918266|12167639|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947045|NCT02918266|12167640|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947046|NCT02918266|12167641|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947047|NCT02918266|12167642|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947048|NCT02918266|12167643|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947049|NCT02918266|12167644|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947050|NCT02918266|12167645|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947051|NCT02918266|12167646|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947052|NCT02918266|12167647|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947053|NCT02918266|12167648|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
4947054|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947055|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947056|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947057|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947058|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947059|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947060|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947061|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947062|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947063|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947064|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947065|NCT02918266|12167638|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947066|NCT02918266|12167639|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947067|NCT02918266|12167640|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947068|NCT02918266|12167641|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947069|NCT02918266|12167642|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947070|NCT02918266|12167643|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947071|NCT02918266|12167644|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947072|NCT02918266|12167645|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947073|NCT02918266|12167646|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947074|NCT02918266|12167647|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947075|NCT02918266|12167648|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
4947076|NCT02918266|12167638|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947077|NCT02918266|12167639|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947078|NCT02918266|12167640|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947079|NCT02918266|12167641|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947080|NCT02918266|12167642|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947081|NCT02918266|12167643|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947082|NCT02918266|12167644|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947083|NCT02918266|12167645|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947084|NCT02918266|12167646|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947085|NCT02918266|12167647|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947086|NCT02918266|12167648|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
4947087|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947088|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947089|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947090|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947091|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947092|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947093|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947094|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947095|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947096|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947097|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947098|NCT02918266|12167638|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947099|NCT02918266|12167639|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947100|NCT02918266|12167640|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947101|NCT02918266|12167641|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947102|NCT02918266|12167642|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947103|NCT02918266|12167643|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947104|NCT02918266|12167644|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947105|NCT02918266|12167645|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947106|NCT02918266|12167646|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947107|NCT02918266|12167647|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947108|NCT02918266|12167648|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
4947109|NCT02918266|12167638|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947110|NCT02918266|12167639|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947111|NCT02918266|12167640|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947112|NCT02918266|12167641|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947113|NCT02918266|12167642|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947114|NCT02918266|12167643|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947115|NCT02918266|12167644|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947116|NCT02918266|12167645|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947117|NCT02918266|12167646|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947118|NCT02918266|12167647|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947119|NCT02918266|12167648|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
4947120|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947121|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947122|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947123|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947124|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947125|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947126|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947127|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947128|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947129|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947130|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947131|NCT02918266|12167638|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947132|NCT02918266|12167639|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947133|NCT02918266|12167640|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947134|NCT02918266|12167641|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947135|NCT02918266|12167642|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947136|NCT02918266|12167643|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947137|NCT02918266|12167644|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947138|NCT02918266|12167645|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947139|NCT02918266|12167646|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947140|NCT02918266|12167647|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947141|NCT02918266|12167648|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
4947142|NCT02918266|12167638|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947143|NCT02918266|12167639|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947144|NCT02918266|12167640|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947145|NCT02918266|12167641|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947146|NCT02918266|12167642|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947147|NCT02918266|12167643|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947148|NCT02918266|12167644|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947149|NCT02918266|12167645|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947150|NCT02918266|12167646|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947151|NCT02918266|12167647|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947152|NCT02918266|12167648|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
4947153|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947154|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947155|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947156|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947157|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947158|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947159|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947160|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947161|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947162|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947163|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947164|NCT02918266|12167638|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947165|NCT02918266|12167639|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947166|NCT02918266|12167640|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947167|NCT02918266|12167641|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947168|NCT02918266|12167642|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947169|NCT02918266|12167643|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947170|NCT02918266|12167644|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947171|NCT02918266|12167645|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947172|NCT02918266|12167646|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947173|NCT02918266|12167647|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947174|NCT02918266|12167648|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
4947175|NCT02918266|12167638|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947176|NCT02918266|12167639|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947177|NCT02918266|12167640|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947178|NCT02918266|12167641|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947179|NCT02918266|12167642|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947180|NCT02918266|12167643|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947181|NCT02918266|12167644|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947182|NCT02918266|12167645|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947183|NCT02918266|12167646|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947184|NCT02918266|12167647|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947185|NCT02918266|12167648|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
4947186|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947187|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947188|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947189|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947190|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947191|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947192|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947193|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947194|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947195|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947196|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947197|NCT02918266|12167638|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947198|NCT02918266|12167639|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947199|NCT02918266|12167640|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947200|NCT02918266|12167641|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947201|NCT02918266|12167642|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947202|NCT02918266|12167643|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947203|NCT02918266|12167644|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947204|NCT02918266|12167645|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947205|NCT02918266|12167646|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947206|NCT02918266|12167647|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947207|NCT02918266|12167648|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
4947208|NCT02918266|12167638|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947209|NCT02918266|12167639|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947210|NCT02918266|12167640|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947211|NCT02918266|12167641|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947212|NCT02918266|12167642|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947213|NCT02918266|12167643|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947214|NCT02918266|12167644|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947215|NCT02918266|12167645|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947216|NCT02918266|12167646|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947217|NCT02918266|12167647|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947218|NCT02918266|12167648|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
4947219|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947220|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947221|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947222|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947223|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947224|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947225|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947226|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947227|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947228|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947229|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947230|NCT02918266|12167638|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947231|NCT02918266|12167639|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947232|NCT02918266|12167640|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947233|NCT02918266|12167641|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947234|NCT02918266|12167642|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947235|NCT02918266|12167643|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947236|NCT02918266|12167644|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947237|NCT02918266|12167645|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947238|NCT02918266|12167646|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947239|NCT02918266|12167647|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947240|NCT02918266|12167648|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
4947241|NCT02918266|12167638|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947242|NCT02918266|12167639|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947243|NCT02918266|12167640|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947244|NCT02918266|12167641|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947245|NCT02918266|12167642|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947246|NCT02918266|12167643|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947247|NCT02918266|12167644|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947248|NCT02918266|12167645|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947249|NCT02918266|12167646|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947250|NCT02918266|12167647|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947251|NCT02918266|12167648|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
4947252|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947253|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947254|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947255|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947256|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947257|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947258|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947259|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947260|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947261|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947262|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947263|NCT02918266|12167638|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947264|NCT02918266|12167639|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947265|NCT02918266|12167640|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947266|NCT02918266|12167641|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947267|NCT02918266|12167642|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947268|NCT02918266|12167643|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947269|NCT02918266|12167644|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947270|NCT02918266|12167645|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947271|NCT02918266|12167646|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947272|NCT02918266|12167647|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947273|NCT02918266|12167648|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
4947274|NCT02918266|12167638|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947275|NCT02918266|12167639|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947276|NCT02918266|12167640|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947277|NCT02918266|12167641|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947278|NCT02918266|12167642|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947279|NCT02918266|12167643|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947280|NCT02918266|12167644|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947281|NCT02918266|12167645|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947282|NCT02918266|12167646|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947283|NCT02918266|12167647|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947284|NCT02918266|12167648|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
4947285|NCT02918266|12167638|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947286|NCT02918266|12167639|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947287|NCT02918266|12167640|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
4947288|NCT02918266|12167641|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947289|NCT02918266|12167642|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
4947290|NCT02918266|12167643|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947291|NCT02918266|12167644|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947292|NCT02918266|12167645|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947293|NCT02918266|12167646|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947294|NCT02918266|12167647|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
4947295|NCT02918266|12167648|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947296|NCT02918266|12167638|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947297|NCT02918266|12167639|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947298|NCT02918266|12167640|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947299|NCT02918266|12167641|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947300|NCT02918266|12167642|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947301|NCT02918266|12167643|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947302|NCT02918266|12167644|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947303|NCT02918266|12167645|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947304|NCT02918266|12167646|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947305|NCT02918266|12167647|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947306|NCT02918266|12167648|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
4947307|NCT02918266|12167638|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947308|NCT02918266|12167639|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947309|NCT02918266|12167640|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
4947310|NCT02918266|12167641|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947311|NCT02918266|12167642|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
4947312|NCT02918266|12167643|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947313|NCT02918266|12167644|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947314|NCT02918266|12167645|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947315|NCT02918266|12167646|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947316|NCT02918266|12167647|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
4947317|NCT02918266|12167648|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
4947318|NCT02918266|12167638|P11|NOT COMPLETED|Part 1||0
4947319|NCT02918266|12167639|P10|NOT COMPLETED|Part 1||0
4947320|NCT02918266|12167640|P9|NOT COMPLETED|Part 1||0
4947321|NCT02918266|12167641|P8|NOT COMPLETED|Part 1||0
4947322|NCT02918266|12167642|P7|NOT COMPLETED|Part 1||0
4947323|NCT02918266|12167643|P6|NOT COMPLETED|Part 1||0
4947324|NCT02918266|12167644|P5|NOT COMPLETED|Part 1||0
4947325|NCT02918266|12167645|P4|NOT COMPLETED|Part 1||0
4947326|NCT02918266|12167646|P3|NOT COMPLETED|Part 1||0
4947327|NCT02918266|12167647|P2|NOT COMPLETED|Part 1||0
4947328|NCT02918266|12167648|P1|NOT COMPLETED|Part 1||0
4947329|NCT02918266|12167638|P11|COMPLETED|Part 1||0
4947330|NCT02918266|12167639|P10|COMPLETED|Part 1||0
4947331|NCT02918266|12167640|P9|COMPLETED|Part 1||0
4947332|NCT02918266|12167641|P8|COMPLETED|Part 1||0
4947333|NCT02918266|12167642|P7|COMPLETED|Part 1||0
4947334|NCT02918266|12167643|P6|COMPLETED|Part 1||0
4947335|NCT02918266|12167644|P5|COMPLETED|Part 1||0
4947336|NCT02918266|12167645|P4|COMPLETED|Part 1||0
4947337|NCT02918266|12167646|P3|COMPLETED|Part 1||0
4947338|NCT02918266|12167647|P2|COMPLETED|Part 1||0
4947339|NCT02918266|12167648|P1|COMPLETED|Part 1||6
4947340|NCT02918266|12167638|P11|STARTED|Part 1||0
4947341|NCT02918266|12167639|P10|STARTED|Part 1||0
4947342|NCT02918266|12167640|P9|STARTED|Part 1||0
4947343|NCT02918266|12167641|P8|STARTED|Part 1||0
4947344|NCT02918266|12167642|P7|STARTED|Part 1||0
4947345|NCT02918266|12167643|P6|STARTED|Part 1||0
4947346|NCT02918266|12167644|P5|STARTED|Part 1||0
4947347|NCT02918266|12167645|P4|STARTED|Part 1||0
4947348|NCT02918266|12167646|P3|STARTED|Part 1||0
4947349|NCT02918266|12167647|P2|STARTED|Part 1||0
4947350|NCT02918266|12167648|P1|STARTED|Part 1||6
4947351|NCT02918071|12167747|P1|NOT COMPLETED|Overall Study||3
4947352|NCT02918071|12167747|P1|COMPLETED|Overall Study||118
4947353|NCT02918071|12167747|P1|STARTED|Overall Study||121
4947354|NCT02917642|12167759|P2|NOT COMPLETED|Overall Study||0
4947355|NCT02917642|12167760|P1|NOT COMPLETED|Overall Study||0
4947356|NCT02917642|12167759|P2|COMPLETED|Overall Study||25
4947357|NCT02917642|12167760|P1|COMPLETED|Overall Study||25
4947358|NCT02917642|12167759|P2|STARTED|Overall Study||25
4947359|NCT02917642|12167760|P1|STARTED|Overall Study||25
4947360|NCT02917603|12167770|P2|NOT COMPLETED|Overall Study||4
4947361|NCT02917603|12167771|P1|NOT COMPLETED|Overall Study||1
4947362|NCT02917603|12167770|P2|COMPLETED|Overall Study||16
4947363|NCT02917603|12167771|P1|COMPLETED|Overall Study||19
4947364|NCT02917603|12167770|P2|STARTED|Overall Study||20
4947365|NCT02917603|12167771|P1|STARTED|Overall Study||20
4947366|NCT02917447|12167785|P2|NOT COMPLETED|Overall Study||3
4947367|NCT02917447|12167786|P1|NOT COMPLETED|Overall Study||7
4947368|NCT02917447|12167785|P2|COMPLETED|Overall Study||48
4947369|NCT02917447|12167786|P1|COMPLETED|Overall Study||44
4947370|NCT02917447|12167785|P2|STARTED|Overall Study||51
4947371|NCT02917447|12167786|P1|STARTED|Overall Study||51
4947372|NCT02917265|12167798|P2|NOT COMPLETED|Overall Study||0
4947373|NCT02917265|12167799|P1|NOT COMPLETED|Overall Study||2
4947374|NCT02917265|12167798|P2|COMPLETED|Overall Study||2
4947375|NCT02917265|12167799|P1|COMPLETED|Overall Study||3
4947376|NCT02917265|12167798|P2|STARTED|Overall Study||2
4947377|NCT02917265|12167799|P1|STARTED|Overall Study||5
4947378|NCT02916927|12167815|P2|NOT COMPLETED|Overall Study||3
4947379|NCT02916927|12167816|P1|NOT COMPLETED|Overall Study||1
4947380|NCT02916927|12167815|P2|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
4947381|NCT02916927|12167816|P1|COMPLETED|Overall Study||30
4947382|NCT02916927|12167815|P2|Received Study Drug|Overall Study||29
4947383|NCT02916927|12167816|P1|Received Study Drug|Overall Study||31
4947384|NCT02916927|12167815|P2|STARTED|Overall Study||31
4947385|NCT02916927|12167816|P1|STARTED|Overall Study||31
4947386|NCT02916745|12167830|P1|NOT COMPLETED|Overall Study||0
4947387|NCT02916745|12167830|P1|COMPLETED|Overall Study||5
4947388|NCT02916745|12167830|P1|STARTED|Overall Study||5
4947389|NCT02916498|12167862|P2|NOT COMPLETED|Second Intervention, 21 Days||0
4947390|NCT02916498|12167863|P1|NOT COMPLETED|Second Intervention, 21 Days||0
4947391|NCT02916498|12167862|P2|COMPLETED|Second Intervention, 21 Days||4
4947392|NCT02916498|12167863|P1|COMPLETED|Second Intervention, 21 Days||2
4947393|NCT02916498|12167862|P2|STARTED|Second Intervention, 21 Days||4
4947394|NCT02916498|12167863|P1|STARTED|Second Intervention, 21 Days||2
4947395|NCT02916498|12167862|P2|NOT COMPLETED|First Intervention, 21 Days||0
4947396|NCT02916498|12167863|P1|NOT COMPLETED|First Intervention, 21 Days||0
4947397|NCT02916498|12167862|P2|COMPLETED|First Intervention, 21 Days||4
4947398|NCT02916498|12167863|P1|COMPLETED|First Intervention, 21 Days||2
4947399|NCT02916498|12167862|P2|STARTED|First Intervention, 21 Days||4
4947400|NCT02916498|12167863|P1|STARTED|First Intervention, 21 Days||2
4947401|NCT02916407|12167871|P2|NOT COMPLETED|Overall Study||0
4947402|NCT02916407|12167872|P1|NOT COMPLETED|Overall Study||0
4947403|NCT02916407|12167871|P2|COMPLETED|Overall Study||28
4947404|NCT02916407|12167872|P1|COMPLETED|Overall Study||28
4947405|NCT02916407|12167871|P2|STARTED|Overall Study||28
4947406|NCT02916407|12167872|P1|STARTED|Overall Study||28
4947407|NCT02915978|12167883|P3|NOT COMPLETED|Overall Study||0
4947408|NCT02915978|12167884|P2|NOT COMPLETED|Overall Study||1
4947409|NCT02915978|12167885|P1|NOT COMPLETED|Overall Study||2
4947410|NCT02915978|12167883|P3|COMPLETED|Overall Study||15
4947411|NCT02915978|12167884|P2|COMPLETED|Overall Study||14
4947412|NCT02915978|12167885|P1|COMPLETED|Overall Study||13
4947413|NCT02915978|12167883|P3|STARTED|Overall Study||15
4947414|NCT02915978|12167884|P2|STARTED|Overall Study||15
4947415|NCT02915978|12167885|P1|STARTED|Overall Study||15
4947416|NCT02915874|12167937|P2|NOT COMPLETED|Overall Study||6
4947417|NCT02915874|12167938|P1|NOT COMPLETED|Overall Study||6
4947418|NCT02915874|12167937|P2|COMPLETED|Overall Study||22
4947419|NCT02915874|12167938|P1|COMPLETED|Overall Study||38
4947420|NCT02915874|12167937|P2|Week 6 Follow Up|Overall Study||26
4947421|NCT02915874|12167938|P1|Week 6 Follow Up|Overall Study||41
4947422|NCT02915874|12167937|P2|STARTED|Overall Study||28
4947423|NCT02915874|12167938|P1|STARTED|Overall Study||44
4947424|NCT02915835|12167958|P2|NOT COMPLETED|Overall Study||1
4947425|NCT02915835|12167959|P1|NOT COMPLETED|Overall Study||1
4947426|NCT02915835|12167958|P2|COMPLETED|Overall Study||7
4947427|NCT02915835|12167959|P1|COMPLETED|Overall Study||8
4947428|NCT02915835|12167958|P2|STARTED|Overall Study||8
4947429|NCT02915835|12167959|P1|STARTED|Overall Study||9
4947430|NCT02915783|12168083|P1|NOT COMPLETED|Overall Study||14
4947431|NCT02915783|12168083|P1|COMPLETED|Overall Study||17
4947432|NCT02915783|12168083|P1|STARTED|Overall Study||31
4947433|NCT02915705|12168091|P2|NOT COMPLETED|Long Term Extension Period||0
4947434|NCT02915705|12168092|P1|NOT COMPLETED|Long Term Extension Period||0
4947435|NCT02915705|12168091|P2|COMPLETED|Long Term Extension Period||25
4947436|NCT02915705|12168092|P1|COMPLETED|Long Term Extension Period||26
4947437|NCT02915705|12168091|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
4947438|NCT02915705|12168092|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
4947439|NCT02915705|12168091|P2|NOT COMPLETED|Treatment Period||0
4947440|NCT02915705|12168092|P1|NOT COMPLETED|Treatment Period||0
4947441|NCT02915705|12168091|P2|COMPLETED|Treatment Period||29
4947442|NCT02915705|12168092|P1|COMPLETED|Treatment Period||32
4947443|NCT02915705|12168091|P2|Completed Week 64|Treatment Period||29
4947444|NCT02915705|12168092|P1|Completed Week 64|Treatment Period||32
4947445|NCT02915705|12168091|P2|Completed Week 40|Treatment Period||29
4947446|NCT02915705|12168092|P1|Completed Week 40|Treatment Period||32
4947447|NCT02915705|12168091|P2|STARTED|Treatment Period||29
4947448|NCT02915705|12168092|P1|STARTED|Treatment Period||32
4947449|NCT02915302|12168165|P2|NOT COMPLETED|Overall Study||78
4947450|NCT02915302|12168166|P1|NOT COMPLETED|Overall Study||65
4947451|NCT02915302|12168165|P2|COMPLETED|Overall Study||917
4947452|NCT02915302|12168166|P1|COMPLETED|Overall Study||890
4947453|NCT02915302|12168165|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
4947454|NCT02915302|12168166|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
4947455|NCT02915302|12168165|P2|STARTED|Overall Study||995
4947456|NCT02915302|12168166|P1|STARTED|Overall Study||955
4947457|NCT02915159|12168178|P2|NOT COMPLETED|Overall Study||8
4947458|NCT02915159|12168179|P1|NOT COMPLETED|Overall Study||11
4947459|NCT02915159|12168178|P2|COMPLETED|Overall Study||87
4947460|NCT02915159|12168179|P1|COMPLETED|Overall Study||81
4947461|NCT02915159|12168178|P2|STARTED|Overall Study||95
4947462|NCT02915159|12168179|P1|STARTED|Overall Study||92
4947463|NCT02915029|12168261|P2|NOT COMPLETED|Overall Study||14
4947464|NCT02915029|12168262|P1|NOT COMPLETED|Overall Study||13
4947465|NCT02915029|12168261|P2|COMPLETED|Overall Study||48
4947466|NCT02915029|12168262|P1|COMPLETED|Overall Study||50
4947467|NCT02915029|12168261|P2|STARTED|Overall Study||62
4947468|NCT02915029|12168262|P1|STARTED|Overall Study||63
4947469|NCT02914548|12168309|P3|NOT COMPLETED|Overall Study||20
4947470|NCT02914548|12168310|P2|NOT COMPLETED|Overall Study||14
4947471|NCT02914548|12168311|P1|NOT COMPLETED|Overall Study||21
4947472|NCT02914548|12168309|P3|COMPLETED|Overall Study||46
4947473|NCT02914548|12168310|P2|COMPLETED|Overall Study||53
4947474|NCT02914548|12168311|P1|COMPLETED|Overall Study||46
4947475|NCT02914548|12168309|P3|STARTED|Overall Study||66
4947476|NCT02914548|12168310|P2|STARTED|Overall Study||67
4947477|NCT02914548|12168311|P1|STARTED|Overall Study||67
4947478|NCT02914275|12168344|P2|NOT COMPLETED|Overall Study||42
4947479|NCT02914275|12168345|P1|NOT COMPLETED|Overall Study||121
4947480|NCT02914275|12168344|P2|COMPLETED|Overall Study||521
4947481|NCT02914275|12168345|P1|COMPLETED|Overall Study||1566
4947482|NCT02914275|12168344|P2|Included in Clinical Database / FAS|Overall Study||563
4947483|NCT02914275|12168345|P1|Included in Clinical Database / FAS|Overall Study||1684
4947484|NCT02914275|12168344|P2|STARTED|Overall Study||563
4947485|NCT02914275|12168345|P1|STARTED|Overall Study||1687
4947486|NCT02914236|12168377|P1|NOT COMPLETED|Overall Study||1
4947487|NCT02914236|12168377|P1|COMPLETED|Overall Study||49
4947488|NCT02914236|12168377|P1|26-week Follow-up Visit|Overall Study||49
4947489|NCT02914236|12168377|P1|12-week Follow-up Visit|Overall Study||50
4947490|NCT02914236|12168377|P1|4-week Follow-up Visit|Overall Study||50
4947491|NCT02914236|12168377|P1|STARTED|Overall Study||50
4947492|NCT02914210|12168387|P2|NOT COMPLETED|Overall Study||9
4947493|NCT02914210|12168388|P1|NOT COMPLETED|Overall Study||10
4947494|NCT02914210|12168387|P2|COMPLETED|Overall Study||144
4947495|NCT02914210|12168388|P1|COMPLETED|Overall Study||143
4947496|NCT02914210|12168387|P2|STARTED|Overall Study||153
4947497|NCT02914210|12168388|P1|STARTED|Overall Study||153
4947498|NCT02914184|12168423|P4|NOT COMPLETED|Overall Study||11
4947499|NCT02914184|12168424|P3|NOT COMPLETED|Overall Study||17
4947500|NCT02914184|12168425|P2|NOT COMPLETED|Overall Study||13
4947501|NCT02914184|12168426|P1|NOT COMPLETED|Overall Study||14
4947502|NCT02914184|12168423|P4|COMPLETED|Overall Study||391
4947503|NCT02914184|12168424|P3|COMPLETED|Overall Study||385
4947504|NCT02914184|12168425|P2|COMPLETED|Overall Study||383
4947505|NCT02914184|12168426|P1|COMPLETED|Overall Study||386
4947506|NCT02914184|12168423|P4|STARTED|Overall Study||402
4947507|NCT02914184|12168424|P3|STARTED|Overall Study||402
4947508|NCT02914184|12168425|P2|STARTED|Overall Study||396
4947509|NCT02914184|12168426|P1|STARTED|Overall Study||400
4947510|NCT02914132|12168465|P1|NOT COMPLETED|Overall Study||0
4947511|NCT02914132|12168465|P1|COMPLETED|Overall Study||15
4947512|NCT02914132|12168465|P1|STARTED|Overall Study||15
4947513|NCT02914119|12168470|P1|NOT COMPLETED|Overall Study||0
4947514|NCT02914119|12168470|P1|COMPLETED|Overall Study||30430
4947515|NCT02914119|12168470|P1|STARTED|Overall Study||30430
4947516|NCT02913326|12168483|P2|NOT COMPLETED|Overall Study||2
4947517|NCT02913326|12168484|P1|NOT COMPLETED|Overall Study||1
4947518|NCT02913326|12168483|P2|COMPLETED|Overall Study||58
4947519|NCT02913326|12168484|P1|COMPLETED|Overall Study||59
4947520|NCT02913326|12168483|P2|STARTED|Overall Study||60
4947521|NCT02913326|12168484|P1|STARTED|Overall Study||60
4947522|NCT02913222|12168506|P2|NOT COMPLETED|Overall Study||2
4947523|NCT02913222|12168507|P1|NOT COMPLETED|Overall Study||1
4947524|NCT02913222|12168506|P2|COMPLETED|Overall Study||21
4947525|NCT02913222|12168507|P1|COMPLETED|Overall Study||22
4947526|NCT02913222|12168506|P2|STARTED|Overall Study||23
4947527|NCT02913222|12168507|P1|STARTED|Overall Study||23
4947528|NCT02913105|12168520|P3|NOT COMPLETED|Overall Study||7
4947529|NCT02913105|12168521|P2|NOT COMPLETED|Overall Study||5
4947530|NCT02913105|12168522|P1|NOT COMPLETED|Overall Study||15
4947531|NCT02913105|12168520|P3|COMPLETED|Overall Study||33
4947532|NCT02913105|12168521|P2|COMPLETED|Overall Study||39
4947533|NCT02913105|12168522|P1|COMPLETED|Overall Study||22
4947534|NCT02913105|12168520|P3|STARTED|Overall Study||40
4947535|NCT02913105|12168521|P2|STARTED|Overall Study||44
4947536|NCT02913105|12168522|P1|STARTED|Overall Study||37
4947537|NCT02912650|12168575|P4|NOT COMPLETED|Overall Study||5
4947538|NCT02912650|12168576|P3|NOT COMPLETED|Overall Study||2
4947539|NCT02912650|12168577|P2|NOT COMPLETED|Overall Study||0
4947540|NCT02912650|12168578|P1|NOT COMPLETED|Overall Study||1
4947541|NCT02912650|12168575|P4|COMPLETED|Overall Study||160
4947542|NCT02912650|12168576|P3|COMPLETED|Overall Study||173
4947543|NCT02912650|12168577|P2|COMPLETED|Overall Study||172
4947544|NCT02912650|12168578|P1|COMPLETED|Overall Study||55
4947545|NCT02912650|12168575|P4|STARTED|Overall Study||165
4947546|NCT02912650|12168576|P3|STARTED|Overall Study||175
4947547|NCT02912650|12168577|P2|STARTED|Overall Study||172
4947548|NCT02912650|12168578|P1|STARTED|Overall Study||56
4947549|NCT02912468|12168662|P2|NOT COMPLETED|Overall Study||5
4947550|NCT02912468|12168663|P1|NOT COMPLETED|Overall Study||9
4947551|NCT02912468|12168662|P2|COMPLETED|Overall Study||138
4947552|NCT02912468|12168663|P1|COMPLETED|Overall Study||124
4947553|NCT02912468|12168662|P2|Safety Population|Overall Study||143
4947554|NCT02912468|12168663|P1|Safety Population|Overall Study||132
4947555|NCT02912468|12168662|P2|Treated|Overall Study||142
4947556|NCT02912468|12168663|P1|Treated|Overall Study||133
4947557|NCT02912468|12168662|P2|STARTED|Overall Study||143
4947558|NCT02912468|12168663|P1|STARTED|Overall Study||133
4947559|NCT02912455|12168742|P2|NOT COMPLETED|Overall Study||3
4947560|NCT02912455|12168743|P1|NOT COMPLETED|Overall Study||2
4947561|NCT02912455|12168742|P2|COMPLETED|Overall Study||2
4947562|NCT02912455|12168743|P1|COMPLETED|Overall Study||9
4947563|NCT02912455|12168742|P2|STARTED|Overall Study||5
4947564|NCT02912455|12168743|P1|STARTED|Overall Study||11
4947565|NCT02912364|12168781|P2|NOT COMPLETED|Treatment 2||0
4947566|NCT02912364|12168782|P1|NOT COMPLETED|Treatment 2||1
4947567|NCT02912364|12168781|P2|COMPLETED|Treatment 2||11
4947568|NCT02912364|12168782|P1|COMPLETED|Treatment 2||12
4947569|NCT02912364|12168781|P2|Received Intervention|Treatment 2||11
4947570|NCT02912364|12168782|P1|Received Intervention|Treatment 2||12
4947571|NCT02912364|12168781|P2|STARTED|Treatment 2||11
4947572|NCT02912364|12168782|P1|STARTED|Treatment 2||13
4947573|NCT02912364|12168781|P2|NOT COMPLETED|Washout Period||0
4947574|NCT02912364|12168782|P1|NOT COMPLETED|Washout Period||0
4947575|NCT02912364|12168781|P2|COMPLETED|Washout Period||11
4947576|NCT02912364|12168782|P1|COMPLETED|Washout Period||13
4947577|NCT02912364|12168781|P2|STARTED|Washout Period||11
4947578|NCT02912364|12168782|P1|STARTED|Washout Period||13
4947579|NCT02912364|12168781|P2|NOT COMPLETED|Treatment 1||12
4947580|NCT02912364|12168782|P1|NOT COMPLETED|Treatment 1||10
4947581|NCT02912364|12168781|P2|COMPLETED|Treatment 1||11
4947582|NCT02912364|12168782|P1|COMPLETED|Treatment 1||13
4947583|NCT02912364|12168781|P2|Received Intervention|Treatment 1||18
4947584|NCT02912364|12168782|P1|Received Intervention|Treatment 1||18
4947585|NCT02912364|12168781|P2|STARTED|Treatment 1||23
4947586|NCT02912364|12168782|P1|STARTED|Treatment 1||23
4947587|NCT02912195|12168801|P2|NOT COMPLETED|Overall Study||0
4947588|NCT02912195|12168802|P1|NOT COMPLETED|Overall Study||0
4947589|NCT02912195|12168801|P2|COMPLETED|Overall Study||16
4947590|NCT02912195|12168802|P1|COMPLETED|Overall Study||16
4947591|NCT02912195|12168801|P2|STARTED|Overall Study||16
4947592|NCT02912195|12168802|P1|STARTED|Overall Study||16
4947593|NCT02911948|12168838|P2|NOT COMPLETED|Overall Study||7
4947594|NCT02911948|12168839|P1|NOT COMPLETED|Overall Study||0
4947595|NCT02911948|12168838|P2|COMPLETED|Overall Study||98
4947596|NCT02911948|12168839|P1|COMPLETED|Overall Study||105
4947597|NCT02911948|12168838|P2|STARTED|Overall Study||105
4947598|NCT02911948|12168839|P1|STARTED|Overall Study||105
4947599|NCT02911922|12168901|P2|NOT COMPLETED|Overall Study||0
4947600|NCT02911922|12168902|P1|NOT COMPLETED|Overall Study||0
4947601|NCT02911922|12168901|P2|COMPLETED|Overall Study||0
4947602|NCT02911922|12168902|P1|COMPLETED|Overall Study||1
4947603|NCT02911922|12168901|P2|STARTED|Overall Study||0
4947604|NCT02911922|12168902|P1|STARTED|Overall Study||1
4947605|NCT02911909|12168922|P2|NOT COMPLETED|Overall Study||3
4947606|NCT02911909|12168923|P1|NOT COMPLETED|Overall Study||2
4947607|NCT02911909|12168922|P2|COMPLETED|Overall Study|No Data was obtained in the study group.|0
4947608|NCT02911909|12168923|P1|COMPLETED|Overall Study||2
4947609|NCT02911909|12168922|P2|STARTED|Overall Study||3
4947610|NCT02911909|12168923|P1|STARTED|Overall Study||4
4947611|NCT02911857|12168952|P3|NOT COMPLETED|Overall Study||0
4947612|NCT02911857|12168953|P2|NOT COMPLETED|Overall Study||0
4947613|NCT02911857|12168954|P1|NOT COMPLETED|Overall Study||0
4947614|NCT02911857|12168952|P3|COMPLETED|Overall Study||1
4947615|NCT02911857|12168953|P2|COMPLETED|Overall Study||1
4947616|NCT02911857|12168954|P1|COMPLETED|Overall Study||2
4947617|NCT02911857|12168952|P3|STARTED|Overall Study||1
4947618|NCT02911857|12168953|P2|STARTED|Overall Study||1
4947619|NCT02911857|12168954|P1|STARTED|Overall Study||2
4947620|NCT02911844|12168962|P1|NOT COMPLETED|Overall Study||0
4947621|NCT02911844|12168962|P1|COMPLETED|Overall Study||5
4947622|NCT02911844|12168962|P1|STARTED|Overall Study||5
4947623|NCT02911818|12168972|P5|NOT COMPLETED|12 Week Extension Study||1
4947624|NCT02911818|12168973|P4|NOT COMPLETED|12 Week Extension Study||0
4947625|NCT02911818|12168974|P3|NOT COMPLETED|12 Week Extension Study||0
4947626|NCT02911818|12168975|P2|NOT COMPLETED|12 Week Extension Study||0
4947627|NCT02911818|12168976|P1|NOT COMPLETED|12 Week Extension Study||0
4947628|NCT02911818|12168972|P5|COMPLETED|12 Week Extension Study||22
4947629|NCT02911818|12168973|P4|COMPLETED|12 Week Extension Study||22
4947630|NCT02911818|12168974|P3|COMPLETED|12 Week Extension Study||0
4947631|NCT02911818|12168975|P2|COMPLETED|12 Week Extension Study||0
4947632|NCT02911818|12168976|P1|COMPLETED|12 Week Extension Study||0
4947633|NCT02911818|12168972|P5|STARTED|12 Week Extension Study||23
4947634|NCT02911818|12168973|P4|STARTED|12 Week Extension Study||22
4947635|NCT02911818|12168974|P3|STARTED|12 Week Extension Study||0
4947636|NCT02911818|12168975|P2|STARTED|12 Week Extension Study||0
4947637|NCT02911818|12168976|P1|STARTED|12 Week Extension Study||0
4947638|NCT02911818|12168972|P5|NOT COMPLETED|52 Week Study||0
4947639|NCT02911818|12168973|P4|NOT COMPLETED|52 Week Study||0
4947640|NCT02911818|12168974|P3|NOT COMPLETED|52 Week Study||4
4947641|NCT02911818|12168975|P2|NOT COMPLETED|52 Week Study||5
4947642|NCT02911818|12168976|P1|NOT COMPLETED|52 Week Study||4
4947643|NCT02911818|12168972|P5|COMPLETED|52 Week Study||0
4947644|NCT02911818|12168973|P4|COMPLETED|52 Week Study||0
4947645|NCT02911818|12168974|P3|COMPLETED|52 Week Study||46
4947646|NCT02911818|12168975|P2|COMPLETED|52 Week Study||45
4947647|NCT02911818|12168976|P1|COMPLETED|52 Week Study||46
4947648|NCT02911818|12168972|P5|STARTED|52 Week Study||0
4947649|NCT02911818|12168973|P4|STARTED|52 Week Study||0
4947650|NCT02911818|12168974|P3|STARTED|52 Week Study||50
4947651|NCT02911818|12168975|P2|STARTED|52 Week Study||50
4947652|NCT02911818|12168976|P1|STARTED|52 Week Study||50
4947653|NCT02911753|12169071|P3|NOT COMPLETED|Overall Study||0
4947654|NCT02911753|12169072|P2|NOT COMPLETED|Overall Study||3
4947655|NCT02911753|12169073|P1|NOT COMPLETED|Overall Study||3
4947656|NCT02911753|12169071|P3|COMPLETED|Overall Study||10
4947657|NCT02911753|12169072|P2|COMPLETED|Overall Study||16
4947658|NCT02911753|12169073|P1|COMPLETED|Overall Study||18
4947659|NCT02911753|12169071|P3|STARTED|Overall Study||10
4947660|NCT02911753|12169072|P2|STARTED|Overall Study||19
4947661|NCT02911753|12169073|P1|STARTED|Overall Study||21
4947662|NCT02911688|12169101|P2|NOT COMPLETED|Second Intervention||0
4947663|NCT02911688|12169102|P1|NOT COMPLETED|Second Intervention||0
4947664|NCT02911688|12169101|P2|COMPLETED|Second Intervention||7
4947665|NCT02911688|12169102|P1|COMPLETED|Second Intervention||8
4947666|NCT02911688|12169101|P2|STARTED|Second Intervention||7
4947667|NCT02911688|12169102|P1|STARTED|Second Intervention||8
4947668|NCT02911688|12169101|P2|NOT COMPLETED|Washout||2
4947669|NCT02911688|12169102|P1|NOT COMPLETED|Washout||1
4947670|NCT02911688|12169101|P2|COMPLETED|Washout||7
4947671|NCT02911688|12169102|P1|COMPLETED|Washout||8
4947672|NCT02911688|12169101|P2|STARTED|Washout||9
4947673|NCT02911688|12169102|P1|STARTED|Washout||9
4947674|NCT02911688|12169101|P2|NOT COMPLETED|First Intervention||0
4947675|NCT02911688|12169102|P1|NOT COMPLETED|First Intervention||0
4947676|NCT02911688|12169101|P2|COMPLETED|First Intervention||9
4947677|NCT02911688|12169102|P1|COMPLETED|First Intervention||9
4947678|NCT02911688|12169101|P2|Received Intervention|First Intervention||9
4947679|NCT02911688|12169102|P1|Received Intervention|First Intervention||9
4947680|NCT02911688|12169101|P2|STARTED|First Intervention||9
4947681|NCT02911688|12169102|P1|STARTED|First Intervention||9
4947682|NCT02911519|12169126|P2|NOT COMPLETED|Overall Study||4
4947683|NCT02911519|12169127|P1|NOT COMPLETED|Overall Study||2
4947684|NCT02911519|12169126|P2|COMPLETED|Overall Study||82
4947685|NCT02911519|12169127|P1|COMPLETED|Overall Study||88
4947686|NCT02911519|12169126|P2|STARTED|Overall Study||86
4947687|NCT02911519|12169127|P1|STARTED|Overall Study||90
4947688|NCT02911324|12169149|P2|NOT COMPLETED|Overall Study||1
4947689|NCT02911324|12169150|P1|NOT COMPLETED|Overall Study||3
4947690|NCT02911324|12169149|P2|COMPLETED|Overall Study||6
4947691|NCT02911324|12169150|P1|COMPLETED|Overall Study||6
4947692|NCT02911324|12169149|P2|STARTED|Overall Study||7
4947693|NCT02911324|12169150|P1|STARTED|Overall Study||9
4947694|NCT02910739|12169159|P4|NOT COMPLETED|Overall Study||0
4947695|NCT02910739|12169160|P3|NOT COMPLETED|Overall Study||0
4947696|NCT02910739|12169161|P2|NOT COMPLETED|Overall Study||0
4947697|NCT02910739|12169162|P1|NOT COMPLETED|Overall Study||1
4947698|NCT02910739|12169159|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
4947699|NCT02910739|12169160|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
4947700|NCT02910739|12169161|P2|COMPLETED|Overall Study||8
4947701|NCT02910739|12169162|P1|COMPLETED|Overall Study||7
4947702|NCT02910739|12169159|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
4947703|NCT02910739|12169160|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
4947704|NCT02910739|12169161|P2|STARTED|Overall Study||8
4947705|NCT02910739|12169162|P1|STARTED|Overall Study||8
4947706|NCT02910713|12169188|P1|NOT COMPLETED|Overall Study||42
4947707|NCT02910713|12169188|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
4947708|NCT02910713|12169188|P1|Safety Population: Entered CAE|Overall Study||171
4947709|NCT02910713|12169188|P1|STARTED|Overall Study||185
4947710|NCT02910362|12169197|P2|NOT COMPLETED|Overall Study||0
4947711|NCT02910362|12169198|P1|NOT COMPLETED|Overall Study||0
4947712|NCT02910362|12169197|P2|COMPLETED|Overall Study||7
4947713|NCT02910362|12169198|P1|COMPLETED|Overall Study||8
4947714|NCT02910362|12169197|P2|STARTED|Overall Study||7
4947715|NCT02910362|12169198|P1|STARTED|Overall Study||8
4947716|NCT02910167|12169204|P1|NOT COMPLETED|Overall Study||19
4947717|NCT02910167|12169204|P1|COMPLETED|Overall Study||341
4947718|NCT02910167|12169204|P1|STARTED|Overall Study||360
4947719|NCT02910102|12169214|P2|NOT COMPLETED|Overall Study||0
4947720|NCT02910102|12169215|P1|NOT COMPLETED|Overall Study||0
4947721|NCT02910102|12169214|P2|COMPLETED|Overall Study||17
4947722|NCT02910102|12169215|P1|COMPLETED|Overall Study||21
4947723|NCT02910102|12169214|P2|Per-Protocol Population|Overall Study||17
4947724|NCT02910102|12169215|P1|Per-Protocol Population|Overall Study||20
4947725|NCT02910102|12169214|P2|Intent to Treat (ITT) Population|Overall Study||17
4947726|NCT02910102|12169215|P1|Intent to Treat (ITT) Population|Overall Study||21
4947727|NCT02910102|12169214|P2|Safety Population|Overall Study||17
4947728|NCT02910102|12169215|P1|Safety Population|Overall Study||21
4947729|NCT02910102|12169214|P2|STARTED|Overall Study||17
4947730|NCT02910102|12169215|P1|STARTED|Overall Study||21
4947731|NCT02910089|12169229|P2|NOT COMPLETED|Overall Study||16
4947732|NCT02910089|12169230|P1|NOT COMPLETED|Overall Study||22
4947733|NCT02910089|12169229|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
4947734|NCT02910089|12169230|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
4947735|NCT02910089|12169229|P2|STARTED|Overall Study|Patients allocated to control|700
4947736|NCT02910089|12169230|P1|STARTED|Overall Study|Patients allocated to intervention|700
4947737|NCT02910011|12169242|P1|NOT COMPLETED|Overall Study||2
4947738|NCT02910011|12169242|P1|COMPLETED|Overall Study||13
4947739|NCT02910011|12169242|P1|STARTED|Overall Study||15
4947740|NCT02909959|12169250|P2|NOT COMPLETED|Overall Study||0
4947741|NCT02909959|12169251|P1|NOT COMPLETED|Overall Study||0
4947742|NCT02909959|12169250|P2|COMPLETED|Overall Study||24
4947743|NCT02909959|12169251|P1|COMPLETED|Overall Study||24
4947744|NCT02909959|12169250|P2|STARTED|Overall Study||24
4947745|NCT02909959|12169251|P1|STARTED|Overall Study||24
4947746|NCT02909907|12169351|P2|NOT COMPLETED|Overall Study||1
4947747|NCT02909907|12169352|P1|NOT COMPLETED|Overall Study||0
4947748|NCT02909907|12169351|P2|COMPLETED|Overall Study||9
4947749|NCT02909907|12169352|P1|COMPLETED|Overall Study||10
4947750|NCT02909907|12169351|P2|STARTED|Overall Study||10
4947751|NCT02909907|12169352|P1|STARTED|Overall Study||10
4947752|NCT02909764|12169376|P2|NOT COMPLETED|Overall Study||0
4947753|NCT02909764|12169377|P1|NOT COMPLETED|Overall Study||0
4947754|NCT02909764|12169376|P2|COMPLETED|Overall Study||20
4947755|NCT02909764|12169377|P1|COMPLETED|Overall Study||19
4947756|NCT02909764|12169376|P2|STARTED|Overall Study||20
4947757|NCT02909764|12169377|P1|STARTED|Overall Study||19
4947758|NCT02909504|12169393|P1|NOT COMPLETED|Overall Study||12
4947759|NCT02909504|12169393|P1|COMPLETED|Overall Study||12
4947760|NCT02909504|12169393|P1|STARTED|Overall Study||24
4947761|NCT02909439|12169400|P2|NOT COMPLETED|Overall Study||0
4947762|NCT02909439|12169401|P1|NOT COMPLETED|Overall Study||0
4947763|NCT02909439|12169400|P2|COMPLETED|Overall Study||31
4947764|NCT02909439|12169401|P1|COMPLETED|Overall Study||31
4947765|NCT02909439|12169400|P2|STARTED|Overall Study||31
4947766|NCT02909439|12169401|P1|STARTED|Overall Study||31
4947767|NCT02909153|12169430|P5|NOT COMPLETED|Overall Study||0
4947768|NCT02909153|12169431|P4|NOT COMPLETED|Overall Study||0
4947769|NCT02909153|12169432|P3|NOT COMPLETED|Overall Study||0
4947770|NCT02909153|12169433|P2|NOT COMPLETED|Overall Study||1
4947771|NCT02909153|12169434|P1|NOT COMPLETED|Overall Study||0
4947772|NCT02909153|12169430|P5|COMPLETED|Overall Study||6
4947773|NCT02909153|12169431|P4|COMPLETED|Overall Study||6
4947774|NCT02909153|12169432|P3|COMPLETED|Overall Study||6
4947775|NCT02909153|12169433|P2|COMPLETED|Overall Study||5
4947776|NCT02909153|12169434|P1|COMPLETED|Overall Study||6
4947777|NCT02909153|12169430|P5|Triferic in Extraneal PD Solution|Overall Study||6
4947778|NCT02909153|12169431|P4|Triferic in Extraneal PD Solution|Overall Study||6
4947779|NCT02909153|12169432|P3|Triferic in Extraneal PD Solution|Overall Study||0
4947780|NCT02909153|12169433|P2|Triferic in Extraneal PD Solution|Overall Study||0
4947781|NCT02909153|12169434|P1|Triferic in Extraneal PD Solution|Overall Study||0
4947782|NCT02909153|12169430|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
4947783|NCT02909153|12169431|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
4947784|NCT02909153|12169432|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
4947785|NCT02909153|12169433|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
4947786|NCT02909153|12169434|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
4947787|NCT02909153|12169430|P5|Triferic in Dianeal PD Solution|Overall Study||0
4947788|NCT02909153|12169431|P4|Triferic in Dianeal PD Solution|Overall Study||0
4947789|NCT02909153|12169432|P3|Triferic in Dianeal PD Solution|Overall Study||6
4947790|NCT02909153|12169433|P2|Triferic in Dianeal PD Solution|Overall Study||6
4947791|NCT02909153|12169434|P1|Triferic in Dianeal PD Solution|Overall Study||6
4947792|NCT02909153|12169430|P5|STARTED|Overall Study||6
4947793|NCT02909153|12169431|P4|STARTED|Overall Study||6
4947794|NCT02909153|12169432|P3|STARTED|Overall Study||6
4947795|NCT02909153|12169433|P2|STARTED|Overall Study||6
4947796|NCT02909153|12169434|P1|STARTED|Overall Study||6
4947797|NCT02909140|12169479|P3|NOT COMPLETED|Overall Study||0
4947798|NCT02909140|12169480|P2|NOT COMPLETED|Overall Study||0
4947799|NCT02909140|12169481|P1|NOT COMPLETED|Overall Study||0
4947800|NCT02909140|12169479|P3|COMPLETED|Overall Study||0
4947801|NCT02909140|12169480|P2|COMPLETED|Overall Study||2
4947802|NCT02909140|12169481|P1|COMPLETED|Overall Study||0
4947803|NCT02909140|12169479|P3|STARTED|Overall Study||0
4947804|NCT02909140|12169480|P2|STARTED|Overall Study||2
4947805|NCT02909140|12169481|P1|STARTED|Overall Study||0
4947806|NCT02909101|12169524|P2|NOT COMPLETED|Overall Study||1
4947807|NCT02909101|12169525|P1|NOT COMPLETED|Overall Study||1
4947808|NCT02909101|12169524|P2|COMPLETED|Overall Study||28
4947809|NCT02909101|12169525|P1|COMPLETED|Overall Study||28
4947810|NCT02909101|12169524|P2|STARTED|Overall Study||29
4947811|NCT02909101|12169525|P1|STARTED|Overall Study||29
4947812|NCT02908880|12169543|P1|NOT COMPLETED|Overall Study||27
4947813|NCT02908880|12169543|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
4947814|NCT02908880|12169543|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
4947815|NCT02908620|12169555|P4|NOT COMPLETED|Overall Study||0
4947816|NCT02908620|12169556|P3|NOT COMPLETED|Overall Study||0
4947817|NCT02908620|12169557|P2|NOT COMPLETED|Overall Study||0
4947818|NCT02908620|12169558|P1|NOT COMPLETED|Overall Study||0
4947819|NCT02908620|12169555|P4|COMPLETED|Overall Study||10
4947820|NCT02908620|12169556|P3|COMPLETED|Overall Study||10
4947821|NCT02908620|12169557|P2|COMPLETED|Overall Study||10
4947822|NCT02908620|12169558|P1|COMPLETED|Overall Study||10
4947823|NCT02908620|12169555|P4|STARTED|Overall Study||10
4947824|NCT02908620|12169556|P3|STARTED|Overall Study||10
4947825|NCT02908620|12169557|P2|STARTED|Overall Study||10
4947826|NCT02908620|12169558|P1|STARTED|Overall Study||10
4947827|NCT02908529|12169592|P2|NOT COMPLETED|Overall Study||2
4947828|NCT02908529|12169593|P1|NOT COMPLETED|Overall Study||0
4947829|NCT02908529|12169592|P2|COMPLETED|Overall Study||10
4947830|NCT02908529|12169593|P1|COMPLETED|Overall Study||10
4947831|NCT02908529|12169592|P2|STARTED|Overall Study||12
4947832|NCT02908529|12169593|P1|STARTED|Overall Study||10
4947833|NCT02908516|12169603|P2|NOT COMPLETED|Overall Study||3
4947834|NCT02908516|12169604|P1|NOT COMPLETED|Overall Study||3
4947835|NCT02908516|12169603|P2|COMPLETED|Overall Study||0
4947836|NCT02908516|12169604|P1|COMPLETED|Overall Study||0
4947837|NCT02908516|12169603|P2|STARTED|Overall Study||3
4947838|NCT02908516|12169604|P1|STARTED|Overall Study||3
4947839|NCT02908464|12169620|P2|NOT COMPLETED|Overall Study||3
4947840|NCT02908464|12169621|P1|NOT COMPLETED|Overall Study||2
4947841|NCT02908464|12169620|P2|COMPLETED|Overall Study||20
4947842|NCT02908464|12169621|P1|COMPLETED|Overall Study||20
4947843|NCT02908464|12169620|P2|STARTED|Overall Study||23
4947844|NCT02908464|12169621|P1|STARTED|Overall Study||22
4947845|NCT02908347|12169642|P2|NOT COMPLETED|Overall Study||1
4947846|NCT02908347|12169643|P1|NOT COMPLETED|Overall Study||1
4947847|NCT02908347|12169642|P2|COMPLETED|Overall Study||22
4947848|NCT02908347|12169643|P1|COMPLETED|Overall Study||22
4947849|NCT02908347|12169642|P2|STARTED|Overall Study||23
4947850|NCT02908347|12169643|P1|STARTED|Overall Study||23
4947851|NCT02908269|12169694|P3|NOT COMPLETED|Overall Study||0
4947852|NCT02908269|12169695|P2|NOT COMPLETED|Overall Study||0
4947853|NCT02908269|12169696|P1|NOT COMPLETED|Overall Study||0
4947854|NCT02908269|12169694|P3|COMPLETED|Overall Study||60
4947855|NCT02908269|12169695|P2|COMPLETED|Overall Study||60
4947856|NCT02908269|12169696|P1|COMPLETED|Overall Study||60
4947857|NCT02908269|12169694|P3|STARTED|Overall Study||60
4947858|NCT02908269|12169695|P2|STARTED|Overall Study||60
4947859|NCT02908269|12169696|P1|STARTED|Overall Study||60
4947860|NCT02908178|12169714|P4|NOT COMPLETED|Overall Study||6819
4947861|NCT02908178|12169715|P3|NOT COMPLETED|Overall Study||0
4947862|NCT02908178|12169716|P2|NOT COMPLETED|Overall Study||8388
4947863|NCT02908178|12169717|P1|NOT COMPLETED|Overall Study||0
4947864|NCT02908178|12169714|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
4947865|NCT02908178|12169715|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
4947866|NCT02908178|12169716|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
4947867|NCT02908178|12169717|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
4947868|NCT02908178|12169714|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
4947869|NCT02908178|12169715|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
4947870|NCT02908178|12169716|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
4947871|NCT02908178|12169717|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
4947872|NCT02908100|12169739|P3|NOT COMPLETED|Overall Study||21
4947873|NCT02908100|12169740|P2|NOT COMPLETED|Overall Study||21
4947874|NCT02908100|12169741|P1|NOT COMPLETED|Overall Study||23
4947875|NCT02908100|12169739|P3|COMPLETED|Overall Study||66
4947876|NCT02908100|12169740|P2|COMPLETED|Overall Study||66
4947877|NCT02908100|12169741|P1|COMPLETED|Overall Study||63
4947878|NCT02908100|12169739|P3|STARTED|Overall Study||87
4947879|NCT02908100|12169740|P2|STARTED|Overall Study||87
4947880|NCT02908100|12169741|P1|STARTED|Overall Study||86
4947881|NCT02907892|12169777|P2|NOT COMPLETED|Overall Study||40
4947882|NCT02907892|12169778|P1|NOT COMPLETED|Overall Study||27
4947883|NCT02907892|12169777|P2|COMPLETED|Overall Study||236
4947884|NCT02907892|12169778|P1|COMPLETED|Overall Study||250
4947885|NCT02907892|12169777|P2|STARTED|Overall Study||276
4947886|NCT02907892|12169778|P1|STARTED|Overall Study||277
4947887|NCT02907814|12169786|P2|NOT COMPLETED|Overall Study||0
4947888|NCT02907814|12169787|P1|NOT COMPLETED|Overall Study||6
4947889|NCT02907814|12169786|P2|COMPLETED|Overall Study||0
4947890|NCT02907814|12169787|P1|COMPLETED|Overall Study||0
4947891|NCT02907814|12169786|P2|STARTED|Overall Study||0
4947892|NCT02907814|12169787|P1|STARTED|Overall Study||6
4947893|NCT02907619|12169798|P3|NOT COMPLETED|Overall Study||20
4947894|NCT02907619|12169799|P2|NOT COMPLETED|Overall Study||20
4947895|NCT02907619|12169800|P1|NOT COMPLETED|Overall Study||19
4947896|NCT02907619|12169798|P3|COMPLETED|Overall Study||0
4947897|NCT02907619|12169799|P2|COMPLETED|Overall Study||0
4947898|NCT02907619|12169800|P1|COMPLETED|Overall Study||0
4947899|NCT02907619|12169798|P3|Received Treatment|Overall Study||20
4947900|NCT02907619|12169799|P2|Received Treatment|Overall Study||20
4947901|NCT02907619|12169800|P1|Received Treatment|Overall Study||19
4947902|NCT02907619|12169798|P3|STARTED|Overall Study||20
4947903|NCT02907619|12169799|P2|STARTED|Overall Study||20
4947904|NCT02907619|12169800|P1|STARTED|Overall Study||19
4947905|NCT02907489|12170007|P2|NOT COMPLETED|Overall Study||1
4947906|NCT02907489|12170008|P1|NOT COMPLETED|Overall Study||2
4947907|NCT02907489|12170007|P2|COMPLETED|Overall Study||41
4947908|NCT02907489|12170008|P1|COMPLETED|Overall Study||40
4947909|NCT02907489|12170007|P2|STARTED|Overall Study||42
4947910|NCT02907489|12170008|P1|STARTED|Overall Study||42
4947911|NCT02907463|12170016|P1|NOT COMPLETED|Overall Study||37
4947912|NCT02907463|12170016|P1|COMPLETED|Overall Study||243
4947913|NCT02907463|12170016|P1|Per Protocol Cohort|Overall Study||276
4947914|NCT02907463|12170016|P1|Enrolled Cohort|Overall Study||280
4947915|NCT02907463|12170016|P1|STARTED|Overall Study||280
4947916|NCT02907268|12170088|P2|NOT COMPLETED|Overall Study||0
4947917|NCT02907268|12170089|P1|NOT COMPLETED|Overall Study||0
4947918|NCT02907268|12170088|P2|COMPLETED|Overall Study||5
4947919|NCT02907268|12170089|P1|COMPLETED|Overall Study||5
4947920|NCT02907268|12170088|P2|STARTED|Overall Study||5
4947921|NCT02907268|12170089|P1|STARTED|Overall Study||5
4947922|NCT02907216|12170098|P2|NOT COMPLETED|Overall Study||1
4947923|NCT02907216|12170099|P1|NOT COMPLETED|Overall Study||1
4947924|NCT02907216|12170098|P2|COMPLETED|Overall Study||144
4947925|NCT02907216|12170099|P1|COMPLETED|Overall Study||146
4947926|NCT02907216|12170098|P2|STARTED|Overall Study||145
4947927|NCT02907216|12170099|P1|STARTED|Overall Study||147
4947928|NCT02907073|12170134|P3|NOT COMPLETED|Overall Study||0
4947929|NCT02907073|12170135|P2|NOT COMPLETED|Overall Study||0
4947930|NCT02907073|12170136|P1|NOT COMPLETED|Overall Study||0
4947931|NCT02907073|12170134|P3|COMPLETED|Overall Study||0
4947932|NCT02907073|12170135|P2|COMPLETED|Overall Study||0
4947933|NCT02907073|12170136|P1|COMPLETED|Overall Study||8
4947934|NCT02907073|12170134|P3|STARTED|Overall Study||0
4947935|NCT02907073|12170135|P2|STARTED|Overall Study||0
4947936|NCT02907073|12170136|P1|STARTED|Overall Study||8
4947937|NCT02906930|12170151|P4|NOT COMPLETED|Overall Study||8
4947938|NCT02906930|12170152|P3|NOT COMPLETED|Overall Study||12
4947939|NCT02906930|12170153|P2|NOT COMPLETED|Overall Study||14
4947940|NCT02906930|12170154|P1|NOT COMPLETED|Overall Study||6
4947941|NCT02906930|12170151|P4|COMPLETED|Overall Study||170
4947942|NCT02906930|12170152|P3|COMPLETED|Overall Study||163
4947943|NCT02906930|12170153|P2|COMPLETED|Overall Study||161
4947944|NCT02906930|12170154|P1|COMPLETED|Overall Study||169
4947945|NCT02906930|12170151|P4|Safety Analysis Set (SAS)|Overall Study||178
4947946|NCT02906930|12170152|P3|Safety Analysis Set (SAS)|Overall Study||175
4947947|NCT02906930|12170153|P2|Safety Analysis Set (SAS)|Overall Study||175
4947948|NCT02906930|12170154|P1|Safety Analysis Set (SAS)|Overall Study||175
4947949|NCT02906930|12170151|P4|Full Analysis Set (FAS)|Overall Study||178
4947950|NCT02906930|12170152|P3|Full Analysis Set (FAS)|Overall Study||175
4947951|NCT02906930|12170153|P2|Full Analysis Set (FAS)|Overall Study||175
4947952|NCT02906930|12170154|P1|Full Analysis Set (FAS)|Overall Study||175
4947953|NCT02906930|12170151|P4|STARTED|Overall Study||178
4947954|NCT02906930|12170152|P3|STARTED|Overall Study||175
4947955|NCT02906930|12170153|P2|STARTED|Overall Study||175
4947956|NCT02906930|12170154|P1|STARTED|Overall Study||175
4947957|NCT02906917|12170347|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
4947958|NCT02906917|12170348|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
4947959|NCT02906917|12170347|P2|COMPLETED|Intensification Period (Week 26-38)||247
4947960|NCT02906917|12170348|P1|COMPLETED|Intensification Period (Week 26-38)||252
4947961|NCT02906917|12170347|P2|STARTED|Intensification Period (Week 26-38)||254
4947962|NCT02906917|12170348|P1|STARTED|Intensification Period (Week 26-38)||261
4947963|NCT02906917|12170347|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
4947964|NCT02906917|12170348|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
4947965|NCT02906917|12170347|P2|COMPLETED|Initiation Period (Week 0-26)||254
4947966|NCT02906917|12170348|P1|COMPLETED|Initiation Period (Week 0-26)||261
4947967|NCT02906917|12170347|P2|Exposed|Initiation Period (Week 0-26)||263
4947968|NCT02906917|12170348|P1|Exposed|Initiation Period (Week 0-26)||265
4947969|NCT02906917|12170347|P2|STARTED|Initiation Period (Week 0-26)||265
4947970|NCT02906917|12170348|P1|STARTED|Initiation Period (Week 0-26)||267
4947971|NCT02906813|12170379|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4947972|NCT02906813|12170380|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4947973|NCT02906813|12170381|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4947974|NCT02906813|12170379|P3|COMPLETED|Intervention Period 3 (3 Days)||3
4947975|NCT02906813|12170380|P2|COMPLETED|Intervention Period 3 (3 Days)||3
4947976|NCT02906813|12170381|P1|COMPLETED|Intervention Period 3 (3 Days)||3
4947977|NCT02906813|12170379|P3|STARTED|Intervention Period 3 (3 Days)||3
4947978|NCT02906813|12170380|P2|STARTED|Intervention Period 3 (3 Days)||3
4947979|NCT02906813|12170381|P1|STARTED|Intervention Period 3 (3 Days)||3
4947980|NCT02906813|12170379|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
4947981|NCT02906813|12170380|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
4947982|NCT02906813|12170381|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
4947983|NCT02906813|12170379|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
4947984|NCT02906813|12170380|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
4947985|NCT02906813|12170381|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
4947986|NCT02906813|12170379|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
4947987|NCT02906813|12170380|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
4947988|NCT02906813|12170381|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
4947989|NCT02906813|12170379|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4947990|NCT02906813|12170380|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4947991|NCT02906813|12170381|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4947992|NCT02906813|12170379|P3|COMPLETED|Intervention Period 2 (3 Days)||3
4947993|NCT02906813|12170380|P2|COMPLETED|Intervention Period 2 (3 Days)||3
4947994|NCT02906813|12170381|P1|COMPLETED|Intervention Period 2 (3 Days)||3
4947995|NCT02906813|12170379|P3|STARTED|Intervention Period 2 (3 Days)||3
4947996|NCT02906813|12170380|P2|STARTED|Intervention Period 2 (3 Days)||3
4947997|NCT02906813|12170381|P1|STARTED|Intervention Period 2 (3 Days)||3
4947998|NCT02906813|12170379|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
4947999|NCT02906813|12170380|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
4948000|NCT02906813|12170381|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
4948001|NCT02906813|12170379|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
4948002|NCT02906813|12170380|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
4948003|NCT02906813|12170381|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
4948004|NCT02906813|12170379|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
4948005|NCT02906813|12170380|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
4948006|NCT02906813|12170381|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
4948007|NCT02906813|12170379|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4948008|NCT02906813|12170380|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4948009|NCT02906813|12170381|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4948010|NCT02906813|12170379|P3|COMPLETED|Intervention Period 1 (3 Days)||3
4948011|NCT02906813|12170380|P2|COMPLETED|Intervention Period 1 (3 Days)||3
4948012|NCT02906813|12170381|P1|COMPLETED|Intervention Period 1 (3 Days)||3
4948013|NCT02906813|12170379|P3|STARTED|Intervention Period 1 (3 Days)||3
4948014|NCT02906813|12170380|P2|STARTED|Intervention Period 1 (3 Days)||3
4948015|NCT02906813|12170381|P1|STARTED|Intervention Period 1 (3 Days)||3
4948016|NCT02906709|12170409|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
4948017|NCT02906709|12170410|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
4948018|NCT02906709|12170409|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
4948019|NCT02906709|12170410|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
4948020|NCT02906709|12170409|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
4948021|NCT02906709|12170410|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
4948022|NCT02906709|12170409|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
4948023|NCT02906709|12170410|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
4948024|NCT02906709|12170409|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
4948025|NCT02906709|12170410|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
4948026|NCT02906709|12170409|P2|STARTED|Phase A (Week 0 to Week 16)||61
4948027|NCT02906709|12170410|P1|STARTED|Phase A (Week 0 to Week 16)||123
4948028|NCT02906696|12170442|P1|NOT COMPLETED|Overall Study||0
4948029|NCT02906696|12170442|P1|COMPLETED|Overall Study||8
4948030|NCT02906696|12170442|P1|STARTED|Overall Study||8
4948031|NCT02906644|12170456|P2|NOT COMPLETED|Weeks 3 to 14||11
4948032|NCT02906644|12170457|P1|NOT COMPLETED|Weeks 3 to 14||16
4948033|NCT02906644|12170456|P2|COMPLETED|Weeks 3 to 14||16
4948034|NCT02906644|12170457|P1|COMPLETED|Weeks 3 to 14||14
4948035|NCT02906644|12170456|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
4948036|NCT02906644|12170457|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
4948037|NCT02906644|12170456|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
4948038|NCT02906644|12170457|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
4948039|NCT02906644|12170456|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
4948040|NCT02906644|12170457|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
4948041|NCT02906644|12170456|P2|NOT COMPLETED|First 2 Weeks||3
4948042|NCT02906644|12170457|P1|NOT COMPLETED|First 2 Weeks||1
4948043|NCT02906644|12170456|P2|COMPLETED|First 2 Weeks||27
4948044|NCT02906644|12170457|P1|COMPLETED|First 2 Weeks||30
4948045|NCT02906644|12170456|P2|STARTED|First 2 Weeks||30
4948046|NCT02906644|12170457|P1|STARTED|First 2 Weeks||31
4948047|NCT02906579|12170473|P1|NOT COMPLETED|Overall Study||2
4948048|NCT02906579|12170473|P1|COMPLETED|Overall Study||9
4948049|NCT02906579|12170473|P1|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
4948050|NCT02906579|12170473|P1|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
4948051|NCT02906579|12170473|P1|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
4948052|NCT02906579|12170473|P1|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
4948053|NCT02906579|12170473|P1|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
4948054|NCT02906579|12170473|P1|Completed Cycle 1 (Placebo)|Overall Study||11
4948055|NCT02906579|12170473|P1|STARTED|Overall Study||11
4948056|NCT02906566|12170660|P2|NOT COMPLETED|Overall Study||0
4948057|NCT02906566|12170661|P1|NOT COMPLETED|Overall Study||3
4948058|NCT02906566|12170660|P2|COMPLETED|Overall Study||10
4948059|NCT02906566|12170661|P1|COMPLETED|Overall Study||21
4948060|NCT02906566|12170660|P2|STARTED|Overall Study||10
4948061|NCT02906566|12170661|P1|STARTED|Overall Study||24
4948062|NCT02906358|12170677|P2|NOT COMPLETED|Overall Study||22
4948063|NCT02906358|12170678|P1|NOT COMPLETED|Overall Study||22
4948064|NCT02906358|12170677|P2|COMPLETED|Overall Study||31
4948065|NCT02906358|12170678|P1|COMPLETED|Overall Study||36
4948066|NCT02906358|12170677|P2|Completed 3 Month Measures|Overall Study||33
4948067|NCT02906358|12170678|P1|Completed 3 Month Measures|Overall Study||36
4948068|NCT02906358|12170677|P2|STARTED|Overall Study||53
4948069|NCT02906358|12170678|P1|STARTED|Overall Study||58
4948070|NCT02905825|12170706|P1|NOT COMPLETED|Overall Study||12
4948071|NCT02905825|12170706|P1|COMPLETED|Overall Study||41
4948072|NCT02905825|12170706|P1|STARTED|Overall Study||53
4948073|NCT02905331|12170714|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
4948074|NCT02905331|12170715|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
4948075|NCT02905331|12170716|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
4948076|NCT02905331|12170714|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
4948077|NCT02905331|12170715|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
4948078|NCT02905331|12170716|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
4948079|NCT02905331|12170714|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
4948080|NCT02905331|12170715|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
4948081|NCT02905331|12170716|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
4948082|NCT02905331|12170714|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
4948083|NCT02905331|12170715|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
4948084|NCT02905331|12170716|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
4948085|NCT02905331|12170714|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
4948086|NCT02905331|12170715|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
4948087|NCT02905331|12170716|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
4948088|NCT02905331|12170714|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
4948089|NCT02905331|12170715|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
4948090|NCT02905331|12170716|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
4948091|NCT02905266|12170744|P2|NOT COMPLETED|Maintenance Phase Part 2||22
4948092|NCT02905266|12170745|P1|NOT COMPLETED|Maintenance Phase Part 2||19
4948093|NCT02905266|12170744|P2|COMPLETED|Maintenance Phase Part 2||0
4948094|NCT02905266|12170745|P1|COMPLETED|Maintenance Phase Part 2||0
4948095|NCT02905266|12170744|P2|STARTED|Maintenance Phase Part 2||22
4948096|NCT02905266|12170745|P1|STARTED|Maintenance Phase Part 2||19
4948097|NCT02905266|12170744|P2|NOT COMPLETED|Treatment Period Part 1||23
4948098|NCT02905266|12170745|P1|NOT COMPLETED|Treatment Period Part 1||29
4948099|NCT02905266|12170744|P2|COMPLETED|Treatment Period Part 1||30
4948100|NCT02905266|12170745|P1|COMPLETED|Treatment Period Part 1||24
4948101|NCT02905266|12170744|P2|STARTED|Treatment Period Part 1||53
4948102|NCT02905266|12170745|P1|STARTED|Treatment Period Part 1||53
4948103|NCT02905149|12170767|P2|NOT COMPLETED|Overall Study||0
4948104|NCT02905149|12170768|P1|NOT COMPLETED|Overall Study||2
4948105|NCT02905149|12170767|P2|COMPLETED|Overall Study||30
4948106|NCT02905149|12170768|P1|COMPLETED|Overall Study||28
4948107|NCT02905149|12170767|P2|STARTED|Overall Study||30
4948108|NCT02905149|12170768|P1|STARTED|Overall Study||30
4948109|NCT02904915|12170782|P2|NOT COMPLETED|Overall Study||0
4948110|NCT02904915|12170783|P1|NOT COMPLETED|Overall Study||0
4948111|NCT02904915|12170782|P2|COMPLETED|Overall Study||25
4948112|NCT02904915|12170783|P1|COMPLETED|Overall Study||25
4948113|NCT02904915|12170782|P2|STARTED|Overall Study||25
4948114|NCT02904915|12170783|P1|STARTED|Overall Study||25
4948115|NCT02904902|12170793|P1|NOT COMPLETED|Overall Study||1
4948116|NCT02904902|12170793|P1|COMPLETED|Overall Study||14
4948117|NCT02904902|12170793|P1|STARTED|Overall Study||15
4948118|NCT02904356|12170800|P1|NOT COMPLETED|Overall Study||0
4948119|NCT02904356|12170800|P1|COMPLETED|Overall Study||2
4948120|NCT02904356|12170800|P1|STARTED|Overall Study||2
4948121|NCT02904265|12170806|P2|NOT COMPLETED|Overall Study||2
4948122|NCT02904265|12170807|P1|NOT COMPLETED|Overall Study||1
4948123|NCT02904265|12170806|P2|COMPLETED|Overall Study||0
4948124|NCT02904265|12170807|P1|COMPLETED|Overall Study||0
4948125|NCT02904265|12170806|P2|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
4948126|NCT02904265|12170807|P1|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
4948127|NCT02904096|12170815|P2|NOT COMPLETED|Overall Study||21
4948128|NCT02904096|12170816|P1|NOT COMPLETED|Overall Study||19
4948129|NCT02904096|12170815|P2|COMPLETED|Overall Study||105
4948130|NCT02904096|12170816|P1|COMPLETED|Overall Study||111
4948131|NCT02904096|12170815|P2|STARTED|Overall Study||126
4948132|NCT02904096|12170816|P1|STARTED|Overall Study||130
4948133|NCT02903966|12170842|P2|NOT COMPLETED|Part B (Day 44 to 112)||2
4948134|NCT02903966|12170843|P1|NOT COMPLETED|Part B (Day 44 to 112)||0
4948135|NCT02903966|12170842|P2|COMPLETED|Part B (Day 44 to 112)||22
4948136|NCT02903966|12170843|P1|COMPLETED|Part B (Day 44 to 112)||11
4948137|NCT02903966|12170842|P2|STARTED|Part B (Day 44 to 112)||24
4948138|NCT02903966|12170843|P1|STARTED|Part B (Day 44 to 112)||11
4948139|NCT02903966|12170842|P2|NOT COMPLETED|Part A (Day 1 to 43)||0
4948140|NCT02903966|12170843|P1|NOT COMPLETED|Part A (Day 1 to 43)||1
4948141|NCT02903966|12170842|P2|COMPLETED|Part A (Day 1 to 43)||24
4948142|NCT02903966|12170843|P1|COMPLETED|Part A (Day 1 to 43)||11
4948143|NCT02903966|12170842|P2|STARTED|Part A (Day 1 to 43)||24
4948144|NCT02903966|12170843|P1|STARTED|Part A (Day 1 to 43)||12
4948145|NCT02903836|12170912|P3|NOT COMPLETED|Overall Study||4
4948146|NCT02903836|12170913|P2|NOT COMPLETED|Overall Study||4
4948147|NCT02903836|12170914|P1|NOT COMPLETED|Overall Study||3
4948148|NCT02903836|12170912|P3|COMPLETED|Overall Study||73
4948149|NCT02903836|12170913|P2|COMPLETED|Overall Study||69
4948150|NCT02903836|12170914|P1|COMPLETED|Overall Study||71
4948151|NCT02903836|12170912|P3|STARTED|Overall Study||77
4948152|NCT02903836|12170913|P2|STARTED|Overall Study||73
4948153|NCT02903836|12170914|P1|STARTED|Overall Study||74
4948154|NCT02903407|12170927|P2|NOT COMPLETED|Overall Study||0
4948155|NCT02903407|12170928|P1|NOT COMPLETED|Overall Study||0
4948156|NCT02903407|12170927|P2|COMPLETED|Overall Study||3
4948157|NCT02903407|12170928|P1|COMPLETED|Overall Study||4
4948158|NCT02903407|12170927|P2|STARTED|Overall Study||3
4948159|NCT02903407|12170928|P1|STARTED|Overall Study||4
4948160|NCT02903394|12170960|P2|NOT COMPLETED|Overall Study||0
4948161|NCT02903394|12170961|P1|NOT COMPLETED|Overall Study||0
4948162|NCT02903394|12170960|P2|COMPLETED|Overall Study||50
4948163|NCT02903394|12170961|P1|COMPLETED|Overall Study||5
4948164|NCT02903394|12170960|P2|STARTED|Overall Study||50
4948165|NCT02903394|12170961|P1|STARTED|Overall Study||5
4948166|NCT02903238|12170971|P1|NOT COMPLETED|Overall Study||4
4948167|NCT02903238|12170971|P1|COMPLETED|Overall Study||17
4948168|NCT02903238|12170971|P1|STARTED|Overall Study||21
4948169|NCT02903121|12170982|P2|NOT COMPLETED|Overall Study||14
4948170|NCT02903121|12170983|P1|NOT COMPLETED|Overall Study||23
4948171|NCT02903121|12170982|P2|COMPLETED|Overall Study||38
4948172|NCT02903121|12170983|P1|COMPLETED|Overall Study||34
4948173|NCT02903121|12170982|P2|STARTED|Overall Study||52
4948174|NCT02903121|12170983|P1|STARTED|Overall Study||57
4948175|NCT02903030|12170997|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
4948176|NCT02903030|12170998|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
4948177|NCT02903030|12170997|P2|COMPLETED|Second Intervention (8 Weeks)||4
4948178|NCT02903030|12170998|P1|COMPLETED|Second Intervention (8 Weeks)||6
4948179|NCT02903030|12170997|P2|STARTED|Second Intervention (8 Weeks)||4
4948180|NCT02903030|12170998|P1|STARTED|Second Intervention (8 Weeks)||6
4948181|NCT02903030|12170997|P2|NOT COMPLETED|Washout (3 Weeks)||0
4948182|NCT02903030|12170998|P1|NOT COMPLETED|Washout (3 Weeks)||0
4948183|NCT02903030|12170997|P2|COMPLETED|Washout (3 Weeks)||4
4948184|NCT02903030|12170998|P1|COMPLETED|Washout (3 Weeks)||6
4948185|NCT02903030|12170997|P2|STARTED|Washout (3 Weeks)||4
4948186|NCT02903030|12170998|P1|STARTED|Washout (3 Weeks)||6
4948187|NCT02903030|12170997|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
4948188|NCT02903030|12170998|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
4948189|NCT02903030|12170997|P2|COMPLETED|First Intervention (8 Weeks)||4
4948190|NCT02903030|12170998|P1|COMPLETED|First Intervention (8 Weeks)||6
4948191|NCT02903030|12170997|P2|Received Intervention|First Intervention (8 Weeks)||4
4948192|NCT02903030|12170998|P1|Received Intervention|First Intervention (8 Weeks)||6
4948193|NCT02903030|12170997|P2|STARTED|First Intervention (8 Weeks)||5
4948194|NCT02903030|12170998|P1|STARTED|First Intervention (8 Weeks)||8
4948195|NCT02902965|12171016|P1|NOT COMPLETED|Overall Study||10
4948196|NCT02902965|12171016|P1|COMPLETED|Overall Study||64
4948197|NCT02902965|12171016|P1|STARTED|Overall Study||74
4948198|NCT02902913|12171026|P1|NOT COMPLETED|Overall Study||0
4948199|NCT02902913|12171026|P1|COMPLETED|Overall Study||9
4948200|NCT02902913|12171026|P1|Ibuprofen (400mg)|Overall Study||9
4948201|NCT02902913|12171026|P1|Washout (7 Days)|Overall Study||9
4948202|NCT02902913|12171026|P1|Third Intervention (1 Day)|Overall Study||9
4948203|NCT02902913|12171026|P1|Washout (7 Days)|Overall Study||9
4948204|NCT02902913|12171026|P1|Second Intervention (1 Day)|Overall Study||9
4948205|NCT02902913|12171026|P1|Washout (7 Days)|Overall Study||9
4948206|NCT02902913|12171026|P1|First Intervention (1 Day)|Overall Study||9
4948207|NCT02902913|12171026|P1|STARTED|Overall Study||9
4948208|NCT02902809|12171034|P1|NOT COMPLETED|Overall Study||28
4948209|NCT02902809|12171034|P1|COMPLETED|Overall Study||0
4948210|NCT02902809|12171034|P1|Treatment Completed|Overall Study||2
4948211|NCT02902809|12171034|P1|Treatment Received|Overall Study||28
4948212|NCT02902809|12171034|P1|STARTED|Overall Study||28
4948213|NCT02902770|12171045|P3|NOT COMPLETED|Overall Study||0
4948214|NCT02902770|12171046|P2|NOT COMPLETED|Overall Study||0
4948215|NCT02902770|12171047|P1|NOT COMPLETED|Overall Study||0
4948216|NCT02902770|12171045|P3|COMPLETED|Overall Study||50
4948217|NCT02902770|12171046|P2|COMPLETED|Overall Study||50
4948218|NCT02902770|12171047|P1|COMPLETED|Overall Study||50
4948219|NCT02902770|12171045|P3|STARTED|Overall Study||50
4948220|NCT02902770|12171046|P2|STARTED|Overall Study||50
4948221|NCT02902770|12171047|P1|STARTED|Overall Study||50
4948222|NCT02902172|12171057|P2|NOT COMPLETED|Overall Study||0
4948223|NCT02902172|12171058|P1|NOT COMPLETED|Overall Study||0
4948224|NCT02902172|12171057|P2|COMPLETED|Overall Study||20
4948225|NCT02902172|12171058|P1|COMPLETED|Overall Study||16
4948226|NCT02902172|12171057|P2|STARTED|Overall Study||20
4948227|NCT02902172|12171058|P1|STARTED|Overall Study||16
4948228|NCT02902146|12171068|P2|NOT COMPLETED|Overall Study||0
4948229|NCT02902146|12171069|P1|NOT COMPLETED|Overall Study||0
4948230|NCT02902146|12171068|P2|COMPLETED|Overall Study||376
4948231|NCT02902146|12171069|P1|COMPLETED|Overall Study||381
4948232|NCT02902146|12171068|P2|STARTED|Overall Study||376
4948233|NCT02902146|12171069|P1|STARTED|Overall Study||381
4948234|NCT02902081|12171083|P1|NOT COMPLETED|Overall Study||0
4948235|NCT02902081|12171083|P1|COMPLETED|Overall Study||38
4948236|NCT02902081|12171083|P1|STARTED|Overall Study||38
4948237|NCT02901951|12171091|P1|NOT COMPLETED|Overall Study||0
4948238|NCT02901951|12171091|P1|COMPLETED|Overall Study||103
4948239|NCT02901951|12171091|P1|STARTED|Overall Study||103
4948240|NCT02901080|12171102|P1|NOT COMPLETED|Overall Study||49
4948241|NCT02901080|12171102|P1|COMPLETED|Overall Study||112
4948242|NCT02901080|12171102|P1|STARTED|Overall Study||161
4948243|NCT02901054|12171109|P1|NOT COMPLETED|Overall Study||4
4948244|NCT02901054|12171109|P1|COMPLETED|Overall Study||15
4948245|NCT02901054|12171109|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
4948246|NCT02900781|12171115|P2|NOT COMPLETED|Overall Study||5
4948247|NCT02900781|12171116|P1|NOT COMPLETED|Overall Study||4
4948248|NCT02900781|12171115|P2|COMPLETED|Overall Study||0
4948249|NCT02900781|12171116|P1|COMPLETED|Overall Study||0
4948250|NCT02900781|12171115|P2|STARTED|Overall Study||5
4948251|NCT02900781|12171116|P1|STARTED|Overall Study||4
4948252|NCT02900378|12171124|P2|NOT COMPLETED|Treatment Phase||0
4948253|NCT02900378|12171125|P1|NOT COMPLETED|Treatment Phase||0
4948254|NCT02900378|12171124|P2|COMPLETED|Treatment Phase||310
4948255|NCT02900378|12171125|P1|COMPLETED|Treatment Phase||309
4948256|NCT02900378|12171124|P2|Full Analysis Set|Treatment Phase||302
4948257|NCT02900378|12171125|P1|Full Analysis Set|Treatment Phase||302
4948258|NCT02900378|12171124|P2|STARTED|Treatment Phase||310
4948259|NCT02900378|12171125|P1|STARTED|Treatment Phase||309
4948260|NCT02900378|12171124|P2|NOT COMPLETED|Randomization (Visit 2)||28
4948261|NCT02900378|12171125|P1|NOT COMPLETED|Randomization (Visit 2)||23
4948262|NCT02900378|12171124|P2|COMPLETED|Randomization (Visit 2)||283
4948263|NCT02900378|12171125|P1|COMPLETED|Randomization (Visit 2)||287
4948264|NCT02900378|12171124|P2|STARTED|Randomization (Visit 2)||311
4948265|NCT02900378|12171125|P1|STARTED|Randomization (Visit 2)||310
4948266|NCT02900170|12171169|P1|NOT COMPLETED|Overall Study||8
4948267|NCT02900170|12171169|P1|COMPLETED|Overall Study||0
4948268|NCT02900170|12171169|P1|STARTED|Overall Study||8
4948269|NCT02900092|12171173|P1|NOT COMPLETED|Overall Study||1
4948270|NCT02900092|12171173|P1|COMPLETED|Overall Study||9
4948271|NCT02900092|12171173|P1|STARTED|Overall Study||10
4948272|NCT02899988|12171181|P11|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948273|NCT02899988|12171182|P10|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948274|NCT02899988|12171183|P9|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948275|NCT02899988|12171184|P8|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948276|NCT02899988|12171185|P7|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948277|NCT02899988|12171186|P6|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948278|NCT02899988|12171187|P5|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948279|NCT02899988|12171188|P4|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948280|NCT02899988|12171189|P3|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948281|NCT02899988|12171190|P2|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948282|NCT02899988|12171191|P1|NOT COMPLETED|Follow-Up (16 Weeks)||0
4948283|NCT02899988|12171181|P11|COMPLETED|Follow-Up (16 Weeks)||0
4948284|NCT02899988|12171182|P10|COMPLETED|Follow-Up (16 Weeks)||2
4948285|NCT02899988|12171183|P9|COMPLETED|Follow-Up (16 Weeks)||6
4948286|NCT02899988|12171184|P8|COMPLETED|Follow-Up (16 Weeks)||3
4948287|NCT02899988|12171185|P7|COMPLETED|Follow-Up (16 Weeks)||3
4948288|NCT02899988|12171186|P6|COMPLETED|Follow-Up (16 Weeks)||4
4948289|NCT02899988|12171187|P5|COMPLETED|Follow-Up (16 Weeks)||2
4948290|NCT02899988|12171188|P4|COMPLETED|Follow-Up (16 Weeks)||0
4948291|NCT02899988|12171189|P3|COMPLETED|Follow-Up (16 Weeks)||0
4948292|NCT02899988|12171190|P2|COMPLETED|Follow-Up (16 Weeks)||0
4948293|NCT02899988|12171191|P1|COMPLETED|Follow-Up (16 Weeks)||0
4948294|NCT02899988|12171181|P11|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
4948295|NCT02899988|12171182|P10|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
4948296|NCT02899988|12171183|P9|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
4948297|NCT02899988|12171184|P8|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
4948298|NCT02899988|12171185|P7|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
4948299|NCT02899988|12171186|P6|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
4948300|NCT02899988|12171187|P5|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
4948301|NCT02899988|12171188|P4|STARTED|Follow-Up (16 Weeks)||0
4948302|NCT02899988|12171189|P3|STARTED|Follow-Up (16 Weeks)||0
4948303|NCT02899988|12171190|P2|STARTED|Follow-Up (16 Weeks)||0
4948304|NCT02899988|12171191|P1|STARTED|Follow-Up (16 Weeks)||0
4948305|NCT02899988|12171181|P11|NOT COMPLETED|Maintenance Period (88 Weeks)||2
4948306|NCT02899988|12171182|P10|NOT COMPLETED|Maintenance Period (88 Weeks)||2
4948307|NCT02899988|12171183|P9|NOT COMPLETED|Maintenance Period (88 Weeks)||4
4948308|NCT02899988|12171184|P8|NOT COMPLETED|Maintenance Period (88 Weeks)||5
4948309|NCT02899988|12171185|P7|NOT COMPLETED|Maintenance Period (88 Weeks)||4
4948310|NCT02899988|12171186|P6|NOT COMPLETED|Maintenance Period (88 Weeks)||3
4948311|NCT02899988|12171187|P5|NOT COMPLETED|Maintenance Period (88 Weeks)||2
4948312|NCT02899988|12171188|P4|NOT COMPLETED|Maintenance Period (88 Weeks)||0
4948313|NCT02899988|12171189|P3|NOT COMPLETED|Maintenance Period (88 Weeks)||0
4948314|NCT02899988|12171190|P2|NOT COMPLETED|Maintenance Period (88 Weeks)||0
4948315|NCT02899988|12171191|P1|NOT COMPLETED|Maintenance Period (88 Weeks)||0
4948316|NCT02899988|12171181|P11|COMPLETED|Maintenance Period (88 Weeks)||13
4948317|NCT02899988|12171182|P10|COMPLETED|Maintenance Period (88 Weeks)||19
4948318|NCT02899988|12171183|P9|COMPLETED|Maintenance Period (88 Weeks)||30
4948319|NCT02899988|12171184|P8|COMPLETED|Maintenance Period (88 Weeks)||45
4948320|NCT02899988|12171185|P7|COMPLETED|Maintenance Period (88 Weeks)||30
4948321|NCT02899988|12171186|P6|COMPLETED|Maintenance Period (88 Weeks)||27
4948322|NCT02899988|12171187|P5|COMPLETED|Maintenance Period (88 Weeks)||13
4948323|NCT02899988|12171188|P4|COMPLETED|Maintenance Period (88 Weeks)||0
4948324|NCT02899988|12171189|P3|COMPLETED|Maintenance Period (88 Weeks)||0
4948325|NCT02899988|12171190|P2|COMPLETED|Maintenance Period (88 Weeks)||0
4948326|NCT02899988|12171191|P1|COMPLETED|Maintenance Period (88 Weeks)||0
4948327|NCT02899988|12171181|P11|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
4948328|NCT02899988|12171182|P10|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
4948329|NCT02899988|12171183|P9|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
4948330|NCT02899988|12171184|P8|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
4948331|NCT02899988|12171185|P7|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
4948332|NCT02899988|12171186|P6|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
4948333|NCT02899988|12171187|P5|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
4948334|NCT02899988|12171188|P4|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
4948335|NCT02899988|12171189|P3|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
4948336|NCT02899988|12171190|P2|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
4948337|NCT02899988|12171191|P1|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
4948338|NCT02899988|12171181|P11|Rescue Participants|Maintenance Period (88 Weeks)||0
4948339|NCT02899988|12171182|P10|Rescue Participants|Maintenance Period (88 Weeks)||0
4948340|NCT02899988|12171183|P9|Rescue Participants|Maintenance Period (88 Weeks)||0
4948341|NCT02899988|12171184|P8|Rescue Participants|Maintenance Period (88 Weeks)||0
4948342|NCT02899988|12171185|P7|Rescue Participants|Maintenance Period (88 Weeks)||0
4948343|NCT02899988|12171186|P6|Rescue Participants|Maintenance Period (88 Weeks)||0
4948344|NCT02899988|12171187|P5|Rescue Participants|Maintenance Period (88 Weeks)||0
4948345|NCT02899988|12171188|P4|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
4948346|NCT02899988|12171189|P3|Rescue Participants|Maintenance Period (88 Weeks)||0
4948347|NCT02899988|12171190|P2|Rescue Participants|Maintenance Period (88 Weeks)||0
4948348|NCT02899988|12171191|P1|Rescue Participants|Maintenance Period (88 Weeks)||0
4948349|NCT02899988|12171181|P11|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
4948350|NCT02899988|12171182|P10|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
4948351|NCT02899988|12171183|P9|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
4948352|NCT02899988|12171184|P8|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
4948353|NCT02899988|12171185|P7|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
4948354|NCT02899988|12171186|P6|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
4948355|NCT02899988|12171187|P5|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
4948356|NCT02899988|12171188|P4|STARTED|Maintenance Period (88 Weeks)||0
4948357|NCT02899988|12171189|P3|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
4948358|NCT02899988|12171190|P2|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
4948359|NCT02899988|12171191|P1|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
4948360|NCT02899988|12171181|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
4948361|NCT02899988|12171182|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
4948362|NCT02899988|12171183|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
4948363|NCT02899988|12171184|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
4948364|NCT02899988|12171185|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
4948365|NCT02899988|12171186|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
4948366|NCT02899988|12171187|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
4948367|NCT02899988|12171188|P4|NOT COMPLETED|Induction Period (16 Weeks)||2
4948368|NCT02899988|12171189|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
4948369|NCT02899988|12171190|P2|NOT COMPLETED|Induction Period (16 Weeks)||2
4948370|NCT02899988|12171191|P1|NOT COMPLETED|Induction Period (16 Weeks)||2
4948371|NCT02899988|12171181|P11|COMPLETED|Induction Period (16 Weeks)||0
4948372|NCT02899988|12171182|P10|COMPLETED|Induction Period (16 Weeks)||0
4948373|NCT02899988|12171183|P9|COMPLETED|Induction Period (16 Weeks)||0
4948374|NCT02899988|12171184|P8|COMPLETED|Induction Period (16 Weeks)||0
4948375|NCT02899988|12171185|P7|COMPLETED|Induction Period (16 Weeks)||0
4948376|NCT02899988|12171186|P6|COMPLETED|Induction Period (16 Weeks)||0
4948377|NCT02899988|12171187|P5|COMPLETED|Induction Period (16 Weeks)||0
4948378|NCT02899988|12171188|P4|COMPLETED|Induction Period (16 Weeks)||49
4948379|NCT02899988|12171189|P3|COMPLETED|Induction Period (16 Weeks)||51
4948380|NCT02899988|12171190|P2|COMPLETED|Induction Period (16 Weeks)||49
4948381|NCT02899988|12171191|P1|COMPLETED|Induction Period (16 Weeks)||50
4948382|NCT02899988|12171181|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948383|NCT02899988|12171182|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948384|NCT02899988|12171183|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948385|NCT02899988|12171184|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948386|NCT02899988|12171185|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948387|NCT02899988|12171186|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948388|NCT02899988|12171187|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
4948389|NCT02899988|12171188|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
4948390|NCT02899988|12171189|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
4948391|NCT02899988|12171190|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
4948392|NCT02899988|12171191|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
4948393|NCT02899988|12171181|P11|STARTED|Induction Period (16 Weeks)||0
4948394|NCT02899988|12171182|P10|STARTED|Induction Period (16 Weeks)||0
4948395|NCT02899988|12171183|P9|STARTED|Induction Period (16 Weeks)||0
4948396|NCT02899988|12171184|P8|STARTED|Induction Period (16 Weeks)||0
4948397|NCT02899988|12171185|P7|STARTED|Induction Period (16 Weeks)||0
4948398|NCT02899988|12171186|P6|STARTED|Induction Period (16 Weeks)||0
4948399|NCT02899988|12171187|P5|STARTED|Induction Period (16 Weeks)||0
4948400|NCT02899988|12171188|P4|STARTED|Induction Period (16 Weeks)||51
4948401|NCT02899988|12171189|P3|STARTED|Induction Period (16 Weeks)||51
4948402|NCT02899988|12171190|P2|STARTED|Induction Period (16 Weeks)||51
4948403|NCT02899988|12171191|P1|STARTED|Induction Period (16 Weeks)||52
4948404|NCT02899884|12171250|P1|NOT COMPLETED|Overall Study||0
4948405|NCT02899884|12171250|P1|COMPLETED|Overall Study||3765
4948406|NCT02899884|12171250|P1|STARTED|Overall Study||3765
4948407|NCT02899377|12171264|P2|NOT COMPLETED|Overall Study||0
4948408|NCT02899377|12171265|P1|NOT COMPLETED|Overall Study||1
4948409|NCT02899377|12171264|P2|COMPLETED|Overall Study||12
4948410|NCT02899377|12171265|P1|COMPLETED|Overall Study||12
4948411|NCT02899377|12171264|P2|STARTED|Overall Study||12
4948412|NCT02899377|12171265|P1|STARTED|Overall Study||13
4948413|NCT02899338|12171298|P2|NOT COMPLETED|Overall Study||2
4948414|NCT02899338|12171299|P1|NOT COMPLETED|Overall Study||3
4948415|NCT02899338|12171298|P2|COMPLETED|Overall Study||79
4948416|NCT02899338|12171299|P1|COMPLETED|Overall Study||78
4948417|NCT02899338|12171298|P2|STARTED|Overall Study||81
4948418|NCT02899338|12171299|P1|STARTED|Overall Study||81
4948419|NCT02899156|12171313|P2|NOT COMPLETED|Overall Study||1
4948420|NCT02899156|12171314|P1|NOT COMPLETED|Overall Study||1
4948421|NCT02899156|12171313|P2|COMPLETED|Overall Study||10
4948422|NCT02899156|12171314|P1|COMPLETED|Overall Study||10
4948423|NCT02899156|12171313|P2|STARTED|Overall Study||11
4948424|NCT02899156|12171314|P1|STARTED|Overall Study||11
4948425|NCT02898974|12171334|P2|NOT COMPLETED|Overall Study||0
4948426|NCT02898974|12171335|P1|NOT COMPLETED|Overall Study||0
4948427|NCT02898974|12171334|P2|COMPLETED|Overall Study||9
4948428|NCT02898974|12171335|P1|COMPLETED|Overall Study||13
4948429|NCT02898974|12171334|P2|STARTED|Overall Study||9
4948430|NCT02898974|12171335|P1|STARTED|Overall Study||13
4948431|NCT02898740|12171347|P2|NOT COMPLETED|Overall Study||0
4948432|NCT02898740|12171348|P1|NOT COMPLETED|Overall Study||0
4948433|NCT02898740|12171347|P2|COMPLETED|Overall Study||19
4948434|NCT02898740|12171348|P1|COMPLETED|Overall Study||21
4948435|NCT02898740|12171347|P2|STARTED|Overall Study||19
4948436|NCT02898740|12171348|P1|STARTED|Overall Study||21
4948437|NCT02898662|12171356|P2|NOT COMPLETED|Overall Study||28
4948438|NCT02898662|12171357|P1|NOT COMPLETED|Overall Study||29
4948439|NCT02898662|12171356|P2|COMPLETED|Overall Study||13
4948440|NCT02898662|12171357|P1|COMPLETED|Overall Study||11
4948441|NCT02898662|12171356|P2|Completed Treatment|Overall Study||29
4948442|NCT02898662|12171357|P1|Completed Treatment|Overall Study||25
4948443|NCT02898662|12171356|P2|STARTED|Overall Study||41
4948444|NCT02898662|12171357|P1|STARTED|Overall Study||40
4948445|NCT02898597|12171381|P2|NOT COMPLETED|Overall Study||12
4948446|NCT02898597|12171382|P1|NOT COMPLETED|Overall Study||4
4948447|NCT02898597|12171381|P2|COMPLETED|Overall Study||12
4948448|NCT02898597|12171382|P1|COMPLETED|Overall Study||21
4948449|NCT02898597|12171381|P2|STARTED|Overall Study||24
4948450|NCT02898597|12171382|P1|STARTED|Overall Study||25
4948451|NCT02898454|12171391|P3|NOT COMPLETED|Overall Study||6
4948452|NCT02898454|12171392|P2|NOT COMPLETED|Overall Study||5
4948453|NCT02898454|12171393|P1|NOT COMPLETED|Overall Study||17
4948454|NCT02898454|12171391|P3|COMPLETED|Overall Study||144
4948455|NCT02898454|12171392|P2|COMPLETED|Overall Study||140
4948456|NCT02898454|12171393|P1|COMPLETED|Overall Study||136
4948457|NCT02898454|12171391|P3|Safety Population|Overall Study||149
4948458|NCT02898454|12171392|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
4948459|NCT02898454|12171393|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
4948460|NCT02898454|12171391|P3|Treated|Overall Study||150
4948461|NCT02898454|12171392|P2|Treated|Overall Study||145
4948462|NCT02898454|12171393|P1|Treated|Overall Study||152
4948463|NCT02898454|12171391|P3|Intent-to-Treat (ITT) Population|Overall Study||150
4948464|NCT02898454|12171392|P2|Intent-to-Treat (ITT) Population|Overall Study||145
4948465|NCT02898454|12171393|P1|Intent-to-Treat (ITT) Population|Overall Study||153
4948466|NCT02898454|12171391|P3|STARTED|Overall Study||150
4948467|NCT02898454|12171392|P2|STARTED|Overall Study||145
4948468|NCT02898454|12171393|P1|STARTED|Overall Study||153
4948469|NCT02898116|12171506|P1|NOT COMPLETED|Overall Study||2
4948470|NCT02898116|12171506|P1|COMPLETED|Overall Study||0
4948471|NCT02898116|12171506|P1|STARTED|Overall Study||2
4948472|NCT02897349|12171514|P2|NOT COMPLETED|Overall Study||6
4948473|NCT02897349|12171515|P1|NOT COMPLETED|Overall Study||5
4948474|NCT02897349|12171514|P2|COMPLETED|Overall Study||98
4948475|NCT02897349|12171515|P1|COMPLETED|Overall Study||97
4948476|NCT02897349|12171514|P2|STARTED|Overall Study||104
4948477|NCT02897349|12171515|P1|STARTED|Overall Study||102
4948478|NCT02897141|12171537|P2|NOT COMPLETED|Overall Study||1
4948479|NCT02897141|12171538|P1|NOT COMPLETED|Overall Study||2
4948480|NCT02897141|12171537|P2|COMPLETED|Overall Study||39
4948481|NCT02897141|12171538|P1|COMPLETED|Overall Study||38
4948482|NCT02897141|12171537|P2|STARTED|Overall Study||40
4948483|NCT02897141|12171538|P1|STARTED|Overall Study||40
4948484|NCT02897115|12171557|P2|NOT COMPLETED|Overall Study||8
4948485|NCT02897115|12171558|P1|NOT COMPLETED|Overall Study||11
4948486|NCT02897115|12171557|P2|COMPLETED|Overall Study||0
4948487|NCT02897115|12171558|P1|COMPLETED|Overall Study||3
4948488|NCT02897115|12171557|P2|STARTED|Overall Study||8
4948489|NCT02897115|12171558|P1|STARTED|Overall Study||14
4948490|NCT02896907|12171628|P1|NOT COMPLETED|Overall Study||0
4948491|NCT02896907|12171628|P1|COMPLETED|Overall Study||8
4948492|NCT02896907|12171628|P1|STARTED|Overall Study||8
4948493|NCT02896855|12171635|P2|NOT COMPLETED|Overall Study||122
4948494|NCT02896855|12171636|P1|NOT COMPLETED|Overall Study||121
4948495|NCT02896855|12171635|P2|COMPLETED|Overall Study||0
4948496|NCT02896855|12171636|P1|COMPLETED|Overall Study||0
4948497|NCT02896855|12171635|P2|Received Any Study Treatment|Overall Study||122
4948498|NCT02896855|12171636|P1|Received Any Study Treatment|Overall Study||120
4948499|NCT02896855|12171635|P2|STARTED|Overall Study||122
4948500|NCT02896855|12171636|P1|STARTED|Overall Study||121
4948501|NCT02896595|12171668|P2|NOT COMPLETED|Overall Study||0
4948502|NCT02896595|12171669|P1|NOT COMPLETED|Overall Study||0
4948503|NCT02896595|12171668|P2|COMPLETED|Overall Study||50
4948504|NCT02896595|12171669|P1|COMPLETED|Overall Study||50
4948505|NCT02896595|12171668|P2|STARTED|Overall Study||50
4948506|NCT02896595|12171669|P1|STARTED|Overall Study||50
4948507|NCT02896361|12171717|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
4948508|NCT02896361|12171718|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
4948509|NCT02896361|12171719|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
4948510|NCT02896361|12171717|P3|COMPLETED|Third Intervention (2 Weeks)||8
4948511|NCT02896361|12171718|P2|COMPLETED|Third Intervention (2 Weeks)||9
4948512|NCT02896361|12171719|P1|COMPLETED|Third Intervention (2 Weeks)||8
4948513|NCT02896361|12171717|P3|STARTED|Third Intervention (2 Weeks)||8
4948514|NCT02896361|12171718|P2|STARTED|Third Intervention (2 Weeks)||10
4948515|NCT02896361|12171719|P1|STARTED|Third Intervention (2 Weeks)||9
4948516|NCT02896361|12171717|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
4948517|NCT02896361|12171718|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
4948518|NCT02896361|12171719|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4948519|NCT02896361|12171717|P3|COMPLETED|Second Intervention (2 Weeks)||8
4948520|NCT02896361|12171718|P2|COMPLETED|Second Intervention (2 Weeks)||10
4948521|NCT02896361|12171719|P1|COMPLETED|Second Intervention (2 Weeks)||9
4948522|NCT02896361|12171717|P3|STARTED|Second Intervention (2 Weeks)||8
4948523|NCT02896361|12171718|P2|STARTED|Second Intervention (2 Weeks)||10
4948524|NCT02896361|12171719|P1|STARTED|Second Intervention (2 Weeks)||9
4948525|NCT02896361|12171717|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
4948526|NCT02896361|12171718|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
4948527|NCT02896361|12171719|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
4948528|NCT02896361|12171717|P3|COMPLETED|First Intervention (2 Weeks)||8
4948529|NCT02896361|12171718|P2|COMPLETED|First Intervention (2 Weeks)||10
4948530|NCT02896361|12171719|P1|COMPLETED|First Intervention (2 Weeks)||9
4948531|NCT02896361|12171717|P3|STARTED|First Intervention (2 Weeks)||8
4948532|NCT02896361|12171718|P2|STARTED|First Intervention (2 Weeks)||10
4948533|NCT02896361|12171719|P1|STARTED|First Intervention (2 Weeks)||9
4948534|NCT02896296|12171737|P1|NOT COMPLETED|Overall Study||42
4948535|NCT02896296|12171737|P1|COMPLETED|Overall Study||166
4948536|NCT02896296|12171737|P1|STARTED|Overall Study||208
4948537|NCT02895347|12171745|P2|NOT COMPLETED|Overall Study||1
4948538|NCT02895347|12171746|P1|NOT COMPLETED|Overall Study||3
4948539|NCT02895347|12171745|P2|COMPLETED|Overall Study||19
4948540|NCT02895347|12171746|P1|COMPLETED|Overall Study||17
4948541|NCT02895347|12171745|P2|STARTED|Overall Study||20
4948542|NCT02895347|12171746|P1|STARTED|Overall Study||20
4948543|NCT02895295|12171758|P3|NOT COMPLETED|Overall Study||92
4948544|NCT02895295|12171759|P2|NOT COMPLETED|Overall Study||94
4948545|NCT02895295|12171760|P1|NOT COMPLETED|Overall Study||71
4948546|NCT02895295|12171758|P3|COMPLETED|Overall Study||299
4948547|NCT02895295|12171759|P2|COMPLETED|Overall Study||316
4948548|NCT02895295|12171760|P1|COMPLETED|Overall Study||313
4948549|NCT02895295|12171758|P3|STARTED|Overall Study||391
4948550|NCT02895295|12171759|P2|STARTED|Overall Study||410
4948551|NCT02895295|12171760|P1|STARTED|Overall Study||384
4948552|NCT02895035|12171777|P2|NOT COMPLETED|Overall Study||12
4948553|NCT02895035|12171778|P1|NOT COMPLETED|Overall Study||5
4948554|NCT02895035|12171777|P2|COMPLETED|Overall Study||24
4948555|NCT02895035|12171778|P1|COMPLETED|Overall Study||18
4948556|NCT02895035|12171777|P2|STARTED|Overall Study||36
4948557|NCT02895035|12171778|P1|STARTED|Overall Study||23
4948558|NCT02894840|12171794|P4|NOT COMPLETED|Overall Study||0
4948559|NCT02894840|12171795|P3|NOT COMPLETED|Overall Study||3
4948560|NCT02894840|12171796|P2|NOT COMPLETED|Overall Study||0
4948561|NCT02894840|12171797|P1|NOT COMPLETED|Overall Study||1
4948562|NCT02894840|12171794|P4|COMPLETED|Overall Study||100
4948563|NCT02894840|12171795|P3|COMPLETED|Overall Study||197
4948564|NCT02894840|12171796|P2|COMPLETED|Overall Study||20
4948565|NCT02894840|12171797|P1|COMPLETED|Overall Study||19
4948566|NCT02894840|12171794|P4|STARTED|Overall Study||100
4948567|NCT02894840|12171795|P3|STARTED|Overall Study||200
4948568|NCT02894840|12171796|P2|STARTED|Overall Study||20
4948569|NCT02894840|12171797|P1|STARTED|Overall Study||20
4948570|NCT02893878|12171822|P3|NOT COMPLETED|Overall Study||0
4948571|NCT02893878|12171823|P2|NOT COMPLETED|Overall Study||0
4948572|NCT02893878|12171824|P1|NOT COMPLETED|Overall Study||0
4948573|NCT02893878|12171822|P3|COMPLETED|Overall Study||3178
4948574|NCT02893878|12171823|P2|COMPLETED|Overall Study||2295
4948575|NCT02893878|12171824|P1|COMPLETED|Overall Study||13861
4948576|NCT02893878|12171822|P3|STARTED|Overall Study||3178
4948577|NCT02893878|12171823|P2|STARTED|Overall Study||2295
4948578|NCT02893878|12171824|P1|STARTED|Overall Study||13861
4948579|NCT02892734|12172069|P1|NOT COMPLETED|Follow up for 2 Years||3
4948580|NCT02892734|12172069|P1|COMPLETED|Follow up for 2 Years||0
4948581|NCT02892734|12172069|P1|STARTED|Follow up for 2 Years||3
4948582|NCT02892734|12172069|P1|NOT COMPLETED|Treatment on Study||2
4948583|NCT02892734|12172069|P1|COMPLETED|Treatment on Study||1
4948584|NCT02892734|12172069|P1|Went on to Start Cycle 2|Treatment on Study||1
4948585|NCT02892734|12172069|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
4948586|NCT02892734|12172069|P1|STARTED|Treatment on Study||3
4948587|NCT02892513|12172079|P2|NOT COMPLETED|Overall Study||1
4948588|NCT02892513|12172080|P1|NOT COMPLETED|Overall Study||0
4948589|NCT02892513|12172079|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
4948590|NCT02892513|12172080|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
4948591|NCT02892513|12172079|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
4948592|NCT02892513|12172080|P1|STARTED|Overall Study||28
4948593|NCT02892409|12172088|P2|NOT COMPLETED|Overall Study||1
4948594|NCT02892409|12172089|P1|NOT COMPLETED|Overall Study||3
4948595|NCT02892409|12172088|P2|COMPLETED|Overall Study||14
4948596|NCT02892409|12172089|P1|COMPLETED|Overall Study||12
4948597|NCT02892409|12172088|P2|STARTED|Overall Study||15
4948598|NCT02892409|12172089|P1|STARTED|Overall Study||15
4948599|NCT02892344|12172111|P2|NOT COMPLETED|Overall Study||21
4948600|NCT02892344|12172112|P1|NOT COMPLETED|Overall Study||4
4948601|NCT02892344|12172111|P2|COMPLETED|Overall Study||383
4948602|NCT02892344|12172112|P1|COMPLETED|Overall Study||394
4948603|NCT02892344|12172111|P2|Full Analysis Set|Overall Study||399
4948604|NCT02892344|12172112|P1|Full Analysis Set|Overall Study||395
4948605|NCT02892344|12172111|P2|STARTED|Overall Study||404
4948606|NCT02892344|12172112|P1|STARTED|Overall Study||398
4948607|NCT02892110|12172148|P2|NOT COMPLETED|Overall Study||12
4948608|NCT02892110|12172149|P1|NOT COMPLETED|Overall Study||13
4948609|NCT02892110|12172148|P2|COMPLETED|Overall Study||25
4948610|NCT02892110|12172149|P1|COMPLETED|Overall Study||22
4948611|NCT02892110|12172148|P2|STARTED|Overall Study||37
4948612|NCT02892110|12172149|P1|STARTED|Overall Study||35
4948613|NCT02892019|12172161|P2|NOT COMPLETED|Overall Study||3
4948614|NCT02892019|12172162|P1|NOT COMPLETED|Overall Study||1
4948615|NCT02892019|12172161|P2|COMPLETED|Overall Study||36
4948616|NCT02892019|12172162|P1|COMPLETED|Overall Study||40
4948617|NCT02892019|12172161|P2|STARTED|Overall Study||39
4948618|NCT02892019|12172162|P1|STARTED|Overall Study||41
4948619|NCT02891863|12172184|P1|NOT COMPLETED|Overall Study||0
4948620|NCT02891863|12172184|P1|COMPLETED|Overall Study||9
4948621|NCT02891863|12172184|P1|STARTED|Overall Study||9
4948622|NCT02891629|12172191|P2|NOT COMPLETED|Overall Study||1
4948623|NCT02891629|12172192|P1|NOT COMPLETED|Overall Study||0
4948624|NCT02891629|12172191|P2|COMPLETED|Overall Study||4
4948625|NCT02891629|12172192|P1|COMPLETED|Overall Study||10
4948626|NCT02891629|12172191|P2|STARTED|Overall Study||5
4948627|NCT02891629|12172192|P1|STARTED|Overall Study||10
4948628|NCT02891200|12172202|P2|NOT COMPLETED|Overall Study||49
4948629|NCT02891200|12172203|P1|NOT COMPLETED|Overall Study||42
4948630|NCT02891200|12172202|P2|COMPLETED|Overall Study||98
4948631|NCT02891200|12172203|P1|COMPLETED|Overall Study||103
4948632|NCT02891200|12172202|P2|STARTED|Overall Study||147
4948633|NCT02891200|12172203|P1|STARTED|Overall Study||145
4948634|NCT02891174|12172231|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
4948635|NCT02891174|12172232|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
4948636|NCT02891174|12172231|P2|COMPLETED|Second Intervention (24 Hours)||3
4948637|NCT02891174|12172232|P1|COMPLETED|Second Intervention (24 Hours)||11
4948638|NCT02891174|12172231|P2|STARTED|Second Intervention (24 Hours)||10
4948639|NCT02891174|12172232|P1|STARTED|Second Intervention (24 Hours)||17
4948640|NCT02891174|12172231|P2|NOT COMPLETED|First Intervention (24 Hours)||13
4948641|NCT02891174|12172232|P1|NOT COMPLETED|First Intervention (24 Hours)||3
4948642|NCT02891174|12172231|P2|COMPLETED|First Intervention (24 Hours)||10
4948643|NCT02891174|12172232|P1|COMPLETED|First Intervention (24 Hours)||17
4948644|NCT02891174|12172231|P2|Received First Intervention|First Intervention (24 Hours)||18
4948645|NCT02891174|12172232|P1|Received First Intervention|First Intervention (24 Hours)||19
4948646|NCT02891174|12172231|P2|STARTED|First Intervention (24 Hours)||23
4948647|NCT02891174|12172232|P1|STARTED|First Intervention (24 Hours)||20
4948648|NCT02891070|12172246|P2|NOT COMPLETED|Overall Study||8
4948649|NCT02891070|12172247|P1|NOT COMPLETED|Overall Study||10
4948650|NCT02891070|12172246|P2|COMPLETED|Overall Study||106
4948651|NCT02891070|12172247|P1|COMPLETED|Overall Study||100
4948652|NCT02891070|12172246|P2|STARTED|Overall Study||114
4948653|NCT02891070|12172247|P1|STARTED|Overall Study||110
4948654|NCT02890992|12172273|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
4948655|NCT02890992|12172274|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
4948656|NCT02890992|12172275|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
4948657|NCT02890992|12172276|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
4948658|NCT02890992|12172277|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
4948659|NCT02890992|12172278|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
4948660|NCT02890992|12172279|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
4948661|NCT02890992|12172280|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
4948662|NCT02890992|12172273|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
4948663|NCT02890992|12172274|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
4948664|NCT02890992|12172275|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
4948665|NCT02890992|12172276|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
4948666|NCT02890992|12172277|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
4948667|NCT02890992|12172278|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
4948668|NCT02890992|12172279|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
4948669|NCT02890992|12172280|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
4948670|NCT02890992|12172273|P8|Treated|130 Weeks Open-Label Extension Period||4
4948671|NCT02890992|12172274|P7|Treated|130 Weeks Open-Label Extension Period||5
4948672|NCT02890992|12172275|P6|Treated|130 Weeks Open-Label Extension Period||5
4948673|NCT02890992|12172276|P5|Treated|130 Weeks Open-Label Extension Period||6
4948674|NCT02890992|12172277|P4|Treated|130 Weeks Open-Label Extension Period||6
4948675|NCT02890992|12172278|P3|Treated|130 Weeks Open-Label Extension Period||4
4948676|NCT02890992|12172279|P2|Treated|130 Weeks Open-Label Extension Period||6
4948677|NCT02890992|12172280|P1|Treated|130 Weeks Open-Label Extension Period||3
4948678|NCT02890992|12172273|P8|STARTED|130 Weeks Open-Label Extension Period||5
4948679|NCT02890992|12172274|P7|STARTED|130 Weeks Open-Label Extension Period||6
4948680|NCT02890992|12172275|P6|STARTED|130 Weeks Open-Label Extension Period||5
4948681|NCT02890992|12172276|P5|STARTED|130 Weeks Open-Label Extension Period||6
4948682|NCT02890992|12172277|P4|STARTED|130 Weeks Open-Label Extension Period||6
4948683|NCT02890992|12172278|P3|STARTED|130 Weeks Open-Label Extension Period||4
4948684|NCT02890992|12172279|P2|STARTED|130 Weeks Open-Label Extension Period||6
4948685|NCT02890992|12172280|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
4948686|NCT02890992|12172273|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948687|NCT02890992|12172274|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948688|NCT02890992|12172275|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948689|NCT02890992|12172276|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948690|NCT02890992|12172277|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948691|NCT02890992|12172278|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948692|NCT02890992|12172279|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948693|NCT02890992|12172280|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
4948694|NCT02890992|12172273|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
4948695|NCT02890992|12172274|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
4948696|NCT02890992|12172275|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
4948697|NCT02890992|12172276|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
4948698|NCT02890992|12172277|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
4948699|NCT02890992|12172278|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
4948700|NCT02890992|12172279|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
4948701|NCT02890992|12172280|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
4948702|NCT02890992|12172273|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
4948703|NCT02890992|12172274|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
4948704|NCT02890992|12172275|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
4948705|NCT02890992|12172276|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
4948706|NCT02890992|12172277|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
4948707|NCT02890992|12172278|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
4948708|NCT02890992|12172279|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
4948709|NCT02890992|12172280|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
4948710|NCT02890992|12172273|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
4948711|NCT02890992|12172274|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
4948712|NCT02890992|12172275|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
4948713|NCT02890992|12172276|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
4948714|NCT02890992|12172277|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
4948715|NCT02890992|12172278|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
4948716|NCT02890992|12172279|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
4948717|NCT02890992|12172280|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
4948718|NCT02890381|12172448|P2|NOT COMPLETED|Overall Study||0
4948719|NCT02890381|12172449|P1|NOT COMPLETED|Overall Study||0
4948720|NCT02890381|12172448|P2|COMPLETED|Overall Study||6
4948721|NCT02890381|12172449|P1|COMPLETED|Overall Study||11
4948722|NCT02890381|12172448|P2|STARTED|Overall Study||6
4948723|NCT02890381|12172449|P1|STARTED|Overall Study||11
4948724|NCT02890303|12172475|P1|NOT COMPLETED|Overall Study||0
4948725|NCT02890303|12172475|P1|COMPLETED|Overall Study||100
4948726|NCT02890303|12172475|P1|STARTED|Overall Study||100
4948727|NCT02889861|12172479|P1|NOT COMPLETED|Overall Study||2
4948728|NCT02889861|12172479|P1|COMPLETED|Overall Study||1
4948729|NCT02889861|12172479|P1|STARTED|Overall Study||3
4948730|NCT02889289|12172500|P1|NOT COMPLETED|Overall Study||0
4948731|NCT02889289|12172500|P1|COMPLETED|Overall Study||1
4948732|NCT02889289|12172500|P1|STARTED|Overall Study||1
4948733|NCT02888756|12172512|P3|NOT COMPLETED|Analytical Treatment Interruption||5
4948734|NCT02888756|12172513|P2|NOT COMPLETED|Analytical Treatment Interruption||6
4948735|NCT02888756|12172514|P1|NOT COMPLETED|Analytical Treatment Interruption||10
4948736|NCT02888756|12172512|P3|COMPLETED|Analytical Treatment Interruption||3
4948737|NCT02888756|12172513|P2|COMPLETED|Analytical Treatment Interruption||3
4948738|NCT02888756|12172514|P1|COMPLETED|Analytical Treatment Interruption||5
4948739|NCT02888756|12172512|P3|STARTED|Analytical Treatment Interruption||8
4948740|NCT02888756|12172513|P2|STARTED|Analytical Treatment Interruption||9
4948741|NCT02888756|12172514|P1|STARTED|Analytical Treatment Interruption||15
4948742|NCT02888756|12172512|P3|NOT COMPLETED|Vaccination Period||0
4948743|NCT02888756|12172513|P2|NOT COMPLETED|Vaccination Period||0
4948744|NCT02888756|12172514|P1|NOT COMPLETED|Vaccination Period||0
4948745|NCT02888756|12172512|P3|COMPLETED|Vaccination Period||8
4948746|NCT02888756|12172513|P2|COMPLETED|Vaccination Period||9
4948747|NCT02888756|12172514|P1|COMPLETED|Vaccination Period||16
4948748|NCT02888756|12172512|P3|STARTED|Vaccination Period||8
4948749|NCT02888756|12172513|P2|STARTED|Vaccination Period||9
4948750|NCT02888756|12172514|P1|STARTED|Vaccination Period||16
4948751|NCT02888171|12172557|P2|NOT COMPLETED|Overall Study||4
4948752|NCT02888171|12172558|P1|NOT COMPLETED|Overall Study||5
4948753|NCT02888171|12172557|P2|COMPLETED|Overall Study||26
4948754|NCT02888171|12172558|P1|COMPLETED|Overall Study||25
4948755|NCT02888171|12172557|P2|STARTED|Overall Study||30
4948756|NCT02888171|12172558|P1|STARTED|Overall Study||30
4948757|NCT02888093|12172574|P2|NOT COMPLETED|Overall Study||2
4948758|NCT02888093|12172575|P1|NOT COMPLETED|Overall Study||2
4948759|NCT02888093|12172574|P2|COMPLETED|Overall Study||20
4948760|NCT02888093|12172575|P1|COMPLETED|Overall Study||20
4948761|NCT02888093|12172574|P2|STARTED|Overall Study||22
4948762|NCT02888093|12172575|P1|STARTED|Overall Study||22
4948763|NCT02888080|12172587|P2|NOT COMPLETED|Overall Study||5
4948764|NCT02888080|12172588|P1|NOT COMPLETED|Overall Study||2
4948765|NCT02888080|12172587|P2|COMPLETED|Overall Study||15
4948766|NCT02888080|12172588|P1|COMPLETED|Overall Study||18
4948767|NCT02888080|12172587|P2|STARTED|Overall Study||20
4948768|NCT02888080|12172588|P1|STARTED|Overall Study||20
4948769|NCT02887989|12172614|P2|NOT COMPLETED|Overall Study||11
4948770|NCT02887989|12172615|P1|NOT COMPLETED|Overall Study||9
4948771|NCT02887989|12172614|P2|COMPLETED|Overall Study||59
4948772|NCT02887989|12172615|P1|COMPLETED|Overall Study||61
4948773|NCT02887989|12172614|P2|STARTED|Overall Study||70
4948774|NCT02887989|12172615|P1|STARTED|Overall Study||70
4948775|NCT02887521|12172627|P2|NOT COMPLETED|Overall Study||3
4948776|NCT02887521|12172628|P1|NOT COMPLETED|Overall Study||0
4948777|NCT02887521|12172627|P2|COMPLETED|Overall Study||2
4948778|NCT02887521|12172628|P1|COMPLETED|Overall Study||4
4948779|NCT02887521|12172627|P2|STARTED|Overall Study||5
4948780|NCT02887521|12172628|P1|STARTED|Overall Study||4
4948781|NCT02887404|12172642|P2|NOT COMPLETED|Overall Study||0
4948782|NCT02887404|12172643|P1|NOT COMPLETED|Overall Study||0
4948783|NCT02887404|12172642|P2|COMPLETED|Overall Study||149
4948784|NCT02887404|12172643|P1|COMPLETED|Overall Study||150
4948785|NCT02887404|12172642|P2|STARTED|Overall Study||149
4948786|NCT02887404|12172643|P1|STARTED|Overall Study||150
4948787|NCT02887183|12172691|P1|NOT COMPLETED|Overall Study||141
4948788|NCT02887183|12172691|P1|COMPLETED|Overall Study||654
4948789|NCT02887183|12172691|P1|Full Analysis Set|Overall Study||794
4948790|NCT02887183|12172691|P1|STARTED|Overall Study||795
4948791|NCT02886923|12172704|P2|NOT COMPLETED|Period 2||0
4948792|NCT02886923|12172705|P1|NOT COMPLETED|Period 2||0
4948793|NCT02886923|12172704|P2|COMPLETED|Period 2||11
4948794|NCT02886923|12172705|P1|COMPLETED|Period 2||12
4948795|NCT02886923|12172704|P2|STARTED|Period 2||11
4948796|NCT02886923|12172705|P1|STARTED|Period 2||12
4948797|NCT02886923|12172704|P2|NOT COMPLETED|Period 1||0
4948798|NCT02886923|12172705|P1|NOT COMPLETED|Period 1||0
4948799|NCT02886923|12172704|P2|COMPLETED|Period 1||11
4948800|NCT02886923|12172705|P1|COMPLETED|Period 1||12
4948801|NCT02886923|12172704|P2|STARTED|Period 1||11
4948802|NCT02886923|12172705|P1|STARTED|Period 1||12
4948803|NCT02886715|12172718|P3|NOT COMPLETED|Overall Study||20
4948804|NCT02886715|12172719|P2|NOT COMPLETED|Overall Study||55
4948805|NCT02886715|12172720|P1|NOT COMPLETED|Overall Study||64
4948806|NCT02886715|12172718|P3|COMPLETED|Overall Study||203
4948807|NCT02886715|12172719|P2|COMPLETED|Overall Study||390
4948808|NCT02886715|12172720|P1|COMPLETED|Overall Study||378
4948809|NCT02886715|12172718|P3|Per Protocol (PP) Population|Overall Study||176
4948810|NCT02886715|12172719|P2|Per Protocol (PP) Population|Overall Study||351
4948811|NCT02886715|12172720|P1|Per Protocol (PP) Population|Overall Study||346
4948812|NCT02886715|12172718|P3|Modified ITT (mITT)|Overall Study||217
4948813|NCT02886715|12172719|P2|Modified ITT (mITT)|Overall Study||418
4948814|NCT02886715|12172720|P1|Modified ITT (mITT)|Overall Study||421
4948815|NCT02886715|12172718|P3|STARTED|Overall Study||223
4948816|NCT02886715|12172719|P2|STARTED|Overall Study||445
4948817|NCT02886715|12172720|P1|STARTED|Overall Study||442
4948818|NCT02886702|12172737|P3|NOT COMPLETED|Overall Study||53
4948819|NCT02886702|12172738|P2|NOT COMPLETED|Overall Study||51
4948820|NCT02886702|12172739|P1|NOT COMPLETED|Overall Study||48
4948821|NCT02886702|12172737|P3|COMPLETED|Overall Study||232
4948822|NCT02886702|12172738|P2|COMPLETED|Overall Study||235
4948823|NCT02886702|12172739|P1|COMPLETED|Overall Study||236
4948824|NCT02886702|12172737|P3|Per-Protocol Population (PP)|Overall Study||201
4948825|NCT02886702|12172738|P2|Per-Protocol Population (PP)|Overall Study||209
4948826|NCT02886702|12172739|P1|Per-Protocol Population (PP)|Overall Study||208
4948827|NCT02886702|12172737|P3|Modified Intent-to Treat (mITT)|Overall Study||275
4948828|NCT02886702|12172738|P2|Modified Intent-to Treat (mITT)|Overall Study||266
4948829|NCT02886702|12172739|P1|Modified Intent-to Treat (mITT)|Overall Study||263
4948830|NCT02886702|12172737|P3|STARTED|Overall Study||285
4948831|NCT02886702|12172738|P2|STARTED|Overall Study||286
4948832|NCT02886702|12172739|P1|STARTED|Overall Study||284
4948833|NCT02886624|12172753|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
4948834|NCT02886624|12172753|P1|COMPLETED|48-week Post Treatment Follow-up||28
4948835|NCT02886624|12172753|P1|STARTED|48-week Post Treatment Follow-up||29
4948836|NCT02886624|12172753|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
4948837|NCT02886624|12172753|P1|COMPLETED|12-week Post Treatment Follow-up||29
4948838|NCT02886624|12172753|P1|STARTED|12-week Post Treatment Follow-up||30
4948839|NCT02886624|12172753|P1|NOT COMPLETED|8-week Treatment||0
4948840|NCT02886624|12172753|P1|COMPLETED|8-week Treatment||30
4948841|NCT02886624|12172753|P1|STARTED|8-week Treatment||30
4948842|NCT02886338|12172762|P1|NOT COMPLETED|Overall Study||1
4948843|NCT02886338|12172762|P1|COMPLETED|Overall Study||9
4948844|NCT02886338|12172762|P1|STARTED|Overall Study||10
4948845|NCT02886234|12172768|P2|NOT COMPLETED|Overall Study||2
4948846|NCT02886234|12172769|P1|NOT COMPLETED|Overall Study||0
4948847|NCT02886234|12172768|P2|COMPLETED|Overall Study||22
4948848|NCT02886234|12172769|P1|COMPLETED|Overall Study||20
4948849|NCT02886234|12172768|P2|STARTED|Overall Study||24
4948850|NCT02886234|12172769|P1|STARTED|Overall Study||20
4948851|NCT02885636|12172791|P2|NOT COMPLETED|Overall Study||0
4948852|NCT02885636|12172792|P1|NOT COMPLETED|Overall Study||0
4948853|NCT02885636|12172791|P2|COMPLETED|Overall Study||15
4948854|NCT02885636|12172792|P1|COMPLETED|Overall Study||15
4948855|NCT02885636|12172791|P2|STARTED|Overall Study||15
4948856|NCT02885636|12172792|P1|STARTED|Overall Study||15
4948857|NCT02885506|12172834|P10|NOT COMPLETED|Part B||0
4948858|NCT02885506|12172835|P9|NOT COMPLETED|Part B||0
4948859|NCT02885506|12172836|P8|NOT COMPLETED|Part B||0
4948860|NCT02885506|12172837|P7|NOT COMPLETED|Part B||0
4948861|NCT02885506|12172838|P6|NOT COMPLETED|Part B||0
4948862|NCT02885506|12172839|P5|NOT COMPLETED|Part B||0
4948863|NCT02885506|12172840|P4|NOT COMPLETED|Part B||0
4948864|NCT02885506|12172841|P3|NOT COMPLETED|Part B||0
4948865|NCT02885506|12172842|P2|NOT COMPLETED|Part B||0
4948866|NCT02885506|12172843|P1|NOT COMPLETED|Part B||0
4948867|NCT02885506|12172834|P10|COMPLETED|Part B||4
4948868|NCT02885506|12172835|P9|COMPLETED|Part B||4
4948869|NCT02885506|12172836|P8|COMPLETED|Part B||0
4948870|NCT02885506|12172837|P7|COMPLETED|Part B||0
4948871|NCT02885506|12172838|P6|COMPLETED|Part B||0
4948872|NCT02885506|12172839|P5|COMPLETED|Part B||0
4948873|NCT02885506|12172840|P4|COMPLETED|Part B||0
4948874|NCT02885506|12172841|P3|COMPLETED|Part B||0
4948875|NCT02885506|12172842|P2|COMPLETED|Part B||0
4948876|NCT02885506|12172843|P1|COMPLETED|Part B||0
4948877|NCT02885506|12172834|P10|STARTED|Part B||4
4948878|NCT02885506|12172835|P9|STARTED|Part B||4
4948879|NCT02885506|12172836|P8|STARTED|Part B||0
4948880|NCT02885506|12172837|P7|STARTED|Part B||0
4948881|NCT02885506|12172838|P6|STARTED|Part B||0
4948882|NCT02885506|12172839|P5|STARTED|Part B||0
4948883|NCT02885506|12172840|P4|STARTED|Part B||0
4948884|NCT02885506|12172841|P3|STARTED|Part B||0
4948885|NCT02885506|12172842|P2|STARTED|Part B||0
4948886|NCT02885506|12172843|P1|STARTED|Part B||0
4948887|NCT02885506|12172834|P10|NOT COMPLETED|Part A||0
4948888|NCT02885506|12172835|P9|NOT COMPLETED|Part A||0
4948889|NCT02885506|12172836|P8|NOT COMPLETED|Part A||0
4948890|NCT02885506|12172837|P7|NOT COMPLETED|Part A||0
4948891|NCT02885506|12172838|P6|NOT COMPLETED|Part A||0
4948892|NCT02885506|12172839|P5|NOT COMPLETED|Part A||0
4948893|NCT02885506|12172840|P4|NOT COMPLETED|Part A||0
4948894|NCT02885506|12172841|P3|NOT COMPLETED|Part A||0
4948895|NCT02885506|12172842|P2|NOT COMPLETED|Part A||0
4948896|NCT02885506|12172843|P1|NOT COMPLETED|Part A||0
4948897|NCT02885506|12172834|P10|COMPLETED|Part A||0
4948898|NCT02885506|12172835|P9|COMPLETED|Part A||0
4948899|NCT02885506|12172836|P8|COMPLETED|Part A||14
4948900|NCT02885506|12172837|P7|COMPLETED|Part A||6
4948901|NCT02885506|12172838|P6|COMPLETED|Part A||6
4948902|NCT02885506|12172839|P5|COMPLETED|Part A||6
4948903|NCT02885506|12172840|P4|COMPLETED|Part A||6
4948904|NCT02885506|12172841|P3|COMPLETED|Part A||6
4948905|NCT02885506|12172842|P2|COMPLETED|Part A||6
4948906|NCT02885506|12172843|P1|COMPLETED|Part A||6
4948907|NCT02885506|12172834|P10|STARTED|Part A||0
4948908|NCT02885506|12172835|P9|STARTED|Part A||0
4948909|NCT02885506|12172836|P8|STARTED|Part A||14
4948910|NCT02885506|12172837|P7|STARTED|Part A||6
4948911|NCT02885506|12172838|P6|STARTED|Part A||6
4948912|NCT02885506|12172839|P5|STARTED|Part A||6
4948913|NCT02885506|12172840|P4|STARTED|Part A||6
4948914|NCT02885506|12172841|P3|STARTED|Part A||6
4948915|NCT02885506|12172842|P2|STARTED|Part A||6
4948916|NCT02885506|12172843|P1|STARTED|Part A||6
4948917|NCT02885246|12172935|P1|NOT COMPLETED|Overall Study||0
4948918|NCT02885246|12172935|P1|COMPLETED|Overall Study||1839
4948919|NCT02885246|12172935|P1|STARTED|Overall Study||1839
4948920|NCT02885181|12172951|P4|NOT COMPLETED|Overall Study||3
4948921|NCT02885181|12172952|P3|NOT COMPLETED|Overall Study||0
4948922|NCT02885181|12172953|P2|NOT COMPLETED|Overall Study||1
4948923|NCT02885181|12172954|P1|NOT COMPLETED|Overall Study||0
4948924|NCT02885181|12172951|P4|COMPLETED|Overall Study||19
4948925|NCT02885181|12172952|P3|COMPLETED|Overall Study||21
4948926|NCT02885181|12172953|P2|COMPLETED|Overall Study||19
4948927|NCT02885181|12172954|P1|COMPLETED|Overall Study||20
4948928|NCT02885181|12172951|P4|STARTED|Overall Study||22
4948929|NCT02885181|12172952|P3|STARTED|Overall Study||21
4948930|NCT02885181|12172953|P2|STARTED|Overall Study||20
4948931|NCT02885181|12172954|P1|STARTED|Overall Study||20
4948932|NCT02885025|12172984|P4|NOT COMPLETED|Overall Study||0
4948933|NCT02885025|12172985|P3|NOT COMPLETED|Overall Study||0
4948934|NCT02885025|12172986|P2|NOT COMPLETED|Overall Study||2
4948935|NCT02885025|12172987|P1|NOT COMPLETED|Overall Study||0
4948936|NCT02885025|12172984|P4|COMPLETED|Overall Study||8
4948937|NCT02885025|12172985|P3|COMPLETED|Overall Study||9
4948938|NCT02885025|12172986|P2|COMPLETED|Overall Study||12
4948939|NCT02885025|12172987|P1|COMPLETED|Overall Study||16
4948940|NCT02885025|12172984|P4|STARTED|Overall Study||8
4948941|NCT02885025|12172985|P3|STARTED|Overall Study||9
4948942|NCT02885025|12172986|P2|STARTED|Overall Study||14
4948943|NCT02885025|12172987|P1|STARTED|Overall Study||16
4948944|NCT02885012|12173027|P2|NOT COMPLETED|Overall Study||0
4948945|NCT02885012|12173028|P1|NOT COMPLETED|Overall Study||0
4948946|NCT02885012|12173027|P2|COMPLETED|Overall Study||2
4948947|NCT02885012|12173028|P1|COMPLETED|Overall Study||1
4948948|NCT02885012|12173027|P2|STARTED|Overall Study||2
4948949|NCT02885012|12173028|P1|STARTED|Overall Study||1
4948950|NCT02884492|12173040|P2|NOT COMPLETED|Overall Study||0
4948951|NCT02884492|12173041|P1|NOT COMPLETED|Overall Study||0
4948952|NCT02884492|12173040|P2|COMPLETED|Overall Study||10
4948953|NCT02884492|12173041|P1|COMPLETED|Overall Study||7
4948954|NCT02884492|12173040|P2|STARTED|Overall Study||10
4948955|NCT02884492|12173041|P1|STARTED|Overall Study||7
4948956|NCT02884427|12173050|P3|NOT COMPLETED|Overall Study||0
4948957|NCT02884427|12173051|P2|NOT COMPLETED|Overall Study||0
4948958|NCT02884427|12173052|P1|NOT COMPLETED|Overall Study||0
4948959|NCT02884427|12173050|P3|COMPLETED|Overall Study||50
4948960|NCT02884427|12173051|P2|COMPLETED|Overall Study||52
4948961|NCT02884427|12173052|P1|COMPLETED|Overall Study||48
4948962|NCT02884427|12173050|P3|STARTED|Overall Study||50
4948963|NCT02884427|12173051|P2|STARTED|Overall Study||52
4948964|NCT02884427|12173052|P1|STARTED|Overall Study||48
4948965|NCT02884089|12173066|P4|NOT COMPLETED|Follow-up Visit||1
4948966|NCT02884089|12173067|P3|NOT COMPLETED|Follow-up Visit||0
4948967|NCT02884089|12173068|P2|NOT COMPLETED|Follow-up Visit||0
4948968|NCT02884089|12173069|P1|NOT COMPLETED|Follow-up Visit||1
4948969|NCT02884089|12173066|P4|COMPLETED|Follow-up Visit||6
4948970|NCT02884089|12173067|P3|COMPLETED|Follow-up Visit||7
4948971|NCT02884089|12173068|P2|COMPLETED|Follow-up Visit||6
4948972|NCT02884089|12173069|P1|COMPLETED|Follow-up Visit||6
4948973|NCT02884089|12173066|P4|STARTED|Follow-up Visit||7
4948974|NCT02884089|12173067|P3|STARTED|Follow-up Visit||7
4948975|NCT02884089|12173068|P2|STARTED|Follow-up Visit||6
4948976|NCT02884089|12173069|P1|STARTED|Follow-up Visit||7
4948977|NCT02884089|12173066|P4|NOT COMPLETED|Period 4||0
4948978|NCT02884089|12173067|P3|NOT COMPLETED|Period 4||0
4948979|NCT02884089|12173068|P2|NOT COMPLETED|Period 4||1
4948980|NCT02884089|12173069|P1|NOT COMPLETED|Period 4||1
4948981|NCT02884089|12173066|P4|COMPLETED|Period 4||7
4948982|NCT02884089|12173067|P3|COMPLETED|Period 4||7
4948983|NCT02884089|12173068|P2|COMPLETED|Period 4||6
4948984|NCT02884089|12173069|P1|COMPLETED|Period 4||7
4948985|NCT02884089|12173066|P4|STARTED|Period 4||7
4948986|NCT02884089|12173067|P3|STARTED|Period 4||7
4948987|NCT02884089|12173068|P2|STARTED|Period 4||7
4948988|NCT02884089|12173069|P1|STARTED|Period 4||8
4948989|NCT02884089|12173066|P4|NOT COMPLETED|Washout Period 3||1
4948990|NCT02884089|12173067|P3|NOT COMPLETED|Washout Period 3||1
4948991|NCT02884089|12173068|P2|NOT COMPLETED|Washout Period 3||0
4948992|NCT02884089|12173069|P1|NOT COMPLETED|Washout Period 3||0
4948993|NCT02884089|12173066|P4|COMPLETED|Washout Period 3||7
4948994|NCT02884089|12173067|P3|COMPLETED|Washout Period 3||7
4948995|NCT02884089|12173068|P2|COMPLETED|Washout Period 3||7
4948996|NCT02884089|12173069|P1|COMPLETED|Washout Period 3||8
4948997|NCT02884089|12173066|P4|STARTED|Washout Period 3||8
4948998|NCT02884089|12173067|P3|STARTED|Washout Period 3||8
4948999|NCT02884089|12173068|P2|STARTED|Washout Period 3||7
4949000|NCT02884089|12173069|P1|STARTED|Washout Period 3||8
4949001|NCT02884089|12173066|P4|NOT COMPLETED|Period 3||0
4949002|NCT02884089|12173067|P3|NOT COMPLETED|Period 3||1
4949003|NCT02884089|12173068|P2|NOT COMPLETED|Period 3||0
4949004|NCT02884089|12173069|P1|NOT COMPLETED|Period 3||0
4949005|NCT02884089|12173066|P4|COMPLETED|Period 3||8
4949006|NCT02884089|12173067|P3|COMPLETED|Period 3||8
4949007|NCT02884089|12173068|P2|COMPLETED|Period 3||7
4949008|NCT02884089|12173069|P1|COMPLETED|Period 3||8
4949009|NCT02884089|12173066|P4|STARTED|Period 3||8
4949010|NCT02884089|12173067|P3|STARTED|Period 3||9
4949011|NCT02884089|12173068|P2|STARTED|Period 3||7
4949012|NCT02884089|12173069|P1|STARTED|Period 3||8
4949013|NCT02884089|12173066|P4|NOT COMPLETED|Washout Period 2||0
4949014|NCT02884089|12173067|P3|NOT COMPLETED|Washout Period 2||0
4949015|NCT02884089|12173068|P2|NOT COMPLETED|Washout Period 2||0
4949016|NCT02884089|12173069|P1|NOT COMPLETED|Washout Period 2||0
4949017|NCT02884089|12173066|P4|COMPLETED|Washout Period 2||8
4949018|NCT02884089|12173067|P3|COMPLETED|Washout Period 2||9
4949019|NCT02884089|12173068|P2|COMPLETED|Washout Period 2||7
4949020|NCT02884089|12173069|P1|COMPLETED|Washout Period 2||8
4949021|NCT02884089|12173066|P4|STARTED|Washout Period 2||8
4949022|NCT02884089|12173067|P3|STARTED|Washout Period 2||9
4949023|NCT02884089|12173068|P2|STARTED|Washout Period 2||7
4949024|NCT02884089|12173069|P1|STARTED|Washout Period 2||8
4949025|NCT02884089|12173066|P4|NOT COMPLETED|Period 2||0
4949026|NCT02884089|12173067|P3|NOT COMPLETED|Period 2||0
4949027|NCT02884089|12173068|P2|NOT COMPLETED|Period 2||0
4949028|NCT02884089|12173069|P1|NOT COMPLETED|Period 2||1
4949029|NCT02884089|12173066|P4|COMPLETED|Period 2||8
4949030|NCT02884089|12173067|P3|COMPLETED|Period 2||9
4949031|NCT02884089|12173068|P2|COMPLETED|Period 2||7
4949032|NCT02884089|12173069|P1|COMPLETED|Period 2||8
4949033|NCT02884089|12173066|P4|STARTED|Period 2||8
4949034|NCT02884089|12173067|P3|STARTED|Period 2||9
4949035|NCT02884089|12173068|P2|STARTED|Period 2||7
4949036|NCT02884089|12173069|P1|STARTED|Period 2||9
4949037|NCT02884089|12173066|P4|NOT COMPLETED|Washout Period 1||1
4949038|NCT02884089|12173067|P3|NOT COMPLETED|Washout Period 1||0
4949039|NCT02884089|12173068|P2|NOT COMPLETED|Washout Period 1||2
4949040|NCT02884089|12173069|P1|NOT COMPLETED|Washout Period 1||0
4949041|NCT02884089|12173066|P4|COMPLETED|Washout Period 1||8
4949042|NCT02884089|12173067|P3|COMPLETED|Washout Period 1||9
4949043|NCT02884089|12173068|P2|COMPLETED|Washout Period 1||7
4949044|NCT02884089|12173069|P1|COMPLETED|Washout Period 1||9
4949045|NCT02884089|12173066|P4|STARTED|Washout Period 1||9
4949046|NCT02884089|12173067|P3|STARTED|Washout Period 1||9
4949047|NCT02884089|12173068|P2|STARTED|Washout Period 1||9
4949048|NCT02884089|12173069|P1|STARTED|Washout Period 1||9
4949049|NCT02884089|12173066|P4|NOT COMPLETED|Period 1||0
4949050|NCT02884089|12173067|P3|NOT COMPLETED|Period 1||0
4949051|NCT02884089|12173068|P2|NOT COMPLETED|Period 1||2
4949052|NCT02884089|12173069|P1|NOT COMPLETED|Period 1||2
4949053|NCT02884089|12173066|P4|COMPLETED|Period 1||9
4949054|NCT02884089|12173067|P3|COMPLETED|Period 1||9
4949055|NCT02884089|12173068|P2|COMPLETED|Period 1||9
4949056|NCT02884089|12173069|P1|COMPLETED|Period 1||9
4949057|NCT02884089|12173066|P4|Received at Least One Dose of Study Drug|Period 1||9
4949058|NCT02884089|12173067|P3|Received at Least One Dose of Study Drug|Period 1||9
4949059|NCT02884089|12173068|P2|Received at Least One Dose of Study Drug|Period 1||11
4949060|NCT02884089|12173069|P1|Received at Least One Dose of Study Drug|Period 1||11
4949061|NCT02884089|12173066|P4|STARTED|Period 1||9
4949062|NCT02884089|12173067|P3|STARTED|Period 1||9
4949063|NCT02884089|12173068|P2|STARTED|Period 1||11
4949064|NCT02884089|12173069|P1|STARTED|Period 1||11
4949065|NCT02883452|12173089|P6|NOT COMPLETED|Overall Study||15
4949066|NCT02883452|12173090|P5|NOT COMPLETED|Overall Study||11
4949067|NCT02883452|12173091|P4|NOT COMPLETED|Overall Study||2
4949068|NCT02883452|12173092|P3|NOT COMPLETED|Overall Study||5
4949069|NCT02883452|12173093|P2|NOT COMPLETED|Overall Study||2
4949070|NCT02883452|12173094|P1|NOT COMPLETED|Overall Study||5
4949071|NCT02883452|12173089|P6|COMPLETED|Overall Study||50
4949072|NCT02883452|12173090|P5|COMPLETED|Overall Study||55
4949073|NCT02883452|12173091|P4|COMPLETED|Overall Study||6
4949074|NCT02883452|12173092|P3|COMPLETED|Overall Study||7
4949075|NCT02883452|12173093|P2|COMPLETED|Overall Study||9
4949076|NCT02883452|12173094|P1|COMPLETED|Overall Study||8
4949077|NCT02883452|12173089|P6|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
4949078|NCT02883452|12173090|P5|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
4949079|NCT02883452|12173091|P4|STARTED|Overall Study|This cohort is only for Part 1.|8
4949080|NCT02883452|12173092|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
4949081|NCT02883452|12173093|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
4949082|NCT02883452|12173094|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
4949083|NCT02883244|12173122|P2|NOT COMPLETED|Overall Study||1
4949084|NCT02883244|12173123|P1|NOT COMPLETED|Overall Study||0
4949085|NCT02883244|12173122|P2|COMPLETED|Overall Study||25
4949086|NCT02883244|12173123|P1|COMPLETED|Overall Study||24
4949087|NCT02883244|12173122|P2|STARTED|Overall Study||26
4949088|NCT02883244|12173123|P1|STARTED|Overall Study||24
4949089|NCT02882854|12173141|P2|NOT COMPLETED|Overall Study||3
4949090|NCT02882854|12173142|P1|NOT COMPLETED|Overall Study||1
4949091|NCT02882854|12173141|P2|COMPLETED|Overall Study||41
4949092|NCT02882854|12173142|P1|COMPLETED|Overall Study||39
4949093|NCT02882854|12173141|P2|STARTED|Overall Study||44
4949094|NCT02882854|12173142|P1|STARTED|Overall Study||40
4949095|NCT02882633|12173166|P2|NOT COMPLETED|Overall Study||0
4949096|NCT02882633|12173167|P1|NOT COMPLETED|Overall Study||2
4949097|NCT02882633|12173166|P2|COMPLETED|Overall Study||25
4949098|NCT02882633|12173167|P1|COMPLETED|Overall Study||23
4949099|NCT02882633|12173166|P2|STARTED|Overall Study||25
4949100|NCT02882633|12173167|P1|STARTED|Overall Study||25
4949101|NCT02882152|12173179|P2|NOT COMPLETED|Overall Study||0
4949102|NCT02882152|12173180|P1|NOT COMPLETED|Overall Study||1
4949103|NCT02882152|12173179|P2|COMPLETED|Overall Study||20
4949104|NCT02882152|12173180|P1|COMPLETED|Overall Study||19
4949105|NCT02882152|12173179|P2|STARTED|Overall Study||20
4949106|NCT02882152|12173180|P1|STARTED|Overall Study||20
4949107|NCT02881840|12173188|P1|NOT COMPLETED|Overall Study||0
4949108|NCT02881840|12173188|P1|COMPLETED|Overall Study||6
4949109|NCT02881840|12173188|P1|STARTED|Overall Study||6
4949110|NCT02881775|12173192|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
4949111|NCT02881775|12173193|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
4949112|NCT02881775|12173192|P2|COMPLETED|Second Intervention (1-Hour Session)||7
4949113|NCT02881775|12173193|P1|COMPLETED|Second Intervention (1-Hour Session)||9
4949114|NCT02881775|12173192|P2|STARTED|Second Intervention (1-Hour Session)||7
4949115|NCT02881775|12173193|P1|STARTED|Second Intervention (1-Hour Session)||9
4949116|NCT02881775|12173192|P2|NOT COMPLETED|Washout (1 Week)||0
4949117|NCT02881775|12173193|P1|NOT COMPLETED|Washout (1 Week)||0
4949118|NCT02881775|12173192|P2|COMPLETED|Washout (1 Week)||7
4949119|NCT02881775|12173193|P1|COMPLETED|Washout (1 Week)||9
4949120|NCT02881775|12173192|P2|STARTED|Washout (1 Week)||7
4949121|NCT02881775|12173193|P1|STARTED|Washout (1 Week)||9
4949122|NCT02881775|12173192|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
4949123|NCT02881775|12173193|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
4949124|NCT02881775|12173192|P2|COMPLETED|First Intervention (1-hr Session)||7
4949125|NCT02881775|12173193|P1|COMPLETED|First Intervention (1-hr Session)||9
4949126|NCT02881775|12173192|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
4949127|NCT02881775|12173193|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
4949128|NCT02881775|12173192|P2|NOT COMPLETED|Baseline||0
4949129|NCT02881775|12173193|P1|NOT COMPLETED|Baseline||0
4949130|NCT02881775|12173192|P2|COMPLETED|Baseline||9
4949131|NCT02881775|12173193|P1|COMPLETED|Baseline||11
4949132|NCT02881775|12173192|P2|STARTED|Baseline||9
4949133|NCT02881775|12173193|P1|STARTED|Baseline||11
4949134|NCT02881658|12173215|P2|NOT COMPLETED|Overall Study||5
4949135|NCT02881658|12173216|P1|NOT COMPLETED|Overall Study||2
4949136|NCT02881658|12173215|P2|COMPLETED|Overall Study||96
4949137|NCT02881658|12173216|P1|COMPLETED|Overall Study||98
4949138|NCT02881658|12173215|P2|STARTED|Overall Study||101
4949139|NCT02881658|12173216|P1|STARTED|Overall Study||100
4949140|NCT02881567|12173250|P1|NOT COMPLETED|Overall Study||18
4949141|NCT02881567|12173250|P1|COMPLETED|Overall Study||23
4949142|NCT02881567|12173250|P1|STARTED|Overall Study||41
4949143|NCT02881112|12173262|P1|NOT COMPLETED|Overall Study||28
4949144|NCT02881112|12173262|P1|COMPLETED|Overall Study||152
4949145|NCT02881112|12173262|P1|STARTED|Overall Study||180
4949146|NCT02881047|12173266|P1|NOT COMPLETED|Overall Study||2
4949147|NCT02881047|12173266|P1|COMPLETED|Overall Study||6
4949148|NCT02881047|12173266|P1|STARTED|Overall Study||8
4949149|NCT02881008|12173278|P6|NOT COMPLETED|Overall Study||0
4949150|NCT02881008|12173279|P5|NOT COMPLETED|Overall Study||0
4949151|NCT02881008|12173280|P4|NOT COMPLETED|Overall Study||0
4949152|NCT02881008|12173281|P3|NOT COMPLETED|Overall Study||0
4949153|NCT02881008|12173282|P2|NOT COMPLETED|Overall Study||0
4949154|NCT02881008|12173283|P1|NOT COMPLETED|Overall Study||0
4949155|NCT02881008|12173278|P6|COMPLETED|Overall Study||8
4949156|NCT02881008|12173279|P5|COMPLETED|Overall Study||8
4949157|NCT02881008|12173280|P4|COMPLETED|Overall Study||8
4949158|NCT02881008|12173281|P3|COMPLETED|Overall Study||8
4949159|NCT02881008|12173282|P2|COMPLETED|Overall Study||8
4949160|NCT02881008|12173283|P1|COMPLETED|Overall Study||8
4949161|NCT02881008|12173278|P6|STARTED|Overall Study||8
4949162|NCT02881008|12173279|P5|STARTED|Overall Study||8
4949163|NCT02881008|12173280|P4|STARTED|Overall Study||8
4949164|NCT02881008|12173281|P3|STARTED|Overall Study||8
4949165|NCT02881008|12173282|P2|STARTED|Overall Study||8
4949166|NCT02881008|12173283|P1|STARTED|Overall Study||8
4949167|NCT02880852|12173316|P1|NOT COMPLETED|Overall Study||0
4949168|NCT02880852|12173316|P1|COMPLETED|Overall Study||20
4949169|NCT02880852|12173316|P1|STARTED|Overall Study||20
4949170|NCT02880761|12173344|P2|NOT COMPLETED|Overall Study||21
4949171|NCT02880761|12173345|P1|NOT COMPLETED|Overall Study||16
4949172|NCT02880761|12173344|P2|COMPLETED|Overall Study||85
4949173|NCT02880761|12173345|P1|COMPLETED|Overall Study||87
4949174|NCT02880761|12173344|P2|STARTED|Overall Study||106
4949175|NCT02880761|12173345|P1|STARTED|Overall Study||103
4949176|NCT02880514|12173355|P2|NOT COMPLETED|Overall Study||0
4949177|NCT02880514|12173356|P1|NOT COMPLETED|Overall Study||0
4949178|NCT02880514|12173355|P2|COMPLETED|Overall Study||50
4949179|NCT02880514|12173356|P1|COMPLETED|Overall Study||50
4949180|NCT02880514|12173355|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
4949181|NCT02880514|12173356|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
4949182|NCT02880475|12173365|P2|NOT COMPLETED|Overall Study||0
4949183|NCT02880475|12173366|P1|NOT COMPLETED|Overall Study||0
4949184|NCT02880475|12173365|P2|COMPLETED|Overall Study||17
4949185|NCT02880475|12173366|P1|COMPLETED|Overall Study||13
4949186|NCT02880475|12173365|P2|STARTED|Overall Study||17
4949187|NCT02880475|12173366|P1|STARTED|Overall Study||13
4949188|NCT02880254|12173500|P2|NOT COMPLETED|Overall Study||10
4949189|NCT02880254|12173501|P1|NOT COMPLETED|Overall Study||9
4949190|NCT02880254|12173500|P2|COMPLETED|Overall Study||4
4949191|NCT02880254|12173501|P1|COMPLETED|Overall Study||4
4949192|NCT02880254|12173500|P2|STARTED|Overall Study||14
4949193|NCT02880254|12173501|P1|STARTED|Overall Study||13
4949194|NCT02880228|12173509|P1|NOT COMPLETED|Overall Study||0
4949195|NCT02880228|12173509|P1|COMPLETED|Overall Study||11
4949196|NCT02880228|12173509|P1|STARTED|Overall Study||11
4949197|NCT02880189|12173517|P1|NOT COMPLETED|Overall Study||0
4949198|NCT02880189|12173517|P1|COMPLETED|Overall Study||21
4949199|NCT02880189|12173517|P1|STARTED|Overall Study||21
4949200|NCT02880137|12173522|P1|NOT COMPLETED|Overall Study||0
4949201|NCT02880137|12173522|P1|COMPLETED|Overall Study||36
4949202|NCT02880137|12173522|P1|STARTED|Overall Study||36
4949203|NCT02879747|12173529|P3|NOT COMPLETED|Overall Study||2
4949204|NCT02879747|12173530|P2|NOT COMPLETED|Overall Study||6
4949205|NCT02879747|12173531|P1|NOT COMPLETED|Overall Study||4
4949206|NCT02879747|12173529|P3|COMPLETED|Overall Study||31
4949207|NCT02879747|12173530|P2|COMPLETED|Overall Study||32
4949208|NCT02879747|12173531|P1|COMPLETED|Overall Study||23
4949209|NCT02879747|12173529|P3|STARTED|Overall Study||33
4949210|NCT02879747|12173530|P2|STARTED|Overall Study||38
4949211|NCT02879747|12173531|P1|STARTED|Overall Study||27
4949212|NCT02879032|12173548|P1|NOT COMPLETED|Overall Study||0
4949213|NCT02879032|12173548|P1|COMPLETED|Overall Study||130
4949214|NCT02879032|12173548|P1|STARTED|Overall Study||130
4949215|NCT02878590|12173554|P1|NOT COMPLETED|Overall Study||2
4949216|NCT02878590|12173554|P1|COMPLETED|Overall Study||10
4949217|NCT02878590|12173554|P1|STARTED|Overall Study||12
4949218|NCT02878486|12173560|P2|NOT COMPLETED|Overall Study||0
4949219|NCT02878486|12173561|P1|NOT COMPLETED|Overall Study||0
4949220|NCT02878486|12173560|P2|COMPLETED|Overall Study||3
4949221|NCT02878486|12173561|P1|COMPLETED|Overall Study||3
4949222|NCT02878486|12173560|P2|STARTED|Overall Study||3
4949223|NCT02878486|12173561|P1|STARTED|Overall Study||3
4949224|NCT02878330|12173579|P2|NOT COMPLETED|Overall Study||56
4949225|NCT02878330|12173580|P1|NOT COMPLETED|Overall Study||29
4949226|NCT02878330|12173579|P2|COMPLETED|Overall Study||913
4949227|NCT02878330|12173580|P1|COMPLETED|Overall Study||455
4949228|NCT02878330|12173579|P2|STARTED|Overall Study||969
4949229|NCT02878330|12173580|P1|STARTED|Overall Study||484
4949230|NCT02878213|12173596|P1|NOT COMPLETED|Overall Study||3
4949231|NCT02878213|12173596|P1|COMPLETED|Overall Study||36
4949232|NCT02878213|12173596|P1|STARTED|Overall Study||39
4949233|NCT02877927|12173603|P2|NOT COMPLETED|Overall Study||57
4949234|NCT02877927|12173604|P1|NOT COMPLETED|Overall Study||54
4949235|NCT02877927|12173603|P2|COMPLETED|Overall Study||310
4949236|NCT02877927|12173604|P1|COMPLETED|Overall Study||314
4949237|NCT02877927|12173603|P2|STARTED|Overall Study||367
4949238|NCT02877927|12173604|P1|STARTED|Overall Study||368
4949239|NCT02877732|12173616|P2|NOT COMPLETED|Overall Study||6
4949240|NCT02877732|12173617|P1|NOT COMPLETED|Overall Study||6
4949241|NCT02877732|12173616|P2|COMPLETED|Overall Study||0
4949242|NCT02877732|12173617|P1|COMPLETED|Overall Study||0
4949243|NCT02877732|12173616|P2|STARTED|Overall Study||6
4949244|NCT02877732|12173617|P1|STARTED|Overall Study||6
4949245|NCT02877680|12173635|P2|NOT COMPLETED|Overall Study||1
4949246|NCT02877680|12173636|P1|NOT COMPLETED|Overall Study||1
4949247|NCT02877680|12173635|P2|COMPLETED|Overall Study||24
4949248|NCT02877680|12173636|P1|COMPLETED|Overall Study||54
4949249|NCT02877680|12173635|P2|STARTED|Overall Study||25
4949250|NCT02877680|12173636|P1|STARTED|Overall Study||55
4949251|NCT02877095|12173677|P2|NOT COMPLETED|Overall Study||0
4949252|NCT02877095|12173678|P1|NOT COMPLETED|Overall Study||0
4949253|NCT02877095|12173677|P2|COMPLETED|Overall Study||20
4949254|NCT02877095|12173678|P1|COMPLETED|Overall Study||20
4949255|NCT02877095|12173677|P2|STARTED|Overall Study||20
4949256|NCT02877095|12173678|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
4949257|NCT02877082|12173684|P1|NOT COMPLETED|Overall Study||5
4949258|NCT02877082|12173684|P1|COMPLETED|Overall Study||0
4949259|NCT02877082|12173684|P1|STARTED|Overall Study||5
4949260|NCT02877004|12173695|P3|NOT COMPLETED|Overall Study||1
4949261|NCT02877004|12173696|P2|NOT COMPLETED|Overall Study||0
4949262|NCT02877004|12173697|P1|NOT COMPLETED|Overall Study||0
4949263|NCT02877004|12173695|P3|COMPLETED|Overall Study||19
4949264|NCT02877004|12173696|P2|COMPLETED|Overall Study||20
4949265|NCT02877004|12173697|P1|COMPLETED|Overall Study||20
4949266|NCT02877004|12173695|P3|STARTED|Overall Study||20
4949267|NCT02877004|12173696|P2|STARTED|Overall Study||20
4949268|NCT02877004|12173697|P1|STARTED|Overall Study||20
4949269|NCT02876926|12173711|P3|NOT COMPLETED|Overall Study||20
4949270|NCT02876926|12173712|P2|NOT COMPLETED|Overall Study||19
4949271|NCT02876926|12173713|P1|NOT COMPLETED|Overall Study||18
4949272|NCT02876926|12173711|P3|COMPLETED|Overall Study||2
4949273|NCT02876926|12173712|P2|COMPLETED|Overall Study||3
4949274|NCT02876926|12173713|P1|COMPLETED|Overall Study||3
4949275|NCT02876926|12173711|P3|STARTED|Overall Study||22
4949276|NCT02876926|12173712|P2|STARTED|Overall Study||22
4949277|NCT02876926|12173713|P1|STARTED|Overall Study||21
4949278|NCT02876900|12173730|P3|NOT COMPLETED|Overall Study||44
4949279|NCT02876900|12173731|P2|NOT COMPLETED|Overall Study||48
4949280|NCT02876900|12173732|P1|NOT COMPLETED|Overall Study||39
4949281|NCT02876900|12173730|P3|COMPLETED|Overall Study||162
4949282|NCT02876900|12173731|P2|COMPLETED|Overall Study||158
4949283|NCT02876900|12173732|P1|COMPLETED|Overall Study||166
4949284|NCT02876900|12173730|P3|STARTED|Overall Study||206
4949285|NCT02876900|12173731|P2|STARTED|Overall Study||206
4949286|NCT02876900|12173732|P1|STARTED|Overall Study||205
4949287|NCT02876757|12173745|P2|NOT COMPLETED|Overall Study||0
4949288|NCT02876757|12173746|P1|NOT COMPLETED|Overall Study||0
4949289|NCT02876757|12173745|P2|COMPLETED|Overall Study||93197
4949290|NCT02876757|12173746|P1|COMPLETED|Overall Study||93197
4949291|NCT02876757|12173745|P2|STARTED|Overall Study||93197
4949292|NCT02876757|12173746|P1|STARTED|Overall Study||93197
4949293|NCT02876601|12173760|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
4949294|NCT02876601|12173761|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
4949295|NCT02876601|12173762|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
4949296|NCT02876601|12173763|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
4949297|NCT02876601|12173760|P4|COMPLETED|Second Intervention (24 Hours)||2
4949298|NCT02876601|12173761|P3|COMPLETED|Second Intervention (24 Hours)||1
4949299|NCT02876601|12173762|P2|COMPLETED|Second Intervention (24 Hours)||8
4949300|NCT02876601|12173763|P1|COMPLETED|Second Intervention (24 Hours)||8
4949301|NCT02876601|12173760|P4|STARTED|Second Intervention (24 Hours)||2
4949302|NCT02876601|12173761|P3|STARTED|Second Intervention (24 Hours)||1
4949303|NCT02876601|12173762|P2|STARTED|Second Intervention (24 Hours)||8
4949304|NCT02876601|12173763|P1|STARTED|Second Intervention (24 Hours)||8
4949305|NCT02876601|12173760|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
4949306|NCT02876601|12173761|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
4949307|NCT02876601|12173762|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
4949308|NCT02876601|12173763|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
4949309|NCT02876601|12173760|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
4949310|NCT02876601|12173761|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
4949311|NCT02876601|12173762|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
4949312|NCT02876601|12173763|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
4949313|NCT02876601|12173760|P4|STARTED|Washout (Minimum of 6 Weeks)||2
4949314|NCT02876601|12173761|P3|STARTED|Washout (Minimum of 6 Weeks)||2
4949315|NCT02876601|12173762|P2|STARTED|Washout (Minimum of 6 Weeks)||8
4949316|NCT02876601|12173763|P1|STARTED|Washout (Minimum of 6 Weeks)||8
4949317|NCT02876601|12173760|P4|NOT COMPLETED|First Intervention (24 Hours)||0
4949318|NCT02876601|12173761|P3|NOT COMPLETED|First Intervention (24 Hours)||0
4949319|NCT02876601|12173762|P2|NOT COMPLETED|First Intervention (24 Hours)||0
4949320|NCT02876601|12173763|P1|NOT COMPLETED|First Intervention (24 Hours)||0
4949321|NCT02876601|12173760|P4|COMPLETED|First Intervention (24 Hours)||2
4949322|NCT02876601|12173761|P3|COMPLETED|First Intervention (24 Hours)||2
4949323|NCT02876601|12173762|P2|COMPLETED|First Intervention (24 Hours)||8
4949324|NCT02876601|12173763|P1|COMPLETED|First Intervention (24 Hours)||8
4949325|NCT02876601|12173760|P4|STARTED|First Intervention (24 Hours)||2
4949326|NCT02876601|12173761|P3|STARTED|First Intervention (24 Hours)||2
4949327|NCT02876601|12173762|P2|STARTED|First Intervention (24 Hours)||8
4949328|NCT02876601|12173763|P1|STARTED|First Intervention (24 Hours)||8
4949329|NCT02876575|12173813|P1|NOT COMPLETED|Overall Study||0
4949330|NCT02876575|12173813|P1|COMPLETED|Overall Study||48
4949331|NCT02876575|12173813|P1|STARTED|Overall Study||48
4949332|NCT02876159|12173829|P2|NOT COMPLETED|Overall Study||0
4949333|NCT02876159|12173830|P1|NOT COMPLETED|Overall Study||0
4949334|NCT02876159|12173829|P2|COMPLETED|Overall Study||10
4949335|NCT02876159|12173830|P1|COMPLETED|Overall Study||10
4949336|NCT02876159|12173829|P2|STARTED|Overall Study||10
4949337|NCT02876159|12173830|P1|STARTED|Overall Study||10
4949338|NCT02876055|12173849|P3|NOT COMPLETED|Overall Study||0
4949339|NCT02876055|12173850|P2|NOT COMPLETED|Overall Study||0
4949340|NCT02876055|12173851|P1|NOT COMPLETED|Overall Study||0
4949341|NCT02876055|12173849|P3|COMPLETED|Overall Study||42
4949342|NCT02876055|12173850|P2|COMPLETED|Overall Study||41
4949343|NCT02876055|12173851|P1|COMPLETED|Overall Study||42
4949344|NCT02876055|12173849|P3|STARTED|Overall Study||42
4949345|NCT02876055|12173850|P2|STARTED|Overall Study||41
4949346|NCT02876055|12173851|P1|STARTED|Overall Study||42
4949347|NCT02875977|12173861|P2|NOT COMPLETED|Overall Study||29
4949348|NCT02875977|12173862|P1|NOT COMPLETED|Overall Study||42
4949349|NCT02875977|12173861|P2|COMPLETED|Overall Study||71
4949350|NCT02875977|12173862|P1|COMPLETED|Overall Study||58
4949351|NCT02875977|12173861|P2|STARTED|Overall Study||100
4949352|NCT02875977|12173862|P1|STARTED|Overall Study||100
4949353|NCT02875613|12173876|P1|NOT COMPLETED|Overall Study||1
4949354|NCT02875613|12173876|P1|COMPLETED|Overall Study||4
4949355|NCT02875613|12173876|P1|STARTED|Overall Study||5
4949356|NCT02875366|12173882|P2|NOT COMPLETED|Overall Study||3
4949357|NCT02875366|12173883|P1|NOT COMPLETED|Overall Study||0
4949358|NCT02875366|12173882|P2|COMPLETED|Overall Study||31
4949359|NCT02875366|12173883|P1|COMPLETED|Overall Study||36
4949360|NCT02875366|12173882|P2|STARTED|Overall Study||34
4949361|NCT02875366|12173883|P1|STARTED|Overall Study||36
4949362|NCT02875340|12173935|P1|NOT COMPLETED|Overall Study||8
4949363|NCT02875340|12173935|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
4949364|NCT02875340|12173935|P1|STARTED|Overall Study||8
4949365|NCT02875028|12173959|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
4949366|NCT02875028|12173960|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
4949367|NCT02875028|12173959|P2|COMPLETED|Second Intervention (24 Hours)||7
4949368|NCT02875028|12173960|P1|COMPLETED|Second Intervention (24 Hours)||8
4949369|NCT02875028|12173959|P2|STARTED|Second Intervention (24 Hours)||7
4949370|NCT02875028|12173960|P1|STARTED|Second Intervention (24 Hours)||8
4949371|NCT02875028|12173959|P2|NOT COMPLETED|Washout Period||1
4949372|NCT02875028|12173960|P1|NOT COMPLETED|Washout Period||0
4949373|NCT02875028|12173959|P2|COMPLETED|Washout Period||7
4949374|NCT02875028|12173960|P1|COMPLETED|Washout Period||8
4949375|NCT02875028|12173959|P2|STARTED|Washout Period||8
4949376|NCT02875028|12173960|P1|STARTED|Washout Period||8
4949377|NCT02875028|12173959|P2|NOT COMPLETED|First Intervention (24 Hours)||0
4949378|NCT02875028|12173960|P1|NOT COMPLETED|First Intervention (24 Hours)||0
4949379|NCT02875028|12173959|P2|COMPLETED|First Intervention (24 Hours)||8
4949380|NCT02875028|12173960|P1|COMPLETED|First Intervention (24 Hours)||8
4949381|NCT02875028|12173959|P2|STARTED|First Intervention (24 Hours)||8
4949382|NCT02875028|12173960|P1|STARTED|First Intervention (24 Hours)||8
4949383|NCT02874924|12173991|P3|NOT COMPLETED|Overall Study||0
4949384|NCT02874924|12173992|P2|NOT COMPLETED|Overall Study||0
4949385|NCT02874924|12173993|P1|NOT COMPLETED|Overall Study||3
4949386|NCT02874924|12173991|P3|COMPLETED|Overall Study||6
4949387|NCT02874924|12173992|P2|COMPLETED|Overall Study||14
4949388|NCT02874924|12173993|P1|COMPLETED|Overall Study||11
4949389|NCT02874924|12173991|P3|STARTED|Overall Study||6
4949390|NCT02874924|12173992|P2|STARTED|Overall Study||14
4949391|NCT02874924|12173993|P1|STARTED|Overall Study||14
4949392|NCT02874846|12174015|P2|NOT COMPLETED|Overall Study||0
4949393|NCT02874846|12174016|P1|NOT COMPLETED|Overall Study||0
4949394|NCT02874846|12174015|P2|COMPLETED|Overall Study||4
4949395|NCT02874846|12174016|P1|COMPLETED|Overall Study||8
4949396|NCT02874846|12174015|P2|STARTED|Overall Study||4
4949397|NCT02874846|12174016|P1|STARTED|Overall Study||8
4949398|NCT02874794|12174026|P2|NOT COMPLETED|Overall Study||11
4949399|NCT02874794|12174027|P1|NOT COMPLETED|Overall Study||7
4949400|NCT02874794|12174026|P2|COMPLETED|Overall Study||221
4949401|NCT02874794|12174027|P1|COMPLETED|Overall Study||226
4949402|NCT02874794|12174026|P2|STARTED|Overall Study||232
4949403|NCT02874794|12174027|P1|STARTED|Overall Study||233
4949404|NCT02874742|12174059|P3|NOT COMPLETED|Overall Study||16
4949405|NCT02874742|12174060|P2|NOT COMPLETED|Overall Study||104
4949406|NCT02874742|12174061|P1|NOT COMPLETED|Overall Study||103
4949407|NCT02874742|12174059|P3|COMPLETED|Overall Study||0
4949408|NCT02874742|12174060|P2|COMPLETED|Overall Study||0
4949409|NCT02874742|12174061|P1|COMPLETED|Overall Study||0
4949410|NCT02874742|12174059|P3|Safety|Overall Study||16
4949411|NCT02874742|12174060|P2|Safety|Overall Study||99
4949412|NCT02874742|12174061|P1|Safety|Overall Study||102
4949413|NCT02874742|12174059|P3|STARTED|Overall Study||16
4949414|NCT02874742|12174060|P2|STARTED|Overall Study||104
4949415|NCT02874742|12174061|P1|STARTED|Overall Study||103
4949416|NCT02874534|12174115|P2|NOT COMPLETED|Overall Study||11
4949417|NCT02874534|12174116|P1|NOT COMPLETED|Overall Study||8
4949418|NCT02874534|12174115|P2|COMPLETED|Overall Study||15
4949419|NCT02874534|12174116|P1|COMPLETED|Overall Study||23
4949420|NCT02874534|12174115|P2|STARTED|Overall Study||26
4949421|NCT02874534|12174116|P1|STARTED|Overall Study||31
4949422|NCT02874404|12174124|P1|NOT COMPLETED|Overall Study||0
4949423|NCT02874404|12174124|P1|COMPLETED|Overall Study||13
4949424|NCT02874404|12174124|P1|STARTED|Overall Study||13
4949425|NCT02874066|12174130|P1|NOT COMPLETED|Overall Study||0
4949426|NCT02874066|12174130|P1|COMPLETED|Overall Study||46
4949427|NCT02874066|12174130|P1|STARTED|Overall Study||46
4949428|NCT02873754|12174138|P1|NOT COMPLETED|Overall Study||6
4949429|NCT02873754|12174138|P1|COMPLETED|Overall Study||5
4949430|NCT02873754|12174138|P1|STARTED|Overall Study||11
4949431|NCT02873702|12174155|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
4949432|NCT02873702|12174156|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
4949433|NCT02873702|12174157|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
4949434|NCT02873702|12174158|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
4949435|NCT02873702|12174155|P4|COMPLETED|Maintenance Period (up to Month 6)||6
4949436|NCT02873702|12174156|P3|COMPLETED|Maintenance Period (up to Month 6)||1
4949437|NCT02873702|12174157|P2|COMPLETED|Maintenance Period (up to Month 6)||0
4949438|NCT02873702|12174158|P1|COMPLETED|Maintenance Period (up to Month 6)||0
4949439|NCT02873702|12174155|P4|STARTED|Maintenance Period (up to Month 6)||8
4949440|NCT02873702|12174156|P3|STARTED|Maintenance Period (up to Month 6)||8
4949441|NCT02873702|12174157|P2|STARTED|Maintenance Period (up to Month 6)||0
4949442|NCT02873702|12174158|P1|STARTED|Maintenance Period (up to Month 6)||0
4949443|NCT02873702|12174155|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
4949444|NCT02873702|12174156|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
4949445|NCT02873702|12174157|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
4949446|NCT02873702|12174158|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
4949447|NCT02873702|12174155|P4|COMPLETED|Healing Period (up to Week 8)||0
4949448|NCT02873702|12174156|P3|COMPLETED|Healing Period (up to Week 8)||0
4949449|NCT02873702|12174157|P2|COMPLETED|Healing Period (up to Week 8)||16
4949450|NCT02873702|12174158|P1|COMPLETED|Healing Period (up to Week 8)||19
4949451|NCT02873702|12174155|P4|STARTED|Healing Period (up to Week 8)||0
4949452|NCT02873702|12174156|P3|STARTED|Healing Period (up to Week 8)||0
4949453|NCT02873702|12174157|P2|STARTED|Healing Period (up to Week 8)||17
4949454|NCT02873702|12174158|P1|STARTED|Healing Period (up to Week 8)||20
4949455|NCT02873689|12174170|P2|NOT COMPLETED|Overall Study||5
4949456|NCT02873689|12174171|P1|NOT COMPLETED|Overall Study||7
4949457|NCT02873689|12174170|P2|COMPLETED|Overall Study||103
4949458|NCT02873689|12174171|P1|COMPLETED|Overall Study||102
4949459|NCT02873689|12174170|P2|Treated|Overall Study||107
4949460|NCT02873689|12174171|P1|Treated|Overall Study||108
4949461|NCT02873689|12174170|P2|STARTED|Overall Study||108
4949462|NCT02873689|12174171|P1|STARTED|Overall Study||109
4949463|NCT02873481|12174181|P2|NOT COMPLETED|Overall Study||0
4949464|NCT02873481|12174182|P1|NOT COMPLETED|Overall Study||0
4949465|NCT02873481|12174181|P2|COMPLETED|Overall Study||17
4949466|NCT02873481|12174182|P1|COMPLETED|Overall Study||15
4949467|NCT02873481|12174181|P2|STARTED|Overall Study||17
4949468|NCT02873481|12174182|P1|STARTED|Overall Study||15
4949469|NCT02873429|12174199|P2|NOT COMPLETED|16 Weeks||2
4949470|NCT02873429|12174200|P1|NOT COMPLETED|16 Weeks||5
4949471|NCT02873429|12174199|P2|COMPLETED|16 Weeks||96
4949472|NCT02873429|12174200|P1|COMPLETED|16 Weeks||100
4949473|NCT02873429|12174199|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
4949474|NCT02873429|12174200|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
4949475|NCT02873429|12174199|P2|NOT COMPLETED|6-8 Weeks||1
4949476|NCT02873429|12174200|P1|NOT COMPLETED|6-8 Weeks||10
4949477|NCT02873429|12174199|P2|COMPLETED|6-8 Weeks||97
4949478|NCT02873429|12174200|P1|COMPLETED|6-8 Weeks||95
4949479|NCT02873429|12174199|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
4949480|NCT02873429|12174200|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
4949481|NCT02873429|12174199|P2|NOT COMPLETED|Baseline||0
4949482|NCT02873429|12174200|P1|NOT COMPLETED|Baseline||0
4949483|NCT02873429|12174199|P2|COMPLETED|Baseline||100
4949484|NCT02873429|12174200|P1|COMPLETED|Baseline||109
4949485|NCT02873429|12174199|P2|STARTED|Baseline||100
4949486|NCT02873429|12174200|P1|STARTED|Baseline||109
4949487|NCT02873377|12174212|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
4949488|NCT02873377|12174213|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
4949489|NCT02873377|12174212|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
4949490|NCT02873377|12174213|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
4949491|NCT02873377|12174212|P2|STARTED|Period Title 3: 6 Months Follow up||69
4949492|NCT02873377|12174213|P1|STARTED|Period Title 3: 6 Months Follow up||65
4949493|NCT02873377|12174212|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
4949494|NCT02873377|12174213|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
4949495|NCT02873377|12174212|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
4949496|NCT02873377|12174213|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
4949497|NCT02873377|12174212|P2|STARTED|Period Title 2: 3 Months Follow up||69
4949498|NCT02873377|12174213|P1|STARTED|Period Title 2: 3 Months Follow up||65
4949499|NCT02873377|12174212|P2|NOT COMPLETED|Period 1: Enrollment||0
4949500|NCT02873377|12174213|P1|NOT COMPLETED|Period 1: Enrollment||0
4949501|NCT02873377|12174212|P2|COMPLETED|Period 1: Enrollment||69
4949502|NCT02873377|12174213|P1|COMPLETED|Period 1: Enrollment||65
4949503|NCT02873377|12174212|P2|STARTED|Period 1: Enrollment||69
4949504|NCT02873377|12174213|P1|STARTED|Period 1: Enrollment||65
4949505|NCT02873221|12174235|P3|NOT COMPLETED|Safety Follow-up Period||14
4949506|NCT02873221|12174236|P2|NOT COMPLETED|Safety Follow-up Period||17
4949507|NCT02873221|12174237|P1|NOT COMPLETED|Safety Follow-up Period||7
4949508|NCT02873221|12174235|P3|COMPLETED|Safety Follow-up Period||350
4949509|NCT02873221|12174236|P2|COMPLETED|Safety Follow-up Period||339
4949510|NCT02873221|12174237|P1|COMPLETED|Safety Follow-up Period||343
4949511|NCT02873221|12174235|P3|STARTED|Safety Follow-up Period||364
4949512|NCT02873221|12174236|P2|STARTED|Safety Follow-up Period||356
4949513|NCT02873221|12174237|P1|STARTED|Safety Follow-up Period||350
4949514|NCT02873221|12174235|P3|NOT COMPLETED|Treatment Period||105
4949515|NCT02873221|12174236|P2|NOT COMPLETED|Treatment Period||126
4949516|NCT02873221|12174237|P1|NOT COMPLETED|Treatment Period||88
4949517|NCT02873221|12174235|P3|COMPLETED|Treatment Period||315
4949518|NCT02873221|12174236|P2|COMPLETED|Treatment Period||291
4949519|NCT02873221|12174237|P1|COMPLETED|Treatment Period||329
4949520|NCT02873221|12174235|P3|Safety Population: Received Study Drug|Treatment Period||409
4949521|NCT02873221|12174236|P2|Safety Population: Received Study Drug|Treatment Period||404
4949522|NCT02873221|12174237|P1|Safety Population: Received Study Drug|Treatment Period||417
4949523|NCT02873221|12174235|P3|STARTED|Treatment Period||420
4949524|NCT02873221|12174236|P2|STARTED|Treatment Period||417
4949525|NCT02873221|12174237|P1|STARTED|Treatment Period||417
4949526|NCT02873195|12174259|P2|NOT COMPLETED|Overall Study||0
4949527|NCT02873195|12174260|P1|NOT COMPLETED|Overall Study||5
4949528|NCT02873195|12174259|P2|COMPLETED|Overall Study||46
4949529|NCT02873195|12174260|P1|COMPLETED|Overall Study||82
4949530|NCT02873195|12174259|P2|Never Began Treatment (Cancel)|Overall Study||0
4949531|NCT02873195|12174260|P1|Never Began Treatment (Cancel)|Overall Study||1
4949532|NCT02873195|12174259|P2|STARTED|Overall Study||46
4949533|NCT02873195|12174260|P1|STARTED|Overall Study||87
4949534|NCT02873104|12174274|P2|NOT COMPLETED|Overall Study||0
4949535|NCT02873104|12174275|P1|NOT COMPLETED|Overall Study||1
4949536|NCT02873104|12174274|P2|COMPLETED|Overall Study||23
4949537|NCT02873104|12174275|P1|COMPLETED|Overall Study||46
4949538|NCT02873104|12174274|P2|STARTED|Overall Study||23
4949539|NCT02873104|12174275|P1|STARTED|Overall Study||47
4949540|NCT02872935|12174289|P2|NOT COMPLETED|Overall Study||1
4949541|NCT02872935|12174290|P1|NOT COMPLETED|Overall Study||0
4949542|NCT02872935|12174289|P2|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
4949543|NCT02872935|12174290|P1|COMPLETED|Overall Study||11
4949544|NCT02872935|12174289|P2|STARTED|Overall Study||11
4949545|NCT02872935|12174290|P1|STARTED|Overall Study||11
4949546|NCT02872909|12174300|P2|NOT COMPLETED|Overall Study||0
4949547|NCT02872909|12174301|P1|NOT COMPLETED|Overall Study||0
4949548|NCT02872909|12174300|P2|COMPLETED|Overall Study||18
4949549|NCT02872909|12174301|P1|COMPLETED|Overall Study||32
4949550|NCT02872909|12174300|P2|STARTED|Overall Study||18
4949551|NCT02872909|12174301|P1|STARTED|Overall Study||32
4949552|NCT02872311|12174318|P5|NOT COMPLETED|Overall Study||0
4949553|NCT02872311|12174319|P4|NOT COMPLETED|Overall Study||0
4949554|NCT02872311|12174320|P3|NOT COMPLETED|Overall Study||1
4949555|NCT02872311|12174321|P2|NOT COMPLETED|Overall Study||2
4949556|NCT02872311|12174322|P1|NOT COMPLETED|Overall Study||4
4949557|NCT02872311|12174318|P5|COMPLETED|Overall Study||20
4949558|NCT02872311|12174319|P4|COMPLETED|Overall Study||20
4949559|NCT02872311|12174320|P3|COMPLETED|Overall Study||19
4949560|NCT02872311|12174321|P2|COMPLETED|Overall Study||58
4949561|NCT02872311|12174322|P1|COMPLETED|Overall Study||55
4949562|NCT02872311|12174318|P5|STARTED|Overall Study||20
4949563|NCT02872311|12174319|P4|STARTED|Overall Study||20
4949564|NCT02872311|12174320|P3|STARTED|Overall Study||20
4949565|NCT02872311|12174321|P2|STARTED|Overall Study||60
4949566|NCT02872311|12174322|P1|STARTED|Overall Study||59
4949567|NCT02872285|12174383|P2|NOT COMPLETED|Overall Study||2
4949568|NCT02872285|12174384|P1|NOT COMPLETED|Overall Study||5
4949569|NCT02872285|12174383|P2|COMPLETED|Overall Study||9
4949570|NCT02872285|12174384|P1|COMPLETED|Overall Study||17
4949571|NCT02872285|12174383|P2|STARTED|Overall Study||11
4949572|NCT02872285|12174384|P1|STARTED|Overall Study||22
4949573|NCT02872103|12174400|P2|NOT COMPLETED|Cycle 2-4||1
4949574|NCT02872103|12174401|P1|NOT COMPLETED|Cycle 2-4||2
4949575|NCT02872103|12174400|P2|COMPLETED|Cycle 2-4||37
4949576|NCT02872103|12174401|P1|COMPLETED|Cycle 2-4||81
4949577|NCT02872103|12174400|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
4949578|NCT02872103|12174401|P1|STARTED|Cycle 2-4||83
4949579|NCT02872103|12174400|P2|NOT COMPLETED|Cycle 1||1
4949580|NCT02872103|12174401|P1|NOT COMPLETED|Cycle 1||0
4949581|NCT02872103|12174400|P2|COMPLETED|Cycle 1||38
4949582|NCT02872103|12174401|P1|COMPLETED|Cycle 1||83
4949583|NCT02872103|12174400|P2|STARTED|Cycle 1||39
4949584|NCT02872103|12174401|P1|STARTED|Cycle 1||83
4949585|NCT02872012|12174430|P5|NOT COMPLETED|Overall Study||0
4949586|NCT02872012|12174431|P4|NOT COMPLETED|Overall Study||0
4949587|NCT02872012|12174432|P3|NOT COMPLETED|Overall Study||0
4949588|NCT02872012|12174433|P2|NOT COMPLETED|Overall Study||0
4949589|NCT02872012|12174434|P1|NOT COMPLETED|Overall Study||1
4949590|NCT02872012|12174430|P5|COMPLETED|Overall Study||5
4949591|NCT02872012|12174431|P4|COMPLETED|Overall Study||3
4949592|NCT02872012|12174432|P3|COMPLETED|Overall Study||4
4949593|NCT02872012|12174433|P2|COMPLETED|Overall Study||7
4949594|NCT02872012|12174434|P1|COMPLETED|Overall Study||3
4949595|NCT02872012|12174430|P5|STARTED|Overall Study||5
4949596|NCT02872012|12174431|P4|STARTED|Overall Study||3
4949597|NCT02872012|12174432|P3|STARTED|Overall Study||4
4949598|NCT02872012|12174433|P2|STARTED|Overall Study||7
4949599|NCT02872012|12174434|P1|STARTED|Overall Study||4
4949600|NCT02871739|12174452|P4|NOT COMPLETED|Overall Study||2
4949601|NCT02871739|12174453|P3|NOT COMPLETED|Overall Study||0
4949602|NCT02871739|12174454|P2|NOT COMPLETED|Overall Study||2
4949603|NCT02871739|12174455|P1|NOT COMPLETED|Overall Study||3
4949604|NCT02871739|12174452|P4|COMPLETED|Overall Study||5
4949605|NCT02871739|12174453|P3|COMPLETED|Overall Study||4
4949606|NCT02871739|12174454|P2|COMPLETED|Overall Study||4
4949607|NCT02871739|12174455|P1|COMPLETED|Overall Study||3
4949608|NCT02871739|12174452|P4|Complete Final Survey|Overall Study||5
4949609|NCT02871739|12174453|P3|Complete Final Survey|Overall Study||4
4949610|NCT02871739|12174454|P2|Complete Final Survey|Overall Study||4
4949611|NCT02871739|12174455|P1|Complete Final Survey|Overall Study||3
4949612|NCT02871739|12174452|P4|Completed Second SPI|Overall Study||5
4949613|NCT02871739|12174453|P3|Completed Second SPI|Overall Study||4
4949614|NCT02871739|12174454|P2|Completed Second SPI|Overall Study||4
4949615|NCT02871739|12174455|P1|Completed Second SPI|Overall Study||3
4949616|NCT02871739|12174452|P4|Completed First SPI|Overall Study||6
4949617|NCT02871739|12174453|P3|Completed First SPI|Overall Study||4
4949618|NCT02871739|12174454|P2|Completed First SPI|Overall Study||5
4949619|NCT02871739|12174455|P1|Completed First SPI|Overall Study||3
4949620|NCT02871739|12174452|P4|STARTED|Overall Study||7
4949621|NCT02871739|12174453|P3|STARTED|Overall Study||4
4949622|NCT02871739|12174454|P2|STARTED|Overall Study||6
4949623|NCT02871739|12174455|P1|STARTED|Overall Study||6
4949624|NCT02871635|12174467|P2|NOT COMPLETED|Overall Study||19
4949625|NCT02871635|12174468|P1|NOT COMPLETED|Overall Study||18
4949626|NCT02871635|12174467|P2|COMPLETED|Overall Study||56
4949627|NCT02871635|12174468|P1|COMPLETED|Overall Study||54
4949628|NCT02871635|12174467|P2|STARTED|Overall Study||75
4949629|NCT02871635|12174468|P1|STARTED|Overall Study||72
4949630|NCT02871570|12174494|P2|NOT COMPLETED|Overall Study||0
4949631|NCT02871570|12174495|P1|NOT COMPLETED|Overall Study||0
4949632|NCT02871570|12174494|P2|COMPLETED|Overall Study||8
4949633|NCT02871570|12174495|P1|COMPLETED|Overall Study||8
4949634|NCT02871570|12174494|P2|STARTED|Overall Study||8
4949635|NCT02871570|12174495|P1|STARTED|Overall Study||8
4949636|NCT02871479|12174526|P3|NOT COMPLETED|Overall Study||0
4949637|NCT02871479|12174527|P2|NOT COMPLETED|Overall Study||3
4949638|NCT02871479|12174528|P1|NOT COMPLETED|Overall Study||3
4949639|NCT02871479|12174526|P3|COMPLETED|Overall Study||11
4949640|NCT02871479|12174527|P2|COMPLETED|Overall Study||21
4949641|NCT02871479|12174528|P1|COMPLETED|Overall Study||33
4949642|NCT02871479|12174526|P3|STARTED|Overall Study||11
4949643|NCT02871479|12174527|P2|STARTED|Overall Study||24
4949644|NCT02871479|12174528|P1|STARTED|Overall Study||36
4949645|NCT02871440|12174542|P3|NOT COMPLETED|Overall Study||0
4949646|NCT02871440|12174543|P2|NOT COMPLETED|Overall Study||0
4949647|NCT02871440|12174544|P1|NOT COMPLETED|Overall Study||0
4949648|NCT02871440|12174542|P3|COMPLETED|Overall Study||15
4949649|NCT02871440|12174543|P2|COMPLETED|Overall Study||13
4949650|NCT02871440|12174544|P1|COMPLETED|Overall Study||12
4949651|NCT02871440|12174542|P3|STARTED|Overall Study||15
4949652|NCT02871440|12174543|P2|STARTED|Overall Study||13
4949653|NCT02871440|12174544|P1|STARTED|Overall Study||12
4949654|NCT02871375|12174558|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
4949655|NCT02871375|12174559|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
4949656|NCT02871375|12174558|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
4949657|NCT02871375|12174559|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
4949658|NCT02871375|12174558|P2|STARTED|Period 2, Second 14 Days of Wear||76
4949659|NCT02871375|12174559|P1|STARTED|Period 2, Second 14 Days of Wear||89
4949660|NCT02871375|12174558|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
4949661|NCT02871375|12174559|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
4949662|NCT02871375|12174558|P2|COMPLETED|Period 1, First 14 Days of Wear||76
4949663|NCT02871375|12174559|P1|COMPLETED|Period 1, First 14 Days of Wear||89
4949664|NCT02871375|12174558|P2|STARTED|Period 1, First 14 Days of Wear||77
4949665|NCT02871375|12174559|P1|STARTED|Period 1, First 14 Days of Wear||89
4949666|NCT02871011|12174570|P2|NOT COMPLETED|Overall Study||0
4949667|NCT02871011|12174571|P1|NOT COMPLETED|Overall Study||0
4949668|NCT02871011|12174570|P2|COMPLETED|Overall Study||13
4949669|NCT02871011|12174571|P1|COMPLETED|Overall Study||7
4949670|NCT02871011|12174570|P2|STARTED|Overall Study||13
4949671|NCT02871011|12174571|P1|STARTED|Overall Study||7
4949672|NCT02870933|12174589|P2|NOT COMPLETED|Overall Study||2
4949673|NCT02870933|12174590|P1|NOT COMPLETED|Overall Study||2
4949674|NCT02870933|12174589|P2|COMPLETED|Overall Study||13
4949675|NCT02870933|12174590|P1|COMPLETED|Overall Study||13
4949676|NCT02870933|12174589|P2|STARTED|Overall Study||15
4949677|NCT02870933|12174590|P1|STARTED|Overall Study||15
4949678|NCT02870205|12174616|P4|NOT COMPLETED|Overall Study||7
4949679|NCT02870205|12174617|P3|NOT COMPLETED|Overall Study||7
4949680|NCT02870205|12174618|P2|NOT COMPLETED|Overall Study||5
4949681|NCT02870205|12174619|P1|NOT COMPLETED|Overall Study||10
4949682|NCT02870205|12174616|P4|COMPLETED|Overall Study||287
4949683|NCT02870205|12174617|P3|COMPLETED|Overall Study||287
4949684|NCT02870205|12174618|P2|COMPLETED|Overall Study||289
4949685|NCT02870205|12174619|P1|COMPLETED|Overall Study||284
4949686|NCT02870205|12174616|P4|STARTED|Overall Study||294
4949687|NCT02870205|12174617|P3|STARTED|Overall Study||294
4949688|NCT02870205|12174618|P2|STARTED|Overall Study||294
4949689|NCT02870205|12174619|P1|STARTED|Overall Study||294
4949690|NCT02870101|12174629|P1|NOT COMPLETED|Overall Study||169
4949691|NCT02870101|12174629|P1|COMPLETED|Overall Study||2598
4949692|NCT02870101|12174629|P1|STARTED|Overall Study||2767
4949693|NCT02869451|12174644|P1|NOT COMPLETED|Overall Study||0
4949694|NCT02869451|12174644|P1|COMPLETED|Overall Study||5
4949695|NCT02869451|12174644|P1|STARTED|Overall Study||5
4949696|NCT02869438|12174668|P2|NOT COMPLETED|Overall Study||2
4949697|NCT02869438|12174669|P1|NOT COMPLETED|Overall Study||3
4949698|NCT02869438|12174668|P2|COMPLETED|Overall Study||113
4949699|NCT02869438|12174669|P1|COMPLETED|Overall Study||115
4949700|NCT02869438|12174668|P2|STARTED|Overall Study||115
4949701|NCT02869438|12174669|P1|STARTED|Overall Study||118
4949702|NCT02868892|12174717|P1|NOT COMPLETED|Overall Study||6
4949703|NCT02868892|12174717|P1|COMPLETED|Overall Study||0
4949704|NCT02868892|12174717|P1|STARTED|Overall Study||6
4949705|NCT02868554|12174726|P3|NOT COMPLETED|Overall Study||1
4949706|NCT02868554|12174727|P2|NOT COMPLETED|Overall Study||0
4949707|NCT02868554|12174728|P1|NOT COMPLETED|Overall Study||3
4949708|NCT02868554|12174726|P3|COMPLETED|Overall Study||11
4949709|NCT02868554|12174727|P2|COMPLETED|Overall Study||12
4949710|NCT02868554|12174728|P1|COMPLETED|Overall Study||7
4949711|NCT02868554|12174726|P3|STARTED|Overall Study||12
4949712|NCT02868554|12174727|P2|STARTED|Overall Study||12
4949713|NCT02868554|12174728|P1|STARTED|Overall Study||10
4949714|NCT02868242|12174751|P1|NOT COMPLETED|Overall Study||0
4949715|NCT02868242|12174751|P1|COMPLETED|Overall Study||19
4949716|NCT02868242|12174751|P1|STARTED|Overall Study||19
4949717|NCT02868216|12174763|P2|NOT COMPLETED|Overall Study||6
4949718|NCT02868216|12174764|P1|NOT COMPLETED|Overall Study||8
4949719|NCT02868216|12174763|P2|COMPLETED|Overall Study||41
4949720|NCT02868216|12174764|P1|COMPLETED|Overall Study||35
4949721|NCT02868216|12174763|P2|STARTED|Overall Study||47
4949722|NCT02868216|12174764|P1|STARTED|Overall Study||43
4949723|NCT02867995|12174772|P2|NOT COMPLETED|Overall Study||3
4949724|NCT02867995|12174773|P1|NOT COMPLETED|Overall Study||0
4949725|NCT02867995|12174772|P2|COMPLETED|Overall Study|Total patients completed|27
4949726|NCT02867995|12174773|P1|COMPLETED|Overall Study|Total patients completed|9
4949727|NCT02867995|12174772|P2|STARTED|Overall Study|Total patients consented|30
4949728|NCT02867995|12174773|P1|STARTED|Overall Study|Total patients consented|9
4949729|NCT02867709|12174792|P3|NOT COMPLETED|Safety Follow-up Period||14
4949730|NCT02867709|12174793|P2|NOT COMPLETED|Safety Follow-up Period||15
4949731|NCT02867709|12174794|P1|NOT COMPLETED|Safety Follow-up Period||11
4949732|NCT02867709|12174792|P3|COMPLETED|Safety Follow-up Period||473
4949733|NCT02867709|12174793|P2|COMPLETED|Safety Follow-up Period||459
4949734|NCT02867709|12174794|P1|COMPLETED|Safety Follow-up Period||482
4949735|NCT02867709|12174792|P3|STARTED|Safety Follow-up Period||487
4949736|NCT02867709|12174793|P2|STARTED|Safety Follow-up Period||474
4949737|NCT02867709|12174794|P1|STARTED|Safety Follow-up Period||493
4949738|NCT02867709|12174792|P3|NOT COMPLETED|Treatment Period||75
4949739|NCT02867709|12174793|P2|NOT COMPLETED|Treatment Period||87
4949740|NCT02867709|12174794|P1|NOT COMPLETED|Treatment Period||70
4949741|NCT02867709|12174792|P3|COMPLETED|Treatment Period||487
4949742|NCT02867709|12174793|P2|COMPLETED|Treatment Period||474
4949743|NCT02867709|12174794|P1|COMPLETED|Treatment Period||493
4949744|NCT02867709|12174792|P3|Safety Population: Received Study Drug|Treatment Period||488
4949745|NCT02867709|12174793|P2|Safety Population: Received Study Drug|Treatment Period||478
4949746|NCT02867709|12174794|P1|Safety Population: Received Study Drug|Treatment Period||499
4949747|NCT02867709|12174792|P3|STARTED|Treatment Period||562
4949748|NCT02867709|12174793|P2|STARTED|Treatment Period||561
4949749|NCT02867709|12174794|P1|STARTED|Treatment Period||563
4949750|NCT02867202|12174825|P2|NOT COMPLETED|Overall Study||32
4949751|NCT02867202|12174826|P1|NOT COMPLETED|Overall Study||21
4949752|NCT02867202|12174825|P2|COMPLETED|Overall Study||56
4949753|NCT02867202|12174826|P1|COMPLETED|Overall Study||62
4949754|NCT02867202|12174825|P2|STARTED|Overall Study||88
4949755|NCT02867202|12174826|P1|STARTED|Overall Study||83
4949756|NCT02867163|12174832|P1|NOT COMPLETED|Overall Study||0
4949757|NCT02867163|12174832|P1|COMPLETED|Overall Study||25
4949758|NCT02867163|12174832|P1|STARTED|Overall Study||25
4949759|NCT02867150|12174836|P1|NOT COMPLETED|Overall Study||0
4949760|NCT02867150|12174836|P1|COMPLETED|Overall Study||58
4949761|NCT02867150|12174836|P1|STARTED|Overall Study||58
4949762|NCT02867059|12174842|P2|NOT COMPLETED|Overall Study||2
4949763|NCT02867059|12174843|P1|NOT COMPLETED|Overall Study||0
4949764|NCT02867059|12174842|P2|COMPLETED|Overall Study||8
4949765|NCT02867059|12174843|P1|COMPLETED|Overall Study||7
4949766|NCT02867059|12174842|P2|STARTED|Overall Study||10
4949767|NCT02867059|12174843|P1|STARTED|Overall Study||7
4949768|NCT02866942|12174851|P1|NOT COMPLETED|Overall Study||1
4949769|NCT02866942|12174851|P1|COMPLETED|Overall Study||478
4949770|NCT02866942|12174851|P1|STARTED|Overall Study||479
4949771|NCT02866695|12174856|P1|NOT COMPLETED|Overall Study||2
4949772|NCT02866695|12174856|P1|COMPLETED|Overall Study||18
4949773|NCT02866695|12174856|P1|STARTED|Overall Study||20
4949774|NCT02866175|12174864|P2|NOT COMPLETED|Overall Study||175
4949775|NCT02866175|12174865|P1|NOT COMPLETED|Overall Study||135
4949776|NCT02866175|12174864|P2|COMPLETED|Overall Study||580
4949777|NCT02866175|12174865|P1|COMPLETED|Overall Study||616
4949778|NCT02866175|12174864|P2|STARTED|Overall Study||755
4949779|NCT02866175|12174865|P1|STARTED|Overall Study||751
4949780|NCT02865915|12174885|P2|NOT COMPLETED|Overall Study||30
4949781|NCT02865915|12174886|P1|NOT COMPLETED|Overall Study||25
4949782|NCT02865915|12174885|P2|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
4949783|NCT02865915|12174886|P1|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
4949784|NCT02865915|12174885|P2|STARTED|Overall Study||30
4949785|NCT02865915|12174886|P1|STARTED|Overall Study||25
4949786|NCT02865720|12174896|P2|NOT COMPLETED|Overall Study||0
4949787|NCT02865720|12174897|P1|NOT COMPLETED|Overall Study||0
4949788|NCT02865720|12174896|P2|COMPLETED|Overall Study||8
4949789|NCT02865720|12174897|P1|COMPLETED|Overall Study||0
4949790|NCT02865720|12174896|P2|STARTED|Overall Study||8
4949791|NCT02865720|12174897|P1|STARTED|Overall Study||0
4949792|NCT02865590|12174922|P2|NOT COMPLETED|Overall Study||0
4949793|NCT02865590|12174923|P1|NOT COMPLETED|Overall Study||0
4949794|NCT02865590|12174922|P2|COMPLETED|Overall Study||8
4949795|NCT02865590|12174923|P1|COMPLETED|Overall Study||8
4949796|NCT02865590|12174922|P2|STARTED|Overall Study||8
4949797|NCT02865590|12174923|P1|STARTED|Overall Study||8
4949798|NCT02865499|12174929|P1|NOT COMPLETED|12 Weeks||0
4949799|NCT02865499|12174929|P1|COMPLETED|12 Weeks||6
4949800|NCT02865499|12174929|P1|STARTED|12 Weeks||6
4949801|NCT02865499|12174929|P1|NOT COMPLETED|8 Weeks||0
4949802|NCT02865499|12174929|P1|COMPLETED|8 Weeks||6
4949803|NCT02865499|12174929|P1|STARTED|8 Weeks||6
4949804|NCT02865499|12174929|P1|NOT COMPLETED|Baseline||2
4949805|NCT02865499|12174929|P1|COMPLETED|Baseline||6
4949806|NCT02865499|12174929|P1|STARTED|Baseline||8
4949807|NCT02865395|12174936|P3|NOT COMPLETED|Overall Study||7
4949808|NCT02865395|12174937|P2|NOT COMPLETED|Overall Study||10
4949809|NCT02865395|12174938|P1|NOT COMPLETED|Overall Study||6
4949810|NCT02865395|12174936|P3|COMPLETED|Overall Study|Data Not Collected|0
4949811|NCT02865395|12174937|P2|COMPLETED|Overall Study|Data Not Collected|0
4949812|NCT02865395|12174938|P1|COMPLETED|Overall Study|Data Not Collected|0
4949813|NCT02865395|12174936|P3|STARTED|Overall Study||7
4949814|NCT02865395|12174937|P2|STARTED|Overall Study||10
4949815|NCT02865395|12174938|P1|STARTED|Overall Study||6
4949816|NCT02865343|12174951|P2|NOT COMPLETED|Overall Study||2
4949817|NCT02865343|12174952|P1|NOT COMPLETED|Overall Study||0
4949818|NCT02865343|12174951|P2|COMPLETED|Overall Study||3
4949819|NCT02865343|12174952|P1|COMPLETED|Overall Study||6
4949820|NCT02865343|12174951|P2|STARTED|Overall Study||5
4949821|NCT02865343|12174952|P1|STARTED|Overall Study||6
4949822|NCT02865083|12174964|P2|NOT COMPLETED|Overall Study||1
4949823|NCT02865083|12174965|P1|NOT COMPLETED|Overall Study||3
4949824|NCT02865083|12174964|P2|COMPLETED|Overall Study||0
4949825|NCT02865083|12174965|P1|COMPLETED|Overall Study||0
4949826|NCT02865083|12174964|P2|STARTED|Overall Study||1
4949827|NCT02865083|12174965|P1|STARTED|Overall Study||3
4949828|NCT02864732|12174985|P2|NOT COMPLETED|Overall Study||2
4949829|NCT02864732|12174986|P1|NOT COMPLETED|Overall Study||2
4949830|NCT02864732|12174985|P2|COMPLETED|Overall Study||13
4949831|NCT02864732|12174986|P1|COMPLETED|Overall Study||13
4949832|NCT02864732|12174985|P2|STARTED|Overall Study||15
4949833|NCT02864732|12174986|P1|STARTED|Overall Study||15
4949834|NCT02864706|12175003|P2|NOT COMPLETED|Overall Study||0
4949835|NCT02864706|12175004|P1|NOT COMPLETED|Overall Study||0
4949836|NCT02864706|12175003|P2|COMPLETED|Overall Study||47
4949837|NCT02864706|12175004|P1|COMPLETED|Overall Study||48
4949838|NCT02864706|12175003|P2|Intent to Treat|Overall Study||47
4949839|NCT02864706|12175004|P1|Intent to Treat|Overall Study||46
4949840|NCT02864706|12175003|P2|Safety Set|Overall Study||47
4949841|NCT02864706|12175004|P1|Safety Set|Overall Study||48
4949842|NCT02864706|12175003|P2|STARTED|Overall Study||47
4949843|NCT02864706|12175004|P1|STARTED|Overall Study||48
4949844|NCT02864342|12175026|P2|NOT COMPLETED|Overall Study||19
4949845|NCT02864342|12175027|P1|NOT COMPLETED|Overall Study||15
4949846|NCT02864342|12175026|P2|COMPLETED|Overall Study||49
4949847|NCT02864342|12175027|P1|COMPLETED|Overall Study||55
4949848|NCT02864342|12175026|P2|Full Analysis Set (FAS)|Overall Study||67
4949849|NCT02864342|12175027|P1|Full Analysis Set (FAS)|Overall Study||70
4949850|NCT02864342|12175026|P2|STARTED|Overall Study||68
4949851|NCT02864342|12175027|P1|STARTED|Overall Study||70
4949852|NCT02864316|12175044|P2|NOT COMPLETED|Overall Study||2
4949853|NCT02864316|12175045|P1|NOT COMPLETED|Overall Study||2
4949854|NCT02864316|12175044|P2|COMPLETED|Overall Study||0
4949855|NCT02864316|12175045|P1|COMPLETED|Overall Study||0
4949856|NCT02864316|12175044|P2|STARTED|Overall Study||2
4949857|NCT02864316|12175045|P1|STARTED|Overall Study||2
4949858|NCT02864069|12175064|P3|NOT COMPLETED|Overall Study||8
4949859|NCT02864069|12175065|P2|NOT COMPLETED|Overall Study||8
4949860|NCT02864069|12175066|P1|NOT COMPLETED|Overall Study||6
4949861|NCT02864069|12175064|P3|COMPLETED|Overall Study||13
4949862|NCT02864069|12175065|P2|COMPLETED|Overall Study||5
4949863|NCT02864069|12175066|P1|COMPLETED|Overall Study||12
4949864|NCT02864069|12175064|P3|STARTED|Overall Study||21
4949865|NCT02864069|12175065|P2|STARTED|Overall Study||13
4949866|NCT02864069|12175066|P1|STARTED|Overall Study||18
4949867|NCT02863575|12175083|P3|NOT COMPLETED|Overall Study||1
4949868|NCT02863575|12175084|P2|NOT COMPLETED|Overall Study||2
4949869|NCT02863575|12175085|P1|NOT COMPLETED|Overall Study||1
4949870|NCT02863575|12175083|P3|COMPLETED|Overall Study||51
4949871|NCT02863575|12175084|P2|COMPLETED|Overall Study||159
4949872|NCT02863575|12175085|P1|COMPLETED|Overall Study||160
4949873|NCT02863575|12175083|P3|STARTED|Overall Study||52
4949874|NCT02863575|12175084|P2|STARTED|Overall Study||161
4949875|NCT02863575|12175085|P1|STARTED|Overall Study||161
4949876|NCT02863419|12175137|P3|NOT COMPLETED|Overall Study||8
4949877|NCT02863419|12175138|P2|NOT COMPLETED|Overall Study||10
4949878|NCT02863419|12175139|P1|NOT COMPLETED|Overall Study||8
4949879|NCT02863419|12175137|P3|COMPLETED|Overall Study||134
4949880|NCT02863419|12175138|P2|COMPLETED|Overall Study||274
4949881|NCT02863419|12175139|P1|COMPLETED|Overall Study||277
4949882|NCT02863419|12175137|P3|Safety Analysis Set (SAS)|Overall Study||142
4949883|NCT02863419|12175138|P2|Safety Analysis Set (SAS)|Overall Study||284
4949884|NCT02863419|12175139|P1|Safety Analysis Set (SAS)|Overall Study||285
4949885|NCT02863419|12175137|P3|Full Analysis Set (FAS)|Overall Study||142
4949886|NCT02863419|12175138|P2|Full Analysis Set (FAS)|Overall Study||284
4949887|NCT02863419|12175139|P1|Full Analysis Set (FAS)|Overall Study||285
4949888|NCT02863419|12175137|P3|STARTED|Overall Study||142
4949889|NCT02863419|12175138|P2|STARTED|Overall Study||284
4949890|NCT02863419|12175139|P1|STARTED|Overall Study||285
4949891|NCT02863328|12175256|P2|NOT COMPLETED|Overall Study||23
4949892|NCT02863328|12175257|P1|NOT COMPLETED|Overall Study||11
4949893|NCT02863328|12175256|P2|COMPLETED|Overall Study||387
4949894|NCT02863328|12175257|P1|COMPLETED|Overall Study||400
4949895|NCT02863328|12175256|P2|Safety Analysis Set (SAS)|Overall Study||409
4949896|NCT02863328|12175257|P1|Safety Analysis Set (SAS)|Overall Study||410
4949897|NCT02863328|12175256|P2|Full Analysis Set (FAS)|Overall Study||410
4949898|NCT02863328|12175257|P1|Full Analysis Set (FAS)|Overall Study||411
4949899|NCT02863328|12175256|P2|STARTED|Overall Study||410
4949900|NCT02863328|12175257|P1|STARTED|Overall Study||411
4949901|NCT02863289|12175354|P1|NOT COMPLETED|Overall Study||83
4949902|NCT02863289|12175354|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
4949903|NCT02863289|12175354|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
4949904|NCT02863263|12175361|P2|NOT COMPLETED|Overall Study||1
4949905|NCT02863263|12175362|P1|NOT COMPLETED|Overall Study||1
4949906|NCT02863263|12175361|P2|COMPLETED|Overall Study||1
4949907|NCT02863263|12175362|P1|COMPLETED|Overall Study||2
4949908|NCT02863263|12175361|P2|STARTED|Overall Study||2
4949909|NCT02863263|12175362|P1|STARTED|Overall Study||3
4949910|NCT02863198|12175384|P2|NOT COMPLETED|Overall Study||0
4949911|NCT02863198|12175385|P1|NOT COMPLETED|Overall Study||0
4949912|NCT02863198|12175384|P2|COMPLETED|Overall Study||60
4949913|NCT02863198|12175385|P1|COMPLETED|Overall Study||60
4949914|NCT02863198|12175384|P2|STARTED|Overall Study||60
4949915|NCT02863198|12175385|P1|STARTED|Overall Study||60
4949916|NCT02862912|12175403|P2|NOT COMPLETED|Overall Study||0
4949917|NCT02862912|12175404|P1|NOT COMPLETED|Overall Study||1
4949918|NCT02862912|12175403|P2|COMPLETED|Overall Study||20
4949919|NCT02862912|12175404|P1|COMPLETED|Overall Study||22
4949920|NCT02862912|12175403|P2|STARTED|Overall Study||20
4949921|NCT02862912|12175404|P1|STARTED|Overall Study||23
4949922|NCT02862730|12175412|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949923|NCT02862730|12175413|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949924|NCT02862730|12175414|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949925|NCT02862730|12175415|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949926|NCT02862730|12175416|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949927|NCT02862730|12175417|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949928|NCT02862730|12175418|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
4949929|NCT02862730|12175412|P7|COMPLETED|Fourth Intervention (84 Hours)||1
4949930|NCT02862730|12175413|P6|COMPLETED|Fourth Intervention (84 Hours)||1
4949931|NCT02862730|12175414|P5|COMPLETED|Fourth Intervention (84 Hours)||4
4949932|NCT02862730|12175415|P4|COMPLETED|Fourth Intervention (84 Hours)||4
4949933|NCT02862730|12175416|P3|COMPLETED|Fourth Intervention (84 Hours)||6
4949934|NCT02862730|12175417|P2|COMPLETED|Fourth Intervention (84 Hours)||1
4949935|NCT02862730|12175418|P1|COMPLETED|Fourth Intervention (84 Hours)||3
4949936|NCT02862730|12175412|P7|STARTED|Fourth Intervention (84 Hours)||1
4949937|NCT02862730|12175413|P6|STARTED|Fourth Intervention (84 Hours)||1
4949938|NCT02862730|12175414|P5|STARTED|Fourth Intervention (84 Hours)||4
4949939|NCT02862730|12175415|P4|STARTED|Fourth Intervention (84 Hours)||4
4949940|NCT02862730|12175416|P3|STARTED|Fourth Intervention (84 Hours)||6
4949941|NCT02862730|12175417|P2|STARTED|Fourth Intervention (84 Hours)||1
4949942|NCT02862730|12175418|P1|STARTED|Fourth Intervention (84 Hours)||3
4949943|NCT02862730|12175412|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949944|NCT02862730|12175413|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949945|NCT02862730|12175414|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949946|NCT02862730|12175415|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949947|NCT02862730|12175416|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949948|NCT02862730|12175417|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949949|NCT02862730|12175418|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
4949950|NCT02862730|12175412|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
4949951|NCT02862730|12175413|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
4949952|NCT02862730|12175414|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
4949953|NCT02862730|12175415|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
4949954|NCT02862730|12175416|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
4949955|NCT02862730|12175417|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
4949956|NCT02862730|12175418|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
4949957|NCT02862730|12175412|P7|STARTED|Fourth Rest Period (7-45 Days)||1
4949958|NCT02862730|12175413|P6|STARTED|Fourth Rest Period (7-45 Days)||1
4949959|NCT02862730|12175414|P5|STARTED|Fourth Rest Period (7-45 Days)||4
4949960|NCT02862730|12175415|P4|STARTED|Fourth Rest Period (7-45 Days)||4
4949961|NCT02862730|12175416|P3|STARTED|Fourth Rest Period (7-45 Days)||6
4949962|NCT02862730|12175417|P2|STARTED|Fourth Rest Period (7-45 Days)||1
4949963|NCT02862730|12175418|P1|STARTED|Fourth Rest Period (7-45 Days)||3
4949964|NCT02862730|12175412|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
4949965|NCT02862730|12175413|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
4949966|NCT02862730|12175414|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
4949967|NCT02862730|12175415|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
4949968|NCT02862730|12175416|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
4949969|NCT02862730|12175417|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
4949970|NCT02862730|12175418|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
4949971|NCT02862730|12175412|P7|COMPLETED|Third Intervention (84 Hours)||1
4949972|NCT02862730|12175413|P6|COMPLETED|Third Intervention (84 Hours)||1
4949973|NCT02862730|12175414|P5|COMPLETED|Third Intervention (84 Hours)||4
4949974|NCT02862730|12175415|P4|COMPLETED|Third Intervention (84 Hours)||4
4949975|NCT02862730|12175416|P3|COMPLETED|Third Intervention (84 Hours)||6
4949976|NCT02862730|12175417|P2|COMPLETED|Third Intervention (84 Hours)||1
4949977|NCT02862730|12175418|P1|COMPLETED|Third Intervention (84 Hours)||3
4949978|NCT02862730|12175412|P7|STARTED|Third Intervention (84 Hours)||1
4949979|NCT02862730|12175413|P6|STARTED|Third Intervention (84 Hours)||1
4949980|NCT02862730|12175414|P5|STARTED|Third Intervention (84 Hours)||4
4949981|NCT02862730|12175415|P4|STARTED|Third Intervention (84 Hours)||5
4949982|NCT02862730|12175416|P3|STARTED|Third Intervention (84 Hours)||6
4949983|NCT02862730|12175417|P2|STARTED|Third Intervention (84 Hours)||1
4949984|NCT02862730|12175418|P1|STARTED|Third Intervention (84 Hours)||3
4949985|NCT02862730|12175412|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4949986|NCT02862730|12175413|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4949987|NCT02862730|12175414|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
4949988|NCT02862730|12175415|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4949989|NCT02862730|12175416|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
4949990|NCT02862730|12175417|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4949991|NCT02862730|12175418|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
4949992|NCT02862730|12175412|P7|COMPLETED|Third Rest Period (7-45 Days)||1
4949993|NCT02862730|12175413|P6|COMPLETED|Third Rest Period (7-45 Days)||1
4949994|NCT02862730|12175414|P5|COMPLETED|Third Rest Period (7-45 Days)||4
4949995|NCT02862730|12175415|P4|COMPLETED|Third Rest Period (7-45 Days)||5
4949996|NCT02862730|12175416|P3|COMPLETED|Third Rest Period (7-45 Days)||6
4949997|NCT02862730|12175417|P2|COMPLETED|Third Rest Period (7-45 Days)||1
4949998|NCT02862730|12175418|P1|COMPLETED|Third Rest Period (7-45 Days)||3
4949999|NCT02862730|12175412|P7|STARTED|Third Rest Period (7-45 Days)||1
4950000|NCT02862730|12175413|P6|STARTED|Third Rest Period (7-45 Days)||1
4950001|NCT02862730|12175414|P5|STARTED|Third Rest Period (7-45 Days)||5
4950002|NCT02862730|12175415|P4|STARTED|Third Rest Period (7-45 Days)||5
4950003|NCT02862730|12175416|P3|STARTED|Third Rest Period (7-45 Days)||7
4950004|NCT02862730|12175417|P2|STARTED|Third Rest Period (7-45 Days)||1
4950005|NCT02862730|12175418|P1|STARTED|Third Rest Period (7-45 Days)||3
4950006|NCT02862730|12175412|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
4950007|NCT02862730|12175413|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
4950008|NCT02862730|12175414|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
4950009|NCT02862730|12175415|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
4950010|NCT02862730|12175416|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
4950011|NCT02862730|12175417|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
4950012|NCT02862730|12175418|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
4950013|NCT02862730|12175412|P7|COMPLETED|Second Intervention (84 Hours)||1
4950014|NCT02862730|12175413|P6|COMPLETED|Second Intervention (84 Hours)||1
4950015|NCT02862730|12175414|P5|COMPLETED|Second Intervention (84 Hours)||5
4950016|NCT02862730|12175415|P4|COMPLETED|Second Intervention (84 Hours)||5
4950017|NCT02862730|12175416|P3|COMPLETED|Second Intervention (84 Hours)||7
4950018|NCT02862730|12175417|P2|COMPLETED|Second Intervention (84 Hours)||1
4950019|NCT02862730|12175418|P1|COMPLETED|Second Intervention (84 Hours)||3
4950020|NCT02862730|12175412|P7|STARTED|Second Intervention (84 Hours)||1
4950021|NCT02862730|12175413|P6|STARTED|Second Intervention (84 Hours)||1
4950022|NCT02862730|12175414|P5|STARTED|Second Intervention (84 Hours)||5
4950023|NCT02862730|12175415|P4|STARTED|Second Intervention (84 Hours)||5
4950024|NCT02862730|12175416|P3|STARTED|Second Intervention (84 Hours)||7
4950025|NCT02862730|12175417|P2|STARTED|Second Intervention (84 Hours)||1
4950026|NCT02862730|12175418|P1|STARTED|Second Intervention (84 Hours)||4
4950027|NCT02862730|12175412|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950028|NCT02862730|12175413|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950029|NCT02862730|12175414|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950030|NCT02862730|12175415|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950031|NCT02862730|12175416|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950032|NCT02862730|12175417|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950033|NCT02862730|12175418|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
4950034|NCT02862730|12175412|P7|COMPLETED|Second Rest Period (7-45 Days)||1
4950035|NCT02862730|12175413|P6|COMPLETED|Second Rest Period (7-45 Days)||1
4950036|NCT02862730|12175414|P5|COMPLETED|Second Rest Period (7-45 Days)||5
4950037|NCT02862730|12175415|P4|COMPLETED|Second Rest Period (7-45 Days)||5
4950038|NCT02862730|12175416|P3|COMPLETED|Second Rest Period (7-45 Days)||7
4950039|NCT02862730|12175417|P2|COMPLETED|Second Rest Period (7-45 Days)||1
4950040|NCT02862730|12175418|P1|COMPLETED|Second Rest Period (7-45 Days)||4
4950041|NCT02862730|12175412|P7|STARTED|Second Rest Period (7-45 Days)||1
4950042|NCT02862730|12175413|P6|STARTED|Second Rest Period (7-45 Days)||1
4950043|NCT02862730|12175414|P5|STARTED|Second Rest Period (7-45 Days)||5
4950044|NCT02862730|12175415|P4|STARTED|Second Rest Period (7-45 Days)||5
4950045|NCT02862730|12175416|P3|STARTED|Second Rest Period (7-45 Days)||7
4950046|NCT02862730|12175417|P2|STARTED|Second Rest Period (7-45 Days)||1
4950047|NCT02862730|12175418|P1|STARTED|Second Rest Period (7-45 Days)||4
4950048|NCT02862730|12175412|P7|NOT COMPLETED|First Intervention (84 Hours)||0
4950049|NCT02862730|12175413|P6|NOT COMPLETED|First Intervention (84 Hours)||0
4950050|NCT02862730|12175414|P5|NOT COMPLETED|First Intervention (84 Hours)||0
4950051|NCT02862730|12175415|P4|NOT COMPLETED|First Intervention (84 Hours)||0
4950052|NCT02862730|12175416|P3|NOT COMPLETED|First Intervention (84 Hours)||0
4950053|NCT02862730|12175417|P2|NOT COMPLETED|First Intervention (84 Hours)||0
4950054|NCT02862730|12175418|P1|NOT COMPLETED|First Intervention (84 Hours)||0
4950055|NCT02862730|12175412|P7|COMPLETED|First Intervention (84 Hours)||1
4950056|NCT02862730|12175413|P6|COMPLETED|First Intervention (84 Hours)||1
4950057|NCT02862730|12175414|P5|COMPLETED|First Intervention (84 Hours)||5
4950058|NCT02862730|12175415|P4|COMPLETED|First Intervention (84 Hours)||5
4950059|NCT02862730|12175416|P3|COMPLETED|First Intervention (84 Hours)||7
4950060|NCT02862730|12175417|P2|COMPLETED|First Intervention (84 Hours)||1
4950061|NCT02862730|12175418|P1|COMPLETED|First Intervention (84 Hours)||4
4950062|NCT02862730|12175412|P7|STARTED|First Intervention (84 Hours)||1
4950063|NCT02862730|12175413|P6|STARTED|First Intervention (84 Hours)||1
4950064|NCT02862730|12175414|P5|STARTED|First Intervention (84 Hours)||5
4950065|NCT02862730|12175415|P4|STARTED|First Intervention (84 Hours)||5
4950066|NCT02862730|12175416|P3|STARTED|First Intervention (84 Hours)||7
4950067|NCT02862730|12175417|P2|STARTED|First Intervention (84 Hours)||1
4950068|NCT02862730|12175418|P1|STARTED|First Intervention (84 Hours)||4
4950069|NCT02862730|12175412|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950070|NCT02862730|12175413|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950071|NCT02862730|12175414|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950072|NCT02862730|12175415|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950073|NCT02862730|12175416|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950074|NCT02862730|12175417|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950075|NCT02862730|12175418|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
4950076|NCT02862730|12175412|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
4950077|NCT02862730|12175413|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
4950078|NCT02862730|12175414|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
4950079|NCT02862730|12175415|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
4950080|NCT02862730|12175416|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
4950081|NCT02862730|12175417|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
4950082|NCT02862730|12175418|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
4950083|NCT02862730|12175412|P7|STARTED|First Rest Period (1-12 Weeks)||1
4950084|NCT02862730|12175413|P6|STARTED|First Rest Period (1-12 Weeks)||1
4950085|NCT02862730|12175414|P5|STARTED|First Rest Period (1-12 Weeks)||5
4950086|NCT02862730|12175415|P4|STARTED|First Rest Period (1-12 Weeks)||5
4950087|NCT02862730|12175416|P3|STARTED|First Rest Period (1-12 Weeks)||7
4950088|NCT02862730|12175417|P2|STARTED|First Rest Period (1-12 Weeks)||1
4950089|NCT02862730|12175418|P1|STARTED|First Rest Period (1-12 Weeks)||4
4950090|NCT02862730|12175412|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950091|NCT02862730|12175413|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950092|NCT02862730|12175414|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950093|NCT02862730|12175415|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950094|NCT02862730|12175416|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
4950095|NCT02862730|12175417|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950096|NCT02862730|12175418|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
4950097|NCT02862730|12175412|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
4950098|NCT02862730|12175413|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
4950099|NCT02862730|12175414|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
4950100|NCT02862730|12175415|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
4950101|NCT02862730|12175416|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
4950102|NCT02862730|12175417|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
4950103|NCT02862730|12175418|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
4950104|NCT02862730|12175412|P7|STARTED|Tslim Training Visit (2 Weeks)||1
4950105|NCT02862730|12175413|P6|STARTED|Tslim Training Visit (2 Weeks)||1
4950106|NCT02862730|12175414|P5|STARTED|Tslim Training Visit (2 Weeks)||5
4950107|NCT02862730|12175415|P4|STARTED|Tslim Training Visit (2 Weeks)||5
4950108|NCT02862730|12175416|P3|STARTED|Tslim Training Visit (2 Weeks)||8
4950109|NCT02862730|12175417|P2|STARTED|Tslim Training Visit (2 Weeks)||1
4950110|NCT02862730|12175418|P1|STARTED|Tslim Training Visit (2 Weeks)||4
4950111|NCT02862600|12175473|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
4950112|NCT02862600|12175473|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
4950113|NCT02862600|12175473|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
4950114|NCT02862600|12175473|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
4950115|NCT02862600|12175473|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
4950116|NCT02862600|12175473|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
4950117|NCT02862574|12175483|P3|NOT COMPLETED|Open-Label Treatment Period||1
4950118|NCT02862574|12175484|P2|NOT COMPLETED|Open-Label Treatment Period||3
4950119|NCT02862574|12175485|P1|NOT COMPLETED|Open-Label Treatment Period||2
4950120|NCT02862574|12175483|P3|COMPLETED|Open-Label Treatment Period||0
4950121|NCT02862574|12175484|P2|COMPLETED|Open-Label Treatment Period||0
4950122|NCT02862574|12175485|P1|COMPLETED|Open-Label Treatment Period||0
4950123|NCT02862574|12175483|P3|STARTED|Open-Label Treatment Period||1
4950124|NCT02862574|12175484|P2|STARTED|Open-Label Treatment Period||3
4950125|NCT02862574|12175485|P1|STARTED|Open-Label Treatment Period||2
4950126|NCT02862574|12175483|P3|NOT COMPLETED|Double-Blind Treatment Period||4
4950127|NCT02862574|12175484|P2|NOT COMPLETED|Double-Blind Treatment Period||2
4950128|NCT02862574|12175485|P1|NOT COMPLETED|Double-Blind Treatment Period||3
4950129|NCT02862574|12175483|P3|COMPLETED|Double-Blind Treatment Period||1
4950130|NCT02862574|12175484|P2|COMPLETED|Double-Blind Treatment Period||3
4950131|NCT02862574|12175485|P1|COMPLETED|Double-Blind Treatment Period||2
4950132|NCT02862574|12175483|P3|STARTED|Double-Blind Treatment Period||5
4950133|NCT02862574|12175484|P2|STARTED|Double-Blind Treatment Period||5
4950134|NCT02862574|12175485|P1|STARTED|Double-Blind Treatment Period||5
4950135|NCT02862548|12175505|P2|NOT COMPLETED|Open-Label Extension Phase||24
4950136|NCT02862548|12175506|P1|NOT COMPLETED|Open-Label Extension Phase||26
4950137|NCT02862548|12175505|P2|COMPLETED|Open-Label Extension Phase||0
4950138|NCT02862548|12175506|P1|COMPLETED|Open-Label Extension Phase||0
4950139|NCT02862548|12175505|P2|STARTED|Open-Label Extension Phase||24
4950140|NCT02862548|12175506|P1|STARTED|Open-Label Extension Phase||26
4950141|NCT02862548|12175505|P2|NOT COMPLETED|Open-Label Phase||1
4950142|NCT02862548|12175506|P1|NOT COMPLETED|Open-Label Phase||0
4950143|NCT02862548|12175505|P2|COMPLETED|Open-Label Phase||24
4950144|NCT02862548|12175506|P1|COMPLETED|Open-Label Phase||26
4950145|NCT02862548|12175505|P2|STARTED|Open-Label Phase||25
4950146|NCT02862548|12175506|P1|STARTED|Open-Label Phase||26
4950147|NCT02862106|12175536|P2|NOT COMPLETED|Overall Study||6
4950148|NCT02862106|12175537|P1|NOT COMPLETED|Overall Study||38
4950149|NCT02862106|12175536|P2|COMPLETED|Overall Study||20
4950150|NCT02862106|12175537|P1|COMPLETED|Overall Study||145
4950151|NCT02862106|12175536|P2|STARTED|Overall Study||26
4950152|NCT02862106|12175537|P1|STARTED|Overall Study||183
4950153|NCT02861807|12175597|P2|NOT COMPLETED|Overall Study||14
4950154|NCT02861807|12175598|P1|NOT COMPLETED|Overall Study||12
4950155|NCT02861807|12175597|P2|COMPLETED|Overall Study||23
4950156|NCT02861807|12175598|P1|COMPLETED|Overall Study||35
4950157|NCT02861807|12175597|P2|Attended 2-month Follow-up|Overall Study||20
4950158|NCT02861807|12175598|P1|Attended 2-month Follow-up|Overall Study||32
4950159|NCT02861807|12175597|P2|Attended Post-treatment Assessment|Overall Study||18
4950160|NCT02861807|12175598|P1|Attended Post-treatment Assessment|Overall Study||34
4950161|NCT02861807|12175597|P2|STARTED|Overall Study||37
4950162|NCT02861807|12175598|P1|STARTED|Overall Study||47
4950163|NCT02861664|12175614|P2|NOT COMPLETED|Overall Study||1
4950164|NCT02861664|12175615|P1|NOT COMPLETED|Overall Study||0
4950165|NCT02861664|12175614|P2|COMPLETED|Overall Study||67
4950166|NCT02861664|12175615|P1|COMPLETED|Overall Study||67
4950167|NCT02861664|12175614|P2|STARTED|Overall Study||68
4950168|NCT02861664|12175615|P1|STARTED|Overall Study||67
4950169|NCT02861534|12175627|P2|NOT COMPLETED|Overall Study||587
4950170|NCT02861534|12175628|P1|NOT COMPLETED|Overall Study||574
4950171|NCT02861534|12175627|P2|COMPLETED|Overall Study||1937
4950172|NCT02861534|12175628|P1|COMPLETED|Overall Study||1952
4950173|NCT02861534|12175627|P2|Treated|Overall Study||2515
4950174|NCT02861534|12175628|P1|Treated|Overall Study||2519
4950175|NCT02861534|12175627|P2|STARTED|Overall Study||2524
4950176|NCT02861534|12175628|P1|STARTED|Overall Study||2526
4950177|NCT02861131|12175654|P2|NOT COMPLETED|Overall Study||0
4950178|NCT02861131|12175655|P1|NOT COMPLETED|Overall Study||0
4950179|NCT02861131|12175654|P2|COMPLETED|Overall Study||100
4950180|NCT02861131|12175655|P1|COMPLETED|Overall Study||100
4950181|NCT02861131|12175654|P2|STARTED|Overall Study||100
4950182|NCT02861131|12175655|P1|STARTED|Overall Study||100
4950183|NCT02861118|12175673|P2|NOT COMPLETED|Overall Study||0
4950184|NCT02861118|12175674|P1|NOT COMPLETED|Overall Study||0
4950185|NCT02861118|12175673|P2|COMPLETED|Overall Study||116
4950186|NCT02861118|12175674|P1|COMPLETED|Overall Study||194
4950187|NCT02861118|12175673|P2|STARTED|Overall Study||116
4950188|NCT02861118|12175674|P1|STARTED|Overall Study||194
4950189|NCT02860845|12175688|P2|NOT COMPLETED|Overall Study||1
4950190|NCT02860845|12175689|P1|NOT COMPLETED|Overall Study||2
4950191|NCT02860845|12175688|P2|COMPLETED|Overall Study||23
4950192|NCT02860845|12175689|P1|COMPLETED|Overall Study||22
4950193|NCT02860845|12175688|P2|Analyzed Patients|Overall Study||23
4950194|NCT02860845|12175689|P1|Analyzed Patients|Overall Study||22
4950195|NCT02860845|12175688|P2|STARTED|Overall Study||24
4950196|NCT02860845|12175689|P1|STARTED|Overall Study||24
4950197|NCT02860507|12175705|P2|NOT COMPLETED|Overall Study||0
4950198|NCT02860507|12175706|P1|NOT COMPLETED|Overall Study||0
4950199|NCT02860507|12175705|P2|COMPLETED|Overall Study||25
4950200|NCT02860507|12175706|P1|COMPLETED|Overall Study||25
4950201|NCT02860507|12175705|P2|STARTED|Overall Study||25
4950202|NCT02860507|12175706|P1|STARTED|Overall Study||25
4950203|NCT02860169|12175716|P1|NOT COMPLETED|Part C||1
4950204|NCT02860169|12175716|P1|COMPLETED|Part C||47
4950205|NCT02860169|12175716|P1|Participants With Cold and Flu|Part C||42
4950206|NCT02860169|12175716|P1|Healthy Participants|Part C||6
4950207|NCT02860169|12175716|P1|STARTED|Part C||48
4950208|NCT02860169|12175716|P1|NOT COMPLETED|Part B||11
4950209|NCT02860169|12175716|P1|COMPLETED|Part B||9
4950210|NCT02860169|12175716|P1|Participants With Cold and Flu|Part B||10
4950211|NCT02860169|12175716|P1|Healthy Participants|Part B||10
4950212|NCT02860169|12175716|P1|STARTED|Part B||20
4950213|NCT02860169|12175716|P1|NOT COMPLETED|Part A||11
4950214|NCT02860169|12175716|P1|COMPLETED|Part A||35
4950215|NCT02860169|12175716|P1|Participants With Cold and Flu|Part A||0
4950216|NCT02860169|12175716|P1|Healthy Participants|Part A||46
4950217|NCT02860169|12175716|P1|STARTED|Part A||46
4950218|NCT02859597|12175734|P2|NOT COMPLETED|Overall Study||0
4950219|NCT02859597|12175735|P1|NOT COMPLETED|Overall Study||0
4950220|NCT02859597|12175734|P2|COMPLETED|Overall Study|September 2018|19
4950221|NCT02859597|12175735|P1|COMPLETED|Overall Study|September 2018|22
4950222|NCT02859597|12175734|P2|STARTED|Overall Study|Started Dec 2016|19
4950223|NCT02859597|12175735|P1|STARTED|Overall Study|started Dec 2016|22
4950224|NCT02859454|12175745|P1|NOT COMPLETED|Overall Study||1
4950225|NCT02859454|12175745|P1|COMPLETED|Overall Study||12
4950226|NCT02859454|12175745|P1|STARTED|Overall Study||13
4950227|NCT02859441|12175756|P1|NOT COMPLETED|Overall Study||0
4950228|NCT02859441|12175756|P1|COMPLETED|Overall Study||3
4950229|NCT02859441|12175756|P1|STARTED|Overall Study||3
4950230|NCT02859246|12175801|P1|NOT COMPLETED|Overall Study||5
4950231|NCT02859246|12175801|P1|COMPLETED|Overall Study|10 subjects completed the study|10
4950232|NCT02859246|12175801|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
4950233|NCT02858726|12175810|P4|NOT COMPLETED|Overall Study||3
4950234|NCT02858726|12175811|P3|NOT COMPLETED|Overall Study||11
4950235|NCT02858726|12175812|P2|NOT COMPLETED|Overall Study||7
4950236|NCT02858726|12175813|P1|NOT COMPLETED|Overall Study||5
4950237|NCT02858726|12175810|P4|COMPLETED|Overall Study||42
4950238|NCT02858726|12175811|P3|COMPLETED|Overall Study||33
4950239|NCT02858726|12175812|P2|COMPLETED|Overall Study||35
4950240|NCT02858726|12175813|P1|COMPLETED|Overall Study||39
4950241|NCT02858726|12175810|P4|STARTED|Overall Study||45
4950242|NCT02858726|12175811|P3|STARTED|Overall Study||44
4950243|NCT02858726|12175812|P2|STARTED|Overall Study||42
4950244|NCT02858726|12175813|P1|STARTED|Overall Study||44
4950245|NCT02858713|12175829|P2|NOT COMPLETED|Overall Study||5
4950246|NCT02858713|12175830|P1|NOT COMPLETED|Overall Study||7
4950247|NCT02858713|12175829|P2|COMPLETED|Overall Study||61
4950248|NCT02858713|12175830|P1|COMPLETED|Overall Study||61
4950249|NCT02858713|12175829|P2|STARTED|Overall Study||66
4950250|NCT02858713|12175830|P1|STARTED|Overall Study||68
4950251|NCT02858492|12175844|P4|NOT COMPLETED|Overall Study||6
4950252|NCT02858492|12175845|P3|NOT COMPLETED|Overall Study||0
4950253|NCT02858492|12175846|P2|NOT COMPLETED|Overall Study||1
4950254|NCT02858492|12175847|P1|NOT COMPLETED|Overall Study||0
4950255|NCT02858492|12175844|P4|COMPLETED|Overall Study||22
4950256|NCT02858492|12175845|P3|COMPLETED|Overall Study||5
4950257|NCT02858492|12175846|P2|COMPLETED|Overall Study||14
4950258|NCT02858492|12175847|P1|COMPLETED|Overall Study||3
4950259|NCT02858492|12175844|P4|STARTED|Overall Study||28
4950260|NCT02858492|12175845|P3|STARTED|Overall Study||5
4950261|NCT02858492|12175846|P2|STARTED|Overall Study||15
4950262|NCT02858492|12175847|P1|STARTED|Overall Study||3
4950263|NCT02858440|12176023|P1|NOT COMPLETED|Overall Study||12
4950264|NCT02858440|12176023|P1|COMPLETED|Overall Study||223
4950265|NCT02858440|12176023|P1|STARTED|Overall Study||235
4950266|NCT02858401|12176056|P7|NOT COMPLETED|Overall Study||0
4950267|NCT02858401|12176057|P6|NOT COMPLETED|Overall Study||1
4950268|NCT02858401|12176058|P5|NOT COMPLETED|Overall Study||0
4950269|NCT02858401|12176059|P4|NOT COMPLETED|Overall Study||0
4950270|NCT02858401|12176060|P3|NOT COMPLETED|Overall Study||0
4950271|NCT02858401|12176061|P2|NOT COMPLETED|Overall Study||1
4950272|NCT02858401|12176062|P1|NOT COMPLETED|Overall Study||0
4950273|NCT02858401|12176056|P7|COMPLETED|Overall Study||12
4950274|NCT02858401|12176057|P6|COMPLETED|Overall Study||5
4950275|NCT02858401|12176058|P5|COMPLETED|Overall Study||6
4950276|NCT02858401|12176059|P4|COMPLETED|Overall Study||6
4950277|NCT02858401|12176060|P3|COMPLETED|Overall Study||6
4950278|NCT02858401|12176061|P2|COMPLETED|Overall Study||5
4950279|NCT02858401|12176062|P1|COMPLETED|Overall Study||6
4950280|NCT02858401|12176056|P7|STARTED|Overall Study||12
4950281|NCT02858401|12176057|P6|STARTED|Overall Study||6
4950282|NCT02858401|12176058|P5|STARTED|Overall Study||6
4950283|NCT02858401|12176059|P4|STARTED|Overall Study||6
4950284|NCT02858401|12176060|P3|STARTED|Overall Study||6
4950285|NCT02858401|12176061|P2|STARTED|Overall Study||6
4950286|NCT02858401|12176062|P1|STARTED|Overall Study||6
4950287|NCT02858362|12176473|P3|NOT COMPLETED|Overall Study||3
4950288|NCT02858362|12176474|P2|NOT COMPLETED|Overall Study||1
4950289|NCT02858362|12176475|P1|NOT COMPLETED|Overall Study||2
4950290|NCT02858362|12176473|P3|COMPLETED|Overall Study||0
4950291|NCT02858362|12176474|P2|COMPLETED|Overall Study||9
4950292|NCT02858362|12176475|P1|COMPLETED|Overall Study||28
4950293|NCT02858362|12176473|P3|Did Not Enter Extension Phase|Overall Study||0
4950294|NCT02858362|12176474|P2|Did Not Enter Extension Phase|Overall Study||2
4950295|NCT02858362|12176475|P1|Did Not Enter Extension Phase|Overall Study||1
4950296|NCT02858362|12176473|P3|STARTED|Overall Study||3
4950297|NCT02858362|12176474|P2|STARTED|Overall Study||10
4950298|NCT02858362|12176475|P1|STARTED|Overall Study||30
4950299|NCT02858349|12176510|P1|NOT COMPLETED|Overall Study||0
4950300|NCT02858349|12176510|P1|COMPLETED|Overall Study||10
4950301|NCT02858349|12176510|P1|STARTED|Overall Study||10
4950302|NCT02858180|12176516|P2|NOT COMPLETED|Overall Study||2
4950303|NCT02858180|12176517|P1|NOT COMPLETED|Overall Study||0
4950304|NCT02858180|12176516|P2|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
4950305|NCT02858180|12176517|P1|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
4950306|NCT02858180|12176516|P2|STARTED|Overall Study||5
4950307|NCT02858180|12176517|P1|STARTED|Overall Study||10
4950308|NCT02858050|12176531|P2|NOT COMPLETED|Overall Study||0
4950309|NCT02858050|12176532|P1|NOT COMPLETED|Overall Study||0
4950310|NCT02858050|12176531|P2|COMPLETED|Overall Study||20
4950311|NCT02858050|12176532|P1|COMPLETED|Overall Study||20
4950312|NCT02858050|12176531|P2|STARTED|Overall Study||20
4950313|NCT02858050|12176532|P1|STARTED|Overall Study||20
4950314|NCT02857816|12176538|P1|NOT COMPLETED|Overall Study||38
4950315|NCT02857816|12176538|P1|COMPLETED|Overall Study||116
4950316|NCT02857816|12176538|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
4950317|NCT02857816|12176538|P1|STARTED|Overall Study||154
4950318|NCT02857283|12176546|P2|NOT COMPLETED|Second Exposure||0
4950319|NCT02857283|12176547|P1|NOT COMPLETED|Second Exposure||0
4950320|NCT02857283|12176546|P2|COMPLETED|Second Exposure||7
4950321|NCT02857283|12176547|P1|COMPLETED|Second Exposure||7
4950322|NCT02857283|12176546|P2|STARTED|Second Exposure||7
4950323|NCT02857283|12176547|P1|STARTED|Second Exposure||7
4950324|NCT02857283|12176546|P2|NOT COMPLETED|Washout (2 Weeks)||0
4950325|NCT02857283|12176547|P1|NOT COMPLETED|Washout (2 Weeks)||0
4950326|NCT02857283|12176546|P2|COMPLETED|Washout (2 Weeks)||7
4950327|NCT02857283|12176547|P1|COMPLETED|Washout (2 Weeks)||7
4950328|NCT02857283|12176546|P2|STARTED|Washout (2 Weeks)||7
4950329|NCT02857283|12176547|P1|STARTED|Washout (2 Weeks)||7
4950330|NCT02857283|12176546|P2|NOT COMPLETED|First Exposure||0
4950331|NCT02857283|12176547|P1|NOT COMPLETED|First Exposure||1
4950332|NCT02857283|12176546|P2|COMPLETED|First Exposure||7
4950333|NCT02857283|12176547|P1|COMPLETED|First Exposure||7
4950334|NCT02857283|12176546|P2|STARTED|First Exposure||7
4950335|NCT02857283|12176547|P1|STARTED|First Exposure||8
4950336|NCT02856880|12176573|P1|NOT COMPLETED|Overall Study||1
4950337|NCT02856880|12176573|P1|COMPLETED|Overall Study||44
4950338|NCT02856880|12176573|P1|Received SLS Negative Control|Overall Study||44
4950339|NCT02856880|12176573|P1|Received Non-SLS Negative Control|Overall Study||44
4950340|NCT02856880|12176573|P1|Received Positive Control|Overall Study||45
4950341|NCT02856880|12176573|P1|Received Test Zinc Non-IPMP|Overall Study||44
4950342|NCT02856880|12176573|P1|Received Test Zinc-IPMP|Overall Study||44
4950343|NCT02856880|12176573|P1|STARTED|Overall Study||45
4950344|NCT02856828|12176599|P2|NOT COMPLETED|Overall Study||0
4950345|NCT02856828|12176600|P1|NOT COMPLETED|Overall Study||0
4950346|NCT02856828|12176599|P2|COMPLETED|Overall Study||3
4950347|NCT02856828|12176600|P1|COMPLETED|Overall Study||2
4950348|NCT02856828|12176599|P2|STARTED|Overall Study||3
4950349|NCT02856828|12176600|P1|STARTED|Overall Study||2
4950350|NCT02856555|12176617|P3|NOT COMPLETED|Overall Study||0
4950351|NCT02856555|12176618|P2|NOT COMPLETED|Overall Study||4
4950352|NCT02856555|12176619|P1|NOT COMPLETED|Overall Study||5
4950353|NCT02856555|12176617|P3|COMPLETED|Overall Study||26
4950354|NCT02856555|12176618|P2|COMPLETED|Overall Study||46
4950355|NCT02856555|12176619|P1|COMPLETED|Overall Study||46
4950356|NCT02856555|12176617|P3|STARTED|Overall Study||26
4950357|NCT02856555|12176618|P2|STARTED|Overall Study||50
4950358|NCT02856555|12176619|P1|STARTED|Overall Study||51
4950359|NCT02856282|12176627|P1|NOT COMPLETED|Overall Study||1
4950360|NCT02856282|12176627|P1|COMPLETED|Overall Study||45
4950361|NCT02856282|12176627|P1|STARTED|Overall Study||46
4950362|NCT02856035|12176637|P1|NOT COMPLETED|Overall Study||0
4950363|NCT02856035|12176637|P1|COMPLETED|Overall Study||4
4950364|NCT02856035|12176637|P1|STARTED|Overall Study||4
4950365|NCT02855567|12176644|P2|NOT COMPLETED|Overall Study||0
4950366|NCT02855567|12176645|P1|NOT COMPLETED|Overall Study||0
4950367|NCT02855567|12176644|P2|COMPLETED|Overall Study||56
4950368|NCT02855567|12176645|P1|COMPLETED|Overall Study||54
4950369|NCT02855567|12176644|P2|STARTED|Overall Study||56
4950370|NCT02855567|12176645|P1|STARTED|Overall Study||54
4950371|NCT02855541|12176659|P1|NOT COMPLETED|Overall Study||4
4950372|NCT02855541|12176659|P1|COMPLETED|Overall Study||21
4950373|NCT02855541|12176659|P1|STARTED|Overall Study||25
4950374|NCT02855437|12176670|P2|NOT COMPLETED|Phase 2||1
4950375|NCT02855437|12176671|P1|NOT COMPLETED|Phase 2||1
4950376|NCT02855437|12176670|P2|COMPLETED|Phase 2||18
4950377|NCT02855437|12176671|P1|COMPLETED|Phase 2||20
4950378|NCT02855437|12176670|P2|STARTED|Phase 2||19
4950379|NCT02855437|12176671|P1|STARTED|Phase 2||21
4950380|NCT02855437|12176670|P2|NOT COMPLETED|Crossover Period (Same Day)||0
4950381|NCT02855437|12176671|P1|NOT COMPLETED|Crossover Period (Same Day)||0
4950382|NCT02855437|12176670|P2|COMPLETED|Crossover Period (Same Day)||19
4950383|NCT02855437|12176671|P1|COMPLETED|Crossover Period (Same Day)||21
4950384|NCT02855437|12176670|P2|STARTED|Crossover Period (Same Day)||19
4950385|NCT02855437|12176671|P1|STARTED|Crossover Period (Same Day)||21
4950386|NCT02855437|12176670|P2|NOT COMPLETED|Phase 1||2
4950387|NCT02855437|12176671|P1|NOT COMPLETED|Phase 1||2
4950388|NCT02855437|12176670|P2|COMPLETED|Phase 1||19
4950389|NCT02855437|12176671|P1|COMPLETED|Phase 1||21
4950390|NCT02855437|12176670|P2|STARTED|Phase 1||21
4950391|NCT02855437|12176671|P1|STARTED|Phase 1||23
4950392|NCT02855411|12176679|P1|NOT COMPLETED|Overall Study||35
4950393|NCT02855411|12176679|P1|COMPLETED|Overall Study||0
4950394|NCT02855411|12176679|P1|Assigned to Study Treatment|Overall Study||0
4950395|NCT02855411|12176679|P1|STARTED|Overall Study||35
4950396|NCT02855359|12176701|P4|NOT COMPLETED|Overall Study||0
4950397|NCT02855359|12176702|P3|NOT COMPLETED|Overall Study||0
4950398|NCT02855359|12176703|P2|NOT COMPLETED|Overall Study||13
4950399|NCT02855359|12176704|P1|NOT COMPLETED|Overall Study||11
4950400|NCT02855359|12176701|P4|COMPLETED|Overall Study||0
4950401|NCT02855359|12176702|P3|COMPLETED|Overall Study||0
4950402|NCT02855359|12176703|P2|COMPLETED|Overall Study||0
4950403|NCT02855359|12176704|P1|COMPLETED|Overall Study||0
4950404|NCT02855359|12176701|P4|STARTED|Overall Study||0
4950405|NCT02855359|12176702|P3|STARTED|Overall Study||0
4950406|NCT02855359|12176703|P2|STARTED|Overall Study||13
4950407|NCT02855359|12176704|P1|STARTED|Overall Study||11
4950408|NCT02855086|12176738|P2|NOT COMPLETED|Overall Study||0
4950409|NCT02855086|12176739|P1|NOT COMPLETED|Overall Study||0
4950410|NCT02855086|12176738|P2|COMPLETED|Overall Study||1
4950411|NCT02855086|12176739|P1|COMPLETED|Overall Study||2
4950412|NCT02855086|12176738|P2|STARTED|Overall Study||1
4950413|NCT02855086|12176739|P1|STARTED|Overall Study||2
4950414|NCT02854631|12176749|P2|NOT COMPLETED|Overall Study||15
4950415|NCT02854631|12176750|P1|NOT COMPLETED|Overall Study||26
4950416|NCT02854631|12176749|P2|COMPLETED|Overall Study||37
4950417|NCT02854631|12176750|P1|COMPLETED|Overall Study||26
4950418|NCT02854631|12176749|P2|STARTED|Overall Study||52
4950419|NCT02854631|12176750|P1|STARTED|Overall Study||52
4950420|NCT02854605|12176811|P3|NOT COMPLETED|Overall Study||4
4950421|NCT02854605|12176812|P2|NOT COMPLETED|Overall Study||7
4950422|NCT02854605|12176813|P1|NOT COMPLETED|Overall Study||3
4950423|NCT02854605|12176811|P3|COMPLETED|Overall Study||24
4950424|NCT02854605|12176812|P2|COMPLETED|Overall Study||49
4950425|NCT02854605|12176813|P1|COMPLETED|Overall Study||53
4950426|NCT02854605|12176811|P3|STARTED|Overall Study||28
4950427|NCT02854605|12176812|P2|STARTED|Overall Study||56
4950428|NCT02854605|12176813|P1|STARTED|Overall Study||56
4950429|NCT02854540|12176824|P1|NOT COMPLETED|Overall Study||2
4950430|NCT02854540|12176824|P1|COMPLETED|Overall Study||11
4950431|NCT02854540|12176824|P1|STARTED|Overall Study||13
4950432|NCT02854527|12176843|P10|NOT COMPLETED|Overall Study||0
4950433|NCT02854527|12176844|P9|NOT COMPLETED|Overall Study||0
4950434|NCT02854527|12176845|P8|NOT COMPLETED|Overall Study||0
4950435|NCT02854527|12176846|P7|NOT COMPLETED|Overall Study||0
4950436|NCT02854527|12176847|P6|NOT COMPLETED|Overall Study||0
4950437|NCT02854527|12176848|P5|NOT COMPLETED|Overall Study||1
4950438|NCT02854527|12176849|P4|NOT COMPLETED|Overall Study||1
4950439|NCT02854527|12176850|P3|NOT COMPLETED|Overall Study||0
4950440|NCT02854527|12176851|P2|NOT COMPLETED|Overall Study||0
4950441|NCT02854527|12176852|P1|NOT COMPLETED|Overall Study||0
4950442|NCT02854527|12176843|P10|COMPLETED|Overall Study||3
4950443|NCT02854527|12176844|P9|COMPLETED|Overall Study||3
4950444|NCT02854527|12176845|P8|COMPLETED|Overall Study||3
4950445|NCT02854527|12176846|P7|COMPLETED|Overall Study||3
4950446|NCT02854527|12176847|P6|COMPLETED|Overall Study||3
4950447|NCT02854527|12176848|P5|COMPLETED|Overall Study||2
4950448|NCT02854527|12176849|P4|COMPLETED|Overall Study||2
4950449|NCT02854527|12176850|P3|COMPLETED|Overall Study||3
4950450|NCT02854527|12176851|P2|COMPLETED|Overall Study||3
4950451|NCT02854527|12176852|P1|COMPLETED|Overall Study||3
4950452|NCT02854527|12176843|P10|Received T|Overall Study||3
4950453|NCT02854527|12176844|P9|Received T|Overall Study||3
4950454|NCT02854527|12176845|P8|Received T|Overall Study||3
4950455|NCT02854527|12176846|P7|Received T|Overall Study||3
4950456|NCT02854527|12176847|P6|Received T|Overall Study||3
4950457|NCT02854527|12176848|P5|Received T|Overall Study||2
4950458|NCT02854527|12176849|P4|Received T|Overall Study||2
4950459|NCT02854527|12176850|P3|Received T|Overall Study||3
4950460|NCT02854527|12176851|P2|Received T|Overall Study||3
4950461|NCT02854527|12176852|P1|Received T|Overall Study||3
4950462|NCT02854527|12176843|P10|Received R4|Overall Study||3
4950463|NCT02854527|12176844|P9|Received R4|Overall Study||3
4950464|NCT02854527|12176845|P8|Received R4|Overall Study||3
4950465|NCT02854527|12176846|P7|Received R4|Overall Study||3
4950466|NCT02854527|12176847|P6|Received R4|Overall Study||3
4950467|NCT02854527|12176848|P5|Received R4|Overall Study||3
4950468|NCT02854527|12176849|P4|Received R4|Overall Study||2
4950469|NCT02854527|12176850|P3|Received R4|Overall Study||3
4950470|NCT02854527|12176851|P2|Received R4|Overall Study||3
4950471|NCT02854527|12176852|P1|Received R4|Overall Study||3
4950472|NCT02854527|12176843|P10|Received R3|Overall Study||3
4950473|NCT02854527|12176844|P9|Received R3|Overall Study||3
4950474|NCT02854527|12176845|P8|Received R3|Overall Study||3
4950475|NCT02854527|12176846|P7|Received R3|Overall Study||3
4950476|NCT02854527|12176847|P6|Received R3|Overall Study||3
4950477|NCT02854527|12176848|P5|Received R3|Overall Study||3
4950478|NCT02854527|12176849|P4|Received R3|Overall Study||2
4950479|NCT02854527|12176850|P3|Received R3|Overall Study||3
4950480|NCT02854527|12176851|P2|Received R3|Overall Study||3
4950481|NCT02854527|12176852|P1|Received R3|Overall Study||3
4950482|NCT02854527|12176843|P10|Received R2|Overall Study||3
4950483|NCT02854527|12176844|P9|Received R2|Overall Study||3
4950484|NCT02854527|12176845|P8|Received R2|Overall Study||3
4950485|NCT02854527|12176846|P7|Received R2|Overall Study||3
4950486|NCT02854527|12176847|P6|Received R2|Overall Study||3
4950487|NCT02854527|12176848|P5|Received R2|Overall Study||3
4950488|NCT02854527|12176849|P4|Received R2|Overall Study||3
4950489|NCT02854527|12176850|P3|Received R2|Overall Study||3
4950490|NCT02854527|12176851|P2|Received R2|Overall Study||3
4950491|NCT02854527|12176852|P1|Received R2|Overall Study||3
4950492|NCT02854527|12176843|P10|Received R1|Overall Study||3
4950493|NCT02854527|12176844|P9|Received R1|Overall Study||3
4950494|NCT02854527|12176845|P8|Received R1|Overall Study||3
4950495|NCT02854527|12176846|P7|Received R1|Overall Study||3
4950496|NCT02854527|12176847|P6|Received R1|Overall Study||3
4950497|NCT02854527|12176848|P5|Received R1|Overall Study||2
4950498|NCT02854527|12176849|P4|Received R1|Overall Study||2
4950499|NCT02854527|12176850|P3|Received R1|Overall Study||3
4950500|NCT02854527|12176851|P2|Received R1|Overall Study||3
4950501|NCT02854527|12176852|P1|Received R1|Overall Study||3
4950502|NCT02854527|12176843|P10|STARTED|Overall Study||3
4950503|NCT02854527|12176844|P9|STARTED|Overall Study||3
4950504|NCT02854527|12176845|P8|STARTED|Overall Study||3
4950505|NCT02854527|12176846|P7|STARTED|Overall Study||3
4950506|NCT02854527|12176847|P6|STARTED|Overall Study||3
4950507|NCT02854527|12176848|P5|STARTED|Overall Study||3
4950508|NCT02854527|12176849|P4|STARTED|Overall Study||3
4950509|NCT02854527|12176850|P3|STARTED|Overall Study||3
4950510|NCT02854527|12176851|P2|STARTED|Overall Study||3
4950511|NCT02854527|12176852|P1|STARTED|Overall Study||3
4950512|NCT02854059|12176885|P2|NOT COMPLETED|Overall Study||0
4950513|NCT02854059|12176886|P1|NOT COMPLETED|Overall Study||0
4950514|NCT02854059|12176885|P2|COMPLETED|Overall Study||0
4950515|NCT02854059|12176886|P1|COMPLETED|Overall Study||2
4950516|NCT02854059|12176885|P2|STARTED|Overall Study||0
4950517|NCT02854059|12176886|P1|STARTED|Overall Study||2
4950518|NCT02853929|12176910|P2|NOT COMPLETED|Overall Study||4
4950519|NCT02853929|12176911|P1|NOT COMPLETED|Overall Study||11
4950520|NCT02853929|12176910|P2|COMPLETED|Overall Study||277
4950521|NCT02853929|12176911|P1|COMPLETED|Overall Study||259
4950522|NCT02853929|12176910|P2|Vaccinated|Overall Study||277
4950523|NCT02853929|12176911|P1|Vaccinated|Overall Study||263
4950524|NCT02853929|12176910|P2|STARTED|Overall Study||281
4950525|NCT02853929|12176911|P1|STARTED|Overall Study||270
4950526|NCT02853435|12176952|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950527|NCT02853435|12176953|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950528|NCT02853435|12176954|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950529|NCT02853435|12176955|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950530|NCT02853435|12176956|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950531|NCT02853435|12176957|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
4950532|NCT02853435|12176952|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
4950533|NCT02853435|12176953|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
4950534|NCT02853435|12176954|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
4950535|NCT02853435|12176955|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
4950536|NCT02853435|12176956|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
4950537|NCT02853435|12176957|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
4950538|NCT02853435|12176952|P6|STARTED|Part 3, Period 3 (3 Days)||2
4950539|NCT02853435|12176953|P5|STARTED|Part 3, Period 3 (3 Days)||9
4950540|NCT02853435|12176954|P4|STARTED|Part 3, Period 3 (3 Days)||0
4950541|NCT02853435|12176955|P3|STARTED|Part 3, Period 3 (3 Days)||0
4950542|NCT02853435|12176956|P2|STARTED|Part 3, Period 3 (3 Days)||0
4950543|NCT02853435|12176957|P1|STARTED|Part 3, Period 3 (3 Days)||0
4950544|NCT02853435|12176952|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950545|NCT02853435|12176953|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
4950546|NCT02853435|12176954|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950547|NCT02853435|12176955|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950548|NCT02853435|12176956|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950549|NCT02853435|12176957|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950550|NCT02853435|12176952|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
4950551|NCT02853435|12176953|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
4950552|NCT02853435|12176954|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950553|NCT02853435|12176955|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950554|NCT02853435|12176956|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950555|NCT02853435|12176957|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
4950556|NCT02853435|12176952|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
4950557|NCT02853435|12176953|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
4950558|NCT02853435|12176954|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
4950559|NCT02853435|12176955|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
4950560|NCT02853435|12176956|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
4950561|NCT02853435|12176957|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
4950562|NCT02853435|12176952|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950563|NCT02853435|12176953|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950564|NCT02853435|12176954|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950565|NCT02853435|12176955|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950566|NCT02853435|12176956|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950567|NCT02853435|12176957|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
4950568|NCT02853435|12176952|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
4950569|NCT02853435|12176953|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
4950570|NCT02853435|12176954|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
4950571|NCT02853435|12176955|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
4950572|NCT02853435|12176956|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
4950573|NCT02853435|12176957|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
4950574|NCT02853435|12176952|P6|STARTED|Part 3, Period 2 (3 Days)||2
4950575|NCT02853435|12176953|P5|STARTED|Part 3, Period 2 (3 Days)||10
4950576|NCT02853435|12176954|P4|STARTED|Part 3, Period 2 (3 Days)||0
4950577|NCT02853435|12176955|P3|STARTED|Part 3, Period 2 (3 Days)||0
4950578|NCT02853435|12176956|P2|STARTED|Part 3, Period 2 (3 Days)||0
4950579|NCT02853435|12176957|P1|STARTED|Part 3, Period 2 (3 Days)||0
4950580|NCT02853435|12176952|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950581|NCT02853435|12176953|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950582|NCT02853435|12176954|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950583|NCT02853435|12176955|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950584|NCT02853435|12176956|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950585|NCT02853435|12176957|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950586|NCT02853435|12176952|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
4950587|NCT02853435|12176953|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
4950588|NCT02853435|12176954|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950589|NCT02853435|12176955|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950590|NCT02853435|12176956|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950591|NCT02853435|12176957|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
4950592|NCT02853435|12176952|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
4950593|NCT02853435|12176953|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
4950594|NCT02853435|12176954|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
4950595|NCT02853435|12176955|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
4950596|NCT02853435|12176956|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
4950597|NCT02853435|12176957|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
4950598|NCT02853435|12176952|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950599|NCT02853435|12176953|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950600|NCT02853435|12176954|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950601|NCT02853435|12176955|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950602|NCT02853435|12176956|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950603|NCT02853435|12176957|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
4950604|NCT02853435|12176952|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
4950605|NCT02853435|12176953|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
4950606|NCT02853435|12176954|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
4950607|NCT02853435|12176955|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
4950608|NCT02853435|12176956|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
4950609|NCT02853435|12176957|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
4950610|NCT02853435|12176952|P6|STARTED|Part 3, Period 1 (3 Days)||2
4950611|NCT02853435|12176953|P5|STARTED|Part 3, Period 1 (3 Days)||10
4950612|NCT02853435|12176954|P4|STARTED|Part 3, Period 1 (3 Days)||0
4950613|NCT02853435|12176955|P3|STARTED|Part 3, Period 1 (3 Days)||0
4950614|NCT02853435|12176956|P2|STARTED|Part 3, Period 1 (3 Days)||0
4950615|NCT02853435|12176957|P1|STARTED|Part 3, Period 1 (3 Days)||0
4950616|NCT02853435|12176952|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950617|NCT02853435|12176953|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950618|NCT02853435|12176954|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950619|NCT02853435|12176955|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950620|NCT02853435|12176956|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950621|NCT02853435|12176957|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
4950622|NCT02853435|12176952|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
4950623|NCT02853435|12176953|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
4950624|NCT02853435|12176954|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
4950625|NCT02853435|12176955|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
4950626|NCT02853435|12176956|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
4950627|NCT02853435|12176957|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
4950628|NCT02853435|12176952|P6|STARTED|Part 2, Period 2 (3 Days)||0
4950629|NCT02853435|12176953|P5|STARTED|Part 2, Period 2 (3 Days)||0
4950630|NCT02853435|12176954|P4|STARTED|Part 2, Period 2 (3 Days)||10
4950631|NCT02853435|12176955|P3|STARTED|Part 2, Period 2 (3 Days)||0
4950632|NCT02853435|12176956|P2|STARTED|Part 2, Period 2 (3 Days)||0
4950633|NCT02853435|12176957|P1|STARTED|Part 2, Period 2 (3 Days)||0
4950634|NCT02853435|12176952|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950635|NCT02853435|12176953|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950636|NCT02853435|12176954|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950637|NCT02853435|12176955|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950638|NCT02853435|12176956|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950639|NCT02853435|12176957|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950640|NCT02853435|12176952|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950641|NCT02853435|12176953|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950642|NCT02853435|12176954|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
4950643|NCT02853435|12176955|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950644|NCT02853435|12176956|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950645|NCT02853435|12176957|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
4950646|NCT02853435|12176952|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
4950647|NCT02853435|12176953|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
4950648|NCT02853435|12176954|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
4950649|NCT02853435|12176955|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
4950650|NCT02853435|12176956|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
4950651|NCT02853435|12176957|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
4950652|NCT02853435|12176952|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950653|NCT02853435|12176953|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950654|NCT02853435|12176954|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950655|NCT02853435|12176955|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950656|NCT02853435|12176956|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950657|NCT02853435|12176957|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
4950658|NCT02853435|12176952|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
4950659|NCT02853435|12176953|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
4950660|NCT02853435|12176954|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
4950661|NCT02853435|12176955|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
4950662|NCT02853435|12176956|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
4950663|NCT02853435|12176957|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
4950664|NCT02853435|12176952|P6|STARTED|Part 2, Period 1 (3 Days)||0
4950665|NCT02853435|12176953|P5|STARTED|Part 2, Period 1 (3 Days)||0
4950666|NCT02853435|12176954|P4|STARTED|Part 2, Period 1 (3 Days)||10
4950667|NCT02853435|12176955|P3|STARTED|Part 2, Period 1 (3 Days)||0
4950668|NCT02853435|12176956|P2|STARTED|Part 2, Period 1 (3 Days)||0
4950669|NCT02853435|12176957|P1|STARTED|Part 2, Period 1 (3 Days)||0
4950670|NCT02853435|12176952|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950671|NCT02853435|12176953|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950672|NCT02853435|12176954|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950673|NCT02853435|12176955|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950674|NCT02853435|12176956|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950675|NCT02853435|12176957|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
4950676|NCT02853435|12176952|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
4950677|NCT02853435|12176953|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
4950678|NCT02853435|12176954|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
4950679|NCT02853435|12176955|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
4950680|NCT02853435|12176956|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
4950681|NCT02853435|12176957|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
4950682|NCT02853435|12176952|P6|STARTED|Part 1a, Period 3 (3 Days)||0
4950683|NCT02853435|12176953|P5|STARTED|Part 1a, Period 3 (3 Days)||0
4950684|NCT02853435|12176954|P4|STARTED|Part 1a, Period 3 (3 Days)||0
4950685|NCT02853435|12176955|P3|STARTED|Part 1a, Period 3 (3 Days)||8
4950686|NCT02853435|12176956|P2|STARTED|Part 1a, Period 3 (3 Days)||9
4950687|NCT02853435|12176957|P1|STARTED|Part 1a, Period 3 (3 Days)||9
4950688|NCT02853435|12176952|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950689|NCT02853435|12176953|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950690|NCT02853435|12176954|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950691|NCT02853435|12176955|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950692|NCT02853435|12176956|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950693|NCT02853435|12176957|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950694|NCT02853435|12176952|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950695|NCT02853435|12176953|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950696|NCT02853435|12176954|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
4950697|NCT02853435|12176955|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
4950698|NCT02853435|12176956|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
4950699|NCT02853435|12176957|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
4950700|NCT02853435|12176952|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
4950701|NCT02853435|12176953|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
4950702|NCT02853435|12176954|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
4950703|NCT02853435|12176955|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
4950704|NCT02853435|12176956|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
4950705|NCT02853435|12176957|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
4950706|NCT02853435|12176952|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950707|NCT02853435|12176953|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950708|NCT02853435|12176954|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950709|NCT02853435|12176955|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950710|NCT02853435|12176956|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950711|NCT02853435|12176957|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
4950712|NCT02853435|12176952|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
4950713|NCT02853435|12176953|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
4950714|NCT02853435|12176954|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
4950715|NCT02853435|12176955|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
4950716|NCT02853435|12176956|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
4950717|NCT02853435|12176957|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
4950718|NCT02853435|12176952|P6|STARTED|Part 1a, Period 2 (3 Days)||0
4950719|NCT02853435|12176953|P5|STARTED|Part 1a, Period 2 (3 Days)||0
4950720|NCT02853435|12176954|P4|STARTED|Part 1a, Period 2 (3 Days)||0
4950721|NCT02853435|12176955|P3|STARTED|Part 1a, Period 2 (3 Days)||8
4950722|NCT02853435|12176956|P2|STARTED|Part 1a, Period 2 (3 Days)||9
4950723|NCT02853435|12176957|P1|STARTED|Part 1a, Period 2 (3 Days)||9
4950724|NCT02853435|12176952|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950725|NCT02853435|12176953|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950726|NCT02853435|12176954|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950727|NCT02853435|12176955|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950728|NCT02853435|12176956|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950729|NCT02853435|12176957|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950730|NCT02853435|12176952|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950731|NCT02853435|12176953|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950732|NCT02853435|12176954|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
4950733|NCT02853435|12176955|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
4950734|NCT02853435|12176956|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
4950735|NCT02853435|12176957|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
4950736|NCT02853435|12176952|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
4950737|NCT02853435|12176953|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
4950738|NCT02853435|12176954|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
4950739|NCT02853435|12176955|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
4950740|NCT02853435|12176956|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
4950741|NCT02853435|12176957|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
4950742|NCT02853435|12176952|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950743|NCT02853435|12176953|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950744|NCT02853435|12176954|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950745|NCT02853435|12176955|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950746|NCT02853435|12176956|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950747|NCT02853435|12176957|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
4950748|NCT02853435|12176952|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
4950749|NCT02853435|12176953|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
4950750|NCT02853435|12176954|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
4950751|NCT02853435|12176955|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
4950752|NCT02853435|12176956|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
4950753|NCT02853435|12176957|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
4950754|NCT02853435|12176952|P6|STARTED|Part 1a, Period 1 (3 Days)||0
4950755|NCT02853435|12176953|P5|STARTED|Part 1a, Period 1 (3 Days)||0
4950756|NCT02853435|12176954|P4|STARTED|Part 1a, Period 1 (3 Days)||0
4950757|NCT02853435|12176955|P3|STARTED|Part 1a, Period 1 (3 Days)||8
4950758|NCT02853435|12176956|P2|STARTED|Part 1a, Period 1 (3 Days)||9
4950759|NCT02853435|12176957|P1|STARTED|Part 1a, Period 1 (3 Days)||9
4950760|NCT02853331|12177267|P2|NOT COMPLETED|Overall Study||429
4950761|NCT02853331|12177268|P1|NOT COMPLETED|Overall Study||432
4950762|NCT02853331|12177267|P2|COMPLETED|Overall Study||0
4950763|NCT02853331|12177268|P1|COMPLETED|Overall Study||0
4950764|NCT02853331|12177267|P2|Treated|Overall Study||425
4950765|NCT02853331|12177268|P1|Treated|Overall Study||429
4950766|NCT02853331|12177267|P2|STARTED|Overall Study||429
4950767|NCT02853331|12177268|P1|STARTED|Overall Study||432
4950768|NCT02853123|12177300|P2|NOT COMPLETED|Treatment Period 2||0
4950769|NCT02853123|12177301|P1|NOT COMPLETED|Treatment Period 2||0
4950770|NCT02853123|12177300|P2|COMPLETED|Treatment Period 2||48
4950771|NCT02853123|12177301|P1|COMPLETED|Treatment Period 2||51
4950772|NCT02853123|12177300|P2|STARTED|Treatment Period 2||48
4950773|NCT02853123|12177301|P1|STARTED|Treatment Period 2||51
4950774|NCT02853123|12177300|P2|NOT COMPLETED|Washout Period||3
4950775|NCT02853123|12177301|P1|NOT COMPLETED|Washout Period||1
4950776|NCT02853123|12177300|P2|COMPLETED|Washout Period||48
4950777|NCT02853123|12177301|P1|COMPLETED|Washout Period||51
4950778|NCT02853123|12177300|P2|STARTED|Washout Period||51
4950779|NCT02853123|12177301|P1|STARTED|Washout Period||52
4950780|NCT02853123|12177300|P2|NOT COMPLETED|Treatment Period 1||3
4950781|NCT02853123|12177301|P1|NOT COMPLETED|Treatment Period 1||0
4950782|NCT02853123|12177300|P2|COMPLETED|Treatment Period 1||51
4950783|NCT02853123|12177301|P1|COMPLETED|Treatment Period 1||52
4950784|NCT02853123|12177300|P2|STARTED|Treatment Period 1||54
4950785|NCT02853123|12177301|P1|STARTED|Treatment Period 1||52
4950786|NCT02852434|12177324|P2|NOT COMPLETED|Overall Study||1
4950787|NCT02852434|12177325|P1|NOT COMPLETED|Overall Study||2
4950788|NCT02852434|12177324|P2|COMPLETED|Overall Study||35
4950789|NCT02852434|12177325|P1|COMPLETED|Overall Study||34
4950790|NCT02852434|12177324|P2|STARTED|Overall Study||36
4950791|NCT02852434|12177325|P1|STARTED|Overall Study||36
4950792|NCT02852265|12177341|P2|NOT COMPLETED|6-month Follow-up||0
4950793|NCT02852265|12177342|P1|NOT COMPLETED|6-month Follow-up||0
4950794|NCT02852265|12177341|P2|COMPLETED|6-month Follow-up||9
4950795|NCT02852265|12177342|P1|COMPLETED|6-month Follow-up||9
4950796|NCT02852265|12177341|P2|STARTED|6-month Follow-up||9
4950797|NCT02852265|12177342|P1|STARTED|6-month Follow-up||9
4950798|NCT02852265|12177341|P2|NOT COMPLETED|3-month Follow-up||1
4950799|NCT02852265|12177342|P1|NOT COMPLETED|3-month Follow-up||1
4950800|NCT02852265|12177341|P2|COMPLETED|3-month Follow-up||9
4950801|NCT02852265|12177342|P1|COMPLETED|3-month Follow-up||9
4950802|NCT02852265|12177341|P2|STARTED|3-month Follow-up||10
4950803|NCT02852265|12177342|P1|STARTED|3-month Follow-up||10
4950804|NCT02852265|12177341|P2|NOT COMPLETED|1-month Follow-up||0
4950805|NCT02852265|12177342|P1|NOT COMPLETED|1-month Follow-up||0
4950806|NCT02852265|12177341|P2|COMPLETED|1-month Follow-up||10
4950807|NCT02852265|12177342|P1|COMPLETED|1-month Follow-up||10
4950808|NCT02852265|12177341|P2|STARTED|1-month Follow-up||10
4950809|NCT02852265|12177342|P1|STARTED|1-month Follow-up||10
4950810|NCT02851823|12177358|P1|NOT COMPLETED|Overall Study||0
4950811|NCT02851823|12177358|P1|COMPLETED|Overall Study||25
4950812|NCT02851823|12177358|P1|3 Months|Overall Study||25
4950813|NCT02851823|12177358|P1|1 Month|Overall Study||25
4950814|NCT02851823|12177358|P1|STARTED|Overall Study||25
4950815|NCT02851108|12177368|P2|NOT COMPLETED|Overall Study||1
4950816|NCT02851108|12177369|P1|NOT COMPLETED|Overall Study||8
4950817|NCT02851108|12177368|P2|COMPLETED|Overall Study||49
4950818|NCT02851108|12177369|P1|COMPLETED|Overall Study||42
4950819|NCT02851108|12177368|P2|STARTED|Overall Study||50
4950820|NCT02851108|12177369|P1|STARTED|Overall Study||50
4950821|NCT02851069|12177375|P1|NOT COMPLETED|Overall Study||6
4950822|NCT02851069|12177375|P1|COMPLETED|Overall Study||59
4950823|NCT02851069|12177375|P1|STARTED|Overall Study||65
4950824|NCT02850978|12177397|P1|NOT COMPLETED|Overall Study||426
4950825|NCT02850978|12177397|P1|COMPLETED|Overall Study||909
4950826|NCT02850978|12177397|P1|Treated|Overall Study||1308
4950827|NCT02850978|12177397|P1|Case Report Form (CRF) Collected|Overall Study||1308
4950828|NCT02850978|12177397|P1|STARTED|Overall Study||1335
4950829|NCT02850965|12177404|P2|NOT COMPLETED|Overall Study||25
4950830|NCT02850965|12177405|P1|NOT COMPLETED|Overall Study||18
4950831|NCT02850965|12177404|P2|COMPLETED|Overall Study||134
4950832|NCT02850965|12177405|P1|COMPLETED|Overall Study||141
4950833|NCT02850965|12177404|P2|Treated|Overall Study||158
4950834|NCT02850965|12177405|P1|Treated|Overall Study||159
4950835|NCT02850965|12177404|P2|STARTED|Overall Study||159
4950836|NCT02850965|12177405|P1|STARTED|Overall Study||159
4950837|NCT02850276|12177421|P1|NOT COMPLETED|Overall Study||61
4950838|NCT02850276|12177421|P1|COMPLETED|Overall Study||15
4950839|NCT02850276|12177421|P1|STARTED|Overall Study||76
4950840|NCT02850159|12177434|P2|NOT COMPLETED|Overall Study||0
4950841|NCT02850159|12177435|P1|NOT COMPLETED|Overall Study||0
4950842|NCT02850159|12177434|P2|COMPLETED|Overall Study||16
4950843|NCT02850159|12177435|P1|COMPLETED|Overall Study||16
4950844|NCT02850159|12177434|P2|STARTED|Overall Study||16
4950845|NCT02850159|12177435|P1|STARTED|Overall Study||16
4950846|NCT02850068|12177441|P1|NOT COMPLETED|Overall Study||20
4950847|NCT02850068|12177441|P1|COMPLETED|Overall Study||0
4950848|NCT02850068|12177441|P1|STARTED|Overall Study||20
4950849|NCT02849990|12177448|P1|NOT COMPLETED|Overall Study||2
4950850|NCT02849990|12177448|P1|COMPLETED|Overall Study||20
4950851|NCT02849990|12177448|P1|STARTED|Overall Study||22
4950852|NCT02849938|12177460|P2|NOT COMPLETED|Overall Study||0
4950853|NCT02849938|12177461|P1|NOT COMPLETED|Overall Study||0
4950854|NCT02849938|12177460|P2|COMPLETED|Overall Study||15
4950855|NCT02849938|12177461|P1|COMPLETED|Overall Study||9
4950856|NCT02849938|12177460|P2|STARTED|Overall Study||15
4950857|NCT02849938|12177461|P1|STARTED|Overall Study||9
4950858|NCT02849704|12177473|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
4950859|NCT02849704|12177474|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
4950860|NCT02849704|12177473|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
4950861|NCT02849704|12177474|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
4950862|NCT02849704|12177473|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
4950863|NCT02849704|12177474|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
4950864|NCT02849704|12177473|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
4950865|NCT02849704|12177474|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
4950866|NCT02849704|12177473|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
4950867|NCT02849704|12177474|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
4950868|NCT02849704|12177473|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
4950869|NCT02849704|12177474|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
4950870|NCT02849704|12177473|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
4950871|NCT02849704|12177474|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
4950872|NCT02849704|12177473|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
4950873|NCT02849704|12177474|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
4950874|NCT02849704|12177473|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
4950875|NCT02849704|12177474|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
4950876|NCT02849678|12177489|P2|NOT COMPLETED|Overall Study||6
4950877|NCT02849678|12177490|P1|NOT COMPLETED|Overall Study||3
4950878|NCT02849678|12177489|P2|COMPLETED|Overall Study||18
4950879|NCT02849678|12177490|P1|COMPLETED|Overall Study||17
4950880|NCT02849678|12177489|P2|STARTED|Overall Study||24
4950881|NCT02849678|12177490|P1|STARTED|Overall Study||20
4950882|NCT02849626|12177510|P2|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
4950883|NCT02849626|12177511|P1|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
4950884|NCT02849626|12177510|P2|COMPLETED|Extension Phase A (up to 29 Weeks)||17
4950885|NCT02849626|12177511|P1|COMPLETED|Extension Phase A (up to 29 Weeks)||105
4950886|NCT02849626|12177510|P2|STARTED|Extension Phase A (up to 29 Weeks)||20
4950887|NCT02849626|12177511|P1|STARTED|Extension Phase A (up to 29 Weeks)||116
4950888|NCT02849626|12177510|P2|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
4950889|NCT02849626|12177511|P1|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
4950890|NCT02849626|12177510|P2|COMPLETED|Core Phase (up to 23 Weeks)||24
4950891|NCT02849626|12177511|P1|COMPLETED|Core Phase (up to 23 Weeks)||122
4950892|NCT02849626|12177510|P2|STARTED|Core Phase (up to 23 Weeks)||31
4950893|NCT02849626|12177511|P1|STARTED|Core Phase (up to 23 Weeks)||149
4950894|NCT02849509|12177574|P3|NOT COMPLETED|Overall Study||85
4950895|NCT02849509|12177575|P2|NOT COMPLETED|Overall Study||166
4950896|NCT02849509|12177576|P1|NOT COMPLETED|Overall Study||90
4950897|NCT02849509|12177574|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
4950898|NCT02849509|12177575|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
4950899|NCT02849509|12177576|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
4950900|NCT02849509|12177574|P3|STARTED|Overall Study||343
4950901|NCT02849509|12177575|P2|STARTED|Overall Study||591
4950902|NCT02849509|12177576|P1|STARTED|Overall Study||379
4950903|NCT02849418|12177605|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950904|NCT02849418|12177606|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950905|NCT02849418|12177607|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950906|NCT02849418|12177608|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950907|NCT02849418|12177609|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950908|NCT02849418|12177610|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950909|NCT02849418|12177605|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
4950910|NCT02849418|12177606|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
4950911|NCT02849418|12177607|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950912|NCT02849418|12177608|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950913|NCT02849418|12177609|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950914|NCT02849418|12177610|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
4950915|NCT02849418|12177605|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
4950916|NCT02849418|12177606|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
4950917|NCT02849418|12177607|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
4950918|NCT02849418|12177608|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
4950919|NCT02849418|12177609|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
4950920|NCT02849418|12177610|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
4950921|NCT02849418|12177605|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950922|NCT02849418|12177606|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950923|NCT02849418|12177607|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950924|NCT02849418|12177608|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950925|NCT02849418|12177609|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950926|NCT02849418|12177610|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950927|NCT02849418|12177605|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950928|NCT02849418|12177606|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950929|NCT02849418|12177607|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
4950930|NCT02849418|12177608|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
4950931|NCT02849418|12177609|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950932|NCT02849418|12177610|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
4950933|NCT02849418|12177605|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
4950934|NCT02849418|12177606|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
4950935|NCT02849418|12177607|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
4950936|NCT02849418|12177608|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
4950937|NCT02849418|12177609|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
4950938|NCT02849418|12177610|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
4950939|NCT02849418|12177605|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950940|NCT02849418|12177606|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950941|NCT02849418|12177607|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950942|NCT02849418|12177608|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950943|NCT02849418|12177609|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950944|NCT02849418|12177610|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950945|NCT02849418|12177605|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950946|NCT02849418|12177606|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950947|NCT02849418|12177607|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950948|NCT02849418|12177608|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4950949|NCT02849418|12177609|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
4950950|NCT02849418|12177610|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
4950951|NCT02849418|12177605|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
4950952|NCT02849418|12177606|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
4950953|NCT02849418|12177607|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
4950954|NCT02849418|12177608|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
4950955|NCT02849418|12177609|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
4950956|NCT02849418|12177610|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
4950957|NCT02849184|12177760|P2|NOT COMPLETED|Overall Study||0
4950958|NCT02849184|12177761|P1|NOT COMPLETED|Overall Study||0
4950959|NCT02849184|12177760|P2|COMPLETED|Overall Study||42
4950960|NCT02849184|12177761|P1|COMPLETED|Overall Study||40
4950961|NCT02849184|12177760|P2|STARTED|Overall Study||42
4950962|NCT02849184|12177761|P1|STARTED|Overall Study||40
4950963|NCT02849080|12177783|P4|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
4950964|NCT02849080|12177784|P3|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
4950965|NCT02849080|12177785|P2|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
4950966|NCT02849080|12177786|P1|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
4950967|NCT02849080|12177783|P4|COMPLETED|Extension Phase: 53 - 104 Weeks||98
4950968|NCT02849080|12177784|P3|COMPLETED|Extension Phase: 53 - 104 Weeks||99
4950969|NCT02849080|12177785|P2|COMPLETED|Extension Phase: 53 - 104 Weeks||0
4950970|NCT02849080|12177786|P1|COMPLETED|Extension Phase: 53 - 104 Weeks||182
4950971|NCT02849080|12177783|P4|Exposed|Extension Phase: 53 - 104 Weeks||97
4950972|NCT02849080|12177784|P3|Exposed|Extension Phase: 53 - 104 Weeks||100
4950973|NCT02849080|12177785|P2|Exposed|Extension Phase: 53 - 104 Weeks||0
4950974|NCT02849080|12177786|P1|Exposed|Extension Phase: 53 - 104 Weeks||184
4950975|NCT02849080|12177783|P4|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
4950976|NCT02849080|12177784|P3|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
4950977|NCT02849080|12177785|P2|STARTED|Extension Phase: 53 - 104 Weeks||0
4950978|NCT02849080|12177786|P1|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
4950979|NCT02849080|12177783|P4|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
4950980|NCT02849080|12177784|P3|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
4950981|NCT02849080|12177785|P2|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
4950982|NCT02849080|12177786|P1|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
4950983|NCT02849080|12177783|P4|COMPLETED|Main Phase: 0 - 52 Weeks||0
4950984|NCT02849080|12177784|P3|COMPLETED|Main Phase: 0 - 52 Weeks||0
4950985|NCT02849080|12177785|P2|COMPLETED|Main Phase: 0 - 52 Weeks||244
4950986|NCT02849080|12177786|P1|COMPLETED|Main Phase: 0 - 52 Weeks||241
4950987|NCT02849080|12177783|P4|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
4950988|NCT02849080|12177784|P3|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
4950989|NCT02849080|12177785|P2|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
4950990|NCT02849080|12177786|P1|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
4950991|NCT02849080|12177783|P4|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
4950992|NCT02849080|12177784|P3|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
4950993|NCT02849080|12177785|P2|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
4950994|NCT02849080|12177786|P1|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
4950995|NCT02849080|12177783|P4|Exposed|Main Phase: 0 - 52 Weeks||0
4950996|NCT02849080|12177784|P3|Exposed|Main Phase: 0 - 52 Weeks||0
4950997|NCT02849080|12177785|P2|Exposed|Main Phase: 0 - 52 Weeks||250
4950998|NCT02849080|12177786|P1|Exposed|Main Phase: 0 - 52 Weeks||253
4950999|NCT02849080|12177783|P4|STARTED|Main Phase: 0 - 52 Weeks||0
4951000|NCT02849080|12177784|P3|STARTED|Main Phase: 0 - 52 Weeks||0
4951001|NCT02849080|12177785|P2|STARTED|Main Phase: 0 - 52 Weeks||251
4951002|NCT02849080|12177786|P1|STARTED|Main Phase: 0 - 52 Weeks||253
4951003|NCT02848729|12177913|P2|NOT COMPLETED|Overall Study||11
4951004|NCT02848729|12177914|P1|NOT COMPLETED|Overall Study||16
4951005|NCT02848729|12177913|P2|COMPLETED|Overall Study||12
4951006|NCT02848729|12177914|P1|COMPLETED|Overall Study||11
4951007|NCT02848729|12177913|P2|Safety Population|Overall Study||23
4951008|NCT02848729|12177914|P1|Safety Population|Overall Study||27
4951009|NCT02848729|12177913|P2|Per Protocol Population|Overall Study||11
4951010|NCT02848729|12177914|P1|Per Protocol Population|Overall Study||11
4951011|NCT02848729|12177913|P2|STARTED|Overall Study||23
4951012|NCT02848729|12177914|P1|STARTED|Overall Study||27
4951013|NCT02848664|12177931|P1|NOT COMPLETED|Overall Study||4
4951014|NCT02848664|12177931|P1|COMPLETED|Overall Study||7
4951015|NCT02848664|12177931|P1|STARTED|Overall Study||11
4951016|NCT02848651|12177939|P1|NOT COMPLETED|Overall Study||106
4951017|NCT02848651|12177939|P1|COMPLETED|Overall Study||47
4951018|NCT02848651|12177939|P1|Received Treatment|Overall Study||152
4951019|NCT02848651|12177939|P1|STARTED|Overall Study||153
4951020|NCT02848326|12177972|P6|NOT COMPLETED|Safety Follow-up Period||5
4951021|NCT02848326|12177973|P5|NOT COMPLETED|Safety Follow-up Period||1
4951022|NCT02848326|12177974|P4|NOT COMPLETED|Safety Follow-up Period||0
4951023|NCT02848326|12177975|P3|NOT COMPLETED|Safety Follow-up Period||3
4951024|NCT02848326|12177976|P2|NOT COMPLETED|Safety Follow-up Period||1
4951025|NCT02848326|12177977|P1|NOT COMPLETED|Safety Follow-up Period||4
4951026|NCT02848326|12177972|P6|COMPLETED|Safety Follow-up Period||77
4951027|NCT02848326|12177973|P5|COMPLETED|Safety Follow-up Period||76
4951028|NCT02848326|12177974|P4|COMPLETED|Safety Follow-up Period||169
4951029|NCT02848326|12177975|P3|COMPLETED|Safety Follow-up Period||153
4951030|NCT02848326|12177976|P2|COMPLETED|Safety Follow-up Period||83
4951031|NCT02848326|12177977|P1|COMPLETED|Safety Follow-up Period||157
4951032|NCT02848326|12177972|P6|STARTED|Safety Follow-up Period||82
4951033|NCT02848326|12177973|P5|STARTED|Safety Follow-up Period||77
4951034|NCT02848326|12177974|P4|STARTED|Safety Follow-up Period||169
4951035|NCT02848326|12177975|P3|STARTED|Safety Follow-up Period||156
4951036|NCT02848326|12177976|P2|STARTED|Safety Follow-up Period||84
4951037|NCT02848326|12177977|P1|STARTED|Safety Follow-up Period||161
4951038|NCT02848326|12177972|P6|NOT COMPLETED|Treatment Period||20
4951039|NCT02848326|12177973|P5|NOT COMPLETED|Treatment Period||19
4951040|NCT02848326|12177974|P4|NOT COMPLETED|Treatment Period||23
4951041|NCT02848326|12177975|P3|NOT COMPLETED|Treatment Period||36
4951042|NCT02848326|12177976|P2|NOT COMPLETED|Treatment Period||14
4951043|NCT02848326|12177977|P1|NOT COMPLETED|Treatment Period||38
4951044|NCT02848326|12177972|P6|COMPLETED|Treatment Period||73
4951045|NCT02848326|12177973|P5|COMPLETED|Treatment Period||70
4951046|NCT02848326|12177974|P4|COMPLETED|Treatment Period||164
4951047|NCT02848326|12177975|P3|COMPLETED|Treatment Period||149
4951048|NCT02848326|12177976|P2|COMPLETED|Treatment Period||80
4951049|NCT02848326|12177977|P1|COMPLETED|Treatment Period||148
4951050|NCT02848326|12177972|P6|Safety Population: Received Study Drug|Treatment Period||91
4951051|NCT02848326|12177973|P5|Safety Population: Received Study Drug|Treatment Period||86
4951052|NCT02848326|12177974|P4|Safety Population: Received Study Drug|Treatment Period||186
4951053|NCT02848326|12177975|P3|Safety Population: Received Study Drug|Treatment Period||183
4951054|NCT02848326|12177976|P2|Safety Population: Received Study Drug|Treatment Period||93
4951055|NCT02848326|12177977|P1|Safety Population: Received Study Drug|Treatment Period||186
4951056|NCT02848326|12177972|P6|STARTED|Treatment Period||93
4951057|NCT02848326|12177973|P5|STARTED|Treatment Period||89
4951058|NCT02848326|12177974|P4|STARTED|Treatment Period||187
4951059|NCT02848326|12177975|P3|STARTED|Treatment Period||185
4951060|NCT02848326|12177976|P2|STARTED|Treatment Period||94
4951061|NCT02848326|12177977|P1|STARTED|Treatment Period||186
4951062|NCT02848222|12178012|P3|NOT COMPLETED|Overall Study||0
4951063|NCT02848222|12178013|P2|NOT COMPLETED|Overall Study||1
4951064|NCT02848222|12178014|P1|NOT COMPLETED|Overall Study||7
4951065|NCT02848222|12178012|P3|COMPLETED|Overall Study||17
4951066|NCT02848222|12178013|P2|COMPLETED|Overall Study||17
4951067|NCT02848222|12178014|P1|COMPLETED|Overall Study||18
4951068|NCT02848222|12178012|P3|STARTED|Overall Study||17
4951069|NCT02848222|12178013|P2|STARTED|Overall Study||18
4951070|NCT02848222|12178014|P1|STARTED|Overall Study||25
4951071|NCT02847858|12178024|P2|NOT COMPLETED|Overall Study||269
4951072|NCT02847858|12178025|P1|NOT COMPLETED|Overall Study||401
4951073|NCT02847858|12178024|P2|COMPLETED|Overall Study||398
4951074|NCT02847858|12178025|P1|COMPLETED|Overall Study||292
4951075|NCT02847858|12178024|P2|STARTED|Overall Study||667
4951076|NCT02847858|12178025|P1|STARTED|Overall Study||693
4951077|NCT02847650|12178051|P2|NOT COMPLETED|Overall Study||6
4951078|NCT02847650|12178052|P1|NOT COMPLETED|Overall Study||4
4951079|NCT02847650|12178051|P2|COMPLETED|Overall Study||22
4951080|NCT02847650|12178052|P1|COMPLETED|Overall Study||25
4951081|NCT02847650|12178051|P2|STARTED|Overall Study||28
4951082|NCT02847650|12178052|P1|STARTED|Overall Study||29
4951083|NCT02847637|12178076|P4|NOT COMPLETED|Overall Study||63
4951084|NCT02847637|12178077|P3|NOT COMPLETED|Overall Study||35
4951085|NCT02847637|12178078|P2|NOT COMPLETED|Overall Study||35
4951086|NCT02847637|12178079|P1|NOT COMPLETED|Overall Study||17
4951087|NCT02847637|12178076|P4|COMPLETED|Overall Study||0
4951088|NCT02847637|12178077|P3|COMPLETED|Overall Study||0
4951089|NCT02847637|12178078|P2|COMPLETED|Overall Study||1
4951090|NCT02847637|12178079|P1|COMPLETED|Overall Study||1
4951091|NCT02847637|12178076|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
4951092|NCT02847637|12178077|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
4951093|NCT02847637|12178078|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
4951094|NCT02847637|12178079|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
4951095|NCT02847637|12178076|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
4951096|NCT02847637|12178077|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
4951097|NCT02847637|12178078|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
4951098|NCT02847637|12178079|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
4951099|NCT02847637|12178076|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
4951100|NCT02847637|12178077|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
4951101|NCT02847637|12178078|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
4951102|NCT02847637|12178079|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
4951103|NCT02847637|12178076|P4|STARTED|Overall Study||63
4951104|NCT02847637|12178077|P3|STARTED|Overall Study||35
4951105|NCT02847637|12178078|P2|STARTED|Overall Study||36
4951106|NCT02847637|12178079|P1|STARTED|Overall Study||18
4951107|NCT02847494|12178193|P2|NOT COMPLETED|Overall Study||5
4951108|NCT02847494|12178194|P1|NOT COMPLETED|Overall Study||8
4951109|NCT02847494|12178193|P2|COMPLETED|Overall Study||106
4951110|NCT02847494|12178194|P1|COMPLETED|Overall Study||101
4951111|NCT02847494|12178193|P2|STARTED|Overall Study||111
4951112|NCT02847494|12178194|P1|STARTED|Overall Study||109
4951113|NCT02847260|12178204|P1|NOT COMPLETED|Overall Study||7
4951114|NCT02847260|12178204|P1|COMPLETED|Overall Study||32
4951115|NCT02847260|12178204|P1|STARTED|Overall Study||39
4951116|NCT02847182|12178218|P2|NOT COMPLETED|Overall Study||1
4951117|NCT02847182|12178219|P1|NOT COMPLETED|Overall Study||0
4951118|NCT02847182|12178218|P2|COMPLETED|Overall Study||60
4951119|NCT02847182|12178219|P1|COMPLETED|Overall Study||119
4951120|NCT02847182|12178218|P2|Second Intervention (6 Months)|Overall Study||119
4951121|NCT02847182|12178219|P1|Second Intervention (6 Months)|Overall Study||61
4951122|NCT02847182|12178218|P2|First Intervention (6 Months)|Overall Study||61
4951123|NCT02847182|12178219|P1|First Intervention (6 Months)|Overall Study||119
4951124|NCT02847182|12178218|P2|STARTED|Overall Study||61
4951125|NCT02847182|12178219|P1|STARTED|Overall Study||119
4951126|NCT02847169|12178295|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4951127|NCT02847169|12178296|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4951128|NCT02847169|12178295|P2|COMPLETED|Second Intervention (1 Week)||15
4951129|NCT02847169|12178296|P1|COMPLETED|Second Intervention (1 Week)||15
4951130|NCT02847169|12178295|P2|STARTED|Second Intervention (1 Week)||15
4951131|NCT02847169|12178296|P1|STARTED|Second Intervention (1 Week)||15
4951132|NCT02847169|12178295|P2|NOT COMPLETED|First Intervention (1 Week)||0
4951133|NCT02847169|12178296|P1|NOT COMPLETED|First Intervention (1 Week)||0
4951134|NCT02847169|12178295|P2|COMPLETED|First Intervention (1 Week)||15
4951135|NCT02847169|12178296|P1|COMPLETED|First Intervention (1 Week)||15
4951136|NCT02847169|12178295|P2|STARTED|First Intervention (1 Week)||15
4951137|NCT02847169|12178296|P1|STARTED|First Intervention (1 Week)||15
4951138|NCT02846792|12178330|P1|NOT COMPLETED|Overall Study||0
4951139|NCT02846792|12178330|P1|COMPLETED|Overall Study||5
4951140|NCT02846792|12178330|P1|STARTED|Overall Study||5
4951141|NCT02846779|12178343|P3|NOT COMPLETED|Overall Study||138
4951142|NCT02846779|12178344|P2|NOT COMPLETED|Overall Study||127
4951143|NCT02846779|12178345|P1|NOT COMPLETED|Overall Study||139
4951144|NCT02846779|12178343|P3|COMPLETED|Overall Study||1862
4951145|NCT02846779|12178344|P2|COMPLETED|Overall Study||1873
4951146|NCT02846779|12178345|P1|COMPLETED|Overall Study||1861
4951147|NCT02846779|12178343|P3|STARTED|Overall Study||2000
4951148|NCT02846779|12178344|P2|STARTED|Overall Study||2000
4951149|NCT02846779|12178345|P1|STARTED|Overall Study||2000
4951150|NCT02846740|12178370|P2|NOT COMPLETED|Overall Study||1
4951151|NCT02846740|12178371|P1|NOT COMPLETED|Overall Study||0
4951152|NCT02846740|12178370|P2|COMPLETED|Overall Study||14
4951153|NCT02846740|12178371|P1|COMPLETED|Overall Study||15
4951154|NCT02846740|12178370|P2|STARTED|Overall Study||15
4951155|NCT02846740|12178371|P1|STARTED|Overall Study||15
4951156|NCT02846714|12178381|P1|NOT COMPLETED|Overall Study||6
4951157|NCT02846714|12178381|P1|COMPLETED|Overall Study||36
4951158|NCT02846714|12178381|P1|STARTED|Overall Study||42
4951159|NCT02846558|12178401|P4|NOT COMPLETED|Overall Study||2
4951160|NCT02846558|12178402|P3|NOT COMPLETED|Overall Study||2
4951161|NCT02846558|12178403|P2|NOT COMPLETED|Overall Study||4
4951162|NCT02846558|12178404|P1|NOT COMPLETED|Overall Study||8
4951163|NCT02846558|12178401|P4|COMPLETED|Overall Study||11
4951164|NCT02846558|12178402|P3|COMPLETED|Overall Study||12
4951165|NCT02846558|12178403|P2|COMPLETED|Overall Study||8
4951166|NCT02846558|12178404|P1|COMPLETED|Overall Study||7
4951167|NCT02846558|12178401|P4|3 Month Study Visit|Overall Study||11
4951168|NCT02846558|12178402|P3|3 Month Study Visit|Overall Study||12
4951169|NCT02846558|12178403|P2|3 Month Study Visit|Overall Study||8
4951170|NCT02846558|12178404|P1|3 Month Study Visit|Overall Study||7
4951171|NCT02846558|12178401|P4|Baseline Study Visit|Overall Study||12
4951172|NCT02846558|12178402|P3|Baseline Study Visit|Overall Study||14
4951173|NCT02846558|12178403|P2|Baseline Study Visit|Overall Study||9
4951174|NCT02846558|12178404|P1|Baseline Study Visit|Overall Study||10
4951175|NCT02846558|12178401|P4|STARTED|Overall Study||13
4951176|NCT02846558|12178402|P3|STARTED|Overall Study||14
4951177|NCT02846558|12178403|P2|STARTED|Overall Study||12
4951178|NCT02846558|12178404|P1|STARTED|Overall Study||15
4951179|NCT02845752|12178442|P2|NOT COMPLETED|Second Intervention (7 Days)||0
4951180|NCT02845752|12178443|P1|NOT COMPLETED|Second Intervention (7 Days)||0
4951181|NCT02845752|12178442|P2|COMPLETED|Second Intervention (7 Days)||7
4951182|NCT02845752|12178443|P1|COMPLETED|Second Intervention (7 Days)||7
4951183|NCT02845752|12178442|P2|STARTED|Second Intervention (7 Days)||7
4951184|NCT02845752|12178443|P1|STARTED|Second Intervention (7 Days)||7
4951185|NCT02845752|12178442|P2|NOT COMPLETED|Washout (14 Days)||0
4951186|NCT02845752|12178443|P1|NOT COMPLETED|Washout (14 Days)||0
4951187|NCT02845752|12178442|P2|COMPLETED|Washout (14 Days)||7
4951188|NCT02845752|12178443|P1|COMPLETED|Washout (14 Days)||7
4951189|NCT02845752|12178442|P2|STARTED|Washout (14 Days)||7
4951190|NCT02845752|12178443|P1|STARTED|Washout (14 Days)||7
4951191|NCT02845752|12178442|P2|NOT COMPLETED|First Intervention (7 Days)||0
4951192|NCT02845752|12178443|P1|NOT COMPLETED|First Intervention (7 Days)||0
4951193|NCT02845752|12178442|P2|COMPLETED|First Intervention (7 Days)||7
4951194|NCT02845752|12178443|P1|COMPLETED|First Intervention (7 Days)||7
4951195|NCT02845752|12178442|P2|STARTED|First Intervention (7 Days)||7
4951196|NCT02845752|12178443|P1|STARTED|First Intervention (7 Days)||7
4951197|NCT02845700|12178463|P2|NOT COMPLETED|Month 1 Follow-Up||0
4951198|NCT02845700|12178464|P1|NOT COMPLETED|Month 1 Follow-Up||0
4951199|NCT02845700|12178463|P2|COMPLETED|Month 1 Follow-Up||4
4951200|NCT02845700|12178464|P1|COMPLETED|Month 1 Follow-Up||2
4951201|NCT02845700|12178463|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
4951202|NCT02845700|12178464|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
4951203|NCT02845700|12178463|P2|NOT COMPLETED|Intervention Session 2||0
4951204|NCT02845700|12178464|P1|NOT COMPLETED|Intervention Session 2||0
4951205|NCT02845700|12178463|P2|COMPLETED|Intervention Session 2||6
4951206|NCT02845700|12178464|P1|COMPLETED|Intervention Session 2||5
4951207|NCT02845700|12178463|P2|STARTED|Intervention Session 2||6
4951208|NCT02845700|12178464|P1|STARTED|Intervention Session 2||5
4951209|NCT02845700|12178463|P2|NOT COMPLETED|Intervention Session 1||0
4951210|NCT02845700|12178464|P1|NOT COMPLETED|Intervention Session 1||0
4951211|NCT02845700|12178463|P2|COMPLETED|Intervention Session 1||6
4951212|NCT02845700|12178464|P1|COMPLETED|Intervention Session 1||5
4951213|NCT02845700|12178463|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
4951214|NCT02845700|12178464|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
4951215|NCT02845700|12178463|P2|NOT COMPLETED|Baseline Appointment||0
4951216|NCT02845700|12178464|P1|NOT COMPLETED|Baseline Appointment||0
4951217|NCT02845700|12178463|P2|COMPLETED|Baseline Appointment||7
4951218|NCT02845700|12178464|P1|COMPLETED|Baseline Appointment||6
4951219|NCT02845700|12178463|P2|STARTED|Baseline Appointment||7
4951220|NCT02845700|12178464|P1|STARTED|Baseline Appointment||6
4951221|NCT02845674|12178480|P2|NOT COMPLETED|Overall Study||50
4951222|NCT02845674|12178481|P1|NOT COMPLETED|Overall Study||18
4951223|NCT02845674|12178480|P2|COMPLETED|Overall Study||79
4951224|NCT02845674|12178481|P1|COMPLETED|Overall Study||111
4951225|NCT02845674|12178480|P2|STARTED|Overall Study||129
4951226|NCT02845674|12178481|P1|STARTED|Overall Study||129
4951227|NCT02845375|12178490|P3|NOT COMPLETED|Overall Study||1
4951228|NCT02845375|12178491|P2|NOT COMPLETED|Overall Study||2
4951229|NCT02845375|12178492|P1|NOT COMPLETED|Overall Study||1
4951230|NCT02845375|12178490|P3|COMPLETED|Overall Study||12
4951231|NCT02845375|12178491|P2|COMPLETED|Overall Study||12
4951232|NCT02845375|12178492|P1|COMPLETED|Overall Study||12
4951233|NCT02845375|12178490|P3|STARTED|Overall Study||13
4951234|NCT02845375|12178491|P2|STARTED|Overall Study||14
4951235|NCT02845375|12178492|P1|STARTED|Overall Study||13
4951236|NCT02845336|12178505|P2|NOT COMPLETED|Overall Study||1
4951237|NCT02845336|12178506|P1|NOT COMPLETED|Overall Study||5
4951238|NCT02845336|12178505|P2|COMPLETED|Overall Study||0
4951239|NCT02845336|12178506|P1|COMPLETED|Overall Study||1
4951240|NCT02845336|12178505|P2|STARTED|Overall Study||1
4951241|NCT02845336|12178506|P1|STARTED|Overall Study||6
4951242|NCT02844998|12178533|P3|NOT COMPLETED|Overall Study||4
4951243|NCT02844998|12178534|P2|NOT COMPLETED|Overall Study||4
4951244|NCT02844998|12178535|P1|NOT COMPLETED|Overall Study||7
4951245|NCT02844998|12178533|P3|COMPLETED|Overall Study||35
4951246|NCT02844998|12178534|P2|COMPLETED|Overall Study||35
4951247|NCT02844998|12178535|P1|COMPLETED|Overall Study||35
4951248|NCT02844998|12178533|P3|STARTED|Overall Study||39
4951249|NCT02844998|12178534|P2|STARTED|Overall Study||39
4951250|NCT02844998|12178535|P1|STARTED|Overall Study||42
4951251|NCT02844946|12178548|P2|NOT COMPLETED|Overall Study||0
4951252|NCT02844946|12178549|P1|NOT COMPLETED|Overall Study||7
4951253|NCT02844946|12178548|P2|COMPLETED|Overall Study||12
4951254|NCT02844946|12178549|P1|COMPLETED|Overall Study||20
4951255|NCT02844946|12178548|P2|STARTED|Overall Study||12
4951256|NCT02844946|12178549|P1|STARTED|Overall Study||27
4951257|NCT02844920|12178567|P1|NOT COMPLETED|Overall Study||2
4951258|NCT02844920|12178567|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
4951259|NCT02844920|12178567|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
4951260|NCT02844920|12178567|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
4951261|NCT02844920|12178567|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
4951262|NCT02844920|12178567|P1|STARTED|Overall Study||37
4951263|NCT02844569|12178574|P2|NOT COMPLETED|Overall Study||0
4951264|NCT02844569|12178575|P1|NOT COMPLETED|Overall Study||0
4951265|NCT02844569|12178574|P2|COMPLETED|Overall Study||12
4951266|NCT02844569|12178575|P1|COMPLETED|Overall Study||12
4951267|NCT02844569|12178574|P2|STARTED|Overall Study||12
4951268|NCT02844569|12178575|P1|STARTED|Overall Study||12
4951269|NCT02844543|12178585|P1|NOT COMPLETED|Overall Study||5
4951270|NCT02844543|12178585|P1|COMPLETED|Overall Study||150
4951271|NCT02844543|12178585|P1|STARTED|Overall Study||155
4951272|NCT02843659|12178595|P3|NOT COMPLETED|Overall Study||5
4951273|NCT02843659|12178596|P2|NOT COMPLETED|Overall Study||6
4951274|NCT02843659|12178597|P1|NOT COMPLETED|Overall Study||4
4951275|NCT02843659|12178595|P3|COMPLETED|Overall Study||2
4951276|NCT02843659|12178596|P2|COMPLETED|Overall Study||0
4951277|NCT02843659|12178597|P1|COMPLETED|Overall Study||1
4951278|NCT02843659|12178595|P3|STARTED|Overall Study||7
4951279|NCT02843659|12178596|P2|STARTED|Overall Study||6
4951280|NCT02843659|12178597|P1|STARTED|Overall Study||5
4951281|NCT02843178|12178666|P4|NOT COMPLETED|Overall Study||4
4951282|NCT02843178|12178667|P3|NOT COMPLETED|Overall Study||7
4951283|NCT02843178|12178668|P2|NOT COMPLETED|Overall Study||8
4951284|NCT02843178|12178669|P1|NOT COMPLETED|Overall Study||8
4951285|NCT02843178|12178666|P4|COMPLETED|Overall Study||87
4951286|NCT02843178|12178667|P3|COMPLETED|Overall Study||85
4951287|NCT02843178|12178668|P2|COMPLETED|Overall Study||82
4951288|NCT02843178|12178669|P1|COMPLETED|Overall Study||78
4951289|NCT02843178|12178666|P4|STARTED|Overall Study||91
4951290|NCT02843178|12178667|P3|STARTED|Overall Study||92
4951291|NCT02843178|12178668|P2|STARTED|Overall Study||90
4951292|NCT02843178|12178669|P1|STARTED|Overall Study||86
4951293|NCT02842866|12178709|P2|NOT COMPLETED|Overall Study||3
4951294|NCT02842866|12178710|P1|NOT COMPLETED|Overall Study||7
4951295|NCT02842866|12178709|P2|COMPLETED|Overall Study||452
4951296|NCT02842866|12178710|P1|COMPLETED|Overall Study||444
4951297|NCT02842866|12178709|P2|Vaccinated|Overall Study||453
4951298|NCT02842866|12178710|P1|Vaccinated|Overall Study||448
4951299|NCT02842866|12178709|P2|STARTED|Overall Study||455
4951300|NCT02842866|12178710|P1|STARTED|Overall Study||451
4951301|NCT02842853|12178722|P4|NOT COMPLETED|Overall Study||24
4951302|NCT02842853|12178723|P3|NOT COMPLETED|Overall Study||21
4951303|NCT02842853|12178724|P2|NOT COMPLETED|Overall Study||34
4951304|NCT02842853|12178725|P1|NOT COMPLETED|Overall Study||23
4951305|NCT02842853|12178722|P4|COMPLETED|Overall Study||617
4951306|NCT02842853|12178723|P3|COMPLETED|Overall Study||885
4951307|NCT02842853|12178724|P2|COMPLETED|Overall Study||861
4951308|NCT02842853|12178725|P1|COMPLETED|Overall Study||879
4951309|NCT02842853|12178722|P4|Safety Analysis Set (SafAS)|Overall Study||635
4951310|NCT02842853|12178723|P3|Safety Analysis Set (SafAS)|Overall Study||898
4951311|NCT02842853|12178724|P2|Safety Analysis Set (SafAS)|Overall Study||883
4951312|NCT02842853|12178725|P1|Safety Analysis Set (SafAS)|Overall Study||895
4951313|NCT02842853|12178722|P4|Vaccinated|Overall Study||636
4951314|NCT02842853|12178723|P3|Vaccinated|Overall Study||900
4951315|NCT02842853|12178724|P2|Vaccinated|Overall Study||886
4951316|NCT02842853|12178725|P1|Vaccinated|Overall Study||895
4951317|NCT02842853|12178722|P4|STARTED|Overall Study||641
4951318|NCT02842853|12178723|P3|STARTED|Overall Study||906
4951319|NCT02842853|12178724|P2|STARTED|Overall Study||895
4951320|NCT02842853|12178725|P1|STARTED|Overall Study||902
4951321|NCT02842736|12178745|P1|NOT COMPLETED|Overall Study||12
4951322|NCT02842736|12178745|P1|COMPLETED|Overall Study|Known Month 12 outcome|230
4951323|NCT02842736|12178745|P1|STARTED|Overall Study|Treated|242
4951324|NCT02842242|12178752|P2|NOT COMPLETED|Overall Study||0
4951325|NCT02842242|12178753|P1|NOT COMPLETED|Overall Study||1
4951326|NCT02842242|12178752|P2|COMPLETED|Overall Study||10
4951327|NCT02842242|12178753|P1|COMPLETED|Overall Study||10
4951328|NCT02842242|12178752|P2|STARTED|Overall Study||10
4951329|NCT02842242|12178753|P1|STARTED|Overall Study||11
4951330|NCT02842151|12178775|P1|NOT COMPLETED|Overall Study||2
4951331|NCT02842151|12178775|P1|COMPLETED|Overall Study||148
4951332|NCT02842151|12178775|P1|STARTED|Overall Study||150
4951333|NCT02842086|12178783|P2|NOT COMPLETED|Overall Study||493
4951334|NCT02842086|12178784|P1|NOT COMPLETED|Overall Study||544
4951335|NCT02842086|12178783|P2|COMPLETED|Overall Study||2206
4951336|NCT02842086|12178784|P1|COMPLETED|Overall Study||2156
4951337|NCT02842086|12178783|P2|STARTED|Overall Study||2699
4951338|NCT02842086|12178784|P1|STARTED|Overall Study||2700
4951339|NCT02842073|12178820|P1|NOT COMPLETED|Overall Study||1
4951340|NCT02842073|12178820|P1|COMPLETED|Overall Study||11
4951341|NCT02842073|12178820|P1|STARTED|Overall Study||12
4951342|NCT02842060|12178830|P2|NOT COMPLETED|Overall Study||0
4951343|NCT02842060|12178831|P1|NOT COMPLETED|Overall Study||0
4951344|NCT02842060|12178830|P2|COMPLETED|Overall Study||60
4951345|NCT02842060|12178831|P1|COMPLETED|Overall Study||120
4951346|NCT02842060|12178830|P2|STARTED|Overall Study||60
4951347|NCT02842060|12178831|P1|STARTED|Overall Study||120
4951348|NCT02841787|12178846|P3|NOT COMPLETED|Overall Study||0
4951349|NCT02841787|12178847|P2|NOT COMPLETED|Overall Study||4
4951350|NCT02841787|12178848|P1|NOT COMPLETED|Overall Study||3
4951351|NCT02841787|12178846|P3|COMPLETED|Overall Study||12
4951352|NCT02841787|12178847|P2|COMPLETED|Overall Study||19
4951353|NCT02841787|12178848|P1|COMPLETED|Overall Study||9
4951354|NCT02841787|12178846|P3|STARTED|Overall Study||12
4951355|NCT02841787|12178847|P2|STARTED|Overall Study||23
4951356|NCT02841787|12178848|P1|STARTED|Overall Study||12
4951357|NCT02841709|12178862|P5|NOT COMPLETED|5th Intervention||2
4951358|NCT02841709|12178863|P4|NOT COMPLETED|5th Intervention||0
4951359|NCT02841709|12178864|P3|NOT COMPLETED|5th Intervention||0
4951360|NCT02841709|12178865|P2|NOT COMPLETED|5th Intervention||0
4951361|NCT02841709|12178866|P1|NOT COMPLETED|5th Intervention||2
4951362|NCT02841709|12178862|P5|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
4951363|NCT02841709|12178863|P4|COMPLETED|5th Intervention||12
4951364|NCT02841709|12178864|P3|COMPLETED|5th Intervention||12
4951365|NCT02841709|12178865|P2|COMPLETED|5th Intervention||11
4951366|NCT02841709|12178866|P1|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
4951367|NCT02841709|12178862|P5|STARTED|5th Intervention||11
4951368|NCT02841709|12178863|P4|STARTED|5th Intervention||12
4951369|NCT02841709|12178864|P3|STARTED|5th Intervention||12
4951370|NCT02841709|12178865|P2|STARTED|5th Intervention||11
4951371|NCT02841709|12178866|P1|STARTED|5th Intervention||12
4951372|NCT02841709|12178862|P5|NOT COMPLETED|Washout Period 4||0
4951373|NCT02841709|12178863|P4|NOT COMPLETED|Washout Period 4||0
4951374|NCT02841709|12178864|P3|NOT COMPLETED|Washout Period 4||0
4951375|NCT02841709|12178865|P2|NOT COMPLETED|Washout Period 4||0
4951376|NCT02841709|12178866|P1|NOT COMPLETED|Washout Period 4||0
4951377|NCT02841709|12178862|P5|COMPLETED|Washout Period 4||11
4951378|NCT02841709|12178863|P4|COMPLETED|Washout Period 4||12
4951379|NCT02841709|12178864|P3|COMPLETED|Washout Period 4||12
4951380|NCT02841709|12178865|P2|COMPLETED|Washout Period 4||11
4951381|NCT02841709|12178866|P1|COMPLETED|Washout Period 4||12
4951382|NCT02841709|12178862|P5|STARTED|Washout Period 4||11
4951383|NCT02841709|12178863|P4|STARTED|Washout Period 4||12
4951384|NCT02841709|12178864|P3|STARTED|Washout Period 4||12
4951385|NCT02841709|12178865|P2|STARTED|Washout Period 4||11
4951386|NCT02841709|12178866|P1|STARTED|Washout Period 4||12
4951387|NCT02841709|12178862|P5|NOT COMPLETED|4th Intervention||0
4951388|NCT02841709|12178863|P4|NOT COMPLETED|4th Intervention||0
4951389|NCT02841709|12178864|P3|NOT COMPLETED|4th Intervention||0
4951390|NCT02841709|12178865|P2|NOT COMPLETED|4th Intervention||0
4951391|NCT02841709|12178866|P1|NOT COMPLETED|4th Intervention||0
4951392|NCT02841709|12178862|P5|COMPLETED|4th Intervention||11
4951393|NCT02841709|12178863|P4|COMPLETED|4th Intervention||12
4951394|NCT02841709|12178864|P3|COMPLETED|4th Intervention||12
4951395|NCT02841709|12178865|P2|COMPLETED|4th Intervention||11
4951396|NCT02841709|12178866|P1|COMPLETED|4th Intervention||12
4951397|NCT02841709|12178862|P5|STARTED|4th Intervention||11
4951398|NCT02841709|12178863|P4|STARTED|4th Intervention||12
4951399|NCT02841709|12178864|P3|STARTED|4th Intervention||12
4951400|NCT02841709|12178865|P2|STARTED|4th Intervention||11
4951401|NCT02841709|12178866|P1|STARTED|4th Intervention||12
4951402|NCT02841709|12178862|P5|NOT COMPLETED|Washout Period 3||0
4951403|NCT02841709|12178863|P4|NOT COMPLETED|Washout Period 3||0
4951404|NCT02841709|12178864|P3|NOT COMPLETED|Washout Period 3||0
4951405|NCT02841709|12178865|P2|NOT COMPLETED|Washout Period 3||0
4951406|NCT02841709|12178866|P1|NOT COMPLETED|Washout Period 3||0
4951407|NCT02841709|12178862|P5|COMPLETED|Washout Period 3||11
4951408|NCT02841709|12178863|P4|COMPLETED|Washout Period 3||12
4951409|NCT02841709|12178864|P3|COMPLETED|Washout Period 3||12
4951410|NCT02841709|12178865|P2|COMPLETED|Washout Period 3||11
4951411|NCT02841709|12178866|P1|COMPLETED|Washout Period 3||12
4951412|NCT02841709|12178862|P5|STARTED|Washout Period 3||11
4951413|NCT02841709|12178863|P4|STARTED|Washout Period 3||12
4951414|NCT02841709|12178864|P3|STARTED|Washout Period 3||12
4951415|NCT02841709|12178865|P2|STARTED|Washout Period 3||11
4951416|NCT02841709|12178866|P1|STARTED|Washout Period 3||12
4951417|NCT02841709|12178862|P5|NOT COMPLETED|3rd Intervention||0
4951418|NCT02841709|12178863|P4|NOT COMPLETED|3rd Intervention||0
4951419|NCT02841709|12178864|P3|NOT COMPLETED|3rd Intervention||0
4951420|NCT02841709|12178865|P2|NOT COMPLETED|3rd Intervention||0
4951421|NCT02841709|12178866|P1|NOT COMPLETED|3rd Intervention||0
4951422|NCT02841709|12178862|P5|COMPLETED|3rd Intervention||11
4951423|NCT02841709|12178863|P4|COMPLETED|3rd Intervention||12
4951424|NCT02841709|12178864|P3|COMPLETED|3rd Intervention||12
4951425|NCT02841709|12178865|P2|COMPLETED|3rd Intervention||11
4951426|NCT02841709|12178866|P1|COMPLETED|3rd Intervention||12
4951427|NCT02841709|12178862|P5|STARTED|3rd Intervention||11
4951428|NCT02841709|12178863|P4|STARTED|3rd Intervention||12
4951429|NCT02841709|12178864|P3|STARTED|3rd Intervention||12
4951430|NCT02841709|12178865|P2|STARTED|3rd Intervention||11
4951431|NCT02841709|12178866|P1|STARTED|3rd Intervention||12
4951432|NCT02841709|12178862|P5|NOT COMPLETED|Washout Period 2||0
4951433|NCT02841709|12178863|P4|NOT COMPLETED|Washout Period 2||0
4951434|NCT02841709|12178864|P3|NOT COMPLETED|Washout Period 2||0
4951435|NCT02841709|12178865|P2|NOT COMPLETED|Washout Period 2||0
4951436|NCT02841709|12178866|P1|NOT COMPLETED|Washout Period 2||0
4951437|NCT02841709|12178862|P5|COMPLETED|Washout Period 2||11
4951438|NCT02841709|12178863|P4|COMPLETED|Washout Period 2||12
4951439|NCT02841709|12178864|P3|COMPLETED|Washout Period 2||12
4951440|NCT02841709|12178865|P2|COMPLETED|Washout Period 2||11
4951441|NCT02841709|12178866|P1|COMPLETED|Washout Period 2||12
4951442|NCT02841709|12178862|P5|STARTED|Washout Period 2||11
4951443|NCT02841709|12178863|P4|STARTED|Washout Period 2||12
4951444|NCT02841709|12178864|P3|STARTED|Washout Period 2||12
4951445|NCT02841709|12178865|P2|STARTED|Washout Period 2||11
4951446|NCT02841709|12178866|P1|STARTED|Washout Period 2||12
4951447|NCT02841709|12178862|P5|NOT COMPLETED|2nd Intervention||0
4951448|NCT02841709|12178863|P4|NOT COMPLETED|2nd Intervention||0
4951449|NCT02841709|12178864|P3|NOT COMPLETED|2nd Intervention||0
4951450|NCT02841709|12178865|P2|NOT COMPLETED|2nd Intervention||0
4951451|NCT02841709|12178866|P1|NOT COMPLETED|2nd Intervention||0
4951452|NCT02841709|12178862|P5|COMPLETED|2nd Intervention||11
4951453|NCT02841709|12178863|P4|COMPLETED|2nd Intervention||12
4951454|NCT02841709|12178864|P3|COMPLETED|2nd Intervention||12
4951455|NCT02841709|12178865|P2|COMPLETED|2nd Intervention||11
4951456|NCT02841709|12178866|P1|COMPLETED|2nd Intervention||12
4951457|NCT02841709|12178862|P5|STARTED|2nd Intervention||11
4951458|NCT02841709|12178863|P4|STARTED|2nd Intervention||12
4951459|NCT02841709|12178864|P3|STARTED|2nd Intervention||12
4951460|NCT02841709|12178865|P2|STARTED|2nd Intervention||11
4951461|NCT02841709|12178866|P1|STARTED|2nd Intervention||12
4951462|NCT02841709|12178862|P5|NOT COMPLETED|Washout Period 1||0
4951463|NCT02841709|12178863|P4|NOT COMPLETED|Washout Period 1||0
4951464|NCT02841709|12178864|P3|NOT COMPLETED|Washout Period 1||0
4951465|NCT02841709|12178865|P2|NOT COMPLETED|Washout Period 1||0
4951466|NCT02841709|12178866|P1|NOT COMPLETED|Washout Period 1||0
4951467|NCT02841709|12178862|P5|COMPLETED|Washout Period 1||11
4951468|NCT02841709|12178863|P4|COMPLETED|Washout Period 1||12
4951469|NCT02841709|12178864|P3|COMPLETED|Washout Period 1||12
4951470|NCT02841709|12178865|P2|COMPLETED|Washout Period 1||11
4951471|NCT02841709|12178866|P1|COMPLETED|Washout Period 1||12
4951472|NCT02841709|12178862|P5|STARTED|Washout Period 1||11
4951473|NCT02841709|12178863|P4|STARTED|Washout Period 1||12
4951474|NCT02841709|12178864|P3|STARTED|Washout Period 1||12
4951475|NCT02841709|12178865|P2|STARTED|Washout Period 1||11
4951476|NCT02841709|12178866|P1|STARTED|Washout Period 1||12
4951477|NCT02841709|12178862|P5|NOT COMPLETED|1st Intervention||0
4951478|NCT02841709|12178863|P4|NOT COMPLETED|1st Intervention||0
4951479|NCT02841709|12178864|P3|NOT COMPLETED|1st Intervention||0
4951480|NCT02841709|12178865|P2|NOT COMPLETED|1st Intervention||0
4951481|NCT02841709|12178866|P1|NOT COMPLETED|1st Intervention||0
4951482|NCT02841709|12178862|P5|COMPLETED|1st Intervention||11
4951483|NCT02841709|12178863|P4|COMPLETED|1st Intervention||12
4951484|NCT02841709|12178864|P3|COMPLETED|1st Intervention||12
4951485|NCT02841709|12178865|P2|COMPLETED|1st Intervention||11
4951486|NCT02841709|12178866|P1|COMPLETED|1st Intervention||12
4951487|NCT02841709|12178862|P5|STARTED|1st Intervention||11
4951488|NCT02841709|12178863|P4|STARTED|1st Intervention||12
4951489|NCT02841709|12178864|P3|STARTED|1st Intervention||12
4951490|NCT02841709|12178865|P2|STARTED|1st Intervention||11
4951491|NCT02841709|12178866|P1|STARTED|1st Intervention||12
4951492|NCT02841449|12178886|P2|NOT COMPLETED|Overall Study||0
4951493|NCT02841449|12178887|P1|NOT COMPLETED|Overall Study||0
4951494|NCT02841449|12178886|P2|COMPLETED|Overall Study||9
4951495|NCT02841449|12178887|P1|COMPLETED|Overall Study||7
4951496|NCT02841449|12178886|P2|STARTED|Overall Study||9
4951497|NCT02841449|12178887|P1|STARTED|Overall Study||7
4951498|NCT02841241|12178911|P1|NOT COMPLETED|Overall Study||0
4951499|NCT02841241|12178911|P1|COMPLETED|Overall Study||7
4951500|NCT02841241|12178911|P1|STARTED|Overall Study||7
4951501|NCT02841189|12178922|P1|NOT COMPLETED|Overall Study||35
4951502|NCT02841189|12178922|P1|COMPLETED|Overall Study||65
4951503|NCT02841189|12178922|P1|STARTED|Overall Study||100
4951504|NCT02841046|12178928|P2|NOT COMPLETED|Overall Study||0
4951505|NCT02841046|12178929|P1|NOT COMPLETED|Overall Study||0
4951506|NCT02841046|12178928|P2|COMPLETED|Overall Study||25
4951507|NCT02841046|12178929|P1|COMPLETED|Overall Study||25
4951508|NCT02841046|12178928|P2|STARTED|Overall Study||25
4951509|NCT02841046|12178929|P1|STARTED|Overall Study||25
4951510|NCT02840916|12178937|P2|NOT COMPLETED|Overall Study||3
4951511|NCT02840916|12178938|P1|NOT COMPLETED|Overall Study||1
4951512|NCT02840916|12178937|P2|COMPLETED|Overall Study||30
4951513|NCT02840916|12178938|P1|COMPLETED|Overall Study||32
4951514|NCT02840916|12178937|P2|STARTED|Overall Study||33
4951515|NCT02840916|12178938|P1|STARTED|Overall Study||33
4951516|NCT02840721|12178948|P1|NOT COMPLETED|Follow-Up||7
4951517|NCT02840721|12178948|P1|COMPLETED|Follow-Up||42
4951518|NCT02840721|12178948|P1|STARTED|Follow-Up||49
4951519|NCT02840721|12178948|P1|NOT COMPLETED|Treatment Period||1
4951520|NCT02840721|12178948|P1|COMPLETED|Treatment Period||49
4951521|NCT02840721|12178948|P1|STARTED|Treatment Period||50
4951522|NCT02840461|12178970|P3|NOT COMPLETED|Overall Study||14
4951523|NCT02840461|12178971|P2|NOT COMPLETED|Overall Study||22
4951524|NCT02840461|12178972|P1|NOT COMPLETED|Overall Study||23
4951525|NCT02840461|12178970|P3|COMPLETED|Overall Study||100
4951526|NCT02840461|12178971|P2|COMPLETED|Overall Study||235
4951527|NCT02840461|12178972|P1|COMPLETED|Overall Study||236
4951528|NCT02840461|12178970|P3|STARTED|Overall Study||114
4951529|NCT02840461|12178971|P2|STARTED|Overall Study||257
4951530|NCT02840461|12178972|P1|STARTED|Overall Study||259
4951531|NCT02840253|12178983|P1|NOT COMPLETED|Overall Study||4
4951532|NCT02840253|12178983|P1|COMPLETED|Overall Study||19
4951533|NCT02840253|12178983|P1|STARTED|Overall Study||23
4951534|NCT02839902|12178990|P2|NOT COMPLETED|Overall Study||0
4951535|NCT02839902|12178991|P1|NOT COMPLETED|Overall Study||0
4951536|NCT02839902|12178990|P2|COMPLETED|Overall Study||29
4951537|NCT02839902|12178991|P1|COMPLETED|Overall Study||24
4951538|NCT02839902|12178990|P2|STARTED|Overall Study||29
4951539|NCT02839902|12178991|P1|STARTED|Overall Study||24
4951540|NCT02839889|12179029|P2|NOT COMPLETED|Open-Label Period||1
4951541|NCT02839889|12179030|P1|NOT COMPLETED|Open-Label Period||0
4951542|NCT02839889|12179029|P2|COMPLETED|Open-Label Period||4
4951543|NCT02839889|12179030|P1|COMPLETED|Open-Label Period||0
4951544|NCT02839889|12179029|P2|STARTED|Open-Label Period||5
4951545|NCT02839889|12179030|P1|STARTED|Open-Label Period||0
4951546|NCT02839889|12179029|P2|NOT COMPLETED|Randomization Period||0
4951547|NCT02839889|12179030|P1|NOT COMPLETED|Randomization Period||0
4951548|NCT02839889|12179029|P2|COMPLETED|Randomization Period||3
4951549|NCT02839889|12179030|P1|COMPLETED|Randomization Period||2
4951550|NCT02839889|12179029|P2|STARTED|Randomization Period||3
4951551|NCT02839889|12179030|P1|STARTED|Randomization Period||2
4951552|NCT02839876|12179068|P2|NOT COMPLETED|Overall Study||11
4951553|NCT02839876|12179069|P1|NOT COMPLETED|Overall Study||10
4951554|NCT02839876|12179068|P2|COMPLETED|Overall Study||29
4951555|NCT02839876|12179069|P1|COMPLETED|Overall Study||31
4951556|NCT02839876|12179068|P2|STARTED|Overall Study||40
4951557|NCT02839876|12179069|P1|STARTED|Overall Study||41
4951558|NCT02839798|12179131|P1|NOT COMPLETED|Overall Study||2
4951559|NCT02839798|12179131|P1|COMPLETED|Overall Study||4
4951560|NCT02839798|12179131|P1|STARTED|Overall Study||6
4951561|NCT02839772|12179139|P2|NOT COMPLETED|Overall Study||0
4951562|NCT02839772|12179140|P1|NOT COMPLETED|Overall Study||1
4951563|NCT02839772|12179139|P2|COMPLETED|Overall Study||96
4951564|NCT02839772|12179140|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
4951565|NCT02839772|12179139|P2|STARTED|Overall Study||96
4951566|NCT02839772|12179140|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
4951567|NCT02839746|12179177|P1|NOT COMPLETED|Overall Study||12
4951568|NCT02839746|12179177|P1|COMPLETED|Overall Study||659
4951569|NCT02839746|12179177|P1|STARTED|Overall Study||671
4951570|NCT02839681|12179191|P1|NOT COMPLETED|Overall Study||2
4951571|NCT02839681|12179191|P1|COMPLETED|Overall Study||0
4951572|NCT02839681|12179191|P1|STARTED|Overall Study||2
4951573|NCT02839330|12179204|P4|NOT COMPLETED|Overall Study||51
4951574|NCT02839330|12179205|P3|NOT COMPLETED|Overall Study||48
4951575|NCT02839330|12179206|P2|NOT COMPLETED|Overall Study||58
4951576|NCT02839330|12179207|P1|NOT COMPLETED|Overall Study||58
4951577|NCT02839330|12179204|P4|COMPLETED|Overall Study||747
4951578|NCT02839330|12179205|P3|COMPLETED|Overall Study||747
4951579|NCT02839330|12179206|P2|COMPLETED|Overall Study||741
4951580|NCT02839330|12179207|P1|COMPLETED|Overall Study||746
4951581|NCT02839330|12179204|P4|Exposed|Overall Study||797
4951582|NCT02839330|12179205|P3|Exposed|Overall Study||793
4951583|NCT02839330|12179206|P2|Exposed|Overall Study||797
4951584|NCT02839330|12179207|P1|Exposed|Overall Study||804
4951585|NCT02839330|12179204|P4|STARTED|Overall Study||798
4951586|NCT02839330|12179205|P3|STARTED|Overall Study||795
4951587|NCT02839330|12179206|P2|STARTED|Overall Study||799
4951588|NCT02839330|12179207|P1|STARTED|Overall Study||804
4951589|NCT02839200|12179242|P6|NOT COMPLETED|Overall Study||1
4951590|NCT02839200|12179243|P5|NOT COMPLETED|Overall Study||2
4951591|NCT02839200|12179244|P4|NOT COMPLETED|Overall Study||0
4951592|NCT02839200|12179245|P3|NOT COMPLETED|Overall Study||1
4951593|NCT02839200|12179246|P2|NOT COMPLETED|Overall Study||1
4951594|NCT02839200|12179247|P1|NOT COMPLETED|Overall Study||4
4951595|NCT02839200|12179242|P6|COMPLETED|Overall Study||59
4951596|NCT02839200|12179243|P5|COMPLETED|Overall Study||58
4951597|NCT02839200|12179244|P4|COMPLETED|Overall Study||61
4951598|NCT02839200|12179245|P3|COMPLETED|Overall Study||59
4951599|NCT02839200|12179246|P2|COMPLETED|Overall Study||58
4951600|NCT02839200|12179247|P1|COMPLETED|Overall Study||56
4951601|NCT02839200|12179242|P6|STARTED|Overall Study||60
4951602|NCT02839200|12179243|P5|STARTED|Overall Study||60
4951603|NCT02839200|12179244|P4|STARTED|Overall Study||61
4951604|NCT02839200|12179245|P3|STARTED|Overall Study||60
4951605|NCT02839200|12179246|P2|STARTED|Overall Study||59
4951606|NCT02839200|12179247|P1|STARTED|Overall Study||60
4951607|NCT02838901|12179281|P2|NOT COMPLETED|Overall Study||2
4951608|NCT02838901|12179282|P1|NOT COMPLETED|Overall Study||2
4951609|NCT02838901|12179281|P2|COMPLETED|Overall Study||7
4951610|NCT02838901|12179282|P1|COMPLETED|Overall Study||7
4951611|NCT02838901|12179281|P2|STARTED|Overall Study||9
4951612|NCT02838901|12179282|P1|STARTED|Overall Study||9
4951613|NCT02838420|12179312|P2|NOT COMPLETED|Overall Study||62
4951614|NCT02838420|12179313|P1|NOT COMPLETED|Overall Study||125
4951615|NCT02838420|12179312|P2|COMPLETED|Overall Study||0
4951616|NCT02838420|12179313|P1|COMPLETED|Overall Study||0
4951617|NCT02838420|12179312|P2|STARTED|Overall Study||62
4951618|NCT02838420|12179313|P1|STARTED|Overall Study||125
4951619|NCT02838407|12179327|P1|NOT COMPLETED|Overall Study||0
4951620|NCT02838407|12179327|P1|COMPLETED|Overall Study||197
4951621|NCT02838407|12179327|P1|STARTED|Overall Study||197
4951622|NCT02838134|12179376|P2|NOT COMPLETED|Overall Study||3
4951623|NCT02838134|12179377|P1|NOT COMPLETED|Overall Study||2
4951624|NCT02838134|12179376|P2|COMPLETED|Overall Study||48
4951625|NCT02838134|12179377|P1|COMPLETED|Overall Study||48
4951626|NCT02838134|12179376|P2|STARTED|Overall Study||51
4951627|NCT02838134|12179377|P1|STARTED|Overall Study||50
4951628|NCT02838017|12179409|P2|NOT COMPLETED|Overall Study||11
4951629|NCT02838017|12179410|P1|NOT COMPLETED|Overall Study||14
4951630|NCT02838017|12179409|P2|COMPLETED|Overall Study||241
4951631|NCT02838017|12179410|P1|COMPLETED|Overall Study||238
4951632|NCT02838017|12179409|P2|STARTED|Overall Study||252
4951633|NCT02838017|12179410|P1|STARTED|Overall Study||252
4951634|NCT02837952|12179428|P2|NOT COMPLETED|Overall Study||6
4951635|NCT02837952|12179429|P1|NOT COMPLETED|Overall Study||5
4951636|NCT02837952|12179428|P2|COMPLETED|Overall Study||76
4951637|NCT02837952|12179429|P1|COMPLETED|Overall Study||36
4951638|NCT02837952|12179428|P2|STARTED|Overall Study||82
4951639|NCT02837952|12179429|P1|STARTED|Overall Study||41
4951640|NCT02837913|12179443|P2|NOT COMPLETED|Overall Study||0
4951641|NCT02837913|12179444|P1|NOT COMPLETED|Overall Study||0
4951642|NCT02837913|12179443|P2|COMPLETED|Overall Study||9
4951643|NCT02837913|12179444|P1|COMPLETED|Overall Study||10
4951644|NCT02837913|12179443|P2|STARTED|Overall Study||9
4951645|NCT02837913|12179444|P1|STARTED|Overall Study||10
4951646|NCT02837328|12179466|P2|NOT COMPLETED|Overall Study||0
4951647|NCT02837328|12179467|P1|NOT COMPLETED|Overall Study||0
4951648|NCT02837328|12179466|P2|COMPLETED|Overall Study||30
4951649|NCT02837328|12179467|P1|COMPLETED|Overall Study||29
4951650|NCT02837328|12179466|P2|STARTED|Overall Study||30
4951651|NCT02837328|12179467|P1|STARTED|Overall Study||29
4951652|NCT02837237|12179475|P1|NOT COMPLETED|Overall Study||0
4951653|NCT02837237|12179475|P1|COMPLETED|Overall Study||11
4951654|NCT02837237|12179475|P1|STARTED|Overall Study||11
4951655|NCT02836613|12179481|P2|NOT COMPLETED|Overall Study||3
4951656|NCT02836613|12179482|P1|NOT COMPLETED|Overall Study||1
4951657|NCT02836613|12179481|P2|COMPLETED|Overall Study||77
4951658|NCT02836613|12179482|P1|COMPLETED|Overall Study||79
4951659|NCT02836613|12179481|P2|STARTED|Overall Study||80
4951660|NCT02836613|12179482|P1|STARTED|Overall Study||80
4951661|NCT02836496|12179496|P2|NOT COMPLETED|Overall Study||2
4951662|NCT02836496|12179497|P1|NOT COMPLETED|Overall Study||2
4951663|NCT02836496|12179496|P2|COMPLETED|Overall Study||52
4951664|NCT02836496|12179497|P1|COMPLETED|Overall Study||52
4951665|NCT02836496|12179496|P2|STARTED|Overall Study||54
4951666|NCT02836496|12179497|P1|STARTED|Overall Study||54
4951667|NCT02836249|12179513|P2|NOT COMPLETED|Overall Study||58
4951668|NCT02836249|12179514|P1|NOT COMPLETED|Overall Study||123
4951669|NCT02836249|12179513|P2|COMPLETED|Overall Study||0
4951670|NCT02836249|12179514|P1|COMPLETED|Overall Study||0
4951671|NCT02836249|12179513|P2|STARTED|Overall Study||58
4951672|NCT02836249|12179514|P1|STARTED|Overall Study||123
4951673|NCT02836236|12179532|P2|NOT COMPLETED|Overall Study||50
4951674|NCT02836236|12179533|P1|NOT COMPLETED|Overall Study||105
4951675|NCT02836236|12179532|P2|COMPLETED|Overall Study||0
4951676|NCT02836236|12179533|P1|COMPLETED|Overall Study||0
4951677|NCT02836236|12179532|P2|STARTED|Overall Study||50
4951678|NCT02836236|12179533|P1|STARTED|Overall Study||105
4951679|NCT02835820|12179549|P2|NOT COMPLETED|Overall Study||3
4951680|NCT02835820|12179550|P1|NOT COMPLETED|Overall Study||0
4951681|NCT02835820|12179549|P2|COMPLETED|Overall Study||7
4951682|NCT02835820|12179550|P1|COMPLETED|Overall Study||7
4951683|NCT02835820|12179549|P2|Baseline Screen (OGTT)|Overall Study||7
4951684|NCT02835820|12179550|P1|Baseline Screen (OGTT)|Overall Study||7
4951685|NCT02835820|12179549|P2|STARTED|Overall Study||10
4951686|NCT02835820|12179550|P1|STARTED|Overall Study||7
4951687|NCT02835690|12179597|P3|NOT COMPLETED|Overall Study||15
4951688|NCT02835690|12179598|P2|NOT COMPLETED|Overall Study||15
4951689|NCT02835690|12179599|P1|NOT COMPLETED|Overall Study||14
4951690|NCT02835690|12179597|P3|COMPLETED|Overall Study||0
4951691|NCT02835690|12179598|P2|COMPLETED|Overall Study||0
4951692|NCT02835690|12179599|P1|COMPLETED|Overall Study||0
4951693|NCT02835690|12179597|P3|Treated|Overall Study||15
4951694|NCT02835690|12179598|P2|Treated|Overall Study||13
4951695|NCT02835690|12179599|P1|Treated|Overall Study||14
4951696|NCT02835690|12179597|P3|STARTED|Overall Study||15
4951697|NCT02835690|12179598|P2|STARTED|Overall Study||15
4951698|NCT02835690|12179599|P1|STARTED|Overall Study||14
4951699|NCT02835677|12179652|P1|NOT COMPLETED|Overall Study||0
4951700|NCT02835677|12179652|P1|COMPLETED|Overall Study||25
4951701|NCT02835677|12179652|P1|STARTED|Overall Study||25
4951702|NCT02835339|12179662|P2|NOT COMPLETED|Overall Study||16
4951703|NCT02835339|12179663|P1|NOT COMPLETED|Overall Study||13
4951704|NCT02835339|12179662|P2|COMPLETED|Overall Study||19
4951705|NCT02835339|12179663|P1|COMPLETED|Overall Study||18
4951706|NCT02835339|12179662|P2|STARTED|Overall Study||35
4951707|NCT02835339|12179663|P1|STARTED|Overall Study||31
4951708|NCT02835274|12179675|P2|NOT COMPLETED|Overall Study||0
4951709|NCT02835274|12179676|P1|NOT COMPLETED|Overall Study||0
4951710|NCT02835274|12179675|P2|COMPLETED|Overall Study||6
4951711|NCT02835274|12179676|P1|COMPLETED|Overall Study||6
4951712|NCT02835274|12179675|P2|STARTED|Overall Study||6
4951713|NCT02835274|12179676|P1|STARTED|Overall Study||6
4951714|NCT02835092|12179685|P3|NOT COMPLETED|Overall Study||3
4951715|NCT02835092|12179686|P2|NOT COMPLETED|Overall Study||8
4951716|NCT02835092|12179687|P1|NOT COMPLETED|Overall Study||3
4951717|NCT02835092|12179685|P3|COMPLETED|Overall Study||64
4951718|NCT02835092|12179686|P2|COMPLETED|Overall Study||57
4951719|NCT02835092|12179687|P1|COMPLETED|Overall Study||63
4951720|NCT02835092|12179685|P3|STARTED|Overall Study||67
4951721|NCT02835092|12179686|P2|STARTED|Overall Study||65
4951722|NCT02835092|12179687|P1|STARTED|Overall Study||66
4951723|NCT02834819|12179697|P2|NOT COMPLETED|Overall Study||0
4951724|NCT02834819|12179698|P1|NOT COMPLETED|Overall Study||5
4951725|NCT02834819|12179697|P2|COMPLETED|Overall Study||9
4951726|NCT02834819|12179698|P1|COMPLETED|Overall Study||4
4951727|NCT02834819|12179697|P2|STARTED|Overall Study||9
4951728|NCT02834819|12179698|P1|STARTED|Overall Study||9
4951729|NCT02834663|12179718|P1|NOT COMPLETED|Overall Study||0
4951730|NCT02834663|12179718|P1|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
4951731|NCT02834663|12179718|P1|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
4951732|NCT02834624|12179738|P2|NOT COMPLETED|Overall Study||0
4951733|NCT02834624|12179739|P1|NOT COMPLETED|Overall Study||0
4951734|NCT02834624|12179738|P2|COMPLETED|Overall Study||15
4951735|NCT02834624|12179739|P1|COMPLETED|Overall Study||15
4951736|NCT02834624|12179738|P2|STARTED|Overall Study||15
4951737|NCT02834624|12179739|P1|STARTED|Overall Study||15
4951738|NCT02834247|12179753|P4|NOT COMPLETED|Dose Expansion Phase||17
4951739|NCT02834247|12179754|P3|NOT COMPLETED|Dose Expansion Phase||0
4951740|NCT02834247|12179755|P2|NOT COMPLETED|Dose Expansion Phase||0
4951741|NCT02834247|12179756|P1|NOT COMPLETED|Dose Expansion Phase||0
4951742|NCT02834247|12179753|P4|COMPLETED|Dose Expansion Phase||0
4951743|NCT02834247|12179754|P3|COMPLETED|Dose Expansion Phase||0
4951744|NCT02834247|12179755|P2|COMPLETED|Dose Expansion Phase||0
4951745|NCT02834247|12179756|P1|COMPLETED|Dose Expansion Phase||0
4951746|NCT02834247|12179753|P4|STARTED|Dose Expansion Phase||17
4951747|NCT02834247|12179754|P3|STARTED|Dose Expansion Phase||0
4951748|NCT02834247|12179755|P2|STARTED|Dose Expansion Phase||0
4951749|NCT02834247|12179756|P1|STARTED|Dose Expansion Phase||0
4951750|NCT02834247|12179753|P4|NOT COMPLETED|Dose Escalation Phase||0
4951751|NCT02834247|12179754|P3|NOT COMPLETED|Dose Escalation Phase||5
4951752|NCT02834247|12179755|P2|NOT COMPLETED|Dose Escalation Phase||11
4951753|NCT02834247|12179756|P1|NOT COMPLETED|Dose Escalation Phase||8
4951754|NCT02834247|12179753|P4|COMPLETED|Dose Escalation Phase||0
4951755|NCT02834247|12179754|P3|COMPLETED|Dose Escalation Phase||0
4951756|NCT02834247|12179755|P2|COMPLETED|Dose Escalation Phase||0
4951757|NCT02834247|12179756|P1|COMPLETED|Dose Escalation Phase||0
4951758|NCT02834247|12179753|P4|STARTED|Dose Escalation Phase||0
4951759|NCT02834247|12179754|P3|STARTED|Dose Escalation Phase||5
4951760|NCT02834247|12179755|P2|STARTED|Dose Escalation Phase||11
4951761|NCT02834247|12179756|P1|STARTED|Dose Escalation Phase||8
4951762|NCT02833974|12179785|P2|NOT COMPLETED|Overall Study||3
4951763|NCT02833974|12179786|P1|NOT COMPLETED|Overall Study||1
4951764|NCT02833974|12179785|P2|COMPLETED|Overall Study||19
4951765|NCT02833974|12179786|P1|COMPLETED|Overall Study||13
4951766|NCT02833974|12179785|P2|STARTED|Overall Study||22
4951767|NCT02833974|12179786|P1|STARTED|Overall Study||14
4951768|NCT02833948|12179812|P2|NOT COMPLETED|Overall Study||18
4951769|NCT02833948|12179813|P1|NOT COMPLETED|Overall Study||15
4951770|NCT02833948|12179812|P2|COMPLETED|Overall Study||97
4951771|NCT02833948|12179813|P1|COMPLETED|Overall Study||101
4951772|NCT02833948|12179812|P2|STARTED|Overall Study||115
4951773|NCT02833948|12179813|P1|STARTED|Overall Study||116
4951774|NCT02833922|12179837|P1|NOT COMPLETED|Overall Study||382
4951775|NCT02833922|12179837|P1|COMPLETED|Overall Study||336
4951776|NCT02833922|12179837|P1|STARTED|Overall Study||718
4951777|NCT02833857|12179845|P1|NOT COMPLETED|Overall Study||0
4951778|NCT02833857|12179845|P1|COMPLETED|Overall Study||11
4951779|NCT02833857|12179845|P1|STARTED|Overall Study||11
4951780|NCT02833844|12179872|P2|NOT COMPLETED|Overall Study||7
4951781|NCT02833844|12179873|P1|NOT COMPLETED|Overall Study||2
4951782|NCT02833844|12179872|P2|COMPLETED|Overall Study|completed double-blind period|303
4951783|NCT02833844|12179873|P1|COMPLETED|Overall Study|completed double-blind period|155
4951784|NCT02833844|12179872|P2|Randomized and Treated|Overall Study||307
4951785|NCT02833844|12179873|P1|Randomized and Treated|Overall Study||157
4951786|NCT02833844|12179872|P2|STARTED|Overall Study||310
4951787|NCT02833844|12179873|P1|STARTED|Overall Study||157
4951788|NCT02833415|12179901|P2|NOT COMPLETED|Overall Study||3
4951789|NCT02833415|12179902|P1|NOT COMPLETED|Overall Study||2
4951790|NCT02833415|12179901|P2|COMPLETED|Overall Study||17
4951791|NCT02833415|12179902|P1|COMPLETED|Overall Study||18
4951792|NCT02833415|12179901|P2|STARTED|Overall Study||20
4951793|NCT02833415|12179902|P1|STARTED|Overall Study||20
4951794|NCT02833350|12179915|P7|NOT COMPLETED|Overall Study||5
4951795|NCT02833350|12179916|P6|NOT COMPLETED|Overall Study||1
4951796|NCT02833350|12179917|P5|NOT COMPLETED|Overall Study||3
4951797|NCT02833350|12179918|P4|NOT COMPLETED|Overall Study||8
4951798|NCT02833350|12179919|P3|NOT COMPLETED|Overall Study||8
4951799|NCT02833350|12179920|P2|NOT COMPLETED|Overall Study||9
4951800|NCT02833350|12179921|P1|NOT COMPLETED|Overall Study||3
4951801|NCT02833350|12179915|P7|COMPLETED|Overall Study||44
4951802|NCT02833350|12179916|P6|COMPLETED|Overall Study||48
4951803|NCT02833350|12179917|P5|COMPLETED|Overall Study||108
4951804|NCT02833350|12179918|P4|COMPLETED|Overall Study||102
4951805|NCT02833350|12179919|P3|COMPLETED|Overall Study||102
4951806|NCT02833350|12179920|P2|COMPLETED|Overall Study||100
4951807|NCT02833350|12179921|P1|COMPLETED|Overall Study||37
4951808|NCT02833350|12179915|P7|Randomized|Overall Study||50
4951809|NCT02833350|12179916|P6|Randomized|Overall Study||48
4951810|NCT02833350|12179917|P5|Randomized|Overall Study||111
4951811|NCT02833350|12179918|P4|Randomized|Overall Study||110
4951812|NCT02833350|12179919|P3|Randomized|Overall Study||110
4951813|NCT02833350|12179920|P2|Randomized|Overall Study||109
4951814|NCT02833350|12179921|P1|Randomized|Overall Study||40
4951815|NCT02833350|12179915|P7|STARTED|Overall Study||49
4951816|NCT02833350|12179916|P6|STARTED|Overall Study||49
4951817|NCT02833350|12179917|P5|STARTED|Overall Study||111
4951818|NCT02833350|12179918|P4|STARTED|Overall Study||110
4951819|NCT02833350|12179919|P3|STARTED|Overall Study||110
4951820|NCT02833350|12179920|P2|STARTED|Overall Study||109
4951821|NCT02833350|12179921|P1|STARTED|Overall Study||40
4951822|NCT02833077|12180124|P2|NOT COMPLETED|Overall Study||8
4951823|NCT02833077|12180125|P1|NOT COMPLETED|Overall Study||17
4951824|NCT02833077|12180124|P2|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
4951825|NCT02833077|12180125|P1|COMPLETED|Overall Study||127
4951826|NCT02833077|12180124|P2|Participants Treated|Overall Study||38
4951827|NCT02833077|12180125|P1|Participants Treated|Overall Study||144
4951828|NCT02833077|12180124|P2|STARTED|Overall Study||48
4951829|NCT02833077|12180125|P1|STARTED|Overall Study||144
4951830|NCT02832674|12180137|P1|NOT COMPLETED|Overall Study||5
4951831|NCT02832674|12180137|P1|COMPLETED|Overall Study||67
4951832|NCT02832674|12180137|P1|STARTED|Overall Study||72
4951833|NCT02832375|12180148|P2|NOT COMPLETED|Overall Study||0
4951834|NCT02832375|12180149|P1|NOT COMPLETED|Overall Study||2
4951835|NCT02832375|12180148|P2|COMPLETED|Overall Study||121
4951836|NCT02832375|12180149|P1|COMPLETED|Overall Study||119
4951837|NCT02832375|12180148|P2|STARTED|Overall Study||121
4951838|NCT02832375|12180149|P1|STARTED|Overall Study||121
4951839|NCT02832284|12180159|P1|NOT COMPLETED|Overall Study||0
4951840|NCT02832284|12180159|P1|COMPLETED|Overall Study||23
4951841|NCT02832284|12180159|P1|STARTED|Overall Study||23
4951842|NCT02832154|12180167|P1|NOT COMPLETED|Overall Study||0
4951843|NCT02832154|12180167|P1|COMPLETED|Overall Study||43
4951844|NCT02832154|12180167|P1|STARTED|Overall Study||43
4951845|NCT02831855|12180180|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
4951846|NCT02831855|12180181|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
4951847|NCT02831855|12180182|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
4951848|NCT02831855|12180180|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
4951849|NCT02831855|12180181|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
4951850|NCT02831855|12180182|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
4951851|NCT02831855|12180180|P3|Treated|Double Blind Phase (24 Weeks)||266
4951852|NCT02831855|12180181|P2|Treated|Double Blind Phase (24 Weeks)||264
4951853|NCT02831855|12180182|P1|Treated|Double Blind Phase (24 Weeks)||0
4951854|NCT02831855|12180180|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
4951855|NCT02831855|12180181|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
4951856|NCT02831855|12180182|P1|STARTED|Double Blind Phase (24 Weeks)||0
4951857|NCT02831855|12180180|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
4951858|NCT02831855|12180181|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
4951859|NCT02831855|12180182|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
4951860|NCT02831855|12180180|P3|COMPLETED|Open Label Phase (24 Weeks)||0
4951861|NCT02831855|12180181|P2|COMPLETED|Open Label Phase (24 Weeks)||0
4951862|NCT02831855|12180182|P1|COMPLETED|Open Label Phase (24 Weeks)||623
4951863|NCT02831855|12180180|P3|STARTED|Open Label Phase (24 Weeks)||0
4951864|NCT02831855|12180181|P2|STARTED|Open Label Phase (24 Weeks)||0
4951865|NCT02831855|12180182|P1|STARTED|Open Label Phase (24 Weeks)||694
4951866|NCT02831764|12180243|P2|NOT COMPLETED|Overall Study||359
4951867|NCT02831764|12180244|P1|NOT COMPLETED|Overall Study||360
4951868|NCT02831764|12180243|P2|COMPLETED|Overall Study||0
4951869|NCT02831764|12180244|P1|COMPLETED|Overall Study||0
4951870|NCT02831764|12180243|P2|STARTED|Overall Study||359
4951871|NCT02831764|12180244|P1|STARTED|Overall Study||360
4951872|NCT02831673|12180308|P2|NOT COMPLETED|Overall Study||358
4951873|NCT02831673|12180309|P1|NOT COMPLETED|Overall Study||356
4951874|NCT02831673|12180308|P2|COMPLETED|Overall Study||0
4951875|NCT02831673|12180309|P1|COMPLETED|Overall Study||0
4951876|NCT02831673|12180308|P2|STARTED|Overall Study||358
4951877|NCT02831673|12180309|P1|STARTED|Overall Study||356
4951878|NCT02831660|12180371|P1|NOT COMPLETED|Overall Study||0
4951879|NCT02831660|12180371|P1|COMPLETED|Overall Study||1
4951880|NCT02831660|12180371|P1|STARTED|Overall Study||1
4951881|NCT02831569|12180375|P1|NOT COMPLETED|Overall Study||0
4951882|NCT02831569|12180375|P1|COMPLETED|Overall Study||80
4951883|NCT02831569|12180375|P1|STARTED|Overall Study||80
4951884|NCT02831387|12180382|P2|NOT COMPLETED|Overall Study||2
4951885|NCT02831387|12180383|P1|NOT COMPLETED|Overall Study||1
4951886|NCT02831387|12180382|P2|COMPLETED|Overall Study||22
4951887|NCT02831387|12180383|P1|COMPLETED|Overall Study||22
4951888|NCT02831387|12180382|P2|STARTED|Overall Study||24
4951889|NCT02831387|12180383|P1|STARTED|Overall Study||23
4951890|NCT02830893|12180403|P2|NOT COMPLETED|Overall Study||3
4951891|NCT02830893|12180404|P1|NOT COMPLETED|Overall Study||1
4951892|NCT02830893|12180403|P2|COMPLETED|Overall Study||8
4951893|NCT02830893|12180404|P1|COMPLETED|Overall Study||11
4951894|NCT02830893|12180403|P2|STARTED|Overall Study||11
4951895|NCT02830893|12180404|P1|STARTED|Overall Study||12
4951896|NCT02830880|12180416|P1|NOT COMPLETED|Overall Study||3
4951897|NCT02830880|12180416|P1|COMPLETED|Overall Study||4
4951898|NCT02830880|12180416|P1|Completed Visit After Cyle 1|Overall Study||7
4951899|NCT02830880|12180416|P1|STARTED|Overall Study||7
4951900|NCT02830438|12180425|P1|NOT COMPLETED|Overall Study||0
4951901|NCT02830438|12180425|P1|COMPLETED|Overall Study||8
4951902|NCT02830438|12180425|P1|STARTED|Overall Study||8
4951903|NCT02830087|12180435|P6|NOT COMPLETED|Overall Study||3
4951904|NCT02830087|12180436|P5|NOT COMPLETED|Overall Study||3
4951905|NCT02830087|12180437|P4|NOT COMPLETED|Overall Study||3
4951906|NCT02830087|12180438|P3|NOT COMPLETED|Overall Study||4
4951907|NCT02830087|12180439|P2|NOT COMPLETED|Overall Study||4
4951908|NCT02830087|12180440|P1|NOT COMPLETED|Overall Study||4
4951909|NCT02830087|12180435|P6|COMPLETED|Overall Study||0
4951910|NCT02830087|12180436|P5|COMPLETED|Overall Study||0
4951911|NCT02830087|12180437|P4|COMPLETED|Overall Study||0
4951912|NCT02830087|12180438|P3|COMPLETED|Overall Study||0
4951913|NCT02830087|12180439|P2|COMPLETED|Overall Study||0
4951914|NCT02830087|12180440|P1|COMPLETED|Overall Study||0
4951915|NCT02830087|12180435|P6|STARTED|Overall Study||3
4951916|NCT02830087|12180436|P5|STARTED|Overall Study||3
4951917|NCT02830087|12180437|P4|STARTED|Overall Study||3
4951918|NCT02830087|12180438|P3|STARTED|Overall Study||4
4951919|NCT02830087|12180439|P2|STARTED|Overall Study||4
4951920|NCT02830087|12180440|P1|STARTED|Overall Study||4
4951921|NCT02829996|12180507|P5|NOT COMPLETED|Overall Study||0
4951922|NCT02829996|12180508|P4|NOT COMPLETED|Overall Study||0
4951923|NCT02829996|12180509|P3|NOT COMPLETED|Overall Study||0
4951924|NCT02829996|12180510|P2|NOT COMPLETED|Overall Study||0
4951925|NCT02829996|12180511|P1|NOT COMPLETED|Overall Study||1
4951926|NCT02829996|12180507|P5|COMPLETED|Overall Study||42
4951927|NCT02829996|12180508|P4|COMPLETED|Overall Study||41
4951928|NCT02829996|12180509|P3|COMPLETED|Overall Study||40
4951929|NCT02829996|12180510|P2|COMPLETED|Overall Study||39
4951930|NCT02829996|12180511|P1|COMPLETED|Overall Study||38
4951931|NCT02829996|12180507|P5|STARTED|Overall Study||42
4951932|NCT02829996|12180508|P4|STARTED|Overall Study||41
4951933|NCT02829996|12180509|P3|STARTED|Overall Study||40
4951934|NCT02829996|12180510|P2|STARTED|Overall Study||39
4951935|NCT02829996|12180511|P1|STARTED|Overall Study||39
4951936|NCT02829983|12180525|P2|NOT COMPLETED|Overall Study||0
4951937|NCT02829983|12180526|P1|NOT COMPLETED|Overall Study||0
4951938|NCT02829983|12180525|P2|COMPLETED|Overall Study||20
4951939|NCT02829983|12180526|P1|COMPLETED|Overall Study||20
4951940|NCT02829983|12180525|P2|STARTED|Overall Study||20
4951941|NCT02829983|12180526|P1|STARTED|Overall Study||20
4951942|NCT02829944|12180536|P2|NOT COMPLETED|Overall Study||7
4951943|NCT02829944|12180537|P1|NOT COMPLETED|Overall Study||6
4951944|NCT02829944|12180536|P2|COMPLETED|Overall Study||33
4951945|NCT02829944|12180537|P1|COMPLETED|Overall Study||38
4951946|NCT02829944|12180536|P2|STARTED|Overall Study||40
4951947|NCT02829944|12180537|P1|STARTED|Overall Study||44
4951948|NCT02829918|12180587|P1|NOT COMPLETED|Overall Study||8
4951949|NCT02829918|12180587|P1|COMPLETED|Overall Study||46
4951950|NCT02829918|12180587|P1|STARTED|Overall Study||54
4951951|NCT02829775|12180592|P1|NOT COMPLETED|Overall Study||5
4951952|NCT02829775|12180592|P1|COMPLETED|Overall Study||4
4951953|NCT02829775|12180592|P1|STARTED|Overall Study||9
4951954|NCT02829463|12180599|P2|NOT COMPLETED|Overall Study||0
4951955|NCT02829463|12180600|P1|NOT COMPLETED|Overall Study||0
4951956|NCT02829463|12180599|P2|COMPLETED|Overall Study||62
4951957|NCT02829463|12180600|P1|COMPLETED|Overall Study||59
4951958|NCT02829463|12180599|P2|STARTED|Overall Study||62
4951959|NCT02829463|12180600|P1|STARTED|Overall Study||59
4951960|NCT02829320|12180606|P1|NOT COMPLETED|Overall Study||0
4951961|NCT02829320|12180606|P1|COMPLETED|Overall Study||28
4951962|NCT02829320|12180606|P1|STARTED|Overall Study||28
4951963|NCT02829307|12180643|P1|NOT COMPLETED|Overall Study||0
4951964|NCT02829307|12180643|P1|COMPLETED|Overall Study||8
4951965|NCT02829307|12180643|P1|STARTED|Overall Study||8
4951966|NCT02829294|12180666|P1|NOT COMPLETED|Overall Study||0
4951967|NCT02829294|12180666|P1|COMPLETED|Overall Study||19
4951968|NCT02829294|12180666|P1|STARTED|Overall Study||19
4951969|NCT02829138|12180674|P2|NOT COMPLETED|Overall Study||0
4951970|NCT02829138|12180675|P1|NOT COMPLETED|Overall Study||1
4951971|NCT02829138|12180674|P2|COMPLETED|Overall Study||28
4951972|NCT02829138|12180675|P1|COMPLETED|Overall Study||28
4951973|NCT02829138|12180674|P2|STARTED|Overall Study||28
4951974|NCT02829138|12180675|P1|STARTED|Overall Study||29
4951975|NCT02829034|12180687|P2|NOT COMPLETED|Overall Study||2
4951976|NCT02829034|12180688|P1|NOT COMPLETED|Overall Study||5
4951977|NCT02829034|12180687|P2|COMPLETED|Overall Study||6
4951978|NCT02829034|12180688|P1|COMPLETED|Overall Study||9
4951979|NCT02829034|12180687|P2|STARTED|Overall Study||8
4951980|NCT02829034|12180688|P1|STARTED|Overall Study||14
4951981|NCT02828644|12180700|P2|NOT COMPLETED|Overall Study||22
4951982|NCT02828644|12180701|P1|NOT COMPLETED|Overall Study||23
4951983|NCT02828644|12180700|P2|COMPLETED|Overall Study||65
4951984|NCT02828644|12180701|P1|COMPLETED|Overall Study||65
4951985|NCT02828644|12180700|P2|STARTED|Overall Study||87
4951986|NCT02828644|12180701|P1|STARTED|Overall Study||88
4951987|NCT02828241|12180710|P2|NOT COMPLETED|Overall Study||2
4951988|NCT02828241|12180711|P1|NOT COMPLETED|Overall Study||8
4951989|NCT02828241|12180710|P2|COMPLETED|Overall Study||21
4951990|NCT02828241|12180711|P1|COMPLETED|Overall Study||30
4951991|NCT02828241|12180710|P2|STARTED|Overall Study||23
4951992|NCT02828241|12180711|P1|STARTED|Overall Study||38
4951993|NCT02828137|12180724|P3|NOT COMPLETED|Overall Study||0
4951994|NCT02828137|12180725|P2|NOT COMPLETED|Overall Study||0
4951995|NCT02828137|12180726|P1|NOT COMPLETED|Overall Study||0
4951996|NCT02828137|12180724|P3|COMPLETED|Overall Study||41
4951997|NCT02828137|12180725|P2|COMPLETED|Overall Study||41
4951998|NCT02828137|12180726|P1|COMPLETED|Overall Study||41
4951999|NCT02828137|12180724|P3|STARTED|Overall Study||41
4952000|NCT02828137|12180725|P2|STARTED|Overall Study||41
4952001|NCT02828137|12180726|P1|STARTED|Overall Study||41
4952002|NCT02828124|12180738|P4|NOT COMPLETED|Overall Study||6
4952003|NCT02828124|12180739|P3|NOT COMPLETED|Overall Study||1
4952004|NCT02828124|12180740|P2|NOT COMPLETED|Overall Study||2
4952005|NCT02828124|12180741|P1|NOT COMPLETED|Overall Study||1
4952006|NCT02828124|12180738|P4|COMPLETED|Overall Study||0
4952007|NCT02828124|12180739|P3|COMPLETED|Overall Study||0
4952008|NCT02828124|12180740|P2|COMPLETED|Overall Study||0
4952009|NCT02828124|12180741|P1|COMPLETED|Overall Study||0
4952010|NCT02828124|12180738|P4|STARTED|Overall Study||6
4952011|NCT02828124|12180739|P3|STARTED|Overall Study||1
4952012|NCT02828124|12180740|P2|STARTED|Overall Study||2
4952013|NCT02828124|12180741|P1|STARTED|Overall Study||1
4952014|NCT02828111|12180856|P5|NOT COMPLETED|Overall Study||1
4952015|NCT02828111|12180857|P4|NOT COMPLETED|Overall Study||1
4952016|NCT02828111|12180858|P3|NOT COMPLETED|Overall Study||2
4952017|NCT02828111|12180859|P2|NOT COMPLETED|Overall Study||0
4952018|NCT02828111|12180860|P1|NOT COMPLETED|Overall Study||0
4952019|NCT02828111|12180856|P5|COMPLETED|Overall Study||11
4952020|NCT02828111|12180857|P4|COMPLETED|Overall Study||5
4952021|NCT02828111|12180858|P3|COMPLETED|Overall Study||4
4952022|NCT02828111|12180859|P2|COMPLETED|Overall Study||6
4952023|NCT02828111|12180860|P1|COMPLETED|Overall Study||6
4952024|NCT02828111|12180856|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
4952025|NCT02828111|12180857|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
4952026|NCT02828111|12180858|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
4952027|NCT02828111|12180859|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
4952028|NCT02828111|12180860|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
4952029|NCT02828111|12180856|P5|STARTED|Overall Study||12
4952030|NCT02828111|12180857|P4|STARTED|Overall Study||6
4952031|NCT02828111|12180858|P3|STARTED|Overall Study||6
4952032|NCT02828111|12180859|P2|STARTED|Overall Study||6
4952033|NCT02828111|12180860|P1|STARTED|Overall Study||6
4952034|NCT02828020|12180921|P3|NOT COMPLETED|Safety Follow-up Period||19
4952035|NCT02828020|12180922|P2|NOT COMPLETED|Safety Follow-up Period||18
4952036|NCT02828020|12180923|P1|NOT COMPLETED|Safety Follow-up Period||20
4952037|NCT02828020|12180921|P3|COMPLETED|Safety Follow-up Period||461
4952038|NCT02828020|12180922|P2|COMPLETED|Safety Follow-up Period||440
4952039|NCT02828020|12180923|P1|COMPLETED|Safety Follow-up Period||460
4952040|NCT02828020|12180921|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
4952041|NCT02828020|12180922|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
4952042|NCT02828020|12180923|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
4952043|NCT02828020|12180921|P3|NOT COMPLETED|Treatment Period||78
4952044|NCT02828020|12180922|P2|NOT COMPLETED|Treatment Period||99
4952045|NCT02828020|12180923|P1|NOT COMPLETED|Treatment Period||80
4952046|NCT02828020|12180921|P3|COMPLETED|Treatment Period||479
4952047|NCT02828020|12180922|P2|COMPLETED|Treatment Period||457
4952048|NCT02828020|12180923|P1|COMPLETED|Treatment Period||479
4952049|NCT02828020|12180921|P3|Safety Population: Received Study Drug|Treatment Period||485
4952050|NCT02828020|12180922|P2|Safety Population: Received Study Drug|Treatment Period||466
4952051|NCT02828020|12180923|P1|Safety Population: Received Study Drug|Treatment Period||485
4952052|NCT02828020|12180921|P3|STARTED|Treatment Period||557
4952053|NCT02828020|12180922|P2|STARTED|Treatment Period||556
4952054|NCT02828020|12180923|P1|STARTED|Treatment Period||559
4952055|NCT02827708|12180954|P2|NOT COMPLETED|Overall Study||5
4952056|NCT02827708|12180955|P1|NOT COMPLETED|Overall Study||5
4952057|NCT02827708|12180954|P2|COMPLETED|Overall Study||156
4952058|NCT02827708|12180955|P1|COMPLETED|Overall Study||158
4952059|NCT02827708|12180954|P2|Safety Analysis Set (SAS)|Overall Study||161
4952060|NCT02827708|12180955|P1|Safety Analysis Set (SAS)|Overall Study||163
4952061|NCT02827708|12180954|P2|Full Analysis Set (FAS)|Overall Study||161
4952062|NCT02827708|12180955|P1|Full Analysis Set (FAS)|Overall Study||163
4952063|NCT02827708|12180954|P2|STARTED|Overall Study||161
4952064|NCT02827708|12180955|P1|STARTED|Overall Study||163
4952065|NCT02827500|12181034|P2|NOT COMPLETED|Overall Study||7
4952066|NCT02827500|12181035|P1|NOT COMPLETED|Overall Study||19
4952067|NCT02827500|12181034|P2|COMPLETED|Overall Study||45
4952068|NCT02827500|12181035|P1|COMPLETED|Overall Study||33
4952069|NCT02827500|12181034|P2|STARTED|Overall Study||52
4952070|NCT02827500|12181035|P1|STARTED|Overall Study||52
4952071|NCT02826798|12181056|P5|NOT COMPLETED|Overall Study||0
4952072|NCT02826798|12181057|P4|NOT COMPLETED|Overall Study||1
4952073|NCT02826798|12181058|P3|NOT COMPLETED|Overall Study||0
4952074|NCT02826798|12181059|P2|NOT COMPLETED|Overall Study||1
4952075|NCT02826798|12181060|P1|NOT COMPLETED|Overall Study||0
4952076|NCT02826798|12181056|P5|COMPLETED|Overall Study||26
4952077|NCT02826798|12181057|P4|COMPLETED|Overall Study||24
4952078|NCT02826798|12181058|P3|COMPLETED|Overall Study||26
4952079|NCT02826798|12181059|P2|COMPLETED|Overall Study||25
4952080|NCT02826798|12181060|P1|COMPLETED|Overall Study||25
4952081|NCT02826798|12181056|P5|STARTED|Overall Study||26
4952082|NCT02826798|12181057|P4|STARTED|Overall Study||25
4952083|NCT02826798|12181058|P3|STARTED|Overall Study||26
4952084|NCT02826798|12181059|P2|STARTED|Overall Study||26
4952085|NCT02826798|12181060|P1|STARTED|Overall Study||25
4952086|NCT02826694|12181109|P2|NOT COMPLETED|Overall Study||0
4952087|NCT02826694|12181110|P1|NOT COMPLETED|Overall Study||0
4952088|NCT02826694|12181109|P2|COMPLETED|Overall Study||45
4952089|NCT02826694|12181110|P1|COMPLETED|Overall Study||61
4952090|NCT02826694|12181109|P2|Control Group|Overall Study||15
4952091|NCT02826694|12181110|P1|Control Group|Overall Study||20
4952092|NCT02826694|12181109|P2|Decision Group|Overall Study||30
4952093|NCT02826694|12181110|P1|Decision Group|Overall Study||41
4952094|NCT02826694|12181109|P2|STARTED|Overall Study||45
4952095|NCT02826694|12181110|P1|STARTED|Overall Study||61
4952096|NCT02826603|12181122|P2|NOT COMPLETED|Overall Study||64
4952097|NCT02826603|12181123|P1|NOT COMPLETED|Overall Study||61
4952098|NCT02826603|12181122|P2|COMPLETED|Overall Study||488
4952099|NCT02826603|12181123|P1|COMPLETED|Overall Study||489
4952100|NCT02826603|12181122|P2|STARTED|Overall Study||552
4952101|NCT02826603|12181123|P1|STARTED|Overall Study||550
4952102|NCT02826551|12181150|P2|NOT COMPLETED|Overall Study||0
4952103|NCT02826551|12181151|P1|NOT COMPLETED|Overall Study||0
4952104|NCT02826551|12181150|P2|COMPLETED|Overall Study||12
4952105|NCT02826551|12181151|P1|COMPLETED|Overall Study||11
4952106|NCT02826551|12181150|P2|STARTED|Overall Study||12
4952107|NCT02826551|12181151|P1|STARTED|Overall Study||11
4952108|NCT02826421|12181163|P4|NOT COMPLETED|Overall Study||2
4952109|NCT02826421|12181164|P3|NOT COMPLETED|Overall Study||2
4952110|NCT02826421|12181165|P2|NOT COMPLETED|Overall Study||3
4952111|NCT02826421|12181166|P1|NOT COMPLETED|Overall Study||3
4952112|NCT02826421|12181163|P4|COMPLETED|Overall Study||28
4952113|NCT02826421|12181164|P3|COMPLETED|Overall Study||26
4952114|NCT02826421|12181165|P2|COMPLETED|Overall Study||26
4952115|NCT02826421|12181166|P1|COMPLETED|Overall Study||19
4952116|NCT02826421|12181163|P4|Treated|Overall Study||28
4952117|NCT02826421|12181164|P3|Treated|Overall Study||26
4952118|NCT02826421|12181165|P2|Treated|Overall Study||26
4952119|NCT02826421|12181166|P1|Treated|Overall Study||19
4952120|NCT02826421|12181163|P4|STARTED|Overall Study||30
4952121|NCT02826421|12181164|P3|STARTED|Overall Study||28
4952122|NCT02826421|12181165|P2|STARTED|Overall Study||29
4952123|NCT02826421|12181166|P1|STARTED|Overall Study||22
4952124|NCT02825992|12181178|P1|NOT COMPLETED|Overall Study||8
4952125|NCT02825992|12181178|P1|COMPLETED|Overall Study||121
4952126|NCT02825992|12181178|P1|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
4952127|NCT02825550|12181190|P1|NOT COMPLETED|Overall Study||1
4952128|NCT02825550|12181190|P1|COMPLETED|Overall Study||12
4952129|NCT02825550|12181190|P1|STARTED|Overall Study||13
4952130|NCT02825251|12181198|P2|NOT COMPLETED|Overall Study||6
4952131|NCT02825251|12181199|P1|NOT COMPLETED|Overall Study||3
4952132|NCT02825251|12181198|P2|COMPLETED|Overall Study||230
4952133|NCT02825251|12181199|P1|COMPLETED|Overall Study||233
4952134|NCT02825251|12181198|P2|STARTED|Overall Study||236
4952135|NCT02825251|12181199|P1|STARTED|Overall Study||236
4952136|NCT02825043|12181385|P1|NOT COMPLETED|Overall Study||4
4952137|NCT02825043|12181385|P1|COMPLETED|Overall Study||2
4952138|NCT02825043|12181385|P1|STARTED|Overall Study||6
4952139|NCT02824913|12181392|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4952140|NCT02824913|12181393|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4952141|NCT02824913|12181392|P2|COMPLETED|Second Intervention (1 Day)||0
4952142|NCT02824913|12181393|P1|COMPLETED|Second Intervention (1 Day)||1
4952143|NCT02824913|12181392|P2|STARTED|Second Intervention (1 Day)||0
4952144|NCT02824913|12181393|P1|STARTED|Second Intervention (1 Day)||1
4952145|NCT02824913|12181392|P2|NOT COMPLETED|Washout (7-14 Days)||0
4952146|NCT02824913|12181393|P1|NOT COMPLETED|Washout (7-14 Days)||0
4952147|NCT02824913|12181392|P2|COMPLETED|Washout (7-14 Days)||0
4952148|NCT02824913|12181393|P1|COMPLETED|Washout (7-14 Days)||1
4952149|NCT02824913|12181392|P2|STARTED|Washout (7-14 Days)||0
4952150|NCT02824913|12181393|P1|STARTED|Washout (7-14 Days)||1
4952151|NCT02824913|12181392|P2|NOT COMPLETED|First Intervention (1 Day)||0
4952152|NCT02824913|12181393|P1|NOT COMPLETED|First Intervention (1 Day)||0
4952153|NCT02824913|12181392|P2|COMPLETED|First Intervention (1 Day)||0
4952154|NCT02824913|12181393|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
4952155|NCT02824913|12181392|P2|STARTED|First Intervention (1 Day)||0
4952156|NCT02824913|12181393|P1|STARTED|First Intervention (1 Day)||1
4952157|NCT02824562|12181407|P2|NOT COMPLETED|Overall Study||5
4952158|NCT02824562|12181408|P1|NOT COMPLETED|Overall Study||3
4952159|NCT02824562|12181407|P2|COMPLETED|Overall Study||17
4952160|NCT02824562|12181408|P1|COMPLETED|Overall Study||19
4952161|NCT02824562|12181407|P2|STARTED|Overall Study||22
4952162|NCT02824562|12181408|P1|STARTED|Overall Study||22
4952163|NCT02824432|12181417|P2|NOT COMPLETED|Overall Study||0
4952164|NCT02824432|12181418|P1|NOT COMPLETED|Overall Study||1
4952165|NCT02824432|12181417|P2|COMPLETED|Overall Study||19
4952166|NCT02824432|12181418|P1|COMPLETED|Overall Study||17
4952167|NCT02824432|12181417|P2|STARTED|Overall Study||19
4952168|NCT02824432|12181418|P1|STARTED|Overall Study||18
4952169|NCT02824224|12181494|P2|NOT COMPLETED|Overall Study||1
4952170|NCT02824224|12181495|P1|NOT COMPLETED|Overall Study||2
4952171|NCT02824224|12181494|P2|COMPLETED|Overall Study||17
4952172|NCT02824224|12181495|P1|COMPLETED|Overall Study||17
4952173|NCT02824224|12181494|P2|STARTED|Overall Study||18
4952174|NCT02824224|12181495|P1|STARTED|Overall Study||19
4952175|NCT02824198|12181515|P2|NOT COMPLETED|Overall Study||3
4952176|NCT02824198|12181516|P1|NOT COMPLETED|Overall Study||15
4952177|NCT02824198|12181515|P2|COMPLETED|Overall Study||26
4952178|NCT02824198|12181516|P1|COMPLETED|Overall Study||74
4952179|NCT02824198|12181515|P2|STARTED|Overall Study||29
4952180|NCT02824198|12181516|P1|STARTED|Overall Study||89
4952181|NCT02823964|12181546|P1|NOT COMPLETED|Overall Study||5
4952182|NCT02823964|12181546|P1|COMPLETED|Overall Study||20
4952183|NCT02823964|12181546|P1|STARTED|Overall Study||25
4952184|NCT02823600|12181550|P1|NOT COMPLETED|Overall Study||0
4952185|NCT02823600|12181550|P1|COMPLETED|Overall Study||68
4952186|NCT02823600|12181550|P1|STARTED|Overall Study||68
4952187|NCT02823470|12181560|P2|NOT COMPLETED|Overall Study||15
4952188|NCT02823470|12181561|P1|NOT COMPLETED|Overall Study||9
4952189|NCT02823470|12181560|P2|COMPLETED|Overall Study||0
4952190|NCT02823470|12181561|P1|COMPLETED|Overall Study||0
4952191|NCT02823470|12181560|P2|STARTED|Overall Study||15
4952192|NCT02823470|12181561|P1|STARTED|Overall Study||9
4952193|NCT02823431|12181575|P2|NOT COMPLETED|Overall Study||0
4952194|NCT02823431|12181576|P1|NOT COMPLETED|Overall Study||0
4952195|NCT02823431|12181575|P2|COMPLETED|Overall Study||12
4952196|NCT02823431|12181576|P1|COMPLETED|Overall Study||11
4952197|NCT02823431|12181575|P2|STARTED|Overall Study||12
4952198|NCT02823431|12181576|P1|STARTED|Overall Study||11
4952199|NCT02823080|12181590|P2|NOT COMPLETED|Overall Study||0
4952200|NCT02823080|12181591|P1|NOT COMPLETED|Overall Study||0
4952201|NCT02823080|12181590|P2|COMPLETED|Overall Study||24
4952202|NCT02823080|12181591|P1|COMPLETED|Overall Study||24
4952203|NCT02823080|12181590|P2|STARTED|Overall Study||24
4952204|NCT02823080|12181591|P1|STARTED|Overall Study||24
4952205|NCT02822950|12181609|P1|NOT COMPLETED|Overall Study||0
4952206|NCT02822950|12181609|P1|COMPLETED|Overall Study||10
4952207|NCT02822950|12181609|P1|STARTED|Overall Study||10
4952208|NCT02822885|12181617|P1|NOT COMPLETED|Overall Study||0
4952209|NCT02822885|12181617|P1|COMPLETED|Overall Study||70
4952210|NCT02822885|12181617|P1|STARTED|Overall Study||70
4952211|NCT02822794|12181629|P2|NOT COMPLETED|Overall Study||0
4952212|NCT02822794|12181630|P1|NOT COMPLETED|Overall Study||1
4952213|NCT02822794|12181629|P2|COMPLETED|Overall Study||60
4952214|NCT02822794|12181630|P1|COMPLETED|Overall Study||56
4952215|NCT02822794|12181629|P2|STARTED|Overall Study||60
4952216|NCT02822794|12181630|P1|STARTED|Overall Study||57
4952217|NCT02822612|12181693|P5|NOT COMPLETED|Overall Study||0
4952218|NCT02822612|12181694|P4|NOT COMPLETED|Overall Study||0
4952219|NCT02822612|12181695|P3|NOT COMPLETED|Overall Study||0
4952220|NCT02822612|12181696|P2|NOT COMPLETED|Overall Study||0
4952221|NCT02822612|12181697|P1|NOT COMPLETED|Overall Study||0
4952222|NCT02822612|12181693|P5|COMPLETED|Overall Study||15
4952223|NCT02822612|12181694|P4|COMPLETED|Overall Study||4
4952224|NCT02822612|12181695|P3|COMPLETED|Overall Study||14
4952225|NCT02822612|12181696|P2|COMPLETED|Overall Study||13
4952226|NCT02822612|12181697|P1|COMPLETED|Overall Study||14
4952227|NCT02822612|12181693|P5|STARTED|Overall Study||15
4952228|NCT02822612|12181694|P4|STARTED|Overall Study||4
4952229|NCT02822612|12181695|P3|STARTED|Overall Study||14
4952230|NCT02822612|12181696|P2|STARTED|Overall Study||13
4952231|NCT02822612|12181697|P1|STARTED|Overall Study||14
4952232|NCT02822287|12181719|P1|NOT COMPLETED|Overall Study||0
4952233|NCT02822287|12181719|P1|COMPLETED|Overall Study||57
4952234|NCT02822287|12181719|P1|STARTED|Overall Study||57
4952235|NCT02822235|12181731|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
4952236|NCT02822235|12181732|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
4952237|NCT02822235|12181731|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
4952238|NCT02822235|12181732|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
4952239|NCT02822235|12181731|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
4952240|NCT02822235|12181732|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
4952241|NCT02822235|12181731|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
4952242|NCT02822235|12181732|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
4952243|NCT02822235|12181731|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
4952244|NCT02822235|12181732|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
4952245|NCT02822235|12181731|P2|STARTED|Cross-sectional Phase (Day 1)||143
4952246|NCT02822235|12181732|P1|STARTED|Cross-sectional Phase (Day 1)||264
4952247|NCT02821962|12181787|P2|NOT COMPLETED|Overall Study||0
4952248|NCT02821962|12181788|P1|NOT COMPLETED|Overall Study||2
4952249|NCT02821962|12181787|P2|COMPLETED|Overall Study||21
4952250|NCT02821962|12181788|P1|COMPLETED|Overall Study||17
4952251|NCT02821962|12181787|P2|STARTED|Overall Study||21
4952252|NCT02821962|12181788|P1|STARTED|Overall Study||19
4952253|NCT02821910|12181832|P6|NOT COMPLETED|Overall Study||1
4952254|NCT02821910|12181833|P5|NOT COMPLETED|Overall Study||0
4952255|NCT02821910|12181834|P4|NOT COMPLETED|Overall Study||0
4952256|NCT02821910|12181835|P3|NOT COMPLETED|Overall Study||2
4952257|NCT02821910|12181836|P2|NOT COMPLETED|Overall Study||0
4952258|NCT02821910|12181837|P1|NOT COMPLETED|Overall Study||1
4952259|NCT02821910|12181832|P6|COMPLETED|Overall Study||7
4952260|NCT02821910|12181833|P5|COMPLETED|Overall Study||7
4952261|NCT02821910|12181834|P4|COMPLETED|Overall Study||10
4952262|NCT02821910|12181835|P3|COMPLETED|Overall Study||8
4952263|NCT02821910|12181836|P2|COMPLETED|Overall Study||8
4952264|NCT02821910|12181837|P1|COMPLETED|Overall Study||6
4952265|NCT02821910|12181832|P6|STARTED|Overall Study||8
4952266|NCT02821910|12181833|P5|STARTED|Overall Study||7
4952267|NCT02821910|12181834|P4|STARTED|Overall Study||10
4952268|NCT02821910|12181835|P3|STARTED|Overall Study||10
4952269|NCT02821910|12181836|P2|STARTED|Overall Study||8
4952270|NCT02821910|12181837|P1|STARTED|Overall Study||7
4952271|NCT02821819|12181899|P1|NOT COMPLETED|Overall Study||1
4952272|NCT02821819|12181899|P1|COMPLETED|Overall Study||14
4952273|NCT02821819|12181899|P1|STARTED|Overall Study||15
4952274|NCT02821455|12181904|P1|NOT COMPLETED|Overall Study||0
4952275|NCT02821455|12181904|P1|COMPLETED|Overall Study||19
4952276|NCT02821455|12181904|P1|STARTED|Overall Study||19
4952432|NCT02819726|12182355|P2|NOT COMPLETED|Part B (All Participants)||2
4952277|NCT02821403|12181911|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
4952278|NCT02821403|12181912|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
4952279|NCT02821403|12181911|P2|COMPLETED|"Third Intervention (1 Month)"||40
4952280|NCT02821403|12181912|P1|COMPLETED|"Third Intervention (1 Month)"||40
4952281|NCT02821403|12181911|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
4952282|NCT02821403|12181912|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
4952283|NCT02821403|12181911|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
4952284|NCT02821403|12181912|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
4952285|NCT02821403|12181911|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
4952286|NCT02821403|12181912|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
4952287|NCT02821403|12181911|P2|STARTED|"Third Intervention (1 Month)"||40
4952288|NCT02821403|12181912|P1|STARTED|"Third Intervention (1 Month)"||40
4952289|NCT02821403|12181911|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
4952290|NCT02821403|12181912|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
4952291|NCT02821403|12181911|P2|COMPLETED|"Second Intervention (1 Month)"||40
4952292|NCT02821403|12181912|P1|COMPLETED|"Second Intervention (1 Month)"||40
4952293|NCT02821403|12181911|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
4952294|NCT02821403|12181912|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
4952295|NCT02821403|12181911|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
4952296|NCT02821403|12181912|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
4952297|NCT02821403|12181911|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
4952298|NCT02821403|12181912|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
4952299|NCT02821403|12181911|P2|STARTED|"Second Intervention (1 Month)"||40
4952300|NCT02821403|12181912|P1|STARTED|"Second Intervention (1 Month)"||40
4952301|NCT02821403|12181911|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
4952302|NCT02821403|12181912|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
4952303|NCT02821403|12181911|P2|COMPLETED|"First Intervention (1 Month)"||40
4952304|NCT02821403|12181912|P1|COMPLETED|"First Intervention (1 Month)"||40
4952305|NCT02821403|12181911|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
4952306|NCT02821403|12181912|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
4952307|NCT02821403|12181911|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
4952308|NCT02821403|12181912|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
4952309|NCT02821403|12181911|P2|Used Clear Lens|"First Intervention (1 Month)"||13
4952310|NCT02821403|12181912|P1|Used Clear Lens|"First Intervention (1 Month)"||13
4952311|NCT02821403|12181911|P2|STARTED|"First Intervention (1 Month)"||40
4952312|NCT02821403|12181912|P1|STARTED|"First Intervention (1 Month)"||40
4952313|NCT02821338|12181930|P2|NOT COMPLETED|Overall Study||2
4952314|NCT02821338|12181931|P1|NOT COMPLETED|Overall Study||3
4952315|NCT02821338|12181930|P2|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
4952316|NCT02821338|12181931|P1|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
4952317|NCT02821338|12181930|P2|STARTED|Overall Study||15
4952318|NCT02821338|12181931|P1|STARTED|Overall Study||15
4952319|NCT02821000|12181947|P1|NOT COMPLETED|Overall Study||103
4952320|NCT02821000|12181947|P1|COMPLETED|Overall Study||0
4952321|NCT02821000|12181947|P1|Treated|Overall Study||103
4952322|NCT02821000|12181947|P1|STARTED|Overall Study||103
4952323|NCT02820870|12181972|P2|NOT COMPLETED|Post Intervention||0
4952324|NCT02820870|12181973|P1|NOT COMPLETED|Post Intervention||0
4952325|NCT02820870|12181972|P2|COMPLETED|Post Intervention||28
4952326|NCT02820870|12181973|P1|COMPLETED|Post Intervention||15
4952327|NCT02820870|12181972|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
4952328|NCT02820870|12181973|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
4952329|NCT02820870|12181972|P2|NOT COMPLETED|Intervention||0
4952330|NCT02820870|12181973|P1|NOT COMPLETED|Intervention||0
4952331|NCT02820870|12181972|P2|COMPLETED|Intervention||28
4952332|NCT02820870|12181973|P1|COMPLETED|Intervention||15
4952333|NCT02820870|12181972|P2|STARTED|Intervention||28
4952334|NCT02820870|12181973|P1|STARTED|Intervention||15
4952335|NCT02820870|12181972|P2|NOT COMPLETED|Before Intervention||0
4952336|NCT02820870|12181973|P1|NOT COMPLETED|Before Intervention||0
4952337|NCT02820870|12181972|P2|COMPLETED|Before Intervention||28
4952338|NCT02820870|12181973|P1|COMPLETED|Before Intervention||15
4952339|NCT02820870|12181972|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
4952340|NCT02820870|12181973|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
4952341|NCT02820844|12181985|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
4952342|NCT02820844|12181986|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
4952343|NCT02820844|12181987|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952344|NCT02820844|12181988|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952345|NCT02820844|12181989|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952346|NCT02820844|12181990|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952347|NCT02820844|12181985|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
4952348|NCT02820844|12181986|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
4952349|NCT02820844|12181987|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952350|NCT02820844|12181988|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952351|NCT02820844|12181989|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952352|NCT02820844|12181990|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952353|NCT02820844|12181985|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
4952354|NCT02820844|12181986|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
4952355|NCT02820844|12181987|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952356|NCT02820844|12181988|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952357|NCT02820844|12181989|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952358|NCT02820844|12181990|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
4952359|NCT02820844|12181985|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952360|NCT02820844|12181986|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952361|NCT02820844|12181987|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
4952362|NCT02820844|12181988|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
4952363|NCT02820844|12181989|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952364|NCT02820844|12181990|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952365|NCT02820844|12181985|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952366|NCT02820844|12181986|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952367|NCT02820844|12181987|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
4952368|NCT02820844|12181988|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
4952369|NCT02820844|12181989|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952370|NCT02820844|12181990|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952371|NCT02820844|12181985|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952372|NCT02820844|12181986|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952373|NCT02820844|12181987|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
4952374|NCT02820844|12181988|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
4952375|NCT02820844|12181989|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952376|NCT02820844|12181990|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
4952377|NCT02820844|12181985|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952378|NCT02820844|12181986|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952379|NCT02820844|12181987|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952380|NCT02820844|12181988|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952381|NCT02820844|12181989|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
4952382|NCT02820844|12181990|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
4952383|NCT02820844|12181985|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952384|NCT02820844|12181986|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952385|NCT02820844|12181987|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952386|NCT02820844|12181988|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
4952387|NCT02820844|12181989|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
4952388|NCT02820844|12181990|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
4952389|NCT02820844|12181985|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
4952390|NCT02820844|12181986|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
4952391|NCT02820844|12181987|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
4952392|NCT02820844|12181988|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
4952393|NCT02820844|12181989|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
4952394|NCT02820844|12181990|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
4952395|NCT02820597|12182204|P1|NOT COMPLETED|Overall Study||12
4952396|NCT02820597|12182204|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
4952397|NCT02820597|12182204|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
4952398|NCT02820597|12182204|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
4952399|NCT02820597|12182204|P1|30-day Post Treatment|Overall Study||27
4952400|NCT02820597|12182204|P1|7-day Post Treatment|Overall Study||27
4952401|NCT02820597|12182204|P1|1-day Post Treatment|Overall Study||27
4952402|NCT02820597|12182204|P1|STARTED|Overall Study||27
4952403|NCT02820038|12182216|P4|NOT COMPLETED|Overall Study||22
4952404|NCT02820038|12182217|P3|NOT COMPLETED|Overall Study||5
4952405|NCT02820038|12182218|P2|NOT COMPLETED|Overall Study||25
4952406|NCT02820038|12182219|P1|NOT COMPLETED|Overall Study||10
4952407|NCT02820038|12182216|P4|COMPLETED|Overall Study||44
4952408|NCT02820038|12182217|P3|COMPLETED|Overall Study||60
4952409|NCT02820038|12182218|P2|COMPLETED|Overall Study||52
4952410|NCT02820038|12182219|P1|COMPLETED|Overall Study||68
4952411|NCT02820038|12182216|P4|STARTED|Overall Study||66
4952412|NCT02820038|12182217|P3|STARTED|Overall Study||65
4952413|NCT02820038|12182218|P2|STARTED|Overall Study||77
4952414|NCT02820038|12182219|P1|STARTED|Overall Study||78
4952415|NCT02819908|12182323|P2|NOT COMPLETED|Overall Study||0
4952416|NCT02819908|12182324|P1|NOT COMPLETED|Overall Study||0
4952417|NCT02819908|12182323|P2|COMPLETED|Overall Study||13
4952418|NCT02819908|12182324|P1|COMPLETED|Overall Study||12
4952419|NCT02819908|12182323|P2|STARTED|Overall Study||13
4952420|NCT02819908|12182324|P1|STARTED|Overall Study||12
4952421|NCT02819804|12182346|P1|NOT COMPLETED|Follow-up for 1 Year||0
4952422|NCT02819804|12182346|P1|COMPLETED|Follow-up for 1 Year||1
4952423|NCT02819804|12182346|P1|STARTED|Follow-up for 1 Year||1
4952424|NCT02819804|12182346|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
4952425|NCT02819804|12182346|P1|COMPLETED|Start Cycle 2 and Beyond||0
4952426|NCT02819804|12182346|P1|STARTED|Start Cycle 2 and Beyond||0
4952427|NCT02819804|12182346|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
4952428|NCT02819804|12182346|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
4952429|NCT02819804|12182346|P1|STARTED|Complete Cycle 1 (28 Days)||1
4952430|NCT02819726|12182353|P4|NOT COMPLETED|Part B (All Participants)||2
4952431|NCT02819726|12182354|P3|NOT COMPLETED|Part B (All Participants)||4
4952433|NCT02819726|12182356|P1|NOT COMPLETED|Part B (All Participants)||3
4952434|NCT02819726|12182353|P4|COMPLETED|Part B (All Participants)||36
4952435|NCT02819726|12182354|P3|COMPLETED|Part B (All Participants)||35
4952436|NCT02819726|12182355|P2|COMPLETED|Part B (All Participants)||68
4952437|NCT02819726|12182356|P1|COMPLETED|Part B (All Participants)||70
4952438|NCT02819726|12182353|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
4952439|NCT02819726|12182354|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
4952440|NCT02819726|12182355|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
4952441|NCT02819726|12182356|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
4952442|NCT02819726|12182353|P4|NOT COMPLETED|Part A (All Participants)||0
4952443|NCT02819726|12182354|P3|NOT COMPLETED|Part A (All Participants)||11
4952444|NCT02819726|12182355|P2|NOT COMPLETED|Part A (All Participants)||10
4952445|NCT02819726|12182356|P1|NOT COMPLETED|Part A (All Participants)||6
4952446|NCT02819726|12182353|P4|COMPLETED|Part A (All Participants)||0
4952447|NCT02819726|12182354|P3|COMPLETED|Part A (All Participants)||87
4952448|NCT02819726|12182355|P2|COMPLETED|Part A (All Participants)||88
4952449|NCT02819726|12182356|P1|COMPLETED|Part A (All Participants)||92
4952450|NCT02819726|12182353|P4|STARTED|Part A (All Participants)||0
4952451|NCT02819726|12182354|P3|STARTED|Part A (All Participants)||98
4952452|NCT02819726|12182355|P2|STARTED|Part A (All Participants)||98
4952453|NCT02819726|12182356|P1|STARTED|Part A (All Participants)||98
4952454|NCT02819310|12182466|P1|NOT COMPLETED|Overall Study||109
4952455|NCT02819310|12182466|P1|COMPLETED|Overall Study||221
4952456|NCT02819310|12182466|P1|STARTED|Overall Study||330
4952457|NCT02819297|12182472|P2|NOT COMPLETED|Overall Study||52
4952458|NCT02819297|12182473|P1|NOT COMPLETED|Overall Study||60
4952459|NCT02819297|12182472|P2|COMPLETED|Overall Study||252
4952460|NCT02819297|12182473|P1|COMPLETED|Overall Study||239
4952461|NCT02819297|12182472|P2|STARTED|Overall Study||304
4952462|NCT02819297|12182473|P1|STARTED|Overall Study||299
4952463|NCT02819011|12182481|P2|NOT COMPLETED|Overall Study||5
4952464|NCT02819011|12182482|P1|NOT COMPLETED|Overall Study||7
4952465|NCT02819011|12182481|P2|COMPLETED|Overall Study||17
4952466|NCT02819011|12182482|P1|COMPLETED|Overall Study||15
4952467|NCT02819011|12182481|P2|STARTED|Overall Study||22
4952468|NCT02819011|12182482|P1|STARTED|Overall Study||22
4952469|NCT02818998|12182512|P3|NOT COMPLETED|Overall Study||18
4952470|NCT02818998|12182513|P2|NOT COMPLETED|Overall Study||16
4952471|NCT02818998|12182514|P1|NOT COMPLETED|Overall Study||18
4952472|NCT02818998|12182512|P3|COMPLETED|Overall Study||136
4952473|NCT02818998|12182513|P2|COMPLETED|Overall Study||138
4952474|NCT02818998|12182514|P1|COMPLETED|Overall Study||137
4952475|NCT02818998|12182512|P3|Completed Week 52 Visit|Overall Study||140
4952476|NCT02818998|12182513|P2|Completed Week 52 Visit|Overall Study||146
4952477|NCT02818998|12182514|P1|Completed Week 52 Visit|Overall Study||144
4952478|NCT02818998|12182512|P3|STARTED|Overall Study||154
4952479|NCT02818998|12182513|P2|STARTED|Overall Study||154
4952480|NCT02818998|12182514|P1|STARTED|Overall Study||155
4952481|NCT02818946|12182540|P1|NOT COMPLETED|Overall Study||0
4952482|NCT02818946|12182540|P1|COMPLETED|Overall Study||30
4952483|NCT02818946|12182540|P1|STARTED|Overall Study||30
4952484|NCT02818920|12182547|P1|NOT COMPLETED|Overall Study||18
4952485|NCT02818920|12182547|P1|COMPLETED|Overall Study||12
4952486|NCT02818920|12182547|P1|Received Adjuvant Therapy|Overall Study||17
4952487|NCT02818920|12182547|P1|Completed Surgery|Overall Study||25
4952488|NCT02818920|12182547|P1|STARTED|Overall Study||30
4952489|NCT02818777|12182551|P1|NOT COMPLETED|Overall Study||3
4952490|NCT02818777|12182551|P1|COMPLETED|Overall Study||10
4952491|NCT02818777|12182551|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
4952492|NCT02818569|12182579|P2|NOT COMPLETED|Overall Study||0
4952493|NCT02818569|12182580|P1|NOT COMPLETED|Overall Study||0
4952494|NCT02818569|12182579|P2|COMPLETED|Overall Study||7
4952495|NCT02818569|12182580|P1|COMPLETED|Overall Study||8
4952496|NCT02818569|12182579|P2|STARTED|Overall Study||7
4952497|NCT02818569|12182580|P1|STARTED|Overall Study||8
4952498|NCT02818244|12182598|P4|NOT COMPLETED|Overall Study||0
4952499|NCT02818244|12182599|P3|NOT COMPLETED|Overall Study||0
4952500|NCT02818244|12182600|P2|NOT COMPLETED|Overall Study||0
4952501|NCT02818244|12182601|P1|NOT COMPLETED|Overall Study||0
4952502|NCT02818244|12182598|P4|COMPLETED|Overall Study||25
4952503|NCT02818244|12182599|P3|COMPLETED|Overall Study||25
4952504|NCT02818244|12182600|P2|COMPLETED|Overall Study||25
4952505|NCT02818244|12182601|P1|COMPLETED|Overall Study||25
4952506|NCT02818244|12182598|P4|STARTED|Overall Study||25
4952507|NCT02818244|12182599|P3|STARTED|Overall Study||25
4952508|NCT02818244|12182600|P2|STARTED|Overall Study||25
4952509|NCT02818244|12182601|P1|STARTED|Overall Study||25
4952510|NCT02818114|12182611|P1|NOT COMPLETED|Overall Study||1
4952511|NCT02818114|12182611|P1|COMPLETED|Overall Study||7
4952512|NCT02818114|12182611|P1|STARTED|Overall Study||8
4952513|NCT02818036|12182618|P2|NOT COMPLETED|Overall Study||0
4952514|NCT02818036|12182619|P1|NOT COMPLETED|Overall Study||2
4952515|NCT02818036|12182618|P2|COMPLETED|Overall Study||40
4952516|NCT02818036|12182619|P1|COMPLETED|Overall Study||40
4952517|NCT02818036|12182618|P2|STARTED|Overall Study||40
4952518|NCT02818036|12182619|P1|STARTED|Overall Study||42
4952519|NCT02817841|12182627|P1|NOT COMPLETED|Overall Study||848
4952520|NCT02817841|12182627|P1|COMPLETED|Overall Study||1016
4952521|NCT02817841|12182627|P1|STARTED|Overall Study||1864
4952522|NCT02817828|12182654|P1|NOT COMPLETED|Overall Study||335
4952523|NCT02817828|12182654|P1|COMPLETED|Overall Study||1218
4952524|NCT02817828|12182654|P1|STARTED|Overall Study||1553
4952525|NCT02817763|12182680|P2|NOT COMPLETED|Overall Study||0
4952526|NCT02817763|12182681|P1|NOT COMPLETED|Overall Study||0
4952527|NCT02817763|12182680|P2|COMPLETED|Overall Study||20
4952528|NCT02817763|12182681|P1|COMPLETED|Overall Study||20
4952529|NCT02817763|12182680|P2|STARTED|Overall Study||20
4952530|NCT02817763|12182681|P1|STARTED|Overall Study||20
4952531|NCT02817594|12182689|P1|NOT COMPLETED|Overall Study||3
4952532|NCT02817594|12182689|P1|COMPLETED|Overall Study||48
4952533|NCT02817594|12182689|P1|Received Treatment|Overall Study||50
4952534|NCT02817594|12182689|P1|STARTED|Overall Study||51
4952535|NCT02817555|12182710|P2|NOT COMPLETED|Overall Study||5
4952536|NCT02817555|12182711|P1|NOT COMPLETED|Overall Study||3
4952537|NCT02817555|12182710|P2|COMPLETED|Overall Study||21
4952538|NCT02817555|12182711|P1|COMPLETED|Overall Study||21
4952539|NCT02817555|12182710|P2|STARTED|Overall Study||26
4952540|NCT02817555|12182711|P1|STARTED|Overall Study||24
4952541|NCT02817516|12182731|P4|NOT COMPLETED|Overall Study||0
4952542|NCT02817516|12182732|P3|NOT COMPLETED|Overall Study||1
4952543|NCT02817516|12182733|P2|NOT COMPLETED|Overall Study||0
4952544|NCT02817516|12182734|P1|NOT COMPLETED|Overall Study||0
4952545|NCT02817516|12182731|P4|COMPLETED|Overall Study||6
4952546|NCT02817516|12182732|P3|COMPLETED|Overall Study||5
4952547|NCT02817516|12182733|P2|COMPLETED|Overall Study||6
4952548|NCT02817516|12182734|P1|COMPLETED|Overall Study||6
4952549|NCT02817516|12182731|P4|STARTED|Overall Study||6
4952550|NCT02817516|12182732|P3|STARTED|Overall Study||6
4952551|NCT02817516|12182733|P2|STARTED|Overall Study||6
4952552|NCT02817516|12182734|P1|STARTED|Overall Study||6
4952553|NCT02816723|12182771|P2|NOT COMPLETED|Overall Study||2
4952554|NCT02816723|12182772|P1|NOT COMPLETED|Overall Study||6
4952555|NCT02816723|12182771|P2|COMPLETED|Overall Study||28
4952556|NCT02816723|12182772|P1|COMPLETED|Overall Study||24
4952557|NCT02816723|12182771|P2|STARTED|Overall Study||30
4952558|NCT02816723|12182772|P1|STARTED|Overall Study||30
4952559|NCT02816710|12182785|P3|NOT COMPLETED|Overall Study||7
4952560|NCT02816710|12182786|P2|NOT COMPLETED|Overall Study||3
4952561|NCT02816710|12182787|P1|NOT COMPLETED|Overall Study||4
4952562|NCT02816710|12182785|P3|COMPLETED|Overall Study||29
4952563|NCT02816710|12182786|P2|COMPLETED|Overall Study||35
4952564|NCT02816710|12182787|P1|COMPLETED|Overall Study||34
4952565|NCT02816710|12182785|P3|STARTED|Overall Study||36
4952566|NCT02816710|12182786|P2|STARTED|Overall Study||38
4952567|NCT02816710|12182787|P1|STARTED|Overall Study||38
4952568|NCT02816346|12182827|P5|NOT COMPLETED|Overall Study||0
4952569|NCT02816346|12182828|P4|NOT COMPLETED|Overall Study||0
4952570|NCT02816346|12182829|P3|NOT COMPLETED|Overall Study||0
4952571|NCT02816346|12182830|P2|NOT COMPLETED|Overall Study||0
4952572|NCT02816346|12182831|P1|NOT COMPLETED|Overall Study||0
4952573|NCT02816346|12182827|P5|COMPLETED|Overall Study||16
4952574|NCT02816346|12182828|P4|COMPLETED|Overall Study||10
4952575|NCT02816346|12182829|P3|COMPLETED|Overall Study||10
4952576|NCT02816346|12182830|P2|COMPLETED|Overall Study||10
4952577|NCT02816346|12182831|P1|COMPLETED|Overall Study||10
4952578|NCT02816346|12182827|P5|STARTED|Overall Study||16
4952579|NCT02816346|12182828|P4|STARTED|Overall Study||10
4952580|NCT02816346|12182829|P3|STARTED|Overall Study||10
4952581|NCT02816346|12182830|P2|STARTED|Overall Study||10
4952582|NCT02816346|12182831|P1|STARTED|Overall Study||10
4952583|NCT02816138|12182873|P1|NOT COMPLETED|Overall Study||1
4952584|NCT02816138|12182873|P1|COMPLETED|Overall Study||14
4952585|NCT02816138|12182873|P1|STARTED|Overall Study||15
4952586|NCT02815982|12182890|P4|NOT COMPLETED|Overall Study||0
4952587|NCT02815982|12182891|P3|NOT COMPLETED|Overall Study||0
4952588|NCT02815982|12182892|P2|NOT COMPLETED|Overall Study||0
4952589|NCT02815982|12182893|P1|NOT COMPLETED|Overall Study||0
4952590|NCT02815982|12182890|P4|COMPLETED|Overall Study||26
4952591|NCT02815982|12182891|P3|COMPLETED|Overall Study||27
4952592|NCT02815982|12182892|P2|COMPLETED|Overall Study||26
4952593|NCT02815982|12182893|P1|COMPLETED|Overall Study||27
4952594|NCT02815982|12182890|P4|STARTED|Overall Study||26
4952595|NCT02815982|12182891|P3|STARTED|Overall Study||27
4952596|NCT02815982|12182892|P2|STARTED|Overall Study||26
4952597|NCT02815982|12182893|P1|STARTED|Overall Study||27
4952598|NCT02815735|12182919|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
4952599|NCT02815735|12182920|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
4952600|NCT02815735|12182919|P2|COMPLETED|Second Intervention (4 Weeks)||37
4952601|NCT02815735|12182920|P1|COMPLETED|Second Intervention (4 Weeks)||33
4952602|NCT02815735|12182919|P2|STARTED|Second Intervention (4 Weeks)||37
4952603|NCT02815735|12182920|P1|STARTED|Second Intervention (4 Weeks)||34
4952604|NCT02815735|12182919|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
4952605|NCT02815735|12182920|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
4952606|NCT02815735|12182919|P2|COMPLETED|First Intervention (4 Weeks)||37
4952607|NCT02815735|12182920|P1|COMPLETED|First Intervention (4 Weeks)||34
4952608|NCT02815735|12182919|P2|STARTED|First Intervention (4 Weeks)||38
4952609|NCT02815735|12182920|P1|STARTED|First Intervention (4 Weeks)||36
4952610|NCT02815670|12182935|P1|NOT COMPLETED|Overall Study||1
4952611|NCT02815670|12182935|P1|COMPLETED|Overall Study||0
4952612|NCT02815670|12182935|P1|STARTED|Overall Study||1
4952613|NCT02815644|12182948|P2|NOT COMPLETED|Treatment Period 2||0
4952614|NCT02815644|12182949|P1|NOT COMPLETED|Treatment Period 2||0
4952615|NCT02815644|12182948|P2|COMPLETED|Treatment Period 2||11
4952616|NCT02815644|12182949|P1|COMPLETED|Treatment Period 2||11
4952617|NCT02815644|12182948|P2|STARTED|Treatment Period 2||11
4952618|NCT02815644|12182949|P1|STARTED|Treatment Period 2||11
4952619|NCT02815644|12182948|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
4952620|NCT02815644|12182949|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
4952621|NCT02815644|12182948|P2|COMPLETED|Treatment Period 1 + Washout||11
4952622|NCT02815644|12182949|P1|COMPLETED|Treatment Period 1 + Washout||11
4952623|NCT02815644|12182948|P2|STARTED|Treatment Period 1 + Washout||11
4952624|NCT02815644|12182949|P1|STARTED|Treatment Period 1 + Washout||11
4952625|NCT02815397|12182967|P1|NOT COMPLETED|Overall Study||2
4952626|NCT02815397|12182967|P1|COMPLETED|Overall Study||0
4952627|NCT02815397|12182967|P1|STARTED|Overall Study||2
4952628|NCT02815293|12182977|P3|NOT COMPLETED|Overall Study||18
4952629|NCT02815293|12182978|P2|NOT COMPLETED|Overall Study||8
4952630|NCT02815293|12182979|P1|NOT COMPLETED|Overall Study||10
4952631|NCT02815293|12182977|P3|COMPLETED|Overall Study||0
4952632|NCT02815293|12182978|P2|COMPLETED|Overall Study||0
4952633|NCT02815293|12182979|P1|COMPLETED|Overall Study||0
4952634|NCT02815293|12182977|P3|STARTED|Overall Study||18
4952635|NCT02815293|12182978|P2|STARTED|Overall Study||8
4952636|NCT02815293|12182979|P1|STARTED|Overall Study||10
4952637|NCT02814656|12182991|P4|NOT COMPLETED|Overall Study||0
4952638|NCT02814656|12182992|P3|NOT COMPLETED|Overall Study||0
4952639|NCT02814656|12182993|P2|NOT COMPLETED|Overall Study||0
4952640|NCT02814656|12182994|P1|NOT COMPLETED|Overall Study||0
4952641|NCT02814656|12182991|P4|COMPLETED|Overall Study||6
4952642|NCT02814656|12182992|P3|COMPLETED|Overall Study||6
4952643|NCT02814656|12182993|P2|COMPLETED|Overall Study||6
4952644|NCT02814656|12182994|P1|COMPLETED|Overall Study||6
4952645|NCT02814656|12182991|P4|STARTED|Overall Study||6
4952646|NCT02814656|12182992|P3|STARTED|Overall Study||6
4952647|NCT02814656|12182993|P2|STARTED|Overall Study||6
4952648|NCT02814656|12182994|P1|STARTED|Overall Study||6
4952649|NCT02814643|12183094|P2|NOT COMPLETED|Overall Study||3
4952650|NCT02814643|12183095|P1|NOT COMPLETED|Overall Study||1
4952651|NCT02814643|12183094|P2|COMPLETED|Overall Study||49
4952652|NCT02814643|12183095|P1|COMPLETED|Overall Study||50
4952653|NCT02814643|12183094|P2|STARTED|Overall Study||52
4952654|NCT02814643|12183095|P1|STARTED|Overall Study||51
4952655|NCT02814565|12183119|P2|NOT COMPLETED|Overall Study||2
4952656|NCT02814565|12183120|P1|NOT COMPLETED|Overall Study||1
4952657|NCT02814565|12183119|P2|COMPLETED|Overall Study||88
4952658|NCT02814565|12183120|P1|COMPLETED|Overall Study||89
4952659|NCT02814565|12183119|P2|STARTED|Overall Study||90
4952660|NCT02814565|12183120|P1|STARTED|Overall Study||90
4952661|NCT02814448|12183149|P5|NOT COMPLETED|Overall Study||2
4952662|NCT02814448|12183150|P4|NOT COMPLETED|Overall Study||0
4952663|NCT02814448|12183151|P3|NOT COMPLETED|Overall Study||1
4952664|NCT02814448|12183152|P2|NOT COMPLETED|Overall Study||0
4952665|NCT02814448|12183153|P1|NOT COMPLETED|Overall Study||0
4952666|NCT02814448|12183149|P5|COMPLETED|Overall Study||26
4952667|NCT02814448|12183150|P4|COMPLETED|Overall Study||25
4952668|NCT02814448|12183151|P3|COMPLETED|Overall Study||25
4952669|NCT02814448|12183152|P2|COMPLETED|Overall Study||24
4952670|NCT02814448|12183153|P1|COMPLETED|Overall Study||27
4952671|NCT02814448|12183149|P5|STARTED|Overall Study||28
4952672|NCT02814448|12183150|P4|STARTED|Overall Study||25
4952673|NCT02814448|12183151|P3|STARTED|Overall Study||26
4952674|NCT02814448|12183152|P2|STARTED|Overall Study||24
4952675|NCT02814448|12183153|P1|STARTED|Overall Study||27
4952676|NCT02814279|12183172|P2|NOT COMPLETED|Overall Study||0
4952677|NCT02814279|12183173|P1|NOT COMPLETED|Overall Study||0
4952678|NCT02814279|12183172|P2|COMPLETED|Overall Study||21
4952679|NCT02814279|12183173|P1|COMPLETED|Overall Study||21
4952680|NCT02814279|12183172|P2|STARTED|Overall Study||21
4952681|NCT02814279|12183173|P1|STARTED|Overall Study||21
4952682|NCT02814227|12183181|P1|NOT COMPLETED|Overall Study||0
4952683|NCT02814227|12183181|P1|COMPLETED|Overall Study||52
4952684|NCT02814227|12183181|P1|STARTED|Overall Study||52
4952685|NCT02813694|12183190|P2|NOT COMPLETED|Overall Study||14
4952686|NCT02813694|12183191|P1|NOT COMPLETED|Overall Study||17
4952687|NCT02813694|12183190|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
4952688|NCT02813694|12183191|P1|COMPLETED|Overall Study||353
4952689|NCT02813694|12183190|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
4952690|NCT02813694|12183191|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
4952691|NCT02813681|12183204|P3|NOT COMPLETED|Overall Study||0
4952692|NCT02813681|12183205|P2|NOT COMPLETED|Overall Study||6
4952693|NCT02813681|12183206|P1|NOT COMPLETED|Overall Study||5
4952694|NCT02813681|12183204|P3|COMPLETED|Overall Study||19
4952695|NCT02813681|12183205|P2|COMPLETED|Overall Study||28
4952696|NCT02813681|12183206|P1|COMPLETED|Overall Study||22
4952697|NCT02813681|12183204|P3|STARTED|Overall Study||19
4952698|NCT02813681|12183205|P2|STARTED|Overall Study||34
4952699|NCT02813681|12183206|P1|STARTED|Overall Study||27
4952700|NCT02813577|12183227|P1|NOT COMPLETED|Overall Study||4
4952701|NCT02813577|12183227|P1|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
4952702|NCT02813577|12183227|P1|STARTED|Overall Study||4
4952703|NCT02813551|12183245|P2|NOT COMPLETED|Overall Study||2
4952704|NCT02813551|12183246|P1|NOT COMPLETED|Overall Study||1
4952705|NCT02813551|12183245|P2|COMPLETED|Overall Study||57
4952706|NCT02813551|12183246|P1|COMPLETED|Overall Study||58
4952707|NCT02813551|12183245|P2|STARTED|Overall Study||59
4952708|NCT02813551|12183246|P1|STARTED|Overall Study||59
4952709|NCT02813473|12183272|P1|NOT COMPLETED|Overall Study||0
4952710|NCT02813473|12183272|P1|COMPLETED|Overall Study||223
4952711|NCT02813473|12183272|P1|STARTED|Overall Study||223
4952712|NCT02813070|12183279|P3|NOT COMPLETED|Overall Study||11
4952713|NCT02813070|12183280|P2|NOT COMPLETED|Overall Study||3
4952714|NCT02813070|12183281|P1|NOT COMPLETED|Overall Study||3
4952715|NCT02813070|12183279|P3|COMPLETED|Overall Study||25
4952716|NCT02813070|12183280|P2|COMPLETED|Overall Study||20
4952717|NCT02813070|12183281|P1|COMPLETED|Overall Study||25
4952718|NCT02813070|12183279|P3|Treated (Safety Population)|Overall Study||25
4952719|NCT02813070|12183280|P2|Treated (Safety Population)|Overall Study||20
4952720|NCT02813070|12183281|P1|Treated (Safety Population)|Overall Study||25
4952721|NCT02813070|12183279|P3|STARTED|Overall Study||36
4952722|NCT02813070|12183280|P2|STARTED|Overall Study||23
4952723|NCT02813070|12183281|P1|STARTED|Overall Study||28
4952724|NCT02812342|12183290|P1|NOT COMPLETED|Overall Study||0
4952725|NCT02812342|12183290|P1|COMPLETED|Overall Study||10
4952726|NCT02812342|12183290|P1|STARTED|Overall Study||10
4952727|NCT02812238|12183295|P2|NOT COMPLETED|Second Intervention||1
4952728|NCT02812238|12183296|P1|NOT COMPLETED|Second Intervention||0
4952729|NCT02812238|12183295|P2|COMPLETED|Second Intervention||18
4952730|NCT02812238|12183296|P1|COMPLETED|Second Intervention||18
4952731|NCT02812238|12183295|P2|STARTED|Second Intervention||19
4952732|NCT02812238|12183296|P1|STARTED|Second Intervention||18
4952733|NCT02812238|12183295|P2|NOT COMPLETED|First Intervention||0
4952734|NCT02812238|12183296|P1|NOT COMPLETED|First Intervention||1
4952735|NCT02812238|12183295|P2|COMPLETED|First Intervention||19
4952736|NCT02812238|12183296|P1|COMPLETED|First Intervention||18
4952737|NCT02812238|12183295|P2|STARTED|First Intervention||19
4952738|NCT02812238|12183296|P1|STARTED|First Intervention||19
4952739|NCT02812186|12183304|P2|NOT COMPLETED|Period 2||0
4952740|NCT02812186|12183305|P1|NOT COMPLETED|Period 2||0
4952741|NCT02812186|12183304|P2|COMPLETED|Period 2||24
4952742|NCT02812186|12183305|P1|COMPLETED|Period 2||29
4952743|NCT02812186|12183304|P2|STARTED|Period 2||24
4952744|NCT02812186|12183305|P1|STARTED|Period 2||29
4952745|NCT02812186|12183304|P2|NOT COMPLETED|Period 1||15
4952746|NCT02812186|12183305|P1|NOT COMPLETED|Period 1||11
4952747|NCT02812186|12183304|P2|COMPLETED|Period 1||24
4952748|NCT02812186|12183305|P1|COMPLETED|Period 1||29
4952749|NCT02812186|12183304|P2|STARTED|Period 1||39
4952750|NCT02812186|12183305|P1|STARTED|Period 1||40
4952751|NCT02811965|12183315|P1|NOT COMPLETED|Overall Study||0
4952752|NCT02811965|12183315|P1|COMPLETED|Overall Study||21
4952753|NCT02811965|12183315|P1|STARTED|Overall Study||21
4952754|NCT02811419|12183340|P2|NOT COMPLETED|Overall Study||13
4952755|NCT02811419|12183341|P1|NOT COMPLETED|Overall Study||12
4952756|NCT02811419|12183340|P2|COMPLETED|Overall Study||358
4952757|NCT02811419|12183341|P1|COMPLETED|Overall Study||357
4952758|NCT02811419|12183340|P2|STARTED|Overall Study||371
4952759|NCT02811419|12183341|P1|STARTED|Overall Study||369
4952760|NCT02811302|12183349|P1|NOT COMPLETED|Overall Study||213
4952761|NCT02811302|12183349|P1|COMPLETED|Overall Study||1282
4952762|NCT02811302|12183349|P1|STARTED|Overall Study||1495
4952763|NCT02811159|12183354|P1|NOT COMPLETED|Treatment Course 2||0
4952764|NCT02811159|12183354|P1|COMPLETED|Treatment Course 2||4
4952765|NCT02811159|12183354|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
4952766|NCT02811159|12183354|P1|NOT COMPLETED|Treatment Course 1||1
4952767|NCT02811159|12183354|P1|COMPLETED|Treatment Course 1||19
4952768|NCT02811159|12183354|P1|STARTED|Treatment Course 1||20
4952769|NCT02810873|12183371|P2|NOT COMPLETED|Overall Study||0
4952770|NCT02810873|12183372|P1|NOT COMPLETED|Overall Study||0
4952771|NCT02810873|12183371|P2|COMPLETED|Overall Study||13
4952772|NCT02810873|12183372|P1|COMPLETED|Overall Study||6
4952773|NCT02810873|12183371|P2|STARTED|Overall Study||13
4952774|NCT02810873|12183372|P1|STARTED|Overall Study||6
4952775|NCT02810509|12183382|P2|NOT COMPLETED|Overall Study||0
4952776|NCT02810509|12183383|P1|NOT COMPLETED|Overall Study||0
4952777|NCT02810509|12183382|P2|COMPLETED|Overall Study||1230
4952778|NCT02810509|12183383|P1|COMPLETED|Overall Study||584
4952779|NCT02810509|12183382|P2|STARTED|Overall Study||1230
4952780|NCT02810509|12183383|P1|STARTED|Overall Study||584
4952781|NCT02810457|12183393|P2|NOT COMPLETED|Overall Study||329
4952782|NCT02810457|12183394|P1|NOT COMPLETED|Overall Study||327
4952783|NCT02810457|12183393|P2|COMPLETED|Overall Study||38
4952784|NCT02810457|12183394|P1|COMPLETED|Overall Study||37
4952785|NCT02810457|12183393|P2|STARTED|Overall Study|366 patients received study treatment|367
4952786|NCT02810457|12183394|P1|STARTED|Overall Study|362 patients received study treatment|364
4952787|NCT02810327|12183416|P2|NOT COMPLETED|Overall Study||7
4952788|NCT02810327|12183417|P1|NOT COMPLETED|Overall Study||7
4952789|NCT02810327|12183416|P2|COMPLETED|Overall Study||34
4952790|NCT02810327|12183417|P1|COMPLETED|Overall Study||69
4952791|NCT02810327|12183416|P2|STARTED|Overall Study||41
4952792|NCT02810327|12183417|P1|STARTED|Overall Study||76
4952793|NCT02809911|12183425|P2|NOT COMPLETED|Overall Study||0
4952794|NCT02809911|12183426|P1|NOT COMPLETED|Overall Study||0
4952795|NCT02809911|12183425|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
4952796|NCT02809911|12183426|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
4952797|NCT02809911|12183425|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
4952798|NCT02809911|12183426|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
4952799|NCT02809859|12183434|P1|NOT COMPLETED|Overall Study||14
4952800|NCT02809859|12183434|P1|COMPLETED|Overall Study||125
4952801|NCT02809859|12183434|P1|STARTED|Overall Study||139
4952802|NCT02809846|12183444|P2|NOT COMPLETED|Overall Study||7
4952803|NCT02809846|12183445|P1|NOT COMPLETED|Overall Study||9
4952804|NCT02809846|12183444|P2|COMPLETED|Overall Study||9
4952805|NCT02809846|12183445|P1|COMPLETED|Overall Study||8
4952806|NCT02809846|12183444|P2|STARTED|Overall Study||16
4952807|NCT02809846|12183445|P1|STARTED|Overall Study||17
4952808|NCT02809833|12183451|P1|NOT COMPLETED|Overall Study||300
4952809|NCT02809833|12183451|P1|COMPLETED|Overall Study||550
4952810|NCT02809833|12183451|P1|STARTED|Overall Study||850
4952811|NCT02809183|12183530|P6|NOT COMPLETED|Overall Study||0
4952812|NCT02809183|12183531|P5|NOT COMPLETED|Overall Study||0
4952813|NCT02809183|12183532|P4|NOT COMPLETED|Overall Study||0
4952814|NCT02809183|12183533|P3|NOT COMPLETED|Overall Study||0
4952815|NCT02809183|12183534|P2|NOT COMPLETED|Overall Study||0
4952816|NCT02809183|12183535|P1|NOT COMPLETED|Overall Study||0
4952817|NCT02809183|12183530|P6|COMPLETED|Overall Study||28
4952818|NCT02809183|12183531|P5|COMPLETED|Overall Study||6
4952819|NCT02809183|12183532|P4|COMPLETED|Overall Study||26
4952820|NCT02809183|12183533|P3|COMPLETED|Overall Study||25
4952821|NCT02809183|12183534|P2|COMPLETED|Overall Study||25
4952822|NCT02809183|12183535|P1|COMPLETED|Overall Study||25
4952823|NCT02809183|12183530|P6|STARTED|Overall Study||28
4952824|NCT02809183|12183531|P5|STARTED|Overall Study||6
4952825|NCT02809183|12183532|P4|STARTED|Overall Study||26
4952826|NCT02809183|12183533|P3|STARTED|Overall Study||25
4952827|NCT02809183|12183534|P2|STARTED|Overall Study||25
4952828|NCT02809183|12183535|P1|STARTED|Overall Study||25
4952829|NCT02808975|12183571|P2|NOT COMPLETED|Overall Study||19
4952830|NCT02808975|12183572|P1|NOT COMPLETED|Overall Study||22
4952831|NCT02808975|12183571|P2|COMPLETED|Overall Study||84
4952832|NCT02808975|12183572|P1|COMPLETED|Overall Study||81
4952833|NCT02808975|12183571|P2|STARTED|Overall Study||103
4952834|NCT02808975|12183572|P1|STARTED|Overall Study||103
4952835|NCT02808390|12183589|P3|NOT COMPLETED|Overall Study||3
4952836|NCT02808390|12183590|P2|NOT COMPLETED|Overall Study||6
4952837|NCT02808390|12183591|P1|NOT COMPLETED|Overall Study||2
4952838|NCT02808390|12183589|P3|COMPLETED|Overall Study||4
4952839|NCT02808390|12183590|P2|COMPLETED|Overall Study||2
4952840|NCT02808390|12183591|P1|COMPLETED|Overall Study||2
4952841|NCT02808390|12183589|P3|STARTED|Overall Study||7
4952842|NCT02808390|12183590|P2|STARTED|Overall Study||8
4952843|NCT02808390|12183591|P1|STARTED|Overall Study||4
4952844|NCT02808338|12183599|P1|NOT COMPLETED|Take Home Period||0
4952845|NCT02808338|12183599|P1|COMPLETED|Take Home Period||13
4952846|NCT02808338|12183599|P1|STARTED|Take Home Period||13
4952847|NCT02808338|12183599|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
4952848|NCT02808338|12183599|P1|COMPLETED|Overnight In-lab Polysomonography||13
4952849|NCT02808338|12183599|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
4952850|NCT02808338|12183599|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
4952851|NCT02808338|12183599|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
4952852|NCT02808338|12183599|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
4952853|NCT02808338|12183599|P1|STARTED|Overnight In-lab Polysomonography||15
4952854|NCT02808338|12183599|P1|NOT COMPLETED|Screening||10
4952855|NCT02808338|12183599|P1|COMPLETED|Screening||15
4952856|NCT02808338|12183599|P1|STARTED|Screening||25
4952857|NCT02808130|12183616|P6|NOT COMPLETED|Overall Study||0
4952858|NCT02808130|12183617|P5|NOT COMPLETED|Overall Study||0
4952859|NCT02808130|12183618|P4|NOT COMPLETED|Overall Study||0
4952860|NCT02808130|12183619|P3|NOT COMPLETED|Overall Study||0
4952861|NCT02808130|12183620|P2|NOT COMPLETED|Overall Study||0
4952862|NCT02808130|12183621|P1|NOT COMPLETED|Overall Study||0
4952863|NCT02808130|12183616|P6|COMPLETED|Overall Study||15
4952864|NCT02808130|12183617|P5|COMPLETED|Overall Study||15
4952865|NCT02808130|12183618|P4|COMPLETED|Overall Study||15
4952866|NCT02808130|12183619|P3|COMPLETED|Overall Study||15
4952867|NCT02808130|12183620|P2|COMPLETED|Overall Study||15
4952868|NCT02808130|12183621|P1|COMPLETED|Overall Study||15
4952869|NCT02808130|12183616|P6|STARTED|Overall Study||15
4952870|NCT02808130|12183617|P5|STARTED|Overall Study||15
4952871|NCT02808130|12183618|P4|STARTED|Overall Study||15
4952872|NCT02808130|12183619|P3|STARTED|Overall Study||15
4952873|NCT02808130|12183620|P2|STARTED|Overall Study||15
4952874|NCT02808130|12183621|P1|STARTED|Overall Study||15
4952875|NCT02808052|12183650|P3|NOT COMPLETED|Overall Study||0
4952876|NCT02808052|12183651|P2|NOT COMPLETED|Overall Study||0
4952877|NCT02808052|12183652|P1|NOT COMPLETED|Overall Study||0
4952878|NCT02808052|12183650|P3|COMPLETED|Overall Study||2
4952879|NCT02808052|12183651|P2|COMPLETED|Overall Study||3
4952880|NCT02808052|12183652|P1|COMPLETED|Overall Study||4
4952881|NCT02808052|12183650|P3|STARTED|Overall Study||2
4952882|NCT02808052|12183651|P2|STARTED|Overall Study||3
4952883|NCT02808052|12183652|P1|STARTED|Overall Study||4
4952884|NCT02807948|12183660|P2|NOT COMPLETED|Overall Study||0
4952885|NCT02807948|12183661|P1|NOT COMPLETED|Overall Study||1
4952886|NCT02807948|12183660|P2|COMPLETED|Overall Study||57
4952887|NCT02807948|12183661|P1|COMPLETED|Overall Study||131
4952888|NCT02807948|12183660|P2|STARTED|Overall Study||57
4952889|NCT02807948|12183661|P1|STARTED|Overall Study||132
4952890|NCT02807402|12183666|P1|NOT COMPLETED|Overall Study||6
4952891|NCT02807402|12183666|P1|COMPLETED|Overall Study||516
4952892|NCT02807402|12183666|P1|STARTED|Overall Study||522
4952893|NCT02807376|12183704|P2|NOT COMPLETED|Overall Study||1
4952894|NCT02807376|12183705|P1|NOT COMPLETED|Overall Study||3
4952895|NCT02807376|12183704|P2|COMPLETED|Overall Study||130
4952896|NCT02807376|12183705|P1|COMPLETED|Overall Study||136
4952897|NCT02807376|12183704|P2|STARTED|Overall Study||131
4952898|NCT02807376|12183705|P1|STARTED|Overall Study||139
4952899|NCT02807259|12183715|P2|NOT COMPLETED|Endline (3 Months)||87
4952900|NCT02807259|12183716|P1|NOT COMPLETED|Endline (3 Months)||35
4952901|NCT02807259|12183715|P2|COMPLETED|Endline (3 Months)||259
4952902|NCT02807259|12183716|P1|COMPLETED|Endline (3 Months)||288
4952903|NCT02807259|12183715|P2|STARTED|Endline (3 Months)||346
4952904|NCT02807259|12183716|P1|STARTED|Endline (3 Months)||323
4952905|NCT02807259|12183715|P2|NOT COMPLETED|Midline (3 Months)||34
4952906|NCT02807259|12183716|P1|NOT COMPLETED|Midline (3 Months)||30
4952907|NCT02807259|12183715|P2|COMPLETED|Midline (3 Months)||189
4952908|NCT02807259|12183716|P1|COMPLETED|Midline (3 Months)||322
4952909|NCT02807259|12183715|P2|STARTED|Midline (3 Months)||223
4952910|NCT02807259|12183716|P1|STARTED|Midline (3 Months)||352
4952911|NCT02807259|12183715|P2|NOT COMPLETED|Baseline (3 Months)||112
4952912|NCT02807259|12183716|P1|NOT COMPLETED|Baseline (3 Months)||77
4952913|NCT02807259|12183715|P2|COMPLETED|Baseline (3 Months)||292
4952914|NCT02807259|12183716|P1|COMPLETED|Baseline (3 Months)||328
4952915|NCT02807259|12183715|P2|STARTED|Baseline (3 Months)||404
4952916|NCT02807259|12183716|P1|STARTED|Baseline (3 Months)||405
4952917|NCT02806986|12183734|P1|NOT COMPLETED|Treatment Stage 2||5
4952918|NCT02806986|12183734|P1|COMPLETED|Treatment Stage 2||55
4952919|NCT02806986|12183734|P1|STARTED|Treatment Stage 2||60
4952920|NCT02806986|12183734|P1|NOT COMPLETED|Treatment Stage 1||1
4952921|NCT02806986|12183734|P1|COMPLETED|Treatment Stage 1||60
4952922|NCT02806986|12183734|P1|STARTED|Treatment Stage 1||61
4952923|NCT02806973|12183754|P4|NOT COMPLETED|Period 4||0
4952924|NCT02806973|12183755|P3|NOT COMPLETED|Period 4||0
4952925|NCT02806973|12183756|P2|NOT COMPLETED|Period 4||0
4952926|NCT02806973|12183757|P1|NOT COMPLETED|Period 4||0
4952927|NCT02806973|12183754|P4|COMPLETED|Period 4||3
4952928|NCT02806973|12183755|P3|COMPLETED|Period 4||6
4952929|NCT02806973|12183756|P2|COMPLETED|Period 4||6
4952930|NCT02806973|12183757|P1|COMPLETED|Period 4||8
4952931|NCT02806973|12183754|P4|STARTED|Period 4||3
4952932|NCT02806973|12183755|P3|STARTED|Period 4||6
4952933|NCT02806973|12183756|P2|STARTED|Period 4||6
4952934|NCT02806973|12183757|P1|STARTED|Period 4||8
4952935|NCT02806973|12183754|P4|NOT COMPLETED|Period 3||3
4952936|NCT02806973|12183755|P3|NOT COMPLETED|Period 3||1
4952937|NCT02806973|12183756|P2|NOT COMPLETED|Period 3||0
4952938|NCT02806973|12183757|P1|NOT COMPLETED|Period 3||0
4952939|NCT02806973|12183754|P4|COMPLETED|Period 3||3
4952940|NCT02806973|12183755|P3|COMPLETED|Period 3||6
4952941|NCT02806973|12183756|P2|COMPLETED|Period 3||6
4952942|NCT02806973|12183757|P1|COMPLETED|Period 3||8
4952943|NCT02806973|12183754|P4|STARTED|Period 3||6
4952944|NCT02806973|12183755|P3|STARTED|Period 3||7
4952945|NCT02806973|12183756|P2|STARTED|Period 3||6
4952946|NCT02806973|12183757|P1|STARTED|Period 3||8
4952947|NCT02806973|12183754|P4|NOT COMPLETED|Period 2||0
4952948|NCT02806973|12183755|P3|NOT COMPLETED|Period 2||0
4952949|NCT02806973|12183756|P2|NOT COMPLETED|Period 2||0
4952950|NCT02806973|12183757|P1|NOT COMPLETED|Period 2||0
4952951|NCT02806973|12183754|P4|COMPLETED|Period 2||6
4952952|NCT02806973|12183755|P3|COMPLETED|Period 2||7
4952953|NCT02806973|12183756|P2|COMPLETED|Period 2||6
4952954|NCT02806973|12183757|P1|COMPLETED|Period 2||8
4952955|NCT02806973|12183754|P4|STARTED|Period 2||6
4952956|NCT02806973|12183755|P3|STARTED|Period 2||7
4952957|NCT02806973|12183756|P2|STARTED|Period 2||6
4952958|NCT02806973|12183757|P1|STARTED|Period 2||8
4952959|NCT02806973|12183754|P4|NOT COMPLETED|Period 1||2
4952960|NCT02806973|12183755|P3|NOT COMPLETED|Period 1||1
4952961|NCT02806973|12183756|P2|NOT COMPLETED|Period 1||2
4952962|NCT02806973|12183757|P1|NOT COMPLETED|Period 1||0
4952963|NCT02806973|12183754|P4|COMPLETED|Period 1||6
4952964|NCT02806973|12183755|P3|COMPLETED|Period 1||7
4952965|NCT02806973|12183756|P2|COMPLETED|Period 1||6
4952966|NCT02806973|12183757|P1|COMPLETED|Period 1||8
4952967|NCT02806973|12183754|P4|STARTED|Period 1||8
4952968|NCT02806973|12183755|P3|STARTED|Period 1||8
4952969|NCT02806973|12183756|P2|STARTED|Period 1||8
4952970|NCT02806973|12183757|P1|STARTED|Period 1||8
4952971|NCT02806960|12183791|P4|NOT COMPLETED|Period 4||0
4952972|NCT02806960|12183792|P3|NOT COMPLETED|Period 4||0
4952973|NCT02806960|12183793|P2|NOT COMPLETED|Period 4||0
4952974|NCT02806960|12183794|P1|NOT COMPLETED|Period 4||0
4952975|NCT02806960|12183791|P4|COMPLETED|Period 4||0
4952976|NCT02806960|12183792|P3|COMPLETED|Period 4||0
4952977|NCT02806960|12183793|P2|COMPLETED|Period 4||0
4952978|NCT02806960|12183794|P1|COMPLETED|Period 4||0
4952979|NCT02806960|12183791|P4|STARTED|Period 4||0
4952980|NCT02806960|12183792|P3|STARTED|Period 4||0
4952981|NCT02806960|12183793|P2|STARTED|Period 4||0
4952982|NCT02806960|12183794|P1|STARTED|Period 4||0
4952983|NCT02806960|12183791|P4|NOT COMPLETED|Period 3||0
4952984|NCT02806960|12183792|P3|NOT COMPLETED|Period 3||0
4952985|NCT02806960|12183793|P2|NOT COMPLETED|Period 3||0
4952986|NCT02806960|12183794|P1|NOT COMPLETED|Period 3||0
4952987|NCT02806960|12183791|P4|COMPLETED|Period 3||0
4952988|NCT02806960|12183792|P3|COMPLETED|Period 3||0
4952989|NCT02806960|12183793|P2|COMPLETED|Period 3||0
4952990|NCT02806960|12183794|P1|COMPLETED|Period 3||0
4952991|NCT02806960|12183791|P4|STARTED|Period 3||0
4952992|NCT02806960|12183792|P3|STARTED|Period 3||0
4952993|NCT02806960|12183793|P2|STARTED|Period 3||0
4952994|NCT02806960|12183794|P1|STARTED|Period 3||0
4952995|NCT02806960|12183791|P4|NOT COMPLETED|Period 2||0
4952996|NCT02806960|12183792|P3|NOT COMPLETED|Period 2||0
4952997|NCT02806960|12183793|P2|NOT COMPLETED|Period 2||0
4952998|NCT02806960|12183794|P1|NOT COMPLETED|Period 2||0
4952999|NCT02806960|12183791|P4|COMPLETED|Period 2||0
4953000|NCT02806960|12183792|P3|COMPLETED|Period 2||0
4953001|NCT02806960|12183793|P2|COMPLETED|Period 2||0
4953002|NCT02806960|12183794|P1|COMPLETED|Period 2||0
4953003|NCT02806960|12183791|P4|STARTED|Period 2||0
4953004|NCT02806960|12183792|P3|STARTED|Period 2||0
4953005|NCT02806960|12183793|P2|STARTED|Period 2||0
4953006|NCT02806960|12183794|P1|STARTED|Period 2||0
4953007|NCT02806960|12183791|P4|NOT COMPLETED|Period 1||3
4953008|NCT02806960|12183792|P3|NOT COMPLETED|Period 1||3
4953009|NCT02806960|12183793|P2|NOT COMPLETED|Period 1||3
4953010|NCT02806960|12183794|P1|NOT COMPLETED|Period 1||3
4953011|NCT02806960|12183791|P4|COMPLETED|Period 1||0
4953012|NCT02806960|12183792|P3|COMPLETED|Period 1||0
4953013|NCT02806960|12183793|P2|COMPLETED|Period 1||0
4953014|NCT02806960|12183794|P1|COMPLETED|Period 1||0
4953015|NCT02806960|12183791|P4|STARTED|Period 1||3
4953016|NCT02806960|12183792|P3|STARTED|Period 1||3
4953017|NCT02806960|12183793|P2|STARTED|Period 1||3
4953018|NCT02806960|12183794|P1|STARTED|Period 1||3
4953019|NCT02806947|12183830|P2|NOT COMPLETED|Overall Study||1
4953020|NCT02806947|12183831|P1|NOT COMPLETED|Overall Study||5
4953021|NCT02806947|12183830|P2|COMPLETED|Overall Study||63
4953022|NCT02806947|12183831|P1|COMPLETED|Overall Study||53
4953023|NCT02806947|12183830|P2|STARTED|Overall Study||64
4953024|NCT02806947|12183831|P1|STARTED|Overall Study||58
4953025|NCT02806895|12183861|P2|NOT COMPLETED|Overall Study||0
4953026|NCT02806895|12183862|P1|NOT COMPLETED|Overall Study||1
4953027|NCT02806895|12183861|P2|COMPLETED|Overall Study||17
4953028|NCT02806895|12183862|P1|COMPLETED|Overall Study||16
4953029|NCT02806895|12183861|P2|STARTED|Overall Study||17
4953030|NCT02806895|12183862|P1|STARTED|Overall Study||17
4953031|NCT02806869|12183902|P2|NOT COMPLETED|Second Intervention (1 Day)||2
4953032|NCT02806869|12183903|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4953033|NCT02806869|12183902|P2|COMPLETED|Second Intervention (1 Day)||5
4953034|NCT02806869|12183903|P1|COMPLETED|Second Intervention (1 Day)||7
4953035|NCT02806869|12183902|P2|STARTED|Second Intervention (1 Day)||7
4953036|NCT02806869|12183903|P1|STARTED|Second Intervention (1 Day)||7
4953037|NCT02806869|12183902|P2|NOT COMPLETED|Washout (7 Days)||0
4953038|NCT02806869|12183903|P1|NOT COMPLETED|Washout (7 Days)||0
4953039|NCT02806869|12183902|P2|COMPLETED|Washout (7 Days)||7
4953040|NCT02806869|12183903|P1|COMPLETED|Washout (7 Days)||7
4953041|NCT02806869|12183902|P2|STARTED|Washout (7 Days)||7
4953042|NCT02806869|12183903|P1|STARTED|Washout (7 Days)||7
4953043|NCT02806869|12183902|P2|NOT COMPLETED|First Intervention (1 Day)||12
4953044|NCT02806869|12183903|P1|NOT COMPLETED|First Intervention (1 Day)||11
4953045|NCT02806869|12183902|P2|COMPLETED|First Intervention (1 Day)||12
4953046|NCT02806869|12183903|P1|COMPLETED|First Intervention (1 Day)||13
4953047|NCT02806869|12183902|P2|STARTED|First Intervention (1 Day)||24
4953048|NCT02806869|12183903|P1|STARTED|First Intervention (1 Day)||24
4953049|NCT02806726|12183913|P1|NOT COMPLETED|Overall Study||1
4953050|NCT02806726|12183913|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
4953051|NCT02806726|12183913|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
4953052|NCT02806713|12183922|P2|NOT COMPLETED|Overall Study||2
4953053|NCT02806713|12183923|P1|NOT COMPLETED|Overall Study||2
4953054|NCT02806713|12183922|P2|COMPLETED|Overall Study||44
4953055|NCT02806713|12183923|P1|COMPLETED|Overall Study||44
4953056|NCT02806713|12183922|P2|STARTED|Overall Study||46
4953057|NCT02806713|12183923|P1|STARTED|Overall Study||46
4953058|NCT02806544|12183931|P1|NOT COMPLETED|Overall Study||4
4953059|NCT02806544|12183931|P1|COMPLETED|Overall Study||31
4953060|NCT02806544|12183931|P1|STARTED|Overall Study||35
4953061|NCT02806505|12183942|P2|NOT COMPLETED|Overall Study||11
4953062|NCT02806505|12183943|P1|NOT COMPLETED|Overall Study||10
4953063|NCT02806505|12183942|P2|COMPLETED|Overall Study||32
4953064|NCT02806505|12183943|P1|COMPLETED|Overall Study||28
4953065|NCT02806505|12183942|P2|STARTED|Overall Study||43
4953066|NCT02806505|12183943|P1|STARTED|Overall Study||38
4953067|NCT02806414|12183953|P1|NOT COMPLETED|Overall Study||2
4953068|NCT02806414|12183953|P1|COMPLETED|Overall Study||13
4953069|NCT02806414|12183953|P1|STARTED|Overall Study||15
4953070|NCT02806232|12183967|P9|NOT COMPLETED|Overall Study||0
4953071|NCT02806232|12183968|P8|NOT COMPLETED|Overall Study||0
4953072|NCT02806232|12183969|P7|NOT COMPLETED|Overall Study||0
4953073|NCT02806232|12183970|P6|NOT COMPLETED|Overall Study||2
4953074|NCT02806232|12183971|P5|NOT COMPLETED|Overall Study||2
4953075|NCT02806232|12183972|P4|NOT COMPLETED|Overall Study||0
4953076|NCT02806232|12183973|P3|NOT COMPLETED|Overall Study||1
4953077|NCT02806232|12183974|P2|NOT COMPLETED|Overall Study||4
4953078|NCT02806232|12183975|P1|NOT COMPLETED|Overall Study||1
4953079|NCT02806232|12183967|P9|COMPLETED|Overall Study||4
4953080|NCT02806232|12183968|P8|COMPLETED|Overall Study||20
4953081|NCT02806232|12183969|P7|COMPLETED|Overall Study||60
4953082|NCT02806232|12183970|P6|COMPLETED|Overall Study||58
4953083|NCT02806232|12183971|P5|COMPLETED|Overall Study||58
4953084|NCT02806232|12183972|P4|COMPLETED|Overall Study||60
4953085|NCT02806232|12183973|P3|COMPLETED|Overall Study||59
4953086|NCT02806232|12183974|P2|COMPLETED|Overall Study||56
4953087|NCT02806232|12183975|P1|COMPLETED|Overall Study||59
4953088|NCT02806232|12183967|P9|STARTED|Overall Study||4
4953089|NCT02806232|12183968|P8|STARTED|Overall Study||20
4953090|NCT02806232|12183969|P7|STARTED|Overall Study||60
4953091|NCT02806232|12183970|P6|STARTED|Overall Study||60
4953092|NCT02806232|12183971|P5|STARTED|Overall Study||60
4953093|NCT02806232|12183972|P4|STARTED|Overall Study||60
4953094|NCT02806232|12183973|P3|STARTED|Overall Study||60
4953095|NCT02806232|12183974|P2|STARTED|Overall Study||60
4953096|NCT02806232|12183975|P1|STARTED|Overall Study||60
4953097|NCT02806024|12184015|P2|NOT COMPLETED|Overall Study||2
4953098|NCT02806024|12184016|P1|NOT COMPLETED|Overall Study||1
4953099|NCT02806024|12184015|P2|COMPLETED|Overall Study||5
4953100|NCT02806024|12184016|P1|COMPLETED|Overall Study||6
4953101|NCT02806024|12184015|P2|STARTED|Overall Study||7
4953102|NCT02806024|12184016|P1|STARTED|Overall Study||7
4953103|NCT02805907|12184026|P2|NOT COMPLETED|Overall Study||3
4953104|NCT02805907|12184027|P1|NOT COMPLETED|Overall Study||3
4953105|NCT02805907|12184026|P2|COMPLETED|Overall Study||53
4953106|NCT02805907|12184027|P1|COMPLETED|Overall Study||53
4953107|NCT02805907|12184026|P2|STARTED|Overall Study||56
4953108|NCT02805907|12184027|P1|STARTED|Overall Study||56
4953109|NCT02805790|12184041|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
4953110|NCT02805790|12184042|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
4953111|NCT02805790|12184041|P2|COMPLETED|Second Intervention (4 Weeks)||15
4953112|NCT02805790|12184042|P1|COMPLETED|Second Intervention (4 Weeks)||14
4953113|NCT02805790|12184041|P2|STARTED|Second Intervention (4 Weeks)||16
4953114|NCT02805790|12184042|P1|STARTED|Second Intervention (4 Weeks)||14
4953115|NCT02805790|12184041|P2|NOT COMPLETED|Washout (4 Weeks)||0
4953116|NCT02805790|12184042|P1|NOT COMPLETED|Washout (4 Weeks)||0
4953117|NCT02805790|12184041|P2|COMPLETED|Washout (4 Weeks)||16
4953118|NCT02805790|12184042|P1|COMPLETED|Washout (4 Weeks)||14
4953119|NCT02805790|12184041|P2|STARTED|Washout (4 Weeks)||16
4953120|NCT02805790|12184042|P1|STARTED|Washout (4 Weeks)||14
4953121|NCT02805790|12184041|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
4953122|NCT02805790|12184042|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
4953123|NCT02805790|12184041|P2|COMPLETED|First Intervention (4 Weeks)||16
4953124|NCT02805790|12184042|P1|COMPLETED|First Intervention (4 Weeks)||14
4953125|NCT02805790|12184041|P2|STARTED|First Intervention (4 Weeks)||16
4953126|NCT02805790|12184042|P1|STARTED|First Intervention (4 Weeks)||14
4953127|NCT02805647|12184068|P2|NOT COMPLETED|Overall Study||0
4953128|NCT02805647|12184069|P1|NOT COMPLETED|Overall Study||0
4953129|NCT02805647|12184068|P2|COMPLETED|Overall Study|after laboratory tests|122
4953130|NCT02805647|12184069|P1|COMPLETED|Overall Study|after laboratory tests|100
4953131|NCT02805647|12184068|P2|STARTED|Overall Study|at the moment of submision|122
4953132|NCT02805647|12184069|P1|STARTED|Overall Study|at the moment of submision|100
4953133|NCT02804750|12184077|P2|NOT COMPLETED|Period 4||5
4953134|NCT02804750|12184078|P1|NOT COMPLETED|Period 4||0
4953135|NCT02804750|12184077|P2|COMPLETED|Period 4||7
4953136|NCT02804750|12184078|P1|COMPLETED|Period 4||0
4953137|NCT02804750|12184077|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
4953138|NCT02804750|12184078|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
4953139|NCT02804750|12184077|P2|NOT COMPLETED|Period 3||2
4953140|NCT02804750|12184078|P1|NOT COMPLETED|Period 3||0
4953141|NCT02804750|12184077|P2|COMPLETED|Period 3||13
4953142|NCT02804750|12184078|P1|COMPLETED|Period 3||16
4953143|NCT02804750|12184077|P2|STARTED|Period 3||15
4953144|NCT02804750|12184078|P1|STARTED|Period 3||16
4953145|NCT02804750|12184077|P2|NOT COMPLETED|Period 2||0
4953146|NCT02804750|12184078|P1|NOT COMPLETED|Period 2||1
4953147|NCT02804750|12184077|P2|COMPLETED|Period 2||15
4953148|NCT02804750|12184078|P1|COMPLETED|Period 2||16
4953149|NCT02804750|12184077|P2|STARTED|Period 2||15
4953150|NCT02804750|12184078|P1|STARTED|Period 2||17
4953151|NCT02804750|12184077|P2|NOT COMPLETED|Period 1||3
4953152|NCT02804750|12184078|P1|NOT COMPLETED|Period 1||0
4953153|NCT02804750|12184077|P2|COMPLETED|Period 1||15
4953154|NCT02804750|12184078|P1|COMPLETED|Period 1||17
4953155|NCT02804750|12184077|P2|STARTED|Period 1||18
4953156|NCT02804750|12184078|P1|STARTED|Period 1||17
4953157|NCT02804594|12184094|P2|NOT COMPLETED|Overall Study||0
4953158|NCT02804594|12184095|P1|NOT COMPLETED|Overall Study||0
4953159|NCT02804594|12184094|P2|COMPLETED|Overall Study||5
4953160|NCT02804594|12184095|P1|COMPLETED|Overall Study||10
4953161|NCT02804594|12184094|P2|STARTED|Overall Study||5
4953162|NCT02804594|12184095|P1|STARTED|Overall Study||10
4953163|NCT02804399|12184105|P2|NOT COMPLETED|Period 2||1
4953164|NCT02804399|12184106|P1|NOT COMPLETED|Period 2||0
4953165|NCT02804399|12184105|P2|COMPLETED|Period 2||11
4953166|NCT02804399|12184106|P1|COMPLETED|Period 2||0
4953167|NCT02804399|12184105|P2|STARTED|Period 2||12
4953168|NCT02804399|12184106|P1|STARTED|Period 2||0
4953169|NCT02804399|12184105|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
4953170|NCT02804399|12184106|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
4953171|NCT02804399|12184105|P2|COMPLETED|Washout Period at Least 10 Days||0
4953172|NCT02804399|12184106|P1|COMPLETED|Washout Period at Least 10 Days||12
4953173|NCT02804399|12184105|P2|STARTED|Washout Period at Least 10 Days||0
4953174|NCT02804399|12184106|P1|STARTED|Washout Period at Least 10 Days||12
4953175|NCT02804399|12184105|P2|NOT COMPLETED|Period 1||0
4953176|NCT02804399|12184106|P1|NOT COMPLETED|Period 1||0
4953177|NCT02804399|12184105|P2|COMPLETED|Period 1||0
4953178|NCT02804399|12184106|P1|COMPLETED|Period 1||12
4953179|NCT02804399|12184105|P2|STARTED|Period 1||0
4953180|NCT02804399|12184106|P1|STARTED|Period 1||12
4953181|NCT02803749|12184157|P2|NOT COMPLETED|Overall Study||0
4953182|NCT02803749|12184158|P1|NOT COMPLETED|Overall Study||5
4953183|NCT02803749|12184157|P2|COMPLETED|Overall Study||4
4953184|NCT02803749|12184158|P1|COMPLETED|Overall Study||12
4953185|NCT02803749|12184157|P2|STARTED|Overall Study||4
4953186|NCT02803749|12184158|P1|STARTED|Overall Study||17
4953187|NCT02803580|12184178|P1|NOT COMPLETED|Overall Study||36
4953188|NCT02803580|12184178|P1|COMPLETED|Overall Study||173
4953189|NCT02803580|12184178|P1|STARTED|Overall Study||209
4953190|NCT02803138|12184217|P1|NOT COMPLETED|Overall Study||70
4953191|NCT02803138|12184217|P1|COMPLETED|Overall Study||166
4953192|NCT02803138|12184217|P1|STARTED|Overall Study||236
4953193|NCT02802878|12184233|P2|NOT COMPLETED|Overall Study||3
4953194|NCT02802878|12184234|P1|NOT COMPLETED|Overall Study||4
4953195|NCT02802878|12184233|P2|COMPLETED|Overall Study||18
4953196|NCT02802878|12184234|P1|COMPLETED|Overall Study||17
4953197|NCT02802878|12184233|P2|STARTED|Overall Study||21
4953198|NCT02802878|12184234|P1|STARTED|Overall Study||21
4953199|NCT02802865|12184250|P2|NOT COMPLETED|Overall Study||2
4953200|NCT02802865|12184251|P1|NOT COMPLETED|Overall Study||1
4953201|NCT02802865|12184250|P2|COMPLETED|Overall Study||33
4953202|NCT02802865|12184251|P1|COMPLETED|Overall Study||34
4953203|NCT02802865|12184250|P2|STARTED|Overall Study||35
4953204|NCT02802865|12184251|P1|STARTED|Overall Study||35
4953205|NCT02802592|12184273|P1|NOT COMPLETED|Overall Study||4
4953206|NCT02802592|12184273|P1|COMPLETED|Overall Study||0
4953207|NCT02802592|12184273|P1|STARTED|Overall Study||4
4953208|NCT02802501|12184287|P3|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
4953209|NCT02802501|12184288|P2|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
4953210|NCT02802501|12184289|P1|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
4953211|NCT02802501|12184287|P3|COMPLETED|Open-Label (Day 180 to Day 195)||26
4953212|NCT02802501|12184288|P2|COMPLETED|Open-Label (Day 180 to Day 195)||12
4953213|NCT02802501|12184289|P1|COMPLETED|Open-Label (Day 180 to Day 195)||6
4953214|NCT02802501|12184287|P3|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
4953215|NCT02802501|12184288|P2|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
4953216|NCT02802501|12184289|P1|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
4953217|NCT02802501|12184287|P3|NOT COMPLETED|Double-blind (Up to Day 180)||0
4953218|NCT02802501|12184288|P2|NOT COMPLETED|Double-blind (Up to Day 180)||0
4953219|NCT02802501|12184289|P1|NOT COMPLETED|Double-blind (Up to Day 180)||0
4953220|NCT02802501|12184287|P3|COMPLETED|Double-blind (Up to Day 180)||50
4953221|NCT02802501|12184288|P2|COMPLETED|Double-blind (Up to Day 180)||50
4953222|NCT02802501|12184289|P1|COMPLETED|Double-blind (Up to Day 180)||50
4953223|NCT02802501|12184287|P3|STARTED|Double-blind (Up to Day 180)||50
4953224|NCT02802501|12184288|P2|STARTED|Double-blind (Up to Day 180)||50
4953225|NCT02802501|12184289|P1|STARTED|Double-blind (Up to Day 180)||50
4953226|NCT02802449|12184355|P2|NOT COMPLETED|Overall Study||17
4953227|NCT02802449|12184356|P1|NOT COMPLETED|Overall Study||9
4953228|NCT02802449|12184355|P2|COMPLETED|Overall Study||202
4953229|NCT02802449|12184356|P1|COMPLETED|Overall Study||102
4953230|NCT02802449|12184355|P2|STARTED|Overall Study||219
4953231|NCT02802449|12184356|P1|STARTED|Overall Study||111
4953232|NCT02802345|12184374|P2|NOT COMPLETED|Overall Study||30
4953233|NCT02802345|12184375|P1|NOT COMPLETED|Overall Study||32
4953234|NCT02802345|12184374|P2|COMPLETED|Overall Study||108
4953235|NCT02802345|12184375|P1|COMPLETED|Overall Study||104
4953236|NCT02802345|12184374|P2|Treated|Overall Study||137
4953237|NCT02802345|12184375|P1|Treated|Overall Study||136
4953238|NCT02802345|12184374|P2|STARTED|Overall Study||138
4953239|NCT02802345|12184375|P1|STARTED|Overall Study||136
4953240|NCT02802319|12184391|P2|NOT COMPLETED|Overall Study||5
4953241|NCT02802319|12184392|P1|NOT COMPLETED|Overall Study||2
4953242|NCT02802319|12184391|P2|COMPLETED|Overall Study||17
4953243|NCT02802319|12184392|P1|COMPLETED|Overall Study||20
4953244|NCT02802319|12184391|P2|STARTED|Overall Study||22
4953245|NCT02802319|12184392|P1|STARTED|Overall Study||22
4953246|NCT02801942|12184402|P2|NOT COMPLETED|Overall Study||0
4953247|NCT02801942|12184403|P1|NOT COMPLETED|Overall Study||0
4953248|NCT02801942|12184402|P2|COMPLETED|Overall Study||10
4953249|NCT02801942|12184403|P1|COMPLETED|Overall Study||12
4953250|NCT02801942|12184402|P2|STARTED|Overall Study||10
4953251|NCT02801942|12184403|P1|STARTED|Overall Study||12
4953252|NCT02801877|12184527|P4|NOT COMPLETED|Overall Study||0
4953253|NCT02801877|12184528|P3|NOT COMPLETED|Overall Study||6
4953254|NCT02801877|12184529|P2|NOT COMPLETED|Overall Study||1
4953255|NCT02801877|12184530|P1|NOT COMPLETED|Overall Study||3
4953256|NCT02801877|12184527|P4|COMPLETED|Overall Study||76
4953257|NCT02801877|12184528|P3|COMPLETED|Overall Study||70
4953258|NCT02801877|12184529|P2|COMPLETED|Overall Study||74
4953259|NCT02801877|12184530|P1|COMPLETED|Overall Study||71
4953260|NCT02801877|12184527|P4|STARTED|Overall Study||76
4953261|NCT02801877|12184528|P3|STARTED|Overall Study||76
4953262|NCT02801877|12184529|P2|STARTED|Overall Study||75
4953263|NCT02801877|12184530|P1|STARTED|Overall Study||74
4953264|NCT02801617|12184550|P2|NOT COMPLETED|Overall Study||6
4953265|NCT02801617|12184551|P1|NOT COMPLETED|Overall Study||2
4953266|NCT02801617|12184550|P2|COMPLETED|Overall Study||50
4953267|NCT02801617|12184551|P1|COMPLETED|Overall Study||49
4953268|NCT02801617|12184550|P2|STARTED|Overall Study||56
4953269|NCT02801617|12184551|P1|STARTED|Overall Study||51
4953270|NCT02801578|12184569|P1|NOT COMPLETED|Overall Study||2
4953271|NCT02801578|12184569|P1|COMPLETED|Overall Study||9
4953272|NCT02801578|12184569|P1|STARTED|Overall Study||11
4953273|NCT02801396|12184573|P6|NOT COMPLETED|Period 3||0
4953274|NCT02801396|12184574|P5|NOT COMPLETED|Period 3||0
4953275|NCT02801396|12184575|P4|NOT COMPLETED|Period 3||0
4953276|NCT02801396|12184576|P3|NOT COMPLETED|Period 3||0
4953277|NCT02801396|12184577|P2|NOT COMPLETED|Period 3||0
4953278|NCT02801396|12184578|P1|NOT COMPLETED|Period 3||0
4953279|NCT02801396|12184573|P6|COMPLETED|Period 3||17
4953280|NCT02801396|12184574|P5|COMPLETED|Period 3||16
4953281|NCT02801396|12184575|P4|COMPLETED|Period 3||16
4953282|NCT02801396|12184576|P3|COMPLETED|Period 3||17
4953283|NCT02801396|12184577|P2|COMPLETED|Period 3||17
4953284|NCT02801396|12184578|P1|COMPLETED|Period 3||17
4953285|NCT02801396|12184573|P6|STARTED|Period 3||17
4953286|NCT02801396|12184574|P5|STARTED|Period 3||16
4953287|NCT02801396|12184575|P4|STARTED|Period 3||16
4953288|NCT02801396|12184576|P3|STARTED|Period 3||17
4953289|NCT02801396|12184577|P2|STARTED|Period 3||17
4953290|NCT02801396|12184578|P1|STARTED|Period 3||17
4953291|NCT02801396|12184573|P6|NOT COMPLETED|Period 2||0
4953292|NCT02801396|12184574|P5|NOT COMPLETED|Period 2||0
4953293|NCT02801396|12184575|P4|NOT COMPLETED|Period 2||0
4953294|NCT02801396|12184576|P3|NOT COMPLETED|Period 2||0
4953295|NCT02801396|12184577|P2|NOT COMPLETED|Period 2||0
4953296|NCT02801396|12184578|P1|NOT COMPLETED|Period 2||0
4953297|NCT02801396|12184573|P6|COMPLETED|Period 2||17
4953298|NCT02801396|12184574|P5|COMPLETED|Period 2||16
4953299|NCT02801396|12184575|P4|COMPLETED|Period 2||16
4953300|NCT02801396|12184576|P3|COMPLETED|Period 2||17
4953301|NCT02801396|12184577|P2|COMPLETED|Period 2||17
4953302|NCT02801396|12184578|P1|COMPLETED|Period 2||17
4953303|NCT02801396|12184573|P6|STARTED|Period 2||17
4953304|NCT02801396|12184574|P5|STARTED|Period 2||16
4953305|NCT02801396|12184575|P4|STARTED|Period 2||16
4953306|NCT02801396|12184576|P3|STARTED|Period 2||17
4953307|NCT02801396|12184577|P2|STARTED|Period 2||17
4953308|NCT02801396|12184578|P1|STARTED|Period 2||17
4953309|NCT02801396|12184573|P6|NOT COMPLETED|Period 1||0
4953310|NCT02801396|12184574|P5|NOT COMPLETED|Period 1||1
4953311|NCT02801396|12184575|P4|NOT COMPLETED|Period 1||0
4953312|NCT02801396|12184576|P3|NOT COMPLETED|Period 1||0
4953313|NCT02801396|12184577|P2|NOT COMPLETED|Period 1||0
4953314|NCT02801396|12184578|P1|NOT COMPLETED|Period 1||0
4953315|NCT02801396|12184573|P6|COMPLETED|Period 1||17
4953316|NCT02801396|12184574|P5|COMPLETED|Period 1||16
4953317|NCT02801396|12184575|P4|COMPLETED|Period 1||16
4953318|NCT02801396|12184576|P3|COMPLETED|Period 1||17
4953319|NCT02801396|12184577|P2|COMPLETED|Period 1||17
4953320|NCT02801396|12184578|P1|COMPLETED|Period 1||17
4953321|NCT02801396|12184573|P6|STARTED|Period 1||17
4953322|NCT02801396|12184574|P5|STARTED|Period 1||17
4953323|NCT02801396|12184575|P4|STARTED|Period 1||16
4953324|NCT02801396|12184576|P3|STARTED|Period 1||17
4953325|NCT02801396|12184577|P2|STARTED|Period 1||17
4953326|NCT02801396|12184578|P1|STARTED|Period 1||17
4953327|NCT02801006|12184595|P2|NOT COMPLETED|Lens 2||0
4953328|NCT02801006|12184596|P1|NOT COMPLETED|Lens 2||0
4953329|NCT02801006|12184595|P2|COMPLETED|Lens 2||19
4953330|NCT02801006|12184596|P1|COMPLETED|Lens 2||22
4953331|NCT02801006|12184595|P2|STARTED|Lens 2||19
4953332|NCT02801006|12184596|P1|STARTED|Lens 2||22
4953333|NCT02801006|12184595|P2|NOT COMPLETED|Lens 1||0
4953334|NCT02801006|12184596|P1|NOT COMPLETED|Lens 1||0
4953335|NCT02801006|12184595|P2|COMPLETED|Lens 1||19
4953336|NCT02801006|12184596|P1|COMPLETED|Lens 1||22
4953337|NCT02801006|12184595|P2|STARTED|Lens 1||19
4953338|NCT02801006|12184596|P1|STARTED|Lens 1||22
4953339|NCT02800928|12184612|P2|NOT COMPLETED|Overall Study||2
4953340|NCT02800928|12184613|P1|NOT COMPLETED|Overall Study||2
4953341|NCT02800928|12184612|P2|COMPLETED|Overall Study||6
4953342|NCT02800928|12184613|P1|COMPLETED|Overall Study||7
4953343|NCT02800928|12184612|P2|STARTED|Overall Study||8
4953344|NCT02800928|12184613|P1|STARTED|Overall Study||9
4953345|NCT02800642|12184621|P1|NOT COMPLETED|Overall Study||25
4953346|NCT02800642|12184621|P1|COMPLETED|Overall Study||137
4953347|NCT02800642|12184621|P1|STARTED|Overall Study||162
4953348|NCT02800356|12184634|P1|NOT COMPLETED|Overall Study||0
4953349|NCT02800356|12184634|P1|COMPLETED|Overall Study||20
4953350|NCT02800356|12184634|P1|STARTED|Overall Study||20
4953351|NCT02800213|12184645|P2|NOT COMPLETED|Second Intervention||0
4953352|NCT02800213|12184646|P1|NOT COMPLETED|Second Intervention||0
4953353|NCT02800213|12184645|P2|COMPLETED|Second Intervention||35
4953354|NCT02800213|12184646|P1|COMPLETED|Second Intervention||35
4953355|NCT02800213|12184645|P2|STARTED|Second Intervention||35
4953356|NCT02800213|12184646|P1|STARTED|Second Intervention||35
4953357|NCT02800213|12184645|P2|NOT COMPLETED|First Intervention||0
4953358|NCT02800213|12184646|P1|NOT COMPLETED|First Intervention||0
4953359|NCT02800213|12184645|P2|COMPLETED|First Intervention||35
4953360|NCT02800213|12184646|P1|COMPLETED|First Intervention||35
4953361|NCT02800213|12184645|P2|STARTED|First Intervention||35
4953362|NCT02800213|12184646|P1|STARTED|First Intervention||35
4953363|NCT02799784|12184652|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
4953364|NCT02799784|12184653|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
4953365|NCT02799784|12184652|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
4953366|NCT02799784|12184653|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
4953367|NCT02799784|12184652|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
4953368|NCT02799784|12184653|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
4953369|NCT02799784|12184652|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
4953370|NCT02799784|12184653|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
4953371|NCT02799784|12184652|P2|COMPLETED|Washout Period (3 Weeks)||118
4953372|NCT02799784|12184653|P1|COMPLETED|Washout Period (3 Weeks)||111
4953373|NCT02799784|12184652|P2|STARTED|Washout Period (3 Weeks)||118
4953374|NCT02799784|12184653|P1|STARTED|Washout Period (3 Weeks)||111
4953375|NCT02799784|12184652|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
4953376|NCT02799784|12184653|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
4953377|NCT02799784|12184652|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
4953378|NCT02799784|12184653|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
4953379|NCT02799784|12184652|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
4953380|NCT02799784|12184653|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
4953381|NCT02799472|12184661|P2|NOT COMPLETED|Overall Study||5
4953382|NCT02799472|12184662|P1|NOT COMPLETED|Overall Study||4
4953383|NCT02799472|12184661|P2|COMPLETED|Overall Study||23
4953384|NCT02799472|12184662|P1|COMPLETED|Overall Study||7
4953385|NCT02799472|12184661|P2|STARTED|Overall Study||28
4953386|NCT02799472|12184662|P1|STARTED|Overall Study||11
4953387|NCT02799082|12184722|P2|NOT COMPLETED|Overall Study||4
4953388|NCT02799082|12184723|P1|NOT COMPLETED|Overall Study||4
4953389|NCT02799082|12184722|P2|COMPLETED|Overall Study||77
4953390|NCT02799082|12184723|P1|COMPLETED|Overall Study||37
4953391|NCT02799082|12184722|P2|STARTED|Overall Study||81
4953392|NCT02799082|12184723|P1|STARTED|Overall Study||41
4953393|NCT02799069|12184760|P3|NOT COMPLETED|Overall Study||7
4953394|NCT02799069|12184761|P2|NOT COMPLETED|Overall Study||7
4953395|NCT02799069|12184762|P1|NOT COMPLETED|Overall Study||8
4953396|NCT02799069|12184760|P3|COMPLETED|Overall Study||240
4953397|NCT02799069|12184761|P2|COMPLETED|Overall Study||241
4953398|NCT02799069|12184762|P1|COMPLETED|Overall Study||68
4953399|NCT02799069|12184760|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
4953400|NCT02799069|12184761|P2|ITT/Safety|Overall Study||248
4953401|NCT02799069|12184762|P1|ITT/Safety|Overall Study||76
4953402|NCT02799069|12184760|P3|STARTED|Overall Study||247
4953403|NCT02799069|12184761|P2|STARTED|Overall Study||248
4953404|NCT02799069|12184762|P1|STARTED|Overall Study||76
4953405|NCT02798978|12184879|P7|NOT COMPLETED|Part 2 (45 Days)||0
4953406|NCT02798978|12184880|P6|NOT COMPLETED|Part 2 (45 Days)||0
4953407|NCT02798978|12184881|P5|NOT COMPLETED|Part 2 (45 Days)||0
4953408|NCT02798978|12184882|P4|NOT COMPLETED|Part 2 (45 Days)||0
4953409|NCT02798978|12184883|P3|NOT COMPLETED|Part 2 (45 Days)||0
4953410|NCT02798978|12184884|P2|NOT COMPLETED|Part 2 (45 Days)||0
4953411|NCT02798978|12184885|P1|NOT COMPLETED|Part 2 (45 Days)||0
4953412|NCT02798978|12184879|P7|COMPLETED|Part 2 (45 Days)||0
4953413|NCT02798978|12184880|P6|COMPLETED|Part 2 (45 Days)||0
4953414|NCT02798978|12184881|P5|COMPLETED|Part 2 (45 Days)||0
4953415|NCT02798978|12184882|P4|COMPLETED|Part 2 (45 Days)||0
4953416|NCT02798978|12184883|P3|COMPLETED|Part 2 (45 Days)||0
4953417|NCT02798978|12184884|P2|COMPLETED|Part 2 (45 Days)||0
4953418|NCT02798978|12184885|P1|COMPLETED|Part 2 (45 Days)||0
4953419|NCT02798978|12184879|P7|STARTED|Part 2 (45 Days)||0
4953420|NCT02798978|12184880|P6|STARTED|Part 2 (45 Days)||0
4953421|NCT02798978|12184881|P5|STARTED|Part 2 (45 Days)||0
4953422|NCT02798978|12184882|P4|STARTED|Part 2 (45 Days)||0
4953423|NCT02798978|12184883|P3|STARTED|Part 2 (45 Days)||0
4953424|NCT02798978|12184884|P2|STARTED|Part 2 (45 Days)||0
4953425|NCT02798978|12184885|P1|STARTED|Part 2 (45 Days)||0
4953426|NCT02798978|12184879|P7|NOT COMPLETED|Part 1 (30 Days)||0
4953427|NCT02798978|12184880|P6|NOT COMPLETED|Part 1 (30 Days)||0
4953428|NCT02798978|12184881|P5|NOT COMPLETED|Part 1 (30 Days)||0
4953429|NCT02798978|12184882|P4|NOT COMPLETED|Part 1 (30 Days)||0
4953430|NCT02798978|12184883|P3|NOT COMPLETED|Part 1 (30 Days)||0
4953431|NCT02798978|12184884|P2|NOT COMPLETED|Part 1 (30 Days)||0
4953432|NCT02798978|12184885|P1|NOT COMPLETED|Part 1 (30 Days)||0
4953433|NCT02798978|12184879|P7|COMPLETED|Part 1 (30 Days)||0
4953434|NCT02798978|12184880|P6|COMPLETED|Part 1 (30 Days)||6
4953435|NCT02798978|12184881|P5|COMPLETED|Part 1 (30 Days)||6
4953436|NCT02798978|12184882|P4|COMPLETED|Part 1 (30 Days)||6
4953437|NCT02798978|12184883|P3|COMPLETED|Part 1 (30 Days)||6
4953438|NCT02798978|12184884|P2|COMPLETED|Part 1 (30 Days)||6
4953439|NCT02798978|12184885|P1|COMPLETED|Part 1 (30 Days)||10
4953440|NCT02798978|12184879|P7|STARTED|Part 1 (30 Days)||0
4953441|NCT02798978|12184880|P6|STARTED|Part 1 (30 Days)||6
4953442|NCT02798978|12184881|P5|STARTED|Part 1 (30 Days)||6
4953443|NCT02798978|12184882|P4|STARTED|Part 1 (30 Days)||6
4953444|NCT02798978|12184883|P3|STARTED|Part 1 (30 Days)||6
4953445|NCT02798978|12184884|P2|STARTED|Part 1 (30 Days)||6
4953446|NCT02798978|12184885|P1|STARTED|Part 1 (30 Days)||10
4953447|NCT02798952|12185088|P1|NOT COMPLETED|Overall Study||0
4953448|NCT02798952|12185088|P1|COMPLETED|Overall Study||302
4953449|NCT02798952|12185088|P1|STARTED|Overall Study||302
4953450|NCT02798861|12185100|P1|NOT COMPLETED|Overall Study||23
4953451|NCT02798861|12185100|P1|COMPLETED|Overall Study||137
4953452|NCT02798861|12185100|P1|STARTED|Overall Study||160
4953453|NCT02798380|12185105|P1|NOT COMPLETED|Overall Study||0
4953454|NCT02798380|12185105|P1|COMPLETED|Overall Study||30
4953455|NCT02798380|12185105|P1|STARTED|Overall Study||30
4953456|NCT02798354|12185112|P3|NOT COMPLETED|Third Intervention Period||0
4953457|NCT02798354|12185113|P2|NOT COMPLETED|Third Intervention Period||0
4953458|NCT02798354|12185114|P1|NOT COMPLETED|Third Intervention Period||0
4953459|NCT02798354|12185112|P3|COMPLETED|Third Intervention Period||2715
4953460|NCT02798354|12185113|P2|COMPLETED|Third Intervention Period||1010
4953461|NCT02798354|12185114|P1|COMPLETED|Third Intervention Period||746
4953462|NCT02798354|12185112|P3|Intervention Data Error 3|Third Intervention Period||1248
4953463|NCT02798354|12185113|P2|Intervention Data Error 3|Third Intervention Period||390
4953464|NCT02798354|12185114|P1|Intervention Data Error 3|Third Intervention Period||327
4953465|NCT02798354|12185112|P3|Control Data Error 3|Third Intervention Period||1467
4953466|NCT02798354|12185113|P2|Control Data Error 3|Third Intervention Period||620
4953467|NCT02798354|12185114|P1|Control Data Error 3|Third Intervention Period||419
4953468|NCT02798354|12185112|P3|STARTED|Third Intervention Period||2715
4953469|NCT02798354|12185113|P2|STARTED|Third Intervention Period||1010
4953470|NCT02798354|12185114|P1|STARTED|Third Intervention Period||746
4953471|NCT02798354|12185112|P3|NOT COMPLETED|Second Intervention Period||0
4953472|NCT02798354|12185113|P2|NOT COMPLETED|Second Intervention Period||0
4953473|NCT02798354|12185114|P1|NOT COMPLETED|Second Intervention Period||0
4953474|NCT02798354|12185112|P3|COMPLETED|Second Intervention Period||1368
4953475|NCT02798354|12185113|P2|COMPLETED|Second Intervention Period||1047
4953476|NCT02798354|12185114|P1|COMPLETED|Second Intervention Period||2617
4953477|NCT02798354|12185112|P3|Intervention Data Error 2|Second Intervention Period||700
4953478|NCT02798354|12185113|P2|Intervention Data Error 2|Second Intervention Period||454
4953479|NCT02798354|12185114|P1|Intervention Data Error 2|Second Intervention Period||1239
4953480|NCT02798354|12185112|P3|Control Data Error 2|Second Intervention Period||668
4953481|NCT02798354|12185113|P2|Control Data Error 2|Second Intervention Period||593
4953482|NCT02798354|12185114|P1|Control Data Error 2|Second Intervention Period||1378
4953483|NCT02798354|12185112|P3|STARTED|Second Intervention Period||1368
4953484|NCT02798354|12185113|P2|STARTED|Second Intervention Period||1047
4953485|NCT02798354|12185114|P1|STARTED|Second Intervention Period||2617
4953486|NCT02798354|12185112|P3|NOT COMPLETED|First Intervention Period||0
4953487|NCT02798354|12185113|P2|NOT COMPLETED|First Intervention Period||0
4953488|NCT02798354|12185114|P1|NOT COMPLETED|First Intervention Period||0
4953489|NCT02798354|12185112|P3|COMPLETED|First Intervention Period||990
4953490|NCT02798354|12185113|P2|COMPLETED|First Intervention Period||2176
4953491|NCT02798354|12185114|P1|COMPLETED|First Intervention Period||1184
4953492|NCT02798354|12185112|P3|Intervention Data Error 1|First Intervention Period||645
4953493|NCT02798354|12185113|P2|Intervention Data Error 1|First Intervention Period||1627
4953494|NCT02798354|12185114|P1|Intervention Data Error 1|First Intervention Period||744
4953495|NCT02798354|12185112|P3|Control Data Error 1|First Intervention Period||345
4953496|NCT02798354|12185113|P2|Control Data Error 1|First Intervention Period||549
4953497|NCT02798354|12185114|P1|Control Data Error 1|First Intervention Period||440
4953498|NCT02798354|12185112|P3|STARTED|First Intervention Period||990
4953499|NCT02798354|12185113|P2|STARTED|First Intervention Period||2176
4953500|NCT02798354|12185114|P1|STARTED|First Intervention Period||1184
4953501|NCT02798315|12185136|P1|NOT COMPLETED|Overall Study||1
4953502|NCT02798315|12185136|P1|COMPLETED|Overall Study||39
4953503|NCT02798315|12185136|P1|STARTED|Overall Study||40
4953504|NCT02798289|12185150|P1|NOT COMPLETED|Overall Study||0
4953505|NCT02798289|12185150|P1|COMPLETED|Overall Study||55
4953506|NCT02798289|12185150|P1|STARTED|Overall Study||55
4953507|NCT02797821|12185157|P3|NOT COMPLETED|Overall Study||0
4953508|NCT02797821|12185158|P2|NOT COMPLETED|Overall Study||0
4953509|NCT02797821|12185159|P1|NOT COMPLETED|Overall Study||0
4953510|NCT02797821|12185157|P3|COMPLETED|Overall Study||9
4953511|NCT02797821|12185158|P2|COMPLETED|Overall Study||10
4953512|NCT02797821|12185159|P1|COMPLETED|Overall Study||8
4953513|NCT02797821|12185157|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
4953514|NCT02797821|12185158|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
4953515|NCT02797821|12185159|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
4953516|NCT02797821|12185157|P3|STARTED|Overall Study||9
4953517|NCT02797821|12185158|P2|STARTED|Overall Study||10
4953518|NCT02797821|12185159|P1|STARTED|Overall Study||8
4953519|NCT02797678|12185170|P4|NOT COMPLETED|Sub-Study||0
4953520|NCT02797678|12185171|P3|NOT COMPLETED|Sub-Study||0
4953521|NCT02797678|12185172|P2|NOT COMPLETED|Sub-Study||0
4953522|NCT02797678|12185173|P1|NOT COMPLETED|Sub-Study||0
4953523|NCT02797678|12185170|P4|COMPLETED|Sub-Study||9
4953524|NCT02797678|12185171|P3|COMPLETED|Sub-Study||0
4953525|NCT02797678|12185172|P2|COMPLETED|Sub-Study||0
4953526|NCT02797678|12185173|P1|COMPLETED|Sub-Study||0
4953527|NCT02797678|12185170|P4|STARTED|Sub-Study||9
4953528|NCT02797678|12185171|P3|STARTED|Sub-Study||0
4953529|NCT02797678|12185172|P2|STARTED|Sub-Study||0
4953530|NCT02797678|12185173|P1|STARTED|Sub-Study||0
4953531|NCT02797678|12185170|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
4953532|NCT02797678|12185171|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
4953533|NCT02797678|12185172|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
4953534|NCT02797678|12185173|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
4953535|NCT02797678|12185170|P4|COMPLETED|Second Intervention (5 Nights)||0
4953536|NCT02797678|12185171|P3|COMPLETED|Second Intervention (5 Nights)||16
4953537|NCT02797678|12185172|P2|COMPLETED|Second Intervention (5 Nights)||19
4953538|NCT02797678|12185173|P1|COMPLETED|Second Intervention (5 Nights)||0
4953539|NCT02797678|12185170|P4|STARTED|Second Intervention (5 Nights)||0
4953540|NCT02797678|12185171|P3|STARTED|Second Intervention (5 Nights)||17
4953541|NCT02797678|12185172|P2|STARTED|Second Intervention (5 Nights)||19
4953542|NCT02797678|12185173|P1|STARTED|Second Intervention (5 Nights)||0
4953543|NCT02797678|12185170|P4|NOT COMPLETED|Washout||0
4953544|NCT02797678|12185171|P3|NOT COMPLETED|Washout||0
4953545|NCT02797678|12185172|P2|NOT COMPLETED|Washout||0
4953546|NCT02797678|12185173|P1|NOT COMPLETED|Washout||0
4953547|NCT02797678|12185170|P4|COMPLETED|Washout||0
4953548|NCT02797678|12185171|P3|COMPLETED|Washout||17
4953549|NCT02797678|12185172|P2|COMPLETED|Washout||19
4953550|NCT02797678|12185173|P1|COMPLETED|Washout||0
4953551|NCT02797678|12185170|P4|STARTED|Washout||0
4953552|NCT02797678|12185171|P3|STARTED|Washout||17
4953553|NCT02797678|12185172|P2|STARTED|Washout||19
4953554|NCT02797678|12185173|P1|STARTED|Washout||0
4953555|NCT02797678|12185170|P4|NOT COMPLETED|First Intervention (5 Nights)||0
4953556|NCT02797678|12185171|P3|NOT COMPLETED|First Intervention (5 Nights)||0
4953557|NCT02797678|12185172|P2|NOT COMPLETED|First Intervention (5 Nights)||1
4953558|NCT02797678|12185173|P1|NOT COMPLETED|First Intervention (5 Nights)||0
4953559|NCT02797678|12185170|P4|COMPLETED|First Intervention (5 Nights)||0
4953560|NCT02797678|12185171|P3|COMPLETED|First Intervention (5 Nights)||17
4953561|NCT02797678|12185172|P2|COMPLETED|First Intervention (5 Nights)||19
4953562|NCT02797678|12185173|P1|COMPLETED|First Intervention (5 Nights)||0
4953563|NCT02797678|12185170|P4|STARTED|First Intervention (5 Nights)||0
4953564|NCT02797678|12185171|P3|STARTED|First Intervention (5 Nights)||17
4953565|NCT02797678|12185172|P2|STARTED|First Intervention (5 Nights)||20
4953566|NCT02797678|12185173|P1|STARTED|First Intervention (5 Nights)||0
4953567|NCT02797678|12185170|P4|NOT COMPLETED|Screening Phase||0
4953568|NCT02797678|12185171|P3|NOT COMPLETED|Screening Phase||0
4953569|NCT02797678|12185172|P2|NOT COMPLETED|Screening Phase||0
4953570|NCT02797678|12185173|P1|NOT COMPLETED|Screening Phase||25
4953571|NCT02797678|12185170|P4|COMPLETED|Screening Phase||0
4953572|NCT02797678|12185171|P3|COMPLETED|Screening Phase||0
4953573|NCT02797678|12185172|P2|COMPLETED|Screening Phase||0
4953574|NCT02797678|12185173|P1|COMPLETED|Screening Phase||37
4953575|NCT02797678|12185170|P4|STARTED|Screening Phase||0
4953576|NCT02797678|12185171|P3|STARTED|Screening Phase||0
4953577|NCT02797678|12185172|P2|STARTED|Screening Phase||0
4953578|NCT02797678|12185173|P1|STARTED|Screening Phase||62
4953579|NCT02797613|12185190|P2|NOT COMPLETED|Overall Study||0
4953580|NCT02797613|12185191|P1|NOT COMPLETED|Overall Study||0
4953581|NCT02797613|12185190|P2|COMPLETED|Overall Study||55
4953582|NCT02797613|12185191|P1|COMPLETED|Overall Study||55
4953583|NCT02797613|12185190|P2|STARTED|Overall Study||55
4953584|NCT02797613|12185191|P1|STARTED|Overall Study||55
4953585|NCT02797522|12185208|P11|NOT COMPLETED|Overall Study||1
4953586|NCT02797522|12185209|P10|NOT COMPLETED|Overall Study||4
4953587|NCT02797522|12185210|P9|NOT COMPLETED|Overall Study||2
4953588|NCT02797522|12185211|P8|NOT COMPLETED|Overall Study||4
4953589|NCT02797522|12185212|P7|NOT COMPLETED|Overall Study||0
4953590|NCT02797522|12185213|P6|NOT COMPLETED|Overall Study||0
4953591|NCT02797522|12185214|P5|NOT COMPLETED|Overall Study||0
4953592|NCT02797522|12185215|P4|NOT COMPLETED|Overall Study||0
4953593|NCT02797522|12185216|P3|NOT COMPLETED|Overall Study||0
4953594|NCT02797522|12185217|P2|NOT COMPLETED|Overall Study||0
4953595|NCT02797522|12185218|P1|NOT COMPLETED|Overall Study||0
4953596|NCT02797522|12185208|P11|COMPLETED|Overall Study||0
4953597|NCT02797522|12185209|P10|COMPLETED|Overall Study||0
4953598|NCT02797522|12185210|P9|COMPLETED|Overall Study||0
4953599|NCT02797522|12185211|P8|COMPLETED|Overall Study||0
4953600|NCT02797522|12185212|P7|COMPLETED|Overall Study||12
4953601|NCT02797522|12185213|P6|COMPLETED|Overall Study||4
4953602|NCT02797522|12185214|P5|COMPLETED|Overall Study||4
4953603|NCT02797522|12185215|P4|COMPLETED|Overall Study||4
4953604|NCT02797522|12185216|P3|COMPLETED|Overall Study||4
4953605|NCT02797522|12185217|P2|COMPLETED|Overall Study||4
4953606|NCT02797522|12185218|P1|COMPLETED|Overall Study||4
4953607|NCT02797522|12185208|P11|STARTED|Overall Study||1
4953608|NCT02797522|12185209|P10|STARTED|Overall Study||4
4953609|NCT02797522|12185210|P9|STARTED|Overall Study||2
4953610|NCT02797522|12185211|P8|STARTED|Overall Study||4
4953611|NCT02797522|12185212|P7|STARTED|Overall Study||12
4953612|NCT02797522|12185213|P6|STARTED|Overall Study||4
4953613|NCT02797522|12185214|P5|STARTED|Overall Study||4
4953614|NCT02797522|12185215|P4|STARTED|Overall Study||4
4953615|NCT02797522|12185216|P3|STARTED|Overall Study||4
4953616|NCT02797522|12185217|P2|STARTED|Overall Study||4
4953617|NCT02797522|12185218|P1|STARTED|Overall Study||4
4953618|NCT02797132|12185324|P1|NOT COMPLETED|Part B (24 Weeks)||3
4953619|NCT02797132|12185324|P1|COMPLETED|Part B (24 Weeks)||57
4953620|NCT02797132|12185324|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
4953621|NCT02797132|12185324|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
4953622|NCT02797132|12185324|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
4953623|NCT02797132|12185324|P1|NOT COMPLETED|Part A (15 Days)||1
4953624|NCT02797132|12185324|P1|COMPLETED|Part A (15 Days)||11
4953625|NCT02797132|12185324|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
4953626|NCT02797132|12185324|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
4953627|NCT02797132|12185324|P1|STARTED|Part A (15 Days)||12
4953628|NCT02797080|12185376|P1|NOT COMPLETED|Overall Study||2
4953629|NCT02797080|12185376|P1|COMPLETED|Overall Study||36
4953630|NCT02797080|12185376|P1|STARTED|Overall Study||38
4953631|NCT02797054|12185383|P3|NOT COMPLETED|Follow-up||285
4953632|NCT02797054|12185384|P2|NOT COMPLETED|Follow-up||228
4953633|NCT02797054|12185385|P1|NOT COMPLETED|Follow-up||209
4953634|NCT02797054|12185383|P3|COMPLETED|Follow-up||150
4953635|NCT02797054|12185384|P2|COMPLETED|Follow-up||155
4953636|NCT02797054|12185385|P1|COMPLETED|Follow-up||178
4953637|NCT02797054|12185383|P3|STARTED|Follow-up||435
4953638|NCT02797054|12185384|P2|STARTED|Follow-up||383
4953639|NCT02797054|12185385|P1|STARTED|Follow-up||387
4953640|NCT02797054|12185383|P3|NOT COMPLETED|Post-test||348
4953641|NCT02797054|12185384|P2|NOT COMPLETED|Post-test||11
4953642|NCT02797054|12185385|P1|NOT COMPLETED|Post-test||7
4953643|NCT02797054|12185383|P3|COMPLETED|Post-test||87
4953644|NCT02797054|12185384|P2|COMPLETED|Post-test||372
4953645|NCT02797054|12185385|P1|COMPLETED|Post-test||380
4953646|NCT02797054|12185383|P3|STARTED|Post-test||435
4953647|NCT02797054|12185384|P2|STARTED|Post-test||383
4953648|NCT02797054|12185385|P1|STARTED|Post-test||387
4953649|NCT02796963|12185418|P4|NOT COMPLETED|Overall Study||72
4953650|NCT02796963|12185419|P3|NOT COMPLETED|Overall Study||69
4953651|NCT02796963|12185420|P2|NOT COMPLETED|Overall Study||76
4953652|NCT02796963|12185421|P1|NOT COMPLETED|Overall Study||89
4953653|NCT02796963|12185418|P4|COMPLETED|Overall Study||282
4953654|NCT02796963|12185419|P3|COMPLETED|Overall Study||247
4953655|NCT02796963|12185420|P2|COMPLETED|Overall Study||252
4953656|NCT02796963|12185421|P1|COMPLETED|Overall Study||294
4953657|NCT02796963|12185418|P4|HIV Sero Converted|Overall Study||19
4953658|NCT02796963|12185419|P3|HIV Sero Converted|Overall Study||11
4953659|NCT02796963|12185420|P2|HIV Sero Converted|Overall Study||19
4953660|NCT02796963|12185421|P1|HIV Sero Converted|Overall Study||19
4953661|NCT02796963|12185418|P4|Fourth Follow up|Overall Study||263
4953662|NCT02796963|12185419|P3|Fourth Follow up|Overall Study||236
4953663|NCT02796963|12185420|P2|Fourth Follow up|Overall Study||233
4953664|NCT02796963|12185421|P1|Fourth Follow up|Overall Study||275
4953665|NCT02796963|12185418|P4|Third Follow up|Overall Study||286
4953666|NCT02796963|12185419|P3|Third Follow up|Overall Study||245
4953667|NCT02796963|12185420|P2|Third Follow up|Overall Study||237
4953668|NCT02796963|12185421|P1|Third Follow up|Overall Study||276
4953669|NCT02796963|12185418|P4|Second Follow up|Overall Study||293
4953670|NCT02796963|12185419|P3|Second Follow up|Overall Study||255
4953671|NCT02796963|12185420|P2|Second Follow up|Overall Study||260
4953672|NCT02796963|12185421|P1|Second Follow up|Overall Study||280
4953673|NCT02796963|12185418|P4|First Follow up|Overall Study||291
4953674|NCT02796963|12185419|P3|First Follow up|Overall Study||257
4953675|NCT02796963|12185420|P2|First Follow up|Overall Study||279
4953676|NCT02796963|12185421|P1|First Follow up|Overall Study||293
4953677|NCT02796963|12185418|P4|STARTED|Overall Study||354
4953678|NCT02796963|12185419|P3|STARTED|Overall Study||316
4953679|NCT02796963|12185420|P2|STARTED|Overall Study||328
4953680|NCT02796963|12185421|P1|STARTED|Overall Study||383
4953681|NCT02796677|12185487|P4|NOT COMPLETED|Overall Study||74
4953682|NCT02796677|12185488|P3|NOT COMPLETED|Overall Study||53
4953683|NCT02796677|12185489|P2|NOT COMPLETED|Overall Study||73
4953684|NCT02796677|12185490|P1|NOT COMPLETED|Overall Study||38
4953685|NCT02796677|12185487|P4|COMPLETED|Overall Study||405
4953686|NCT02796677|12185488|P3|COMPLETED|Overall Study||267
4953687|NCT02796677|12185489|P2|COMPLETED|Overall Study||405
4953688|NCT02796677|12185490|P1|COMPLETED|Overall Study||279
4953689|NCT02796677|12185487|P4|Completed Treatment and Follow-up|Overall Study||403
4953690|NCT02796677|12185488|P3|Completed Treatment and Follow-up|Overall Study||267
4953691|NCT02796677|12185489|P2|Completed Treatment and Follow-up|Overall Study||405
4953692|NCT02796677|12185490|P1|Completed Treatment and Follow-up|Overall Study||279
4953693|NCT02796677|12185487|P4|STARTED|Overall Study||479
4953694|NCT02796677|12185488|P3|STARTED|Overall Study||320
4953695|NCT02796677|12185489|P2|STARTED|Overall Study||478
4953696|NCT02796677|12185490|P1|STARTED|Overall Study||317
4953697|NCT02796651|12185514|P1|NOT COMPLETED|Overall Study||26
4953698|NCT02796651|12185514|P1|COMPLETED|Overall Study||106
4953699|NCT02796651|12185514|P1|Placebo (Lactose Monohydrate)|Overall Study||38
4953700|NCT02796651|12185514|P1|Perforomist 40 μg|Overall Study||108
4953701|NCT02796651|12185514|P1|Perforomist 20 μg|Overall Study||118
4953702|NCT02796651|12185514|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
4953703|NCT02796651|12185514|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
4953704|NCT02796651|12185514|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
4953705|NCT02796651|12185514|P1|STARTED|Overall Study||132
4953706|NCT02796352|12185543|P1|NOT COMPLETED|Overall Study||0
4953707|NCT02796352|12185543|P1|COMPLETED|Overall Study||1
4953708|NCT02796352|12185543|P1|STARTED|Overall Study||1
4953709|NCT02796300|12185552|P2|NOT COMPLETED|Overall Study||0
4953710|NCT02796300|12185553|P1|NOT COMPLETED|Overall Study||0
4953711|NCT02796300|12185552|P2|COMPLETED|Overall Study||22
4953712|NCT02796300|12185553|P1|COMPLETED|Overall Study||10
4953713|NCT02796300|12185552|P2|STARTED|Overall Study||22
4953714|NCT02796300|12185553|P1|STARTED|Overall Study||10
4953715|NCT02796274|12185563|P1|NOT COMPLETED|Overall Study||0
4953716|NCT02796274|12185563|P1|COMPLETED|Overall Study||219
4953717|NCT02796274|12185563|P1|STARTED|Overall Study||219
4953718|NCT02796092|12185569|P2|NOT COMPLETED|Overall Study||0
4953719|NCT02796092|12185570|P1|NOT COMPLETED|Overall Study||0
4953720|NCT02796092|12185569|P2|COMPLETED|Overall Study||50
4953721|NCT02796092|12185570|P1|COMPLETED|Overall Study||50
4953722|NCT02796092|12185569|P2|STARTED|Overall Study||50
4953723|NCT02796092|12185570|P1|STARTED|Overall Study||50
4953724|NCT02795832|12185608|P6|NOT COMPLETED|Overall Study||3
4953725|NCT02795832|12185609|P5|NOT COMPLETED|Overall Study||0
4953726|NCT02795832|12185610|P4|NOT COMPLETED|Overall Study||0
4953727|NCT02795832|12185611|P3|NOT COMPLETED|Overall Study||0
4953728|NCT02795832|12185612|P2|NOT COMPLETED|Overall Study||0
4953729|NCT02795832|12185613|P1|NOT COMPLETED|Overall Study||0
4953730|NCT02795832|12185608|P6|COMPLETED|Overall Study||7
4953731|NCT02795832|12185609|P5|COMPLETED|Overall Study||20
4953732|NCT02795832|12185610|P4|COMPLETED|Overall Study||3
4953733|NCT02795832|12185611|P3|COMPLETED|Overall Study||8
4953734|NCT02795832|12185612|P2|COMPLETED|Overall Study||4
4953735|NCT02795832|12185613|P1|COMPLETED|Overall Study||8
4953736|NCT02795832|12185608|P6|STARTED|Overall Study||10
4953737|NCT02795832|12185609|P5|STARTED|Overall Study||20
4953738|NCT02795832|12185610|P4|STARTED|Overall Study||3
4953739|NCT02795832|12185611|P3|STARTED|Overall Study||8
4953740|NCT02795832|12185612|P2|STARTED|Overall Study||4
4953741|NCT02795832|12185613|P1|STARTED|Overall Study||8
4953742|NCT02795819|12185647|P7|NOT COMPLETED|Overall Study||0
4953743|NCT02795819|12185648|P6|NOT COMPLETED|Overall Study||0
4953744|NCT02795819|12185649|P5|NOT COMPLETED|Overall Study||0
4953745|NCT02795819|12185650|P4|NOT COMPLETED|Overall Study||0
4953746|NCT02795819|12185651|P3|NOT COMPLETED|Overall Study||0
4953747|NCT02795819|12185652|P2|NOT COMPLETED|Overall Study||0
4953748|NCT02795819|12185653|P1|NOT COMPLETED|Overall Study||0
4953749|NCT02795819|12185647|P7|COMPLETED|Overall Study||0
4953750|NCT02795819|12185648|P6|COMPLETED|Overall Study||0
4953751|NCT02795819|12185649|P5|COMPLETED|Overall Study||0
4953752|NCT02795819|12185650|P4|COMPLETED|Overall Study||0
4953753|NCT02795819|12185651|P3|COMPLETED|Overall Study||0
4953754|NCT02795819|12185652|P2|COMPLETED|Overall Study||6
4953755|NCT02795819|12185653|P1|COMPLETED|Overall Study||0
4953756|NCT02795819|12185647|P7|STARTED|Overall Study||0
4953757|NCT02795819|12185648|P6|STARTED|Overall Study||0
4953758|NCT02795819|12185649|P5|STARTED|Overall Study||0
4953759|NCT02795819|12185650|P4|STARTED|Overall Study||0
4953760|NCT02795819|12185651|P3|STARTED|Overall Study||0
4953761|NCT02795819|12185652|P2|STARTED|Overall Study||6
4953762|NCT02795819|12185653|P1|STARTED|Overall Study||0
4953763|NCT02795767|12185680|P3|NOT COMPLETED|Overall Study||10
4953764|NCT02795767|12185681|P2|NOT COMPLETED|Overall Study||10
4953765|NCT02795767|12185682|P1|NOT COMPLETED|Overall Study||68
4953766|NCT02795767|12185680|P3|COMPLETED|Overall Study||0
4953767|NCT02795767|12185681|P2|COMPLETED|Overall Study||0
4953768|NCT02795767|12185682|P1|COMPLETED|Overall Study||0
4953769|NCT02795767|12185680|P3|Discontinued From Study Treatment|Overall Study||1
4953770|NCT02795767|12185681|P2|Discontinued From Study Treatment|Overall Study||0
4953771|NCT02795767|12185682|P1|Discontinued From Study Treatment|Overall Study||2
4953772|NCT02795767|12185680|P3|Completed 52 Weeks in Study|Overall Study||0
4953773|NCT02795767|12185681|P2|Completed 52 Weeks in Study|Overall Study||0
4953774|NCT02795767|12185682|P1|Completed 52 Weeks in Study|Overall Study||59
4953775|NCT02795767|12185680|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
4953776|NCT02795767|12185681|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
4953777|NCT02795767|12185682|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
4953778|NCT02795767|12185680|P3|STARTED|Overall Study||10
4953779|NCT02795767|12185681|P2|STARTED|Overall Study||10
4953780|NCT02795767|12185682|P1|STARTED|Overall Study||68
4953781|NCT02794974|12185803|P2|NOT COMPLETED|Overall Study||1
4953782|NCT02794974|12185804|P1|NOT COMPLETED|Overall Study||0
4953783|NCT02794974|12185803|P2|COMPLETED|Overall Study||14
4953784|NCT02794974|12185804|P1|COMPLETED|Overall Study||14
4953785|NCT02794974|12185803|P2|STARTED|Overall Study||15
4953786|NCT02794974|12185804|P1|STARTED|Overall Study||14
4953787|NCT02794870|12185820|P2|NOT COMPLETED|Overall Study||0
4953788|NCT02794870|12185821|P1|NOT COMPLETED|Overall Study||2
4953789|NCT02794870|12185820|P2|COMPLETED|Overall Study||11
4953790|NCT02794870|12185821|P1|COMPLETED|Overall Study||20
4953791|NCT02794870|12185820|P2|Received Inoculation|Overall Study||11
4953792|NCT02794870|12185821|P1|Received Inoculation|Overall Study||21
4953793|NCT02794870|12185820|P2|STARTED|Overall Study||11
4953794|NCT02794870|12185821|P1|STARTED|Overall Study||22
4953795|NCT02794844|12185847|P1|NOT COMPLETED|Overall Study||5
4953796|NCT02794844|12185847|P1|COMPLETED|Overall Study||23
4953797|NCT02794844|12185847|P1|STARTED|Overall Study||28
4953798|NCT02794727|12185858|P3|NOT COMPLETED|Overall Study||1
4953799|NCT02794727|12185859|P2|NOT COMPLETED|Overall Study||0
4953800|NCT02794727|12185860|P1|NOT COMPLETED|Overall Study||0
4953801|NCT02794727|12185858|P3|COMPLETED|Overall Study||44
4953802|NCT02794727|12185859|P2|COMPLETED|Overall Study||46
4953803|NCT02794727|12185860|P1|COMPLETED|Overall Study||44
4953804|NCT02794727|12185858|P3|STARTED|Overall Study||45
4953805|NCT02794727|12185859|P2|STARTED|Overall Study||46
4953806|NCT02794727|12185860|P1|STARTED|Overall Study||44
4953807|NCT02794480|12185869|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
4953808|NCT02794480|12185870|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
4953809|NCT02794480|12185871|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
4953810|NCT02794480|12185872|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
4953811|NCT02794480|12185869|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
4953812|NCT02794480|12185870|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
4953813|NCT02794480|12185871|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
4953814|NCT02794480|12185872|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
4953815|NCT02794480|12185869|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
4953816|NCT02794480|12185870|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
4953817|NCT02794480|12185871|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
4953818|NCT02794480|12185872|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
4953819|NCT02794480|12185869|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
4953820|NCT02794480|12185870|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
4953986|NCT02793232|12185995|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
4953821|NCT02794480|12185871|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
4953822|NCT02794480|12185872|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
4953823|NCT02794480|12185869|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
4953824|NCT02794480|12185870|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
4953825|NCT02794480|12185871|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
4953826|NCT02794480|12185872|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
4953827|NCT02794480|12185869|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
4953828|NCT02794480|12185870|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
4953829|NCT02794480|12185871|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
4953830|NCT02794480|12185872|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
4953831|NCT02794441|12185892|P2|NOT COMPLETED|Overall Study||0
4953832|NCT02794441|12185893|P1|NOT COMPLETED|Overall Study||1
4953833|NCT02794441|12185892|P2|COMPLETED|Overall Study||5
4953834|NCT02794441|12185893|P1|COMPLETED|Overall Study||6
4953835|NCT02794441|12185892|P2|STARTED|Overall Study||5
4953836|NCT02794441|12185893|P1|STARTED|Overall Study||7
4953837|NCT02794246|12185915|P1|NOT COMPLETED|Overall Study||6
4953838|NCT02794246|12185915|P1|COMPLETED|Overall Study||0
4953839|NCT02794246|12185915|P1|Treated|Overall Study||3
4953840|NCT02794246|12185915|P1|STARTED|Overall Study||6
4953841|NCT02794207|12185921|P2|NOT COMPLETED|Overall Study||0
4953842|NCT02794207|12185922|P1|NOT COMPLETED|Overall Study||0
4953843|NCT02794207|12185921|P2|COMPLETED|Overall Study||54
4953844|NCT02794207|12185922|P1|COMPLETED|Overall Study||32
4953845|NCT02794207|12185921|P2|STARTED|Overall Study||54
4953846|NCT02794207|12185922|P1|STARTED|Overall Study||32
4953847|NCT02794103|12185927|P1|NOT COMPLETED|Overall Study||3
4953848|NCT02794103|12185927|P1|COMPLETED|Overall Study||15
4953849|NCT02794103|12185927|P1|STARTED|Overall Study||18
4953850|NCT02793947|12185938|P2|NOT COMPLETED|Overall Study||5
4953851|NCT02793947|12185939|P1|NOT COMPLETED|Overall Study||2
4953852|NCT02793947|12185938|P2|COMPLETED|Overall Study||50
4953853|NCT02793947|12185939|P1|COMPLETED|Overall Study||45
4953854|NCT02793947|12185938|P2|STARTED|Overall Study||55
4953855|NCT02793947|12185939|P1|STARTED|Overall Study||47
4953856|NCT02793817|12185951|P2|NOT COMPLETED|Overall Study||5
4953857|NCT02793817|12185952|P1|NOT COMPLETED|Overall Study||3
4953858|NCT02793817|12185951|P2|COMPLETED|Overall Study||254
4953859|NCT02793817|12185952|P1|COMPLETED|Overall Study||258
4953860|NCT02793817|12185951|P2|STARTED|Overall Study||259
4953861|NCT02793817|12185952|P1|STARTED|Overall Study||261
4953862|NCT02793674|12185972|P2|NOT COMPLETED|Overall Study||0
4953863|NCT02793674|12185973|P1|NOT COMPLETED|Overall Study||0
4953864|NCT02793674|12185972|P2|COMPLETED|Overall Study||12
4953865|NCT02793674|12185973|P1|COMPLETED|Overall Study||9
4953866|NCT02793674|12185972|P2|STARTED|Overall Study||12
4953867|NCT02793674|12185973|P1|STARTED|Overall Study||9
4953868|NCT02793232|12185994|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953869|NCT02793232|12185995|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953870|NCT02793232|12185996|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953871|NCT02793232|12185997|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953872|NCT02793232|12185998|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953873|NCT02793232|12185999|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953874|NCT02793232|12186000|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953875|NCT02793232|12186001|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953876|NCT02793232|12186002|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
4953877|NCT02793232|12185994|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
4953878|NCT02793232|12185995|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
4953879|NCT02793232|12185996|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
4953880|NCT02793232|12185997|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
4953881|NCT02793232|12185998|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
4953882|NCT02793232|12185999|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
4953883|NCT02793232|12186000|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
4953884|NCT02793232|12186001|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
4953885|NCT02793232|12186002|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
4953886|NCT02793232|12185994|P9|STARTED|Period 4 (Part A: 5 Days)||0
4953887|NCT02793232|12185995|P8|STARTED|Period 4 (Part A: 5 Days)||0
4953888|NCT02793232|12185996|P7|STARTED|Period 4 (Part A: 5 Days)||0
4953889|NCT02793232|12185997|P6|STARTED|Period 4 (Part A: 5 Days)||0
4953890|NCT02793232|12185998|P5|STARTED|Period 4 (Part A: 5 Days)||0
4953891|NCT02793232|12185999|P4|STARTED|Period 4 (Part A: 5 Days)||2
4953892|NCT02793232|12186000|P3|STARTED|Period 4 (Part A: 5 Days)||2
4953893|NCT02793232|12186001|P2|STARTED|Period 4 (Part A: 5 Days)||2
4953894|NCT02793232|12186002|P1|STARTED|Period 4 (Part A: 5 Days)||2
4953895|NCT02793232|12185994|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953896|NCT02793232|12185995|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953897|NCT02793232|12185996|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953898|NCT02793232|12185997|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953899|NCT02793232|12185998|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953900|NCT02793232|12185999|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953901|NCT02793232|12186000|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953902|NCT02793232|12186001|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953903|NCT02793232|12186002|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953904|NCT02793232|12185994|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953905|NCT02793232|12185995|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953906|NCT02793232|12185996|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953907|NCT02793232|12185997|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953908|NCT02793232|12185998|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
4953909|NCT02793232|12185999|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
4953910|NCT02793232|12186000|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
4953911|NCT02793232|12186001|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
4953912|NCT02793232|12186002|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
4953913|NCT02793232|12185994|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
4953914|NCT02793232|12185995|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
4953915|NCT02793232|12185996|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
4953916|NCT02793232|12185997|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
4953917|NCT02793232|12185998|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
4953918|NCT02793232|12185999|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
4953919|NCT02793232|12186000|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
4953920|NCT02793232|12186001|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
4953921|NCT02793232|12186002|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
4953922|NCT02793232|12185994|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953923|NCT02793232|12185995|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953924|NCT02793232|12185996|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953925|NCT02793232|12185997|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953926|NCT02793232|12185998|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953927|NCT02793232|12185999|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953928|NCT02793232|12186000|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953929|NCT02793232|12186001|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953930|NCT02793232|12186002|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
4953931|NCT02793232|12185994|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
4953932|NCT02793232|12185995|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
4953933|NCT02793232|12185996|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
4953934|NCT02793232|12185997|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
4953935|NCT02793232|12185998|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
4953936|NCT02793232|12185999|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
4953937|NCT02793232|12186000|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
4953938|NCT02793232|12186001|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
4953939|NCT02793232|12186002|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
4953940|NCT02793232|12185994|P9|STARTED|Period 3 (Part A: 5 Days)||0
4953941|NCT02793232|12185995|P8|STARTED|Period 3 (Part A: 5 Days)||0
4953942|NCT02793232|12185996|P7|STARTED|Period 3 (Part A: 5 Days)||0
4953943|NCT02793232|12185997|P6|STARTED|Period 3 (Part A: 5 Days)||0
4953944|NCT02793232|12185998|P5|STARTED|Period 3 (Part A: 5 Days)||0
4953945|NCT02793232|12185999|P4|STARTED|Period 3 (Part A: 5 Days)||2
4953946|NCT02793232|12186000|P3|STARTED|Period 3 (Part A: 5 Days)||2
4953947|NCT02793232|12186001|P2|STARTED|Period 3 (Part A: 5 Days)||2
4953948|NCT02793232|12186002|P1|STARTED|Period 3 (Part A: 5 Days)||2
4953949|NCT02793232|12185994|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953950|NCT02793232|12185995|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953951|NCT02793232|12185996|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953952|NCT02793232|12185997|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953953|NCT02793232|12185998|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953954|NCT02793232|12185999|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953955|NCT02793232|12186000|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953956|NCT02793232|12186001|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953957|NCT02793232|12186002|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953958|NCT02793232|12185994|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953959|NCT02793232|12185995|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953960|NCT02793232|12185996|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953961|NCT02793232|12185997|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953962|NCT02793232|12185998|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
4953963|NCT02793232|12185999|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
4953964|NCT02793232|12186000|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
4953965|NCT02793232|12186001|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
4953966|NCT02793232|12186002|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
4953967|NCT02793232|12185994|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
4953968|NCT02793232|12185995|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
4953969|NCT02793232|12185996|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
4953970|NCT02793232|12185997|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
4953971|NCT02793232|12185998|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
4953972|NCT02793232|12185999|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
4953973|NCT02793232|12186000|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
4953974|NCT02793232|12186001|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
4953975|NCT02793232|12186002|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
4953976|NCT02793232|12185994|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953977|NCT02793232|12185995|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953978|NCT02793232|12185996|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953979|NCT02793232|12185997|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953980|NCT02793232|12185998|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953981|NCT02793232|12185999|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953982|NCT02793232|12186000|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953983|NCT02793232|12186001|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953984|NCT02793232|12186002|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
4953985|NCT02793232|12185994|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
4953987|NCT02793232|12185996|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
4953988|NCT02793232|12185997|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
4953989|NCT02793232|12185998|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
4953990|NCT02793232|12185999|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
4953991|NCT02793232|12186000|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
4953992|NCT02793232|12186001|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
4953993|NCT02793232|12186002|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
4953994|NCT02793232|12185994|P9|STARTED|Period 2 (Part A: 5 Days)||0
4953995|NCT02793232|12185995|P8|STARTED|Period 2 (Part A: 5 Days)||0
4953996|NCT02793232|12185996|P7|STARTED|Period 2 (Part A: 5 Days)||0
4953997|NCT02793232|12185997|P6|STARTED|Period 2 (Part A: 5 Days)||0
4953998|NCT02793232|12185998|P5|STARTED|Period 2 (Part A: 5 Days)||0
4953999|NCT02793232|12185999|P4|STARTED|Period 2 (Part A: 5 Days)||2
4954000|NCT02793232|12186000|P3|STARTED|Period 2 (Part A: 5 Days)||2
4954001|NCT02793232|12186001|P2|STARTED|Period 2 (Part A: 5 Days)||2
4954002|NCT02793232|12186002|P1|STARTED|Period 2 (Part A: 5 Days)||2
4954003|NCT02793232|12185994|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954004|NCT02793232|12185995|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954005|NCT02793232|12185996|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954006|NCT02793232|12185997|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954007|NCT02793232|12185998|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954008|NCT02793232|12185999|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954009|NCT02793232|12186000|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954010|NCT02793232|12186001|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954011|NCT02793232|12186002|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954012|NCT02793232|12185994|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954013|NCT02793232|12185995|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954014|NCT02793232|12185996|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954015|NCT02793232|12185997|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954016|NCT02793232|12185998|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
4954017|NCT02793232|12185999|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
4954018|NCT02793232|12186000|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
4954019|NCT02793232|12186001|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
4954020|NCT02793232|12186002|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
4954021|NCT02793232|12185994|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
4954022|NCT02793232|12185995|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
4954023|NCT02793232|12185996|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
4954024|NCT02793232|12185997|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
4954025|NCT02793232|12185998|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
4954026|NCT02793232|12185999|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
4954027|NCT02793232|12186000|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
4954028|NCT02793232|12186001|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
4954029|NCT02793232|12186002|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
4954030|NCT02793232|12185994|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954031|NCT02793232|12185995|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954032|NCT02793232|12185996|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
4954033|NCT02793232|12185997|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954034|NCT02793232|12185998|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
4954035|NCT02793232|12185999|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954036|NCT02793232|12186000|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954037|NCT02793232|12186001|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954038|NCT02793232|12186002|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
4954039|NCT02793232|12185994|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
4954040|NCT02793232|12185995|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954041|NCT02793232|12185996|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
4954042|NCT02793232|12185997|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
4954043|NCT02793232|12185998|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
4954044|NCT02793232|12185999|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954045|NCT02793232|12186000|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954046|NCT02793232|12186001|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954047|NCT02793232|12186002|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954048|NCT02793232|12185994|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
4954049|NCT02793232|12185995|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954050|NCT02793232|12185996|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
4954051|NCT02793232|12185997|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
4954052|NCT02793232|12185998|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
4954053|NCT02793232|12185999|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954054|NCT02793232|12186000|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954055|NCT02793232|12186001|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954056|NCT02793232|12186002|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
4954057|NCT02793154|12186187|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954058|NCT02793154|12186188|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954059|NCT02793154|12186189|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954060|NCT02793154|12186187|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954061|NCT02793154|12186188|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954062|NCT02793154|12186189|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
4954063|NCT02793154|12186187|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
4954064|NCT02793154|12186188|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
4954065|NCT02793154|12186189|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
4954066|NCT02793154|12186187|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
4954067|NCT02793154|12186188|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
4954068|NCT02793154|12186189|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
4954069|NCT02793154|12186187|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
4954070|NCT02793154|12186188|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
4954071|NCT02793154|12186189|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
4954072|NCT02793154|12186187|P3|STARTED|Part A (Single Group-up to 12 Days)||0
4954073|NCT02793154|12186188|P2|STARTED|Part A (Single Group-up to 12 Days)||0
4954074|NCT02793154|12186189|P1|STARTED|Part A (Single Group-up to 12 Days)||4
4954075|NCT02792829|12186263|P8|NOT COMPLETED|Treatment Period 2||2
4954076|NCT02792829|12186264|P7|NOT COMPLETED|Treatment Period 2||1
4954077|NCT02792829|12186265|P6|NOT COMPLETED|Treatment Period 2||0
4954078|NCT02792829|12186266|P5|NOT COMPLETED|Treatment Period 2||1
4954079|NCT02792829|12186267|P4|NOT COMPLETED|Treatment Period 2||0
4954080|NCT02792829|12186268|P3|NOT COMPLETED|Treatment Period 2||0
4954081|NCT02792829|12186269|P2|NOT COMPLETED|Treatment Period 2||1
4954082|NCT02792829|12186270|P1|NOT COMPLETED|Treatment Period 2||0
4954083|NCT02792829|12186263|P8|COMPLETED|Treatment Period 2||8
4954084|NCT02792829|12186264|P7|COMPLETED|Treatment Period 2||9
4954085|NCT02792829|12186265|P6|COMPLETED|Treatment Period 2||5
4954086|NCT02792829|12186266|P5|COMPLETED|Treatment Period 2||4
4954087|NCT02792829|12186267|P4|COMPLETED|Treatment Period 2||5
4954088|NCT02792829|12186268|P3|COMPLETED|Treatment Period 2||5
4954089|NCT02792829|12186269|P2|COMPLETED|Treatment Period 2||9
4954090|NCT02792829|12186270|P1|COMPLETED|Treatment Period 2||10
4954091|NCT02792829|12186263|P8|STARTED|Treatment Period 2||10
4954092|NCT02792829|12186264|P7|STARTED|Treatment Period 2||10
4954093|NCT02792829|12186265|P6|STARTED|Treatment Period 2||5
4954094|NCT02792829|12186266|P5|STARTED|Treatment Period 2||5
4954095|NCT02792829|12186267|P4|STARTED|Treatment Period 2||5
4954096|NCT02792829|12186268|P3|STARTED|Treatment Period 2||5
4954097|NCT02792829|12186269|P2|STARTED|Treatment Period 2||10
4954098|NCT02792829|12186270|P1|STARTED|Treatment Period 2||10
4954099|NCT02792829|12186263|P8|NOT COMPLETED|Wash Out Period||0
4954100|NCT02792829|12186264|P7|NOT COMPLETED|Wash Out Period||0
4954101|NCT02792829|12186265|P6|NOT COMPLETED|Wash Out Period||0
4954102|NCT02792829|12186266|P5|NOT COMPLETED|Wash Out Period||0
4954103|NCT02792829|12186267|P4|NOT COMPLETED|Wash Out Period||0
4954104|NCT02792829|12186268|P3|NOT COMPLETED|Wash Out Period||0
4954105|NCT02792829|12186269|P2|NOT COMPLETED|Wash Out Period||0
4954106|NCT02792829|12186270|P1|NOT COMPLETED|Wash Out Period||0
4954107|NCT02792829|12186263|P8|COMPLETED|Wash Out Period||10
4954108|NCT02792829|12186264|P7|COMPLETED|Wash Out Period||10
4954109|NCT02792829|12186265|P6|COMPLETED|Wash Out Period||5
4954110|NCT02792829|12186266|P5|COMPLETED|Wash Out Period||5
4954111|NCT02792829|12186267|P4|COMPLETED|Wash Out Period||5
4954112|NCT02792829|12186268|P3|COMPLETED|Wash Out Period||5
4954113|NCT02792829|12186269|P2|COMPLETED|Wash Out Period||10
4954114|NCT02792829|12186270|P1|COMPLETED|Wash Out Period||10
4954115|NCT02792829|12186263|P8|STARTED|Wash Out Period||10
4954116|NCT02792829|12186264|P7|STARTED|Wash Out Period||10
4954117|NCT02792829|12186265|P6|STARTED|Wash Out Period||5
4954118|NCT02792829|12186266|P5|STARTED|Wash Out Period||5
4954119|NCT02792829|12186267|P4|STARTED|Wash Out Period||5
4954120|NCT02792829|12186268|P3|STARTED|Wash Out Period||5
4954121|NCT02792829|12186269|P2|STARTED|Wash Out Period||10
4954122|NCT02792829|12186270|P1|STARTED|Wash Out Period||10
4954123|NCT02792829|12186263|P8|NOT COMPLETED|Treatment Period 1||0
4954124|NCT02792829|12186264|P7|NOT COMPLETED|Treatment Period 1||0
4954125|NCT02792829|12186265|P6|NOT COMPLETED|Treatment Period 1||0
4954126|NCT02792829|12186266|P5|NOT COMPLETED|Treatment Period 1||0
4954127|NCT02792829|12186267|P4|NOT COMPLETED|Treatment Period 1||0
4954128|NCT02792829|12186268|P3|NOT COMPLETED|Treatment Period 1||0
4954129|NCT02792829|12186269|P2|NOT COMPLETED|Treatment Period 1||0
4954130|NCT02792829|12186270|P1|NOT COMPLETED|Treatment Period 1||0
4954131|NCT02792829|12186263|P8|COMPLETED|Treatment Period 1||10
4954132|NCT02792829|12186264|P7|COMPLETED|Treatment Period 1||10
4954133|NCT02792829|12186265|P6|COMPLETED|Treatment Period 1||5
4954134|NCT02792829|12186266|P5|COMPLETED|Treatment Period 1||5
4954135|NCT02792829|12186267|P4|COMPLETED|Treatment Period 1||5
4954136|NCT02792829|12186268|P3|COMPLETED|Treatment Period 1||5
4954137|NCT02792829|12186269|P2|COMPLETED|Treatment Period 1||10
4954138|NCT02792829|12186270|P1|COMPLETED|Treatment Period 1||10
4954139|NCT02792829|12186263|P8|STARTED|Treatment Period 1||10
4954140|NCT02792829|12186264|P7|STARTED|Treatment Period 1||10
4954141|NCT02792829|12186265|P6|STARTED|Treatment Period 1||5
4954142|NCT02792829|12186266|P5|STARTED|Treatment Period 1||5
4954143|NCT02792829|12186267|P4|STARTED|Treatment Period 1||5
4954144|NCT02792829|12186268|P3|STARTED|Treatment Period 1||5
4954145|NCT02792829|12186269|P2|STARTED|Treatment Period 1||10
4954146|NCT02792829|12186270|P1|STARTED|Treatment Period 1||10
4954147|NCT02792777|12186378|P2|NOT COMPLETED|Overall Study||0
4954148|NCT02792777|12186379|P1|NOT COMPLETED|Overall Study||7
4954149|NCT02792777|12186378|P2|COMPLETED|Overall Study||52
4954150|NCT02792777|12186379|P1|COMPLETED|Overall Study||89
4954151|NCT02792777|12186378|P2|STARTED|Overall Study||52
4954152|NCT02792777|12186379|P1|STARTED|Overall Study||96
4954153|NCT02792699|12186395|P3|NOT COMPLETED|Overall Study||10
4954154|NCT02792699|12186396|P2|NOT COMPLETED|Overall Study||10
4954155|NCT02792699|12186397|P1|NOT COMPLETED|Overall Study||9
4954156|NCT02792699|12186395|P3|COMPLETED|Overall Study||93
4954157|NCT02792699|12186396|P2|COMPLETED|Overall Study||94
4954158|NCT02792699|12186397|P1|COMPLETED|Overall Study||95
4954159|NCT02792699|12186395|P3|Received Second Infusion of Second Dose|Overall Study||93
4954160|NCT02792699|12186396|P2|Received Second Infusion of Second Dose|Overall Study||99
4954161|NCT02792699|12186397|P1|Received Second Infusion of Second Dose|Overall Study||97
4954162|NCT02792699|12186395|P3|Received First Infusion of Second Dose|Overall Study||95
4954163|NCT02792699|12186396|P2|Received First Infusion of Second Dose|Overall Study||99
4954164|NCT02792699|12186397|P1|Received First Infusion of Second Dose|Overall Study||97
4954165|NCT02792699|12186395|P3|Received Second Infusion of First Dose|Overall Study||99
4954166|NCT02792699|12186396|P2|Received Second Infusion of First Dose|Overall Study||103
4954167|NCT02792699|12186397|P1|Received Second Infusion of First Dose|Overall Study||102
4954168|NCT02792699|12186395|P3|Received First Infusion of First Dose|Overall Study||103
4954169|NCT02792699|12186396|P2|Received First Infusion of First Dose|Overall Study||104
4954170|NCT02792699|12186397|P1|Received First Infusion of First Dose|Overall Study||104
4954171|NCT02792699|12186395|P3|STARTED|Overall Study||103
4954172|NCT02792699|12186396|P2|STARTED|Overall Study||104
4954173|NCT02792699|12186397|P1|STARTED|Overall Study||104
4954174|NCT02792517|12186478|P1|NOT COMPLETED|Overall Study||20
4954175|NCT02792517|12186478|P1|COMPLETED|Overall Study||21
4954176|NCT02792517|12186478|P1|Received Erenumab|Overall Study||24
4954177|NCT02792517|12186478|P1|STARTED|Overall Study||41
4954178|NCT02792062|12186498|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954179|NCT02792062|12186499|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954180|NCT02792062|12186500|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954181|NCT02792062|12186501|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954182|NCT02792062|12186502|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954183|NCT02792062|12186503|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
4954184|NCT02792062|12186498|P6|COMPLETED|Intervention Period 3 (6 Days)||2
4954185|NCT02792062|12186499|P5|COMPLETED|Intervention Period 3 (6 Days)||2
4954186|NCT02792062|12186500|P4|COMPLETED|Intervention Period 3 (6 Days)||2
4954187|NCT02792062|12186501|P3|COMPLETED|Intervention Period 3 (6 Days)||2
4954188|NCT02792062|12186502|P2|COMPLETED|Intervention Period 3 (6 Days)||2
4954189|NCT02792062|12186503|P1|COMPLETED|Intervention Period 3 (6 Days)||1
4954190|NCT02792062|12186498|P6|STARTED|Intervention Period 3 (6 Days)||2
4954191|NCT02792062|12186499|P5|STARTED|Intervention Period 3 (6 Days)||2
4954192|NCT02792062|12186500|P4|STARTED|Intervention Period 3 (6 Days)||2
4954193|NCT02792062|12186501|P3|STARTED|Intervention Period 3 (6 Days)||2
4954194|NCT02792062|12186502|P2|STARTED|Intervention Period 3 (6 Days)||2
4954195|NCT02792062|12186503|P1|STARTED|Intervention Period 3 (6 Days)||1
4954196|NCT02792062|12186498|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954197|NCT02792062|12186499|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954198|NCT02792062|12186500|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954199|NCT02792062|12186501|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954200|NCT02792062|12186502|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954201|NCT02792062|12186503|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
4954202|NCT02792062|12186498|P6|COMPLETED|Washout Period (at Least 14 Days)||2
4954203|NCT02792062|12186499|P5|COMPLETED|Washout Period (at Least 14 Days)||2
4954204|NCT02792062|12186500|P4|COMPLETED|Washout Period (at Least 14 Days)||2
4954205|NCT02792062|12186501|P3|COMPLETED|Washout Period (at Least 14 Days)||2
4954206|NCT02792062|12186502|P2|COMPLETED|Washout Period (at Least 14 Days)||2
4954207|NCT02792062|12186503|P1|COMPLETED|Washout Period (at Least 14 Days)||1
4954208|NCT02792062|12186498|P6|STARTED|Washout Period (at Least 14 Days)||2
4954209|NCT02792062|12186499|P5|STARTED|Washout Period (at Least 14 Days)||2
4954210|NCT02792062|12186500|P4|STARTED|Washout Period (at Least 14 Days)||2
4954211|NCT02792062|12186501|P3|STARTED|Washout Period (at Least 14 Days)||2
4954212|NCT02792062|12186502|P2|STARTED|Washout Period (at Least 14 Days)||2
4954213|NCT02792062|12186503|P1|STARTED|Washout Period (at Least 14 Days)||2
4954214|NCT02792062|12186498|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954215|NCT02792062|12186499|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954216|NCT02792062|12186500|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954217|NCT02792062|12186501|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954218|NCT02792062|12186502|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954219|NCT02792062|12186503|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4954220|NCT02792062|12186498|P6|COMPLETED|Intervention Period 2 (6 Days)||2
4954221|NCT02792062|12186499|P5|COMPLETED|Intervention Period 2 (6 Days)||2
4954222|NCT02792062|12186500|P4|COMPLETED|Intervention Period 2 (6 Days)||2
4954223|NCT02792062|12186501|P3|COMPLETED|Intervention Period 2 (6 Days)||2
4954224|NCT02792062|12186502|P2|COMPLETED|Intervention Period 2 (6 Days)||2
4954225|NCT02792062|12186503|P1|COMPLETED|Intervention Period 2 (6 Days)||2
4954226|NCT02792062|12186498|P6|STARTED|Intervention Period 2 (6 Days)||2
4954227|NCT02792062|12186499|P5|STARTED|Intervention Period 2 (6 Days)||2
4954228|NCT02792062|12186500|P4|STARTED|Intervention Period 2 (6 Days)||2
4954229|NCT02792062|12186501|P3|STARTED|Intervention Period 2 (6 Days)||2
4954230|NCT02792062|12186502|P2|STARTED|Intervention Period 2 (6 Days)||2
4954231|NCT02792062|12186503|P1|STARTED|Intervention Period 2 (6 Days)||2
4954232|NCT02792062|12186498|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954233|NCT02792062|12186499|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954234|NCT02792062|12186500|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954235|NCT02792062|12186501|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954236|NCT02792062|12186502|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954237|NCT02792062|12186503|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
4954238|NCT02792062|12186498|P6|COMPLETED|Washout Period (at Least 14 Days)||2
4954239|NCT02792062|12186499|P5|COMPLETED|Washout Period (at Least 14 Days)||2
4954240|NCT02792062|12186500|P4|COMPLETED|Washout Period (at Least 14 Days)||2
4954241|NCT02792062|12186501|P3|COMPLETED|Washout Period (at Least 14 Days)||2
4954242|NCT02792062|12186502|P2|COMPLETED|Washout Period (at Least 14 Days)||2
4954243|NCT02792062|12186503|P1|COMPLETED|Washout Period (at Least 14 Days)||2
4954244|NCT02792062|12186498|P6|STARTED|Washout Period (at Least 14 Days)||2
4954245|NCT02792062|12186499|P5|STARTED|Washout Period (at Least 14 Days)||2
4954246|NCT02792062|12186500|P4|STARTED|Washout Period (at Least 14 Days)||2
4954247|NCT02792062|12186501|P3|STARTED|Washout Period (at Least 14 Days)||2
4954248|NCT02792062|12186502|P2|STARTED|Washout Period (at Least 14 Days)||2
4954249|NCT02792062|12186503|P1|STARTED|Washout Period (at Least 14 Days)||2
4954250|NCT02792062|12186498|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954251|NCT02792062|12186499|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954252|NCT02792062|12186500|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954253|NCT02792062|12186501|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954254|NCT02792062|12186502|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954255|NCT02792062|12186503|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4954256|NCT02792062|12186498|P6|COMPLETED|Intervention Period 1 (6 Days)||2
4954257|NCT02792062|12186499|P5|COMPLETED|Intervention Period 1 (6 Days)||2
4954258|NCT02792062|12186500|P4|COMPLETED|Intervention Period 1 (6 Days)||2
4954259|NCT02792062|12186501|P3|COMPLETED|Intervention Period 1 (6 Days)||2
4954260|NCT02792062|12186502|P2|COMPLETED|Intervention Period 1 (6 Days)||2
4954261|NCT02792062|12186503|P1|COMPLETED|Intervention Period 1 (6 Days)||2
4954262|NCT02792062|12186498|P6|STARTED|Intervention Period 1 (6 Days)||2
4954263|NCT02792062|12186499|P5|STARTED|Intervention Period 1 (6 Days)||2
4954264|NCT02792062|12186500|P4|STARTED|Intervention Period 1 (6 Days)||2
4954265|NCT02792062|12186501|P3|STARTED|Intervention Period 1 (6 Days)||2
4954266|NCT02792062|12186502|P2|STARTED|Intervention Period 1 (6 Days)||2
4954267|NCT02792062|12186503|P1|STARTED|Intervention Period 1 (6 Days)||2
4954268|NCT02792049|12186537|P2|NOT COMPLETED|Overall Study||0
4954269|NCT02792049|12186538|P1|NOT COMPLETED|Overall Study||0
4954270|NCT02792049|12186537|P2|COMPLETED|Overall Study||35
4954271|NCT02792049|12186538|P1|COMPLETED|Overall Study||35
4954272|NCT02792049|12186537|P2|STARTED|Overall Study||35
4954273|NCT02792049|12186538|P1|STARTED|Overall Study||35
4954274|NCT02791763|12186555|P3|NOT COMPLETED|Overall Study||13
4954275|NCT02791763|12186556|P2|NOT COMPLETED|Overall Study||37
4954276|NCT02791763|12186557|P1|NOT COMPLETED|Overall Study||38
4954277|NCT02791763|12186555|P3|COMPLETED|Overall Study||43
4954278|NCT02791763|12186556|P2|COMPLETED|Overall Study||113
4954279|NCT02791763|12186557|P1|COMPLETED|Overall Study||111
4954280|NCT02791763|12186555|P3|STARTED|Overall Study||56
4954281|NCT02791763|12186556|P2|STARTED|Overall Study||150
4954282|NCT02791763|12186557|P1|STARTED|Overall Study||149
4954283|NCT02791659|12186676|P2|NOT COMPLETED|Overall Study||1
4954284|NCT02791659|12186677|P1|NOT COMPLETED|Overall Study||0
4954285|NCT02791659|12186676|P2|COMPLETED|Overall Study||27
4954286|NCT02791659|12186677|P1|COMPLETED|Overall Study||27
4954287|NCT02791659|12186676|P2|STARTED|Overall Study||28
4954288|NCT02791659|12186677|P1|STARTED|Overall Study||27
4954289|NCT02791516|12186685|P2|NOT COMPLETED|Overall Study||1
4954290|NCT02791516|12186686|P1|NOT COMPLETED|Overall Study||1
4954291|NCT02791516|12186685|P2|COMPLETED|Overall Study||33
4954292|NCT02791516|12186686|P1|COMPLETED|Overall Study||32
4954293|NCT02791516|12186685|P2|Completed 6-month Treatment Period|Overall Study||33
4954294|NCT02791516|12186686|P1|Completed 6-month Treatment Period|Overall Study||33
4954295|NCT02791516|12186685|P2|STARTED|Overall Study||34
4954296|NCT02791516|12186686|P1|STARTED|Overall Study||33
4954297|NCT02791490|12186698|P2|NOT COMPLETED|Overall Study||8
4954298|NCT02791490|12186699|P1|NOT COMPLETED|Overall Study||3
4954299|NCT02791490|12186698|P2|COMPLETED|Overall Study||221
4954300|NCT02791490|12186699|P1|COMPLETED|Overall Study||226
4954301|NCT02791490|12186698|P2|STARTED|Overall Study||229
4954302|NCT02791490|12186699|P1|STARTED|Overall Study||229
4954303|NCT02791438|12186719|P2|NOT COMPLETED|Treatment Period||1
4954304|NCT02791438|12186720|P1|NOT COMPLETED|Treatment Period||3
4954305|NCT02791438|12186719|P2|COMPLETED|Treatment Period||4
4954306|NCT02791438|12186720|P1|COMPLETED|Treatment Period||19
4954307|NCT02791438|12186719|P2|STARTED|Treatment Period||5
4954308|NCT02791438|12186720|P1|STARTED|Treatment Period||22
4954309|NCT02791438|12186719|P2|NOT COMPLETED|Run-In Period||0
4954310|NCT02791438|12186720|P1|NOT COMPLETED|Run-In Period||0
4954311|NCT02791438|12186719|P2|COMPLETED|Run-In Period||5
4954312|NCT02791438|12186720|P1|COMPLETED|Run-In Period||22
4954313|NCT02791438|12186719|P2|STARTED|Run-In Period||5
4954314|NCT02791438|12186720|P1|STARTED|Run-In Period||22
4954315|NCT02791308|12186749|P3|NOT COMPLETED|Overall Study||17
4954316|NCT02791308|12186750|P2|NOT COMPLETED|Overall Study||9
4954317|NCT02791308|12186751|P1|NOT COMPLETED|Overall Study||10
4954318|NCT02791308|12186749|P3|COMPLETED|Overall Study||179
4954319|NCT02791308|12186750|P2|COMPLETED|Overall Study||187
4954320|NCT02791308|12186751|P1|COMPLETED|Overall Study||185
4954321|NCT02791308|12186749|P3|STARTED|Overall Study||196
4954322|NCT02791308|12186750|P2|STARTED|Overall Study||196
4954323|NCT02791308|12186751|P1|STARTED|Overall Study||195
4954324|NCT02791269|12186761|P2|NOT COMPLETED|Overall Study||1
4954325|NCT02791269|12186762|P1|NOT COMPLETED|Overall Study||0
4954326|NCT02791269|12186761|P2|COMPLETED|Overall Study||19
4954327|NCT02791269|12186762|P1|COMPLETED|Overall Study||4
4954328|NCT02791269|12186761|P2|STARTED|Overall Study||20
4954329|NCT02791269|12186762|P1|STARTED|Overall Study||4
4954330|NCT02790788|12186778|P2|NOT COMPLETED|Overall Study||0
4954331|NCT02790788|12186779|P1|NOT COMPLETED|Overall Study||0
4954332|NCT02790788|12186778|P2|COMPLETED|Overall Study||54
4954333|NCT02790788|12186779|P1|COMPLETED|Overall Study||46
4954334|NCT02790788|12186778|P2|STARTED|Overall Study||54
4954335|NCT02790788|12186779|P1|STARTED|Overall Study||46
4954336|NCT02790736|12186831|P2|NOT COMPLETED|Overall Study||0
4954337|NCT02790736|12186832|P1|NOT COMPLETED|Overall Study||0
4954338|NCT02790736|12186831|P2|COMPLETED|Overall Study||1
4954339|NCT02790736|12186832|P1|COMPLETED|Overall Study||5
4954340|NCT02790736|12186831|P2|STARTED|Overall Study||1
4954341|NCT02790736|12186832|P1|STARTED|Overall Study||5
4954342|NCT02790606|12186840|P1|NOT COMPLETED|Overall Study||35
4954343|NCT02790606|12186840|P1|COMPLETED|Overall Study||75
4954344|NCT02790606|12186840|P1|STARTED|Overall Study||110
4954345|NCT02790463|12186857|P2|NOT COMPLETED|Overall Study||309
4954346|NCT02790463|12186858|P1|NOT COMPLETED|Overall Study||0
4954347|NCT02790463|12186857|P2|COMPLETED|Overall Study||372
4954348|NCT02790463|12186858|P1|COMPLETED|Overall Study||782
4954349|NCT02790463|12186857|P2|STARTED|Overall Study||681
4954350|NCT02790463|12186858|P1|STARTED|Overall Study||782
4954351|NCT02790281|12186866|P1|NOT COMPLETED|Overall Study||0
4954352|NCT02790281|12186866|P1|COMPLETED|Overall Study||33
4954353|NCT02790281|12186866|P1|STARTED|Overall Study||33
4954354|NCT02790073|12186872|P1|NOT COMPLETED|Overall Study||3
4954355|NCT02790073|12186872|P1|COMPLETED|Overall Study||11
4954356|NCT02790073|12186872|P1|STARTED|Overall Study||14
4954357|NCT02789410|12186880|P2|NOT COMPLETED|Overall Study||0
4954358|NCT02789410|12186881|P1|NOT COMPLETED|Overall Study||0
4954359|NCT02789410|12186880|P2|COMPLETED|Overall Study||68
4954360|NCT02789410|12186881|P1|COMPLETED|Overall Study||66
4954361|NCT02789410|12186880|P2|STARTED|Overall Study||68
4954362|NCT02789410|12186881|P1|STARTED|Overall Study||66
4954363|NCT02788747|12186894|P3|NOT COMPLETED|Overall Study||0
4954364|NCT02788747|12186895|P2|NOT COMPLETED|Overall Study||0
4954365|NCT02788747|12186896|P1|NOT COMPLETED|Overall Study||1
4954366|NCT02788747|12186894|P3|COMPLETED|Overall Study||24
4954367|NCT02788747|12186895|P2|COMPLETED|Overall Study||24
4954368|NCT02788747|12186896|P1|COMPLETED|Overall Study||22
4954369|NCT02788747|12186894|P3|STARTED|Overall Study||24
4954370|NCT02788747|12186895|P2|STARTED|Overall Study||24
4954371|NCT02788747|12186896|P1|STARTED|Overall Study||23
4954372|NCT02788656|12186966|P2|NOT COMPLETED|Overall Study||0
4954373|NCT02788656|12186967|P1|NOT COMPLETED|Overall Study||1
4954374|NCT02788656|12186966|P2|COMPLETED|Overall Study||2
4954375|NCT02788656|12186967|P1|COMPLETED|Overall Study||1
4954376|NCT02788656|12186966|P2|STARTED|Overall Study||2
4954377|NCT02788656|12186967|P1|STARTED|Overall Study||2
4954378|NCT02788474|12186989|P2|NOT COMPLETED|Open Label Treatment Period||12
4954379|NCT02788474|12186990|P1|NOT COMPLETED|Open Label Treatment Period||32
4954380|NCT02788474|12186989|P2|COMPLETED|Open Label Treatment Period||100
4954381|NCT02788474|12186990|P1|COMPLETED|Open Label Treatment Period||189
4954382|NCT02788474|12186989|P2|STARTED|Open Label Treatment Period||112
4954383|NCT02788474|12186990|P1|STARTED|Open Label Treatment Period||221
4954384|NCT02788474|12186989|P2|NOT COMPLETED|Double Blind Treatment Period||4
4954385|NCT02788474|12186990|P1|NOT COMPLETED|Double Blind Treatment Period||10
4954386|NCT02788474|12186989|P2|COMPLETED|Double Blind Treatment Period||112
4954387|NCT02788474|12186990|P1|COMPLETED|Double Blind Treatment Period||221
4954388|NCT02788474|12186989|P2|Treated|Double Blind Treatment Period||116
4954389|NCT02788474|12186990|P1|Treated|Double Blind Treatment Period||230
4954390|NCT02788474|12186989|P2|STARTED|Double Blind Treatment Period||116
4954391|NCT02788474|12186990|P1|STARTED|Double Blind Treatment Period||231
4954392|NCT02788357|12187005|P2|NOT COMPLETED|Overall Study||0
4954393|NCT02788357|12187006|P1|NOT COMPLETED|Overall Study||3
4954394|NCT02788357|12187005|P2|COMPLETED|Overall Study||6
4954395|NCT02788357|12187006|P1|COMPLETED|Overall Study||3
4954396|NCT02788357|12187005|P2|STARTED|Overall Study||6
4954397|NCT02788357|12187006|P1|STARTED|Overall Study||6
4954398|NCT02788279|12187021|P3|NOT COMPLETED|Overall Study||90
4954399|NCT02788279|12187022|P2|NOT COMPLETED|Overall Study||183
4954400|NCT02788279|12187023|P1|NOT COMPLETED|Overall Study||90
4954401|NCT02788279|12187021|P3|COMPLETED|Overall Study||0
4954402|NCT02788279|12187022|P2|COMPLETED|Overall Study||0
4954403|NCT02788279|12187023|P1|COMPLETED|Overall Study||0
4954404|NCT02788279|12187021|P3|Modified ITT Population|Overall Study||61
4954405|NCT02788279|12187022|P2|Modified ITT Population|Overall Study||125
4954406|NCT02788279|12187023|P1|Modified ITT Population|Overall Study||57
4954407|NCT02788279|12187021|P3|Received Treatment (Safety Population)|Overall Study||90
4954408|NCT02788279|12187022|P2|Received Treatment (Safety Population)|Overall Study||179
4954409|NCT02788279|12187023|P1|Received Treatment (Safety Population)|Overall Study||80
4954410|NCT02788279|12187021|P3|STARTED|Overall Study||90
4954411|NCT02788279|12187022|P2|STARTED|Overall Study||183
4954412|NCT02788279|12187023|P1|STARTED|Overall Study||90
4954413|NCT02788188|12187061|P7|NOT COMPLETED|Overall Study||0
4954414|NCT02788188|12187062|P6|NOT COMPLETED|Overall Study||0
4954415|NCT02788188|12187063|P5|NOT COMPLETED|Overall Study||0
4954416|NCT02788188|12187064|P4|NOT COMPLETED|Overall Study||0
4954417|NCT02788188|12187065|P3|NOT COMPLETED|Overall Study||0
4954418|NCT02788188|12187066|P2|NOT COMPLETED|Overall Study||0
4954419|NCT02788188|12187067|P1|NOT COMPLETED|Overall Study||0
4954420|NCT02788188|12187061|P7|COMPLETED|Overall Study||10
4954421|NCT02788188|12187062|P6|COMPLETED|Overall Study||8
4954422|NCT02788188|12187063|P5|COMPLETED|Overall Study||8
4954423|NCT02788188|12187064|P4|COMPLETED|Overall Study||4
4954424|NCT02788188|12187065|P3|COMPLETED|Overall Study||4
4954425|NCT02788188|12187066|P2|COMPLETED|Overall Study||2
4954426|NCT02788188|12187067|P1|COMPLETED|Overall Study||2
4954427|NCT02788188|12187061|P7|STARTED|Overall Study||10
4954428|NCT02788188|12187062|P6|STARTED|Overall Study||8
4954429|NCT02788188|12187063|P5|STARTED|Overall Study||8
4954430|NCT02788188|12187064|P4|STARTED|Overall Study||4
4954431|NCT02788188|12187065|P3|STARTED|Overall Study||4
4954432|NCT02788188|12187066|P2|STARTED|Overall Study||2
4954433|NCT02788188|12187067|P1|STARTED|Overall Study||2
4954434|NCT02788175|12187083|P1|NOT COMPLETED|Overall Study||13
4954435|NCT02788175|12187083|P1|COMPLETED|Overall Study||13
4954436|NCT02788175|12187083|P1|Received Study Agent|Overall Study||20
4954437|NCT02788175|12187083|P1|STARTED|Overall Study||26
4954438|NCT02788097|12187090|P2|NOT COMPLETED|Overall Study||0
4954439|NCT02788097|12187091|P1|NOT COMPLETED|Overall Study||0
4954440|NCT02788097|12187090|P2|COMPLETED|Overall Study||69
4954441|NCT02788097|12187091|P1|COMPLETED|Overall Study||61
4954442|NCT02788097|12187090|P2|STARTED|Overall Study||69
4954443|NCT02788097|12187091|P1|STARTED|Overall Study||61
4954444|NCT02787863|12187105|P8|NOT COMPLETED|Overall Study||0
4954445|NCT02787863|12187106|P7|NOT COMPLETED|Overall Study||0
4954446|NCT02787863|12187107|P6|NOT COMPLETED|Overall Study||0
4954447|NCT02787863|12187108|P5|NOT COMPLETED|Overall Study||0
4954448|NCT02787863|12187109|P4|NOT COMPLETED|Overall Study||0
4954449|NCT02787863|12187110|P3|NOT COMPLETED|Overall Study||2
4954450|NCT02787863|12187111|P2|NOT COMPLETED|Overall Study||1
4954451|NCT02787863|12187112|P1|NOT COMPLETED|Overall Study||1
4954452|NCT02787863|12187105|P8|COMPLETED|Overall Study||27
4954453|NCT02787863|12187106|P7|COMPLETED|Overall Study||25
4954454|NCT02787863|12187107|P6|COMPLETED|Overall Study||18
4954455|NCT02787863|12187108|P5|COMPLETED|Overall Study||32
4954456|NCT02787863|12187109|P4|COMPLETED|Overall Study||25
4954457|NCT02787863|12187110|P3|COMPLETED|Overall Study||23
4954458|NCT02787863|12187111|P2|COMPLETED|Overall Study||33
4954459|NCT02787863|12187112|P1|COMPLETED|Overall Study||32
4954460|NCT02787863|12187105|P8|4 Years After Vaccination|Overall Study||27
4954461|NCT02787863|12187106|P7|4 Years After Vaccination|Overall Study||25
4954462|NCT02787863|12187107|P6|4 Years After Vaccination|Overall Study||18
4954463|NCT02787863|12187108|P5|4 Years After Vaccination|Overall Study||32
4954464|NCT02787863|12187109|P4|4 Years After Vaccination|Overall Study||25
4954465|NCT02787863|12187110|P3|4 Years After Vaccination|Overall Study||23
4954466|NCT02787863|12187111|P2|4 Years After Vaccination|Overall Study||33
4954467|NCT02787863|12187112|P1|4 Years After Vaccination|Overall Study||32
4954468|NCT02787863|12187105|P8|1 Year After Vaccination|Overall Study||27
4954469|NCT02787863|12187106|P7|1 Year After Vaccination|Overall Study||25
4954470|NCT02787863|12187107|P6|1 Year After Vaccination|Overall Study||18
4954471|NCT02787863|12187108|P5|1 Year After Vaccination|Overall Study||32
4954472|NCT02787863|12187109|P4|1 Year After Vaccination|Overall Study||25
4954473|NCT02787863|12187110|P3|1 Year After Vaccination|Overall Study||23
4954474|NCT02787863|12187111|P2|1 Year After Vaccination|Overall Study||33
4954475|NCT02787863|12187112|P1|1 Year After Vaccination|Overall Study||32
4954476|NCT02787863|12187105|P8|STARTED|Overall Study||27
4954477|NCT02787863|12187106|P7|STARTED|Overall Study||25
4954478|NCT02787863|12187107|P6|STARTED|Overall Study||18
4954479|NCT02787863|12187108|P5|STARTED|Overall Study||32
4954480|NCT02787863|12187109|P4|STARTED|Overall Study||25
4954481|NCT02787863|12187110|P3|STARTED|Overall Study||25
4954482|NCT02787863|12187111|P2|STARTED|Overall Study||34
4954483|NCT02787863|12187112|P1|STARTED|Overall Study||33
4954484|NCT02787694|12187172|P1|NOT COMPLETED|Overall Study||5
4954485|NCT02787694|12187172|P1|COMPLETED|Overall Study||17
4954486|NCT02787694|12187172|P1|STARTED|Overall Study||22
4954487|NCT02787655|12187178|P2|NOT COMPLETED|Overall Study||12
4954488|NCT02787655|12187179|P1|NOT COMPLETED|Overall Study||11
4954489|NCT02787655|12187178|P2|COMPLETED|Overall Study||26
4954490|NCT02787655|12187179|P1|COMPLETED|Overall Study||29
4954491|NCT02787655|12187178|P2|STARTED|Overall Study||38
4954492|NCT02787655|12187179|P1|STARTED|Overall Study||40
4954493|NCT02787564|12187187|P2|NOT COMPLETED|Overall Study||2
4954494|NCT02787564|12187188|P1|NOT COMPLETED|Overall Study||7
4954495|NCT02787564|12187187|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
4954496|NCT02787564|12187188|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
4954497|NCT02787564|12187187|P2|STARTED|Overall Study||29
4954498|NCT02787564|12187188|P1|STARTED|Overall Study||32
4954499|NCT02787551|12187206|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
4954500|NCT02787551|12187207|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
4954501|NCT02787551|12187206|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
4954502|NCT02787551|12187207|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
4954503|NCT02787551|12187206|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
4954589|NCT02786355|12187404|P1|STARTED|Overall Study||35
4954504|NCT02787551|12187207|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
4954505|NCT02787551|12187206|P2|NOT COMPLETED|Core Period: 26 Weeks||11
4954506|NCT02787551|12187207|P1|NOT COMPLETED|Core Period: 26 Weeks||27
4954507|NCT02787551|12187206|P2|COMPLETED|Core Period: 26 Weeks||246
4954508|NCT02787551|12187207|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
4954509|NCT02787551|12187206|P2|Treated|Core Period: 26 Weeks||256
4954510|NCT02787551|12187207|P1|Treated|Core Period: 26 Weeks||255
4954511|NCT02787551|12187206|P2|STARTED|Core Period: 26 Weeks||257
4954512|NCT02787551|12187207|P1|STARTED|Core Period: 26 Weeks||257
4954513|NCT02787304|12187243|P4|NOT COMPLETED|Overall Study||34
4954514|NCT02787304|12187244|P3|NOT COMPLETED|Overall Study||41
4954515|NCT02787304|12187245|P2|NOT COMPLETED|Overall Study||38
4954516|NCT02787304|12187246|P1|NOT COMPLETED|Overall Study||36
4954517|NCT02787304|12187243|P4|COMPLETED|Overall Study||15
4954518|NCT02787304|12187244|P3|COMPLETED|Overall Study||8
4954519|NCT02787304|12187245|P2|COMPLETED|Overall Study||12
4954520|NCT02787304|12187246|P1|COMPLETED|Overall Study||13
4954521|NCT02787304|12187243|P4|STARTED|Overall Study||49
4954522|NCT02787304|12187244|P3|STARTED|Overall Study||49
4954523|NCT02787304|12187245|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
4954524|NCT02787304|12187246|P1|STARTED|Overall Study||49
4954525|NCT02787083|12187294|P2|NOT COMPLETED|Overall Study||2
4954526|NCT02787083|12187295|P1|NOT COMPLETED|Overall Study||3
4954527|NCT02787083|12187294|P2|COMPLETED|Overall Study||3
4954528|NCT02787083|12187295|P1|COMPLETED|Overall Study||1
4954529|NCT02787083|12187294|P2|STARTED|Overall Study||5
4954530|NCT02787083|12187295|P1|STARTED|Overall Study||4
4954531|NCT02787057|12187305|P2|NOT COMPLETED|Overall Study||0
4954532|NCT02787057|12187306|P1|NOT COMPLETED|Overall Study||0
4954533|NCT02787057|12187305|P2|COMPLETED|Overall Study||40
4954534|NCT02787057|12187306|P1|COMPLETED|Overall Study||40
4954535|NCT02787057|12187305|P2|STARTED|Overall Study||40
4954536|NCT02787057|12187306|P1|STARTED|Overall Study||40
4954537|NCT02786953|12187320|P2|NOT COMPLETED|Overall Study||1
4954538|NCT02786953|12187321|P1|NOT COMPLETED|Overall Study||3
4954539|NCT02786953|12187320|P2|COMPLETED|Overall Study||18
4954540|NCT02786953|12187321|P1|COMPLETED|Overall Study||17
4954541|NCT02786953|12187320|P2|A1C 3 Month|Overall Study||17
4954542|NCT02786953|12187321|P1|A1C 3 Month|Overall Study||15
4954543|NCT02786953|12187320|P2|3 Month Parent Survey Completed|Overall Study||18
4954544|NCT02786953|12187321|P1|3 Month Parent Survey Completed|Overall Study||17
4954545|NCT02786953|12187320|P2|3 Month Teen Survey Completed|Overall Study||18
4954546|NCT02786953|12187321|P1|3 Month Teen Survey Completed|Overall Study||17
4954547|NCT02786953|12187320|P2|Session 3 Completed|Overall Study||0
4954548|NCT02786953|12187321|P1|Session 3 Completed|Overall Study||16
4954549|NCT02786953|12187320|P2|Session 2 Completed|Overall Study||0
4954550|NCT02786953|12187321|P1|Session 2 Completed|Overall Study||16
4954551|NCT02786953|12187320|P2|Session 1 Completed|Overall Study||0
4954552|NCT02786953|12187321|P1|Session 1 Completed|Overall Study||17
4954553|NCT02786953|12187320|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
4954554|NCT02786953|12187321|P1|A1C Data Baseline|Overall Study||20
4954555|NCT02786953|12187320|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
4954556|NCT02786953|12187321|P1|Actigraph Data Complete|Overall Study||14
4954557|NCT02786953|12187320|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
4954558|NCT02786953|12187321|P1|Baseline Parent Survey Completed|Overall Study||20
4954559|NCT02786953|12187320|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
4954560|NCT02786953|12187321|P1|Baseline Teen Survey Data Completed|Overall Study||20
4954561|NCT02786953|12187320|P2|STARTED|Overall Study||19
4954562|NCT02786953|12187321|P1|STARTED|Overall Study||20
4954563|NCT02786927|12187343|P1|NOT COMPLETED|Overall Study||5
4954564|NCT02786927|12187343|P1|COMPLETED|Overall Study||207
4954565|NCT02786927|12187343|P1|STARTED|Overall Study||212
4954566|NCT02786901|12187353|P3|NOT COMPLETED|Overall Study||41
4954567|NCT02786901|12187354|P2|NOT COMPLETED|Overall Study||56
4954568|NCT02786901|12187355|P1|NOT COMPLETED|Overall Study||77
4954569|NCT02786901|12187353|P3|COMPLETED|Overall Study||159
4954570|NCT02786901|12187354|P2|COMPLETED|Overall Study||145
4954571|NCT02786901|12187355|P1|COMPLETED|Overall Study||122
4954572|NCT02786901|12187353|P3|STARTED|Overall Study||200
4954573|NCT02786901|12187354|P2|STARTED|Overall Study||201
4954574|NCT02786901|12187355|P1|STARTED|Overall Study||199
4954575|NCT02786810|12187384|P1|NOT COMPLETED|Overall Study||0
4954576|NCT02786810|12187384|P1|COMPLETED|Overall Study||10
4954577|NCT02786810|12187384|P1|STARTED|Overall Study||10
4954578|NCT02786771|12187391|P2|NOT COMPLETED|Overall Study||6
4954579|NCT02786771|12187392|P1|NOT COMPLETED|Overall Study||10
4954580|NCT02786771|12187391|P2|COMPLETED|Overall Study||56
4954581|NCT02786771|12187392|P1|COMPLETED|Overall Study||53
4954582|NCT02786771|12187391|P2|STARTED|Overall Study||62
4954583|NCT02786771|12187392|P1|STARTED|Overall Study||63
4954584|NCT02786719|12187398|P1|NOT COMPLETED|Overall Study||1
4954585|NCT02786719|12187398|P1|COMPLETED|Overall Study||12
4954586|NCT02786719|12187398|P1|STARTED|Overall Study||13
4954587|NCT02786355|12187404|P1|NOT COMPLETED|Overall Study||0
4954588|NCT02786355|12187404|P1|COMPLETED|Overall Study||35
4954590|NCT02786004|12187413|P2|NOT COMPLETED|Overall Study||1
4954591|NCT02786004|12187414|P1|NOT COMPLETED|Overall Study||0
4954592|NCT02786004|12187413|P2|COMPLETED|Overall Study||9
4954593|NCT02786004|12187414|P1|COMPLETED|Overall Study||14
4954594|NCT02786004|12187413|P2|STARTED|Overall Study||10
4954595|NCT02786004|12187414|P1|STARTED|Overall Study||14
4954596|NCT02785913|12187422|P1|NOT COMPLETED|Overall Study||31
4954597|NCT02785913|12187422|P1|COMPLETED|Overall Study||0
4954598|NCT02785913|12187422|P1|Eligible and Began Protocol Therapy|Overall Study||26
4954599|NCT02785913|12187422|P1|Eligible|Overall Study||27
4954600|NCT02785913|12187422|P1|STARTED|Overall Study||31
4954601|NCT02785900|12187431|P2|NOT COMPLETED|Overall Study||123
4954602|NCT02785900|12187432|P1|NOT COMPLETED|Overall Study||117
4954603|NCT02785900|12187431|P2|COMPLETED|Overall Study||0
4954604|NCT02785900|12187432|P1|COMPLETED|Overall Study||0
4954605|NCT02785900|12187431|P2|STARTED|Overall Study||123
4954606|NCT02785900|12187432|P1|STARTED|Overall Study||117
4954607|NCT02785770|12187456|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
4954608|NCT02785770|12187457|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
4954609|NCT02785770|12187458|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
4954610|NCT02785770|12187459|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
4954611|NCT02785770|12187456|P4|COMPLETED|Intervention Period 4 (1 Day)||10
4954612|NCT02785770|12187457|P3|COMPLETED|Intervention Period 4 (1 Day)||10
4954613|NCT02785770|12187458|P2|COMPLETED|Intervention Period 4 (1 Day)||10
4954614|NCT02785770|12187459|P1|COMPLETED|Intervention Period 4 (1 Day)||11
4954615|NCT02785770|12187456|P4|STARTED|Intervention Period 4 (1 Day)||10
4954616|NCT02785770|12187457|P3|STARTED|Intervention Period 4 (1 Day)||10
4954617|NCT02785770|12187458|P2|STARTED|Intervention Period 4 (1 Day)||10
4954618|NCT02785770|12187459|P1|STARTED|Intervention Period 4 (1 Day)||11
4954619|NCT02785770|12187456|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
4954620|NCT02785770|12187457|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
4954621|NCT02785770|12187458|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
4954622|NCT02785770|12187459|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
4954623|NCT02785770|12187456|P4|COMPLETED|Washout Period 3 (7 Days)||10
4954624|NCT02785770|12187457|P3|COMPLETED|Washout Period 3 (7 Days)||10
4954625|NCT02785770|12187458|P2|COMPLETED|Washout Period 3 (7 Days)||10
4954626|NCT02785770|12187459|P1|COMPLETED|Washout Period 3 (7 Days)||11
4954627|NCT02785770|12187456|P4|STARTED|Washout Period 3 (7 Days)||10
4954628|NCT02785770|12187457|P3|STARTED|Washout Period 3 (7 Days)||10
4954629|NCT02785770|12187458|P2|STARTED|Washout Period 3 (7 Days)||10
4954630|NCT02785770|12187459|P1|STARTED|Washout Period 3 (7 Days)||11
4954631|NCT02785770|12187456|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
4954632|NCT02785770|12187457|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
4954633|NCT02785770|12187458|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
4954634|NCT02785770|12187459|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
4954635|NCT02785770|12187456|P4|COMPLETED|Intervention Period 3 (1 Day)||10
4954636|NCT02785770|12187457|P3|COMPLETED|Intervention Period 3 (1 Day)||10
4954637|NCT02785770|12187458|P2|COMPLETED|Intervention Period 3 (1 Day)||10
4954638|NCT02785770|12187459|P1|COMPLETED|Intervention Period 3 (1 Day)||11
4954639|NCT02785770|12187456|P4|STARTED|Intervention Period 3 (1 Day)||11
4954640|NCT02785770|12187457|P3|STARTED|Intervention Period 3 (1 Day)||10
4954641|NCT02785770|12187458|P2|STARTED|Intervention Period 3 (1 Day)||10
4954642|NCT02785770|12187459|P1|STARTED|Intervention Period 3 (1 Day)||11
4954643|NCT02785770|12187456|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4954644|NCT02785770|12187457|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4954645|NCT02785770|12187458|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4954646|NCT02785770|12187459|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4954647|NCT02785770|12187456|P4|COMPLETED|Washout Period 2 (7 Days)||11
4954648|NCT02785770|12187457|P3|COMPLETED|Washout Period 2 (7 Days)||10
4954649|NCT02785770|12187458|P2|COMPLETED|Washout Period 2 (7 Days)||10
4954650|NCT02785770|12187459|P1|COMPLETED|Washout Period 2 (7 Days)||11
4954651|NCT02785770|12187456|P4|STARTED|Washout Period 2 (7 Days)||11
4954652|NCT02785770|12187457|P3|STARTED|Washout Period 2 (7 Days)||10
4954653|NCT02785770|12187458|P2|STARTED|Washout Period 2 (7 Days)||10
4954654|NCT02785770|12187459|P1|STARTED|Washout Period 2 (7 Days)||11
4954655|NCT02785770|12187456|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
4954656|NCT02785770|12187457|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
4954657|NCT02785770|12187458|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
4954658|NCT02785770|12187459|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
4954659|NCT02785770|12187456|P4|COMPLETED|Intervention Period 2 (1 Day)||11
4954660|NCT02785770|12187457|P3|COMPLETED|Intervention Period 2 (1 Day)||10
4954661|NCT02785770|12187458|P2|COMPLETED|Intervention Period 2 (1 Day)||10
4954662|NCT02785770|12187459|P1|COMPLETED|Intervention Period 2 (1 Day)||11
4954663|NCT02785770|12187456|P4|STARTED|Intervention Period 2 (1 Day)||11
4954664|NCT02785770|12187457|P3|STARTED|Intervention Period 2 (1 Day)||11
4954665|NCT02785770|12187458|P2|STARTED|Intervention Period 2 (1 Day)||11
4954666|NCT02785770|12187459|P1|STARTED|Intervention Period 2 (1 Day)||11
4954667|NCT02785770|12187456|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
4954668|NCT02785770|12187457|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4954669|NCT02785770|12187458|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4954670|NCT02785770|12187459|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4954671|NCT02785770|12187456|P4|COMPLETED|Washout Period 1 (7 Days)||11
4954672|NCT02785770|12187457|P3|COMPLETED|Washout Period 1 (7 Days)||11
4954673|NCT02785770|12187458|P2|COMPLETED|Washout Period 1 (7 Days)||11
4954674|NCT02785770|12187459|P1|COMPLETED|Washout Period 1 (7 Days)||11
4954675|NCT02785770|12187456|P4|STARTED|Washout Period 1 (7 Days)||11
4954676|NCT02785770|12187457|P3|STARTED|Washout Period 1 (7 Days)||11
4954677|NCT02785770|12187458|P2|STARTED|Washout Period 1 (7 Days)||11
4954678|NCT02785770|12187459|P1|STARTED|Washout Period 1 (7 Days)||11
4954679|NCT02785770|12187456|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4954680|NCT02785770|12187457|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4954681|NCT02785770|12187458|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4954682|NCT02785770|12187459|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
4954683|NCT02785770|12187456|P4|COMPLETED|Intervention Period 1 (1 Day)||11
4954684|NCT02785770|12187457|P3|COMPLETED|Intervention Period 1 (1 Day)||11
4954685|NCT02785770|12187458|P2|COMPLETED|Intervention Period 1 (1 Day)||11
4954686|NCT02785770|12187459|P1|COMPLETED|Intervention Period 1 (1 Day)||11
4954687|NCT02785770|12187456|P4|STARTED|Intervention Period 1 (1 Day)||11
4954688|NCT02785770|12187457|P3|STARTED|Intervention Period 1 (1 Day)||11
4954689|NCT02785770|12187458|P2|STARTED|Intervention Period 1 (1 Day)||11
4954690|NCT02785770|12187459|P1|STARTED|Intervention Period 1 (1 Day)||11
4954691|NCT02785588|12187526|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
4954692|NCT02785588|12187526|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
4954693|NCT02785588|12187526|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
4954694|NCT02785588|12187526|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
4954695|NCT02785588|12187526|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
4954696|NCT02785588|12187526|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
4954697|NCT02785432|12187542|P2|NOT COMPLETED|Overall Study||0
4954698|NCT02785432|12187543|P1|NOT COMPLETED|Overall Study||0
4954699|NCT02785432|12187542|P2|COMPLETED|Overall Study||7
4954700|NCT02785432|12187543|P1|COMPLETED|Overall Study||4
4954701|NCT02785432|12187542|P2|STARTED|Overall Study||7
4954702|NCT02785432|12187543|P1|STARTED|Overall Study||4
4954703|NCT02785406|12187557|P2|NOT COMPLETED|Overall Study||0
4954704|NCT02785406|12187558|P1|NOT COMPLETED|Overall Study||0
4954705|NCT02785406|12187557|P2|COMPLETED|Overall Study||10
4954706|NCT02785406|12187558|P1|COMPLETED|Overall Study||10
4954707|NCT02785406|12187557|P2|Completed Second Week|Overall Study||10
4954708|NCT02785406|12187558|P1|Completed Second Week|Overall Study||10
4954709|NCT02785406|12187557|P2|Completed First Week|Overall Study||10
4954710|NCT02785406|12187558|P1|Completed First Week|Overall Study||10
4954711|NCT02785406|12187557|P2|STARTED|Overall Study||10
4954712|NCT02785406|12187558|P1|STARTED|Overall Study||10
4954713|NCT02785354|12187633|P3|NOT COMPLETED|Overall Study||0
4954714|NCT02785354|12187634|P2|NOT COMPLETED|Overall Study||0
4954715|NCT02785354|12187635|P1|NOT COMPLETED|Overall Study||0
4954716|NCT02785354|12187633|P3|COMPLETED|Overall Study||44653
4954717|NCT02785354|12187634|P2|COMPLETED|Overall Study||31388
4954718|NCT02785354|12187635|P1|COMPLETED|Overall Study||27060
4954719|NCT02785354|12187633|P3|STARTED|Overall Study||44653
4954720|NCT02785354|12187634|P2|STARTED|Overall Study||31388
4954721|NCT02785354|12187635|P1|STARTED|Overall Study||27060
4954722|NCT02784925|12187664|P1|NOT COMPLETED|Overall Study||0
4954723|NCT02784925|12187664|P1|COMPLETED|Overall Study||30
4954724|NCT02784925|12187664|P1|STARTED|Overall Study||30
4954725|NCT02784834|12187668|P1|NOT COMPLETED|Overall Study||1
4954726|NCT02784834|12187668|P1|COMPLETED|Overall Study||1
4954727|NCT02784834|12187668|P1|STARTED|Overall Study||2
4954728|NCT02784704|12187674|P2|NOT COMPLETED|Overall Study||9
4954729|NCT02784704|12187675|P1|NOT COMPLETED|Overall Study||13
4954730|NCT02784704|12187674|P2|COMPLETED|Overall Study||241
4954731|NCT02784704|12187675|P1|COMPLETED|Overall Study||237
4954732|NCT02784704|12187674|P2|Treated|Overall Study||249
4954733|NCT02784704|12187675|P1|Treated|Overall Study||250
4954734|NCT02784704|12187674|P2|STARTED|Overall Study||250
4954735|NCT02784704|12187675|P1|STARTED|Overall Study||250
4954736|NCT02784613|12187685|P1|NOT COMPLETED|Overall Study||2
4954737|NCT02784613|12187685|P1|COMPLETED|Overall Study||8
4954738|NCT02784613|12187685|P1|STARTED|Overall Study||10
4954739|NCT02784587|12187691|P1|NOT COMPLETED|Overall Study||0
4954740|NCT02784587|12187691|P1|COMPLETED|Overall Study||25
4954741|NCT02784587|12187691|P1|STARTED|Overall Study||25
4954742|NCT02784548|12187695|P1|NOT COMPLETED|Overall Study||0
4954743|NCT02784548|12187695|P1|COMPLETED|Overall Study||15
4954744|NCT02784548|12187695|P1|STARTED|Overall Study||15
4954745|NCT02784275|12187704|P4|NOT COMPLETED|Overall Study||1
4954746|NCT02784275|12187705|P3|NOT COMPLETED|Overall Study||1
4954747|NCT02784275|12187706|P2|NOT COMPLETED|Overall Study||0
4954748|NCT02784275|12187707|P1|NOT COMPLETED|Overall Study||1
4954749|NCT02784275|12187704|P4|COMPLETED|Overall Study||14
4954750|NCT02784275|12187705|P3|COMPLETED|Overall Study||16
4954751|NCT02784275|12187706|P2|COMPLETED|Overall Study||16
4954752|NCT02784275|12187707|P1|COMPLETED|Overall Study||15
4954753|NCT02784275|12187704|P4|STARTED|Overall Study||15
4954754|NCT02784275|12187705|P3|STARTED|Overall Study||17
4954755|NCT02784275|12187706|P2|STARTED|Overall Study||16
4954756|NCT02784275|12187707|P1|STARTED|Overall Study||16
4954757|NCT02784106|12187751|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
4954758|NCT02784106|12187752|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
4954759|NCT02784106|12187753|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
4954760|NCT02784106|12187754|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
4954761|NCT02784106|12187751|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
4954762|NCT02784106|12187752|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
4954763|NCT02784106|12187753|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
4954764|NCT02784106|12187754|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
4954765|NCT02784106|12187751|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
4954766|NCT02784106|12187752|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
4954767|NCT02784106|12187753|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
4954768|NCT02784106|12187754|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
4954769|NCT02784106|12187751|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
4954770|NCT02784106|12187752|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
4954771|NCT02784106|12187753|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
4954772|NCT02784106|12187754|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
4954773|NCT02784106|12187751|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
4954774|NCT02784106|12187752|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
4954775|NCT02784106|12187753|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
4954776|NCT02784106|12187754|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
4954777|NCT02784106|12187751|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
4954778|NCT02784106|12187752|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
4954779|NCT02784106|12187753|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
4954780|NCT02784106|12187754|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
4954781|NCT02783898|12187817|P2|NOT COMPLETED|Overall Study||1
4954782|NCT02783898|12187818|P1|NOT COMPLETED|Overall Study||1
4954783|NCT02783898|12187817|P2|COMPLETED|Overall Study||116
4954784|NCT02783898|12187818|P1|COMPLETED|Overall Study||124
4954785|NCT02783898|12187817|P2|STARTED|Overall Study||117
4954786|NCT02783898|12187818|P1|STARTED|Overall Study||125
4954787|NCT02783820|12187842|P4|NOT COMPLETED|Overall Study||0
4954788|NCT02783820|12187843|P3|NOT COMPLETED|Overall Study||0
4954789|NCT02783820|12187844|P2|NOT COMPLETED|Overall Study||0
4954790|NCT02783820|12187845|P1|NOT COMPLETED|Overall Study||0
4954791|NCT02783820|12187842|P4|COMPLETED|Overall Study||6
4954792|NCT02783820|12187843|P3|COMPLETED|Overall Study||6
4954793|NCT02783820|12187844|P2|COMPLETED|Overall Study||6
4954794|NCT02783820|12187845|P1|COMPLETED|Overall Study||6
4954795|NCT02783820|12187842|P4|STARTED|Overall Study||6
4954796|NCT02783820|12187843|P3|STARTED|Overall Study||6
4954797|NCT02783820|12187844|P2|STARTED|Overall Study||6
4954798|NCT02783820|12187845|P1|STARTED|Overall Study||6
4954799|NCT02783729|12187859|P4|NOT COMPLETED|Overall Study||9
4954800|NCT02783729|12187860|P3|NOT COMPLETED|Overall Study||8
4954801|NCT02783729|12187861|P2|NOT COMPLETED|Overall Study||17
4954802|NCT02783729|12187862|P1|NOT COMPLETED|Overall Study||10
4954803|NCT02783729|12187859|P4|COMPLETED|Overall Study||260
4954804|NCT02783729|12187860|P3|COMPLETED|Overall Study||258
4954805|NCT02783729|12187861|P2|COMPLETED|Overall Study||246
4954806|NCT02783729|12187862|P1|COMPLETED|Overall Study||198
4954807|NCT02783729|12187859|P4|STARTED|Overall Study||269
4954808|NCT02783729|12187860|P3|STARTED|Overall Study||266
4954809|NCT02783729|12187861|P2|STARTED|Overall Study||263
4954810|NCT02783729|12187862|P1|STARTED|Overall Study||208
4954811|NCT02783599|12187928|P1|NOT COMPLETED|Overall Study||40
4954812|NCT02783599|12187928|P1|COMPLETED|Overall Study||11
4954813|NCT02783599|12187928|P1|Received At Least One Dose of Study Drug|Overall Study||51
4954814|NCT02783599|12187928|P1|STARTED|Overall Study||51
4954815|NCT02783573|12187944|P3|NOT COMPLETED|Delayed-Start Period||12
4954816|NCT02783573|12187945|P2|NOT COMPLETED|Delayed-Start Period||17
4954817|NCT02783573|12187946|P1|NOT COMPLETED|Delayed-Start Period||0
4954818|NCT02783573|12187944|P3|COMPLETED|Delayed-Start Period||0
4954819|NCT02783573|12187945|P2|COMPLETED|Delayed-Start Period||0
4954820|NCT02783573|12187946|P1|COMPLETED|Delayed-Start Period||0
4954821|NCT02783573|12187944|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
4954822|NCT02783573|12187945|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
4954823|NCT02783573|12187946|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
4954824|NCT02783573|12187944|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
4954825|NCT02783573|12187945|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
4954826|NCT02783573|12187946|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
4954827|NCT02783573|12187944|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
4954828|NCT02783573|12187945|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
4954829|NCT02783573|12187946|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
4954830|NCT02783573|12187944|P3|COMPLETED|Placebo-Controlled Treatment Period||22
4954831|NCT02783573|12187945|P2|COMPLETED|Placebo-Controlled Treatment Period||28
4954832|NCT02783573|12187946|P1|COMPLETED|Placebo-Controlled Treatment Period||26
4954833|NCT02783573|12187944|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
4954834|NCT02783573|12187945|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
4954835|NCT02783573|12187946|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
4954836|NCT02783573|12187944|P3|STARTED|Placebo-Controlled Treatment Period||570
4954837|NCT02783573|12187945|P2|STARTED|Placebo-Controlled Treatment Period||590
4954838|NCT02783573|12187946|P1|STARTED|Placebo-Controlled Treatment Period||562
4954839|NCT02783443|12188002|P2|NOT COMPLETED|Overall Study||0
4954840|NCT02783443|12188003|P1|NOT COMPLETED|Overall Study||0
4954841|NCT02783443|12188002|P2|COMPLETED|Overall Study||30
4954842|NCT02783443|12188003|P1|COMPLETED|Overall Study||30
4954843|NCT02783443|12188002|P2|STARTED|Overall Study||30
4954844|NCT02783443|12188003|P1|STARTED|Overall Study||30
4954845|NCT02783170|12188011|P2|NOT COMPLETED|Overall Study||0
4954846|NCT02783170|12188012|P1|NOT COMPLETED|Overall Study||1
4954847|NCT02783170|12188011|P2|COMPLETED|Overall Study||38
4954848|NCT02783170|12188012|P1|COMPLETED|Overall Study||42
4954849|NCT02783170|12188011|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
4954850|NCT02783170|12188012|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
4954851|NCT02783170|12188011|P2|STARTED|Overall Study||38
4954852|NCT02783170|12188012|P1|STARTED|Overall Study||43
4954853|NCT02783027|12188055|P2|NOT COMPLETED|Overall Study||17
4954854|NCT02783027|12188056|P1|NOT COMPLETED|Overall Study||23
4954855|NCT02783027|12188055|P2|COMPLETED|Overall Study||27
4954856|NCT02783027|12188056|P1|COMPLETED|Overall Study||16
4954857|NCT02783027|12188055|P2|STARTED|Overall Study||44
4954858|NCT02783027|12188056|P1|STARTED|Overall Study||39
4954859|NCT02782923|12188070|P1|NOT COMPLETED|Overall Study||15
4954860|NCT02782923|12188070|P1|COMPLETED|Overall Study||4
4954861|NCT02782923|12188070|P1|STARTED|Overall Study||19
4954862|NCT02782676|12188076|P2|NOT COMPLETED|Overall Study||1
4954863|NCT02782676|12188077|P1|NOT COMPLETED|Overall Study||0
4954864|NCT02782676|12188076|P2|COMPLETED|Overall Study||209
4954865|NCT02782676|12188077|P1|COMPLETED|Overall Study||211
4954866|NCT02782676|12188076|P2|STARTED|Overall Study||210
4954867|NCT02782676|12188077|P1|STARTED|Overall Study||211
4954868|NCT02782377|12188105|P1|NOT COMPLETED|Overall Study||5
4954869|NCT02782377|12188105|P1|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
4954870|NCT02782377|12188105|P1|STARTED|Overall Study||40
4954871|NCT02782325|12188120|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
4954872|NCT02782325|12188121|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
4954873|NCT02782325|12188122|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
4954874|NCT02782325|12188120|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
4954875|NCT02782325|12188121|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
4954876|NCT02782325|12188122|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
4954877|NCT02782325|12188120|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
4954878|NCT02782325|12188121|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
4954879|NCT02782325|12188122|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
4954880|NCT02782325|12188120|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
4954881|NCT02782325|12188121|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
4954882|NCT02782325|12188122|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
4954883|NCT02782325|12188120|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
4954884|NCT02782325|12188121|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
4954885|NCT02782325|12188122|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
4954886|NCT02782325|12188120|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
4954887|NCT02782325|12188121|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
4954888|NCT02782325|12188122|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
4954889|NCT02782169|12188150|P2|NOT COMPLETED|Overall Study||2
4954890|NCT02782169|12188151|P1|NOT COMPLETED|Overall Study||1
4954891|NCT02782169|12188150|P2|COMPLETED|Overall Study||52
4954892|NCT02782169|12188151|P1|COMPLETED|Overall Study||55
4954893|NCT02782169|12188150|P2|STARTED|Overall Study||54
4954894|NCT02782169|12188151|P1|STARTED|Overall Study||56
4954895|NCT02781844|12188169|P8|NOT COMPLETED|Treatment Period 2||0
4954896|NCT02781844|12188170|P7|NOT COMPLETED|Treatment Period 2||0
4954897|NCT02781844|12188171|P6|NOT COMPLETED|Treatment Period 2||0
4954898|NCT02781844|12188172|P5|NOT COMPLETED|Treatment Period 2||0
4954899|NCT02781844|12188173|P4|NOT COMPLETED|Treatment Period 2||0
4954900|NCT02781844|12188174|P3|NOT COMPLETED|Treatment Period 2||0
4954901|NCT02781844|12188175|P2|NOT COMPLETED|Treatment Period 2||0
4954902|NCT02781844|12188176|P1|NOT COMPLETED|Treatment Period 2||0
4954903|NCT02781844|12188169|P8|COMPLETED|Treatment Period 2||4
4954904|NCT02781844|12188170|P7|COMPLETED|Treatment Period 2||4
4954905|NCT02781844|12188171|P6|COMPLETED|Treatment Period 2||4
4954906|NCT02781844|12188172|P5|COMPLETED|Treatment Period 2||4
4954907|NCT02781844|12188173|P4|COMPLETED|Treatment Period 2||4
4954908|NCT02781844|12188174|P3|COMPLETED|Treatment Period 2||4
4954909|NCT02781844|12188175|P2|COMPLETED|Treatment Period 2||4
4954910|NCT02781844|12188176|P1|COMPLETED|Treatment Period 2||5
4954911|NCT02781844|12188169|P8|STARTED|Treatment Period 2||4
4954912|NCT02781844|12188170|P7|STARTED|Treatment Period 2||4
4954913|NCT02781844|12188171|P6|STARTED|Treatment Period 2||4
4954914|NCT02781844|12188172|P5|STARTED|Treatment Period 2||4
4954915|NCT02781844|12188173|P4|STARTED|Treatment Period 2||4
4954916|NCT02781844|12188174|P3|STARTED|Treatment Period 2||4
4954917|NCT02781844|12188175|P2|STARTED|Treatment Period 2||4
4954918|NCT02781844|12188176|P1|STARTED|Treatment Period 2||5
4954919|NCT02781844|12188169|P8|NOT COMPLETED|Treatment Period 1||0
4954920|NCT02781844|12188170|P7|NOT COMPLETED|Treatment Period 1||0
4954921|NCT02781844|12188171|P6|NOT COMPLETED|Treatment Period 1||1
4954922|NCT02781844|12188172|P5|NOT COMPLETED|Treatment Period 1||0
4954923|NCT02781844|12188173|P4|NOT COMPLETED|Treatment Period 1||0
4954924|NCT02781844|12188174|P3|NOT COMPLETED|Treatment Period 1||0
4954925|NCT02781844|12188175|P2|NOT COMPLETED|Treatment Period 1||0
4954926|NCT02781844|12188176|P1|NOT COMPLETED|Treatment Period 1||0
4954927|NCT02781844|12188169|P8|COMPLETED|Treatment Period 1||4
4954928|NCT02781844|12188170|P7|COMPLETED|Treatment Period 1||4
4954929|NCT02781844|12188171|P6|COMPLETED|Treatment Period 1||4
4954930|NCT02781844|12188172|P5|COMPLETED|Treatment Period 1||4
4954931|NCT02781844|12188173|P4|COMPLETED|Treatment Period 1||4
4954932|NCT02781844|12188174|P3|COMPLETED|Treatment Period 1||4
4954933|NCT02781844|12188175|P2|COMPLETED|Treatment Period 1||4
4954934|NCT02781844|12188176|P1|COMPLETED|Treatment Period 1||5
4954935|NCT02781844|12188169|P8|STARTED|Treatment Period 1||4
4954936|NCT02781844|12188170|P7|STARTED|Treatment Period 1||4
4954937|NCT02781844|12188171|P6|STARTED|Treatment Period 1||5
4954938|NCT02781844|12188172|P5|STARTED|Treatment Period 1||4
4954939|NCT02781844|12188173|P4|STARTED|Treatment Period 1||4
4954940|NCT02781844|12188174|P3|STARTED|Treatment Period 1||4
4954941|NCT02781844|12188175|P2|STARTED|Treatment Period 1||4
4954942|NCT02781844|12188176|P1|STARTED|Treatment Period 1||5
4954943|NCT02781818|12188309|P3|NOT COMPLETED|Overall Study||1
4954944|NCT02781818|12188310|P2|NOT COMPLETED|Overall Study||2
4954945|NCT02781818|12188311|P1|NOT COMPLETED|Overall Study||4
4954946|NCT02781818|12188309|P3|COMPLETED|Overall Study||16
4954947|NCT02781818|12188310|P2|COMPLETED|Overall Study||16
4954948|NCT02781818|12188311|P1|COMPLETED|Overall Study||16
4954949|NCT02781818|12188309|P3|STARTED|Overall Study||17
4954950|NCT02781818|12188310|P2|STARTED|Overall Study||18
4954951|NCT02781818|12188311|P1|STARTED|Overall Study||20
4954952|NCT02781649|12188328|P3|NOT COMPLETED|Overall Study||0
4954953|NCT02781649|12188329|P2|NOT COMPLETED|Overall Study||0
4954954|NCT02781649|12188330|P1|NOT COMPLETED|Overall Study||0
4954955|NCT02781649|12188328|P3|COMPLETED|Overall Study||3
4954956|NCT02781649|12188329|P2|COMPLETED|Overall Study||0
4954957|NCT02781649|12188330|P1|COMPLETED|Overall Study||7
4954958|NCT02781649|12188328|P3|STARTED|Overall Study||3
4954959|NCT02781649|12188329|P2|STARTED|Overall Study||0
4954960|NCT02781649|12188330|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
4954961|NCT02781571|12188356|P1|NOT COMPLETED|Overall Study||0
4954962|NCT02781571|12188356|P1|COMPLETED|Overall Study||79
4954963|NCT02781571|12188356|P1|STARTED|Overall Study||79
4954964|NCT02781558|12188377|P2|NOT COMPLETED|Overall Study||2
4954965|NCT02781558|12188378|P1|NOT COMPLETED|Overall Study||3
4954966|NCT02781558|12188377|P2|COMPLETED|Overall Study||101
4954967|NCT02781558|12188378|P1|COMPLETED|Overall Study||98
4954968|NCT02781558|12188377|P2|STARTED|Overall Study||103
4954969|NCT02781558|12188378|P1|STARTED|Overall Study||101
4954970|NCT02781454|12188417|P3|NOT COMPLETED|Overall Study||1
4954971|NCT02781454|12188418|P2|NOT COMPLETED|Overall Study||0
4954972|NCT02781454|12188419|P1|NOT COMPLETED|Overall Study||0
4954973|NCT02781454|12188417|P3|COMPLETED|Overall Study||5
4954974|NCT02781454|12188418|P2|COMPLETED|Overall Study||6
4954975|NCT02781454|12188419|P1|COMPLETED|Overall Study||8
4954976|NCT02781454|12188417|P3|STARTED|Overall Study||6
4954977|NCT02781454|12188418|P2|STARTED|Overall Study||6
4954978|NCT02781454|12188419|P1|STARTED|Overall Study||8
4954979|NCT02781324|12188465|P2|NOT COMPLETED|Overall Study||2
4954980|NCT02781324|12188466|P1|NOT COMPLETED|Overall Study||2
4954981|NCT02781324|12188465|P2|COMPLETED|Overall Study||31
4954982|NCT02781324|12188466|P1|COMPLETED|Overall Study||31
4954983|NCT02781324|12188465|P2|STARTED|Overall Study||33
4954984|NCT02781324|12188466|P1|STARTED|Overall Study||33
4954985|NCT02781311|12188495|P3|NOT COMPLETED|Overall Study||4
4954986|NCT02781311|12188496|P2|NOT COMPLETED|Overall Study||26
4954987|NCT02781311|12188497|P1|NOT COMPLETED|Overall Study||26
4954988|NCT02781311|12188495|P3|COMPLETED|Overall Study||8
4954989|NCT02781311|12188496|P2|COMPLETED|Overall Study||57
4954990|NCT02781311|12188497|P1|COMPLETED|Overall Study||48
4954991|NCT02781311|12188495|P3|mITT Population|Overall Study||11
4954992|NCT02781311|12188496|P2|mITT Population|Overall Study||78
4954993|NCT02781311|12188497|P1|mITT Population|Overall Study||70
4954994|NCT02781311|12188495|P3|Safety Population (Treated)|Overall Study||12
4954995|NCT02781311|12188496|P2|Safety Population (Treated)|Overall Study||81
4954996|NCT02781311|12188497|P1|Safety Population (Treated)|Overall Study||73
4954997|NCT02781311|12188495|P3|STARTED|Overall Study||12
4954998|NCT02781311|12188496|P2|STARTED|Overall Study||83
4954999|NCT02781311|12188497|P1|STARTED|Overall Study||74
4955000|NCT02781051|12188506|P1|NOT COMPLETED|Overall Study||2
4955001|NCT02781051|12188506|P1|COMPLETED|Overall Study||14
4955002|NCT02781051|12188506|P1|STARTED|Overall Study||16
4955003|NCT02780869|12188513|P2|NOT COMPLETED|Overall Study||9
4955004|NCT02780869|12188514|P1|NOT COMPLETED|Overall Study||13
4955005|NCT02780869|12188513|P2|COMPLETED|Overall Study||74
4955006|NCT02780869|12188514|P1|COMPLETED|Overall Study||162
4955007|NCT02780869|12188513|P2|STARTED|Overall Study||83
4955008|NCT02780869|12188514|P1|STARTED|Overall Study||175
4955009|NCT02780856|12188524|P1|NOT COMPLETED|Overall Study||1
4955010|NCT02780856|12188524|P1|COMPLETED|Overall Study||109
4955011|NCT02780856|12188524|P1|STARTED|Overall Study||110
4955012|NCT02780765|12188534|P2|NOT COMPLETED|Overall Study||0
4955013|NCT02780765|12188535|P1|NOT COMPLETED|Overall Study||0
4955014|NCT02780765|12188534|P2|COMPLETED|Overall Study||30
4955015|NCT02780765|12188535|P1|COMPLETED|Overall Study||30
4955016|NCT02780765|12188534|P2|STARTED|Overall Study||30
4955017|NCT02780765|12188535|P1|STARTED|Overall Study||30
4955018|NCT02780700|12188543|P1|NOT COMPLETED|Overall Study||1
4955019|NCT02780700|12188543|P1|COMPLETED|Overall Study||0
4955020|NCT02780700|12188543|P1|STARTED|Overall Study||1
4955021|NCT02780661|12188551|P2|NOT COMPLETED|Period 2||0
4955022|NCT02780661|12188552|P1|NOT COMPLETED|Period 2||0
4955023|NCT02780661|12188551|P2|COMPLETED|Period 2||9
4955024|NCT02780661|12188552|P1|COMPLETED|Period 2||10
4955025|NCT02780661|12188551|P2|STARTED|Period 2||9
4955026|NCT02780661|12188552|P1|STARTED|Period 2||10
4955027|NCT02780661|12188551|P2|NOT COMPLETED|Wash Out Period||0
4955028|NCT02780661|12188552|P1|NOT COMPLETED|Wash Out Period||0
4955029|NCT02780661|12188551|P2|COMPLETED|Wash Out Period||9
4955030|NCT02780661|12188552|P1|COMPLETED|Wash Out Period||10
4955031|NCT02780661|12188551|P2|STARTED|Wash Out Period||9
4955032|NCT02780661|12188552|P1|STARTED|Wash Out Period||10
4955033|NCT02780661|12188551|P2|NOT COMPLETED|Period 1||0
4955034|NCT02780661|12188552|P1|NOT COMPLETED|Period 1||0
4955035|NCT02780661|12188551|P2|COMPLETED|Period 1||9
4955036|NCT02780661|12188552|P1|COMPLETED|Period 1||10
4955037|NCT02780661|12188551|P2|STARTED|Period 1||9
4955038|NCT02780661|12188552|P1|STARTED|Period 1||10
4955039|NCT02780622|12188568|P2|NOT COMPLETED|Treatment Period 2||0
4955040|NCT02780622|12188569|P1|NOT COMPLETED|Treatment Period 2||0
4955041|NCT02780622|12188568|P2|COMPLETED|Treatment Period 2||10
4955042|NCT02780622|12188569|P1|COMPLETED|Treatment Period 2||10
4955043|NCT02780622|12188568|P2|STARTED|Treatment Period 2||10
4955044|NCT02780622|12188569|P1|STARTED|Treatment Period 2||10
4955045|NCT02780622|12188568|P2|NOT COMPLETED|Treatment Period 1||0
4955046|NCT02780622|12188569|P1|NOT COMPLETED|Treatment Period 1||0
4955047|NCT02780622|12188568|P2|COMPLETED|Treatment Period 1||10
4955048|NCT02780622|12188569|P1|COMPLETED|Treatment Period 1||10
4955049|NCT02780622|12188568|P2|STARTED|Treatment Period 1||10
4955050|NCT02780622|12188569|P1|STARTED|Treatment Period 1||10
4955051|NCT02780388|12188612|P5|NOT COMPLETED|Overall Study||0
4955052|NCT02780388|12188613|P4|NOT COMPLETED|Overall Study||0
4955053|NCT02780388|12188614|P3|NOT COMPLETED|Overall Study||0
4955054|NCT02780388|12188615|P2|NOT COMPLETED|Overall Study||2
4955055|NCT02780388|12188616|P1|NOT COMPLETED|Overall Study||1
4955056|NCT02780388|12188612|P5|COMPLETED|Overall Study||12
4955057|NCT02780388|12188613|P4|COMPLETED|Overall Study||12
4955058|NCT02780388|12188614|P3|COMPLETED|Overall Study||10
4955059|NCT02780388|12188615|P2|COMPLETED|Overall Study||6
4955060|NCT02780388|12188616|P1|COMPLETED|Overall Study||14
4955061|NCT02780388|12188612|P5|STARTED|Overall Study||12
4955062|NCT02780388|12188613|P4|STARTED|Overall Study||12
4955063|NCT02780388|12188614|P3|STARTED|Overall Study||10
4955064|NCT02780388|12188615|P2|STARTED|Overall Study||8
4955065|NCT02780388|12188616|P1|STARTED|Overall Study||15
4955066|NCT02780349|12188673|P1|NOT COMPLETED|Overall Study||2
4955067|NCT02780349|12188673|P1|COMPLETED|Overall Study||101
4955068|NCT02780349|12188673|P1|STARTED|Overall Study||103
4955069|NCT02780167|12188682|P5|NOT COMPLETED|Overall Study||17
4955070|NCT02780167|12188683|P4|NOT COMPLETED|Overall Study||19
4955071|NCT02780167|12188684|P3|NOT COMPLETED|Overall Study||24
4955072|NCT02780167|12188685|P2|NOT COMPLETED|Overall Study||22
4955073|NCT02780167|12188686|P1|NOT COMPLETED|Overall Study||28
4955074|NCT02780167|12188682|P5|COMPLETED|Overall Study||38
4955075|NCT02780167|12188683|P4|COMPLETED|Overall Study||37
4955076|NCT02780167|12188684|P3|COMPLETED|Overall Study||27
4955077|NCT02780167|12188685|P2|COMPLETED|Overall Study||27
4955078|NCT02780167|12188686|P1|COMPLETED|Overall Study||28
4955079|NCT02780167|12188682|P5|STARTED|Overall Study||55
4955080|NCT02780167|12188683|P4|STARTED|Overall Study||56
4955081|NCT02780167|12188684|P3|STARTED|Overall Study||51
4955082|NCT02780167|12188685|P2|STARTED|Overall Study||49
4955083|NCT02780167|12188686|P1|STARTED|Overall Study||56
4955084|NCT02779543|12188820|P2|NOT COMPLETED|Overall Study||0
4955085|NCT02779543|12188821|P1|NOT COMPLETED|Overall Study||0
4955086|NCT02779543|12188820|P2|COMPLETED|Overall Study||100
4955087|NCT02779543|12188821|P1|COMPLETED|Overall Study||100
4955088|NCT02779543|12188820|P2|STARTED|Overall Study||100
4955089|NCT02779543|12188821|P1|STARTED|Overall Study||100
4955090|NCT02779491|12188837|P4|NOT COMPLETED|Overall Study||2
4955091|NCT02779491|12188838|P3|NOT COMPLETED|Overall Study||1
4955092|NCT02779491|12188839|P2|NOT COMPLETED|Overall Study||1
4955093|NCT02779491|12188840|P1|NOT COMPLETED|Overall Study||0
4955094|NCT02779491|12188837|P4|COMPLETED|Overall Study||15
4955095|NCT02779491|12188838|P3|COMPLETED|Overall Study||17
4955096|NCT02779491|12188839|P2|COMPLETED|Overall Study||26
4955097|NCT02779491|12188840|P1|COMPLETED|Overall Study||32
4955098|NCT02779491|12188837|P4|STARTED|Overall Study||17
4955099|NCT02779491|12188838|P3|STARTED|Overall Study||18
4955100|NCT02779491|12188839|P2|STARTED|Overall Study||27
4955101|NCT02779491|12188840|P1|STARTED|Overall Study||32
4955102|NCT02779166|12188860|P2|NOT COMPLETED|Overall Study||0
4955103|NCT02779166|12188861|P1|NOT COMPLETED|Overall Study||0
4955104|NCT02779166|12188860|P2|COMPLETED|Overall Study||48
4955105|NCT02779166|12188861|P1|COMPLETED|Overall Study||50
4955106|NCT02779166|12188860|P2|STARTED|Overall Study||48
4955107|NCT02779166|12188861|P1|STARTED|Overall Study||50
4955108|NCT02779075|12188871|P2|NOT COMPLETED|Overall Study||3
4955109|NCT02779075|12188872|P1|NOT COMPLETED|Overall Study||2
4955110|NCT02779075|12188871|P2|COMPLETED|Overall Study||10
4955111|NCT02779075|12188872|P1|COMPLETED|Overall Study||14
4955112|NCT02779075|12188871|P2|STARTED|Overall Study||13
4955113|NCT02779075|12188872|P1|STARTED|Overall Study||16
4955114|NCT02778867|12188882|P4|NOT COMPLETED|Phase 2||2
4955115|NCT02778867|12188883|P3|NOT COMPLETED|Phase 2||1
4955116|NCT02778867|12188884|P2|NOT COMPLETED|Phase 2||0
4955117|NCT02778867|12188885|P1|NOT COMPLETED|Phase 2||0
4955118|NCT02778867|12188882|P4|COMPLETED|Phase 2||9
4955119|NCT02778867|12188883|P3|COMPLETED|Phase 2||20
4955120|NCT02778867|12188884|P2|COMPLETED|Phase 2||0
4955121|NCT02778867|12188885|P1|COMPLETED|Phase 2||0
4955122|NCT02778867|12188882|P4|STARTED|Phase 2|Optional phase for 6FED non-responders|11
4955123|NCT02778867|12188883|P3|STARTED|Phase 2|Optional phase for 1FED non-responders|21
4955124|NCT02778867|12188884|P2|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
4955125|NCT02778867|12188885|P1|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
4955126|NCT02778867|12188882|P4|NOT COMPLETED|Phase 1||0
4955127|NCT02778867|12188883|P3|NOT COMPLETED|Phase 1||0
4955128|NCT02778867|12188884|P2|NOT COMPLETED|Phase 1||3
4955129|NCT02778867|12188885|P1|NOT COMPLETED|Phase 1||2
4955130|NCT02778867|12188882|P4|COMPLETED|Phase 1||0
4955131|NCT02778867|12188883|P3|COMPLETED|Phase 1||0
4955132|NCT02778867|12188884|P2|COMPLETED|Phase 1||59
4955133|NCT02778867|12188885|P1|COMPLETED|Phase 1||65
4955134|NCT02778867|12188882|P4|STARTED|Phase 1||0
4955135|NCT02778867|12188883|P3|STARTED|Phase 1||0
4955136|NCT02778867|12188884|P2|STARTED|Phase 1||62
4955137|NCT02778867|12188885|P1|STARTED|Phase 1||67
4955138|NCT02778555|12188906|P3|NOT COMPLETED|Overall Study||107
4955139|NCT02778555|12188907|P2|NOT COMPLETED|Overall Study||32
4955140|NCT02778555|12188908|P1|NOT COMPLETED|Overall Study||55
4955141|NCT02778555|12188906|P3|COMPLETED|Overall Study||211
4955142|NCT02778555|12188907|P2|COMPLETED|Overall Study||177
4955143|NCT02778555|12188908|P1|COMPLETED|Overall Study||131
4955144|NCT02778555|12188906|P3|STARTED|Overall Study||318
4955145|NCT02778555|12188907|P2|STARTED|Overall Study||209
4955146|NCT02778555|12188908|P1|STARTED|Overall Study||186
4955147|NCT02778152|12188916|P1|NOT COMPLETED|Overall Study||0
4955148|NCT02778152|12188916|P1|COMPLETED|Overall Study||13
4955149|NCT02778152|12188916|P1|STARTED|Overall Study||13
4955150|NCT02778113|12188921|P4|NOT COMPLETED|Study Period Four||0
4955151|NCT02778113|12188922|P3|NOT COMPLETED|Study Period Four||0
4955152|NCT02778113|12188923|P2|NOT COMPLETED|Study Period Four||0
4955153|NCT02778113|12188924|P1|NOT COMPLETED|Study Period Four||0
4955154|NCT02778113|12188921|P4|COMPLETED|Study Period Four||4
4955155|NCT02778113|12188922|P3|COMPLETED|Study Period Four||2
4955156|NCT02778113|12188923|P2|COMPLETED|Study Period Four||4
4955157|NCT02778113|12188924|P1|COMPLETED|Study Period Four||3
4955158|NCT02778113|12188921|P4|Received Study Drug|Study Period Four||4
4955159|NCT02778113|12188922|P3|Received Study Drug|Study Period Four||2
4955160|NCT02778113|12188923|P2|Received Study Drug|Study Period Four||4
4955161|NCT02778113|12188924|P1|Received Study Drug|Study Period Four||3
4955162|NCT02778113|12188921|P4|STARTED|Study Period Four||4
4955163|NCT02778113|12188922|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
4955164|NCT02778113|12188923|P2|STARTED|Study Period Four||4
4955165|NCT02778113|12188924|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
4955166|NCT02778113|12188921|P4|NOT COMPLETED|Study Period Three||0
4955167|NCT02778113|12188922|P3|NOT COMPLETED|Study Period Three||0
4955168|NCT02778113|12188923|P2|NOT COMPLETED|Study Period Three||0
4955169|NCT02778113|12188924|P1|NOT COMPLETED|Study Period Three||0
4955170|NCT02778113|12188921|P4|COMPLETED|Study Period Three||4
4955171|NCT02778113|12188922|P3|COMPLETED|Study Period Three||3
4955172|NCT02778113|12188923|P2|COMPLETED|Study Period Three||4
4955173|NCT02778113|12188924|P1|COMPLETED|Study Period Three||4
4955174|NCT02778113|12188921|P4|Received Study Drug|Study Period Three||4
4955175|NCT02778113|12188922|P3|Received Study Drug|Study Period Three||3
4955176|NCT02778113|12188923|P2|Received Study Drug|Study Period Three||4
4955177|NCT02778113|12188924|P1|Received Study Drug|Study Period Three||4
4955178|NCT02778113|12188921|P4|STARTED|Study Period Three||4
4955179|NCT02778113|12188922|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
4955180|NCT02778113|12188923|P2|STARTED|Study Period Three||4
4955181|NCT02778113|12188924|P1|STARTED|Study Period Three||4
4955182|NCT02778113|12188921|P4|NOT COMPLETED|Study Period Two||0
4955183|NCT02778113|12188922|P3|NOT COMPLETED|Study Period Two||0
4955184|NCT02778113|12188923|P2|NOT COMPLETED|Study Period Two||0
4955185|NCT02778113|12188924|P1|NOT COMPLETED|Study Period Two||0
4955186|NCT02778113|12188921|P4|COMPLETED|Study Period Two||4
4955187|NCT02778113|12188922|P3|COMPLETED|Study Period Two||4
4955188|NCT02778113|12188923|P2|COMPLETED|Study Period Two||4
4955189|NCT02778113|12188924|P1|COMPLETED|Study Period Two||4
4955190|NCT02778113|12188921|P4|Received Study Drug|Study Period Two||4
4955191|NCT02778113|12188922|P3|Received Study Drug|Study Period Two||4
4955192|NCT02778113|12188923|P2|Received Study Drug|Study Period Two||4
4955193|NCT02778113|12188924|P1|Received Study Drug|Study Period Two||4
4955194|NCT02778113|12188921|P4|STARTED|Study Period Two||4
4955195|NCT02778113|12188922|P3|STARTED|Study Period Two||4
4955196|NCT02778113|12188923|P2|STARTED|Study Period Two||4
4955197|NCT02778113|12188924|P1|STARTED|Study Period Two||4
4955198|NCT02778113|12188921|P4|NOT COMPLETED|Study Period One||0
4955199|NCT02778113|12188922|P3|NOT COMPLETED|Study Period One||0
4955200|NCT02778113|12188923|P2|NOT COMPLETED|Study Period One||0
4955201|NCT02778113|12188924|P1|NOT COMPLETED|Study Period One||0
4955202|NCT02778113|12188921|P4|COMPLETED|Study Period One||4
4955203|NCT02778113|12188922|P3|COMPLETED|Study Period One||4
4955204|NCT02778113|12188923|P2|COMPLETED|Study Period One||4
4955205|NCT02778113|12188924|P1|COMPLETED|Study Period One||4
4955206|NCT02778113|12188921|P4|Received Study Drug|Study Period One||4
4955207|NCT02778113|12188922|P3|Received Study Drug|Study Period One||4
4955208|NCT02778113|12188923|P2|Received Study Drug|Study Period One||4
4955209|NCT02778113|12188924|P1|Received Study Drug|Study Period One||4
4955210|NCT02778113|12188921|P4|STARTED|Study Period One||4
4955211|NCT02778113|12188922|P3|STARTED|Study Period One||4
4955212|NCT02778113|12188923|P2|STARTED|Study Period One||4
4955213|NCT02778113|12188924|P1|STARTED|Study Period One||4
4955214|NCT02778100|12188964|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
4955215|NCT02778100|12188965|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
4955216|NCT02778100|12188964|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
4955217|NCT02778100|12188965|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
4955218|NCT02778100|12188964|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
4955219|NCT02778100|12188965|P1|STARTED|Period 2 (No Cold Symptoms)||17
4955220|NCT02778100|12188964|P2|NOT COMPLETED|Period 1 (Common Cold)||0
4955221|NCT02778100|12188965|P1|NOT COMPLETED|Period 1 (Common Cold)||1
4955222|NCT02778100|12188964|P2|COMPLETED|Period 1 (Common Cold)||18
4955223|NCT02778100|12188965|P1|COMPLETED|Period 1 (Common Cold)||17
4955224|NCT02778100|12188964|P2|STARTED|Period 1 (Common Cold)||18
4955225|NCT02778100|12188965|P1|STARTED|Period 1 (Common Cold)||18
4955226|NCT02778074|12188996|P2|NOT COMPLETED|Overall Study||10
4955227|NCT02778074|12188997|P1|NOT COMPLETED|Overall Study||7
4955228|NCT02778074|12188996|P2|COMPLETED|Overall Study||62
4955229|NCT02778074|12188997|P1|COMPLETED|Overall Study||65
4955230|NCT02778074|12188996|P2|STARTED|Overall Study||72
4955231|NCT02778074|12188997|P1|STARTED|Overall Study||72
4955232|NCT02777944|12189005|P2|NOT COMPLETED|Overall Study||0
4955233|NCT02777944|12189006|P1|NOT COMPLETED|Overall Study||0
4955234|NCT02777944|12189005|P2|COMPLETED|Overall Study||156
4955235|NCT02777944|12189006|P1|COMPLETED|Overall Study||157
4955236|NCT02777944|12189005|P2|STARTED|Overall Study||156
4955237|NCT02777944|12189006|P1|STARTED|Overall Study||157
4955238|NCT02777931|12189018|P2|NOT COMPLETED|Overall Study||13
4955239|NCT02777931|12189019|P1|NOT COMPLETED|Overall Study||12
4955240|NCT02777931|12189018|P2|COMPLETED|Overall Study||39
4955241|NCT02777931|12189019|P1|COMPLETED|Overall Study||37
4955242|NCT02777931|12189018|P2|Modified Intent to Treat Population|Overall Study||50
4955243|NCT02777931|12189019|P1|Modified Intent to Treat Population|Overall Study||46
4955244|NCT02777931|12189018|P2|Safety Population|Overall Study||50
4955245|NCT02777931|12189019|P1|Safety Population|Overall Study||47
4955246|NCT02777931|12189018|P2|STARTED|Overall Study||52
4955247|NCT02777931|12189019|P1|STARTED|Overall Study||49
4955248|NCT02777918|12189029|P2|NOT COMPLETED|Overall Study||4
4955249|NCT02777918|12189030|P1|NOT COMPLETED|Overall Study||3
4955250|NCT02777918|12189029|P2|COMPLETED|Overall Study||43
4955251|NCT02777918|12189030|P1|COMPLETED|Overall Study||50
4955252|NCT02777918|12189029|P2|STARTED|Overall Study||47
4955253|NCT02777918|12189030|P1|STARTED|Overall Study||53
4955254|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 6||0
4955255|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 6||0
4955256|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 6||0
4955257|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 6||0
4955258|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 6||0
4955259|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 6||0
4955260|NCT02777827|12189048|P6|COMPLETED|Treatment Period 6||6
4955261|NCT02777827|12189049|P5|COMPLETED|Treatment Period 6||4
4955262|NCT02777827|12189050|P4|COMPLETED|Treatment Period 6||5
4955263|NCT02777827|12189051|P3|COMPLETED|Treatment Period 6||4
4955264|NCT02777827|12189052|P2|COMPLETED|Treatment Period 6||5
4955265|NCT02777827|12189053|P1|COMPLETED|Treatment Period 6||5
4955266|NCT02777827|12189048|P6|STARTED|Treatment Period 6||6
4955267|NCT02777827|12189049|P5|STARTED|Treatment Period 6||4
4955268|NCT02777827|12189050|P4|STARTED|Treatment Period 6||5
4955269|NCT02777827|12189051|P3|STARTED|Treatment Period 6||4
4955270|NCT02777827|12189052|P2|STARTED|Treatment Period 6||5
4955271|NCT02777827|12189053|P1|STARTED|Treatment Period 6||5
4955272|NCT02777827|12189048|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955273|NCT02777827|12189049|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955274|NCT02777827|12189050|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955275|NCT02777827|12189051|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955276|NCT02777827|12189052|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955277|NCT02777827|12189053|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
4955278|NCT02777827|12189048|P6|COMPLETED|Washout Between Periods 5 and 6||6
4955279|NCT02777827|12189049|P5|COMPLETED|Washout Between Periods 5 and 6||4
4955280|NCT02777827|12189050|P4|COMPLETED|Washout Between Periods 5 and 6||5
4955281|NCT02777827|12189051|P3|COMPLETED|Washout Between Periods 5 and 6||4
4955282|NCT02777827|12189052|P2|COMPLETED|Washout Between Periods 5 and 6||5
4955283|NCT02777827|12189053|P1|COMPLETED|Washout Between Periods 5 and 6||5
4955284|NCT02777827|12189048|P6|STARTED|Washout Between Periods 5 and 6||6
4955285|NCT02777827|12189049|P5|STARTED|Washout Between Periods 5 and 6||4
4955286|NCT02777827|12189050|P4|STARTED|Washout Between Periods 5 and 6||5
4955287|NCT02777827|12189051|P3|STARTED|Washout Between Periods 5 and 6||4
4955288|NCT02777827|12189052|P2|STARTED|Washout Between Periods 5 and 6||5
4955289|NCT02777827|12189053|P1|STARTED|Washout Between Periods 5 and 6||5
4955290|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 5||0
4955291|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 5||0
4955292|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 5||0
4955293|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 5||0
4955294|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 5||0
4955295|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 5||0
4955296|NCT02777827|12189048|P6|COMPLETED|Treatment Period 5||6
4955297|NCT02777827|12189049|P5|COMPLETED|Treatment Period 5||4
4955298|NCT02777827|12189050|P4|COMPLETED|Treatment Period 5||5
4955299|NCT02777827|12189051|P3|COMPLETED|Treatment Period 5||4
4955300|NCT02777827|12189052|P2|COMPLETED|Treatment Period 5||5
4955301|NCT02777827|12189053|P1|COMPLETED|Treatment Period 5||5
4955302|NCT02777827|12189048|P6|STARTED|Treatment Period 5||6
4955303|NCT02777827|12189049|P5|STARTED|Treatment Period 5||4
4955304|NCT02777827|12189050|P4|STARTED|Treatment Period 5||5
4955305|NCT02777827|12189051|P3|STARTED|Treatment Period 5||4
4955306|NCT02777827|12189052|P2|STARTED|Treatment Period 5||5
4955307|NCT02777827|12189053|P1|STARTED|Treatment Period 5||5
4955308|NCT02777827|12189048|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955309|NCT02777827|12189049|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955310|NCT02777827|12189050|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955311|NCT02777827|12189051|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955312|NCT02777827|12189052|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955313|NCT02777827|12189053|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
4955314|NCT02777827|12189048|P6|COMPLETED|Washout Between Periods 4 and 5||6
4955315|NCT02777827|12189049|P5|COMPLETED|Washout Between Periods 4 and 5||4
4955316|NCT02777827|12189050|P4|COMPLETED|Washout Between Periods 4 and 5||5
4955317|NCT02777827|12189051|P3|COMPLETED|Washout Between Periods 4 and 5||4
4955318|NCT02777827|12189052|P2|COMPLETED|Washout Between Periods 4 and 5||5
4955319|NCT02777827|12189053|P1|COMPLETED|Washout Between Periods 4 and 5||5
4955320|NCT02777827|12189048|P6|STARTED|Washout Between Periods 4 and 5||6
4955321|NCT02777827|12189049|P5|STARTED|Washout Between Periods 4 and 5||4
4955322|NCT02777827|12189050|P4|STARTED|Washout Between Periods 4 and 5||5
4955323|NCT02777827|12189051|P3|STARTED|Washout Between Periods 4 and 5||4
4955324|NCT02777827|12189052|P2|STARTED|Washout Between Periods 4 and 5||5
4955325|NCT02777827|12189053|P1|STARTED|Washout Between Periods 4 and 5||5
4955326|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 4||0
4955327|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 4||0
4955328|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 4||0
4955329|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 4||0
4955330|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 4||0
4955331|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 4||0
4955332|NCT02777827|12189048|P6|COMPLETED|Treatment Period 4||6
4955333|NCT02777827|12189049|P5|COMPLETED|Treatment Period 4||4
4955334|NCT02777827|12189050|P4|COMPLETED|Treatment Period 4||5
4955335|NCT02777827|12189051|P3|COMPLETED|Treatment Period 4||4
4955336|NCT02777827|12189052|P2|COMPLETED|Treatment Period 4||5
4955337|NCT02777827|12189053|P1|COMPLETED|Treatment Period 4||5
4955338|NCT02777827|12189048|P6|STARTED|Treatment Period 4||6
4955339|NCT02777827|12189049|P5|STARTED|Treatment Period 4||4
4955340|NCT02777827|12189050|P4|STARTED|Treatment Period 4||5
4955341|NCT02777827|12189051|P3|STARTED|Treatment Period 4||4
4955342|NCT02777827|12189052|P2|STARTED|Treatment Period 4||5
4955343|NCT02777827|12189053|P1|STARTED|Treatment Period 4||5
4955344|NCT02777827|12189048|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
4955345|NCT02777827|12189049|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
4955346|NCT02777827|12189050|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
4955347|NCT02777827|12189051|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
4955348|NCT02777827|12189052|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
4955349|NCT02777827|12189053|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
4955350|NCT02777827|12189048|P6|COMPLETED|Washout Between Periods 3 and 4||6
4955351|NCT02777827|12189049|P5|COMPLETED|Washout Between Periods 3 and 4||4
4955352|NCT02777827|12189050|P4|COMPLETED|Washout Between Periods 3 and 4||5
4955353|NCT02777827|12189051|P3|COMPLETED|Washout Between Periods 3 and 4||4
4955354|NCT02777827|12189052|P2|COMPLETED|Washout Between Periods 3 and 4||5
4955355|NCT02777827|12189053|P1|COMPLETED|Washout Between Periods 3 and 4||5
4955356|NCT02777827|12189048|P6|STARTED|Washout Between Periods 3 and 4||6
4955357|NCT02777827|12189049|P5|STARTED|Washout Between Periods 3 and 4||4
4955358|NCT02777827|12189050|P4|STARTED|Washout Between Periods 3 and 4||5
4955359|NCT02777827|12189051|P3|STARTED|Washout Between Periods 3 and 4||5
4955360|NCT02777827|12189052|P2|STARTED|Washout Between Periods 3 and 4||5
4955361|NCT02777827|12189053|P1|STARTED|Washout Between Periods 3 and 4||5
4955362|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 3||0
4955363|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 3||0
4955364|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 3||0
4955365|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 3||0
4955366|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 3||0
4955367|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 3||0
4955368|NCT02777827|12189048|P6|COMPLETED|Treatment Period 3||6
4955369|NCT02777827|12189049|P5|COMPLETED|Treatment Period 3||4
4955370|NCT02777827|12189050|P4|COMPLETED|Treatment Period 3||5
4955371|NCT02777827|12189051|P3|COMPLETED|Treatment Period 3||5
4955372|NCT02777827|12189052|P2|COMPLETED|Treatment Period 3||5
4955373|NCT02777827|12189053|P1|COMPLETED|Treatment Period 3||5
4955374|NCT02777827|12189048|P6|STARTED|Treatment Period 3||6
4955375|NCT02777827|12189049|P5|STARTED|Treatment Period 3||4
4955376|NCT02777827|12189050|P4|STARTED|Treatment Period 3||5
4955377|NCT02777827|12189051|P3|STARTED|Treatment Period 3||5
4955378|NCT02777827|12189052|P2|STARTED|Treatment Period 3||5
4955379|NCT02777827|12189053|P1|STARTED|Treatment Period 3||5
4955380|NCT02777827|12189048|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955381|NCT02777827|12189049|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955382|NCT02777827|12189050|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955383|NCT02777827|12189051|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955384|NCT02777827|12189052|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955385|NCT02777827|12189053|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
4955386|NCT02777827|12189048|P6|COMPLETED|Washout Between Periods 2 and 3||6
4955387|NCT02777827|12189049|P5|COMPLETED|Washout Between Periods 2 and 3||4
4955388|NCT02777827|12189050|P4|COMPLETED|Washout Between Periods 2 and 3||5
4955389|NCT02777827|12189051|P3|COMPLETED|Washout Between Periods 2 and 3||5
4955390|NCT02777827|12189052|P2|COMPLETED|Washout Between Periods 2 and 3||5
4955391|NCT02777827|12189053|P1|COMPLETED|Washout Between Periods 2 and 3||5
4955392|NCT02777827|12189048|P6|STARTED|Washout Between Periods 2 and 3||6
4955393|NCT02777827|12189049|P5|STARTED|Washout Between Periods 2 and 3||4
4955394|NCT02777827|12189050|P4|STARTED|Washout Between Periods 2 and 3||5
4955395|NCT02777827|12189051|P3|STARTED|Washout Between Periods 2 and 3||5
4955396|NCT02777827|12189052|P2|STARTED|Washout Between Periods 2 and 3||5
4955397|NCT02777827|12189053|P1|STARTED|Washout Between Periods 2 and 3||5
4955398|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 2||0
4955399|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 2||0
4955400|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 2||0
4955401|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 2||0
4955402|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 2||0
4955403|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 2||0
4955404|NCT02777827|12189048|P6|COMPLETED|Treatment Period 2||6
4955405|NCT02777827|12189049|P5|COMPLETED|Treatment Period 2||4
4955406|NCT02777827|12189050|P4|COMPLETED|Treatment Period 2||5
4955407|NCT02777827|12189051|P3|COMPLETED|Treatment Period 2||5
4955408|NCT02777827|12189052|P2|COMPLETED|Treatment Period 2||5
4955409|NCT02777827|12189053|P1|COMPLETED|Treatment Period 2||5
4955410|NCT02777827|12189048|P6|STARTED|Treatment Period 2||6
4955411|NCT02777827|12189049|P5|STARTED|Treatment Period 2||4
4955412|NCT02777827|12189050|P4|STARTED|Treatment Period 2||5
4955413|NCT02777827|12189051|P3|STARTED|Treatment Period 2||5
4955414|NCT02777827|12189052|P2|STARTED|Treatment Period 2||5
4955415|NCT02777827|12189053|P1|STARTED|Treatment Period 2||5
4955416|NCT02777827|12189048|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955417|NCT02777827|12189049|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955418|NCT02777827|12189050|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955419|NCT02777827|12189051|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955420|NCT02777827|12189052|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955421|NCT02777827|12189053|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
4955422|NCT02777827|12189048|P6|COMPLETED|Washout Between Periods 1 and 2||6
4955423|NCT02777827|12189049|P5|COMPLETED|Washout Between Periods 1 and 2||4
4955424|NCT02777827|12189050|P4|COMPLETED|Washout Between Periods 1 and 2||5
4955425|NCT02777827|12189051|P3|COMPLETED|Washout Between Periods 1 and 2||5
4955426|NCT02777827|12189052|P2|COMPLETED|Washout Between Periods 1 and 2||5
4955427|NCT02777827|12189053|P1|COMPLETED|Washout Between Periods 1 and 2||5
4955428|NCT02777827|12189048|P6|STARTED|Washout Between Periods 1 and 2||6
4955429|NCT02777827|12189049|P5|STARTED|Washout Between Periods 1 and 2||4
4955430|NCT02777827|12189050|P4|STARTED|Washout Between Periods 1 and 2||5
4955431|NCT02777827|12189051|P3|STARTED|Washout Between Periods 1 and 2||5
4955432|NCT02777827|12189052|P2|STARTED|Washout Between Periods 1 and 2||5
4955433|NCT02777827|12189053|P1|STARTED|Washout Between Periods 1 and 2||5
4955434|NCT02777827|12189048|P6|NOT COMPLETED|Treatment Period 1||0
4955435|NCT02777827|12189049|P5|NOT COMPLETED|Treatment Period 1||0
4955436|NCT02777827|12189050|P4|NOT COMPLETED|Treatment Period 1||0
4955437|NCT02777827|12189051|P3|NOT COMPLETED|Treatment Period 1||0
4955438|NCT02777827|12189052|P2|NOT COMPLETED|Treatment Period 1||0
4955439|NCT02777827|12189053|P1|NOT COMPLETED|Treatment Period 1||0
4955440|NCT02777827|12189048|P6|COMPLETED|Treatment Period 1||6
4955441|NCT02777827|12189049|P5|COMPLETED|Treatment Period 1||4
4955442|NCT02777827|12189050|P4|COMPLETED|Treatment Period 1||5
4955443|NCT02777827|12189051|P3|COMPLETED|Treatment Period 1||5
4955444|NCT02777827|12189052|P2|COMPLETED|Treatment Period 1||5
4955445|NCT02777827|12189053|P1|COMPLETED|Treatment Period 1||5
4955446|NCT02777827|12189048|P6|STARTED|Treatment Period 1||6
4955447|NCT02777827|12189049|P5|STARTED|Treatment Period 1||4
4955448|NCT02777827|12189050|P4|STARTED|Treatment Period 1||5
4955449|NCT02777827|12189051|P3|STARTED|Treatment Period 1||5
4955450|NCT02777827|12189052|P2|STARTED|Treatment Period 1||5
4955451|NCT02777827|12189053|P1|STARTED|Treatment Period 1||5
4955452|NCT02777749|12189208|P3|NOT COMPLETED|Overall Study||0
4955453|NCT02777749|12189209|P2|NOT COMPLETED|Overall Study||0
4955454|NCT02777749|12189210|P1|NOT COMPLETED|Overall Study||0
4955455|NCT02777749|12189208|P3|COMPLETED|Overall Study||51
4955456|NCT02777749|12189209|P2|COMPLETED|Overall Study||51
4955457|NCT02777749|12189210|P1|COMPLETED|Overall Study||53
4955458|NCT02777749|12189208|P3|STARTED|Overall Study||51
4955459|NCT02777749|12189209|P2|STARTED|Overall Study||51
4955460|NCT02777749|12189210|P1|STARTED|Overall Study||53
4955461|NCT02777268|12189230|P1|NOT COMPLETED|Overall Study||0
4955462|NCT02777268|12189230|P1|COMPLETED|Overall Study||16
4955463|NCT02777268|12189230|P1|STARTED|Overall Study||16
4955464|NCT02777242|12189256|P1|NOT COMPLETED|Overall Study||6
4955465|NCT02777242|12189256|P1|COMPLETED|Overall Study||59
4955466|NCT02777242|12189256|P1|STARTED|Overall Study||65
4955467|NCT02777125|12189262|P2|NOT COMPLETED|Overall Study||47
4955468|NCT02777125|12189263|P1|NOT COMPLETED|Overall Study||43
4955469|NCT02777125|12189262|P2|COMPLETED|Overall Study||445
4955470|NCT02777125|12189263|P1|COMPLETED|Overall Study||445
4955471|NCT02777125|12189262|P2|STARTED|Overall Study||492
4955472|NCT02777125|12189263|P1|STARTED|Overall Study||488
4955473|NCT02777021|12189279|P2|NOT COMPLETED|Overall Study||17
4955474|NCT02777021|12189280|P1|NOT COMPLETED|Overall Study||17
4955475|NCT02777021|12189279|P2|COMPLETED|Overall Study||77
4955476|NCT02777021|12189280|P1|COMPLETED|Overall Study||43
4955477|NCT02777021|12189279|P2|STARTED|Overall Study||94
4955478|NCT02777021|12189280|P1|STARTED|Overall Study||60
4955479|NCT02776904|12189288|P2|NOT COMPLETED|Overall Study||0
4955480|NCT02776904|12189289|P1|NOT COMPLETED|Overall Study||0
4955481|NCT02776904|12189288|P2|COMPLETED|Overall Study||46
4955482|NCT02776904|12189289|P1|COMPLETED|Overall Study||281
4955483|NCT02776904|12189288|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
4955484|NCT02776904|12189289|P1|ImPACT|Overall Study||21
4955485|NCT02776904|12189288|P2|Gait Assessment|Overall Study||32
4955486|NCT02776904|12189289|P1|Gait Assessment|Overall Study||178
4955487|NCT02776904|12189288|P2|STARTED|Overall Study||46
4955488|NCT02776904|12189289|P1|STARTED|Overall Study||281
4955489|NCT02776774|12189303|P1|NOT COMPLETED|Overall Study||0
4955490|NCT02776774|12189303|P1|COMPLETED|Overall Study|Total after data cleaning|91
4955491|NCT02776774|12189303|P1|STARTED|Overall Study||91
4955492|NCT02776683|12189308|P2|NOT COMPLETED|Post-switch Period||43
4955493|NCT02776683|12189309|P1|NOT COMPLETED|Post-switch Period||0
4955494|NCT02776683|12189308|P2|COMPLETED|Post-switch Period||0
4955495|NCT02776683|12189309|P1|COMPLETED|Post-switch Period||0
4955496|NCT02776683|12189308|P2|STARTED|Post-switch Period|Entered into Switch Set|43
4955497|NCT02776683|12189309|P1|STARTED|Post-switch Period||0
4955498|NCT02776683|12189308|P2|NOT COMPLETED|Pre-switch Period||0
4955499|NCT02776683|12189309|P1|NOT COMPLETED|Pre-switch Period||80
4955500|NCT02776683|12189308|P2|COMPLETED|Pre-switch Period||0
4955501|NCT02776683|12189309|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
4955502|NCT02776683|12189308|P2|STARTED|Pre-switch Period||0
4955503|NCT02776683|12189309|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
4955504|NCT02776670|12189320|P2|NOT COMPLETED|Overall Study||6
4955505|NCT02776670|12189321|P1|NOT COMPLETED|Overall Study||0
4955506|NCT02776670|12189320|P2|COMPLETED|Overall Study||108
4955507|NCT02776670|12189321|P1|COMPLETED|Overall Study||117
4955508|NCT02776670|12189320|P2|Safety Analysis Set|Overall Study||114
4955509|NCT02776670|12189321|P1|Safety Analysis Set|Overall Study||117
4955510|NCT02776670|12189320|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
4955511|NCT02776670|12189321|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
4955512|NCT02776670|12189320|P2|Full Analysis Set (FAS)|Overall Study||114
4955513|NCT02776670|12189321|P1|Full Analysis Set (FAS)|Overall Study||117
4955514|NCT02776670|12189320|P2|STARTED|Overall Study||114
4955515|NCT02776670|12189321|P1|STARTED|Overall Study||117
4955516|NCT02776644|12189335|P2|NOT COMPLETED|Overall Study||0
4955517|NCT02776644|12189336|P1|NOT COMPLETED|Overall Study||0
4955518|NCT02776644|12189335|P2|COMPLETED|Overall Study||126
4955519|NCT02776644|12189336|P1|COMPLETED|Overall Study||1223
4955520|NCT02776644|12189335|P2|STARTED|Overall Study||126
4955521|NCT02776644|12189336|P1|STARTED|Overall Study||1223
4955522|NCT02776033|12189379|P3|NOT COMPLETED|Overall Study||2
4955523|NCT02776033|12189380|P2|NOT COMPLETED|Overall Study||2
4955524|NCT02776033|12189381|P1|NOT COMPLETED|Overall Study||4
4955525|NCT02776033|12189379|P3|COMPLETED|Overall Study||22
4955526|NCT02776033|12189380|P2|COMPLETED|Overall Study||21
4955527|NCT02776033|12189381|P1|COMPLETED|Overall Study||14
4955528|NCT02776033|12189379|P3|STARTED|Overall Study||24
4955529|NCT02776033|12189380|P2|STARTED|Overall Study||23
4955530|NCT02776033|12189381|P1|STARTED|Overall Study||18
4955531|NCT02775916|12189446|P2|NOT COMPLETED|Overall Study||0
4955532|NCT02775916|12189447|P1|NOT COMPLETED|Overall Study||3
4955533|NCT02775916|12189446|P2|COMPLETED|Overall Study||10
4955534|NCT02775916|12189447|P1|COMPLETED|Overall Study||17
4955535|NCT02775916|12189446|P2|STARTED|Overall Study||10
4955536|NCT02775916|12189447|P1|STARTED|Overall Study||20
4955537|NCT02775903|12189469|P4|NOT COMPLETED|Overall Study||65
4955538|NCT02775903|12189470|P3|NOT COMPLETED|Overall Study||64
4955539|NCT02775903|12189471|P2|NOT COMPLETED|Overall Study||41
4955540|NCT02775903|12189472|P1|NOT COMPLETED|Overall Study||42
4955541|NCT02775903|12189469|P4|COMPLETED|Overall Study||0
4955542|NCT02775903|12189470|P3|COMPLETED|Overall Study||0
4955543|NCT02775903|12189471|P2|COMPLETED|Overall Study||1
4955544|NCT02775903|12189472|P1|COMPLETED|Overall Study||0
4955545|NCT02775903|12189469|P4|Received Study Treatment|Overall Study||62
4955546|NCT02775903|12189470|P3|Received Study Treatment|Overall Study||64
4955547|NCT02775903|12189471|P2|Received Study Treatment|Overall Study||41
4955548|NCT02775903|12189472|P1|Received Study Treatment|Overall Study||38
4955549|NCT02775903|12189469|P4|STARTED|Overall Study||65
4955550|NCT02775903|12189470|P3|STARTED|Overall Study||64
4955551|NCT02775903|12189471|P2|STARTED|Overall Study||42
4955552|NCT02775903|12189472|P1|STARTED|Overall Study||42
4955553|NCT02775864|12189524|P4|NOT COMPLETED|Overall Study||2084
4955554|NCT02775864|12189525|P3|NOT COMPLETED|Overall Study||1860
4955555|NCT02775864|12189526|P2|NOT COMPLETED|Overall Study||4899
4955556|NCT02775864|12189527|P1|NOT COMPLETED|Overall Study||3242
4955557|NCT02775864|12189524|P4|COMPLETED|Overall Study||10765
4955558|NCT02775864|12189525|P3|COMPLETED|Overall Study||10081
4955559|NCT02775864|12189526|P2|COMPLETED|Overall Study||26218
4955560|NCT02775864|12189527|P1|COMPLETED|Overall Study||22772
4955561|NCT02775864|12189524|P4|STARTED|Overall Study||12849
4955562|NCT02775864|12189525|P3|STARTED|Overall Study||11941
4955563|NCT02775864|12189526|P2|STARTED|Overall Study||31117
4955564|NCT02775864|12189527|P1|STARTED|Overall Study||26014
4955565|NCT02775617|12189547|P2|NOT COMPLETED|Overall Study||160
4955566|NCT02775617|12189548|P1|NOT COMPLETED|Overall Study||48
4955567|NCT02775617|12189547|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
4955568|NCT02775617|12189548|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
4955569|NCT02775617|12189547|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
4955570|NCT02775617|12189548|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
4955571|NCT02775435|12189560|P2|NOT COMPLETED|Overall Study||281
4955572|NCT02775435|12189561|P1|NOT COMPLETED|Overall Study||278
4955573|NCT02775435|12189560|P2|COMPLETED|Overall Study||0
4955574|NCT02775435|12189561|P1|COMPLETED|Overall Study||0
4955575|NCT02775435|12189560|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
4955576|NCT02775435|12189561|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
4955577|NCT02775435|12189560|P2|Treated|Overall Study||280
4955578|NCT02775435|12189561|P1|Treated|Overall Study||278
4955579|NCT02775435|12189560|P2|STARTED|Overall Study||281
4955580|NCT02775435|12189561|P1|STARTED|Overall Study||278
4955581|NCT02775344|12189579|P2|NOT COMPLETED|Overall Study||2
4955582|NCT02775344|12189580|P1|NOT COMPLETED|Overall Study||3
4955583|NCT02775344|12189579|P2|COMPLETED|Overall Study||38
4955584|NCT02775344|12189580|P1|COMPLETED|Overall Study||37
4955585|NCT02775344|12189579|P2|STARTED|Overall Study||40
4955586|NCT02775344|12189580|P1|STARTED|Overall Study||40
4955587|NCT02775240|12189598|P1|NOT COMPLETED|Overall Study||1
4955588|NCT02775240|12189598|P1|COMPLETED|Overall Study||17
4955589|NCT02775240|12189598|P1|Started Treatment B|Overall Study||17
4955590|NCT02775240|12189598|P1|Started Treatment A|Overall Study||18
4955591|NCT02775240|12189598|P1|STARTED|Overall Study||18
4955592|NCT02774941|12189663|P2|NOT COMPLETED|Overall Study||2
4955593|NCT02774941|12189664|P1|NOT COMPLETED|Overall Study||1
4955594|NCT02774941|12189663|P2|COMPLETED|Overall Study||108
4955595|NCT02774941|12189664|P1|COMPLETED|Overall Study||109
4955596|NCT02774941|12189663|P2|Subjects Excluded|Overall Study||2
4955597|NCT02774941|12189664|P1|Subjects Excluded|Overall Study||1
4955598|NCT02774941|12189663|P2|STARTED|Overall Study||110
4955599|NCT02774941|12189664|P1|STARTED|Overall Study||110
4955600|NCT02774850|12189674|P1|NOT COMPLETED|Overall Study||35
4955601|NCT02774850|12189674|P1|COMPLETED|Overall Study||575
4955602|NCT02774850|12189674|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
4955603|NCT02774850|12189674|P1|Intensification III|Overall Study||48
4955604|NCT02774850|12189674|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
4955605|NCT02774850|12189674|P1|Intensification II|Overall Study||342
4955606|NCT02774850|12189674|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
4955607|NCT02774850|12189674|P1|Intensification I|Overall Study||476
4955608|NCT02774850|12189674|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
4955609|NCT02774850|12189674|P1|Induction II|Overall Study||564
4955610|NCT02774850|12189674|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
4955611|NCT02774850|12189674|P1|Induction I|Overall Study||585
4955612|NCT02774850|12189674|P1|STARTED|Overall Study||610
4955613|NCT02774798|12189685|P3|NOT COMPLETED|Overall Study||0
4955614|NCT02774798|12189686|P2|NOT COMPLETED|Overall Study||0
4955615|NCT02774798|12189687|P1|NOT COMPLETED|Overall Study||0
4955616|NCT02774798|12189685|P3|COMPLETED|Overall Study||7
4955617|NCT02774798|12189686|P2|COMPLETED|Overall Study||17
4955618|NCT02774798|12189687|P1|COMPLETED|Overall Study||7
4955619|NCT02774798|12189685|P3|STARTED|Overall Study||7
4955620|NCT02774798|12189686|P2|STARTED|Overall Study||17
4955621|NCT02774798|12189687|P1|STARTED|Overall Study||7
4955622|NCT02774681|12189713|P1|NOT COMPLETED|Follow-Up for 3 Years||12
4955623|NCT02774681|12189713|P1|COMPLETED|Follow-Up for 3 Years||0
4955624|NCT02774681|12189713|P1|STARTED|Follow-Up for 3 Years||12
4955625|NCT02774681|12189713|P1|NOT COMPLETED|Treatment on Study||7
4955626|NCT02774681|12189713|P1|COMPLETED|Treatment on Study||5
4955627|NCT02774681|12189713|P1|Went on to Start Cycle 3|Treatment on Study||5
4955628|NCT02774681|12189713|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
4955629|NCT02774681|12189713|P1|STARTED|Treatment on Study||12
4955630|NCT02774616|12189725|P3|NOT COMPLETED|Overall Study||3
4955631|NCT02774616|12189726|P2|NOT COMPLETED|Overall Study||11
4955632|NCT02774616|12189727|P1|NOT COMPLETED|Overall Study||15
4955633|NCT02774616|12189725|P3|COMPLETED|Overall Study||13
4955634|NCT02774616|12189726|P2|COMPLETED|Overall Study||156
4955635|NCT02774616|12189727|P1|COMPLETED|Overall Study||80
4955636|NCT02774616|12189725|P3|Other|Overall Study||1
4955637|NCT02774616|12189726|P2|Other|Overall Study||4
4955638|NCT02774616|12189727|P1|Other|Overall Study||2
4955639|NCT02774616|12189725|P3|Device Explanted|Overall Study||1
4955640|NCT02774616|12189726|P2|Device Explanted|Overall Study||1
4955641|NCT02774616|12189727|P1|Device Explanted|Overall Study||2
4955642|NCT02774616|12189725|P3|Lost to FU|Overall Study||0
4955643|NCT02774616|12189726|P2|Lost to FU|Overall Study||0
4955644|NCT02774616|12189727|P1|Lost to FU|Overall Study||2
4955645|NCT02774616|12189725|P3|Withdrew Consent|Overall Study||0
4955646|NCT02774616|12189726|P2|Withdrew Consent|Overall Study||3
4955647|NCT02774616|12189727|P1|Withdrew Consent|Overall Study||3
4955648|NCT02774616|12189725|P3|Died|Overall Study||1
4955649|NCT02774616|12189726|P2|Died|Overall Study||3
4955650|NCT02774616|12189727|P1|Died|Overall Study||6
4955651|NCT02774616|12189725|P3|STARTED|Overall Study||16
4955652|NCT02774616|12189726|P2|STARTED|Overall Study||167
4955653|NCT02774616|12189727|P1|STARTED|Overall Study||95
4955654|NCT02774343|12189740|P2|NOT COMPLETED|Overall Study||3
4955655|NCT02774343|12189741|P1|NOT COMPLETED|Overall Study||6
4955656|NCT02774343|12189740|P2|COMPLETED|Overall Study||12
4955657|NCT02774343|12189741|P1|COMPLETED|Overall Study||9
4955658|NCT02774343|12189740|P2|Received at Least One Capsule|Overall Study||14
4955659|NCT02774343|12189741|P1|Received at Least One Capsule|Overall Study||12
4955660|NCT02774343|12189740|P2|STARTED|Overall Study||15
4955661|NCT02774343|12189741|P1|STARTED|Overall Study||15
4955662|NCT02774278|12189777|P1|NOT COMPLETED|Overall Study||264
4955663|NCT02774278|12189777|P1|COMPLETED|Overall Study||0
4955664|NCT02774278|12189777|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
4955665|NCT02774278|12189777|P1|STARTED|Overall Study||264
4955666|NCT02774265|12189787|P2|NOT COMPLETED|Overall Study||6
4955667|NCT02774265|12189788|P1|NOT COMPLETED|Overall Study||13
4955668|NCT02774265|12189787|P2|COMPLETED|Overall Study||159
4955669|NCT02774265|12189788|P1|COMPLETED|Overall Study||151
4955670|NCT02774265|12189787|P2|STARTED|Overall Study||165
4955671|NCT02774265|12189788|P1|STARTED|Overall Study||164
4955672|NCT02774213|12189798|P1|NOT COMPLETED|Overall Study||19
4955673|NCT02774213|12189798|P1|COMPLETED|Overall Study||55
4955674|NCT02774213|12189798|P1|STARTED|Overall Study||74
4955675|NCT02774148|12189811|P2|NOT COMPLETED|Overall Study||0
4955676|NCT02774148|12189812|P1|NOT COMPLETED|Overall Study||0
4955677|NCT02774148|12189811|P2|COMPLETED|Overall Study||0
4955678|NCT02774148|12189812|P1|COMPLETED|Overall Study||0
4955679|NCT02774148|12189811|P2|STARTED|Overall Study||0
4955680|NCT02774148|12189812|P1|STARTED|Overall Study||0
4955681|NCT02773836|12189832|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955682|NCT02773836|12189833|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955683|NCT02773836|12189834|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955684|NCT02773836|12189835|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955685|NCT02773836|12189836|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955686|NCT02773836|12189837|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
4955687|NCT02773836|12189832|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
4955688|NCT02773836|12189833|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
4955689|NCT02773836|12189834|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
4955690|NCT02773836|12189835|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
4955691|NCT02773836|12189836|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
4955692|NCT02773836|12189837|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
4955693|NCT02773836|12189832|P6|STARTED|Wave 2- Post-TPD Implementation||998
4955694|NCT02773836|12189833|P5|STARTED|Wave 2- Post-TPD Implementation||1002
4955695|NCT02773836|12189834|P4|STARTED|Wave 2- Post-TPD Implementation||1010
4955696|NCT02773836|12189835|P3|STARTED|Wave 2- Post-TPD Implementation||1003
4955697|NCT02773836|12189836|P2|STARTED|Wave 2- Post-TPD Implementation||1013
4955698|NCT02773836|12189837|P1|STARTED|Wave 2- Post-TPD Implementation||1010
4955699|NCT02773836|12189832|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955700|NCT02773836|12189833|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955701|NCT02773836|12189834|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955702|NCT02773836|12189835|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955703|NCT02773836|12189836|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955704|NCT02773836|12189837|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
4955705|NCT02773836|12189832|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
4955706|NCT02773836|12189833|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
4955707|NCT02773836|12189834|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
4955708|NCT02773836|12189835|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
4955709|NCT02773836|12189836|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
4955710|NCT02773836|12189837|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
4955711|NCT02773836|12189832|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
4955712|NCT02773836|12189833|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
4955713|NCT02773836|12189834|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
4955714|NCT02773836|12189835|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
4955715|NCT02773836|12189836|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
4955716|NCT02773836|12189837|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
4955717|NCT02773758|12189925|P2|NOT COMPLETED|Overall Study||0
4955718|NCT02773758|12189926|P1|NOT COMPLETED|Overall Study||0
4955719|NCT02773758|12189925|P2|COMPLETED|Overall Study||70
4955720|NCT02773758|12189926|P1|COMPLETED|Overall Study||71
4955721|NCT02773758|12189925|P2|STARTED|Overall Study||70
4955722|NCT02773758|12189926|P1|STARTED|Overall Study||71
4955723|NCT02773576|12189938|P2|NOT COMPLETED|Overall Study||0
4955724|NCT02773576|12189939|P1|NOT COMPLETED|Overall Study||0
4955725|NCT02773576|12189938|P2|COMPLETED|Overall Study||0
4955726|NCT02773576|12189939|P1|COMPLETED|Overall Study||0
4955727|NCT02773576|12189938|P2|STARTED|Overall Study||0
4955728|NCT02773576|12189939|P1|STARTED|Overall Study||0
4955729|NCT02773537|12189952|P3|NOT COMPLETED|Overall Study||4
4955730|NCT02773537|12189953|P2|NOT COMPLETED|Overall Study||1
4955731|NCT02773537|12189954|P1|NOT COMPLETED|Overall Study||0
4955732|NCT02773537|12189952|P3|COMPLETED|Overall Study||21
4955733|NCT02773537|12189953|P2|COMPLETED|Overall Study||24
4955734|NCT02773537|12189954|P1|COMPLETED|Overall Study||25
4955735|NCT02773537|12189952|P3|STARTED|Overall Study||25
4955736|NCT02773537|12189953|P2|STARTED|Overall Study||25
4955737|NCT02773537|12189954|P1|STARTED|Overall Study||25
4955738|NCT02773446|12189989|P6|NOT COMPLETED|Second Admission||0
4955739|NCT02773446|12189990|P5|NOT COMPLETED|Second Admission||0
4955740|NCT02773446|12189991|P4|NOT COMPLETED|Second Admission||0
4955741|NCT02773446|12189992|P3|NOT COMPLETED|Second Admission||0
4955742|NCT02773446|12189993|P2|NOT COMPLETED|Second Admission||0
4955743|NCT02773446|12189994|P1|NOT COMPLETED|Second Admission||0
4955744|NCT02773446|12189989|P6|COMPLETED|Second Admission||19
4955745|NCT02773446|12189990|P5|COMPLETED|Second Admission||11
4955746|NCT02773446|12189991|P4|COMPLETED|Second Admission||0
4955747|NCT02773446|12189992|P3|COMPLETED|Second Admission||0
4955748|NCT02773446|12189993|P2|COMPLETED|Second Admission||0
4955749|NCT02773446|12189994|P1|COMPLETED|Second Admission||0
4955750|NCT02773446|12189989|P6|STARTED|Second Admission||19
4955751|NCT02773446|12189990|P5|STARTED|Second Admission||11
4955752|NCT02773446|12189991|P4|STARTED|Second Admission||0
4955753|NCT02773446|12189992|P3|STARTED|Second Admission||0
4955754|NCT02773446|12189993|P2|STARTED|Second Admission||0
4955755|NCT02773446|12189994|P1|STARTED|Second Admission||0
4955756|NCT02773446|12189989|P6|NOT COMPLETED|First Admission||0
4955757|NCT02773446|12189990|P5|NOT COMPLETED|First Admission||0
4955758|NCT02773446|12189991|P4|NOT COMPLETED|First Admission||1
4955759|NCT02773446|12189992|P3|NOT COMPLETED|First Admission||0
4955760|NCT02773446|12189993|P2|NOT COMPLETED|First Admission||0
4955761|NCT02773446|12189994|P1|NOT COMPLETED|First Admission||1
4955762|NCT02773446|12189989|P6|COMPLETED|First Admission||0
4955763|NCT02773446|12189990|P5|COMPLETED|First Admission||0
4955764|NCT02773446|12189991|P4|COMPLETED|First Admission||6
4955765|NCT02773446|12189992|P3|COMPLETED|First Admission||7
4955766|NCT02773446|12189993|P2|COMPLETED|First Admission||7
4955767|NCT02773446|12189994|P1|COMPLETED|First Admission||6
4955768|NCT02773446|12189989|P6|STARTED|First Admission||0
4955769|NCT02773446|12189990|P5|STARTED|First Admission||0
4955770|NCT02773446|12189991|P4|STARTED|First Admission||7
4955771|NCT02773446|12189992|P3|STARTED|First Admission||7
4955772|NCT02773446|12189993|P2|STARTED|First Admission||7
4955773|NCT02773446|12189994|P1|STARTED|First Admission||7
4955774|NCT02773368|12190035|P2|NOT COMPLETED|Overall Study||4
4955775|NCT02773368|12190036|P1|NOT COMPLETED|Overall Study||10
4955776|NCT02773368|12190035|P2|COMPLETED|Overall Study||206
4955777|NCT02773368|12190036|P1|COMPLETED|Overall Study||200
4955778|NCT02773368|12190035|P2|Exposed|Overall Study||210
4955779|NCT02773368|12190036|P1|Exposed|Overall Study||209
4955780|NCT02773368|12190035|P2|STARTED|Overall Study||210
4955781|NCT02773368|12190036|P1|STARTED|Overall Study||210
4955782|NCT02772757|12190109|P3|NOT COMPLETED|Overall Study||5
4955783|NCT02772757|12190110|P2|NOT COMPLETED|Overall Study||3
4955784|NCT02772757|12190111|P1|NOT COMPLETED|Overall Study||1
4955785|NCT02772757|12190109|P3|COMPLETED|Overall Study||21
4955786|NCT02772757|12190110|P2|COMPLETED|Overall Study||21
4955787|NCT02772757|12190111|P1|COMPLETED|Overall Study||21
4955788|NCT02772757|12190109|P3|STARTED|Overall Study||26
4955789|NCT02772757|12190110|P2|STARTED|Overall Study||24
4955790|NCT02772757|12190111|P1|STARTED|Overall Study||22
4955791|NCT02772666|12190128|P1|NOT COMPLETED|SFT Then O-Glass||0
4955792|NCT02772666|12190128|P1|COMPLETED|SFT Then O-Glass||44
4955793|NCT02772666|12190128|P1|STARTED|SFT Then O-Glass||44
4955794|NCT02772666|12190128|P1|NOT COMPLETED|O-Glas Then SFT||0
4955795|NCT02772666|12190128|P1|COMPLETED|O-Glas Then SFT||44
4955796|NCT02772666|12190128|P1|STARTED|O-Glas Then SFT||44
4955797|NCT02772432|12190135|P2|NOT COMPLETED|Overall Study||1
4955798|NCT02772432|12190136|P1|NOT COMPLETED|Overall Study||12
4955799|NCT02772432|12190135|P2|COMPLETED|Overall Study||21
4955800|NCT02772432|12190136|P1|COMPLETED|Overall Study||19
4955801|NCT02772432|12190135|P2|STARTED|Overall Study||22
4955802|NCT02772432|12190136|P1|STARTED|Overall Study||31
4955803|NCT02771522|12190146|P1|NOT COMPLETED|Overall Study||8
4955804|NCT02771522|12190146|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
4955805|NCT02771522|12190146|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
4955806|NCT02771366|12190157|P2|NOT COMPLETED|Period 2 (Crossover)||0
4955807|NCT02771366|12190158|P1|NOT COMPLETED|Period 2 (Crossover)||2
4955808|NCT02771366|12190157|P2|COMPLETED|Period 2 (Crossover)||13
4955809|NCT02771366|12190158|P1|COMPLETED|Period 2 (Crossover)||13
4955810|NCT02771366|12190157|P2|STARTED|Period 2 (Crossover)||13
4955811|NCT02771366|12190158|P1|STARTED|Period 2 (Crossover)||15
4955812|NCT02771366|12190157|P2|NOT COMPLETED|Period 1||2
4955813|NCT02771366|12190158|P1|NOT COMPLETED|Period 1||0
4955814|NCT02771366|12190157|P2|COMPLETED|Period 1||13
4955815|NCT02771366|12190158|P1|COMPLETED|Period 1||15
4955816|NCT02771366|12190157|P2|STARTED|Period 1||15
4955817|NCT02771366|12190158|P1|STARTED|Period 1||15
4955818|NCT02771275|12190165|P1|NOT COMPLETED|Overall Study||13
4955819|NCT02771275|12190165|P1|COMPLETED|Overall Study||0
4955820|NCT02771275|12190165|P1|STARTED|Overall Study||13
4955821|NCT02771145|12190173|P1|NOT COMPLETED|Overall Study||4
4955822|NCT02771145|12190173|P1|COMPLETED|Overall Study||86
4955823|NCT02771145|12190173|P1|STARTED|Overall Study||90
4955824|NCT02771093|12190214|P2|NOT COMPLETED|Overall Study||0
4955825|NCT02771093|12190215|P1|NOT COMPLETED|Overall Study||0
4955826|NCT02771093|12190214|P2|COMPLETED|Overall Study||14
4955827|NCT02771093|12190215|P1|COMPLETED|Overall Study||13
4955828|NCT02771093|12190214|P2|STARTED|Overall Study||14
4955829|NCT02771093|12190215|P1|STARTED|Overall Study||13
4955830|NCT02770846|12190269|P2|NOT COMPLETED|Overall Study||0
4955831|NCT02770846|12190270|P1|NOT COMPLETED|Overall Study||0
4955832|NCT02770846|12190269|P2|COMPLETED|Overall Study||25
4955833|NCT02770846|12190270|P1|COMPLETED|Overall Study||25
4955834|NCT02770846|12190269|P2|STARTED|Overall Study||25
4955835|NCT02770846|12190270|P1|STARTED|Overall Study||25
4955836|NCT02770625|12190294|P1|NOT COMPLETED|Overall Study||0
4955837|NCT02770625|12190294|P1|COMPLETED|Overall Study||8
4955838|NCT02770625|12190294|P1|STARTED|Overall Study||8
4955839|NCT02770612|12190307|P1|NOT COMPLETED|Overall Study||1
4955840|NCT02770612|12190307|P1|COMPLETED|Overall Study||50
4955841|NCT02770612|12190307|P1|STARTED|Overall Study||51
4955842|NCT02770547|12190313|P2|NOT COMPLETED|Overall Study||1
4955843|NCT02770547|12190314|P1|NOT COMPLETED|Overall Study||1
4955844|NCT02770547|12190313|P2|COMPLETED|Overall Study||15
4955845|NCT02770547|12190314|P1|COMPLETED|Overall Study||15
4955846|NCT02770547|12190313|P2|STARTED|Overall Study||16
4955847|NCT02770547|12190314|P1|STARTED|Overall Study||16
4955848|NCT02770521|12190336|P6|NOT COMPLETED|Period Three||0
4955849|NCT02770521|12190337|P5|NOT COMPLETED|Period Three||0
4955850|NCT02770521|12190338|P4|NOT COMPLETED|Period Three||0
4955851|NCT02770521|12190339|P3|NOT COMPLETED|Period Three||0
4955852|NCT02770521|12190340|P2|NOT COMPLETED|Period Three||0
4955853|NCT02770521|12190341|P1|NOT COMPLETED|Period Three||0
4955854|NCT02770521|12190336|P6|COMPLETED|Period Three||9
4955855|NCT02770521|12190337|P5|COMPLETED|Period Three||2
4955856|NCT02770521|12190338|P4|COMPLETED|Period Three||2
4955857|NCT02770521|12190339|P3|COMPLETED|Period Three||2
4955858|NCT02770521|12190340|P2|COMPLETED|Period Three||0
4955859|NCT02770521|12190341|P1|COMPLETED|Period Three||0
4955860|NCT02770521|12190336|P6|Received Study Drug|Period Three||9
4955861|NCT02770521|12190337|P5|Received Study Drug|Period Three||2
4955862|NCT02770521|12190338|P4|Received Study Drug|Period Three||2
4955863|NCT02770521|12190339|P3|Received Study Drug|Period Three||2
4955864|NCT02770521|12190340|P2|Received Study Drug|Period Three||0
4955865|NCT02770521|12190341|P1|Received Study Drug|Period Three||0
4955866|NCT02770521|12190336|P6|STARTED|Period Three||9
4955867|NCT02770521|12190337|P5|STARTED|Period Three||2
4955868|NCT02770521|12190338|P4|STARTED|Period Three||2
4955869|NCT02770521|12190339|P3|STARTED|Period Three||2
4955870|NCT02770521|12190340|P2|STARTED|Period Three|Not applicable. Part A only had two periods.|0
4955871|NCT02770521|12190341|P1|STARTED|Period Three|Not applicable. Part A only had two periods.|0
4955872|NCT02770521|12190336|P6|NOT COMPLETED|Period Two||0
4955873|NCT02770521|12190337|P5|NOT COMPLETED|Period Two||0
4955874|NCT02770521|12190338|P4|NOT COMPLETED|Period Two||0
4955875|NCT02770521|12190339|P3|NOT COMPLETED|Period Two||0
4955876|NCT02770521|12190340|P2|NOT COMPLETED|Period Two||0
4955877|NCT02770521|12190341|P1|NOT COMPLETED|Period Two||0
4955878|NCT02770521|12190336|P6|COMPLETED|Period Two||9
4955879|NCT02770521|12190337|P5|COMPLETED|Period Two||2
4955880|NCT02770521|12190338|P4|COMPLETED|Period Two||2
4955881|NCT02770521|12190339|P3|COMPLETED|Period Two||2
4955882|NCT02770521|12190340|P2|COMPLETED|Period Two||4
4955883|NCT02770521|12190341|P1|COMPLETED|Period Two||4
4955884|NCT02770521|12190336|P6|Received Study Drug|Period Two||9
4955885|NCT02770521|12190337|P5|Received Study Drug|Period Two||2
4955886|NCT02770521|12190338|P4|Received Study Drug|Period Two||2
4955887|NCT02770521|12190339|P3|Received Study Drug|Period Two||2
4955888|NCT02770521|12190340|P2|Received Study Drug|Period Two||4
4955889|NCT02770521|12190341|P1|Received Study Drug|Period Two||4
4955890|NCT02770521|12190336|P6|STARTED|Period Two||9
4955891|NCT02770521|12190337|P5|STARTED|Period Two||2
4955892|NCT02770521|12190338|P4|STARTED|Period Two||2
4955893|NCT02770521|12190339|P3|STARTED|Period Two||2
4955894|NCT02770521|12190340|P2|STARTED|Period Two||4
4955895|NCT02770521|12190341|P1|STARTED|Period Two||4
4955896|NCT02770521|12190336|P6|NOT COMPLETED|Period One||0
4955897|NCT02770521|12190337|P5|NOT COMPLETED|Period One||0
4955898|NCT02770521|12190338|P4|NOT COMPLETED|Period One||0
4955899|NCT02770521|12190339|P3|NOT COMPLETED|Period One||0
4955900|NCT02770521|12190340|P2|NOT COMPLETED|Period One||0
4955901|NCT02770521|12190341|P1|NOT COMPLETED|Period One||0
4955902|NCT02770521|12190336|P6|COMPLETED|Period One||9
4955903|NCT02770521|12190337|P5|COMPLETED|Period One||2
4955904|NCT02770521|12190338|P4|COMPLETED|Period One||2
4955905|NCT02770521|12190339|P3|COMPLETED|Period One||2
4955906|NCT02770521|12190340|P2|COMPLETED|Period One||4
4955907|NCT02770521|12190341|P1|COMPLETED|Period One||4
4955908|NCT02770521|12190336|P6|Received Study Drug|Period One||9
4955909|NCT02770521|12190337|P5|Received Study Drug|Period One||2
4955910|NCT02770521|12190338|P4|Received Study Drug|Period One||2
4955911|NCT02770521|12190339|P3|Received Study Drug|Period One||2
4955912|NCT02770521|12190340|P2|Received Study Drug|Period One||4
4955913|NCT02770521|12190341|P1|Received Study Drug|Period One||4
4955914|NCT02770521|12190336|P6|STARTED|Period One||9
4955915|NCT02770521|12190337|P5|STARTED|Period One||2
4955916|NCT02770521|12190338|P4|STARTED|Period One||2
4955917|NCT02770521|12190339|P3|STARTED|Period One||2
4955918|NCT02770521|12190340|P2|STARTED|Period One||4
4955919|NCT02770521|12190341|P1|STARTED|Period One||4
4955920|NCT02770287|12190363|P1|NOT COMPLETED|Overall Study||0
4955921|NCT02770287|12190363|P1|COMPLETED|Overall Study||11
4955922|NCT02770287|12190363|P1|STARTED|Overall Study||11
4955923|NCT02770248|12190372|P2|NOT COMPLETED|Overall Study||2
4955924|NCT02770248|12190373|P1|NOT COMPLETED|Overall Study||0
4955925|NCT02770248|12190372|P2|COMPLETED|Overall Study||61
4955926|NCT02770248|12190373|P1|COMPLETED|Overall Study||62
4955927|NCT02770248|12190372|P2|STARTED|Overall Study||63
4955928|NCT02770248|12190373|P1|STARTED|Overall Study||62
4955929|NCT02770014|12190385|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
4955930|NCT02770014|12190385|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
4955931|NCT02770014|12190385|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
4955932|NCT02770014|12190385|P1|NOT COMPLETED|Plasma Genotyping||0
4955933|NCT02770014|12190385|P1|COMPLETED|Plasma Genotyping||43
4955934|NCT02770014|12190385|P1|STARTED|Plasma Genotyping||43
4955935|NCT02769858|12190391|P1|NOT COMPLETED|Overall Study||2
4955936|NCT02769858|12190391|P1|COMPLETED|Overall Study||8
4955937|NCT02769858|12190391|P1|STARTED|Overall Study||10
4955938|NCT02769702|12190397|P1|NOT COMPLETED|Overall Study||0
4955939|NCT02769702|12190397|P1|COMPLETED|Overall Study||2
4955940|NCT02769702|12190397|P1|STARTED|Overall Study||2
4955941|NCT02769624|12190402|P2|NOT COMPLETED|Overall Study||1
4955942|NCT02769624|12190403|P1|NOT COMPLETED|Overall Study||0
4955943|NCT02769624|12190402|P2|COMPLETED|Overall Study||7
4955944|NCT02769624|12190403|P1|COMPLETED|Overall Study||7
4955945|NCT02769624|12190402|P2|STARTED|Overall Study||8
4955946|NCT02769624|12190403|P1|STARTED|Overall Study||7
4955947|NCT02769442|12190421|P2|NOT COMPLETED|Overall Study||0
4955948|NCT02769442|12190422|P1|NOT COMPLETED|Overall Study||0
4955949|NCT02769442|12190421|P2|COMPLETED|Overall Study||291
4955950|NCT02769442|12190422|P1|COMPLETED|Overall Study||309
4955951|NCT02769442|12190421|P2|STARTED|Overall Study||291
4955952|NCT02769442|12190422|P1|STARTED|Overall Study||309
4955953|NCT02769312|12190432|P2|NOT COMPLETED|Follow-up||1
4955954|NCT02769312|12190433|P1|NOT COMPLETED|Follow-up||1
4955955|NCT02769312|12190432|P2|COMPLETED|Follow-up||23
4955956|NCT02769312|12190433|P1|COMPLETED|Follow-up||22
4955957|NCT02769312|12190432|P2|STARTED|Follow-up||24
4955958|NCT02769312|12190433|P1|STARTED|Follow-up||23
4955959|NCT02769312|12190432|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
4955960|NCT02769312|12190433|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
4955961|NCT02769312|12190432|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
4955962|NCT02769312|12190433|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
4955963|NCT02769312|12190432|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
4955964|NCT02769312|12190433|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
4955965|NCT02769312|12190432|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
4955966|NCT02769312|12190433|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
4955967|NCT02769312|12190432|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
4955968|NCT02769312|12190433|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
4955969|NCT02769312|12190432|P2|STARTED|Double-Blind (0-2 Weeks)||25
4955970|NCT02769312|12190433|P1|STARTED|Double-Blind (0-2 Weeks)||25
4955971|NCT02769247|12190450|P4|NOT COMPLETED|Overall Study||1
4955972|NCT02769247|12190451|P3|NOT COMPLETED|Overall Study||1
4955973|NCT02769247|12190452|P2|NOT COMPLETED|Overall Study||0
4955974|NCT02769247|12190453|P1|NOT COMPLETED|Overall Study||2
4955975|NCT02769247|12190450|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
4955976|NCT02769247|12190451|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
4955977|NCT02769247|12190452|P2|COMPLETED|Overall Study||40
4955978|NCT02769247|12190453|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
4955979|NCT02769247|12190450|P4|STARTED|Overall Study||40
4955980|NCT02769247|12190451|P3|STARTED|Overall Study||40
4955981|NCT02769247|12190452|P2|STARTED|Overall Study||40
4955982|NCT02769247|12190453|P1|STARTED|Overall Study||40
4955983|NCT02769065|12190521|P30|NOT COMPLETED|Overall Study||0
4955984|NCT02769065|12190522|P29|NOT COMPLETED|Overall Study||0
4955985|NCT02769065|12190523|P28|NOT COMPLETED|Overall Study||0
4955986|NCT02769065|12190524|P27|NOT COMPLETED|Overall Study||0
4955987|NCT02769065|12190525|P26|NOT COMPLETED|Overall Study||0
4955988|NCT02769065|12190526|P25|NOT COMPLETED|Overall Study||0
4955989|NCT02769065|12190527|P24|NOT COMPLETED|Overall Study||0
4955990|NCT02769065|12190528|P23|NOT COMPLETED|Overall Study||0
4955991|NCT02769065|12190529|P22|NOT COMPLETED|Overall Study||0
4955992|NCT02769065|12190530|P21|NOT COMPLETED|Overall Study||0
4955993|NCT02769065|12190531|P20|NOT COMPLETED|Overall Study||0
4955994|NCT02769065|12190532|P19|NOT COMPLETED|Overall Study||0
4955995|NCT02769065|12190533|P18|NOT COMPLETED|Overall Study||0
4955996|NCT02769065|12190534|P17|NOT COMPLETED|Overall Study||0
4955997|NCT02769065|12190535|P16|NOT COMPLETED|Overall Study||0
4955998|NCT02769065|12190536|P15|NOT COMPLETED|Overall Study||0
4955999|NCT02769065|12190537|P14|NOT COMPLETED|Overall Study||0
4956000|NCT02769065|12190538|P13|NOT COMPLETED|Overall Study||0
4956001|NCT02769065|12190539|P12|NOT COMPLETED|Overall Study||0
4956002|NCT02769065|12190540|P11|NOT COMPLETED|Overall Study||1
4956003|NCT02769065|12190541|P10|NOT COMPLETED|Overall Study||0
4956004|NCT02769065|12190542|P9|NOT COMPLETED|Overall Study||0
4956005|NCT02769065|12190543|P8|NOT COMPLETED|Overall Study||0
4956006|NCT02769065|12190544|P7|NOT COMPLETED|Overall Study||1
4956007|NCT02769065|12190545|P6|NOT COMPLETED|Overall Study||0
4956008|NCT02769065|12190546|P5|NOT COMPLETED|Overall Study||0
4956009|NCT02769065|12190547|P4|NOT COMPLETED|Overall Study||0
4956010|NCT02769065|12190548|P3|NOT COMPLETED|Overall Study||0
4956011|NCT02769065|12190549|P2|NOT COMPLETED|Overall Study||0
4956012|NCT02769065|12190550|P1|NOT COMPLETED|Overall Study||1
4956013|NCT02769065|12190521|P30|COMPLETED|Overall Study||6
4956014|NCT02769065|12190522|P29|COMPLETED|Overall Study||6
4956015|NCT02769065|12190523|P28|COMPLETED|Overall Study||5
4956016|NCT02769065|12190524|P27|COMPLETED|Overall Study||9
4956017|NCT02769065|12190525|P26|COMPLETED|Overall Study||9
4956018|NCT02769065|12190526|P25|COMPLETED|Overall Study||6
4956019|NCT02769065|12190527|P24|COMPLETED|Overall Study||6
4956020|NCT02769065|12190528|P23|COMPLETED|Overall Study||4
4956021|NCT02769065|12190529|P22|COMPLETED|Overall Study||4
4956022|NCT02769065|12190530|P21|COMPLETED|Overall Study||4
4956023|NCT02769065|12190531|P20|COMPLETED|Overall Study||0
4956024|NCT02769065|12190532|P19|COMPLETED|Overall Study||5
4956025|NCT02769065|12190533|P18|COMPLETED|Overall Study||5
4956026|NCT02769065|12190534|P17|COMPLETED|Overall Study||5
4956027|NCT02769065|12190535|P16|COMPLETED|Overall Study||3
4956028|NCT02769065|12190536|P15|COMPLETED|Overall Study||6
4956029|NCT02769065|12190537|P14|COMPLETED|Overall Study||6
4956030|NCT02769065|12190538|P13|COMPLETED|Overall Study||6
4956031|NCT02769065|12190539|P12|COMPLETED|Overall Study||6
4956032|NCT02769065|12190540|P11|COMPLETED|Overall Study||5
4956033|NCT02769065|12190541|P10|COMPLETED|Overall Study||6
4956034|NCT02769065|12190542|P9|COMPLETED|Overall Study||6
4956035|NCT02769065|12190543|P8|COMPLETED|Overall Study||6
4956036|NCT02769065|12190544|P7|COMPLETED|Overall Study||6
4956037|NCT02769065|12190545|P6|COMPLETED|Overall Study||6
4956038|NCT02769065|12190546|P5|COMPLETED|Overall Study||6
4956039|NCT02769065|12190547|P4|COMPLETED|Overall Study||6
4956040|NCT02769065|12190548|P3|COMPLETED|Overall Study||6
4956041|NCT02769065|12190549|P2|COMPLETED|Overall Study||6
4956042|NCT02769065|12190550|P1|COMPLETED|Overall Study||16
4956043|NCT02769065|12190521|P30|STARTED|Overall Study||6
4956044|NCT02769065|12190522|P29|STARTED|Overall Study||6
4956045|NCT02769065|12190523|P28|STARTED|Overall Study||5
4956046|NCT02769065|12190524|P27|STARTED|Overall Study||9
4956047|NCT02769065|12190525|P26|STARTED|Overall Study||9
4956048|NCT02769065|12190526|P25|STARTED|Overall Study||6
4956049|NCT02769065|12190527|P24|STARTED|Overall Study||6
4956050|NCT02769065|12190528|P23|STARTED|Overall Study||4
4956051|NCT02769065|12190529|P22|STARTED|Overall Study||4
4956052|NCT02769065|12190530|P21|STARTED|Overall Study||4
4956053|NCT02769065|12190531|P20|STARTED|Overall Study||0
4956054|NCT02769065|12190532|P19|STARTED|Overall Study||5
4956055|NCT02769065|12190533|P18|STARTED|Overall Study||5
4956056|NCT02769065|12190534|P17|STARTED|Overall Study||5
4956057|NCT02769065|12190535|P16|STARTED|Overall Study||3
4956058|NCT02769065|12190536|P15|STARTED|Overall Study||6
4956059|NCT02769065|12190537|P14|STARTED|Overall Study||6
4956060|NCT02769065|12190538|P13|STARTED|Overall Study||6
4956061|NCT02769065|12190539|P12|STARTED|Overall Study||6
4956062|NCT02769065|12190540|P11|STARTED|Overall Study||6
4956063|NCT02769065|12190541|P10|STARTED|Overall Study||6
4956064|NCT02769065|12190542|P9|STARTED|Overall Study||6
4956065|NCT02769065|12190543|P8|STARTED|Overall Study||6
4956066|NCT02769065|12190544|P7|STARTED|Overall Study||7
4956067|NCT02769065|12190545|P6|STARTED|Overall Study||6
4956068|NCT02769065|12190546|P5|STARTED|Overall Study||6
4956069|NCT02769065|12190547|P4|STARTED|Overall Study||6
4956070|NCT02769065|12190548|P3|STARTED|Overall Study||6
4956071|NCT02769065|12190549|P2|STARTED|Overall Study||6
4956072|NCT02769065|12190550|P1|STARTED|Overall Study||17
4956073|NCT02768870|12190960|P1|NOT COMPLETED|Overall Study||26
4956074|NCT02768870|12190960|P1|COMPLETED|Overall Study||0
4956075|NCT02768870|12190960|P1|Implanted With Device|Overall Study||24
4956076|NCT02768870|12190960|P1|STARTED|Overall Study||26
4956077|NCT02768753|12190970|P2|NOT COMPLETED|Overall Study||0
4956078|NCT02768753|12190971|P1|NOT COMPLETED|Overall Study||0
4956079|NCT02768753|12190970|P2|COMPLETED|Overall Study||30
4956080|NCT02768753|12190971|P1|COMPLETED|Overall Study||30
4956081|NCT02768753|12190970|P2|STARTED|Overall Study||30
4956082|NCT02768753|12190971|P1|STARTED|Overall Study||30
4956083|NCT02768558|12190985|P2|NOT COMPLETED|Overall Study||0
4956084|NCT02768558|12190986|P1|NOT COMPLETED|Overall Study||0
4956085|NCT02768558|12190985|P2|COMPLETED|Overall Study||5
4956086|NCT02768558|12190986|P1|COMPLETED|Overall Study||3
4956087|NCT02768558|12190985|P2|Eligible|Overall Study||5
4956088|NCT02768558|12190986|P1|Eligible|Overall Study||3
4956089|NCT02768558|12190985|P2|STARTED|Overall Study||5
4956090|NCT02768558|12190986|P1|STARTED|Overall Study||3
4956091|NCT02768194|12191002|P6|NOT COMPLETED|Period 3||0
4956092|NCT02768194|12191003|P5|NOT COMPLETED|Period 3||0
4956093|NCT02768194|12191004|P4|NOT COMPLETED|Period 3||0
4956094|NCT02768194|12191005|P3|NOT COMPLETED|Period 3||0
4956095|NCT02768194|12191006|P2|NOT COMPLETED|Period 3||1
4956096|NCT02768194|12191007|P1|NOT COMPLETED|Period 3||0
4956097|NCT02768194|12191002|P6|COMPLETED|Period 3||4
4956098|NCT02768194|12191003|P5|COMPLETED|Period 3||4
4956099|NCT02768194|12191004|P4|COMPLETED|Period 3||3
4956100|NCT02768194|12191005|P3|COMPLETED|Period 3||4
4956101|NCT02768194|12191006|P2|COMPLETED|Period 3||3
4956102|NCT02768194|12191007|P1|COMPLETED|Period 3||3
4956103|NCT02768194|12191002|P6|STARTED|Period 3||4
4956104|NCT02768194|12191003|P5|STARTED|Period 3||4
4956105|NCT02768194|12191004|P4|STARTED|Period 3||3
4956106|NCT02768194|12191005|P3|STARTED|Period 3||4
4956107|NCT02768194|12191006|P2|STARTED|Period 3||4
4956108|NCT02768194|12191007|P1|STARTED|Period 3||3
4956109|NCT02768194|12191002|P6|NOT COMPLETED|Period 2||0
4956110|NCT02768194|12191003|P5|NOT COMPLETED|Period 2||0
4956111|NCT02768194|12191004|P4|NOT COMPLETED|Period 2||0
4956112|NCT02768194|12191005|P3|NOT COMPLETED|Period 2||0
4956113|NCT02768194|12191006|P2|NOT COMPLETED|Period 2||0
4956114|NCT02768194|12191007|P1|NOT COMPLETED|Period 2||1
4956115|NCT02768194|12191002|P6|COMPLETED|Period 2||4
4956116|NCT02768194|12191003|P5|COMPLETED|Period 2||4
4956117|NCT02768194|12191004|P4|COMPLETED|Period 2||3
4956118|NCT02768194|12191005|P3|COMPLETED|Period 2||4
4956119|NCT02768194|12191006|P2|COMPLETED|Period 2||4
4956120|NCT02768194|12191007|P1|COMPLETED|Period 2||3
4956121|NCT02768194|12191002|P6|STARTED|Period 2||4
4956122|NCT02768194|12191003|P5|STARTED|Period 2||4
4956123|NCT02768194|12191004|P4|STARTED|Period 2||3
4956124|NCT02768194|12191005|P3|STARTED|Period 2||4
4956125|NCT02768194|12191006|P2|STARTED|Period 2||4
4956126|NCT02768194|12191007|P1|STARTED|Period 2||4
4956127|NCT02768194|12191002|P6|NOT COMPLETED|Period 1||0
4956128|NCT02768194|12191003|P5|NOT COMPLETED|Period 1||0
4956129|NCT02768194|12191004|P4|NOT COMPLETED|Period 1||1
4956130|NCT02768194|12191005|P3|NOT COMPLETED|Period 1||0
4956131|NCT02768194|12191006|P2|NOT COMPLETED|Period 1||0
4956132|NCT02768194|12191007|P1|NOT COMPLETED|Period 1||0
4956133|NCT02768194|12191002|P6|COMPLETED|Period 1||4
4956134|NCT02768194|12191003|P5|COMPLETED|Period 1||4
4956135|NCT02768194|12191004|P4|COMPLETED|Period 1||3
4956136|NCT02768194|12191005|P3|COMPLETED|Period 1||4
4956137|NCT02768194|12191006|P2|COMPLETED|Period 1||4
4956138|NCT02768194|12191007|P1|COMPLETED|Period 1||4
4956139|NCT02768194|12191002|P6|STARTED|Period 1||4
4956140|NCT02768194|12191003|P5|STARTED|Period 1||4
4956141|NCT02768194|12191004|P4|STARTED|Period 1||4
4956142|NCT02768194|12191005|P3|STARTED|Period 1||4
4956143|NCT02768194|12191006|P2|STARTED|Period 1||4
4956144|NCT02768194|12191007|P1|STARTED|Period 1||4
4956145|NCT02768129|12191020|P2|NOT COMPLETED|Overall Study||0
4956146|NCT02768129|12191021|P1|NOT COMPLETED|Overall Study||0
4956147|NCT02768129|12191020|P2|COMPLETED|Overall Study||10
4956148|NCT02768129|12191021|P1|COMPLETED|Overall Study||11
4956149|NCT02768129|12191020|P2|STARTED|Overall Study||10
4956150|NCT02768129|12191021|P1|STARTED|Overall Study||11
4956151|NCT02768103|12191029|P1|NOT COMPLETED|Overall Study||1
4956152|NCT02768103|12191029|P1|COMPLETED|Overall Study||4
4956153|NCT02768103|12191029|P1|STARTED|Overall Study||5
4956154|NCT02767947|12191036|P2|NOT COMPLETED|Overall Study||0
4956155|NCT02767947|12191037|P1|NOT COMPLETED|Overall Study||0
4956156|NCT02767947|12191036|P2|COMPLETED|Overall Study||15
4956157|NCT02767947|12191037|P1|COMPLETED|Overall Study||60
4956158|NCT02767947|12191036|P2|Pharmacokinetic (PK) Population|Overall Study||3
4956159|NCT02767947|12191037|P1|Pharmacokinetic (PK) Population|Overall Study||12
4956160|NCT02767947|12191036|P2|Safety Population|Overall Study||15
4956161|NCT02767947|12191037|P1|Safety Population|Overall Study||60
4956162|NCT02767947|12191036|P2|STARTED|Overall Study||15
4956163|NCT02767947|12191037|P1|STARTED|Overall Study||60
4956164|NCT02767843|12191045|P1|NOT COMPLETED|Overall Study||0
4956165|NCT02767843|12191045|P1|COMPLETED|Overall Study||4
4956166|NCT02767843|12191045|P1|STARTED|Overall Study||4
4956167|NCT02767765|12191051|P1|NOT COMPLETED|Overall Study||11
4956168|NCT02767765|12191051|P1|COMPLETED|Overall Study||50
4956169|NCT02767765|12191051|P1|STARTED|Overall Study||61
4956170|NCT02767609|12191060|P1|NOT COMPLETED|Overall Study||0
4956171|NCT02767609|12191060|P1|COMPLETED|Overall Study||1
4956172|NCT02767609|12191060|P1|STARTED|Overall Study||1
4956173|NCT02767531|12191064|P2|NOT COMPLETED|Period 4||0
4956174|NCT02767531|12191065|P1|NOT COMPLETED|Period 4||0
4956175|NCT02767531|12191064|P2|COMPLETED|Period 4||1
4956176|NCT02767531|12191065|P1|COMPLETED|Period 4||1
4956177|NCT02767531|12191064|P2|STARTED|Period 4|Orlistat Therapy|1
4956178|NCT02767531|12191065|P1|STARTED|Period 4|Off Orlistat|1
4956179|NCT02767531|12191064|P2|NOT COMPLETED|Period 3||0
4956180|NCT02767531|12191065|P1|NOT COMPLETED|Period 3||0
4956181|NCT02767531|12191064|P2|COMPLETED|Period 3||1
4956182|NCT02767531|12191065|P1|COMPLETED|Period 3||1
4956183|NCT02767531|12191064|P2|STARTED|Period 3|Off Orlistat|1
4956184|NCT02767531|12191065|P1|STARTED|Period 3|Orlistat Therapy|1
4956185|NCT02767531|12191064|P2|NOT COMPLETED|Period 2||0
4956186|NCT02767531|12191065|P1|NOT COMPLETED|Period 2||0
4956187|NCT02767531|12191064|P2|COMPLETED|Period 2||1
4956188|NCT02767531|12191065|P1|COMPLETED|Period 2||1
4956189|NCT02767531|12191064|P2|STARTED|Period 2|Orlistat Therapy|1
4956190|NCT02767531|12191065|P1|STARTED|Period 2|Off Orlistat|1
4956191|NCT02767531|12191064|P2|NOT COMPLETED|Period 1||0
4956192|NCT02767531|12191065|P1|NOT COMPLETED|Period 1||0
4956193|NCT02767531|12191064|P2|COMPLETED|Period 1||1
4956194|NCT02767531|12191065|P1|COMPLETED|Period 1||1
4956195|NCT02767531|12191064|P2|STARTED|Period 1|Off Orlistat|1
4956196|NCT02767531|12191065|P1|STARTED|Period 1|Orlistat therapy|1
4956197|NCT02767427|12191073|P2|NOT COMPLETED|Overall Study||0
4956198|NCT02767427|12191074|P1|NOT COMPLETED|Overall Study||0
4956199|NCT02767427|12191073|P2|COMPLETED|Overall Study||19
4956200|NCT02767427|12191074|P1|COMPLETED|Overall Study||21
4956201|NCT02767427|12191073|P2|STARTED|Overall Study||19
4956202|NCT02767427|12191074|P1|STARTED|Overall Study||21
4956203|NCT02767388|12191083|P3|NOT COMPLETED|Overall Study||3
4956204|NCT02767388|12191084|P2|NOT COMPLETED|Overall Study||5
4956205|NCT02767388|12191085|P1|NOT COMPLETED|Overall Study||7
4956206|NCT02767388|12191083|P3|COMPLETED|Overall Study||12
4956207|NCT02767388|12191084|P2|COMPLETED|Overall Study||10
4956208|NCT02767388|12191085|P1|COMPLETED|Overall Study||8
4956209|NCT02767388|12191083|P3|STARTED|Overall Study||15
4956210|NCT02767388|12191084|P2|STARTED|Overall Study||15
4956211|NCT02767388|12191085|P1|STARTED|Overall Study||15
4956212|NCT02767271|12191104|P2|NOT COMPLETED|Overall Study||0
4956213|NCT02767271|12191105|P1|NOT COMPLETED|Overall Study||0
4956214|NCT02767271|12191104|P2|COMPLETED|Overall Study||15
4956215|NCT02767271|12191105|P1|COMPLETED|Overall Study||15
4956216|NCT02767271|12191104|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
4956217|NCT02767271|12191105|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
4956218|NCT02767271|12191104|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
4956219|NCT02767271|12191105|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
4956220|NCT02767271|12191104|P2|Safety Population|Overall Study||15
4956221|NCT02767271|12191105|P1|Safety Population|Overall Study||15
4956222|NCT02767271|12191104|P2|STARTED|Overall Study||15
4956223|NCT02767271|12191105|P1|STARTED|Overall Study||15
4956224|NCT02767128|12191115|P1|NOT COMPLETED|Overall Study||0
4956225|NCT02767128|12191115|P1|COMPLETED|Overall Study||14
4956226|NCT02767128|12191115|P1|Shohl's + Triferic Immediately|Overall Study||14
4956227|NCT02767128|12191115|P1|Shohl's + Triferic After 10 Min|Overall Study||14
4956228|NCT02767128|12191115|P1|Triferic|Overall Study||14
4956229|NCT02767128|12191115|P1|Shohl's + Fer-In-Sol|Overall Study||14
4956230|NCT02767128|12191115|P1|Fer-In-Sol|Overall Study||14
4956231|NCT02767128|12191115|P1|Baseline|Overall Study||14
4956232|NCT02767128|12191115|P1|STARTED|Overall Study||14
4956233|NCT02767011|12191143|P2|NOT COMPLETED|Overall Study||0
4956234|NCT02767011|12191144|P1|NOT COMPLETED|Overall Study||0
4956235|NCT02767011|12191143|P2|COMPLETED|Overall Study||14
4956236|NCT02767011|12191144|P1|COMPLETED|Overall Study||16
4956237|NCT02767011|12191143|P2|STARTED|Overall Study||14
4956238|NCT02767011|12191144|P1|STARTED|Overall Study||16
4956239|NCT02766907|12191168|P2|NOT COMPLETED|Overall Study||1
4956240|NCT02766907|12191169|P1|NOT COMPLETED|Overall Study||1
4956241|NCT02766907|12191168|P2|COMPLETED|Overall Study||9
4956242|NCT02766907|12191169|P1|COMPLETED|Overall Study||9
4956243|NCT02766907|12191168|P2|STARTED|Overall Study||10
4956244|NCT02766907|12191169|P1|STARTED|Overall Study||10
4956245|NCT02766777|12191177|P1|NOT COMPLETED|Overall Study||34
4956246|NCT02766777|12191177|P1|COMPLETED|Overall Study||53
4956247|NCT02766777|12191177|P1|Treated (Safety [SAF] Population)|Overall Study||87
4956248|NCT02766777|12191177|P1|STARTED|Overall Study||87
4956249|NCT02766673|12191181|P6|NOT COMPLETED|Overall Study||1
4956250|NCT02766673|12191182|P5|NOT COMPLETED|Overall Study||0
4956251|NCT02766673|12191183|P4|NOT COMPLETED|Overall Study||0
4956252|NCT02766673|12191184|P3|NOT COMPLETED|Overall Study||0
4956253|NCT02766673|12191185|P2|NOT COMPLETED|Overall Study||0
4956254|NCT02766673|12191186|P1|NOT COMPLETED|Overall Study||1
4956255|NCT02766673|12191181|P6|COMPLETED|Overall Study||3
4956256|NCT02766673|12191182|P5|COMPLETED|Overall Study||4
4956257|NCT02766673|12191183|P4|COMPLETED|Overall Study||4
4956258|NCT02766673|12191184|P3|COMPLETED|Overall Study||4
4956259|NCT02766673|12191185|P2|COMPLETED|Overall Study||4
4956260|NCT02766673|12191186|P1|COMPLETED|Overall Study||3
4956261|NCT02766673|12191181|P6|STARTED|Overall Study||4
4956262|NCT02766673|12191182|P5|STARTED|Overall Study||4
4956263|NCT02766673|12191183|P4|STARTED|Overall Study||4
4956264|NCT02766673|12191184|P3|STARTED|Overall Study||4
4956265|NCT02766673|12191185|P2|STARTED|Overall Study||4
4956266|NCT02766673|12191186|P1|STARTED|Overall Study||4
4956267|NCT02766608|12191202|P5|NOT COMPLETED|Overall Study||29
4956268|NCT02766608|12191203|P4|NOT COMPLETED|Overall Study||37
4956269|NCT02766608|12191204|P3|NOT COMPLETED|Overall Study||90
4956270|NCT02766608|12191205|P2|NOT COMPLETED|Overall Study||70
4956271|NCT02766608|12191206|P1|NOT COMPLETED|Overall Study||79
4956272|NCT02766608|12191202|P5|COMPLETED|Overall Study||190
4956273|NCT02766608|12191203|P4|COMPLETED|Overall Study||169
4956274|NCT02766608|12191204|P3|COMPLETED|Overall Study||554
4956275|NCT02766608|12191205|P2|COMPLETED|Overall Study||567
4956276|NCT02766608|12191206|P1|COMPLETED|Overall Study||576
4956277|NCT02766608|12191202|P5|STARTED|Overall Study||219
4956278|NCT02766608|12191203|P4|STARTED|Overall Study||206
4956279|NCT02766608|12191204|P3|STARTED|Overall Study||644
4956280|NCT02766608|12191205|P2|STARTED|Overall Study||637
4956281|NCT02766608|12191206|P1|STARTED|Overall Study||655
4956282|NCT02766517|12191283|P3|NOT COMPLETED|Overall Study||0
4956283|NCT02766517|12191284|P2|NOT COMPLETED|Overall Study||0
4956284|NCT02766517|12191285|P1|NOT COMPLETED|Overall Study||0
4956285|NCT02766517|12191283|P3|COMPLETED|Overall Study||9
4956286|NCT02766517|12191284|P2|COMPLETED|Overall Study||9
4956287|NCT02766517|12191285|P1|COMPLETED|Overall Study||19
4956288|NCT02766517|12191283|P3|STARTED|Overall Study||9
4956289|NCT02766517|12191284|P2|STARTED|Overall Study||9
4956290|NCT02766517|12191285|P1|STARTED|Overall Study||19
4956291|NCT02766400|12191298|P2|NOT COMPLETED|Overall Study||2
4956292|NCT02766400|12191299|P1|NOT COMPLETED|Overall Study||2
4956293|NCT02766400|12191298|P2|COMPLETED|Overall Study||20
4956294|NCT02766400|12191299|P1|COMPLETED|Overall Study||19
4956295|NCT02766400|12191298|P2|STARTED|Overall Study||22
4956296|NCT02766400|12191299|P1|STARTED|Overall Study||21
4956297|NCT02766374|12191307|P2|NOT COMPLETED|Overall Study||3
4956298|NCT02766374|12191308|P1|NOT COMPLETED|Overall Study||10
4956299|NCT02766374|12191307|P2|COMPLETED|Overall Study||30
4956300|NCT02766374|12191308|P1|COMPLETED|Overall Study||25
4956301|NCT02766374|12191307|P2|STARTED|Overall Study||33
4956302|NCT02766374|12191308|P1|STARTED|Overall Study||35
4956303|NCT02766283|12191314|P1|NOT COMPLETED|Overall Study||27
4956304|NCT02766283|12191314|P1|COMPLETED|Overall Study||816
4956305|NCT02766283|12191314|P1|STARTED|Overall Study||843
4956306|NCT02766244|12191338|P1|NOT COMPLETED|Overall Study||0
4956307|NCT02766244|12191338|P1|COMPLETED|Overall Study||3
4956308|NCT02766244|12191338|P1|STARTED|Overall Study||3
4956309|NCT02766088|12191347|P1|NOT COMPLETED|Overall Study||506
4956310|NCT02766088|12191347|P1|COMPLETED|Overall Study||344
4956311|NCT02766088|12191347|P1|STARTED|Overall Study||850
4956312|NCT02766023|12191362|P2|NOT COMPLETED|Overall Study||17
4956313|NCT02766023|12191363|P1|NOT COMPLETED|Overall Study||30
4956314|NCT02766023|12191362|P2|COMPLETED|Overall Study||59
4956315|NCT02766023|12191363|P1|COMPLETED|Overall Study||122
4956316|NCT02766023|12191362|P2|STARTED|Overall Study||76
4956317|NCT02766023|12191363|P1|STARTED|Overall Study||152
4956318|NCT02765490|12191413|P2|NOT COMPLETED|Overall Study||3
4956319|NCT02765490|12191414|P1|NOT COMPLETED|Overall Study||1
4956320|NCT02765490|12191413|P2|COMPLETED|Overall Study||179
4956321|NCT02765490|12191414|P1|COMPLETED|Overall Study||182
4956322|NCT02765490|12191413|P2|STARTED|Overall Study||182
4956323|NCT02765490|12191414|P1|STARTED|Overall Study||183
4956324|NCT02765269|12191432|P2|NOT COMPLETED|Overall Study||0
4956325|NCT02765269|12191433|P1|NOT COMPLETED|Overall Study||0
4956326|NCT02765269|12191432|P2|COMPLETED|Overall Study||21
4956327|NCT02765269|12191433|P1|COMPLETED|Overall Study||25
4956328|NCT02765269|12191432|P2|STARTED|Overall Study||21
4956329|NCT02765269|12191433|P1|STARTED|Overall Study||25
4956330|NCT02765100|12191447|P2|NOT COMPLETED|Overall Study||2
4956331|NCT02765100|12191448|P1|NOT COMPLETED|Overall Study||1
4956332|NCT02765100|12191447|P2|COMPLETED|Overall Study||10
4956333|NCT02765100|12191448|P1|COMPLETED|Overall Study||8
4956334|NCT02765100|12191447|P2|STARTED|Overall Study||12
4956335|NCT02765100|12191448|P1|STARTED|Overall Study||9
4956336|NCT02764970|12191456|P2|NOT COMPLETED|Overall Study||0
4956337|NCT02764970|12191457|P1|NOT COMPLETED|Overall Study||0
4956338|NCT02764970|12191456|P2|COMPLETED|Overall Study||47
4956339|NCT02764970|12191457|P1|COMPLETED|Overall Study||65
4956340|NCT02764970|12191456|P2|STARTED|Overall Study||47
4956341|NCT02764970|12191457|P1|STARTED|Overall Study||65
4956342|NCT02764775|12191469|P1|NOT COMPLETED|Overall Study||6
4956343|NCT02764775|12191469|P1|COMPLETED|Overall Study||8
4956344|NCT02764775|12191469|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
4956345|NCT02764697|12191473|P1|NOT COMPLETED|Overall Study||3
4956346|NCT02764697|12191473|P1|COMPLETED|Overall Study||2
4956347|NCT02764697|12191473|P1|STARTED|Overall Study||5
4956348|NCT02764229|12191478|P1|NOT COMPLETED|Overall Study||102
4956349|NCT02764229|12191478|P1|COMPLETED|Overall Study||10
4956350|NCT02764229|12191478|P1|STARTED|Overall Study||112
4956351|NCT02764190|12191484|P2|NOT COMPLETED|Overall Study||13
4956352|NCT02764190|12191485|P1|NOT COMPLETED|Overall Study||17
4956353|NCT02764190|12191484|P2|COMPLETED|Overall Study||122
4956354|NCT02764190|12191485|P1|COMPLETED|Overall Study||150
4956355|NCT02764190|12191484|P2|12 Month Follow-up|Overall Study||122
4956356|NCT02764190|12191485|P1|12 Month Follow-up|Overall Study||150
4956357|NCT02764190|12191484|P2|6 Month Follow-up|Overall Study||128
4956358|NCT02764190|12191485|P1|6 Month Follow-up|Overall Study||155
4956359|NCT02764190|12191484|P2|3 Month Follow-up|Overall Study||128
4956360|NCT02764190|12191485|P1|3 Month Follow-up|Overall Study||156
4956361|NCT02764190|12191484|P2|1 Day Follow-up|Overall Study||131
4956362|NCT02764190|12191485|P1|1 Day Follow-up|Overall Study||161
4956363|NCT02764190|12191484|P2|STARTED|Overall Study||135
4956364|NCT02764190|12191485|P1|STARTED|Overall Study||167
4956365|NCT02764151|12191533|P4|NOT COMPLETED|Overall Study||3
4956366|NCT02764151|12191534|P3|NOT COMPLETED|Overall Study||0
4956367|NCT02764151|12191535|P2|NOT COMPLETED|Overall Study||0
4956368|NCT02764151|12191536|P1|NOT COMPLETED|Overall Study||0
4956369|NCT02764151|12191533|P4|COMPLETED|Overall Study||5
4956370|NCT02764151|12191534|P3|COMPLETED|Overall Study||3
4956371|NCT02764151|12191535|P2|COMPLETED|Overall Study||4
4956372|NCT02764151|12191536|P1|COMPLETED|Overall Study||2
4956373|NCT02764151|12191533|P4|STARTED|Overall Study||8
4956374|NCT02764151|12191534|P3|STARTED|Overall Study||3
4956375|NCT02764151|12191535|P2|STARTED|Overall Study||4
4956376|NCT02764151|12191536|P1|STARTED|Overall Study||2
4956377|NCT02763865|12191660|P2|NOT COMPLETED|Overall Study||0
4956378|NCT02763865|12191661|P1|NOT COMPLETED|Overall Study||0
4956379|NCT02763865|12191660|P2|COMPLETED|Overall Study||5
4956380|NCT02763865|12191661|P1|COMPLETED|Overall Study||5
4956381|NCT02763865|12191660|P2|STARTED|Overall Study||5
4956382|NCT02763865|12191661|P1|STARTED|Overall Study||5
4956383|NCT02763644|12191675|P2|NOT COMPLETED|Overall Study||2
4956384|NCT02763644|12191676|P1|NOT COMPLETED|Overall Study||3
4956385|NCT02763644|12191675|P2|COMPLETED|Overall Study||2
4956386|NCT02763644|12191676|P1|COMPLETED|Overall Study||0
4956387|NCT02763644|12191675|P2|STARTED|Overall Study||4
4956388|NCT02763644|12191676|P1|STARTED|Overall Study||3
4956389|NCT02763579|12191696|P2|NOT COMPLETED|Overall Study||202
4956390|NCT02763579|12191697|P1|NOT COMPLETED|Overall Study||201
4956391|NCT02763579|12191696|P2|COMPLETED|Overall Study||0
4956392|NCT02763579|12191697|P1|COMPLETED|Overall Study||0
4956393|NCT02763579|12191696|P2|STARTED|Overall Study||202
4956394|NCT02763579|12191697|P1|STARTED|Overall Study||201
4956395|NCT02763566|12191709|P4|NOT COMPLETED|Overall Study||14
4956396|NCT02763566|12191710|P3|NOT COMPLETED|Overall Study||54
4956397|NCT02763566|12191711|P2|NOT COMPLETED|Overall Study||39
4956398|NCT02763566|12191712|P1|NOT COMPLETED|Overall Study||118
4956399|NCT02763566|12191709|P4|COMPLETED|Overall Study||39
4956400|NCT02763566|12191710|P3|COMPLETED|Overall Study||50
4956401|NCT02763566|12191711|P2|COMPLETED|Overall Study||60
4956402|NCT02763566|12191712|P1|COMPLETED|Overall Study||89
4956403|NCT02763566|12191709|P4|STARTED|Overall Study||53
4956404|NCT02763566|12191710|P3|STARTED|Overall Study||104
4956405|NCT02763566|12191711|P2|STARTED|Overall Study||99
4956406|NCT02763566|12191712|P1|STARTED|Overall Study||207
4956407|NCT02763254|12191740|P1|NOT COMPLETED|Overall Study||1
4956408|NCT02763254|12191740|P1|COMPLETED|Overall Study||0
4956409|NCT02763254|12191740|P1|STARTED|Overall Study||1
4956410|NCT02763189|12191747|P2|NOT COMPLETED|Overall Study||2
4956411|NCT02763189|12191748|P1|NOT COMPLETED|Overall Study||0
4956412|NCT02763189|12191747|P2|COMPLETED|Overall Study||2
4956413|NCT02763189|12191748|P1|COMPLETED|Overall Study||4
4956414|NCT02763189|12191747|P2|STARTED|Overall Study||4
4956415|NCT02763189|12191748|P1|STARTED|Overall Study||4
4956416|NCT02763124|12191756|P1|NOT COMPLETED|Overall Study||0
4956417|NCT02763124|12191756|P1|COMPLETED|Overall Study||18
4956418|NCT02763124|12191756|P1|STARTED|Overall Study||18
4956419|NCT02762877|12191765|P2|NOT COMPLETED|Overall Study||0
4956420|NCT02762877|12191766|P1|NOT COMPLETED|Overall Study||0
4956421|NCT02762877|12191765|P2|COMPLETED|Overall Study||19
4956422|NCT02762877|12191766|P1|COMPLETED|Overall Study||121
4956423|NCT02762877|12191765|P2|STARTED|Overall Study||19
4956424|NCT02762877|12191766|P1|STARTED|Overall Study||121
4956425|NCT02762799|12191777|P4|NOT COMPLETED|Overall Study||0
4956426|NCT02762799|12191778|P3|NOT COMPLETED|Overall Study||1
4956427|NCT02762799|12191779|P2|NOT COMPLETED|Overall Study||0
4956428|NCT02762799|12191780|P1|NOT COMPLETED|Overall Study||0
4956429|NCT02762799|12191777|P4|COMPLETED|Overall Study||12
4956430|NCT02762799|12191778|P3|COMPLETED|Overall Study||11
4956431|NCT02762799|12191779|P2|COMPLETED|Overall Study||18
4956432|NCT02762799|12191780|P1|COMPLETED|Overall Study||18
4956433|NCT02762799|12191777|P4|STARTED|Overall Study||12
4956434|NCT02762799|12191778|P3|STARTED|Overall Study||12
4956435|NCT02762799|12191779|P2|STARTED|Overall Study||18
4956436|NCT02762799|12191780|P1|STARTED|Overall Study||18
4956437|NCT02762578|12191852|P2|NOT COMPLETED|Overall Study||10
4956438|NCT02762578|12191853|P1|NOT COMPLETED|Overall Study||15
4956439|NCT02762578|12191852|P2|COMPLETED|Overall Study||172
4956440|NCT02762578|12191853|P1|COMPLETED|Overall Study||346
4956441|NCT02762578|12191852|P2|Exposed|Overall Study||181
4956442|NCT02762578|12191853|P1|Exposed|Overall Study||360
4956443|NCT02762578|12191852|P2|STARTED|Overall Study||182
4956444|NCT02762578|12191853|P1|STARTED|Overall Study||361
4956445|NCT02762500|12191955|P2|NOT COMPLETED|Overall Study||3
4956446|NCT02762500|12191956|P1|NOT COMPLETED|Overall Study||2
4956447|NCT02762500|12191955|P2|COMPLETED|Overall Study||59
4956448|NCT02762500|12191956|P1|COMPLETED|Overall Study||60
4956449|NCT02762500|12191955|P2|STARTED|Overall Study||62
4956450|NCT02762500|12191956|P1|STARTED|Overall Study||62
4956451|NCT02762370|12191976|P2|NOT COMPLETED|Overall Study||0
4956452|NCT02762370|12191977|P1|NOT COMPLETED|Overall Study||1
4956453|NCT02762370|12191976|P2|COMPLETED|Overall Study||15
4956454|NCT02762370|12191977|P1|COMPLETED|Overall Study||17
4956455|NCT02762370|12191976|P2|STARTED|Overall Study||15
4956456|NCT02762370|12191977|P1|STARTED|Overall Study||18
4956457|NCT02762331|12191997|P2|NOT COMPLETED|Overall Study||0
4956458|NCT02762331|12191998|P1|NOT COMPLETED|Overall Study||0
4956459|NCT02762331|12191997|P2|COMPLETED|Overall Study||2
4956460|NCT02762331|12191998|P1|COMPLETED|Overall Study||4
4956461|NCT02762331|12191997|P2|STARTED|Overall Study||2
4956462|NCT02762331|12191998|P1|STARTED|Overall Study||4
4956463|NCT02762084|12192017|P3|NOT COMPLETED|Overall Study||1
4956464|NCT02762084|12192018|P2|NOT COMPLETED|Overall Study||0
4956465|NCT02762084|12192019|P1|NOT COMPLETED|Overall Study||1
4956466|NCT02762084|12192017|P3|COMPLETED|Overall Study||4
4956467|NCT02762084|12192018|P2|COMPLETED|Overall Study||6
4956468|NCT02762084|12192019|P1|COMPLETED|Overall Study||5
4956469|NCT02762084|12192017|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
4956470|NCT02762084|12192018|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
4956471|NCT02762084|12192019|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
4956472|NCT02762084|12192017|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
4956473|NCT02762084|12192018|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
4956474|NCT02762084|12192019|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
4956475|NCT02762084|12192017|P3|STARTED|Overall Study||5
4956476|NCT02762084|12192018|P2|STARTED|Overall Study||6
4956477|NCT02762084|12192019|P1|STARTED|Overall Study||6
4956478|NCT02762071|12192059|P2|NOT COMPLETED|Overall Study||0
4956479|NCT02762071|12192060|P1|NOT COMPLETED|Overall Study||0
4956480|NCT02762071|12192059|P2|COMPLETED|Overall Study||54
4956481|NCT02762071|12192060|P1|COMPLETED|Overall Study||54
4956482|NCT02762071|12192059|P2|STARTED|Overall Study||54
4956483|NCT02762071|12192060|P1|STARTED|Overall Study||54
4956484|NCT02761980|12192080|P4|NOT COMPLETED|Overall Study||6
4956485|NCT02761980|12192081|P3|NOT COMPLETED|Overall Study||6
4956486|NCT02761980|12192082|P2|NOT COMPLETED|Overall Study||7
4956487|NCT02761980|12192083|P1|NOT COMPLETED|Overall Study||4
4956488|NCT02761980|12192080|P4|COMPLETED|Overall Study||81
4956489|NCT02761980|12192081|P3|COMPLETED|Overall Study||81
4956490|NCT02761980|12192082|P2|COMPLETED|Overall Study||80
4956491|NCT02761980|12192083|P1|COMPLETED|Overall Study||25
4956492|NCT02761980|12192080|P4|STARTED|Overall Study||87
4956493|NCT02761980|12192081|P3|STARTED|Overall Study||87
4956494|NCT02761980|12192082|P2|STARTED|Overall Study||87
4956495|NCT02761980|12192083|P1|STARTED|Overall Study||29
4956496|NCT02761967|12192115|P2|NOT COMPLETED|Overall Study||6
4956497|NCT02761967|12192116|P1|NOT COMPLETED|Overall Study||5
4956498|NCT02761967|12192115|P2|COMPLETED|Overall Study||64
4956499|NCT02761967|12192116|P1|COMPLETED|Overall Study||65
4956500|NCT02761967|12192115|P2|STARTED|Overall Study||70
4956501|NCT02761967|12192116|P1|STARTED|Overall Study||70
4956502|NCT02761733|12192130|P4|NOT COMPLETED|Overall Study||15
4956503|NCT02761733|12192131|P3|NOT COMPLETED|Overall Study||27
4956504|NCT02761733|12192132|P2|NOT COMPLETED|Overall Study||21
4956505|NCT02761733|12192133|P1|NOT COMPLETED|Overall Study||30
4956506|NCT02761733|12192130|P4|COMPLETED|Overall Study||45
4956507|NCT02761733|12192131|P3|COMPLETED|Overall Study||33
4956508|NCT02761733|12192132|P2|COMPLETED|Overall Study||39
4956509|NCT02761733|12192133|P1|COMPLETED|Overall Study||30
4956510|NCT02761733|12192130|P4|9/30/2015|Overall Study||50
4956511|NCT02761733|12192131|P3|9/30/2015|Overall Study||33
4956512|NCT02761733|12192132|P2|9/30/2015|Overall Study||44
4956513|NCT02761733|12192133|P1|9/30/2015|Overall Study||40
4956514|NCT02761733|12192130|P4|3/31/2015|Overall Study||50
4956515|NCT02761733|12192131|P3|3/31/2015|Overall Study||43
4956516|NCT02761733|12192132|P2|3/31/2015|Overall Study||47
4956517|NCT02761733|12192133|P1|3/31/2015|Overall Study||48
4956518|NCT02761733|12192130|P4|9/30/2014|Overall Study||55
4956519|NCT02761733|12192131|P3|9/30/2014|Overall Study||48
4956520|NCT02761733|12192132|P2|9/30/2014|Overall Study||56
4956521|NCT02761733|12192133|P1|9/30/2014|Overall Study||53
4956522|NCT02761733|12192130|P4|STARTED|Overall Study||60
4956523|NCT02761733|12192131|P3|STARTED|Overall Study||60
4956524|NCT02761733|12192132|P2|STARTED|Overall Study||60
4956525|NCT02761733|12192133|P1|STARTED|Overall Study||60
4956526|NCT02761642|12192163|P1|NOT COMPLETED|Overall Study||70
4956527|NCT02761642|12192163|P1|COMPLETED|Overall Study||130
4956528|NCT02761642|12192163|P1|Treated|Overall Study||197
4956529|NCT02761642|12192163|P1|STARTED|Overall Study||200
4956530|NCT02761629|12192176|P2|NOT COMPLETED|Overall Study||32
4956531|NCT02761629|12192177|P1|NOT COMPLETED|Overall Study||27
4956532|NCT02761629|12192176|P2|COMPLETED|Overall Study||58
4956533|NCT02761629|12192177|P1|COMPLETED|Overall Study||63
4956534|NCT02761629|12192176|P2|Treated|Overall Study||86
4956535|NCT02761629|12192177|P1|Treated|Overall Study||82
4956536|NCT02761629|12192176|P2|STARTED|Overall Study||90
4956537|NCT02761629|12192177|P1|STARTED|Overall Study||90
4956538|NCT02761252|12192200|P3|NOT COMPLETED|Overall Study||14
4956539|NCT02761252|12192201|P2|NOT COMPLETED|Overall Study||8
4956540|NCT02761252|12192202|P1|NOT COMPLETED|Overall Study||10
4956541|NCT02761252|12192200|P3|COMPLETED|Overall Study||123
4956542|NCT02761252|12192201|P2|COMPLETED|Overall Study||132
4956543|NCT02761252|12192202|P1|COMPLETED|Overall Study||133
4956544|NCT02761252|12192200|P3|STARTED|Overall Study||137
4956545|NCT02761252|12192201|P2|STARTED|Overall Study||140
4956546|NCT02761252|12192202|P1|STARTED|Overall Study||143
4956547|NCT02760927|12192224|P1|NOT COMPLETED|Overall Study||1
4956548|NCT02760927|12192224|P1|COMPLETED|Overall Study||3
4956549|NCT02760927|12192224|P1|STARTED|Overall Study||4
4956550|NCT02760810|12192232|P1|NOT COMPLETED|Overall Study||1
4956551|NCT02760810|12192232|P1|COMPLETED|Overall Study||29
4956552|NCT02760810|12192232|P1|STARTED|Overall Study||30
4956553|NCT02760654|12192240|P2|NOT COMPLETED|Overall Study||6
4956554|NCT02760654|12192241|P1|NOT COMPLETED|Overall Study||7
4956555|NCT02760654|12192240|P2|COMPLETED|Overall Study||24
4956556|NCT02760654|12192241|P1|COMPLETED|Overall Study||23
4956557|NCT02760654|12192240|P2|STARTED|Overall Study||30
4956558|NCT02760654|12192241|P1|STARTED|Overall Study||30
4956559|NCT02760602|12192267|P2|NOT COMPLETED|Overall Study||13
4956560|NCT02760602|12192268|P1|NOT COMPLETED|Overall Study||13
4956561|NCT02760602|12192267|P2|COMPLETED|Overall Study||0
4956562|NCT02760602|12192268|P1|COMPLETED|Overall Study||0
4956563|NCT02760602|12192267|P2|STARTED|Overall Study||13
4956564|NCT02760602|12192268|P1|STARTED|Overall Study||13
4956565|NCT02760277|12192310|P4|NOT COMPLETED|6.0 mg/kg/Day||0
4956566|NCT02760277|12192311|P3|NOT COMPLETED|6.0 mg/kg/Day||0
4956567|NCT02760277|12192312|P2|NOT COMPLETED|6.0 mg/kg/Day||0
4956568|NCT02760277|12192313|P1|NOT COMPLETED|6.0 mg/kg/Day||0
4956569|NCT02760277|12192310|P4|COMPLETED|6.0 mg/kg/Day||12
4956570|NCT02760277|12192311|P3|COMPLETED|6.0 mg/kg/Day||0
4956571|NCT02760277|12192312|P2|COMPLETED|6.0 mg/kg/Day||0
4956572|NCT02760277|12192313|P1|COMPLETED|6.0 mg/kg/Day||0
4956573|NCT02760277|12192310|P4|STARTED|6.0 mg/kg/Day||12
4956574|NCT02760277|12192311|P3|STARTED|6.0 mg/kg/Day||0
4956575|NCT02760277|12192312|P2|STARTED|6.0 mg/kg/Day||0
4956576|NCT02760277|12192313|P1|STARTED|6.0 mg/kg/Day||0
4956577|NCT02760277|12192310|P4|NOT COMPLETED|2.0 mg/kg/Day||0
4956578|NCT02760277|12192311|P3|NOT COMPLETED|2.0 mg/kg/Day||0
4956579|NCT02760277|12192312|P2|NOT COMPLETED|2.0 mg/kg/Day||0
4956580|NCT02760277|12192313|P1|NOT COMPLETED|2.0 mg/kg/Day||0
4956581|NCT02760277|12192310|P4|COMPLETED|2.0 mg/kg/Day||0
4956582|NCT02760277|12192311|P3|COMPLETED|2.0 mg/kg/Day||12
4956583|NCT02760277|12192312|P2|COMPLETED|2.0 mg/kg/Day||0
4956584|NCT02760277|12192313|P1|COMPLETED|2.0 mg/kg/Day||0
4956585|NCT02760277|12192310|P4|STARTED|2.0 mg/kg/Day||0
4956586|NCT02760277|12192311|P3|STARTED|2.0 mg/kg/Day||12
4956587|NCT02760277|12192312|P2|STARTED|2.0 mg/kg/Day||0
4956588|NCT02760277|12192313|P1|STARTED|2.0 mg/kg/Day||0
4956589|NCT02760277|12192310|P4|NOT COMPLETED|0.75 mg/kg/Day||0
4956590|NCT02760277|12192311|P3|NOT COMPLETED|0.75 mg/kg/Day||0
4956591|NCT02760277|12192312|P2|NOT COMPLETED|0.75 mg/kg/Day||0
4956592|NCT02760277|12192313|P1|NOT COMPLETED|0.75 mg/kg/Day||0
4956593|NCT02760277|12192310|P4|COMPLETED|0.75 mg/kg/Day||0
4956594|NCT02760277|12192311|P3|COMPLETED|0.75 mg/kg/Day||0
4956595|NCT02760277|12192312|P2|COMPLETED|0.75 mg/kg/Day||12
4956596|NCT02760277|12192313|P1|COMPLETED|0.75 mg/kg/Day||0
4956597|NCT02760277|12192310|P4|STARTED|0.75 mg/kg/Day||0
4956598|NCT02760277|12192311|P3|STARTED|0.75 mg/kg/Day||0
4956599|NCT02760277|12192312|P2|STARTED|0.75 mg/kg/Day||12
4956600|NCT02760277|12192313|P1|STARTED|0.75 mg/kg/Day||0
4956601|NCT02760277|12192310|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956602|NCT02760277|12192311|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956603|NCT02760277|12192312|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956604|NCT02760277|12192313|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956605|NCT02760277|12192310|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956606|NCT02760277|12192311|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956607|NCT02760277|12192312|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
4956608|NCT02760277|12192313|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
4956609|NCT02760277|12192310|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
4956610|NCT02760277|12192311|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
4956611|NCT02760277|12192312|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
4956612|NCT02760277|12192313|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
4956613|NCT02760264|12192387|P4|NOT COMPLETED|6.0 mg/kg/Day||0
4956614|NCT02760264|12192388|P3|NOT COMPLETED|6.0 mg/kg/Day||0
4956615|NCT02760264|12192389|P2|NOT COMPLETED|6.0 mg/kg/Day||0
4956616|NCT02760264|12192390|P1|NOT COMPLETED|6.0 mg/kg/Day||0
4956617|NCT02760264|12192387|P4|COMPLETED|6.0 mg/kg/Day||12
4956618|NCT02760264|12192388|P3|COMPLETED|6.0 mg/kg/Day||0
4956619|NCT02760264|12192389|P2|COMPLETED|6.0 mg/kg/Day||0
4956620|NCT02760264|12192390|P1|COMPLETED|6.0 mg/kg/Day||0
4956621|NCT02760264|12192387|P4|STARTED|6.0 mg/kg/Day||12
4956622|NCT02760264|12192388|P3|STARTED|6.0 mg/kg/Day||0
4956623|NCT02760264|12192389|P2|STARTED|6.0 mg/kg/Day||0
4956624|NCT02760264|12192390|P1|STARTED|6.0 mg/kg/Day||0
4956625|NCT02760264|12192387|P4|NOT COMPLETED|2.0 mg/kg/Day||0
4956626|NCT02760264|12192388|P3|NOT COMPLETED|2.0 mg/kg/Day||0
4956627|NCT02760264|12192389|P2|NOT COMPLETED|2.0 mg/kg/Day||0
4956628|NCT02760264|12192390|P1|NOT COMPLETED|2.0 mg/kg/Day||0
4956629|NCT02760264|12192387|P4|COMPLETED|2.0 mg/kg/Day||0
4956630|NCT02760264|12192388|P3|COMPLETED|2.0 mg/kg/Day||12
4956631|NCT02760264|12192389|P2|COMPLETED|2.0 mg/kg/Day||0
4956632|NCT02760264|12192390|P1|COMPLETED|2.0 mg/kg/Day||0
4956633|NCT02760264|12192387|P4|STARTED|2.0 mg/kg/Day||0
4956634|NCT02760264|12192388|P3|STARTED|2.0 mg/kg/Day||12
4956635|NCT02760264|12192389|P2|STARTED|2.0 mg/kg/Day||0
4956636|NCT02760264|12192390|P1|STARTED|2.0 mg/kg/Day||0
4956637|NCT02760264|12192387|P4|NOT COMPLETED|0.75 mg/kg/Day||0
4956638|NCT02760264|12192388|P3|NOT COMPLETED|0.75 mg/kg/Day||0
4956639|NCT02760264|12192389|P2|NOT COMPLETED|0.75 mg/kg/Day||0
4956640|NCT02760264|12192390|P1|NOT COMPLETED|0.75 mg/kg/Day||0
4956641|NCT02760264|12192387|P4|COMPLETED|0.75 mg/kg/Day||0
4956642|NCT02760264|12192388|P3|COMPLETED|0.75 mg/kg/Day||0
4956643|NCT02760264|12192389|P2|COMPLETED|0.75 mg/kg/Day||12
4956644|NCT02760264|12192390|P1|COMPLETED|0.75 mg/kg/Day||0
4956645|NCT02760264|12192387|P4|STARTED|0.75 mg/kg/Day||0
4956646|NCT02760264|12192388|P3|STARTED|0.75 mg/kg/Day||0
4956647|NCT02760264|12192389|P2|STARTED|0.75 mg/kg/Day||12
4956648|NCT02760264|12192390|P1|STARTED|0.75 mg/kg/Day||0
4956649|NCT02760264|12192387|P4|NOT COMPLETED|0.25 mg/kg/Day||0
4956650|NCT02760264|12192388|P3|NOT COMPLETED|0.25 mg/kg/Day||0
4956651|NCT02760264|12192389|P2|NOT COMPLETED|0.25 mg/kg/Day||0
4956652|NCT02760264|12192390|P1|NOT COMPLETED|0.25 mg/kg/Day||0
4956653|NCT02760264|12192387|P4|COMPLETED|0.25 mg/kg/Day||0
4956654|NCT02760264|12192388|P3|COMPLETED|0.25 mg/kg/Day||0
4956655|NCT02760264|12192389|P2|COMPLETED|0.25 mg/kg/Day||0
4956656|NCT02760264|12192390|P1|COMPLETED|0.25 mg/kg/Day||12
4956657|NCT02760264|12192387|P4|STARTED|0.25 mg/kg/Day||0
4956658|NCT02760264|12192388|P3|STARTED|0.25 mg/kg/Day||0
4956659|NCT02760264|12192389|P2|STARTED|0.25 mg/kg/Day||0
4956660|NCT02760264|12192390|P1|STARTED|0.25 mg/kg/Day||12
4956661|NCT02760069|12192468|P3|NOT COMPLETED|Overall Study||1
4956662|NCT02760069|12192469|P2|NOT COMPLETED|Overall Study||1
4956663|NCT02760069|12192470|P1|NOT COMPLETED|Overall Study||0
4956664|NCT02760069|12192468|P3|COMPLETED|Overall Study||40
4956665|NCT02760069|12192469|P2|COMPLETED|Overall Study||40
4956666|NCT02760069|12192470|P1|COMPLETED|Overall Study||40
4956667|NCT02760069|12192468|P3|STARTED|Overall Study||41
4956668|NCT02760069|12192469|P2|STARTED|Overall Study||41
4956669|NCT02760069|12192470|P1|STARTED|Overall Study||40
4956670|NCT02760056|12192483|P2|NOT COMPLETED|Overall Study||0
4956671|NCT02760056|12192484|P1|NOT COMPLETED|Overall Study||0
4956672|NCT02760056|12192483|P2|COMPLETED|Overall Study||5
4956673|NCT02760056|12192484|P1|COMPLETED|Overall Study||10
4956674|NCT02760056|12192483|P2|STARTED|Overall Study||5
4956675|NCT02760056|12192484|P1|STARTED|Overall Study||10
4956676|NCT02759939|12192496|P4|NOT COMPLETED|Overall Study||1043
4956677|NCT02759939|12192497|P3|NOT COMPLETED|Overall Study||1154
4956678|NCT02759939|12192498|P2|NOT COMPLETED|Overall Study||972
4956679|NCT02759939|12192499|P1|NOT COMPLETED|Overall Study||1056
4956680|NCT02759939|12192496|P4|COMPLETED|Overall Study||203
4956681|NCT02759939|12192497|P3|COMPLETED|Overall Study||239
4956682|NCT02759939|12192498|P2|COMPLETED|Overall Study||171
4956683|NCT02759939|12192499|P1|COMPLETED|Overall Study||200
4956684|NCT02759939|12192496|P4|Consented to T2 and T3|Overall Study||564
4956685|NCT02759939|12192497|P3|Consented to T2 and T3|Overall Study||702
4956686|NCT02759939|12192498|P2|Consented to T2 and T3|Overall Study||626
4956687|NCT02759939|12192499|P1|Consented to T2 and T3|Overall Study||579
4956688|NCT02759939|12192496|P4|Analyzed at T2 and/or T3|Overall Study||304
4956689|NCT02759939|12192497|P3|Analyzed at T2 and/or T3|Overall Study||373
4956690|NCT02759939|12192498|P2|Analyzed at T2 and/or T3|Overall Study||278
4956691|NCT02759939|12192499|P1|Analyzed at T2 and/or T3|Overall Study||303
4956692|NCT02759939|12192496|P4|Eligible for T2 and T3|Overall Study||853
4956693|NCT02759939|12192497|P3|Eligible for T2 and T3|Overall Study||1022
4956694|NCT02759939|12192498|P2|Eligible for T2 and T3|Overall Study||962
4956695|NCT02759939|12192499|P1|Eligible for T2 and T3|Overall Study||935
4956696|NCT02759939|12192496|P4|Analyzed at T1|Overall Study||1244
4956697|NCT02759939|12192497|P3|Analyzed at T1|Overall Study||1388
4956698|NCT02759939|12192498|P2|Analyzed at T1|Overall Study||1141
4956699|NCT02759939|12192499|P1|Analyzed at T1|Overall Study||1245
4956700|NCT02759939|12192496|P4|STARTED|Overall Study||1246
4956701|NCT02759939|12192497|P3|STARTED|Overall Study||1393
4956702|NCT02759939|12192498|P2|STARTED|Overall Study||1143
4956703|NCT02759939|12192499|P1|STARTED|Overall Study||1256
4956704|NCT02759692|12192509|P2|NOT COMPLETED|Period 3||0
4956705|NCT02759692|12192510|P1|NOT COMPLETED|Period 3||0
4956706|NCT02759692|12192509|P2|COMPLETED|Period 3||139
4956707|NCT02759692|12192510|P1|COMPLETED|Period 3||137
4956708|NCT02759692|12192509|P2|STARTED|Period 3||139
4956709|NCT02759692|12192510|P1|STARTED|Period 3||137
4956710|NCT02759692|12192509|P2|NOT COMPLETED|Period 2||1
4956711|NCT02759692|12192510|P1|NOT COMPLETED|Period 2||1
4956712|NCT02759692|12192509|P2|COMPLETED|Period 2||139
4956713|NCT02759692|12192510|P1|COMPLETED|Period 2||137
4956714|NCT02759692|12192509|P2|STARTED|Period 2||140
4956715|NCT02759692|12192510|P1|STARTED|Period 2||138
4956716|NCT02759692|12192509|P2|NOT COMPLETED|Period 1||2
4956717|NCT02759692|12192510|P1|NOT COMPLETED|Period 1||3
4956718|NCT02759692|12192509|P2|COMPLETED|Period 1||140
4956719|NCT02759692|12192510|P1|COMPLETED|Period 1||138
4956720|NCT02759692|12192509|P2|STARTED|Period 1||142
4956721|NCT02759692|12192510|P1|STARTED|Period 1||141
4956722|NCT02759562|12192528|P2|NOT COMPLETED|Open-Label Treatment Period||2
4956723|NCT02759562|12192529|P1|NOT COMPLETED|Open-Label Treatment Period||2
4956724|NCT02759562|12192528|P2|COMPLETED|Open-Label Treatment Period||0
4956725|NCT02759562|12192529|P1|COMPLETED|Open-Label Treatment Period||0
4956726|NCT02759562|12192528|P2|STARTED|Open-Label Treatment Period||2
4956727|NCT02759562|12192529|P1|STARTED|Open-Label Treatment Period||2
4956728|NCT02759562|12192528|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
4956729|NCT02759562|12192529|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
4956730|NCT02759562|12192528|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
4956731|NCT02759562|12192529|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
4956732|NCT02759562|12192528|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
4956733|NCT02759562|12192529|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
4956734|NCT02759471|12192542|P1|NOT COMPLETED|Overall Study||2
4956735|NCT02759471|12192542|P1|COMPLETED|Overall Study||52
4956736|NCT02759471|12192542|P1|STARTED|Overall Study||54
4956737|NCT02759354|12192556|P4|NOT COMPLETED|Overall Study||0
4956738|NCT02759354|12192557|P3|NOT COMPLETED|Overall Study||0
4956739|NCT02759354|12192558|P2|NOT COMPLETED|Overall Study||0
4956740|NCT02759354|12192559|P1|NOT COMPLETED|Overall Study||0
4956741|NCT02759354|12192556|P4|COMPLETED|Overall Study||191
4956742|NCT02759354|12192557|P3|COMPLETED|Overall Study||181
4956743|NCT02759354|12192558|P2|COMPLETED|Overall Study||190
4956744|NCT02759354|12192559|P1|COMPLETED|Overall Study||192
4956745|NCT02759354|12192556|P4|STARTED|Overall Study||191
4956746|NCT02759354|12192557|P3|STARTED|Overall Study||181
4956747|NCT02759354|12192558|P2|STARTED|Overall Study||190
4956748|NCT02759354|12192559|P1|STARTED|Overall Study||192
4956749|NCT02759315|12192598|P5|NOT COMPLETED|Overall Study||1
4956750|NCT02759315|12192599|P4|NOT COMPLETED|Overall Study||1
4956751|NCT02759315|12192600|P3|NOT COMPLETED|Overall Study||10
4956752|NCT02759315|12192601|P2|NOT COMPLETED|Overall Study||1
4956753|NCT02759315|12192602|P1|NOT COMPLETED|Overall Study||4
4956754|NCT02759315|12192598|P5|COMPLETED|Overall Study||2
4956755|NCT02759315|12192599|P4|COMPLETED|Overall Study||19
4956756|NCT02759315|12192600|P3|COMPLETED|Overall Study||29
4956757|NCT02759315|12192601|P2|COMPLETED|Overall Study||28
4956758|NCT02759315|12192602|P1|COMPLETED|Overall Study||65
4956759|NCT02759315|12192598|P5|STARTED|Overall Study||3
4956760|NCT02759315|12192599|P4|STARTED|Overall Study||20
4956761|NCT02759315|12192600|P3|STARTED|Overall Study||39
4956762|NCT02759315|12192601|P2|STARTED|Overall Study||29
4956763|NCT02759315|12192602|P1|STARTED|Overall Study||69
4956764|NCT02759016|12192648|P2|NOT COMPLETED|Overall Study||3
4956765|NCT02759016|12192649|P1|NOT COMPLETED|Overall Study||4
4956766|NCT02759016|12192648|P2|COMPLETED|Overall Study||0
4956767|NCT02759016|12192649|P1|COMPLETED|Overall Study||0
4956768|NCT02759016|12192648|P2|Treated With BI 836826 and Ibrutinib|Overall Study||3
4956769|NCT02759016|12192649|P1|Treated With BI 836826 and Ibrutinib|Overall Study||3
4956770|NCT02759016|12192648|P2|STARTED|Overall Study||3
4956771|NCT02759016|12192649|P1|STARTED|Overall Study||4
4956772|NCT02758613|12192661|P4|NOT COMPLETED|Follow-up||0
4956773|NCT02758613|12192662|P3|NOT COMPLETED|Follow-up||0
4956774|NCT02758613|12192663|P2|NOT COMPLETED|Follow-up||0
4956775|NCT02758613|12192664|P1|NOT COMPLETED|Follow-up||0
4956776|NCT02758613|12192661|P4|COMPLETED|Follow-up||8
4956777|NCT02758613|12192662|P3|COMPLETED|Follow-up||8
4956778|NCT02758613|12192663|P2|COMPLETED|Follow-up||8
4956779|NCT02758613|12192664|P1|COMPLETED|Follow-up||6
4956780|NCT02758613|12192661|P4|STARTED|Follow-up||8
4956781|NCT02758613|12192662|P3|STARTED|Follow-up||8
4956782|NCT02758613|12192663|P2|STARTED|Follow-up||8
4956783|NCT02758613|12192664|P1|STARTED|Follow-up||6
4956784|NCT02758613|12192661|P4|NOT COMPLETED|Treatment||0
4956785|NCT02758613|12192662|P3|NOT COMPLETED|Treatment||1
4956786|NCT02758613|12192663|P2|NOT COMPLETED|Treatment||0
4956787|NCT02758613|12192664|P1|NOT COMPLETED|Treatment||2
4956788|NCT02758613|12192661|P4|COMPLETED|Treatment||8
4956789|NCT02758613|12192662|P3|COMPLETED|Treatment||8
4956790|NCT02758613|12192663|P2|COMPLETED|Treatment||8
4956791|NCT02758613|12192664|P1|COMPLETED|Treatment||6
4956792|NCT02758613|12192661|P4|Received at Least One Dose of Study Drug|Treatment||8
4956793|NCT02758613|12192662|P3|Received at Least One Dose of Study Drug|Treatment||9
4956794|NCT02758613|12192663|P2|Received at Least One Dose of Study Drug|Treatment||8
4956795|NCT02758613|12192664|P1|Received at Least One Dose of Study Drug|Treatment||8
4956796|NCT02758613|12192661|P4|STARTED|Treatment||8
4956797|NCT02758613|12192662|P3|STARTED|Treatment||9
4956798|NCT02758613|12192663|P2|STARTED|Treatment||8
4956799|NCT02758613|12192664|P1|STARTED|Treatment||8
4956800|NCT02758301|12192682|P2|NOT COMPLETED|Overall Study||8
4956801|NCT02758301|12192683|P1|NOT COMPLETED|Overall Study||34
4956802|NCT02758301|12192682|P2|COMPLETED|Overall Study||0
4956803|NCT02758301|12192683|P1|COMPLETED|Overall Study||70
4956804|NCT02758301|12192682|P2|STARTED|Overall Study||8
4956805|NCT02758301|12192683|P1|STARTED|Overall Study||104
4956806|NCT02758210|12192691|P1|NOT COMPLETED|Overall Study||0
4956807|NCT02758210|12192691|P1|COMPLETED|Overall Study||20
4956808|NCT02758210|12192691|P1|STARTED|Overall Study||20
4956809|NCT02758171|12192702|P2|NOT COMPLETED|Treatment Period 2||0
4956810|NCT02758171|12192703|P1|NOT COMPLETED|Treatment Period 2||0
4956811|NCT02758171|12192702|P2|COMPLETED|Treatment Period 2||28
4956812|NCT02758171|12192703|P1|COMPLETED|Treatment Period 2||26
4956813|NCT02758171|12192702|P2|STARTED|Treatment Period 2||28
4956814|NCT02758171|12192703|P1|STARTED|Treatment Period 2||26
4956815|NCT02758171|12192702|P2|NOT COMPLETED|Wash-out||0
4956816|NCT02758171|12192703|P1|NOT COMPLETED|Wash-out||2
4956817|NCT02758171|12192702|P2|COMPLETED|Wash-out||28
4956818|NCT02758171|12192703|P1|COMPLETED|Wash-out||26
4956819|NCT02758171|12192702|P2|STARTED|Wash-out||28
4956820|NCT02758171|12192703|P1|STARTED|Wash-out||28
4956821|NCT02758171|12192702|P2|NOT COMPLETED|Treatment Period 1||0
4956822|NCT02758171|12192703|P1|NOT COMPLETED|Treatment Period 1||0
4956823|NCT02758171|12192702|P2|COMPLETED|Treatment Period 1||28
4956824|NCT02758171|12192703|P1|COMPLETED|Treatment Period 1||28
4956825|NCT02758171|12192702|P2|STARTED|Treatment Period 1||28
4956826|NCT02758171|12192703|P1|STARTED|Treatment Period 1||28
4956827|NCT02758132|12192721|P2|NOT COMPLETED|Overall Study||1
4956828|NCT02758132|12192722|P1|NOT COMPLETED|Overall Study||0
4956829|NCT02758132|12192721|P2|COMPLETED|Overall Study||0
4956830|NCT02758132|12192722|P1|COMPLETED|Overall Study||0
4956831|NCT02758132|12192721|P2|STARTED|Overall Study||1
4956832|NCT02758132|12192722|P1|STARTED|Overall Study||0
4956833|NCT02758119|12192744|P2|NOT COMPLETED|Overall Study||1
4956834|NCT02758119|12192745|P1|NOT COMPLETED|Overall Study||2
4956835|NCT02758119|12192744|P2|COMPLETED|Overall Study||40
4956836|NCT02758119|12192745|P1|COMPLETED|Overall Study||39
4956837|NCT02758119|12192744|P2|STARTED|Overall Study||41
4956838|NCT02758119|12192745|P1|STARTED|Overall Study||41
4956839|NCT02757963|12192757|P1|NOT COMPLETED|Overall Study||1097
4956840|NCT02757963|12192757|P1|COMPLETED|Overall Study||561
4956841|NCT02757963|12192757|P1|STARTED|Overall Study||1658
4956842|NCT02757950|12192775|P2|NOT COMPLETED|Overall Study||11
4956843|NCT02757950|12192776|P1|NOT COMPLETED|Overall Study||4
4956844|NCT02757950|12192775|P2|COMPLETED|Overall Study||1248
4956845|NCT02757950|12192776|P1|COMPLETED|Overall Study||1199
4956846|NCT02757950|12192775|P2|STARTED|Overall Study||1259
4956847|NCT02757950|12192776|P1|STARTED|Overall Study||1203
4956848|NCT02757768|12192797|P2|NOT COMPLETED|Overall Study||28
4956849|NCT02757768|12192798|P1|NOT COMPLETED|Overall Study||33
4956850|NCT02757768|12192797|P2|COMPLETED|Overall Study||331
4956851|NCT02757768|12192798|P1|COMPLETED|Overall Study||323
4956852|NCT02757768|12192797|P2|Treated|Overall Study||354
4956853|NCT02757768|12192798|P1|Treated|Overall Study||352
4956854|NCT02757768|12192797|P2|STARTED|Overall Study||359
4956855|NCT02757768|12192798|P1|STARTED|Overall Study||356
4956856|NCT02757625|12192848|P4|NOT COMPLETED|Overall Study||0
4956857|NCT02757625|12192849|P3|NOT COMPLETED|Overall Study||2
4956858|NCT02757625|12192850|P2|NOT COMPLETED|Overall Study||0
4956859|NCT02757625|12192851|P1|NOT COMPLETED|Overall Study||0
4956860|NCT02757625|12192848|P4|COMPLETED|Overall Study||12
4956861|NCT02757625|12192849|P3|COMPLETED|Overall Study||17
4956862|NCT02757625|12192850|P2|COMPLETED|Overall Study||18
4956863|NCT02757625|12192851|P1|COMPLETED|Overall Study||14
4956864|NCT02757625|12192848|P4|STARTED|Overall Study||12
4956865|NCT02757625|12192849|P3|STARTED|Overall Study||19
4956866|NCT02757625|12192850|P2|STARTED|Overall Study||18
4956867|NCT02757625|12192851|P1|STARTED|Overall Study||14
4956868|NCT02757547|12193003|P1|NOT COMPLETED|Overall Study||0
4956869|NCT02757547|12193003|P1|COMPLETED|Overall Study||2
4956870|NCT02757547|12193003|P1|STARTED|Overall Study||2
4956871|NCT02757521|12193010|P2|NOT COMPLETED|Overall Study||0
4956872|NCT02757521|12193011|P1|NOT COMPLETED|Overall Study||1
4956873|NCT02757521|12193010|P2|COMPLETED|Overall Study||0
4956874|NCT02757521|12193011|P1|COMPLETED|Overall Study||0
4956875|NCT02757521|12193010|P2|STARTED|Overall Study||0
4956876|NCT02757521|12193011|P1|STARTED|Overall Study||1
4956877|NCT02757430|12193017|P1|NOT COMPLETED|Overall Study||12
4956878|NCT02757430|12193017|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
4956879|NCT02757430|12193017|P1|EP Mapping/Ablation Procedure|Overall Study||503
4956880|NCT02757430|12193017|P1|Baseline Visits|Overall Study||503
4956881|NCT02757430|12193017|P1|STARTED|Overall Study||515
4956882|NCT02757352|12193036|P10|NOT COMPLETED|Follow-Up Period||3
4956883|NCT02757352|12193037|P9|NOT COMPLETED|Follow-Up Period||10
4956884|NCT02757352|12193038|P8|NOT COMPLETED|Follow-Up Period||1
4956885|NCT02757352|12193039|P7|NOT COMPLETED|Follow-Up Period||1
4956886|NCT02757352|12193040|P6|NOT COMPLETED|Follow-Up Period||0
4956887|NCT02757352|12193041|P5|NOT COMPLETED|Follow-Up Period||0
4956888|NCT02757352|12193042|P4|NOT COMPLETED|Follow-Up Period||0
4956889|NCT02757352|12193043|P3|NOT COMPLETED|Follow-Up Period||0
4956890|NCT02757352|12193044|P2|NOT COMPLETED|Follow-Up Period||0
4956891|NCT02757352|12193045|P1|NOT COMPLETED|Follow-Up Period||0
4956892|NCT02757352|12193036|P10|COMPLETED|Follow-Up Period||2
4956893|NCT02757352|12193037|P9|COMPLETED|Follow-Up Period||18
4956894|NCT02757352|12193038|P8|COMPLETED|Follow-Up Period||4
4956895|NCT02757352|12193039|P7|COMPLETED|Follow-Up Period||2
4956896|NCT02757352|12193040|P6|COMPLETED|Follow-Up Period||0
4956897|NCT02757352|12193041|P5|COMPLETED|Follow-Up Period||0
4956898|NCT02757352|12193042|P4|COMPLETED|Follow-Up Period||0
4956899|NCT02757352|12193043|P3|COMPLETED|Follow-Up Period||0
4956900|NCT02757352|12193044|P2|COMPLETED|Follow-Up Period||0
4956901|NCT02757352|12193045|P1|COMPLETED|Follow-Up Period||0
4956902|NCT02757352|12193036|P10|STARTED|Follow-Up Period||5
4956903|NCT02757352|12193037|P9|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
4956904|NCT02757352|12193038|P8|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
4956905|NCT02757352|12193039|P7|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
4956906|NCT02757352|12193040|P6|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
4956907|NCT02757352|12193041|P5|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
4956908|NCT02757352|12193042|P4|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
4956909|NCT02757352|12193043|P3|STARTED|Follow-Up Period||0
4956910|NCT02757352|12193044|P2|STARTED|Follow-Up Period||0
4956911|NCT02757352|12193045|P1|STARTED|Follow-Up Period||0
4956912|NCT02757352|12193036|P10|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956913|NCT02757352|12193037|P9|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956914|NCT02757352|12193038|P8|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956915|NCT02757352|12193039|P7|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956916|NCT02757352|12193040|P6|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
4956917|NCT02757352|12193041|P5|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
4956918|NCT02757352|12193042|P4|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
4956919|NCT02757352|12193043|P3|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956920|NCT02757352|12193044|P2|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956921|NCT02757352|12193045|P1|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956922|NCT02757352|12193036|P10|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956923|NCT02757352|12193037|P9|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956924|NCT02757352|12193038|P8|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956925|NCT02757352|12193039|P7|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956926|NCT02757352|12193040|P6|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
4956927|NCT02757352|12193041|P5|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
4956928|NCT02757352|12193042|P4|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
4956929|NCT02757352|12193043|P3|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956930|NCT02757352|12193044|P2|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956931|NCT02757352|12193045|P1|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
4956932|NCT02757352|12193036|P10|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956933|NCT02757352|12193037|P9|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956934|NCT02757352|12193038|P8|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956935|NCT02757352|12193039|P7|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956936|NCT02757352|12193040|P6|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
4956937|NCT02757352|12193041|P5|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956938|NCT02757352|12193042|P4|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
4956939|NCT02757352|12193043|P3|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956940|NCT02757352|12193044|P2|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956941|NCT02757352|12193045|P1|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
4956942|NCT02757352|12193036|P10|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
4956943|NCT02757352|12193037|P9|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
4956944|NCT02757352|12193038|P8|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
4956945|NCT02757352|12193039|P7|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
4956946|NCT02757352|12193040|P6|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
4956947|NCT02757352|12193041|P5|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
4956948|NCT02757352|12193042|P4|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
4956949|NCT02757352|12193043|P3|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
4956950|NCT02757352|12193044|P2|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
4956951|NCT02757352|12193045|P1|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
4956952|NCT02757352|12193036|P10|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956953|NCT02757352|12193037|P9|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956954|NCT02757352|12193038|P8|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956955|NCT02757352|12193039|P7|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956956|NCT02757352|12193040|P6|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956957|NCT02757352|12193041|P5|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956958|NCT02757352|12193042|P4|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956959|NCT02757352|12193043|P3|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
4956960|NCT02757352|12193044|P2|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
4956961|NCT02757352|12193045|P1|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
4956962|NCT02757352|12193036|P10|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956963|NCT02757352|12193037|P9|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956964|NCT02757352|12193038|P8|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956965|NCT02757352|12193039|P7|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956966|NCT02757352|12193040|P6|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956967|NCT02757352|12193041|P5|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956968|NCT02757352|12193042|P4|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
4956969|NCT02757352|12193043|P3|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
4956970|NCT02757352|12193044|P2|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
4956971|NCT02757352|12193045|P1|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
4956972|NCT02757352|12193036|P10|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956973|NCT02757352|12193037|P9|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956974|NCT02757352|12193038|P8|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956975|NCT02757352|12193039|P7|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956976|NCT02757352|12193040|P6|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956977|NCT02757352|12193041|P5|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956978|NCT02757352|12193042|P4|STARTED|Double-Blind Period (Week 16 - Week 52)||0
4956979|NCT02757352|12193043|P3|STARTED|Double-Blind Period (Week 16 - Week 52)||98
4956980|NCT02757352|12193044|P2|STARTED|Double-Blind Period (Week 16 - Week 52)||95
4956981|NCT02757352|12193045|P1|STARTED|Double-Blind Period (Week 16 - Week 52)||97
4956982|NCT02757352|12193036|P10|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956983|NCT02757352|12193037|P9|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956984|NCT02757352|12193038|P8|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956985|NCT02757352|12193039|P7|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956986|NCT02757352|12193040|P6|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956987|NCT02757352|12193041|P5|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956988|NCT02757352|12193042|P4|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956989|NCT02757352|12193043|P3|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
4956990|NCT02757352|12193044|P2|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
4956991|NCT02757352|12193045|P1|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
4956992|NCT02757352|12193036|P10|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956993|NCT02757352|12193037|P9|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956994|NCT02757352|12193038|P8|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956995|NCT02757352|12193039|P7|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956996|NCT02757352|12193040|P6|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956997|NCT02757352|12193041|P5|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956998|NCT02757352|12193042|P4|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
4956999|NCT02757352|12193043|P3|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
4957000|NCT02757352|12193044|P2|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
4957001|NCT02757352|12193045|P1|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
4957002|NCT02757352|12193036|P10|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957003|NCT02757352|12193037|P9|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957004|NCT02757352|12193038|P8|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957005|NCT02757352|12193039|P7|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957006|NCT02757352|12193040|P6|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957007|NCT02757352|12193041|P5|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957008|NCT02757352|12193042|P4|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
4957009|NCT02757352|12193043|P3|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
4957010|NCT02757352|12193044|P2|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
4957011|NCT02757352|12193045|P1|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
4957012|NCT02757352|12193036|P10|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957013|NCT02757352|12193037|P9|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957014|NCT02757352|12193038|P8|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957015|NCT02757352|12193039|P7|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957016|NCT02757352|12193040|P6|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957017|NCT02757352|12193041|P5|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957018|NCT02757352|12193042|P4|STARTED|Double-Blind Period (Week 0 - Week 16)||0
4957019|NCT02757352|12193043|P3|STARTED|Double-Blind Period (Week 0 - Week 16)||102
4957020|NCT02757352|12193044|P2|STARTED|Double-Blind Period (Week 0 - Week 16)||96
4957021|NCT02757352|12193045|P1|STARTED|Double-Blind Period (Week 0 - Week 16)||105
4957022|NCT02757105|12193154|P2|NOT COMPLETED|Overall Study||11
4957023|NCT02757105|12193155|P1|NOT COMPLETED|Overall Study||12
4957024|NCT02757105|12193154|P2|COMPLETED|Overall Study||41
4957025|NCT02757105|12193155|P1|COMPLETED|Overall Study||63
4957026|NCT02757105|12193154|P2|Treated|Overall Study||51
4957027|NCT02757105|12193155|P1|Treated|Overall Study||75
4957028|NCT02757105|12193154|P2|STARTED|Overall Study||52
4957029|NCT02757105|12193155|P1|STARTED|Overall Study||75
4957030|NCT02757053|12193177|P2|NOT COMPLETED|Overall Study||5
4957031|NCT02757053|12193178|P1|NOT COMPLETED|Overall Study||3
4957032|NCT02757053|12193177|P2|COMPLETED|Overall Study||0
4957033|NCT02757053|12193178|P1|COMPLETED|Overall Study||0
4957034|NCT02757053|12193177|P2|STARTED|Overall Study||5
4957035|NCT02757053|12193178|P1|STARTED|Overall Study||3
4957036|NCT02756949|12193192|P2|NOT COMPLETED|Overall Study||8
4957037|NCT02756949|12193193|P1|NOT COMPLETED|Overall Study||0
4957038|NCT02756949|12193192|P2|COMPLETED|Overall Study||164
4957039|NCT02756949|12193193|P1|COMPLETED|Overall Study||181
4957040|NCT02756949|12193192|P2|STARTED|Overall Study||172
4957041|NCT02756949|12193193|P1|STARTED|Overall Study||181
4957042|NCT02756832|12193201|P1|NOT COMPLETED|Overall Study||53
4957043|NCT02756832|12193201|P1|COMPLETED|Overall Study||1356
4957044|NCT02756832|12193201|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
4957045|NCT02756832|12193201|P1|Received Therapy|Overall Study||1393
4957046|NCT02756832|12193201|P1|STARTED|Overall Study||1409
4957047|NCT02756819|12193215|P1|NOT COMPLETED|Overall Study||52
4957048|NCT02756819|12193215|P1|COMPLETED|Overall Study||1893
4957049|NCT02756819|12193215|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
4957050|NCT02756819|12193215|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
4957051|NCT02756819|12193215|P1|STARTED|Overall Study||1945
4957052|NCT02756689|12193227|P2|NOT COMPLETED|Overall Study||0
4957053|NCT02756689|12193228|P1|NOT COMPLETED|Overall Study||0
4957054|NCT02756689|12193227|P2|COMPLETED|Overall Study||65
4957055|NCT02756689|12193228|P1|COMPLETED|Overall Study||64
4957056|NCT02756689|12193227|P2|STARTED|Overall Study||65
4957057|NCT02756689|12193228|P1|STARTED|Overall Study||64
4957058|NCT02756650|12193314|P1|NOT COMPLETED|Overall Study||2
4957059|NCT02756650|12193314|P1|COMPLETED|Overall Study||6
4957060|NCT02756650|12193314|P1|STARTED|Overall Study||8
4957061|NCT02756637|12193337|P2|NOT COMPLETED|Overall Study||54
4957062|NCT02756637|12193338|P1|NOT COMPLETED|Overall Study||87
4957063|NCT02756637|12193337|P2|COMPLETED|Overall Study||263
4957064|NCT02756637|12193338|P1|COMPLETED|Overall Study||230
4957065|NCT02756637|12193337|P2|Completed Curative Treatment|Overall Study||0
4957066|NCT02756637|12193338|P1|Completed Curative Treatment|Overall Study||230
4957067|NCT02756637|12193337|P2|Had NLR Value|Overall Study||263
4957068|NCT02756637|12193338|P1|Had NLR Value|Overall Study||263
4957069|NCT02756637|12193337|P2|Eligible for SWOG 8710|Overall Study||307
4957070|NCT02756637|12193338|P1|Eligible for SWOG 8710|Overall Study||307
4957071|NCT02756637|12193337|P2|STARTED|Overall Study||317
4957072|NCT02756637|12193338|P1|STARTED|Overall Study||317
4957073|NCT02756624|12193346|P2|NOT COMPLETED|Overall Study||7
4957074|NCT02756624|12193347|P1|NOT COMPLETED|Overall Study||16
4957075|NCT02756624|12193346|P2|COMPLETED|Overall Study||166
4957076|NCT02756624|12193347|P1|COMPLETED|Overall Study||327
4957077|NCT02756624|12193346|P2|STARTED|Overall Study||173
4957078|NCT02756624|12193347|P1|STARTED|Overall Study||343
4957079|NCT02756611|12193359|P1|NOT COMPLETED|Overall Study||256
4957080|NCT02756611|12193359|P1|COMPLETED|Overall Study||2
4957081|NCT02756611|12193359|P1|STARTED|Overall Study||258
4957082|NCT02756351|12193372|P2|NOT COMPLETED|Overall Study||0
4957083|NCT02756351|12193373|P1|NOT COMPLETED|Overall Study||0
4957084|NCT02756351|12193372|P2|COMPLETED|Overall Study||24
4957085|NCT02756351|12193373|P1|COMPLETED|Overall Study||24
4957086|NCT02756351|12193372|P2|STARTED|Overall Study||24
4957087|NCT02756351|12193373|P1|STARTED|Overall Study||24
4957088|NCT02756338|12193381|P1|NOT COMPLETED|Overall Study||5
4957089|NCT02756338|12193381|P1|COMPLETED|Overall Study||72
4957090|NCT02756338|12193381|P1|STARTED|Overall Study||77
4957091|NCT02756182|12193390|P1|NOT COMPLETED|Overall Study||4
4957092|NCT02756182|12193390|P1|COMPLETED|Overall Study||21
4957093|NCT02756182|12193390|P1|STARTED|Overall Study||25
4957094|NCT02756078|12193405|P2|NOT COMPLETED|Period 2||7
4957095|NCT02756078|12193406|P1|NOT COMPLETED|Period 2||6
4957096|NCT02756078|12193405|P2|COMPLETED|Period 2||57
4957097|NCT02756078|12193406|P1|COMPLETED|Period 2||70
4957098|NCT02756078|12193405|P2|STARTED|Period 2||64
4957099|NCT02756078|12193406|P1|STARTED|Period 2||76
4957100|NCT02756078|12193405|P2|NOT COMPLETED|Period 1||22
4957101|NCT02756078|12193406|P1|NOT COMPLETED|Period 1||9
4957102|NCT02756078|12193405|P2|COMPLETED|Period 1||64
4957103|NCT02756078|12193406|P1|COMPLETED|Period 1||76
4957104|NCT02756078|12193405|P2|STARTED|Period 1||86
4957105|NCT02756078|12193406|P1|STARTED|Period 1||85
4957106|NCT02755935|12193424|P1|NOT COMPLETED|Overall Study||2
4957107|NCT02755935|12193424|P1|COMPLETED|Overall Study||22
4957108|NCT02755935|12193424|P1|STARTED|Overall Study||24
4957109|NCT02755831|12193431|P2|NOT COMPLETED|Overall Study||3
4957110|NCT02755831|12193432|P1|NOT COMPLETED|Overall Study||3
4957111|NCT02755831|12193431|P2|COMPLETED|Overall Study||90
4957112|NCT02755831|12193432|P1|COMPLETED|Overall Study||97
4957113|NCT02755831|12193431|P2|STARTED|Overall Study||93
4957114|NCT02755831|12193432|P1|STARTED|Overall Study||100
4957115|NCT02755818|12193448|P4|NOT COMPLETED|Overall Study||3
4957116|NCT02755818|12193449|P3|NOT COMPLETED|Overall Study||1
4957117|NCT02755818|12193450|P2|NOT COMPLETED|Overall Study||0
4957118|NCT02755818|12193451|P1|NOT COMPLETED|Overall Study||0
4957119|NCT02755818|12193448|P4|COMPLETED|Overall Study||14
4957120|NCT02755818|12193449|P3|COMPLETED|Overall Study||1
4957121|NCT02755818|12193450|P2|COMPLETED|Overall Study||2
4957122|NCT02755818|12193451|P1|COMPLETED|Overall Study||30
4957123|NCT02755818|12193448|P4|STARTED|Overall Study||17
4957124|NCT02755818|12193449|P3|STARTED|Overall Study||2
4957125|NCT02755818|12193450|P2|STARTED|Overall Study||2
4957126|NCT02755818|12193451|P1|STARTED|Overall Study||30
4957127|NCT02755805|12193487|P2|NOT COMPLETED|Overall Study||4
4957128|NCT02755805|12193488|P1|NOT COMPLETED|Overall Study||2
4957129|NCT02755805|12193487|P2|COMPLETED|Overall Study||11
4957130|NCT02755805|12193488|P1|COMPLETED|Overall Study||13
4957131|NCT02755805|12193487|P2|STARTED|Overall Study||15
4957132|NCT02755805|12193488|P1|STARTED|Overall Study||15
4957133|NCT02755285|12193500|P1|NOT COMPLETED|Overall Study||0
4957134|NCT02755285|12193500|P1|COMPLETED|Overall Study||20
4957135|NCT02755285|12193500|P1|STARTED|Overall Study||20
4957136|NCT02755129|12193504|P1|NOT COMPLETED|Overall Study||0
4957137|NCT02755129|12193504|P1|COMPLETED|Overall Study||15
4957138|NCT02755129|12193504|P1|STARTED|Overall Study||15
4957139|NCT02755116|12193513|P2|NOT COMPLETED|Overall Study||1
4957140|NCT02755116|12193514|P1|NOT COMPLETED|Overall Study||3
4957141|NCT02755116|12193513|P2|COMPLETED|Overall Study||69
4957142|NCT02755116|12193514|P1|COMPLETED|Overall Study||71
4957143|NCT02755116|12193513|P2|STARTED|Overall Study||70
4957144|NCT02755116|12193514|P1|STARTED|Overall Study||74
4957145|NCT02755090|12193530|P2|NOT COMPLETED|Overall Study||0
4957146|NCT02755090|12193531|P1|NOT COMPLETED|Overall Study||1
4957147|NCT02755090|12193530|P2|COMPLETED|Overall Study||20
4957148|NCT02755090|12193531|P1|COMPLETED|Overall Study||18
4957149|NCT02755090|12193530|P2|STARTED|Overall Study||20
4957150|NCT02755090|12193531|P1|STARTED|Overall Study||19
4957151|NCT02754674|12193541|P2|NOT COMPLETED|Overall Study||7
4957152|NCT02754674|12193542|P1|NOT COMPLETED|Overall Study||6
4957153|NCT02754674|12193541|P2|COMPLETED|Overall Study||26
4957154|NCT02754674|12193542|P1|COMPLETED|Overall Study||28
4957155|NCT02754674|12193541|P2|STARTED|Overall Study||33
4957156|NCT02754674|12193542|P1|STARTED|Overall Study||34
4957157|NCT02754661|12193558|P2|NOT COMPLETED|Overall Study||19
4957158|NCT02754661|12193559|P1|NOT COMPLETED|Overall Study||15
4957159|NCT02754661|12193558|P2|COMPLETED|Overall Study||141
4957160|NCT02754661|12193559|P1|COMPLETED|Overall Study||145
4957161|NCT02754661|12193558|P2|STARTED|Overall Study||160
4957162|NCT02754661|12193559|P1|STARTED|Overall Study||160
4957163|NCT02754570|12193573|P1|NOT COMPLETED|Overall Study||0
4957164|NCT02754570|12193573|P1|COMPLETED|Overall Study||27
4957165|NCT02754570|12193573|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
4957166|NCT02754570|12193573|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
4957167|NCT02754570|12193573|P1|STARTED|Overall Study||27
4957168|NCT02754492|12193583|P4|NOT COMPLETED|Overall Study||23
4957169|NCT02754492|12193584|P3|NOT COMPLETED|Overall Study||2
4957170|NCT02754492|12193585|P2|NOT COMPLETED|Overall Study||2
4957171|NCT02754492|12193586|P1|NOT COMPLETED|Overall Study||4
4957172|NCT02754492|12193583|P4|COMPLETED|Overall Study||0
4957173|NCT02754492|12193584|P3|COMPLETED|Overall Study||93
4957174|NCT02754492|12193585|P2|COMPLETED|Overall Study||93
4957175|NCT02754492|12193586|P1|COMPLETED|Overall Study||93
4957176|NCT02754492|12193583|P4|STARTED|Overall Study||23
4957177|NCT02754492|12193584|P3|STARTED|Overall Study||95
4957178|NCT02754492|12193585|P2|STARTED|Overall Study||95
4957179|NCT02754492|12193586|P1|STARTED|Overall Study||97
4957180|NCT02754440|12193602|P4|NOT COMPLETED|Overall Study||35
4957181|NCT02754440|12193603|P3|NOT COMPLETED|Overall Study||7
4957182|NCT02754440|12193604|P2|NOT COMPLETED|Overall Study||8
4957183|NCT02754440|12193605|P1|NOT COMPLETED|Overall Study||6
4957184|NCT02754440|12193602|P4|COMPLETED|Overall Study||0
4957185|NCT02754440|12193603|P3|COMPLETED|Overall Study||93
4957186|NCT02754440|12193604|P2|COMPLETED|Overall Study||93
4957187|NCT02754440|12193605|P1|COMPLETED|Overall Study||93
4957188|NCT02754440|12193602|P4|STARTED|Overall Study||35
4957189|NCT02754440|12193603|P3|STARTED|Overall Study||100
4957190|NCT02754440|12193604|P2|STARTED|Overall Study||101
4957191|NCT02754440|12193605|P1|STARTED|Overall Study||99
4957192|NCT02754427|12193619|P2|NOT COMPLETED|Overall Study||1
4957193|NCT02754427|12193620|P1|NOT COMPLETED|Overall Study||0
4957194|NCT02754427|12193619|P2|COMPLETED|Overall Study||19
4957195|NCT02754427|12193620|P1|COMPLETED|Overall Study||21
4957196|NCT02754427|12193619|P2|STARTED|Overall Study||20
4957197|NCT02754427|12193620|P1|STARTED|Overall Study||21
4957198|NCT02754310|12193634|P2|NOT COMPLETED|Overall Study||0
4957199|NCT02754310|12193635|P1|NOT COMPLETED|Overall Study||0
4957200|NCT02754310|12193634|P2|COMPLETED|Overall Study||43
4957201|NCT02754310|12193635|P1|COMPLETED|Overall Study||42
4957202|NCT02754310|12193634|P2|STARTED|Overall Study||43
4957203|NCT02754310|12193635|P1|STARTED|Overall Study||42
4957204|NCT02753946|12193657|P2|NOT COMPLETED|Overall Study||9
4957205|NCT02753946|12193658|P1|NOT COMPLETED|Overall Study||14
4957206|NCT02753946|12193657|P2|COMPLETED|Overall Study||222
4957207|NCT02753946|12193658|P1|COMPLETED|Overall Study||219
4957208|NCT02753946|12193657|P2|STARTED|Overall Study||231
4957209|NCT02753946|12193658|P1|STARTED|Overall Study||233
4957210|NCT02753920|12193670|P2|NOT COMPLETED|Overall Study||0
4957211|NCT02753920|12193671|P1|NOT COMPLETED|Overall Study||0
4957212|NCT02753920|12193670|P2|COMPLETED|Overall Study||86
4957213|NCT02753920|12193671|P1|COMPLETED|Overall Study||87
4957214|NCT02753920|12193670|P2|STARTED|Overall Study||86
4957215|NCT02753920|12193671|P1|STARTED|Overall Study||87
4957216|NCT02753699|12193684|P3|NOT COMPLETED|Overall Study||23
4957217|NCT02753699|12193685|P2|NOT COMPLETED|Overall Study||43
4957218|NCT02753699|12193686|P1|NOT COMPLETED|Overall Study||14
4957219|NCT02753699|12193684|P3|COMPLETED|Overall Study||139
4957220|NCT02753699|12193685|P2|COMPLETED|Overall Study||354
4957221|NCT02753699|12193686|P1|COMPLETED|Overall Study||150
4957222|NCT02753699|12193684|P3|STARTED|Overall Study||162
4957223|NCT02753699|12193685|P2|STARTED|Overall Study||397
4957224|NCT02753699|12193686|P1|STARTED|Overall Study||164
4957225|NCT02753595|12193702|P2|NOT COMPLETED|Overall Study||2
4957226|NCT02753595|12193703|P1|NOT COMPLETED|Overall Study||2
4957227|NCT02753595|12193702|P2|COMPLETED|Overall Study||7
4957228|NCT02753595|12193703|P1|COMPLETED|Overall Study||3
4957229|NCT02753595|12193702|P2|STARTED|Overall Study||9
4957230|NCT02753595|12193703|P1|STARTED|Overall Study||5
4957231|NCT02753413|12193711|P2|NOT COMPLETED|Overall Study||0
4957232|NCT02753413|12193712|P1|NOT COMPLETED|Overall Study||0
4957233|NCT02753413|12193711|P2|COMPLETED|Overall Study||51
4957234|NCT02753413|12193712|P1|COMPLETED|Overall Study||49
4957235|NCT02753413|12193711|P2|STARTED|Overall Study||51
4957236|NCT02753413|12193712|P1|STARTED|Overall Study||49
4957237|NCT02753075|12193747|P3|NOT COMPLETED|Overall Study||3
4957238|NCT02753075|12193748|P2|NOT COMPLETED|Overall Study||3
4957239|NCT02753075|12193749|P1|NOT COMPLETED|Overall Study||8
4957240|NCT02753075|12193747|P3|COMPLETED|Overall Study||78
4957241|NCT02753075|12193748|P2|COMPLETED|Overall Study||77
4957242|NCT02753075|12193749|P1|COMPLETED|Overall Study||71
4957243|NCT02753075|12193747|P3|STARTED|Overall Study||81
4957244|NCT02753075|12193748|P2|STARTED|Overall Study||80
4957245|NCT02753075|12193749|P1|STARTED|Overall Study||79
4957246|NCT02752958|12193774|P1|NOT COMPLETED|Overall Study||9
4957247|NCT02752958|12193774|P1|COMPLETED|Overall Study||66
4957248|NCT02752958|12193774|P1|STARTED|Overall Study||75
4957249|NCT02752906|12193845|P2|NOT COMPLETED|Overall Study||5
4957250|NCT02752906|12193846|P1|NOT COMPLETED|Overall Study||7
4957251|NCT02752906|12193845|P2|COMPLETED|Overall Study||402
4957252|NCT02752906|12193846|P1|COMPLETED|Overall Study||396
4957253|NCT02752906|12193845|P2|Vaccinated|Overall Study||407
4957254|NCT02752906|12193846|P1|Vaccinated|Overall Study||402
4957255|NCT02752906|12193845|P2|STARTED|Overall Study||407
4957256|NCT02752906|12193846|P1|STARTED|Overall Study||403
4957257|NCT02752880|12193860|P2|NOT COMPLETED|Overall Study||3
4957258|NCT02752880|12193861|P1|NOT COMPLETED|Overall Study||2
4957259|NCT02752880|12193860|P2|COMPLETED|Overall Study||20
4957260|NCT02752880|12193861|P1|COMPLETED|Overall Study||21
4957261|NCT02752880|12193860|P2|STARTED|Overall Study||23
4957262|NCT02752880|12193861|P1|STARTED|Overall Study||23
4957263|NCT02752802|12193871|P2|NOT COMPLETED|Overall Study||0
4957264|NCT02752802|12193872|P1|NOT COMPLETED|Overall Study||1
4957265|NCT02752802|12193871|P2|COMPLETED|Overall Study||48
4957266|NCT02752802|12193872|P1|COMPLETED|Overall Study||47
4957267|NCT02752802|12193871|P2|STARTED|Overall Study||48
4957268|NCT02752802|12193872|P1|STARTED|Overall Study||48
4957269|NCT02752776|12193884|P3|NOT COMPLETED|Overall Study||48
4957270|NCT02752776|12193885|P2|NOT COMPLETED|Overall Study||76
4957271|NCT02752776|12193886|P1|NOT COMPLETED|Overall Study||52
4957272|NCT02752776|12193884|P3|COMPLETED|Overall Study||276
4957273|NCT02752776|12193885|P2|COMPLETED|Overall Study||597
4957274|NCT02752776|12193886|P1|COMPLETED|Overall Study||611
4957275|NCT02752776|12193884|P3|STARTED|Overall Study||324
4957276|NCT02752776|12193885|P2|STARTED|Overall Study||673
4957277|NCT02752776|12193886|P1|STARTED|Overall Study||663
4957278|NCT02752633|12193932|P1|NOT COMPLETED|Overall Study||1
4957279|NCT02752633|12193932|P1|COMPLETED|Overall Study||8
4957280|NCT02752633|12193932|P1|STARTED|Overall Study||9
4957281|NCT02752490|12193938|P2|NOT COMPLETED|Overall Study||0
4957282|NCT02752490|12193939|P1|NOT COMPLETED|Overall Study||0
4957283|NCT02752490|12193938|P2|COMPLETED|Overall Study||435
4957284|NCT02752490|12193939|P1|COMPLETED|Overall Study||409
4957285|NCT02752490|12193938|P2|STARTED|Overall Study||435
4957286|NCT02752490|12193939|P1|STARTED|Overall Study||409
4957287|NCT02752256|12193961|P2|NOT COMPLETED|Overall Study||0
4957288|NCT02752256|12193962|P1|NOT COMPLETED|Overall Study||0
4957289|NCT02752256|12193961|P2|COMPLETED|Overall Study||41
4957290|NCT02752256|12193962|P1|COMPLETED|Overall Study||35
4957291|NCT02752256|12193961|P2|STARTED|Overall Study||41
4957292|NCT02752256|12193962|P1|STARTED|Overall Study||35
4957293|NCT02752087|12193970|P2|NOT COMPLETED|Follow-up||0
4957294|NCT02752087|12193971|P1|NOT COMPLETED|Follow-up||0
4957295|NCT02752087|12193970|P2|COMPLETED|Follow-up||12
4957296|NCT02752087|12193971|P1|COMPLETED|Follow-up||11
4957297|NCT02752087|12193970|P2|STARTED|Follow-up||12
4957298|NCT02752087|12193971|P1|STARTED|Follow-up||11
4957299|NCT02752087|12193970|P2|NOT COMPLETED|Study Period 4||0
4957300|NCT02752087|12193971|P1|NOT COMPLETED|Study Period 4||0
4957301|NCT02752087|12193970|P2|COMPLETED|Study Period 4||12
4957302|NCT02752087|12193971|P1|COMPLETED|Study Period 4||11
4957303|NCT02752087|12193970|P2|Received Study Drug|Study Period 4||12
4957304|NCT02752087|12193971|P1|Received Study Drug|Study Period 4||11
4957305|NCT02752087|12193970|P2|STARTED|Study Period 4||12
4957306|NCT02752087|12193971|P1|STARTED|Study Period 4||11
4957307|NCT02752087|12193970|P2|NOT COMPLETED|Washout||0
4957308|NCT02752087|12193971|P1|NOT COMPLETED|Washout||0
4957309|NCT02752087|12193970|P2|COMPLETED|Washout||12
4957310|NCT02752087|12193971|P1|COMPLETED|Washout||11
4957311|NCT02752087|12193970|P2|STARTED|Washout||12
4957312|NCT02752087|12193971|P1|STARTED|Washout||11
4957313|NCT02752087|12193970|P2|NOT COMPLETED|Study Period 3||0
4957314|NCT02752087|12193971|P1|NOT COMPLETED|Study Period 3||0
4957315|NCT02752087|12193970|P2|COMPLETED|Study Period 3||12
4957316|NCT02752087|12193971|P1|COMPLETED|Study Period 3||11
4957317|NCT02752087|12193970|P2|Received Study Drug|Study Period 3||12
4957318|NCT02752087|12193971|P1|Received Study Drug|Study Period 3||11
4957319|NCT02752087|12193970|P2|STARTED|Study Period 3||12
4957320|NCT02752087|12193971|P1|STARTED|Study Period 3||11
4957321|NCT02752087|12193970|P2|NOT COMPLETED|Washout||0
4957322|NCT02752087|12193971|P1|NOT COMPLETED|Washout||0
4957323|NCT02752087|12193970|P2|COMPLETED|Washout||12
4957324|NCT02752087|12193971|P1|COMPLETED|Washout||11
4957325|NCT02752087|12193970|P2|STARTED|Washout||12
4957326|NCT02752087|12193971|P1|STARTED|Washout||11
4957327|NCT02752087|12193970|P2|NOT COMPLETED|Study Period 2||0
4957328|NCT02752087|12193971|P1|NOT COMPLETED|Study Period 2||0
4957329|NCT02752087|12193970|P2|COMPLETED|Study Period 2||12
4957330|NCT02752087|12193971|P1|COMPLETED|Study Period 2||11
4957331|NCT02752087|12193970|P2|Received Study Drug|Study Period 2||12
4957332|NCT02752087|12193971|P1|Received Study Drug|Study Period 2||11
4957333|NCT02752087|12193970|P2|STARTED|Study Period 2||12
4957334|NCT02752087|12193971|P1|STARTED|Study Period 2||11
4957335|NCT02752087|12193970|P2|NOT COMPLETED|Washout||0
4957336|NCT02752087|12193971|P1|NOT COMPLETED|Washout||1
4957337|NCT02752087|12193970|P2|COMPLETED|Washout||12
4957338|NCT02752087|12193971|P1|COMPLETED|Washout||11
4957339|NCT02752087|12193970|P2|STARTED|Washout||12
4957340|NCT02752087|12193971|P1|STARTED|Washout||12
4957341|NCT02752087|12193970|P2|NOT COMPLETED|Study Period 1||0
4957342|NCT02752087|12193971|P1|NOT COMPLETED|Study Period 1||0
4957343|NCT02752087|12193970|P2|COMPLETED|Study Period 1||12
4957344|NCT02752087|12193971|P1|COMPLETED|Study Period 1||12
4957345|NCT02752087|12193970|P2|Received Study Drug|Study Period 1||12
4957346|NCT02752087|12193971|P1|Received Study Drug|Study Period 1||12
4957347|NCT02752087|12193970|P2|STARTED|Study Period 1||12
4957348|NCT02752087|12193971|P1|STARTED|Study Period 1||12
4957349|NCT02752074|12193981|P2|NOT COMPLETED|Overall Study||352
4957350|NCT02752074|12193982|P1|NOT COMPLETED|Overall Study||354
4957351|NCT02752074|12193981|P2|COMPLETED|Overall Study||0
4957352|NCT02752074|12193982|P1|COMPLETED|Overall Study||0
4957353|NCT02752074|12193981|P2|Treated|Overall Study||352
4957354|NCT02752074|12193982|P1|Treated|Overall Study||353
4957355|NCT02752074|12193981|P2|STARTED|Overall Study||352
4957356|NCT02752074|12193982|P1|STARTED|Overall Study||354
4957357|NCT02752048|12194007|P3|NOT COMPLETED|Overall Study||3
4957358|NCT02752048|12194008|P2|NOT COMPLETED|Overall Study||0
4957359|NCT02752048|12194009|P1|NOT COMPLETED|Overall Study||0
4957360|NCT02752048|12194007|P3|COMPLETED|Overall Study||10
4957361|NCT02752048|12194008|P2|COMPLETED|Overall Study||12
4957362|NCT02752048|12194009|P1|COMPLETED|Overall Study||11
4957363|NCT02752048|12194007|P3|STARTED|Overall Study||13
4957364|NCT02752048|12194008|P2|STARTED|Overall Study||12
4957365|NCT02752048|12194009|P1|STARTED|Overall Study||11
4957366|NCT02751983|12194028|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
4957367|NCT02751983|12194029|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
4957368|NCT02751983|12194028|P2|COMPLETED|Three-Month Follow-Up Assessments||19
4957369|NCT02751983|12194029|P1|COMPLETED|Three-Month Follow-Up Assessments||23
4957370|NCT02751983|12194028|P2|STARTED|Three-Month Follow-Up Assessments||35
4957371|NCT02751983|12194029|P1|STARTED|Three-Month Follow-Up Assessments||35
4957372|NCT02751983|12194028|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
4957373|NCT02751983|12194029|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
4957374|NCT02751983|12194028|P2|COMPLETED|One-Month Follow-Up Assessments||23
4957375|NCT02751983|12194029|P1|COMPLETED|One-Month Follow-Up Assessments||21
4957376|NCT02751983|12194028|P2|STARTED|One-Month Follow-Up Assessments||35
4957377|NCT02751983|12194029|P1|STARTED|One-Month Follow-Up Assessments||35
4957378|NCT02751983|12194028|P2|NOT COMPLETED|Post-Treatment Assessment||0
4957379|NCT02751983|12194029|P1|NOT COMPLETED|Post-Treatment Assessment||5
4957380|NCT02751983|12194028|P2|COMPLETED|Post-Treatment Assessment||0
4957381|NCT02751983|12194029|P1|COMPLETED|Post-Treatment Assessment||30
4957382|NCT02751983|12194028|P2|STARTED|Post-Treatment Assessment||0
4957383|NCT02751983|12194029|P1|STARTED|Post-Treatment Assessment||35
4957384|NCT02751983|12194028|P2|NOT COMPLETED|Treatment||0
4957385|NCT02751983|12194029|P1|NOT COMPLETED|Treatment||4
4957386|NCT02751983|12194028|P2|COMPLETED|Treatment||35
4957387|NCT02751983|12194029|P1|COMPLETED|Treatment||31
4957388|NCT02751983|12194028|P2|STARTED|Treatment||35
4957389|NCT02751983|12194029|P1|STARTED|Treatment||35
4957390|NCT02751983|12194028|P2|NOT COMPLETED|Baseline and Randomization||0
4957391|NCT02751983|12194029|P1|NOT COMPLETED|Baseline and Randomization||0
4957392|NCT02751983|12194028|P2|COMPLETED|Baseline and Randomization||35
4957393|NCT02751983|12194029|P1|COMPLETED|Baseline and Randomization||35
4957394|NCT02751983|12194028|P2|STARTED|Baseline and Randomization||35
4957395|NCT02751983|12194029|P1|STARTED|Baseline and Randomization||35
4957396|NCT02751931|12194050|P2|NOT COMPLETED|Overall Study||8
4957397|NCT02751931|12194051|P1|NOT COMPLETED|Overall Study||13
4957398|NCT02751931|12194050|P2|COMPLETED|Overall Study||27
4957399|NCT02751931|12194051|P1|COMPLETED|Overall Study||43
4957400|NCT02751931|12194050|P2|Treated|Overall Study||31
4957401|NCT02751931|12194051|P1|Treated|Overall Study||55
4957402|NCT02751931|12194050|P2|STARTED|Overall Study||35
4957403|NCT02751931|12194051|P1|STARTED|Overall Study||56
4957404|NCT02751879|12194125|P2|NOT COMPLETED|Overall Study||0
4957405|NCT02751879|12194126|P1|NOT COMPLETED|Overall Study||0
4957406|NCT02751879|12194125|P2|COMPLETED|Overall Study||71
4957407|NCT02751879|12194126|P1|COMPLETED|Overall Study||157
4957408|NCT02751879|12194125|P2|On Treatment at Study Completion|Overall Study||41
4957409|NCT02751879|12194126|P1|On Treatment at Study Completion|Overall Study||81
4957410|NCT02751879|12194125|P2|STARTED|Overall Study||71
4957411|NCT02751879|12194126|P1|STARTED|Overall Study||157
4957412|NCT02751450|12194141|P2|NOT COMPLETED|Overall Study||0
4957413|NCT02751450|12194142|P1|NOT COMPLETED|Overall Study||1
4957414|NCT02751450|12194141|P2|COMPLETED|Overall Study||116
4957415|NCT02751450|12194142|P1|COMPLETED|Overall Study||116
4957416|NCT02751450|12194141|P2|STARTED|Overall Study||116
4957417|NCT02751450|12194142|P1|STARTED|Overall Study||117
4957418|NCT02751424|12194163|P9|NOT COMPLETED|Part 2||0
4957419|NCT02751424|12194164|P8|NOT COMPLETED|Part 2||5
4957420|NCT02751424|12194165|P7|NOT COMPLETED|Part 2||0
4957421|NCT02751424|12194166|P6|NOT COMPLETED|Part 2||0
4957422|NCT02751424|12194167|P5|NOT COMPLETED|Part 2||0
4957423|NCT02751424|12194168|P4|NOT COMPLETED|Part 2||0
4957424|NCT02751424|12194169|P3|NOT COMPLETED|Part 2||0
4957425|NCT02751424|12194170|P2|NOT COMPLETED|Part 2||0
4957426|NCT02751424|12194171|P1|NOT COMPLETED|Part 2||0
4957427|NCT02751424|12194163|P9|COMPLETED|Part 2||3
4957428|NCT02751424|12194164|P8|COMPLETED|Part 2||6
4957429|NCT02751424|12194165|P7|COMPLETED|Part 2||0
4957430|NCT02751424|12194166|P6|COMPLETED|Part 2||0
4957431|NCT02751424|12194167|P5|COMPLETED|Part 2||0
4957432|NCT02751424|12194168|P4|COMPLETED|Part 2||0
4957433|NCT02751424|12194169|P3|COMPLETED|Part 2||0
4957434|NCT02751424|12194170|P2|COMPLETED|Part 2||0
4957435|NCT02751424|12194171|P1|COMPLETED|Part 2||0
4957436|NCT02751424|12194163|P9|STARTED|Part 2||3
4957437|NCT02751424|12194164|P8|STARTED|Part 2||11
4957438|NCT02751424|12194165|P7|STARTED|Part 2||0
4957439|NCT02751424|12194166|P6|STARTED|Part 2||0
4957440|NCT02751424|12194167|P5|STARTED|Part 2||0
4957441|NCT02751424|12194168|P4|STARTED|Part 2||0
4957442|NCT02751424|12194169|P3|STARTED|Part 2||0
4957443|NCT02751424|12194170|P2|STARTED|Part 2||0
4957444|NCT02751424|12194171|P1|STARTED|Part 2||0
4957445|NCT02751424|12194163|P9|NOT COMPLETED|Part 1||0
4957446|NCT02751424|12194164|P8|NOT COMPLETED|Part 1||0
4957447|NCT02751424|12194165|P7|NOT COMPLETED|Part 1||0
4957448|NCT02751424|12194166|P6|NOT COMPLETED|Part 1||0
4957449|NCT02751424|12194167|P5|NOT COMPLETED|Part 1||0
4957450|NCT02751424|12194168|P4|NOT COMPLETED|Part 1||0
4957451|NCT02751424|12194169|P3|NOT COMPLETED|Part 1||0
4957452|NCT02751424|12194170|P2|NOT COMPLETED|Part 1||0
4957453|NCT02751424|12194171|P1|NOT COMPLETED|Part 1||0
4957454|NCT02751424|12194163|P9|COMPLETED|Part 1||0
4957455|NCT02751424|12194164|P8|COMPLETED|Part 1||0
4957456|NCT02751424|12194165|P7|COMPLETED|Part 1||12
4957457|NCT02751424|12194166|P6|COMPLETED|Part 1||6
4957458|NCT02751424|12194167|P5|COMPLETED|Part 1||6
4957459|NCT02751424|12194168|P4|COMPLETED|Part 1||6
4957460|NCT02751424|12194169|P3|COMPLETED|Part 1||6
4957461|NCT02751424|12194170|P2|COMPLETED|Part 1||6
4957462|NCT02751424|12194171|P1|COMPLETED|Part 1||6
4957463|NCT02751424|12194163|P9|STARTED|Part 1||0
4957464|NCT02751424|12194164|P8|STARTED|Part 1||0
4957465|NCT02751424|12194165|P7|STARTED|Part 1||12
4957466|NCT02751424|12194166|P6|STARTED|Part 1||6
4957467|NCT02751424|12194167|P5|STARTED|Part 1||6
4957468|NCT02751424|12194168|P4|STARTED|Part 1||6
4957469|NCT02751424|12194169|P3|STARTED|Part 1||6
4957470|NCT02751424|12194170|P2|STARTED|Part 1||6
4957471|NCT02751424|12194171|P1|STARTED|Part 1||6
4957472|NCT02751385|12194314|P2|NOT COMPLETED|Period 2||0
4957473|NCT02751385|12194315|P1|NOT COMPLETED|Period 2||0
4957474|NCT02751385|12194314|P2|COMPLETED|Period 2||2
4957475|NCT02751385|12194315|P1|COMPLETED|Period 2||0
4957476|NCT02751385|12194314|P2|STARTED|Period 2||2
4957477|NCT02751385|12194315|P1|STARTED|Period 2||0
4957478|NCT02751385|12194314|P2|NOT COMPLETED|Period 1||0
4957479|NCT02751385|12194315|P1|NOT COMPLETED|Period 1||0
4957480|NCT02751385|12194314|P2|COMPLETED|Period 1||0
4957481|NCT02751385|12194315|P1|COMPLETED|Period 1||2
4957482|NCT02751385|12194314|P2|STARTED|Period 1||0
4957483|NCT02751385|12194315|P1|STARTED|Period 1||2
4957484|NCT02751320|12194327|P1|NOT COMPLETED|Overall Study||3
4957485|NCT02751320|12194327|P1|COMPLETED|Overall Study||42
4957486|NCT02751320|12194327|P1|Received Reference Product 3|Overall Study||28
4957487|NCT02751320|12194327|P1|Received Reference Product 2|Overall Study||28
4957488|NCT02751320|12194327|P1|Received Reference Product 1|Overall Study||29
4957489|NCT02751320|12194327|P1|Received Test Prodcut 3|Overall Study||28
4957490|NCT02751320|12194327|P1|Received Test Prodcut 2|Overall Study||28
4957491|NCT02751320|12194327|P1|Received Test Product 1|Overall Study||29
4957492|NCT02751320|12194327|P1|STARTED|Overall Study||45
4957493|NCT02750943|12194365|P2|NOT COMPLETED|Overall Study||9
4957494|NCT02750943|12194366|P1|NOT COMPLETED|Overall Study||6
4957495|NCT02750943|12194365|P2|COMPLETED|Overall Study||119
4957496|NCT02750943|12194366|P1|COMPLETED|Overall Study||119
4957497|NCT02750943|12194365|P2|STARTED|Overall Study||128
4957498|NCT02750943|12194366|P1|STARTED|Overall Study||125
4957499|NCT02750930|12194380|P1|NOT COMPLETED|Overall Study||8
4957500|NCT02750930|12194380|P1|COMPLETED|Overall Study||0
4957501|NCT02750930|12194380|P1|STARTED|Overall Study||8
4957502|NCT02750813|12194392|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
4957503|NCT02750813|12194393|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
4957504|NCT02750813|12194392|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
4957505|NCT02750813|12194393|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
4957506|NCT02750813|12194392|P2|STARTED|Period 2, Second 14 Days of Wear||120
4957507|NCT02750813|12194393|P1|STARTED|Period 2, Second 14 Days of Wear||124
4957508|NCT02750813|12194392|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
4957509|NCT02750813|12194393|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
4957510|NCT02750813|12194392|P2|COMPLETED|Period 1, First 14 Days of Wear||120
4957511|NCT02750813|12194393|P1|COMPLETED|Period 1, First 14 Days of Wear||124
4957512|NCT02750813|12194392|P2|STARTED|Period 1, First 14 Days of Wear||121
4957513|NCT02750813|12194393|P1|STARTED|Period 1, First 14 Days of Wear||125
4957514|NCT02750800|12194408|P1|NOT COMPLETED|Overall Study||98
4957515|NCT02750800|12194408|P1|COMPLETED|Overall Study||314
4957516|NCT02750800|12194408|P1|STARTED|Overall Study||412
4957517|NCT02750761|12194513|P6|NOT COMPLETED|Overall Study||0
4957518|NCT02750761|12194514|P5|NOT COMPLETED|Overall Study||0
4957519|NCT02750761|12194515|P4|NOT COMPLETED|Overall Study||0
4957520|NCT02750761|12194516|P3|NOT COMPLETED|Overall Study||1
4957521|NCT02750761|12194517|P2|NOT COMPLETED|Overall Study||0
4957522|NCT02750761|12194518|P1|NOT COMPLETED|Overall Study||0
4957523|NCT02750761|12194513|P6|COMPLETED|Overall Study||6
4957524|NCT02750761|12194514|P5|COMPLETED|Overall Study||6
4957525|NCT02750761|12194515|P4|COMPLETED|Overall Study||5
4957526|NCT02750761|12194516|P3|COMPLETED|Overall Study||4
4957527|NCT02750761|12194517|P2|COMPLETED|Overall Study||5
4957528|NCT02750761|12194518|P1|COMPLETED|Overall Study||5
4957529|NCT02750761|12194513|P6|STARTED|Overall Study||6
4957530|NCT02750761|12194514|P5|STARTED|Overall Study||6
4957531|NCT02750761|12194515|P4|STARTED|Overall Study||5
4957532|NCT02750761|12194516|P3|STARTED|Overall Study||5
4957533|NCT02750761|12194517|P2|STARTED|Overall Study||5
4957534|NCT02750761|12194518|P1|STARTED|Overall Study||5
4957535|NCT02750709|12194614|P6|NOT COMPLETED|Treatment Period 3||0
4957536|NCT02750709|12194615|P5|NOT COMPLETED|Treatment Period 3||0
4957537|NCT02750709|12194616|P4|NOT COMPLETED|Treatment Period 3||0
4957538|NCT02750709|12194617|P3|NOT COMPLETED|Treatment Period 3||0
4957539|NCT02750709|12194618|P2|NOT COMPLETED|Treatment Period 3||0
4957540|NCT02750709|12194619|P1|NOT COMPLETED|Treatment Period 3||0
4957541|NCT02750709|12194614|P6|COMPLETED|Treatment Period 3||3
4957542|NCT02750709|12194615|P5|COMPLETED|Treatment Period 3||4
4957543|NCT02750709|12194616|P4|COMPLETED|Treatment Period 3||4
4957544|NCT02750709|12194617|P3|COMPLETED|Treatment Period 3||4
4957545|NCT02750709|12194618|P2|COMPLETED|Treatment Period 3||4
4957546|NCT02750709|12194619|P1|COMPLETED|Treatment Period 3||4
4957547|NCT02750709|12194614|P6|STARTED|Treatment Period 3||3
4957548|NCT02750709|12194615|P5|STARTED|Treatment Period 3||4
4957549|NCT02750709|12194616|P4|STARTED|Treatment Period 3||4
4957550|NCT02750709|12194617|P3|STARTED|Treatment Period 3||4
4957551|NCT02750709|12194618|P2|STARTED|Treatment Period 3||4
4957552|NCT02750709|12194619|P1|STARTED|Treatment Period 3||4
4957553|NCT02750709|12194614|P6|NOT COMPLETED|Treatment Period 2||0
4957554|NCT02750709|12194615|P5|NOT COMPLETED|Treatment Period 2||0
4957555|NCT02750709|12194616|P4|NOT COMPLETED|Treatment Period 2||0
4957556|NCT02750709|12194617|P3|NOT COMPLETED|Treatment Period 2||0
4957557|NCT02750709|12194618|P2|NOT COMPLETED|Treatment Period 2||0
4957558|NCT02750709|12194619|P1|NOT COMPLETED|Treatment Period 2||0
4957559|NCT02750709|12194614|P6|COMPLETED|Treatment Period 2||3
4957560|NCT02750709|12194615|P5|COMPLETED|Treatment Period 2||4
4957561|NCT02750709|12194616|P4|COMPLETED|Treatment Period 2||4
4957562|NCT02750709|12194617|P3|COMPLETED|Treatment Period 2||4
4957563|NCT02750709|12194618|P2|COMPLETED|Treatment Period 2||4
4957564|NCT02750709|12194619|P1|COMPLETED|Treatment Period 2||4
4957565|NCT02750709|12194614|P6|STARTED|Treatment Period 2||3
4957566|NCT02750709|12194615|P5|STARTED|Treatment Period 2||4
4957567|NCT02750709|12194616|P4|STARTED|Treatment Period 2||4
4957568|NCT02750709|12194617|P3|STARTED|Treatment Period 2||4
4957569|NCT02750709|12194618|P2|STARTED|Treatment Period 2||4
4957570|NCT02750709|12194619|P1|STARTED|Treatment Period 2||4
4957571|NCT02750709|12194614|P6|NOT COMPLETED|Treatment Period 1||1
4957572|NCT02750709|12194615|P5|NOT COMPLETED|Treatment Period 1||0
4957573|NCT02750709|12194616|P4|NOT COMPLETED|Treatment Period 1||0
4957574|NCT02750709|12194617|P3|NOT COMPLETED|Treatment Period 1||0
4957575|NCT02750709|12194618|P2|NOT COMPLETED|Treatment Period 1||0
4957576|NCT02750709|12194619|P1|NOT COMPLETED|Treatment Period 1||0
4957577|NCT02750709|12194614|P6|COMPLETED|Treatment Period 1||3
4957578|NCT02750709|12194615|P5|COMPLETED|Treatment Period 1||4
4957579|NCT02750709|12194616|P4|COMPLETED|Treatment Period 1||4
4957580|NCT02750709|12194617|P3|COMPLETED|Treatment Period 1||4
4957581|NCT02750709|12194618|P2|COMPLETED|Treatment Period 1||4
4957582|NCT02750709|12194619|P1|COMPLETED|Treatment Period 1||4
4957583|NCT02750709|12194614|P6|STARTED|Treatment Period 1||4
4957584|NCT02750709|12194615|P5|STARTED|Treatment Period 1||4
4957585|NCT02750709|12194616|P4|STARTED|Treatment Period 1||4
4957586|NCT02750709|12194617|P3|STARTED|Treatment Period 1||4
4957587|NCT02750709|12194618|P2|STARTED|Treatment Period 1||4
4957588|NCT02750709|12194619|P1|STARTED|Treatment Period 1||4
4957589|NCT02750618|12194645|P1|NOT COMPLETED|Overall Study||1
4957590|NCT02750618|12194645|P1|COMPLETED|Overall Study||12
4957591|NCT02750618|12194645|P1|Completed Week 64|Overall Study||13
4957592|NCT02750618|12194645|P1|Completed Week 40|Overall Study||13
4957593|NCT02750618|12194645|P1|STARTED|Overall Study||13
4957594|NCT02750592|12194661|P1|NOT COMPLETED|Overall Study||5
4957595|NCT02750592|12194661|P1|COMPLETED|Overall Study||25
4957596|NCT02750592|12194661|P1|STARTED|Overall Study||30
4957597|NCT02750501|12194680|P1|NOT COMPLETED|Overall Study||8
4957598|NCT02750501|12194680|P1|COMPLETED|Overall Study||36
4957599|NCT02750501|12194680|P1|Treated|Overall Study||39
4957600|NCT02750501|12194680|P1|Enrolled|Overall Study||44
4957601|NCT02750501|12194680|P1|STARTED|Overall Study||44
4957602|NCT02750410|12194694|P2|NOT COMPLETED|Open-Label Extension Period||6
4957603|NCT02750410|12194695|P1|NOT COMPLETED|Open-Label Extension Period||6
4957604|NCT02750410|12194694|P2|COMPLETED|Open-Label Extension Period||111
4957605|NCT02750410|12194695|P1|COMPLETED|Open-Label Extension Period||31
4957606|NCT02750410|12194694|P2|STARTED|Open-Label Extension Period||117
4957607|NCT02750410|12194695|P1|STARTED|Open-Label Extension Period||37
4957608|NCT02750410|12194694|P2|NOT COMPLETED|Double-Blind Treatment Period||3
4957609|NCT02750410|12194695|P1|NOT COMPLETED|Double-Blind Treatment Period||2
4957610|NCT02750410|12194694|P2|COMPLETED|Double-Blind Treatment Period||117
4957611|NCT02750410|12194695|P1|COMPLETED|Double-Blind Treatment Period||37
4957612|NCT02750410|12194694|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
4957613|NCT02750410|12194695|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
4957614|NCT02750410|12194694|P2|STARTED|Double-Blind Treatment Period||120
4957615|NCT02750410|12194695|P1|STARTED|Double-Blind Treatment Period||39
4957616|NCT02750345|12194713|P6|NOT COMPLETED|Intervention 3||0
4957617|NCT02750345|12194714|P5|NOT COMPLETED|Intervention 3||0
4957618|NCT02750345|12194715|P4|NOT COMPLETED|Intervention 3||0
4957619|NCT02750345|12194716|P3|NOT COMPLETED|Intervention 3||0
4957620|NCT02750345|12194717|P2|NOT COMPLETED|Intervention 3||0
4957621|NCT02750345|12194718|P1|NOT COMPLETED|Intervention 3||0
4957622|NCT02750345|12194713|P6|COMPLETED|Intervention 3||4
4957623|NCT02750345|12194714|P5|COMPLETED|Intervention 3||3
4957624|NCT02750345|12194715|P4|COMPLETED|Intervention 3||4
4957625|NCT02750345|12194716|P3|COMPLETED|Intervention 3||4
4957626|NCT02750345|12194717|P2|COMPLETED|Intervention 3||4
4957627|NCT02750345|12194718|P1|COMPLETED|Intervention 3||4
4957628|NCT02750345|12194713|P6|STARTED|Intervention 3||4
4957629|NCT02750345|12194714|P5|STARTED|Intervention 3||3
4957630|NCT02750345|12194715|P4|STARTED|Intervention 3||4
4957631|NCT02750345|12194716|P3|STARTED|Intervention 3||4
4957632|NCT02750345|12194717|P2|STARTED|Intervention 3||4
4957633|NCT02750345|12194718|P1|STARTED|Intervention 3||4
4957634|NCT02750345|12194713|P6|NOT COMPLETED|Intervention 2||0
4957635|NCT02750345|12194714|P5|NOT COMPLETED|Intervention 2||0
4957636|NCT02750345|12194715|P4|NOT COMPLETED|Intervention 2||0
4957637|NCT02750345|12194716|P3|NOT COMPLETED|Intervention 2||0
4957638|NCT02750345|12194717|P2|NOT COMPLETED|Intervention 2||0
4957639|NCT02750345|12194718|P1|NOT COMPLETED|Intervention 2||0
4957640|NCT02750345|12194713|P6|COMPLETED|Intervention 2||4
4957641|NCT02750345|12194714|P5|COMPLETED|Intervention 2||3
4957642|NCT02750345|12194715|P4|COMPLETED|Intervention 2||4
4957643|NCT02750345|12194716|P3|COMPLETED|Intervention 2||4
4957644|NCT02750345|12194717|P2|COMPLETED|Intervention 2||4
4957645|NCT02750345|12194718|P1|COMPLETED|Intervention 2||4
4957646|NCT02750345|12194713|P6|STARTED|Intervention 2||4
4957647|NCT02750345|12194714|P5|STARTED|Intervention 2||3
4957648|NCT02750345|12194715|P4|STARTED|Intervention 2||4
4957649|NCT02750345|12194716|P3|STARTED|Intervention 2||4
4957650|NCT02750345|12194717|P2|STARTED|Intervention 2||4
4957651|NCT02750345|12194718|P1|STARTED|Intervention 2||4
4957652|NCT02750345|12194713|P6|NOT COMPLETED|Intervention 1||0
4957653|NCT02750345|12194714|P5|NOT COMPLETED|Intervention 1||1
4957654|NCT02750345|12194715|P4|NOT COMPLETED|Intervention 1||0
4957655|NCT02750345|12194716|P3|NOT COMPLETED|Intervention 1||0
4957656|NCT02750345|12194717|P2|NOT COMPLETED|Intervention 1||0
4957657|NCT02750345|12194718|P1|NOT COMPLETED|Intervention 1||0
4957658|NCT02750345|12194713|P6|COMPLETED|Intervention 1||4
4957659|NCT02750345|12194714|P5|COMPLETED|Intervention 1||3
4957660|NCT02750345|12194715|P4|COMPLETED|Intervention 1||4
4957661|NCT02750345|12194716|P3|COMPLETED|Intervention 1||4
4957662|NCT02750345|12194717|P2|COMPLETED|Intervention 1||4
4957663|NCT02750345|12194718|P1|COMPLETED|Intervention 1||4
4957664|NCT02750345|12194713|P6|STARTED|Intervention 1||4
4957665|NCT02750345|12194714|P5|STARTED|Intervention 1||4
4957666|NCT02750345|12194715|P4|STARTED|Intervention 1||4
4957667|NCT02750345|12194716|P3|STARTED|Intervention 1||4
4957668|NCT02750345|12194717|P2|STARTED|Intervention 1||4
4957669|NCT02750345|12194718|P1|STARTED|Intervention 1||4
4957670|NCT02750332|12194744|P2|NOT COMPLETED|Treatment Period 2||0
4957671|NCT02750332|12194745|P1|NOT COMPLETED|Treatment Period 2||0
4957672|NCT02750332|12194744|P2|COMPLETED|Treatment Period 2||9
4957673|NCT02750332|12194745|P1|COMPLETED|Treatment Period 2||10
4957674|NCT02750332|12194744|P2|STARTED|Treatment Period 2||9
4957675|NCT02750332|12194745|P1|STARTED|Treatment Period 2||10
4957676|NCT02750332|12194744|P2|NOT COMPLETED|Treatment Period 1||1
4957677|NCT02750332|12194745|P1|NOT COMPLETED|Treatment Period 1||0
4957678|NCT02750332|12194744|P2|COMPLETED|Treatment Period 1||9
4957679|NCT02750332|12194745|P1|COMPLETED|Treatment Period 1||10
4957680|NCT02750332|12194744|P2|STARTED|Treatment Period 1||10
4957681|NCT02750332|12194745|P1|STARTED|Treatment Period 1||10
4957682|NCT02750306|12194765|P2|NOT COMPLETED|Overall Study||2
4957683|NCT02750306|12194766|P1|NOT COMPLETED|Overall Study||6
4957684|NCT02750306|12194765|P2|COMPLETED|Overall Study||141
4957685|NCT02750306|12194766|P1|COMPLETED|Overall Study||136
4957686|NCT02750306|12194765|P2|STARTED|Overall Study||143
4957687|NCT02750306|12194766|P1|STARTED|Overall Study||142
4957688|NCT02750267|12194780|P2|NOT COMPLETED|Overall Study||0
4957689|NCT02750267|12194781|P1|NOT COMPLETED|Overall Study||0
4957690|NCT02750267|12194780|P2|COMPLETED|Overall Study||6
4957691|NCT02750267|12194781|P1|COMPLETED|Overall Study||6
4957692|NCT02750267|12194780|P2|STARTED|Overall Study||6
4957693|NCT02750267|12194781|P1|STARTED|Overall Study||6
4957694|NCT02749903|12194819|P1|NOT COMPLETED|Overall Study||0
4957695|NCT02749903|12194819|P1|COMPLETED|Overall Study||46
4957696|NCT02749903|12194819|P1|STARTED|Overall Study||46
4957697|NCT02749370|12194825|P1|NOT COMPLETED|Overall Study||14
4957698|NCT02749370|12194825|P1|COMPLETED|Overall Study||66
4957699|NCT02749370|12194825|P1|STARTED|Overall Study||80
4957700|NCT02749201|12194852|P1|NOT COMPLETED|Overall Study||0
4957701|NCT02749201|12194852|P1|COMPLETED|Overall Study||10
4957702|NCT02749201|12194852|P1|STARTED|Overall Study||10
4957703|NCT02748928|12194856|P1|NOT COMPLETED|Overall Study||0
4957704|NCT02748928|12194856|P1|COMPLETED|Overall Study||62
4957705|NCT02748928|12194856|P1|STARTED|Overall Study||62
4957706|NCT02748889|12194867|P2|NOT COMPLETED|Overall Study||0
4957707|NCT02748889|12194868|P1|NOT COMPLETED|Overall Study||0
4957708|NCT02748889|12194867|P2|COMPLETED|Overall Study||1
4957709|NCT02748889|12194868|P1|COMPLETED|Overall Study||0
4957710|NCT02748889|12194867|P2|STARTED|Overall Study||1
4957711|NCT02748889|12194868|P1|STARTED|Overall Study||0
4957712|NCT02748863|12194875|P5|NOT COMPLETED|Treatment Period 2||1
4957713|NCT02748863|12194876|P4|NOT COMPLETED|Treatment Period 2||2
4957714|NCT02748863|12194877|P3|NOT COMPLETED|Treatment Period 2||0
4957715|NCT02748863|12194878|P2|NOT COMPLETED|Treatment Period 2||3
4957716|NCT02748863|12194879|P1|NOT COMPLETED|Treatment Period 2||5
4957717|NCT02748863|12194875|P5|COMPLETED|Treatment Period 2||33
4957718|NCT02748863|12194876|P4|COMPLETED|Treatment Period 2||32
4957719|NCT02748863|12194877|P3|COMPLETED|Treatment Period 2||0
4957720|NCT02748863|12194878|P2|COMPLETED|Treatment Period 2||66
4957721|NCT02748863|12194879|P1|COMPLETED|Treatment Period 2||67
4957722|NCT02748863|12194875|P5|STARTED|Treatment Period 2||34
4957723|NCT02748863|12194876|P4|STARTED|Treatment Period 2||34
4957724|NCT02748863|12194877|P3|STARTED|Treatment Period 2||0
4957725|NCT02748863|12194878|P2|STARTED|Treatment Period 2||69
4957726|NCT02748863|12194879|P1|STARTED|Treatment Period 2||72
4957727|NCT02748863|12194875|P5|NOT COMPLETED|Treatment Period 1||0
4957728|NCT02748863|12194876|P4|NOT COMPLETED|Treatment Period 1||0
4957729|NCT02748863|12194877|P3|NOT COMPLETED|Treatment Period 1||2
4957730|NCT02748863|12194878|P2|NOT COMPLETED|Treatment Period 1||2
4957731|NCT02748863|12194879|P1|NOT COMPLETED|Treatment Period 1||0
4957732|NCT02748863|12194875|P5|COMPLETED|Treatment Period 1||0
4957733|NCT02748863|12194876|P4|COMPLETED|Treatment Period 1||0
4957734|NCT02748863|12194877|P3|COMPLETED|Treatment Period 1||69
4957735|NCT02748863|12194878|P2|COMPLETED|Treatment Period 1||69
4957736|NCT02748863|12194879|P1|COMPLETED|Treatment Period 1||72
4957737|NCT02748863|12194875|P5|STARTED|Treatment Period 1|Not applicable for this period|0
4957738|NCT02748863|12194876|P4|STARTED|Treatment Period 1|Not applicable for this period|0
4957739|NCT02748863|12194877|P3|STARTED|Treatment Period 1||71
4957740|NCT02748863|12194878|P2|STARTED|Treatment Period 1||71
4957741|NCT02748863|12194879|P1|STARTED|Treatment Period 1||72
4957742|NCT02748785|12194905|P4|NOT COMPLETED|Visit 3- Visit 4||2
4957743|NCT02748785|12194906|P3|NOT COMPLETED|Visit 3- Visit 4||2
4957744|NCT02748785|12194907|P2|NOT COMPLETED|Visit 3- Visit 4||1
4957745|NCT02748785|12194908|P1|NOT COMPLETED|Visit 3- Visit 4||1
4957746|NCT02748785|12194905|P4|COMPLETED|Visit 3- Visit 4||50
4957747|NCT02748785|12194906|P3|COMPLETED|Visit 3- Visit 4||47
4957748|NCT02748785|12194907|P2|COMPLETED|Visit 3- Visit 4||43
4957749|NCT02748785|12194908|P1|COMPLETED|Visit 3- Visit 4||53
4957750|NCT02748785|12194905|P4|STARTED|Visit 3- Visit 4||52
4957751|NCT02748785|12194906|P3|STARTED|Visit 3- Visit 4||49
4957752|NCT02748785|12194907|P2|STARTED|Visit 3- Visit 4||44
4957753|NCT02748785|12194908|P1|STARTED|Visit 3- Visit 4||54
4957754|NCT02748785|12194905|P4|NOT COMPLETED|Visit 2-Visit 3||11
4957755|NCT02748785|12194906|P3|NOT COMPLETED|Visit 2-Visit 3||8
4957756|NCT02748785|12194907|P2|NOT COMPLETED|Visit 2-Visit 3||5
4957757|NCT02748785|12194908|P1|NOT COMPLETED|Visit 2-Visit 3||5
4957758|NCT02748785|12194905|P4|COMPLETED|Visit 2-Visit 3||52
4957759|NCT02748785|12194906|P3|COMPLETED|Visit 2-Visit 3||49
4957760|NCT02748785|12194907|P2|COMPLETED|Visit 2-Visit 3||44
4957761|NCT02748785|12194908|P1|COMPLETED|Visit 2-Visit 3||54
4957762|NCT02748785|12194905|P4|STARTED|Visit 2-Visit 3||63
4957763|NCT02748785|12194906|P3|STARTED|Visit 2-Visit 3||57
4957764|NCT02748785|12194907|P2|STARTED|Visit 2-Visit 3||49
4957765|NCT02748785|12194908|P1|STARTED|Visit 2-Visit 3||59
4957766|NCT02748785|12194905|P4|NOT COMPLETED|Visit 1- Visit 2||6
4957767|NCT02748785|12194906|P3|NOT COMPLETED|Visit 1- Visit 2||14
4957768|NCT02748785|12194907|P2|NOT COMPLETED|Visit 1- Visit 2||19
4957769|NCT02748785|12194908|P1|NOT COMPLETED|Visit 1- Visit 2||10
4957770|NCT02748785|12194905|P4|COMPLETED|Visit 1- Visit 2||63
4957771|NCT02748785|12194906|P3|COMPLETED|Visit 1- Visit 2||57
4957772|NCT02748785|12194907|P2|COMPLETED|Visit 1- Visit 2||49
4957773|NCT02748785|12194908|P1|COMPLETED|Visit 1- Visit 2||59
4957774|NCT02748785|12194905|P4|STARTED|Visit 1- Visit 2||69
4957775|NCT02748785|12194906|P3|STARTED|Visit 1- Visit 2||71
4957776|NCT02748785|12194907|P2|STARTED|Visit 1- Visit 2||68
4957777|NCT02748785|12194908|P1|STARTED|Visit 1- Visit 2||69
4957778|NCT02748525|12194954|P1|NOT COMPLETED|Overall Study||11
4957779|NCT02748525|12194954|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
4957780|NCT02748525|12194954|P1|Completed Study Intervention|Overall Study||50
4957781|NCT02748525|12194954|P1|STARTED|Overall Study||50
4957782|NCT02748512|12194963|P2|NOT COMPLETED|Overall Study||1
4957783|NCT02748512|12194964|P1|NOT COMPLETED|Overall Study||1
4957784|NCT02748512|12194963|P2|COMPLETED|Overall Study||11
4957785|NCT02748512|12194964|P1|COMPLETED|Overall Study||13
4957786|NCT02748512|12194963|P2|STARTED|Overall Study||12
4957787|NCT02748512|12194964|P1|STARTED|Overall Study||14
4957788|NCT02748356|12194972|P1|NOT COMPLETED|Overall Study||1
4957789|NCT02748356|12194972|P1|COMPLETED|Overall Study||6
4957790|NCT02748356|12194972|P1|STARTED|Overall Study||7
4957791|NCT02748317|12194977|P1|NOT COMPLETED|Overall Study||23
4957792|NCT02748317|12194977|P1|COMPLETED|Overall Study||73
4957793|NCT02748317|12194977|P1|STARTED|Overall Study||96
4957794|NCT02748213|12194984|P2|NOT COMPLETED|Overall Study||112
4957795|NCT02748213|12194985|P1|NOT COMPLETED|Overall Study||113
4957796|NCT02748213|12194984|P2|COMPLETED|Overall Study||0
4957797|NCT02748213|12194985|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
4957798|NCT02748213|12194984|P2|Treated|Overall Study||110
4957799|NCT02748213|12194985|P1|Treated|Overall Study||112
4957800|NCT02748213|12194984|P2|STARTED|Overall Study||112
4957801|NCT02748213|12194985|P1|STARTED|Overall Study||113
4957802|NCT02748070|12195003|P2|NOT COMPLETED|Overall Study||1
4957803|NCT02748070|12195004|P1|NOT COMPLETED|Overall Study||8
4957804|NCT02748070|12195003|P2|COMPLETED|Overall Study||39
4957805|NCT02748070|12195004|P1|COMPLETED|Overall Study||33
4957806|NCT02748070|12195003|P2|Randomized and Treated|Overall Study||40
4957807|NCT02748070|12195004|P1|Randomized and Treated|Overall Study||40
4957808|NCT02748070|12195003|P2|STARTED|Overall Study||40
4957809|NCT02748070|12195004|P1|STARTED|Overall Study||41
4957810|NCT02748057|12195014|P2|NOT COMPLETED|Overall Study||2
4957811|NCT02748057|12195015|P1|NOT COMPLETED|Overall Study||5
4957812|NCT02748057|12195014|P2|COMPLETED|Overall Study||19
4957813|NCT02748057|12195015|P1|COMPLETED|Overall Study||109
4957814|NCT02748057|12195014|P2|STARTED|Overall Study||21
4957815|NCT02748057|12195015|P1|STARTED|Overall Study||114
4957816|NCT02747433|12195027|P2|NOT COMPLETED|Overall Study||0
4957817|NCT02747433|12195028|P1|NOT COMPLETED|Overall Study||0
4957818|NCT02747433|12195027|P2|COMPLETED|Overall Study||5
4957819|NCT02747433|12195028|P1|COMPLETED|Overall Study||5
4957820|NCT02747433|12195027|P2|STARTED|Overall Study||5
4957821|NCT02747433|12195028|P1|STARTED|Overall Study||5
4957822|NCT02747186|12195058|P2|NOT COMPLETED|Second Intervention||0
4957823|NCT02747186|12195059|P1|NOT COMPLETED|Second Intervention||0
4957824|NCT02747186|12195058|P2|COMPLETED|Second Intervention||12
4957825|NCT02747186|12195059|P1|COMPLETED|Second Intervention||12
4957826|NCT02747186|12195058|P2|STARTED|Second Intervention||12
4957827|NCT02747186|12195059|P1|STARTED|Second Intervention||12
4957828|NCT02747186|12195058|P2|NOT COMPLETED|Washout (1 Week)||0
4957829|NCT02747186|12195059|P1|NOT COMPLETED|Washout (1 Week)||0
4957830|NCT02747186|12195058|P2|COMPLETED|Washout (1 Week)||12
4957831|NCT02747186|12195059|P1|COMPLETED|Washout (1 Week)||12
4957832|NCT02747186|12195058|P2|STARTED|Washout (1 Week)||12
4957833|NCT02747186|12195059|P1|STARTED|Washout (1 Week)||12
4957834|NCT02747186|12195058|P2|NOT COMPLETED|First Intervention||0
4957835|NCT02747186|12195059|P1|NOT COMPLETED|First Intervention||0
4957836|NCT02747186|12195058|P2|COMPLETED|First Intervention||12
4957837|NCT02747186|12195059|P1|COMPLETED|First Intervention||12
4957838|NCT02747186|12195058|P2|STARTED|First Intervention||12
4957839|NCT02747186|12195059|P1|STARTED|First Intervention||12
4957840|NCT02747004|12195070|P3|NOT COMPLETED|Overall Study||47
4957841|NCT02747004|12195071|P2|NOT COMPLETED|Overall Study||49
4957842|NCT02747004|12195072|P1|NOT COMPLETED|Overall Study||57
4957843|NCT02747004|12195070|P3|COMPLETED|Overall Study||30
4957844|NCT02747004|12195071|P2|COMPLETED|Overall Study||30
4957845|NCT02747004|12195072|P1|COMPLETED|Overall Study||21
4957846|NCT02747004|12195070|P3|Received at Least One Dose of Study Drug|Overall Study||77
4957847|NCT02747004|12195071|P2|Received at Least One Dose of Study Drug|Overall Study||79
4957848|NCT02747004|12195072|P1|Received at Least One Dose of Study Drug|Overall Study||78
4957849|NCT02747004|12195070|P3|STARTED|Overall Study||77
4957850|NCT02747004|12195071|P2|STARTED|Overall Study||79
4957851|NCT02747004|12195072|P1|STARTED|Overall Study||78
4957852|NCT02746991|12195102|P2|NOT COMPLETED|Overall Study||34
4957853|NCT02746991|12195103|P1|NOT COMPLETED|Overall Study||28
4957854|NCT02746991|12195102|P2|COMPLETED|Overall Study||67
4957855|NCT02746991|12195103|P1|COMPLETED|Overall Study||24
4957856|NCT02746991|12195102|P2|STARTED|Overall Study||101
4957857|NCT02746991|12195103|P1|STARTED|Overall Study||52
4957858|NCT02746809|12195111|P1|NOT COMPLETED|Baseline-6 Months||5
4957859|NCT02746809|12195111|P1|COMPLETED|Baseline-6 Months||54
4957860|NCT02746809|12195111|P1|STARTED|Baseline-6 Months||59
4957861|NCT02746809|12195111|P1|NOT COMPLETED|Baseline- 30 Days||1
4957862|NCT02746809|12195111|P1|COMPLETED|Baseline- 30 Days||59
4957863|NCT02746809|12195111|P1|STARTED|Baseline- 30 Days||60
4957864|NCT02746705|12195131|P2|NOT COMPLETED|Overall Study||2
4957865|NCT02746705|12195132|P1|NOT COMPLETED|Overall Study||2
4957866|NCT02746705|12195131|P2|COMPLETED|Overall Study||12
4957867|NCT02746705|12195132|P1|COMPLETED|Overall Study||15
4957868|NCT02746705|12195131|P2|STARTED|Overall Study||14
4957869|NCT02746705|12195132|P1|STARTED|Overall Study||17
4957870|NCT02746679|12195146|P2|NOT COMPLETED|Overall Study||6
4957871|NCT02746679|12195147|P1|NOT COMPLETED|Overall Study||4
4957872|NCT02746679|12195146|P2|COMPLETED|Overall Study||75
4957873|NCT02746679|12195147|P1|COMPLETED|Overall Study||76
4957874|NCT02746679|12195146|P2|STARTED|Overall Study||81
4957875|NCT02746679|12195147|P1|STARTED|Overall Study||80
4957876|NCT02746627|12195180|P3|NOT COMPLETED|Overall Study||1
4957877|NCT02746627|12195181|P2|NOT COMPLETED|Overall Study||1
4957878|NCT02746627|12195182|P1|NOT COMPLETED|Overall Study||1
4957879|NCT02746627|12195180|P3|COMPLETED|Overall Study||29
4957880|NCT02746627|12195181|P2|COMPLETED|Overall Study||29
4957881|NCT02746627|12195182|P1|COMPLETED|Overall Study||59
4957882|NCT02746627|12195180|P3|STARTED|Overall Study||30
4957883|NCT02746627|12195181|P2|STARTED|Overall Study||30
4957884|NCT02746627|12195182|P1|STARTED|Overall Study||60
4957885|NCT02746575|12195205|P1|NOT COMPLETED|Overall Study||50
4957886|NCT02746575|12195205|P1|COMPLETED|Overall Study||20
4957887|NCT02746575|12195205|P1|STARTED|Overall Study||70
4957888|NCT02746406|12195209|P1|NOT COMPLETED|Overall Study||0
4957889|NCT02746406|12195209|P1|COMPLETED|Overall Study||5
4957890|NCT02746406|12195209|P1|STARTED|Overall Study||5
4957891|NCT02746263|12195215|P2|NOT COMPLETED|Overall Study||0
4957892|NCT02746263|12195216|P1|NOT COMPLETED|Overall Study||0
4957893|NCT02746263|12195215|P2|COMPLETED|Overall Study||1
4957894|NCT02746263|12195216|P1|COMPLETED|Overall Study||0
4957895|NCT02746263|12195215|P2|Per Protocol Analysis Set|Overall Study||0
4957896|NCT02746263|12195216|P1|Per Protocol Analysis Set|Overall Study||0
4957897|NCT02746263|12195215|P2|STARTED|Overall Study||1
4957898|NCT02746263|12195216|P1|STARTED|Overall Study||0
4957899|NCT02746107|12195222|P1|NOT COMPLETED|Overall Study||0
4957900|NCT02746107|12195222|P1|COMPLETED|Overall Study||968
4957901|NCT02746107|12195222|P1|CHA2DS2-VASC Score = 5|Overall Study||192
4957902|NCT02746107|12195222|P1|CHA2DS2-VASC Score = 4|Overall Study||197
4957903|NCT02746107|12195222|P1|CHA2DS2-VASC Score = 3|Overall Study||195
4957904|NCT02746107|12195222|P1|CHA2DS2-VASC Score = 2|Overall Study||189
4957905|NCT02746107|12195222|P1|CHA2DS2-VASC Score = 1|Overall Study||195
4957906|NCT02746107|12195222|P1|Target=Physician|Overall Study||482
4957907|NCT02746107|12195222|P1|Target=Patient|Overall Study||486
4957908|NCT02746107|12195222|P1|5year Risk Estimate|Overall Study||485
4957909|NCT02746107|12195222|P1|1year Risk Estimate|Overall Study||483
4957910|NCT02746107|12195222|P1|1 Diagram DA|Overall Study||486
4957911|NCT02746107|12195222|P1|2 Diagrams DA|Overall Study||482
4957912|NCT02746107|12195222|P1|STARTED|Overall Study||968
4957913|NCT02745626|12195240|P3|NOT COMPLETED|Overall Study||3
4957914|NCT02745626|12195241|P2|NOT COMPLETED|Overall Study||6
4957915|NCT02745626|12195242|P1|NOT COMPLETED|Overall Study||3
4957916|NCT02745626|12195240|P3|COMPLETED|Overall Study||19
4957917|NCT02745626|12195241|P2|COMPLETED|Overall Study||16
4957918|NCT02745626|12195242|P1|COMPLETED|Overall Study||21
4957919|NCT02745626|12195240|P3|STARTED|Overall Study||22
4957920|NCT02745626|12195241|P2|STARTED|Overall Study||22
4957921|NCT02745626|12195242|P1|STARTED|Overall Study||24
4957922|NCT02745535|12195268|P1|NOT COMPLETED|Overall Study||6
4957923|NCT02745535|12195268|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
4957924|NCT02745535|12195268|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
4957925|NCT02745535|12195268|P1|STARTED|Overall Study||77
4957926|NCT02745392|12195280|P4|NOT COMPLETED|Overall Study||0
4957927|NCT02745392|12195281|P3|NOT COMPLETED|Overall Study||0
4957928|NCT02745392|12195282|P2|NOT COMPLETED|Overall Study||1
4957929|NCT02745392|12195283|P1|NOT COMPLETED|Overall Study||0
4957930|NCT02745392|12195280|P4|COMPLETED|Overall Study||92
4957931|NCT02745392|12195281|P3|COMPLETED|Overall Study||92
4957932|NCT02745392|12195282|P2|COMPLETED|Overall Study||89
4957933|NCT02745392|12195283|P1|COMPLETED|Overall Study||91
4957934|NCT02745392|12195280|P4|STARTED|Overall Study||92
4957935|NCT02745392|12195281|P3|STARTED|Overall Study||92
4957936|NCT02745392|12195282|P2|STARTED|Overall Study||90
4957937|NCT02745392|12195283|P1|STARTED|Overall Study||91
4957938|NCT02745353|12195299|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
4957939|NCT02745353|12195300|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4957940|NCT02745353|12195299|P2|COMPLETED|Second Intervention (2 Weeks)||0
4957941|NCT02745353|12195300|P1|COMPLETED|Second Intervention (2 Weeks)||1
4957942|NCT02745353|12195299|P2|STARTED|Second Intervention (2 Weeks)||1
4957943|NCT02745353|12195300|P1|STARTED|Second Intervention (2 Weeks)||1
4957944|NCT02745353|12195299|P2|NOT COMPLETED|Washout (3 Days)||0
4957945|NCT02745353|12195300|P1|NOT COMPLETED|Washout (3 Days)||0
4957946|NCT02745353|12195299|P2|COMPLETED|Washout (3 Days)||1
4957947|NCT02745353|12195300|P1|COMPLETED|Washout (3 Days)||1
4957948|NCT02745353|12195299|P2|STARTED|Washout (3 Days)||1
4957949|NCT02745353|12195300|P1|STARTED|Washout (3 Days)||1
4957950|NCT02745353|12195299|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
4957951|NCT02745353|12195300|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
4957952|NCT02745353|12195299|P2|COMPLETED|First Intervention (2 Weeks)||1
4957953|NCT02745353|12195300|P1|COMPLETED|First Intervention (2 Weeks)||1
4957954|NCT02745353|12195299|P2|STARTED|First Intervention (2 Weeks)||3
4957955|NCT02745353|12195300|P1|STARTED|First Intervention (2 Weeks)||4
4957956|NCT02745145|12195309|P3|NOT COMPLETED|Overall Study||9
4957957|NCT02745145|12195310|P2|NOT COMPLETED|Overall Study||5
4957958|NCT02745145|12195311|P1|NOT COMPLETED|Overall Study||10
4957959|NCT02745145|12195309|P3|COMPLETED|Overall Study||0
4957960|NCT02745145|12195310|P2|COMPLETED|Overall Study||0
4957961|NCT02745145|12195311|P1|COMPLETED|Overall Study||0
4957962|NCT02745145|12195309|P3|STARTED|Overall Study||9
4957963|NCT02745145|12195310|P2|STARTED|Overall Study||5
4957964|NCT02745145|12195311|P1|STARTED|Overall Study||10
4957965|NCT02745119|12195350|P4|NOT COMPLETED|Overall Study||277
4957966|NCT02745119|12195351|P3|NOT COMPLETED|Overall Study||146
4957967|NCT02745119|12195352|P2|NOT COMPLETED|Overall Study||274
4957968|NCT02745119|12195353|P1|NOT COMPLETED|Overall Study||145
4957969|NCT02745119|12195350|P4|COMPLETED|Overall Study||0
4957970|NCT02745119|12195351|P3|COMPLETED|Overall Study||0
4957971|NCT02745119|12195352|P2|COMPLETED|Overall Study||0
4957972|NCT02745119|12195353|P1|COMPLETED|Overall Study||0
4957973|NCT02745119|12195350|P4|STARTED|Overall Study||277
4957974|NCT02745119|12195351|P3|STARTED|Overall Study||146
4957975|NCT02745119|12195352|P2|STARTED|Overall Study||274
4957976|NCT02745119|12195353|P1|STARTED|Overall Study||145
4957977|NCT02744898|12195375|P1|NOT COMPLETED|Overall Study||4
4957978|NCT02744898|12195375|P1|COMPLETED|Overall Study||19
4957979|NCT02744898|12195375|P1|STARTED|Overall Study||23
4957980|NCT02744846|12195379|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
4957981|NCT02744846|12195379|P1|COMPLETED|10 Year Outcome Assessment||56730
4957982|NCT02744846|12195379|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
4957983|NCT02744846|12195379|P1|STARTED|10 Year Outcome Assessment||362550
4957984|NCT02744846|12195379|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
4957985|NCT02744846|12195379|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
4957986|NCT02744846|12195379|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
4957987|NCT02744846|12195379|P1|STARTED|5 Year Outcome Assessment||681739
4957988|NCT02744755|12195389|P2|NOT COMPLETED|Study Period 2||8
4957989|NCT02744755|12195390|P1|NOT COMPLETED|Study Period 2||14
4957990|NCT02744755|12195389|P2|COMPLETED|Study Period 2||158
4957991|NCT02744755|12195390|P1|COMPLETED|Study Period 2||145
4957992|NCT02744755|12195389|P2|STARTED|Study Period 2||166
4957993|NCT02744755|12195390|P1|STARTED|Study Period 2||159
4957994|NCT02744755|12195389|P2|NOT COMPLETED|Study Period 1||8
4957995|NCT02744755|12195390|P1|NOT COMPLETED|Study Period 1||14
4957996|NCT02744755|12195389|P2|COMPLETED|Study Period 1||168
4957997|NCT02744755|12195390|P1|COMPLETED|Study Period 1||163
4957998|NCT02744755|12195389|P2|STARTED|Study Period 1||176
4957999|NCT02744755|12195390|P1|STARTED|Study Period 1||177
4958000|NCT02744534|12195444|P1|NOT COMPLETED|Overall Study||0
4958001|NCT02744534|12195444|P1|COMPLETED|Overall Study||21
4958002|NCT02744534|12195444|P1|STARTED|Overall Study||21
4958003|NCT02744391|12195450|P1|NOT COMPLETED|Overall Study||14
4958004|NCT02744391|12195450|P1|COMPLETED|Overall Study||33
4958005|NCT02744391|12195450|P1|STARTED|Overall Study||47
4958006|NCT02744352|12195474|P2|NOT COMPLETED|Overall Study||0
4958007|NCT02744352|12195475|P1|NOT COMPLETED|Overall Study||0
4958008|NCT02744352|12195474|P2|COMPLETED|Overall Study||4
4958009|NCT02744352|12195475|P1|COMPLETED|Overall Study||4
4958010|NCT02744352|12195474|P2|STARTED|Overall Study||4
4958011|NCT02744352|12195475|P1|STARTED|Overall Study||4
4958012|NCT02744066|12195491|P2|NOT COMPLETED|Overall Study||5
4958013|NCT02744066|12195492|P1|NOT COMPLETED|Overall Study||0
4958014|NCT02744066|12195491|P2|COMPLETED|Overall Study||25
4958015|NCT02744066|12195492|P1|COMPLETED|Overall Study||25
4958016|NCT02744066|12195491|P2|STARTED|Overall Study||30
4958017|NCT02744066|12195492|P1|STARTED|Overall Study||25
4958018|NCT02743962|12195502|P2|NOT COMPLETED|Overall Study||0
4958019|NCT02743962|12195503|P1|NOT COMPLETED|Overall Study||1
4958020|NCT02743962|12195502|P2|COMPLETED|Overall Study||5
4958021|NCT02743962|12195503|P1|COMPLETED|Overall Study||4
4958022|NCT02743962|12195502|P2|STARTED|Overall Study||5
4958023|NCT02743962|12195503|P1|STARTED|Overall Study||5
4958024|NCT02743949|12195525|P3|NOT COMPLETED|Overall Study||3
4958025|NCT02743949|12195526|P2|NOT COMPLETED|Overall Study||1
4958026|NCT02743949|12195527|P1|NOT COMPLETED|Overall Study||4
4958027|NCT02743949|12195525|P3|COMPLETED|Overall Study||82
4958028|NCT02743949|12195526|P2|COMPLETED|Overall Study||84
4958029|NCT02743949|12195527|P1|COMPLETED|Overall Study||82
4958030|NCT02743949|12195525|P3|STARTED|Overall Study||85
4958031|NCT02743949|12195526|P2|STARTED|Overall Study||85
4958032|NCT02743949|12195527|P1|STARTED|Overall Study||86
4958033|NCT02743936|12195540|P2|NOT COMPLETED|Overall Study||0
4958034|NCT02743936|12195541|P1|NOT COMPLETED|Overall Study||0
4958035|NCT02743936|12195540|P2|COMPLETED|Overall Study||32
4958036|NCT02743936|12195541|P1|COMPLETED|Overall Study||32
4958037|NCT02743936|12195540|P2|STARTED|Overall Study||32
4958038|NCT02743936|12195541|P1|STARTED|Overall Study||32
4958039|NCT02743780|12195554|P5|NOT COMPLETED|Part 3 (7 Days)||0
4958040|NCT02743780|12195555|P4|NOT COMPLETED|Part 3 (7 Days)||0
4958041|NCT02743780|12195556|P3|NOT COMPLETED|Part 3 (7 Days)||1
4958042|NCT02743780|12195557|P2|NOT COMPLETED|Part 3 (7 Days)||0
4958043|NCT02743780|12195558|P1|NOT COMPLETED|Part 3 (7 Days)||0
4958044|NCT02743780|12195554|P5|COMPLETED|Part 3 (7 Days)||25
4958045|NCT02743780|12195555|P4|COMPLETED|Part 3 (7 Days)||0
4958046|NCT02743780|12195556|P3|COMPLETED|Part 3 (7 Days)||24
4958047|NCT02743780|12195557|P2|COMPLETED|Part 3 (7 Days)||0
4958048|NCT02743780|12195558|P1|COMPLETED|Part 3 (7 Days)||0
4958049|NCT02743780|12195554|P5|STARTED|Part 3 (7 Days)||25
4958050|NCT02743780|12195555|P4|STARTED|Part 3 (7 Days)||0
4958051|NCT02743780|12195556|P3|STARTED|Part 3 (7 Days)||25
4958052|NCT02743780|12195557|P2|STARTED|Part 3 (7 Days)||0
4958053|NCT02743780|12195558|P1|STARTED|Part 3 (7 Days)||0
4958054|NCT02743780|12195554|P5|NOT COMPLETED|Part 2 (8 Days)||0
4958055|NCT02743780|12195555|P4|NOT COMPLETED|Part 2 (8 Days)||0
4958056|NCT02743780|12195556|P3|NOT COMPLETED|Part 2 (8 Days)||0
4958057|NCT02743780|12195557|P2|NOT COMPLETED|Part 2 (8 Days)||0
4958058|NCT02743780|12195558|P1|NOT COMPLETED|Part 2 (8 Days)||0
4958059|NCT02743780|12195554|P5|COMPLETED|Part 2 (8 Days)||4
4958060|NCT02743780|12195555|P4|COMPLETED|Part 2 (8 Days)||0
4958061|NCT02743780|12195556|P3|COMPLETED|Part 2 (8 Days)||6
4958062|NCT02743780|12195557|P2|COMPLETED|Part 2 (8 Days)||6
4958063|NCT02743780|12195558|P1|COMPLETED|Part 2 (8 Days)||0
4958064|NCT02743780|12195554|P5|STARTED|Part 2 (8 Days)||4
4958065|NCT02743780|12195555|P4|STARTED|Part 2 (8 Days)||0
4958066|NCT02743780|12195556|P3|STARTED|Part 2 (8 Days)||6
4958067|NCT02743780|12195557|P2|STARTED|Part 2 (8 Days)||6
4958068|NCT02743780|12195558|P1|STARTED|Part 2 (8 Days)||0
4958069|NCT02743780|12195554|P5|NOT COMPLETED|Part 1 (3 Days)||0
4958070|NCT02743780|12195555|P4|NOT COMPLETED|Part 1 (3 Days)||0
4958071|NCT02743780|12195556|P3|NOT COMPLETED|Part 1 (3 Days)||0
4958072|NCT02743780|12195557|P2|NOT COMPLETED|Part 1 (3 Days)||0
4958073|NCT02743780|12195558|P1|NOT COMPLETED|Part 1 (3 Days)||0
4958074|NCT02743780|12195554|P5|COMPLETED|Part 1 (3 Days)||8
4958075|NCT02743780|12195555|P4|COMPLETED|Part 1 (3 Days)||6
4958076|NCT02743780|12195556|P3|COMPLETED|Part 1 (3 Days)||6
4958077|NCT02743780|12195557|P2|COMPLETED|Part 1 (3 Days)||6
4958078|NCT02743780|12195558|P1|COMPLETED|Part 1 (3 Days)||6
4958079|NCT02743780|12195554|P5|STARTED|Part 1 (3 Days)||8
4958080|NCT02743780|12195555|P4|STARTED|Part 1 (3 Days)||6
4958081|NCT02743780|12195556|P3|STARTED|Part 1 (3 Days)||6
4958082|NCT02743780|12195557|P2|STARTED|Part 1 (3 Days)||6
4958083|NCT02743780|12195558|P1|STARTED|Part 1 (3 Days)||6
4958084|NCT02743702|12195605|P2|NOT COMPLETED|Overall Study||0
4958085|NCT02743702|12195606|P1|NOT COMPLETED|Overall Study||0
4958086|NCT02743702|12195605|P2|COMPLETED|Overall Study||10
4958087|NCT02743702|12195606|P1|COMPLETED|Overall Study||11
4958088|NCT02743702|12195605|P2|STARTED|Overall Study||10
4958089|NCT02743702|12195606|P1|STARTED|Overall Study||11
4958090|NCT02743312|12195614|P2|NOT COMPLETED|Overall Study||0
4958091|NCT02743312|12195615|P1|NOT COMPLETED|Overall Study||0
4958092|NCT02743312|12195614|P2|COMPLETED|Overall Study||2
4958093|NCT02743312|12195615|P1|COMPLETED|Overall Study||3
4958094|NCT02743312|12195614|P2|STARTED|Overall Study||2
4958095|NCT02743312|12195615|P1|STARTED|Overall Study||3
4958096|NCT02743221|12195648|P2|NOT COMPLETED|Overall Study||60
4958097|NCT02743221|12195649|P1|NOT COMPLETED|Overall Study||56
4958098|NCT02743221|12195648|P2|COMPLETED|Overall Study||17
4958099|NCT02743221|12195649|P1|COMPLETED|Overall Study||21
4958100|NCT02743221|12195648|P2|STARTED|Overall Study||77
4958101|NCT02743221|12195649|P1|STARTED|Overall Study||77
4958102|NCT02743117|12195665|P2|NOT COMPLETED|Overall Study||1
4958103|NCT02743117|12195666|P1|NOT COMPLETED|Overall Study||1
4958104|NCT02743117|12195665|P2|COMPLETED|Overall Study||240
4958105|NCT02743117|12195666|P1|COMPLETED|Overall Study||59
4958106|NCT02743117|12195665|P2|Treated|Overall Study||241
4958107|NCT02743117|12195666|P1|Treated|Overall Study||59
4958108|NCT02743117|12195665|P2|STARTED|Overall Study||241
4958109|NCT02743117|12195666|P1|STARTED|Overall Study||60
4958110|NCT02742987|12195682|P2|NOT COMPLETED|Overall Study||0
4958111|NCT02742987|12195683|P1|NOT COMPLETED|Overall Study||0
4958112|NCT02742987|12195682|P2|COMPLETED|Overall Study||21
4958113|NCT02742987|12195683|P1|COMPLETED|Overall Study||21
4958114|NCT02742987|12195682|P2|STARTED|Overall Study||21
4958115|NCT02742987|12195683|P1|STARTED|Overall Study||21
4958116|NCT02742818|12195691|P2|NOT COMPLETED|Overall Study||2
4958117|NCT02742818|12195692|P1|NOT COMPLETED|Overall Study||0
4958118|NCT02742818|12195691|P2|COMPLETED|Overall Study||23
4958119|NCT02742818|12195692|P1|COMPLETED|Overall Study||25
4958120|NCT02742818|12195691|P2|STARTED|Overall Study||25
4958121|NCT02742818|12195692|P1|STARTED|Overall Study||25
4958122|NCT02742766|12195725|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958123|NCT02742766|12195726|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958124|NCT02742766|12195727|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958125|NCT02742766|12195728|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958126|NCT02742766|12195729|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958127|NCT02742766|12195730|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958128|NCT02742766|12195731|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958129|NCT02742766|12195732|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958130|NCT02742766|12195733|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958131|NCT02742766|12195734|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958132|NCT02742766|12195735|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958133|NCT02742766|12195736|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958134|NCT02742766|12195737|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958135|NCT02742766|12195738|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958136|NCT02742766|12195739|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958137|NCT02742766|12195740|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958138|NCT02742766|12195741|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958139|NCT02742766|12195742|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958140|NCT02742766|12195743|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
4958141|NCT02742766|12195725|P19|COMPLETED|Part 3 (Up to 36 Days)||0
4958142|NCT02742766|12195726|P18|COMPLETED|Part 3 (Up to 36 Days)||0
4958143|NCT02742766|12195727|P17|COMPLETED|Part 3 (Up to 36 Days)||0
4958144|NCT02742766|12195728|P16|COMPLETED|Part 3 (Up to 36 Days)||0
4958145|NCT02742766|12195729|P15|COMPLETED|Part 3 (Up to 36 Days)||0
4958146|NCT02742766|12195730|P14|COMPLETED|Part 3 (Up to 36 Days)||0
4958147|NCT02742766|12195731|P13|COMPLETED|Part 3 (Up to 36 Days)||0
4958148|NCT02742766|12195732|P12|COMPLETED|Part 3 (Up to 36 Days)||0
4958149|NCT02742766|12195733|P11|COMPLETED|Part 3 (Up to 36 Days)||0
4958150|NCT02742766|12195734|P10|COMPLETED|Part 3 (Up to 36 Days)||0
4958151|NCT02742766|12195735|P9|COMPLETED|Part 3 (Up to 36 Days)||0
4958152|NCT02742766|12195736|P8|COMPLETED|Part 3 (Up to 36 Days)||0
4958153|NCT02742766|12195737|P7|COMPLETED|Part 3 (Up to 36 Days)||0
4958154|NCT02742766|12195738|P6|COMPLETED|Part 3 (Up to 36 Days)||0
4958155|NCT02742766|12195739|P5|COMPLETED|Part 3 (Up to 36 Days)||0
4958156|NCT02742766|12195740|P4|COMPLETED|Part 3 (Up to 36 Days)||0
4958157|NCT02742766|12195741|P3|COMPLETED|Part 3 (Up to 36 Days)||0
4958158|NCT02742766|12195742|P2|COMPLETED|Part 3 (Up to 36 Days)||0
4958159|NCT02742766|12195743|P1|COMPLETED|Part 3 (Up to 36 Days)||0
4958160|NCT02742766|12195725|P19|STARTED|Part 3 (Up to 36 Days)||0
4958161|NCT02742766|12195726|P18|STARTED|Part 3 (Up to 36 Days)||0
4958162|NCT02742766|12195727|P17|STARTED|Part 3 (Up to 36 Days)||0
4958163|NCT02742766|12195728|P16|STARTED|Part 3 (Up to 36 Days)||0
4958164|NCT02742766|12195729|P15|STARTED|Part 3 (Up to 36 Days)||0
4958165|NCT02742766|12195730|P14|STARTED|Part 3 (Up to 36 Days)||0
4958166|NCT02742766|12195731|P13|STARTED|Part 3 (Up to 36 Days)||0
4958167|NCT02742766|12195732|P12|STARTED|Part 3 (Up to 36 Days)||0
4958168|NCT02742766|12195733|P11|STARTED|Part 3 (Up to 36 Days)||0
4958169|NCT02742766|12195734|P10|STARTED|Part 3 (Up to 36 Days)||0
4958170|NCT02742766|12195735|P9|STARTED|Part 3 (Up to 36 Days)||0
4958171|NCT02742766|12195736|P8|STARTED|Part 3 (Up to 36 Days)||0
4958172|NCT02742766|12195737|P7|STARTED|Part 3 (Up to 36 Days)||0
4958173|NCT02742766|12195738|P6|STARTED|Part 3 (Up to 36 Days)||0
4958174|NCT02742766|12195739|P5|STARTED|Part 3 (Up to 36 Days)||0
4958175|NCT02742766|12195740|P4|STARTED|Part 3 (Up to 36 Days)||0
4958176|NCT02742766|12195741|P3|STARTED|Part 3 (Up to 36 Days)||0
4958177|NCT02742766|12195742|P2|STARTED|Part 3 (Up to 36 Days)||0
4958178|NCT02742766|12195743|P1|STARTED|Part 3 (Up to 36 Days)||0
4958179|NCT02742766|12195725|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958180|NCT02742766|12195726|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958181|NCT02742766|12195727|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958182|NCT02742766|12195728|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
4958183|NCT02742766|12195729|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958184|NCT02742766|12195730|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
4958185|NCT02742766|12195731|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
4958186|NCT02742766|12195732|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958187|NCT02742766|12195733|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958188|NCT02742766|12195734|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958189|NCT02742766|12195735|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958190|NCT02742766|12195736|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958191|NCT02742766|12195737|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958192|NCT02742766|12195738|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958193|NCT02742766|12195739|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958194|NCT02742766|12195740|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958195|NCT02742766|12195741|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958196|NCT02742766|12195742|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958197|NCT02742766|12195743|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
4958198|NCT02742766|12195725|P19|COMPLETED|Part 2 (Up to 22 Days)||0
4958199|NCT02742766|12195726|P18|COMPLETED|Part 2 (Up to 22 Days)||0
4958200|NCT02742766|12195727|P17|COMPLETED|Part 2 (Up to 22 Days)||0
4958201|NCT02742766|12195728|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
4958202|NCT02742766|12195729|P15|COMPLETED|Part 2 (Up to 22 Days)||6
4958203|NCT02742766|12195730|P14|COMPLETED|Part 2 (Up to 22 Days)||0
4958204|NCT02742766|12195731|P13|COMPLETED|Part 2 (Up to 22 Days)||4
4958205|NCT02742766|12195732|P12|COMPLETED|Part 2 (Up to 22 Days)||0
4958206|NCT02742766|12195733|P11|COMPLETED|Part 2 (Up to 22 Days)||0
4958207|NCT02742766|12195734|P10|COMPLETED|Part 2 (Up to 22 Days)||0
4958208|NCT02742766|12195735|P9|COMPLETED|Part 2 (Up to 22 Days)||0
4958209|NCT02742766|12195736|P8|COMPLETED|Part 2 (Up to 22 Days)||0
4958210|NCT02742766|12195737|P7|COMPLETED|Part 2 (Up to 22 Days)||0
4958211|NCT02742766|12195738|P6|COMPLETED|Part 2 (Up to 22 Days)||0
4958212|NCT02742766|12195739|P5|COMPLETED|Part 2 (Up to 22 Days)||0
4958213|NCT02742766|12195740|P4|COMPLETED|Part 2 (Up to 22 Days)||0
4958214|NCT02742766|12195741|P3|COMPLETED|Part 2 (Up to 22 Days)||0
4958215|NCT02742766|12195742|P2|COMPLETED|Part 2 (Up to 22 Days)||0
4958216|NCT02742766|12195743|P1|COMPLETED|Part 2 (Up to 22 Days)||0
4958217|NCT02742766|12195725|P19|STARTED|Part 2 (Up to 22 Days)||0
4958218|NCT02742766|12195726|P18|STARTED|Part 2 (Up to 22 Days)||0
4958219|NCT02742766|12195727|P17|STARTED|Part 2 (Up to 22 Days)||0
4958220|NCT02742766|12195728|P16|STARTED|Part 2 (Up to 22 Days)||6
4958221|NCT02742766|12195729|P15|STARTED|Part 2 (Up to 22 Days)||6
4958222|NCT02742766|12195730|P14|STARTED|Part 2 (Up to 22 Days)||6
4958223|NCT02742766|12195731|P13|STARTED|Part 2 (Up to 22 Days)||6
4958224|NCT02742766|12195732|P12|STARTED|Part 2 (Up to 22 Days)||0
4958225|NCT02742766|12195733|P11|STARTED|Part 2 (Up to 22 Days)||0
4958226|NCT02742766|12195734|P10|STARTED|Part 2 (Up to 22 Days)||0
4958227|NCT02742766|12195735|P9|STARTED|Part 2 (Up to 22 Days)||0
4958228|NCT02742766|12195736|P8|STARTED|Part 2 (Up to 22 Days)||0
4958229|NCT02742766|12195737|P7|STARTED|Part 2 (Up to 22 Days)||0
4958230|NCT02742766|12195738|P6|STARTED|Part 2 (Up to 22 Days)||0
4958231|NCT02742766|12195739|P5|STARTED|Part 2 (Up to 22 Days)||0
4958232|NCT02742766|12195740|P4|STARTED|Part 2 (Up to 22 Days)||0
4958233|NCT02742766|12195741|P3|STARTED|Part 2 (Up to 22 Days)||0
4958234|NCT02742766|12195742|P2|STARTED|Part 2 (Up to 22 Days)||0
4958235|NCT02742766|12195743|P1|STARTED|Part 2 (Up to 22 Days)||0
4958236|NCT02742766|12195725|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958237|NCT02742766|12195726|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958238|NCT02742766|12195727|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958239|NCT02742766|12195728|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958240|NCT02742766|12195729|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958241|NCT02742766|12195730|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958242|NCT02742766|12195731|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958243|NCT02742766|12195732|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958244|NCT02742766|12195733|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958245|NCT02742766|12195734|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958246|NCT02742766|12195735|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958247|NCT02742766|12195736|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958248|NCT02742766|12195737|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958249|NCT02742766|12195738|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958250|NCT02742766|12195739|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958251|NCT02742766|12195740|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958252|NCT02742766|12195741|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958253|NCT02742766|12195742|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958254|NCT02742766|12195743|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
4958255|NCT02742766|12195725|P19|COMPLETED|Part 1 (Up to 8 Days)||0
4958256|NCT02742766|12195726|P18|COMPLETED|Part 1 (Up to 8 Days)||0
4958257|NCT02742766|12195727|P17|COMPLETED|Part 1 (Up to 8 Days)||0
4958258|NCT02742766|12195728|P16|COMPLETED|Part 1 (Up to 8 Days)||0
4958259|NCT02742766|12195729|P15|COMPLETED|Part 1 (Up to 8 Days)||0
4958260|NCT02742766|12195730|P14|COMPLETED|Part 1 (Up to 8 Days)||0
4958261|NCT02742766|12195731|P13|COMPLETED|Part 1 (Up to 8 Days)||0
4958262|NCT02742766|12195732|P12|COMPLETED|Part 1 (Up to 8 Days)||6
4958263|NCT02742766|12195733|P11|COMPLETED|Part 1 (Up to 8 Days)||6
4958264|NCT02742766|12195734|P10|COMPLETED|Part 1 (Up to 8 Days)||0
4958265|NCT02742766|12195735|P9|COMPLETED|Part 1 (Up to 8 Days)||6
4958266|NCT02742766|12195736|P8|COMPLETED|Part 1 (Up to 8 Days)||6
4958267|NCT02742766|12195737|P7|COMPLETED|Part 1 (Up to 8 Days)||6
4958268|NCT02742766|12195738|P6|COMPLETED|Part 1 (Up to 8 Days)||6
4958269|NCT02742766|12195739|P5|COMPLETED|Part 1 (Up to 8 Days)||6
4958270|NCT02742766|12195740|P4|COMPLETED|Part 1 (Up to 8 Days)||6
4958271|NCT02742766|12195741|P3|COMPLETED|Part 1 (Up to 8 Days)||6
4958272|NCT02742766|12195742|P2|COMPLETED|Part 1 (Up to 8 Days)||6
4958273|NCT02742766|12195743|P1|COMPLETED|Part 1 (Up to 8 Days)||20
4958274|NCT02742766|12195725|P19|STARTED|Part 1 (Up to 8 Days)||0
4958275|NCT02742766|12195726|P18|STARTED|Part 1 (Up to 8 Days)||0
4958276|NCT02742766|12195727|P17|STARTED|Part 1 (Up to 8 Days)||0
4958277|NCT02742766|12195728|P16|STARTED|Part 1 (Up to 8 Days)||0
4958278|NCT02742766|12195729|P15|STARTED|Part 1 (Up to 8 Days)||0
4958279|NCT02742766|12195730|P14|STARTED|Part 1 (Up to 8 Days)||0
4958280|NCT02742766|12195731|P13|STARTED|Part 1 (Up to 8 Days)||0
4958281|NCT02742766|12195732|P12|STARTED|Part 1 (Up to 8 Days)||6
4958282|NCT02742766|12195733|P11|STARTED|Part 1 (Up to 8 Days)||6
4958283|NCT02742766|12195734|P10|STARTED|Part 1 (Up to 8 Days)||0
4958284|NCT02742766|12195735|P9|STARTED|Part 1 (Up to 8 Days)||6
4958285|NCT02742766|12195736|P8|STARTED|Part 1 (Up to 8 Days)||6
4958286|NCT02742766|12195737|P7|STARTED|Part 1 (Up to 8 Days)||6
4958287|NCT02742766|12195738|P6|STARTED|Part 1 (Up to 8 Days)||6
4958288|NCT02742766|12195739|P5|STARTED|Part 1 (Up to 8 Days)||6
4958289|NCT02742766|12195740|P4|STARTED|Part 1 (Up to 8 Days)||6
4958290|NCT02742766|12195741|P3|STARTED|Part 1 (Up to 8 Days)||6
4958291|NCT02742766|12195742|P2|STARTED|Part 1 (Up to 8 Days)||6
4958292|NCT02742766|12195743|P1|STARTED|Part 1 (Up to 8 Days)||20
4958293|NCT02742649|12196003|P5|NOT COMPLETED|Open-Label Period||1
4958294|NCT02742649|12196004|P4|NOT COMPLETED|Open-Label Period||0
4958295|NCT02742649|12196005|P3|NOT COMPLETED|Open-Label Period||0
4958296|NCT02742649|12196006|P2|NOT COMPLETED|Open-Label Period||0
4958297|NCT02742649|12196007|P1|NOT COMPLETED|Open-Label Period||0
4958298|NCT02742649|12196003|P5|COMPLETED|Open-Label Period||48
4958299|NCT02742649|12196004|P4|COMPLETED|Open-Label Period||0
4958300|NCT02742649|12196005|P3|COMPLETED|Open-Label Period||0
4958301|NCT02742649|12196006|P2|COMPLETED|Open-Label Period||0
4958302|NCT02742649|12196007|P1|COMPLETED|Open-Label Period||0
4958303|NCT02742649|12196003|P5|STARTED|Open-Label Period||49
4958304|NCT02742649|12196004|P4|STARTED|Open-Label Period||0
4958305|NCT02742649|12196005|P3|STARTED|Open-Label Period||0
4958306|NCT02742649|12196006|P2|STARTED|Open-Label Period||0
4958307|NCT02742649|12196007|P1|STARTED|Open-Label Period||0
4958308|NCT02742649|12196003|P5|NOT COMPLETED|Double-Blind Treatment Period||0
4958309|NCT02742649|12196004|P4|NOT COMPLETED|Double-Blind Treatment Period||0
4958310|NCT02742649|12196005|P3|NOT COMPLETED|Double-Blind Treatment Period||0
4958311|NCT02742649|12196006|P2|NOT COMPLETED|Double-Blind Treatment Period||1
4958312|NCT02742649|12196007|P1|NOT COMPLETED|Double-Blind Treatment Period||0
4958313|NCT02742649|12196003|P5|COMPLETED|Double-Blind Treatment Period||0
4958314|NCT02742649|12196004|P4|COMPLETED|Double-Blind Treatment Period||16
4958315|NCT02742649|12196005|P3|COMPLETED|Double-Blind Treatment Period||17
4958316|NCT02742649|12196006|P2|COMPLETED|Double-Blind Treatment Period||16
4958317|NCT02742649|12196007|P1|COMPLETED|Double-Blind Treatment Period||0
4958318|NCT02742649|12196003|P5|STARTED|Double-Blind Treatment Period||0
4958319|NCT02742649|12196004|P4|STARTED|Double-Blind Treatment Period||16
4958320|NCT02742649|12196005|P3|STARTED|Double-Blind Treatment Period||17
4958321|NCT02742649|12196006|P2|STARTED|Double-Blind Treatment Period||17
4958322|NCT02742649|12196007|P1|STARTED|Double-Blind Treatment Period||0
4958323|NCT02742649|12196003|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
4958324|NCT02742649|12196004|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
4958325|NCT02742649|12196005|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
4958326|NCT02742649|12196006|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
4958327|NCT02742649|12196007|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
4958328|NCT02742649|12196003|P5|COMPLETED|Pre-Randomization Washout Period||0
4958329|NCT02742649|12196004|P4|COMPLETED|Pre-Randomization Washout Period||0
4958330|NCT02742649|12196005|P3|COMPLETED|Pre-Randomization Washout Period||0
4958331|NCT02742649|12196006|P2|COMPLETED|Pre-Randomization Washout Period||0
4958332|NCT02742649|12196007|P1|COMPLETED|Pre-Randomization Washout Period||50
4958333|NCT02742649|12196003|P5|STARTED|Pre-Randomization Washout Period||0
4958334|NCT02742649|12196004|P4|STARTED|Pre-Randomization Washout Period||0
4958335|NCT02742649|12196005|P3|STARTED|Pre-Randomization Washout Period||0
4958336|NCT02742649|12196006|P2|STARTED|Pre-Randomization Washout Period||0
4958337|NCT02742649|12196007|P1|STARTED|Pre-Randomization Washout Period||55
4958338|NCT02742519|12196035|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
4958339|NCT02742519|12196036|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
4958340|NCT02742519|12196037|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
4958341|NCT02742519|12196035|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
4958342|NCT02742519|12196036|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
4958343|NCT02742519|12196037|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
4958344|NCT02742519|12196035|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
4958345|NCT02742519|12196036|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
4958346|NCT02742519|12196037|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
4958347|NCT02742519|12196035|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
4958348|NCT02742519|12196036|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
4958349|NCT02742519|12196037|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
4958350|NCT02742519|12196035|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
4958351|NCT02742519|12196036|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
4958352|NCT02742519|12196037|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
4958353|NCT02742519|12196035|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
4958354|NCT02742519|12196036|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
4958355|NCT02742519|12196037|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
4958356|NCT02742519|12196035|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
4958357|NCT02742519|12196036|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
4958358|NCT02742519|12196037|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
4958359|NCT02742519|12196035|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
4958360|NCT02742519|12196036|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
4958361|NCT02742519|12196037|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
4958362|NCT02742519|12196035|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
4958363|NCT02742519|12196036|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
4958364|NCT02742519|12196037|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
4958365|NCT02742441|12196057|P2|NOT COMPLETED|Overall Study||8
4958366|NCT02742441|12196058|P1|NOT COMPLETED|Overall Study||6
4958367|NCT02742441|12196057|P2|COMPLETED|Overall Study||196
4958368|NCT02742441|12196058|P1|COMPLETED|Overall Study||199
4958369|NCT02742441|12196057|P2|STARTED|Overall Study||204
4958370|NCT02742441|12196058|P1|STARTED|Overall Study||205
4958371|NCT02742129|12196076|P2|NOT COMPLETED|Phase 2||2
4958372|NCT02742129|12196077|P1|NOT COMPLETED|Phase 2||1
4958373|NCT02742129|12196076|P2|COMPLETED|Phase 2||48
4958374|NCT02742129|12196077|P1|COMPLETED|Phase 2||50
4958375|NCT02742129|12196076|P2|STARTED|Phase 2||50
4958376|NCT02742129|12196077|P1|STARTED|Phase 2||51
4958377|NCT02742129|12196076|P2|NOT COMPLETED|Phase 1||2
4958378|NCT02742129|12196077|P1|NOT COMPLETED|Phase 1||2
4958379|NCT02742129|12196076|P2|COMPLETED|Phase 1||50
4958380|NCT02742129|12196077|P1|COMPLETED|Phase 1||51
4958381|NCT02742129|12196076|P2|STARTED|Phase 1||52
4958382|NCT02742129|12196077|P1|STARTED|Phase 1||53
4958383|NCT02742103|12196105|P2|NOT COMPLETED|Overall Study||5
4958384|NCT02742103|12196106|P1|NOT COMPLETED|Overall Study||9
4958385|NCT02742103|12196105|P2|COMPLETED|Overall Study||23
4958386|NCT02742103|12196106|P1|COMPLETED|Overall Study||46
4958387|NCT02742103|12196105|P2|STARTED|Overall Study||28
4958388|NCT02742103|12196106|P1|STARTED|Overall Study||55
4958389|NCT02741713|12196145|P2|NOT COMPLETED|Overall Study||1
4958390|NCT02741713|12196146|P1|NOT COMPLETED|Overall Study||2
4958391|NCT02741713|12196145|P2|COMPLETED|Overall Study||19
4958392|NCT02741713|12196146|P1|COMPLETED|Overall Study||18
4958393|NCT02741713|12196145|P2|STARTED|Overall Study||20
4958394|NCT02741713|12196146|P1|STARTED|Overall Study||20
4958395|NCT02741687|12196161|P2|NOT COMPLETED|Overall Study||0
4958396|NCT02741687|12196162|P1|NOT COMPLETED|Overall Study||0
4958397|NCT02741687|12196161|P2|COMPLETED|Overall Study||44
4958398|NCT02741687|12196162|P1|COMPLETED|Overall Study||36
4958399|NCT02741687|12196161|P2|STARTED|Overall Study||44
4958400|NCT02741687|12196162|P1|STARTED|Overall Study||36
4958401|NCT02741635|12196186|P1|NOT COMPLETED|Overall Study||1
4958402|NCT02741635|12196186|P1|COMPLETED|Overall Study||14
4958403|NCT02741635|12196186|P1|STARTED|Overall Study||15
4958404|NCT02741596|12196194|P2|NOT COMPLETED|Overall Study||78
4958405|NCT02741596|12196195|P1|NOT COMPLETED|Overall Study||78
4958406|NCT02741596|12196194|P2|COMPLETED|Overall Study||25
4958407|NCT02741596|12196195|P1|COMPLETED|Overall Study||31
4958408|NCT02741596|12196194|P2|STARTED|Overall Study||103
4958409|NCT02741596|12196195|P1|STARTED|Overall Study||109
4958410|NCT02741518|12196213|P2|NOT COMPLETED|Overall Study||1
4958411|NCT02741518|12196214|P1|NOT COMPLETED|Overall Study||1
4958412|NCT02741518|12196213|P2|COMPLETED|Overall Study||10
4958413|NCT02741518|12196214|P1|COMPLETED|Overall Study||10
4958414|NCT02741518|12196213|P2|STARTED|Overall Study||11
4958415|NCT02741518|12196214|P1|STARTED|Overall Study||11
4958416|NCT02741310|12196224|P2|NOT COMPLETED|Overall Study||2
4958417|NCT02741310|12196225|P1|NOT COMPLETED|Overall Study||2
4958418|NCT02741310|12196224|P2|COMPLETED|Overall Study||20
4958419|NCT02741310|12196225|P1|COMPLETED|Overall Study||10
4958420|NCT02741310|12196224|P2|STARTED|Overall Study||22
4958421|NCT02741310|12196225|P1|STARTED|Overall Study||12
4958422|NCT02741297|12196245|P1|NOT COMPLETED|Overall Study||14
4958423|NCT02741297|12196245|P1|COMPLETED|Overall Study||59
4958424|NCT02741297|12196245|P1|STARTED|Overall Study||73
4958425|NCT02741284|12196251|P2|NOT COMPLETED|Overall Study||9
4958426|NCT02741284|12196252|P1|NOT COMPLETED|Overall Study||6
4958427|NCT02741284|12196251|P2|COMPLETED|Overall Study||48
4958428|NCT02741284|12196252|P1|COMPLETED|Overall Study||51
4958429|NCT02741284|12196251|P2|STARTED|Overall Study||57
4958430|NCT02741284|12196252|P1|STARTED|Overall Study||57
4958431|NCT02741271|12196270|P2|NOT COMPLETED|Overall Study||2
4958432|NCT02741271|12196271|P1|NOT COMPLETED|Overall Study||2
4958433|NCT02741271|12196270|P2|COMPLETED|Overall Study||88
4958434|NCT02741271|12196271|P1|COMPLETED|Overall Study||89
4958435|NCT02741271|12196270|P2|STARTED|Overall Study||90
4958436|NCT02741271|12196271|P1|STARTED|Overall Study||91
4958437|NCT02741245|12196304|P5|NOT COMPLETED|Overall Study||2
4958438|NCT02741245|12196305|P4|NOT COMPLETED|Overall Study||4
4958439|NCT02741245|12196306|P3|NOT COMPLETED|Overall Study||0
4958440|NCT02741245|12196307|P2|NOT COMPLETED|Overall Study||1
4958441|NCT02741245|12196308|P1|NOT COMPLETED|Overall Study||0
4958442|NCT02741245|12196304|P5|COMPLETED|Overall Study||70
4958443|NCT02741245|12196305|P4|COMPLETED|Overall Study||67
4958444|NCT02741245|12196306|P3|COMPLETED|Overall Study||71
4958445|NCT02741245|12196307|P2|COMPLETED|Overall Study||71
4958446|NCT02741245|12196308|P1|COMPLETED|Overall Study||35
4958447|NCT02741245|12196304|P5|STARTED|Overall Study||72
4958448|NCT02741245|12196305|P4|STARTED|Overall Study||71
4958449|NCT02741245|12196306|P3|STARTED|Overall Study||71
4958450|NCT02741245|12196307|P2|STARTED|Overall Study||72
4958451|NCT02741245|12196308|P1|STARTED|Overall Study||35
4958452|NCT02741076|12196414|P4|NOT COMPLETED|Overall Study||2
4958453|NCT02741076|12196415|P3|NOT COMPLETED|Overall Study||2
4958454|NCT02741076|12196416|P2|NOT COMPLETED|Overall Study||5
4958455|NCT02741076|12196417|P1|NOT COMPLETED|Overall Study||3
4958456|NCT02741076|12196414|P4|COMPLETED|Overall Study||2
4958457|NCT02741076|12196415|P3|COMPLETED|Overall Study||1
4958458|NCT02741076|12196416|P2|COMPLETED|Overall Study||7
4958459|NCT02741076|12196417|P1|COMPLETED|Overall Study||10
4958460|NCT02741076|12196414|P4|STARTED|Overall Study||4
4958461|NCT02741076|12196415|P3|STARTED|Overall Study||3
4958462|NCT02741076|12196416|P2|STARTED|Overall Study||12
4958463|NCT02741076|12196417|P1|STARTED|Overall Study||13
4958464|NCT02740920|12196475|P1|NOT COMPLETED|Overall Study||0
4958465|NCT02740920|12196475|P1|COMPLETED|Overall Study||9
4958466|NCT02740920|12196475|P1|STARTED|Overall Study||9
4958467|NCT02740660|12196482|P2|NOT COMPLETED|Overall Study||0
4958468|NCT02740660|12196483|P1|NOT COMPLETED|Overall Study||0
4958469|NCT02740660|12196482|P2|COMPLETED|Overall Study||6
4958470|NCT02740660|12196483|P1|COMPLETED|Overall Study||6
4958471|NCT02740660|12196482|P2|STARTED|Overall Study||6
4958472|NCT02740660|12196483|P1|STARTED|Overall Study||6
4958473|NCT02740413|12196495|P1|NOT COMPLETED|Overall Study||0
4958474|NCT02740413|12196495|P1|COMPLETED|Overall Study||86
4958475|NCT02740413|12196495|P1|STARTED|Overall Study||86
4958476|NCT02740049|12196533|P1|NOT COMPLETED|Overall Study||1
4958477|NCT02740049|12196533|P1|COMPLETED|Overall Study||8
4958478|NCT02740049|12196533|P1|STARTED|Overall Study||9
4958479|NCT02739997|12196539|P1|NOT COMPLETED|Overall Study||2
4958480|NCT02739997|12196539|P1|COMPLETED|Overall Study||98
4958481|NCT02739997|12196539|P1|STARTED|Overall Study||100
4958482|NCT02739984|12196553|P2|NOT COMPLETED|Overall Study||2
4958483|NCT02739984|12196554|P1|NOT COMPLETED|Overall Study||5
4958484|NCT02739984|12196553|P2|COMPLETED|Overall Study||279
4958485|NCT02739984|12196554|P1|COMPLETED|Overall Study||138
4958486|NCT02739984|12196553|P2|Received Study Drug|Overall Study||280
4958487|NCT02739984|12196554|P1|Received Study Drug|Overall Study||141
4958488|NCT02739984|12196553|P2|STARTED|Overall Study||281
4958489|NCT02739984|12196554|P1|STARTED|Overall Study||143
4958490|NCT02739828|12196602|P1|NOT COMPLETED|Overall Study||5
4958491|NCT02739828|12196602|P1|COMPLETED|Overall Study||19
4958492|NCT02739828|12196602|P1|STARTED|Overall Study||24
4958493|NCT02739789|12196638|P2|NOT COMPLETED|Second fMRI Scan||0
4958494|NCT02739789|12196639|P1|NOT COMPLETED|Second fMRI Scan||0
4958495|NCT02739789|12196638|P2|COMPLETED|Second fMRI Scan||7
4958496|NCT02739789|12196639|P1|COMPLETED|Second fMRI Scan||9
4958497|NCT02739789|12196638|P2|STARTED|Second fMRI Scan||7
4958498|NCT02739789|12196639|P1|STARTED|Second fMRI Scan||9
4958499|NCT02739789|12196638|P2|NOT COMPLETED|~1 Week Waiting Period||3
4958500|NCT02739789|12196639|P1|NOT COMPLETED|~1 Week Waiting Period||0
4958501|NCT02739789|12196638|P2|COMPLETED|~1 Week Waiting Period||7
4958502|NCT02739789|12196639|P1|COMPLETED|~1 Week Waiting Period||9
4958503|NCT02739789|12196638|P2|STARTED|~1 Week Waiting Period||10
4958504|NCT02739789|12196639|P1|STARTED|~1 Week Waiting Period||9
4958505|NCT02739789|12196638|P2|NOT COMPLETED|First fMRI Scan||0
4958506|NCT02739789|12196639|P1|NOT COMPLETED|First fMRI Scan||0
4958507|NCT02739789|12196638|P2|COMPLETED|First fMRI Scan||10
4958508|NCT02739789|12196639|P1|COMPLETED|First fMRI Scan||9
4958509|NCT02739789|12196638|P2|STARTED|First fMRI Scan||10
4958510|NCT02739789|12196639|P1|STARTED|First fMRI Scan||9
4958511|NCT02739698|12196653|P2|NOT COMPLETED|Overall Study||5
4958512|NCT02739698|12196654|P1|NOT COMPLETED|Overall Study||6
4958513|NCT02739698|12196653|P2|COMPLETED|Overall Study||16
4958514|NCT02739698|12196654|P1|COMPLETED|Overall Study||16
4958515|NCT02739698|12196653|P2|STARTED|Overall Study||21
4958516|NCT02739698|12196654|P1|STARTED|Overall Study||22
4958517|NCT02739594|12196662|P2|NOT COMPLETED|Overall Study||28
4958518|NCT02739594|12196663|P1|NOT COMPLETED|Overall Study||25
4958519|NCT02739594|12196662|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
4958520|NCT02739594|12196663|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
4958521|NCT02739594|12196662|P2|Completed at Week 96|Overall Study||10
4958522|NCT02739594|12196663|P1|Completed at Week 96|Overall Study||10
4958523|NCT02739594|12196662|P2|Completed at Week 44|Overall Study||5
4958524|NCT02739594|12196663|P1|Completed at Week 44|Overall Study||11
4958525|NCT02739594|12196662|P2|STARTED|Overall Study||43
4958526|NCT02739594|12196663|P1|STARTED|Overall Study||46
4958527|NCT02739360|12196693|P1|NOT COMPLETED|Overall Study||3
4958528|NCT02739360|12196693|P1|COMPLETED|Overall Study||0
4958529|NCT02739360|12196693|P1|STARTED|Overall Study||3
4958530|NCT02739321|12196699|P2|NOT COMPLETED|Overall Study||4
4958531|NCT02739321|12196700|P1|NOT COMPLETED|Overall Study||3
4958532|NCT02739321|12196699|P2|COMPLETED|Overall Study||18
4958533|NCT02739321|12196700|P1|COMPLETED|Overall Study||20
4958534|NCT02739321|12196699|P2|STARTED|Overall Study||22
4958535|NCT02739321|12196700|P1|STARTED|Overall Study||23
4958536|NCT02739269|12196746|P2|NOT COMPLETED|Overall Study||4
4958537|NCT02739269|12196747|P1|NOT COMPLETED|Overall Study||7
4958538|NCT02739269|12196746|P2|COMPLETED|Overall Study||96
4958539|NCT02739269|12196747|P1|COMPLETED|Overall Study||93
4958540|NCT02739269|12196746|P2|STARTED|Overall Study||100
4958541|NCT02739269|12196747|P1|STARTED|Overall Study||100
4958542|NCT02739100|12196755|P1|NOT COMPLETED|Overall Study||0
4958543|NCT02739100|12196755|P1|COMPLETED|Overall Study||13
4958544|NCT02739100|12196755|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
4958545|NCT02739100|12196755|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
4958546|NCT02739100|12196755|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
4958547|NCT02739100|12196755|P1|STARTED|Overall Study||13
4958548|NCT02738879|12196774|P2|NOT COMPLETED|Overall Study||25
4958549|NCT02738879|12196775|P1|NOT COMPLETED|Overall Study||13
4958550|NCT02738879|12196774|P2|COMPLETED|Overall Study||347
4958551|NCT02738879|12196775|P1|COMPLETED|Overall Study||361
4958552|NCT02738879|12196774|P2|Treated|Overall Study||370
4958553|NCT02738879|12196775|P1|Treated|Overall Study||373
4958554|NCT02738879|12196774|P2|STARTED|Overall Study||372
4958555|NCT02738879|12196775|P1|STARTED|Overall Study||374
4958556|NCT02738853|12196809|P1|NOT COMPLETED|30 Days- 6 Months||2
4958557|NCT02738853|12196809|P1|COMPLETED|30 Days- 6 Months||57
4958558|NCT02738853|12196809|P1|STARTED|30 Days- 6 Months||59
4958559|NCT02738853|12196809|P1|NOT COMPLETED|Baseline -30 Days||1
4958560|NCT02738853|12196809|P1|COMPLETED|Baseline -30 Days||59
4958561|NCT02738853|12196809|P1|STARTED|Baseline -30 Days||60
4958562|NCT02738580|12196827|P2|NOT COMPLETED|Overall Study||4
4958563|NCT02738580|12196828|P1|NOT COMPLETED|Overall Study||4
4958564|NCT02738580|12196827|P2|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
4958565|NCT02738580|12196828|P1|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
4958566|NCT02738580|12196827|P2|STARTED|Overall Study||56
4958567|NCT02738580|12196828|P1|STARTED|Overall Study|56 patients were assigned to this arms.|56
4958568|NCT02738333|12196839|P3|NOT COMPLETED|Overall Study||0
4958569|NCT02738333|12196840|P2|NOT COMPLETED|Overall Study||0
4958570|NCT02738333|12196841|P1|NOT COMPLETED|Overall Study||2
4958571|NCT02738333|12196839|P3|COMPLETED|Overall Study||25
4958572|NCT02738333|12196840|P2|COMPLETED|Overall Study||108
4958573|NCT02738333|12196841|P1|COMPLETED|Overall Study||104
4958574|NCT02738333|12196839|P3|STARTED|Overall Study||25
4958575|NCT02738333|12196840|P2|STARTED|Overall Study||108
4958576|NCT02738333|12196841|P1|STARTED|Overall Study||106
4958577|NCT02738255|12196917|P2|NOT COMPLETED|Overall Study||1
4958578|NCT02738255|12196918|P1|NOT COMPLETED|Overall Study||0
4958579|NCT02738255|12196917|P2|COMPLETED|Overall Study||14
4958580|NCT02738255|12196918|P1|COMPLETED|Overall Study||11
4958581|NCT02738255|12196917|P2|STARTED|Overall Study||15
4958582|NCT02738255|12196918|P1|STARTED|Overall Study||11
4958583|NCT02738203|12196930|P2|NOT COMPLETED|Overall Study||3
4958584|NCT02738203|12196931|P1|NOT COMPLETED|Overall Study||2
4958585|NCT02738203|12196930|P2|COMPLETED|Overall Study||107
4958586|NCT02738203|12196931|P1|COMPLETED|Overall Study||108
4958587|NCT02738203|12196930|P2|STARTED|Overall Study||110
4958588|NCT02738203|12196931|P1|STARTED|Overall Study||110
4958589|NCT02738151|12196947|P2|NOT COMPLETED|Overall Study||31
4958590|NCT02738151|12196948|P1|NOT COMPLETED|Overall Study||23
4958591|NCT02738151|12196947|P2|COMPLETED|Overall Study||432
4958592|NCT02738151|12196948|P1|COMPLETED|Overall Study||443
4958593|NCT02738151|12196947|P2|Treated|Overall Study||462
4958594|NCT02738151|12196948|P1|Treated|Overall Study||462
4958595|NCT02738151|12196947|P2|STARTED|Overall Study||463
4958596|NCT02738151|12196948|P1|STARTED|Overall Study||466
4958597|NCT02738138|12196992|P2|NOT COMPLETED|Overall Study||1
4958598|NCT02738138|12196993|P1|NOT COMPLETED|Overall Study||3
4958599|NCT02738138|12196992|P2|COMPLETED|Overall Study||15
4958600|NCT02738138|12196993|P1|COMPLETED|Overall Study||134
4958601|NCT02738138|12196992|P2|STARTED|Overall Study||16
4958602|NCT02738138|12196993|P1|STARTED|Overall Study||137
4958603|NCT02738086|12197002|P2|NOT COMPLETED|Overall Study||2
4958604|NCT02738086|12197003|P1|NOT COMPLETED|Overall Study||2
4958605|NCT02738086|12197002|P2|COMPLETED|Overall Study||13
4958606|NCT02738086|12197003|P1|COMPLETED|Overall Study||14
4958607|NCT02738086|12197002|P2|STARTED|Overall Study||15
4958608|NCT02738086|12197003|P1|STARTED|Overall Study||16
4958609|NCT02738008|12197030|P3|NOT COMPLETED|Overall Study||5
4958610|NCT02738008|12197031|P2|NOT COMPLETED|Overall Study||6
4958611|NCT02738008|12197032|P1|NOT COMPLETED|Overall Study||1
4958612|NCT02738008|12197030|P3|COMPLETED|Overall Study||0
4958613|NCT02738008|12197031|P2|COMPLETED|Overall Study||0
4958614|NCT02738008|12197032|P1|COMPLETED|Overall Study||0
4958615|NCT02738008|12197030|P3|STARTED|Overall Study||5
4958616|NCT02738008|12197031|P2|STARTED|Overall Study||6
4958617|NCT02738008|12197032|P1|STARTED|Overall Study||1
4958618|NCT02737917|12197048|P2|NOT COMPLETED|Overall Study||3
4958619|NCT02737917|12197049|P1|NOT COMPLETED|Overall Study||3
4958620|NCT02737917|12197048|P2|COMPLETED|Overall Study||100
4958621|NCT02737917|12197049|P1|COMPLETED|Overall Study||100
4958622|NCT02737917|12197048|P2|STARTED|Overall Study||103
4958623|NCT02737917|12197049|P1|STARTED|Overall Study||103
4958624|NCT02737891|12197059|P2|NOT COMPLETED|Overall Study||2
4958625|NCT02737891|12197060|P1|NOT COMPLETED|Overall Study||0
4958626|NCT02737891|12197059|P2|COMPLETED|Overall Study||28
4958627|NCT02737891|12197060|P1|COMPLETED|Overall Study||30
4958628|NCT02737891|12197059|P2|STARTED|Overall Study||30
4958629|NCT02737891|12197060|P1|STARTED|Overall Study||30
4958630|NCT02737852|12197070|P1|NOT COMPLETED|Overall Study||2
4958631|NCT02737852|12197070|P1|COMPLETED|Overall Study||30
4958632|NCT02737852|12197070|P1|STARTED|Overall Study||32
4958633|NCT02737722|12197079|P4|NOT COMPLETED|Overall Study||0
4958634|NCT02737722|12197080|P3|NOT COMPLETED|Overall Study||1
4958635|NCT02737722|12197081|P2|NOT COMPLETED|Overall Study||0
4958636|NCT02737722|12197082|P1|NOT COMPLETED|Overall Study||0
4958637|NCT02737722|12197079|P4|COMPLETED|Overall Study||6
4958638|NCT02737722|12197080|P3|COMPLETED|Overall Study||7
4958639|NCT02737722|12197081|P2|COMPLETED|Overall Study||8
4958640|NCT02737722|12197082|P1|COMPLETED|Overall Study||8
4958641|NCT02737722|12197079|P4|STARTED|Overall Study||6
4958642|NCT02737722|12197080|P3|STARTED|Overall Study||8
4958643|NCT02737722|12197081|P2|STARTED|Overall Study||8
4958644|NCT02737722|12197082|P1|STARTED|Overall Study||8
4958645|NCT02737631|12197128|P1|NOT COMPLETED|Overall Study||0
4958646|NCT02737631|12197128|P1|COMPLETED|Overall Study||222
4958647|NCT02737631|12197128|P1|STARTED|Overall Study||222
4958648|NCT02737618|12197133|P1|NOT COMPLETED|Overall Study||9
4958649|NCT02737618|12197133|P1|COMPLETED|Overall Study||34
4958650|NCT02737618|12197133|P1|STARTED|Overall Study||43
4958651|NCT02737592|12197138|P1|NOT COMPLETED|Overall Study||1
4958652|NCT02737592|12197138|P1|COMPLETED|Overall Study||33
4958653|NCT02737592|12197138|P1|STARTED|Overall Study||34
4958654|NCT02737397|12197143|P1|NOT COMPLETED|Overall Study||0
4958655|NCT02737397|12197143|P1|COMPLETED|Overall Study||13
4958656|NCT02737397|12197143|P1|Placebo|Overall Study||13
4958657|NCT02737397|12197143|P1|SJP-223|Overall Study||13
4958658|NCT02737397|12197143|P1|SJP-304|Overall Study||12
4958659|NCT02737397|12197143|P1|JMI-001|Overall Study||13
4958660|NCT02737397|12197143|P1|STARTED|Overall Study||13
4958661|NCT02737163|12197157|P1|NOT COMPLETED|Overall Study||0
4958662|NCT02737163|12197157|P1|COMPLETED|Overall Study||95
4958663|NCT02737163|12197157|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
4958664|NCT02737072|12197167|P3|NOT COMPLETED|Overall Study||0
4958665|NCT02737072|12197168|P2|NOT COMPLETED|Overall Study||0
4958666|NCT02737072|12197169|P1|NOT COMPLETED|Overall Study||0
4958667|NCT02737072|12197167|P3|COMPLETED|Overall Study||3
4958668|NCT02737072|12197168|P2|COMPLETED|Overall Study||3
4958669|NCT02737072|12197169|P1|COMPLETED|Overall Study||3
4958670|NCT02737072|12197167|P3|Received at Least One Dose of Drug|Overall Study||3
4958671|NCT02737072|12197168|P2|Received at Least One Dose of Drug|Overall Study||3
4958672|NCT02737072|12197169|P1|Received at Least One Dose of Drug|Overall Study||3
4958673|NCT02737072|12197167|P3|STARTED|Overall Study||3
4958674|NCT02737072|12197168|P2|STARTED|Overall Study||3
4958675|NCT02737072|12197169|P1|STARTED|Overall Study||3
4958676|NCT02736955|12197193|P3|NOT COMPLETED|Overall Study||2
4958677|NCT02736955|12197194|P2|NOT COMPLETED|Overall Study||14
4958678|NCT02736955|12197195|P1|NOT COMPLETED|Overall Study||7
4958679|NCT02736955|12197193|P3|COMPLETED|Overall Study||6
4958680|NCT02736955|12197194|P2|COMPLETED|Overall Study||103
4958681|NCT02736955|12197195|P1|COMPLETED|Overall Study||29
4958682|NCT02736955|12197193|P3|STARTED|Overall Study||8
4958683|NCT02736955|12197194|P2|STARTED|Overall Study||117
4958684|NCT02736955|12197195|P1|STARTED|Overall Study||36
4958685|NCT02736890|12197211|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
4958686|NCT02736890|12197212|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
4958687|NCT02736890|12197211|P2|COMPLETED|Crossover Next 12 Weeks||1
4958688|NCT02736890|12197212|P1|COMPLETED|Crossover Next 12 Weeks||3
4958689|NCT02736890|12197211|P2|STARTED|Crossover Next 12 Weeks||3
4958690|NCT02736890|12197212|P1|STARTED|Crossover Next 12 Weeks||5
4958691|NCT02736890|12197211|P2|NOT COMPLETED|First 12 Weeks||0
4958692|NCT02736890|12197212|P1|NOT COMPLETED|First 12 Weeks||0
4958693|NCT02736890|12197211|P2|COMPLETED|First 12 Weeks||3
4958694|NCT02736890|12197212|P1|COMPLETED|First 12 Weeks||5
4958695|NCT02736890|12197211|P2|STARTED|First 12 Weeks||3
4958696|NCT02736890|12197212|P1|STARTED|First 12 Weeks||5
4958697|NCT02736825|12197234|P2|NOT COMPLETED|Overall Study||12
4958698|NCT02736825|12197235|P1|NOT COMPLETED|Overall Study||10
4958699|NCT02736825|12197234|P2|COMPLETED|Overall Study||123
4958700|NCT02736825|12197235|P1|COMPLETED|Overall Study||117
4958701|NCT02736825|12197234|P2|STARTED|Overall Study||135
4958702|NCT02736825|12197235|P1|STARTED|Overall Study||127
4958703|NCT02736721|12197275|P1|NOT COMPLETED|Overall Study||16
4958704|NCT02736721|12197275|P1|COMPLETED|Overall Study||25
4958705|NCT02736721|12197275|P1|STARTED|Overall Study||41
4958706|NCT02736578|12197286|P2|NOT COMPLETED|Overall Study||0
4958707|NCT02736578|12197287|P1|NOT COMPLETED|Overall Study||1
4958708|NCT02736578|12197286|P2|COMPLETED|Overall Study||2
4958709|NCT02736578|12197287|P1|COMPLETED|Overall Study||5
4958710|NCT02736578|12197286|P2|STARTED|Overall Study||2
4958711|NCT02736578|12197287|P1|STARTED|Overall Study||6
4958712|NCT02736188|12197305|P1|NOT COMPLETED|Overall Study||142
4958713|NCT02736188|12197305|P1|COMPLETED|Overall Study||0
4958714|NCT02736188|12197305|P1|STARTED|Overall Study||142
4958715|NCT02736175|12197331|P2|NOT COMPLETED|Overall Study||1
4958716|NCT02736175|12197332|P1|NOT COMPLETED|Overall Study||2
4958717|NCT02736175|12197331|P2|COMPLETED|Overall Study||221
4958718|NCT02736175|12197332|P1|COMPLETED|Overall Study||214
4958719|NCT02736175|12197331|P2|STARTED|Overall Study||222
4958720|NCT02736175|12197332|P1|STARTED|Overall Study||216
4958721|NCT02735980|12197343|P3|NOT COMPLETED|Overall Study||1
4958722|NCT02735980|12197344|P2|NOT COMPLETED|Overall Study||11
4958723|NCT02735980|12197345|P1|NOT COMPLETED|Overall Study||10
4958724|NCT02735980|12197343|P3|COMPLETED|Overall Study||14
4958725|NCT02735980|12197344|P2|COMPLETED|Overall Study||49
4958726|NCT02735980|12197345|P1|COMPLETED|Overall Study||48
4958727|NCT02735980|12197343|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
4958728|NCT02735980|12197344|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
4958729|NCT02735980|12197345|P1|Received at Least 1 Dose of Study Drug|Overall Study||56
4958730|NCT02735980|12197343|P3|STARTED|Overall Study||15
4958731|NCT02735980|12197344|P2|STARTED|Overall Study||60
4958732|NCT02735980|12197345|P1|STARTED|Overall Study||58
4958733|NCT02735915|12197374|P1|NOT COMPLETED|Overall Study||11
4958734|NCT02735915|12197374|P1|COMPLETED|Overall Study||59
4958735|NCT02735915|12197374|P1|Vaccinated|Overall Study||62
4958736|NCT02735915|12197374|P1|STARTED|Overall Study||70
4958737|NCT02735551|12197396|P3|NOT COMPLETED|Overall Study||0
4958738|NCT02735551|12197397|P2|NOT COMPLETED|Overall Study||0
4958739|NCT02735551|12197398|P1|NOT COMPLETED|Overall Study||0
4958740|NCT02735551|12197396|P3|COMPLETED|Overall Study||0
4958741|NCT02735551|12197397|P2|COMPLETED|Overall Study||0
4958742|NCT02735551|12197398|P1|COMPLETED|Overall Study||3
4958743|NCT02735551|12197396|P3|STARTED|Overall Study||0
4958744|NCT02735551|12197397|P2|STARTED|Overall Study||0
4958745|NCT02735551|12197398|P1|STARTED|Overall Study||3
4958746|NCT02735421|12197406|P1|NOT COMPLETED|Overall Study||13
4958747|NCT02735421|12197406|P1|COMPLETED|Overall Study||54
4958748|NCT02735421|12197406|P1|STARTED|Overall Study||67
4958749|NCT02735382|12197417|P4|NOT COMPLETED|Overall Study||0
4958750|NCT02735382|12197418|P3|NOT COMPLETED|Overall Study||0
4958751|NCT02735382|12197419|P2|NOT COMPLETED|Overall Study||0
4958752|NCT02735382|12197420|P1|NOT COMPLETED|Overall Study||0
4958753|NCT02735382|12197417|P4|COMPLETED|Overall Study||110
4958754|NCT02735382|12197418|P3|COMPLETED|Overall Study||184
4958755|NCT02735382|12197419|P2|COMPLETED|Overall Study||7155
4958756|NCT02735382|12197420|P1|COMPLETED|Overall Study||7481
4958757|NCT02735382|12197417|P4|STARTED|Overall Study||110
4958758|NCT02735382|12197418|P3|STARTED|Overall Study||184
4958759|NCT02735382|12197419|P2|STARTED|Overall Study||7155
4958760|NCT02735382|12197420|P1|STARTED|Overall Study||7481
4958761|NCT02735200|12197436|P2|NOT COMPLETED|Overall Study||5
4958762|NCT02735200|12197437|P1|NOT COMPLETED|Overall Study||8
4958763|NCT02735200|12197436|P2|COMPLETED|Overall Study||345
4958764|NCT02735200|12197437|P1|COMPLETED|Overall Study||192
4958765|NCT02735200|12197436|P2|STARTED|Overall Study||350
4958766|NCT02735200|12197437|P1|STARTED|Overall Study||200
4958767|NCT02735187|12197445|P2|NOT COMPLETED|Overall Study||1
4958768|NCT02735187|12197446|P1|NOT COMPLETED|Overall Study||4
4958769|NCT02735187|12197445|P2|COMPLETED|Overall Study||25
4958770|NCT02735187|12197446|P1|COMPLETED|Overall Study||21
4958771|NCT02735187|12197445|P2|STARTED|Overall Study||26
4958772|NCT02735187|12197446|P1|STARTED|Overall Study||25
4958773|NCT02735096|12197476|P1|NOT COMPLETED|Overall Study||1
4958774|NCT02735096|12197476|P1|COMPLETED|Overall Study||3
4958775|NCT02735096|12197476|P1|STARTED|Overall Study||4
4958776|NCT02735044|12197485|P2|NOT COMPLETED|Overall Study||23
4958777|NCT02735044|12197486|P1|NOT COMPLETED|Overall Study||16
4958778|NCT02735044|12197485|P2|COMPLETED|Overall Study||207
4958779|NCT02735044|12197486|P1|COMPLETED|Overall Study||217
4958780|NCT02735044|12197485|P2|Treated|Overall Study||228
4958781|NCT02735044|12197486|P1|Treated|Overall Study||233
4958782|NCT02735044|12197485|P2|STARTED|Overall Study||230
4958783|NCT02735044|12197486|P1|STARTED|Overall Study||233
4958784|NCT02734953|12197512|P1|NOT COMPLETED|Overall Study||0
4958785|NCT02734953|12197512|P1|COMPLETED|Overall Study||10
4958786|NCT02734953|12197512|P1|STARTED|Overall Study||10
4958787|NCT02734940|12197529|P2|NOT COMPLETED|Overall Study||0
4958788|NCT02734940|12197530|P1|NOT COMPLETED|Overall Study||0
4958789|NCT02734940|12197529|P2|COMPLETED|Overall Study||0
4958790|NCT02734940|12197530|P1|COMPLETED|Overall Study||0
4958791|NCT02734940|12197529|P2|STARTED|Overall Study||0
4958792|NCT02734940|12197530|P1|STARTED|Overall Study||0
4958793|NCT02734810|12197554|P2|NOT COMPLETED|Overall Study||0
4958794|NCT02734810|12197555|P1|NOT COMPLETED|Overall Study||2
4958795|NCT02734810|12197554|P2|COMPLETED|Overall Study||0
4958796|NCT02734810|12197555|P1|COMPLETED|Overall Study||13
4958797|NCT02734810|12197554|P2|STARTED|Overall Study||0
4958798|NCT02734810|12197555|P1|STARTED|Overall Study||15
4958799|NCT02734693|12197564|P3|NOT COMPLETED|Overall Study||3
4958800|NCT02734693|12197565|P2|NOT COMPLETED|Overall Study||3
4958801|NCT02734693|12197566|P1|NOT COMPLETED|Overall Study||6
4958802|NCT02734693|12197564|P3|COMPLETED|Overall Study||17
4958803|NCT02734693|12197565|P2|COMPLETED|Overall Study||53
4958804|NCT02734693|12197566|P1|COMPLETED|Overall Study||50
4958805|NCT02734693|12197564|P3|STARTED|Overall Study||20
4958806|NCT02734693|12197565|P2|STARTED|Overall Study||56
4958807|NCT02734693|12197566|P1|STARTED|Overall Study||56
4958808|NCT02734498|12197586|P3|NOT COMPLETED|Overall Study||0
4958809|NCT02734498|12197587|P2|NOT COMPLETED|Overall Study||0
4958810|NCT02734498|12197588|P1|NOT COMPLETED|Overall Study||0
4958811|NCT02734498|12197586|P3|COMPLETED|Overall Study||0
4958812|NCT02734498|12197587|P2|COMPLETED|Overall Study||0
4958813|NCT02734498|12197588|P1|COMPLETED|Overall Study||2
4958814|NCT02734498|12197586|P3|STARTED|Overall Study||0
4958815|NCT02734498|12197587|P2|STARTED|Overall Study||0
4958816|NCT02734498|12197588|P1|STARTED|Overall Study||2
4958817|NCT02734433|12197607|P2|NOT COMPLETED|Overall Study||8
4958818|NCT02734433|12197608|P1|NOT COMPLETED|Overall Study||2
4958819|NCT02734433|12197607|P2|COMPLETED|Overall Study||0
4958820|NCT02734433|12197608|P1|COMPLETED|Overall Study||1
4958821|NCT02734433|12197607|P2|STARTED|Overall Study||8
4958822|NCT02734433|12197608|P1|STARTED|Overall Study||3
4958823|NCT02734355|12197642|P2|NOT COMPLETED|Overall Study||0
4958824|NCT02734355|12197643|P1|NOT COMPLETED|Overall Study||0
4958825|NCT02734355|12197642|P2|COMPLETED|Overall Study||30
4958826|NCT02734355|12197643|P1|COMPLETED|Overall Study||34
4958827|NCT02734355|12197642|P2|STARTED|Overall Study||30
4958828|NCT02734355|12197643|P1|STARTED|Overall Study||34
4958829|NCT02734238|12197675|P2|NOT COMPLETED|Overall Study||0
4958830|NCT02734238|12197676|P1|NOT COMPLETED|Overall Study||0
4958831|NCT02734238|12197675|P2|COMPLETED|Overall Study||24
4958832|NCT02734238|12197676|P1|COMPLETED|Overall Study||26
4958833|NCT02734238|12197675|P2|STARTED|Overall Study||24
4958834|NCT02734238|12197676|P1|STARTED|Overall Study||26
4958835|NCT02734212|12197684|P2|NOT COMPLETED|Overall Study||10
4958836|NCT02734212|12197685|P1|NOT COMPLETED|Overall Study||5
4958837|NCT02734212|12197684|P2|COMPLETED|Overall Study||18
4958838|NCT02734212|12197685|P1|COMPLETED|Overall Study||24
4958839|NCT02734212|12197684|P2|STARTED|Overall Study||28
4958840|NCT02734212|12197685|P1|STARTED|Overall Study||29
4958841|NCT02734056|12197697|P2|NOT COMPLETED|Overall Study||1
4958842|NCT02734056|12197698|P1|NOT COMPLETED|Overall Study||0
4958843|NCT02734056|12197697|P2|COMPLETED|Overall Study||49
4958844|NCT02734056|12197698|P1|COMPLETED|Overall Study||50
4958845|NCT02734056|12197697|P2|STARTED|Overall Study||50
4958846|NCT02734056|12197698|P1|STARTED|Overall Study||50
4958847|NCT02733991|12197706|P2|NOT COMPLETED|Overall Study||5
4958848|NCT02733991|12197707|P1|NOT COMPLETED|Overall Study||1
4958849|NCT02733991|12197706|P2|COMPLETED|Overall Study||72
4958850|NCT02733991|12197707|P1|COMPLETED|Overall Study||75
4958851|NCT02733991|12197706|P2|STARTED|Overall Study||77
4958852|NCT02733991|12197707|P1|STARTED|Overall Study||76
4958853|NCT02733653|12197717|P1|NOT COMPLETED|Overall Study||1
4958854|NCT02733653|12197717|P1|COMPLETED|Overall Study||49
4958855|NCT02733653|12197717|P1|STARTED|Overall Study||50
4958856|NCT02733588|12197723|P1|NOT COMPLETED|Overall Study||0
4958857|NCT02733588|12197723|P1|COMPLETED|Overall Study||7
4958858|NCT02733588|12197723|P1|STARTED|Overall Study||7
4958859|NCT02733367|12197730|P1|NOT COMPLETED|Overall Study||6
4958860|NCT02733367|12197730|P1|COMPLETED|Overall Study||12
4958861|NCT02733367|12197730|P1|STARTED|Overall Study||18
4958862|NCT02733042|12197756|P19|NOT COMPLETED|Follow-up Period||2
4958863|NCT02733042|12197757|P18|NOT COMPLETED|Follow-up Period||2
4958864|NCT02733042|12197758|P17|NOT COMPLETED|Follow-up Period||0
4958865|NCT02733042|12197759|P16|NOT COMPLETED|Follow-up Period||5
4958866|NCT02733042|12197760|P15|NOT COMPLETED|Follow-up Period||1
4958867|NCT02733042|12197761|P14|NOT COMPLETED|Follow-up Period||4
4958868|NCT02733042|12197762|P13|NOT COMPLETED|Follow-up Period||9
4958869|NCT02733042|12197763|P12|NOT COMPLETED|Follow-up Period||9
4958870|NCT02733042|12197764|P11|NOT COMPLETED|Follow-up Period||5
4958871|NCT02733042|12197765|P10|NOT COMPLETED|Follow-up Period||2
4958872|NCT02733042|12197766|P9|NOT COMPLETED|Follow-up Period||4
4958873|NCT02733042|12197767|P8|NOT COMPLETED|Follow-up Period||4
4958874|NCT02733042|12197768|P7|NOT COMPLETED|Follow-up Period||0
4958875|NCT02733042|12197769|P6|NOT COMPLETED|Follow-up Period||2
4958876|NCT02733042|12197770|P5|NOT COMPLETED|Follow-up Period||1
4958877|NCT02733042|12197771|P4|NOT COMPLETED|Follow-up Period||3
4958878|NCT02733042|12197772|P3|NOT COMPLETED|Follow-up Period||6
4958879|NCT02733042|12197773|P2|NOT COMPLETED|Follow-up Period||3
4958880|NCT02733042|12197774|P1|NOT COMPLETED|Follow-up Period||3
4958881|NCT02733042|12197756|P19|COMPLETED|Follow-up Period||0
4958882|NCT02733042|12197757|P18|COMPLETED|Follow-up Period||1
4958883|NCT02733042|12197758|P17|COMPLETED|Follow-up Period||0
4958884|NCT02733042|12197759|P16|COMPLETED|Follow-up Period||0
4958885|NCT02733042|12197760|P15|COMPLETED|Follow-up Period||0
4958886|NCT02733042|12197761|P14|COMPLETED|Follow-up Period||0
4958887|NCT02733042|12197762|P13|COMPLETED|Follow-up Period||0
4958888|NCT02733042|12197763|P12|COMPLETED|Follow-up Period||0
4958889|NCT02733042|12197764|P11|COMPLETED|Follow-up Period||0
4958890|NCT02733042|12197765|P10|COMPLETED|Follow-up Period||0
4958891|NCT02733042|12197766|P9|COMPLETED|Follow-up Period||0
4958892|NCT02733042|12197767|P8|COMPLETED|Follow-up Period||0
4958893|NCT02733042|12197768|P7|COMPLETED|Follow-up Period||0
4958894|NCT02733042|12197769|P6|COMPLETED|Follow-up Period||0
4958895|NCT02733042|12197770|P5|COMPLETED|Follow-up Period||0
4958896|NCT02733042|12197771|P4|COMPLETED|Follow-up Period||0
4958897|NCT02733042|12197772|P3|COMPLETED|Follow-up Period||0
4958898|NCT02733042|12197773|P2|COMPLETED|Follow-up Period||0
4958899|NCT02733042|12197774|P1|COMPLETED|Follow-up Period||0
4958900|NCT02733042|12197756|P19|STARTED|Follow-up Period||2
4958901|NCT02733042|12197757|P18|STARTED|Follow-up Period||3
4958902|NCT02733042|12197758|P17|STARTED|Follow-up Period||0
4958903|NCT02733042|12197759|P16|STARTED|Follow-up Period||5
4958904|NCT02733042|12197760|P15|STARTED|Follow-up Period||1
4958905|NCT02733042|12197761|P14|STARTED|Follow-up Period||4
4958906|NCT02733042|12197762|P13|STARTED|Follow-up Period||9
4958907|NCT02733042|12197763|P12|STARTED|Follow-up Period||9
4958908|NCT02733042|12197764|P11|STARTED|Follow-up Period||5
4958909|NCT02733042|12197765|P10|STARTED|Follow-up Period||2
4958910|NCT02733042|12197766|P9|STARTED|Follow-up Period||4
4958911|NCT02733042|12197767|P8|STARTED|Follow-up Period||4
4958912|NCT02733042|12197768|P7|STARTED|Follow-up Period||0
4958913|NCT02733042|12197769|P6|STARTED|Follow-up Period||2
4958914|NCT02733042|12197770|P5|STARTED|Follow-up Period||1
4958915|NCT02733042|12197771|P4|STARTED|Follow-up Period||3
4958916|NCT02733042|12197772|P3|STARTED|Follow-up Period||6
4958917|NCT02733042|12197773|P2|STARTED|Follow-up Period||3
4958918|NCT02733042|12197774|P1|STARTED|Follow-up Period||3
4958919|NCT02733042|12197756|P19|NOT COMPLETED|Treatment Period||5
4958920|NCT02733042|12197757|P18|NOT COMPLETED|Treatment Period||5
4958921|NCT02733042|12197758|P17|NOT COMPLETED|Treatment Period||2
4958922|NCT02733042|12197759|P16|NOT COMPLETED|Treatment Period||10
4958923|NCT02733042|12197760|P15|NOT COMPLETED|Treatment Period||5
4958924|NCT02733042|12197761|P14|NOT COMPLETED|Treatment Period||4
4958925|NCT02733042|12197762|P13|NOT COMPLETED|Treatment Period||9
4958926|NCT02733042|12197763|P12|NOT COMPLETED|Treatment Period||6
4958927|NCT02733042|12197764|P11|NOT COMPLETED|Treatment Period||10
4958928|NCT02733042|12197765|P10|NOT COMPLETED|Treatment Period||10
4958929|NCT02733042|12197766|P9|NOT COMPLETED|Treatment Period||5
4958930|NCT02733042|12197767|P8|NOT COMPLETED|Treatment Period||3
4958931|NCT02733042|12197768|P7|NOT COMPLETED|Treatment Period||1
4958932|NCT02733042|12197769|P6|NOT COMPLETED|Treatment Period||3
4958933|NCT02733042|12197770|P5|NOT COMPLETED|Treatment Period||4
4958934|NCT02733042|12197771|P4|NOT COMPLETED|Treatment Period||3
4958935|NCT02733042|12197772|P3|NOT COMPLETED|Treatment Period||7
4958936|NCT02733042|12197773|P2|NOT COMPLETED|Treatment Period||2
4958937|NCT02733042|12197774|P1|NOT COMPLETED|Treatment Period||3
4958938|NCT02733042|12197756|P19|COMPLETED|Treatment Period||0
4958939|NCT02733042|12197757|P18|COMPLETED|Treatment Period||0
4958940|NCT02733042|12197758|P17|COMPLETED|Treatment Period||0
4958941|NCT02733042|12197759|P16|COMPLETED|Treatment Period||0
4958942|NCT02733042|12197760|P15|COMPLETED|Treatment Period||0
4958943|NCT02733042|12197761|P14|COMPLETED|Treatment Period||1
4958944|NCT02733042|12197762|P13|COMPLETED|Treatment Period||1
4958945|NCT02733042|12197763|P12|COMPLETED|Treatment Period||4
4958946|NCT02733042|12197764|P11|COMPLETED|Treatment Period||0
4958947|NCT02733042|12197765|P10|COMPLETED|Treatment Period||0
4958948|NCT02733042|12197766|P9|COMPLETED|Treatment Period||0
4958949|NCT02733042|12197767|P8|COMPLETED|Treatment Period||1
4958950|NCT02733042|12197768|P7|COMPLETED|Treatment Period||0
4958951|NCT02733042|12197769|P6|COMPLETED|Treatment Period||0
4958952|NCT02733042|12197770|P5|COMPLETED|Treatment Period||0
4958953|NCT02733042|12197771|P4|COMPLETED|Treatment Period||0
4958954|NCT02733042|12197772|P3|COMPLETED|Treatment Period||1
4958955|NCT02733042|12197773|P2|COMPLETED|Treatment Period||1
4958956|NCT02733042|12197774|P1|COMPLETED|Treatment Period||0
4958957|NCT02733042|12197756|P19|STARTED|Treatment Period||5
4958958|NCT02733042|12197757|P18|STARTED|Treatment Period||5
4958959|NCT02733042|12197758|P17|STARTED|Treatment Period||2
4958960|NCT02733042|12197759|P16|STARTED|Treatment Period||10
4958961|NCT02733042|12197760|P15|STARTED|Treatment Period||5
4958962|NCT02733042|12197761|P14|STARTED|Treatment Period||5
4958963|NCT02733042|12197762|P13|STARTED|Treatment Period||10
4958964|NCT02733042|12197763|P12|STARTED|Treatment Period||10
4958965|NCT02733042|12197764|P11|STARTED|Treatment Period||10
4958966|NCT02733042|12197765|P10|STARTED|Treatment Period||10
4958967|NCT02733042|12197766|P9|STARTED|Treatment Period||5
4958968|NCT02733042|12197767|P8|STARTED|Treatment Period||4
4958969|NCT02733042|12197768|P7|STARTED|Treatment Period||1
4958970|NCT02733042|12197769|P6|STARTED|Treatment Period||3
4958971|NCT02733042|12197770|P5|STARTED|Treatment Period||4
4958972|NCT02733042|12197771|P4|STARTED|Treatment Period||3
4958973|NCT02733042|12197772|P3|STARTED|Treatment Period||8
4958974|NCT02733042|12197773|P2|STARTED|Treatment Period||3
4958975|NCT02733042|12197774|P1|STARTED|Treatment Period||3
4958976|NCT02732951|12197979|P2|NOT COMPLETED|Overall Study||6
4958977|NCT02732951|12197980|P1|NOT COMPLETED|Overall Study||5
4958978|NCT02732951|12197979|P2|COMPLETED|Overall Study||46
4958979|NCT02732951|12197980|P1|COMPLETED|Overall Study||48
4958980|NCT02732951|12197979|P2|STARTED|Overall Study||52
4958981|NCT02732951|12197980|P1|STARTED|Overall Study||53
4958982|NCT02732938|12197990|P3|NOT COMPLETED|Overall Study||0
4958983|NCT02732938|12197991|P2|NOT COMPLETED|Overall Study||18
4958984|NCT02732938|12197992|P1|NOT COMPLETED|Overall Study||4
4958985|NCT02732938|12197990|P3|COMPLETED|Overall Study||0
4958986|NCT02732938|12197991|P2|COMPLETED|Overall Study||0
4958987|NCT02732938|12197992|P1|COMPLETED|Overall Study||0
4958988|NCT02732938|12197990|P3|Received Treatment|Overall Study||0
4958989|NCT02732938|12197991|P2|Received Treatment|Overall Study||17
4958990|NCT02732938|12197992|P1|Received Treatment|Overall Study||4
4958991|NCT02732938|12197990|P3|STARTED|Overall Study||0
4958992|NCT02732938|12197991|P2|STARTED|Overall Study||18
4958993|NCT02732938|12197992|P1|STARTED|Overall Study||4
4958994|NCT02732912|12198038|P2|NOT COMPLETED|Overall Study||18
4958995|NCT02732912|12198039|P1|NOT COMPLETED|Overall Study||10
4958996|NCT02732912|12198038|P2|COMPLETED|Overall Study||91
4958997|NCT02732912|12198039|P1|COMPLETED|Overall Study||87
4958998|NCT02732912|12198038|P2|STARTED|Overall Study||109
4958999|NCT02732912|12198039|P1|STARTED|Overall Study||97
4959000|NCT02732899|12198055|P2|NOT COMPLETED|Overall Study||0
4959001|NCT02732899|12198056|P1|NOT COMPLETED|Overall Study||0
4959002|NCT02732899|12198055|P2|COMPLETED|Overall Study||10
4959003|NCT02732899|12198056|P1|COMPLETED|Overall Study||10
4959004|NCT02732899|12198055|P2|STARTED|Overall Study||10
4959005|NCT02732899|12198056|P1|STARTED|Overall Study||10
4959006|NCT02732639|12198064|P1|NOT COMPLETED|Overall Study||1
4959007|NCT02732639|12198064|P1|COMPLETED|Overall Study||30
4959008|NCT02732639|12198064|P1|STARTED|Overall Study||31
4959009|NCT02732600|12198077|P2|NOT COMPLETED|Overall Study||108
4959010|NCT02732600|12198078|P1|NOT COMPLETED|Overall Study||94
4959011|NCT02732600|12198077|P2|COMPLETED|Overall Study||113
4959012|NCT02732600|12198078|P1|COMPLETED|Overall Study||100
4959013|NCT02732600|12198077|P2|1-Year|Overall Study||113
4959014|NCT02732600|12198078|P1|1-Year|Overall Study||100
4959015|NCT02732600|12198077|P2|6-months|Overall Study||129
4959016|NCT02732600|12198078|P1|6-months|Overall Study||121
4959017|NCT02732600|12198077|P2|STARTED|Overall Study||221
4959018|NCT02732600|12198078|P1|STARTED|Overall Study||194
4959019|NCT02732587|12198084|P1|NOT COMPLETED|Overall Study||0
4959020|NCT02732587|12198084|P1|COMPLETED|Overall Study||5
4959021|NCT02732587|12198084|P1|STARTED|Overall Study||5
4959022|NCT02732561|12198090|P2|NOT COMPLETED|Overall Study||1
4959023|NCT02732561|12198091|P1|NOT COMPLETED|Overall Study||2
4959024|NCT02732561|12198090|P2|COMPLETED|Overall Study||4
4959025|NCT02732561|12198091|P1|COMPLETED|Overall Study||3
4959026|NCT02732561|12198090|P2|STARTED|Overall Study||5
4959027|NCT02732561|12198091|P1|STARTED|Overall Study||5
4959028|NCT02732366|12198101|P2|NOT COMPLETED|Overall Study||2
4959029|NCT02732366|12198102|P1|NOT COMPLETED|Overall Study||5
4959030|NCT02732366|12198101|P2|COMPLETED|Overall Study||21
4959031|NCT02732366|12198102|P1|COMPLETED|Overall Study||18
4959032|NCT02732366|12198101|P2|Withdrawal by Participant|Overall Study||2
4959033|NCT02732366|12198102|P1|Withdrawal by Participant|Overall Study||5
4959034|NCT02732366|12198101|P2|STARTED|Overall Study||23
4959035|NCT02732366|12198102|P1|STARTED|Overall Study||23
4959036|NCT02732327|12198117|P2|NOT COMPLETED|Overall Study||1
4959037|NCT02732327|12198118|P1|NOT COMPLETED|Overall Study||0
4959038|NCT02732327|12198117|P2|COMPLETED|Overall Study||1
4959039|NCT02732327|12198118|P1|COMPLETED|Overall Study||0
4959040|NCT02732327|12198117|P2|STARTED|Overall Study||2
4959041|NCT02732327|12198118|P1|STARTED|Overall Study||0
4959042|NCT02732210|12198126|P2|NOT COMPLETED|Overall Study||294
4959043|NCT02732210|12198127|P1|NOT COMPLETED|Overall Study||85
4959044|NCT02732210|12198126|P2|COMPLETED|Overall Study||338
4959045|NCT02732210|12198127|P1|COMPLETED|Overall Study||218
4959046|NCT02732210|12198126|P2|STARTED|Overall Study||632
4959047|NCT02732210|12198127|P1|STARTED|Overall Study||303
4959048|NCT02732145|12198147|P4|NOT COMPLETED|Overall Study||0
4959049|NCT02732145|12198148|P3|NOT COMPLETED|Overall Study||0
4959050|NCT02732145|12198149|P2|NOT COMPLETED|Overall Study||0
4959051|NCT02732145|12198150|P1|NOT COMPLETED|Overall Study||0
4959052|NCT02732145|12198147|P4|COMPLETED|Overall Study||82
4959053|NCT02732145|12198148|P3|COMPLETED|Overall Study||82
4959054|NCT02732145|12198149|P2|COMPLETED|Overall Study||82
4959055|NCT02732145|12198150|P1|COMPLETED|Overall Study||82
4959056|NCT02732145|12198147|P4|STARTED|Overall Study||82
4959057|NCT02732145|12198148|P3|STARTED|Overall Study||82
4959058|NCT02732145|12198149|P2|STARTED|Overall Study||82
4959059|NCT02732145|12198150|P1|STARTED|Overall Study||82
4959060|NCT02731833|12198278|P2|NOT COMPLETED|Overall Study||0
4959061|NCT02731833|12198279|P1|NOT COMPLETED|Overall Study||0
4959062|NCT02731833|12198278|P2|COMPLETED|Overall Study||111
4959063|NCT02731833|12198279|P1|COMPLETED|Overall Study||111
4959064|NCT02731833|12198278|P2|STARTED|Overall Study||111
4959065|NCT02731833|12198279|P1|STARTED|Overall Study||111
4959066|NCT02731820|12198293|P2|NOT COMPLETED|Overall Study||2
4959067|NCT02731820|12198294|P1|NOT COMPLETED|Overall Study||3
4959068|NCT02731820|12198293|P2|COMPLETED|Overall Study||18
4959069|NCT02731820|12198294|P1|COMPLETED|Overall Study||17
4959070|NCT02731820|12198293|P2|STARTED|Overall Study||20
4959071|NCT02731820|12198294|P1|STARTED|Overall Study||20
4959072|NCT02731755|12198306|P2|NOT COMPLETED|Second Intervention||0
4959073|NCT02731755|12198307|P1|NOT COMPLETED|Second Intervention||0
4959074|NCT02731755|12198306|P2|COMPLETED|Second Intervention||8
4959075|NCT02731755|12198307|P1|COMPLETED|Second Intervention||8
4959076|NCT02731755|12198306|P2|STARTED|Second Intervention||8
4959077|NCT02731755|12198307|P1|STARTED|Second Intervention||8
4959078|NCT02731755|12198306|P2|NOT COMPLETED|First Intervention||2
4959079|NCT02731755|12198307|P1|NOT COMPLETED|First Intervention||0
4959080|NCT02731755|12198306|P2|COMPLETED|First Intervention||8
4959081|NCT02731755|12198307|P1|COMPLETED|First Intervention||8
4959082|NCT02731755|12198306|P2|STARTED|First Intervention||10
4959083|NCT02731755|12198307|P1|STARTED|First Intervention||8
4959084|NCT02731742|12198331|P4|NOT COMPLETED|Overall Study||2
4959085|NCT02731742|12198332|P3|NOT COMPLETED|Overall Study||6
4959086|NCT02731742|12198333|P2|NOT COMPLETED|Overall Study||3
4959087|NCT02731742|12198334|P1|NOT COMPLETED|Overall Study||3
4959088|NCT02731742|12198331|P4|COMPLETED|Overall Study||0
4959089|NCT02731742|12198332|P3|COMPLETED|Overall Study||0
4959090|NCT02731742|12198333|P2|COMPLETED|Overall Study||0
4959091|NCT02731742|12198334|P1|COMPLETED|Overall Study||0
4959092|NCT02731742|12198331|P4|STARTED|Overall Study||2
4959093|NCT02731742|12198332|P3|STARTED|Overall Study||6
4959094|NCT02731742|12198333|P2|STARTED|Overall Study||3
4959095|NCT02731742|12198334|P1|STARTED|Overall Study||3
4959096|NCT02731690|12198352|P1|NOT COMPLETED|Overall Study||30
4959097|NCT02731690|12198352|P1|COMPLETED|Overall Study||12
4959098|NCT02731690|12198352|P1|STARTED|Overall Study||42
4959099|NCT02731638|12198372|P2|NOT COMPLETED|Overall Study||9
4959100|NCT02731638|12198373|P1|NOT COMPLETED|Overall Study||6
4959101|NCT02731638|12198372|P2|COMPLETED|Overall Study||26
4959102|NCT02731638|12198373|P1|COMPLETED|Overall Study||29
4959103|NCT02731638|12198372|P2|STARTED|Overall Study||35
4959104|NCT02731638|12198373|P1|STARTED|Overall Study||35
4959105|NCT02731469|12198398|P11|NOT COMPLETED|Overall Study||0
4959106|NCT02731469|12198399|P10|NOT COMPLETED|Overall Study||0
4959107|NCT02731469|12198400|P9|NOT COMPLETED|Overall Study||0
4959108|NCT02731469|12198401|P8|NOT COMPLETED|Overall Study||0
4959109|NCT02731469|12198402|P7|NOT COMPLETED|Overall Study||0
4959110|NCT02731469|12198403|P6|NOT COMPLETED|Overall Study||0
4959111|NCT02731469|12198404|P5|NOT COMPLETED|Overall Study||0
4959112|NCT02731469|12198405|P4|NOT COMPLETED|Overall Study||0
4959113|NCT02731469|12198406|P3|NOT COMPLETED|Overall Study||0
4959114|NCT02731469|12198407|P2|NOT COMPLETED|Overall Study||0
4959115|NCT02731469|12198408|P1|NOT COMPLETED|Overall Study||0
4959116|NCT02731469|12198398|P11|COMPLETED|Overall Study||6
4959117|NCT02731469|12198399|P10|COMPLETED|Overall Study||6
4959118|NCT02731469|12198400|P9|COMPLETED|Overall Study||6
4959119|NCT02731469|12198401|P8|COMPLETED|Overall Study||6
4959120|NCT02731469|12198402|P7|COMPLETED|Overall Study||3
4959121|NCT02731469|12198403|P6|COMPLETED|Overall Study||3
4959122|NCT02731469|12198404|P5|COMPLETED|Overall Study||3
4959123|NCT02731469|12198405|P4|COMPLETED|Overall Study||3
4959124|NCT02731469|12198406|P3|COMPLETED|Overall Study||3
4959125|NCT02731469|12198407|P2|COMPLETED|Overall Study||3
4959126|NCT02731469|12198408|P1|COMPLETED|Overall Study||3
4959127|NCT02731469|12198398|P11|STARTED|Overall Study||6
4959128|NCT02731469|12198399|P10|STARTED|Overall Study||6
4959129|NCT02731469|12198400|P9|STARTED|Overall Study||6
4959130|NCT02731469|12198401|P8|STARTED|Overall Study||6
4959131|NCT02731469|12198402|P7|STARTED|Overall Study||3
4959132|NCT02731469|12198403|P6|STARTED|Overall Study||3
4959133|NCT02731469|12198404|P5|STARTED|Overall Study||3
4959134|NCT02731469|12198405|P4|STARTED|Overall Study||3
4959135|NCT02731469|12198406|P3|STARTED|Overall Study||3
4959136|NCT02731469|12198407|P2|STARTED|Overall Study||3
4959137|NCT02731469|12198408|P1|STARTED|Overall Study||3
4959138|NCT02731313|12198597|P1|NOT COMPLETED|Overall Study||0
4959139|NCT02731313|12198597|P1|COMPLETED|Overall Study||367
4959140|NCT02731313|12198597|P1|STARTED|Overall Study||367
4959141|NCT02731300|12198607|P2|NOT COMPLETED|Overall Study||0
4959142|NCT02731300|12198608|P1|NOT COMPLETED|Overall Study||0
4959143|NCT02731300|12198607|P2|COMPLETED|Overall Study||7
4959144|NCT02731300|12198608|P1|COMPLETED|Overall Study||15
4959145|NCT02731300|12198607|P2|STARTED|Overall Study||7
4959146|NCT02731300|12198608|P1|STARTED|Overall Study||15
4959147|NCT02731157|12198616|P1|NOT COMPLETED|Third Standard RCE||0
4959148|NCT02731157|12198616|P1|COMPLETED|Third Standard RCE||3
4959149|NCT02731157|12198616|P1|STARTED|Third Standard RCE||3
4959150|NCT02731157|12198616|P1|NOT COMPLETED|Second Standard RCE||0
4959151|NCT02731157|12198616|P1|COMPLETED|Second Standard RCE||3
4959152|NCT02731157|12198616|P1|STARTED|Second Standard RCE||3
4959153|NCT02731157|12198616|P1|NOT COMPLETED|Third Rejuvenated RCE||0
4959154|NCT02731157|12198616|P1|COMPLETED|Third Rejuvenated RCE||3
4959155|NCT02731157|12198616|P1|STARTED|Third Rejuvenated RCE||3
4959156|NCT02731157|12198616|P1|NOT COMPLETED|Second Rejuvenated RCE||0
4959157|NCT02731157|12198616|P1|COMPLETED|Second Rejuvenated RCE||3
4959158|NCT02731157|12198616|P1|STARTED|Second Rejuvenated RCE||3
4959159|NCT02731157|12198616|P1|NOT COMPLETED|First Rejuvenated RCE||1
4959160|NCT02731157|12198616|P1|COMPLETED|First Rejuvenated RCE||3
4959161|NCT02731157|12198616|P1|STARTED|First Rejuvenated RCE||4
4959162|NCT02731157|12198616|P1|NOT COMPLETED|First Standard RCE||0
4959163|NCT02731157|12198616|P1|COMPLETED|First Standard RCE||4
4959164|NCT02731157|12198616|P1|STARTED|First Standard RCE||4
4959165|NCT02731131|12198634|P2|NOT COMPLETED|Overall Study||2
4959166|NCT02731131|12198635|P1|NOT COMPLETED|Overall Study||0
4959167|NCT02731131|12198634|P2|COMPLETED|Overall Study||4
4959168|NCT02731131|12198635|P1|COMPLETED|Overall Study||6
4959169|NCT02731131|12198634|P2|STARTED|Overall Study||6
4959170|NCT02731131|12198635|P1|STARTED|Overall Study||6
4959171|NCT02730988|12198653|P2|NOT COMPLETED|Overall Study||10
4959172|NCT02730988|12198654|P1|NOT COMPLETED|Overall Study||4
4959173|NCT02730988|12198653|P2|COMPLETED|Overall Study||39
4959174|NCT02730988|12198654|P1|COMPLETED|Overall Study||43
4959175|NCT02730988|12198653|P2|STARTED|Overall Study||49
4959176|NCT02730988|12198654|P1|STARTED|Overall Study||47
4959177|NCT02730871|12198664|P2|NOT COMPLETED|Overall Study||0
4959178|NCT02730871|12198665|P1|NOT COMPLETED|Overall Study||6
4959179|NCT02730871|12198664|P2|COMPLETED|Overall Study||67
4959180|NCT02730871|12198665|P1|COMPLETED|Overall Study||61
4959181|NCT02730871|12198664|P2|Safety Analysis Set|Overall Study||67
4959182|NCT02730871|12198665|P1|Safety Analysis Set|Overall Study||67
4959183|NCT02730871|12198664|P2|Full Analysis Set (FAS)|Overall Study||67
4959184|NCT02730871|12198665|P1|Full Analysis Set (FAS)|Overall Study||67
4959185|NCT02730871|12198664|P2|STARTED|Overall Study||67
4959186|NCT02730871|12198665|P1|STARTED|Overall Study||67
4959187|NCT02730819|12198679|P1|NOT COMPLETED|Overall Study||9
4959188|NCT02730819|12198679|P1|COMPLETED|Overall Study||10
4959189|NCT02730819|12198679|P1|Follow-up Week 20|Overall Study||10
4959190|NCT02730819|12198679|P1|Follow-up Week 16|Overall Study||11
4959191|NCT02730819|12198679|P1|Follow-up Week 12|Overall Study||11
4959192|NCT02730819|12198679|P1|Follow-up Week 8|Overall Study||14
4959193|NCT02730819|12198679|P1|Follow-up Week 4|Overall Study||16
4959194|NCT02730819|12198679|P1|Follow-up Week 2|Overall Study||15
4959195|NCT02730819|12198679|P1|STARTED|Overall Study||19
4959196|NCT02730728|12198688|P3|NOT COMPLETED|Overall Study||1
4959197|NCT02730728|12198689|P2|NOT COMPLETED|Overall Study||2
4959198|NCT02730728|12198690|P1|NOT COMPLETED|Overall Study||0
4959199|NCT02730728|12198688|P3|COMPLETED|Overall Study||52
4959200|NCT02730728|12198689|P2|COMPLETED|Overall Study||51
4959201|NCT02730728|12198690|P1|COMPLETED|Overall Study||53
4959202|NCT02730728|12198688|P3|STARTED|Overall Study||53
4959203|NCT02730728|12198689|P2|STARTED|Overall Study||53
4959204|NCT02730728|12198690|P1|STARTED|Overall Study||53
4959205|NCT02730663|12198707|P1|NOT COMPLETED|Overall Study||1
4959206|NCT02730663|12198707|P1|COMPLETED|Overall Study||35
4959207|NCT02730663|12198707|P1|STARTED|Overall Study||36
4959208|NCT02730598|12198719|P2|NOT COMPLETED|Overall Study||4
4959209|NCT02730598|12198720|P1|NOT COMPLETED|Overall Study||4
4959210|NCT02730598|12198719|P2|COMPLETED|Overall Study||10
4959211|NCT02730598|12198720|P1|COMPLETED|Overall Study||10
4959212|NCT02730598|12198719|P2|STARTED|Overall Study||14
4959213|NCT02730598|12198720|P1|STARTED|Overall Study||14
4959214|NCT02730455|12198743|P3|NOT COMPLETED|Overall Study||11
4959215|NCT02730455|12198744|P2|NOT COMPLETED|Overall Study||14
4959216|NCT02730455|12198745|P1|NOT COMPLETED|Overall Study||13
4959217|NCT02730455|12198743|P3|COMPLETED|Overall Study||81
4959218|NCT02730455|12198744|P2|COMPLETED|Overall Study||77
4959219|NCT02730455|12198745|P1|COMPLETED|Overall Study||81
4959220|NCT02730455|12198743|P3|Who Received Total Volume of Study Drug|Overall Study||89
4959221|NCT02730455|12198744|P2|Who Received Total Volume of Study Drug|Overall Study||88
4959222|NCT02730455|12198745|P1|Who Received Total Volume of Study Drug|Overall Study||90
4959223|NCT02730455|12198743|P3|Participants Dosed|Overall Study||91
4959224|NCT02730455|12198744|P2|Participants Dosed|Overall Study||88
4959225|NCT02730455|12198745|P1|Participants Dosed|Overall Study||91
4959226|NCT02730455|12198743|P3|Safety Population|Overall Study||89
4959227|NCT02730455|12198744|P2|Safety Population|Overall Study||90
4959228|NCT02730455|12198745|P1|Safety Population|Overall Study||91
4959229|NCT02730455|12198743|P3|STARTED|Overall Study||92
4959230|NCT02730455|12198744|P2|STARTED|Overall Study||91
4959231|NCT02730455|12198745|P1|STARTED|Overall Study||94
4959232|NCT02730403|12198777|P1|NOT COMPLETED|Overall Study||54
4959233|NCT02730403|12198777|P1|COMPLETED|Overall Study||157
4959234|NCT02730403|12198777|P1|STARTED|Overall Study||211
4959235|NCT02730377|12198795|P2|NOT COMPLETED|Overall Study||633
4959236|NCT02730377|12198796|P1|NOT COMPLETED|Overall Study||550
4959237|NCT02730377|12198795|P2|COMPLETED|Overall Study||362
4959238|NCT02730377|12198796|P1|COMPLETED|Overall Study||446
4959239|NCT02730377|12198795|P2|Safety Analysis Set (SAS)|Overall Study||984
4959240|NCT02730377|12198796|P1|Safety Analysis Set (SAS)|Overall Study||980
4959241|NCT02730377|12198795|P2|Full Analysis Set (FAS)|Overall Study||995
4959242|NCT02730377|12198796|P1|Full Analysis Set (FAS)|Overall Study||996
4959243|NCT02730377|12198795|P2|Treated|Overall Study||984
4959244|NCT02730377|12198796|P1|Treated|Overall Study||980
4959245|NCT02730377|12198795|P2|STARTED|Overall Study||995
4959246|NCT02730377|12198796|P1|STARTED|Overall Study||996
4959247|NCT02730351|12198846|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
4959248|NCT02730351|12198847|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
4959249|NCT02730351|12198846|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
4959250|NCT02730351|12198847|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
4959251|NCT02730351|12198846|P2|STARTED|Treatment Period 2 (2 Weeks)||36
4959252|NCT02730351|12198847|P1|STARTED|Treatment Period 2 (2 Weeks)||35
4959253|NCT02730351|12198846|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
4959254|NCT02730351|12198847|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
4959255|NCT02730351|12198846|P2|COMPLETED|Wash-out Period (2 Weeks)||36
4959256|NCT02730351|12198847|P1|COMPLETED|Wash-out Period (2 Weeks)||35
4959257|NCT02730351|12198846|P2|STARTED|Wash-out Period (2 Weeks)||37
4959258|NCT02730351|12198847|P1|STARTED|Wash-out Period (2 Weeks)||36
4959259|NCT02730351|12198846|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
4959260|NCT02730351|12198847|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
4959261|NCT02730351|12198846|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
4959262|NCT02730351|12198847|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
4959263|NCT02730351|12198846|P2|STARTED|Treatment Period 1 (2 Weeks)||37
4959264|NCT02730351|12198847|P1|STARTED|Treatment Period 1 (2 Weeks)||37
4959265|NCT02730260|12198861|P2|NOT COMPLETED|Overall Study||75
4959266|NCT02730260|12198862|P1|NOT COMPLETED|Overall Study||82
4959267|NCT02730260|12198861|P2|COMPLETED|Overall Study||185
4959268|NCT02730260|12198862|P1|COMPLETED|Overall Study||176
4959269|NCT02730260|12198861|P2|STARTED|Overall Study||260
4959270|NCT02730260|12198862|P1|STARTED|Overall Study||258
4959271|NCT02730208|12198870|P2|NOT COMPLETED|Overall Study||1
4959272|NCT02730208|12198871|P1|NOT COMPLETED|Overall Study||0
4959273|NCT02730208|12198870|P2|COMPLETED|Overall Study||20
4959274|NCT02730208|12198871|P1|COMPLETED|Overall Study||20
4959275|NCT02730208|12198870|P2|STARTED|Overall Study||21
4959276|NCT02730208|12198871|P1|STARTED|Overall Study||20
4959277|NCT02730195|12198879|P1|NOT COMPLETED|Overall Study||1
4959278|NCT02730195|12198879|P1|COMPLETED|Overall Study||8
4959279|NCT02730195|12198879|P1|STARTED|Overall Study||9
4959280|NCT02730130|12198885|P1|NOT COMPLETED|Overall Study||0
4959281|NCT02730130|12198885|P1|COMPLETED|Overall Study||17
4959282|NCT02730130|12198885|P1|STARTED|Overall Study||17
4959283|NCT02729909|12198893|P2|NOT COMPLETED|Overall Study||5
4959284|NCT02729909|12198894|P1|NOT COMPLETED|Overall Study||1
4959285|NCT02729909|12198893|P2|COMPLETED|Overall Study||101
4959286|NCT02729909|12198894|P1|COMPLETED|Overall Study||104
4959287|NCT02729909|12198893|P2|STARTED|Overall Study||106
4959288|NCT02729909|12198894|P1|STARTED|Overall Study||105
4959289|NCT02729896|12198913|P3|NOT COMPLETED|Overall Study||16
4959290|NCT02729896|12198914|P2|NOT COMPLETED|Overall Study||2
4959291|NCT02729896|12198915|P1|NOT COMPLETED|Overall Study||0
4959292|NCT02729896|12198913|P3|COMPLETED|Overall Study||7
4959293|NCT02729896|12198914|P2|COMPLETED|Overall Study||8
4959294|NCT02729896|12198915|P1|COMPLETED|Overall Study||3
4959295|NCT02729896|12198913|P3|STARTED|Overall Study||23
4959296|NCT02729896|12198914|P2|STARTED|Overall Study||10
4959297|NCT02729896|12198915|P1|STARTED|Overall Study||3
4959298|NCT02729831|12198936|P4|NOT COMPLETED|6 Month Follow-up||43
4959299|NCT02729831|12198937|P3|NOT COMPLETED|6 Month Follow-up||48
4959300|NCT02729831|12198938|P2|NOT COMPLETED|6 Month Follow-up||54
4959301|NCT02729831|12198939|P1|NOT COMPLETED|6 Month Follow-up||55
4959302|NCT02729831|12198936|P4|COMPLETED|6 Month Follow-up||232
4959303|NCT02729831|12198937|P3|COMPLETED|6 Month Follow-up||227
4959304|NCT02729831|12198938|P2|COMPLETED|6 Month Follow-up||238
4959305|NCT02729831|12198939|P1|COMPLETED|6 Month Follow-up||227
4959306|NCT02729831|12198936|P4|STARTED|6 Month Follow-up||275
4959307|NCT02729831|12198937|P3|STARTED|6 Month Follow-up||275
4959308|NCT02729831|12198938|P2|STARTED|6 Month Follow-up||292
4959309|NCT02729831|12198939|P1|STARTED|6 Month Follow-up||282
4959310|NCT02729831|12198936|P4|NOT COMPLETED|1 Week Post-visit||36
4959311|NCT02729831|12198937|P3|NOT COMPLETED|1 Week Post-visit||38
4959312|NCT02729831|12198938|P2|NOT COMPLETED|1 Week Post-visit||40
4959313|NCT02729831|12198939|P1|NOT COMPLETED|1 Week Post-visit||43
4959314|NCT02729831|12198936|P4|COMPLETED|1 Week Post-visit||239
4959315|NCT02729831|12198937|P3|COMPLETED|1 Week Post-visit||237
4959316|NCT02729831|12198938|P2|COMPLETED|1 Week Post-visit||252
4959317|NCT02729831|12198939|P1|COMPLETED|1 Week Post-visit||239
4959318|NCT02729831|12198936|P4|STARTED|1 Week Post-visit||275
4959319|NCT02729831|12198937|P3|STARTED|1 Week Post-visit||275
4959320|NCT02729831|12198938|P2|STARTED|1 Week Post-visit||292
4959321|NCT02729831|12198939|P1|STARTED|1 Week Post-visit||282
4959322|NCT02729831|12198936|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
4959323|NCT02729831|12198937|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
4959324|NCT02729831|12198938|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
4959325|NCT02729831|12198939|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
4959326|NCT02729831|12198936|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
4959327|NCT02729831|12198937|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
4959328|NCT02729831|12198938|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
4959329|NCT02729831|12198939|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
4959330|NCT02729831|12198936|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
4959331|NCT02729831|12198937|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
4959332|NCT02729831|12198938|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
4959333|NCT02729831|12198939|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
4959334|NCT02729753|12198967|P2|NOT COMPLETED|Overall Study||1
4959335|NCT02729753|12198968|P1|NOT COMPLETED|Overall Study||0
4959336|NCT02729753|12198967|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
4959337|NCT02729753|12198968|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
4959338|NCT02729753|12198967|P2|STARTED|Overall Study|First patient enrolled April 2016|7
4959339|NCT02729753|12198968|P1|STARTED|Overall Study|First patient enrolled April 2016|3
4959340|NCT02729545|12198982|P2|NOT COMPLETED|Overall Study||5
4959341|NCT02729545|12198983|P1|NOT COMPLETED|Overall Study||3
4959342|NCT02729545|12198982|P2|COMPLETED|Overall Study||25
4959343|NCT02729545|12198983|P1|COMPLETED|Overall Study||27
4959344|NCT02729545|12198982|P2|STARTED|Overall Study||30
4959345|NCT02729545|12198983|P1|STARTED|Overall Study||30
4959346|NCT02729194|12199005|P1|NOT COMPLETED|Overall Study||3
4959347|NCT02729194|12199005|P1|COMPLETED|Overall Study||13
4959348|NCT02729194|12199005|P1|STARTED|Overall Study||16
4959349|NCT02729051|12199017|P2|NOT COMPLETED|Overall Study||32
4959350|NCT02729051|12199018|P1|NOT COMPLETED|Overall Study||30
4959351|NCT02729051|12199017|P2|COMPLETED|Overall Study||496
4959352|NCT02729051|12199018|P1|COMPLETED|Overall Study||497
4959353|NCT02729051|12199017|P2|STARTED|Overall Study||528
4959354|NCT02729051|12199018|P1|STARTED|Overall Study||527
4959355|NCT02729038|12199038|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
4959356|NCT02729038|12199039|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
4959357|NCT02729038|12199040|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
4959358|NCT02729038|12199041|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
4959359|NCT02729038|12199038|P4|COMPLETED|Part 2 (Up to 50 Days)||8
4959360|NCT02729038|12199039|P3|COMPLETED|Part 2 (Up to 50 Days)||0
4959361|NCT02729038|12199040|P2|COMPLETED|Part 2 (Up to 50 Days)||0
4959362|NCT02729038|12199041|P1|COMPLETED|Part 2 (Up to 50 Days)||0
4959363|NCT02729038|12199038|P4|STARTED|Part 2 (Up to 50 Days)||8
4959364|NCT02729038|12199039|P3|STARTED|Part 2 (Up to 50 Days)||0
4959365|NCT02729038|12199040|P2|STARTED|Part 2 (Up to 50 Days)||0
4959366|NCT02729038|12199041|P1|STARTED|Part 2 (Up to 50 Days)||0
4959367|NCT02729038|12199038|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
4959368|NCT02729038|12199039|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
4959369|NCT02729038|12199040|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
4959370|NCT02729038|12199041|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
4959371|NCT02729038|12199038|P4|COMPLETED|Part 1 (Up to 44 Days)||0
4959372|NCT02729038|12199039|P3|COMPLETED|Part 1 (Up to 44 Days)||8
4959373|NCT02729038|12199040|P2|COMPLETED|Part 1 (Up to 44 Days)||8
4959374|NCT02729038|12199041|P1|COMPLETED|Part 1 (Up to 44 Days)||8
4959375|NCT02729038|12199038|P4|STARTED|Part 1 (Up to 44 Days)||0
4959376|NCT02729038|12199039|P3|STARTED|Part 1 (Up to 44 Days)||8
4959377|NCT02729038|12199040|P2|STARTED|Part 1 (Up to 44 Days)||8
4959378|NCT02729038|12199041|P1|STARTED|Part 1 (Up to 44 Days)||8
4959379|NCT02729025|12199162|P2|NOT COMPLETED|Overall Study||1
4959380|NCT02729025|12199163|P1|NOT COMPLETED|Overall Study||0
4959381|NCT02729025|12199162|P2|COMPLETED|Overall Study||64
4959382|NCT02729025|12199163|P1|COMPLETED|Overall Study||64
4959383|NCT02729025|12199162|P2|STARTED|Overall Study||65
4959384|NCT02729025|12199163|P1|STARTED|Overall Study||64
4959385|NCT02728895|12199177|P2|NOT COMPLETED|Overall Study||5
4959386|NCT02728895|12199178|P1|NOT COMPLETED|Overall Study||1
4959387|NCT02728895|12199177|P2|COMPLETED|Overall Study||16
4959388|NCT02728895|12199178|P1|COMPLETED|Overall Study||2
4959389|NCT02728895|12199177|P2|STARTED|Overall Study||21
4959390|NCT02728895|12199178|P1|STARTED|Overall Study||3
4959391|NCT02728830|12199198|P1|NOT COMPLETED|Overall Study||24
4959392|NCT02728830|12199198|P1|COMPLETED|Overall Study||15
4959393|NCT02728830|12199198|P1|STARTED|Overall Study||39
4959394|NCT02728258|12199205|P1|NOT COMPLETED|Overall Study||0
4959395|NCT02728258|12199205|P1|COMPLETED|Overall Study||11
4959396|NCT02728258|12199205|P1|STARTED|Overall Study||11
4959397|NCT02728206|12199213|P1|NOT COMPLETED|Overall Study||1
4959398|NCT02728206|12199213|P1|COMPLETED|Overall Study||8
4959399|NCT02728206|12199213|P1|STARTED|Overall Study||9
4959400|NCT02728089|12199221|P1|NOT COMPLETED|Overall Study||3
4959401|NCT02728089|12199221|P1|COMPLETED|Overall Study||112
4959402|NCT02728089|12199221|P1|Treated|Overall Study||114
4959403|NCT02728089|12199221|P1|STARTED|Overall Study||115
4959404|NCT02727894|12199238|P2|NOT COMPLETED|Overall Study||0
4959405|NCT02727894|12199239|P1|NOT COMPLETED|Overall Study||0
4959406|NCT02727894|12199238|P2|COMPLETED|Overall Study|September 2015|192
4959407|NCT02727894|12199239|P1|COMPLETED|Overall Study|September 2015|73
4959408|NCT02727894|12199238|P2|STARTED|Overall Study|March 2013|192
4959409|NCT02727894|12199239|P1|STARTED|Overall Study|March 2013|73
4959410|NCT02727842|12199255|P1|NOT COMPLETED|Overall Study||0
4959411|NCT02727842|12199255|P1|COMPLETED|Overall Study||30
4959412|NCT02727842|12199255|P1|STARTED|Overall Study||30
4959413|NCT02727816|12199259|P1|NOT COMPLETED|Overall Study||0
4959414|NCT02727816|12199259|P1|COMPLETED|Overall Study||35
4959415|NCT02727816|12199259|P1|STARTED|Overall Study||35
4959416|NCT02727777|12199309|P3|NOT COMPLETED|Overall Study||0
4959417|NCT02727777|12199310|P2|NOT COMPLETED|Overall Study||0
4959418|NCT02727777|12199311|P1|NOT COMPLETED|Overall Study||4
4959419|NCT02727777|12199309|P3|COMPLETED|Overall Study||0
4959420|NCT02727777|12199310|P2|COMPLETED|Overall Study||0
4959421|NCT02727777|12199311|P1|COMPLETED|Overall Study||0
4959422|NCT02727777|12199309|P3|STARTED|Overall Study||0
4959423|NCT02727777|12199310|P2|STARTED|Overall Study||0
4959424|NCT02727777|12199311|P1|STARTED|Overall Study||4
4959425|NCT02727751|12199325|P1|NOT COMPLETED|Overall Study||50
4959426|NCT02727751|12199325|P1|COMPLETED|Overall Study||262
4959427|NCT02727751|12199325|P1|STARTED|Overall Study||312
4959428|NCT02727660|12199332|P3|NOT COMPLETED|Overall Study||165
4959429|NCT02727660|12199333|P2|NOT COMPLETED|Overall Study||116
4959430|NCT02727660|12199334|P1|NOT COMPLETED|Overall Study||116
4959431|NCT02727660|12199332|P3|COMPLETED|Overall Study||442
4959432|NCT02727660|12199333|P2|COMPLETED|Overall Study||501
4959433|NCT02727660|12199334|P1|COMPLETED|Overall Study||503
4959434|NCT02727660|12199332|P3|STARTED|Overall Study||607
4959435|NCT02727660|12199333|P2|STARTED|Overall Study||617
4959436|NCT02727660|12199334|P1|STARTED|Overall Study||619
4959437|NCT02727322|12199353|P2|NOT COMPLETED|Overall Study||1
4959438|NCT02727322|12199354|P1|NOT COMPLETED|Overall Study||2
4959439|NCT02727322|12199353|P2|COMPLETED|Overall Study||76
4959440|NCT02727322|12199354|P1|COMPLETED|Overall Study||75
4959441|NCT02727322|12199353|P2|STARTED|Overall Study||77
4959442|NCT02727322|12199354|P1|STARTED|Overall Study||77
4959443|NCT02726971|12199366|P2|NOT COMPLETED|Overall Study||9
4959444|NCT02726971|12199367|P1|NOT COMPLETED|Overall Study||11
4959445|NCT02726971|12199366|P2|COMPLETED|Overall Study||62
4959446|NCT02726971|12199367|P1|COMPLETED|Overall Study||59
4959447|NCT02726971|12199366|P2|STARTED|Overall Study||71
4959448|NCT02726971|12199367|P1|STARTED|Overall Study||70
4959449|NCT02726945|12199380|P3|NOT COMPLETED|Overall Study||1
4959450|NCT02726945|12199381|P2|NOT COMPLETED|Overall Study||1
4959451|NCT02726945|12199382|P1|NOT COMPLETED|Overall Study||0
4959452|NCT02726945|12199380|P3|COMPLETED|Overall Study||12
4959453|NCT02726945|12199381|P2|COMPLETED|Overall Study||12
4959454|NCT02726945|12199382|P1|COMPLETED|Overall Study||13
4959455|NCT02726945|12199380|P3|STARTED|Overall Study||13
4959456|NCT02726945|12199381|P2|STARTED|Overall Study||13
4959457|NCT02726945|12199382|P1|STARTED|Overall Study||13
4959458|NCT02726789|12199393|P1|NOT COMPLETED|Overall Study||0
4959459|NCT02726789|12199393|P1|COMPLETED|Overall Study||5
4959460|NCT02726789|12199393|P1|STARTED|Overall Study||5
4959461|NCT02726620|12199402|P2|NOT COMPLETED|Through End of Study: All Interventions||0
4959462|NCT02726620|12199403|P1|NOT COMPLETED|Through End of Study: All Interventions||0
4959463|NCT02726620|12199402|P2|COMPLETED|Through End of Study: All Interventions||3234
4959464|NCT02726620|12199403|P1|COMPLETED|Through End of Study: All Interventions||0
4959465|NCT02726620|12199402|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
4959466|NCT02726620|12199403|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
4959467|NCT02726620|12199402|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
4959468|NCT02726620|12199403|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
4959469|NCT02726620|12199402|P2|STARTED|Through End of Study: All Interventions||3234
4959470|NCT02726620|12199403|P1|STARTED|Through End of Study: All Interventions||0
4959471|NCT02726620|12199402|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
4959472|NCT02726620|12199403|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
4959473|NCT02726620|12199402|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
4959474|NCT02726620|12199403|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
4959475|NCT02726620|12199402|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
4959476|NCT02726620|12199403|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
4959477|NCT02726620|12199402|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
4959478|NCT02726620|12199403|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
4959479|NCT02726620|12199402|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
4959480|NCT02726620|12199403|P1|STARTED|Months 2-3: In-room Providers Randomized||0
4959481|NCT02726620|12199402|P2|NOT COMPLETED|Month 1: Attending Randomization||0
4959482|NCT02726620|12199403|P1|NOT COMPLETED|Month 1: Attending Randomization||0
4959483|NCT02726620|12199402|P2|COMPLETED|Month 1: Attending Randomization||485
4959484|NCT02726620|12199403|P1|COMPLETED|Month 1: Attending Randomization||0
4959485|NCT02726620|12199402|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
4959486|NCT02726620|12199403|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
4959487|NCT02726620|12199402|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
4959488|NCT02726620|12199403|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
4959489|NCT02726620|12199402|P2|STARTED|Month 1: Attending Randomization||485
4959490|NCT02726620|12199403|P1|STARTED|Month 1: Attending Randomization||0
4959491|NCT02726620|12199402|P2|NOT COMPLETED|Historic Cohort - Three Years||0
4959492|NCT02726620|12199403|P1|NOT COMPLETED|Historic Cohort - Three Years||0
4959493|NCT02726620|12199402|P2|COMPLETED|Historic Cohort - Three Years||0
4959494|NCT02726620|12199403|P1|COMPLETED|Historic Cohort - Three Years||17463
4959495|NCT02726620|12199402|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
4959496|NCT02726620|12199403|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
4959497|NCT02726620|12199402|P2|STARTED|Historic Cohort - Three Years||0
4959498|NCT02726620|12199403|P1|STARTED|Historic Cohort - Three Years||17463
4959499|NCT02726399|12199499|P1|NOT COMPLETED|Overall Study||7
4959500|NCT02726399|12199499|P1|COMPLETED|Overall Study||0
4959501|NCT02726399|12199499|P1|STARTED|Overall Study||7
4959502|NCT02726178|12199505|P2|NOT COMPLETED|Overall Study||0
4959503|NCT02726178|12199506|P1|NOT COMPLETED|Overall Study||0
4959504|NCT02726178|12199505|P2|COMPLETED|Overall Study||28
4959505|NCT02726178|12199506|P1|COMPLETED|Overall Study||28
4959506|NCT02726178|12199505|P2|STARTED|Overall Study||28
4959507|NCT02726178|12199506|P1|STARTED|Overall Study||28
4959508|NCT02726113|12199516|P2|NOT COMPLETED|Genomic Analysis||2
4959509|NCT02726113|12199517|P1|NOT COMPLETED|Genomic Analysis||4
4959510|NCT02726113|12199516|P2|COMPLETED|Genomic Analysis||12
4959511|NCT02726113|12199517|P1|COMPLETED|Genomic Analysis||15
4959512|NCT02726113|12199516|P2|STARTED|Genomic Analysis||14
4959513|NCT02726113|12199517|P1|STARTED|Genomic Analysis||19
4959514|NCT02726113|12199516|P2|NOT COMPLETED|Total Enrollment||3
4959515|NCT02726113|12199517|P1|NOT COMPLETED|Total Enrollment||4
4959516|NCT02726113|12199516|P2|COMPLETED|Total Enrollment||19
4959517|NCT02726113|12199517|P1|COMPLETED|Total Enrollment||24
4959518|NCT02726113|12199516|P2|STARTED|Total Enrollment||22
4959519|NCT02726113|12199517|P1|STARTED|Total Enrollment||28
4959520|NCT02726074|12199524|P1|NOT COMPLETED|Overall Study||26
4959521|NCT02726074|12199524|P1|COMPLETED|Overall Study||80
4959522|NCT02726074|12199524|P1|Treated|Overall Study||102
4959523|NCT02726074|12199524|P1|STARTED|Overall Study||106
4959524|NCT02726022|12199536|P1|NOT COMPLETED|Overall Study||36
4959525|NCT02726022|12199536|P1|COMPLETED|Overall Study||78
4959526|NCT02726022|12199536|P1|STARTED|Overall Study||114
4959527|NCT02725866|12199545|P1|NOT COMPLETED|Overall Study||14
4959528|NCT02725866|12199545|P1|COMPLETED|Overall Study||202
4959529|NCT02725866|12199545|P1|STARTED|Overall Study||216
4959530|NCT02725788|12199558|P2|NOT COMPLETED|Overall Study||2
4959531|NCT02725788|12199559|P1|NOT COMPLETED|Overall Study||1
4959532|NCT02725788|12199558|P2|COMPLETED|Overall Study||122
4959533|NCT02725788|12199559|P1|COMPLETED|Overall Study||122
4959534|NCT02725788|12199558|P2|STARTED|Overall Study||124
4959535|NCT02725788|12199559|P1|STARTED|Overall Study||123
4959536|NCT02725710|12199567|P2|NOT COMPLETED|Overall Study||0
4959537|NCT02725710|12199568|P1|NOT COMPLETED|Overall Study||1
4959538|NCT02725710|12199567|P2|COMPLETED|Overall Study||47
4959539|NCT02725710|12199568|P1|COMPLETED|Overall Study||47
4959540|NCT02725710|12199567|P2|STARTED|Overall Study||47
4959541|NCT02725710|12199568|P1|STARTED|Overall Study||48
4959542|NCT02725671|12199596|P1|NOT COMPLETED|Overall Study||1
4959543|NCT02725671|12199596|P1|COMPLETED|Overall Study||1
4959544|NCT02725671|12199596|P1|STARTED|Overall Study||2
4959545|NCT02725645|12199605|P1|NOT COMPLETED|Overall Study||0
4959546|NCT02725645|12199605|P1|COMPLETED|Overall Study||14
4959547|NCT02725645|12199605|P1|STARTED|Overall Study||14
4959548|NCT02725515|12199611|P2|NOT COMPLETED|Overall Study||35
4959549|NCT02725515|12199612|P1|NOT COMPLETED|Overall Study||25
4959550|NCT02725515|12199611|P2|COMPLETED|Overall Study||17
4959551|NCT02725515|12199612|P1|COMPLETED|Overall Study||28
4959552|NCT02725515|12199611|P2|STARTED|Overall Study||52
4959553|NCT02725515|12199612|P1|STARTED|Overall Study||53
4959554|NCT02725476|12199624|P2|NOT COMPLETED|Overall Study||1
4959555|NCT02725476|12199625|P1|NOT COMPLETED|Overall Study||3
4959556|NCT02725476|12199624|P2|COMPLETED|Overall Study||4
4959557|NCT02725476|12199625|P1|COMPLETED|Overall Study||12
4959558|NCT02725476|12199624|P2|STARTED|Overall Study||5
4959559|NCT02725476|12199625|P1|STARTED|Overall Study||15
4959560|NCT02725268|12199637|P4|NOT COMPLETED|Overall Study||17
4959561|NCT02725268|12199638|P3|NOT COMPLETED|Overall Study||37
4959562|NCT02725268|12199639|P2|NOT COMPLETED|Overall Study||59
4959563|NCT02725268|12199640|P1|NOT COMPLETED|Overall Study||59
4959564|NCT02725268|12199637|P4|COMPLETED|Overall Study||3
4959565|NCT02725268|12199638|P3|COMPLETED|Overall Study||4
4959566|NCT02725268|12199639|P2|COMPLETED|Overall Study||31
4959567|NCT02725268|12199640|P1|COMPLETED|Overall Study||31
4959568|NCT02725268|12199637|P4|STARTED|Overall Study||20
4959569|NCT02725268|12199638|P3|STARTED|Overall Study||41
4959570|NCT02725268|12199639|P2|STARTED|Overall Study||90
4959571|NCT02725268|12199640|P1|STARTED|Overall Study||90
4959572|NCT02725008|12199676|P2|NOT COMPLETED|Overall Study||12
4959573|NCT02725008|12199677|P1|NOT COMPLETED|Overall Study||9
4959574|NCT02725008|12199676|P2|COMPLETED|Overall Study||39
4959575|NCT02725008|12199677|P1|COMPLETED|Overall Study||37
4959576|NCT02725008|12199676|P2|STARTED|Overall Study||51
4959577|NCT02725008|12199677|P1|STARTED|Overall Study||46
4959578|NCT02724787|12199685|P1|NOT COMPLETED|Overall Study||2
4959579|NCT02724787|12199685|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
4959580|NCT02724787|12199685|P1|STARTED|Overall Study||24
4959581|NCT02724644|12199695|P2|NOT COMPLETED|Overall Study||4
4959582|NCT02724644|12199696|P1|NOT COMPLETED|Overall Study||21
4959583|NCT02724644|12199695|P2|COMPLETED|Overall Study||182
4959584|NCT02724644|12199696|P1|COMPLETED|Overall Study||168
4959585|NCT02724644|12199695|P2|STARTED|Overall Study||186
4959586|NCT02724644|12199696|P1|STARTED|Overall Study||189
4959587|NCT02724449|12199724|P1|NOT COMPLETED|Overall Study||0
4959588|NCT02724449|12199724|P1|COMPLETED|Overall Study||16
4959589|NCT02724449|12199724|P1|STARTED|Overall Study||16
4959590|NCT02724111|12199730|P2|NOT COMPLETED|Overall Study||5
4959591|NCT02724111|12199731|P1|NOT COMPLETED|Overall Study||2
4959592|NCT02724111|12199730|P2|COMPLETED|Overall Study||40
4959593|NCT02724111|12199731|P1|COMPLETED|Overall Study||43
4959594|NCT02724111|12199730|P2|STARTED|Overall Study||45
4959595|NCT02724111|12199731|P1|STARTED|Overall Study||45
4959596|NCT02724033|12199754|P3|NOT COMPLETED|Overall Study||0
4959597|NCT02724033|12199755|P2|NOT COMPLETED|Overall Study||0
4959598|NCT02724033|12199756|P1|NOT COMPLETED|Overall Study||0
4959599|NCT02724033|12199754|P3|COMPLETED|Overall Study||12
4959600|NCT02724033|12199755|P2|COMPLETED|Overall Study||14
4959601|NCT02724033|12199756|P1|COMPLETED|Overall Study||11
4959602|NCT02724033|12199754|P3|STARTED|Overall Study||12
4959603|NCT02724033|12199755|P2|STARTED|Overall Study||14
4959604|NCT02724033|12199756|P1|STARTED|Overall Study||11
4959605|NCT02723786|12199764|P1|NOT COMPLETED|Overall Study||1
4959606|NCT02723786|12199764|P1|COMPLETED|Overall Study||6
4959607|NCT02723786|12199764|P1|STARTED|Overall Study||7
4959608|NCT02723630|12199792|P6|NOT COMPLETED|Intervention Period 3||0
4959609|NCT02723630|12199793|P5|NOT COMPLETED|Intervention Period 3||0
4959610|NCT02723630|12199794|P4|NOT COMPLETED|Intervention Period 3||0
4959611|NCT02723630|12199795|P3|NOT COMPLETED|Intervention Period 3||0
4959612|NCT02723630|12199796|P2|NOT COMPLETED|Intervention Period 3||1
4959613|NCT02723630|12199797|P1|NOT COMPLETED|Intervention Period 3||0
4959614|NCT02723630|12199792|P6|COMPLETED|Intervention Period 3||10
4959615|NCT02723630|12199793|P5|COMPLETED|Intervention Period 3||10
4959616|NCT02723630|12199794|P4|COMPLETED|Intervention Period 3||10
4959617|NCT02723630|12199795|P3|COMPLETED|Intervention Period 3||10
4959618|NCT02723630|12199796|P2|COMPLETED|Intervention Period 3||9
4959619|NCT02723630|12199797|P1|COMPLETED|Intervention Period 3||9
4959620|NCT02723630|12199792|P6|STARTED|Intervention Period 3||10
4959621|NCT02723630|12199793|P5|STARTED|Intervention Period 3||10
4959622|NCT02723630|12199794|P4|STARTED|Intervention Period 3||10
4959623|NCT02723630|12199795|P3|STARTED|Intervention Period 3||10
4959624|NCT02723630|12199796|P2|STARTED|Intervention Period 3||10
4959625|NCT02723630|12199797|P1|STARTED|Intervention Period 3||9
4959626|NCT02723630|12199792|P6|NOT COMPLETED|Intervention Period 2||0
4959627|NCT02723630|12199793|P5|NOT COMPLETED|Intervention Period 2||0
4959628|NCT02723630|12199794|P4|NOT COMPLETED|Intervention Period 2||0
4959629|NCT02723630|12199795|P3|NOT COMPLETED|Intervention Period 2||0
4959630|NCT02723630|12199796|P2|NOT COMPLETED|Intervention Period 2||0
4959631|NCT02723630|12199797|P1|NOT COMPLETED|Intervention Period 2||0
4959632|NCT02723630|12199792|P6|COMPLETED|Intervention Period 2||10
4959633|NCT02723630|12199793|P5|COMPLETED|Intervention Period 2||10
4959634|NCT02723630|12199794|P4|COMPLETED|Intervention Period 2||10
4959635|NCT02723630|12199795|P3|COMPLETED|Intervention Period 2||10
4959636|NCT02723630|12199796|P2|COMPLETED|Intervention Period 2||10
4959637|NCT02723630|12199797|P1|COMPLETED|Intervention Period 2||9
4959638|NCT02723630|12199792|P6|STARTED|Intervention Period 2||10
4959639|NCT02723630|12199793|P5|STARTED|Intervention Period 2||10
4959640|NCT02723630|12199794|P4|STARTED|Intervention Period 2||10
4959641|NCT02723630|12199795|P3|STARTED|Intervention Period 2||10
4959642|NCT02723630|12199796|P2|STARTED|Intervention Period 2||10
4959643|NCT02723630|12199797|P1|STARTED|Intervention Period 2||9
4959644|NCT02723630|12199792|P6|NOT COMPLETED|Intervention Period 1||0
4959645|NCT02723630|12199793|P5|NOT COMPLETED|Intervention Period 1||0
4959646|NCT02723630|12199794|P4|NOT COMPLETED|Intervention Period 1||0
4959647|NCT02723630|12199795|P3|NOT COMPLETED|Intervention Period 1||0
4959648|NCT02723630|12199796|P2|NOT COMPLETED|Intervention Period 1||0
4959649|NCT02723630|12199797|P1|NOT COMPLETED|Intervention Period 1||1
4959650|NCT02723630|12199792|P6|COMPLETED|Intervention Period 1||10
4959651|NCT02723630|12199793|P5|COMPLETED|Intervention Period 1||10
4959652|NCT02723630|12199794|P4|COMPLETED|Intervention Period 1||10
4959653|NCT02723630|12199795|P3|COMPLETED|Intervention Period 1||10
4959654|NCT02723630|12199796|P2|COMPLETED|Intervention Period 1||10
4959655|NCT02723630|12199797|P1|COMPLETED|Intervention Period 1||9
4959656|NCT02723630|12199792|P6|STARTED|Intervention Period 1||10
4959657|NCT02723630|12199793|P5|STARTED|Intervention Period 1||10
4959658|NCT02723630|12199794|P4|STARTED|Intervention Period 1||10
4959659|NCT02723630|12199795|P3|STARTED|Intervention Period 1||10
4959660|NCT02723630|12199796|P2|STARTED|Intervention Period 1||10
4959661|NCT02723630|12199797|P1|STARTED|Intervention Period 1||10
4959662|NCT02723591|12199828|P2|NOT COMPLETED|Overall Study||101
4959663|NCT02723591|12199829|P1|NOT COMPLETED|Overall Study||96
4959664|NCT02723591|12199828|P2|COMPLETED|Overall Study||198
4959665|NCT02723591|12199829|P1|COMPLETED|Overall Study||204
4959666|NCT02723591|12199828|P2|STARTED|Overall Study||299
4959667|NCT02723591|12199829|P1|STARTED|Overall Study||300
4959668|NCT02723344|12199957|P2|NOT COMPLETED|Overall Study||4
4959669|NCT02723344|12199958|P1|NOT COMPLETED|Overall Study||0
4959670|NCT02723344|12199957|P2|COMPLETED|Overall Study||12
4959671|NCT02723344|12199958|P1|COMPLETED|Overall Study||15
4959672|NCT02723344|12199957|P2|STARTED|Overall Study||16
4959673|NCT02723344|12199958|P1|STARTED|Overall Study||15
4959674|NCT02723201|12199981|P3|NOT COMPLETED|Fourth Intervention Period||0
4959675|NCT02723201|12199982|P2|NOT COMPLETED|Fourth Intervention Period||0
4959676|NCT02723201|12199983|P1|NOT COMPLETED|Fourth Intervention Period||0
4959677|NCT02723201|12199981|P3|COMPLETED|Fourth Intervention Period||0
4959678|NCT02723201|12199982|P2|COMPLETED|Fourth Intervention Period||0
4959679|NCT02723201|12199983|P1|COMPLETED|Fourth Intervention Period||9
4959680|NCT02723201|12199981|P3|STARTED|Fourth Intervention Period||0
4959681|NCT02723201|12199982|P2|STARTED|Fourth Intervention Period||0
4959682|NCT02723201|12199983|P1|STARTED|Fourth Intervention Period||9
4959683|NCT02723201|12199981|P3|NOT COMPLETED|Washout Period 3||0
4959684|NCT02723201|12199982|P2|NOT COMPLETED|Washout Period 3||0
4959685|NCT02723201|12199983|P1|NOT COMPLETED|Washout Period 3||0
4959686|NCT02723201|12199981|P3|COMPLETED|Washout Period 3||0
4959687|NCT02723201|12199982|P2|COMPLETED|Washout Period 3||0
4959688|NCT02723201|12199983|P1|COMPLETED|Washout Period 3||9
4959689|NCT02723201|12199981|P3|STARTED|Washout Period 3||0
4959690|NCT02723201|12199982|P2|STARTED|Washout Period 3||0
4959691|NCT02723201|12199983|P1|STARTED|Washout Period 3||9
4959692|NCT02723201|12199981|P3|NOT COMPLETED|Third Intervention Period||0
4959693|NCT02723201|12199982|P2|NOT COMPLETED|Third Intervention Period||0
4959694|NCT02723201|12199983|P1|NOT COMPLETED|Third Intervention Period||0
4959695|NCT02723201|12199981|P3|COMPLETED|Third Intervention Period||0
4959696|NCT02723201|12199982|P2|COMPLETED|Third Intervention Period||0
4959697|NCT02723201|12199983|P1|COMPLETED|Third Intervention Period||9
4959698|NCT02723201|12199981|P3|STARTED|Third Intervention Period||0
4959699|NCT02723201|12199982|P2|STARTED|Third Intervention Period||0
4959700|NCT02723201|12199983|P1|STARTED|Third Intervention Period||9
4959701|NCT02723201|12199981|P3|NOT COMPLETED|Washout Period 2||0
4959702|NCT02723201|12199982|P2|NOT COMPLETED|Washout Period 2||0
4959703|NCT02723201|12199983|P1|NOT COMPLETED|Washout Period 2||0
4959704|NCT02723201|12199981|P3|COMPLETED|Washout Period 2||0
4959705|NCT02723201|12199982|P2|COMPLETED|Washout Period 2||0
4959706|NCT02723201|12199983|P1|COMPLETED|Washout Period 2||9
4959707|NCT02723201|12199981|P3|STARTED|Washout Period 2||0
4959708|NCT02723201|12199982|P2|STARTED|Washout Period 2||0
4959709|NCT02723201|12199983|P1|STARTED|Washout Period 2||9
4959710|NCT02723201|12199981|P3|NOT COMPLETED|Second Intervention Period||0
4959711|NCT02723201|12199982|P2|NOT COMPLETED|Second Intervention Period||0
4959712|NCT02723201|12199983|P1|NOT COMPLETED|Second Intervention Period||2
4959713|NCT02723201|12199981|P3|COMPLETED|Second Intervention Period||7
4959714|NCT02723201|12199982|P2|COMPLETED|Second Intervention Period||7
4959715|NCT02723201|12199983|P1|COMPLETED|Second Intervention Period||9
4959716|NCT02723201|12199981|P3|STARTED|Second Intervention Period||7
4959717|NCT02723201|12199982|P2|STARTED|Second Intervention Period||7
4959718|NCT02723201|12199983|P1|STARTED|Second Intervention Period||11
4959719|NCT02723201|12199981|P3|NOT COMPLETED|Washout Period 1||0
4959720|NCT02723201|12199982|P2|NOT COMPLETED|Washout Period 1||0
4959721|NCT02723201|12199983|P1|NOT COMPLETED|Washout Period 1||0
4959722|NCT02723201|12199981|P3|COMPLETED|Washout Period 1||7
4959723|NCT02723201|12199982|P2|COMPLETED|Washout Period 1||7
4959724|NCT02723201|12199983|P1|COMPLETED|Washout Period 1||11
4959725|NCT02723201|12199981|P3|STARTED|Washout Period 1||7
4959726|NCT02723201|12199982|P2|STARTED|Washout Period 1||7
4959727|NCT02723201|12199983|P1|STARTED|Washout Period 1||11
4959728|NCT02723201|12199981|P3|NOT COMPLETED|First Intervention Period||0
4959729|NCT02723201|12199982|P2|NOT COMPLETED|First Intervention Period||0
4959730|NCT02723201|12199983|P1|NOT COMPLETED|First Intervention Period||0
4959731|NCT02723201|12199981|P3|COMPLETED|First Intervention Period||7
4959732|NCT02723201|12199982|P2|COMPLETED|First Intervention Period||7
4959733|NCT02723201|12199983|P1|COMPLETED|First Intervention Period||11
4959734|NCT02723201|12199981|P3|STARTED|First Intervention Period||7
4959735|NCT02723201|12199982|P2|STARTED|First Intervention Period||7
4959736|NCT02723201|12199983|P1|STARTED|First Intervention Period||11
4959737|NCT02723188|12200042|P3|NOT COMPLETED|Overall Study||0
4959738|NCT02723188|12200043|P2|NOT COMPLETED|Overall Study||0
4959739|NCT02723188|12200044|P1|NOT COMPLETED|Overall Study||1
4959740|NCT02723188|12200042|P3|COMPLETED|Overall Study||15
4959741|NCT02723188|12200043|P2|COMPLETED|Overall Study||15
4959742|NCT02723188|12200044|P1|COMPLETED|Overall Study||14
4959743|NCT02723188|12200042|P3|STARTED|Overall Study||15
4959744|NCT02723188|12200043|P2|STARTED|Overall Study||15
4959745|NCT02723188|12200044|P1|STARTED|Overall Study||15
4959746|NCT02723175|12200057|P2|NOT COMPLETED|Overall Study||3
4959747|NCT02723175|12200058|P1|NOT COMPLETED|Overall Study||4
4959748|NCT02723175|12200057|P2|COMPLETED|Overall Study||4
4959749|NCT02723175|12200058|P1|COMPLETED|Overall Study||4
4959750|NCT02723175|12200057|P2|STARTED|Overall Study||7
4959751|NCT02723175|12200058|P1|STARTED|Overall Study||8
4959752|NCT02723084|12200100|P2|NOT COMPLETED|Overall Study||1
4959753|NCT02723084|12200101|P1|NOT COMPLETED|Overall Study||4
4959754|NCT02723084|12200100|P2|COMPLETED|Overall Study||45
4959755|NCT02723084|12200101|P1|COMPLETED|Overall Study||86
4959756|NCT02723084|12200100|P2|STARTED|Overall Study||46
4959757|NCT02723084|12200101|P1|STARTED|Overall Study||90
4959758|NCT02722967|12200115|P3|NOT COMPLETED|Overall Study||4
4959759|NCT02722967|12200116|P2|NOT COMPLETED|Overall Study||2
4959760|NCT02722967|12200117|P1|NOT COMPLETED|Overall Study||5
4959761|NCT02722967|12200115|P3|COMPLETED|Overall Study||11
4959762|NCT02722967|12200116|P2|COMPLETED|Overall Study||10
4959763|NCT02722967|12200117|P1|COMPLETED|Overall Study||17
4959764|NCT02722967|12200115|P3|STARTED|Overall Study||15
4959765|NCT02722967|12200116|P2|STARTED|Overall Study||12
4959766|NCT02722967|12200117|P1|STARTED|Overall Study||22
4959767|NCT02722928|12200127|P2|NOT COMPLETED|Overall Study||20
4959768|NCT02722928|12200128|P1|NOT COMPLETED|Overall Study||10
4959769|NCT02722928|12200127|P2|COMPLETED|Overall Study||31
4959770|NCT02722928|12200128|P1|COMPLETED|Overall Study||39
4959771|NCT02722928|12200127|P2|STARTED|Overall Study||51
4959772|NCT02722928|12200128|P1|STARTED|Overall Study||49
4959773|NCT02722863|12200142|P1|NOT COMPLETED|Overall Study||0
4959774|NCT02722863|12200142|P1|COMPLETED|Overall Study||908
4959775|NCT02722863|12200142|P1|STARTED|Overall Study||908
4959776|NCT02722837|12200147|P1|NOT COMPLETED|Overall Study||0
4959777|NCT02722837|12200147|P1|COMPLETED|Overall Study||119
4959778|NCT02722837|12200147|P1|STARTED|Overall Study||119
4959779|NCT02722577|12200165|P1|NOT COMPLETED|Overall Study||0
4959780|NCT02722577|12200165|P1|COMPLETED|Overall Study||20
4959781|NCT02722577|12200165|P1|STARTED|Overall Study||20
4959782|NCT02722564|12200169|P1|NOT COMPLETED|Overall Study||0
4959783|NCT02722564|12200169|P1|COMPLETED|Overall Study||55
4959784|NCT02722564|12200169|P1|STARTED|Overall Study||55
4959785|NCT02722408|12200173|P1|NOT COMPLETED|Overall Study||0
4959786|NCT02722408|12200173|P1|COMPLETED|Overall Study||8
4959787|NCT02722408|12200173|P1|STARTED|Overall Study||8
4959788|NCT02722330|12200227|P1|NOT COMPLETED|Overall Study||0
4959789|NCT02722330|12200227|P1|COMPLETED|Overall Study||23
4959790|NCT02722330|12200227|P1|STARTED|Overall Study||23
4959791|NCT02722304|12200258|P5|NOT COMPLETED|Overall Study||2
4959792|NCT02722304|12200259|P4|NOT COMPLETED|Overall Study||2
4959793|NCT02722304|12200260|P3|NOT COMPLETED|Overall Study||2
4959794|NCT02722304|12200261|P2|NOT COMPLETED|Overall Study||0
4959795|NCT02722304|12200262|P1|NOT COMPLETED|Overall Study||1
4959796|NCT02722304|12200258|P5|COMPLETED|Overall Study||0
4959797|NCT02722304|12200259|P4|COMPLETED|Overall Study||0
4959798|NCT02722304|12200260|P3|COMPLETED|Overall Study||0
4959799|NCT02722304|12200261|P2|COMPLETED|Overall Study||0
4959800|NCT02722304|12200262|P1|COMPLETED|Overall Study||0
4959801|NCT02722304|12200258|P5|Treated|Overall Study||2
4959802|NCT02722304|12200259|P4|Treated|Overall Study||1
4959803|NCT02722304|12200260|P3|Treated|Overall Study||1
4959804|NCT02722304|12200261|P2|Treated|Overall Study||0
4959805|NCT02722304|12200262|P1|Treated|Overall Study||1
4959806|NCT02722304|12200258|P5|STARTED|Overall Study||2
4959807|NCT02722304|12200259|P4|STARTED|Overall Study||2
4959808|NCT02722304|12200260|P3|STARTED|Overall Study||2
4959809|NCT02722304|12200261|P2|STARTED|Overall Study||0
4959810|NCT02722304|12200262|P1|STARTED|Overall Study||1
4959811|NCT02722278|12200314|P2|NOT COMPLETED|Overall Study||7
4959812|NCT02722278|12200315|P1|NOT COMPLETED|Overall Study||12
4959813|NCT02722278|12200314|P2|COMPLETED|Overall Study||49
4959814|NCT02722278|12200315|P1|COMPLETED|Overall Study||154
4959815|NCT02722278|12200314|P2|STARTED|Overall Study||56
4959816|NCT02722278|12200315|P1|STARTED|Overall Study||166
4959817|NCT02722239|12200325|P2|NOT COMPLETED|Overall Study||0
4959818|NCT02722239|12200326|P1|NOT COMPLETED|Overall Study||0
4959819|NCT02722239|12200325|P2|COMPLETED|Overall Study||20
4959820|NCT02722239|12200326|P1|COMPLETED|Overall Study||20
4959821|NCT02722239|12200325|P2|Second Intervention (1 Day)|Overall Study||20
4959822|NCT02722239|12200326|P1|Second Intervention (1 Day)|Overall Study||20
4959823|NCT02722239|12200325|P2|Washout (7 Days)|Overall Study||20
4959824|NCT02722239|12200326|P1|Washout (7 Days)|Overall Study||20
4959825|NCT02722239|12200325|P2|First Intervention (1 Day)|Overall Study||20
4959826|NCT02722239|12200326|P1|First Intervention (1 Day)|Overall Study||20
4959827|NCT02722239|12200325|P2|STARTED|Overall Study||20
4959828|NCT02722239|12200326|P1|STARTED|Overall Study||20
4959829|NCT02722148|12200339|P1|NOT COMPLETED|Overall Study||5
4959830|NCT02722148|12200339|P1|COMPLETED|Overall Study||19
4959831|NCT02722148|12200339|P1|STARTED|Overall Study||24
4959832|NCT02722044|12200346|P1|NOT COMPLETED|Overall Study||5
4959833|NCT02722044|12200346|P1|COMPLETED|Overall Study||28
4959834|NCT02722044|12200346|P1|STARTED|Overall Study||33
4959835|NCT02721875|12200375|P2|NOT COMPLETED|Overall Study||0
4959836|NCT02721875|12200376|P1|NOT COMPLETED|Overall Study||1
4959837|NCT02721875|12200375|P2|COMPLETED|Overall Study||0
4959838|NCT02721875|12200376|P1|COMPLETED|Overall Study||0
4959839|NCT02721875|12200375|P2|STARTED|Overall Study||0
4959840|NCT02721875|12200376|P1|STARTED|Overall Study||1
4959841|NCT02721641|12200389|P1|NOT COMPLETED|Overall Study||0
4959842|NCT02721641|12200389|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
4959843|NCT02721641|12200389|P1|STARTED|Overall Study||69
4959844|NCT02721277|12200395|P1|NOT COMPLETED|Overall Study||0
4959845|NCT02721277|12200395|P1|COMPLETED|Overall Study||2
4959846|NCT02721277|12200395|P1|STARTED|Overall Study||2
4959847|NCT02721147|12200427|P3|NOT COMPLETED|Overall Study||0
4959848|NCT02721147|12200428|P2|NOT COMPLETED|Overall Study||0
4959849|NCT02721147|12200429|P1|NOT COMPLETED|Overall Study||2
4959850|NCT02721147|12200427|P3|COMPLETED|Overall Study||31
4959851|NCT02721147|12200428|P2|COMPLETED|Overall Study||18
4959852|NCT02721147|12200429|P1|COMPLETED|Overall Study||38
4959853|NCT02721147|12200427|P3|STARTED|Overall Study||31
4959854|NCT02721147|12200428|P2|STARTED|Overall Study||18
4959855|NCT02721147|12200429|P1|STARTED|Overall Study||40
4959856|NCT02720952|12200464|P1|NOT COMPLETED|Overall Study||0
4959857|NCT02720952|12200464|P1|COMPLETED|Overall Study||24
4959858|NCT02720952|12200464|P1|STARTED|Overall Study||24
4959859|NCT02720757|12200473|P1|NOT COMPLETED|Overall Study||18
4959860|NCT02720757|12200473|P1|COMPLETED|Overall Study||114
4959861|NCT02720757|12200473|P1|STARTED|Overall Study||132
4959862|NCT02720536|12200482|P1|NOT COMPLETED|Overall Study||19
4959863|NCT02720536|12200482|P1|COMPLETED|Overall Study||34
4959864|NCT02720536|12200482|P1|STARTED|Overall Study||53
4959865|NCT02720523|12200517|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
4959866|NCT02720523|12200518|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
4959867|NCT02720523|12200519|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
4959868|NCT02720523|12200520|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
4959869|NCT02720523|12200521|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
4959870|NCT02720523|12200522|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
4959871|NCT02720523|12200523|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
4959872|NCT02720523|12200517|P7|COMPLETED|Period 2: Long-term Extension Period||0
4959873|NCT02720523|12200518|P6|COMPLETED|Period 2: Long-term Extension Period||0
4959874|NCT02720523|12200519|P5|COMPLETED|Period 2: Long-term Extension Period||0
4959875|NCT02720523|12200520|P4|COMPLETED|Period 2: Long-term Extension Period||0
4959876|NCT02720523|12200521|P3|COMPLETED|Period 2: Long-term Extension Period||0
4959877|NCT02720523|12200522|P2|COMPLETED|Period 2: Long-term Extension Period||0
4959878|NCT02720523|12200523|P1|COMPLETED|Period 2: Long-term Extension Period||0
4959879|NCT02720523|12200517|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
4959880|NCT02720523|12200518|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
4959881|NCT02720523|12200519|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
4959882|NCT02720523|12200520|P4|STARTED|Period 2: Long-term Extension Period||0
4959883|NCT02720523|12200521|P3|STARTED|Period 2: Long-term Extension Period||0
4959884|NCT02720523|12200522|P2|STARTED|Period 2: Long-term Extension Period||0
4959885|NCT02720523|12200523|P1|STARTED|Period 2: Long-term Extension Period||0
4959886|NCT02720523|12200517|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
4959887|NCT02720523|12200518|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
4959888|NCT02720523|12200519|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
4959889|NCT02720523|12200520|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
4959890|NCT02720523|12200521|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
4959891|NCT02720523|12200522|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
4959892|NCT02720523|12200523|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
4959893|NCT02720523|12200517|P7|COMPLETED|Period 1: Placebo-controlled Period||0
4959894|NCT02720523|12200518|P6|COMPLETED|Period 1: Placebo-controlled Period||0
4959895|NCT02720523|12200519|P5|COMPLETED|Period 1: Placebo-controlled Period||0
4959896|NCT02720523|12200520|P4|COMPLETED|Period 1: Placebo-controlled Period||44
4959897|NCT02720523|12200521|P3|COMPLETED|Period 1: Placebo-controlled Period||47
4959898|NCT02720523|12200522|P2|COMPLETED|Period 1: Placebo-controlled Period||49
4959899|NCT02720523|12200523|P1|COMPLETED|Period 1: Placebo-controlled Period||47
4959900|NCT02720523|12200517|P7|STARTED|Period 1: Placebo-controlled Period||0
4959901|NCT02720523|12200518|P6|STARTED|Period 1: Placebo-controlled Period||0
4959902|NCT02720523|12200519|P5|STARTED|Period 1: Placebo-controlled Period||0
4959903|NCT02720523|12200520|P4|STARTED|Period 1: Placebo-controlled Period||50
4959904|NCT02720523|12200521|P3|STARTED|Period 1: Placebo-controlled Period||49
4959905|NCT02720523|12200522|P2|STARTED|Period 1: Placebo-controlled Period||49
4959906|NCT02720523|12200523|P1|STARTED|Period 1: Placebo-controlled Period||49
4959907|NCT02720510|12200582|P2|NOT COMPLETED|Overall Study||3
4959908|NCT02720510|12200583|P1|NOT COMPLETED|Overall Study||3
4959909|NCT02720510|12200582|P2|COMPLETED|Overall Study||0
4959910|NCT02720510|12200583|P1|COMPLETED|Overall Study||0
4959911|NCT02720510|12200582|P2|STARTED|Overall Study||3
4959912|NCT02720510|12200583|P1|STARTED|Overall Study||3
4959913|NCT02720484|12200601|P1|NOT COMPLETED|Follow Up for 2 Years||6
4959914|NCT02720484|12200601|P1|COMPLETED|Follow Up for 2 Years||1
4959915|NCT02720484|12200601|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
4959916|NCT02720484|12200601|P1|NOT COMPLETED|Treatment on Study||6
4959917|NCT02720484|12200601|P1|COMPLETED|Treatment on Study||4
4959918|NCT02720484|12200601|P1|Treated Cycle 3|Treatment on Study||4
4959919|NCT02720484|12200601|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
4959920|NCT02720484|12200601|P1|STARTED|Treatment on Study||10
4959921|NCT02720224|12200609|P1|NOT COMPLETED|Overall Study||0
4959922|NCT02720224|12200609|P1|COMPLETED|Overall Study||6
4959923|NCT02720224|12200609|P1|STARTED|Overall Study||6
4959924|NCT02720198|12200633|P2|NOT COMPLETED|Overall Study||1
4959925|NCT02720198|12200634|P1|NOT COMPLETED|Overall Study||0
4959926|NCT02720198|12200633|P2|COMPLETED|Overall Study||30
4959927|NCT02720198|12200634|P1|COMPLETED|Overall Study||29
4959928|NCT02720198|12200633|P2|STARTED|Overall Study||31
4959929|NCT02720198|12200634|P1|STARTED|Overall Study||29
4959930|NCT02720107|12200660|P1|NOT COMPLETED|Overall Study||0
4959931|NCT02720107|12200660|P1|COMPLETED|Overall Study||130
4959932|NCT02720107|12200660|P1|STARTED|Overall Study||130
4959933|NCT02720081|12200669|P2|NOT COMPLETED|Overall Study||4
4959934|NCT02720081|12200670|P1|NOT COMPLETED|Overall Study||4
4959935|NCT02720081|12200669|P2|COMPLETED|Overall Study||66
4959936|NCT02720081|12200670|P1|COMPLETED|Overall Study||68
4959937|NCT02720081|12200669|P2|Treated|Overall Study||69
4959938|NCT02720081|12200670|P1|Treated|Overall Study||70
4959939|NCT02720081|12200669|P2|STARTED|Overall Study||70
4959940|NCT02720081|12200670|P1|STARTED|Overall Study||72
4959941|NCT02720042|12200726|P1|NOT COMPLETED|Overall Study||15
4959942|NCT02720042|12200726|P1|COMPLETED|Overall Study||69
4959943|NCT02720042|12200726|P1|STARTED|Overall Study||84
4959944|NCT02719938|12200743|P2|NOT COMPLETED|Overall Study||1
4959945|NCT02719938|12200744|P1|NOT COMPLETED|Overall Study||4
4959946|NCT02719938|12200743|P2|COMPLETED|Overall Study||31
4959947|NCT02719938|12200744|P1|COMPLETED|Overall Study||26
4959948|NCT02719938|12200743|P2|STARTED|Overall Study||32
4959949|NCT02719938|12200744|P1|STARTED|Overall Study||30
4959950|NCT02719743|12200767|P5|NOT COMPLETED|Overall Study||2
4959951|NCT02719743|12200768|P4|NOT COMPLETED|Overall Study||1
4959952|NCT02719743|12200769|P3|NOT COMPLETED|Overall Study||0
4959953|NCT02719743|12200770|P2|NOT COMPLETED|Overall Study||3
4959954|NCT02719743|12200771|P1|NOT COMPLETED|Overall Study||1
4959955|NCT02719743|12200767|P5|COMPLETED|Overall Study||33
4959956|NCT02719743|12200768|P4|COMPLETED|Overall Study||36
4959957|NCT02719743|12200769|P3|COMPLETED|Overall Study||38
4959958|NCT02719743|12200770|P2|COMPLETED|Overall Study||34
4959959|NCT02719743|12200771|P1|COMPLETED|Overall Study||37
4959960|NCT02719743|12200767|P5|STARTED|Overall Study||35
4959961|NCT02719743|12200768|P4|STARTED|Overall Study||37
4959962|NCT02719743|12200769|P3|STARTED|Overall Study||38
4959963|NCT02719743|12200770|P2|STARTED|Overall Study||37
4959964|NCT02719743|12200771|P1|STARTED|Overall Study||38
4959965|NCT02719639|12200898|P1|NOT COMPLETED|Overall Study||0
4959966|NCT02719639|12200898|P1|COMPLETED|Overall Study||7443
4959967|NCT02719639|12200898|P1|STARTED|Overall Study||7443
4959968|NCT02719535|12200907|P1|NOT COMPLETED|Overall Study||22
4959969|NCT02719535|12200907|P1|COMPLETED|Overall Study||37
4959970|NCT02719535|12200907|P1|STARTED|Overall Study||59
4959971|NCT02719522|12200912|P1|NOT COMPLETED|Overall Study||11
4959972|NCT02719522|12200912|P1|COMPLETED|Overall Study||193
4959973|NCT02719522|12200912|P1|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
4959974|NCT02719366|12200920|P2|NOT COMPLETED|Second Intervention||0
4959975|NCT02719366|12200921|P1|NOT COMPLETED|Second Intervention||0
4959976|NCT02719366|12200920|P2|COMPLETED|Second Intervention||6
4959977|NCT02719366|12200921|P1|COMPLETED|Second Intervention||6
4959978|NCT02719366|12200920|P2|STARTED|Second Intervention||6
4959979|NCT02719366|12200921|P1|STARTED|Second Intervention||6
4959980|NCT02719366|12200920|P2|NOT COMPLETED|First Intervention||0
4959981|NCT02719366|12200921|P1|NOT COMPLETED|First Intervention||0
4959982|NCT02719366|12200920|P2|COMPLETED|First Intervention||6
4959983|NCT02719366|12200921|P1|COMPLETED|First Intervention||6
4959984|NCT02719366|12200920|P2|STARTED|First Intervention||6
4959985|NCT02719366|12200921|P1|STARTED|First Intervention||6
4959986|NCT02719353|12200954|P2|NOT COMPLETED|Second Intervention||0
4959987|NCT02719353|12200955|P1|NOT COMPLETED|Second Intervention||0
4959988|NCT02719353|12200954|P2|COMPLETED|Second Intervention||6
4959989|NCT02719353|12200955|P1|COMPLETED|Second Intervention||7
4959990|NCT02719353|12200954|P2|STARTED|Second Intervention||6
4959991|NCT02719353|12200955|P1|STARTED|Second Intervention||7
4959992|NCT02719353|12200954|P2|NOT COMPLETED|First Intervention||1
4959993|NCT02719353|12200955|P1|NOT COMPLETED|First Intervention||0
4959994|NCT02719353|12200954|P2|COMPLETED|First Intervention||6
4959995|NCT02719353|12200955|P1|COMPLETED|First Intervention||7
4959996|NCT02719353|12200954|P2|STARTED|First Intervention||7
4959997|NCT02719353|12200955|P1|STARTED|First Intervention||7
4959998|NCT02719171|12200994|P5|NOT COMPLETED|Overall Study||2
4959999|NCT02719171|12200995|P4|NOT COMPLETED|Overall Study||2
4960000|NCT02719171|12200996|P3|NOT COMPLETED|Overall Study||3
4960001|NCT02719171|12200997|P2|NOT COMPLETED|Overall Study||4
4960002|NCT02719171|12200998|P1|NOT COMPLETED|Overall Study||1
4960003|NCT02719171|12200994|P5|COMPLETED|Overall Study||18
4960004|NCT02719171|12200995|P4|COMPLETED|Overall Study||37
4960005|NCT02719171|12200996|P3|COMPLETED|Overall Study||39
4960006|NCT02719171|12200997|P2|COMPLETED|Overall Study||38
4960007|NCT02719171|12200998|P1|COMPLETED|Overall Study||41
4960008|NCT02719171|12200994|P5|STARTED|Overall Study||20
4960009|NCT02719171|12200995|P4|STARTED|Overall Study||39
4960010|NCT02719171|12200996|P3|STARTED|Overall Study||42
4960011|NCT02719171|12200997|P2|STARTED|Overall Study||42
4960012|NCT02719171|12200998|P1|STARTED|Overall Study||42
4960013|NCT02719028|12201093|P4|NOT COMPLETED|Overall Study||10
4960014|NCT02719028|12201094|P3|NOT COMPLETED|Overall Study||6
4960015|NCT02719028|12201095|P2|NOT COMPLETED|Overall Study||2
4960016|NCT02719028|12201096|P1|NOT COMPLETED|Overall Study||2
4960017|NCT02719028|12201093|P4|COMPLETED|Overall Study||20
4960018|NCT02719028|12201094|P3|COMPLETED|Overall Study||24
4960019|NCT02719028|12201095|P2|COMPLETED|Overall Study||28
4960020|NCT02719028|12201096|P1|COMPLETED|Overall Study||28
4960021|NCT02719028|12201093|P4|STARTED|Overall Study||30
4960022|NCT02719028|12201094|P3|STARTED|Overall Study||30
4960023|NCT02719028|12201095|P2|STARTED|Overall Study||30
4960024|NCT02719028|12201096|P1|STARTED|Overall Study||30
4960025|NCT02718898|12201120|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
4960026|NCT02718898|12201121|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
4960027|NCT02718898|12201122|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
4960028|NCT02718898|12201123|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
4960029|NCT02718898|12201124|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
4960030|NCT02718898|12201125|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
4960031|NCT02718898|12201126|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
4960032|NCT02718898|12201120|P7|COMPLETED|Post Treatment Follow-up Period||44
4960033|NCT02718898|12201121|P6|COMPLETED|Post Treatment Follow-up Period||67
4960034|NCT02718898|12201122|P5|COMPLETED|Post Treatment Follow-up Period||0
4960035|NCT02718898|12201123|P4|COMPLETED|Post Treatment Follow-up Period||0
4960036|NCT02718898|12201124|P3|COMPLETED|Post Treatment Follow-up Period||0
4960037|NCT02718898|12201125|P2|COMPLETED|Post Treatment Follow-up Period||0
4960038|NCT02718898|12201126|P1|COMPLETED|Post Treatment Follow-up Period||0
4960039|NCT02718898|12201120|P7|STARTED|Post Treatment Follow-up Period||49
4960040|NCT02718898|12201121|P6|STARTED|Post Treatment Follow-up Period||78
4960041|NCT02718898|12201122|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
4960042|NCT02718898|12201123|P4|STARTED|Post Treatment Follow-up Period||0
4960043|NCT02718898|12201124|P3|STARTED|Post Treatment Follow-up Period||0
4960044|NCT02718898|12201125|P2|STARTED|Post Treatment Follow-up Period||0
4960045|NCT02718898|12201126|P1|STARTED|Post Treatment Follow-up Period||0
4960046|NCT02718898|12201120|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
4960047|NCT02718898|12201121|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
4960048|NCT02718898|12201122|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
4960049|NCT02718898|12201123|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
4960050|NCT02718898|12201124|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
4960051|NCT02718898|12201125|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
4960052|NCT02718898|12201126|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
4960053|NCT02718898|12201120|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
4960054|NCT02718898|12201121|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
4960055|NCT02718898|12201122|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
4960056|NCT02718898|12201123|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
4960057|NCT02718898|12201124|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
4960058|NCT02718898|12201125|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
4960059|NCT02718898|12201126|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
4960060|NCT02718898|12201120|P7|STARTED|Open Label Treatment Period (OLTP)||0
4960061|NCT02718898|12201121|P6|STARTED|Open Label Treatment Period (OLTP)||0
4960062|NCT02718898|12201122|P5|STARTED|Open Label Treatment Period (OLTP)||0
4960063|NCT02718898|12201123|P4|STARTED|Open Label Treatment Period (OLTP)||74
4960064|NCT02718898|12201124|P3|STARTED|Open Label Treatment Period (OLTP)||65
4960065|NCT02718898|12201125|P2|STARTED|Open Label Treatment Period (OLTP)||0
4960066|NCT02718898|12201126|P1|STARTED|Open Label Treatment Period (OLTP)||0
4960067|NCT02718898|12201120|P7|NOT COMPLETED|Blinded Treatment Period||0
4960068|NCT02718898|12201121|P6|NOT COMPLETED|Blinded Treatment Period||0
4960069|NCT02718898|12201122|P5|NOT COMPLETED|Blinded Treatment Period||0
4960070|NCT02718898|12201123|P4|NOT COMPLETED|Blinded Treatment Period||0
4960071|NCT02718898|12201124|P3|NOT COMPLETED|Blinded Treatment Period||0
4960072|NCT02718898|12201125|P2|NOT COMPLETED|Blinded Treatment Period||1
4960073|NCT02718898|12201126|P1|NOT COMPLETED|Blinded Treatment Period||9
4960074|NCT02718898|12201120|P7|COMPLETED|Blinded Treatment Period||0
4960075|NCT02718898|12201121|P6|COMPLETED|Blinded Treatment Period||0
4960076|NCT02718898|12201122|P5|COMPLETED|Blinded Treatment Period||0
4960077|NCT02718898|12201123|P4|COMPLETED|Blinded Treatment Period||0
4960078|NCT02718898|12201124|P3|COMPLETED|Blinded Treatment Period||0
4960079|NCT02718898|12201125|P2|COMPLETED|Blinded Treatment Period||74
4960080|NCT02718898|12201126|P1|COMPLETED|Blinded Treatment Period||65
4960081|NCT02718898|12201120|P7|STARTED|Blinded Treatment Period||0
4960082|NCT02718898|12201121|P6|STARTED|Blinded Treatment Period||0
4960083|NCT02718898|12201122|P5|STARTED|Blinded Treatment Period||0
4960084|NCT02718898|12201123|P4|STARTED|Blinded Treatment Period||0
4960085|NCT02718898|12201124|P3|STARTED|Blinded Treatment Period||0
4960086|NCT02718898|12201125|P2|STARTED|Blinded Treatment Period||75
4960087|NCT02718898|12201126|P1|STARTED|Blinded Treatment Period||74
4960088|NCT02718625|12201161|P2|NOT COMPLETED|Overall Study||2
4960089|NCT02718625|12201162|P1|NOT COMPLETED|Overall Study||0
4960090|NCT02718625|12201161|P2|COMPLETED|Overall Study||0
4960091|NCT02718625|12201162|P1|COMPLETED|Overall Study||1
4960092|NCT02718625|12201161|P2|STARTED|Overall Study||2
4960093|NCT02718625|12201162|P1|STARTED|Overall Study||1
4960094|NCT02718417|12201181|P3|NOT COMPLETED|Long-term Follow-up Phase||135
4960095|NCT02718417|12201182|P2|NOT COMPLETED|Long-term Follow-up Phase||112
4960096|NCT02718417|12201183|P1|NOT COMPLETED|Long-term Follow-up Phase||139
4960097|NCT02718417|12201181|P3|COMPLETED|Long-term Follow-up Phase||0
4960098|NCT02718417|12201182|P2|COMPLETED|Long-term Follow-up Phase||0
4960099|NCT02718417|12201183|P1|COMPLETED|Long-term Follow-up Phase||0
4960100|NCT02718417|12201181|P3|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
4960101|NCT02718417|12201182|P2|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
4960102|NCT02718417|12201183|P1|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
4960103|NCT02718417|12201181|P3|NOT COMPLETED|Follow-up Phase||19
4960104|NCT02718417|12201182|P2|NOT COMPLETED|Follow-up Phase||172
4960105|NCT02718417|12201183|P1|NOT COMPLETED|Follow-up Phase||135
4960106|NCT02718417|12201181|P3|COMPLETED|Follow-up Phase||20
4960107|NCT02718417|12201182|P2|COMPLETED|Follow-up Phase||91
4960108|NCT02718417|12201183|P1|COMPLETED|Follow-up Phase||103
4960109|NCT02718417|12201181|P3|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
4960110|NCT02718417|12201182|P2|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
4960111|NCT02718417|12201183|P1|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
4960112|NCT02718417|12201181|P3|NOT COMPLETED|Observation Phase (OP)||282
4960113|NCT02718417|12201182|P2|NOT COMPLETED|Observation Phase (OP)||0
4960114|NCT02718417|12201183|P1|NOT COMPLETED|Observation Phase (OP)||0
4960115|NCT02718417|12201181|P3|COMPLETED|Observation Phase (OP)||2
4960116|NCT02718417|12201182|P2|COMPLETED|Observation Phase (OP)||0
4960117|NCT02718417|12201183|P1|COMPLETED|Observation Phase (OP)||0
4960118|NCT02718417|12201181|P3|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
4960119|NCT02718417|12201182|P2|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
4960120|NCT02718417|12201183|P1|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
4960121|NCT02718417|12201181|P3|NOT COMPLETED|Maintenance Phase (MP)||0
4960122|NCT02718417|12201182|P2|NOT COMPLETED|Maintenance Phase (MP)||287
4960123|NCT02718417|12201183|P1|NOT COMPLETED|Maintenance Phase (MP)||266
4960124|NCT02718417|12201181|P3|COMPLETED|Maintenance Phase (MP)||0
4960125|NCT02718417|12201182|P2|COMPLETED|Maintenance Phase (MP)||1
4960126|NCT02718417|12201183|P1|COMPLETED|Maintenance Phase (MP)||1
4960127|NCT02718417|12201181|P3|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
4960128|NCT02718417|12201182|P2|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
4960129|NCT02718417|12201183|P1|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
4960130|NCT02718417|12201181|P3|NOT COMPLETED|Chemotherapy Phase (CP)||46
4960131|NCT02718417|12201182|P2|NOT COMPLETED|Chemotherapy Phase (CP)||37
4960132|NCT02718417|12201183|P1|NOT COMPLETED|Chemotherapy Phase (CP)||52
4960133|NCT02718417|12201181|P3|COMPLETED|Chemotherapy Phase (CP)||289
4960134|NCT02718417|12201182|P2|COMPLETED|Chemotherapy Phase (CP)||294
4960135|NCT02718417|12201183|P1|COMPLETED|Chemotherapy Phase (CP)||280
4960136|NCT02718417|12201181|P3|Safety Population|Chemotherapy Phase (CP)||334
4960137|NCT02718417|12201182|P2|Safety Population|Chemotherapy Phase (CP)||329
4960138|NCT02718417|12201183|P1|Safety Population|Chemotherapy Phase (CP)||328
4960139|NCT02718417|12201181|P3|STARTED|Chemotherapy Phase (CP)||335
4960140|NCT02718417|12201182|P2|STARTED|Chemotherapy Phase (CP)||331
4960141|NCT02718417|12201183|P1|STARTED|Chemotherapy Phase (CP)||332
4960142|NCT02718326|12201289|P3|NOT COMPLETED|Overall Study||22
4960143|NCT02718326|12201290|P2|NOT COMPLETED|Overall Study||24
4960144|NCT02718326|12201291|P1|NOT COMPLETED|Overall Study||36
4960145|NCT02718326|12201289|P3|COMPLETED|Overall Study||112
4960146|NCT02718326|12201290|P2|COMPLETED|Overall Study||111
4960147|NCT02718326|12201291|P1|COMPLETED|Overall Study||97
4960148|NCT02718326|12201289|P3|Completed Week 52|Overall Study||124
4960149|NCT02718326|12201290|P2|Completed Week 52|Overall Study||122
4960150|NCT02718326|12201291|P1|Completed Week 52|Overall Study||109
4960151|NCT02718326|12201289|P3|STARTED|Overall Study||134
4960152|NCT02718326|12201290|P2|STARTED|Overall Study||135
4960153|NCT02718326|12201291|P1|STARTED|Overall Study||133
4960154|NCT02718248|12201322|P1|NOT COMPLETED|Overall Study||0
4960155|NCT02718248|12201322|P1|COMPLETED|Overall Study||7
4960156|NCT02718248|12201322|P1|STARTED|Overall Study||7
4960157|NCT02718157|12201338|P1|NOT COMPLETED|Overall Study||162
4960158|NCT02718157|12201338|P1|COMPLETED|Overall Study||609
4960159|NCT02718157|12201338|P1|STARTED|Overall Study||771
4960160|NCT02718118|12201347|P2|NOT COMPLETED|Overall Study||1
4960161|NCT02718118|12201348|P1|NOT COMPLETED|Overall Study||2
4960162|NCT02718118|12201347|P2|COMPLETED|Overall Study||29
4960163|NCT02718118|12201348|P1|COMPLETED|Overall Study||28
4960164|NCT02718118|12201347|P2|STARTED|Overall Study||30
4960165|NCT02718118|12201348|P1|STARTED|Overall Study||30
4960166|NCT02718040|12201382|P1|NOT COMPLETED|Overall Study||0
4960167|NCT02718040|12201382|P1|COMPLETED|Overall Study||30
4960168|NCT02718040|12201382|P1|STARTED|Overall Study||30
4960169|NCT02717949|12201397|P2|NOT COMPLETED|Overall Study||0
4960170|NCT02717949|12201398|P1|NOT COMPLETED|Overall Study||0
4960171|NCT02717949|12201397|P2|COMPLETED|Overall Study||0
4960172|NCT02717949|12201398|P1|COMPLETED|Overall Study||0
4960173|NCT02717949|12201397|P2|STARTED|Overall Study||0
4960174|NCT02717949|12201398|P1|STARTED|Overall Study||0
4960175|NCT02717754|12201412|P6|NOT COMPLETED|Overall Study||20
4960176|NCT02717754|12201413|P5|NOT COMPLETED|Overall Study||20
4960177|NCT02717754|12201414|P4|NOT COMPLETED|Overall Study||10
4960178|NCT02717754|12201415|P3|NOT COMPLETED|Overall Study||0
4960179|NCT02717754|12201416|P2|NOT COMPLETED|Overall Study||0
4960180|NCT02717754|12201417|P1|NOT COMPLETED|Overall Study||0
4960181|NCT02717754|12201412|P6|COMPLETED|Overall Study||0
4960182|NCT02717754|12201413|P5|COMPLETED|Overall Study||0
4960183|NCT02717754|12201414|P4|COMPLETED|Overall Study||0
4960184|NCT02717754|12201415|P3|COMPLETED|Overall Study||20
4960185|NCT02717754|12201416|P2|COMPLETED|Overall Study||19
4960186|NCT02717754|12201417|P1|COMPLETED|Overall Study||10
4960187|NCT02717754|12201412|P6|STARTED|Overall Study||20
4960188|NCT02717754|12201413|P5|STARTED|Overall Study||20
4960189|NCT02717754|12201414|P4|STARTED|Overall Study||10
4960190|NCT02717754|12201415|P3|STARTED|Overall Study||20
4960191|NCT02717754|12201416|P2|STARTED|Overall Study||19
4960192|NCT02717754|12201417|P1|STARTED|Overall Study||10
4960193|NCT02717494|12201448|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
4960194|NCT02717494|12201449|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
4960195|NCT02717494|12201450|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
4960196|NCT02717494|12201448|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
4960197|NCT02717494|12201449|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
4960198|NCT02717494|12201450|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
4960199|NCT02717494|12201448|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
4960200|NCT02717494|12201449|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
4960201|NCT02717494|12201450|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
4960202|NCT02717494|12201448|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
4960203|NCT02717494|12201449|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
4960204|NCT02717494|12201450|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
4960205|NCT02717494|12201448|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
4960206|NCT02717494|12201449|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
4960207|NCT02717494|12201450|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
4960208|NCT02717494|12201448|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
4960209|NCT02717494|12201449|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
4960210|NCT02717494|12201450|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
4960211|NCT02717494|12201448|P3|NOT COMPLETED|First Intervention (Step 1)||5
4960212|NCT02717494|12201449|P2|NOT COMPLETED|First Intervention (Step 1)||7
4960213|NCT02717494|12201450|P1|NOT COMPLETED|First Intervention (Step 1)||6
4960214|NCT02717494|12201448|P3|COMPLETED|First Intervention (Step 1)||111
4960215|NCT02717494|12201449|P2|COMPLETED|First Intervention (Step 1)||108
4960216|NCT02717494|12201450|P1|COMPLETED|First Intervention (Step 1)||109
4960217|NCT02717494|12201448|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
4960218|NCT02717494|12201449|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
4960219|NCT02717494|12201450|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
4960220|NCT02717494|12201448|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
4960221|NCT02717494|12201449|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
4960222|NCT02717494|12201450|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
4960223|NCT02717494|12201448|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
4960224|NCT02717494|12201449|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
4960225|NCT02717494|12201450|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
4960226|NCT02717494|12201448|P3|STARTED|First Intervention (Step 1)||116
4960227|NCT02717494|12201449|P2|STARTED|First Intervention (Step 1)||115
4960228|NCT02717494|12201450|P1|STARTED|First Intervention (Step 1)||115
4960229|NCT02717273|12201489|P2|NOT COMPLETED|Overall Study||2
4960230|NCT02717273|12201490|P1|NOT COMPLETED|Overall Study||3
4960231|NCT02717273|12201489|P2|COMPLETED|Overall Study||48
4960232|NCT02717273|12201490|P1|COMPLETED|Overall Study||49
4960233|NCT02717273|12201489|P2|STARTED|Overall Study||50
4960234|NCT02717273|12201490|P1|STARTED|Overall Study||52
4960235|NCT02717195|12201512|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
4960236|NCT02717195|12201513|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
4960237|NCT02717195|12201514|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
4960238|NCT02717195|12201515|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
4960239|NCT02717195|12201516|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
4960240|NCT02717195|12201512|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
4960241|NCT02717195|12201513|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
4960242|NCT02717195|12201514|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
4960243|NCT02717195|12201515|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
4960244|NCT02717195|12201516|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
4960245|NCT02717195|12201512|P5|STARTED|Double-blind Treatment (DBT) Period||230
4960246|NCT02717195|12201513|P4|STARTED|Double-blind Treatment (DBT) Period||232
4960247|NCT02717195|12201514|P3|STARTED|Double-blind Treatment (DBT) Period||235
4960248|NCT02717195|12201515|P2|STARTED|Double-blind Treatment (DBT) Period||0
4960249|NCT02717195|12201516|P1|STARTED|Double-blind Treatment (DBT) Period||0
4960250|NCT02717195|12201512|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
4960251|NCT02717195|12201513|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
4960252|NCT02717195|12201514|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
4960253|NCT02717195|12201515|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
4960254|NCT02717195|12201516|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
4960255|NCT02717195|12201512|P5|COMPLETED|Prospective Confirmation (PC) Period||0
4960256|NCT02717195|12201513|P4|COMPLETED|Prospective Confirmation (PC) Period||0
4960257|NCT02717195|12201514|P3|COMPLETED|Prospective Confirmation (PC) Period||0
4960258|NCT02717195|12201515|P2|COMPLETED|Prospective Confirmation (PC) Period||276
4960259|NCT02717195|12201516|P1|COMPLETED|Prospective Confirmation (PC) Period||421
4960260|NCT02717195|12201512|P5|STARTED|Prospective Confirmation (PC) Period||0
4960261|NCT02717195|12201513|P4|STARTED|Prospective Confirmation (PC) Period||0
4960262|NCT02717195|12201514|P3|STARTED|Prospective Confirmation (PC) Period||0
4960263|NCT02717195|12201515|P2|STARTED|Prospective Confirmation (PC) Period||387
4960264|NCT02717195|12201516|P1|STARTED|Prospective Confirmation (PC) Period||711
4960265|NCT02717130|12201547|P1|NOT COMPLETED|Overall Study||7
4960266|NCT02717130|12201547|P1|COMPLETED|Overall Study||1
4960267|NCT02717130|12201547|P1|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
4960268|NCT02716896|12201553|P2|NOT COMPLETED|Overall Study||1
4960269|NCT02716896|12201554|P1|NOT COMPLETED|Overall Study||0
4960270|NCT02716896|12201553|P2|COMPLETED|Overall Study||0
4960271|NCT02716896|12201554|P1|COMPLETED|Overall Study||1
4960272|NCT02716896|12201553|P2|STARTED|Overall Study||1
4960273|NCT02716896|12201554|P1|STARTED|Overall Study||1
4960274|NCT02716818|12201574|P2|NOT COMPLETED|Overall Study||2
4960275|NCT02716818|12201575|P1|NOT COMPLETED|Overall Study||3
4960276|NCT02716818|12201574|P2|COMPLETED|Overall Study||59
4960277|NCT02716818|12201575|P1|COMPLETED|Overall Study||58
4960278|NCT02716818|12201574|P2|STARTED|Overall Study||61
4960279|NCT02716818|12201575|P1|STARTED|Overall Study||61
4960280|NCT02716805|12201605|P4|NOT COMPLETED|Overall Study||0
4960281|NCT02716805|12201606|P3|NOT COMPLETED|Overall Study||0
4960282|NCT02716805|12201607|P2|NOT COMPLETED|Overall Study||0
4960283|NCT02716805|12201608|P1|NOT COMPLETED|Overall Study||2
4960284|NCT02716805|12201605|P4|COMPLETED|Overall Study||0
4960285|NCT02716805|12201606|P3|COMPLETED|Overall Study||0
4960286|NCT02716805|12201607|P2|COMPLETED|Overall Study||0
4960287|NCT02716805|12201608|P1|COMPLETED|Overall Study||4
4960288|NCT02716805|12201605|P4|STARTED|Overall Study||0
4960289|NCT02716805|12201606|P3|STARTED|Overall Study||0
4960290|NCT02716805|12201607|P2|STARTED|Overall Study||0
4960291|NCT02716805|12201608|P1|STARTED|Overall Study||6
4960292|NCT02716779|12201616|P3|NOT COMPLETED|Combination Therapy||1
4960293|NCT02716779|12201617|P2|NOT COMPLETED|Combination Therapy||2
4960294|NCT02716779|12201618|P1|NOT COMPLETED|Combination Therapy||0
4960295|NCT02716779|12201616|P3|COMPLETED|Combination Therapy||25
4960296|NCT02716779|12201617|P2|COMPLETED|Combination Therapy||23
4960297|NCT02716779|12201618|P1|COMPLETED|Combination Therapy||14
4960298|NCT02716779|12201616|P3|STARTED|Combination Therapy||26
4960299|NCT02716779|12201617|P2|STARTED|Combination Therapy||25
4960300|NCT02716779|12201618|P1|STARTED|Combination Therapy||14
4960301|NCT02716779|12201616|P3|NOT COMPLETED|Monotherapy||1
4960302|NCT02716779|12201617|P2|NOT COMPLETED|Monotherapy||1
4960303|NCT02716779|12201618|P1|NOT COMPLETED|Monotherapy||0
4960304|NCT02716779|12201616|P3|COMPLETED|Monotherapy||26
4960305|NCT02716779|12201617|P2|COMPLETED|Monotherapy||25
4960306|NCT02716779|12201618|P1|COMPLETED|Monotherapy||14
4960307|NCT02716779|12201616|P3|STARTED|Monotherapy||27
4960308|NCT02716779|12201617|P2|STARTED|Monotherapy||26
4960309|NCT02716779|12201618|P1|STARTED|Monotherapy||14
4960310|NCT02716714|12201664|P2|NOT COMPLETED|Overall Study||2
4960311|NCT02716714|12201665|P1|NOT COMPLETED|Overall Study||12
4960312|NCT02716714|12201664|P2|COMPLETED|Overall Study||8
4960313|NCT02716714|12201665|P1|COMPLETED|Overall Study||55
4960314|NCT02716714|12201664|P2|STARTED|Overall Study||10
4960315|NCT02716714|12201665|P1|STARTED|Overall Study||67
4960316|NCT02716584|12201693|P2|NOT COMPLETED|Overall Study||5
4960317|NCT02716584|12201694|P1|NOT COMPLETED|Overall Study||8
4960318|NCT02716584|12201693|P2|COMPLETED|Overall Study||13
4960319|NCT02716584|12201694|P1|COMPLETED|Overall Study||27
4960320|NCT02716584|12201693|P2|STARTED|Overall Study||18
4960321|NCT02716584|12201694|P1|STARTED|Overall Study||35
4960322|NCT02716506|12201718|P1|NOT COMPLETED|Overall Study||1164
4960323|NCT02716506|12201718|P1|COMPLETED|Overall Study||2351
4960324|NCT02716506|12201718|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
4960325|NCT02716506|12201718|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
4960326|NCT02716506|12201718|P1|STARTED|Overall Study||3515
4960327|NCT02716324|12201725|P2|NOT COMPLETED|Overall Study||11
4960328|NCT02716324|12201726|P1|NOT COMPLETED|Overall Study||19
4960329|NCT02716324|12201725|P2|COMPLETED|Overall Study||143
4960330|NCT02716324|12201726|P1|COMPLETED|Overall Study||130
4960331|NCT02716324|12201725|P2|STARTED|Overall Study||154
4960332|NCT02716324|12201726|P1|STARTED|Overall Study||149
4960333|NCT02716298|12201750|P2|NOT COMPLETED|Second Intervention (1 Month)||0
4960334|NCT02716298|12201751|P1|NOT COMPLETED|Second Intervention (1 Month)||0
4960335|NCT02716298|12201750|P2|COMPLETED|Second Intervention (1 Month)||23
4960336|NCT02716298|12201751|P1|COMPLETED|Second Intervention (1 Month)||24
4960337|NCT02716298|12201750|P2|STARTED|Second Intervention (1 Month)||23
4960338|NCT02716298|12201751|P1|STARTED|Second Intervention (1 Month)||24
4960339|NCT02716298|12201750|P2|NOT COMPLETED|First Intervention (1 Month)||1
4960340|NCT02716298|12201751|P1|NOT COMPLETED|First Intervention (1 Month)||1
4960341|NCT02716298|12201750|P2|COMPLETED|First Intervention (1 Month)||23
4960342|NCT02716298|12201751|P1|COMPLETED|First Intervention (1 Month)||24
4960343|NCT02716298|12201750|P2|STARTED|First Intervention (1 Month)||24
4960344|NCT02716298|12201751|P1|STARTED|First Intervention (1 Month)||25
4960345|NCT02716194|12201769|P3|NOT COMPLETED|Period 2 - BAX 826||0
4960346|NCT02716194|12201770|P2|NOT COMPLETED|Period 2 - BAX 826||0
4960347|NCT02716194|12201771|P1|NOT COMPLETED|Period 2 - BAX 826||0
4960348|NCT02716194|12201769|P3|COMPLETED|Period 2 - BAX 826||13
4960349|NCT02716194|12201770|P2|COMPLETED|Period 2 - BAX 826||15
4960350|NCT02716194|12201771|P1|COMPLETED|Period 2 - BAX 826||10
4960351|NCT02716194|12201769|P3|STARTED|Period 2 - BAX 826||13
4960352|NCT02716194|12201770|P2|STARTED|Period 2 - BAX 826||15
4960353|NCT02716194|12201771|P1|STARTED|Period 2 - BAX 826||10
4960354|NCT02716194|12201769|P3|NOT COMPLETED|Period 1 - ADVATE||0
4960355|NCT02716194|12201770|P2|NOT COMPLETED|Period 1 - ADVATE||1
4960356|NCT02716194|12201771|P1|NOT COMPLETED|Period 1 - ADVATE||1
4960357|NCT02716194|12201769|P3|COMPLETED|Period 1 - ADVATE||13
4960358|NCT02716194|12201770|P2|COMPLETED|Period 1 - ADVATE||15
4960359|NCT02716194|12201771|P1|COMPLETED|Period 1 - ADVATE||10
4960360|NCT02716194|12201769|P3|STARTED|Period 1 - ADVATE||13
4960361|NCT02716194|12201770|P2|STARTED|Period 1 - ADVATE||16
4960362|NCT02716194|12201771|P1|STARTED|Period 1 - ADVATE||11
4960363|NCT02715804|12201851|P2|NOT COMPLETED|Overall Study||113
4960364|NCT02715804|12201852|P1|NOT COMPLETED|Overall Study||229
4960365|NCT02715804|12201851|P2|COMPLETED|Overall Study||52
4960366|NCT02715804|12201852|P1|COMPLETED|Overall Study||98
4960367|NCT02715804|12201851|P2|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
4960368|NCT02715804|12201852|P1|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
4960369|NCT02715804|12201851|P2|Received at Least 1 Dose of Study Drug|Overall Study||158
4960370|NCT02715804|12201852|P1|Received at Least 1 Dose of Study Drug|Overall Study||323
4960371|NCT02715804|12201851|P2|STARTED|Overall Study||165
4960372|NCT02715804|12201852|P1|STARTED|Overall Study||327
4960373|NCT02715726|12201874|P2|NOT COMPLETED|Overall Study||27
4960374|NCT02715726|12201875|P1|NOT COMPLETED|Overall Study||18
4960375|NCT02715726|12201874|P2|COMPLETED|Overall Study||380
4960376|NCT02715726|12201875|P1|COMPLETED|Overall Study||190
4960377|NCT02715726|12201874|P2|Safety Population|Overall Study||406
4960378|NCT02715726|12201875|P1|Safety Population|Overall Study||206
4960379|NCT02715726|12201874|P2|Treated|Overall Study||405
4960380|NCT02715726|12201875|P1|Treated|Overall Study||207
4960381|NCT02715726|12201874|P2|STARTED|Overall Study|Randomized|407
4960382|NCT02715726|12201875|P1|STARTED|Overall Study|Randomized|208
4960383|NCT02715700|12201923|P1|NOT COMPLETED|Overall Study||0
4960384|NCT02715700|12201923|P1|COMPLETED|Overall Study||14
4960385|NCT02715700|12201923|P1|STARTED|Overall Study||14
4960386|NCT02714868|12201955|P2|NOT COMPLETED|Overall Study||0
4960387|NCT02714868|12201956|P1|NOT COMPLETED|Overall Study||5
4960388|NCT02714868|12201955|P2|COMPLETED|Overall Study||35
4960389|NCT02714868|12201956|P1|COMPLETED|Overall Study||42
4960390|NCT02714868|12201955|P2|STARTED|Overall Study||35
4960391|NCT02714868|12201956|P1|STARTED|Overall Study||47
4960392|NCT02714504|12201974|P2|NOT COMPLETED|Overall Study||0
4960393|NCT02714504|12201975|P1|NOT COMPLETED|Overall Study||0
4960394|NCT02714504|12201974|P2|COMPLETED|Overall Study||178
4960395|NCT02714504|12201975|P1|COMPLETED|Overall Study||61
4960396|NCT02714504|12201974|P2|STARTED|Overall Study||178
4960397|NCT02714504|12201975|P1|STARTED|Overall Study||61
4960398|NCT02714426|12201983|P2|NOT COMPLETED|Overall Study||2
4960399|NCT02714426|12201984|P1|NOT COMPLETED|Overall Study||2
4960400|NCT02714426|12201983|P2|COMPLETED|Overall Study||19
4960401|NCT02714426|12201984|P1|COMPLETED|Overall Study||19
4960402|NCT02714426|12201983|P2|STARTED|Overall Study||21
4960403|NCT02714426|12201984|P1|STARTED|Overall Study||21
4960404|NCT02714400|12202000|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4960405|NCT02714400|12202001|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4960406|NCT02714400|12202000|P2|COMPLETED|Second Intervention (1 Day)||8
4960407|NCT02714400|12202001|P1|COMPLETED|Second Intervention (1 Day)||12
4960408|NCT02714400|12202000|P2|STARTED|Second Intervention (1 Day)||8
4960409|NCT02714400|12202001|P1|STARTED|Second Intervention (1 Day)||12
4960410|NCT02714400|12202000|P2|NOT COMPLETED|Washout (>4 Days)||0
4960411|NCT02714400|12202001|P1|NOT COMPLETED|Washout (>4 Days)||0
4960412|NCT02714400|12202000|P2|COMPLETED|Washout (>4 Days)||8
4960413|NCT02714400|12202001|P1|COMPLETED|Washout (>4 Days)||12
4960414|NCT02714400|12202000|P2|STARTED|Washout (>4 Days)||8
4960415|NCT02714400|12202001|P1|STARTED|Washout (>4 Days)||12
4960416|NCT02714400|12202000|P2|NOT COMPLETED|First Intervention (1 Day)||0
4960417|NCT02714400|12202001|P1|NOT COMPLETED|First Intervention (1 Day)||0
4960418|NCT02714400|12202000|P2|COMPLETED|First Intervention (1 Day)||8
4960419|NCT02714400|12202001|P1|COMPLETED|First Intervention (1 Day)||12
4960420|NCT02714400|12202000|P2|STARTED|First Intervention (1 Day)||8
4960421|NCT02714400|12202001|P1|STARTED|First Intervention (1 Day)||12
4960422|NCT02714283|12202017|P2|NOT COMPLETED|Overall Study||0
4960423|NCT02714283|12202018|P1|NOT COMPLETED|Overall Study||0
4960424|NCT02714283|12202017|P2|COMPLETED|Overall Study||6500
4960425|NCT02714283|12202018|P1|COMPLETED|Overall Study||83589
4960426|NCT02714283|12202017|P2|STARTED|Overall Study||6500
4960427|NCT02714283|12202018|P1|STARTED|Overall Study||83589
4960428|NCT02714218|12202045|P3|NOT COMPLETED|Overall Study||19
4960429|NCT02714218|12202046|P2|NOT COMPLETED|Overall Study||143
4960430|NCT02714218|12202047|P1|NOT COMPLETED|Overall Study||130
4960431|NCT02714218|12202045|P3|COMPLETED|Overall Study||8
4960432|NCT02714218|12202046|P2|COMPLETED|Overall Study||35
4960433|NCT02714218|12202047|P1|COMPLETED|Overall Study||50
4960434|NCT02714218|12202045|P3|STARTED|Overall Study||27
4960435|NCT02714218|12202046|P2|STARTED|Overall Study||178
4960436|NCT02714218|12202047|P1|STARTED|Overall Study||180
4960437|NCT02714062|12202097|P3|NOT COMPLETED|Overall Study||3
4960438|NCT02714062|12202098|P2|NOT COMPLETED|Overall Study||1
4960439|NCT02714062|12202099|P1|NOT COMPLETED|Overall Study||1
4960440|NCT02714062|12202097|P3|COMPLETED|Overall Study||10
4960441|NCT02714062|12202098|P2|COMPLETED|Overall Study||14
4960442|NCT02714062|12202099|P1|COMPLETED|Overall Study||13
4960443|NCT02714062|12202097|P3|STARTED|Overall Study||13
4960444|NCT02714062|12202098|P2|STARTED|Overall Study||15
4960445|NCT02714062|12202099|P1|STARTED|Overall Study||14
4960446|NCT02713867|12202145|P2|NOT COMPLETED|Treatment Period||150
4960447|NCT02713867|12202146|P1|NOT COMPLETED|Treatment Period||147
4960448|NCT02713867|12202145|P2|COMPLETED|Treatment Period||30
4960449|NCT02713867|12202146|P1|COMPLETED|Treatment Period||31
4960450|NCT02713867|12202145|P2|STARTED|Treatment Period||180
4960451|NCT02713867|12202146|P1|STARTED|Treatment Period||178
4960452|NCT02713867|12202145|P2|NOT COMPLETED|Randomization||3
4960453|NCT02713867|12202146|P1|NOT COMPLETED|Randomization||2
4960454|NCT02713867|12202145|P2|COMPLETED|Randomization||180
4960455|NCT02713867|12202146|P1|COMPLETED|Randomization||178
4960456|NCT02713867|12202145|P2|STARTED|Randomization||183
4960457|NCT02713867|12202146|P1|STARTED|Randomization||180
4960458|NCT02713828|12202184|P2|NOT COMPLETED|Overall Study||0
4960459|NCT02713828|12202185|P1|NOT COMPLETED|Overall Study||5
4960460|NCT02713828|12202184|P2|COMPLETED|Overall Study||0
4960461|NCT02713828|12202185|P1|COMPLETED|Overall Study||8
4960462|NCT02713828|12202184|P2|STARTED|Overall Study||0
4960463|NCT02713828|12202185|P1|STARTED|Overall Study||13
4960464|NCT02713789|12202197|P3|NOT COMPLETED|Overall Study||1
4960465|NCT02713789|12202198|P2|NOT COMPLETED|Overall Study||1
4960466|NCT02713789|12202199|P1|NOT COMPLETED|Overall Study||0
4960467|NCT02713789|12202197|P3|COMPLETED|Overall Study||7
4960468|NCT02713789|12202198|P2|COMPLETED|Overall Study||9
4960469|NCT02713789|12202199|P1|COMPLETED|Overall Study||8
4960470|NCT02713789|12202197|P3|STARTED|Overall Study||8
4960471|NCT02713789|12202198|P2|STARTED|Overall Study||10
4960472|NCT02713789|12202199|P1|STARTED|Overall Study||8
4960473|NCT02713698|12202237|P3|NOT COMPLETED|Overall Study||0
4960474|NCT02713698|12202238|P2|NOT COMPLETED|Overall Study||0
4960475|NCT02713698|12202239|P1|NOT COMPLETED|Overall Study||0
4960476|NCT02713698|12202237|P3|COMPLETED|Overall Study||20
4960477|NCT02713698|12202238|P2|COMPLETED|Overall Study||20
4960478|NCT02713698|12202239|P1|COMPLETED|Overall Study||20
4960479|NCT02713698|12202237|P3|STARTED|Overall Study||20
4960480|NCT02713698|12202238|P2|STARTED|Overall Study||20
4960481|NCT02713698|12202239|P1|STARTED|Overall Study||20
4960482|NCT02713659|12202249|P2|NOT COMPLETED|24 Month Study Visit||8
4960483|NCT02713659|12202250|P1|NOT COMPLETED|24 Month Study Visit||8
4960484|NCT02713659|12202249|P2|COMPLETED|24 Month Study Visit||44
4960485|NCT02713659|12202250|P1|COMPLETED|24 Month Study Visit||49
4960486|NCT02713659|12202249|P2|STARTED|24 Month Study Visit||52
4960487|NCT02713659|12202250|P1|STARTED|24 Month Study Visit||57
4960488|NCT02713659|12202249|P2|NOT COMPLETED|18 Month Study Visit||3
4960489|NCT02713659|12202250|P1|NOT COMPLETED|18 Month Study Visit||8
4960490|NCT02713659|12202249|P2|COMPLETED|18 Month Study Visit||50
4960491|NCT02713659|12202250|P1|COMPLETED|18 Month Study Visit||50
4960492|NCT02713659|12202249|P2|STARTED|18 Month Study Visit||53
4960493|NCT02713659|12202250|P1|STARTED|18 Month Study Visit||58
4960494|NCT02713659|12202249|P2|NOT COMPLETED|12 Month Study Visit||3
4960495|NCT02713659|12202250|P1|NOT COMPLETED|12 Month Study Visit||3
4960496|NCT02713659|12202249|P2|COMPLETED|12 Month Study Visit||52
4960497|NCT02713659|12202250|P1|COMPLETED|12 Month Study Visit||54
4960498|NCT02713659|12202249|P2|STARTED|12 Month Study Visit||55
4960499|NCT02713659|12202250|P1|STARTED|12 Month Study Visit||57
4960500|NCT02713659|12202249|P2|NOT COMPLETED|6 Month Study Visit||13
4960501|NCT02713659|12202250|P1|NOT COMPLETED|6 Month Study Visit||7
4960502|NCT02713659|12202249|P2|COMPLETED|6 Month Study Visit||47
4960503|NCT02713659|12202250|P1|COMPLETED|6 Month Study Visit||53
4960504|NCT02713659|12202249|P2|STARTED|6 Month Study Visit||60
4960505|NCT02713659|12202250|P1|STARTED|6 Month Study Visit||60
4960506|NCT02713659|12202249|P2|NOT COMPLETED|Baseline||0
4960507|NCT02713659|12202250|P1|NOT COMPLETED|Baseline||0
4960508|NCT02713659|12202249|P2|COMPLETED|Baseline||60
4960509|NCT02713659|12202250|P1|COMPLETED|Baseline||60
4960510|NCT02713659|12202249|P2|STARTED|Baseline||60
4960511|NCT02713659|12202250|P1|STARTED|Baseline||60
4960512|NCT02713594|12202262|P2|NOT COMPLETED|Overall Study||396
4960513|NCT02713594|12202263|P1|NOT COMPLETED|Overall Study||390
4960514|NCT02713594|12202262|P2|COMPLETED|Overall Study||552
4960515|NCT02713594|12202263|P1|COMPLETED|Overall Study||562
4960516|NCT02713594|12202262|P2|STARTED|Overall Study||948
4960517|NCT02713594|12202263|P1|STARTED|Overall Study||952
4960518|NCT02713542|12202275|P2|NOT COMPLETED|Overall Study||6
4960519|NCT02713542|12202276|P1|NOT COMPLETED|Overall Study||18
4960520|NCT02713542|12202275|P2|COMPLETED|Overall Study||24
4960521|NCT02713542|12202276|P1|COMPLETED|Overall Study||42
4960522|NCT02713542|12202275|P2|STARTED|Overall Study||30
4960523|NCT02713542|12202276|P1|STARTED|Overall Study||60
4960524|NCT02713529|12202289|P7|NOT COMPLETED|Overall Study||4
4960525|NCT02713529|12202290|P6|NOT COMPLETED|Overall Study||14
4960526|NCT02713529|12202291|P5|NOT COMPLETED|Overall Study||3
4960527|NCT02713529|12202292|P4|NOT COMPLETED|Overall Study||29
4960528|NCT02713529|12202293|P3|NOT COMPLETED|Overall Study||31
4960529|NCT02713529|12202294|P2|NOT COMPLETED|Overall Study||4
4960530|NCT02713529|12202295|P1|NOT COMPLETED|Overall Study||7
4960531|NCT02713529|12202289|P7|COMPLETED|Overall Study||2
4960532|NCT02713529|12202290|P6|COMPLETED|Overall Study||5
4960533|NCT02713529|12202291|P5|COMPLETED|Overall Study||1
4960534|NCT02713529|12202292|P4|COMPLETED|Overall Study||2
4960535|NCT02713529|12202293|P3|COMPLETED|Overall Study||11
4960536|NCT02713529|12202294|P2|COMPLETED|Overall Study||3
4960537|NCT02713529|12202295|P1|COMPLETED|Overall Study||1
4960538|NCT02713529|12202289|P7|STARTED|Overall Study||6
4960539|NCT02713529|12202290|P6|STARTED|Overall Study||19
4960540|NCT02713529|12202291|P5|STARTED|Overall Study||4
4960541|NCT02713529|12202292|P4|STARTED|Overall Study||31
4960542|NCT02713529|12202293|P3|STARTED|Overall Study||42
4960543|NCT02713529|12202294|P2|STARTED|Overall Study||7
4960544|NCT02713529|12202295|P1|STARTED|Overall Study||8
4960545|NCT02713425|12202375|P1|NOT COMPLETED|Overall Study||0
4960546|NCT02713425|12202375|P1|COMPLETED|Overall Study||20
4960547|NCT02713425|12202375|P1|STARTED|Overall Study||20
4960548|NCT02713256|12202380|P1|NOT COMPLETED|Overall Study||0
4960549|NCT02713256|12202380|P1|COMPLETED|Overall Study||15
4960550|NCT02713256|12202380|P1|STARTED|Overall Study||15
4960551|NCT02713243|12202388|P2|NOT COMPLETED|Overall Study||2
4960552|NCT02713243|12202389|P1|NOT COMPLETED|Overall Study||1
4960553|NCT02713243|12202388|P2|COMPLETED|Overall Study||8
4960554|NCT02713243|12202389|P1|COMPLETED|Overall Study||9
4960555|NCT02713243|12202388|P2|PK Analysis Set|Overall Study||9
4960556|NCT02713243|12202389|P1|PK Analysis Set|Overall Study||8
4960557|NCT02713243|12202388|P2|PD Analysis Set|Overall Study||10
4960558|NCT02713243|12202389|P1|PD Analysis Set|Overall Study||9
4960559|NCT02713243|12202388|P2|STARTED|Overall Study||10
4960560|NCT02713243|12202389|P1|STARTED|Overall Study||10
4960561|NCT02713204|12202407|P8|NOT COMPLETED|From Week 12 up to Week 36||4
4960562|NCT02713204|12202408|P7|NOT COMPLETED|From Week 12 up to Week 36||2
4960563|NCT02713204|12202409|P6|NOT COMPLETED|From Week 12 up to Week 36||1
4960564|NCT02713204|12202410|P5|NOT COMPLETED|From Week 12 up to Week 36||2
4960565|NCT02713204|12202411|P4|NOT COMPLETED|From Week 12 up to Week 36||4
4960566|NCT02713204|12202412|P3|NOT COMPLETED|From Week 12 up to Week 36||0
4960567|NCT02713204|12202413|P2|NOT COMPLETED|From Week 12 up to Week 36||0
4960568|NCT02713204|12202414|P1|NOT COMPLETED|From Week 12 up to Week 36||1
4960569|NCT02713204|12202407|P8|COMPLETED|From Week 12 up to Week 36||54
4960570|NCT02713204|12202408|P7|COMPLETED|From Week 12 up to Week 36||60
4960571|NCT02713204|12202409|P6|COMPLETED|From Week 12 up to Week 36||59
4960572|NCT02713204|12202410|P5|COMPLETED|From Week 12 up to Week 36||60
4960573|NCT02713204|12202411|P4|COMPLETED|From Week 12 up to Week 36||53
4960574|NCT02713204|12202412|P3|COMPLETED|From Week 12 up to Week 36||0
4960575|NCT02713204|12202413|P2|COMPLETED|From Week 12 up to Week 36||0
4960576|NCT02713204|12202414|P1|COMPLETED|From Week 12 up to Week 36||57
4960577|NCT02713204|12202407|P8|STARTED|From Week 12 up to Week 36||58
4960578|NCT02713204|12202408|P7|STARTED|From Week 12 up to Week 36||62
4960579|NCT02713204|12202409|P6|STARTED|From Week 12 up to Week 36||60
4960580|NCT02713204|12202410|P5|STARTED|From Week 12 up to Week 36||62
4960581|NCT02713204|12202411|P4|STARTED|From Week 12 up to Week 36||57
4960582|NCT02713204|12202412|P3|STARTED|From Week 12 up to Week 36||0
4960583|NCT02713204|12202413|P2|STARTED|From Week 12 up to Week 36||0
4960584|NCT02713204|12202414|P1|STARTED|From Week 12 up to Week 36||58
4960585|NCT02713204|12202407|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960586|NCT02713204|12202408|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960587|NCT02713204|12202409|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960588|NCT02713204|12202410|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960589|NCT02713204|12202411|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960590|NCT02713204|12202412|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
4960591|NCT02713204|12202413|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
4960592|NCT02713204|12202414|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
4960593|NCT02713204|12202407|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
4960594|NCT02713204|12202408|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
4960595|NCT02713204|12202409|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
4960596|NCT02713204|12202410|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
4960597|NCT02713204|12202411|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
4960598|NCT02713204|12202412|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
4960599|NCT02713204|12202413|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
4960600|NCT02713204|12202414|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
4960601|NCT02713204|12202407|P8|STARTED|Baseline (Day 1) up to Week 12||0
4960602|NCT02713204|12202408|P7|STARTED|Baseline (Day 1) up to Week 12||0
4960603|NCT02713204|12202409|P6|STARTED|Baseline (Day 1) up to Week 12||0
4960604|NCT02713204|12202410|P5|STARTED|Baseline (Day 1) up to Week 12||0
4960605|NCT02713204|12202411|P4|STARTED|Baseline (Day 1) up to Week 12||0
4960606|NCT02713204|12202412|P3|STARTED|Baseline (Day 1) up to Week 12||183
4960607|NCT02713204|12202413|P2|STARTED|Baseline (Day 1) up to Week 12||122
4960608|NCT02713204|12202414|P1|STARTED|Baseline (Day 1) up to Week 12||60
4960609|NCT02712996|12202473|P2|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
4960610|NCT02712996|12202474|P1|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
4960611|NCT02712996|12202473|P2|COMPLETED|Second Intervention (Study Days 43-84)||8
4960612|NCT02712996|12202474|P1|COMPLETED|Second Intervention (Study Days 43-84)||8
4960613|NCT02712996|12202473|P2|STARTED|Second Intervention (Study Days 43-84)||9
4960614|NCT02712996|12202474|P1|STARTED|Second Intervention (Study Days 43-84)||8
4960615|NCT02712996|12202473|P2|NOT COMPLETED|First Intervention (Study Days 1-42)||0
4960616|NCT02712996|12202474|P1|NOT COMPLETED|First Intervention (Study Days 1-42)||0
4960617|NCT02712996|12202473|P2|COMPLETED|First Intervention (Study Days 1-42)||9
4960618|NCT02712996|12202474|P1|COMPLETED|First Intervention (Study Days 1-42)||8
4960619|NCT02712996|12202473|P2|STARTED|First Intervention (Study Days 1-42)||9
4960620|NCT02712996|12202474|P1|STARTED|First Intervention (Study Days 1-42)||8
4960621|NCT02712788|12202526|P2|NOT COMPLETED|Overall Study||0
4960622|NCT02712788|12202527|P1|NOT COMPLETED|Overall Study||2
4960623|NCT02712788|12202526|P2|COMPLETED|Overall Study||2
4960624|NCT02712788|12202527|P1|COMPLETED|Overall Study||0
4960625|NCT02712788|12202526|P2|STARTED|Overall Study||2
4960626|NCT02712788|12202527|P1|STARTED|Overall Study||2
4960627|NCT02712554|12202537|P2|NOT COMPLETED|Part B: Treatment Phase||3
4960628|NCT02712554|12202538|P1|NOT COMPLETED|Part B: Treatment Phase||0
4960629|NCT02712554|12202537|P2|COMPLETED|Part B: Treatment Phase||37
4960630|NCT02712554|12202538|P1|COMPLETED|Part B: Treatment Phase||0
4960631|NCT02712554|12202537|P2|STARTED|Part B: Treatment Phase||40
4960632|NCT02712554|12202538|P1|STARTED|Part B: Treatment Phase||0
4960633|NCT02712554|12202537|P2|NOT COMPLETED|Part B: Qualification Phase||21
4960634|NCT02712554|12202538|P1|NOT COMPLETED|Part B: Qualification Phase||0
4960635|NCT02712554|12202537|P2|COMPLETED|Part B: Qualification Phase||40
4960636|NCT02712554|12202538|P1|COMPLETED|Part B: Qualification Phase||0
4960637|NCT02712554|12202537|P2|STARTED|Part B: Qualification Phase||61
4960638|NCT02712554|12202538|P1|STARTED|Part B: Qualification Phase||0
4960639|NCT02712554|12202537|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
4960640|NCT02712554|12202538|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
4960641|NCT02712554|12202537|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
4960642|NCT02712554|12202538|P1|COMPLETED|Part A: Dose Selection Phase||12
4960643|NCT02712554|12202537|P2|STARTED|Part A: Dose Selection Phase||0
4960644|NCT02712554|12202538|P1|STARTED|Part A: Dose Selection Phase||12
4960645|NCT02712359|12202660|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
4960646|NCT02712359|12202661|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
4960647|NCT02712359|12202662|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
4960648|NCT02712359|12202663|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
4960649|NCT02712359|12202660|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
4960650|NCT02712359|12202661|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
4960651|NCT02712359|12202662|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
4960652|NCT02712359|12202663|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
4960653|NCT02712359|12202660|P4|STARTED|Epoch 002: Persistence at Year 10||300
4960654|NCT02712359|12202661|P3|STARTED|Epoch 002: Persistence at Year 10||299
4960655|NCT02712359|12202662|P2|STARTED|Epoch 002: Persistence at Year 10||0
4960656|NCT02712359|12202663|P1|STARTED|Epoch 002: Persistence at Year 10||0
4960657|NCT02712359|12202660|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
4960658|NCT02712359|12202661|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
4960659|NCT02712359|12202662|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
4960660|NCT02712359|12202663|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
4960661|NCT02712359|12202660|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
4960662|NCT02712359|12202661|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
4960663|NCT02712359|12202662|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
4960664|NCT02712359|12202663|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
4960665|NCT02712359|12202660|P4|STARTED|Epoch 001: Persistence at Year 8||0
4960666|NCT02712359|12202661|P3|STARTED|Epoch 001: Persistence at Year 8||0
4960667|NCT02712359|12202662|P2|STARTED|Epoch 001: Persistence at Year 8||300
4960668|NCT02712359|12202663|P1|STARTED|Epoch 001: Persistence at Year 8||300
4960669|NCT02712333|12202683|P2|NOT COMPLETED|Second Period||0
4960670|NCT02712333|12202684|P1|NOT COMPLETED|Second Period||0
4960671|NCT02712333|12202683|P2|COMPLETED|Second Period||24
4960672|NCT02712333|12202684|P1|COMPLETED|Second Period||31
4960673|NCT02712333|12202683|P2|STARTED|Second Period||24
4960674|NCT02712333|12202684|P1|STARTED|Second Period||31
4960675|NCT02712333|12202683|P2|NOT COMPLETED|First Period||2
4960676|NCT02712333|12202684|P1|NOT COMPLETED|First Period||3
4960677|NCT02712333|12202683|P2|COMPLETED|First Period||24
4960678|NCT02712333|12202684|P1|COMPLETED|First Period||31
4960679|NCT02712333|12202683|P2|STARTED|First Period||26
4960680|NCT02712333|12202684|P1|STARTED|First Period||34
4960681|NCT02712320|12202702|P1|NOT COMPLETED|Overall Study||5
4960682|NCT02712320|12202702|P1|COMPLETED|Overall Study||25
4960683|NCT02712320|12202702|P1|STARTED|Overall Study||30
4960684|NCT02712099|12202712|P2|NOT COMPLETED|Overall Study||0
4960685|NCT02712099|12202713|P1|NOT COMPLETED|Overall Study||0
4960686|NCT02712099|12202712|P2|COMPLETED|Overall Study||20
4960687|NCT02712099|12202713|P1|COMPLETED|Overall Study||30
4960688|NCT02712099|12202712|P2|STARTED|Overall Study||20
4960689|NCT02712099|12202713|P1|STARTED|Overall Study||30
4960690|NCT02712047|12202729|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
4960691|NCT02712047|12202730|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
4960692|NCT02712047|12202729|P2|COMPLETED|Treatment Period 2 (35 Days)||13
4960693|NCT02712047|12202730|P1|COMPLETED|Treatment Period 2 (35 Days)||14
4960694|NCT02712047|12202729|P2|STARTED|Treatment Period 2 (35 Days)||13
4960695|NCT02712047|12202730|P1|STARTED|Treatment Period 2 (35 Days)||14
4960696|NCT02712047|12202729|P2|NOT COMPLETED|Washout Period (21 Days)||0
4960697|NCT02712047|12202730|P1|NOT COMPLETED|Washout Period (21 Days)||0
4960698|NCT02712047|12202729|P2|COMPLETED|Washout Period (21 Days)||13
4960699|NCT02712047|12202730|P1|COMPLETED|Washout Period (21 Days)||14
4960700|NCT02712047|12202729|P2|STARTED|Washout Period (21 Days)||13
4960701|NCT02712047|12202730|P1|STARTED|Washout Period (21 Days)||14
4960702|NCT02712047|12202729|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
4960703|NCT02712047|12202730|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
4960704|NCT02712047|12202729|P2|COMPLETED|Treatment Period 1 (35 Days)||13
4960705|NCT02712047|12202730|P1|COMPLETED|Treatment Period 1 (35 Days)||14
4960706|NCT02712047|12202729|P2|STARTED|Treatment Period 1 (35 Days)||13
4960707|NCT02712047|12202730|P1|STARTED|Treatment Period 1 (35 Days)||14
4960708|NCT02712008|12202745|P8|NOT COMPLETED|From Week 12 up to Week 36||4
4960709|NCT02712008|12202746|P7|NOT COMPLETED|From Week 12 up to Week 36||5
4960710|NCT02712008|12202747|P6|NOT COMPLETED|From Week 12 up to Week 36||0
4960711|NCT02712008|12202748|P5|NOT COMPLETED|From Week 12 up to Week 36||2
4960712|NCT02712008|12202749|P4|NOT COMPLETED|From Week 12 up to Week 36||2
4960713|NCT02712008|12202750|P3|NOT COMPLETED|From Week 12 up to Week 36||0
4960714|NCT02712008|12202751|P2|NOT COMPLETED|From Week 12 up to Week 36||0
4960715|NCT02712008|12202752|P1|NOT COMPLETED|From Week 12 up to Week 36||1
4960716|NCT02712008|12202745|P8|COMPLETED|From Week 12 up to Week 36||45
4960717|NCT02712008|12202746|P7|COMPLETED|From Week 12 up to Week 36||43
4960718|NCT02712008|12202747|P6|COMPLETED|From Week 12 up to Week 36||46
4960719|NCT02712008|12202748|P5|COMPLETED|From Week 12 up to Week 36||50
4960720|NCT02712008|12202749|P4|COMPLETED|From Week 12 up to Week 36||42
4960721|NCT02712008|12202750|P3|COMPLETED|From Week 12 up to Week 36||0
4960722|NCT02712008|12202751|P2|COMPLETED|From Week 12 up to Week 36||0
4960723|NCT02712008|12202752|P1|COMPLETED|From Week 12 up to Week 36||44
4960724|NCT02712008|12202745|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
4960725|NCT02712008|12202746|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
4960726|NCT02712008|12202747|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
4960727|NCT02712008|12202748|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
4960728|NCT02712008|12202749|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
4960729|NCT02712008|12202750|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
4960730|NCT02712008|12202751|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
4960731|NCT02712008|12202752|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
4960732|NCT02712008|12202745|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960733|NCT02712008|12202746|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960734|NCT02712008|12202747|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960735|NCT02712008|12202748|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960736|NCT02712008|12202749|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
4960737|NCT02712008|12202750|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
4960738|NCT02712008|12202751|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
4960739|NCT02712008|12202752|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
4960740|NCT02712008|12202745|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
4960741|NCT02712008|12202746|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
4960742|NCT02712008|12202747|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
4960743|NCT02712008|12202748|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
4960744|NCT02712008|12202749|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
4960745|NCT02712008|12202750|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
4960746|NCT02712008|12202751|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
4960747|NCT02712008|12202752|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
4960748|NCT02712008|12202745|P8|STARTED|Baseline (Day 1) up to Week 12||0
4960749|NCT02712008|12202746|P7|STARTED|Baseline (Day 1) up to Week 12||0
4960750|NCT02712008|12202747|P6|STARTED|Baseline (Day 1) up to Week 12||0
4960751|NCT02712008|12202748|P5|STARTED|Baseline (Day 1) up to Week 12||0
4960752|NCT02712008|12202749|P4|STARTED|Baseline (Day 1) up to Week 12||0
4960753|NCT02712008|12202750|P3|STARTED|Baseline (Day 1) up to Week 12||152
4960754|NCT02712008|12202751|P2|STARTED|Baseline (Day 1) up to Week 12||100
4960755|NCT02712008|12202752|P1|STARTED|Baseline (Day 1) up to Week 12||50
4960756|NCT02711995|12202784|P1|NOT COMPLETED|Second Intervention (30 Days)||0
4960757|NCT02711995|12202784|P1|COMPLETED|Second Intervention (30 Days)||7
4960758|NCT02711995|12202784|P1|STARTED|Second Intervention (30 Days)||7
4960759|NCT02711995|12202784|P1|NOT COMPLETED|Washout (90 Days)||1
4960760|NCT02711995|12202784|P1|COMPLETED|Washout (90 Days)||7
4960761|NCT02711995|12202784|P1|STARTED|Washout (90 Days)||8
4960762|NCT02711995|12202784|P1|NOT COMPLETED|First Intervention (30 Days)||0
4960763|NCT02711995|12202784|P1|COMPLETED|First Intervention (30 Days)||8
4960764|NCT02711995|12202784|P1|STARTED|First Intervention (30 Days)||8
4960765|NCT02711839|12202808|P2|NOT COMPLETED|Overall Study||10
4960766|NCT02711839|12202809|P1|NOT COMPLETED|Overall Study||4
4960767|NCT02711839|12202808|P2|COMPLETED|Overall Study||24
4960768|NCT02711839|12202809|P1|COMPLETED|Overall Study||16
4960769|NCT02711839|12202808|P2|STARTED|Overall Study||34
4960770|NCT02711839|12202809|P1|STARTED|Overall Study||20
4960771|NCT02711800|12202823|P1|NOT COMPLETED|Overall Study||2
4960772|NCT02711800|12202823|P1|COMPLETED|Overall Study||7
4960773|NCT02711800|12202823|P1|STARTED|Overall Study||9
4960774|NCT02711345|12202842|P10|NOT COMPLETED|Overall Study||12
4960775|NCT02711345|12202843|P9|NOT COMPLETED|Overall Study||6
4960776|NCT02711345|12202844|P8|NOT COMPLETED|Overall Study||6
4960777|NCT02711345|12202845|P7|NOT COMPLETED|Overall Study||12
4960778|NCT02711345|12202846|P6|NOT COMPLETED|Overall Study||6
4960779|NCT02711345|12202847|P5|NOT COMPLETED|Overall Study||8
4960780|NCT02711345|12202848|P4|NOT COMPLETED|Overall Study||4
4960781|NCT02711345|12202849|P3|NOT COMPLETED|Overall Study||6
4960782|NCT02711345|12202850|P2|NOT COMPLETED|Overall Study||3
4960783|NCT02711345|12202851|P1|NOT COMPLETED|Overall Study||2
4960784|NCT02711345|12202842|P10|COMPLETED|Overall Study||0
4960785|NCT02711345|12202843|P9|COMPLETED|Overall Study||0
4960786|NCT02711345|12202844|P8|COMPLETED|Overall Study||0
4960787|NCT02711345|12202845|P7|COMPLETED|Overall Study||0
4960788|NCT02711345|12202846|P6|COMPLETED|Overall Study||0
4960789|NCT02711345|12202847|P5|COMPLETED|Overall Study||0
4960790|NCT02711345|12202848|P4|COMPLETED|Overall Study||0
4960791|NCT02711345|12202849|P3|COMPLETED|Overall Study||0
4960792|NCT02711345|12202850|P2|COMPLETED|Overall Study||0
4960793|NCT02711345|12202851|P1|COMPLETED|Overall Study||0
4960794|NCT02711345|12202842|P10|STARTED|Overall Study||12
4960795|NCT02711345|12202843|P9|STARTED|Overall Study||6
4960796|NCT02711345|12202844|P8|STARTED|Overall Study||6
4960797|NCT02711345|12202845|P7|STARTED|Overall Study||12
4960798|NCT02711345|12202846|P6|STARTED|Overall Study||6
4960799|NCT02711345|12202847|P5|STARTED|Overall Study||8
4960800|NCT02711345|12202848|P4|STARTED|Overall Study||4
4960801|NCT02711345|12202849|P3|STARTED|Overall Study||6
4960802|NCT02711345|12202850|P2|STARTED|Overall Study||3
4960803|NCT02711345|12202851|P1|STARTED|Overall Study||2
4960804|NCT02711306|12203037|P2|NOT COMPLETED|Overall Study||2
4960805|NCT02711306|12203038|P1|NOT COMPLETED|Overall Study||2
4960806|NCT02711306|12203037|P2|COMPLETED|Overall Study||16
4960807|NCT02711306|12203038|P1|COMPLETED|Overall Study||16
4960808|NCT02711306|12203037|P2|STARTED|Overall Study||18
4960809|NCT02711306|12203038|P1|STARTED|Overall Study||18
4960810|NCT02710981|12203050|P2|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
4960811|NCT02710981|12203051|P1|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
4960812|NCT02710981|12203050|P2|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
4960813|NCT02710981|12203051|P1|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
4960814|NCT02710981|12203050|P2|STARTED|7th Ovulation Induction Cycle (5 Days)||41
4960815|NCT02710981|12203051|P1|STARTED|7th Ovulation Induction Cycle (5 Days)||0
4960816|NCT02710981|12203050|P2|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
4960817|NCT02710981|12203051|P1|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
4960818|NCT02710981|12203050|P2|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
4960819|NCT02710981|12203051|P1|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
4960820|NCT02710981|12203050|P2|STARTED|6th Ovulation Induction Cycle (5 Days)||0
4960821|NCT02710981|12203051|P1|STARTED|6th Ovulation Induction Cycle (5 Days)||42
4960822|NCT02710890|12203063|P2|NOT COMPLETED|Overall Study||0
4960823|NCT02710890|12203064|P1|NOT COMPLETED|Overall Study||0
4960824|NCT02710890|12203063|P2|COMPLETED|Overall Study||55
4960825|NCT02710890|12203064|P1|COMPLETED|Overall Study||48
4960826|NCT02710890|12203063|P2|STARTED|Overall Study||55
4960827|NCT02710890|12203064|P1|STARTED|Overall Study||48
4960828|NCT02710630|12203077|P5|NOT COMPLETED|Period 6||0
4960829|NCT02710630|12203078|P4|NOT COMPLETED|Period 6||0
4960830|NCT02710630|12203079|P3|NOT COMPLETED|Period 6||0
4960831|NCT02710630|12203080|P2|NOT COMPLETED|Period 6||0
4960832|NCT02710630|12203081|P1|NOT COMPLETED|Period 6||0
4960833|NCT02710630|12203077|P5|COMPLETED|Period 6||7
4960834|NCT02710630|12203078|P4|COMPLETED|Period 6||7
4960835|NCT02710630|12203079|P3|COMPLETED|Period 6||7
4960836|NCT02710630|12203080|P2|COMPLETED|Period 6||7
4960837|NCT02710630|12203081|P1|COMPLETED|Period 6||7
4960838|NCT02710630|12203077|P5|STARTED|Period 6||7
4960839|NCT02710630|12203078|P4|STARTED|Period 6||7
4960840|NCT02710630|12203079|P3|STARTED|Period 6||7
4960841|NCT02710630|12203080|P2|STARTED|Period 6||7
4960842|NCT02710630|12203081|P1|STARTED|Period 6||7
4960843|NCT02710630|12203077|P5|NOT COMPLETED|Period 5||0
4960844|NCT02710630|12203078|P4|NOT COMPLETED|Period 5||0
4960845|NCT02710630|12203079|P3|NOT COMPLETED|Period 5||0
4960846|NCT02710630|12203080|P2|NOT COMPLETED|Period 5||0
4960847|NCT02710630|12203081|P1|NOT COMPLETED|Period 5||0
4960848|NCT02710630|12203077|P5|COMPLETED|Period 5||7
4960849|NCT02710630|12203078|P4|COMPLETED|Period 5||7
4960850|NCT02710630|12203079|P3|COMPLETED|Period 5||7
4960851|NCT02710630|12203080|P2|COMPLETED|Period 5||7
4960852|NCT02710630|12203081|P1|COMPLETED|Period 5||7
4960853|NCT02710630|12203077|P5|STARTED|Period 5||7
4960854|NCT02710630|12203078|P4|STARTED|Period 5||7
4960855|NCT02710630|12203079|P3|STARTED|Period 5||7
4960856|NCT02710630|12203080|P2|STARTED|Period 5||7
4960857|NCT02710630|12203081|P1|STARTED|Period 5||7
4960858|NCT02710630|12203077|P5|NOT COMPLETED|Period 4||0
4960859|NCT02710630|12203078|P4|NOT COMPLETED|Period 4||0
4960860|NCT02710630|12203079|P3|NOT COMPLETED|Period 4||0
4960861|NCT02710630|12203080|P2|NOT COMPLETED|Period 4||0
4960862|NCT02710630|12203081|P1|NOT COMPLETED|Period 4||0
4960863|NCT02710630|12203077|P5|COMPLETED|Period 4||7
4960864|NCT02710630|12203078|P4|COMPLETED|Period 4||7
4960865|NCT02710630|12203079|P3|COMPLETED|Period 4||7
4960866|NCT02710630|12203080|P2|COMPLETED|Period 4||7
4960867|NCT02710630|12203081|P1|COMPLETED|Period 4||7
4960868|NCT02710630|12203077|P5|STARTED|Period 4||7
4960869|NCT02710630|12203078|P4|STARTED|Period 4||7
4960870|NCT02710630|12203079|P3|STARTED|Period 4||7
4960871|NCT02710630|12203080|P2|STARTED|Period 4||7
4960872|NCT02710630|12203081|P1|STARTED|Period 4||7
4960873|NCT02710630|12203077|P5|NOT COMPLETED|Period 3||0
4960874|NCT02710630|12203078|P4|NOT COMPLETED|Period 3||0
4960875|NCT02710630|12203079|P3|NOT COMPLETED|Period 3||0
4960876|NCT02710630|12203080|P2|NOT COMPLETED|Period 3||0
4960877|NCT02710630|12203081|P1|NOT COMPLETED|Period 3||0
4960878|NCT02710630|12203077|P5|COMPLETED|Period 3||7
4960879|NCT02710630|12203078|P4|COMPLETED|Period 3||7
4960880|NCT02710630|12203079|P3|COMPLETED|Period 3||7
4960881|NCT02710630|12203080|P2|COMPLETED|Period 3||7
4960882|NCT02710630|12203081|P1|COMPLETED|Period 3||7
4960883|NCT02710630|12203077|P5|STARTED|Period 3||7
4960884|NCT02710630|12203078|P4|STARTED|Period 3||7
4960885|NCT02710630|12203079|P3|STARTED|Period 3||7
4960886|NCT02710630|12203080|P2|STARTED|Period 3||7
4960887|NCT02710630|12203081|P1|STARTED|Period 3||7
4960888|NCT02710630|12203077|P5|NOT COMPLETED|Period 2||0
4960889|NCT02710630|12203078|P4|NOT COMPLETED|Period 2||0
4960890|NCT02710630|12203079|P3|NOT COMPLETED|Period 2||0
4960891|NCT02710630|12203080|P2|NOT COMPLETED|Period 2||0
4960892|NCT02710630|12203081|P1|NOT COMPLETED|Period 2||0
4960893|NCT02710630|12203077|P5|COMPLETED|Period 2||7
4960894|NCT02710630|12203078|P4|COMPLETED|Period 2||7
4960895|NCT02710630|12203079|P3|COMPLETED|Period 2||7
4960896|NCT02710630|12203080|P2|COMPLETED|Period 2||7
4960897|NCT02710630|12203081|P1|COMPLETED|Period 2||7
4960898|NCT02710630|12203077|P5|Not Treated|Period 2||0
4960899|NCT02710630|12203078|P4|Not Treated|Period 2||0
4960900|NCT02710630|12203079|P3|Not Treated|Period 2||0
4960901|NCT02710630|12203080|P2|Not Treated|Period 2||0
4960902|NCT02710630|12203081|P1|Not Treated|Period 2||1
4960903|NCT02710630|12203077|P5|STARTED|Period 2||7
4960904|NCT02710630|12203078|P4|STARTED|Period 2||7
4960905|NCT02710630|12203079|P3|STARTED|Period 2||7
4960906|NCT02710630|12203080|P2|STARTED|Period 2||7
4960907|NCT02710630|12203081|P1|STARTED|Period 2||7
4960908|NCT02710630|12203077|P5|NOT COMPLETED|Period 1||0
4960909|NCT02710630|12203078|P4|NOT COMPLETED|Period 1||0
4960910|NCT02710630|12203079|P3|NOT COMPLETED|Period 1||0
4960911|NCT02710630|12203080|P2|NOT COMPLETED|Period 1||0
4960912|NCT02710630|12203081|P1|NOT COMPLETED|Period 1||0
4960913|NCT02710630|12203077|P5|COMPLETED|Period 1||7
4960914|NCT02710630|12203078|P4|COMPLETED|Period 1||7
4960915|NCT02710630|12203079|P3|COMPLETED|Period 1||7
4960916|NCT02710630|12203080|P2|COMPLETED|Period 1||7
4960917|NCT02710630|12203081|P1|COMPLETED|Period 1||7
4960918|NCT02710630|12203077|P5|STARTED|Period 1||7
4960919|NCT02710630|12203078|P4|STARTED|Period 1||7
4960920|NCT02710630|12203079|P3|STARTED|Period 1||7
4960921|NCT02710630|12203080|P2|STARTED|Period 1||7
4960922|NCT02710630|12203081|P1|STARTED|Period 1||7
4960923|NCT02710591|12203129|P4|NOT COMPLETED|Overall Study||0
4960924|NCT02710591|12203130|P3|NOT COMPLETED|Overall Study||0
4960925|NCT02710591|12203131|P2|NOT COMPLETED|Overall Study||0
4960926|NCT02710591|12203132|P1|NOT COMPLETED|Overall Study||0
4960927|NCT02710591|12203129|P4|COMPLETED|Overall Study||5
4960928|NCT02710591|12203130|P3|COMPLETED|Overall Study||5
4960929|NCT02710591|12203131|P2|COMPLETED|Overall Study||5
4960930|NCT02710591|12203132|P1|COMPLETED|Overall Study||5
4960931|NCT02710591|12203129|P4|STARTED|Overall Study||5
4960932|NCT02710591|12203130|P3|STARTED|Overall Study||5
4960933|NCT02710591|12203131|P2|STARTED|Overall Study||5
4960934|NCT02710591|12203132|P1|STARTED|Overall Study||5
4960935|NCT02710526|12203149|P3|NOT COMPLETED|Safety Extension||0
4960936|NCT02710526|12203150|P2|NOT COMPLETED|Safety Extension||0
4960937|NCT02710526|12203151|P1|NOT COMPLETED|Safety Extension||1
4960938|NCT02710526|12203149|P3|COMPLETED|Safety Extension||0
4960939|NCT02710526|12203150|P2|COMPLETED|Safety Extension||12
4960940|NCT02710526|12203151|P1|COMPLETED|Safety Extension||14
4960941|NCT02710526|12203149|P3|STARTED|Safety Extension||0
4960942|NCT02710526|12203150|P2|STARTED|Safety Extension||12
4960943|NCT02710526|12203151|P1|STARTED|Safety Extension||15
4960944|NCT02710526|12203149|P3|NOT COMPLETED|Treatment Phase||6
4960945|NCT02710526|12203150|P2|NOT COMPLETED|Treatment Phase||4
4960946|NCT02710526|12203151|P1|NOT COMPLETED|Treatment Phase||6
4960947|NCT02710526|12203149|P3|COMPLETED|Treatment Phase||12
4960948|NCT02710526|12203150|P2|COMPLETED|Treatment Phase||16
4960949|NCT02710526|12203151|P1|COMPLETED|Treatment Phase||22
4960950|NCT02710526|12203149|P3|STARTED|Treatment Phase||18
4960951|NCT02710526|12203150|P2|STARTED|Treatment Phase||20
4960952|NCT02710526|12203151|P1|STARTED|Treatment Phase||28
4960953|NCT02710422|12203231|P2|NOT COMPLETED|Overall Study||9
4960954|NCT02710422|12203232|P1|NOT COMPLETED|Overall Study||9
4960955|NCT02710422|12203231|P2|COMPLETED|Overall Study||3
4960956|NCT02710422|12203232|P1|COMPLETED|Overall Study||3
4960957|NCT02710422|12203231|P2|12 Month Visit|Overall Study||3
4960958|NCT02710422|12203232|P1|12 Month Visit|Overall Study||3
4960959|NCT02710422|12203231|P2|9 Month Visit|Overall Study||5
4960960|NCT02710422|12203232|P1|9 Month Visit|Overall Study||5
4960961|NCT02710422|12203231|P2|6 Month Visit|Overall Study||8
4960962|NCT02710422|12203232|P1|6 Month Visit|Overall Study||7
4960963|NCT02710422|12203231|P2|3 Month Visit|Overall Study||11
4960964|NCT02710422|12203232|P1|3 Month Visit|Overall Study||9
4960965|NCT02710422|12203231|P2|STARTED|Overall Study||12
4960966|NCT02710422|12203232|P1|STARTED|Overall Study||12
4960967|NCT02710292|12203248|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
4960968|NCT02710292|12203249|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
4960969|NCT02710292|12203248|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
4960970|NCT02710292|12203249|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
4960971|NCT02710292|12203248|P2|STARTED|Period 2, Second 10 Days of Wear||49
4960972|NCT02710292|12203249|P1|STARTED|Period 2, Second 10 Days of Wear||46
4960973|NCT02710292|12203248|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
4960974|NCT02710292|12203249|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
4960975|NCT02710292|12203248|P2|COMPLETED|Period 1, First 10 Days of Wear||49
4960976|NCT02710292|12203249|P1|COMPLETED|Period 1, First 10 Days of Wear||46
4960977|NCT02710292|12203248|P2|STARTED|Period 1, First 10 Days of Wear||52
4960978|NCT02710292|12203249|P1|STARTED|Period 1, First 10 Days of Wear||47
4960979|NCT02710214|12203258|P2|NOT COMPLETED|Overall Study||2
4960980|NCT02710214|12203259|P1|NOT COMPLETED|Overall Study||1
4960981|NCT02710214|12203258|P2|COMPLETED|Overall Study||10
4960982|NCT02710214|12203259|P1|COMPLETED|Overall Study||11
4960983|NCT02710214|12203258|P2|STARTED|Overall Study||12
4960984|NCT02710214|12203259|P1|STARTED|Overall Study||12
4960985|NCT02710136|12203293|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
4960986|NCT02710136|12203294|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
4960987|NCT02710136|12203293|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
4960988|NCT02710136|12203294|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
4960989|NCT02710136|12203293|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
4960990|NCT02710136|12203294|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
4960991|NCT02710136|12203293|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
4960992|NCT02710136|12203294|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
4960993|NCT02710136|12203293|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
4960994|NCT02710136|12203294|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
4960995|NCT02710136|12203293|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
4960996|NCT02710136|12203294|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
4960997|NCT02710136|12203293|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
4960998|NCT02710136|12203294|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
4960999|NCT02710136|12203293|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
4961000|NCT02710136|12203294|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
4961001|NCT02710136|12203293|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
4961002|NCT02710136|12203294|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
4961003|NCT02710136|12203293|P2|NOT COMPLETED|Study Enrollment||0
4961004|NCT02710136|12203294|P1|NOT COMPLETED|Study Enrollment||0
4961005|NCT02710136|12203293|P2|COMPLETED|Study Enrollment||25
4961006|NCT02710136|12203294|P1|COMPLETED|Study Enrollment||10
4961007|NCT02710136|12203293|P2|STARTED|Study Enrollment||25
4961008|NCT02710136|12203294|P1|STARTED|Study Enrollment||10
4961009|NCT02710045|12203320|P3|NOT COMPLETED|Overall Study||13
4961010|NCT02710045|12203321|P2|NOT COMPLETED|Overall Study||17
4961011|NCT02710045|12203322|P1|NOT COMPLETED|Overall Study||11
4961012|NCT02710045|12203320|P3|COMPLETED|Overall Study||68
4961013|NCT02710045|12203321|P2|COMPLETED|Overall Study||98
4961014|NCT02710045|12203322|P1|COMPLETED|Overall Study||95
4961015|NCT02710045|12203320|P3|STARTED|Overall Study||81
4961016|NCT02710045|12203321|P2|STARTED|Overall Study||115
4961017|NCT02710045|12203322|P1|STARTED|Overall Study||106
4961018|NCT02709785|12203351|P3|NOT COMPLETED|Overall Study||1
4961019|NCT02709785|12203352|P2|NOT COMPLETED|Overall Study||2
4961020|NCT02709785|12203353|P1|NOT COMPLETED|Overall Study||1
4961021|NCT02709785|12203351|P3|COMPLETED|Overall Study||27
4961022|NCT02709785|12203352|P2|COMPLETED|Overall Study||26
4961023|NCT02709785|12203353|P1|COMPLETED|Overall Study||23
4961024|NCT02709785|12203351|P3|6 Weeks|Overall Study||27
4961025|NCT02709785|12203352|P2|6 Weeks|Overall Study||26
4961026|NCT02709785|12203353|P1|6 Weeks|Overall Study||23
4961027|NCT02709785|12203351|P3|3 Weeks|Overall Study||27
4961028|NCT02709785|12203352|P2|3 Weeks|Overall Study||27
4961029|NCT02709785|12203353|P1|3 Weeks|Overall Study||23
4961030|NCT02709785|12203351|P3|STARTED|Overall Study||28
4961031|NCT02709785|12203352|P2|STARTED|Overall Study||28
4961032|NCT02709785|12203353|P1|STARTED|Overall Study||24
4961033|NCT02709577|12203375|P4|NOT COMPLETED|Overall Study||0
4961034|NCT02709577|12203376|P3|NOT COMPLETED|Overall Study||2
4961035|NCT02709577|12203377|P2|NOT COMPLETED|Overall Study||5
4961036|NCT02709577|12203378|P1|NOT COMPLETED|Overall Study||2
4961037|NCT02709577|12203375|P4|COMPLETED|Overall Study||5
4961038|NCT02709577|12203376|P3|COMPLETED|Overall Study||4
4961039|NCT02709577|12203377|P2|COMPLETED|Overall Study||8
4961040|NCT02709577|12203378|P1|COMPLETED|Overall Study||10
4961041|NCT02709577|12203375|P4|STARTED|Overall Study||5
4961042|NCT02709577|12203376|P3|STARTED|Overall Study||6
4961043|NCT02709577|12203377|P2|STARTED|Overall Study||13
4961044|NCT02709577|12203378|P1|STARTED|Overall Study||12
4961045|NCT02709538|12203393|P3|NOT COMPLETED|Overall Study||20
4961046|NCT02709538|12203394|P2|NOT COMPLETED|Overall Study||28
4961047|NCT02709538|12203395|P1|NOT COMPLETED|Overall Study||113
4961048|NCT02709538|12203393|P3|COMPLETED|Overall Study||81
4961049|NCT02709538|12203394|P2|COMPLETED|Overall Study||72
4961050|NCT02709538|12203395|P1|COMPLETED|Overall Study||287
4961051|NCT02709538|12203393|P3|STARTED|Overall Study||101
4961052|NCT02709538|12203394|P2|STARTED|Overall Study||100
4961053|NCT02709538|12203395|P1|STARTED|Overall Study||400
4961054|NCT02709486|12203406|P3|NOT COMPLETED|Overall Study||45
4961055|NCT02709486|12203407|P2|NOT COMPLETED|Overall Study||34
4961056|NCT02709486|12203408|P1|NOT COMPLETED|Overall Study||44
4961057|NCT02709486|12203406|P3|COMPLETED|Overall Study||239
4961058|NCT02709486|12203407|P2|COMPLETED|Overall Study||249
4961059|NCT02709486|12203408|P1|COMPLETED|Overall Study||238
4961060|NCT02709486|12203406|P3|STARTED|Overall Study||284
4961061|NCT02709486|12203407|P2|STARTED|Overall Study||283
4961062|NCT02709486|12203408|P1|STARTED|Overall Study||282
4961063|NCT02709369|12203599|P1|NOT COMPLETED|Overall Study||27
4961064|NCT02709369|12203599|P1|COMPLETED|Overall Study||273
4961065|NCT02709369|12203599|P1|STARTED|Overall Study||300
4961066|NCT02709330|12203633|P2|NOT COMPLETED|Overall Study||0
4961067|NCT02709330|12203634|P1|NOT COMPLETED|Overall Study||13
4961068|NCT02709330|12203633|P2|COMPLETED|Overall Study||10
4961069|NCT02709330|12203634|P1|COMPLETED|Overall Study||37
4961070|NCT02709330|12203633|P2|STARTED|Overall Study||10
4961071|NCT02709330|12203634|P1|STARTED|Overall Study||50
4961072|NCT02709096|12203648|P2|NOT COMPLETED|Overall Study||1
4961073|NCT02709096|12203649|P1|NOT COMPLETED|Overall Study||1
4961074|NCT02709096|12203648|P2|COMPLETED|Overall Study||10
4961075|NCT02709096|12203649|P1|COMPLETED|Overall Study||21
4961076|NCT02709096|12203648|P2|STARTED|Overall Study||11
4961077|NCT02709096|12203649|P1|STARTED|Overall Study||22
4961078|NCT02709083|12203655|P1|NOT COMPLETED|Overall Study||7
4961079|NCT02709083|12203655|P1|COMPLETED|Overall Study||0
4961080|NCT02709083|12203655|P1|STARTED|Overall Study||7
4961081|NCT02709005|12203668|P2|NOT COMPLETED|Overall Study||1
4961082|NCT02709005|12203669|P1|NOT COMPLETED|Overall Study||4
4961083|NCT02709005|12203668|P2|COMPLETED|Overall Study||35
4961084|NCT02709005|12203669|P1|COMPLETED|Overall Study||69
4961085|NCT02709005|12203668|P2|STARTED|Overall Study||36
4961086|NCT02709005|12203669|P1|STARTED|Overall Study||73
4961087|NCT02708862|12203697|P1|NOT COMPLETED|Overall Study||0
4961088|NCT02708862|12203697|P1|COMPLETED|Overall Study||26
4961089|NCT02708862|12203697|P1|STARTED|Overall Study||26
4961090|NCT02708849|12203706|P2|NOT COMPLETED|Overall Study||0
4961091|NCT02708849|12203707|P1|NOT COMPLETED|Overall Study||1
4961092|NCT02708849|12203706|P2|COMPLETED|Overall Study||1
4961093|NCT02708849|12203707|P1|COMPLETED|Overall Study||1
4961094|NCT02708849|12203706|P2|STARTED|Overall Study||1
4961095|NCT02708849|12203707|P1|STARTED|Overall Study||2
4961096|NCT02708745|12203719|P4|NOT COMPLETED|Overall Study||82
4961097|NCT02708745|12203720|P3|NOT COMPLETED|Overall Study||83
4961098|NCT02708745|12203721|P2|NOT COMPLETED|Overall Study||4
4961099|NCT02708745|12203722|P1|NOT COMPLETED|Overall Study||0
4961100|NCT02708745|12203719|P4|COMPLETED|Overall Study||116
4961101|NCT02708745|12203720|P3|COMPLETED|Overall Study||121
4961102|NCT02708745|12203721|P2|COMPLETED|Overall Study||65
4961103|NCT02708745|12203722|P1|COMPLETED|Overall Study||91
4961104|NCT02708745|12203719|P4|STARTED|Overall Study||198
4961105|NCT02708745|12203720|P3|STARTED|Overall Study||204
4961106|NCT02708745|12203721|P2|STARTED|Overall Study||69
4961107|NCT02708745|12203722|P1|STARTED|Overall Study||91
4961108|NCT02708524|12203738|P4|NOT COMPLETED|Overall Study||0
4961109|NCT02708524|12203739|P3|NOT COMPLETED|Overall Study||3
4961110|NCT02708524|12203740|P2|NOT COMPLETED|Overall Study||6
4961111|NCT02708524|12203741|P1|NOT COMPLETED|Overall Study||4
4961112|NCT02708524|12203738|P4|COMPLETED|Overall Study||136
4961113|NCT02708524|12203739|P3|COMPLETED|Overall Study||134
4961114|NCT02708524|12203740|P2|COMPLETED|Overall Study||130
4961115|NCT02708524|12203741|P1|COMPLETED|Overall Study||135
4961116|NCT02708524|12203738|P4|STARTED|Overall Study||136
4961117|NCT02708524|12203739|P3|STARTED|Overall Study||137
4961118|NCT02708524|12203740|P2|STARTED|Overall Study||136
4961119|NCT02708524|12203741|P1|STARTED|Overall Study||139
4961120|NCT02708485|12203789|P2|NOT COMPLETED|Overall Study||2
4961121|NCT02708485|12203790|P1|NOT COMPLETED|Overall Study||3
4961122|NCT02708485|12203789|P2|COMPLETED|Overall Study||10
4961123|NCT02708485|12203790|P1|COMPLETED|Overall Study||0
4961124|NCT02708485|12203789|P2|STARTED|Overall Study||12
4961125|NCT02708485|12203790|P1|STARTED|Overall Study||3
4961126|NCT02708433|12203798|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
4961127|NCT02708433|12203799|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
4961128|NCT02708433|12203798|P2|COMPLETED|Second Intervention (Visit 2)||11
4961129|NCT02708433|12203799|P1|COMPLETED|Second Intervention (Visit 2)||12
4961130|NCT02708433|12203798|P2|STARTED|Second Intervention (Visit 2)||11
4961131|NCT02708433|12203799|P1|STARTED|Second Intervention (Visit 2)||12
4961132|NCT02708433|12203798|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
4961133|NCT02708433|12203799|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
4961134|NCT02708433|12203798|P2|COMPLETED|Washout (at Least 1 Week)||11
4961135|NCT02708433|12203799|P1|COMPLETED|Washout (at Least 1 Week)||12
4961136|NCT02708433|12203798|P2|STARTED|Washout (at Least 1 Week)||11
4961137|NCT02708433|12203799|P1|STARTED|Washout (at Least 1 Week)||12
4961138|NCT02708433|12203798|P2|NOT COMPLETED|First Intervention (Visit 1)||0
4961139|NCT02708433|12203799|P1|NOT COMPLETED|First Intervention (Visit 1)||0
4961140|NCT02708433|12203798|P2|COMPLETED|First Intervention (Visit 1)||11
4961141|NCT02708433|12203799|P1|COMPLETED|First Intervention (Visit 1)||12
4961142|NCT02708433|12203798|P2|STARTED|First Intervention (Visit 1)||11
4961143|NCT02708433|12203799|P1|STARTED|First Intervention (Visit 1)||12
4961144|NCT02708355|12203810|P3|NOT COMPLETED|Overall Study||0
4961145|NCT02708355|12203811|P2|NOT COMPLETED|Overall Study||0
4961146|NCT02708355|12203812|P1|NOT COMPLETED|Overall Study||1
4961147|NCT02708355|12203810|P3|COMPLETED|Overall Study||12
4961148|NCT02708355|12203811|P2|COMPLETED|Overall Study||22
4961149|NCT02708355|12203812|P1|COMPLETED|Overall Study||20
4961150|NCT02708355|12203810|P3|STARTED|Overall Study||12
4961151|NCT02708355|12203811|P2|STARTED|Overall Study||22
4961152|NCT02708355|12203812|P1|STARTED|Overall Study||21
4961153|NCT02708290|12203825|P2|NOT COMPLETED|Overall Study||0
4961154|NCT02708290|12203826|P1|NOT COMPLETED|Overall Study||0
4961155|NCT02708290|12203825|P2|COMPLETED|Overall Study||5226
4961156|NCT02708290|12203826|P1|COMPLETED|Overall Study||3540
4961157|NCT02708290|12203825|P2|STARTED|Overall Study||5226
4961158|NCT02708290|12203826|P1|STARTED|Overall Study||3540
4961159|NCT02708277|12203836|P2|NOT COMPLETED|Overall Study||4
4961160|NCT02708277|12203837|P1|NOT COMPLETED|Overall Study||7
4961161|NCT02708277|12203836|P2|COMPLETED|Overall Study||39
4961162|NCT02708277|12203837|P1|COMPLETED|Overall Study||43
4961163|NCT02708277|12203836|P2|STARTED|Overall Study||43
4961164|NCT02708277|12203837|P1|STARTED|Overall Study||50
4961165|NCT02708238|12203852|P3|NOT COMPLETED|Overall Study||3
4961166|NCT02708238|12203853|P2|NOT COMPLETED|Overall Study||1
4961167|NCT02708238|12203854|P1|NOT COMPLETED|Overall Study||0
4961168|NCT02708238|12203852|P3|COMPLETED|Overall Study||57
4961169|NCT02708238|12203853|P2|COMPLETED|Overall Study||59
4961170|NCT02708238|12203854|P1|COMPLETED|Overall Study||60
4961171|NCT02708238|12203852|P3|STARTED|Overall Study||60
4961172|NCT02708238|12203853|P2|STARTED|Overall Study||60
4961173|NCT02708238|12203854|P1|STARTED|Overall Study||60
4961174|NCT02708212|12203867|P2|NOT COMPLETED|Overall Study||0
4961175|NCT02708212|12203868|P1|NOT COMPLETED|Overall Study||0
4961176|NCT02708212|12203867|P2|COMPLETED|Overall Study||60
4961177|NCT02708212|12203868|P1|COMPLETED|Overall Study||60
4961178|NCT02708212|12203867|P2|STARTED|Overall Study||60
4961179|NCT02708212|12203868|P1|STARTED|Overall Study||60
4961180|NCT02708186|12203880|P2|NOT COMPLETED|Overall Study||2
4961181|NCT02708186|12203881|P1|NOT COMPLETED|Overall Study||2
4961182|NCT02708186|12203880|P2|COMPLETED|Overall Study||16
4961183|NCT02708186|12203881|P1|COMPLETED|Overall Study||14
4961184|NCT02708186|12203880|P2|STARTED|Overall Study||18
4961185|NCT02708186|12203881|P1|STARTED|Overall Study||16
4961186|NCT02708121|12203889|P2|NOT COMPLETED|Overall Study||5
4961187|NCT02708121|12203890|P1|NOT COMPLETED|Overall Study||1
4961188|NCT02708121|12203889|P2|COMPLETED|Overall Study||26
4961189|NCT02708121|12203890|P1|COMPLETED|Overall Study||34
4961190|NCT02708121|12203889|P2|6 Month Weight Data Via EHR|Overall Study||13
4961191|NCT02708121|12203890|P1|6 Month Weight Data Via EHR|Overall Study||14
4961192|NCT02708121|12203889|P2|6 Month In-Person Follow Up Data|Overall Study||19
4961193|NCT02708121|12203890|P1|6 Month In-Person Follow Up Data|Overall Study||22
4961194|NCT02708121|12203889|P2|Treatment Program Use Data Available|Overall Study||24
4961195|NCT02708121|12203890|P1|Treatment Program Use Data Available|Overall Study||34
4961196|NCT02708121|12203889|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
4961197|NCT02708121|12203890|P1|Provided Acceptability Data|Overall Study||20
4961198|NCT02708121|12203889|P2|STARTED|Overall Study||31
4961199|NCT02708121|12203890|P1|STARTED|Overall Study||35
4961200|NCT02708095|12203902|P3|NOT COMPLETED|Overall Study||18
4961201|NCT02708095|12203903|P2|NOT COMPLETED|Overall Study||19
4961202|NCT02708095|12203904|P1|NOT COMPLETED|Overall Study||22
4961203|NCT02708095|12203902|P3|COMPLETED|Overall Study||86
4961204|NCT02708095|12203903|P2|COMPLETED|Overall Study||86
4961205|NCT02708095|12203904|P1|COMPLETED|Overall Study||83
4961206|NCT02708095|12203902|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
4961207|NCT02708095|12203903|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
4961208|NCT02708095|12203904|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
4961209|NCT02708095|12203902|P3|STARTED|Overall Study||104
4961210|NCT02708095|12203903|P2|STARTED|Overall Study||105
4961211|NCT02708095|12203904|P1|STARTED|Overall Study||105
4961212|NCT02707991|12203927|P2|NOT COMPLETED|Overall Study||1
4961213|NCT02707991|12203928|P1|NOT COMPLETED|Overall Study||1
4961214|NCT02707991|12203927|P2|COMPLETED|Overall Study||34
4961215|NCT02707991|12203928|P1|COMPLETED|Overall Study||32
4961216|NCT02707991|12203927|P2|Month 6 Data Collection|Overall Study||34
4961217|NCT02707991|12203928|P1|Month 6 Data Collection|Overall Study||32
4961218|NCT02707991|12203927|P2|Day 60 Data Collectio|Overall Study||34
4961219|NCT02707991|12203928|P1|Day 60 Data Collectio|Overall Study||32
4961220|NCT02707991|12203927|P2|STARTED|Overall Study||35
4961221|NCT02707991|12203928|P1|STARTED|Overall Study||33
4961222|NCT02707965|12203945|P16|NOT COMPLETED|Overall Study||0
4961223|NCT02707965|12203946|P15|NOT COMPLETED|Overall Study||2
4961224|NCT02707965|12203947|P14|NOT COMPLETED|Overall Study||0
4961225|NCT02707965|12203948|P13|NOT COMPLETED|Overall Study||0
4961226|NCT02707965|12203949|P12|NOT COMPLETED|Overall Study||0
4961227|NCT02707965|12203950|P11|NOT COMPLETED|Overall Study||0
4961228|NCT02707965|12203951|P10|NOT COMPLETED|Overall Study||0
4961229|NCT02707965|12203952|P9|NOT COMPLETED|Overall Study||0
4961230|NCT02707965|12203953|P8|NOT COMPLETED|Overall Study||3
4961231|NCT02707965|12203954|P7|NOT COMPLETED|Overall Study||0
4961232|NCT02707965|12203955|P6|NOT COMPLETED|Overall Study||0
4961233|NCT02707965|12203956|P5|NOT COMPLETED|Overall Study||0
4961234|NCT02707965|12203957|P4|NOT COMPLETED|Overall Study||0
4961235|NCT02707965|12203958|P3|NOT COMPLETED|Overall Study||1
4961236|NCT02707965|12203959|P2|NOT COMPLETED|Overall Study||1
4961237|NCT02707965|12203960|P1|NOT COMPLETED|Overall Study||1
4961238|NCT02707965|12203945|P16|COMPLETED|Overall Study||0
4961239|NCT02707965|12203946|P15|COMPLETED|Overall Study||0
4961240|NCT02707965|12203947|P14|COMPLETED|Overall Study||2
4961241|NCT02707965|12203948|P13|COMPLETED|Overall Study||0
4961242|NCT02707965|12203949|P12|COMPLETED|Overall Study||0
4961243|NCT02707965|12203950|P11|COMPLETED|Overall Study||1
4961244|NCT02707965|12203951|P10|COMPLETED|Overall Study||0
4961245|NCT02707965|12203952|P9|COMPLETED|Overall Study||1
4961246|NCT02707965|12203953|P8|COMPLETED|Overall Study||0
4961247|NCT02707965|12203954|P7|COMPLETED|Overall Study||0
4961248|NCT02707965|12203955|P6|COMPLETED|Overall Study||1
4961249|NCT02707965|12203956|P5|COMPLETED|Overall Study||2
4961250|NCT02707965|12203957|P4|COMPLETED|Overall Study||0
4961251|NCT02707965|12203958|P3|COMPLETED|Overall Study||3
4961252|NCT02707965|12203959|P2|COMPLETED|Overall Study||1
4961253|NCT02707965|12203960|P1|COMPLETED|Overall Study||2
4961254|NCT02707965|12203945|P16|STARTED|Overall Study||0
4961255|NCT02707965|12203946|P15|STARTED|Overall Study||2
4961256|NCT02707965|12203947|P14|STARTED|Overall Study||2
4961257|NCT02707965|12203948|P13|STARTED|Overall Study||0
4961258|NCT02707965|12203949|P12|STARTED|Overall Study||0
4961259|NCT02707965|12203950|P11|STARTED|Overall Study||1
4961260|NCT02707965|12203951|P10|STARTED|Overall Study||0
4961261|NCT02707965|12203952|P9|STARTED|Overall Study||1
4961262|NCT02707965|12203953|P8|STARTED|Overall Study||3
4961263|NCT02707965|12203954|P7|STARTED|Overall Study||0
4961264|NCT02707965|12203955|P6|STARTED|Overall Study||1
4961265|NCT02707965|12203956|P5|STARTED|Overall Study||2
4961266|NCT02707965|12203957|P4|STARTED|Overall Study||0
4961267|NCT02707965|12203958|P3|STARTED|Overall Study||4
4961268|NCT02707965|12203959|P2|STARTED|Overall Study||2
4961269|NCT02707965|12203960|P1|STARTED|Overall Study||3
4961270|NCT02707952|12204012|P4|NOT COMPLETED|Overall Study||0
4961271|NCT02707952|12204013|P3|NOT COMPLETED|Overall Study||2
4961272|NCT02707952|12204014|P2|NOT COMPLETED|Overall Study||1
4961273|NCT02707952|12204015|P1|NOT COMPLETED|Overall Study||2
4961274|NCT02707952|12204012|P4|COMPLETED|Overall Study||10
4961275|NCT02707952|12204013|P3|COMPLETED|Overall Study||101
4961276|NCT02707952|12204014|P2|COMPLETED|Overall Study||52
4961277|NCT02707952|12204015|P1|COMPLETED|Overall Study||127
4961278|NCT02707952|12204012|P4|Participants Who Received Study Drug|Overall Study||10
4961279|NCT02707952|12204013|P3|Participants Who Received Study Drug|Overall Study||103
4961280|NCT02707952|12204014|P2|Participants Who Received Study Drug|Overall Study||52
4961281|NCT02707952|12204015|P1|Participants Who Received Study Drug|Overall Study||129
4961282|NCT02707952|12204012|P4|STARTED|Overall Study||10
4961283|NCT02707952|12204013|P3|STARTED|Overall Study||103
4961284|NCT02707952|12204014|P2|STARTED|Overall Study||53
4961285|NCT02707952|12204015|P1|STARTED|Overall Study||129
4961286|NCT02707640|12204036|P2|NOT COMPLETED|Overall Study||7
4961287|NCT02707640|12204037|P1|NOT COMPLETED|Overall Study||9
4961288|NCT02707640|12204036|P2|COMPLETED|Overall Study||55
4961289|NCT02707640|12204037|P1|COMPLETED|Overall Study||52
4961290|NCT02707640|12204036|P2|STARTED|Overall Study||62
4961291|NCT02707640|12204037|P1|STARTED|Overall Study||61
4961292|NCT02707601|12204057|P2|NOT COMPLETED|Overall Study||4
4961293|NCT02707601|12204058|P1|NOT COMPLETED|Overall Study||4
4961294|NCT02707601|12204057|P2|COMPLETED|Overall Study||70
4961295|NCT02707601|12204058|P1|COMPLETED|Overall Study||72
4961296|NCT02707601|12204057|P2|STARTED|Overall Study||74
4961297|NCT02707601|12204058|P1|STARTED|Overall Study||76
4961298|NCT02707523|12204075|P3|NOT COMPLETED|Overall Study||0
4961299|NCT02707523|12204076|P2|NOT COMPLETED|Overall Study||0
4961300|NCT02707523|12204077|P1|NOT COMPLETED|Overall Study||0
4961301|NCT02707523|12204075|P3|COMPLETED|Overall Study||16
4961302|NCT02707523|12204076|P2|COMPLETED|Overall Study||16
4961303|NCT02707523|12204077|P1|COMPLETED|Overall Study||16
4961304|NCT02707523|12204075|P3|STARTED|Overall Study||16
4961305|NCT02707523|12204076|P2|STARTED|Overall Study||16
4961306|NCT02707523|12204077|P1|STARTED|Overall Study||16
4961307|NCT02707432|12204117|P2|NOT COMPLETED|Overall Study||20
4961308|NCT02707432|12204118|P1|NOT COMPLETED|Overall Study||15
4961309|NCT02707432|12204117|P2|COMPLETED|Overall Study||51
4961310|NCT02707432|12204118|P1|COMPLETED|Overall Study||57
4961311|NCT02707432|12204117|P2|STARTED|Overall Study||71
4961312|NCT02707432|12204118|P1|STARTED|Overall Study||72
4961313|NCT02707172|12204128|P1|NOT COMPLETED|2nd Set of Experiment||0
4961314|NCT02707172|12204128|P1|COMPLETED|2nd Set of Experiment||28
4961315|NCT02707172|12204128|P1|STARTED|2nd Set of Experiment||28
4961316|NCT02707172|12204128|P1|NOT COMPLETED|Wash Out||0
4961317|NCT02707172|12204128|P1|COMPLETED|Wash Out||28
4961318|NCT02707172|12204128|P1|STARTED|Wash Out||28
4961319|NCT02707172|12204128|P1|NOT COMPLETED|1st Set of Experiment||0
4961320|NCT02707172|12204128|P1|COMPLETED|1st Set of Experiment||28
4961321|NCT02707172|12204128|P1|STARTED|1st Set of Experiment||28
4961322|NCT02707146|12204135|P2|NOT COMPLETED|Overall Study||3
4961323|NCT02707146|12204136|P1|NOT COMPLETED|Overall Study||0
4961324|NCT02707146|12204135|P2|COMPLETED|Overall Study||388
4961325|NCT02707146|12204136|P1|COMPLETED|Overall Study||359
4961326|NCT02707146|12204135|P2|STARTED|Overall Study||391
4961327|NCT02707146|12204136|P1|STARTED|Overall Study||359
4961328|NCT02706951|12204147|P3|NOT COMPLETED|Overall Study||10
4961329|NCT02706951|12204148|P2|NOT COMPLETED|Overall Study||16
4961330|NCT02706951|12204149|P1|NOT COMPLETED|Overall Study||14
4961331|NCT02706951|12204147|P3|COMPLETED|Overall Study||205
4961332|NCT02706951|12204148|P2|COMPLETED|Overall Study||201
4961333|NCT02706951|12204149|P1|COMPLETED|Overall Study||202
4961334|NCT02706951|12204147|P3|STARTED|Overall Study||215
4961335|NCT02706951|12204148|P2|STARTED|Overall Study||217
4961336|NCT02706951|12204149|P1|STARTED|Overall Study||216
4961337|NCT02706938|12204183|P2|NOT COMPLETED|Second Period, 6 Weeks||10
4961338|NCT02706938|12204184|P1|NOT COMPLETED|Second Period, 6 Weeks||0
4961339|NCT02706938|12204183|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
4961340|NCT02706938|12204184|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
4961341|NCT02706938|12204183|P2|STARTED|Second Period, 6 Weeks||31
4961342|NCT02706938|12204184|P1|STARTED|Second Period, 6 Weeks||21
4961343|NCT02706938|12204183|P2|NOT COMPLETED|First Period, 6 Weeks||2
4961344|NCT02706938|12204184|P1|NOT COMPLETED|First Period, 6 Weeks||11
4961345|NCT02706938|12204183|P2|COMPLETED|First Period, 6 Weeks||31
4961346|NCT02706938|12204184|P1|COMPLETED|First Period, 6 Weeks||21
4961347|NCT02706938|12204183|P2|STARTED|First Period, 6 Weeks||33
4961348|NCT02706938|12204184|P1|STARTED|First Period, 6 Weeks||32
4961349|NCT02706925|12204202|P9|NOT COMPLETED|Overall Study||0
4961350|NCT02706925|12204203|P8|NOT COMPLETED|Overall Study||0
4961351|NCT02706925|12204204|P7|NOT COMPLETED|Overall Study||0
4961352|NCT02706925|12204205|P6|NOT COMPLETED|Overall Study||0
4961353|NCT02706925|12204206|P5|NOT COMPLETED|Overall Study||0
4961354|NCT02706925|12204207|P4|NOT COMPLETED|Overall Study||0
4961355|NCT02706925|12204208|P3|NOT COMPLETED|Overall Study||0
4961356|NCT02706925|12204209|P2|NOT COMPLETED|Overall Study||0
4961357|NCT02706925|12204210|P1|NOT COMPLETED|Overall Study||0
4961358|NCT02706925|12204202|P9|COMPLETED|Overall Study||6
4961359|NCT02706925|12204203|P8|COMPLETED|Overall Study||6
4961360|NCT02706925|12204204|P7|COMPLETED|Overall Study||6
4961361|NCT02706925|12204205|P6|COMPLETED|Overall Study||5
4961362|NCT02706925|12204206|P5|COMPLETED|Overall Study||6
4961363|NCT02706925|12204207|P4|COMPLETED|Overall Study||6
4961364|NCT02706925|12204208|P3|COMPLETED|Overall Study||6
4961365|NCT02706925|12204209|P2|COMPLETED|Overall Study||6
4961366|NCT02706925|12204210|P1|COMPLETED|Overall Study||16
4961367|NCT02706925|12204202|P9|STARTED|Overall Study||6
4961368|NCT02706925|12204203|P8|STARTED|Overall Study||6
4961369|NCT02706925|12204204|P7|STARTED|Overall Study||6
4961370|NCT02706925|12204205|P6|STARTED|Overall Study||5
4961371|NCT02706925|12204206|P5|STARTED|Overall Study||6
4961372|NCT02706925|12204207|P4|STARTED|Overall Study||6
4961373|NCT02706925|12204208|P3|STARTED|Overall Study||6
4961374|NCT02706925|12204209|P2|STARTED|Overall Study||6
4961375|NCT02706925|12204210|P1|STARTED|Overall Study||16
4961376|NCT02706899|12204248|P2|NOT COMPLETED|Overall Study||6
4961377|NCT02706899|12204249|P1|NOT COMPLETED|Overall Study||13
4961378|NCT02706899|12204248|P2|COMPLETED|Overall Study||0
4961379|NCT02706899|12204249|P1|COMPLETED|Overall Study||0
4961380|NCT02706899|12204248|P2|STARTED|Overall Study||6
4961381|NCT02706899|12204249|P1|STARTED|Overall Study||13
4961382|NCT02706886|12204280|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961383|NCT02706886|12204281|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961384|NCT02706886|12204282|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961385|NCT02706886|12204283|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961386|NCT02706886|12204284|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961387|NCT02706886|12204285|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961388|NCT02706886|12204286|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961389|NCT02706886|12204287|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961390|NCT02706886|12204288|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961391|NCT02706886|12204280|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
4961392|NCT02706886|12204281|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
4961393|NCT02706886|12204282|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
4961394|NCT02706886|12204283|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961395|NCT02706886|12204284|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961396|NCT02706886|12204285|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961397|NCT02706886|12204286|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961398|NCT02706886|12204287|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961399|NCT02706886|12204288|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
4961400|NCT02706886|12204280|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
4961401|NCT02706886|12204281|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
4961402|NCT02706886|12204282|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
4961403|NCT02706886|12204283|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
4961404|NCT02706886|12204284|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
4961405|NCT02706886|12204285|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
4961406|NCT02706886|12204286|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
4961407|NCT02706886|12204287|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
4961408|NCT02706886|12204288|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
4961409|NCT02706886|12204280|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961410|NCT02706886|12204281|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961411|NCT02706886|12204282|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961412|NCT02706886|12204283|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961413|NCT02706886|12204284|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961414|NCT02706886|12204285|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961415|NCT02706886|12204286|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961416|NCT02706886|12204287|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961417|NCT02706886|12204288|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
4961418|NCT02706886|12204280|P9|COMPLETED|Part B: MAD Study Days 1-85||3
4961419|NCT02706886|12204281|P8|COMPLETED|Part B: MAD Study Days 1-85||7
4961420|NCT02706886|12204282|P7|COMPLETED|Part B: MAD Study Days 1-85||7
4961421|NCT02706886|12204283|P6|COMPLETED|Part B: MAD Study Days 1-85||3
4961422|NCT02706886|12204284|P5|COMPLETED|Part B: MAD Study Days 1-85||0
4961423|NCT02706886|12204285|P4|COMPLETED|Part B: MAD Study Days 1-85||0
4961424|NCT02706886|12204286|P3|COMPLETED|Part B: MAD Study Days 1-85||0
4961425|NCT02706886|12204287|P2|COMPLETED|Part B: MAD Study Days 1-85||0
4961426|NCT02706886|12204288|P1|COMPLETED|Part B: MAD Study Days 1-85||0
4961427|NCT02706886|12204280|P9|STARTED|Part B: MAD Study Days 1-85||3
4961428|NCT02706886|12204281|P8|STARTED|Part B: MAD Study Days 1-85||7
4961429|NCT02706886|12204282|P7|STARTED|Part B: MAD Study Days 1-85||7
4961430|NCT02706886|12204283|P6|STARTED|Part B: MAD Study Days 1-85||3
4961431|NCT02706886|12204284|P5|STARTED|Part B: MAD Study Days 1-85||0
4961432|NCT02706886|12204285|P4|STARTED|Part B: MAD Study Days 1-85||0
4961433|NCT02706886|12204286|P3|STARTED|Part B: MAD Study Days 1-85||0
4961434|NCT02706886|12204287|P2|STARTED|Part B: MAD Study Days 1-85||0
4961435|NCT02706886|12204288|P1|STARTED|Part B: MAD Study Days 1-85||0
4961436|NCT02706886|12204280|P9|NOT COMPLETED|Part A: SAD Period||0
4961437|NCT02706886|12204281|P8|NOT COMPLETED|Part A: SAD Period||0
4961438|NCT02706886|12204282|P7|NOT COMPLETED|Part A: SAD Period||0
4961439|NCT02706886|12204283|P6|NOT COMPLETED|Part A: SAD Period||0
4961440|NCT02706886|12204284|P5|NOT COMPLETED|Part A: SAD Period||0
4961441|NCT02706886|12204285|P4|NOT COMPLETED|Part A: SAD Period||2
4961442|NCT02706886|12204286|P3|NOT COMPLETED|Part A: SAD Period||0
4961443|NCT02706886|12204287|P2|NOT COMPLETED|Part A: SAD Period||0
4961444|NCT02706886|12204288|P1|NOT COMPLETED|Part A: SAD Period||0
4961445|NCT02706886|12204280|P9|COMPLETED|Part A: SAD Period||0
4961446|NCT02706886|12204281|P8|COMPLETED|Part A: SAD Period||0
4961447|NCT02706886|12204282|P7|COMPLETED|Part A: SAD Period||0
4961448|NCT02706886|12204283|P6|COMPLETED|Part A: SAD Period||0
4961449|NCT02706886|12204284|P5|COMPLETED|Part A: SAD Period||6
4961450|NCT02706886|12204285|P4|COMPLETED|Part A: SAD Period||4
4961451|NCT02706886|12204286|P3|COMPLETED|Part A: SAD Period||6
4961452|NCT02706886|12204287|P2|COMPLETED|Part A: SAD Period||6
4961453|NCT02706886|12204288|P1|COMPLETED|Part A: SAD Period||8
4961454|NCT02706886|12204280|P9|STARTED|Part A: SAD Period||0
4961455|NCT02706886|12204281|P8|STARTED|Part A: SAD Period||0
4961456|NCT02706886|12204282|P7|STARTED|Part A: SAD Period||0
4961457|NCT02706886|12204283|P6|STARTED|Part A: SAD Period||0
4961458|NCT02706886|12204284|P5|STARTED|Part A: SAD Period||6
4961459|NCT02706886|12204285|P4|STARTED|Part A: SAD Period||6
4961460|NCT02706886|12204286|P3|STARTED|Part A: SAD Period||6
4961461|NCT02706886|12204287|P2|STARTED|Part A: SAD Period||6
4961462|NCT02706886|12204288|P1|STARTED|Part A: SAD Period||8
4961463|NCT02706873|12204405|P4|NOT COMPLETED|Overall Study||33
4961464|NCT02706873|12204406|P3|NOT COMPLETED|Overall Study||27
4961465|NCT02706873|12204407|P2|NOT COMPLETED|Overall Study||4
4961466|NCT02706873|12204408|P1|NOT COMPLETED|Overall Study||47
4961467|NCT02706873|12204405|P4|COMPLETED|Overall Study||282
4961468|NCT02706873|12204406|P3|COMPLETED|Overall Study||290
4961469|NCT02706873|12204407|P2|COMPLETED|Overall Study||51
4961470|NCT02706873|12204408|P1|COMPLETED|Overall Study||268
4961471|NCT02706873|12204405|P4|Japan Sub-study|Overall Study||28
4961472|NCT02706873|12204406|P3|Japan Sub-study|Overall Study||27
4961473|NCT02706873|12204407|P2|Japan Sub-study|Overall Study||55
4961474|NCT02706873|12204408|P1|Japan Sub-study|Overall Study||28
4961475|NCT02706873|12204405|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
4961476|NCT02706873|12204406|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
4961477|NCT02706873|12204407|P2|Global Analysis Population|Overall Study||0
4961478|NCT02706873|12204408|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
4961479|NCT02706873|12204405|P4|Received Study Drug|Overall Study||314
4961480|NCT02706873|12204406|P3|Received Study Drug|Overall Study||317
4961481|NCT02706873|12204407|P2|Received Study Drug|Overall Study||55
4961482|NCT02706873|12204408|P1|Received Study Drug|Overall Study||314
4961483|NCT02706873|12204405|P4|STARTED|Overall Study||315
4961484|NCT02706873|12204406|P3|STARTED|Overall Study||317
4961485|NCT02706873|12204407|P2|STARTED|Overall Study||55
4961486|NCT02706873|12204408|P1|STARTED|Overall Study||315
4961487|NCT02706847|12204508|P4|NOT COMPLETED|Week 12 to Week 24||14
4961488|NCT02706847|12204509|P3|NOT COMPLETED|Week 12 to Week 24||4
4961489|NCT02706847|12204510|P2|NOT COMPLETED|Week 12 to Week 24||2
4961490|NCT02706847|12204511|P1|NOT COMPLETED|Week 12 to Week 24||3
4961491|NCT02706847|12204508|P4|COMPLETED|Week 12 to Week 24||135
4961492|NCT02706847|12204509|P3|COMPLETED|Week 12 to Week 24||153
4961493|NCT02706847|12204510|P2|COMPLETED|Week 12 to Week 24||74
4961494|NCT02706847|12204511|P1|COMPLETED|Week 12 to Week 24||72
4961495|NCT02706847|12204508|P4|Received Study Treatment|Week 12 to Week 24||148
4961496|NCT02706847|12204509|P3|Received Study Treatment|Week 12 to Week 24||156
4961497|NCT02706847|12204510|P2|Received Study Treatment|Week 12 to Week 24||75
4961498|NCT02706847|12204511|P1|Received Study Treatment|Week 12 to Week 24||72
4961499|NCT02706847|12204508|P4|STARTED|Week 12 to Week 24||149
4961500|NCT02706847|12204509|P3|STARTED|Week 12 to Week 24||157
4961501|NCT02706847|12204510|P2|STARTED|Week 12 to Week 24||76
4961502|NCT02706847|12204511|P1|STARTED|Week 12 to Week 24||75
4961503|NCT02706847|12204508|P4|NOT COMPLETED|Day 1 to Week 12||16
4961504|NCT02706847|12204509|P3|NOT COMPLETED|Day 1 to Week 12||8
4961505|NCT02706847|12204510|P2|NOT COMPLETED|Day 1 to Week 12||8
4961506|NCT02706847|12204511|P1|NOT COMPLETED|Day 1 to Week 12||10
4961507|NCT02706847|12204508|P4|COMPLETED|Day 1 to Week 12||149
4961508|NCT02706847|12204509|P3|COMPLETED|Day 1 to Week 12||157
4961509|NCT02706847|12204510|P2|COMPLETED|Day 1 to Week 12||76
4961510|NCT02706847|12204511|P1|COMPLETED|Day 1 to Week 12||75
4961511|NCT02706847|12204508|P4|Received Study Treatment|Day 1 to Week 12||165
4961512|NCT02706847|12204509|P3|Received Study Treatment|Day 1 to Week 12||164
4961513|NCT02706847|12204510|P2|Received Study Treatment|Day 1 to Week 12||84
4961514|NCT02706847|12204511|P1|Received Study Treatment|Day 1 to Week 12||85
4961515|NCT02706847|12204508|P4|STARTED|Day 1 to Week 12||165
4961516|NCT02706847|12204509|P3|STARTED|Day 1 to Week 12||165
4961517|NCT02706847|12204510|P2|STARTED|Day 1 to Week 12||84
4961518|NCT02706847|12204511|P1|STARTED|Day 1 to Week 12||85
4961519|NCT02706834|12204553|P11|NOT COMPLETED|Overall Study||1
4961520|NCT02706834|12204554|P10|NOT COMPLETED|Overall Study||1
4961521|NCT02706834|12204555|P9|NOT COMPLETED|Overall Study||0
4961522|NCT02706834|12204556|P8|NOT COMPLETED|Overall Study||0
4961523|NCT02706834|12204557|P7|NOT COMPLETED|Overall Study||0
4961524|NCT02706834|12204558|P6|NOT COMPLETED|Overall Study||0
4961525|NCT02706834|12204559|P5|NOT COMPLETED|Overall Study||1
4961526|NCT02706834|12204560|P4|NOT COMPLETED|Overall Study||0
4961527|NCT02706834|12204561|P3|NOT COMPLETED|Overall Study||1
4961528|NCT02706834|12204562|P2|NOT COMPLETED|Overall Study||1
4961529|NCT02706834|12204563|P1|NOT COMPLETED|Overall Study||2
4961530|NCT02706834|12204553|P11|COMPLETED|Overall Study||3
4961531|NCT02706834|12204554|P10|COMPLETED|Overall Study||3
4961532|NCT02706834|12204555|P9|COMPLETED|Overall Study||4
4961533|NCT02706834|12204556|P8|COMPLETED|Overall Study||3
4961534|NCT02706834|12204557|P7|COMPLETED|Overall Study||3
4961535|NCT02706834|12204558|P6|COMPLETED|Overall Study||3
4961536|NCT02706834|12204559|P5|COMPLETED|Overall Study||2
4961537|NCT02706834|12204560|P4|COMPLETED|Overall Study||3
4961538|NCT02706834|12204561|P3|COMPLETED|Overall Study||2
4961539|NCT02706834|12204562|P2|COMPLETED|Overall Study||2
4961540|NCT02706834|12204563|P1|COMPLETED|Overall Study|Completed = completed study drug|1
4961541|NCT02706834|12204553|P11|STARTED|Overall Study||4
4961542|NCT02706834|12204554|P10|STARTED|Overall Study||4
4961543|NCT02706834|12204555|P9|STARTED|Overall Study||4
4961544|NCT02706834|12204556|P8|STARTED|Overall Study||3
4961545|NCT02706834|12204557|P7|STARTED|Overall Study||3
4961546|NCT02706834|12204558|P6|STARTED|Overall Study||3
4961547|NCT02706834|12204559|P5|STARTED|Overall Study||3
4961548|NCT02706834|12204560|P4|STARTED|Overall Study||3
4961549|NCT02706834|12204561|P3|STARTED|Overall Study||3
4961550|NCT02706834|12204562|P2|STARTED|Overall Study||3
4961551|NCT02706834|12204563|P1|STARTED|Overall Study||3
4961552|NCT02706717|12204707|P2|NOT COMPLETED|Overall Study||11
4961553|NCT02706717|12204708|P1|NOT COMPLETED|Overall Study||1
4961554|NCT02706717|12204707|P2|COMPLETED|Overall Study||35
4961555|NCT02706717|12204708|P1|COMPLETED|Overall Study||46
4961556|NCT02706717|12204707|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
4961557|NCT02706717|12204708|P1|STARTED|Overall Study||47
4961558|NCT02706691|12204772|P1|NOT COMPLETED|Overall Study||1
4961559|NCT02706691|12204772|P1|COMPLETED|Overall Study||0
4961560|NCT02706691|12204772|P1|STARTED|Overall Study||1
4961561|NCT02706327|12204782|P3|NOT COMPLETED|Overall Study||2
4961562|NCT02706327|12204783|P2|NOT COMPLETED|Overall Study||1
4961563|NCT02706327|12204784|P1|NOT COMPLETED|Overall Study||1
4961564|NCT02706327|12204782|P3|COMPLETED|Overall Study||21
4961565|NCT02706327|12204783|P2|COMPLETED|Overall Study||21
4961566|NCT02706327|12204784|P1|COMPLETED|Overall Study||21
4961567|NCT02706327|12204782|P3|STARTED|Overall Study||23
4961568|NCT02706327|12204783|P2|STARTED|Overall Study||22
4961569|NCT02706327|12204784|P1|STARTED|Overall Study||22
4961570|NCT02705807|12204804|P1|NOT COMPLETED|Overall Study||0
4961571|NCT02705807|12204804|P1|COMPLETED|Overall Study||10
4961572|NCT02705807|12204804|P1|STARTED|Overall Study||10
4961573|NCT02705716|12204836|P2|NOT COMPLETED|Overall Study||2
4961574|NCT02705716|12204837|P1|NOT COMPLETED|Overall Study||4
4961575|NCT02705716|12204836|P2|COMPLETED|Overall Study||68
4961576|NCT02705716|12204837|P1|COMPLETED|Overall Study||68
4961577|NCT02705716|12204836|P2|STARTED|Overall Study||70
4961578|NCT02705716|12204837|P1|STARTED|Overall Study||72
4961579|NCT02705625|12204850|P3|NOT COMPLETED|Overall Study||11
4961580|NCT02705625|12204851|P2|NOT COMPLETED|Overall Study||10
4961581|NCT02705625|12204852|P1|NOT COMPLETED|Overall Study||8
4961582|NCT02705625|12204850|P3|COMPLETED|Overall Study||69
4961583|NCT02705625|12204851|P2|COMPLETED|Overall Study||72
4961584|NCT02705625|12204852|P1|COMPLETED|Overall Study||74
4961585|NCT02705625|12204850|P3|STARTED|Overall Study||80
4961586|NCT02705625|12204851|P2|STARTED|Overall Study||82
4961587|NCT02705625|12204852|P1|STARTED|Overall Study||82
4961588|NCT02705586|12204881|P1|NOT COMPLETED|Overall Study||8
4961589|NCT02705586|12204881|P1|COMPLETED|Overall Study||5
4961590|NCT02705586|12204881|P1|STARTED|Overall Study||13
4961591|NCT02705365|12204887|P2|NOT COMPLETED|Overall Study||0
4961592|NCT02705365|12204888|P1|NOT COMPLETED|Overall Study||0
4961593|NCT02705365|12204887|P2|COMPLETED|Overall Study||800
4961594|NCT02705365|12204888|P1|COMPLETED|Overall Study||400
4961595|NCT02705365|12204887|P2|STARTED|Overall Study||800
4961596|NCT02705365|12204888|P1|STARTED|Overall Study||400
4961597|NCT02705352|12204898|P2|NOT COMPLETED|Overall Study||0
4961598|NCT02705352|12204899|P1|NOT COMPLETED|Overall Study||0
4961599|NCT02705352|12204898|P2|COMPLETED|Overall Study||0
4961600|NCT02705352|12204899|P1|COMPLETED|Overall Study||1
4961601|NCT02705352|12204898|P2|STARTED|Overall Study||0
4961602|NCT02705352|12204899|P1|STARTED|Overall Study||1
4961603|NCT02705105|12204919|P2|NOT COMPLETED|Follow-Up||110
4961604|NCT02705105|12204920|P1|NOT COMPLETED|Follow-Up||4
4961605|NCT02705105|12204919|P2|COMPLETED|Follow-Up||0
4961606|NCT02705105|12204920|P1|COMPLETED|Follow-Up||0
4961607|NCT02705105|12204919|P2|STARTED|Follow-Up||110
4961608|NCT02705105|12204920|P1|STARTED|Follow-Up||4
4961609|NCT02705105|12204919|P2|NOT COMPLETED|Treatment||109
4961610|NCT02705105|12204920|P1|NOT COMPLETED|Treatment||4
4961611|NCT02705105|12204919|P2|COMPLETED|Treatment||1
4961612|NCT02705105|12204920|P1|COMPLETED|Treatment||0
4961613|NCT02705105|12204919|P2|D/C From Follow-Up|Treatment||110
4961614|NCT02705105|12204920|P1|D/C From Follow-Up|Treatment||4
4961615|NCT02705105|12204919|P2|D/C From Treatment Phase|Treatment||107
4961616|NCT02705105|12204920|P1|D/C From Treatment Phase|Treatment||4
4961617|NCT02705105|12204919|P2|Subjects Who Were Replaced|Treatment||0
4961618|NCT02705105|12204920|P1|Subjects Who Were Replaced|Treatment||1
4961619|NCT02705105|12204919|P2|STARTED|Treatment||110
4961620|NCT02705105|12204920|P1|STARTED|Treatment||4
4961621|NCT02704702|12204946|P6|NOT COMPLETED|Overall Study||2
4961622|NCT02704702|12204947|P5|NOT COMPLETED|Overall Study||2
4961623|NCT02704702|12204948|P4|NOT COMPLETED|Overall Study||1
4961624|NCT02704702|12204949|P3|NOT COMPLETED|Overall Study||0
4961625|NCT02704702|12204950|P2|NOT COMPLETED|Overall Study||0
4961626|NCT02704702|12204951|P1|NOT COMPLETED|Overall Study||1
4961627|NCT02704702|12204946|P6|COMPLETED|Overall Study||4
4961628|NCT02704702|12204947|P5|COMPLETED|Overall Study||4
4961629|NCT02704702|12204948|P4|COMPLETED|Overall Study||5
4961630|NCT02704702|12204949|P3|COMPLETED|Overall Study||6
4961631|NCT02704702|12204950|P2|COMPLETED|Overall Study||6
4961632|NCT02704702|12204951|P1|COMPLETED|Overall Study||5
4961633|NCT02704702|12204946|P6|STARTED|Overall Study||6
4961634|NCT02704702|12204947|P5|STARTED|Overall Study||6
4961635|NCT02704702|12204948|P4|STARTED|Overall Study||6
4961636|NCT02704702|12204949|P3|STARTED|Overall Study||6
4961637|NCT02704702|12204950|P2|STARTED|Overall Study||6
4961638|NCT02704702|12204951|P1|STARTED|Overall Study||6
4961639|NCT02704689|12204983|P1|NOT COMPLETED|Overall Study||3
4961640|NCT02704689|12204983|P1|COMPLETED|Overall Study||6
4961641|NCT02704689|12204983|P1|STARTED|Overall Study||9
4961642|NCT02704143|12205000|P1|NOT COMPLETED|Overall Study||0
4961643|NCT02704143|12205000|P1|COMPLETED|Overall Study||63
4961644|NCT02704143|12205000|P1|STARTED|Overall Study||63
4961645|NCT02704104|12205009|P1|NOT COMPLETED|Overall Study||0
4961646|NCT02704104|12205009|P1|COMPLETED|Overall Study||46
4961647|NCT02704104|12205009|P1|STARTED|Overall Study||46
4961648|NCT02704091|12205025|P2|NOT COMPLETED|Overall Study||23
4961649|NCT02704091|12205026|P1|NOT COMPLETED|Overall Study||28
4961650|NCT02704091|12205025|P2|COMPLETED|Overall Study||400
4961651|NCT02704091|12205026|P1|COMPLETED|Overall Study||402
4961652|NCT02704091|12205025|P2|STARTED|Overall Study||423
4961653|NCT02704091|12205026|P1|STARTED|Overall Study||430
4961654|NCT02703987|12205048|P2|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
4961655|NCT02703987|12205049|P1|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
4961656|NCT02703987|12205048|P2|COMPLETED|Visit 4 Intervention (1 Day)||10
4961657|NCT02703987|12205049|P1|COMPLETED|Visit 4 Intervention (1 Day)||12
4961658|NCT02703987|12205048|P2|STARTED|Visit 4 Intervention (1 Day)||11
4961659|NCT02703987|12205049|P1|STARTED|Visit 4 Intervention (1 Day)||13
4961660|NCT02703987|12205048|P2|NOT COMPLETED|Washout (Minimum 5 Days)||0
4961661|NCT02703987|12205049|P1|NOT COMPLETED|Washout (Minimum 5 Days)||0
4961662|NCT02703987|12205048|P2|COMPLETED|Washout (Minimum 5 Days)||11
4961663|NCT02703987|12205049|P1|COMPLETED|Washout (Minimum 5 Days)||13
4961664|NCT02703987|12205048|P2|STARTED|Washout (Minimum 5 Days)||11
4961665|NCT02703987|12205049|P1|STARTED|Washout (Minimum 5 Days)||13
4961666|NCT02703987|12205048|P2|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
4961667|NCT02703987|12205049|P1|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
4961668|NCT02703987|12205048|P2|COMPLETED|Visit 3 Intervention (1 Day)||11
4961669|NCT02703987|12205049|P1|COMPLETED|Visit 3 Intervention (1 Day)||13
4961670|NCT02703987|12205048|P2|STARTED|Visit 3 Intervention (1 Day)||14
4961671|NCT02703987|12205049|P1|STARTED|Visit 3 Intervention (1 Day)||14
4961672|NCT02703948|12205059|P1|NOT COMPLETED|Overall Study||3
4961673|NCT02703948|12205059|P1|COMPLETED|Overall Study||57
4961674|NCT02703948|12205059|P1|STARTED|Overall Study||60
4961675|NCT02703909|12205067|P4|NOT COMPLETED|Overall Study||0
4961676|NCT02703909|12205068|P3|NOT COMPLETED|Overall Study||0
4961677|NCT02703909|12205069|P2|NOT COMPLETED|Overall Study||0
4961678|NCT02703909|12205070|P1|NOT COMPLETED|Overall Study||0
4961679|NCT02703909|12205067|P4|COMPLETED|Overall Study||35
4961680|NCT02703909|12205068|P3|COMPLETED|Overall Study||36
4961681|NCT02703909|12205069|P2|COMPLETED|Overall Study||37
4961682|NCT02703909|12205070|P1|COMPLETED|Overall Study||36
4961683|NCT02703909|12205067|P4|STARTED|Overall Study||35
4961684|NCT02703909|12205068|P3|STARTED|Overall Study||36
4961685|NCT02703909|12205069|P2|STARTED|Overall Study||37
4961686|NCT02703909|12205070|P1|STARTED|Overall Study||36
4961687|NCT02703636|12205086|P1|NOT COMPLETED|Overall Study||16
4961688|NCT02703636|12205086|P1|COMPLETED|Overall Study||102
4961689|NCT02703636|12205086|P1|STARTED|Overall Study||118
4961690|NCT02703532|12205101|P4|NOT COMPLETED|Overall Study||1
4961691|NCT02703532|12205102|P3|NOT COMPLETED|Overall Study||2
4961692|NCT02703532|12205103|P2|NOT COMPLETED|Overall Study||1
4961693|NCT02703532|12205104|P1|NOT COMPLETED|Overall Study||2
4961694|NCT02703532|12205101|P4|COMPLETED|Overall Study||10
4961695|NCT02703532|12205102|P3|COMPLETED|Overall Study||19
4961696|NCT02703532|12205103|P2|COMPLETED|Overall Study||10
4961697|NCT02703532|12205104|P1|COMPLETED|Overall Study||19
4961698|NCT02703532|12205101|P4|STARTED|Overall Study||11
4961699|NCT02703532|12205102|P3|STARTED|Overall Study||21
4961700|NCT02703532|12205103|P2|STARTED|Overall Study||11
4961701|NCT02703532|12205104|P1|STARTED|Overall Study||21
4961702|NCT02703467|12205142|P3|NOT COMPLETED|Overall Study||0
4961703|NCT02703467|12205143|P2|NOT COMPLETED|Overall Study||0
4961704|NCT02703467|12205144|P1|NOT COMPLETED|Overall Study||0
4961705|NCT02703467|12205142|P3|COMPLETED|Overall Study||45
4961706|NCT02703467|12205143|P2|COMPLETED|Overall Study||5
4961707|NCT02703467|12205144|P1|COMPLETED|Overall Study||20
4961708|NCT02703467|12205142|P3|STARTED|Overall Study||45
4961709|NCT02703467|12205143|P2|STARTED|Overall Study||5
4961710|NCT02703467|12205144|P1|STARTED|Overall Study||20
4961711|NCT02703454|12205166|P2|NOT COMPLETED|Overall Study||16
4961712|NCT02703454|12205167|P1|NOT COMPLETED|Overall Study||11
4961713|NCT02703454|12205166|P2|COMPLETED|Overall Study||11
4961714|NCT02703454|12205167|P1|COMPLETED|Overall Study||13
4961715|NCT02703454|12205166|P2|Treated|Overall Study||24
4961716|NCT02703454|12205167|P1|Treated|Overall Study||23
4961717|NCT02703454|12205166|P2|STARTED|Overall Study||27
4961718|NCT02703454|12205167|P1|STARTED|Overall Study||24
4961719|NCT02703350|12205175|P8|NOT COMPLETED|Part B||0
4961720|NCT02703350|12205176|P7|NOT COMPLETED|Part B||0
4961721|NCT02703350|12205177|P6|NOT COMPLETED|Part B||0
4961722|NCT02703350|12205178|P5|NOT COMPLETED|Part B||0
4961723|NCT02703350|12205179|P4|NOT COMPLETED|Part B||0
4961724|NCT02703350|12205180|P3|NOT COMPLETED|Part B||0
4961725|NCT02703350|12205181|P2|NOT COMPLETED|Part B||0
4961726|NCT02703350|12205182|P1|NOT COMPLETED|Part B||0
4961727|NCT02703350|12205175|P8|COMPLETED|Part B||15
4961728|NCT02703350|12205176|P7|COMPLETED|Part B||15
4961729|NCT02703350|12205177|P6|COMPLETED|Part B||0
4961730|NCT02703350|12205178|P5|COMPLETED|Part B||0
4961731|NCT02703350|12205179|P4|COMPLETED|Part B||0
4961732|NCT02703350|12205180|P3|COMPLETED|Part B||0
4961733|NCT02703350|12205181|P2|COMPLETED|Part B||0
4961734|NCT02703350|12205182|P1|COMPLETED|Part B||0
4961735|NCT02703350|12205175|P8|Received Study Drug|Part B||15
4961736|NCT02703350|12205176|P7|Received Study Drug|Part B||15
4961737|NCT02703350|12205177|P6|Received Study Drug|Part B||0
4961738|NCT02703350|12205178|P5|Received Study Drug|Part B||0
4961739|NCT02703350|12205179|P4|Received Study Drug|Part B||0
4961740|NCT02703350|12205180|P3|Received Study Drug|Part B||0
4961741|NCT02703350|12205181|P2|Received Study Drug|Part B||0
4961742|NCT02703350|12205182|P1|Received Study Drug|Part B||0
4961743|NCT02703350|12205175|P8|STARTED|Part B||15
4961744|NCT02703350|12205176|P7|STARTED|Part B||15
4961745|NCT02703350|12205177|P6|STARTED|Part B||0
4961746|NCT02703350|12205178|P5|STARTED|Part B||0
4961747|NCT02703350|12205179|P4|STARTED|Part B||0
4961748|NCT02703350|12205180|P3|STARTED|Part B||0
4961749|NCT02703350|12205181|P2|STARTED|Part B||0
4961750|NCT02703350|12205182|P1|STARTED|Part B||0
4961751|NCT02703350|12205175|P8|NOT COMPLETED|Period Six (Part A)||0
4961752|NCT02703350|12205176|P7|NOT COMPLETED|Period Six (Part A)||0
4961753|NCT02703350|12205177|P6|NOT COMPLETED|Period Six (Part A)||0
4961754|NCT02703350|12205178|P5|NOT COMPLETED|Period Six (Part A)||0
4961755|NCT02703350|12205179|P4|NOT COMPLETED|Period Six (Part A)||0
4961756|NCT02703350|12205180|P3|NOT COMPLETED|Period Six (Part A)||0
4961757|NCT02703350|12205181|P2|NOT COMPLETED|Period Six (Part A)||0
4961758|NCT02703350|12205182|P1|NOT COMPLETED|Period Six (Part A)||0
4961759|NCT02703350|12205175|P8|COMPLETED|Period Six (Part A)||0
4961760|NCT02703350|12205176|P7|COMPLETED|Period Six (Part A)||0
4961761|NCT02703350|12205177|P6|COMPLETED|Period Six (Part A)||5
4961762|NCT02703350|12205178|P5|COMPLETED|Period Six (Part A)||5
4961763|NCT02703350|12205179|P4|COMPLETED|Period Six (Part A)||5
4961764|NCT02703350|12205180|P3|COMPLETED|Period Six (Part A)||5
4961765|NCT02703350|12205181|P2|COMPLETED|Period Six (Part A)||5
4961766|NCT02703350|12205182|P1|COMPLETED|Period Six (Part A)||5
4961767|NCT02703350|12205175|P8|Received Study Drug|Period Six (Part A)||0
4961768|NCT02703350|12205176|P7|Received Study Drug|Period Six (Part A)||0
4961769|NCT02703350|12205177|P6|Received Study Drug|Period Six (Part A)||5
4961770|NCT02703350|12205178|P5|Received Study Drug|Period Six (Part A)||5
4961771|NCT02703350|12205179|P4|Received Study Drug|Period Six (Part A)||5
4961772|NCT02703350|12205180|P3|Received Study Drug|Period Six (Part A)||5
4961773|NCT02703350|12205181|P2|Received Study Drug|Period Six (Part A)||5
4961774|NCT02703350|12205182|P1|Received Study Drug|Period Six (Part A)||5
4961775|NCT02703350|12205175|P8|STARTED|Period Six (Part A)||0
4961776|NCT02703350|12205176|P7|STARTED|Period Six (Part A)||0
4961777|NCT02703350|12205177|P6|STARTED|Period Six (Part A)||5
4961778|NCT02703350|12205178|P5|STARTED|Period Six (Part A)||5
4961779|NCT02703350|12205179|P4|STARTED|Period Six (Part A)||5
4961780|NCT02703350|12205180|P3|STARTED|Period Six (Part A)||5
4961781|NCT02703350|12205181|P2|STARTED|Period Six (Part A)||5
4961782|NCT02703350|12205182|P1|STARTED|Period Six (Part A)||5
4961783|NCT02703350|12205175|P8|NOT COMPLETED|Period Five (Part A)||0
4961784|NCT02703350|12205176|P7|NOT COMPLETED|Period Five (Part A)||0
4961785|NCT02703350|12205177|P6|NOT COMPLETED|Period Five (Part A)||0
4961786|NCT02703350|12205178|P5|NOT COMPLETED|Period Five (Part A)||0
4961787|NCT02703350|12205179|P4|NOT COMPLETED|Period Five (Part A)||0
4961788|NCT02703350|12205180|P3|NOT COMPLETED|Period Five (Part A)||0
4961789|NCT02703350|12205181|P2|NOT COMPLETED|Period Five (Part A)||0
4961790|NCT02703350|12205182|P1|NOT COMPLETED|Period Five (Part A)||0
4961791|NCT02703350|12205175|P8|COMPLETED|Period Five (Part A)||0
4961792|NCT02703350|12205176|P7|COMPLETED|Period Five (Part A)||0
4961793|NCT02703350|12205177|P6|COMPLETED|Period Five (Part A)||5
4961794|NCT02703350|12205178|P5|COMPLETED|Period Five (Part A)||5
4961795|NCT02703350|12205179|P4|COMPLETED|Period Five (Part A)||5
4961796|NCT02703350|12205180|P3|COMPLETED|Period Five (Part A)||5
4961797|NCT02703350|12205181|P2|COMPLETED|Period Five (Part A)||5
4961798|NCT02703350|12205182|P1|COMPLETED|Period Five (Part A)||5
4961799|NCT02703350|12205175|P8|Received Study Drug|Period Five (Part A)||0
4961800|NCT02703350|12205176|P7|Received Study Drug|Period Five (Part A)||0
4961801|NCT02703350|12205177|P6|Received Study Drug|Period Five (Part A)||5
4961802|NCT02703350|12205178|P5|Received Study Drug|Period Five (Part A)||5
4961803|NCT02703350|12205179|P4|Received Study Drug|Period Five (Part A)||5
4961804|NCT02703350|12205180|P3|Received Study Drug|Period Five (Part A)||5
4961805|NCT02703350|12205181|P2|Received Study Drug|Period Five (Part A)||5
4961806|NCT02703350|12205182|P1|Received Study Drug|Period Five (Part A)||5
4961807|NCT02703350|12205175|P8|STARTED|Period Five (Part A)||0
4961808|NCT02703350|12205176|P7|STARTED|Period Five (Part A)||0
4961809|NCT02703350|12205177|P6|STARTED|Period Five (Part A)||5
4961810|NCT02703350|12205178|P5|STARTED|Period Five (Part A)||5
4961811|NCT02703350|12205179|P4|STARTED|Period Five (Part A)||5
4961812|NCT02703350|12205180|P3|STARTED|Period Five (Part A)||5
4961813|NCT02703350|12205181|P2|STARTED|Period Five (Part A)||5
4961814|NCT02703350|12205182|P1|STARTED|Period Five (Part A)||5
4961815|NCT02703350|12205175|P8|NOT COMPLETED|Period Four (Part A)||0
4961816|NCT02703350|12205176|P7|NOT COMPLETED|Period Four (Part A)||0
4961817|NCT02703350|12205177|P6|NOT COMPLETED|Period Four (Part A)||0
4961818|NCT02703350|12205178|P5|NOT COMPLETED|Period Four (Part A)||0
4961819|NCT02703350|12205179|P4|NOT COMPLETED|Period Four (Part A)||0
4961820|NCT02703350|12205180|P3|NOT COMPLETED|Period Four (Part A)||0
4961821|NCT02703350|12205181|P2|NOT COMPLETED|Period Four (Part A)||0
4961822|NCT02703350|12205182|P1|NOT COMPLETED|Period Four (Part A)||0
4961823|NCT02703350|12205175|P8|COMPLETED|Period Four (Part A)||0
4961824|NCT02703350|12205176|P7|COMPLETED|Period Four (Part A)||0
4961825|NCT02703350|12205177|P6|COMPLETED|Period Four (Part A)||5
4961826|NCT02703350|12205178|P5|COMPLETED|Period Four (Part A)||5
4961827|NCT02703350|12205179|P4|COMPLETED|Period Four (Part A)||5
4961828|NCT02703350|12205180|P3|COMPLETED|Period Four (Part A)||5
4961829|NCT02703350|12205181|P2|COMPLETED|Period Four (Part A)||5
4961830|NCT02703350|12205182|P1|COMPLETED|Period Four (Part A)||5
4961831|NCT02703350|12205175|P8|Received Study Drug|Period Four (Part A)||0
4961832|NCT02703350|12205176|P7|Received Study Drug|Period Four (Part A)||0
4961833|NCT02703350|12205177|P6|Received Study Drug|Period Four (Part A)||5
4961834|NCT02703350|12205178|P5|Received Study Drug|Period Four (Part A)||5
4961835|NCT02703350|12205179|P4|Received Study Drug|Period Four (Part A)||5
4961836|NCT02703350|12205180|P3|Received Study Drug|Period Four (Part A)||5
4961837|NCT02703350|12205181|P2|Received Study Drug|Period Four (Part A)||5
4961838|NCT02703350|12205182|P1|Received Study Drug|Period Four (Part A)||5
4961839|NCT02703350|12205175|P8|STARTED|Period Four (Part A)||0
4961840|NCT02703350|12205176|P7|STARTED|Period Four (Part A)||0
4961841|NCT02703350|12205177|P6|STARTED|Period Four (Part A)||5
4961842|NCT02703350|12205178|P5|STARTED|Period Four (Part A)||5
4961843|NCT02703350|12205179|P4|STARTED|Period Four (Part A)||5
4961844|NCT02703350|12205180|P3|STARTED|Period Four (Part A)||5
4961845|NCT02703350|12205181|P2|STARTED|Period Four (Part A)||5
4961846|NCT02703350|12205182|P1|STARTED|Period Four (Part A)||5
4961847|NCT02703350|12205175|P8|NOT COMPLETED|Period Three (Part A)||0
4961848|NCT02703350|12205176|P7|NOT COMPLETED|Period Three (Part A)||0
4961849|NCT02703350|12205177|P6|NOT COMPLETED|Period Three (Part A)||0
4961850|NCT02703350|12205178|P5|NOT COMPLETED|Period Three (Part A)||0
4961851|NCT02703350|12205179|P4|NOT COMPLETED|Period Three (Part A)||0
4961852|NCT02703350|12205180|P3|NOT COMPLETED|Period Three (Part A)||0
4961853|NCT02703350|12205181|P2|NOT COMPLETED|Period Three (Part A)||0
4961854|NCT02703350|12205182|P1|NOT COMPLETED|Period Three (Part A)||0
4961855|NCT02703350|12205175|P8|COMPLETED|Period Three (Part A)||0
4961856|NCT02703350|12205176|P7|COMPLETED|Period Three (Part A)||0
4961857|NCT02703350|12205177|P6|COMPLETED|Period Three (Part A)||5
4961858|NCT02703350|12205178|P5|COMPLETED|Period Three (Part A)||5
4961859|NCT02703350|12205179|P4|COMPLETED|Period Three (Part A)||5
4961860|NCT02703350|12205180|P3|COMPLETED|Period Three (Part A)||5
4961861|NCT02703350|12205181|P2|COMPLETED|Period Three (Part A)||5
4961862|NCT02703350|12205182|P1|COMPLETED|Period Three (Part A)||5
4961863|NCT02703350|12205175|P8|Received Study Drug|Period Three (Part A)||0
4961864|NCT02703350|12205176|P7|Received Study Drug|Period Three (Part A)||0
4961865|NCT02703350|12205177|P6|Received Study Drug|Period Three (Part A)||5
4961866|NCT02703350|12205178|P5|Received Study Drug|Period Three (Part A)||5
4961867|NCT02703350|12205179|P4|Received Study Drug|Period Three (Part A)||5
4961868|NCT02703350|12205180|P3|Received Study Drug|Period Three (Part A)||5
4961869|NCT02703350|12205181|P2|Received Study Drug|Period Three (Part A)||5
4961870|NCT02703350|12205182|P1|Received Study Drug|Period Three (Part A)||5
4961871|NCT02703350|12205175|P8|STARTED|Period Three (Part A)||0
4961872|NCT02703350|12205176|P7|STARTED|Period Three (Part A)||0
4961873|NCT02703350|12205177|P6|STARTED|Period Three (Part A)||5
4961874|NCT02703350|12205178|P5|STARTED|Period Three (Part A)||5
4961875|NCT02703350|12205179|P4|STARTED|Period Three (Part A)||5
4961876|NCT02703350|12205180|P3|STARTED|Period Three (Part A)||5
4961877|NCT02703350|12205181|P2|STARTED|Period Three (Part A)||5
4961878|NCT02703350|12205182|P1|STARTED|Period Three (Part A)||5
4961879|NCT02703350|12205175|P8|NOT COMPLETED|Period Two (Part A)||0
4961880|NCT02703350|12205176|P7|NOT COMPLETED|Period Two (Part A)||0
4961881|NCT02703350|12205177|P6|NOT COMPLETED|Period Two (Part A)||0
4961882|NCT02703350|12205178|P5|NOT COMPLETED|Period Two (Part A)||0
4961883|NCT02703350|12205179|P4|NOT COMPLETED|Period Two (Part A)||0
4961884|NCT02703350|12205180|P3|NOT COMPLETED|Period Two (Part A)||0
4961885|NCT02703350|12205181|P2|NOT COMPLETED|Period Two (Part A)||0
4961886|NCT02703350|12205182|P1|NOT COMPLETED|Period Two (Part A)||0
4961887|NCT02703350|12205175|P8|COMPLETED|Period Two (Part A)||0
4961888|NCT02703350|12205176|P7|COMPLETED|Period Two (Part A)||0
4961889|NCT02703350|12205177|P6|COMPLETED|Period Two (Part A)||5
4961890|NCT02703350|12205178|P5|COMPLETED|Period Two (Part A)||5
4961891|NCT02703350|12205179|P4|COMPLETED|Period Two (Part A)||5
4961892|NCT02703350|12205180|P3|COMPLETED|Period Two (Part A)||5
4961893|NCT02703350|12205181|P2|COMPLETED|Period Two (Part A)||5
4961894|NCT02703350|12205182|P1|COMPLETED|Period Two (Part A)||5
4961895|NCT02703350|12205175|P8|Received Study Drug|Period Two (Part A)||0
4961896|NCT02703350|12205176|P7|Received Study Drug|Period Two (Part A)||0
4961897|NCT02703350|12205177|P6|Received Study Drug|Period Two (Part A)||5
4961898|NCT02703350|12205178|P5|Received Study Drug|Period Two (Part A)||5
4961899|NCT02703350|12205179|P4|Received Study Drug|Period Two (Part A)||5
4961900|NCT02703350|12205180|P3|Received Study Drug|Period Two (Part A)||5
4961901|NCT02703350|12205181|P2|Received Study Drug|Period Two (Part A)||5
4961902|NCT02703350|12205182|P1|Received Study Drug|Period Two (Part A)||5
4961903|NCT02703350|12205175|P8|STARTED|Period Two (Part A)||0
4961904|NCT02703350|12205176|P7|STARTED|Period Two (Part A)||0
4961905|NCT02703350|12205177|P6|STARTED|Period Two (Part A)||5
4961906|NCT02703350|12205178|P5|STARTED|Period Two (Part A)||5
4961907|NCT02703350|12205179|P4|STARTED|Period Two (Part A)||5
4961908|NCT02703350|12205180|P3|STARTED|Period Two (Part A)||5
4961909|NCT02703350|12205181|P2|STARTED|Period Two (Part A)||5
4961910|NCT02703350|12205182|P1|STARTED|Period Two (Part A)||5
4961911|NCT02703350|12205175|P8|NOT COMPLETED|Period One (Part A)||0
4961912|NCT02703350|12205176|P7|NOT COMPLETED|Period One (Part A)||0
4961913|NCT02703350|12205177|P6|NOT COMPLETED|Period One (Part A)||0
4961914|NCT02703350|12205178|P5|NOT COMPLETED|Period One (Part A)||0
4961915|NCT02703350|12205179|P4|NOT COMPLETED|Period One (Part A)||0
4961916|NCT02703350|12205180|P3|NOT COMPLETED|Period One (Part A)||0
4961917|NCT02703350|12205181|P2|NOT COMPLETED|Period One (Part A)||0
4961918|NCT02703350|12205182|P1|NOT COMPLETED|Period One (Part A)||0
4961919|NCT02703350|12205175|P8|COMPLETED|Period One (Part A)||0
4961920|NCT02703350|12205176|P7|COMPLETED|Period One (Part A)||0
4961921|NCT02703350|12205177|P6|COMPLETED|Period One (Part A)||5
4961922|NCT02703350|12205178|P5|COMPLETED|Period One (Part A)||5
4961923|NCT02703350|12205179|P4|COMPLETED|Period One (Part A)||5
4961924|NCT02703350|12205180|P3|COMPLETED|Period One (Part A)||5
4961925|NCT02703350|12205181|P2|COMPLETED|Period One (Part A)||5
4961926|NCT02703350|12205182|P1|COMPLETED|Period One (Part A)||5
4961927|NCT02703350|12205175|P8|Received Study Drug|Period One (Part A)||0
4961928|NCT02703350|12205176|P7|Received Study Drug|Period One (Part A)||0
4961929|NCT02703350|12205177|P6|Received Study Drug|Period One (Part A)||5
4961930|NCT02703350|12205178|P5|Received Study Drug|Period One (Part A)||5
4961931|NCT02703350|12205179|P4|Received Study Drug|Period One (Part A)||5
4961932|NCT02703350|12205180|P3|Received Study Drug|Period One (Part A)||5
4961933|NCT02703350|12205181|P2|Received Study Drug|Period One (Part A)||5
4961934|NCT02703350|12205182|P1|Received Study Drug|Period One (Part A)||5
4961935|NCT02703350|12205175|P8|STARTED|Period One (Part A)||0
4961936|NCT02703350|12205176|P7|STARTED|Period One (Part A)||0
4961937|NCT02703350|12205177|P6|STARTED|Period One (Part A)||5
4961938|NCT02703350|12205178|P5|STARTED|Period One (Part A)||5
4961939|NCT02703350|12205179|P4|STARTED|Period One (Part A)||5
4961940|NCT02703350|12205180|P3|STARTED|Period One (Part A)||5
4961941|NCT02703350|12205181|P2|STARTED|Period One (Part A)||5
4961942|NCT02703350|12205182|P1|STARTED|Period One (Part A)||5
4961943|NCT02703337|12205202|P8|NOT COMPLETED|Part B||0
4961944|NCT02703337|12205203|P7|NOT COMPLETED|Part B||0
4961945|NCT02703337|12205204|P6|NOT COMPLETED|Part B||0
4961946|NCT02703337|12205205|P5|NOT COMPLETED|Part B||0
4961947|NCT02703337|12205206|P4|NOT COMPLETED|Part B||0
4961948|NCT02703337|12205207|P3|NOT COMPLETED|Part B||0
4961949|NCT02703337|12205208|P2|NOT COMPLETED|Part B||0
4961950|NCT02703337|12205209|P1|NOT COMPLETED|Part B||0
4961951|NCT02703337|12205202|P8|COMPLETED|Part B||14
4961952|NCT02703337|12205203|P7|COMPLETED|Part B||15
4961953|NCT02703337|12205204|P6|COMPLETED|Part B||0
4961954|NCT02703337|12205205|P5|COMPLETED|Part B||0
4961955|NCT02703337|12205206|P4|COMPLETED|Part B||0
4961956|NCT02703337|12205207|P3|COMPLETED|Part B||0
4961957|NCT02703337|12205208|P2|COMPLETED|Part B||0
4961958|NCT02703337|12205209|P1|COMPLETED|Part B||0
4961959|NCT02703337|12205202|P8|Received Study Drug|Part B||14
4961960|NCT02703337|12205203|P7|Received Study Drug|Part B||15
4961961|NCT02703337|12205204|P6|Received Study Drug|Part B||0
4961962|NCT02703337|12205205|P5|Received Study Drug|Part B||0
4961963|NCT02703337|12205206|P4|Received Study Drug|Part B||0
4961964|NCT02703337|12205207|P3|Received Study Drug|Part B||0
4961965|NCT02703337|12205208|P2|Received Study Drug|Part B||0
4961966|NCT02703337|12205209|P1|Received Study Drug|Part B||0
4961967|NCT02703337|12205202|P8|STARTED|Part B||14
4961968|NCT02703337|12205203|P7|STARTED|Part B||15
4961969|NCT02703337|12205204|P6|STARTED|Part B||0
4961970|NCT02703337|12205205|P5|STARTED|Part B||0
4961971|NCT02703337|12205206|P4|STARTED|Part B||0
4961972|NCT02703337|12205207|P3|STARTED|Part B||0
4961973|NCT02703337|12205208|P2|STARTED|Part B||0
4961974|NCT02703337|12205209|P1|STARTED|Part B||0
4961975|NCT02703337|12205202|P8|NOT COMPLETED|Period Six (Part A)||0
4961976|NCT02703337|12205203|P7|NOT COMPLETED|Period Six (Part A)||0
4961977|NCT02703337|12205204|P6|NOT COMPLETED|Period Six (Part A)||0
4961978|NCT02703337|12205205|P5|NOT COMPLETED|Period Six (Part A)||0
4961979|NCT02703337|12205206|P4|NOT COMPLETED|Period Six (Part A)||0
4961980|NCT02703337|12205207|P3|NOT COMPLETED|Period Six (Part A)||0
4961981|NCT02703337|12205208|P2|NOT COMPLETED|Period Six (Part A)||0
4961982|NCT02703337|12205209|P1|NOT COMPLETED|Period Six (Part A)||0
4961983|NCT02703337|12205202|P8|COMPLETED|Period Six (Part A)||0
4961984|NCT02703337|12205203|P7|COMPLETED|Period Six (Part A)||0
4961985|NCT02703337|12205204|P6|COMPLETED|Period Six (Part A)||5
4961986|NCT02703337|12205205|P5|COMPLETED|Period Six (Part A)||4
4961987|NCT02703337|12205206|P4|COMPLETED|Period Six (Part A)||5
4961988|NCT02703337|12205207|P3|COMPLETED|Period Six (Part A)||5
4961989|NCT02703337|12205208|P2|COMPLETED|Period Six (Part A)||5
4961990|NCT02703337|12205209|P1|COMPLETED|Period Six (Part A)||5
4961991|NCT02703337|12205202|P8|Received Study Drug|Period Six (Part A)||0
4961992|NCT02703337|12205203|P7|Received Study Drug|Period Six (Part A)||0
4961993|NCT02703337|12205204|P6|Received Study Drug|Period Six (Part A)||5
4961994|NCT02703337|12205205|P5|Received Study Drug|Period Six (Part A)||4
4961995|NCT02703337|12205206|P4|Received Study Drug|Period Six (Part A)||5
4961996|NCT02703337|12205207|P3|Received Study Drug|Period Six (Part A)||5
4961997|NCT02703337|12205208|P2|Received Study Drug|Period Six (Part A)||5
4961998|NCT02703337|12205209|P1|Received Study Drug|Period Six (Part A)||5
4961999|NCT02703337|12205202|P8|STARTED|Period Six (Part A)||0
4962000|NCT02703337|12205203|P7|STARTED|Period Six (Part A)||0
4962001|NCT02703337|12205204|P6|STARTED|Period Six (Part A)||5
4962002|NCT02703337|12205205|P5|STARTED|Period Six (Part A)||4
4962003|NCT02703337|12205206|P4|STARTED|Period Six (Part A)||5
4962004|NCT02703337|12205207|P3|STARTED|Period Six (Part A)||5
4962005|NCT02703337|12205208|P2|STARTED|Period Six (Part A)||5
4962006|NCT02703337|12205209|P1|STARTED|Period Six (Part A)||5
4962007|NCT02703337|12205202|P8|NOT COMPLETED|Period Five (Part A)||0
4962008|NCT02703337|12205203|P7|NOT COMPLETED|Period Five (Part A)||0
4962009|NCT02703337|12205204|P6|NOT COMPLETED|Period Five (Part A)||0
4962010|NCT02703337|12205205|P5|NOT COMPLETED|Period Five (Part A)||0
4962011|NCT02703337|12205206|P4|NOT COMPLETED|Period Five (Part A)||0
4962012|NCT02703337|12205207|P3|NOT COMPLETED|Period Five (Part A)||0
4962013|NCT02703337|12205208|P2|NOT COMPLETED|Period Five (Part A)||0
4962014|NCT02703337|12205209|P1|NOT COMPLETED|Period Five (Part A)||0
4962015|NCT02703337|12205202|P8|COMPLETED|Period Five (Part A)||0
4962016|NCT02703337|12205203|P7|COMPLETED|Period Five (Part A)||0
4962017|NCT02703337|12205204|P6|COMPLETED|Period Five (Part A)||5
4962018|NCT02703337|12205205|P5|COMPLETED|Period Five (Part A)||4
4962019|NCT02703337|12205206|P4|COMPLETED|Period Five (Part A)||5
4962020|NCT02703337|12205207|P3|COMPLETED|Period Five (Part A)||5
4962021|NCT02703337|12205208|P2|COMPLETED|Period Five (Part A)||5
4962022|NCT02703337|12205209|P1|COMPLETED|Period Five (Part A)||5
4962023|NCT02703337|12205202|P8|Received Study Drug|Period Five (Part A)||0
4962024|NCT02703337|12205203|P7|Received Study Drug|Period Five (Part A)||0
4962025|NCT02703337|12205204|P6|Received Study Drug|Period Five (Part A)||5
4962026|NCT02703337|12205205|P5|Received Study Drug|Period Five (Part A)||4
4962027|NCT02703337|12205206|P4|Received Study Drug|Period Five (Part A)||5
4962028|NCT02703337|12205207|P3|Received Study Drug|Period Five (Part A)||5
4962029|NCT02703337|12205208|P2|Received Study Drug|Period Five (Part A)||5
4962030|NCT02703337|12205209|P1|Received Study Drug|Period Five (Part A)||5
4962031|NCT02703337|12205202|P8|STARTED|Period Five (Part A)||0
4962032|NCT02703337|12205203|P7|STARTED|Period Five (Part A)||0
4962033|NCT02703337|12205204|P6|STARTED|Period Five (Part A)||5
4962034|NCT02703337|12205205|P5|STARTED|Period Five (Part A)||4
4962035|NCT02703337|12205206|P4|STARTED|Period Five (Part A)||5
4962036|NCT02703337|12205207|P3|STARTED|Period Five (Part A)||5
4962037|NCT02703337|12205208|P2|STARTED|Period Five (Part A)||5
4962038|NCT02703337|12205209|P1|STARTED|Period Five (Part A)||5
4962039|NCT02703337|12205202|P8|NOT COMPLETED|Period Four (Part A)||0
4962040|NCT02703337|12205203|P7|NOT COMPLETED|Period Four (Part A)||0
4962041|NCT02703337|12205204|P6|NOT COMPLETED|Period Four (Part A)||0
4962042|NCT02703337|12205205|P5|NOT COMPLETED|Period Four (Part A)||0
4962043|NCT02703337|12205206|P4|NOT COMPLETED|Period Four (Part A)||0
4962044|NCT02703337|12205207|P3|NOT COMPLETED|Period Four (Part A)||0
4962045|NCT02703337|12205208|P2|NOT COMPLETED|Period Four (Part A)||0
4962046|NCT02703337|12205209|P1|NOT COMPLETED|Period Four (Part A)||0
4962047|NCT02703337|12205202|P8|COMPLETED|Period Four (Part A)||0
4962048|NCT02703337|12205203|P7|COMPLETED|Period Four (Part A)||0
4962049|NCT02703337|12205204|P6|COMPLETED|Period Four (Part A)||5
4962050|NCT02703337|12205205|P5|COMPLETED|Period Four (Part A)||4
4962051|NCT02703337|12205206|P4|COMPLETED|Period Four (Part A)||5
4962052|NCT02703337|12205207|P3|COMPLETED|Period Four (Part A)||5
4962053|NCT02703337|12205208|P2|COMPLETED|Period Four (Part A)||5
4962054|NCT02703337|12205209|P1|COMPLETED|Period Four (Part A)||5
4962055|NCT02703337|12205202|P8|Received Study Drug|Period Four (Part A)||0
4962056|NCT02703337|12205203|P7|Received Study Drug|Period Four (Part A)||0
4962057|NCT02703337|12205204|P6|Received Study Drug|Period Four (Part A)||5
4962058|NCT02703337|12205205|P5|Received Study Drug|Period Four (Part A)||4
4962059|NCT02703337|12205206|P4|Received Study Drug|Period Four (Part A)||5
4962060|NCT02703337|12205207|P3|Received Study Drug|Period Four (Part A)||5
4962061|NCT02703337|12205208|P2|Received Study Drug|Period Four (Part A)||5
4962062|NCT02703337|12205209|P1|Received Study Drug|Period Four (Part A)||5
4962063|NCT02703337|12205202|P8|STARTED|Period Four (Part A)||0
4962064|NCT02703337|12205203|P7|STARTED|Period Four (Part A)||0
4962065|NCT02703337|12205204|P6|STARTED|Period Four (Part A)||5
4962066|NCT02703337|12205205|P5|STARTED|Period Four (Part A)||4
4962067|NCT02703337|12205206|P4|STARTED|Period Four (Part A)||5
4962068|NCT02703337|12205207|P3|STARTED|Period Four (Part A)||5
4962069|NCT02703337|12205208|P2|STARTED|Period Four (Part A)||5
4962070|NCT02703337|12205209|P1|STARTED|Period Four (Part A)||5
4962071|NCT02703337|12205202|P8|NOT COMPLETED|Period Three (Part A)||0
4962072|NCT02703337|12205203|P7|NOT COMPLETED|Period Three (Part A)||0
4962073|NCT02703337|12205204|P6|NOT COMPLETED|Period Three (Part A)||0
4962074|NCT02703337|12205205|P5|NOT COMPLETED|Period Three (Part A)||0
4962075|NCT02703337|12205206|P4|NOT COMPLETED|Period Three (Part A)||0
4962076|NCT02703337|12205207|P3|NOT COMPLETED|Period Three (Part A)||0
4962077|NCT02703337|12205208|P2|NOT COMPLETED|Period Three (Part A)||0
4962078|NCT02703337|12205209|P1|NOT COMPLETED|Period Three (Part A)||0
4962079|NCT02703337|12205202|P8|COMPLETED|Period Three (Part A)||0
4962080|NCT02703337|12205203|P7|COMPLETED|Period Three (Part A)||0
4962081|NCT02703337|12205204|P6|COMPLETED|Period Three (Part A)||5
4962082|NCT02703337|12205205|P5|COMPLETED|Period Three (Part A)||4
4962083|NCT02703337|12205206|P4|COMPLETED|Period Three (Part A)||5
4962084|NCT02703337|12205207|P3|COMPLETED|Period Three (Part A)||5
4962085|NCT02703337|12205208|P2|COMPLETED|Period Three (Part A)||5
4962086|NCT02703337|12205209|P1|COMPLETED|Period Three (Part A)||5
4962087|NCT02703337|12205202|P8|Received Study Drug|Period Three (Part A)||0
4962088|NCT02703337|12205203|P7|Received Study Drug|Period Three (Part A)||0
4962089|NCT02703337|12205204|P6|Received Study Drug|Period Three (Part A)||5
4962090|NCT02703337|12205205|P5|Received Study Drug|Period Three (Part A)||4
4962091|NCT02703337|12205206|P4|Received Study Drug|Period Three (Part A)||5
4962092|NCT02703337|12205207|P3|Received Study Drug|Period Three (Part A)||5
4962093|NCT02703337|12205208|P2|Received Study Drug|Period Three (Part A)||5
4962094|NCT02703337|12205209|P1|Received Study Drug|Period Three (Part A)||5
4962095|NCT02703337|12205202|P8|STARTED|Period Three (Part A)||0
4962096|NCT02703337|12205203|P7|STARTED|Period Three (Part A)||0
4962097|NCT02703337|12205204|P6|STARTED|Period Three (Part A)||5
4962098|NCT02703337|12205205|P5|STARTED|Period Three (Part A)||4
4962099|NCT02703337|12205206|P4|STARTED|Period Three (Part A)||5
4962100|NCT02703337|12205207|P3|STARTED|Period Three (Part A)||5
4962101|NCT02703337|12205208|P2|STARTED|Period Three (Part A)||5
4962102|NCT02703337|12205209|P1|STARTED|Period Three (Part A)||5
4962103|NCT02703337|12205202|P8|NOT COMPLETED|Period Two (Part A)||0
4962104|NCT02703337|12205203|P7|NOT COMPLETED|Period Two (Part A)||0
4962105|NCT02703337|12205204|P6|NOT COMPLETED|Period Two (Part A)||0
4962106|NCT02703337|12205205|P5|NOT COMPLETED|Period Two (Part A)||0
4962107|NCT02703337|12205206|P4|NOT COMPLETED|Period Two (Part A)||0
4962108|NCT02703337|12205207|P3|NOT COMPLETED|Period Two (Part A)||0
4962109|NCT02703337|12205208|P2|NOT COMPLETED|Period Two (Part A)||0
4962110|NCT02703337|12205209|P1|NOT COMPLETED|Period Two (Part A)||0
4962111|NCT02703337|12205202|P8|COMPLETED|Period Two (Part A)||0
4962112|NCT02703337|12205203|P7|COMPLETED|Period Two (Part A)||0
4962113|NCT02703337|12205204|P6|COMPLETED|Period Two (Part A)||5
4962114|NCT02703337|12205205|P5|COMPLETED|Period Two (Part A)||4
4962115|NCT02703337|12205206|P4|COMPLETED|Period Two (Part A)||5
4962116|NCT02703337|12205207|P3|COMPLETED|Period Two (Part A)||5
4962117|NCT02703337|12205208|P2|COMPLETED|Period Two (Part A)||5
4962118|NCT02703337|12205209|P1|COMPLETED|Period Two (Part A)||5
4962119|NCT02703337|12205202|P8|Received Study Drug|Period Two (Part A)||0
4962120|NCT02703337|12205203|P7|Received Study Drug|Period Two (Part A)||0
4962121|NCT02703337|12205204|P6|Received Study Drug|Period Two (Part A)||5
4962122|NCT02703337|12205205|P5|Received Study Drug|Period Two (Part A)||4
4962123|NCT02703337|12205206|P4|Received Study Drug|Period Two (Part A)||5
4962124|NCT02703337|12205207|P3|Received Study Drug|Period Two (Part A)||5
4962125|NCT02703337|12205208|P2|Received Study Drug|Period Two (Part A)||5
4962126|NCT02703337|12205209|P1|Received Study Drug|Period Two (Part A)||5
4962127|NCT02703337|12205202|P8|STARTED|Period Two (Part A)||0
4962128|NCT02703337|12205203|P7|STARTED|Period Two (Part A)||0
4962129|NCT02703337|12205204|P6|STARTED|Period Two (Part A)||5
4962130|NCT02703337|12205205|P5|STARTED|Period Two (Part A)||4
4962131|NCT02703337|12205206|P4|STARTED|Period Two (Part A)||5
4962132|NCT02703337|12205207|P3|STARTED|Period Two (Part A)||5
4962133|NCT02703337|12205208|P2|STARTED|Period Two (Part A)||5
4962134|NCT02703337|12205209|P1|STARTED|Period Two (Part A)||5
4962135|NCT02703337|12205202|P8|NOT COMPLETED|Period One (Part A)||0
4962136|NCT02703337|12205203|P7|NOT COMPLETED|Period One (Part A)||0
4962137|NCT02703337|12205204|P6|NOT COMPLETED|Period One (Part A)||0
4962138|NCT02703337|12205205|P5|NOT COMPLETED|Period One (Part A)||1
4962139|NCT02703337|12205206|P4|NOT COMPLETED|Period One (Part A)||0
4962140|NCT02703337|12205207|P3|NOT COMPLETED|Period One (Part A)||0
4962141|NCT02703337|12205208|P2|NOT COMPLETED|Period One (Part A)||0
4962142|NCT02703337|12205209|P1|NOT COMPLETED|Period One (Part A)||0
4962143|NCT02703337|12205202|P8|COMPLETED|Period One (Part A)||0
4962144|NCT02703337|12205203|P7|COMPLETED|Period One (Part A)||0
4962145|NCT02703337|12205204|P6|COMPLETED|Period One (Part A)||5
4962146|NCT02703337|12205205|P5|COMPLETED|Period One (Part A)||4
4962147|NCT02703337|12205206|P4|COMPLETED|Period One (Part A)||5
4962148|NCT02703337|12205207|P3|COMPLETED|Period One (Part A)||5
4962149|NCT02703337|12205208|P2|COMPLETED|Period One (Part A)||5
4962150|NCT02703337|12205209|P1|COMPLETED|Period One (Part A)||5
4962151|NCT02703337|12205202|P8|Received Study Drug|Period One (Part A)||0
4962152|NCT02703337|12205203|P7|Received Study Drug|Period One (Part A)||0
4962153|NCT02703337|12205204|P6|Received Study Drug|Period One (Part A)||5
4962154|NCT02703337|12205205|P5|Received Study Drug|Period One (Part A)||5
4962155|NCT02703337|12205206|P4|Received Study Drug|Period One (Part A)||5
4962156|NCT02703337|12205207|P3|Received Study Drug|Period One (Part A)||5
4962157|NCT02703337|12205208|P2|Received Study Drug|Period One (Part A)||5
4962158|NCT02703337|12205209|P1|Received Study Drug|Period One (Part A)||5
4962159|NCT02703337|12205202|P8|STARTED|Period One (Part A)||0
4962160|NCT02703337|12205203|P7|STARTED|Period One (Part A)||0
4962161|NCT02703337|12205204|P6|STARTED|Period One (Part A)||5
4962162|NCT02703337|12205205|P5|STARTED|Period One (Part A)||5
4962163|NCT02703337|12205206|P4|STARTED|Period One (Part A)||5
4962164|NCT02703337|12205207|P3|STARTED|Period One (Part A)||5
4962165|NCT02703337|12205208|P2|STARTED|Period One (Part A)||5
4962166|NCT02703337|12205209|P1|STARTED|Period One (Part A)||5
4962167|NCT02703324|12205229|P6|NOT COMPLETED|Period Four||0
4962168|NCT02703324|12205230|P5|NOT COMPLETED|Period Four||0
4962169|NCT02703324|12205231|P4|NOT COMPLETED|Period Four||0
4962170|NCT02703324|12205232|P3|NOT COMPLETED|Period Four||0
4962171|NCT02703324|12205233|P2|NOT COMPLETED|Period Four||0
4962172|NCT02703324|12205234|P1|NOT COMPLETED|Period Four||0
4962173|NCT02703324|12205229|P6|COMPLETED|Period Four||5
4962174|NCT02703324|12205230|P5|COMPLETED|Period Four||5
4962175|NCT02703324|12205231|P4|COMPLETED|Period Four||5
4962176|NCT02703324|12205232|P3|COMPLETED|Period Four||4
4962177|NCT02703324|12205233|P2|COMPLETED|Period Four||4
4962178|NCT02703324|12205234|P1|COMPLETED|Period Four||5
4962179|NCT02703324|12205229|P6|Received Study Drug|Period Four||5
4962180|NCT02703324|12205230|P5|Received Study Drug|Period Four||5
4962181|NCT02703324|12205231|P4|Received Study Drug|Period Four||5
4962182|NCT02703324|12205232|P3|Received Study Drug|Period Four||4
4962183|NCT02703324|12205233|P2|Received Study Drug|Period Four||4
4962184|NCT02703324|12205234|P1|Received Study Drug|Period Four||5
4962185|NCT02703324|12205229|P6|STARTED|Period Four||5
4962186|NCT02703324|12205230|P5|STARTED|Period Four||5
4962187|NCT02703324|12205231|P4|STARTED|Period Four||5
4962188|NCT02703324|12205232|P3|STARTED|Period Four||4
4962189|NCT02703324|12205233|P2|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
4962190|NCT02703324|12205234|P1|STARTED|Period Four||5
4962191|NCT02703324|12205229|P6|NOT COMPLETED|Period Three||0
4962192|NCT02703324|12205230|P5|NOT COMPLETED|Period Three||0
4962193|NCT02703324|12205231|P4|NOT COMPLETED|Period Three||0
4962194|NCT02703324|12205232|P3|NOT COMPLETED|Period Three||0
4962195|NCT02703324|12205233|P2|NOT COMPLETED|Period Three||0
4962196|NCT02703324|12205234|P1|NOT COMPLETED|Period Three||0
4962197|NCT02703324|12205229|P6|COMPLETED|Period Three||5
4962198|NCT02703324|12205230|P5|COMPLETED|Period Three||5
4962199|NCT02703324|12205231|P4|COMPLETED|Period Three||5
4962200|NCT02703324|12205232|P3|COMPLETED|Period Three||4
4962201|NCT02703324|12205233|P2|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
4962202|NCT02703324|12205234|P1|COMPLETED|Period Three||5
4962203|NCT02703324|12205229|P6|Received Study Drug|Period Three||5
4962204|NCT02703324|12205230|P5|Received Study Drug|Period Three||5
4962205|NCT02703324|12205231|P4|Received Study Drug|Period Three||5
4962206|NCT02703324|12205232|P3|Received Study Drug|Period Three||4
4962207|NCT02703324|12205233|P2|Received Study Drug|Period Three||5
4962208|NCT02703324|12205234|P1|Received Study Drug|Period Three||5
4962209|NCT02703324|12205229|P6|STARTED|Period Three||5
4962210|NCT02703324|12205230|P5|STARTED|Period Three||5
4962211|NCT02703324|12205231|P4|STARTED|Period Three||5
4962212|NCT02703324|12205232|P3|STARTED|Period Three||4
4962213|NCT02703324|12205233|P2|STARTED|Period Three||5
4962214|NCT02703324|12205234|P1|STARTED|Period Three||5
4962215|NCT02703324|12205229|P6|NOT COMPLETED|Period Two||0
4962216|NCT02703324|12205230|P5|NOT COMPLETED|Period Two||0
4962217|NCT02703324|12205231|P4|NOT COMPLETED|Period Two||0
4962218|NCT02703324|12205232|P3|NOT COMPLETED|Period Two||1
4962219|NCT02703324|12205233|P2|NOT COMPLETED|Period Two||0
4962220|NCT02703324|12205234|P1|NOT COMPLETED|Period Two||0
4962221|NCT02703324|12205229|P6|COMPLETED|Period Two||5
4962222|NCT02703324|12205230|P5|COMPLETED|Period Two||5
4962223|NCT02703324|12205231|P4|COMPLETED|Period Two||5
4962224|NCT02703324|12205232|P3|COMPLETED|Period Two||4
4962225|NCT02703324|12205233|P2|COMPLETED|Period Two||5
4962226|NCT02703324|12205234|P1|COMPLETED|Period Two||5
4962227|NCT02703324|12205229|P6|Received Study Drug|Period Two||5
4962228|NCT02703324|12205230|P5|Received Study Drug|Period Two||5
4962229|NCT02703324|12205231|P4|Received Study Drug|Period Two||5
4962230|NCT02703324|12205232|P3|Received Study Drug|Period Two||5
4962231|NCT02703324|12205233|P2|Received Study Drug|Period Two||5
4962232|NCT02703324|12205234|P1|Received Study Drug|Period Two||5
4962233|NCT02703324|12205229|P6|STARTED|Period Two||5
4962234|NCT02703324|12205230|P5|STARTED|Period Two||5
4962235|NCT02703324|12205231|P4|STARTED|Period Two||5
4962236|NCT02703324|12205232|P3|STARTED|Period Two||5
4962237|NCT02703324|12205233|P2|STARTED|Period Two||5
4962238|NCT02703324|12205234|P1|STARTED|Period Two||5
4962239|NCT02703324|12205229|P6|NOT COMPLETED|Period One||0
4962240|NCT02703324|12205230|P5|NOT COMPLETED|Period One||0
4962241|NCT02703324|12205231|P4|NOT COMPLETED|Period One||0
4962242|NCT02703324|12205232|P3|NOT COMPLETED|Period One||0
4962243|NCT02703324|12205233|P2|NOT COMPLETED|Period One||0
4962244|NCT02703324|12205234|P1|NOT COMPLETED|Period One||0
4962245|NCT02703324|12205229|P6|COMPLETED|Period One||5
4962246|NCT02703324|12205230|P5|COMPLETED|Period One||5
4962247|NCT02703324|12205231|P4|COMPLETED|Period One||5
4962248|NCT02703324|12205232|P3|COMPLETED|Period One||5
4962249|NCT02703324|12205233|P2|COMPLETED|Period One||5
4962250|NCT02703324|12205234|P1|COMPLETED|Period One||5
4962251|NCT02703324|12205229|P6|Received Study Drug|Period One||5
4962252|NCT02703324|12205230|P5|Received Study Drug|Period One||5
4962253|NCT02703324|12205231|P4|Received Study Drug|Period One||5
4962254|NCT02703324|12205232|P3|Received Study Drug|Period One||5
4962255|NCT02703324|12205233|P2|Received Study Drug|Period One||5
4962256|NCT02703324|12205234|P1|Received Study Drug|Period One||5
4962257|NCT02703324|12205229|P6|STARTED|Period One||5
4962258|NCT02703324|12205230|P5|STARTED|Period One||5
4962259|NCT02703324|12205231|P4|STARTED|Period One||5
4962260|NCT02703324|12205232|P3|STARTED|Period One||5
4962261|NCT02703324|12205233|P2|STARTED|Period One||5
4962262|NCT02703324|12205234|P1|STARTED|Period One||5
4962263|NCT02703259|12205245|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
4962264|NCT02703259|12205246|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
4962265|NCT02703259|12205245|P2|COMPLETED|2 Weeks Postoperative Assessment||51
4962266|NCT02703259|12205246|P1|COMPLETED|2 Weeks Postoperative Assessment||58
4962267|NCT02703259|12205245|P2|STARTED|2 Weeks Postoperative Assessment||61
4962268|NCT02703259|12205246|P1|STARTED|2 Weeks Postoperative Assessment||68
4962269|NCT02703259|12205245|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
4962270|NCT02703259|12205246|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
4962271|NCT02703259|12205245|P2|COMPLETED|24 Hours Postoperative Assessment||61
4962272|NCT02703259|12205246|P1|COMPLETED|24 Hours Postoperative Assessment||68
4962273|NCT02703259|12205245|P2|STARTED|24 Hours Postoperative Assessment||67
4962274|NCT02703259|12205246|P1|STARTED|24 Hours Postoperative Assessment||70
4962275|NCT02702999|12205264|P2|NOT COMPLETED|Overall Study||0
4962276|NCT02702999|12205265|P1|NOT COMPLETED|Overall Study||0
4962277|NCT02702999|12205264|P2|COMPLETED|Overall Study||104
4962278|NCT02702999|12205265|P1|COMPLETED|Overall Study||102
4962279|NCT02702999|12205264|P2|STARTED|Overall Study||104
4962280|NCT02702999|12205265|P1|STARTED|Overall Study||102
4962281|NCT02702921|12205283|P2|NOT COMPLETED|Overall Study||8
4962282|NCT02702921|12205284|P1|NOT COMPLETED|Overall Study||14
4962283|NCT02702921|12205283|P2|COMPLETED|Overall Study||95
4962284|NCT02702921|12205284|P1|COMPLETED|Overall Study||84
4962285|NCT02702921|12205283|P2|STARTED|Overall Study||103
4962286|NCT02702921|12205284|P1|STARTED|Overall Study||98
4962287|NCT02702401|12205294|P2|NOT COMPLETED|Overall Study||135
4962288|NCT02702401|12205295|P1|NOT COMPLETED|Overall Study||278
4962289|NCT02702401|12205294|P2|COMPLETED|Overall Study||0
4962290|NCT02702401|12205295|P1|COMPLETED|Overall Study||0
4962291|NCT02702401|12205294|P2|Treated|Overall Study||135
4962292|NCT02702401|12205295|P1|Treated|Overall Study||278
4962293|NCT02702401|12205294|P2|STARTED|Overall Study||135
4962294|NCT02702401|12205295|P1|STARTED|Overall Study||278
4962295|NCT02702193|12205317|P2|NOT COMPLETED|12 Month Follow up||18
4962296|NCT02702193|12205318|P1|NOT COMPLETED|12 Month Follow up||17
4962297|NCT02702193|12205317|P2|COMPLETED|12 Month Follow up||69
4962298|NCT02702193|12205318|P1|COMPLETED|12 Month Follow up||69
4962299|NCT02702193|12205317|P2|STARTED|12 Month Follow up||87
4962300|NCT02702193|12205318|P1|STARTED|12 Month Follow up||86
4962301|NCT02702193|12205317|P2|NOT COMPLETED|8 Month Follow up||18
4962302|NCT02702193|12205318|P1|NOT COMPLETED|8 Month Follow up||15
4962303|NCT02702193|12205317|P2|COMPLETED|8 Month Follow up||69
4962304|NCT02702193|12205318|P1|COMPLETED|8 Month Follow up||71
4962305|NCT02702193|12205317|P2|STARTED|8 Month Follow up||87
4962306|NCT02702193|12205318|P1|STARTED|8 Month Follow up||86
4962307|NCT02702193|12205317|P2|NOT COMPLETED|4 Month Follow up||18
4962308|NCT02702193|12205318|P1|NOT COMPLETED|4 Month Follow up||18
4962309|NCT02702193|12205317|P2|COMPLETED|4 Month Follow up||69
4962310|NCT02702193|12205318|P1|COMPLETED|4 Month Follow up||68
4962311|NCT02702193|12205317|P2|STARTED|4 Month Follow up||87
4962312|NCT02702193|12205318|P1|STARTED|4 Month Follow up||86
4962313|NCT02702193|12205317|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
4962314|NCT02702193|12205318|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
4962315|NCT02702193|12205317|P2|COMPLETED|Baseline Assessment/Randomization||87
4962316|NCT02702193|12205318|P1|COMPLETED|Baseline Assessment/Randomization||85
4962317|NCT02702193|12205317|P2|STARTED|Baseline Assessment/Randomization||87
4962318|NCT02702193|12205318|P1|STARTED|Baseline Assessment/Randomization||86
4962319|NCT02702011|12205346|P4|NOT COMPLETED|Overall Study||0
4962320|NCT02702011|12205347|P3|NOT COMPLETED|Overall Study||0
4962321|NCT02702011|12205348|P2|NOT COMPLETED|Overall Study||1
4962322|NCT02702011|12205349|P1|NOT COMPLETED|Overall Study||0
4962323|NCT02702011|12205346|P4|COMPLETED|Overall Study||12
4962324|NCT02702011|12205347|P3|COMPLETED|Overall Study||12
4962325|NCT02702011|12205348|P2|COMPLETED|Overall Study||12
4962326|NCT02702011|12205349|P1|COMPLETED|Overall Study||11
4962327|NCT02702011|12205346|P4|STARTED|Overall Study|Started are the treated patients.|12
4962328|NCT02702011|12205347|P3|STARTED|Overall Study|Started are the treated patients.|12
4962329|NCT02702011|12205348|P2|STARTED|Overall Study|Started are the treated patients.|13
4962330|NCT02702011|12205349|P1|STARTED|Overall Study|Started are the treated patients.|11
4962331|NCT02701985|12205361|P2|NOT COMPLETED|Overall Study||6
4962332|NCT02701985|12205362|P1|NOT COMPLETED|Overall Study||3
4962333|NCT02701985|12205361|P2|COMPLETED|Overall Study||32
4962334|NCT02701985|12205362|P1|COMPLETED|Overall Study||34
4962335|NCT02701985|12205361|P2|STARTED|Overall Study||38
4962336|NCT02701985|12205362|P1|STARTED|Overall Study||37
4962337|NCT02701764|12205405|P2|NOT COMPLETED|Overall Study||1
4962338|NCT02701764|12205406|P1|NOT COMPLETED|Overall Study||0
4962339|NCT02701764|12205405|P2|COMPLETED|Overall Study||21
4962340|NCT02701764|12205406|P1|COMPLETED|Overall Study||21
4962341|NCT02701764|12205405|P2|STARTED|Overall Study||22
4962342|NCT02701764|12205406|P1|STARTED|Overall Study||21
4962343|NCT02701647|12205429|P3|NOT COMPLETED|Overall Study||1
4962344|NCT02701647|12205430|P2|NOT COMPLETED|Overall Study||0
4962345|NCT02701647|12205431|P1|NOT COMPLETED|Overall Study||0
4962346|NCT02701647|12205429|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
4962347|NCT02701647|12205430|P2|COMPLETED|Overall Study||17
4962348|NCT02701647|12205431|P1|COMPLETED|Overall Study||17
4962349|NCT02701647|12205429|P3|STARTED|Overall Study||17
4962350|NCT02701647|12205430|P2|STARTED|Overall Study||17
4962351|NCT02701647|12205431|P1|STARTED|Overall Study||17
4962352|NCT02701634|12205465|P2|NOT COMPLETED|Overall Study||31
4962353|NCT02701634|12205466|P1|NOT COMPLETED|Overall Study||32
4962354|NCT02701634|12205465|P2|COMPLETED|Overall Study||2
4962355|NCT02701634|12205466|P1|COMPLETED|Overall Study||1
4962356|NCT02701634|12205465|P2|STARTED|Overall Study||33
4962357|NCT02701634|12205466|P1|STARTED|Overall Study||33
4962358|NCT02701582|12205496|P2|NOT COMPLETED|Overall Study||0
4962359|NCT02701582|12205497|P1|NOT COMPLETED|Overall Study||2
4962360|NCT02701582|12205496|P2|COMPLETED|Overall Study||33
4962361|NCT02701582|12205497|P1|COMPLETED|Overall Study||33
4962362|NCT02701582|12205496|P2|STARTED|Overall Study||33
4962363|NCT02701582|12205497|P1|STARTED|Overall Study||35
4962364|NCT02701556|12205521|P2|NOT COMPLETED|Overall Study||20
4962365|NCT02701556|12205522|P1|NOT COMPLETED|Overall Study||23
4962366|NCT02701556|12205521|P2|COMPLETED|Overall Study||178
4962367|NCT02701556|12205522|P1|COMPLETED|Overall Study||175
4962368|NCT02701556|12205521|P2|STARTED|Overall Study||198
4962369|NCT02701556|12205522|P1|STARTED|Overall Study||198
4962370|NCT02701387|12205528|P1|NOT COMPLETED|Overall Study||0
4962371|NCT02701387|12205528|P1|COMPLETED|Overall Study||7
4962372|NCT02701387|12205528|P1|STARTED|Overall Study||7
4962373|NCT02701361|12205536|P3|NOT COMPLETED|Overall Study||2
4962374|NCT02701361|12205537|P2|NOT COMPLETED|Overall Study||3
4962375|NCT02701361|12205538|P1|NOT COMPLETED|Overall Study||9
4962376|NCT02701361|12205536|P3|COMPLETED|Overall Study||16
4962377|NCT02701361|12205537|P2|COMPLETED|Overall Study||28
4962378|NCT02701361|12205538|P1|COMPLETED|Overall Study||22
4962379|NCT02701361|12205536|P3|STARTED|Overall Study||18
4962380|NCT02701361|12205537|P2|STARTED|Overall Study||31
4962381|NCT02701361|12205538|P1|STARTED|Overall Study||31
4962382|NCT02701296|12205579|P2|NOT COMPLETED|Overall Study||2
4962383|NCT02701296|12205580|P1|NOT COMPLETED|Overall Study||0
4962384|NCT02701296|12205579|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
4962385|NCT02701296|12205580|P1|COMPLETED|Overall Study||42
4962386|NCT02701296|12205579|P2|STARTED|Overall Study||38
4962387|NCT02701296|12205580|P1|STARTED|Overall Study||42
4962388|NCT02701270|12205596|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
4962389|NCT02701270|12205597|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
4962390|NCT02701270|12205598|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
4962391|NCT02701270|12205599|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
4962392|NCT02701270|12205596|P4|COMPLETED|Fourth Intervention at Visit 4||3
4962393|NCT02701270|12205597|P3|COMPLETED|Fourth Intervention at Visit 4||3
4962394|NCT02701270|12205598|P2|COMPLETED|Fourth Intervention at Visit 4||3
4962395|NCT02701270|12205599|P1|COMPLETED|Fourth Intervention at Visit 4||2
4962396|NCT02701270|12205596|P4|STARTED|Fourth Intervention at Visit 4||3
4962397|NCT02701270|12205597|P3|STARTED|Fourth Intervention at Visit 4||3
4962398|NCT02701270|12205598|P2|STARTED|Fourth Intervention at Visit 4||3
4962399|NCT02701270|12205599|P1|STARTED|Fourth Intervention at Visit 4||2
4962400|NCT02701270|12205596|P4|NOT COMPLETED|Third Intervention at Visit 3||0
4962401|NCT02701270|12205597|P3|NOT COMPLETED|Third Intervention at Visit 3||0
4962402|NCT02701270|12205598|P2|NOT COMPLETED|Third Intervention at Visit 3||0
4962403|NCT02701270|12205599|P1|NOT COMPLETED|Third Intervention at Visit 3||0
4962404|NCT02701270|12205596|P4|COMPLETED|Third Intervention at Visit 3||3
4962405|NCT02701270|12205597|P3|COMPLETED|Third Intervention at Visit 3||3
4962406|NCT02701270|12205598|P2|COMPLETED|Third Intervention at Visit 3||3
4962407|NCT02701270|12205599|P1|COMPLETED|Third Intervention at Visit 3||2
4962408|NCT02701270|12205596|P4|STARTED|Third Intervention at Visit 3||3
4962409|NCT02701270|12205597|P3|STARTED|Third Intervention at Visit 3||3
4962410|NCT02701270|12205598|P2|STARTED|Third Intervention at Visit 3||3
4962411|NCT02701270|12205599|P1|STARTED|Third Intervention at Visit 3||2
4962412|NCT02701270|12205596|P4|NOT COMPLETED|Second Intervention at Visit 2||0
4962413|NCT02701270|12205597|P3|NOT COMPLETED|Second Intervention at Visit 2||0
4962414|NCT02701270|12205598|P2|NOT COMPLETED|Second Intervention at Visit 2||0
4962415|NCT02701270|12205599|P1|NOT COMPLETED|Second Intervention at Visit 2||0
4962416|NCT02701270|12205596|P4|COMPLETED|Second Intervention at Visit 2||3
4962417|NCT02701270|12205597|P3|COMPLETED|Second Intervention at Visit 2||3
4962418|NCT02701270|12205598|P2|COMPLETED|Second Intervention at Visit 2||3
4962419|NCT02701270|12205599|P1|COMPLETED|Second Intervention at Visit 2||2
4962420|NCT02701270|12205596|P4|STARTED|Second Intervention at Visit 2||3
4962421|NCT02701270|12205597|P3|STARTED|Second Intervention at Visit 2||3
4962422|NCT02701270|12205598|P2|STARTED|Second Intervention at Visit 2||3
4962423|NCT02701270|12205599|P1|STARTED|Second Intervention at Visit 2||2
4962424|NCT02701270|12205596|P4|NOT COMPLETED|First Intervention at Visit 1||0
4962425|NCT02701270|12205597|P3|NOT COMPLETED|First Intervention at Visit 1||0
4962426|NCT02701270|12205598|P2|NOT COMPLETED|First Intervention at Visit 1||0
4962427|NCT02701270|12205599|P1|NOT COMPLETED|First Intervention at Visit 1||0
4962428|NCT02701270|12205596|P4|COMPLETED|First Intervention at Visit 1||3
4962429|NCT02701270|12205597|P3|COMPLETED|First Intervention at Visit 1||3
4962430|NCT02701270|12205598|P2|COMPLETED|First Intervention at Visit 1||3
4962431|NCT02701270|12205599|P1|COMPLETED|First Intervention at Visit 1||2
4962432|NCT02701270|12205596|P4|STARTED|First Intervention at Visit 1||3
4962433|NCT02701270|12205597|P3|STARTED|First Intervention at Visit 1||3
4962434|NCT02701270|12205598|P2|STARTED|First Intervention at Visit 1||3
4962435|NCT02701270|12205599|P1|STARTED|First Intervention at Visit 1||2
4962436|NCT02701257|12205618|P5|NOT COMPLETED|Overall Study||3
4962437|NCT02701257|12205619|P4|NOT COMPLETED|Overall Study||1
4962438|NCT02701257|12205620|P3|NOT COMPLETED|Overall Study||0
4962439|NCT02701257|12205621|P2|NOT COMPLETED|Overall Study||3
4962440|NCT02701257|12205622|P1|NOT COMPLETED|Overall Study||0
4962441|NCT02701257|12205618|P5|COMPLETED|Overall Study||1
4962442|NCT02701257|12205619|P4|COMPLETED|Overall Study||3
4962443|NCT02701257|12205620|P3|COMPLETED|Overall Study||0
4962444|NCT02701257|12205621|P2|COMPLETED|Overall Study||3
4962445|NCT02701257|12205622|P1|COMPLETED|Overall Study||6
4962446|NCT02701257|12205618|P5|STARTED|Overall Study||4
4962447|NCT02701257|12205619|P4|STARTED|Overall Study||4
4962448|NCT02701257|12205620|P3|STARTED|Overall Study||0
4962449|NCT02701257|12205621|P2|STARTED|Overall Study||6
4962450|NCT02701257|12205622|P1|STARTED|Overall Study||6
4962451|NCT02701049|12205812|P3|NOT COMPLETED|Overall Study||0
4962452|NCT02701049|12205813|P2|NOT COMPLETED|Overall Study||0
4962453|NCT02701049|12205814|P1|NOT COMPLETED|Overall Study||0
4962454|NCT02701049|12205812|P3|COMPLETED|Overall Study|Total patients included in analysis|198
4962455|NCT02701049|12205813|P2|COMPLETED|Overall Study|Total patients included in analysis|342
4962456|NCT02701049|12205814|P1|COMPLETED|Overall Study|Total patients included in analysis|209
4962457|NCT02701049|12205812|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
4962458|NCT02701049|12205813|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
4962459|NCT02701049|12205814|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
4962460|NCT02700997|12205826|P1|NOT COMPLETED|Overall Study||2
4962461|NCT02700997|12205826|P1|COMPLETED|Overall Study||15
4962462|NCT02700997|12205826|P1|STARTED|Overall Study||17
4962463|NCT02700984|12205832|P2|NOT COMPLETED|Overall Study||14
4962464|NCT02700984|12205833|P1|NOT COMPLETED|Overall Study||15
4962465|NCT02700984|12205832|P2|COMPLETED|Overall Study||53
4962466|NCT02700984|12205833|P1|COMPLETED|Overall Study||200
4962467|NCT02700984|12205832|P2|STARTED|Overall Study||67
4962468|NCT02700984|12205833|P1|STARTED|Overall Study||215
4962469|NCT02700815|12205886|P4|NOT COMPLETED|Overall Study||7
4962470|NCT02700815|12205887|P3|NOT COMPLETED|Overall Study||4
4962471|NCT02700815|12205888|P2|NOT COMPLETED|Overall Study||7
4962472|NCT02700815|12205889|P1|NOT COMPLETED|Overall Study||1
4962473|NCT02700815|12205886|P4|COMPLETED|Overall Study||218
4962474|NCT02700815|12205887|P3|COMPLETED|Overall Study||219
4962475|NCT02700815|12205888|P2|COMPLETED|Overall Study||216
4962476|NCT02700815|12205889|P1|COMPLETED|Overall Study||74
4962477|NCT02700815|12205886|P4|STARTED|Overall Study||225
4962478|NCT02700815|12205887|P3|STARTED|Overall Study||223
4962479|NCT02700815|12205888|P2|STARTED|Overall Study||223
4962480|NCT02700815|12205889|P1|STARTED|Overall Study||75
4962481|NCT02700412|12205927|P1|NOT COMPLETED|Overall Study||33
4962482|NCT02700412|12205927|P1|COMPLETED|Overall Study||47
4962483|NCT02700412|12205927|P1|STARTED|Overall Study||80
4962484|NCT02699983|12205937|P2|NOT COMPLETED|Overall Study||0
4962485|NCT02699983|12205938|P1|NOT COMPLETED|Overall Study||1
4962486|NCT02699983|12205937|P2|COMPLETED|Overall Study||17
4962487|NCT02699983|12205938|P1|COMPLETED|Overall Study||17
4962488|NCT02699983|12205937|P2|STARTED|Overall Study||17
4962489|NCT02699983|12205938|P1|STARTED|Overall Study||18
4962490|NCT02699970|12205998|P1|NOT COMPLETED|Overall Study||0
4962491|NCT02699970|12205998|P1|COMPLETED|Overall Study||399
4962492|NCT02699970|12205998|P1|Inter-system|Overall Study||399
4962493|NCT02699970|12205998|P1|Intra-system|Overall Study||399
4962494|NCT02699970|12205998|P1|STARTED|Overall Study||399
4962495|NCT02699892|12206003|P1|NOT COMPLETED|Overall Study||36
4962496|NCT02699892|12206003|P1|COMPLETED|Overall Study||94
4962497|NCT02699892|12206003|P1|STARTED|Overall Study||130
4962498|NCT02699684|12206008|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
4962499|NCT02699684|12206009|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4962500|NCT02699684|12206008|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
4962501|NCT02699684|12206009|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
4962502|NCT02699684|12206008|P2|STARTED|Period 2, Second 30 Days of Wear||38
4962503|NCT02699684|12206009|P1|STARTED|Period 2, Second 30 Days of Wear||37
4962504|NCT02699684|12206008|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4962505|NCT02699684|12206009|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4962506|NCT02699684|12206008|P2|COMPLETED|Period 1, First 30 Days of Wear||38
4962507|NCT02699684|12206009|P1|COMPLETED|Period 1, First 30 Days of Wear||37
4962508|NCT02699684|12206008|P2|STARTED|Period 1, First 30 Days of Wear||38
4962509|NCT02699684|12206009|P1|STARTED|Period 1, First 30 Days of Wear||37
4962510|NCT02699632|12206019|P1|NOT COMPLETED|Overall Study||2
4962511|NCT02699632|12206019|P1|COMPLETED|Overall Study||358
4962512|NCT02699632|12206019|P1|STARTED|Overall Study||360
4962513|NCT02699593|12206026|P2|NOT COMPLETED|Period 2||2
4962514|NCT02699593|12206027|P1|NOT COMPLETED|Period 2||2
4962515|NCT02699593|12206026|P2|COMPLETED|Period 2||60
4962516|NCT02699593|12206027|P1|COMPLETED|Period 2||65
4962517|NCT02699593|12206026|P2|STARTED|Period 2||62
4962518|NCT02699593|12206027|P1|STARTED|Period 2||67
4962519|NCT02699593|12206026|P2|NOT COMPLETED|Period 1||7
4962520|NCT02699593|12206027|P1|NOT COMPLETED|Period 1||5
4962521|NCT02699593|12206026|P2|COMPLETED|Period 1||62
4962522|NCT02699593|12206027|P1|COMPLETED|Period 1||67
4962523|NCT02699593|12206026|P2|STARTED|Period 1||69
4962524|NCT02699593|12206027|P1|STARTED|Period 1||72
4962525|NCT02699099|12206038|P3|NOT COMPLETED|Overall Study||3
4962526|NCT02699099|12206039|P2|NOT COMPLETED|Overall Study||2
4962527|NCT02699099|12206040|P1|NOT COMPLETED|Overall Study||7
4962528|NCT02699099|12206038|P3|COMPLETED|Overall Study||229
4962529|NCT02699099|12206039|P2|COMPLETED|Overall Study||234
4962530|NCT02699099|12206040|P1|COMPLETED|Overall Study||224
4962531|NCT02699099|12206038|P3|STARTED|Overall Study||232
4962532|NCT02699099|12206039|P2|STARTED|Overall Study||236
4962533|NCT02699099|12206040|P1|STARTED|Overall Study||231
4962534|NCT02698865|12206116|P2|NOT COMPLETED|Overall Study||33
4962535|NCT02698865|12206117|P1|NOT COMPLETED|Overall Study||35
4962536|NCT02698865|12206116|P2|COMPLETED|Overall Study||47
4962537|NCT02698865|12206117|P1|COMPLETED|Overall Study||105
4962538|NCT02698865|12206116|P2|Treated|Overall Study||80
4962539|NCT02698865|12206117|P1|Treated|Overall Study||140
4962540|NCT02698865|12206116|P2|STARTED|Overall Study||80
4962541|NCT02698865|12206117|P1|STARTED|Overall Study||140
4962542|NCT02698800|12206125|P2|NOT COMPLETED|Overall Study||0
4962543|NCT02698800|12206126|P1|NOT COMPLETED|Overall Study||1
4962544|NCT02698800|12206125|P2|COMPLETED|Overall Study||8
4962545|NCT02698800|12206126|P1|COMPLETED|Overall Study||6
4962546|NCT02698800|12206125|P2|STARTED|Overall Study||8
4962547|NCT02698800|12206126|P1|STARTED|Overall Study||7
4962548|NCT02698735|12206134|P1|NOT COMPLETED|Overall Study||0
4962549|NCT02698735|12206134|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
4962550|NCT02698735|12206134|P1|STARTED|Overall Study||5
4962551|NCT02698566|12206148|P2|NOT COMPLETED|Overall Study||0
4962552|NCT02698566|12206149|P1|NOT COMPLETED|Overall Study||0
4962553|NCT02698566|12206148|P2|COMPLETED|Overall Study||3
4962554|NCT02698566|12206149|P1|COMPLETED|Overall Study||35
4962555|NCT02698566|12206148|P2|STARTED|Overall Study||3
4962556|NCT02698566|12206149|P1|STARTED|Overall Study||35
4962557|NCT02698436|12206157|P2|NOT COMPLETED|Overall Study||7
4962558|NCT02698436|12206158|P1|NOT COMPLETED|Overall Study||7
4962559|NCT02698436|12206157|P2|COMPLETED|Overall Study||51
4962560|NCT02698436|12206158|P1|COMPLETED|Overall Study||52
4962561|NCT02698436|12206157|P2|STARTED|Overall Study||58
4962562|NCT02698436|12206158|P1|STARTED|Overall Study||59
4962563|NCT02698423|12206198|P2|NOT COMPLETED|Overall Study||24
4962564|NCT02698423|12206199|P1|NOT COMPLETED|Overall Study||19
4962565|NCT02698423|12206198|P2|COMPLETED|Overall Study||307
4962566|NCT02698423|12206199|P1|COMPLETED|Overall Study||317
4962567|NCT02698423|12206198|P2|STARTED|Overall Study||331
4962568|NCT02698423|12206199|P1|STARTED|Overall Study||336
4962569|NCT02698371|12206207|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
4962570|NCT02698371|12206207|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
4962571|NCT02698371|12206207|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
4962572|NCT02698371|12206207|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
4962573|NCT02698371|12206207|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
4962574|NCT02698371|12206207|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
4962575|NCT02698371|12206207|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
4962576|NCT02698371|12206207|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
4962577|NCT02698371|12206207|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
4962578|NCT02698371|12206207|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
4962579|NCT02698371|12206207|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
4962580|NCT02698371|12206207|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
4962581|NCT02698371|12206207|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
4962582|NCT02698371|12206207|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
4962583|NCT02698371|12206207|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
4962584|NCT02698371|12206207|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
4962585|NCT02698371|12206207|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
4962586|NCT02698371|12206207|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
4962587|NCT02698371|12206207|P1|NOT COMPLETED|All Participants Flow||3
4962588|NCT02698371|12206207|P1|COMPLETED|All Participants Flow||35
4962589|NCT02698371|12206207|P1|STARTED|All Participants Flow||38
4962590|NCT02698241|12206329|P1|NOT COMPLETED|Overall Study||34
4962591|NCT02698241|12206329|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
4962592|NCT02698241|12206329|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
4962593|NCT02698241|12206329|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
4962594|NCT02698189|12206336|P2|NOT COMPLETED|Overall Study||6
4962595|NCT02698189|12206337|P1|NOT COMPLETED|Overall Study||3
4962596|NCT02698189|12206336|P2|COMPLETED|Overall Study||0
4962597|NCT02698189|12206337|P1|COMPLETED|Overall Study||0
4962598|NCT02698189|12206336|P2|STARTED|Overall Study||6
4962599|NCT02698189|12206337|P1|STARTED|Overall Study||3
4962600|NCT02698176|12206367|P4|NOT COMPLETED|Overall Study||0
4962601|NCT02698176|12206368|P3|NOT COMPLETED|Overall Study||1
4962602|NCT02698176|12206369|P2|NOT COMPLETED|Overall Study||3
4962603|NCT02698176|12206370|P1|NOT COMPLETED|Overall Study||9
4962604|NCT02698176|12206367|P4|COMPLETED|Overall Study||0
4962605|NCT02698176|12206368|P3|COMPLETED|Overall Study||0
4962606|NCT02698176|12206369|P2|COMPLETED|Overall Study||0
4962607|NCT02698176|12206370|P1|COMPLETED|Overall Study||0
4962608|NCT02698176|12206367|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
4962609|NCT02698176|12206368|P3|STARTED|Overall Study||1
4962610|NCT02698176|12206369|P2|STARTED|Overall Study||3
4962611|NCT02698176|12206370|P1|STARTED|Overall Study||9
4962612|NCT02698033|12206405|P1|NOT COMPLETED|Overall Study||1
4962613|NCT02698033|12206405|P1|COMPLETED|Overall Study||6
4962614|NCT02698033|12206405|P1|STARTED|Overall Study||7
4962615|NCT02697890|12206411|P2|NOT COMPLETED|Overall Study||0
4962616|NCT02697890|12206412|P1|NOT COMPLETED|Overall Study||0
4962617|NCT02697890|12206411|P2|COMPLETED|Overall Study||14
4962618|NCT02697890|12206412|P1|COMPLETED|Overall Study||14
4962619|NCT02697890|12206411|P2|STARTED|Overall Study||14
4962620|NCT02697890|12206412|P1|STARTED|Overall Study||14
4962621|NCT02697773|12206427|P3|NOT COMPLETED|Overall Study||40
4962622|NCT02697773|12206428|P2|NOT COMPLETED|Overall Study||38
4962623|NCT02697773|12206429|P1|NOT COMPLETED|Overall Study||38
4962624|NCT02697773|12206427|P3|COMPLETED|Overall Study||193
4962625|NCT02697773|12206428|P2|COMPLETED|Overall Study||194
4962626|NCT02697773|12206429|P1|COMPLETED|Overall Study||195
4962627|NCT02697773|12206427|P3|Treated|Overall Study||233
4962628|NCT02697773|12206428|P2|Treated|Overall Study||231
4962629|NCT02697773|12206429|P1|Treated|Overall Study||232
4962630|NCT02697773|12206427|P3|STARTED|Overall Study||233
4962631|NCT02697773|12206428|P2|STARTED|Overall Study||232
4962632|NCT02697773|12206429|P1|STARTED|Overall Study||233
4962633|NCT02697435|12206610|P2|NOT COMPLETED|Overall Study||4
4962634|NCT02697435|12206611|P1|NOT COMPLETED|Overall Study||1
4962635|NCT02697435|12206610|P2|COMPLETED|Overall Study||26
4962636|NCT02697435|12206611|P1|COMPLETED|Overall Study||24
4962637|NCT02697435|12206610|P2|STARTED|Overall Study||30
4962638|NCT02697435|12206611|P1|STARTED|Overall Study||25
4962639|NCT02697292|12206621|P2|NOT COMPLETED|Overall Study||0
4962640|NCT02697292|12206622|P1|NOT COMPLETED|Overall Study||0
4962641|NCT02697292|12206621|P2|COMPLETED|Overall Study||8
4962642|NCT02697292|12206622|P1|COMPLETED|Overall Study||9
4962643|NCT02697292|12206621|P2|STARTED|Overall Study||8
4962644|NCT02697292|12206622|P1|STARTED|Overall Study||9
4962645|NCT02697240|12206630|P1|NOT COMPLETED|Overall Study||0
4962646|NCT02697240|12206630|P1|COMPLETED|Overall Study||4
4962647|NCT02697240|12206630|P1|STARTED|Overall Study||4
4962648|NCT02697214|12206639|P6|NOT COMPLETED|Overall Study||0
4962649|NCT02697214|12206640|P5|NOT COMPLETED|Overall Study||0
4962650|NCT02697214|12206641|P4|NOT COMPLETED|Overall Study||0
4962651|NCT02697214|12206642|P3|NOT COMPLETED|Overall Study||0
4962652|NCT02697214|12206643|P2|NOT COMPLETED|Overall Study||0
4962653|NCT02697214|12206644|P1|NOT COMPLETED|Overall Study||0
4962654|NCT02697214|12206639|P6|COMPLETED|Overall Study||50
4962655|NCT02697214|12206640|P5|COMPLETED|Overall Study||50
4962656|NCT02697214|12206641|P4|COMPLETED|Overall Study||24
4962657|NCT02697214|12206642|P3|COMPLETED|Overall Study||25
4962658|NCT02697214|12206643|P2|COMPLETED|Overall Study||25
4962659|NCT02697214|12206644|P1|COMPLETED|Overall Study||26
4962660|NCT02697214|12206639|P6|Heart Rate at 6mph|Overall Study||50
4962661|NCT02697214|12206640|P5|Heart Rate at 6mph|Overall Study||50
4962662|NCT02697214|12206641|P4|Heart Rate at 6mph|Overall Study||24
4962663|NCT02697214|12206642|P3|Heart Rate at 6mph|Overall Study||25
4962664|NCT02697214|12206643|P2|Heart Rate at 6mph|Overall Study||25
4962665|NCT02697214|12206644|P1|Heart Rate at 6mph|Overall Study||26
4962666|NCT02697214|12206639|P6|Heart Rate at 4mph|Overall Study||50
4962667|NCT02697214|12206640|P5|Heart Rate at 4mph|Overall Study||50
4962668|NCT02697214|12206641|P4|Heart Rate at 4mph|Overall Study||24
4962669|NCT02697214|12206642|P3|Heart Rate at 4mph|Overall Study||25
4962670|NCT02697214|12206643|P2|Heart Rate at 4mph|Overall Study||25
4962671|NCT02697214|12206644|P1|Heart Rate at 4mph|Overall Study||26
4962672|NCT02697214|12206639|P6|Heart Rate at 3mph|Overall Study||50
4962673|NCT02697214|12206640|P5|Heart Rate at 3mph|Overall Study||50
4962674|NCT02697214|12206641|P4|Heart Rate at 3mph|Overall Study||24
4962675|NCT02697214|12206642|P3|Heart Rate at 3mph|Overall Study||25
4962676|NCT02697214|12206643|P2|Heart Rate at 3mph|Overall Study||25
4962677|NCT02697214|12206644|P1|Heart Rate at 3mph|Overall Study||26
4962678|NCT02697214|12206639|P6|Heart Rate at 2mph|Overall Study||50
4962679|NCT02697214|12206640|P5|Heart Rate at 2mph|Overall Study||50
4962680|NCT02697214|12206641|P4|Heart Rate at 2mph|Overall Study||24
4962681|NCT02697214|12206642|P3|Heart Rate at 2mph|Overall Study||25
4962682|NCT02697214|12206643|P2|Heart Rate at 2mph|Overall Study||25
4962683|NCT02697214|12206644|P1|Heart Rate at 2mph|Overall Study||26
4962684|NCT02697214|12206639|P6|STARTED|Overall Study||50
4962685|NCT02697214|12206640|P5|STARTED|Overall Study||50
4962686|NCT02697214|12206641|P4|STARTED|Overall Study||24
4962687|NCT02697214|12206642|P3|STARTED|Overall Study||25
4962688|NCT02697214|12206643|P2|STARTED|Overall Study||25
4962689|NCT02697214|12206644|P1|STARTED|Overall Study||26
4962690|NCT02697188|12206654|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
4962691|NCT02697188|12206654|P1|COMPLETED|TE Period 5 - 800 mg BID||12
4962692|NCT02697188|12206654|P1|STARTED|TE Period 5 - 800 mg BID||12
4962693|NCT02697188|12206654|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
4962694|NCT02697188|12206654|P1|COMPLETED|TU Period 4 - 400 BID||12
4962695|NCT02697188|12206654|P1|STARTED|TU Period 4 - 400 BID||12
4962696|NCT02697188|12206654|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
4962697|NCT02697188|12206654|P1|COMPLETED|TU Period 3 - 200 mg BID||12
4962698|NCT02697188|12206654|P1|STARTED|TU Period 3 - 200 mg BID||12
4962699|NCT02697188|12206654|P1|NOT COMPLETED|TU Period 2 – 200 mg QD||0
4962700|NCT02697188|12206654|P1|COMPLETED|TU Period 2 – 200 mg QD||12
4962701|NCT02697188|12206654|P1|STARTED|TU Period 2 – 200 mg QD||12
4962702|NCT02697188|12206654|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
4962703|NCT02697188|12206654|P1|COMPLETED|TE Period 1 - 400 mg QD||12
4962704|NCT02697188|12206654|P1|STARTED|TE Period 1 - 400 mg QD||12
4962705|NCT02696967|12206667|P4|NOT COMPLETED|Overall Study||0
4962706|NCT02696967|12206668|P3|NOT COMPLETED|Overall Study||0
4962707|NCT02696967|12206669|P2|NOT COMPLETED|Overall Study||0
4962708|NCT02696967|12206670|P1|NOT COMPLETED|Overall Study||0
4962709|NCT02696967|12206667|P4|COMPLETED|Overall Study||10
4962710|NCT02696967|12206668|P3|COMPLETED|Overall Study||6
4962711|NCT02696967|12206669|P2|COMPLETED|Overall Study||6
4962712|NCT02696967|12206670|P1|COMPLETED|Overall Study||4
4962713|NCT02696967|12206667|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||0
4962714|NCT02696967|12206668|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||4
4962715|NCT02696967|12206669|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||6
4962716|NCT02696967|12206670|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
4962717|NCT02696967|12206667|P4|STARTED|Overall Study||10
4962718|NCT02696967|12206668|P3|STARTED|Overall Study||6
4962719|NCT02696967|12206669|P2|STARTED|Overall Study||6
4962720|NCT02696967|12206670|P1|STARTED|Overall Study||4
4962721|NCT02696850|12206719|P2|NOT COMPLETED|Overall Study||8
4962722|NCT02696850|12206720|P1|NOT COMPLETED|Overall Study||11
4962723|NCT02696850|12206719|P2|COMPLETED|Overall Study||32
4962724|NCT02696850|12206720|P1|COMPLETED|Overall Study||29
4962725|NCT02696850|12206719|P2|STARTED|Overall Study||40
4962726|NCT02696850|12206720|P1|STARTED|Overall Study||40
4962727|NCT02696798|12206733|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
4962728|NCT02696798|12206734|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
4962729|NCT02696798|12206735|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
4962730|NCT02696798|12206733|P3|COMPLETED|Post-treatment Follow-up Period||3
4962731|NCT02696798|12206734|P2|COMPLETED|Post-treatment Follow-up Period||8
4962732|NCT02696798|12206735|P1|COMPLETED|Post-treatment Follow-up Period||0
4962733|NCT02696798|12206733|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
4962734|NCT02696798|12206734|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
4962735|NCT02696798|12206735|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
4962736|NCT02696798|12206733|P3|NOT COMPLETED|Extended Treatment Period||10
4962737|NCT02696798|12206734|P2|NOT COMPLETED|Extended Treatment Period||9
4962738|NCT02696798|12206735|P1|NOT COMPLETED|Extended Treatment Period||12
4962739|NCT02696798|12206733|P3|COMPLETED|Extended Treatment Period||80
4962740|NCT02696798|12206734|P2|COMPLETED|Extended Treatment Period||89
4962741|NCT02696798|12206735|P1|COMPLETED|Extended Treatment Period||81
4962742|NCT02696798|12206733|P3|STARTED|Extended Treatment Period||90
4962743|NCT02696798|12206734|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
4962744|NCT02696798|12206735|P1|STARTED|Extended Treatment Period||93
4962745|NCT02696798|12206733|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
4962746|NCT02696798|12206734|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
4962747|NCT02696798|12206735|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
4962748|NCT02696798|12206733|P3|COMPLETED|Blinded Treatment Dosing Period||90
4962749|NCT02696798|12206734|P2|COMPLETED|Blinded Treatment Dosing Period||99
4962750|NCT02696798|12206735|P1|COMPLETED|Blinded Treatment Dosing Period||93
4962751|NCT02696798|12206733|P3|STARTED|Blinded Treatment Dosing Period||98
4962752|NCT02696798|12206734|P2|STARTED|Blinded Treatment Dosing Period||114
4962753|NCT02696798|12206735|P1|STARTED|Blinded Treatment Dosing Period||104
4962754|NCT02696785|12206832|P4|NOT COMPLETED|Follow-up Period||8
4962755|NCT02696785|12206833|P3|NOT COMPLETED|Follow-up Period||13
4962756|NCT02696785|12206834|P2|NOT COMPLETED|Follow-up Period||0
4962757|NCT02696785|12206835|P1|NOT COMPLETED|Follow-up Period||1
4962758|NCT02696785|12206832|P4|COMPLETED|Follow-up Period||8
4962759|NCT02696785|12206833|P3|COMPLETED|Follow-up Period||11
4962760|NCT02696785|12206834|P2|COMPLETED|Follow-up Period||0
4962761|NCT02696785|12206835|P1|COMPLETED|Follow-up Period||0
4962762|NCT02696785|12206832|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
4962763|NCT02696785|12206833|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
4962764|NCT02696785|12206834|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
4962765|NCT02696785|12206835|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
4962766|NCT02696785|12206832|P4|NOT COMPLETED|Extended Treatment Period||6
4962767|NCT02696785|12206833|P3|NOT COMPLETED|Extended Treatment Period||5
4962768|NCT02696785|12206834|P2|NOT COMPLETED|Extended Treatment Period||6
4962769|NCT02696785|12206835|P1|NOT COMPLETED|Extended Treatment Period||3
4962770|NCT02696785|12206832|P4|COMPLETED|Extended Treatment Period||72
4962771|NCT02696785|12206833|P3|COMPLETED|Extended Treatment Period||74
4962772|NCT02696785|12206834|P2|COMPLETED|Extended Treatment Period||80
4962773|NCT02696785|12206835|P1|COMPLETED|Extended Treatment Period||83
4962774|NCT02696785|12206832|P4|STARTED|Extended Treatment Period||78
4962775|NCT02696785|12206833|P3|STARTED|Extended Treatment Period||79
4962776|NCT02696785|12206834|P2|STARTED|Extended Treatment Period||86
4962777|NCT02696785|12206835|P1|STARTED|Extended Treatment Period||86
4962778|NCT02696785|12206832|P4|NOT COMPLETED|Washout Period||0
4962779|NCT02696785|12206833|P3|NOT COMPLETED|Washout Period||0
4962780|NCT02696785|12206834|P2|NOT COMPLETED|Washout Period||2
4962781|NCT02696785|12206835|P1|NOT COMPLETED|Washout Period||0
4962782|NCT02696785|12206832|P4|COMPLETED|Washout Period||0
4962783|NCT02696785|12206833|P3|COMPLETED|Washout Period||0
4962784|NCT02696785|12206834|P2|COMPLETED|Washout Period||86
4962785|NCT02696785|12206835|P1|COMPLETED|Washout Period||0
4962786|NCT02696785|12206832|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
4962787|NCT02696785|12206833|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
4962788|NCT02696785|12206834|P2|STARTED|Washout Period||88
4962789|NCT02696785|12206835|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
4962790|NCT02696785|12206832|P4|NOT COMPLETED|Blinded Treatment Period||3
4962791|NCT02696785|12206833|P3|NOT COMPLETED|Blinded Treatment Period||4
4962792|NCT02696785|12206834|P2|NOT COMPLETED|Blinded Treatment Period||2
4962793|NCT02696785|12206835|P1|NOT COMPLETED|Blinded Treatment Period||1
4962794|NCT02696785|12206832|P4|COMPLETED|Blinded Treatment Period||78
4962795|NCT02696785|12206833|P3|COMPLETED|Blinded Treatment Period||79
4962796|NCT02696785|12206834|P2|COMPLETED|Blinded Treatment Period||88
4962797|NCT02696785|12206835|P1|COMPLETED|Blinded Treatment Period||86
4962798|NCT02696785|12206832|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
4962799|NCT02696785|12206833|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
4962800|NCT02696785|12206834|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
4962801|NCT02696785|12206835|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
4962802|NCT02696785|12206832|P4|STARTED|Blinded Treatment Period||81
4962803|NCT02696785|12206833|P3|STARTED|Blinded Treatment Period||83
4962804|NCT02696785|12206834|P2|STARTED|Blinded Treatment Period||90
4962805|NCT02696785|12206835|P1|STARTED|Blinded Treatment Period||87
4962806|NCT02696434|12206955|P2|NOT COMPLETED|Overall Study||18
4962807|NCT02696434|12206956|P1|NOT COMPLETED|Overall Study||22
4962808|NCT02696434|12206955|P2|COMPLETED|Overall Study||33
4962809|NCT02696434|12206956|P1|COMPLETED|Overall Study||28
4962810|NCT02696434|12206955|P2|STARTED|Overall Study||51
4962811|NCT02696434|12206956|P1|STARTED|Overall Study||50
4962812|NCT02696317|12206974|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
4962813|NCT02696317|12206975|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
4962814|NCT02696317|12206974|P2|COMPLETED|Period 2, 10 Days of Wear||36
4962815|NCT02696317|12206975|P1|COMPLETED|Period 2, 10 Days of Wear||39
4962816|NCT02696317|12206974|P2|STARTED|Period 2, 10 Days of Wear||36
4962817|NCT02696317|12206975|P1|STARTED|Period 2, 10 Days of Wear||40
4962818|NCT02696317|12206974|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
4962819|NCT02696317|12206975|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
4962820|NCT02696317|12206974|P2|COMPLETED|Period 1, 10 Days of Wear||36
4962821|NCT02696317|12206975|P1|COMPLETED|Period 1, 10 Days of Wear||40
4962822|NCT02696317|12206974|P2|STARTED|Period 1, 10 Days of Wear||36
4962823|NCT02696317|12206975|P1|STARTED|Period 1, 10 Days of Wear||40
4962824|NCT02696317|12206974|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
4962825|NCT02696317|12206975|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
4962826|NCT02696317|12206974|P2|COMPLETED|Habitual, 10 Days of Wear||36
4962827|NCT02696317|12206975|P1|COMPLETED|Habitual, 10 Days of Wear||40
4962828|NCT02696317|12206974|P2|STARTED|Habitual, 10 Days of Wear||40
4962829|NCT02696317|12206975|P1|STARTED|Habitual, 10 Days of Wear||42
4962830|NCT02696291|12206991|P2|NOT COMPLETED|Overall Study||0
4962831|NCT02696291|12206992|P1|NOT COMPLETED|Overall Study||0
4962832|NCT02696291|12206991|P2|COMPLETED|Overall Study||2
4962833|NCT02696291|12206992|P1|COMPLETED|Overall Study||5
4962834|NCT02696291|12206991|P2|STARTED|Overall Study||2
4962835|NCT02696291|12206992|P1|STARTED|Overall Study||5
4962836|NCT02696226|12207019|P4|NOT COMPLETED|Overall Study||0
4962837|NCT02696226|12207020|P3|NOT COMPLETED|Overall Study||2
4962838|NCT02696226|12207021|P2|NOT COMPLETED|Overall Study||0
4962839|NCT02696226|12207022|P1|NOT COMPLETED|Overall Study||1
4962840|NCT02696226|12207019|P4|COMPLETED|Overall Study||0
4962841|NCT02696226|12207020|P3|COMPLETED|Overall Study||0
4962842|NCT02696226|12207021|P2|COMPLETED|Overall Study||0
4962843|NCT02696226|12207022|P1|COMPLETED|Overall Study||0
4962844|NCT02696226|12207019|P4|STARTED|Overall Study||0
4962845|NCT02696226|12207020|P3|STARTED|Overall Study||2
4962846|NCT02696226|12207021|P2|STARTED|Overall Study||0
4962847|NCT02696226|12207022|P1|STARTED|Overall Study||1
4962848|NCT02696083|12207032|P1|NOT COMPLETED|Overall Study||6
4962849|NCT02696083|12207032|P1|COMPLETED|Overall Study||13
4962850|NCT02696083|12207032|P1|STARTED|Overall Study||19
4962851|NCT02696070|12207043|P2|NOT COMPLETED|Overall Study||2
4962852|NCT02696070|12207044|P1|NOT COMPLETED|Overall Study||1
4962853|NCT02696070|12207043|P2|COMPLETED|Overall Study||12
4962854|NCT02696070|12207044|P1|COMPLETED|Overall Study||7
4962855|NCT02696070|12207043|P2|STARTED|Overall Study||14
4962856|NCT02696070|12207044|P1|STARTED|Overall Study||8
4962857|NCT02695719|12207052|P2|NOT COMPLETED|Overall Study||10
4962858|NCT02695719|12207053|P1|NOT COMPLETED|Overall Study||3
4962859|NCT02695719|12207052|P2|COMPLETED|Overall Study||72
4962860|NCT02695719|12207053|P1|COMPLETED|Overall Study||71
4962861|NCT02695719|12207052|P2|STARTED|Overall Study||82
4962862|NCT02695719|12207053|P1|STARTED|Overall Study||74
4962863|NCT02695628|12207071|P1|NOT COMPLETED|Overall Study||1
4962864|NCT02695628|12207071|P1|COMPLETED|Overall Study||4
4962865|NCT02695628|12207071|P1|STARTED|Overall Study||5
4962866|NCT02695537|12207077|P1|NOT COMPLETED|Overall Study||38
4962867|NCT02695537|12207077|P1|COMPLETED|Overall Study||51
4962868|NCT02695537|12207077|P1|STARTED|Overall Study||89
4962869|NCT02695524|12207087|P2|NOT COMPLETED|Overall Study||3
4962870|NCT02695524|12207088|P1|NOT COMPLETED|Overall Study||3
4962871|NCT02695524|12207087|P2|COMPLETED|Overall Study||27
4962872|NCT02695524|12207088|P1|COMPLETED|Overall Study||27
4962873|NCT02695524|12207087|P2|STARTED|Overall Study||30
4962874|NCT02695524|12207088|P1|STARTED|Overall Study||30
4962875|NCT02695446|12207108|P1|NOT COMPLETED|Overall Study||0
4962876|NCT02695446|12207108|P1|COMPLETED|Overall Study||12
4962877|NCT02695446|12207108|P1|STARTED|Overall Study||12
4962878|NCT02695420|12207117|P4|NOT COMPLETED|Overall Study||0
4962879|NCT02695420|12207118|P3|NOT COMPLETED|Overall Study||0
4962880|NCT02695420|12207119|P2|NOT COMPLETED|Overall Study||1
4962881|NCT02695420|12207120|P1|NOT COMPLETED|Overall Study||0
4962882|NCT02695420|12207117|P4|COMPLETED|Overall Study||20
4962883|NCT02695420|12207118|P3|COMPLETED|Overall Study||19
4962884|NCT02695420|12207119|P2|COMPLETED|Overall Study||20
4962885|NCT02695420|12207120|P1|COMPLETED|Overall Study||21
4962886|NCT02695420|12207117|P4|STARTED|Overall Study||20
4962887|NCT02695420|12207118|P3|STARTED|Overall Study||19
4962888|NCT02695420|12207119|P2|STARTED|Overall Study||21
4962889|NCT02695420|12207120|P1|STARTED|Overall Study||21
4962890|NCT02695329|12207142|P2|NOT COMPLETED|Overall Study||5
4962891|NCT02695329|12207143|P1|NOT COMPLETED|Overall Study||5
4962892|NCT02695329|12207142|P2|COMPLETED|Overall Study||45
4962893|NCT02695329|12207143|P1|COMPLETED|Overall Study||45
4962894|NCT02695329|12207142|P2|STARTED|Overall Study||50
4962895|NCT02695329|12207143|P1|STARTED|Overall Study||50
4962896|NCT02695290|12207155|P1|NOT COMPLETED|Overall Study||0
4962897|NCT02695290|12207155|P1|COMPLETED|Overall Study||1
4962898|NCT02695290|12207155|P1|STARTED|Overall Study||1
4962899|NCT02694978|12207163|P2|NOT COMPLETED|Overall Study||60
4962900|NCT02694978|12207164|P1|NOT COMPLETED|Overall Study||71
4962901|NCT02694978|12207163|P2|COMPLETED|Overall Study||948
4962902|NCT02694978|12207164|P1|COMPLETED|Overall Study||935
4962903|NCT02694978|12207163|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
4962904|NCT02694978|12207164|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
4962905|NCT02694978|12207163|P2|STARTED|Overall Study||1008
4962906|NCT02694978|12207164|P1|STARTED|Overall Study||1006
4962907|NCT02694835|12207178|P2|NOT COMPLETED|Overall Study||0
4962908|NCT02694835|12207179|P1|NOT COMPLETED|Overall Study||0
4962909|NCT02694835|12207178|P2|COMPLETED|Overall Study||39
4962910|NCT02694835|12207179|P1|COMPLETED|Overall Study||41
4962911|NCT02694835|12207178|P2|STARTED|Overall Study||39
4962912|NCT02694835|12207179|P1|STARTED|Overall Study||41
4962913|NCT02694757|12207185|P1|NOT COMPLETED|Overall Study||3
4962914|NCT02694757|12207185|P1|COMPLETED|Overall Study||0
4962915|NCT02694757|12207185|P1|STARTED|Overall Study||3
4962916|NCT02694744|12207191|P2|NOT COMPLETED|Overall Study||5
4962917|NCT02694744|12207192|P1|NOT COMPLETED|Overall Study||6
4962918|NCT02694744|12207191|P2|COMPLETED|Overall Study||52
4962919|NCT02694744|12207192|P1|COMPLETED|Overall Study||51
4962920|NCT02694744|12207191|P2|ITT|Overall Study||55
4962921|NCT02694744|12207192|P1|ITT|Overall Study||57
4962922|NCT02694744|12207191|P2|Safety Population|Overall Study||56
4962923|NCT02694744|12207192|P1|Safety Population|Overall Study||57
4962924|NCT02694744|12207191|P2|STARTED|Overall Study||57
4962925|NCT02694744|12207192|P1|STARTED|Overall Study||57
4962926|NCT02694718|12207200|P1|NOT COMPLETED|Overall Study||2
4962927|NCT02694718|12207200|P1|COMPLETED|Overall Study||58
4962928|NCT02694718|12207200|P1|STARTED|Overall Study||60
4962929|NCT02694601|12207210|P1|NOT COMPLETED|Overall Study||0
4962930|NCT02694601|12207210|P1|COMPLETED|Overall Study||10
4962931|NCT02694601|12207210|P1|STARTED|Overall Study||10
4962932|NCT02694562|12207218|P1|NOT COMPLETED|Overall Study||18
4962933|NCT02694562|12207218|P1|COMPLETED|Overall Study||2
4962934|NCT02694562|12207218|P1|STARTED|Overall Study||20
4962935|NCT02694549|12207227|P1|NOT COMPLETED|Overall Study||2
4962936|NCT02694549|12207227|P1|COMPLETED|Overall Study||10
4962937|NCT02694549|12207227|P1|STARTED|Overall Study||12
4962938|NCT02694536|12207233|P1|NOT COMPLETED|Overall Study||80
4962939|NCT02694536|12207233|P1|COMPLETED|Overall Study||0
4962940|NCT02694536|12207233|P1|STARTED|Overall Study||80
4962941|NCT02694523|12207244|P7|NOT COMPLETED|Part B||2
4962942|NCT02694523|12207245|P6|NOT COMPLETED|Part B||5
4962943|NCT02694523|12207246|P5|NOT COMPLETED|Part B||4
4962944|NCT02694523|12207247|P4|NOT COMPLETED|Part B||4
4962945|NCT02694523|12207248|P3|NOT COMPLETED|Part B||20
4962946|NCT02694523|12207249|P2|NOT COMPLETED|Part B||0
4962947|NCT02694523|12207250|P1|NOT COMPLETED|Part B||0
4962948|NCT02694523|12207244|P7|COMPLETED|Part B||51
4962949|NCT02694523|12207245|P6|COMPLETED|Part B||51
4962950|NCT02694523|12207246|P5|COMPLETED|Part B||34
4962951|NCT02694523|12207247|P4|COMPLETED|Part B||140
4962952|NCT02694523|12207248|P3|COMPLETED|Part B||274
4962953|NCT02694523|12207249|P2|COMPLETED|Part B||0
4962954|NCT02694523|12207250|P1|COMPLETED|Part B||0
4962955|NCT02694523|12207244|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
4962956|NCT02694523|12207245|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
4962957|NCT02694523|12207246|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
4962958|NCT02694523|12207247|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
4962959|NCT02694523|12207248|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
4962960|NCT02694523|12207249|P2|STARTED|Part B||0
4962961|NCT02694523|12207250|P1|STARTED|Part B||0
4962962|NCT02694523|12207244|P7|NOT COMPLETED|Part A||0
4962963|NCT02694523|12207245|P6|NOT COMPLETED|Part A||0
4962964|NCT02694523|12207246|P5|NOT COMPLETED|Part A||0
4962965|NCT02694523|12207247|P4|NOT COMPLETED|Part A||0
4962966|NCT02694523|12207248|P3|NOT COMPLETED|Part A||0
4962967|NCT02694523|12207249|P2|NOT COMPLETED|Part A||7
4962968|NCT02694523|12207250|P1|NOT COMPLETED|Part A||13
4962969|NCT02694523|12207244|P7|COMPLETED|Part A||0
4962970|NCT02694523|12207245|P6|COMPLETED|Part A||0
4962971|NCT02694523|12207246|P5|COMPLETED|Part A||0
4962972|NCT02694523|12207247|P4|COMPLETED|Part A||0
4962973|NCT02694523|12207248|P3|COMPLETED|Part A||0
4962974|NCT02694523|12207249|P2|COMPLETED|Part A||294
4962975|NCT02694523|12207250|P1|COMPLETED|Part A||291
4962976|NCT02694523|12207244|P7|STARTED|Part A||0
4962977|NCT02694523|12207245|P6|STARTED|Part A||0
4962978|NCT02694523|12207246|P5|STARTED|Part A||0
4962979|NCT02694523|12207247|P4|STARTED|Part A||0
4962980|NCT02694523|12207248|P3|STARTED|Part A||0
4962981|NCT02694523|12207249|P2|STARTED|Part A||301
4962982|NCT02694523|12207250|P1|STARTED|Part A||304
4962983|NCT02694445|12207274|P1|NOT COMPLETED|Overall Study||52
4962984|NCT02694445|12207274|P1|COMPLETED|Overall Study||3046
4962985|NCT02694445|12207274|P1|STARTED|Overall Study||3098
4962986|NCT02694328|12207280|P2|NOT COMPLETED|Overall Study||98
4962987|NCT02694328|12207281|P1|NOT COMPLETED|Overall Study||100
4962988|NCT02694328|12207280|P2|COMPLETED|Overall Study||176
4962989|NCT02694328|12207281|P1|COMPLETED|Overall Study||176
4962990|NCT02694328|12207280|P2|STARTED|Overall Study||274
4962991|NCT02694328|12207281|P1|STARTED|Overall Study||276
4962992|NCT02694315|12207293|P1|NOT COMPLETED|Overall Study||0
4962993|NCT02694315|12207293|P1|COMPLETED|Overall Study||200
4962994|NCT02694315|12207293|P1|STARTED|Overall Study||200
4962995|NCT02694198|12207298|P1|NOT COMPLETED|Overall Study||0
4962996|NCT02694198|12207298|P1|COMPLETED|Overall Study||135
4962997|NCT02694198|12207298|P1|STARTED|Overall Study||135
4962998|NCT02693834|12207303|P2|NOT COMPLETED|Week 2 Practice||1
4962999|NCT02693834|12207304|P1|NOT COMPLETED|Week 2 Practice||0
4963000|NCT02693834|12207303|P2|COMPLETED|Week 2 Practice||10
4963001|NCT02693834|12207304|P1|COMPLETED|Week 2 Practice||10
4963002|NCT02693834|12207303|P2|STARTED|Week 2 Practice||11
4963003|NCT02693834|12207304|P1|STARTED|Week 2 Practice||10
4963004|NCT02693834|12207303|P2|NOT COMPLETED|Week 1 Practice||0
4963005|NCT02693834|12207304|P1|NOT COMPLETED|Week 1 Practice||0
4963006|NCT02693834|12207303|P2|COMPLETED|Week 1 Practice||11
4963007|NCT02693834|12207304|P1|COMPLETED|Week 1 Practice||10
4963008|NCT02693834|12207303|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
4963009|NCT02693834|12207304|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
4963010|NCT02693834|12207303|P2|NOT COMPLETED|Baseline Measurement||0
4963011|NCT02693834|12207304|P1|NOT COMPLETED|Baseline Measurement||2
4963012|NCT02693834|12207303|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
4963013|NCT02693834|12207304|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
4963014|NCT02693834|12207303|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
4963015|NCT02693834|12207304|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
4963016|NCT02693743|12207314|P2|NOT COMPLETED|Overall Study||0
4963017|NCT02693743|12207315|P1|NOT COMPLETED|Overall Study||1
4963018|NCT02693743|12207314|P2|COMPLETED|Overall Study||0
4963019|NCT02693743|12207315|P1|COMPLETED|Overall Study||0
4963020|NCT02693743|12207314|P2|STARTED|Overall Study||0
4963021|NCT02693743|12207315|P1|STARTED|Overall Study||1
4963022|NCT02693704|12207325|P4|NOT COMPLETED|Overall Study||0
4963023|NCT02693704|12207326|P3|NOT COMPLETED|Overall Study||0
4963024|NCT02693704|12207327|P2|NOT COMPLETED|Overall Study||0
4963025|NCT02693704|12207328|P1|NOT COMPLETED|Overall Study||0
4963026|NCT02693704|12207325|P4|COMPLETED|Overall Study||10
4963027|NCT02693704|12207326|P3|COMPLETED|Overall Study||10
4963028|NCT02693704|12207327|P2|COMPLETED|Overall Study||10
4963029|NCT02693704|12207328|P1|COMPLETED|Overall Study||10
4963030|NCT02693704|12207325|P4|STARTED|Overall Study||10
4963031|NCT02693704|12207326|P3|STARTED|Overall Study||10
4963032|NCT02693704|12207327|P2|STARTED|Overall Study||10
4963033|NCT02693704|12207328|P1|STARTED|Overall Study||10
4963034|NCT02693171|12207346|P1|NOT COMPLETED|Overall Study||9
4963035|NCT02693171|12207346|P1|COMPLETED|Overall Study||3
4963036|NCT02693171|12207346|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
4963037|NCT02693132|12207356|P3|NOT COMPLETED|Overall Study||1
4963038|NCT02693132|12207357|P2|NOT COMPLETED|Overall Study||1
4963039|NCT02693132|12207358|P1|NOT COMPLETED|Overall Study||1
4963040|NCT02693132|12207356|P3|COMPLETED|Overall Study||17
4963041|NCT02693132|12207357|P2|COMPLETED|Overall Study||16
4963042|NCT02693132|12207358|P1|COMPLETED|Overall Study||16
4963043|NCT02693132|12207356|P3|STARTED|Overall Study||18
4963044|NCT02693132|12207357|P2|STARTED|Overall Study||17
4963045|NCT02693132|12207358|P1|STARTED|Overall Study||17
4963046|NCT02693106|12207378|P1|NOT COMPLETED|Overall Study||3
4963047|NCT02693106|12207378|P1|COMPLETED|Overall Study||10
4963048|NCT02693106|12207378|P1|STARTED|Overall Study||13
4963049|NCT02693002|12207390|P2|NOT COMPLETED|Overall Study||0
4963050|NCT02693002|12207391|P1|NOT COMPLETED|Overall Study||1
4963051|NCT02693002|12207390|P2|COMPLETED|Overall Study||2
4963052|NCT02693002|12207391|P1|COMPLETED|Overall Study||1
4963053|NCT02693002|12207390|P2|STARTED|Overall Study||2
4963054|NCT02693002|12207391|P1|STARTED|Overall Study||2
4963055|NCT02692859|12207405|P2|NOT COMPLETED|Overall Study||95
4963056|NCT02692859|12207406|P1|NOT COMPLETED|Overall Study||84
4963057|NCT02692859|12207405|P2|COMPLETED|Overall Study||901
4963058|NCT02692859|12207406|P1|COMPLETED|Overall Study||912
4963059|NCT02692859|12207405|P2|STARTED|Overall Study||996
4963060|NCT02692859|12207406|P1|STARTED|Overall Study||996
4963061|NCT02692716|12207414|P2|NOT COMPLETED|Overall Study||6
4963062|NCT02692716|12207415|P1|NOT COMPLETED|Overall Study||5
4963063|NCT02692716|12207414|P2|COMPLETED|Overall Study||1586
4963064|NCT02692716|12207415|P1|COMPLETED|Overall Study||1586
4963065|NCT02692716|12207414|P2|Exposed|Overall Study||1591
4963066|NCT02692716|12207415|P1|Exposed|Overall Study||1591
4963067|NCT02692716|12207414|P2|Full Analysis Set (FAS)|Overall Study||1592
4963068|NCT02692716|12207415|P1|Full Analysis Set (FAS)|Overall Study||1591
4963069|NCT02692716|12207414|P2|STARTED|Overall Study||1592
4963070|NCT02692716|12207415|P1|STARTED|Overall Study||1591
4963071|NCT02692703|12207455|P1|NOT COMPLETED|Overall Study||2
4963072|NCT02692703|12207455|P1|COMPLETED|Overall Study||98
4963073|NCT02692703|12207455|P1|STARTED|Overall Study||100
4963074|NCT02692560|12207463|P2|NOT COMPLETED|Overall Study||6
4963075|NCT02692560|12207464|P1|NOT COMPLETED|Overall Study||0
4963076|NCT02692560|12207463|P2|COMPLETED|Overall Study||25
4963077|NCT02692560|12207464|P1|COMPLETED|Overall Study||29
4963078|NCT02692560|12207463|P2|STARTED|Overall Study||31
4963079|NCT02692560|12207464|P1|STARTED|Overall Study||29
4963080|NCT02692495|12207486|P2|NOT COMPLETED|Overall Study||0
4963081|NCT02692495|12207487|P1|NOT COMPLETED|Overall Study||0
4963082|NCT02692495|12207486|P2|COMPLETED|Overall Study||4
4963083|NCT02692495|12207487|P1|COMPLETED|Overall Study||12
4963084|NCT02692495|12207486|P2|STARTED|Overall Study||4
4963085|NCT02692495|12207487|P1|STARTED|Overall Study||12
4963086|NCT02692482|12207504|P2|NOT COMPLETED|Overall Study||4
4963087|NCT02692482|12207505|P1|NOT COMPLETED|Overall Study||3
4963088|NCT02692482|12207504|P2|COMPLETED|Overall Study||178
4963089|NCT02692482|12207505|P1|COMPLETED|Overall Study||174
4963090|NCT02692482|12207504|P2|STARTED|Overall Study||182
4963091|NCT02692482|12207505|P1|STARTED|Overall Study||177
4963092|NCT02692417|12207519|P2|NOT COMPLETED|Overall Study||1
4963093|NCT02692417|12207520|P1|NOT COMPLETED|Overall Study||6
4963094|NCT02692417|12207519|P2|COMPLETED|Overall Study||6
4963095|NCT02692417|12207520|P1|COMPLETED|Overall Study||3
4963096|NCT02692417|12207519|P2|STARTED|Overall Study||7
4963097|NCT02692417|12207520|P1|STARTED|Overall Study||9
4963098|NCT02692235|12207532|P2|NOT COMPLETED|Overall Study||3
4963099|NCT02692235|12207533|P1|NOT COMPLETED|Overall Study||3
4963100|NCT02692235|12207532|P2|COMPLETED|Overall Study||11
4963101|NCT02692235|12207533|P1|COMPLETED|Overall Study||11
4963102|NCT02692235|12207532|P2|STARTED|Overall Study||14
4963103|NCT02692235|12207533|P1|STARTED|Overall Study||14
4963104|NCT02692209|12207541|P1|NOT COMPLETED|Overall Study||0
4963105|NCT02692209|12207541|P1|COMPLETED|Overall Study||298
4963106|NCT02692209|12207541|P1|STARTED|Overall Study||298
4963107|NCT02691936|12207549|P2|NOT COMPLETED|Overall Study||5
4963108|NCT02691936|12207550|P1|NOT COMPLETED|Overall Study||2
4963109|NCT02691936|12207549|P2|COMPLETED|Overall Study||29
4963110|NCT02691936|12207550|P1|COMPLETED|Overall Study||33
4963111|NCT02691936|12207549|P2|STARTED|Overall Study||34
4963112|NCT02691936|12207550|P1|STARTED|Overall Study||35
4963113|NCT02691741|12207572|P2|NOT COMPLETED|Overall Study||7
4963114|NCT02691741|12207573|P1|NOT COMPLETED|Overall Study||1
4963115|NCT02691741|12207572|P2|COMPLETED|Overall Study||87
4963116|NCT02691741|12207573|P1|COMPLETED|Overall Study||93
4963117|NCT02691741|12207572|P2|Safety Analysis Set|Overall Study||89
4963118|NCT02691741|12207573|P1|Safety Analysis Set|Overall Study||93
4963119|NCT02691741|12207572|P2|Best-Case Analysis Set|Overall Study||85
4963120|NCT02691741|12207573|P1|Best-Case Analysis Set|Overall Study||86
4963121|NCT02691741|12207572|P2|All-Implanted Analysis Set|Overall Study||89
4963122|NCT02691741|12207573|P1|All-Implanted Analysis Set|Overall Study||93
4963123|NCT02691741|12207572|P2|STARTED|Overall Study||94
4963124|NCT02691741|12207573|P1|STARTED|Overall Study||94
4963125|NCT02691702|12207613|P11|NOT COMPLETED|Overall Study||2
4963126|NCT02691702|12207614|P10|NOT COMPLETED|Overall Study||2
4963127|NCT02691702|12207615|P9|NOT COMPLETED|Overall Study||2
4963128|NCT02691702|12207616|P8|NOT COMPLETED|Overall Study||0
4963129|NCT02691702|12207617|P7|NOT COMPLETED|Overall Study||3
4963130|NCT02691702|12207618|P6|NOT COMPLETED|Overall Study||3
4963131|NCT02691702|12207619|P5|NOT COMPLETED|Overall Study||0
4963132|NCT02691702|12207620|P4|NOT COMPLETED|Overall Study||0
4963133|NCT02691702|12207621|P3|NOT COMPLETED|Overall Study||1
4963134|NCT02691702|12207622|P2|NOT COMPLETED|Overall Study||1
4963135|NCT02691702|12207623|P1|NOT COMPLETED|Overall Study||2
4963136|NCT02691702|12207613|P11|COMPLETED|Overall Study||6
4963137|NCT02691702|12207614|P10|COMPLETED|Overall Study||6
4963138|NCT02691702|12207615|P9|COMPLETED|Overall Study||6
4963139|NCT02691702|12207616|P8|COMPLETED|Overall Study||12
4963140|NCT02691702|12207617|P7|COMPLETED|Overall Study||5
4963141|NCT02691702|12207618|P6|COMPLETED|Overall Study||5
4963142|NCT02691702|12207619|P5|COMPLETED|Overall Study||8
4963143|NCT02691702|12207620|P4|COMPLETED|Overall Study||8
4963144|NCT02691702|12207621|P3|COMPLETED|Overall Study||7
4963145|NCT02691702|12207622|P2|COMPLETED|Overall Study||10
4963146|NCT02691702|12207623|P1|COMPLETED|Overall Study||8
4963147|NCT02691702|12207613|P11|STARTED|Overall Study||8
4963148|NCT02691702|12207614|P10|STARTED|Overall Study||8
4963149|NCT02691702|12207615|P9|STARTED|Overall Study||8
4963150|NCT02691702|12207616|P8|STARTED|Overall Study||12
4963151|NCT02691702|12207617|P7|STARTED|Overall Study||8
4963152|NCT02691702|12207618|P6|STARTED|Overall Study||8
4963153|NCT02691702|12207619|P5|STARTED|Overall Study||8
4963154|NCT02691702|12207620|P4|STARTED|Overall Study||8
4963155|NCT02691702|12207621|P3|STARTED|Overall Study||8
4963156|NCT02691702|12207622|P2|STARTED|Overall Study||11
4963157|NCT02691702|12207623|P1|STARTED|Overall Study||10
4963158|NCT02691572|12207909|P2|NOT COMPLETED|Overall Study||1
4963159|NCT02691572|12207910|P1|NOT COMPLETED|Overall Study||1
4963160|NCT02691572|12207909|P2|COMPLETED|Overall Study||39
4963161|NCT02691572|12207910|P1|COMPLETED|Overall Study||39
4963162|NCT02691572|12207909|P2|STARTED|Overall Study||40
4963163|NCT02691572|12207910|P1|STARTED|Overall Study||40
4963164|NCT02691507|12207918|P2|NOT COMPLETED|Overall Study||1
4963165|NCT02691507|12207919|P1|NOT COMPLETED|Overall Study||0
4963166|NCT02691507|12207918|P2|COMPLETED|Overall Study||12
4963167|NCT02691507|12207919|P1|COMPLETED|Overall Study||40
4963168|NCT02691507|12207918|P2|STARTED|Overall Study||13
4963169|NCT02691507|12207919|P1|STARTED|Overall Study||40
4963170|NCT02691494|12208052|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||17
4963171|NCT02691494|12208053|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||7
4963172|NCT02691494|12208054|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||5
4963173|NCT02691494|12208052|P3|COMPLETED|Post-Treatment Follow-Up Period||42
4963174|NCT02691494|12208053|P2|COMPLETED|Post-Treatment Follow-Up Period||18
4963175|NCT02691494|12208054|P1|COMPLETED|Post-Treatment Follow-Up Period||9
4963176|NCT02691494|12208052|P3|STARTED|Post-Treatment Follow-Up Period||59
4963177|NCT02691494|12208053|P2|STARTED|Post-Treatment Follow-Up Period||25
4963178|NCT02691494|12208054|P1|STARTED|Post-Treatment Follow-Up Period||14
4963179|NCT02691494|12208052|P3|NOT COMPLETED|Treatment Period||41
4963180|NCT02691494|12208053|P2|NOT COMPLETED|Treatment Period||26
4963181|NCT02691494|12208054|P1|NOT COMPLETED|Treatment Period||22
4963182|NCT02691494|12208052|P3|COMPLETED|Treatment Period|completed treatment period|148
4963183|NCT02691494|12208053|P2|COMPLETED|Treatment Period|completed treatment period|69
4963184|NCT02691494|12208054|P1|COMPLETED|Treatment Period|completed treatment period|72
4963185|NCT02691494|12208052|P3|STARTED|Treatment Period||189
4963186|NCT02691494|12208053|P2|STARTED|Treatment Period||95
4963187|NCT02691494|12208054|P1|STARTED|Treatment Period||94
4963188|NCT02691468|12208082|P2|NOT COMPLETED|Overall Study||2
4963189|NCT02691468|12208083|P1|NOT COMPLETED|Overall Study||6
4963190|NCT02691468|12208082|P2|COMPLETED|Overall Study||52
4963191|NCT02691468|12208083|P1|COMPLETED|Overall Study||48
4963192|NCT02691468|12208082|P2|STARTED|Overall Study||54
4963193|NCT02691468|12208083|P1|STARTED|Overall Study||54
4963194|NCT02691416|12208093|P2|NOT COMPLETED|Overall Study||0
4963195|NCT02691416|12208094|P1|NOT COMPLETED|Overall Study||0
4963196|NCT02691416|12208093|P2|COMPLETED|Overall Study||30
4963197|NCT02691416|12208094|P1|COMPLETED|Overall Study||30
4963198|NCT02691416|12208093|P2|STARTED|Overall Study||30
4963199|NCT02691416|12208094|P1|STARTED|Overall Study||30
4963200|NCT02691260|12208118|P4|NOT COMPLETED|Overall Study||3
4963201|NCT02691260|12208119|P3|NOT COMPLETED|Overall Study||2
4963202|NCT02691260|12208120|P2|NOT COMPLETED|Overall Study||2
4963203|NCT02691260|12208121|P1|NOT COMPLETED|Overall Study||2
4963204|NCT02691260|12208118|P4|COMPLETED|Overall Study||23
4963205|NCT02691260|12208119|P3|COMPLETED|Overall Study||25
4963206|NCT02691260|12208120|P2|COMPLETED|Overall Study||24
4963207|NCT02691260|12208121|P1|COMPLETED|Overall Study||24
4963208|NCT02691260|12208118|P4|STARTED|Overall Study||26
4963209|NCT02691260|12208119|P3|STARTED|Overall Study||27
4963210|NCT02691260|12208120|P2|STARTED|Overall Study||26
4963211|NCT02691260|12208121|P1|STARTED|Overall Study||26
4963212|NCT02691143|12208133|P2|NOT COMPLETED|Overall Study||0
4963213|NCT02691143|12208134|P1|NOT COMPLETED|Overall Study||0
4963214|NCT02691143|12208133|P2|COMPLETED|Overall Study||23
4963215|NCT02691143|12208134|P1|COMPLETED|Overall Study||27
4963216|NCT02691143|12208133|P2|STARTED|Overall Study||23
4963217|NCT02691143|12208134|P1|STARTED|Overall Study||27
4963218|NCT02691013|12208144|P2|NOT COMPLETED|Overall Study||0
4963219|NCT02691013|12208145|P1|NOT COMPLETED|Overall Study||3
4963220|NCT02691013|12208144|P2|COMPLETED|Overall Study||59
4963221|NCT02691013|12208145|P1|COMPLETED|Overall Study||58
4963222|NCT02691013|12208144|P2|STARTED|Overall Study||59
4963223|NCT02691013|12208145|P1|STARTED|Overall Study||61
4963224|NCT02690974|12208159|P1|NOT COMPLETED|Overall Study||40
4963225|NCT02690974|12208159|P1|COMPLETED|Overall Study||262
4963226|NCT02690974|12208159|P1|STARTED|Overall Study||302
4963227|NCT02690948|12208172|P2|NOT COMPLETED|Overall Study||0
4963228|NCT02690948|12208173|P1|NOT COMPLETED|Overall Study||0
4963229|NCT02690948|12208172|P2|COMPLETED|Overall Study||7
4963230|NCT02690948|12208173|P1|COMPLETED|Overall Study||9
4963231|NCT02690948|12208172|P2|STARTED|Overall Study||7
4963232|NCT02690948|12208173|P1|STARTED|Overall Study||9
4963233|NCT02690935|12208191|P2|NOT COMPLETED|Overall Study||0
4963234|NCT02690935|12208192|P1|NOT COMPLETED|Overall Study||0
4963235|NCT02690935|12208191|P2|COMPLETED|Overall Study|Count of participants|51
4963236|NCT02690935|12208192|P1|COMPLETED|Overall Study|Count of participants|51
4963237|NCT02690935|12208191|P2|STARTED|Overall Study|Count of participants|51
4963238|NCT02690935|12208192|P1|STARTED|Overall Study|Count of participants|51
4963239|NCT02690727|12208200|P2|NOT COMPLETED|Overall Study||2
4963240|NCT02690727|12208201|P1|NOT COMPLETED|Overall Study||2
4963241|NCT02690727|12208200|P2|COMPLETED|Overall Study||7
4963242|NCT02690727|12208201|P1|COMPLETED|Overall Study||7
4963243|NCT02690727|12208200|P2|STARTED|Overall Study||9
4963244|NCT02690727|12208201|P1|STARTED|Overall Study||9
4963245|NCT02690701|12208213|P2|NOT COMPLETED|Treatment Period 2||5
4963246|NCT02690701|12208214|P1|NOT COMPLETED|Treatment Period 2||3
4963247|NCT02690701|12208213|P2|COMPLETED|Treatment Period 2||37
4963248|NCT02690701|12208214|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
4963249|NCT02690701|12208213|P2|STARTED|Treatment Period 2||42
4963250|NCT02690701|12208214|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
4963251|NCT02690701|12208213|P2|NOT COMPLETED|Treatment Period 1||3
4963252|NCT02690701|12208214|P1|NOT COMPLETED|Treatment Period 1||2
4963253|NCT02690701|12208213|P2|COMPLETED|Treatment Period 1||42
4963254|NCT02690701|12208214|P1|COMPLETED|Treatment Period 1||44
4963255|NCT02690701|12208213|P2|STARTED|Treatment Period 1||45
4963256|NCT02690701|12208214|P1|STARTED|Treatment Period 1||46
4963257|NCT02690207|12208279|P1|NOT COMPLETED|Overall Study||253
4963258|NCT02690207|12208279|P1|COMPLETED|Overall Study||8434
4963259|NCT02690207|12208279|P1|STARTED|Overall Study||8687
4963260|NCT02690194|12208289|P3|NOT COMPLETED|Overall Study||0
4963261|NCT02690194|12208290|P2|NOT COMPLETED|Overall Study||4
4963262|NCT02690194|12208291|P1|NOT COMPLETED|Overall Study||1
4963263|NCT02690194|12208289|P3|COMPLETED|Overall Study||19
4963264|NCT02690194|12208290|P2|COMPLETED|Overall Study||14
4963265|NCT02690194|12208291|P1|COMPLETED|Overall Study||16
4963266|NCT02690194|12208289|P3|STARTED|Overall Study||19
4963267|NCT02690194|12208290|P2|STARTED|Overall Study||18
4963268|NCT02690194|12208291|P1|STARTED|Overall Study||17
4963269|NCT02690181|12208340|P6|NOT COMPLETED|Overall Study||0
4963270|NCT02690181|12208341|P5|NOT COMPLETED|Overall Study||0
4963271|NCT02690181|12208342|P4|NOT COMPLETED|Overall Study||0
4963272|NCT02690181|12208343|P3|NOT COMPLETED|Overall Study||0
4963273|NCT02690181|12208344|P2|NOT COMPLETED|Overall Study||0
4963274|NCT02690181|12208345|P1|NOT COMPLETED|Overall Study||0
4963275|NCT02690181|12208340|P6|COMPLETED|Overall Study||21
4963276|NCT02690181|12208341|P5|COMPLETED|Overall Study||6
4963277|NCT02690181|12208342|P4|COMPLETED|Overall Study||10
4963278|NCT02690181|12208343|P3|COMPLETED|Overall Study||15
4963279|NCT02690181|12208344|P2|COMPLETED|Overall Study||14
4963280|NCT02690181|12208345|P1|COMPLETED|Overall Study||14
4963281|NCT02690181|12208340|P6|STARTED|Overall Study||21
4963282|NCT02690181|12208341|P5|STARTED|Overall Study||6
4963283|NCT02690181|12208342|P4|STARTED|Overall Study||10
4963284|NCT02690181|12208343|P3|STARTED|Overall Study||15
4963285|NCT02690181|12208344|P2|STARTED|Overall Study||14
4963286|NCT02690181|12208345|P1|STARTED|Overall Study||14
4963287|NCT02689973|12208471|P4|NOT COMPLETED|Overall Study||53
4963288|NCT02689973|12208472|P3|NOT COMPLETED|Overall Study||72
4963289|NCT02689973|12208473|P2|NOT COMPLETED|Overall Study||49
4963290|NCT02689973|12208474|P1|NOT COMPLETED|Overall Study||54
4963291|NCT02689973|12208471|P4|COMPLETED|Overall Study||232
4963292|NCT02689973|12208472|P3|COMPLETED|Overall Study||279
4963293|NCT02689973|12208473|P2|COMPLETED|Overall Study||221
4963294|NCT02689973|12208474|P1|COMPLETED|Overall Study||257
4963295|NCT02689973|12208471|P4|STARTED|Overall Study||285
4963296|NCT02689973|12208472|P3|STARTED|Overall Study||351
4963297|NCT02689973|12208473|P2|STARTED|Overall Study||270
4963298|NCT02689973|12208474|P1|STARTED|Overall Study||311
4963299|NCT02689804|12208498|P2|NOT COMPLETED|Overall Study||0
4963300|NCT02689804|12208499|P1|NOT COMPLETED|Overall Study||2
4963301|NCT02689804|12208498|P2|COMPLETED|Overall Study||16
4963302|NCT02689804|12208499|P1|COMPLETED|Overall Study||16
4963303|NCT02689804|12208498|P2|STARTED|Overall Study||16
4963304|NCT02689804|12208499|P1|STARTED|Overall Study||18
4963305|NCT02689492|12208525|P1|NOT COMPLETED|Overall Study||86
4963306|NCT02689492|12208525|P1|COMPLETED|Overall Study||315
4963307|NCT02689492|12208525|P1|STARTED|Overall Study||401
4963308|NCT02689219|12208541|P2|NOT COMPLETED|Overall Study||7
4963309|NCT02689219|12208542|P1|NOT COMPLETED|Overall Study||11
4963310|NCT02689219|12208541|P2|COMPLETED|Overall Study||0
4963311|NCT02689219|12208542|P1|COMPLETED|Overall Study||0
4963312|NCT02689219|12208541|P2|STARTED|Overall Study||7
4963313|NCT02689219|12208542|P1|STARTED|Overall Study||11
4963314|NCT02689206|12208559|P5|NOT COMPLETED|Overall Study||8
4963315|NCT02689206|12208560|P4|NOT COMPLETED|Overall Study||4
4963316|NCT02689206|12208561|P3|NOT COMPLETED|Overall Study||4
4963317|NCT02689206|12208562|P2|NOT COMPLETED|Overall Study||1
4963318|NCT02689206|12208563|P1|NOT COMPLETED|Overall Study||3
4963319|NCT02689206|12208559|P5|COMPLETED|Overall Study||14
4963320|NCT02689206|12208560|P4|COMPLETED|Overall Study||17
4963321|NCT02689206|12208561|P3|COMPLETED|Overall Study||16
4963322|NCT02689206|12208562|P2|COMPLETED|Overall Study||19
4963323|NCT02689206|12208563|P1|COMPLETED|Overall Study||17
4963324|NCT02689206|12208559|P5|STARTED|Overall Study||22
4963325|NCT02689206|12208560|P4|STARTED|Overall Study||21
4963326|NCT02689206|12208561|P3|STARTED|Overall Study||20
4963327|NCT02689206|12208562|P2|STARTED|Overall Study||20
4963328|NCT02689206|12208563|P1|STARTED|Overall Study||20
4963329|NCT02689154|12208767|P1|NOT COMPLETED|Overall Study||0
4963330|NCT02689154|12208767|P1|COMPLETED|Overall Study||18
4963331|NCT02689154|12208767|P1|STARTED|Overall Study||18
4963332|NCT02688933|12208776|P2|NOT COMPLETED|Overall Study||37
4963333|NCT02688933|12208777|P1|NOT COMPLETED|Overall Study||29
4963334|NCT02688933|12208776|P2|COMPLETED|Overall Study||281
4963335|NCT02688933|12208777|P1|COMPLETED|Overall Study||291
4963336|NCT02688933|12208776|P2|STARTED|Overall Study||318
4963337|NCT02688933|12208777|P1|STARTED|Overall Study||320
4963338|NCT02688868|12208797|P1|NOT COMPLETED|Overall Study||4
4963339|NCT02688868|12208797|P1|COMPLETED|Overall Study||34
4963340|NCT02688868|12208797|P1|STARTED|Overall Study||38
4963341|NCT02688842|12208809|P1|NOT COMPLETED|Overall Study||0
4963342|NCT02688842|12208809|P1|COMPLETED|Overall Study||38
4963343|NCT02688842|12208809|P1|STARTED|Overall Study||38
4963344|NCT02688829|12208825|P1|NOT COMPLETED|Overall Study||2
4963345|NCT02688829|12208825|P1|COMPLETED|Overall Study||19
4963346|NCT02688829|12208825|P1|STARTED|Overall Study||21
4963347|NCT02688764|12208837|P2|NOT COMPLETED|Overall Study||17
4963348|NCT02688764|12208838|P1|NOT COMPLETED|Overall Study||40
4963349|NCT02688764|12208837|P2|COMPLETED|Overall Study||2
4963350|NCT02688764|12208838|P1|COMPLETED|Overall Study||26
4963351|NCT02688764|12208837|P2|Treated in Stage 2|Overall Study||8
4963352|NCT02688764|12208838|P1|Treated in Stage 2|Overall Study||43
4963353|NCT02688764|12208837|P2|Treated in Stage 1|Overall Study||19
4963354|NCT02688764|12208838|P1|Treated in Stage 1|Overall Study||66
4963355|NCT02688764|12208837|P2|STARTED|Overall Study||19
4963356|NCT02688764|12208838|P1|STARTED|Overall Study||66
4963357|NCT02688556|12208888|P2|NOT COMPLETED|Overall Study||12
4963358|NCT02688556|12208889|P1|NOT COMPLETED|Overall Study||25
4963359|NCT02688556|12208888|P2|COMPLETED|Overall Study||361
4963360|NCT02688556|12208889|P1|COMPLETED|Overall Study||347
4963361|NCT02688556|12208888|P2|STARTED|Overall Study||373
4963362|NCT02688556|12208889|P1|STARTED|Overall Study||372
4963363|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963364|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963365|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963366|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963367|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963368|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963369|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963370|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963371|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963372|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963373|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963374|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963375|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963376|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963377|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963378|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963379|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963380|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963381|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963382|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963383|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963384|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963385|NCT02688387|12208905|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
4963386|NCT02688387|12208906|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
4963387|NCT02688387|12208907|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
4963388|NCT02688387|12208908|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
4963389|NCT02688387|12208909|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963390|NCT02688387|12208910|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963391|NCT02688387|12208911|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963392|NCT02688387|12208912|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963393|NCT02688387|12208913|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963394|NCT02688387|12208914|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963395|NCT02688387|12208915|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963396|NCT02688387|12208916|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963397|NCT02688387|12208917|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963398|NCT02688387|12208918|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963399|NCT02688387|12208919|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963400|NCT02688387|12208920|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963401|NCT02688387|12208921|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963402|NCT02688387|12208922|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963403|NCT02688387|12208923|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963404|NCT02688387|12208924|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963405|NCT02688387|12208925|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963406|NCT02688387|12208926|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
4963407|NCT02688387|12208905|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
4963408|NCT02688387|12208906|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
4963409|NCT02688387|12208907|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
4963410|NCT02688387|12208908|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
4963411|NCT02688387|12208909|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963412|NCT02688387|12208910|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963413|NCT02688387|12208911|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963414|NCT02688387|12208912|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963415|NCT02688387|12208913|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963416|NCT02688387|12208914|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963417|NCT02688387|12208915|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963418|NCT02688387|12208916|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963419|NCT02688387|12208917|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963420|NCT02688387|12208918|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963421|NCT02688387|12208919|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963422|NCT02688387|12208920|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963423|NCT02688387|12208921|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963424|NCT02688387|12208922|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963425|NCT02688387|12208923|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963426|NCT02688387|12208924|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963427|NCT02688387|12208925|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963428|NCT02688387|12208926|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
4963429|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963430|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
4963431|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
4963432|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
4963433|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963434|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963435|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963436|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963437|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963438|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963439|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963440|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963441|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963442|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963443|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963444|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963445|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963446|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963447|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963448|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963449|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963450|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963451|NCT02688387|12208905|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
4963452|NCT02688387|12208906|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
4963453|NCT02688387|12208907|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
4963454|NCT02688387|12208908|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
4963455|NCT02688387|12208909|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963456|NCT02688387|12208910|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963457|NCT02688387|12208911|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963458|NCT02688387|12208912|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963459|NCT02688387|12208913|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963460|NCT02688387|12208914|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963461|NCT02688387|12208915|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963462|NCT02688387|12208916|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963463|NCT02688387|12208917|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963464|NCT02688387|12208918|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963465|NCT02688387|12208919|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963466|NCT02688387|12208920|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963467|NCT02688387|12208921|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963468|NCT02688387|12208922|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963469|NCT02688387|12208923|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963470|NCT02688387|12208924|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963471|NCT02688387|12208925|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963472|NCT02688387|12208926|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
4963473|NCT02688387|12208905|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
4963474|NCT02688387|12208906|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
4963475|NCT02688387|12208907|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
4963476|NCT02688387|12208908|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
4963477|NCT02688387|12208909|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963478|NCT02688387|12208910|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963479|NCT02688387|12208911|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963480|NCT02688387|12208912|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963481|NCT02688387|12208913|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963482|NCT02688387|12208914|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963483|NCT02688387|12208915|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963484|NCT02688387|12208916|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963485|NCT02688387|12208917|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963486|NCT02688387|12208918|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963487|NCT02688387|12208919|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963488|NCT02688387|12208920|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963489|NCT02688387|12208921|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963490|NCT02688387|12208922|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963491|NCT02688387|12208923|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963492|NCT02688387|12208924|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963493|NCT02688387|12208925|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963494|NCT02688387|12208926|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
4963495|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963496|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
4963497|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963498|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963499|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963500|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963501|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963502|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963503|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963504|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963505|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963506|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963507|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963508|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963509|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963510|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963511|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963512|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963513|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963514|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963515|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963516|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963517|NCT02688387|12208905|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
4963518|NCT02688387|12208906|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
4963519|NCT02688387|12208907|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
4963520|NCT02688387|12208908|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
4963521|NCT02688387|12208909|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963522|NCT02688387|12208910|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963523|NCT02688387|12208911|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963524|NCT02688387|12208912|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963525|NCT02688387|12208913|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963526|NCT02688387|12208914|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963527|NCT02688387|12208915|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963528|NCT02688387|12208916|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963529|NCT02688387|12208917|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963530|NCT02688387|12208918|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963531|NCT02688387|12208919|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963532|NCT02688387|12208920|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963533|NCT02688387|12208921|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963534|NCT02688387|12208922|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963535|NCT02688387|12208923|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963536|NCT02688387|12208924|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963537|NCT02688387|12208925|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963538|NCT02688387|12208926|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
4963539|NCT02688387|12208905|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
4963540|NCT02688387|12208906|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
4963541|NCT02688387|12208907|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
4963542|NCT02688387|12208908|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
4963543|NCT02688387|12208909|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963544|NCT02688387|12208910|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963545|NCT02688387|12208911|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963546|NCT02688387|12208912|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963547|NCT02688387|12208913|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963548|NCT02688387|12208914|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963549|NCT02688387|12208915|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963550|NCT02688387|12208916|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963551|NCT02688387|12208917|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963552|NCT02688387|12208918|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963553|NCT02688387|12208919|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963554|NCT02688387|12208920|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963555|NCT02688387|12208921|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963556|NCT02688387|12208922|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963557|NCT02688387|12208923|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963558|NCT02688387|12208924|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963559|NCT02688387|12208925|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963560|NCT02688387|12208926|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
4963561|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963562|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963563|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963564|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963565|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963566|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963567|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963568|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963569|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963570|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963571|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963572|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963573|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963574|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963575|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963576|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963577|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963578|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963579|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963580|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963581|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963582|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963583|NCT02688387|12208905|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
4963584|NCT02688387|12208906|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
4963585|NCT02688387|12208907|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
4963586|NCT02688387|12208908|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
4963587|NCT02688387|12208909|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963588|NCT02688387|12208910|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963589|NCT02688387|12208911|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963590|NCT02688387|12208912|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963591|NCT02688387|12208913|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963592|NCT02688387|12208914|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963593|NCT02688387|12208915|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963594|NCT02688387|12208916|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963595|NCT02688387|12208917|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963596|NCT02688387|12208918|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963597|NCT02688387|12208919|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963598|NCT02688387|12208920|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963599|NCT02688387|12208921|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963600|NCT02688387|12208922|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963601|NCT02688387|12208923|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963602|NCT02688387|12208924|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963603|NCT02688387|12208925|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963604|NCT02688387|12208926|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
4963605|NCT02688387|12208905|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
4963606|NCT02688387|12208906|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
4963607|NCT02688387|12208907|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
4963608|NCT02688387|12208908|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
4963609|NCT02688387|12208909|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963610|NCT02688387|12208910|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963611|NCT02688387|12208911|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963612|NCT02688387|12208912|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963613|NCT02688387|12208913|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963614|NCT02688387|12208914|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963615|NCT02688387|12208915|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963616|NCT02688387|12208916|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963617|NCT02688387|12208917|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963618|NCT02688387|12208918|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963619|NCT02688387|12208919|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963620|NCT02688387|12208920|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963621|NCT02688387|12208921|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963622|NCT02688387|12208922|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963623|NCT02688387|12208923|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963624|NCT02688387|12208924|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963625|NCT02688387|12208925|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963626|NCT02688387|12208926|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
4963627|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963628|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963629|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963630|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963631|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963632|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963633|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963634|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963635|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963636|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963637|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963638|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963639|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963640|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963641|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963642|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963643|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963644|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963645|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963646|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963647|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963648|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963649|NCT02688387|12208905|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
4963650|NCT02688387|12208906|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
4963651|NCT02688387|12208907|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
4963652|NCT02688387|12208908|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
4963653|NCT02688387|12208909|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963654|NCT02688387|12208910|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963655|NCT02688387|12208911|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963656|NCT02688387|12208912|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963657|NCT02688387|12208913|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963658|NCT02688387|12208914|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963659|NCT02688387|12208915|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963660|NCT02688387|12208916|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963661|NCT02688387|12208917|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963662|NCT02688387|12208918|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963663|NCT02688387|12208919|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963664|NCT02688387|12208920|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963665|NCT02688387|12208921|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963666|NCT02688387|12208922|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963667|NCT02688387|12208923|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963668|NCT02688387|12208924|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963669|NCT02688387|12208925|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963670|NCT02688387|12208926|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
4963671|NCT02688387|12208905|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
4963672|NCT02688387|12208906|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
4963673|NCT02688387|12208907|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
4963674|NCT02688387|12208908|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
4963675|NCT02688387|12208909|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963676|NCT02688387|12208910|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963677|NCT02688387|12208911|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963678|NCT02688387|12208912|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963679|NCT02688387|12208913|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963680|NCT02688387|12208914|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963681|NCT02688387|12208915|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963682|NCT02688387|12208916|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963683|NCT02688387|12208917|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963684|NCT02688387|12208918|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963685|NCT02688387|12208919|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963686|NCT02688387|12208920|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963687|NCT02688387|12208921|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963688|NCT02688387|12208922|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963689|NCT02688387|12208923|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963690|NCT02688387|12208924|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963691|NCT02688387|12208925|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963692|NCT02688387|12208926|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
4963693|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963694|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963695|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963696|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963697|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963698|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963699|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963700|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963701|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963702|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963703|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963704|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963705|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963706|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963707|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963708|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963709|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963710|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963711|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963712|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963713|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963714|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963715|NCT02688387|12208905|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
4963716|NCT02688387|12208906|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
4963717|NCT02688387|12208907|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
4963718|NCT02688387|12208908|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
4963719|NCT02688387|12208909|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963720|NCT02688387|12208910|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963721|NCT02688387|12208911|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963722|NCT02688387|12208912|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963723|NCT02688387|12208913|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963724|NCT02688387|12208914|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963725|NCT02688387|12208915|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963726|NCT02688387|12208916|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963727|NCT02688387|12208917|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963728|NCT02688387|12208918|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963729|NCT02688387|12208919|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963730|NCT02688387|12208920|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963731|NCT02688387|12208921|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963732|NCT02688387|12208922|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963733|NCT02688387|12208923|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963734|NCT02688387|12208924|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963735|NCT02688387|12208925|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963736|NCT02688387|12208926|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
4963737|NCT02688387|12208905|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
4963738|NCT02688387|12208906|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
4963739|NCT02688387|12208907|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
4963740|NCT02688387|12208908|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
4963741|NCT02688387|12208909|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963742|NCT02688387|12208910|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963743|NCT02688387|12208911|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963744|NCT02688387|12208912|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963745|NCT02688387|12208913|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963746|NCT02688387|12208914|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963747|NCT02688387|12208915|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963748|NCT02688387|12208916|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963749|NCT02688387|12208917|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963750|NCT02688387|12208918|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963751|NCT02688387|12208919|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963752|NCT02688387|12208920|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963753|NCT02688387|12208921|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963754|NCT02688387|12208922|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963755|NCT02688387|12208923|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963756|NCT02688387|12208924|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963757|NCT02688387|12208925|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963758|NCT02688387|12208926|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
4963759|NCT02688387|12208905|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963760|NCT02688387|12208906|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963761|NCT02688387|12208907|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963762|NCT02688387|12208908|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963763|NCT02688387|12208909|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963764|NCT02688387|12208910|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963765|NCT02688387|12208911|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963766|NCT02688387|12208912|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963767|NCT02688387|12208913|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963768|NCT02688387|12208914|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963769|NCT02688387|12208915|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963770|NCT02688387|12208916|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963771|NCT02688387|12208917|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963772|NCT02688387|12208918|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963773|NCT02688387|12208919|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963774|NCT02688387|12208920|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963775|NCT02688387|12208921|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963776|NCT02688387|12208922|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963777|NCT02688387|12208923|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963778|NCT02688387|12208924|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963779|NCT02688387|12208925|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963780|NCT02688387|12208926|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963781|NCT02688387|12208905|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
4963782|NCT02688387|12208906|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
4963783|NCT02688387|12208907|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
4963784|NCT02688387|12208908|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
4963785|NCT02688387|12208909|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963786|NCT02688387|12208910|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963787|NCT02688387|12208911|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963788|NCT02688387|12208912|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963789|NCT02688387|12208913|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963790|NCT02688387|12208914|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963791|NCT02688387|12208915|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963792|NCT02688387|12208916|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963793|NCT02688387|12208917|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963794|NCT02688387|12208918|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963795|NCT02688387|12208919|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963796|NCT02688387|12208920|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963797|NCT02688387|12208921|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963798|NCT02688387|12208922|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963799|NCT02688387|12208923|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963800|NCT02688387|12208924|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963801|NCT02688387|12208925|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963802|NCT02688387|12208926|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
4963803|NCT02688387|12208905|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
4963804|NCT02688387|12208906|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
4963805|NCT02688387|12208907|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
4963806|NCT02688387|12208908|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
4963807|NCT02688387|12208909|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963808|NCT02688387|12208910|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963809|NCT02688387|12208911|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963810|NCT02688387|12208912|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963811|NCT02688387|12208913|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963812|NCT02688387|12208914|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963813|NCT02688387|12208915|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963814|NCT02688387|12208916|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963815|NCT02688387|12208917|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963816|NCT02688387|12208918|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963817|NCT02688387|12208919|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963818|NCT02688387|12208920|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963819|NCT02688387|12208921|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963820|NCT02688387|12208922|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963821|NCT02688387|12208923|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963822|NCT02688387|12208924|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963823|NCT02688387|12208925|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963824|NCT02688387|12208926|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
4963825|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963826|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963827|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963828|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963829|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963830|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963831|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963832|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963833|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963834|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963835|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963836|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963837|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963838|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963839|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963840|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963841|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963842|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963843|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963844|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963845|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963846|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963847|NCT02688387|12208905|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963848|NCT02688387|12208906|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963849|NCT02688387|12208907|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963850|NCT02688387|12208908|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963851|NCT02688387|12208909|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
4963852|NCT02688387|12208910|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
4963853|NCT02688387|12208911|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
4963854|NCT02688387|12208912|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
4963855|NCT02688387|12208913|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963856|NCT02688387|12208914|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963857|NCT02688387|12208915|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963858|NCT02688387|12208916|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963859|NCT02688387|12208917|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963860|NCT02688387|12208918|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963861|NCT02688387|12208919|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963862|NCT02688387|12208920|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963863|NCT02688387|12208921|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963864|NCT02688387|12208922|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963865|NCT02688387|12208923|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963866|NCT02688387|12208924|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963867|NCT02688387|12208925|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963868|NCT02688387|12208926|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
4963869|NCT02688387|12208905|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963870|NCT02688387|12208906|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963871|NCT02688387|12208907|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963872|NCT02688387|12208908|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963873|NCT02688387|12208909|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
4963874|NCT02688387|12208910|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
4963875|NCT02688387|12208911|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
4963876|NCT02688387|12208912|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
4963877|NCT02688387|12208913|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963878|NCT02688387|12208914|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963879|NCT02688387|12208915|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963880|NCT02688387|12208916|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963881|NCT02688387|12208917|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963882|NCT02688387|12208918|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963883|NCT02688387|12208919|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963884|NCT02688387|12208920|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963885|NCT02688387|12208921|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963886|NCT02688387|12208922|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963887|NCT02688387|12208923|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963888|NCT02688387|12208924|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963889|NCT02688387|12208925|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963890|NCT02688387|12208926|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
4963891|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963892|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963893|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963894|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963895|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963896|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963897|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963898|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963899|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963900|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963901|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963902|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963903|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963904|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963905|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963906|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963907|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963908|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963909|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963910|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963911|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963912|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963913|NCT02688387|12208905|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963914|NCT02688387|12208906|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963915|NCT02688387|12208907|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963916|NCT02688387|12208908|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963917|NCT02688387|12208909|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
4963918|NCT02688387|12208910|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
4963919|NCT02688387|12208911|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
4963920|NCT02688387|12208912|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
4963921|NCT02688387|12208913|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963922|NCT02688387|12208914|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963923|NCT02688387|12208915|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963924|NCT02688387|12208916|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963925|NCT02688387|12208917|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963926|NCT02688387|12208918|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963927|NCT02688387|12208919|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963928|NCT02688387|12208920|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963929|NCT02688387|12208921|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963930|NCT02688387|12208922|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963931|NCT02688387|12208923|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963932|NCT02688387|12208924|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963933|NCT02688387|12208925|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963934|NCT02688387|12208926|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
4963935|NCT02688387|12208905|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963936|NCT02688387|12208906|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963937|NCT02688387|12208907|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963938|NCT02688387|12208908|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963939|NCT02688387|12208909|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
4963940|NCT02688387|12208910|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
4963941|NCT02688387|12208911|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
4963942|NCT02688387|12208912|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
4963943|NCT02688387|12208913|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963944|NCT02688387|12208914|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963945|NCT02688387|12208915|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963946|NCT02688387|12208916|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963947|NCT02688387|12208917|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963948|NCT02688387|12208918|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963949|NCT02688387|12208919|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963950|NCT02688387|12208920|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963951|NCT02688387|12208921|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963952|NCT02688387|12208922|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963953|NCT02688387|12208923|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963954|NCT02688387|12208924|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963955|NCT02688387|12208925|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963956|NCT02688387|12208926|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
4963957|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963958|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963959|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963960|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963961|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963962|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963963|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963964|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963965|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963966|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963967|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963968|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963969|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963970|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963971|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963972|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963973|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963974|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963975|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963976|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963977|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963978|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963979|NCT02688387|12208905|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963980|NCT02688387|12208906|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963981|NCT02688387|12208907|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963982|NCT02688387|12208908|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963983|NCT02688387|12208909|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
4963984|NCT02688387|12208910|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
4963985|NCT02688387|12208911|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
4963986|NCT02688387|12208912|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
4963987|NCT02688387|12208913|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963988|NCT02688387|12208914|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963989|NCT02688387|12208915|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963990|NCT02688387|12208916|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963991|NCT02688387|12208917|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963992|NCT02688387|12208918|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963993|NCT02688387|12208919|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963994|NCT02688387|12208920|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963995|NCT02688387|12208921|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963996|NCT02688387|12208922|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963997|NCT02688387|12208923|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963998|NCT02688387|12208924|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4963999|NCT02688387|12208925|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4964000|NCT02688387|12208926|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
4964001|NCT02688387|12208905|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964002|NCT02688387|12208906|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964003|NCT02688387|12208907|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964004|NCT02688387|12208908|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964005|NCT02688387|12208909|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
4964006|NCT02688387|12208910|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
4964007|NCT02688387|12208911|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
4964008|NCT02688387|12208912|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
4964009|NCT02688387|12208913|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964010|NCT02688387|12208914|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964011|NCT02688387|12208915|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964012|NCT02688387|12208916|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964013|NCT02688387|12208917|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964014|NCT02688387|12208918|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964015|NCT02688387|12208919|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964016|NCT02688387|12208920|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964017|NCT02688387|12208921|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964018|NCT02688387|12208922|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964019|NCT02688387|12208923|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964020|NCT02688387|12208924|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964021|NCT02688387|12208925|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964022|NCT02688387|12208926|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
4964023|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964024|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964025|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964026|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964027|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964028|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964029|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964030|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964031|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964032|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964033|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964034|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964035|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964036|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964037|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964038|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964039|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964040|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964041|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964042|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964043|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964044|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964045|NCT02688387|12208905|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964046|NCT02688387|12208906|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964047|NCT02688387|12208907|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964048|NCT02688387|12208908|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964049|NCT02688387|12208909|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
4964050|NCT02688387|12208910|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
4964051|NCT02688387|12208911|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
4964052|NCT02688387|12208912|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
4964053|NCT02688387|12208913|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964054|NCT02688387|12208914|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964055|NCT02688387|12208915|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964056|NCT02688387|12208916|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964057|NCT02688387|12208917|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964058|NCT02688387|12208918|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964059|NCT02688387|12208919|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964060|NCT02688387|12208920|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964061|NCT02688387|12208921|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964062|NCT02688387|12208922|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964063|NCT02688387|12208923|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964064|NCT02688387|12208924|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964065|NCT02688387|12208925|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964066|NCT02688387|12208926|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
4964067|NCT02688387|12208905|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964068|NCT02688387|12208906|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964069|NCT02688387|12208907|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964070|NCT02688387|12208908|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964071|NCT02688387|12208909|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
4964072|NCT02688387|12208910|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
4964073|NCT02688387|12208911|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
4964074|NCT02688387|12208912|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
4964075|NCT02688387|12208913|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964076|NCT02688387|12208914|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964077|NCT02688387|12208915|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964078|NCT02688387|12208916|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964079|NCT02688387|12208917|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964080|NCT02688387|12208918|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964081|NCT02688387|12208919|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964082|NCT02688387|12208920|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964083|NCT02688387|12208921|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964084|NCT02688387|12208922|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964085|NCT02688387|12208923|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964086|NCT02688387|12208924|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964087|NCT02688387|12208925|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964088|NCT02688387|12208926|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
4964089|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964090|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964091|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964092|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964093|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964094|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964095|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964096|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964097|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964098|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964099|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964100|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964101|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964102|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964103|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964104|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964105|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964106|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964107|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964108|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964109|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964110|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964111|NCT02688387|12208905|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964112|NCT02688387|12208906|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964113|NCT02688387|12208907|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964114|NCT02688387|12208908|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964115|NCT02688387|12208909|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
4964116|NCT02688387|12208910|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
4964117|NCT02688387|12208911|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
4964118|NCT02688387|12208912|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
4964119|NCT02688387|12208913|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964120|NCT02688387|12208914|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964121|NCT02688387|12208915|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964122|NCT02688387|12208916|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964123|NCT02688387|12208917|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964124|NCT02688387|12208918|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964125|NCT02688387|12208919|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964126|NCT02688387|12208920|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964127|NCT02688387|12208921|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964128|NCT02688387|12208922|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964129|NCT02688387|12208923|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964130|NCT02688387|12208924|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964131|NCT02688387|12208925|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964132|NCT02688387|12208926|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
4964133|NCT02688387|12208905|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964134|NCT02688387|12208906|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964135|NCT02688387|12208907|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964136|NCT02688387|12208908|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964137|NCT02688387|12208909|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
4964138|NCT02688387|12208910|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
4964139|NCT02688387|12208911|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
4964140|NCT02688387|12208912|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
4964141|NCT02688387|12208913|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964142|NCT02688387|12208914|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964143|NCT02688387|12208915|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964144|NCT02688387|12208916|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964145|NCT02688387|12208917|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964146|NCT02688387|12208918|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964147|NCT02688387|12208919|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964148|NCT02688387|12208920|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964149|NCT02688387|12208921|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964150|NCT02688387|12208922|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964151|NCT02688387|12208923|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964152|NCT02688387|12208924|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964153|NCT02688387|12208925|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964154|NCT02688387|12208926|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
4964155|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964156|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964157|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964158|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964159|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964160|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964161|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964162|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964163|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964164|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964165|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964166|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964167|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964168|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964169|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964170|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964171|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964172|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964173|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964174|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964175|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964176|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964177|NCT02688387|12208905|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964178|NCT02688387|12208906|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964179|NCT02688387|12208907|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964180|NCT02688387|12208908|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964181|NCT02688387|12208909|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
4964182|NCT02688387|12208910|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
4964183|NCT02688387|12208911|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
4964184|NCT02688387|12208912|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
4964185|NCT02688387|12208913|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964186|NCT02688387|12208914|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964187|NCT02688387|12208915|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964188|NCT02688387|12208916|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964189|NCT02688387|12208917|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964190|NCT02688387|12208918|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964191|NCT02688387|12208919|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964192|NCT02688387|12208920|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964193|NCT02688387|12208921|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964194|NCT02688387|12208922|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964195|NCT02688387|12208923|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964196|NCT02688387|12208924|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964197|NCT02688387|12208925|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964198|NCT02688387|12208926|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
4964199|NCT02688387|12208905|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964200|NCT02688387|12208906|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964201|NCT02688387|12208907|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964202|NCT02688387|12208908|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964203|NCT02688387|12208909|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
4964204|NCT02688387|12208910|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
4964205|NCT02688387|12208911|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
4964206|NCT02688387|12208912|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
4964207|NCT02688387|12208913|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964208|NCT02688387|12208914|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964209|NCT02688387|12208915|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964210|NCT02688387|12208916|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964211|NCT02688387|12208917|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964212|NCT02688387|12208918|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964213|NCT02688387|12208919|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964214|NCT02688387|12208920|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964215|NCT02688387|12208921|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964216|NCT02688387|12208922|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964217|NCT02688387|12208923|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964218|NCT02688387|12208924|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964219|NCT02688387|12208925|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964220|NCT02688387|12208926|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
4964221|NCT02688387|12208905|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964222|NCT02688387|12208906|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964223|NCT02688387|12208907|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964224|NCT02688387|12208908|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964225|NCT02688387|12208909|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964226|NCT02688387|12208910|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964227|NCT02688387|12208911|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964228|NCT02688387|12208912|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
4964229|NCT02688387|12208913|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964230|NCT02688387|12208914|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964231|NCT02688387|12208915|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964232|NCT02688387|12208916|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964233|NCT02688387|12208917|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964234|NCT02688387|12208918|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964235|NCT02688387|12208919|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964236|NCT02688387|12208920|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964237|NCT02688387|12208921|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964238|NCT02688387|12208922|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964239|NCT02688387|12208923|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964240|NCT02688387|12208924|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964241|NCT02688387|12208925|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964242|NCT02688387|12208926|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964243|NCT02688387|12208905|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964244|NCT02688387|12208906|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964245|NCT02688387|12208907|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964246|NCT02688387|12208908|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964247|NCT02688387|12208909|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
4964248|NCT02688387|12208910|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
4964249|NCT02688387|12208911|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
4964250|NCT02688387|12208912|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
4964251|NCT02688387|12208913|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964252|NCT02688387|12208914|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964253|NCT02688387|12208915|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964254|NCT02688387|12208916|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964255|NCT02688387|12208917|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964256|NCT02688387|12208918|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964257|NCT02688387|12208919|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964258|NCT02688387|12208920|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964259|NCT02688387|12208921|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964260|NCT02688387|12208922|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964261|NCT02688387|12208923|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964262|NCT02688387|12208924|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964263|NCT02688387|12208925|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964264|NCT02688387|12208926|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
4964265|NCT02688387|12208905|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964266|NCT02688387|12208906|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964267|NCT02688387|12208907|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964268|NCT02688387|12208908|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964269|NCT02688387|12208909|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
4964270|NCT02688387|12208910|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
4964271|NCT02688387|12208911|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
4964272|NCT02688387|12208912|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
4964273|NCT02688387|12208913|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964274|NCT02688387|12208914|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964275|NCT02688387|12208915|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964276|NCT02688387|12208916|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964277|NCT02688387|12208917|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964278|NCT02688387|12208918|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964279|NCT02688387|12208919|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964280|NCT02688387|12208920|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964281|NCT02688387|12208921|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964282|NCT02688387|12208922|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964283|NCT02688387|12208923|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964284|NCT02688387|12208924|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964285|NCT02688387|12208925|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964286|NCT02688387|12208926|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
4964287|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964288|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964289|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964290|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964291|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964292|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964293|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964294|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964295|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964296|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964297|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964298|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964299|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964300|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964301|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964302|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964303|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964304|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964305|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964306|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964307|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964308|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964309|NCT02688387|12208905|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964310|NCT02688387|12208906|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964311|NCT02688387|12208907|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964312|NCT02688387|12208908|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964313|NCT02688387|12208909|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964314|NCT02688387|12208910|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964315|NCT02688387|12208911|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964316|NCT02688387|12208912|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964317|NCT02688387|12208913|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
4964318|NCT02688387|12208914|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
4964319|NCT02688387|12208915|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
4964320|NCT02688387|12208916|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
4964321|NCT02688387|12208917|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964322|NCT02688387|12208918|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964323|NCT02688387|12208919|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964324|NCT02688387|12208920|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964325|NCT02688387|12208921|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964326|NCT02688387|12208922|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964327|NCT02688387|12208923|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964328|NCT02688387|12208924|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964329|NCT02688387|12208925|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964330|NCT02688387|12208926|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
4964331|NCT02688387|12208905|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964332|NCT02688387|12208906|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964333|NCT02688387|12208907|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964334|NCT02688387|12208908|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964335|NCT02688387|12208909|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964336|NCT02688387|12208910|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964337|NCT02688387|12208911|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964338|NCT02688387|12208912|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964339|NCT02688387|12208913|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
4964340|NCT02688387|12208914|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
4964341|NCT02688387|12208915|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
4964342|NCT02688387|12208916|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
4964343|NCT02688387|12208917|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964344|NCT02688387|12208918|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964345|NCT02688387|12208919|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964346|NCT02688387|12208920|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964347|NCT02688387|12208921|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964348|NCT02688387|12208922|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964349|NCT02688387|12208923|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964350|NCT02688387|12208924|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964351|NCT02688387|12208925|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964352|NCT02688387|12208926|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
4964353|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964354|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964355|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964356|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964357|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964358|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964359|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964360|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964361|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964362|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964363|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964364|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964365|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964366|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964367|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964368|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964369|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964370|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964371|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964372|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964373|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964374|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964375|NCT02688387|12208905|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964376|NCT02688387|12208906|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964377|NCT02688387|12208907|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964378|NCT02688387|12208908|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964379|NCT02688387|12208909|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964380|NCT02688387|12208910|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964381|NCT02688387|12208911|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964382|NCT02688387|12208912|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964383|NCT02688387|12208913|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
4964384|NCT02688387|12208914|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
4964385|NCT02688387|12208915|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
4964386|NCT02688387|12208916|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
4964387|NCT02688387|12208917|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964388|NCT02688387|12208918|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964389|NCT02688387|12208919|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964390|NCT02688387|12208920|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964391|NCT02688387|12208921|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964392|NCT02688387|12208922|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964393|NCT02688387|12208923|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964394|NCT02688387|12208924|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964395|NCT02688387|12208925|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964396|NCT02688387|12208926|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
4964397|NCT02688387|12208905|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964398|NCT02688387|12208906|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964399|NCT02688387|12208907|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964400|NCT02688387|12208908|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964401|NCT02688387|12208909|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964402|NCT02688387|12208910|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964403|NCT02688387|12208911|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964404|NCT02688387|12208912|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964405|NCT02688387|12208913|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
4964406|NCT02688387|12208914|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
4964407|NCT02688387|12208915|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
4964408|NCT02688387|12208916|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
4964409|NCT02688387|12208917|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964410|NCT02688387|12208918|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964411|NCT02688387|12208919|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964412|NCT02688387|12208920|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964413|NCT02688387|12208921|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964414|NCT02688387|12208922|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964415|NCT02688387|12208923|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964416|NCT02688387|12208924|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964417|NCT02688387|12208925|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964418|NCT02688387|12208926|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
4964419|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964420|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964421|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964422|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964423|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964424|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964425|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964426|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964427|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964428|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964429|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964430|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964431|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964432|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964433|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964434|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964435|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964436|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964437|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964438|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964439|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964440|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964441|NCT02688387|12208905|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964442|NCT02688387|12208906|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964443|NCT02688387|12208907|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964444|NCT02688387|12208908|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964445|NCT02688387|12208909|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964446|NCT02688387|12208910|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964447|NCT02688387|12208911|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964448|NCT02688387|12208912|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964449|NCT02688387|12208913|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
4964450|NCT02688387|12208914|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
4964451|NCT02688387|12208915|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
4964452|NCT02688387|12208916|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
4964453|NCT02688387|12208917|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964454|NCT02688387|12208918|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964455|NCT02688387|12208919|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964456|NCT02688387|12208920|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964457|NCT02688387|12208921|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964458|NCT02688387|12208922|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964459|NCT02688387|12208923|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964460|NCT02688387|12208924|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964461|NCT02688387|12208925|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964462|NCT02688387|12208926|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
4964463|NCT02688387|12208905|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964464|NCT02688387|12208906|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964465|NCT02688387|12208907|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964466|NCT02688387|12208908|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964467|NCT02688387|12208909|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964468|NCT02688387|12208910|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964469|NCT02688387|12208911|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964470|NCT02688387|12208912|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964471|NCT02688387|12208913|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
4964472|NCT02688387|12208914|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
4964473|NCT02688387|12208915|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
4964474|NCT02688387|12208916|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
4964475|NCT02688387|12208917|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964476|NCT02688387|12208918|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964477|NCT02688387|12208919|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964478|NCT02688387|12208920|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964479|NCT02688387|12208921|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964480|NCT02688387|12208922|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964481|NCT02688387|12208923|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964482|NCT02688387|12208924|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964483|NCT02688387|12208925|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964484|NCT02688387|12208926|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
4964485|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964486|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964487|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964488|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964489|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964490|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964491|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964492|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964493|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964494|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964495|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964496|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964497|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964498|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964499|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964500|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964501|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964502|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964503|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964504|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964505|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964506|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964507|NCT02688387|12208905|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964508|NCT02688387|12208906|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964509|NCT02688387|12208907|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964510|NCT02688387|12208908|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964511|NCT02688387|12208909|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964512|NCT02688387|12208910|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964513|NCT02688387|12208911|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964514|NCT02688387|12208912|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964515|NCT02688387|12208913|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
4964516|NCT02688387|12208914|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
4964517|NCT02688387|12208915|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
4964518|NCT02688387|12208916|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
4964519|NCT02688387|12208917|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964520|NCT02688387|12208918|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964521|NCT02688387|12208919|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964522|NCT02688387|12208920|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964523|NCT02688387|12208921|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964524|NCT02688387|12208922|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964525|NCT02688387|12208923|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964526|NCT02688387|12208924|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964527|NCT02688387|12208925|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964528|NCT02688387|12208926|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
4964529|NCT02688387|12208905|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964530|NCT02688387|12208906|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964531|NCT02688387|12208907|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964532|NCT02688387|12208908|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964533|NCT02688387|12208909|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964534|NCT02688387|12208910|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964535|NCT02688387|12208911|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964536|NCT02688387|12208912|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964537|NCT02688387|12208913|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
4964538|NCT02688387|12208914|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
4964539|NCT02688387|12208915|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
4964540|NCT02688387|12208916|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
4964541|NCT02688387|12208917|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964542|NCT02688387|12208918|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964543|NCT02688387|12208919|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964544|NCT02688387|12208920|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964545|NCT02688387|12208921|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964546|NCT02688387|12208922|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964547|NCT02688387|12208923|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964548|NCT02688387|12208924|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964549|NCT02688387|12208925|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964550|NCT02688387|12208926|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
4964551|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964552|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964553|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964554|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964555|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964556|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964557|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964558|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964559|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964560|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964561|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964562|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964563|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964564|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964565|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964566|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964567|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964568|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964569|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964570|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964571|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964572|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964573|NCT02688387|12208905|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964574|NCT02688387|12208906|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964575|NCT02688387|12208907|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964576|NCT02688387|12208908|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964577|NCT02688387|12208909|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964578|NCT02688387|12208910|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964579|NCT02688387|12208911|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964580|NCT02688387|12208912|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964581|NCT02688387|12208913|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
4964582|NCT02688387|12208914|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
4964583|NCT02688387|12208915|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
4964584|NCT02688387|12208916|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
4964585|NCT02688387|12208917|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964586|NCT02688387|12208918|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964587|NCT02688387|12208919|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964588|NCT02688387|12208920|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964589|NCT02688387|12208921|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964590|NCT02688387|12208922|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964591|NCT02688387|12208923|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964592|NCT02688387|12208924|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964593|NCT02688387|12208925|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964594|NCT02688387|12208926|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
4964595|NCT02688387|12208905|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964596|NCT02688387|12208906|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964597|NCT02688387|12208907|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964598|NCT02688387|12208908|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964599|NCT02688387|12208909|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964600|NCT02688387|12208910|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964601|NCT02688387|12208911|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964602|NCT02688387|12208912|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964603|NCT02688387|12208913|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
4964604|NCT02688387|12208914|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
4964605|NCT02688387|12208915|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
4964606|NCT02688387|12208916|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
4964607|NCT02688387|12208917|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964608|NCT02688387|12208918|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964609|NCT02688387|12208919|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964610|NCT02688387|12208920|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964611|NCT02688387|12208921|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964612|NCT02688387|12208922|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964613|NCT02688387|12208923|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964614|NCT02688387|12208924|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964615|NCT02688387|12208925|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964616|NCT02688387|12208926|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
4964617|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964618|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964619|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964620|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964621|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964622|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964623|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964624|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964625|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964626|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964627|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964628|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964629|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964630|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964631|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964632|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964633|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964634|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964635|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964636|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964637|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964638|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964639|NCT02688387|12208905|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964640|NCT02688387|12208906|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964641|NCT02688387|12208907|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964642|NCT02688387|12208908|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964643|NCT02688387|12208909|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964644|NCT02688387|12208910|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964645|NCT02688387|12208911|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964646|NCT02688387|12208912|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964647|NCT02688387|12208913|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
4964648|NCT02688387|12208914|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
4964649|NCT02688387|12208915|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
4964650|NCT02688387|12208916|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
4964651|NCT02688387|12208917|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964652|NCT02688387|12208918|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964653|NCT02688387|12208919|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964654|NCT02688387|12208920|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964655|NCT02688387|12208921|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964656|NCT02688387|12208922|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964657|NCT02688387|12208923|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964658|NCT02688387|12208924|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964659|NCT02688387|12208925|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964660|NCT02688387|12208926|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
4964661|NCT02688387|12208905|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964662|NCT02688387|12208906|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964663|NCT02688387|12208907|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964664|NCT02688387|12208908|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964665|NCT02688387|12208909|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964666|NCT02688387|12208910|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964667|NCT02688387|12208911|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964668|NCT02688387|12208912|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964669|NCT02688387|12208913|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
4964670|NCT02688387|12208914|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
4964671|NCT02688387|12208915|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
4964672|NCT02688387|12208916|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
4964673|NCT02688387|12208917|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964674|NCT02688387|12208918|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964675|NCT02688387|12208919|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964676|NCT02688387|12208920|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964677|NCT02688387|12208921|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964678|NCT02688387|12208922|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964679|NCT02688387|12208923|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964680|NCT02688387|12208924|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964681|NCT02688387|12208925|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964682|NCT02688387|12208926|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
4964683|NCT02688387|12208905|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964684|NCT02688387|12208906|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964685|NCT02688387|12208907|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964686|NCT02688387|12208908|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964687|NCT02688387|12208909|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964688|NCT02688387|12208910|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964689|NCT02688387|12208911|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964690|NCT02688387|12208912|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964691|NCT02688387|12208913|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964692|NCT02688387|12208914|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964693|NCT02688387|12208915|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964694|NCT02688387|12208916|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
4964695|NCT02688387|12208917|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964696|NCT02688387|12208918|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964697|NCT02688387|12208919|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964698|NCT02688387|12208920|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964699|NCT02688387|12208921|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964700|NCT02688387|12208922|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964701|NCT02688387|12208923|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964702|NCT02688387|12208924|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964703|NCT02688387|12208925|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964704|NCT02688387|12208926|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964705|NCT02688387|12208905|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964706|NCT02688387|12208906|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964707|NCT02688387|12208907|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964708|NCT02688387|12208908|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964709|NCT02688387|12208909|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964710|NCT02688387|12208910|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964711|NCT02688387|12208911|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964712|NCT02688387|12208912|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964713|NCT02688387|12208913|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
4964714|NCT02688387|12208914|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
4964715|NCT02688387|12208915|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
4964716|NCT02688387|12208916|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
4964717|NCT02688387|12208917|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964718|NCT02688387|12208918|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964719|NCT02688387|12208919|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964720|NCT02688387|12208920|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964721|NCT02688387|12208921|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964722|NCT02688387|12208922|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964723|NCT02688387|12208923|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964724|NCT02688387|12208924|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964725|NCT02688387|12208925|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964726|NCT02688387|12208926|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
4964727|NCT02688387|12208905|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964728|NCT02688387|12208906|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964729|NCT02688387|12208907|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964730|NCT02688387|12208908|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964731|NCT02688387|12208909|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964732|NCT02688387|12208910|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964733|NCT02688387|12208911|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964734|NCT02688387|12208912|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964735|NCT02688387|12208913|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
4964736|NCT02688387|12208914|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
4964737|NCT02688387|12208915|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
4964738|NCT02688387|12208916|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
4964739|NCT02688387|12208917|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964740|NCT02688387|12208918|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964741|NCT02688387|12208919|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964742|NCT02688387|12208920|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964743|NCT02688387|12208921|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964744|NCT02688387|12208922|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964745|NCT02688387|12208923|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964746|NCT02688387|12208924|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964747|NCT02688387|12208925|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964748|NCT02688387|12208926|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
4964749|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964750|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964751|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964752|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964753|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964754|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964755|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964756|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964757|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964758|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964759|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964760|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964761|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964762|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964763|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964764|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964765|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964766|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964767|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964768|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964769|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964770|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964771|NCT02688387|12208905|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964772|NCT02688387|12208906|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964773|NCT02688387|12208907|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964774|NCT02688387|12208908|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964775|NCT02688387|12208909|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964776|NCT02688387|12208910|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964777|NCT02688387|12208911|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964778|NCT02688387|12208912|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964779|NCT02688387|12208913|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964780|NCT02688387|12208914|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964781|NCT02688387|12208915|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964782|NCT02688387|12208916|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
4964783|NCT02688387|12208917|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964784|NCT02688387|12208918|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964785|NCT02688387|12208919|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964786|NCT02688387|12208920|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964787|NCT02688387|12208921|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964788|NCT02688387|12208922|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964789|NCT02688387|12208923|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964790|NCT02688387|12208924|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964791|NCT02688387|12208925|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964792|NCT02688387|12208926|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
4964793|NCT02688387|12208905|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964794|NCT02688387|12208906|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964795|NCT02688387|12208907|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964796|NCT02688387|12208908|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964797|NCT02688387|12208909|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964798|NCT02688387|12208910|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964799|NCT02688387|12208911|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964800|NCT02688387|12208912|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964801|NCT02688387|12208913|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964802|NCT02688387|12208914|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964803|NCT02688387|12208915|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964804|NCT02688387|12208916|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
4964805|NCT02688387|12208917|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964806|NCT02688387|12208918|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964807|NCT02688387|12208919|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964808|NCT02688387|12208920|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964809|NCT02688387|12208921|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964810|NCT02688387|12208922|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964811|NCT02688387|12208923|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964812|NCT02688387|12208924|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964813|NCT02688387|12208925|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964814|NCT02688387|12208926|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
4964815|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964816|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964817|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964818|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964819|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964820|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964821|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964822|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964823|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964824|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964825|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964826|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964827|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964828|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964829|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964830|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964831|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964832|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964833|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964834|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964835|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964836|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964837|NCT02688387|12208905|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964838|NCT02688387|12208906|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964839|NCT02688387|12208907|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964840|NCT02688387|12208908|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964841|NCT02688387|12208909|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964842|NCT02688387|12208910|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964843|NCT02688387|12208911|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964844|NCT02688387|12208912|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964845|NCT02688387|12208913|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964846|NCT02688387|12208914|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964847|NCT02688387|12208915|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964848|NCT02688387|12208916|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
4964849|NCT02688387|12208917|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964850|NCT02688387|12208918|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964851|NCT02688387|12208919|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964852|NCT02688387|12208920|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964853|NCT02688387|12208921|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964854|NCT02688387|12208922|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964855|NCT02688387|12208923|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964856|NCT02688387|12208924|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964857|NCT02688387|12208925|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964858|NCT02688387|12208926|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
4964859|NCT02688387|12208905|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964860|NCT02688387|12208906|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964861|NCT02688387|12208907|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964862|NCT02688387|12208908|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964863|NCT02688387|12208909|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964864|NCT02688387|12208910|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964865|NCT02688387|12208911|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964866|NCT02688387|12208912|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964867|NCT02688387|12208913|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964868|NCT02688387|12208914|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964869|NCT02688387|12208915|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964870|NCT02688387|12208916|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
4964871|NCT02688387|12208917|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964872|NCT02688387|12208918|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964873|NCT02688387|12208919|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964874|NCT02688387|12208920|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964875|NCT02688387|12208921|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964876|NCT02688387|12208922|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964877|NCT02688387|12208923|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964878|NCT02688387|12208924|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964879|NCT02688387|12208925|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964880|NCT02688387|12208926|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
4964881|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964882|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964883|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964884|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964885|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964886|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964887|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964888|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964889|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964890|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964891|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964892|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964893|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964894|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964895|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4965053|NCT02688387|12208923|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4964896|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964897|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964898|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964899|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964900|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964901|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964902|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964903|NCT02688387|12208905|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964904|NCT02688387|12208906|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964905|NCT02688387|12208907|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964906|NCT02688387|12208908|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964907|NCT02688387|12208909|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964908|NCT02688387|12208910|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964909|NCT02688387|12208911|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964910|NCT02688387|12208912|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964911|NCT02688387|12208913|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964912|NCT02688387|12208914|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964913|NCT02688387|12208915|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964914|NCT02688387|12208916|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
4964915|NCT02688387|12208917|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964916|NCT02688387|12208918|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964917|NCT02688387|12208919|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964918|NCT02688387|12208920|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964919|NCT02688387|12208921|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964920|NCT02688387|12208922|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964921|NCT02688387|12208923|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964922|NCT02688387|12208924|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964923|NCT02688387|12208925|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964924|NCT02688387|12208926|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
4964925|NCT02688387|12208905|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964926|NCT02688387|12208906|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964927|NCT02688387|12208907|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964928|NCT02688387|12208908|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964929|NCT02688387|12208909|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964930|NCT02688387|12208910|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964931|NCT02688387|12208911|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964932|NCT02688387|12208912|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964933|NCT02688387|12208913|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964934|NCT02688387|12208914|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964935|NCT02688387|12208915|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964936|NCT02688387|12208916|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
4964937|NCT02688387|12208917|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964938|NCT02688387|12208918|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964939|NCT02688387|12208919|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964940|NCT02688387|12208920|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964941|NCT02688387|12208921|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964942|NCT02688387|12208922|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964943|NCT02688387|12208923|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964944|NCT02688387|12208924|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964945|NCT02688387|12208925|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964946|NCT02688387|12208926|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
4964947|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964948|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964949|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964950|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964951|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964952|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964953|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964954|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964955|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964956|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964957|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964958|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964959|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964960|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964961|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964962|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964963|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964964|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964965|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964966|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964967|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964968|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
4964969|NCT02688387|12208905|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964970|NCT02688387|12208906|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964971|NCT02688387|12208907|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964972|NCT02688387|12208908|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964973|NCT02688387|12208909|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964974|NCT02688387|12208910|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964975|NCT02688387|12208911|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964976|NCT02688387|12208912|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964977|NCT02688387|12208913|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964978|NCT02688387|12208914|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964979|NCT02688387|12208915|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964980|NCT02688387|12208916|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
4964981|NCT02688387|12208917|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964982|NCT02688387|12208918|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964983|NCT02688387|12208919|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964984|NCT02688387|12208920|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964985|NCT02688387|12208921|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964986|NCT02688387|12208922|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964987|NCT02688387|12208923|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964988|NCT02688387|12208924|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964989|NCT02688387|12208925|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964990|NCT02688387|12208926|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
4964991|NCT02688387|12208905|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964992|NCT02688387|12208906|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964993|NCT02688387|12208907|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964994|NCT02688387|12208908|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964995|NCT02688387|12208909|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964996|NCT02688387|12208910|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964997|NCT02688387|12208911|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964998|NCT02688387|12208912|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
4964999|NCT02688387|12208913|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
4965000|NCT02688387|12208914|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
4965001|NCT02688387|12208915|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
4965002|NCT02688387|12208916|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
4965003|NCT02688387|12208917|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965004|NCT02688387|12208918|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965005|NCT02688387|12208919|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965006|NCT02688387|12208920|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965007|NCT02688387|12208921|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965008|NCT02688387|12208922|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965009|NCT02688387|12208923|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965010|NCT02688387|12208924|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965011|NCT02688387|12208925|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
4965012|NCT02688387|12208926|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
4965013|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965014|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965015|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965016|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965017|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965018|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965019|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965020|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965021|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965022|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965023|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965024|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965025|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965026|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965027|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965028|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965029|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965030|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965031|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965032|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965033|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965034|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965035|NCT02688387|12208905|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965036|NCT02688387|12208906|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965037|NCT02688387|12208907|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965038|NCT02688387|12208908|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965039|NCT02688387|12208909|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965040|NCT02688387|12208910|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965041|NCT02688387|12208911|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965042|NCT02688387|12208912|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965043|NCT02688387|12208913|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965044|NCT02688387|12208914|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965045|NCT02688387|12208915|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965046|NCT02688387|12208916|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
4965047|NCT02688387|12208917|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965048|NCT02688387|12208918|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965049|NCT02688387|12208919|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965050|NCT02688387|12208920|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965051|NCT02688387|12208921|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965052|NCT02688387|12208922|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965054|NCT02688387|12208924|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965055|NCT02688387|12208925|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
4965056|NCT02688387|12208926|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
4965057|NCT02688387|12208905|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965058|NCT02688387|12208906|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965059|NCT02688387|12208907|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965060|NCT02688387|12208908|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965061|NCT02688387|12208909|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965062|NCT02688387|12208910|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965063|NCT02688387|12208911|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965064|NCT02688387|12208912|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965065|NCT02688387|12208913|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965066|NCT02688387|12208914|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965067|NCT02688387|12208915|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965068|NCT02688387|12208916|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
4965069|NCT02688387|12208917|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965070|NCT02688387|12208918|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965071|NCT02688387|12208919|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965072|NCT02688387|12208920|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965073|NCT02688387|12208921|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965074|NCT02688387|12208922|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965075|NCT02688387|12208923|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965076|NCT02688387|12208924|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965077|NCT02688387|12208925|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
4965078|NCT02688387|12208926|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
4965079|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965080|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965081|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965082|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965083|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965084|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965085|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965086|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965087|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965088|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965089|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965090|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965091|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965092|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965093|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965094|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965095|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965096|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965097|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965098|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965099|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965100|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965101|NCT02688387|12208905|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965102|NCT02688387|12208906|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965103|NCT02688387|12208907|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965104|NCT02688387|12208908|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965105|NCT02688387|12208909|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965106|NCT02688387|12208910|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965107|NCT02688387|12208911|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965108|NCT02688387|12208912|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965109|NCT02688387|12208913|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965110|NCT02688387|12208914|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965111|NCT02688387|12208915|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965112|NCT02688387|12208916|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
4965113|NCT02688387|12208917|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965114|NCT02688387|12208918|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965115|NCT02688387|12208919|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965116|NCT02688387|12208920|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965117|NCT02688387|12208921|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965118|NCT02688387|12208922|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965119|NCT02688387|12208923|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965120|NCT02688387|12208924|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965121|NCT02688387|12208925|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
4965122|NCT02688387|12208926|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
4965123|NCT02688387|12208905|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965124|NCT02688387|12208906|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965125|NCT02688387|12208907|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965126|NCT02688387|12208908|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965127|NCT02688387|12208909|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965128|NCT02688387|12208910|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965129|NCT02688387|12208911|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965130|NCT02688387|12208912|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965131|NCT02688387|12208913|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965132|NCT02688387|12208914|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965133|NCT02688387|12208915|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965134|NCT02688387|12208916|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
4965135|NCT02688387|12208917|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965136|NCT02688387|12208918|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965137|NCT02688387|12208919|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965138|NCT02688387|12208920|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965139|NCT02688387|12208921|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965140|NCT02688387|12208922|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965141|NCT02688387|12208923|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965142|NCT02688387|12208924|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965143|NCT02688387|12208925|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
4965144|NCT02688387|12208926|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
4965145|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965146|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965147|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965148|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965149|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965150|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965151|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965152|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965153|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965154|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965155|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965156|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965157|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965158|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965159|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965160|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965161|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965162|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
4965163|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965164|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
4965165|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965166|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965167|NCT02688387|12208905|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965168|NCT02688387|12208906|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965169|NCT02688387|12208907|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965170|NCT02688387|12208908|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965171|NCT02688387|12208909|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965172|NCT02688387|12208910|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965173|NCT02688387|12208911|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965174|NCT02688387|12208912|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965175|NCT02688387|12208913|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965176|NCT02688387|12208914|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965177|NCT02688387|12208915|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965178|NCT02688387|12208916|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
4965179|NCT02688387|12208917|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965180|NCT02688387|12208918|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965181|NCT02688387|12208919|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965182|NCT02688387|12208920|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965183|NCT02688387|12208921|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965184|NCT02688387|12208922|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965185|NCT02688387|12208923|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965186|NCT02688387|12208924|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965187|NCT02688387|12208925|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
4965188|NCT02688387|12208926|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
4965189|NCT02688387|12208905|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965190|NCT02688387|12208906|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965191|NCT02688387|12208907|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965192|NCT02688387|12208908|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965193|NCT02688387|12208909|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965194|NCT02688387|12208910|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965195|NCT02688387|12208911|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965196|NCT02688387|12208912|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965197|NCT02688387|12208913|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965198|NCT02688387|12208914|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965199|NCT02688387|12208915|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965200|NCT02688387|12208916|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
4965201|NCT02688387|12208917|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965202|NCT02688387|12208918|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965203|NCT02688387|12208919|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965204|NCT02688387|12208920|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965205|NCT02688387|12208921|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965206|NCT02688387|12208922|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
4965207|NCT02688387|12208923|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965208|NCT02688387|12208924|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
4965209|NCT02688387|12208925|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
4965210|NCT02688387|12208926|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
4965211|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965212|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965213|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965214|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965215|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965216|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965217|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965218|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965219|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965220|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965221|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965222|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965223|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965224|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965225|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965226|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965227|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965228|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965229|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965230|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965231|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
4965232|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965233|NCT02688387|12208905|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965234|NCT02688387|12208906|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965235|NCT02688387|12208907|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965236|NCT02688387|12208908|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965237|NCT02688387|12208909|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965238|NCT02688387|12208910|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965239|NCT02688387|12208911|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965240|NCT02688387|12208912|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965241|NCT02688387|12208913|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965242|NCT02688387|12208914|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965243|NCT02688387|12208915|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965244|NCT02688387|12208916|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
4965245|NCT02688387|12208917|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965246|NCT02688387|12208918|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965247|NCT02688387|12208919|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965248|NCT02688387|12208920|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965249|NCT02688387|12208921|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965250|NCT02688387|12208922|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
4965251|NCT02688387|12208923|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965252|NCT02688387|12208924|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
4965253|NCT02688387|12208925|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
4965254|NCT02688387|12208926|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
4965255|NCT02688387|12208905|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965256|NCT02688387|12208906|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965257|NCT02688387|12208907|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965258|NCT02688387|12208908|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965259|NCT02688387|12208909|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965260|NCT02688387|12208910|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965261|NCT02688387|12208911|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965262|NCT02688387|12208912|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965263|NCT02688387|12208913|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965264|NCT02688387|12208914|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965265|NCT02688387|12208915|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965266|NCT02688387|12208916|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
4965267|NCT02688387|12208917|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965268|NCT02688387|12208918|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965269|NCT02688387|12208919|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965270|NCT02688387|12208920|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965271|NCT02688387|12208921|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965272|NCT02688387|12208922|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
4965273|NCT02688387|12208923|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
4965274|NCT02688387|12208924|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
4965275|NCT02688387|12208925|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
4965276|NCT02688387|12208926|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
4965277|NCT02688387|12208905|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965278|NCT02688387|12208906|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965279|NCT02688387|12208907|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965280|NCT02688387|12208908|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965281|NCT02688387|12208909|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965282|NCT02688387|12208910|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965283|NCT02688387|12208911|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965284|NCT02688387|12208912|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965285|NCT02688387|12208913|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965286|NCT02688387|12208914|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965287|NCT02688387|12208915|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965369|NCT02688153|12209214|P2|COMPLETED|Overall Study||51
4965288|NCT02688387|12208916|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965289|NCT02688387|12208917|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965290|NCT02688387|12208918|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965291|NCT02688387|12208919|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965292|NCT02688387|12208920|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965293|NCT02688387|12208921|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965294|NCT02688387|12208922|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965295|NCT02688387|12208923|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
4965296|NCT02688387|12208924|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
4965297|NCT02688387|12208925|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965298|NCT02688387|12208926|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965299|NCT02688387|12208905|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965300|NCT02688387|12208906|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965301|NCT02688387|12208907|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965302|NCT02688387|12208908|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965303|NCT02688387|12208909|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965304|NCT02688387|12208910|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965305|NCT02688387|12208911|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965306|NCT02688387|12208912|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965307|NCT02688387|12208913|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965308|NCT02688387|12208914|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965309|NCT02688387|12208915|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965310|NCT02688387|12208916|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
4965311|NCT02688387|12208917|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965312|NCT02688387|12208918|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965313|NCT02688387|12208919|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965314|NCT02688387|12208920|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965315|NCT02688387|12208921|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965316|NCT02688387|12208922|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
4965317|NCT02688387|12208923|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
4965318|NCT02688387|12208924|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
4965319|NCT02688387|12208925|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
4965320|NCT02688387|12208926|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
4965321|NCT02688387|12208905|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965322|NCT02688387|12208906|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965323|NCT02688387|12208907|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965324|NCT02688387|12208908|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965325|NCT02688387|12208909|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965326|NCT02688387|12208910|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965327|NCT02688387|12208911|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965328|NCT02688387|12208912|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965329|NCT02688387|12208913|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965330|NCT02688387|12208914|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965331|NCT02688387|12208915|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965332|NCT02688387|12208916|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
4965333|NCT02688387|12208917|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
4965334|NCT02688387|12208918|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
4965335|NCT02688387|12208919|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
4965336|NCT02688387|12208920|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
4965337|NCT02688387|12208921|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
4965338|NCT02688387|12208922|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
4965339|NCT02688387|12208923|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
4965340|NCT02688387|12208924|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
4965341|NCT02688387|12208925|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
4965342|NCT02688387|12208926|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
4965343|NCT02688218|12209185|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
4965344|NCT02688218|12209186|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
4965345|NCT02688218|12209185|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
4965346|NCT02688218|12209186|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
4965347|NCT02688218|12209185|P2|STARTED|Second Exercise Intervention (2 Hours)||6
4965348|NCT02688218|12209186|P1|STARTED|Second Exercise Intervention (2 Hours)||24
4965349|NCT02688218|12209185|P2|NOT COMPLETED|Washout (30 Minutes)||0
4965350|NCT02688218|12209186|P1|NOT COMPLETED|Washout (30 Minutes)||0
4965351|NCT02688218|12209185|P2|COMPLETED|Washout (30 Minutes)||6
4965352|NCT02688218|12209186|P1|COMPLETED|Washout (30 Minutes)||24
4965353|NCT02688218|12209185|P2|STARTED|Washout (30 Minutes)||6
4965354|NCT02688218|12209186|P1|STARTED|Washout (30 Minutes)||24
4965355|NCT02688218|12209185|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
4965356|NCT02688218|12209186|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
4965357|NCT02688218|12209185|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
4965358|NCT02688218|12209186|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
4965359|NCT02688218|12209185|P2|STARTED|First Exercise Intervention (2 Hours)||6
4965360|NCT02688218|12209186|P1|STARTED|First Exercise Intervention (2 Hours)||24
4965361|NCT02688192|12209194|P2|NOT COMPLETED|Overall Study||5
4965362|NCT02688192|12209195|P1|NOT COMPLETED|Overall Study||12
4965363|NCT02688192|12209194|P2|COMPLETED|Overall Study||19
4965364|NCT02688192|12209195|P1|COMPLETED|Overall Study||13
4965365|NCT02688192|12209194|P2|STARTED|Overall Study||24
4965366|NCT02688192|12209195|P1|STARTED|Overall Study||25
4965367|NCT02688153|12209214|P2|NOT COMPLETED|Overall Study||7
4965368|NCT02688153|12209215|P1|NOT COMPLETED|Overall Study||15
4965370|NCT02688153|12209215|P1|COMPLETED|Overall Study||47
4965371|NCT02688153|12209214|P2|Final Randomized Arm/Group|Overall Study||61
4965372|NCT02688153|12209215|P1|Final Randomized Arm/Group|Overall Study||59
4965373|NCT02688153|12209214|P2|STARTED|Overall Study||58
4965374|NCT02688153|12209215|P1|STARTED|Overall Study||62
4965375|NCT02687919|12209275|P2|NOT COMPLETED|Overall Study||6
4965376|NCT02687919|12209276|P1|NOT COMPLETED|Overall Study||8
4965377|NCT02687919|12209275|P2|COMPLETED|Overall Study||9
4965378|NCT02687919|12209276|P1|COMPLETED|Overall Study||8
4965379|NCT02687919|12209275|P2|STARTED|Overall Study||15
4965380|NCT02687919|12209276|P1|STARTED|Overall Study||16
4965381|NCT02687542|12209309|P5|NOT COMPLETED|Overall Study||20
4965382|NCT02687542|12209310|P4|NOT COMPLETED|Overall Study||10
4965383|NCT02687542|12209311|P3|NOT COMPLETED|Overall Study||14
4965384|NCT02687542|12209312|P2|NOT COMPLETED|Overall Study||12
4965385|NCT02687542|12209313|P1|NOT COMPLETED|Overall Study||8
4965386|NCT02687542|12209309|P5|COMPLETED|Overall Study||24
4965387|NCT02687542|12209310|P4|COMPLETED|Overall Study||3
4965388|NCT02687542|12209311|P3|COMPLETED|Overall Study||1
4965389|NCT02687542|12209312|P2|COMPLETED|Overall Study||1
4965390|NCT02687542|12209313|P1|COMPLETED|Overall Study||15
4965391|NCT02687542|12209309|P5|STARTED|Overall Study||44
4965392|NCT02687542|12209310|P4|STARTED|Overall Study||13
4965393|NCT02687542|12209311|P3|STARTED|Overall Study||15
4965394|NCT02687542|12209312|P2|STARTED|Overall Study||13
4965395|NCT02687542|12209313|P1|STARTED|Overall Study||23
4965396|NCT02687529|12209387|P2|NOT COMPLETED|Overall Study||0
4965397|NCT02687529|12209388|P1|NOT COMPLETED|Overall Study||0
4965398|NCT02687529|12209387|P2|COMPLETED|Overall Study||32
4965399|NCT02687529|12209388|P1|COMPLETED|Overall Study||34
4965400|NCT02687529|12209387|P2|STARTED|Overall Study||32
4965401|NCT02687529|12209388|P1|STARTED|Overall Study||34
4965402|NCT02687412|12209396|P2|NOT COMPLETED|Overall Study||0
4965403|NCT02687412|12209397|P1|NOT COMPLETED|Overall Study||0
4965404|NCT02687412|12209396|P2|COMPLETED|Overall Study||57
4965405|NCT02687412|12209397|P1|COMPLETED|Overall Study||50
4965406|NCT02687412|12209396|P2|STARTED|Overall Study||57
4965407|NCT02687412|12209397|P1|STARTED|Overall Study||50
4965408|NCT02687217|12209425|P2|NOT COMPLETED|Overall Study||0
4965409|NCT02687217|12209426|P1|NOT COMPLETED|Overall Study||0
4965410|NCT02687217|12209425|P2|COMPLETED|Overall Study||30
4965411|NCT02687217|12209426|P1|COMPLETED|Overall Study||30
4965412|NCT02687217|12209425|P2|STARTED|Overall Study||30
4965413|NCT02687217|12209426|P1|STARTED|Overall Study||30
4965414|NCT02687191|12209442|P6|NOT COMPLETED|Overall Study||1
4965415|NCT02687191|12209443|P5|NOT COMPLETED|Overall Study||1
4965416|NCT02687191|12209444|P4|NOT COMPLETED|Overall Study||1
4965417|NCT02687191|12209445|P3|NOT COMPLETED|Overall Study||1
4965418|NCT02687191|12209446|P2|NOT COMPLETED|Overall Study||1
4965419|NCT02687191|12209447|P1|NOT COMPLETED|Overall Study||0
4965420|NCT02687191|12209442|P6|COMPLETED|Overall Study||2
4965421|NCT02687191|12209443|P5|COMPLETED|Overall Study||2
4965422|NCT02687191|12209444|P4|COMPLETED|Overall Study||5
4965423|NCT02687191|12209445|P3|COMPLETED|Overall Study||2
4965424|NCT02687191|12209446|P2|COMPLETED|Overall Study||2
4965425|NCT02687191|12209447|P1|COMPLETED|Overall Study||3
4965426|NCT02687191|12209442|P6|STARTED|Overall Study||3
4965427|NCT02687191|12209443|P5|STARTED|Overall Study||3
4965428|NCT02687191|12209444|P4|STARTED|Overall Study||6
4965429|NCT02687191|12209445|P3|STARTED|Overall Study||3
4965430|NCT02687191|12209446|P2|STARTED|Overall Study||3
4965431|NCT02687191|12209447|P1|STARTED|Overall Study||3
4965432|NCT02687165|12209581|P2|NOT COMPLETED|Overall Study||0
4965433|NCT02687165|12209582|P1|NOT COMPLETED|Overall Study||0
4965434|NCT02687165|12209581|P2|COMPLETED|Overall Study||0
4965435|NCT02687165|12209582|P1|COMPLETED|Overall Study||0
4965436|NCT02687165|12209581|P2|STARTED|Overall Study||0
4965437|NCT02687165|12209582|P1|STARTED|Overall Study||0
4965438|NCT02687139|12209588|P1|NOT COMPLETED|Overall Study||0
4965439|NCT02687139|12209588|P1|COMPLETED|Overall Study||34
4965440|NCT02687139|12209588|P1|STARTED|Overall Study||34
4965441|NCT02687126|12209593|P1|NOT COMPLETED|Data Analysis||0
4965442|NCT02687126|12209593|P1|COMPLETED|Data Analysis||106
4965443|NCT02687126|12209593|P1|STARTED|Data Analysis||106
4965444|NCT02687126|12209593|P1|NOT COMPLETED|Data Collection||0
4965445|NCT02687126|12209593|P1|COMPLETED|Data Collection||106
4965446|NCT02687126|12209593|P1|STARTED|Data Collection||106
4965447|NCT02686437|12209602|P2|NOT COMPLETED|Overall Study||8
4965448|NCT02686437|12209603|P1|NOT COMPLETED|Overall Study||3
4965449|NCT02686437|12209602|P2|COMPLETED|Overall Study||12
4965450|NCT02686437|12209603|P1|COMPLETED|Overall Study||13
4965451|NCT02686437|12209602|P2|STARTED|Overall Study||20
4965452|NCT02686437|12209603|P1|STARTED|Overall Study||16
4965453|NCT02686164|12209611|P1|NOT COMPLETED|Overall Study||3
4965454|NCT02686164|12209611|P1|COMPLETED|Overall Study||27
4965455|NCT02686164|12209611|P1|STARTED|Overall Study||30
4965456|NCT02686138|12209623|P2|NOT COMPLETED|Overall Study||65
4965457|NCT02686138|12209624|P1|NOT COMPLETED|Overall Study||74
4965458|NCT02686138|12209623|P2|COMPLETED|Overall Study||235
4965459|NCT02686138|12209624|P1|COMPLETED|Overall Study||219
4965460|NCT02686138|12209623|P2|STARTED|Overall Study||300
4965461|NCT02686138|12209624|P1|STARTED|Overall Study||293
4965462|NCT02686034|12209648|P2|NOT COMPLETED|Open Label Period 3||1
4965463|NCT02686034|12209649|P1|NOT COMPLETED|Open Label Period 3||0
4965464|NCT02686034|12209648|P2|COMPLETED|Open Label Period 3||121
4965465|NCT02686034|12209649|P1|COMPLETED|Open Label Period 3||117
4965466|NCT02686034|12209648|P2|STARTED|Open Label Period 3||122
4965467|NCT02686034|12209649|P1|STARTED|Open Label Period 3||117
4965468|NCT02686034|12209648|P2|NOT COMPLETED|Randomized Controlled Period 2||4
4965469|NCT02686034|12209649|P1|NOT COMPLETED|Randomized Controlled Period 2||5
4965470|NCT02686034|12209648|P2|COMPLETED|Randomized Controlled Period 2||122
4965471|NCT02686034|12209649|P1|COMPLETED|Randomized Controlled Period 2||117
4965472|NCT02686034|12209648|P2|STARTED|Randomized Controlled Period 2||126
4965473|NCT02686034|12209649|P1|STARTED|Randomized Controlled Period 2||122
4965474|NCT02686034|12209648|P2|NOT COMPLETED|Run-In Period 1||17
4965475|NCT02686034|12209649|P1|NOT COMPLETED|Run-In Period 1||20
4965476|NCT02686034|12209648|P2|COMPLETED|Run-In Period 1||126
4965477|NCT02686034|12209649|P1|COMPLETED|Run-In Period 1||122
4965478|NCT02686034|12209648|P2|STARTED|Run-In Period 1||143
4965479|NCT02686034|12209649|P1|STARTED|Run-In Period 1||142
4965480|NCT02685956|12209687|P2|NOT COMPLETED|Overall Study||0
4965481|NCT02685956|12209688|P1|NOT COMPLETED|Overall Study||0
4965482|NCT02685956|12209687|P2|COMPLETED|Overall Study||1978
4965483|NCT02685956|12209688|P1|COMPLETED|Overall Study||317
4965484|NCT02685956|12209687|P2|STARTED|Overall Study||1978
4965485|NCT02685956|12209688|P1|STARTED|Overall Study||317
4965486|NCT02685826|12209699|P3|NOT COMPLETED|Overall Study||21
4965487|NCT02685826|12209700|P2|NOT COMPLETED|Overall Study||10
4965488|NCT02685826|12209701|P1|NOT COMPLETED|Overall Study||25
4965489|NCT02685826|12209699|P3|COMPLETED|Overall Study||0
4965490|NCT02685826|12209700|P2|COMPLETED|Overall Study||0
4965491|NCT02685826|12209701|P1|COMPLETED|Overall Study||0
4965492|NCT02685826|12209699|P3|STARTED|Overall Study||21
4965493|NCT02685826|12209700|P2|STARTED|Overall Study||10
4965494|NCT02685826|12209701|P1|STARTED|Overall Study||25
4965495|NCT02685566|12209784|P2|NOT COMPLETED|Second Reading Session||0
4965496|NCT02685566|12209785|P1|NOT COMPLETED|Second Reading Session||0
4965497|NCT02685566|12209784|P2|COMPLETED|Second Reading Session||50
4965498|NCT02685566|12209785|P1|COMPLETED|Second Reading Session||50
4965499|NCT02685566|12209784|P2|STARTED|Second Reading Session||50
4965500|NCT02685566|12209785|P1|STARTED|Second Reading Session||50
4965501|NCT02685566|12209784|P2|NOT COMPLETED|4 Week Memory Washout Period||0
4965502|NCT02685566|12209785|P1|NOT COMPLETED|4 Week Memory Washout Period||0
4965503|NCT02685566|12209784|P2|COMPLETED|4 Week Memory Washout Period||50
4965504|NCT02685566|12209785|P1|COMPLETED|4 Week Memory Washout Period||50
4965505|NCT02685566|12209784|P2|STARTED|4 Week Memory Washout Period||50
4965506|NCT02685566|12209785|P1|STARTED|4 Week Memory Washout Period||50
4965507|NCT02685566|12209784|P2|NOT COMPLETED|First Reading Session||0
4965508|NCT02685566|12209785|P1|NOT COMPLETED|First Reading Session||0
4965509|NCT02685566|12209784|P2|COMPLETED|First Reading Session||50
4965510|NCT02685566|12209785|P1|COMPLETED|First Reading Session||50
4965511|NCT02685566|12209784|P2|STARTED|First Reading Session||50
4965512|NCT02685566|12209785|P1|STARTED|First Reading Session||50
4965513|NCT02685488|12209795|P2|NOT COMPLETED|Overall Study||1
4965514|NCT02685488|12209796|P1|NOT COMPLETED|Overall Study||0
4965515|NCT02685488|12209795|P2|COMPLETED|Overall Study||13
4965516|NCT02685488|12209796|P1|COMPLETED|Overall Study||12
4965517|NCT02685488|12209795|P2|STARTED|Overall Study||14
4965518|NCT02685488|12209796|P1|STARTED|Overall Study||12
4965519|NCT02685436|12209810|P1|NOT COMPLETED|Overall Study||14
4965520|NCT02685436|12209810|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
4965521|NCT02685436|12209810|P1|STARTED|Overall Study|the overall studied group|52
4965522|NCT02685293|12209814|P2|NOT COMPLETED|Treatment Period 2||0
4965523|NCT02685293|12209815|P1|NOT COMPLETED|Treatment Period 2||0
4965524|NCT02685293|12209814|P2|COMPLETED|Treatment Period 2||3
4965525|NCT02685293|12209815|P1|COMPLETED|Treatment Period 2||1
4965526|NCT02685293|12209814|P2|STARTED|Treatment Period 2||3
4965527|NCT02685293|12209815|P1|STARTED|Treatment Period 2||1
4965528|NCT02685293|12209814|P2|NOT COMPLETED|Washout Period||0
4965529|NCT02685293|12209815|P1|NOT COMPLETED|Washout Period||0
4965530|NCT02685293|12209814|P2|COMPLETED|Washout Period||3
4965531|NCT02685293|12209815|P1|COMPLETED|Washout Period||1
4965532|NCT02685293|12209814|P2|STARTED|Washout Period||3
4965533|NCT02685293|12209815|P1|STARTED|Washout Period||1
4965534|NCT02685293|12209814|P2|NOT COMPLETED|Treatment Period 1||0
4965535|NCT02685293|12209815|P1|NOT COMPLETED|Treatment Period 1||0
4965536|NCT02685293|12209814|P2|COMPLETED|Treatment Period 1||3
4965537|NCT02685293|12209815|P1|COMPLETED|Treatment Period 1||1
4965538|NCT02685293|12209814|P2|STARTED|Treatment Period 1||3
4965539|NCT02685293|12209815|P1|STARTED|Treatment Period 1||1
4965540|NCT02685202|12209849|P1|NOT COMPLETED|Overall Study||9
4965541|NCT02685202|12209849|P1|COMPLETED|Overall Study||0
4965542|NCT02685202|12209849|P1|STARTED|Overall Study||9
4965543|NCT02685072|12209857|P2|NOT COMPLETED|3-Month Follow-Up||0
4965544|NCT02685072|12209858|P1|NOT COMPLETED|3-Month Follow-Up||0
4965545|NCT02685072|12209857|P2|COMPLETED|3-Month Follow-Up||22
4965546|NCT02685072|12209858|P1|COMPLETED|3-Month Follow-Up||19
4965547|NCT02685072|12209857|P2|STARTED|3-Month Follow-Up||22
4965548|NCT02685072|12209858|P1|STARTED|3-Month Follow-Up||19
4965549|NCT02685072|12209857|P2|NOT COMPLETED|1-Month Follow-Up||0
4965550|NCT02685072|12209858|P1|NOT COMPLETED|1-Month Follow-Up||1
4965551|NCT02685072|12209857|P2|COMPLETED|1-Month Follow-Up||22
4965552|NCT02685072|12209858|P1|COMPLETED|1-Month Follow-Up||19
4965553|NCT02685072|12209857|P2|STARTED|1-Month Follow-Up||22
4965554|NCT02685072|12209858|P1|STARTED|1-Month Follow-Up||20
4965555|NCT02685072|12209857|P2|NOT COMPLETED|Treatment Period||9
4965556|NCT02685072|12209858|P1|NOT COMPLETED|Treatment Period||13
4965557|NCT02685072|12209857|P2|COMPLETED|Treatment Period||22
4965558|NCT02685072|12209858|P1|COMPLETED|Treatment Period||20
4965559|NCT02685072|12209857|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
4965560|NCT02685072|12209858|P1|Completed Week 8 Visit|Treatment Period||20
4965561|NCT02685072|12209857|P2|Completed Week 7 Visit|Treatment Period||18
4965562|NCT02685072|12209858|P1|Completed Week 7 Visit|Treatment Period||17
4965563|NCT02685072|12209857|P2|Completed Week 6 Visit|Treatment Period||19
4965564|NCT02685072|12209858|P1|Completed Week 6 Visit|Treatment Period||18
4965565|NCT02685072|12209857|P2|Completed Week 5 Visit|Treatment Period||22
4965566|NCT02685072|12209858|P1|Completed Week 5 Visit|Treatment Period||19
4965567|NCT02685072|12209857|P2|Completed Week 4 Visit|Treatment Period||23
4965568|NCT02685072|12209858|P1|Completed Week 4 Visit|Treatment Period||19
4965569|NCT02685072|12209857|P2|Completed Week 3 Visit|Treatment Period||23
4965570|NCT02685072|12209858|P1|Completed Week 3 Visit|Treatment Period||20
4965571|NCT02685072|12209857|P2|Completed Week 2 Visit|Treatment Period||26
4965572|NCT02685072|12209858|P1|Completed Week 2 Visit|Treatment Period||23
4965573|NCT02685072|12209857|P2|STARTED|Treatment Period||31
4965574|NCT02685072|12209858|P1|STARTED|Treatment Period||33
4965575|NCT02685033|12209902|P2|NOT COMPLETED|Overall Study||2
4965576|NCT02685033|12209903|P1|NOT COMPLETED|Overall Study||3
4965577|NCT02685033|12209902|P2|COMPLETED|Overall Study||8
4965578|NCT02685033|12209903|P1|COMPLETED|Overall Study||67
4965579|NCT02685033|12209902|P2|STARTED|Overall Study||10
4965580|NCT02685033|12209903|P1|STARTED|Overall Study||70
4965581|NCT02685007|12209929|P1|NOT COMPLETED|Overall Study||0
4965582|NCT02685007|12209929|P1|COMPLETED|Overall Study||131
4965583|NCT02685007|12209929|P1|STARTED|Overall Study||131
4965584|NCT02684981|12209939|P3|NOT COMPLETED|Overall Study||127
4965585|NCT02684981|12209940|P2|NOT COMPLETED|Overall Study||210
4965586|NCT02684981|12209941|P1|NOT COMPLETED|Overall Study||240
4965587|NCT02684981|12209939|P3|COMPLETED|Overall Study||2059
4965588|NCT02684981|12209940|P2|COMPLETED|Overall Study||2969
4965589|NCT02684981|12209941|P1|COMPLETED|Overall Study||3860
4965590|NCT02684981|12209939|P3|STARTED|Overall Study||2186
4965591|NCT02684981|12209940|P2|STARTED|Overall Study||3179
4965592|NCT02684981|12209941|P1|STARTED|Overall Study||4100
4965593|NCT02684942|12209977|P6|NOT COMPLETED|Overall Study||0
4965594|NCT02684942|12209978|P5|NOT COMPLETED|Overall Study||0
4965595|NCT02684942|12209979|P4|NOT COMPLETED|Overall Study||0
4965596|NCT02684942|12209980|P3|NOT COMPLETED|Overall Study||0
4965597|NCT02684942|12209981|P2|NOT COMPLETED|Overall Study||0
4965598|NCT02684942|12209982|P1|NOT COMPLETED|Overall Study||0
4965599|NCT02684942|12209977|P6|COMPLETED|Overall Study||6
4965600|NCT02684942|12209978|P5|COMPLETED|Overall Study||6
4965601|NCT02684942|12209979|P4|COMPLETED|Overall Study||7
4965602|NCT02684942|12209980|P3|COMPLETED|Overall Study||7
4965603|NCT02684942|12209981|P2|COMPLETED|Overall Study||7
4965604|NCT02684942|12209982|P1|COMPLETED|Overall Study||7
4965605|NCT02684942|12209977|P6|STARTED|Overall Study||6
4965606|NCT02684942|12209978|P5|STARTED|Overall Study||6
4965607|NCT02684942|12209979|P4|STARTED|Overall Study||7
4965608|NCT02684942|12209980|P3|STARTED|Overall Study||7
4965609|NCT02684942|12209981|P2|STARTED|Overall Study||7
4965610|NCT02684942|12209982|P1|STARTED|Overall Study||7
4965611|NCT02684630|12209998|P2|NOT COMPLETED|Overall Study||3
4965612|NCT02684630|12209999|P1|NOT COMPLETED|Overall Study||5
4965613|NCT02684630|12209998|P2|COMPLETED|Overall Study||60
4965614|NCT02684630|12209999|P1|COMPLETED|Overall Study||60
4965615|NCT02684630|12209998|P2|STARTED|Overall Study||63
4965616|NCT02684630|12209999|P1|STARTED|Overall Study||65
4965617|NCT02684604|12210009|P2|NOT COMPLETED|Overall Study||0
4965618|NCT02684604|12210010|P1|NOT COMPLETED|Overall Study||0
4965619|NCT02684604|12210009|P2|COMPLETED|Overall Study||44
4965620|NCT02684604|12210010|P1|COMPLETED|Overall Study||44
4965621|NCT02684604|12210009|P2|STARTED|Overall Study||44
4965622|NCT02684604|12210010|P1|STARTED|Overall Study||44
4965623|NCT02684591|12210018|P2|NOT COMPLETED|Overall Study||3
4965624|NCT02684591|12210019|P1|NOT COMPLETED|Overall Study||1
4965625|NCT02684591|12210018|P2|COMPLETED|Overall Study||22
4965626|NCT02684591|12210019|P1|COMPLETED|Overall Study||24
4965627|NCT02684591|12210018|P2|STARTED|Overall Study||25
4965628|NCT02684591|12210019|P1|STARTED|Overall Study||25
4965629|NCT02684435|12210027|P1|NOT COMPLETED|Overall Study||0
4965630|NCT02684435|12210027|P1|COMPLETED|Overall Study||63
4965631|NCT02684435|12210027|P1|STARTED|Overall Study||63
4965632|NCT02684396|12210041|P6|NOT COMPLETED|Overall Study||0
4965633|NCT02684396|12210042|P5|NOT COMPLETED|Overall Study||0
4965634|NCT02684396|12210043|P4|NOT COMPLETED|Overall Study||0
4965635|NCT02684396|12210044|P3|NOT COMPLETED|Overall Study||0
4965636|NCT02684396|12210045|P2|NOT COMPLETED|Overall Study||0
4965637|NCT02684396|12210046|P1|NOT COMPLETED|Overall Study||0
4965638|NCT02684396|12210041|P6|COMPLETED|Overall Study||10
4965639|NCT02684396|12210042|P5|COMPLETED|Overall Study||5
4965640|NCT02684396|12210043|P4|COMPLETED|Overall Study||6
4965641|NCT02684396|12210044|P3|COMPLETED|Overall Study||6
4965642|NCT02684396|12210045|P2|COMPLETED|Overall Study||6
4965643|NCT02684396|12210046|P1|COMPLETED|Overall Study||6
4965644|NCT02684396|12210041|P6|STARTED|Overall Study||10
4965645|NCT02684396|12210042|P5|STARTED|Overall Study||5
4965646|NCT02684396|12210043|P4|STARTED|Overall Study||6
4965647|NCT02684396|12210044|P3|STARTED|Overall Study||6
4965648|NCT02684396|12210045|P2|STARTED|Overall Study||6
4965649|NCT02684396|12210046|P1|STARTED|Overall Study||6
4965650|NCT02684370|12210101|P6|NOT COMPLETED|Part B||8
4965651|NCT02684370|12210102|P5|NOT COMPLETED|Part B||5
4965652|NCT02684370|12210103|P4|NOT COMPLETED|Part B||2
4965653|NCT02684370|12210104|P3|NOT COMPLETED|Part B||0
4965654|NCT02684370|12210105|P2|NOT COMPLETED|Part B||0
4965655|NCT02684370|12210106|P1|NOT COMPLETED|Part B||0
4965656|NCT02684370|12210101|P6|COMPLETED|Part B||289
4965657|NCT02684370|12210102|P5|COMPLETED|Part B||94
4965658|NCT02684370|12210103|P4|COMPLETED|Part B||95
4965659|NCT02684370|12210104|P3|COMPLETED|Part B||0
4965660|NCT02684370|12210105|P2|COMPLETED|Part B||0
4965661|NCT02684370|12210106|P1|COMPLETED|Part B||0
4965662|NCT02684370|12210101|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
4965663|NCT02684370|12210102|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
4965664|NCT02684370|12210103|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
4965665|NCT02684370|12210104|P3|STARTED|Part B||0
4965666|NCT02684370|12210105|P2|STARTED|Part B||0
4965667|NCT02684370|12210106|P1|STARTED|Part B||0
4965668|NCT02684370|12210101|P6|NOT COMPLETED|Part A||0
4965669|NCT02684370|12210102|P5|NOT COMPLETED|Part A||0
4965670|NCT02684370|12210103|P4|NOT COMPLETED|Part A||0
4965671|NCT02684370|12210104|P3|NOT COMPLETED|Part A||5
4965672|NCT02684370|12210105|P2|NOT COMPLETED|Part A||1
4965673|NCT02684370|12210106|P1|NOT COMPLETED|Part A||4
4965674|NCT02684370|12210101|P6|COMPLETED|Part A||0
4965675|NCT02684370|12210102|P5|COMPLETED|Part A||0
4965676|NCT02684370|12210103|P4|COMPLETED|Part A||0
4965677|NCT02684370|12210104|P3|COMPLETED|Part A||299
4965678|NCT02684370|12210105|P2|COMPLETED|Part A||99
4965679|NCT02684370|12210106|P1|COMPLETED|Part A||98
4965680|NCT02684370|12210101|P6|STARTED|Part A||0
4965681|NCT02684370|12210102|P5|STARTED|Part A||0
4965682|NCT02684370|12210103|P4|STARTED|Part A||0
4965683|NCT02684370|12210104|P3|STARTED|Part A||304
4965684|NCT02684370|12210105|P2|STARTED|Part A||100
4965685|NCT02684370|12210106|P1|STARTED|Part A||102
4965686|NCT02684357|12210151|P6|NOT COMPLETED|Part B||13
4965687|NCT02684357|12210152|P5|NOT COMPLETED|Part B||4
4965688|NCT02684357|12210153|P4|NOT COMPLETED|Part B||3
4965689|NCT02684357|12210154|P3|NOT COMPLETED|Part B||0
4965690|NCT02684357|12210155|P2|NOT COMPLETED|Part B||0
4965691|NCT02684357|12210156|P1|NOT COMPLETED|Part B||0
4965692|NCT02684357|12210151|P6|COMPLETED|Part B||278
4965693|NCT02684357|12210152|P5|COMPLETED|Part B||90
4965694|NCT02684357|12210153|P4|COMPLETED|Part B||91
4965695|NCT02684357|12210154|P3|COMPLETED|Part B||0
4965696|NCT02684357|12210155|P2|COMPLETED|Part B||0
4965697|NCT02684357|12210156|P1|COMPLETED|Part B||0
4965698|NCT02684357|12210151|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
4965699|NCT02684357|12210152|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
4965700|NCT02684357|12210153|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
4965701|NCT02684357|12210154|P3|STARTED|Part B||0
4965702|NCT02684357|12210155|P2|STARTED|Part B||0
4965703|NCT02684357|12210156|P1|STARTED|Part B||0
4965704|NCT02684357|12210151|P6|NOT COMPLETED|Part A||0
4965705|NCT02684357|12210152|P5|NOT COMPLETED|Part A||0
4965706|NCT02684357|12210153|P4|NOT COMPLETED|Part A||0
4965707|NCT02684357|12210154|P3|NOT COMPLETED|Part A||2
4965708|NCT02684357|12210155|P2|NOT COMPLETED|Part A||3
4965709|NCT02684357|12210156|P1|NOT COMPLETED|Part A||4
4965710|NCT02684357|12210151|P6|COMPLETED|Part A||0
4965711|NCT02684357|12210152|P5|COMPLETED|Part A||0
4965712|NCT02684357|12210153|P4|COMPLETED|Part A||0
4965713|NCT02684357|12210154|P3|COMPLETED|Part A||292
4965714|NCT02684357|12210155|P2|COMPLETED|Part A||96
4965715|NCT02684357|12210156|P1|COMPLETED|Part A||94
4965716|NCT02684357|12210151|P6|STARTED|Part A||0
4965717|NCT02684357|12210152|P5|STARTED|Part A||0
4965718|NCT02684357|12210153|P4|STARTED|Part A||0
4965719|NCT02684357|12210154|P3|STARTED|Part A||294
4965720|NCT02684357|12210155|P2|STARTED|Part A||99
4965721|NCT02684357|12210156|P1|STARTED|Part A||98
4965722|NCT02684344|12210206|P2|NOT COMPLETED|Overall Study||1
4965723|NCT02684344|12210207|P1|NOT COMPLETED|Overall Study||0
4965724|NCT02684344|12210206|P2|COMPLETED|Overall Study||3
4965725|NCT02684344|12210207|P1|COMPLETED|Overall Study||1
4965726|NCT02684344|12210206|P2|STARTED|Overall Study||4
4965727|NCT02684344|12210207|P1|STARTED|Overall Study||1
4965728|NCT02684188|12210215|P2|NOT COMPLETED|Overall Study||3
4965729|NCT02684188|12210216|P1|NOT COMPLETED|Overall Study||2
4965730|NCT02684188|12210215|P2|COMPLETED|Overall Study||47
4965731|NCT02684188|12210216|P1|COMPLETED|Overall Study||75
4965732|NCT02684188|12210215|P2|STARTED|Overall Study||50
4965733|NCT02684188|12210216|P1|STARTED|Overall Study||77
4965734|NCT02684097|12210242|P2|NOT COMPLETED|Overall Study||6
4965735|NCT02684097|12210243|P1|NOT COMPLETED|Overall Study||13
4965736|NCT02684097|12210242|P2|COMPLETED|Overall Study||1
4965737|NCT02684097|12210243|P1|COMPLETED|Overall Study||2
4965738|NCT02684097|12210242|P2|STARTED|Overall Study||7
4965739|NCT02684097|12210243|P1|STARTED|Overall Study||15
4965740|NCT02683954|12210261|P2|NOT COMPLETED|Overall Study||0
4965741|NCT02683954|12210262|P1|NOT COMPLETED|Overall Study||0
4965742|NCT02683954|12210261|P2|COMPLETED|Overall Study||30
4965743|NCT02683954|12210262|P1|COMPLETED|Overall Study||30
4965744|NCT02683954|12210261|P2|STARTED|Overall Study||30
4965745|NCT02683954|12210262|P1|STARTED|Overall Study||30
4965746|NCT02683928|12210270|P2|NOT COMPLETED|Overall Study||8
4965747|NCT02683928|12210271|P1|NOT COMPLETED|Overall Study||22
4965748|NCT02683928|12210270|P2|COMPLETED|Overall Study||8
4965749|NCT02683928|12210271|P1|COMPLETED|Overall Study||26
4965750|NCT02683928|12210270|P2|STARTED|Overall Study||16
4965751|NCT02683928|12210271|P1|STARTED|Overall Study||48
4965752|NCT02683889|12210289|P1|NOT COMPLETED|Overall Study||1
4965753|NCT02683889|12210289|P1|COMPLETED|Overall Study||2
4965754|NCT02683889|12210289|P1|STARTED|Overall Study||3
4965755|NCT02683785|12210297|P2|NOT COMPLETED|Overall Study||4
4965756|NCT02683785|12210298|P1|NOT COMPLETED|Overall Study||1
4965757|NCT02683785|12210297|P2|COMPLETED|Overall Study||18
4965758|NCT02683785|12210298|P1|COMPLETED|Overall Study||21
4965759|NCT02683785|12210297|P2|STARTED|Overall Study||22
4965760|NCT02683785|12210298|P1|STARTED|Overall Study||22
4965761|NCT02683772|12210338|P2|NOT COMPLETED|Overall Study||0
4965762|NCT02683772|12210339|P1|NOT COMPLETED|Overall Study||0
4965763|NCT02683772|12210338|P2|COMPLETED|Overall Study||23
4965764|NCT02683772|12210339|P1|COMPLETED|Overall Study||15
4965765|NCT02683772|12210338|P2|STARTED|Overall Study||23
4965766|NCT02683772|12210339|P1|STARTED|Overall Study||15
4965767|NCT02683746|12210355|P2|NOT COMPLETED|Overall Study||14
4965768|NCT02683746|12210356|P1|NOT COMPLETED|Overall Study||16
4965769|NCT02683746|12210355|P2|COMPLETED|Overall Study||140
4965770|NCT02683746|12210356|P1|COMPLETED|Overall Study||138
4965771|NCT02683746|12210355|P2|STARTED|Overall Study||154
4965772|NCT02683746|12210356|P1|STARTED|Overall Study||154
4965773|NCT02683707|12210386|P2|NOT COMPLETED|Overall Study||0
4965774|NCT02683707|12210387|P1|NOT COMPLETED|Overall Study||0
4965775|NCT02683707|12210386|P2|COMPLETED|Overall Study||107
4965776|NCT02683707|12210387|P1|COMPLETED|Overall Study||105
4965777|NCT02683707|12210386|P2|STARTED|Overall Study||107
4965778|NCT02683707|12210387|P1|STARTED|Overall Study||105
4965779|NCT02683668|12210399|P3|NOT COMPLETED|Period 3||0
4965780|NCT02683668|12210400|P2|NOT COMPLETED|Period 3||0
4965781|NCT02683668|12210401|P1|NOT COMPLETED|Period 3||0
4965782|NCT02683668|12210399|P3|COMPLETED|Period 3||43
4965783|NCT02683668|12210400|P2|COMPLETED|Period 3||0
4965784|NCT02683668|12210401|P1|COMPLETED|Period 3||0
4965785|NCT02683668|12210399|P3|STARTED|Period 3||43
4965786|NCT02683668|12210400|P2|STARTED|Period 3||0
4965787|NCT02683668|12210401|P1|STARTED|Period 3||0
4965788|NCT02683668|12210399|P3|NOT COMPLETED|Period 2||0
4965789|NCT02683668|12210400|P2|NOT COMPLETED|Period 2||1
4965790|NCT02683668|12210401|P1|NOT COMPLETED|Period 2||0
4965791|NCT02683668|12210399|P3|COMPLETED|Period 2||0
4965792|NCT02683668|12210400|P2|COMPLETED|Period 2||43
4965793|NCT02683668|12210401|P1|COMPLETED|Period 2||0
4965794|NCT02683668|12210399|P3|STARTED|Period 2||0
4965795|NCT02683668|12210400|P2|STARTED|Period 2||44
4965796|NCT02683668|12210401|P1|STARTED|Period 2||0
4965797|NCT02683668|12210399|P3|NOT COMPLETED|Period 1||0
4965798|NCT02683668|12210400|P2|NOT COMPLETED|Period 1||0
4965799|NCT02683668|12210401|P1|NOT COMPLETED|Period 1||0
4965800|NCT02683668|12210399|P3|COMPLETED|Period 1||0
4965801|NCT02683668|12210400|P2|COMPLETED|Period 1||0
4965802|NCT02683668|12210401|P1|COMPLETED|Period 1||44
4965803|NCT02683668|12210399|P3|STARTED|Period 1||0
4965804|NCT02683668|12210400|P2|STARTED|Period 1||0
4965805|NCT02683668|12210401|P1|STARTED|Period 1||44
4965806|NCT02683577|12210419|P3|NOT COMPLETED|Overall Study||0
4965807|NCT02683577|12210420|P2|NOT COMPLETED|Overall Study||0
4965808|NCT02683577|12210421|P1|NOT COMPLETED|Overall Study||0
4965809|NCT02683577|12210419|P3|COMPLETED|Overall Study||8
4965810|NCT02683577|12210420|P2|COMPLETED|Overall Study||8
4965811|NCT02683577|12210421|P1|COMPLETED|Overall Study||8
4965812|NCT02683577|12210419|P3|STARTED|Overall Study||8
4965813|NCT02683577|12210420|P2|STARTED|Overall Study||8
4965814|NCT02683577|12210421|P1|STARTED|Overall Study||8
4965815|NCT02683421|12210471|P4|NOT COMPLETED|Overall Study||0
4965816|NCT02683421|12210472|P3|NOT COMPLETED|Overall Study||0
4965817|NCT02683421|12210473|P2|NOT COMPLETED|Overall Study||0
4965818|NCT02683421|12210474|P1|NOT COMPLETED|Overall Study||0
4965819|NCT02683421|12210471|P4|COMPLETED|Overall Study||5
4965820|NCT02683421|12210472|P3|COMPLETED|Overall Study||4
4965821|NCT02683421|12210473|P2|COMPLETED|Overall Study||4
4965822|NCT02683421|12210474|P1|COMPLETED|Overall Study||5
4965823|NCT02683421|12210471|P4|STARTED|Overall Study||5
4965824|NCT02683421|12210472|P3|STARTED|Overall Study||4
4965825|NCT02683421|12210473|P2|STARTED|Overall Study||4
4965826|NCT02683421|12210474|P1|STARTED|Overall Study||5
4965827|NCT02683174|12210492|P1|NOT COMPLETED|Overall Study||0
4965828|NCT02683174|12210492|P1|COMPLETED|Overall Study||86
4965829|NCT02683174|12210492|P1|STARTED|Overall Study||86
4965830|NCT02683161|12210502|P1|NOT COMPLETED|Overall Study||0
4965831|NCT02683161|12210502|P1|COMPLETED|Overall Study||5
4965832|NCT02683161|12210502|P1|STARTED|Overall Study||5
4965833|NCT02683109|12210508|P2|NOT COMPLETED|Overall Study||0
4965834|NCT02683109|12210509|P1|NOT COMPLETED|Overall Study||1
4965835|NCT02683109|12210508|P2|COMPLETED|Overall Study||111
4965836|NCT02683109|12210509|P1|COMPLETED|Overall Study||109
4965837|NCT02683109|12210508|P2|STARTED|Overall Study||111
4965838|NCT02683109|12210509|P1|STARTED|Overall Study||110
4965839|NCT02683083|12210520|P1|NOT COMPLETED|Overall Study||0
4965840|NCT02683083|12210520|P1|COMPLETED|Overall Study||9
4965841|NCT02683083|12210520|P1|STARTED|Overall Study||9
4965842|NCT02682823|12210530|P5|NOT COMPLETED|Overall Study||1
4965843|NCT02682823|12210531|P4|NOT COMPLETED|Overall Study||1
4965844|NCT02682823|12210532|P3|NOT COMPLETED|Overall Study||1
4965845|NCT02682823|12210533|P2|NOT COMPLETED|Overall Study||1
4965846|NCT02682823|12210534|P1|NOT COMPLETED|Overall Study||0
4965847|NCT02682823|12210530|P5|COMPLETED|Overall Study||18
4965848|NCT02682823|12210531|P4|COMPLETED|Overall Study||16
4965849|NCT02682823|12210532|P3|COMPLETED|Overall Study||18
4965850|NCT02682823|12210533|P2|COMPLETED|Overall Study||18
4965851|NCT02682823|12210534|P1|COMPLETED|Overall Study||17
4965852|NCT02682823|12210530|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
4965853|NCT02682823|12210531|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
4965854|NCT02682823|12210532|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
4965855|NCT02682823|12210533|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
4965856|NCT02682823|12210534|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
4965857|NCT02682823|12210530|P5|STARTED|Overall Study||19
4965858|NCT02682823|12210531|P4|STARTED|Overall Study||17
4965859|NCT02682823|12210532|P3|STARTED|Overall Study||19
4965860|NCT02682823|12210533|P2|STARTED|Overall Study||19
4965861|NCT02682823|12210534|P1|STARTED|Overall Study||17
4965862|NCT02682602|12210570|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
4965863|NCT02682602|12210571|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
4965864|NCT02682602|12210570|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
4965865|NCT02682602|12210571|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
4965866|NCT02682602|12210570|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
4965867|NCT02682602|12210571|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
4965868|NCT02682602|12210570|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
4965869|NCT02682602|12210571|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
4965870|NCT02682602|12210570|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
4965871|NCT02682602|12210571|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
4965872|NCT02682602|12210570|P2|STARTED|Pre-operative Diseased & Normal Hips||10
4965873|NCT02682602|12210571|P1|STARTED|Pre-operative Diseased & Normal Hips||11
4965874|NCT02682563|12210590|P2|NOT COMPLETED|Overall Study||0
4965875|NCT02682563|12210591|P1|NOT COMPLETED|Overall Study||0
4965876|NCT02682563|12210590|P2|COMPLETED|Overall Study||20
4965877|NCT02682563|12210591|P1|COMPLETED|Overall Study||24
4965878|NCT02682563|12210590|P2|STARTED|Overall Study||20
4965879|NCT02682563|12210591|P1|STARTED|Overall Study||24
4965880|NCT02682498|12210617|P2|NOT COMPLETED|Overall Study||0
4965881|NCT02682498|12210618|P1|NOT COMPLETED|Overall Study||0
4965882|NCT02682498|12210617|P2|COMPLETED|Overall Study||20
4965883|NCT02682498|12210618|P1|COMPLETED|Overall Study||18
4965884|NCT02682498|12210617|P2|STARTED|Overall Study||20
4965885|NCT02682498|12210618|P1|STARTED|Overall Study||18
4965886|NCT02682381|12210635|P3|NOT COMPLETED|Overall Study||0
4965887|NCT02682381|12210636|P2|NOT COMPLETED|Overall Study||0
4965888|NCT02682381|12210637|P1|NOT COMPLETED|Overall Study||0
4965889|NCT02682381|12210635|P3|COMPLETED|Overall Study||9
4965890|NCT02682381|12210636|P2|COMPLETED|Overall Study||26
4965891|NCT02682381|12210637|P1|COMPLETED|Overall Study||24
4965892|NCT02682381|12210635|P3|STARTED|Overall Study||9
4965893|NCT02682381|12210636|P2|STARTED|Overall Study||26
4965894|NCT02682381|12210637|P1|STARTED|Overall Study||24
4965895|NCT02682069|12210702|P1|NOT COMPLETED|Overall Study||0
4965896|NCT02682069|12210702|P1|COMPLETED|Overall Study||30
4965897|NCT02682069|12210702|P1|STARTED|Overall Study||30
4965898|NCT02682056|12210706|P1|NOT COMPLETED|Overall Study||0
4965899|NCT02682056|12210706|P1|COMPLETED|Overall Study||15
4965900|NCT02682056|12210706|P1|STARTED|Overall Study||15
4965901|NCT02681757|12210722|P2|NOT COMPLETED|Overall Study||0
4965902|NCT02681757|12210723|P1|NOT COMPLETED|Overall Study||0
4965903|NCT02681757|12210722|P2|COMPLETED|Overall Study||49
4965904|NCT02681757|12210723|P1|COMPLETED|Overall Study||47
4965905|NCT02681757|12210722|P2|STARTED|Overall Study||49
4965906|NCT02681757|12210723|P1|STARTED|Overall Study||47
4965907|NCT02681614|12210733|P1|NOT COMPLETED|Overall Study||0
4965908|NCT02681614|12210733|P1|COMPLETED|Overall Study||5
4965909|NCT02681614|12210733|P1|STARTED|Overall Study||5
4965910|NCT02681510|12210747|P1|NOT COMPLETED|Overall Study||10
4965911|NCT02681510|12210747|P1|COMPLETED|Overall Study||26
4965912|NCT02681510|12210747|P1|STARTED|Overall Study||36
4965913|NCT02681458|12210756|P2|NOT COMPLETED|Overall Study||656
4965914|NCT02681458|12210757|P1|NOT COMPLETED|Overall Study||645
4965915|NCT02681458|12210756|P2|COMPLETED|Overall Study||62
4965916|NCT02681458|12210757|P1|COMPLETED|Overall Study||73
4965917|NCT02681458|12210756|P2|STARTED|Overall Study||718
4965918|NCT02681458|12210757|P1|STARTED|Overall Study||718
4965919|NCT02681172|12210763|P1|NOT COMPLETED|Overall Study||13
4965920|NCT02681172|12210763|P1|COMPLETED|Overall Study||205
4965921|NCT02681172|12210763|P1|Per Protocol Set|Overall Study||205
4965922|NCT02681172|12210763|P1|Full Analysis Set|Overall Study||205
4965923|NCT02681172|12210763|P1|Safety Analysis Set|Overall Study||205
4965924|NCT02681172|12210763|P1|STARTED|Overall Study||218
4965925|NCT02681094|12210777|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
4965926|NCT02681094|12210778|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
4965927|NCT02681094|12210779|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
4965928|NCT02681094|12210777|P3|COMPLETED|2 - Enrolled Participants Set||248
4965929|NCT02681094|12210778|P2|COMPLETED|2 - Enrolled Participants Set||261
4965930|NCT02681094|12210779|P1|COMPLETED|2 - Enrolled Participants Set||261
4965931|NCT02681094|12210777|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
4965932|NCT02681094|12210778|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
4965933|NCT02681094|12210779|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
4965934|NCT02681094|12210777|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
4965935|NCT02681094|12210778|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
4965936|NCT02681094|12210779|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
4965937|NCT02681094|12210777|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
4965938|NCT02681094|12210778|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
4965939|NCT02681094|12210779|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
4965940|NCT02681094|12210777|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
4965941|NCT02681094|12210778|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
4965942|NCT02681094|12210779|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
4965943|NCT02681094|12210777|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
4965944|NCT02681094|12210778|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
4965945|NCT02681094|12210779|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
4965946|NCT02681094|12210777|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
4965947|NCT02681094|12210778|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
4965948|NCT02681094|12210779|P1|STARTED|1 -Modified Enrolled Participants Set||293
4965949|NCT02680847|12210798|P3|NOT COMPLETED|Overall Study||3
4965950|NCT02680847|12210799|P2|NOT COMPLETED|Overall Study||3
4965951|NCT02680847|12210800|P1|NOT COMPLETED|Overall Study||5
4965952|NCT02680847|12210798|P3|COMPLETED|Overall Study||4
4965953|NCT02680847|12210799|P2|COMPLETED|Overall Study||6
4965954|NCT02680847|12210800|P1|COMPLETED|Overall Study||11
4965955|NCT02680847|12210798|P3|STARTED|Overall Study||7
4965956|NCT02680847|12210799|P2|STARTED|Overall Study||9
4965957|NCT02680847|12210800|P1|STARTED|Overall Study||16
4965958|NCT02680834|12210837|P2|NOT COMPLETED|Overall Study||3
4965959|NCT02680834|12210838|P1|NOT COMPLETED|Overall Study||11
4965960|NCT02680834|12210837|P2|COMPLETED|Overall Study||27
4965961|NCT02680834|12210838|P1|COMPLETED|Overall Study||15
4965962|NCT02680834|12210837|P2|STARTED|Overall Study||30
4965963|NCT02680834|12210838|P1|STARTED|Overall Study||26
4965964|NCT02680756|12210850|P2|NOT COMPLETED|Overall Study||19
4965965|NCT02680756|12210851|P1|NOT COMPLETED|Overall Study||32
4965966|NCT02680756|12210850|P2|COMPLETED|Overall Study||106
4965967|NCT02680756|12210851|P1|COMPLETED|Overall Study||93
4965968|NCT02680756|12210850|P2|Received Treatment|Overall Study||120
4965969|NCT02680756|12210851|P1|Received Treatment|Overall Study||127
4965970|NCT02680756|12210850|P2|STARTED|Overall Study||125
4965971|NCT02680756|12210851|P1|STARTED|Overall Study||125
4965972|NCT02680665|12210899|P1|NOT COMPLETED|Overall Study||5
4965973|NCT02680665|12210899|P1|COMPLETED|Overall Study||115
4965974|NCT02680665|12210899|P1|STARTED|Overall Study||120
4965975|NCT02680639|12210905|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
4965976|NCT02680639|12210906|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
4965977|NCT02680639|12210907|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
4965978|NCT02680639|12210905|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
4965979|NCT02680639|12210906|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
4965980|NCT02680639|12210907|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
4965981|NCT02680639|12210905|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
4965982|NCT02680639|12210906|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
4965983|NCT02680639|12210907|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
4965984|NCT02680639|12210905|P3|NOT COMPLETED|Screening Period||0
4965985|NCT02680639|12210906|P2|NOT COMPLETED|Screening Period||0
4965986|NCT02680639|12210907|P1|NOT COMPLETED|Screening Period||7
4965987|NCT02680639|12210905|P3|COMPLETED|Screening Period||0
4965988|NCT02680639|12210906|P2|COMPLETED|Screening Period||0
4965989|NCT02680639|12210907|P1|COMPLETED|Screening Period||3
4965990|NCT02680639|12210905|P3|STARTED|Screening Period||0
4965991|NCT02680639|12210906|P2|STARTED|Screening Period||0
4965992|NCT02680639|12210907|P1|STARTED|Screening Period||10
4965993|NCT02680301|12210930|P2|NOT COMPLETED|Overall Study||1
4965994|NCT02680301|12210931|P1|NOT COMPLETED|Overall Study||0
4965995|NCT02680301|12210930|P2|COMPLETED|Overall Study||17
4965996|NCT02680301|12210931|P1|COMPLETED|Overall Study||22
4965997|NCT02680301|12210930|P2|STARTED|Overall Study||18
4965998|NCT02680301|12210931|P1|STARTED|Overall Study||22
4965999|NCT02680158|12210939|P6|NOT COMPLETED|Overall Study||0
4966000|NCT02680158|12210940|P5|NOT COMPLETED|Overall Study||0
4966001|NCT02680158|12210941|P4|NOT COMPLETED|Overall Study||0
4966002|NCT02680158|12210942|P3|NOT COMPLETED|Overall Study||0
4966003|NCT02680158|12210943|P2|NOT COMPLETED|Overall Study||0
4966004|NCT02680158|12210944|P1|NOT COMPLETED|Overall Study||0
4966005|NCT02680158|12210939|P6|COMPLETED|Overall Study||8
4966006|NCT02680158|12210940|P5|COMPLETED|Overall Study||8
4966007|NCT02680158|12210941|P4|COMPLETED|Overall Study||8
4966008|NCT02680158|12210942|P3|COMPLETED|Overall Study||8
4966009|NCT02680158|12210943|P2|COMPLETED|Overall Study||8
4966010|NCT02680158|12210944|P1|COMPLETED|Overall Study||8
4966011|NCT02680158|12210939|P6|STARTED|Overall Study||8
4966012|NCT02680158|12210940|P5|STARTED|Overall Study||8
4966013|NCT02680158|12210941|P4|STARTED|Overall Study||8
4966014|NCT02680158|12210942|P3|STARTED|Overall Study||8
4966015|NCT02680158|12210943|P2|STARTED|Overall Study||8
4966016|NCT02680158|12210944|P1|STARTED|Overall Study||8
4966017|NCT02680054|12210955|P1|NOT COMPLETED|Overall Study||11
4966018|NCT02680054|12210955|P1|COMPLETED|Overall Study||27
4966019|NCT02680054|12210955|P1|STARTED|Overall Study||38
4966020|NCT02680041|12210973|P1|NOT COMPLETED|Overall Study||10
4966021|NCT02680041|12210973|P1|COMPLETED|Overall Study||211
4966022|NCT02680041|12210973|P1|Received 18F-fluciclovine|Overall Study||213
4966023|NCT02680041|12210973|P1|STARTED|Overall Study||221
4966024|NCT02679976|12210982|P1|NOT COMPLETED|Overall Study||0
4966025|NCT02679976|12210982|P1|COMPLETED|Overall Study||30
4966026|NCT02679976|12210982|P1|Myopes|Overall Study||14
4966027|NCT02679976|12210982|P1|Hyperopes|Overall Study||16
4966028|NCT02679976|12210982|P1|STARTED|Overall Study||30
4966029|NCT02679911|12210991|P1|NOT COMPLETED|Overall Study||0
4966030|NCT02679911|12210991|P1|COMPLETED|Overall Study||20
4966031|NCT02679911|12210991|P1|STARTED|Overall Study|Intra-individual study|20
4966032|NCT02679807|12211000|P2|NOT COMPLETED|Overall Study||16
4966033|NCT02679807|12211001|P1|NOT COMPLETED|Overall Study||22
4966034|NCT02679807|12211000|P2|COMPLETED|Overall Study||153
4966035|NCT02679807|12211001|P1|COMPLETED|Overall Study||143
4966036|NCT02679807|12211000|P2|STARTED|Overall Study||169
4966037|NCT02679807|12211001|P1|STARTED|Overall Study||165
4966038|NCT02679729|12211016|P9|NOT COMPLETED|Overall Study||0
4966039|NCT02679729|12211017|P8|NOT COMPLETED|Overall Study||0
4966040|NCT02679729|12211018|P7|NOT COMPLETED|Overall Study||1
4966041|NCT02679729|12211019|P6|NOT COMPLETED|Overall Study||0
4966042|NCT02679729|12211020|P5|NOT COMPLETED|Overall Study||1
4966043|NCT02679729|12211021|P4|NOT COMPLETED|Overall Study||0
4966044|NCT02679729|12211022|P3|NOT COMPLETED|Overall Study||0
4966045|NCT02679729|12211023|P2|NOT COMPLETED|Overall Study||2
4966046|NCT02679729|12211024|P1|NOT COMPLETED|Overall Study||0
4966047|NCT02679729|12211016|P9|COMPLETED|Overall Study||6
4966048|NCT02679729|12211017|P8|COMPLETED|Overall Study||14
4966049|NCT02679729|12211018|P7|COMPLETED|Overall Study||5
4966050|NCT02679729|12211019|P6|COMPLETED|Overall Study||6
4966051|NCT02679729|12211020|P5|COMPLETED|Overall Study||5
4966052|NCT02679729|12211021|P4|COMPLETED|Overall Study||6
4966053|NCT02679729|12211022|P3|COMPLETED|Overall Study||6
4966054|NCT02679729|12211023|P2|COMPLETED|Overall Study||5
4966055|NCT02679729|12211024|P1|COMPLETED|Overall Study||6
4966056|NCT02679729|12211016|P9|STARTED|Overall Study||6
4966057|NCT02679729|12211017|P8|STARTED|Overall Study||14
4966058|NCT02679729|12211018|P7|STARTED|Overall Study||6
4966059|NCT02679729|12211019|P6|STARTED|Overall Study||6
4966060|NCT02679729|12211020|P5|STARTED|Overall Study||6
4966061|NCT02679729|12211021|P4|STARTED|Overall Study||6
4966062|NCT02679729|12211022|P3|STARTED|Overall Study||6
4966063|NCT02679729|12211023|P2|STARTED|Overall Study||7
4966064|NCT02679729|12211024|P1|STARTED|Overall Study||6
4966065|NCT02679690|12211128|P1|NOT COMPLETED|Overall Study||1
4966066|NCT02679690|12211128|P1|COMPLETED|Overall Study||9
4966067|NCT02679690|12211128|P1|STARTED|Overall Study||10
4966068|NCT02679573|12211136|P2|NOT COMPLETED|Overall Study||39
4966069|NCT02679573|12211137|P1|NOT COMPLETED|Overall Study||37
4966070|NCT02679573|12211136|P2|COMPLETED|Overall Study||389
4966071|NCT02679573|12211137|P1|COMPLETED|Overall Study||394
4966072|NCT02679573|12211136|P2|STARTED|Overall Study||428
4966073|NCT02679573|12211137|P1|STARTED|Overall Study||431
4966074|NCT02679469|12211153|P1|NOT COMPLETED|Overall Study||0
4966075|NCT02679469|12211153|P1|COMPLETED|Overall Study||7
4966076|NCT02679469|12211153|P1|STARTED|Overall Study||7
4966077|NCT02679287|12211161|P2|NOT COMPLETED|Phase 4||0
4966078|NCT02679287|12211162|P1|NOT COMPLETED|Phase 4||0
4966079|NCT02679287|12211161|P2|COMPLETED|Phase 4||39
4966080|NCT02679287|12211162|P1|COMPLETED|Phase 4||40
4966081|NCT02679287|12211161|P2|STARTED|Phase 4||39
4966082|NCT02679287|12211162|P1|STARTED|Phase 4||40
4966083|NCT02679287|12211161|P2|NOT COMPLETED|Period 3||1
4966084|NCT02679287|12211162|P1|NOT COMPLETED|Period 3||0
4966085|NCT02679287|12211161|P2|COMPLETED|Period 3||39
4966086|NCT02679287|12211162|P1|COMPLETED|Period 3||40
4966087|NCT02679287|12211161|P2|STARTED|Period 3||40
4966088|NCT02679287|12211162|P1|STARTED|Period 3||40
4966089|NCT02679287|12211161|P2|NOT COMPLETED|Period 2||0
4966090|NCT02679287|12211162|P1|NOT COMPLETED|Period 2||3
4966091|NCT02679287|12211161|P2|COMPLETED|Period 2||40
4966092|NCT02679287|12211162|P1|COMPLETED|Period 2||40
4966093|NCT02679287|12211161|P2|STARTED|Period 2||40
4966094|NCT02679287|12211162|P1|STARTED|Period 2||43
4966095|NCT02679287|12211161|P2|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
4966096|NCT02679287|12211162|P1|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
4966097|NCT02679287|12211161|P2|COMPLETED|Period 1: Randomization-Study Session 1||40
4966098|NCT02679287|12211162|P1|COMPLETED|Period 1: Randomization-Study Session 1||43
4966099|NCT02679287|12211161|P2|STARTED|Period 1: Randomization-Study Session 1||46
4966100|NCT02679287|12211162|P1|STARTED|Period 1: Randomization-Study Session 1||47
4966101|NCT02679274|12211192|P2|NOT COMPLETED|Overall Study||0
4966102|NCT02679274|12211193|P1|NOT COMPLETED|Overall Study||1
4966103|NCT02679274|12211192|P2|COMPLETED|Overall Study||1
4966104|NCT02679274|12211193|P1|COMPLETED|Overall Study||1
4966105|NCT02679274|12211192|P2|STARTED|Overall Study||1
4966106|NCT02679274|12211193|P1|STARTED|Overall Study||2
4966107|NCT02679235|12211223|P1|NOT COMPLETED|Overall Study||4
4966108|NCT02679235|12211223|P1|COMPLETED|Overall Study||11
4966109|NCT02679235|12211223|P1|STARTED|Overall Study||15
4966110|NCT02679222|12211230|P1|NOT COMPLETED|Overall Study||1
4966111|NCT02679222|12211230|P1|COMPLETED|Overall Study||9
4966112|NCT02679222|12211230|P1|STARTED|Overall Study||10
4966113|NCT02679066|12211249|P2|NOT COMPLETED|Overall Study||0
4966114|NCT02679066|12211250|P1|NOT COMPLETED|Overall Study||0
4966115|NCT02679066|12211249|P2|COMPLETED|Overall Study||100
4966116|NCT02679066|12211250|P1|COMPLETED|Overall Study||100
4966117|NCT02679066|12211249|P2|STARTED|Overall Study||100
4966118|NCT02679066|12211250|P1|STARTED|Overall Study||100
4966119|NCT02678923|12211260|P2|NOT COMPLETED|Overall Study||5
4966120|NCT02678923|12211261|P1|NOT COMPLETED|Overall Study||6
4966121|NCT02678923|12211260|P2|COMPLETED|Overall Study||62
4966122|NCT02678923|12211261|P1|COMPLETED|Overall Study||53
4966123|NCT02678923|12211260|P2|mITT Population|Overall Study||61
4966124|NCT02678923|12211261|P1|mITT Population|Overall Study||52
4966125|NCT02678923|12211260|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
4966126|NCT02678923|12211261|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
4966127|NCT02678923|12211260|P2|STARTED|Overall Study||67
4966128|NCT02678923|12211261|P1|STARTED|Overall Study||59
4966129|NCT02678676|12211277|P2|NOT COMPLETED|Overall Study||872
4966130|NCT02678676|12211278|P1|NOT COMPLETED|Overall Study||888
4966131|NCT02678676|12211277|P2|COMPLETED|Overall Study||907
4966132|NCT02678676|12211278|P1|COMPLETED|Overall Study||932
4966133|NCT02678676|12211277|P2|STARTED|Overall Study||1779
4966134|NCT02678676|12211278|P1|STARTED|Overall Study||1820
4966135|NCT02678442|12211288|P2|NOT COMPLETED|Second Intervention||2
4966136|NCT02678442|12211289|P1|NOT COMPLETED|Second Intervention||2
4966137|NCT02678442|12211288|P2|COMPLETED|Second Intervention||23
4966138|NCT02678442|12211289|P1|COMPLETED|Second Intervention||23
4966139|NCT02678442|12211288|P2|STARTED|Second Intervention||25
4966140|NCT02678442|12211289|P1|STARTED|Second Intervention||25
4966141|NCT02678442|12211288|P2|NOT COMPLETED|First Intervention||0
4966142|NCT02678442|12211289|P1|NOT COMPLETED|First Intervention||0
4966143|NCT02678442|12211288|P2|COMPLETED|First Intervention||25
4966144|NCT02678442|12211289|P1|COMPLETED|First Intervention||25
4966145|NCT02678442|12211288|P2|STARTED|First Intervention||25
4966146|NCT02678442|12211289|P1|STARTED|First Intervention||25
4966147|NCT02678416|12211309|P1|NOT COMPLETED|Part 2||3
4966148|NCT02678416|12211309|P1|COMPLETED|Part 2||64
4966149|NCT02678416|12211309|P1|Per Protocol Population|Part 2||64
4966150|NCT02678416|12211309|P1|Pharmacokinetic Population|Part 2||65
4966151|NCT02678416|12211309|P1|Modified Intent to Treat Population|Part 2||66
4966152|NCT02678416|12211309|P1|Treated (Safety Population)|Part 2||66
4966153|NCT02678416|12211309|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
4966154|NCT02678416|12211309|P1|NOT COMPLETED|Part 1||1
4966155|NCT02678416|12211309|P1|COMPLETED|Part 1||11
4966156|NCT02678416|12211309|P1|Per Protocol Population|Part 1||8
4966157|NCT02678416|12211309|P1|Modified Intent to Treat (mITT)|Part 1||12
4966158|NCT02678416|12211309|P1|Safety Population|Part 1||12
4966159|NCT02678416|12211309|P1|STARTED|Part 1||12
4966160|NCT02678390|12211329|P2|NOT COMPLETED|MCT + AE (5 Days)||0
4966161|NCT02678390|12211330|P1|NOT COMPLETED|MCT + AE (5 Days)||0
4966162|NCT02678390|12211329|P2|COMPLETED|MCT + AE (5 Days)||9
4966163|NCT02678390|12211330|P1|COMPLETED|MCT + AE (5 Days)||10
4966164|NCT02678390|12211329|P2|STARTED|MCT + AE (5 Days)||9
4966165|NCT02678390|12211330|P1|STARTED|MCT + AE (5 Days)||10
4966166|NCT02678390|12211329|P2|NOT COMPLETED|AE (1 Day)||1
4966167|NCT02678390|12211330|P1|NOT COMPLETED|AE (1 Day)||0
4966168|NCT02678390|12211329|P2|COMPLETED|AE (1 Day)||9
4966169|NCT02678390|12211330|P1|COMPLETED|AE (1 Day)||10
4966170|NCT02678390|12211329|P2|STARTED|AE (1 Day)||10
4966171|NCT02678390|12211330|P1|STARTED|AE (1 Day)||10
4966172|NCT02678390|12211329|P2|NOT COMPLETED|MCT (5 Days)||0
4966173|NCT02678390|12211330|P1|NOT COMPLETED|MCT (5 Days)||0
4966174|NCT02678390|12211329|P2|COMPLETED|MCT (5 Days)||10
4966175|NCT02678390|12211330|P1|COMPLETED|MCT (5 Days)||10
4966176|NCT02678390|12211329|P2|STARTED|MCT (5 Days)||10
4966177|NCT02678390|12211330|P1|STARTED|MCT (5 Days)||10
4966178|NCT02678390|12211329|P2|NOT COMPLETED|Control (5 Days)||0
4966179|NCT02678390|12211330|P1|NOT COMPLETED|Control (5 Days)||0
4966180|NCT02678390|12211329|P2|COMPLETED|Control (5 Days)||10
4966181|NCT02678390|12211330|P1|COMPLETED|Control (5 Days)||10
4966182|NCT02678390|12211329|P2|STARTED|Control (5 Days)||10
4966183|NCT02678390|12211330|P1|STARTED|Control (5 Days)||10
4966184|NCT02678286|12211346|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
4966185|NCT02678286|12211347|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
4966186|NCT02678286|12211346|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
4966187|NCT02678286|12211347|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
4966188|NCT02678286|12211346|P2|STARTED|Study Overall (28 Day Follow-Up)||109
4966189|NCT02678286|12211347|P1|STARTED|Study Overall (28 Day Follow-Up)||110
4966190|NCT02678286|12211346|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
4966191|NCT02678286|12211347|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
4966192|NCT02678286|12211346|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
4966193|NCT02678286|12211347|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
4966194|NCT02678286|12211346|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
4966195|NCT02678286|12211347|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
4966196|NCT02678039|12211379|P2|NOT COMPLETED|Overall Study||0
4966197|NCT02678039|12211380|P1|NOT COMPLETED|Overall Study||0
4966198|NCT02678039|12211379|P2|COMPLETED|Overall Study||47
4966199|NCT02678039|12211380|P1|COMPLETED|Overall Study||53
4966200|NCT02678039|12211379|P2|STARTED|Overall Study||47
4966201|NCT02678039|12211380|P1|STARTED|Overall Study||53
4966202|NCT02678000|12211399|P5|NOT COMPLETED|PART 2||0
4966203|NCT02678000|12211400|P4|NOT COMPLETED|PART 2||1
4966204|NCT02678000|12211401|P3|NOT COMPLETED|PART 2||3
4966205|NCT02678000|12211402|P2|NOT COMPLETED|PART 2||0
4966206|NCT02678000|12211403|P1|NOT COMPLETED|PART 2||0
4966207|NCT02678000|12211399|P5|COMPLETED|PART 2||18
4966208|NCT02678000|12211400|P4|COMPLETED|PART 2||26
4966209|NCT02678000|12211401|P3|COMPLETED|PART 2||25
4966210|NCT02678000|12211402|P2|COMPLETED|PART 2||0
4966211|NCT02678000|12211403|P1|COMPLETED|PART 2||0
4966212|NCT02678000|12211399|P5|STARTED|PART 2||18
4966213|NCT02678000|12211400|P4|STARTED|PART 2||27
4966214|NCT02678000|12211401|P3|STARTED|PART 2||28
4966215|NCT02678000|12211402|P2|STARTED|PART 2||0
4966216|NCT02678000|12211403|P1|STARTED|PART 2||0
4966217|NCT02678000|12211399|P5|NOT COMPLETED|PART 1||0
4966218|NCT02678000|12211400|P4|NOT COMPLETED|PART 1||0
4966219|NCT02678000|12211401|P3|NOT COMPLETED|PART 1||0
4966220|NCT02678000|12211402|P2|NOT COMPLETED|PART 1||0
4966221|NCT02678000|12211403|P1|NOT COMPLETED|PART 1||0
4966222|NCT02678000|12211399|P5|COMPLETED|PART 1||0
4966223|NCT02678000|12211400|P4|COMPLETED|PART 1||0
4966224|NCT02678000|12211401|P3|COMPLETED|PART 1||0
4966225|NCT02678000|12211402|P2|COMPLETED|PART 1||4
4966226|NCT02678000|12211403|P1|COMPLETED|PART 1||7
4966227|NCT02678000|12211399|P5|STARTED|PART 1||0
4966228|NCT02678000|12211400|P4|STARTED|PART 1||0
4966229|NCT02678000|12211401|P3|STARTED|PART 1||0
4966230|NCT02678000|12211402|P2|STARTED|PART 1||4
4966231|NCT02678000|12211403|P1|STARTED|PART 1||7
4966232|NCT02677896|12211441|P2|NOT COMPLETED|Overall Study||244
4966233|NCT02677896|12211442|P1|NOT COMPLETED|Overall Study||137
4966234|NCT02677896|12211441|P2|COMPLETED|Overall Study||332
4966235|NCT02677896|12211442|P1|COMPLETED|Overall Study||437
4966236|NCT02677896|12211441|P2|Treated|Overall Study||574
4966237|NCT02677896|12211442|P1|Treated|Overall Study||572
4966238|NCT02677896|12211441|P2|STARTED|Overall Study||576
4966239|NCT02677896|12211442|P1|STARTED|Overall Study||574
4966240|NCT02677844|12211470|P7|NOT COMPLETED|Period 7||0
4966241|NCT02677844|12211471|P6|NOT COMPLETED|Period 7||0
4966242|NCT02677844|12211472|P5|NOT COMPLETED|Period 7||0
4966243|NCT02677844|12211473|P4|NOT COMPLETED|Period 7||0
4966244|NCT02677844|12211474|P3|NOT COMPLETED|Period 7||0
4966245|NCT02677844|12211475|P2|NOT COMPLETED|Period 7||0
4966246|NCT02677844|12211476|P1|NOT COMPLETED|Period 7||0
4966247|NCT02677844|12211470|P7|COMPLETED|Period 7||4
4966248|NCT02677844|12211471|P6|COMPLETED|Period 7||4
4966249|NCT02677844|12211472|P5|COMPLETED|Period 7||7
4966250|NCT02677844|12211473|P4|COMPLETED|Period 7||0
4966251|NCT02677844|12211474|P3|COMPLETED|Period 7||0
4966252|NCT02677844|12211475|P2|COMPLETED|Period 7||0
4966253|NCT02677844|12211476|P1|COMPLETED|Period 7||0
4966254|NCT02677844|12211470|P7|STARTED|Period 7||4
4966255|NCT02677844|12211471|P6|STARTED|Period 7||4
4966256|NCT02677844|12211472|P5|STARTED|Period 7||7
4966257|NCT02677844|12211473|P4|STARTED|Period 7||0
4966258|NCT02677844|12211474|P3|STARTED|Period 7||0
4966259|NCT02677844|12211475|P2|STARTED|Period 7||0
4966260|NCT02677844|12211476|P1|STARTED|Period 7||0
4966261|NCT02677844|12211470|P7|NOT COMPLETED|Period 6||0
4966262|NCT02677844|12211471|P6|NOT COMPLETED|Period 6||0
4966263|NCT02677844|12211472|P5|NOT COMPLETED|Period 6||0
4966264|NCT02677844|12211473|P4|NOT COMPLETED|Period 6||0
4966265|NCT02677844|12211474|P3|NOT COMPLETED|Period 6||0
4966266|NCT02677844|12211475|P2|NOT COMPLETED|Period 6||0
4966267|NCT02677844|12211476|P1|NOT COMPLETED|Period 6||0
4966268|NCT02677844|12211470|P7|COMPLETED|Period 6||4
4966269|NCT02677844|12211471|P6|COMPLETED|Period 6||4
4966270|NCT02677844|12211472|P5|COMPLETED|Period 6||7
4966271|NCT02677844|12211473|P4|COMPLETED|Period 6||0
4966272|NCT02677844|12211474|P3|COMPLETED|Period 6||0
4966273|NCT02677844|12211475|P2|COMPLETED|Period 6||0
4966274|NCT02677844|12211476|P1|COMPLETED|Period 6||0
4966275|NCT02677844|12211470|P7|STARTED|Period 6||4
4966276|NCT02677844|12211471|P6|STARTED|Period 6||4
4966277|NCT02677844|12211472|P5|STARTED|Period 6||7
4966278|NCT02677844|12211473|P4|STARTED|Period 6||0
4966279|NCT02677844|12211474|P3|STARTED|Period 6||0
4966280|NCT02677844|12211475|P2|STARTED|Period 6||0
4966281|NCT02677844|12211476|P1|STARTED|Period 6||0
4966282|NCT02677844|12211470|P7|NOT COMPLETED|Period 5||0
4966283|NCT02677844|12211471|P6|NOT COMPLETED|Period 5||0
4966284|NCT02677844|12211472|P5|NOT COMPLETED|Period 5||0
4966285|NCT02677844|12211473|P4|NOT COMPLETED|Period 5||0
4966286|NCT02677844|12211474|P3|NOT COMPLETED|Period 5||0
4966287|NCT02677844|12211475|P2|NOT COMPLETED|Period 5||0
4966288|NCT02677844|12211476|P1|NOT COMPLETED|Period 5||0
4966289|NCT02677844|12211470|P7|COMPLETED|Period 5||4
4966290|NCT02677844|12211471|P6|COMPLETED|Period 5||4
4966291|NCT02677844|12211472|P5|COMPLETED|Period 5||7
4966292|NCT02677844|12211473|P4|COMPLETED|Period 5||0
4966293|NCT02677844|12211474|P3|COMPLETED|Period 5||0
4966294|NCT02677844|12211475|P2|COMPLETED|Period 5||0
4966295|NCT02677844|12211476|P1|COMPLETED|Period 5||0
4966296|NCT02677844|12211470|P7|STARTED|Period 5||4
4966297|NCT02677844|12211471|P6|STARTED|Period 5||4
4966298|NCT02677844|12211472|P5|STARTED|Period 5||7
4966299|NCT02677844|12211473|P4|STARTED|Period 5||0
4966300|NCT02677844|12211474|P3|STARTED|Period 5||0
4966301|NCT02677844|12211475|P2|STARTED|Period 5||0
4966302|NCT02677844|12211476|P1|STARTED|Period 5||0
4966303|NCT02677844|12211470|P7|NOT COMPLETED|Period 4 (DDI)||0
4966304|NCT02677844|12211471|P6|NOT COMPLETED|Period 4 (DDI)||0
4966305|NCT02677844|12211472|P5|NOT COMPLETED|Period 4 (DDI)||0
4966306|NCT02677844|12211473|P4|NOT COMPLETED|Period 4 (DDI)||0
4966307|NCT02677844|12211474|P3|NOT COMPLETED|Period 4 (DDI)||0
4966308|NCT02677844|12211475|P2|NOT COMPLETED|Period 4 (DDI)||0
4966309|NCT02677844|12211476|P1|NOT COMPLETED|Period 4 (DDI)||0
4966310|NCT02677844|12211470|P7|COMPLETED|Period 4 (DDI)||4
4966311|NCT02677844|12211471|P6|COMPLETED|Period 4 (DDI)||4
4966312|NCT02677844|12211472|P5|COMPLETED|Period 4 (DDI)||7
4966313|NCT02677844|12211473|P4|COMPLETED|Period 4 (DDI)||0
4966314|NCT02677844|12211474|P3|COMPLETED|Period 4 (DDI)||0
4966315|NCT02677844|12211475|P2|COMPLETED|Period 4 (DDI)||0
4966316|NCT02677844|12211476|P1|COMPLETED|Period 4 (DDI)||0
4966317|NCT02677844|12211470|P7|STARTED|Period 4 (DDI)||4
4966318|NCT02677844|12211471|P6|STARTED|Period 4 (DDI)||4
4966319|NCT02677844|12211472|P5|STARTED|Period 4 (DDI)||7
4966320|NCT02677844|12211473|P4|STARTED|Period 4 (DDI)||0
4966321|NCT02677844|12211474|P3|STARTED|Period 4 (DDI)||0
4966322|NCT02677844|12211475|P2|STARTED|Period 4 (DDI)||0
4966323|NCT02677844|12211476|P1|STARTED|Period 4 (DDI)||0
4966324|NCT02677844|12211470|P7|NOT COMPLETED|Period 4||0
4966325|NCT02677844|12211471|P6|NOT COMPLETED|Period 4||0
4966326|NCT02677844|12211472|P5|NOT COMPLETED|Period 4||0
4966327|NCT02677844|12211473|P4|NOT COMPLETED|Period 4||0
4966328|NCT02677844|12211474|P3|NOT COMPLETED|Period 4||0
4966329|NCT02677844|12211475|P2|NOT COMPLETED|Period 4||0
4966330|NCT02677844|12211476|P1|NOT COMPLETED|Period 4||0
4966331|NCT02677844|12211470|P7|COMPLETED|Period 4||0
4966332|NCT02677844|12211471|P6|COMPLETED|Period 4||0
4966333|NCT02677844|12211472|P5|COMPLETED|Period 4||0
4966334|NCT02677844|12211473|P4|COMPLETED|Period 4||4
4966335|NCT02677844|12211474|P3|COMPLETED|Period 4||5
4966336|NCT02677844|12211475|P2|COMPLETED|Period 4||5
4966337|NCT02677844|12211476|P1|COMPLETED|Period 4||5
4966338|NCT02677844|12211470|P7|STARTED|Period 4||0
4966339|NCT02677844|12211471|P6|STARTED|Period 4||0
4966340|NCT02677844|12211472|P5|STARTED|Period 4||0
4966341|NCT02677844|12211473|P4|STARTED|Period 4||4
4966342|NCT02677844|12211474|P3|STARTED|Period 4||5
4966343|NCT02677844|12211475|P2|STARTED|Period 4||5
4966344|NCT02677844|12211476|P1|STARTED|Period 4||5
4966345|NCT02677844|12211470|P7|NOT COMPLETED|Period 3||0
4966346|NCT02677844|12211471|P6|NOT COMPLETED|Period 3||0
4966347|NCT02677844|12211472|P5|NOT COMPLETED|Period 3||0
4966348|NCT02677844|12211473|P4|NOT COMPLETED|Period 3||1
4966349|NCT02677844|12211474|P3|NOT COMPLETED|Period 3||0
4966350|NCT02677844|12211475|P2|NOT COMPLETED|Period 3||0
4966351|NCT02677844|12211476|P1|NOT COMPLETED|Period 3||0
4966352|NCT02677844|12211470|P7|COMPLETED|Period 3||0
4966353|NCT02677844|12211471|P6|COMPLETED|Period 3||0
4966354|NCT02677844|12211472|P5|COMPLETED|Period 3||0
4966355|NCT02677844|12211473|P4|COMPLETED|Period 3||4
4966356|NCT02677844|12211474|P3|COMPLETED|Period 3||5
4966357|NCT02677844|12211475|P2|COMPLETED|Period 3||5
4966358|NCT02677844|12211476|P1|COMPLETED|Period 3||5
4966359|NCT02677844|12211470|P7|STARTED|Period 3||0
4966360|NCT02677844|12211471|P6|STARTED|Period 3||0
4966361|NCT02677844|12211472|P5|STARTED|Period 3||0
4966362|NCT02677844|12211473|P4|STARTED|Period 3||5
4966363|NCT02677844|12211474|P3|STARTED|Period 3||5
4966364|NCT02677844|12211475|P2|STARTED|Period 3||5
4966365|NCT02677844|12211476|P1|STARTED|Period 3||5
4966366|NCT02677844|12211470|P7|NOT COMPLETED|Period 2||0
4966367|NCT02677844|12211471|P6|NOT COMPLETED|Period 2||0
4966368|NCT02677844|12211472|P5|NOT COMPLETED|Period 2||0
4966369|NCT02677844|12211473|P4|NOT COMPLETED|Period 2||0
4966370|NCT02677844|12211474|P3|NOT COMPLETED|Period 2||0
4966371|NCT02677844|12211475|P2|NOT COMPLETED|Period 2||0
4966372|NCT02677844|12211476|P1|NOT COMPLETED|Period 2||0
4966373|NCT02677844|12211470|P7|COMPLETED|Period 2||0
4966374|NCT02677844|12211471|P6|COMPLETED|Period 2||0
4966375|NCT02677844|12211472|P5|COMPLETED|Period 2||0
4966376|NCT02677844|12211473|P4|COMPLETED|Period 2||5
4966377|NCT02677844|12211474|P3|COMPLETED|Period 2||5
4966378|NCT02677844|12211475|P2|COMPLETED|Period 2||5
4966379|NCT02677844|12211476|P1|COMPLETED|Period 2||5
4966380|NCT02677844|12211470|P7|STARTED|Period 2||0
4966381|NCT02677844|12211471|P6|STARTED|Period 2||0
4966382|NCT02677844|12211472|P5|STARTED|Period 2||0
4966383|NCT02677844|12211473|P4|STARTED|Period 2||5
4966384|NCT02677844|12211474|P3|STARTED|Period 2||5
4966385|NCT02677844|12211475|P2|STARTED|Period 2||5
4966386|NCT02677844|12211476|P1|STARTED|Period 2||5
4966387|NCT02677844|12211470|P7|NOT COMPLETED|Period 1||0
4966388|NCT02677844|12211471|P6|NOT COMPLETED|Period 1||0
4966389|NCT02677844|12211472|P5|NOT COMPLETED|Period 1||0
4966390|NCT02677844|12211473|P4|NOT COMPLETED|Period 1||0
4966391|NCT02677844|12211474|P3|NOT COMPLETED|Period 1||0
4966392|NCT02677844|12211475|P2|NOT COMPLETED|Period 1||0
4966393|NCT02677844|12211476|P1|NOT COMPLETED|Period 1||0
4966394|NCT02677844|12211470|P7|COMPLETED|Period 1||0
4966395|NCT02677844|12211471|P6|COMPLETED|Period 1||0
4966396|NCT02677844|12211472|P5|COMPLETED|Period 1||0
4966397|NCT02677844|12211473|P4|COMPLETED|Period 1||5
4966398|NCT02677844|12211474|P3|COMPLETED|Period 1||5
4966399|NCT02677844|12211475|P2|COMPLETED|Period 1||5
4966400|NCT02677844|12211476|P1|COMPLETED|Period 1||5
4966401|NCT02677844|12211470|P7|STARTED|Period 1||0
4966402|NCT02677844|12211471|P6|STARTED|Period 1||0
4966403|NCT02677844|12211472|P5|STARTED|Period 1||0
4966404|NCT02677844|12211473|P4|STARTED|Period 1||5
4966405|NCT02677844|12211474|P3|STARTED|Period 1||5
4966406|NCT02677844|12211475|P2|STARTED|Period 1||5
4966407|NCT02677844|12211476|P1|STARTED|Period 1||5
4966408|NCT02677779|12211506|P2|NOT COMPLETED|Overall Study||0
4966409|NCT02677779|12211507|P1|NOT COMPLETED|Overall Study||0
4966410|NCT02677779|12211506|P2|COMPLETED|Overall Study||10
4966411|NCT02677779|12211507|P1|COMPLETED|Overall Study||10
4966412|NCT02677779|12211506|P2|STARTED|Overall Study||10
4966413|NCT02677779|12211507|P1|STARTED|Overall Study||10
4966414|NCT02677766|12211523|P2|NOT COMPLETED|Overall Study||3
4966415|NCT02677766|12211524|P1|NOT COMPLETED|Overall Study||5
4966416|NCT02677766|12211523|P2|COMPLETED|Overall Study||17
4966417|NCT02677766|12211524|P1|COMPLETED|Overall Study||15
4966418|NCT02677766|12211523|P2|STARTED|Overall Study||20
4966419|NCT02677766|12211524|P1|STARTED|Overall Study||20
4966420|NCT02677753|12211532|P2|NOT COMPLETED|Overall Study||0
4966421|NCT02677753|12211533|P1|NOT COMPLETED|Overall Study||1
4966422|NCT02677753|12211532|P2|COMPLETED|Overall Study||38
4966423|NCT02677753|12211533|P1|COMPLETED|Overall Study||36
4966424|NCT02677753|12211532|P2|STARTED|Overall Study||38
4966425|NCT02677753|12211533|P1|STARTED|Overall Study||37
4966426|NCT02677740|12211541|P2|NOT COMPLETED|Overall Study||0
4966427|NCT02677740|12211542|P1|NOT COMPLETED|Overall Study||0
4966428|NCT02677740|12211541|P2|COMPLETED|Overall Study||1
4966429|NCT02677740|12211542|P1|COMPLETED|Overall Study||7
4966430|NCT02677740|12211541|P2|STARTED|Overall Study||1
4966431|NCT02677740|12211542|P1|STARTED|Overall Study||7
4966432|NCT02677623|12211558|P4|NOT COMPLETED|Overall Study||0
4966433|NCT02677623|12211559|P3|NOT COMPLETED|Overall Study||0
4966434|NCT02677623|12211560|P2|NOT COMPLETED|Overall Study||0
4966435|NCT02677623|12211561|P1|NOT COMPLETED|Overall Study||0
4966436|NCT02677623|12211558|P4|COMPLETED|Overall Study||33
4966437|NCT02677623|12211559|P3|COMPLETED|Overall Study||32
4966438|NCT02677623|12211560|P2|COMPLETED|Overall Study||32
4966439|NCT02677623|12211561|P1|COMPLETED|Overall Study||33
4966440|NCT02677623|12211558|P4|STARTED|Overall Study||33
4966441|NCT02677623|12211559|P3|STARTED|Overall Study||32
4966442|NCT02677623|12211560|P2|STARTED|Overall Study||32
4966443|NCT02677623|12211561|P1|STARTED|Overall Study||33
4966444|NCT02677493|12211574|P3|NOT COMPLETED|Overall Study||3
4966445|NCT02677493|12211575|P2|NOT COMPLETED|Overall Study||2
4966446|NCT02677493|12211576|P1|NOT COMPLETED|Overall Study||11
4966447|NCT02677493|12211574|P3|COMPLETED|Overall Study||296
4966448|NCT02677493|12211575|P2|COMPLETED|Overall Study||296
4966449|NCT02677493|12211576|P1|COMPLETED|Overall Study||1186
4966450|NCT02677493|12211574|P3|STARTED|Overall Study||299
4966451|NCT02677493|12211575|P2|STARTED|Overall Study||298
4966452|NCT02677493|12211576|P1|STARTED|Overall Study||1197
4966453|NCT02677220|12211603|P1|NOT COMPLETED|Overall Study||1
4966454|NCT02677220|12211603|P1|COMPLETED|Overall Study||0
4966455|NCT02677220|12211603|P1|STARTED|Overall Study||1
4966456|NCT02677116|12211618|P9|NOT COMPLETED|Overall Study||2
4966457|NCT02677116|12211619|P8|NOT COMPLETED|Overall Study||2
4966458|NCT02677116|12211620|P7|NOT COMPLETED|Overall Study||4
4966459|NCT02677116|12211621|P6|NOT COMPLETED|Overall Study||4
4966460|NCT02677116|12211622|P5|NOT COMPLETED|Overall Study||1
4966461|NCT02677116|12211623|P4|NOT COMPLETED|Overall Study||3
4966462|NCT02677116|12211624|P3|NOT COMPLETED|Overall Study||3
4966463|NCT02677116|12211625|P2|NOT COMPLETED|Overall Study||4
4966464|NCT02677116|12211626|P1|NOT COMPLETED|Overall Study||3
4966465|NCT02677116|12211618|P9|COMPLETED|Overall Study||2
4966466|NCT02677116|12211619|P8|COMPLETED|Overall Study||2
4966467|NCT02677116|12211620|P7|COMPLETED|Overall Study||2
4966468|NCT02677116|12211621|P6|COMPLETED|Overall Study||9
4966469|NCT02677116|12211622|P5|COMPLETED|Overall Study||0
4966470|NCT02677116|12211623|P4|COMPLETED|Overall Study||7
4966471|NCT02677116|12211624|P3|COMPLETED|Overall Study||6
4966472|NCT02677116|12211625|P2|COMPLETED|Overall Study||7
4966473|NCT02677116|12211626|P1|COMPLETED|Overall Study||7
4966474|NCT02677116|12211618|P9|Progressive Disease|Overall Study||2
4966475|NCT02677116|12211619|P8|Progressive Disease|Overall Study||2
4966476|NCT02677116|12211620|P7|Progressive Disease|Overall Study||2
4966477|NCT02677116|12211621|P6|Progressive Disease|Overall Study||9
4966478|NCT02677116|12211622|P5|Progressive Disease|Overall Study||0
4966479|NCT02677116|12211623|P4|Progressive Disease|Overall Study||7
4966480|NCT02677116|12211624|P3|Progressive Disease|Overall Study||6
4966481|NCT02677116|12211625|P2|Progressive Disease|Overall Study||7
4966482|NCT02677116|12211626|P1|Progressive Disease|Overall Study||7
4966483|NCT02677116|12211618|P9|Cycle 1 Olaratumab Alone|Overall Study||4
4966484|NCT02677116|12211619|P8|Cycle 1 Olaratumab Alone|Overall Study||4
4966485|NCT02677116|12211620|P7|Cycle 1 Olaratumab Alone|Overall Study||6
4966486|NCT02677116|12211621|P6|Cycle 1 Olaratumab Alone|Overall Study||13
4966487|NCT02677116|12211622|P5|Cycle 1 Olaratumab Alone|Overall Study||1
4966488|NCT02677116|12211623|P4|Cycle 1 Olaratumab Alone|Overall Study||10
4966489|NCT02677116|12211624|P3|Cycle 1 Olaratumab Alone|Overall Study||9
4966490|NCT02677116|12211625|P2|Cycle 1 Olaratumab Alone|Overall Study||11
4966491|NCT02677116|12211626|P1|Cycle 1 Olaratumab Alone|Overall Study||10
4966492|NCT02677116|12211618|P9|STARTED|Overall Study||4
4966493|NCT02677116|12211619|P8|STARTED|Overall Study||4
4966494|NCT02677116|12211620|P7|STARTED|Overall Study||6
4966495|NCT02677116|12211621|P6|STARTED|Overall Study||13
4966496|NCT02677116|12211622|P5|STARTED|Overall Study||1
4966497|NCT02677116|12211623|P4|STARTED|Overall Study||10
4966498|NCT02677116|12211624|P3|STARTED|Overall Study||9
4966499|NCT02677116|12211625|P2|STARTED|Overall Study||11
4966500|NCT02677116|12211626|P1|STARTED|Overall Study||10
4966501|NCT02676895|12211699|P3|NOT COMPLETED|Overall Study||3
4966502|NCT02676895|12211700|P2|NOT COMPLETED|Overall Study||3
4966503|NCT02676895|12211701|P1|NOT COMPLETED|Overall Study||2
4966504|NCT02676895|12211699|P3|COMPLETED|Overall Study||21
4966505|NCT02676895|12211700|P2|COMPLETED|Overall Study||23
4966506|NCT02676895|12211701|P1|COMPLETED|Overall Study||20
4966507|NCT02676895|12211699|P3|STARTED|Overall Study||24
4966508|NCT02676895|12211700|P2|STARTED|Overall Study||26
4966509|NCT02676895|12211701|P1|STARTED|Overall Study||22
4966510|NCT02676882|12211744|P2|NOT COMPLETED|Overall Study||2
4966511|NCT02676882|12211745|P1|NOT COMPLETED|Overall Study||3
4966512|NCT02676882|12211744|P2|COMPLETED|Overall Study||5
4966513|NCT02676882|12211745|P1|COMPLETED|Overall Study||10
4966514|NCT02676882|12211744|P2|Evaluable|Overall Study||6
4966515|NCT02676882|12211745|P1|Evaluable|Overall Study||11
4966516|NCT02676882|12211744|P2|STARTED|Overall Study||7
4966517|NCT02676882|12211745|P1|STARTED|Overall Study||13
4966518|NCT02676843|12211751|P1|NOT COMPLETED|Overall Study||0
4966519|NCT02676843|12211751|P1|COMPLETED|Overall Study||7
4966520|NCT02676843|12211751|P1|STARTED|Overall Study||7
4966521|NCT02676466|12211764|P8|NOT COMPLETED|Overall Study||1
4966522|NCT02676466|12211765|P7|NOT COMPLETED|Overall Study||1
4966523|NCT02676466|12211766|P6|NOT COMPLETED|Overall Study||1
4966524|NCT02676466|12211767|P5|NOT COMPLETED|Overall Study||3
4966525|NCT02676466|12211768|P4|NOT COMPLETED|Overall Study||0
4966526|NCT02676466|12211769|P3|NOT COMPLETED|Overall Study||2
4966527|NCT02676466|12211770|P2|NOT COMPLETED|Overall Study||5
4966528|NCT02676466|12211771|P1|NOT COMPLETED|Overall Study||4
4966529|NCT02676466|12211764|P8|COMPLETED|Overall Study||13
4966530|NCT02676466|12211765|P7|COMPLETED|Overall Study||12
4966531|NCT02676466|12211766|P6|COMPLETED|Overall Study||12
4966532|NCT02676466|12211767|P5|COMPLETED|Overall Study||23
4966533|NCT02676466|12211768|P4|COMPLETED|Overall Study||17
4966534|NCT02676466|12211769|P3|COMPLETED|Overall Study||24
4966535|NCT02676466|12211770|P2|COMPLETED|Overall Study||66
4966536|NCT02676466|12211771|P1|COMPLETED|Overall Study||105
4966537|NCT02676466|12211764|P8|STARTED|Overall Study||14
4966538|NCT02676466|12211765|P7|STARTED|Overall Study||13
4966539|NCT02676466|12211766|P6|STARTED|Overall Study||13
4966540|NCT02676466|12211767|P5|STARTED|Overall Study||26
4966541|NCT02676466|12211768|P4|STARTED|Overall Study||17
4966542|NCT02676466|12211769|P3|STARTED|Overall Study||26
4966543|NCT02676466|12211770|P2|STARTED|Overall Study||71
4966544|NCT02676466|12211771|P1|STARTED|Overall Study||109
4966545|NCT02676375|12211840|P3|NOT COMPLETED|Overall Study||3
4966546|NCT02676375|12211841|P2|NOT COMPLETED|Overall Study||4
4966547|NCT02676375|12211842|P1|NOT COMPLETED|Overall Study||1
4966548|NCT02676375|12211840|P3|COMPLETED|Overall Study||11
4966549|NCT02676375|12211841|P2|COMPLETED|Overall Study||10
4966550|NCT02676375|12211842|P1|COMPLETED|Overall Study||13
4966551|NCT02676375|12211840|P3|STARTED|Overall Study||14
4966552|NCT02676375|12211841|P2|STARTED|Overall Study||14
4966553|NCT02676375|12211842|P1|STARTED|Overall Study||14
4966554|NCT02675907|12211852|P2|NOT COMPLETED|Study Overall||4
4966555|NCT02675907|12211853|P1|NOT COMPLETED|Study Overall||3
4966556|NCT02675907|12211852|P2|COMPLETED|Study Overall||97
4966557|NCT02675907|12211853|P1|COMPLETED|Study Overall||97
4966558|NCT02675907|12211852|P2|STARTED|Study Overall||101
4966559|NCT02675907|12211853|P1|STARTED|Study Overall||100
4966560|NCT02675907|12211852|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
4966561|NCT02675907|12211853|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
4966562|NCT02675907|12211852|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
4966563|NCT02675907|12211853|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
4966564|NCT02675907|12211852|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
4966565|NCT02675907|12211853|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
4966566|NCT02675764|12211885|P2|NOT COMPLETED|Overall Study||0
4966567|NCT02675764|12211886|P1|NOT COMPLETED|Overall Study||0
4966568|NCT02675764|12211885|P2|COMPLETED|Overall Study||6
4966569|NCT02675764|12211886|P1|COMPLETED|Overall Study||6
4966570|NCT02675764|12211885|P2|STARTED|Overall Study||6
4966571|NCT02675764|12211886|P1|STARTED|Overall Study||6
4966572|NCT02675751|12211898|P1|NOT COMPLETED|Overall Study||16
4966573|NCT02675751|12211898|P1|COMPLETED|Overall Study||151
4966574|NCT02675751|12211898|P1|STARTED|Overall Study||167
4966575|NCT02675634|12211902|P6|NOT COMPLETED|Test Period 3||0
4966576|NCT02675634|12211903|P5|NOT COMPLETED|Test Period 3||0
4966577|NCT02675634|12211904|P4|NOT COMPLETED|Test Period 3||0
4966578|NCT02675634|12211905|P3|NOT COMPLETED|Test Period 3||0
4966579|NCT02675634|12211906|P2|NOT COMPLETED|Test Period 3||0
4966580|NCT02675634|12211907|P1|NOT COMPLETED|Test Period 3||0
4966581|NCT02675634|12211902|P6|COMPLETED|Test Period 3||8
4966582|NCT02675634|12211903|P5|COMPLETED|Test Period 3||10
4966583|NCT02675634|12211904|P4|COMPLETED|Test Period 3||8
4966584|NCT02675634|12211905|P3|COMPLETED|Test Period 3||8
4966585|NCT02675634|12211906|P2|COMPLETED|Test Period 3||7
4966586|NCT02675634|12211907|P1|COMPLETED|Test Period 3||9
4966587|NCT02675634|12211902|P6|STARTED|Test Period 3||8
4966588|NCT02675634|12211903|P5|STARTED|Test Period 3||10
4966589|NCT02675634|12211904|P4|STARTED|Test Period 3||8
4966590|NCT02675634|12211905|P3|STARTED|Test Period 3||8
4966591|NCT02675634|12211906|P2|STARTED|Test Period 3||7
4966592|NCT02675634|12211907|P1|STARTED|Test Period 3||9
4966593|NCT02675634|12211902|P6|NOT COMPLETED|Test Period 2||1
4966594|NCT02675634|12211903|P5|NOT COMPLETED|Test Period 2||0
4966595|NCT02675634|12211904|P4|NOT COMPLETED|Test Period 2||0
4966596|NCT02675634|12211905|P3|NOT COMPLETED|Test Period 2||0
4966597|NCT02675634|12211906|P2|NOT COMPLETED|Test Period 2||0
4966598|NCT02675634|12211907|P1|NOT COMPLETED|Test Period 2||1
4966599|NCT02675634|12211902|P6|COMPLETED|Test Period 2||8
4966600|NCT02675634|12211903|P5|COMPLETED|Test Period 2||10
4966601|NCT02675634|12211904|P4|COMPLETED|Test Period 2||8
4966602|NCT02675634|12211905|P3|COMPLETED|Test Period 2||8
4966603|NCT02675634|12211906|P2|COMPLETED|Test Period 2||7
4966604|NCT02675634|12211907|P1|COMPLETED|Test Period 2||9
4966605|NCT02675634|12211902|P6|STARTED|Test Period 2||9
4966606|NCT02675634|12211903|P5|STARTED|Test Period 2||10
4966607|NCT02675634|12211904|P4|STARTED|Test Period 2||8
4966608|NCT02675634|12211905|P3|STARTED|Test Period 2||8
4966609|NCT02675634|12211906|P2|STARTED|Test Period 2||7
4966610|NCT02675634|12211907|P1|STARTED|Test Period 2||10
4966611|NCT02675634|12211902|P6|NOT COMPLETED|Test Period 1||0
4966612|NCT02675634|12211903|P5|NOT COMPLETED|Test Period 1||0
4966613|NCT02675634|12211904|P4|NOT COMPLETED|Test Period 1||1
4966614|NCT02675634|12211905|P3|NOT COMPLETED|Test Period 1||1
4966615|NCT02675634|12211906|P2|NOT COMPLETED|Test Period 1||1
4966616|NCT02675634|12211907|P1|NOT COMPLETED|Test Period 1||0
4966617|NCT02675634|12211902|P6|COMPLETED|Test Period 1||9
4966618|NCT02675634|12211903|P5|COMPLETED|Test Period 1||10
4966619|NCT02675634|12211904|P4|COMPLETED|Test Period 1||8
4966620|NCT02675634|12211905|P3|COMPLETED|Test Period 1||8
4966621|NCT02675634|12211906|P2|COMPLETED|Test Period 1||7
4966622|NCT02675634|12211907|P1|COMPLETED|Test Period 1||10
4966623|NCT02675634|12211902|P6|STARTED|Test Period 1||9
4966624|NCT02675634|12211903|P5|STARTED|Test Period 1||10
4966625|NCT02675634|12211904|P4|STARTED|Test Period 1||9
4966626|NCT02675634|12211905|P3|STARTED|Test Period 1||9
4966627|NCT02675634|12211906|P2|STARTED|Test Period 1||8
4966628|NCT02675634|12211907|P1|STARTED|Test Period 1||10
4966629|NCT02675543|12211917|P2|NOT COMPLETED|Overall Study||0
4966630|NCT02675543|12211918|P1|NOT COMPLETED|Overall Study||0
4966631|NCT02675543|12211917|P2|COMPLETED|Overall Study||20
4966632|NCT02675543|12211918|P1|COMPLETED|Overall Study||15
4966633|NCT02675543|12211917|P2|STARTED|Overall Study||20
4966634|NCT02675543|12211918|P1|STARTED|Overall Study||15
4966635|NCT02675517|12211924|P1|NOT COMPLETED|Overall Study||159
4966636|NCT02675517|12211924|P1|COMPLETED|Overall Study||1578
4966637|NCT02675517|12211924|P1|STARTED|Overall Study||1737
4966638|NCT02675426|12211936|P3|NOT COMPLETED|Overall Study||18
4966639|NCT02675426|12211937|P2|NOT COMPLETED|Overall Study||8
4966640|NCT02675426|12211938|P1|NOT COMPLETED|Overall Study||13
4966641|NCT02675426|12211936|P3|COMPLETED|Overall Study||201
4966642|NCT02675426|12211937|P2|COMPLETED|Overall Study||213
4966643|NCT02675426|12211938|P1|COMPLETED|Overall Study||208
4966644|NCT02675426|12211936|P3|Treated|Overall Study||219
4966645|NCT02675426|12211937|P2|Treated|Overall Study||221
4966646|NCT02675426|12211938|P1|Treated|Overall Study||221
4966647|NCT02675426|12211936|P3|STARTED|Overall Study||219
4966648|NCT02675426|12211937|P2|STARTED|Overall Study||221
4966649|NCT02675426|12211938|P1|STARTED|Overall Study||221
4966650|NCT02675231|12211982|P3|NOT COMPLETED|Overall Study||26
4966651|NCT02675231|12211983|P2|NOT COMPLETED|Overall Study||36
4966652|NCT02675231|12211984|P1|NOT COMPLETED|Overall Study||26
4966653|NCT02675231|12211982|P3|COMPLETED|Overall Study||53
4966654|NCT02675231|12211983|P2|COMPLETED|Overall Study||43
4966655|NCT02675231|12211984|P1|COMPLETED|Overall Study||53
4966656|NCT02675231|12211982|P3|Received at Least One Dose of Drug|Overall Study||72
4966657|NCT02675231|12211983|P2|Received at Least One Dose of Drug|Overall Study||77
4966658|NCT02675231|12211984|P1|Received at Least One Dose of Drug|Overall Study||78
4966659|NCT02675231|12211982|P3|STARTED|Overall Study||79
4966660|NCT02675231|12211983|P2|STARTED|Overall Study||79
4966661|NCT02675231|12211984|P1|STARTED|Overall Study||79
4966662|NCT02674854|12212021|P3|NOT COMPLETED|Overall Study||14
4966663|NCT02674854|12212022|P2|NOT COMPLETED|Overall Study||27
4966664|NCT02674854|12212023|P1|NOT COMPLETED|Overall Study||24
4966665|NCT02674854|12212021|P3|COMPLETED|Overall Study||236
4966666|NCT02674854|12212022|P2|COMPLETED|Overall Study||228
4966667|NCT02674854|12212023|P1|COMPLETED|Overall Study||221
4966668|NCT02674854|12212021|P3|STARTED|Overall Study||250
4966669|NCT02674854|12212022|P2|STARTED|Overall Study||255
4966670|NCT02674854|12212023|P1|STARTED|Overall Study||245
4966671|NCT02674685|12212031|P1|NOT COMPLETED|Overall Study||4
4966672|NCT02674685|12212031|P1|COMPLETED|Overall Study||233
4966673|NCT02674685|12212031|P1|STARTED|Overall Study||237
4966674|NCT02674659|12212047|P2|NOT COMPLETED|Overall Study||4
4966675|NCT02674659|12212048|P1|NOT COMPLETED|Overall Study||4
4966676|NCT02674659|12212047|P2|COMPLETED|Overall Study||40
4966677|NCT02674659|12212048|P1|COMPLETED|Overall Study||39
4966678|NCT02674659|12212047|P2|STARTED|Overall Study||44
4966679|NCT02674659|12212048|P1|STARTED|Overall Study||43
4966680|NCT02674633|12212072|P2|NOT COMPLETED|Overall Study||4
4966681|NCT02674633|12212073|P1|NOT COMPLETED|Overall Study||5
4966682|NCT02674633|12212072|P2|COMPLETED|Overall Study||164
4966683|NCT02674633|12212073|P1|COMPLETED|Overall Study||175
4966684|NCT02674633|12212072|P2|STARTED|Overall Study||168
4966685|NCT02674633|12212073|P1|STARTED|Overall Study||180
4966686|NCT02674568|12212093|P1|NOT COMPLETED|Overall Study||339
4966687|NCT02674568|12212093|P1|COMPLETED|Overall Study||0
4966688|NCT02674568|12212093|P1|DLL3 Positive|Overall Study||287
4966689|NCT02674568|12212093|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
4966690|NCT02674568|12212093|P1|STARTED|Overall Study|Enrolled and dosed.|339
4966691|NCT02674477|12212118|P2|NOT COMPLETED|Overall Study||2
4966692|NCT02674477|12212119|P1|NOT COMPLETED|Overall Study||8
4966693|NCT02674477|12212118|P2|COMPLETED|Overall Study||45
4966694|NCT02674477|12212119|P1|COMPLETED|Overall Study||40
4966695|NCT02674477|12212118|P2|STARTED|Overall Study||47
4966696|NCT02674477|12212119|P1|STARTED|Overall Study||48
4966697|NCT02674412|12212129|P2|NOT COMPLETED|Overall Study||0
4966698|NCT02674412|12212130|P1|NOT COMPLETED|Overall Study||0
4966699|NCT02674412|12212129|P2|COMPLETED|Overall Study||5
4966700|NCT02674412|12212130|P1|COMPLETED|Overall Study||5
4966701|NCT02674412|12212129|P2|STARTED|Overall Study||5
4966702|NCT02674412|12212130|P1|STARTED|Overall Study||5
4966703|NCT02674386|12212143|P3|NOT COMPLETED|Overall Study||1
4966704|NCT02674386|12212144|P2|NOT COMPLETED|Overall Study||10
4966705|NCT02674386|12212145|P1|NOT COMPLETED|Overall Study||0
4966706|NCT02674386|12212143|P3|COMPLETED|Overall Study||16
4966707|NCT02674386|12212144|P2|COMPLETED|Overall Study||107
4966708|NCT02674386|12212145|P1|COMPLETED|Overall Study||20
4966709|NCT02674386|12212143|P3|Safety Analysis Set|Overall Study||17
4966710|NCT02674386|12212144|P2|Safety Analysis Set|Overall Study||113
4966711|NCT02674386|12212145|P1|Safety Analysis Set|Overall Study||20
4966712|NCT02674386|12212143|P3|STARTED|Overall Study||17
4966713|NCT02674386|12212144|P2|STARTED|Overall Study||117
4966714|NCT02674386|12212145|P1|STARTED|Overall Study||20
4966715|NCT02674334|12212200|P2|NOT COMPLETED|Overall Study||3
4966716|NCT02674334|12212201|P1|NOT COMPLETED|Overall Study||7
4966717|NCT02674334|12212200|P2|COMPLETED|Overall Study||40
4966718|NCT02674334|12212201|P1|COMPLETED|Overall Study||40
4966719|NCT02674334|12212200|P2|STARTED|Overall Study||43
4966720|NCT02674334|12212201|P1|STARTED|Overall Study||47
4966721|NCT02674204|12212211|P2|NOT COMPLETED|Overall Study||0
4966722|NCT02674204|12212212|P1|NOT COMPLETED|Overall Study||1
4966723|NCT02674204|12212211|P2|COMPLETED|Overall Study||1
4966724|NCT02674204|12212212|P1|COMPLETED|Overall Study||0
4966725|NCT02674204|12212211|P2|STARTED|Overall Study||1
4966726|NCT02674204|12212212|P1|STARTED|Overall Study||1
4966727|NCT02673944|12212246|P1|NOT COMPLETED|Overall Study||0
4966728|NCT02673944|12212246|P1|COMPLETED|Overall Study||10
4966729|NCT02673944|12212246|P1|STARTED|Overall Study||10
4966730|NCT02673918|12212253|P2|NOT COMPLETED|Overall Study||4
4966731|NCT02673918|12212254|P1|NOT COMPLETED|Overall Study||6
4966732|NCT02673918|12212253|P2|COMPLETED|Overall Study||20
4966733|NCT02673918|12212254|P1|COMPLETED|Overall Study||29
4966734|NCT02673918|12212253|P2|STARTED|Overall Study||24
4966735|NCT02673918|12212254|P1|STARTED|Overall Study||35
4966736|NCT02673684|12212282|P2|NOT COMPLETED|Overall Study||8
4966737|NCT02673684|12212283|P1|NOT COMPLETED|Overall Study||9
4966738|NCT02673684|12212282|P2|COMPLETED|Overall Study||0
4966739|NCT02673684|12212283|P1|COMPLETED|Overall Study||0
4966740|NCT02673684|12212282|P2|STARTED|Overall Study||8
4966741|NCT02673684|12212283|P1|STARTED|Overall Study||9
4966742|NCT02673619|12212299|P4|NOT COMPLETED|Overall Study||0
4966743|NCT02673619|12212300|P3|NOT COMPLETED|Overall Study||3
4966744|NCT02673619|12212301|P2|NOT COMPLETED|Overall Study||1
4966745|NCT02673619|12212302|P1|NOT COMPLETED|Overall Study||2
4966746|NCT02673619|12212299|P4|COMPLETED|Overall Study||7
4966747|NCT02673619|12212300|P3|COMPLETED|Overall Study||23
4966748|NCT02673619|12212301|P2|COMPLETED|Overall Study||4
4966749|NCT02673619|12212302|P1|COMPLETED|Overall Study||18
4966750|NCT02673619|12212299|P4|STARTED|Overall Study||7
4966751|NCT02673619|12212300|P3|STARTED|Overall Study||26
4966752|NCT02673619|12212301|P2|STARTED|Overall Study||5
4966753|NCT02673619|12212302|P1|STARTED|Overall Study||20
4966754|NCT02673541|12212394|P2|NOT COMPLETED|Overall Study||0
4966755|NCT02673541|12212395|P1|NOT COMPLETED|Overall Study||0
4966756|NCT02673541|12212394|P2|COMPLETED|Overall Study||2
4966757|NCT02673541|12212395|P1|COMPLETED|Overall Study||3
4966758|NCT02673541|12212394|P2|STARTED|Overall Study||2
4966759|NCT02673541|12212395|P1|STARTED|Overall Study||3
4966760|NCT02673515|12212413|P2|NOT COMPLETED|Overall Study||1
4966761|NCT02673515|12212414|P1|NOT COMPLETED|Overall Study||2
4966762|NCT02673515|12212413|P2|COMPLETED|Overall Study||29
4966763|NCT02673515|12212414|P1|COMPLETED|Overall Study||28
4966764|NCT02673515|12212413|P2|STARTED|Overall Study||30
4966765|NCT02673515|12212414|P1|STARTED|Overall Study||30
4966766|NCT02673489|12212430|P2|NOT COMPLETED|Follow Up Period||2
4966767|NCT02673489|12212431|P1|NOT COMPLETED|Follow Up Period||0
4966768|NCT02673489|12212430|P2|COMPLETED|Follow Up Period||21
4966769|NCT02673489|12212431|P1|COMPLETED|Follow Up Period||50
4966770|NCT02673489|12212430|P2|STARTED|Follow Up Period||23
4966771|NCT02673489|12212431|P1|STARTED|Follow Up Period||50
4966772|NCT02673489|12212430|P2|NOT COMPLETED|Treatment Period||3
4966773|NCT02673489|12212431|P1|NOT COMPLETED|Treatment Period||5
4966774|NCT02673489|12212430|P2|COMPLETED|Treatment Period||21
4966775|NCT02673489|12212431|P1|COMPLETED|Treatment Period||49
4966776|NCT02673489|12212430|P2|STARTED|Treatment Period||24
4966777|NCT02673489|12212431|P1|STARTED|Treatment Period||54
4966778|NCT02673372|12212446|P2|NOT COMPLETED|Overall Study||0
4966779|NCT02673372|12212447|P1|NOT COMPLETED|Overall Study||0
4966780|NCT02673372|12212446|P2|COMPLETED|Overall Study||30
4966781|NCT02673372|12212447|P1|COMPLETED|Overall Study||30
4966782|NCT02673372|12212446|P2|STARTED|Overall Study||30
4966783|NCT02673372|12212447|P1|STARTED|Overall Study||30
4966784|NCT02673333|12212453|P1|NOT COMPLETED|Overall Study||0
4966785|NCT02673333|12212453|P1|COMPLETED|Overall Study||39
4966786|NCT02673333|12212453|P1|STARTED|Overall Study||39
4966787|NCT02673203|12212459|P2|NOT COMPLETED|Overall Study||0
4966788|NCT02673203|12212460|P1|NOT COMPLETED|Overall Study||0
4966789|NCT02673203|12212459|P2|COMPLETED|Overall Study||15
4966790|NCT02673203|12212460|P1|COMPLETED|Overall Study||16
4966791|NCT02673203|12212459|P2|STARTED|Overall Study||15
4966792|NCT02673203|12212460|P1|STARTED|Overall Study||16
4966793|NCT02673138|12212482|P1|NOT COMPLETED|Overall Study||0
4966794|NCT02673138|12212482|P1|COMPLETED|Overall Study||10
4966795|NCT02673138|12212482|P1|STARTED|Overall Study||10
4966796|NCT02672852|12212496|P7|NOT COMPLETED|Part B||12
4966797|NCT02672852|12212497|P6|NOT COMPLETED|Part B||11
4966798|NCT02672852|12212498|P5|NOT COMPLETED|Part B||16
4966799|NCT02672852|12212499|P4|NOT COMPLETED|Part B||0
4966800|NCT02672852|12212500|P3|NOT COMPLETED|Part B||0
4966801|NCT02672852|12212501|P2|NOT COMPLETED|Part B||0
4966802|NCT02672852|12212502|P1|NOT COMPLETED|Part B||0
4966803|NCT02672852|12212496|P7|COMPLETED|Part B||51
4966804|NCT02672852|12212497|P6|COMPLETED|Part B||100
4966805|NCT02672852|12212498|P5|COMPLETED|Part B||209
4966806|NCT02672852|12212499|P4|COMPLETED|Part B||0
4966807|NCT02672852|12212500|P3|COMPLETED|Part B||0
4966808|NCT02672852|12212501|P2|COMPLETED|Part B||0
4966809|NCT02672852|12212502|P1|COMPLETED|Part B||0
4966810|NCT02672852|12212496|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
4966811|NCT02672852|12212497|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
4966812|NCT02672852|12212498|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
4966813|NCT02672852|12212499|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
4966814|NCT02672852|12212500|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
4966815|NCT02672852|12212501|P2|STARTED|Part B||0
4966816|NCT02672852|12212502|P1|STARTED|Part B||0
4966817|NCT02672852|12212496|P7|NOT COMPLETED|Part A2||0
4966818|NCT02672852|12212497|P6|NOT COMPLETED|Part A2||0
4966819|NCT02672852|12212498|P5|NOT COMPLETED|Part A2||0
4966820|NCT02672852|12212499|P4|NOT COMPLETED|Part A2||4
4966821|NCT02672852|12212500|P3|NOT COMPLETED|Part A2||10
4966822|NCT02672852|12212501|P2|NOT COMPLETED|Part A2||0
4966823|NCT02672852|12212502|P1|NOT COMPLETED|Part A2||0
4966824|NCT02672852|12212496|P7|COMPLETED|Part A2||0
4966825|NCT02672852|12212497|P6|COMPLETED|Part A2||0
4966826|NCT02672852|12212498|P5|COMPLETED|Part A2||0
4966827|NCT02672852|12212499|P4|COMPLETED|Part A2||399
4966828|NCT02672852|12212500|P3|COMPLETED|Part A2||83
4966829|NCT02672852|12212501|P2|COMPLETED|Part A2||0
4966830|NCT02672852|12212502|P1|COMPLETED|Part A2||0
4966831|NCT02672852|12212496|P7|STARTED|Part A2||0
4966832|NCT02672852|12212497|P6|STARTED|Part A2||0
4966833|NCT02672852|12212498|P5|STARTED|Part A2||0
4966834|NCT02672852|12212499|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
4966835|NCT02672852|12212500|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
4966836|NCT02672852|12212501|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
4966837|NCT02672852|12212502|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
4966838|NCT02672852|12212496|P7|NOT COMPLETED|Part A1||0
4966839|NCT02672852|12212497|P6|NOT COMPLETED|Part A1||0
4966840|NCT02672852|12212498|P5|NOT COMPLETED|Part A1||0
4966841|NCT02672852|12212499|P4|NOT COMPLETED|Part A1||0
4966842|NCT02672852|12212500|P3|NOT COMPLETED|Part A1||0
4966843|NCT02672852|12212501|P2|NOT COMPLETED|Part A1||4
4966844|NCT02672852|12212502|P1|NOT COMPLETED|Part A1||3
4966845|NCT02672852|12212496|P7|COMPLETED|Part A1||0
4966846|NCT02672852|12212497|P6|COMPLETED|Part A1||0
4966847|NCT02672852|12212498|P5|COMPLETED|Part A1||0
4966848|NCT02672852|12212499|P4|COMPLETED|Part A1||0
4966849|NCT02672852|12212500|P3|COMPLETED|Part A1||0
4966850|NCT02672852|12212501|P2|COMPLETED|Part A1||403
4966851|NCT02672852|12212502|P1|COMPLETED|Part A1||97
4966852|NCT02672852|12212496|P7|STARTED|Part A1||0
4966853|NCT02672852|12212497|P6|STARTED|Part A1||0
4966854|NCT02672852|12212498|P5|STARTED|Part A1||0
4966855|NCT02672852|12212499|P4|STARTED|Part A1||0
4966856|NCT02672852|12212500|P3|STARTED|Part A1||0
4966857|NCT02672852|12212501|P2|STARTED|Part A1||407
4966858|NCT02672852|12212502|P1|STARTED|Part A1||100
4966859|NCT02672553|12212533|P2|NOT COMPLETED|Overall Study||8
4966860|NCT02672553|12212534|P1|NOT COMPLETED|Overall Study||12
4966861|NCT02672553|12212533|P2|COMPLETED|Overall Study||41
4966862|NCT02672553|12212534|P1|COMPLETED|Overall Study||39
4966863|NCT02672553|12212533|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
4966864|NCT02672553|12212534|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
4966865|NCT02672553|12212533|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
4966866|NCT02672553|12212534|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
4966867|NCT02672553|12212533|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
4966868|NCT02672553|12212534|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
4966869|NCT02672553|12212533|P2|STARTED|Overall Study||49
4966870|NCT02672553|12212534|P1|STARTED|Overall Study||51
4966871|NCT02672514|12212596|P2|NOT COMPLETED|Overall Study||0
4966872|NCT02672514|12212597|P1|NOT COMPLETED|Overall Study||0
4966873|NCT02672514|12212596|P2|COMPLETED|Overall Study||51
4966874|NCT02672514|12212597|P1|COMPLETED|Overall Study||53
4966875|NCT02672514|12212596|P2|STARTED|Overall Study||51
4966876|NCT02672514|12212597|P1|STARTED|Overall Study||53
4966877|NCT02672423|12212606|P10|NOT COMPLETED|Period 3||0
4966878|NCT02672423|12212607|P9|NOT COMPLETED|Period 3||0
4966879|NCT02672423|12212608|P8|NOT COMPLETED|Period 3||1
4966880|NCT02672423|12212609|P7|NOT COMPLETED|Period 3||0
4966881|NCT02672423|12212610|P6|NOT COMPLETED|Period 3||1
4966882|NCT02672423|12212611|P5|NOT COMPLETED|Period 3||0
4966883|NCT02672423|12212612|P4|NOT COMPLETED|Period 3||0
4966884|NCT02672423|12212613|P3|NOT COMPLETED|Period 3||0
4966885|NCT02672423|12212614|P2|NOT COMPLETED|Period 3||0
4966886|NCT02672423|12212615|P1|NOT COMPLETED|Period 3||0
4966887|NCT02672423|12212606|P10|COMPLETED|Period 3||0
4966888|NCT02672423|12212607|P9|COMPLETED|Period 3||0
4966889|NCT02672423|12212608|P8|COMPLETED|Period 3||14
4966890|NCT02672423|12212609|P7|COMPLETED|Period 3||15
4966891|NCT02672423|12212610|P6|COMPLETED|Period 3||14
4966892|NCT02672423|12212611|P5|COMPLETED|Period 3||14
4966893|NCT02672423|12212612|P4|COMPLETED|Period 3||15
4966894|NCT02672423|12212613|P3|COMPLETED|Period 3||13
4966895|NCT02672423|12212614|P2|COMPLETED|Period 3||0
4966896|NCT02672423|12212615|P1|COMPLETED|Period 3||0
4966897|NCT02672423|12212606|P10|STARTED|Period 3|Part C was a 2-period study design.|0
4966898|NCT02672423|12212607|P9|STARTED|Period 3|Part C was a 2-period study design.|0
4966899|NCT02672423|12212608|P8|STARTED|Period 3||15
4966900|NCT02672423|12212609|P7|STARTED|Period 3||15
4966901|NCT02672423|12212610|P6|STARTED|Period 3||15
4966902|NCT02672423|12212611|P5|STARTED|Period 3||14
4966903|NCT02672423|12212612|P4|STARTED|Period 3||15
4966904|NCT02672423|12212613|P3|STARTED|Period 3||13
4966905|NCT02672423|12212614|P2|STARTED|Period 3|Part A was a 2-period study design.|0
4966906|NCT02672423|12212615|P1|STARTED|Period 3|Part A was a 2-period study design.|0
4966907|NCT02672423|12212606|P10|NOT COMPLETED|Washout 2||0
4966908|NCT02672423|12212607|P9|NOT COMPLETED|Washout 2||0
4966909|NCT02672423|12212608|P8|NOT COMPLETED|Washout 2||0
4966910|NCT02672423|12212609|P7|NOT COMPLETED|Washout 2||0
4966911|NCT02672423|12212610|P6|NOT COMPLETED|Washout 2||0
4966912|NCT02672423|12212611|P5|NOT COMPLETED|Washout 2||0
4966913|NCT02672423|12212612|P4|NOT COMPLETED|Washout 2||0
4966914|NCT02672423|12212613|P3|NOT COMPLETED|Washout 2||0
4966915|NCT02672423|12212614|P2|NOT COMPLETED|Washout 2||0
4966916|NCT02672423|12212615|P1|NOT COMPLETED|Washout 2||0
4966917|NCT02672423|12212606|P10|COMPLETED|Washout 2||12
4966918|NCT02672423|12212607|P9|COMPLETED|Washout 2||12
4966919|NCT02672423|12212608|P8|COMPLETED|Washout 2||15
4966920|NCT02672423|12212609|P7|COMPLETED|Washout 2||15
4966921|NCT02672423|12212610|P6|COMPLETED|Washout 2||15
4966922|NCT02672423|12212611|P5|COMPLETED|Washout 2||14
4966923|NCT02672423|12212612|P4|COMPLETED|Washout 2||15
4966924|NCT02672423|12212613|P3|COMPLETED|Washout 2||13
4966925|NCT02672423|12212614|P2|COMPLETED|Washout 2||7
4966926|NCT02672423|12212615|P1|COMPLETED|Washout 2||7
4966927|NCT02672423|12212606|P10|STARTED|Washout 2||12
4966928|NCT02672423|12212607|P9|STARTED|Washout 2||12
4966929|NCT02672423|12212608|P8|STARTED|Washout 2||15
4966930|NCT02672423|12212609|P7|STARTED|Washout 2||15
4966931|NCT02672423|12212610|P6|STARTED|Washout 2||15
4966932|NCT02672423|12212611|P5|STARTED|Washout 2||14
4966933|NCT02672423|12212612|P4|STARTED|Washout 2||15
4966934|NCT02672423|12212613|P3|STARTED|Washout 2||13
4966935|NCT02672423|12212614|P2|STARTED|Washout 2||7
4966936|NCT02672423|12212615|P1|STARTED|Washout 2||7
4966937|NCT02672423|12212606|P10|NOT COMPLETED|Period 2||0
4966938|NCT02672423|12212607|P9|NOT COMPLETED|Period 2||0
4966939|NCT02672423|12212608|P8|NOT COMPLETED|Period 2||0
4966940|NCT02672423|12212609|P7|NOT COMPLETED|Period 2||0
4966941|NCT02672423|12212610|P6|NOT COMPLETED|Period 2||0
4966942|NCT02672423|12212611|P5|NOT COMPLETED|Period 2||0
4966943|NCT02672423|12212612|P4|NOT COMPLETED|Period 2||0
4966944|NCT02672423|12212613|P3|NOT COMPLETED|Period 2||1
4966945|NCT02672423|12212614|P2|NOT COMPLETED|Period 2||0
4966946|NCT02672423|12212615|P1|NOT COMPLETED|Period 2||0
4966947|NCT02672423|12212606|P10|COMPLETED|Period 2||12
4966948|NCT02672423|12212607|P9|COMPLETED|Period 2||12
4966949|NCT02672423|12212608|P8|COMPLETED|Period 2||15
4966950|NCT02672423|12212609|P7|COMPLETED|Period 2||15
4966951|NCT02672423|12212610|P6|COMPLETED|Period 2||15
4966952|NCT02672423|12212611|P5|COMPLETED|Period 2||14
4966953|NCT02672423|12212612|P4|COMPLETED|Period 2||15
4966954|NCT02672423|12212613|P3|COMPLETED|Period 2||13
4966955|NCT02672423|12212614|P2|COMPLETED|Period 2||7
4966956|NCT02672423|12212615|P1|COMPLETED|Period 2||7
4966957|NCT02672423|12212606|P10|STARTED|Period 2||12
4966958|NCT02672423|12212607|P9|STARTED|Period 2||12
4966959|NCT02672423|12212608|P8|STARTED|Period 2||15
4966960|NCT02672423|12212609|P7|STARTED|Period 2||15
4966961|NCT02672423|12212610|P6|STARTED|Period 2||15
4966962|NCT02672423|12212611|P5|STARTED|Period 2||14
4966963|NCT02672423|12212612|P4|STARTED|Period 2||15
4966964|NCT02672423|12212613|P3|STARTED|Period 2||14
4966965|NCT02672423|12212614|P2|STARTED|Period 2||7
4966966|NCT02672423|12212615|P1|STARTED|Period 2||7
4966967|NCT02672423|12212606|P10|NOT COMPLETED|Washout 1||0
4966968|NCT02672423|12212607|P9|NOT COMPLETED|Washout 1||0
4966969|NCT02672423|12212608|P8|NOT COMPLETED|Washout 1||0
4966970|NCT02672423|12212609|P7|NOT COMPLETED|Washout 1||0
4966971|NCT02672423|12212610|P6|NOT COMPLETED|Washout 1||0
4966972|NCT02672423|12212611|P5|NOT COMPLETED|Washout 1||0
4966973|NCT02672423|12212612|P4|NOT COMPLETED|Washout 1||0
4966974|NCT02672423|12212613|P3|NOT COMPLETED|Washout 1||0
4966975|NCT02672423|12212614|P2|NOT COMPLETED|Washout 1||0
4966976|NCT02672423|12212615|P1|NOT COMPLETED|Washout 1||0
4966977|NCT02672423|12212606|P10|COMPLETED|Washout 1||12
4966978|NCT02672423|12212607|P9|COMPLETED|Washout 1||12
4966979|NCT02672423|12212608|P8|COMPLETED|Washout 1||15
4966980|NCT02672423|12212609|P7|COMPLETED|Washout 1||15
4966981|NCT02672423|12212610|P6|COMPLETED|Washout 1||15
4966982|NCT02672423|12212611|P5|COMPLETED|Washout 1||14
4966983|NCT02672423|12212612|P4|COMPLETED|Washout 1||15
4966984|NCT02672423|12212613|P3|COMPLETED|Washout 1||14
4966985|NCT02672423|12212614|P2|COMPLETED|Washout 1||7
4966986|NCT02672423|12212615|P1|COMPLETED|Washout 1||7
4966987|NCT02672423|12212606|P10|STARTED|Washout 1||12
4966988|NCT02672423|12212607|P9|STARTED|Washout 1||12
4966989|NCT02672423|12212608|P8|STARTED|Washout 1||15
4966990|NCT02672423|12212609|P7|STARTED|Washout 1||15
4966991|NCT02672423|12212610|P6|STARTED|Washout 1||15
4966992|NCT02672423|12212611|P5|STARTED|Washout 1||14
4966993|NCT02672423|12212612|P4|STARTED|Washout 1||15
4966994|NCT02672423|12212613|P3|STARTED|Washout 1||14
4966995|NCT02672423|12212614|P2|STARTED|Washout 1||7
4966996|NCT02672423|12212615|P1|STARTED|Washout 1||7
4966997|NCT02672423|12212606|P10|NOT COMPLETED|Period 1||0
4966998|NCT02672423|12212607|P9|NOT COMPLETED|Period 1||0
4966999|NCT02672423|12212608|P8|NOT COMPLETED|Period 1||0
4967000|NCT02672423|12212609|P7|NOT COMPLETED|Period 1||0
4967001|NCT02672423|12212610|P6|NOT COMPLETED|Period 1||0
4967002|NCT02672423|12212611|P5|NOT COMPLETED|Period 1||1
4967003|NCT02672423|12212612|P4|NOT COMPLETED|Period 1||0
4967004|NCT02672423|12212613|P3|NOT COMPLETED|Period 1||0
4967005|NCT02672423|12212614|P2|NOT COMPLETED|Period 1||0
4967006|NCT02672423|12212615|P1|NOT COMPLETED|Period 1||0
4967007|NCT02672423|12212606|P10|COMPLETED|Period 1||12
4967008|NCT02672423|12212607|P9|COMPLETED|Period 1||12
4967009|NCT02672423|12212608|P8|COMPLETED|Period 1||15
4967010|NCT02672423|12212609|P7|COMPLETED|Period 1||15
4967011|NCT02672423|12212610|P6|COMPLETED|Period 1||15
4967012|NCT02672423|12212611|P5|COMPLETED|Period 1||14
4967013|NCT02672423|12212612|P4|COMPLETED|Period 1||15
4967014|NCT02672423|12212613|P3|COMPLETED|Period 1||14
4967015|NCT02672423|12212614|P2|COMPLETED|Period 1||7
4967016|NCT02672423|12212615|P1|COMPLETED|Period 1||7
4967017|NCT02672423|12212606|P10|Received at Least One Dose of Study Drug|Period 1||12
4967018|NCT02672423|12212607|P9|Received at Least One Dose of Study Drug|Period 1||12
4967019|NCT02672423|12212608|P8|Received at Least One Dose of Study Drug|Period 1||15
4967020|NCT02672423|12212609|P7|Received at Least One Dose of Study Drug|Period 1||15
4967021|NCT02672423|12212610|P6|Received at Least One Dose of Study Drug|Period 1||15
4967022|NCT02672423|12212611|P5|Received at Least One Dose of Study Drug|Period 1||15
4967023|NCT02672423|12212612|P4|Received at Least One Dose of Study Drug|Period 1||15
4967024|NCT02672423|12212613|P3|Received at Least One Dose of Study Drug|Period 1||14
4967025|NCT02672423|12212614|P2|Received at Least One Dose of Study Drug|Period 1||7
4967026|NCT02672423|12212615|P1|Received at Least One Dose of Study Drug|Period 1||7
4967027|NCT02672423|12212606|P10|STARTED|Period 1||12
4967028|NCT02672423|12212607|P9|STARTED|Period 1||12
4967029|NCT02672423|12212608|P8|STARTED|Period 1||15
4967030|NCT02672423|12212609|P7|STARTED|Period 1||15
4967031|NCT02672423|12212610|P6|STARTED|Period 1||15
4967032|NCT02672423|12212611|P5|STARTED|Period 1||15
4967033|NCT02672423|12212612|P4|STARTED|Period 1||15
4967034|NCT02672423|12212613|P3|STARTED|Period 1||14
4967035|NCT02672423|12212614|P2|STARTED|Period 1||7
4967036|NCT02672423|12212615|P1|STARTED|Period 1||7
4967037|NCT02672176|12212640|P2|NOT COMPLETED|Overall Study||26
4967038|NCT02672176|12212641|P1|NOT COMPLETED|Overall Study||6
4967039|NCT02672176|12212640|P2|COMPLETED|Overall Study||132
4967040|NCT02672176|12212641|P1|COMPLETED|Overall Study||155
4967041|NCT02672176|12212640|P2|STARTED|Overall Study||158
4967042|NCT02672176|12212641|P1|STARTED|Overall Study||161
4967043|NCT02672111|12212677|P2|NOT COMPLETED|Overall Study||12
4967044|NCT02672111|12212678|P1|NOT COMPLETED|Overall Study||58
4967045|NCT02672111|12212677|P2|COMPLETED|Overall Study||25
4967046|NCT02672111|12212678|P1|COMPLETED|Overall Study||132
4967047|NCT02672111|12212677|P2|Completed Treatment|Overall Study||29
4967048|NCT02672111|12212678|P1|Completed Treatment|Overall Study||138
4967049|NCT02672111|12212677|P2|STARTED|Overall Study||37
4967050|NCT02672111|12212678|P1|STARTED|Overall Study||190
4967051|NCT02672033|12212700|P1|NOT COMPLETED|Overall Study||0
4967052|NCT02672033|12212700|P1|COMPLETED|Overall Study||2
4967053|NCT02672033|12212700|P1|STARTED|Overall Study||2
4967054|NCT02671760|12212710|P3|NOT COMPLETED|Overall Study||0
4967055|NCT02671760|12212711|P2|NOT COMPLETED|Overall Study||1
4967056|NCT02671760|12212712|P1|NOT COMPLETED|Overall Study||0
4967057|NCT02671760|12212710|P3|COMPLETED|Overall Study||13
4967058|NCT02671760|12212711|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
4967059|NCT02671760|12212712|P1|COMPLETED|Overall Study||13
4967060|NCT02671760|12212710|P3|STARTED|Overall Study||13
4967061|NCT02671760|12212711|P2|STARTED|Overall Study||13
4967062|NCT02671760|12212712|P1|STARTED|Overall Study||13
4967063|NCT02671500|12212738|P1|NOT COMPLETED|Overall Study||14
4967064|NCT02671500|12212738|P1|COMPLETED|Overall Study||361
4967065|NCT02671500|12212738|P1|STARTED|Overall Study||375
4967066|NCT02671461|12212753|P3|NOT COMPLETED|Follow-up||1
4967067|NCT02671461|12212754|P2|NOT COMPLETED|Follow-up||1
4967068|NCT02671461|12212755|P1|NOT COMPLETED|Follow-up||1
4967069|NCT02671461|12212753|P3|COMPLETED|Follow-up||6
4967070|NCT02671461|12212754|P2|COMPLETED|Follow-up||4
4967071|NCT02671461|12212755|P1|COMPLETED|Follow-up||1
4967072|NCT02671461|12212753|P3|STARTED|Follow-up||7
4967073|NCT02671461|12212754|P2|STARTED|Follow-up||5
4967074|NCT02671461|12212755|P1|STARTED|Follow-up||2
4967075|NCT02671461|12212753|P3|NOT COMPLETED|Treatment||5
4967076|NCT02671461|12212754|P2|NOT COMPLETED|Treatment||3
4967077|NCT02671461|12212755|P1|NOT COMPLETED|Treatment||2
4967078|NCT02671461|12212753|P3|COMPLETED|Treatment||2
4967079|NCT02671461|12212754|P2|COMPLETED|Treatment||2
4967080|NCT02671461|12212755|P1|COMPLETED|Treatment||1
4967081|NCT02671461|12212753|P3|STARTED|Treatment||7
4967082|NCT02671461|12212754|P2|STARTED|Treatment||5
4967083|NCT02671461|12212755|P1|STARTED|Treatment||3
4967084|NCT02671266|12212780|P2|NOT COMPLETED|Overall Study||1
4967085|NCT02671266|12212781|P1|NOT COMPLETED|Overall Study||1
4967086|NCT02671266|12212780|P2|COMPLETED|Overall Study||20
4967087|NCT02671266|12212781|P1|COMPLETED|Overall Study||19
4967088|NCT02671266|12212780|P2|Healthy Participants|Overall Study||8
4967089|NCT02671266|12212781|P1|Healthy Participants|Overall Study||8
4967090|NCT02671266|12212780|P2|OCD Participants|Overall Study||3
4967091|NCT02671266|12212781|P1|OCD Participants|Overall Study||2
4967092|NCT02671266|12212780|P2|BDD Participants|Overall Study||9
4967093|NCT02671266|12212781|P1|BDD Participants|Overall Study||9
4967094|NCT02671266|12212780|P2|STARTED|Overall Study||21
4967095|NCT02671266|12212781|P1|STARTED|Overall Study||20
4967096|NCT02671136|12212795|P2|NOT COMPLETED|Overall Study||0
4967097|NCT02671136|12212796|P1|NOT COMPLETED|Overall Study||0
4967098|NCT02671136|12212795|P2|COMPLETED|Overall Study||0
4967099|NCT02671136|12212796|P1|COMPLETED|Overall Study||3
4967100|NCT02671136|12212795|P2|STARTED|Overall Study||0
4967101|NCT02671136|12212796|P1|STARTED|Overall Study||3
4967102|NCT02670928|12212804|P2|NOT COMPLETED|Overall Study||1
4967103|NCT02670928|12212805|P1|NOT COMPLETED|Overall Study||10
4967104|NCT02670928|12212804|P2|COMPLETED|Overall Study||29
4967105|NCT02670928|12212805|P1|COMPLETED|Overall Study||90
4967106|NCT02670928|12212804|P2|STARTED|Overall Study||30
4967107|NCT02670928|12212805|P1|STARTED|Overall Study||100
4967108|NCT02670915|12212832|P3|NOT COMPLETED|Overall Study||5
4967109|NCT02670915|12212833|P2|NOT COMPLETED|Overall Study||8
4967110|NCT02670915|12212834|P1|NOT COMPLETED|Overall Study||4
4967111|NCT02670915|12212832|P3|COMPLETED|Overall Study||253
4967112|NCT02670915|12212833|P2|COMPLETED|Overall Study||251
4967113|NCT02670915|12212834|P1|COMPLETED|Overall Study||256
4967114|NCT02670915|12212832|P3|STARTED|Overall Study||258
4967115|NCT02670915|12212833|P2|STARTED|Overall Study||259
4967116|NCT02670915|12212834|P1|STARTED|Overall Study||260
4967117|NCT02670811|12213081|P2|NOT COMPLETED|Overall Study||0
4967118|NCT02670811|12213082|P1|NOT COMPLETED|Overall Study||1
4967119|NCT02670811|12213081|P2|COMPLETED|Overall Study||18
4967120|NCT02670811|12213082|P1|COMPLETED|Overall Study||17
4967121|NCT02670811|12213081|P2|STARTED|Overall Study||18
4967122|NCT02670811|12213082|P1|STARTED|Overall Study||18
4967123|NCT02670629|12213100|P2|NOT COMPLETED|Overall Study||0
4967124|NCT02670629|12213101|P1|NOT COMPLETED|Overall Study||0
4967125|NCT02670629|12213100|P2|COMPLETED|Overall Study||29
4967126|NCT02670629|12213101|P1|COMPLETED|Overall Study||29
4967127|NCT02670629|12213100|P2|STARTED|Overall Study||29
4967128|NCT02670629|12213101|P1|STARTED|Overall Study||29
4967129|NCT02670551|12213118|P3|NOT COMPLETED|Overall Study||31
4967130|NCT02670551|12213119|P2|NOT COMPLETED|Overall Study||26
4967131|NCT02670551|12213120|P1|NOT COMPLETED|Overall Study||28
4967132|NCT02670551|12213118|P3|COMPLETED|Overall Study||134
4967133|NCT02670551|12213119|P2|COMPLETED|Overall Study||134
4967134|NCT02670551|12213120|P1|COMPLETED|Overall Study||135
4967135|NCT02670551|12213118|P3|Received Treatment (Safety Population)|Overall Study||165
4967136|NCT02670551|12213119|P2|Received Treatment (Safety Population)|Overall Study||157
4967137|NCT02670551|12213120|P1|Received Treatment (Safety Population)|Overall Study||158
4967138|NCT02670551|12213118|P3|STARTED|Overall Study||165
4967139|NCT02670551|12213119|P2|STARTED|Overall Study||160
4967140|NCT02670551|12213120|P1|STARTED|Overall Study||163
4967141|NCT02670538|12213134|P3|NOT COMPLETED|Overall Study||30
4967142|NCT02670538|12213135|P2|NOT COMPLETED|Overall Study||32
4967143|NCT02670538|12213136|P1|NOT COMPLETED|Overall Study||32
4967144|NCT02670538|12213134|P3|COMPLETED|Overall Study||128
4967145|NCT02670538|12213135|P2|COMPLETED|Overall Study||136
4967146|NCT02670538|12213136|P1|COMPLETED|Overall Study||135
4967147|NCT02670538|12213134|P3|Intent-to-Treat Population|Overall Study||153
4967148|NCT02670538|12213135|P2|Intent-to-Treat Population|Overall Study||162
4967149|NCT02670538|12213136|P1|Intent-to-Treat Population|Overall Study||163
4967150|NCT02670538|12213134|P3|Safety Population : Received Study Drug|Overall Study||158
4967151|NCT02670538|12213135|P2|Safety Population : Received Study Drug|Overall Study||167
4967152|NCT02670538|12213136|P1|Safety Population : Received Study Drug|Overall Study||165
4967153|NCT02670538|12213134|P3|STARTED|Overall Study||158
4967154|NCT02670538|12213135|P2|STARTED|Overall Study||168
4967155|NCT02670538|12213136|P1|STARTED|Overall Study||167
4967156|NCT02670473|12213147|P1|NOT COMPLETED|Overall Study||1
4967157|NCT02670473|12213147|P1|COMPLETED|Overall Study||34
4967158|NCT02670473|12213147|P1|STARTED|Overall Study||35
4967159|NCT02670343|12213200|P1|NOT COMPLETED|Overall Study||0
4967160|NCT02670343|12213200|P1|COMPLETED|Overall Study||8
4967161|NCT02670343|12213200|P1|STARTED|Overall Study||8
4967162|NCT02670330|12213206|P2|NOT COMPLETED|Overall Study||77
4967163|NCT02670330|12213207|P1|NOT COMPLETED|Overall Study||75
4967164|NCT02670330|12213206|P2|COMPLETED|Overall Study||0
4967165|NCT02670330|12213207|P1|COMPLETED|Overall Study||0
4967166|NCT02670330|12213206|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
4967167|NCT02670330|12213207|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
4967168|NCT02670330|12213206|P2|STARTED|Overall Study||77
4967169|NCT02670330|12213207|P1|STARTED|Overall Study||75
4967170|NCT02670083|12213219|P2|NOT COMPLETED|Overall Study||319
4967171|NCT02670083|12213220|P1|NOT COMPLETED|Overall Study||321
4967172|NCT02670083|12213219|P2|COMPLETED|Overall Study||85
4967173|NCT02670083|12213220|P1|COMPLETED|Overall Study||88
4967174|NCT02670083|12213219|P2|STARTED|Overall Study||404
4967175|NCT02670083|12213220|P1|STARTED|Overall Study||409
4967176|NCT02669940|12213265|P2|NOT COMPLETED|Overall Study||3
4967177|NCT02669940|12213266|P1|NOT COMPLETED|Overall Study||1
4967178|NCT02669940|12213265|P2|COMPLETED|Overall Study||92
4967179|NCT02669940|12213266|P1|COMPLETED|Overall Study||62
4967180|NCT02669940|12213265|P2|STARTED|Overall Study||95
4967181|NCT02669940|12213266|P1|STARTED|Overall Study||63
4967182|NCT02669914|12213322|P3|NOT COMPLETED|Overall Study||0
4967183|NCT02669914|12213323|P2|NOT COMPLETED|Overall Study||0
4967184|NCT02669914|12213324|P1|NOT COMPLETED|Overall Study||0
4967185|NCT02669914|12213322|P3|COMPLETED|Overall Study||0
4967186|NCT02669914|12213323|P2|COMPLETED|Overall Study||0
4967187|NCT02669914|12213324|P1|COMPLETED|Overall Study||4
4967188|NCT02669914|12213322|P3|STARTED|Overall Study||0
4967189|NCT02669914|12213323|P2|STARTED|Overall Study||0
4967190|NCT02669914|12213324|P1|STARTED|Overall Study||4
4967191|NCT02669862|12213368|P3|NOT COMPLETED|Overall Study||5
4967192|NCT02669862|12213369|P2|NOT COMPLETED|Overall Study||5
4967193|NCT02669862|12213370|P1|NOT COMPLETED|Overall Study||2
4967194|NCT02669862|12213368|P3|COMPLETED|Overall Study||26
4967195|NCT02669862|12213369|P2|COMPLETED|Overall Study||29
4967196|NCT02669862|12213370|P1|COMPLETED|Overall Study||31
4967197|NCT02669862|12213368|P3|STARTED|Overall Study||31
4967198|NCT02669862|12213369|P2|STARTED|Overall Study||34
4967199|NCT02669862|12213370|P1|STARTED|Overall Study||33
4967200|NCT02669849|12213386|P3|NOT COMPLETED|Overall Study||24
4967201|NCT02669849|12213387|P2|NOT COMPLETED|Overall Study||2
4967202|NCT02669849|12213388|P1|NOT COMPLETED|Overall Study||18
4967203|NCT02669849|12213386|P3|COMPLETED|Overall Study||8
4967204|NCT02669849|12213387|P2|COMPLETED|Overall Study||4
4967205|NCT02669849|12213388|P1|COMPLETED|Overall Study||11
4967206|NCT02669849|12213386|P3|STARTED|Overall Study||32
4967207|NCT02669849|12213387|P2|STARTED|Overall Study||6
4967208|NCT02669849|12213388|P1|STARTED|Overall Study||29
4967209|NCT02669784|12213410|P2|NOT COMPLETED|Overall Study||0
4967210|NCT02669784|12213411|P1|NOT COMPLETED|Overall Study||0
4967211|NCT02669784|12213410|P2|COMPLETED|Overall Study||16
4967212|NCT02669784|12213411|P1|COMPLETED|Overall Study||18
4967213|NCT02669784|12213410|P2|STARTED|Overall Study||16
4967214|NCT02669784|12213411|P1|STARTED|Overall Study||18
4967215|NCT02669758|12213431|P1|NOT COMPLETED|Overall Study||94
4967216|NCT02669758|12213431|P1|COMPLETED|Overall Study||183
4967217|NCT02669758|12213431|P1|STARTED|Overall Study||277
4967218|NCT02669667|12213442|P7|NOT COMPLETED|Overall Study||0
4967219|NCT02669667|12213443|P6|NOT COMPLETED|Overall Study||1
4967220|NCT02669667|12213444|P5|NOT COMPLETED|Overall Study||0
4967221|NCT02669667|12213445|P4|NOT COMPLETED|Overall Study||0
4967222|NCT02669667|12213446|P3|NOT COMPLETED|Overall Study||0
4967223|NCT02669667|12213447|P2|NOT COMPLETED|Overall Study||0
4967224|NCT02669667|12213448|P1|NOT COMPLETED|Overall Study||0
4967225|NCT02669667|12213442|P7|COMPLETED|Overall Study||6
4967226|NCT02669667|12213443|P6|COMPLETED|Overall Study||5
4967227|NCT02669667|12213444|P5|COMPLETED|Overall Study||6
4967228|NCT02669667|12213445|P4|COMPLETED|Overall Study||6
4967229|NCT02669667|12213446|P3|COMPLETED|Overall Study||4
4967230|NCT02669667|12213447|P2|COMPLETED|Overall Study||4
4967231|NCT02669667|12213448|P1|COMPLETED|Overall Study||12
4967232|NCT02669667|12213442|P7|STARTED|Overall Study||6
4967233|NCT02669667|12213443|P6|STARTED|Overall Study||6
4967234|NCT02669667|12213444|P5|STARTED|Overall Study||6
4967235|NCT02669667|12213445|P4|STARTED|Overall Study||6
4967236|NCT02669667|12213446|P3|STARTED|Overall Study||4
4967237|NCT02669667|12213447|P2|STARTED|Overall Study||4
4967238|NCT02669667|12213448|P1|STARTED|Overall Study||12
4967239|NCT02669615|12213542|P1|NOT COMPLETED|Overall Study||0
4967240|NCT02669615|12213542|P1|COMPLETED|Overall Study||24
4967241|NCT02669615|12213542|P1|STARTED|Overall Study||24
4967242|NCT02669433|12213551|P3|NOT COMPLETED|Overall Study||15
4967243|NCT02669433|12213552|P2|NOT COMPLETED|Overall Study||14
4967244|NCT02669433|12213553|P1|NOT COMPLETED|Overall Study||15
4967245|NCT02669433|12213551|P3|COMPLETED|Overall Study||74
4967246|NCT02669433|12213552|P2|COMPLETED|Overall Study||75
4967247|NCT02669433|12213553|P1|COMPLETED|Overall Study||76
4967248|NCT02669433|12213551|P3|UPDRS Primary Population|Overall Study||84
4967249|NCT02669433|12213552|P2|UPDRS Primary Population|Overall Study||87
4967250|NCT02669433|12213553|P1|UPDRS Primary Population|Overall Study||87
4967251|NCT02669433|12213551|P3|Completers Population|Overall Study||69
4967252|NCT02669433|12213552|P2|Completers Population|Overall Study||72
4967253|NCT02669433|12213553|P1|Completers Population|Overall Study||73
4967254|NCT02669433|12213551|P3|Per-Protocol Population|Overall Study||82
4967255|NCT02669433|12213552|P2|Per-Protocol Population|Overall Study||79
4967256|NCT02669433|12213553|P1|Per-Protocol Population|Overall Study||78
4967257|NCT02669433|12213551|P3|Intent to Treat (ITT) Population|Overall Study||87
4967258|NCT02669433|12213552|P2|Intent to Treat (ITT) Population|Overall Study||89
4967259|NCT02669433|12213553|P1|Intent to Treat (ITT) Population|Overall Study||89
4967260|NCT02669433|12213551|P3|Safety Population|Overall Study||88
4967261|NCT02669433|12213552|P2|Safety Population|Overall Study||89
4967262|NCT02669433|12213553|P1|Safety Population|Overall Study||91
4967263|NCT02669433|12213551|P3|STARTED|Overall Study||89
4967264|NCT02669433|12213552|P2|STARTED|Overall Study||89
4967265|NCT02669433|12213553|P1|STARTED|Overall Study||91
4967266|NCT02669407|12213567|P1|NOT COMPLETED|Overall Study||3
4967267|NCT02669407|12213567|P1|COMPLETED|Overall Study||11
4967268|NCT02669407|12213567|P1|STARTED|Overall Study||14
4967269|NCT02669264|12213591|P7|NOT COMPLETED|Overall Study||5
4967270|NCT02669264|12213592|P6|NOT COMPLETED|Overall Study||6
4967271|NCT02669264|12213593|P5|NOT COMPLETED|Overall Study||5
4967272|NCT02669264|12213594|P4|NOT COMPLETED|Overall Study||3
4967273|NCT02669264|12213595|P3|NOT COMPLETED|Overall Study||3
4967274|NCT02669264|12213596|P2|NOT COMPLETED|Overall Study||6
4967275|NCT02669264|12213597|P1|NOT COMPLETED|Overall Study||5
4967276|NCT02669264|12213591|P7|COMPLETED|Overall Study||0
4967277|NCT02669264|12213592|P6|COMPLETED|Overall Study||0
4967278|NCT02669264|12213593|P5|COMPLETED|Overall Study||0
4967279|NCT02669264|12213594|P4|COMPLETED|Overall Study||1
4967280|NCT02669264|12213595|P3|COMPLETED|Overall Study||0
4967281|NCT02669264|12213596|P2|COMPLETED|Overall Study||1
4967282|NCT02669264|12213597|P1|COMPLETED|Overall Study||0
4967283|NCT02669264|12213591|P7|STARTED|Overall Study||5
4967284|NCT02669264|12213592|P6|STARTED|Overall Study||6
4967285|NCT02669264|12213593|P5|STARTED|Overall Study||5
4967286|NCT02669264|12213594|P4|STARTED|Overall Study||4
4967287|NCT02669264|12213595|P3|STARTED|Overall Study||3
4967288|NCT02669264|12213596|P2|STARTED|Overall Study||7
4967289|NCT02669264|12213597|P1|STARTED|Overall Study||5
4967290|NCT02669095|12213743|P2|NOT COMPLETED|Overall Study||3
4967291|NCT02669095|12213744|P1|NOT COMPLETED|Overall Study||1
4967292|NCT02669095|12213743|P2|COMPLETED|Overall Study||72
4967293|NCT02669095|12213744|P1|COMPLETED|Overall Study||74
4967294|NCT02669095|12213743|P2|STARTED|Overall Study||75
4967295|NCT02669095|12213744|P1|STARTED|Overall Study||75
4967296|NCT02669082|12213752|P1|NOT COMPLETED|Overall Study||1
4967297|NCT02669082|12213752|P1|COMPLETED|Overall Study||25
4967298|NCT02669082|12213752|P1|STARTED|Overall Study||26
4967299|NCT02669043|12213764|P1|NOT COMPLETED|Overall Study||4
4967300|NCT02669043|12213764|P1|COMPLETED|Overall Study||4
4967301|NCT02669043|12213764|P1|STARTED|Overall Study||8
4967302|NCT02669017|12213777|P9|NOT COMPLETED|Overall Study||25
4967303|NCT02669017|12213778|P8|NOT COMPLETED|Overall Study||62
4967304|NCT02669017|12213779|P7|NOT COMPLETED|Overall Study||11
4967305|NCT02669017|12213780|P6|NOT COMPLETED|Overall Study||19
4967306|NCT02669017|12213781|P5|NOT COMPLETED|Overall Study||12
4967307|NCT02669017|12213782|P4|NOT COMPLETED|Overall Study||4
4967308|NCT02669017|12213783|P3|NOT COMPLETED|Overall Study||2
4967309|NCT02669017|12213784|P2|NOT COMPLETED|Overall Study||2
4967310|NCT02669017|12213785|P1|NOT COMPLETED|Overall Study||1
4967311|NCT02669017|12213777|P9|COMPLETED|Overall Study||11
4967312|NCT02669017|12213778|P8|COMPLETED|Overall Study||7
4967313|NCT02669017|12213779|P7|COMPLETED|Overall Study||8
4967314|NCT02669017|12213780|P6|COMPLETED|Overall Study||7
4967315|NCT02669017|12213781|P5|COMPLETED|Overall Study||4
4967316|NCT02669017|12213782|P4|COMPLETED|Overall Study||1
4967317|NCT02669017|12213783|P3|COMPLETED|Overall Study||2
4967318|NCT02669017|12213784|P2|COMPLETED|Overall Study||2
4967319|NCT02669017|12213785|P1|COMPLETED|Overall Study||3
4967320|NCT02669017|12213777|P9|STARTED|Overall Study||36
4967321|NCT02669017|12213778|P8|STARTED|Overall Study||69
4967322|NCT02669017|12213779|P7|STARTED|Overall Study||19
4967323|NCT02669017|12213780|P6|STARTED|Overall Study||26
4967324|NCT02669017|12213781|P5|STARTED|Overall Study||16
4967325|NCT02669017|12213782|P4|STARTED|Overall Study||5
4967326|NCT02669017|12213783|P3|STARTED|Overall Study||4
4967327|NCT02669017|12213784|P2|STARTED|Overall Study||4
4967328|NCT02669017|12213785|P1|STARTED|Overall Study||4
4967329|NCT02668952|12213909|P2|NOT COMPLETED|Overall Study||0
4967330|NCT02668952|12213910|P1|NOT COMPLETED|Overall Study||0
4967331|NCT02668952|12213909|P2|COMPLETED|Overall Study||14
4967332|NCT02668952|12213910|P1|COMPLETED|Overall Study||16
4967333|NCT02668952|12213909|P2|STARTED|Overall Study||14
4967334|NCT02668952|12213910|P1|STARTED|Overall Study||16
4967335|NCT02668822|12213930|P2|NOT COMPLETED|Overall Study||9
4967336|NCT02668822|12213931|P1|NOT COMPLETED|Overall Study||9
4967337|NCT02668822|12213930|P2|COMPLETED|Overall Study||0
4967338|NCT02668822|12213931|P1|COMPLETED|Overall Study||0
4967339|NCT02668822|12213930|P2|STARTED|Overall Study||9
4967340|NCT02668822|12213931|P1|STARTED|Overall Study||9
4967341|NCT02668783|12213953|P2|NOT COMPLETED|Overall Study||12
4967342|NCT02668783|12213954|P1|NOT COMPLETED|Overall Study||13
4967343|NCT02668783|12213953|P2|COMPLETED|Overall Study||0
4967344|NCT02668783|12213954|P1|COMPLETED|Overall Study||0
4967345|NCT02668783|12213953|P2|Treated|Overall Study||11
4967346|NCT02668783|12213954|P1|Treated|Overall Study||13
4967347|NCT02668783|12213953|P2|STARTED|Overall Study||12
4967348|NCT02668783|12213954|P1|STARTED|Overall Study||13
4967349|NCT02668640|12213974|P1|NOT COMPLETED|Overall Study||14
4967350|NCT02668640|12213974|P1|COMPLETED|Overall Study||41
4967351|NCT02668640|12213974|P1|STARTED|Overall Study||55
4967352|NCT02668432|12213987|P2|NOT COMPLETED|Overall Study||0
4967353|NCT02668432|12213988|P1|NOT COMPLETED|Overall Study||0
4967354|NCT02668432|12213987|P2|COMPLETED|Overall Study||4
4967355|NCT02668432|12213988|P1|COMPLETED|Overall Study||5
4967356|NCT02668432|12213987|P2|STARTED|Overall Study||4
4967357|NCT02668432|12213988|P1|STARTED|Overall Study||5
4967358|NCT02668302|12214026|P2|NOT COMPLETED|Overall Study||0
4967359|NCT02668302|12214027|P1|NOT COMPLETED|Overall Study||1
4967360|NCT02668302|12214026|P2|COMPLETED|Overall Study||20
4967361|NCT02668302|12214027|P1|COMPLETED|Overall Study||19
4967362|NCT02668302|12214026|P2|STARTED|Overall Study||20
4967363|NCT02668302|12214027|P1|STARTED|Overall Study||20
4967364|NCT02668198|12214033|P1|NOT COMPLETED|Overall Study||0
4967365|NCT02668198|12214033|P1|COMPLETED|Overall Study||230
4967366|NCT02668198|12214033|P1|STARTED|Overall Study||230
4967367|NCT02667912|12214047|P2|NOT COMPLETED|Overall Study||3
4967368|NCT02667912|12214048|P1|NOT COMPLETED|Overall Study||5
4967369|NCT02667912|12214047|P2|COMPLETED|Overall Study||24
4967370|NCT02667912|12214048|P1|COMPLETED|Overall Study||23
4967371|NCT02667912|12214047|P2|Six Months|Overall Study||24
4967372|NCT02667912|12214048|P1|Six Months|Overall Study||27
4967373|NCT02667912|12214047|P2|STARTED|Overall Study||27
4967374|NCT02667912|12214048|P1|STARTED|Overall Study||28
4967375|NCT02667821|12214100|P1|NOT COMPLETED|Overall Study||0
4967376|NCT02667821|12214100|P1|COMPLETED|Overall Study||20
4967377|NCT02667821|12214100|P1|STARTED|Overall Study||20
4967378|NCT02667704|12214106|P1|NOT COMPLETED|Treatment Period 2||0
4967379|NCT02667704|12214106|P1|COMPLETED|Treatment Period 2||13
4967380|NCT02667704|12214106|P1|STARTED|Treatment Period 2||13
4967381|NCT02667704|12214106|P1|NOT COMPLETED|Treatment Period 1||0
4967382|NCT02667704|12214106|P1|COMPLETED|Treatment Period 1||13
4967383|NCT02667704|12214106|P1|STARTED|Treatment Period 1||13
4967384|NCT02667639|12214119|P2|NOT COMPLETED|Overall Study||0
4967385|NCT02667639|12214120|P1|NOT COMPLETED|Overall Study||0
4967386|NCT02667639|12214119|P2|COMPLETED|Overall Study||10
4967387|NCT02667639|12214120|P1|COMPLETED|Overall Study||25
4967388|NCT02667639|12214119|P2|STARTED|Overall Study||10
4967389|NCT02667639|12214120|P1|STARTED|Overall Study||25
4967390|NCT02667626|12214148|P2|NOT COMPLETED|Overall Study||1
4967391|NCT02667626|12214149|P1|NOT COMPLETED|Overall Study||0
4967392|NCT02667626|12214148|P2|COMPLETED|Overall Study||95
4967393|NCT02667626|12214149|P1|COMPLETED|Overall Study||86
4967394|NCT02667626|12214148|P2|STARTED|Overall Study||96
4967395|NCT02667626|12214149|P1|STARTED|Overall Study||86
4967396|NCT02667288|12214163|P1|NOT COMPLETED|Overall Study||13
4967397|NCT02667288|12214163|P1|COMPLETED|Overall Study||134
4967398|NCT02667288|12214163|P1|STARTED|Overall Study||147
4967399|NCT02667275|12214170|P2|NOT COMPLETED|Overall Study||15
4967400|NCT02667275|12214171|P1|NOT COMPLETED|Overall Study||11
4967401|NCT02667275|12214170|P2|COMPLETED|Overall Study||228
4967402|NCT02667275|12214171|P1|COMPLETED|Overall Study||233
4967403|NCT02667275|12214170|P2|STARTED|Overall Study||243
4967404|NCT02667275|12214171|P1|STARTED|Overall Study||244
4967405|NCT02667236|12214181|P2|NOT COMPLETED|Overall Study||1
4967406|NCT02667236|12214182|P1|NOT COMPLETED|Overall Study||3
4967407|NCT02667236|12214181|P2|COMPLETED|Overall Study||226
4967408|NCT02667236|12214182|P1|COMPLETED|Overall Study||220
4967409|NCT02667236|12214181|P2|STARTED|Overall Study||227
4967410|NCT02667236|12214182|P1|STARTED|Overall Study||223
4967411|NCT02666950|12214190|P1|NOT COMPLETED|Overall Study||0
4967412|NCT02666950|12214190|P1|COMPLETED|Overall Study||3
4967413|NCT02666950|12214190|P1|STARTED|Overall Study||3
4967414|NCT02666664|12214202|P2|NOT COMPLETED|Overall Study||84
4967415|NCT02666664|12214203|P1|NOT COMPLETED|Overall Study||36
4967416|NCT02666664|12214202|P2|COMPLETED|Overall Study||1404
4967417|NCT02666664|12214203|P1|COMPLETED|Overall Study||706
4967418|NCT02666664|12214202|P2|STARTED|Overall Study||1488
4967419|NCT02666664|12214203|P1|STARTED|Overall Study||742
4967420|NCT02666560|12214267|P2|NOT COMPLETED|Condition 2 (1 Day)||0
4967421|NCT02666560|12214268|P1|NOT COMPLETED|Condition 2 (1 Day)||0
4967422|NCT02666560|12214267|P2|COMPLETED|Condition 2 (1 Day)||11
4967423|NCT02666560|12214268|P1|COMPLETED|Condition 2 (1 Day)||8
4967424|NCT02666560|12214267|P2|STARTED|Condition 2 (1 Day)||11
4967425|NCT02666560|12214268|P1|STARTED|Condition 2 (1 Day)||8
4967426|NCT02666560|12214267|P2|NOT COMPLETED|Condition 1 (1 Day)||0
4967427|NCT02666560|12214268|P1|NOT COMPLETED|Condition 1 (1 Day)||0
4967428|NCT02666560|12214267|P2|COMPLETED|Condition 1 (1 Day)||11
4967429|NCT02666560|12214268|P1|COMPLETED|Condition 1 (1 Day)||8
4967430|NCT02666560|12214267|P2|STARTED|Condition 1 (1 Day)||11
4967431|NCT02666560|12214268|P1|STARTED|Condition 1 (1 Day)||8
4967432|NCT02666352|12214287|P3|NOT COMPLETED|Overall Study||0
4967433|NCT02666352|12214288|P2|NOT COMPLETED|Overall Study||0
4967434|NCT02666352|12214289|P1|NOT COMPLETED|Overall Study||0
4967435|NCT02666352|12214287|P3|COMPLETED|Overall Study||8
4967436|NCT02666352|12214288|P2|COMPLETED|Overall Study||8
4967437|NCT02666352|12214289|P1|COMPLETED|Overall Study||8
4967438|NCT02666352|12214287|P3|STARTED|Overall Study||8
4967439|NCT02666352|12214288|P2|STARTED|Overall Study||8
4967440|NCT02666352|12214289|P1|STARTED|Overall Study||8
4967441|NCT02666222|12214393|P1|NOT COMPLETED|Overall Study||2
4967442|NCT02666222|12214393|P1|COMPLETED|Overall Study||49
4967443|NCT02666222|12214393|P1|STARTED|Overall Study||51
4967444|NCT02665741|12214404|P3|NOT COMPLETED|Overall Study||0
4967445|NCT02665741|12214405|P2|NOT COMPLETED|Overall Study||0
4967446|NCT02665741|12214406|P1|NOT COMPLETED|Overall Study||0
4967447|NCT02665741|12214404|P3|COMPLETED|Overall Study||42
4967448|NCT02665741|12214405|P2|COMPLETED|Overall Study||42
4967449|NCT02665741|12214406|P1|COMPLETED|Overall Study||42
4967450|NCT02665741|12214404|P3|STARTED|Overall Study||42
4967451|NCT02665741|12214405|P2|STARTED|Overall Study||42
4967452|NCT02665741|12214406|P1|STARTED|Overall Study||42
4967453|NCT02665728|12214423|P1|NOT COMPLETED|Overall Study||0
4967454|NCT02665728|12214423|P1|COMPLETED|Overall Study||33
4967455|NCT02665728|12214423|P1|STARTED|Overall Study||33
4967456|NCT02665689|12214429|P2|NOT COMPLETED|Overall Study||2
4967457|NCT02665689|12214430|P1|NOT COMPLETED|Overall Study||2
4967458|NCT02665689|12214429|P2|COMPLETED|Overall Study||0
4967459|NCT02665689|12214430|P1|COMPLETED|Overall Study||0
4967460|NCT02665689|12214429|P2|STARTED|Overall Study||2
4967461|NCT02665689|12214430|P1|STARTED|Overall Study||2
4967462|NCT02665468|12214452|P2|NOT COMPLETED|Overall Study||0
4967463|NCT02665468|12214453|P1|NOT COMPLETED|Overall Study||0
4967464|NCT02665468|12214452|P2|COMPLETED|Overall Study||601
4967465|NCT02665468|12214453|P1|COMPLETED|Overall Study||595
4967466|NCT02665468|12214452|P2|STARTED|Overall Study||601
4967467|NCT02665468|12214453|P1|STARTED|Overall Study||595
4967468|NCT02665455|12214465|P1|NOT COMPLETED|Overall Study||9
4967469|NCT02665455|12214465|P1|COMPLETED|Overall Study||74
4967470|NCT02665455|12214465|P1|STARTED|Overall Study||83
4967471|NCT02665364|12214471|P2|NOT COMPLETED|Overall Study||9
4967472|NCT02665364|12214472|P1|NOT COMPLETED|Overall Study||6
4967473|NCT02665364|12214471|P2|COMPLETED|Overall Study||84
4967474|NCT02665364|12214472|P1|COMPLETED|Overall Study||85
4967475|NCT02665364|12214471|P2|STARTED|Overall Study||93
4967476|NCT02665364|12214472|P1|STARTED|Overall Study||91
4967477|NCT02665286|12214509|P3|NOT COMPLETED|Overall Study||1
4967478|NCT02665286|12214510|P2|NOT COMPLETED|Overall Study||2
4967479|NCT02665286|12214511|P1|NOT COMPLETED|Overall Study||3
4967480|NCT02665286|12214509|P3|COMPLETED|Overall Study||80
4967481|NCT02665286|12214510|P2|COMPLETED|Overall Study||78
4967482|NCT02665286|12214511|P1|COMPLETED|Overall Study||76
4967483|NCT02665286|12214509|P3|STARTED|Overall Study||81
4967484|NCT02665286|12214510|P2|STARTED|Overall Study||80
4967485|NCT02665286|12214511|P1|STARTED|Overall Study||79
4967486|NCT02665260|12214532|P4|NOT COMPLETED|Overall Study||1
4967487|NCT02665260|12214533|P3|NOT COMPLETED|Overall Study||4
4967488|NCT02665260|12214534|P2|NOT COMPLETED|Overall Study||1
4967489|NCT02665260|12214535|P1|NOT COMPLETED|Overall Study||2
4967490|NCT02665260|12214532|P4|COMPLETED|Overall Study||21
4967491|NCT02665260|12214533|P3|COMPLETED|Overall Study||21
4967492|NCT02665260|12214534|P2|COMPLETED|Overall Study||22
4967493|NCT02665260|12214535|P1|COMPLETED|Overall Study||22
4967494|NCT02665260|12214532|P4|STARTED|Overall Study||22
4967495|NCT02665260|12214533|P3|STARTED|Overall Study||25
4967496|NCT02665260|12214534|P2|STARTED|Overall Study||23
4967497|NCT02665260|12214535|P1|STARTED|Overall Study||24
4967498|NCT02665221|12214551|P2|NOT COMPLETED|Overall Study||15
4967499|NCT02665221|12214552|P1|NOT COMPLETED|Overall Study||15
4967500|NCT02665221|12214551|P2|COMPLETED|Overall Study||0
4967501|NCT02665221|12214552|P1|COMPLETED|Overall Study||0
4967502|NCT02665221|12214551|P2|STARTED|Overall Study||15
4967503|NCT02665221|12214552|P1|STARTED|Overall Study||15
4967504|NCT02664987|12214564|P1|NOT COMPLETED|Overall Study||0
4967505|NCT02664987|12214564|P1|COMPLETED|Overall Study||462
4967506|NCT02664987|12214564|P1|STARTED|Overall Study||462
4967507|NCT02664961|12214573|P1|NOT COMPLETED|Overall Study||0
4967508|NCT02664961|12214573|P1|COMPLETED|Overall Study||3
4967509|NCT02664961|12214573|P1|STARTED|Overall Study||3
4967510|NCT02664610|12214584|P2|NOT COMPLETED|Overall Study||7
4967511|NCT02664610|12214585|P1|NOT COMPLETED|Overall Study||14
4967512|NCT02664610|12214584|P2|COMPLETED|Overall Study||41
4967513|NCT02664610|12214585|P1|COMPLETED|Overall Study||32
4967514|NCT02664610|12214584|P2|STARTED|Overall Study||48
4967515|NCT02664610|12214585|P1|STARTED|Overall Study||46
4967516|NCT02664532|12214595|P2|NOT COMPLETED|Overall Study||0
4967517|NCT02664532|12214596|P1|NOT COMPLETED|Overall Study||0
4967518|NCT02664532|12214595|P2|COMPLETED|Overall Study||75
4967519|NCT02664532|12214596|P1|COMPLETED|Overall Study||75
4967520|NCT02664532|12214595|P2|STARTED|Overall Study||75
4967521|NCT02664532|12214596|P1|STARTED|Overall Study||75
4967522|NCT02664415|12214610|P2|NOT COMPLETED|Overall Study||0
4967523|NCT02664415|12214611|P1|NOT COMPLETED|Overall Study||1
4967524|NCT02664415|12214610|P2|COMPLETED|Overall Study||5
4967525|NCT02664415|12214611|P1|COMPLETED|Overall Study||13
4967526|NCT02664415|12214610|P2|STARTED|Overall Study||5
4967527|NCT02664415|12214611|P1|STARTED|Overall Study||14
4967528|NCT02664363|12214639|P1|NOT COMPLETED|Overall Study||0
4967529|NCT02664363|12214639|P1|COMPLETED|Overall Study||3
4967530|NCT02664363|12214639|P1|STARTED|Overall Study||3
4967531|NCT02664311|12214646|P2|NOT COMPLETED|Overall Study||0
4967532|NCT02664311|12214647|P1|NOT COMPLETED|Overall Study||0
4967533|NCT02664311|12214646|P2|COMPLETED|Overall Study||3
4967534|NCT02664311|12214647|P1|COMPLETED|Overall Study||6
4967535|NCT02664311|12214646|P2|STARTED|Overall Study||3
4967536|NCT02664311|12214647|P1|STARTED|Overall Study||6
4967537|NCT02664272|12214657|P1|NOT COMPLETED|Overall Study||2
4967538|NCT02664272|12214657|P1|COMPLETED|Overall Study||38
4967539|NCT02664272|12214657|P1|STARTED|Overall Study||40
4967540|NCT02664220|12214665|P2|NOT COMPLETED|Overall Study||0
4967541|NCT02664220|12214666|P1|NOT COMPLETED|Overall Study||0
4967542|NCT02664220|12214665|P2|COMPLETED|Overall Study||50
4967543|NCT02664220|12214666|P1|COMPLETED|Overall Study||50
4967544|NCT02664220|12214665|P2|STARTED|Overall Study||50
4967545|NCT02664220|12214666|P1|STARTED|Overall Study||50
4967546|NCT02663817|12214678|P1|NOT COMPLETED|Overall Study||2
4967547|NCT02663817|12214678|P1|COMPLETED|Overall Study||50
4967548|NCT02663817|12214678|P1|STARTED|Overall Study||52
4967549|NCT02663752|12214684|P1|NOT COMPLETED|Overall Study||0
4967550|NCT02663752|12214684|P1|COMPLETED|Overall Study||1
4967551|NCT02663752|12214684|P1|STARTED|Overall Study||1
4967552|NCT02663687|12214698|P5|NOT COMPLETED|Overall Study||0
4967553|NCT02663687|12214699|P4|NOT COMPLETED|Overall Study||0
4967554|NCT02663687|12214700|P3|NOT COMPLETED|Overall Study||1
4967555|NCT02663687|12214701|P2|NOT COMPLETED|Overall Study||0
4967556|NCT02663687|12214702|P1|NOT COMPLETED|Overall Study||2
4967557|NCT02663687|12214698|P5|COMPLETED|Overall Study||9
4967558|NCT02663687|12214699|P4|COMPLETED|Overall Study||9
4967559|NCT02663687|12214700|P3|COMPLETED|Overall Study||8
4967560|NCT02663687|12214701|P2|COMPLETED|Overall Study||9
4967561|NCT02663687|12214702|P1|COMPLETED|Overall Study||10
4967562|NCT02663687|12214698|P5|Treatment Period 2 (SC)|Overall Study||9
4967563|NCT02663687|12214699|P4|Treatment Period 2 (SC)|Overall Study||9
4967564|NCT02663687|12214700|P3|Treatment Period 2 (SC)|Overall Study||8
4967565|NCT02663687|12214701|P2|Treatment Period 2 (SC)|Overall Study||9
4967566|NCT02663687|12214702|P1|Treatment Period 2 (SC)|Overall Study||10
4967567|NCT02663687|12214698|P5|Treatment Period 1 (IV)|Overall Study||9
4967568|NCT02663687|12214699|P4|Treatment Period 1 (IV)|Overall Study||9
4967569|NCT02663687|12214700|P3|Treatment Period 1 (IV)|Overall Study||9
4967570|NCT02663687|12214701|P2|Treatment Period 1 (IV)|Overall Study||9
4967571|NCT02663687|12214702|P1|Treatment Period 1 (IV)|Overall Study||12
4967572|NCT02663687|12214698|P5|STARTED|Overall Study||9
4967573|NCT02663687|12214699|P4|STARTED|Overall Study||9
4967574|NCT02663687|12214700|P3|STARTED|Overall Study||9
4967575|NCT02663687|12214701|P2|STARTED|Overall Study||9
4967576|NCT02663687|12214702|P1|STARTED|Overall Study||12
4967577|NCT02663674|12214756|P2|NOT COMPLETED|Overall Study||10
4967578|NCT02663674|12214757|P1|NOT COMPLETED|Overall Study||7
4967579|NCT02663674|12214756|P2|COMPLETED|Overall Study||29
4967580|NCT02663674|12214757|P1|COMPLETED|Overall Study||26
4967581|NCT02663674|12214756|P2|STARTED|Overall Study||39
4967582|NCT02663674|12214757|P1|STARTED|Overall Study||33
4967583|NCT02663453|12215021|P2|NOT COMPLETED|Overall Study||4
4967584|NCT02663453|12215022|P1|NOT COMPLETED|Overall Study||5
4967585|NCT02663453|12215021|P2|COMPLETED|Overall Study||18
4967586|NCT02663453|12215022|P1|COMPLETED|Overall Study||17
4967587|NCT02663453|12215021|P2|STARTED|Overall Study||22
4967588|NCT02663453|12215022|P1|STARTED|Overall Study||22
4967589|NCT02663232|12215044|P1|NOT COMPLETED|Overall Study||0
4967590|NCT02663232|12215044|P1|COMPLETED|Overall Study||264
4967591|NCT02663232|12215044|P1|STARTED|Overall Study||264
4967592|NCT02663128|12215067|P6|NOT COMPLETED|Period 3||0
4967593|NCT02663128|12215068|P5|NOT COMPLETED|Period 3||0
4967594|NCT02663128|12215069|P4|NOT COMPLETED|Period 3||0
4967595|NCT02663128|12215070|P3|NOT COMPLETED|Period 3||0
4967596|NCT02663128|12215071|P2|NOT COMPLETED|Period 3||0
4967597|NCT02663128|12215072|P1|NOT COMPLETED|Period 3||0
4967598|NCT02663128|12215067|P6|COMPLETED|Period 3||3
4967599|NCT02663128|12215068|P5|COMPLETED|Period 3||2
4967600|NCT02663128|12215069|P4|COMPLETED|Period 3||3
4967601|NCT02663128|12215070|P3|COMPLETED|Period 3||3
4967602|NCT02663128|12215071|P2|COMPLETED|Period 3||3
4967603|NCT02663128|12215072|P1|COMPLETED|Period 3||3
4967604|NCT02663128|12215067|P6|STARTED|Period 3||3
4967605|NCT02663128|12215068|P5|STARTED|Period 3||2
4967606|NCT02663128|12215069|P4|STARTED|Period 3||3
4967607|NCT02663128|12215070|P3|STARTED|Period 3||3
4967608|NCT02663128|12215071|P2|STARTED|Period 3||3
4967609|NCT02663128|12215072|P1|STARTED|Period 3||3
4967610|NCT02663128|12215067|P6|NOT COMPLETED|Period 2||0
4967611|NCT02663128|12215068|P5|NOT COMPLETED|Period 2||1
4967612|NCT02663128|12215069|P4|NOT COMPLETED|Period 2||0
4967613|NCT02663128|12215070|P3|NOT COMPLETED|Period 2||0
4967614|NCT02663128|12215071|P2|NOT COMPLETED|Period 2||0
4967615|NCT02663128|12215072|P1|NOT COMPLETED|Period 2||0
4967616|NCT02663128|12215067|P6|COMPLETED|Period 2||3
4967617|NCT02663128|12215068|P5|COMPLETED|Period 2||2
4967618|NCT02663128|12215069|P4|COMPLETED|Period 2||3
4967619|NCT02663128|12215070|P3|COMPLETED|Period 2||3
4967620|NCT02663128|12215071|P2|COMPLETED|Period 2||3
4967621|NCT02663128|12215072|P1|COMPLETED|Period 2||3
4967622|NCT02663128|12215067|P6|STARTED|Period 2||3
4967623|NCT02663128|12215068|P5|STARTED|Period 2||3
4967624|NCT02663128|12215069|P4|STARTED|Period 2||3
4967625|NCT02663128|12215070|P3|STARTED|Period 2||3
4967626|NCT02663128|12215071|P2|STARTED|Period 2||3
4967627|NCT02663128|12215072|P1|STARTED|Period 2||3
4967628|NCT02663128|12215067|P6|NOT COMPLETED|Period 1||0
4967629|NCT02663128|12215068|P5|NOT COMPLETED|Period 1||0
4967630|NCT02663128|12215069|P4|NOT COMPLETED|Period 1||0
4967631|NCT02663128|12215070|P3|NOT COMPLETED|Period 1||0
4967632|NCT02663128|12215071|P2|NOT COMPLETED|Period 1||0
4967633|NCT02663128|12215072|P1|NOT COMPLETED|Period 1||0
4967634|NCT02663128|12215067|P6|COMPLETED|Period 1||3
4967635|NCT02663128|12215068|P5|COMPLETED|Period 1||3
4967636|NCT02663128|12215069|P4|COMPLETED|Period 1||3
4967637|NCT02663128|12215070|P3|COMPLETED|Period 1||3
4967638|NCT02663128|12215071|P2|COMPLETED|Period 1||3
4967639|NCT02663128|12215072|P1|COMPLETED|Period 1||3
4967640|NCT02663128|12215067|P6|Received at Least One Dose of Study Drug|Period 1||3
4967641|NCT02663128|12215068|P5|Received at Least One Dose of Study Drug|Period 1||3
4967642|NCT02663128|12215069|P4|Received at Least One Dose of Study Drug|Period 1||3
4967643|NCT02663128|12215070|P3|Received at Least One Dose of Study Drug|Period 1||3
4967644|NCT02663128|12215071|P2|Received at Least One Dose of Study Drug|Period 1||3
4967645|NCT02663128|12215072|P1|Received at Least One Dose of Study Drug|Period 1||3
4967646|NCT02663128|12215067|P6|STARTED|Period 1||3
4967647|NCT02663128|12215068|P5|STARTED|Period 1||3
4967648|NCT02663128|12215069|P4|STARTED|Period 1||3
4967649|NCT02663128|12215070|P3|STARTED|Period 1||3
4967650|NCT02663128|12215071|P2|STARTED|Period 1||3
4967651|NCT02663128|12215072|P1|STARTED|Period 1||3
4967652|NCT02662764|12215086|P1|NOT COMPLETED|Overall Study||30
4967653|NCT02662764|12215086|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
4967654|NCT02662764|12215086|P1|STARTED|Overall Study||320
4967655|NCT02662608|12215146|P1|NOT COMPLETED|Overall Study||0
4967656|NCT02662608|12215146|P1|COMPLETED|Overall Study||1
4967657|NCT02662608|12215146|P1|STARTED|Overall Study||1
4967658|NCT02662569|12215154|P4|NOT COMPLETED|Overall Study||4
4967659|NCT02662569|12215155|P3|NOT COMPLETED|Overall Study||6
4967660|NCT02662569|12215156|P2|NOT COMPLETED|Overall Study||1
4967661|NCT02662569|12215157|P1|NOT COMPLETED|Overall Study||7
4967662|NCT02662569|12215154|P4|COMPLETED|Overall Study||328
4967663|NCT02662569|12215155|P3|COMPLETED|Overall Study||321
4967664|NCT02662569|12215156|P2|COMPLETED|Overall Study||160
4967665|NCT02662569|12215157|P1|COMPLETED|Overall Study||159
4967666|NCT02662569|12215154|P4|Received Study Drug|Overall Study||332
4967667|NCT02662569|12215155|P3|Received Study Drug|Overall Study||325
4967668|NCT02662569|12215156|P2|Received Study Drug|Overall Study||160
4967669|NCT02662569|12215157|P1|Received Study Drug|Overall Study||164
4967670|NCT02662569|12215154|P4|STARTED|Overall Study||332
4967671|NCT02662569|12215155|P3|STARTED|Overall Study||327
4967672|NCT02662569|12215156|P2|STARTED|Overall Study||161
4967673|NCT02662569|12215157|P1|STARTED|Overall Study||166
4967674|NCT02662556|12215255|P1|NOT COMPLETED|Overall Study||8
4967675|NCT02662556|12215255|P1|COMPLETED|Overall Study||132
4967676|NCT02662556|12215255|P1|STARTED|Overall Study||140
4967677|NCT02662387|12215264|P2|NOT COMPLETED|Overall Study||0
4967678|NCT02662387|12215265|P1|NOT COMPLETED|Overall Study||0
4967679|NCT02662387|12215264|P2|COMPLETED|Overall Study||28
4967680|NCT02662387|12215265|P1|COMPLETED|Overall Study||27
4967681|NCT02662387|12215264|P2|STARTED|Overall Study||28
4967682|NCT02662387|12215265|P1|STARTED|Overall Study||27
4967683|NCT02662244|12215273|P1|NOT COMPLETED|Overall Study||2
4967684|NCT02662244|12215273|P1|COMPLETED|Overall Study||31
4967685|NCT02662244|12215273|P1|STARTED|Overall Study||33
4967686|NCT02662036|12215283|P2|NOT COMPLETED|Overall Study||13
4967687|NCT02662036|12215284|P1|NOT COMPLETED|Overall Study||13
4967688|NCT02662036|12215283|P2|COMPLETED|Overall Study||22
4967689|NCT02662036|12215284|P1|COMPLETED|Overall Study||22
4967690|NCT02662036|12215283|P2|STARTED|Overall Study||35
4967691|NCT02662036|12215284|P1|STARTED|Overall Study||35
4967692|NCT02661828|12215312|P2|NOT COMPLETED|Overall Study||0
4967693|NCT02661828|12215313|P1|NOT COMPLETED|Overall Study||0
4967694|NCT02661828|12215312|P2|COMPLETED|Overall Study||0
4967695|NCT02661828|12215313|P1|COMPLETED|Overall Study||1
4967696|NCT02661828|12215312|P2|STARTED|Overall Study||0
4967697|NCT02661828|12215313|P1|STARTED|Overall Study||1
4967698|NCT02661815|12215324|P4|NOT COMPLETED|Overall Study||0
4967699|NCT02661815|12215325|P3|NOT COMPLETED|Overall Study||0
4967700|NCT02661815|12215326|P2|NOT COMPLETED|Overall Study||0
4967701|NCT02661815|12215327|P1|NOT COMPLETED|Overall Study||1
4967702|NCT02661815|12215324|P4|COMPLETED|Overall Study||0
4967703|NCT02661815|12215325|P3|COMPLETED|Overall Study||0
4967704|NCT02661815|12215326|P2|COMPLETED|Overall Study||0
4967705|NCT02661815|12215327|P1|COMPLETED|Overall Study||5
4967706|NCT02661815|12215324|P4|STARTED|Overall Study||0
4967707|NCT02661815|12215325|P3|STARTED|Overall Study||0
4967708|NCT02661815|12215326|P2|STARTED|Overall Study||0
4967709|NCT02661815|12215327|P1|STARTED|Overall Study||6
4967710|NCT02661737|12215341|P1|NOT COMPLETED|Overall Study||34
4967711|NCT02661737|12215341|P1|COMPLETED|Overall Study||469
4967712|NCT02661737|12215341|P1|STARTED|Overall Study||503
4967713|NCT02661594|12215349|P4|NOT COMPLETED|Overall Study||0
4967714|NCT02661594|12215350|P3|NOT COMPLETED|Overall Study||1
4967715|NCT02661594|12215351|P2|NOT COMPLETED|Overall Study||0
4967716|NCT02661594|12215352|P1|NOT COMPLETED|Overall Study||1
4967717|NCT02661594|12215349|P4|COMPLETED|Overall Study||9
4967718|NCT02661594|12215350|P3|COMPLETED|Overall Study||9
4967719|NCT02661594|12215351|P2|COMPLETED|Overall Study||11
4967720|NCT02661594|12215352|P1|COMPLETED|Overall Study||9
4967721|NCT02661594|12215349|P4|STARTED|Overall Study||9
4967722|NCT02661594|12215350|P3|STARTED|Overall Study||10
4967723|NCT02661594|12215351|P2|STARTED|Overall Study||11
4967724|NCT02661594|12215352|P1|STARTED|Overall Study||10
4967725|NCT02661490|12215367|P5|NOT COMPLETED|Overall Study||3
4967726|NCT02661490|12215368|P4|NOT COMPLETED|Overall Study||1
4967727|NCT02661490|12215369|P3|NOT COMPLETED|Overall Study||2
4967728|NCT02661490|12215370|P2|NOT COMPLETED|Overall Study||2
4967729|NCT02661490|12215371|P1|NOT COMPLETED|Overall Study||3
4967730|NCT02661490|12215367|P5|COMPLETED|Overall Study||23
4967731|NCT02661490|12215368|P4|COMPLETED|Overall Study||71
4967732|NCT02661490|12215369|P3|COMPLETED|Overall Study||70
4967733|NCT02661490|12215370|P2|COMPLETED|Overall Study||72
4967734|NCT02661490|12215371|P1|COMPLETED|Overall Study||73
4967735|NCT02661490|12215367|P5|STARTED|Overall Study||26
4967736|NCT02661490|12215368|P4|STARTED|Overall Study||72
4967737|NCT02661490|12215369|P3|STARTED|Overall Study||72
4967738|NCT02661490|12215370|P2|STARTED|Overall Study||74
4967739|NCT02661490|12215371|P1|STARTED|Overall Study||76
4967740|NCT02661256|12215508|P1|NOT COMPLETED|Overall Study||0
4967741|NCT02661256|12215508|P1|COMPLETED|Overall Study||7
4967742|NCT02661256|12215508|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
4967743|NCT02661178|12215539|P15|NOT COMPLETED|Part 2||0
4967744|NCT02661178|12215540|P14|NOT COMPLETED|Part 2||0
4967745|NCT02661178|12215541|P13|NOT COMPLETED|Part 2||0
4967746|NCT02661178|12215542|P12|NOT COMPLETED|Part 2||0
4967747|NCT02661178|12215543|P11|NOT COMPLETED|Part 2||0
4967748|NCT02661178|12215544|P10|NOT COMPLETED|Part 2||0
4967749|NCT02661178|12215545|P9|NOT COMPLETED|Part 2||0
4967750|NCT02661178|12215546|P8|NOT COMPLETED|Part 2||0
4967751|NCT02661178|12215547|P7|NOT COMPLETED|Part 2||0
4967752|NCT02661178|12215548|P6|NOT COMPLETED|Part 2||0
4967753|NCT02661178|12215549|P5|NOT COMPLETED|Part 2||0
4967754|NCT02661178|12215550|P4|NOT COMPLETED|Part 2||0
4967755|NCT02661178|12215551|P3|NOT COMPLETED|Part 2||0
4967756|NCT02661178|12215552|P2|NOT COMPLETED|Part 2||0
4967757|NCT02661178|12215553|P1|NOT COMPLETED|Part 2||0
4967758|NCT02661178|12215539|P15|COMPLETED|Part 2||2
4967759|NCT02661178|12215540|P14|COMPLETED|Part 2||2
4967760|NCT02661178|12215541|P13|COMPLETED|Part 2||6
4967761|NCT02661178|12215542|P12|COMPLETED|Part 2||6
4967762|NCT02661178|12215543|P11|COMPLETED|Part 2||0
4967763|NCT02661178|12215544|P10|COMPLETED|Part 2||0
4967764|NCT02661178|12215545|P9|COMPLETED|Part 2||0
4967765|NCT02661178|12215546|P8|COMPLETED|Part 2||0
4967766|NCT02661178|12215547|P7|COMPLETED|Part 2||0
4967767|NCT02661178|12215548|P6|COMPLETED|Part 2||0
4967768|NCT02661178|12215549|P5|COMPLETED|Part 2||0
4967769|NCT02661178|12215550|P4|COMPLETED|Part 2||0
4967770|NCT02661178|12215551|P3|COMPLETED|Part 2||0
4967771|NCT02661178|12215552|P2|COMPLETED|Part 2||0
4967772|NCT02661178|12215553|P1|COMPLETED|Part 2||0
4967773|NCT02661178|12215539|P15|STARTED|Part 2||2
4967774|NCT02661178|12215540|P14|STARTED|Part 2||2
4967775|NCT02661178|12215541|P13|STARTED|Part 2||6
4967776|NCT02661178|12215542|P12|STARTED|Part 2||6
4967777|NCT02661178|12215543|P11|STARTED|Part 2||0
4967778|NCT02661178|12215544|P10|STARTED|Part 2||0
4967779|NCT02661178|12215545|P9|STARTED|Part 2||0
4967780|NCT02661178|12215546|P8|STARTED|Part 2||0
4967781|NCT02661178|12215547|P7|STARTED|Part 2||0
4967782|NCT02661178|12215548|P6|STARTED|Part 2||0
4967783|NCT02661178|12215549|P5|STARTED|Part 2||0
4967784|NCT02661178|12215550|P4|STARTED|Part 2||0
4967785|NCT02661178|12215551|P3|STARTED|Part 2||0
4967786|NCT02661178|12215552|P2|STARTED|Part 2||0
4967787|NCT02661178|12215553|P1|STARTED|Part 2||0
4967788|NCT02661178|12215539|P15|NOT COMPLETED|Part 1||0
4967789|NCT02661178|12215540|P14|NOT COMPLETED|Part 1||0
4967790|NCT02661178|12215541|P13|NOT COMPLETED|Part 1||0
4967791|NCT02661178|12215542|P12|NOT COMPLETED|Part 1||0
4967792|NCT02661178|12215543|P11|NOT COMPLETED|Part 1||0
4967793|NCT02661178|12215544|P10|NOT COMPLETED|Part 1||0
4967794|NCT02661178|12215545|P9|NOT COMPLETED|Part 1||0
4967795|NCT02661178|12215546|P8|NOT COMPLETED|Part 1||0
4967796|NCT02661178|12215547|P7|NOT COMPLETED|Part 1||0
4967797|NCT02661178|12215548|P6|NOT COMPLETED|Part 1||0
4967798|NCT02661178|12215549|P5|NOT COMPLETED|Part 1||0
4967799|NCT02661178|12215550|P4|NOT COMPLETED|Part 1||0
4967800|NCT02661178|12215551|P3|NOT COMPLETED|Part 1||0
4967801|NCT02661178|12215552|P2|NOT COMPLETED|Part 1||0
4967802|NCT02661178|12215553|P1|NOT COMPLETED|Part 1||1
4967803|NCT02661178|12215539|P15|COMPLETED|Part 1||0
4967804|NCT02661178|12215540|P14|COMPLETED|Part 1||0
4967805|NCT02661178|12215541|P13|COMPLETED|Part 1||0
4967806|NCT02661178|12215542|P12|COMPLETED|Part 1||0
4967807|NCT02661178|12215543|P11|COMPLETED|Part 1||4
4967808|NCT02661178|12215544|P10|COMPLETED|Part 1||12
4967809|NCT02661178|12215545|P9|COMPLETED|Part 1||6
4967810|NCT02661178|12215546|P8|COMPLETED|Part 1||6
4967811|NCT02661178|12215547|P7|COMPLETED|Part 1||6
4967812|NCT02661178|12215548|P6|COMPLETED|Part 1||6
4967813|NCT02661178|12215549|P5|COMPLETED|Part 1||5
4967814|NCT02661178|12215550|P4|COMPLETED|Part 1||6
4967815|NCT02661178|12215551|P3|COMPLETED|Part 1||6
4967816|NCT02661178|12215552|P2|COMPLETED|Part 1||5
4967817|NCT02661178|12215553|P1|COMPLETED|Part 1||0
4967818|NCT02661178|12215539|P15|STARTED|Part 1||0
4967819|NCT02661178|12215540|P14|STARTED|Part 1||0
4967820|NCT02661178|12215541|P13|STARTED|Part 1||0
4967821|NCT02661178|12215542|P12|STARTED|Part 1||0
4967822|NCT02661178|12215543|P11|STARTED|Part 1||4
4967823|NCT02661178|12215544|P10|STARTED|Part 1||12
4967824|NCT02661178|12215545|P9|STARTED|Part 1||6
4967825|NCT02661178|12215546|P8|STARTED|Part 1||6
4967826|NCT02661178|12215547|P7|STARTED|Part 1||6
4967827|NCT02661178|12215548|P6|STARTED|Part 1||6
4967828|NCT02661178|12215549|P5|STARTED|Part 1||5
4967829|NCT02661178|12215550|P4|STARTED|Part 1||6
4967830|NCT02661178|12215551|P3|STARTED|Part 1||6
4967831|NCT02661178|12215552|P2|STARTED|Part 1||5
4967832|NCT02661178|12215553|P1|STARTED|Part 1||1
4967833|NCT02661126|12215820|P2|NOT COMPLETED|Overall Study||0
4967834|NCT02661126|12215821|P1|NOT COMPLETED|Overall Study||0
4967835|NCT02661126|12215820|P2|COMPLETED|Overall Study||8
4967836|NCT02661126|12215821|P1|COMPLETED|Overall Study||8
4967837|NCT02661126|12215820|P2|STARTED|Overall Study||8
4967838|NCT02661126|12215821|P1|STARTED|Overall Study||8
4967839|NCT02661061|12215911|P2|NOT COMPLETED|Overall Study||2
4967840|NCT02661061|12215912|P1|NOT COMPLETED|Overall Study||2
4967841|NCT02661061|12215911|P2|COMPLETED|Overall Study||2
4967842|NCT02661061|12215912|P1|COMPLETED|Overall Study||3
4967843|NCT02661061|12215911|P2|STARTED|Overall Study||4
4967844|NCT02661061|12215912|P1|STARTED|Overall Study||5
4967845|NCT02660983|12215922|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
4967846|NCT02660983|12215923|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
4967847|NCT02660983|12215922|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
4967848|NCT02660983|12215923|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
4967849|NCT02660983|12215922|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
4967850|NCT02660983|12215923|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
4967851|NCT02660983|12215922|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
4967852|NCT02660983|12215923|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
4967853|NCT02660983|12215922|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
4967854|NCT02660983|12215923|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
4967855|NCT02660983|12215922|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
4967856|NCT02660983|12215923|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
4967857|NCT02660983|12215922|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
4967858|NCT02660983|12215923|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
4967859|NCT02660983|12215922|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
4967860|NCT02660983|12215923|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
4967861|NCT02660918|12215938|P2|NOT COMPLETED|Overall Study||1
4967862|NCT02660918|12215939|P1|NOT COMPLETED|Overall Study||1
4967863|NCT02660918|12215938|P2|COMPLETED|Overall Study|Age ineligible|41
4967864|NCT02660918|12215939|P1|COMPLETED|Overall Study|Age ineligible|41
4967865|NCT02660918|12215938|P2|STARTED|Overall Study||42
4967866|NCT02660918|12215939|P1|STARTED|Overall Study||42
4967867|NCT02660853|12215961|P1|NOT COMPLETED|Overall Study||0
4967868|NCT02660853|12215961|P1|COMPLETED|Overall Study||25
4967869|NCT02660853|12215961|P1|STARTED|Overall Study||25
4967870|NCT02660827|12215974|P1|NOT COMPLETED|2-6 Years Old Age Group||1
4967871|NCT02660827|12215974|P1|COMPLETED|2-6 Years Old Age Group||45
4967872|NCT02660827|12215974|P1|STARTED|2-6 Years Old Age Group||46
4967873|NCT02660827|12215974|P1|NOT COMPLETED|7-13 Years Old Age Group||0
4967874|NCT02660827|12215974|P1|COMPLETED|7-13 Years Old Age Group||105
4967875|NCT02660827|12215974|P1|STARTED|7-13 Years Old Age Group||105
4967876|NCT02660801|12215991|P2|NOT COMPLETED|Overall Study||0
4967877|NCT02660801|12215992|P1|NOT COMPLETED|Overall Study||0
4967878|NCT02660801|12215991|P2|COMPLETED|Overall Study||15
4967879|NCT02660801|12215992|P1|COMPLETED|Overall Study||11
4967880|NCT02660801|12215991|P2|STARTED|Overall Study||15
4967881|NCT02660801|12215992|P1|STARTED|Overall Study||11
4967882|NCT02660580|12216008|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
4967883|NCT02660580|12216009|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
4967884|NCT02660580|12216010|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
4967885|NCT02660580|12216011|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
4967886|NCT02660580|12216012|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
4967887|NCT02660580|12216008|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
4967888|NCT02660580|12216009|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
4967889|NCT02660580|12216010|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
4967890|NCT02660580|12216011|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
4967891|NCT02660580|12216012|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
4967892|NCT02660580|12216008|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
4967893|NCT02660580|12216009|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
4967894|NCT02660580|12216010|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
4967895|NCT02660580|12216011|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
4967896|NCT02660580|12216012|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
4967897|NCT02660580|12216008|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967898|NCT02660580|12216009|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967899|NCT02660580|12216010|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967900|NCT02660580|12216011|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
4967901|NCT02660580|12216012|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
4967902|NCT02660580|12216008|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967903|NCT02660580|12216009|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967904|NCT02660580|12216010|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
4967905|NCT02660580|12216011|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
4967906|NCT02660580|12216012|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
4967907|NCT02660580|12216008|P5|Treated|Core Treatment Period (Week 1 to 16)||0
4967908|NCT02660580|12216009|P4|Treated|Core Treatment Period (Week 1 to 16)||0
4967909|NCT02660580|12216010|P3|Treated|Core Treatment Period (Week 1 to 16)||0
4967910|NCT02660580|12216011|P2|Treated|Core Treatment Period (Week 1 to 16)||220
4967911|NCT02660580|12216012|P1|Treated|Core Treatment Period (Week 1 to 16)||221
4967912|NCT02660580|12216008|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
4967913|NCT02660580|12216009|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
4967914|NCT02660580|12216010|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
4967915|NCT02660580|12216011|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
4967916|NCT02660580|12216012|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
4967917|NCT02660242|12216121|P1|NOT COMPLETED|Glucagon Injection||1
4967918|NCT02660242|12216121|P1|COMPLETED|Glucagon Injection||15
4967919|NCT02660242|12216121|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
4967920|NCT02660242|12216121|P1|NOT COMPLETED|Glucose Tabs||1
4967921|NCT02660242|12216121|P1|COMPLETED|Glucose Tabs||15
4967922|NCT02660242|12216121|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
4967923|NCT02660242|12216121|P1|NOT COMPLETED|Basal Insulin Reduction||0
4967924|NCT02660242|12216121|P1|COMPLETED|Basal Insulin Reduction||16
4967925|NCT02660242|12216121|P1|STARTED|Basal Insulin Reduction||16
4967926|NCT02660242|12216121|P1|NOT COMPLETED|Control||0
4967927|NCT02660242|12216121|P1|COMPLETED|Control||16
4967928|NCT02660242|12216121|P1|STARTED|Control||16
4967929|NCT02660229|12216177|P2|NOT COMPLETED|Overall Study||1
4967930|NCT02660229|12216178|P1|NOT COMPLETED|Overall Study||2
4967931|NCT02660229|12216177|P2|COMPLETED|Overall Study||31
4967932|NCT02660229|12216178|P1|COMPLETED|Overall Study||32
4967933|NCT02660229|12216177|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
4967934|NCT02660229|12216178|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
4967935|NCT02660229|12216177|P2|FAS Set|Overall Study||32
4967936|NCT02660229|12216178|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
4967937|NCT02660229|12216177|P2|Safety Analysis Set|Overall Study||32
4967938|NCT02660229|12216178|P1|Safety Analysis Set|Overall Study||34
4967939|NCT02660229|12216177|P2|STARTED|Overall Study|Randomization|32
4967940|NCT02660229|12216178|P1|STARTED|Overall Study|Randomization|34
4967941|NCT02660112|12216190|P1|NOT COMPLETED|Overall Study||0
4967942|NCT02660112|12216190|P1|COMPLETED|Overall Study||10
4967943|NCT02660112|12216190|P1|STARTED|Overall Study||10
4967944|NCT02659787|12216195|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4967945|NCT02659787|12216196|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4967946|NCT02659787|12216195|P2|COMPLETED|Second Intervention (1 Day)||19
4967947|NCT02659787|12216196|P1|COMPLETED|Second Intervention (1 Day)||19
4967948|NCT02659787|12216195|P2|STARTED|Second Intervention (1 Day)||19
4967949|NCT02659787|12216196|P1|STARTED|Second Intervention (1 Day)||19
4967950|NCT02659787|12216195|P2|NOT COMPLETED|Washout (3 Days)||0
4967951|NCT02659787|12216196|P1|NOT COMPLETED|Washout (3 Days)||0
4967952|NCT02659787|12216195|P2|COMPLETED|Washout (3 Days)||19
4967953|NCT02659787|12216196|P1|COMPLETED|Washout (3 Days)||19
4967954|NCT02659787|12216195|P2|STARTED|Washout (3 Days)||19
4967955|NCT02659787|12216196|P1|STARTED|Washout (3 Days)||19
4967956|NCT02659787|12216195|P2|NOT COMPLETED|First Intervention (1 Day)||0
4967957|NCT02659787|12216196|P1|NOT COMPLETED|First Intervention (1 Day)||0
4967958|NCT02659787|12216195|P2|COMPLETED|First Intervention (1 Day)||19
4967959|NCT02659787|12216196|P1|COMPLETED|First Intervention (1 Day)||19
4967960|NCT02659787|12216195|P2|STARTED|First Intervention (1 Day)||19
4967961|NCT02659787|12216196|P1|STARTED|First Intervention (1 Day)||19
4967962|NCT02659709|12216202|P1|NOT COMPLETED|Overall Study||0
4967963|NCT02659709|12216202|P1|COMPLETED|Overall Study||50
4967964|NCT02659709|12216202|P1|STARTED|Overall Study||50
4967965|NCT02659631|12216219|P10|NOT COMPLETED|Overall Study||0
4967966|NCT02659631|12216220|P9|NOT COMPLETED|Overall Study||2
4967967|NCT02659631|12216221|P8|NOT COMPLETED|Overall Study||3
4967968|NCT02659631|12216222|P7|NOT COMPLETED|Overall Study||1
4967969|NCT02659631|12216223|P6|NOT COMPLETED|Overall Study||3
4967970|NCT02659631|12216224|P5|NOT COMPLETED|Overall Study||5
4967971|NCT02659631|12216225|P4|NOT COMPLETED|Overall Study||2
4967972|NCT02659631|12216226|P3|NOT COMPLETED|Overall Study||3
4967973|NCT02659631|12216227|P2|NOT COMPLETED|Overall Study||2
4967974|NCT02659631|12216228|P1|NOT COMPLETED|Overall Study||1
4967975|NCT02659631|12216219|P10|COMPLETED|Overall Study||1
4967976|NCT02659631|12216220|P9|COMPLETED|Overall Study||0
4967977|NCT02659631|12216221|P8|COMPLETED|Overall Study||0
4967978|NCT02659631|12216222|P7|COMPLETED|Overall Study||3
4967979|NCT02659631|12216223|P6|COMPLETED|Overall Study||2
4967980|NCT02659631|12216224|P5|COMPLETED|Overall Study||0
4967981|NCT02659631|12216225|P4|COMPLETED|Overall Study||0
4967982|NCT02659631|12216226|P3|COMPLETED|Overall Study||0
4967983|NCT02659631|12216227|P2|COMPLETED|Overall Study||0
4967984|NCT02659631|12216228|P1|COMPLETED|Overall Study||0
4967985|NCT02659631|12216219|P10|STARTED|Overall Study||1
4967986|NCT02659631|12216220|P9|STARTED|Overall Study||2
4967987|NCT02659631|12216221|P8|STARTED|Overall Study||3
4967988|NCT02659631|12216222|P7|STARTED|Overall Study||4
4967989|NCT02659631|12216223|P6|STARTED|Overall Study||5
4967990|NCT02659631|12216224|P5|STARTED|Overall Study||5
4967991|NCT02659631|12216225|P4|STARTED|Overall Study||2
4967992|NCT02659631|12216226|P3|STARTED|Overall Study||3
4967993|NCT02659631|12216227|P2|STARTED|Overall Study||2
4967994|NCT02659631|12216228|P1|STARTED|Overall Study||1
4967995|NCT02659540|12216362|P2|NOT COMPLETED|Overall Study||8
4967996|NCT02659540|12216363|P1|NOT COMPLETED|Overall Study||6
4967997|NCT02659540|12216362|P2|COMPLETED|Overall Study||2
4967998|NCT02659540|12216363|P1|COMPLETED|Overall Study||4
4967999|NCT02659540|12216362|P2|STARTED|Overall Study||10
4968000|NCT02659540|12216363|P1|STARTED|Overall Study||10
4968001|NCT02659501|12216379|P2|NOT COMPLETED|Overall Study||0
4968002|NCT02659501|12216380|P1|NOT COMPLETED|Overall Study||0
4968003|NCT02659501|12216379|P2|COMPLETED|Overall Study||12
4968004|NCT02659501|12216380|P1|COMPLETED|Overall Study||12
4968005|NCT02659501|12216379|P2|STARTED|Overall Study||12
4968006|NCT02659501|12216380|P1|STARTED|Overall Study||12
4968007|NCT02659098|12216394|P1|NOT COMPLETED|Overall Study||7
4968008|NCT02659098|12216394|P1|COMPLETED|Overall Study||14
4968009|NCT02659098|12216394|P1|STARTED|Overall Study||21
4968010|NCT02658877|12216425|P2|NOT COMPLETED|Overall Study||0
4968011|NCT02658877|12216426|P1|NOT COMPLETED|Overall Study||0
4968012|NCT02658877|12216425|P2|COMPLETED|Overall Study||0
4968013|NCT02658877|12216426|P1|COMPLETED|Overall Study||3
4968014|NCT02658877|12216425|P2|STARTED|Overall Study||0
4968015|NCT02658877|12216426|P1|STARTED|Overall Study||3
4968016|NCT02658487|12216452|P1|NOT COMPLETED|Overall Study||16
4968017|NCT02658487|12216452|P1|COMPLETED|Overall Study||26
4968018|NCT02658487|12216452|P1|STARTED|Overall Study||42
4968019|NCT02658461|12216465|P3|NOT COMPLETED|Overall Study||0
4968020|NCT02658461|12216466|P2|NOT COMPLETED|Overall Study||0
4968021|NCT02658461|12216467|P1|NOT COMPLETED|Overall Study||0
4968022|NCT02658461|12216465|P3|COMPLETED|Overall Study||12
4968023|NCT02658461|12216466|P2|COMPLETED|Overall Study||12
4968024|NCT02658461|12216467|P1|COMPLETED|Overall Study||12
4968025|NCT02658461|12216465|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
4968026|NCT02658461|12216466|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
4968027|NCT02658461|12216467|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
4968028|NCT02658357|12216495|P2|NOT COMPLETED|Overall Study||0
4968029|NCT02658357|12216496|P1|NOT COMPLETED|Overall Study||0
4968030|NCT02658357|12216495|P2|COMPLETED|Overall Study||0
4968031|NCT02658357|12216496|P1|COMPLETED|Overall Study||0
4968032|NCT02658357|12216495|P2|STARTED|Overall Study||0
4968033|NCT02658357|12216496|P1|STARTED|Overall Study||0
4968034|NCT02658240|12216508|P2|NOT COMPLETED|Overall Study||0
4968035|NCT02658240|12216509|P1|NOT COMPLETED|Overall Study||0
4968036|NCT02658240|12216508|P2|COMPLETED|Overall Study||30
4968037|NCT02658240|12216509|P1|COMPLETED|Overall Study||30
4968038|NCT02658240|12216508|P2|STARTED|Overall Study||30
4968039|NCT02658240|12216509|P1|STARTED|Overall Study||30
4968040|NCT02658149|12216523|P2|NOT COMPLETED|Overall Study||0
4968041|NCT02658149|12216524|P1|NOT COMPLETED|Overall Study||1
4968042|NCT02658149|12216523|P2|COMPLETED|Overall Study||50
4968043|NCT02658149|12216524|P1|COMPLETED|Overall Study||49
4968044|NCT02658149|12216523|P2|STARTED|Overall Study||50
4968045|NCT02658149|12216524|P1|STARTED|Overall Study||50
4968046|NCT02658084|12216540|P2|NOT COMPLETED|Overall Study||0
4968047|NCT02658084|12216541|P1|NOT COMPLETED|Overall Study||2
4968048|NCT02658084|12216540|P2|COMPLETED|Overall Study||0
4968049|NCT02658084|12216541|P1|COMPLETED|Overall Study||0
4968050|NCT02658084|12216540|P2|STARTED|Overall Study||0
4968051|NCT02658084|12216541|P1|STARTED|Overall Study||2
4968052|NCT02657928|12216552|P2|NOT COMPLETED|Overall Study||0
4968053|NCT02657928|12216553|P1|NOT COMPLETED|Overall Study||0
4968054|NCT02657928|12216552|P2|COMPLETED|Overall Study||20
4968055|NCT02657928|12216553|P1|COMPLETED|Overall Study||20
4968056|NCT02657928|12216552|P2|STARTED|Overall Study||20
4968057|NCT02657928|12216553|P1|STARTED|Overall Study||20
4968058|NCT02657915|12216569|P2|NOT COMPLETED|Overall Study||0
4968059|NCT02657915|12216570|P1|NOT COMPLETED|Overall Study||0
4968060|NCT02657915|12216569|P2|COMPLETED|Overall Study||28
4968061|NCT02657915|12216570|P1|COMPLETED|Overall Study||24
4968062|NCT02657915|12216569|P2|Per-protocol Population|Overall Study||24
4968063|NCT02657915|12216570|P1|Per-protocol Population|Overall Study||23
4968064|NCT02657915|12216569|P2|Intent-to Treat (ITT) Population|Overall Study||28
4968065|NCT02657915|12216570|P1|Intent-to Treat (ITT) Population|Overall Study||24
4968066|NCT02657915|12216569|P2|STARTED|Overall Study||28
4968067|NCT02657915|12216570|P1|STARTED|Overall Study||24
4968068|NCT02657889|12216594|P4|NOT COMPLETED|Overall Study||55
4968069|NCT02657889|12216595|P3|NOT COMPLETED|Overall Study||53
4968070|NCT02657889|12216596|P2|NOT COMPLETED|Overall Study||7
4968071|NCT02657889|12216597|P1|NOT COMPLETED|Overall Study||7
4968072|NCT02657889|12216594|P4|COMPLETED|Overall Study||0
4968073|NCT02657889|12216595|P3|COMPLETED|Overall Study||0
4968074|NCT02657889|12216596|P2|COMPLETED|Overall Study||0
4968075|NCT02657889|12216597|P1|COMPLETED|Overall Study||0
4968076|NCT02657889|12216594|P4|STARTED|Overall Study||55
4968077|NCT02657889|12216595|P3|STARTED|Overall Study||53
4968078|NCT02657889|12216596|P2|STARTED|Overall Study||7
4968079|NCT02657889|12216597|P1|STARTED|Overall Study||7
4968080|NCT02657629|12216617|P2|NOT COMPLETED|Overall Study||0
4968081|NCT02657629|12216618|P1|NOT COMPLETED|Overall Study||2
4968082|NCT02657629|12216617|P2|COMPLETED|Overall Study||14
4968083|NCT02657629|12216618|P1|COMPLETED|Overall Study||12
4968084|NCT02657629|12216617|P2|STARTED|Overall Study||14
4968085|NCT02657629|12216618|P1|STARTED|Overall Study||14
4968086|NCT02657564|12216624|P1|NOT COMPLETED|Overall Study||74
4968087|NCT02657564|12216624|P1|COMPLETED|Overall Study||1163
4968088|NCT02657564|12216624|P1|STARTED|Overall Study||1237
4968089|NCT02657538|12216629|P1|NOT COMPLETED|Overall Study||4
4968090|NCT02657538|12216629|P1|COMPLETED|Overall Study||31
4968091|NCT02657538|12216629|P1|Received Visual Caries Detection + Bite|Overall Study||35
4968092|NCT02657538|12216629|P1|Received Near Infrared Transillumination|Overall Study||35
4968093|NCT02657538|12216629|P1|STARTED|Overall Study||35
4968094|NCT02657408|12216638|P2|NOT COMPLETED|Overall Study||7
4968095|NCT02657408|12216639|P1|NOT COMPLETED|Overall Study||3
4968096|NCT02657408|12216638|P2|COMPLETED|Overall Study||22
4968097|NCT02657408|12216639|P1|COMPLETED|Overall Study||25
4968098|NCT02657408|12216638|P2|STARTED|Overall Study||29
4968099|NCT02657408|12216639|P1|STARTED|Overall Study||28
4968100|NCT02657369|12216663|P1|NOT COMPLETED|Overall Study||34
4968101|NCT02657369|12216663|P1|COMPLETED|Overall Study||0
4968102|NCT02657369|12216663|P1|STARTED|Overall Study||34
4968103|NCT02657252|12216673|P2|NOT COMPLETED|Overall Study||7
4968104|NCT02657252|12216674|P1|NOT COMPLETED|Overall Study||10
4968105|NCT02657252|12216673|P2|COMPLETED|Overall Study||51
4968106|NCT02657252|12216674|P1|COMPLETED|Overall Study||47
4968107|NCT02657252|12216673|P2|STARTED|Overall Study||58
4968108|NCT02657252|12216674|P1|STARTED|Overall Study||57
4968109|NCT02657226|12216684|P1|NOT COMPLETED|Overall Study||0
4968110|NCT02657226|12216684|P1|COMPLETED|Overall Study||15724
4968111|NCT02657226|12216684|P1|STARTED|Overall Study||15724
4968112|NCT02657031|12216694|P2|NOT COMPLETED|Overall Study||2
4968113|NCT02657031|12216695|P1|NOT COMPLETED|Overall Study||1
4968114|NCT02657031|12216694|P2|COMPLETED|Overall Study||23
4968115|NCT02657031|12216695|P1|COMPLETED|Overall Study||28
4968116|NCT02657031|12216694|P2|STARTED|Overall Study||25
4968117|NCT02657031|12216695|P1|STARTED|Overall Study||29
4968118|NCT02656836|12216709|P1|NOT COMPLETED|Overall Study||3
4968119|NCT02656836|12216709|P1|COMPLETED|Overall Study||6
4968120|NCT02656836|12216709|P1|STARTED|Overall Study||9
4968121|NCT02656745|12216713|P1|NOT COMPLETED|Overall Study||0
4968122|NCT02656745|12216713|P1|COMPLETED|Overall Study||416
4968123|NCT02656745|12216713|P1|STARTED|Overall Study||416
4968124|NCT02656693|12216723|P3|NOT COMPLETED|Overall Study||3
4968125|NCT02656693|12216724|P2|NOT COMPLETED|Overall Study||2
4968126|NCT02656693|12216725|P1|NOT COMPLETED|Overall Study||1
4968127|NCT02656693|12216723|P3|COMPLETED|Overall Study||295
4968128|NCT02656693|12216724|P2|COMPLETED|Overall Study||214
4968129|NCT02656693|12216725|P1|COMPLETED|Overall Study||325
4968130|NCT02656693|12216723|P3|STARTED|Overall Study||298
4968131|NCT02656693|12216724|P2|STARTED|Overall Study||216
4968132|NCT02656693|12216725|P1|STARTED|Overall Study||326
4968133|NCT02656485|12216770|P4|NOT COMPLETED|Overall Study||2
4968134|NCT02656485|12216771|P3|NOT COMPLETED|Overall Study||2
4968135|NCT02656485|12216772|P2|NOT COMPLETED|Overall Study||3
4968136|NCT02656485|12216773|P1|NOT COMPLETED|Overall Study||2
4968137|NCT02656485|12216770|P4|COMPLETED|Overall Study||7
4968138|NCT02656485|12216771|P3|COMPLETED|Overall Study||7
4968139|NCT02656485|12216772|P2|COMPLETED|Overall Study||6
4968140|NCT02656485|12216773|P1|COMPLETED|Overall Study||7
4968141|NCT02656485|12216770|P4|STARTED|Overall Study||9
4968142|NCT02656485|12216771|P3|STARTED|Overall Study||9
4968143|NCT02656485|12216772|P2|STARTED|Overall Study||9
4968144|NCT02656485|12216773|P1|STARTED|Overall Study||9
4968145|NCT02656420|12216789|P4|NOT COMPLETED|Overall Study||0
4968146|NCT02656420|12216790|P3|NOT COMPLETED|Overall Study||0
4968147|NCT02656420|12216791|P2|NOT COMPLETED|Overall Study||1
4968148|NCT02656420|12216792|P1|NOT COMPLETED|Overall Study||0
4968149|NCT02656420|12216789|P4|COMPLETED|Overall Study||55
4968150|NCT02656420|12216790|P3|COMPLETED|Overall Study||35
4968151|NCT02656420|12216791|P2|COMPLETED|Overall Study||24
4968152|NCT02656420|12216792|P1|COMPLETED|Overall Study||55
4968153|NCT02656420|12216789|P4|STARTED|Overall Study||55
4968154|NCT02656420|12216790|P3|STARTED|Overall Study||35
4968155|NCT02656420|12216791|P2|STARTED|Overall Study||25
4968156|NCT02656420|12216792|P1|STARTED|Overall Study||55
4968157|NCT02656329|12216808|P2|NOT COMPLETED|Overall Study||157
4968158|NCT02656329|12216809|P1|NOT COMPLETED|Overall Study||164
4968159|NCT02656329|12216808|P2|COMPLETED|Overall Study||0
4968160|NCT02656329|12216809|P1|COMPLETED|Overall Study||0
4968161|NCT02656329|12216808|P2|STARTED|Overall Study||157
4968162|NCT02656329|12216809|P1|STARTED|Overall Study||164
4968163|NCT02656290|12216832|P1|NOT COMPLETED|Overall Study||26
4968164|NCT02656290|12216832|P1|COMPLETED|Overall Study||0
4968165|NCT02656290|12216832|P1|3 Year|Overall Study||6
4968166|NCT02656290|12216832|P1|2 Year|Overall Study||17
4968167|NCT02656290|12216832|P1|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
4968168|NCT02656290|12216832|P1|STARTED|Overall Study||26
4968169|NCT02656199|12216836|P1|NOT COMPLETED|Overall Study||0
4968170|NCT02656199|12216836|P1|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
4968171|NCT02656199|12216836|P1|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
4968172|NCT02656173|12216842|P2|NOT COMPLETED|Overall Study||11
4968173|NCT02656173|12216843|P1|NOT COMPLETED|Overall Study||13
4968174|NCT02656173|12216842|P2|COMPLETED|Overall Study||272
4968175|NCT02656173|12216843|P1|COMPLETED|Overall Study||272
4968176|NCT02656173|12216842|P2|Received Treatment|Overall Study||282
4968177|NCT02656173|12216843|P1|Received Treatment|Overall Study||284
4968178|NCT02656173|12216842|P2|STARTED|Overall Study||283
4968179|NCT02656173|12216843|P1|STARTED|Overall Study||285
4968180|NCT02656160|12216879|P2|NOT COMPLETED|Second Study Night||0
4968181|NCT02656160|12216880|P1|NOT COMPLETED|Second Study Night||0
4968182|NCT02656160|12216879|P2|COMPLETED|Second Study Night||6
4968183|NCT02656160|12216880|P1|COMPLETED|Second Study Night||4
4968184|NCT02656160|12216879|P2|STARTED|Second Study Night||6
4968185|NCT02656160|12216880|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
4968186|NCT02656160|12216879|P2|NOT COMPLETED|First Study Night||0
4968187|NCT02656160|12216880|P1|NOT COMPLETED|First Study Night||0
4968188|NCT02656160|12216879|P2|COMPLETED|First Study Night||6
4968189|NCT02656160|12216880|P1|COMPLETED|First Study Night||7
4968190|NCT02656160|12216879|P2|STARTED|First Study Night||6
4968191|NCT02656160|12216880|P1|STARTED|First Study Night||7
4968192|NCT02656069|12216890|P2|NOT COMPLETED|Second Intervention||1
4968193|NCT02656069|12216891|P1|NOT COMPLETED|Second Intervention||1
4968194|NCT02656069|12216890|P2|COMPLETED|Second Intervention||35
4968195|NCT02656069|12216891|P1|COMPLETED|Second Intervention||43
4968196|NCT02656069|12216890|P2|STARTED|Second Intervention||36
4968197|NCT02656069|12216891|P1|STARTED|Second Intervention||44
4968198|NCT02656069|12216890|P2|NOT COMPLETED|First Intervention||0
4968199|NCT02656069|12216891|P1|NOT COMPLETED|First Intervention||0
4968200|NCT02656069|12216890|P2|COMPLETED|First Intervention||36
4968201|NCT02656069|12216891|P1|COMPLETED|First Intervention||44
4968202|NCT02656069|12216890|P2|STARTED|First Intervention||36
4968203|NCT02656069|12216891|P1|STARTED|First Intervention||44
4968204|NCT02655887|12216915|P1|NOT COMPLETED|Overall Study||14
4968205|NCT02655887|12216915|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
4968206|NCT02655887|12216915|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
4968207|NCT02655679|12216934|P5|NOT COMPLETED|Overall Study||1
4968208|NCT02655679|12216935|P4|NOT COMPLETED|Overall Study||4
4968209|NCT02655679|12216936|P3|NOT COMPLETED|Overall Study||1
4968210|NCT02655679|12216937|P2|NOT COMPLETED|Overall Study||3
4968211|NCT02655679|12216938|P1|NOT COMPLETED|Overall Study||3
4968212|NCT02655679|12216934|P5|COMPLETED|Overall Study||19
4968213|NCT02655679|12216935|P4|COMPLETED|Overall Study||20
4968214|NCT02655679|12216936|P3|COMPLETED|Overall Study||19
4968215|NCT02655679|12216937|P2|COMPLETED|Overall Study||16
4968216|NCT02655679|12216938|P1|COMPLETED|Overall Study||18
4968217|NCT02655679|12216934|P5|Received Study Drug (Safety Population)|Overall Study||20
4968218|NCT02655679|12216935|P4|Received Study Drug (Safety Population)|Overall Study||24
4968219|NCT02655679|12216936|P3|Received Study Drug (Safety Population)|Overall Study||20
4968220|NCT02655679|12216937|P2|Received Study Drug (Safety Population)|Overall Study||19
4968221|NCT02655679|12216938|P1|Received Study Drug (Safety Population)|Overall Study||20
4968222|NCT02655679|12216934|P5|STARTED|Overall Study||20
4968223|NCT02655679|12216935|P4|STARTED|Overall Study||24
4968224|NCT02655679|12216936|P3|STARTED|Overall Study||20
4968225|NCT02655679|12216937|P2|STARTED|Overall Study||19
4968226|NCT02655679|12216938|P1|STARTED|Overall Study||21
4968227|NCT02655666|12217010|P1|NOT COMPLETED|Overall Study||12
4968228|NCT02655666|12217010|P1|COMPLETED|Overall Study||4
4968229|NCT02655666|12217010|P1|STARTED|Overall Study||16
4968230|NCT02655653|12217026|P2|NOT COMPLETED|Overall Study||0
4968231|NCT02655653|12217027|P1|NOT COMPLETED|Overall Study||0
4968232|NCT02655653|12217026|P2|COMPLETED|Overall Study||58
4968233|NCT02655653|12217027|P1|COMPLETED|Overall Study||56
4968234|NCT02655653|12217026|P2|STARTED|Overall Study||58
4968235|NCT02655653|12217027|P1|STARTED|Overall Study||56
4968236|NCT02655510|12217052|P3|NOT COMPLETED|Overall Study||0
4968237|NCT02655510|12217053|P2|NOT COMPLETED|Overall Study||0
4968238|NCT02655510|12217054|P1|NOT COMPLETED|Overall Study||0
4968239|NCT02655510|12217052|P3|COMPLETED|Overall Study||6
4968240|NCT02655510|12217053|P2|COMPLETED|Overall Study||6
4968241|NCT02655510|12217054|P1|COMPLETED|Overall Study||6
4968242|NCT02655510|12217052|P3|STARTED|Overall Study||6
4968243|NCT02655510|12217053|P2|STARTED|Overall Study||6
4968244|NCT02655510|12217054|P1|STARTED|Overall Study||6
4968245|NCT02655419|12217064|P2|NOT COMPLETED|Overall Study||7
4968246|NCT02655419|12217065|P1|NOT COMPLETED|Overall Study||5
4968247|NCT02655419|12217064|P2|COMPLETED|Overall Study||16
4968248|NCT02655419|12217065|P1|COMPLETED|Overall Study||12
4968249|NCT02655419|12217064|P2|Treated|Overall Study||18
4968250|NCT02655419|12217065|P1|Treated|Overall Study||16
4968251|NCT02655419|12217064|P2|STARTED|Overall Study||23
4968252|NCT02655419|12217065|P1|STARTED|Overall Study||17
4968253|NCT02655237|12217185|P2|NOT COMPLETED|Overall Study||11
4968254|NCT02655237|12217186|P1|NOT COMPLETED|Overall Study||17
4968255|NCT02655237|12217185|P2|COMPLETED|Overall Study||131
4968256|NCT02655237|12217186|P1|COMPLETED|Overall Study||122
4968257|NCT02655237|12217185|P2|STARTED|Overall Study||142
4968258|NCT02655237|12217186|P1|STARTED|Overall Study||139
4968259|NCT02655224|12217226|P2|NOT COMPLETED|Overall Study||1
4968260|NCT02655224|12217227|P1|NOT COMPLETED|Overall Study||1
4968261|NCT02655224|12217226|P2|COMPLETED|Overall Study||31
4968262|NCT02655224|12217227|P1|COMPLETED|Overall Study||32
4968263|NCT02655224|12217226|P2|STARTED|Overall Study||32
4968264|NCT02655224|12217227|P1|STARTED|Overall Study||33
4968265|NCT02655016|12217259|P2|NOT COMPLETED|Overall Study||90
4968266|NCT02655016|12217260|P1|NOT COMPLETED|Overall Study||55
4968267|NCT02655016|12217259|P2|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
4968268|NCT02655016|12217260|P1|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
4968269|NCT02655016|12217259|P2|Ongoing With Treatment in the Study|Overall Study||177
4968270|NCT02655016|12217260|P1|Ongoing With Treatment in the Study|Overall Study||69
4968271|NCT02655016|12217259|P2|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
4968272|NCT02655016|12217260|P1|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
4968273|NCT02655016|12217259|P2|STARTED|Overall Study||487
4968274|NCT02655016|12217260|P1|STARTED|Overall Study||246
4968275|NCT02654782|12217294|P2|NOT COMPLETED|Overall Study||0
4968276|NCT02654782|12217295|P1|NOT COMPLETED|Overall Study||0
4968277|NCT02654782|12217294|P2|COMPLETED|Overall Study||5
4968278|NCT02654782|12217295|P1|COMPLETED|Overall Study||5
4968279|NCT02654782|12217294|P2|STARTED|Overall Study||5
4968280|NCT02654782|12217295|P1|STARTED|Overall Study||5
4968281|NCT02654769|12217306|P3|NOT COMPLETED|Overall Study||1
4968282|NCT02654769|12217307|P2|NOT COMPLETED|Overall Study||1
4968283|NCT02654769|12217308|P1|NOT COMPLETED|Overall Study||4
4968284|NCT02654769|12217306|P3|COMPLETED|Overall Study||142
4968285|NCT02654769|12217307|P2|COMPLETED|Overall Study||148
4968286|NCT02654769|12217308|P1|COMPLETED|Overall Study||145
4968287|NCT02654769|12217306|P3|STARTED|Overall Study||143
4968288|NCT02654769|12217307|P2|STARTED|Overall Study||149
4968289|NCT02654769|12217308|P1|STARTED|Overall Study||149
4968290|NCT02654717|12217321|P2|NOT COMPLETED|Overall Study||5
4968291|NCT02654717|12217322|P1|NOT COMPLETED|Overall Study||6
4968292|NCT02654717|12217321|P2|COMPLETED|Overall Study||50
4968293|NCT02654717|12217322|P1|COMPLETED|Overall Study||50
4968294|NCT02654717|12217321|P2|STARTED|Overall Study||55
4968295|NCT02654717|12217322|P1|STARTED|Overall Study||56
4968296|NCT02654652|12217330|P2|NOT COMPLETED|Overall Study||3
4968297|NCT02654652|12217331|P1|NOT COMPLETED|Overall Study||1
4968298|NCT02654652|12217330|P2|COMPLETED|Overall Study||18
4968299|NCT02654652|12217331|P1|COMPLETED|Overall Study||18
4968300|NCT02654652|12217330|P2|STARTED|Overall Study||21
4968301|NCT02654652|12217331|P1|STARTED|Overall Study||19
4968302|NCT02654639|12217339|P1|NOT COMPLETED|Overall Study||0
4968303|NCT02654639|12217339|P1|COMPLETED|Overall Study||4
4968304|NCT02654639|12217339|P1|STARTED|Overall Study||4
4968305|NCT02654483|12217345|P2|NOT COMPLETED|Open-label||0
4968306|NCT02654483|12217346|P1|NOT COMPLETED|Open-label||0
4968307|NCT02654483|12217345|P2|COMPLETED|Open-label||3
4968308|NCT02654483|12217346|P1|COMPLETED|Open-label||5
4968309|NCT02654483|12217345|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
4968310|NCT02654483|12217346|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
4968311|NCT02654483|12217345|P2|NOT COMPLETED|Double-blind||0
4968312|NCT02654483|12217346|P1|NOT COMPLETED|Double-blind||0
4968313|NCT02654483|12217345|P2|COMPLETED|Double-blind||7
4968314|NCT02654483|12217346|P1|COMPLETED|Double-blind||7
4968315|NCT02654483|12217345|P2|STARTED|Double-blind||7
4968316|NCT02654483|12217346|P1|STARTED|Double-blind||7
4968317|NCT02654314|12217360|P2|NOT COMPLETED|Overall Study||0
4968318|NCT02654314|12217361|P1|NOT COMPLETED|Overall Study||0
4968319|NCT02654314|12217360|P2|COMPLETED|Overall Study||141
4968320|NCT02654314|12217361|P1|COMPLETED|Overall Study||136
4968321|NCT02654314|12217360|P2|STARTED|Overall Study||141
4968322|NCT02654314|12217361|P1|STARTED|Overall Study||136
4968323|NCT02654145|12217373|P1|NOT COMPLETED|Overall Study||7
4968324|NCT02654145|12217373|P1|COMPLETED|Overall Study||138
4968325|NCT02654145|12217373|P1|STARTED|Overall Study||145
4968326|NCT02654132|12217382|P2|NOT COMPLETED|Overall Study||46
4968327|NCT02654132|12217383|P1|NOT COMPLETED|Overall Study||36
4968328|NCT02654132|12217382|P2|COMPLETED|Overall Study||11
4968329|NCT02654132|12217383|P1|COMPLETED|Overall Study||24
4968330|NCT02654132|12217382|P2|STARTED|Overall Study||57
4968331|NCT02654132|12217383|P1|STARTED|Overall Study||60
4968332|NCT02654054|12217394|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||30
4968333|NCT02654054|12217395|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||8
4968334|NCT02654054|12217396|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||8
4968335|NCT02654054|12217394|P3|COMPLETED|Post-Treatment Follow-Up Period||29
4968336|NCT02654054|12217395|P2|COMPLETED|Post-Treatment Follow-Up Period||24
4968337|NCT02654054|12217396|P1|COMPLETED|Post-Treatment Follow-Up Period||17
4968338|NCT02654054|12217394|P3|STARTED|Post-Treatment Follow-Up Period||59
4968339|NCT02654054|12217395|P2|STARTED|Post-Treatment Follow-Up Period||32
4968340|NCT02654054|12217396|P1|STARTED|Post-Treatment Follow-Up Period||25
4968341|NCT02654054|12217394|P3|NOT COMPLETED|Treatment Period||43
4968342|NCT02654054|12217395|P2|NOT COMPLETED|Treatment Period||23
4968343|NCT02654054|12217396|P1|NOT COMPLETED|Treatment Period||19
4968344|NCT02654054|12217394|P3|COMPLETED|Treatment Period||164
4968345|NCT02654054|12217395|P2|COMPLETED|Treatment Period||81
4968346|NCT02654054|12217396|P1|COMPLETED|Treatment Period||83
4968347|NCT02654054|12217394|P3|Randomized and Treated|Treatment Period||206
4968348|NCT02654054|12217395|P2|Randomized and Treated|Treatment Period||104
4968349|NCT02654054|12217396|P1|Randomized and Treated|Treatment Period||102
4968350|NCT02654054|12217394|P3|STARTED|Treatment Period||207
4968351|NCT02654054|12217395|P2|STARTED|Treatment Period||104
4968352|NCT02654054|12217396|P1|STARTED|Treatment Period||102
4968353|NCT02653872|12217422|P1|NOT COMPLETED|Overall Study||0
4968354|NCT02653872|12217422|P1|COMPLETED|Overall Study||15
4968355|NCT02653872|12217422|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
4968356|NCT02653872|12217422|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
4968357|NCT02653872|12217422|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
4968358|NCT02653872|12217422|P1|STARTED|Overall Study||15
4968359|NCT02653768|12217459|P2|NOT COMPLETED|9-Month Follow-Up (Primary)||16
4968360|NCT02653768|12217460|P1|NOT COMPLETED|9-Month Follow-Up (Primary)||33
4968361|NCT02653768|12217459|P2|COMPLETED|9-Month Follow-Up (Primary)||95
4968362|NCT02653768|12217460|P1|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
4968363|NCT02653768|12217459|P2|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
4968364|NCT02653768|12217460|P1|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
4968365|NCT02653768|12217459|P2|NOT COMPLETED|6-Month Follow-Up||13
4968366|NCT02653768|12217460|P1|NOT COMPLETED|6-Month Follow-Up||45
4968367|NCT02653768|12217459|P2|COMPLETED|6-Month Follow-Up||100
4968368|NCT02653768|12217460|P1|COMPLETED|6-Month Follow-Up||164
4968464|NCT02653170|12217586|P3|COMPLETED|Overall Study||72
4968369|NCT02653768|12217459|P2|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
4968370|NCT02653768|12217460|P1|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
4968371|NCT02653768|12217459|P2|NOT COMPLETED|3-Month Follow-Up||15
4968372|NCT02653768|12217460|P1|NOT COMPLETED|3-Month Follow-Up||66
4968373|NCT02653768|12217459|P2|COMPLETED|3-Month Follow-Up||100
4968374|NCT02653768|12217460|P1|COMPLETED|3-Month Follow-Up||164
4968375|NCT02653768|12217459|P2|STARTED|3-Month Follow-Up||115
4968376|NCT02653768|12217460|P1|STARTED|3-Month Follow-Up||230
4968377|NCT02653625|12217470|P1|NOT COMPLETED|Overall Study||4
4968378|NCT02653625|12217470|P1|COMPLETED|Overall Study||20
4968379|NCT02653625|12217470|P1|STARTED|Overall Study||24
4968380|NCT02653560|12217479|P4|NOT COMPLETED|Placebo Phase||0
4968381|NCT02653560|12217480|P3|NOT COMPLETED|Placebo Phase||0
4968382|NCT02653560|12217481|P2|NOT COMPLETED|Placebo Phase||0
4968383|NCT02653560|12217482|P1|NOT COMPLETED|Placebo Phase||0
4968384|NCT02653560|12217479|P4|COMPLETED|Placebo Phase||30
4968385|NCT02653560|12217480|P3|COMPLETED|Placebo Phase||0
4968386|NCT02653560|12217481|P2|COMPLETED|Placebo Phase||0
4968387|NCT02653560|12217482|P1|COMPLETED|Placebo Phase||0
4968388|NCT02653560|12217479|P4|STARTED|Placebo Phase||30
4968389|NCT02653560|12217480|P3|STARTED|Placebo Phase||0
4968390|NCT02653560|12217481|P2|STARTED|Placebo Phase||0
4968391|NCT02653560|12217482|P1|STARTED|Placebo Phase||0
4968392|NCT02653560|12217479|P4|NOT COMPLETED|KCl Phase||0
4968393|NCT02653560|12217480|P3|NOT COMPLETED|KCl Phase||0
4968394|NCT02653560|12217481|P2|NOT COMPLETED|KCl Phase||0
4968395|NCT02653560|12217482|P1|NOT COMPLETED|KCl Phase||0
4968396|NCT02653560|12217479|P4|COMPLETED|KCl Phase||0
4968397|NCT02653560|12217480|P3|COMPLETED|KCl Phase||30
4968398|NCT02653560|12217481|P2|COMPLETED|KCl Phase||0
4968399|NCT02653560|12217482|P1|COMPLETED|KCl Phase||0
4968400|NCT02653560|12217479|P4|STARTED|KCl Phase||0
4968401|NCT02653560|12217480|P3|STARTED|KCl Phase||30
4968402|NCT02653560|12217481|P2|STARTED|KCl Phase||0
4968403|NCT02653560|12217482|P1|STARTED|KCl Phase||0
4968404|NCT02653560|12217479|P4|NOT COMPLETED|K Citrate Phase||0
4968405|NCT02653560|12217480|P3|NOT COMPLETED|K Citrate Phase||0
4968406|NCT02653560|12217481|P2|NOT COMPLETED|K Citrate Phase||0
4968407|NCT02653560|12217482|P1|NOT COMPLETED|K Citrate Phase||0
4968408|NCT02653560|12217479|P4|COMPLETED|K Citrate Phase||0
4968409|NCT02653560|12217480|P3|COMPLETED|K Citrate Phase||0
4968410|NCT02653560|12217481|P2|COMPLETED|K Citrate Phase||30
4968411|NCT02653560|12217482|P1|COMPLETED|K Citrate Phase||0
4968412|NCT02653560|12217479|P4|STARTED|K Citrate Phase||0
4968413|NCT02653560|12217480|P3|STARTED|K Citrate Phase||0
4968414|NCT02653560|12217481|P2|STARTED|K Citrate Phase||30
4968415|NCT02653560|12217482|P1|STARTED|K Citrate Phase||0
4968416|NCT02653560|12217479|P4|NOT COMPLETED|KMgCit Phase||0
4968417|NCT02653560|12217480|P3|NOT COMPLETED|KMgCit Phase||0
4968418|NCT02653560|12217481|P2|NOT COMPLETED|KMgCit Phase||0
4968419|NCT02653560|12217482|P1|NOT COMPLETED|KMgCit Phase||0
4968420|NCT02653560|12217479|P4|COMPLETED|KMgCit Phase||0
4968421|NCT02653560|12217480|P3|COMPLETED|KMgCit Phase||0
4968422|NCT02653560|12217481|P2|COMPLETED|KMgCit Phase||0
4968423|NCT02653560|12217482|P1|COMPLETED|KMgCit Phase||30
4968424|NCT02653560|12217479|P4|STARTED|KMgCit Phase||0
4968425|NCT02653560|12217480|P3|STARTED|KMgCit Phase||0
4968426|NCT02653560|12217481|P2|STARTED|KMgCit Phase||0
4968427|NCT02653560|12217482|P1|STARTED|KMgCit Phase||30
4968428|NCT02653495|12217494|P2|NOT COMPLETED|Overall Study||0
4968429|NCT02653495|12217495|P1|NOT COMPLETED|Overall Study||12
4968430|NCT02653495|12217494|P2|COMPLETED|Overall Study||2
4968431|NCT02653495|12217495|P1|COMPLETED|Overall Study||3
4968432|NCT02653495|12217494|P2|STARTED|Overall Study||2
4968433|NCT02653495|12217495|P1|STARTED|Overall Study||15
4968434|NCT02653456|12217509|P1|NOT COMPLETED|Overall Study||5
4968435|NCT02653456|12217509|P1|COMPLETED|Overall Study||59
4968436|NCT02653456|12217509|P1|STARTED|Overall Study||64
4968437|NCT02653417|12217520|P4|NOT COMPLETED|Overall Study||5
4968438|NCT02653417|12217521|P3|NOT COMPLETED|Overall Study||3
4968439|NCT02653417|12217522|P2|NOT COMPLETED|Overall Study||2
4968440|NCT02653417|12217523|P1|NOT COMPLETED|Overall Study||1
4968441|NCT02653417|12217520|P4|COMPLETED|Overall Study||33
4968442|NCT02653417|12217521|P3|COMPLETED|Overall Study||26
4968443|NCT02653417|12217522|P2|COMPLETED|Overall Study||32
4968444|NCT02653417|12217523|P1|COMPLETED|Overall Study||37
4968445|NCT02653417|12217520|P4|STARTED|Overall Study||38
4968446|NCT02653417|12217521|P3|STARTED|Overall Study||29
4968447|NCT02653417|12217522|P2|STARTED|Overall Study||34
4968448|NCT02653417|12217523|P1|STARTED|Overall Study||38
4968449|NCT02653326|12217547|P2|NOT COMPLETED|Overall Study||7
4968450|NCT02653326|12217548|P1|NOT COMPLETED|Overall Study||10
4968451|NCT02653326|12217547|P2|COMPLETED|Overall Study||27
4968452|NCT02653326|12217548|P1|COMPLETED|Overall Study||22
4968453|NCT02653326|12217547|P2|STARTED|Overall Study||34
4968454|NCT02653326|12217548|P1|STARTED|Overall Study||32
4968455|NCT02653183|12217562|P2|NOT COMPLETED|Overall Study||4
4968456|NCT02653183|12217563|P1|NOT COMPLETED|Overall Study||4
4968457|NCT02653183|12217562|P2|COMPLETED|Overall Study||46
4968458|NCT02653183|12217563|P1|COMPLETED|Overall Study||49
4968459|NCT02653183|12217562|P2|STARTED|Overall Study||50
4968460|NCT02653183|12217563|P1|STARTED|Overall Study||53
4968461|NCT02653170|12217586|P3|NOT COMPLETED|Overall Study||18
4968462|NCT02653170|12217587|P2|NOT COMPLETED|Overall Study||16
4968463|NCT02653170|12217588|P1|NOT COMPLETED|Overall Study||17
4968465|NCT02653170|12217587|P2|COMPLETED|Overall Study||72
4968466|NCT02653170|12217588|P1|COMPLETED|Overall Study||70
4968467|NCT02653170|12217586|P3|STARTED|Overall Study||90
4968468|NCT02653170|12217587|P2|STARTED|Overall Study||88
4968469|NCT02653170|12217588|P1|STARTED|Overall Study||87
4968470|NCT02653144|12217611|P3|NOT COMPLETED|Overall Study||0
4968471|NCT02653144|12217612|P2|NOT COMPLETED|Overall Study||0
4968472|NCT02653144|12217613|P1|NOT COMPLETED|Overall Study||0
4968473|NCT02653144|12217611|P3|COMPLETED|Overall Study||31
4968474|NCT02653144|12217612|P2|COMPLETED|Overall Study||28
4968475|NCT02653144|12217613|P1|COMPLETED|Overall Study||30
4968476|NCT02653144|12217611|P3|STARTED|Overall Study||31
4968477|NCT02653144|12217612|P2|STARTED|Overall Study||28
4968478|NCT02653144|12217613|P1|STARTED|Overall Study||30
4968479|NCT02652949|12217630|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
4968480|NCT02652949|12217630|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
4968481|NCT02652949|12217630|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
4968482|NCT02652949|12217630|P1|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
4968483|NCT02652949|12217630|P1|COMPLETED|6-Month Follow-up Secondary Endpoint||91
4968484|NCT02652949|12217630|P1|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
4968485|NCT02652949|12217630|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
4968486|NCT02652949|12217630|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
4968487|NCT02652949|12217630|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
4968488|NCT02652949|12217630|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
4968489|NCT02652949|12217630|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
4968490|NCT02652949|12217630|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
4968491|NCT02652780|12217639|P1|NOT COMPLETED|Overall Study||0
4968492|NCT02652780|12217639|P1|COMPLETED|Overall Study||37
4968493|NCT02652780|12217639|P1|STARTED|Overall Study||37
4968494|NCT02652767|12217665|P1|NOT COMPLETED|Overall Study||4
4968495|NCT02652767|12217665|P1|COMPLETED|Overall Study||35
4968496|NCT02652767|12217665|P1|Completed Week 48|Overall Study||38
4968497|NCT02652767|12217665|P1|STARTED|Overall Study||39
4968498|NCT02652624|12217693|P2|NOT COMPLETED|Extension Phase||4
4968499|NCT02652624|12217694|P1|NOT COMPLETED|Extension Phase||4
4968500|NCT02652624|12217693|P2|COMPLETED|Extension Phase||224
4968501|NCT02652624|12217694|P1|COMPLETED|Extension Phase||227
4968502|NCT02652624|12217693|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
4968503|NCT02652624|12217694|P1|STARTED|Extension Phase||231
4968504|NCT02652624|12217693|P2|NOT COMPLETED|Randomized Phase||5
4968505|NCT02652624|12217694|P1|NOT COMPLETED|Randomized Phase||3
4968506|NCT02652624|12217693|P2|COMPLETED|Randomized Phase||231
4968507|NCT02652624|12217694|P1|COMPLETED|Randomized Phase||231
4968508|NCT02652624|12217693|P2|STARTED|Randomized Phase||236
4968509|NCT02652624|12217694|P1|STARTED|Randomized Phase||234
4968510|NCT02652481|12217706|P1|NOT COMPLETED|Phase 2||18
4968511|NCT02652481|12217706|P1|COMPLETED|Phase 2||243
4968512|NCT02652481|12217706|P1|STARTED|Phase 2||261
4968513|NCT02652481|12217706|P1|NOT COMPLETED|Phase 1||98
4968514|NCT02652481|12217706|P1|COMPLETED|Phase 1||141
4968515|NCT02652481|12217706|P1|STARTED|Phase 1||239
4968516|NCT02652468|12217714|P1|NOT COMPLETED|Overall Study||0
4968517|NCT02652468|12217714|P1|COMPLETED|Overall Study||11
4968518|NCT02652468|12217714|P1|STARTED|Overall Study||11
4968519|NCT02652416|12217722|P4|NOT COMPLETED|Overall Study||0
4968520|NCT02652416|12217723|P3|NOT COMPLETED|Overall Study||0
4968521|NCT02652416|12217724|P2|NOT COMPLETED|Overall Study||0
4968522|NCT02652416|12217725|P1|NOT COMPLETED|Overall Study||0
4968523|NCT02652416|12217722|P4|COMPLETED|Overall Study||18
4968524|NCT02652416|12217723|P3|COMPLETED|Overall Study||18
4968525|NCT02652416|12217724|P2|COMPLETED|Overall Study||18
4968526|NCT02652416|12217725|P1|COMPLETED|Overall Study||18
4968527|NCT02652416|12217722|P4|Subjects Who Participated in MD Part|Overall Study||18
4968528|NCT02652416|12217723|P3|Subjects Who Participated in MD Part|Overall Study||0
4968529|NCT02652416|12217724|P2|Subjects Who Participated in MD Part|Overall Study||0
4968530|NCT02652416|12217725|P1|Subjects Who Participated in MD Part|Overall Study||6
4968531|NCT02652416|12217722|P4|STARTED|Overall Study||18
4968532|NCT02652416|12217723|P3|STARTED|Overall Study||18
4968533|NCT02652416|12217724|P2|STARTED|Overall Study||18
4968534|NCT02652416|12217725|P1|STARTED|Overall Study||18
4968535|NCT02652390|12217756|P3|NOT COMPLETED|Overall Study||0
4968536|NCT02652390|12217757|P2|NOT COMPLETED|Overall Study||0
4968537|NCT02652390|12217758|P1|NOT COMPLETED|Overall Study||0
4968538|NCT02652390|12217756|P3|COMPLETED|Overall Study||37
4968539|NCT02652390|12217757|P2|COMPLETED|Overall Study||37
4968540|NCT02652390|12217758|P1|COMPLETED|Overall Study||37
4968541|NCT02652390|12217756|P3|STARTED|Overall Study||37
4968542|NCT02652390|12217757|P2|STARTED|Overall Study||37
4968543|NCT02652390|12217758|P1|STARTED|Overall Study||37
4968544|NCT02652260|12217782|P2|NOT COMPLETED|Overall Study||2
4968545|NCT02652260|12217783|P1|NOT COMPLETED|Overall Study||0
4968546|NCT02652260|12217782|P2|COMPLETED|Overall Study||41
4968547|NCT02652260|12217783|P1|COMPLETED|Overall Study||43
4968548|NCT02652260|12217782|P2|STARTED|Overall Study||43
4968549|NCT02652260|12217783|P1|STARTED|Overall Study||43
4968550|NCT02652221|12217819|P1|NOT COMPLETED|Overall Study||0
4968551|NCT02652221|12217819|P1|COMPLETED|Overall Study||55
4968552|NCT02652221|12217819|P1|STARTED|Overall Study||55
4968553|NCT02652208|12217828|P2|NOT COMPLETED|Overall Study||2
4968554|NCT02652208|12217829|P1|NOT COMPLETED|Overall Study||4
4968555|NCT02652208|12217828|P2|COMPLETED|Overall Study||15
4968556|NCT02652208|12217829|P1|COMPLETED|Overall Study||13
4968557|NCT02652208|12217828|P2|STARTED|Overall Study||17
4968558|NCT02652208|12217829|P1|STARTED|Overall Study||17
4968559|NCT02652156|12217842|P3|NOT COMPLETED|Overall Study||0
4968560|NCT02652156|12217843|P2|NOT COMPLETED|Overall Study||0
4968561|NCT02652156|12217844|P1|NOT COMPLETED|Overall Study||1
4968562|NCT02652156|12217842|P3|COMPLETED|Overall Study||4
4968563|NCT02652156|12217843|P2|COMPLETED|Overall Study||6
4968564|NCT02652156|12217844|P1|COMPLETED|Overall Study||3
4968565|NCT02652156|12217842|P3|STARTED|Overall Study||4
4968566|NCT02652156|12217843|P2|STARTED|Overall Study||6
4968567|NCT02652156|12217844|P1|STARTED|Overall Study||4
4968568|NCT02651922|12217870|P1|NOT COMPLETED|Overall Study||2
4968569|NCT02651922|12217870|P1|COMPLETED|Overall Study||154
4968570|NCT02651922|12217870|P1|STARTED|Overall Study||156
4968571|NCT02651688|12217890|P3|NOT COMPLETED|Overall Study||3
4968572|NCT02651688|12217891|P2|NOT COMPLETED|Overall Study||5
4968573|NCT02651688|12217892|P1|NOT COMPLETED|Overall Study||2
4968574|NCT02651688|12217890|P3|COMPLETED|Overall Study||12
4968575|NCT02651688|12217891|P2|COMPLETED|Overall Study||12
4968576|NCT02651688|12217892|P1|COMPLETED|Overall Study||16
4968577|NCT02651688|12217890|P3|STARTED|Overall Study||15
4968578|NCT02651688|12217891|P2|STARTED|Overall Study||17
4968579|NCT02651688|12217892|P1|STARTED|Overall Study||18
4968580|NCT02651584|12217959|P2|NOT COMPLETED|Overall Study||92
4968581|NCT02651584|12217960|P1|NOT COMPLETED|Overall Study||89
4968582|NCT02651584|12217959|P2|COMPLETED|Overall Study||121
4968583|NCT02651584|12217960|P1|COMPLETED|Overall Study||126
4968584|NCT02651584|12217959|P2|STARTED|Overall Study||213
4968585|NCT02651584|12217960|P1|STARTED|Overall Study||215
4968586|NCT02651467|12217975|P3|NOT COMPLETED|Overall Study||4
4968587|NCT02651467|12217976|P2|NOT COMPLETED|Overall Study||0
4968588|NCT02651467|12217977|P1|NOT COMPLETED|Overall Study||1
4968589|NCT02651467|12217975|P3|COMPLETED|Overall Study||69
4968590|NCT02651467|12217976|P2|COMPLETED|Overall Study||74
4968591|NCT02651467|12217977|P1|COMPLETED|Overall Study||73
4968592|NCT02651467|12217975|P3|STARTED|Overall Study||73
4968593|NCT02651467|12217976|P2|STARTED|Overall Study||74
4968594|NCT02651467|12217977|P1|STARTED|Overall Study||74
4968595|NCT02651415|12217996|P1|NOT COMPLETED|Overall Study||2
4968596|NCT02651415|12217996|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
4968597|NCT02651415|12217996|P1|STARTED|Overall Study|12 patients were enrolled.|12
4968598|NCT02651259|12218007|P2|NOT COMPLETED|Overall Study||0
4968599|NCT02651259|12218008|P1|NOT COMPLETED|Overall Study||0
4968600|NCT02651259|12218007|P2|COMPLETED|Overall Study||25
4968601|NCT02651259|12218008|P1|COMPLETED|Overall Study||25
4968602|NCT02651259|12218007|P2|STARTED|Overall Study||25
4968603|NCT02651259|12218008|P1|STARTED|Overall Study||25
4968604|NCT02651220|12218052|P3|NOT COMPLETED|Overall Study||29
4968605|NCT02651220|12218053|P2|NOT COMPLETED|Overall Study||27
4968606|NCT02651220|12218054|P1|NOT COMPLETED|Overall Study||23
4968607|NCT02651220|12218052|P3|COMPLETED|Overall Study||300
4968608|NCT02651220|12218053|P2|COMPLETED|Overall Study||308
4968609|NCT02651220|12218054|P1|COMPLETED|Overall Study||314
4968610|NCT02651220|12218052|P3|STARTED|Overall Study||329
4968611|NCT02651220|12218053|P2|STARTED|Overall Study||335
4968612|NCT02651220|12218054|P1|STARTED|Overall Study||337
4968613|NCT02651194|12218068|P1|NOT COMPLETED|Overall Study||5
4968614|NCT02651194|12218068|P1|COMPLETED|Overall Study||99
4968615|NCT02651194|12218068|P1|STARTED|Overall Study||104
4968616|NCT02651155|12218076|P2|NOT COMPLETED|Overall Study||2
4968617|NCT02651155|12218077|P1|NOT COMPLETED|Overall Study||6
4968618|NCT02651155|12218076|P2|COMPLETED|Overall Study||103
4968619|NCT02651155|12218077|P1|COMPLETED|Overall Study||93
4968620|NCT02651155|12218076|P2|STARTED|Overall Study||105
4968621|NCT02651155|12218077|P1|STARTED|Overall Study||99
4968622|NCT02651103|12218093|P1|NOT COMPLETED|Overall Study||0
4968623|NCT02651103|12218093|P1|COMPLETED|Overall Study||30
4968624|NCT02651103|12218093|P1|STARTED|Overall Study||30
4968625|NCT02650999|12218097|P1|NOT COMPLETED|Overall Study||0
4968626|NCT02650999|12218097|P1|COMPLETED|Overall Study||12
4968627|NCT02650999|12218097|P1|STARTED|Overall Study||12
4968628|NCT02650921|12218102|P1|NOT COMPLETED|Overall Study||8
4968629|NCT02650921|12218102|P1|COMPLETED|Overall Study||84
4968630|NCT02650921|12218102|P1|STARTED|Overall Study||92
4968631|NCT02650895|12218156|P6|NOT COMPLETED|Overall Study||0
4968632|NCT02650895|12218157|P5|NOT COMPLETED|Overall Study||0
4968633|NCT02650895|12218158|P4|NOT COMPLETED|Overall Study||0
4968634|NCT02650895|12218159|P3|NOT COMPLETED|Overall Study||0
4968635|NCT02650895|12218160|P2|NOT COMPLETED|Overall Study||1
4968636|NCT02650895|12218161|P1|NOT COMPLETED|Overall Study||0
4968637|NCT02650895|12218156|P6|COMPLETED|Overall Study||6
4968638|NCT02650895|12218157|P5|COMPLETED|Overall Study||6
4968639|NCT02650895|12218158|P4|COMPLETED|Overall Study||6
4968640|NCT02650895|12218159|P3|COMPLETED|Overall Study||6
4968641|NCT02650895|12218160|P2|COMPLETED|Overall Study||5
4968642|NCT02650895|12218161|P1|COMPLETED|Overall Study||10
4968643|NCT02650895|12218156|P6|STARTED|Overall Study||6
4968644|NCT02650895|12218157|P5|STARTED|Overall Study||6
4968645|NCT02650895|12218158|P4|STARTED|Overall Study||6
4968646|NCT02650895|12218159|P3|STARTED|Overall Study||6
4968647|NCT02650895|12218160|P2|STARTED|Overall Study||6
4968648|NCT02650895|12218161|P1|STARTED|Overall Study||10
4968649|NCT02650856|12218197|P2|NOT COMPLETED|Overall Study||0
4968650|NCT02650856|12218198|P1|NOT COMPLETED|Overall Study||0
4968651|NCT02650856|12218197|P2|COMPLETED|Overall Study||21
4968652|NCT02650856|12218198|P1|COMPLETED|Overall Study||19
4968653|NCT02650856|12218197|P2|72 Hours|Overall Study||21
4968654|NCT02650856|12218198|P1|72 Hours|Overall Study||19
4968655|NCT02650856|12218197|P2|48 Hours|Overall Study||21
4968656|NCT02650856|12218198|P1|48 Hours|Overall Study||19
4968657|NCT02650856|12218197|P2|24 Hours|Overall Study||21
4968658|NCT02650856|12218198|P1|24 Hours|Overall Study||19
4968659|NCT02650856|12218197|P2|Baseline|Overall Study||21
4968660|NCT02650856|12218198|P1|Baseline|Overall Study||19
4968661|NCT02650856|12218197|P2|STARTED|Overall Study||21
4968662|NCT02650856|12218198|P1|STARTED|Overall Study||19
4968663|NCT02650466|12218208|P1|NOT COMPLETED|Overall Study||7
4968664|NCT02650466|12218208|P1|COMPLETED|Overall Study||17
4968665|NCT02650466|12218208|P1|STARTED|Overall Study||24
4968666|NCT02650440|12218216|P2|NOT COMPLETED|Overall Study||2
4968667|NCT02650440|12218217|P1|NOT COMPLETED|Overall Study||0
4968668|NCT02650440|12218216|P2|COMPLETED|Overall Study||8
4968669|NCT02650440|12218217|P1|COMPLETED|Overall Study||10
4968670|NCT02650440|12218216|P2|STARTED|Overall Study||10
4968671|NCT02650440|12218217|P1|STARTED|Overall Study||10
4968672|NCT02650219|12218235|P2|NOT COMPLETED|Overall Study||0
4968673|NCT02650219|12218236|P1|NOT COMPLETED|Overall Study||0
4968674|NCT02650219|12218235|P2|COMPLETED|Overall Study||20
4968675|NCT02650219|12218236|P1|COMPLETED|Overall Study||40
4968676|NCT02650219|12218235|P2|STARTED|Overall Study||20
4968677|NCT02650219|12218236|P1|STARTED|Overall Study||40
4968678|NCT02650193|12218249|P3|NOT COMPLETED|Overall Study||0
4968679|NCT02650193|12218250|P2|NOT COMPLETED|Overall Study||0
4968680|NCT02650193|12218251|P1|NOT COMPLETED|Overall Study||0
4968681|NCT02650193|12218249|P3|COMPLETED|Overall Study||13
4968682|NCT02650193|12218250|P2|COMPLETED|Overall Study||6
4968683|NCT02650193|12218251|P1|COMPLETED|Overall Study||6
4968684|NCT02650193|12218249|P3|STARTED|Overall Study||13
4968685|NCT02650193|12218250|P2|STARTED|Overall Study||6
4968686|NCT02650193|12218251|P1|STARTED|Overall Study||6
4968687|NCT02650128|12218338|P1|NOT COMPLETED|Overall Study||2
4968688|NCT02650128|12218338|P1|COMPLETED|Overall Study||58
4968689|NCT02650128|12218338|P1|30 Day Primary and Safety Endpoint|Overall Study||60
4968690|NCT02650128|12218338|P1|STARTED|Overall Study||60
4968691|NCT02649946|12218347|P2|NOT COMPLETED|Overall Study||15
4968692|NCT02649946|12218348|P1|NOT COMPLETED|Overall Study||12
4968693|NCT02649946|12218347|P2|COMPLETED|Overall Study||123
4968694|NCT02649946|12218348|P1|COMPLETED|Overall Study||130
4968695|NCT02649946|12218347|P2|STARTED|Overall Study||138
4968696|NCT02649946|12218348|P1|STARTED|Overall Study||142
4968697|NCT02649842|12218375|P1|NOT COMPLETED|Overall Study||0
4968698|NCT02649842|12218375|P1|COMPLETED|Overall Study||101
4968699|NCT02649842|12218375|P1|STARTED|Overall Study||101
4968700|NCT02649634|12218383|P2|NOT COMPLETED|Overall Study||6
4968701|NCT02649634|12218384|P1|NOT COMPLETED|Overall Study||3
4968702|NCT02649634|12218383|P2|COMPLETED|Overall Study||60
4968703|NCT02649634|12218384|P1|COMPLETED|Overall Study||66
4968704|NCT02649634|12218383|P2|STARTED|Overall Study||66
4968705|NCT02649634|12218384|P1|STARTED|Overall Study||69
4968706|NCT02649608|12218440|P7|NOT COMPLETED|Overall Study||0
4968707|NCT02649608|12218441|P6|NOT COMPLETED|Overall Study||0
4968708|NCT02649608|12218442|P5|NOT COMPLETED|Overall Study||0
4968709|NCT02649608|12218443|P4|NOT COMPLETED|Overall Study||0
4968710|NCT02649608|12218444|P3|NOT COMPLETED|Overall Study||0
4968711|NCT02649608|12218445|P2|NOT COMPLETED|Overall Study||0
4968712|NCT02649608|12218446|P1|NOT COMPLETED|Overall Study||0
4968713|NCT02649608|12218440|P7|COMPLETED|Overall Study||1
4968714|NCT02649608|12218441|P6|COMPLETED|Overall Study||2
4968715|NCT02649608|12218442|P5|COMPLETED|Overall Study||3
4968716|NCT02649608|12218443|P4|COMPLETED|Overall Study||3
4968717|NCT02649608|12218444|P3|COMPLETED|Overall Study||3
4968718|NCT02649608|12218445|P2|COMPLETED|Overall Study||1
4968719|NCT02649608|12218446|P1|COMPLETED|Overall Study||2
4968720|NCT02649608|12218440|P7|STARTED|Overall Study||1
4968721|NCT02649608|12218441|P6|STARTED|Overall Study||2
4968722|NCT02649608|12218442|P5|STARTED|Overall Study||3
4968723|NCT02649608|12218443|P4|STARTED|Overall Study||3
4968724|NCT02649608|12218444|P3|STARTED|Overall Study||3
4968725|NCT02649608|12218445|P2|STARTED|Overall Study||1
4968726|NCT02649608|12218446|P1|STARTED|Overall Study||2
4968727|NCT02649322|12218490|P2|NOT COMPLETED|Overall Study||0
4968728|NCT02649322|12218491|P1|NOT COMPLETED|Overall Study||0
4968729|NCT02649322|12218490|P2|COMPLETED|Overall Study||57
4968730|NCT02649322|12218491|P1|COMPLETED|Overall Study||58
4968731|NCT02649322|12218490|P2|STARTED|Overall Study||57
4968732|NCT02649322|12218491|P1|STARTED|Overall Study||58
4968733|NCT02649192|12218507|P6|NOT COMPLETED|Overall Study||0
4968734|NCT02649192|12218508|P5|NOT COMPLETED|Overall Study||1
4968735|NCT02649192|12218509|P4|NOT COMPLETED|Overall Study||2
4968736|NCT02649192|12218510|P3|NOT COMPLETED|Overall Study||1
4968737|NCT02649192|12218511|P2|NOT COMPLETED|Overall Study||0
4968738|NCT02649192|12218512|P1|NOT COMPLETED|Overall Study||0
4968739|NCT02649192|12218507|P6|COMPLETED|Overall Study||14
4968740|NCT02649192|12218508|P5|COMPLETED|Overall Study||11
4968741|NCT02649192|12218509|P4|COMPLETED|Overall Study||20
4968742|NCT02649192|12218510|P3|COMPLETED|Overall Study||21
4968743|NCT02649192|12218511|P2|COMPLETED|Overall Study||4
4968744|NCT02649192|12218512|P1|COMPLETED|Overall Study||5
4968745|NCT02649192|12218507|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
4968746|NCT02649192|12218508|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
4968747|NCT02649192|12218509|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
4968748|NCT02649192|12218510|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
4968749|NCT02649192|12218511|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
4968750|NCT02649192|12218512|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
4968751|NCT02649192|12218507|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
4968752|NCT02649192|12218508|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
4968753|NCT02649192|12218509|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
4968754|NCT02649192|12218510|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
4968755|NCT02649192|12218511|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
4968756|NCT02649192|12218512|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
4968757|NCT02649192|12218507|P6|STARTED|Overall Study||14
4968758|NCT02649192|12218508|P5|STARTED|Overall Study||12
4968759|NCT02649192|12218509|P4|STARTED|Overall Study||22
4968760|NCT02649192|12218510|P3|STARTED|Overall Study||22
4968761|NCT02649192|12218511|P2|STARTED|Overall Study||4
4968762|NCT02649192|12218512|P1|STARTED|Overall Study||5
4968763|NCT02648698|12218570|P2|NOT COMPLETED|Overall Study||5
4968764|NCT02648698|12218571|P1|NOT COMPLETED|Overall Study||1
4968765|NCT02648698|12218570|P2|COMPLETED|Overall Study||55
4968766|NCT02648698|12218571|P1|COMPLETED|Overall Study||59
4968767|NCT02648698|12218570|P2|STARTED|Overall Study||60
4968768|NCT02648698|12218571|P1|STARTED|Overall Study||60
4968769|NCT02648646|12218577|P1|NOT COMPLETED|Overall Study||2
4968770|NCT02648646|12218577|P1|COMPLETED|Overall Study||8
4968771|NCT02648646|12218577|P1|STARTED|Overall Study||10
4968772|NCT02648438|12218628|P3|NOT COMPLETED|Overall Study||0
4968773|NCT02648438|12218629|P2|NOT COMPLETED|Overall Study||3
4968774|NCT02648438|12218630|P1|NOT COMPLETED|Overall Study||3
4968775|NCT02648438|12218628|P3|COMPLETED|Overall Study||6
4968776|NCT02648438|12218629|P2|COMPLETED|Overall Study||9
4968777|NCT02648438|12218630|P1|COMPLETED|Overall Study||9
4968778|NCT02648438|12218628|P3|STARTED|Overall Study||6
4968779|NCT02648438|12218629|P2|STARTED|Overall Study||12
4968780|NCT02648438|12218630|P1|STARTED|Overall Study||12
4968781|NCT02648230|12218670|P1|NOT COMPLETED|Overall Study||0
4968782|NCT02648230|12218670|P1|COMPLETED|Overall Study||74
4968783|NCT02648230|12218670|P1|STARTED|Overall Study||74
4968784|NCT02648217|12218676|P2|NOT COMPLETED|Overall Study||5
4968785|NCT02648217|12218677|P1|NOT COMPLETED|Overall Study||10
4968786|NCT02648217|12218676|P2|COMPLETED|Overall Study||127
4968787|NCT02648217|12218677|P1|COMPLETED|Overall Study||121
4968788|NCT02648217|12218676|P2|Exposed|Overall Study||132
4968789|NCT02648217|12218677|P1|Exposed|Overall Study||130
4968790|NCT02648217|12218676|P2|STARTED|Overall Study||132
4968791|NCT02648217|12218677|P1|STARTED|Overall Study||131
4968792|NCT02648204|12218699|P4|NOT COMPLETED|Overall Study||16
4968793|NCT02648204|12218700|P3|NOT COMPLETED|Overall Study||13
4968794|NCT02648204|12218701|P2|NOT COMPLETED|Overall Study||21
4968795|NCT02648204|12218702|P1|NOT COMPLETED|Overall Study||22
4968796|NCT02648204|12218699|P4|COMPLETED|Overall Study||284
4968797|NCT02648204|12218700|P3|COMPLETED|Overall Study||287
4968798|NCT02648204|12218701|P2|COMPLETED|Overall Study||279
4968799|NCT02648204|12218702|P1|COMPLETED|Overall Study||279
4968800|NCT02648204|12218699|P4|Exposed|Overall Study||299
4968801|NCT02648204|12218700|P3|Exposed|Overall Study||299
4968802|NCT02648204|12218701|P2|Exposed|Overall Study||300
4968803|NCT02648204|12218702|P1|Exposed|Overall Study||301
4968804|NCT02648204|12218699|P4|STARTED|Overall Study||300
4968805|NCT02648204|12218700|P3|STARTED|Overall Study||300
4968806|NCT02648204|12218701|P2|STARTED|Overall Study||300
4968807|NCT02648204|12218702|P1|STARTED|Overall Study||301
4968808|NCT02648178|12218820|P1|NOT COMPLETED|Overall Study||9
4968809|NCT02648178|12218820|P1|COMPLETED|Overall Study||10
4968810|NCT02648178|12218820|P1|STARTED|Overall Study||19
4968811|NCT02648022|12218827|P2|NOT COMPLETED|Overall Study||0
4968812|NCT02648022|12218828|P1|NOT COMPLETED|Overall Study||0
4968813|NCT02648022|12218827|P2|COMPLETED|Overall Study||39
4968814|NCT02648022|12218828|P1|COMPLETED|Overall Study||40
4968815|NCT02648022|12218827|P2|STARTED|Overall Study||39
4968816|NCT02648022|12218828|P1|STARTED|Overall Study||40
4968817|NCT02647944|12218840|P2|NOT COMPLETED|Overall Study||3
4968818|NCT02647944|12218841|P1|NOT COMPLETED|Overall Study||2
4968819|NCT02647944|12218840|P2|COMPLETED|Overall Study||18
4968820|NCT02647944|12218841|P1|COMPLETED|Overall Study||17
4968821|NCT02647944|12218840|P2|STARTED|Overall Study||21
4968822|NCT02647944|12218841|P1|STARTED|Overall Study||19
4968823|NCT02647905|12218865|P1|NOT COMPLETED|Overall Study||3
4968824|NCT02647905|12218865|P1|COMPLETED|Overall Study||87
4968825|NCT02647905|12218865|P1|STARTED|Overall Study||90
4968826|NCT02647866|12218875|P5|NOT COMPLETED|Overall Study||8
4968827|NCT02647866|12218876|P4|NOT COMPLETED|Overall Study||6
4968828|NCT02647866|12218877|P3|NOT COMPLETED|Overall Study||5
4968829|NCT02647866|12218878|P2|NOT COMPLETED|Overall Study||4
4968830|NCT02647866|12218879|P1|NOT COMPLETED|Overall Study||5
4968831|NCT02647866|12218875|P5|COMPLETED|Overall Study||9
4968832|NCT02647866|12218876|P4|COMPLETED|Overall Study||15
4968833|NCT02647866|12218877|P3|COMPLETED|Overall Study||4
4968834|NCT02647866|12218878|P2|COMPLETED|Overall Study||6
4968835|NCT02647866|12218879|P1|COMPLETED|Overall Study||4
4968836|NCT02647866|12218875|P5|Discontinued the Study|Overall Study||8
4968837|NCT02647866|12218876|P4|Discontinued the Study|Overall Study||6
4968838|NCT02647866|12218877|P3|Discontinued the Study|Overall Study||5
4968839|NCT02647866|12218878|P2|Discontinued the Study|Overall Study||4
4968840|NCT02647866|12218879|P1|Discontinued the Study|Overall Study||5
4968841|NCT02647866|12218875|P5|Discontinued the Treatment|Overall Study||8
4968842|NCT02647866|12218876|P4|Discontinued the Treatment|Overall Study||5
4968843|NCT02647866|12218877|P3|Discontinued the Treatment|Overall Study||5
4968844|NCT02647866|12218878|P2|Discontinued the Treatment|Overall Study||5
4968845|NCT02647866|12218879|P1|Discontinued the Treatment|Overall Study||4
4968846|NCT02647866|12218875|P5|Moved From LTE to OLE Therapy|Overall Study||2
4968847|NCT02647866|12218876|P4|Moved From LTE to OLE Therapy|Overall Study||0
4968848|NCT02647866|12218877|P3|Moved From LTE to OLE Therapy|Overall Study||0
4968849|NCT02647866|12218878|P2|Moved From LTE to OLE Therapy|Overall Study||5
4968850|NCT02647866|12218879|P1|Moved From LTE to OLE Therapy|Overall Study||0
4968851|NCT02647866|12218875|P5|Completed OLE Follow-up|Overall Study||10
4968852|NCT02647866|12218876|P4|Completed OLE Follow-up|Overall Study||14
4968853|NCT02647866|12218877|P3|Completed OLE Follow-up|Overall Study||4
4968854|NCT02647866|12218878|P2|Completed OLE Follow-up|Overall Study||6
4968855|NCT02647866|12218879|P1|Completed OLE Follow-up|Overall Study||0
4968856|NCT02647866|12218875|P5|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
4968857|NCT02647866|12218876|P4|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
4968858|NCT02647866|12218877|P3|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
4968859|NCT02647866|12218878|P2|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
4968860|NCT02647866|12218879|P1|Completed Open-Label Extension Therapy|Overall Study||0
4968861|NCT02647866|12218875|P5|Completed LTE Follow-up|Overall Study||0
4968862|NCT02647866|12218876|P4|Completed LTE Follow-up|Overall Study||0
4968863|NCT02647866|12218877|P3|Completed LTE Follow-up|Overall Study||0
4968864|NCT02647866|12218878|P2|Completed LTE Follow-up|Overall Study||0
4968865|NCT02647866|12218879|P1|Completed LTE Follow-up|Overall Study||2
4968866|NCT02647866|12218875|P5|Completed Long-Term Extension Therapy|Overall Study||0
4968867|NCT02647866|12218876|P4|Completed Long-Term Extension Therapy|Overall Study||0
4968868|NCT02647866|12218877|P3|Completed Long-Term Extension Therapy|Overall Study||0
4968869|NCT02647866|12218878|P2|Completed Long-Term Extension Therapy|Overall Study||0
4968870|NCT02647866|12218879|P1|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
4968871|NCT02647866|12218875|P5|Completed Induction Therapy Follow-Up|Overall Study||2
4968872|NCT02647866|12218876|P4|Completed Induction Therapy Follow-Up|Overall Study||0
4968873|NCT02647866|12218877|P3|Completed Induction Therapy Follow-Up|Overall Study||2
4968874|NCT02647866|12218878|P2|Completed Induction Therapy Follow-Up|Overall Study||1
4968875|NCT02647866|12218879|P1|Completed Induction Therapy Follow-Up|Overall Study||5
4968876|NCT02647866|12218875|P5|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
4968877|NCT02647866|12218876|P4|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
4968878|NCT02647866|12218877|P3|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
4968879|NCT02647866|12218878|P2|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
4968880|NCT02647866|12218879|P1|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
4968881|NCT02647866|12218875|P5|STARTED|Overall Study||17
4968882|NCT02647866|12218876|P4|STARTED|Overall Study||21
4968883|NCT02647866|12218877|P3|STARTED|Overall Study||9
4968884|NCT02647866|12218878|P2|STARTED|Overall Study||10
4968885|NCT02647866|12218879|P1|STARTED|Overall Study||9
4968886|NCT02647788|12218956|P2|NOT COMPLETED|Overall Study||13
4968887|NCT02647788|12218957|P1|NOT COMPLETED|Overall Study||16
4968888|NCT02647788|12218956|P2|COMPLETED|Overall Study||57
4968889|NCT02647788|12218957|P1|COMPLETED|Overall Study||54
4968890|NCT02647788|12218956|P2|STARTED|Overall Study||70
4968891|NCT02647788|12218957|P1|STARTED|Overall Study||70
4968892|NCT02647658|12218969|P2|NOT COMPLETED|Overall Study||24
4968893|NCT02647658|12218970|P1|NOT COMPLETED|Overall Study||15
4968894|NCT02647658|12218969|P2|COMPLETED|Overall Study||1069
4968895|NCT02647658|12218970|P1|COMPLETED|Overall Study||1192
4968896|NCT02647658|12218969|P2|6 Month Assessment|Overall Study||635
4968897|NCT02647658|12218970|P1|6 Month Assessment|Overall Study||658
4968898|NCT02647658|12218969|P2|STARTED|Overall Study||1093
4968899|NCT02647658|12218970|P1|STARTED|Overall Study||1207
4968900|NCT02647645|12218998|P2|NOT COMPLETED|Overall Study||1
4968901|NCT02647645|12218999|P1|NOT COMPLETED|Overall Study||2
4968902|NCT02647645|12218998|P2|COMPLETED|Overall Study||9
4968903|NCT02647645|12218999|P1|COMPLETED|Overall Study||9
4968904|NCT02647645|12218998|P2|STARTED|Overall Study||10
4968905|NCT02647645|12218999|P1|STARTED|Overall Study||11
4968906|NCT02647346|12219009|P1|NOT COMPLETED|Overall Study||3
4968907|NCT02647346|12219009|P1|COMPLETED|Overall Study||129
4968908|NCT02647346|12219009|P1|STARTED|Overall Study||132
4968909|NCT02647320|12219021|P5|NOT COMPLETED|Overall Study||17
4968910|NCT02647320|12219022|P4|NOT COMPLETED|Overall Study||10
4968911|NCT02647320|12219023|P3|NOT COMPLETED|Overall Study||15
4968912|NCT02647320|12219024|P2|NOT COMPLETED|Overall Study||11
4968913|NCT02647320|12219025|P1|NOT COMPLETED|Overall Study||12
4968914|NCT02647320|12219021|P5|COMPLETED|Overall Study||52
4968915|NCT02647320|12219022|P4|COMPLETED|Overall Study||58
4968916|NCT02647320|12219023|P3|COMPLETED|Overall Study||54
4968917|NCT02647320|12219024|P2|COMPLETED|Overall Study||35
4968918|NCT02647320|12219025|P1|COMPLETED|Overall Study||34
4968919|NCT02647320|12219021|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
4968920|NCT02647320|12219022|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
4968921|NCT02647320|12219023|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
4968922|NCT02647320|12219024|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
4968923|NCT02647320|12219025|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
4968924|NCT02647320|12219021|P5|Safety Set|Overall Study||69
4968925|NCT02647320|12219022|P4|Safety Set|Overall Study||68
4968926|NCT02647320|12219023|P3|Safety Set|Overall Study||68
4968927|NCT02647320|12219024|P2|Safety Set|Overall Study||44
4968928|NCT02647320|12219025|P1|Safety Set|Overall Study||43
4968929|NCT02647320|12219021|P5|Inadvertently Randomized|Overall Study||0
4968930|NCT02647320|12219022|P4|Inadvertently Randomized|Overall Study||1
4968931|NCT02647320|12219023|P3|Inadvertently Randomized|Overall Study||0
4968932|NCT02647320|12219024|P2|Inadvertently Randomized|Overall Study||0
4968933|NCT02647320|12219025|P1|Inadvertently Randomized|Overall Study||0
4968934|NCT02647320|12219021|P5|STARTED|Overall Study||69
4968935|NCT02647320|12219022|P4|STARTED|Overall Study||68
4968936|NCT02647320|12219023|P3|STARTED|Overall Study||69
4968937|NCT02647320|12219024|P2|STARTED|Overall Study||46
4968938|NCT02647320|12219025|P1|STARTED|Overall Study||46
4968939|NCT02647281|12219116|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
4968940|NCT02647281|12219117|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968941|NCT02647281|12219118|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968942|NCT02647281|12219119|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968943|NCT02647281|12219120|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968944|NCT02647281|12219121|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968945|NCT02647281|12219122|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968946|NCT02647281|12219123|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968947|NCT02647281|12219124|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968948|NCT02647281|12219116|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
4968949|NCT02647281|12219117|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968950|NCT02647281|12219118|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968951|NCT02647281|12219119|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968952|NCT02647281|12219120|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968953|NCT02647281|12219121|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968954|NCT02647281|12219122|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968955|NCT02647281|12219123|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968956|NCT02647281|12219124|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968957|NCT02647281|12219116|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968958|NCT02647281|12219117|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968959|NCT02647281|12219118|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968960|NCT02647281|12219119|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
4968961|NCT02647281|12219120|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968962|NCT02647281|12219121|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968963|NCT02647281|12219122|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968964|NCT02647281|12219123|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968965|NCT02647281|12219124|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
4968966|NCT02647281|12219116|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968967|NCT02647281|12219117|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968968|NCT02647281|12219118|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968969|NCT02647281|12219119|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968970|NCT02647281|12219120|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968971|NCT02647281|12219121|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968972|NCT02647281|12219122|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968973|NCT02647281|12219123|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968974|NCT02647281|12219124|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968975|NCT02647281|12219116|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968976|NCT02647281|12219117|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968977|NCT02647281|12219118|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968978|NCT02647281|12219119|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
4968979|NCT02647281|12219120|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
4968980|NCT02647281|12219121|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
4968981|NCT02647281|12219122|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
4968982|NCT02647281|12219123|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
4968983|NCT02647281|12219124|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
4968984|NCT02647281|12219116|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
4968985|NCT02647281|12219117|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
4968986|NCT02647281|12219118|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
4968987|NCT02647281|12219119|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
4968988|NCT02647281|12219120|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
4968989|NCT02647281|12219121|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
4968990|NCT02647281|12219122|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
4968991|NCT02647281|12219123|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
4968992|NCT02647281|12219124|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
4968993|NCT02646891|12219312|P10|NOT COMPLETED|Overall Study||5
4968994|NCT02646891|12219313|P9|NOT COMPLETED|Overall Study||10
4968995|NCT02646891|12219314|P8|NOT COMPLETED|Overall Study||13
4968996|NCT02646891|12219315|P7|NOT COMPLETED|Overall Study||9
4968997|NCT02646891|12219316|P6|NOT COMPLETED|Overall Study||0
4968998|NCT02646891|12219317|P5|NOT COMPLETED|Overall Study||0
4968999|NCT02646891|12219318|P4|NOT COMPLETED|Overall Study||0
4969000|NCT02646891|12219319|P3|NOT COMPLETED|Overall Study||1
4969001|NCT02646891|12219320|P2|NOT COMPLETED|Overall Study||1
4969002|NCT02646891|12219321|P1|NOT COMPLETED|Overall Study||2
4969003|NCT02646891|12219312|P10|COMPLETED|Overall Study||134
4969004|NCT02646891|12219313|P9|COMPLETED|Overall Study||130
4969005|NCT02646891|12219314|P8|COMPLETED|Overall Study||127
4969006|NCT02646891|12219315|P7|COMPLETED|Overall Study||130
4969007|NCT02646891|12219316|P6|COMPLETED|Overall Study||12
4969008|NCT02646891|12219317|P5|COMPLETED|Overall Study||12
4969009|NCT02646891|12219318|P4|COMPLETED|Overall Study||6
4969010|NCT02646891|12219319|P3|COMPLETED|Overall Study||11
4969011|NCT02646891|12219320|P2|COMPLETED|Overall Study||11
4969012|NCT02646891|12219321|P1|COMPLETED|Overall Study||4
4969013|NCT02646891|12219312|P10|Received at Least 1 Dose|Overall Study||139
4969014|NCT02646891|12219313|P9|Received at Least 1 Dose|Overall Study||140
4969015|NCT02646891|12219314|P8|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
4969016|NCT02646891|12219315|P7|Received at Least 1 Dose|Overall Study||139
4969017|NCT02646891|12219316|P6|Received at Least 1 Dose|Overall Study||12
4969018|NCT02646891|12219317|P5|Received at Least 1 Dose|Overall Study||12
4969019|NCT02646891|12219318|P4|Received at Least 1 Dose|Overall Study||6
4969020|NCT02646891|12219319|P3|Received at Least 1 Dose|Overall Study||12
4969021|NCT02646891|12219320|P2|Received at Least 1 Dose|Overall Study||12
4969022|NCT02646891|12219321|P1|Received at Least 1 Dose|Overall Study||6
4969023|NCT02646891|12219312|P10|STARTED|Overall Study||139
4969024|NCT02646891|12219313|P9|STARTED|Overall Study||140
4969025|NCT02646891|12219314|P8|STARTED|Overall Study||140
4969026|NCT02646891|12219315|P7|STARTED|Overall Study||139
4969027|NCT02646891|12219316|P6|STARTED|Overall Study||12
4969028|NCT02646891|12219317|P5|STARTED|Overall Study||12
4969029|NCT02646891|12219318|P4|STARTED|Overall Study||6
4969030|NCT02646891|12219319|P3|STARTED|Overall Study||12
4969031|NCT02646891|12219320|P2|STARTED|Overall Study||12
4969032|NCT02646891|12219321|P1|STARTED|Overall Study||6
4969033|NCT02646826|12219449|P4|NOT COMPLETED|Overall Study||1
4969034|NCT02646826|12219450|P3|NOT COMPLETED|Overall Study||1
4969035|NCT02646826|12219451|P2|NOT COMPLETED|Overall Study||0
4969036|NCT02646826|12219452|P1|NOT COMPLETED|Overall Study||2
4969037|NCT02646826|12219449|P4|COMPLETED|Overall Study||21
4969038|NCT02646826|12219450|P3|COMPLETED|Overall Study||20
4969039|NCT02646826|12219451|P2|COMPLETED|Overall Study||22
4969040|NCT02646826|12219452|P1|COMPLETED|Overall Study||19
4969041|NCT02646826|12219449|P4|STARTED|Overall Study||22
4969042|NCT02646826|12219450|P3|STARTED|Overall Study||21
4969043|NCT02646826|12219451|P2|STARTED|Overall Study||22
4969044|NCT02646826|12219452|P1|STARTED|Overall Study||21
4969045|NCT02646761|12219476|P2|NOT COMPLETED|Overall Study||10
4969046|NCT02646761|12219477|P1|NOT COMPLETED|Overall Study||8
4969047|NCT02646761|12219476|P2|COMPLETED|Overall Study||10
4969048|NCT02646761|12219477|P1|COMPLETED|Overall Study||10
4969049|NCT02646761|12219476|P2|5-week Assessment|Overall Study||10
4969050|NCT02646761|12219477|P1|5-week Assessment|Overall Study||12
4969051|NCT02646761|12219476|P2|Baseline Assessment|Overall Study||12
4969052|NCT02646761|12219477|P1|Baseline Assessment|Overall Study||13
4969053|NCT02646761|12219476|P2|Subject Withdrew Before Baseline|Overall Study||8
4969054|NCT02646761|12219477|P1|Subject Withdrew Before Baseline|Overall Study||5
4969055|NCT02646761|12219476|P2|STARTED|Overall Study||20
4969056|NCT02646761|12219477|P1|STARTED|Overall Study||18
4969057|NCT02646566|12219495|P3|NOT COMPLETED|Overall Study||5
4969058|NCT02646566|12219496|P2|NOT COMPLETED|Overall Study||4
4969059|NCT02646566|12219497|P1|NOT COMPLETED|Overall Study||6
4969060|NCT02646566|12219495|P3|COMPLETED|Overall Study||230
4969061|NCT02646566|12219496|P2|COMPLETED|Overall Study||226
4969062|NCT02646566|12219497|P1|COMPLETED|Overall Study||231
4969063|NCT02646566|12219495|P3|STARTED|Overall Study||235
4969064|NCT02646566|12219496|P2|STARTED|Overall Study||230
4969065|NCT02646566|12219497|P1|STARTED|Overall Study||237
4969066|NCT02646449|12219537|P2|NOT COMPLETED|Overall Study||0
4969067|NCT02646449|12219538|P1|NOT COMPLETED|Overall Study||0
4969068|NCT02646449|12219537|P2|COMPLETED|Overall Study||3
4969069|NCT02646449|12219538|P1|COMPLETED|Overall Study||4
4969070|NCT02646449|12219537|P2|STARTED|Overall Study||3
4969071|NCT02646449|12219538|P1|STARTED|Overall Study||4
4969072|NCT02646124|12219548|P2|NOT COMPLETED|Overall Study||2
4969073|NCT02646124|12219549|P1|NOT COMPLETED|Overall Study||0
4969074|NCT02646124|12219548|P2|COMPLETED|Overall Study||55
4969075|NCT02646124|12219549|P1|COMPLETED|Overall Study||57
4969076|NCT02646124|12219548|P2|STARTED|Overall Study||57
4969077|NCT02646124|12219549|P1|STARTED|Overall Study||57
4969078|NCT02645760|12219565|P2|NOT COMPLETED|Overall Study||0
4969079|NCT02645760|12219566|P1|NOT COMPLETED|Overall Study||0
4969080|NCT02645760|12219565|P2|COMPLETED|Overall Study||19
4969081|NCT02645760|12219566|P1|COMPLETED|Overall Study||19
4969082|NCT02645760|12219565|P2|STARTED|Overall Study||19
4969083|NCT02645760|12219566|P1|STARTED|Overall Study||19
4969084|NCT02645617|12219578|P1|NOT COMPLETED|Overall Study||0
4969085|NCT02645617|12219578|P1|COMPLETED|Overall Study||12
4969086|NCT02645617|12219578|P1|STARTED|Overall Study||12
4969087|NCT02645409|12219585|P2|NOT COMPLETED|Overall Study||0
4969088|NCT02645409|12219586|P1|NOT COMPLETED|Overall Study||4
4969089|NCT02645409|12219585|P2|COMPLETED|Overall Study||0
4969090|NCT02645409|12219586|P1|COMPLETED|Overall Study||10
4969091|NCT02645409|12219585|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
4969092|NCT02645409|12219586|P1|STARTED|Overall Study||14
4969093|NCT02645253|12219595|P4|NOT COMPLETED|Overall Study||0
4969094|NCT02645253|12219596|P3|NOT COMPLETED|Overall Study||0
4969095|NCT02645253|12219597|P2|NOT COMPLETED|Overall Study||0
4969096|NCT02645253|12219598|P1|NOT COMPLETED|Overall Study||0
4969097|NCT02645253|12219595|P4|COMPLETED|Overall Study||6
4969098|NCT02645253|12219596|P3|COMPLETED|Overall Study||7
4969099|NCT02645253|12219597|P2|COMPLETED|Overall Study||7
4969100|NCT02645253|12219598|P1|COMPLETED|Overall Study||7
4969101|NCT02645253|12219595|P4|STARTED|Overall Study||6
4969102|NCT02645253|12219596|P3|STARTED|Overall Study||7
4969103|NCT02645253|12219597|P2|STARTED|Overall Study||7
4969104|NCT02645253|12219598|P1|STARTED|Overall Study||7
4969105|NCT02645123|12219720|P3|NOT COMPLETED|Overall Study||0
4969106|NCT02645123|12219721|P2|NOT COMPLETED|Overall Study||0
4969107|NCT02645123|12219722|P1|NOT COMPLETED|Overall Study||0
4969108|NCT02645123|12219720|P3|COMPLETED|Overall Study||25
4969109|NCT02645123|12219721|P2|COMPLETED|Overall Study||25
4969110|NCT02645123|12219722|P1|COMPLETED|Overall Study||25
4969111|NCT02645123|12219720|P3|STARTED|Overall Study||25
4969112|NCT02645123|12219721|P2|STARTED|Overall Study||25
4969113|NCT02645123|12219722|P1|STARTED|Overall Study||25
4969114|NCT02645019|12219744|P5|NOT COMPLETED|Overall Study||0
4969115|NCT02645019|12219745|P4|NOT COMPLETED|Overall Study||0
4969116|NCT02645019|12219746|P3|NOT COMPLETED|Overall Study||0
4969117|NCT02645019|12219747|P2|NOT COMPLETED|Overall Study||0
4969118|NCT02645019|12219748|P1|NOT COMPLETED|Overall Study||0
4969119|NCT02645019|12219744|P5|COMPLETED|Overall Study||24
4969120|NCT02645019|12219745|P4|COMPLETED|Overall Study||33
4969121|NCT02645019|12219746|P3|COMPLETED|Overall Study||15
4969122|NCT02645019|12219747|P2|COMPLETED|Overall Study||15
4969123|NCT02645019|12219748|P1|COMPLETED|Overall Study||13
4969124|NCT02645019|12219744|P5|STARTED|Overall Study||24
4969125|NCT02645019|12219745|P4|STARTED|Overall Study||33
4969126|NCT02645019|12219746|P3|STARTED|Overall Study||15
4969127|NCT02645019|12219747|P2|STARTED|Overall Study||15
4969128|NCT02645019|12219748|P1|STARTED|Overall Study||13
4969129|NCT02644356|12219770|P1|NOT COMPLETED|Overall Study||2
4969130|NCT02644356|12219770|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
4969131|NCT02644356|12219770|P1|STARTED|Overall Study||51
4969132|NCT02644278|12219784|P4|NOT COMPLETED|Overall Study||0
4969133|NCT02644278|12219785|P3|NOT COMPLETED|Overall Study||0
4969134|NCT02644278|12219786|P2|NOT COMPLETED|Overall Study||0
4969135|NCT02644278|12219787|P1|NOT COMPLETED|Overall Study||0
4969136|NCT02644278|12219784|P4|COMPLETED|Overall Study||3
4969137|NCT02644278|12219785|P3|COMPLETED|Overall Study||6
4969138|NCT02644278|12219786|P2|COMPLETED|Overall Study||3
4969139|NCT02644278|12219787|P1|COMPLETED|Overall Study||3
4969140|NCT02644278|12219784|P4|STARTED|Overall Study||3
4969141|NCT02644278|12219785|P3|STARTED|Overall Study||6
4969142|NCT02644278|12219786|P2|STARTED|Overall Study||3
4969143|NCT02644278|12219787|P1|STARTED|Overall Study||3
4969144|NCT02644122|12219853|P1|NOT COMPLETED|Overall Study||1
4969145|NCT02644122|12219853|P1|COMPLETED|Overall Study||0
4969146|NCT02644122|12219853|P1|STARTED|Overall Study||1
4969147|NCT02644109|12219863|P2|NOT COMPLETED|Overall Study||4
4969148|NCT02644109|12219864|P1|NOT COMPLETED|Overall Study||0
4969149|NCT02644109|12219863|P2|COMPLETED|Overall Study||24
4969150|NCT02644109|12219864|P1|COMPLETED|Overall Study||24
4969151|NCT02644109|12219863|P2|STARTED|Overall Study||28
4969152|NCT02644109|12219864|P1|STARTED|Overall Study||24
4969153|NCT02644096|12219872|P2|NOT COMPLETED|Overall Study||25
4969154|NCT02644096|12219873|P1|NOT COMPLETED|Overall Study||28
4969155|NCT02644096|12219872|P2|COMPLETED|Overall Study||57
4969156|NCT02644096|12219873|P1|COMPLETED|Overall Study||65
4969157|NCT02644096|12219872|P2|9 Month SF-36 Questionnaire|Overall Study||57
4969158|NCT02644096|12219873|P1|9 Month SF-36 Questionnaire|Overall Study||65
4969159|NCT02644096|12219872|P2|12 Week SF-36 Questionnaire|Overall Study||59
4969160|NCT02644096|12219873|P1|12 Week SF-36 Questionnaire|Overall Study||68
4969161|NCT02644096|12219872|P2|10 Week Interview|Overall Study||59
4969162|NCT02644096|12219873|P1|10 Week Interview|Overall Study|Not done in control group|0
4969163|NCT02644096|12219872|P2|2 Week Interview|Overall Study||68
4969164|NCT02644096|12219873|P1|2 Week Interview|Overall Study|Not done in control group|0
4969165|NCT02644096|12219872|P2|STARTED|Overall Study||82
4969166|NCT02644096|12219873|P1|STARTED|Overall Study||93
4969167|NCT02643979|12219881|P2|NOT COMPLETED|Overall Study||0
4969168|NCT02643979|12219882|P1|NOT COMPLETED|Overall Study||0
4969169|NCT02643979|12219881|P2|COMPLETED|Overall Study||11
4969170|NCT02643979|12219882|P1|COMPLETED|Overall Study||11
4969171|NCT02643979|12219881|P2|STARTED|Overall Study||11
4969172|NCT02643979|12219882|P1|STARTED|Overall Study||11
4969173|NCT02643862|12219902|P2|NOT COMPLETED|Overall Study||0
4969174|NCT02643862|12219903|P1|NOT COMPLETED|Overall Study||0
4969175|NCT02643862|12219902|P2|COMPLETED|Overall Study||12
4969176|NCT02643862|12219903|P1|COMPLETED|Overall Study||36
4969177|NCT02643862|12219902|P2|STARTED|Overall Study||12
4969178|NCT02643862|12219903|P1|STARTED|Overall Study||36
4969179|NCT02643693|12219911|P6|NOT COMPLETED|Overall Study||1
4969180|NCT02643693|12219912|P5|NOT COMPLETED|Overall Study||0
4969181|NCT02643693|12219913|P4|NOT COMPLETED|Overall Study||0
4969182|NCT02643693|12219914|P3|NOT COMPLETED|Overall Study||1
4969183|NCT02643693|12219915|P2|NOT COMPLETED|Overall Study||2
4969184|NCT02643693|12219916|P1|NOT COMPLETED|Overall Study||2
4969185|NCT02643693|12219911|P6|COMPLETED|Overall Study||3
4969186|NCT02643693|12219912|P5|COMPLETED|Overall Study||4
4969187|NCT02643693|12219913|P4|COMPLETED|Overall Study||4
4969188|NCT02643693|12219914|P3|COMPLETED|Overall Study||3
4969189|NCT02643693|12219915|P2|COMPLETED|Overall Study||2
4969190|NCT02643693|12219916|P1|COMPLETED|Overall Study||2
4969191|NCT02643693|12219911|P6|STARTED|Overall Study||4
4969192|NCT02643693|12219912|P5|STARTED|Overall Study||4
4969193|NCT02643693|12219913|P4|STARTED|Overall Study||4
4969194|NCT02643693|12219914|P3|STARTED|Overall Study||4
4969195|NCT02643693|12219915|P2|STARTED|Overall Study||4
4969196|NCT02643693|12219916|P1|STARTED|Overall Study||4
4969197|NCT02643628|12219929|P2|NOT COMPLETED|Overall Study||6
4969198|NCT02643628|12219930|P1|NOT COMPLETED|Overall Study||1
4969199|NCT02643628|12219929|P2|COMPLETED|Overall Study||17
4969200|NCT02643628|12219930|P1|COMPLETED|Overall Study||20
4969201|NCT02643628|12219929|P2|STARTED|Overall Study||23
4969202|NCT02643628|12219930|P1|STARTED|Overall Study||21
4969203|NCT02643615|12219946|P2|NOT COMPLETED|Overall Study||0
4969204|NCT02643615|12219947|P1|NOT COMPLETED|Overall Study||0
4969205|NCT02643615|12219946|P2|COMPLETED|Overall Study||11
4969206|NCT02643615|12219947|P1|COMPLETED|Overall Study||9
4969207|NCT02643615|12219946|P2|STARTED|Overall Study||11
4969208|NCT02643615|12219947|P1|STARTED|Overall Study||9
4969209|NCT02643472|12219961|P2|NOT COMPLETED|Overall Study||34
4969210|NCT02643472|12219962|P1|NOT COMPLETED|Overall Study||27
4969211|NCT02643472|12219961|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
4969212|NCT02643472|12219962|P1|COMPLETED|Overall Study||123
4969213|NCT02643472|12219961|P2|STARTED|Overall Study||150
4969214|NCT02643472|12219962|P1|STARTED|Overall Study||150
4969215|NCT02643394|12219988|P2|NOT COMPLETED|Overall Study||5
4969216|NCT02643394|12219989|P1|NOT COMPLETED|Overall Study||4
4969217|NCT02643394|12219988|P2|COMPLETED|Overall Study||50
4969218|NCT02643394|12219989|P1|COMPLETED|Overall Study||51
4969219|NCT02643394|12219988|P2|STARTED|Overall Study||55
4969220|NCT02643394|12219989|P1|STARTED|Overall Study||55
4969221|NCT02643355|12219999|P2|NOT COMPLETED|Overall Study||5
4969222|NCT02643355|12220000|P1|NOT COMPLETED|Overall Study||1
4969223|NCT02643355|12219999|P2|COMPLETED|Overall Study||30
4969224|NCT02643355|12220000|P1|COMPLETED|Overall Study||33
4969225|NCT02643355|12219999|P2|STARTED|Overall Study||35
4969226|NCT02643355|12220000|P1|STARTED|Overall Study||34
4969227|NCT02643251|12220014|P2|NOT COMPLETED|Overall Study||2
4969228|NCT02643251|12220015|P1|NOT COMPLETED|Overall Study||11
4969229|NCT02643251|12220014|P2|COMPLETED|Overall Study||67
4969230|NCT02643251|12220015|P1|COMPLETED|Overall Study||58
4969231|NCT02643251|12220014|P2|STARTED|Overall Study||69
4969232|NCT02643251|12220015|P1|STARTED|Overall Study||69
4969233|NCT02643225|12220025|P2|NOT COMPLETED|Overall Study||0
4969234|NCT02643225|12220026|P1|NOT COMPLETED|Overall Study||0
4969235|NCT02643225|12220025|P2|COMPLETED|Overall Study||40
4969236|NCT02643225|12220026|P1|COMPLETED|Overall Study||40
4969237|NCT02643225|12220025|P2|STARTED|Overall Study||40
4969238|NCT02643225|12220026|P1|STARTED|Overall Study||40
4969239|NCT02643199|12220038|P1|NOT COMPLETED|Overall Study||0
4969240|NCT02643199|12220038|P1|COMPLETED|Overall Study||90
4969241|NCT02643199|12220038|P1|STARTED|Overall Study||90
4969242|NCT02643095|12220043|P1|NOT COMPLETED|Overall Study||1
4969243|NCT02643095|12220043|P1|COMPLETED|Overall Study||21
4969244|NCT02643095|12220043|P1|STARTED|Overall Study||22
4969245|NCT02643082|12220047|P2|NOT COMPLETED|Period 2||0
4969246|NCT02643082|12220048|P1|NOT COMPLETED|Period 2||0
4969247|NCT02643082|12220047|P2|COMPLETED|Period 2||10
4969248|NCT02643082|12220048|P1|COMPLETED|Period 2||9
4969249|NCT02643082|12220047|P2|STARTED|Period 2||10
4969250|NCT02643082|12220048|P1|STARTED|Period 2||9
4969251|NCT02643082|12220047|P2|NOT COMPLETED|Washout||0
4969252|NCT02643082|12220048|P1|NOT COMPLETED|Washout||0
4969253|NCT02643082|12220047|P2|COMPLETED|Washout||10
4969254|NCT02643082|12220048|P1|COMPLETED|Washout||9
4969255|NCT02643082|12220047|P2|STARTED|Washout||10
4969256|NCT02643082|12220048|P1|STARTED|Washout||9
4969257|NCT02643082|12220047|P2|NOT COMPLETED|Period 1||0
4969258|NCT02643082|12220048|P1|NOT COMPLETED|Period 1||1
4969259|NCT02643082|12220047|P2|COMPLETED|Period 1||10
4969260|NCT02643082|12220048|P1|COMPLETED|Period 1||9
4969261|NCT02643082|12220047|P2|STARTED|Period 1||10
4969262|NCT02643082|12220048|P1|STARTED|Period 1||10
4969263|NCT02643004|12220065|P2|NOT COMPLETED|Second Intervention (One Week)||0
4969264|NCT02643004|12220066|P1|NOT COMPLETED|Second Intervention (One Week)||0
4969265|NCT02643004|12220065|P2|COMPLETED|Second Intervention (One Week)||35
4969266|NCT02643004|12220066|P1|COMPLETED|Second Intervention (One Week)||35
4969267|NCT02643004|12220065|P2|STARTED|Second Intervention (One Week)||35
4969268|NCT02643004|12220066|P1|STARTED|Second Intervention (One Week)||35
4969269|NCT02643004|12220065|P2|NOT COMPLETED|First Intervention (One Week)||0
4969270|NCT02643004|12220066|P1|NOT COMPLETED|First Intervention (One Week)||0
4969271|NCT02643004|12220065|P2|COMPLETED|First Intervention (One Week)||35
4969272|NCT02643004|12220066|P1|COMPLETED|First Intervention (One Week)||35
4969273|NCT02643004|12220065|P2|STARTED|First Intervention (One Week)||35
4969274|NCT02643004|12220066|P1|STARTED|First Intervention (One Week)||35
4969275|NCT02642965|12220106|P1|NOT COMPLETED|Overall Study||13
4969276|NCT02642965|12220106|P1|COMPLETED|Overall Study||25
4969277|NCT02642965|12220106|P1|STARTED|Overall Study||38
4969278|NCT02642952|12220122|P2|NOT COMPLETED|Overall Study||5
4969279|NCT02642952|12220123|P1|NOT COMPLETED|Overall Study||2
4969280|NCT02642952|12220122|P2|COMPLETED|Overall Study||25
4969281|NCT02642952|12220123|P1|COMPLETED|Overall Study||19
4969282|NCT02642952|12220122|P2|STARTED|Overall Study||30
4969283|NCT02642952|12220123|P1|STARTED|Overall Study||21
4969284|NCT02642835|12220137|P1|NOT COMPLETED|Overall Study||0
4969285|NCT02642835|12220137|P1|COMPLETED|Overall Study||48
4969286|NCT02642835|12220137|P1|STARTED|Overall Study||48
4969287|NCT02642679|12220150|P1|NOT COMPLETED|Overall Study||3
4969288|NCT02642679|12220150|P1|COMPLETED|Overall Study||16
4969289|NCT02642679|12220150|P1|STARTED|Overall Study||19
4969290|NCT02642653|12220158|P2|NOT COMPLETED|Overall Study||0
4969291|NCT02642653|12220159|P1|NOT COMPLETED|Overall Study||2
4969292|NCT02642653|12220158|P2|COMPLETED|Overall Study||16
4969293|NCT02642653|12220159|P1|COMPLETED|Overall Study||12
4969294|NCT02642653|12220158|P2|STARTED|Overall Study||16
4969295|NCT02642653|12220159|P1|STARTED|Overall Study||14
4969296|NCT02642627|12220191|P1|NOT COMPLETED|Overall Study||3
4969297|NCT02642627|12220191|P1|COMPLETED|Overall Study||39
4969298|NCT02642627|12220191|P1|STARTED|Overall Study||42
4969299|NCT02642614|12220200|P4|NOT COMPLETED|Overall Study||2
4969300|NCT02642614|12220201|P3|NOT COMPLETED|Overall Study||2
4969301|NCT02642614|12220202|P2|NOT COMPLETED|Overall Study||2
4969302|NCT02642614|12220203|P1|NOT COMPLETED|Overall Study||3
4969303|NCT02642614|12220200|P4|COMPLETED|Overall Study||28
4969304|NCT02642614|12220201|P3|COMPLETED|Overall Study||28
4969305|NCT02642614|12220202|P2|COMPLETED|Overall Study||28
4969306|NCT02642614|12220203|P1|COMPLETED|Overall Study||27
4969307|NCT02642614|12220200|P4|STARTED|Overall Study||30
4969308|NCT02642614|12220201|P3|STARTED|Overall Study||30
4969309|NCT02642614|12220202|P2|STARTED|Overall Study||30
4969310|NCT02642614|12220203|P1|STARTED|Overall Study||30
4969311|NCT02642575|12220235|P1|NOT COMPLETED|Overall Study||0
4969312|NCT02642575|12220235|P1|COMPLETED|Overall Study||67
4969313|NCT02642575|12220235|P1|STARTED|Overall Study||67
4969314|NCT02642536|12220243|P2|NOT COMPLETED|Overall Study||5
4969315|NCT02642536|12220244|P1|NOT COMPLETED|Overall Study||2
4969316|NCT02642536|12220243|P2|COMPLETED|Overall Study||18
4969317|NCT02642536|12220244|P1|COMPLETED|Overall Study||19
4969318|NCT02642536|12220243|P2|STARTED|Overall Study||23
4969319|NCT02642536|12220244|P1|STARTED|Overall Study||21
4969320|NCT02642432|12220270|P1|NOT COMPLETED|Overall Study||8
4969321|NCT02642432|12220270|P1|COMPLETED|Overall Study||138
4969322|NCT02642432|12220270|P1|STARTED|Overall Study||146
4969323|NCT02642393|12220278|P2|NOT COMPLETED|Overall Study||92
4969324|NCT02642393|12220279|P1|NOT COMPLETED|Overall Study||99
4969325|NCT02642393|12220278|P2|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
4969326|NCT02642393|12220279|P1|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
4969327|NCT02642393|12220278|P2|STARTED|Overall Study||149
4969328|NCT02642393|12220279|P1|STARTED|Overall Study||149
4969329|NCT02642237|12220307|P2|NOT COMPLETED|Overall Study||0
4969330|NCT02642237|12220308|P1|NOT COMPLETED|Overall Study||0
4969331|NCT02642237|12220307|P2|COMPLETED|Overall Study||15
4969332|NCT02642237|12220308|P1|COMPLETED|Overall Study||15
4969333|NCT02642237|12220307|P2|STARTED|Overall Study||15
4969334|NCT02642237|12220308|P1|STARTED|Overall Study||15
4969335|NCT02642159|12220316|P2|NOT COMPLETED|Overall Study||8
4969336|NCT02642159|12220317|P1|NOT COMPLETED|Overall Study||31
4969337|NCT02642159|12220316|P2|COMPLETED|Overall Study||129
4969338|NCT02642159|12220317|P1|COMPLETED|Overall Study||245
4969339|NCT02642159|12220316|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
4969340|NCT02642159|12220317|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
4969341|NCT02642159|12220316|P2|ITT Population|Overall Study||136
4969342|NCT02642159|12220317|P1|ITT Population|Overall Study||273
4969343|NCT02642159|12220316|P2|Treated (Safety Population)|Overall Study||137
4969344|NCT02642159|12220317|P1|Treated (Safety Population)|Overall Study||275
4969345|NCT02642159|12220316|P2|STARTED|Overall Study|Randomized|137
4969346|NCT02642159|12220317|P1|STARTED|Overall Study|Randomized|276
4969347|NCT02641912|12220369|P2|NOT COMPLETED|Overall Study||0
4969348|NCT02641912|12220370|P1|NOT COMPLETED|Overall Study||0
4969349|NCT02641912|12220369|P2|COMPLETED|Overall Study||47
4969350|NCT02641912|12220370|P1|COMPLETED|Overall Study||53
4969351|NCT02641912|12220369|P2|STARTED|Overall Study||47
4969352|NCT02641912|12220370|P1|STARTED|Overall Study||53
4969353|NCT02641730|12220441|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
4969354|NCT02641730|12220442|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
4969355|NCT02641730|12220443|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
4969356|NCT02641730|12220444|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
4969357|NCT02641730|12220445|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
4969358|NCT02641730|12220441|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
4969359|NCT02641730|12220442|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
4969360|NCT02641730|12220443|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
4969445|NCT02641379|12220692|P11|COMPLETED|Overall Study||0
4969361|NCT02641730|12220444|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
4969362|NCT02641730|12220445|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
4969363|NCT02641730|12220441|P5|STARTED|Observational Period (Week 60 - Week 84)||44
4969364|NCT02641730|12220442|P4|STARTED|Observational Period (Week 60 - Week 84)||45
4969365|NCT02641730|12220443|P3|STARTED|Observational Period (Week 60 - Week 84)||24
4969366|NCT02641730|12220444|P2|STARTED|Observational Period (Week 60 - Week 84)||21
4969367|NCT02641730|12220445|P1|STARTED|Observational Period (Week 60 - Week 84)||0
4969368|NCT02641730|12220441|P5|NOT COMPLETED|After Controlled Period (Week 16 – 52)||6
4969369|NCT02641730|12220442|P4|NOT COMPLETED|After Controlled Period (Week 16 – 52)||8
4969370|NCT02641730|12220443|P3|NOT COMPLETED|After Controlled Period (Week 16 – 52)||2
4969371|NCT02641730|12220444|P2|NOT COMPLETED|After Controlled Period (Week 16 – 52)||4
4969372|NCT02641730|12220445|P1|NOT COMPLETED|After Controlled Period (Week 16 – 52)||0
4969373|NCT02641730|12220441|P5|COMPLETED|After Controlled Period (Week 16 – 52)||44
4969374|NCT02641730|12220442|P4|COMPLETED|After Controlled Period (Week 16 – 52)||45
4969375|NCT02641730|12220443|P3|COMPLETED|After Controlled Period (Week 16 – 52)||24
4969376|NCT02641730|12220444|P2|COMPLETED|After Controlled Period (Week 16 – 52)||21
4969377|NCT02641730|12220445|P1|COMPLETED|After Controlled Period (Week 16 – 52)||0
4969378|NCT02641730|12220441|P5|STARTED|After Controlled Period (Week 16 – 52)||50
4969379|NCT02641730|12220442|P4|STARTED|After Controlled Period (Week 16 – 52)||53
4969380|NCT02641730|12220443|P3|STARTED|After Controlled Period (Week 16 – 52)||26
4969381|NCT02641730|12220444|P2|STARTED|After Controlled Period (Week 16 – 52)||25
4969382|NCT02641730|12220445|P1|STARTED|After Controlled Period (Week 16 – 52)||0
4969383|NCT02641730|12220441|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
4969384|NCT02641730|12220442|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
4969385|NCT02641730|12220443|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
4969386|NCT02641730|12220444|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
4969387|NCT02641730|12220445|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
4969388|NCT02641730|12220441|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
4969389|NCT02641730|12220442|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
4969390|NCT02641730|12220443|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
4969391|NCT02641730|12220444|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
4969392|NCT02641730|12220445|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
4969393|NCT02641730|12220441|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
4969394|NCT02641730|12220442|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
4969395|NCT02641730|12220443|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
4969396|NCT02641730|12220444|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
4969397|NCT02641730|12220445|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
4969398|NCT02641587|12220549|P2|NOT COMPLETED|Ambulatory Period||0
4969399|NCT02641587|12220550|P1|NOT COMPLETED|Ambulatory Period||1
4969400|NCT02641587|12220549|P2|COMPLETED|Ambulatory Period||39
4969401|NCT02641587|12220550|P1|COMPLETED|Ambulatory Period||76
4969402|NCT02641587|12220549|P2|STARTED|Ambulatory Period||39
4969403|NCT02641587|12220550|P1|STARTED|Ambulatory Period||77
4969404|NCT02641587|12220549|P2|NOT COMPLETED|Confinement Period||1
4969405|NCT02641587|12220550|P1|NOT COMPLETED|Confinement Period||3
4969406|NCT02641587|12220549|P2|COMPLETED|Confinement Period||39
4969407|NCT02641587|12220550|P1|COMPLETED|Confinement Period||77
4969408|NCT02641587|12220549|P2|STARTED|Confinement Period||40
4969409|NCT02641587|12220550|P1|STARTED|Confinement Period||80
4969410|NCT02641561|12220575|P4|NOT COMPLETED|Overall Study||0
4969411|NCT02641561|12220576|P3|NOT COMPLETED|Overall Study||0
4969412|NCT02641561|12220577|P2|NOT COMPLETED|Overall Study||0
4969413|NCT02641561|12220578|P1|NOT COMPLETED|Overall Study||0
4969414|NCT02641561|12220575|P4|COMPLETED|Overall Study||48
4969415|NCT02641561|12220576|P3|COMPLETED|Overall Study||48
4969416|NCT02641561|12220577|P2|COMPLETED|Overall Study||48
4969417|NCT02641561|12220578|P1|COMPLETED|Overall Study||48
4969418|NCT02641561|12220575|P4|STARTED|Overall Study||48
4969419|NCT02641561|12220576|P3|STARTED|Overall Study||48
4969420|NCT02641561|12220577|P2|STARTED|Overall Study||48
4969421|NCT02641561|12220578|P1|STARTED|Overall Study||48
4969422|NCT02641522|12220664|P1|NOT COMPLETED|Overall Study||0
4969423|NCT02641522|12220664|P1|COMPLETED|Overall Study||10
4969424|NCT02641522|12220664|P1|STARTED|Overall Study||10
4969425|NCT02641392|12220671|P3|NOT COMPLETED|Overall Study||293
4969426|NCT02641392|12220672|P2|NOT COMPLETED|Overall Study||13
4969427|NCT02641392|12220673|P1|NOT COMPLETED|Overall Study||4
4969428|NCT02641392|12220671|P3|COMPLETED|Overall Study||0
4969429|NCT02641392|12220672|P2|COMPLETED|Overall Study||0
4969430|NCT02641392|12220673|P1|COMPLETED|Overall Study||0
4969431|NCT02641392|12220671|P3|STARTED|Overall Study||293
4969432|NCT02641392|12220672|P2|STARTED|Overall Study||13
4969433|NCT02641392|12220673|P1|STARTED|Overall Study||4
4969434|NCT02641379|12220692|P11|NOT COMPLETED|Overall Study||8
4969435|NCT02641379|12220693|P10|NOT COMPLETED|Overall Study||9
4969436|NCT02641379|12220694|P9|NOT COMPLETED|Overall Study||6
4969437|NCT02641379|12220695|P8|NOT COMPLETED|Overall Study||19
4969438|NCT02641379|12220696|P7|NOT COMPLETED|Overall Study||13
4969439|NCT02641379|12220697|P6|NOT COMPLETED|Overall Study||16
4969440|NCT02641379|12220698|P5|NOT COMPLETED|Overall Study||17
4969441|NCT02641379|12220699|P4|NOT COMPLETED|Overall Study||17
4969442|NCT02641379|12220700|P3|NOT COMPLETED|Overall Study||71
4969443|NCT02641379|12220701|P2|NOT COMPLETED|Overall Study||51
4969444|NCT02641379|12220702|P1|NOT COMPLETED|Overall Study||35
4969446|NCT02641379|12220693|P10|COMPLETED|Overall Study||36
4969447|NCT02641379|12220694|P9|COMPLETED|Overall Study||36
4969448|NCT02641379|12220695|P8|COMPLETED|Overall Study||1
4969449|NCT02641379|12220696|P7|COMPLETED|Overall Study||12
4969450|NCT02641379|12220697|P6|COMPLETED|Overall Study||20
4969451|NCT02641379|12220698|P5|COMPLETED|Overall Study||0
4969452|NCT02641379|12220699|P4|COMPLETED|Overall Study||139
4969453|NCT02641379|12220700|P3|COMPLETED|Overall Study||7
4969454|NCT02641379|12220701|P2|COMPLETED|Overall Study||101
4969455|NCT02641379|12220702|P1|COMPLETED|Overall Study||107
4969456|NCT02641379|12220692|P11|STARTED|Overall Study||8
4969457|NCT02641379|12220693|P10|STARTED|Overall Study||45
4969458|NCT02641379|12220694|P9|STARTED|Overall Study||42
4969459|NCT02641379|12220695|P8|STARTED|Overall Study||20
4969460|NCT02641379|12220696|P7|STARTED|Overall Study||25
4969461|NCT02641379|12220697|P6|STARTED|Overall Study||36
4969462|NCT02641379|12220698|P5|STARTED|Overall Study||17
4969463|NCT02641379|12220699|P4|STARTED|Overall Study||156
4969464|NCT02641379|12220700|P3|STARTED|Overall Study||78
4969465|NCT02641379|12220701|P2|STARTED|Overall Study||152
4969466|NCT02641379|12220702|P1|STARTED|Overall Study||142
4969467|NCT02641249|12220767|P1|NOT COMPLETED|Overall Study||4
4969468|NCT02641249|12220767|P1|COMPLETED|Overall Study||15
4969469|NCT02641249|12220767|P1|STARTED|Overall Study||19
4969470|NCT02641067|12220778|P2|NOT COMPLETED|Overall Study||0
4969471|NCT02641067|12220779|P1|NOT COMPLETED|Overall Study||0
4969472|NCT02641067|12220778|P2|COMPLETED|Overall Study||8
4969473|NCT02641067|12220779|P1|COMPLETED|Overall Study||8
4969474|NCT02641067|12220778|P2|STARTED|Overall Study||8
4969475|NCT02641067|12220779|P1|STARTED|Overall Study||8
4969476|NCT02640807|12220802|P3|NOT COMPLETED|Overall Study||0
4969477|NCT02640807|12220803|P2|NOT COMPLETED|Overall Study||0
4969478|NCT02640807|12220804|P1|NOT COMPLETED|Overall Study||0
4969479|NCT02640807|12220802|P3|COMPLETED|Overall Study||10
4969480|NCT02640807|12220803|P2|COMPLETED|Overall Study||8
4969481|NCT02640807|12220804|P1|COMPLETED|Overall Study||9
4969482|NCT02640807|12220802|P3|STARTED|Overall Study||10
4969483|NCT02640807|12220803|P2|STARTED|Overall Study||8
4969484|NCT02640807|12220804|P1|STARTED|Overall Study||9
4969485|NCT02640755|12220820|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
4969486|NCT02640755|12220821|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
4969487|NCT02640755|12220820|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
4969488|NCT02640755|12220821|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
4969489|NCT02640755|12220820|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
4969490|NCT02640755|12220821|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
4969491|NCT02640755|12220820|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
4969492|NCT02640755|12220821|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
4969493|NCT02640755|12220820|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
4969494|NCT02640755|12220821|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
4969495|NCT02640755|12220820|P2|STARTED|Single Dose Period (Day 1 - 8)||1
4969496|NCT02640755|12220821|P1|STARTED|Single Dose Period (Day 1 - 8)||3
4969497|NCT02640716|12220858|P2|NOT COMPLETED|Overall Study||9
4969498|NCT02640716|12220859|P1|NOT COMPLETED|Overall Study||7
4969499|NCT02640716|12220858|P2|COMPLETED|Overall Study||21
4969500|NCT02640716|12220859|P1|COMPLETED|Overall Study||23
4969501|NCT02640716|12220858|P2|Training Completion|Overall Study||27
4969502|NCT02640716|12220859|P1|Training Completion|Overall Study||27
4969503|NCT02640716|12220858|P2|STARTED|Overall Study||30
4969504|NCT02640716|12220859|P1|STARTED|Overall Study||30
4969505|NCT02640625|12220875|P1|NOT COMPLETED|Overall Study||1
4969506|NCT02640625|12220875|P1|COMPLETED|Overall Study||19
4969507|NCT02640625|12220875|P1|STARTED|Overall Study||20
4969508|NCT02640612|12220884|P3|NOT COMPLETED|Overall Study||6
4969509|NCT02640612|12220885|P2|NOT COMPLETED|Overall Study||14
4969510|NCT02640612|12220886|P1|NOT COMPLETED|Overall Study||22
4969511|NCT02640612|12220884|P3|COMPLETED|Overall Study||96
4969512|NCT02640612|12220885|P2|COMPLETED|Overall Study||89
4969513|NCT02640612|12220886|P1|COMPLETED|Overall Study||203
4969514|NCT02640612|12220884|P3|STARTED|Overall Study||102
4969515|NCT02640612|12220885|P2|STARTED|Overall Study||103
4969516|NCT02640612|12220886|P1|STARTED|Overall Study||225
4969517|NCT02640573|12220906|P1|NOT COMPLETED|Overall Study||1
4969518|NCT02640573|12220906|P1|COMPLETED|Overall Study||0
4969519|NCT02640573|12220906|P1|STARTED|Overall Study||1
4969520|NCT02640547|12220910|P1|NOT COMPLETED|Overall Study||11
4969521|NCT02640547|12220910|P1|COMPLETED|Overall Study||383
4969522|NCT02640547|12220910|P1|STARTED|Overall Study||394
4969523|NCT02640482|12220987|P2|NOT COMPLETED|Overall Study||0
4969524|NCT02640482|12220988|P1|NOT COMPLETED|Overall Study||3
4969525|NCT02640482|12220987|P2|COMPLETED|Overall Study||100
4969526|NCT02640482|12220988|P1|COMPLETED|Overall Study||199
4969527|NCT02640482|12220987|P2|STARTED|Overall Study||100
4969528|NCT02640482|12220988|P1|STARTED|Overall Study||202
4969529|NCT02640404|12221000|P2|NOT COMPLETED|Overall Study||0
4969530|NCT02640404|12221001|P1|NOT COMPLETED|Overall Study||2
4969531|NCT02640404|12221000|P2|COMPLETED|Overall Study||112
4969532|NCT02640404|12221001|P1|COMPLETED|Overall Study||110
4969533|NCT02640404|12221000|P2|STARTED|Overall Study||112
4969534|NCT02640404|12221001|P1|STARTED|Overall Study||112
4969535|NCT02640157|12221012|P3|NOT COMPLETED|Overall Study||10
4969536|NCT02640157|12221013|P2|NOT COMPLETED|Overall Study||5
4969537|NCT02640157|12221014|P1|NOT COMPLETED|Overall Study||13
4969538|NCT02640157|12221012|P3|COMPLETED|Overall Study||147
4969539|NCT02640157|12221013|P2|COMPLETED|Overall Study||111
4969540|NCT02640157|12221014|P1|COMPLETED|Overall Study||220
4969541|NCT02640157|12221012|P3|Discontinued Study Drug|Overall Study||3
4969542|NCT02640157|12221013|P2|Discontinued Study Drug|Overall Study||3
4969543|NCT02640157|12221014|P1|Discontinued Study Drug|Overall Study||8
4969544|NCT02640157|12221012|P3|Completed Study Drug|Overall Study||154
4969545|NCT02640157|12221013|P2|Completed Study Drug|Overall Study||112
4969546|NCT02640157|12221014|P1|Completed Study Drug|Overall Study||225
4969547|NCT02640157|12221012|P3|Received Study Drug|Overall Study||157
4969548|NCT02640157|12221013|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
4969549|NCT02640157|12221014|P1|Received Study Drug|Overall Study||233
4969550|NCT02640157|12221012|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
4969551|NCT02640157|12221013|P2|STARTED|Overall Study||116
4969552|NCT02640157|12221014|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
4969553|NCT02640053|12221033|P2|NOT COMPLETED|Overall Study||4
4969554|NCT02640053|12221034|P1|NOT COMPLETED|Overall Study||4
4969555|NCT02640053|12221033|P2|COMPLETED|Overall Study||17
4969556|NCT02640053|12221034|P1|COMPLETED|Overall Study||17
4969557|NCT02640053|12221033|P2|STARTED|Overall Study||21
4969558|NCT02640053|12221034|P1|STARTED|Overall Study||21
4969559|NCT02639910|12221056|P2|NOT COMPLETED|Overall Study||8
4969560|NCT02639910|12221057|P1|NOT COMPLETED|Overall Study||4
4969561|NCT02639910|12221056|P2|COMPLETED|Overall Study||5
4969562|NCT02639910|12221057|P1|COMPLETED|Overall Study||7
4969563|NCT02639910|12221056|P2|STARTED|Overall Study||13
4969564|NCT02639910|12221057|P1|STARTED|Overall Study||11
4969565|NCT02639637|12221074|P4|NOT COMPLETED|Overall Study||0
4969566|NCT02639637|12221075|P3|NOT COMPLETED|Overall Study||0
4969567|NCT02639637|12221076|P2|NOT COMPLETED|Overall Study||0
4969568|NCT02639637|12221077|P1|NOT COMPLETED|Overall Study||0
4969569|NCT02639637|12221074|P4|COMPLETED|Overall Study||3
4969570|NCT02639637|12221075|P3|COMPLETED|Overall Study||2
4969571|NCT02639637|12221076|P2|COMPLETED|Overall Study||6
4969572|NCT02639637|12221077|P1|COMPLETED|Overall Study||7
4969573|NCT02639637|12221074|P4|STARTED|Overall Study||3
4969574|NCT02639637|12221075|P3|STARTED|Overall Study||2
4969575|NCT02639637|12221076|P2|STARTED|Overall Study||6
4969576|NCT02639637|12221077|P1|STARTED|Overall Study||7
4969577|NCT02639559|12221141|P2|NOT COMPLETED|Overall Study||3
4969578|NCT02639559|12221142|P1|NOT COMPLETED|Overall Study||1
4969579|NCT02639559|12221141|P2|COMPLETED|Overall Study||22
4969580|NCT02639559|12221142|P1|COMPLETED|Overall Study||24
4969581|NCT02639559|12221141|P2|STARTED|Overall Study||25
4969582|NCT02639559|12221142|P1|STARTED|Overall Study||25
4969583|NCT02639494|12221168|P1|NOT COMPLETED|Overall Study||0
4969584|NCT02639494|12221168|P1|COMPLETED|Overall Study||20
4969585|NCT02639494|12221168|P1|STARTED|Overall Study||20
4969586|NCT02639429|12221185|P2|NOT COMPLETED|Overall Study||0
4969587|NCT02639429|12221186|P1|NOT COMPLETED|Overall Study||0
4969588|NCT02639429|12221185|P2|COMPLETED|Overall Study||123
4969589|NCT02639429|12221186|P1|COMPLETED|Overall Study||113
4969590|NCT02639429|12221185|P2|STARTED|Overall Study||123
4969591|NCT02639429|12221186|P1|STARTED|Overall Study||113
4969592|NCT02639351|12221225|P5|NOT COMPLETED|Overall Study||0
4969593|NCT02639351|12221226|P4|NOT COMPLETED|Overall Study||0
4969594|NCT02639351|12221227|P3|NOT COMPLETED|Overall Study||0
4969595|NCT02639351|12221228|P2|NOT COMPLETED|Overall Study||0
4969596|NCT02639351|12221229|P1|NOT COMPLETED|Overall Study||0
4969597|NCT02639351|12221225|P5|COMPLETED|Overall Study||16
4969598|NCT02639351|12221226|P4|COMPLETED|Overall Study||16
4969599|NCT02639351|12221227|P3|COMPLETED|Overall Study||16
4969600|NCT02639351|12221228|P2|COMPLETED|Overall Study||16
4969601|NCT02639351|12221229|P1|COMPLETED|Overall Study||16
4969602|NCT02639351|12221225|P5|STARTED|Overall Study||16
4969603|NCT02639351|12221226|P4|STARTED|Overall Study||16
4969604|NCT02639351|12221227|P3|STARTED|Overall Study||16
4969605|NCT02639351|12221228|P2|STARTED|Overall Study||16
4969606|NCT02639351|12221229|P1|STARTED|Overall Study||16
4969607|NCT02639338|12221578|P2|NOT COMPLETED|Overall Study||5
4969608|NCT02639338|12221579|P1|NOT COMPLETED|Overall Study||4
4969609|NCT02639338|12221578|P2|COMPLETED|Overall Study||105
4969610|NCT02639338|12221579|P1|COMPLETED|Overall Study||106
4969611|NCT02639338|12221578|P2|STARTED|Overall Study||110
4969612|NCT02639338|12221579|P1|STARTED|Overall Study||110
4969613|NCT02639247|12221597|P2|NOT COMPLETED|Overall Study||2
4969614|NCT02639247|12221598|P1|NOT COMPLETED|Overall Study||5
4969615|NCT02639247|12221597|P2|COMPLETED|Overall Study||149
4969616|NCT02639247|12221598|P1|COMPLETED|Overall Study||177
4969617|NCT02639247|12221597|P2|STARTED|Overall Study||151
4969618|NCT02639247|12221598|P1|STARTED|Overall Study||182
4969619|NCT02639052|12221614|P1|NOT COMPLETED|Overall Study||1
4969620|NCT02639052|12221614|P1|COMPLETED|Overall Study||34
4969621|NCT02639052|12221614|P1|Visit 4 (3-month Follow-up)|Overall Study||34
4969622|NCT02639052|12221614|P1|Visit 3 (1-month Follow-up)|Overall Study||35
4969623|NCT02639052|12221614|P1|Visit 2 (1-week Follow-up)|Overall Study||35
4969624|NCT02639052|12221614|P1|Visit 1 (Baseline)|Overall Study||35
4969625|NCT02639052|12221614|P1|STARTED|Overall Study||35
4969626|NCT02638974|12221630|P2|NOT COMPLETED|Overall Study||3
4969627|NCT02638974|12221631|P1|NOT COMPLETED|Overall Study||3
4969628|NCT02638974|12221630|P2|COMPLETED|Overall Study||22
4969629|NCT02638974|12221631|P1|COMPLETED|Overall Study||23
4969630|NCT02638974|12221630|P2|STARTED|Overall Study||25
4969631|NCT02638974|12221631|P1|STARTED|Overall Study||26
4969632|NCT02638948|12221651|P4|NOT COMPLETED|Overall Study||8
4969633|NCT02638948|12221652|P3|NOT COMPLETED|Overall Study||7
4969634|NCT02638948|12221653|P2|NOT COMPLETED|Overall Study||11
4969635|NCT02638948|12221654|P1|NOT COMPLETED|Overall Study||9
4969636|NCT02638948|12221651|P4|COMPLETED|Overall Study||18
4969637|NCT02638948|12221652|P3|COMPLETED|Overall Study||66
4969638|NCT02638948|12221653|P2|COMPLETED|Overall Study||62
4969639|NCT02638948|12221654|P1|COMPLETED|Overall Study||66
4969640|NCT02638948|12221651|P4|STARTED|Overall Study||26
4969641|NCT02638948|12221652|P3|STARTED|Overall Study||73
4969642|NCT02638948|12221653|P2|STARTED|Overall Study||73
4969643|NCT02638948|12221654|P1|STARTED|Overall Study||75
4969644|NCT02638597|12221741|P2|NOT COMPLETED|Overall Study||5
4969645|NCT02638597|12221742|P1|NOT COMPLETED|Overall Study||4
4969646|NCT02638597|12221741|P2|COMPLETED|Overall Study||3
4969647|NCT02638597|12221742|P1|COMPLETED|Overall Study||4
4969648|NCT02638597|12221741|P2|STARTED|Overall Study||8
4969649|NCT02638597|12221742|P1|STARTED|Overall Study||8
4969650|NCT02638493|12221753|P3|NOT COMPLETED|Overall Study||0
4969651|NCT02638493|12221754|P2|NOT COMPLETED|Overall Study||0
4969652|NCT02638493|12221755|P1|NOT COMPLETED|Overall Study||2
4969653|NCT02638493|12221753|P3|COMPLETED|Overall Study||8
4969654|NCT02638493|12221754|P2|COMPLETED|Overall Study||8
4969655|NCT02638493|12221755|P1|COMPLETED|Overall Study||8
4969656|NCT02638493|12221753|P3|STARTED|Overall Study||8
4969657|NCT02638493|12221754|P2|STARTED|Overall Study||8
4969658|NCT02638493|12221755|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
4969659|NCT02638337|12221786|P2|NOT COMPLETED|Overall Study||36
4969660|NCT02638337|12221787|P1|NOT COMPLETED|Overall Study||33
4969661|NCT02638337|12221786|P2|COMPLETED|Overall Study||279
4969662|NCT02638337|12221787|P1|COMPLETED|Overall Study||283
4969663|NCT02638337|12221786|P2|Received Treatment|Overall Study||315
4969664|NCT02638337|12221787|P1|Received Treatment|Overall Study||313
4969665|NCT02638337|12221786|P2|STARTED|Overall Study||315
4969666|NCT02638337|12221787|P1|STARTED|Overall Study||316
4969667|NCT02638259|12221871|P2|NOT COMPLETED|Treatment Period 2||11
4969668|NCT02638259|12221872|P1|NOT COMPLETED|Treatment Period 2||6
4969669|NCT02638259|12221871|P2|COMPLETED|Treatment Period 2||155
4969670|NCT02638259|12221872|P1|COMPLETED|Treatment Period 2||169
4969671|NCT02638259|12221871|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
4969672|NCT02638259|12221872|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
4969673|NCT02638259|12221871|P2|NOT COMPLETED|Treatment Period 1||18
4969674|NCT02638259|12221872|P1|NOT COMPLETED|Treatment Period 1||5
4969675|NCT02638259|12221871|P2|COMPLETED|Treatment Period 1||172
4969676|NCT02638259|12221872|P1|COMPLETED|Treatment Period 1||181
4969677|NCT02638259|12221871|P2|STARTED|Treatment Period 1||190
4969678|NCT02638259|12221872|P1|STARTED|Treatment Period 1||186
4969679|NCT02638168|12221946|P2|NOT COMPLETED|Overall Study||0
4969680|NCT02638168|12221947|P1|NOT COMPLETED|Overall Study||0
4969681|NCT02638168|12221946|P2|COMPLETED|Overall Study||0
4969682|NCT02638168|12221947|P1|COMPLETED|Overall Study||3
4969683|NCT02638168|12221946|P2|STARTED|Overall Study||0
4969684|NCT02638168|12221947|P1|STARTED|Overall Study||3
4969685|NCT02638129|12221964|P2|NOT COMPLETED|Overall Study||30
4969686|NCT02638129|12221965|P1|NOT COMPLETED|Overall Study||28
4969687|NCT02638129|12221964|P2|COMPLETED|Overall Study||0
4969688|NCT02638129|12221965|P1|COMPLETED|Overall Study||0
4969689|NCT02638129|12221964|P2|STARTED|Overall Study||30
4969690|NCT02638129|12221965|P1|STARTED|Overall Study||28
4969691|NCT02638103|12221981|P4|NOT COMPLETED|Overall Study||142
4969692|NCT02638103|12221982|P3|NOT COMPLETED|Overall Study||85
4969693|NCT02638103|12221983|P2|NOT COMPLETED|Overall Study||118
4969694|NCT02638103|12221984|P1|NOT COMPLETED|Overall Study||106
4969695|NCT02638103|12221981|P4|COMPLETED|Overall Study||383
4969696|NCT02638103|12221982|P3|COMPLETED|Overall Study||335
4969697|NCT02638103|12221983|P2|COMPLETED|Overall Study||408
4969698|NCT02638103|12221984|P1|COMPLETED|Overall Study||313
4969699|NCT02638103|12221981|P4|Full Analysis Set (FAS)|Overall Study||523
4969700|NCT02638103|12221982|P3|Full Analysis Set (FAS)|Overall Study||419
4969701|NCT02638103|12221983|P2|Full Analysis Set (FAS)|Overall Study||520
4969702|NCT02638103|12221984|P1|Full Analysis Set (FAS)|Overall Study||416
4969703|NCT02638103|12221981|P4|Safety Analysis Set|Overall Study||525
4969704|NCT02638103|12221982|P3|Safety Analysis Set|Overall Study||419
4969705|NCT02638103|12221983|P2|Safety Analysis Set|Overall Study||526
4969706|NCT02638103|12221984|P1|Safety Analysis Set|Overall Study||418
4969707|NCT02638103|12221981|P4|STARTED|Overall Study||525
4969708|NCT02638103|12221982|P3|STARTED|Overall Study||420
4969709|NCT02638103|12221983|P2|STARTED|Overall Study||526
4969710|NCT02638103|12221984|P1|STARTED|Overall Study||419
4969711|NCT02638051|12222060|P2|NOT COMPLETED|Overall Study||0
4969712|NCT02638051|12222061|P1|NOT COMPLETED|Overall Study||0
4969713|NCT02638051|12222060|P2|COMPLETED|Overall Study||130
4969714|NCT02638051|12222061|P1|COMPLETED|Overall Study||130
4969715|NCT02638051|12222060|P2|STARTED|Overall Study||130
4969716|NCT02638051|12222061|P1|STARTED|Overall Study||130
4969717|NCT02638012|12222071|P1|NOT COMPLETED|Overall Study||1
4969718|NCT02638012|12222071|P1|COMPLETED|Overall Study||7
4969719|NCT02638012|12222071|P1|STARTED|Overall Study||8
4969720|NCT02637999|12222082|P3|NOT COMPLETED|Overall Study||2
4969721|NCT02637999|12222083|P2|NOT COMPLETED|Overall Study||2
4969722|NCT02637999|12222084|P1|NOT COMPLETED|Overall Study||1
4969723|NCT02637999|12222082|P3|COMPLETED|Overall Study||6
4969724|NCT02637999|12222083|P2|COMPLETED|Overall Study||6
4969725|NCT02637999|12222084|P1|COMPLETED|Overall Study||7
4969726|NCT02637999|12222082|P3|STARTED|Overall Study||8
4969727|NCT02637999|12222083|P2|STARTED|Overall Study||8
4969728|NCT02637999|12222084|P1|STARTED|Overall Study||8
4969729|NCT02637856|12222116|P2|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
4969730|NCT02637856|12222117|P1|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
4969731|NCT02637856|12222116|P2|COMPLETED|Sub-Study (Week 72 to Week 100)||125
4969732|NCT02637856|12222117|P1|COMPLETED|Sub-Study (Week 72 to Week 100)||0
4969733|NCT02637856|12222116|P2|STARTED|Sub-Study (Week 72 to Week 100)||129
4969734|NCT02637856|12222117|P1|STARTED|Sub-Study (Week 72 to Week 100)||0
4969735|NCT02637856|12222116|P2|NOT COMPLETED|Main Study (Baseline to Week 100)||0
4969736|NCT02637856|12222117|P1|NOT COMPLETED|Main Study (Baseline to Week 100)||219
4969737|NCT02637856|12222116|P2|COMPLETED|Main Study (Baseline to Week 100)||0
4969738|NCT02637856|12222117|P1|COMPLETED|Main Study (Baseline to Week 100)||389
4969739|NCT02637856|12222116|P2|STARTED|Main Study (Baseline to Week 100)||0
4969740|NCT02637856|12222117|P1|STARTED|Main Study (Baseline to Week 100)||608
4969741|NCT02637804|12222136|P4|NOT COMPLETED|Second Intervention (1 Week)||0
4969742|NCT02637804|12222137|P3|NOT COMPLETED|Second Intervention (1 Week)||0
4969743|NCT02637804|12222138|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4969744|NCT02637804|12222139|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4969745|NCT02637804|12222136|P4|COMPLETED|Second Intervention (1 Week)||26
4969746|NCT02637804|12222137|P3|COMPLETED|Second Intervention (1 Week)||25
4969747|NCT02637804|12222138|P2|COMPLETED|Second Intervention (1 Week)||28
4969748|NCT02637804|12222139|P1|COMPLETED|Second Intervention (1 Week)||27
4969749|NCT02637804|12222136|P4|STARTED|Second Intervention (1 Week)||26
4969750|NCT02637804|12222137|P3|STARTED|Second Intervention (1 Week)||25
4969751|NCT02637804|12222138|P2|STARTED|Second Intervention (1 Week)||28
4969752|NCT02637804|12222139|P1|STARTED|Second Intervention (1 Week)||27
4969753|NCT02637804|12222136|P4|NOT COMPLETED|First Intervention (1 Week)||0
4969754|NCT02637804|12222137|P3|NOT COMPLETED|First Intervention (1 Week)||0
4969755|NCT02637804|12222138|P2|NOT COMPLETED|First Intervention (1 Week)||0
4969756|NCT02637804|12222139|P1|NOT COMPLETED|First Intervention (1 Week)||0
4969757|NCT02637804|12222136|P4|COMPLETED|First Intervention (1 Week)||26
4969758|NCT02637804|12222137|P3|COMPLETED|First Intervention (1 Week)||25
4969759|NCT02637804|12222138|P2|COMPLETED|First Intervention (1 Week)||28
4969760|NCT02637804|12222139|P1|COMPLETED|First Intervention (1 Week)||27
4969761|NCT02637804|12222136|P4|STARTED|First Intervention (1 Week)||26
4969762|NCT02637804|12222137|P3|STARTED|First Intervention (1 Week)||25
4969763|NCT02637804|12222138|P2|STARTED|First Intervention (1 Week)||28
4969764|NCT02637804|12222139|P1|STARTED|First Intervention (1 Week)||27
4969765|NCT02637557|12222247|P4|NOT COMPLETED|Overall Study||7
4969766|NCT02637557|12222248|P3|NOT COMPLETED|Overall Study||9
4969767|NCT02637557|12222249|P2|NOT COMPLETED|Overall Study||5
4969768|NCT02637557|12222250|P1|NOT COMPLETED|Overall Study||8
4969769|NCT02637557|12222247|P4|COMPLETED|Overall Study||62
4969770|NCT02637557|12222248|P3|COMPLETED|Overall Study||62
4969771|NCT02637557|12222249|P2|COMPLETED|Overall Study||66
4969772|NCT02637557|12222250|P1|COMPLETED|Overall Study||63
4969773|NCT02637557|12222247|P4|STARTED|Overall Study||69
4969774|NCT02637557|12222248|P3|STARTED|Overall Study||71
4969775|NCT02637557|12222249|P2|STARTED|Overall Study||71
4969776|NCT02637557|12222250|P1|STARTED|Overall Study||71
4969777|NCT02637323|12222342|P2|NOT COMPLETED|Overall Study||1
4969778|NCT02637323|12222343|P1|NOT COMPLETED|Overall Study||2
4969779|NCT02637323|12222342|P2|COMPLETED|Overall Study||17
4969780|NCT02637323|12222343|P1|COMPLETED|Overall Study||61
4969781|NCT02637323|12222342|P2|STARTED|Overall Study||18
4969782|NCT02637323|12222343|P1|STARTED|Overall Study||63
4969783|NCT02637141|12222354|P3|NOT COMPLETED|Overall Study||1
4969784|NCT02637141|12222355|P2|NOT COMPLETED|Overall Study||2
4969785|NCT02637141|12222356|P1|NOT COMPLETED|Overall Study||2
4969786|NCT02637141|12222354|P3|COMPLETED|Overall Study||19
4969787|NCT02637141|12222355|P2|COMPLETED|Overall Study||20
4969788|NCT02637141|12222356|P1|COMPLETED|Overall Study||20
4969789|NCT02637141|12222354|P3|Received Study Drug|Overall Study||19
4969790|NCT02637141|12222355|P2|Received Study Drug|Overall Study||21
4969791|NCT02637141|12222356|P1|Received Study Drug|Overall Study||22
4969792|NCT02637141|12222354|P3|STARTED|Overall Study||20
4969793|NCT02637141|12222355|P2|STARTED|Overall Study||22
4969794|NCT02637141|12222356|P1|STARTED|Overall Study||22
4969795|NCT02637063|12222391|P3|NOT COMPLETED|Overall Study||6
4969796|NCT02637063|12222392|P2|NOT COMPLETED|Overall Study||4
4969797|NCT02637063|12222393|P1|NOT COMPLETED|Overall Study||5
4969798|NCT02637063|12222391|P3|COMPLETED|Overall Study||62
4969799|NCT02637063|12222392|P2|COMPLETED|Overall Study||64
4969800|NCT02637063|12222393|P1|COMPLETED|Overall Study||62
4969801|NCT02637063|12222391|P3|STARTED|Overall Study||68
4969802|NCT02637063|12222392|P2|STARTED|Overall Study||68
4969803|NCT02637063|12222393|P1|STARTED|Overall Study||67
4969804|NCT02637037|12222421|P2|NOT COMPLETED|Overall Study||1
4969805|NCT02637037|12222422|P1|NOT COMPLETED|Overall Study||4
4969806|NCT02637037|12222421|P2|COMPLETED|Overall Study||39
4969807|NCT02637037|12222422|P1|COMPLETED|Overall Study||36
4969808|NCT02637037|12222421|P2|STARTED|Overall Study||40
4969809|NCT02637037|12222422|P1|STARTED|Overall Study||40
4969810|NCT02636907|12222488|P1|NOT COMPLETED|Extension Phase||10
4969811|NCT02636907|12222488|P1|COMPLETED|Extension Phase||62
4969812|NCT02636907|12222488|P1|STARTED|Extension Phase||72
4969813|NCT02636907|12222488|P1|NOT COMPLETED|Autoinjector Assessment Period||4
4969814|NCT02636907|12222488|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
4969815|NCT02636907|12222488|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
4969816|NCT02636712|12222497|P1|NOT COMPLETED|Overall Study||0
4969817|NCT02636712|12222497|P1|COMPLETED|Overall Study||10
4969818|NCT02636712|12222497|P1|STARTED|Overall Study||10
4969819|NCT02636608|12222505|P1|NOT COMPLETED|Overall Study||11
4969820|NCT02636608|12222505|P1|COMPLETED|Overall Study||233
4969821|NCT02636608|12222505|P1|Received Treatment|Overall Study||243
4969822|NCT02636608|12222505|P1|STARTED|Overall Study||244
4969823|NCT02636595|12222533|P1|NOT COMPLETED|Overall Study||2
4969824|NCT02636595|12222533|P1|COMPLETED|Overall Study||119
4969825|NCT02636595|12222533|P1|STARTED|Overall Study||121
4969826|NCT02636361|12222539|P5|NOT COMPLETED|Period 5||0
4969827|NCT02636361|12222540|P4|NOT COMPLETED|Period 5||0
4969828|NCT02636361|12222541|P3|NOT COMPLETED|Period 5||0
4969829|NCT02636361|12222542|P2|NOT COMPLETED|Period 5||0
4969830|NCT02636361|12222543|P1|NOT COMPLETED|Period 5||0
4969831|NCT02636361|12222539|P5|COMPLETED|Period 5||4
4969832|NCT02636361|12222540|P4|COMPLETED|Period 5||4
4969833|NCT02636361|12222541|P3|COMPLETED|Period 5||5
4969834|NCT02636361|12222542|P2|COMPLETED|Period 5||5
4969835|NCT02636361|12222543|P1|COMPLETED|Period 5||5
4969836|NCT02636361|12222539|P5|STARTED|Period 5||4
4969837|NCT02636361|12222540|P4|STARTED|Period 5||4
4969838|NCT02636361|12222541|P3|STARTED|Period 5||5
4969839|NCT02636361|12222542|P2|STARTED|Period 5||5
4969840|NCT02636361|12222543|P1|STARTED|Period 5||5
4969841|NCT02636361|12222539|P5|NOT COMPLETED|Period 4||0
4969842|NCT02636361|12222540|P4|NOT COMPLETED|Period 4||1
4969843|NCT02636361|12222541|P3|NOT COMPLETED|Period 4||0
4969844|NCT02636361|12222542|P2|NOT COMPLETED|Period 4||0
4969845|NCT02636361|12222543|P1|NOT COMPLETED|Period 4||0
4969846|NCT02636361|12222539|P5|COMPLETED|Period 4||4
4969847|NCT02636361|12222540|P4|COMPLETED|Period 4||4
4969848|NCT02636361|12222541|P3|COMPLETED|Period 4||5
4969849|NCT02636361|12222542|P2|COMPLETED|Period 4||5
4969850|NCT02636361|12222543|P1|COMPLETED|Period 4||5
4969851|NCT02636361|12222539|P5|STARTED|Period 4||4
4969852|NCT02636361|12222540|P4|STARTED|Period 4||5
4969853|NCT02636361|12222541|P3|STARTED|Period 4||5
4969854|NCT02636361|12222542|P2|STARTED|Period 4||5
4969855|NCT02636361|12222543|P1|STARTED|Period 4||5
4969856|NCT02636361|12222539|P5|NOT COMPLETED|Period 3||0
4969857|NCT02636361|12222540|P4|NOT COMPLETED|Period 3||0
4969858|NCT02636361|12222541|P3|NOT COMPLETED|Period 3||0
4969859|NCT02636361|12222542|P2|NOT COMPLETED|Period 3||0
4969860|NCT02636361|12222543|P1|NOT COMPLETED|Period 3||0
4969861|NCT02636361|12222539|P5|COMPLETED|Period 3||4
4969862|NCT02636361|12222540|P4|COMPLETED|Period 3||5
4969863|NCT02636361|12222541|P3|COMPLETED|Period 3||5
4969864|NCT02636361|12222542|P2|COMPLETED|Period 3||5
4969865|NCT02636361|12222543|P1|COMPLETED|Period 3||5
4969866|NCT02636361|12222539|P5|STARTED|Period 3||4
4969867|NCT02636361|12222540|P4|STARTED|Period 3||5
4969868|NCT02636361|12222541|P3|STARTED|Period 3||5
4969869|NCT02636361|12222542|P2|STARTED|Period 3||5
4969870|NCT02636361|12222543|P1|STARTED|Period 3||5
4969871|NCT02636361|12222539|P5|NOT COMPLETED|Period 2||0
4969872|NCT02636361|12222540|P4|NOT COMPLETED|Period 2||0
4969873|NCT02636361|12222541|P3|NOT COMPLETED|Period 2||0
4969874|NCT02636361|12222542|P2|NOT COMPLETED|Period 2||0
4969875|NCT02636361|12222543|P1|NOT COMPLETED|Period 2||0
4969876|NCT02636361|12222539|P5|COMPLETED|Period 2||4
4969877|NCT02636361|12222540|P4|COMPLETED|Period 2||5
4969878|NCT02636361|12222541|P3|COMPLETED|Period 2||5
4969879|NCT02636361|12222542|P2|COMPLETED|Period 2||5
4969880|NCT02636361|12222543|P1|COMPLETED|Period 2||5
4969881|NCT02636361|12222539|P5|STARTED|Period 2||4
4969882|NCT02636361|12222540|P4|STARTED|Period 2||5
4969883|NCT02636361|12222541|P3|STARTED|Period 2||5
4969884|NCT02636361|12222542|P2|STARTED|Period 2||5
4969885|NCT02636361|12222543|P1|STARTED|Period 2||5
4969886|NCT02636361|12222539|P5|NOT COMPLETED|Period 1||1
4969887|NCT02636361|12222540|P4|NOT COMPLETED|Period 1||0
4969888|NCT02636361|12222541|P3|NOT COMPLETED|Period 1||0
4969889|NCT02636361|12222542|P2|NOT COMPLETED|Period 1||1
4969890|NCT02636361|12222543|P1|NOT COMPLETED|Period 1||0
4969891|NCT02636361|12222539|P5|COMPLETED|Period 1||4
4969892|NCT02636361|12222540|P4|COMPLETED|Period 1||5
4969893|NCT02636361|12222541|P3|COMPLETED|Period 1||5
4969894|NCT02636361|12222542|P2|COMPLETED|Period 1||5
4969895|NCT02636361|12222543|P1|COMPLETED|Period 1||5
4969896|NCT02636361|12222539|P5|Received at Least One Dose of Study Drug|Period 1||4
4969897|NCT02636361|12222540|P4|Received at Least One Dose of Study Drug|Period 1||5
4969898|NCT02636361|12222541|P3|Received at Least One Dose of Study Drug|Period 1||5
4969899|NCT02636361|12222542|P2|Received at Least One Dose of Study Drug|Period 1||5
4969900|NCT02636361|12222543|P1|Received at Least One Dose of Study Drug|Period 1||5
4969901|NCT02636361|12222539|P5|STARTED|Period 1||5
4969902|NCT02636361|12222540|P4|STARTED|Period 1||5
4969903|NCT02636361|12222541|P3|STARTED|Period 1||5
4969904|NCT02636361|12222542|P2|STARTED|Period 1||6
4969905|NCT02636361|12222543|P1|STARTED|Period 1||5
4969906|NCT02636283|12222562|P2|NOT COMPLETED|Overall Study||3
4969907|NCT02636283|12222563|P1|NOT COMPLETED|Overall Study||2
4969908|NCT02636283|12222562|P2|COMPLETED|Overall Study||0
4969909|NCT02636283|12222563|P1|COMPLETED|Overall Study||1
4969910|NCT02636283|12222562|P2|STARTED|Overall Study||3
4969911|NCT02636283|12222563|P1|STARTED|Overall Study||3
4969912|NCT02636049|12222577|P1|NOT COMPLETED|Overall Study||0
4969913|NCT02636049|12222577|P1|COMPLETED|Overall Study||12
4969914|NCT02636049|12222577|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
4969915|NCT02636049|12222577|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
4969916|NCT02636049|12222577|P1|STARTED|Overall Study||12
4969917|NCT02635984|12222591|P2|NOT COMPLETED|Overall Study||4
4969918|NCT02635984|12222592|P1|NOT COMPLETED|Overall Study||3
4969919|NCT02635984|12222591|P2|COMPLETED|Overall Study||51
4969920|NCT02635984|12222592|P1|COMPLETED|Overall Study||50
4969921|NCT02635984|12222591|P2|STARTED|Overall Study||55
4969922|NCT02635984|12222592|P1|STARTED|Overall Study||53
4969923|NCT02635880|12222612|P1|NOT COMPLETED|Overall Study||0
4969924|NCT02635880|12222612|P1|COMPLETED|Overall Study||32
4969925|NCT02635880|12222612|P1|STARTED|Overall Study||32
4969926|NCT02635828|12222617|P1|NOT COMPLETED|Overall Study||14
4969927|NCT02635828|12222617|P1|COMPLETED|Overall Study||40
4969928|NCT02635828|12222617|P1|STARTED|Overall Study||54
4969929|NCT02635646|12222624|P2|NOT COMPLETED|Overall Study||26
4969930|NCT02635646|12222625|P1|NOT COMPLETED|Overall Study||25
4969931|NCT02635646|12222624|P2|COMPLETED|Overall Study||39
4969932|NCT02635646|12222625|P1|COMPLETED|Overall Study||32
4969933|NCT02635646|12222624|P2|STARTED|Overall Study||65
4969934|NCT02635646|12222625|P1|STARTED|Overall Study||57
4969935|NCT02635542|12222641|P2|NOT COMPLETED|Overall Study||0
4969936|NCT02635542|12222642|P1|NOT COMPLETED|Overall Study||0
4969937|NCT02635542|12222641|P2|COMPLETED|Overall Study||50
4969938|NCT02635542|12222642|P1|COMPLETED|Overall Study||50
4969939|NCT02635542|12222641|P2|STARTED|Overall Study||50
4969940|NCT02635542|12222642|P1|STARTED|Overall Study||50
4969941|NCT02635425|12222652|P2|NOT COMPLETED|Overall Study||0
4969942|NCT02635425|12222653|P1|NOT COMPLETED|Overall Study||0
4969943|NCT02635425|12222652|P2|COMPLETED|Overall Study||15
4969944|NCT02635425|12222653|P1|COMPLETED|Overall Study||15
4969945|NCT02635425|12222652|P2|STARTED|Overall Study||15
4969946|NCT02635425|12222653|P1|STARTED|Overall Study||15
4969947|NCT02635347|12222661|P2|NOT COMPLETED|Overall Study||7
4969948|NCT02635347|12222662|P1|NOT COMPLETED|Overall Study||20
4969949|NCT02635347|12222661|P2|COMPLETED|Overall Study||63
4969950|NCT02635347|12222662|P1|COMPLETED|Overall Study||31
4969951|NCT02635347|12222661|P2|Analyses|Overall Study||63
4969952|NCT02635347|12222662|P1|Analyses|Overall Study||30
4969953|NCT02635347|12222661|P2|Follow up|Overall Study||63
4969954|NCT02635347|12222662|P1|Follow up|Overall Study||31
4969955|NCT02635347|12222661|P2|Protocol Completion|Overall Study||63
4969956|NCT02635347|12222662|P1|Protocol Completion|Overall Study||22
4969957|NCT02635347|12222661|P2|Enrollment|Overall Study||63
4969958|NCT02635347|12222662|P1|Enrollment|Overall Study||31
4969959|NCT02635347|12222661|P2|Screening|Overall Study||70
4969960|NCT02635347|12222662|P1|Screening|Overall Study||51
4969961|NCT02635347|12222661|P2|STARTED|Overall Study||70
4969962|NCT02635347|12222662|P1|STARTED|Overall Study||51
4969963|NCT02635204|12222693|P2|NOT COMPLETED|Overall Study||1
4969964|NCT02635204|12222694|P1|NOT COMPLETED|Overall Study||2
4969965|NCT02635204|12222693|P2|COMPLETED|Overall Study||88
4969966|NCT02635204|12222694|P1|COMPLETED|Overall Study||176
4969967|NCT02635204|12222693|P2|STARTED|Overall Study||89
4969968|NCT02635204|12222694|P1|STARTED|Overall Study||178
4969969|NCT02634983|12222704|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
4969970|NCT02634983|12222705|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
4969971|NCT02634983|12222704|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
4969972|NCT02634983|12222705|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
4969973|NCT02634983|12222704|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
4969974|NCT02634983|12222705|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
4969975|NCT02634983|12222704|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
4969976|NCT02634983|12222705|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
4969977|NCT02634983|12222704|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
4969978|NCT02634983|12222705|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
4969979|NCT02634983|12222704|P2|STARTED|Washout (Approximately 7-14 Days)||15
4969980|NCT02634983|12222705|P1|STARTED|Washout (Approximately 7-14 Days)||16
4969981|NCT02634983|12222704|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
4969982|NCT02634983|12222705|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
4969983|NCT02634983|12222704|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
4969984|NCT02634983|12222705|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
4969985|NCT02634983|12222704|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
4969986|NCT02634983|12222705|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
4969987|NCT02634827|12222725|P1|NOT COMPLETED|Overall Study||0
4969988|NCT02634827|12222725|P1|COMPLETED|Overall Study||1
4969989|NCT02634827|12222725|P1|STARTED|Overall Study||1
4969990|NCT02634814|12222739|P3|NOT COMPLETED|Overall Study||0
4969991|NCT02634814|12222740|P2|NOT COMPLETED|Overall Study||6
4969992|NCT02634814|12222741|P1|NOT COMPLETED|Overall Study||2
4969993|NCT02634814|12222739|P3|COMPLETED|Overall Study||29
4969994|NCT02634814|12222740|P2|COMPLETED|Overall Study||23
4969995|NCT02634814|12222741|P1|COMPLETED|Overall Study||30
4969996|NCT02634814|12222739|P3|STARTED|Overall Study||29
4969997|NCT02634814|12222740|P2|STARTED|Overall Study||29
4969998|NCT02634814|12222741|P1|STARTED|Overall Study||32
4969999|NCT02634801|12222764|P3|NOT COMPLETED|Follow-up Period||8
4970000|NCT02634801|12222765|P2|NOT COMPLETED|Follow-up Period||8
4970001|NCT02634801|12222766|P1|NOT COMPLETED|Follow-up Period||5
4970002|NCT02634801|12222764|P3|COMPLETED|Follow-up Period||38
4970003|NCT02634801|12222765|P2|COMPLETED|Follow-up Period||18
4970004|NCT02634801|12222766|P1|COMPLETED|Follow-up Period||36
4970005|NCT02634801|12222764|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
4970006|NCT02634801|12222765|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
4970007|NCT02634801|12222766|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
4970008|NCT02634801|12222764|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
4970009|NCT02634801|12222765|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
4970010|NCT02634801|12222766|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
4970011|NCT02634801|12222764|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
4970012|NCT02634801|12222765|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
4970013|NCT02634801|12222766|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
4970014|NCT02634801|12222764|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
4970015|NCT02634801|12222765|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
4970016|NCT02634801|12222766|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
4970017|NCT02634801|12222764|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
4970018|NCT02634801|12222765|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
4970019|NCT02634801|12222766|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
4970020|NCT02634801|12222764|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
4970021|NCT02634801|12222765|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
4970022|NCT02634801|12222766|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
4970023|NCT02634801|12222764|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
4970024|NCT02634801|12222765|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
4970025|NCT02634801|12222766|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
4970026|NCT02634801|12222764|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
4970027|NCT02634801|12222765|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
4970028|NCT02634801|12222766|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
4970029|NCT02634788|12222866|P4|NOT COMPLETED|Overall Study||5
4970030|NCT02634788|12222867|P3|NOT COMPLETED|Overall Study||5
4970031|NCT02634788|12222868|P2|NOT COMPLETED|Overall Study||10
4970032|NCT02634788|12222869|P1|NOT COMPLETED|Overall Study||4
4970033|NCT02634788|12222866|P4|COMPLETED|Overall Study||77
4970034|NCT02634788|12222867|P3|COMPLETED|Overall Study||75
4970035|NCT02634788|12222868|P2|COMPLETED|Overall Study||71
4970036|NCT02634788|12222869|P1|COMPLETED|Overall Study||75
4970037|NCT02634788|12222866|P4|STARTED|Overall Study||82
4970038|NCT02634788|12222867|P3|STARTED|Overall Study||80
4970039|NCT02634788|12222868|P2|STARTED|Overall Study||81
4970040|NCT02634788|12222869|P1|STARTED|Overall Study||79
4970041|NCT02634606|12222935|P1|NOT COMPLETED|Overall Study||13
4970042|NCT02634606|12222935|P1|COMPLETED|Overall Study||0
4970043|NCT02634606|12222935|P1|STARTED|Overall Study||13
4970044|NCT02634580|12222947|P4|NOT COMPLETED|Overall Study||1
4970045|NCT02634580|12222948|P3|NOT COMPLETED|Overall Study||1
4970046|NCT02634580|12222949|P2|NOT COMPLETED|Overall Study||0
4970047|NCT02634580|12222950|P1|NOT COMPLETED|Overall Study||1
4970048|NCT02634580|12222947|P4|COMPLETED|Overall Study||20
4970049|NCT02634580|12222948|P3|COMPLETED|Overall Study||18
4970050|NCT02634580|12222949|P2|COMPLETED|Overall Study||11
4970051|NCT02634580|12222950|P1|COMPLETED|Overall Study||9
4970052|NCT02634580|12222947|P4|STARTED|Overall Study||21
4970053|NCT02634580|12222948|P3|STARTED|Overall Study||19
4970054|NCT02634580|12222949|P2|STARTED|Overall Study||11
4970055|NCT02634580|12222950|P1|STARTED|Overall Study||10
4970056|NCT02634346|12223007|P3|NOT COMPLETED|Overall Study||23
4970057|NCT02634346|12223008|P2|NOT COMPLETED|Overall Study||14
4970058|NCT02634346|12223009|P1|NOT COMPLETED|Overall Study||12
4970059|NCT02634346|12223007|P3|COMPLETED|Overall Study||111
4970060|NCT02634346|12223008|P2|COMPLETED|Overall Study||119
4970061|NCT02634346|12223009|P1|COMPLETED|Overall Study||122
4970062|NCT02634346|12223007|P3|STARTED|Overall Study||134
4970063|NCT02634346|12223008|P2|STARTED|Overall Study||133
4970064|NCT02634346|12223009|P1|STARTED|Overall Study||134
4970065|NCT02634320|12223023|P1|NOT COMPLETED|Overall Study||16
4970066|NCT02634320|12223023|P1|COMPLETED|Overall Study||35
4970067|NCT02634320|12223023|P1|STARTED|Overall Study||51
4970068|NCT02634151|12223034|P2|NOT COMPLETED|Overall Study||2
4970069|NCT02634151|12223035|P1|NOT COMPLETED|Overall Study||1
4970070|NCT02634151|12223034|P2|COMPLETED|Overall Study||50
4970071|NCT02634151|12223035|P1|COMPLETED|Overall Study||52
4970072|NCT02634151|12223034|P2|Safety Set|Overall Study||51
4970073|NCT02634151|12223035|P1|Safety Set|Overall Study||54
4970074|NCT02634151|12223034|P2|Full Analysis Set|Overall Study||52
4970075|NCT02634151|12223035|P1|Full Analysis Set|Overall Study||53
4970076|NCT02634151|12223034|P2|STARTED|Overall Study||52
4970077|NCT02634151|12223035|P1|STARTED|Overall Study||53
4970078|NCT02634073|12223121|P4|NOT COMPLETED|Overall Study||0
4970079|NCT02634073|12223122|P3|NOT COMPLETED|Overall Study||0
4970080|NCT02634073|12223123|P2|NOT COMPLETED|Overall Study||0
4970081|NCT02634073|12223124|P1|NOT COMPLETED|Overall Study||0
4970082|NCT02634073|12223121|P4|COMPLETED|Overall Study||4
4970083|NCT02634073|12223122|P3|COMPLETED|Overall Study||4
4970084|NCT02634073|12223123|P2|COMPLETED|Overall Study||4
4970085|NCT02634073|12223124|P1|COMPLETED|Overall Study||4
4970086|NCT02634073|12223121|P4|STARTED|Overall Study||4
4970087|NCT02634073|12223122|P3|STARTED|Overall Study||4
4970088|NCT02634073|12223123|P2|STARTED|Overall Study||4
4970089|NCT02634073|12223124|P1|STARTED|Overall Study||4
4970090|NCT02633956|12223214|P4|NOT COMPLETED|Overall Study||0
4970091|NCT02633956|12223215|P3|NOT COMPLETED|Overall Study||2
4970092|NCT02633956|12223216|P2|NOT COMPLETED|Overall Study||2
4970093|NCT02633956|12223217|P1|NOT COMPLETED|Overall Study||1
4970094|NCT02633956|12223214|P4|COMPLETED|Overall Study||21
4970095|NCT02633956|12223215|P3|COMPLETED|Overall Study||20
4970096|NCT02633956|12223216|P2|COMPLETED|Overall Study||19
4970097|NCT02633956|12223217|P1|COMPLETED|Overall Study||19
4970098|NCT02633956|12223214|P4|STARTED|Overall Study||21
4970099|NCT02633956|12223215|P3|STARTED|Overall Study||22
4970100|NCT02633956|12223216|P2|STARTED|Overall Study||21
4970101|NCT02633956|12223217|P1|STARTED|Overall Study||20
4970102|NCT02633800|12223237|P2|NOT COMPLETED|Overall Study||43
4970103|NCT02633800|12223238|P1|NOT COMPLETED|Overall Study||44
4970104|NCT02633800|12223237|P2|COMPLETED|Overall Study||0
4970105|NCT02633800|12223238|P1|COMPLETED|Overall Study||0
4970106|NCT02633800|12223237|P2|STARTED|Overall Study||43
4970107|NCT02633800|12223238|P1|STARTED|Overall Study||44
4970108|NCT02633787|12223248|P1|NOT COMPLETED|Overall Study||1
4970109|NCT02633787|12223248|P1|COMPLETED|Overall Study||109
4970110|NCT02633787|12223248|P1|STARTED|Overall Study||110
4970111|NCT02633735|12223256|P2|NOT COMPLETED|Implementation Phase||0
4970112|NCT02633735|12223257|P1|NOT COMPLETED|Implementation Phase||0
4970113|NCT02633735|12223256|P2|COMPLETED|Implementation Phase||2150
4970114|NCT02633735|12223257|P1|COMPLETED|Implementation Phase||1991
4970115|NCT02633735|12223256|P2|STARTED|Implementation Phase||2150
4970116|NCT02633735|12223257|P1|STARTED|Implementation Phase||1991
4970117|NCT02633735|12223256|P2|NOT COMPLETED|Pre-implementation Phase||0
4970118|NCT02633735|12223257|P1|NOT COMPLETED|Pre-implementation Phase||0
4970119|NCT02633735|12223256|P2|COMPLETED|Pre-implementation Phase||1011
4970120|NCT02633735|12223257|P1|COMPLETED|Pre-implementation Phase||788
4970121|NCT02633735|12223256|P2|STARTED|Pre-implementation Phase||1011
4970122|NCT02633735|12223257|P1|STARTED|Pre-implementation Phase||788
4970123|NCT02633501|12223269|P6|NOT COMPLETED|Overall Study||15
4970124|NCT02633501|12223270|P5|NOT COMPLETED|Overall Study||11
4970125|NCT02633501|12223271|P4|NOT COMPLETED|Overall Study||4
4970126|NCT02633501|12223272|P3|NOT COMPLETED|Overall Study||7
4970127|NCT02633501|12223273|P2|NOT COMPLETED|Overall Study||3
4970128|NCT02633501|12223274|P1|NOT COMPLETED|Overall Study||2
4970129|NCT02633501|12223269|P6|COMPLETED|Overall Study||48
4970130|NCT02633501|12223270|P5|COMPLETED|Overall Study||53
4970131|NCT02633501|12223271|P4|COMPLETED|Overall Study||59
4970132|NCT02633501|12223272|P3|COMPLETED|Overall Study||55
4970133|NCT02633501|12223273|P2|COMPLETED|Overall Study||11
4970134|NCT02633501|12223274|P1|COMPLETED|Overall Study||12
4970135|NCT02633501|12223269|P6|STARTED|Overall Study||63
4970136|NCT02633501|12223270|P5|STARTED|Overall Study||64
4970137|NCT02633501|12223271|P4|STARTED|Overall Study||63
4970138|NCT02633501|12223272|P3|STARTED|Overall Study||62
4970139|NCT02633501|12223273|P2|STARTED|Overall Study||14
4970140|NCT02633501|12223274|P1|STARTED|Overall Study||14
4970141|NCT02633488|12223295|P2|NOT COMPLETED|Overall Study||0
4970142|NCT02633488|12223296|P1|NOT COMPLETED|Overall Study||0
4970143|NCT02633488|12223295|P2|COMPLETED|Overall Study||5
4970144|NCT02633488|12223296|P1|COMPLETED|Overall Study||6
4970145|NCT02633488|12223295|P2|STARTED|Overall Study||5
4970146|NCT02633488|12223296|P1|STARTED|Overall Study||6
4970147|NCT02633371|12223302|P1|NOT COMPLETED|Overall Study||3
4970148|NCT02633371|12223302|P1|COMPLETED|Overall Study||7
4970149|NCT02633371|12223302|P1|STARTED|Overall Study||10
4970150|NCT02633358|12223308|P2|NOT COMPLETED|Overall Study||0
4970151|NCT02633358|12223309|P1|NOT COMPLETED|Overall Study||0
4970152|NCT02633358|12223308|P2|COMPLETED|Overall Study||54
4970153|NCT02633358|12223309|P1|COMPLETED|Overall Study||87
4970154|NCT02633358|12223308|P2|STARTED|Overall Study||54
4970155|NCT02633358|12223309|P1|STARTED|Overall Study||87
4970156|NCT02633241|12223323|P1|NOT COMPLETED|Overall Study||3
4970157|NCT02633241|12223323|P1|COMPLETED|Overall Study||27
4970158|NCT02633241|12223323|P1|STARTED|Overall Study||30
4970159|NCT02633215|12223336|P2|NOT COMPLETED|Overall Study||3
4970160|NCT02633215|12223337|P1|NOT COMPLETED|Overall Study||2
4970161|NCT02633215|12223336|P2|COMPLETED|Overall Study||15
4970162|NCT02633215|12223337|P1|COMPLETED|Overall Study||16
4970163|NCT02633215|12223336|P2|STARTED|Overall Study||18
4970164|NCT02633215|12223337|P1|STARTED|Overall Study||18
4970165|NCT02633020|12223349|P2|NOT COMPLETED|Overall Study||0
4970166|NCT02633020|12223350|P1|NOT COMPLETED|Overall Study||1
4970167|NCT02633020|12223349|P2|COMPLETED|Overall Study||9
4970168|NCT02633020|12223350|P1|COMPLETED|Overall Study||18
4970169|NCT02633020|12223349|P2|STARTED|Overall Study||9
4970170|NCT02633020|12223350|P1|STARTED|Overall Study||19
4970171|NCT02632838|12223374|P2|NOT COMPLETED|Overall Study||2
4970172|NCT02632838|12223375|P1|NOT COMPLETED|Overall Study||3
4970173|NCT02632838|12223374|P2|COMPLETED|Overall Study||13
4970174|NCT02632838|12223375|P1|COMPLETED|Overall Study||12
4970175|NCT02632838|12223374|P2|STARTED|Overall Study||15
4970176|NCT02632838|12223375|P1|STARTED|Overall Study||15
4970177|NCT02632812|12223391|P2|NOT COMPLETED|Overall Study||0
4970178|NCT02632812|12223392|P1|NOT COMPLETED|Overall Study||0
4970179|NCT02632812|12223391|P2|COMPLETED|Overall Study||12
4970180|NCT02632812|12223392|P1|COMPLETED|Overall Study||12
4970181|NCT02632812|12223391|P2|STARTED|Overall Study||12
4970182|NCT02632812|12223392|P1|STARTED|Overall Study||12
4970183|NCT02632786|12223412|P2|NOT COMPLETED|Overall Study||7
4970184|NCT02632786|12223413|P1|NOT COMPLETED|Overall Study||11
4970185|NCT02632786|12223412|P2|COMPLETED|Overall Study||56
4970186|NCT02632786|12223413|P1|COMPLETED|Overall Study||55
4970187|NCT02632786|12223412|P2|Randomized and Dosed|Overall Study||63
4970188|NCT02632786|12223413|P1|Randomized and Dosed|Overall Study||66
4970189|NCT02632786|12223412|P2|Informed Consent Obtained|Overall Study||63
4970190|NCT02632786|12223413|P1|Informed Consent Obtained|Overall Study||66
4970191|NCT02632786|12223412|P2|STARTED|Overall Study||63
4970192|NCT02632786|12223413|P1|STARTED|Overall Study||66
4970193|NCT02632747|12223433|P2|NOT COMPLETED|Treatment Period 2||0
4970194|NCT02632747|12223434|P1|NOT COMPLETED|Treatment Period 2||0
4970195|NCT02632747|12223433|P2|COMPLETED|Treatment Period 2||15
4970196|NCT02632747|12223434|P1|COMPLETED|Treatment Period 2||15
4970197|NCT02632747|12223433|P2|STARTED|Treatment Period 2||15
4970198|NCT02632747|12223434|P1|STARTED|Treatment Period 2||15
4970199|NCT02632747|12223433|P2|NOT COMPLETED|Wash-out Period||0
4970200|NCT02632747|12223434|P1|NOT COMPLETED|Wash-out Period||1
4970201|NCT02632747|12223433|P2|COMPLETED|Wash-out Period||15
4970202|NCT02632747|12223434|P1|COMPLETED|Wash-out Period||15
4970203|NCT02632747|12223433|P2|STARTED|Wash-out Period||15
4970204|NCT02632747|12223434|P1|STARTED|Wash-out Period||16
4970205|NCT02632747|12223433|P2|NOT COMPLETED|Treatment Period 1||0
4970206|NCT02632747|12223434|P1|NOT COMPLETED|Treatment Period 1||0
4970207|NCT02632747|12223433|P2|COMPLETED|Treatment Period 1||15
4970208|NCT02632747|12223434|P1|COMPLETED|Treatment Period 1||16
4970209|NCT02632747|12223433|P2|STARTED|Treatment Period 1||15
4970210|NCT02632747|12223434|P1|STARTED|Treatment Period 1||16
4970211|NCT02632526|12223448|P6|NOT COMPLETED|Overall Study||0
4970212|NCT02632526|12223449|P5|NOT COMPLETED|Overall Study||0
4970213|NCT02632526|12223450|P4|NOT COMPLETED|Overall Study||0
4970214|NCT02632526|12223451|P3|NOT COMPLETED|Overall Study||0
4970215|NCT02632526|12223452|P2|NOT COMPLETED|Overall Study||0
4970216|NCT02632526|12223453|P1|NOT COMPLETED|Overall Study||0
4970217|NCT02632526|12223448|P6|COMPLETED|Overall Study||8
4970218|NCT02632526|12223449|P5|COMPLETED|Overall Study||4
4970219|NCT02632526|12223450|P4|COMPLETED|Overall Study||12
4970220|NCT02632526|12223451|P3|COMPLETED|Overall Study||24
4970221|NCT02632526|12223452|P2|COMPLETED|Overall Study||12
4970222|NCT02632526|12223453|P1|COMPLETED|Overall Study||36
4970223|NCT02632526|12223448|P6|STARTED|Overall Study||8
4970224|NCT02632526|12223449|P5|STARTED|Overall Study||4
4970225|NCT02632526|12223450|P4|STARTED|Overall Study||12
4970226|NCT02632526|12223451|P3|STARTED|Overall Study||24
4970227|NCT02632526|12223452|P2|STARTED|Overall Study||12
4970228|NCT02632526|12223453|P1|STARTED|Overall Study||36
4970229|NCT02632110|12223634|P10|NOT COMPLETED|Overall Study||1
4970230|NCT02632110|12223635|P9|NOT COMPLETED|Overall Study||1
4970231|NCT02632110|12223636|P8|NOT COMPLETED|Overall Study||3
4970232|NCT02632110|12223637|P7|NOT COMPLETED|Overall Study||3
4970233|NCT02632110|12223638|P6|NOT COMPLETED|Overall Study||1
4970234|NCT02632110|12223639|P5|NOT COMPLETED|Overall Study||1
4970235|NCT02632110|12223640|P4|NOT COMPLETED|Overall Study||0
4970236|NCT02632110|12223641|P3|NOT COMPLETED|Overall Study||0
4970237|NCT02632110|12223642|P2|NOT COMPLETED|Overall Study||1
4970238|NCT02632110|12223643|P1|NOT COMPLETED|Overall Study||1
4970239|NCT02632110|12223634|P10|COMPLETED|Overall Study||29
4970240|NCT02632110|12223635|P9|COMPLETED|Overall Study||29
4970241|NCT02632110|12223636|P8|COMPLETED|Overall Study||23
4970242|NCT02632110|12223637|P7|COMPLETED|Overall Study||23
4970243|NCT02632110|12223638|P6|COMPLETED|Overall Study||28
4970244|NCT02632110|12223639|P5|COMPLETED|Overall Study||28
4970245|NCT02632110|12223640|P4|COMPLETED|Overall Study||27
4970246|NCT02632110|12223641|P3|COMPLETED|Overall Study||27
4970247|NCT02632110|12223642|P2|COMPLETED|Overall Study||24
4970248|NCT02632110|12223643|P1|COMPLETED|Overall Study||24
4970249|NCT02632110|12223634|P10|STARTED|Overall Study||30
4970250|NCT02632110|12223635|P9|STARTED|Overall Study||30
4970251|NCT02632110|12223636|P8|STARTED|Overall Study||26
4970252|NCT02632110|12223637|P7|STARTED|Overall Study||26
4970253|NCT02632110|12223638|P6|STARTED|Overall Study||29
4970254|NCT02632110|12223639|P5|STARTED|Overall Study||29
4970255|NCT02632110|12223640|P4|STARTED|Overall Study||27
4970256|NCT02632110|12223641|P3|STARTED|Overall Study||27
4970257|NCT02632110|12223642|P2|STARTED|Overall Study||25
4970258|NCT02632110|12223643|P1|STARTED|Overall Study||25
4970259|NCT02631954|12224112|P2|NOT COMPLETED|Overall Study||0
4970260|NCT02631954|12224113|P1|NOT COMPLETED|Overall Study||0
4970261|NCT02631954|12224112|P2|COMPLETED|Overall Study||12
4970262|NCT02631954|12224113|P1|COMPLETED|Overall Study||12
4970263|NCT02631954|12224112|P2|STARTED|Overall Study||12
4970264|NCT02631954|12224113|P1|STARTED|Overall Study||12
4970265|NCT02631876|12224133|P2|NOT COMPLETED|Overall Study||63
4970266|NCT02631876|12224134|P1|NOT COMPLETED|Overall Study||119
4970267|NCT02631876|12224133|P2|COMPLETED|Overall Study||55
4970268|NCT02631876|12224134|P1|COMPLETED|Overall Study||129
4970269|NCT02631876|12224133|P2|Safety Population|Overall Study||109
4970270|NCT02631876|12224134|P1|Safety Population|Overall Study||243
4970271|NCT02631876|12224133|P2|STARTED|Overall Study||118
4970272|NCT02631876|12224134|P1|STARTED|Overall Study||248
4970273|NCT02631837|12224160|P2|NOT COMPLETED|Overall Study||0
4970274|NCT02631837|12224161|P1|NOT COMPLETED|Overall Study||0
4970275|NCT02631837|12224160|P2|COMPLETED|Overall Study||35
4970276|NCT02631837|12224161|P1|COMPLETED|Overall Study||35
4970277|NCT02631837|12224160|P2|STARTED|Overall Study||35
4970278|NCT02631837|12224161|P1|STARTED|Overall Study||35
4970279|NCT02631772|12224199|P2|NOT COMPLETED|Overall Study||0
4970280|NCT02631772|12224200|P1|NOT COMPLETED|Overall Study||0
4970281|NCT02631772|12224199|P2|COMPLETED|Overall Study||16
4970282|NCT02631772|12224200|P1|COMPLETED|Overall Study||16
4970283|NCT02631772|12224199|P2|STARTED|Overall Study||16
4970284|NCT02631772|12224200|P1|STARTED|Overall Study||16
4970285|NCT02631746|12224210|P1|NOT COMPLETED|Overall Study||3
4970286|NCT02631746|12224210|P1|COMPLETED|Overall Study||0
4970287|NCT02631746|12224210|P1|STARTED|Overall Study||3
4970288|NCT02631577|12224223|P2|NOT COMPLETED|Overall Study||4
4970289|NCT02631577|12224224|P1|NOT COMPLETED|Overall Study||1
4970290|NCT02631577|12224223|P2|COMPLETED|Overall Study||30
4970291|NCT02631577|12224224|P1|COMPLETED|Overall Study||3
4970292|NCT02631577|12224223|P2|STARTED|Overall Study||34
4970293|NCT02631577|12224224|P1|STARTED|Overall Study||4
4970294|NCT02631551|12224242|P4|NOT COMPLETED|Overall Study||11
4970295|NCT02631551|12224243|P3|NOT COMPLETED|Overall Study||11
4970296|NCT02631551|12224244|P2|NOT COMPLETED|Overall Study||19
4970297|NCT02631551|12224245|P1|NOT COMPLETED|Overall Study||13
4970298|NCT02631551|12224242|P4|COMPLETED|Overall Study||276
4970299|NCT02631551|12224243|P3|COMPLETED|Overall Study||283
4970300|NCT02631551|12224244|P2|COMPLETED|Overall Study||278
4970301|NCT02631551|12224245|P1|COMPLETED|Overall Study||289
4970302|NCT02631551|12224242|P4|STARTED|Overall Study||287
4970303|NCT02631551|12224243|P3|STARTED|Overall Study||294
4970304|NCT02631551|12224244|P2|STARTED|Overall Study||297
4970305|NCT02631551|12224245|P1|STARTED|Overall Study||302
4970306|NCT02631070|12224257|P2|NOT COMPLETED|Overall Study||76
4970307|NCT02631070|12224258|P1|NOT COMPLETED|Overall Study||112
4970308|NCT02631070|12224257|P2|COMPLETED|Overall Study||0
4970309|NCT02631070|12224258|P1|COMPLETED|Overall Study||41
4970310|NCT02631070|12224257|P2|Completed 48 Weeks of Treatment|Overall Study||12
4970311|NCT02631070|12224258|P1|Completed 48 Weeks of Treatment|Overall Study||83
4970312|NCT02631070|12224257|P2|Completed 24 Weeks of Treatment|Overall Study||68
4970313|NCT02631070|12224258|P1|Completed 24 Weeks of Treatment|Overall Study||128
4970314|NCT02631070|12224257|P2|STARTED|Overall Study||76
4970315|NCT02631070|12224258|P1|STARTED|Overall Study||153
4970316|NCT02631057|12224326|P2|NOT COMPLETED|Overall Study||0
4970317|NCT02631057|12224327|P1|NOT COMPLETED|Overall Study||0
4970318|NCT02631057|12224326|P2|COMPLETED|Overall Study||3414
4970319|NCT02631057|12224327|P1|COMPLETED|Overall Study||899
4970320|NCT02631057|12224326|P2|STARTED|Overall Study||3414
4970321|NCT02631057|12224327|P1|STARTED|Overall Study||899
4970322|NCT02630992|12224333|P1|NOT COMPLETED|Overall Study||13
4970323|NCT02630992|12224333|P1|COMPLETED|Overall Study||99
4970324|NCT02630992|12224333|P1|STARTED|Overall Study||112
4970325|NCT02630966|12224352|P2|NOT COMPLETED|Overall Study||8
4970326|NCT02630966|12224353|P1|NOT COMPLETED|Overall Study||2
4970327|NCT02630966|12224352|P2|COMPLETED|Overall Study||10
4970328|NCT02630966|12224353|P1|COMPLETED|Overall Study||14
4970329|NCT02630966|12224352|P2|STARTED|Overall Study||18
4970330|NCT02630966|12224353|P1|STARTED|Overall Study||16
4970331|NCT02630719|12224371|P2|NOT COMPLETED|Overall Study||0
4970332|NCT02630719|12224372|P1|NOT COMPLETED|Overall Study||0
4970333|NCT02630719|12224371|P2|COMPLETED|Overall Study||6
4970334|NCT02630719|12224372|P1|COMPLETED|Overall Study||4
4970335|NCT02630719|12224371|P2|STARTED|Overall Study||6
4970336|NCT02630719|12224372|P1|STARTED|Overall Study||4
4970337|NCT02630706|12224381|P3|NOT COMPLETED|Overall Study||10
4970338|NCT02630706|12224382|P2|NOT COMPLETED|Overall Study||9
4970339|NCT02630706|12224383|P1|NOT COMPLETED|Overall Study||7
4970340|NCT02630706|12224381|P3|COMPLETED|Overall Study||157
4970341|NCT02630706|12224382|P2|COMPLETED|Overall Study||160
4970342|NCT02630706|12224383|P1|COMPLETED|Overall Study||163
4970343|NCT02630706|12224381|P3|Treated|Overall Study||167
4970344|NCT02630706|12224382|P2|Treated|Overall Study||169
4970345|NCT02630706|12224383|P1|Treated|Overall Study||170
4970346|NCT02630706|12224381|P3|STARTED|Overall Study||167
4970347|NCT02630706|12224382|P2|STARTED|Overall Study||169
4970348|NCT02630706|12224383|P1|STARTED|Overall Study||170
4970349|NCT02630693|12224492|P2|NOT COMPLETED|Overall Study||1
4970350|NCT02630693|12224493|P1|NOT COMPLETED|Overall Study||0
4970351|NCT02630693|12224492|P2|COMPLETED|Overall Study||89
4970352|NCT02630693|12224493|P1|COMPLETED|Overall Study||90
4970353|NCT02630693|12224492|P2|STARTED|Overall Study||90
4970354|NCT02630693|12224493|P1|STARTED|Overall Study||90
4970355|NCT02630563|12224505|P1|NOT COMPLETED|Overall Study||1
4970356|NCT02630563|12224505|P1|COMPLETED|Overall Study||8
4970357|NCT02630563|12224505|P1|STARTED|Overall Study||9
4970358|NCT02630472|12224516|P2|NOT COMPLETED|Overall Study||0
4970359|NCT02630472|12224517|P1|NOT COMPLETED|Overall Study||10
4970360|NCT02630472|12224516|P2|COMPLETED|Overall Study||0
4970361|NCT02630472|12224517|P1|COMPLETED|Overall Study||0
4970362|NCT02630472|12224516|P2|STARTED|Overall Study||0
4970363|NCT02630472|12224517|P1|STARTED|Overall Study||10
4970364|NCT02630459|12224535|P4|NOT COMPLETED|Overall Study||3
4970365|NCT02630459|12224536|P3|NOT COMPLETED|Overall Study||5
4970366|NCT02630459|12224537|P2|NOT COMPLETED|Overall Study||2
4970367|NCT02630459|12224538|P1|NOT COMPLETED|Overall Study||3
4970368|NCT02630459|12224535|P4|COMPLETED|Overall Study||134
4970369|NCT02630459|12224536|P3|COMPLETED|Overall Study||130
4970370|NCT02630459|12224537|P2|COMPLETED|Overall Study||65
4970371|NCT02630459|12224538|P1|COMPLETED|Overall Study||133
4970372|NCT02630459|12224535|P4|Received Investigational Product|Overall Study||137
4970373|NCT02630459|12224536|P3|Received Investigational Product|Overall Study||135
4970374|NCT02630459|12224537|P2|Received Investigational Product|Overall Study||66
4970375|NCT02630459|12224538|P1|Received Investigational Product|Overall Study||136
4970376|NCT02630459|12224535|P4|STARTED|Overall Study||137
4970377|NCT02630459|12224536|P3|STARTED|Overall Study||135
4970378|NCT02630459|12224537|P2|STARTED|Overall Study||67
4970379|NCT02630459|12224538|P1|STARTED|Overall Study||136
4970380|NCT02630251|12224560|P4|NOT COMPLETED|Overall Study||0
4970381|NCT02630251|12224561|P3|NOT COMPLETED|Overall Study||1
4970382|NCT02630251|12224562|P2|NOT COMPLETED|Overall Study||0
4970383|NCT02630251|12224563|P1|NOT COMPLETED|Overall Study||0
4970384|NCT02630251|12224560|P4|COMPLETED|Overall Study||1
4970385|NCT02630251|12224561|P3|COMPLETED|Overall Study||0
4970386|NCT02630251|12224562|P2|COMPLETED|Overall Study||1
4970387|NCT02630251|12224563|P1|COMPLETED|Overall Study||2
4970388|NCT02630251|12224560|P4|STARTED|Overall Study||1
4970389|NCT02630251|12224561|P3|STARTED|Overall Study||1
4970390|NCT02630251|12224562|P2|STARTED|Overall Study||1
4970391|NCT02630251|12224563|P1|STARTED|Overall Study||2
4970392|NCT02630186|12224677|P1|NOT COMPLETED|Overall Study||1
4970393|NCT02630186|12224677|P1|COMPLETED|Overall Study||2
4970394|NCT02630186|12224677|P1|STARTED|Overall Study||3
4970395|NCT02629965|12224693|P2|NOT COMPLETED|Period 2||0
4970396|NCT02629965|12224694|P1|NOT COMPLETED|Period 2||1
4970397|NCT02629965|12224693|P2|COMPLETED|Period 2||90
4970398|NCT02629965|12224694|P1|COMPLETED|Period 2||87
4970399|NCT02629965|12224693|P2|STARTED|Period 2||90
4970400|NCT02629965|12224694|P1|STARTED|Period 2||88
4970401|NCT02629965|12224693|P2|NOT COMPLETED|Period 1||2
4970402|NCT02629965|12224694|P1|NOT COMPLETED|Period 1||4
4970403|NCT02629965|12224693|P2|COMPLETED|Period 1||90
4970404|NCT02629965|12224694|P1|COMPLETED|Period 1||88
4970405|NCT02629965|12224693|P2|STARTED|Period 1||92
4970406|NCT02629965|12224694|P1|STARTED|Period 1||92
4970407|NCT02629861|12224733|P3|NOT COMPLETED|Overall Study||28
4970408|NCT02629861|12224734|P2|NOT COMPLETED|Overall Study||27
4970409|NCT02629861|12224735|P1|NOT COMPLETED|Overall Study||29
4970410|NCT02629861|12224733|P3|COMPLETED|Overall Study||262
4970411|NCT02629861|12224734|P2|COMPLETED|Overall Study||264
4970412|NCT02629861|12224735|P1|COMPLETED|Overall Study||265
4970413|NCT02629861|12224733|P3|Full Analysis Set|Overall Study||287
4970414|NCT02629861|12224734|P2|Full Analysis Set|Overall Study||288
4970415|NCT02629861|12224735|P1|Full Analysis Set|Overall Study||290
4970416|NCT02629861|12224733|P3|Safety Population|Overall Study||289
4970417|NCT02629861|12224734|P2|Safety Population|Overall Study||291
4970418|NCT02629861|12224735|P1|Safety Population|Overall Study||294
4970419|NCT02629861|12224733|P3|Intent to Treat (ITT)|Overall Study||290
4970420|NCT02629861|12224734|P2|Intent to Treat (ITT)|Overall Study||291
4970421|NCT02629861|12224735|P1|Intent to Treat (ITT)|Overall Study||294
4970422|NCT02629861|12224733|P3|STARTED|Overall Study||290
4970423|NCT02629861|12224734|P2|STARTED|Overall Study||291
4970424|NCT02629861|12224735|P1|STARTED|Overall Study||294
4970425|NCT02629822|12224782|P1|NOT COMPLETED|Extension Study||6
4970426|NCT02629822|12224782|P1|COMPLETED|Extension Study||0
4970427|NCT02629822|12224782|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
4970428|NCT02629822|12224782|P1|NOT COMPLETED|Base Study||3
4970429|NCT02629822|12224782|P1|COMPLETED|Base Study||7
4970430|NCT02629822|12224782|P1|STARTED|Base Study||10
4970431|NCT02629354|12224798|P2|NOT COMPLETED|Follow-up||0
4970432|NCT02629354|12224799|P1|NOT COMPLETED|Follow-up||0
4970433|NCT02629354|12224798|P2|COMPLETED|Follow-up||18
4970434|NCT02629354|12224799|P1|COMPLETED|Follow-up||18
4970435|NCT02629354|12224798|P2|STARTED|Follow-up||18
4970436|NCT02629354|12224799|P1|STARTED|Follow-up||18
4970437|NCT02629354|12224798|P2|NOT COMPLETED|Period 2||0
4970438|NCT02629354|12224799|P1|NOT COMPLETED|Period 2||0
4970439|NCT02629354|12224798|P2|COMPLETED|Period 2||18
4970440|NCT02629354|12224799|P1|COMPLETED|Period 2||18
4970441|NCT02629354|12224798|P2|STARTED|Period 2||18
4970442|NCT02629354|12224799|P1|STARTED|Period 2||18
4970443|NCT02629354|12224798|P2|NOT COMPLETED|Washout Period||0
4970444|NCT02629354|12224799|P1|NOT COMPLETED|Washout Period||0
4970445|NCT02629354|12224798|P2|COMPLETED|Washout Period||18
4970446|NCT02629354|12224799|P1|COMPLETED|Washout Period||18
4970447|NCT02629354|12224798|P2|STARTED|Washout Period||18
4970448|NCT02629354|12224799|P1|STARTED|Washout Period||18
4970449|NCT02629354|12224798|P2|NOT COMPLETED|Period 1||0
4970450|NCT02629354|12224799|P1|NOT COMPLETED|Period 1||0
4970451|NCT02629354|12224798|P2|COMPLETED|Period 1||18
4970452|NCT02629354|12224799|P1|COMPLETED|Period 1||18
4970453|NCT02629354|12224798|P2|STARTED|Period 1||18
4970454|NCT02629354|12224799|P1|STARTED|Period 1||18
4970455|NCT02629159|12224824|P3|NOT COMPLETED|Overall Study||51
4970456|NCT02629159|12224825|P2|NOT COMPLETED|Overall Study||39
4970457|NCT02629159|12224826|P1|NOT COMPLETED|Overall Study||56
4970458|NCT02629159|12224824|P3|COMPLETED|Overall Study||600
4970459|NCT02629159|12224825|P2|COMPLETED|Overall Study||288
4970460|NCT02629159|12224826|P1|COMPLETED|Overall Study||595
4970461|NCT02629159|12224824|P3|Rescued at Week 22|Overall Study||18
4970462|NCT02629159|12224825|P2|Rescued at Week 22|Overall Study||7
4970463|NCT02629159|12224826|P1|Rescued at Week 22|Overall Study||26
4970464|NCT02629159|12224824|P3|Rescued at Week 18|Overall Study||29
4970465|NCT02629159|12224825|P2|Rescued at Week 18|Overall Study||14
4970466|NCT02629159|12224826|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
4970467|NCT02629159|12224824|P3|Rescued at Week 14|Overall Study||78
4970468|NCT02629159|12224825|P2|Rescued at Week 14|Overall Study||56
4970469|NCT02629159|12224826|P1|Rescued at Week 14|Overall Study||231
4970470|NCT02629159|12224824|P3|Completed Week 14 on Study Drug|Overall Study||620
4970471|NCT02629159|12224825|P2|Completed Week 14 on Study Drug|Overall Study||300
4970472|NCT02629159|12224826|P1|Completed Week 14 on Study Drug|Overall Study||620
4970473|NCT02629159|12224824|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
4970474|NCT02629159|12224825|P2|Received Assigned Study Drug|Overall Study||327
4970475|NCT02629159|12224826|P1|Received Assigned Study Drug|Overall Study||651
4970476|NCT02629159|12224824|P3|STARTED|Overall Study||651
4970477|NCT02629159|12224825|P2|STARTED|Overall Study||327
4970478|NCT02629159|12224826|P1|STARTED|Overall Study||651
4970479|NCT02629133|12224878|P2|NOT COMPLETED|Overall Study||2
4970480|NCT02629133|12224879|P1|NOT COMPLETED|Overall Study||4
4970481|NCT02629133|12224878|P2|COMPLETED|Overall Study||23
4970482|NCT02629133|12224879|P1|COMPLETED|Overall Study||21
4970483|NCT02629133|12224878|P2|STARTED|Overall Study||25
4970484|NCT02629133|12224879|P1|STARTED|Overall Study||25
4970485|NCT02629094|12224893|P1|NOT COMPLETED|Overall Study||0
4970486|NCT02629094|12224893|P1|COMPLETED|Overall Study||5
4970487|NCT02629094|12224893|P1|STARTED|Overall Study||5
4970488|NCT02628964|12224900|P2|NOT COMPLETED|Overall Study||1
4970489|NCT02628964|12224901|P1|NOT COMPLETED|Overall Study||0
4970490|NCT02628964|12224900|P2|COMPLETED|Overall Study||49
4970491|NCT02628964|12224901|P1|COMPLETED|Overall Study||50
4970492|NCT02628964|12224900|P2|STARTED|Overall Study||50
4970493|NCT02628964|12224901|P1|STARTED|Overall Study||50
4970494|NCT02628938|12224922|P3|NOT COMPLETED|Overall Study||4
4970495|NCT02628938|12224923|P2|NOT COMPLETED|Overall Study||2
4970496|NCT02628938|12224924|P1|NOT COMPLETED|Overall Study||5
4970497|NCT02628938|12224922|P3|COMPLETED|Overall Study||11
4970498|NCT02628938|12224923|P2|COMPLETED|Overall Study||13
4970499|NCT02628938|12224924|P1|COMPLETED|Overall Study||10
4970500|NCT02628938|12224922|P3|STARTED|Overall Study||15
4970501|NCT02628938|12224923|P2|STARTED|Overall Study||15
4970502|NCT02628938|12224924|P1|STARTED|Overall Study||15
4970503|NCT02628769|12224938|P2|NOT COMPLETED|Second Intervention||1
4970504|NCT02628769|12224939|P1|NOT COMPLETED|Second Intervention||2
4970505|NCT02628769|12224938|P2|COMPLETED|Second Intervention||1
4970506|NCT02628769|12224939|P1|COMPLETED|Second Intervention||0
4970507|NCT02628769|12224938|P2|STARTED|Second Intervention||2
4970508|NCT02628769|12224939|P1|STARTED|Second Intervention||2
4970509|NCT02628769|12224938|P2|NOT COMPLETED|Wash Out (28 Days)||0
4970510|NCT02628769|12224939|P1|NOT COMPLETED|Wash Out (28 Days)||0
4970511|NCT02628769|12224938|P2|COMPLETED|Wash Out (28 Days)||2
4970512|NCT02628769|12224939|P1|COMPLETED|Wash Out (28 Days)||2
4970513|NCT02628769|12224938|P2|STARTED|Wash Out (28 Days)||2
4970514|NCT02628769|12224939|P1|STARTED|Wash Out (28 Days)||2
4970515|NCT02628769|12224938|P2|NOT COMPLETED|First Intervention||1
4970516|NCT02628769|12224939|P1|NOT COMPLETED|First Intervention||1
4970517|NCT02628769|12224938|P2|COMPLETED|First Intervention||2
4970518|NCT02628769|12224939|P1|COMPLETED|First Intervention||2
4970519|NCT02628769|12224938|P2|STARTED|First Intervention||3
4970520|NCT02628769|12224939|P1|STARTED|First Intervention||3
4970521|NCT02628743|12224977|P1|NOT COMPLETED|Overall Study||131
4970522|NCT02628743|12224977|P1|COMPLETED|Overall Study||0
4970523|NCT02628743|12224977|P1|STARTED|Overall Study||131
4970524|NCT02628600|12225003|P2|NOT COMPLETED|Overall Study||32
4970525|NCT02628600|12225004|P1|NOT COMPLETED|Overall Study||24
4970526|NCT02628600|12225003|P2|COMPLETED|Overall Study||58
4970527|NCT02628600|12225004|P1|COMPLETED|Overall Study||49
4970528|NCT02628600|12225003|P2|Participant Discontinued the Study|Overall Study||32
4970529|NCT02628600|12225004|P1|Participant Discontinued the Study|Overall Study||24
4970530|NCT02628600|12225003|P2|STARTED|Overall Study||90
4970531|NCT02628600|12225004|P1|STARTED|Overall Study||73
4970532|NCT02628418|12225018|P2|NOT COMPLETED|Overall Study||2
4970533|NCT02628418|12225019|P1|NOT COMPLETED|Overall Study||1
4970534|NCT02628418|12225018|P2|COMPLETED|Overall Study||13
4970535|NCT02628418|12225019|P1|COMPLETED|Overall Study||14
4970536|NCT02628418|12225018|P2|STARTED|Overall Study||15
4970537|NCT02628418|12225019|P1|STARTED|Overall Study||15
4970538|NCT02628236|12225040|P1|NOT COMPLETED|Overall Study||0
4970539|NCT02628236|12225040|P1|COMPLETED|Overall Study||14
4970540|NCT02628236|12225040|P1|STARTED|Overall Study||14
4970541|NCT02628106|12225077|P1|NOT COMPLETED|Overall Study||0
4970542|NCT02628106|12225077|P1|COMPLETED|Overall Study||21
4970543|NCT02628106|12225077|P1|STARTED|Overall Study||21
4970544|NCT02628093|12225083|P2|NOT COMPLETED|Overall Study||0
4970545|NCT02628093|12225084|P1|NOT COMPLETED|Overall Study||0
4970546|NCT02628093|12225083|P2|COMPLETED|Overall Study||29
4970547|NCT02628093|12225084|P1|COMPLETED|Overall Study||31
4970548|NCT02628093|12225083|P2|STARTED|Overall Study||29
4970549|NCT02628093|12225084|P1|STARTED|Overall Study||31
4970550|NCT02628028|12225110|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
4970551|NCT02628028|12225111|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
4970552|NCT02628028|12225112|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
4970553|NCT02628028|12225113|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
4970554|NCT02628028|12225114|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
4970555|NCT02628028|12225115|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
4970556|NCT02628028|12225116|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
4970557|NCT02628028|12225117|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
4970558|NCT02628028|12225110|P8|COMPLETED|Long-term Extension (LTE) Period||0
4970559|NCT02628028|12225111|P7|COMPLETED|Long-term Extension (LTE) Period||0
4970560|NCT02628028|12225112|P6|COMPLETED|Long-term Extension (LTE) Period||1
4970561|NCT02628028|12225113|P5|COMPLETED|Long-term Extension (LTE) Period||0
4970562|NCT02628028|12225114|P4|COMPLETED|Long-term Extension (LTE) Period||0
4970563|NCT02628028|12225115|P3|COMPLETED|Long-term Extension (LTE) Period||0
4970564|NCT02628028|12225116|P2|COMPLETED|Long-term Extension (LTE) Period||0
4970565|NCT02628028|12225117|P1|COMPLETED|Long-term Extension (LTE) Period||0
4970566|NCT02628028|12225110|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
4970567|NCT02628028|12225111|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
4970568|NCT02628028|12225112|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
4970569|NCT02628028|12225113|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
4970570|NCT02628028|12225114|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
4970571|NCT02628028|12225115|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
4970572|NCT02628028|12225116|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
4970573|NCT02628028|12225117|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
4970574|NCT02628028|12225110|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
4970575|NCT02628028|12225111|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
4970576|NCT02628028|12225112|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
4970577|NCT02628028|12225113|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
4970578|NCT02628028|12225114|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
4970579|NCT02628028|12225115|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
4970580|NCT02628028|12225116|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
4970581|NCT02628028|12225117|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
4970582|NCT02628028|12225110|P8|NOT COMPLETED|Dosing Period||15
4970583|NCT02628028|12225111|P7|NOT COMPLETED|Dosing Period||16
4970584|NCT02628028|12225112|P6|NOT COMPLETED|Dosing Period||14
4970585|NCT02628028|12225113|P5|NOT COMPLETED|Dosing Period||16
4970586|NCT02628028|12225114|P4|NOT COMPLETED|Dosing Period||0
4970587|NCT02628028|12225115|P3|NOT COMPLETED|Dosing Period||1
4970588|NCT02628028|12225116|P2|NOT COMPLETED|Dosing Period||0
4970589|NCT02628028|12225117|P1|NOT COMPLETED|Dosing Period||0
4970590|NCT02628028|12225110|P8|COMPLETED|Dosing Period||48
4970591|NCT02628028|12225111|P7|COMPLETED|Dosing Period||46
4970592|NCT02628028|12225112|P6|COMPLETED|Dosing Period||49
4970593|NCT02628028|12225113|P5|COMPLETED|Dosing Period||46
4970594|NCT02628028|12225114|P4|COMPLETED|Dosing Period||8
4970595|NCT02628028|12225115|P3|COMPLETED|Dosing Period||9
4970596|NCT02628028|12225116|P2|COMPLETED|Dosing Period||9
4970597|NCT02628028|12225117|P1|COMPLETED|Dosing Period||9
4970598|NCT02628028|12225110|P8|Received at Least 1dose of Study Drug|Dosing Period||63
4970599|NCT02628028|12225111|P7|Received at Least 1dose of Study Drug|Dosing Period||62
4970600|NCT02628028|12225112|P6|Received at Least 1dose of Study Drug|Dosing Period||63
4970601|NCT02628028|12225113|P5|Received at Least 1dose of Study Drug|Dosing Period||62
4970602|NCT02628028|12225114|P4|Received at Least 1dose of Study Drug|Dosing Period||8
4970603|NCT02628028|12225115|P3|Received at Least 1dose of Study Drug|Dosing Period||10
4970604|NCT02628028|12225116|P2|Received at Least 1dose of Study Drug|Dosing Period||9
4970605|NCT02628028|12225117|P1|Received at Least 1dose of Study Drug|Dosing Period||9
4970606|NCT02628028|12225110|P8|STARTED|Dosing Period||63
4970607|NCT02628028|12225111|P7|STARTED|Dosing Period||62
4970608|NCT02628028|12225112|P6|STARTED|Dosing Period||63
4970609|NCT02628028|12225113|P5|STARTED|Dosing Period||62
4970610|NCT02628028|12225114|P4|STARTED|Dosing Period||8
4970611|NCT02628028|12225115|P3|STARTED|Dosing Period||10
4970612|NCT02628028|12225116|P2|STARTED|Dosing Period||9
4970613|NCT02628028|12225117|P1|STARTED|Dosing Period||9
4970614|NCT02627963|12225161|P2|NOT COMPLETED|Overall Study||14
4970615|NCT02627963|12225162|P1|NOT COMPLETED|Overall Study||36
4970616|NCT02627963|12225161|P2|COMPLETED|Overall Study||161
4970617|NCT02627963|12225162|P1|COMPLETED|Overall Study||139
4970618|NCT02627963|12225161|P2|STARTED|Overall Study||175
4970619|NCT02627963|12225162|P1|STARTED|Overall Study||175
4970620|NCT02627924|12225172|P1|NOT COMPLETED|Overall Study||12
4970621|NCT02627924|12225172|P1|COMPLETED|Overall Study||79
4970622|NCT02627924|12225172|P1|STARTED|Overall Study||91
4970623|NCT02627794|12225189|P1|NOT COMPLETED|Overall Study||0
4970624|NCT02627794|12225189|P1|COMPLETED|Overall Study||3
4970625|NCT02627794|12225189|P1|STARTED|Overall Study||3
4970626|NCT02627144|12225202|P1|NOT COMPLETED|Overall Study||365
4970627|NCT02627144|12225202|P1|COMPLETED|Overall Study||0
4970628|NCT02627144|12225202|P1|Treated|Overall Study||359
4970629|NCT02627144|12225202|P1|STARTED|Overall Study||365
4970630|NCT02627118|12225210|P1|NOT COMPLETED|Overall Study||0
4970631|NCT02627118|12225210|P1|COMPLETED|Overall Study||10
4970632|NCT02627118|12225210|P1|STARTED|Overall Study||10
4970633|NCT02627001|12225217|P2|NOT COMPLETED|Overall Study||0
4970634|NCT02627001|12225218|P1|NOT COMPLETED|Overall Study||0
4970635|NCT02627001|12225217|P2|COMPLETED|Overall Study||14
4970636|NCT02627001|12225218|P1|COMPLETED|Overall Study||13
4970637|NCT02627001|12225217|P2|STARTED|Overall Study||14
4970638|NCT02627001|12225218|P1|STARTED|Overall Study||13
4970639|NCT02626910|12225228|P4|NOT COMPLETED|Overall Study||0
4970640|NCT02626910|12225229|P3|NOT COMPLETED|Overall Study||0
4970641|NCT02626910|12225230|P2|NOT COMPLETED|Overall Study||0
4970642|NCT02626910|12225231|P1|NOT COMPLETED|Overall Study||0
4970643|NCT02626910|12225228|P4|COMPLETED|Overall Study||10
4970644|NCT02626910|12225229|P3|COMPLETED|Overall Study||6
4970645|NCT02626910|12225230|P2|COMPLETED|Overall Study||10
4970646|NCT02626910|12225231|P1|COMPLETED|Overall Study||23
4970647|NCT02626910|12225228|P4|STARTED|Overall Study||10
4970648|NCT02626910|12225229|P3|STARTED|Overall Study||6
4970649|NCT02626910|12225230|P2|STARTED|Overall Study||10
4970650|NCT02626910|12225231|P1|STARTED|Overall Study||23
4970651|NCT02626819|12225243|P2|NOT COMPLETED|Overall Study||3
4970652|NCT02626819|12225244|P1|NOT COMPLETED|Overall Study||4
4970653|NCT02626819|12225243|P2|COMPLETED|Overall Study||20
4970654|NCT02626819|12225244|P1|COMPLETED|Overall Study||18
4970655|NCT02626819|12225243|P2|STARTED|Overall Study||23
4970656|NCT02626819|12225244|P1|STARTED|Overall Study||22
4970657|NCT02626780|12225264|P1|NOT COMPLETED|Overall Study||3
4970658|NCT02626780|12225264|P1|COMPLETED|Overall Study||4
4970659|NCT02626780|12225264|P1|Withdrew From Study|Overall Study||3
4970660|NCT02626780|12225264|P1|STARTED|Overall Study||7
4970661|NCT02626611|12225272|P3|NOT COMPLETED|Overall Study||3
4970662|NCT02626611|12225273|P2|NOT COMPLETED|Overall Study||1
4970663|NCT02626611|12225274|P1|NOT COMPLETED|Overall Study||4
4970664|NCT02626611|12225272|P3|COMPLETED|Overall Study||16
4970665|NCT02626611|12225273|P2|COMPLETED|Overall Study||20
4970666|NCT02626611|12225274|P1|COMPLETED|Overall Study||16
4970667|NCT02626611|12225272|P3|STARTED|Overall Study||19
4970668|NCT02626611|12225273|P2|STARTED|Overall Study||21
4970669|NCT02626611|12225274|P1|STARTED|Overall Study||20
4970670|NCT02626520|12225297|P2|NOT COMPLETED|Overall Study||10
4970671|NCT02626520|12225298|P1|NOT COMPLETED|Overall Study||1
4970672|NCT02626520|12225297|P2|COMPLETED|Overall Study||0
4970673|NCT02626520|12225298|P1|COMPLETED|Overall Study||0
4970674|NCT02626520|12225297|P2|STARTED|Overall Study||10
4970675|NCT02626520|12225298|P1|STARTED|Overall Study||1
4970676|NCT02626182|12225310|P2|NOT COMPLETED|Overall Study||0
4970677|NCT02626182|12225311|P1|NOT COMPLETED|Overall Study||2
4970678|NCT02626182|12225310|P2|COMPLETED|Overall Study||3
4970679|NCT02626182|12225311|P1|COMPLETED|Overall Study||9
4970680|NCT02626182|12225310|P2|STARTED|Overall Study||3
4970681|NCT02626182|12225311|P1|STARTED|Overall Study||11
4970682|NCT02626000|12225321|P1|NOT COMPLETED|Overall Study||36
4970683|NCT02626000|12225321|P1|COMPLETED|Overall Study||0
4970684|NCT02626000|12225321|P1|STARTED|Overall Study||36
4970685|NCT02625974|12225335|P2|NOT COMPLETED|Overall Study||6
4970686|NCT02625974|12225336|P1|NOT COMPLETED|Overall Study||16
4970687|NCT02625974|12225335|P2|COMPLETED|Overall Study||105
4970688|NCT02625974|12225336|P1|COMPLETED|Overall Study||203
4970689|NCT02625974|12225335|P2|Received Treatment|Overall Study||111
4970690|NCT02625974|12225336|P1|Received Treatment|Overall Study||219
4970691|NCT02625974|12225335|P2|STARTED|Overall Study||111
4970692|NCT02625974|12225336|P1|STARTED|Overall Study||219
4970693|NCT02625922|12225444|P2|NOT COMPLETED|Overall Study||2
4970694|NCT02625922|12225445|P1|NOT COMPLETED|Overall Study||2
4970695|NCT02625922|12225444|P2|COMPLETED|Overall Study||10
4970696|NCT02625922|12225445|P1|COMPLETED|Overall Study||12
4970697|NCT02625922|12225444|P2|Completed Treatment Period 2|Overall Study||8
4970698|NCT02625922|12225445|P1|Completed Treatment Period 2|Overall Study||11
4970699|NCT02625922|12225444|P2|Completed Treatment Period 1|Overall Study||10
4970700|NCT02625922|12225445|P1|Completed Treatment Period 1|Overall Study||12
4970701|NCT02625922|12225444|P2|STARTED|Overall Study||12
4970702|NCT02625922|12225445|P1|STARTED|Overall Study||14
4970703|NCT02625844|12225458|P1|NOT COMPLETED|Overall Study||0
4970704|NCT02625844|12225458|P1|COMPLETED|Overall Study||110
4970705|NCT02625844|12225458|P1|STARTED|Overall Study||110
4970706|NCT02625623|12225464|P2|NOT COMPLETED|Overall Study||35
4970707|NCT02625623|12225465|P1|NOT COMPLETED|Overall Study||49
4970708|NCT02625623|12225464|P2|COMPLETED|Overall Study||150
4970709|NCT02625623|12225465|P1|COMPLETED|Overall Study||137
4970710|NCT02625623|12225464|P2|Treated|Overall Study||184
4970711|NCT02625623|12225465|P1|Treated|Overall Study||177
4970712|NCT02625623|12225464|P2|STARTED|Overall Study||185
4970713|NCT02625623|12225465|P1|STARTED|Overall Study||186
4970714|NCT02625571|12225485|P1|NOT COMPLETED|Overall Study||3
4970715|NCT02625571|12225485|P1|COMPLETED|Overall Study||10
4970716|NCT02625571|12225485|P1|STARTED|Overall Study||13
4970717|NCT02625545|12225490|P1|NOT COMPLETED|Overall Study||0
4970718|NCT02625545|12225490|P1|COMPLETED|Overall Study||45
4970719|NCT02625545|12225490|P1|12 Month|Overall Study||45
4970720|NCT02625545|12225490|P1|6 Month|Overall Study||45
4970721|NCT02625545|12225490|P1|3 Month|Overall Study||45
4970722|NCT02625545|12225490|P1|STARTED|Overall Study||45
4970723|NCT02625428|12225506|P2|NOT COMPLETED|Overall Study||0
4970724|NCT02625428|12225507|P1|NOT COMPLETED|Overall Study||0
4970725|NCT02625428|12225506|P2|COMPLETED|Overall Study||20
4970726|NCT02625428|12225507|P1|COMPLETED|Overall Study||20
4970727|NCT02625428|12225506|P2|STARTED|Overall Study||20
4970728|NCT02625428|12225507|P1|STARTED|Overall Study||20
4970729|NCT02625402|12225517|P2|NOT COMPLETED|Overall Study||12
4970730|NCT02625402|12225518|P1|NOT COMPLETED|Overall Study||9
4970731|NCT02625402|12225517|P2|COMPLETED|Overall Study||25
4970732|NCT02625402|12225518|P1|COMPLETED|Overall Study||33
4970733|NCT02625402|12225517|P2|STARTED|Overall Study||37
4970734|NCT02625402|12225518|P1|STARTED|Overall Study||42
4970735|NCT02625324|12225528|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
4970736|NCT02625324|12225528|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
4970737|NCT02625324|12225528|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
4970738|NCT02625324|12225528|P1|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
4970739|NCT02625324|12225528|P1|COMPLETED|6-Month Follow-up Subject Accountability||91
4970740|NCT02625324|12225528|P1|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
4970741|NCT02625324|12225528|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
4970742|NCT02625324|12225528|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
4970743|NCT02625324|12225528|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
4970744|NCT02625324|12225528|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
4970745|NCT02625324|12225528|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
4970746|NCT02625324|12225528|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
4970747|NCT02625298|12225539|P2|NOT COMPLETED|Overall Study||0
4970748|NCT02625298|12225540|P1|NOT COMPLETED|Overall Study||1
4970749|NCT02625298|12225539|P2|COMPLETED|Overall Study||13
4970750|NCT02625298|12225540|P1|COMPLETED|Overall Study||10
4970751|NCT02625298|12225539|P2|STARTED|Overall Study||13
4970752|NCT02625298|12225540|P1|STARTED|Overall Study||11
4970753|NCT02625259|12225553|P5|NOT COMPLETED|Second Intervention (Day 15)||0
4970754|NCT02625259|12225554|P4|NOT COMPLETED|Second Intervention (Day 15)||0
4970755|NCT02625259|12225555|P3|NOT COMPLETED|Second Intervention (Day 15)||0
4970756|NCT02625259|12225556|P2|NOT COMPLETED|Second Intervention (Day 15)||0
4970757|NCT02625259|12225557|P1|NOT COMPLETED|Second Intervention (Day 15)||0
4970758|NCT02625259|12225553|P5|COMPLETED|Second Intervention (Day 15)||0
4970759|NCT02625259|12225554|P4|COMPLETED|Second Intervention (Day 15)||9
4970760|NCT02625259|12225555|P3|COMPLETED|Second Intervention (Day 15)||7
4970761|NCT02625259|12225556|P2|COMPLETED|Second Intervention (Day 15)||8
4970762|NCT02625259|12225557|P1|COMPLETED|Second Intervention (Day 15)||9
4970763|NCT02625259|12225553|P5|STARTED|Second Intervention (Day 15)||0
4970764|NCT02625259|12225554|P4|STARTED|Second Intervention (Day 15)||9
4970765|NCT02625259|12225555|P3|STARTED|Second Intervention (Day 15)||7
4970766|NCT02625259|12225556|P2|STARTED|Second Intervention (Day 15)||8
4970767|NCT02625259|12225557|P1|STARTED|Second Intervention (Day 15)||9
4970768|NCT02625259|12225553|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
4970769|NCT02625259|12225554|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
4970770|NCT02625259|12225555|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
4970771|NCT02625259|12225556|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
4970772|NCT02625259|12225557|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
4970773|NCT02625259|12225553|P5|COMPLETED|Washout (Day 2 to Day 14)||0
4970774|NCT02625259|12225554|P4|COMPLETED|Washout (Day 2 to Day 14)||9
4970775|NCT02625259|12225555|P3|COMPLETED|Washout (Day 2 to Day 14)||7
4970776|NCT02625259|12225556|P2|COMPLETED|Washout (Day 2 to Day 14)||8
4970777|NCT02625259|12225557|P1|COMPLETED|Washout (Day 2 to Day 14)||9
4970778|NCT02625259|12225553|P5|STARTED|Washout (Day 2 to Day 14)||0
4970779|NCT02625259|12225554|P4|STARTED|Washout (Day 2 to Day 14)||9
4970780|NCT02625259|12225555|P3|STARTED|Washout (Day 2 to Day 14)||7
4970781|NCT02625259|12225556|P2|STARTED|Washout (Day 2 to Day 14)||8
4970782|NCT02625259|12225557|P1|STARTED|Washout (Day 2 to Day 14)||9
4970783|NCT02625259|12225553|P5|NOT COMPLETED|First Intervention (Day 1)||0
4970784|NCT02625259|12225554|P4|NOT COMPLETED|First Intervention (Day 1)||1
4970785|NCT02625259|12225555|P3|NOT COMPLETED|First Intervention (Day 1)||1
4970786|NCT02625259|12225556|P2|NOT COMPLETED|First Intervention (Day 1)||1
4970787|NCT02625259|12225557|P1|NOT COMPLETED|First Intervention (Day 1)||2
4970788|NCT02625259|12225553|P5|COMPLETED|First Intervention (Day 1)||16
4970789|NCT02625259|12225554|P4|COMPLETED|First Intervention (Day 1)||9
4970790|NCT02625259|12225555|P3|COMPLETED|First Intervention (Day 1)||7
4970791|NCT02625259|12225556|P2|COMPLETED|First Intervention (Day 1)||8
4970792|NCT02625259|12225557|P1|COMPLETED|First Intervention (Day 1)||9
4970793|NCT02625259|12225553|P5|STARTED|First Intervention (Day 1)||16
4970794|NCT02625259|12225554|P4|STARTED|First Intervention (Day 1)||10
4970795|NCT02625259|12225555|P3|STARTED|First Intervention (Day 1)||8
4970796|NCT02625259|12225556|P2|STARTED|First Intervention (Day 1)||9
4970797|NCT02625259|12225557|P1|STARTED|First Intervention (Day 1)||11
4970798|NCT02625233|12225594|P2|NOT COMPLETED|Overall Study||0
4970799|NCT02625233|12225595|P1|NOT COMPLETED|Overall Study||2
4970800|NCT02625233|12225594|P2|COMPLETED|Overall Study||56
4970801|NCT02625233|12225595|P1|COMPLETED|Overall Study||47
4970802|NCT02625233|12225594|P2|STARTED|Overall Study||56
4970803|NCT02625233|12225595|P1|STARTED|Overall Study||49
4970804|NCT02625220|12225603|P1|NOT COMPLETED|Overall Study||7
4970805|NCT02625220|12225603|P1|COMPLETED|Overall Study||163
4970806|NCT02625220|12225603|P1|STARTED|Overall Study||170
4970807|NCT02625207|12225614|P4|NOT COMPLETED|Part 2 (11 Days)||0
4970808|NCT02625207|12225615|P3|NOT COMPLETED|Part 2 (11 Days)||0
4970809|NCT02625207|12225616|P2|NOT COMPLETED|Part 2 (11 Days)||0
4970810|NCT02625207|12225617|P1|NOT COMPLETED|Part 2 (11 Days)||0
4970811|NCT02625207|12225614|P4|COMPLETED|Part 2 (11 Days)||0
4970812|NCT02625207|12225615|P3|COMPLETED|Part 2 (11 Days)||12
4970813|NCT02625207|12225616|P2|COMPLETED|Part 2 (11 Days)||0
4970814|NCT02625207|12225617|P1|COMPLETED|Part 2 (11 Days)||11
4970815|NCT02625207|12225614|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
4970816|NCT02625207|12225615|P3|STARTED|Part 2 (11 Days)||12
4970817|NCT02625207|12225616|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
4970818|NCT02625207|12225617|P1|STARTED|Part 2 (11 Days)||11
4970819|NCT02625207|12225614|P4|NOT COMPLETED|Part 1 (6 Days)||0
4970820|NCT02625207|12225615|P3|NOT COMPLETED|Part 1 (6 Days)||0
4970821|NCT02625207|12225616|P2|NOT COMPLETED|Part 1 (6 Days)||0
4970822|NCT02625207|12225617|P1|NOT COMPLETED|Part 1 (6 Days)||0
4970823|NCT02625207|12225614|P4|COMPLETED|Part 1 (6 Days)||12
4970824|NCT02625207|12225615|P3|COMPLETED|Part 1 (6 Days)||12
4970825|NCT02625207|12225616|P2|COMPLETED|Part 1 (6 Days)||12
4970826|NCT02625207|12225617|P1|COMPLETED|Part 1 (6 Days)||11
4970827|NCT02625207|12225614|P4|STARTED|Part 1 (6 Days)||12
4970828|NCT02625207|12225615|P3|STARTED|Part 1 (6 Days)||12
4970829|NCT02625207|12225616|P2|STARTED|Part 1 (6 Days)||12
4970830|NCT02625207|12225617|P1|STARTED|Part 1 (6 Days)||11
4970831|NCT02625181|12225706|P3|NOT COMPLETED|Overall Study||0
4970832|NCT02625181|12225707|P2|NOT COMPLETED|Overall Study||0
4970833|NCT02625181|12225708|P1|NOT COMPLETED|Overall Study||0
4970834|NCT02625181|12225706|P3|COMPLETED|Overall Study||12707
4970835|NCT02625181|12225707|P2|COMPLETED|Overall Study||12809
4970836|NCT02625181|12225708|P1|COMPLETED|Overall Study||1518
4970837|NCT02625181|12225706|P3|STARTED|Overall Study||12707
4970838|NCT02625181|12225707|P2|STARTED|Overall Study||12809
4970839|NCT02625181|12225708|P1|STARTED|Overall Study||1518
4970840|NCT02624986|12225731|P8|NOT COMPLETED|Overall Study||5
4970841|NCT02624986|12225732|P7|NOT COMPLETED|Overall Study||4
4970842|NCT02624986|12225733|P6|NOT COMPLETED|Overall Study||2
4970843|NCT02624986|12225734|P5|NOT COMPLETED|Overall Study||4
4970844|NCT02624986|12225735|P4|NOT COMPLETED|Overall Study||3
4970845|NCT02624986|12225736|P3|NOT COMPLETED|Overall Study||2
4970846|NCT02624986|12225737|P2|NOT COMPLETED|Overall Study||3
4970847|NCT02624986|12225738|P1|NOT COMPLETED|Overall Study||2
4970848|NCT02624986|12225731|P8|COMPLETED|Overall Study||0
4970849|NCT02624986|12225732|P7|COMPLETED|Overall Study||0
4970850|NCT02624986|12225733|P6|COMPLETED|Overall Study||0
4970851|NCT02624986|12225734|P5|COMPLETED|Overall Study||0
4970852|NCT02624986|12225735|P4|COMPLETED|Overall Study||0
4970853|NCT02624986|12225736|P3|COMPLETED|Overall Study||0
4970854|NCT02624986|12225737|P2|COMPLETED|Overall Study||0
4970855|NCT02624986|12225738|P1|COMPLETED|Overall Study||0
4970856|NCT02624986|12225731|P8|Received Any Study Treatment|Overall Study||5
4970857|NCT02624986|12225732|P7|Received Any Study Treatment|Overall Study||4
4970858|NCT02624986|12225733|P6|Received Any Study Treatment|Overall Study||2
4970859|NCT02624986|12225734|P5|Received Any Study Treatment|Overall Study||4
4970860|NCT02624986|12225735|P4|Received Any Study Treatment|Overall Study||3
4970861|NCT02624986|12225736|P3|Received Any Study Treatment|Overall Study||2
4970862|NCT02624986|12225737|P2|Received Any Study Treatment|Overall Study||3
4970863|NCT02624986|12225738|P1|Received Any Study Treatment|Overall Study||1
4970864|NCT02624986|12225731|P8|STARTED|Overall Study||5
4970865|NCT02624986|12225732|P7|STARTED|Overall Study||4
4970866|NCT02624986|12225733|P6|STARTED|Overall Study||2
4970867|NCT02624986|12225734|P5|STARTED|Overall Study||4
4970868|NCT02624986|12225735|P4|STARTED|Overall Study||3
4970869|NCT02624986|12225736|P3|STARTED|Overall Study||2
4970870|NCT02624986|12225737|P2|STARTED|Overall Study||3
4970871|NCT02624986|12225738|P1|STARTED|Overall Study||2
4970872|NCT02624791|12225915|P6|NOT COMPLETED|Overall Study||0
4970873|NCT02624791|12225916|P5|NOT COMPLETED|Overall Study||0
4970874|NCT02624791|12225917|P4|NOT COMPLETED|Overall Study||0
4970875|NCT02624791|12225918|P3|NOT COMPLETED|Overall Study||0
4970876|NCT02624791|12225919|P2|NOT COMPLETED|Overall Study||0
4970877|NCT02624791|12225920|P1|NOT COMPLETED|Overall Study||2
4970878|NCT02624791|12225915|P6|COMPLETED|Overall Study||2
4970879|NCT02624791|12225916|P5|COMPLETED|Overall Study||2
4970880|NCT02624791|12225917|P4|COMPLETED|Overall Study||2
4970881|NCT02624791|12225918|P3|COMPLETED|Overall Study||2
4970882|NCT02624791|12225919|P2|COMPLETED|Overall Study||1
4970883|NCT02624791|12225920|P1|COMPLETED|Overall Study||0
4970884|NCT02624791|12225915|P6|STARTED|Overall Study||2
4970885|NCT02624791|12225916|P5|STARTED|Overall Study||2
4970886|NCT02624791|12225917|P4|STARTED|Overall Study||2
4970887|NCT02624791|12225918|P3|STARTED|Overall Study||2
4970888|NCT02624791|12225919|P2|STARTED|Overall Study||1
4970889|NCT02624791|12225920|P1|STARTED|Overall Study||2
4970890|NCT02624713|12225927|P2|NOT COMPLETED|Overall Study||0
4970891|NCT02624713|12225928|P1|NOT COMPLETED|Overall Study||14
4970892|NCT02624713|12225927|P2|COMPLETED|Overall Study||81
4970893|NCT02624713|12225928|P1|COMPLETED|Overall Study||64
4970894|NCT02624713|12225927|P2|STARTED|Overall Study||81
4970895|NCT02624713|12225928|P1|STARTED|Overall Study||78
4970896|NCT02624700|12225937|P2|NOT COMPLETED|Overall Study||0
4970897|NCT02624700|12225938|P1|NOT COMPLETED|Overall Study||0
4970898|NCT02624700|12225937|P2|COMPLETED|Overall Study||4
4970899|NCT02624700|12225938|P1|COMPLETED|Overall Study||9
4970900|NCT02624700|12225937|P2|STARTED|Overall Study||4
4970901|NCT02624700|12225938|P1|STARTED|Overall Study||9
4970902|NCT02624687|12225952|P2|NOT COMPLETED|Overall Study||2
4970903|NCT02624687|12225953|P1|NOT COMPLETED|Overall Study||1
4970904|NCT02624687|12225952|P2|COMPLETED|Overall Study||12
4970905|NCT02624687|12225953|P1|COMPLETED|Overall Study||12
4970906|NCT02624687|12225952|P2|STARTED|Overall Study||14
4970907|NCT02624687|12225953|P1|STARTED|Overall Study||13
4970908|NCT02624492|12225984|P3|NOT COMPLETED|Overall Study||5
4970909|NCT02624492|12225985|P2|NOT COMPLETED|Overall Study||4
4970910|NCT02624492|12225986|P1|NOT COMPLETED|Overall Study||2
4970911|NCT02624492|12225984|P3|COMPLETED|Overall Study||3
4970912|NCT02624492|12225985|P2|COMPLETED|Overall Study||4
4970913|NCT02624492|12225986|P1|COMPLETED|Overall Study||3
4970914|NCT02624492|12225984|P3|STARTED|Overall Study||8
4970915|NCT02624492|12225985|P2|STARTED|Overall Study||8
4970916|NCT02624492|12225986|P1|STARTED|Overall Study||5
4970917|NCT02624375|12226012|P1|NOT COMPLETED|Overall Study||0
4970918|NCT02624375|12226012|P1|COMPLETED|Overall Study||10
4970919|NCT02624375|12226012|P1|STARTED|Overall Study||10
4970920|NCT02624284|12226021|P3|NOT COMPLETED|Overall Study||11
4970921|NCT02624284|12226022|P2|NOT COMPLETED|Overall Study||18
4970922|NCT02624284|12226023|P1|NOT COMPLETED|Overall Study||14
4970923|NCT02624284|12226021|P3|COMPLETED|Overall Study||36
4970924|NCT02624284|12226022|P2|COMPLETED|Overall Study||35
4970925|NCT02624284|12226023|P1|COMPLETED|Overall Study||35
4970926|NCT02624284|12226021|P3|STARTED|Overall Study||47
4970927|NCT02624284|12226022|P2|STARTED|Overall Study||53
4970928|NCT02624284|12226023|P1|STARTED|Overall Study||49
4970929|NCT02624050|12226042|P2|NOT COMPLETED|Overall Study||0
4970930|NCT02624050|12226043|P1|NOT COMPLETED|Overall Study||6
4970931|NCT02624050|12226042|P2|COMPLETED|Overall Study||25
4970932|NCT02624050|12226043|P1|COMPLETED|Overall Study||20
4970933|NCT02624050|12226042|P2|STARTED|Overall Study||25
4970934|NCT02624050|12226043|P1|STARTED|Overall Study||26
4970935|NCT02623959|12226071|P2|NOT COMPLETED|Overall Study||1
4970936|NCT02623959|12226072|P1|NOT COMPLETED|Overall Study||0
4970937|NCT02623959|12226071|P2|COMPLETED|Overall Study|due to progression|0
4970938|NCT02623959|12226072|P1|COMPLETED|Overall Study||0
4970939|NCT02623959|12226071|P2|STARTED|Overall Study||1
4970940|NCT02623959|12226072|P1|STARTED|Overall Study||0
4970941|NCT02623855|12226082|P2|NOT COMPLETED|Overall Study||16
4970942|NCT02623855|12226083|P1|NOT COMPLETED|Overall Study||10
4970943|NCT02623855|12226082|P2|COMPLETED|Overall Study||84
4970944|NCT02623855|12226083|P1|COMPLETED|Overall Study||46
4970945|NCT02623855|12226082|P2|STARTED|Overall Study||100
4970946|NCT02623855|12226083|P1|STARTED|Overall Study||56
4970947|NCT02623803|12226105|P2|NOT COMPLETED|Overall Study||0
4970948|NCT02623803|12226106|P1|NOT COMPLETED|Overall Study||0
4970949|NCT02623803|12226105|P2|COMPLETED|Overall Study||23
4970950|NCT02623803|12226106|P1|COMPLETED|Overall Study||25
4970951|NCT02623803|12226105|P2|STARTED|Overall Study||23
4970952|NCT02623803|12226106|P1|STARTED|Overall Study||25
4970953|NCT02623725|12226152|P2|NOT COMPLETED|Overall Study||6
4970954|NCT02623725|12226153|P1|NOT COMPLETED|Overall Study||16
4970955|NCT02623725|12226152|P2|COMPLETED|Overall Study||58
4970956|NCT02623725|12226153|P1|COMPLETED|Overall Study||171
4970957|NCT02623725|12226152|P2|STARTED|Overall Study||64
4970958|NCT02623725|12226153|P1|STARTED|Overall Study||187
4970959|NCT02623361|12226187|P2|NOT COMPLETED|Overall Study||2
4970960|NCT02623361|12226188|P1|NOT COMPLETED|Overall Study||0
4970961|NCT02623361|12226187|P2|COMPLETED|Overall Study||38
4970962|NCT02623361|12226188|P1|COMPLETED|Overall Study||40
4970963|NCT02623361|12226187|P2|STARTED|Overall Study||40
4970964|NCT02623361|12226188|P1|STARTED|Overall Study||40
4970965|NCT02623348|12226200|P2|NOT COMPLETED|Overall Study||2
4970966|NCT02623348|12226201|P1|NOT COMPLETED|Overall Study||3
4970967|NCT02623348|12226200|P2|COMPLETED|Overall Study||28
4970968|NCT02623348|12226201|P1|COMPLETED|Overall Study||27
4970969|NCT02623348|12226200|P2|3-month Assessment|Overall Study||26
4970970|NCT02623348|12226201|P1|3-month Assessment|Overall Study||27
4970971|NCT02623348|12226200|P2|STARTED|Overall Study||30
4970972|NCT02623348|12226201|P1|STARTED|Overall Study||30
4970973|NCT02623335|12226227|P2|NOT COMPLETED|Overall Study||36
4970974|NCT02623335|12226228|P1|NOT COMPLETED|Overall Study||27
4970975|NCT02623335|12226227|P2|COMPLETED|Overall Study||187
4970976|NCT02623335|12226228|P1|COMPLETED|Overall Study||196
4970977|NCT02623335|12226227|P2|T3 Survey (12-14 Weeks)|Overall Study||187
4970978|NCT02623335|12226228|P1|T3 Survey (12-14 Weeks)|Overall Study||196
4970979|NCT02623335|12226227|P2|T2 Survey (6-8 Weeks)|Overall Study||192
4970980|NCT02623335|12226228|P1|T2 Survey (6-8 Weeks)|Overall Study||199
4970981|NCT02623335|12226227|P2|T1 Survey (24-48 Hours)|Overall Study||214
4970982|NCT02623335|12226228|P1|T1 Survey (24-48 Hours)|Overall Study||216
4970983|NCT02623335|12226227|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
4970984|NCT02623335|12226228|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
4970985|NCT02623335|12226227|P2|STARTED|Overall Study||223
4970986|NCT02623335|12226228|P1|STARTED|Overall Study||223
4970987|NCT02623322|12226255|P3|NOT COMPLETED|Overall Study||0
4970988|NCT02623322|12226256|P2|NOT COMPLETED|Overall Study||1
4970989|NCT02623322|12226257|P1|NOT COMPLETED|Overall Study||2
4970990|NCT02623322|12226255|P3|COMPLETED|Overall Study||40
4970991|NCT02623322|12226256|P2|COMPLETED|Overall Study||40
4970992|NCT02623322|12226257|P1|COMPLETED|Overall Study||41
4970993|NCT02623322|12226255|P3|STARTED|Overall Study||40
4970994|NCT02623322|12226256|P2|STARTED|Overall Study||41
4970995|NCT02623322|12226257|P1|STARTED|Overall Study||43
4970996|NCT02623218|12226295|P5|NOT COMPLETED|Overall Study||0
4970997|NCT02623218|12226296|P4|NOT COMPLETED|Overall Study||0
4970998|NCT02623218|12226297|P3|NOT COMPLETED|Overall Study||0
4970999|NCT02623218|12226298|P2|NOT COMPLETED|Overall Study||1
4971000|NCT02623218|12226299|P1|NOT COMPLETED|Overall Study||0
4971001|NCT02623218|12226295|P5|COMPLETED|Overall Study||4
4971002|NCT02623218|12226296|P4|COMPLETED|Overall Study||4
4971003|NCT02623218|12226297|P3|COMPLETED|Overall Study||4
4971004|NCT02623218|12226298|P2|COMPLETED|Overall Study||3
4971005|NCT02623218|12226299|P1|COMPLETED|Overall Study||5
4971006|NCT02623218|12226295|P5|STARTED|Overall Study||4
4971007|NCT02623218|12226296|P4|STARTED|Overall Study||4
4971008|NCT02623218|12226297|P3|STARTED|Overall Study||4
4971009|NCT02623218|12226298|P2|STARTED|Overall Study||4
4971010|NCT02623218|12226299|P1|STARTED|Overall Study||5
4971011|NCT02622828|12226321|P1|NOT COMPLETED|Overall Study||3
4971012|NCT02622828|12226321|P1|COMPLETED|Overall Study||1
4971013|NCT02622828|12226321|P1|STARTED|Overall Study||4
4971014|NCT02622724|12226328|P2|NOT COMPLETED|Overall Study||103
4971015|NCT02622724|12226329|P1|NOT COMPLETED|Overall Study||93
4971016|NCT02622724|12226328|P2|COMPLETED|Overall Study||49
4971017|NCT02622724|12226329|P1|COMPLETED|Overall Study||51
4971018|NCT02622724|12226328|P2|Long-Term Follow-Up (Day 180)|Overall Study||74
4971019|NCT02622724|12226329|P1|Long-Term Follow-Up (Day 180)|Overall Study||73
4971020|NCT02622724|12226328|P2|Long-Term Follow-Up (Day 90)|Overall Study||101
4971021|NCT02622724|12226329|P1|Long-Term Follow-Up (Day 90)|Overall Study||96
4971022|NCT02622724|12226328|P2|Short-Term Follow-Up (Day 28)|Overall Study||115
4971023|NCT02622724|12226329|P1|Short-Term Follow-Up (Day 28)|Overall Study||105
4971024|NCT02622724|12226328|P2|Subjects Randomised|Overall Study||155
4971025|NCT02622724|12226329|P1|Subjects Randomised|Overall Study||146
4971026|NCT02622724|12226328|P2|STARTED|Overall Study||152
4971027|NCT02622724|12226329|P1|STARTED|Overall Study||144
4971028|NCT02622568|12226407|P2|NOT COMPLETED|Overall Study||5
4971029|NCT02622568|12226408|P1|NOT COMPLETED|Overall Study||5
4971030|NCT02622568|12226407|P2|COMPLETED|Overall Study||9
4971031|NCT02622568|12226408|P1|COMPLETED|Overall Study||9
4971032|NCT02622568|12226407|P2|STARTED|Overall Study||14
4971033|NCT02622568|12226408|P1|STARTED|Overall Study||14
4971034|NCT02622321|12226418|P4|NOT COMPLETED|Overall Study||7
4971035|NCT02622321|12226419|P3|NOT COMPLETED|Overall Study||49
4971036|NCT02622321|12226420|P2|NOT COMPLETED|Overall Study||18
4971037|NCT02622321|12226421|P1|NOT COMPLETED|Overall Study||35
4971038|NCT02622321|12226418|P4|COMPLETED|Overall Study||0
4971039|NCT02622321|12226419|P3|COMPLETED|Overall Study||0
4971040|NCT02622321|12226420|P2|COMPLETED|Overall Study||0
4971041|NCT02622321|12226421|P1|COMPLETED|Overall Study||0
4971042|NCT02622321|12226418|P4|Treated|Overall Study||7
4971043|NCT02622321|12226419|P3|Treated|Overall Study||49
4971044|NCT02622321|12226420|P2|Treated|Overall Study||18
4971045|NCT02622321|12226421|P1|Treated|Overall Study||34
4971046|NCT02622321|12226418|P4|STARTED|Overall Study||7
4971047|NCT02622321|12226419|P3|STARTED|Overall Study||49
4971048|NCT02622321|12226420|P2|STARTED|Overall Study||18
4971049|NCT02622321|12226421|P1|STARTED|Overall Study||35
4971050|NCT02622191|12226466|P2|NOT COMPLETED|Overall Study||0
4971051|NCT02622191|12226467|P1|NOT COMPLETED|Overall Study||0
4971052|NCT02622191|12226466|P2|COMPLETED|Overall Study||14
4971053|NCT02622191|12226467|P1|COMPLETED|Overall Study||19
4971054|NCT02622191|12226466|P2|STARTED|Overall Study||14
4971055|NCT02622191|12226467|P1|STARTED|Overall Study||19
4971056|NCT02622178|12226477|P3|NOT COMPLETED|Overall Study||0
4971057|NCT02622178|12226478|P2|NOT COMPLETED|Overall Study||0
4971058|NCT02622178|12226479|P1|NOT COMPLETED|Overall Study||0
4971059|NCT02622178|12226477|P3|COMPLETED|Overall Study||49
4971060|NCT02622178|12226478|P2|COMPLETED|Overall Study||45
4971061|NCT02622178|12226479|P1|COMPLETED|Overall Study||42
4971062|NCT02622178|12226477|P3|STARTED|Overall Study||49
4971063|NCT02622178|12226478|P2|STARTED|Overall Study||45
4971064|NCT02622178|12226479|P1|STARTED|Overall Study||42
4971065|NCT02622113|12226492|P2|NOT COMPLETED|Overall Study||10
4971066|NCT02622113|12226493|P1|NOT COMPLETED|Overall Study||5
4971067|NCT02622113|12226492|P2|COMPLETED|Overall Study||66
4971068|NCT02622113|12226493|P1|COMPLETED|Overall Study||62
4971069|NCT02622113|12226492|P2|STARTED|Overall Study||76
4971070|NCT02622113|12226493|P1|STARTED|Overall Study||67
4971071|NCT02622074|12226511|P6|NOT COMPLETED|Overall Study||10
4971072|NCT02622074|12226512|P5|NOT COMPLETED|Overall Study||10
4971073|NCT02622074|12226513|P4|NOT COMPLETED|Overall Study||10
4971074|NCT02622074|12226514|P3|NOT COMPLETED|Overall Study||10
4971075|NCT02622074|12226515|P2|NOT COMPLETED|Overall Study||10
4971076|NCT02622074|12226516|P1|NOT COMPLETED|Overall Study||10
4971077|NCT02622074|12226511|P6|COMPLETED|Overall Study||0
4971078|NCT02622074|12226512|P5|COMPLETED|Overall Study||0
4971079|NCT02622074|12226513|P4|COMPLETED|Overall Study||0
4971080|NCT02622074|12226514|P3|COMPLETED|Overall Study||0
4971081|NCT02622074|12226515|P2|COMPLETED|Overall Study||0
4971082|NCT02622074|12226516|P1|COMPLETED|Overall Study||0
4971083|NCT02622074|12226511|P6|STARTED|Overall Study||10
4971084|NCT02622074|12226512|P5|STARTED|Overall Study||10
4971085|NCT02622074|12226513|P4|STARTED|Overall Study||10
4971086|NCT02622074|12226514|P3|STARTED|Overall Study||10
4971087|NCT02622074|12226515|P2|STARTED|Overall Study||10
4971088|NCT02622074|12226516|P1|STARTED|Overall Study||10
4971089|NCT02621983|12226592|P2|NOT COMPLETED|Overall Study||11
4971090|NCT02621983|12226593|P1|NOT COMPLETED|Overall Study||12
4971091|NCT02621983|12226592|P2|COMPLETED|Overall Study||6
4971092|NCT02621983|12226593|P1|COMPLETED|Overall Study||9
4971093|NCT02621983|12226592|P2|STARTED|Overall Study||17
4971094|NCT02621983|12226593|P1|STARTED|Overall Study||21
4971095|NCT02621931|12226608|P3|NOT COMPLETED|Overall Study||36
4971096|NCT02621931|12226609|P2|NOT COMPLETED|Overall Study||27
4971097|NCT02621931|12226610|P1|NOT COMPLETED|Overall Study||33
4971098|NCT02621931|12226608|P3|COMPLETED|Overall Study||343
4971099|NCT02621931|12226609|P2|COMPLETED|Overall Study||349
4971100|NCT02621931|12226610|P1|COMPLETED|Overall Study||342
4971101|NCT02621931|12226608|P3|Full Analysis Set|Overall Study||375
4971102|NCT02621931|12226609|P2|Full Analysis Set|Overall Study||375
4971103|NCT02621931|12226610|P1|Full Analysis Set|Overall Study||371
4971104|NCT02621931|12226608|P3|Safety and ITT Populations|Overall Study||379
4971105|NCT02621931|12226609|P2|Safety and ITT Populations|Overall Study||376
4971106|NCT02621931|12226610|P1|Safety and ITT Populations|Overall Study||375
4971107|NCT02621931|12226608|P3|STARTED|Overall Study||379
4971108|NCT02621931|12226609|P2|STARTED|Overall Study||376
4971109|NCT02621931|12226610|P1|STARTED|Overall Study||375
4971110|NCT02621892|12226661|P2|NOT COMPLETED|Randomized Withdrawal Period||12
4971111|NCT02621892|12226662|P1|NOT COMPLETED|Randomized Withdrawal Period||11
4971112|NCT02621892|12226661|P2|COMPLETED|Randomized Withdrawal Period||260
4971113|NCT02621892|12226662|P1|COMPLETED|Randomized Withdrawal Period||250
4971114|NCT02621892|12226661|P2|STARTED|Randomized Withdrawal Period||272
4971115|NCT02621892|12226662|P1|STARTED|Randomized Withdrawal Period||261
4971116|NCT02621892|12226661|P2|NOT COMPLETED|Treatment Period||27
4971117|NCT02621892|12226662|P1|NOT COMPLETED|Treatment Period||46
4971118|NCT02621892|12226661|P2|COMPLETED|Treatment Period||272
4971119|NCT02621892|12226662|P1|COMPLETED|Treatment Period||261
4971120|NCT02621892|12226661|P2|STARTED|Treatment Period||299
4971121|NCT02621892|12226662|P1|STARTED|Treatment Period||307
4971122|NCT02621619|12226680|P2|NOT COMPLETED|Overall Study||0
4971123|NCT02621619|12226681|P1|NOT COMPLETED|Overall Study||0
4971124|NCT02621619|12226680|P2|COMPLETED|Overall Study||79
4971125|NCT02621619|12226681|P1|COMPLETED|Overall Study||80
4971126|NCT02621619|12226680|P2|STARTED|Overall Study||79
4971127|NCT02621619|12226681|P1|STARTED|Overall Study||80
4971128|NCT02621606|12226692|P3|NOT COMPLETED|Overall Study||0
4971129|NCT02621606|12226693|P2|NOT COMPLETED|Overall Study||1
4971130|NCT02621606|12226694|P1|NOT COMPLETED|Overall Study||0
4971131|NCT02621606|12226692|P3|COMPLETED|Overall Study||10
4971132|NCT02621606|12226693|P2|COMPLETED|Overall Study||6
4971133|NCT02621606|12226694|P1|COMPLETED|Overall Study||3
4971134|NCT02621606|12226692|P3|Treated|Overall Study||10
4971135|NCT02621606|12226693|P2|Treated|Overall Study||7
4971136|NCT02621606|12226694|P1|Treated|Overall Study||3
4971137|NCT02621606|12226692|P3|STARTED|Overall Study||10
4971138|NCT02621606|12226693|P2|STARTED|Overall Study||7
4971139|NCT02621606|12226694|P1|STARTED|Overall Study||3
4971140|NCT02621424|12226722|P2|NOT COMPLETED|Overall Study||2
4971141|NCT02621424|12226723|P1|NOT COMPLETED|Overall Study||1
4971142|NCT02621424|12226722|P2|COMPLETED|Overall Study||16
4971143|NCT02621424|12226723|P1|COMPLETED|Overall Study||13
4971144|NCT02621424|12226722|P2|STARTED|Overall Study||18
4971145|NCT02621424|12226723|P1|STARTED|Overall Study||14
4971146|NCT02621073|12226731|P2|NOT COMPLETED|Overall Study||3
4971147|NCT02621073|12226732|P1|NOT COMPLETED|Overall Study||3
4971148|NCT02621073|12226731|P2|COMPLETED|Overall Study||0
4971149|NCT02621073|12226732|P1|COMPLETED|Overall Study||1
4971150|NCT02621073|12226731|P2|STARTED|Overall Study||3
4971151|NCT02621073|12226732|P1|STARTED|Overall Study||4
4971152|NCT02621060|12226742|P2|NOT COMPLETED|Overall Study||1
4971153|NCT02621060|12226743|P1|NOT COMPLETED|Overall Study||3
4971154|NCT02621060|12226742|P2|COMPLETED|Overall Study||14
4971155|NCT02621060|12226743|P1|COMPLETED|Overall Study||12
4971156|NCT02621060|12226742|P2|STARTED|Overall Study||15
4971157|NCT02621060|12226743|P1|STARTED|Overall Study||15
4971158|NCT02621047|12226794|P3|NOT COMPLETED|Overall Study||1
4971159|NCT02621047|12226795|P2|NOT COMPLETED|Overall Study||0
4971160|NCT02621047|12226796|P1|NOT COMPLETED|Overall Study||0
4971161|NCT02621047|12226794|P3|COMPLETED|Overall Study||11
4971162|NCT02621047|12226795|P2|COMPLETED|Overall Study||8
4971163|NCT02621047|12226796|P1|COMPLETED|Overall Study||8
4971164|NCT02621047|12226794|P3|STARTED|Overall Study||12
4971165|NCT02621047|12226795|P2|STARTED|Overall Study||8
4971166|NCT02621047|12226796|P1|STARTED|Overall Study||8
4971167|NCT02621034|12226912|P3|NOT COMPLETED|Overall Study||5
4971168|NCT02621034|12226913|P2|NOT COMPLETED|Overall Study||2
4971169|NCT02621034|12226914|P1|NOT COMPLETED|Overall Study||3
4971170|NCT02621034|12226912|P3|COMPLETED|Overall Study||50
4971171|NCT02621034|12226913|P2|COMPLETED|Overall Study||50
4971172|NCT02621034|12226914|P1|COMPLETED|Overall Study||50
4971173|NCT02621034|12226912|P3|STARTED|Overall Study||55
4971174|NCT02621034|12226913|P2|STARTED|Overall Study||52
4971175|NCT02621034|12226914|P1|STARTED|Overall Study||53
4971176|NCT02620917|12226927|P1|NOT COMPLETED|Overall Study||0
4971177|NCT02620917|12226927|P1|COMPLETED|Overall Study||6623
4971178|NCT02620917|12226927|P1|STARTED|Overall Study||6623
4971179|NCT02620878|12226936|P2|NOT COMPLETED|Overall Study||0
4971180|NCT02620878|12226937|P1|NOT COMPLETED|Overall Study||0
4971181|NCT02620878|12226936|P2|COMPLETED|Overall Study||16
4971182|NCT02620878|12226937|P1|COMPLETED|Overall Study||16
4971183|NCT02620878|12226936|P2|STARTED|Overall Study||16
4971184|NCT02620878|12226937|P1|STARTED|Overall Study||16
4971185|NCT02620787|12226948|P2|NOT COMPLETED|Overall Study||0
4971186|NCT02620787|12226949|P1|NOT COMPLETED|Overall Study||2
4971187|NCT02620787|12226948|P2|COMPLETED|Overall Study||6
4971188|NCT02620787|12226949|P1|COMPLETED|Overall Study||10
4971189|NCT02620787|12226948|P2|STARTED|Overall Study||6
4971190|NCT02620787|12226949|P1|STARTED|Overall Study||12
4971191|NCT02620774|12226961|P2|NOT COMPLETED|Overall Study||0
4971192|NCT02620774|12226962|P1|NOT COMPLETED|Overall Study||0
4971193|NCT02620774|12226961|P2|COMPLETED|Overall Study||6
4971194|NCT02620774|12226962|P1|COMPLETED|Overall Study||10
4971195|NCT02620774|12226961|P2|STARTED|Overall Study||6
4971196|NCT02620774|12226962|P1|STARTED|Overall Study||10
4971197|NCT02620683|12226980|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
4971198|NCT02620683|12226981|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
4971199|NCT02620683|12226980|P2|COMPLETED|Second Intervention (Visit 2)||11
4971200|NCT02620683|12226981|P1|COMPLETED|Second Intervention (Visit 2)||12
4971201|NCT02620683|12226980|P2|STARTED|Second Intervention (Visit 2)||11
4971202|NCT02620683|12226981|P1|STARTED|Second Intervention (Visit 2)||12
4971203|NCT02620683|12226980|P2|NOT COMPLETED|Washout (2 Weeks)||0
4971204|NCT02620683|12226981|P1|NOT COMPLETED|Washout (2 Weeks)||0
4971205|NCT02620683|12226980|P2|COMPLETED|Washout (2 Weeks)||11
4971206|NCT02620683|12226981|P1|COMPLETED|Washout (2 Weeks)||12
4971207|NCT02620683|12226980|P2|STARTED|Washout (2 Weeks)||11
4971208|NCT02620683|12226981|P1|STARTED|Washout (2 Weeks)||12
4971209|NCT02620683|12226980|P2|NOT COMPLETED|First Intervention (Visit 1)||0
4971210|NCT02620683|12226981|P1|NOT COMPLETED|First Intervention (Visit 1)||0
4971211|NCT02620683|12226980|P2|COMPLETED|First Intervention (Visit 1)||11
4971212|NCT02620683|12226981|P1|COMPLETED|First Intervention (Visit 1)||12
4971213|NCT02620683|12226980|P2|STARTED|First Intervention (Visit 1)||11
4971214|NCT02620683|12226981|P1|STARTED|First Intervention (Visit 1)||12
4971215|NCT02620384|12226991|P2|NOT COMPLETED|Overall Study||7
4971216|NCT02620384|12226992|P1|NOT COMPLETED|Overall Study||4
4971217|NCT02620384|12226991|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
4971218|NCT02620384|12226992|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
4971219|NCT02620384|12226991|P2|STARTED|Overall Study||73
4971220|NCT02620384|12226992|P1|STARTED|Overall Study||70
4971221|NCT02620020|12227024|P4|NOT COMPLETED|Overall Study||26
4971222|NCT02620020|12227025|P3|NOT COMPLETED|Overall Study||25
4971223|NCT02620020|12227026|P2|NOT COMPLETED|Overall Study||35
4971224|NCT02620020|12227027|P1|NOT COMPLETED|Overall Study||44
4971225|NCT02620020|12227024|P4|COMPLETED|Overall Study||115
4971226|NCT02620020|12227025|P3|COMPLETED|Overall Study||115
4971227|NCT02620020|12227026|P2|COMPLETED|Overall Study||106
4971228|NCT02620020|12227027|P1|COMPLETED|Overall Study||97
4971229|NCT02620020|12227024|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
4971230|NCT02620020|12227025|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
4971231|NCT02620020|12227026|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
4971232|NCT02620020|12227027|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
4971233|NCT02620020|12227024|P4|STARTED|Overall Study||141
4971234|NCT02620020|12227025|P3|STARTED|Overall Study||140
4971235|NCT02620020|12227026|P2|STARTED|Overall Study||141
4971236|NCT02620020|12227027|P1|STARTED|Overall Study||141
4971237|NCT02619812|12227053|P4|NOT COMPLETED|Overall Study||2
4971238|NCT02619812|12227054|P3|NOT COMPLETED|Overall Study||1
4971239|NCT02619812|12227055|P2|NOT COMPLETED|Overall Study||0
4971240|NCT02619812|12227056|P1|NOT COMPLETED|Overall Study||0
4971241|NCT02619812|12227053|P4|COMPLETED|Overall Study||0
4971242|NCT02619812|12227054|P3|COMPLETED|Overall Study||0
4971243|NCT02619812|12227055|P2|COMPLETED|Overall Study||0
4971244|NCT02619812|12227056|P1|COMPLETED|Overall Study||0
4971245|NCT02619812|12227053|P4|STARTED|Overall Study||2
4971246|NCT02619812|12227054|P3|STARTED|Overall Study||1
4971247|NCT02619812|12227055|P2|STARTED|Overall Study||0
4971248|NCT02619812|12227056|P1|STARTED|Overall Study||0
4971249|NCT02619799|12227072|P2|NOT COMPLETED|Overall Study||0
4971250|NCT02619799|12227073|P1|NOT COMPLETED|Overall Study||0
4971251|NCT02619799|12227072|P2|COMPLETED|Overall Study||25
4971252|NCT02619799|12227073|P1|COMPLETED|Overall Study||25
4971253|NCT02619799|12227072|P2|STARTED|Overall Study||25
4971254|NCT02619799|12227073|P1|STARTED|Overall Study||25
4971255|NCT02619617|12227089|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
4971256|NCT02619617|12227090|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
4971257|NCT02619617|12227089|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
4971258|NCT02619617|12227090|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
4971259|NCT02619617|12227089|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
4971260|NCT02619617|12227090|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
4971261|NCT02619617|12227089|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
4971262|NCT02619617|12227090|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
4971263|NCT02619617|12227089|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
4971264|NCT02619617|12227090|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
4971265|NCT02619617|12227089|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
4971266|NCT02619617|12227090|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
4971267|NCT02619617|12227089|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
4971268|NCT02619617|12227090|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
4971269|NCT02619617|12227089|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
4971270|NCT02619617|12227090|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
4971271|NCT02619617|12227089|P2|STARTED|Period 1 Placebo - 1st AttacK||0
4971272|NCT02619617|12227090|P1|STARTED|Period 1 Placebo - 1st AttacK||28
4971273|NCT02619591|12227102|P2|NOT COMPLETED|Overall Study||121
4971274|NCT02619591|12227103|P1|NOT COMPLETED|Overall Study||139
4971275|NCT02619591|12227102|P2|COMPLETED|Overall Study||0
4971276|NCT02619591|12227103|P1|COMPLETED|Overall Study||0
4971277|NCT02619591|12227102|P2|STARTED|Overall Study||121
4971278|NCT02619591|12227103|P1|STARTED|Overall Study||139
4971279|NCT02619409|12227114|P5|NOT COMPLETED|Overall Study||0
4971280|NCT02619409|12227115|P4|NOT COMPLETED|Overall Study||0
4971281|NCT02619409|12227116|P3|NOT COMPLETED|Overall Study||0
4971282|NCT02619409|12227117|P2|NOT COMPLETED|Overall Study||0
4971283|NCT02619409|12227118|P1|NOT COMPLETED|Overall Study||0
4971284|NCT02619409|12227114|P5|COMPLETED|Overall Study||6
4971285|NCT02619409|12227115|P4|COMPLETED|Overall Study||6
4971286|NCT02619409|12227116|P3|COMPLETED|Overall Study||6
4971287|NCT02619409|12227117|P2|COMPLETED|Overall Study||6
4971288|NCT02619409|12227118|P1|COMPLETED|Overall Study||6
4971289|NCT02619409|12227114|P5|STARTED|Overall Study||6
4971290|NCT02619409|12227115|P4|STARTED|Overall Study||6
4971291|NCT02619409|12227116|P3|STARTED|Overall Study||6
4971292|NCT02619409|12227117|P2|STARTED|Overall Study||6
4971293|NCT02619409|12227118|P1|STARTED|Overall Study||6
4971294|NCT02619396|12227139|P4|NOT COMPLETED|Overall Study||0
4971295|NCT02619396|12227140|P3|NOT COMPLETED|Overall Study||0
4971296|NCT02619396|12227141|P2|NOT COMPLETED|Overall Study||0
4971297|NCT02619396|12227142|P1|NOT COMPLETED|Overall Study||0
4971298|NCT02619396|12227139|P4|COMPLETED|Overall Study||20
4971299|NCT02619396|12227140|P3|COMPLETED|Overall Study||20
4971300|NCT02619396|12227141|P2|COMPLETED|Overall Study||20
4971301|NCT02619396|12227142|P1|COMPLETED|Overall Study||20
4971302|NCT02619396|12227139|P4|STARTED|Overall Study||20
4971303|NCT02619396|12227140|P3|STARTED|Overall Study||20
4971304|NCT02619396|12227141|P2|STARTED|Overall Study||20
4971305|NCT02619396|12227142|P1|STARTED|Overall Study||20
4971306|NCT02619175|12227186|P2|NOT COMPLETED|Overall Study||0
4971307|NCT02619175|12227187|P1|NOT COMPLETED|Overall Study||2
4971308|NCT02619175|12227186|P2|COMPLETED|Overall Study||16
4971309|NCT02619175|12227187|P1|COMPLETED|Overall Study||16
4971310|NCT02619175|12227186|P2|STARTED|Overall Study||16
4971311|NCT02619175|12227187|P1|STARTED|Overall Study||18
4971312|NCT02618928|12227201|P1|NOT COMPLETED|Overall Study||58
4971313|NCT02618928|12227201|P1|COMPLETED|Overall Study||677
4971314|NCT02618928|12227201|P1|Received Treatment|Overall Study||728
4971315|NCT02618928|12227201|P1|STARTED|Overall Study||735
4971316|NCT02618915|12227234|P2|NOT COMPLETED|Overall Study||0
4971317|NCT02618915|12227235|P1|NOT COMPLETED|Overall Study||0
4971318|NCT02618915|12227234|P2|COMPLETED|Overall Study||3
4971319|NCT02618915|12227235|P1|COMPLETED|Overall Study||3
4971320|NCT02618915|12227234|P2|STARTED|Overall Study||3
4971321|NCT02618915|12227235|P1|STARTED|Overall Study||3
4971322|NCT02618772|12227261|P2|NOT COMPLETED|Overall Study||0
4971323|NCT02618772|12227262|P1|NOT COMPLETED|Overall Study||1
4971324|NCT02618772|12227261|P2|COMPLETED|Overall Study||40
4971325|NCT02618772|12227262|P1|COMPLETED|Overall Study||38
4971326|NCT02618772|12227261|P2|Withdrawal by Subject|Overall Study||0
4971327|NCT02618772|12227262|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
4971328|NCT02618772|12227261|P2|STARTED|Overall Study||40
4971329|NCT02618772|12227262|P1|STARTED|Overall Study||39
4971330|NCT02618759|12227296|P2|NOT COMPLETED|Overall Study||5
4971331|NCT02618759|12227297|P1|NOT COMPLETED|Overall Study||2
4971332|NCT02618759|12227296|P2|COMPLETED|Overall Study||54
4971333|NCT02618759|12227297|P1|COMPLETED|Overall Study||58
4971334|NCT02618759|12227296|P2|STARTED|Overall Study||59
4971335|NCT02618759|12227297|P1|STARTED|Overall Study||60
4971336|NCT02618642|12227317|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
4971337|NCT02618642|12227318|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
4971338|NCT02618642|12227319|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
4971339|NCT02618642|12227320|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
4971340|NCT02618642|12227317|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
4971341|NCT02618642|12227318|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
4971342|NCT02618642|12227319|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
4971343|NCT02618642|12227320|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
4971344|NCT02618642|12227317|P4|STARTED|After 10 PILER Irradiation Treatments||15
4971345|NCT02618642|12227318|P3|STARTED|After 10 PILER Irradiation Treatments||15
4971346|NCT02618642|12227319|P2|STARTED|After 10 PILER Irradiation Treatments||15
4971347|NCT02618642|12227320|P1|STARTED|After 10 PILER Irradiation Treatments||15
4971348|NCT02618642|12227317|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
4971349|NCT02618642|12227318|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
4971350|NCT02618642|12227319|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
4971351|NCT02618642|12227320|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
4971352|NCT02618642|12227317|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
4971353|NCT02618642|12227318|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
4971354|NCT02618642|12227319|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
4971355|NCT02618642|12227320|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
4971356|NCT02618642|12227317|P4|STARTED|Before 10 PILER Irradiation Treatments||15
4971357|NCT02618642|12227318|P3|STARTED|Before 10 PILER Irradiation Treatments||15
4971358|NCT02618642|12227319|P2|STARTED|Before 10 PILER Irradiation Treatments||15
4971359|NCT02618642|12227320|P1|STARTED|Before 10 PILER Irradiation Treatments||15
4971360|NCT02618512|12227346|P1|NOT COMPLETED|Overall Study||0
4971361|NCT02618512|12227346|P1|COMPLETED|Overall Study||3
4971362|NCT02618512|12227346|P1|STARTED|Overall Study||3
4971363|NCT02618187|12227354|P4|NOT COMPLETED|Overall Study||5
4971364|NCT02618187|12227355|P3|NOT COMPLETED|Overall Study||4
4971365|NCT02618187|12227356|P2|NOT COMPLETED|Overall Study||2
4971366|NCT02618187|12227357|P1|NOT COMPLETED|Overall Study||2
4971367|NCT02618187|12227354|P4|COMPLETED|Overall Study||12
4971368|NCT02618187|12227355|P3|COMPLETED|Overall Study||11
4971369|NCT02618187|12227356|P2|COMPLETED|Overall Study||9
4971370|NCT02618187|12227357|P1|COMPLETED|Overall Study||13
4971371|NCT02618187|12227354|P4|Completed|Overall Study||13
4971372|NCT02618187|12227355|P3|Completed|Overall Study||13
4971373|NCT02618187|12227356|P2|Completed|Overall Study||10
4971374|NCT02618187|12227357|P1|Completed|Overall Study||13
4971375|NCT02618187|12227354|P4|STARTED|Overall Study||17
4971376|NCT02618187|12227355|P3|STARTED|Overall Study||15
4971377|NCT02618187|12227356|P2|STARTED|Overall Study||11
4971378|NCT02618187|12227357|P1|STARTED|Overall Study||15
4971379|NCT02618031|12227385|P2|NOT COMPLETED|Overall Study||0
4971380|NCT02618031|12227386|P1|NOT COMPLETED|Overall Study||1
4971381|NCT02618031|12227385|P2|COMPLETED|Overall Study||11
4971382|NCT02618031|12227386|P1|COMPLETED|Overall Study||45
4971383|NCT02618031|12227385|P2|STARTED|Overall Study||11
4971384|NCT02618031|12227386|P1|STARTED|Overall Study||46
4971385|NCT02617901|12227398|P1|NOT COMPLETED|Overall Study||0
4971386|NCT02617901|12227398|P1|COMPLETED|Overall Study||20
4971387|NCT02617901|12227398|P1|STARTED|Overall Study||20
4971388|NCT02617888|12227405|P3|NOT COMPLETED|Overall Study||0
4971389|NCT02617888|12227406|P2|NOT COMPLETED|Overall Study||7
4971390|NCT02617888|12227407|P1|NOT COMPLETED|Overall Study||1
4971391|NCT02617888|12227405|P3|COMPLETED|Overall Study||127
4971392|NCT02617888|12227406|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
4971393|NCT02617888|12227407|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
4971394|NCT02617888|12227405|P3|STARTED|Overall Study||127
4971395|NCT02617888|12227406|P2|STARTED|Overall Study||51
4971396|NCT02617888|12227407|P1|STARTED|Overall Study||50
4971397|NCT02617784|12227416|P2|NOT COMPLETED|Overall Study||0
4971398|NCT02617784|12227417|P1|NOT COMPLETED|Overall Study||0
4971399|NCT02617784|12227416|P2|COMPLETED|Overall Study||12
4971400|NCT02617784|12227417|P1|COMPLETED|Overall Study||12
4971401|NCT02617784|12227416|P2|Second Dose Assessment Period|Overall Study||12
4971402|NCT02617784|12227417|P1|Second Dose Assessment Period|Overall Study||11
4971403|NCT02617784|12227416|P2|First Dose Assessment Period|Overall Study||12
4971404|NCT02617784|12227417|P1|First Dose Assessment Period|Overall Study||12
4971405|NCT02617784|12227416|P2|STARTED|Overall Study||12
4971406|NCT02617784|12227417|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
4971407|NCT02617667|12227468|P4|NOT COMPLETED|Overall Study||1
4971408|NCT02617667|12227469|P3|NOT COMPLETED|Overall Study||4
4971409|NCT02617667|12227470|P2|NOT COMPLETED|Overall Study||1
4971410|NCT02617667|12227471|P1|NOT COMPLETED|Overall Study||1
4971411|NCT02617667|12227468|P4|COMPLETED|Overall Study||52
4971412|NCT02617667|12227469|P3|COMPLETED|Overall Study||48
4971413|NCT02617667|12227470|P2|COMPLETED|Overall Study||50
4971414|NCT02617667|12227471|P1|COMPLETED|Overall Study||50
4971415|NCT02617667|12227468|P4|STARTED|Overall Study||53
4971416|NCT02617667|12227469|P3|STARTED|Overall Study||52
4971417|NCT02617667|12227470|P2|STARTED|Overall Study||51
4971418|NCT02617667|12227471|P1|STARTED|Overall Study||51
4971419|NCT02617628|12227485|P2|NOT COMPLETED|Overall Study||61
4971420|NCT02617628|12227486|P1|NOT COMPLETED|Overall Study||62
4971421|NCT02617628|12227485|P2|COMPLETED|Overall Study||11
4971422|NCT02617628|12227486|P1|COMPLETED|Overall Study||12
4971423|NCT02617628|12227485|P2|STARTED|Overall Study||72
4971424|NCT02617628|12227486|P1|STARTED|Overall Study||74
4971425|NCT02616900|12227494|P1|NOT COMPLETED|Overall Study||23
4971426|NCT02616900|12227494|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
4971427|NCT02616900|12227494|P1|Completed 3mo Trial|Overall Study||57
4971428|NCT02616900|12227494|P1|STARTED|Overall Study||74
4971429|NCT02616783|12227502|P2|NOT COMPLETED|Overall Study||2
4971430|NCT02616783|12227503|P1|NOT COMPLETED|Overall Study||6
4971431|NCT02616783|12227502|P2|COMPLETED|Overall Study||54
4971432|NCT02616783|12227503|P1|COMPLETED|Overall Study||105
4971433|NCT02616783|12227502|P2|STARTED|Overall Study||56
4971434|NCT02616783|12227503|P1|STARTED|Overall Study||111
4971435|NCT02616614|12227526|P3|NOT COMPLETED|Overall Study||29
4971436|NCT02616614|12227527|P2|NOT COMPLETED|Overall Study||60
4971437|NCT02616614|12227528|P1|NOT COMPLETED|Overall Study||65
4971438|NCT02616614|12227526|P3|COMPLETED|Overall Study||141
4971439|NCT02616614|12227527|P2|COMPLETED|Overall Study||285
4971440|NCT02616614|12227528|P1|COMPLETED|Overall Study||282
4971441|NCT02616614|12227526|P3|PP Population|Overall Study||122
4971442|NCT02616614|12227527|P2|PP Population|Overall Study||255
4971443|NCT02616614|12227528|P1|PP Population|Overall Study||253
4971444|NCT02616614|12227526|P3|mITT Population|Overall Study||160
4971445|NCT02616614|12227527|P2|mITT Population|Overall Study||325
4971446|NCT02616614|12227528|P1|mITT Population|Overall Study||325
4971447|NCT02616614|12227526|P3|Safety Population|Overall Study||161
4971448|NCT02616614|12227527|P2|Safety Population|Overall Study||328
4971449|NCT02616614|12227528|P1|Safety Population|Overall Study||329
4971450|NCT02616614|12227526|P3|STARTED|Overall Study||170
4971451|NCT02616614|12227527|P2|STARTED|Overall Study||345
4971452|NCT02616614|12227528|P1|STARTED|Overall Study||347
4971453|NCT02616601|12227545|P3|NOT COMPLETED|Overall Study||7
4971454|NCT02616601|12227546|P2|NOT COMPLETED|Overall Study||4
4971455|NCT02616601|12227547|P1|NOT COMPLETED|Overall Study||9
4971456|NCT02616601|12227545|P3|COMPLETED|Overall Study||135
4971457|NCT02616601|12227546|P2|COMPLETED|Overall Study||136
4971458|NCT02616601|12227547|P1|COMPLETED|Overall Study||131
4971459|NCT02616601|12227545|P3|PP Population|Overall Study||123
4971460|NCT02616601|12227546|P2|PP Population|Overall Study||121
4971461|NCT02616601|12227547|P1|PP Population|Overall Study||112
4971462|NCT02616601|12227545|P3|mITT Population|Overall Study||138
4971463|NCT02616601|12227546|P2|mITT Population|Overall Study||136
4971464|NCT02616601|12227547|P1|mITT Population|Overall Study||137
4971465|NCT02616601|12227545|P3|Safety Population|Overall Study||142
4971466|NCT02616601|12227546|P2|Safety Population|Overall Study||140
4971467|NCT02616601|12227547|P1|Safety Population|Overall Study||140
4971468|NCT02616601|12227545|P3|STARTED|Overall Study||142
4971469|NCT02616601|12227546|P2|STARTED|Overall Study||140
4971470|NCT02616601|12227547|P1|STARTED|Overall Study||140
4971471|NCT02616523|12227558|P3|NOT COMPLETED|Overall Study||0
4971472|NCT02616523|12227559|P2|NOT COMPLETED|Overall Study||0
4971473|NCT02616523|12227560|P1|NOT COMPLETED|Overall Study||1
4971474|NCT02616523|12227558|P3|COMPLETED|Overall Study|April 2015|20
4971475|NCT02616523|12227559|P2|COMPLETED|Overall Study|April 2015|20
4971476|NCT02616523|12227560|P1|COMPLETED|Overall Study|April 2015|19
4971477|NCT02616523|12227558|P3|STARTED|Overall Study|June 2014|20
4971478|NCT02616523|12227559|P2|STARTED|Overall Study|June 2014|20
4971479|NCT02616523|12227560|P1|STARTED|Overall Study|June 2014|20
4971480|NCT02616380|12227574|P1|NOT COMPLETED|Overall Study||3
4971481|NCT02616380|12227574|P1|COMPLETED|Overall Study||97
4971482|NCT02616380|12227574|P1|STARTED|Overall Study||100
4971483|NCT02616250|12227589|P2|NOT COMPLETED|Overall Study||9
4971484|NCT02616250|12227590|P1|NOT COMPLETED|Overall Study||10
4971485|NCT02616250|12227589|P2|COMPLETED|Overall Study||86
4971486|NCT02616250|12227590|P1|COMPLETED|Overall Study||85
4971487|NCT02616250|12227589|P2|STARTED|Overall Study||95
4971488|NCT02616250|12227590|P1|STARTED|Overall Study||95
4971489|NCT02616146|12227598|P2|NOT COMPLETED|Overall Study||504
4971490|NCT02616146|12227599|P1|NOT COMPLETED|Overall Study||1512
4971491|NCT02616146|12227598|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
4971492|NCT02616146|12227599|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
4971493|NCT02616146|12227598|P2|STARTED|Overall Study||504
4971494|NCT02616146|12227599|P1|STARTED|Overall Study||1512
4971495|NCT02616029|12227615|P2|NOT COMPLETED|Overall Study||2
4971496|NCT02616029|12227616|P1|NOT COMPLETED|Overall Study||4
4971497|NCT02616029|12227615|P2|COMPLETED|Overall Study||26
4971498|NCT02616029|12227616|P1|COMPLETED|Overall Study||34
4971499|NCT02616029|12227615|P2|STARTED|Overall Study||28
4971500|NCT02616029|12227616|P1|STARTED|Overall Study||38
4971501|NCT02615990|12227687|P2|NOT COMPLETED|Overall Study||1
4971502|NCT02615990|12227688|P1|NOT COMPLETED|Overall Study||1
4971503|NCT02615990|12227687|P2|COMPLETED|Overall Study||0
4971504|NCT02615990|12227688|P1|COMPLETED|Overall Study||0
4971505|NCT02615990|12227687|P2|STARTED|Overall Study||1
4971506|NCT02615990|12227688|P1|STARTED|Overall Study||1
4971507|NCT02615743|12227734|P2|NOT COMPLETED|Overall Study||3
4971508|NCT02615743|12227735|P1|NOT COMPLETED|Overall Study||6
4971509|NCT02615743|12227734|P2|COMPLETED|Overall Study||17
4971510|NCT02615743|12227735|P1|COMPLETED|Overall Study||15
4971511|NCT02615743|12227734|P2|STARTED|Overall Study||20
4971512|NCT02615743|12227735|P1|STARTED|Overall Study||21
4971513|NCT02615717|12227749|P2|NOT COMPLETED|Overall Study||0
4971514|NCT02615717|12227750|P1|NOT COMPLETED|Overall Study||0
4971515|NCT02615717|12227749|P2|COMPLETED|Overall Study||3
4971516|NCT02615717|12227750|P1|COMPLETED|Overall Study||3
4971517|NCT02615717|12227749|P2|STARTED|Overall Study||3
4971518|NCT02615717|12227750|P1|STARTED|Overall Study||3
4971519|NCT02615535|12227764|P2|NOT COMPLETED|Overall Study||1
4971520|NCT02615535|12227765|P1|NOT COMPLETED|Overall Study||4
4971521|NCT02615535|12227764|P2|COMPLETED|Overall Study||10
4971522|NCT02615535|12227765|P1|COMPLETED|Overall Study||10
4971523|NCT02615535|12227764|P2|STARTED|Overall Study||11
4971524|NCT02615535|12227765|P1|STARTED|Overall Study||14
4971525|NCT02615509|12227785|P1|NOT COMPLETED|Overall Study||146
4971526|NCT02615509|12227785|P1|COMPLETED|Overall Study||201
4971527|NCT02615509|12227785|P1|STARTED|Overall Study||347
4971528|NCT02615470|12227795|P2|NOT COMPLETED|Overall Study||32
4971529|NCT02615470|12227796|P1|NOT COMPLETED|Overall Study||21
4971530|NCT02615470|12227795|P2|COMPLETED|Overall Study||30
4971531|NCT02615470|12227796|P1|COMPLETED|Overall Study||37
4971532|NCT02615470|12227795|P2|Completed the Baseline Surveys|Overall Study||47
4971533|NCT02615470|12227796|P1|Completed the Baseline Surveys|Overall Study||46
4971534|NCT02615470|12227795|P2|STARTED|Overall Study||62
4971535|NCT02615470|12227796|P1|STARTED|Overall Study||58
4971536|NCT02615158|12227809|P3|NOT COMPLETED|Overall Study||16
4971537|NCT02615158|12227810|P2|NOT COMPLETED|Overall Study||16
4971538|NCT02615158|12227811|P1|NOT COMPLETED|Overall Study||21
4971539|NCT02615158|12227809|P3|COMPLETED|Overall Study||75
4971540|NCT02615158|12227810|P2|COMPLETED|Overall Study||76
4971541|NCT02615158|12227811|P1|COMPLETED|Overall Study||73
4971542|NCT02615158|12227809|P3|STARTED|Overall Study||91
4971543|NCT02615158|12227810|P2|STARTED|Overall Study||92
4971544|NCT02615158|12227811|P1|STARTED|Overall Study||94
4971545|NCT02615145|12227840|P4|NOT COMPLETED|Overall Study||1
4971546|NCT02615145|12227841|P3|NOT COMPLETED|Overall Study||8
4971547|NCT02615145|12227842|P2|NOT COMPLETED|Overall Study||15
4971548|NCT02615145|12227843|P1|NOT COMPLETED|Overall Study||27
4971549|NCT02615145|12227840|P4|COMPLETED|Overall Study||0
4971550|NCT02615145|12227841|P3|COMPLETED|Overall Study||40
4971551|NCT02615145|12227842|P2|COMPLETED|Overall Study||263
4971552|NCT02615145|12227843|P1|COMPLETED|Overall Study||118
4971553|NCT02615145|12227840|P4|3DAA + RBV|Overall Study||0
4971554|NCT02615145|12227841|P3|3DAA + RBV|Overall Study||2
4971555|NCT02615145|12227842|P2|3DAA + RBV|Overall Study||17
4971556|NCT02615145|12227843|P1|3DAA + RBV|Overall Study||140
4971557|NCT02615145|12227840|P4|3DAA|Overall Study||0
4971558|NCT02615145|12227841|P3|3DAA|Overall Study||0
4971559|NCT02615145|12227842|P2|3DAA|Overall Study||261
4971560|NCT02615145|12227843|P1|3DAA|Overall Study||5
4971561|NCT02615145|12227840|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
4971562|NCT02615145|12227841|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
4971563|NCT02615145|12227842|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
4971564|NCT02615145|12227843|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
4971565|NCT02615145|12227840|P4|STARTED|Overall Study||1
4971566|NCT02615145|12227841|P3|STARTED|Overall Study||48
4971567|NCT02615145|12227842|P2|STARTED|Overall Study||278
4971568|NCT02615145|12227843|P1|STARTED|Overall Study||145
4971569|NCT02614924|12227919|P2|NOT COMPLETED|Overall Study||0
4971570|NCT02614924|12227920|P1|NOT COMPLETED|Overall Study||0
4971571|NCT02614924|12227919|P2|COMPLETED|Overall Study||20
4971572|NCT02614924|12227920|P1|COMPLETED|Overall Study||20
4971573|NCT02614924|12227919|P2|STARTED|Overall Study||20
4971574|NCT02614924|12227920|P1|STARTED|Overall Study||20
4971575|NCT02614898|12227930|P2|NOT COMPLETED|Overall Study||51
4971576|NCT02614898|12227931|P1|NOT COMPLETED|Overall Study||15
4971577|NCT02614898|12227930|P2|COMPLETED|Overall Study||1
4971578|NCT02614898|12227931|P1|COMPLETED|Overall Study||0
4971579|NCT02614898|12227930|P2|Safety Population|Overall Study||52
4971580|NCT02614898|12227931|P1|Safety Population|Overall Study||15
4971581|NCT02614898|12227930|P2|STARTED|Overall Study||52
4971582|NCT02614898|12227931|P1|STARTED|Overall Study||15
4971583|NCT02614729|12227943|P2|NOT COMPLETED|Overall Study||0
4971584|NCT02614729|12227944|P1|NOT COMPLETED|Overall Study||1
4971585|NCT02614729|12227943|P2|COMPLETED|Overall Study||17
4971586|NCT02614729|12227944|P1|COMPLETED|Overall Study||17
4971587|NCT02614729|12227943|P2|STARTED|Overall Study||17
4971588|NCT02614729|12227944|P1|STARTED|Overall Study||18
4971589|NCT02614703|12227964|P2|NOT COMPLETED|Overall Study||1
4971590|NCT02614703|12227965|P1|NOT COMPLETED|Overall Study||7
4971591|NCT02614703|12227964|P2|COMPLETED|Overall Study||28
4971592|NCT02614703|12227965|P1|COMPLETED|Overall Study||24
4971593|NCT02614703|12227964|P2|STARTED|Overall Study||29
4971594|NCT02614703|12227965|P1|STARTED|Overall Study||31
4971595|NCT02614690|12227974|P3|NOT COMPLETED|Overall Study||0
4971596|NCT02614690|12227975|P2|NOT COMPLETED|Overall Study||0
4971597|NCT02614690|12227976|P1|NOT COMPLETED|Overall Study||0
4971598|NCT02614690|12227974|P3|COMPLETED|Overall Study||20
4971599|NCT02614690|12227975|P2|COMPLETED|Overall Study||20
4971600|NCT02614690|12227976|P1|COMPLETED|Overall Study||20
4971601|NCT02614690|12227974|P3|STARTED|Overall Study||20
4971602|NCT02614690|12227975|P2|STARTED|Overall Study||20
4971603|NCT02614690|12227976|P1|STARTED|Overall Study||20
4971604|NCT02614586|12228002|P1|NOT COMPLETED|Overall Study||0
4971605|NCT02614586|12228002|P1|COMPLETED|Overall Study||11
4971606|NCT02614586|12228002|P1|STARTED|Overall Study||11
4971607|NCT02614560|12228009|P2|NOT COMPLETED|Overall Study||2
4971608|NCT02614560|12228010|P1|NOT COMPLETED|Overall Study||6
4971609|NCT02614560|12228009|P2|COMPLETED|Overall Study||6
4971610|NCT02614560|12228010|P1|COMPLETED|Overall Study||0
4971611|NCT02614560|12228009|P2|STARTED|Overall Study||8
4971612|NCT02614560|12228010|P1|STARTED|Overall Study||6
4971613|NCT02614469|12228027|P2|NOT COMPLETED|Period 2||0
4971614|NCT02614469|12228028|P1|NOT COMPLETED|Period 2||0
4971615|NCT02614469|12228027|P2|COMPLETED|Period 2||9
4971616|NCT02614469|12228028|P1|COMPLETED|Period 2||9
4971617|NCT02614469|12228027|P2|STARTED|Period 2||9
4971618|NCT02614469|12228028|P1|STARTED|Period 2||9
4971619|NCT02614469|12228027|P2|NOT COMPLETED|Period 1||0
4971620|NCT02614469|12228028|P1|NOT COMPLETED|Period 1||0
4971621|NCT02614469|12228027|P2|COMPLETED|Period 1||9
4971622|NCT02614469|12228028|P1|COMPLETED|Period 1||9
4971623|NCT02614469|12228027|P2|STARTED|Period 1||9
4971624|NCT02614469|12228028|P1|STARTED|Period 1||9
4971625|NCT02614287|12228058|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
4971626|NCT02614287|12228059|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
4971627|NCT02614287|12228058|P2|COMPLETED|Post Treatment Follow-up Phase||119
4971628|NCT02614287|12228059|P1|COMPLETED|Post Treatment Follow-up Phase||103
4971629|NCT02614287|12228058|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
4971630|NCT02614287|12228059|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
4971631|NCT02614287|12228058|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
4971632|NCT02614287|12228059|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
4971633|NCT02614287|12228058|P2|COMPLETED|Open Label (OL) Treatment Phase||113
4971634|NCT02614287|12228059|P1|COMPLETED|Open Label (OL) Treatment Phase||97
4971635|NCT02614287|12228058|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
4971636|NCT02614287|12228059|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
4971637|NCT02614287|12228058|P2|STARTED|Open Label (OL) Treatment Phase||135
4971638|NCT02614287|12228059|P1|STARTED|Open Label (OL) Treatment Phase||135
4971639|NCT02614274|12228093|P1|NOT COMPLETED|Overall Study||4
4971640|NCT02614274|12228093|P1|COMPLETED|Overall Study||5
4971641|NCT02614274|12228093|P1|STARTED|Overall Study||9
4971642|NCT02614261|12228105|P3|NOT COMPLETED|Overall Study||11
4971643|NCT02614261|12228106|P2|NOT COMPLETED|Overall Study||15
4971644|NCT02614261|12228107|P1|NOT COMPLETED|Overall Study||49
4971645|NCT02614261|12228105|P3|COMPLETED|Overall Study||266
4971646|NCT02614261|12228106|P2|COMPLETED|Overall Study||263
4971647|NCT02614261|12228107|P1|COMPLETED|Overall Study||509
4971648|NCT02614261|12228105|P3|Received at Least One Dose of Study Drug|Overall Study||277
4971649|NCT02614261|12228106|P2|Received at Least One Dose of Study Drug|Overall Study||278
4971650|NCT02614261|12228107|P1|Received at Least One Dose of Study Drug|Overall Study||558
4971651|NCT02614261|12228105|P3|STARTED|Overall Study||277
4971652|NCT02614261|12228106|P2|STARTED|Overall Study||278
4971653|NCT02614261|12228107|P1|STARTED|Overall Study||558
4971654|NCT02614222|12228146|P2|NOT COMPLETED|Overall Study||0
4971655|NCT02614222|12228147|P1|NOT COMPLETED|Overall Study||0
4971656|NCT02614222|12228146|P2|COMPLETED|Overall Study||14
4971657|NCT02614222|12228147|P1|COMPLETED|Overall Study||13
4971658|NCT02614222|12228146|P2|STARTED|Overall Study||14
4971659|NCT02614222|12228147|P1|STARTED|Overall Study||13
4971660|NCT02614196|12228173|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
4971661|NCT02614196|12228174|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
4971662|NCT02614196|12228175|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
4971663|NCT02614196|12228176|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
4971664|NCT02614196|12228177|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
4971665|NCT02614196|12228178|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
4971666|NCT02614196|12228173|P6|COMPLETED|Post Treatment Follow-up Phase||19
4971667|NCT02614196|12228174|P5|COMPLETED|Post Treatment Follow-up Phase||13
4971668|NCT02614196|12228175|P4|COMPLETED|Post Treatment Follow-up Phase||24
4971669|NCT02614196|12228176|P3|COMPLETED|Post Treatment Follow-up Phase||199
4971670|NCT02614196|12228177|P2|COMPLETED|Post Treatment Follow-up Phase||208
4971671|NCT02614196|12228178|P1|COMPLETED|Post Treatment Follow-up Phase||390
4971672|NCT02614196|12228173|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
4971673|NCT02614196|12228174|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
4971674|NCT02614196|12228175|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
4971675|NCT02614196|12228176|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
4971676|NCT02614196|12228177|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
4971677|NCT02614196|12228178|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
4971678|NCT02614196|12228173|P6|NOT COMPLETED|Double Blind Treatment Phase||0
4971679|NCT02614196|12228174|P5|NOT COMPLETED|Double Blind Treatment Phase||1
4971680|NCT02614196|12228175|P4|NOT COMPLETED|Double Blind Treatment Phase||4
4971681|NCT02614196|12228176|P3|NOT COMPLETED|Double Blind Treatment Phase||31
4971682|NCT02614196|12228177|P2|NOT COMPLETED|Double Blind Treatment Phase||30
4971683|NCT02614196|12228178|P1|NOT COMPLETED|Double Blind Treatment Phase||76
4971684|NCT02614196|12228173|P6|COMPLETED|Double Blind Treatment Phase||19
4971685|NCT02614196|12228174|P5|COMPLETED|Double Blind Treatment Phase||14
4971686|NCT02614196|12228175|P4|COMPLETED|Double Blind Treatment Phase||26
4971687|NCT02614196|12228176|P3|COMPLETED|Double Blind Treatment Phase||195
4971688|NCT02614196|12228177|P2|COMPLETED|Double Blind Treatment Phase||203
4971689|NCT02614196|12228178|P1|COMPLETED|Double Blind Treatment Phase||387
4971690|NCT02614196|12228173|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
4971691|NCT02614196|12228174|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
4971692|NCT02614196|12228175|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
4971693|NCT02614196|12228176|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
4971694|NCT02614196|12228177|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
4971695|NCT02614196|12228178|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
4971696|NCT02614196|12228173|P6|STARTED|Double Blind Treatment Phase||19
4971697|NCT02614196|12228174|P5|STARTED|Double Blind Treatment Phase||15
4971698|NCT02614196|12228175|P4|STARTED|Double Blind Treatment Phase||30
4971699|NCT02614196|12228176|P3|STARTED|Double Blind Treatment Phase||226
4971700|NCT02614196|12228177|P2|STARTED|Double Blind Treatment Phase||233
4971701|NCT02614196|12228178|P1|STARTED|Double Blind Treatment Phase||463
4971702|NCT02614183|12228224|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
4971703|NCT02614183|12228225|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
4971704|NCT02614183|12228226|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
4971705|NCT02614183|12228224|P3|COMPLETED|Post Treatment Follow-up Phase||171
4971706|NCT02614183|12228225|P2|COMPLETED|Post Treatment Follow-up Phase||179
4971707|NCT02614183|12228226|P1|COMPLETED|Post Treatment Follow-up Phase||354
4971708|NCT02614183|12228224|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
4971709|NCT02614183|12228225|P2|Safety Population|Post Treatment Follow-up Phase||183
4971710|NCT02614183|12228226|P1|Safety Population|Post Treatment Follow-up Phase||372
4971711|NCT02614183|12228224|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
4971712|NCT02614183|12228225|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
4971798|NCT02613403|12228450|P1|Treated|Overall Study||35
4971713|NCT02614183|12228226|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
4971714|NCT02614183|12228224|P3|NOT COMPLETED|Double Blind Treatment Phase||39
4971715|NCT02614183|12228225|P2|NOT COMPLETED|Double Blind Treatment Phase||37
4971716|NCT02614183|12228226|P1|NOT COMPLETED|Double Blind Treatment Phase||83
4971717|NCT02614183|12228224|P3|COMPLETED|Double Blind Treatment Phase||175
4971718|NCT02614183|12228225|P2|COMPLETED|Double Blind Treatment Phase||177
4971719|NCT02614183|12228226|P1|COMPLETED|Double Blind Treatment Phase||351
4971720|NCT02614183|12228224|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
4971721|NCT02614183|12228225|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
4971722|NCT02614183|12228226|P1|Safety Population|Double Blind Treatment Phase||432
4971723|NCT02614183|12228224|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
4971724|NCT02614183|12228225|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
4971725|NCT02614183|12228226|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
4971726|NCT02614183|12228224|P3|STARTED|Double Blind Treatment Phase||214
4971727|NCT02614183|12228225|P2|STARTED|Double Blind Treatment Phase||214
4971728|NCT02614183|12228226|P1|STARTED|Double Blind Treatment Phase||434
4971729|NCT02614131|12228270|P7|NOT COMPLETED|Overall Study||1
4971730|NCT02614131|12228271|P6|NOT COMPLETED|Overall Study||0
4971731|NCT02614131|12228272|P5|NOT COMPLETED|Overall Study||0
4971732|NCT02614131|12228273|P4|NOT COMPLETED|Overall Study||0
4971733|NCT02614131|12228274|P3|NOT COMPLETED|Overall Study||0
4971734|NCT02614131|12228275|P2|NOT COMPLETED|Overall Study||0
4971735|NCT02614131|12228276|P1|NOT COMPLETED|Overall Study||1
4971736|NCT02614131|12228270|P7|COMPLETED|Overall Study||4
4971737|NCT02614131|12228271|P6|COMPLETED|Overall Study||2
4971738|NCT02614131|12228272|P5|COMPLETED|Overall Study||8
4971739|NCT02614131|12228273|P4|COMPLETED|Overall Study||8
4971740|NCT02614131|12228274|P3|COMPLETED|Overall Study||8
4971741|NCT02614131|12228275|P2|COMPLETED|Overall Study||8
4971742|NCT02614131|12228276|P1|COMPLETED|Overall Study||10
4971743|NCT02614131|12228270|P7|Received at Least One Dose of Drug|Overall Study||5
4971744|NCT02614131|12228271|P6|Received at Least One Dose of Drug|Overall Study||2
4971745|NCT02614131|12228272|P5|Received at Least One Dose of Drug|Overall Study||8
4971746|NCT02614131|12228273|P4|Received at Least One Dose of Drug|Overall Study||8
4971747|NCT02614131|12228274|P3|Received at Least One Dose of Drug|Overall Study||8
4971748|NCT02614131|12228275|P2|Received at Least One Dose of Drug|Overall Study||8
4971749|NCT02614131|12228276|P1|Received at Least One Dose of Drug|Overall Study||11
4971750|NCT02614131|12228270|P7|STARTED|Overall Study||5
4971751|NCT02614131|12228271|P6|STARTED|Overall Study||2
4971752|NCT02614131|12228272|P5|STARTED|Overall Study||8
4971753|NCT02614131|12228273|P4|STARTED|Overall Study||8
4971754|NCT02614131|12228274|P3|STARTED|Overall Study||8
4971755|NCT02614131|12228275|P2|STARTED|Overall Study||8
4971756|NCT02614131|12228276|P1|STARTED|Overall Study||11
4971757|NCT02614079|12228307|P1|NOT COMPLETED|Overall Study||1
4971758|NCT02614079|12228307|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
4971759|NCT02614079|12228307|P1|STARTED|Overall Study||6
4971760|NCT02613910|12228311|P1|NOT COMPLETED|Overall Study||1
4971761|NCT02613910|12228311|P1|COMPLETED|Overall Study||0
4971762|NCT02613910|12228311|P1|STARTED|Overall Study||1
4971763|NCT02613897|12228363|P3|NOT COMPLETED|Overall Study||0
4971764|NCT02613897|12228364|P2|NOT COMPLETED|Overall Study||0
4971765|NCT02613897|12228365|P1|NOT COMPLETED|Overall Study||0
4971766|NCT02613897|12228363|P3|COMPLETED|Overall Study||12
4971767|NCT02613897|12228364|P2|COMPLETED|Overall Study||22
4971768|NCT02613897|12228365|P1|COMPLETED|Overall Study||22
4971769|NCT02613897|12228363|P3|STARTED|Overall Study||12
4971770|NCT02613897|12228364|P2|STARTED|Overall Study||22
4971771|NCT02613897|12228365|P1|STARTED|Overall Study||22
4971772|NCT02613871|12228397|P1|NOT COMPLETED|Overall Study||3
4971773|NCT02613871|12228397|P1|COMPLETED|Overall Study||108
4971774|NCT02613871|12228397|P1|STARTED|Overall Study||111
4971775|NCT02613507|12228418|P2|NOT COMPLETED|Overall Study||164
4971776|NCT02613507|12228419|P1|NOT COMPLETED|Overall Study||288
4971777|NCT02613507|12228418|P2|COMPLETED|Overall Study||2
4971778|NCT02613507|12228419|P1|COMPLETED|Overall Study||50
4971779|NCT02613507|12228418|P2|STARTED|Overall Study||166
4971780|NCT02613507|12228419|P1|STARTED|Overall Study||338
4971781|NCT02613481|12228435|P1|NOT COMPLETED|Overall Study||9
4971782|NCT02613481|12228435|P1|COMPLETED|Overall Study||41
4971783|NCT02613481|12228435|P1|STARTED|Overall Study||50
4971784|NCT02613403|12228446|P5|NOT COMPLETED|Overall Study||0
4971785|NCT02613403|12228447|P4|NOT COMPLETED|Overall Study||0
4971786|NCT02613403|12228448|P3|NOT COMPLETED|Overall Study||0
4971787|NCT02613403|12228449|P2|NOT COMPLETED|Overall Study||1
4971788|NCT02613403|12228450|P1|NOT COMPLETED|Overall Study||2
4971789|NCT02613403|12228446|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
4971790|NCT02613403|12228447|P4|COMPLETED|Overall Study||13
4971791|NCT02613403|12228448|P3|COMPLETED|Overall Study||9
4971792|NCT02613403|12228449|P2|COMPLETED|Overall Study||35
4971793|NCT02613403|12228450|P1|COMPLETED|Overall Study||34
4971794|NCT02613403|12228446|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
4971795|NCT02613403|12228447|P4|Treated|Overall Study||13
4971796|NCT02613403|12228448|P3|Treated|Overall Study||9
4971797|NCT02613403|12228449|P2|Treated|Overall Study||36
4971799|NCT02613403|12228446|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
4971800|NCT02613403|12228447|P4|STARTED|Overall Study||13
4971801|NCT02613403|12228448|P3|STARTED|Overall Study||9
4971802|NCT02613403|12228449|P2|STARTED|Overall Study||36
4971803|NCT02613403|12228450|P1|STARTED|Overall Study||36
4971804|NCT02613338|12228492|P1|NOT COMPLETED|Overall Study||0
4971805|NCT02613338|12228492|P1|COMPLETED|Overall Study||30
4971806|NCT02613338|12228492|P1|STARTED|Overall Study||30
4971807|NCT02613221|12228502|P1|NOT COMPLETED|Overall Study||55
4971808|NCT02613221|12228502|P1|COMPLETED|Overall Study||1
4971809|NCT02613221|12228502|P1|Safety Population: Received Study Drug|Overall Study||55
4971810|NCT02613221|12228502|P1|STARTED|Overall Study||56
4971811|NCT02613208|12228514|P1|NOT COMPLETED|Overall Study||47
4971812|NCT02613208|12228514|P1|COMPLETED|Overall Study||64
4971813|NCT02613208|12228514|P1|STARTED|Overall Study||111
4971814|NCT02613182|12228528|P1|NOT COMPLETED|Overall Study||34
4971815|NCT02613182|12228528|P1|COMPLETED|Overall Study||0
4971816|NCT02613182|12228528|P1|Number of Patients Dosed|Overall Study||34
4971817|NCT02613182|12228528|P1|STARTED|Overall Study||34
4971818|NCT02612909|12228537|P5|NOT COMPLETED|Phase 3||0
4971819|NCT02612909|12228538|P4|NOT COMPLETED|Phase 3||1
4971820|NCT02612909|12228539|P3|NOT COMPLETED|Phase 3||0
4971821|NCT02612909|12228540|P2|NOT COMPLETED|Phase 3||0
4971822|NCT02612909|12228541|P1|NOT COMPLETED|Phase 3||0
4971823|NCT02612909|12228537|P5|COMPLETED|Phase 3||525
4971824|NCT02612909|12228538|P4|COMPLETED|Phase 3||104
4971825|NCT02612909|12228539|P3|COMPLETED|Phase 3||0
4971826|NCT02612909|12228540|P2|COMPLETED|Phase 3||0
4971827|NCT02612909|12228541|P1|COMPLETED|Phase 3||0
4971828|NCT02612909|12228537|P5|Completed Day 43 Clinic Visit|Phase 3||524
4971829|NCT02612909|12228538|P4|Completed Day 43 Clinic Visit|Phase 3||104
4971830|NCT02612909|12228539|P3|Completed Day 43 Clinic Visit|Phase 3||0
4971831|NCT02612909|12228540|P2|Completed Day 43 Clinic Visit|Phase 3||0
4971832|NCT02612909|12228541|P1|Completed Day 43 Clinic Visit|Phase 3||0
4971833|NCT02612909|12228537|P5|Completed Day 29 Clinic Visit|Phase 3||525
4971834|NCT02612909|12228538|P4|Completed Day 29 Clinic Visit|Phase 3||104
4971835|NCT02612909|12228539|P3|Completed Day 29 Clinic Visit|Phase 3||0
4971836|NCT02612909|12228540|P2|Completed Day 29 Clinic Visit|Phase 3||0
4971837|NCT02612909|12228541|P1|Completed Day 29 Clinic Visit|Phase 3||0
4971838|NCT02612909|12228537|P5|Received Injection 2|Phase 3||520
4971839|NCT02612909|12228538|P4|Received Injection 2|Phase 3||103
4971840|NCT02612909|12228539|P3|Received Injection 2|Phase 3||0
4971841|NCT02612909|12228540|P2|Received Injection 2|Phase 3||0
4971842|NCT02612909|12228541|P1|Received Injection 2|Phase 3||0
4971843|NCT02612909|12228537|P5|Received Injection 1|Phase 3||525
4971844|NCT02612909|12228538|P4|Received Injection 1|Phase 3||105
4971845|NCT02612909|12228539|P3|Received Injection 1|Phase 3||0
4971846|NCT02612909|12228540|P2|Received Injection 1|Phase 3||0
4971847|NCT02612909|12228541|P1|Received Injection 1|Phase 3||0
4971848|NCT02612909|12228537|P5|STARTED|Phase 3||525
4971849|NCT02612909|12228538|P4|STARTED|Phase 3||105
4971850|NCT02612909|12228539|P3|STARTED|Phase 3||0
4971851|NCT02612909|12228540|P2|STARTED|Phase 3||0
4971852|NCT02612909|12228541|P1|STARTED|Phase 3||0
4971853|NCT02612909|12228537|P5|NOT COMPLETED|Phase 2||0
4971854|NCT02612909|12228538|P4|NOT COMPLETED|Phase 2||0
4971855|NCT02612909|12228539|P3|NOT COMPLETED|Phase 2||1
4971856|NCT02612909|12228540|P2|NOT COMPLETED|Phase 2||5
4971857|NCT02612909|12228541|P1|NOT COMPLETED|Phase 2||2
4971858|NCT02612909|12228537|P5|COMPLETED|Phase 2||0
4971859|NCT02612909|12228538|P4|COMPLETED|Phase 2||0
4971860|NCT02612909|12228539|P3|COMPLETED|Phase 2||99
4971861|NCT02612909|12228540|P2|COMPLETED|Phase 2||95
4971862|NCT02612909|12228541|P1|COMPLETED|Phase 2||98
4971863|NCT02612909|12228537|P5|Completed Day 43 Clinic Visit|Phase 2||0
4971864|NCT02612909|12228538|P4|Completed Day 43 Clinic Visit|Phase 2||0
4971865|NCT02612909|12228539|P3|Completed Day 43 Clinic Visit|Phase 2||99
4971866|NCT02612909|12228540|P2|Completed Day 43 Clinic Visit|Phase 2||94
4971867|NCT02612909|12228541|P1|Completed Day 43 Clinic Visit|Phase 2||97
4971868|NCT02612909|12228537|P5|Completed Day 29 Clinic Visit|Phase 2||0
4971869|NCT02612909|12228538|P4|Completed Day 29 Clinic Visit|Phase 2||0
4971870|NCT02612909|12228539|P3|Completed Day 29 Clinic Visit|Phase 2||99
4971871|NCT02612909|12228540|P2|Completed Day 29 Clinic Visit|Phase 2||95
4971872|NCT02612909|12228541|P1|Completed Day 29 Clinic Visit|Phase 2||98
4971873|NCT02612909|12228537|P5|Received Injection 2|Phase 2||0
4971874|NCT02612909|12228538|P4|Received Injection 2|Phase 2||0
4971875|NCT02612909|12228539|P3|Received Injection 2|Phase 2||99
4971876|NCT02612909|12228540|P2|Received Injection 2|Phase 2||95
4971877|NCT02612909|12228541|P1|Received Injection 2|Phase 2||98
4971878|NCT02612909|12228537|P5|Received Injection 1|Phase 2||0
4971879|NCT02612909|12228538|P4|Received Injection 1|Phase 2||0
4971880|NCT02612909|12228539|P3|Received Injection 1|Phase 2||100
4971881|NCT02612909|12228540|P2|Received Injection 1|Phase 2||100
4971882|NCT02612909|12228541|P1|Received Injection 1|Phase 2||100
4971883|NCT02612909|12228537|P5|STARTED|Phase 2||0
4971884|NCT02612909|12228538|P4|STARTED|Phase 2||0
4971885|NCT02612909|12228539|P3|STARTED|Phase 2||100
4971886|NCT02612909|12228540|P2|STARTED|Phase 2||100
4971887|NCT02612909|12228541|P1|STARTED|Phase 2||100
4971888|NCT02612857|12228609|P3|NOT COMPLETED|Overall Study||4
4971889|NCT02612857|12228610|P2|NOT COMPLETED|Overall Study||4
4971890|NCT02612857|12228611|P1|NOT COMPLETED|Overall Study||3
4971891|NCT02612857|12228609|P3|COMPLETED|Overall Study||6
4971892|NCT02612857|12228610|P2|COMPLETED|Overall Study||5
4971893|NCT02612857|12228611|P1|COMPLETED|Overall Study||8
4971894|NCT02612857|12228609|P3|STARTED|Overall Study||10
4971895|NCT02612857|12228610|P2|STARTED|Overall Study||9
4971896|NCT02612857|12228611|P1|STARTED|Overall Study||11
4971897|NCT02612727|12228624|P2|NOT COMPLETED|Overall Study||4
4971898|NCT02612727|12228625|P1|NOT COMPLETED|Overall Study||5
4971899|NCT02612727|12228624|P2|COMPLETED|Overall Study||83
4971900|NCT02612727|12228625|P1|COMPLETED|Overall Study||82
4971901|NCT02612727|12228624|P2|STARTED|Overall Study||87
4971902|NCT02612727|12228625|P1|STARTED|Overall Study||87
4971903|NCT02612688|12228635|P2|NOT COMPLETED|Overall Study||0
4971904|NCT02612688|12228636|P1|NOT COMPLETED|Overall Study||0
4971905|NCT02612688|12228635|P2|COMPLETED|Overall Study||70013
4971906|NCT02612688|12228636|P1|COMPLETED|Overall Study||33035
4971907|NCT02612688|12228635|P2|STARTED|Overall Study||70013
4971908|NCT02612688|12228636|P1|STARTED|Overall Study||33035
4971909|NCT02612623|12228676|P4|NOT COMPLETED|Overall Study||0
4971910|NCT02612623|12228677|P3|NOT COMPLETED|Overall Study||1
4971911|NCT02612623|12228678|P2|NOT COMPLETED|Overall Study||1
4971912|NCT02612623|12228679|P1|NOT COMPLETED|Overall Study||1
4971913|NCT02612623|12228676|P4|COMPLETED|Overall Study||4
4971914|NCT02612623|12228677|P3|COMPLETED|Overall Study||5
4971915|NCT02612623|12228678|P2|COMPLETED|Overall Study||5
4971916|NCT02612623|12228679|P1|COMPLETED|Overall Study||7
4971917|NCT02612623|12228676|P4|Treated|Overall Study||4
4971918|NCT02612623|12228677|P3|Treated|Overall Study||6
4971919|NCT02612623|12228678|P2|Treated|Overall Study||5
4971920|NCT02612623|12228679|P1|Treated|Overall Study||8
4971921|NCT02612623|12228676|P4|STARTED|Overall Study||4
4971922|NCT02612623|12228677|P3|STARTED|Overall Study||6
4971923|NCT02612623|12228678|P2|STARTED|Overall Study||6
4971924|NCT02612623|12228679|P1|STARTED|Overall Study||8
4971925|NCT02612610|12228693|P4|NOT COMPLETED|Overall Study||13
4971926|NCT02612610|12228694|P3|NOT COMPLETED|Overall Study||5
4971927|NCT02612610|12228695|P2|NOT COMPLETED|Overall Study||8
4971928|NCT02612610|12228696|P1|NOT COMPLETED|Overall Study||5
4971929|NCT02612610|12228693|P4|COMPLETED|Overall Study||50
4971930|NCT02612610|12228694|P3|COMPLETED|Overall Study||58
4971931|NCT02612610|12228695|P2|COMPLETED|Overall Study||56
4971932|NCT02612610|12228696|P1|COMPLETED|Overall Study||58
4971933|NCT02612610|12228693|P4|Treated|Overall Study||63
4971934|NCT02612610|12228694|P3|Treated|Overall Study||63
4971935|NCT02612610|12228695|P2|Treated|Overall Study||63
4971936|NCT02612610|12228696|P1|Treated|Overall Study||63
4971937|NCT02612610|12228693|P4|STARTED|Overall Study||63
4971938|NCT02612610|12228694|P3|STARTED|Overall Study||63
4971939|NCT02612610|12228695|P2|STARTED|Overall Study||64
4971940|NCT02612610|12228696|P1|STARTED|Overall Study||63
4971941|NCT02612428|12228940|P2|NOT COMPLETED|VTL-308E||7
4971942|NCT02612428|12228941|P1|NOT COMPLETED|VTL-308E||11
4971943|NCT02612428|12228940|P2|COMPLETED|VTL-308E||49
4971944|NCT02612428|12228941|P1|COMPLETED|VTL-308E||53
4971945|NCT02612428|12228940|P2|STARTED|VTL-308E||56
4971946|NCT02612428|12228941|P1|STARTED|VTL-308E||64
4971947|NCT02612428|12228940|P2|NOT COMPLETED|VTL-308||17
4971948|NCT02612428|12228941|P1|NOT COMPLETED|VTL-308||14
4971949|NCT02612428|12228940|P2|COMPLETED|VTL-308||56
4971950|NCT02612428|12228941|P1|COMPLETED|VTL-308||64
4971951|NCT02612428|12228940|P2|STARTED|VTL-308||73
4971952|NCT02612428|12228941|P1|STARTED|VTL-308||78
4971953|NCT02612285|12228951|P1|NOT COMPLETED|Overall Study||1
4971954|NCT02612285|12228951|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
4971955|NCT02612285|12228951|P1|STARTED|Overall Study||1
4971956|NCT02612077|12228955|P1|NOT COMPLETED|Overall Study||466
4971957|NCT02612077|12228955|P1|COMPLETED|Overall Study||299
4971958|NCT02612077|12228955|P1|Efficacy Analysis Set|Overall Study||737
4971959|NCT02612077|12228955|P1|Safety Analysis Set|Overall Study||760
4971960|NCT02612077|12228955|P1|Did Not Receive Study Product|Overall Study||5
4971961|NCT02612077|12228955|P1|STARTED|Overall Study||765
4971962|NCT02612064|12228967|P2|NOT COMPLETED|Overall Study||3
4971963|NCT02612064|12228968|P1|NOT COMPLETED|Overall Study||1
4971964|NCT02612064|12228967|P2|COMPLETED|Overall Study||112
4971965|NCT02612064|12228968|P1|COMPLETED|Overall Study||114
4971966|NCT02612064|12228967|P2|STARTED|Overall Study||115
4971967|NCT02612064|12228968|P1|STARTED|Overall Study||115
4971968|NCT02611830|12228982|P4|NOT COMPLETED|Maintenance Phase||15
4971969|NCT02611830|12228983|P3|NOT COMPLETED|Maintenance Phase||31
4971970|NCT02611830|12228984|P2|NOT COMPLETED|Maintenance Phase||36
4971971|NCT02611830|12228985|P1|NOT COMPLETED|Maintenance Phase||0
4971972|NCT02611830|12228982|P4|COMPLETED|Maintenance Phase||39
4971973|NCT02611830|12228983|P3|COMPLETED|Maintenance Phase||75
4971974|NCT02611830|12228984|P2|COMPLETED|Maintenance Phase||20
4971975|NCT02611830|12228985|P1|COMPLETED|Maintenance Phase||0
4971976|NCT02611830|12228982|P4|STARTED|Maintenance Phase||54
4971977|NCT02611830|12228983|P3|STARTED|Maintenance Phase||106
4971978|NCT02611830|12228984|P2|STARTED|Maintenance Phase||56
4971979|NCT02611830|12228985|P1|STARTED|Maintenance Phase||0
4971980|NCT02611830|12228982|P4|NOT COMPLETED|OL Induction Phase||0
4971981|NCT02611830|12228983|P3|NOT COMPLETED|OL Induction Phase||0
4971982|NCT02611830|12228984|P2|NOT COMPLETED|OL Induction Phase||0
4971983|NCT02611830|12228985|P1|NOT COMPLETED|OL Induction Phase||30
4971984|NCT02611830|12228982|P4|COMPLETED|OL Induction Phase||0
4971985|NCT02611830|12228983|P3|COMPLETED|OL Induction Phase||0
4971986|NCT02611830|12228984|P2|COMPLETED|OL Induction Phase||0
4971987|NCT02611830|12228985|P1|COMPLETED|OL Induction Phase||353
4971988|NCT02611830|12228982|P4|STARTED|OL Induction Phase||0
4971989|NCT02611830|12228983|P3|STARTED|OL Induction Phase||0
4971990|NCT02611830|12228984|P2|STARTED|OL Induction Phase||0
4971991|NCT02611830|12228985|P1|STARTED|OL Induction Phase||383
4971992|NCT02611817|12229009|P3|NOT COMPLETED|Double-blind Maintenance Phase||107
4971993|NCT02611817|12229010|P2|NOT COMPLETED|Double-blind Maintenance Phase||62
4971994|NCT02611817|12229011|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
4971995|NCT02611817|12229009|P3|COMPLETED|Double-blind Maintenance Phase||168
4971996|NCT02611817|12229010|P2|COMPLETED|Double-blind Maintenance Phase||73
4971997|NCT02611817|12229011|P1|COMPLETED|Double-blind Maintenance Phase||0
4971998|NCT02611817|12229009|P3|STARTED|Double-blind Maintenance Phase||275
4971999|NCT02611817|12229010|P2|STARTED|Double-blind Maintenance Phase||135
4972000|NCT02611817|12229011|P1|STARTED|Double-blind Maintenance Phase||0
4972001|NCT02611817|12229009|P3|NOT COMPLETED|Open-label Induction Phase||0
4972002|NCT02611817|12229010|P2|NOT COMPLETED|Open-label Induction Phase||0
4972003|NCT02611817|12229011|P1|NOT COMPLETED|Open-label Induction Phase||50
4972004|NCT02611817|12229009|P3|COMPLETED|Open-label Induction Phase||0
4972005|NCT02611817|12229010|P2|COMPLETED|Open-label Induction Phase||0
4972006|NCT02611817|12229011|P1|COMPLETED|Open-label Induction Phase||594
4972007|NCT02611817|12229009|P3|STARTED|Open-label Induction Phase||0
4972008|NCT02611817|12229010|P2|STARTED|Open-label Induction Phase||0
4972009|NCT02611817|12229011|P1|STARTED|Open-label Induction Phase||644
4972010|NCT02611765|12229026|P2|NOT COMPLETED|Overall Study||6
4972011|NCT02611765|12229027|P1|NOT COMPLETED|Overall Study||2
4972012|NCT02611765|12229026|P2|COMPLETED|Overall Study||29
4972013|NCT02611765|12229027|P1|COMPLETED|Overall Study||27
4972014|NCT02611765|12229026|P2|STARTED|Overall Study||35
4972015|NCT02611765|12229027|P1|STARTED|Overall Study||29
4972016|NCT02611752|12229035|P2|NOT COMPLETED|Overall Study||1
4972017|NCT02611752|12229036|P1|NOT COMPLETED|Overall Study||0
4972018|NCT02611752|12229035|P2|COMPLETED|Overall Study||24
4972019|NCT02611752|12229036|P1|COMPLETED|Overall Study||22
4972020|NCT02611752|12229035|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
4972021|NCT02611752|12229036|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
4972022|NCT02611752|12229035|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
4972023|NCT02611752|12229036|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
4972024|NCT02611752|12229035|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
4972025|NCT02611752|12229036|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
4972026|NCT02611752|12229035|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
4972027|NCT02611752|12229036|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
4972028|NCT02611752|12229035|P2|STARTED|Overall Study||25
4972029|NCT02611752|12229036|P1|STARTED|Overall Study||22
4972030|NCT02611479|12229068|P1|NOT COMPLETED|Data Cleaning||2
4972031|NCT02611479|12229068|P1|COMPLETED|Data Cleaning||149
4972032|NCT02611479|12229068|P1|STARTED|Data Cleaning||151
4972033|NCT02611479|12229068|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
4972034|NCT02611479|12229068|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
4972035|NCT02611479|12229068|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
4972036|NCT02611479|12229068|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
4972037|NCT02611479|12229068|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
4972038|NCT02611479|12229068|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
4972039|NCT02611479|12229068|P1|NOT COMPLETED|Baseline Enrollment||13
4972040|NCT02611479|12229068|P1|COMPLETED|Baseline Enrollment||171
4972041|NCT02611479|12229068|P1|STARTED|Baseline Enrollment||184
4972042|NCT02611154|12229072|P1|NOT COMPLETED|Overall Study||0
4972043|NCT02611154|12229072|P1|COMPLETED|Overall Study||5
4972044|NCT02611154|12229072|P1|STARTED|Overall Study||5
4972045|NCT02610972|12229093|P2|NOT COMPLETED|Overall Study||0
4972046|NCT02610972|12229094|P1|NOT COMPLETED|Overall Study||0
4972047|NCT02610972|12229093|P2|COMPLETED|Overall Study||50
4972048|NCT02610972|12229094|P1|COMPLETED|Overall Study||100
4972049|NCT02610972|12229093|P2|STARTED|Overall Study||50
4972050|NCT02610972|12229094|P1|STARTED|Overall Study||100
4972051|NCT02610868|12229100|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
4972052|NCT02610868|12229100|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
4972053|NCT02610868|12229100|P1|STARTED|MYOBLOC: Treatment Session 4||24
4972054|NCT02610868|12229100|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
4972055|NCT02610868|12229100|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
4972056|NCT02610868|12229100|P1|STARTED|MYOBLOC: Treatment Session 3||50
4972057|NCT02610868|12229100|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
4972058|NCT02610868|12229100|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
4972059|NCT02610868|12229100|P1|STARTED|MYOBLOC: Treatment Session 2||177
4972060|NCT02610868|12229100|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
4972061|NCT02610868|12229100|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
4972062|NCT02610868|12229100|P1|STARTED|MYOBLOC: Treatment Session 1||187
4972063|NCT02610842|12229200|P1|NOT COMPLETED|Overall Study||5
4972064|NCT02610842|12229200|P1|COMPLETED|Overall Study||22
4972065|NCT02610842|12229200|P1|STARTED|Overall Study||27
4972066|NCT02610816|12229209|P4|NOT COMPLETED|Phase 2||6
4972067|NCT02610816|12229210|P3|NOT COMPLETED|Phase 2||11
4972068|NCT02610816|12229211|P2|NOT COMPLETED|Phase 2||0
4972069|NCT02610816|12229212|P1|NOT COMPLETED|Phase 2||0
4972070|NCT02610816|12229209|P4|COMPLETED|Phase 2||4
4972071|NCT02610816|12229210|P3|COMPLETED|Phase 2||8
4972072|NCT02610816|12229211|P2|COMPLETED|Phase 2||0
4972073|NCT02610816|12229212|P1|COMPLETED|Phase 2||0
4972074|NCT02610816|12229209|P4|STARTED|Phase 2||10
4972075|NCT02610816|12229210|P3|STARTED|Phase 2||19
4972076|NCT02610816|12229211|P2|STARTED|Phase 2||0
4972077|NCT02610816|12229212|P1|STARTED|Phase 2||0
4972078|NCT02610816|12229209|P4|NOT COMPLETED|Phase 1||0
4972079|NCT02610816|12229210|P3|NOT COMPLETED|Phase 1||0
4972080|NCT02610816|12229211|P2|NOT COMPLETED|Phase 1||8
4972081|NCT02610816|12229212|P1|NOT COMPLETED|Phase 1||4
4972082|NCT02610816|12229209|P4|COMPLETED|Phase 1||0
4972083|NCT02610816|12229210|P3|COMPLETED|Phase 1||0
4972084|NCT02610816|12229211|P2|COMPLETED|Phase 1||17
4972085|NCT02610816|12229212|P1|COMPLETED|Phase 1||34
4972086|NCT02610816|12229209|P4|STARTED|Phase 1||0
4972087|NCT02610816|12229210|P3|STARTED|Phase 1||0
4972088|NCT02610816|12229211|P2|STARTED|Phase 1||25
4972089|NCT02610816|12229212|P1|STARTED|Phase 1||38
4972090|NCT02610725|12229233|P1|NOT COMPLETED|Overall Study||206
4972091|NCT02610725|12229233|P1|COMPLETED|Overall Study||75
4972092|NCT02610725|12229233|P1|STARTED|Overall Study||281
4972093|NCT02610634|12229241|P2|NOT COMPLETED|Overall Study||0
4972094|NCT02610634|12229242|P1|NOT COMPLETED|Overall Study||0
4972095|NCT02610634|12229241|P2|COMPLETED|Overall Study||40
4972096|NCT02610634|12229242|P1|COMPLETED|Overall Study||60
4972097|NCT02610634|12229241|P2|STARTED|Overall Study||40
4972098|NCT02610634|12229242|P1|STARTED|Overall Study||60
4972099|NCT02610231|12229248|P1|NOT COMPLETED|Overall Study||60
4972100|NCT02610231|12229248|P1|COMPLETED|Overall Study||179
4972101|NCT02610231|12229248|P1|STARTED|Overall Study||239
4972102|NCT02610192|12229255|P1|NOT COMPLETED|Overall Study||9
4972103|NCT02610192|12229255|P1|COMPLETED|Overall Study||41
4972104|NCT02610192|12229255|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
4972105|NCT02610140|12229270|P2|NOT COMPLETED|Long-term Follow-up||66
4972106|NCT02610140|12229271|P1|NOT COMPLETED|Long-term Follow-up||123
4972107|NCT02610140|12229270|P2|COMPLETED|Long-term Follow-up||0
4972108|NCT02610140|12229271|P1|COMPLETED|Long-term Follow-up||0
4972109|NCT02610140|12229270|P2|STARTED|Long-term Follow-up||66
4972110|NCT02610140|12229271|P1|STARTED|Long-term Follow-up||123
4972111|NCT02610140|12229270|P2|NOT COMPLETED|Active Follow-up||26
4972112|NCT02610140|12229271|P1|NOT COMPLETED|Active Follow-up||48
4972113|NCT02610140|12229270|P2|COMPLETED|Active Follow-up||0
4972114|NCT02610140|12229271|P1|COMPLETED|Active Follow-up||0
4972115|NCT02610140|12229270|P2|STARTED|Active Follow-up||26
4972116|NCT02610140|12229271|P1|STARTED|Active Follow-up||48
4972117|NCT02610140|12229270|P2|NOT COMPLETED|Safety Follow-up||24
4972118|NCT02610140|12229271|P1|NOT COMPLETED|Safety Follow-up||45
4972119|NCT02610140|12229270|P2|COMPLETED|Safety Follow-up||21
4972120|NCT02610140|12229271|P1|COMPLETED|Safety Follow-up||57
4972121|NCT02610140|12229270|P2|STARTED|Safety Follow-up||45
4972122|NCT02610140|12229271|P1|STARTED|Safety Follow-up||102
4972123|NCT02610140|12229270|P2|NOT COMPLETED|Randomization and Treatment Period||82
4972124|NCT02610140|12229271|P1|NOT COMPLETED|Randomization and Treatment Period||166
4972125|NCT02610140|12229270|P2|COMPLETED|Randomization and Treatment Period||0
4972126|NCT02610140|12229271|P1|COMPLETED|Randomization and Treatment Period||0
4972127|NCT02610140|12229270|P2|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
4972128|NCT02610140|12229271|P1|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
4972129|NCT02610140|12229270|P2|STARTED|Randomization and Treatment Period||82
4972130|NCT02610140|12229271|P1|STARTED|Randomization and Treatment Period||166
4972131|NCT02609984|12229301|P2|NOT COMPLETED|Overall Study||39
4972132|NCT02609984|12229302|P1|NOT COMPLETED|Overall Study||44
4972133|NCT02609984|12229301|P2|COMPLETED|Overall Study||5
4972134|NCT02609984|12229302|P1|COMPLETED|Overall Study||1
4972135|NCT02609984|12229301|P2|Treated|Overall Study||43
4972136|NCT02609984|12229302|P1|Treated|Overall Study||45
4972137|NCT02609984|12229301|P2|STARTED|Overall Study||44
4972138|NCT02609984|12229302|P1|STARTED|Overall Study||45
4972139|NCT02609841|12229336|P1|NOT COMPLETED|Overall Study||28
4972140|NCT02609841|12229336|P1|COMPLETED|Overall Study||212
4972141|NCT02609841|12229336|P1|STARTED|Overall Study||240
4972142|NCT02609672|12229344|P2|NOT COMPLETED|Overall Study||1
4972143|NCT02609672|12229345|P1|NOT COMPLETED|Overall Study||3
4972144|NCT02609672|12229344|P2|COMPLETED|Overall Study||11
4972145|NCT02609672|12229345|P1|COMPLETED|Overall Study||9
4972146|NCT02609672|12229344|P2|STARTED|Overall Study||12
4972147|NCT02609672|12229345|P1|STARTED|Overall Study||12
4972148|NCT02609659|12229379|P1|NOT COMPLETED|Overall Study||8
4972149|NCT02609659|12229379|P1|COMPLETED|Overall Study||97
4972150|NCT02609659|12229379|P1|STARTED|Overall Study||105
4972151|NCT02609633|12229389|P2|NOT COMPLETED|Overall Study||2
4972152|NCT02609633|12229390|P1|NOT COMPLETED|Overall Study||5
4972153|NCT02609633|12229389|P2|COMPLETED|Overall Study||54
4972154|NCT02609633|12229390|P1|COMPLETED|Overall Study||37
4972155|NCT02609633|12229389|P2|Full Analysis Set (FAS)|Overall Study||46
4972156|NCT02609633|12229390|P1|Full Analysis Set (FAS)|Overall Study||32
4972157|NCT02609633|12229389|P2|STARTED|Overall Study||56
4972158|NCT02609633|12229390|P1|STARTED|Overall Study||42
4972159|NCT02609607|12229417|P2|NOT COMPLETED|Overall Study||1
4972160|NCT02609607|12229418|P1|NOT COMPLETED|Overall Study||0
4972161|NCT02609607|12229417|P2|COMPLETED|Overall Study||4
4972162|NCT02609607|12229418|P1|COMPLETED|Overall Study||6
4972163|NCT02609607|12229417|P2|STARTED|Overall Study||5
4972164|NCT02609607|12229418|P1|STARTED|Overall Study||6
4972165|NCT02609399|12229442|P2|NOT COMPLETED|Influenza Season 2016-2017||5
4972166|NCT02609399|12229443|P1|NOT COMPLETED|Influenza Season 2016-2017||9
4972167|NCT02609399|12229442|P2|COMPLETED|Influenza Season 2016-2017||59
4972168|NCT02609399|12229443|P1|COMPLETED|Influenza Season 2016-2017||49
4972169|NCT02609399|12229442|P2|STARTED|Influenza Season 2016-2017||64
4972170|NCT02609399|12229443|P1|STARTED|Influenza Season 2016-2017||58
4972171|NCT02609399|12229442|P2|NOT COMPLETED|Influenza Season 2015-2016||2
4972172|NCT02609399|12229443|P1|NOT COMPLETED|Influenza Season 2015-2016||3
4972173|NCT02609399|12229442|P2|COMPLETED|Influenza Season 2015-2016||29
4972174|NCT02609399|12229443|P1|COMPLETED|Influenza Season 2015-2016||24
4972175|NCT02609399|12229442|P2|STARTED|Influenza Season 2015-2016||31
4972176|NCT02609399|12229443|P1|STARTED|Influenza Season 2015-2016||27
4972177|NCT02609308|12229457|P2|NOT COMPLETED|Overall Study||0
4972178|NCT02609308|12229458|P1|NOT COMPLETED|Overall Study||0
4972179|NCT02609308|12229457|P2|COMPLETED|Overall Study||11
4972180|NCT02609308|12229458|P1|COMPLETED|Overall Study||10
4972181|NCT02609308|12229457|P2|STARTED|Overall Study||11
4972182|NCT02609308|12229458|P1|STARTED|Overall Study||10
4972183|NCT02609204|12229468|P1|NOT COMPLETED|Overall Study||0
4972184|NCT02609204|12229468|P1|COMPLETED|Overall Study||51
4972185|NCT02609204|12229468|P1|STARTED|Overall Study||51
4972186|NCT02609178|12229473|P6|NOT COMPLETED|Third Crown||0
4972187|NCT02609178|12229474|P5|NOT COMPLETED|Third Crown||0
4972188|NCT02609178|12229475|P4|NOT COMPLETED|Third Crown||0
4972189|NCT02609178|12229476|P3|NOT COMPLETED|Third Crown||0
4972190|NCT02609178|12229477|P2|NOT COMPLETED|Third Crown||0
4972191|NCT02609178|12229478|P1|NOT COMPLETED|Third Crown||0
4972192|NCT02609178|12229473|P6|COMPLETED|Third Crown||2
4972193|NCT02609178|12229474|P5|COMPLETED|Third Crown||0
4972194|NCT02609178|12229475|P4|COMPLETED|Third Crown||2
4972195|NCT02609178|12229476|P3|COMPLETED|Third Crown||5
4972196|NCT02609178|12229477|P2|COMPLETED|Third Crown||1
4972197|NCT02609178|12229478|P1|COMPLETED|Third Crown||0
4972198|NCT02609178|12229473|P6|STARTED|Third Crown||2
4972199|NCT02609178|12229474|P5|STARTED|Third Crown||0
4972200|NCT02609178|12229475|P4|STARTED|Third Crown||2
4972201|NCT02609178|12229476|P3|STARTED|Third Crown||5
4972202|NCT02609178|12229477|P2|STARTED|Third Crown||1
4972203|NCT02609178|12229478|P1|STARTED|Third Crown||0
4972204|NCT02609178|12229473|P6|NOT COMPLETED|5-minute Washout Time||0
4972205|NCT02609178|12229474|P5|NOT COMPLETED|5-minute Washout Time||0
4972206|NCT02609178|12229475|P4|NOT COMPLETED|5-minute Washout Time||0
4972207|NCT02609178|12229476|P3|NOT COMPLETED|5-minute Washout Time||0
4972208|NCT02609178|12229477|P2|NOT COMPLETED|5-minute Washout Time||0
4972209|NCT02609178|12229478|P1|NOT COMPLETED|5-minute Washout Time||0
4972210|NCT02609178|12229473|P6|COMPLETED|5-minute Washout Time||2
4972211|NCT02609178|12229474|P5|COMPLETED|5-minute Washout Time||0
4972212|NCT02609178|12229475|P4|COMPLETED|5-minute Washout Time||2
4972213|NCT02609178|12229476|P3|COMPLETED|5-minute Washout Time||5
4972214|NCT02609178|12229477|P2|COMPLETED|5-minute Washout Time||1
4972215|NCT02609178|12229478|P1|COMPLETED|5-minute Washout Time||0
4972216|NCT02609178|12229473|P6|STARTED|5-minute Washout Time||2
4972217|NCT02609178|12229474|P5|STARTED|5-minute Washout Time||0
4972218|NCT02609178|12229475|P4|STARTED|5-minute Washout Time||2
4972219|NCT02609178|12229476|P3|STARTED|5-minute Washout Time||5
4972220|NCT02609178|12229477|P2|STARTED|5-minute Washout Time||1
4972221|NCT02609178|12229478|P1|STARTED|5-minute Washout Time||0
4972222|NCT02609178|12229473|P6|NOT COMPLETED|Second Crown||0
4972223|NCT02609178|12229474|P5|NOT COMPLETED|Second Crown||0
4972224|NCT02609178|12229475|P4|NOT COMPLETED|Second Crown||0
4972225|NCT02609178|12229476|P3|NOT COMPLETED|Second Crown||0
4972226|NCT02609178|12229477|P2|NOT COMPLETED|Second Crown||0
4972227|NCT02609178|12229478|P1|NOT COMPLETED|Second Crown||0
4972228|NCT02609178|12229473|P6|COMPLETED|Second Crown||2
4972229|NCT02609178|12229474|P5|COMPLETED|Second Crown||0
4972230|NCT02609178|12229475|P4|COMPLETED|Second Crown||2
4972231|NCT02609178|12229476|P3|COMPLETED|Second Crown||5
4972232|NCT02609178|12229477|P2|COMPLETED|Second Crown||1
4972233|NCT02609178|12229478|P1|COMPLETED|Second Crown||0
4972234|NCT02609178|12229473|P6|STARTED|Second Crown||2
4972235|NCT02609178|12229474|P5|STARTED|Second Crown||0
4972236|NCT02609178|12229475|P4|STARTED|Second Crown||2
4972237|NCT02609178|12229476|P3|STARTED|Second Crown||5
4972238|NCT02609178|12229477|P2|STARTED|Second Crown||1
4972239|NCT02609178|12229478|P1|STARTED|Second Crown||0
4972240|NCT02609178|12229473|P6|NOT COMPLETED|5-minute Washout Time||0
4972241|NCT02609178|12229474|P5|NOT COMPLETED|5-minute Washout Time||0
4972242|NCT02609178|12229475|P4|NOT COMPLETED|5-minute Washout Time||0
4972243|NCT02609178|12229476|P3|NOT COMPLETED|5-minute Washout Time||0
4972244|NCT02609178|12229477|P2|NOT COMPLETED|5-minute Washout Time||0
4972245|NCT02609178|12229478|P1|NOT COMPLETED|5-minute Washout Time||0
4972246|NCT02609178|12229473|P6|COMPLETED|5-minute Washout Time||2
4972247|NCT02609178|12229474|P5|COMPLETED|5-minute Washout Time||0
4972248|NCT02609178|12229475|P4|COMPLETED|5-minute Washout Time||2
4972249|NCT02609178|12229476|P3|COMPLETED|5-minute Washout Time||5
4972250|NCT02609178|12229477|P2|COMPLETED|5-minute Washout Time||1
4972251|NCT02609178|12229478|P1|COMPLETED|5-minute Washout Time||0
4972252|NCT02609178|12229473|P6|STARTED|5-minute Washout Time||2
4972253|NCT02609178|12229474|P5|STARTED|5-minute Washout Time||0
4972254|NCT02609178|12229475|P4|STARTED|5-minute Washout Time||2
4972255|NCT02609178|12229476|P3|STARTED|5-minute Washout Time||5
4972256|NCT02609178|12229477|P2|STARTED|5-minute Washout Time||1
4972257|NCT02609178|12229478|P1|STARTED|5-minute Washout Time||0
4972258|NCT02609178|12229473|P6|NOT COMPLETED|First Crown||0
4972259|NCT02609178|12229474|P5|NOT COMPLETED|First Crown||0
4972260|NCT02609178|12229475|P4|NOT COMPLETED|First Crown||1
4972261|NCT02609178|12229476|P3|NOT COMPLETED|First Crown||1
4972262|NCT02609178|12229477|P2|NOT COMPLETED|First Crown||0
4972263|NCT02609178|12229478|P1|NOT COMPLETED|First Crown||0
4972264|NCT02609178|12229473|P6|COMPLETED|First Crown||2
4972265|NCT02609178|12229474|P5|COMPLETED|First Crown||0
4972266|NCT02609178|12229475|P4|COMPLETED|First Crown||2
4972267|NCT02609178|12229476|P3|COMPLETED|First Crown||5
4972268|NCT02609178|12229477|P2|COMPLETED|First Crown||1
4972269|NCT02609178|12229478|P1|COMPLETED|First Crown||0
4972270|NCT02609178|12229473|P6|STARTED|First Crown||2
4972271|NCT02609178|12229474|P5|STARTED|First Crown||0
4972272|NCT02609178|12229475|P4|STARTED|First Crown||3
4972273|NCT02609178|12229476|P3|STARTED|First Crown||6
4972274|NCT02609178|12229477|P2|STARTED|First Crown||1
4972275|NCT02609178|12229478|P1|STARTED|First Crown||0
4972276|NCT02609113|12229495|P2|NOT COMPLETED|Overall Study||2
4972277|NCT02609113|12229496|P1|NOT COMPLETED|Overall Study||2
4972278|NCT02609113|12229495|P2|COMPLETED|Overall Study||9
4972279|NCT02609113|12229496|P1|COMPLETED|Overall Study||9
4972280|NCT02609113|12229495|P2|STARTED|Overall Study||11
4972281|NCT02609113|12229496|P1|STARTED|Overall Study||11
4972282|NCT02609100|12229510|P2|NOT COMPLETED|Overall Study||0
4972283|NCT02609100|12229511|P1|NOT COMPLETED|Overall Study||0
4972284|NCT02609100|12229510|P2|COMPLETED|Overall Study||2
4972285|NCT02609100|12229511|P1|COMPLETED|Overall Study||2
4972286|NCT02609100|12229510|P2|STARTED|Overall Study||2
4972287|NCT02609100|12229511|P1|STARTED|Overall Study||2
4972288|NCT02608905|12229529|P2|NOT COMPLETED|Overall Study||0
4972289|NCT02608905|12229530|P1|NOT COMPLETED|Overall Study||2
4972290|NCT02608905|12229529|P2|COMPLETED|Overall Study||10
4972291|NCT02608905|12229530|P1|COMPLETED|Overall Study||5
4972292|NCT02608905|12229529|P2|STARTED|Overall Study||10
4972293|NCT02608905|12229530|P1|STARTED|Overall Study||7
4972294|NCT02608892|12229540|P2|NOT COMPLETED|Overall Study||0
4972295|NCT02608892|12229541|P1|NOT COMPLETED|Overall Study||1
4972296|NCT02608892|12229540|P2|COMPLETED|Overall Study||49
4972297|NCT02608892|12229541|P1|COMPLETED|Overall Study||50
4972298|NCT02608892|12229540|P2|STARTED|Overall Study||49
4972299|NCT02608892|12229541|P1|STARTED|Overall Study||51
4972300|NCT02608684|12229550|P1|NOT COMPLETED|Overall Study||3
4972301|NCT02608684|12229550|P1|COMPLETED|Overall Study||18
4972302|NCT02608684|12229550|P1|STARTED|Overall Study||21
4972303|NCT02608489|12229562|P2|NOT COMPLETED|Overall Study||10
4972304|NCT02608489|12229563|P1|NOT COMPLETED|Overall Study||13
4972305|NCT02608489|12229562|P2|COMPLETED|Overall Study||33
4972306|NCT02608489|12229563|P1|COMPLETED|Overall Study||30
4972307|NCT02608489|12229562|P2|STARTED|Overall Study||43
4972308|NCT02608489|12229563|P1|STARTED|Overall Study||43
4972309|NCT02608229|12229585|P2|NOT COMPLETED|Overall Study||0
4972310|NCT02608229|12229586|P1|NOT COMPLETED|Overall Study||0
4972311|NCT02608229|12229585|P2|COMPLETED|Overall Study||8
4972312|NCT02608229|12229586|P1|COMPLETED|Overall Study||10
4972313|NCT02608229|12229585|P2|450 mg BVD-523|Overall Study||6
4972314|NCT02608229|12229586|P1|450 mg BVD-523|Overall Study||0
4972315|NCT02608229|12229585|P2|600 mg BVD-523|Overall Study||2
4972316|NCT02608229|12229586|P1|600 mg BVD-523|Overall Study||10
4972317|NCT02608229|12229585|P2|STARTED|Overall Study||8
4972318|NCT02608229|12229586|P1|STARTED|Overall Study||10
4972319|NCT02608177|12229604|P2|NOT COMPLETED|Overall Study||0
4972320|NCT02608177|12229605|P1|NOT COMPLETED|Overall Study||0
4972321|NCT02608177|12229604|P2|COMPLETED|Overall Study||1
4972322|NCT02608177|12229605|P1|COMPLETED|Overall Study||2
4972323|NCT02608177|12229604|P2|STARTED|Overall Study||1
4972324|NCT02608177|12229605|P1|STARTED|Overall Study||2
4972325|NCT02608099|12229627|P2|NOT COMPLETED|Overall Study||2
4972326|NCT02608099|12229628|P1|NOT COMPLETED|Overall Study||3
4972327|NCT02608099|12229627|P2|COMPLETED|Overall Study||150
4972328|NCT02608099|12229628|P1|COMPLETED|Overall Study||145
4972329|NCT02608099|12229627|P2|Safety|Overall Study||151
4972330|NCT02608099|12229628|P1|Safety|Overall Study||149
4972331|NCT02608099|12229627|P2|STARTED|Overall Study||152
4972332|NCT02608099|12229628|P1|STARTED|Overall Study||148
4972333|NCT02607956|12229666|P2|NOT COMPLETED|Overall Study||330
4972334|NCT02607956|12229667|P1|NOT COMPLETED|Overall Study||327
4972335|NCT02607956|12229666|P2|COMPLETED|Overall Study||0
4972336|NCT02607956|12229667|P1|COMPLETED|Overall Study||0
4972337|NCT02607956|12229666|P2|STARTED|Overall Study||330
4972338|NCT02607956|12229667|P1|STARTED|Overall Study||327
4972339|NCT02607930|12229697|P2|NOT COMPLETED|Overall Study||315
4972340|NCT02607930|12229698|P1|NOT COMPLETED|Overall Study||316
4972341|NCT02607930|12229697|P2|COMPLETED|Overall Study||0
4972342|NCT02607930|12229698|P1|COMPLETED|Overall Study||0
4972343|NCT02607930|12229697|P2|STARTED|Overall Study||315
4972344|NCT02607930|12229698|P1|STARTED|Overall Study||316
4972345|NCT02607865|12229742|P4|NOT COMPLETED|Overall Study||16
4972346|NCT02607865|12229743|P3|NOT COMPLETED|Overall Study||27
4972347|NCT02607865|12229744|P2|NOT COMPLETED|Overall Study||30
4972348|NCT02607865|12229745|P1|NOT COMPLETED|Overall Study||33
4972349|NCT02607865|12229742|P4|COMPLETED|Overall Study||451
4972350|NCT02607865|12229743|P3|COMPLETED|Overall Study||438
4972351|NCT02607865|12229744|P2|COMPLETED|Overall Study||436
4972352|NCT02607865|12229745|P1|COMPLETED|Overall Study||433
4972353|NCT02607865|12229742|P4|Safety Analysis Set (SAS)|Overall Study||466
4972354|NCT02607865|12229743|P3|Safety Analysis Set (SAS)|Overall Study||465
4972355|NCT02607865|12229744|P2|Safety Analysis Set (SAS)|Overall Study||464
4972356|NCT02607865|12229745|P1|Safety Analysis Set (SAS)|Overall Study||466
4972357|NCT02607865|12229742|P4|Full Analysis Set (FAS)|Overall Study||467
4972358|NCT02607865|12229743|P3|Full Analysis Set (FAS)|Overall Study||465
4972359|NCT02607865|12229744|P2|Full Analysis Set (FAS)|Overall Study||465
4972360|NCT02607865|12229745|P1|Full Analysis Set (FAS)|Overall Study||466
4972361|NCT02607865|12229742|P4|STARTED|Overall Study||467
4972362|NCT02607865|12229743|P3|STARTED|Overall Study||465
4972363|NCT02607865|12229744|P2|STARTED|Overall Study||466
4972364|NCT02607865|12229745|P1|STARTED|Overall Study||466
4972365|NCT02607800|12229919|P2|NOT COMPLETED|Overall Study||11
4972366|NCT02607800|12229920|P1|NOT COMPLETED|Overall Study||10
4972367|NCT02607800|12229919|P2|COMPLETED|Overall Study||430
4972368|NCT02607800|12229920|P1|COMPLETED|Overall Study||492
4972369|NCT02607800|12229919|P2|STARTED|Overall Study||441
4972370|NCT02607800|12229920|P1|STARTED|Overall Study||502
4972371|NCT02607735|12229938|P3|NOT COMPLETED|Deferred Treatment Substudy||5
4972372|NCT02607735|12229939|P2|NOT COMPLETED|Deferred Treatment Substudy||0
4972373|NCT02607735|12229940|P1|NOT COMPLETED|Deferred Treatment Substudy||0
4972374|NCT02607735|12229938|P3|COMPLETED|Deferred Treatment Substudy||142
4972375|NCT02607735|12229939|P2|COMPLETED|Deferred Treatment Substudy||0
4972376|NCT02607735|12229940|P1|COMPLETED|Deferred Treatment Substudy||0
4972377|NCT02607735|12229938|P3|STARTED|Deferred Treatment Substudy||147
4972378|NCT02607735|12229939|P2|STARTED|Deferred Treatment Substudy||0
4972379|NCT02607735|12229940|P1|STARTED|Deferred Treatment Substudy||0
4972380|NCT02607735|12229938|P3|NOT COMPLETED|Primary Study||0
4972381|NCT02607735|12229939|P2|NOT COMPLETED|Primary Study||0
4972382|NCT02607735|12229940|P1|NOT COMPLETED|Primary Study||7
4972383|NCT02607735|12229938|P3|COMPLETED|Primary Study||0
4972384|NCT02607735|12229939|P2|COMPLETED|Primary Study||152
4972385|NCT02607735|12229940|P1|COMPLETED|Primary Study||257
4972386|NCT02607735|12229938|P3|STARTED|Primary Study||0
4972387|NCT02607735|12229939|P2|STARTED|Primary Study||152
4972388|NCT02607735|12229940|P1|STARTED|Primary Study||264
4972389|NCT02607618|12229962|P2|NOT COMPLETED|Overall Study||2
4972390|NCT02607618|12229963|P1|NOT COMPLETED|Overall Study||11
4972391|NCT02607618|12229962|P2|COMPLETED|Overall Study||305
4972392|NCT02607618|12229963|P1|COMPLETED|Overall Study||295
4972393|NCT02607618|12229962|P2|STARTED|Overall Study||307
4972394|NCT02607618|12229963|P1|STARTED|Overall Study||306
4972395|NCT02607306|12229974|P3|NOT COMPLETED|Overall Study||10
4972396|NCT02607306|12229975|P2|NOT COMPLETED|Overall Study||23
4972397|NCT02607306|12229976|P1|NOT COMPLETED|Overall Study||21
4972398|NCT02607306|12229974|P3|COMPLETED|Overall Study||263
4972399|NCT02607306|12229975|P2|COMPLETED|Overall Study||248
4972400|NCT02607306|12229976|P1|COMPLETED|Overall Study||254
4972401|NCT02607306|12229974|P3|STARTED|Overall Study||273
4972402|NCT02607306|12229975|P2|STARTED|Overall Study||271
4972403|NCT02607306|12229976|P1|STARTED|Overall Study||275
4972404|NCT02607254|12230099|P3|NOT COMPLETED|Overall Study||0
4972405|NCT02607254|12230100|P2|NOT COMPLETED|Overall Study||0
4972406|NCT02607254|12230101|P1|NOT COMPLETED|Overall Study||0
4972407|NCT02607254|12230099|P3|COMPLETED|Overall Study||5
4972408|NCT02607254|12230100|P2|COMPLETED|Overall Study||3
4972409|NCT02607254|12230101|P1|COMPLETED|Overall Study||3
4972410|NCT02607254|12230099|P3|STARTED|Overall Study||5
4972411|NCT02607254|12230100|P2|STARTED|Overall Study||3
4972412|NCT02607254|12230101|P1|STARTED|Overall Study||3
4972413|NCT02606903|12230120|P2|NOT COMPLETED|Overall Study||0
4972414|NCT02606903|12230121|P1|NOT COMPLETED|Overall Study||0
4972415|NCT02606903|12230120|P2|COMPLETED|Overall Study||36
4972416|NCT02606903|12230121|P1|COMPLETED|Overall Study||35
4972417|NCT02606903|12230120|P2|STARTED|Overall Study||36
4972418|NCT02606903|12230121|P1|STARTED|Overall Study||35
4972419|NCT02606877|12230135|P2|NOT COMPLETED|Overall Study||1
4972420|NCT02606877|12230136|P1|NOT COMPLETED|Overall Study||4
4972421|NCT02606877|12230135|P2|COMPLETED|Overall Study||16
4972422|NCT02606877|12230136|P1|COMPLETED|Overall Study||16
4972423|NCT02606877|12230135|P2|STARTED|Overall Study||17
4972424|NCT02606877|12230136|P1|STARTED|Overall Study||20
4972425|NCT02606838|12230150|P1|NOT COMPLETED|Overall Study||0
4972426|NCT02606838|12230150|P1|COMPLETED|Overall Study||119
4972427|NCT02606838|12230150|P1|STARTED|Overall Study||119
4972428|NCT02606734|12230158|P1|NOT COMPLETED|Overall Study||0
4972429|NCT02606734|12230158|P1|COMPLETED|Overall Study||44
4972430|NCT02606734|12230158|P1|STARTED|Overall Study||44
4972431|NCT02606643|12230164|P2|NOT COMPLETED|Overall Study||3
4972432|NCT02606643|12230165|P1|NOT COMPLETED|Overall Study||1
4972433|NCT02606643|12230164|P2|COMPLETED|Overall Study||73
4972434|NCT02606643|12230165|P1|COMPLETED|Overall Study||67
4972435|NCT02606643|12230164|P2|STARTED|Overall Study||76
4972436|NCT02606643|12230165|P1|STARTED|Overall Study||68
4972437|NCT02606604|12230177|P2|NOT COMPLETED|Overall Study||0
4972438|NCT02606604|12230178|P1|NOT COMPLETED|Overall Study||1
4972439|NCT02606604|12230177|P2|COMPLETED|Overall Study||7
4972440|NCT02606604|12230178|P1|COMPLETED|Overall Study||7
4972441|NCT02606604|12230177|P2|STARTED|Overall Study||7
4972442|NCT02606604|12230178|P1|STARTED|Overall Study||8
4972443|NCT02606500|12230204|P2|NOT COMPLETED|Overall Study||0
4972444|NCT02606500|12230205|P1|NOT COMPLETED|Overall Study||0
4972445|NCT02606500|12230204|P2|COMPLETED|Overall Study||35
4972446|NCT02606500|12230205|P1|COMPLETED|Overall Study||35
4972447|NCT02606500|12230204|P2|STARTED|Overall Study||35
4972448|NCT02606500|12230205|P1|STARTED|Overall Study||35
4972449|NCT02606279|12230223|P2|NOT COMPLETED|Overall Study||1
4972450|NCT02606279|12230224|P1|NOT COMPLETED|Overall Study||0
4972451|NCT02606279|12230223|P2|COMPLETED|Overall Study||0
4972452|NCT02606279|12230224|P1|COMPLETED|Overall Study||0
4972453|NCT02606279|12230223|P2|STARTED|Overall Study||1
4972454|NCT02606279|12230224|P1|STARTED|Overall Study||0
4972455|NCT02606253|12230239|P3|NOT COMPLETED|Overall Study||0
4972456|NCT02606253|12230240|P2|NOT COMPLETED|Overall Study||2
4972457|NCT02606253|12230241|P1|NOT COMPLETED|Overall Study||5
4972458|NCT02606253|12230239|P3|COMPLETED|Overall Study||20
4972459|NCT02606253|12230240|P2|COMPLETED|Overall Study||18
4972460|NCT02606253|12230241|P1|COMPLETED|Overall Study||15
4972461|NCT02606253|12230239|P3|STARTED|Overall Study||20
4972462|NCT02606253|12230240|P2|STARTED|Overall Study||20
4972463|NCT02606253|12230241|P1|STARTED|Overall Study||20
4972464|NCT02605993|12230304|P4|NOT COMPLETED|Extension Period||7
4972465|NCT02605993|12230305|P3|NOT COMPLETED|Extension Period||7
4972466|NCT02605993|12230306|P2|NOT COMPLETED|Extension Period||6
4972467|NCT02605993|12230307|P1|NOT COMPLETED|Extension Period||6
4972468|NCT02605993|12230304|P4|COMPLETED|Extension Period||0
4972469|NCT02605993|12230305|P3|COMPLETED|Extension Period||0
4972470|NCT02605993|12230306|P2|COMPLETED|Extension Period||0
4972471|NCT02605993|12230307|P1|COMPLETED|Extension Period||0
4972472|NCT02605993|12230304|P4|STARTED|Extension Period||7
4972473|NCT02605993|12230305|P3|STARTED|Extension Period||7
4972474|NCT02605993|12230306|P2|STARTED|Extension Period||6
4972475|NCT02605993|12230307|P1|STARTED|Extension Period||6
4972476|NCT02605993|12230304|P4|NOT COMPLETED|Treatment Period||0
4972477|NCT02605993|12230305|P3|NOT COMPLETED|Treatment Period||0
4972478|NCT02605993|12230306|P2|NOT COMPLETED|Treatment Period||0
4972479|NCT02605993|12230307|P1|NOT COMPLETED|Treatment Period||0
4972480|NCT02605993|12230304|P4|COMPLETED|Treatment Period||7
4972481|NCT02605993|12230305|P3|COMPLETED|Treatment Period||7
4972482|NCT02605993|12230306|P2|COMPLETED|Treatment Period||6
4972483|NCT02605993|12230307|P1|COMPLETED|Treatment Period||6
4972484|NCT02605993|12230304|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
4972485|NCT02605993|12230305|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
4972486|NCT02605993|12230306|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
4972487|NCT02605993|12230307|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
4972488|NCT02605993|12230304|P4|STARTED|Treatment Period||7
4972489|NCT02605993|12230305|P3|STARTED|Treatment Period||7
4972490|NCT02605993|12230306|P2|STARTED|Treatment Period||6
4972491|NCT02605993|12230307|P1|STARTED|Treatment Period||6
4972492|NCT02605954|12230343|P2|NOT COMPLETED|Overall Study||4
4972493|NCT02605954|12230344|P1|NOT COMPLETED|Overall Study||12
4972494|NCT02605954|12230343|P2|COMPLETED|Overall Study||88
4972495|NCT02605954|12230344|P1|COMPLETED|Overall Study||171
4972496|NCT02605954|12230343|P2|STARTED|Overall Study||92
4972497|NCT02605954|12230344|P1|STARTED|Overall Study||183
4972498|NCT02605928|12230361|P1|NOT COMPLETED|Overall Study||33
4972499|NCT02605928|12230361|P1|COMPLETED|Overall Study||46
4972500|NCT02605928|12230361|P1|Pivotal Phase, Statistical Phase|Overall Study||51
4972501|NCT02605928|12230361|P1|STARTED|Overall Study||79
4972502|NCT02605876|12230368|P3|NOT COMPLETED|Overall Study||0
4972503|NCT02605876|12230369|P2|NOT COMPLETED|Overall Study||0
4972504|NCT02605876|12230370|P1|NOT COMPLETED|Overall Study||0
4972505|NCT02605876|12230368|P3|COMPLETED|Overall Study||25
4972506|NCT02605876|12230369|P2|COMPLETED|Overall Study||25
4972507|NCT02605876|12230370|P1|COMPLETED|Overall Study||25
4972508|NCT02605876|12230368|P3|STARTED|Overall Study||25
4972509|NCT02605876|12230369|P2|STARTED|Overall Study||25
4972510|NCT02605876|12230370|P1|STARTED|Overall Study||25
4972511|NCT02605863|12230395|P2|NOT COMPLETED|Overall Study||0
4972512|NCT02605863|12230396|P1|NOT COMPLETED|Overall Study||0
4972513|NCT02605863|12230395|P2|COMPLETED|Overall Study||0
4972514|NCT02605863|12230396|P1|COMPLETED|Overall Study||1
4972515|NCT02605863|12230395|P2|STARTED|Overall Study||0
4972516|NCT02605863|12230396|P1|STARTED|Overall Study||1
4972517|NCT02605837|12230404|P2|NOT COMPLETED|Overall Study||11
4972518|NCT02605837|12230405|P1|NOT COMPLETED|Overall Study||11
4972519|NCT02605837|12230404|P2|COMPLETED|Overall Study||202
4972520|NCT02605837|12230405|P1|COMPLETED|Overall Study||94
4972521|NCT02605837|12230404|P2|STARTED|Overall Study||213
4972522|NCT02605837|12230405|P1|STARTED|Overall Study||105
4972523|NCT02605824|12230444|P2|NOT COMPLETED|Overall Study||0
4972524|NCT02605824|12230445|P1|NOT COMPLETED|Overall Study||1
4972525|NCT02605824|12230444|P2|COMPLETED|Overall Study||0
4972526|NCT02605824|12230445|P1|COMPLETED|Overall Study||0
4972527|NCT02605824|12230444|P2|STARTED|Overall Study||0
4972528|NCT02605824|12230445|P1|STARTED|Overall Study||1
4972529|NCT02605642|12230455|P2|NOT COMPLETED|Overall Study||21
4972530|NCT02605642|12230456|P1|NOT COMPLETED|Overall Study||96
4972531|NCT02605642|12230455|P2|COMPLETED|Overall Study||86
4972532|NCT02605642|12230456|P1|COMPLETED|Overall Study||131
4972533|NCT02605642|12230455|P2|Safety Set|Overall Study||107
4972534|NCT02605642|12230456|P1|Safety Set|Overall Study||221
4972535|NCT02605642|12230455|P2|STARTED|Overall Study||107
4972536|NCT02605642|12230456|P1|STARTED|Overall Study||227
4972537|NCT02605395|12230498|P2|NOT COMPLETED|Period 2, Day 8||0
4972538|NCT02605395|12230499|P1|NOT COMPLETED|Period 2, Day 8||0
4972539|NCT02605395|12230498|P2|COMPLETED|Period 2, Day 8||35
4972540|NCT02605395|12230499|P1|COMPLETED|Period 2, Day 8||35
4972541|NCT02605395|12230498|P2|STARTED|Period 2, Day 8||35
4972542|NCT02605395|12230499|P1|STARTED|Period 2, Day 8||35
4972543|NCT02605395|12230498|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
4972544|NCT02605395|12230499|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
4972545|NCT02605395|12230498|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
4972546|NCT02605395|12230499|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
4972547|NCT02605395|12230498|P2|STARTED|Washout Period, Day 2 to Day 7||35
4972548|NCT02605395|12230499|P1|STARTED|Washout Period, Day 2 to Day 7||35
4972549|NCT02605395|12230498|P2|NOT COMPLETED|Period 1, Day 1||0
4972550|NCT02605395|12230499|P1|NOT COMPLETED|Period 1, Day 1||0
4972551|NCT02605395|12230498|P2|COMPLETED|Period 1, Day 1||35
4972552|NCT02605395|12230499|P1|COMPLETED|Period 1, Day 1||35
4972553|NCT02605395|12230498|P2|STARTED|Period 1, Day 1||35
4972554|NCT02605395|12230499|P1|STARTED|Period 1, Day 1||35
4972555|NCT02605304|12230517|P2|NOT COMPLETED|Overall Study||0
4972556|NCT02605304|12230518|P1|NOT COMPLETED|Overall Study||0
4972557|NCT02605304|12230517|P2|COMPLETED|Overall Study||3
4972558|NCT02605304|12230518|P1|COMPLETED|Overall Study||4
4972559|NCT02605304|12230517|P2|STARTED|Overall Study||3
4972560|NCT02605304|12230518|P1|STARTED|Overall Study||4
4972561|NCT02605187|12230542|P4|NOT COMPLETED|Overall Study||1
4972562|NCT02605187|12230543|P3|NOT COMPLETED|Overall Study||11
4972563|NCT02605187|12230544|P2|NOT COMPLETED|Overall Study||2
4972564|NCT02605187|12230545|P1|NOT COMPLETED|Overall Study||8
4972565|NCT02605187|12230542|P4|COMPLETED|Overall Study||15
4972566|NCT02605187|12230543|P3|COMPLETED|Overall Study||72
4972567|NCT02605187|12230544|P2|COMPLETED|Overall Study||19
4972568|NCT02605187|12230545|P1|COMPLETED|Overall Study||32
4972569|NCT02605187|12230542|P4|STARTED|Overall Study||16
4972570|NCT02605187|12230543|P3|STARTED|Overall Study||83
4972571|NCT02605187|12230544|P2|STARTED|Overall Study||21
4972572|NCT02605187|12230545|P1|STARTED|Overall Study||40
4972573|NCT02605174|12230603|P7|NOT COMPLETED|Overall Study||89
4972574|NCT02605174|12230604|P6|NOT COMPLETED|Overall Study||32
4972575|NCT02605174|12230605|P5|NOT COMPLETED|Overall Study||53
4972576|NCT02605174|12230606|P4|NOT COMPLETED|Overall Study||36
4972577|NCT02605174|12230607|P3|NOT COMPLETED|Overall Study||76
4972578|NCT02605174|12230608|P2|NOT COMPLETED|Overall Study||23
4972579|NCT02605174|12230609|P1|NOT COMPLETED|Overall Study||64
4972580|NCT02605174|12230603|P7|COMPLETED|Overall Study||662
4972581|NCT02605174|12230604|P6|COMPLETED|Overall Study||217
4972582|NCT02605174|12230605|P5|COMPLETED|Overall Study||448
4972583|NCT02605174|12230606|P4|COMPLETED|Overall Study||216
4972584|NCT02605174|12230607|P3|COMPLETED|Overall Study||426
4972585|NCT02605174|12230608|P2|COMPLETED|Overall Study||226
4972586|NCT02605174|12230609|P1|COMPLETED|Overall Study||437
4972587|NCT02605174|12230603|P7|Received Optional 2nd Dose|Overall Study||361
4972588|NCT02605174|12230604|P6|Received Optional 2nd Dose|Overall Study||74
4972589|NCT02605174|12230605|P5|Received Optional 2nd Dose|Overall Study||144
4972590|NCT02605174|12230606|P4|Received Optional 2nd Dose|Overall Study||83
4972591|NCT02605174|12230607|P3|Received Optional 2nd Dose|Overall Study||177
4972592|NCT02605174|12230608|P2|Received Optional 2nd Dose|Overall Study||96
4972593|NCT02605174|12230609|P1|Received Optional 2nd Dose|Overall Study||206
4972594|NCT02605174|12230603|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
4972595|NCT02605174|12230604|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
4972596|NCT02605174|12230605|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
4972597|NCT02605174|12230606|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
4972598|NCT02605174|12230607|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
4972599|NCT02605174|12230608|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
4972600|NCT02605174|12230609|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
4972601|NCT02605174|12230603|P7|STARTED|Overall Study||751
4972602|NCT02605174|12230604|P6|STARTED|Overall Study||249
4972603|NCT02605174|12230605|P5|STARTED|Overall Study||501
4972604|NCT02605174|12230606|P4|STARTED|Overall Study||252
4972605|NCT02605174|12230607|P3|STARTED|Overall Study||502
4972606|NCT02605174|12230608|P2|STARTED|Overall Study||249
4972607|NCT02605174|12230609|P1|STARTED|Overall Study||501
4972608|NCT02605122|12230671|P2|NOT COMPLETED|Overall Study||2
4972609|NCT02605122|12230672|P1|NOT COMPLETED|Overall Study||5
4972610|NCT02605122|12230671|P2|COMPLETED|Overall Study||22
4972611|NCT02605122|12230672|P1|COMPLETED|Overall Study||68
4972612|NCT02605122|12230671|P2|Received Study Drug|Overall Study||24
4972613|NCT02605122|12230672|P1|Received Study Drug|Overall Study||70
4972614|NCT02605122|12230671|P2|STARTED|Overall Study||24
4972615|NCT02605122|12230672|P1|STARTED|Overall Study||73
4972616|NCT02604810|12230684|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
4972617|NCT02604810|12230684|P1|COMPLETED|IGSC 20%, 24 Weeks||42
4972618|NCT02604810|12230684|P1|STARTED|IGSC 20%, 24 Weeks||49
4972619|NCT02604810|12230684|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
4972620|NCT02604810|12230684|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
4972621|NCT02604810|12230684|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
4972622|NCT02604589|12230695|P3|NOT COMPLETED|Overall Study||1
4972623|NCT02604589|12230696|P2|NOT COMPLETED|Overall Study||0
4972624|NCT02604589|12230697|P1|NOT COMPLETED|Overall Study||0
4972625|NCT02604589|12230695|P3|COMPLETED|Overall Study||1
4972626|NCT02604589|12230696|P2|COMPLETED|Overall Study||5
4972627|NCT02604589|12230697|P1|COMPLETED|Overall Study||3
4972628|NCT02604589|12230695|P3|STARTED|Overall Study||2
4972629|NCT02604589|12230696|P2|STARTED|Overall Study||5
4972630|NCT02604589|12230697|P1|STARTED|Overall Study||3
4972631|NCT02604550|12230725|P2|NOT COMPLETED|Overall Study||26
4972632|NCT02604550|12230726|P1|NOT COMPLETED|Overall Study||25
4972633|NCT02604550|12230725|P2|COMPLETED|Overall Study||33
4972634|NCT02604550|12230726|P1|COMPLETED|Overall Study||31
4972635|NCT02604550|12230725|P2|STARTED|Overall Study||59
4972636|NCT02604550|12230726|P1|STARTED|Overall Study||56
4972637|NCT02604433|12230752|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
4972638|NCT02604433|12230753|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
4972639|NCT02604433|12230752|P2|COMPLETED|Post Treatment Follow-up Period||0
4972640|NCT02604433|12230753|P1|COMPLETED|Post Treatment Follow-up Period||0
4972641|NCT02604433|12230752|P2|STARTED|Post Treatment Follow-up Period||24
4972642|NCT02604433|12230753|P1|STARTED|Post Treatment Follow-up Period||42
4972643|NCT02604433|12230752|P2|NOT COMPLETED|Open-Label Treatment Period||0
4972644|NCT02604433|12230753|P1|NOT COMPLETED|Open-Label Treatment Period||0
4972645|NCT02604433|12230752|P2|COMPLETED|Open-Label Treatment Period||0
4972646|NCT02604433|12230753|P1|COMPLETED|Open-Label Treatment Period||0
4972647|NCT02604433|12230752|P2|STARTED|Open-Label Treatment Period||0
4972648|NCT02604433|12230753|P1|STARTED|Open-Label Treatment Period||0
4972649|NCT02604433|12230752|P2|NOT COMPLETED|Double-blind Treatment Period||106
4972650|NCT02604433|12230753|P1|NOT COMPLETED|Double-blind Treatment Period||218
4972651|NCT02604433|12230752|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
4972652|NCT02604433|12230753|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
4972653|NCT02604433|12230752|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
4972654|NCT02604433|12230753|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
4972655|NCT02604433|12230752|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
4972656|NCT02604433|12230753|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
4972657|NCT02604433|12230752|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
4972658|NCT02604433|12230753|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
4972659|NCT02604433|12230752|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
4972660|NCT02604433|12230753|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
4972661|NCT02604433|12230752|P2|Safety Population|Double-blind Treatment Period||109
4972662|NCT02604433|12230753|P1|Safety Population|Double-blind Treatment Period||223
4972663|NCT02604433|12230752|P2|Intent to Treat Population|Double-blind Treatment Period||112
4972664|NCT02604433|12230753|P1|Intent to Treat Population|Double-blind Treatment Period||224
4972665|NCT02604433|12230752|P2|STARTED|Double-blind Treatment Period||112
4972666|NCT02604433|12230753|P1|STARTED|Double-blind Treatment Period||224
4972667|NCT02604407|12230822|P3|NOT COMPLETED|Overall Study||16
4972668|NCT02604407|12230823|P2|NOT COMPLETED|Overall Study||12
4972669|NCT02604407|12230824|P1|NOT COMPLETED|Overall Study||11
4972670|NCT02604407|12230822|P3|COMPLETED|Overall Study||76
4972671|NCT02604407|12230823|P2|COMPLETED|Overall Study||80
4972672|NCT02604407|12230824|P1|COMPLETED|Overall Study||80
4972673|NCT02604407|12230822|P3|TREATED|Overall Study||90
4972674|NCT02604407|12230823|P2|TREATED|Overall Study||92
4972675|NCT02604407|12230824|P1|TREATED|Overall Study||89
4972676|NCT02604407|12230822|P3|STARTED|Overall Study||92
4972677|NCT02604407|12230823|P2|STARTED|Overall Study||92
4972678|NCT02604407|12230824|P1|STARTED|Overall Study||91
4972679|NCT02604342|12230837|P2|NOT COMPLETED|Overall Study||23
4972680|NCT02604342|12230838|P1|NOT COMPLETED|Overall Study||43
4972681|NCT02604342|12230837|P2|COMPLETED|Overall Study||17
4972682|NCT02604342|12230838|P1|COMPLETED|Overall Study||36
4972683|NCT02604342|12230837|P2|STARTED|Overall Study||40
4972684|NCT02604342|12230838|P1|STARTED|Overall Study||79
4972685|NCT02604264|12230890|P2|NOT COMPLETED|Intervention||242
4972686|NCT02604264|12230891|P1|NOT COMPLETED|Intervention||200
4972687|NCT02604264|12230890|P2|COMPLETED|Intervention||1225
4972688|NCT02604264|12230891|P1|COMPLETED|Intervention||1245
4972689|NCT02604264|12230890|P2|STARTED|Intervention||1467
4972690|NCT02604264|12230891|P1|STARTED|Intervention||1445
4972691|NCT02604264|12230890|P2|NOT COMPLETED|Run-In||0
4972692|NCT02604264|12230891|P1|NOT COMPLETED|Run-In||0
4972693|NCT02604264|12230890|P2|COMPLETED|Run-In||611
4972694|NCT02604264|12230891|P1|COMPLETED|Run-In||618
4972695|NCT02604264|12230890|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
4972696|NCT02604264|12230891|P1|STARTED|Run-In||618
4972697|NCT02604212|12230901|P4|NOT COMPLETED|Overall Study||3
4972698|NCT02604212|12230902|P3|NOT COMPLETED|Overall Study||4
4972699|NCT02604212|12230903|P2|NOT COMPLETED|Overall Study||1
4972700|NCT02604212|12230904|P1|NOT COMPLETED|Overall Study||2
4972701|NCT02604212|12230901|P4|COMPLETED|Overall Study||8
4972702|NCT02604212|12230902|P3|COMPLETED|Overall Study||6
4972703|NCT02604212|12230903|P2|COMPLETED|Overall Study||4
4972704|NCT02604212|12230904|P1|COMPLETED|Overall Study||4
4972705|NCT02604212|12230901|P4|STARTED|Overall Study||11
4972706|NCT02604212|12230902|P3|STARTED|Overall Study||10
4972707|NCT02604212|12230903|P2|STARTED|Overall Study||5
4972708|NCT02604212|12230904|P1|STARTED|Overall Study||6
4972709|NCT02604199|12230972|P4|NOT COMPLETED|Overall Study||3
4972710|NCT02604199|12230973|P3|NOT COMPLETED|Overall Study||0
4972711|NCT02604199|12230974|P2|NOT COMPLETED|Overall Study||3
4972712|NCT02604199|12230975|P1|NOT COMPLETED|Overall Study||0
4972713|NCT02604199|12230972|P4|COMPLETED|Overall Study||18
4972714|NCT02604199|12230973|P3|COMPLETED|Overall Study||17
4972715|NCT02604199|12230974|P2|COMPLETED|Overall Study||8
4972716|NCT02604199|12230975|P1|COMPLETED|Overall Study||9
4972717|NCT02604199|12230972|P4|STARTED|Overall Study||21
4972718|NCT02604199|12230973|P3|STARTED|Overall Study||17
4972719|NCT02604199|12230974|P2|STARTED|Overall Study||11
4972720|NCT02604199|12230975|P1|STARTED|Overall Study||9
4972721|NCT02604173|12231026|P3|NOT COMPLETED|Overall Study||0
4972722|NCT02604173|12231027|P2|NOT COMPLETED|Overall Study||0
4972723|NCT02604173|12231028|P1|NOT COMPLETED|Overall Study||0
4972724|NCT02604173|12231026|P3|COMPLETED|Overall Study||35
4972725|NCT02604173|12231027|P2|COMPLETED|Overall Study||35
4972726|NCT02604173|12231028|P1|COMPLETED|Overall Study||33
4972727|NCT02604173|12231026|P3|STARTED|Overall Study||35
4972728|NCT02604173|12231027|P2|STARTED|Overall Study||35
4972729|NCT02604173|12231028|P1|STARTED|Overall Study||33
4972730|NCT02604160|12231044|P2|NOT COMPLETED|Overall Study||2
4972731|NCT02604160|12231045|P1|NOT COMPLETED|Overall Study||0
4972732|NCT02604160|12231044|P2|COMPLETED|Overall Study||3
4972733|NCT02604160|12231045|P1|COMPLETED|Overall Study||2
4972734|NCT02604160|12231044|P2|Received at Least One Dose of Study Drug|Overall Study||5
4972735|NCT02604160|12231045|P1|Received at Least One Dose of Study Drug|Overall Study||2
4972736|NCT02604160|12231044|P2|STARTED|Overall Study||5
4972737|NCT02604160|12231045|P1|STARTED|Overall Study||2
4972738|NCT02604017|12231059|P2|NOT COMPLETED|Overall Study||8
4972739|NCT02604017|12231060|P1|NOT COMPLETED|Overall Study||6
4972740|NCT02604017|12231059|P2|COMPLETED|Overall Study||343
4972741|NCT02604017|12231060|P1|COMPLETED|Overall Study||346
4972742|NCT02604017|12231059|P2|STARTED|Overall Study||351
4972743|NCT02604017|12231060|P1|STARTED|Overall Study||352
4972744|NCT02603952|12231089|P4|NOT COMPLETED|Overall Study||1
4972745|NCT02603952|12231090|P3|NOT COMPLETED|Overall Study||0
4972746|NCT02603952|12231091|P2|NOT COMPLETED|Overall Study||0
4972747|NCT02603952|12231092|P1|NOT COMPLETED|Overall Study||1
4972748|NCT02603952|12231089|P4|COMPLETED|Overall Study||31
4972749|NCT02603952|12231090|P3|COMPLETED|Overall Study||31
4972750|NCT02603952|12231091|P2|COMPLETED|Overall Study||31
4972751|NCT02603952|12231092|P1|COMPLETED|Overall Study||31
4972752|NCT02603952|12231089|P4|Treated|Overall Study||31
4972753|NCT02603952|12231090|P3|Treated|Overall Study||31
4972754|NCT02603952|12231091|P2|Treated|Overall Study||31
4972755|NCT02603952|12231092|P1|Treated|Overall Study||32
4972756|NCT02603952|12231089|P4|STARTED|Overall Study||32
4972757|NCT02603952|12231090|P3|STARTED|Overall Study||31
4972758|NCT02603952|12231091|P2|STARTED|Overall Study||31
4972759|NCT02603952|12231092|P1|STARTED|Overall Study||32
4972760|NCT02603926|12231133|P1|NOT COMPLETED|Overall Study||0
4972761|NCT02603926|12231133|P1|COMPLETED|Overall Study||6
4972762|NCT02603926|12231133|P1|STARTED|Overall Study||6
4972763|NCT02603887|12231140|P1|NOT COMPLETED|Overall Study||6
4972764|NCT02603887|12231140|P1|COMPLETED|Overall Study||7
4972765|NCT02603887|12231140|P1|Cycle 8|Overall Study||7
4972766|NCT02603887|12231140|P1|Cycle 1|Overall Study||13
4972767|NCT02603887|12231140|P1|STARTED|Overall Study||13
4972768|NCT02603809|12231153|P6|NOT COMPLETED|Overall Study||10
4972769|NCT02603809|12231154|P5|NOT COMPLETED|Overall Study||11
4972770|NCT02603809|12231155|P4|NOT COMPLETED|Overall Study||12
4972771|NCT02603809|12231156|P3|NOT COMPLETED|Overall Study||7
4972772|NCT02603809|12231157|P2|NOT COMPLETED|Overall Study||8
4972773|NCT02603809|12231158|P1|NOT COMPLETED|Overall Study||12
4972774|NCT02603809|12231153|P6|COMPLETED|Overall Study||71
4972775|NCT02603809|12231154|P5|COMPLETED|Overall Study||70
4972776|NCT02603809|12231155|P4|COMPLETED|Overall Study||70
4972777|NCT02603809|12231156|P3|COMPLETED|Overall Study||75
4972778|NCT02603809|12231157|P2|COMPLETED|Overall Study||74
4972779|NCT02603809|12231158|P1|COMPLETED|Overall Study||70
4972780|NCT02603809|12231153|P6|Completed Study|Overall Study||75
4972781|NCT02603809|12231154|P5|Completed Study|Overall Study||78
4972782|NCT02603809|12231155|P4|Completed Study|Overall Study||76
4972783|NCT02603809|12231156|P3|Completed Study|Overall Study||79
4972784|NCT02603809|12231157|P2|Completed Study|Overall Study||79
4972785|NCT02603809|12231158|P1|Completed Study|Overall Study||75
4972786|NCT02603809|12231153|P6|Modified Per-Protocol Set|Overall Study||69
4972787|NCT02603809|12231154|P5|Modified Per-Protocol Set|Overall Study||68
4972788|NCT02603809|12231155|P4|Modified Per-Protocol Set|Overall Study||67
4972789|NCT02603809|12231156|P3|Modified Per-Protocol Set|Overall Study||71
4972790|NCT02603809|12231157|P2|Modified Per-Protocol Set|Overall Study||68
4972791|NCT02603809|12231158|P1|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
4972792|NCT02603809|12231153|P6|Per-protocol Set|Overall Study||69
4972793|NCT02603809|12231154|P5|Per-protocol Set|Overall Study||68
4972794|NCT02603809|12231155|P4|Per-protocol Set|Overall Study||67
4972795|NCT02603809|12231156|P3|Per-protocol Set|Overall Study||71
4972796|NCT02603809|12231157|P2|Per-protocol Set|Overall Study||68
4972797|NCT02603809|12231158|P1|Per-protocol Set|Overall Study||67
4972798|NCT02603809|12231153|P6|STARTED|Overall Study||81
4972799|NCT02603809|12231154|P5|STARTED|Overall Study||81
4972800|NCT02603809|12231155|P4|STARTED|Overall Study||82
4972801|NCT02603809|12231156|P3|STARTED|Overall Study||82
4972802|NCT02603809|12231157|P2|STARTED|Overall Study||82
4972803|NCT02603809|12231158|P1|STARTED|Overall Study||82
4972804|NCT02603666|12231214|P1|NOT COMPLETED|Overall Study||0
4972805|NCT02603666|12231214|P1|COMPLETED|Overall Study||130
4972806|NCT02603666|12231214|P1|STARTED|Overall Study||130
4972807|NCT02603419|12231224|P6|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
4972808|NCT02603419|12231225|P5|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972809|NCT02603419|12231226|P4|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972810|NCT02603419|12231227|P3|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972811|NCT02603419|12231228|P2|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972812|NCT02603419|12231229|P1|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972813|NCT02603419|12231224|P6|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972814|NCT02603419|12231225|P5|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972815|NCT02603419|12231226|P4|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972816|NCT02603419|12231227|P3|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972817|NCT02603419|12231228|P2|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972818|NCT02603419|12231229|P1|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
4972819|NCT02603419|12231224|P6|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
4972820|NCT02603419|12231225|P5|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
4972821|NCT02603419|12231226|P4|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
4972822|NCT02603419|12231227|P3|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
4972823|NCT02603419|12231228|P2|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
4972824|NCT02603419|12231229|P1|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
4972825|NCT02603419|12231224|P6|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972826|NCT02603419|12231225|P5|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972827|NCT02603419|12231226|P4|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972828|NCT02603419|12231227|P3|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972829|NCT02603419|12231228|P2|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
4972830|NCT02603419|12231229|P1|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972831|NCT02603419|12231224|P6|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972832|NCT02603419|12231225|P5|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972833|NCT02603419|12231226|P4|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972834|NCT02603419|12231227|P3|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972835|NCT02603419|12231228|P2|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972836|NCT02603419|12231229|P1|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972837|NCT02603419|12231224|P6|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
4972838|NCT02603419|12231225|P5|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
4972839|NCT02603419|12231226|P4|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
4972840|NCT02603419|12231227|P3|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
4972841|NCT02603419|12231228|P2|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
4972842|NCT02603419|12231229|P1|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
4972843|NCT02603419|12231224|P6|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
4972844|NCT02603419|12231225|P5|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972845|NCT02603419|12231226|P4|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972846|NCT02603419|12231227|P3|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972847|NCT02603419|12231228|P2|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
4972848|NCT02603419|12231229|P1|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
4972849|NCT02603393|12231416|P2|NOT COMPLETED|Overall Study||54
4972850|NCT02603393|12231417|P1|NOT COMPLETED|Overall Study||71
4972851|NCT02603393|12231416|P2|COMPLETED|Overall Study||472
4972852|NCT02603393|12231417|P1|COMPLETED|Overall Study||456
4972853|NCT02603393|12231416|P2|STARTED|Overall Study||526
4972854|NCT02603393|12231417|P1|STARTED|Overall Study||527
4972855|NCT02603211|12231443|P1|NOT COMPLETED|Overall Study||0
4972856|NCT02603211|12231443|P1|COMPLETED|Overall Study||20
4972857|NCT02603211|12231443|P1|STARTED|Overall Study||20
4972858|NCT02603172|12231456|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972859|NCT02603172|12231457|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972860|NCT02603172|12231458|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972861|NCT02603172|12231459|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972862|NCT02603172|12231460|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972863|NCT02603172|12231461|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972864|NCT02603172|12231462|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972865|NCT02603172|12231463|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
4972866|NCT02603172|12231456|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
4972867|NCT02603172|12231457|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
4972868|NCT02603172|12231458|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
4972869|NCT02603172|12231459|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
4972870|NCT02603172|12231460|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
4972871|NCT02603172|12231461|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
4972872|NCT02603172|12231462|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
4972873|NCT02603172|12231463|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
4972874|NCT02603172|12231456|P8|STARTED|Part C (Approximately 13 Weeks)||0
4972875|NCT02603172|12231457|P7|STARTED|Part C (Approximately 13 Weeks)||0
4972876|NCT02603172|12231458|P6|STARTED|Part C (Approximately 13 Weeks)||0
4972877|NCT02603172|12231459|P5|STARTED|Part C (Approximately 13 Weeks)||0
4972878|NCT02603172|12231460|P4|STARTED|Part C (Approximately 13 Weeks)||0
4972879|NCT02603172|12231461|P3|STARTED|Part C (Approximately 13 Weeks)||0
4972880|NCT02603172|12231462|P2|STARTED|Part C (Approximately 13 Weeks)||0
4972881|NCT02603172|12231463|P1|STARTED|Part C (Approximately 13 Weeks)||0
4972882|NCT02603172|12231456|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972883|NCT02603172|12231457|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972884|NCT02603172|12231458|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972885|NCT02603172|12231459|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972886|NCT02603172|12231460|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972887|NCT02603172|12231461|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972888|NCT02603172|12231462|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972889|NCT02603172|12231463|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
4972890|NCT02603172|12231456|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
4972891|NCT02603172|12231457|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
4972892|NCT02603172|12231458|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
4972893|NCT02603172|12231459|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
4972894|NCT02603172|12231460|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
4972895|NCT02603172|12231461|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
4972896|NCT02603172|12231462|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
4972897|NCT02603172|12231463|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
4972898|NCT02603172|12231456|P8|STARTED|Part B (Approximately 7 Weeks)||0
4972899|NCT02603172|12231457|P7|STARTED|Part B (Approximately 7 Weeks)||0
4972900|NCT02603172|12231458|P6|STARTED|Part B (Approximately 7 Weeks)||0
4972901|NCT02603172|12231459|P5|STARTED|Part B (Approximately 7 Weeks)||6
4972902|NCT02603172|12231460|P4|STARTED|Part B (Approximately 7 Weeks)||1
4972903|NCT02603172|12231461|P3|STARTED|Part B (Approximately 7 Weeks)||0
4972904|NCT02603172|12231462|P2|STARTED|Part B (Approximately 7 Weeks)||1
4972905|NCT02603172|12231463|P1|STARTED|Part B (Approximately 7 Weeks)||0
4972906|NCT02603172|12231456|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972907|NCT02603172|12231457|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972908|NCT02603172|12231458|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972909|NCT02603172|12231459|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972910|NCT02603172|12231460|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972911|NCT02603172|12231461|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
4972912|NCT02603172|12231462|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972913|NCT02603172|12231463|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
4972914|NCT02603172|12231456|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
4972915|NCT02603172|12231457|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
4972916|NCT02603172|12231458|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
4972917|NCT02603172|12231459|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
4972918|NCT02603172|12231460|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
4972919|NCT02603172|12231461|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
4972920|NCT02603172|12231462|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
4972921|NCT02603172|12231463|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
4972922|NCT02603172|12231456|P8|STARTED|Part A (Approximately 16 Weeks)||0
4972923|NCT02603172|12231457|P7|STARTED|Part A (Approximately 16 Weeks)||0
4972924|NCT02603172|12231458|P6|STARTED|Part A (Approximately 16 Weeks)||0
4972925|NCT02603172|12231459|P5|STARTED|Part A (Approximately 16 Weeks)||0
4972926|NCT02603172|12231460|P4|STARTED|Part A (Approximately 16 Weeks)||1
4972927|NCT02603172|12231461|P3|STARTED|Part A (Approximately 16 Weeks)||8
4972928|NCT02603172|12231462|P2|STARTED|Part A (Approximately 16 Weeks)||1
4972929|NCT02603172|12231463|P1|STARTED|Part A (Approximately 16 Weeks)||7
4972930|NCT02603120|12231591|P2|NOT COMPLETED|Overall Study||283
4972931|NCT02603120|12231592|P1|NOT COMPLETED|Overall Study||284
4972932|NCT02603120|12231591|P2|COMPLETED|Overall Study||0
4972933|NCT02603120|12231592|P1|COMPLETED|Overall Study||0
4972934|NCT02603120|12231591|P2|STARTED|Overall Study||283
4972935|NCT02603120|12231592|P1|STARTED|Overall Study||284
4972936|NCT02603107|12231612|P2|NOT COMPLETED|Optional Extension Phase||213
4972937|NCT02603107|12231613|P1|NOT COMPLETED|Optional Extension Phase||241
4972938|NCT02603107|12231612|P2|COMPLETED|Optional Extension Phase||0
4972939|NCT02603107|12231613|P1|COMPLETED|Optional Extension Phase||0
4972940|NCT02603107|12231612|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
4972941|NCT02603107|12231613|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
4972942|NCT02603107|12231612|P2|NOT COMPLETED|Randomized Phase||48
4972943|NCT02603107|12231613|P1|NOT COMPLETED|Randomized Phase||45
4972944|NCT02603107|12231612|P2|COMPLETED|Randomized Phase||240
4972945|NCT02603107|12231613|P1|COMPLETED|Randomized Phase||245
4972946|NCT02603107|12231612|P2|STARTED|Randomized Phase||288
4972947|NCT02603107|12231613|P1|STARTED|Randomized Phase||290
4972948|NCT02602496|12231626|P3|NOT COMPLETED|Overall Study||0
4972949|NCT02602496|12231627|P2|NOT COMPLETED|Overall Study||2
4972950|NCT02602496|12231628|P1|NOT COMPLETED|Overall Study||1
4972951|NCT02602496|12231626|P3|COMPLETED|Overall Study||17
4972952|NCT02602496|12231627|P2|COMPLETED|Overall Study||18
4972953|NCT02602496|12231628|P1|COMPLETED|Overall Study||14
4972954|NCT02602496|12231626|P3|STARTED|Overall Study||17
4972955|NCT02602496|12231627|P2|STARTED|Overall Study||20
4972956|NCT02602496|12231628|P1|STARTED|Overall Study||15
4972957|NCT02602223|12231657|P1|NOT COMPLETED|Overall Study||0
4972958|NCT02602223|12231657|P1|COMPLETED|Overall Study||9
4972959|NCT02602223|12231657|P1|STARTED|Overall Study||9
4972960|NCT02602080|12231676|P3|NOT COMPLETED|Overall Study||3
4972961|NCT02602080|12231677|P2|NOT COMPLETED|Overall Study||1
4972962|NCT02602080|12231678|P1|NOT COMPLETED|Overall Study||6
4972963|NCT02602080|12231676|P3|COMPLETED|Overall Study||15
4972964|NCT02602080|12231677|P2|COMPLETED|Overall Study||15
4972965|NCT02602080|12231678|P1|COMPLETED|Overall Study||15
4972966|NCT02602080|12231676|P3|STARTED|Overall Study||18
4972967|NCT02602080|12231677|P2|STARTED|Overall Study||16
4972968|NCT02602080|12231678|P1|STARTED|Overall Study||21
4972969|NCT02601976|12231713|P1|NOT COMPLETED|Overall Study||0
4972970|NCT02601976|12231713|P1|COMPLETED|Overall Study||64
4972971|NCT02601976|12231713|P1|STARTED|Overall Study||64
4972972|NCT02601820|12231721|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
4972973|NCT02601820|12231721|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
4972974|NCT02601820|12231721|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
4972975|NCT02601820|12231721|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
4972976|NCT02601820|12231721|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
4972977|NCT02601820|12231721|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
4972978|NCT02601820|12231721|P1|NOT COMPLETED|Late On-Treatment (T3)||49
4972979|NCT02601820|12231721|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
4972980|NCT02601820|12231721|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
4972981|NCT02601820|12231721|P1|NOT COMPLETED|Early On-Treatment (T2)||51
4972982|NCT02601820|12231721|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
4972983|NCT02601820|12231721|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
4972984|NCT02601820|12231721|P1|NOT COMPLETED|Pre-Treatment (T1)||0
4972985|NCT02601820|12231721|P1|COMPLETED|Pre-Treatment (T1)||1601
4972986|NCT02601820|12231721|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
4972987|NCT02601625|12231750|P4|NOT COMPLETED|Overall Study||1
4972988|NCT02601625|12231751|P3|NOT COMPLETED|Overall Study||1
4972989|NCT02601625|12231752|P2|NOT COMPLETED|Overall Study||0
4972990|NCT02601625|12231753|P1|NOT COMPLETED|Overall Study||0
4972991|NCT02601625|12231750|P4|COMPLETED|Overall Study||11
4972992|NCT02601625|12231751|P3|COMPLETED|Overall Study||5
4972993|NCT02601625|12231752|P2|COMPLETED|Overall Study||6
4972994|NCT02601625|12231753|P1|COMPLETED|Overall Study||6
4972995|NCT02601625|12231750|P4|STARTED|Overall Study||12
4972996|NCT02601625|12231751|P3|STARTED|Overall Study||6
4972997|NCT02601625|12231752|P2|STARTED|Overall Study||6
4972998|NCT02601625|12231753|P1|STARTED|Overall Study||6
4972999|NCT02601573|12231806|P5|NOT COMPLETED|Overall Study||2
4973000|NCT02601573|12231807|P4|NOT COMPLETED|Overall Study||1
4973001|NCT02601573|12231808|P3|NOT COMPLETED|Overall Study||1
4973002|NCT02601573|12231809|P2|NOT COMPLETED|Overall Study||4
4973003|NCT02601573|12231810|P1|NOT COMPLETED|Overall Study||0
4973004|NCT02601573|12231806|P5|COMPLETED|Overall Study||16
4973005|NCT02601573|12231807|P4|COMPLETED|Overall Study||17
4973006|NCT02601573|12231808|P3|COMPLETED|Overall Study||16
4973007|NCT02601573|12231809|P2|COMPLETED|Overall Study||20
4973008|NCT02601573|12231810|P1|COMPLETED|Overall Study||23
4973009|NCT02601573|12231806|P5|STARTED|Overall Study|Number randomized and treated.|18
4973010|NCT02601573|12231807|P4|STARTED|Overall Study|Number randomized and treated.|18
4973011|NCT02601573|12231808|P3|STARTED|Overall Study|Number randomized and treated.|17
4973012|NCT02601573|12231809|P2|STARTED|Overall Study|Number randomized and treated.|24
4973013|NCT02601573|12231810|P1|STARTED|Overall Study|Number randomized and treated.|23
4973014|NCT02601560|12231845|P8|NOT COMPLETED|Overall Study||0
4973015|NCT02601560|12231846|P7|NOT COMPLETED|Overall Study||1
4973016|NCT02601560|12231847|P6|NOT COMPLETED|Overall Study||0
4973017|NCT02601560|12231848|P5|NOT COMPLETED|Overall Study||0
4973018|NCT02601560|12231849|P4|NOT COMPLETED|Overall Study||0
4973019|NCT02601560|12231850|P3|NOT COMPLETED|Overall Study||0
4973020|NCT02601560|12231851|P2|NOT COMPLETED|Overall Study||0
4973021|NCT02601560|12231852|P1|NOT COMPLETED|Overall Study||0
4973022|NCT02601560|12231845|P8|COMPLETED|Overall Study||6
4973023|NCT02601560|12231846|P7|COMPLETED|Overall Study||5
4973024|NCT02601560|12231847|P6|COMPLETED|Overall Study||4
4973025|NCT02601560|12231848|P5|COMPLETED|Overall Study||6
4973026|NCT02601560|12231849|P4|COMPLETED|Overall Study||6
4973027|NCT02601560|12231850|P3|COMPLETED|Overall Study||6
4973028|NCT02601560|12231851|P2|COMPLETED|Overall Study||6
4973029|NCT02601560|12231852|P1|COMPLETED|Overall Study||8
4973030|NCT02601560|12231845|P8|STARTED|Overall Study||6
4973031|NCT02601560|12231846|P7|STARTED|Overall Study||6
4973032|NCT02601560|12231847|P6|STARTED|Overall Study||4
4973033|NCT02601560|12231848|P5|STARTED|Overall Study||6
4973034|NCT02601560|12231849|P4|STARTED|Overall Study||6
4973035|NCT02601560|12231850|P3|STARTED|Overall Study||6
4973036|NCT02601560|12231851|P2|STARTED|Overall Study||6
4973037|NCT02601560|12231852|P1|STARTED|Overall Study||8
4973038|NCT02601469|12232036|P2|NOT COMPLETED|Overall Study||0
4973039|NCT02601469|12232037|P1|NOT COMPLETED|Overall Study||1
4973040|NCT02601469|12232036|P2|COMPLETED|Overall Study||1
4973041|NCT02601469|12232037|P1|COMPLETED|Overall Study||24
4973042|NCT02601469|12232036|P2|STARTED|Overall Study||1
4973043|NCT02601469|12232037|P1|STARTED|Overall Study||25
4973044|NCT02601300|12232043|P1|NOT COMPLETED|Extension Phase||17
4973045|NCT02601300|12232043|P1|COMPLETED|Extension Phase||18
4973046|NCT02601300|12232043|P1|Treated With IP|Extension Phase||34
4973047|NCT02601300|12232043|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
4973048|NCT02601300|12232043|P1|NOT COMPLETED|Induction Phase||3
4973049|NCT02601300|12232043|P1|COMPLETED|Induction Phase||38
4973050|NCT02601300|12232043|P1|STARTED|Induction Phase||41
4973051|NCT02601209|12232063|P9|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
4973052|NCT02601209|12232064|P8|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
4973053|NCT02601209|12232065|P7|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973054|NCT02601209|12232066|P6|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973055|NCT02601209|12232067|P5|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973056|NCT02601209|12232068|P4|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973057|NCT02601209|12232069|P3|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973058|NCT02601209|12232070|P2|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973059|NCT02601209|12232071|P1|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
4973060|NCT02601209|12232063|P9|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
4973061|NCT02601209|12232064|P8|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
4973062|NCT02601209|12232065|P7|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973063|NCT02601209|12232066|P6|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973064|NCT02601209|12232067|P5|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973065|NCT02601209|12232068|P4|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973066|NCT02601209|12232069|P3|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973067|NCT02601209|12232070|P2|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973068|NCT02601209|12232071|P1|COMPLETED|Optional Crossover (Up to 2 Months)||0
4973069|NCT02601209|12232063|P9|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
4973070|NCT02601209|12232064|P8|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
4973071|NCT02601209|12232065|P7|STARTED|Optional Crossover (Up to 2 Months)||0
4973072|NCT02601209|12232066|P6|STARTED|Optional Crossover (Up to 2 Months)||0
4973073|NCT02601209|12232067|P5|STARTED|Optional Crossover (Up to 2 Months)||0
4973074|NCT02601209|12232068|P4|STARTED|Optional Crossover (Up to 2 Months)||0
4973075|NCT02601209|12232069|P3|STARTED|Optional Crossover (Up to 2 Months)||0
4973076|NCT02601209|12232070|P2|STARTED|Optional Crossover (Up to 2 Months)||0
4973077|NCT02601209|12232071|P1|STARTED|Optional Crossover (Up to 2 Months)||0
4973078|NCT02601209|12232063|P9|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
4973079|NCT02601209|12232064|P8|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
4973080|NCT02601209|12232065|P7|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
4973081|NCT02601209|12232066|P6|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
4973082|NCT02601209|12232067|P5|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
4973083|NCT02601209|12232068|P4|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
4973084|NCT02601209|12232069|P3|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
4973085|NCT02601209|12232070|P2|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
4973086|NCT02601209|12232071|P1|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
4973087|NCT02601209|12232063|P9|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
4973088|NCT02601209|12232064|P8|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
4973089|NCT02601209|12232065|P7|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
4973090|NCT02601209|12232066|P6|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
4973091|NCT02601209|12232067|P5|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
4973092|NCT02601209|12232068|P4|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
4973093|NCT02601209|12232069|P3|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
4973094|NCT02601209|12232070|P2|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
4973095|NCT02601209|12232071|P1|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
4973096|NCT02601209|12232063|P9|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
4973097|NCT02601209|12232064|P8|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
4973098|NCT02601209|12232065|P7|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
4973099|NCT02601209|12232066|P6|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
4973100|NCT02601209|12232067|P5|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
4973101|NCT02601209|12232068|P4|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
4973102|NCT02601209|12232069|P3|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
4973103|NCT02601209|12232070|P2|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
4973104|NCT02601209|12232071|P1|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
4973105|NCT02600923|12232097|P1|NOT COMPLETED|Overall Study||131
4973106|NCT02600923|12232097|P1|COMPLETED|Overall Study||0
4973107|NCT02600923|12232097|P1|Treated|Overall Study||130
4973108|NCT02600923|12232097|P1|STARTED|Overall Study||131
4973109|NCT02600871|12232107|P2|NOT COMPLETED|Overall Study||10
4973110|NCT02600871|12232108|P1|NOT COMPLETED|Overall Study||13
4973111|NCT02600871|12232107|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
4973112|NCT02600871|12232108|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
4973113|NCT02600871|12232107|P2|STARTED|Overall Study||49
4973114|NCT02600871|12232108|P1|STARTED|Overall Study||52
4973115|NCT02600845|12232118|P1|NOT COMPLETED|Overall Study||18
4973116|NCT02600845|12232118|P1|COMPLETED|Overall Study||104
4973117|NCT02600845|12232118|P1|STARTED|Overall Study||122
4973118|NCT02600819|12232133|P2|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||7
4973119|NCT02600819|12232134|P1|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
4973120|NCT02600819|12232133|P2|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
4973121|NCT02600819|12232134|P1|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
4973122|NCT02600819|12232133|P2|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|7
4973123|NCT02600819|12232134|P1|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
4973124|NCT02600819|12232133|P2|NOT COMPLETED|Main Study (E/C/F/TAF)||0
4973125|NCT02600819|12232134|P1|NOT COMPLETED|Main Study (E/C/F/TAF)||19
4973126|NCT02600819|12232133|P2|COMPLETED|Main Study (E/C/F/TAF)||0
4973127|NCT02600819|12232134|P1|COMPLETED|Main Study (E/C/F/TAF)||36
4973128|NCT02600819|12232133|P2|STARTED|Main Study (E/C/F/TAF)||0
4973129|NCT02600819|12232134|P1|STARTED|Main Study (E/C/F/TAF)||55
4973130|NCT02600767|12232146|P1|NOT COMPLETED|Overall Study||5
4973131|NCT02600767|12232146|P1|COMPLETED|Overall Study||74
4973132|NCT02600767|12232146|P1|STARTED|Overall Study||79
4973133|NCT02600715|12232152|P2|NOT COMPLETED|Overall Study||0
4973134|NCT02600715|12232153|P1|NOT COMPLETED|Overall Study||0
4973135|NCT02600715|12232152|P2|COMPLETED|Overall Study||13
4973136|NCT02600715|12232153|P1|COMPLETED|Overall Study||13
4973137|NCT02600715|12232152|P2|Completed 2-week Follow-up Appointment|Overall Study||12
4973138|NCT02600715|12232153|P1|Completed 2-week Follow-up Appointment|Overall Study||13
4973139|NCT02600715|12232152|P2|Received Treatment and Suppository|Overall Study||13
4973140|NCT02600715|12232153|P1|Received Treatment and Suppository|Overall Study||13
4973141|NCT02600715|12232152|P2|Allocated to Randomization|Overall Study||13
4973142|NCT02600715|12232153|P1|Allocated to Randomization|Overall Study||13
4973143|NCT02600715|12232152|P2|STARTED|Overall Study||13
4973144|NCT02600715|12232153|P1|STARTED|Overall Study||13
4973145|NCT02600637|12232184|P2|NOT COMPLETED|Overall Study||5
4973146|NCT02600637|12232185|P1|NOT COMPLETED|Overall Study||5
4973147|NCT02600637|12232184|P2|COMPLETED|Overall Study||13
4973148|NCT02600637|12232185|P1|COMPLETED|Overall Study||14
4973149|NCT02600637|12232184|P2|STARTED|Overall Study||18
4973150|NCT02600637|12232185|P1|STARTED|Overall Study||19
4973151|NCT02600611|12232197|P2|NOT COMPLETED|Overall Study||0
4973152|NCT02600611|12232198|P1|NOT COMPLETED|Overall Study||2
4973153|NCT02600611|12232197|P2|COMPLETED|Overall Study||300
4973154|NCT02600611|12232198|P1|COMPLETED|Overall Study||298
4973155|NCT02600611|12232197|P2|STARTED|Overall Study||300
4973156|NCT02600611|12232198|P1|STARTED|Overall Study||300
4973157|NCT02600403|12232209|P3|NOT COMPLETED|Overall Study||0
4973158|NCT02600403|12232210|P2|NOT COMPLETED|Overall Study||0
4973159|NCT02600403|12232211|P1|NOT COMPLETED|Overall Study||0
4973160|NCT02600403|12232209|P3|COMPLETED|Overall Study||11
4973161|NCT02600403|12232210|P2|COMPLETED|Overall Study||6
4973162|NCT02600403|12232211|P1|COMPLETED|Overall Study||44
4973163|NCT02600403|12232209|P3|STARTED|Overall Study||11
4973164|NCT02600403|12232210|P2|STARTED|Overall Study||6
4973165|NCT02600403|12232211|P1|STARTED|Overall Study||44
4973166|NCT02600351|12232238|P4|NOT COMPLETED|Overall Study||5
4973167|NCT02600351|12232239|P3|NOT COMPLETED|Overall Study||6
4973168|NCT02600351|12232240|P2|NOT COMPLETED|Overall Study||0
4973169|NCT02600351|12232241|P1|NOT COMPLETED|Overall Study||5
4973170|NCT02600351|12232238|P4|COMPLETED|Overall Study||22
4973171|NCT02600351|12232239|P3|COMPLETED|Overall Study||20
4973172|NCT02600351|12232240|P2|COMPLETED|Overall Study||17
4973173|NCT02600351|12232241|P1|COMPLETED|Overall Study||12
4973174|NCT02600351|12232238|P4|STARTED|Overall Study||27
4973175|NCT02600351|12232239|P3|STARTED|Overall Study||26
4973176|NCT02600351|12232240|P2|STARTED|Overall Study||17
4973177|NCT02600351|12232241|P1|STARTED|Overall Study||17
4973178|NCT02600325|12232271|P1|NOT COMPLETED|Overall Study||0
4973179|NCT02600325|12232271|P1|COMPLETED|Overall Study||80
4973180|NCT02600325|12232271|P1|STARTED|Overall Study||80
4973181|NCT02599961|12232276|P1|NOT COMPLETED|Overall Study||15
4973182|NCT02599961|12232276|P1|COMPLETED|Overall Study||0
4973183|NCT02599961|12232276|P1|STARTED|Overall Study||15
4973184|NCT02599766|12232286|P1|NOT COMPLETED|Overall Study||3
4973185|NCT02599766|12232286|P1|COMPLETED|Overall Study||19
4973186|NCT02599766|12232286|P1|STARTED|Overall Study||22
4973187|NCT02599649|12232322|P4|NOT COMPLETED|Overall Study||0
4973188|NCT02599649|12232323|P3|NOT COMPLETED|Overall Study||0
4973189|NCT02599649|12232324|P2|NOT COMPLETED|Overall Study||0
4973190|NCT02599649|12232325|P1|NOT COMPLETED|Overall Study||0
4973191|NCT02599649|12232322|P4|COMPLETED|Overall Study||0
4973192|NCT02599649|12232323|P3|COMPLETED|Overall Study||8
4973193|NCT02599649|12232324|P2|COMPLETED|Overall Study||0
4973194|NCT02599649|12232325|P1|COMPLETED|Overall Study||2
4973195|NCT02599649|12232322|P4|STARTED|Overall Study||0
4973196|NCT02599649|12232323|P3|STARTED|Overall Study||8
4973197|NCT02599649|12232324|P2|STARTED|Overall Study||0
4973198|NCT02599649|12232325|P1|STARTED|Overall Study||2
4973199|NCT02599441|12232335|P1|NOT COMPLETED|Overall Study||0
4973200|NCT02599441|12232335|P1|COMPLETED|Overall Study||9
4973201|NCT02599441|12232335|P1|STARTED|Overall Study||9
4973202|NCT02599194|12232341|P1|NOT COMPLETED|Overall Study||0
4973203|NCT02599194|12232341|P1|COMPLETED|Overall Study||7
4973204|NCT02599194|12232341|P1|STARTED|Overall Study||7
4973205|NCT02599129|12232350|P2|NOT COMPLETED|Overall Study||3
4973206|NCT02599129|12232351|P1|NOT COMPLETED|Overall Study||5
4973207|NCT02599129|12232350|P2|COMPLETED|Overall Study||1
4973208|NCT02599129|12232351|P1|COMPLETED|Overall Study||2
4973209|NCT02599129|12232350|P2|STARTED|Overall Study||4
4973210|NCT02599129|12232351|P1|STARTED|Overall Study||7
4973211|NCT02598934|12232367|P2|NOT COMPLETED|Overall Study||22
4973212|NCT02598934|12232368|P1|NOT COMPLETED|Overall Study||19
4973213|NCT02598934|12232367|P2|COMPLETED|Overall Study||132
4973214|NCT02598934|12232368|P1|COMPLETED|Overall Study||135
4973215|NCT02598934|12232367|P2|STARTED|Overall Study||154
4973216|NCT02598934|12232368|P1|STARTED|Overall Study||154
4973217|NCT02598622|12232380|P2|NOT COMPLETED|Overall Study||0
4973218|NCT02598622|12232381|P1|NOT COMPLETED|Overall Study||6
4973219|NCT02598622|12232380|P2|COMPLETED|Overall Study||0
4973220|NCT02598622|12232381|P1|COMPLETED|Overall Study||2
4973221|NCT02598622|12232380|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
4973222|NCT02598622|12232381|P1|STARTED|Overall Study||8
4973223|NCT02598583|12232389|P2|NOT COMPLETED|Overall Study||0
4973224|NCT02598583|12232390|P1|NOT COMPLETED|Overall Study||0
4973225|NCT02598583|12232389|P2|COMPLETED|Overall Study||7
4973226|NCT02598583|12232390|P1|COMPLETED|Overall Study||6
4973227|NCT02598583|12232389|P2|STARTED|Overall Study||7
4973228|NCT02598583|12232390|P1|STARTED|Overall Study||6
4973229|NCT02598297|12232410|P2|NOT COMPLETED|Overall Study||24
4973230|NCT02598297|12232411|P1|NOT COMPLETED|Overall Study||25
4973231|NCT02598297|12232410|P2|COMPLETED|Overall Study||0
4973232|NCT02598297|12232411|P1|COMPLETED|Overall Study||0
4973233|NCT02598297|12232410|P2|Subjects Followed for Survival|Overall Study||0
4973234|NCT02598297|12232411|P1|Subjects Followed for Survival|Overall Study||1
4973235|NCT02598297|12232410|P2|Not Treted Wit Study Drug|Overall Study||0
4973236|NCT02598297|12232411|P1|Not Treted Wit Study Drug|Overall Study||1
4973237|NCT02598297|12232410|P2|STARTED|Overall Study||24
4973238|NCT02598297|12232411|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
4973239|NCT02598193|12232437|P1|NOT COMPLETED|Overall Study||16
4973240|NCT02598193|12232437|P1|COMPLETED|Overall Study||73
4973241|NCT02598193|12232437|P1|STARTED|Overall Study||89
4973242|NCT02598128|12232445|P4|NOT COMPLETED|Period C: Days 12 to 20||0
4973243|NCT02598128|12232446|P3|NOT COMPLETED|Period C: Days 12 to 20||0
4973244|NCT02598128|12232447|P2|NOT COMPLETED|Period C: Days 12 to 20||0
4973245|NCT02598128|12232448|P1|NOT COMPLETED|Period C: Days 12 to 20||0
4973246|NCT02598128|12232445|P4|COMPLETED|Period C: Days 12 to 20||33
4973247|NCT02598128|12232446|P3|COMPLETED|Period C: Days 12 to 20||0
4973248|NCT02598128|12232447|P2|COMPLETED|Period C: Days 12 to 20||0
4973249|NCT02598128|12232448|P1|COMPLETED|Period C: Days 12 to 20||0
4973250|NCT02598128|12232445|P4|STARTED|Period C: Days 12 to 20||33
4973251|NCT02598128|12232446|P3|STARTED|Period C: Days 12 to 20||0
4973252|NCT02598128|12232447|P2|STARTED|Period C: Days 12 to 20||0
4973253|NCT02598128|12232448|P1|STARTED|Period C: Days 12 to 20||0
4973254|NCT02598128|12232445|P4|NOT COMPLETED|Period B: Days 1 to 11||0
4973255|NCT02598128|12232446|P3|NOT COMPLETED|Period B: Days 1 to 11||0
4973256|NCT02598128|12232447|P2|NOT COMPLETED|Period B: Days 1 to 11||0
4973257|NCT02598128|12232448|P1|NOT COMPLETED|Period B: Days 1 to 11||0
4973258|NCT02598128|12232445|P4|COMPLETED|Period B: Days 1 to 11||0
4973259|NCT02598128|12232446|P3|COMPLETED|Period B: Days 1 to 11||16
4973260|NCT02598128|12232447|P2|COMPLETED|Period B: Days 1 to 11||17
4973261|NCT02598128|12232448|P1|COMPLETED|Period B: Days 1 to 11||0
4973262|NCT02598128|12232445|P4|STARTED|Period B: Days 1 to 11||0
4973263|NCT02598128|12232446|P3|STARTED|Period B: Days 1 to 11||16
4973264|NCT02598128|12232447|P2|STARTED|Period B: Days 1 to 11||17
4973265|NCT02598128|12232448|P1|STARTED|Period B: Days 1 to 11||0
4973266|NCT02598128|12232445|P4|NOT COMPLETED|Period A: Days -7 to -1||0
4973267|NCT02598128|12232446|P3|NOT COMPLETED|Period A: Days -7 to -1||0
4973268|NCT02598128|12232447|P2|NOT COMPLETED|Period A: Days -7 to -1||0
4973269|NCT02598128|12232448|P1|NOT COMPLETED|Period A: Days -7 to -1||1
4973270|NCT02598128|12232445|P4|COMPLETED|Period A: Days -7 to -1||0
4973271|NCT02598128|12232446|P3|COMPLETED|Period A: Days -7 to -1||0
4973272|NCT02598128|12232447|P2|COMPLETED|Period A: Days -7 to -1||0
4973273|NCT02598128|12232448|P1|COMPLETED|Period A: Days -7 to -1||33
4973274|NCT02598128|12232445|P4|STARTED|Period A: Days -7 to -1||0
4973275|NCT02598128|12232446|P3|STARTED|Period A: Days -7 to -1||0
4973276|NCT02598128|12232447|P2|STARTED|Period A: Days -7 to -1||0
4973277|NCT02598128|12232448|P1|STARTED|Period A: Days -7 to -1||34
4973278|NCT02598089|12232462|P2|NOT COMPLETED|Overall Study||0
4973279|NCT02598089|12232463|P1|NOT COMPLETED|Overall Study||0
4973280|NCT02598089|12232462|P2|COMPLETED|Overall Study||30
4973281|NCT02598089|12232463|P1|COMPLETED|Overall Study||30
4973282|NCT02598089|12232462|P2|STARTED|Overall Study||30
4973283|NCT02598089|12232463|P1|STARTED|Overall Study||30
4973284|NCT02598076|12232491|P2|NOT COMPLETED|Overall Study||3
4973285|NCT02598076|12232492|P1|NOT COMPLETED|Overall Study||2
4973286|NCT02598076|12232491|P2|COMPLETED|Overall Study||26
4973287|NCT02598076|12232492|P1|COMPLETED|Overall Study||29
4973288|NCT02598076|12232491|P2|STARTED|Overall Study||29
4973289|NCT02598076|12232492|P1|STARTED|Overall Study||31
4973290|NCT02597946|12232506|P1|NOT COMPLETED|Overall Study||18
4973291|NCT02597946|12232506|P1|COMPLETED|Overall Study||0
4973292|NCT02597946|12232506|P1|STARTED|Overall Study||18
4973293|NCT02597933|12232517|P2|NOT COMPLETED|Overall Study||51
4973294|NCT02597933|12232518|P1|NOT COMPLETED|Overall Study||38
4973295|NCT02597933|12232517|P2|COMPLETED|Overall Study||239
4973296|NCT02597933|12232518|P1|COMPLETED|Overall Study||252
4973297|NCT02597933|12232517|P2|Treated Patients|Overall Study||288
4973298|NCT02597933|12232518|P1|Treated Patients|Overall Study||288
4973299|NCT02597933|12232517|P2|STARTED|Overall Study|Started are randomised|290
4973300|NCT02597933|12232518|P1|STARTED|Overall Study|Started are randomised|290
4973301|NCT02597920|12232549|P3|NOT COMPLETED|Overall Study||6
4973302|NCT02597920|12232550|P2|NOT COMPLETED|Overall Study||84
4973303|NCT02597920|12232551|P1|NOT COMPLETED|Overall Study||41
4973304|NCT02597920|12232549|P3|COMPLETED|Overall Study||72
4973305|NCT02597920|12232550|P2|COMPLETED|Overall Study||1075
4973306|NCT02597920|12232551|P1|COMPLETED|Overall Study||544
4973307|NCT02597920|12232549|P3|STARTED|Overall Study||78
4973308|NCT02597920|12232550|P2|STARTED|Overall Study||1159
4973309|NCT02597920|12232551|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
4973310|NCT02597907|12232576|P2|NOT COMPLETED|Overall Study||0
4973311|NCT02597907|12232577|P1|NOT COMPLETED|Overall Study||0
4973312|NCT02597907|12232576|P2|COMPLETED|Overall Study||44
4973313|NCT02597907|12232577|P1|COMPLETED|Overall Study||44
4973314|NCT02597907|12232576|P2|STARTED|Overall Study||44
4973315|NCT02597907|12232577|P1|STARTED|Overall Study||44
4973316|NCT02597855|12232585|P2|NOT COMPLETED|Overall Study||1
4973317|NCT02597855|12232586|P1|NOT COMPLETED|Overall Study||2
4973318|NCT02597855|12232585|P2|COMPLETED|Overall Study||13
4973319|NCT02597855|12232586|P1|COMPLETED|Overall Study||16
4973320|NCT02597855|12232585|P2|STARTED|Overall Study||14
4973321|NCT02597855|12232586|P1|STARTED|Overall Study||18
4973322|NCT02597582|12232596|P2|NOT COMPLETED|Overall Study||0
4973323|NCT02597582|12232597|P1|NOT COMPLETED|Overall Study||0
4973324|NCT02597582|12232596|P2|COMPLETED|Overall Study||20
4973325|NCT02597582|12232597|P1|COMPLETED|Overall Study||21
4973326|NCT02597582|12232596|P2|STARTED|Overall Study||20
4973327|NCT02597582|12232597|P1|STARTED|Overall Study||21
4973328|NCT02597543|12232615|P2|NOT COMPLETED|Overall Study||0
4973329|NCT02597543|12232616|P1|NOT COMPLETED|Overall Study||0
4973330|NCT02597543|12232615|P2|COMPLETED|Overall Study||8
4973331|NCT02597543|12232616|P1|COMPLETED|Overall Study||6
4973332|NCT02597543|12232615|P2|STARTED|Overall Study||8
4973333|NCT02597543|12232616|P1|STARTED|Overall Study||6
4973334|NCT02597452|12232632|P1|NOT COMPLETED|Overall Study||30
4973335|NCT02597452|12232632|P1|COMPLETED|Overall Study||486
4973336|NCT02597452|12232632|P1|STARTED|Overall Study||516
4973337|NCT02597127|12232650|P8|NOT COMPLETED|Overall Study||2
4973338|NCT02597127|12232651|P7|NOT COMPLETED|Overall Study||4
4973339|NCT02597127|12232652|P6|NOT COMPLETED|Overall Study||4
4973340|NCT02597127|12232653|P5|NOT COMPLETED|Overall Study||5
4973341|NCT02597127|12232654|P4|NOT COMPLETED|Overall Study||5
4973342|NCT02597127|12232655|P3|NOT COMPLETED|Overall Study||8
4973343|NCT02597127|12232656|P2|NOT COMPLETED|Overall Study||3
4973344|NCT02597127|12232657|P1|NOT COMPLETED|Overall Study||1
4973345|NCT02597127|12232650|P8|COMPLETED|Overall Study||60
4973346|NCT02597127|12232651|P7|COMPLETED|Overall Study||57
4973347|NCT02597127|12232652|P6|COMPLETED|Overall Study||59
4973348|NCT02597127|12232653|P5|COMPLETED|Overall Study||57
4973349|NCT02597127|12232654|P4|COMPLETED|Overall Study||60
4973350|NCT02597127|12232655|P3|COMPLETED|Overall Study||58
4973351|NCT02597127|12232656|P2|COMPLETED|Overall Study||59
4973352|NCT02597127|12232657|P1|COMPLETED|Overall Study||59
4973353|NCT02597127|12232650|P8|Treated|Overall Study||62
4973354|NCT02597127|12232651|P7|Treated|Overall Study||61
4973355|NCT02597127|12232652|P6|Treated|Overall Study||62
4973356|NCT02597127|12232653|P5|Treated|Overall Study||61
4973357|NCT02597127|12232654|P4|Treated|Overall Study||65
4973358|NCT02597127|12232655|P3|Treated|Overall Study||65
4973359|NCT02597127|12232656|P2|Treated|Overall Study||61
4973360|NCT02597127|12232657|P1|Treated|Overall Study||60
4973361|NCT02597127|12232650|P8|STARTED|Overall Study||62
4973362|NCT02597127|12232651|P7|STARTED|Overall Study||61
4973363|NCT02597127|12232652|P6|STARTED|Overall Study||63
4973364|NCT02597127|12232653|P5|STARTED|Overall Study||62
4973365|NCT02597127|12232654|P4|STARTED|Overall Study||65
4973366|NCT02597127|12232655|P3|STARTED|Overall Study||66
4973367|NCT02597127|12232656|P2|STARTED|Overall Study||62
4973368|NCT02597127|12232657|P1|STARTED|Overall Study||60
4973369|NCT02597062|12232744|P1|NOT COMPLETED|Overall Study||1
4973370|NCT02597062|12232744|P1|COMPLETED|Overall Study||75
4973371|NCT02597062|12232744|P1|STARTED|Overall Study||76
4973372|NCT02597049|12232753|P3|NOT COMPLETED|Overall Study||3
4973373|NCT02597049|12232754|P2|NOT COMPLETED|Overall Study||5
4973374|NCT02597049|12232755|P1|NOT COMPLETED|Overall Study||7
4973375|NCT02597049|12232753|P3|COMPLETED|Overall Study||137
4973376|NCT02597049|12232754|P2|COMPLETED|Overall Study||137
4973377|NCT02597049|12232755|P1|COMPLETED|Overall Study||135
4973378|NCT02597049|12232753|P3|Received at Least One Dose of Study Drug|Overall Study||140
4973379|NCT02597049|12232754|P2|Received at Least One Dose of Study Drug|Overall Study||141
4973380|NCT02597049|12232755|P1|Received at Least One Dose of Study Drug|Overall Study||142
4973381|NCT02597049|12232753|P3|STARTED|Overall Study||140
4973382|NCT02597049|12232754|P2|STARTED|Overall Study||142
4973383|NCT02597049|12232755|P1|STARTED|Overall Study||142
4973384|NCT02596971|12232796|P3|NOT COMPLETED|Overall Study||42
4973385|NCT02596971|12232797|P2|NOT COMPLETED|Overall Study||7
4973386|NCT02596971|12232798|P1|NOT COMPLETED|Overall Study||42
4973387|NCT02596971|12232796|P3|COMPLETED|Overall Study||0
4973388|NCT02596971|12232797|P2|COMPLETED|Overall Study||0
4973389|NCT02596971|12232798|P1|COMPLETED|Overall Study||0
4973390|NCT02596971|12232796|P3|STARTED|Overall Study||42
4973391|NCT02596971|12232797|P2|STARTED|Overall Study||7
4973392|NCT02596971|12232798|P1|STARTED|Overall Study||42
4973393|NCT02596958|12232827|P1|NOT COMPLETED|Overall Study||996
4973394|NCT02596958|12232827|P1|COMPLETED|Overall Study||0
4973395|NCT02596958|12232827|P1|STARTED|Overall Study||996
4973396|NCT02596945|12232839|P1|NOT COMPLETED|Overall Study||56
4973397|NCT02596945|12232839|P1|COMPLETED|Overall Study||167
4973398|NCT02596945|12232839|P1|Treated|Overall Study||220
4973399|NCT02596945|12232839|P1|STARTED|Overall Study||223
4973400|NCT02596893|12232849|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
4973401|NCT02596893|12232850|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
4973402|NCT02596893|12232851|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
4973403|NCT02596893|12232852|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
4973404|NCT02596893|12232849|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
4973405|NCT02596893|12232850|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
4973406|NCT02596893|12232851|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
4973407|NCT02596893|12232852|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
4973408|NCT02596893|12232849|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
4973409|NCT02596893|12232850|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
4973410|NCT02596893|12232851|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
4973411|NCT02596893|12232852|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
4973412|NCT02596893|12232849|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
4973413|NCT02596893|12232850|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
4973414|NCT02596893|12232851|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
4973415|NCT02596893|12232852|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
4973416|NCT02596893|12232849|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
4973417|NCT02596893|12232850|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
4973418|NCT02596893|12232851|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
4973419|NCT02596893|12232852|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
4973420|NCT02596893|12232849|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
4973421|NCT02596893|12232850|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
4973422|NCT02596893|12232851|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
4973423|NCT02596893|12232852|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
4973424|NCT02596867|12232906|P1|NOT COMPLETED|Overall Study||0
4973425|NCT02596867|12232906|P1|COMPLETED|Overall Study||2
4973426|NCT02596867|12232906|P1|2 Patients Prospectively Recruited|Overall Study||2
4973427|NCT02596867|12232906|P1|STARTED|Overall Study||2
4973428|NCT02596854|12232911|P1|NOT COMPLETED|Overall Study||8
4973429|NCT02596854|12232911|P1|COMPLETED|Overall Study||109
4973430|NCT02596854|12232911|P1|STARTED|Overall Study||117
4973431|NCT02596750|12232917|P2|NOT COMPLETED|30 Minutes||0
4973432|NCT02596750|12232918|P1|NOT COMPLETED|30 Minutes||0
4973433|NCT02596750|12232917|P2|COMPLETED|30 Minutes||21
4973434|NCT02596750|12232918|P1|COMPLETED|30 Minutes||21
4973435|NCT02596750|12232917|P2|STARTED|30 Minutes||21
4973436|NCT02596750|12232918|P1|STARTED|30 Minutes||21
4973437|NCT02596750|12232917|P2|NOT COMPLETED|10 Minutes||0
4973438|NCT02596750|12232918|P1|NOT COMPLETED|10 Minutes||0
4973439|NCT02596750|12232917|P2|COMPLETED|10 Minutes||21
4973440|NCT02596750|12232918|P1|COMPLETED|10 Minutes||21
4973441|NCT02596750|12232917|P2|STARTED|10 Minutes||21
4973442|NCT02596750|12232918|P1|STARTED|10 Minutes||21
4973443|NCT02596750|12232917|P2|NOT COMPLETED|5 Minutes||0
4973444|NCT02596750|12232918|P1|NOT COMPLETED|5 Minutes||0
4973445|NCT02596750|12232917|P2|COMPLETED|5 Minutes||21
4973446|NCT02596750|12232918|P1|COMPLETED|5 Minutes||21
4973447|NCT02596750|12232917|P2|STARTED|5 Minutes||21
4973448|NCT02596750|12232918|P1|STARTED|5 Minutes||21
4973449|NCT02596750|12232917|P2|NOT COMPLETED|2 Minutes||0
4973450|NCT02596750|12232918|P1|NOT COMPLETED|2 Minutes||0
4973451|NCT02596750|12232917|P2|COMPLETED|2 Minutes||21
4973452|NCT02596750|12232918|P1|COMPLETED|2 Minutes||21
4973453|NCT02596750|12232917|P2|STARTED|2 Minutes||21
4973454|NCT02596750|12232918|P1|STARTED|2 Minutes||21
4973455|NCT02596750|12232917|P2|NOT COMPLETED|Baseline||0
4973456|NCT02596750|12232918|P1|NOT COMPLETED|Baseline||0
4973457|NCT02596750|12232917|P2|COMPLETED|Baseline||21
4973458|NCT02596750|12232918|P1|COMPLETED|Baseline||21
4973459|NCT02596750|12232917|P2|STARTED|Baseline||21
4973460|NCT02596750|12232918|P1|STARTED|Baseline||21
4973461|NCT02596711|12232933|P3|NOT COMPLETED|Overall Study||3
4973462|NCT02596711|12232934|P2|NOT COMPLETED|Overall Study||2
4973463|NCT02596711|12232935|P1|NOT COMPLETED|Overall Study||1
4973464|NCT02596711|12232933|P3|COMPLETED|Overall Study||5
4973465|NCT02596711|12232934|P2|COMPLETED|Overall Study||6
4973466|NCT02596711|12232935|P1|COMPLETED|Overall Study||8
4973467|NCT02596711|12232933|P3|6 Month Follow-up|Overall Study||5
4973468|NCT02596711|12232934|P2|6 Month Follow-up|Overall Study||6
4973469|NCT02596711|12232935|P1|6 Month Follow-up|Overall Study||8
4973470|NCT02596711|12232933|P3|3 Month Follow-up|Overall Study||6
4973471|NCT02596711|12232934|P2|3 Month Follow-up|Overall Study||6
4973472|NCT02596711|12232935|P1|3 Month Follow-up|Overall Study||8
4973473|NCT02596711|12232933|P3|Visit 3|Overall Study||6
4973474|NCT02596711|12232934|P2|Visit 3|Overall Study||8
4973475|NCT02596711|12232935|P1|Visit 3|Overall Study||7
4973476|NCT02596711|12232933|P3|Visit 2|Overall Study||6
4973477|NCT02596711|12232934|P2|Visit 2|Overall Study||7
4973478|NCT02596711|12232935|P1|Visit 2|Overall Study||9
4973479|NCT02596711|12232933|P3|STARTED|Overall Study||8
4973480|NCT02596711|12232934|P2|STARTED|Overall Study||8
4973481|NCT02596711|12232935|P1|STARTED|Overall Study||9
4973482|NCT02596620|12232951|P2|NOT COMPLETED|Overall Study||1
4973483|NCT02596620|12232952|P1|NOT COMPLETED|Overall Study||1
4973484|NCT02596620|12232951|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
4973485|NCT02596620|12232952|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
4973486|NCT02596620|12232951|P2|STARTED|Overall Study|Started from 1st October 2013|82
4973487|NCT02596620|12232952|P1|STARTED|Overall Study|Started from 1st October 2013|82
4973488|NCT02596451|12232961|P3|NOT COMPLETED|Overall Study||14
4973489|NCT02596451|12232962|P2|NOT COMPLETED|Overall Study||18
4973490|NCT02596451|12232963|P1|NOT COMPLETED|Overall Study||4
4973491|NCT02596451|12232961|P3|COMPLETED|Overall Study||373
4973492|NCT02596451|12232962|P2|COMPLETED|Overall Study||374
4973493|NCT02596451|12232963|P1|COMPLETED|Overall Study||381
4973494|NCT02596451|12232961|P3|STARTED|Overall Study||387
4973495|NCT02596451|12232962|P2|STARTED|Overall Study||392
4973496|NCT02596451|12232963|P1|STARTED|Overall Study||385
4973497|NCT02596321|12232972|P2|NOT COMPLETED|Overall Study||0
4973498|NCT02596321|12232973|P1|NOT COMPLETED|Overall Study||3
4973499|NCT02596321|12232972|P2|COMPLETED|Overall Study||56
4973500|NCT02596321|12232973|P1|COMPLETED|Overall Study||53
4973501|NCT02596321|12232972|P2|STARTED|Overall Study||56
4973502|NCT02596321|12232973|P1|STARTED|Overall Study||56
4973503|NCT02596230|12232990|P5|NOT COMPLETED|Objective 2, One Year||78
4973504|NCT02596230|12232991|P4|NOT COMPLETED|Objective 2, One Year||58
4973505|NCT02596230|12232992|P3|NOT COMPLETED|Objective 2, One Year||98
4973506|NCT02596230|12232993|P2|NOT COMPLETED|Objective 2, One Year||68
4973507|NCT02596230|12232994|P1|NOT COMPLETED|Objective 2, One Year||0
4973508|NCT02596230|12232990|P5|COMPLETED|Objective 2, One Year||714
4973509|NCT02596230|12232991|P4|COMPLETED|Objective 2, One Year||471
4973510|NCT02596230|12232992|P3|COMPLETED|Objective 2, One Year||812
4973511|NCT02596230|12232993|P2|COMPLETED|Objective 2, One Year||710
4973512|NCT02596230|12232994|P1|COMPLETED|Objective 2, One Year||0
4973513|NCT02596230|12232990|P5|STARTED|Objective 2, One Year||792
4973514|NCT02596230|12232991|P4|STARTED|Objective 2, One Year||529
4973515|NCT02596230|12232992|P3|STARTED|Objective 2, One Year||910
4973516|NCT02596230|12232993|P2|STARTED|Objective 2, One Year||778
4973517|NCT02596230|12232994|P1|STARTED|Objective 2, One Year||0
4973518|NCT02596230|12232990|P5|NOT COMPLETED|Screening Period for Objective 2||0
4973519|NCT02596230|12232991|P4|NOT COMPLETED|Screening Period for Objective 2||846
4973520|NCT02596230|12232992|P3|NOT COMPLETED|Screening Period for Objective 2||0
4973521|NCT02596230|12232993|P2|NOT COMPLETED|Screening Period for Objective 2||228
4973522|NCT02596230|12232994|P1|NOT COMPLETED|Screening Period for Objective 2||3714
4973523|NCT02596230|12232990|P5|COMPLETED|Screening Period for Objective 2||792
4973524|NCT02596230|12232991|P4|COMPLETED|Screening Period for Objective 2||529
4973525|NCT02596230|12232992|P3|COMPLETED|Screening Period for Objective 2||910
4973526|NCT02596230|12232993|P2|COMPLETED|Screening Period for Objective 2||778
4973527|NCT02596230|12232994|P1|COMPLETED|Screening Period for Objective 2||0
4973528|NCT02596230|12232990|P5|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
4973529|NCT02596230|12232991|P4|STARTED|Screening Period for Objective 2||1375
4973530|NCT02596230|12232992|P3|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
4973531|NCT02596230|12232993|P2|STARTED|Screening Period for Objective 2||1006
4973532|NCT02596230|12232994|P1|STARTED|Screening Period for Objective 2||3714
4973533|NCT02596230|12232990|P5|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
4973534|NCT02596230|12232991|P4|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
4973535|NCT02596230|12232992|P3|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
4973536|NCT02596230|12232993|P2|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
4973537|NCT02596230|12232994|P1|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
4973538|NCT02596230|12232990|P5|COMPLETED|Objective 1, One Visit During 14 Days||0
4973539|NCT02596230|12232991|P4|COMPLETED|Objective 1, One Visit During 14 Days||1375
4973540|NCT02596230|12232992|P3|COMPLETED|Objective 1, One Visit During 14 Days||0
4973541|NCT02596230|12232993|P2|COMPLETED|Objective 1, One Visit During 14 Days||1006
4973542|NCT02596230|12232994|P1|COMPLETED|Objective 1, One Visit During 14 Days||3714
4973543|NCT02596230|12232990|P5|STARTED|Objective 1, One Visit During 14 Days||0
4973544|NCT02596230|12232991|P4|STARTED|Objective 1, One Visit During 14 Days||1375
4973545|NCT02596230|12232992|P3|STARTED|Objective 1, One Visit During 14 Days||0
4973546|NCT02596230|12232993|P2|STARTED|Objective 1, One Visit During 14 Days||1006
4973547|NCT02596230|12232994|P1|STARTED|Objective 1, One Visit During 14 Days||3714
4973548|NCT02596035|12233018|P3|NOT COMPLETED|Overall Study||1
4973549|NCT02596035|12233019|P2|NOT COMPLETED|Overall Study||44
4973550|NCT02596035|12233020|P1|NOT COMPLETED|Overall Study||86
4973551|NCT02596035|12233018|P3|COMPLETED|Overall Study||0
4973552|NCT02596035|12233019|P2|COMPLETED|Overall Study||0
4973553|NCT02596035|12233020|P1|COMPLETED|Overall Study||11
4973554|NCT02596035|12233018|P3|STARTED|Overall Study||1
4973555|NCT02596035|12233019|P2|STARTED|Overall Study||44
4973556|NCT02596035|12233020|P1|STARTED|Overall Study||97
4973557|NCT02596022|12233049|P2|NOT COMPLETED|Overall Study||0
4973558|NCT02596022|12233050|P1|NOT COMPLETED|Overall Study||0
4973559|NCT02596022|12233049|P2|COMPLETED|Overall Study||8
4973560|NCT02596022|12233050|P1|COMPLETED|Overall Study||10
4973561|NCT02596022|12233049|P2|STARTED|Overall Study||8
4973562|NCT02596022|12233050|P1|STARTED|Overall Study||10
4973563|NCT02596009|12233056|P6|NOT COMPLETED|Overall Study||0
4973564|NCT02596009|12233057|P5|NOT COMPLETED|Overall Study||0
4973565|NCT02596009|12233058|P4|NOT COMPLETED|Overall Study||0
4973566|NCT02596009|12233059|P3|NOT COMPLETED|Overall Study||0
4973567|NCT02596009|12233060|P2|NOT COMPLETED|Overall Study||1
4973568|NCT02596009|12233061|P1|NOT COMPLETED|Overall Study||0
4973569|NCT02596009|12233056|P6|COMPLETED|Overall Study||17
4973570|NCT02596009|12233057|P5|COMPLETED|Overall Study||18
4973571|NCT02596009|12233058|P4|COMPLETED|Overall Study||16
4973572|NCT02596009|12233059|P3|COMPLETED|Overall Study||16
4973573|NCT02596009|12233060|P2|COMPLETED|Overall Study||15
4973574|NCT02596009|12233061|P1|COMPLETED|Overall Study||14
4973575|NCT02596009|12233056|P6|STARTED|Overall Study||17
4973576|NCT02596009|12233057|P5|STARTED|Overall Study||18
4973577|NCT02596009|12233058|P4|STARTED|Overall Study||16
4973578|NCT02596009|12233059|P3|STARTED|Overall Study||16
4973579|NCT02596009|12233060|P2|STARTED|Overall Study||16
4973580|NCT02596009|12233061|P1|STARTED|Overall Study||14
4973581|NCT02595983|12233070|P1|NOT COMPLETED|Overall Study||4
4973582|NCT02595983|12233070|P1|COMPLETED|Overall Study||8
4973583|NCT02595983|12233070|P1|STARTED|Overall Study||12
4973584|NCT02595970|12233078|P1|NOT COMPLETED|Overall Study||20
4973585|NCT02595970|12233078|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
4973586|NCT02595970|12233078|P1|STARTED|Overall Study||120
4973587|NCT02595723|12233095|P3|NOT COMPLETED|Third Intervention (4 Days)||0
4973588|NCT02595723|12233096|P2|NOT COMPLETED|Third Intervention (4 Days)||0
4973589|NCT02595723|12233097|P1|NOT COMPLETED|Third Intervention (4 Days)||0
4973590|NCT02595723|12233095|P3|COMPLETED|Third Intervention (4 Days)||7
4973591|NCT02595723|12233096|P2|COMPLETED|Third Intervention (4 Days)||5
4973592|NCT02595723|12233097|P1|COMPLETED|Third Intervention (4 Days)||6
4973593|NCT02595723|12233095|P3|STARTED|Third Intervention (4 Days)||7
4973594|NCT02595723|12233096|P2|STARTED|Third Intervention (4 Days)||5
4973595|NCT02595723|12233097|P1|STARTED|Third Intervention (4 Days)||6
4973596|NCT02595723|12233095|P3|NOT COMPLETED|Second Washout (21 Days)||0
4973597|NCT02595723|12233096|P2|NOT COMPLETED|Second Washout (21 Days)||1
4973598|NCT02595723|12233097|P1|NOT COMPLETED|Second Washout (21 Days)||0
4973599|NCT02595723|12233095|P3|COMPLETED|Second Washout (21 Days)||7
4973600|NCT02595723|12233096|P2|COMPLETED|Second Washout (21 Days)||5
4973601|NCT02595723|12233097|P1|COMPLETED|Second Washout (21 Days)||6
4973602|NCT02595723|12233095|P3|STARTED|Second Washout (21 Days)||7
4973603|NCT02595723|12233096|P2|STARTED|Second Washout (21 Days)||6
4973604|NCT02595723|12233097|P1|STARTED|Second Washout (21 Days)||6
4973605|NCT02595723|12233095|P3|NOT COMPLETED|Second Intervention (4 Days)||0
4973606|NCT02595723|12233096|P2|NOT COMPLETED|Second Intervention (4 Days)||0
4973607|NCT02595723|12233097|P1|NOT COMPLETED|Second Intervention (4 Days)||0
4973608|NCT02595723|12233095|P3|COMPLETED|Second Intervention (4 Days)||7
4973609|NCT02595723|12233096|P2|COMPLETED|Second Intervention (4 Days)||6
4973610|NCT02595723|12233097|P1|COMPLETED|Second Intervention (4 Days)||6
4973611|NCT02595723|12233095|P3|STARTED|Second Intervention (4 Days)||7
4973612|NCT02595723|12233096|P2|STARTED|Second Intervention (4 Days)||6
4973613|NCT02595723|12233097|P1|STARTED|Second Intervention (4 Days)||6
4973614|NCT02595723|12233095|P3|NOT COMPLETED|First Washout (21 Days)||0
4973615|NCT02595723|12233096|P2|NOT COMPLETED|First Washout (21 Days)||0
4973616|NCT02595723|12233097|P1|NOT COMPLETED|First Washout (21 Days)||2
4973617|NCT02595723|12233095|P3|COMPLETED|First Washout (21 Days)||7
4973618|NCT02595723|12233096|P2|COMPLETED|First Washout (21 Days)||6
4973619|NCT02595723|12233097|P1|COMPLETED|First Washout (21 Days)||6
4973620|NCT02595723|12233095|P3|STARTED|First Washout (21 Days)||7
4973621|NCT02595723|12233096|P2|STARTED|First Washout (21 Days)||6
4973622|NCT02595723|12233097|P1|STARTED|First Washout (21 Days)||8
4973623|NCT02595723|12233095|P3|NOT COMPLETED|First Intervention (4 Days)||0
4973624|NCT02595723|12233096|P2|NOT COMPLETED|First Intervention (4 Days)||0
4973625|NCT02595723|12233097|P1|NOT COMPLETED|First Intervention (4 Days)||0
4973626|NCT02595723|12233095|P3|COMPLETED|First Intervention (4 Days)||7
4973627|NCT02595723|12233096|P2|COMPLETED|First Intervention (4 Days)||6
4973628|NCT02595723|12233097|P1|COMPLETED|First Intervention (4 Days)||8
4973629|NCT02595723|12233095|P3|STARTED|First Intervention (4 Days)||7
4973630|NCT02595723|12233096|P2|STARTED|First Intervention (4 Days)||6
4973631|NCT02595723|12233097|P1|STARTED|First Intervention (4 Days)||8
4973632|NCT02595567|12233105|P1|NOT COMPLETED|Overall Study||0
4973633|NCT02595567|12233105|P1|COMPLETED|Overall Study||25
4973634|NCT02595567|12233105|P1|STARTED|Overall Study||25
4973635|NCT02595502|12233109|P2|NOT COMPLETED|Period 3||2
4973636|NCT02595502|12233110|P1|NOT COMPLETED|Period 3||1
4973637|NCT02595502|12233109|P2|COMPLETED|Period 3||136
4973638|NCT02595502|12233110|P1|COMPLETED|Period 3||140
4973639|NCT02595502|12233109|P2|STARTED|Period 3||138
4973640|NCT02595502|12233110|P1|STARTED|Period 3||141
4973641|NCT02595502|12233109|P2|NOT COMPLETED|Period 2||2
4973642|NCT02595502|12233110|P1|NOT COMPLETED|Period 2||1
4973643|NCT02595502|12233109|P2|COMPLETED|Period 2||138
4973644|NCT02595502|12233110|P1|COMPLETED|Period 2||141
4973645|NCT02595502|12233109|P2|STARTED|Period 2||140
4973646|NCT02595502|12233110|P1|STARTED|Period 2||142
4973647|NCT02595502|12233109|P2|NOT COMPLETED|Period 1||2
4973648|NCT02595502|12233110|P1|NOT COMPLETED|Period 1||1
4973649|NCT02595502|12233109|P2|COMPLETED|Period 1||140
4973650|NCT02595502|12233110|P1|COMPLETED|Period 1||142
4973651|NCT02595502|12233109|P2|STARTED|Period 1||142
4973652|NCT02595502|12233110|P1|STARTED|Period 1||143
4973653|NCT02595450|12233116|P1|NOT COMPLETED|Overall Study||81
4973654|NCT02595450|12233116|P1|COMPLETED|Overall Study||218
4973655|NCT02595450|12233116|P1|Treated|Overall Study||291
4973656|NCT02595450|12233116|P1|STARTED|Overall Study||299
4973657|NCT02595437|12233122|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
4973658|NCT02595437|12233122|P1|COMPLETED|Triferic Via Hemodialysate||21
4973659|NCT02595437|12233122|P1|STARTED|Triferic Via Hemodialysate||21
4973660|NCT02595437|12233122|P1|NOT COMPLETED|Triferic Via IV||1
4973661|NCT02595437|12233122|P1|COMPLETED|Triferic Via IV||21
4973662|NCT02595437|12233122|P1|STARTED|Triferic Via IV||22
4973663|NCT02595372|12233140|P1|NOT COMPLETED|Overall Study||9
4973664|NCT02595372|12233140|P1|COMPLETED|Overall Study||33
4973665|NCT02595372|12233140|P1|STARTED|Overall Study||42
4973666|NCT02595073|12233151|P2|NOT COMPLETED|Overall Study||1
4973667|NCT02595073|12233152|P1|NOT COMPLETED|Overall Study||2
4973668|NCT02595073|12233151|P2|COMPLETED|Overall Study||62
4973669|NCT02595073|12233152|P1|COMPLETED|Overall Study||59
4973670|NCT02595073|12233151|P2|STARTED|Overall Study||63
4973671|NCT02595073|12233152|P1|STARTED|Overall Study||61
4973672|NCT02595008|12233162|P2|NOT COMPLETED|Overall Study||0
4973673|NCT02595008|12233163|P1|NOT COMPLETED|Overall Study||1
4973674|NCT02595008|12233162|P2|COMPLETED|Overall Study||4
4973675|NCT02595008|12233163|P1|COMPLETED|Overall Study||19
4973676|NCT02595008|12233162|P2|STARTED|Overall Study||4
4973677|NCT02595008|12233163|P1|STARTED|Overall Study||20
4973678|NCT02594826|12233171|P2|NOT COMPLETED|Overall Study||60
4973679|NCT02594826|12233172|P1|NOT COMPLETED|Overall Study||57
4973680|NCT02594826|12233171|P2|COMPLETED|Overall Study||298
4973681|NCT02594826|12233172|P1|COMPLETED|Overall Study||290
4973682|NCT02594826|12233171|P2|STARTED|Overall Study||358
4973683|NCT02594826|12233172|P1|STARTED|Overall Study||347
4973684|NCT02594644|12233182|P2|NOT COMPLETED|Overall Study||1
4973685|NCT02594644|12233183|P1|NOT COMPLETED|Overall Study||0
4973686|NCT02594644|12233182|P2|COMPLETED|Overall Study||15
4973687|NCT02594644|12233183|P1|COMPLETED|Overall Study||16
4973688|NCT02594644|12233182|P2|STARTED|Overall Study||16
4973689|NCT02594644|12233183|P1|STARTED|Overall Study||16
4973690|NCT02594163|12233201|P2|NOT COMPLETED|Follow-up Period||12
4973691|NCT02594163|12233202|P1|NOT COMPLETED|Follow-up Period||11
4973692|NCT02594163|12233201|P2|COMPLETED|Follow-up Period||1
4973693|NCT02594163|12233202|P1|COMPLETED|Follow-up Period||1
4973694|NCT02594163|12233201|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
4973695|NCT02594163|12233202|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
4973696|NCT02594163|12233201|P2|NOT COMPLETED|Treatment Period||12
4973697|NCT02594163|12233202|P1|NOT COMPLETED|Treatment Period||7
4973698|NCT02594163|12233201|P2|COMPLETED|Treatment Period||1
4973699|NCT02594163|12233202|P1|COMPLETED|Treatment Period||5
4973700|NCT02594163|12233201|P2|STARTED|Treatment Period||13
4973701|NCT02594163|12233202|P1|STARTED|Treatment Period||12
4973702|NCT02594111|12233220|P2|NOT COMPLETED|Overall Study||0
4973703|NCT02594111|12233221|P1|NOT COMPLETED|Overall Study||0
4973704|NCT02594111|12233220|P2|COMPLETED|Overall Study||348
4973705|NCT02594111|12233221|P1|COMPLETED|Overall Study||366
4973706|NCT02594111|12233220|P2|STARTED|Overall Study||348
4973707|NCT02594111|12233221|P1|STARTED|Overall Study||366
4973708|NCT02594098|12233233|P2|NOT COMPLETED|Overall Study||13
4973709|NCT02594098|12233234|P1|NOT COMPLETED|Overall Study||26
4973710|NCT02594098|12233233|P2|COMPLETED|Overall Study||1
4973711|NCT02594098|12233234|P1|COMPLETED|Overall Study||1
4973712|NCT02594098|12233233|P2|STARTED|Overall Study||14
4973713|NCT02594098|12233234|P1|STARTED|Overall Study||27
4973714|NCT02593903|12233296|P2|NOT COMPLETED|Overall Study||1
4973715|NCT02593903|12233297|P1|NOT COMPLETED|Overall Study||0
4973716|NCT02593903|12233296|P2|COMPLETED|Overall Study||31
4973717|NCT02593903|12233297|P1|COMPLETED|Overall Study||35
4973718|NCT02593903|12233296|P2|STARTED|Overall Study||32
4973719|NCT02593903|12233297|P1|STARTED|Overall Study||35
4973720|NCT02593864|12233303|P1|NOT COMPLETED|Overall Study||6
4973721|NCT02593864|12233303|P1|COMPLETED|Overall Study||19
4973722|NCT02593864|12233303|P1|STARTED|Overall Study||25
4973723|NCT02593773|12233308|P1|NOT COMPLETED|Overall Study||35
4973724|NCT02593773|12233308|P1|COMPLETED|Overall Study||51
4973725|NCT02593773|12233308|P1|STARTED|Overall Study||86
4973726|NCT02593630|12233318|P1|NOT COMPLETED|Overall Study||1
4973727|NCT02593630|12233318|P1|COMPLETED|Overall Study||53
4973728|NCT02593630|12233318|P1|STARTED|Overall Study||54
4973729|NCT02593396|12233326|P2|NOT COMPLETED|Overall Study||14
4973730|NCT02593396|12233327|P1|NOT COMPLETED|Overall Study||15
4973731|NCT02593396|12233326|P2|COMPLETED|Overall Study||26
4973732|NCT02593396|12233327|P1|COMPLETED|Overall Study||25
4973733|NCT02593396|12233326|P2|At Least Done One Efficacy Assessment|Overall Study||36
4973734|NCT02593396|12233327|P1|At Least Done One Efficacy Assessment|Overall Study||36
4973735|NCT02593396|12233326|P2|STARTED|Overall Study||40
4973736|NCT02593396|12233327|P1|STARTED|Overall Study||40
4973737|NCT02593305|12233340|P3|NOT COMPLETED|Post 2||0
4973738|NCT02593305|12233341|P2|NOT COMPLETED|Post 2||0
4973739|NCT02593305|12233342|P1|NOT COMPLETED|Post 2||0
4973740|NCT02593305|12233340|P3|COMPLETED|Post 2||0
4973741|NCT02593305|12233341|P2|COMPLETED|Post 2||6
4973742|NCT02593305|12233342|P1|COMPLETED|Post 2||7
4973743|NCT02593305|12233340|P3|STARTED|Post 2||0
4973744|NCT02593305|12233341|P2|STARTED|Post 2||6
4973745|NCT02593305|12233342|P1|STARTED|Post 2||7
4973746|NCT02593305|12233340|P3|NOT COMPLETED|Baseline 2||0
4973747|NCT02593305|12233341|P2|NOT COMPLETED|Baseline 2||0
4973748|NCT02593305|12233342|P1|NOT COMPLETED|Baseline 2||0
4973749|NCT02593305|12233340|P3|COMPLETED|Baseline 2||0
4973750|NCT02593305|12233341|P2|COMPLETED|Baseline 2||6
4973751|NCT02593305|12233342|P1|COMPLETED|Baseline 2||7
4973752|NCT02593305|12233340|P3|STARTED|Baseline 2||0
4973753|NCT02593305|12233341|P2|STARTED|Baseline 2||6
4973754|NCT02593305|12233342|P1|STARTED|Baseline 2||7
4973755|NCT02593305|12233340|P3|NOT COMPLETED|Post 1||10
4973756|NCT02593305|12233341|P2|NOT COMPLETED|Post 1||0
4973757|NCT02593305|12233342|P1|NOT COMPLETED|Post 1||0
4973758|NCT02593305|12233340|P3|COMPLETED|Post 1||0
4973759|NCT02593305|12233341|P2|COMPLETED|Post 1||6
4973760|NCT02593305|12233342|P1|COMPLETED|Post 1||7
4973761|NCT02593305|12233340|P3|STARTED|Post 1||10
4973762|NCT02593305|12233341|P2|STARTED|Post 1||6
4973763|NCT02593305|12233342|P1|STARTED|Post 1||7
4973764|NCT02593305|12233340|P3|NOT COMPLETED|Baseline 1||0
4973765|NCT02593305|12233341|P2|NOT COMPLETED|Baseline 1||0
4973766|NCT02593305|12233342|P1|NOT COMPLETED|Baseline 1||0
4973767|NCT02593305|12233340|P3|COMPLETED|Baseline 1||10
4973768|NCT02593305|12233341|P2|COMPLETED|Baseline 1||6
4973769|NCT02593305|12233342|P1|COMPLETED|Baseline 1||7
4973770|NCT02593305|12233340|P3|STARTED|Baseline 1||10
4973771|NCT02593305|12233341|P2|STARTED|Baseline 1||6
4973772|NCT02593305|12233342|P1|STARTED|Baseline 1||7
4973773|NCT02593149|12233357|P2|NOT COMPLETED|Intervention||115
4973774|NCT02593149|12233358|P1|NOT COMPLETED|Intervention||116
4973775|NCT02593149|12233357|P2|COMPLETED|Intervention||845
4973776|NCT02593149|12233358|P1|COMPLETED|Intervention||826
4973777|NCT02593149|12233357|P2|STARTED|Intervention||960
4973778|NCT02593149|12233358|P1|STARTED|Intervention||942
4973779|NCT02593149|12233357|P2|NOT COMPLETED|Run-In||38
4973780|NCT02593149|12233358|P1|NOT COMPLETED|Run-In||36
4973781|NCT02593149|12233357|P2|COMPLETED|Run-In||323
4973782|NCT02593149|12233358|P1|COMPLETED|Run-In||304
4973783|NCT02593149|12233357|P2|STARTED|Run-In||361
4973784|NCT02593149|12233358|P1|STARTED|Run-In||340
4973785|NCT02593097|12233366|P2|NOT COMPLETED|Second Intervention (12 Weeks)||1
4973786|NCT02593097|12233367|P1|NOT COMPLETED|Second Intervention (12 Weeks)||3
4973787|NCT02593097|12233366|P2|COMPLETED|Second Intervention (12 Weeks)||15
4973788|NCT02593097|12233367|P1|COMPLETED|Second Intervention (12 Weeks)||9
4973789|NCT02593097|12233366|P2|STARTED|Second Intervention (12 Weeks)||16
4973790|NCT02593097|12233367|P1|STARTED|Second Intervention (12 Weeks)||12
4973791|NCT02593097|12233366|P2|NOT COMPLETED|Washout (4 Weeks)||0
4973792|NCT02593097|12233367|P1|NOT COMPLETED|Washout (4 Weeks)||0
4973793|NCT02593097|12233366|P2|COMPLETED|Washout (4 Weeks)||16
4973794|NCT02593097|12233367|P1|COMPLETED|Washout (4 Weeks)||12
4973795|NCT02593097|12233366|P2|STARTED|Washout (4 Weeks)||16
4973796|NCT02593097|12233367|P1|STARTED|Washout (4 Weeks)||12
4973797|NCT02593097|12233366|P2|NOT COMPLETED|First Intervention (12 Weeks)||4
4973798|NCT02593097|12233367|P1|NOT COMPLETED|First Intervention (12 Weeks)||2
4973799|NCT02593097|12233366|P2|COMPLETED|First Intervention (12 Weeks)||16
4973800|NCT02593097|12233367|P1|COMPLETED|First Intervention (12 Weeks)||12
4973801|NCT02593097|12233366|P2|Received Intervention|First Intervention (12 Weeks)||20
4973802|NCT02593097|12233367|P1|Received Intervention|First Intervention (12 Weeks)||14
4973803|NCT02593097|12233366|P2|STARTED|First Intervention (12 Weeks)||20
4973804|NCT02593097|12233367|P1|STARTED|First Intervention (12 Weeks)||14
4973805|NCT02592876|12233379|P2|NOT COMPLETED|Overall Study||40
4973806|NCT02592876|12233380|P1|NOT COMPLETED|Overall Study||41
4973807|NCT02592876|12233379|P2|COMPLETED|Overall Study||0
4973808|NCT02592876|12233380|P1|COMPLETED|Overall Study||0
4973809|NCT02592876|12233379|P2|Completed Treatment|Overall Study||32
4973810|NCT02592876|12233380|P1|Completed Treatment|Overall Study||34
4973811|NCT02592876|12233379|P2|Received Study Drug|Overall Study||40
4973812|NCT02592876|12233380|P1|Received Study Drug|Overall Study||40
4973813|NCT02592876|12233379|P2|STARTED|Overall Study||40
4973814|NCT02592876|12233380|P1|STARTED|Overall Study||41
4973815|NCT02592655|12233406|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
4973816|NCT02592655|12233406|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
4973817|NCT02592655|12233406|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
4973818|NCT02592655|12233406|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
4973819|NCT02592655|12233406|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
4973820|NCT02592655|12233406|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
4973821|NCT02592655|12233406|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
4973822|NCT02592655|12233406|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
4973823|NCT02592655|12233406|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
4973824|NCT02592655|12233406|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
4973825|NCT02592655|12233406|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
4973826|NCT02592655|12233406|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
4973827|NCT02592655|12233406|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
4973828|NCT02592655|12233406|P1|STARTED|Third Tourniquet, Left Thigh.||19
4973829|NCT02592655|12233406|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
4973830|NCT02592655|12233406|P1|COMPLETED|Second Tourniquet Right Thigh.||19
4973831|NCT02592655|12233406|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
4973832|NCT02592655|12233406|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
4973833|NCT02592655|12233406|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
4973834|NCT02592655|12233406|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
4973835|NCT02592655|12233406|P1|STARTED|Second Tourniquet Right Thigh.||19
4973836|NCT02592655|12233406|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
4973837|NCT02592655|12233406|P1|COMPLETED|First Tourniquet, Left Thigh.||19
4973838|NCT02592655|12233406|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
4973839|NCT02592655|12233406|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
4973840|NCT02592655|12233406|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
4973841|NCT02592655|12233406|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
4973842|NCT02592655|12233406|P1|STARTED|First Tourniquet, Left Thigh.||19
4973843|NCT02592629|12233424|P3|NOT COMPLETED|Overall Study||0
4973844|NCT02592629|12233425|P2|NOT COMPLETED|Overall Study||0
4973845|NCT02592629|12233426|P1|NOT COMPLETED|Overall Study||0
4973846|NCT02592629|12233424|P3|COMPLETED|Overall Study||5
4973847|NCT02592629|12233425|P2|COMPLETED|Overall Study||9
4973848|NCT02592629|12233426|P1|COMPLETED|Overall Study||5
4973849|NCT02592629|12233424|P3|STARTED|Overall Study||5
4973850|NCT02592629|12233425|P2|STARTED|Overall Study||9
4973851|NCT02592629|12233426|P1|STARTED|Overall Study||5
4973852|NCT02592486|12233436|P2|NOT COMPLETED|Overall Study||5
4973853|NCT02592486|12233437|P1|NOT COMPLETED|Overall Study||0
4973854|NCT02592486|12233436|P2|COMPLETED|Overall Study||76
4973855|NCT02592486|12233437|P1|COMPLETED|Overall Study||81
4973856|NCT02592486|12233436|P2|STARTED|Overall Study||81
4973857|NCT02592486|12233437|P1|STARTED|Overall Study||81
4973858|NCT02592447|12233451|P2|NOT COMPLETED|Overall Study||1
4973859|NCT02592447|12233452|P1|NOT COMPLETED|Overall Study||2
4973860|NCT02592447|12233451|P2|COMPLETED|Overall Study||14
4973861|NCT02592447|12233452|P1|COMPLETED|Overall Study||27
4973862|NCT02592447|12233451|P2|STARTED|Overall Study||15
4973863|NCT02592447|12233452|P1|STARTED|Overall Study||29
4973864|NCT02592434|12233460|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
4973865|NCT02592434|12233461|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
4973866|NCT02592434|12233462|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
4973867|NCT02592434|12233460|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
4973868|NCT02592434|12233461|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
4973869|NCT02592434|12233462|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
4973870|NCT02592434|12233460|P3|Treated|Double Blind Phase (26 Weeks)||85
4973871|NCT02592434|12233461|P2|Treated|Double Blind Phase (26 Weeks)||88
4973872|NCT02592434|12233462|P1|Treated|Double Blind Phase (26 Weeks)||0
4973873|NCT02592434|12233460|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
4973874|NCT02592434|12233461|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
4973875|NCT02592434|12233462|P1|STARTED|Double Blind Phase (26 Weeks)||0
4973876|NCT02592434|12233460|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
4973877|NCT02592434|12233461|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
4973878|NCT02592434|12233462|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
4973879|NCT02592434|12233460|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
4973880|NCT02592434|12233461|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
4973881|NCT02592434|12233462|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
4973882|NCT02592434|12233460|P3|Treated|Open-Label Phase (18 Weeks)||0
4973883|NCT02592434|12233461|P2|Treated|Open-Label Phase (18 Weeks)||0
4973884|NCT02592434|12233462|P1|Treated|Open-Label Phase (18 Weeks)||225
4973885|NCT02592434|12233460|P3|STARTED|Open-Label Phase (18 Weeks)||0
4973886|NCT02592434|12233461|P2|STARTED|Open-Label Phase (18 Weeks)||0
4973887|NCT02592434|12233462|P1|STARTED|Open-Label Phase (18 Weeks)||225
4973888|NCT02592421|12233580|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
4973889|NCT02592421|12233581|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
4973890|NCT02592421|12233580|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
4973891|NCT02592421|12233581|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
4973892|NCT02592421|12233580|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
4973893|NCT02592421|12233581|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
4973894|NCT02592421|12233580|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
4973895|NCT02592421|12233581|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
4973896|NCT02592421|12233580|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
4973897|NCT02592421|12233581|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
4973898|NCT02592421|12233580|P2|STARTED|Study 2: Glucose Clamp Conditions||10
4973899|NCT02592421|12233581|P1|STARTED|Study 2: Glucose Clamp Conditions||20
4973900|NCT02592421|12233580|P2|NOT COMPLETED|Study 1||0
4973901|NCT02592421|12233581|P1|NOT COMPLETED|Study 1||0
4973902|NCT02592421|12233580|P2|COMPLETED|Study 1||10
4973903|NCT02592421|12233581|P1|COMPLETED|Study 1||20
4973904|NCT02592421|12233580|P2|STARTED|Study 1||10
4973905|NCT02592421|12233581|P1|STARTED|Study 1||20
4973906|NCT02591537|12233595|P2|NOT COMPLETED|Overall Study||0
4973907|NCT02591537|12233596|P1|NOT COMPLETED|Overall Study||0
4973908|NCT02591537|12233595|P2|COMPLETED|Overall Study||8
4973909|NCT02591537|12233596|P1|COMPLETED|Overall Study||8
4973910|NCT02591537|12233595|P2|STARTED|Overall Study||8
4973911|NCT02591537|12233596|P1|STARTED|Overall Study||8
4973912|NCT02591511|12233618|P2|NOT COMPLETED|Overall Study||0
4973913|NCT02591511|12233619|P1|NOT COMPLETED|Overall Study||0
4973914|NCT02591511|12233618|P2|COMPLETED|Overall Study||33
4973915|NCT02591511|12233619|P1|COMPLETED|Overall Study||30
4973916|NCT02591511|12233618|P2|STARTED|Overall Study||33
4973917|NCT02591511|12233619|P1|STARTED|Overall Study||30
4973918|NCT02591290|12233625|P1|NOT COMPLETED|Overall Study||2
4973919|NCT02591290|12233625|P1|COMPLETED|Overall Study||58
4973920|NCT02591290|12233625|P1|Vaccinated Dose 2|Overall Study||58
4973921|NCT02591290|12233625|P1|Vaccinated Dose 1|Overall Study||60
4973922|NCT02591290|12233625|P1|STARTED|Overall Study||60
4973923|NCT02591238|12233635|P4|NOT COMPLETED|Overall Study||3
4973924|NCT02591238|12233636|P3|NOT COMPLETED|Overall Study||0
4973925|NCT02591238|12233637|P2|NOT COMPLETED|Overall Study||1
4973926|NCT02591238|12233638|P1|NOT COMPLETED|Overall Study||1
4973927|NCT02591238|12233635|P4|COMPLETED|Overall Study||15
4973928|NCT02591238|12233636|P3|COMPLETED|Overall Study||17
4973929|NCT02591238|12233637|P2|COMPLETED|Overall Study||16
4973930|NCT02591238|12233638|P1|COMPLETED|Overall Study||15
4973931|NCT02591238|12233635|P4|STARTED|Overall Study||18
4973932|NCT02591238|12233636|P3|STARTED|Overall Study||17
4973933|NCT02591238|12233637|P2|STARTED|Overall Study||17
4973934|NCT02591238|12233638|P1|STARTED|Overall Study||16
4973935|NCT02591056|12233668|P1|NOT COMPLETED|Overall Study||0
4973936|NCT02591056|12233668|P1|COMPLETED|Overall Study||27
4973937|NCT02591056|12233668|P1|STARTED|Overall Study||27
4973938|NCT02590939|12233674|P2|NOT COMPLETED|Overall Study||2
4973939|NCT02590939|12233675|P1|NOT COMPLETED|Overall Study||5
4973940|NCT02590939|12233674|P2|COMPLETED|Overall Study||52
4973941|NCT02590939|12233675|P1|COMPLETED|Overall Study||47
4973942|NCT02590939|12233674|P2|STARTED|Overall Study||54
4973943|NCT02590939|12233675|P1|STARTED|Overall Study||52
4973944|NCT02590588|12233695|P1|NOT COMPLETED|Overall Study||1
4973945|NCT02590588|12233695|P1|COMPLETED|Overall Study||0
4973946|NCT02590588|12233695|P1|STARTED|Overall Study||1
4973947|NCT02590562|12233703|P1|NOT COMPLETED|Overall Study||6
4973948|NCT02590562|12233703|P1|COMPLETED|Overall Study||802
4973949|NCT02590562|12233703|P1|STARTED|Overall Study||808
4973950|NCT02590432|12233762|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
4973951|NCT02590432|12233763|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
4973952|NCT02590432|12233764|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973953|NCT02590432|12233765|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973954|NCT02590432|12233766|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973955|NCT02590432|12233767|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973956|NCT02590432|12233768|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973957|NCT02590432|12233769|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973958|NCT02590432|12233770|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
4973959|NCT02590432|12233762|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
4973960|NCT02590432|12233763|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
4973961|NCT02590432|12233764|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973962|NCT02590432|12233765|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973963|NCT02590432|12233766|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973964|NCT02590432|12233767|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973965|NCT02590432|12233768|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973966|NCT02590432|12233769|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973967|NCT02590432|12233770|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
4973968|NCT02590432|12233762|P9|STARTED|Dose-reduced Open Label Treatment Period||26
4973969|NCT02590432|12233763|P8|STARTED|Dose-reduced Open Label Treatment Period||31
4973970|NCT02590432|12233764|P7|STARTED|Dose-reduced Open Label Treatment Period||0
4973971|NCT02590432|12233765|P6|STARTED|Dose-reduced Open Label Treatment Period||0
4973972|NCT02590432|12233766|P5|STARTED|Dose-reduced Open Label Treatment Period||0
4973973|NCT02590432|12233767|P4|STARTED|Dose-reduced Open Label Treatment Period||0
4973974|NCT02590432|12233768|P3|STARTED|Dose-reduced Open Label Treatment Period||0
4973975|NCT02590432|12233769|P2|STARTED|Dose-reduced Open Label Treatment Period||0
4973976|NCT02590432|12233770|P1|STARTED|Dose-reduced Open Label Treatment Period||0
4973977|NCT02590432|12233762|P9|NOT COMPLETED|Double-blind Treatment Period||0
4973978|NCT02590432|12233763|P8|NOT COMPLETED|Double-blind Treatment Period||0
4973979|NCT02590432|12233764|P7|NOT COMPLETED|Double-blind Treatment Period||21
4973980|NCT02590432|12233765|P6|NOT COMPLETED|Double-blind Treatment Period||26
4973981|NCT02590432|12233766|P5|NOT COMPLETED|Double-blind Treatment Period||9
4973982|NCT02590432|12233767|P4|NOT COMPLETED|Double-blind Treatment Period||15
4973983|NCT02590432|12233768|P3|NOT COMPLETED|Double-blind Treatment Period||17
4973984|NCT02590432|12233769|P2|NOT COMPLETED|Double-blind Treatment Period||0
4973985|NCT02590432|12233770|P1|NOT COMPLETED|Double-blind Treatment Period||0
4973986|NCT02590432|12233762|P9|COMPLETED|Double-blind Treatment Period||0
4973987|NCT02590432|12233763|P8|COMPLETED|Double-blind Treatment Period||0
4973988|NCT02590432|12233764|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
4973989|NCT02590432|12233765|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
4973990|NCT02590432|12233766|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
4973991|NCT02590432|12233767|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
4973992|NCT02590432|12233768|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
4973993|NCT02590432|12233769|P2|COMPLETED|Double-blind Treatment Period||0
4973994|NCT02590432|12233770|P1|COMPLETED|Double-blind Treatment Period||0
4973995|NCT02590432|12233762|P9|STARTED|Double-blind Treatment Period||0
4973996|NCT02590432|12233763|P8|STARTED|Double-blind Treatment Period||0
4973997|NCT02590432|12233764|P7|STARTED|Double-blind Treatment Period||30
4973998|NCT02590432|12233765|P6|STARTED|Double-blind Treatment Period||32
4973999|NCT02590432|12233766|P5|STARTED|Double-blind Treatment Period||16
4974000|NCT02590432|12233767|P4|STARTED|Double-blind Treatment Period||18
4974001|NCT02590432|12233768|P3|STARTED|Double-blind Treatment Period||18
4974002|NCT02590432|12233769|P2|STARTED|Double-blind Treatment Period||0
4974003|NCT02590432|12233770|P1|STARTED|Double-blind Treatment Period||0
4974004|NCT02590432|12233762|P9|NOT COMPLETED|Open-label Treatment Period||0
4974005|NCT02590432|12233763|P8|NOT COMPLETED|Open-label Treatment Period||0
4974006|NCT02590432|12233764|P7|NOT COMPLETED|Open-label Treatment Period||0
4974007|NCT02590432|12233765|P6|NOT COMPLETED|Open-label Treatment Period||0
4974008|NCT02590432|12233766|P5|NOT COMPLETED|Open-label Treatment Period||0
4974009|NCT02590432|12233767|P4|NOT COMPLETED|Open-label Treatment Period||0
4974010|NCT02590432|12233768|P3|NOT COMPLETED|Open-label Treatment Period||0
4974011|NCT02590432|12233769|P2|NOT COMPLETED|Open-label Treatment Period||152
4974012|NCT02590432|12233770|P1|NOT COMPLETED|Open-label Treatment Period||232
4974013|NCT02590432|12233762|P9|COMPLETED|Open-label Treatment Period||0
4974014|NCT02590432|12233763|P8|COMPLETED|Open-label Treatment Period||0
4974015|NCT02590432|12233764|P7|COMPLETED|Open-label Treatment Period||0
4974016|NCT02590432|12233765|P6|COMPLETED|Open-label Treatment Period||0
4974017|NCT02590432|12233766|P5|COMPLETED|Open-label Treatment Period||0
4974018|NCT02590432|12233767|P4|COMPLETED|Open-label Treatment Period||0
4974019|NCT02590432|12233768|P3|COMPLETED|Open-label Treatment Period||0
4974020|NCT02590432|12233769|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
4974021|NCT02590432|12233770|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
4974022|NCT02590432|12233762|P9|STARTED|Open-label Treatment Period||0
4974023|NCT02590432|12233763|P8|STARTED|Open-label Treatment Period||0
4974024|NCT02590432|12233764|P7|STARTED|Open-label Treatment Period||0
4974025|NCT02590432|12233765|P6|STARTED|Open-label Treatment Period||0
4974026|NCT02590432|12233766|P5|STARTED|Open-label Treatment Period||0
4974027|NCT02590432|12233767|P4|STARTED|Open-label Treatment Period||0
4974028|NCT02590432|12233768|P3|STARTED|Open-label Treatment Period||0
4974029|NCT02590432|12233769|P2|STARTED|Open-label Treatment Period||318
4974030|NCT02590432|12233770|P1|STARTED|Open-label Treatment Period||508
4974031|NCT02590406|12233806|P2|NOT COMPLETED|Overall Study||1
4974032|NCT02590406|12233807|P1|NOT COMPLETED|Overall Study||1
4974033|NCT02590406|12233806|P2|COMPLETED|Overall Study||24
4974034|NCT02590406|12233807|P1|COMPLETED|Overall Study||24
4974035|NCT02590406|12233806|P2|STARTED|Overall Study||25
4974036|NCT02590406|12233807|P1|STARTED|Overall Study||25
4974037|NCT02590354|12233821|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
4974038|NCT02590354|12233821|P1|COMPLETED|Phase 2 - Treatment Interruption||14
4974039|NCT02590354|12233821|P1|STARTED|Phase 2 - Treatment Interruption||16
4974040|NCT02590354|12233821|P1|NOT COMPLETED|Phase 1||98
4974041|NCT02590354|12233821|P1|COMPLETED|Phase 1||16
4974042|NCT02590354|12233821|P1|STARTED|Phase 1||114
4974043|NCT02590068|12233831|P2|NOT COMPLETED|Overall Study||0
4974044|NCT02590068|12233832|P1|NOT COMPLETED|Overall Study||0
4974045|NCT02590068|12233831|P2|COMPLETED|Overall Study||14
4974046|NCT02590068|12233832|P1|COMPLETED|Overall Study||0
4974047|NCT02590068|12233831|P2|STARTED|Overall Study||14
4974048|NCT02590068|12233832|P1|STARTED|Overall Study||0
4974049|NCT02590003|12233848|P2|NOT COMPLETED|Overall Study||2
4974050|NCT02590003|12233849|P1|NOT COMPLETED|Overall Study||1
4974051|NCT02590003|12233848|P2|COMPLETED|Overall Study||0
4974052|NCT02590003|12233849|P1|COMPLETED|Overall Study||0
4974053|NCT02590003|12233848|P2|STARTED|Overall Study||2
4974054|NCT02590003|12233849|P1|STARTED|Overall Study||1
4974055|NCT02589847|12233871|P2|NOT COMPLETED|Overall Study||0
4974056|NCT02589847|12233872|P1|NOT COMPLETED|Overall Study||15
4974057|NCT02589847|12233871|P2|COMPLETED|Overall Study||110
4974058|NCT02589847|12233872|P1|COMPLETED|Overall Study||136
4974059|NCT02589847|12233871|P2|STARTED|Overall Study||110
4974060|NCT02589847|12233872|P1|STARTED|Overall Study||151
4974061|NCT02589808|12233878|P1|NOT COMPLETED|Overall Study||0
4974062|NCT02589808|12233878|P1|COMPLETED|Overall Study||76
4974063|NCT02589808|12233878|P1|STARTED|Overall Study||76
4974064|NCT02589665|12233886|P10|NOT COMPLETED|Maintenance Extension Period||68
4974065|NCT02589665|12233887|P9|NOT COMPLETED|Maintenance Extension Period||0
4974066|NCT02589665|12233888|P8|NOT COMPLETED|Maintenance Extension Period||0
4974067|NCT02589665|12233889|P7|NOT COMPLETED|Maintenance Extension Period||0
4974068|NCT02589665|12233890|P6|NOT COMPLETED|Maintenance Extension Period||0
4974069|NCT02589665|12233891|P5|NOT COMPLETED|Maintenance Extension Period||0
4974070|NCT02589665|12233892|P4|NOT COMPLETED|Maintenance Extension Period||0
4974071|NCT02589665|12233893|P3|NOT COMPLETED|Maintenance Extension Period||0
4974072|NCT02589665|12233894|P2|NOT COMPLETED|Maintenance Extension Period||0
4974073|NCT02589665|12233895|P1|NOT COMPLETED|Maintenance Extension Period||0
4974074|NCT02589665|12233886|P10|COMPLETED|Maintenance Extension Period||0
4974075|NCT02589665|12233887|P9|COMPLETED|Maintenance Extension Period||0
4974076|NCT02589665|12233888|P8|COMPLETED|Maintenance Extension Period||0
4974077|NCT02589665|12233889|P7|COMPLETED|Maintenance Extension Period||0
4974078|NCT02589665|12233890|P6|COMPLETED|Maintenance Extension Period||0
4974079|NCT02589665|12233891|P5|COMPLETED|Maintenance Extension Period||0
4974080|NCT02589665|12233892|P4|COMPLETED|Maintenance Extension Period||0
4974081|NCT02589665|12233893|P3|COMPLETED|Maintenance Extension Period||0
4974082|NCT02589665|12233894|P2|COMPLETED|Maintenance Extension Period||0
4974083|NCT02589665|12233895|P1|COMPLETED|Maintenance Extension Period||0
4974084|NCT02589665|12233886|P10|STARTED|Maintenance Extension Period||68
4974085|NCT02589665|12233887|P9|STARTED|Maintenance Extension Period||0
4974086|NCT02589665|12233888|P8|STARTED|Maintenance Extension Period||0
4974087|NCT02589665|12233889|P7|STARTED|Maintenance Extension Period||0
4974088|NCT02589665|12233890|P6|STARTED|Maintenance Extension Period||0
4974089|NCT02589665|12233891|P5|STARTED|Maintenance Extension Period||0
4974090|NCT02589665|12233892|P4|STARTED|Maintenance Extension Period||0
4974091|NCT02589665|12233893|P3|STARTED|Maintenance Extension Period||0
4974092|NCT02589665|12233894|P2|STARTED|Maintenance Extension Period||0
4974093|NCT02589665|12233895|P1|STARTED|Maintenance Extension Period||0
4974094|NCT02589665|12233886|P10|NOT COMPLETED|Induction Extension Period||0
4974095|NCT02589665|12233887|P9|NOT COMPLETED|Induction Extension Period||12
4974096|NCT02589665|12233888|P8|NOT COMPLETED|Induction Extension Period||2
4974097|NCT02589665|12233889|P7|NOT COMPLETED|Induction Extension Period||0
4974098|NCT02589665|12233890|P6|NOT COMPLETED|Induction Extension Period||0
4974099|NCT02589665|12233891|P5|NOT COMPLETED|Induction Extension Period||0
4974100|NCT02589665|12233892|P4|NOT COMPLETED|Induction Extension Period||0
4974101|NCT02589665|12233893|P3|NOT COMPLETED|Induction Extension Period||0
4974102|NCT02589665|12233894|P2|NOT COMPLETED|Induction Extension Period||0
4974103|NCT02589665|12233895|P1|NOT COMPLETED|Induction Extension Period||0
4974104|NCT02589665|12233886|P10|COMPLETED|Induction Extension Period||0
4974105|NCT02589665|12233887|P9|COMPLETED|Induction Extension Period||84
4974106|NCT02589665|12233888|P8|COMPLETED|Induction Extension Period||30
4974107|NCT02589665|12233889|P7|COMPLETED|Induction Extension Period||0
4974108|NCT02589665|12233890|P6|COMPLETED|Induction Extension Period||0
4974109|NCT02589665|12233891|P5|COMPLETED|Induction Extension Period||0
4974110|NCT02589665|12233892|P4|COMPLETED|Induction Extension Period||0
4974111|NCT02589665|12233893|P3|COMPLETED|Induction Extension Period||0
4974112|NCT02589665|12233894|P2|COMPLETED|Induction Extension Period||0
4974113|NCT02589665|12233895|P1|COMPLETED|Induction Extension Period||0
4974114|NCT02589665|12233886|P10|STARTED|Induction Extension Period||0
4974115|NCT02589665|12233887|P9|STARTED|Induction Extension Period||96
4974116|NCT02589665|12233888|P8|STARTED|Induction Extension Period||32
4974117|NCT02589665|12233889|P7|STARTED|Induction Extension Period||0
4974118|NCT02589665|12233890|P6|STARTED|Induction Extension Period||0
4974119|NCT02589665|12233891|P5|STARTED|Induction Extension Period||0
4974120|NCT02589665|12233892|P4|STARTED|Induction Extension Period||0
4974121|NCT02589665|12233893|P3|STARTED|Induction Extension Period||0
4974122|NCT02589665|12233894|P2|STARTED|Induction Extension Period||0
4974123|NCT02589665|12233895|P1|STARTED|Induction Extension Period||0
4974124|NCT02589665|12233886|P10|NOT COMPLETED|Maintenance Period||0
4974125|NCT02589665|12233887|P9|NOT COMPLETED|Maintenance Period||0
4974126|NCT02589665|12233888|P8|NOT COMPLETED|Maintenance Period||0
4974127|NCT02589665|12233889|P7|NOT COMPLETED|Maintenance Period||46
4974128|NCT02589665|12233890|P6|NOT COMPLETED|Maintenance Period||47
4974129|NCT02589665|12233891|P5|NOT COMPLETED|Maintenance Period||13
4974130|NCT02589665|12233892|P4|NOT COMPLETED|Maintenance Period||0
4974131|NCT02589665|12233893|P3|NOT COMPLETED|Maintenance Period||0
4974132|NCT02589665|12233894|P2|NOT COMPLETED|Maintenance Period||0
4974133|NCT02589665|12233895|P1|NOT COMPLETED|Maintenance Period||0
4974134|NCT02589665|12233886|P10|COMPLETED|Maintenance Period||0
4974135|NCT02589665|12233887|P9|COMPLETED|Maintenance Period||0
4974136|NCT02589665|12233888|P8|COMPLETED|Maintenance Period||0
4974137|NCT02589665|12233889|P7|COMPLETED|Maintenance Period||0
4974138|NCT02589665|12233890|P6|COMPLETED|Maintenance Period||0
4974139|NCT02589665|12233891|P5|COMPLETED|Maintenance Period||0
4974140|NCT02589665|12233892|P4|COMPLETED|Maintenance Period||0
4974141|NCT02589665|12233893|P3|COMPLETED|Maintenance Period||0
4974142|NCT02589665|12233894|P2|COMPLETED|Maintenance Period||0
4974143|NCT02589665|12233895|P1|COMPLETED|Maintenance Period||0
4974144|NCT02589665|12233886|P10|STARTED|Maintenance Period||0
4974145|NCT02589665|12233887|P9|STARTED|Maintenance Period||0
4974146|NCT02589665|12233888|P8|STARTED|Maintenance Period||0
4974147|NCT02589665|12233889|P7|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
4974148|NCT02589665|12233890|P6|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
4974149|NCT02589665|12233891|P5|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
4974150|NCT02589665|12233892|P4|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
4974151|NCT02589665|12233893|P3|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
4974152|NCT02589665|12233894|P2|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
4974153|NCT02589665|12233895|P1|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
4974154|NCT02589665|12233886|P10|NOT COMPLETED|Induction Period||0
4974155|NCT02589665|12233887|P9|NOT COMPLETED|Induction Period||0
4974156|NCT02589665|12233888|P8|NOT COMPLETED|Induction Period||0
4974157|NCT02589665|12233889|P7|NOT COMPLETED|Induction Period||0
4974158|NCT02589665|12233890|P6|NOT COMPLETED|Induction Period||0
4974159|NCT02589665|12233891|P5|NOT COMPLETED|Induction Period||0
4974160|NCT02589665|12233892|P4|NOT COMPLETED|Induction Period||4
4974161|NCT02589665|12233893|P3|NOT COMPLETED|Induction Period||2
4974162|NCT02589665|12233894|P2|NOT COMPLETED|Induction Period||2
4974163|NCT02589665|12233895|P1|NOT COMPLETED|Induction Period||3
4974164|NCT02589665|12233886|P10|COMPLETED|Induction Period||0
4974165|NCT02589665|12233887|P9|COMPLETED|Induction Period||0
4974166|NCT02589665|12233888|P8|COMPLETED|Induction Period||0
4974167|NCT02589665|12233889|P7|COMPLETED|Induction Period||0
4974168|NCT02589665|12233890|P6|COMPLETED|Induction Period||0
4974169|NCT02589665|12233891|P5|COMPLETED|Induction Period||0
4974170|NCT02589665|12233892|P4|COMPLETED|Induction Period||57
4974171|NCT02589665|12233893|P3|COMPLETED|Induction Period||60
4974172|NCT02589665|12233894|P2|COMPLETED|Induction Period||61
4974173|NCT02589665|12233895|P1|COMPLETED|Induction Period||60
4974174|NCT02589665|12233886|P10|Received at Least One Dose of Study Drug|Induction Period||0
4974175|NCT02589665|12233887|P9|Received at Least One Dose of Study Drug|Induction Period||0
4974176|NCT02589665|12233888|P8|Received at Least One Dose of Study Drug|Induction Period||0
4974177|NCT02589665|12233889|P7|Received at Least One Dose of Study Drug|Induction Period||0
4974178|NCT02589665|12233890|P6|Received at Least One Dose of Study Drug|Induction Period||0
4974179|NCT02589665|12233891|P5|Received at Least One Dose of Study Drug|Induction Period||0
4974180|NCT02589665|12233892|P4|Received at Least One Dose of Study Drug|Induction Period||60
4974181|NCT02589665|12233893|P3|Received at Least One Dose of Study Drug|Induction Period||62
4974182|NCT02589665|12233894|P2|Received at Least One Dose of Study Drug|Induction Period||63
4974183|NCT02589665|12233895|P1|Received at Least One Dose of Study Drug|Induction Period||63
4974184|NCT02589665|12233886|P10|STARTED|Induction Period||0
4974185|NCT02589665|12233887|P9|STARTED|Induction Period||0
4974186|NCT02589665|12233888|P8|STARTED|Induction Period||0
4974187|NCT02589665|12233889|P7|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
4974188|NCT02589665|12233890|P6|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
4974189|NCT02589665|12233891|P5|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
4974190|NCT02589665|12233892|P4|STARTED|Induction Period||61
4974191|NCT02589665|12233893|P3|STARTED|Induction Period||62
4974192|NCT02589665|12233894|P2|STARTED|Induction Period||63
4974193|NCT02589665|12233895|P1|STARTED|Induction Period||63
4974194|NCT02589639|12233960|P3|NOT COMPLETED|Overall Study||4
4974195|NCT02589639|12233961|P2|NOT COMPLETED|Overall Study||10
4974196|NCT02589639|12233962|P1|NOT COMPLETED|Overall Study||10
4974197|NCT02589639|12233960|P3|COMPLETED|Overall Study||86
4974198|NCT02589639|12233961|P2|COMPLETED|Overall Study||79
4974199|NCT02589639|12233962|P1|COMPLETED|Overall Study||80
4974200|NCT02589639|12233960|P3|Treated|Overall Study||90
4974201|NCT02589639|12233961|P2|Treated|Overall Study||86
4974202|NCT02589639|12233962|P1|Treated|Overall Study||90
4974203|NCT02589639|12233960|P3|STARTED|Overall Study||90
4974204|NCT02589639|12233961|P2|STARTED|Overall Study||89
4974205|NCT02589639|12233962|P1|STARTED|Overall Study||90
4974206|NCT02589626|12233975|P2|NOT COMPLETED|Overall Study||2
4974207|NCT02589626|12233976|P1|NOT COMPLETED|Overall Study||3
4974208|NCT02589626|12233975|P2|COMPLETED|Overall Study||31
4974209|NCT02589626|12233976|P1|COMPLETED|Overall Study||29
4974210|NCT02589626|12233975|P2|STARTED|Overall Study|Entered are treated patients|33
4974211|NCT02589626|12233976|P1|STARTED|Overall Study|Entered are treated patients|32
4974212|NCT02589405|12233984|P1|NOT COMPLETED|Overall Study||4
4974213|NCT02589405|12233984|P1|COMPLETED|Overall Study||46
4974214|NCT02589405|12233984|P1|STARTED|Overall Study||50
4974215|NCT02589171|12233990|P2|NOT COMPLETED|Overall Study||5
4974216|NCT02589171|12233991|P1|NOT COMPLETED|Overall Study||7
4974217|NCT02589171|12233990|P2|COMPLETED|Overall Study||30
4974218|NCT02589171|12233991|P1|COMPLETED|Overall Study||28
4974219|NCT02589171|12233990|P2|Week 6 Follow up|Overall Study||30
4974220|NCT02589171|12233991|P1|Week 6 Follow up|Overall Study||28
4974221|NCT02589171|12233990|P2|Week 1 Follow up|Overall Study||34
4974222|NCT02589171|12233991|P1|Week 1 Follow up|Overall Study||35
4974223|NCT02589171|12233990|P2|Day 1 Follow up|Overall Study||35
4974224|NCT02589171|12233991|P1|Day 1 Follow up|Overall Study||35
4974225|NCT02589171|12233990|P2|STARTED|Overall Study||35
4974226|NCT02589171|12233991|P1|STARTED|Overall Study||35
4974227|NCT02589145|12234034|P3|NOT COMPLETED|Overall Study||0
4974228|NCT02589145|12234035|P2|NOT COMPLETED|Overall Study||0
4974229|NCT02589145|12234036|P1|NOT COMPLETED|Overall Study||0
4974230|NCT02589145|12234034|P3|COMPLETED|Overall Study||2
4974231|NCT02589145|12234035|P2|COMPLETED|Overall Study||2
4974232|NCT02589145|12234036|P1|COMPLETED|Overall Study||4
4974233|NCT02589145|12234034|P3|STARTED|Overall Study||2
4974234|NCT02589145|12234035|P2|STARTED|Overall Study||2
4974235|NCT02589145|12234036|P1|STARTED|Overall Study||4
4974236|NCT02588976|12234062|P1|NOT COMPLETED|Overall Study||0
4974237|NCT02588976|12234062|P1|COMPLETED|Overall Study||30
4974238|NCT02588976|12234062|P1|STARTED|Overall Study||30
4974239|NCT02588872|12234069|P2|NOT COMPLETED|Overall Study||0
4974240|NCT02588872|12234070|P1|NOT COMPLETED|Overall Study||0
4974241|NCT02588872|12234069|P2|COMPLETED|Overall Study||52
4974242|NCT02588872|12234070|P1|COMPLETED|Overall Study||59
4974243|NCT02588872|12234069|P2|STARTED|Overall Study||52
4974244|NCT02588872|12234070|P1|STARTED|Overall Study||59
4974245|NCT02588599|12234084|P1|NOT COMPLETED|Overall Study||0
4974246|NCT02588599|12234084|P1|COMPLETED|Overall Study||54
4974247|NCT02588599|12234084|P1|STARTED|Overall Study||54
4974248|NCT02588573|12234091|P2|NOT COMPLETED|Overall Study||0
4974249|NCT02588573|12234092|P1|NOT COMPLETED|Overall Study||0
4974250|NCT02588573|12234091|P2|COMPLETED|Overall Study||45
4974251|NCT02588573|12234092|P1|COMPLETED|Overall Study||45
4974252|NCT02588573|12234091|P2|Randomized Eye Somofilcon A|Overall Study||45
4974253|NCT02588573|12234092|P1|Randomized Eye Somofilcon A|Overall Study||45
4974254|NCT02588573|12234091|P2|Randomized Eye Etafilcon A|Overall Study||45
4974255|NCT02588573|12234092|P1|Randomized Eye Etafilcon A|Overall Study||45
4974256|NCT02588573|12234091|P2|STARTED|Overall Study||45
4974257|NCT02588573|12234092|P1|STARTED|Overall Study||45
4974258|NCT02588339|12234122|P1|NOT COMPLETED|Overall Study||3
4974259|NCT02588339|12234122|P1|COMPLETED|Overall Study||39
4974260|NCT02588339|12234122|P1|STARTED|Overall Study||42
4974261|NCT02588261|12234134|P2|NOT COMPLETED|Overall Study||263
4974262|NCT02588261|12234135|P1|NOT COMPLETED|Overall Study||267
4974263|NCT02588261|12234134|P2|COMPLETED|Overall Study||0
4974264|NCT02588261|12234135|P1|COMPLETED|Overall Study||0
4974265|NCT02588261|12234134|P2|Treated|Overall Study||262
4974266|NCT02588261|12234135|P1|Treated|Overall Study||265
4974267|NCT02588261|12234134|P2|STARTED|Overall Study||263
4974268|NCT02588261|12234135|P1|STARTED|Overall Study||267
4974269|NCT02588092|12234171|P10|NOT COMPLETED|Overall Study||3
4974270|NCT02588092|12234172|P9|NOT COMPLETED|Overall Study||6
4974271|NCT02588092|12234173|P8|NOT COMPLETED|Overall Study||4
4974272|NCT02588092|12234174|P7|NOT COMPLETED|Overall Study||3
4974273|NCT02588092|12234175|P6|NOT COMPLETED|Overall Study||3
4974274|NCT02588092|12234176|P5|NOT COMPLETED|Overall Study||3
4974275|NCT02588092|12234177|P4|NOT COMPLETED|Overall Study||3
4974276|NCT02588092|12234178|P3|NOT COMPLETED|Overall Study||3
4974277|NCT02588092|12234179|P2|NOT COMPLETED|Overall Study||3
4974278|NCT02588092|12234180|P1|NOT COMPLETED|Overall Study||4
4974279|NCT02588092|12234171|P10|COMPLETED|Overall Study||0
4974280|NCT02588092|12234172|P9|COMPLETED|Overall Study||0
4974281|NCT02588092|12234173|P8|COMPLETED|Overall Study||0
4974282|NCT02588092|12234174|P7|COMPLETED|Overall Study||0
4974283|NCT02588092|12234175|P6|COMPLETED|Overall Study||0
4974284|NCT02588092|12234176|P5|COMPLETED|Overall Study||0
4974285|NCT02588092|12234177|P4|COMPLETED|Overall Study||0
4974286|NCT02588092|12234178|P3|COMPLETED|Overall Study||0
4974287|NCT02588092|12234179|P2|COMPLETED|Overall Study||0
4974288|NCT02588092|12234180|P1|COMPLETED|Overall Study||0
4974289|NCT02588092|12234171|P10|STARTED|Overall Study||3
4974290|NCT02588092|12234172|P9|STARTED|Overall Study||6
4974291|NCT02588092|12234173|P8|STARTED|Overall Study||4
4974292|NCT02588092|12234174|P7|STARTED|Overall Study||3
4974293|NCT02588092|12234175|P6|STARTED|Overall Study||3
4974294|NCT02588092|12234176|P5|STARTED|Overall Study||3
4974295|NCT02588092|12234177|P4|STARTED|Overall Study||3
4974296|NCT02588092|12234178|P3|STARTED|Overall Study||3
4974297|NCT02588092|12234179|P2|STARTED|Overall Study||3
4974298|NCT02588092|12234180|P1|STARTED|Overall Study||4
4974299|NCT02587819|12234374|P1|NOT COMPLETED|Overall Study||2
4974300|NCT02587819|12234374|P1|COMPLETED|Overall Study||19
4974301|NCT02587819|12234374|P1|Exposed|Overall Study||21
4974302|NCT02587819|12234374|P1|STARTED|Overall Study||21
4974303|NCT02587650|12234381|P4|NOT COMPLETED|Overall Study||0
4974304|NCT02587650|12234382|P3|NOT COMPLETED|Overall Study||0
4974305|NCT02587650|12234383|P2|NOT COMPLETED|Overall Study||0
4974306|NCT02587650|12234384|P1|NOT COMPLETED|Overall Study||0
4974307|NCT02587650|12234381|P4|COMPLETED|Overall Study||0
4974308|NCT02587650|12234382|P3|COMPLETED|Overall Study||1
4974309|NCT02587650|12234383|P2|COMPLETED|Overall Study||0
4974310|NCT02587650|12234384|P1|COMPLETED|Overall Study||0
4974311|NCT02587650|12234381|P4|STARTED|Overall Study||0
4974312|NCT02587650|12234382|P3|STARTED|Overall Study||1
4974313|NCT02587650|12234383|P2|STARTED|Overall Study||0
4974314|NCT02587650|12234384|P1|STARTED|Overall Study||0
4974315|NCT02587520|12234410|P18|NOT COMPLETED|Overall Study||0
4974316|NCT02587520|12234411|P17|NOT COMPLETED|Overall Study||0
4974317|NCT02587520|12234412|P16|NOT COMPLETED|Overall Study||0
4974318|NCT02587520|12234413|P15|NOT COMPLETED|Overall Study||0
4974319|NCT02587520|12234414|P14|NOT COMPLETED|Overall Study||1
4974320|NCT02587520|12234415|P13|NOT COMPLETED|Overall Study||0
4974321|NCT02587520|12234416|P12|NOT COMPLETED|Overall Study||4
4974322|NCT02587520|12234417|P11|NOT COMPLETED|Overall Study||3
4974323|NCT02587520|12234418|P10|NOT COMPLETED|Overall Study||5
4974324|NCT02587520|12234419|P9|NOT COMPLETED|Overall Study||3
4974325|NCT02587520|12234420|P8|NOT COMPLETED|Overall Study||2
4974326|NCT02587520|12234421|P7|NOT COMPLETED|Overall Study||3
4974327|NCT02587520|12234422|P6|NOT COMPLETED|Overall Study||3
4974328|NCT02587520|12234423|P5|NOT COMPLETED|Overall Study||0
4974329|NCT02587520|12234424|P4|NOT COMPLETED|Overall Study||5
4974330|NCT02587520|12234425|P3|NOT COMPLETED|Overall Study||1
4974331|NCT02587520|12234426|P2|NOT COMPLETED|Overall Study||2
4974332|NCT02587520|12234427|P1|NOT COMPLETED|Overall Study||2
4974333|NCT02587520|12234410|P18|COMPLETED|Overall Study||78
4974334|NCT02587520|12234411|P17|COMPLETED|Overall Study||76
4974335|NCT02587520|12234412|P16|COMPLETED|Overall Study||72
4974336|NCT02587520|12234413|P15|COMPLETED|Overall Study||78
4974337|NCT02587520|12234414|P14|COMPLETED|Overall Study||73
4974338|NCT02587520|12234415|P13|COMPLETED|Overall Study||77
4974339|NCT02587520|12234416|P12|COMPLETED|Overall Study||69
4974340|NCT02587520|12234417|P11|COMPLETED|Overall Study||73
4974341|NCT02587520|12234418|P10|COMPLETED|Overall Study||71
4974342|NCT02587520|12234419|P9|COMPLETED|Overall Study||73
4974343|NCT02587520|12234420|P8|COMPLETED|Overall Study||71
4974344|NCT02587520|12234421|P7|COMPLETED|Overall Study||73
4974345|NCT02587520|12234422|P6|COMPLETED|Overall Study||72
4974346|NCT02587520|12234423|P5|COMPLETED|Overall Study||75
4974347|NCT02587520|12234424|P4|COMPLETED|Overall Study||74
4974348|NCT02587520|12234425|P3|COMPLETED|Overall Study||77
4974349|NCT02587520|12234426|P2|COMPLETED|Overall Study||69
4974350|NCT02587520|12234427|P1|COMPLETED|Overall Study||78
4974351|NCT02587520|12234410|P18|Safety Analysis Set (SafAS)|Overall Study||78
4974352|NCT02587520|12234411|P17|Safety Analysis Set (SafAS)|Overall Study||76
4974353|NCT02587520|12234412|P16|Safety Analysis Set (SafAS)|Overall Study||72
4974354|NCT02587520|12234413|P15|Safety Analysis Set (SafAS)|Overall Study||78
4974355|NCT02587520|12234414|P14|Safety Analysis Set (SafAS)|Overall Study||73
4974356|NCT02587520|12234415|P13|Safety Analysis Set (SafAS)|Overall Study||77
4974357|NCT02587520|12234416|P12|Safety Analysis Set (SafAS)|Overall Study||72
4974358|NCT02587520|12234417|P11|Safety Analysis Set (SafAS)|Overall Study||76
4974359|NCT02587520|12234418|P10|Safety Analysis Set (SafAS)|Overall Study||76
4974360|NCT02587520|12234419|P9|Safety Analysis Set (SafAS)|Overall Study||76
4974361|NCT02587520|12234420|P8|Safety Analysis Set (SafAS)|Overall Study||73
4974362|NCT02587520|12234421|P7|Safety Analysis Set (SafAS)|Overall Study||76
4974363|NCT02587520|12234422|P6|Safety Analysis Set (SafAS)|Overall Study||75
4974364|NCT02587520|12234423|P5|Safety Analysis Set (SafAS)|Overall Study||75
4974365|NCT02587520|12234424|P4|Safety Analysis Set (SafAS)|Overall Study||77
4974366|NCT02587520|12234425|P3|Safety Analysis Set (SafAS)|Overall Study||77
4974367|NCT02587520|12234426|P2|Safety Analysis Set (SafAS)|Overall Study||71
4974368|NCT02587520|12234427|P1|Safety Analysis Set (SafAS)|Overall Study||79
4974369|NCT02587520|12234410|P18|STARTED|Overall Study||78
4974370|NCT02587520|12234411|P17|STARTED|Overall Study||76
4974371|NCT02587520|12234412|P16|STARTED|Overall Study||72
4974372|NCT02587520|12234413|P15|STARTED|Overall Study||78
4974373|NCT02587520|12234414|P14|STARTED|Overall Study||74
4974374|NCT02587520|12234415|P13|STARTED|Overall Study||77
4974375|NCT02587520|12234416|P12|STARTED|Overall Study||73
4974376|NCT02587520|12234417|P11|STARTED|Overall Study||76
4974377|NCT02587520|12234418|P10|STARTED|Overall Study||76
4974378|NCT02587520|12234419|P9|STARTED|Overall Study||76
4974379|NCT02587520|12234420|P8|STARTED|Overall Study||73
4974380|NCT02587520|12234421|P7|STARTED|Overall Study||76
4974381|NCT02587520|12234422|P6|STARTED|Overall Study||75
4974382|NCT02587520|12234423|P5|STARTED|Overall Study||75
4974383|NCT02587520|12234424|P4|STARTED|Overall Study||79
4974384|NCT02587520|12234425|P3|STARTED|Overall Study||78
4974385|NCT02587520|12234426|P2|STARTED|Overall Study||71
4974386|NCT02587520|12234427|P1|STARTED|Overall Study||80
4974387|NCT02587234|12234467|P2|NOT COMPLETED|Overall Study||3
4974388|NCT02587234|12234468|P1|NOT COMPLETED|Overall Study||1
4974389|NCT02587234|12234467|P2|COMPLETED|Overall Study||7
4974390|NCT02587234|12234468|P1|COMPLETED|Overall Study||10
4974391|NCT02587234|12234467|P2|STARTED|Overall Study||10
4974392|NCT02587234|12234468|P1|STARTED|Overall Study||11
4974393|NCT02587221|12234480|P2|NOT COMPLETED|Overall Study||123
4974394|NCT02587221|12234481|P1|NOT COMPLETED|Overall Study||131
4974395|NCT02587221|12234480|P2|COMPLETED|Overall Study||3273
4974396|NCT02587221|12234481|P1|COMPLETED|Overall Study||3263
4974397|NCT02587221|12234480|P2|Treated|Overall Study||3382
4974398|NCT02587221|12234481|P1|Treated|Overall Study||3379
4974399|NCT02587221|12234480|P2|STARTED|Overall Study||3396
4974400|NCT02587221|12234481|P1|STARTED|Overall Study||3394
4974401|NCT02587143|12234527|P2|NOT COMPLETED|Overall Study||0
4974402|NCT02587143|12234528|P1|NOT COMPLETED|Overall Study||1
4974403|NCT02587143|12234527|P2|COMPLETED|Overall Study||60
4974404|NCT02587143|12234528|P1|COMPLETED|Overall Study||65
4974405|NCT02587143|12234527|P2|STARTED|Overall Study||60
4974406|NCT02587143|12234528|P1|STARTED|Overall Study||66
4974407|NCT02587117|12234536|P2|NOT COMPLETED|Overall Study||0
4974408|NCT02587117|12234537|P1|NOT COMPLETED|Overall Study||0
4974409|NCT02587117|12234536|P2|COMPLETED|Overall Study||15
4974410|NCT02587117|12234537|P1|COMPLETED|Overall Study||13
4974411|NCT02587117|12234536|P2|STARTED|Overall Study||15
4974412|NCT02587117|12234537|P1|STARTED|Overall Study||13
4974413|NCT02587065|12234545|P1|NOT COMPLETED|Overall Study||27
4974414|NCT02587065|12234545|P1|COMPLETED|Overall Study||166
4974415|NCT02587065|12234545|P1|STARTED|Overall Study||193
4974416|NCT02586974|12234561|P2|NOT COMPLETED|Overall Study||0
4974417|NCT02586974|12234562|P1|NOT COMPLETED|Overall Study||0
4974418|NCT02586974|12234561|P2|COMPLETED|Overall Study||32
4974419|NCT02586974|12234562|P1|COMPLETED|Overall Study||32
4974420|NCT02586974|12234561|P2|STARTED|Overall Study||32
4974421|NCT02586974|12234562|P1|STARTED|Overall Study||32
4974422|NCT02586909|12234574|P1|NOT COMPLETED|Overall Study||948
4974423|NCT02586909|12234574|P1|COMPLETED|Overall Study||151
4974424|NCT02586909|12234574|P1|STARTED|Overall Study||1099
4974425|NCT02586896|12234580|P2|NOT COMPLETED|Overall Study||17
4974426|NCT02586896|12234581|P1|NOT COMPLETED|Overall Study||19
4974427|NCT02586896|12234580|P2|COMPLETED|Overall Study||133
4974428|NCT02586896|12234581|P1|COMPLETED|Overall Study||131
4974429|NCT02586896|12234580|P2|3-Month Follow-up|Overall Study||123
4974430|NCT02586896|12234581|P1|3-Month Follow-up|Overall Study||126
4974431|NCT02586896|12234580|P2|STARTED|Overall Study||150
4974432|NCT02586896|12234581|P1|STARTED|Overall Study||150
4974433|NCT02586857|12234599|P2|NOT COMPLETED|Overall Study||0
4974434|NCT02586857|12234600|P1|NOT COMPLETED|Overall Study||1
4974435|NCT02586857|12234599|P2|COMPLETED|Overall Study||9
4974436|NCT02586857|12234600|P1|COMPLETED|Overall Study||14
4974437|NCT02586857|12234599|P2|Discontinued Study|Overall Study||9
4974438|NCT02586857|12234600|P1|Discontinued Study|Overall Study||14
4974439|NCT02586857|12234599|P2|Received Study Medication|Overall Study||9
4974440|NCT02586857|12234600|P1|Received Study Medication|Overall Study||15
4974441|NCT02586857|12234599|P2|Enrolled|Overall Study||9
4974442|NCT02586857|12234600|P1|Enrolled|Overall Study||15
4974443|NCT02586857|12234599|P2|STARTED|Overall Study||9
4974444|NCT02586857|12234600|P1|STARTED|Overall Study||15
4974445|NCT02586805|12234610|P4|NOT COMPLETED|Overall Study||2
4974446|NCT02586805|12234611|P3|NOT COMPLETED|Overall Study||3
4974447|NCT02586805|12234612|P2|NOT COMPLETED|Overall Study||1
4974448|NCT02586805|12234613|P1|NOT COMPLETED|Overall Study||6
4974449|NCT02586805|12234610|P4|COMPLETED|Overall Study||25
4974450|NCT02586805|12234611|P3|COMPLETED|Overall Study||26
4974451|NCT02586805|12234612|P2|COMPLETED|Overall Study||27
4974452|NCT02586805|12234613|P1|COMPLETED|Overall Study||35
4974453|NCT02586805|12234610|P4|STARTED|Overall Study||27
4974454|NCT02586805|12234611|P3|STARTED|Overall Study||29
4974455|NCT02586805|12234612|P2|STARTED|Overall Study||28
4974456|NCT02586805|12234613|P1|STARTED|Overall Study||41
4974457|NCT02586675|12234635|P1|NOT COMPLETED|Overall Study||0
4974458|NCT02586675|12234635|P1|COMPLETED|Overall Study||7
4974459|NCT02586675|12234635|P1|STARTED|Overall Study||7
4974460|NCT02586506|12234641|P1|NOT COMPLETED|Overall Study||9
4974461|NCT02586506|12234641|P1|COMPLETED|Overall Study||250
4974462|NCT02586506|12234641|P1|STARTED|Overall Study||259
4974463|NCT02586493|12234647|P1|NOT COMPLETED|Overall Study||12
4974464|NCT02586493|12234647|P1|COMPLETED|Overall Study||266
4974465|NCT02586493|12234647|P1|STARTED|Overall Study||278
4974466|NCT02586415|12234655|P2|NOT COMPLETED|Overall Study||25
4974467|NCT02586415|12234656|P1|NOT COMPLETED|Overall Study||14
4974468|NCT02586415|12234655|P2|COMPLETED|Overall Study||65
4974469|NCT02586415|12234656|P1|COMPLETED|Overall Study||78
4974470|NCT02586415|12234655|P2|Day 90 Assessment|Overall Study||65
4974471|NCT02586415|12234656|P1|Day 90 Assessment|Overall Study||78
4974472|NCT02586415|12234655|P2|Day 30 Assessment|Overall Study||70
4974473|NCT02586415|12234656|P1|Day 30 Assessment|Overall Study||81
4974474|NCT02586415|12234655|P2|24 Hour Assessment|Overall Study||90
4974475|NCT02586415|12234656|P1|24 Hour Assessment|Overall Study||91
4974476|NCT02586415|12234655|P2|STARTED|Overall Study||90
4974477|NCT02586415|12234656|P1|STARTED|Overall Study||92
4974478|NCT02586025|12234668|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
4974479|NCT02586025|12234669|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
4974480|NCT02586025|12234668|P2|COMPLETED|Treatment-Free Follow-Up||3
4974481|NCT02586025|12234669|P1|COMPLETED|Treatment-Free Follow-Up||3
4974482|NCT02586025|12234668|P2|STARTED|Treatment-Free Follow-Up||38
4974483|NCT02586025|12234669|P1|STARTED|Treatment-Free Follow-Up||59
4974484|NCT02586025|12234668|P2|NOT COMPLETED|Adjuvant Treatment||69
4974485|NCT02586025|12234669|P1|NOT COMPLETED|Adjuvant Treatment||139
4974486|NCT02586025|12234668|P2|COMPLETED|Adjuvant Treatment||34
4974487|NCT02586025|12234669|P1|COMPLETED|Adjuvant Treatment||69
4974488|NCT02586025|12234668|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
4974489|NCT02586025|12234669|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
4974490|NCT02586025|12234668|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
4974491|NCT02586025|12234669|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
4974492|NCT02586025|12234668|P2|STARTED|Adjuvant Treatment||103
4974493|NCT02586025|12234669|P1|STARTED|Adjuvant Treatment||208
4974494|NCT02586025|12234668|P2|NOT COMPLETED|Neoadjuvant Treatment||7
4974495|NCT02586025|12234669|P1|NOT COMPLETED|Neoadjuvant Treatment||11
4974496|NCT02586025|12234668|P2|COMPLETED|Neoadjuvant Treatment||103
4974497|NCT02586025|12234669|P1|COMPLETED|Neoadjuvant Treatment||208
4974498|NCT02586025|12234668|P2|Underwent Surgery|Neoadjuvant Treatment||105
4974499|NCT02586025|12234669|P1|Underwent Surgery|Neoadjuvant Treatment||210
4974500|NCT02586025|12234668|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
4974501|NCT02586025|12234669|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
4974502|NCT02586025|12234668|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
4974503|NCT02586025|12234669|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
4974504|NCT02586025|12234668|P2|STARTED|Neoadjuvant Treatment||110
4974505|NCT02586025|12234669|P1|STARTED|Neoadjuvant Treatment||219
4974506|NCT02585999|12234705|P1|NOT COMPLETED|Overall Study||2
4974507|NCT02585999|12234705|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
4974508|NCT02585999|12234705|P1|STARTED|Overall Study||28
4974509|NCT02585960|12234713|P3|NOT COMPLETED|Prophylactic Treatment Period||0
4974510|NCT02585960|12234714|P2|NOT COMPLETED|Prophylactic Treatment Period||5
4974511|NCT02585960|12234715|P1|NOT COMPLETED|Prophylactic Treatment Period||0
4974512|NCT02585960|12234713|P3|COMPLETED|Prophylactic Treatment Period||0
4974513|NCT02585960|12234714|P2|COMPLETED|Prophylactic Treatment Period||43
4974514|NCT02585960|12234715|P1|COMPLETED|Prophylactic Treatment Period||52
4974515|NCT02585960|12234713|P3|STARTED|Prophylactic Treatment Period||0
4974516|NCT02585960|12234714|P2|STARTED|Prophylactic Treatment Period||48
4974517|NCT02585960|12234715|P1|STARTED|Prophylactic Treatment Period||52
4974518|NCT02585960|12234713|P3|NOT COMPLETED|PK/Safety Assessment Period||6
4974519|NCT02585960|12234714|P2|NOT COMPLETED|PK/Safety Assessment Period||10
4974520|NCT02585960|12234715|P1|NOT COMPLETED|PK/Safety Assessment Period||5
4974521|NCT02585960|12234713|P3|COMPLETED|PK/Safety Assessment Period||0
4974522|NCT02585960|12234714|P2|COMPLETED|PK/Safety Assessment Period||48
4974523|NCT02585960|12234715|P1|COMPLETED|PK/Safety Assessment Period||52
4974524|NCT02585960|12234713|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
4974525|NCT02585960|12234714|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
4974526|NCT02585960|12234715|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
4974527|NCT02585960|12234713|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
4974528|NCT02585960|12234714|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
4974529|NCT02585960|12234715|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
4974530|NCT02585960|12234713|P3|STARTED|PK/Safety Assessment Period||6
4974531|NCT02585960|12234714|P2|STARTED|PK/Safety Assessment Period||58
4974532|NCT02585960|12234715|P1|STARTED|PK/Safety Assessment Period||57
4974533|NCT02585934|12234785|P2|NOT COMPLETED|Overall Study||73
4974534|NCT02585934|12234786|P1|NOT COMPLETED|Overall Study||69
4974535|NCT02585934|12234785|P2|COMPLETED|Overall Study||581
4974536|NCT02585934|12234786|P1|COMPLETED|Overall Study||592
4974537|NCT02585934|12234785|P2|Per Protocol (PP)|Overall Study||582
4974538|NCT02585934|12234786|P1|Per Protocol (PP)|Overall Study||603
4974539|NCT02585934|12234785|P2|Intent to Treat (ITT)|Overall Study||633
4974540|NCT02585934|12234786|P1|Intent to Treat (ITT)|Overall Study||643
4974541|NCT02585934|12234785|P2|Safety Population|Overall Study||651
4974542|NCT02585934|12234786|P1|Safety Population|Overall Study||656
4974543|NCT02585934|12234785|P2|STARTED|Overall Study||654
4974544|NCT02585934|12234786|P1|STARTED|Overall Study||661
4974545|NCT02585895|12234809|P2|NOT COMPLETED|Post-primary Period||0
4974546|NCT02585895|12234810|P1|NOT COMPLETED|Post-primary Period||0
4974547|NCT02585895|12234809|P2|COMPLETED|Post-primary Period||19
4974548|NCT02585895|12234810|P1|COMPLETED|Post-primary Period||20
4974549|NCT02585895|12234809|P2|STARTED|Post-primary Period||19
4974550|NCT02585895|12234810|P1|STARTED|Post-primary Period||20
4974551|NCT02585895|12234809|P2|NOT COMPLETED|Primary Period||0
4974552|NCT02585895|12234810|P1|NOT COMPLETED|Primary Period||0
4974553|NCT02585895|12234809|P2|COMPLETED|Primary Period||19
4974554|NCT02585895|12234810|P1|COMPLETED|Primary Period||20
4974555|NCT02585895|12234809|P2|STARTED|Primary Period||19
4974556|NCT02585895|12234810|P1|STARTED|Primary Period||20
4974557|NCT02585843|12234827|P2|NOT COMPLETED|Overall Study||0
4974558|NCT02585843|12234828|P1|NOT COMPLETED|Overall Study||1
4974559|NCT02585843|12234827|P2|COMPLETED|Overall Study||10
4974560|NCT02585843|12234828|P1|COMPLETED|Overall Study||9
4974561|NCT02585843|12234827|P2|STARTED|Overall Study||10
4974562|NCT02585843|12234828|P1|STARTED|Overall Study||10
4974563|NCT02585830|12234842|P1|NOT COMPLETED|Overall Study||3
4974564|NCT02585830|12234842|P1|COMPLETED|Overall Study||22
4974565|NCT02585830|12234842|P1|STARTED|Overall Study||25
4974566|NCT02585778|12234851|P2|NOT COMPLETED|Overall Study||15
4974567|NCT02585778|12234852|P1|NOT COMPLETED|Overall Study||33
4974568|NCT02585778|12234851|P2|COMPLETED|Overall Study||157
4974569|NCT02585778|12234852|P1|COMPLETED|Overall Study||312
4974570|NCT02585778|12234851|P2|T2DM Participants|Overall Study||147
4974571|NCT02585778|12234852|P1|T2DM Participants|Overall Study||294
4974572|NCT02585778|12234851|P2|T1DM Participants|Overall Study||25
4974573|NCT02585778|12234852|P1|T1DM Participants|Overall Study||51
4974574|NCT02585778|12234851|P2|mITT Population|Overall Study||164
4974575|NCT02585778|12234852|P1|mITT Population|Overall Study||333
4974576|NCT02585778|12234851|P2|ITT Population|Overall Study||167
4974577|NCT02585778|12234852|P1|ITT Population|Overall Study||336
4974578|NCT02585778|12234851|P2|Treated (Safety Population)|Overall Study||170
4974579|NCT02585778|12234852|P1|Treated (Safety Population)|Overall Study||344
4974580|NCT02585778|12234851|P2|STARTED|Overall Study|Randomized|172
4974581|NCT02585778|12234852|P1|STARTED|Overall Study|Randomized|345
4974582|NCT02585713|12234968|P2|NOT COMPLETED|Overall Study||8
4974583|NCT02585713|12234969|P1|NOT COMPLETED|Overall Study||5
4974584|NCT02585713|12234968|P2|COMPLETED|Overall Study||142
4974585|NCT02585713|12234969|P1|COMPLETED|Overall Study||145
4974586|NCT02585713|12234968|P2|STARTED|Overall Study||150
4974587|NCT02585713|12234969|P1|STARTED|Overall Study||150
4974588|NCT02585700|12234981|P2|NOT COMPLETED|Overall Study||0
4974589|NCT02585700|12234982|P1|NOT COMPLETED|Overall Study||0
4974590|NCT02585700|12234981|P2|COMPLETED|Overall Study||30
4974591|NCT02585700|12234982|P1|COMPLETED|Overall Study||30
4974592|NCT02585700|12234981|P2|STARTED|Overall Study||30
4974593|NCT02585700|12234982|P1|STARTED|Overall Study||30
4974594|NCT02585245|12235008|P1|NOT COMPLETED|Overall Study||13
4974595|NCT02585245|12235008|P1|COMPLETED|Overall Study||594
4974596|NCT02585245|12235008|P1|STARTED|Overall Study||607
4974597|NCT02584998|12235016|P3|NOT COMPLETED|Overall Study||0
4974598|NCT02584998|12235017|P2|NOT COMPLETED|Overall Study||0
4974599|NCT02584998|12235018|P1|NOT COMPLETED|Overall Study||0
4974600|NCT02584998|12235016|P3|COMPLETED|Overall Study||261
4974601|NCT02584998|12235017|P2|COMPLETED|Overall Study||261
4974602|NCT02584998|12235018|P1|COMPLETED|Overall Study||260
4974603|NCT02584998|12235016|P3|STARTED|Overall Study||261
4974604|NCT02584998|12235017|P2|STARTED|Overall Study||261
4974605|NCT02584998|12235018|P1|STARTED|Overall Study||260
4974606|NCT02584959|12235032|P3|NOT COMPLETED|Period 2||2
4974607|NCT02584959|12235033|P2|NOT COMPLETED|Period 2||1
4974608|NCT02584959|12235034|P1|NOT COMPLETED|Period 2||6
4974609|NCT02584959|12235032|P3|COMPLETED|Period 2||13
4974610|NCT02584959|12235033|P2|COMPLETED|Period 2||24
4974611|NCT02584959|12235034|P1|COMPLETED|Period 2||22
4974612|NCT02584959|12235032|P3|STARTED|Period 2||15
4974613|NCT02584959|12235033|P2|STARTED|Period 2||25
4974614|NCT02584959|12235034|P1|STARTED|Period 2||28
4974615|NCT02584959|12235032|P3|NOT COMPLETED|Period 1||0
4974616|NCT02584959|12235033|P2|NOT COMPLETED|Period 1||4
4974617|NCT02584959|12235034|P1|NOT COMPLETED|Period 1||3
4974618|NCT02584959|12235032|P3|COMPLETED|Period 1||15
4974619|NCT02584959|12235033|P2|COMPLETED|Period 1||25
4974620|NCT02584959|12235034|P1|COMPLETED|Period 1||28
4974621|NCT02584959|12235032|P3|STARTED|Period 1||15
4974622|NCT02584959|12235033|P2|STARTED|Period 1||29
4974623|NCT02584959|12235034|P1|STARTED|Period 1||31
4974624|NCT02584855|12235089|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
4974625|NCT02584855|12235090|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
4974626|NCT02584855|12235091|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
4974627|NCT02584855|12235092|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
4974628|NCT02584855|12235093|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
4974629|NCT02584855|12235094|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
4974630|NCT02584855|12235089|P6|COMPLETED|Post Treatment Follow-up Period||12
4974631|NCT02584855|12235090|P5|COMPLETED|Post Treatment Follow-up Period||347
4974632|NCT02584855|12235091|P4|COMPLETED|Post Treatment Follow-up Period||0
4974633|NCT02584855|12235092|P3|COMPLETED|Post Treatment Follow-up Period||0
4974634|NCT02584855|12235093|P2|COMPLETED|Post Treatment Follow-up Period||0
4974635|NCT02584855|12235094|P1|COMPLETED|Post Treatment Follow-up Period||0
4974636|NCT02584855|12235089|P6|STARTED|Post Treatment Follow-up Period||12
4974637|NCT02584855|12235090|P5|STARTED|Post Treatment Follow-up Period||355
4974638|NCT02584855|12235091|P4|STARTED|Post Treatment Follow-up Period||0
4974639|NCT02584855|12235092|P3|STARTED|Post Treatment Follow-up Period||0
4974640|NCT02584855|12235093|P2|STARTED|Post Treatment Follow-up Period||0
4974641|NCT02584855|12235094|P1|STARTED|Post Treatment Follow-up Period||0
4974642|NCT02584855|12235089|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
4974643|NCT02584855|12235090|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
4974644|NCT02584855|12235091|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
4974645|NCT02584855|12235092|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
4974646|NCT02584855|12235093|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
4974647|NCT02584855|12235094|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
4974648|NCT02584855|12235089|P6|COMPLETED|Double-Blind Withdrawal Period||0
4974649|NCT02584855|12235090|P5|COMPLETED|Double-Blind Withdrawal Period||0
4974650|NCT02584855|12235091|P4|COMPLETED|Double-Blind Withdrawal Period||78
4974651|NCT02584855|12235092|P3|COMPLETED|Double-Blind Withdrawal Period||77
4974652|NCT02584855|12235093|P2|COMPLETED|Double-Blind Withdrawal Period||118
4974653|NCT02584855|12235094|P1|COMPLETED|Double-Blind Withdrawal Period||0
4974654|NCT02584855|12235089|P6|Relapsed|Double-Blind Withdrawal Period||0
4974655|NCT02584855|12235090|P5|Relapsed|Double-Blind Withdrawal Period||0
4974656|NCT02584855|12235091|P4|Relapsed|Double-Blind Withdrawal Period||30
4974657|NCT02584855|12235092|P3|Relapsed|Double-Blind Withdrawal Period||67
4974658|NCT02584855|12235093|P2|Relapsed|Double-Blind Withdrawal Period||0
4974659|NCT02584855|12235094|P1|Relapsed|Double-Blind Withdrawal Period||0
4974660|NCT02584855|12235089|P6|STARTED|Double-Blind Withdrawal Period||0
4974661|NCT02584855|12235090|P5|STARTED|Double-Blind Withdrawal Period||0
4974662|NCT02584855|12235091|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
4974663|NCT02584855|12235092|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
4974664|NCT02584855|12235093|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
4974665|NCT02584855|12235094|P1|STARTED|Double-Blind Withdrawal Period||0
4974666|NCT02584855|12235089|P6|NOT COMPLETED|Open-Label Treatment Period||0
4974667|NCT02584855|12235090|P5|NOT COMPLETED|Open-Label Treatment Period||0
4974668|NCT02584855|12235091|P4|NOT COMPLETED|Open-Label Treatment Period||0
4974669|NCT02584855|12235092|P3|NOT COMPLETED|Open-Label Treatment Period||0
4974670|NCT02584855|12235093|P2|NOT COMPLETED|Open-Label Treatment Period||0
4974671|NCT02584855|12235094|P1|NOT COMPLETED|Open-Label Treatment Period||103
4974672|NCT02584855|12235089|P6|COMPLETED|Open-Label Treatment Period||0
4974673|NCT02584855|12235090|P5|COMPLETED|Open-Label Treatment Period||0
4974674|NCT02584855|12235091|P4|COMPLETED|Open-Label Treatment Period||0
4974675|NCT02584855|12235092|P3|COMPLETED|Open-Label Treatment Period||0
4974676|NCT02584855|12235093|P2|COMPLETED|Open-Label Treatment Period||0
4974677|NCT02584855|12235094|P1|COMPLETED|Open-Label Treatment Period||291
4974678|NCT02584855|12235089|P6|Non-randomized|Open-Label Treatment Period||0
4974679|NCT02584855|12235090|P5|Non-randomized|Open-Label Treatment Period||0
4974680|NCT02584855|12235091|P4|Non-randomized|Open-Label Treatment Period||0
4974681|NCT02584855|12235092|P3|Non-randomized|Open-Label Treatment Period||0
4974682|NCT02584855|12235093|P2|Non-randomized|Open-Label Treatment Period||0
4974683|NCT02584855|12235094|P1|Non-randomized|Open-Label Treatment Period||133
4974684|NCT02584855|12235089|P6|Met Randomization Criteria|Open-Label Treatment Period||0
4974685|NCT02584855|12235090|P5|Met Randomization Criteria|Open-Label Treatment Period||0
4974686|NCT02584855|12235091|P4|Met Randomization Criteria|Open-Label Treatment Period||0
4974687|NCT02584855|12235092|P3|Met Randomization Criteria|Open-Label Treatment Period||0
4974688|NCT02584855|12235093|P2|Met Randomization Criteria|Open-Label Treatment Period||0
4974689|NCT02584855|12235094|P1|Met Randomization Criteria|Open-Label Treatment Period||158
4974690|NCT02584855|12235089|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
4974691|NCT02584855|12235090|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
4974692|NCT02584855|12235091|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
4974693|NCT02584855|12235092|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
4974694|NCT02584855|12235093|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
4974695|NCT02584855|12235094|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
4974696|NCT02584855|12235089|P6|STARTED|Open-Label Treatment Period||0
4974697|NCT02584855|12235090|P5|STARTED|Open-Label Treatment Period||0
4974698|NCT02584855|12235091|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
4974699|NCT02584855|12235092|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
4974700|NCT02584855|12235093|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
4974701|NCT02584855|12235094|P1|STARTED|Open-Label Treatment Period||394
4974702|NCT02584790|12235128|P1|NOT COMPLETED|Overall Study||15
4974703|NCT02584790|12235128|P1|COMPLETED|Overall Study||40
4974704|NCT02584790|12235128|P1|STARTED|Overall Study||55
4974705|NCT02584686|12235136|P2|NOT COMPLETED|Overall Study||0
4974706|NCT02584686|12235137|P1|NOT COMPLETED|Overall Study||0
4974707|NCT02584686|12235136|P2|COMPLETED|Overall Study||12
4974708|NCT02584686|12235137|P1|COMPLETED|Overall Study||12
4974709|NCT02584686|12235136|P2|STARTED|Overall Study||12
4974710|NCT02584686|12235137|P1|STARTED|Overall Study||12
4974711|NCT02584673|12235165|P2|NOT COMPLETED|Overall Study||0
4974712|NCT02584673|12235166|P1|NOT COMPLETED|Overall Study||0
4974713|NCT02584673|12235165|P2|COMPLETED|Overall Study||15
4974714|NCT02584673|12235166|P1|COMPLETED|Overall Study||15
4974715|NCT02584673|12235165|P2|STARTED|Overall Study||15
4974716|NCT02584673|12235166|P1|STARTED|Overall Study||15
4974717|NCT02584660|12235180|P2|NOT COMPLETED|Overall Study||8
4974718|NCT02584660|12235181|P1|NOT COMPLETED|Overall Study||7
4974719|NCT02584660|12235180|P2|COMPLETED|Overall Study||55
4974720|NCT02584660|12235181|P1|COMPLETED|Overall Study||44
4974721|NCT02584660|12235180|P2|Treated|Overall Study||63
4974722|NCT02584660|12235181|P1|Treated|Overall Study||49
4974723|NCT02584660|12235180|P2|STARTED|Overall Study||63
4974724|NCT02584660|12235181|P1|STARTED|Overall Study||51
4974725|NCT02584504|12235200|P3|NOT COMPLETED|Open-label Treatment||8
4974726|NCT02584504|12235201|P2|NOT COMPLETED|Open-label Treatment||4
4974727|NCT02584504|12235202|P1|NOT COMPLETED|Open-label Treatment||2
4974728|NCT02584504|12235200|P3|COMPLETED|Open-label Treatment||47
4974729|NCT02584504|12235201|P2|COMPLETED|Open-label Treatment||47
4974730|NCT02584504|12235202|P1|COMPLETED|Open-label Treatment||52
4974731|NCT02584504|12235200|P3|Treated|Open-label Treatment||54
4974732|NCT02584504|12235201|P2|Treated|Open-label Treatment||50
4974733|NCT02584504|12235202|P1|Treated|Open-label Treatment||54
4974734|NCT02584504|12235200|P3|STARTED|Open-label Treatment||55
4974735|NCT02584504|12235201|P2|STARTED|Open-label Treatment||51
4974736|NCT02584504|12235202|P1|STARTED|Open-label Treatment||54
4974737|NCT02584504|12235200|P3|NOT COMPLETED|Double-blind Treatment||1
4974738|NCT02584504|12235201|P2|NOT COMPLETED|Double-blind Treatment||2
4974739|NCT02584504|12235202|P1|NOT COMPLETED|Double-blind Treatment||0
4974740|NCT02584504|12235200|P3|COMPLETED|Double-blind Treatment||55
4974741|NCT02584504|12235201|P2|COMPLETED|Double-blind Treatment||51
4974742|NCT02584504|12235202|P1|COMPLETED|Double-blind Treatment||54
4974743|NCT02584504|12235200|P3|Safety Population|Double-blind Treatment||56
4974744|NCT02584504|12235201|P2|Safety Population|Double-blind Treatment||53
4974745|NCT02584504|12235202|P1|Safety Population|Double-blind Treatment||54
4974746|NCT02584504|12235200|P3|mITT Population|Double-blind Treatment||56
4974747|NCT02584504|12235201|P2|mITT Population|Double-blind Treatment||53
4974748|NCT02584504|12235202|P1|mITT Population|Double-blind Treatment||54
4974749|NCT02584504|12235200|P3|ITT Population|Double-blind Treatment||56
4974750|NCT02584504|12235201|P2|ITT Population|Double-blind Treatment||53
4974751|NCT02584504|12235202|P1|ITT Population|Double-blind Treatment||54
4974752|NCT02584504|12235200|P3|STARTED|Double-blind Treatment|Randomized|56
4974753|NCT02584504|12235201|P2|STARTED|Double-blind Treatment|Randomized|53
4974754|NCT02584504|12235202|P1|STARTED|Double-blind Treatment|Randomized|54
4974755|NCT02584452|12235258|P2|NOT COMPLETED|Overall Study||2
4974756|NCT02584452|12235259|P1|NOT COMPLETED|Overall Study||2
4974757|NCT02584452|12235258|P2|COMPLETED|Overall Study||21
4974758|NCT02584452|12235259|P1|COMPLETED|Overall Study||32
4974759|NCT02584452|12235258|P2|STARTED|Overall Study||23
4974760|NCT02584452|12235259|P1|STARTED|Overall Study||34
4974761|NCT02584140|12235287|P1|NOT COMPLETED|Overall Study||53
4974762|NCT02584140|12235287|P1|COMPLETED|Overall Study||83
4974763|NCT02584140|12235287|P1|STARTED|Overall Study||136
4974764|NCT02583477|12235296|P2|NOT COMPLETED|Overall Study||20
4974765|NCT02583477|12235297|P1|NOT COMPLETED|Overall Study||3
4974766|NCT02583477|12235296|P2|COMPLETED|Overall Study||0
4974767|NCT02583477|12235297|P1|COMPLETED|Overall Study||0
4974768|NCT02583477|12235296|P2|Completed Treatment|Overall Study||0
4974769|NCT02583477|12235297|P1|Completed Treatment|Overall Study||0
4974770|NCT02583477|12235296|P2|Received Treatment|Overall Study||20
4974771|NCT02583477|12235297|P1|Received Treatment|Overall Study||3
4974772|NCT02583477|12235296|P2|STARTED|Overall Study||20
4974773|NCT02583477|12235297|P1|STARTED|Overall Study||3
4974774|NCT02583425|12235317|P1|NOT COMPLETED|Treatment Period||1
4974775|NCT02583425|12235317|P1|COMPLETED|Treatment Period||9
4974776|NCT02583425|12235317|P1|STARTED|Treatment Period||10
4974777|NCT02583425|12235317|P1|NOT COMPLETED|Baseline||5
4974778|NCT02583425|12235317|P1|COMPLETED|Baseline||10
4974779|NCT02583425|12235317|P1|STARTED|Baseline||15
4974780|NCT02583425|12235317|P1|NOT COMPLETED|Screening||12
4974781|NCT02583425|12235317|P1|COMPLETED|Screening||15
4974782|NCT02583425|12235317|P1|STARTED|Screening||27
4974783|NCT02583269|12235327|P5|NOT COMPLETED|Overall Study||0
4974784|NCT02583269|12235328|P4|NOT COMPLETED|Overall Study||0
4974785|NCT02583269|12235329|P3|NOT COMPLETED|Overall Study||0
4974786|NCT02583269|12235330|P2|NOT COMPLETED|Overall Study||0
4974787|NCT02583269|12235331|P1|NOT COMPLETED|Overall Study||1
4974788|NCT02583269|12235327|P5|COMPLETED|Overall Study||6
4974789|NCT02583269|12235328|P4|COMPLETED|Overall Study||5
4974790|NCT02583269|12235329|P3|COMPLETED|Overall Study||3
4974791|NCT02583269|12235330|P2|COMPLETED|Overall Study||7
4974792|NCT02583269|12235331|P1|COMPLETED|Overall Study||2
4974793|NCT02583269|12235327|P5|STARTED|Overall Study||6
4974794|NCT02583269|12235328|P4|STARTED|Overall Study||5
4974795|NCT02583269|12235329|P3|STARTED|Overall Study||3
4974796|NCT02583269|12235330|P2|STARTED|Overall Study||7
4974797|NCT02583269|12235331|P1|STARTED|Overall Study||3
4974798|NCT02583256|12235360|P4|NOT COMPLETED|Overall Study||3
4974799|NCT02583256|12235361|P3|NOT COMPLETED|Overall Study||2
4974800|NCT02583256|12235362|P2|NOT COMPLETED|Overall Study||2
4974801|NCT02583256|12235363|P1|NOT COMPLETED|Overall Study||3
4974802|NCT02583256|12235360|P4|COMPLETED|Overall Study||390
4974803|NCT02583256|12235361|P3|COMPLETED|Overall Study||400
4974804|NCT02583256|12235362|P2|COMPLETED|Overall Study||401
4974805|NCT02583256|12235363|P1|COMPLETED|Overall Study||400
4974806|NCT02583256|12235360|P4|Exposed|Overall Study||393
4974807|NCT02583256|12235361|P3|Exposed|Overall Study||402
4974808|NCT02583256|12235362|P2|Exposed|Overall Study||403
4974809|NCT02583256|12235363|P1|Exposed|Overall Study||403
4974810|NCT02583256|12235360|P4|STARTED|Overall Study||393
4974811|NCT02583256|12235361|P3|STARTED|Overall Study||402
4974812|NCT02583256|12235362|P2|STARTED|Overall Study||403
4974813|NCT02583256|12235363|P1|STARTED|Overall Study||403
4974814|NCT02583230|12235451|P1|NOT COMPLETED|Overall Study||0
4974815|NCT02583230|12235451|P1|COMPLETED|Overall Study||11
4974816|NCT02583230|12235451|P1|STARTED|Overall Study||11
4974817|NCT02583048|12235460|P3|NOT COMPLETED|Overall Study||1
4974818|NCT02583048|12235461|P2|NOT COMPLETED|Overall Study||1
4974819|NCT02583048|12235462|P1|NOT COMPLETED|Overall Study||0
4974820|NCT02583048|12235460|P3|COMPLETED|Overall Study||27
4974821|NCT02583048|12235461|P2|COMPLETED|Overall Study||27
4974822|NCT02583048|12235462|P1|COMPLETED|Overall Study||28
4974823|NCT02583048|12235460|P3|STARTED|Overall Study||28
4974824|NCT02583048|12235461|P2|STARTED|Overall Study||28
4974825|NCT02583048|12235462|P1|STARTED|Overall Study||28
4974826|NCT02582983|12235497|P1|NOT COMPLETED|Overall Study||6
4974827|NCT02582983|12235497|P1|COMPLETED|Overall Study||17
4974828|NCT02582983|12235497|P1|STARTED|Overall Study||23
4974829|NCT02582970|12235502|P1|NOT COMPLETED|Overall Study||0
4974830|NCT02582970|12235502|P1|COMPLETED|Overall Study||40
4974831|NCT02582970|12235502|P1|STARTED|Overall Study||40
4974832|NCT02582840|12235515|P3|NOT COMPLETED|Overall Study||0
4974833|NCT02582840|12235516|P2|NOT COMPLETED|Overall Study||0
4974834|NCT02582840|12235517|P1|NOT COMPLETED|Overall Study||0
4974835|NCT02582840|12235515|P3|COMPLETED|Overall Study||14
4974836|NCT02582840|12235516|P2|COMPLETED|Overall Study||14
4974837|NCT02582840|12235517|P1|COMPLETED|Overall Study||14
4974838|NCT02582840|12235515|P3|STARTED|Overall Study||14
4974839|NCT02582840|12235516|P2|STARTED|Overall Study||14
4974840|NCT02582840|12235517|P1|STARTED|Overall Study||14
4974841|NCT02582814|12235560|P2|NOT COMPLETED|Overall Study||7
4974842|NCT02582814|12235561|P1|NOT COMPLETED|Overall Study||9
4974843|NCT02582814|12235560|P2|COMPLETED|Overall Study||68
4974844|NCT02582814|12235561|P1|COMPLETED|Overall Study||67
4974845|NCT02582814|12235560|P2|STARTED|Overall Study||75
4974846|NCT02582814|12235561|P1|STARTED|Overall Study||76
4974847|NCT02582749|12235601|P2|NOT COMPLETED|Overall Study||11
4974848|NCT02582749|12235602|P1|NOT COMPLETED|Overall Study||5
4974849|NCT02582749|12235601|P2|COMPLETED|Overall Study||0
4974850|NCT02582749|12235602|P1|COMPLETED|Overall Study||0
4974851|NCT02582749|12235601|P2|STARTED|Overall Study||11
4974852|NCT02582749|12235602|P1|STARTED|Overall Study||5
4974853|NCT02582684|12235632|P1|NOT COMPLETED|Overall Study||17
4974854|NCT02582684|12235632|P1|COMPLETED|Overall Study||105
4974855|NCT02582684|12235632|P1|STARTED|Overall Study||122
4974856|NCT02582671|12235651|P1|NOT COMPLETED|Overall Study||2
4974857|NCT02582671|12235651|P1|COMPLETED|Overall Study||99
4974858|NCT02582671|12235651|P1|STARTED|Overall Study||101
4974859|NCT02582658|12235663|P1|NOT COMPLETED|Overall Study||25
4974860|NCT02582658|12235663|P1|COMPLETED|Overall Study||146
4974861|NCT02582658|12235663|P1|STARTED|Overall Study||171
4974862|NCT02582632|12235681|P1|NOT COMPLETED|Overall Study||1
4974863|NCT02582632|12235681|P1|COMPLETED|Overall Study||165
4974864|NCT02582632|12235681|P1|STARTED|Overall Study||166
4974865|NCT02582515|12235696|P2|NOT COMPLETED|Overall Study||1
4974866|NCT02582515|12235697|P1|NOT COMPLETED|Overall Study||0
4974867|NCT02582515|12235696|P2|COMPLETED|Overall Study||10
4974868|NCT02582515|12235697|P1|COMPLETED|Overall Study||9
4974869|NCT02582515|12235696|P2|Received Study Intervention|Overall Study||10
4974870|NCT02582515|12235697|P1|Received Study Intervention|Overall Study||9
4974871|NCT02582515|12235696|P2|STARTED|Overall Study||11
4974872|NCT02582515|12235697|P1|STARTED|Overall Study||9
4974873|NCT02582255|12235705|P2|NOT COMPLETED|Overall Study||3
4974874|NCT02582255|12235706|P1|NOT COMPLETED|Overall Study||0
4974875|NCT02582255|12235705|P2|COMPLETED|Overall Study||47
4974876|NCT02582255|12235706|P1|COMPLETED|Overall Study||50
4974877|NCT02582255|12235705|P2|STARTED|Overall Study||50
4974878|NCT02582255|12235706|P1|STARTED|Overall Study||50
4974879|NCT02582242|12235719|P2|NOT COMPLETED|Overall Study||17
4974880|NCT02582242|12235720|P1|NOT COMPLETED|Overall Study||20
4974881|NCT02582242|12235719|P2|COMPLETED|Overall Study||200
4974882|NCT02582242|12235720|P1|COMPLETED|Overall Study||200
4974883|NCT02582242|12235719|P2|STARTED|Overall Study||217
4974884|NCT02582242|12235720|P1|STARTED|Overall Study||220
4974885|NCT02582151|12235762|P2|NOT COMPLETED|Overall Study||0
4974886|NCT02582151|12235763|P1|NOT COMPLETED|Overall Study||2
4974887|NCT02582151|12235762|P2|COMPLETED|Overall Study||16
4974888|NCT02582151|12235763|P1|COMPLETED|Overall Study||12
4974889|NCT02582151|12235762|P2|STARTED|Overall Study||16
4974890|NCT02582151|12235763|P1|STARTED|Overall Study||14
4974891|NCT02581995|12235779|P1|NOT COMPLETED|Overall Study||31
4974892|NCT02581995|12235779|P1|COMPLETED|Overall Study||529
4974893|NCT02581995|12235779|P1|Treated|Overall Study||560
4974894|NCT02581995|12235779|P1|STARTED|Overall Study||560
4974895|NCT02581930|12235793|P1|NOT COMPLETED|Overall Study||2
4974896|NCT02581930|12235793|P1|COMPLETED|Overall Study||16
4974897|NCT02581930|12235793|P1|STARTED|Overall Study||18
4974898|NCT02581891|12235801|P2|NOT COMPLETED|Overall Study||19
4974899|NCT02581891|12235802|P1|NOT COMPLETED|Overall Study||16
4974900|NCT02581891|12235801|P2|COMPLETED|Overall Study||117
4974901|NCT02581891|12235802|P1|COMPLETED|Overall Study||119
4974902|NCT02581891|12235801|P2|Completed Treatment|Overall Study||117
4974903|NCT02581891|12235802|P1|Completed Treatment|Overall Study||120
4974904|NCT02581891|12235801|P2|STARTED|Overall Study||136
4974905|NCT02581891|12235802|P1|STARTED|Overall Study||135
4974906|NCT02581865|12235828|P3|NOT COMPLETED|Overall Study||16
4974907|NCT02581865|12235829|P2|NOT COMPLETED|Overall Study||7
4974908|NCT02581865|12235830|P1|NOT COMPLETED|Overall Study||4
4974909|NCT02581865|12235828|P3|COMPLETED|Overall Study||26
4974910|NCT02581865|12235829|P2|COMPLETED|Overall Study||35
4974911|NCT02581865|12235830|P1|COMPLETED|Overall Study||36
4974912|NCT02581865|12235828|P3|STARTED|Overall Study||42
4974913|NCT02581865|12235829|P2|STARTED|Overall Study||42
4974914|NCT02581865|12235830|P1|STARTED|Overall Study||40
4974915|NCT02581839|12235853|P1|NOT COMPLETED|Overall Study||0
4974916|NCT02581839|12235853|P1|COMPLETED|Overall Study||9
4974917|NCT02581839|12235853|P1|STARTED|Overall Study||9
4974918|NCT02581488|12235865|P2|NOT COMPLETED|Overall Study||11
4974919|NCT02581488|12235866|P1|NOT COMPLETED|Overall Study||9
4974920|NCT02581488|12235865|P2|COMPLETED|Overall Study||40
4974921|NCT02581488|12235866|P1|COMPLETED|Overall Study||42
4974922|NCT02581488|12235865|P2|STARTED|Overall Study||51
4974923|NCT02581488|12235866|P1|STARTED|Overall Study||51
4974924|NCT02581475|12235882|P2|NOT COMPLETED|Overall Study||15
4974925|NCT02581475|12235883|P1|NOT COMPLETED|Overall Study||11
4974926|NCT02581475|12235882|P2|COMPLETED|Overall Study||178
4974927|NCT02581475|12235883|P1|COMPLETED|Overall Study||182
4974928|NCT02581475|12235882|P2|STARTED|Overall Study||193
4974929|NCT02581475|12235883|P1|STARTED|Overall Study||193
4974930|NCT02581410|12235897|P2|NOT COMPLETED|End of Study Phase||11
4974931|NCT02581410|12235898|P1|NOT COMPLETED|End of Study Phase||5
4974932|NCT02581410|12235897|P2|COMPLETED|End of Study Phase||204
4974933|NCT02581410|12235898|P1|COMPLETED|End of Study Phase||210
4974934|NCT02581410|12235897|P2|STARTED|End of Study Phase||215
4974935|NCT02581410|12235898|P1|STARTED|End of Study Phase||215
4974936|NCT02581410|12235897|P2|NOT COMPLETED|Vaccination Phase||3
4974937|NCT02581410|12235898|P1|NOT COMPLETED|Vaccination Phase||2
4974938|NCT02581410|12235897|P2|COMPLETED|Vaccination Phase||212
4974939|NCT02581410|12235898|P1|COMPLETED|Vaccination Phase||213
4974940|NCT02581410|12235897|P2|STARTED|Vaccination Phase||215
4974941|NCT02581410|12235898|P1|STARTED|Vaccination Phase||215
4974942|NCT02581345|12235928|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
4974943|NCT02581345|12235929|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
4974944|NCT02581345|12235930|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
4974945|NCT02581345|12235931|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
4974946|NCT02581345|12235928|P4|COMPLETED|Part 2: Week 17 to Week 47||119
4974947|NCT02581345|12235929|P3|COMPLETED|Part 2: Week 17 to Week 47||117
4974948|NCT02581345|12235930|P2|COMPLETED|Part 2: Week 17 to Week 47||0
4974949|NCT02581345|12235931|P1|COMPLETED|Part 2: Week 17 to Week 47||242
4974950|NCT02581345|12235928|P4|STARTED|Part 2: Week 17 to Week 47||131
4974951|NCT02581345|12235929|P3|STARTED|Part 2: Week 17 to Week 47||132
4974952|NCT02581345|12235930|P2|STARTED|Part 2: Week 17 to Week 47||0
4974953|NCT02581345|12235931|P1|STARTED|Part 2: Week 17 to Week 47||271
4974954|NCT02581345|12235928|P4|NOT COMPLETED|Part 1: up to Week 16||0
4974955|NCT02581345|12235929|P3|NOT COMPLETED|Part 1: up to Week 16||0
4974956|NCT02581345|12235930|P2|NOT COMPLETED|Part 1: up to Week 16||23
4974957|NCT02581345|12235931|P1|NOT COMPLETED|Part 1: up to Week 16||15
4974958|NCT02581345|12235928|P4|COMPLETED|Part 1: up to Week 16||0
4974959|NCT02581345|12235929|P3|COMPLETED|Part 1: up to Week 16||0
4974960|NCT02581345|12235930|P2|COMPLETED|Part 1: up to Week 16||263
4974961|NCT02581345|12235931|P1|COMPLETED|Part 1: up to Week 16||271
4974962|NCT02581345|12235928|P4|STARTED|Part 1: up to Week 16||0
4974963|NCT02581345|12235929|P3|STARTED|Part 1: up to Week 16||0
4974964|NCT02581345|12235930|P2|STARTED|Part 1: up to Week 16||286
4974965|NCT02581345|12235931|P1|STARTED|Part 1: up to Week 16||286
4974966|NCT02581202|12236033|P1|NOT COMPLETED|Overall Study||14
4974967|NCT02581202|12236033|P1|COMPLETED|Overall Study||202
4974968|NCT02581202|12236033|P1|STARTED|Overall Study||216
4974969|NCT02581189|12236072|P1|NOT COMPLETED|Overall Study||53
4974970|NCT02581189|12236072|P1|COMPLETED|Overall Study||481
4974971|NCT02581189|12236072|P1|STARTED|Overall Study||534
4974972|NCT02581163|12236086|P1|NOT COMPLETED|Overall Study||29
4974973|NCT02581163|12236086|P1|COMPLETED|Overall Study||282
4974974|NCT02581163|12236086|P1|STARTED|Overall Study||311
4974975|NCT02581137|12236100|P1|NOT COMPLETED|Overall Study||4
4974976|NCT02581137|12236100|P1|COMPLETED|Overall Study||22
4974977|NCT02581137|12236100|P1|STARTED|Overall Study||26
4974978|NCT02581111|12236107|P2|NOT COMPLETED|Overall Study||7
4974979|NCT02581111|12236108|P1|NOT COMPLETED|Overall Study||2
4974980|NCT02581111|12236107|P2|COMPLETED|Overall Study||94
4974981|NCT02581111|12236108|P1|COMPLETED|Overall Study||96
4974982|NCT02581111|12236107|P2|STARTED|Overall Study||101
4974983|NCT02581111|12236108|P1|STARTED|Overall Study||98
4974984|NCT02580877|12236120|P2|NOT COMPLETED|Overall Study||4
4974985|NCT02580877|12236121|P1|NOT COMPLETED|Overall Study||1
4974986|NCT02580877|12236120|P2|COMPLETED|Overall Study||43
4974987|NCT02580877|12236121|P1|COMPLETED|Overall Study||44
4974988|NCT02580877|12236120|P2|STARTED|Overall Study||47
4974989|NCT02580877|12236121|P1|STARTED|Overall Study||45
4974990|NCT02580799|12236129|P1|NOT COMPLETED|Overall Study||0
4974991|NCT02580799|12236129|P1|COMPLETED|Overall Study||30
4974992|NCT02580799|12236129|P1|STARTED|Overall Study||30
4974993|NCT02580591|12236155|P4|NOT COMPLETED|Overall Study||12
4974994|NCT02580591|12236156|P3|NOT COMPLETED|Overall Study||13
4974995|NCT02580591|12236157|P2|NOT COMPLETED|Overall Study||10
4974996|NCT02580591|12236158|P1|NOT COMPLETED|Overall Study||18
4974997|NCT02580591|12236155|P4|COMPLETED|Overall Study||233
4974998|NCT02580591|12236156|P3|COMPLETED|Overall Study||235
4974999|NCT02580591|12236157|P2|COMPLETED|Overall Study||232
4975000|NCT02580591|12236158|P1|COMPLETED|Overall Study||224
4975001|NCT02580591|12236155|P4|Treated|Overall Study||245
4975002|NCT02580591|12236156|P3|Treated|Overall Study||248
4975003|NCT02580591|12236157|P2|Treated|Overall Study||241
4975004|NCT02580591|12236158|P1|Treated|Overall Study||241
4975005|NCT02580591|12236155|P4|STARTED|Overall Study||245
4975006|NCT02580591|12236156|P3|STARTED|Overall Study||248
4975007|NCT02580591|12236157|P2|STARTED|Overall Study||242
4975008|NCT02580591|12236158|P1|STARTED|Overall Study||242
4975009|NCT02580357|12236191|P3|NOT COMPLETED|Overall Study||0
4975010|NCT02580357|12236192|P2|NOT COMPLETED|Overall Study||0
4975011|NCT02580357|12236193|P1|NOT COMPLETED|Overall Study||3
4975012|NCT02580357|12236191|P3|COMPLETED|Overall Study||18
4975013|NCT02580357|12236192|P2|COMPLETED|Overall Study||18
4975014|NCT02580357|12236193|P1|COMPLETED|Overall Study||15
4975015|NCT02580357|12236191|P3|STARTED|Overall Study||18
4975016|NCT02580357|12236192|P2|STARTED|Overall Study||18
4975017|NCT02580357|12236193|P1|STARTED|Overall Study||18
4975018|NCT02580318|12236204|P1|NOT COMPLETED|Overall Study||0
4975019|NCT02580318|12236204|P1|COMPLETED|Overall Study||54
4975020|NCT02580318|12236204|P1|Drinking Water (5 Minutes)|Overall Study||54
4975021|NCT02580318|12236204|P1|Drinking Water (Immediate)|Overall Study||51
4975022|NCT02580318|12236204|P1|Hyperventilation (10 Minutes)|Overall Study||54
4975023|NCT02580318|12236204|P1|Hyperventilation (5 Minutes)|Overall Study||54
4975024|NCT02580318|12236204|P1|Hyperventilation (Immediate)|Overall Study||54
4975025|NCT02580318|12236204|P1|Poor Effort|Overall Study||53
4975026|NCT02580318|12236204|P1|STARTED|Overall Study||54
4975027|NCT02580240|12236210|P2|NOT COMPLETED|Overall Study||0
4975028|NCT02580240|12236211|P1|NOT COMPLETED|Overall Study||2
4975029|NCT02580240|12236210|P2|COMPLETED|Overall Study||58
4975030|NCT02580240|12236211|P1|COMPLETED|Overall Study||60
4975031|NCT02580240|12236210|P2|STARTED|Overall Study||58
4975032|NCT02580240|12236211|P1|STARTED|Overall Study||62
4975033|NCT02580188|12236221|P2|NOT COMPLETED|Overall Study||3
4975034|NCT02580188|12236222|P1|NOT COMPLETED|Overall Study||3
4975035|NCT02580188|12236221|P2|COMPLETED|Overall Study||32
4975036|NCT02580188|12236222|P1|COMPLETED|Overall Study||32
4975037|NCT02580188|12236221|P2|STARTED|Overall Study||35
4975038|NCT02580188|12236222|P1|STARTED|Overall Study||35
4975039|NCT02580058|12236235|P3|NOT COMPLETED|Overall Study||86
4975040|NCT02580058|12236236|P2|NOT COMPLETED|Overall Study||86
4975041|NCT02580058|12236237|P1|NOT COMPLETED|Overall Study||79
4975042|NCT02580058|12236235|P3|COMPLETED|Overall Study||104
4975043|NCT02580058|12236236|P2|COMPLETED|Overall Study||102
4975044|NCT02580058|12236237|P1|COMPLETED|Overall Study||109
4975045|NCT02580058|12236235|P3|Treated|Overall Study||177
4975046|NCT02580058|12236236|P2|Treated|Overall Study||182
4975047|NCT02580058|12236237|P1|Treated|Overall Study||187
4975048|NCT02580058|12236235|P3|STARTED|Overall Study||190
4975049|NCT02580058|12236236|P2|STARTED|Overall Study||188
4975050|NCT02580058|12236237|P1|STARTED|Overall Study||188
4975051|NCT02579928|12236304|P2|NOT COMPLETED|Overall Study||0
4975052|NCT02579928|12236305|P1|NOT COMPLETED|Overall Study||1
4975053|NCT02579928|12236304|P2|COMPLETED|Overall Study||11
4975054|NCT02579928|12236305|P1|COMPLETED|Overall Study||5
4975055|NCT02579928|12236304|P2|STARTED|Overall Study||11
4975056|NCT02579928|12236305|P1|STARTED|Overall Study||6
4975057|NCT02579915|12236313|P2|NOT COMPLETED|Overall Study||5
4975058|NCT02579915|12236314|P1|NOT COMPLETED|Overall Study||10
4975059|NCT02579915|12236313|P2|COMPLETED|Overall Study||16
4975060|NCT02579915|12236314|P1|COMPLETED|Overall Study||9
4975061|NCT02579915|12236313|P2|STARTED|Overall Study||21
4975062|NCT02579915|12236314|P1|STARTED|Overall Study||19
4975063|NCT02579876|12236322|P2|NOT COMPLETED|Overall Study||0
4975064|NCT02579876|12236323|P1|NOT COMPLETED|Overall Study||1
4975065|NCT02579876|12236322|P2|COMPLETED|Overall Study||5
4975066|NCT02579876|12236323|P1|COMPLETED|Overall Study||14
4975067|NCT02579876|12236322|P2|STARTED|Overall Study||5
4975068|NCT02579876|12236323|P1|STARTED|Overall Study||15
4975069|NCT02579863|12236345|P2|NOT COMPLETED|Overall Study||154
4975070|NCT02579863|12236346|P1|NOT COMPLETED|Overall Study||156
4975071|NCT02579863|12236345|P2|COMPLETED|Overall Study||0
4975072|NCT02579863|12236346|P1|COMPLETED|Overall Study||0
4975073|NCT02579863|12236345|P2|Treated|Overall Study||148
4975074|NCT02579863|12236346|P1|Treated|Overall Study||154
4975075|NCT02579863|12236345|P2|STARTED|Overall Study||154
4975076|NCT02579863|12236346|P1|STARTED|Overall Study||156
4975077|NCT02579772|12236366|P2|NOT COMPLETED|Overall Study||2
4975078|NCT02579772|12236367|P1|NOT COMPLETED|Overall Study||2
4975079|NCT02579772|12236366|P2|COMPLETED|Overall Study||3
4975080|NCT02579772|12236367|P1|COMPLETED|Overall Study||6
4975081|NCT02579772|12236366|P2|STARTED|Overall Study||5
4975082|NCT02579772|12236367|P1|STARTED|Overall Study||8
4975083|NCT02579759|12236388|P3|NOT COMPLETED|Overall Study||21
4975084|NCT02579759|12236389|P2|NOT COMPLETED|Overall Study||64
4975085|NCT02579759|12236390|P1|NOT COMPLETED|Overall Study||24
4975086|NCT02579759|12236388|P3|COMPLETED|Overall Study||80
4975087|NCT02579759|12236389|P2|COMPLETED|Overall Study||49
4975088|NCT02579759|12236390|P1|COMPLETED|Overall Study||85
4975089|NCT02579759|12236388|P3|STARTED|Overall Study||101
4975090|NCT02579759|12236389|P2|STARTED|Overall Study||113
4975091|NCT02579759|12236390|P1|STARTED|Overall Study||109
4975092|NCT02579603|12236436|P2|NOT COMPLETED|Overall Study||2
4975093|NCT02579603|12236437|P1|NOT COMPLETED|Overall Study||4
4975094|NCT02579603|12236436|P2|COMPLETED|Overall Study||51
4975095|NCT02579603|12236437|P1|COMPLETED|Overall Study||48
4975096|NCT02579603|12236436|P2|Number of Patients Treated|Overall Study||53
4975097|NCT02579603|12236437|P1|Number of Patients Treated|Overall Study||51
4975098|NCT02579603|12236436|P2|STARTED|Overall Study|Started are the randomised patients|53
4975099|NCT02579603|12236437|P1|STARTED|Overall Study|Started are the randomised patients|52
4975100|NCT02579421|12236450|P4|NOT COMPLETED|Overall Study||3
4975101|NCT02579421|12236451|P3|NOT COMPLETED|Overall Study||1
4975102|NCT02579421|12236452|P2|NOT COMPLETED|Overall Study||5
4975103|NCT02579421|12236453|P1|NOT COMPLETED|Overall Study||6
4975104|NCT02579421|12236450|P4|COMPLETED|Overall Study||3
4975105|NCT02579421|12236451|P3|COMPLETED|Overall Study||5
4975106|NCT02579421|12236452|P2|COMPLETED|Overall Study||18
4975107|NCT02579421|12236453|P1|COMPLETED|Overall Study||17
4975108|NCT02579421|12236450|P4|STARTED|Overall Study||6
4975109|NCT02579421|12236451|P3|STARTED|Overall Study||6
4975110|NCT02579421|12236452|P2|STARTED|Overall Study||23
4975111|NCT02579421|12236453|P1|STARTED|Overall Study||23
4975112|NCT02579382|12236467|P4|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
4975113|NCT02579382|12236468|P3|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
4975114|NCT02579382|12236469|P2|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
4975115|NCT02579382|12236470|P1|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
4975116|NCT02579382|12236467|P4|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
4975117|NCT02579382|12236468|P3|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
4975118|NCT02579382|12236469|P2|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
4975119|NCT02579382|12236470|P1|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
4975120|NCT02579382|12236467|P4|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
4975121|NCT02579382|12236468|P3|STARTED|Optional Treatment Extension Phase(OTEP)||54
4975122|NCT02579382|12236469|P2|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
4975123|NCT02579382|12236470|P1|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
4975124|NCT02579382|12236467|P4|NOT COMPLETED|Main Study Phase||3
4975125|NCT02579382|12236468|P3|NOT COMPLETED|Main Study Phase||2
4975126|NCT02579382|12236469|P2|NOT COMPLETED|Main Study Phase||0
4975127|NCT02579382|12236470|P1|NOT COMPLETED|Main Study Phase||0
4975128|NCT02579382|12236467|P4|COMPLETED|Main Study Phase||52
4975129|NCT02579382|12236468|P3|COMPLETED|Main Study Phase||54
4975130|NCT02579382|12236469|P2|COMPLETED|Main Study Phase||53
4975131|NCT02579382|12236470|P1|COMPLETED|Main Study Phase||28
4975132|NCT02579382|12236467|P4|STARTED|Main Study Phase||55
4975133|NCT02579382|12236468|P3|STARTED|Main Study Phase||56
4975134|NCT02579382|12236469|P2|STARTED|Main Study Phase||53
4975135|NCT02579382|12236470|P1|STARTED|Main Study Phase||28
4975136|NCT02579135|12236565|P2|NOT COMPLETED|Overall Study||9
4975137|NCT02579135|12236566|P1|NOT COMPLETED|Overall Study||2
4975138|NCT02579135|12236565|P2|COMPLETED|Overall Study||106
4975139|NCT02579135|12236566|P1|COMPLETED|Overall Study||105
4975140|NCT02579135|12236565|P2|STARTED|Overall Study||115
4975141|NCT02579135|12236566|P1|STARTED|Overall Study||107
4975142|NCT02579057|12236577|P2|NOT COMPLETED|Overall Study||0
4975143|NCT02579057|12236578|P1|NOT COMPLETED|Overall Study||0
4975144|NCT02579057|12236577|P2|COMPLETED|Overall Study||21
4975145|NCT02579057|12236578|P1|COMPLETED|Overall Study||19
4975146|NCT02579057|12236577|P2|STARTED|Overall Study||21
4975147|NCT02579057|12236578|P1|STARTED|Overall Study||19
4975148|NCT02578992|12236592|P2|NOT COMPLETED|Overall Study||3
4975149|NCT02578992|12236593|P1|NOT COMPLETED|Overall Study||3
4975150|NCT02578992|12236592|P2|COMPLETED|Overall Study|October 2015|62
4975151|NCT02578992|12236593|P1|COMPLETED|Overall Study|October 2015|62
4975152|NCT02578992|12236592|P2|STARTED|Overall Study|November 2014|65
4975153|NCT02578992|12236593|P1|STARTED|Overall Study|November 2014|65
4975154|NCT02578940|12236605|P1|NOT COMPLETED|Overall Study||6
4975155|NCT02578940|12236605|P1|COMPLETED|Overall Study||103
4975156|NCT02578940|12236605|P1|Received 18F-fluciclovine|Overall Study||104
4975157|NCT02578940|12236605|P1|STARTED|Overall Study||109
4975158|NCT02578862|12236614|P2|NOT COMPLETED|Overall Study||2
4975159|NCT02578862|12236615|P1|NOT COMPLETED|Overall Study||0
4975160|NCT02578862|12236614|P2|COMPLETED|Overall Study||33
4975161|NCT02578862|12236615|P1|COMPLETED|Overall Study||37
4975162|NCT02578862|12236614|P2|STARTED|Overall Study||35
4975163|NCT02578862|12236615|P1|STARTED|Overall Study||37
4975164|NCT02578745|12236633|P2|NOT COMPLETED|Overall Study||0
4975165|NCT02578745|12236634|P1|NOT COMPLETED|Overall Study||0
4975166|NCT02578745|12236633|P2|COMPLETED|Overall Study||60
4975167|NCT02578745|12236634|P1|COMPLETED|Overall Study||60
4975168|NCT02578745|12236633|P2|STARTED|Overall Study||60
4975169|NCT02578745|12236634|P1|STARTED|Overall Study||60
4975170|NCT02578706|12236653|P3|NOT COMPLETED|Overall Study||0
4975171|NCT02578706|12236654|P2|NOT COMPLETED|Overall Study||5
4975172|NCT02578706|12236655|P1|NOT COMPLETED|Overall Study||1
4975173|NCT02578706|12236653|P3|COMPLETED|Overall Study||8
4975174|NCT02578706|12236654|P2|COMPLETED|Overall Study||5
4975175|NCT02578706|12236655|P1|COMPLETED|Overall Study||8
4975176|NCT02578706|12236653|P3|STARTED|Overall Study||8
4975177|NCT02578706|12236654|P2|STARTED|Overall Study||10
4975178|NCT02578706|12236655|P1|STARTED|Overall Study||9
4975179|NCT02578680|12236734|P2|NOT COMPLETED|Overall Study||206
4975180|NCT02578680|12236735|P1|NOT COMPLETED|Overall Study||410
4975181|NCT02578680|12236734|P2|COMPLETED|Overall Study||0
4975182|NCT02578680|12236735|P1|COMPLETED|Overall Study||0
4975183|NCT02578680|12236734|P2|Switched to Pembrolizumab|Overall Study||67
4975184|NCT02578680|12236735|P1|Switched to Pembrolizumab|Overall Study||0
4975185|NCT02578680|12236734|P2|Treated|Overall Study||202
4975186|NCT02578680|12236735|P1|Treated|Overall Study||405
4975187|NCT02578680|12236734|P2|STARTED|Overall Study||206
4975188|NCT02578680|12236735|P1|STARTED|Overall Study||410
4975189|NCT02578316|12236751|P1|NOT COMPLETED|Extension Phase||6
4975190|NCT02578316|12236751|P1|COMPLETED|Extension Phase||0
4975191|NCT02578316|12236751|P1|STARTED|Extension Phase||6
4975192|NCT02578316|12236751|P1|NOT COMPLETED|Study Phase||0
4975193|NCT02578316|12236751|P1|COMPLETED|Study Phase||6
4975194|NCT02578316|12236751|P1|STARTED|Study Phase||6
4975195|NCT02578238|12236775|P1|NOT COMPLETED|Overall Study||0
4975196|NCT02578238|12236775|P1|COMPLETED|Overall Study||143
4975197|NCT02578238|12236775|P1|STARTED|Overall Study||143
4975198|NCT02578199|12236779|P1|NOT COMPLETED|Overall Study||4
4975199|NCT02578199|12236779|P1|COMPLETED|Overall Study||27
4975200|NCT02578199|12236779|P1|STARTED|Overall Study||31
4975201|NCT02578186|12236784|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
4975202|NCT02578186|12236785|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
4975203|NCT02578186|12236784|P2|COMPLETED|Period 2 (Second of Crossover)||13
4975204|NCT02578186|12236785|P1|COMPLETED|Period 2 (Second of Crossover)||12
4975205|NCT02578186|12236784|P2|STARTED|Period 2 (Second of Crossover)||13
4975206|NCT02578186|12236785|P1|STARTED|Period 2 (Second of Crossover)||12
4975207|NCT02578186|12236784|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
4975208|NCT02578186|12236785|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
4975209|NCT02578186|12236784|P2|COMPLETED|Period 1 (First of Crossover)||13
4975210|NCT02578186|12236785|P1|COMPLETED|Period 1 (First of Crossover)||12
4975211|NCT02578186|12236784|P2|STARTED|Period 1 (First of Crossover)||18
4975212|NCT02578186|12236785|P1|STARTED|Period 1 (First of Crossover)||17
4975213|NCT02577991|12236794|P3|NOT COMPLETED|Overall Study||0
4975214|NCT02577991|12236795|P2|NOT COMPLETED|Overall Study||2
4975215|NCT02577991|12236796|P1|NOT COMPLETED|Overall Study||3
4975216|NCT02577991|12236794|P3|COMPLETED|Overall Study||29
4975217|NCT02577991|12236795|P2|COMPLETED|Overall Study||25
4975218|NCT02577991|12236796|P1|COMPLETED|Overall Study||21
4975219|NCT02577991|12236794|P3|STARTED|Overall Study||29
4975220|NCT02577991|12236795|P2|STARTED|Overall Study||27
4975221|NCT02577991|12236796|P1|STARTED|Overall Study||24
4975222|NCT02577978|12236818|P2|NOT COMPLETED|Overall Study||4
4975223|NCT02577978|12236819|P1|NOT COMPLETED|Overall Study||7
4975224|NCT02577978|12236818|P2|COMPLETED|Overall Study||25
4975225|NCT02577978|12236819|P1|COMPLETED|Overall Study||25
4975226|NCT02577978|12236818|P2|STARTED|Overall Study||29
4975227|NCT02577978|12236819|P1|STARTED|Overall Study||32
4975228|NCT02577900|12236852|P3|NOT COMPLETED|Overall Study||0
4975229|NCT02577900|12236853|P2|NOT COMPLETED|Overall Study||0
4975230|NCT02577900|12236854|P1|NOT COMPLETED|Overall Study||0
4975231|NCT02577900|12236852|P3|COMPLETED|Overall Study||10
4975232|NCT02577900|12236853|P2|COMPLETED|Overall Study||10
4975233|NCT02577900|12236854|P1|COMPLETED|Overall Study||11
4975234|NCT02577900|12236852|P3|STARTED|Overall Study||10
4975235|NCT02577900|12236853|P2|STARTED|Overall Study||10
4975236|NCT02577900|12236854|P1|STARTED|Overall Study||11
4975237|NCT02577887|12236874|P1|NOT COMPLETED|Overall Study||298
4975238|NCT02577887|12236874|P1|COMPLETED|Overall Study||1803
4975239|NCT02577887|12236874|P1|6 Month Follow-up|Overall Study||1938
4975240|NCT02577887|12236874|P1|STARTED|Overall Study||2101
4975241|NCT02577822|12236883|P2|NOT COMPLETED|Overall Study||13
4975242|NCT02577822|12236884|P1|NOT COMPLETED|Overall Study||6
4975243|NCT02577822|12236883|P2|COMPLETED|Overall Study||20
4975244|NCT02577822|12236884|P1|COMPLETED|Overall Study||21
4975245|NCT02577822|12236883|P2|STARTED|Overall Study||33
4975246|NCT02577822|12236884|P1|STARTED|Overall Study||27
4975247|NCT02577718|12236900|P1|NOT COMPLETED|Overall Study||8
4975248|NCT02577718|12236900|P1|COMPLETED|Overall Study||52
4975249|NCT02577718|12236900|P1|STARTED|Overall Study||60
4975250|NCT02577601|12236906|P1|NOT COMPLETED|UPA+COC (1 Month)||0
4975251|NCT02577601|12236906|P1|COMPLETED|UPA+COC (1 Month)||33
4975252|NCT02577601|12236906|P1|STARTED|UPA+COC (1 Month)||33
4975253|NCT02577601|12236906|P1|NOT COMPLETED|Washout (1 Month)||0
4975254|NCT02577601|12236906|P1|COMPLETED|Washout (1 Month)||33
4975255|NCT02577601|12236906|P1|STARTED|Washout (1 Month)||33
4975256|NCT02577601|12236906|P1|NOT COMPLETED|UPA Only (1 Month)||0
4975257|NCT02577601|12236906|P1|COMPLETED|UPA Only (1 Month)||36
4975258|NCT02577601|12236906|P1|STARTED|UPA Only (1 Month)||36
4975259|NCT02577510|12236913|P2|NOT COMPLETED|Overall Study||0
4975260|NCT02577510|12236914|P1|NOT COMPLETED|Overall Study||0
4975261|NCT02577510|12236913|P2|COMPLETED|Overall Study||21
4975262|NCT02577510|12236914|P1|COMPLETED|Overall Study||21
4975263|NCT02577510|12236913|P2|STARTED|Overall Study||21
4975264|NCT02577510|12236914|P1|STARTED|Overall Study||21
4975265|NCT02577445|12236928|P2|NOT COMPLETED|Overall Study||17
4975266|NCT02577445|12236929|P1|NOT COMPLETED|Overall Study||14
4975267|NCT02577445|12236928|P2|COMPLETED|Overall Study|study terminated prematurely|0
4975268|NCT02577445|12236929|P1|COMPLETED|Overall Study|study terminated prematurely|0
4975269|NCT02577445|12236928|P2|STARTED|Overall Study||17
4975270|NCT02577445|12236929|P1|STARTED|Overall Study||14
4975271|NCT02577315|12236942|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4975272|NCT02577315|12236943|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
4975273|NCT02577315|12236942|P2|COMPLETED|Treatment Period 2 (4 Days)||12
4975274|NCT02577315|12236943|P1|COMPLETED|Treatment Period 2 (4 Days)||12
4975275|NCT02577315|12236942|P2|STARTED|Treatment Period 2 (4 Days)||12
4975276|NCT02577315|12236943|P1|STARTED|Treatment Period 2 (4 Days)||12
4975277|NCT02577315|12236942|P2|NOT COMPLETED|Washout Period (5 Days)||0
4975278|NCT02577315|12236943|P1|NOT COMPLETED|Washout Period (5 Days)||0
4975279|NCT02577315|12236942|P2|COMPLETED|Washout Period (5 Days)||12
4975280|NCT02577315|12236943|P1|COMPLETED|Washout Period (5 Days)||12
4975281|NCT02577315|12236942|P2|STARTED|Washout Period (5 Days)||12
4975282|NCT02577315|12236943|P1|STARTED|Washout Period (5 Days)||12
4975283|NCT02577315|12236942|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
4975284|NCT02577315|12236943|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
4975285|NCT02577315|12236942|P2|COMPLETED|Treatment Period 1 (4 Days)||12
4975286|NCT02577315|12236943|P1|COMPLETED|Treatment Period 1 (4 Days)||12
4975287|NCT02577315|12236942|P2|STARTED|Treatment Period 1 (4 Days)||13
4975288|NCT02577315|12236943|P1|STARTED|Treatment Period 1 (4 Days)||12
4975289|NCT02577146|12236959|P1|NOT COMPLETED|Overall Study||28
4975290|NCT02577146|12236959|P1|COMPLETED|Overall Study||46
4975291|NCT02577146|12236959|P1|STARTED|Overall Study||74
4975292|NCT02577107|12236966|P2|NOT COMPLETED|Overall Study||1
4975293|NCT02577107|12236967|P1|NOT COMPLETED|Overall Study||0
4975294|NCT02577107|12236966|P2|COMPLETED|Overall Study||5
4975295|NCT02577107|12236967|P1|COMPLETED|Overall Study||6
4975296|NCT02577107|12236966|P2|STARTED|Overall Study||6
4975297|NCT02577107|12236967|P1|STARTED|Overall Study||6
4975298|NCT02577042|12236981|P2|NOT COMPLETED|Overall Study||3
4975299|NCT02577042|12236982|P1|NOT COMPLETED|Overall Study||5
4975300|NCT02577042|12236981|P2|COMPLETED|Overall Study||19
4975301|NCT02577042|12236982|P1|COMPLETED|Overall Study||15
4975302|NCT02577042|12236981|P2|STARTED|Overall Study||22
4975303|NCT02577042|12236982|P1|STARTED|Overall Study||20
4975304|NCT02577029|12236996|P8|NOT COMPLETED|Overall Study||12
4975305|NCT02577029|12236997|P7|NOT COMPLETED|Overall Study||12
4975306|NCT02577029|12236998|P6|NOT COMPLETED|Overall Study||13
4975307|NCT02577029|12236999|P5|NOT COMPLETED|Overall Study||11
4975308|NCT02577029|12237000|P4|NOT COMPLETED|Overall Study||12
4975309|NCT02577029|12237001|P3|NOT COMPLETED|Overall Study||7
4975310|NCT02577029|12237002|P2|NOT COMPLETED|Overall Study||2
4975311|NCT02577029|12237003|P1|NOT COMPLETED|Overall Study||10
4975312|NCT02577029|12236996|P8|COMPLETED|Overall Study||0
4975313|NCT02577029|12236997|P7|COMPLETED|Overall Study||0
4975314|NCT02577029|12236998|P6|COMPLETED|Overall Study||0
4975315|NCT02577029|12236999|P5|COMPLETED|Overall Study||0
4975316|NCT02577029|12237000|P4|COMPLETED|Overall Study||0
4975317|NCT02577029|12237001|P3|COMPLETED|Overall Study||0
4975318|NCT02577029|12237002|P2|COMPLETED|Overall Study||0
4975319|NCT02577029|12237003|P1|COMPLETED|Overall Study||0
4975320|NCT02577029|12236996|P8|STARTED|Overall Study||12
4975321|NCT02577029|12236997|P7|STARTED|Overall Study||12
4975322|NCT02577029|12236998|P6|STARTED|Overall Study||13
4975323|NCT02577029|12236999|P5|STARTED|Overall Study||11
4975324|NCT02577029|12237000|P4|STARTED|Overall Study||12
4975325|NCT02577029|12237001|P3|STARTED|Overall Study||7
4975326|NCT02577029|12237002|P2|STARTED|Overall Study||2
4975327|NCT02577029|12237003|P1|STARTED|Overall Study||10
4975328|NCT02577016|12237111|P2|NOT COMPLETED|Overall Study||2
4975329|NCT02577016|12237112|P1|NOT COMPLETED|Overall Study||2
4975330|NCT02577016|12237111|P2|COMPLETED|Overall Study||69
4975331|NCT02577016|12237112|P1|COMPLETED|Overall Study||68
4975332|NCT02577016|12237111|P2|STARTED|Overall Study||71
4975333|NCT02577016|12237112|P1|STARTED|Overall Study||70
4975334|NCT02577003|12237130|P2|NOT COMPLETED|Overall Study||5
4975335|NCT02577003|12237131|P1|NOT COMPLETED|Overall Study||2
4975336|NCT02577003|12237130|P2|COMPLETED|Overall Study||65
4975337|NCT02577003|12237131|P1|COMPLETED|Overall Study||71
4975338|NCT02577003|12237130|P2|STARTED|Overall Study||70
4975339|NCT02577003|12237131|P1|STARTED|Overall Study||73
4975340|NCT02576990|12237151|P2|NOT COMPLETED|Overall Study||24
4975341|NCT02576990|12237152|P1|NOT COMPLETED|Overall Study||43
4975342|NCT02576990|12237151|P2|COMPLETED|Overall Study||0
4975343|NCT02576990|12237152|P1|COMPLETED|Overall Study||13
4975344|NCT02576990|12237151|P2|Treated|Overall Study||23
4975345|NCT02576990|12237152|P1|Treated|Overall Study||53
4975346|NCT02576990|12237151|P2|STARTED|Overall Study||24
4975347|NCT02576990|12237152|P1|STARTED|Overall Study||56
4975348|NCT02576977|12237180|P2|NOT COMPLETED|Overall Study||125
4975349|NCT02576977|12237181|P1|NOT COMPLETED|Overall Study||126
4975350|NCT02576977|12237180|P2|COMPLETED|Overall Study||0
4975351|NCT02576977|12237181|P1|COMPLETED|Overall Study||0
4975352|NCT02576977|12237180|P2|Treated|Overall Study||123
4975353|NCT02576977|12237181|P1|Treated|Overall Study||122
4975354|NCT02576977|12237180|P2|STARTED|Overall Study||125
4975355|NCT02576977|12237181|P1|STARTED|Overall Study||126
4975356|NCT02576951|12237203|P4|NOT COMPLETED|Overall Study||5
4975357|NCT02576951|12237204|P3|NOT COMPLETED|Overall Study||2
4975358|NCT02576951|12237205|P2|NOT COMPLETED|Overall Study||0
4975359|NCT02576951|12237206|P1|NOT COMPLETED|Overall Study||1
4975360|NCT02576951|12237203|P4|COMPLETED|Overall Study||75
4975361|NCT02576951|12237204|P3|COMPLETED|Overall Study||78
4975362|NCT02576951|12237205|P2|COMPLETED|Overall Study||3
4975363|NCT02576951|12237206|P1|COMPLETED|Overall Study||14
4975364|NCT02576951|12237203|P4|Received at Least One Dose of Study Drug|Overall Study||80
4975365|NCT02576951|12237204|P3|Received at Least One Dose of Study Drug|Overall Study||80
4975366|NCT02576951|12237205|P2|Received at Least One Dose of Study Drug|Overall Study||3
4975367|NCT02576951|12237206|P1|Received at Least One Dose of Study Drug|Overall Study||15
4975368|NCT02576951|12237203|P4|STARTED|Overall Study||80
4975369|NCT02576951|12237204|P3|STARTED|Overall Study||80
4975370|NCT02576951|12237205|P2|STARTED|Overall Study||3
4975371|NCT02576951|12237206|P1|STARTED|Overall Study||15
4975372|NCT02576938|12237230|P3|NOT COMPLETED|Overall Study||12
4975373|NCT02576938|12237231|P2|NOT COMPLETED|Overall Study||12
4975374|NCT02576938|12237232|P1|NOT COMPLETED|Overall Study||20
4975375|NCT02576938|12237230|P3|COMPLETED|Overall Study||26
4975376|NCT02576938|12237231|P2|COMPLETED|Overall Study||25
4975377|NCT02576938|12237232|P1|COMPLETED|Overall Study||29
4975378|NCT02576938|12237230|P3|Received at Least One Dose of Study Drug|Overall Study||38
4975379|NCT02576938|12237231|P2|Received at Least One Dose of Study Drug|Overall Study||37
4975380|NCT02576938|12237232|P1|Received at Least One Dose of Study Drug|Overall Study||49
4975381|NCT02576938|12237230|P3|STARTED|Overall Study||38
4975382|NCT02576938|12237231|P2|STARTED|Overall Study||37
4975383|NCT02576938|12237232|P1|STARTED|Overall Study||49
4975384|NCT02576899|12237262|P2|NOT COMPLETED|Overall Study||13
4975385|NCT02576899|12237263|P1|NOT COMPLETED|Overall Study||11
4975386|NCT02576899|12237262|P2|COMPLETED|Overall Study||7
4975387|NCT02576899|12237263|P1|COMPLETED|Overall Study||5
4975388|NCT02576899|12237262|P2|STARTED|Overall Study||20
4975389|NCT02576899|12237263|P1|STARTED|Overall Study||16
4975390|NCT02576678|12237278|P3|NOT COMPLETED|Overall Study||5
4975391|NCT02576678|12237279|P2|NOT COMPLETED|Overall Study||1
4975392|NCT02576678|12237280|P1|NOT COMPLETED|Overall Study||5
4975393|NCT02576678|12237278|P3|COMPLETED|Overall Study||16
4975394|NCT02576678|12237279|P2|COMPLETED|Overall Study||7
4975395|NCT02576678|12237280|P1|COMPLETED|Overall Study||8
4975396|NCT02576678|12237278|P3|Pharmacokinetic (PK) Population|Overall Study||18
4975397|NCT02576678|12237279|P2|Pharmacokinetic (PK) Population|Overall Study||8
4975398|NCT02576678|12237280|P1|Pharmacokinetic (PK) Population|Overall Study||12
4975399|NCT02576678|12237278|P3|STARTED|Overall Study||21
4975400|NCT02576678|12237279|P2|STARTED|Overall Study||8
4975401|NCT02576678|12237280|P1|STARTED|Overall Study||13
4975402|NCT02576652|12237312|P1|NOT COMPLETED|Overall Study||2
4975403|NCT02576652|12237312|P1|COMPLETED|Overall Study||4
4975404|NCT02576652|12237312|P1|STARTED|Overall Study||6
4975405|NCT02576639|12237324|P5|NOT COMPLETED|Overall Study||4
4975406|NCT02576639|12237325|P4|NOT COMPLETED|Overall Study||1
4975407|NCT02576639|12237326|P3|NOT COMPLETED|Overall Study||2
4975408|NCT02576639|12237327|P2|NOT COMPLETED|Overall Study||2
4975409|NCT02576639|12237328|P1|NOT COMPLETED|Overall Study||2
4975410|NCT02576639|12237324|P5|COMPLETED|Overall Study||20
4975411|NCT02576639|12237325|P4|COMPLETED|Overall Study||25
4975412|NCT02576639|12237326|P3|COMPLETED|Overall Study||23
4975413|NCT02576639|12237327|P2|COMPLETED|Overall Study||23
4975414|NCT02576639|12237328|P1|COMPLETED|Overall Study||22
4975415|NCT02576639|12237324|P5|Safety Analysis Set|Overall Study||24
4975416|NCT02576639|12237325|P4|Safety Analysis Set|Overall Study||26
4975417|NCT02576639|12237326|P3|Safety Analysis Set|Overall Study||25
4975418|NCT02576639|12237327|P2|Safety Analysis Set|Overall Study||25
4975419|NCT02576639|12237328|P1|Safety Analysis Set|Overall Study||24
4975420|NCT02576639|12237324|P5|Pharmacokinetic Analysis Set|Overall Study||24
4975421|NCT02576639|12237325|P4|Pharmacokinetic Analysis Set|Overall Study||26
4975422|NCT02576639|12237326|P3|Pharmacokinetic Analysis Set|Overall Study||25
4975423|NCT02576639|12237327|P2|Pharmacokinetic Analysis Set|Overall Study||25
4975424|NCT02576639|12237328|P1|Pharmacokinetic Analysis Set|Overall Study||0
4975425|NCT02576639|12237324|P5|Pharmacodynamic Analysis Set|Overall Study||25
4975426|NCT02576639|12237325|P4|Pharmacodynamic Analysis Set|Overall Study||25
4975427|NCT02576639|12237326|P3|Pharmacodynamic Analysis Set|Overall Study||25
4975428|NCT02576639|12237327|P2|Pharmacodynamic Analysis Set|Overall Study||24
4975429|NCT02576639|12237328|P1|Pharmacodynamic Analysis Set|Overall Study||24
4975430|NCT02576639|12237324|P5|STARTED|Overall Study||24
4975431|NCT02576639|12237325|P4|STARTED|Overall Study||26
4975432|NCT02576639|12237326|P3|STARTED|Overall Study||25
4975433|NCT02576639|12237327|P2|STARTED|Overall Study||25
4975434|NCT02576639|12237328|P1|STARTED|Overall Study||24
4975435|NCT02576587|12237387|P2|NOT COMPLETED|Follow up Period (Case Only)||155
4975436|NCT02576587|12237388|P1|NOT COMPLETED|Follow up Period (Case Only)||117
4975437|NCT02576587|12237387|P2|COMPLETED|Follow up Period (Case Only)||0
4975438|NCT02576587|12237388|P1|COMPLETED|Follow up Period (Case Only)||44
4975439|NCT02576587|12237387|P2|Selected for Follow up|Follow up Period (Case Only)||0
4975440|NCT02576587|12237388|P1|Selected for Follow up|Follow up Period (Case Only)||61
4975441|NCT02576587|12237387|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
4975442|NCT02576587|12237388|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
4975443|NCT02576587|12237387|P2|NOT COMPLETED|Baseline||1
4975444|NCT02576587|12237388|P1|NOT COMPLETED|Baseline||0
4975445|NCT02576587|12237387|P2|COMPLETED|Baseline|Baseline visit completed|155
4975446|NCT02576587|12237388|P1|COMPLETED|Baseline|Baseline visit completed|161
4975447|NCT02576587|12237387|P2|STARTED|Baseline|Total controls baseline visit|156
4975448|NCT02576587|12237388|P1|STARTED|Baseline|Total cases baseline visit|161
4975449|NCT02576535|12237406|P1|NOT COMPLETED|Overall Study||2
4975450|NCT02576535|12237406|P1|COMPLETED|Overall Study||16
4975451|NCT02576535|12237406|P1|STARTED|Overall Study||18
4975452|NCT02576509|12237417|P2|NOT COMPLETED|Follow-up Period||52
4975453|NCT02576509|12237418|P1|NOT COMPLETED|Follow-up Period||49
4975454|NCT02576509|12237417|P2|COMPLETED|Follow-up Period||311
4975455|NCT02576509|12237418|P1|COMPLETED|Follow-up Period||318
4975456|NCT02576509|12237417|P2|STARTED|Follow-up Period||363
4975457|NCT02576509|12237418|P1|STARTED|Follow-up Period||367
4975458|NCT02576509|12237417|P2|NOT COMPLETED|Treatment Period||355
4975459|NCT02576509|12237418|P1|NOT COMPLETED|Treatment Period||329
4975460|NCT02576509|12237417|P2|COMPLETED|Treatment Period||8
4975461|NCT02576509|12237418|P1|COMPLETED|Treatment Period||38
4975462|NCT02576509|12237417|P2|STARTED|Treatment Period||363
4975463|NCT02576509|12237418|P1|STARTED|Treatment Period||367
4975464|NCT02576509|12237417|P2|NOT COMPLETED|Pre-Treatment Period||9
4975465|NCT02576509|12237418|P1|NOT COMPLETED|Pre-Treatment Period||4
4975466|NCT02576509|12237417|P2|COMPLETED|Pre-Treatment Period||363
4975467|NCT02576509|12237418|P1|COMPLETED|Pre-Treatment Period||367
4975468|NCT02576509|12237417|P2|STARTED|Pre-Treatment Period||372
4975469|NCT02576509|12237418|P1|STARTED|Pre-Treatment Period||371
4975470|NCT02576249|12237434|P2|NOT COMPLETED|Overall Study||0
4975471|NCT02576249|12237435|P1|NOT COMPLETED|Overall Study||0
4975472|NCT02576249|12237434|P2|COMPLETED|Overall Study||14
4975473|NCT02576249|12237435|P1|COMPLETED|Overall Study||15
4975474|NCT02576249|12237434|P2|STARTED|Overall Study||14
4975475|NCT02576249|12237435|P1|STARTED|Overall Study||15
4975476|NCT02576145|12237447|P2|NOT COMPLETED|Overall Study||1
4975477|NCT02576145|12237448|P1|NOT COMPLETED|Overall Study||3
4975478|NCT02576145|12237447|P2|COMPLETED|Overall Study||4
4975479|NCT02576145|12237448|P1|COMPLETED|Overall Study||3
4975480|NCT02576145|12237447|P2|STARTED|Overall Study||5
4975481|NCT02576145|12237448|P1|STARTED|Overall Study||6
4975482|NCT02576067|12237486|P2|NOT COMPLETED|Overall Study||36
4975483|NCT02576067|12237487|P1|NOT COMPLETED|Overall Study||34
4975484|NCT02576067|12237486|P2|COMPLETED|Overall Study||27
4975485|NCT02576067|12237487|P1|COMPLETED|Overall Study||26
4975486|NCT02576067|12237486|P2|STARTED|Overall Study||63
4975487|NCT02576067|12237487|P1|STARTED|Overall Study||60
4975488|NCT02576054|12237497|P1|NOT COMPLETED|Overall Study||1
4975489|NCT02576054|12237497|P1|COMPLETED|Overall Study||100
4975490|NCT02576054|12237497|P1|Vaccination 3|Overall Study||100
4975491|NCT02576054|12237497|P1|Vaccination 2|Overall Study||100
4975492|NCT02576054|12237497|P1|Vaccination 1|Overall Study||100
4975493|NCT02576054|12237497|P1|STARTED|Overall Study||101
4975494|NCT02576041|12237512|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
4975495|NCT02576041|12237512|P1|COMPLETED|Bilastine (Active Treatement)||18
4975496|NCT02576041|12237512|P1|STARTED|Bilastine (Active Treatement)||18
4975497|NCT02576041|12237512|P1|NOT COMPLETED|Placebo (run-in)||0
4975498|NCT02576041|12237512|P1|COMPLETED|Placebo (run-in)||18
4975499|NCT02576041|12237512|P1|STARTED|Placebo (run-in)||18
4975500|NCT02575950|12237518|P4|NOT COMPLETED|Overall Study||5
4975501|NCT02575950|12237519|P3|NOT COMPLETED|Overall Study||0
4975502|NCT02575950|12237520|P2|NOT COMPLETED|Overall Study||1
4975503|NCT02575950|12237521|P1|NOT COMPLETED|Overall Study||0
4975504|NCT02575950|12237518|P4|COMPLETED|Overall Study||20
4975505|NCT02575950|12237519|P3|COMPLETED|Overall Study||6
4975506|NCT02575950|12237520|P2|COMPLETED|Overall Study||5
4975507|NCT02575950|12237521|P1|COMPLETED|Overall Study||3
4975508|NCT02575950|12237518|P4|STARTED|Overall Study||25
4975509|NCT02575950|12237519|P3|STARTED|Overall Study||6
4975510|NCT02575950|12237520|P2|STARTED|Overall Study||6
4975511|NCT02575950|12237521|P1|STARTED|Overall Study||3
4975512|NCT02575911|12237550|P1|NOT COMPLETED|Overall Study||1
4975513|NCT02575911|12237550|P1|COMPLETED|Overall Study||29
4975514|NCT02575911|12237550|P1|STARTED|Overall Study||30
4975515|NCT02575833|12237570|P2|NOT COMPLETED|Overall Study||1
4975516|NCT02575833|12237571|P1|NOT COMPLETED|Overall Study||1
4975517|NCT02575833|12237570|P2|COMPLETED|Overall Study||44
4975518|NCT02575833|12237571|P1|COMPLETED|Overall Study||43
4975519|NCT02575833|12237570|P2|Received Study Drug|Overall Study||44
4975520|NCT02575833|12237571|P1|Received Study Drug|Overall Study||44
4975521|NCT02575833|12237570|P2|STARTED|Overall Study||45
4975522|NCT02575833|12237571|P1|STARTED|Overall Study||44
4975523|NCT02575807|12237586|P5|NOT COMPLETED|Overall Study||4
4975524|NCT02575807|12237587|P4|NOT COMPLETED|Overall Study||2
4975525|NCT02575807|12237588|P3|NOT COMPLETED|Overall Study||16
4975526|NCT02575807|12237589|P2|NOT COMPLETED|Overall Study||4
4975527|NCT02575807|12237590|P1|NOT COMPLETED|Overall Study||9
4975528|NCT02575807|12237586|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
4975529|NCT02575807|12237587|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
4975530|NCT02575807|12237588|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
4975531|NCT02575807|12237589|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
4975532|NCT02575807|12237590|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
4975533|NCT02575807|12237586|P5|Treated|Overall Study||3
4975534|NCT02575807|12237587|P4|Treated|Overall Study||1
4975535|NCT02575807|12237588|P3|Treated|Overall Study||16
4975536|NCT02575807|12237589|P2|Treated|Overall Study||4
4975537|NCT02575807|12237590|P1|Treated|Overall Study||8
4975538|NCT02575807|12237586|P5|STARTED|Overall Study||4
4975539|NCT02575807|12237587|P4|STARTED|Overall Study||2
4975540|NCT02575807|12237588|P3|STARTED|Overall Study||16
4975541|NCT02575807|12237589|P2|STARTED|Overall Study||4
4975542|NCT02575807|12237590|P1|STARTED|Overall Study||9
4975543|NCT02575365|12237630|P1|NOT COMPLETED|Overall Study||4
4975544|NCT02575365|12237630|P1|COMPLETED|Overall Study||0
4975545|NCT02575365|12237630|P1|STARTED|Overall Study||4
4975546|NCT02575300|12237640|P1|NOT COMPLETED|Overall Study||0
4975547|NCT02575300|12237640|P1|COMPLETED|Overall Study||20
4975548|NCT02575300|12237640|P1|STARTED|Overall Study||20
4975549|NCT02575079|12237650|P2|NOT COMPLETED|Overall Study||0
4975550|NCT02575079|12237651|P1|NOT COMPLETED|Overall Study||6
4975551|NCT02575079|12237650|P2|COMPLETED|Overall Study||71
4975552|NCT02575079|12237651|P1|COMPLETED|Overall Study||42
4975553|NCT02575079|12237650|P2|STARTED|Overall Study||71
4975554|NCT02575079|12237651|P1|STARTED|Overall Study||48
4975555|NCT02574858|12237665|P1|NOT COMPLETED|Overall Study||0
4975556|NCT02574858|12237665|P1|COMPLETED|Overall Study||25
4975557|NCT02574858|12237665|P1|STARTED|Overall Study||25
4975558|NCT02574845|12237676|P6|NOT COMPLETED|Overall Study||1
4975559|NCT02574845|12237677|P5|NOT COMPLETED|Overall Study||1
4975560|NCT02574845|12237678|P4|NOT COMPLETED|Overall Study||0
4975561|NCT02574845|12237679|P3|NOT COMPLETED|Overall Study||0
4975562|NCT02574845|12237680|P2|NOT COMPLETED|Overall Study||1
4975563|NCT02574845|12237681|P1|NOT COMPLETED|Overall Study||0
4975564|NCT02574845|12237676|P6|COMPLETED|Overall Study||2
4975565|NCT02574845|12237677|P5|COMPLETED|Overall Study||2
4975566|NCT02574845|12237678|P4|COMPLETED|Overall Study||3
4975567|NCT02574845|12237679|P3|COMPLETED|Overall Study||3
4975568|NCT02574845|12237680|P2|COMPLETED|Overall Study||2
4975569|NCT02574845|12237681|P1|COMPLETED|Overall Study||3
4975570|NCT02574845|12237676|P6|Received R|Overall Study||3
4975571|NCT02574845|12237677|P5|Received R|Overall Study||2
4975572|NCT02574845|12237678|P4|Received R|Overall Study||3
4975573|NCT02574845|12237679|P3|Received R|Overall Study||3
4975574|NCT02574845|12237680|P2|Received R|Overall Study||2
4975575|NCT02574845|12237681|P1|Received R|Overall Study||3
4975576|NCT02574845|12237676|P6|Received T5|Overall Study||2
4975577|NCT02574845|12237677|P5|Received T5|Overall Study||3
4975578|NCT02574845|12237678|P4|Received T5|Overall Study||3
4975579|NCT02574845|12237679|P3|Received T5|Overall Study||3
4975580|NCT02574845|12237680|P2|Received T5|Overall Study||2
4975581|NCT02574845|12237681|P1|Received T5|Overall Study||3
4975582|NCT02574845|12237676|P6|Received T4|Overall Study||2
4975583|NCT02574845|12237677|P5|Received T4|Overall Study||2
4975584|NCT02574845|12237678|P4|Received T4|Overall Study||3
4975585|NCT02574845|12237679|P3|Received T4|Overall Study||3
4975586|NCT02574845|12237680|P2|Received T4|Overall Study||2
4975587|NCT02574845|12237681|P1|Received T4|Overall Study||3
4975588|NCT02574845|12237676|P6|Received T3|Overall Study||3
4975589|NCT02574845|12237677|P5|Received T3|Overall Study||2
4975590|NCT02574845|12237678|P4|Received T3|Overall Study||3
4975591|NCT02574845|12237679|P3|Received T3|Overall Study||3
4975592|NCT02574845|12237680|P2|Received T3|Overall Study||2
4975593|NCT02574845|12237681|P1|Received T3|Overall Study|one subject missed treatment period 2|2
4975594|NCT02574845|12237676|P6|Received T2|Overall Study||3
4975595|NCT02574845|12237677|P5|Received T2|Overall Study||2
4975596|NCT02574845|12237678|P4|Received T2|Overall Study||3
4975597|NCT02574845|12237679|P3|Received T2|Overall Study||3
4975598|NCT02574845|12237680|P2|Received T2|Overall Study||3
4975599|NCT02574845|12237681|P1|Received T2|Overall Study||3
4975600|NCT02574845|12237676|P6|Received T1|Overall Study|one subject missed treatment period 2|2
4975601|NCT02574845|12237677|P5|Received T1|Overall Study||2
4975602|NCT02574845|12237678|P4|Received T1|Overall Study||3
4975603|NCT02574845|12237679|P3|Received T1|Overall Study||3
4975604|NCT02574845|12237680|P2|Received T1|Overall Study||2
4975605|NCT02574845|12237681|P1|Received T1|Overall Study||3
4975606|NCT02574845|12237676|P6|STARTED|Overall Study||3
4975607|NCT02574845|12237677|P5|STARTED|Overall Study||3
4975608|NCT02574845|12237678|P4|STARTED|Overall Study||3
4975609|NCT02574845|12237679|P3|STARTED|Overall Study||3
4975610|NCT02574845|12237680|P2|STARTED|Overall Study||3
4975611|NCT02574845|12237681|P1|STARTED|Overall Study||3
4975612|NCT02574832|12237707|P1|NOT COMPLETED|Overall Study||0
4975613|NCT02574832|12237707|P1|COMPLETED|Overall Study||2
4975614|NCT02574832|12237707|P1|STARTED|Overall Study||2
4975615|NCT02574637|12237716|P10|NOT COMPLETED|Open-label (OL) Period||1
4975616|NCT02574637|12237717|P9|NOT COMPLETED|Open-label (OL) Period||2
4975617|NCT02574637|12237718|P8|NOT COMPLETED|Open-label (OL) Period||1
4975618|NCT02574637|12237719|P7|NOT COMPLETED|Open-label (OL) Period||2
4975619|NCT02574637|12237720|P6|NOT COMPLETED|Open-label (OL) Period||2
4975620|NCT02574637|12237721|P5|NOT COMPLETED|Open-label (OL) Period||0
4975621|NCT02574637|12237722|P4|NOT COMPLETED|Open-label (OL) Period||0
4975622|NCT02574637|12237723|P3|NOT COMPLETED|Open-label (OL) Period||0
4975623|NCT02574637|12237724|P2|NOT COMPLETED|Open-label (OL) Period||0
4975624|NCT02574637|12237725|P1|NOT COMPLETED|Open-label (OL) Period||0
4975625|NCT02574637|12237716|P10|COMPLETED|Open-label (OL) Period||0
4975626|NCT02574637|12237717|P9|COMPLETED|Open-label (OL) Period||1
4975627|NCT02574637|12237718|P8|COMPLETED|Open-label (OL) Period||1
4975628|NCT02574637|12237719|P7|COMPLETED|Open-label (OL) Period||1
4975629|NCT02574637|12237720|P6|COMPLETED|Open-label (OL) Period||0
4975630|NCT02574637|12237721|P5|COMPLETED|Open-label (OL) Period||0
4975631|NCT02574637|12237722|P4|COMPLETED|Open-label (OL) Period||0
4975632|NCT02574637|12237723|P3|COMPLETED|Open-label (OL) Period||0
4975633|NCT02574637|12237724|P2|COMPLETED|Open-label (OL) Period||0
4975634|NCT02574637|12237725|P1|COMPLETED|Open-label (OL) Period||0
4975635|NCT02574637|12237716|P10|STARTED|Open-label (OL) Period||1
4975636|NCT02574637|12237717|P9|STARTED|Open-label (OL) Period||3
4975637|NCT02574637|12237718|P8|STARTED|Open-label (OL) Period||2
4975638|NCT02574637|12237719|P7|STARTED|Open-label (OL) Period||3
4975639|NCT02574637|12237720|P6|STARTED|Open-label (OL) Period||2
4975640|NCT02574637|12237721|P5|STARTED|Open-label (OL) Period||0
4975641|NCT02574637|12237722|P4|STARTED|Open-label (OL) Period||0
4975642|NCT02574637|12237723|P3|STARTED|Open-label (OL) Period||0
4975643|NCT02574637|12237724|P2|STARTED|Open-label (OL) Period||0
4975644|NCT02574637|12237725|P1|STARTED|Open-label (OL) Period||0
4975645|NCT02574637|12237716|P10|NOT COMPLETED|Double-blind Period||0
4975646|NCT02574637|12237717|P9|NOT COMPLETED|Double-blind Period||0
4975647|NCT02574637|12237718|P8|NOT COMPLETED|Double-blind Period||0
4975648|NCT02574637|12237719|P7|NOT COMPLETED|Double-blind Period||0
4975649|NCT02574637|12237720|P6|NOT COMPLETED|Double-blind Period||0
4975650|NCT02574637|12237721|P5|NOT COMPLETED|Double-blind Period||2
4975651|NCT02574637|12237722|P4|NOT COMPLETED|Double-blind Period||4
4975652|NCT02574637|12237723|P3|NOT COMPLETED|Double-blind Period||7
4975653|NCT02574637|12237724|P2|NOT COMPLETED|Double-blind Period||1
4975654|NCT02574637|12237725|P1|NOT COMPLETED|Double-blind Period||3
4975655|NCT02574637|12237716|P10|COMPLETED|Double-blind Period||0
4975656|NCT02574637|12237717|P9|COMPLETED|Double-blind Period||0
4975657|NCT02574637|12237718|P8|COMPLETED|Double-blind Period||0
4975658|NCT02574637|12237719|P7|COMPLETED|Double-blind Period||0
4975659|NCT02574637|12237720|P6|COMPLETED|Double-blind Period||0
4975660|NCT02574637|12237721|P5|COMPLETED|Double-blind Period||1
4975661|NCT02574637|12237722|P4|COMPLETED|Double-blind Period||3
4975662|NCT02574637|12237723|P3|COMPLETED|Double-blind Period||2
4975663|NCT02574637|12237724|P2|COMPLETED|Double-blind Period||4
4975664|NCT02574637|12237725|P1|COMPLETED|Double-blind Period||2
4975665|NCT02574637|12237716|P10|STARTED|Double-blind Period||0
4975666|NCT02574637|12237717|P9|STARTED|Double-blind Period||0
4975667|NCT02574637|12237718|P8|STARTED|Double-blind Period||0
4975668|NCT02574637|12237719|P7|STARTED|Double-blind Period||0
4975669|NCT02574637|12237720|P6|STARTED|Double-blind Period||0
4975670|NCT02574637|12237721|P5|STARTED|Double-blind Period||3
4975671|NCT02574637|12237722|P4|STARTED|Double-blind Period||7
4975672|NCT02574637|12237723|P3|STARTED|Double-blind Period||9
4975673|NCT02574637|12237724|P2|STARTED|Double-blind Period||5
4975674|NCT02574637|12237725|P1|STARTED|Double-blind Period||5
4975675|NCT02574481|12237825|P4|NOT COMPLETED|Overall Study||0
4975676|NCT02574481|12237826|P3|NOT COMPLETED|Overall Study||3
4975677|NCT02574481|12237827|P2|NOT COMPLETED|Overall Study||14
4975678|NCT02574481|12237828|P1|NOT COMPLETED|Overall Study||27
4975679|NCT02574481|12237825|P4|COMPLETED|Overall Study||13
4975680|NCT02574481|12237826|P3|COMPLETED|Overall Study||47
4975681|NCT02574481|12237827|P2|COMPLETED|Overall Study||142
4975682|NCT02574481|12237828|P1|COMPLETED|Overall Study||282
4975683|NCT02574481|12237825|P4|STARTED|Overall Study||13
4975684|NCT02574481|12237826|P3|STARTED|Overall Study||50
4975685|NCT02574481|12237827|P2|STARTED|Overall Study||156
4975686|NCT02574481|12237828|P1|STARTED|Overall Study||309
4975687|NCT02574312|12237868|P2|NOT COMPLETED|3 Months Follow-up||0
4975688|NCT02574312|12237869|P1|NOT COMPLETED|3 Months Follow-up||1
4975689|NCT02574312|12237868|P2|COMPLETED|3 Months Follow-up||44
4975690|NCT02574312|12237869|P1|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
4975691|NCT02574312|12237868|P2|STARTED|3 Months Follow-up||44
4975692|NCT02574312|12237869|P1|STARTED|3 Months Follow-up||44
4975693|NCT02574312|12237868|P2|NOT COMPLETED|Pre-Operative||0
4975694|NCT02574312|12237869|P1|NOT COMPLETED|Pre-Operative||0
4975695|NCT02574312|12237868|P2|COMPLETED|Pre-Operative||44
4975696|NCT02574312|12237869|P1|COMPLETED|Pre-Operative||44
4975697|NCT02574312|12237868|P2|STARTED|Pre-Operative||44
4975698|NCT02574312|12237869|P1|STARTED|Pre-Operative||44
4975699|NCT02574260|12237885|P1|NOT COMPLETED|Overall Study||1
4975700|NCT02574260|12237885|P1|COMPLETED|Overall Study||2
4975701|NCT02574260|12237885|P1|STARTED|Overall Study||3
4975702|NCT02574247|12237894|P3|NOT COMPLETED|Overall Study||5
4975703|NCT02574247|12237895|P2|NOT COMPLETED|Overall Study||3
4975704|NCT02574247|12237896|P1|NOT COMPLETED|Overall Study||5
4975705|NCT02574247|12237894|P3|COMPLETED|Overall Study||5
4975706|NCT02574247|12237895|P2|COMPLETED|Overall Study||5
4975707|NCT02574247|12237896|P1|COMPLETED|Overall Study||5
4975708|NCT02574247|12237894|P3|STARTED|Overall Study||10
4975709|NCT02574247|12237895|P2|STARTED|Overall Study||8
4975710|NCT02574247|12237896|P1|STARTED|Overall Study||10
4975711|NCT02573948|12237908|P1|NOT COMPLETED|Longitudinal Cohort||56
4975712|NCT02573948|12237908|P1|COMPLETED|Longitudinal Cohort||194
4975713|NCT02573948|12237908|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
4975714|NCT02573948|12237908|P1|NOT COMPLETED|RDS||0
4975715|NCT02573948|12237908|P1|COMPLETED|RDS||603
4975716|NCT02573948|12237908|P1|STARTED|RDS||603
4975717|NCT02573870|12237918|P2|NOT COMPLETED|Overall Study||7
4975718|NCT02573870|12237919|P1|NOT COMPLETED|Overall Study||0
4975719|NCT02573870|12237918|P2|COMPLETED|Overall Study||35
4975720|NCT02573870|12237919|P1|COMPLETED|Overall Study||20
4975721|NCT02573870|12237918|P2|STARTED|Overall Study||42
4975722|NCT02573870|12237919|P1|STARTED|Overall Study||20
4975723|NCT02573857|12237927|P2|NOT COMPLETED|Overall Study||0
4975724|NCT02573857|12237928|P1|NOT COMPLETED|Overall Study||0
4975725|NCT02573857|12237927|P2|COMPLETED|Overall Study||8
4975726|NCT02573857|12237928|P1|COMPLETED|Overall Study||8
4975727|NCT02573857|12237927|P2|STARTED|Overall Study||8
4975728|NCT02573857|12237928|P1|STARTED|Overall Study||8
4975729|NCT02573779|12237940|P2|NOT COMPLETED|Overall Study||0
4975730|NCT02573779|12237941|P1|NOT COMPLETED|Overall Study||0
4975731|NCT02573779|12237940|P2|COMPLETED|Overall Study||43
4975732|NCT02573779|12237941|P1|COMPLETED|Overall Study||74
4975733|NCT02573779|12237940|P2|STARTED|Overall Study||43
4975734|NCT02573779|12237941|P1|STARTED|Overall Study||74
4975735|NCT02573467|12237967|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
4975736|NCT02573467|12237968|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
4975737|NCT02573467|12237969|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
4975738|NCT02573467|12237970|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
4975739|NCT02573467|12237967|P4|COMPLETED|Post-treatment Follow up Epoch||44
4975740|NCT02573467|12237968|P3|COMPLETED|Post-treatment Follow up Epoch||34
4975741|NCT02573467|12237969|P2|COMPLETED|Post-treatment Follow up Epoch||41
4975742|NCT02573467|12237970|P1|COMPLETED|Post-treatment Follow up Epoch||35
4975743|NCT02573467|12237967|P4|STARTED|Post-treatment Follow up Epoch||47
4975744|NCT02573467|12237968|P3|STARTED|Post-treatment Follow up Epoch||44
4975745|NCT02573467|12237969|P2|STARTED|Post-treatment Follow up Epoch||46
4975746|NCT02573467|12237970|P1|STARTED|Post-treatment Follow up Epoch||41
4975747|NCT02573467|12237967|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
4975748|NCT02573467|12237968|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
4975749|NCT02573467|12237969|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
4975750|NCT02573467|12237970|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
4975751|NCT02573467|12237967|P4|COMPLETED|Double-blind Treatment Epoch||0
4975752|NCT02573467|12237968|P3|COMPLETED|Double-blind Treatment Epoch||0
4975753|NCT02573467|12237969|P2|COMPLETED|Double-blind Treatment Epoch||0
4975754|NCT02573467|12237970|P1|COMPLETED|Double-blind Treatment Epoch||0
4975755|NCT02573467|12237967|P4|Full Analysis Set|Double-blind Treatment Epoch||55
4975756|NCT02573467|12237968|P3|Full Analysis Set|Double-blind Treatment Epoch||51
4975757|NCT02573467|12237969|P2|Full Analysis Set|Double-blind Treatment Epoch||52
4975758|NCT02573467|12237970|P1|Full Analysis Set|Double-blind Treatment Epoch||53
4975759|NCT02573467|12237967|P4|STARTED|Double-blind Treatment Epoch||55
4975760|NCT02573467|12237968|P3|STARTED|Double-blind Treatment Epoch||51
4975761|NCT02573467|12237969|P2|STARTED|Double-blind Treatment Epoch||52
4975762|NCT02573467|12237970|P1|STARTED|Double-blind Treatment Epoch||53
4975763|NCT02573402|12238011|P2|NOT COMPLETED|Overall Study||0
4975764|NCT02573402|12238012|P1|NOT COMPLETED|Overall Study||0
4975765|NCT02573402|12238011|P2|COMPLETED|Overall Study||7
4975766|NCT02573402|12238012|P1|COMPLETED|Overall Study||12
4975767|NCT02573402|12238011|P2|STARTED|Overall Study||7
4975768|NCT02573402|12238012|P1|STARTED|Overall Study||12
4975769|NCT02573311|12238034|P2|NOT COMPLETED|Disposition for Part 2||26
4975770|NCT02573311|12238035|P1|NOT COMPLETED|Disposition for Part 2||210
4975771|NCT02573311|12238034|P2|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
4975772|NCT02573311|12238035|P1|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
4975773|NCT02573311|12238034|P2|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
4975774|NCT02573311|12238035|P1|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
4975775|NCT02573311|12238034|P2|NOT COMPLETED|Disposition for Part 1||3
4975776|NCT02573311|12238035|P1|NOT COMPLETED|Disposition for Part 1||7
4975777|NCT02573311|12238034|P2|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
4975778|NCT02573311|12238035|P1|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
4975779|NCT02573311|12238034|P2|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
4975780|NCT02573311|12238035|P1|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
4975781|NCT02573233|12238051|P2|NOT COMPLETED|Overall Study||0
4975782|NCT02573233|12238052|P1|NOT COMPLETED|Overall Study||0
4975783|NCT02573233|12238051|P2|COMPLETED|Overall Study||20
4975784|NCT02573233|12238052|P1|COMPLETED|Overall Study||22
4975785|NCT02573233|12238051|P2|STARTED|Overall Study||20
4975786|NCT02573233|12238052|P1|STARTED|Overall Study||22
4975787|NCT02573181|12238079|P2|NOT COMPLETED|Overall Study||0
4975788|NCT02573181|12238080|P1|NOT COMPLETED|Overall Study||0
4975789|NCT02573181|12238079|P2|COMPLETED|Overall Study||126
4975790|NCT02573181|12238080|P1|COMPLETED|Overall Study||127
4975791|NCT02573181|12238079|P2|Vaccinated|Overall Study||126
4975792|NCT02573181|12238080|P1|Vaccinated|Overall Study||127
4975793|NCT02573181|12238079|P2|STARTED|Overall Study||126
4975794|NCT02573181|12238080|P1|STARTED|Overall Study||127
4975795|NCT02573155|12238104|P2|NOT COMPLETED|Period 5||0
4975796|NCT02573155|12238105|P1|NOT COMPLETED|Period 5||0
4975797|NCT02573155|12238104|P2|COMPLETED|Period 5||28
4975798|NCT02573155|12238105|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
4975799|NCT02573155|12238104|P2|STARTED|Period 5||28
4975800|NCT02573155|12238105|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
4975801|NCT02573155|12238104|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
4975802|NCT02573155|12238105|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
4975803|NCT02573155|12238104|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
4975804|NCT02573155|12238105|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
4975805|NCT02573155|12238104|P2|STARTED|Washout Between Treatment Period 4 and 5||29
4975806|NCT02573155|12238105|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
4975807|NCT02573155|12238104|P2|NOT COMPLETED|Period 4||0
4975808|NCT02573155|12238105|P1|NOT COMPLETED|Period 4||0
4975809|NCT02573155|12238104|P2|COMPLETED|Period 4||29
4975810|NCT02573155|12238105|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
4975811|NCT02573155|12238104|P2|STARTED|Period 4||29
4975812|NCT02573155|12238105|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
4975813|NCT02573155|12238104|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
4975814|NCT02573155|12238105|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
4975815|NCT02573155|12238104|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
4975816|NCT02573155|12238105|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
4975817|NCT02573155|12238104|P2|STARTED|Washout Between Treatment Period 3 and 4||31
4975818|NCT02573155|12238105|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
4975819|NCT02573155|12238104|P2|NOT COMPLETED|Period 3||0
4975820|NCT02573155|12238105|P1|NOT COMPLETED|Period 3||0
4975821|NCT02573155|12238104|P2|COMPLETED|Period 3||31
4975822|NCT02573155|12238105|P1|COMPLETED|Period 3||15
4975823|NCT02573155|12238104|P2|STARTED|Period 3||31
4975824|NCT02573155|12238105|P1|STARTED|Period 3||15
4975825|NCT02573155|12238104|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
4975826|NCT02573155|12238105|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
4975827|NCT02573155|12238104|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
4975828|NCT02573155|12238105|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
4975829|NCT02573155|12238104|P2|STARTED|Washout Between Treatment Period 2 and 3||33
4975830|NCT02573155|12238105|P1|STARTED|Washout Between Treatment Period 2 and 3||16
4975831|NCT02573155|12238104|P2|NOT COMPLETED|Period 2||0
4975832|NCT02573155|12238105|P1|NOT COMPLETED|Period 2||0
4975833|NCT02573155|12238104|P2|COMPLETED|Period 2||33
4975834|NCT02573155|12238105|P1|COMPLETED|Period 2||16
4975835|NCT02573155|12238104|P2|STARTED|Period 2||33
4975836|NCT02573155|12238105|P1|STARTED|Period 2||16
4975837|NCT02573155|12238104|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
4975838|NCT02573155|12238105|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
4975839|NCT02573155|12238104|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
4975840|NCT02573155|12238105|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
4975841|NCT02573155|12238104|P2|STARTED|Washout Between Treatment Period 1 and 2||38
4975842|NCT02573155|12238105|P1|STARTED|Washout Between Treatment Period 1 and 2||16
4975843|NCT02573155|12238104|P2|NOT COMPLETED|Treatment Period 1||0
4975844|NCT02573155|12238105|P1|NOT COMPLETED|Treatment Period 1||0
4975845|NCT02573155|12238104|P2|COMPLETED|Treatment Period 1||38
4975846|NCT02573155|12238105|P1|COMPLETED|Treatment Period 1||16
4975847|NCT02573155|12238104|P2|STARTED|Treatment Period 1||38
4975848|NCT02573155|12238105|P1|STARTED|Treatment Period 1||16
4975849|NCT02573012|12238253|P2|NOT COMPLETED|Overall Study||15
4975850|NCT02573012|12238254|P1|NOT COMPLETED|Overall Study||15
4975851|NCT02573012|12238253|P2|COMPLETED|Overall Study||113
4975852|NCT02573012|12238254|P1|COMPLETED|Overall Study||116
4975853|NCT02573012|12238253|P2|STARTED|Overall Study||128
4975854|NCT02573012|12238254|P1|STARTED|Overall Study||131
4975855|NCT02572817|12238306|P2|NOT COMPLETED|Overall Study||6
4975856|NCT02572817|12238307|P1|NOT COMPLETED|Overall Study||9
4975857|NCT02572817|12238306|P2|COMPLETED|Overall Study||41
4975858|NCT02572817|12238307|P1|COMPLETED|Overall Study||82
4975859|NCT02572817|12238306|P2|STARTED|Overall Study||47
4975860|NCT02572817|12238307|P1|STARTED|Overall Study||91
4975861|NCT02572752|12238374|P3|NOT COMPLETED|Period 3 Including Washout||0
4975862|NCT02572752|12238375|P2|NOT COMPLETED|Period 3 Including Washout||0
4975863|NCT02572752|12238376|P1|NOT COMPLETED|Period 3 Including Washout||0
4975864|NCT02572752|12238374|P3|COMPLETED|Period 3 Including Washout||24
4975865|NCT02572752|12238375|P2|COMPLETED|Period 3 Including Washout||23
4975866|NCT02572752|12238376|P1|COMPLETED|Period 3 Including Washout||23
4975867|NCT02572752|12238374|P3|STARTED|Period 3 Including Washout||24
4975868|NCT02572752|12238375|P2|STARTED|Period 3 Including Washout||23
4975869|NCT02572752|12238376|P1|STARTED|Period 3 Including Washout||23
4975870|NCT02572752|12238374|P3|NOT COMPLETED|Period 2 Including Washout||0
4975871|NCT02572752|12238375|P2|NOT COMPLETED|Period 2 Including Washout||0
4975872|NCT02572752|12238376|P1|NOT COMPLETED|Period 2 Including Washout||0
4975873|NCT02572752|12238374|P3|COMPLETED|Period 2 Including Washout||24
4975874|NCT02572752|12238375|P2|COMPLETED|Period 2 Including Washout||23
4975875|NCT02572752|12238376|P1|COMPLETED|Period 2 Including Washout||23
4975876|NCT02572752|12238374|P3|STARTED|Period 2 Including Washout||24
4975877|NCT02572752|12238375|P2|STARTED|Period 2 Including Washout||23
4975878|NCT02572752|12238376|P1|STARTED|Period 2 Including Washout||23
4975879|NCT02572752|12238374|P3|NOT COMPLETED|Period 1 Including Washout||0
4975880|NCT02572752|12238375|P2|NOT COMPLETED|Period 1 Including Washout||0
4975881|NCT02572752|12238376|P1|NOT COMPLETED|Period 1 Including Washout||0
4975882|NCT02572752|12238374|P3|COMPLETED|Period 1 Including Washout||24
4975883|NCT02572752|12238375|P2|COMPLETED|Period 1 Including Washout||23
4975884|NCT02572752|12238376|P1|COMPLETED|Period 1 Including Washout||23
4975885|NCT02572752|12238374|P3|STARTED|Period 1 Including Washout||24
4975886|NCT02572752|12238375|P2|STARTED|Period 1 Including Washout||23
4975887|NCT02572752|12238376|P1|STARTED|Period 1 Including Washout||23
4975888|NCT02572609|12238391|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
4975889|NCT02572609|12238392|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
4975890|NCT02572609|12238391|P2|COMPLETED|Period 2: Treatment Period 2||18
4975891|NCT02572609|12238392|P1|COMPLETED|Period 2: Treatment Period 2||18
4975892|NCT02572609|12238391|P2|STARTED|Period 2: Treatment Period 2||18
4975893|NCT02572609|12238392|P1|STARTED|Period 2: Treatment Period 2||18
4975894|NCT02572609|12238391|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
4975895|NCT02572609|12238392|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
4975896|NCT02572609|12238391|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
4975897|NCT02572609|12238392|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
4975898|NCT02572609|12238391|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
4975899|NCT02572609|12238392|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
4975900|NCT02572427|12238402|P2|NOT COMPLETED|Overall Study||9
4975901|NCT02572427|12238403|P1|NOT COMPLETED|Overall Study||6
4975902|NCT02572427|12238402|P2|COMPLETED|Overall Study||36
4975903|NCT02572427|12238403|P1|COMPLETED|Overall Study||31
4975904|NCT02572427|12238402|P2|STARTED|Overall Study||45
4975905|NCT02572427|12238403|P1|STARTED|Overall Study||37
4975906|NCT02572401|12238415|P4|NOT COMPLETED|Overall Study||10
4975907|NCT02572401|12238416|P3|NOT COMPLETED|Overall Study||9
4975908|NCT02572401|12238417|P2|NOT COMPLETED|Overall Study||8
4975909|NCT02572401|12238418|P1|NOT COMPLETED|Overall Study||5
4975910|NCT02572401|12238415|P4|COMPLETED|Overall Study||88
4975911|NCT02572401|12238416|P3|COMPLETED|Overall Study||89
4975912|NCT02572401|12238417|P2|COMPLETED|Overall Study||90
4975913|NCT02572401|12238418|P1|COMPLETED|Overall Study||92
4975914|NCT02572401|12238415|P4|STARTED|Overall Study||98
4975915|NCT02572401|12238416|P3|STARTED|Overall Study||98
4975916|NCT02572401|12238417|P2|STARTED|Overall Study||98
4975917|NCT02572401|12238418|P1|STARTED|Overall Study||97
4975918|NCT02572388|12238448|P4|NOT COMPLETED|Overall Study||2
4975919|NCT02572388|12238449|P3|NOT COMPLETED|Overall Study||2
4975920|NCT02572388|12238450|P2|NOT COMPLETED|Overall Study||1
4975921|NCT02572388|12238451|P1|NOT COMPLETED|Overall Study||1
4975922|NCT02572388|12238448|P4|COMPLETED|Overall Study||4
4975923|NCT02572388|12238449|P3|COMPLETED|Overall Study||8
4975924|NCT02572388|12238450|P2|COMPLETED|Overall Study||3
4975925|NCT02572388|12238451|P1|COMPLETED|Overall Study||10
4975926|NCT02572388|12238448|P4|STARTED|Overall Study||6
4975927|NCT02572388|12238449|P3|STARTED|Overall Study||10
4975928|NCT02572388|12238450|P2|STARTED|Overall Study||4
4975929|NCT02572388|12238451|P1|STARTED|Overall Study||11
4975930|NCT02572167|12238476|P3|NOT COMPLETED|Overall Study||31
4975931|NCT02572167|12238477|P2|NOT COMPLETED|Overall Study||56
4975932|NCT02572167|12238478|P1|NOT COMPLETED|Overall Study||6
4975933|NCT02572167|12238476|P3|COMPLETED|Overall Study||0
4975934|NCT02572167|12238477|P2|COMPLETED|Overall Study||0
4975935|NCT02572167|12238478|P1|COMPLETED|Overall Study||0
4975936|NCT02572167|12238476|P3|STARTED|Overall Study||31
4975937|NCT02572167|12238477|P2|STARTED|Overall Study||56
4975938|NCT02572167|12238478|P1|STARTED|Overall Study||6
4975939|NCT02572076|12238492|P1|NOT COMPLETED|Overall Study||1
4975940|NCT02572076|12238492|P1|COMPLETED|Overall Study||9
4975941|NCT02572076|12238492|P1|STARTED|Overall Study||10
4975942|NCT02571972|12238496|P1|NOT COMPLETED|Overall Study||4
4975943|NCT02571972|12238496|P1|COMPLETED|Overall Study||10
4975944|NCT02571972|12238496|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
4975945|NCT02571777|12238508|P5|NOT COMPLETED|Overall Study||36
4975946|NCT02571777|12238509|P4|NOT COMPLETED|Overall Study||37
4975947|NCT02571777|12238510|P3|NOT COMPLETED|Overall Study||41
4975948|NCT02571777|12238511|P2|NOT COMPLETED|Overall Study||38
4975949|NCT02571777|12238512|P1|NOT COMPLETED|Overall Study||39
4975950|NCT02571777|12238508|P5|COMPLETED|Overall Study||582
4975951|NCT02571777|12238509|P4|COMPLETED|Overall Study||580
4975952|NCT02571777|12238510|P3|COMPLETED|Overall Study||577
4975953|NCT02571777|12238511|P2|COMPLETED|Overall Study||582
4975954|NCT02571777|12238512|P1|COMPLETED|Overall Study||580
4975955|NCT02571777|12238508|P5|Safety Set (SAF)|Overall Study||618
4975956|NCT02571777|12238509|P4|Safety Set (SAF)|Overall Study||608
4975957|NCT02571777|12238510|P3|Safety Set (SAF)|Overall Study||613
4975958|NCT02571777|12238511|P2|Safety Set (SAF)|Overall Study||617
4975959|NCT02571777|12238512|P1|Safety Set (SAF)|Overall Study||616
4975960|NCT02571777|12238508|P5|Full Analysis Set (FAS)|Overall Study||612
4975961|NCT02571777|12238509|P4|Full Analysis Set (FAS)|Overall Study||607
4975962|NCT02571777|12238510|P3|Full Analysis Set (FAS)|Overall Study||611
4975963|NCT02571777|12238511|P2|Full Analysis Set (FAS)|Overall Study||616
4975964|NCT02571777|12238512|P1|Full Analysis Set (FAS)|Overall Study||615
4975965|NCT02571777|12238508|P5|STARTED|Overall Study||618
4975966|NCT02571777|12238509|P4|STARTED|Overall Study||617
4975967|NCT02571777|12238510|P3|STARTED|Overall Study||618
4975968|NCT02571777|12238511|P2|STARTED|Overall Study||620
4975969|NCT02571777|12238512|P1|STARTED|Overall Study||619
4975970|NCT02571634|12238639|P1|NOT COMPLETED|Overall Study||0
4975971|NCT02571634|12238639|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
4975972|NCT02571634|12238639|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
4975973|NCT02571452|12238649|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
4975974|NCT02571452|12238650|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
4975975|NCT02571452|12238649|P2|COMPLETED|Overall Study 6-Month Follow-up||0
4975976|NCT02571452|12238650|P1|COMPLETED|Overall Study 6-Month Follow-up||42
4976070|NCT02570165|12238886|P3|NOT COMPLETED|Overall Study||5
4975977|NCT02571452|12238649|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
4975978|NCT02571452|12238650|P1|STARTED|Overall Study 6-Month Follow-up||47
4975979|NCT02571452|12238649|P2|NOT COMPLETED|Overall Study Treatment||1
4975980|NCT02571452|12238650|P1|NOT COMPLETED|Overall Study Treatment||0
4975981|NCT02571452|12238649|P2|COMPLETED|Overall Study Treatment||45
4975982|NCT02571452|12238650|P1|COMPLETED|Overall Study Treatment||47
4975983|NCT02571452|12238649|P2|STARTED|Overall Study Treatment||46
4975984|NCT02571452|12238650|P1|STARTED|Overall Study Treatment||47
4975985|NCT02571439|12238664|P2|NOT COMPLETED|Overall Study||0
4975986|NCT02571439|12238665|P1|NOT COMPLETED|Overall Study||0
4975987|NCT02571439|12238664|P2|COMPLETED|Overall Study||21
4975988|NCT02571439|12238665|P1|COMPLETED|Overall Study||20
4975989|NCT02571439|12238664|P2|STARTED|Overall Study||21
4975990|NCT02571439|12238665|P1|STARTED|Overall Study||20
4975991|NCT02571244|12238691|P2|NOT COMPLETED|Overall Study||1
4975992|NCT02571244|12238692|P1|NOT COMPLETED|Overall Study||3
4975993|NCT02571244|12238691|P2|COMPLETED|Overall Study||21
4975994|NCT02571244|12238692|P1|COMPLETED|Overall Study||41
4975995|NCT02571244|12238691|P2|STARTED|Overall Study||22
4975996|NCT02571244|12238692|P1|STARTED|Overall Study||44
4975997|NCT02571218|12238708|P2|NOT COMPLETED|Overall Study||0
4975998|NCT02571218|12238709|P1|NOT COMPLETED|Overall Study||0
4975999|NCT02571218|12238708|P2|COMPLETED|Overall Study||41
4976000|NCT02571218|12238709|P1|COMPLETED|Overall Study||40
4976001|NCT02571218|12238708|P2|STARTED|Overall Study||41
4976002|NCT02571218|12238709|P1|STARTED|Overall Study||40
4976003|NCT02571153|12238720|P3|NOT COMPLETED|Overall Study||2
4976004|NCT02571153|12238721|P2|NOT COMPLETED|Overall Study||8
4976005|NCT02571153|12238722|P1|NOT COMPLETED|Overall Study||6
4976006|NCT02571153|12238720|P3|COMPLETED|Overall Study||43
4976007|NCT02571153|12238721|P2|COMPLETED|Overall Study||37
4976008|NCT02571153|12238722|P1|COMPLETED|Overall Study||39
4976009|NCT02571153|12238720|P3|STARTED|Overall Study||45
4976010|NCT02571153|12238721|P2|STARTED|Overall Study||45
4976011|NCT02571153|12238722|P1|STARTED|Overall Study||45
4976012|NCT02571075|12238750|P2|NOT COMPLETED|Overall Study||24
4976013|NCT02571075|12238751|P1|NOT COMPLETED|Overall Study||20
4976014|NCT02571075|12238750|P2|COMPLETED|Overall Study||26
4976015|NCT02571075|12238751|P1|COMPLETED|Overall Study||25
4976016|NCT02571075|12238750|P2|STARTED|Overall Study||50
4976017|NCT02571075|12238751|P1|STARTED|Overall Study||45
4976018|NCT02571049|12238765|P2|NOT COMPLETED|Randomization||2
4976019|NCT02571049|12238766|P1|NOT COMPLETED|Randomization||0
4976020|NCT02571049|12238765|P2|COMPLETED|Randomization||10
4976021|NCT02571049|12238766|P1|COMPLETED|Randomization||8
4976022|NCT02571049|12238765|P2|STARTED|Randomization||12
4976023|NCT02571049|12238766|P1|STARTED|Randomization||8
4976024|NCT02571049|12238765|P2|NOT COMPLETED|Screening||2
4976025|NCT02571049|12238766|P1|NOT COMPLETED|Screening||2
4976026|NCT02571049|12238765|P2|COMPLETED|Screening||12
4976027|NCT02571049|12238766|P1|COMPLETED|Screening||8
4976028|NCT02571049|12238765|P2|STARTED|Screening||14
4976029|NCT02571049|12238766|P1|STARTED|Screening||10
4976030|NCT02570750|12238774|P2|NOT COMPLETED|Overall Study||5
4976031|NCT02570750|12238775|P1|NOT COMPLETED|Overall Study||14
4976032|NCT02570750|12238774|P2|COMPLETED|Overall Study||68
4976033|NCT02570750|12238775|P1|COMPLETED|Overall Study||96
4976034|NCT02570750|12238774|P2|STARTED|Overall Study||73
4976035|NCT02570750|12238775|P1|STARTED|Overall Study||110
4976036|NCT02570711|12238793|P2|NOT COMPLETED|Overall Study||2
4976037|NCT02570711|12238794|P1|NOT COMPLETED|Overall Study||1
4976038|NCT02570711|12238793|P2|COMPLETED|Overall Study||0
4976039|NCT02570711|12238794|P1|COMPLETED|Overall Study||0
4976040|NCT02570711|12238793|P2|STARTED|Overall Study||2
4976041|NCT02570711|12238794|P1|STARTED|Overall Study||1
4976042|NCT02570425|12238802|P2|NOT COMPLETED|Visit 3||0
4976043|NCT02570425|12238803|P1|NOT COMPLETED|Visit 3||0
4976044|NCT02570425|12238802|P2|COMPLETED|Visit 3||231
4976045|NCT02570425|12238803|P1|COMPLETED|Visit 3||229
4976046|NCT02570425|12238802|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
4976047|NCT02570425|12238803|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
4976048|NCT02570425|12238802|P2|NOT COMPLETED|Visit 2||0
4976049|NCT02570425|12238803|P1|NOT COMPLETED|Visit 2||0
4976050|NCT02570425|12238802|P2|COMPLETED|Visit 2||247
4976051|NCT02570425|12238803|P1|COMPLETED|Visit 2||251
4976052|NCT02570425|12238802|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
4976053|NCT02570425|12238803|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
4976054|NCT02570425|12238802|P2|NOT COMPLETED|Visit 1||0
4976055|NCT02570425|12238803|P1|NOT COMPLETED|Visit 1||0
4976056|NCT02570425|12238802|P2|COMPLETED|Visit 1||242
4976057|NCT02570425|12238803|P1|COMPLETED|Visit 1||274
4976058|NCT02570425|12238802|P2|STARTED|Visit 1||242
4976059|NCT02570425|12238803|P1|STARTED|Visit 1||274
4976060|NCT02570295|12238852|P2|NOT COMPLETED|Overall Study||58
4976061|NCT02570295|12238853|P1|NOT COMPLETED|Overall Study||11
4976062|NCT02570295|12238852|P2|COMPLETED|Overall Study||289
4976063|NCT02570295|12238853|P1|COMPLETED|Overall Study||364
4976064|NCT02570295|12238852|P2|STARTED|Overall Study||347
4976065|NCT02570295|12238853|P1|STARTED|Overall Study||375
4976066|NCT02570165|12238882|P7|NOT COMPLETED|Overall Study||0
4976067|NCT02570165|12238883|P6|NOT COMPLETED|Overall Study||2
4976068|NCT02570165|12238884|P5|NOT COMPLETED|Overall Study||6
4976069|NCT02570165|12238885|P4|NOT COMPLETED|Overall Study||5
4976071|NCT02570165|12238887|P2|NOT COMPLETED|Overall Study||3
4976072|NCT02570165|12238888|P1|NOT COMPLETED|Overall Study||2
4976073|NCT02570165|12238882|P7|COMPLETED|Overall Study||47
4976074|NCT02570165|12238883|P6|COMPLETED|Overall Study||44
4976075|NCT02570165|12238884|P5|COMPLETED|Overall Study||41
4976076|NCT02570165|12238885|P4|COMPLETED|Overall Study||40
4976077|NCT02570165|12238886|P3|COMPLETED|Overall Study||41
4976078|NCT02570165|12238887|P2|COMPLETED|Overall Study||43
4976079|NCT02570165|12238888|P1|COMPLETED|Overall Study||44
4976080|NCT02570165|12238882|P7|STARTED|Overall Study||47
4976081|NCT02570165|12238883|P6|STARTED|Overall Study||46
4976082|NCT02570165|12238884|P5|STARTED|Overall Study||47
4976083|NCT02570165|12238885|P4|STARTED|Overall Study||45
4976084|NCT02570165|12238886|P3|STARTED|Overall Study||46
4976085|NCT02570165|12238887|P2|STARTED|Overall Study||46
4976086|NCT02570165|12238888|P1|STARTED|Overall Study||46
4976087|NCT02570152|12238911|P1|NOT COMPLETED|Overall Study||15
4976088|NCT02570152|12238911|P1|COMPLETED|Overall Study||1989
4976089|NCT02570152|12238911|P1|STARTED|Overall Study||2004
4976090|NCT02570139|12238927|P2|NOT COMPLETED|Overall Study||0
4976091|NCT02570139|12238928|P1|NOT COMPLETED|Overall Study||0
4976092|NCT02570139|12238927|P2|COMPLETED|Overall Study||21
4976093|NCT02570139|12238928|P1|COMPLETED|Overall Study||24
4976094|NCT02570139|12238927|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
4976095|NCT02570139|12238928|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
4976096|NCT02570126|12238942|P2|NOT COMPLETED|Overall Study||9
4976097|NCT02570126|12238943|P1|NOT COMPLETED|Overall Study||6
4976098|NCT02570126|12238942|P2|COMPLETED|Overall Study||607
4976099|NCT02570126|12238943|P1|COMPLETED|Overall Study||609
4976100|NCT02570126|12238942|P2|STARTED|Overall Study||616
4976101|NCT02570126|12238943|P1|STARTED|Overall Study||615
4976102|NCT02570074|12238969|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
4976103|NCT02570074|12238970|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
4976104|NCT02570074|12238969|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
4976105|NCT02570074|12238970|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
4976106|NCT02570074|12238969|P2|STARTED|Period 2 (Second Dosing Regimen)||10
4976107|NCT02570074|12238970|P1|STARTED|Period 2 (Second Dosing Regimen)||9
4976108|NCT02570074|12238969|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
4976109|NCT02570074|12238970|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
4976110|NCT02570074|12238969|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
4976111|NCT02570074|12238970|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
4976112|NCT02570074|12238969|P2|STARTED|Period 1 (First Dosing Regimen)||10
4976113|NCT02570074|12238970|P1|STARTED|Period 1 (First Dosing Regimen)||9
4976114|NCT02570022|12239030|P2|NOT COMPLETED|Overall Study||0
4976115|NCT02570022|12239031|P1|NOT COMPLETED|Overall Study||0
4976116|NCT02570022|12239030|P2|COMPLETED|Overall Study||31
4976117|NCT02570022|12239031|P1|COMPLETED|Overall Study||26
4976118|NCT02570022|12239030|P2|STARTED|Overall Study||31
4976119|NCT02570022|12239031|P1|STARTED|Overall Study||26
4976120|NCT02569996|12239039|P1|NOT COMPLETED|Overall Study||55
4976121|NCT02569996|12239039|P1|COMPLETED|Overall Study||69
4976122|NCT02569996|12239039|P1|STARTED|Overall Study||124
4976123|NCT02569957|12239051|P2|NOT COMPLETED|Overall Study||1
4976124|NCT02569957|12239052|P1|NOT COMPLETED|Overall Study||0
4976125|NCT02569957|12239051|P2|COMPLETED|Overall Study||0
4976126|NCT02569957|12239052|P1|COMPLETED|Overall Study||0
4976127|NCT02569957|12239051|P2|STARTED|Overall Study||1
4976128|NCT02569957|12239052|P1|STARTED|Overall Study||0
4976129|NCT02569853|12239084|P2|NOT COMPLETED|Overall Study||14
4976130|NCT02569853|12239085|P1|NOT COMPLETED|Overall Study||20
4976131|NCT02569853|12239084|P2|COMPLETED|Overall Study||123
4976132|NCT02569853|12239085|P1|COMPLETED|Overall Study||111
4976133|NCT02569853|12239084|P2|STARTED|Overall Study||137
4976134|NCT02569853|12239085|P1|STARTED|Overall Study||131
4976135|NCT02569710|12239103|P10|NOT COMPLETED|Overall Study||0
4976136|NCT02569710|12239104|P9|NOT COMPLETED|Overall Study||1
4976137|NCT02569710|12239105|P8|NOT COMPLETED|Overall Study||0
4976138|NCT02569710|12239106|P7|NOT COMPLETED|Overall Study||2
4976139|NCT02569710|12239107|P6|NOT COMPLETED|Overall Study||1
4976140|NCT02569710|12239108|P5|NOT COMPLETED|Overall Study||1
4976141|NCT02569710|12239109|P4|NOT COMPLETED|Overall Study||0
4976142|NCT02569710|12239110|P3|NOT COMPLETED|Overall Study||0
4976143|NCT02569710|12239111|P2|NOT COMPLETED|Overall Study||0
4976144|NCT02569710|12239112|P1|NOT COMPLETED|Overall Study||1
4976145|NCT02569710|12239103|P10|COMPLETED|Overall Study||4
4976146|NCT02569710|12239104|P9|COMPLETED|Overall Study||14
4976147|NCT02569710|12239105|P8|COMPLETED|Overall Study||30
4976148|NCT02569710|12239106|P7|COMPLETED|Overall Study||12
4976149|NCT02569710|12239107|P6|COMPLETED|Overall Study||4
4976150|NCT02569710|12239108|P5|COMPLETED|Overall Study||7
4976151|NCT02569710|12239109|P4|COMPLETED|Overall Study||20
4976152|NCT02569710|12239110|P3|COMPLETED|Overall Study||20
4976153|NCT02569710|12239111|P2|COMPLETED|Overall Study||25
4976154|NCT02569710|12239112|P1|COMPLETED|Overall Study||19
4976155|NCT02569710|12239103|P10|STARTED|Overall Study||4
4976156|NCT02569710|12239104|P9|STARTED|Overall Study||15
4976157|NCT02569710|12239105|P8|STARTED|Overall Study||30
4976158|NCT02569710|12239106|P7|STARTED|Overall Study||14
4976159|NCT02569710|12239107|P6|STARTED|Overall Study||5
4976160|NCT02569710|12239108|P5|STARTED|Overall Study||8
4976161|NCT02569710|12239109|P4|STARTED|Overall Study||20
4976162|NCT02569710|12239110|P3|STARTED|Overall Study||20
4976163|NCT02569710|12239111|P2|STARTED|Overall Study||25
4976164|NCT02569710|12239112|P1|STARTED|Overall Study||20
4976165|NCT02569658|12239422|P2|NOT COMPLETED|Overall Study||1
4976166|NCT02569658|12239423|P1|NOT COMPLETED|Overall Study||1
4976167|NCT02569658|12239422|P2|COMPLETED|Overall Study||56
4976168|NCT02569658|12239423|P1|COMPLETED|Overall Study||52
4976169|NCT02569658|12239422|P2|STARTED|Overall Study||57
4976170|NCT02569658|12239423|P1|STARTED|Overall Study||53
4976171|NCT02569541|12239439|P1|NOT COMPLETED|Overall Study||21
4976172|NCT02569541|12239439|P1|COMPLETED|Overall Study||9
4976173|NCT02569541|12239439|P1|STARTED|Overall Study||30
4976174|NCT02569437|12239452|P2|NOT COMPLETED|Overall Study||14
4976175|NCT02569437|12239453|P1|NOT COMPLETED|Overall Study||12
4976176|NCT02569437|12239452|P2|COMPLETED|Overall Study||11
4976177|NCT02569437|12239453|P1|COMPLETED|Overall Study||12
4976178|NCT02569437|12239452|P2|STARTED|Overall Study||25
4976179|NCT02569437|12239453|P1|STARTED|Overall Study||24
4976180|NCT02569411|12239469|P2|NOT COMPLETED|Overall Study||64
4976181|NCT02569411|12239470|P1|NOT COMPLETED|Overall Study||65
4976182|NCT02569411|12239469|P2|COMPLETED|Overall Study||0
4976183|NCT02569411|12239470|P1|COMPLETED|Overall Study||0
4976184|NCT02569411|12239469|P2|STARTED|Overall Study||64
4976185|NCT02569411|12239470|P1|STARTED|Overall Study||65
4976186|NCT02569398|12239483|P3|NOT COMPLETED|Overall Study||183
4976187|NCT02569398|12239484|P2|NOT COMPLETED|Overall Study||189
4976188|NCT02569398|12239485|P1|NOT COMPLETED|Overall Study||185
4976189|NCT02569398|12239483|P3|COMPLETED|Overall Study||0
4976190|NCT02569398|12239484|P2|COMPLETED|Overall Study||0
4976191|NCT02569398|12239485|P1|COMPLETED|Overall Study||0
4976192|NCT02569398|12239483|P3|STARTED|Overall Study||183
4976193|NCT02569398|12239484|P2|STARTED|Overall Study||189
4976194|NCT02569398|12239485|P1|STARTED|Overall Study||185
4976195|NCT02569112|12239508|P2|NOT COMPLETED|Overall Study||0
4976196|NCT02569112|12239509|P1|NOT COMPLETED|Overall Study||0
4976197|NCT02569112|12239508|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
4976198|NCT02569112|12239509|P1|COMPLETED|Overall Study||10
4976199|NCT02569112|12239508|P2|STARTED|Overall Study||10
4976200|NCT02569112|12239509|P1|STARTED|Overall Study||10
4976201|NCT02569086|12239514|P1|NOT COMPLETED|Overall Study||0
4976202|NCT02569086|12239514|P1|COMPLETED|Overall Study||22
4976203|NCT02569086|12239514|P1|STARTED|Overall Study||22
4976204|NCT02568852|12239521|P2|NOT COMPLETED|Overall Study||0
4976205|NCT02568852|12239522|P1|NOT COMPLETED|Overall Study||0
4976206|NCT02568852|12239521|P2|COMPLETED|Overall Study||25
4976207|NCT02568852|12239522|P1|COMPLETED|Overall Study||25
4976208|NCT02568852|12239521|P2|STARTED|Overall Study||25
4976209|NCT02568852|12239522|P1|STARTED|Overall Study||25
4976210|NCT02568683|12239560|P2|NOT COMPLETED|Overall Study||4
4976211|NCT02568683|12239561|P1|NOT COMPLETED|Overall Study||6
4976212|NCT02568683|12239560|P2|COMPLETED|Overall Study||0
4976213|NCT02568683|12239561|P1|COMPLETED|Overall Study||0
4976214|NCT02568683|12239560|P2|STARTED|Overall Study||4
4976215|NCT02568683|12239561|P1|STARTED|Overall Study||6
4976216|NCT02568644|12239575|P2|NOT COMPLETED|Overall Study||0
4976217|NCT02568644|12239576|P1|NOT COMPLETED|Overall Study||0
4976218|NCT02568644|12239575|P2|COMPLETED|Overall Study||30
4976219|NCT02568644|12239576|P1|COMPLETED|Overall Study||30
4976220|NCT02568644|12239575|P2|STARTED|Overall Study||30
4976221|NCT02568644|12239576|P1|STARTED|Overall Study||30
4976222|NCT02568397|12239588|P2|NOT COMPLETED|Period 2||2
4976223|NCT02568397|12239589|P1|NOT COMPLETED|Period 2||0
4976224|NCT02568397|12239588|P2|COMPLETED|Period 2||58
4976225|NCT02568397|12239589|P1|COMPLETED|Period 2||0
4976226|NCT02568397|12239588|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
4976227|NCT02568397|12239589|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
4976228|NCT02568397|12239588|P2|NOT COMPLETED|Period 1||0
4976229|NCT02568397|12239589|P1|NOT COMPLETED|Period 1||0
4976230|NCT02568397|12239588|P2|COMPLETED|Period 1||0
4976231|NCT02568397|12239589|P1|COMPLETED|Period 1||60
4976232|NCT02568397|12239588|P2|Received at Least 1 Dose of Study Drug|Period 1||0
4976233|NCT02568397|12239589|P1|Received at Least 1 Dose of Study Drug|Period 1||60
4976234|NCT02568397|12239588|P2|STARTED|Period 1||0
4976235|NCT02568397|12239589|P1|STARTED|Period 1||60
4976236|NCT02568384|12239613|P1|NOT COMPLETED|Overall Study||2
4976237|NCT02568384|12239613|P1|COMPLETED|Overall Study||43
4976238|NCT02568384|12239613|P1|STARTED|Overall Study||45
4976239|NCT02568345|12239623|P1|NOT COMPLETED|Overall Study||0
4976240|NCT02568345|12239623|P1|COMPLETED|Overall Study||31
4976241|NCT02568345|12239623|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
4976242|NCT02568345|12239623|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
4976243|NCT02568345|12239623|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
4976244|NCT02568345|12239623|P1|STARTED|Overall Study||31
4976245|NCT02568254|12239627|P6|NOT COMPLETED|Period 3||0
4976246|NCT02568254|12239628|P5|NOT COMPLETED|Period 3||1
4976247|NCT02568254|12239629|P4|NOT COMPLETED|Period 3||0
4976248|NCT02568254|12239630|P3|NOT COMPLETED|Period 3||0
4976249|NCT02568254|12239631|P2|NOT COMPLETED|Period 3||0
4976250|NCT02568254|12239632|P1|NOT COMPLETED|Period 3||0
4976251|NCT02568254|12239627|P6|COMPLETED|Period 3||12
4976252|NCT02568254|12239628|P5|COMPLETED|Period 3||11
4976253|NCT02568254|12239629|P4|COMPLETED|Period 3||12
4976254|NCT02568254|12239630|P3|COMPLETED|Period 3||12
4976255|NCT02568254|12239631|P2|COMPLETED|Period 3||12
4976256|NCT02568254|12239632|P1|COMPLETED|Period 3||13
4976257|NCT02568254|12239627|P6|STARTED|Period 3||12
4976258|NCT02568254|12239628|P5|STARTED|Period 3||12
4976259|NCT02568254|12239629|P4|STARTED|Period 3||12
4976260|NCT02568254|12239630|P3|STARTED|Period 3||12
4976261|NCT02568254|12239631|P2|STARTED|Period 3||12
4976262|NCT02568254|12239632|P1|STARTED|Period 3||13
4976263|NCT02568254|12239627|P6|NOT COMPLETED|Period 2||0
4976264|NCT02568254|12239628|P5|NOT COMPLETED|Period 2||0
4976265|NCT02568254|12239629|P4|NOT COMPLETED|Period 2||0
4976266|NCT02568254|12239630|P3|NOT COMPLETED|Period 2||1
4976267|NCT02568254|12239631|P2|NOT COMPLETED|Period 2||0
4976268|NCT02568254|12239632|P1|NOT COMPLETED|Period 2||0
4976269|NCT02568254|12239627|P6|COMPLETED|Period 2||12
4976270|NCT02568254|12239628|P5|COMPLETED|Period 2||12
4976271|NCT02568254|12239629|P4|COMPLETED|Period 2||12
4976272|NCT02568254|12239630|P3|COMPLETED|Period 2||12
4976273|NCT02568254|12239631|P2|COMPLETED|Period 2||12
4976274|NCT02568254|12239632|P1|COMPLETED|Period 2||13
4976275|NCT02568254|12239627|P6|STARTED|Period 2||12
4976276|NCT02568254|12239628|P5|STARTED|Period 2||12
4976277|NCT02568254|12239629|P4|STARTED|Period 2||12
4976278|NCT02568254|12239630|P3|STARTED|Period 2||13
4976279|NCT02568254|12239631|P2|STARTED|Period 2||12
4976280|NCT02568254|12239632|P1|STARTED|Period 2||13
4976281|NCT02568254|12239627|P6|NOT COMPLETED|Period 1||0
4976282|NCT02568254|12239628|P5|NOT COMPLETED|Period 1||0
4976283|NCT02568254|12239629|P4|NOT COMPLETED|Period 1||0
4976284|NCT02568254|12239630|P3|NOT COMPLETED|Period 1||0
4976285|NCT02568254|12239631|P2|NOT COMPLETED|Period 1||0
4976286|NCT02568254|12239632|P1|NOT COMPLETED|Period 1||0
4976287|NCT02568254|12239627|P6|COMPLETED|Period 1||12
4976288|NCT02568254|12239628|P5|COMPLETED|Period 1||12
4976289|NCT02568254|12239629|P4|COMPLETED|Period 1||12
4976290|NCT02568254|12239630|P3|COMPLETED|Period 1||13
4976291|NCT02568254|12239631|P2|COMPLETED|Period 1||12
4976292|NCT02568254|12239632|P1|COMPLETED|Period 1||13
4976293|NCT02568254|12239627|P6|STARTED|Period 1||12
4976294|NCT02568254|12239628|P5|STARTED|Period 1||12
4976295|NCT02568254|12239629|P4|STARTED|Period 1||12
4976296|NCT02568254|12239630|P3|STARTED|Period 1||13
4976297|NCT02568254|12239631|P2|STARTED|Period 1||12
4976298|NCT02568254|12239632|P1|STARTED|Period 1||13
4976299|NCT02568046|12239642|P2|NOT COMPLETED|Overall Study||3
4976300|NCT02568046|12239643|P1|NOT COMPLETED|Overall Study||5
4976301|NCT02568046|12239642|P2|COMPLETED|Overall Study||2
4976302|NCT02568046|12239643|P1|COMPLETED|Overall Study||0
4976303|NCT02568046|12239642|P2|STARTED|Overall Study||5
4976304|NCT02568046|12239643|P1|STARTED|Overall Study||5
4976305|NCT02568007|12239652|P3|NOT COMPLETED|Overall Study||0
4976306|NCT02568007|12239653|P2|NOT COMPLETED|Overall Study||0
4976307|NCT02568007|12239654|P1|NOT COMPLETED|Overall Study||0
4976308|NCT02568007|12239652|P3|COMPLETED|Overall Study||0
4976309|NCT02568007|12239653|P2|COMPLETED|Overall Study||2
4976310|NCT02568007|12239654|P1|COMPLETED|Overall Study||2
4976311|NCT02568007|12239652|P3|STARTED|Overall Study||0
4976312|NCT02568007|12239653|P2|STARTED|Overall Study||2
4976313|NCT02568007|12239654|P1|STARTED|Overall Study||2
4976314|NCT02567968|12239683|P2|NOT COMPLETED|Second Intervention||0
4976315|NCT02567968|12239684|P1|NOT COMPLETED|Second Intervention||0
4976316|NCT02567968|12239683|P2|COMPLETED|Second Intervention||4
4976317|NCT02567968|12239684|P1|COMPLETED|Second Intervention||4
4976318|NCT02567968|12239683|P2|STARTED|Second Intervention||4
4976319|NCT02567968|12239684|P1|STARTED|Second Intervention||4
4976320|NCT02567968|12239683|P2|NOT COMPLETED|Washout (2 Weeks)||0
4976321|NCT02567968|12239684|P1|NOT COMPLETED|Washout (2 Weeks)||0
4976322|NCT02567968|12239683|P2|COMPLETED|Washout (2 Weeks)||4
4976323|NCT02567968|12239684|P1|COMPLETED|Washout (2 Weeks)||4
4976324|NCT02567968|12239683|P2|STARTED|Washout (2 Weeks)||4
4976325|NCT02567968|12239684|P1|STARTED|Washout (2 Weeks)||4
4976326|NCT02567968|12239683|P2|NOT COMPLETED|First Intervention||0
4976327|NCT02567968|12239684|P1|NOT COMPLETED|First Intervention||0
4976328|NCT02567968|12239683|P2|COMPLETED|First Intervention||4
4976329|NCT02567968|12239684|P1|COMPLETED|First Intervention||4
4976330|NCT02567968|12239683|P2|STARTED|First Intervention||4
4976331|NCT02567968|12239684|P1|STARTED|First Intervention||4
4976332|NCT02567708|12239706|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
4976333|NCT02567708|12239707|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
4976334|NCT02567708|12239706|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
4976335|NCT02567708|12239707|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
4976336|NCT02567708|12239706|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
4976337|NCT02567708|12239707|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
4976338|NCT02567708|12239706|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
4976339|NCT02567708|12239707|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
4976340|NCT02567708|12239706|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
4976341|NCT02567708|12239707|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
4976342|NCT02567708|12239706|P2|STARTED|Washout Period (Up to 4 Weeks)||23
4976343|NCT02567708|12239707|P1|STARTED|Washout Period (Up to 4 Weeks)||22
4976344|NCT02567708|12239706|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
4976345|NCT02567708|12239707|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
4976346|NCT02567708|12239706|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
4976347|NCT02567708|12239707|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
4976348|NCT02567708|12239706|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
4976349|NCT02567708|12239707|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
4976350|NCT02567656|12239752|P6|NOT COMPLETED|Overall Study||0
4976351|NCT02567656|12239753|P5|NOT COMPLETED|Overall Study||0
4976352|NCT02567656|12239754|P4|NOT COMPLETED|Overall Study||0
4976353|NCT02567656|12239755|P3|NOT COMPLETED|Overall Study||2
4976354|NCT02567656|12239756|P2|NOT COMPLETED|Overall Study||1
4976355|NCT02567656|12239757|P1|NOT COMPLETED|Overall Study||1
4976356|NCT02567656|12239752|P6|COMPLETED|Overall Study||20
4976357|NCT02567656|12239753|P5|COMPLETED|Overall Study||19
4976358|NCT02567656|12239754|P4|COMPLETED|Overall Study||6
4976359|NCT02567656|12239755|P3|COMPLETED|Overall Study||3
4976360|NCT02567656|12239756|P2|COMPLETED|Overall Study||3
4976361|NCT02567656|12239757|P1|COMPLETED|Overall Study||3
4976362|NCT02567656|12239752|P6|STARTED|Overall Study||20
4976363|NCT02567656|12239753|P5|STARTED|Overall Study||19
4976364|NCT02567656|12239754|P4|STARTED|Overall Study||6
4976365|NCT02567656|12239755|P3|STARTED|Overall Study||5
4976366|NCT02567656|12239756|P2|STARTED|Overall Study||4
4976367|NCT02567656|12239757|P1|STARTED|Overall Study||4
4976368|NCT02567552|12239789|P2|NOT COMPLETED|Overall Study||1
4976369|NCT02567552|12239790|P1|NOT COMPLETED|Overall Study||0
4976370|NCT02567552|12239789|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
4976371|NCT02567552|12239790|P1|COMPLETED|Overall Study||12
4976372|NCT02567552|12239789|P2|STARTED|Overall Study||12
4976373|NCT02567552|12239790|P1|STARTED|Overall Study||12
4976374|NCT02567188|12239820|P1|NOT COMPLETED|Overall Study||35
4976375|NCT02567188|12239820|P1|COMPLETED|Overall Study||109
4976376|NCT02567188|12239820|P1|STARTED|Overall Study||144
4976377|NCT02566889|12239851|P2|NOT COMPLETED|Overall Study||5
4976378|NCT02566889|12239852|P1|NOT COMPLETED|Overall Study||13
4976379|NCT02566889|12239851|P2|COMPLETED|Overall Study||3
4976380|NCT02566889|12239852|P1|COMPLETED|Overall Study||32
4976381|NCT02566889|12239851|P2|Cross-over to Dose Escalation Group|Overall Study||0
4976382|NCT02566889|12239852|P1|Cross-over to Dose Escalation Group|Overall Study||1
4976383|NCT02566889|12239851|P2|STARTED|Overall Study||8
4976384|NCT02566889|12239852|P1|STARTED|Overall Study||45
4976385|NCT02566785|12239870|P2|NOT COMPLETED|Overall Study||3
4976386|NCT02566785|12239871|P1|NOT COMPLETED|Overall Study||1
4976387|NCT02566785|12239870|P2|COMPLETED|Overall Study||15
4976388|NCT02566785|12239871|P1|COMPLETED|Overall Study||14
4976389|NCT02566785|12239870|P2|STARTED|Overall Study||18
4976390|NCT02566785|12239871|P1|STARTED|Overall Study||15
4976391|NCT02566759|12239898|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976392|NCT02566759|12239899|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976393|NCT02566759|12239900|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976394|NCT02566759|12239901|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976395|NCT02566759|12239902|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976396|NCT02566759|12239903|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976397|NCT02566759|12239904|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976398|NCT02566759|12239905|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976399|NCT02566759|12239906|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976400|NCT02566759|12239907|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976401|NCT02566759|12239908|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976402|NCT02566759|12239909|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976403|NCT02566759|12239910|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976404|NCT02566759|12239911|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976405|NCT02566759|12239912|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976406|NCT02566759|12239913|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976407|NCT02566759|12239914|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976408|NCT02566759|12239898|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
4976409|NCT02566759|12239899|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
4976410|NCT02566759|12239900|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
4976411|NCT02566759|12239901|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976412|NCT02566759|12239902|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976413|NCT02566759|12239903|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976414|NCT02566759|12239904|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976415|NCT02566759|12239905|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976416|NCT02566759|12239906|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976417|NCT02566759|12239907|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976418|NCT02566759|12239908|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976419|NCT02566759|12239909|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976420|NCT02566759|12239910|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976421|NCT02566759|12239911|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976422|NCT02566759|12239912|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976423|NCT02566759|12239913|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976424|NCT02566759|12239914|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976425|NCT02566759|12239898|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
4976426|NCT02566759|12239899|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
4976427|NCT02566759|12239900|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
4976428|NCT02566759|12239901|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976429|NCT02566759|12239902|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976430|NCT02566759|12239903|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976431|NCT02566759|12239904|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976432|NCT02566759|12239905|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976433|NCT02566759|12239906|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976434|NCT02566759|12239907|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976435|NCT02566759|12239908|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976436|NCT02566759|12239909|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976437|NCT02566759|12239910|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976438|NCT02566759|12239911|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976439|NCT02566759|12239912|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976440|NCT02566759|12239913|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976441|NCT02566759|12239914|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976442|NCT02566759|12239898|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976443|NCT02566759|12239899|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976444|NCT02566759|12239900|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976445|NCT02566759|12239901|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976446|NCT02566759|12239902|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976447|NCT02566759|12239903|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976448|NCT02566759|12239904|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976449|NCT02566759|12239905|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976450|NCT02566759|12239906|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976451|NCT02566759|12239907|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976452|NCT02566759|12239908|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976453|NCT02566759|12239909|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976454|NCT02566759|12239910|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976455|NCT02566759|12239911|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976456|NCT02566759|12239912|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976457|NCT02566759|12239913|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976458|NCT02566759|12239914|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976459|NCT02566759|12239898|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
4976460|NCT02566759|12239899|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
4976461|NCT02566759|12239900|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
4976462|NCT02566759|12239901|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976463|NCT02566759|12239902|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976464|NCT02566759|12239903|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976465|NCT02566759|12239904|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976466|NCT02566759|12239905|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976467|NCT02566759|12239906|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976468|NCT02566759|12239907|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976469|NCT02566759|12239908|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976470|NCT02566759|12239909|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976471|NCT02566759|12239910|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976472|NCT02566759|12239911|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976473|NCT02566759|12239912|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976474|NCT02566759|12239913|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976475|NCT02566759|12239914|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976476|NCT02566759|12239898|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
4976477|NCT02566759|12239899|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
4976478|NCT02566759|12239900|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
4976479|NCT02566759|12239901|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976480|NCT02566759|12239902|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976481|NCT02566759|12239903|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976482|NCT02566759|12239904|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976483|NCT02566759|12239905|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976484|NCT02566759|12239906|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976485|NCT02566759|12239907|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976486|NCT02566759|12239908|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976487|NCT02566759|12239909|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976488|NCT02566759|12239910|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976489|NCT02566759|12239911|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976490|NCT02566759|12239912|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976491|NCT02566759|12239913|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976492|NCT02566759|12239914|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976493|NCT02566759|12239898|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
4976494|NCT02566759|12239899|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976495|NCT02566759|12239900|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976496|NCT02566759|12239901|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976497|NCT02566759|12239902|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976498|NCT02566759|12239903|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976499|NCT02566759|12239904|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976500|NCT02566759|12239905|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976501|NCT02566759|12239906|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976502|NCT02566759|12239907|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976503|NCT02566759|12239908|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976504|NCT02566759|12239909|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976505|NCT02566759|12239910|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976506|NCT02566759|12239911|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976507|NCT02566759|12239912|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976663|NCT02566369|12240106|P1|STARTED|Overall Study||612
4976508|NCT02566759|12239913|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976509|NCT02566759|12239914|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976510|NCT02566759|12239898|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
4976511|NCT02566759|12239899|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
4976512|NCT02566759|12239900|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
4976513|NCT02566759|12239901|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976514|NCT02566759|12239902|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976515|NCT02566759|12239903|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976516|NCT02566759|12239904|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976517|NCT02566759|12239905|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976518|NCT02566759|12239906|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976519|NCT02566759|12239907|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976520|NCT02566759|12239908|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976521|NCT02566759|12239909|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976522|NCT02566759|12239910|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976523|NCT02566759|12239911|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976524|NCT02566759|12239912|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976525|NCT02566759|12239913|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976526|NCT02566759|12239914|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
4976527|NCT02566759|12239898|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
4976528|NCT02566759|12239899|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
4976529|NCT02566759|12239900|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
4976530|NCT02566759|12239901|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976531|NCT02566759|12239902|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976532|NCT02566759|12239903|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976533|NCT02566759|12239904|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976534|NCT02566759|12239905|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976535|NCT02566759|12239906|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976536|NCT02566759|12239907|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976537|NCT02566759|12239908|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976538|NCT02566759|12239909|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976539|NCT02566759|12239910|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976540|NCT02566759|12239911|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976541|NCT02566759|12239912|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976542|NCT02566759|12239913|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976543|NCT02566759|12239914|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
4976544|NCT02566759|12239898|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976545|NCT02566759|12239899|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976546|NCT02566759|12239900|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976547|NCT02566759|12239901|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976548|NCT02566759|12239902|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976549|NCT02566759|12239903|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976550|NCT02566759|12239904|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976551|NCT02566759|12239905|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976552|NCT02566759|12239906|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976553|NCT02566759|12239907|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976554|NCT02566759|12239908|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976555|NCT02566759|12239909|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976556|NCT02566759|12239910|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976557|NCT02566759|12239911|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976558|NCT02566759|12239912|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976559|NCT02566759|12239913|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976560|NCT02566759|12239914|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976561|NCT02566759|12239898|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
4976562|NCT02566759|12239899|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
4976563|NCT02566759|12239900|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
4976564|NCT02566759|12239901|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976565|NCT02566759|12239902|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976566|NCT02566759|12239903|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976567|NCT02566759|12239904|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976568|NCT02566759|12239905|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976569|NCT02566759|12239906|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976570|NCT02566759|12239907|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976571|NCT02566759|12239908|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976572|NCT02566759|12239909|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976573|NCT02566759|12239910|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976574|NCT02566759|12239911|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976575|NCT02566759|12239912|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976576|NCT02566759|12239913|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976577|NCT02566759|12239914|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
4976578|NCT02566759|12239898|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
4976579|NCT02566759|12239899|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
4976580|NCT02566759|12239900|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
4976581|NCT02566759|12239901|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976582|NCT02566759|12239902|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976583|NCT02566759|12239903|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976584|NCT02566759|12239904|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976585|NCT02566759|12239905|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976586|NCT02566759|12239906|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976587|NCT02566759|12239907|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976588|NCT02566759|12239908|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976589|NCT02566759|12239909|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976590|NCT02566759|12239910|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976591|NCT02566759|12239911|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976592|NCT02566759|12239912|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976593|NCT02566759|12239913|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976594|NCT02566759|12239914|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
4976595|NCT02566759|12239898|P17|NOT COMPLETED|All Parts||0
4976596|NCT02566759|12239899|P16|NOT COMPLETED|All Parts||0
4976597|NCT02566759|12239900|P15|NOT COMPLETED|All Parts||0
4976598|NCT02566759|12239901|P14|NOT COMPLETED|All Parts||5
4976599|NCT02566759|12239902|P13|NOT COMPLETED|All Parts||1
4976600|NCT02566759|12239903|P12|NOT COMPLETED|All Parts||0
4976601|NCT02566759|12239904|P11|NOT COMPLETED|All Parts||0
4976602|NCT02566759|12239905|P10|NOT COMPLETED|All Parts||0
4976603|NCT02566759|12239906|P9|NOT COMPLETED|All Parts||0
4976604|NCT02566759|12239907|P8|NOT COMPLETED|All Parts||0
4976605|NCT02566759|12239908|P7|NOT COMPLETED|All Parts||0
4976606|NCT02566759|12239909|P6|NOT COMPLETED|All Parts||0
4976607|NCT02566759|12239910|P5|NOT COMPLETED|All Parts||0
4976608|NCT02566759|12239911|P4|NOT COMPLETED|All Parts||0
4976609|NCT02566759|12239912|P3|NOT COMPLETED|All Parts||0
4976610|NCT02566759|12239913|P2|NOT COMPLETED|All Parts||1
4976611|NCT02566759|12239914|P1|NOT COMPLETED|All Parts||0
4976612|NCT02566759|12239898|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
4976613|NCT02566759|12239899|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
4976614|NCT02566759|12239900|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
4976615|NCT02566759|12239901|P14|COMPLETED|All Parts||0
4976616|NCT02566759|12239902|P13|COMPLETED|All Parts||0
4976617|NCT02566759|12239903|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976618|NCT02566759|12239904|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976619|NCT02566759|12239905|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976620|NCT02566759|12239906|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976621|NCT02566759|12239907|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
4976622|NCT02566759|12239908|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976623|NCT02566759|12239909|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976624|NCT02566759|12239910|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976625|NCT02566759|12239911|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976626|NCT02566759|12239912|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
4976627|NCT02566759|12239913|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
4976628|NCT02566759|12239914|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
4976629|NCT02566759|12239898|P17|STARTED|All Parts||8
4976630|NCT02566759|12239899|P16|STARTED|All Parts||8
4976631|NCT02566759|12239900|P15|STARTED|All Parts||8
4976632|NCT02566759|12239901|P14|STARTED|All Parts||5
4976633|NCT02566759|12239902|P13|STARTED|All Parts||1
4976634|NCT02566759|12239903|P12|STARTED|All Parts||6
4976635|NCT02566759|12239904|P11|STARTED|All Parts||6
4976636|NCT02566759|12239905|P10|STARTED|All Parts||6
4976637|NCT02566759|12239906|P9|STARTED|All Parts||6
4976638|NCT02566759|12239907|P8|STARTED|All Parts||8
4976639|NCT02566759|12239908|P7|STARTED|All Parts||6
4976640|NCT02566759|12239909|P6|STARTED|All Parts||6
4976641|NCT02566759|12239910|P5|STARTED|All Parts||6
4976642|NCT02566759|12239911|P4|STARTED|All Parts||6
4976643|NCT02566759|12239912|P3|STARTED|All Parts||6
4976644|NCT02566759|12239913|P2|STARTED|All Parts||6
4976645|NCT02566759|12239914|P1|STARTED|All Parts||12
4976646|NCT02566590|12240067|P2|NOT COMPLETED|Overall Study||0
4976647|NCT02566590|12240068|P1|NOT COMPLETED|Overall Study||0
4976648|NCT02566590|12240067|P2|COMPLETED|Overall Study||10
4976649|NCT02566590|12240068|P1|COMPLETED|Overall Study||10
4976650|NCT02566590|12240067|P2|STARTED|Overall Study||10
4976651|NCT02566590|12240068|P1|STARTED|Overall Study||10
4976652|NCT02566577|12240076|P2|NOT COMPLETED|Overall Study||2
4976653|NCT02566577|12240077|P1|NOT COMPLETED|Overall Study||3
4976654|NCT02566577|12240076|P2|COMPLETED|Overall Study||4
4976655|NCT02566577|12240077|P1|COMPLETED|Overall Study||6
4976656|NCT02566577|12240076|P2|STARTED|Overall Study||6
4976657|NCT02566577|12240077|P1|STARTED|Overall Study||9
4976658|NCT02566369|12240105|P2|NOT COMPLETED|Overall Study||61
4976659|NCT02566369|12240106|P1|NOT COMPLETED|Overall Study||72
4976660|NCT02566369|12240105|P2|COMPLETED|Overall Study||535
4976661|NCT02566369|12240106|P1|COMPLETED|Overall Study||540
4976662|NCT02566369|12240105|P2|STARTED|Overall Study||596
4976664|NCT02566317|12240114|P2|NOT COMPLETED|Overall Study||62
4976665|NCT02566317|12240115|P1|NOT COMPLETED|Overall Study||29
4976666|NCT02566317|12240114|P2|COMPLETED|Overall Study||292
4976667|NCT02566317|12240115|P1|COMPLETED|Overall Study||247
4976668|NCT02566317|12240114|P2|STARTED|Overall Study||354
4976669|NCT02566317|12240115|P1|STARTED|Overall Study||276
4976670|NCT02566265|12240127|P2|NOT COMPLETED|Overall Study||6
4976671|NCT02566265|12240128|P1|NOT COMPLETED|Overall Study||9
4976672|NCT02566265|12240127|P2|COMPLETED|Overall Study||35
4976673|NCT02566265|12240128|P1|COMPLETED|Overall Study||72
4976674|NCT02566265|12240127|P2|End of Study Visit (Optional)|Overall Study||18
4976675|NCT02566265|12240128|P1|End of Study Visit (Optional)|Overall Study||38
4976676|NCT02566265|12240127|P2|30 Days Following 2nd Vaccine|Overall Study||35
4976677|NCT02566265|12240128|P1|30 Days Following 2nd Vaccine|Overall Study||72
4976678|NCT02566265|12240127|P2|Day of Second Vaccine|Overall Study||41
4976679|NCT02566265|12240128|P1|Day of Second Vaccine|Overall Study||74
4976680|NCT02566265|12240127|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
4976681|NCT02566265|12240128|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
4976682|NCT02566265|12240127|P2|STARTED|Overall Study||41
4976683|NCT02566265|12240128|P1|STARTED|Overall Study||81
4976684|NCT02566135|12240136|P2|NOT COMPLETED|Overall Study||0
4976685|NCT02566135|12240137|P1|NOT COMPLETED|Overall Study||0
4976686|NCT02566135|12240136|P2|COMPLETED|Overall Study||29
4976687|NCT02566135|12240137|P1|COMPLETED|Overall Study||29
4976688|NCT02566135|12240136|P2|STARTED|Overall Study||29
4976689|NCT02566135|12240137|P1|STARTED|Overall Study||29
4976690|NCT02566109|12240157|P1|NOT COMPLETED|Overall Study||1
4976691|NCT02566109|12240157|P1|COMPLETED|Overall Study||5
4976692|NCT02566109|12240157|P1|STARTED|Overall Study||6
4976693|NCT02566083|12240169|P2|NOT COMPLETED|Overall Study||10
4976694|NCT02566083|12240170|P1|NOT COMPLETED|Overall Study||16
4976695|NCT02566083|12240169|P2|COMPLETED|Overall Study||141
4976696|NCT02566083|12240170|P1|COMPLETED|Overall Study||198
4976697|NCT02566083|12240169|P2|STARTED|Overall Study||151
4976698|NCT02566083|12240170|P1|STARTED|Overall Study||214
4976699|NCT02566044|12240179|P3|NOT COMPLETED|Overall Study||0
4976700|NCT02566044|12240180|P2|NOT COMPLETED|Overall Study||0
4976701|NCT02566044|12240181|P1|NOT COMPLETED|Overall Study||0
4976702|NCT02566044|12240179|P3|COMPLETED|Overall Study||4
4976703|NCT02566044|12240180|P2|COMPLETED|Overall Study||6
4976704|NCT02566044|12240181|P1|COMPLETED|Overall Study||6
4976705|NCT02566044|12240179|P3|STARTED|Overall Study||4
4976706|NCT02566044|12240180|P2|STARTED|Overall Study||6
4976707|NCT02566044|12240181|P1|STARTED|Overall Study||6
4976708|NCT02566031|12240221|P2|NOT COMPLETED|Overall Study||12
4976709|NCT02566031|12240222|P1|NOT COMPLETED|Overall Study||20
4976710|NCT02566031|12240221|P2|COMPLETED|Overall Study||178
4976711|NCT02566031|12240222|P1|COMPLETED|Overall Study||169
4976712|NCT02566031|12240221|P2|STARTED|Overall Study||190
4976713|NCT02566031|12240222|P1|STARTED|Overall Study||189
4976714|NCT02566005|12240239|P2|NOT COMPLETED|Overall Study||6
4976715|NCT02566005|12240240|P1|NOT COMPLETED|Overall Study||8
4976716|NCT02566005|12240239|P2|COMPLETED|Overall Study||94
4976717|NCT02566005|12240240|P1|COMPLETED|Overall Study||92
4976718|NCT02566005|12240239|P2|STARTED|Overall Study||100
4976719|NCT02566005|12240240|P1|STARTED|Overall Study||100
4976720|NCT02565914|12240268|P1|NOT COMPLETED|Overall Study||93
4976721|NCT02565914|12240268|P1|COMPLETED|Overall Study||951
4976722|NCT02565914|12240268|P1|Safety Set|Overall Study||1042
4976723|NCT02565914|12240268|P1|STARTED|Overall Study||1044
4976724|NCT02565810|12240302|P1|NOT COMPLETED|Overall Study||1
4976725|NCT02565810|12240302|P1|COMPLETED|Overall Study||48
4976726|NCT02565810|12240302|P1|STARTED|Overall Study||49
4976727|NCT02565784|12240311|P1|NOT COMPLETED|Second Treatment||2
4976728|NCT02565784|12240311|P1|COMPLETED|Second Treatment||96
4976729|NCT02565784|12240311|P1|12 Months Follow-up|Second Treatment||96
4976730|NCT02565784|12240311|P1|6 Months Follow-up|Second Treatment||97
4976731|NCT02565784|12240311|P1|STARTED|Second Treatment||98
4976732|NCT02565784|12240311|P1|NOT COMPLETED|First Treatment||2
4976733|NCT02565784|12240311|P1|COMPLETED|First Treatment||98
4976734|NCT02565784|12240311|P1|12 Months Follow-up|First Treatment||98
4976735|NCT02565784|12240311|P1|6 Months Follow-up|First Treatment||99
4976736|NCT02565784|12240311|P1|STARTED|First Treatment||100
4976737|NCT02565706|12240323|P4|NOT COMPLETED|Overall Study||85
4976738|NCT02565706|12240324|P3|NOT COMPLETED|Overall Study||89
4976739|NCT02565706|12240325|P2|NOT COMPLETED|Overall Study||82
4976740|NCT02565706|12240326|P1|NOT COMPLETED|Overall Study||77
4976741|NCT02565706|12240323|P4|COMPLETED|Overall Study||116
4976742|NCT02565706|12240324|P3|COMPLETED|Overall Study||104
4976743|NCT02565706|12240325|P2|COMPLETED|Overall Study||90
4976744|NCT02565706|12240326|P1|COMPLETED|Overall Study||101
4976745|NCT02565706|12240323|P4|STARTED|Overall Study||201
4976746|NCT02565706|12240324|P3|STARTED|Overall Study||193
4976747|NCT02565706|12240325|P2|STARTED|Overall Study||172
4976748|NCT02565706|12240326|P1|STARTED|Overall Study||178
4976749|NCT02565628|12240398|P2|NOT COMPLETED|Overall Study||0
4976750|NCT02565628|12240399|P1|NOT COMPLETED|Overall Study||0
4976751|NCT02565628|12240398|P2|COMPLETED|Overall Study||9
4976752|NCT02565628|12240399|P1|COMPLETED|Overall Study||10
4976753|NCT02565628|12240398|P2|Received Treatment|Overall Study||9
4976754|NCT02565628|12240399|P1|Received Treatment|Overall Study||10
4976755|NCT02565628|12240398|P2|STARTED|Overall Study||9
4976756|NCT02565628|12240399|P1|STARTED|Overall Study||10
4976757|NCT02565615|12240432|P5|NOT COMPLETED|Overall Study||1601
4976758|NCT02565615|12240433|P4|NOT COMPLETED|Overall Study||3
4976759|NCT02565615|12240434|P3|NOT COMPLETED|Overall Study||0
4976760|NCT02565615|12240435|P2|NOT COMPLETED|Overall Study||36
4976761|NCT02565615|12240436|P1|NOT COMPLETED|Overall Study||3
4976762|NCT02565615|12240432|P5|COMPLETED|Overall Study||21
4976763|NCT02565615|12240433|P4|COMPLETED|Overall Study||98
4976764|NCT02565615|12240434|P3|COMPLETED|Overall Study||21
4976765|NCT02565615|12240435|P2|COMPLETED|Overall Study||3044
4976766|NCT02565615|12240436|P1|COMPLETED|Overall Study||288
4976767|NCT02565615|12240432|P5|Treated|Overall Study||1055
4976768|NCT02565615|12240433|P4|Treated|Overall Study||101
4976769|NCT02565615|12240434|P3|Treated|Overall Study||21
4976770|NCT02565615|12240435|P2|Treated|Overall Study||3080
4976771|NCT02565615|12240436|P1|Treated|Overall Study||291
4976772|NCT02565615|12240432|P5|STARTED|Overall Study||1622
4976773|NCT02565615|12240433|P4|STARTED|Overall Study||101
4976774|NCT02565615|12240434|P3|STARTED|Overall Study||21
4976775|NCT02565615|12240435|P2|STARTED|Overall Study||3080
4976776|NCT02565615|12240436|P1|STARTED|Overall Study||291
4976777|NCT02565576|12240550|P2|NOT COMPLETED|Overall Study||5
4976778|NCT02565576|12240551|P1|NOT COMPLETED|Overall Study||5
4976779|NCT02565576|12240550|P2|COMPLETED|Overall Study||17
4976780|NCT02565576|12240551|P1|COMPLETED|Overall Study||17
4976781|NCT02565576|12240550|P2|STARTED|Overall Study||22
4976782|NCT02565576|12240551|P1|STARTED|Overall Study||22
4976783|NCT02565485|12240578|P2|NOT COMPLETED|Overall Study||0
4976784|NCT02565485|12240579|P1|NOT COMPLETED|Overall Study||0
4976785|NCT02565485|12240578|P2|COMPLETED|Overall Study||137
4976786|NCT02565485|12240579|P1|COMPLETED|Overall Study||139
4976787|NCT02565485|12240578|P2|STARTED|Overall Study||137
4976788|NCT02565485|12240579|P1|STARTED|Overall Study||139
4976789|NCT02565381|12240594|P3|NOT COMPLETED|Overall Study||1
4976790|NCT02565381|12240595|P2|NOT COMPLETED|Overall Study||0
4976791|NCT02565381|12240596|P1|NOT COMPLETED|Overall Study||1
4976792|NCT02565381|12240594|P3|COMPLETED|Overall Study||24
4976793|NCT02565381|12240595|P2|COMPLETED|Overall Study||25
4976794|NCT02565381|12240596|P1|COMPLETED|Overall Study||24
4976795|NCT02565381|12240594|P3|STARTED|Overall Study||25
4976796|NCT02565381|12240595|P2|STARTED|Overall Study||25
4976797|NCT02565381|12240596|P1|STARTED|Overall Study||25
4976798|NCT02565147|12240636|P2|NOT COMPLETED|Overall Study||3
4976799|NCT02565147|12240637|P1|NOT COMPLETED|Overall Study||6
4976800|NCT02565147|12240636|P2|COMPLETED|Overall Study||37
4976801|NCT02565147|12240637|P1|COMPLETED|Overall Study||32
4976802|NCT02565147|12240636|P2|Per-Protocol Population|Overall Study||36
4976803|NCT02565147|12240637|P1|Per-Protocol Population|Overall Study||28
4976804|NCT02565147|12240636|P2|Received Study Drug|Overall Study||40
4976805|NCT02565147|12240637|P1|Received Study Drug|Overall Study||38
4976806|NCT02565147|12240636|P2|STARTED|Overall Study||40
4976807|NCT02565147|12240637|P1|STARTED|Overall Study||38
4976808|NCT02565108|12240661|P2|NOT COMPLETED|Overall Study||0
4976809|NCT02565108|12240662|P1|NOT COMPLETED|Overall Study||2
4976810|NCT02565108|12240661|P2|COMPLETED|Overall Study||4
4976811|NCT02565108|12240662|P1|COMPLETED|Overall Study||14
4976812|NCT02565108|12240661|P2|Pharmacokinetic (PK) Set|Overall Study||3
4976813|NCT02565108|12240662|P1|Pharmacokinetic (PK) Set|Overall Study||10
4976814|NCT02565108|12240661|P2|Safety Set|Overall Study||4
4976815|NCT02565108|12240662|P1|Safety Set|Overall Study||16
4976816|NCT02565108|12240661|P2|STARTED|Overall Study||4
4976817|NCT02565108|12240662|P1|STARTED|Overall Study||16
4976818|NCT02564952|12240678|P1|NOT COMPLETED|Overall Study||11
4976819|NCT02564952|12240678|P1|COMPLETED|Overall Study||7
4976820|NCT02564952|12240678|P1|Completed OLE Titration Period|Overall Study||16
4976821|NCT02564952|12240678|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
4976822|NCT02564952|12240678|P1|STARTED|Overall Study||18
4976823|NCT02564926|12240684|P2|NOT COMPLETED|Overall Study||7
4976824|NCT02564926|12240685|P1|NOT COMPLETED|Overall Study||8
4976825|NCT02564926|12240684|P2|COMPLETED|Overall Study||54
4976826|NCT02564926|12240685|P1|COMPLETED|Overall Study||52
4976827|NCT02564926|12240684|P2|STARTED|Overall Study||61
4976828|NCT02564926|12240685|P1|STARTED|Overall Study||60
4976829|NCT02564887|12240723|P2|NOT COMPLETED|Overall Study||0
4976830|NCT02564887|12240724|P1|NOT COMPLETED|Overall Study||6
4976831|NCT02564887|12240723|P2|COMPLETED|Overall Study||10
4976832|NCT02564887|12240724|P1|COMPLETED|Overall Study||10
4976833|NCT02564887|12240723|P2|STARTED|Overall Study||10
4976834|NCT02564887|12240724|P1|STARTED|Overall Study||16
4976835|NCT02564718|12240742|P2|NOT COMPLETED|Overall Study||1
4976836|NCT02564718|12240743|P1|NOT COMPLETED|Overall Study||0
4976837|NCT02564718|12240742|P2|COMPLETED|Overall Study||4
4976838|NCT02564718|12240743|P1|COMPLETED|Overall Study||5
4976839|NCT02564718|12240742|P2|STARTED|Overall Study||5
4976840|NCT02564718|12240743|P1|STARTED|Overall Study||5
4976841|NCT02564497|12240773|P2|NOT COMPLETED|Overall Study||0
4976842|NCT02564497|12240774|P1|NOT COMPLETED|Overall Study||0
4976843|NCT02564497|12240773|P2|COMPLETED|Overall Study||72
4976844|NCT02564497|12240774|P1|COMPLETED|Overall Study||74
4976845|NCT02564497|12240773|P2|STARTED|Overall Study||72
4976846|NCT02564497|12240774|P1|STARTED|Overall Study||74
4976847|NCT02564432|12240792|P1|NOT COMPLETED|Overall Study||2
4976848|NCT02564432|12240792|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
4976849|NCT02564432|12240792|P1|STARTED|Overall Study||10
4976850|NCT02564263|12240800|P2|NOT COMPLETED|Overall Study||314
4976851|NCT02564263|12240801|P1|NOT COMPLETED|Overall Study||314
4976852|NCT02564263|12240800|P2|COMPLETED|Overall Study||0
4976853|NCT02564263|12240801|P1|COMPLETED|Overall Study||0
4976854|NCT02564263|12240800|P2|Treated|Overall Study||296
4976855|NCT02564263|12240801|P1|Treated|Overall Study||314
4976856|NCT02564263|12240800|P2|STARTED|Overall Study||314
4976857|NCT02564263|12240801|P1|STARTED|Overall Study||314
4976858|NCT02564211|12240823|P1|NOT COMPLETED|Overall Study||4
4976859|NCT02564211|12240823|P1|COMPLETED|Overall Study||73
4976860|NCT02564211|12240823|P1|STARTED|Overall Study||77
4976861|NCT02564120|12240834|P1|NOT COMPLETED|Overall Study||446
4976862|NCT02564120|12240834|P1|COMPLETED|Overall Study||1110
4976863|NCT02564120|12240834|P1|STARTED|Overall Study||1556
4976864|NCT02564055|12240882|P6|NOT COMPLETED|Overall Study||12
4976865|NCT02564055|12240883|P5|NOT COMPLETED|Overall Study||15
4976866|NCT02564055|12240884|P4|NOT COMPLETED|Overall Study||6
4976867|NCT02564055|12240885|P3|NOT COMPLETED|Overall Study||12
4976868|NCT02564055|12240886|P2|NOT COMPLETED|Overall Study||5
4976869|NCT02564055|12240887|P1|NOT COMPLETED|Overall Study||6
4976870|NCT02564055|12240882|P6|COMPLETED|Overall Study||28
4976871|NCT02564055|12240883|P5|COMPLETED|Overall Study||27
4976872|NCT02564055|12240884|P4|COMPLETED|Overall Study||35
4976873|NCT02564055|12240885|P3|COMPLETED|Overall Study||31
4976874|NCT02564055|12240886|P2|COMPLETED|Overall Study||36
4976875|NCT02564055|12240887|P1|COMPLETED|Overall Study||34
4976876|NCT02564055|12240882|P6|STARTED|Overall Study||40
4976877|NCT02564055|12240883|P5|STARTED|Overall Study||42
4976878|NCT02564055|12240884|P4|STARTED|Overall Study||41
4976879|NCT02564055|12240885|P3|STARTED|Overall Study||43
4976880|NCT02564055|12240886|P2|STARTED|Overall Study||41
4976881|NCT02564055|12240887|P1|STARTED|Overall Study||40
4976882|NCT02564042|12241141|P6|NOT COMPLETED|Overall Study||14
4976883|NCT02564042|12241142|P5|NOT COMPLETED|Overall Study||11
4976884|NCT02564042|12241143|P4|NOT COMPLETED|Overall Study||3
4976885|NCT02564042|12241144|P3|NOT COMPLETED|Overall Study||6
4976886|NCT02564042|12241145|P2|NOT COMPLETED|Overall Study||8
4976887|NCT02564042|12241146|P1|NOT COMPLETED|Overall Study||11
4976888|NCT02564042|12241141|P6|COMPLETED|Overall Study||24
4976889|NCT02564042|12241142|P5|COMPLETED|Overall Study||26
4976890|NCT02564042|12241143|P4|COMPLETED|Overall Study||35
4976891|NCT02564042|12241144|P3|COMPLETED|Overall Study||32
4976892|NCT02564042|12241145|P2|COMPLETED|Overall Study||30
4976893|NCT02564042|12241146|P1|COMPLETED|Overall Study||27
4976894|NCT02564042|12241141|P6|STARTED|Overall Study||38
4976895|NCT02564042|12241142|P5|STARTED|Overall Study||37
4976896|NCT02564042|12241143|P4|STARTED|Overall Study||38
4976897|NCT02564042|12241144|P3|STARTED|Overall Study||38
4976898|NCT02564042|12241145|P2|STARTED|Overall Study||38
4976899|NCT02564042|12241146|P1|STARTED|Overall Study||38
4976900|NCT02564029|12241358|P1|NOT COMPLETED|Overall Study||0
4976901|NCT02564029|12241358|P1|COMPLETED|Overall Study||7
4976902|NCT02564029|12241358|P1|STARTED|Overall Study||7
4976903|NCT02564016|12241401|P2|NOT COMPLETED|Overall Study||10
4976904|NCT02564016|12241402|P1|NOT COMPLETED|Overall Study||18
4976905|NCT02564016|12241401|P2|COMPLETED|Overall Study||4
4976906|NCT02564016|12241402|P1|COMPLETED|Overall Study||4
4976907|NCT02564016|12241401|P2|STARTED|Overall Study||14
4976908|NCT02564016|12241402|P1|STARTED|Overall Study||22
4976909|NCT02563990|12241414|P2|NOT COMPLETED|Overall Study||0
4976910|NCT02563990|12241415|P1|NOT COMPLETED|Overall Study||0
4976911|NCT02563990|12241414|P2|COMPLETED|Overall Study||14
4976912|NCT02563990|12241415|P1|COMPLETED|Overall Study||12
4976913|NCT02563990|12241414|P2|STARTED|Overall Study||14
4976914|NCT02563990|12241415|P1|STARTED|Overall Study||12
4976915|NCT02563899|12241441|P4|NOT COMPLETED|Overall Study||0
4976916|NCT02563899|12241442|P3|NOT COMPLETED|Overall Study||1
4976917|NCT02563899|12241443|P2|NOT COMPLETED|Overall Study||0
4976918|NCT02563899|12241444|P1|NOT COMPLETED|Overall Study||1
4976919|NCT02563899|12241441|P4|COMPLETED|Overall Study||6
4976920|NCT02563899|12241442|P3|COMPLETED|Overall Study||9
4976921|NCT02563899|12241443|P2|COMPLETED|Overall Study||5
4976922|NCT02563899|12241444|P1|COMPLETED|Overall Study||17
4976923|NCT02563899|12241441|P4|STARTED|Overall Study||6
4976924|NCT02563899|12241442|P3|STARTED|Overall Study||10
4976925|NCT02563899|12241443|P2|STARTED|Overall Study||5
4976926|NCT02563899|12241444|P1|STARTED|Overall Study||18
4976927|NCT02563860|12241485|P1|NOT COMPLETED|Overall Study||1
4976928|NCT02563860|12241485|P1|COMPLETED|Overall Study||19
4976929|NCT02563860|12241485|P1|STARTED|Overall Study||20
4976930|NCT02563834|12241492|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
4976931|NCT02563834|12241493|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
4976932|NCT02563834|12241492|P2|COMPLETED|Insulin Infusion (*Day 2)||8
4976933|NCT02563834|12241493|P1|COMPLETED|Insulin Infusion (*Day 2)||10
4976934|NCT02563834|12241492|P2|STARTED|Insulin Infusion (*Day 2)||8
4976935|NCT02563834|12241493|P1|STARTED|Insulin Infusion (*Day 2)||10
4976936|NCT02563834|12241492|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
4976937|NCT02563834|12241493|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
4976938|NCT02563834|12241492|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
4976939|NCT02563834|12241493|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
4976940|NCT02563834|12241492|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
4976941|NCT02563834|12241493|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
4976942|NCT02563808|12241511|P2|NOT COMPLETED|Overall Study||0
4976943|NCT02563808|12241512|P1|NOT COMPLETED|Overall Study||0
4976944|NCT02563808|12241511|P2|COMPLETED|Overall Study||88
4976945|NCT02563808|12241512|P1|COMPLETED|Overall Study||96
4977027|NCT02562924|12241668|P2|NOT COMPLETED|Overall Study||11
4976946|NCT02563808|12241511|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
4976947|NCT02563808|12241512|P1|STARTED|Overall Study||96
4976948|NCT02563548|12241520|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
4976949|NCT02563548|12241521|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
4976950|NCT02563548|12241522|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976951|NCT02563548|12241523|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976952|NCT02563548|12241524|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976953|NCT02563548|12241525|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976954|NCT02563548|12241520|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976955|NCT02563548|12241521|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976956|NCT02563548|12241522|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976957|NCT02563548|12241523|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976958|NCT02563548|12241524|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976959|NCT02563548|12241525|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
4976960|NCT02563548|12241520|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
4976961|NCT02563548|12241521|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
4976962|NCT02563548|12241522|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
4976963|NCT02563548|12241523|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
4976964|NCT02563548|12241524|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
4976965|NCT02563548|12241525|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
4976966|NCT02563548|12241520|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
4976967|NCT02563548|12241521|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
4976968|NCT02563548|12241522|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
4976969|NCT02563548|12241523|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
4976970|NCT02563548|12241524|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
4976971|NCT02563548|12241525|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
4976972|NCT02563548|12241520|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976973|NCT02563548|12241521|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976974|NCT02563548|12241522|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
4976975|NCT02563548|12241523|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
4976976|NCT02563548|12241524|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
4976977|NCT02563548|12241525|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
4976978|NCT02563548|12241520|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976979|NCT02563548|12241521|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976980|NCT02563548|12241522|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976981|NCT02563548|12241523|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976982|NCT02563548|12241524|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976983|NCT02563548|12241525|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
4976984|NCT02563548|12241520|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
4976985|NCT02563548|12241521|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
4976986|NCT02563548|12241522|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
4976987|NCT02563548|12241523|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
4976988|NCT02563548|12241524|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
4976989|NCT02563548|12241525|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
4976990|NCT02563548|12241520|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
4976991|NCT02563548|12241521|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
4976992|NCT02563548|12241522|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
4976993|NCT02563548|12241523|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
4976994|NCT02563548|12241524|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
4976995|NCT02563548|12241525|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
4976996|NCT02563106|12241589|P2|NOT COMPLETED|Overall Study||29
4976997|NCT02563106|12241590|P1|NOT COMPLETED|Overall Study||34
4976998|NCT02563106|12241589|P2|COMPLETED|Overall Study||178
4976999|NCT02563106|12241590|P1|COMPLETED|Overall Study||172
4977000|NCT02563106|12241589|P2|STARTED|Overall Study||207
4977001|NCT02563106|12241590|P1|STARTED|Overall Study||206
4977002|NCT02563093|12241600|P4|NOT COMPLETED|Overall Study||0
4977003|NCT02563093|12241601|P3|NOT COMPLETED|Overall Study||0
4977004|NCT02563093|12241602|P2|NOT COMPLETED|Overall Study||0
4977005|NCT02563093|12241603|P1|NOT COMPLETED|Overall Study||0
4977006|NCT02563093|12241600|P4|COMPLETED|Overall Study||51
4977007|NCT02563093|12241601|P3|COMPLETED|Overall Study||53
4977008|NCT02563093|12241602|P2|COMPLETED|Overall Study||52
4977009|NCT02563093|12241603|P1|COMPLETED|Overall Study||52
4977010|NCT02563093|12241600|P4|STARTED|Overall Study||51
4977011|NCT02563093|12241601|P3|STARTED|Overall Study||53
4977012|NCT02563093|12241602|P2|STARTED|Overall Study||52
4977013|NCT02563093|12241603|P1|STARTED|Overall Study||52
4977014|NCT02563028|12241629|P1|NOT COMPLETED|Overall Study||2
4977015|NCT02563028|12241629|P1|COMPLETED|Overall Study||18
4977016|NCT02563028|12241629|P1|STARTED|Overall Study||20
4977017|NCT02562989|12241639|P3|NOT COMPLETED|Overall Study||0
4977018|NCT02562989|12241640|P2|NOT COMPLETED|Overall Study||0
4977019|NCT02562989|12241641|P1|NOT COMPLETED|Overall Study||0
4977020|NCT02562989|12241639|P3|COMPLETED|Overall Study||6
4977021|NCT02562989|12241640|P2|COMPLETED|Overall Study||4
4977022|NCT02562989|12241641|P1|COMPLETED|Overall Study||3
4977023|NCT02562989|12241639|P3|STARTED|Overall Study||6
4977024|NCT02562989|12241640|P2|STARTED|Overall Study||4
4977025|NCT02562989|12241641|P1|STARTED|Overall Study||3
4977026|NCT02562924|12241667|P3|NOT COMPLETED|Overall Study||4
4977028|NCT02562924|12241669|P1|NOT COMPLETED|Overall Study||1
4977029|NCT02562924|12241667|P3|COMPLETED|Overall Study||8
4977030|NCT02562924|12241668|P2|COMPLETED|Overall Study||1
4977031|NCT02562924|12241669|P1|COMPLETED|Overall Study||12
4977032|NCT02562924|12241667|P3|STARTED|Overall Study||12
4977033|NCT02562924|12241668|P2|STARTED|Overall Study||12
4977034|NCT02562924|12241669|P1|STARTED|Overall Study||13
4977035|NCT02562898|12241688|P2|NOT COMPLETED|Overall Study||0
4977036|NCT02562898|12241689|P1|NOT COMPLETED|Overall Study||0
4977037|NCT02562898|12241688|P2|COMPLETED|Overall Study||8
4977038|NCT02562898|12241689|P1|COMPLETED|Overall Study||10
4977039|NCT02562898|12241688|P2|STARTED|Overall Study||8
4977040|NCT02562898|12241689|P1|STARTED|Overall Study||10
4977041|NCT02562521|12241701|P2|NOT COMPLETED|Overall Study||0
4977042|NCT02562521|12241702|P1|NOT COMPLETED|Overall Study||0
4977043|NCT02562521|12241701|P2|COMPLETED|Overall Study||7
4977044|NCT02562521|12241702|P1|COMPLETED|Overall Study||18
4977045|NCT02562521|12241701|P2|STARTED|Overall Study||7
4977046|NCT02562521|12241702|P1|STARTED|Overall Study||18
4977047|NCT02562482|12241718|P2|NOT COMPLETED|Overall Study||16
4977048|NCT02562482|12241719|P1|NOT COMPLETED|Overall Study||21
4977049|NCT02562482|12241718|P2|COMPLETED|Overall Study||183
4977050|NCT02562482|12241719|P1|COMPLETED|Overall Study||180
4977051|NCT02562482|12241718|P2|Received 2nd Injection|Overall Study||192
4977052|NCT02562482|12241719|P1|Received 2nd Injection|Overall Study||192
4977053|NCT02562482|12241718|P2|Received 1st Injection|Overall Study||199
4977054|NCT02562482|12241719|P1|Received 1st Injection|Overall Study||197
4977055|NCT02562482|12241718|P2|STARTED|Overall Study||199
4977056|NCT02562482|12241719|P1|STARTED|Overall Study||201
4977057|NCT02561897|12241743|P2|NOT COMPLETED|Overall Study||0
4977058|NCT02561897|12241744|P1|NOT COMPLETED|Overall Study||0
4977059|NCT02561897|12241743|P2|COMPLETED|Overall Study||3
4977060|NCT02561897|12241744|P1|COMPLETED|Overall Study||2
4977061|NCT02561897|12241743|P2|STARTED|Overall Study||3
4977062|NCT02561897|12241744|P1|STARTED|Overall Study||2
4977063|NCT02561832|12241754|P2|NOT COMPLETED|Overall Study||4
4977064|NCT02561832|12241755|P1|NOT COMPLETED|Overall Study||7
4977065|NCT02561832|12241754|P2|COMPLETED|Overall Study||3
4977066|NCT02561832|12241755|P1|COMPLETED|Overall Study||1
4977067|NCT02561832|12241754|P2|INFORMED CONSENT OBTAINED|Overall Study||7
4977068|NCT02561832|12241755|P1|INFORMED CONSENT OBTAINED|Overall Study||8
4977069|NCT02561832|12241754|P2|STARTED|Overall Study||7
4977070|NCT02561832|12241755|P1|STARTED|Overall Study||8
4977071|NCT02561806|12241763|P2|NOT COMPLETED|Post-Treatment Follow-up||1
4977072|NCT02561806|12241764|P1|NOT COMPLETED|Post-Treatment Follow-up||2
4977073|NCT02561806|12241763|P2|COMPLETED|Post-Treatment Follow-up||59
4977074|NCT02561806|12241764|P1|COMPLETED|Post-Treatment Follow-up||155
4977075|NCT02561806|12241763|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
4977076|NCT02561806|12241764|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
4977077|NCT02561806|12241763|P2|NOT COMPLETED|Maintenance Period||8
4977078|NCT02561806|12241764|P1|NOT COMPLETED|Maintenance Period||13
4977079|NCT02561806|12241763|P2|COMPLETED|Maintenance Period||123
4977080|NCT02561806|12241764|P1|COMPLETED|Maintenance Period||151
4977081|NCT02561806|12241763|P2|STARTED|Maintenance Period||131
4977082|NCT02561806|12241764|P1|STARTED|Maintenance Period||164
4977083|NCT02561806|12241763|P2|NOT COMPLETED|Induction Period||5
4977084|NCT02561806|12241764|P1|NOT COMPLETED|Induction Period||2
4977085|NCT02561806|12241763|P2|COMPLETED|Induction Period||131
4977086|NCT02561806|12241764|P1|COMPLETED|Induction Period||164
4977087|NCT02561806|12241763|P2|Received At Least One Dose of Study Drug|Induction Period||135
4977088|NCT02561806|12241764|P1|Received At Least One Dose of Study Drug|Induction Period||166
4977089|NCT02561806|12241763|P2|STARTED|Induction Period||136
4977090|NCT02561806|12241764|P1|STARTED|Induction Period||166
4977091|NCT02561702|12241820|P2|NOT COMPLETED|Second Intervention||0
4977092|NCT02561702|12241821|P1|NOT COMPLETED|Second Intervention||0
4977093|NCT02561702|12241820|P2|COMPLETED|Second Intervention||2
4977094|NCT02561702|12241821|P1|COMPLETED|Second Intervention||2
4977095|NCT02561702|12241820|P2|STARTED|Second Intervention||2
4977096|NCT02561702|12241821|P1|STARTED|Second Intervention||2
4977097|NCT02561702|12241820|P2|NOT COMPLETED|Washout||0
4977098|NCT02561702|12241821|P1|NOT COMPLETED|Washout||0
4977099|NCT02561702|12241820|P2|COMPLETED|Washout||2
4977100|NCT02561702|12241821|P1|COMPLETED|Washout||2
4977101|NCT02561702|12241820|P2|STARTED|Washout||2
4977102|NCT02561702|12241821|P1|STARTED|Washout||2
4977103|NCT02561702|12241820|P2|NOT COMPLETED|First Intervention||0
4977104|NCT02561702|12241821|P1|NOT COMPLETED|First Intervention||0
4977105|NCT02561702|12241820|P2|COMPLETED|First Intervention||2
4977106|NCT02561702|12241821|P1|COMPLETED|First Intervention||2
4977107|NCT02561702|12241820|P2|STARTED|First Intervention||2
4977108|NCT02561702|12241821|P1|STARTED|First Intervention||2
4977109|NCT02561585|12241831|P2|NOT COMPLETED|Overall Study||5
4977110|NCT02561585|12241832|P1|NOT COMPLETED|Overall Study||3
4977111|NCT02561585|12241831|P2|COMPLETED|Overall Study||6
4977112|NCT02561585|12241832|P1|COMPLETED|Overall Study||17
4977113|NCT02561585|12241831|P2|STARTED|Overall Study||11
4977114|NCT02561585|12241832|P1|STARTED|Overall Study||20
4977115|NCT02561572|12241868|P2|NOT COMPLETED|Overall Study||2
4977116|NCT02561572|12241869|P1|NOT COMPLETED|Overall Study||2
4977117|NCT02561572|12241868|P2|COMPLETED|Overall Study||62
4977118|NCT02561572|12241869|P1|COMPLETED|Overall Study||62
4977119|NCT02561572|12241868|P2|STARTED|Overall Study||64
4977120|NCT02561572|12241869|P1|STARTED|Overall Study||64
4977121|NCT02561338|12241890|P5|NOT COMPLETED|Overall Study||2
4977122|NCT02561338|12241891|P4|NOT COMPLETED|Overall Study||5
4977123|NCT02561338|12241892|P3|NOT COMPLETED|Overall Study||9
4977124|NCT02561338|12241893|P2|NOT COMPLETED|Overall Study||6
4977125|NCT02561338|12241894|P1|NOT COMPLETED|Overall Study||8
4977126|NCT02561338|12241890|P5|COMPLETED|Overall Study||51
4977127|NCT02561338|12241891|P4|COMPLETED|Overall Study||46
4977128|NCT02561338|12241892|P3|COMPLETED|Overall Study||42
4977129|NCT02561338|12241893|P2|COMPLETED|Overall Study||44
4977130|NCT02561338|12241894|P1|COMPLETED|Overall Study||45
4977131|NCT02561338|12241890|P5|STARTED|Overall Study||53
4977132|NCT02561338|12241891|P4|STARTED|Overall Study||51
4977133|NCT02561338|12241892|P3|STARTED|Overall Study||51
4977134|NCT02561338|12241893|P2|STARTED|Overall Study||50
4977135|NCT02561338|12241894|P1|STARTED|Overall Study||53
4977136|NCT02561195|12241927|P6|NOT COMPLETED|Overall Study||10
4977137|NCT02561195|12241928|P5|NOT COMPLETED|Overall Study||28
4977138|NCT02561195|12241929|P4|NOT COMPLETED|Overall Study||26
4977139|NCT02561195|12241930|P3|NOT COMPLETED|Overall Study||6
4977140|NCT02561195|12241931|P2|NOT COMPLETED|Overall Study||22
4977141|NCT02561195|12241932|P1|NOT COMPLETED|Overall Study||23
4977142|NCT02561195|12241927|P6|COMPLETED|Overall Study||51
4977143|NCT02561195|12241928|P5|COMPLETED|Overall Study||155
4977144|NCT02561195|12241929|P4|COMPLETED|Overall Study||157
4977145|NCT02561195|12241930|P3|COMPLETED|Overall Study||55
4977146|NCT02561195|12241931|P2|COMPLETED|Overall Study||162
4977147|NCT02561195|12241932|P1|COMPLETED|Overall Study||160
4977148|NCT02561195|12241927|P6|Treated|Overall Study||61
4977149|NCT02561195|12241928|P5|Treated|Overall Study||183
4977150|NCT02561195|12241929|P4|Treated|Overall Study||183
4977151|NCT02561195|12241930|P3|Treated|Overall Study||61
4977152|NCT02561195|12241931|P2|Treated|Overall Study||184
4977153|NCT02561195|12241932|P1|Treated|Overall Study||182
4977154|NCT02561195|12241927|P6|STARTED|Overall Study||61
4977155|NCT02561195|12241928|P5|STARTED|Overall Study||183
4977156|NCT02561195|12241929|P4|STARTED|Overall Study||183
4977157|NCT02561195|12241930|P3|STARTED|Overall Study||61
4977158|NCT02561195|12241931|P2|STARTED|Overall Study||184
4977159|NCT02561195|12241932|P1|STARTED|Overall Study||183
4977160|NCT02561156|12242093|P13|NOT COMPLETED|Part 2||0
4977161|NCT02561156|12242094|P12|NOT COMPLETED|Part 2||1
4977162|NCT02561156|12242095|P11|NOT COMPLETED|Part 2||0
4977163|NCT02561156|12242096|P10|NOT COMPLETED|Part 2||0
4977164|NCT02561156|12242097|P9|NOT COMPLETED|Part 2||0
4977165|NCT02561156|12242098|P8|NOT COMPLETED|Part 2||0
4977166|NCT02561156|12242099|P7|NOT COMPLETED|Part 2||0
4977167|NCT02561156|12242100|P6|NOT COMPLETED|Part 2||0
4977168|NCT02561156|12242101|P5|NOT COMPLETED|Part 2||0
4977169|NCT02561156|12242102|P4|NOT COMPLETED|Part 2||0
4977170|NCT02561156|12242103|P3|NOT COMPLETED|Part 2||0
4977171|NCT02561156|12242104|P2|NOT COMPLETED|Part 2||0
4977172|NCT02561156|12242105|P1|NOT COMPLETED|Part 2||0
4977173|NCT02561156|12242093|P13|COMPLETED|Part 2||6
4977174|NCT02561156|12242094|P12|COMPLETED|Part 2||5
4977175|NCT02561156|12242095|P11|COMPLETED|Part 2||6
4977176|NCT02561156|12242096|P10|COMPLETED|Part 2||6
4977177|NCT02561156|12242097|P9|COMPLETED|Part 2||6
4977178|NCT02561156|12242098|P8|COMPLETED|Part 2||10
4977179|NCT02561156|12242099|P7|COMPLETED|Part 2||0
4977180|NCT02561156|12242100|P6|COMPLETED|Part 2||0
4977181|NCT02561156|12242101|P5|COMPLETED|Part 2||0
4977182|NCT02561156|12242102|P4|COMPLETED|Part 2||0
4977183|NCT02561156|12242103|P3|COMPLETED|Part 2||0
4977184|NCT02561156|12242104|P2|COMPLETED|Part 2||0
4977185|NCT02561156|12242105|P1|COMPLETED|Part 2||0
4977186|NCT02561156|12242093|P13|STARTED|Part 2||6
4977187|NCT02561156|12242094|P12|STARTED|Part 2||6
4977188|NCT02561156|12242095|P11|STARTED|Part 2||6
4977189|NCT02561156|12242096|P10|STARTED|Part 2||6
4977190|NCT02561156|12242097|P9|STARTED|Part 2||6
4977191|NCT02561156|12242098|P8|STARTED|Part 2||10
4977192|NCT02561156|12242099|P7|STARTED|Part 2||0
4977193|NCT02561156|12242100|P6|STARTED|Part 2||0
4977194|NCT02561156|12242101|P5|STARTED|Part 2||0
4977195|NCT02561156|12242102|P4|STARTED|Part 2||0
4977196|NCT02561156|12242103|P3|STARTED|Part 2||0
4977197|NCT02561156|12242104|P2|STARTED|Part 2||0
4977198|NCT02561156|12242105|P1|STARTED|Part 2||0
4977199|NCT02561156|12242093|P13|NOT COMPLETED|Part 1||0
4977200|NCT02561156|12242094|P12|NOT COMPLETED|Part 1||0
4977201|NCT02561156|12242095|P11|NOT COMPLETED|Part 1||0
4977202|NCT02561156|12242096|P10|NOT COMPLETED|Part 1||0
4977203|NCT02561156|12242097|P9|NOT COMPLETED|Part 1||0
4977204|NCT02561156|12242098|P8|NOT COMPLETED|Part 1||0
4977205|NCT02561156|12242099|P7|NOT COMPLETED|Part 1||0
4977206|NCT02561156|12242100|P6|NOT COMPLETED|Part 1||0
4977207|NCT02561156|12242101|P5|NOT COMPLETED|Part 1||0
4977208|NCT02561156|12242102|P4|NOT COMPLETED|Part 1||0
4977209|NCT02561156|12242103|P3|NOT COMPLETED|Part 1||0
4977210|NCT02561156|12242104|P2|NOT COMPLETED|Part 1||0
4977211|NCT02561156|12242105|P1|NOT COMPLETED|Part 1||0
4977212|NCT02561156|12242093|P13|COMPLETED|Part 1||0
4977213|NCT02561156|12242094|P12|COMPLETED|Part 1||0
4977214|NCT02561156|12242095|P11|COMPLETED|Part 1||0
4977215|NCT02561156|12242096|P10|COMPLETED|Part 1||0
4977216|NCT02561156|12242097|P9|COMPLETED|Part 1||0
4977217|NCT02561156|12242098|P8|COMPLETED|Part 1||0
4977218|NCT02561156|12242099|P7|COMPLETED|Part 1||6
4977219|NCT02561156|12242100|P6|COMPLETED|Part 1||6
4977220|NCT02561156|12242101|P5|COMPLETED|Part 1||6
4977221|NCT02561156|12242102|P4|COMPLETED|Part 1||6
4977222|NCT02561156|12242103|P3|COMPLETED|Part 1||6
4977223|NCT02561156|12242104|P2|COMPLETED|Part 1||6
4977224|NCT02561156|12242105|P1|COMPLETED|Part 1||12
4977225|NCT02561156|12242093|P13|STARTED|Part 1||0
4977226|NCT02561156|12242094|P12|STARTED|Part 1||0
4977227|NCT02561156|12242095|P11|STARTED|Part 1||0
4977228|NCT02561156|12242096|P10|STARTED|Part 1||0
4977229|NCT02561156|12242097|P9|STARTED|Part 1||0
4977230|NCT02561156|12242098|P8|STARTED|Part 1||0
4977231|NCT02561156|12242099|P7|STARTED|Part 1||6
4977232|NCT02561156|12242100|P6|STARTED|Part 1||6
4977233|NCT02561156|12242101|P5|STARTED|Part 1||6
4977234|NCT02561156|12242102|P4|STARTED|Part 1||6
4977235|NCT02561156|12242103|P3|STARTED|Part 1||6
4977236|NCT02561156|12242104|P2|STARTED|Part 1||6
4977237|NCT02561156|12242105|P1|STARTED|Part 1||12
4977238|NCT02561078|12242277|P2|NOT COMPLETED|Overall Study||25
4977239|NCT02561078|12242278|P1|NOT COMPLETED|Overall Study||30
4977240|NCT02561078|12242277|P2|COMPLETED|Overall Study||186
4977241|NCT02561078|12242278|P1|COMPLETED|Overall Study||179
4977242|NCT02561078|12242277|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
4977243|NCT02561078|12242278|P1|Received at Least 1 Dose of Study Drug|Overall Study||208
4977244|NCT02561078|12242277|P2|STARTED|Overall Study||211
4977245|NCT02561078|12242278|P1|STARTED|Overall Study||209
4977246|NCT02560922|12242302|P2|NOT COMPLETED|Overall Study||12
4977247|NCT02560922|12242303|P1|NOT COMPLETED|Overall Study||26
4977248|NCT02560922|12242302|P2|COMPLETED|Overall Study||112
4977249|NCT02560922|12242303|P1|COMPLETED|Overall Study||98
4977250|NCT02560922|12242302|P2|STARTED|Overall Study||124
4977251|NCT02560922|12242303|P1|STARTED|Overall Study||124
4977252|NCT02560779|12242329|P2|NOT COMPLETED|Overall Study||0
4977253|NCT02560779|12242330|P1|NOT COMPLETED|Overall Study||0
4977254|NCT02560779|12242329|P2|COMPLETED|Overall Study||13
4977255|NCT02560779|12242330|P1|COMPLETED|Overall Study||14
4977256|NCT02560779|12242329|P2|STARTED|Overall Study||13
4977257|NCT02560779|12242330|P1|STARTED|Overall Study||14
4977258|NCT02560753|12242346|P4|NOT COMPLETED|Overall Study||0
4977259|NCT02560753|12242347|P3|NOT COMPLETED|Overall Study||1
4977260|NCT02560753|12242348|P2|NOT COMPLETED|Overall Study||0
4977261|NCT02560753|12242349|P1|NOT COMPLETED|Overall Study||1
4977262|NCT02560753|12242346|P4|COMPLETED|Overall Study||8
4977263|NCT02560753|12242347|P3|COMPLETED|Overall Study||9
4977264|NCT02560753|12242348|P2|COMPLETED|Overall Study||9
4977265|NCT02560753|12242349|P1|COMPLETED|Overall Study||8
4977266|NCT02560753|12242346|P4|STARTED|Overall Study||8
4977267|NCT02560753|12242347|P3|STARTED|Overall Study||10
4977268|NCT02560753|12242348|P2|STARTED|Overall Study||9
4977269|NCT02560753|12242349|P1|STARTED|Overall Study||9
4977270|NCT02560701|12242377|P2|NOT COMPLETED|Overall Study||51466
4977271|NCT02560701|12242378|P1|NOT COMPLETED|Overall Study||4543
4977272|NCT02560701|12242377|P2|COMPLETED|Overall Study||37776
4977273|NCT02560701|12242378|P1|COMPLETED|Overall Study||3517
4977274|NCT02560701|12242377|P2|Matched Cohort|Overall Study||37776
4977275|NCT02560701|12242378|P1|Matched Cohort|Overall Study||3517
4977276|NCT02560701|12242377|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
4977277|NCT02560701|12242378|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
4977278|NCT02560701|12242377|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
4977279|NCT02560701|12242378|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
4977280|NCT02560701|12242377|P2|Carve Out|Overall Study||88729
4977281|NCT02560701|12242378|P1|Carve Out|Overall Study||8060
4977282|NCT02560701|12242377|P2|STARTED|Overall Study||89242
4977283|NCT02560701|12242378|P1|STARTED|Overall Study||8060
4977284|NCT02560584|12242394|P1|NOT COMPLETED|Overall Study||0
4977285|NCT02560584|12242394|P1|COMPLETED|Overall Study||304
4977286|NCT02560584|12242394|P1|STARTED|Overall Study||304
4977287|NCT02560493|12242403|P2|NOT COMPLETED|Overall Study||0
4977288|NCT02560493|12242404|P1|NOT COMPLETED|Overall Study||1
4977289|NCT02560493|12242403|P2|COMPLETED|Overall Study||23
4977290|NCT02560493|12242404|P1|COMPLETED|Overall Study||22
4977291|NCT02560493|12242403|P2|STARTED|Overall Study||23
4977292|NCT02560493|12242404|P1|STARTED|Overall Study||23
4977293|NCT02560389|12242427|P3|NOT COMPLETED|Overall Study||2
4977294|NCT02560389|12242428|P2|NOT COMPLETED|Overall Study||3
4977295|NCT02560389|12242429|P1|NOT COMPLETED|Overall Study||1
4977296|NCT02560389|12242427|P3|COMPLETED|Overall Study||27
4977297|NCT02560389|12242428|P2|COMPLETED|Overall Study||25
4977298|NCT02560389|12242429|P1|COMPLETED|Overall Study||33
4977299|NCT02560389|12242427|P3|STARTED|Overall Study||29
4977300|NCT02560389|12242428|P2|STARTED|Overall Study||28
4977301|NCT02560389|12242429|P1|STARTED|Overall Study||34
4977302|NCT02560324|12242445|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
4977303|NCT02560324|12242446|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
4977304|NCT02560324|12242445|P2|COMPLETED|Period 2 (2 Weeks)||21
4977305|NCT02560324|12242446|P1|COMPLETED|Period 2 (2 Weeks)||22
4977306|NCT02560324|12242445|P2|STARTED|Period 2 (2 Weeks)||23
4977307|NCT02560324|12242446|P1|STARTED|Period 2 (2 Weeks)||23
4977308|NCT02560324|12242445|P2|NOT COMPLETED|Washout (2 Weeks)||2
4977309|NCT02560324|12242446|P1|NOT COMPLETED|Washout (2 Weeks)||0
4977310|NCT02560324|12242445|P2|COMPLETED|Washout (2 Weeks)||23
4977311|NCT02560324|12242446|P1|COMPLETED|Washout (2 Weeks)||23
4977312|NCT02560324|12242445|P2|STARTED|Washout (2 Weeks)||25
4977313|NCT02560324|12242446|P1|STARTED|Washout (2 Weeks)||23
4977314|NCT02560324|12242445|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
4977315|NCT02560324|12242446|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
4977316|NCT02560324|12242445|P2|COMPLETED|Period 1 (2 Weeks)||25
4977317|NCT02560324|12242446|P1|COMPLETED|Period 1 (2 Weeks)||23
4977318|NCT02560324|12242445|P2|STARTED|Period 1 (2 Weeks)||34
4977319|NCT02560324|12242446|P1|STARTED|Period 1 (2 Weeks)||35
4977320|NCT02560051|12242463|P3|NOT COMPLETED|Overall Study||1
4977321|NCT02560051|12242464|P2|NOT COMPLETED|Overall Study||4
4977322|NCT02560051|12242465|P1|NOT COMPLETED|Overall Study||3
4977323|NCT02560051|12242463|P3|COMPLETED|Overall Study||4
4977324|NCT02560051|12242464|P2|COMPLETED|Overall Study||4
4977325|NCT02560051|12242465|P1|COMPLETED|Overall Study||3
4977326|NCT02560051|12242463|P3|STARTED|Overall Study||5
4977327|NCT02560051|12242464|P2|STARTED|Overall Study||8
4977328|NCT02560051|12242465|P1|STARTED|Overall Study||6
4977329|NCT02560038|12242521|P1|NOT COMPLETED|Overall Study||2
4977330|NCT02560038|12242521|P1|COMPLETED|Overall Study||1
4977331|NCT02560038|12242521|P1|STARTED|Overall Study||3
4977332|NCT02560025|12242527|P1|NOT COMPLETED|Overall Study||3
4977333|NCT02560025|12242527|P1|COMPLETED|Overall Study||39
4977334|NCT02560025|12242527|P1|STARTED|Overall Study||42
4977335|NCT02560012|12242536|P1|NOT COMPLETED|Overall Study||2
4977336|NCT02560012|12242536|P1|COMPLETED|Overall Study||1
4977337|NCT02560012|12242536|P1|STARTED|Overall Study||3
4977338|NCT02559895|12242544|P4|NOT COMPLETED|Overall Study||60
4977339|NCT02559895|12242545|P3|NOT COMPLETED|Overall Study||54
4977340|NCT02559895|12242546|P2|NOT COMPLETED|Overall Study||53
4977341|NCT02559895|12242547|P1|NOT COMPLETED|Overall Study||55
4977342|NCT02559895|12242544|P4|COMPLETED|Overall Study||165
4977343|NCT02559895|12242545|P3|COMPLETED|Overall Study||170
4977344|NCT02559895|12242546|P2|COMPLETED|Overall Study||172
4977345|NCT02559895|12242547|P1|COMPLETED|Overall Study||169
4977346|NCT02559895|12242544|P4|Participants Treated|Overall Study||222
4977347|NCT02559895|12242545|P3|Participants Treated|Overall Study||223
4977348|NCT02559895|12242546|P2|Participants Treated|Overall Study||221
4977349|NCT02559895|12242547|P1|Participants Treated|Overall Study||222
4977350|NCT02559895|12242544|P4|STARTED|Overall Study||225
4977351|NCT02559895|12242545|P3|STARTED|Overall Study||224
4977352|NCT02559895|12242546|P2|STARTED|Overall Study||225
4977353|NCT02559895|12242547|P1|STARTED|Overall Study||224
4977354|NCT02559713|12242637|P1|NOT COMPLETED|Overall Study||1
4977355|NCT02559713|12242637|P1|COMPLETED|Overall Study||10
4977356|NCT02559713|12242637|P1|Pharmacokinetic Set|Overall Study||11
4977357|NCT02559713|12242637|P1|Safety Set|Overall Study||11
4977358|NCT02559713|12242637|P1|STARTED|Overall Study||11
4977359|NCT02559687|12242647|P1|NOT COMPLETED|Overall Study||121
4977360|NCT02559687|12242647|P1|COMPLETED|Overall Study||0
4977361|NCT02559687|12242647|P1|STARTED|Overall Study||121
4977362|NCT02559622|12242660|P4|NOT COMPLETED|Overall Study||3
4977363|NCT02559622|12242661|P3|NOT COMPLETED|Overall Study||2
4977364|NCT02559622|12242662|P2|NOT COMPLETED|Overall Study||5
4977365|NCT02559622|12242663|P1|NOT COMPLETED|Overall Study||1
4977366|NCT02559622|12242660|P4|COMPLETED|Overall Study||20
4977367|NCT02559622|12242661|P3|COMPLETED|Overall Study||24
4977368|NCT02559622|12242662|P2|COMPLETED|Overall Study||49
4977369|NCT02559622|12242663|P1|COMPLETED|Overall Study||47
4977370|NCT02559622|12242660|P4|STARTED|Overall Study||23
4977371|NCT02559622|12242661|P3|STARTED|Overall Study||26
4977372|NCT02559622|12242662|P2|STARTED|Overall Study||54
4977373|NCT02559622|12242663|P1|STARTED|Overall Study||48
4977374|NCT02559570|12242747|P5|NOT COMPLETED|Overall Study||2
4977375|NCT02559570|12242748|P4|NOT COMPLETED|Overall Study||3
4977376|NCT02559570|12242749|P3|NOT COMPLETED|Overall Study||2
4977377|NCT02559570|12242750|P2|NOT COMPLETED|Overall Study||2
4977378|NCT02559570|12242751|P1|NOT COMPLETED|Overall Study||2
4977379|NCT02559570|12242747|P5|COMPLETED|Overall Study||14
4977380|NCT02559570|12242748|P4|COMPLETED|Overall Study||36
4977381|NCT02559570|12242749|P3|COMPLETED|Overall Study||39
4977382|NCT02559570|12242750|P2|COMPLETED|Overall Study||34
4977383|NCT02559570|12242751|P1|COMPLETED|Overall Study||39
4977384|NCT02559570|12242747|P5|STARTED|Overall Study||16
4977385|NCT02559570|12242748|P4|STARTED|Overall Study||39
4977386|NCT02559570|12242749|P3|STARTED|Overall Study||41
4977387|NCT02559570|12242750|P2|STARTED|Overall Study||36
4977388|NCT02559570|12242751|P1|STARTED|Overall Study||41
4977389|NCT02559414|12242789|P3|NOT COMPLETED|Overall Study||2
4977390|NCT02559414|12242790|P2|NOT COMPLETED|Overall Study||2
4977391|NCT02559414|12242791|P1|NOT COMPLETED|Overall Study||1
4977392|NCT02559414|12242789|P3|COMPLETED|Overall Study||20
4977393|NCT02559414|12242790|P2|COMPLETED|Overall Study||20
4977394|NCT02559414|12242791|P1|COMPLETED|Overall Study||10
4977395|NCT02559414|12242789|P3|STARTED|Overall Study||22
4977396|NCT02559414|12242790|P2|STARTED|Overall Study||22
4977397|NCT02559414|12242791|P1|STARTED|Overall Study||11
4977398|NCT02559310|12242831|P2|NOT COMPLETED|Overall Study||19
4977399|NCT02559310|12242832|P1|NOT COMPLETED|Overall Study||27
4977400|NCT02559310|12242831|P2|COMPLETED|Overall Study||256
4977401|NCT02559310|12242832|P1|COMPLETED|Overall Study||249
4977402|NCT02559310|12242831|P2|STARTED|Overall Study||275
4977403|NCT02559310|12242832|P1|STARTED|Overall Study||276
4977404|NCT02559206|12242850|P8|NOT COMPLETED|Overall Study||9
4977405|NCT02559206|12242851|P7|NOT COMPLETED|Overall Study||6
4977406|NCT02559206|12242852|P6|NOT COMPLETED|Overall Study||14
4977407|NCT02559206|12242853|P5|NOT COMPLETED|Overall Study||12
4977408|NCT02559206|12242854|P4|NOT COMPLETED|Overall Study||14
4977409|NCT02559206|12242855|P3|NOT COMPLETED|Overall Study||9
4977410|NCT02559206|12242856|P2|NOT COMPLETED|Overall Study||12
4977411|NCT02559206|12242857|P1|NOT COMPLETED|Overall Study||8
4977412|NCT02559206|12242850|P8|COMPLETED|Overall Study||57
4977413|NCT02559206|12242851|P7|COMPLETED|Overall Study||60
4977414|NCT02559206|12242852|P6|COMPLETED|Overall Study||53
4977415|NCT02559206|12242853|P5|COMPLETED|Overall Study||55
4977416|NCT02559206|12242854|P4|COMPLETED|Overall Study||53
4977417|NCT02559206|12242855|P3|COMPLETED|Overall Study||58
4977418|NCT02559206|12242856|P2|COMPLETED|Overall Study||54
4977419|NCT02559206|12242857|P1|COMPLETED|Overall Study||58
4977420|NCT02559206|12242850|P8|STARTED|Overall Study||66
4977421|NCT02559206|12242851|P7|STARTED|Overall Study||66
4977422|NCT02559206|12242852|P6|STARTED|Overall Study||67
4977423|NCT02559206|12242853|P5|STARTED|Overall Study||67
4977424|NCT02559206|12242854|P4|STARTED|Overall Study||67
4977425|NCT02559206|12242855|P3|STARTED|Overall Study||67
4977426|NCT02559206|12242856|P2|STARTED|Overall Study||66
4977427|NCT02559206|12242857|P1|STARTED|Overall Study||66
4977428|NCT02558894|12242899|P2|NOT COMPLETED|Overall Study||33
4977429|NCT02558894|12242900|P1|NOT COMPLETED|Overall Study||32
4977430|NCT02558894|12242899|P2|COMPLETED|Overall Study||0
4977431|NCT02558894|12242900|P1|COMPLETED|Overall Study||0
4977432|NCT02558894|12242899|P2|Patients Who Received IP|Overall Study||32
4977433|NCT02558894|12242900|P1|Patients Who Received IP|Overall Study||32
4977434|NCT02558894|12242899|P2|STARTED|Overall Study||33
4977435|NCT02558894|12242900|P1|STARTED|Overall Study||32
4977436|NCT02558829|12242928|P8|NOT COMPLETED|Overall Study||3
4977437|NCT02558829|12242929|P7|NOT COMPLETED|Overall Study||1
4977438|NCT02558829|12242930|P6|NOT COMPLETED|Overall Study||2
4977439|NCT02558829|12242931|P5|NOT COMPLETED|Overall Study||2
4977440|NCT02558829|12242932|P4|NOT COMPLETED|Overall Study||2
4977441|NCT02558829|12242933|P3|NOT COMPLETED|Overall Study||3
4977442|NCT02558829|12242934|P2|NOT COMPLETED|Overall Study||3
4977443|NCT02558829|12242935|P1|NOT COMPLETED|Overall Study||1
4977444|NCT02558829|12242928|P8|COMPLETED|Overall Study||8
4977445|NCT02558829|12242929|P7|COMPLETED|Overall Study||17
4977446|NCT02558829|12242930|P6|COMPLETED|Overall Study||24
4977447|NCT02558829|12242931|P5|COMPLETED|Overall Study||16
4977448|NCT02558829|12242932|P4|COMPLETED|Overall Study||16
4977449|NCT02558829|12242933|P3|COMPLETED|Overall Study||21
4977450|NCT02558829|12242934|P2|COMPLETED|Overall Study||18
4977451|NCT02558829|12242935|P1|COMPLETED|Overall Study||20
4977452|NCT02558829|12242928|P8|STARTED|Overall Study||11
4977453|NCT02558829|12242929|P7|STARTED|Overall Study||18
4977454|NCT02558829|12242930|P6|STARTED|Overall Study||26
4977455|NCT02558829|12242931|P5|STARTED|Overall Study||18
4977456|NCT02558829|12242932|P4|STARTED|Overall Study||18
4977457|NCT02558829|12242933|P3|STARTED|Overall Study||24
4977458|NCT02558829|12242934|P2|STARTED|Overall Study||21
4977459|NCT02558829|12242935|P1|STARTED|Overall Study||21
4977460|NCT02558790|12242961|P1|NOT COMPLETED|Overall Study||7
4977461|NCT02558790|12242961|P1|COMPLETED|Overall Study||13
4977462|NCT02558790|12242961|P1|Treated|Overall Study||15
4977463|NCT02558790|12242961|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
4977464|NCT02558400|12242968|P3|NOT COMPLETED|Overall Study||33
4977465|NCT02558400|12242969|P2|NOT COMPLETED|Overall Study||96
4977466|NCT02558400|12242970|P1|NOT COMPLETED|Overall Study||79
4977467|NCT02558400|12242968|P3|COMPLETED|Overall Study||203
4977468|NCT02558400|12242969|P2|COMPLETED|Overall Study||148
4977469|NCT02558400|12242970|P1|COMPLETED|Overall Study||159
4977470|NCT02558400|12242968|P3|STARTED|Overall Study||236
4977471|NCT02558400|12242969|P2|STARTED|Overall Study||244
4977472|NCT02558400|12242970|P1|STARTED|Overall Study||238
4977473|NCT02558374|12242983|P2|NOT COMPLETED|Overall Study||43
4977474|NCT02558374|12242984|P1|NOT COMPLETED|Overall Study||108
4977475|NCT02558374|12242983|P2|COMPLETED|Overall Study||314
4977476|NCT02558374|12242984|P1|COMPLETED|Overall Study||243
4977477|NCT02558374|12242983|P2|STARTED|Overall Study||357
4977478|NCT02558374|12242984|P1|STARTED|Overall Study||351
4977479|NCT02557698|12242994|P2|NOT COMPLETED|Overall Study||0
4977480|NCT02557698|12242995|P1|NOT COMPLETED|Overall Study||0
4977481|NCT02557698|12242994|P2|COMPLETED|Overall Study||30
4977482|NCT02557698|12242995|P1|COMPLETED|Overall Study||30
4977483|NCT02557698|12242994|P2|STARTED|Overall Study||30
4977484|NCT02557698|12242995|P1|STARTED|Overall Study||30
4977485|NCT02557646|12243059|P1|NOT COMPLETED|Overall Study||276
4977486|NCT02557646|12243059|P1|COMPLETED|Overall Study||417
4977487|NCT02557646|12243059|P1|STARTED|Overall Study||693
4977488|NCT02557555|12243077|P1|NOT COMPLETED|Overall Study||0
4977489|NCT02557555|12243077|P1|COMPLETED|Overall Study||100
4977490|NCT02557555|12243077|P1|STARTED|Overall Study||100
4977491|NCT02557516|12243086|P4|NOT COMPLETED|Overall Study||9
4977492|NCT02557516|12243087|P3|NOT COMPLETED|Overall Study||4
4977493|NCT02557516|12243088|P2|NOT COMPLETED|Overall Study||5
4977494|NCT02557516|12243089|P1|NOT COMPLETED|Overall Study||1
4977495|NCT02557516|12243086|P4|COMPLETED|Overall Study||0
4977496|NCT02557516|12243087|P3|COMPLETED|Overall Study||0
4977497|NCT02557516|12243088|P2|COMPLETED|Overall Study||1
4977498|NCT02557516|12243089|P1|COMPLETED|Overall Study||2
4977499|NCT02557516|12243086|P4|STARTED|Overall Study||9
4977500|NCT02557516|12243087|P3|STARTED|Overall Study||4
4977501|NCT02557516|12243088|P2|STARTED|Overall Study||6
4977502|NCT02557516|12243089|P1|STARTED|Overall Study||3
4977503|NCT02557399|12243110|P2|NOT COMPLETED|Overall Study||8
4977504|NCT02557399|12243111|P1|NOT COMPLETED|Overall Study||7
4977505|NCT02557399|12243110|P2|COMPLETED|Overall Study||169
4977506|NCT02557399|12243111|P1|COMPLETED|Overall Study||165
4977507|NCT02557399|12243110|P2|STARTED|Overall Study||177
4977508|NCT02557399|12243111|P1|STARTED|Overall Study||172
4977509|NCT02557035|12243145|P2|NOT COMPLETED|Overall Study||9
4977510|NCT02557035|12243146|P1|NOT COMPLETED|Overall Study||7
4977511|NCT02557035|12243145|P2|COMPLETED|Overall Study||206
4977512|NCT02557035|12243146|P1|COMPLETED|Overall Study||218
4977513|NCT02557035|12243145|P2|STARTED|Overall Study||215
4977514|NCT02557035|12243146|P1|STARTED|Overall Study||225
4977515|NCT02556918|12243170|P2|NOT COMPLETED|Overall Study||10
4977516|NCT02556918|12243171|P1|NOT COMPLETED|Overall Study||9
4977517|NCT02556918|12243170|P2|COMPLETED|Overall Study||91
4977518|NCT02556918|12243171|P1|COMPLETED|Overall Study||91
4977519|NCT02556918|12243170|P2|STARTED|Overall Study||101
4977520|NCT02556918|12243171|P1|STARTED|Overall Study||100
4977521|NCT02556801|12243231|P4|NOT COMPLETED|Overall Study||5
4977522|NCT02556801|12243232|P3|NOT COMPLETED|Overall Study||4
4977523|NCT02556801|12243233|P2|NOT COMPLETED|Overall Study||7
4977524|NCT02556801|12243234|P1|NOT COMPLETED|Overall Study||2
4977525|NCT02556801|12243231|P4|COMPLETED|Overall Study||37
4977526|NCT02556801|12243232|P3|COMPLETED|Overall Study||38
4977527|NCT02556801|12243233|P2|COMPLETED|Overall Study||35
4977528|NCT02556801|12243234|P1|COMPLETED|Overall Study||40
4977529|NCT02556801|12243231|P4|STARTED|Overall Study||42
4977530|NCT02556801|12243232|P3|STARTED|Overall Study||42
4977531|NCT02556801|12243233|P2|STARTED|Overall Study||42
4977532|NCT02556801|12243234|P1|STARTED|Overall Study||42
4977533|NCT02556788|12243286|P2|NOT COMPLETED|Overall Study||37
4977534|NCT02556788|12243287|P1|NOT COMPLETED|Overall Study||44
4977535|NCT02556788|12243286|P2|COMPLETED|Overall Study||573
4977536|NCT02556788|12243287|P1|COMPLETED|Overall Study||558
4977537|NCT02556788|12243286|P2|STARTED|Overall Study||610
4977538|NCT02556788|12243287|P1|STARTED|Overall Study||602
4977539|NCT02556632|12243296|P3|NOT COMPLETED|Overall Study||9
4977540|NCT02556632|12243297|P2|NOT COMPLETED|Overall Study||6
4977541|NCT02556632|12243298|P1|NOT COMPLETED|Overall Study||5
4977542|NCT02556632|12243296|P3|COMPLETED|Overall Study||53
4977543|NCT02556632|12243297|P2|COMPLETED|Overall Study||59
4977544|NCT02556632|12243298|P1|COMPLETED|Overall Study||59
4977545|NCT02556632|12243296|P3|STARTED|Overall Study||62
4977546|NCT02556632|12243297|P2|STARTED|Overall Study||65
4977547|NCT02556632|12243298|P1|STARTED|Overall Study||64
4977548|NCT02556554|12243315|P5|NOT COMPLETED|Overall Study||0
4977549|NCT02556554|12243316|P4|NOT COMPLETED|Overall Study||0
4977550|NCT02556554|12243317|P3|NOT COMPLETED|Overall Study||4
4977551|NCT02556554|12243318|P2|NOT COMPLETED|Overall Study||1
4977552|NCT02556554|12243319|P1|NOT COMPLETED|Overall Study||0
4977553|NCT02556554|12243315|P5|COMPLETED|Overall Study||14
4977554|NCT02556554|12243316|P4|COMPLETED|Overall Study||12
4977555|NCT02556554|12243317|P3|COMPLETED|Overall Study||15
4977556|NCT02556554|12243318|P2|COMPLETED|Overall Study||13
4977557|NCT02556554|12243319|P1|COMPLETED|Overall Study||8
4977558|NCT02556554|12243315|P5|STARTED|Overall Study||14
4977559|NCT02556554|12243316|P4|STARTED|Overall Study||12
4977560|NCT02556554|12243317|P3|STARTED|Overall Study||19
4977561|NCT02556554|12243318|P2|STARTED|Overall Study||14
4977562|NCT02556554|12243319|P1|STARTED|Overall Study||8
4977563|NCT02556333|12243334|P1|NOT COMPLETED|Overall Study||0
4977564|NCT02556333|12243334|P1|COMPLETED|Overall Study||1
4977565|NCT02556333|12243334|P1|STARTED|Overall Study||1
4977566|NCT02556307|12243338|P1|NOT COMPLETED|Overall Study||53
4977567|NCT02556307|12243338|P1|COMPLETED|Overall Study||217
4977568|NCT02556307|12243338|P1|Treated|Overall Study||268
4977569|NCT02556307|12243338|P1|STARTED|Overall Study||270
4977570|NCT02556255|12243348|P1|NOT COMPLETED|Overall Study||4
4977571|NCT02556255|12243348|P1|COMPLETED|Overall Study||46
4977572|NCT02556255|12243348|P1|STARTED|Overall Study||50
4977573|NCT02556203|12243363|P2|NOT COMPLETED|Overall Study||26
4977574|NCT02556203|12243364|P1|NOT COMPLETED|Overall Study||27
4977575|NCT02556203|12243363|P2|COMPLETED|Overall Study||792
4977576|NCT02556203|12243364|P1|COMPLETED|Overall Study||799
4977577|NCT02556203|12243363|P2|Received Treatment|Overall Study||807
4977578|NCT02556203|12243364|P1|Received Treatment|Overall Study||801
4977579|NCT02556203|12243363|P2|STARTED|Overall Study||818
4977580|NCT02556203|12243364|P1|STARTED|Overall Study||826
4977581|NCT02556177|12243386|P2|NOT COMPLETED|Overall Study||61
4977582|NCT02556177|12243387|P1|NOT COMPLETED|Overall Study||283
4977583|NCT02556177|12243386|P2|COMPLETED|Overall Study||91
4977584|NCT02556177|12243387|P1|COMPLETED|Overall Study||42
4977585|NCT02556177|12243386|P2|STARTED|Overall Study||152
4977586|NCT02556177|12243387|P1|STARTED|Overall Study||325
4977587|NCT02556138|12243395|P1|NOT COMPLETED|Overall Study||1
4977588|NCT02556138|12243395|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
4977589|NCT02556138|12243395|P1|STARTED|Overall Study||8
4977590|NCT02556112|12243404|P3|NOT COMPLETED|Overall Study||12
4977591|NCT02556112|12243405|P2|NOT COMPLETED|Overall Study||17
4977592|NCT02556112|12243406|P1|NOT COMPLETED|Overall Study||10
4977593|NCT02556112|12243404|P3|COMPLETED|Overall Study||30
4977594|NCT02556112|12243405|P2|COMPLETED|Overall Study||23
4977595|NCT02556112|12243406|P1|COMPLETED|Overall Study||30
4977596|NCT02556112|12243404|P3|STARTED|Overall Study||42
4977597|NCT02556112|12243405|P2|STARTED|Overall Study||40
4977598|NCT02556112|12243406|P1|STARTED|Overall Study||40
4977599|NCT02555878|12243431|P2|NOT COMPLETED|Overall Study||150
4977600|NCT02555878|12243432|P1|NOT COMPLETED|Overall Study||166
4977601|NCT02555878|12243431|P2|COMPLETED|Overall Study||270
4977602|NCT02555878|12243432|P1|COMPLETED|Overall Study||255
4977603|NCT02555878|12243431|P2|Treated|Overall Study||405
4977604|NCT02555878|12243432|P1|Treated|Overall Study||404
4977605|NCT02555878|12243431|P2|STARTED|Overall Study||420
4977606|NCT02555878|12243432|P1|STARTED|Overall Study||421
4977607|NCT02555722|12243464|P2|NOT COMPLETED|Month 3||0
4977608|NCT02555722|12243465|P1|NOT COMPLETED|Month 3||0
4977609|NCT02555722|12243464|P2|COMPLETED|Month 3||29
4977610|NCT02555722|12243465|P1|COMPLETED|Month 3||54
4977611|NCT02555722|12243464|P2|STARTED|Month 3||29
4977612|NCT02555722|12243465|P1|STARTED|Month 3||54
4977613|NCT02555722|12243464|P2|NOT COMPLETED|Month 2||0
4977614|NCT02555722|12243465|P1|NOT COMPLETED|Month 2||4
4977615|NCT02555722|12243464|P2|COMPLETED|Month 2||29
4977616|NCT02555722|12243465|P1|COMPLETED|Month 2||54
4977617|NCT02555722|12243464|P2|STARTED|Month 2||29
4977618|NCT02555722|12243465|P1|STARTED|Month 2||58
4977619|NCT02555722|12243464|P2|NOT COMPLETED|Month 1||0
4977620|NCT02555722|12243465|P1|NOT COMPLETED|Month 1||1
4977621|NCT02555722|12243464|P2|COMPLETED|Month 1||29
4977622|NCT02555722|12243465|P1|COMPLETED|Month 1||58
4977623|NCT02555722|12243464|P2|STARTED|Month 1||29
4977624|NCT02555722|12243465|P1|STARTED|Month 1||59
4977625|NCT02555722|12243464|P2|NOT COMPLETED|Week 2||1
4977626|NCT02555722|12243465|P1|NOT COMPLETED|Week 2||1
4977627|NCT02555722|12243464|P2|COMPLETED|Week 2||29
4977628|NCT02555722|12243465|P1|COMPLETED|Week 2||59
4977629|NCT02555722|12243464|P2|STARTED|Week 2||30
4977630|NCT02555722|12243465|P1|STARTED|Week 2||60
4977631|NCT02555722|12243464|P2|NOT COMPLETED|Week 1||0
4977632|NCT02555722|12243465|P1|NOT COMPLETED|Week 1||0
4977633|NCT02555722|12243464|P2|COMPLETED|Week 1||30
4977634|NCT02555722|12243465|P1|COMPLETED|Week 1||60
4977635|NCT02555722|12243464|P2|STARTED|Week 1||30
4977636|NCT02555722|12243465|P1|STARTED|Week 1||60
4977637|NCT02555722|12243464|P2|NOT COMPLETED|Lens Dispensed||0
4977638|NCT02555722|12243465|P1|NOT COMPLETED|Lens Dispensed||0
4977639|NCT02555722|12243464|P2|COMPLETED|Lens Dispensed||30
4977640|NCT02555722|12243465|P1|COMPLETED|Lens Dispensed||60
4977641|NCT02555722|12243464|P2|STARTED|Lens Dispensed||30
4977642|NCT02555722|12243465|P1|STARTED|Lens Dispensed||60
4977643|NCT02555683|12243650|P3|NOT COMPLETED|Overall Study||29
4977644|NCT02555683|12243651|P2|NOT COMPLETED|Overall Study||17
4977645|NCT02555683|12243652|P1|NOT COMPLETED|Overall Study||19
4977646|NCT02555683|12243650|P3|COMPLETED|Overall Study||269
4977647|NCT02555683|12243651|P2|COMPLETED|Overall Study||278
4977648|NCT02555683|12243652|P1|COMPLETED|Overall Study||282
4977649|NCT02555683|12243650|P3|FAS/SAF: Overall Population|Overall Study||298
4977650|NCT02555683|12243651|P2|FAS/SAF: Overall Population|Overall Study||293
4977651|NCT02555683|12243652|P1|FAS/SAF: Overall Population|Overall Study||299
4977652|NCT02555683|12243650|P3|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
4977653|NCT02555683|12243651|P2|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
4977654|NCT02555683|12243652|P1|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
4977655|NCT02555683|12243650|P3|STARTED|Overall Study||298
4977656|NCT02555683|12243651|P2|STARTED|Overall Study||295
4977657|NCT02555683|12243652|P1|STARTED|Overall Study||301
4977658|NCT02555657|12243683|P2|NOT COMPLETED|Overall Study||310
4977659|NCT02555657|12243684|P1|NOT COMPLETED|Overall Study||312
4977660|NCT02555657|12243683|P2|COMPLETED|Overall Study||0
4977661|NCT02555657|12243684|P1|COMPLETED|Overall Study||0
4977662|NCT02555657|12243683|P2|Treated|Overall Study||292
4977663|NCT02555657|12243684|P1|Treated|Overall Study||309
4977664|NCT02555657|12243683|P2|STARTED|Overall Study||310
4977665|NCT02555657|12243684|P1|STARTED|Overall Study||312
4977666|NCT02555631|12243722|P1|NOT COMPLETED|Overall Study||4
4977667|NCT02555631|12243722|P1|COMPLETED|Overall Study||25
4977668|NCT02555631|12243722|P1|STARTED|Overall Study||29
4977669|NCT02555618|12243731|P2|NOT COMPLETED|Overall Study||0
4977670|NCT02555618|12243732|P1|NOT COMPLETED|Overall Study||1
4977671|NCT02555618|12243731|P2|COMPLETED|Overall Study||200
4977672|NCT02555618|12243732|P1|COMPLETED|Overall Study||199
4977673|NCT02555618|12243731|P2|STARTED|Overall Study||200
4977674|NCT02555618|12243732|P1|STARTED|Overall Study||200
4977675|NCT02555371|12243774|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
4977676|NCT02555371|12243775|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
4977677|NCT02555371|12243776|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977678|NCT02555371|12243777|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977679|NCT02555371|12243778|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977680|NCT02555371|12243774|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
4977681|NCT02555371|12243775|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
4977682|NCT02555371|12243776|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977683|NCT02555371|12243777|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977684|NCT02555371|12243778|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
4977685|NCT02555371|12243774|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
4977686|NCT02555371|12243775|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
4977687|NCT02555371|12243776|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
4977688|NCT02555371|12243777|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
4977689|NCT02555371|12243778|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
4977690|NCT02555371|12243774|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
4977691|NCT02555371|12243775|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
4977692|NCT02555371|12243776|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
4977693|NCT02555371|12243777|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
4977694|NCT02555371|12243778|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
4977695|NCT02555371|12243774|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
4977696|NCT02555371|12243775|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
4977697|NCT02555371|12243776|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
4977698|NCT02555371|12243777|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
4977699|NCT02555371|12243778|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
4977700|NCT02555371|12243774|P5|STARTED|Part C (DB Period: Up to 52W)||0
4977701|NCT02555371|12243775|P4|STARTED|Part C (DB Period: Up to 52W)||0
4977702|NCT02555371|12243776|P3|STARTED|Part C (DB Period: Up to 52W)||144
4977703|NCT02555371|12243777|P2|STARTED|Part C (DB Period: Up to 52W)||151
4977704|NCT02555371|12243778|P1|STARTED|Part C (DB Period: Up to 52W)||0
4977705|NCT02555371|12243774|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977706|NCT02555371|12243775|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977707|NCT02555371|12243776|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977708|NCT02555371|12243777|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977709|NCT02555371|12243778|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
4977710|NCT02555371|12243774|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977711|NCT02555371|12243775|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977712|NCT02555371|12243776|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977713|NCT02555371|12243777|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977714|NCT02555371|12243778|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
4977715|NCT02555371|12243774|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977716|NCT02555371|12243775|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977717|NCT02555371|12243776|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977718|NCT02555371|12243777|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
4977719|NCT02555371|12243778|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
4977720|NCT02555306|12243797|P4|NOT COMPLETED|Overall Study||0
4977721|NCT02555306|12243798|P3|NOT COMPLETED|Overall Study||0
4977722|NCT02555306|12243799|P2|NOT COMPLETED|Overall Study||0
4977723|NCT02555306|12243800|P1|NOT COMPLETED|Overall Study||0
4977724|NCT02555306|12243797|P4|COMPLETED|Overall Study||3
4977725|NCT02555306|12243798|P3|COMPLETED|Overall Study||3
4977726|NCT02555306|12243799|P2|COMPLETED|Overall Study||3
4977727|NCT02555306|12243800|P1|COMPLETED|Overall Study||3
4977728|NCT02555306|12243797|P4|STARTED|Overall Study||3
4977729|NCT02555306|12243798|P3|STARTED|Overall Study||3
4977730|NCT02555306|12243799|P2|STARTED|Overall Study||3
4977731|NCT02555306|12243800|P1|STARTED|Overall Study||3
4977732|NCT02555228|12243816|P2|NOT COMPLETED|Overall Study||0
4977733|NCT02555228|12243817|P1|NOT COMPLETED|Overall Study||0
4977734|NCT02555228|12243816|P2|COMPLETED|Overall Study|29th October 2015|27
4977735|NCT02555228|12243817|P1|COMPLETED|Overall Study|19th November 2015|27
4977736|NCT02555228|12243816|P2|STARTED|Overall Study|14th August 2015|27
4977737|NCT02555228|12243817|P1|STARTED|Overall Study|20th August 2015|27
4977738|NCT02555215|12243829|P1|NOT COMPLETED|Overall Study||3
4977739|NCT02555215|12243829|P1|COMPLETED|Overall Study||17
4977740|NCT02555215|12243829|P1|STARTED|Overall Study||20
4977741|NCT02554981|12243840|P1|NOT COMPLETED|Overall Study||5
4977742|NCT02554981|12243840|P1|COMPLETED|Overall Study||46
4977743|NCT02554981|12243840|P1|STARTED|Overall Study||51
4977744|NCT02554929|12243866|P2|NOT COMPLETED|Overall Study||12
4977745|NCT02554929|12243867|P1|NOT COMPLETED|Overall Study||6
4977746|NCT02554929|12243866|P2|COMPLETED|Overall Study||32
4977747|NCT02554929|12243867|P1|COMPLETED|Overall Study||40
4977748|NCT02554929|12243866|P2|Per Protocol 6 Month Follow-up|Overall Study||32
4977749|NCT02554929|12243867|P1|Per Protocol 6 Month Follow-up|Overall Study||40
4977750|NCT02554929|12243866|P2|Per Protocol Post-Intervention|Overall Study||36
4977751|NCT02554929|12243867|P1|Per Protocol Post-Intervention|Overall Study||42
4977752|NCT02554929|12243866|P2|Per Protocol Received Intervention|Overall Study||36
4977753|NCT02554929|12243867|P1|Per Protocol Received Intervention|Overall Study||44
4977754|NCT02554929|12243866|P2|STARTED|Overall Study||44
4977755|NCT02554929|12243867|P1|STARTED|Overall Study||46
4977756|NCT02554890|12243885|P2|NOT COMPLETED|Open-label||52
4977757|NCT02554890|12243886|P1|NOT COMPLETED|Open-label||0
4977758|NCT02554890|12243885|P2|COMPLETED|Open-label||835
4977759|NCT02554890|12243886|P1|COMPLETED|Open-label||0
4977760|NCT02554890|12243885|P2|STARTED|Open-label||887
4977761|NCT02554890|12243886|P1|STARTED|Open-label||0
4977762|NCT02554890|12243885|P2|NOT COMPLETED|Double-blind||91
4977763|NCT02554890|12243886|P1|NOT COMPLETED|Double-blind||96
4977764|NCT02554890|12243885|P2|COMPLETED|Double-blind||352
4977765|NCT02554890|12243886|P1|COMPLETED|Double-blind||348
4977766|NCT02554890|12243885|P2|Treated Patients|Double-blind||439
4977767|NCT02554890|12243886|P1|Treated Patients|Double-blind||436
4977768|NCT02554890|12243885|P2|STARTED|Double-blind||443
4977769|NCT02554890|12243886|P1|STARTED|Double-blind||444
4977770|NCT02554877|12243914|P4|NOT COMPLETED|Overall Study||7
4977771|NCT02554877|12243915|P3|NOT COMPLETED|Overall Study||6
4977772|NCT02554877|12243916|P2|NOT COMPLETED|Overall Study||7
4977773|NCT02554877|12243917|P1|NOT COMPLETED|Overall Study||12
4977774|NCT02554877|12243914|P4|COMPLETED|Overall Study||45
4977775|NCT02554877|12243915|P3|COMPLETED|Overall Study||46
4977776|NCT02554877|12243916|P2|COMPLETED|Overall Study||44
4977777|NCT02554877|12243917|P1|COMPLETED|Overall Study||39
4977778|NCT02554877|12243914|P4|STARTED|Overall Study||52
4977779|NCT02554877|12243915|P3|STARTED|Overall Study||52
4977780|NCT02554877|12243916|P2|STARTED|Overall Study||51
4977781|NCT02554877|12243917|P1|STARTED|Overall Study||51
4977782|NCT02554799|12243981|P2|NOT COMPLETED|Overall Study||0
4977783|NCT02554799|12243982|P1|NOT COMPLETED|Overall Study||0
4977784|NCT02554799|12243981|P2|COMPLETED|Overall Study||9
4977785|NCT02554799|12243982|P1|COMPLETED|Overall Study||9
4977786|NCT02554799|12243981|P2|STARTED|Overall Study||9
4977787|NCT02554799|12243982|P1|STARTED|Overall Study||9
4977788|NCT02554786|12244005|P5|NOT COMPLETED|Overall Study||30
4977789|NCT02554786|12244006|P4|NOT COMPLETED|Overall Study||41
4977790|NCT02554786|12244007|P3|NOT COMPLETED|Overall Study||30
4977791|NCT02554786|12244008|P2|NOT COMPLETED|Overall Study||26
4977792|NCT02554786|12244009|P1|NOT COMPLETED|Overall Study||35
4977793|NCT02554786|12244005|P5|COMPLETED|Overall Study||416
4977794|NCT02554786|12244006|P4|COMPLETED|Overall Study||403
4977795|NCT02554786|12244007|P3|COMPLETED|Overall Study||412
4977796|NCT02554786|12244008|P2|COMPLETED|Overall Study||413
4977797|NCT02554786|12244009|P1|COMPLETED|Overall Study||410
4977798|NCT02554786|12244005|P5|STARTED|Overall Study||446
4977799|NCT02554786|12244006|P4|STARTED|Overall Study||444
4977800|NCT02554786|12244007|P3|STARTED|Overall Study||442
4977801|NCT02554786|12244008|P2|STARTED|Overall Study||439
4977802|NCT02554786|12244009|P1|STARTED|Overall Study||445
4977803|NCT02554682|12244161|P10|NOT COMPLETED|Overall Study||2
4977804|NCT02554682|12244162|P9|NOT COMPLETED|Overall Study||2
4977805|NCT02554682|12244163|P8|NOT COMPLETED|Overall Study||6
4977806|NCT02554682|12244164|P7|NOT COMPLETED|Overall Study||6
4977807|NCT02554682|12244165|P6|NOT COMPLETED|Overall Study||1
4977808|NCT02554682|12244166|P5|NOT COMPLETED|Overall Study||2
4977809|NCT02554682|12244167|P4|NOT COMPLETED|Overall Study||3
4977810|NCT02554682|12244168|P3|NOT COMPLETED|Overall Study||4
4977811|NCT02554682|12244169|P2|NOT COMPLETED|Overall Study||12
4977812|NCT02554682|12244170|P1|NOT COMPLETED|Overall Study||15
4977813|NCT02554682|12244161|P10|COMPLETED|Overall Study||24
4977814|NCT02554682|12244162|P9|COMPLETED|Overall Study||24
4977815|NCT02554682|12244163|P8|COMPLETED|Overall Study||22
4977816|NCT02554682|12244164|P7|COMPLETED|Overall Study||22
4977817|NCT02554682|12244165|P6|COMPLETED|Overall Study||39
4977818|NCT02554682|12244166|P5|COMPLETED|Overall Study||38
4977819|NCT02554682|12244167|P4|COMPLETED|Overall Study||37
4977820|NCT02554682|12244168|P3|COMPLETED|Overall Study||36
4977821|NCT02554682|12244169|P2|COMPLETED|Overall Study||28
4977822|NCT02554682|12244170|P1|COMPLETED|Overall Study||25
4977823|NCT02554682|12244161|P10|STARTED|Overall Study||26
4977824|NCT02554682|12244162|P9|STARTED|Overall Study||26
4977825|NCT02554682|12244163|P8|STARTED|Overall Study||28
4977826|NCT02554682|12244164|P7|STARTED|Overall Study||28
4977827|NCT02554682|12244165|P6|STARTED|Overall Study||40
4977828|NCT02554682|12244166|P5|STARTED|Overall Study||40
4977829|NCT02554682|12244167|P4|STARTED|Overall Study||40
4977830|NCT02554682|12244168|P3|STARTED|Overall Study||40
4977831|NCT02554682|12244169|P2|STARTED|Overall Study||40
4977832|NCT02554682|12244170|P1|STARTED|Overall Study||40
4977833|NCT02554656|12244219|P1|NOT COMPLETED|Overall Study||3
4977834|NCT02554656|12244219|P1|COMPLETED|Overall Study||86
4977835|NCT02554656|12244219|P1|STARTED|Overall Study||89
4977836|NCT02554435|12244229|P2|NOT COMPLETED|Overall Study||1
4977837|NCT02554435|12244230|P1|NOT COMPLETED|Overall Study||6
4977838|NCT02554435|12244229|P2|COMPLETED|Overall Study||19
4977839|NCT02554435|12244230|P1|COMPLETED|Overall Study||14
4977840|NCT02554435|12244229|P2|STARTED|Overall Study||20
4977841|NCT02554435|12244230|P1|STARTED|Overall Study||20
4977842|NCT02554279|12244264|P2|NOT COMPLETED|Overall Study||18
4977843|NCT02554279|12244265|P1|NOT COMPLETED|Overall Study||32
4977844|NCT02554279|12244264|P2|COMPLETED|Overall Study||291
4977845|NCT02554279|12244265|P1|COMPLETED|Overall Study||279
4977846|NCT02554279|12244264|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
4977847|NCT02554279|12244265|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
4977848|NCT02554279|12244264|P2|Completed Oocyte Retrieval|Overall Study||306
4977849|NCT02554279|12244265|P1|Completed Oocyte Retrieval|Overall Study||292
4977850|NCT02554279|12244264|P2|Received Trigger|Overall Study||307
4977851|NCT02554279|12244265|P1|Received Trigger|Overall Study||293
4977852|NCT02554279|12244264|P2|Completed Day 6 of Stimulation|Overall Study||309
4977853|NCT02554279|12244265|P1|Completed Day 6 of Stimulation|Overall Study||308
4977854|NCT02554279|12244264|P2|Treated|Overall Study||309
4977855|NCT02554279|12244265|P1|Treated|Overall Study||310
4977856|NCT02554279|12244264|P2|STARTED|Overall Study||309
4977857|NCT02554279|12244265|P1|STARTED|Overall Study||311
4977858|NCT02554019|12244300|P3|NOT COMPLETED|Overall Study||2
4977859|NCT02554019|12244301|P2|NOT COMPLETED|Overall Study||0
4977860|NCT02554019|12244302|P1|NOT COMPLETED|Overall Study||2
4977861|NCT02554019|12244300|P3|COMPLETED|Overall Study||10
4977862|NCT02554019|12244301|P2|COMPLETED|Overall Study||12
4977863|NCT02554019|12244302|P1|COMPLETED|Overall Study||10
4977864|NCT02554019|12244300|P3|STARTED|Overall Study||12
4977865|NCT02554019|12244301|P2|STARTED|Overall Study||12
4977866|NCT02554019|12244302|P1|STARTED|Overall Study||12
4977867|NCT02553928|12244324|P2|NOT COMPLETED|Overall Study||3
4977868|NCT02553928|12244325|P1|NOT COMPLETED|Overall Study||2
4977869|NCT02553928|12244324|P2|COMPLETED|Overall Study||29
4977870|NCT02553928|12244325|P1|COMPLETED|Overall Study||28
4977871|NCT02553928|12244324|P2|STARTED|Overall Study||32
4977872|NCT02553928|12244325|P1|STARTED|Overall Study||30
4977873|NCT02553915|12244337|P4|NOT COMPLETED|Overall Study||3
4977874|NCT02553915|12244338|P3|NOT COMPLETED|Overall Study||3
4977875|NCT02553915|12244339|P2|NOT COMPLETED|Overall Study||1
4977876|NCT02553915|12244340|P1|NOT COMPLETED|Overall Study||4
4977877|NCT02553915|12244337|P4|COMPLETED|Overall Study||13
4977878|NCT02553915|12244338|P3|COMPLETED|Overall Study||12
4977879|NCT02553915|12244339|P2|COMPLETED|Overall Study||14
4977880|NCT02553915|12244340|P1|COMPLETED|Overall Study||11
4977881|NCT02553915|12244337|P4|STARTED|Overall Study||16
4977882|NCT02553915|12244338|P3|STARTED|Overall Study||15
4977883|NCT02553915|12244339|P2|STARTED|Overall Study||15
4977884|NCT02553915|12244340|P1|STARTED|Overall Study||15
4977885|NCT02553798|12244370|P1|NOT COMPLETED|Overall Study||338
4977886|NCT02553798|12244370|P1|COMPLETED|Overall Study||226
4977887|NCT02553798|12244370|P1|STARTED|Overall Study||564
4977888|NCT02553772|12244379|P2|NOT COMPLETED|Overall Study||6
4977889|NCT02553772|12244380|P1|NOT COMPLETED|Overall Study||6
4977890|NCT02553772|12244379|P2|COMPLETED|Overall Study||116
4977891|NCT02553772|12244380|P1|COMPLETED|Overall Study||114
4977892|NCT02553772|12244379|P2|STARTED|Overall Study||122
4977893|NCT02553772|12244380|P1|STARTED|Overall Study||120
4977894|NCT02553746|12244396|P2|NOT COMPLETED|Overall Study||2
4977895|NCT02553746|12244397|P1|NOT COMPLETED|Overall Study||3
4977896|NCT02553746|12244396|P2|COMPLETED|Overall Study||64
4977897|NCT02553746|12244397|P1|COMPLETED|Overall Study||77
4977898|NCT02553746|12244396|P2|STARTED|Overall Study||66
4977899|NCT02553746|12244397|P1|STARTED|Overall Study||80
4977900|NCT02553629|12244425|P2|NOT COMPLETED|Overall Study||6
4977901|NCT02553629|12244426|P1|NOT COMPLETED|Overall Study||3
4977902|NCT02553629|12244425|P2|COMPLETED|Overall Study||50
4977903|NCT02553629|12244426|P1|COMPLETED|Overall Study||50
4977904|NCT02553629|12244425|P2|STARTED|Overall Study||56
4977905|NCT02553629|12244426|P1|STARTED|Overall Study||53
4977906|NCT02553538|12244442|P2|NOT COMPLETED|Overall Study||56
4977907|NCT02553538|12244443|P1|NOT COMPLETED|Overall Study||187
4977908|NCT02553538|12244442|P2|COMPLETED|Overall Study||764
4977909|NCT02553538|12244443|P1|COMPLETED|Overall Study||605
4977910|NCT02553538|12244442|P2|STARTED|Overall Study||820
4977911|NCT02553538|12244443|P1|STARTED|Overall Study||792
4977912|NCT02553512|12244455|P1|NOT COMPLETED|Overall Study||23
4977913|NCT02553512|12244455|P1|COMPLETED|Overall Study||144
4977914|NCT02553512|12244455|P1|STARTED|Overall Study||167
4977915|NCT02553499|12244477|P14|NOT COMPLETED|Overall Study||2
4977916|NCT02553499|12244478|P13|NOT COMPLETED|Overall Study||3
4977917|NCT02553499|12244479|P12|NOT COMPLETED|Overall Study||3
4977918|NCT02553499|12244480|P11|NOT COMPLETED|Overall Study||3
4977919|NCT02553499|12244481|P10|NOT COMPLETED|Overall Study||3
4977920|NCT02553499|12244482|P9|NOT COMPLETED|Overall Study||3
4977921|NCT02553499|12244483|P8|NOT COMPLETED|Overall Study||3
4977922|NCT02553499|12244484|P7|NOT COMPLETED|Overall Study||3
4977923|NCT02553499|12244485|P6|NOT COMPLETED|Overall Study||3
4977924|NCT02553499|12244486|P5|NOT COMPLETED|Overall Study||3
4977925|NCT02553499|12244487|P4|NOT COMPLETED|Overall Study||2
4977926|NCT02553499|12244488|P3|NOT COMPLETED|Overall Study||2
4977927|NCT02553499|12244489|P2|NOT COMPLETED|Overall Study||2
4977928|NCT02553499|12244490|P1|NOT COMPLETED|Overall Study||2
4977929|NCT02553499|12244477|P14|COMPLETED|Overall Study||0
4977930|NCT02553499|12244478|P13|COMPLETED|Overall Study||0
4977931|NCT02553499|12244479|P12|COMPLETED|Overall Study||0
4977932|NCT02553499|12244480|P11|COMPLETED|Overall Study||0
4977933|NCT02553499|12244481|P10|COMPLETED|Overall Study||0
4977934|NCT02553499|12244482|P9|COMPLETED|Overall Study||0
4977935|NCT02553499|12244483|P8|COMPLETED|Overall Study||0
4977936|NCT02553499|12244484|P7|COMPLETED|Overall Study||0
4977937|NCT02553499|12244485|P6|COMPLETED|Overall Study||0
4977938|NCT02553499|12244486|P5|COMPLETED|Overall Study||0
4977939|NCT02553499|12244487|P4|COMPLETED|Overall Study||0
4977940|NCT02553499|12244488|P3|COMPLETED|Overall Study||0
4977941|NCT02553499|12244489|P2|COMPLETED|Overall Study||0
4977942|NCT02553499|12244490|P1|COMPLETED|Overall Study||0
4977943|NCT02553499|12244477|P14|STARTED|Overall Study||2
4977944|NCT02553499|12244478|P13|STARTED|Overall Study||3
4977945|NCT02553499|12244479|P12|STARTED|Overall Study||3
4977946|NCT02553499|12244480|P11|STARTED|Overall Study||3
4977947|NCT02553499|12244481|P10|STARTED|Overall Study||3
4977948|NCT02553499|12244482|P9|STARTED|Overall Study||3
4977949|NCT02553499|12244483|P8|STARTED|Overall Study||3
4977950|NCT02553499|12244484|P7|STARTED|Overall Study||3
4977951|NCT02553499|12244485|P6|STARTED|Overall Study||3
4977952|NCT02553499|12244486|P5|STARTED|Overall Study||3
4977953|NCT02553499|12244487|P4|STARTED|Overall Study||2
4977954|NCT02553499|12244488|P3|STARTED|Overall Study||2
4977955|NCT02553499|12244489|P2|STARTED|Overall Study||2
4977956|NCT02553499|12244490|P1|STARTED|Overall Study||2
4977957|NCT02553421|12244592|P2|NOT COMPLETED|Overall Study||1
4977958|NCT02553421|12244593|P1|NOT COMPLETED|Overall Study||29
4977959|NCT02553421|12244592|P2|COMPLETED|Overall Study||57
4977960|NCT02553421|12244593|P1|COMPLETED|Overall Study||156
4977961|NCT02553421|12244592|P2|STARTED|Overall Study||58
4977962|NCT02553421|12244593|P1|STARTED|Overall Study||185
4977963|NCT02553317|12244603|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
4977964|NCT02553317|12244604|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
4977965|NCT02553317|12244603|P2|COMPLETED|Open-label (OL) Treatment Period||22
4977966|NCT02553317|12244604|P1|COMPLETED|Open-label (OL) Treatment Period||2
4977967|NCT02553317|12244603|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
4977968|NCT02553317|12244604|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
4977969|NCT02553317|12244603|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
4977970|NCT02553317|12244604|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
4977971|NCT02553317|12244603|P2|COMPLETED|Double-blind (DB) Treatment Period||65
4977972|NCT02553317|12244604|P1|COMPLETED|Double-blind (DB) Treatment Period||68
4977973|NCT02553317|12244603|P2|STARTED|Double-blind (DB) Treatment Period||73
4977974|NCT02553317|12244604|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
4977975|NCT02553317|12244603|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
4977976|NCT02553317|12244604|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
4977977|NCT02553317|12244603|P2|COMPLETED|Overall Treatment Period + Follow-up||50
4977978|NCT02553317|12244604|P1|COMPLETED|Overall Treatment Period + Follow-up||58
4977979|NCT02553317|12244603|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
4977980|NCT02553317|12244604|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
4977981|NCT02553317|12244603|P2|STARTED|Overall Treatment Period + Follow-up||73
4977982|NCT02553317|12244604|P1|STARTED|Overall Treatment Period + Follow-up||72
4977983|NCT02553135|12244627|P1|NOT COMPLETED|Overall Study||0
4977984|NCT02553135|12244627|P1|COMPLETED|Overall Study||6
4977985|NCT02553135|12244627|P1|STARTED|Overall Study||6
4977986|NCT02552966|12244634|P1|NOT COMPLETED|Overall Study||5
4977987|NCT02552966|12244634|P1|COMPLETED|Overall Study||15
4977988|NCT02552966|12244634|P1|STARTED|Overall Study||20
4977989|NCT02552810|12244643|P2|NOT COMPLETED|Overall Study||0
4977990|NCT02552810|12244644|P1|NOT COMPLETED|Overall Study||0
4977991|NCT02552810|12244643|P2|COMPLETED|Overall Study||15
4977992|NCT02552810|12244644|P1|COMPLETED|Overall Study||15
4977993|NCT02552810|12244643|P2|STARTED|Overall Study||15
4977994|NCT02552810|12244644|P1|STARTED|Overall Study||15
4977995|NCT02552732|12244660|P1|NOT COMPLETED|Overall Study||9
4977996|NCT02552732|12244660|P1|COMPLETED|Overall Study||20
4977997|NCT02552732|12244660|P1|STARTED|Overall Study||29
4977998|NCT02552368|12244687|P1|NOT COMPLETED|Overall Study||13
4977999|NCT02552368|12244687|P1|COMPLETED|Overall Study||10
4978000|NCT02552368|12244687|P1|STARTED|Overall Study||23
4978001|NCT02552355|12244696|P4|NOT COMPLETED|Overall Study||1
4978002|NCT02552355|12244697|P3|NOT COMPLETED|Overall Study||2
4978003|NCT02552355|12244698|P2|NOT COMPLETED|Overall Study||2
4978004|NCT02552355|12244699|P1|NOT COMPLETED|Overall Study||0
4978005|NCT02552355|12244696|P4|COMPLETED|Overall Study||14
4978006|NCT02552355|12244697|P3|COMPLETED|Overall Study||12
4978007|NCT02552355|12244698|P2|COMPLETED|Overall Study||11
4978008|NCT02552355|12244699|P1|COMPLETED|Overall Study||14
4978009|NCT02552355|12244696|P4|STARTED|Overall Study||15
4978010|NCT02552355|12244697|P3|STARTED|Overall Study||14
4978011|NCT02552355|12244698|P2|STARTED|Overall Study||13
4978012|NCT02552355|12244699|P1|STARTED|Overall Study||14
4978013|NCT02552303|12244745|P4|NOT COMPLETED|Follow-Up||0
4978014|NCT02552303|12244746|P3|NOT COMPLETED|Follow-Up||1
4978015|NCT02552303|12244747|P2|NOT COMPLETED|Follow-Up||2
4978016|NCT02552303|12244748|P1|NOT COMPLETED|Follow-Up||0
4978017|NCT02552303|12244745|P4|COMPLETED|Follow-Up||10
4978018|NCT02552303|12244746|P3|COMPLETED|Follow-Up||6
4978019|NCT02552303|12244747|P2|COMPLETED|Follow-Up||6
4978020|NCT02552303|12244748|P1|COMPLETED|Follow-Up||7
4978021|NCT02552303|12244745|P4|STARTED|Follow-Up||10
4978022|NCT02552303|12244746|P3|STARTED|Follow-Up||7
4978023|NCT02552303|12244747|P2|STARTED|Follow-Up||8
4978024|NCT02552303|12244748|P1|STARTED|Follow-Up||7
4978025|NCT02552303|12244745|P4|NOT COMPLETED|Allocation||1
4978026|NCT02552303|12244746|P3|NOT COMPLETED|Allocation||1
4978027|NCT02552303|12244747|P2|NOT COMPLETED|Allocation||2
4978028|NCT02552303|12244748|P1|NOT COMPLETED|Allocation||3
4978029|NCT02552303|12244745|P4|COMPLETED|Allocation||10
4978030|NCT02552303|12244746|P3|COMPLETED|Allocation||7
4978031|NCT02552303|12244747|P2|COMPLETED|Allocation||8
4978032|NCT02552303|12244748|P1|COMPLETED|Allocation||7
4978033|NCT02552303|12244745|P4|STARTED|Allocation||11
4978034|NCT02552303|12244746|P3|STARTED|Allocation||8
4978035|NCT02552303|12244747|P2|STARTED|Allocation||10
4978036|NCT02552303|12244748|P1|STARTED|Allocation||10
4978037|NCT02552147|12244762|P2|NOT COMPLETED|Second Intervention (7 Days)||0
4978038|NCT02552147|12244763|P1|NOT COMPLETED|Second Intervention (7 Days)||2
4978039|NCT02552147|12244762|P2|COMPLETED|Second Intervention (7 Days)||4
4978040|NCT02552147|12244763|P1|COMPLETED|Second Intervention (7 Days)||1
4978041|NCT02552147|12244762|P2|STARTED|Second Intervention (7 Days)||4
4978042|NCT02552147|12244763|P1|STARTED|Second Intervention (7 Days)||3
4978043|NCT02552147|12244762|P2|NOT COMPLETED|Washout (7 Days)||0
4978044|NCT02552147|12244763|P1|NOT COMPLETED|Washout (7 Days)||0
4978045|NCT02552147|12244762|P2|COMPLETED|Washout (7 Days)||4
4978046|NCT02552147|12244763|P1|COMPLETED|Washout (7 Days)||3
4978047|NCT02552147|12244762|P2|STARTED|Washout (7 Days)||4
4978048|NCT02552147|12244763|P1|STARTED|Washout (7 Days)||3
4978049|NCT02552147|12244762|P2|NOT COMPLETED|First Intervention (7 Days)||0
4978050|NCT02552147|12244763|P1|NOT COMPLETED|First Intervention (7 Days)||1
4978051|NCT02552147|12244762|P2|COMPLETED|First Intervention (7 Days)||4
4978052|NCT02552147|12244763|P1|COMPLETED|First Intervention (7 Days)||3
4978053|NCT02552147|12244762|P2|STARTED|First Intervention (7 Days)||4
4978054|NCT02552147|12244763|P1|STARTED|First Intervention (7 Days)||4
4978055|NCT02552121|12244797|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
4978056|NCT02552121|12244798|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
4978057|NCT02552121|12244799|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
4978058|NCT02552121|12244800|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
4978059|NCT02552121|12244801|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
4978060|NCT02552121|12244802|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
4978061|NCT02552121|12244803|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
4978062|NCT02552121|12244804|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
4978063|NCT02552121|12244797|P8|COMPLETED|Part 2: Cohort Expansion||0
4978064|NCT02552121|12244798|P7|COMPLETED|Part 2: Cohort Expansion||0
4978065|NCT02552121|12244799|P6|COMPLETED|Part 2: Cohort Expansion||1
4978066|NCT02552121|12244800|P5|COMPLETED|Part 2: Cohort Expansion||0
4978067|NCT02552121|12244801|P4|COMPLETED|Part 2: Cohort Expansion||0
4978068|NCT02552121|12244802|P3|COMPLETED|Part 2: Cohort Expansion||0
4978069|NCT02552121|12244803|P2|COMPLETED|Part 2: Cohort Expansion||0
4978070|NCT02552121|12244804|P1|COMPLETED|Part 2: Cohort Expansion||0
4978071|NCT02552121|12244797|P8|STARTED|Part 2: Cohort Expansion||3
4978072|NCT02552121|12244798|P7|STARTED|Part 2: Cohort Expansion||1
4978073|NCT02552121|12244799|P6|STARTED|Part 2: Cohort Expansion||5
4978074|NCT02552121|12244800|P5|STARTED|Part 2: Cohort Expansion||1
4978075|NCT02552121|12244801|P4|STARTED|Part 2: Cohort Expansion||3
4978076|NCT02552121|12244802|P3|STARTED|Part 2: Cohort Expansion||11
4978077|NCT02552121|12244803|P2|STARTED|Part 2: Cohort Expansion||0
4978078|NCT02552121|12244804|P1|STARTED|Part 2: Cohort Expansion||0
4978079|NCT02552121|12244797|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978080|NCT02552121|12244798|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978081|NCT02552121|12244799|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978082|NCT02552121|12244800|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978083|NCT02552121|12244801|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978084|NCT02552121|12244802|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978085|NCT02552121|12244803|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
4978086|NCT02552121|12244804|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978087|NCT02552121|12244797|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978088|NCT02552121|12244798|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978089|NCT02552121|12244799|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978090|NCT02552121|12244800|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978091|NCT02552121|12244801|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978092|NCT02552121|12244802|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978093|NCT02552121|12244803|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978094|NCT02552121|12244804|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
4978095|NCT02552121|12244797|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978096|NCT02552121|12244798|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978097|NCT02552121|12244799|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978098|NCT02552121|12244800|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978099|NCT02552121|12244801|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978100|NCT02552121|12244802|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978101|NCT02552121|12244803|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
4978102|NCT02552121|12244804|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
4978103|NCT02552121|12244797|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978104|NCT02552121|12244798|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978105|NCT02552121|12244799|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978106|NCT02552121|12244800|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978107|NCT02552121|12244801|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978108|NCT02552121|12244802|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978109|NCT02552121|12244803|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978110|NCT02552121|12244804|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
4978111|NCT02552121|12244797|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978112|NCT02552121|12244798|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978113|NCT02552121|12244799|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978114|NCT02552121|12244800|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978115|NCT02552121|12244801|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978116|NCT02552121|12244802|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978117|NCT02552121|12244803|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978118|NCT02552121|12244804|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978119|NCT02552121|12244797|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978120|NCT02552121|12244798|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978121|NCT02552121|12244799|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978122|NCT02552121|12244800|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978123|NCT02552121|12244801|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978124|NCT02552121|12244802|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978125|NCT02552121|12244803|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
4978126|NCT02552121|12244804|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
4978127|NCT02551887|12245050|P3|NOT COMPLETED|Overall Study||0
4978128|NCT02551887|12245051|P2|NOT COMPLETED|Overall Study||0
4978129|NCT02551887|12245052|P1|NOT COMPLETED|Overall Study||0
4978130|NCT02551887|12245050|P3|COMPLETED|Overall Study||222
4978131|NCT02551887|12245051|P2|COMPLETED|Overall Study||124
4978132|NCT02551887|12245052|P1|COMPLETED|Overall Study||301
4978133|NCT02551887|12245050|P3|STARTED|Overall Study||222
4978134|NCT02551887|12245051|P2|STARTED|Overall Study||124
4978135|NCT02551887|12245052|P1|STARTED|Overall Study||301
4978136|NCT02551874|12245065|P2|NOT COMPLETED|Overall Study||39
4978137|NCT02551874|12245066|P1|NOT COMPLETED|Overall Study||28
4978138|NCT02551874|12245065|P2|COMPLETED|Overall Study||287
4978139|NCT02551874|12245066|P1|COMPLETED|Overall Study||296
4978140|NCT02551874|12245065|P2|Received Treatment in Long-term Study|Overall Study||284
4978141|NCT02551874|12245066|P1|Received Treatment in Long-term Study|Overall Study||295
4978142|NCT02551874|12245065|P2|Entered Long-term Study|Overall Study||294
4978143|NCT02551874|12245066|P1|Entered Long-term Study|Overall Study||306
4978144|NCT02551874|12245065|P2|Received Treatment in Short-term Study|Overall Study||319
4978145|NCT02551874|12245066|P1|Received Treatment in Short-term Study|Overall Study||324
4978146|NCT02551874|12245065|P2|STARTED|Overall Study||326
4978147|NCT02551874|12245066|P1|STARTED|Overall Study||324
4978148|NCT02551822|12245084|P2|NOT COMPLETED|Overall Study||2
4978149|NCT02551822|12245085|P1|NOT COMPLETED|Overall Study||2
4978150|NCT02551822|12245084|P2|COMPLETED|Overall Study||10
4978151|NCT02551822|12245085|P1|COMPLETED|Overall Study||9
4978152|NCT02551822|12245084|P2|STARTED|Overall Study||12
4978153|NCT02551822|12245085|P1|STARTED|Overall Study||11
4978154|NCT02551809|12245098|P3|NOT COMPLETED|Overall Study||1
4978155|NCT02551809|12245099|P2|NOT COMPLETED|Overall Study||1
4978156|NCT02551809|12245100|P1|NOT COMPLETED|Overall Study||0
4978157|NCT02551809|12245098|P3|COMPLETED|Overall Study||13
4978158|NCT02551809|12245099|P2|COMPLETED|Overall Study||14
4978159|NCT02551809|12245100|P1|COMPLETED|Overall Study||14
4978160|NCT02551809|12245098|P3|STARTED|Overall Study||14
4978161|NCT02551809|12245099|P2|STARTED|Overall Study||15
4978162|NCT02551809|12245100|P1|STARTED|Overall Study||14
4978163|NCT02551770|12245108|P2|NOT COMPLETED|Overall Study||3
4978164|NCT02551770|12245109|P1|NOT COMPLETED|Overall Study||3
4978165|NCT02551770|12245108|P2|COMPLETED|Overall Study||48
4978166|NCT02551770|12245109|P1|COMPLETED|Overall Study||48
4978167|NCT02551770|12245108|P2|STARTED|Overall Study||51
4978168|NCT02551770|12245109|P1|STARTED|Overall Study||51
4978169|NCT02551744|12245128|P2|NOT COMPLETED|Overall Study||0
4978170|NCT02551744|12245129|P1|NOT COMPLETED|Overall Study||0
4978171|NCT02551744|12245128|P2|COMPLETED|Overall Study||51
4978172|NCT02551744|12245129|P1|COMPLETED|Overall Study||50
4978173|NCT02551744|12245128|P2|STARTED|Overall Study||51
4978174|NCT02551744|12245129|P1|STARTED|Overall Study||50
4978175|NCT02551731|12245135|P1|NOT COMPLETED|Overall Study||2
4978176|NCT02551731|12245135|P1|COMPLETED|Overall Study||7
4978177|NCT02551731|12245135|P1|STARTED|Overall Study||9
4978178|NCT02551692|12245155|P3|NOT COMPLETED|Overall Study||5
4978179|NCT02551692|12245156|P2|NOT COMPLETED|Overall Study||1
4978180|NCT02551692|12245157|P1|NOT COMPLETED|Overall Study||1
4978181|NCT02551692|12245155|P3|COMPLETED|Overall Study||25
4978182|NCT02551692|12245156|P2|COMPLETED|Overall Study||26
4978183|NCT02551692|12245157|P1|COMPLETED|Overall Study||30
4978184|NCT02551692|12245155|P3|STARTED|Overall Study||30
4978185|NCT02551692|12245156|P2|STARTED|Overall Study||27
4978186|NCT02551692|12245157|P1|STARTED|Overall Study||31
4978187|NCT02551666|12245173|P2|NOT COMPLETED|Overall Study||3
4978188|NCT02551666|12245174|P1|NOT COMPLETED|Overall Study||1
4978189|NCT02551666|12245173|P2|COMPLETED|Overall Study||16
4978190|NCT02551666|12245174|P1|COMPLETED|Overall Study||15
4978191|NCT02551666|12245173|P2|STARTED|Overall Study||19
4978192|NCT02551666|12245174|P1|STARTED|Overall Study||16
4978193|NCT02551653|12245202|P2|NOT COMPLETED|Overall Study||0
4978194|NCT02551653|12245203|P1|NOT COMPLETED|Overall Study||0
4978195|NCT02551653|12245202|P2|COMPLETED|Overall Study||5
4978196|NCT02551653|12245203|P1|COMPLETED|Overall Study||5
4978197|NCT02551653|12245202|P2|STARTED|Overall Study||5
4978198|NCT02551653|12245203|P1|STARTED|Overall Study||5
4978199|NCT02551432|12245211|P1|NOT COMPLETED|Overall Study||0
4978200|NCT02551432|12245211|P1|COMPLETED|Overall Study||26
4978201|NCT02551432|12245211|P1|STARTED|Overall Study||26
4978202|NCT02551224|12245217|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
4978203|NCT02551224|12245218|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
4978204|NCT02551224|12245217|P2|COMPLETED|Second Intervention (5 Min After First )||50
4978205|NCT02551224|12245218|P1|COMPLETED|Second Intervention (5 Min After First )||50
4978206|NCT02551224|12245217|P2|STARTED|Second Intervention (5 Min After First )||50
4978207|NCT02551224|12245218|P1|STARTED|Second Intervention (5 Min After First )||50
4978208|NCT02551224|12245217|P2|NOT COMPLETED|First Intervention||0
4978209|NCT02551224|12245218|P1|NOT COMPLETED|First Intervention||0
4978210|NCT02551224|12245217|P2|COMPLETED|First Intervention||50
4978211|NCT02551224|12245218|P1|COMPLETED|First Intervention||50
4978212|NCT02551224|12245217|P2|STARTED|First Intervention||50
4978213|NCT02551224|12245218|P1|STARTED|First Intervention||50
4978214|NCT02551055|12245233|P8|NOT COMPLETED|Overall Study||0
4978215|NCT02551055|12245234|P7|NOT COMPLETED|Overall Study||3
4978216|NCT02551055|12245235|P6|NOT COMPLETED|Overall Study||1
4978217|NCT02551055|12245236|P5|NOT COMPLETED|Overall Study||7
4978218|NCT02551055|12245237|P4|NOT COMPLETED|Overall Study||5
4978219|NCT02551055|12245238|P3|NOT COMPLETED|Overall Study||2
4978220|NCT02551055|12245239|P2|NOT COMPLETED|Overall Study||6
4978221|NCT02551055|12245240|P1|NOT COMPLETED|Overall Study||4
4978222|NCT02551055|12245233|P8|COMPLETED|Overall Study||0
4978223|NCT02551055|12245234|P7|COMPLETED|Overall Study||1
4978224|NCT02551055|12245235|P6|COMPLETED|Overall Study||1
4978225|NCT02551055|12245236|P5|COMPLETED|Overall Study||0
4978226|NCT02551055|12245237|P4|COMPLETED|Overall Study||1
4978227|NCT02551055|12245238|P3|COMPLETED|Overall Study||1
4978228|NCT02551055|12245239|P2|COMPLETED|Overall Study||0
4978229|NCT02551055|12245240|P1|COMPLETED|Overall Study||0
4978230|NCT02551055|12245233|P8|STARTED|Overall Study||0
4978231|NCT02551055|12245234|P7|STARTED|Overall Study||4
4978232|NCT02551055|12245235|P6|STARTED|Overall Study||2
4978233|NCT02551055|12245236|P5|STARTED|Overall Study||7
4978234|NCT02551055|12245237|P4|STARTED|Overall Study||6
4978235|NCT02551055|12245238|P3|STARTED|Overall Study||3
4978236|NCT02551055|12245239|P2|STARTED|Overall Study||6
4978237|NCT02551055|12245240|P1|STARTED|Overall Study||4
4978238|NCT02550873|12245315|P3|NOT COMPLETED|Open Label Extension||111
4978239|NCT02550873|12245316|P2|NOT COMPLETED|Open Label Extension||0
4978240|NCT02550873|12245317|P1|NOT COMPLETED|Open Label Extension||0
4978241|NCT02550873|12245315|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
4978242|NCT02550873|12245316|P2|COMPLETED|Open Label Extension||0
4978243|NCT02550873|12245317|P1|COMPLETED|Open Label Extension||0
4978244|NCT02550873|12245315|P3|STARTED|Open Label Extension||111
4978245|NCT02550873|12245316|P2|STARTED|Open Label Extension||0
4978246|NCT02550873|12245317|P1|STARTED|Open Label Extension||0
4978247|NCT02550873|12245315|P3|NOT COMPLETED|Randomized Double Blind||0
4978248|NCT02550873|12245316|P2|NOT COMPLETED|Randomized Double Blind||2
4978249|NCT02550873|12245317|P1|NOT COMPLETED|Randomized Double Blind||4
4978250|NCT02550873|12245315|P3|COMPLETED|Randomized Double Blind||0
4978251|NCT02550873|12245316|P2|COMPLETED|Randomized Double Blind||37
4978252|NCT02550873|12245317|P1|COMPLETED|Randomized Double Blind||74
4978253|NCT02550873|12245315|P3|Continue to Open Label Extension|Randomized Double Blind||0
4978254|NCT02550873|12245316|P2|Continue to Open Label Extension|Randomized Double Blind||37
4978255|NCT02550873|12245317|P1|Continue to Open Label Extension|Randomized Double Blind||74
4978256|NCT02550873|12245315|P3|Received Treatment|Randomized Double Blind||0
4978257|NCT02550873|12245316|P2|Received Treatment|Randomized Double Blind||39
4978258|NCT02550873|12245317|P1|Received Treatment|Randomized Double Blind||77
4978259|NCT02550873|12245315|P3|STARTED|Randomized Double Blind||0
4978260|NCT02550873|12245316|P2|STARTED|Randomized Double Blind||39
4978261|NCT02550873|12245317|P1|STARTED|Randomized Double Blind||78
4978262|NCT02550652|12245397|P2|NOT COMPLETED|Overall Study||62
4978263|NCT02550652|12245398|P1|NOT COMPLETED|Overall Study||63
4978264|NCT02550652|12245397|P2|COMPLETED|Overall Study||0
4978265|NCT02550652|12245398|P1|COMPLETED|Overall Study||0
4978266|NCT02550652|12245397|P2|STARTED|Overall Study||62
4978267|NCT02550652|12245398|P1|STARTED|Overall Study||63
4978268|NCT02550288|12245445|P5|NOT COMPLETED|Overall Study||3
4978269|NCT02550288|12245446|P4|NOT COMPLETED|Overall Study||3
4978270|NCT02550288|12245447|P3|NOT COMPLETED|Overall Study||1
4978271|NCT02550288|12245448|P2|NOT COMPLETED|Overall Study||3
4978272|NCT02550288|12245449|P1|NOT COMPLETED|Overall Study||2
4978273|NCT02550288|12245445|P5|COMPLETED|Overall Study||66
4978274|NCT02550288|12245446|P4|COMPLETED|Overall Study||65
4978275|NCT02550288|12245447|P3|COMPLETED|Overall Study||68
4978276|NCT02550288|12245448|P2|COMPLETED|Overall Study||65
4978277|NCT02550288|12245449|P1|COMPLETED|Overall Study||33
4978278|NCT02550288|12245445|P5|STARTED|Overall Study||69
4978279|NCT02550288|12245446|P4|STARTED|Overall Study||68
4978280|NCT02550288|12245447|P3|STARTED|Overall Study||69
4978281|NCT02550288|12245448|P2|STARTED|Overall Study||68
4978282|NCT02550288|12245449|P1|STARTED|Overall Study||35
4978283|NCT02550210|12245546|P1|NOT COMPLETED|Overall Study||4
4978284|NCT02550210|12245546|P1|COMPLETED|Overall Study||19
4978285|NCT02550210|12245546|P1|STARTED|Overall Study||23
4978286|NCT02550197|12245555|P2|NOT COMPLETED|Overall Study||0
4978287|NCT02550197|12245556|P1|NOT COMPLETED|Overall Study||0
4978288|NCT02550197|12245555|P2|COMPLETED|Overall Study||100
4978289|NCT02550197|12245556|P1|COMPLETED|Overall Study||200
4978290|NCT02550197|12245555|P2|STARTED|Overall Study||100
4978291|NCT02550197|12245556|P1|STARTED|Overall Study||200
4978292|NCT02550132|12245574|P1|NOT COMPLETED|Overall Study||0
4978293|NCT02550132|12245574|P1|COMPLETED|Overall Study||25
4978294|NCT02550132|12245574|P1|STARTED|Overall Study||25
4978295|NCT02550106|12245605|P1|NOT COMPLETED|Overall Study||12
4978296|NCT02550106|12245605|P1|COMPLETED|Overall Study||124
4978297|NCT02550106|12245605|P1|STARTED|Overall Study||136
4978298|NCT02549755|12245629|P1|NOT COMPLETED|Overall Study||1
4978299|NCT02549755|12245629|P1|COMPLETED|Overall Study||0
4978300|NCT02549755|12245629|P1|STARTED|Overall Study||1
4978301|NCT02549716|12245635|P2|NOT COMPLETED|Overall Study||0
4978302|NCT02549716|12245636|P1|NOT COMPLETED|Overall Study||0
4978303|NCT02549716|12245635|P2|COMPLETED|Overall Study||2
4978304|NCT02549716|12245636|P1|COMPLETED|Overall Study||1
4978305|NCT02549716|12245635|P2|STARTED|Overall Study||2
4978306|NCT02549716|12245636|P1|STARTED|Overall Study||1
4978307|NCT02549573|12245650|P2|NOT COMPLETED|Overall Study||3
4978308|NCT02549573|12245651|P1|NOT COMPLETED|Overall Study||0
4978309|NCT02549573|12245650|P2|COMPLETED|Overall Study||4
4978310|NCT02549573|12245651|P1|COMPLETED|Overall Study||6
4978311|NCT02549573|12245650|P2|STARTED|Overall Study||7
4978312|NCT02549573|12245651|P1|STARTED|Overall Study||6
4978313|NCT02549365|12245695|P2|NOT COMPLETED|Overall Study||0
4978314|NCT02549365|12245696|P1|NOT COMPLETED|Overall Study||0
4978315|NCT02549365|12245695|P2|COMPLETED|Overall Study||112
4978316|NCT02549365|12245696|P1|COMPLETED|Overall Study||164
4978317|NCT02549365|12245695|P2|STARTED|Overall Study||112
4978318|NCT02549365|12245696|P1|STARTED|Overall Study||164
4978319|NCT02549352|12245705|P2|NOT COMPLETED|12-month Follow-up||12
4978320|NCT02549352|12245706|P1|NOT COMPLETED|12-month Follow-up||8
4978321|NCT02549352|12245705|P2|COMPLETED|12-month Follow-up||81
4978322|NCT02549352|12245706|P1|COMPLETED|12-month Follow-up||199
4978323|NCT02549352|12245705|P2|STARTED|12-month Follow-up||93
4978324|NCT02549352|12245706|P1|STARTED|12-month Follow-up||207
4978325|NCT02549352|12245705|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
4978326|NCT02549352|12245706|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
4978327|NCT02549352|12245705|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
4978328|NCT02549352|12245706|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
4978329|NCT02549352|12245705|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
4978330|NCT02549352|12245706|P1|Treated|3-day Treatment and 8-week Follow-up||209
4978331|NCT02549352|12245705|P2|STARTED|3-day Treatment and 8-week Follow-up||102
4978332|NCT02549352|12245706|P1|STARTED|3-day Treatment and 8-week Follow-up||209
4978333|NCT02549339|12245722|P2|NOT COMPLETED|12-month Follow-up||11
4978334|NCT02549339|12245723|P1|NOT COMPLETED|12-month Follow-up||9
4978335|NCT02549339|12245722|P2|COMPLETED|12-month Follow-up||87
4978336|NCT02549339|12245723|P1|COMPLETED|12-month Follow-up||192
4978337|NCT02549339|12245722|P2|STARTED|12-month Follow-up||98
4978338|NCT02549339|12245723|P1|STARTED|12-month Follow-up||201
4978339|NCT02549339|12245722|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
4978340|NCT02549339|12245723|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
4978341|NCT02549339|12245722|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
4978342|NCT02549339|12245723|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
4978343|NCT02549339|12245722|P2|Treated|3-day Treatment and 8-week Follow-up||104
4978344|NCT02549339|12245723|P1|Treated|3-day Treatment and 8-week Follow-up||202
4978345|NCT02549339|12245722|P2|STARTED|3-day Treatment and 8-week Follow-up||104
4978346|NCT02549339|12245723|P1|STARTED|3-day Treatment and 8-week Follow-up||205
4978347|NCT02549287|12245739|P2|NOT COMPLETED|Overall Study||32
4978348|NCT02549287|12245740|P1|NOT COMPLETED|Overall Study||80
4978349|NCT02549287|12245739|P2|COMPLETED|Overall Study||64
4978350|NCT02549287|12245740|P1|COMPLETED|Overall Study||113
4978351|NCT02549287|12245739|P2|STARTED|Overall Study||96
4978352|NCT02549287|12245740|P1|STARTED|Overall Study||193
4978353|NCT02549196|12245774|P4|NOT COMPLETED|Overall Study||1
4978354|NCT02549196|12245775|P3|NOT COMPLETED|Overall Study||1
4978355|NCT02549196|12245776|P2|NOT COMPLETED|Overall Study||0
4978356|NCT02549196|12245777|P1|NOT COMPLETED|Overall Study||1
4978357|NCT02549196|12245774|P4|COMPLETED|Overall Study||12
4978358|NCT02549196|12245775|P3|COMPLETED|Overall Study||5
4978359|NCT02549196|12245776|P2|COMPLETED|Overall Study||1
4978360|NCT02549196|12245777|P1|COMPLETED|Overall Study||7
4978361|NCT02549196|12245774|P4|STARTED|Overall Study||13
4978362|NCT02549196|12245775|P3|STARTED|Overall Study||6
4978363|NCT02549196|12245776|P2|STARTED|Overall Study||1
4978364|NCT02549196|12245777|P1|STARTED|Overall Study||8
4978365|NCT02549040|12245791|P1|NOT COMPLETED|Period 5||0
4978366|NCT02549040|12245791|P1|COMPLETED|Period 5||16
4978367|NCT02549040|12245791|P1|STARTED|Period 5||16
4978368|NCT02549040|12245791|P1|NOT COMPLETED|Period 4||0
4978369|NCT02549040|12245791|P1|COMPLETED|Period 4||16
4978370|NCT02549040|12245791|P1|STARTED|Period 4||16
4978371|NCT02549040|12245791|P1|NOT COMPLETED|Period 3||0
4978372|NCT02549040|12245791|P1|COMPLETED|Period 3||16
4978373|NCT02549040|12245791|P1|STARTED|Period 3||16
4978374|NCT02549040|12245791|P1|NOT COMPLETED|Period 2||0
4978375|NCT02549040|12245791|P1|COMPLETED|Period 2||16
4978376|NCT02549040|12245791|P1|STARTED|Period 2||16
4978377|NCT02549040|12245791|P1|NOT COMPLETED|Period 1||0
4978378|NCT02549040|12245791|P1|COMPLETED|Period 1||16
4978379|NCT02549040|12245791|P1|STARTED|Period 1||16
4978380|NCT02549027|12245833|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
4978381|NCT02549027|12245834|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
4978382|NCT02549027|12245835|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
4978383|NCT02549027|12245836|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
4978384|NCT02549027|12245837|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
4978385|NCT02549027|12245838|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
4978386|NCT02549027|12245833|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
4978387|NCT02549027|12245834|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
4978388|NCT02549027|12245835|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
4978389|NCT02549027|12245836|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
4978390|NCT02549027|12245837|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
4978391|NCT02549027|12245838|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
4978392|NCT02549027|12245833|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
4978393|NCT02549027|12245834|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
4978394|NCT02549027|12245835|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
4978395|NCT02549027|12245836|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
4978396|NCT02549027|12245837|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
4978397|NCT02549027|12245838|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
4978398|NCT02549027|12245833|P6|NOT COMPLETED|Washout After Period 4||0
4978399|NCT02549027|12245834|P5|NOT COMPLETED|Washout After Period 4||0
4978400|NCT02549027|12245835|P4|NOT COMPLETED|Washout After Period 4||1
4978401|NCT02549027|12245836|P3|NOT COMPLETED|Washout After Period 4||1
4978402|NCT02549027|12245837|P2|NOT COMPLETED|Washout After Period 4||1
4978403|NCT02549027|12245838|P1|NOT COMPLETED|Washout After Period 4||0
4978404|NCT02549027|12245833|P6|COMPLETED|Washout After Period 4||0
4978405|NCT02549027|12245834|P5|COMPLETED|Washout After Period 4||0
4978406|NCT02549027|12245835|P4|COMPLETED|Washout After Period 4||4
4978407|NCT02549027|12245836|P3|COMPLETED|Washout After Period 4||4
4978408|NCT02549027|12245837|P2|COMPLETED|Washout After Period 4||4
4978409|NCT02549027|12245838|P1|COMPLETED|Washout After Period 4||5
4978410|NCT02549027|12245833|P6|STARTED|Washout After Period 4||0
4978411|NCT02549027|12245834|P5|STARTED|Washout After Period 4||0
4978412|NCT02549027|12245835|P4|STARTED|Washout After Period 4||5
4978413|NCT02549027|12245836|P3|STARTED|Washout After Period 4||5
4978414|NCT02549027|12245837|P2|STARTED|Washout After Period 4||5
4978415|NCT02549027|12245838|P1|STARTED|Washout After Period 4||5
4978416|NCT02549027|12245833|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978417|NCT02549027|12245834|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978418|NCT02549027|12245835|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978419|NCT02549027|12245836|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978420|NCT02549027|12245837|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978421|NCT02549027|12245838|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
4978422|NCT02549027|12245833|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
4978423|NCT02549027|12245834|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
4978424|NCT02549027|12245835|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
4978425|NCT02549027|12245836|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
4978426|NCT02549027|12245837|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
4978427|NCT02549027|12245838|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
4978428|NCT02549027|12245833|P6|STARTED|Period 4 - MK-1064 or Placebo||0
4978429|NCT02549027|12245834|P5|STARTED|Period 4 - MK-1064 or Placebo||0
4978430|NCT02549027|12245835|P4|STARTED|Period 4 - MK-1064 or Placebo||5
4978431|NCT02549027|12245836|P3|STARTED|Period 4 - MK-1064 or Placebo||5
4978432|NCT02549027|12245837|P2|STARTED|Period 4 - MK-1064 or Placebo||5
4978433|NCT02549027|12245838|P1|STARTED|Period 4 - MK-1064 or Placebo||5
4978434|NCT02549027|12245833|P6|NOT COMPLETED|Washout After Period 3||0
4978435|NCT02549027|12245834|P5|NOT COMPLETED|Washout After Period 3||0
4978436|NCT02549027|12245835|P4|NOT COMPLETED|Washout After Period 3||0
4978437|NCT02549027|12245836|P3|NOT COMPLETED|Washout After Period 3||0
4978438|NCT02549027|12245837|P2|NOT COMPLETED|Washout After Period 3||0
4978439|NCT02549027|12245838|P1|NOT COMPLETED|Washout After Period 3||0
4978440|NCT02549027|12245833|P6|COMPLETED|Washout After Period 3||0
4978441|NCT02549027|12245834|P5|COMPLETED|Washout After Period 3||0
4978442|NCT02549027|12245835|P4|COMPLETED|Washout After Period 3||5
4978443|NCT02549027|12245836|P3|COMPLETED|Washout After Period 3||5
4978444|NCT02549027|12245837|P2|COMPLETED|Washout After Period 3||5
4978445|NCT02549027|12245838|P1|COMPLETED|Washout After Period 3||5
4978446|NCT02549027|12245833|P6|STARTED|Washout After Period 3||0
4978447|NCT02549027|12245834|P5|STARTED|Washout After Period 3||0
4978448|NCT02549027|12245835|P4|STARTED|Washout After Period 3||5
4978449|NCT02549027|12245836|P3|STARTED|Washout After Period 3||5
4978450|NCT02549027|12245837|P2|STARTED|Washout After Period 3||5
4978451|NCT02549027|12245838|P1|STARTED|Washout After Period 3||5
4978452|NCT02549027|12245833|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978453|NCT02549027|12245834|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978454|NCT02549027|12245835|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978455|NCT02549027|12245836|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978456|NCT02549027|12245837|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978457|NCT02549027|12245838|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
4978458|NCT02549027|12245833|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
4978459|NCT02549027|12245834|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
4978460|NCT02549027|12245835|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
4978461|NCT02549027|12245836|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
4978462|NCT02549027|12245837|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
4978463|NCT02549027|12245838|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
4978464|NCT02549027|12245833|P6|STARTED|Period 3 - MK-1064 or Placebo||0
4978465|NCT02549027|12245834|P5|STARTED|Period 3 - MK-1064 or Placebo||0
4978466|NCT02549027|12245835|P4|STARTED|Period 3 - MK-1064 or Placebo||5
4978467|NCT02549027|12245836|P3|STARTED|Period 3 - MK-1064 or Placebo||5
4978468|NCT02549027|12245837|P2|STARTED|Period 3 - MK-1064 or Placebo||5
4978469|NCT02549027|12245838|P1|STARTED|Period 3 - MK-1064 or Placebo||5
4978470|NCT02549027|12245833|P6|NOT COMPLETED|Washout After Period 2||0
4978471|NCT02549027|12245834|P5|NOT COMPLETED|Washout After Period 2||0
4978472|NCT02549027|12245835|P4|NOT COMPLETED|Washout After Period 2||0
4978473|NCT02549027|12245836|P3|NOT COMPLETED|Washout After Period 2||0
4978474|NCT02549027|12245837|P2|NOT COMPLETED|Washout After Period 2||0
4978475|NCT02549027|12245838|P1|NOT COMPLETED|Washout After Period 2||0
4978476|NCT02549027|12245833|P6|COMPLETED|Washout After Period 2||0
4978477|NCT02549027|12245834|P5|COMPLETED|Washout After Period 2||0
4978478|NCT02549027|12245835|P4|COMPLETED|Washout After Period 2||5
4978479|NCT02549027|12245836|P3|COMPLETED|Washout After Period 2||5
4978480|NCT02549027|12245837|P2|COMPLETED|Washout After Period 2||5
4978481|NCT02549027|12245838|P1|COMPLETED|Washout After Period 2||5
4978482|NCT02549027|12245833|P6|STARTED|Washout After Period 2||0
4978483|NCT02549027|12245834|P5|STARTED|Washout After Period 2||0
4978484|NCT02549027|12245835|P4|STARTED|Washout After Period 2||5
4978485|NCT02549027|12245836|P3|STARTED|Washout After Period 2||5
4978486|NCT02549027|12245837|P2|STARTED|Washout After Period 2||5
4978487|NCT02549027|12245838|P1|STARTED|Washout After Period 2||5
4978488|NCT02549027|12245833|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978489|NCT02549027|12245834|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978490|NCT02549027|12245835|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978491|NCT02549027|12245836|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978492|NCT02549027|12245837|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978493|NCT02549027|12245838|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
4978494|NCT02549027|12245833|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
4978495|NCT02549027|12245834|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
4978496|NCT02549027|12245835|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
4978497|NCT02549027|12245836|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
4978498|NCT02549027|12245837|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
4978499|NCT02549027|12245838|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
4978500|NCT02549027|12245833|P6|STARTED|Period 2 - MK-1064 or Placebo||0
4978501|NCT02549027|12245834|P5|STARTED|Period 2 - MK-1064 or Placebo||0
4978502|NCT02549027|12245835|P4|STARTED|Period 2 - MK-1064 or Placebo||5
4978503|NCT02549027|12245836|P3|STARTED|Period 2 - MK-1064 or Placebo||5
4978504|NCT02549027|12245837|P2|STARTED|Period 2 - MK-1064 or Placebo||5
4978505|NCT02549027|12245838|P1|STARTED|Period 2 - MK-1064 or Placebo||5
4978506|NCT02549027|12245833|P6|NOT COMPLETED|Washout After Period 1||0
4978507|NCT02549027|12245834|P5|NOT COMPLETED|Washout After Period 1||0
4978508|NCT02549027|12245835|P4|NOT COMPLETED|Washout After Period 1||0
4978509|NCT02549027|12245836|P3|NOT COMPLETED|Washout After Period 1||0
4978510|NCT02549027|12245837|P2|NOT COMPLETED|Washout After Period 1||0
4978511|NCT02549027|12245838|P1|NOT COMPLETED|Washout After Period 1||0
4978512|NCT02549027|12245833|P6|COMPLETED|Washout After Period 1||0
4978513|NCT02549027|12245834|P5|COMPLETED|Washout After Period 1||0
4978514|NCT02549027|12245835|P4|COMPLETED|Washout After Period 1||5
4978515|NCT02549027|12245836|P3|COMPLETED|Washout After Period 1||5
4978516|NCT02549027|12245837|P2|COMPLETED|Washout After Period 1||5
4978517|NCT02549027|12245838|P1|COMPLETED|Washout After Period 1||5
4978518|NCT02549027|12245833|P6|STARTED|Washout After Period 1||0
4978519|NCT02549027|12245834|P5|STARTED|Washout After Period 1||0
4978520|NCT02549027|12245835|P4|STARTED|Washout After Period 1||5
4978521|NCT02549027|12245836|P3|STARTED|Washout After Period 1||5
4978522|NCT02549027|12245837|P2|STARTED|Washout After Period 1||5
4978523|NCT02549027|12245838|P1|STARTED|Washout After Period 1||5
4978524|NCT02549027|12245833|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978525|NCT02549027|12245834|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978526|NCT02549027|12245835|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978527|NCT02549027|12245836|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978528|NCT02549027|12245837|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978529|NCT02549027|12245838|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
4978530|NCT02549027|12245833|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
4978531|NCT02549027|12245834|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
4978532|NCT02549027|12245835|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
4978533|NCT02549027|12245836|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
4978534|NCT02549027|12245837|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
4978535|NCT02549027|12245838|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
4978536|NCT02549027|12245833|P6|STARTED|Period 1 - MK-1064 or Placebo||0
4978537|NCT02549027|12245834|P5|STARTED|Period 1 - MK-1064 or Placebo||0
4978538|NCT02549027|12245835|P4|STARTED|Period 1 - MK-1064 or Placebo||5
4978539|NCT02549027|12245836|P3|STARTED|Period 1 - MK-1064 or Placebo||5
4978540|NCT02549027|12245837|P2|STARTED|Period 1 - MK-1064 or Placebo||5
4978541|NCT02549027|12245838|P1|STARTED|Period 1 - MK-1064 or Placebo||5
4978542|NCT02549014|12245875|P2|NOT COMPLETED|Overall Study||0
4978543|NCT02549014|12245876|P1|NOT COMPLETED|Overall Study||0
4978544|NCT02549014|12245875|P2|COMPLETED|Overall Study||8
4978545|NCT02549014|12245876|P1|COMPLETED|Overall Study||8
4978546|NCT02549014|12245875|P2|STARTED|Overall Study||8
4978547|NCT02549014|12245876|P1|STARTED|Overall Study||8
4978548|NCT02548962|12245968|P2|NOT COMPLETED|Overall Study||0
4978549|NCT02548962|12245969|P1|NOT COMPLETED|Overall Study||1
4978550|NCT02548962|12245968|P2|COMPLETED|Overall Study||3
4978551|NCT02548962|12245969|P1|COMPLETED|Overall Study||7
4978552|NCT02548962|12245968|P2|STARTED|Overall Study||3
4978553|NCT02548962|12245969|P1|STARTED|Overall Study||8
4978554|NCT02548845|12245979|P1|NOT COMPLETED|Overall Study||0
4978555|NCT02548845|12245979|P1|COMPLETED|Overall Study||70
4978556|NCT02548845|12245979|P1|STARTED|Overall Study||70
4978557|NCT02548754|12245993|P2|NOT COMPLETED|Overall Study||4
4978558|NCT02548754|12245994|P1|NOT COMPLETED|Overall Study||2
4978559|NCT02548754|12245993|P2|COMPLETED|Overall Study||23
4978560|NCT02548754|12245994|P1|COMPLETED|Overall Study||24
4978561|NCT02548754|12245993|P2|STARTED|Overall Study||27
4978562|NCT02548754|12245994|P1|STARTED|Overall Study||26
4978563|NCT02548728|12246006|P2|NOT COMPLETED|Overall Study||0
4978564|NCT02548728|12246007|P1|NOT COMPLETED|Overall Study||0
4978565|NCT02548728|12246006|P2|COMPLETED|Overall Study||6
4978566|NCT02548728|12246007|P1|COMPLETED|Overall Study||6
4978567|NCT02548728|12246006|P2|STARTED|Overall Study||6
4978568|NCT02548728|12246007|P1|STARTED|Overall Study||6
4978569|NCT02548650|12246021|P2|NOT COMPLETED|Double Therapy||2
4978570|NCT02548650|12246022|P1|NOT COMPLETED|Double Therapy||1
4978571|NCT02548650|12246021|P2|COMPLETED|Double Therapy||30
4978572|NCT02548650|12246022|P1|COMPLETED|Double Therapy||28
4978573|NCT02548650|12246021|P2|STARTED|Double Therapy||32
4978574|NCT02548650|12246022|P1|STARTED|Double Therapy||29
4978575|NCT02548650|12246021|P2|NOT COMPLETED|Triple Therapy||4
4978576|NCT02548650|12246022|P1|NOT COMPLETED|Triple Therapy||1
4978577|NCT02548650|12246021|P2|COMPLETED|Triple Therapy||32
4978578|NCT02548650|12246022|P1|COMPLETED|Triple Therapy||29
4978579|NCT02548650|12246021|P2|STARTED|Triple Therapy||36
4978580|NCT02548650|12246022|P1|STARTED|Triple Therapy||30
4978581|NCT02548585|12246037|P7|NOT COMPLETED|Overall Study||1
4978582|NCT02548585|12246038|P6|NOT COMPLETED|Overall Study||2
4978583|NCT02548585|12246039|P5|NOT COMPLETED|Overall Study||3
4978584|NCT02548585|12246040|P4|NOT COMPLETED|Overall Study||2
4978585|NCT02548585|12246041|P3|NOT COMPLETED|Overall Study||0
4978586|NCT02548585|12246042|P2|NOT COMPLETED|Overall Study||0
4978587|NCT02548585|12246043|P1|NOT COMPLETED|Overall Study||2
4978588|NCT02548585|12246037|P7|COMPLETED|Overall Study||11
4978589|NCT02548585|12246038|P6|COMPLETED|Overall Study||10
4978590|NCT02548585|12246039|P5|COMPLETED|Overall Study||22
4978591|NCT02548585|12246040|P4|COMPLETED|Overall Study||5
4978592|NCT02548585|12246041|P3|COMPLETED|Overall Study||6
4978593|NCT02548585|12246042|P2|COMPLETED|Overall Study||6
4978594|NCT02548585|12246043|P1|COMPLETED|Overall Study||43
4978595|NCT02548585|12246037|P7|Treated|Overall Study||12
4978596|NCT02548585|12246038|P6|Treated|Overall Study||11
4978597|NCT02548585|12246039|P5|Treated|Overall Study||25
4978598|NCT02548585|12246040|P4|Treated|Overall Study||7
4978599|NCT02548585|12246041|P3|Treated|Overall Study||6
4978600|NCT02548585|12246042|P2|Treated|Overall Study||6
4978601|NCT02548585|12246043|P1|Treated|Overall Study||45
4978602|NCT02548585|12246037|P7|STARTED|Overall Study||12
4978603|NCT02548585|12246038|P6|STARTED|Overall Study||12
4978604|NCT02548585|12246039|P5|STARTED|Overall Study||25
4978605|NCT02548585|12246040|P4|STARTED|Overall Study||7
4978606|NCT02548585|12246041|P3|STARTED|Overall Study||6
4978607|NCT02548585|12246042|P2|STARTED|Overall Study||6
4978608|NCT02548585|12246043|P1|STARTED|Overall Study||45
4978609|NCT02548455|12246261|P1|NOT COMPLETED|Overall Study||240
4978610|NCT02548455|12246261|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
4978611|NCT02548455|12246261|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
4978612|NCT02548455|12246261|P1|Completed 6-Month Follow-up|Overall Study||259
4978613|NCT02548455|12246261|P1|Completed Pre-Discharge|Overall Study||484
4978614|NCT02548455|12246261|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
4978615|NCT02548312|12246273|P8|NOT COMPLETED|Overall Study||42
4978616|NCT02548312|12246274|P7|NOT COMPLETED|Overall Study||40
4978617|NCT02548312|12246275|P6|NOT COMPLETED|Overall Study||40
4978618|NCT02548312|12246276|P5|NOT COMPLETED|Overall Study||34
4978619|NCT02548312|12246277|P4|NOT COMPLETED|Overall Study||46
4978620|NCT02548312|12246278|P3|NOT COMPLETED|Overall Study||38
4978621|NCT02548312|12246279|P2|NOT COMPLETED|Overall Study||43
4978622|NCT02548312|12246280|P1|NOT COMPLETED|Overall Study||33
4978623|NCT02548312|12246273|P8|COMPLETED|Overall Study||91
4978624|NCT02548312|12246274|P7|COMPLETED|Overall Study||93
4978625|NCT02548312|12246275|P6|COMPLETED|Overall Study||93
4978626|NCT02548312|12246276|P5|COMPLETED|Overall Study||99
4978627|NCT02548312|12246277|P4|COMPLETED|Overall Study||87
4978628|NCT02548312|12246278|P3|COMPLETED|Overall Study||96
4978629|NCT02548312|12246279|P2|COMPLETED|Overall Study||90
4978630|NCT02548312|12246280|P1|COMPLETED|Overall Study||100
4978631|NCT02548312|12246273|P8|STARTED|Overall Study||133
4978632|NCT02548312|12246274|P7|STARTED|Overall Study||133
4978633|NCT02548312|12246275|P6|STARTED|Overall Study||133
4978634|NCT02548312|12246276|P5|STARTED|Overall Study||133
4978635|NCT02548312|12246277|P4|STARTED|Overall Study||133
4978636|NCT02548312|12246278|P3|STARTED|Overall Study||134
4978637|NCT02548312|12246279|P2|STARTED|Overall Study||133
4978638|NCT02548312|12246280|P1|STARTED|Overall Study||133
4978639|NCT02548156|12246322|P6|NOT COMPLETED|Period 3||0
4978640|NCT02548156|12246323|P5|NOT COMPLETED|Period 3||0
4978641|NCT02548156|12246324|P4|NOT COMPLETED|Period 3||0
4978642|NCT02548156|12246325|P3|NOT COMPLETED|Period 3||0
4978643|NCT02548156|12246326|P2|NOT COMPLETED|Period 3||0
4978644|NCT02548156|12246327|P1|NOT COMPLETED|Period 3||0
4978645|NCT02548156|12246322|P6|COMPLETED|Period 3||5
4978646|NCT02548156|12246323|P5|COMPLETED|Period 3||4
4978647|NCT02548156|12246324|P4|COMPLETED|Period 3||5
4978648|NCT02548156|12246325|P3|COMPLETED|Period 3||4
4978649|NCT02548156|12246326|P2|COMPLETED|Period 3||5
4978650|NCT02548156|12246327|P1|COMPLETED|Period 3||5
4978651|NCT02548156|12246322|P6|STARTED|Period 3||5
4978652|NCT02548156|12246323|P5|STARTED|Period 3||4
4978653|NCT02548156|12246324|P4|STARTED|Period 3||5
4978654|NCT02548156|12246325|P3|STARTED|Period 3||4
4978655|NCT02548156|12246326|P2|STARTED|Period 3||5
4978656|NCT02548156|12246327|P1|STARTED|Period 3||5
4978657|NCT02548156|12246322|P6|NOT COMPLETED|Washout Period 2||0
4978658|NCT02548156|12246323|P5|NOT COMPLETED|Washout Period 2||0
4978659|NCT02548156|12246324|P4|NOT COMPLETED|Washout Period 2||0
4978660|NCT02548156|12246325|P3|NOT COMPLETED|Washout Period 2||0
4978661|NCT02548156|12246326|P2|NOT COMPLETED|Washout Period 2||0
4978662|NCT02548156|12246327|P1|NOT COMPLETED|Washout Period 2||0
4978663|NCT02548156|12246322|P6|COMPLETED|Washout Period 2||5
4978664|NCT02548156|12246323|P5|COMPLETED|Washout Period 2||4
4978665|NCT02548156|12246324|P4|COMPLETED|Washout Period 2||5
4978666|NCT02548156|12246325|P3|COMPLETED|Washout Period 2||4
4978667|NCT02548156|12246326|P2|COMPLETED|Washout Period 2||5
4978668|NCT02548156|12246327|P1|COMPLETED|Washout Period 2||5
4978669|NCT02548156|12246322|P6|STARTED|Washout Period 2||5
4978670|NCT02548156|12246323|P5|STARTED|Washout Period 2||4
4978671|NCT02548156|12246324|P4|STARTED|Washout Period 2||5
4978672|NCT02548156|12246325|P3|STARTED|Washout Period 2||4
4978673|NCT02548156|12246326|P2|STARTED|Washout Period 2||5
4978674|NCT02548156|12246327|P1|STARTED|Washout Period 2||5
4978675|NCT02548156|12246322|P6|NOT COMPLETED|Period 2||0
4978676|NCT02548156|12246323|P5|NOT COMPLETED|Period 2||0
4978677|NCT02548156|12246324|P4|NOT COMPLETED|Period 2||0
4978678|NCT02548156|12246325|P3|NOT COMPLETED|Period 2||0
4978679|NCT02548156|12246326|P2|NOT COMPLETED|Period 2||0
4978680|NCT02548156|12246327|P1|NOT COMPLETED|Period 2||0
4978681|NCT02548156|12246322|P6|COMPLETED|Period 2||5
4978682|NCT02548156|12246323|P5|COMPLETED|Period 2||4
4978683|NCT02548156|12246324|P4|COMPLETED|Period 2||5
4978684|NCT02548156|12246325|P3|COMPLETED|Period 2||4
4978685|NCT02548156|12246326|P2|COMPLETED|Period 2||5
4978686|NCT02548156|12246327|P1|COMPLETED|Period 2||5
4978687|NCT02548156|12246322|P6|STARTED|Period 2||5
4978688|NCT02548156|12246323|P5|STARTED|Period 2||4
4978689|NCT02548156|12246324|P4|STARTED|Period 2||5
4978690|NCT02548156|12246325|P3|STARTED|Period 2||4
4978691|NCT02548156|12246326|P2|STARTED|Period 2||5
4978692|NCT02548156|12246327|P1|STARTED|Period 2||5
4978693|NCT02548156|12246322|P6|NOT COMPLETED|Washout Period 1||0
4978694|NCT02548156|12246323|P5|NOT COMPLETED|Washout Period 1||1
4978695|NCT02548156|12246324|P4|NOT COMPLETED|Washout Period 1||0
4978696|NCT02548156|12246325|P3|NOT COMPLETED|Washout Period 1||0
4978697|NCT02548156|12246326|P2|NOT COMPLETED|Washout Period 1||0
4978698|NCT02548156|12246327|P1|NOT COMPLETED|Washout Period 1||0
4978699|NCT02548156|12246322|P6|COMPLETED|Washout Period 1||5
4978700|NCT02548156|12246323|P5|COMPLETED|Washout Period 1||4
4978701|NCT02548156|12246324|P4|COMPLETED|Washout Period 1||5
4978702|NCT02548156|12246325|P3|COMPLETED|Washout Period 1||4
4978703|NCT02548156|12246326|P2|COMPLETED|Washout Period 1||5
4978704|NCT02548156|12246327|P1|COMPLETED|Washout Period 1||5
4978705|NCT02548156|12246322|P6|STARTED|Washout Period 1||5
4978706|NCT02548156|12246323|P5|STARTED|Washout Period 1||5
4978707|NCT02548156|12246324|P4|STARTED|Washout Period 1||5
4978708|NCT02548156|12246325|P3|STARTED|Washout Period 1||4
4978709|NCT02548156|12246326|P2|STARTED|Washout Period 1||5
4978710|NCT02548156|12246327|P1|STARTED|Washout Period 1||5
4978711|NCT02548156|12246322|P6|NOT COMPLETED|Period 1||0
4978712|NCT02548156|12246323|P5|NOT COMPLETED|Period 1||0
4978713|NCT02548156|12246324|P4|NOT COMPLETED|Period 1||0
4978714|NCT02548156|12246325|P3|NOT COMPLETED|Period 1||0
4978715|NCT02548156|12246326|P2|NOT COMPLETED|Period 1||0
4978716|NCT02548156|12246327|P1|NOT COMPLETED|Period 1||0
4978717|NCT02548156|12246322|P6|COMPLETED|Period 1||5
4978718|NCT02548156|12246323|P5|COMPLETED|Period 1||5
4978719|NCT02548156|12246324|P4|COMPLETED|Period 1||5
4978720|NCT02548156|12246325|P3|COMPLETED|Period 1||4
4978721|NCT02548156|12246326|P2|COMPLETED|Period 1||5
4978722|NCT02548156|12246327|P1|COMPLETED|Period 1||5
4978723|NCT02548156|12246322|P6|STARTED|Period 1||5
4978724|NCT02548156|12246323|P5|STARTED|Period 1||5
4978725|NCT02548156|12246324|P4|STARTED|Period 1||5
4978726|NCT02548156|12246325|P3|STARTED|Period 1||4
4978727|NCT02548156|12246326|P2|STARTED|Period 1||5
4978728|NCT02548156|12246327|P1|STARTED|Period 1||5
4978729|NCT02548143|12246346|P2|NOT COMPLETED|Overall Study||1
4978730|NCT02548143|12246347|P1|NOT COMPLETED|Overall Study||1
4978731|NCT02548143|12246346|P2|COMPLETED|Overall Study||5
4978732|NCT02548143|12246347|P1|COMPLETED|Overall Study||5
4978733|NCT02548143|12246346|P2|STARTED|Overall Study||6
4978734|NCT02548143|12246347|P1|STARTED|Overall Study||6
4978735|NCT02548078|12246359|P2|NOT COMPLETED|Overall Study||6
4978736|NCT02548078|12246360|P1|NOT COMPLETED|Overall Study||5
4978737|NCT02548078|12246359|P2|COMPLETED|Overall Study||294
4978738|NCT02548078|12246360|P1|COMPLETED|Overall Study||295
4978739|NCT02548078|12246359|P2|STARTED|Overall Study||300
4978740|NCT02548078|12246360|P1|STARTED|Overall Study||300
4978741|NCT02547987|12246548|P1|NOT COMPLETED|Overall Study||3
4978742|NCT02547987|12246548|P1|COMPLETED|Overall Study||22
4978743|NCT02547987|12246548|P1|STARTED|Overall Study||25
4978744|NCT02547974|12246556|P4|NOT COMPLETED|Overall Study||0
4978745|NCT02547974|12246557|P3|NOT COMPLETED|Overall Study||0
4978746|NCT02547974|12246558|P2|NOT COMPLETED|Overall Study||0
4978747|NCT02547974|12246559|P1|NOT COMPLETED|Overall Study||1
4978748|NCT02547974|12246556|P4|COMPLETED|Overall Study||44
4978749|NCT02547974|12246557|P3|COMPLETED|Overall Study||30
4978750|NCT02547974|12246558|P2|COMPLETED|Overall Study||31
4978751|NCT02547974|12246559|P1|COMPLETED|Overall Study||14
4978752|NCT02547974|12246556|P4|STARTED|Overall Study||44
4978753|NCT02547974|12246557|P3|STARTED|Overall Study||30
4978754|NCT02547974|12246558|P2|STARTED|Overall Study||31
4978755|NCT02547974|12246559|P1|STARTED|Overall Study||15
4978756|NCT02547935|12246646|P3|NOT COMPLETED|Overall Study||5
4978757|NCT02547935|12246647|P2|NOT COMPLETED|Overall Study||8
4978758|NCT02547935|12246648|P1|NOT COMPLETED|Overall Study||5
4978759|NCT02547935|12246646|P3|COMPLETED|Overall Study||143
4978760|NCT02547935|12246647|P2|COMPLETED|Overall Study||137
4978761|NCT02547935|12246648|P1|COMPLETED|Overall Study||150
4978762|NCT02547935|12246646|P3|Safety Analysis Set|Overall Study||148
4978763|NCT02547935|12246647|P2|Safety Analysis Set|Overall Study||145
4978764|NCT02547935|12246648|P1|Safety Analysis Set|Overall Study||152
4978765|NCT02547935|12246646|P3|Full Analysis Set|Overall Study||148
4978766|NCT02547935|12246647|P2|Full Analysis Set|Overall Study||144
4978767|NCT02547935|12246648|P1|Full Analysis Set|Overall Study||152
4978768|NCT02547935|12246646|P3|Received Treatment|Overall Study||148
4978769|NCT02547935|12246647|P2|Received Treatment|Overall Study||145
4978770|NCT02547935|12246648|P1|Received Treatment|Overall Study||152
4978771|NCT02547935|12246646|P3|STARTED|Overall Study||148
4978772|NCT02547935|12246647|P2|STARTED|Overall Study||145
4978773|NCT02547935|12246648|P1|STARTED|Overall Study||155
4978774|NCT02547779|12246677|P2|NOT COMPLETED|Overall Study||0
4978775|NCT02547779|12246678|P1|NOT COMPLETED|Overall Study||0
4978776|NCT02547779|12246677|P2|COMPLETED|Overall Study||5207
4978777|NCT02547779|12246678|P1|COMPLETED|Overall Study||5214
4978778|NCT02547779|12246677|P2|STARTED|Overall Study||5207
4978779|NCT02547779|12246678|P1|STARTED|Overall Study||5214
4978780|NCT02547766|12246686|P1|NOT COMPLETED|Overall Study||1
4978781|NCT02547766|12246686|P1|COMPLETED|Overall Study||9
4978782|NCT02547766|12246686|P1|STARTED|Overall Study||10
4978783|NCT02547714|12246693|P1|NOT COMPLETED|Overall Study||0
4978784|NCT02547714|12246693|P1|COMPLETED|Overall Study||34
4978785|NCT02547714|12246693|P1|STARTED|Overall Study||34
4978786|NCT02547649|12246706|P3|NOT COMPLETED|Overall Study||4
4978787|NCT02547649|12246707|P2|NOT COMPLETED|Overall Study||5
4978788|NCT02547649|12246708|P1|NOT COMPLETED|Overall Study||3
4978789|NCT02547649|12246706|P3|COMPLETED|Overall Study||224
4978790|NCT02547649|12246707|P2|COMPLETED|Overall Study||226
4978791|NCT02547649|12246708|P1|COMPLETED|Overall Study||228
4978792|NCT02547649|12246706|P3|Vaccinated|Overall Study||227
4978793|NCT02547649|12246707|P2|Vaccinated|Overall Study||231
4978794|NCT02547649|12246708|P1|Vaccinated|Overall Study||231
4978795|NCT02547649|12246706|P3|STARTED|Overall Study||228
4978796|NCT02547649|12246707|P2|STARTED|Overall Study||231
4978797|NCT02547649|12246708|P1|STARTED|Overall Study||231
4978798|NCT02547623|12246742|P2|NOT COMPLETED|Overall Study||3
4978799|NCT02547623|12246743|P1|NOT COMPLETED|Overall Study||4
4978800|NCT02547623|12246742|P2|COMPLETED|Overall Study||52
4978801|NCT02547623|12246743|P1|COMPLETED|Overall Study||122
4978802|NCT02547623|12246742|P2|STARTED|Overall Study||55
4978803|NCT02547623|12246743|P1|STARTED|Overall Study||126
4978804|NCT02547454|12246773|P1|NOT COMPLETED|Overall Study||172
4978805|NCT02547454|12246773|P1|COMPLETED|Overall Study||221
4978806|NCT02547454|12246773|P1|STARTED|Overall Study||393
4978807|NCT02547363|12246803|P2|NOT COMPLETED|12-month Follow-up||5
4978808|NCT02547363|12246804|P1|NOT COMPLETED|12-month Follow-up||10
4978809|NCT02547363|12246803|P2|COMPLETED|12-month Follow-up||81
4978810|NCT02547363|12246804|P1|COMPLETED|12-month Follow-up||194
4978811|NCT02547363|12246803|P2|STARTED|12-month Follow-up||86
4978812|NCT02547363|12246804|P1|STARTED|12-month Follow-up||204
4978813|NCT02547363|12246803|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
4978814|NCT02547363|12246804|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
4978815|NCT02547363|12246803|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
4978816|NCT02547363|12246804|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
4978817|NCT02547363|12246803|P2|Treated|3-day Treatment and 8-week Follow-up||104
4978818|NCT02547363|12246804|P1|Treated|3-day Treatment and 8-week Follow-up||209
4978819|NCT02547363|12246803|P2|STARTED|3-day Treatment and 8-week Follow-up||105
4978820|NCT02547363|12246804|P1|STARTED|3-day Treatment and 8-week Follow-up||211
4978821|NCT02547233|12246820|P2|NOT COMPLETED|12-month Follow-up||17
4978822|NCT02547233|12246821|P1|NOT COMPLETED|12-month Follow-up||14
4978823|NCT02547233|12246820|P2|COMPLETED|12-month Follow-up||67
4978824|NCT02547233|12246821|P1|COMPLETED|12-month Follow-up||185
4978825|NCT02547233|12246820|P2|STARTED|12-month Follow-up||84
4978826|NCT02547233|12246821|P1|STARTED|12-month Follow-up||199
4978827|NCT02547233|12246820|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
4978828|NCT02547233|12246821|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
4978829|NCT02547233|12246820|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
4978830|NCT02547233|12246821|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
4978831|NCT02547233|12246820|P2|Treated|3-day Treatment and 8-week Follow-up||100
4978832|NCT02547233|12246821|P1|Treated|3-day Treatment and 8-week Follow-up||205
4978833|NCT02547233|12246820|P2|STARTED|3-day Treatment and 8-week Follow-up||102
4978834|NCT02547233|12246821|P1|STARTED|3-day Treatment and 8-week Follow-up||205
4978835|NCT02547220|12246837|P2|NOT COMPLETED|Overall Study||20
4978836|NCT02547220|12246838|P1|NOT COMPLETED|Overall Study||19
4978837|NCT02547220|12246837|P2|COMPLETED|Overall Study||0
4978838|NCT02547220|12246838|P1|COMPLETED|Overall Study||0
4978839|NCT02547220|12246837|P2|STARTED|Overall Study||20
4978840|NCT02547220|12246838|P1|STARTED|Overall Study||19
4978841|NCT02547129|12246874|P2|NOT COMPLETED|Overall Study||0
4978842|NCT02547129|12246875|P1|NOT COMPLETED|Overall Study||1
4978843|NCT02547129|12246874|P2|COMPLETED|Overall Study||2
4978844|NCT02547129|12246875|P1|COMPLETED|Overall Study||1
4978845|NCT02547129|12246874|P2|STARTED|Overall Study||2
4978846|NCT02547129|12246875|P1|STARTED|Overall Study||2
4978847|NCT02547064|12246889|P2|NOT COMPLETED|Overall Study||2
4978848|NCT02547064|12246890|P1|NOT COMPLETED|Overall Study||3
4978849|NCT02547064|12246889|P2|COMPLETED|Overall Study||79
4978850|NCT02547064|12246890|P1|COMPLETED|Overall Study||78
4978851|NCT02547064|12246889|P2|STARTED|Overall Study||81
4978852|NCT02547064|12246890|P1|STARTED|Overall Study||81
4978853|NCT02547038|12246918|P2|NOT COMPLETED|Overall Study||2
4978854|NCT02547038|12246919|P1|NOT COMPLETED|Overall Study||3
4978855|NCT02547038|12246918|P2|COMPLETED|Overall Study||174
4978856|NCT02547038|12246919|P1|COMPLETED|Overall Study||173
4978857|NCT02547038|12246918|P2|STARTED|Overall Study||176
4978858|NCT02547038|12246919|P1|STARTED|Overall Study||176
4978859|NCT02547012|12246927|P2|NOT COMPLETED|Overall Study||0
4978860|NCT02547012|12246928|P1|NOT COMPLETED|Overall Study||0
4978861|NCT02547012|12246927|P2|COMPLETED|Overall Study||27
4978862|NCT02547012|12246928|P1|COMPLETED|Overall Study||24
4978863|NCT02547012|12246927|P2|STARTED|Overall Study||27
4978864|NCT02547012|12246928|P1|STARTED|Overall Study||24
4978865|NCT02546986|12246936|P2|NOT COMPLETED|Survival Follow-Up Phase||35
4978866|NCT02546986|12246937|P1|NOT COMPLETED|Survival Follow-Up Phase||36
4978867|NCT02546986|12246936|P2|COMPLETED|Survival Follow-Up Phase||0
4978868|NCT02546986|12246937|P1|COMPLETED|Survival Follow-Up Phase||0
4978869|NCT02546986|12246936|P2|STARTED|Survival Follow-Up Phase||35
4978870|NCT02546986|12246937|P1|STARTED|Survival Follow-Up Phase||36
4978871|NCT02546986|12246936|P2|NOT COMPLETED|Treatment Period||49
4978872|NCT02546986|12246937|P1|NOT COMPLETED|Treatment Period||51
4978873|NCT02546986|12246936|P2|COMPLETED|Treatment Period||0
4978874|NCT02546986|12246937|P1|COMPLETED|Treatment Period||0
4978875|NCT02546986|12246936|P2|STARTED|Treatment Period||49
4978876|NCT02546986|12246937|P1|STARTED|Treatment Period||51
4978877|NCT02546765|12246964|P4|NOT COMPLETED|Overall Study||0
4978878|NCT02546765|12246965|P3|NOT COMPLETED|Overall Study||0
4978879|NCT02546765|12246966|P2|NOT COMPLETED|Overall Study||1
4978880|NCT02546765|12246967|P1|NOT COMPLETED|Overall Study||0
4978881|NCT02546765|12246964|P4|COMPLETED|Overall Study||30
4978882|NCT02546765|12246965|P3|COMPLETED|Overall Study||30
4978883|NCT02546765|12246966|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
4978884|NCT02546765|12246967|P1|COMPLETED|Overall Study||31
4978885|NCT02546765|12246964|P4|STARTED|Overall Study||30
4978886|NCT02546765|12246965|P3|STARTED|Overall Study||30
4978887|NCT02546765|12246966|P2|STARTED|Overall Study||30
4978888|NCT02546765|12246967|P1|STARTED|Overall Study||31
4978889|NCT02546609|12247008|P3|NOT COMPLETED|Overall Study||7
4978890|NCT02546609|12247009|P2|NOT COMPLETED|Overall Study||11
4978891|NCT02546609|12247010|P1|NOT COMPLETED|Overall Study||2
4978892|NCT02546609|12247008|P3|COMPLETED|Overall Study||25
4978893|NCT02546609|12247009|P2|COMPLETED|Overall Study||24
4978894|NCT02546609|12247010|P1|COMPLETED|Overall Study||22
4978895|NCT02546609|12247008|P3|STARTED|Overall Study||32
4978896|NCT02546609|12247009|P2|STARTED|Overall Study||35
4978897|NCT02546609|12247010|P1|STARTED|Overall Study||24
4978898|NCT02546570|12247053|P2|NOT COMPLETED|Overall Study||0
4978899|NCT02546570|12247054|P1|NOT COMPLETED|Overall Study||0
4978900|NCT02546570|12247053|P2|COMPLETED|Overall Study||2
4978901|NCT02546570|12247054|P1|COMPLETED|Overall Study||9
4978902|NCT02546570|12247053|P2|Crossover Order: Placebo, Oxytocin|Overall Study||0
4978903|NCT02546570|12247054|P1|Crossover Order: Placebo, Oxytocin|Overall Study||3
4978904|NCT02546570|12247053|P2|Crossover Order: Oxytocin, Placebo|Overall Study||2
4978905|NCT02546570|12247054|P1|Crossover Order: Oxytocin, Placebo|Overall Study||6
4978906|NCT02546570|12247053|P2|STARTED|Overall Study||2
4978907|NCT02546570|12247054|P1|STARTED|Overall Study||9
4978908|NCT02546544|12247090|P1|NOT COMPLETED|Overall Study||16
4978909|NCT02546544|12247090|P1|COMPLETED|Overall Study||0
4978910|NCT02546544|12247090|P1|Received Allocated Intervention|Overall Study||16
4978911|NCT02546544|12247090|P1|STARTED|Overall Study||16
4978912|NCT02546388|12247101|P2|NOT COMPLETED|Overall Study||0
4978913|NCT02546388|12247102|P1|NOT COMPLETED|Overall Study||0
4978914|NCT02546388|12247101|P2|COMPLETED|Overall Study||13
4978915|NCT02546388|12247102|P1|COMPLETED|Overall Study||4
4978916|NCT02546388|12247101|P2|STARTED|Overall Study||13
4978917|NCT02546388|12247102|P1|STARTED|Overall Study||4
4978918|NCT02546375|12247109|P1|NOT COMPLETED|Overall Study||0
4978919|NCT02546375|12247109|P1|COMPLETED|Overall Study||87
4978920|NCT02546375|12247109|P1|STARTED|Overall Study||87
4978921|NCT02546362|12247131|P1|NOT COMPLETED|12-week Treatment Period||9
4978922|NCT02546362|12247131|P1|COMPLETED|12-week Treatment Period||38
4978923|NCT02546362|12247131|P1|STARTED|12-week Treatment Period||47
4978924|NCT02546362|12247131|P1|NOT COMPLETED|4-week Treatment Period||3
4978925|NCT02546362|12247131|P1|COMPLETED|4-week Treatment Period||47
4978926|NCT02546362|12247131|P1|STARTED|4-week Treatment Period||50
4978927|NCT02546323|12247152|P2|NOT COMPLETED|Overall Study||66
4978928|NCT02546323|12247153|P1|NOT COMPLETED|Overall Study||60
4978929|NCT02546323|12247152|P2|COMPLETED|Overall Study||205
4978930|NCT02546323|12247153|P1|COMPLETED|Overall Study||212
4978931|NCT02546323|12247152|P2|Received Treatment|Overall Study||268
4978932|NCT02546323|12247153|P1|Received Treatment|Overall Study||272
4978933|NCT02546323|12247152|P2|STARTED|Overall Study||271
4978934|NCT02546323|12247153|P1|STARTED|Overall Study||272
4978935|NCT02546193|12247173|P4|NOT COMPLETED|Overall Study||0
4978936|NCT02546193|12247174|P3|NOT COMPLETED|Overall Study||2
4978937|NCT02546193|12247175|P2|NOT COMPLETED|Overall Study||6
4978938|NCT02546193|12247176|P1|NOT COMPLETED|Overall Study||6
4978939|NCT02546193|12247173|P4|COMPLETED|Overall Study||0
4978940|NCT02546193|12247174|P3|COMPLETED|Overall Study||0
4978941|NCT02546193|12247175|P2|COMPLETED|Overall Study||4
4978942|NCT02546193|12247176|P1|COMPLETED|Overall Study||4
4978943|NCT02546193|12247173|P4|STARTED|Overall Study||0
4978944|NCT02546193|12247174|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
4978945|NCT02546193|12247175|P2|STARTED|Overall Study||10
4978946|NCT02546193|12247176|P1|STARTED|Overall Study||10
4978947|NCT02545868|12247213|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
4978948|NCT02545868|12247214|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
4978949|NCT02545868|12247215|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
4978950|NCT02545868|12247213|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
4978951|NCT02545868|12247214|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
4978952|NCT02545868|12247215|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
4978953|NCT02545868|12247213|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
4978954|NCT02545868|12247214|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
4978955|NCT02545868|12247215|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
4978956|NCT02545868|12247213|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
4978957|NCT02545868|12247214|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
4978958|NCT02545868|12247215|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
4978959|NCT02545868|12247213|P3|COMPLETED|Immunization Study Period (ISP)||34
4978960|NCT02545868|12247214|P2|COMPLETED|Immunization Study Period (ISP)||35
4978961|NCT02545868|12247215|P1|COMPLETED|Immunization Study Period (ISP)||33
4978962|NCT02545868|12247213|P3|STARTED|Immunization Study Period (ISP)||34
4978963|NCT02545868|12247214|P2|STARTED|Immunization Study Period (ISP)||35
4978964|NCT02545868|12247215|P1|STARTED|Immunization Study Period (ISP)||33
4978965|NCT02545608|12247288|P2|NOT COMPLETED|Overall Study||7
4978966|NCT02545608|12247289|P1|NOT COMPLETED|Overall Study||0
4978967|NCT02545608|12247288|P2|COMPLETED|Overall Study||93
4978968|NCT02545608|12247289|P1|COMPLETED|Overall Study||9
4978969|NCT02545608|12247288|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
4978970|NCT02545608|12247289|P1|STARTED|Overall Study||9
4978971|NCT02545543|12247298|P2|NOT COMPLETED|Overall Study||34
4978972|NCT02545543|12247299|P1|NOT COMPLETED|Overall Study||81
4978973|NCT02545543|12247298|P2|COMPLETED|Overall Study||535
4978974|NCT02545543|12247299|P1|COMPLETED|Overall Study||1628
4978975|NCT02545543|12247298|P2|STARTED|Overall Study||569
4978976|NCT02545543|12247299|P1|STARTED|Overall Study||1709
4978977|NCT02545504|12247325|P2|NOT COMPLETED|Overall Study||214
4978978|NCT02545504|12247326|P1|NOT COMPLETED|Overall Study||218
4978979|NCT02545504|12247325|P2|COMPLETED|Overall Study||0
4978980|NCT02545504|12247326|P1|COMPLETED|Overall Study||0
4978981|NCT02545504|12247325|P2|STARTED|Overall Study||214
4978982|NCT02545504|12247326|P1|STARTED|Overall Study||218
4978983|NCT02545322|12247340|P1|NOT COMPLETED|Overall Study||3
4978984|NCT02545322|12247340|P1|COMPLETED|Overall Study||15
4978985|NCT02545322|12247340|P1|STARTED|Overall Study||18
4978986|NCT02545270|12247348|P3|NOT COMPLETED|Overall Study||2
4978987|NCT02545270|12247349|P2|NOT COMPLETED|Overall Study||1
4978988|NCT02545270|12247350|P1|NOT COMPLETED|Overall Study||0
4978989|NCT02545270|12247348|P3|COMPLETED|Overall Study||3
4978990|NCT02545270|12247349|P2|COMPLETED|Overall Study||4
4978991|NCT02545270|12247350|P1|COMPLETED|Overall Study||6
4978992|NCT02545270|12247348|P3|STARTED|Overall Study||5
4978993|NCT02545270|12247349|P2|STARTED|Overall Study||5
4978994|NCT02545270|12247350|P1|STARTED|Overall Study||6
4978995|NCT02545101|12247360|P1|NOT COMPLETED|Overall Study||0
4978996|NCT02545101|12247360|P1|COMPLETED|Overall Study||100
4978997|NCT02545101|12247360|P1|STARTED|Overall Study||100
4978998|NCT02545075|12247379|P2|NOT COMPLETED|Treatment||53
4978999|NCT02545075|12247380|P1|NOT COMPLETED|Treatment||122
4979000|NCT02545075|12247379|P2|COMPLETED|Treatment||0
4979001|NCT02545075|12247380|P1|COMPLETED|Treatment||0
4979002|NCT02545075|12247379|P2|STARTED|Treatment||53
4979003|NCT02545075|12247380|P1|STARTED|Treatment||122
4979004|NCT02545075|12247379|P2|NOT COMPLETED|Randomization||7
4979005|NCT02545075|12247380|P1|NOT COMPLETED|Randomization||0
4979006|NCT02545075|12247379|P2|COMPLETED|Randomization||53
4979007|NCT02545075|12247380|P1|COMPLETED|Randomization||122
4979008|NCT02545075|12247379|P2|STARTED|Randomization||60
4979009|NCT02545075|12247380|P1|STARTED|Randomization||122
4979010|NCT02544984|12247402|P2|NOT COMPLETED|Overall Study||2
4979011|NCT02544984|12247403|P1|NOT COMPLETED|Overall Study||2
4979012|NCT02544984|12247402|P2|COMPLETED|Overall Study||28
4979013|NCT02544984|12247403|P1|COMPLETED|Overall Study||28
4979014|NCT02544984|12247402|P2|STARTED|Overall Study||30
4979015|NCT02544984|12247403|P1|STARTED|Overall Study||30
4979016|NCT02544633|12247417|P4|NOT COMPLETED|Survival Follow-up Period||12
4979017|NCT02544633|12247418|P3|NOT COMPLETED|Survival Follow-up Period||7
4979018|NCT02544633|12247419|P2|NOT COMPLETED|Survival Follow-up Period||19
4979019|NCT02544633|12247420|P1|NOT COMPLETED|Survival Follow-up Period||28
4979020|NCT02544633|12247417|P4|COMPLETED|Survival Follow-up Period||0
4979021|NCT02544633|12247418|P3|COMPLETED|Survival Follow-up Period||0
4979022|NCT02544633|12247419|P2|COMPLETED|Survival Follow-up Period||0
4979023|NCT02544633|12247420|P1|COMPLETED|Survival Follow-up Period||0
4979024|NCT02544633|12247417|P4|STARTED|Survival Follow-up Period||12
4979025|NCT02544633|12247418|P3|STARTED|Survival Follow-up Period||7
4979026|NCT02544633|12247419|P2|STARTED|Survival Follow-up Period||19
4979027|NCT02544633|12247420|P1|STARTED|Survival Follow-up Period||28
4979028|NCT02544633|12247417|P4|NOT COMPLETED|Treatment Period||12
4979029|NCT02544633|12247418|P3|NOT COMPLETED|Treatment Period||8
4979030|NCT02544633|12247419|P2|NOT COMPLETED|Treatment Period||20
4979031|NCT02544633|12247420|P1|NOT COMPLETED|Treatment Period||28
4979032|NCT02544633|12247417|P4|COMPLETED|Treatment Period||0
4979033|NCT02544633|12247418|P3|COMPLETED|Treatment Period||0
4979034|NCT02544633|12247419|P2|COMPLETED|Treatment Period||0
4979035|NCT02544633|12247420|P1|COMPLETED|Treatment Period||0
4979036|NCT02544633|12247417|P4|STARTED|Treatment Period||12
4979037|NCT02544633|12247418|P3|STARTED|Treatment Period||8
4979038|NCT02544633|12247419|P2|STARTED|Treatment Period||20
4979039|NCT02544633|12247420|P1|STARTED|Treatment Period||28
4979040|NCT02544607|12247493|P1|NOT COMPLETED|Overall Study||0
4979041|NCT02544607|12247493|P1|COMPLETED|Overall Study||16
4979042|NCT02544607|12247493|P1|STARTED|Overall Study||16
4979043|NCT02544451|12247504|P3|NOT COMPLETED|Overall Study||1
4979044|NCT02544451|12247505|P2|NOT COMPLETED|Overall Study||12
4979045|NCT02544451|12247506|P1|NOT COMPLETED|Overall Study||14
4979046|NCT02544451|12247504|P3|COMPLETED|Overall Study||5
4979047|NCT02544451|12247505|P2|COMPLETED|Overall Study||84
4979048|NCT02544451|12247506|P1|COMPLETED|Overall Study||129
4979049|NCT02544451|12247504|P3|STARTED|Overall Study||6
4979050|NCT02544451|12247505|P2|STARTED|Overall Study||96
4979051|NCT02544451|12247506|P1|STARTED|Overall Study||143
4979052|NCT02544152|12247551|P2|NOT COMPLETED|Overall Study||7
4979053|NCT02544152|12247552|P1|NOT COMPLETED|Overall Study||1
4979054|NCT02544152|12247551|P2|COMPLETED|Overall Study||30
4979055|NCT02544152|12247552|P1|COMPLETED|Overall Study||33
4979056|NCT02544152|12247551|P2|Safety Analysis Set (SAS)|Overall Study||37
4979057|NCT02544152|12247552|P1|Safety Analysis Set (SAS)|Overall Study||34
4979058|NCT02544152|12247551|P2|Modified Intent to Treat (mITT)|Overall Study||37
4979059|NCT02544152|12247552|P1|Modified Intent to Treat (mITT)|Overall Study||34
4979060|NCT02544152|12247551|P2|STARTED|Overall Study||37
4979061|NCT02544152|12247552|P1|STARTED|Overall Study||34
4979062|NCT02544074|12247595|P21|NOT COMPLETED|Overall Study||0
4979063|NCT02544074|12247596|P20|NOT COMPLETED|Overall Study||0
4979064|NCT02544074|12247597|P19|NOT COMPLETED|Overall Study||0
4979065|NCT02544074|12247598|P18|NOT COMPLETED|Overall Study||0
4979066|NCT02544074|12247599|P17|NOT COMPLETED|Overall Study||0
4979067|NCT02544074|12247600|P16|NOT COMPLETED|Overall Study||0
4979068|NCT02544074|12247601|P15|NOT COMPLETED|Overall Study||0
4979069|NCT02544074|12247602|P14|NOT COMPLETED|Overall Study||0
4979070|NCT02544074|12247603|P13|NOT COMPLETED|Overall Study||0
4979071|NCT02544074|12247604|P12|NOT COMPLETED|Overall Study||0
4979072|NCT02544074|12247605|P11|NOT COMPLETED|Overall Study||0
4979073|NCT02544074|12247606|P10|NOT COMPLETED|Overall Study||1
4979074|NCT02544074|12247607|P9|NOT COMPLETED|Overall Study||0
4979075|NCT02544074|12247608|P8|NOT COMPLETED|Overall Study||0
4979076|NCT02544074|12247609|P7|NOT COMPLETED|Overall Study||0
4979077|NCT02544074|12247610|P6|NOT COMPLETED|Overall Study||1
4979078|NCT02544074|12247611|P5|NOT COMPLETED|Overall Study||0
4979079|NCT02544074|12247612|P4|NOT COMPLETED|Overall Study||0
4979080|NCT02544074|12247613|P3|NOT COMPLETED|Overall Study||0
4979081|NCT02544074|12247614|P2|NOT COMPLETED|Overall Study||1
4979082|NCT02544074|12247615|P1|NOT COMPLETED|Overall Study||0
4979083|NCT02544074|12247595|P21|COMPLETED|Overall Study||3
4979084|NCT02544074|12247596|P20|COMPLETED|Overall Study||3
4979085|NCT02544074|12247597|P19|COMPLETED|Overall Study||4
4979086|NCT02544074|12247598|P18|COMPLETED|Overall Study||3
4979087|NCT02544074|12247599|P17|COMPLETED|Overall Study||6
4979088|NCT02544074|12247600|P16|COMPLETED|Overall Study||8
4979089|NCT02544074|12247601|P15|COMPLETED|Overall Study||5
4979090|NCT02544074|12247602|P14|COMPLETED|Overall Study||5
4979091|NCT02544074|12247603|P13|COMPLETED|Overall Study||4
4979092|NCT02544074|12247604|P12|COMPLETED|Overall Study||3
4979093|NCT02544074|12247605|P11|COMPLETED|Overall Study||2
4979094|NCT02544074|12247606|P10|COMPLETED|Overall Study||1
4979095|NCT02544074|12247607|P9|COMPLETED|Overall Study||6
4979096|NCT02544074|12247608|P8|COMPLETED|Overall Study||4
4979097|NCT02544074|12247609|P7|COMPLETED|Overall Study||2
4979098|NCT02544074|12247610|P6|COMPLETED|Overall Study||0
4979099|NCT02544074|12247611|P5|COMPLETED|Overall Study||4
4979100|NCT02544074|12247612|P4|COMPLETED|Overall Study||1
4979101|NCT02544074|12247613|P3|COMPLETED|Overall Study||1
4979102|NCT02544074|12247614|P2|COMPLETED|Overall Study||0
4979103|NCT02544074|12247615|P1|COMPLETED|Overall Study||1
4979104|NCT02544074|12247595|P21|STARTED|Overall Study||3
4979105|NCT02544074|12247596|P20|STARTED|Overall Study||3
4979106|NCT02544074|12247597|P19|STARTED|Overall Study||4
4979107|NCT02544074|12247598|P18|STARTED|Overall Study||3
4979108|NCT02544074|12247599|P17|STARTED|Overall Study||6
4979109|NCT02544074|12247600|P16|STARTED|Overall Study||8
4979110|NCT02544074|12247601|P15|STARTED|Overall Study||5
4979111|NCT02544074|12247602|P14|STARTED|Overall Study||5
4979112|NCT02544074|12247603|P13|STARTED|Overall Study||4
4979113|NCT02544074|12247604|P12|STARTED|Overall Study||3
4979114|NCT02544074|12247605|P11|STARTED|Overall Study||2
4979115|NCT02544074|12247606|P10|STARTED|Overall Study||2
4979116|NCT02544074|12247607|P9|STARTED|Overall Study||6
4979117|NCT02544074|12247608|P8|STARTED|Overall Study||4
4979118|NCT02544074|12247609|P7|STARTED|Overall Study||2
4979119|NCT02544074|12247610|P6|STARTED|Overall Study||1
4979120|NCT02544074|12247611|P5|STARTED|Overall Study||4
4979121|NCT02544074|12247612|P4|STARTED|Overall Study||1
4979122|NCT02544074|12247613|P3|STARTED|Overall Study||1
4979123|NCT02544074|12247614|P2|STARTED|Overall Study||1
4979124|NCT02544074|12247615|P1|STARTED|Overall Study||1
4979125|NCT02543918|12247651|P2|NOT COMPLETED|Overall Study||4
4979126|NCT02543918|12247652|P1|NOT COMPLETED|Overall Study||3
4979127|NCT02543918|12247651|P2|COMPLETED|Overall Study||39
4979128|NCT02543918|12247652|P1|COMPLETED|Overall Study||38
4979129|NCT02543918|12247651|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
4979130|NCT02543918|12247652|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
4979131|NCT02543918|12247651|P2|STARTED|Overall Study||43
4979132|NCT02543918|12247652|P1|STARTED|Overall Study||41
4979133|NCT02543892|12247666|P8|NOT COMPLETED|Had Immunology Data||0
4979134|NCT02543892|12247667|P7|NOT COMPLETED|Had Immunology Data||1
4979135|NCT02543892|12247668|P6|NOT COMPLETED|Had Immunology Data||0
4979136|NCT02543892|12247669|P5|NOT COMPLETED|Had Immunology Data||0
4979137|NCT02543892|12247670|P4|NOT COMPLETED|Had Immunology Data||0
4979138|NCT02543892|12247671|P3|NOT COMPLETED|Had Immunology Data||0
4979139|NCT02543892|12247672|P2|NOT COMPLETED|Had Immunology Data||0
4979140|NCT02543892|12247673|P1|NOT COMPLETED|Had Immunology Data||0
4979141|NCT02543892|12247666|P8|COMPLETED|Had Immunology Data||49
4979142|NCT02543892|12247667|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
4979143|NCT02543892|12247668|P6|COMPLETED|Had Immunology Data||49
4979144|NCT02543892|12247669|P5|COMPLETED|Had Immunology Data||50
4979145|NCT02543892|12247670|P4|COMPLETED|Had Immunology Data||12
4979146|NCT02543892|12247671|P3|COMPLETED|Had Immunology Data||12
4979147|NCT02543892|12247672|P2|COMPLETED|Had Immunology Data||11
4979148|NCT02543892|12247673|P1|COMPLETED|Had Immunology Data||11
4979149|NCT02543892|12247666|P8|STARTED|Had Immunology Data||49
4979150|NCT02543892|12247667|P7|STARTED|Had Immunology Data||50
4979151|NCT02543892|12247668|P6|STARTED|Had Immunology Data||49
4979152|NCT02543892|12247669|P5|STARTED|Had Immunology Data||50
4979153|NCT02543892|12247670|P4|STARTED|Had Immunology Data||12
4979154|NCT02543892|12247671|P3|STARTED|Had Immunology Data||12
4979155|NCT02543892|12247672|P2|STARTED|Had Immunology Data||11
4979156|NCT02543892|12247673|P1|STARTED|Had Immunology Data||11
4979157|NCT02543892|12247666|P8|NOT COMPLETED|Received Vaccination 2||1
4979158|NCT02543892|12247667|P7|NOT COMPLETED|Received Vaccination 2||0
4979159|NCT02543892|12247668|P6|NOT COMPLETED|Received Vaccination 2||1
4979160|NCT02543892|12247669|P5|NOT COMPLETED|Received Vaccination 2||0
4979161|NCT02543892|12247670|P4|NOT COMPLETED|Received Vaccination 2||0
4979162|NCT02543892|12247671|P3|NOT COMPLETED|Received Vaccination 2||0
4979163|NCT02543892|12247672|P2|NOT COMPLETED|Received Vaccination 2||1
4979164|NCT02543892|12247673|P1|NOT COMPLETED|Received Vaccination 2||1
4979165|NCT02543892|12247666|P8|COMPLETED|Received Vaccination 2||49
4979166|NCT02543892|12247667|P7|COMPLETED|Received Vaccination 2||50
4979167|NCT02543892|12247668|P6|COMPLETED|Received Vaccination 2||49
4979168|NCT02543892|12247669|P5|COMPLETED|Received Vaccination 2||50
4979169|NCT02543892|12247670|P4|COMPLETED|Received Vaccination 2||12
4979170|NCT02543892|12247671|P3|COMPLETED|Received Vaccination 2||12
4979171|NCT02543892|12247672|P2|COMPLETED|Received Vaccination 2||11
4979172|NCT02543892|12247673|P1|COMPLETED|Received Vaccination 2||11
4979173|NCT02543892|12247666|P8|STARTED|Received Vaccination 2||50
4979174|NCT02543892|12247667|P7|STARTED|Received Vaccination 2||50
4979175|NCT02543892|12247668|P6|STARTED|Received Vaccination 2||50
4979176|NCT02543892|12247669|P5|STARTED|Received Vaccination 2||50
4979177|NCT02543892|12247670|P4|STARTED|Received Vaccination 2||12
4979178|NCT02543892|12247671|P3|STARTED|Received Vaccination 2||12
4979179|NCT02543892|12247672|P2|STARTED|Received Vaccination 2||12
4979180|NCT02543892|12247673|P1|STARTED|Received Vaccination 2||12
4979181|NCT02543892|12247666|P8|NOT COMPLETED|Received Vaccination 1||0
4979182|NCT02543892|12247667|P7|NOT COMPLETED|Received Vaccination 1||0
4979183|NCT02543892|12247668|P6|NOT COMPLETED|Received Vaccination 1||0
4979184|NCT02543892|12247669|P5|NOT COMPLETED|Received Vaccination 1||0
4979185|NCT02543892|12247670|P4|NOT COMPLETED|Received Vaccination 1||0
4979186|NCT02543892|12247671|P3|NOT COMPLETED|Received Vaccination 1||0
4979187|NCT02543892|12247672|P2|NOT COMPLETED|Received Vaccination 1||0
4979188|NCT02543892|12247673|P1|NOT COMPLETED|Received Vaccination 1||0
4979189|NCT02543892|12247666|P8|COMPLETED|Received Vaccination 1||50
4979190|NCT02543892|12247667|P7|COMPLETED|Received Vaccination 1||50
4979191|NCT02543892|12247668|P6|COMPLETED|Received Vaccination 1||50
4979192|NCT02543892|12247669|P5|COMPLETED|Received Vaccination 1||50
4979193|NCT02543892|12247670|P4|COMPLETED|Received Vaccination 1||12
4979194|NCT02543892|12247671|P3|COMPLETED|Received Vaccination 1||12
4979195|NCT02543892|12247672|P2|COMPLETED|Received Vaccination 1||12
4979196|NCT02543892|12247673|P1|COMPLETED|Received Vaccination 1||12
4979197|NCT02543892|12247666|P8|STARTED|Received Vaccination 1||50
4979198|NCT02543892|12247667|P7|STARTED|Received Vaccination 1||50
4979199|NCT02543892|12247668|P6|STARTED|Received Vaccination 1||50
4979200|NCT02543892|12247669|P5|STARTED|Received Vaccination 1||50
4979201|NCT02543892|12247670|P4|STARTED|Received Vaccination 1||12
4979202|NCT02543892|12247671|P3|STARTED|Received Vaccination 1||12
4979203|NCT02543892|12247672|P2|STARTED|Received Vaccination 1||12
4979204|NCT02543892|12247673|P1|STARTED|Received Vaccination 1||12
4979205|NCT02543840|12247721|P2|NOT COMPLETED|Overall Study||0
4979206|NCT02543840|12247722|P1|NOT COMPLETED|Overall Study||0
4979207|NCT02543840|12247721|P2|COMPLETED|Overall Study||62
4979208|NCT02543840|12247722|P1|COMPLETED|Overall Study||1050
4979209|NCT02543840|12247721|P2|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
4979210|NCT02543840|12247722|P1|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
4979211|NCT02543840|12247721|P2|6 Month Timepoint (t6)|Overall Study||0
4979212|NCT02543840|12247722|P1|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
4979213|NCT02543840|12247721|P2|0 Month Timepoint (t0)|Overall Study||40
4979214|NCT02543840|12247722|P1|0 Month Timepoint (t0)|Overall Study||593
4979215|NCT02543840|12247721|P2|STARTED|Overall Study||62
4979216|NCT02543840|12247722|P1|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
4979217|NCT02543801|12247740|P4|NOT COMPLETED|Overall Study||0
4979218|NCT02543801|12247741|P3|NOT COMPLETED|Overall Study||0
4979219|NCT02543801|12247742|P2|NOT COMPLETED|Overall Study||2
4979220|NCT02543801|12247743|P1|NOT COMPLETED|Overall Study||1
4979221|NCT02543801|12247740|P4|COMPLETED|Overall Study||59
4979222|NCT02543801|12247741|P3|COMPLETED|Overall Study||59
4979223|NCT02543801|12247742|P2|COMPLETED|Overall Study||58
4979224|NCT02543801|12247743|P1|COMPLETED|Overall Study||60
4979225|NCT02543801|12247740|P4|STARTED|Overall Study||59
4979226|NCT02543801|12247741|P3|STARTED|Overall Study||59
4979227|NCT02543801|12247742|P2|STARTED|Overall Study||60
4979228|NCT02543801|12247743|P1|STARTED|Overall Study||61
4979229|NCT02543554|12247763|P2|NOT COMPLETED|Overall Study||0
4979230|NCT02543554|12247764|P1|NOT COMPLETED|Overall Study||0
4979231|NCT02543554|12247763|P2|COMPLETED|Overall Study||513
4979232|NCT02543554|12247764|P1|COMPLETED|Overall Study||1192
4979233|NCT02543554|12247763|P2|STARTED|Overall Study||513
4979234|NCT02543554|12247764|P1|STARTED|Overall Study||1192
4979235|NCT02543528|12247772|P5|NOT COMPLETED|Extended Wear Period||0
4979236|NCT02543528|12247773|P4|NOT COMPLETED|Extended Wear Period||12
4979237|NCT02543528|12247774|P3|NOT COMPLETED|Extended Wear Period||23
4979238|NCT02543528|12247775|P2|NOT COMPLETED|Extended Wear Period||21
4979239|NCT02543528|12247776|P1|NOT COMPLETED|Extended Wear Period||28
4979240|NCT02543528|12247772|P5|COMPLETED|Extended Wear Period||0
4979241|NCT02543528|12247773|P4|COMPLETED|Extended Wear Period||23
4979242|NCT02543528|12247774|P3|COMPLETED|Extended Wear Period||13
4979243|NCT02543528|12247775|P2|COMPLETED|Extended Wear Period||14
4979244|NCT02543528|12247776|P1|COMPLETED|Extended Wear Period||8
4979245|NCT02543528|12247772|P5|STARTED|Extended Wear Period||0
4979246|NCT02543528|12247773|P4|STARTED|Extended Wear Period||35
4979247|NCT02543528|12247774|P3|STARTED|Extended Wear Period||36
4979248|NCT02543528|12247775|P2|STARTED|Extended Wear Period||35
4979249|NCT02543528|12247776|P1|STARTED|Extended Wear Period||36
4979250|NCT02543528|12247772|P5|NOT COMPLETED|Adaptation Period||26
4979251|NCT02543528|12247773|P4|NOT COMPLETED|Adaptation Period||0
4979252|NCT02543528|12247774|P3|NOT COMPLETED|Adaptation Period||0
4979253|NCT02543528|12247775|P2|NOT COMPLETED|Adaptation Period||0
4979254|NCT02543528|12247776|P1|NOT COMPLETED|Adaptation Period||0
4979255|NCT02543528|12247772|P5|COMPLETED|Adaptation Period||142
4979256|NCT02543528|12247773|P4|COMPLETED|Adaptation Period||0
4979257|NCT02543528|12247774|P3|COMPLETED|Adaptation Period||0
4979258|NCT02543528|12247775|P2|COMPLETED|Adaptation Period||0
4979259|NCT02543528|12247776|P1|COMPLETED|Adaptation Period||0
4979260|NCT02543528|12247772|P5|STARTED|Adaptation Period||168
4979261|NCT02543528|12247773|P4|STARTED|Adaptation Period||0
4979262|NCT02543528|12247774|P3|STARTED|Adaptation Period||0
4979263|NCT02543528|12247775|P2|STARTED|Adaptation Period||0
4979264|NCT02543528|12247776|P1|STARTED|Adaptation Period||0
4979265|NCT02543437|12247795|P1|NOT COMPLETED|Overall Study||0
4979266|NCT02543437|12247795|P1|COMPLETED|Overall Study||117
4979267|NCT02543437|12247795|P1|STARTED|Overall Study||117
4979268|NCT02543398|12247802|P2|NOT COMPLETED|Overall Study||0
4979269|NCT02543398|12247803|P1|NOT COMPLETED|Overall Study||0
4979270|NCT02543398|12247802|P2|COMPLETED|Overall Study||20
4979271|NCT02543398|12247803|P1|COMPLETED|Overall Study||20
4979272|NCT02543398|12247802|P2|STARTED|Overall Study||20
4979273|NCT02543398|12247803|P1|STARTED|Overall Study||20
4979274|NCT02543346|12247809|P4|NOT COMPLETED|Second Treatment Visit||0
4979275|NCT02543346|12247810|P3|NOT COMPLETED|Second Treatment Visit||0
4979276|NCT02543346|12247811|P2|NOT COMPLETED|Second Treatment Visit||0
4979277|NCT02543346|12247812|P1|NOT COMPLETED|Second Treatment Visit||0
4979278|NCT02543346|12247809|P4|COMPLETED|Second Treatment Visit||21
4979279|NCT02543346|12247810|P3|COMPLETED|Second Treatment Visit||22
4979280|NCT02543346|12247811|P2|COMPLETED|Second Treatment Visit||23
4979281|NCT02543346|12247812|P1|COMPLETED|Second Treatment Visit||25
4979282|NCT02543346|12247809|P4|STARTED|Second Treatment Visit||21
4979283|NCT02543346|12247810|P3|STARTED|Second Treatment Visit||22
4979284|NCT02543346|12247811|P2|STARTED|Second Treatment Visit||23
4979285|NCT02543346|12247812|P1|STARTED|Second Treatment Visit||25
4979286|NCT02543346|12247809|P4|NOT COMPLETED|Second Priming Visit||2
4979287|NCT02543346|12247810|P3|NOT COMPLETED|Second Priming Visit||2
4979288|NCT02543346|12247811|P2|NOT COMPLETED|Second Priming Visit||2
4979289|NCT02543346|12247812|P1|NOT COMPLETED|Second Priming Visit||1
4979290|NCT02543346|12247809|P4|COMPLETED|Second Priming Visit||21
4979291|NCT02543346|12247810|P3|COMPLETED|Second Priming Visit||22
4979292|NCT02543346|12247811|P2|COMPLETED|Second Priming Visit||23
4979293|NCT02543346|12247812|P1|COMPLETED|Second Priming Visit||25
4979294|NCT02543346|12247809|P4|STARTED|Second Priming Visit||23
4979295|NCT02543346|12247810|P3|STARTED|Second Priming Visit||24
4979296|NCT02543346|12247811|P2|STARTED|Second Priming Visit||25
4979297|NCT02543346|12247812|P1|STARTED|Second Priming Visit||26
4979298|NCT02543346|12247809|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
4979299|NCT02543346|12247810|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
4979300|NCT02543346|12247811|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
4979301|NCT02543346|12247812|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
4979302|NCT02543346|12247809|P4|COMPLETED|Washout (at Least 14 Days)||23
4979303|NCT02543346|12247810|P3|COMPLETED|Washout (at Least 14 Days)||24
4979304|NCT02543346|12247811|P2|COMPLETED|Washout (at Least 14 Days)||25
4979305|NCT02543346|12247812|P1|COMPLETED|Washout (at Least 14 Days)||26
4979306|NCT02543346|12247809|P4|STARTED|Washout (at Least 14 Days)||23
4979307|NCT02543346|12247810|P3|STARTED|Washout (at Least 14 Days)||24
4979308|NCT02543346|12247811|P2|STARTED|Washout (at Least 14 Days)||25
4979309|NCT02543346|12247812|P1|STARTED|Washout (at Least 14 Days)||26
4979310|NCT02543346|12247809|P4|NOT COMPLETED|First Treatment Visit||0
4979311|NCT02543346|12247810|P3|NOT COMPLETED|First Treatment Visit||0
4979312|NCT02543346|12247811|P2|NOT COMPLETED|First Treatment Visit||0
4979313|NCT02543346|12247812|P1|NOT COMPLETED|First Treatment Visit||0
4979314|NCT02543346|12247809|P4|COMPLETED|First Treatment Visit||23
4979315|NCT02543346|12247810|P3|COMPLETED|First Treatment Visit||24
4979316|NCT02543346|12247811|P2|COMPLETED|First Treatment Visit||25
4979317|NCT02543346|12247812|P1|COMPLETED|First Treatment Visit||26
4979318|NCT02543346|12247809|P4|STARTED|First Treatment Visit||23
4979319|NCT02543346|12247810|P3|STARTED|First Treatment Visit||24
4979320|NCT02543346|12247811|P2|STARTED|First Treatment Visit||25
4979321|NCT02543346|12247812|P1|STARTED|First Treatment Visit||26
4979322|NCT02543346|12247809|P4|NOT COMPLETED|First Priming Visit||0
4979323|NCT02543346|12247810|P3|NOT COMPLETED|First Priming Visit||0
4979324|NCT02543346|12247811|P2|NOT COMPLETED|First Priming Visit||0
4979325|NCT02543346|12247812|P1|NOT COMPLETED|First Priming Visit||0
4979326|NCT02543346|12247809|P4|COMPLETED|First Priming Visit||23
4979327|NCT02543346|12247810|P3|COMPLETED|First Priming Visit||24
4979328|NCT02543346|12247811|P2|COMPLETED|First Priming Visit||25
4979329|NCT02543346|12247812|P1|COMPLETED|First Priming Visit||26
4979330|NCT02543346|12247809|P4|STARTED|First Priming Visit||23
4979331|NCT02543346|12247810|P3|STARTED|First Priming Visit||24
4979332|NCT02543346|12247811|P2|STARTED|First Priming Visit||25
4979333|NCT02543346|12247812|P1|STARTED|First Priming Visit||26
4979334|NCT02543294|12247838|P1|NOT COMPLETED|Overall Study||12
4979335|NCT02543294|12247838|P1|COMPLETED|Overall Study||8
4979336|NCT02543294|12247838|P1|STARTED|Overall Study||20
4979337|NCT02542943|12247846|P3|NOT COMPLETED|Overall Study||0
4979338|NCT02542943|12247847|P2|NOT COMPLETED|Overall Study||1
4979339|NCT02542943|12247848|P1|NOT COMPLETED|Overall Study||1
4979340|NCT02542943|12247846|P3|COMPLETED|Overall Study||81
4979341|NCT02542943|12247847|P2|COMPLETED|Overall Study||79
4979342|NCT02542943|12247848|P1|COMPLETED|Overall Study||78
4979343|NCT02542943|12247846|P3|STARTED|Overall Study||81
4979344|NCT02542943|12247847|P2|STARTED|Overall Study||80
4979345|NCT02542943|12247848|P1|STARTED|Overall Study||79
4979346|NCT02542865|12247875|P2|NOT COMPLETED|Overall Study||0
4979347|NCT02542865|12247876|P1|NOT COMPLETED|Overall Study||17
4979348|NCT02542865|12247875|P2|COMPLETED|Overall Study||462
4979349|NCT02542865|12247876|P1|COMPLETED|Overall Study||445
4979350|NCT02542865|12247875|P2|Treated|Overall Study||462
4979351|NCT02542865|12247876|P1|Treated|Overall Study||460
4979352|NCT02542865|12247875|P2|STARTED|Overall Study||462
4979353|NCT02542865|12247876|P1|STARTED|Overall Study||462
4979354|NCT02542761|12247920|P2|NOT COMPLETED|Second Intervention||0
4979355|NCT02542761|12247921|P1|NOT COMPLETED|Second Intervention||0
4979356|NCT02542761|12247920|P2|COMPLETED|Second Intervention||5
4979357|NCT02542761|12247921|P1|COMPLETED|Second Intervention||5
4979358|NCT02542761|12247920|P2|STARTED|Second Intervention||5
4979359|NCT02542761|12247921|P1|STARTED|Second Intervention||5
4979360|NCT02542761|12247920|P2|NOT COMPLETED|Acclimation Period 2||0
4979361|NCT02542761|12247921|P1|NOT COMPLETED|Acclimation Period 2||0
4979362|NCT02542761|12247920|P2|COMPLETED|Acclimation Period 2||5
4979363|NCT02542761|12247921|P1|COMPLETED|Acclimation Period 2||5
4979364|NCT02542761|12247920|P2|STARTED|Acclimation Period 2||5
4979365|NCT02542761|12247921|P1|STARTED|Acclimation Period 2||5
4979366|NCT02542761|12247920|P2|NOT COMPLETED|First Intervention||0
4979367|NCT02542761|12247921|P1|NOT COMPLETED|First Intervention||0
4979368|NCT02542761|12247920|P2|COMPLETED|First Intervention||5
4979369|NCT02542761|12247921|P1|COMPLETED|First Intervention||5
4979370|NCT02542761|12247920|P2|STARTED|First Intervention||5
4979371|NCT02542761|12247921|P1|STARTED|First Intervention||5
4979372|NCT02542761|12247920|P2|NOT COMPLETED|Acclimation Period 1||0
4979373|NCT02542761|12247921|P1|NOT COMPLETED|Acclimation Period 1||0
4979374|NCT02542761|12247920|P2|COMPLETED|Acclimation Period 1||5
4979375|NCT02542761|12247921|P1|COMPLETED|Acclimation Period 1||5
4979376|NCT02542761|12247920|P2|STARTED|Acclimation Period 1||5
4979377|NCT02542761|12247921|P1|STARTED|Acclimation Period 1||5
4979378|NCT02542631|12247939|P2|NOT COMPLETED|Overall Study||31
4979379|NCT02542631|12247940|P1|NOT COMPLETED|Overall Study||31
4979380|NCT02542631|12247939|P2|COMPLETED|Overall Study||108
4979381|NCT02542631|12247940|P1|COMPLETED|Overall Study||108
4979382|NCT02542631|12247939|P2|STARTED|Overall Study||139
4979383|NCT02542631|12247940|P1|STARTED|Overall Study||139
4979384|NCT02542605|12247962|P3|NOT COMPLETED|Part B: Randomization Phase||1
4979385|NCT02542605|12247963|P2|NOT COMPLETED|Part B: Randomization Phase||0
4979386|NCT02542605|12247964|P1|NOT COMPLETED|Part B: Randomization Phase||0
4979387|NCT02542605|12247962|P3|COMPLETED|Part B: Randomization Phase||7
4979388|NCT02542605|12247963|P2|COMPLETED|Part B: Randomization Phase||9
4979389|NCT02542605|12247964|P1|COMPLETED|Part B: Randomization Phase||0
4979390|NCT02542605|12247962|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
4979391|NCT02542605|12247963|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
4979392|NCT02542605|12247964|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
4979393|NCT02542605|12247962|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
4979394|NCT02542605|12247963|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
4979395|NCT02542605|12247964|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
4979396|NCT02542605|12247962|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
4979397|NCT02542605|12247963|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
4979398|NCT02542605|12247964|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
4979399|NCT02542605|12247962|P3|STARTED|Part B: Randomization Phase||8
4979400|NCT02542605|12247963|P2|STARTED|Part B: Randomization Phase||9
4979401|NCT02542605|12247964|P1|STARTED|Part B: Randomization Phase||0
4979402|NCT02542605|12247962|P3|NOT COMPLETED|Part B: Challenge Phase||0
4979403|NCT02542605|12247963|P2|NOT COMPLETED|Part B: Challenge Phase||0
4979404|NCT02542605|12247964|P1|NOT COMPLETED|Part B: Challenge Phase||1
4979405|NCT02542605|12247962|P3|COMPLETED|Part B: Challenge Phase||0
4979406|NCT02542605|12247963|P2|COMPLETED|Part B: Challenge Phase||0
4979407|NCT02542605|12247964|P1|COMPLETED|Part B: Challenge Phase||22
4979408|NCT02542605|12247962|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
4979409|NCT02542605|12247963|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
4979410|NCT02542605|12247964|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
4979411|NCT02542605|12247962|P3|Received PACAP-38|Part B: Challenge Phase||0
4979412|NCT02542605|12247963|P2|Received PACAP-38|Part B: Challenge Phase||0
4979413|NCT02542605|12247964|P1|Received PACAP-38|Part B: Challenge Phase||23
4979414|NCT02542605|12247962|P3|STARTED|Part B: Challenge Phase||0
4979415|NCT02542605|12247963|P2|STARTED|Part B: Challenge Phase||0
4979416|NCT02542605|12247964|P1|STARTED|Part B: Challenge Phase||23
4979417|NCT02542605|12247962|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
4979418|NCT02542605|12247963|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
4979419|NCT02542605|12247964|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
4979420|NCT02542605|12247962|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
4979421|NCT02542605|12247963|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
4979422|NCT02542605|12247964|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
4979423|NCT02542605|12247962|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
4979424|NCT02542605|12247963|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
4979425|NCT02542605|12247964|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
4979426|NCT02542605|12247962|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
4979427|NCT02542605|12247963|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
4979428|NCT02542605|12247964|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
4979429|NCT02542605|12247962|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
4979430|NCT02542605|12247963|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
4979431|NCT02542605|12247964|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
4979432|NCT02542462|12248015|P4|NOT COMPLETED|Overall Study||1
4979433|NCT02542462|12248016|P3|NOT COMPLETED|Overall Study||0
4979434|NCT02542462|12248017|P2|NOT COMPLETED|Overall Study||0
4979435|NCT02542462|12248018|P1|NOT COMPLETED|Overall Study||0
4979436|NCT02542462|12248015|P4|COMPLETED|Overall Study||25
4979437|NCT02542462|12248016|P3|COMPLETED|Overall Study||25
4979438|NCT02542462|12248017|P2|COMPLETED|Overall Study||25
4979439|NCT02542462|12248018|P1|COMPLETED|Overall Study||25
4979440|NCT02542462|12248015|P4|STARTED|Overall Study||26
4979441|NCT02542462|12248016|P3|STARTED|Overall Study||25
4979442|NCT02542462|12248017|P2|STARTED|Overall Study||25
4979443|NCT02542462|12248018|P1|STARTED|Overall Study||25
4979444|NCT02542410|12248032|P2|NOT COMPLETED|Overall Study||1
4979445|NCT02542410|12248033|P1|NOT COMPLETED|Overall Study||2
4979446|NCT02542410|12248032|P2|COMPLETED|Overall Study||4
4979447|NCT02542410|12248033|P1|COMPLETED|Overall Study||3
4979448|NCT02542410|12248032|P2|STARTED|Overall Study||5
4979449|NCT02542410|12248033|P1|STARTED|Overall Study||5
4979450|NCT02542280|12248043|P2|NOT COMPLETED|Overall Study||8
4979451|NCT02542280|12248044|P1|NOT COMPLETED|Overall Study||12
4979452|NCT02542280|12248043|P2|COMPLETED|Overall Study||167
4979453|NCT02542280|12248044|P1|COMPLETED|Overall Study||162
4979454|NCT02542280|12248043|P2|STARTED|Overall Study||175
4979455|NCT02542280|12248044|P1|STARTED|Overall Study||174
4979456|NCT02542072|12248054|P2|NOT COMPLETED|Second Intervention (1 Month)||0
4979457|NCT02542072|12248055|P1|NOT COMPLETED|Second Intervention (1 Month)||2
4979458|NCT02542072|12248054|P2|COMPLETED|Second Intervention (1 Month)||43
4979459|NCT02542072|12248055|P1|COMPLETED|Second Intervention (1 Month)||37
4979460|NCT02542072|12248054|P2|STARTED|Second Intervention (1 Month)||43
4979461|NCT02542072|12248055|P1|STARTED|Second Intervention (1 Month)||39
4979462|NCT02542072|12248054|P2|NOT COMPLETED|First Intervention (1 Month)||3
4979463|NCT02542072|12248055|P1|NOT COMPLETED|First Intervention (1 Month)||5
4979464|NCT02542072|12248054|P2|COMPLETED|First Intervention (1 Month)||43
4979465|NCT02542072|12248055|P1|COMPLETED|First Intervention (1 Month)||39
4979466|NCT02542072|12248054|P2|STARTED|First Intervention (1 Month)||46
4979467|NCT02542072|12248055|P1|STARTED|First Intervention (1 Month)||44
4979468|NCT02542046|12248158|P3|NOT COMPLETED|Overall Study||0
4979469|NCT02542046|12248159|P2|NOT COMPLETED|Overall Study||0
4979470|NCT02542046|12248160|P1|NOT COMPLETED|Overall Study||0
4979471|NCT02542046|12248158|P3|COMPLETED|Overall Study||300
4979472|NCT02542046|12248159|P2|COMPLETED|Overall Study||300
4979473|NCT02542046|12248160|P1|COMPLETED|Overall Study||300
4979474|NCT02542046|12248158|P3|STARTED|Overall Study||300
4979475|NCT02542046|12248159|P2|STARTED|Overall Study||300
4979476|NCT02542046|12248160|P1|STARTED|Overall Study||300
4979477|NCT02541942|12248174|P1|NOT COMPLETED|Overall Study||0
4979478|NCT02541942|12248174|P1|COMPLETED|Overall Study||19
4979479|NCT02541942|12248174|P1|STARTED|Overall Study||19
4979480|NCT02541903|12248179|P1|NOT COMPLETED|Overall Study||1
4979481|NCT02541903|12248179|P1|COMPLETED|Overall Study||7
4979482|NCT02541903|12248179|P1|STARTED|Overall Study||8
4979483|NCT02541864|12248188|P2|NOT COMPLETED|Overall Study||0
4979484|NCT02541864|12248189|P1|NOT COMPLETED|Overall Study||0
4979485|NCT02541864|12248188|P2|COMPLETED|Overall Study||166
4979486|NCT02541864|12248189|P1|COMPLETED|Overall Study||164
4979487|NCT02541864|12248188|P2|STARTED|Overall Study||166
4979488|NCT02541864|12248189|P1|STARTED|Overall Study||164
4979489|NCT02541669|12248200|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
4979490|NCT02541669|12248201|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
4979491|NCT02541669|12248202|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
4979492|NCT02541669|12248203|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
4979493|NCT02541669|12248204|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
4979494|NCT02541669|12248200|P5|COMPLETED|Double-Blinded Treatment Period||15
4979495|NCT02541669|12248201|P4|COMPLETED|Double-Blinded Treatment Period||16
4979496|NCT02541669|12248202|P3|COMPLETED|Double-Blinded Treatment Period||15
4979497|NCT02541669|12248203|P2|COMPLETED|Double-Blinded Treatment Period||0
4979498|NCT02541669|12248204|P1|COMPLETED|Double-Blinded Treatment Period||0
4979499|NCT02541669|12248200|P5|STARTED|Double-Blinded Treatment Period||16
4979500|NCT02541669|12248201|P4|STARTED|Double-Blinded Treatment Period||16
4979501|NCT02541669|12248202|P3|STARTED|Double-Blinded Treatment Period||16
4979502|NCT02541669|12248203|P2|STARTED|Double-Blinded Treatment Period||0
4979503|NCT02541669|12248204|P1|STARTED|Double-Blinded Treatment Period||0
4979504|NCT02541669|12248200|P5|NOT COMPLETED|Open Label Treatment Period||0
4979505|NCT02541669|12248201|P4|NOT COMPLETED|Open Label Treatment Period||0
4979506|NCT02541669|12248202|P3|NOT COMPLETED|Open Label Treatment Period||0
4979507|NCT02541669|12248203|P2|NOT COMPLETED|Open Label Treatment Period||0
4979508|NCT02541669|12248204|P1|NOT COMPLETED|Open Label Treatment Period||0
4979509|NCT02541669|12248200|P5|COMPLETED|Open Label Treatment Period||0
4979510|NCT02541669|12248201|P4|COMPLETED|Open Label Treatment Period||0
4979511|NCT02541669|12248202|P3|COMPLETED|Open Label Treatment Period||0
4979512|NCT02541669|12248203|P2|COMPLETED|Open Label Treatment Period||8
4979513|NCT02541669|12248204|P1|COMPLETED|Open Label Treatment Period||8
4979514|NCT02541669|12248200|P5|STARTED|Open Label Treatment Period||0
4979515|NCT02541669|12248201|P4|STARTED|Open Label Treatment Period||0
4979516|NCT02541669|12248202|P3|STARTED|Open Label Treatment Period||0
4979517|NCT02541669|12248203|P2|STARTED|Open Label Treatment Period||8
4979518|NCT02541669|12248204|P1|STARTED|Open Label Treatment Period||8
4979519|NCT02541604|12248251|P12|NOT COMPLETED|Overall Study||3
4979520|NCT02541604|12248252|P11|NOT COMPLETED|Overall Study||2
4979521|NCT02541604|12248253|P10|NOT COMPLETED|Overall Study||4
4979522|NCT02541604|12248254|P9|NOT COMPLETED|Overall Study||4
4979523|NCT02541604|12248255|P8|NOT COMPLETED|Overall Study||10
4979524|NCT02541604|12248256|P7|NOT COMPLETED|Overall Study||10
4979525|NCT02541604|12248257|P6|NOT COMPLETED|Overall Study||10
4979526|NCT02541604|12248258|P5|NOT COMPLETED|Overall Study||10
4979527|NCT02541604|12248259|P4|NOT COMPLETED|Overall Study||3
4979528|NCT02541604|12248260|P3|NOT COMPLETED|Overall Study||11
4979529|NCT02541604|12248261|P2|NOT COMPLETED|Overall Study||9
4979530|NCT02541604|12248262|P1|NOT COMPLETED|Overall Study||11
4979531|NCT02541604|12248251|P12|COMPLETED|Overall Study||0
4979532|NCT02541604|12248252|P11|COMPLETED|Overall Study||0
4979533|NCT02541604|12248253|P10|COMPLETED|Overall Study||0
4979534|NCT02541604|12248254|P9|COMPLETED|Overall Study||0
4979535|NCT02541604|12248255|P8|COMPLETED|Overall Study||0
4979536|NCT02541604|12248256|P7|COMPLETED|Overall Study||0
4979537|NCT02541604|12248257|P6|COMPLETED|Overall Study||0
4979538|NCT02541604|12248258|P5|COMPLETED|Overall Study||0
4979539|NCT02541604|12248259|P4|COMPLETED|Overall Study||0
4979540|NCT02541604|12248260|P3|COMPLETED|Overall Study||0
4979541|NCT02541604|12248261|P2|COMPLETED|Overall Study||0
4979542|NCT02541604|12248262|P1|COMPLETED|Overall Study||0
4979543|NCT02541604|12248251|P12|STARTED|Overall Study||3
4979544|NCT02541604|12248252|P11|STARTED|Overall Study||2
4979545|NCT02541604|12248253|P10|STARTED|Overall Study||4
4979546|NCT02541604|12248254|P9|STARTED|Overall Study||4
4979547|NCT02541604|12248255|P8|STARTED|Overall Study||10
4979548|NCT02541604|12248256|P7|STARTED|Overall Study||10
4979549|NCT02541604|12248257|P6|STARTED|Overall Study||10
4979550|NCT02541604|12248258|P5|STARTED|Overall Study||10
4979551|NCT02541604|12248259|P4|STARTED|Overall Study||3
4979552|NCT02541604|12248260|P3|STARTED|Overall Study||11
4979553|NCT02541604|12248261|P2|STARTED|Overall Study||9
4979554|NCT02541604|12248262|P1|STARTED|Overall Study||11
4979555|NCT02541422|12248367|P2|NOT COMPLETED|Second Intervention||0
4979556|NCT02541422|12248368|P1|NOT COMPLETED|Second Intervention||0
4979557|NCT02541422|12248367|P2|COMPLETED|Second Intervention||26
4979558|NCT02541422|12248368|P1|COMPLETED|Second Intervention||23
4979559|NCT02541422|12248367|P2|STARTED|Second Intervention||26
4979560|NCT02541422|12248368|P1|STARTED|Second Intervention||23
4979561|NCT02541422|12248367|P2|NOT COMPLETED|First Intervention||0
4979562|NCT02541422|12248368|P1|NOT COMPLETED|First Intervention||0
4979563|NCT02541422|12248367|P2|COMPLETED|First Intervention||26
4979564|NCT02541422|12248368|P1|COMPLETED|First Intervention||23
4979565|NCT02541422|12248367|P2|STARTED|First Intervention||26
4979566|NCT02541422|12248368|P1|STARTED|First Intervention||23
4979567|NCT02540850|12248377|P3|NOT COMPLETED|Overall Study||34
4979568|NCT02540850|12248378|P2|NOT COMPLETED|Overall Study||66
4979569|NCT02540850|12248379|P1|NOT COMPLETED|Overall Study||69
4979570|NCT02540850|12248377|P3|COMPLETED|Overall Study||410
4979571|NCT02540850|12248378|P2|COMPLETED|Overall Study||330
4979572|NCT02540850|12248379|P1|COMPLETED|Overall Study||291
4979573|NCT02540850|12248377|P3|STARTED|Overall Study||444
4979574|NCT02540850|12248378|P2|STARTED|Overall Study||396
4979575|NCT02540850|12248379|P1|STARTED|Overall Study||360
4979576|NCT02540772|12248407|P2|NOT COMPLETED|Overall Study||0
4979577|NCT02540772|12248408|P1|NOT COMPLETED|Overall Study||0
4979578|NCT02540772|12248407|P2|COMPLETED|Overall Study||10
4979579|NCT02540772|12248408|P1|COMPLETED|Overall Study||10
4979580|NCT02540772|12248407|P2|STARTED|Overall Study||10
4979581|NCT02540772|12248408|P1|STARTED|Overall Study||10
4979582|NCT02540668|12248420|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
4979583|NCT02540668|12248421|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
4979584|NCT02540668|12248420|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
4979585|NCT02540668|12248421|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
4979586|NCT02540668|12248420|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
4979587|NCT02540668|12248421|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
4979588|NCT02540668|12248420|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
4979589|NCT02540668|12248421|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
4979590|NCT02540668|12248420|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
4979591|NCT02540668|12248421|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
4979592|NCT02540668|12248420|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
4979593|NCT02540668|12248421|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
4979594|NCT02540668|12248420|P2|STARTED|Period 1 - Warfarin Single Dose||0
4979595|NCT02540668|12248421|P1|STARTED|Period 1 - Warfarin Single Dose||15
4979596|NCT02540629|12248440|P2|NOT COMPLETED|Overall Study||0
4979597|NCT02540629|12248441|P1|NOT COMPLETED|Overall Study||0
4979598|NCT02540629|12248440|P2|COMPLETED|Overall Study||6469
4979599|NCT02540629|12248441|P1|COMPLETED|Overall Study||6201
4979600|NCT02540629|12248440|P2|STARTED|Overall Study||6469
4979601|NCT02540629|12248441|P1|STARTED|Overall Study||6201
4979602|NCT02540538|12248452|P3|NOT COMPLETED|Overall Study||0
4979603|NCT02540538|12248453|P2|NOT COMPLETED|Overall Study||1
4979604|NCT02540538|12248454|P1|NOT COMPLETED|Overall Study||0
4979605|NCT02540538|12248452|P3|COMPLETED|Overall Study||10
4979606|NCT02540538|12248453|P2|COMPLETED|Overall Study||11
4979607|NCT02540538|12248454|P1|COMPLETED|Overall Study||12
4979608|NCT02540538|12248452|P3|STARTED|Overall Study||10
4979609|NCT02540538|12248453|P2|STARTED|Overall Study||12
4979610|NCT02540538|12248454|P1|STARTED|Overall Study||12
4979611|NCT02540447|12248470|P2|NOT COMPLETED|Overall Study||0
4979612|NCT02540447|12248471|P1|NOT COMPLETED|Overall Study||0
4979613|NCT02540447|12248470|P2|COMPLETED|Overall Study||40
4979614|NCT02540447|12248471|P1|COMPLETED|Overall Study||40
4979615|NCT02540447|12248470|P2|STARTED|Overall Study||40
4979616|NCT02540447|12248471|P1|STARTED|Overall Study||40
4979617|NCT02540434|12248487|P2|NOT COMPLETED|Overall Study||0
4979618|NCT02540434|12248488|P1|NOT COMPLETED|Overall Study||0
4979619|NCT02540434|12248487|P2|COMPLETED|Overall Study||1
4979620|NCT02540434|12248488|P1|COMPLETED|Overall Study||1
4979621|NCT02540434|12248487|P2|STARTED|Overall Study||1
4979622|NCT02540434|12248488|P1|STARTED|Overall Study||1
4979623|NCT02540356|12248522|P2|NOT COMPLETED|Overall Study||0
4979624|NCT02540356|12248523|P1|NOT COMPLETED|Overall Study||1
4979625|NCT02540356|12248522|P2|COMPLETED|Overall Study||0
4979626|NCT02540356|12248523|P1|COMPLETED|Overall Study||0
4979627|NCT02540356|12248522|P2|STARTED|Overall Study||0
4979628|NCT02540356|12248523|P1|STARTED|Overall Study||1
4979629|NCT02540291|12248558|P4|NOT COMPLETED|Overall Study||7
4979630|NCT02540291|12248559|P3|NOT COMPLETED|Overall Study||7
4979631|NCT02540291|12248560|P2|NOT COMPLETED|Overall Study||8
4979632|NCT02540291|12248561|P1|NOT COMPLETED|Overall Study||8
4979633|NCT02540291|12248558|P4|COMPLETED|Overall Study||0
4979634|NCT02540291|12248559|P3|COMPLETED|Overall Study||0
4979635|NCT02540291|12248560|P2|COMPLETED|Overall Study||0
4979636|NCT02540291|12248561|P1|COMPLETED|Overall Study||0
4979637|NCT02540291|12248558|P4|STARTED|Overall Study||7
4979638|NCT02540291|12248559|P3|STARTED|Overall Study||7
4979639|NCT02540291|12248560|P2|STARTED|Overall Study||8
4979640|NCT02540291|12248561|P1|STARTED|Overall Study||8
4979641|NCT02540265|12248596|P3|NOT COMPLETED|Overall Study||1
4979642|NCT02540265|12248597|P2|NOT COMPLETED|Overall Study||0
4979643|NCT02540265|12248598|P1|NOT COMPLETED|Overall Study||0
4979644|NCT02540265|12248596|P3|COMPLETED|Overall Study||18
4979645|NCT02540265|12248597|P2|COMPLETED|Overall Study||20
4979646|NCT02540265|12248598|P1|COMPLETED|Overall Study||20
4979647|NCT02540265|12248596|P3|Treatment Completion|Overall Study||18
4979648|NCT02540265|12248597|P2|Treatment Completion|Overall Study||19
4979649|NCT02540265|12248598|P1|Treatment Completion|Overall Study||20
4979650|NCT02540265|12248596|P3|STARTED|Overall Study||19
4979651|NCT02540265|12248597|P2|STARTED|Overall Study||20
4979652|NCT02540265|12248598|P1|STARTED|Overall Study||20
4979653|NCT02540226|12248620|P2|NOT COMPLETED|Overall Study||1
4979654|NCT02540226|12248621|P1|NOT COMPLETED|Overall Study||2
4979655|NCT02540226|12248620|P2|COMPLETED|Overall Study||32
4979656|NCT02540226|12248621|P1|COMPLETED|Overall Study||31
4979657|NCT02540226|12248620|P2|STARTED|Overall Study||33
4979658|NCT02540226|12248621|P1|STARTED|Overall Study||33
4979659|NCT02540213|12248653|P1|NOT COMPLETED|Overall Study||39
4979660|NCT02540213|12248653|P1|COMPLETED|Overall Study||201
4979661|NCT02540213|12248653|P1|STARTED|Overall Study||240
4979662|NCT02540161|12248678|P4|NOT COMPLETED|Overall Study||0
4979663|NCT02540161|12248679|P3|NOT COMPLETED|Overall Study||0
4979664|NCT02540161|12248680|P2|NOT COMPLETED|Overall Study||0
4979665|NCT02540161|12248681|P1|NOT COMPLETED|Overall Study||0
4979666|NCT02540161|12248678|P4|COMPLETED|Overall Study||7
4979667|NCT02540161|12248679|P3|COMPLETED|Overall Study||5
4979668|NCT02540161|12248680|P2|COMPLETED|Overall Study||7
4979669|NCT02540161|12248681|P1|COMPLETED|Overall Study||20
4979670|NCT02540161|12248678|P4|STARTED|Overall Study||7
4979671|NCT02540161|12248679|P3|STARTED|Overall Study||5
4979672|NCT02540161|12248680|P2|STARTED|Overall Study||7
4979673|NCT02540161|12248681|P1|STARTED|Overall Study||20
4979674|NCT02540083|12248707|P1|NOT COMPLETED|Overall Study||16
4979675|NCT02540083|12248707|P1|COMPLETED|Overall Study||78
4979676|NCT02540083|12248707|P1|STARTED|Overall Study||94
4979677|NCT02539992|12248720|P3|NOT COMPLETED|Overall Study||4
4979678|NCT02539992|12248721|P2|NOT COMPLETED|Overall Study||4
4979679|NCT02539992|12248722|P1|NOT COMPLETED|Overall Study||0
4979680|NCT02539992|12248720|P3|COMPLETED|Overall Study||14
4979681|NCT02539992|12248721|P2|COMPLETED|Overall Study||7
4979682|NCT02539992|12248722|P1|COMPLETED|Overall Study||15
4979683|NCT02539992|12248720|P3|STARTED|Overall Study||18
4979684|NCT02539992|12248721|P2|STARTED|Overall Study||11
4979685|NCT02539992|12248722|P1|STARTED|Overall Study||15
4979686|NCT02539797|12248748|P3|NOT COMPLETED|Overall Study||0
4979687|NCT02539797|12248749|P2|NOT COMPLETED|Overall Study||1
4979688|NCT02539797|12248750|P1|NOT COMPLETED|Overall Study||0
4979689|NCT02539797|12248748|P3|COMPLETED|Overall Study||13
4979690|NCT02539797|12248749|P2|COMPLETED|Overall Study||12
4979691|NCT02539797|12248750|P1|COMPLETED|Overall Study||12
4979692|NCT02539797|12248748|P3|STARTED|Overall Study||13
4979693|NCT02539797|12248749|P2|STARTED|Overall Study||13
4979694|NCT02539797|12248750|P1|STARTED|Overall Study||12
4979695|NCT02539654|12248761|P1|NOT COMPLETED|Overall Study||0
4979696|NCT02539654|12248761|P1|COMPLETED|Overall Study||14
4979697|NCT02539654|12248761|P1|STARTED|Overall Study||14
4979698|NCT02539563|12248773|P2|NOT COMPLETED|Overall Study||14
4979699|NCT02539563|12248774|P1|NOT COMPLETED|Overall Study||6
4979700|NCT02539563|12248773|P2|COMPLETED|Overall Study||42
4979701|NCT02539563|12248774|P1|COMPLETED|Overall Study||39
4979702|NCT02539563|12248773|P2|STARTED|Overall Study||56
4979703|NCT02539563|12248774|P1|STARTED|Overall Study||45
4979704|NCT02539511|12248790|P2|NOT COMPLETED|Overall Study||0
4979705|NCT02539511|12248791|P1|NOT COMPLETED|Overall Study||6
4979706|NCT02539511|12248790|P2|COMPLETED|Overall Study||17
4979707|NCT02539511|12248791|P1|COMPLETED|Overall Study||17
4979708|NCT02539511|12248790|P2|STARTED|Overall Study||17
4979709|NCT02539511|12248791|P1|STARTED|Overall Study||23
4979710|NCT02539368|12248802|P5|NOT COMPLETED|Overall Study||14
4979711|NCT02539368|12248803|P4|NOT COMPLETED|Overall Study||7
4979712|NCT02539368|12248804|P3|NOT COMPLETED|Overall Study||67
4979713|NCT02539368|12248805|P2|NOT COMPLETED|Overall Study||101
4979714|NCT02539368|12248806|P1|NOT COMPLETED|Overall Study||405
4979715|NCT02539368|12248802|P5|COMPLETED|Overall Study||88
4979716|NCT02539368|12248803|P4|COMPLETED|Overall Study||60
4979717|NCT02539368|12248804|P3|COMPLETED|Overall Study||291
4979718|NCT02539368|12248805|P2|COMPLETED|Overall Study||393
4979719|NCT02539368|12248806|P1|COMPLETED|Overall Study||1117
4979720|NCT02539368|12248802|P5|STARTED|Overall Study||102
4979721|NCT02539368|12248803|P4|STARTED|Overall Study||67
4979722|NCT02539368|12248804|P3|STARTED|Overall Study||358
4979723|NCT02539368|12248805|P2|STARTED|Overall Study||494
4979724|NCT02539368|12248806|P1|STARTED|Overall Study||1522
4979725|NCT02539342|12248928|P2|NOT COMPLETED|Overall Study||0
4979726|NCT02539342|12248929|P1|NOT COMPLETED|Overall Study||0
4979727|NCT02539342|12248928|P2|COMPLETED|Overall Study||0
4979728|NCT02539342|12248929|P1|COMPLETED|Overall Study||1
4979729|NCT02539342|12248928|P2|STARTED|Overall Study||0
4979730|NCT02539342|12248929|P1|STARTED|Overall Study||1
4979731|NCT02539225|12248939|P2|NOT COMPLETED|Part B||16
4979732|NCT02539225|12248940|P1|NOT COMPLETED|Part B||4
4979733|NCT02539225|12248939|P2|COMPLETED|Part B||48
4979734|NCT02539225|12248940|P1|COMPLETED|Part B||54
4979735|NCT02539225|12248939|P2|STARTED|Part B||64
4979736|NCT02539225|12248940|P1|STARTED|Part B||58
4979737|NCT02539225|12248939|P2|NOT COMPLETED|Pre Treatment for Part B||2
4979738|NCT02539225|12248940|P1|NOT COMPLETED|Pre Treatment for Part B||5
4979739|NCT02539225|12248939|P2|COMPLETED|Pre Treatment for Part B||64
4979740|NCT02539225|12248940|P1|COMPLETED|Pre Treatment for Part B||58
4979741|NCT02539225|12248939|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
4979742|NCT02539225|12248940|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
4979743|NCT02539225|12248939|P2|NOT COMPLETED|Part A||16
4979744|NCT02539225|12248940|P1|NOT COMPLETED|Part A||20
4979745|NCT02539225|12248939|P2|COMPLETED|Part A||78
4979746|NCT02539225|12248940|P1|COMPLETED|Part A||77
4979747|NCT02539225|12248939|P2|Received Any Quantity of Study Drug|Part A||93
4979748|NCT02539225|12248940|P1|Received Any Quantity of Study Drug|Part A||96
4979749|NCT02539225|12248939|P2|STARTED|Part A||94
4979750|NCT02539225|12248940|P1|STARTED|Part A||97
4979751|NCT02539134|12248967|P6|NOT COMPLETED|Overall Study||0
4979752|NCT02539134|12248968|P5|NOT COMPLETED|Overall Study||0
4979753|NCT02539134|12248969|P4|NOT COMPLETED|Overall Study||0
4979754|NCT02539134|12248970|P3|NOT COMPLETED|Overall Study||0
4979755|NCT02539134|12248971|P2|NOT COMPLETED|Overall Study||0
4979756|NCT02539134|12248972|P1|NOT COMPLETED|Overall Study||1
4979757|NCT02539134|12248967|P6|COMPLETED|Overall Study||6
4979758|NCT02539134|12248968|P5|COMPLETED|Overall Study||6
4979759|NCT02539134|12248969|P4|COMPLETED|Overall Study||6
4979760|NCT02539134|12248970|P3|COMPLETED|Overall Study||6
4979761|NCT02539134|12248971|P2|COMPLETED|Overall Study||6
4979762|NCT02539134|12248972|P1|COMPLETED|Overall Study||9
4979763|NCT02539134|12248967|P6|STARTED|Overall Study||6
4979764|NCT02539134|12248968|P5|STARTED|Overall Study||6
4979765|NCT02539134|12248969|P4|STARTED|Overall Study||6
4979766|NCT02539134|12248970|P3|STARTED|Overall Study||6
4979767|NCT02539134|12248971|P2|STARTED|Overall Study||6
4979768|NCT02539134|12248972|P1|STARTED|Overall Study||10
4979769|NCT02539108|12249026|P2|NOT COMPLETED|Overall Study||0
4979770|NCT02539108|12249027|P1|NOT COMPLETED|Overall Study||0
4979771|NCT02539108|12249026|P2|COMPLETED|Overall Study||30
4979772|NCT02539108|12249027|P1|COMPLETED|Overall Study||30
4979773|NCT02539108|12249026|P2|STARTED|Overall Study||30
4979774|NCT02539108|12249027|P1|STARTED|Overall Study||30
4979775|NCT02538965|12249041|P1|NOT COMPLETED|Follow-Up Period||17
4979776|NCT02538965|12249041|P1|COMPLETED|Follow-Up Period||0
4979777|NCT02538965|12249041|P1|STARTED|Follow-Up Period||17
4979778|NCT02538965|12249041|P1|NOT COMPLETED|Treatment Period||17
4979779|NCT02538965|12249041|P1|COMPLETED|Treatment Period||0
4979780|NCT02538965|12249041|P1|STARTED|Treatment Period||17
4979781|NCT02538783|12249062|P2|NOT COMPLETED|Overall Study||1
4979782|NCT02538783|12249063|P1|NOT COMPLETED|Overall Study||0
4979783|NCT02538783|12249062|P2|COMPLETED|Overall Study||128
4979784|NCT02538783|12249063|P1|COMPLETED|Overall Study||130
4979785|NCT02538783|12249062|P2|STARTED|Overall Study||129
4979786|NCT02538783|12249063|P1|STARTED|Overall Study||130
4979787|NCT02538679|12249074|P3|NOT COMPLETED|Overall Study||8
4979788|NCT02538679|12249075|P2|NOT COMPLETED|Overall Study||9
4979789|NCT02538679|12249076|P1|NOT COMPLETED|Overall Study||3
4979790|NCT02538679|12249074|P3|COMPLETED|Overall Study||41
4979791|NCT02538679|12249075|P2|COMPLETED|Overall Study||45
4979792|NCT02538679|12249076|P1|COMPLETED|Overall Study||21
4979793|NCT02538679|12249074|P3|STARTED|Overall Study||49
4979794|NCT02538679|12249075|P2|STARTED|Overall Study||54
4979795|NCT02538679|12249076|P1|STARTED|Overall Study||24
4979796|NCT02538666|12249087|P3|NOT COMPLETED|Overall Study||1
4979797|NCT02538666|12249088|P2|NOT COMPLETED|Overall Study||1
4979798|NCT02538666|12249089|P1|NOT COMPLETED|Overall Study||2
4979799|NCT02538666|12249087|P3|COMPLETED|Overall Study||278
4979800|NCT02538666|12249088|P2|COMPLETED|Overall Study||279
4979801|NCT02538666|12249089|P1|COMPLETED|Overall Study||273
4979802|NCT02538666|12249087|P3|STARTED|Overall Study||279
4979803|NCT02538666|12249088|P2|STARTED|Overall Study||280
4979804|NCT02538666|12249089|P1|STARTED|Overall Study||275
4979805|NCT02538523|12249110|P2|NOT COMPLETED|Overall Study||0
4979806|NCT02538523|12249111|P1|NOT COMPLETED|Overall Study||0
4979807|NCT02538523|12249110|P2|COMPLETED|Overall Study||29
4979808|NCT02538523|12249111|P1|COMPLETED|Overall Study||29
4979809|NCT02538523|12249110|P2|STARTED|Overall Study||29
4979810|NCT02538523|12249111|P1|STARTED|Overall Study||29
4979811|NCT02538471|12249119|P1|NOT COMPLETED|Overall Study||2
4979812|NCT02538471|12249119|P1|COMPLETED|Overall Study||1
4979813|NCT02538471|12249119|P1|STARTED|Overall Study||3
4979814|NCT02538419|12249129|P2|NOT COMPLETED|Overall Study||0
4979815|NCT02538419|12249130|P1|NOT COMPLETED|Overall Study||0
4979816|NCT02538419|12249129|P2|COMPLETED|Overall Study||20
4979817|NCT02538419|12249130|P1|COMPLETED|Overall Study||20
4979818|NCT02538419|12249129|P2|STARTED|Overall Study||20
4979819|NCT02538419|12249130|P1|STARTED|Overall Study||20
4979820|NCT02538354|12249148|P2|NOT COMPLETED|Overall Study||0
4979821|NCT02538354|12249149|P1|NOT COMPLETED|Overall Study||0
4979822|NCT02538354|12249148|P2|COMPLETED|Overall Study||30
4979823|NCT02538354|12249149|P1|COMPLETED|Overall Study||40
4979824|NCT02538354|12249148|P2|STARTED|Overall Study||30
4979825|NCT02538354|12249149|P1|STARTED|Overall Study||40
4979826|NCT02538107|12249155|P1|NOT COMPLETED|Overall Study||110
4979827|NCT02538107|12249155|P1|COMPLETED|Overall Study||180
4979828|NCT02538107|12249155|P1|STARTED|Overall Study||290
4979829|NCT02538094|12249175|P2|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
4979830|NCT02538094|12249176|P1|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
4979831|NCT02538094|12249175|P2|COMPLETED|Intervention 2 (5 Days Per Participant)||3
4979832|NCT02538094|12249176|P1|COMPLETED|Intervention 2 (5 Days Per Participant)||2
4979833|NCT02538094|12249175|P2|STARTED|Intervention 2 (5 Days Per Participant)||3
4979834|NCT02538094|12249176|P1|STARTED|Intervention 2 (5 Days Per Participant)||2
4979835|NCT02538094|12249175|P2|NOT COMPLETED|Washout (4 Weeks)||1
4979836|NCT02538094|12249176|P1|NOT COMPLETED|Washout (4 Weeks)||0
4979837|NCT02538094|12249175|P2|COMPLETED|Washout (4 Weeks)||3
4979838|NCT02538094|12249176|P1|COMPLETED|Washout (4 Weeks)||2
4979839|NCT02538094|12249175|P2|STARTED|Washout (4 Weeks)||4
4979840|NCT02538094|12249176|P1|STARTED|Washout (4 Weeks)||2
4979841|NCT02538094|12249175|P2|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
4979842|NCT02538094|12249176|P1|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
4979843|NCT02538094|12249175|P2|COMPLETED|Intervention 1 (5 Days Per Participant)||4
4979844|NCT02538094|12249176|P1|COMPLETED|Intervention 1 (5 Days Per Participant)||2
4979845|NCT02538094|12249175|P2|STARTED|Intervention 1 (5 Days Per Participant)||5
4979846|NCT02538094|12249176|P1|STARTED|Intervention 1 (5 Days Per Participant)||2
4979847|NCT02538042|12249186|P2|NOT COMPLETED|Overall Study||11
4979848|NCT02538042|12249187|P1|NOT COMPLETED|Overall Study||11
4979849|NCT02538042|12249186|P2|COMPLETED|Overall Study||6
4979850|NCT02538042|12249187|P1|COMPLETED|Overall Study||6
4979851|NCT02538042|12249186|P2|Completed All Post-Quit Visits|Overall Study||12
4979852|NCT02538042|12249187|P1|Completed All Post-Quit Visits|Overall Study||12
4979853|NCT02538042|12249186|P2|Attended Post-Quit Visit|Overall Study||14
4979854|NCT02538042|12249187|P1|Attended Post-Quit Visit|Overall Study||15
4979855|NCT02538042|12249186|P2|Completed All MCE Sessions|Overall Study||15
4979856|NCT02538042|12249187|P1|Completed All MCE Sessions|Overall Study||15
4979857|NCT02538042|12249186|P2|STARTED|Overall Study||17
4979858|NCT02538042|12249187|P1|STARTED|Overall Study||17
4979859|NCT02538029|12249206|P3|NOT COMPLETED|Overall Study||1
4979860|NCT02538029|12249207|P2|NOT COMPLETED|Overall Study||0
4979861|NCT02538029|12249208|P1|NOT COMPLETED|Overall Study||1
4979862|NCT02538029|12249206|P3|COMPLETED|Overall Study||10
4979863|NCT02538029|12249207|P2|COMPLETED|Overall Study||10
4979864|NCT02538029|12249208|P1|COMPLETED|Overall Study||23
4979865|NCT02538029|12249206|P3|STARTED|Overall Study||11
4979866|NCT02538029|12249207|P2|STARTED|Overall Study||10
4979867|NCT02538029|12249208|P1|STARTED|Overall Study||24
4979868|NCT02538016|12249230|P1|NOT COMPLETED|Overall Study||0
4979869|NCT02538016|12249230|P1|COMPLETED|Overall Study||4
4979870|NCT02538016|12249230|P1|STARTED|Overall Study||4
4979871|NCT02537951|12249235|P1|NOT COMPLETED|Overall Study||0
4979872|NCT02537951|12249235|P1|COMPLETED|Overall Study||10
4979873|NCT02537951|12249235|P1|STARTED|Overall Study||10
4979874|NCT02537873|12249245|P2|NOT COMPLETED|Overall Study||4
4979875|NCT02537873|12249246|P1|NOT COMPLETED|Overall Study||8
4979876|NCT02537873|12249245|P2|COMPLETED|Overall Study||4
4979877|NCT02537873|12249246|P1|COMPLETED|Overall Study||9
4979878|NCT02537873|12249245|P2|STARTED|Overall Study||8
4979879|NCT02537873|12249246|P1|STARTED|Overall Study||17
4979880|NCT02537730|12249264|P2|NOT COMPLETED|Second Intervention (7 Days)||0
4979881|NCT02537730|12249265|P1|NOT COMPLETED|Second Intervention (7 Days)||0
4979882|NCT02537730|12249264|P2|COMPLETED|Second Intervention (7 Days)||16
4979883|NCT02537730|12249265|P1|COMPLETED|Second Intervention (7 Days)||17
4979884|NCT02537730|12249264|P2|STARTED|Second Intervention (7 Days)||16
4979885|NCT02537730|12249265|P1|STARTED|Second Intervention (7 Days)||17
4979886|NCT02537730|12249264|P2|NOT COMPLETED|First Intervention (7 Days)||0
4979887|NCT02537730|12249265|P1|NOT COMPLETED|First Intervention (7 Days)||0
4979888|NCT02537730|12249264|P2|COMPLETED|First Intervention (7 Days)||16
4979889|NCT02537730|12249265|P1|COMPLETED|First Intervention (7 Days)||17
4979890|NCT02537730|12249264|P2|STARTED|First Intervention (7 Days)||16
4979891|NCT02537730|12249265|P1|STARTED|First Intervention (7 Days)||17
4979892|NCT02537574|12249280|P3|NOT COMPLETED|Overall Study||108
4979893|NCT02537574|12249281|P2|NOT COMPLETED|Overall Study||103
4979894|NCT02537574|12249282|P1|NOT COMPLETED|Overall Study||99
4979895|NCT02537574|12249280|P3|COMPLETED|Overall Study||18
4979896|NCT02537574|12249281|P2|COMPLETED|Overall Study||23
4979897|NCT02537574|12249282|P1|COMPLETED|Overall Study||27
4979898|NCT02537574|12249280|P3|STARTED|Overall Study||126
4979899|NCT02537574|12249281|P2|STARTED|Overall Study||126
4979900|NCT02537574|12249282|P1|STARTED|Overall Study||126
4979901|NCT02537522|12249308|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4979902|NCT02537522|12249309|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4979903|NCT02537522|12249310|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4979904|NCT02537522|12249311|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4979905|NCT02537522|12249308|P4|COMPLETED|Phase II - Period 2 Bilateral||22
4979906|NCT02537522|12249309|P3|COMPLETED|Phase II - Period 2 Bilateral||23
4979907|NCT02537522|12249310|P2|COMPLETED|Phase II - Period 2 Bilateral||0
4979908|NCT02537522|12249311|P1|COMPLETED|Phase II - Period 2 Bilateral||0
4979909|NCT02537522|12249308|P4|STARTED|Phase II - Period 2 Bilateral||22
4979910|NCT02537522|12249309|P3|STARTED|Phase II - Period 2 Bilateral||23
4979911|NCT02537522|12249310|P2|STARTED|Phase II - Period 2 Bilateral||0
4979912|NCT02537522|12249311|P1|STARTED|Phase II - Period 2 Bilateral||0
4979913|NCT02537522|12249308|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
4979914|NCT02537522|12249309|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4979915|NCT02537522|12249310|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4979916|NCT02537522|12249311|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4979917|NCT02537522|12249308|P4|COMPLETED|Phase II - Period 1 Bilateral||22
4979918|NCT02537522|12249309|P3|COMPLETED|Phase II - Period 1 Bilateral||23
4979919|NCT02537522|12249310|P2|COMPLETED|Phase II - Period 1 Bilateral||0
4979920|NCT02537522|12249311|P1|COMPLETED|Phase II - Period 1 Bilateral||0
4979921|NCT02537522|12249308|P4|STARTED|Phase II - Period 1 Bilateral||23
4979922|NCT02537522|12249309|P3|STARTED|Phase II - Period 1 Bilateral||23
4979923|NCT02537522|12249310|P2|STARTED|Phase II - Period 1 Bilateral||0
4979924|NCT02537522|12249311|P1|STARTED|Phase II - Period 1 Bilateral||0
4979925|NCT02537522|12249308|P4|NOT COMPLETED|Phase I - Contralateral||0
4979926|NCT02537522|12249309|P3|NOT COMPLETED|Phase I - Contralateral||0
4979927|NCT02537522|12249310|P2|NOT COMPLETED|Phase I - Contralateral||10
4979928|NCT02537522|12249311|P1|NOT COMPLETED|Phase I - Contralateral||15
4979929|NCT02537522|12249308|P4|COMPLETED|Phase I - Contralateral||0
4979930|NCT02537522|12249309|P3|COMPLETED|Phase I - Contralateral||0
4979931|NCT02537522|12249310|P2|COMPLETED|Phase I - Contralateral||27
4979932|NCT02537522|12249311|P1|COMPLETED|Phase I - Contralateral||19
4979933|NCT02537522|12249308|P4|STARTED|Phase I - Contralateral||0
4979934|NCT02537522|12249309|P3|STARTED|Phase I - Contralateral||0
4979935|NCT02537522|12249310|P2|STARTED|Phase I - Contralateral||37
4979936|NCT02537522|12249311|P1|STARTED|Phase I - Contralateral||34
4979937|NCT02537444|12249321|P2|NOT COMPLETED|Overall Study||39
4979938|NCT02537444|12249322|P1|NOT COMPLETED|Overall Study||39
4979939|NCT02537444|12249321|P2|COMPLETED|Overall Study||0
4979940|NCT02537444|12249322|P1|COMPLETED|Overall Study||0
4979941|NCT02537444|12249321|P2|Discontinued Study|Overall Study||39
4979942|NCT02537444|12249322|P1|Discontinued Study|Overall Study||39
4979943|NCT02537444|12249321|P2|Received Study Medication|Overall Study||39
4979944|NCT02537444|12249322|P1|Received Study Medication|Overall Study||38
4979945|NCT02537444|12249321|P2|Enrolled|Overall Study||39
4979946|NCT02537444|12249322|P1|Enrolled|Overall Study||39
4979947|NCT02537444|12249321|P2|STARTED|Overall Study||39
4979948|NCT02537444|12249322|P1|STARTED|Overall Study||39
4979949|NCT02537431|12249328|P1|NOT COMPLETED|Treatment Extension Period II||0
4979950|NCT02537431|12249328|P1|COMPLETED|Treatment Extension Period II||8
4979951|NCT02537431|12249328|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
4979952|NCT02537431|12249328|P1|NOT COMPLETED|Treatment Extension Period I||0
4979953|NCT02537431|12249328|P1|COMPLETED|Treatment Extension Period I||13
4979954|NCT02537431|12249328|P1|STARTED|Treatment Extension Period I||13
4979955|NCT02537431|12249328|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
4979956|NCT02537431|12249328|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
4979957|NCT02537431|12249328|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
4979958|NCT02537015|12249357|P1|NOT COMPLETED|Overall Study||6
4979959|NCT02537015|12249357|P1|COMPLETED|Overall Study||75
4979960|NCT02537015|12249357|P1|STARTED|Overall Study||81
4979961|NCT02536976|12249363|P2|NOT COMPLETED|Overall Study||1
4979962|NCT02536976|12249364|P1|NOT COMPLETED|Overall Study||0
4979963|NCT02536976|12249363|P2|COMPLETED|Overall Study||1
4979964|NCT02536976|12249364|P1|COMPLETED|Overall Study||3
4979965|NCT02536976|12249363|P2|Washout|Overall Study||1
4979966|NCT02536976|12249364|P1|Washout|Overall Study||3
4979967|NCT02536976|12249363|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
4979968|NCT02536976|12249364|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
4979969|NCT02536976|12249363|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
4979970|NCT02536976|12249364|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
4979971|NCT02536976|12249363|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
4979972|NCT02536976|12249364|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
4979973|NCT02536963|12249374|P1|NOT COMPLETED|Overall Study||18
4979974|NCT02536963|12249374|P1|COMPLETED|Overall Study||300
4979975|NCT02536963|12249374|P1|STARTED|Overall Study||318
4979976|NCT02536781|12249380|P2|NOT COMPLETED|Overall Study||0
4979977|NCT02536781|12249381|P1|NOT COMPLETED|Overall Study||2
4979978|NCT02536781|12249380|P2|COMPLETED|Overall Study||34
4979979|NCT02536781|12249381|P1|COMPLETED|Overall Study||34
4979980|NCT02536781|12249380|P2|STARTED|Overall Study||34
4979981|NCT02536781|12249381|P1|STARTED|Overall Study||36
4979982|NCT02536664|12249391|P2|NOT COMPLETED|Overall Study||80
4979983|NCT02536664|12249392|P1|NOT COMPLETED|Overall Study||107
4979984|NCT02536664|12249391|P2|COMPLETED|Overall Study||97
4979985|NCT02536664|12249392|P1|COMPLETED|Overall Study||205
4979986|NCT02536664|12249391|P2|STARTED|Overall Study||177
4979987|NCT02536664|12249392|P1|STARTED|Overall Study||312
4979988|NCT02536378|12249412|P2|NOT COMPLETED|Overall Study||7
4979989|NCT02536378|12249413|P1|NOT COMPLETED|Overall Study||7
4979990|NCT02536378|12249412|P2|COMPLETED|Overall Study||53
4979991|NCT02536378|12249413|P1|COMPLETED|Overall Study||625
4979992|NCT02536378|12249412|P2|STARTED|Overall Study||60
4979993|NCT02536378|12249413|P1|STARTED|Overall Study||632
4979994|NCT02536339|12249427|P1|NOT COMPLETED|Overall Study||31
4979995|NCT02536339|12249427|P1|COMPLETED|Overall Study||9
4979996|NCT02536339|12249427|P1|Received at Least One Dose of Study Drug|Overall Study||39
4979997|NCT02536339|12249427|P1|STARTED|Overall Study||40
4979998|NCT02536313|12249453|P2|NOT COMPLETED|Overall Study||1
4979999|NCT02536313|12249454|P1|NOT COMPLETED|Overall Study||0
4980000|NCT02536313|12249453|P2|COMPLETED|Overall Study||24
4980001|NCT02536313|12249454|P1|COMPLETED|Overall Study||24
4980002|NCT02536313|12249453|P2|STARTED|Overall Study||25
4980003|NCT02536313|12249454|P1|STARTED|Overall Study||24
4980004|NCT02536248|12249472|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
4980005|NCT02536248|12249473|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
4980006|NCT02536248|12249472|P2|COMPLETED|Second Intervention (6 Weeks)||10
4980007|NCT02536248|12249473|P1|COMPLETED|Second Intervention (6 Weeks)||10
4980008|NCT02536248|12249472|P2|STARTED|Second Intervention (6 Weeks)||10
4980009|NCT02536248|12249473|P1|STARTED|Second Intervention (6 Weeks)||10
4980010|NCT02536248|12249472|P2|NOT COMPLETED|Wash-out (14 Days)||0
4980011|NCT02536248|12249473|P1|NOT COMPLETED|Wash-out (14 Days)||0
4980012|NCT02536248|12249472|P2|COMPLETED|Wash-out (14 Days)||10
4980013|NCT02536248|12249473|P1|COMPLETED|Wash-out (14 Days)||10
4980014|NCT02536248|12249472|P2|STARTED|Wash-out (14 Days)||10
4980015|NCT02536248|12249473|P1|STARTED|Wash-out (14 Days)||10
4980016|NCT02536248|12249472|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
4980017|NCT02536248|12249473|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
4980018|NCT02536248|12249472|P2|COMPLETED|First Intervention (6 Weeks)||10
4980019|NCT02536248|12249473|P1|COMPLETED|First Intervention (6 Weeks)||10
4980020|NCT02536248|12249472|P2|STARTED|First Intervention (6 Weeks)||10
4980021|NCT02536248|12249473|P1|STARTED|First Intervention (6 Weeks)||10
4980022|NCT02536105|12249485|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
4980023|NCT02536105|12249485|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
4980024|NCT02536105|12249485|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
4980025|NCT02536105|12249485|P1|STARTED|Methylphenidate HCl ER Suspension||74
4980026|NCT02536105|12249485|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
4980027|NCT02536105|12249485|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
4980028|NCT02536105|12249485|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
4980029|NCT02536105|12249485|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
4980030|NCT02536105|12249485|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
4980031|NCT02536105|12249485|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
4980032|NCT02536105|12249485|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
4980033|NCT02536105|12249485|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
4980034|NCT02536105|12249485|P1|NOT COMPLETED|Placebo||2
4980035|NCT02536105|12249485|P1|COMPLETED|Placebo||72
4980036|NCT02536105|12249485|P1|Completion of Placebo Day|Placebo||74
4980037|NCT02536105|12249485|P1|STARTED|Placebo||74
4980038|NCT02536105|12249485|P1|NOT COMPLETED|Concerta Open Label||8
4980039|NCT02536105|12249485|P1|COMPLETED|Concerta Open Label||72
4980040|NCT02536105|12249485|P1|Completion of Phase|Concerta Open Label||76
4980041|NCT02536105|12249485|P1|STARTED|Concerta Open Label||80
4980042|NCT02536040|12249509|P2|NOT COMPLETED|Overall Study||1
4980043|NCT02536040|12249510|P1|NOT COMPLETED|Overall Study||1
4980044|NCT02536040|12249509|P2|COMPLETED|Overall Study||35
4980045|NCT02536040|12249510|P1|COMPLETED|Overall Study||29
4980046|NCT02536040|12249509|P2|STARTED|Overall Study||36
4980047|NCT02536040|12249510|P1|STARTED|Overall Study||30
4980048|NCT02535806|12249516|P1|NOT COMPLETED|Overall Study||0
4980049|NCT02535806|12249516|P1|COMPLETED|Overall Study||2
4980050|NCT02535806|12249516|P1|STARTED|Overall Study||2
4980051|NCT02535741|12249523|P1|NOT COMPLETED|Overall Study||32
4980052|NCT02535741|12249523|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
4980053|NCT02535741|12249523|P1|STARTED|Overall Study||168
4980054|NCT02535715|12249531|P3|NOT COMPLETED|Overall Study||1
4980055|NCT02535715|12249532|P2|NOT COMPLETED|Overall Study||0
4980056|NCT02535715|12249533|P1|NOT COMPLETED|Overall Study||0
4980057|NCT02535715|12249531|P3|COMPLETED|Overall Study||2
4980058|NCT02535715|12249532|P2|COMPLETED|Overall Study||4
4980059|NCT02535715|12249533|P1|COMPLETED|Overall Study||4
4980060|NCT02535715|12249531|P3|STARTED|Overall Study||3
4980061|NCT02535715|12249532|P2|STARTED|Overall Study||4
4980062|NCT02535715|12249533|P1|STARTED|Overall Study||4
4980063|NCT02535416|12249562|P9|NOT COMPLETED|Overall Study||0
4980064|NCT02535416|12249563|P8|NOT COMPLETED|Overall Study||0
4980065|NCT02535416|12249564|P7|NOT COMPLETED|Overall Study||0
4980066|NCT02535416|12249565|P6|NOT COMPLETED|Overall Study||0
4980067|NCT02535416|12249566|P5|NOT COMPLETED|Overall Study||0
4980068|NCT02535416|12249567|P4|NOT COMPLETED|Overall Study||0
4980069|NCT02535416|12249568|P3|NOT COMPLETED|Overall Study||0
4980070|NCT02535416|12249569|P2|NOT COMPLETED|Overall Study||0
4980071|NCT02535416|12249570|P1|NOT COMPLETED|Overall Study||1
4980072|NCT02535416|12249562|P9|COMPLETED|Overall Study||6
4980073|NCT02535416|12249563|P8|COMPLETED|Overall Study||6
4980074|NCT02535416|12249564|P7|COMPLETED|Overall Study||6
4980075|NCT02535416|12249565|P6|COMPLETED|Overall Study||4
4980076|NCT02535416|12249566|P5|COMPLETED|Overall Study||4
4980077|NCT02535416|12249567|P4|COMPLETED|Overall Study||4
4980078|NCT02535416|12249568|P3|COMPLETED|Overall Study||4
4980079|NCT02535416|12249569|P2|COMPLETED|Overall Study||2
4980080|NCT02535416|12249570|P1|COMPLETED|Overall Study||3
4980081|NCT02535416|12249562|P9|STARTED|Overall Study||6
4980082|NCT02535416|12249563|P8|STARTED|Overall Study||6
4980083|NCT02535416|12249564|P7|STARTED|Overall Study||6
4980084|NCT02535416|12249565|P6|STARTED|Overall Study||4
4980085|NCT02535416|12249566|P5|STARTED|Overall Study||4
4980086|NCT02535416|12249567|P4|STARTED|Overall Study||4
4980087|NCT02535416|12249568|P3|STARTED|Overall Study||4
4980088|NCT02535416|12249569|P2|STARTED|Overall Study||2
4980089|NCT02535416|12249570|P1|STARTED|Overall Study||4
4980090|NCT02535364|12249622|P1|NOT COMPLETED|12-Month Follow-up Period||35
4980091|NCT02535364|12249622|P1|COMPLETED|12-Month Follow-up Period||3
4980092|NCT02535364|12249622|P1|STARTED|12-Month Follow-up Period||38
4980093|NCT02535364|12249622|P1|NOT COMPLETED|Study Treatment||2
4980094|NCT02535364|12249622|P1|COMPLETED|Study Treatment||38
4980095|NCT02535364|12249622|P1|STARTED|Study Treatment||40
4980096|NCT02535364|12249622|P1|NOT COMPLETED|Part B Screening||17
4980097|NCT02535364|12249622|P1|COMPLETED|Part B Screening||40
4980098|NCT02535364|12249622|P1|STARTED|Part B Screening||57
4980099|NCT02535364|12249622|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
4980100|NCT02535364|12249622|P1|COMPLETED|Part A Screening Through Leukapheresis||57
4980101|NCT02535364|12249622|P1|STARTED|Part A Screening Through Leukapheresis||82
4980102|NCT02535065|12249647|P1|NOT COMPLETED|Overall Study||62
4980103|NCT02535065|12249647|P1|COMPLETED|Overall Study||0
4980104|NCT02535065|12249647|P1|12-Month Follow-up|Overall Study||61
4980105|NCT02535065|12249647|P1|1-Month Follow-up|Overall Study||62
4980106|NCT02535065|12249647|P1|STARTED|Overall Study||62
4980107|NCT02535026|12249652|P1|NOT COMPLETED|Overall Study||0
4980108|NCT02535026|12249652|P1|COMPLETED|Overall Study||580
4980109|NCT02535026|12249652|P1|STARTED|Overall Study||580
4980110|NCT02534935|12249707|P3|NOT COMPLETED|Overall Study||5
4980111|NCT02534935|12249708|P2|NOT COMPLETED|Overall Study||10
4980112|NCT02534935|12249709|P1|NOT COMPLETED|Overall Study||0
4980113|NCT02534935|12249707|P3|COMPLETED|Overall Study||127
4980114|NCT02534935|12249708|P2|COMPLETED|Overall Study||210
4980115|NCT02534935|12249709|P1|COMPLETED|Overall Study||44
4980116|NCT02534935|12249707|P3|STARTED|Overall Study||132
4980117|NCT02534935|12249708|P2|STARTED|Overall Study||220
4980118|NCT02534935|12249709|P1|STARTED|Overall Study||44
4980119|NCT02534896|12249870|P3|NOT COMPLETED|Overall Study||1
4980120|NCT02534896|12249871|P2|NOT COMPLETED|Overall Study||1
4980121|NCT02534896|12249872|P1|NOT COMPLETED|Overall Study||4
4980122|NCT02534896|12249870|P3|COMPLETED|Overall Study||48
4980123|NCT02534896|12249871|P2|COMPLETED|Overall Study||51
4980124|NCT02534896|12249872|P1|COMPLETED|Overall Study||45
4980125|NCT02534896|12249870|P3|STARTED|Overall Study||49
4980126|NCT02534896|12249871|P2|STARTED|Overall Study||52
4980127|NCT02534896|12249872|P1|STARTED|Overall Study||49
4980128|NCT02534883|12249891|P2|NOT COMPLETED|Overall Study||3
4980129|NCT02534883|12249892|P1|NOT COMPLETED|Overall Study||8
4980130|NCT02534883|12249891|P2|COMPLETED|Overall Study||0
4980131|NCT02534883|12249892|P1|COMPLETED|Overall Study||0
4980132|NCT02534883|12249891|P2|STARTED|Overall Study||3
4980133|NCT02534883|12249892|P1|STARTED|Overall Study||8
4980134|NCT02534493|12249908|P1|NOT COMPLETED|Overall Study||2
4980135|NCT02534493|12249908|P1|COMPLETED|Overall Study||11
4980136|NCT02534493|12249908|P1|STARTED|Overall Study||13
4980137|NCT02534350|12249919|P2|NOT COMPLETED|Overall Study||0
4980138|NCT02534350|12249920|P1|NOT COMPLETED|Overall Study||4
4980139|NCT02534350|12249919|P2|COMPLETED|Overall Study||20
4980140|NCT02534350|12249920|P1|COMPLETED|Overall Study||37
4980141|NCT02534350|12249919|P2|STARTED|Overall Study||20
4980142|NCT02534350|12249920|P1|STARTED|Overall Study||41
4980143|NCT02534324|12249934|P2|NOT COMPLETED|Overall Study||8
4980144|NCT02534324|12249935|P1|NOT COMPLETED|Overall Study||25
4980145|NCT02534324|12249934|P2|COMPLETED|Overall Study||40
4980146|NCT02534324|12249935|P1|COMPLETED|Overall Study||73
4980147|NCT02534324|12249934|P2|STARTED|Overall Study||48
4980148|NCT02534324|12249935|P1|STARTED|Overall Study||98
4980149|NCT02534129|12249945|P2|NOT COMPLETED|Overall Study||0
4980150|NCT02534129|12249946|P1|NOT COMPLETED|Overall Study||0
4980151|NCT02534129|12249945|P2|COMPLETED|Overall Study||13
4980152|NCT02534129|12249946|P1|COMPLETED|Overall Study||13
4980153|NCT02534129|12249945|P2|STARTED|Overall Study||13
4980154|NCT02534129|12249946|P1|STARTED|Overall Study||13
4980155|NCT02533999|12249954|P2|NOT COMPLETED|Overall Study||7
4980156|NCT02533999|12249955|P1|NOT COMPLETED|Overall Study||6
4980157|NCT02533999|12249954|P2|COMPLETED|Overall Study||30
4980158|NCT02533999|12249955|P1|COMPLETED|Overall Study||32
4980159|NCT02533999|12249954|P2|STARTED|Overall Study||37
4980160|NCT02533999|12249955|P1|STARTED|Overall Study||38
4980161|NCT02533921|12249975|P2|NOT COMPLETED|Overall Study||11
4980162|NCT02533921|12249976|P1|NOT COMPLETED|Overall Study||16
4980163|NCT02533921|12249975|P2|COMPLETED|Overall Study||95
4980164|NCT02533921|12249976|P1|COMPLETED|Overall Study||88
4980165|NCT02533921|12249975|P2|STARTED|Overall Study||106
4980166|NCT02533921|12249976|P1|STARTED|Overall Study||104
4980167|NCT02533726|12249994|P2|NOT COMPLETED|Treatment||0
4980168|NCT02533726|12249995|P1|NOT COMPLETED|Treatment||0
4980169|NCT02533726|12249994|P2|COMPLETED|Treatment||603
4980170|NCT02533726|12249995|P1|COMPLETED|Treatment||709
4980171|NCT02533726|12249994|P2|Per Protocol Population|Treatment||555
4980172|NCT02533726|12249995|P1|Per Protocol Population|Treatment||671
4980173|NCT02533726|12249994|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
4980174|NCT02533726|12249995|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
4980175|NCT02533726|12249994|P2|NOT COMPLETED|Initial Allocation||0
4980176|NCT02533726|12249995|P1|NOT COMPLETED|Initial Allocation||0
4980177|NCT02533726|12249994|P2|COMPLETED|Initial Allocation||653
4980178|NCT02533726|12249995|P1|COMPLETED|Initial Allocation||659
4980179|NCT02533726|12249994|P2|STARTED|Initial Allocation||653
4980180|NCT02533726|12249995|P1|STARTED|Initial Allocation||659
4980181|NCT02533570|12250006|P3|NOT COMPLETED|Overall Study||1
4980182|NCT02533570|12250007|P2|NOT COMPLETED|Overall Study||1
4980183|NCT02533570|12250008|P1|NOT COMPLETED|Overall Study||0
4980184|NCT02533570|12250006|P3|COMPLETED|Overall Study||7
4980185|NCT02533570|12250007|P2|COMPLETED|Overall Study||7
4980186|NCT02533570|12250008|P1|COMPLETED|Overall Study||4
4980187|NCT02533570|12250006|P3|STARTED|Overall Study||8
4980188|NCT02533570|12250007|P2|STARTED|Overall Study||8
4980189|NCT02533570|12250008|P1|STARTED|Overall Study||4
4980190|NCT02533531|12250019|P1|NOT COMPLETED|Overall Study||1
4980191|NCT02533531|12250019|P1|COMPLETED|Overall Study||0
4980192|NCT02533531|12250019|P1|STARTED|Overall Study||1
4980193|NCT02533505|12250024|P2|NOT COMPLETED|Overall Study||1
4980194|NCT02533505|12250025|P1|NOT COMPLETED|Overall Study||3
4980195|NCT02533505|12250024|P2|COMPLETED|Overall Study||24
4980196|NCT02533505|12250025|P1|COMPLETED|Overall Study||23
4980197|NCT02533505|12250024|P2|STARTED|Overall Study||25
4980198|NCT02533505|12250025|P1|STARTED|Overall Study||26
4980199|NCT02533466|12250057|P2|NOT COMPLETED|Overall Study||0
4980200|NCT02533466|12250058|P1|NOT COMPLETED|Overall Study||0
4980201|NCT02533466|12250057|P2|COMPLETED|Overall Study||14
4980202|NCT02533466|12250058|P1|COMPLETED|Overall Study||16
4980203|NCT02533466|12250057|P2|STARTED|Overall Study||14
4980204|NCT02533466|12250058|P1|STARTED|Overall Study||16
4980205|NCT02533453|12250082|P1|NOT COMPLETED|Overall Study||9
4980206|NCT02533453|12250082|P1|COMPLETED|Overall Study||101
4980207|NCT02533453|12250082|P1|STARTED|Overall Study||110
4980208|NCT02533401|12250091|P1|NOT COMPLETED|Overall Study||11
4980209|NCT02533401|12250091|P1|COMPLETED|Overall Study||23
4980210|NCT02533401|12250091|P1|STARTED|Overall Study||34
4980211|NCT02533375|12250099|P1|NOT COMPLETED|Overall Study||5
4980212|NCT02533375|12250099|P1|COMPLETED|Overall Study||5
4980213|NCT02533375|12250099|P1|STARTED|Overall Study||10
4980214|NCT02533258|12250131|P1|NOT COMPLETED|Overall Study||8
4980215|NCT02533258|12250131|P1|COMPLETED|Overall Study||5
4980216|NCT02533258|12250131|P1|STARTED|Overall Study||13
4980217|NCT02533167|12250143|P1|NOT COMPLETED|Overall Study||15
4980218|NCT02533167|12250143|P1|COMPLETED|Overall Study||55
4980219|NCT02533167|12250143|P1|STARTED|Overall Study||70
4980220|NCT02533089|12250154|P2|NOT COMPLETED|Overall Study||114
4980221|NCT02533089|12250155|P1|NOT COMPLETED|Overall Study||241
4980222|NCT02533089|12250154|P2|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
4980223|NCT02533089|12250155|P1|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
4980224|NCT02533089|12250154|P2|STARTED|Overall Study||548
4980225|NCT02533089|12250155|P1|STARTED|Overall Study||605
4980226|NCT02533063|12250167|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
4980227|NCT02533063|12250168|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
4980228|NCT02533063|12250167|P2|COMPLETED|Intervention 2 (8 Weeks)||11
4980229|NCT02533063|12250168|P1|COMPLETED|Intervention 2 (8 Weeks)||14
4980230|NCT02533063|12250167|P2|STARTED|Intervention 2 (8 Weeks)||11
4980231|NCT02533063|12250168|P1|STARTED|Intervention 2 (8 Weeks)||14
4980232|NCT02533063|12250167|P2|NOT COMPLETED|Washout (4 Weeks)||0
4980233|NCT02533063|12250168|P1|NOT COMPLETED|Washout (4 Weeks)||0
4980234|NCT02533063|12250167|P2|COMPLETED|Washout (4 Weeks)||11
4980235|NCT02533063|12250168|P1|COMPLETED|Washout (4 Weeks)||14
4980236|NCT02533063|12250167|P2|STARTED|Washout (4 Weeks)||11
4980237|NCT02533063|12250168|P1|STARTED|Washout (4 Weeks)||14
4980238|NCT02533063|12250167|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
4980239|NCT02533063|12250168|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
4980240|NCT02533063|12250167|P2|COMPLETED|Intervention 1 (8 Weeks)||11
4980241|NCT02533063|12250168|P1|COMPLETED|Intervention 1 (8 Weeks)||14
4980242|NCT02533063|12250167|P2|STARTED|Intervention 1 (8 Weeks)||16
4980243|NCT02533063|12250168|P1|STARTED|Intervention 1 (8 Weeks)||16
4980244|NCT02532998|12250190|P1|NOT COMPLETED|Overall Study||0
4980245|NCT02532998|12250190|P1|COMPLETED|Overall Study||23
4980246|NCT02532998|12250190|P1|STARTED|Overall Study||23
4980247|NCT02532972|12250272|P1|NOT COMPLETED|Overall Study||1
4980248|NCT02532972|12250272|P1|COMPLETED|Overall Study||10
4980249|NCT02532972|12250272|P1|STARTED|Overall Study||11
4980250|NCT02532933|12250280|P2|NOT COMPLETED|Overall Study||6
4980251|NCT02532933|12250281|P1|NOT COMPLETED|Overall Study||6
4980252|NCT02532933|12250280|P2|COMPLETED|Overall Study||16
4980253|NCT02532933|12250281|P1|COMPLETED|Overall Study||16
4980254|NCT02532933|12250280|P2|STARTED|Overall Study||22
4980255|NCT02532933|12250281|P1|STARTED|Overall Study||22
4980256|NCT02532855|12250289|P2|NOT COMPLETED|Overall Study||11
4980257|NCT02532855|12250290|P1|NOT COMPLETED|Overall Study||8
4980258|NCT02532855|12250289|P2|COMPLETED|Overall Study||296
4980259|NCT02532855|12250290|P1|COMPLETED|Overall Study||299
4980260|NCT02532855|12250289|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
4980261|NCT02532855|12250290|P1|Treated|Overall Study||307
4980262|NCT02532855|12250289|P2|STARTED|Overall Study||307
4980263|NCT02532855|12250290|P1|STARTED|Overall Study||307
4980264|NCT02532764|12250324|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
4980265|NCT02532764|12250325|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
4980266|NCT02532764|12250326|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
4980267|NCT02532764|12250327|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980268|NCT02532764|12250328|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980269|NCT02532764|12250329|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980270|NCT02532764|12250330|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980271|NCT02532764|12250331|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980272|NCT02532764|12250332|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980273|NCT02532764|12250333|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980274|NCT02532764|12250324|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
4980275|NCT02532764|12250325|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
4980276|NCT02532764|12250326|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
4980277|NCT02532764|12250327|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
4980278|NCT02532764|12250328|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
4980279|NCT02532764|12250329|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980280|NCT02532764|12250330|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980281|NCT02532764|12250331|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980282|NCT02532764|12250332|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980283|NCT02532764|12250333|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
4980284|NCT02532764|12250324|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
4980285|NCT02532764|12250325|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
4980286|NCT02532764|12250326|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
4980287|NCT02532764|12250327|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
4980288|NCT02532764|12250328|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
4980289|NCT02532764|12250329|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
4980290|NCT02532764|12250330|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
4980291|NCT02532764|12250331|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
4980292|NCT02532764|12250332|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
4980293|NCT02532764|12250333|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
4980294|NCT02532764|12250324|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980295|NCT02532764|12250325|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980296|NCT02532764|12250326|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980297|NCT02532764|12250327|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980298|NCT02532764|12250328|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980299|NCT02532764|12250329|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980300|NCT02532764|12250330|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980301|NCT02532764|12250331|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980302|NCT02532764|12250332|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980303|NCT02532764|12250333|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980304|NCT02532764|12250324|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980305|NCT02532764|12250325|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980306|NCT02532764|12250326|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980307|NCT02532764|12250327|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980308|NCT02532764|12250328|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
4980309|NCT02532764|12250329|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
4980310|NCT02532764|12250330|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
4980311|NCT02532764|12250331|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
4980312|NCT02532764|12250332|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
4980313|NCT02532764|12250333|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
4980314|NCT02532764|12250324|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
4980315|NCT02532764|12250325|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
4980316|NCT02532764|12250326|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
4980317|NCT02532764|12250327|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
4980318|NCT02532764|12250328|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
4980319|NCT02532764|12250329|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
4980320|NCT02532764|12250330|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
4980321|NCT02532764|12250331|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
4980322|NCT02532764|12250332|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
4980323|NCT02532764|12250333|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
4980324|NCT02532647|12250484|P3|NOT COMPLETED|Overall Study||1
4980325|NCT02532647|12250485|P2|NOT COMPLETED|Overall Study||0
4980326|NCT02532647|12250486|P1|NOT COMPLETED|Overall Study||1
4980327|NCT02532647|12250484|P3|COMPLETED|Overall Study||30
4980328|NCT02532647|12250485|P2|COMPLETED|Overall Study||16
4980329|NCT02532647|12250486|P1|COMPLETED|Overall Study||31
4980330|NCT02532647|12250484|P3|Safety Population|Overall Study||30
4980331|NCT02532647|12250485|P2|Safety Population|Overall Study||16
4980332|NCT02532647|12250486|P1|Safety Population|Overall Study||31
4980333|NCT02532647|12250484|P3|STARTED|Overall Study||31
4980334|NCT02532647|12250485|P2|STARTED|Overall Study||16
4980335|NCT02532647|12250486|P1|STARTED|Overall Study||32
4980336|NCT02532543|12250504|P4|NOT COMPLETED|Overall Study||0
4980337|NCT02532543|12250505|P3|NOT COMPLETED|Overall Study||1
4980338|NCT02532543|12250506|P2|NOT COMPLETED|Overall Study||0
4980339|NCT02532543|12250507|P1|NOT COMPLETED|Overall Study||0
4980340|NCT02532543|12250504|P4|COMPLETED|Overall Study||4
4980341|NCT02532543|12250505|P3|COMPLETED|Overall Study||4
4980342|NCT02532543|12250506|P2|COMPLETED|Overall Study||4
4980343|NCT02532543|12250507|P1|COMPLETED|Overall Study||3
4980344|NCT02532543|12250504|P4|STARTED|Overall Study||4
4980345|NCT02532543|12250505|P3|STARTED|Overall Study||5
4980346|NCT02532543|12250506|P2|STARTED|Overall Study||4
4980347|NCT02532543|12250507|P1|STARTED|Overall Study||3
4980348|NCT02532465|12250543|P2|NOT COMPLETED|Overall Study||1
4980349|NCT02532465|12250544|P1|NOT COMPLETED|Overall Study||1
4980350|NCT02532465|12250543|P2|COMPLETED|Overall Study||24
4980351|NCT02532465|12250544|P1|COMPLETED|Overall Study||24
4980352|NCT02532465|12250543|P2|STARTED|Overall Study||25
4980353|NCT02532465|12250544|P1|STARTED|Overall Study||25
4980354|NCT02532374|12250554|P1|NOT COMPLETED|Overall Study||2
4980355|NCT02532374|12250554|P1|COMPLETED|Overall Study||14
4980356|NCT02532374|12250554|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
4980357|NCT02532374|12250554|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
4980358|NCT02532374|12250554|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
4980359|NCT02532374|12250554|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
4980360|NCT02532374|12250554|P1|STARTED|Overall Study||16
4980361|NCT02532283|12250580|P2|NOT COMPLETED|Overall Study||5
4980362|NCT02532283|12250581|P1|NOT COMPLETED|Overall Study||9
4980363|NCT02532283|12250580|P2|COMPLETED|Overall Study||30
4980364|NCT02532283|12250581|P1|COMPLETED|Overall Study||55
4980365|NCT02532283|12250580|P2|Full Analysis Set|Overall Study||32
4980366|NCT02532283|12250581|P1|Full Analysis Set|Overall Study||63
4980367|NCT02532283|12250580|P2|STARTED|Overall Study||35
4980368|NCT02532283|12250581|P1|STARTED|Overall Study||64
4980369|NCT02532179|12250623|P1|NOT COMPLETED|Overall Study||3
4980370|NCT02532179|12250623|P1|COMPLETED|Overall Study||9
4980371|NCT02532179|12250623|P1|STARTED|Overall Study||12
4980372|NCT02532010|12250634|P2|NOT COMPLETED|Overall Study||4
4980373|NCT02532010|12250635|P1|NOT COMPLETED|Overall Study||9
4980374|NCT02532010|12250634|P2|COMPLETED|Overall Study||0
4980375|NCT02532010|12250635|P1|COMPLETED|Overall Study||0
4980376|NCT02532010|12250634|P2|STARTED|Overall Study||4
4980377|NCT02532010|12250635|P1|STARTED|Overall Study||9
4980378|NCT02531971|12250655|P2|NOT COMPLETED|Overall Study||0
4980379|NCT02531971|12250656|P1|NOT COMPLETED|Overall Study||0
4980380|NCT02531971|12250655|P2|COMPLETED|Overall Study||13
4980381|NCT02531971|12250656|P1|COMPLETED|Overall Study||11
4980382|NCT02531971|12250655|P2|STARTED|Overall Study||13
4980383|NCT02531971|12250656|P1|STARTED|Overall Study||11
4980384|NCT02531867|12250663|P1|NOT COMPLETED|Overall Study||0
4980385|NCT02531867|12250663|P1|COMPLETED|Overall Study||13
4980386|NCT02531867|12250663|P1|STARTED|Overall Study||13
4980387|NCT02531802|12250688|P21|NOT COMPLETED|Received Vaccination 2||1
4980388|NCT02531802|12250689|P20|NOT COMPLETED|Received Vaccination 2||1
4980389|NCT02531802|12250690|P19|NOT COMPLETED|Received Vaccination 2||3
4980390|NCT02531802|12250691|P18|NOT COMPLETED|Received Vaccination 2||4
4980391|NCT02531802|12250692|P17|NOT COMPLETED|Received Vaccination 2||0
4980392|NCT02531802|12250693|P16|NOT COMPLETED|Received Vaccination 2||0
4980393|NCT02531802|12250694|P15|NOT COMPLETED|Received Vaccination 2||1
4980394|NCT02531802|12250695|P14|NOT COMPLETED|Received Vaccination 2||2
4980395|NCT02531802|12250696|P13|NOT COMPLETED|Received Vaccination 2||2
4980396|NCT02531802|12250697|P12|NOT COMPLETED|Received Vaccination 2||0
4980397|NCT02531802|12250698|P11|NOT COMPLETED|Received Vaccination 2||2
4980398|NCT02531802|12250699|P10|NOT COMPLETED|Received Vaccination 2||3
4980399|NCT02531802|12250700|P9|NOT COMPLETED|Received Vaccination 2||0
4980400|NCT02531802|12250701|P8|NOT COMPLETED|Received Vaccination 2||0
4980401|NCT02531802|12250702|P7|NOT COMPLETED|Received Vaccination 2||0
4980402|NCT02531802|12250703|P6|NOT COMPLETED|Received Vaccination 2||3
4980403|NCT02531802|12250704|P5|NOT COMPLETED|Received Vaccination 2||0
4980404|NCT02531802|12250705|P4|NOT COMPLETED|Received Vaccination 2||0
4980405|NCT02531802|12250706|P3|NOT COMPLETED|Received Vaccination 2||1
4980406|NCT02531802|12250707|P2|NOT COMPLETED|Received Vaccination 2||0
4980407|NCT02531802|12250708|P1|NOT COMPLETED|Received Vaccination 2||0
4980408|NCT02531802|12250688|P21|COMPLETED|Received Vaccination 2||49
4980409|NCT02531802|12250689|P20|COMPLETED|Received Vaccination 2||29
4980410|NCT02531802|12250690|P19|COMPLETED|Received Vaccination 2||27
4980411|NCT02531802|12250691|P18|COMPLETED|Received Vaccination 2||26
4980412|NCT02531802|12250692|P17|COMPLETED|Received Vaccination 2||30
4980413|NCT02531802|12250693|P16|COMPLETED|Received Vaccination 2||30
4980414|NCT02531802|12250694|P15|COMPLETED|Received Vaccination 2||39
4980415|NCT02531802|12250695|P14|COMPLETED|Received Vaccination 2||13
4980416|NCT02531802|12250696|P13|COMPLETED|Received Vaccination 2||13
4980417|NCT02531802|12250697|P12|COMPLETED|Received Vaccination 2||15
4980418|NCT02531802|12250698|P11|COMPLETED|Received Vaccination 2||13
4980419|NCT02531802|12250699|P10|COMPLETED|Received Vaccination 2||49
4980420|NCT02531802|12250700|P9|COMPLETED|Received Vaccination 2||15
4980421|NCT02531802|12250701|P8|COMPLETED|Received Vaccination 2||15
4980422|NCT02531802|12250702|P7|COMPLETED|Received Vaccination 2||15
4980423|NCT02531802|12250703|P6|COMPLETED|Received Vaccination 2||0
4980424|NCT02531802|12250704|P5|COMPLETED|Received Vaccination 2||15
4980425|NCT02531802|12250705|P4|COMPLETED|Received Vaccination 2||15
4980426|NCT02531802|12250706|P3|COMPLETED|Received Vaccination 2||14
4980427|NCT02531802|12250707|P2|COMPLETED|Received Vaccination 2||15
4980428|NCT02531802|12250708|P1|COMPLETED|Received Vaccination 2||15
4980429|NCT02531802|12250688|P21|STARTED|Received Vaccination 2||50
4980430|NCT02531802|12250689|P20|STARTED|Received Vaccination 2||30
4980431|NCT02531802|12250690|P19|STARTED|Received Vaccination 2||30
4980432|NCT02531802|12250691|P18|STARTED|Received Vaccination 2||30
4980433|NCT02531802|12250692|P17|STARTED|Received Vaccination 2||30
4980434|NCT02531802|12250693|P16|STARTED|Received Vaccination 2||30
4980435|NCT02531802|12250694|P15|STARTED|Received Vaccination 2||40
4980436|NCT02531802|12250695|P14|STARTED|Received Vaccination 2||15
4980437|NCT02531802|12250696|P13|STARTED|Received Vaccination 2||15
4980438|NCT02531802|12250697|P12|STARTED|Received Vaccination 2||15
4980439|NCT02531802|12250698|P11|STARTED|Received Vaccination 2||15
4980440|NCT02531802|12250699|P10|STARTED|Received Vaccination 2||52
4980441|NCT02531802|12250700|P9|STARTED|Received Vaccination 2||15
4980442|NCT02531802|12250701|P8|STARTED|Received Vaccination 2||15
4980443|NCT02531802|12250702|P7|STARTED|Received Vaccination 2||15
4980444|NCT02531802|12250703|P6|STARTED|Received Vaccination 2||3
4980445|NCT02531802|12250704|P5|STARTED|Received Vaccination 2||15
4980446|NCT02531802|12250705|P4|STARTED|Received Vaccination 2||15
4980447|NCT02531802|12250706|P3|STARTED|Received Vaccination 2||15
4980448|NCT02531802|12250707|P2|STARTED|Received Vaccination 2||15
4980449|NCT02531802|12250708|P1|STARTED|Received Vaccination 2||15
4980450|NCT02531802|12250688|P21|NOT COMPLETED|Received Vaccination 1||0
4980451|NCT02531802|12250689|P20|NOT COMPLETED|Received Vaccination 1||0
4980452|NCT02531802|12250690|P19|NOT COMPLETED|Received Vaccination 1||0
4980453|NCT02531802|12250691|P18|NOT COMPLETED|Received Vaccination 1||0
4980454|NCT02531802|12250692|P17|NOT COMPLETED|Received Vaccination 1||0
4980455|NCT02531802|12250693|P16|NOT COMPLETED|Received Vaccination 1||0
4980456|NCT02531802|12250694|P15|NOT COMPLETED|Received Vaccination 1||0
4980457|NCT02531802|12250695|P14|NOT COMPLETED|Received Vaccination 1||0
4980458|NCT02531802|12250696|P13|NOT COMPLETED|Received Vaccination 1||0
4980459|NCT02531802|12250697|P12|NOT COMPLETED|Received Vaccination 1||0
4980460|NCT02531802|12250698|P11|NOT COMPLETED|Received Vaccination 1||0
4980461|NCT02531802|12250699|P10|NOT COMPLETED|Received Vaccination 1||0
4980462|NCT02531802|12250700|P9|NOT COMPLETED|Received Vaccination 1||0
4980463|NCT02531802|12250701|P8|NOT COMPLETED|Received Vaccination 1||0
4980464|NCT02531802|12250702|P7|NOT COMPLETED|Received Vaccination 1||0
4980465|NCT02531802|12250703|P6|NOT COMPLETED|Received Vaccination 1||0
4980466|NCT02531802|12250704|P5|NOT COMPLETED|Received Vaccination 1||0
4980467|NCT02531802|12250705|P4|NOT COMPLETED|Received Vaccination 1||0
4980468|NCT02531802|12250706|P3|NOT COMPLETED|Received Vaccination 1||0
4980469|NCT02531802|12250707|P2|NOT COMPLETED|Received Vaccination 1||0
4980470|NCT02531802|12250708|P1|NOT COMPLETED|Received Vaccination 1||0
4980471|NCT02531802|12250688|P21|COMPLETED|Received Vaccination 1||50
4980472|NCT02531802|12250689|P20|COMPLETED|Received Vaccination 1||30
4980473|NCT02531802|12250690|P19|COMPLETED|Received Vaccination 1||30
4980474|NCT02531802|12250691|P18|COMPLETED|Received Vaccination 1||30
4980475|NCT02531802|12250692|P17|COMPLETED|Received Vaccination 1||30
4980476|NCT02531802|12250693|P16|COMPLETED|Received Vaccination 1||30
4980477|NCT02531802|12250694|P15|COMPLETED|Received Vaccination 1||40
4980478|NCT02531802|12250695|P14|COMPLETED|Received Vaccination 1||15
4980479|NCT02531802|12250696|P13|COMPLETED|Received Vaccination 1||15
4980480|NCT02531802|12250697|P12|COMPLETED|Received Vaccination 1||15
4980481|NCT02531802|12250698|P11|COMPLETED|Received Vaccination 1||15
4980482|NCT02531802|12250699|P10|COMPLETED|Received Vaccination 1||52
4980483|NCT02531802|12250700|P9|COMPLETED|Received Vaccination 1||15
4980484|NCT02531802|12250701|P8|COMPLETED|Received Vaccination 1||15
4980485|NCT02531802|12250702|P7|COMPLETED|Received Vaccination 1||15
4980486|NCT02531802|12250703|P6|COMPLETED|Received Vaccination 1||3
4980487|NCT02531802|12250704|P5|COMPLETED|Received Vaccination 1||15
4980488|NCT02531802|12250705|P4|COMPLETED|Received Vaccination 1||15
4980489|NCT02531802|12250706|P3|COMPLETED|Received Vaccination 1||15
4980490|NCT02531802|12250707|P2|COMPLETED|Received Vaccination 1||15
4980491|NCT02531802|12250708|P1|COMPLETED|Received Vaccination 1||15
4980492|NCT02531802|12250688|P21|STARTED|Received Vaccination 1||50
4980493|NCT02531802|12250689|P20|STARTED|Received Vaccination 1||30
4980494|NCT02531802|12250690|P19|STARTED|Received Vaccination 1||30
4980495|NCT02531802|12250691|P18|STARTED|Received Vaccination 1||30
4980496|NCT02531802|12250692|P17|STARTED|Received Vaccination 1||30
4980497|NCT02531802|12250693|P16|STARTED|Received Vaccination 1||30
4980498|NCT02531802|12250694|P15|STARTED|Received Vaccination 1||40
4980499|NCT02531802|12250695|P14|STARTED|Received Vaccination 1||15
4980500|NCT02531802|12250696|P13|STARTED|Received Vaccination 1||15
4980501|NCT02531802|12250697|P12|STARTED|Received Vaccination 1||15
4980502|NCT02531802|12250698|P11|STARTED|Received Vaccination 1||15
4980503|NCT02531802|12250699|P10|STARTED|Received Vaccination 1||52
4980504|NCT02531802|12250700|P9|STARTED|Received Vaccination 1||15
4980505|NCT02531802|12250701|P8|STARTED|Received Vaccination 1||15
4980506|NCT02531802|12250702|P7|STARTED|Received Vaccination 1||15
4980507|NCT02531802|12250703|P6|STARTED|Received Vaccination 1||3
4980508|NCT02531802|12250704|P5|STARTED|Received Vaccination 1||15
4980509|NCT02531802|12250705|P4|STARTED|Received Vaccination 1||15
4980510|NCT02531802|12250706|P3|STARTED|Received Vaccination 1||15
4980511|NCT02531802|12250707|P2|STARTED|Received Vaccination 1||15
4980512|NCT02531802|12250708|P1|STARTED|Received Vaccination 1||15
4980513|NCT02531698|12251140|P2|NOT COMPLETED|Overall Study||2
4980514|NCT02531698|12251141|P1|NOT COMPLETED|Overall Study||11
4980515|NCT02531698|12251140|P2|COMPLETED|Overall Study||104
4980516|NCT02531698|12251141|P1|COMPLETED|Overall Study||283
4980517|NCT02531698|12251140|P2|STARTED|Overall Study||106
4980518|NCT02531698|12251141|P1|STARTED|Overall Study||294
4980519|NCT02531646|12251388|P3|NOT COMPLETED|Overall Study||0
4980520|NCT02531646|12251389|P2|NOT COMPLETED|Overall Study||1
4980521|NCT02531646|12251390|P1|NOT COMPLETED|Overall Study||5
4980522|NCT02531646|12251388|P3|COMPLETED|Overall Study||11
4980523|NCT02531646|12251389|P2|COMPLETED|Overall Study||17
4980524|NCT02531646|12251390|P1|COMPLETED|Overall Study||32
4980525|NCT02531646|12251388|P3|STARTED|Overall Study||11
4980526|NCT02531646|12251389|P2|STARTED|Overall Study||18
4980527|NCT02531646|12251390|P1|STARTED|Overall Study||37
4980528|NCT02531633|12251409|P10|NOT COMPLETED|Part B (104 Weeks)||4
4980529|NCT02531633|12251410|P9|NOT COMPLETED|Part B (104 Weeks)||5
4980530|NCT02531633|12251411|P8|NOT COMPLETED|Part B (104 Weeks)||4
4980531|NCT02531633|12251412|P7|NOT COMPLETED|Part B (104 Weeks)||5
4980532|NCT02531633|12251413|P6|NOT COMPLETED|Part B (104 Weeks)||8
4980533|NCT02531633|12251414|P5|NOT COMPLETED|Part B (104 Weeks)||0
4980534|NCT02531633|12251415|P4|NOT COMPLETED|Part B (104 Weeks)||0
4980535|NCT02531633|12251416|P3|NOT COMPLETED|Part B (104 Weeks)||0
4980536|NCT02531633|12251417|P2|NOT COMPLETED|Part B (104 Weeks)||0
4980537|NCT02531633|12251418|P1|NOT COMPLETED|Part B (104 Weeks)||0
4980538|NCT02531633|12251409|P10|COMPLETED|Part B (104 Weeks)||0
4980539|NCT02531633|12251410|P9|COMPLETED|Part B (104 Weeks)||0
4980540|NCT02531633|12251411|P8|COMPLETED|Part B (104 Weeks)||0
4980541|NCT02531633|12251412|P7|COMPLETED|Part B (104 Weeks)||0
4980542|NCT02531633|12251413|P6|COMPLETED|Part B (104 Weeks)||0
4980543|NCT02531633|12251414|P5|COMPLETED|Part B (104 Weeks)||0
4980544|NCT02531633|12251415|P4|COMPLETED|Part B (104 Weeks)||0
4980545|NCT02531633|12251416|P3|COMPLETED|Part B (104 Weeks)||0
4980546|NCT02531633|12251417|P2|COMPLETED|Part B (104 Weeks)||0
4980547|NCT02531633|12251418|P1|COMPLETED|Part B (104 Weeks)||0
4980548|NCT02531633|12251409|P10|STARTED|Part B (104 Weeks)||4
4980549|NCT02531633|12251410|P9|STARTED|Part B (104 Weeks)||5
4980550|NCT02531633|12251411|P8|STARTED|Part B (104 Weeks)||4
4980551|NCT02531633|12251412|P7|STARTED|Part B (104 Weeks)||5
4980552|NCT02531633|12251413|P6|STARTED|Part B (104 Weeks)||8
4980553|NCT02531633|12251414|P5|STARTED|Part B (104 Weeks)||0
4980554|NCT02531633|12251415|P4|STARTED|Part B (104 Weeks)||0
4980555|NCT02531633|12251416|P3|STARTED|Part B (104 Weeks)||0
4980556|NCT02531633|12251417|P2|STARTED|Part B (104 Weeks)||0
4980557|NCT02531633|12251418|P1|STARTED|Part B (104 Weeks)||0
4980558|NCT02531633|12251409|P10|NOT COMPLETED|Part A (52 Weeks)||0
4980559|NCT02531633|12251410|P9|NOT COMPLETED|Part A (52 Weeks)||0
4980560|NCT02531633|12251411|P8|NOT COMPLETED|Part A (52 Weeks)||0
4980561|NCT02531633|12251412|P7|NOT COMPLETED|Part A (52 Weeks)||0
4980562|NCT02531633|12251413|P6|NOT COMPLETED|Part A (52 Weeks)||0
4980563|NCT02531633|12251414|P5|NOT COMPLETED|Part A (52 Weeks)||23
4980564|NCT02531633|12251415|P4|NOT COMPLETED|Part A (52 Weeks)||22
4980565|NCT02531633|12251416|P3|NOT COMPLETED|Part A (52 Weeks)||22
4980566|NCT02531633|12251417|P2|NOT COMPLETED|Part A (52 Weeks)||34
4980567|NCT02531633|12251418|P1|NOT COMPLETED|Part A (52 Weeks)||34
4980568|NCT02531633|12251409|P10|COMPLETED|Part A (52 Weeks)||0
4980569|NCT02531633|12251410|P9|COMPLETED|Part A (52 Weeks)||0
4980570|NCT02531633|12251411|P8|COMPLETED|Part A (52 Weeks)||0
4980571|NCT02531633|12251412|P7|COMPLETED|Part A (52 Weeks)||0
4980572|NCT02531633|12251413|P6|COMPLETED|Part A (52 Weeks)||0
4980573|NCT02531633|12251414|P5|COMPLETED|Part A (52 Weeks)||4
4980574|NCT02531633|12251415|P4|COMPLETED|Part A (52 Weeks)||5
4980575|NCT02531633|12251416|P3|COMPLETED|Part A (52 Weeks)||4
4980576|NCT02531633|12251417|P2|COMPLETED|Part A (52 Weeks)||5
4980577|NCT02531633|12251418|P1|COMPLETED|Part A (52 Weeks)||8
4980578|NCT02531633|12251409|P10|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980579|NCT02531633|12251410|P9|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980580|NCT02531633|12251411|P8|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980581|NCT02531633|12251412|P7|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980582|NCT02531633|12251413|P6|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980583|NCT02531633|12251414|P5|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980584|NCT02531633|12251415|P4|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980585|NCT02531633|12251416|P3|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
4980586|NCT02531633|12251417|P2|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
4980587|NCT02531633|12251418|P1|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
4980588|NCT02531633|12251409|P10|STARTED|Part A (52 Weeks)||0
4980589|NCT02531633|12251410|P9|STARTED|Part A (52 Weeks)||0
4980590|NCT02531633|12251411|P8|STARTED|Part A (52 Weeks)||0
4980591|NCT02531633|12251412|P7|STARTED|Part A (52 Weeks)||0
4980592|NCT02531633|12251413|P6|STARTED|Part A (52 Weeks)||0
4980593|NCT02531633|12251414|P5|STARTED|Part A (52 Weeks)||27
4980594|NCT02531633|12251415|P4|STARTED|Part A (52 Weeks)||27
4980595|NCT02531633|12251416|P3|STARTED|Part A (52 Weeks)||26
4980596|NCT02531633|12251417|P2|STARTED|Part A (52 Weeks)||39
4980597|NCT02531633|12251418|P1|STARTED|Part A (52 Weeks)||42
4980598|NCT02531438|12251897|P2|NOT COMPLETED|Overall Study||26
4980599|NCT02531438|12251898|P1|NOT COMPLETED|Overall Study||30
4980600|NCT02531438|12251897|P2|COMPLETED|Overall Study||362
4980601|NCT02531438|12251898|P1|COMPLETED|Overall Study||356
4980602|NCT02531438|12251897|P2|STARTED|Overall Study||388
4980603|NCT02531438|12251898|P1|STARTED|Overall Study||386
4980604|NCT02531373|12251917|P9|NOT COMPLETED|Overall Study||9
4980605|NCT02531373|12251918|P8|NOT COMPLETED|Overall Study||9
4980606|NCT02531373|12251919|P7|NOT COMPLETED|Overall Study||11
4980607|NCT02531373|12251920|P6|NOT COMPLETED|Overall Study||9
4980608|NCT02531373|12251921|P5|NOT COMPLETED|Overall Study||8
4980609|NCT02531373|12251922|P4|NOT COMPLETED|Overall Study||0
4980610|NCT02531373|12251923|P3|NOT COMPLETED|Overall Study||0
4980611|NCT02531373|12251924|P2|NOT COMPLETED|Overall Study||0
4980612|NCT02531373|12251925|P1|NOT COMPLETED|Overall Study||0
4980613|NCT02531373|12251917|P9|COMPLETED|Overall Study||43
4980614|NCT02531373|12251918|P8|COMPLETED|Overall Study||43
4980615|NCT02531373|12251919|P7|COMPLETED|Overall Study||41
4980616|NCT02531373|12251920|P6|COMPLETED|Overall Study||42
4980617|NCT02531373|12251921|P5|COMPLETED|Overall Study||43
4980618|NCT02531373|12251922|P4|COMPLETED|Overall Study||20
4980619|NCT02531373|12251923|P3|COMPLETED|Overall Study||20
4980620|NCT02531373|12251924|P2|COMPLETED|Overall Study||20
4980621|NCT02531373|12251925|P1|COMPLETED|Overall Study||20
4980622|NCT02531373|12251917|P9|Vaccination 4|Overall Study||43
4980623|NCT02531373|12251918|P8|Vaccination 4|Overall Study||43
4980624|NCT02531373|12251919|P7|Vaccination 4|Overall Study||43
4980625|NCT02531373|12251920|P6|Vaccination 4|Overall Study||43
4980626|NCT02531373|12251921|P5|Vaccination 4|Overall Study||44
4980627|NCT02531373|12251922|P4|Vaccination 4|Overall Study||0
4980628|NCT02531373|12251923|P3|Vaccination 4|Overall Study||0
4980629|NCT02531373|12251924|P2|Vaccination 4|Overall Study||0
4980630|NCT02531373|12251925|P1|Vaccination 4|Overall Study||0
4980631|NCT02531373|12251917|P9|Vaccination 3|Overall Study||49
4980632|NCT02531373|12251918|P8|Vaccination 3|Overall Study||51
4980633|NCT02531373|12251919|P7|Vaccination 3|Overall Study||49
4980634|NCT02531373|12251920|P6|Vaccination 3|Overall Study||47
4980635|NCT02531373|12251921|P5|Vaccination 3|Overall Study||48
4980636|NCT02531373|12251922|P4|Vaccination 3|Overall Study||0
4980637|NCT02531373|12251923|P3|Vaccination 3|Overall Study||0
4980638|NCT02531373|12251924|P2|Vaccination 3|Overall Study||0
4980639|NCT02531373|12251925|P1|Vaccination 3|Overall Study||0
4980640|NCT02531373|12251917|P9|Vaccination 2|Overall Study||51
4980641|NCT02531373|12251918|P8|Vaccination 2|Overall Study||51
4980642|NCT02531373|12251919|P7|Vaccination 2|Overall Study||50
4980643|NCT02531373|12251920|P6|Vaccination 2|Overall Study||48
4980644|NCT02531373|12251921|P5|Vaccination 2|Overall Study||49
4980645|NCT02531373|12251922|P4|Vaccination 2|Overall Study||0
4980646|NCT02531373|12251923|P3|Vaccination 2|Overall Study||0
4980647|NCT02531373|12251924|P2|Vaccination 2|Overall Study||0
4980648|NCT02531373|12251925|P1|Vaccination 2|Overall Study||0
4980649|NCT02531373|12251917|P9|Vaccination 1|Overall Study||52
4980650|NCT02531373|12251918|P8|Vaccination 1|Overall Study||52
4980651|NCT02531373|12251919|P7|Vaccination 1|Overall Study||52
4980652|NCT02531373|12251920|P6|Vaccination 1|Overall Study||50
4980653|NCT02531373|12251921|P5|Vaccination 1|Overall Study||50
4980654|NCT02531373|12251922|P4|Vaccination 1|Overall Study||20
4980655|NCT02531373|12251923|P3|Vaccination 1|Overall Study||20
4980656|NCT02531373|12251924|P2|Vaccination 1|Overall Study||20
4980657|NCT02531373|12251925|P1|Vaccination 1|Overall Study||20
4980658|NCT02531373|12251917|P9|STARTED|Overall Study||52
4980659|NCT02531373|12251918|P8|STARTED|Overall Study||52
4980660|NCT02531373|12251919|P7|STARTED|Overall Study||52
4980661|NCT02531373|12251920|P6|STARTED|Overall Study||51
4980662|NCT02531373|12251921|P5|STARTED|Overall Study||51
4980663|NCT02531373|12251922|P4|STARTED|Overall Study||20
4980664|NCT02531373|12251923|P3|STARTED|Overall Study||20
4980665|NCT02531373|12251924|P2|STARTED|Overall Study||20
4980666|NCT02531373|12251925|P1|STARTED|Overall Study||20
4980667|NCT02531321|12251984|P2|NOT COMPLETED|Overall Study||0
4980668|NCT02531321|12251985|P1|NOT COMPLETED|Overall Study||2
4980669|NCT02531321|12251984|P2|COMPLETED|Overall Study||10
4980670|NCT02531321|12251985|P1|COMPLETED|Overall Study||5
4980671|NCT02531321|12251984|P2|STARTED|Overall Study||10
4980672|NCT02531321|12251985|P1|STARTED|Overall Study||7
4980673|NCT02531308|12251993|P1|NOT COMPLETED|Overall Study||3
4980674|NCT02531308|12251993|P1|COMPLETED|Overall Study||2
4980675|NCT02531308|12251993|P1|STARTED|Overall Study||5
4980676|NCT02531035|12251999|P2|NOT COMPLETED|Overall Study||95
4980677|NCT02531035|12252000|P1|NOT COMPLETED|Overall Study||81
4980678|NCT02531035|12251999|P2|COMPLETED|Overall Study||605
4980679|NCT02531035|12252000|P1|COMPLETED|Overall Study||624
4980680|NCT02531035|12251999|P2|Treated|Overall Study||699
4980681|NCT02531035|12252000|P1|Treated|Overall Study||703
4980682|NCT02531035|12251999|P2|STARTED|Overall Study||700
4980683|NCT02531035|12252000|P1|STARTED|Overall Study||705
4980684|NCT02531022|12252016|P2|NOT COMPLETED|Overall Study||2
4980685|NCT02531022|12252017|P1|NOT COMPLETED|Overall Study||0
4980686|NCT02531022|12252016|P2|COMPLETED|Overall Study||48
4980687|NCT02531022|12252017|P1|COMPLETED|Overall Study||55
4980688|NCT02531022|12252016|P2|STARTED|Overall Study||50
4980689|NCT02531022|12252017|P1|STARTED|Overall Study||55
4980690|NCT02530970|12252025|P1|NOT COMPLETED|Overall Study||134
4980691|NCT02530970|12252025|P1|COMPLETED|Overall Study||891
4980692|NCT02530970|12252025|P1|STARTED|Overall Study||1025
4980693|NCT02530671|12252032|P2|NOT COMPLETED|Overall Study||0
4980694|NCT02530671|12252033|P1|NOT COMPLETED|Overall Study||3
4980695|NCT02530671|12252032|P2|COMPLETED|Overall Study||55
4980696|NCT02530671|12252033|P1|COMPLETED|Overall Study||52
4980697|NCT02530671|12252032|P2|STARTED|Overall Study||55
4980698|NCT02530671|12252033|P1|STARTED|Overall Study||55
4980699|NCT02530515|12252052|P3|NOT COMPLETED|Overall Study||0
4980700|NCT02530515|12252053|P2|NOT COMPLETED|Overall Study||0
4980701|NCT02530515|12252054|P1|NOT COMPLETED|Overall Study||0
4980702|NCT02530515|12252052|P3|COMPLETED|Overall Study||8
4980703|NCT02530515|12252053|P2|COMPLETED|Overall Study||0
4980704|NCT02530515|12252054|P1|COMPLETED|Overall Study||0
4980705|NCT02530515|12252052|P3|STARTED|Overall Study||8
4980706|NCT02530515|12252053|P2|STARTED|Overall Study||0
4980707|NCT02530515|12252054|P1|STARTED|Overall Study||0
4980708|NCT02530476|12252075|P4|NOT COMPLETED|Overall Study||0
4980709|NCT02530476|12252076|P3|NOT COMPLETED|Overall Study||0
4980710|NCT02530476|12252077|P2|NOT COMPLETED|Overall Study||0
4980711|NCT02530476|12252078|P1|NOT COMPLETED|Overall Study||0
4980712|NCT02530476|12252075|P4|COMPLETED|Overall Study||3
4980713|NCT02530476|12252076|P3|COMPLETED|Overall Study||7
4980714|NCT02530476|12252077|P2|COMPLETED|Overall Study||3
4980715|NCT02530476|12252078|P1|COMPLETED|Overall Study||4
4980716|NCT02530476|12252075|P4|STARTED|Overall Study||3
4980717|NCT02530476|12252076|P3|STARTED|Overall Study||7
4980718|NCT02530476|12252077|P2|STARTED|Overall Study||3
4980719|NCT02530476|12252078|P1|STARTED|Overall Study||4
4980720|NCT02530450|12252102|P2|NOT COMPLETED|Overall Study||5
4980721|NCT02530450|12252103|P1|NOT COMPLETED|Overall Study||6
4980722|NCT02530450|12252102|P2|COMPLETED|Overall Study||9
4980723|NCT02530450|12252103|P1|COMPLETED|Overall Study||10
4980724|NCT02530450|12252102|P2|STARTED|Overall Study||14
4980725|NCT02530450|12252103|P1|STARTED|Overall Study||16
4980726|NCT02530385|12252111|P2|NOT COMPLETED|Overall Study||1
4980727|NCT02530385|12252112|P1|NOT COMPLETED|Overall Study||0
4980728|NCT02530385|12252111|P2|COMPLETED|Overall Study||11
4980729|NCT02530385|12252112|P1|COMPLETED|Overall Study||12
4980730|NCT02530385|12252111|P2|STARTED|Overall Study||12
4980731|NCT02530385|12252112|P1|STARTED|Overall Study||12
4980732|NCT02530294|12252128|P2|NOT COMPLETED|Overall Study||6
4980733|NCT02530294|12252129|P1|NOT COMPLETED|Overall Study||16
4980734|NCT02530294|12252128|P2|COMPLETED|Overall Study||113
4980735|NCT02530294|12252129|P1|COMPLETED|Overall Study||218
4980736|NCT02530294|12252128|P2|STARTED|Overall Study||119
4980737|NCT02530294|12252129|P1|STARTED|Overall Study||234
4980738|NCT02530281|12252145|P2|NOT COMPLETED|Overall Study||3
4980739|NCT02530281|12252146|P1|NOT COMPLETED|Overall Study||21
4980740|NCT02530281|12252145|P2|COMPLETED|Overall Study||112
4980741|NCT02530281|12252146|P1|COMPLETED|Overall Study||208
4980742|NCT02530281|12252145|P2|STARTED|Overall Study||115
4980743|NCT02530281|12252146|P1|STARTED|Overall Study||229
4980744|NCT02530151|12252164|P2|NOT COMPLETED|Overall Study||16
4980745|NCT02530151|12252165|P1|NOT COMPLETED|Overall Study||21
4980746|NCT02530151|12252164|P2|COMPLETED|Overall Study||17
4980747|NCT02530151|12252165|P1|COMPLETED|Overall Study||16
4980748|NCT02530151|12252164|P2|STARTED|Overall Study||33
4980749|NCT02530151|12252165|P1|STARTED|Overall Study||37
4980750|NCT02530125|12252175|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
4980751|NCT02530125|12252175|P1|COMPLETED|Followed for Survival for 2 Years||0
4980752|NCT02530125|12252175|P1|STARTED|Followed for Survival for 2 Years||3
4980753|NCT02530125|12252175|P1|NOT COMPLETED|Completed Treatment||1
4980754|NCT02530125|12252175|P1|COMPLETED|Completed Treatment||3
4980755|NCT02530125|12252175|P1|STARTED|Completed Treatment||4
4980756|NCT02529995|12252189|P2|NOT COMPLETED|Part B||12
4980757|NCT02529995|12252190|P1|NOT COMPLETED|Part B||6
4980758|NCT02529995|12252189|P2|COMPLETED|Part B||4
4980759|NCT02529995|12252190|P1|COMPLETED|Part B||9
4980760|NCT02529995|12252189|P2|STARTED|Part B||16
4980761|NCT02529995|12252190|P1|STARTED|Part B||15
4980762|NCT02529995|12252189|P2|NOT COMPLETED|Part A||16
4980763|NCT02529995|12252190|P1|NOT COMPLETED|Part A||15
4980764|NCT02529995|12252189|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
4980765|NCT02529995|12252190|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
4980766|NCT02529995|12252189|P2|STARTED|Part A||16
4980767|NCT02529995|12252190|P1|STARTED|Part A||15
4980768|NCT02529553|12252233|P9|NOT COMPLETED|Overall Study||3
4980769|NCT02529553|12252234|P8|NOT COMPLETED|Overall Study||6
4980770|NCT02529553|12252235|P7|NOT COMPLETED|Overall Study||3
4980771|NCT02529553|12252236|P6|NOT COMPLETED|Overall Study||4
4980772|NCT02529553|12252237|P5|NOT COMPLETED|Overall Study||3
4980773|NCT02529553|12252238|P4|NOT COMPLETED|Overall Study||3
4980774|NCT02529553|12252239|P3|NOT COMPLETED|Overall Study||1
4980775|NCT02529553|12252240|P2|NOT COMPLETED|Overall Study||1
4980776|NCT02529553|12252241|P1|NOT COMPLETED|Overall Study||1
4980777|NCT02529553|12252233|P9|COMPLETED|Overall Study||0
4980778|NCT02529553|12252234|P8|COMPLETED|Overall Study||0
4980779|NCT02529553|12252235|P7|COMPLETED|Overall Study||0
4980780|NCT02529553|12252236|P6|COMPLETED|Overall Study||0
4980781|NCT02529553|12252237|P5|COMPLETED|Overall Study||0
4980782|NCT02529553|12252238|P4|COMPLETED|Overall Study||0
4980783|NCT02529553|12252239|P3|COMPLETED|Overall Study||0
4980784|NCT02529553|12252240|P2|COMPLETED|Overall Study||0
4980785|NCT02529553|12252241|P1|COMPLETED|Overall Study||0
4980786|NCT02529553|12252233|P9|STARTED|Overall Study||3
4980787|NCT02529553|12252234|P8|STARTED|Overall Study||6
4980788|NCT02529553|12252235|P7|STARTED|Overall Study||3
4980789|NCT02529553|12252236|P6|STARTED|Overall Study||4
4980790|NCT02529553|12252237|P5|STARTED|Overall Study||3
4980791|NCT02529553|12252238|P4|STARTED|Overall Study||3
4980792|NCT02529553|12252239|P3|STARTED|Overall Study||1
4980793|NCT02529553|12252240|P2|STARTED|Overall Study||1
4980794|NCT02529553|12252241|P1|STARTED|Overall Study||1
4980795|NCT02529488|12252280|P1|NOT COMPLETED|Overall Study||4
4980796|NCT02529488|12252280|P1|COMPLETED|Overall Study||145
4980797|NCT02529488|12252280|P1|STARTED|Overall Study||149
4980798|NCT02529137|12252288|P1|NOT COMPLETED|Overall Study||8
4980799|NCT02529137|12252288|P1|COMPLETED|Overall Study||1992
4980800|NCT02529137|12252288|P1|STARTED|Overall Study||2000
4980801|NCT02529072|12252295|P2|NOT COMPLETED|Overall Study||0
4980802|NCT02529072|12252296|P1|NOT COMPLETED|Overall Study||0
4980803|NCT02529072|12252295|P2|COMPLETED|Overall Study||3
4980804|NCT02529072|12252296|P1|COMPLETED|Overall Study||3
4980805|NCT02529072|12252295|P2|STARTED|Overall Study||3
4980806|NCT02529072|12252296|P1|STARTED|Overall Study||3
4980807|NCT02528786|12252306|P1|NOT COMPLETED|Overall Study||0
4980808|NCT02528786|12252306|P1|COMPLETED|Overall Study||8
4980809|NCT02528786|12252306|P1|STARTED|Overall Study||8
4980810|NCT02528721|12252312|P2|NOT COMPLETED|Overall Study||3
4980811|NCT02528721|12252313|P1|NOT COMPLETED|Overall Study||7
4980812|NCT02528721|12252312|P2|COMPLETED|Overall Study||76
4980813|NCT02528721|12252313|P1|COMPLETED|Overall Study||196
4980814|NCT02528721|12252312|P2|STARTED|Overall Study||79
4980815|NCT02528721|12252313|P1|STARTED|Overall Study||203
4980816|NCT02528643|12252325|P2|NOT COMPLETED|Overall Study||85
4980817|NCT02528643|12252326|P1|NOT COMPLETED|Overall Study||39
4980818|NCT02528643|12252325|P2|COMPLETED|Overall Study||25
4980819|NCT02528643|12252326|P1|COMPLETED|Overall Study||16
4980820|NCT02528643|12252325|P2|Treated|Overall Study||107
4980821|NCT02528643|12252326|P1|Treated|Overall Study||55
4980822|NCT02528643|12252325|P2|STARTED|Overall Study||110
4980823|NCT02528643|12252326|P1|STARTED|Overall Study||55
4980824|NCT02528500|12252339|P1|NOT COMPLETED|Overall Study||0
4980825|NCT02528500|12252339|P1|COMPLETED|Overall Study||10
4980826|NCT02528500|12252339|P1|STARTED|Overall Study||10
4980827|NCT02528409|12252345|P2|NOT COMPLETED|Overall Study||16
4980828|NCT02528409|12252346|P1|NOT COMPLETED|Overall Study||22
4980829|NCT02528409|12252345|P2|COMPLETED|Overall Study||24
4980830|NCT02528409|12252346|P1|COMPLETED|Overall Study||18
4980831|NCT02528409|12252345|P2|STARTED|Overall Study||40
4980832|NCT02528409|12252346|P1|STARTED|Overall Study||40
4980833|NCT02528331|12252368|P1|NOT COMPLETED|Overall Study||2
4980834|NCT02528331|12252368|P1|COMPLETED|Overall Study||0
4980835|NCT02528331|12252368|P1|STARTED|Overall Study||2
4980836|NCT02528318|12252380|P5|NOT COMPLETED|Overall Study||0
4980837|NCT02528318|12252381|P4|NOT COMPLETED|Overall Study||0
4980838|NCT02528318|12252382|P3|NOT COMPLETED|Overall Study||0
4980839|NCT02528318|12252383|P2|NOT COMPLETED|Overall Study||0
4980840|NCT02528318|12252384|P1|NOT COMPLETED|Overall Study||0
4980841|NCT02528318|12252380|P5|COMPLETED|Overall Study||24
4980842|NCT02528318|12252381|P4|COMPLETED|Overall Study||0
4980843|NCT02528318|12252382|P3|COMPLETED|Overall Study||8
4980844|NCT02528318|12252383|P2|COMPLETED|Overall Study||8
4980845|NCT02528318|12252384|P1|COMPLETED|Overall Study||8
4980846|NCT02528318|12252380|P5|STARTED|Overall Study||24
4980847|NCT02528318|12252381|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
4980848|NCT02528318|12252382|P3|STARTED|Overall Study||8
4980849|NCT02528318|12252383|P2|STARTED|Overall Study||8
4980850|NCT02528318|12252384|P1|STARTED|Overall Study||8
4980851|NCT02528305|12252436|P1|NOT COMPLETED|Overall Study||3
4980852|NCT02528305|12252436|P1|COMPLETED|Overall Study||9
4980853|NCT02528305|12252436|P1|End of Intervention Period Assessment|Overall Study||9
4980854|NCT02528305|12252436|P1|End of Control Period Assessment|Overall Study||11
4980855|NCT02528305|12252436|P1|STARTED|Overall Study||12
4980856|NCT02528253|12252483|P5|NOT COMPLETED|Overall Study||223
4980857|NCT02528253|12252484|P4|NOT COMPLETED|Overall Study||136
4980858|NCT02528253|12252485|P3|NOT COMPLETED|Overall Study||140
4980859|NCT02528253|12252486|P2|NOT COMPLETED|Overall Study||70
4980860|NCT02528253|12252487|P1|NOT COMPLETED|Overall Study||75
4980861|NCT02528253|12252483|P5|COMPLETED|Overall Study||379
4980862|NCT02528253|12252484|P4|COMPLETED|Overall Study||271
4980863|NCT02528253|12252485|P3|COMPLETED|Overall Study||267
4980864|NCT02528253|12252486|P2|COMPLETED|Overall Study||134
4980865|NCT02528253|12252487|P1|COMPLETED|Overall Study||130
4980866|NCT02528253|12252483|P5|Treated at Week 16|Overall Study||307
4980867|NCT02528253|12252484|P4|Treated at Week 16|Overall Study||242
4980868|NCT02528253|12252485|P3|Treated at Week 16|Overall Study||236
4980869|NCT02528253|12252486|P2|Treated at Week 16|Overall Study||95
4980870|NCT02528253|12252487|P1|Treated at Week 16|Overall Study||99
4980871|NCT02528253|12252483|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
4980872|NCT02528253|12252484|P4|Intent to Treat Population|Overall Study||407
4980873|NCT02528253|12252485|P3|Intent to Treat Population|Overall Study||407
4980874|NCT02528253|12252486|P2|Intent to Treat Population|Overall Study||204
4980875|NCT02528253|12252487|P1|Intent to Treat Population|Overall Study||202
4980876|NCT02528253|12252483|P5|STARTED|Overall Study||602
4980877|NCT02528253|12252484|P4|STARTED|Overall Study||407
4980878|NCT02528253|12252485|P3|STARTED|Overall Study||407
4980879|NCT02528253|12252486|P2|STARTED|Overall Study||204
4980880|NCT02528253|12252487|P1|STARTED|Overall Study||205
4980881|NCT02528214|12252780|P2|NOT COMPLETED|Overall Study||3
4980882|NCT02528214|12252781|P1|NOT COMPLETED|Overall Study||0
4980883|NCT02528214|12252780|P2|COMPLETED|Overall Study||100
4980884|NCT02528214|12252781|P1|COMPLETED|Overall Study||107
4980885|NCT02528214|12252780|P2|Treated|Overall Study||103
4980886|NCT02528214|12252781|P1|Treated|Overall Study||107
4980887|NCT02528214|12252780|P2|STARTED|Overall Study||103
4980888|NCT02528214|12252781|P1|STARTED|Overall Study||107
4980889|NCT02528188|12252816|P3|NOT COMPLETED|Overall Study||251
4980890|NCT02528188|12252817|P2|NOT COMPLETED|Overall Study||276
4980891|NCT02528188|12252818|P1|NOT COMPLETED|Overall Study||267
4980892|NCT02528188|12252816|P3|COMPLETED|Overall Study||757
4980893|NCT02528188|12252817|P2|COMPLETED|Overall Study||729
4980894|NCT02528188|12252818|P1|COMPLETED|Overall Study||741
4980895|NCT02528188|12252816|P3|Treated|Overall Study||996
4980896|NCT02528188|12252817|P2|Treated|Overall Study||998
4980897|NCT02528188|12252818|P1|Treated|Overall Study||1002
4980898|NCT02528188|12252816|P3|STARTED|Overall Study||1008
4980899|NCT02528188|12252817|P2|STARTED|Overall Study||1005
4980900|NCT02528188|12252818|P1|STARTED|Overall Study||1008
4980901|NCT02528097|12253070|P2|NOT COMPLETED|Overall Study||0
4980902|NCT02528097|12253071|P1|NOT COMPLETED|Overall Study||0
4980903|NCT02528097|12253070|P2|COMPLETED|Overall Study||1
4980904|NCT02528097|12253071|P1|COMPLETED|Overall Study||1
4980905|NCT02528097|12253070|P2|STARTED|Overall Study||1
4980906|NCT02528097|12253071|P1|STARTED|Overall Study||1
4980907|NCT02527694|12253081|P2|NOT COMPLETED|Overall Study||8
4980908|NCT02527694|12253082|P1|NOT COMPLETED|Overall Study||10
4980909|NCT02527694|12253081|P2|COMPLETED|Overall Study||21
4980910|NCT02527694|12253082|P1|COMPLETED|Overall Study||10
4980911|NCT02527694|12253081|P2|STARTED|Overall Study||29
4980912|NCT02527694|12253082|P1|STARTED|Overall Study||20
4980913|NCT02527434|12253093|P3|NOT COMPLETED|Overall Study||20
4980914|NCT02527434|12253094|P2|NOT COMPLETED|Overall Study||11
4980915|NCT02527434|12253095|P1|NOT COMPLETED|Overall Study||28
4980916|NCT02527434|12253093|P3|COMPLETED|Overall Study||0
4980917|NCT02527434|12253094|P2|COMPLETED|Overall Study||1
4980918|NCT02527434|12253095|P1|COMPLETED|Overall Study||4
4980919|NCT02527434|12253093|P3|Started Retreatment Phase (MEDI)|Overall Study||1
4980920|NCT02527434|12253094|P2|Started Retreatment Phase (MEDI)|Overall Study||0
4980921|NCT02527434|12253095|P1|Started Retreatment Phase (MEDI)|Overall Study||4
4980922|NCT02527434|12253093|P3|Started Retreatment Phase (COMBO)|Overall Study||4
4980923|NCT02527434|12253094|P2|Started Retreatment Phase (COMBO)|Overall Study||5
4980924|NCT02527434|12253095|P1|Started Retreatment Phase (COMBO)|Overall Study||7
4980925|NCT02527434|12253093|P3|STARTED|Overall Study||20
4980926|NCT02527434|12253094|P2|STARTED|Overall Study||12
4980927|NCT02527434|12253095|P1|STARTED|Overall Study||32
4980928|NCT02527161|12253153|P1|NOT COMPLETED|Overall Study||62
4980929|NCT02527161|12253153|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
4980930|NCT02527161|12253153|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
4980931|NCT02527148|12253172|P2|NOT COMPLETED|Overall Study||0
4980932|NCT02527148|12253173|P1|NOT COMPLETED|Overall Study||1
4980933|NCT02527148|12253172|P2|COMPLETED|Overall Study||50
4980934|NCT02527148|12253173|P1|COMPLETED|Overall Study||49
4980935|NCT02527148|12253172|P2|STARTED|Overall Study||50
4980936|NCT02527148|12253173|P1|STARTED|Overall Study||50
4980937|NCT02526693|12253193|P2|NOT COMPLETED|Overall Study||1
4980938|NCT02526693|12253194|P1|NOT COMPLETED|Overall Study||3
4980939|NCT02526693|12253193|P2|COMPLETED|Overall Study||50
4980940|NCT02526693|12253194|P1|COMPLETED|Overall Study||50
4980941|NCT02526693|12253193|P2|STARTED|Overall Study||51
4980942|NCT02526693|12253194|P1|STARTED|Overall Study||53
4980943|NCT02526680|12253204|P1|NOT COMPLETED|Overall Study||0
4980944|NCT02526680|12253204|P1|COMPLETED|Overall Study||27
4980945|NCT02526680|12253204|P1|STARTED|Overall Study||27
4980946|NCT02526654|12253213|P2|NOT COMPLETED|Overall Study||0
4980947|NCT02526654|12253214|P1|NOT COMPLETED|Overall Study||0
4980948|NCT02526654|12253213|P2|COMPLETED|Overall Study||36
4980949|NCT02526654|12253214|P1|COMPLETED|Overall Study||79
4980950|NCT02526654|12253213|P2|STARTED|Overall Study||36
4980951|NCT02526654|12253214|P1|STARTED|Overall Study||79
4980952|NCT02526550|12253223|P1|NOT COMPLETED|Overall Study||1
4980953|NCT02526550|12253223|P1|COMPLETED|Overall Study||49
4980954|NCT02526550|12253223|P1|STARTED|Overall Study||50
4980955|NCT02526524|12253235|P6|NOT COMPLETED|Overall Study||21
4980956|NCT02526524|12253236|P5|NOT COMPLETED|Overall Study||24
4980957|NCT02526524|12253237|P4|NOT COMPLETED|Overall Study||7
4980958|NCT02526524|12253238|P3|NOT COMPLETED|Overall Study||26
4980959|NCT02526524|12253239|P2|NOT COMPLETED|Overall Study||9
4980960|NCT02526524|12253240|P1|NOT COMPLETED|Overall Study||12
4980961|NCT02526524|12253235|P6|COMPLETED|Overall Study||73
4980962|NCT02526524|12253236|P5|COMPLETED|Overall Study||72
4980963|NCT02526524|12253237|P4|COMPLETED|Overall Study||89
4980964|NCT02526524|12253238|P3|COMPLETED|Overall Study||70
4980965|NCT02526524|12253239|P2|COMPLETED|Overall Study||86
4980966|NCT02526524|12253240|P1|COMPLETED|Overall Study||82
4980967|NCT02526524|12253235|P6|STARTED|Overall Study||94
4980968|NCT02526524|12253236|P5|STARTED|Overall Study||96
4980969|NCT02526524|12253237|P4|STARTED|Overall Study||96
4980970|NCT02526524|12253238|P3|STARTED|Overall Study||96
4980971|NCT02526524|12253239|P2|STARTED|Overall Study||95
4980972|NCT02526524|12253240|P1|STARTED|Overall Study||94
4980973|NCT02526290|12253254|P1|NOT COMPLETED|Overall Study||8
4980974|NCT02526290|12253254|P1|COMPLETED|Overall Study||89
4980975|NCT02526290|12253254|P1|STARTED|Overall Study||97
4980976|NCT02526277|12253265|P4|NOT COMPLETED|Overall Study||0
4980977|NCT02526277|12253266|P3|NOT COMPLETED|Overall Study||0
4980978|NCT02526277|12253267|P2|NOT COMPLETED|Overall Study||0
4980979|NCT02526277|12253268|P1|NOT COMPLETED|Overall Study||0
4980980|NCT02526277|12253265|P4|COMPLETED|Overall Study||7
4980981|NCT02526277|12253266|P3|COMPLETED|Overall Study||7
4980982|NCT02526277|12253267|P2|COMPLETED|Overall Study||6
4980983|NCT02526277|12253268|P1|COMPLETED|Overall Study||8
4980984|NCT02526277|12253265|P4|STARTED|Overall Study||7
4980985|NCT02526277|12253266|P3|STARTED|Overall Study||7
4980986|NCT02526277|12253267|P2|STARTED|Overall Study||6
4980987|NCT02526277|12253268|P1|STARTED|Overall Study||8
4980988|NCT02526212|12253288|P2|NOT COMPLETED|Overall Study||1
4980989|NCT02526212|12253289|P1|NOT COMPLETED|Overall Study||2
4980990|NCT02526212|12253288|P2|COMPLETED|Overall Study||7
4980991|NCT02526212|12253289|P1|COMPLETED|Overall Study||8
4980992|NCT02526212|12253288|P2|STARTED|Overall Study||8
4980993|NCT02526212|12253289|P1|STARTED|Overall Study||10
4980994|NCT02525874|12253303|P1|NOT COMPLETED|Overall Study||60
4980995|NCT02525874|12253303|P1|COMPLETED|Overall Study||158
4980996|NCT02525874|12253303|P1|STARTED|Overall Study||218
4980997|NCT02525744|12253316|P4|NOT COMPLETED|Period 5||0
4980998|NCT02525744|12253317|P3|NOT COMPLETED|Period 5||0
4980999|NCT02525744|12253318|P2|NOT COMPLETED|Period 5||0
4981000|NCT02525744|12253319|P1|NOT COMPLETED|Period 5||1
4981001|NCT02525744|12253316|P4|COMPLETED|Period 5||6
4981002|NCT02525744|12253317|P3|COMPLETED|Period 5||5
4981003|NCT02525744|12253318|P2|COMPLETED|Period 5||5
4981004|NCT02525744|12253319|P1|COMPLETED|Period 5||4
4981005|NCT02525744|12253316|P4|Received at Least 1 Dose of Study Drug|Period 5||6
4981006|NCT02525744|12253317|P3|Received at Least 1 Dose of Study Drug|Period 5||5
4981007|NCT02525744|12253318|P2|Received at Least 1 Dose of Study Drug|Period 5||5
4981008|NCT02525744|12253319|P1|Received at Least 1 Dose of Study Drug|Period 5||4
4981009|NCT02525744|12253316|P4|STARTED|Period 5||6
4981010|NCT02525744|12253317|P3|STARTED|Period 5||5
4981011|NCT02525744|12253318|P2|STARTED|Period 5||5
4981012|NCT02525744|12253319|P1|STARTED|Period 5||5
4981013|NCT02525744|12253316|P4|NOT COMPLETED|Period 4||0
4981014|NCT02525744|12253317|P3|NOT COMPLETED|Period 4||0
4981015|NCT02525744|12253318|P2|NOT COMPLETED|Period 4||0
4981016|NCT02525744|12253319|P1|NOT COMPLETED|Period 4||1
4981017|NCT02525744|12253316|P4|COMPLETED|Period 4||6
4981018|NCT02525744|12253317|P3|COMPLETED|Period 4||5
4981019|NCT02525744|12253318|P2|COMPLETED|Period 4||5
4981020|NCT02525744|12253319|P1|COMPLETED|Period 4||5
4981021|NCT02525744|12253316|P4|Received at Least 1 Dose of Study Drug|Period 4||6
4981022|NCT02525744|12253317|P3|Received at Least 1 Dose of Study Drug|Period 4||5
4981023|NCT02525744|12253318|P2|Received at Least 1 Dose of Study Drug|Period 4||5
4981024|NCT02525744|12253319|P1|Received at Least 1 Dose of Study Drug|Period 4||6
4981025|NCT02525744|12253316|P4|STARTED|Period 4||6
4981026|NCT02525744|12253317|P3|STARTED|Period 4||5
4981027|NCT02525744|12253318|P2|STARTED|Period 4||5
4981028|NCT02525744|12253319|P1|STARTED|Period 4||6
4981029|NCT02525744|12253316|P4|NOT COMPLETED|Period 3||0
4981030|NCT02525744|12253317|P3|NOT COMPLETED|Period 3||0
4981031|NCT02525744|12253318|P2|NOT COMPLETED|Period 3||1
4981032|NCT02525744|12253319|P1|NOT COMPLETED|Period 3||0
4981033|NCT02525744|12253316|P4|COMPLETED|Period 3||6
4981034|NCT02525744|12253317|P3|COMPLETED|Period 3||5
4981035|NCT02525744|12253318|P2|COMPLETED|Period 3||5
4981036|NCT02525744|12253319|P1|COMPLETED|Period 3||6
4981037|NCT02525744|12253316|P4|Received at Least 1 Dose of Study Drug|Period 3||6
4981038|NCT02525744|12253317|P3|Received at Least 1 Dose of Study Drug|Period 3||5
4981039|NCT02525744|12253318|P2|Received at Least 1 Dose of Study Drug|Period 3||6
4981040|NCT02525744|12253319|P1|Received at Least 1 Dose of Study Drug|Period 3||6
4981041|NCT02525744|12253316|P4|STARTED|Period 3||6
4981042|NCT02525744|12253317|P3|STARTED|Period 3||5
4981043|NCT02525744|12253318|P2|STARTED|Period 3||6
4981044|NCT02525744|12253319|P1|STARTED|Period 3||6
4981045|NCT02525744|12253316|P4|NOT COMPLETED|Period 2||0
4981046|NCT02525744|12253317|P3|NOT COMPLETED|Period 2||0
4981047|NCT02525744|12253318|P2|NOT COMPLETED|Period 2||0
4981048|NCT02525744|12253319|P1|NOT COMPLETED|Period 2||0
4981049|NCT02525744|12253316|P4|COMPLETED|Period 2||6
4981050|NCT02525744|12253317|P3|COMPLETED|Period 2||5
4981051|NCT02525744|12253318|P2|COMPLETED|Period 2||6
4981052|NCT02525744|12253319|P1|COMPLETED|Period 2||6
4981053|NCT02525744|12253316|P4|Received at Least 1 Dose of Study Drug|Period 2||6
4981054|NCT02525744|12253317|P3|Received at Least 1 Dose of Study Drug|Period 2||5
4981055|NCT02525744|12253318|P2|Received at Least 1 Dose of Study Drug|Period 2||6
4981056|NCT02525744|12253319|P1|Received at Least 1 Dose of Study Drug|Period 2||6
4981057|NCT02525744|12253316|P4|STARTED|Period 2||6
4981058|NCT02525744|12253317|P3|STARTED|Period 2||5
4981059|NCT02525744|12253318|P2|STARTED|Period 2||6
4981060|NCT02525744|12253319|P1|STARTED|Period 2||6
4981061|NCT02525744|12253316|P4|NOT COMPLETED|Period 1||0
4981062|NCT02525744|12253317|P3|NOT COMPLETED|Period 1||1
4981063|NCT02525744|12253318|P2|NOT COMPLETED|Period 1||0
4981064|NCT02525744|12253319|P1|NOT COMPLETED|Period 1||0
4981065|NCT02525744|12253316|P4|COMPLETED|Period 1||6
4981066|NCT02525744|12253317|P3|COMPLETED|Period 1||5
4981067|NCT02525744|12253318|P2|COMPLETED|Period 1||6
4981068|NCT02525744|12253319|P1|COMPLETED|Period 1||6
4981069|NCT02525744|12253316|P4|Received at Least 1 Dose of Study Drug|Period 1||6
4981070|NCT02525744|12253317|P3|Received at Least 1 Dose of Study Drug|Period 1||5
4981071|NCT02525744|12253318|P2|Received at Least 1 Dose of Study Drug|Period 1||6
4981072|NCT02525744|12253319|P1|Received at Least 1 Dose of Study Drug|Period 1||6
4981073|NCT02525744|12253316|P4|STARTED|Period 1||6
4981074|NCT02525744|12253317|P3|STARTED|Period 1||6
4981075|NCT02525744|12253318|P2|STARTED|Period 1||6
4981076|NCT02525744|12253319|P1|STARTED|Period 1||6
4981077|NCT02525718|12253335|P2|NOT COMPLETED|Overall Study||1
4981078|NCT02525718|12253336|P1|NOT COMPLETED|Overall Study||1
4981079|NCT02525718|12253335|P2|COMPLETED|Overall Study||23
4981080|NCT02525718|12253336|P1|COMPLETED|Overall Study||22
4981081|NCT02525718|12253335|P2|STARTED|Overall Study||24
4981082|NCT02525718|12253336|P1|STARTED|Overall Study||23
4981083|NCT02525653|12253348|P1|NOT COMPLETED|Overall Study||0
4981084|NCT02525653|12253348|P1|COMPLETED|Overall Study||40
4981085|NCT02525653|12253348|P1|STARTED|Overall Study||40
4981086|NCT02525627|12253355|P2|NOT COMPLETED|Overall Study||13
4981087|NCT02525627|12253356|P1|NOT COMPLETED|Overall Study||14
4981088|NCT02525627|12253355|P2|COMPLETED|Overall Study||5
4981089|NCT02525627|12253356|P1|COMPLETED|Overall Study||2
4981090|NCT02525627|12253355|P2|STARTED|Overall Study||18
4981091|NCT02525627|12253356|P1|STARTED|Overall Study||16
4981092|NCT02525588|12253368|P2|NOT COMPLETED|Overall Study||3
4981093|NCT02525588|12253369|P1|NOT COMPLETED|Overall Study||6
4981094|NCT02525588|12253368|P2|COMPLETED|Overall Study||45
4981095|NCT02525588|12253369|P1|COMPLETED|Overall Study||42
4981096|NCT02525588|12253368|P2|STARTED|Overall Study||48
4981097|NCT02525588|12253369|P1|STARTED|Overall Study||48
4981098|NCT02525575|12253385|P1|NOT COMPLETED|Overall Study||15
4981099|NCT02525575|12253385|P1|COMPLETED|Overall Study||22
4981100|NCT02525575|12253385|P1|STARTED|Overall Study||37
4981101|NCT02525536|12253395|P3|NOT COMPLETED|Overall Study||0
4981102|NCT02525536|12253396|P2|NOT COMPLETED|Overall Study||0
4981103|NCT02525536|12253397|P1|NOT COMPLETED|Overall Study||0
4981104|NCT02525536|12253395|P3|COMPLETED|Overall Study||6
4981105|NCT02525536|12253396|P2|COMPLETED|Overall Study||6
4981106|NCT02525536|12253397|P1|COMPLETED|Overall Study||6
4981107|NCT02525536|12253395|P3|STARTED|Overall Study||6
4981108|NCT02525536|12253396|P2|STARTED|Overall Study||6
4981109|NCT02525536|12253397|P1|STARTED|Overall Study||6
4981110|NCT02525523|12253470|P2|NOT COMPLETED|Overall Study||25
4981111|NCT02525523|12253471|P1|NOT COMPLETED|Overall Study||23
4981112|NCT02525523|12253470|P2|COMPLETED|Overall Study||44
4981113|NCT02525523|12253471|P1|COMPLETED|Overall Study||46
4981114|NCT02525523|12253470|P2|STARTED|Overall Study||69
4981115|NCT02525523|12253471|P1|STARTED|Overall Study||69
4981116|NCT02525094|12253481|P2|NOT COMPLETED|Overall Study||8
4981117|NCT02525094|12253482|P1|NOT COMPLETED|Overall Study||8
4981118|NCT02525094|12253481|P2|COMPLETED|Overall Study||48
4981119|NCT02525094|12253482|P1|COMPLETED|Overall Study||49
4981120|NCT02525094|12253481|P2|Treated|Overall Study||55
4981121|NCT02525094|12253482|P1|Treated|Overall Study||56
4981122|NCT02525094|12253481|P2|STARTED|Overall Study||56
4981123|NCT02525094|12253482|P1|STARTED|Overall Study||57
4981124|NCT02525055|12253515|P6|NOT COMPLETED|Overall Study||0
4981125|NCT02525055|12253516|P5|NOT COMPLETED|Overall Study||0
4981126|NCT02525055|12253517|P4|NOT COMPLETED|Overall Study||0
4981127|NCT02525055|12253518|P3|NOT COMPLETED|Overall Study||0
4981128|NCT02525055|12253519|P2|NOT COMPLETED|Overall Study||0
4981129|NCT02525055|12253520|P1|NOT COMPLETED|Overall Study||0
4981130|NCT02525055|12253515|P6|COMPLETED|Overall Study||16
4981131|NCT02525055|12253516|P5|COMPLETED|Overall Study||6
4981132|NCT02525055|12253517|P4|COMPLETED|Overall Study||6
4981133|NCT02525055|12253518|P3|COMPLETED|Overall Study||6
4981134|NCT02525055|12253519|P2|COMPLETED|Overall Study||6
4981135|NCT02525055|12253520|P1|COMPLETED|Overall Study||6
4981136|NCT02525055|12253515|P6|STARTED|Overall Study||16
4981137|NCT02525055|12253516|P5|STARTED|Overall Study||6
4981138|NCT02525055|12253517|P4|STARTED|Overall Study||6
4981139|NCT02525055|12253518|P3|STARTED|Overall Study||6
4981140|NCT02525055|12253519|P2|STARTED|Overall Study||6
4981141|NCT02525055|12253520|P1|STARTED|Overall Study||6
4981142|NCT02524977|12253536|P2|NOT COMPLETED|Overall Study||45
4981143|NCT02524977|12253537|P1|NOT COMPLETED|Overall Study||46
4981144|NCT02524977|12253536|P2|COMPLETED|Overall Study||801
4981145|NCT02524977|12253537|P1|COMPLETED|Overall Study||692
4981146|NCT02524977|12253536|P2|STARTED|Overall Study||846
4981147|NCT02524977|12253537|P1|STARTED|Overall Study||738
4981148|NCT02524665|12253545|P1|NOT COMPLETED|Overall Study||1
4981149|NCT02524665|12253545|P1|COMPLETED|Overall Study||19
4981150|NCT02524665|12253545|P1|STARTED|Overall Study||20
4981151|NCT02524561|12253563|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4981152|NCT02524561|12253564|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4981153|NCT02524561|12253565|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4981154|NCT02524561|12253563|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
4981155|NCT02524561|12253564|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
4981156|NCT02524561|12253565|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
4981157|NCT02524561|12253563|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
4981158|NCT02524561|12253564|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
4981159|NCT02524561|12253565|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
4981160|NCT02524561|12253563|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
4981161|NCT02524561|12253564|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
4981162|NCT02524561|12253565|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
4981163|NCT02524561|12253563|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4981164|NCT02524561|12253564|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4981165|NCT02524561|12253565|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4981166|NCT02524561|12253563|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
4981167|NCT02524561|12253564|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
4981168|NCT02524561|12253565|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
4981169|NCT02524561|12253563|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
4981170|NCT02524561|12253564|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
4981171|NCT02524561|12253565|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
4981172|NCT02524561|12253563|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
4981173|NCT02524561|12253564|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
4981174|NCT02524561|12253565|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
4981175|NCT02524561|12253563|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4981176|NCT02524561|12253564|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4981177|NCT02524561|12253565|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4981178|NCT02524561|12253563|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
4981179|NCT02524561|12253564|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
4981180|NCT02524561|12253565|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
4981181|NCT02524561|12253563|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
4981182|NCT02524561|12253564|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
4981183|NCT02524561|12253565|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
4981184|NCT02524561|12253563|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
4981185|NCT02524561|12253564|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
4981186|NCT02524561|12253565|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
4981187|NCT02524418|12253582|P1|NOT COMPLETED|Overall Study||13
4981188|NCT02524418|12253582|P1|COMPLETED|Overall Study||75
4981189|NCT02524418|12253582|P1|STARTED|Overall Study||88
4981190|NCT02524288|12253596|P1|NOT COMPLETED|Overall Study||1941
4981191|NCT02524288|12253596|P1|COMPLETED|Overall Study||0
4981192|NCT02524288|12253596|P1|Treated|Overall Study||1936
4981193|NCT02524288|12253596|P1|STARTED|Overall Study||1941
4981194|NCT02524158|12253606|P2|NOT COMPLETED|6-month Assessment||21
4981195|NCT02524158|12253607|P1|NOT COMPLETED|6-month Assessment||22
4981196|NCT02524158|12253606|P2|COMPLETED|6-month Assessment||55
4981197|NCT02524158|12253607|P1|COMPLETED|6-month Assessment||54
4981198|NCT02524158|12253606|P2|STARTED|6-month Assessment||76
4981199|NCT02524158|12253607|P1|STARTED|6-month Assessment||76
4981200|NCT02524158|12253606|P2|NOT COMPLETED|12-weeks Assessment||13
4981201|NCT02524158|12253607|P1|NOT COMPLETED|12-weeks Assessment||19
4981202|NCT02524158|12253606|P2|COMPLETED|12-weeks Assessment||63
4981203|NCT02524158|12253607|P1|COMPLETED|12-weeks Assessment||57
4981204|NCT02524158|12253606|P2|STARTED|12-weeks Assessment||76
4981205|NCT02524158|12253607|P1|STARTED|12-weeks Assessment||76
4981206|NCT02524145|12253649|P3|NOT COMPLETED|Overall Study||3
4981207|NCT02524145|12253650|P2|NOT COMPLETED|Overall Study||2
4981208|NCT02524145|12253651|P1|NOT COMPLETED|Overall Study||2
4981209|NCT02524145|12253649|P3|COMPLETED|Overall Study||7
4981210|NCT02524145|12253650|P2|COMPLETED|Overall Study||13
4981211|NCT02524145|12253651|P1|COMPLETED|Overall Study||13
4981212|NCT02524145|12253649|P3|STARTED|Overall Study||10
4981213|NCT02524145|12253650|P2|STARTED|Overall Study||15
4981214|NCT02524145|12253651|P1|STARTED|Overall Study||15
4981215|NCT02524106|12253663|P2|NOT COMPLETED|Overall Study||0
4981216|NCT02524106|12253664|P1|NOT COMPLETED|Overall Study||0
4981217|NCT02524106|12253663|P2|COMPLETED|Overall Study||5
4981218|NCT02524106|12253664|P1|COMPLETED|Overall Study||6
4981219|NCT02524106|12253663|P2|STARTED|Overall Study||5
4981220|NCT02524106|12253664|P1|STARTED|Overall Study||6
4981221|NCT02524054|12253674|P3|NOT COMPLETED|Overall Study||0
4981222|NCT02524054|12253675|P2|NOT COMPLETED|Overall Study||0
4981223|NCT02524054|12253676|P1|NOT COMPLETED|Overall Study||0
4981224|NCT02524054|12253674|P3|COMPLETED|Overall Study||8
4981225|NCT02524054|12253675|P2|COMPLETED|Overall Study||9
4981226|NCT02524054|12253676|P1|COMPLETED|Overall Study||7
4981227|NCT02524054|12253674|P3|STARTED|Overall Study||8
4981228|NCT02524054|12253675|P2|STARTED|Overall Study||9
4981229|NCT02524054|12253676|P1|STARTED|Overall Study||7
4981230|NCT02523924|12253687|P1|NOT COMPLETED|Overall Study||0
4981231|NCT02523924|12253687|P1|COMPLETED|Overall Study||31
4981232|NCT02523924|12253687|P1|STARTED|Overall Study||31
4981233|NCT02523690|12253697|P2|NOT COMPLETED|Overall Study||0
4981234|NCT02523690|12253698|P1|NOT COMPLETED|Overall Study||0
4981235|NCT02523690|12253697|P2|COMPLETED|Overall Study||2
4981236|NCT02523690|12253698|P1|COMPLETED|Overall Study||3
4981237|NCT02523690|12253697|P2|STARTED|Overall Study||2
4981238|NCT02523690|12253698|P1|STARTED|Overall Study||3
4981239|NCT02523586|12253714|P1|NOT COMPLETED|Overall Study||4
4981240|NCT02523586|12253714|P1|COMPLETED|Overall Study||10
4981241|NCT02523586|12253714|P1|STARTED|Overall Study||14
4981242|NCT02523235|12253727|P2|NOT COMPLETED|Overall Study||0
4981243|NCT02523235|12253728|P1|NOT COMPLETED|Overall Study||0
4981244|NCT02523235|12253727|P2|COMPLETED|Overall Study||58
4981245|NCT02523235|12253728|P1|COMPLETED|Overall Study||56
4981246|NCT02523235|12253727|P2|STARTED|Overall Study||58
4981247|NCT02523235|12253728|P1|STARTED|Overall Study||56
4981248|NCT02522884|12253748|P1|NOT COMPLETED|Overall Study||18
4981249|NCT02522884|12253748|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
4981250|NCT02522884|12253748|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
4981251|NCT02522845|12253755|P2|NOT COMPLETED|Overall Study||35
4981252|NCT02522845|12253756|P1|NOT COMPLETED|Overall Study||37
4981253|NCT02522845|12253755|P2|COMPLETED|Overall Study||69
4981254|NCT02522845|12253756|P1|COMPLETED|Overall Study||63
4981255|NCT02522845|12253755|P2|STARTED|Overall Study||104
4981256|NCT02522845|12253756|P1|STARTED|Overall Study||100
4981257|NCT02522728|12253780|P2|NOT COMPLETED|Overall Study||11
4981258|NCT02522728|12253781|P1|NOT COMPLETED|Overall Study||12
4981259|NCT02522728|12253780|P2|COMPLETED|Overall Study||19
4981260|NCT02522728|12253781|P1|COMPLETED|Overall Study||16
4981261|NCT02522728|12253780|P2|STARTED|Overall Study||30
4981262|NCT02522728|12253781|P1|STARTED|Overall Study||28
4981263|NCT02522624|12253797|P2|NOT COMPLETED|Overall Study||0
4981264|NCT02522624|12253798|P1|NOT COMPLETED|Overall Study||1
4981265|NCT02522624|12253797|P2|COMPLETED|Overall Study||163
4981266|NCT02522624|12253798|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
4981267|NCT02522624|12253797|P2|STARTED|Overall Study||163
4981268|NCT02522624|12253798|P1|STARTED|Overall Study||165
4981269|NCT02522442|12253816|P2|NOT COMPLETED|Overall Study||0
4981270|NCT02522442|12253817|P1|NOT COMPLETED|Overall Study||0
4981271|NCT02522442|12253816|P2|COMPLETED|Overall Study||22
4981272|NCT02522442|12253817|P1|COMPLETED|Overall Study||26
4981273|NCT02522442|12253816|P2|STARTED|Overall Study||22
4981274|NCT02522442|12253817|P1|STARTED|Overall Study||26
4981275|NCT02522403|12253833|P2|NOT COMPLETED|Overall Study||6
4981276|NCT02522403|12253834|P1|NOT COMPLETED|Overall Study||4
4981277|NCT02522403|12253833|P2|COMPLETED|Overall Study||13
4981278|NCT02522403|12253834|P1|COMPLETED|Overall Study||13
4981279|NCT02522403|12253833|P2|STARTED|Overall Study||19
4981280|NCT02522403|12253834|P1|STARTED|Overall Study||17
4981281|NCT02522377|12253846|P2|NOT COMPLETED|Overall Study||0
4981282|NCT02522377|12253847|P1|NOT COMPLETED|Overall Study||4
4981283|NCT02522377|12253846|P2|COMPLETED|Overall Study||5
4981284|NCT02522377|12253847|P1|COMPLETED|Overall Study||3
4981285|NCT02522377|12253846|P2|STARTED|Overall Study||5
4981286|NCT02522377|12253847|P1|STARTED|Overall Study||7
4981287|NCT02522325|12253863|P2|NOT COMPLETED|Overall Study||1
4981288|NCT02522325|12253864|P1|NOT COMPLETED|Overall Study||0
4981289|NCT02522325|12253863|P2|COMPLETED|Overall Study||14
4981290|NCT02522325|12253864|P1|COMPLETED|Overall Study||15
4981291|NCT02522325|12253863|P2|STARTED|Overall Study||15
4981292|NCT02522325|12253864|P1|STARTED|Overall Study||15
4981293|NCT02522299|12253872|P2|NOT COMPLETED|Overall Study||1
4981294|NCT02522299|12253873|P1|NOT COMPLETED|Overall Study||4
4981295|NCT02522299|12253872|P2|COMPLETED|Overall Study||21
4981296|NCT02522299|12253873|P1|COMPLETED|Overall Study||18
4981297|NCT02522299|12253872|P2|STARTED|Overall Study||22
4981298|NCT02522299|12253873|P1|STARTED|Overall Study||22
4981299|NCT02522286|12253956|P4|NOT COMPLETED|Overall Study||3
4981300|NCT02522286|12253957|P3|NOT COMPLETED|Overall Study||0
4981301|NCT02522286|12253958|P2|NOT COMPLETED|Overall Study||0
4981302|NCT02522286|12253959|P1|NOT COMPLETED|Overall Study||3
4981303|NCT02522286|12253956|P4|COMPLETED|Overall Study||75
4981304|NCT02522286|12253957|P3|COMPLETED|Overall Study||75
4981305|NCT02522286|12253958|P2|COMPLETED|Overall Study||75
4981306|NCT02522286|12253959|P1|COMPLETED|Overall Study||75
4981307|NCT02522286|12253956|P4|STARTED|Overall Study||78
4981308|NCT02522286|12253957|P3|STARTED|Overall Study||75
4981309|NCT02522286|12253958|P2|STARTED|Overall Study||75
4981310|NCT02522286|12253959|P1|STARTED|Overall Study||78
4981311|NCT02521948|12253985|P1|NOT COMPLETED|Overall Study||13
4981312|NCT02521948|12253985|P1|COMPLETED|Overall Study||37
4981313|NCT02521948|12253985|P1|STARTED|Overall Study||50
4981314|NCT02521766|12253996|P2|NOT COMPLETED|Overall Study||3
4981315|NCT02521766|12253997|P1|NOT COMPLETED|Overall Study||5
4981316|NCT02521766|12253996|P2|COMPLETED|Overall Study||62
4981317|NCT02521766|12253997|P1|COMPLETED|Overall Study||44
4981318|NCT02521766|12253996|P2|Per Protocol|Overall Study||65
4981319|NCT02521766|12253997|P1|Per Protocol|Overall Study||47
4981320|NCT02521766|12253996|P2|STARTED|Overall Study||65
4981321|NCT02521766|12253997|P1|STARTED|Overall Study||49
4981322|NCT02521376|12254031|P4|NOT COMPLETED|Overall Study||0
4981323|NCT02521376|12254032|P3|NOT COMPLETED|Overall Study||0
4981324|NCT02521376|12254033|P2|NOT COMPLETED|Overall Study||0
4981325|NCT02521376|12254034|P1|NOT COMPLETED|Overall Study||1
4981326|NCT02521376|12254031|P4|COMPLETED|Overall Study||20
4981327|NCT02521376|12254032|P3|COMPLETED|Overall Study||10
4981328|NCT02521376|12254033|P2|COMPLETED|Overall Study||18
4981329|NCT02521376|12254034|P1|COMPLETED|Overall Study||7
4981330|NCT02521376|12254031|P4|STARTED|Overall Study||20
4981331|NCT02521376|12254032|P3|STARTED|Overall Study||10
4981332|NCT02521376|12254033|P2|STARTED|Overall Study||18
4981333|NCT02521376|12254034|P1|STARTED|Overall Study||8
4981334|NCT02521259|12254066|P2|NOT COMPLETED|Overall Study||5
4981335|NCT02521259|12254067|P1|NOT COMPLETED|Overall Study||1
4981336|NCT02521259|12254066|P2|COMPLETED|Overall Study||28
4981337|NCT02521259|12254067|P1|COMPLETED|Overall Study||34
4981338|NCT02521259|12254066|P2|STARTED|Overall Study||33
4981339|NCT02521259|12254067|P1|STARTED|Overall Study||35
4981340|NCT02520726|12254075|P2|NOT COMPLETED|Overall Study||2
4981341|NCT02520726|12254076|P1|NOT COMPLETED|Overall Study||3
4981342|NCT02520726|12254075|P2|COMPLETED|Overall Study||0
4981343|NCT02520726|12254076|P1|COMPLETED|Overall Study||0
4981344|NCT02520726|12254075|P2|STARTED|Overall Study||2
4981345|NCT02520726|12254076|P1|STARTED|Overall Study||3
4981346|NCT02520531|12254086|P2|NOT COMPLETED|Overall Study||6
4981347|NCT02520531|12254087|P1|NOT COMPLETED|Overall Study||6
4981348|NCT02520531|12254086|P2|COMPLETED|Overall Study||36
4981349|NCT02520531|12254087|P1|COMPLETED|Overall Study||36
4981350|NCT02520531|12254086|P2|STARTED|Overall Study||42
4981351|NCT02520531|12254087|P1|STARTED|Overall Study||42
4981352|NCT02520518|12254105|P4|NOT COMPLETED|Overall Study||1
4981353|NCT02520518|12254106|P3|NOT COMPLETED|Overall Study||2
4981354|NCT02520518|12254107|P2|NOT COMPLETED|Overall Study||0
4981355|NCT02520518|12254108|P1|NOT COMPLETED|Overall Study||0
4981356|NCT02520518|12254105|P4|COMPLETED|Overall Study||1
4981357|NCT02520518|12254106|P3|COMPLETED|Overall Study||1
4981358|NCT02520518|12254107|P2|COMPLETED|Overall Study||1
4981359|NCT02520518|12254108|P1|COMPLETED|Overall Study||3
4981360|NCT02520518|12254105|P4|STARTED|Overall Study||2
4981361|NCT02520518|12254106|P3|STARTED|Overall Study||3
4981362|NCT02520518|12254107|P2|STARTED|Overall Study||1
4981363|NCT02520518|12254108|P1|STARTED|Overall Study||3
4981364|NCT02520414|12254166|P1|NOT COMPLETED|Overall Study||0
4981365|NCT02520414|12254166|P1|COMPLETED|Overall Study||10
4981366|NCT02520414|12254166|P1|STARTED|Overall Study||10
4981367|NCT02520388|12254172|P2|NOT COMPLETED|Overall Study||16
4981368|NCT02520388|12254173|P1|NOT COMPLETED|Overall Study||9
4981369|NCT02520388|12254172|P2|COMPLETED|Overall Study||65
4981370|NCT02520388|12254173|P1|COMPLETED|Overall Study||73
4981371|NCT02520388|12254172|P2|Treated|Overall Study||80
4981372|NCT02520388|12254173|P1|Treated|Overall Study||81
4981373|NCT02520388|12254172|P2|STARTED|Overall Study||81
4981374|NCT02520388|12254173|P1|STARTED|Overall Study||82
4981375|NCT02520310|12254181|P1|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
4981376|NCT02520310|12254181|P1|COMPLETED|AT 3 Year Clinical Follow-up||24
4981377|NCT02520310|12254181|P1|STARTED|AT 3 Year Clinical Follow-up||28
4981378|NCT02520310|12254181|P1|NOT COMPLETED|At 2 Year Clinical Follow-up||0
4981379|NCT02520310|12254181|P1|COMPLETED|At 2 Year Clinical Follow-up||28
4981380|NCT02520310|12254181|P1|STARTED|At 2 Year Clinical Follow-up||28
4981381|NCT02520310|12254181|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
4981382|NCT02520310|12254181|P1|COMPLETED|At 1 Year Clinical Follow-up||28
4981383|NCT02520310|12254181|P1|STARTED|At 1 Year Clinical Follow-up||29
4981384|NCT02520310|12254181|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
4981385|NCT02520310|12254181|P1|COMPLETED|At 6 Months Clinical Follow-up||29
4981386|NCT02520310|12254181|P1|STARTED|At 6 Months Clinical Follow-up||30
4981387|NCT02520310|12254181|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
4981388|NCT02520310|12254181|P1|COMPLETED|At 30 Days Clinical Follow-up||30
4981389|NCT02520310|12254181|P1|STARTED|At 30 Days Clinical Follow-up||30
4981390|NCT02520284|12254355|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
4981391|NCT02520284|12254356|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
4981392|NCT02520284|12254357|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
4981393|NCT02520284|12254355|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
4981394|NCT02520284|12254356|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
4981395|NCT02520284|12254357|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
4981396|NCT02520284|12254355|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
4981397|NCT02520284|12254356|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
4981398|NCT02520284|12254357|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
4981399|NCT02520284|12254355|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
4981400|NCT02520284|12254356|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
4981401|NCT02520284|12254357|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
4981402|NCT02520284|12254355|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
4981403|NCT02520284|12254356|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
4981404|NCT02520284|12254357|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
4981405|NCT02520284|12254355|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
4981406|NCT02520284|12254356|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
4981407|NCT02520284|12254357|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
4981408|NCT02520284|12254355|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
4981409|NCT02520284|12254356|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
4981410|NCT02520284|12254357|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
4981411|NCT02520284|12254355|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
4981412|NCT02520284|12254356|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
4981413|NCT02520284|12254357|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
4981414|NCT02520284|12254355|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
4981415|NCT02520284|12254356|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
4981416|NCT02520284|12254357|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
4981417|NCT02520089|12254391|P2|NOT COMPLETED|Overall Study||4
4981418|NCT02520089|12254392|P1|NOT COMPLETED|Overall Study||3
4981419|NCT02520089|12254391|P2|COMPLETED|Overall Study||7
4981420|NCT02520089|12254392|P1|COMPLETED|Overall Study||9
4981421|NCT02520089|12254391|P2|STARTED|Overall Study||11
4981422|NCT02520089|12254392|P1|STARTED|Overall Study||12
4981423|NCT02519855|12254402|P2|NOT COMPLETED|Overall Study||4
4981424|NCT02519855|12254403|P1|NOT COMPLETED|Overall Study||3
4981425|NCT02519855|12254402|P2|COMPLETED|Overall Study||437
4981426|NCT02519855|12254403|P1|COMPLETED|Overall Study||438
4981427|NCT02519855|12254402|P2|Vaccinated at Week 4|Overall Study||424
4981428|NCT02519855|12254403|P1|Vaccinated at Week 4|Overall Study||432
4981429|NCT02519855|12254402|P2|Vaccinated on Day 1|Overall Study||441
4981430|NCT02519855|12254403|P1|Vaccinated on Day 1|Overall Study||440
4981431|NCT02519855|12254402|P2|STARTED|Overall Study|Participants are included as treated|441
4981432|NCT02519855|12254403|P1|STARTED|Overall Study|Participants are included as treated|441
4981433|NCT02519842|12254421|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
4981434|NCT02519842|12254422|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
4981435|NCT02519842|12254423|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
4981436|NCT02519842|12254421|P3|COMPLETED|Optional Extension: Cycles 2-6||26
4981437|NCT02519842|12254422|P2|COMPLETED|Optional Extension: Cycles 2-6||0
4981438|NCT02519842|12254423|P1|COMPLETED|Optional Extension: Cycles 2-6||0
4981439|NCT02519842|12254421|P3|Treated|Optional Extension: Cycles 2-6||55
4981440|NCT02519842|12254422|P2|Treated|Optional Extension: Cycles 2-6||0
4981441|NCT02519842|12254423|P1|Treated|Optional Extension: Cycles 2-6||0
4981442|NCT02519842|12254421|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
4981443|NCT02519842|12254422|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
4981444|NCT02519842|12254423|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
4981445|NCT02519842|12254421|P3|NOT COMPLETED|Base Study: Cycle 1||0
4981446|NCT02519842|12254422|P2|NOT COMPLETED|Base Study: Cycle 1||3
4981447|NCT02519842|12254423|P1|NOT COMPLETED|Base Study: Cycle 1||2
4981448|NCT02519842|12254421|P3|COMPLETED|Base Study: Cycle 1||0
4981449|NCT02519842|12254422|P2|COMPLETED|Base Study: Cycle 1||34
4981450|NCT02519842|12254423|P1|COMPLETED|Base Study: Cycle 1||36
4981451|NCT02519842|12254421|P3|Treated|Base Study: Cycle 1||0
4981452|NCT02519842|12254422|P2|Treated|Base Study: Cycle 1||34
4981453|NCT02519842|12254423|P1|Treated|Base Study: Cycle 1||37
4981454|NCT02519842|12254421|P3|STARTED|Base Study: Cycle 1||0
4981455|NCT02519842|12254422|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
4981456|NCT02519842|12254423|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
4981457|NCT02519712|12254442|P1|NOT COMPLETED|Overall Study||4
4981458|NCT02519712|12254442|P1|COMPLETED|Overall Study||0
4981459|NCT02519712|12254442|P1|STARTED|Overall Study||4
4981460|NCT02519595|12254449|P3|NOT COMPLETED|Overall Study||16
4981461|NCT02519595|12254450|P2|NOT COMPLETED|Overall Study||22
4981462|NCT02519595|12254451|P1|NOT COMPLETED|Overall Study||8
4981463|NCT02519595|12254449|P3|COMPLETED|Overall Study||40
4981464|NCT02519595|12254450|P2|COMPLETED|Overall Study||35
4981465|NCT02519595|12254451|P1|COMPLETED|Overall Study||50
4981466|NCT02519595|12254449|P3|STARTED|Overall Study||56
4981467|NCT02519595|12254450|P2|STARTED|Overall Study||57
4981468|NCT02519595|12254451|P1|STARTED|Overall Study||58
4981469|NCT02519504|12254476|P2|NOT COMPLETED|Overall Study||103
4981470|NCT02519504|12254477|P1|NOT COMPLETED|Overall Study||113
4981471|NCT02519504|12254476|P2|COMPLETED|Overall Study||144
4981472|NCT02519504|12254477|P1|COMPLETED|Overall Study||206
4981473|NCT02519504|12254476|P2|Attended Direct Testing|Overall Study||149
4981474|NCT02519504|12254477|P1|Attended Direct Testing|Overall Study||212
4981475|NCT02519504|12254476|P2|STARTED|Overall Study||247
4981476|NCT02519504|12254477|P1|STARTED|Overall Study||319
4981477|NCT02519387|12254537|P1|NOT COMPLETED|Overall Study||22
4981478|NCT02519387|12254537|P1|COMPLETED|Overall Study||56
4981479|NCT02519387|12254537|P1|STARTED|Overall Study||78
4981480|NCT02519244|12254545|P1|NOT COMPLETED|Overall Study||0
4981481|NCT02519244|12254545|P1|COMPLETED|Overall Study||10
4981482|NCT02519244|12254545|P1|STARTED|Overall Study||10
4981483|NCT02519036|12254580|P6|NOT COMPLETED|Overall Study||0
4981484|NCT02519036|12254581|P5|NOT COMPLETED|Overall Study||0
4981485|NCT02519036|12254582|P4|NOT COMPLETED|Overall Study||0
4981486|NCT02519036|12254583|P3|NOT COMPLETED|Overall Study||0
4981487|NCT02519036|12254584|P2|NOT COMPLETED|Overall Study||0
4981488|NCT02519036|12254585|P1|NOT COMPLETED|Overall Study||0
4981489|NCT02519036|12254580|P6|COMPLETED|Overall Study||10
4981490|NCT02519036|12254581|P5|COMPLETED|Overall Study||9
4981491|NCT02519036|12254582|P4|COMPLETED|Overall Study||6
4981492|NCT02519036|12254583|P3|COMPLETED|Overall Study||6
4981493|NCT02519036|12254584|P2|COMPLETED|Overall Study||3
4981494|NCT02519036|12254585|P1|COMPLETED|Overall Study||12
4981495|NCT02519036|12254580|P6|STARTED|Overall Study||10
4981496|NCT02519036|12254581|P5|STARTED|Overall Study||9
4981497|NCT02519036|12254582|P4|STARTED|Overall Study||6
4981498|NCT02519036|12254583|P3|STARTED|Overall Study||6
4981499|NCT02519036|12254584|P2|STARTED|Overall Study||3
4981500|NCT02519036|12254585|P1|STARTED|Overall Study||12
4981501|NCT02519023|12254640|P2|NOT COMPLETED|Overall Study||7
4981502|NCT02519023|12254641|P1|NOT COMPLETED|Overall Study||18
4981503|NCT02519023|12254640|P2|COMPLETED|Overall Study||31
4981504|NCT02519023|12254641|P1|COMPLETED|Overall Study||31
4981505|NCT02519023|12254640|P2|STARTED|Overall Study||38
4981506|NCT02519023|12254641|P1|STARTED|Overall Study||49
4981507|NCT02518997|12254673|P1|NOT COMPLETED|Overall Study||0
4981508|NCT02518997|12254673|P1|COMPLETED|Overall Study||18
4981509|NCT02518997|12254673|P1|STARTED|Overall Study||18
4981510|NCT02518971|12254682|P2|NOT COMPLETED|Overall Study||20
4981511|NCT02518971|12254683|P1|NOT COMPLETED|Overall Study||23
4981512|NCT02518971|12254682|P2|COMPLETED|Overall Study||67
4981513|NCT02518971|12254683|P1|COMPLETED|Overall Study||64
4981514|NCT02518971|12254682|P2|STARTED|Overall Study||87
4981515|NCT02518971|12254683|P1|STARTED|Overall Study||87
4981516|NCT02518919|12254703|P3|NOT COMPLETED|Overall Study||2
4981517|NCT02518919|12254704|P2|NOT COMPLETED|Overall Study||1
4981518|NCT02518919|12254705|P1|NOT COMPLETED|Overall Study||1
4981519|NCT02518919|12254703|P3|COMPLETED|Overall Study||19
4981520|NCT02518919|12254704|P2|COMPLETED|Overall Study||20
4981521|NCT02518919|12254705|P1|COMPLETED|Overall Study||20
4981522|NCT02518919|12254703|P3|STARTED|Overall Study||21
4981523|NCT02518919|12254704|P2|STARTED|Overall Study||21
4981524|NCT02518919|12254705|P1|STARTED|Overall Study||21
4981525|NCT02518750|12254725|P1|NOT COMPLETED|Overall Study||2
4981526|NCT02518750|12254725|P1|COMPLETED|Overall Study||1
4981527|NCT02518750|12254725|P1|STARTED|Overall Study||3
4981528|NCT02518685|12254735|P2|NOT COMPLETED|Overall Study||10
4981529|NCT02518685|12254736|P1|NOT COMPLETED|Overall Study||49
4981530|NCT02518685|12254735|P2|COMPLETED|Overall Study||79
4981531|NCT02518685|12254736|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
4981532|NCT02518685|12254735|P2|Per Protocol Analysis|Overall Study||89
4981533|NCT02518685|12254736|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
4981534|NCT02518685|12254735|P2|Enrolled|Overall Study||89
4981535|NCT02518685|12254736|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
4981536|NCT02518685|12254735|P2|Randomized Cohort|Overall Study||89
4981537|NCT02518685|12254736|P1|Randomized Cohort|Overall Study||181
4981538|NCT02518685|12254735|P2|Safety Cohort|Overall Study||89
4981539|NCT02518685|12254736|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
4981540|NCT02518685|12254735|P2|STARTED|Overall Study||89
4981541|NCT02518685|12254736|P1|STARTED|Overall Study||213
4981542|NCT02518620|12254745|P2|NOT COMPLETED|Overall Study||26
4981543|NCT02518620|12254746|P1|NOT COMPLETED|Overall Study||52
4981544|NCT02518620|12254745|P2|COMPLETED|Overall Study||123
4981545|NCT02518620|12254746|P1|COMPLETED|Overall Study||205
4981546|NCT02518620|12254745|P2|STARTED|Overall Study||149
4981547|NCT02518620|12254746|P1|STARTED|Overall Study||257
4981548|NCT02518464|12254769|P1|NOT COMPLETED|Overall Study||2
4981549|NCT02518464|12254769|P1|COMPLETED|Overall Study||38
4981550|NCT02518464|12254769|P1|STARTED|Overall Study||40
4981551|NCT02518139|12254776|P3|NOT COMPLETED|Overall Study||94
4981552|NCT02518139|12254777|P2|NOT COMPLETED|Overall Study||144
4981553|NCT02518139|12254778|P1|NOT COMPLETED|Overall Study||145
4981554|NCT02518139|12254776|P3|COMPLETED|Overall Study||262
4981555|NCT02518139|12254777|P2|COMPLETED|Overall Study||191
4981556|NCT02518139|12254778|P1|COMPLETED|Overall Study||219
4981557|NCT02518139|12254776|P3|STARTED|Overall Study||356
4981558|NCT02518139|12254777|P2|STARTED|Overall Study||335
4981559|NCT02518139|12254778|P1|STARTED|Overall Study||364
4981560|NCT02518113|12254790|P4|NOT COMPLETED|Overall Study||0
4981561|NCT02518113|12254791|P3|NOT COMPLETED|Overall Study||4
4981562|NCT02518113|12254792|P2|NOT COMPLETED|Overall Study||5
4981563|NCT02518113|12254793|P1|NOT COMPLETED|Overall Study||3
4981564|NCT02518113|12254790|P4|COMPLETED|Overall Study||3
4981565|NCT02518113|12254791|P3|COMPLETED|Overall Study||11
4981566|NCT02518113|12254792|P2|COMPLETED|Overall Study||7
4981567|NCT02518113|12254793|P1|COMPLETED|Overall Study||3
4981568|NCT02518113|12254790|P4|STARTED|Overall Study||3
4981569|NCT02518113|12254791|P3|STARTED|Overall Study||15
4981570|NCT02518113|12254792|P2|STARTED|Overall Study||12
4981571|NCT02518113|12254793|P1|STARTED|Overall Study||6
4981572|NCT02518048|12254834|P1|NOT COMPLETED|Overall Study||1
4981573|NCT02518048|12254834|P1|COMPLETED|Overall Study||34
4981574|NCT02518048|12254834|P1|STARTED|Overall Study||35
4981575|NCT02517996|12254847|P2|NOT COMPLETED|Overall Study||0
4981576|NCT02517996|12254848|P1|NOT COMPLETED|Overall Study||0
4981577|NCT02517996|12254847|P2|COMPLETED|Overall Study||9
4981578|NCT02517996|12254848|P1|COMPLETED|Overall Study||8
4981579|NCT02517996|12254847|P2|STARTED|Overall Study||9
4981580|NCT02517996|12254848|P1|STARTED|Overall Study||8
4981581|NCT02517866|12254860|P3|NOT COMPLETED|Overall Study||0
4981582|NCT02517866|12254861|P2|NOT COMPLETED|Overall Study||6
4981583|NCT02517866|12254862|P1|NOT COMPLETED|Overall Study||20
4981584|NCT02517866|12254860|P3|COMPLETED|Overall Study||1
4981585|NCT02517866|12254861|P2|COMPLETED|Overall Study||84
4981586|NCT02517866|12254862|P1|COMPLETED|Overall Study||269
4981587|NCT02517866|12254860|P3|STARTED|Overall Study||1
4981588|NCT02517866|12254861|P2|STARTED|Overall Study||90
4981589|NCT02517866|12254862|P1|STARTED|Overall Study||289
4981590|NCT02517658|12254907|P3|NOT COMPLETED|Overall Study||0
4981591|NCT02517658|12254908|P2|NOT COMPLETED|Overall Study||0
4981592|NCT02517658|12254909|P1|NOT COMPLETED|Overall Study||0
4981593|NCT02517658|12254907|P3|COMPLETED|Overall Study||33
4981594|NCT02517658|12254908|P2|COMPLETED|Overall Study||33
4981595|NCT02517658|12254909|P1|COMPLETED|Overall Study||33
4981596|NCT02517658|12254907|P3|STARTED|Overall Study||33
4981597|NCT02517658|12254908|P2|STARTED|Overall Study||33
4981598|NCT02517658|12254909|P1|STARTED|Overall Study||33
4981599|NCT02517580|12254917|P1|NOT COMPLETED|Overall Study||4
4981600|NCT02517580|12254917|P1|COMPLETED|Overall Study||56
4981601|NCT02517580|12254917|P1|STARTED|Overall Study||60
4981602|NCT02517567|12254921|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
4981603|NCT02517567|12254922|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
4981604|NCT02517567|12254923|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
4981605|NCT02517567|12254924|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
4981606|NCT02517567|12254921|P4|COMPLETED|Fourth Exposure (8 Hours)||8
4981607|NCT02517567|12254922|P3|COMPLETED|Fourth Exposure (8 Hours)||6
4981608|NCT02517567|12254923|P2|COMPLETED|Fourth Exposure (8 Hours)||8
4981609|NCT02517567|12254924|P1|COMPLETED|Fourth Exposure (8 Hours)||6
4981610|NCT02517567|12254921|P4|STARTED|Fourth Exposure (8 Hours)||8
4981611|NCT02517567|12254922|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
4981612|NCT02517567|12254923|P2|STARTED|Fourth Exposure (8 Hours)||8
4981613|NCT02517567|12254924|P1|STARTED|Fourth Exposure (8 Hours)||6
4981614|NCT02517567|12254921|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
4981615|NCT02517567|12254922|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
4981616|NCT02517567|12254923|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
4981617|NCT02517567|12254924|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
4981618|NCT02517567|12254921|P4|COMPLETED|Third Exposure (8 Hours)||8
4981619|NCT02517567|12254922|P3|COMPLETED|Third Exposure (8 Hours)||7
4981620|NCT02517567|12254923|P2|COMPLETED|Third Exposure (8 Hours)||8
4981621|NCT02517567|12254924|P1|COMPLETED|Third Exposure (8 Hours)||6
4981622|NCT02517567|12254921|P4|STARTED|Third Exposure (8 Hours)||8
4981623|NCT02517567|12254922|P3|STARTED|Third Exposure (8 Hours)||7
4981624|NCT02517567|12254923|P2|STARTED|Third Exposure (8 Hours)||8
4981625|NCT02517567|12254924|P1|STARTED|Third Exposure (8 Hours)||6
4981626|NCT02517567|12254921|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
4981627|NCT02517567|12254922|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
4981628|NCT02517567|12254923|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
4981629|NCT02517567|12254924|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
4981630|NCT02517567|12254921|P4|COMPLETED|Second Exposure (8 Hours)||8
4981631|NCT02517567|12254922|P3|COMPLETED|Second Exposure (8 Hours)||7
4981632|NCT02517567|12254923|P2|COMPLETED|Second Exposure (8 Hours)||8
4981633|NCT02517567|12254924|P1|COMPLETED|Second Exposure (8 Hours)||6
4981634|NCT02517567|12254921|P4|STARTED|Second Exposure (8 Hours)||8
4981635|NCT02517567|12254922|P3|STARTED|Second Exposure (8 Hours)||7
4981636|NCT02517567|12254923|P2|STARTED|Second Exposure (8 Hours)||8
4981637|NCT02517567|12254924|P1|STARTED|Second Exposure (8 Hours)||6
4981638|NCT02517567|12254921|P4|NOT COMPLETED|First Exposure (8 Hours)||0
4981639|NCT02517567|12254922|P3|NOT COMPLETED|First Exposure (8 Hours)||0
4981640|NCT02517567|12254923|P2|NOT COMPLETED|First Exposure (8 Hours)||0
4981641|NCT02517567|12254924|P1|NOT COMPLETED|First Exposure (8 Hours)||0
4981642|NCT02517567|12254921|P4|COMPLETED|First Exposure (8 Hours)||8
4981643|NCT02517567|12254922|P3|COMPLETED|First Exposure (8 Hours)||7
4981644|NCT02517567|12254923|P2|COMPLETED|First Exposure (8 Hours)||8
4981645|NCT02517567|12254924|P1|COMPLETED|First Exposure (8 Hours)||6
4981646|NCT02517567|12254921|P4|STARTED|First Exposure (8 Hours)||8
4981647|NCT02517567|12254922|P3|STARTED|First Exposure (8 Hours)||7
4981648|NCT02517567|12254923|P2|STARTED|First Exposure (8 Hours)||8
4981649|NCT02517567|12254924|P1|STARTED|First Exposure (8 Hours)||6
4981650|NCT02517541|12254933|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
4981651|NCT02517541|12254933|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
4981652|NCT02517541|12254933|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
4981653|NCT02517541|12254933|P1|NOT COMPLETED|Baseline Period (Own Product)||1
4981654|NCT02517541|12254933|P1|COMPLETED|Baseline Period (Own Product)||73
4981655|NCT02517541|12254933|P1|STARTED|Baseline Period (Own Product)||74
4981656|NCT02517528|12254939|P1|NOT COMPLETED|Overall Study||1
4981657|NCT02517528|12254939|P1|COMPLETED|Overall Study||103
4981658|NCT02517528|12254939|P1|STARTED|Overall Study||104
4981659|NCT02517515|12254949|P2|NOT COMPLETED|Overall Study||2
4981660|NCT02517515|12254950|P1|NOT COMPLETED|Overall Study||2
4981661|NCT02517515|12254949|P2|COMPLETED|Overall Study||323
4981662|NCT02517515|12254950|P1|COMPLETED|Overall Study||323
4981663|NCT02517515|12254949|P2|STARTED|Overall Study||325
4981664|NCT02517515|12254950|P1|STARTED|Overall Study||325
4981665|NCT02517463|12254967|P2|NOT COMPLETED|Overall Study||2
4981666|NCT02517463|12254968|P1|NOT COMPLETED|Overall Study||5
4981667|NCT02517463|12254967|P2|COMPLETED|Overall Study||329
4981668|NCT02517463|12254968|P1|COMPLETED|Overall Study||364
4981669|NCT02517463|12254967|P2|STARTED|Overall Study||331
4981670|NCT02517463|12254968|P1|STARTED|Overall Study||369
4981671|NCT02517268|12254980|P2|NOT COMPLETED|Overall Study||0
4981672|NCT02517268|12254981|P1|NOT COMPLETED|Overall Study||1
4981673|NCT02517268|12254980|P2|COMPLETED|Overall Study||37
4981674|NCT02517268|12254981|P1|COMPLETED|Overall Study||39
4981675|NCT02517268|12254980|P2|STARTED|Overall Study||37
4981676|NCT02517268|12254981|P1|STARTED|Overall Study||40
4981677|NCT02517047|12254995|P1|NOT COMPLETED|Overall Study||2
4981678|NCT02517047|12254995|P1|COMPLETED|Overall Study||24
4981679|NCT02517047|12254995|P1|STARTED|Overall Study||26
4981680|NCT02517021|12255004|P2|NOT COMPLETED|Overall Study||85
4981681|NCT02517021|12255005|P1|NOT COMPLETED|Overall Study||83
4981682|NCT02517021|12255004|P2|COMPLETED|Overall Study||117
4981683|NCT02517021|12255005|P1|COMPLETED|Overall Study||120
4981684|NCT02517021|12255004|P2|STARTED|Overall Study||202
4981685|NCT02517021|12255005|P1|STARTED|Overall Study||203
4981686|NCT02516982|12255033|P4|NOT COMPLETED|Overall Study||50
4981687|NCT02516982|12255034|P3|NOT COMPLETED|Overall Study||48
4981688|NCT02516982|12255035|P2|NOT COMPLETED|Overall Study||35
4981689|NCT02516982|12255036|P1|NOT COMPLETED|Overall Study||32
4981690|NCT02516982|12255033|P4|COMPLETED|Overall Study||125
4981691|NCT02516982|12255034|P3|COMPLETED|Overall Study||126
4981692|NCT02516982|12255035|P2|COMPLETED|Overall Study||257
4981693|NCT02516982|12255036|P1|COMPLETED|Overall Study||273
4981694|NCT02516982|12255033|P4|STARTED|Overall Study||175
4981695|NCT02516982|12255034|P3|STARTED|Overall Study||174
4981696|NCT02516982|12255035|P2|STARTED|Overall Study||292
4981697|NCT02516982|12255036|P1|STARTED|Overall Study||305
4981698|NCT02516605|12255063|P5|NOT COMPLETED|Overall Study||1
4981699|NCT02516605|12255064|P4|NOT COMPLETED|Overall Study||1
4981700|NCT02516605|12255065|P3|NOT COMPLETED|Overall Study||0
4981701|NCT02516605|12255066|P2|NOT COMPLETED|Overall Study||0
4981702|NCT02516605|12255067|P1|NOT COMPLETED|Overall Study||0
4981703|NCT02516605|12255063|P5|COMPLETED|Overall Study||20
4981704|NCT02516605|12255064|P4|COMPLETED|Overall Study||7
4981705|NCT02516605|12255065|P3|COMPLETED|Overall Study||12
4981706|NCT02516605|12255066|P2|COMPLETED|Overall Study||9
4981707|NCT02516605|12255067|P1|COMPLETED|Overall Study||11
4981708|NCT02516605|12255063|P5|STARTED|Overall Study||21
4981709|NCT02516605|12255064|P4|STARTED|Overall Study||8
4981710|NCT02516605|12255065|P3|STARTED|Overall Study||12
4981711|NCT02516605|12255066|P2|STARTED|Overall Study||9
4981712|NCT02516605|12255067|P1|STARTED|Overall Study||11
4981713|NCT02516592|12255138|P2|NOT COMPLETED|Overall Study||13
4981714|NCT02516592|12255139|P1|NOT COMPLETED|Overall Study||16
4981715|NCT02516592|12255138|P2|COMPLETED|Overall Study||238
4981716|NCT02516592|12255139|P1|COMPLETED|Overall Study||235
4981717|NCT02516592|12255138|P2|Full Analysis Set|Overall Study||250
4981718|NCT02516592|12255139|P1|Full Analysis Set|Overall Study||248
4981719|NCT02516592|12255138|P2|STARTED|Overall Study||251
4981720|NCT02516592|12255139|P1|STARTED|Overall Study||251
4981721|NCT02516579|12255153|P1|NOT COMPLETED|Overall Study||0
4981722|NCT02516579|12255153|P1|COMPLETED|Overall Study||1906
4981723|NCT02516579|12255153|P1|STARTED|Overall Study||1906
4981724|NCT02516410|12255161|P2|NOT COMPLETED|Overall Study||2
4981725|NCT02516410|12255162|P1|NOT COMPLETED|Overall Study||0
4981726|NCT02516410|12255161|P2|COMPLETED|Overall Study||81
4981727|NCT02516410|12255162|P1|COMPLETED|Overall Study||85
4981728|NCT02516410|12255161|P2|STARTED|Overall Study||83
4981729|NCT02516410|12255162|P1|STARTED|Overall Study||85
4981730|NCT02516306|12255191|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
4981731|NCT02516306|12255192|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
4981732|NCT02516306|12255191|P2|COMPLETED|Period 2: Day 8 - 91||23
4981733|NCT02516306|12255192|P1|COMPLETED|Period 2: Day 8 - 91||49
4981734|NCT02516306|12255191|P2|STARTED|Period 2: Day 8 - 91||25
4981735|NCT02516306|12255192|P1|STARTED|Period 2: Day 8 - 91||50
4981736|NCT02516306|12255191|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
4981737|NCT02516306|12255192|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
4981738|NCT02516306|12255191|P2|COMPLETED|Period 1: Day 1 - 7||25
4981739|NCT02516306|12255192|P1|COMPLETED|Period 1: Day 1 - 7||50
4981740|NCT02516306|12255191|P2|STARTED|Period 1: Day 1 - 7||25
4981741|NCT02516306|12255192|P1|STARTED|Period 1: Day 1 - 7||50
4981742|NCT02516228|12255198|P1|NOT COMPLETED|Overall Study||3
4981743|NCT02516228|12255198|P1|COMPLETED|Overall Study||3
4981744|NCT02516228|12255198|P1|STARTED|Overall Study||6
4981745|NCT02516202|12255209|P3|NOT COMPLETED|Overall Study||3
4981746|NCT02516202|12255210|P2|NOT COMPLETED|Overall Study||1
4981747|NCT02516202|12255211|P1|NOT COMPLETED|Overall Study||2
4981748|NCT02516202|12255209|P3|COMPLETED|Overall Study||97
4981749|NCT02516202|12255210|P2|COMPLETED|Overall Study||99
4981750|NCT02516202|12255211|P1|COMPLETED|Overall Study||100
4981751|NCT02516202|12255209|P3|STARTED|Overall Study||100
4981752|NCT02516202|12255210|P2|STARTED|Overall Study||100
4981753|NCT02516202|12255211|P1|STARTED|Overall Study||102
4981754|NCT02516163|12255237|P1|NOT COMPLETED|Overall Study||28
4981755|NCT02516163|12255237|P1|COMPLETED|Overall Study||24
4981756|NCT02516163|12255237|P1|STARTED|Overall Study||52
4981757|NCT02516150|12255241|P1|NOT COMPLETED|Overall Study||0
4981758|NCT02516150|12255241|P1|COMPLETED|Overall Study||15
4981759|NCT02516150|12255241|P1|STARTED|Overall Study||15
4981760|NCT02516098|12255251|P2|NOT COMPLETED|Washout After Period 2||0
4981761|NCT02516098|12255252|P1|NOT COMPLETED|Washout After Period 2||0
4981762|NCT02516098|12255251|P2|COMPLETED|Washout After Period 2||26
4981763|NCT02516098|12255252|P1|COMPLETED|Washout After Period 2||27
4981764|NCT02516098|12255251|P2|STARTED|Washout After Period 2||26
4981765|NCT02516098|12255252|P1|STARTED|Washout After Period 2||27
4981766|NCT02516098|12255251|P2|NOT COMPLETED|Period 2||1
4981767|NCT02516098|12255252|P1|NOT COMPLETED|Period 2||0
4981768|NCT02516098|12255251|P2|COMPLETED|Period 2||26
4981769|NCT02516098|12255252|P1|COMPLETED|Period 2||27
4981770|NCT02516098|12255251|P2|STARTED|Period 2||27
4981771|NCT02516098|12255252|P1|STARTED|Period 2||27
4981772|NCT02516098|12255251|P2|NOT COMPLETED|Washout After Period 1||1
4981773|NCT02516098|12255252|P1|NOT COMPLETED|Washout After Period 1||0
4981774|NCT02516098|12255251|P2|COMPLETED|Washout After Period 1||27
4981775|NCT02516098|12255252|P1|COMPLETED|Washout After Period 1||27
4981776|NCT02516098|12255251|P2|STARTED|Washout After Period 1||28
4981777|NCT02516098|12255252|P1|STARTED|Washout After Period 1||27
4981778|NCT02516098|12255251|P2|NOT COMPLETED|Period 1||0
4981779|NCT02516098|12255252|P1|NOT COMPLETED|Period 1||1
4981780|NCT02516098|12255251|P2|COMPLETED|Period 1||28
4981781|NCT02516098|12255252|P1|COMPLETED|Period 1||27
4981782|NCT02516098|12255251|P2|STARTED|Period 1||28
4981783|NCT02516098|12255252|P1|STARTED|Period 1||28
4981784|NCT02515994|12255266|P2|NOT COMPLETED|Overall Study||7
4981785|NCT02515994|12255267|P1|NOT COMPLETED|Overall Study||10
4981786|NCT02515994|12255266|P2|COMPLETED|Overall Study||105
4981787|NCT02515994|12255267|P1|COMPLETED|Overall Study||99
4981788|NCT02515994|12255266|P2|STARTED|Overall Study||112
4981789|NCT02515994|12255267|P1|STARTED|Overall Study||109
4981790|NCT02515942|12255282|P3|NOT COMPLETED|Overall Study||4
4981791|NCT02515942|12255283|P2|NOT COMPLETED|Overall Study||3
4981792|NCT02515942|12255284|P1|NOT COMPLETED|Overall Study||7
4981793|NCT02515942|12255282|P3|COMPLETED|Overall Study||35
4981794|NCT02515942|12255283|P2|COMPLETED|Overall Study||36
4981795|NCT02515942|12255284|P1|COMPLETED|Overall Study||29
4981796|NCT02515942|12255282|P3|Completed Day 337|Overall Study||35
4981797|NCT02515942|12255283|P2|Completed Day 337|Overall Study||36
4981798|NCT02515942|12255284|P1|Completed Day 337|Overall Study||30
4981799|NCT02515942|12255282|P3|Completed Day 253|Overall Study||36
4981800|NCT02515942|12255283|P2|Completed Day 253|Overall Study||37
4981801|NCT02515942|12255284|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
4981802|NCT02515942|12255282|P3|Completed Day 169|Overall Study||37
4981803|NCT02515942|12255283|P2|Completed Day 169|Overall Study||37
4981804|NCT02515942|12255284|P1|Completed Day 169|Overall Study||32
4981805|NCT02515942|12255282|P3|Completed Day 85|Overall Study||37
4981806|NCT02515942|12255283|P2|Completed Day 85|Overall Study||38
4981807|NCT02515942|12255284|P1|Completed Day 85|Overall Study||35
4981808|NCT02515942|12255282|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
4981809|NCT02515942|12255283|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
4981810|NCT02515942|12255284|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
4981811|NCT02515942|12255282|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
4981812|NCT02515942|12255283|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
4981813|NCT02515942|12255284|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
4981814|NCT02515942|12255282|P3|Full Analysis Set (FAS)|Overall Study||38
4981815|NCT02515942|12255283|P2|Full Analysis Set (FAS)|Overall Study||37
4981816|NCT02515942|12255284|P1|Full Analysis Set (FAS)|Overall Study||35
4981817|NCT02515942|12255282|P3|Safety Analysis Set|Overall Study||39
4981818|NCT02515942|12255283|P2|Safety Analysis Set|Overall Study||39
4981819|NCT02515942|12255284|P1|Safety Analysis Set|Overall Study||36
4981820|NCT02515942|12255282|P3|STARTED|Overall Study||39
4981821|NCT02515942|12255283|P2|STARTED|Overall Study||39
4981822|NCT02515942|12255284|P1|STARTED|Overall Study||36
4981823|NCT02515890|12255336|P5|NOT COMPLETED|Overall Study||0
4981824|NCT02515890|12255337|P4|NOT COMPLETED|Overall Study||0
4981825|NCT02515890|12255338|P3|NOT COMPLETED|Overall Study||0
4981826|NCT02515890|12255339|P2|NOT COMPLETED|Overall Study||0
4981827|NCT02515890|12255340|P1|NOT COMPLETED|Overall Study||0
4981828|NCT02515890|12255336|P5|COMPLETED|Overall Study||8
4981829|NCT02515890|12255337|P4|COMPLETED|Overall Study||8
4981830|NCT02515890|12255338|P3|COMPLETED|Overall Study||5
4981831|NCT02515890|12255339|P2|COMPLETED|Overall Study||4
4981832|NCT02515890|12255340|P1|COMPLETED|Overall Study||7
4981833|NCT02515890|12255336|P5|STARTED|Overall Study||8
4981834|NCT02515890|12255337|P4|STARTED|Overall Study||8
4981835|NCT02515890|12255338|P3|STARTED|Overall Study||5
4981836|NCT02515890|12255339|P2|STARTED|Overall Study||4
4981837|NCT02515890|12255340|P1|STARTED|Overall Study||7
4981838|NCT02515851|12255353|P2|NOT COMPLETED|Overall Study||0
4981839|NCT02515851|12255354|P1|NOT COMPLETED|Overall Study||0
4981840|NCT02515851|12255353|P2|COMPLETED|Overall Study||15
4981841|NCT02515851|12255354|P1|COMPLETED|Overall Study||15
4981842|NCT02515851|12255353|P2|STARTED|Overall Study||15
4981843|NCT02515851|12255354|P1|STARTED|Overall Study||15
4981844|NCT02515669|12255370|P4|NOT COMPLETED|48 Week Open-Label Phase||0
4981845|NCT02515669|12255371|P3|NOT COMPLETED|48 Week Open-Label Phase||1
4981846|NCT02515669|12255372|P2|NOT COMPLETED|48 Week Open-Label Phase||0
4981847|NCT02515669|12255373|P1|NOT COMPLETED|48 Week Open-Label Phase||0
4981848|NCT02515669|12255370|P4|COMPLETED|48 Week Open-Label Phase||26
4981849|NCT02515669|12255371|P3|COMPLETED|48 Week Open-Label Phase||7
4981850|NCT02515669|12255372|P2|COMPLETED|48 Week Open-Label Phase||9
4981851|NCT02515669|12255373|P1|COMPLETED|48 Week Open-Label Phase||0
4981852|NCT02515669|12255370|P4|STARTED|48 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
4981853|NCT02515669|12255371|P3|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
4981854|NCT02515669|12255372|P2|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
4981855|NCT02515669|12255373|P1|STARTED|48 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
4981856|NCT02515669|12255370|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
4981857|NCT02515669|12255371|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
4981858|NCT02515669|12255372|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
4981859|NCT02515669|12255373|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
4981860|NCT02515669|12255370|P4|COMPLETED|24 Week Double-Blind Phase||19
4981861|NCT02515669|12255371|P3|COMPLETED|24 Week Double-Blind Phase||6
4981862|NCT02515669|12255372|P2|COMPLETED|24 Week Double-Blind Phase||7
4981863|NCT02515669|12255373|P1|COMPLETED|24 Week Double-Blind Phase||11
4981864|NCT02515669|12255370|P4|STARTED|24 Week Double-Blind Phase||19
4981865|NCT02515669|12255371|P3|STARTED|24 Week Double-Blind Phase||6
4981866|NCT02515669|12255372|P2|STARTED|24 Week Double-Blind Phase||7
4981867|NCT02515669|12255373|P1|STARTED|24 Week Double-Blind Phase||11
4981868|NCT02515656|12255438|P2|NOT COMPLETED|Overall Study||71
4981869|NCT02515656|12255439|P1|NOT COMPLETED|Overall Study||56
4981870|NCT02515656|12255438|P2|COMPLETED|Overall Study||261
4981871|NCT02515656|12255439|P1|COMPLETED|Overall Study||270
4981872|NCT02515656|12255438|P2|Safety Population|Overall Study||328
4981873|NCT02515656|12255439|P1|Safety Population|Overall Study||325
4981874|NCT02515656|12255438|P2|Per Protocol Set (PPS)|Overall Study||275
4981875|NCT02515656|12255439|P1|Per Protocol Set (PPS)|Overall Study||277
4981876|NCT02515656|12255438|P2|Full Analysis Set (FAS)|Overall Study||309
4981877|NCT02515656|12255439|P1|Full Analysis Set (FAS)|Overall Study||302
4981878|NCT02515656|12255438|P2|STARTED|Overall Study||332
4981879|NCT02515656|12255439|P1|STARTED|Overall Study||326
4981880|NCT02515331|12255458|P3|NOT COMPLETED|Overall Study||4
4981881|NCT02515331|12255459|P2|NOT COMPLETED|Overall Study||0
4981882|NCT02515331|12255460|P1|NOT COMPLETED|Overall Study||2
4981883|NCT02515331|12255458|P3|COMPLETED|Overall Study||28
4981884|NCT02515331|12255459|P2|COMPLETED|Overall Study||15
4981885|NCT02515331|12255460|P1|COMPLETED|Overall Study||15
4981886|NCT02515331|12255458|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
4981887|NCT02515331|12255459|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
4981888|NCT02515331|12255460|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
4981889|NCT02515331|12255458|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
4981890|NCT02515331|12255459|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
4981891|NCT02515331|12255460|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
4981892|NCT02515331|12255458|P3|STARTED|Overall Study||32
4981893|NCT02515331|12255459|P2|STARTED|Overall Study||15
4981894|NCT02515331|12255460|P1|STARTED|Overall Study||17
4981895|NCT02515279|12255481|P1|NOT COMPLETED|Overall Study||104
4981896|NCT02515279|12255481|P1|COMPLETED|Overall Study||359
4981897|NCT02515279|12255481|P1|STARTED|Overall Study||463
4981898|NCT02515253|12255489|P2|NOT COMPLETED|Overall Study||8
4981899|NCT02515253|12255490|P1|NOT COMPLETED|Overall Study||7
4981900|NCT02515253|12255489|P2|COMPLETED|Overall Study||8
4981901|NCT02515253|12255490|P1|COMPLETED|Overall Study||10
4981902|NCT02515253|12255489|P2|STARTED|Overall Study||16
4981903|NCT02515253|12255490|P1|STARTED|Overall Study||17
4981904|NCT02515097|12255500|P2|NOT COMPLETED|Overall Study||6
4981905|NCT02515097|12255501|P1|NOT COMPLETED|Overall Study||7
4981906|NCT02515097|12255500|P2|COMPLETED|Overall Study||65
4981907|NCT02515097|12255501|P1|COMPLETED|Overall Study||135
4981908|NCT02515097|12255500|P2|Safety Population|Overall Study||70
4981909|NCT02515097|12255501|P1|Safety Population|Overall Study||142
4981910|NCT02515097|12255500|P2|Intent-to-Treat (ITT) Population|Overall Study||71
4981911|NCT02515097|12255501|P1|Intent-to-Treat (ITT) Population|Overall Study||142
4981912|NCT02515097|12255500|P2|STARTED|Overall Study||71
4981913|NCT02515097|12255501|P1|STARTED|Overall Study||142
4981914|NCT02515058|12255511|P2|NOT COMPLETED|Overall Study||2
4981915|NCT02515058|12255512|P1|NOT COMPLETED|Overall Study||3
4981916|NCT02515058|12255511|P2|COMPLETED|Overall Study||20
4981917|NCT02515058|12255512|P1|COMPLETED|Overall Study||18
4981918|NCT02515058|12255511|P2|STARTED|Overall Study||22
4981919|NCT02515058|12255512|P1|STARTED|Overall Study||21
4981920|NCT02515045|12255522|P3|NOT COMPLETED|Overall Study||4
4981921|NCT02515045|12255523|P2|NOT COMPLETED|Overall Study||4
4981922|NCT02515045|12255524|P1|NOT COMPLETED|Overall Study||0
4981923|NCT02515045|12255522|P3|COMPLETED|Overall Study||55
4981924|NCT02515045|12255523|P2|COMPLETED|Overall Study||26
4981925|NCT02515045|12255524|P1|COMPLETED|Overall Study||29
4981926|NCT02515045|12255522|P3|STARTED|Overall Study||59
4981927|NCT02515045|12255523|P2|STARTED|Overall Study||30
4981928|NCT02515045|12255524|P1|STARTED|Overall Study||29
4981929|NCT02514889|12255540|P2|NOT COMPLETED|Follow-up Assessment Participation||12
4981930|NCT02514889|12255541|P1|NOT COMPLETED|Follow-up Assessment Participation||10
4981931|NCT02514889|12255540|P2|COMPLETED|Follow-up Assessment Participation||86
4981932|NCT02514889|12255541|P1|COMPLETED|Follow-up Assessment Participation||92
4981933|NCT02514889|12255540|P2|STARTED|Follow-up Assessment Participation||98
4981934|NCT02514889|12255541|P1|STARTED|Follow-up Assessment Participation||102
4981935|NCT02514889|12255540|P2|NOT COMPLETED|Intervention Participation||8
4981936|NCT02514889|12255541|P1|NOT COMPLETED|Intervention Participation||9
4981937|NCT02514889|12255540|P2|COMPLETED|Intervention Participation||98
4981938|NCT02514889|12255541|P1|COMPLETED|Intervention Participation||102
4981939|NCT02514889|12255540|P2|STARTED|Intervention Participation||106
4981940|NCT02514889|12255541|P1|STARTED|Intervention Participation||111
4981941|NCT02514889|12255540|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
4981942|NCT02514889|12255541|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
4981943|NCT02514889|12255540|P2|COMPLETED|Randomization/Allocation to Condition||106
4981944|NCT02514889|12255541|P1|COMPLETED|Randomization/Allocation to Condition||111
4981945|NCT02514889|12255540|P2|STARTED|Randomization/Allocation to Condition||130
4981946|NCT02514889|12255541|P1|STARTED|Randomization/Allocation to Condition||131
4981947|NCT02514772|12255561|P2|NOT COMPLETED|Overall Study||2
4981948|NCT02514772|12255562|P1|NOT COMPLETED|Overall Study||3
4981949|NCT02514772|12255561|P2|COMPLETED|Overall Study||52
4981950|NCT02514772|12255562|P1|COMPLETED|Overall Study||50
4981951|NCT02514772|12255561|P2|STARTED|Overall Study||54
4981952|NCT02514772|12255562|P1|STARTED|Overall Study||53
4981953|NCT02514577|12255576|P2|NOT COMPLETED|Overall Study||13
4981954|NCT02514577|12255577|P1|NOT COMPLETED|Overall Study||14
4981955|NCT02514577|12255576|P2|COMPLETED|Overall Study||61
4981956|NCT02514577|12255577|P1|COMPLETED|Overall Study||129
4981957|NCT02514577|12255576|P2|Safety Population|Overall Study||72
4981958|NCT02514577|12255577|P1|Safety Population|Overall Study||142
4981959|NCT02514577|12255576|P2|Intent-to-Treat (ITT) Population|Overall Study||74
4981960|NCT02514577|12255577|P1|Intent-to-Treat (ITT) Population|Overall Study||143
4981961|NCT02514577|12255576|P2|STARTED|Overall Study||74
4981962|NCT02514577|12255577|P1|STARTED|Overall Study||143
4981963|NCT02514551|12255587|P2|NOT COMPLETED|Overall Study||3
4981964|NCT02514551|12255588|P1|NOT COMPLETED|Overall Study||0
4981965|NCT02514551|12255587|P2|COMPLETED|Overall Study||119
4981966|NCT02514551|12255588|P1|COMPLETED|Overall Study||123
4981967|NCT02514551|12255587|P2|Received at Least One Dose of Study Drug|Overall Study||120
4981968|NCT02514551|12255588|P1|Received at Least One Dose of Study Drug|Overall Study||123
4981969|NCT02514551|12255587|P2|STARTED|Overall Study||122
4981970|NCT02514551|12255588|P1|STARTED|Overall Study||123
4981971|NCT02514473|12255605|P2|NOT COMPLETED|Overall Study||5
4981972|NCT02514473|12255606|P1|NOT COMPLETED|Overall Study||3
4981973|NCT02514473|12255605|P2|COMPLETED|Overall Study||98
4981974|NCT02514473|12255606|P1|COMPLETED|Overall Study||98
4981975|NCT02514473|12255605|P2|STARTED|Overall Study||103
4981976|NCT02514473|12255606|P1|STARTED|Overall Study||101
4981977|NCT02514174|12255647|P1|NOT COMPLETED|Overall Study||25
4981978|NCT02514174|12255647|P1|COMPLETED|Overall Study||0
4981979|NCT02514174|12255647|P1|STARTED|Overall Study||25
4981980|NCT02514122|12255658|P2|NOT COMPLETED|Overall Study||0
4981981|NCT02514122|12255659|P1|NOT COMPLETED|Overall Study||2
4981982|NCT02514122|12255658|P2|COMPLETED|Overall Study||29
4981983|NCT02514122|12255659|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
4981984|NCT02514122|12255658|P2|STARTED|Overall Study||29
4981985|NCT02514122|12255659|P1|STARTED|Overall Study||32
4981986|NCT02514044|12255667|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
4981987|NCT02514044|12255667|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
4981988|NCT02514044|12255667|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
4981989|NCT02514044|12255667|P1|NOT COMPLETED|Washout (1 Week)||0
4981990|NCT02514044|12255667|P1|COMPLETED|Washout (1 Week)||10
4981991|NCT02514044|12255667|P1|STARTED|Washout (1 Week)||10
4981992|NCT02514044|12255667|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
4981993|NCT02514044|12255667|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
4981994|NCT02514044|12255667|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
4981995|NCT02513940|12255681|P6|NOT COMPLETED|Overall Study||0
4981996|NCT02513940|12255682|P5|NOT COMPLETED|Overall Study||0
4981997|NCT02513940|12255683|P4|NOT COMPLETED|Overall Study||0
4981998|NCT02513940|12255684|P3|NOT COMPLETED|Overall Study||0
4981999|NCT02513940|12255685|P2|NOT COMPLETED|Overall Study||0
4982000|NCT02513940|12255686|P1|NOT COMPLETED|Overall Study||0
4982001|NCT02513940|12255681|P6|COMPLETED|Overall Study||3
4982002|NCT02513940|12255682|P5|COMPLETED|Overall Study||2
4982003|NCT02513940|12255683|P4|COMPLETED|Overall Study||2
4982004|NCT02513940|12255684|P3|COMPLETED|Overall Study||2
4982005|NCT02513940|12255685|P2|COMPLETED|Overall Study||3
4982006|NCT02513940|12255686|P1|COMPLETED|Overall Study||2
4982007|NCT02513940|12255681|P6|STARTED|Overall Study||3
4982008|NCT02513940|12255682|P5|STARTED|Overall Study||2
4982009|NCT02513940|12255683|P4|STARTED|Overall Study||2
4982010|NCT02513940|12255684|P3|STARTED|Overall Study||2
4982011|NCT02513940|12255685|P2|STARTED|Overall Study||3
4982012|NCT02513940|12255686|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
4982013|NCT02513823|12255706|P1|NOT COMPLETED|Overall Study||5
4982014|NCT02513823|12255706|P1|COMPLETED|Overall Study||22
4982015|NCT02513823|12255706|P1|STARTED|Overall Study||27
4982016|NCT02513771|12255713|P2|NOT COMPLETED|Overall Study||1
4982017|NCT02513771|12255714|P1|NOT COMPLETED|Overall Study||2
4982018|NCT02513771|12255713|P2|COMPLETED|Overall Study||44
4982019|NCT02513771|12255714|P1|COMPLETED|Overall Study||43
4982020|NCT02513771|12255713|P2|STARTED|Overall Study||45
4982021|NCT02513771|12255714|P1|STARTED|Overall Study||45
4982022|NCT02513745|12255752|P2|NOT COMPLETED|Overall Study||3
4982023|NCT02513745|12255753|P1|NOT COMPLETED|Overall Study||3
4982024|NCT02513745|12255752|P2|COMPLETED|Overall Study||39
4982025|NCT02513745|12255753|P1|COMPLETED|Overall Study||39
4982026|NCT02513745|12255752|P2|STARTED|Overall Study||42
4982027|NCT02513745|12255753|P1|STARTED|Overall Study||42
4982028|NCT02513732|12255763|P1|NOT COMPLETED|Overall Study||0
4982029|NCT02513732|12255763|P1|COMPLETED|Overall Study||100
4982030|NCT02513732|12255763|P1|STARTED|Overall Study||100
4982031|NCT02513719|12255893|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||19
4982032|NCT02513719|12255893|P1|COMPLETED|At 5 Years Clinical Follow-up||254
4982033|NCT02513719|12255893|P1|STARTED|At 5 Years Clinical Follow-up||273
4982034|NCT02513719|12255893|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
4982035|NCT02513719|12255893|P1|COMPLETED|At 4 Years Clinical Follow-up||273
4982036|NCT02513719|12255893|P1|STARTED|At 4 Years Clinical Follow-up||289
4982037|NCT02513719|12255893|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
4982038|NCT02513719|12255893|P1|COMPLETED|At 3 Years Clinical Follow-up||289
4982039|NCT02513719|12255893|P1|STARTED|At 3 Years Clinical Follow-up||300
4982040|NCT02513719|12255893|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
4982041|NCT02513719|12255893|P1|COMPLETED|At 2 Years Clinical Follow-up||300
4982042|NCT02513719|12255893|P1|STARTED|At 2 Years Clinical Follow-up||305
4982043|NCT02513719|12255893|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
4982044|NCT02513719|12255893|P1|COMPLETED|At 1 Year Clinical Follow-up||305
4982045|NCT02513719|12255893|P1|STARTED|At 1 Year Clinical Follow-up||312
4982046|NCT02513719|12255893|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
4982047|NCT02513719|12255893|P1|COMPLETED|At 8 Months Clinical Follow-up||312
4982048|NCT02513719|12255893|P1|STARTED|At 8 Months Clinical Follow-up||312
4982049|NCT02513641|12255993|P1|NOT COMPLETED|Overall Study||0
4982050|NCT02513641|12255993|P1|COMPLETED|Overall Study||8
4982051|NCT02513641|12255993|P1|STARTED|Overall Study||8
4982052|NCT02513550|12256007|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
4982053|NCT02513550|12256008|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
4982054|NCT02513550|12256009|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
4982055|NCT02513550|12256010|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
4982056|NCT02513550|12256011|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
4982057|NCT02513550|12256012|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
4982058|NCT02513550|12256007|P6|COMPLETED|Post-Treatment Follow-up Period||15
4982059|NCT02513550|12256008|P5|COMPLETED|Post-Treatment Follow-up Period||4
4982060|NCT02513550|12256009|P4|COMPLETED|Post-Treatment Follow-up Period||9
4982061|NCT02513550|12256010|P3|COMPLETED|Post-Treatment Follow-up Period||496
4982062|NCT02513550|12256011|P2|COMPLETED|Post-Treatment Follow-up Period||244
4982063|NCT02513550|12256012|P1|COMPLETED|Post-Treatment Follow-up Period||254
4982064|NCT02513550|12256007|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
4982065|NCT02513550|12256008|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
4982066|NCT02513550|12256009|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
4982067|NCT02513550|12256010|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
4982068|NCT02513550|12256011|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
4982069|NCT02513550|12256012|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
4982070|NCT02513550|12256007|P6|NOT COMPLETED|Double Blind Treatment Period||1
4982071|NCT02513550|12256008|P5|NOT COMPLETED|Double Blind Treatment Period||1
4982072|NCT02513550|12256009|P4|NOT COMPLETED|Double Blind Treatment Period||0
4982073|NCT02513550|12256010|P3|NOT COMPLETED|Double Blind Treatment Period||74
4982074|NCT02513550|12256011|P2|NOT COMPLETED|Double Blind Treatment Period||38
4982075|NCT02513550|12256012|P1|NOT COMPLETED|Double Blind Treatment Period||36
4982076|NCT02513550|12256007|P6|COMPLETED|Double Blind Treatment Period||15
4982077|NCT02513550|12256008|P5|COMPLETED|Double Blind Treatment Period||4
4982078|NCT02513550|12256009|P4|COMPLETED|Double Blind Treatment Period||9
4982079|NCT02513550|12256010|P3|COMPLETED|Double Blind Treatment Period||537
4982080|NCT02513550|12256011|P2|COMPLETED|Double Blind Treatment Period||268
4982081|NCT02513550|12256012|P1|COMPLETED|Double Blind Treatment Period||274
4982082|NCT02513550|12256007|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
4982083|NCT02513550|12256008|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
4982084|NCT02513550|12256009|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
4982085|NCT02513550|12256010|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
4982086|NCT02513550|12256011|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
4982087|NCT02513550|12256012|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
4982088|NCT02513550|12256007|P6|STARTED|Double Blind Treatment Period||16
4982089|NCT02513550|12256008|P5|STARTED|Double Blind Treatment Period||5
4982090|NCT02513550|12256009|P4|STARTED|Double Blind Treatment Period||9
4982091|NCT02513550|12256010|P3|STARTED|Double Blind Treatment Period||611
4982092|NCT02513550|12256011|P2|STARTED|Double Blind Treatment Period||306
4982093|NCT02513550|12256012|P1|STARTED|Double Blind Treatment Period||310
4982094|NCT02513498|12256084|P1|NOT COMPLETED|Overall Study||24
4982095|NCT02513498|12256084|P1|COMPLETED|Overall Study||26
4982096|NCT02513498|12256084|P1|STARTED|Overall Study||50
4982097|NCT02513459|12256104|P1|NOT COMPLETED|Overall Study||21
4982098|NCT02513459|12256104|P1|COMPLETED|Overall Study||44
4982099|NCT02513459|12256104|P1|STARTED|Overall Study||65
4982100|NCT02513446|12256145|P2|NOT COMPLETED|Period 2||0
4982101|NCT02513446|12256146|P1|NOT COMPLETED|Period 2||0
4982102|NCT02513446|12256145|P2|COMPLETED|Period 2||8
4982103|NCT02513446|12256146|P1|COMPLETED|Period 2||8
4982104|NCT02513446|12256145|P2|STARTED|Period 2||8
4982105|NCT02513446|12256146|P1|STARTED|Period 2||8
4982106|NCT02513446|12256145|P2|NOT COMPLETED|Washout Period of 10 Days||0
4982107|NCT02513446|12256146|P1|NOT COMPLETED|Washout Period of 10 Days||0
4982108|NCT02513446|12256145|P2|COMPLETED|Washout Period of 10 Days||8
4982109|NCT02513446|12256146|P1|COMPLETED|Washout Period of 10 Days||8
4982110|NCT02513446|12256145|P2|STARTED|Washout Period of 10 Days||8
4982111|NCT02513446|12256146|P1|STARTED|Washout Period of 10 Days||8
4982112|NCT02513446|12256145|P2|NOT COMPLETED|Period 1||0
4982113|NCT02513446|12256146|P1|NOT COMPLETED|Period 1||0
4982114|NCT02513446|12256145|P2|COMPLETED|Period 1||8
4982115|NCT02513446|12256146|P1|COMPLETED|Period 1||8
4982116|NCT02513446|12256145|P2|STARTED|Period 1||8
4982117|NCT02513446|12256146|P1|STARTED|Period 1||8
4982118|NCT02513160|12256161|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
4982119|NCT02513160|12256162|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
4982120|NCT02513160|12256163|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
4982121|NCT02513160|12256164|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
4982122|NCT02513160|12256161|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
4982123|NCT02513160|12256162|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
4982124|NCT02513160|12256163|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
4982125|NCT02513160|12256164|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
4982126|NCT02513160|12256161|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
4982127|NCT02513160|12256162|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
4982128|NCT02513160|12256163|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
4982129|NCT02513160|12256164|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
4982130|NCT02513160|12256161|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982131|NCT02513160|12256162|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982132|NCT02513160|12256163|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982133|NCT02513160|12256164|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
4982134|NCT02513160|12256161|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982135|NCT02513160|12256162|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982136|NCT02513160|12256163|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4982137|NCT02513160|12256164|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
4982138|NCT02513160|12256161|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
4982139|NCT02513160|12256162|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
4982140|NCT02513160|12256163|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
4982141|NCT02513160|12256164|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
4982142|NCT02513121|12256201|P2|NOT COMPLETED|Overall Study||0
4982143|NCT02513121|12256202|P1|NOT COMPLETED|Overall Study||0
4982144|NCT02513121|12256201|P2|COMPLETED|Overall Study||20
4982145|NCT02513121|12256202|P1|COMPLETED|Overall Study||20
4982146|NCT02513121|12256201|P2|STARTED|Overall Study||20
4982147|NCT02513121|12256202|P1|STARTED|Overall Study||20
4982148|NCT02513095|12256222|P2|NOT COMPLETED|Overall Study||16
4982149|NCT02513095|12256223|P1|NOT COMPLETED|Overall Study||14
4982150|NCT02513095|12256222|P2|COMPLETED|Overall Study||1
4982151|NCT02513095|12256223|P1|COMPLETED|Overall Study||3
4982152|NCT02513095|12256222|P2|STARTED|Overall Study||17
4982153|NCT02513095|12256223|P1|STARTED|Overall Study||17
4982154|NCT02512900|12256231|P2|NOT COMPLETED|Overall Study||0
4982155|NCT02512900|12256232|P1|NOT COMPLETED|Overall Study||0
4982156|NCT02512900|12256231|P2|COMPLETED|Overall Study||10
4982157|NCT02512900|12256232|P1|COMPLETED|Overall Study||11
4982158|NCT02512900|12256231|P2|STARTED|Overall Study||10
4982159|NCT02512900|12256232|P1|STARTED|Overall Study||11
4982160|NCT02512874|12256263|P1|NOT COMPLETED|Overall Study||2
4982161|NCT02512874|12256263|P1|COMPLETED|Overall Study||63
4982162|NCT02512874|12256263|P1|STARTED|Overall Study||65
4982163|NCT02512861|12256274|P2|NOT COMPLETED|Overall Study||9
4982164|NCT02512861|12256275|P1|NOT COMPLETED|Overall Study||6
4982165|NCT02512861|12256274|P2|COMPLETED|Overall Study||40
4982166|NCT02512861|12256275|P1|COMPLETED|Overall Study||38
4982167|NCT02512861|12256274|P2|STARTED|Overall Study||49
4982168|NCT02512861|12256275|P1|STARTED|Overall Study||44
4982169|NCT02512809|12256296|P1|NOT COMPLETED|Overall Study||0
4982170|NCT02512809|12256296|P1|COMPLETED|Overall Study||25
4982171|NCT02512809|12256296|P1|STARTED|Overall Study||25
4982172|NCT02512783|12256302|P2|NOT COMPLETED|Overall Study||0
4982173|NCT02512783|12256303|P1|NOT COMPLETED|Overall Study||0
4982174|NCT02512783|12256302|P2|COMPLETED|Overall Study||75
4982175|NCT02512783|12256303|P1|COMPLETED|Overall Study||96
4982176|NCT02512783|12256302|P2|STARTED|Overall Study||75
4982177|NCT02512783|12256303|P1|STARTED|Overall Study||96
4982178|NCT02512679|12256311|P2|NOT COMPLETED|Overall Study||0
4982179|NCT02512679|12256312|P1|NOT COMPLETED|Overall Study||0
4982180|NCT02512679|12256311|P2|COMPLETED|Overall Study||0
4982181|NCT02512679|12256312|P1|COMPLETED|Overall Study||20
4982182|NCT02512679|12256311|P2|STARTED|Overall Study||0
4982183|NCT02512679|12256312|P1|STARTED|Overall Study||20
4982184|NCT02512575|12256330|P10|NOT COMPLETED|Overall Study||0
4982185|NCT02512575|12256331|P9|NOT COMPLETED|Overall Study||0
4982186|NCT02512575|12256332|P8|NOT COMPLETED|Overall Study||0
4982187|NCT02512575|12256333|P7|NOT COMPLETED|Overall Study||0
4982188|NCT02512575|12256334|P6|NOT COMPLETED|Overall Study||0
4982189|NCT02512575|12256335|P5|NOT COMPLETED|Overall Study||0
4982190|NCT02512575|12256336|P4|NOT COMPLETED|Overall Study||0
4982191|NCT02512575|12256337|P3|NOT COMPLETED|Overall Study||0
4982192|NCT02512575|12256338|P2|NOT COMPLETED|Overall Study||0
4982193|NCT02512575|12256339|P1|NOT COMPLETED|Overall Study||0
4982194|NCT02512575|12256330|P10|COMPLETED|Overall Study||18
4982195|NCT02512575|12256331|P9|COMPLETED|Overall Study||6
4982196|NCT02512575|12256332|P8|COMPLETED|Overall Study||6
4982197|NCT02512575|12256333|P7|COMPLETED|Overall Study||6
4982198|NCT02512575|12256334|P6|COMPLETED|Overall Study||6
4982199|NCT02512575|12256335|P5|COMPLETED|Overall Study||6
4982200|NCT02512575|12256336|P4|COMPLETED|Overall Study||6
4982201|NCT02512575|12256337|P3|COMPLETED|Overall Study||6
4982202|NCT02512575|12256338|P2|COMPLETED|Overall Study||6
4982203|NCT02512575|12256339|P1|COMPLETED|Overall Study||6
4982204|NCT02512575|12256330|P10|STARTED|Overall Study||18
4982205|NCT02512575|12256331|P9|STARTED|Overall Study||6
4982206|NCT02512575|12256332|P8|STARTED|Overall Study||6
4982207|NCT02512575|12256333|P7|STARTED|Overall Study||6
4982208|NCT02512575|12256334|P6|STARTED|Overall Study||6
4982209|NCT02512575|12256335|P5|STARTED|Overall Study||6
4982210|NCT02512575|12256336|P4|STARTED|Overall Study||6
4982211|NCT02512575|12256337|P3|STARTED|Overall Study||6
4982212|NCT02512575|12256338|P2|STARTED|Overall Study||6
4982213|NCT02512575|12256339|P1|STARTED|Overall Study||6
4982214|NCT02512510|12256434|P3|NOT COMPLETED|Overall Study||52
4982215|NCT02512510|12256435|P2|NOT COMPLETED|Overall Study||35
4982216|NCT02512510|12256436|P1|NOT COMPLETED|Overall Study||42
4982217|NCT02512510|12256434|P3|COMPLETED|Overall Study||157
4982218|NCT02512510|12256435|P2|COMPLETED|Overall Study||162
4982219|NCT02512510|12256436|P1|COMPLETED|Overall Study||163
4982220|NCT02512510|12256434|P3|STARTED|Overall Study||209
4982221|NCT02512510|12256435|P2|STARTED|Overall Study||197
4982222|NCT02512510|12256436|P1|STARTED|Overall Study||205
4982223|NCT02512419|12256461|P2|NOT COMPLETED|Overall Study||0
4982224|NCT02512419|12256462|P1|NOT COMPLETED|Overall Study||2
4982225|NCT02512419|12256461|P2|COMPLETED|Overall Study||24
4982226|NCT02512419|12256462|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
4982227|NCT02512419|12256461|P2|STARTED|Overall Study||24
4982228|NCT02512419|12256462|P1|STARTED|Overall Study||24
4982229|NCT02512393|12256472|P2|NOT COMPLETED|Overall Study||0
4982230|NCT02512393|12256473|P1|NOT COMPLETED|Overall Study||1
4982231|NCT02512393|12256472|P2|COMPLETED|Overall Study||20
4982232|NCT02512393|12256473|P1|COMPLETED|Overall Study||20
4982233|NCT02512393|12256472|P2|STARTED|Overall Study||20
4982234|NCT02512393|12256473|P1|STARTED|Overall Study||21
4982235|NCT02512302|12256553|P10|NOT COMPLETED|Period 5||0
4982236|NCT02512302|12256554|P9|NOT COMPLETED|Period 5||0
4982237|NCT02512302|12256555|P8|NOT COMPLETED|Period 5||0
4982238|NCT02512302|12256556|P7|NOT COMPLETED|Period 5||0
4982239|NCT02512302|12256557|P6|NOT COMPLETED|Period 5||0
4982240|NCT02512302|12256558|P5|NOT COMPLETED|Period 5||0
4982241|NCT02512302|12256559|P4|NOT COMPLETED|Period 5||0
4982242|NCT02512302|12256560|P3|NOT COMPLETED|Period 5||0
4982243|NCT02512302|12256561|P2|NOT COMPLETED|Period 5||0
4982244|NCT02512302|12256562|P1|NOT COMPLETED|Period 5||0
4982245|NCT02512302|12256553|P10|COMPLETED|Period 5||2
4982246|NCT02512302|12256554|P9|COMPLETED|Period 5||3
4982247|NCT02512302|12256555|P8|COMPLETED|Period 5||3
4982248|NCT02512302|12256556|P7|COMPLETED|Period 5||1
4982249|NCT02512302|12256557|P6|COMPLETED|Period 5||3
4982250|NCT02512302|12256558|P5|COMPLETED|Period 5||3
4982251|NCT02512302|12256559|P4|COMPLETED|Period 5||3
4982252|NCT02512302|12256560|P3|COMPLETED|Period 5||3
4982253|NCT02512302|12256561|P2|COMPLETED|Period 5||2
4982254|NCT02512302|12256562|P1|COMPLETED|Period 5||3
4982255|NCT02512302|12256553|P10|STARTED|Period 5||2
4982256|NCT02512302|12256554|P9|STARTED|Period 5||3
4982257|NCT02512302|12256555|P8|STARTED|Period 5||3
4982258|NCT02512302|12256556|P7|STARTED|Period 5||1
4982259|NCT02512302|12256557|P6|STARTED|Period 5||3
4982260|NCT02512302|12256558|P5|STARTED|Period 5||3
4982261|NCT02512302|12256559|P4|STARTED|Period 5||3
4982262|NCT02512302|12256560|P3|STARTED|Period 5||3
4982263|NCT02512302|12256561|P2|STARTED|Period 5||2
4982264|NCT02512302|12256562|P1|STARTED|Period 5||3
4982265|NCT02512302|12256553|P10|NOT COMPLETED|Period 4||0
4982266|NCT02512302|12256554|P9|NOT COMPLETED|Period 4||0
4982267|NCT02512302|12256555|P8|NOT COMPLETED|Period 4||0
4982268|NCT02512302|12256556|P7|NOT COMPLETED|Period 4||1
4982269|NCT02512302|12256557|P6|NOT COMPLETED|Period 4||0
4982270|NCT02512302|12256558|P5|NOT COMPLETED|Period 4||0
4982271|NCT02512302|12256559|P4|NOT COMPLETED|Period 4||0
4982272|NCT02512302|12256560|P3|NOT COMPLETED|Period 4||0
4982273|NCT02512302|12256561|P2|NOT COMPLETED|Period 4||0
4982274|NCT02512302|12256562|P1|NOT COMPLETED|Period 4||0
4982275|NCT02512302|12256553|P10|COMPLETED|Period 4||2
4982276|NCT02512302|12256554|P9|COMPLETED|Period 4||3
4982277|NCT02512302|12256555|P8|COMPLETED|Period 4||3
4982278|NCT02512302|12256556|P7|COMPLETED|Period 4||1
4982279|NCT02512302|12256557|P6|COMPLETED|Period 4||3
4982280|NCT02512302|12256558|P5|COMPLETED|Period 4||3
4982281|NCT02512302|12256559|P4|COMPLETED|Period 4||3
4982282|NCT02512302|12256560|P3|COMPLETED|Period 4||3
4982283|NCT02512302|12256561|P2|COMPLETED|Period 4||2
4982284|NCT02512302|12256562|P1|COMPLETED|Period 4||3
4982285|NCT02512302|12256553|P10|STARTED|Period 4||2
4982286|NCT02512302|12256554|P9|STARTED|Period 4||3
4982287|NCT02512302|12256555|P8|STARTED|Period 4||3
4982288|NCT02512302|12256556|P7|STARTED|Period 4||2
4982289|NCT02512302|12256557|P6|STARTED|Period 4||3
4982290|NCT02512302|12256558|P5|STARTED|Period 4||3
4982291|NCT02512302|12256559|P4|STARTED|Period 4||3
4982292|NCT02512302|12256560|P3|STARTED|Period 4||3
4982293|NCT02512302|12256561|P2|STARTED|Period 4||2
4982294|NCT02512302|12256562|P1|STARTED|Period 4||3
4982295|NCT02512302|12256553|P10|NOT COMPLETED|Period 3||0
4982296|NCT02512302|12256554|P9|NOT COMPLETED|Period 3||0
4982297|NCT02512302|12256555|P8|NOT COMPLETED|Period 3||0
4982298|NCT02512302|12256556|P7|NOT COMPLETED|Period 3||0
4982299|NCT02512302|12256557|P6|NOT COMPLETED|Period 3||0
4982300|NCT02512302|12256558|P5|NOT COMPLETED|Period 3||0
4982301|NCT02512302|12256559|P4|NOT COMPLETED|Period 3||0
4982302|NCT02512302|12256560|P3|NOT COMPLETED|Period 3||1
4982303|NCT02512302|12256561|P2|NOT COMPLETED|Period 3||0
4982304|NCT02512302|12256562|P1|NOT COMPLETED|Period 3||0
4982305|NCT02512302|12256553|P10|COMPLETED|Period 3||2
4982306|NCT02512302|12256554|P9|COMPLETED|Period 3||3
4982307|NCT02512302|12256555|P8|COMPLETED|Period 3||3
4982308|NCT02512302|12256556|P7|COMPLETED|Period 3||2
4982309|NCT02512302|12256557|P6|COMPLETED|Period 3||3
4982310|NCT02512302|12256558|P5|COMPLETED|Period 3||3
4982311|NCT02512302|12256559|P4|COMPLETED|Period 3||3
4982312|NCT02512302|12256560|P3|COMPLETED|Period 3||3
4982313|NCT02512302|12256561|P2|COMPLETED|Period 3||2
4982314|NCT02512302|12256562|P1|COMPLETED|Period 3||3
4982315|NCT02512302|12256553|P10|STARTED|Period 3||2
4982316|NCT02512302|12256554|P9|STARTED|Period 3||3
4982317|NCT02512302|12256555|P8|STARTED|Period 3||3
4982318|NCT02512302|12256556|P7|STARTED|Period 3||2
4982319|NCT02512302|12256557|P6|STARTED|Period 3||3
4982320|NCT02512302|12256558|P5|STARTED|Period 3||3
4982321|NCT02512302|12256559|P4|STARTED|Period 3||3
4982322|NCT02512302|12256560|P3|STARTED|Period 3||4
4982323|NCT02512302|12256561|P2|STARTED|Period 3||2
4982324|NCT02512302|12256562|P1|STARTED|Period 3||3
4982325|NCT02512302|12256553|P10|NOT COMPLETED|Period 2||1
4982326|NCT02512302|12256554|P9|NOT COMPLETED|Period 2||0
4982327|NCT02512302|12256555|P8|NOT COMPLETED|Period 2||0
4982328|NCT02512302|12256556|P7|NOT COMPLETED|Period 2||0
4982329|NCT02512302|12256557|P6|NOT COMPLETED|Period 2||0
4982330|NCT02512302|12256558|P5|NOT COMPLETED|Period 2||0
4982331|NCT02512302|12256559|P4|NOT COMPLETED|Period 2||0
4982332|NCT02512302|12256560|P3|NOT COMPLETED|Period 2||0
4982333|NCT02512302|12256561|P2|NOT COMPLETED|Period 2||0
4982334|NCT02512302|12256562|P1|NOT COMPLETED|Period 2||0
4982335|NCT02512302|12256553|P10|COMPLETED|Period 2||2
4982336|NCT02512302|12256554|P9|COMPLETED|Period 2||3
4982337|NCT02512302|12256555|P8|COMPLETED|Period 2||3
4982338|NCT02512302|12256556|P7|COMPLETED|Period 2||2
4982339|NCT02512302|12256557|P6|COMPLETED|Period 2||3
4982340|NCT02512302|12256558|P5|COMPLETED|Period 2||3
4982341|NCT02512302|12256559|P4|COMPLETED|Period 2||3
4982342|NCT02512302|12256560|P3|COMPLETED|Period 2||4
4982343|NCT02512302|12256561|P2|COMPLETED|Period 2||2
4982344|NCT02512302|12256562|P1|COMPLETED|Period 2||3
4982345|NCT02512302|12256553|P10|STARTED|Period 2||3
4982346|NCT02512302|12256554|P9|STARTED|Period 2||3
4982347|NCT02512302|12256555|P8|STARTED|Period 2||3
4982348|NCT02512302|12256556|P7|STARTED|Period 2||2
4982349|NCT02512302|12256557|P6|STARTED|Period 2||3
4982350|NCT02512302|12256558|P5|STARTED|Period 2||3
4982351|NCT02512302|12256559|P4|STARTED|Period 2||3
4982352|NCT02512302|12256560|P3|STARTED|Period 2||4
4982353|NCT02512302|12256561|P2|STARTED|Period 2||2
4982354|NCT02512302|12256562|P1|STARTED|Period 2||3
4982355|NCT02512302|12256553|P10|NOT COMPLETED|Period 1||0
4982356|NCT02512302|12256554|P9|NOT COMPLETED|Period 1||0
4982357|NCT02512302|12256555|P8|NOT COMPLETED|Period 1||0
4982358|NCT02512302|12256556|P7|NOT COMPLETED|Period 1||0
4982359|NCT02512302|12256557|P6|NOT COMPLETED|Period 1||0
4982360|NCT02512302|12256558|P5|NOT COMPLETED|Period 1||0
4982361|NCT02512302|12256559|P4|NOT COMPLETED|Period 1||0
4982362|NCT02512302|12256560|P3|NOT COMPLETED|Period 1||0
4982363|NCT02512302|12256561|P2|NOT COMPLETED|Period 1||1
4982364|NCT02512302|12256562|P1|NOT COMPLETED|Period 1||0
4982365|NCT02512302|12256553|P10|COMPLETED|Period 1||3
4982366|NCT02512302|12256554|P9|COMPLETED|Period 1||3
4982367|NCT02512302|12256555|P8|COMPLETED|Period 1||3
4982368|NCT02512302|12256556|P7|COMPLETED|Period 1||2
4982369|NCT02512302|12256557|P6|COMPLETED|Period 1||3
4982370|NCT02512302|12256558|P5|COMPLETED|Period 1||3
4982371|NCT02512302|12256559|P4|COMPLETED|Period 1||3
4982372|NCT02512302|12256560|P3|COMPLETED|Period 1||4
4982373|NCT02512302|12256561|P2|COMPLETED|Period 1||2
4982374|NCT02512302|12256562|P1|COMPLETED|Period 1||3
4982375|NCT02512302|12256553|P10|STARTED|Period 1||3
4982376|NCT02512302|12256554|P9|STARTED|Period 1||3
4982377|NCT02512302|12256555|P8|STARTED|Period 1||3
4982378|NCT02512302|12256556|P7|STARTED|Period 1||2
4982379|NCT02512302|12256557|P6|STARTED|Period 1||3
4982380|NCT02512302|12256558|P5|STARTED|Period 1||3
4982381|NCT02512302|12256559|P4|STARTED|Period 1||3
4982382|NCT02512302|12256560|P3|STARTED|Period 1||4
4982383|NCT02512302|12256561|P2|STARTED|Period 1||3
4982384|NCT02512302|12256562|P1|STARTED|Period 1||3
4982385|NCT02512276|12256636|P2|NOT COMPLETED|Overall Study||11
4982386|NCT02512276|12256637|P1|NOT COMPLETED|Overall Study||8
4982387|NCT02512276|12256636|P2|COMPLETED|Overall Study||2029
4982388|NCT02512276|12256637|P1|COMPLETED|Overall Study||2030
4982389|NCT02512276|12256636|P2|STARTED|Overall Study||2040
4982390|NCT02512276|12256637|P1|STARTED|Overall Study||2038
4982391|NCT02512224|12256655|P2|NOT COMPLETED|Overall Study||0
4982392|NCT02512224|12256656|P1|NOT COMPLETED|Overall Study||0
4982393|NCT02512224|12256655|P2|COMPLETED|Overall Study||2912
4982394|NCT02512224|12256656|P1|COMPLETED|Overall Study||2912
4982395|NCT02512224|12256655|P2|STARTED|Overall Study||2912
4982396|NCT02512224|12256656|P1|STARTED|Overall Study||2912
4982397|NCT02512094|12256672|P1|NOT COMPLETED|Overall Study||0
4982398|NCT02512094|12256672|P1|COMPLETED|Overall Study||53
4982399|NCT02512094|12256672|P1|STARTED|Overall Study||53
4982400|NCT02512068|12256678|P2|NOT COMPLETED|Overall Study||13
4982401|NCT02512068|12256679|P1|NOT COMPLETED|Overall Study||12
4982402|NCT02512068|12256678|P2|COMPLETED|Overall Study||39
4982403|NCT02512068|12256679|P1|COMPLETED|Overall Study||43
4982404|NCT02512068|12256678|P2|STARTED|Overall Study||52
4982405|NCT02512068|12256679|P1|STARTED|Overall Study||55
4982406|NCT02512042|12256705|P2|NOT COMPLETED|Overall Study||25
4982407|NCT02512042|12256706|P1|NOT COMPLETED|Overall Study||23
4982408|NCT02512042|12256705|P2|COMPLETED|Overall Study||453
4982409|NCT02512042|12256706|P1|COMPLETED|Overall Study||472
4982410|NCT02512042|12256705|P2|STARTED|Overall Study||478
4982411|NCT02512042|12256706|P1|STARTED|Overall Study||495
4982412|NCT02511782|12256715|P3|NOT COMPLETED|Overall Study||0
4982413|NCT02511782|12256716|P2|NOT COMPLETED|Overall Study||0
4982414|NCT02511782|12256717|P1|NOT COMPLETED|Overall Study||1
4982415|NCT02511782|12256715|P3|COMPLETED|Overall Study||10
4982416|NCT02511782|12256716|P2|COMPLETED|Overall Study||2
4982417|NCT02511782|12256717|P1|COMPLETED|Overall Study||50
4982418|NCT02511782|12256715|P3|STARTED|Overall Study||10
4982419|NCT02511782|12256716|P2|STARTED|Overall Study||2
4982420|NCT02511782|12256717|P1|STARTED|Overall Study||51
4982421|NCT02511730|12256727|P2|NOT COMPLETED|Session Reading Session||0
4982422|NCT02511730|12256728|P1|NOT COMPLETED|Session Reading Session||0
4982423|NCT02511730|12256727|P2|COMPLETED|Session Reading Session||50
4982424|NCT02511730|12256728|P1|COMPLETED|Session Reading Session||50
4982425|NCT02511730|12256727|P2|STARTED|Session Reading Session||50
4982426|NCT02511730|12256728|P1|STARTED|Session Reading Session||50
4982427|NCT02511730|12256727|P2|NOT COMPLETED|4 Week Memory Washout Period||0
4982428|NCT02511730|12256728|P1|NOT COMPLETED|4 Week Memory Washout Period||0
4982429|NCT02511730|12256727|P2|COMPLETED|4 Week Memory Washout Period||50
4982430|NCT02511730|12256728|P1|COMPLETED|4 Week Memory Washout Period||50
4982431|NCT02511730|12256727|P2|STARTED|4 Week Memory Washout Period||50
4982432|NCT02511730|12256728|P1|STARTED|4 Week Memory Washout Period||50
4982433|NCT02511730|12256727|P2|NOT COMPLETED|First Reading Session||0
4982434|NCT02511730|12256728|P1|NOT COMPLETED|First Reading Session||0
4982435|NCT02511730|12256727|P2|COMPLETED|First Reading Session||50
4982436|NCT02511730|12256728|P1|COMPLETED|First Reading Session||50
4982437|NCT02511730|12256727|P2|STARTED|First Reading Session||50
4982438|NCT02511730|12256728|P1|STARTED|First Reading Session||50
4982439|NCT02511717|12256736|P2|NOT COMPLETED|Overall Study||0
4982440|NCT02511717|12256737|P1|NOT COMPLETED|Overall Study||2
4982441|NCT02511717|12256736|P2|COMPLETED|Overall Study||10
4982442|NCT02511717|12256737|P1|COMPLETED|Overall Study||8
4982443|NCT02511717|12256736|P2|STARTED|Overall Study||10
4982444|NCT02511717|12256737|P1|STARTED|Overall Study||10
4982445|NCT02511678|12256743|P1|NOT COMPLETED|Overall Study||36
4982446|NCT02511678|12256743|P1|COMPLETED|Overall Study||37
4982447|NCT02511678|12256743|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
4982448|NCT02511678|12256743|P1|Participants Discontinued Pre-Treatment|Overall Study||7
4982449|NCT02511678|12256743|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
4982450|NCT02511678|12256743|P1|STARTED|Overall Study||73
4982451|NCT02511587|12256758|P2|NOT COMPLETED|Overall Study||0
4982452|NCT02511587|12256759|P1|NOT COMPLETED|Overall Study||0
4982453|NCT02511587|12256758|P2|COMPLETED|Overall Study||58
4982454|NCT02511587|12256759|P1|COMPLETED|Overall Study||58
4982455|NCT02511587|12256758|P2|STARTED|Overall Study||58
4982456|NCT02511587|12256759|P1|STARTED|Overall Study||58
4982457|NCT02511535|12256772|P3|NOT COMPLETED|Overall Study||0
4982458|NCT02511535|12256773|P2|NOT COMPLETED|Overall Study||0
4982459|NCT02511535|12256774|P1|NOT COMPLETED|Overall Study||0
4982460|NCT02511535|12256772|P3|COMPLETED|Overall Study||49
4982461|NCT02511535|12256773|P2|COMPLETED|Overall Study||21
4982462|NCT02511535|12256774|P1|COMPLETED|Overall Study||49
4982463|NCT02511535|12256772|P3|STARTED|Overall Study||49
4982464|NCT02511535|12256773|P2|STARTED|Overall Study||21
4982465|NCT02511535|12256774|P1|STARTED|Overall Study||49
4982466|NCT02511431|12256797|P6|NOT COMPLETED|Post-treatment Follow-up||0
4982467|NCT02511431|12256798|P5|NOT COMPLETED|Post-treatment Follow-up||0
4982468|NCT02511431|12256799|P4|NOT COMPLETED|Post-treatment Follow-up||0
4982469|NCT02511431|12256800|P3|NOT COMPLETED|Post-treatment Follow-up||0
4982470|NCT02511431|12256801|P2|NOT COMPLETED|Post-treatment Follow-up||0
4982471|NCT02511431|12256802|P1|NOT COMPLETED|Post-treatment Follow-up||0
4982472|NCT02511431|12256797|P6|COMPLETED|Post-treatment Follow-up||2
4982473|NCT02511431|12256798|P5|COMPLETED|Post-treatment Follow-up||3
4982474|NCT02511431|12256799|P4|COMPLETED|Post-treatment Follow-up||3
4982475|NCT02511431|12256800|P3|COMPLETED|Post-treatment Follow-up||3
4982476|NCT02511431|12256801|P2|COMPLETED|Post-treatment Follow-up||4
4982477|NCT02511431|12256802|P1|COMPLETED|Post-treatment Follow-up||4
4982478|NCT02511431|12256797|P6|STARTED|Post-treatment Follow-up||2
4982479|NCT02511431|12256798|P5|STARTED|Post-treatment Follow-up||3
4982480|NCT02511431|12256799|P4|STARTED|Post-treatment Follow-up||3
4982481|NCT02511431|12256800|P3|STARTED|Post-treatment Follow-up||3
4982482|NCT02511431|12256801|P2|STARTED|Post-treatment Follow-up||4
4982483|NCT02511431|12256802|P1|STARTED|Post-treatment Follow-up||4
4982484|NCT02511431|12256797|P6|NOT COMPLETED|Treatment||1
4982485|NCT02511431|12256798|P5|NOT COMPLETED|Treatment||0
4982486|NCT02511431|12256799|P4|NOT COMPLETED|Treatment||0
4982487|NCT02511431|12256800|P3|NOT COMPLETED|Treatment||1
4982488|NCT02511431|12256801|P2|NOT COMPLETED|Treatment||0
4982489|NCT02511431|12256802|P1|NOT COMPLETED|Treatment||0
4982490|NCT02511431|12256797|P6|COMPLETED|Treatment||2
4982491|NCT02511431|12256798|P5|COMPLETED|Treatment||3
4982492|NCT02511431|12256799|P4|COMPLETED|Treatment||3
4982493|NCT02511431|12256800|P3|COMPLETED|Treatment||3
4982494|NCT02511431|12256801|P2|COMPLETED|Treatment||4
4982495|NCT02511431|12256802|P1|COMPLETED|Treatment||4
4982496|NCT02511431|12256797|P6|STARTED|Treatment||3
4982497|NCT02511431|12256798|P5|STARTED|Treatment||3
4982498|NCT02511431|12256799|P4|STARTED|Treatment||3
4982499|NCT02511431|12256800|P3|STARTED|Treatment||4
4982500|NCT02511431|12256801|P2|STARTED|Treatment||4
4982501|NCT02511431|12256802|P1|STARTED|Treatment||4
4982502|NCT02511379|12256823|P1|NOT COMPLETED|Overall Study||0
4982503|NCT02511379|12256823|P1|COMPLETED|Overall Study||14
4982504|NCT02511379|12256823|P1|STARTED|Overall Study||14
4982505|NCT02511184|12256829|P2|NOT COMPLETED|Overall Study||7
4982506|NCT02511184|12256830|P1|NOT COMPLETED|Overall Study||2
4982507|NCT02511184|12256829|P2|COMPLETED|Overall Study||0
4982508|NCT02511184|12256830|P1|COMPLETED|Overall Study||0
4982509|NCT02511184|12256829|P2|STARTED|Overall Study||7
4982510|NCT02511184|12256830|P1|STARTED|Overall Study||2
4982511|NCT02510820|12256880|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
4982512|NCT02510820|12256881|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
4982513|NCT02510820|12256880|P2|COMPLETED|Second Intervention (4 Weeks)||26
4982514|NCT02510820|12256881|P1|COMPLETED|Second Intervention (4 Weeks)||20
4982515|NCT02510820|12256880|P2|STARTED|Second Intervention (4 Weeks)||26
4982516|NCT02510820|12256881|P1|STARTED|Second Intervention (4 Weeks)||21
4982517|NCT02510820|12256880|P2|NOT COMPLETED|Washout (1 Week)||0
4982518|NCT02510820|12256881|P1|NOT COMPLETED|Washout (1 Week)||0
4982519|NCT02510820|12256880|P2|COMPLETED|Washout (1 Week)||26
4982520|NCT02510820|12256881|P1|COMPLETED|Washout (1 Week)||21
4982521|NCT02510820|12256880|P2|STARTED|Washout (1 Week)||26
4982522|NCT02510820|12256881|P1|STARTED|Washout (1 Week)||21
4982523|NCT02510820|12256880|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
4982524|NCT02510820|12256881|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
4982525|NCT02510820|12256880|P2|COMPLETED|First Intervention (4 Weeks)||26
4982526|NCT02510820|12256881|P1|COMPLETED|First Intervention (4 Weeks)||21
4982527|NCT02510820|12256880|P2|STARTED|First Intervention (4 Weeks)||27
4982528|NCT02510820|12256881|P1|STARTED|First Intervention (4 Weeks)||21
4982529|NCT02510664|12256922|P3|NOT COMPLETED|Overall Study||0
4982530|NCT02510664|12256923|P2|NOT COMPLETED|Overall Study||20
4982531|NCT02510664|12256924|P1|NOT COMPLETED|Overall Study||20
4982532|NCT02510664|12256922|P3|COMPLETED|Overall Study||4
4982533|NCT02510664|12256923|P2|COMPLETED|Overall Study||64
4982534|NCT02510664|12256924|P1|COMPLETED|Overall Study||64
4982535|NCT02510664|12256922|P3|STARTED|Overall Study||4
4982536|NCT02510664|12256923|P2|STARTED|Overall Study||84
4982537|NCT02510664|12256924|P1|STARTED|Overall Study||84
4982538|NCT02510144|12256955|P2|NOT COMPLETED|Overall Study||0
4982539|NCT02510144|12256956|P1|NOT COMPLETED|Overall Study||0
4982540|NCT02510144|12256955|P2|COMPLETED|Overall Study||41
4982541|NCT02510144|12256956|P1|COMPLETED|Overall Study||39
4982542|NCT02510144|12256955|P2|STARTED|Overall Study||41
4982543|NCT02510144|12256956|P1|STARTED|Overall Study||39
4982544|NCT02510014|12256966|P2|NOT COMPLETED|Treatment Period||57
4982545|NCT02510014|12256967|P1|NOT COMPLETED|Treatment Period||206
4982546|NCT02510014|12256966|P2|COMPLETED|Treatment Period||200
4982547|NCT02510014|12256967|P1|COMPLETED|Treatment Period||206
4982548|NCT02510014|12256966|P2|STARTED|Treatment Period||257
4982549|NCT02510014|12256967|P1|STARTED|Treatment Period||412
4982550|NCT02510014|12256966|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
4982551|NCT02510014|12256967|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
4982552|NCT02510014|12256966|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
4982553|NCT02510014|12256967|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
4982554|NCT02510014|12256966|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
4982555|NCT02510014|12256967|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
4982556|NCT02509936|12256989|P2|NOT COMPLETED|Overall Study||16
4982557|NCT02509936|12256990|P1|NOT COMPLETED|Overall Study||12
4982558|NCT02509936|12256989|P2|COMPLETED|Overall Study||145
4982559|NCT02509936|12256990|P1|COMPLETED|Overall Study||151
4982560|NCT02509936|12256989|P2|STARTED|Overall Study||161
4982561|NCT02509936|12256990|P1|STARTED|Overall Study||163
4982562|NCT02509767|12257016|P2|NOT COMPLETED|Overall Study||41
4982563|NCT02509767|12257017|P1|NOT COMPLETED|Overall Study||44
4982564|NCT02509767|12257016|P2|COMPLETED|Overall Study||159
4982565|NCT02509767|12257017|P1|COMPLETED|Overall Study||157
4982566|NCT02509767|12257016|P2|STARTED|Overall Study||200
4982567|NCT02509767|12257017|P1|STARTED|Overall Study||201
4982568|NCT02509585|12257028|P1|NOT COMPLETED|Overall Study||0
4982569|NCT02509585|12257028|P1|COMPLETED|Overall Study||18
4982570|NCT02509585|12257028|P1|STARTED|Overall Study||18
4982571|NCT02509481|12257043|P2|NOT COMPLETED|Overall Study||0
4982572|NCT02509481|12257044|P1|NOT COMPLETED|Overall Study||0
4982573|NCT02509481|12257043|P2|COMPLETED|Overall Study||1447
4982574|NCT02509481|12257044|P1|COMPLETED|Overall Study||1265
4982575|NCT02509481|12257043|P2|STARTED|Overall Study||1447
4982576|NCT02509481|12257044|P1|STARTED|Overall Study||1265
4982577|NCT02509117|12257070|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982578|NCT02509117|12257071|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982579|NCT02509117|12257072|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982580|NCT02509117|12257073|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982581|NCT02509117|12257074|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982582|NCT02509117|12257075|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982583|NCT02509117|12257076|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982584|NCT02509117|12257077|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982585|NCT02509117|12257078|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982586|NCT02509117|12257079|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
4982587|NCT02509117|12257070|P10|COMPLETED|Period 4 -Part A: 4 Days||0
4982588|NCT02509117|12257071|P9|COMPLETED|Period 4 -Part A: 4 Days||0
4982589|NCT02509117|12257072|P8|COMPLETED|Period 4 -Part A: 4 Days||0
4982590|NCT02509117|12257073|P7|COMPLETED|Period 4 -Part A: 4 Days||0
4982591|NCT02509117|12257074|P6|COMPLETED|Period 4 -Part A: 4 Days||0
4982592|NCT02509117|12257075|P5|COMPLETED|Period 4 -Part A: 4 Days||0
4982593|NCT02509117|12257076|P4|COMPLETED|Period 4 -Part A: 4 Days||2
4982594|NCT02509117|12257077|P3|COMPLETED|Period 4 -Part A: 4 Days||2
4982595|NCT02509117|12257078|P2|COMPLETED|Period 4 -Part A: 4 Days||2
4982596|NCT02509117|12257079|P1|COMPLETED|Period 4 -Part A: 4 Days||2
4982597|NCT02509117|12257070|P10|STARTED|Period 4 -Part A: 4 Days||0
4982598|NCT02509117|12257071|P9|STARTED|Period 4 -Part A: 4 Days||0
4982599|NCT02509117|12257072|P8|STARTED|Period 4 -Part A: 4 Days||0
4982600|NCT02509117|12257073|P7|STARTED|Period 4 -Part A: 4 Days||0
4982601|NCT02509117|12257074|P6|STARTED|Period 4 -Part A: 4 Days||0
4982602|NCT02509117|12257075|P5|STARTED|Period 4 -Part A: 4 Days||0
4982603|NCT02509117|12257076|P4|STARTED|Period 4 -Part A: 4 Days||2
4982604|NCT02509117|12257077|P3|STARTED|Period 4 -Part A: 4 Days||2
4982605|NCT02509117|12257078|P2|STARTED|Period 4 -Part A: 4 Days||2
4982606|NCT02509117|12257079|P1|STARTED|Period 4 -Part A: 4 Days||2
4982607|NCT02509117|12257070|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982608|NCT02509117|12257071|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982609|NCT02509117|12257072|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982610|NCT02509117|12257073|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982611|NCT02509117|12257074|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982612|NCT02509117|12257075|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982613|NCT02509117|12257076|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982614|NCT02509117|12257077|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982615|NCT02509117|12257078|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982616|NCT02509117|12257079|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982617|NCT02509117|12257070|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982618|NCT02509117|12257071|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982619|NCT02509117|12257072|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982620|NCT02509117|12257073|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982621|NCT02509117|12257074|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982622|NCT02509117|12257075|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
4982623|NCT02509117|12257076|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
4982624|NCT02509117|12257077|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
4982625|NCT02509117|12257078|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
4982626|NCT02509117|12257079|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
4982627|NCT02509117|12257070|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982628|NCT02509117|12257071|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982629|NCT02509117|12257072|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982630|NCT02509117|12257073|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982631|NCT02509117|12257074|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982632|NCT02509117|12257075|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
4982633|NCT02509117|12257076|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
4982634|NCT02509117|12257077|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
4982635|NCT02509117|12257078|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
4982636|NCT02509117|12257079|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
4982637|NCT02509117|12257070|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982638|NCT02509117|12257071|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982639|NCT02509117|12257072|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982640|NCT02509117|12257073|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982641|NCT02509117|12257074|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982642|NCT02509117|12257075|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982643|NCT02509117|12257076|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982644|NCT02509117|12257077|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982645|NCT02509117|12257078|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982646|NCT02509117|12257079|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
4982647|NCT02509117|12257070|P10|COMPLETED|Period 3 -Part A: 4 Days||0
4982648|NCT02509117|12257071|P9|COMPLETED|Period 3 -Part A: 4 Days||0
4982649|NCT02509117|12257072|P8|COMPLETED|Period 3 -Part A: 4 Days||0
4982650|NCT02509117|12257073|P7|COMPLETED|Period 3 -Part A: 4 Days||0
4982651|NCT02509117|12257074|P6|COMPLETED|Period 3 -Part A: 4 Days||0
4982652|NCT02509117|12257075|P5|COMPLETED|Period 3 -Part A: 4 Days||0
4982653|NCT02509117|12257076|P4|COMPLETED|Period 3 -Part A: 4 Days||2
4982654|NCT02509117|12257077|P3|COMPLETED|Period 3 -Part A: 4 Days||2
4982655|NCT02509117|12257078|P2|COMPLETED|Period 3 -Part A: 4 Days||2
4982656|NCT02509117|12257079|P1|COMPLETED|Period 3 -Part A: 4 Days||2
4982657|NCT02509117|12257070|P10|STARTED|Period 3 -Part A: 4 Days||0
4982658|NCT02509117|12257071|P9|STARTED|Period 3 -Part A: 4 Days||0
4982659|NCT02509117|12257072|P8|STARTED|Period 3 -Part A: 4 Days||0
4982660|NCT02509117|12257073|P7|STARTED|Period 3 -Part A: 4 Days||0
4982661|NCT02509117|12257074|P6|STARTED|Period 3 -Part A: 4 Days||0
4982662|NCT02509117|12257075|P5|STARTED|Period 3 -Part A: 4 Days||0
4982663|NCT02509117|12257076|P4|STARTED|Period 3 -Part A: 4 Days||2
4982664|NCT02509117|12257077|P3|STARTED|Period 3 -Part A: 4 Days||2
4982665|NCT02509117|12257078|P2|STARTED|Period 3 -Part A: 4 Days||2
4982666|NCT02509117|12257079|P1|STARTED|Period 3 -Part A: 4 Days||2
4982667|NCT02509117|12257070|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982668|NCT02509117|12257071|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982669|NCT02509117|12257072|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982670|NCT02509117|12257073|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982671|NCT02509117|12257074|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982672|NCT02509117|12257075|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982673|NCT02509117|12257076|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982674|NCT02509117|12257077|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982675|NCT02509117|12257078|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982676|NCT02509117|12257079|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982677|NCT02509117|12257070|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982678|NCT02509117|12257071|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982679|NCT02509117|12257072|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982680|NCT02509117|12257073|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982681|NCT02509117|12257074|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982682|NCT02509117|12257075|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
4982683|NCT02509117|12257076|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
4982684|NCT02509117|12257077|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
4982685|NCT02509117|12257078|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
4982686|NCT02509117|12257079|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
4982687|NCT02509117|12257070|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982688|NCT02509117|12257071|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982689|NCT02509117|12257072|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982690|NCT02509117|12257073|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982691|NCT02509117|12257074|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982692|NCT02509117|12257075|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
4982693|NCT02509117|12257076|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
4982694|NCT02509117|12257077|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
4982695|NCT02509117|12257078|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
4982696|NCT02509117|12257079|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
4982697|NCT02509117|12257070|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982698|NCT02509117|12257071|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982699|NCT02509117|12257072|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982700|NCT02509117|12257073|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982701|NCT02509117|12257074|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982702|NCT02509117|12257075|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982703|NCT02509117|12257076|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982704|NCT02509117|12257077|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982705|NCT02509117|12257078|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982706|NCT02509117|12257079|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
4982707|NCT02509117|12257070|P10|COMPLETED|Period 2 -Part A: 4 Days||0
4982708|NCT02509117|12257071|P9|COMPLETED|Period 2 -Part A: 4 Days||0
4982709|NCT02509117|12257072|P8|COMPLETED|Period 2 -Part A: 4 Days||0
4982710|NCT02509117|12257073|P7|COMPLETED|Period 2 -Part A: 4 Days||0
4982711|NCT02509117|12257074|P6|COMPLETED|Period 2 -Part A: 4 Days||0
4982712|NCT02509117|12257075|P5|COMPLETED|Period 2 -Part A: 4 Days||0
4982713|NCT02509117|12257076|P4|COMPLETED|Period 2 -Part A: 4 Days||2
4982714|NCT02509117|12257077|P3|COMPLETED|Period 2 -Part A: 4 Days||2
4982715|NCT02509117|12257078|P2|COMPLETED|Period 2 -Part A: 4 Days||2
4982716|NCT02509117|12257079|P1|COMPLETED|Period 2 -Part A: 4 Days||2
4982717|NCT02509117|12257070|P10|Treated|Period 2 -Part A: 4 Days||0
4982718|NCT02509117|12257071|P9|Treated|Period 2 -Part A: 4 Days||0
4982719|NCT02509117|12257072|P8|Treated|Period 2 -Part A: 4 Days||0
4982720|NCT02509117|12257073|P7|Treated|Period 2 -Part A: 4 Days||0
4982721|NCT02509117|12257074|P6|Treated|Period 2 -Part A: 4 Days||0
4982722|NCT02509117|12257075|P5|Treated|Period 2 -Part A: 4 Days||0
4982723|NCT02509117|12257076|P4|Treated|Period 2 -Part A: 4 Days||2
4982724|NCT02509117|12257077|P3|Treated|Period 2 -Part A: 4 Days||2
4982725|NCT02509117|12257078|P2|Treated|Period 2 -Part A: 4 Days||2
4982726|NCT02509117|12257079|P1|Treated|Period 2 -Part A: 4 Days||2
4982727|NCT02509117|12257070|P10|STARTED|Period 2 -Part A: 4 Days||0
4982728|NCT02509117|12257071|P9|STARTED|Period 2 -Part A: 4 Days||0
4982729|NCT02509117|12257072|P8|STARTED|Period 2 -Part A: 4 Days||0
4982730|NCT02509117|12257073|P7|STARTED|Period 2 -Part A: 4 Days||0
4982731|NCT02509117|12257074|P6|STARTED|Period 2 -Part A: 4 Days||0
4982732|NCT02509117|12257075|P5|STARTED|Period 2 -Part A: 4 Days||0
4982733|NCT02509117|12257076|P4|STARTED|Period 2 -Part A: 4 Days||2
4982734|NCT02509117|12257077|P3|STARTED|Period 2 -Part A: 4 Days||2
4982735|NCT02509117|12257078|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
4982736|NCT02509117|12257079|P1|STARTED|Period 2 -Part A: 4 Days||2
4982737|NCT02509117|12257070|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982738|NCT02509117|12257071|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982739|NCT02509117|12257072|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982740|NCT02509117|12257073|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982741|NCT02509117|12257074|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982742|NCT02509117|12257075|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982743|NCT02509117|12257076|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982744|NCT02509117|12257077|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982745|NCT02509117|12257078|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982746|NCT02509117|12257079|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982747|NCT02509117|12257070|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982748|NCT02509117|12257071|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982749|NCT02509117|12257072|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982750|NCT02509117|12257073|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982751|NCT02509117|12257074|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982752|NCT02509117|12257075|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
4982753|NCT02509117|12257076|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
4982754|NCT02509117|12257077|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
4982755|NCT02509117|12257078|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
4982756|NCT02509117|12257079|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
4982757|NCT02509117|12257070|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982758|NCT02509117|12257071|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982759|NCT02509117|12257072|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982760|NCT02509117|12257073|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982761|NCT02509117|12257074|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982762|NCT02509117|12257075|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
4982763|NCT02509117|12257076|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
4982764|NCT02509117|12257077|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
4982765|NCT02509117|12257078|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
4982766|NCT02509117|12257079|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
4982767|NCT02509117|12257070|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982768|NCT02509117|12257071|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982769|NCT02509117|12257072|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982770|NCT02509117|12257073|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982771|NCT02509117|12257074|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982772|NCT02509117|12257075|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982773|NCT02509117|12257076|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982774|NCT02509117|12257077|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982775|NCT02509117|12257078|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
4982776|NCT02509117|12257079|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
4982777|NCT02509117|12257070|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982778|NCT02509117|12257071|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
4982779|NCT02509117|12257072|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982780|NCT02509117|12257073|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982781|NCT02509117|12257074|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982782|NCT02509117|12257075|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982783|NCT02509117|12257076|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982784|NCT02509117|12257077|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982785|NCT02509117|12257078|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
4982786|NCT02509117|12257079|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982787|NCT02509117|12257070|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
4982788|NCT02509117|12257071|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
4982789|NCT02509117|12257072|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982790|NCT02509117|12257073|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982791|NCT02509117|12257074|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982792|NCT02509117|12257075|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982793|NCT02509117|12257076|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982794|NCT02509117|12257077|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982795|NCT02509117|12257078|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
4982796|NCT02509117|12257079|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982797|NCT02509117|12257070|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
4982798|NCT02509117|12257071|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
4982799|NCT02509117|12257072|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982800|NCT02509117|12257073|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982801|NCT02509117|12257074|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982802|NCT02509117|12257075|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
4982803|NCT02509117|12257076|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982804|NCT02509117|12257077|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982805|NCT02509117|12257078|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982806|NCT02509117|12257079|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
4982807|NCT02509078|12257290|P2|NOT COMPLETED|Overall Study||1
4982808|NCT02509078|12257291|P1|NOT COMPLETED|Overall Study||1
4982809|NCT02509078|12257290|P2|COMPLETED|Overall Study||505
4982810|NCT02509078|12257291|P1|COMPLETED|Overall Study||501
4982811|NCT02509078|12257290|P2|STARTED|Overall Study||506
4982812|NCT02509078|12257291|P1|STARTED|Overall Study||502
4982813|NCT02509065|12257327|P23|NOT COMPLETED|Overall Study||0
4982814|NCT02509065|12257328|P22|NOT COMPLETED|Overall Study||0
4982815|NCT02509065|12257329|P21|NOT COMPLETED|Overall Study||0
4982816|NCT02509065|12257330|P20|NOT COMPLETED|Overall Study||0
4982817|NCT02509065|12257331|P19|NOT COMPLETED|Overall Study||0
4982818|NCT02509065|12257332|P18|NOT COMPLETED|Overall Study||0
4982819|NCT02509065|12257333|P17|NOT COMPLETED|Overall Study||0
4982820|NCT02509065|12257334|P16|NOT COMPLETED|Overall Study||0
4982821|NCT02509065|12257335|P15|NOT COMPLETED|Overall Study||0
4982822|NCT02509065|12257336|P14|NOT COMPLETED|Overall Study||0
4982823|NCT02509065|12257337|P13|NOT COMPLETED|Overall Study||0
4982824|NCT02509065|12257338|P12|NOT COMPLETED|Overall Study||0
4982825|NCT02509065|12257339|P11|NOT COMPLETED|Overall Study||0
4982826|NCT02509065|12257340|P10|NOT COMPLETED|Overall Study||0
4982827|NCT02509065|12257341|P9|NOT COMPLETED|Overall Study||0
4982828|NCT02509065|12257342|P8|NOT COMPLETED|Overall Study||0
4982829|NCT02509065|12257343|P7|NOT COMPLETED|Overall Study||0
4982830|NCT02509065|12257344|P6|NOT COMPLETED|Overall Study||0
4982831|NCT02509065|12257345|P5|NOT COMPLETED|Overall Study||0
4982832|NCT02509065|12257346|P4|NOT COMPLETED|Overall Study||0
4982833|NCT02509065|12257347|P3|NOT COMPLETED|Overall Study||0
4982834|NCT02509065|12257348|P2|NOT COMPLETED|Overall Study||0
4982835|NCT02509065|12257349|P1|NOT COMPLETED|Overall Study||0
4982836|NCT02509065|12257327|P23|COMPLETED|Overall Study||1
4982837|NCT02509065|12257328|P22|COMPLETED|Overall Study||1
4982838|NCT02509065|12257329|P21|COMPLETED|Overall Study||1
4982839|NCT02509065|12257330|P20|COMPLETED|Overall Study||1
4982840|NCT02509065|12257331|P19|COMPLETED|Overall Study||1
4982841|NCT02509065|12257332|P18|COMPLETED|Overall Study||1
4982842|NCT02509065|12257333|P17|COMPLETED|Overall Study||1
4982843|NCT02509065|12257334|P16|COMPLETED|Overall Study||1
4982844|NCT02509065|12257335|P15|COMPLETED|Overall Study||1
4982845|NCT02509065|12257336|P14|COMPLETED|Overall Study||1
4982846|NCT02509065|12257337|P13|COMPLETED|Overall Study||1
4982847|NCT02509065|12257338|P12|COMPLETED|Overall Study||1
4982848|NCT02509065|12257339|P11|COMPLETED|Overall Study||1
4982849|NCT02509065|12257340|P10|COMPLETED|Overall Study||1
4982850|NCT02509065|12257341|P9|COMPLETED|Overall Study||1
4982851|NCT02509065|12257342|P8|COMPLETED|Overall Study||1
4982852|NCT02509065|12257343|P7|COMPLETED|Overall Study||1
4982853|NCT02509065|12257344|P6|COMPLETED|Overall Study||1
4982854|NCT02509065|12257345|P5|COMPLETED|Overall Study||1
4982855|NCT02509065|12257346|P4|COMPLETED|Overall Study||1
4982856|NCT02509065|12257347|P3|COMPLETED|Overall Study||2
4982857|NCT02509065|12257348|P2|COMPLETED|Overall Study||1
4982858|NCT02509065|12257349|P1|COMPLETED|Overall Study||1
4982859|NCT02509065|12257327|P23|STARTED|Overall Study||1
4982860|NCT02509065|12257328|P22|STARTED|Overall Study||1
4982861|NCT02509065|12257329|P21|STARTED|Overall Study||1
4982862|NCT02509065|12257330|P20|STARTED|Overall Study||1
4982863|NCT02509065|12257331|P19|STARTED|Overall Study||1
4982864|NCT02509065|12257332|P18|STARTED|Overall Study||1
4982865|NCT02509065|12257333|P17|STARTED|Overall Study||1
4982866|NCT02509065|12257334|P16|STARTED|Overall Study||1
4982867|NCT02509065|12257335|P15|STARTED|Overall Study||1
4982868|NCT02509065|12257336|P14|STARTED|Overall Study||1
4982869|NCT02509065|12257337|P13|STARTED|Overall Study||1
4982870|NCT02509065|12257338|P12|STARTED|Overall Study||1
4982871|NCT02509065|12257339|P11|STARTED|Overall Study||1
4982872|NCT02509065|12257340|P10|STARTED|Overall Study||1
4982873|NCT02509065|12257341|P9|STARTED|Overall Study||1
4982874|NCT02509065|12257342|P8|STARTED|Overall Study||1
4982875|NCT02509065|12257343|P7|STARTED|Overall Study||1
4982876|NCT02509065|12257344|P6|STARTED|Overall Study||1
4982877|NCT02509065|12257345|P5|STARTED|Overall Study||1
4982878|NCT02509065|12257346|P4|STARTED|Overall Study||1
4982879|NCT02509065|12257347|P3|STARTED|Overall Study||2
4982880|NCT02509065|12257348|P2|STARTED|Overall Study||1
4982881|NCT02509065|12257349|P1|STARTED|Overall Study||1
4982882|NCT02509026|12257434|P1|NOT COMPLETED|Retreatment Period (12 Weeks)||4
4982883|NCT02509026|12257434|P1|COMPLETED|Retreatment Period (12 Weeks)||84
4982884|NCT02509026|12257434|P1|Treated|Retreatment Period (12 Weeks)||87
4982885|NCT02509026|12257434|P1|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
4982886|NCT02509026|12257434|P1|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
4982887|NCT02509026|12257434|P1|COMPLETED|Withdrawal Period (40 Weeks)||112
4982888|NCT02509026|12257434|P1|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
4982889|NCT02509026|12257434|P1|NOT COMPLETED|Induction Period (24 Weeks)||22
4982890|NCT02509026|12257434|P1|COMPLETED|Induction Period (24 Weeks)||188
4982891|NCT02509026|12257434|P1|Treated|Induction Period (24 Weeks)||209
4982892|NCT02509026|12257434|P1|STARTED|Induction Period (24 Weeks)||210
4982893|NCT02508935|12257631|P1|NOT COMPLETED|Overall Study||23
4982894|NCT02508935|12257631|P1|COMPLETED|Overall Study||0
4982895|NCT02508935|12257631|P1|STARTED|Overall Study||23
4982896|NCT02508701|12257647|P4|NOT COMPLETED|Overall Study||3
4982897|NCT02508701|12257648|P3|NOT COMPLETED|Overall Study||5
4982898|NCT02508701|12257649|P2|NOT COMPLETED|Overall Study||5
4982899|NCT02508701|12257650|P1|NOT COMPLETED|Overall Study||9
4982900|NCT02508701|12257647|P4|COMPLETED|Overall Study||1
4982901|NCT02508701|12257648|P3|COMPLETED|Overall Study||0
4982902|NCT02508701|12257649|P2|COMPLETED|Overall Study||1
4982903|NCT02508701|12257650|P1|COMPLETED|Overall Study||0
4982904|NCT02508701|12257647|P4|STARTED|Overall Study||4
4982905|NCT02508701|12257648|P3|STARTED|Overall Study||5
4982906|NCT02508701|12257649|P2|STARTED|Overall Study||6
4982907|NCT02508701|12257650|P1|STARTED|Overall Study||9
4982908|NCT02508480|12257674|P2|NOT COMPLETED|Overall Study||4
4982909|NCT02508480|12257675|P1|NOT COMPLETED|Overall Study||5
4982910|NCT02508480|12257674|P2|COMPLETED|Overall Study||93
4982911|NCT02508480|12257675|P1|COMPLETED|Overall Study||90
4982912|NCT02508480|12257674|P2|Six-Month Follow-Up|Overall Study||86
4982913|NCT02508480|12257675|P1|Six-Month Follow-Up|Overall Study||84
4982914|NCT02508480|12257674|P2|Three Month Follow-up|Overall Study||86
4982915|NCT02508480|12257675|P1|Three Month Follow-up|Overall Study||84
4982916|NCT02508480|12257674|P2|Post-Treatment Assessment|Overall Study||89
4982917|NCT02508480|12257675|P1|Post-Treatment Assessment|Overall Study||87
4982918|NCT02508480|12257674|P2|STARTED|Overall Study||97
4982919|NCT02508480|12257675|P1|STARTED|Overall Study||95
4982920|NCT02508259|12257699|P2|NOT COMPLETED|Overall Study||0
4982921|NCT02508259|12257700|P1|NOT COMPLETED|Overall Study||0
4982922|NCT02508259|12257699|P2|COMPLETED|Overall Study||5
4982923|NCT02508259|12257700|P1|COMPLETED|Overall Study||5
4982924|NCT02508259|12257699|P2|STARTED|Overall Study||5
4982925|NCT02508259|12257700|P1|STARTED|Overall Study||5
4982926|NCT02508207|12257718|P2|NOT COMPLETED|Overall Study||0
4982927|NCT02508207|12257719|P1|NOT COMPLETED|Overall Study||0
4982928|NCT02508207|12257718|P2|COMPLETED|Overall Study||27
4982929|NCT02508207|12257719|P1|COMPLETED|Overall Study||7
4982930|NCT02508207|12257718|P2|STARTED|Overall Study||27
4982931|NCT02508207|12257719|P1|STARTED|Overall Study||7
4982932|NCT02508194|12257735|P2|NOT COMPLETED|Overall Study||44
4982933|NCT02508194|12257736|P1|NOT COMPLETED|Overall Study||52
4982934|NCT02508194|12257735|P2|COMPLETED|Overall Study||907
4982935|NCT02508194|12257736|P1|COMPLETED|Overall Study||897
4982936|NCT02508194|12257735|P2|STARTED|Overall Study||951
4982937|NCT02508194|12257736|P1|STARTED|Overall Study||949
4982938|NCT02508116|12257776|P2|NOT COMPLETED|Overall Study||7
4982939|NCT02508116|12257777|P1|NOT COMPLETED|Overall Study||8
4982940|NCT02508116|12257776|P2|COMPLETED|Overall Study||250
4982941|NCT02508116|12257777|P1|COMPLETED|Overall Study||244
4982942|NCT02508116|12257776|P2|Received Intervention as Randomized|Overall Study||255
4982943|NCT02508116|12257777|P1|Received Intervention as Randomized|Overall Study||249
4982944|NCT02508116|12257776|P2|STARTED|Overall Study||257
4982945|NCT02508116|12257777|P1|STARTED|Overall Study||252
4982946|NCT02508103|12257791|P2|NOT COMPLETED|Overall Study||0
4982947|NCT02508103|12257792|P1|NOT COMPLETED|Overall Study||0
4982948|NCT02508103|12257791|P2|COMPLETED|Overall Study||5
4982949|NCT02508103|12257792|P1|COMPLETED|Overall Study||5
4982950|NCT02508103|12257791|P2|STARTED|Overall Study||5
4982951|NCT02508103|12257792|P1|STARTED|Overall Study||5
4982952|NCT02508077|12257800|P1|NOT COMPLETED|Overall Study||0
4982953|NCT02508077|12257800|P1|COMPLETED|Overall Study||1
4982954|NCT02508077|12257800|P1|STARTED|Overall Study||1
4982955|NCT02507973|12257804|P1|NOT COMPLETED|Overall Study||1
4982956|NCT02507973|12257804|P1|COMPLETED|Overall Study||7
4982957|NCT02507973|12257804|P1|STARTED|Overall Study||8
4982958|NCT02507752|12257810|P1|NOT COMPLETED|Overall Study||17
4982959|NCT02507752|12257810|P1|COMPLETED|Overall Study||55
4982960|NCT02507752|12257810|P1|STARTED|Overall Study||72
4982961|NCT02507388|12257830|P2|NOT COMPLETED|Overall Study||0
4982962|NCT02507388|12257831|P1|NOT COMPLETED|Overall Study||0
4982963|NCT02507388|12257830|P2|COMPLETED|Overall Study||25
4982964|NCT02507388|12257831|P1|COMPLETED|Overall Study||25
4982965|NCT02507388|12257830|P2|STARTED|Overall Study||25
4982966|NCT02507388|12257831|P1|STARTED|Overall Study||25
4982967|NCT02507375|12257854|P2|NOT COMPLETED|Overall Study||8
4982968|NCT02507375|12257855|P1|NOT COMPLETED|Overall Study||4
4982969|NCT02507375|12257854|P2|COMPLETED|Overall Study||1
4982970|NCT02507375|12257855|P1|COMPLETED|Overall Study||2
4982971|NCT02507375|12257854|P2|Extension Period|Overall Study||1
4982972|NCT02507375|12257855|P1|Extension Period|Overall Study||2
4982973|NCT02507375|12257854|P2|Cycle 6|Overall Study||1
4982974|NCT02507375|12257855|P1|Cycle 6|Overall Study||3
4982975|NCT02507375|12257854|P2|Cycle 5|Overall Study||1
4982976|NCT02507375|12257855|P1|Cycle 5|Overall Study||3
4982977|NCT02507375|12257854|P2|Cycle 4|Overall Study||2
4982978|NCT02507375|12257855|P1|Cycle 4|Overall Study||4
4982979|NCT02507375|12257854|P2|Cycle 3|Overall Study||5
4982980|NCT02507375|12257855|P1|Cycle 3|Overall Study||4
4982981|NCT02507375|12257854|P2|Cycle 2|Overall Study||5
4982982|NCT02507375|12257855|P1|Cycle 2|Overall Study||5
4982983|NCT02507375|12257854|P2|Received Pertuzumab|Overall Study||6
4982984|NCT02507375|12257855|P1|Received Pertuzumab|Overall Study||6
4982985|NCT02507375|12257854|P2|Cycle 1|Overall Study||9
4982986|NCT02507375|12257855|P1|Cycle 1|Overall Study||6
4982987|NCT02507375|12257854|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
4982988|NCT02507375|12257855|P1|STARTED|Overall Study||6
4982989|NCT02507349|12257874|P2|NOT COMPLETED|Overall Study||161
4982990|NCT02507349|12257875|P1|NOT COMPLETED|Overall Study||187
4982991|NCT02507349|12257874|P2|COMPLETED|Overall Study||1050
4982992|NCT02507349|12257875|P1|COMPLETED|Overall Study||1045
4982993|NCT02507349|12257874|P2|STARTED|Overall Study||1211
4982994|NCT02507349|12257875|P1|STARTED|Overall Study||1232
4982995|NCT02507219|12257899|P6|NOT COMPLETED|Overall Study||0
4982996|NCT02507219|12257900|P5|NOT COMPLETED|Overall Study||1
4982997|NCT02507219|12257901|P4|NOT COMPLETED|Overall Study||0
4982998|NCT02507219|12257902|P3|NOT COMPLETED|Overall Study||0
4982999|NCT02507219|12257903|P2|NOT COMPLETED|Overall Study||0
4983000|NCT02507219|12257904|P1|NOT COMPLETED|Overall Study||1
4983001|NCT02507219|12257899|P6|COMPLETED|Overall Study||3
4983002|NCT02507219|12257900|P5|COMPLETED|Overall Study||3
4983003|NCT02507219|12257901|P4|COMPLETED|Overall Study||3
4983004|NCT02507219|12257902|P3|COMPLETED|Overall Study||3
4983005|NCT02507219|12257903|P2|COMPLETED|Overall Study||4
4983006|NCT02507219|12257904|P1|COMPLETED|Overall Study||4
4983007|NCT02507219|12257899|P6|STARTED|Overall Study||3
4983008|NCT02507219|12257900|P5|STARTED|Overall Study||4
4983009|NCT02507219|12257901|P4|STARTED|Overall Study||3
4983010|NCT02507219|12257902|P3|STARTED|Overall Study||3
4983011|NCT02507219|12257903|P2|STARTED|Overall Study||4
4983012|NCT02507219|12257904|P1|STARTED|Overall Study||5
4983013|NCT02507011|12257912|P2|NOT COMPLETED|Second Intervention||0
4983014|NCT02507011|12257913|P1|NOT COMPLETED|Second Intervention||0
4983015|NCT02507011|12257912|P2|COMPLETED|Second Intervention||1
4983016|NCT02507011|12257913|P1|COMPLETED|Second Intervention||1
4983017|NCT02507011|12257912|P2|STARTED|Second Intervention||1
4983018|NCT02507011|12257913|P1|STARTED|Second Intervention||1
4983019|NCT02507011|12257912|P2|NOT COMPLETED|First Intervention||0
4983020|NCT02507011|12257913|P1|NOT COMPLETED|First Intervention||0
4983021|NCT02507011|12257912|P2|COMPLETED|First Intervention||1
4983022|NCT02507011|12257913|P1|COMPLETED|First Intervention||1
4983023|NCT02507011|12257912|P2|STARTED|First Intervention||1
4983024|NCT02507011|12257913|P1|STARTED|First Intervention||1
4983025|NCT02506985|12257921|P2|NOT COMPLETED|Overall Study||0
4983026|NCT02506985|12257922|P1|NOT COMPLETED|Overall Study||0
4983027|NCT02506985|12257921|P2|COMPLETED|Overall Study||6
4983028|NCT02506985|12257922|P1|COMPLETED|Overall Study||4
4983029|NCT02506985|12257921|P2|STARTED|Overall Study||6
4983030|NCT02506985|12257922|P1|STARTED|Overall Study||4
4983031|NCT02506881|12257940|P4|NOT COMPLETED|Second Intervention (Day 1)||0
4983032|NCT02506881|12257941|P3|NOT COMPLETED|Second Intervention (Day 1)||0
4983033|NCT02506881|12257942|P2|NOT COMPLETED|Second Intervention (Day 1)||0
4983034|NCT02506881|12257943|P1|NOT COMPLETED|Second Intervention (Day 1)||0
4983035|NCT02506881|12257940|P4|COMPLETED|Second Intervention (Day 1)||12
4983036|NCT02506881|12257941|P3|COMPLETED|Second Intervention (Day 1)||12
4983037|NCT02506881|12257942|P2|COMPLETED|Second Intervention (Day 1)||12
4983038|NCT02506881|12257943|P1|COMPLETED|Second Intervention (Day 1)||12
4983039|NCT02506881|12257940|P4|STARTED|Second Intervention (Day 1)||12
4983040|NCT02506881|12257941|P3|STARTED|Second Intervention (Day 1)||12
4983041|NCT02506881|12257942|P2|STARTED|Second Intervention (Day 1)||12
4983042|NCT02506881|12257943|P1|STARTED|Second Intervention (Day 1)||12
4983043|NCT02506881|12257940|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
4983044|NCT02506881|12257941|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
4983045|NCT02506881|12257942|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
4983046|NCT02506881|12257943|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
4983047|NCT02506881|12257940|P4|COMPLETED|Washout (at Least 25 Days)||12
4983048|NCT02506881|12257941|P3|COMPLETED|Washout (at Least 25 Days)||12
4983049|NCT02506881|12257942|P2|COMPLETED|Washout (at Least 25 Days)||12
4983050|NCT02506881|12257943|P1|COMPLETED|Washout (at Least 25 Days)||12
4983051|NCT02506881|12257940|P4|STARTED|Washout (at Least 25 Days)||12
4983052|NCT02506881|12257941|P3|STARTED|Washout (at Least 25 Days)||12
4983053|NCT02506881|12257942|P2|STARTED|Washout (at Least 25 Days)||12
4983054|NCT02506881|12257943|P1|STARTED|Washout (at Least 25 Days)||12
4983055|NCT02506881|12257940|P4|NOT COMPLETED|First Intervention (Day 1)||12
4983056|NCT02506881|12257941|P3|NOT COMPLETED|First Intervention (Day 1)||13
4983057|NCT02506881|12257942|P2|NOT COMPLETED|First Intervention (Day 1)||0
4983058|NCT02506881|12257943|P1|NOT COMPLETED|First Intervention (Day 1)||1
4983059|NCT02506881|12257940|P4|COMPLETED|First Intervention (Day 1)||12
4983060|NCT02506881|12257941|P3|COMPLETED|First Intervention (Day 1)||12
4983061|NCT02506881|12257942|P2|COMPLETED|First Intervention (Day 1)||12
4983062|NCT02506881|12257943|P1|COMPLETED|First Intervention (Day 1)||12
4983063|NCT02506881|12257940|P4|STARTED|First Intervention (Day 1)||24
4983064|NCT02506881|12257941|P3|STARTED|First Intervention (Day 1)||25
4983065|NCT02506881|12257942|P2|STARTED|First Intervention (Day 1)||12
4983066|NCT02506881|12257943|P1|STARTED|First Intervention (Day 1)||13
4983067|NCT02506868|12257979|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
4983068|NCT02506868|12257980|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
4983069|NCT02506868|12257979|P2|COMPLETED|Additional Period of Study (Until 52W)||85
4983070|NCT02506868|12257980|P1|COMPLETED|Additional Period of Study (Until 52W)||83
4983071|NCT02506868|12257979|P2|STARTED|Additional Period of Study (Until 52W)||90
4983072|NCT02506868|12257980|P1|STARTED|Additional Period of Study (Until 52W)||86
4983073|NCT02506868|12257979|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
4983074|NCT02506868|12257980|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
4983075|NCT02506868|12257979|P2|COMPLETED|Main Period of Study (24 Weeks)||90
4983076|NCT02506868|12257980|P1|COMPLETED|Main Period of Study (24 Weeks)||86
4983077|NCT02506868|12257979|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
4983078|NCT02506868|12257980|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
4983079|NCT02506868|12257979|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
4983080|NCT02506868|12257980|P1|mITT Population|Main Period of Study (24 Weeks)||98
4983081|NCT02506868|12257979|P2|STARTED|Main Period of Study (24 Weeks)||98
4983082|NCT02506868|12257980|P1|STARTED|Main Period of Study (24 Weeks)||98
4983083|NCT02506816|12258016|P1|NOT COMPLETED|Overall Study||3
4983084|NCT02506816|12258016|P1|COMPLETED|Overall Study||33
4983085|NCT02506816|12258016|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
4983086|NCT02506816|12258016|P1|STARTED|Overall Study||36
4983087|NCT02506673|12258025|P2|NOT COMPLETED|Overall Study||0
4983088|NCT02506673|12258026|P1|NOT COMPLETED|Overall Study||0
4983089|NCT02506673|12258025|P2|COMPLETED|Overall Study||13
4983090|NCT02506673|12258026|P1|COMPLETED|Overall Study||13
4983091|NCT02506673|12258025|P2|STARTED|Overall Study||13
4983092|NCT02506673|12258026|P1|STARTED|Overall Study||13
4983093|NCT02506660|12258058|P2|NOT COMPLETED|Overall Study||1
4983094|NCT02506660|12258059|P1|NOT COMPLETED|Overall Study||2
4983095|NCT02506660|12258058|P2|COMPLETED|Overall Study||63
4983096|NCT02506660|12258059|P1|COMPLETED|Overall Study||62
4983097|NCT02506660|12258058|P2|STARTED|Overall Study||64
4983098|NCT02506660|12258059|P1|STARTED|Overall Study||64
4983099|NCT02506634|12258085|P1|NOT COMPLETED|Overall Study||17
4983100|NCT02506634|12258085|P1|COMPLETED|Overall Study||357
4983101|NCT02506634|12258085|P1|Participants Who Finished GERDQ|Overall Study||342
4983102|NCT02506634|12258085|P1|Participants Who Received PPI Treatment|Overall Study||357
4983103|NCT02506634|12258085|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
4983104|NCT02506634|12258085|P1|STARTED|Overall Study||374
4983105|NCT02506309|12258125|P2|NOT COMPLETED|Overall Study||20
4983106|NCT02506309|12258126|P1|NOT COMPLETED|Overall Study||18
4983107|NCT02506309|12258125|P2|COMPLETED|Overall Study||64
4983108|NCT02506309|12258126|P1|COMPLETED|Overall Study||66
4983109|NCT02506309|12258125|P2|STARTED|Overall Study||84
4983110|NCT02506309|12258126|P1|STARTED|Overall Study||84
4983111|NCT02506257|12258142|P4|NOT COMPLETED|Overall Study||0
4983112|NCT02506257|12258143|P3|NOT COMPLETED|Overall Study||4
4983113|NCT02506257|12258144|P2|NOT COMPLETED|Overall Study||2
4983114|NCT02506257|12258145|P1|NOT COMPLETED|Overall Study||0
4983115|NCT02506257|12258142|P4|COMPLETED|Overall Study||9
4983116|NCT02506257|12258143|P3|COMPLETED|Overall Study||23
4983117|NCT02506257|12258144|P2|COMPLETED|Overall Study||26
4983118|NCT02506257|12258145|P1|COMPLETED|Overall Study||26
4983119|NCT02506257|12258142|P4|STARTED|Overall Study||9
4983120|NCT02506257|12258143|P3|STARTED|Overall Study||27
4983121|NCT02506257|12258144|P2|STARTED|Overall Study||28
4983122|NCT02506257|12258145|P1|STARTED|Overall Study||26
4983123|NCT02506101|12258177|P2|NOT COMPLETED|Overall Study||0
4983124|NCT02506101|12258178|P1|NOT COMPLETED|Overall Study||2
4983125|NCT02506101|12258177|P2|COMPLETED|Overall Study||0
4983126|NCT02506101|12258178|P1|COMPLETED|Overall Study||0
4983127|NCT02506101|12258177|P2|STARTED|Overall Study||0
4983128|NCT02506101|12258178|P1|STARTED|Overall Study||2
4983129|NCT02506036|12258194|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
4983130|NCT02506036|12258195|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
4983131|NCT02506036|12258194|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
4983132|NCT02506036|12258195|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
4983133|NCT02506036|12258194|P2|STARTED|Second Intervention (4-6 Weeks)||1
4983134|NCT02506036|12258195|P1|STARTED|Second Intervention (4-6 Weeks)||2
4983135|NCT02506036|12258194|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
4983136|NCT02506036|12258195|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
4983137|NCT02506036|12258194|P2|COMPLETED|Washout (1-2 Weeks)||1
4983138|NCT02506036|12258195|P1|COMPLETED|Washout (1-2 Weeks)||2
4983139|NCT02506036|12258194|P2|STARTED|Washout (1-2 Weeks)||1
4983140|NCT02506036|12258195|P1|STARTED|Washout (1-2 Weeks)||2
4983141|NCT02506036|12258194|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
4983142|NCT02506036|12258195|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
4983143|NCT02506036|12258194|P2|COMPLETED|First Intervention (4-6 Weeks)||1
4983144|NCT02506036|12258195|P1|COMPLETED|First Intervention (4-6 Weeks)||2
4983145|NCT02506036|12258194|P2|STARTED|First Intervention (4-6 Weeks)||3
4983146|NCT02506036|12258195|P1|STARTED|First Intervention (4-6 Weeks)||3
4983147|NCT02505945|12258203|P2|NOT COMPLETED|Overall Study||4
4983148|NCT02505945|12258204|P1|NOT COMPLETED|Overall Study||22
4983149|NCT02505945|12258203|P2|COMPLETED|Overall Study||46
4983150|NCT02505945|12258204|P1|COMPLETED|Overall Study||80
4983151|NCT02505945|12258203|P2|STARTED|Overall Study||50
4983152|NCT02505945|12258204|P1|STARTED|Overall Study||102
4983153|NCT02505919|12258214|P2|NOT COMPLETED|36 Months Follow-Up||5
4983154|NCT02505919|12258215|P1|NOT COMPLETED|36 Months Follow-Up||15
4983155|NCT02505919|12258214|P2|COMPLETED|36 Months Follow-Up||55
4983156|NCT02505919|12258215|P1|COMPLETED|36 Months Follow-Up||97
4983157|NCT02505919|12258214|P2|STARTED|36 Months Follow-Up||60
4983158|NCT02505919|12258215|P1|STARTED|36 Months Follow-Up||112
4983159|NCT02505919|12258214|P2|NOT COMPLETED|24 Months Follow-Up||1
4983160|NCT02505919|12258215|P1|NOT COMPLETED|24 Months Follow-Up||3
4983161|NCT02505919|12258214|P2|COMPLETED|24 Months Follow-Up||60
4983162|NCT02505919|12258215|P1|COMPLETED|24 Months Follow-Up||112
4983163|NCT02505919|12258214|P2|STARTED|24 Months Follow-Up||61
4983164|NCT02505919|12258215|P1|STARTED|24 Months Follow-Up||115
4983165|NCT02505919|12258214|P2|NOT COMPLETED|12 Months Follow-Up||2
4983166|NCT02505919|12258215|P1|NOT COMPLETED|12 Months Follow-Up||1
4983167|NCT02505919|12258214|P2|COMPLETED|12 Months Follow-Up||61
4983168|NCT02505919|12258215|P1|COMPLETED|12 Months Follow-Up||115
4983169|NCT02505919|12258214|P2|STARTED|12 Months Follow-Up||63
4983170|NCT02505919|12258215|P1|STARTED|12 Months Follow-Up||116
4983171|NCT02505919|12258214|P2|NOT COMPLETED|6 Months Follow-Up||2
4983172|NCT02505919|12258215|P1|NOT COMPLETED|6 Months Follow-Up||0
4983173|NCT02505919|12258214|P2|COMPLETED|6 Months Follow-Up||63
4983174|NCT02505919|12258215|P1|COMPLETED|6 Months Follow-Up||116
4983175|NCT02505919|12258214|P2|STARTED|6 Months Follow-Up||65
4983176|NCT02505919|12258215|P1|STARTED|6 Months Follow-Up||116
4983177|NCT02505919|12258214|P2|NOT COMPLETED|3 Months Follow-Up||0
4983178|NCT02505919|12258215|P1|NOT COMPLETED|3 Months Follow-Up||0
4983179|NCT02505919|12258214|P2|COMPLETED|3 Months Follow-Up||65
4983180|NCT02505919|12258215|P1|COMPLETED|3 Months Follow-Up||116
4983181|NCT02505919|12258214|P2|STARTED|3 Months Follow-Up||65
4983182|NCT02505919|12258215|P1|STARTED|3 Months Follow-Up||116
4983183|NCT02505919|12258214|P2|NOT COMPLETED|1 Month Follow-Up||0
4983184|NCT02505919|12258215|P1|NOT COMPLETED|1 Month Follow-Up||0
4983185|NCT02505919|12258214|P2|COMPLETED|1 Month Follow-Up||65
4983186|NCT02505919|12258215|P1|COMPLETED|1 Month Follow-Up||116
4983187|NCT02505919|12258214|P2|STARTED|1 Month Follow-Up||65
4983188|NCT02505919|12258215|P1|STARTED|1 Month Follow-Up||116
4983189|NCT02505919|12258214|P2|NOT COMPLETED|1 Week Follow-Up||0
4983190|NCT02505919|12258215|P1|NOT COMPLETED|1 Week Follow-Up||0
4983191|NCT02505919|12258214|P2|COMPLETED|1 Week Follow-Up||65
4983192|NCT02505919|12258215|P1|COMPLETED|1 Week Follow-Up||116
4983193|NCT02505919|12258214|P2|STARTED|1 Week Follow-Up||65
4983194|NCT02505919|12258215|P1|STARTED|1 Week Follow-Up||116
4983195|NCT02505919|12258214|P2|NOT COMPLETED|Treatment||2
4983196|NCT02505919|12258215|P1|NOT COMPLETED|Treatment||1
4983197|NCT02505919|12258214|P2|COMPLETED|Treatment||65
4983198|NCT02505919|12258215|P1|COMPLETED|Treatment||116
4983199|NCT02505919|12258214|P2|STARTED|Treatment||67
4983200|NCT02505919|12258215|P1|STARTED|Treatment||117
4983201|NCT02505867|12258225|P2|NOT COMPLETED|Overall Study||6
4983202|NCT02505867|12258226|P1|NOT COMPLETED|Overall Study||6
4983203|NCT02505867|12258225|P2|COMPLETED|Overall Study||0
4983204|NCT02505867|12258226|P1|COMPLETED|Overall Study||0
4983205|NCT02505867|12258225|P2|STARTED|Overall Study||6
4983206|NCT02505867|12258226|P1|STARTED|Overall Study||6
4983207|NCT02505542|12258232|P4|NOT COMPLETED|Part B: Double-Blind Period||7
4983208|NCT02505542|12258233|P3|NOT COMPLETED|Part B: Double-Blind Period||9
4983209|NCT02505542|12258234|P2|NOT COMPLETED|Part B: Double-Blind Period||12
4983210|NCT02505542|12258235|P1|NOT COMPLETED|Part B: Double-Blind Period||0
4983211|NCT02505542|12258232|P4|COMPLETED|Part B: Double-Blind Period||98
4983212|NCT02505542|12258233|P3|COMPLETED|Part B: Double-Blind Period||95
4983213|NCT02505542|12258234|P2|COMPLETED|Part B: Double-Blind Period||92
4983214|NCT02505542|12258235|P1|COMPLETED|Part B: Double-Blind Period||0
4983215|NCT02505542|12258232|P4|Started Escape Period|Part B: Double-Blind Period||15
4983216|NCT02505542|12258233|P3|Started Escape Period|Part B: Double-Blind Period||7
4983217|NCT02505542|12258234|P2|Started Escape Period|Part B: Double-Blind Period||73
4983218|NCT02505542|12258235|P1|Started Escape Period|Part B: Double-Blind Period||0
4983219|NCT02505542|12258232|P4|STARTED|Part B: Double-Blind Period||105
4983220|NCT02505542|12258233|P3|STARTED|Part B: Double-Blind Period||104
4983221|NCT02505542|12258234|P2|STARTED|Part B: Double-Blind Period||104
4983222|NCT02505542|12258235|P1|STARTED|Part B: Double-Blind Period||0
4983223|NCT02505542|12258232|P4|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
4983224|NCT02505542|12258233|P3|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
4983225|NCT02505542|12258234|P2|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
4983226|NCT02505542|12258235|P1|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
4983227|NCT02505542|12258232|P4|COMPLETED|Completed Part A, Did Not Enter Part B||0
4983228|NCT02505542|12258233|P3|COMPLETED|Completed Part A, Did Not Enter Part B||0
4983229|NCT02505542|12258234|P2|COMPLETED|Completed Part A, Did Not Enter Part B||0
4983230|NCT02505542|12258235|P1|COMPLETED|Completed Part A, Did Not Enter Part B||313
4983231|NCT02505542|12258232|P4|STARTED|Completed Part A, Did Not Enter Part B||0
4983232|NCT02505542|12258233|P3|STARTED|Completed Part A, Did Not Enter Part B||0
4983233|NCT02505542|12258234|P2|STARTED|Completed Part A, Did Not Enter Part B||0
4983234|NCT02505542|12258235|P1|STARTED|Completed Part A, Did Not Enter Part B||659
4983235|NCT02505542|12258232|P4|NOT COMPLETED|Part A: Open-Label Period||0
4983236|NCT02505542|12258233|P3|NOT COMPLETED|Part A: Open-Label Period||0
4983237|NCT02505542|12258234|P2|NOT COMPLETED|Part A: Open-Label Period||0
4983238|NCT02505542|12258235|P1|NOT COMPLETED|Part A: Open-Label Period||77
4983239|NCT02505542|12258232|P4|COMPLETED|Part A: Open-Label Period||0
4983240|NCT02505542|12258233|P3|COMPLETED|Part A: Open-Label Period||0
4983241|NCT02505542|12258234|P2|COMPLETED|Part A: Open-Label Period||0
4983242|NCT02505542|12258235|P1|COMPLETED|Part A: Open-Label Period||659
4983243|NCT02505542|12258232|P4|STARTED|Part A: Open-Label Period||0
4983244|NCT02505542|12258233|P3|STARTED|Part A: Open-Label Period||0
4983245|NCT02505542|12258234|P2|STARTED|Part A: Open-Label Period||0
4983246|NCT02505542|12258235|P1|STARTED|Part A: Open-Label Period||736
4983247|NCT02505334|12258343|P2|NOT COMPLETED|Extension Treatment Period||0
4983248|NCT02505334|12258344|P1|NOT COMPLETED|Extension Treatment Period||18
4983249|NCT02505334|12258343|P2|COMPLETED|Extension Treatment Period||0
4983250|NCT02505334|12258344|P1|COMPLETED|Extension Treatment Period||194
4983251|NCT02505334|12258343|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
4983252|NCT02505334|12258344|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
4983253|NCT02505334|12258343|P2|NOT COMPLETED|Main Treatment Period||39
4983254|NCT02505334|12258344|P1|NOT COMPLETED|Main Treatment Period||15
4983255|NCT02505334|12258343|P2|COMPLETED|Main Treatment Period||194
4983256|NCT02505334|12258344|P1|COMPLETED|Main Treatment Period||218
4983257|NCT02505334|12258343|P2|STARTED|Main Treatment Period||233
4983258|NCT02505334|12258344|P1|STARTED|Main Treatment Period||233
4983259|NCT02505217|12258471|P2|NOT COMPLETED|Overall Study||2
4983260|NCT02505217|12258472|P1|NOT COMPLETED|Overall Study||1
4983261|NCT02505217|12258471|P2|COMPLETED|Overall Study||93
4983262|NCT02505217|12258472|P1|COMPLETED|Overall Study||104
4983263|NCT02505217|12258471|P2|STARTED|Overall Study||95
4983264|NCT02505217|12258472|P1|STARTED|Overall Study||105
4983265|NCT02504931|12258482|P2|NOT COMPLETED|Overall Study||10
4983266|NCT02504931|12258483|P1|NOT COMPLETED|Overall Study||12
4983267|NCT02504931|12258482|P2|COMPLETED|Overall Study||13
4983268|NCT02504931|12258483|P1|COMPLETED|Overall Study||14
4983269|NCT02504931|12258482|P2|STARTED|Overall Study||23
4983270|NCT02504931|12258483|P1|STARTED|Overall Study||26
4983271|NCT02504892|12258491|P1|NOT COMPLETED|Overall Study||2
4983272|NCT02504892|12258491|P1|COMPLETED|Overall Study||1
4983273|NCT02504892|12258491|P1|STARTED|Overall Study||3
4983274|NCT02504827|12258498|P1|NOT COMPLETED|Overall Study||1
4983275|NCT02504827|12258498|P1|COMPLETED|Overall Study||11
4983276|NCT02504827|12258498|P1|STARTED|Overall Study||12
4983277|NCT02504775|12258503|P2|NOT COMPLETED|Period 2||0
4983278|NCT02504775|12258504|P1|NOT COMPLETED|Period 2||0
4983279|NCT02504775|12258503|P2|COMPLETED|Period 2||14
4983280|NCT02504775|12258504|P1|COMPLETED|Period 2||14
4983281|NCT02504775|12258503|P2|STARTED|Period 2||14
4983282|NCT02504775|12258504|P1|STARTED|Period 2||14
4983283|NCT02504775|12258503|P2|NOT COMPLETED|Washout||0
4983284|NCT02504775|12258504|P1|NOT COMPLETED|Washout||0
4983285|NCT02504775|12258503|P2|COMPLETED|Washout||14
4983286|NCT02504775|12258504|P1|COMPLETED|Washout||14
4983287|NCT02504775|12258503|P2|STARTED|Washout||14
4983288|NCT02504775|12258504|P1|STARTED|Washout||14
4983289|NCT02504775|12258503|P2|NOT COMPLETED|Period 1||0
4983290|NCT02504775|12258504|P1|NOT COMPLETED|Period 1||0
4983291|NCT02504775|12258503|P2|COMPLETED|Period 1||14
4983292|NCT02504775|12258504|P1|COMPLETED|Period 1||14
4983293|NCT02504775|12258503|P2|STARTED|Period 1||14
4983294|NCT02504775|12258504|P1|STARTED|Period 1||14
4983295|NCT02504723|12258518|P2|NOT COMPLETED|Overall Study||0
4983296|NCT02504723|12258519|P1|NOT COMPLETED|Overall Study||0
4983297|NCT02504723|12258518|P2|COMPLETED|Overall Study||61
4983298|NCT02504723|12258519|P1|COMPLETED|Overall Study||60
4983299|NCT02504723|12258518|P2|STARTED|Overall Study||61
4983300|NCT02504723|12258519|P1|STARTED|Overall Study||60
4983301|NCT02504671|12258537|P6|NOT COMPLETED|Overall Study||14
4983302|NCT02504671|12258538|P5|NOT COMPLETED|Overall Study||12
4983303|NCT02504671|12258539|P4|NOT COMPLETED|Overall Study||10
4983304|NCT02504671|12258540|P3|NOT COMPLETED|Overall Study||10
4983305|NCT02504671|12258541|P2|NOT COMPLETED|Overall Study||14
4983306|NCT02504671|12258542|P1|NOT COMPLETED|Overall Study||12
4983307|NCT02504671|12258537|P6|COMPLETED|Overall Study||23
4983308|NCT02504671|12258538|P5|COMPLETED|Overall Study||25
4983309|NCT02504671|12258539|P4|COMPLETED|Overall Study||27
4983310|NCT02504671|12258540|P3|COMPLETED|Overall Study||27
4983311|NCT02504671|12258541|P2|COMPLETED|Overall Study||23
4983312|NCT02504671|12258542|P1|COMPLETED|Overall Study||25
4983313|NCT02504671|12258537|P6|STARTED|Overall Study||37
4983314|NCT02504671|12258538|P5|STARTED|Overall Study||37
4983315|NCT02504671|12258539|P4|STARTED|Overall Study||37
4983316|NCT02504671|12258540|P3|STARTED|Overall Study||37
4983317|NCT02504671|12258541|P2|STARTED|Overall Study||37
4983318|NCT02504671|12258542|P1|STARTED|Overall Study||37
4983319|NCT02504645|12258684|P2|NOT COMPLETED|Overall Study||25
4983320|NCT02504645|12258685|P1|NOT COMPLETED|Overall Study||24
4983321|NCT02504645|12258684|P2|COMPLETED|Overall Study||76
4983322|NCT02504645|12258685|P1|COMPLETED|Overall Study||77
4983323|NCT02504645|12258684|P2|STARTED|Overall Study||101
4983324|NCT02504645|12258685|P1|STARTED|Overall Study||101
4983325|NCT02504619|12258693|P1|NOT COMPLETED|Overall Study||0
4983326|NCT02504619|12258693|P1|COMPLETED|Overall Study||1
4983327|NCT02504619|12258693|P1|STARTED|Overall Study||1
4983328|NCT02504554|12258701|P2|NOT COMPLETED|Overall Study||0
4983329|NCT02504554|12258702|P1|NOT COMPLETED|Overall Study||0
4983330|NCT02504554|12258701|P2|COMPLETED|Overall Study||6
4983331|NCT02504554|12258702|P1|COMPLETED|Overall Study||12
4983332|NCT02504554|12258701|P2|STARTED|Overall Study||6
4983421|NCT02503865|12258806|P3|NOT COMPLETED|Overall Study||2
4983333|NCT02504554|12258702|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
4983334|NCT02504541|12258714|P1|NOT COMPLETED|Overall Study||20
4983335|NCT02504541|12258714|P1|COMPLETED|Overall Study||113
4983336|NCT02504541|12258714|P1|STARTED|Overall Study||133
4983337|NCT02504502|12258720|P2|NOT COMPLETED|Crossover to Enhanced Report||0
4983338|NCT02504502|12258721|P1|NOT COMPLETED|Crossover to Enhanced Report||5
4983339|NCT02504502|12258720|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
4983340|NCT02504502|12258721|P1|COMPLETED|Crossover to Enhanced Report||15
4983341|NCT02504502|12258720|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
4983342|NCT02504502|12258721|P1|STARTED|Crossover to Enhanced Report||20
4983343|NCT02504502|12258720|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
4983344|NCT02504502|12258721|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
4983345|NCT02504502|12258720|P2|COMPLETED|Routine Care vs. Enhanced Report||21
4983346|NCT02504502|12258721|P1|COMPLETED|Routine Care vs. Enhanced Report||20
4983347|NCT02504502|12258720|P2|STARTED|Routine Care vs. Enhanced Report||28
4983348|NCT02504502|12258721|P1|STARTED|Routine Care vs. Enhanced Report||24
4983349|NCT02504424|12258727|P1|NOT COMPLETED|Overall Study||2
4983350|NCT02504424|12258727|P1|COMPLETED|Overall Study||48
4983351|NCT02504424|12258727|P1|STARTED|Overall Study||50
4983352|NCT02504320|12258736|P4|NOT COMPLETED|Treatment Period 4||0
4983353|NCT02504320|12258737|P3|NOT COMPLETED|Treatment Period 4||0
4983354|NCT02504320|12258738|P2|NOT COMPLETED|Treatment Period 4||0
4983355|NCT02504320|12258739|P1|NOT COMPLETED|Treatment Period 4||0
4983356|NCT02504320|12258736|P4|COMPLETED|Treatment Period 4||19
4983357|NCT02504320|12258737|P3|COMPLETED|Treatment Period 4||18
4983358|NCT02504320|12258738|P2|COMPLETED|Treatment Period 4||18
4983359|NCT02504320|12258739|P1|COMPLETED|Treatment Period 4||19
4983360|NCT02504320|12258736|P4|STARTED|Treatment Period 4||19
4983361|NCT02504320|12258737|P3|STARTED|Treatment Period 4||18
4983362|NCT02504320|12258738|P2|STARTED|Treatment Period 4||18
4983363|NCT02504320|12258739|P1|STARTED|Treatment Period 4||19
4983364|NCT02504320|12258736|P4|NOT COMPLETED|Treatment Period 3||1
4983365|NCT02504320|12258737|P3|NOT COMPLETED|Treatment Period 3||1
4983366|NCT02504320|12258738|P2|NOT COMPLETED|Treatment Period 3||0
4983367|NCT02504320|12258739|P1|NOT COMPLETED|Treatment Period 3||0
4983368|NCT02504320|12258736|P4|COMPLETED|Treatment Period 3||19
4983369|NCT02504320|12258737|P3|COMPLETED|Treatment Period 3||18
4983370|NCT02504320|12258738|P2|COMPLETED|Treatment Period 3||18
4983371|NCT02504320|12258739|P1|COMPLETED|Treatment Period 3||19
4983372|NCT02504320|12258736|P4|STARTED|Treatment Period 3||20
4983373|NCT02504320|12258737|P3|STARTED|Treatment Period 3||19
4983374|NCT02504320|12258738|P2|STARTED|Treatment Period 3||18
4983375|NCT02504320|12258739|P1|STARTED|Treatment Period 3||19
4983376|NCT02504320|12258736|P4|NOT COMPLETED|Treatment Period 2||0
4983377|NCT02504320|12258737|P3|NOT COMPLETED|Treatment Period 2||0
4983378|NCT02504320|12258738|P2|NOT COMPLETED|Treatment Period 2||1
4983379|NCT02504320|12258739|P1|NOT COMPLETED|Treatment Period 2||0
4983380|NCT02504320|12258736|P4|COMPLETED|Treatment Period 2||20
4983381|NCT02504320|12258737|P3|COMPLETED|Treatment Period 2||19
4983382|NCT02504320|12258738|P2|COMPLETED|Treatment Period 2||18
4983383|NCT02504320|12258739|P1|COMPLETED|Treatment Period 2||19
4983384|NCT02504320|12258736|P4|STARTED|Treatment Period 2||20
4983385|NCT02504320|12258737|P3|STARTED|Treatment Period 2||19
4983386|NCT02504320|12258738|P2|STARTED|Treatment Period 2||19
4983387|NCT02504320|12258739|P1|STARTED|Treatment Period 2||19
4983388|NCT02504320|12258736|P4|NOT COMPLETED|Treatment Period 1||0
4983389|NCT02504320|12258737|P3|NOT COMPLETED|Treatment Period 1||1
4983390|NCT02504320|12258738|P2|NOT COMPLETED|Treatment Period 1||0
4983391|NCT02504320|12258739|P1|NOT COMPLETED|Treatment Period 1||0
4983392|NCT02504320|12258736|P4|COMPLETED|Treatment Period 1||20
4983393|NCT02504320|12258737|P3|COMPLETED|Treatment Period 1||19
4983394|NCT02504320|12258738|P2|COMPLETED|Treatment Period 1||19
4983395|NCT02504320|12258739|P1|COMPLETED|Treatment Period 1||19
4983396|NCT02504320|12258736|P4|STARTED|Treatment Period 1||20
4983397|NCT02504320|12258737|P3|STARTED|Treatment Period 1||20
4983398|NCT02504320|12258738|P2|STARTED|Treatment Period 1||19
4983399|NCT02504320|12258739|P1|STARTED|Treatment Period 1||19
4983400|NCT02504294|12258759|P2|NOT COMPLETED|Overall Study||48
4983401|NCT02504294|12258760|P1|NOT COMPLETED|Overall Study||56
4983402|NCT02504294|12258759|P2|COMPLETED|Overall Study||158
4983403|NCT02504294|12258760|P1|COMPLETED|Overall Study||156
4983404|NCT02504294|12258759|P2|STARTED|Overall Study||206
4983405|NCT02504294|12258760|P1|STARTED|Overall Study||212
4983406|NCT02504268|12258770|P2|NOT COMPLETED|Overall Study||68
4983407|NCT02504268|12258771|P1|NOT COMPLETED|Overall Study||63
4983408|NCT02504268|12258770|P2|COMPLETED|Overall Study||233
4983409|NCT02504268|12258771|P1|COMPLETED|Overall Study||388
4983410|NCT02504268|12258770|P2|STARTED|Overall Study||301
4983411|NCT02504268|12258771|P1|STARTED|Overall Study||451
4983412|NCT02504099|12258785|P1|NOT COMPLETED|Overall Study||0
4983413|NCT02504099|12258785|P1|COMPLETED|Overall Study||3
4983414|NCT02504099|12258785|P1|STARTED|Overall Study||3
4983415|NCT02504073|12258793|P1|NOT COMPLETED|Overall Study||0
4983416|NCT02504073|12258793|P1|COMPLETED|Overall Study||54
4983417|NCT02504073|12258793|P1|STARTED|Overall Study||54
4983418|NCT02503982|12258799|P1|NOT COMPLETED|Overall Study||0
4983419|NCT02503982|12258799|P1|COMPLETED|Overall Study||13
4983420|NCT02503982|12258799|P1|STARTED|Overall Study||13
4983422|NCT02503865|12258807|P2|NOT COMPLETED|Overall Study||47
4983423|NCT02503865|12258808|P1|NOT COMPLETED|Overall Study||5
4983424|NCT02503865|12258806|P3|COMPLETED|Overall Study||64
4983425|NCT02503865|12258807|P2|COMPLETED|Overall Study||222
4983426|NCT02503865|12258808|P1|COMPLETED|Overall Study||65
4983427|NCT02503865|12258806|P3|STARTED|Overall Study||66
4983428|NCT02503865|12258807|P2|STARTED|Overall Study||269
4983429|NCT02503865|12258808|P1|STARTED|Overall Study||70
4983430|NCT02503852|12258832|P4|NOT COMPLETED|Overall Study||1
4983431|NCT02503852|12258833|P3|NOT COMPLETED|Overall Study||3
4983432|NCT02503852|12258834|P2|NOT COMPLETED|Overall Study||3
4983433|NCT02503852|12258835|P1|NOT COMPLETED|Overall Study||4
4983434|NCT02503852|12258832|P4|COMPLETED|Overall Study||8
4983435|NCT02503852|12258833|P3|COMPLETED|Overall Study||21
4983436|NCT02503852|12258834|P2|COMPLETED|Overall Study||19
4983437|NCT02503852|12258835|P1|COMPLETED|Overall Study||12
4983438|NCT02503852|12258832|P4|STARTED|Overall Study||9
4983439|NCT02503852|12258833|P3|STARTED|Overall Study||24
4983440|NCT02503852|12258834|P2|STARTED|Overall Study||22
4983441|NCT02503852|12258835|P1|STARTED|Overall Study||16
4983442|NCT02503787|12258853|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
4983443|NCT02503787|12258853|P1|COMPLETED|Implant to 3 Month Endpoint||29
4983444|NCT02503787|12258853|P1|STARTED|Implant to 3 Month Endpoint||32
4983445|NCT02503787|12258853|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
4983446|NCT02503787|12258853|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
4983447|NCT02503787|12258853|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
4983448|NCT02503787|12258853|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
4983449|NCT02503787|12258853|P1|COMPLETED|Device Trial (HD Programming Trial)||37
4983450|NCT02503787|12258853|P1|STARTED|Device Trial (HD Programming Trial)||44
4983451|NCT02503787|12258853|P1|NOT COMPLETED|Enrollment||20
4983452|NCT02503787|12258853|P1|COMPLETED|Enrollment||44
4983453|NCT02503787|12258853|P1|STARTED|Enrollment||64
4983454|NCT02503735|12258860|P1|NOT COMPLETED|Overall Study||0
4983455|NCT02503735|12258860|P1|COMPLETED|Overall Study||10
4983456|NCT02503735|12258860|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
4983457|NCT02503735|12258860|P1|STARTED|Overall Study||10
4983458|NCT02503540|12258870|P1|NOT COMPLETED|Overall Study||3
4983459|NCT02503540|12258870|P1|COMPLETED|Overall Study||28
4983460|NCT02503540|12258870|P1|STARTED|Overall Study||31
4983461|NCT02503501|12258891|P2|NOT COMPLETED|Overall Study||3
4983462|NCT02503501|12258892|P1|NOT COMPLETED|Overall Study||1
4983463|NCT02503501|12258891|P2|COMPLETED|Overall Study||13
4983464|NCT02503501|12258892|P1|COMPLETED|Overall Study||18
4983465|NCT02503501|12258891|P2|STARTED|Overall Study||16
4983466|NCT02503501|12258892|P1|STARTED|Overall Study||19
4983467|NCT02503410|12258904|P2|NOT COMPLETED|Overall Study||0
4983468|NCT02503410|12258905|P1|NOT COMPLETED|Overall Study||0
4983469|NCT02503410|12258904|P2|COMPLETED|Overall Study||3
4983470|NCT02503410|12258905|P1|COMPLETED|Overall Study||4
4983471|NCT02503410|12258904|P2|STARTED|Overall Study||3
4983472|NCT02503410|12258905|P1|STARTED|Overall Study||4
4983473|NCT02503254|12258927|P2|NOT COMPLETED|Overall Study||0
4983474|NCT02503254|12258928|P1|NOT COMPLETED|Overall Study||0
4983475|NCT02503254|12258927|P2|COMPLETED|Overall Study||39
4983476|NCT02503254|12258928|P1|COMPLETED|Overall Study||41
4983477|NCT02503254|12258927|P2|STARTED|Overall Study||39
4983478|NCT02503254|12258928|P1|STARTED|Overall Study||41
4983479|NCT02503215|12258941|P1|NOT COMPLETED|Overall Study||3
4983480|NCT02503215|12258941|P1|COMPLETED|Overall Study||14
4983481|NCT02503215|12258941|P1|STARTED|Overall Study||17
4983482|NCT02503202|12258952|P5|NOT COMPLETED|Extension: Month 6 to 24||1
4983483|NCT02503202|12258953|P4|NOT COMPLETED|Extension: Month 6 to 24||18
4983484|NCT02503202|12258954|P3|NOT COMPLETED|Extension: Month 6 to 24||9
4983485|NCT02503202|12258955|P2|NOT COMPLETED|Extension: Month 6 to 24||16
4983486|NCT02503202|12258956|P1|NOT COMPLETED|Extension: Month 6 to 24||11
4983487|NCT02503202|12258952|P5|COMPLETED|Extension: Month 6 to 24||67
4983488|NCT02503202|12258953|P4|COMPLETED|Extension: Month 6 to 24||119
4983489|NCT02503202|12258954|P3|COMPLETED|Extension: Month 6 to 24||103
4983490|NCT02503202|12258955|P2|COMPLETED|Extension: Month 6 to 24||114
4983491|NCT02503202|12258956|P1|COMPLETED|Extension: Month 6 to 24||108
4983492|NCT02503202|12258952|P5|STARTED|Extension: Month 6 to 24||68
4983493|NCT02503202|12258953|P4|STARTED|Extension: Month 6 to 24||137
4983494|NCT02503202|12258954|P3|STARTED|Extension: Month 6 to 24||112
4983495|NCT02503202|12258955|P2|STARTED|Extension: Month 6 to 24||130
4983496|NCT02503202|12258956|P1|STARTED|Extension: Month 6 to 24||119
4983497|NCT02503202|12258952|P5|NOT COMPLETED|Base Study: Up to Month 6||3
4983498|NCT02503202|12258953|P4|NOT COMPLETED|Base Study: Up to Month 6||11
4983499|NCT02503202|12258954|P3|NOT COMPLETED|Base Study: Up to Month 6||15
4983500|NCT02503202|12258955|P2|NOT COMPLETED|Base Study: Up to Month 6||12
4983501|NCT02503202|12258956|P1|NOT COMPLETED|Base Study: Up to Month 6||18
4983502|NCT02503202|12258952|P5|COMPLETED|Base Study: Up to Month 6||130
4983503|NCT02503202|12258953|P4|COMPLETED|Base Study: Up to Month 6||255
4983504|NCT02503202|12258954|P3|COMPLETED|Base Study: Up to Month 6||252
4983505|NCT02503202|12258955|P2|COMPLETED|Base Study: Up to Month 6||253
4983506|NCT02503202|12258956|P1|COMPLETED|Base Study: Up to Month 6||248
4983507|NCT02503202|12258952|P5|Vaccinated|Base Study: Up to Month 6||133
4983508|NCT02503202|12258953|P4|Vaccinated|Base Study: Up to Month 6||264
4983509|NCT02503202|12258954|P3|Vaccinated|Base Study: Up to Month 6||266
4983510|NCT02503202|12258955|P2|Vaccinated|Base Study: Up to Month 6||265
4983511|NCT02503202|12258956|P1|Vaccinated|Base Study: Up to Month 6||266
4983512|NCT02503202|12258952|P5|STARTED|Base Study: Up to Month 6||133
4983513|NCT02503202|12258953|P4|STARTED|Base Study: Up to Month 6||266
4983514|NCT02503202|12258954|P3|STARTED|Base Study: Up to Month 6||267
4983515|NCT02503202|12258955|P2|STARTED|Base Study: Up to Month 6||265
4983516|NCT02503202|12258956|P1|STARTED|Base Study: Up to Month 6||266
4983517|NCT02503085|12258998|P4|NOT COMPLETED|Period 4||0
4983518|NCT02503085|12258999|P3|NOT COMPLETED|Period 4||0
4983519|NCT02503085|12259000|P2|NOT COMPLETED|Period 4||0
4983520|NCT02503085|12259001|P1|NOT COMPLETED|Period 4||0
4983521|NCT02503085|12258998|P4|COMPLETED|Period 4||7
4983522|NCT02503085|12258999|P3|COMPLETED|Period 4||6
4983523|NCT02503085|12259000|P2|COMPLETED|Period 4||7
4983524|NCT02503085|12259001|P1|COMPLETED|Period 4||6
4983525|NCT02503085|12258998|P4|STARTED|Period 4||7
4983526|NCT02503085|12258999|P3|STARTED|Period 4||6
4983527|NCT02503085|12259000|P2|STARTED|Period 4||7
4983528|NCT02503085|12259001|P1|STARTED|Period 4||6
4983529|NCT02503085|12258998|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4983530|NCT02503085|12258999|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4983531|NCT02503085|12259000|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4983532|NCT02503085|12259001|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
4983533|NCT02503085|12258998|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
4983534|NCT02503085|12258999|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4983535|NCT02503085|12259000|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
4983536|NCT02503085|12259001|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
4983537|NCT02503085|12258998|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
4983538|NCT02503085|12258999|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
4983539|NCT02503085|12259000|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
4983540|NCT02503085|12259001|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
4983541|NCT02503085|12258998|P4|NOT COMPLETED|Period 3||0
4983542|NCT02503085|12258999|P3|NOT COMPLETED|Period 3||0
4983543|NCT02503085|12259000|P2|NOT COMPLETED|Period 3||0
4983544|NCT02503085|12259001|P1|NOT COMPLETED|Period 3||0
4983545|NCT02503085|12258998|P4|COMPLETED|Period 3||7
4983546|NCT02503085|12258999|P3|COMPLETED|Period 3||6
4983547|NCT02503085|12259000|P2|COMPLETED|Period 3||7
4983548|NCT02503085|12259001|P1|COMPLETED|Period 3||6
4983549|NCT02503085|12258998|P4|STARTED|Period 3||7
4983550|NCT02503085|12258999|P3|STARTED|Period 3||6
4983551|NCT02503085|12259000|P2|STARTED|Period 3||7
4983552|NCT02503085|12259001|P1|STARTED|Period 3||6
4983553|NCT02503085|12258998|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4983554|NCT02503085|12258999|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
4983555|NCT02503085|12259000|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
4983556|NCT02503085|12259001|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
4983557|NCT02503085|12258998|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
4983558|NCT02503085|12258999|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4983559|NCT02503085|12259000|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
4983560|NCT02503085|12259001|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
4983561|NCT02503085|12258998|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
4983562|NCT02503085|12258999|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
4983563|NCT02503085|12259000|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
4983564|NCT02503085|12259001|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
4983565|NCT02503085|12258998|P4|NOT COMPLETED|Period 2||0
4983566|NCT02503085|12258999|P3|NOT COMPLETED|Period 2||0
4983567|NCT02503085|12259000|P2|NOT COMPLETED|Period 2||0
4983568|NCT02503085|12259001|P1|NOT COMPLETED|Period 2||0
4983569|NCT02503085|12258998|P4|COMPLETED|Period 2||7
4983570|NCT02503085|12258999|P3|COMPLETED|Period 2||7
4983571|NCT02503085|12259000|P2|COMPLETED|Period 2||7
4983572|NCT02503085|12259001|P1|COMPLETED|Period 2||7
4983573|NCT02503085|12258998|P4|STARTED|Period 2||7
4983574|NCT02503085|12258999|P3|STARTED|Period 2||7
4983575|NCT02503085|12259000|P2|STARTED|Period 2||7
4983576|NCT02503085|12259001|P1|STARTED|Period 2||7
4983577|NCT02503085|12258998|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4983578|NCT02503085|12258999|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4983579|NCT02503085|12259000|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4983580|NCT02503085|12259001|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
4983581|NCT02503085|12258998|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
4983582|NCT02503085|12258999|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
4983583|NCT02503085|12259000|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
4983584|NCT02503085|12259001|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
4983585|NCT02503085|12258998|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
4983586|NCT02503085|12258999|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
4983587|NCT02503085|12259000|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
4983588|NCT02503085|12259001|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
4983589|NCT02503085|12258998|P4|NOT COMPLETED|Period 1||0
4983590|NCT02503085|12258999|P3|NOT COMPLETED|Period 1||0
4983591|NCT02503085|12259000|P2|NOT COMPLETED|Period 1||0
4983592|NCT02503085|12259001|P1|NOT COMPLETED|Period 1||0
4983593|NCT02503085|12258998|P4|COMPLETED|Period 1||7
4983594|NCT02503085|12258999|P3|COMPLETED|Period 1||7
4983595|NCT02503085|12259000|P2|COMPLETED|Period 1||7
4983596|NCT02503085|12259001|P1|COMPLETED|Period 1||7
4983597|NCT02503085|12258998|P4|STARTED|Period 1||7
4983598|NCT02503085|12258999|P3|STARTED|Period 1||7
4983599|NCT02503085|12259000|P2|STARTED|Period 1||7
4983600|NCT02503085|12259001|P1|STARTED|Period 1||7
4983601|NCT02502864|12259040|P1|NOT COMPLETED|Overall Study||1
4983602|NCT02502864|12259040|P1|COMPLETED|Overall Study||8
4983603|NCT02502864|12259040|P1|STARTED|Overall Study||9
4983604|NCT02502734|12259049|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
4983605|NCT02502734|12259050|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
4983606|NCT02502734|12259049|P2|COMPLETED|Double-blind Treatment Period 2||30
4983607|NCT02502734|12259050|P1|COMPLETED|Double-blind Treatment Period 2||28
4983608|NCT02502734|12259049|P2|STARTED|Double-blind Treatment Period 2||30
4983609|NCT02502734|12259050|P1|STARTED|Double-blind Treatment Period 2||28
4983610|NCT02502734|12259049|P2|NOT COMPLETED|Washout Period||0
4983611|NCT02502734|12259050|P1|NOT COMPLETED|Washout Period||1
4983612|NCT02502734|12259049|P2|COMPLETED|Washout Period||30
4983613|NCT02502734|12259050|P1|COMPLETED|Washout Period||28
4983614|NCT02502734|12259049|P2|STARTED|Washout Period||30
4983615|NCT02502734|12259050|P1|STARTED|Washout Period||29
4983616|NCT02502734|12259049|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
4983617|NCT02502734|12259050|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
4983618|NCT02502734|12259049|P2|COMPLETED|Double-blind Treatment Period 1||30
4983619|NCT02502734|12259050|P1|COMPLETED|Double-blind Treatment Period 1||29
4983620|NCT02502734|12259049|P2|STARTED|Double-blind Treatment Period 1||30
4983621|NCT02502734|12259050|P1|STARTED|Double-blind Treatment Period 1||30
4983622|NCT02502526|12259061|P3|NOT COMPLETED|Overall Study||6
4983623|NCT02502526|12259062|P2|NOT COMPLETED|Overall Study||4
4983624|NCT02502526|12259063|P1|NOT COMPLETED|Overall Study||6
4983625|NCT02502526|12259061|P3|COMPLETED|Overall Study||55
4983626|NCT02502526|12259062|P2|COMPLETED|Overall Study||55
4983627|NCT02502526|12259063|P1|COMPLETED|Overall Study||56
4983628|NCT02502526|12259061|P3|Intent-to-Treat (ITT)|Overall Study||59
4983629|NCT02502526|12259062|P2|Intent-to-Treat (ITT)|Overall Study||57
4983630|NCT02502526|12259063|P1|Intent-to-Treat (ITT)|Overall Study||57
4983631|NCT02502526|12259061|P3|STARTED|Overall Study||61
4983632|NCT02502526|12259062|P2|STARTED|Overall Study||59
4983633|NCT02502526|12259063|P1|STARTED|Overall Study||62
4983634|NCT02502487|12259079|P3|NOT COMPLETED|Overall Study||0
4983635|NCT02502487|12259080|P2|NOT COMPLETED|Overall Study||0
4983636|NCT02502487|12259081|P1|NOT COMPLETED|Overall Study||0
4983637|NCT02502487|12259079|P3|COMPLETED|Overall Study||86
4983638|NCT02502487|12259080|P2|COMPLETED|Overall Study||86
4983639|NCT02502487|12259081|P1|COMPLETED|Overall Study||86
4983640|NCT02502487|12259079|P3|STARTED|Overall Study||86
4983641|NCT02502487|12259080|P2|STARTED|Overall Study||86
4983642|NCT02502487|12259081|P1|STARTED|Overall Study||86
4983643|NCT02502461|12259151|P2|NOT COMPLETED|Overall Study||0
4983644|NCT02502461|12259152|P1|NOT COMPLETED|Overall Study||0
4983645|NCT02502461|12259151|P2|COMPLETED|Overall Study||44
4983646|NCT02502461|12259152|P1|COMPLETED|Overall Study||46
4983647|NCT02502461|12259151|P2|STARTED|Overall Study||44
4983648|NCT02502461|12259152|P1|STARTED|Overall Study||46
4983649|NCT02502149|12259160|P5|NOT COMPLETED|Treatment Period||0
4983650|NCT02502149|12259161|P4|NOT COMPLETED|Treatment Period||0
4983651|NCT02502149|12259162|P3|NOT COMPLETED|Treatment Period||0
4983652|NCT02502149|12259163|P2|NOT COMPLETED|Treatment Period||0
4983653|NCT02502149|12259164|P1|NOT COMPLETED|Treatment Period||0
4983654|NCT02502149|12259160|P5|COMPLETED|Treatment Period||12
4983655|NCT02502149|12259161|P4|COMPLETED|Treatment Period||11
4983656|NCT02502149|12259162|P3|COMPLETED|Treatment Period||0
4983657|NCT02502149|12259163|P2|COMPLETED|Treatment Period||0
4983658|NCT02502149|12259164|P1|COMPLETED|Treatment Period||0
4983659|NCT02502149|12259160|P5|STARTED|Treatment Period||12
4983660|NCT02502149|12259161|P4|STARTED|Treatment Period||11
4983661|NCT02502149|12259162|P3|STARTED|Treatment Period||0
4983662|NCT02502149|12259163|P2|STARTED|Treatment Period||0
4983663|NCT02502149|12259164|P1|STARTED|Treatment Period||0
4983664|NCT02502149|12259160|P5|NOT COMPLETED|PK2 Assessment Period||0
4983665|NCT02502149|12259161|P4|NOT COMPLETED|PK2 Assessment Period||0
4983666|NCT02502149|12259162|P3|NOT COMPLETED|PK2 Assessment Period||0
4983667|NCT02502149|12259163|P2|NOT COMPLETED|PK2 Assessment Period||0
4983668|NCT02502149|12259164|P1|NOT COMPLETED|PK2 Assessment Period||0
4983669|NCT02502149|12259160|P5|COMPLETED|PK2 Assessment Period||0
4983670|NCT02502149|12259161|P4|COMPLETED|PK2 Assessment Period||0
4983671|NCT02502149|12259162|P3|COMPLETED|PK2 Assessment Period||12
4983672|NCT02502149|12259163|P2|COMPLETED|PK2 Assessment Period||11
4983673|NCT02502149|12259164|P1|COMPLETED|PK2 Assessment Period||0
4983674|NCT02502149|12259160|P5|STARTED|PK2 Assessment Period||0
4983675|NCT02502149|12259161|P4|STARTED|PK2 Assessment Period||0
4983676|NCT02502149|12259162|P3|STARTED|PK2 Assessment Period||12
4983677|NCT02502149|12259163|P2|STARTED|PK2 Assessment Period||11
4983678|NCT02502149|12259164|P1|STARTED|PK2 Assessment Period||0
4983679|NCT02502149|12259160|P5|NOT COMPLETED|Intermediate||0
4983680|NCT02502149|12259161|P4|NOT COMPLETED|Intermediate||0
4983681|NCT02502149|12259162|P3|NOT COMPLETED|Intermediate||0
4983682|NCT02502149|12259163|P2|NOT COMPLETED|Intermediate||0
4983683|NCT02502149|12259164|P1|NOT COMPLETED|Intermediate||1
4983684|NCT02502149|12259160|P5|COMPLETED|Intermediate||0
4983685|NCT02502149|12259161|P4|COMPLETED|Intermediate||0
4983686|NCT02502149|12259162|P3|COMPLETED|Intermediate||0
4983687|NCT02502149|12259163|P2|COMPLETED|Intermediate||0
4983688|NCT02502149|12259164|P1|COMPLETED|Intermediate||23
4983689|NCT02502149|12259160|P5|STARTED|Intermediate||0
4983690|NCT02502149|12259161|P4|STARTED|Intermediate||0
4983691|NCT02502149|12259162|P3|STARTED|Intermediate||0
4983692|NCT02502149|12259163|P2|STARTED|Intermediate||0
4983693|NCT02502149|12259164|P1|STARTED|Intermediate||24
4983694|NCT02502149|12259160|P5|NOT COMPLETED|PK1 Assessment Period||0
4983695|NCT02502149|12259161|P4|NOT COMPLETED|PK1 Assessment Period||0
4983696|NCT02502149|12259162|P3|NOT COMPLETED|PK1 Assessment Period||0
4983697|NCT02502149|12259163|P2|NOT COMPLETED|PK1 Assessment Period||0
4983698|NCT02502149|12259164|P1|NOT COMPLETED|PK1 Assessment Period||0
4983699|NCT02502149|12259160|P5|COMPLETED|PK1 Assessment Period||0
4983700|NCT02502149|12259161|P4|COMPLETED|PK1 Assessment Period||0
4983701|NCT02502149|12259162|P3|COMPLETED|PK1 Assessment Period||0
4983702|NCT02502149|12259163|P2|COMPLETED|PK1 Assessment Period||0
4983703|NCT02502149|12259164|P1|COMPLETED|PK1 Assessment Period||24
4983704|NCT02502149|12259160|P5|STARTED|PK1 Assessment Period||0
4983705|NCT02502149|12259161|P4|STARTED|PK1 Assessment Period||0
4983706|NCT02502149|12259162|P3|STARTED|PK1 Assessment Period||0
4983707|NCT02502149|12259163|P2|STARTED|PK1 Assessment Period||0
4983708|NCT02502149|12259164|P1|STARTED|PK1 Assessment Period||24
4983709|NCT02502071|12259283|P1|NOT COMPLETED|Overall Study||0
4983710|NCT02502071|12259283|P1|COMPLETED|Overall Study||45
4983711|NCT02502071|12259283|P1|STARTED|Overall Study||45
4983712|NCT02502019|12259288|P1|NOT COMPLETED|Overall Study||0
4983713|NCT02502019|12259288|P1|COMPLETED|Overall Study||27
4983714|NCT02502019|12259288|P1|STARTED|Overall Study||27
4983715|NCT02501759|12259296|P1|NOT COMPLETED|Overall Study||1
4983716|NCT02501759|12259296|P1|COMPLETED|Overall Study||1
4983717|NCT02501759|12259296|P1|STARTED|Overall Study||2
4983718|NCT02501629|12259304|P2|NOT COMPLETED|Overall Study||7
4983719|NCT02501629|12259305|P1|NOT COMPLETED|Overall Study||5
4983720|NCT02501629|12259304|P2|COMPLETED|Overall Study||81
4983721|NCT02501629|12259305|P1|COMPLETED|Overall Study||84
4983722|NCT02501629|12259304|P2|STARTED|Overall Study||88
4983723|NCT02501629|12259305|P1|STARTED|Overall Study||89
4983724|NCT02501590|12259329|P2|NOT COMPLETED|Overall Study||0
4983725|NCT02501590|12259330|P1|NOT COMPLETED|Overall Study||0
4983726|NCT02501590|12259329|P2|COMPLETED|Overall Study||35
4983727|NCT02501590|12259330|P1|COMPLETED|Overall Study||13
4983728|NCT02501590|12259329|P2|STARTED|Overall Study||35
4983729|NCT02501590|12259330|P1|STARTED|Overall Study||13
4983730|NCT02501161|12259338|P2|NOT COMPLETED|Overall Study||25
4983731|NCT02501161|12259339|P1|NOT COMPLETED|Overall Study||22
4983732|NCT02501161|12259338|P2|COMPLETED|Overall Study||481
4983733|NCT02501161|12259339|P1|COMPLETED|Overall Study||484
4983734|NCT02501161|12259338|P2|Exposed|Overall Study||504
4983735|NCT02501161|12259339|P1|Exposed|Overall Study||506
4983736|NCT02501161|12259338|P2|STARTED|Overall Study||506
4983737|NCT02501161|12259339|P1|STARTED|Overall Study||506
4983738|NCT02501135|12259451|P1|NOT COMPLETED|Overall Study||0
4983739|NCT02501135|12259451|P1|COMPLETED|Overall Study||281
4983740|NCT02501135|12259451|P1|STARTED|Overall Study||281
4983741|NCT02500979|12259463|P2|NOT COMPLETED|Period 2||0
4983742|NCT02500979|12259464|P1|NOT COMPLETED|Period 2||1
4983743|NCT02500979|12259463|P2|COMPLETED|Period 2||16
4983744|NCT02500979|12259464|P1|COMPLETED|Period 2||11
4983745|NCT02500979|12259463|P2|STARTED|Period 2||16
4983746|NCT02500979|12259464|P1|STARTED|Period 2||12
4983747|NCT02500979|12259463|P2|NOT COMPLETED|Period 1||1
4983748|NCT02500979|12259464|P1|NOT COMPLETED|Period 1||4
4983749|NCT02500979|12259463|P2|COMPLETED|Period 1||16
4983750|NCT02500979|12259464|P1|COMPLETED|Period 1||12
4983751|NCT02500979|12259463|P2|STARTED|Period 1||17
4983752|NCT02500979|12259464|P1|STARTED|Period 1||16
4983753|NCT02500901|12259498|P1|NOT COMPLETED|Overall Study||2
4983754|NCT02500901|12259498|P1|COMPLETED|Overall Study||0
4983755|NCT02500901|12259498|P1|STARTED|Overall Study||2
4983756|NCT02500836|12259507|P3|NOT COMPLETED|Overall Study||1
4983757|NCT02500836|12259508|P2|NOT COMPLETED|Overall Study||5
4983758|NCT02500836|12259509|P1|NOT COMPLETED|Overall Study||3
4983759|NCT02500836|12259507|P3|COMPLETED|Overall Study||127
4983760|NCT02500836|12259508|P2|COMPLETED|Overall Study||254
4983761|NCT02500836|12259509|P1|COMPLETED|Overall Study||256
4983762|NCT02500836|12259507|P3|STARTED|Overall Study||128
4983763|NCT02500836|12259508|P2|STARTED|Overall Study||259
4983764|NCT02500836|12259509|P1|STARTED|Overall Study||259
4983765|NCT02500797|12259526|P8|NOT COMPLETED|Overall Study||0
4983766|NCT02500797|12259527|P7|NOT COMPLETED|Overall Study||0
4983767|NCT02500797|12259528|P6|NOT COMPLETED|Overall Study||1
4983768|NCT02500797|12259529|P5|NOT COMPLETED|Overall Study||1
4983769|NCT02500797|12259530|P4|NOT COMPLETED|Overall Study||0
4983770|NCT02500797|12259531|P3|NOT COMPLETED|Overall Study||0
4983771|NCT02500797|12259532|P2|NOT COMPLETED|Overall Study||0
4983772|NCT02500797|12259533|P1|NOT COMPLETED|Overall Study||1
4983773|NCT02500797|12259526|P8|COMPLETED|Overall Study||11
4983774|NCT02500797|12259527|P7|COMPLETED|Overall Study||10
4983775|NCT02500797|12259528|P6|COMPLETED|Overall Study||14
4983776|NCT02500797|12259529|P5|COMPLETED|Overall Study||13
4983777|NCT02500797|12259530|P4|COMPLETED|Overall Study||14
4983778|NCT02500797|12259531|P3|COMPLETED|Overall Study||15
4983779|NCT02500797|12259532|P2|COMPLETED|Overall Study||42
4983780|NCT02500797|12259533|P1|COMPLETED|Overall Study||42
4983781|NCT02500797|12259526|P8|Arm I Crossover|Overall Study||0
4983782|NCT02500797|12259527|P7|Arm I Crossover|Overall Study||2
4983783|NCT02500797|12259528|P6|Arm I Crossover|Overall Study||0
4983784|NCT02500797|12259529|P5|Arm I Crossover|Overall Study||1
4983785|NCT02500797|12259530|P4|Arm I Crossover|Overall Study||0
4983786|NCT02500797|12259531|P3|Arm I Crossover|Overall Study||6
4983787|NCT02500797|12259532|P2|Arm I Crossover|Overall Study||0
4983788|NCT02500797|12259533|P1|Arm I Crossover|Overall Study||4
4983789|NCT02500797|12259526|P8|STARTED|Overall Study||11
4983790|NCT02500797|12259527|P7|STARTED|Overall Study||10
4983791|NCT02500797|12259528|P6|STARTED|Overall Study||15
4983792|NCT02500797|12259529|P5|STARTED|Overall Study||14
4983793|NCT02500797|12259530|P4|STARTED|Overall Study||14
4983794|NCT02500797|12259531|P3|STARTED|Overall Study||15
4983795|NCT02500797|12259532|P2|STARTED|Overall Study||42
4983796|NCT02500797|12259533|P1|STARTED|Overall Study||43
4983797|NCT02500758|12259593|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
4983798|NCT02500758|12259594|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
4983799|NCT02500758|12259593|P2|COMPLETED|Second Intervention (2 Minutes)||10
4983800|NCT02500758|12259594|P1|COMPLETED|Second Intervention (2 Minutes)||10
4983801|NCT02500758|12259593|P2|STARTED|Second Intervention (2 Minutes)||12
4983802|NCT02500758|12259594|P1|STARTED|Second Intervention (2 Minutes)||13
4983803|NCT02500758|12259593|P2|NOT COMPLETED|Washout (1 Week)||2
4983804|NCT02500758|12259594|P1|NOT COMPLETED|Washout (1 Week)||2
4983805|NCT02500758|12259593|P2|COMPLETED|Washout (1 Week)||12
4983806|NCT02500758|12259594|P1|COMPLETED|Washout (1 Week)||13
4983807|NCT02500758|12259593|P2|STARTED|Washout (1 Week)||14
4983808|NCT02500758|12259594|P1|STARTED|Washout (1 Week)||15
4983809|NCT02500758|12259593|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
4983810|NCT02500758|12259594|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
4983811|NCT02500758|12259593|P2|COMPLETED|First Intervention (2 Minutes)||14
4983812|NCT02500758|12259594|P1|COMPLETED|First Intervention (2 Minutes)||15
4983813|NCT02500758|12259593|P2|STARTED|First Intervention (2 Minutes)||15
4983814|NCT02500758|12259594|P1|STARTED|First Intervention (2 Minutes)||15
4983815|NCT02500732|12259604|P2|NOT COMPLETED|Overall Study||1
4983816|NCT02500732|12259605|P1|NOT COMPLETED|Overall Study||0
4983817|NCT02500732|12259604|P2|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
4983818|NCT02500732|12259605|P1|COMPLETED|Overall Study||27
4983819|NCT02500732|12259604|P2|STARTED|Overall Study||30
4983820|NCT02500732|12259605|P1|STARTED|Overall Study||27
4983821|NCT02500706|12259622|P3|NOT COMPLETED|Overall Study||7
4983822|NCT02500706|12259623|P2|NOT COMPLETED|Overall Study||7
4983823|NCT02500706|12259624|P1|NOT COMPLETED|Overall Study||4
4983824|NCT02500706|12259622|P3|COMPLETED|Overall Study||335
4983825|NCT02500706|12259623|P2|COMPLETED|Overall Study||334
4983826|NCT02500706|12259624|P1|COMPLETED|Overall Study||338
4983827|NCT02500706|12259622|P3|Exposed|Overall Study||342
4983828|NCT02500706|12259623|P2|Exposed|Overall Study||341
4983829|NCT02500706|12259624|P1|Exposed|Overall Study||342
4983830|NCT02500706|12259622|P3|STARTED|Overall Study||342
4983831|NCT02500706|12259623|P2|STARTED|Overall Study||341
4983832|NCT02500706|12259624|P1|STARTED|Overall Study||342
4983833|NCT02500641|12259778|P2|NOT COMPLETED|Overall Study||12
4983834|NCT02500641|12259779|P1|NOT COMPLETED|Overall Study||10
4983835|NCT02500641|12259778|P2|COMPLETED|Overall Study||86
4983836|NCT02500641|12259779|P1|COMPLETED|Overall Study||88
4983837|NCT02500641|12259778|P2|STARTED|Overall Study||98
4983838|NCT02500641|12259779|P1|STARTED|Overall Study||98
4983839|NCT02500628|12259787|P2|NOT COMPLETED|Overall Study||0
4983840|NCT02500628|12259788|P1|NOT COMPLETED|Overall Study||0
4983841|NCT02500628|12259787|P2|COMPLETED|Overall Study||23
4983842|NCT02500628|12259788|P1|COMPLETED|Overall Study||38
4983843|NCT02500628|12259787|P2|STARTED|Overall Study||23
4983844|NCT02500628|12259788|P1|STARTED|Overall Study||38
4983845|NCT02500537|12259800|P2|NOT COMPLETED|Overall Study||1
4983846|NCT02500537|12259801|P1|NOT COMPLETED|Overall Study||3
4983847|NCT02500537|12259800|P2|COMPLETED|Overall Study||39
4983848|NCT02500537|12259801|P1|COMPLETED|Overall Study||57
4983849|NCT02500537|12259800|P2|STARTED|Overall Study||40
4983850|NCT02500537|12259801|P1|STARTED|Overall Study||60
4983851|NCT02500368|12259819|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4983852|NCT02500368|12259820|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4983853|NCT02500368|12259819|P2|COMPLETED|Second Intervention (1 Week)||20
4983854|NCT02500368|12259820|P1|COMPLETED|Second Intervention (1 Week)||20
4983855|NCT02500368|12259819|P2|STARTED|Second Intervention (1 Week)||20
4983856|NCT02500368|12259820|P1|STARTED|Second Intervention (1 Week)||20
4983857|NCT02500368|12259819|P2|NOT COMPLETED|First Intervention (1 Week)||0
4983858|NCT02500368|12259820|P1|NOT COMPLETED|First Intervention (1 Week)||0
4983859|NCT02500368|12259819|P2|COMPLETED|First Intervention (1 Week)||20
4983860|NCT02500368|12259820|P1|COMPLETED|First Intervention (1 Week)||20
4983861|NCT02500368|12259819|P2|STARTED|First Intervention (1 Week)||20
4983862|NCT02500368|12259820|P1|STARTED|First Intervention (1 Week)||20
4983863|NCT02500056|12259870|P2|NOT COMPLETED|Overall Study||8
4983864|NCT02500056|12259871|P1|NOT COMPLETED|Overall Study||7
4983865|NCT02500056|12259870|P2|COMPLETED|Overall Study||65
4983866|NCT02500056|12259871|P1|COMPLETED|Overall Study||63
4983867|NCT02500056|12259870|P2|STARTED|Overall Study||73
4983868|NCT02500056|12259871|P1|STARTED|Overall Study||70
4983869|NCT02499952|12259881|P1|NOT COMPLETED|Overall Study||10
4983870|NCT02499952|12259881|P1|COMPLETED|Overall Study||2
4983871|NCT02499952|12259881|P1|STARTED|Overall Study||12
4983872|NCT02499900|12259890|P2|NOT COMPLETED|Extension Study Period||20
4983873|NCT02499900|12259891|P1|NOT COMPLETED|Extension Study Period||12
4983874|NCT02499900|12259890|P2|COMPLETED|Extension Study Period||377
4983875|NCT02499900|12259891|P1|COMPLETED|Extension Study Period||380
4983876|NCT02499900|12259890|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
4983877|NCT02499900|12259891|P1|Safety Analysis Set|Extension Study Period||392
4983878|NCT02499900|12259890|P2|STARTED|Extension Study Period||397
4983879|NCT02499900|12259891|P1|STARTED|Extension Study Period||392
4983880|NCT02499900|12259890|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
4983881|NCT02499900|12259891|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
4983882|NCT02499900|12259890|P2|COMPLETED|Completed Core, Continued Into Extension||397
4983883|NCT02499900|12259891|P1|COMPLETED|Completed Core, Continued Into Extension||392
4983884|NCT02499900|12259890|P2|STARTED|Completed Core, Continued Into Extension||399
4983885|NCT02499900|12259891|P1|STARTED|Completed Core, Continued Into Extension||395
4983886|NCT02499900|12259890|P2|NOT COMPLETED|Core Study Period||32
4983887|NCT02499900|12259891|P1|NOT COMPLETED|Core Study Period||35
4983888|NCT02499900|12259890|P2|COMPLETED|Core Study Period||399
4983889|NCT02499900|12259891|P1|COMPLETED|Core Study Period||395
4983890|NCT02499900|12259890|P2|Safety Analysis Set|Core Study Period||430
4983891|NCT02499900|12259891|P1|Safety Analysis Set|Core Study Period||427
4983892|NCT02499900|12259890|P2|STARTED|Core Study Period||431
4983893|NCT02499900|12259891|P1|STARTED|Core Study Period||430
4983894|NCT02499887|12259913|P2|NOT COMPLETED|Overall Study||0
4983895|NCT02499887|12259914|P1|NOT COMPLETED|Overall Study||0
4983896|NCT02499887|12259913|P2|COMPLETED|Overall Study||3
4983897|NCT02499887|12259914|P1|COMPLETED|Overall Study||3
4983898|NCT02499887|12259913|P2|STARTED|Overall Study||3
4983899|NCT02499887|12259914|P1|STARTED|Overall Study||3
4983900|NCT02499783|12259922|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
4983901|NCT02499783|12259923|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
4983902|NCT02499783|12259924|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
4983903|NCT02499783|12259922|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
4983904|NCT02499783|12259923|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
4983905|NCT02499783|12259924|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
4983906|NCT02499783|12259922|P3|STARTED|Open Label Period: Weeks 8 to 26||188
4983907|NCT02499783|12259923|P2|STARTED|Open Label Period: Weeks 8 to 26||0
4983908|NCT02499783|12259924|P1|STARTED|Open Label Period: Weeks 8 to 26||0
4983909|NCT02499783|12259922|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
4983910|NCT02499783|12259923|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
4983911|NCT02499783|12259924|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
4983912|NCT02499783|12259922|P3|COMPLETED|DB Period: Weeks 0-8||0
4983913|NCT02499783|12259923|P2|COMPLETED|DB Period: Weeks 0-8||96
4983914|NCT02499783|12259924|P1|COMPLETED|DB Period: Weeks 0-8||92
4983915|NCT02499783|12259922|P3|STARTED|DB Period: Weeks 0-8||0
4983916|NCT02499783|12259923|P2|STARTED|DB Period: Weeks 0-8||103
4983917|NCT02499783|12259924|P1|STARTED|DB Period: Weeks 0-8||102
4983918|NCT02499783|12259922|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
4983919|NCT02499783|12259923|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
4983920|NCT02499783|12259924|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
4983921|NCT02499783|12259922|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
4983922|NCT02499783|12259923|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
4983923|NCT02499783|12259924|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
4983924|NCT02499783|12259922|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
4983925|NCT02499783|12259923|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
4983926|NCT02499783|12259924|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
4983927|NCT02499770|12259973|P2|NOT COMPLETED|Overall Study||77
4983928|NCT02499770|12259974|P1|NOT COMPLETED|Overall Study||19
4983929|NCT02499770|12259973|P2|COMPLETED|Overall Study||0
4983930|NCT02499770|12259974|P1|COMPLETED|Overall Study||0
4983931|NCT02499770|12259973|P2|STARTED|Overall Study||77
4983932|NCT02499770|12259974|P1|STARTED|Overall Study||19
4983933|NCT02499692|12260083|P1|NOT COMPLETED|Overall Study||0
4983934|NCT02499692|12260083|P1|COMPLETED|Overall Study||103
4983935|NCT02499692|12260083|P1|STARTED|Overall Study||103
4983936|NCT02499575|12260094|P2|NOT COMPLETED|Overall Study||1
4983937|NCT02499575|12260095|P1|NOT COMPLETED|Overall Study||0
4983938|NCT02499575|12260094|P2|COMPLETED|Overall Study||0
4983939|NCT02499575|12260095|P1|COMPLETED|Overall Study||1
4983940|NCT02499575|12260094|P2|STARTED|Overall Study||1
4983941|NCT02499575|12260095|P1|STARTED|Overall Study||1
4983942|NCT02499406|12260105|P1|NOT COMPLETED|Overall Study||4
4983943|NCT02499406|12260105|P1|COMPLETED|Overall Study||13
4983944|NCT02499406|12260105|P1|STARTED|Overall Study||17
4983945|NCT02499380|12260121|P1|NOT COMPLETED|Overall Study||3
4983946|NCT02499380|12260121|P1|COMPLETED|Overall Study||17
4983947|NCT02499380|12260121|P1|STARTED|Overall Study||20
4983948|NCT02499263|12260126|P1|NOT COMPLETED|Overall Study||62
4983949|NCT02499263|12260126|P1|COMPLETED|Overall Study||84
4983950|NCT02499263|12260126|P1|STARTED|Overall Study||146
4983951|NCT02499172|12260163|P4|NOT COMPLETED|Overall Study||436
4983952|NCT02499172|12260164|P3|NOT COMPLETED|Overall Study||523
4983953|NCT02499172|12260165|P2|NOT COMPLETED|Overall Study||64
4983954|NCT02499172|12260166|P1|NOT COMPLETED|Overall Study||65
4983955|NCT02499172|12260163|P4|COMPLETED|Overall Study||0
4983956|NCT02499172|12260164|P3|COMPLETED|Overall Study||0
4983957|NCT02499172|12260165|P2|COMPLETED|Overall Study||835
4983958|NCT02499172|12260166|P1|COMPLETED|Overall Study||835
4983959|NCT02499172|12260163|P4|STARTED|Overall Study||436
4983960|NCT02499172|12260164|P3|STARTED|Overall Study||523
4983961|NCT02499172|12260165|P2|STARTED|Overall Study||899
4983962|NCT02499172|12260166|P1|STARTED|Overall Study||900
4983963|NCT02499159|12260178|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
4983964|NCT02499159|12260179|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
4983965|NCT02499159|12260178|P2|COMPLETED|30-Day Follow-Up Phone Call||47
4983966|NCT02499159|12260179|P1|COMPLETED|30-Day Follow-Up Phone Call||42
4983967|NCT02499159|12260178|P2|STARTED|30-Day Follow-Up Phone Call||49
4983968|NCT02499159|12260179|P1|STARTED|30-Day Follow-Up Phone Call||49
4983969|NCT02499159|12260178|P2|NOT COMPLETED|Randomization||1
4983970|NCT02499159|12260179|P1|NOT COMPLETED|Randomization||1
4983971|NCT02499159|12260178|P2|COMPLETED|Randomization||49
4983972|NCT02499159|12260179|P1|COMPLETED|Randomization||49
4983973|NCT02499159|12260178|P2|STARTED|Randomization||50
4983974|NCT02499159|12260179|P1|STARTED|Randomization||50
4983975|NCT02499146|12260203|P1|NOT COMPLETED|Overall Study||26
4983976|NCT02499146|12260203|P1|COMPLETED|Overall Study||0
4983977|NCT02499146|12260203|P1|STARTED|Overall Study||26
4983978|NCT02499120|12260243|P2|NOT COMPLETED|Overall Study||60
4983979|NCT02499120|12260244|P1|NOT COMPLETED|Overall Study||65
4983980|NCT02499120|12260243|P2|COMPLETED|Overall Study||0
4983981|NCT02499120|12260244|P1|COMPLETED|Overall Study||0
4983982|NCT02499120|12260243|P2|Received Treatment|Overall Study||60
4983983|NCT02499120|12260244|P1|Received Treatment|Overall Study||64
4983984|NCT02499120|12260243|P2|STARTED|Overall Study||60
4983985|NCT02499120|12260244|P1|STARTED|Overall Study||65
4983986|NCT02499029|12260275|P2|NOT COMPLETED|Overall Study||3
4983987|NCT02499029|12260276|P1|NOT COMPLETED|Overall Study||5
4983988|NCT02499029|12260275|P2|COMPLETED|Overall Study||14
4983989|NCT02499029|12260276|P1|COMPLETED|Overall Study||13
4983990|NCT02499029|12260275|P2|STARTED|Overall Study||17
4983991|NCT02499029|12260276|P1|STARTED|Overall Study||18
4983992|NCT02498834|12260290|P2|NOT COMPLETED|Overall Study||10
4983993|NCT02498834|12260291|P1|NOT COMPLETED|Overall Study||10
4983994|NCT02498834|12260290|P2|COMPLETED|Overall Study||164
4983995|NCT02498834|12260291|P1|COMPLETED|Overall Study||175
4983996|NCT02498834|12260290|P2|STARTED|Overall Study||174
4983997|NCT02498834|12260291|P1|STARTED|Overall Study||185
4983998|NCT02498821|12260303|P2|NOT COMPLETED|Overall Study||5
4983999|NCT02498821|12260304|P1|NOT COMPLETED|Overall Study||3
4984000|NCT02498821|12260303|P2|COMPLETED|Overall Study||60
4984001|NCT02498821|12260304|P1|COMPLETED|Overall Study||60
4984002|NCT02498821|12260303|P2|STARTED|Overall Study||65
4984003|NCT02498821|12260304|P1|STARTED|Overall Study||63
4984004|NCT02498769|12260333|P2|NOT COMPLETED|Overall Study||0
4984005|NCT02498769|12260334|P1|NOT COMPLETED|Overall Study||0
4984006|NCT02498769|12260333|P2|COMPLETED|Overall Study||67
4984007|NCT02498769|12260334|P1|COMPLETED|Overall Study||63
4984008|NCT02498769|12260333|P2|STARTED|Overall Study||67
4984009|NCT02498769|12260334|P1|STARTED|Overall Study||63
4984010|NCT02498678|12260348|P2|NOT COMPLETED|Overall Study||2
4984011|NCT02498678|12260349|P1|NOT COMPLETED|Overall Study||0
4984012|NCT02498678|12260348|P2|COMPLETED|Overall Study||23
4984013|NCT02498678|12260349|P1|COMPLETED|Overall Study||25
4984014|NCT02498678|12260348|P2|STARTED|Overall Study||25
4984015|NCT02498678|12260349|P1|STARTED|Overall Study||25
4984016|NCT02498652|12260365|P2|NOT COMPLETED|Overall Study||1
4984017|NCT02498652|12260366|P1|NOT COMPLETED|Overall Study||0
4984018|NCT02498652|12260365|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
4984019|NCT02498652|12260366|P1|COMPLETED|Overall Study||20
4984020|NCT02498652|12260365|P2|STARTED|Overall Study||21
4984021|NCT02498652|12260366|P1|STARTED|Overall Study||20
4984022|NCT02498522|12260467|P2|NOT COMPLETED|Overall Study||2
4984023|NCT02498522|12260468|P1|NOT COMPLETED|Overall Study||2
4984024|NCT02498522|12260467|P2|COMPLETED|Overall Study||83
4984025|NCT02498522|12260468|P1|COMPLETED|Overall Study||83
4984026|NCT02498522|12260467|P2|STARTED|Overall Study||85
4984027|NCT02498522|12260468|P1|STARTED|Overall Study||85
4984028|NCT02498483|12260476|P2|NOT COMPLETED|Overall Study||0
4984029|NCT02498483|12260477|P1|NOT COMPLETED|Overall Study||0
4984030|NCT02498483|12260476|P2|COMPLETED|Overall Study||5
4984031|NCT02498483|12260477|P1|COMPLETED|Overall Study||6
4984032|NCT02498483|12260476|P2|STARTED|Overall Study||5
4984033|NCT02498483|12260477|P1|STARTED|Overall Study||6
4984034|NCT02498418|12260494|P3|NOT COMPLETED|Overall Study||6
4984035|NCT02498418|12260495|P2|NOT COMPLETED|Overall Study||2
4984036|NCT02498418|12260496|P1|NOT COMPLETED|Overall Study||2
4984037|NCT02498418|12260494|P3|COMPLETED|Overall Study||238
4984038|NCT02498418|12260495|P2|COMPLETED|Overall Study||246
4984039|NCT02498418|12260496|P1|COMPLETED|Overall Study||245
4984040|NCT02498418|12260494|P3|Per-protocol Analysis Set|Overall Study||176
4984041|NCT02498418|12260495|P2|Per-protocol Analysis Set|Overall Study||181
4984042|NCT02498418|12260496|P1|Per-protocol Analysis Set|Overall Study||182
4984043|NCT02498418|12260494|P3|Modified Intent-to-treat Population|Overall Study||180
4984044|NCT02498418|12260495|P2|Modified Intent-to-treat Population|Overall Study||186
4984045|NCT02498418|12260496|P1|Modified Intent-to-treat Population|Overall Study||183
4984046|NCT02498418|12260494|P3|Safety Population|Overall Study||244
4984047|NCT02498418|12260495|P2|Safety Population|Overall Study||247
4984048|NCT02498418|12260496|P1|Safety Population|Overall Study||246
4984049|NCT02498418|12260494|P3|STARTED|Overall Study||244
4984050|NCT02498418|12260495|P2|STARTED|Overall Study||248
4984051|NCT02498418|12260496|P1|STARTED|Overall Study||247
4984052|NCT02498236|12260520|P8|NOT COMPLETED|Overall Study||1
4984053|NCT02498236|12260521|P7|NOT COMPLETED|Overall Study||1
4984054|NCT02498236|12260522|P6|NOT COMPLETED|Overall Study||0
4984055|NCT02498236|12260523|P5|NOT COMPLETED|Overall Study||1
4984056|NCT02498236|12260524|P4|NOT COMPLETED|Overall Study||0
4984057|NCT02498236|12260525|P3|NOT COMPLETED|Overall Study||0
4984058|NCT02498236|12260526|P2|NOT COMPLETED|Overall Study||0
4984059|NCT02498236|12260527|P1|NOT COMPLETED|Overall Study||1
4984060|NCT02498236|12260520|P8|COMPLETED|Overall Study||6
4984061|NCT02498236|12260521|P7|COMPLETED|Overall Study||6
4984062|NCT02498236|12260522|P6|COMPLETED|Overall Study||6
4984063|NCT02498236|12260523|P5|COMPLETED|Overall Study||6
4984064|NCT02498236|12260524|P4|COMPLETED|Overall Study||6
4984065|NCT02498236|12260525|P3|COMPLETED|Overall Study||6
4984066|NCT02498236|12260526|P2|COMPLETED|Overall Study||6
4984067|NCT02498236|12260527|P1|COMPLETED|Overall Study||5
4984068|NCT02498236|12260520|P8|Randomized|Overall Study||7
4984069|NCT02498236|12260521|P7|Randomized|Overall Study||7
4984070|NCT02498236|12260522|P6|Randomized|Overall Study||6
4984071|NCT02498236|12260523|P5|Randomized|Overall Study||7
4984072|NCT02498236|12260524|P4|Randomized|Overall Study||6
4984073|NCT02498236|12260525|P3|Randomized|Overall Study||6
4984074|NCT02498236|12260526|P2|Randomized|Overall Study||6
4984075|NCT02498236|12260527|P1|Randomized|Overall Study||6
4984076|NCT02498236|12260520|P8|STARTED|Overall Study||7
4984077|NCT02498236|12260521|P7|STARTED|Overall Study||7
4984078|NCT02498236|12260522|P6|STARTED|Overall Study||6
4984079|NCT02498236|12260523|P5|STARTED|Overall Study||7
4984080|NCT02498236|12260524|P4|STARTED|Overall Study||6
4984081|NCT02498236|12260525|P3|STARTED|Overall Study||6
4984082|NCT02498236|12260526|P2|STARTED|Overall Study||6
4984083|NCT02498236|12260527|P1|STARTED|Overall Study||6
4984084|NCT02498067|12260556|P1|NOT COMPLETED|Overall Study||33
4984085|NCT02498067|12260556|P1|COMPLETED|Overall Study||71
4984086|NCT02498067|12260556|P1|STARTED|Overall Study||104
4984087|NCT02497976|12260577|P2|NOT COMPLETED|Overall Study||1
4984088|NCT02497976|12260578|P1|NOT COMPLETED|Overall Study||2
4984089|NCT02497976|12260577|P2|COMPLETED|Overall Study||13
4984090|NCT02497976|12260578|P1|COMPLETED|Overall Study||26
4984091|NCT02497976|12260577|P2|STARTED|Overall Study||14
4984092|NCT02497976|12260578|P1|STARTED|Overall Study||28
4984093|NCT02497937|12260594|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
4984094|NCT02497937|12260595|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
4984095|NCT02497937|12260594|P2|COMPLETED|Period 2 (Up to 7 Days)||5
4984096|NCT02497937|12260595|P1|COMPLETED|Period 2 (Up to 7 Days)||6
4984097|NCT02497937|12260594|P2|STARTED|Period 2 (Up to 7 Days)||5
4984098|NCT02497937|12260595|P1|STARTED|Period 2 (Up to 7 Days)||6
4984099|NCT02497937|12260594|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4984100|NCT02497937|12260595|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4984101|NCT02497937|12260594|P2|COMPLETED|Washout Period (Up to 14 Days)||5
4984102|NCT02497937|12260595|P1|COMPLETED|Washout Period (Up to 14 Days)||6
4984103|NCT02497937|12260594|P2|STARTED|Washout Period (Up to 14 Days)||5
4984104|NCT02497937|12260595|P1|STARTED|Washout Period (Up to 14 Days)||6
4984105|NCT02497937|12260594|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
4984106|NCT02497937|12260595|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
4984107|NCT02497937|12260594|P2|COMPLETED|Period 1 (Up to 7 Days)||5
4984108|NCT02497937|12260595|P1|COMPLETED|Period 1 (Up to 7 Days)||6
4984109|NCT02497937|12260594|P2|STARTED|Period 1 (Up to 7 Days)||5
4984110|NCT02497937|12260595|P1|STARTED|Period 1 (Up to 7 Days)||6
4984111|NCT02497781|12260673|P2|NOT COMPLETED|Overall Study||3
4984112|NCT02497781|12260674|P1|NOT COMPLETED|Overall Study||4
4984113|NCT02497781|12260673|P2|COMPLETED|Overall Study||26
4984114|NCT02497781|12260674|P1|COMPLETED|Overall Study||64
4984115|NCT02497781|12260673|P2|Treated|Overall Study||28
4984116|NCT02497781|12260674|P1|Treated|Overall Study||67
4984117|NCT02497781|12260673|P2|STARTED|Overall Study||29
4984118|NCT02497781|12260674|P1|STARTED|Overall Study||68
4984119|NCT02497755|12260737|P2|NOT COMPLETED|Overall Study||0
4984120|NCT02497755|12260738|P1|NOT COMPLETED|Overall Study||1
4984121|NCT02497755|12260737|P2|COMPLETED|Overall Study||1
4984122|NCT02497755|12260738|P1|COMPLETED|Overall Study||17
4984123|NCT02497755|12260737|P2|STARTED|Overall Study||1
4984124|NCT02497755|12260738|P1|STARTED|Overall Study||18
4984125|NCT02497469|12260753|P2|NOT COMPLETED|Overall Study||115
4984126|NCT02497469|12260754|P1|NOT COMPLETED|Overall Study||169
4984127|NCT02497469|12260753|P2|COMPLETED|Overall Study||270
4984128|NCT02497469|12260754|P1|COMPLETED|Overall Study||217
4984129|NCT02497469|12260753|P2|Safety Analysis Set|Overall Study||383
4984130|NCT02497469|12260754|P1|Safety Analysis Set|Overall Study||386
4984131|NCT02497469|12260753|P2|STARTED|Overall Study||385
4984132|NCT02497469|12260754|P1|STARTED|Overall Study||386
4984133|NCT02497391|12260764|P6|NOT COMPLETED|Period 3 (14 Days)||0
4984134|NCT02497391|12260765|P5|NOT COMPLETED|Period 3 (14 Days)||1
4984135|NCT02497391|12260766|P4|NOT COMPLETED|Period 3 (14 Days)||0
4984136|NCT02497391|12260767|P3|NOT COMPLETED|Period 3 (14 Days)||1
4984137|NCT02497391|12260768|P2|NOT COMPLETED|Period 3 (14 Days)||1
4984138|NCT02497391|12260769|P1|NOT COMPLETED|Period 3 (14 Days)||0
4984139|NCT02497391|12260764|P6|COMPLETED|Period 3 (14 Days)||13
4984140|NCT02497391|12260765|P5|COMPLETED|Period 3 (14 Days)||13
4984141|NCT02497391|12260766|P4|COMPLETED|Period 3 (14 Days)||13
4984142|NCT02497391|12260767|P3|COMPLETED|Period 3 (14 Days)||12
4984143|NCT02497391|12260768|P2|COMPLETED|Period 3 (14 Days)||13
4984144|NCT02497391|12260769|P1|COMPLETED|Period 3 (14 Days)||12
4984145|NCT02497391|12260764|P6|STARTED|Period 3 (14 Days)||13
4984146|NCT02497391|12260765|P5|STARTED|Period 3 (14 Days)||14
4984147|NCT02497391|12260766|P4|STARTED|Period 3 (14 Days)||13
4984148|NCT02497391|12260767|P3|STARTED|Period 3 (14 Days)||13
4984149|NCT02497391|12260768|P2|STARTED|Period 3 (14 Days)||14
4984150|NCT02497391|12260769|P1|STARTED|Period 3 (14 Days)||12
4984151|NCT02497391|12260764|P6|NOT COMPLETED|Period 2 (14 Days)||3
4984152|NCT02497391|12260765|P5|NOT COMPLETED|Period 2 (14 Days)||2
4984153|NCT02497391|12260766|P4|NOT COMPLETED|Period 2 (14 Days)||3
4984154|NCT02497391|12260767|P3|NOT COMPLETED|Period 2 (14 Days)||3
4984155|NCT02497391|12260768|P2|NOT COMPLETED|Period 2 (14 Days)||1
4984156|NCT02497391|12260769|P1|NOT COMPLETED|Period 2 (14 Days)||4
4984157|NCT02497391|12260764|P6|COMPLETED|Period 2 (14 Days)||13
4984158|NCT02497391|12260765|P5|COMPLETED|Period 2 (14 Days)||14
4984159|NCT02497391|12260766|P4|COMPLETED|Period 2 (14 Days)||13
4984160|NCT02497391|12260767|P3|COMPLETED|Period 2 (14 Days)||13
4984161|NCT02497391|12260768|P2|COMPLETED|Period 2 (14 Days)||14
4984162|NCT02497391|12260769|P1|COMPLETED|Period 2 (14 Days)||12
4984163|NCT02497391|12260764|P6|STARTED|Period 2 (14 Days)||16
4984164|NCT02497391|12260765|P5|STARTED|Period 2 (14 Days)||16
4984165|NCT02497391|12260766|P4|STARTED|Period 2 (14 Days)||16
4984166|NCT02497391|12260767|P3|STARTED|Period 2 (14 Days)||16
4984167|NCT02497391|12260768|P2|STARTED|Period 2 (14 Days)||15
4984168|NCT02497391|12260769|P1|STARTED|Period 2 (14 Days)||16
4984169|NCT02497391|12260764|P6|NOT COMPLETED|Period 1 (14 Days)||0
4984170|NCT02497391|12260765|P5|NOT COMPLETED|Period 1 (14 Days)||0
4984171|NCT02497391|12260766|P4|NOT COMPLETED|Period 1 (14 Days)||0
4984172|NCT02497391|12260767|P3|NOT COMPLETED|Period 1 (14 Days)||0
4984173|NCT02497391|12260768|P2|NOT COMPLETED|Period 1 (14 Days)||0
4984174|NCT02497391|12260769|P1|NOT COMPLETED|Period 1 (14 Days)||0
4984175|NCT02497391|12260764|P6|COMPLETED|Period 1 (14 Days)||16
4984176|NCT02497391|12260765|P5|COMPLETED|Period 1 (14 Days)||16
4984177|NCT02497391|12260766|P4|COMPLETED|Period 1 (14 Days)||16
4984178|NCT02497391|12260767|P3|COMPLETED|Period 1 (14 Days)||16
4984179|NCT02497391|12260768|P2|COMPLETED|Period 1 (14 Days)||15
4984180|NCT02497391|12260769|P1|COMPLETED|Period 1 (14 Days)||16
4984181|NCT02497391|12260764|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
4984182|NCT02497391|12260765|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
4984183|NCT02497391|12260766|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
4984184|NCT02497391|12260767|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
4984185|NCT02497391|12260768|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
4984186|NCT02497391|12260769|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
4984187|NCT02497391|12260764|P6|STARTED|Period 1 (14 Days)||16
4984188|NCT02497391|12260765|P5|STARTED|Period 1 (14 Days)||16
4984189|NCT02497391|12260766|P4|STARTED|Period 1 (14 Days)||16
4984190|NCT02497391|12260767|P3|STARTED|Period 1 (14 Days)||16
4984191|NCT02497391|12260768|P2|STARTED|Period 1 (14 Days)||15
4984192|NCT02497391|12260769|P1|STARTED|Period 1 (14 Days)||16
4984193|NCT02497287|12260780|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
4984194|NCT02497287|12260780|P1|COMPLETED|Follow-up Phase (4 Week)||326
4984195|NCT02497287|12260780|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
4984196|NCT02497287|12260780|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
4984197|NCT02497287|12260780|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
4984198|NCT02497287|12260780|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
4984199|NCT02497287|12260780|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
4984200|NCT02497287|12260780|P1|COMPLETED|Induction Phase (4 Weeks)||580
4984201|NCT02497287|12260780|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
4984202|NCT02497235|12260824|P5|NOT COMPLETED|Overall Study||0
4984203|NCT02497235|12260825|P4|NOT COMPLETED|Overall Study||0
4984204|NCT02497235|12260826|P3|NOT COMPLETED|Overall Study||0
4984205|NCT02497235|12260827|P2|NOT COMPLETED|Overall Study||0
4984206|NCT02497235|12260828|P1|NOT COMPLETED|Overall Study||0
4984207|NCT02497235|12260824|P5|COMPLETED|Overall Study||3
4984208|NCT02497235|12260825|P4|COMPLETED|Overall Study||2
4984209|NCT02497235|12260826|P3|COMPLETED|Overall Study||2
4984210|NCT02497235|12260827|P2|COMPLETED|Overall Study||2
4984211|NCT02497235|12260828|P1|COMPLETED|Overall Study||2
4984212|NCT02497235|12260824|P5|STARTED|Overall Study||3
4984213|NCT02497235|12260825|P4|STARTED|Overall Study||2
4984214|NCT02497235|12260826|P3|STARTED|Overall Study||2
4984215|NCT02497235|12260827|P2|STARTED|Overall Study||2
4984216|NCT02497235|12260828|P1|STARTED|Overall Study||2
4984217|NCT02497040|12260861|P3|NOT COMPLETED|Overall Study||0
4984218|NCT02497040|12260862|P2|NOT COMPLETED|Overall Study||0
4984219|NCT02497040|12260863|P1|NOT COMPLETED|Overall Study||0
4984220|NCT02497040|12260861|P3|COMPLETED|Overall Study||30
4984221|NCT02497040|12260862|P2|COMPLETED|Overall Study||30
4984222|NCT02497040|12260863|P1|COMPLETED|Overall Study||30
4984223|NCT02497040|12260861|P3|STARTED|Overall Study||30
4984224|NCT02497040|12260862|P2|STARTED|Overall Study||30
4984225|NCT02497040|12260863|P1|STARTED|Overall Study||30
4984226|NCT02496767|12260875|P8|NOT COMPLETED|Double-blind, Withdrawal Phase||5
4984227|NCT02496767|12260876|P7|NOT COMPLETED|Double-blind, Withdrawal Phase||4
4984228|NCT02496767|12260877|P6|NOT COMPLETED|Double-blind, Withdrawal Phase||6
4984229|NCT02496767|12260878|P5|NOT COMPLETED|Double-blind, Withdrawal Phase||0
4984230|NCT02496767|12260879|P4|NOT COMPLETED|Double-blind, Withdrawal Phase||0
4984231|NCT02496767|12260880|P3|NOT COMPLETED|Double-blind, Withdrawal Phase||0
4984232|NCT02496767|12260881|P2|NOT COMPLETED|Double-blind, Withdrawal Phase||0
4984233|NCT02496767|12260882|P1|NOT COMPLETED|Double-blind, Withdrawal Phase||0
4984234|NCT02496767|12260875|P8|COMPLETED|Double-blind, Withdrawal Phase||96
4984235|NCT02496767|12260876|P7|COMPLETED|Double-blind, Withdrawal Phase||99
4984236|NCT02496767|12260877|P6|COMPLETED|Double-blind, Withdrawal Phase||126
4984237|NCT02496767|12260878|P5|COMPLETED|Double-blind, Withdrawal Phase||0
4984238|NCT02496767|12260879|P4|COMPLETED|Double-blind, Withdrawal Phase||0
4984239|NCT02496767|12260880|P3|COMPLETED|Double-blind, Withdrawal Phase||0
4984240|NCT02496767|12260881|P2|COMPLETED|Double-blind, Withdrawal Phase||0
4984241|NCT02496767|12260882|P1|COMPLETED|Double-blind, Withdrawal Phase||0
4984242|NCT02496767|12260875|P8|STARTED|Double-blind, Withdrawal Phase||101
4984243|NCT02496767|12260876|P7|STARTED|Double-blind, Withdrawal Phase||103
4984244|NCT02496767|12260877|P6|STARTED|Double-blind, Withdrawal Phase||132
4984245|NCT02496767|12260878|P5|STARTED|Double-blind, Withdrawal Phase||0
4984246|NCT02496767|12260879|P4|STARTED|Double-blind, Withdrawal Phase||0
4984247|NCT02496767|12260880|P3|STARTED|Double-blind, Withdrawal Phase||0
4984248|NCT02496767|12260881|P2|STARTED|Double-blind, Withdrawal Phase||0
4984249|NCT02496767|12260882|P1|STARTED|Double-blind, Withdrawal Phase||0
4984250|NCT02496767|12260875|P8|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
4984251|NCT02496767|12260876|P7|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
4984252|NCT02496767|12260877|P6|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
4984253|NCT02496767|12260878|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
4984254|NCT02496767|12260879|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
4984255|NCT02496767|12260880|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
4984256|NCT02496767|12260881|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
4984257|NCT02496767|12260882|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
4984258|NCT02496767|12260875|P8|COMPLETED|Double-blind, Placebo-controlled Phase||0
4984259|NCT02496767|12260876|P7|COMPLETED|Double-blind, Placebo-controlled Phase||0
4984260|NCT02496767|12260877|P6|COMPLETED|Double-blind, Placebo-controlled Phase||0
4984261|NCT02496767|12260878|P5|COMPLETED|Double-blind, Placebo-controlled Phase||59
4984262|NCT02496767|12260879|P4|COMPLETED|Double-blind, Placebo-controlled Phase||65
4984263|NCT02496767|12260880|P3|COMPLETED|Double-blind, Placebo-controlled Phase||80
4984264|NCT02496767|12260881|P2|COMPLETED|Double-blind, Placebo-controlled Phase||132
4984265|NCT02496767|12260882|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
4984266|NCT02496767|12260875|P8|STARTED|Double-blind, Placebo-controlled Phase||0
4984267|NCT02496767|12260876|P7|STARTED|Double-blind, Placebo-controlled Phase||0
4984268|NCT02496767|12260877|P6|STARTED|Double-blind, Placebo-controlled Phase||0
4984269|NCT02496767|12260878|P5|STARTED|Double-blind, Placebo-controlled Phase||125
4984270|NCT02496767|12260879|P4|STARTED|Double-blind, Placebo-controlled Phase||126
4984271|NCT02496767|12260880|P3|STARTED|Double-blind, Placebo-controlled Phase||126
4984272|NCT02496767|12260881|P2|STARTED|Double-blind, Placebo-controlled Phase||188
4984273|NCT02496767|12260882|P1|STARTED|Double-blind, Placebo-controlled Phase||0
4984274|NCT02496767|12260875|P8|NOT COMPLETED|Open-label Lead-in Phase||0
4984275|NCT02496767|12260876|P7|NOT COMPLETED|Open-label Lead-in Phase||0
4984276|NCT02496767|12260877|P6|NOT COMPLETED|Open-label Lead-in Phase||0
4984277|NCT02496767|12260878|P5|NOT COMPLETED|Open-label Lead-in Phase||0
4984278|NCT02496767|12260879|P4|NOT COMPLETED|Open-label Lead-in Phase||0
4984279|NCT02496767|12260880|P3|NOT COMPLETED|Open-label Lead-in Phase||0
4984280|NCT02496767|12260881|P2|NOT COMPLETED|Open-label Lead-in Phase||0
4984281|NCT02496767|12260882|P1|NOT COMPLETED|Open-label Lead-in Phase||179
4984282|NCT02496767|12260875|P8|COMPLETED|Open-label Lead-in Phase||0
4984283|NCT02496767|12260876|P7|COMPLETED|Open-label Lead-in Phase||0
4984284|NCT02496767|12260877|P6|COMPLETED|Open-label Lead-in Phase||0
4984285|NCT02496767|12260878|P5|COMPLETED|Open-label Lead-in Phase||0
4984286|NCT02496767|12260879|P4|COMPLETED|Open-label Lead-in Phase||0
4984287|NCT02496767|12260880|P3|COMPLETED|Open-label Lead-in Phase||0
4984288|NCT02496767|12260881|P2|COMPLETED|Open-label Lead-in Phase||0
4984289|NCT02496767|12260882|P1|COMPLETED|Open-label Lead-in Phase||565
4984290|NCT02496767|12260875|P8|STARTED|Open-label Lead-in Phase||0
4984291|NCT02496767|12260876|P7|STARTED|Open-label Lead-in Phase||0
4984292|NCT02496767|12260877|P6|STARTED|Open-label Lead-in Phase||0
4984293|NCT02496767|12260878|P5|STARTED|Open-label Lead-in Phase||0
4984294|NCT02496767|12260879|P4|STARTED|Open-label Lead-in Phase||0
4984295|NCT02496767|12260880|P3|STARTED|Open-label Lead-in Phase||0
4984296|NCT02496767|12260881|P2|STARTED|Open-label Lead-in Phase||0
4984297|NCT02496767|12260882|P1|STARTED|Open-label Lead-in Phase||744
4984298|NCT02496702|12260922|P2|NOT COMPLETED|Overall Study||8
4984299|NCT02496702|12260923|P1|NOT COMPLETED|Overall Study||8
4984300|NCT02496702|12260922|P2|COMPLETED|Overall Study||22
4984301|NCT02496702|12260923|P1|COMPLETED|Overall Study||22
4984302|NCT02496702|12260922|P2|Did Not Receive Allocated Intervention|Overall Study||0
4984303|NCT02496702|12260923|P1|Did Not Receive Allocated Intervention|Overall Study||9
4984304|NCT02496702|12260922|P2|Received Allocated Intervention|Overall Study||0
4984305|NCT02496702|12260923|P1|Received Allocated Intervention|Overall Study||21
4984306|NCT02496702|12260922|P2|STARTED|Overall Study||30
4984307|NCT02496702|12260923|P1|STARTED|Overall Study||30
4984308|NCT02496533|12260945|P2|NOT COMPLETED|Overall Study||6
4984309|NCT02496533|12260946|P1|NOT COMPLETED|Overall Study||3
4984310|NCT02496533|12260945|P2|COMPLETED|Overall Study||106
4984311|NCT02496533|12260946|P1|COMPLETED|Overall Study||102
4984312|NCT02496533|12260945|P2|STARTED|Overall Study||112
4984313|NCT02496533|12260946|P1|STARTED|Overall Study||105
4984314|NCT02496221|12260958|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
4984315|NCT02496221|12260959|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
4984316|NCT02496221|12260958|P2|COMPLETED|Treatment Period 2 - 4 Days||9
4984317|NCT02496221|12260959|P1|COMPLETED|Treatment Period 2 - 4 Days||8
4984318|NCT02496221|12260958|P2|STARTED|Treatment Period 2 - 4 Days||10
4984319|NCT02496221|12260959|P1|STARTED|Treatment Period 2 - 4 Days||10
4984320|NCT02496221|12260958|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
4984321|NCT02496221|12260959|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
4984322|NCT02496221|12260958|P2|COMPLETED|Treatment Period 1 - 4 Days||10
4984323|NCT02496221|12260959|P1|COMPLETED|Treatment Period 1 - 4 Days||10
4984324|NCT02496221|12260958|P2|STARTED|Treatment Period 1 - 4 Days||10
4984325|NCT02496221|12260959|P1|STARTED|Treatment Period 1 - 4 Days||10
4984326|NCT02496091|12260993|P1|NOT COMPLETED|Overall Study||2
4984327|NCT02496091|12260993|P1|COMPLETED|Overall Study||142
4984328|NCT02496091|12260993|P1|STARTED|Overall Study||144
4984329|NCT02496039|12261002|P1|NOT COMPLETED|Overall Study||4
4984330|NCT02496039|12261002|P1|COMPLETED|Overall Study||1
4984331|NCT02496039|12261002|P1|STARTED|Overall Study||5
4984332|NCT02496000|12261017|P3|NOT COMPLETED|Overall Study||2
4984333|NCT02496000|12261018|P2|NOT COMPLETED|Overall Study||5
4984334|NCT02496000|12261019|P1|NOT COMPLETED|Overall Study||2
4984335|NCT02496000|12261017|P3|COMPLETED|Overall Study||61
4984336|NCT02496000|12261018|P2|COMPLETED|Overall Study||56
4984337|NCT02496000|12261019|P1|COMPLETED|Overall Study||62
4984338|NCT02496000|12261017|P3|STARTED|Overall Study||63
4984339|NCT02496000|12261018|P2|STARTED|Overall Study||61
4984340|NCT02496000|12261019|P1|STARTED|Overall Study||64
4984341|NCT02495948|12261040|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4984342|NCT02495948|12261041|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4984343|NCT02495948|12261040|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
4984344|NCT02495948|12261041|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
4984345|NCT02495948|12261040|P2|STARTED|Period 2, Second 30 Days of Wear||83
4984346|NCT02495948|12261041|P1|STARTED|Period 2, Second 30 Days of Wear||83
4984347|NCT02495948|12261040|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
4984348|NCT02495948|12261041|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4984349|NCT02495948|12261040|P2|COMPLETED|Period 1, First 30 Days of Wear||83
4984350|NCT02495948|12261041|P1|COMPLETED|Period 1, First 30 Days of Wear||83
4984351|NCT02495948|12261040|P2|STARTED|Period 1, First 30 Days of Wear||84
4984352|NCT02495948|12261041|P1|STARTED|Period 1, First 30 Days of Wear||83
4984353|NCT02495857|12261051|P3|NOT COMPLETED|Overall Study||18
4984354|NCT02495857|12261052|P2|NOT COMPLETED|Overall Study||16
4984355|NCT02495857|12261053|P1|NOT COMPLETED|Overall Study||22
4984356|NCT02495857|12261051|P3|COMPLETED|Overall Study||181
4984357|NCT02495857|12261052|P2|COMPLETED|Overall Study||184
4984358|NCT02495857|12261053|P1|COMPLETED|Overall Study||178
4984359|NCT02495857|12261051|P3|STARTED|Overall Study||199
4984360|NCT02495857|12261052|P2|STARTED|Overall Study||200
4984361|NCT02495857|12261053|P1|STARTED|Overall Study||200
4984362|NCT02495844|12261069|P2|NOT COMPLETED|Overall Study||4
4984363|NCT02495844|12261070|P1|NOT COMPLETED|Overall Study||1
4984364|NCT02495844|12261069|P2|COMPLETED|Overall Study||24
4984365|NCT02495844|12261070|P1|COMPLETED|Overall Study||26
4984366|NCT02495844|12261069|P2|STARTED|Overall Study||28
4984367|NCT02495844|12261070|P1|STARTED|Overall Study||27
4984368|NCT02495831|12261100|P2|NOT COMPLETED|Second Intervention||0
4984369|NCT02495831|12261101|P1|NOT COMPLETED|Second Intervention||0
4984370|NCT02495831|12261100|P2|COMPLETED|Second Intervention||10
4984371|NCT02495831|12261101|P1|COMPLETED|Second Intervention||12
4984372|NCT02495831|12261100|P2|STARTED|Second Intervention||10
4984373|NCT02495831|12261101|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
4984374|NCT02495831|12261100|P2|NOT COMPLETED|First Intervention||0
4984375|NCT02495831|12261101|P1|NOT COMPLETED|First Intervention||0
4984376|NCT02495831|12261100|P2|COMPLETED|First Intervention||10
4984377|NCT02495831|12261101|P1|COMPLETED|First Intervention||13
4984378|NCT02495831|12261100|P2|STARTED|First Intervention||10
4984379|NCT02495831|12261101|P1|STARTED|First Intervention||13
4984380|NCT02495779|12261115|P1|NOT COMPLETED|Overall Study||6
4984381|NCT02495779|12261115|P1|COMPLETED|Overall Study||48
4984382|NCT02495779|12261115|P1|STARTED|Overall Study||54
4984383|NCT02495623|12261122|P3|NOT COMPLETED|Overall Study||8
4984384|NCT02495623|12261123|P2|NOT COMPLETED|Overall Study||9
4984385|NCT02495623|12261124|P1|NOT COMPLETED|Overall Study||5
4984386|NCT02495623|12261122|P3|COMPLETED|Overall Study||20
4984387|NCT02495623|12261123|P2|COMPLETED|Overall Study||17
4984388|NCT02495623|12261124|P1|COMPLETED|Overall Study||20
4984389|NCT02495623|12261122|P3|Dosed|Overall Study||22
4984390|NCT02495623|12261123|P2|Dosed|Overall Study||19
4984391|NCT02495623|12261124|P1|Dosed|Overall Study||22
4984392|NCT02495623|12261122|P3|STARTED|Overall Study||28
4984393|NCT02495623|12261123|P2|STARTED|Overall Study||26
4984394|NCT02495623|12261124|P1|STARTED|Overall Study||25
4984395|NCT02495467|12261134|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
4984396|NCT02495467|12261135|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
4984397|NCT02495467|12261134|P2|COMPLETED|Second Intervention (4 Weeks)||113
4984398|NCT02495467|12261135|P1|COMPLETED|Second Intervention (4 Weeks)||112
4984399|NCT02495467|12261134|P2|STARTED|Second Intervention (4 Weeks)||116
4984400|NCT02495467|12261135|P1|STARTED|Second Intervention (4 Weeks)||112
4984401|NCT02495467|12261134|P2|NOT COMPLETED|Washout (1 Week)||2
4984402|NCT02495467|12261135|P1|NOT COMPLETED|Washout (1 Week)||2
4984403|NCT02495467|12261134|P2|COMPLETED|Washout (1 Week)||116
4984404|NCT02495467|12261135|P1|COMPLETED|Washout (1 Week)||112
4984405|NCT02495467|12261134|P2|STARTED|Washout (1 Week)||118
4984406|NCT02495467|12261135|P1|STARTED|Washout (1 Week)||114
4984407|NCT02495467|12261134|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
4984408|NCT02495467|12261135|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
4984495|NCT02494583|12261367|P3|STARTED|Overall Study||250
4984409|NCT02495467|12261134|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
4984410|NCT02495467|12261135|P1|COMPLETED|First Intervention (4 Weeks)||114
4984411|NCT02495467|12261134|P2|STARTED|First Intervention (4 Weeks)||118
4984412|NCT02495467|12261135|P1|STARTED|First Intervention (4 Weeks)||114
4984413|NCT02495259|12261166|P3|NOT COMPLETED|Overall Study||0
4984414|NCT02495259|12261167|P2|NOT COMPLETED|Overall Study||1
4984415|NCT02495259|12261168|P1|NOT COMPLETED|Overall Study||0
4984416|NCT02495259|12261166|P3|COMPLETED|Overall Study||8
4984417|NCT02495259|12261167|P2|COMPLETED|Overall Study||3
4984418|NCT02495259|12261168|P1|COMPLETED|Overall Study||7
4984419|NCT02495259|12261166|P3|STARTED|Overall Study||8
4984420|NCT02495259|12261167|P2|STARTED|Overall Study||4
4984421|NCT02495259|12261168|P1|STARTED|Overall Study||7
4984422|NCT02495233|12261193|P2|NOT COMPLETED|Overall Study||1
4984423|NCT02495233|12261194|P1|NOT COMPLETED|Overall Study||0
4984424|NCT02495233|12261193|P2|COMPLETED|Overall Study||6
4984425|NCT02495233|12261194|P1|COMPLETED|Overall Study||3
4984426|NCT02495233|12261193|P2|STARTED|Overall Study||7
4984427|NCT02495233|12261194|P1|STARTED|Overall Study||3
4984428|NCT02495168|12261223|P3|NOT COMPLETED|Overall Study||17
4984429|NCT02495168|12261224|P2|NOT COMPLETED|Overall Study||54
4984430|NCT02495168|12261225|P1|NOT COMPLETED|Overall Study||38
4984431|NCT02495168|12261223|P3|COMPLETED|Overall Study||110
4984432|NCT02495168|12261224|P2|COMPLETED|Overall Study||462
4984433|NCT02495168|12261225|P1|COMPLETED|Overall Study||466
4984434|NCT02495168|12261223|P3|Day 42 (D42PPS) Population|Overall Study||88
4984435|NCT02495168|12261224|P2|Day 42 (D42PPS) Population|Overall Study||383
4984436|NCT02495168|12261225|P1|Day 42 (D42PPS) Population|Overall Study||382
4984437|NCT02495168|12261223|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
4984438|NCT02495168|12261224|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
4984439|NCT02495168|12261225|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
4984440|NCT02495168|12261223|P3|Modified Intent-to-Treat Population|Overall Study||111
4984441|NCT02495168|12261224|P2|Modified Intent-to-Treat Population|Overall Study||478
4984442|NCT02495168|12261225|P1|Modified Intent-to-Treat Population|Overall Study||468
4984443|NCT02495168|12261223|P3|Safety Population|Overall Study||126
4984444|NCT02495168|12261224|P2|Safety Population|Overall Study||514
4984445|NCT02495168|12261225|P1|Safety Population|Overall Study||501
4984446|NCT02495168|12261223|P3|STARTED|Overall Study||127
4984447|NCT02495168|12261224|P2|STARTED|Overall Study||516
4984448|NCT02495168|12261225|P1|STARTED|Overall Study||504
4984449|NCT02495038|12261245|P3|NOT COMPLETED|Overall Study||0
4984450|NCT02495038|12261246|P2|NOT COMPLETED|Overall Study||0
4984451|NCT02495038|12261247|P1|NOT COMPLETED|Overall Study||0
4984452|NCT02495038|12261245|P3|COMPLETED|Overall Study||27
4984453|NCT02495038|12261246|P2|COMPLETED|Overall Study||27
4984454|NCT02495038|12261247|P1|COMPLETED|Overall Study||27
4984455|NCT02495038|12261245|P3|STARTED|Overall Study||27
4984456|NCT02495038|12261246|P2|STARTED|Overall Study||27
4984457|NCT02495038|12261247|P1|STARTED|Overall Study||27
4984458|NCT02495025|12261284|P2|NOT COMPLETED|Overall Study||14
4984459|NCT02495025|12261285|P1|NOT COMPLETED|Overall Study||26
4984460|NCT02495025|12261284|P2|COMPLETED|Overall Study||61
4984461|NCT02495025|12261285|P1|COMPLETED|Overall Study||51
4984462|NCT02495025|12261284|P2|STARTED|Overall Study||75
4984463|NCT02495025|12261285|P1|STARTED|Overall Study||77
4984464|NCT02494817|12261299|P2|NOT COMPLETED|Overall Study||49
4984465|NCT02494817|12261300|P1|NOT COMPLETED|Overall Study||55
4984466|NCT02494817|12261299|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
4984467|NCT02494817|12261300|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
4984468|NCT02494817|12261299|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
4984469|NCT02494817|12261300|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
4984470|NCT02494817|12261299|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
4984471|NCT02494817|12261300|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
4984472|NCT02494817|12261299|P2|STARTED|Overall Study|representing 68 couples|136
4984473|NCT02494817|12261300|P1|STARTED|Overall Study|representing 81 couples|162
4984474|NCT02494713|12261320|P1|NOT COMPLETED|Overall Study||0
4984475|NCT02494713|12261320|P1|COMPLETED|Overall Study||4
4984476|NCT02494713|12261320|P1|STARTED|Overall Study||4
4984477|NCT02494596|12261337|P3|NOT COMPLETED|Overall Study||1
4984478|NCT02494596|12261338|P2|NOT COMPLETED|Overall Study||5
4984479|NCT02494596|12261339|P1|NOT COMPLETED|Overall Study||3
4984480|NCT02494596|12261337|P3|COMPLETED|Overall Study||6
4984481|NCT02494596|12261338|P2|COMPLETED|Overall Study||2
4984482|NCT02494596|12261339|P1|COMPLETED|Overall Study||2
4984483|NCT02494596|12261337|P3|STARTED|Overall Study||7
4984484|NCT02494596|12261338|P2|STARTED|Overall Study||7
4984485|NCT02494596|12261339|P1|STARTED|Overall Study||5
4984486|NCT02494583|12261367|P3|NOT COMPLETED|Overall Study||250
4984487|NCT02494583|12261368|P2|NOT COMPLETED|Overall Study||257
4984488|NCT02494583|12261369|P1|NOT COMPLETED|Overall Study||256
4984489|NCT02494583|12261367|P3|COMPLETED|Overall Study||0
4984490|NCT02494583|12261368|P2|COMPLETED|Overall Study||0
4984491|NCT02494583|12261369|P1|COMPLETED|Overall Study||0
4984492|NCT02494583|12261367|P3|Treated|Overall Study||244
4984493|NCT02494583|12261368|P2|Treated|Overall Study||250
4984494|NCT02494583|12261369|P1|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
4984496|NCT02494583|12261368|P2|STARTED|Overall Study||257
4984497|NCT02494583|12261369|P1|STARTED|Overall Study||256
4984498|NCT02494518|12261425|P3|NOT COMPLETED|Overall Study||3
4984499|NCT02494518|12261426|P2|NOT COMPLETED|Overall Study||2
4984500|NCT02494518|12261427|P1|NOT COMPLETED|Overall Study||1
4984501|NCT02494518|12261425|P3|COMPLETED|Overall Study||8
4984502|NCT02494518|12261426|P2|COMPLETED|Overall Study||10
4984503|NCT02494518|12261427|P1|COMPLETED|Overall Study||10
4984504|NCT02494518|12261425|P3|STARTED|Overall Study||11
4984505|NCT02494518|12261426|P2|STARTED|Overall Study||12
4984506|NCT02494518|12261427|P1|STARTED|Overall Study||11
4984507|NCT02494440|12261459|P1|NOT COMPLETED|Overall Study||0
4984508|NCT02494440|12261459|P1|COMPLETED|Overall Study||90
4984509|NCT02494440|12261459|P1|STARTED|Overall Study||90
4984510|NCT02494401|12261467|P2|NOT COMPLETED|Overall Study||27
4984511|NCT02494401|12261468|P1|NOT COMPLETED|Overall Study||25
4984512|NCT02494401|12261467|P2|COMPLETED|Overall Study||106
4984513|NCT02494401|12261468|P1|COMPLETED|Overall Study||109
4984514|NCT02494401|12261467|P2|6 Month Follow up|Overall Study||106
4984515|NCT02494401|12261468|P1|6 Month Follow up|Overall Study||109
4984516|NCT02494401|12261467|P2|Week 16|Overall Study||124
4984517|NCT02494401|12261468|P1|Week 16|Overall Study||123
4984518|NCT02494401|12261467|P2|STARTED|Overall Study||133
4984519|NCT02494401|12261468|P1|STARTED|Overall Study||134
4984520|NCT02494336|12261508|P2|NOT COMPLETED|Overall Study||0
4984521|NCT02494336|12261509|P1|NOT COMPLETED|Overall Study||0
4984522|NCT02494336|12261508|P2|COMPLETED|Overall Study||24
4984523|NCT02494336|12261509|P1|COMPLETED|Overall Study||24
4984524|NCT02494336|12261508|P2|STARTED|Overall Study||24
4984525|NCT02494336|12261509|P1|STARTED|Overall Study||24
4984526|NCT02494323|12261515|P1|NOT COMPLETED|Overall Study||0
4984527|NCT02494323|12261515|P1|COMPLETED|Overall Study||70
4984528|NCT02494323|12261515|P1|STARTED|Overall Study||70
4984529|NCT02494206|12261520|P1|NOT COMPLETED|Overall Study||2
4984530|NCT02494206|12261520|P1|COMPLETED|Overall Study||7
4984531|NCT02494206|12261520|P1|STARTED|Overall Study||9
4984532|NCT02494180|12261526|P2|NOT COMPLETED|Overall Study||0
4984533|NCT02494180|12261527|P1|NOT COMPLETED|Overall Study||0
4984534|NCT02494180|12261526|P2|COMPLETED|Overall Study||85
4984535|NCT02494180|12261527|P1|COMPLETED|Overall Study||85
4984536|NCT02494180|12261526|P2|STARTED|Overall Study||85
4984537|NCT02494180|12261527|P1|STARTED|Overall Study||85
4984538|NCT02494102|12261549|P2|NOT COMPLETED|Overall Study||0
4984539|NCT02494102|12261550|P1|NOT COMPLETED|Overall Study||0
4984540|NCT02494102|12261549|P2|COMPLETED|Overall Study||47
4984541|NCT02494102|12261550|P1|COMPLETED|Overall Study||42
4984542|NCT02494102|12261549|P2|STARTED|Overall Study||47
4984543|NCT02494102|12261550|P1|STARTED|Overall Study||42
4984544|NCT02494076|12261560|P2|NOT COMPLETED|Overall Study||0
4984545|NCT02494076|12261561|P1|NOT COMPLETED|Overall Study||0
4984546|NCT02494076|12261560|P2|COMPLETED|Overall Study||26
4984547|NCT02494076|12261561|P1|COMPLETED|Overall Study||26
4984548|NCT02494076|12261560|P2|STARTED|Overall Study||26
4984549|NCT02494076|12261561|P1|STARTED|Overall Study||26
4984550|NCT02493946|12261574|P3|NOT COMPLETED|Open Label Period||86
4984551|NCT02493946|12261575|P2|NOT COMPLETED|Open Label Period||0
4984552|NCT02493946|12261576|P1|NOT COMPLETED|Open Label Period||0
4984553|NCT02493946|12261574|P3|COMPLETED|Open Label Period||509
4984554|NCT02493946|12261575|P2|COMPLETED|Open Label Period||0
4984555|NCT02493946|12261576|P1|COMPLETED|Open Label Period||0
4984556|NCT02493946|12261574|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
4984557|NCT02493946|12261575|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
4984558|NCT02493946|12261576|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
4984559|NCT02493946|12261574|P3|NOT COMPLETED|DB Period||0
4984560|NCT02493946|12261575|P2|NOT COMPLETED|DB Period||5
4984561|NCT02493946|12261576|P1|NOT COMPLETED|DB Period||8
4984562|NCT02493946|12261574|P3|COMPLETED|DB Period||0
4984563|NCT02493946|12261575|P2|COMPLETED|DB Period||59
4984564|NCT02493946|12261576|P1|COMPLETED|DB Period||118
4984565|NCT02493946|12261574|P3|STARTED|DB Period||0
4984566|NCT02493946|12261575|P2|STARTED|DB Period||64
4984567|NCT02493946|12261576|P1|STARTED|DB Period||126
4984568|NCT02493868|12261609|P2|NOT COMPLETED|Follow-up Phase||2
4984569|NCT02493868|12261610|P1|NOT COMPLETED|Follow-up Phase||11
4984570|NCT02493868|12261609|P2|COMPLETED|Follow-up Phase||62
4984571|NCT02493868|12261610|P1|COMPLETED|Follow-up Phase||470
4984572|NCT02493868|12261609|P2|STARTED|Follow-up Phase||64
4984573|NCT02493868|12261610|P1|STARTED|Follow-up Phase||481
4984574|NCT02493868|12261609|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
4984575|NCT02493868|12261610|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
4984576|NCT02493868|12261609|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
4984577|NCT02493868|12261610|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
4984578|NCT02493868|12261609|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
4984579|NCT02493868|12261610|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
4984580|NCT02493868|12261609|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
4984581|NCT02493868|12261610|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
4984582|NCT02493868|12261609|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
4984583|NCT02493868|12261610|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
4984584|NCT02493868|12261609|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
4984585|NCT02493868|12261610|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
4984586|NCT02493868|12261609|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
4984587|NCT02493868|12261610|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
4984588|NCT02493868|12261609|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
4984589|NCT02493868|12261610|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
4984590|NCT02493868|12261609|P2|NOT COMPLETED|Induction Phase: DE Participants||0
4984591|NCT02493868|12261610|P1|NOT COMPLETED|Induction Phase: DE Participants||164
4984592|NCT02493868|12261609|P2|COMPLETED|Induction Phase: DE Participants||0
4984593|NCT02493868|12261610|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
4984594|NCT02493868|12261609|P2|STARTED|Induction Phase: DE Participants||0
4984595|NCT02493868|12261610|P1|STARTED|Induction Phase: DE Participants||437
4984596|NCT02493855|12261659|P3|NOT COMPLETED|Overall Study||0
4984597|NCT02493855|12261660|P2|NOT COMPLETED|Overall Study||1
4984598|NCT02493855|12261661|P1|NOT COMPLETED|Overall Study||2
4984599|NCT02493855|12261659|P3|COMPLETED|Overall Study||6
4984600|NCT02493855|12261660|P2|COMPLETED|Overall Study||18
4984601|NCT02493855|12261661|P1|COMPLETED|Overall Study||19
4984602|NCT02493855|12261659|P3|STARTED|Overall Study||6
4984603|NCT02493855|12261660|P2|STARTED|Overall Study||19
4984604|NCT02493855|12261661|P1|STARTED|Overall Study||21
4984605|NCT02493777|12261671|P2|NOT COMPLETED|Overall Study||1
4984606|NCT02493777|12261672|P1|NOT COMPLETED|Overall Study||0
4984607|NCT02493777|12261671|P2|COMPLETED|Overall Study||53
4984608|NCT02493777|12261672|P1|COMPLETED|Overall Study||65
4984609|NCT02493777|12261671|P2|STARTED|Overall Study||54
4984610|NCT02493777|12261672|P1|STARTED|Overall Study||65
4984611|NCT02493764|12261682|P2|NOT COMPLETED|Overall Study||82
4984612|NCT02493764|12261683|P1|NOT COMPLETED|Overall Study||83
4984613|NCT02493764|12261682|P2|COMPLETED|Overall Study||187
4984614|NCT02493764|12261683|P1|COMPLETED|Overall Study||185
4984615|NCT02493764|12261682|P2|STARTED|Overall Study||269
4984616|NCT02493764|12261683|P1|STARTED|Overall Study||268
4984617|NCT02493751|12261733|P2|NOT COMPLETED|Overall Study||29
4984618|NCT02493751|12261734|P1|NOT COMPLETED|Overall Study||13
4984619|NCT02493751|12261733|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
4984620|NCT02493751|12261734|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
4984621|NCT02493751|12261733|P2|STARTED|Overall Study||39
4984622|NCT02493751|12261734|P1|STARTED|Overall Study||16
4984623|NCT02493621|12261741|P2|NOT COMPLETED|Overall Study||0
4984624|NCT02493621|12261742|P1|NOT COMPLETED|Overall Study||0
4984625|NCT02493621|12261741|P2|COMPLETED|Overall Study||58
4984626|NCT02493621|12261742|P1|COMPLETED|Overall Study||58
4984627|NCT02493621|12261741|P2|STARTED|Overall Study||58
4984628|NCT02493621|12261742|P1|STARTED|Overall Study||58
4984629|NCT02493608|12261752|P2|NOT COMPLETED|Overall Study||0
4984630|NCT02493608|12261753|P1|NOT COMPLETED|Overall Study||0
4984631|NCT02493608|12261752|P2|COMPLETED|Overall Study||48
4984632|NCT02493608|12261753|P1|COMPLETED|Overall Study||48
4984633|NCT02493608|12261752|P2|STARTED|Overall Study||48
4984634|NCT02493608|12261753|P1|STARTED|Overall Study||48
4984635|NCT02493517|12261765|P2|NOT COMPLETED|Overall Study||7
4984636|NCT02493517|12261766|P1|NOT COMPLETED|Overall Study||2
4984637|NCT02493517|12261765|P2|COMPLETED|Overall Study||57
4984638|NCT02493517|12261766|P1|COMPLETED|Overall Study||62
4984639|NCT02493517|12261765|P2|STARTED|Overall Study||64
4984640|NCT02493517|12261766|P1|STARTED|Overall Study||64
4984641|NCT02493452|12261791|P3|NOT COMPLETED|Overall Study||54
4984642|NCT02493452|12261792|P2|NOT COMPLETED|Overall Study||49
4984643|NCT02493452|12261793|P1|NOT COMPLETED|Overall Study||50
4984644|NCT02493452|12261791|P3|COMPLETED|Overall Study||325
4984645|NCT02493452|12261792|P2|COMPLETED|Overall Study||328
4984646|NCT02493452|12261793|P1|COMPLETED|Overall Study||329
4984647|NCT02493452|12261791|P3|STARTED|Overall Study||379
4984648|NCT02493452|12261792|P2|STARTED|Overall Study||377
4984649|NCT02493452|12261793|P1|STARTED|Overall Study||379
4984650|NCT02493361|12261825|P1|NOT COMPLETED|Overall Study||14
4984651|NCT02493361|12261825|P1|COMPLETED|Overall Study||10
4984652|NCT02493361|12261825|P1|STARTED|Overall Study||24
4984653|NCT02493127|12261831|P2|NOT COMPLETED|Overall Study||1
4984654|NCT02493127|12261832|P1|NOT COMPLETED|Overall Study||1
4984655|NCT02493127|12261831|P2|COMPLETED|Overall Study||60
4984656|NCT02493127|12261832|P1|COMPLETED|Overall Study||60
4984657|NCT02493127|12261831|P2|STARTED|Overall Study||61
4984658|NCT02493127|12261832|P1|STARTED|Overall Study||61
4984659|NCT02493088|12261844|P1|NOT COMPLETED|Overall Study||0
4984660|NCT02493088|12261844|P1|COMPLETED|Overall Study||11
4984661|NCT02493088|12261844|P1|STARTED|Overall Study||11
4984662|NCT02493062|12261850|P1|NOT COMPLETED|Overall Study||12
4984663|NCT02493062|12261850|P1|COMPLETED|Overall Study||23
4984664|NCT02493062|12261850|P1|STARTED|Overall Study||35
4984665|NCT02493036|12261861|P3|NOT COMPLETED|Overall Study||2
4984666|NCT02493036|12261862|P2|NOT COMPLETED|Overall Study||2
4984667|NCT02493036|12261863|P1|NOT COMPLETED|Overall Study||1
4984668|NCT02493036|12261861|P3|COMPLETED|Overall Study||15
4984669|NCT02493036|12261862|P2|COMPLETED|Overall Study||18
4984670|NCT02493036|12261863|P1|COMPLETED|Overall Study||16
4984671|NCT02493036|12261861|P3|STARTED|Overall Study||17
4984672|NCT02493036|12261862|P2|STARTED|Overall Study||20
4984673|NCT02493036|12261863|P1|STARTED|Overall Study||17
4984674|NCT02492984|12261873|P2|NOT COMPLETED|Overall Study||0
4984675|NCT02492984|12261874|P1|NOT COMPLETED|Overall Study||3
4984676|NCT02492984|12261873|P2|COMPLETED|Overall Study||14
4984677|NCT02492984|12261874|P1|COMPLETED|Overall Study||70
4984678|NCT02492984|12261873|P2|STARTED|Overall Study||14
4984679|NCT02492984|12261874|P1|STARTED|Overall Study||73
4984680|NCT02492958|12261898|P4|NOT COMPLETED|Overall Study||0
4984681|NCT02492958|12261899|P3|NOT COMPLETED|Overall Study||2
4984682|NCT02492958|12261900|P2|NOT COMPLETED|Overall Study||0
4984683|NCT02492958|12261901|P1|NOT COMPLETED|Overall Study||1
4984684|NCT02492958|12261898|P4|COMPLETED|Overall Study||34
4984685|NCT02492958|12261899|P3|COMPLETED|Overall Study||32
4984686|NCT02492958|12261900|P2|COMPLETED|Overall Study||34
4984687|NCT02492958|12261901|P1|COMPLETED|Overall Study||33
4984688|NCT02492958|12261898|P4|STARTED|Overall Study||34
4984689|NCT02492958|12261899|P3|STARTED|Overall Study||34
4984690|NCT02492958|12261900|P2|STARTED|Overall Study||34
4984691|NCT02492958|12261901|P1|STARTED|Overall Study||34
4984692|NCT02492880|12261987|P1|NOT COMPLETED|Overall Study||2
4984693|NCT02492880|12261987|P1|COMPLETED|Overall Study||13
4984694|NCT02492880|12261987|P1|STARTED|Overall Study||15
4984695|NCT02492841|12261994|P3|NOT COMPLETED|Overall Study||35
4984696|NCT02492841|12261995|P2|NOT COMPLETED|Overall Study||31
4984697|NCT02492841|12261996|P1|NOT COMPLETED|Overall Study||34
4984698|NCT02492841|12261994|P3|COMPLETED|Overall Study||25
4984699|NCT02492841|12261995|P2|COMPLETED|Overall Study||22
4984700|NCT02492841|12261996|P1|COMPLETED|Overall Study||22
4984701|NCT02492841|12261994|P3|STARTED|Overall Study||60
4984702|NCT02492841|12261995|P2|STARTED|Overall Study||53
4984703|NCT02492841|12261996|P1|STARTED|Overall Study||56
4984704|NCT02492802|12262007|P1|NOT COMPLETED|Overall Study||0
4984705|NCT02492802|12262007|P1|COMPLETED|Overall Study||64
4984706|NCT02492802|12262007|P1|STARTED|Overall Study||64
4984707|NCT02492763|12262015|P4|NOT COMPLETED|Overall Study||13
4984708|NCT02492763|12262016|P3|NOT COMPLETED|Overall Study||10
4984709|NCT02492763|12262017|P2|NOT COMPLETED|Overall Study||15
4984710|NCT02492763|12262018|P1|NOT COMPLETED|Overall Study||16
4984711|NCT02492763|12262015|P4|COMPLETED|Overall Study||30
4984712|NCT02492763|12262016|P3|COMPLETED|Overall Study||33
4984713|NCT02492763|12262017|P2|COMPLETED|Overall Study||29
4984714|NCT02492763|12262018|P1|COMPLETED|Overall Study||30
4984715|NCT02492763|12262015|P4|Treated|Overall Study||42
4984716|NCT02492763|12262016|P3|Treated|Overall Study||43
4984717|NCT02492763|12262017|P2|Treated|Overall Study||44
4984718|NCT02492763|12262018|P1|Treated|Overall Study||46
4984719|NCT02492763|12262015|P4|STARTED|Overall Study||43
4984720|NCT02492763|12262016|P3|STARTED|Overall Study||43
4984721|NCT02492763|12262017|P2|STARTED|Overall Study||44
4984722|NCT02492763|12262018|P1|STARTED|Overall Study||46
4984723|NCT02492750|12262075|P3|NOT COMPLETED|Overall Study||0
4984724|NCT02492750|12262076|P2|NOT COMPLETED|Overall Study||0
4984725|NCT02492750|12262077|P1|NOT COMPLETED|Overall Study||0
4984726|NCT02492750|12262075|P3|COMPLETED|Overall Study||6
4984727|NCT02492750|12262076|P2|COMPLETED|Overall Study||4
4984728|NCT02492750|12262077|P1|COMPLETED|Overall Study||4
4984729|NCT02492750|12262075|P3|STARTED|Overall Study||6
4984730|NCT02492750|12262076|P2|STARTED|Overall Study||4
4984731|NCT02492750|12262077|P1|STARTED|Overall Study||4
4984732|NCT02492451|12262094|P3|NOT COMPLETED|Overall Study||0
4984733|NCT02492451|12262095|P2|NOT COMPLETED|Overall Study||0
4984734|NCT02492451|12262096|P1|NOT COMPLETED|Overall Study||0
4984735|NCT02492451|12262094|P3|COMPLETED|Overall Study||39
4984736|NCT02492451|12262095|P2|COMPLETED|Overall Study||39
4984737|NCT02492451|12262096|P1|COMPLETED|Overall Study||40
4984738|NCT02492451|12262094|P3|STARTED|Overall Study||39
4984739|NCT02492451|12262095|P2|STARTED|Overall Study||39
4984740|NCT02492451|12262096|P1|STARTED|Overall Study||40
4984741|NCT02492295|12262104|P1|NOT COMPLETED|Overall Study||0
4984742|NCT02492295|12262104|P1|COMPLETED|Overall Study||0
4984743|NCT02492295|12262104|P1|STARTED|Overall Study||0
4984744|NCT02492165|12262123|P4|NOT COMPLETED|Overall Study||0
4984745|NCT02492165|12262124|P3|NOT COMPLETED|Overall Study||0
4984746|NCT02492165|12262125|P2|NOT COMPLETED|Overall Study||1
4984747|NCT02492165|12262126|P1|NOT COMPLETED|Overall Study||0
4984748|NCT02492165|12262123|P4|COMPLETED|Overall Study||30
4984749|NCT02492165|12262124|P3|COMPLETED|Overall Study||60
4984750|NCT02492165|12262125|P2|COMPLETED|Overall Study||59
4984751|NCT02492165|12262126|P1|COMPLETED|Overall Study||100
4984752|NCT02492165|12262123|P4|STARTED|Overall Study||30
4984753|NCT02492165|12262124|P3|STARTED|Overall Study||60
4984754|NCT02492165|12262125|P2|STARTED|Overall Study||60
4984755|NCT02492165|12262126|P1|STARTED|Overall Study||100
4984756|NCT02492100|12262148|P1|NOT COMPLETED|Overall Study||1
4984757|NCT02492100|12262148|P1|COMPLETED|Overall Study||46
4984758|NCT02492100|12262148|P1|STARTED|Overall Study||47
4984759|NCT02491944|12262155|P1|NOT COMPLETED|Overall Study||0
4984760|NCT02491944|12262155|P1|COMPLETED|Overall Study||10
4984761|NCT02491944|12262155|P1|STARTED|Overall Study||10
4984762|NCT02491892|12262177|P2|NOT COMPLETED|Overall Study||38
4984763|NCT02491892|12262178|P1|NOT COMPLETED|Overall Study||41
4984764|NCT02491892|12262177|P2|COMPLETED|Overall Study||0
4984765|NCT02491892|12262178|P1|COMPLETED|Overall Study||0
4984766|NCT02491892|12262177|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
4984767|NCT02491892|12262178|P1|Treated|Overall Study||41
4984768|NCT02491892|12262177|P2|STARTED|Overall Study||38
4984769|NCT02491892|12262178|P1|STARTED|Overall Study||41
4984770|NCT02491788|12262224|P2|NOT COMPLETED|Overall Study||0
4984771|NCT02491788|12262225|P1|NOT COMPLETED|Overall Study||0
4984772|NCT02491788|12262224|P2|COMPLETED|Overall Study||11
4984773|NCT02491788|12262225|P1|COMPLETED|Overall Study||8
4984774|NCT02491788|12262224|P2|STARTED|Overall Study||11
4984775|NCT02491788|12262225|P1|STARTED|Overall Study||8
4984776|NCT02491684|12262233|P2|NOT COMPLETED|Treatment Phase||3
4984777|NCT02491684|12262234|P1|NOT COMPLETED|Treatment Phase||3
4984778|NCT02491684|12262233|P2|COMPLETED|Treatment Phase||57
4984779|NCT02491684|12262234|P1|COMPLETED|Treatment Phase||58
4984780|NCT02491684|12262233|P2|STARTED|Treatment Phase||60
4984781|NCT02491684|12262234|P1|STARTED|Treatment Phase||61
4984782|NCT02491684|12262233|P2|NOT COMPLETED|Pre-treatment Phase||0
4984783|NCT02491684|12262234|P1|NOT COMPLETED|Pre-treatment Phase||0
4984784|NCT02491684|12262233|P2|COMPLETED|Pre-treatment Phase||60
4984785|NCT02491684|12262234|P1|COMPLETED|Pre-treatment Phase||61
4984786|NCT02491684|12262233|P2|STARTED|Pre-treatment Phase||60
4984787|NCT02491684|12262234|P1|STARTED|Pre-treatment Phase||61
4984788|NCT02491463|12262272|P4|NOT COMPLETED|Overall Study||1
4984789|NCT02491463|12262273|P3|NOT COMPLETED|Overall Study||4
4984790|NCT02491463|12262274|P2|NOT COMPLETED|Overall Study||10
4984791|NCT02491463|12262275|P1|NOT COMPLETED|Overall Study||2
4984792|NCT02491463|12262272|P4|COMPLETED|Overall Study||14
4984793|NCT02491463|12262273|P3|COMPLETED|Overall Study||15
4984794|NCT02491463|12262274|P2|COMPLETED|Overall Study||21
4984795|NCT02491463|12262275|P1|COMPLETED|Overall Study||5
4984796|NCT02491463|12262272|P4|STARTED|Overall Study||15
4984797|NCT02491463|12262273|P3|STARTED|Overall Study||19
4984798|NCT02491463|12262274|P2|STARTED|Overall Study||31
4984799|NCT02491463|12262275|P1|STARTED|Overall Study||7
4984800|NCT02491437|12262363|P2|NOT COMPLETED|Overall Study||357
4984801|NCT02491437|12262364|P1|NOT COMPLETED|Overall Study||352
4984802|NCT02491437|12262363|P2|COMPLETED|Overall Study||157
4984803|NCT02491437|12262364|P1|COMPLETED|Overall Study||168
4984804|NCT02491437|12262363|P2|Full Analysis Sample|Overall Study||489
4984805|NCT02491437|12262364|P1|Full Analysis Sample|Overall Study||494
4984806|NCT02491437|12262363|P2|Safety Sample|Overall Study||512
4984807|NCT02491437|12262364|P1|Safety Sample|Overall Study||518
4984808|NCT02491437|12262363|P2|STARTED|Overall Study||514
4984809|NCT02491437|12262364|P1|STARTED|Overall Study||520
4984810|NCT02491411|12262378|P1|NOT COMPLETED|Overall Study||4
4984811|NCT02491411|12262378|P1|COMPLETED|Overall Study||0
4984812|NCT02491411|12262378|P1|STARTED|Overall Study||4
4984813|NCT02491359|12262388|P1|NOT COMPLETED|Overall Study||16
4984814|NCT02491359|12262388|P1|COMPLETED|Overall Study||4
4984815|NCT02491359|12262388|P1|STARTED|Overall Study||20
4984816|NCT02491073|12262409|P2|NOT COMPLETED|Overall Study||0
4984817|NCT02491073|12262410|P1|NOT COMPLETED|Overall Study||1
4984818|NCT02491073|12262409|P2|COMPLETED|Overall Study||34
4984819|NCT02491073|12262410|P1|COMPLETED|Overall Study||36
4984820|NCT02491073|12262409|P2|STARTED|Overall Study||34
4984821|NCT02491073|12262410|P1|STARTED|Overall Study||37
4984822|NCT02490670|12262438|P2|NOT COMPLETED|Period 2 (19 Days)||0
4984823|NCT02490670|12262439|P1|NOT COMPLETED|Period 2 (19 Days)||0
4984824|NCT02490670|12262438|P2|COMPLETED|Period 2 (19 Days)||14
4984825|NCT02490670|12262439|P1|COMPLETED|Period 2 (19 Days)||14
4984826|NCT02490670|12262438|P2|STARTED|Period 2 (19 Days)||14
4984827|NCT02490670|12262439|P1|STARTED|Period 2 (19 Days)||14
4984828|NCT02490670|12262438|P2|NOT COMPLETED|Washout Period (7 Days)||0
4984829|NCT02490670|12262439|P1|NOT COMPLETED|Washout Period (7 Days)||0
4984830|NCT02490670|12262438|P2|COMPLETED|Washout Period (7 Days)||14
4984831|NCT02490670|12262439|P1|COMPLETED|Washout Period (7 Days)||14
4984832|NCT02490670|12262438|P2|STARTED|Washout Period (7 Days)||14
4984833|NCT02490670|12262439|P1|STARTED|Washout Period (7 Days)||14
4984834|NCT02490670|12262438|P2|NOT COMPLETED|Period 1 (19 Days)||0
4984835|NCT02490670|12262439|P1|NOT COMPLETED|Period 1 (19 Days)||0
4984836|NCT02490670|12262438|P2|COMPLETED|Period 1 (19 Days)||14
4984837|NCT02490670|12262439|P1|COMPLETED|Period 1 (19 Days)||14
4984838|NCT02490670|12262438|P2|STARTED|Period 1 (19 Days)||14
4984839|NCT02490670|12262439|P1|STARTED|Period 1 (19 Days)||14
4984840|NCT02490631|12262449|P2|NOT COMPLETED|Overall Study||0
4984841|NCT02490631|12262450|P1|NOT COMPLETED|Overall Study||0
4984842|NCT02490631|12262449|P2|COMPLETED|Overall Study||75
4984843|NCT02490631|12262450|P1|COMPLETED|Overall Study||76
4984844|NCT02490631|12262449|P2|STARTED|Overall Study||75
4984845|NCT02490631|12262450|P1|STARTED|Overall Study||76
4984846|NCT02490475|12262462|P4|NOT COMPLETED|Period 2: Extension Phase||1
4984847|NCT02490475|12262463|P3|NOT COMPLETED|Period 2: Extension Phase||3
4984848|NCT02490475|12262464|P2|NOT COMPLETED|Period 2: Extension Phase||0
4984849|NCT02490475|12262465|P1|NOT COMPLETED|Period 2: Extension Phase||1
4984850|NCT02490475|12262462|P4|COMPLETED|Period 2: Extension Phase||0
4984851|NCT02490475|12262463|P3|COMPLETED|Period 2: Extension Phase||0
4984852|NCT02490475|12262464|P2|COMPLETED|Period 2: Extension Phase||0
4984853|NCT02490475|12262465|P1|COMPLETED|Period 2: Extension Phase||0
4984854|NCT02490475|12262462|P4|STARTED|Period 2: Extension Phase||1
4984855|NCT02490475|12262463|P3|STARTED|Period 2: Extension Phase||3
4984856|NCT02490475|12262464|P2|STARTED|Period 2: Extension Phase||0
4984857|NCT02490475|12262465|P1|STARTED|Period 2: Extension Phase||1
4984858|NCT02490475|12262462|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
4984859|NCT02490475|12262463|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
4984860|NCT02490475|12262464|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
4984861|NCT02490475|12262465|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
4984862|NCT02490475|12262462|P4|COMPLETED|Period 1: First 6 Cycles||0
4984863|NCT02490475|12262463|P3|COMPLETED|Period 1: First 6 Cycles||0
4984864|NCT02490475|12262464|P2|COMPLETED|Period 1: First 6 Cycles||0
4984865|NCT02490475|12262465|P1|COMPLETED|Period 1: First 6 Cycles||0
4984866|NCT02490475|12262462|P4|STARTED|Period 1: First 6 Cycles||5
4984867|NCT02490475|12262463|P3|STARTED|Period 1: First 6 Cycles||6
4984868|NCT02490475|12262464|P2|STARTED|Period 1: First 6 Cycles||2
4984869|NCT02490475|12262465|P1|STARTED|Period 1: First 6 Cycles||6
4984870|NCT02490371|12262543|P2|NOT COMPLETED|Overall Study||1
4984871|NCT02490371|12262544|P1|NOT COMPLETED|Overall Study||1
4984872|NCT02490371|12262543|P2|COMPLETED|Overall Study||11
4984873|NCT02490371|12262544|P1|COMPLETED|Overall Study||11
4984874|NCT02490371|12262543|P2|STARTED|Overall Study||12
4984875|NCT02490371|12262544|P1|STARTED|Overall Study||12
4984876|NCT02490293|12262562|P2|NOT COMPLETED|Overall Study||3
4984877|NCT02490293|12262563|P1|NOT COMPLETED|Overall Study||2
4984878|NCT02490293|12262562|P2|COMPLETED|Overall Study||99
4984879|NCT02490293|12262563|P1|COMPLETED|Overall Study||94
4984880|NCT02490293|12262562|P2|STARTED|Overall Study||102
4984881|NCT02490293|12262563|P1|STARTED|Overall Study||96
4984882|NCT02489981|12262571|P1|NOT COMPLETED|Overall Study||127
4984883|NCT02489981|12262571|P1|COMPLETED|Overall Study||213
4984884|NCT02489981|12262571|P1|STARTED|Overall Study||340
4984885|NCT02489968|12262578|P6|NOT COMPLETED|Double-blind Treatment Period||8
4984886|NCT02489968|12262579|P5|NOT COMPLETED|Double-blind Treatment Period||6
4984887|NCT02489968|12262580|P4|NOT COMPLETED|Double-blind Treatment Period||8
4984888|NCT02489968|12262581|P3|NOT COMPLETED|Double-blind Treatment Period||2
4984889|NCT02489968|12262582|P2|NOT COMPLETED|Double-blind Treatment Period||0
4984890|NCT02489968|12262583|P1|NOT COMPLETED|Double-blind Treatment Period||0
4984891|NCT02489968|12262578|P6|COMPLETED|Double-blind Treatment Period||108
4984892|NCT02489968|12262579|P5|COMPLETED|Double-blind Treatment Period||110
4984893|NCT02489968|12262580|P4|COMPLETED|Double-blind Treatment Period||100
4984894|NCT02489968|12262581|P3|COMPLETED|Double-blind Treatment Period||105
4984895|NCT02489968|12262582|P2|COMPLETED|Double-blind Treatment Period||0
4984896|NCT02489968|12262583|P1|COMPLETED|Double-blind Treatment Period||0
4984897|NCT02489968|12262578|P6|STARTED|Double-blind Treatment Period||116
4984898|NCT02489968|12262579|P5|STARTED|Double-blind Treatment Period||116
4984899|NCT02489968|12262580|P4|STARTED|Double-blind Treatment Period||108
4984900|NCT02489968|12262581|P3|STARTED|Double-blind Treatment Period||107
4984901|NCT02489968|12262582|P2|STARTED|Double-blind Treatment Period||0
4984902|NCT02489968|12262583|P1|STARTED|Double-blind Treatment Period||0
4984903|NCT02489968|12262578|P6|NOT COMPLETED|Open-label Treatment Period||0
4984904|NCT02489968|12262579|P5|NOT COMPLETED|Open-label Treatment Period||0
4984905|NCT02489968|12262580|P4|NOT COMPLETED|Open-label Treatment Period||0
4984906|NCT02489968|12262581|P3|NOT COMPLETED|Open-label Treatment Period||0
4984907|NCT02489968|12262582|P2|NOT COMPLETED|Open-label Treatment Period||208
4984908|NCT02489968|12262583|P1|NOT COMPLETED|Open-label Treatment Period||224
4984909|NCT02489968|12262578|P6|COMPLETED|Open-label Treatment Period||0
4984910|NCT02489968|12262579|P5|COMPLETED|Open-label Treatment Period||0
4984911|NCT02489968|12262580|P4|COMPLETED|Open-label Treatment Period||0
4984912|NCT02489968|12262581|P3|COMPLETED|Open-label Treatment Period||0
4984913|NCT02489968|12262582|P2|COMPLETED|Open-label Treatment Period||232
4984914|NCT02489968|12262583|P1|COMPLETED|Open-label Treatment Period||215
4984915|NCT02489968|12262578|P6|STARTED|Open-label Treatment Period||0
4984916|NCT02489968|12262579|P5|STARTED|Open-label Treatment Period||0
4984917|NCT02489968|12262580|P4|STARTED|Open-label Treatment Period||0
4984918|NCT02489968|12262581|P3|STARTED|Open-label Treatment Period||0
4984919|NCT02489968|12262582|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
4984920|NCT02489968|12262583|P1|STARTED|Open-label Treatment Period||439
4984921|NCT02489799|12262597|P2|NOT COMPLETED|Overall Study||9
4984922|NCT02489799|12262598|P1|NOT COMPLETED|Overall Study||9
4984923|NCT02489799|12262597|P2|COMPLETED|Overall Study||38
4984924|NCT02489799|12262598|P1|COMPLETED|Overall Study||36
4984925|NCT02489799|12262597|P2|Postsurgical One Week Visit (V3)|Overall Study||39
4984926|NCT02489799|12262598|P1|Postsurgical One Week Visit (V3)|Overall Study||40
4984927|NCT02489799|12262597|P2|Presurgical Consent Visit (V2)|Overall Study||39
4984928|NCT02489799|12262598|P1|Presurgical Consent Visit (V2)|Overall Study||40
4984929|NCT02489799|12262597|P2|STARTED|Overall Study||47
4984930|NCT02489799|12262598|P1|STARTED|Overall Study||45
4984931|NCT02489773|12262624|P2|NOT COMPLETED|Overall Study||2
4984932|NCT02489773|12262625|P1|NOT COMPLETED|Overall Study||7
4984933|NCT02489773|12262624|P2|COMPLETED|Overall Study||50
4984934|NCT02489773|12262625|P1|COMPLETED|Overall Study||91
4984935|NCT02489773|12262624|P2|STARTED|Overall Study||52
4984936|NCT02489773|12262625|P1|STARTED|Overall Study||98
4984937|NCT02489500|12262635|P2|NOT COMPLETED|Overall Study||1
4984938|NCT02489500|12262636|P1|NOT COMPLETED|Overall Study||1
4984939|NCT02489500|12262635|P2|COMPLETED|Overall Study||0
4984940|NCT02489500|12262636|P1|COMPLETED|Overall Study||1
4984941|NCT02489500|12262635|P2|STARTED|Overall Study||1
4984942|NCT02489500|12262636|P1|STARTED|Overall Study||2
4984943|NCT02489357|12262648|P1|NOT COMPLETED|Overall Study||0
4984944|NCT02489357|12262648|P1|COMPLETED|Overall Study||12
4984945|NCT02489357|12262648|P1|STARTED|Overall Study||12
4984946|NCT02489344|12262654|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
4984947|NCT02489344|12262654|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
4984948|NCT02489344|12262654|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
4984949|NCT02489344|12262654|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
4984950|NCT02489344|12262654|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
4984951|NCT02489344|12262654|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
4984952|NCT02489279|12262696|P2|NOT COMPLETED|Overall Study||10
4984953|NCT02489279|12262697|P1|NOT COMPLETED|Overall Study||12
4984954|NCT02489279|12262696|P2|COMPLETED|Overall Study||31
4984955|NCT02489279|12262697|P1|COMPLETED|Overall Study||32
4984956|NCT02489279|12262696|P2|STARTED|Overall Study||41
4984957|NCT02489279|12262697|P1|STARTED|Overall Study||44
4984958|NCT02489227|12262712|P3|NOT COMPLETED|Overall Study||19
4984959|NCT02489227|12262713|P2|NOT COMPLETED|Overall Study||34
4984960|NCT02489227|12262714|P1|NOT COMPLETED|Overall Study||54
4984961|NCT02489227|12262712|P3|COMPLETED|Overall Study||117
4984962|NCT02489227|12262713|P2|COMPLETED|Overall Study||101
4984963|NCT02489227|12262714|P1|COMPLETED|Overall Study||220
4984964|NCT02489227|12262712|P3|STARTED|Overall Study||136
4984965|NCT02489227|12262713|P2|STARTED|Overall Study||135
4984966|NCT02489227|12262714|P1|STARTED|Overall Study||274
4984967|NCT02489110|12262726|P2|NOT COMPLETED|Overall Study||25
4984968|NCT02489110|12262727|P1|NOT COMPLETED|Overall Study||27
4984969|NCT02489110|12262726|P2|COMPLETED|Overall Study||50
4984970|NCT02489110|12262727|P1|COMPLETED|Overall Study||48
4984971|NCT02489110|12262726|P2|STARTED|Overall Study||75
4984972|NCT02489110|12262727|P1|STARTED|Overall Study||75
4984973|NCT02488980|12262738|P3|NOT COMPLETED|Overall Study||2
4984974|NCT02488980|12262739|P2|NOT COMPLETED|Overall Study||2
4984975|NCT02488980|12262740|P1|NOT COMPLETED|Overall Study||2
4984976|NCT02488980|12262738|P3|COMPLETED|Overall Study||99
4984977|NCT02488980|12262739|P2|COMPLETED|Overall Study||99
4984978|NCT02488980|12262740|P1|COMPLETED|Overall Study||102
4984979|NCT02488980|12262738|P3|STARTED|Overall Study||101
4984980|NCT02488980|12262739|P2|STARTED|Overall Study||101
4984981|NCT02488980|12262740|P1|STARTED|Overall Study||104
4984982|NCT02488915|12262757|P1|NOT COMPLETED|Overall Study||26
4984983|NCT02488915|12262757|P1|COMPLETED|Overall Study||202
4984984|NCT02488915|12262757|P1|STARTED|Overall Study||228
4984985|NCT02488824|12262775|P2|NOT COMPLETED|Overall Study||1
4984986|NCT02488824|12262776|P1|NOT COMPLETED|Overall Study||1
4984987|NCT02488824|12262775|P2|COMPLETED|Overall Study||19
4984988|NCT02488824|12262776|P1|COMPLETED|Overall Study||20
4984989|NCT02488824|12262775|P2|STARTED|Overall Study||20
4984990|NCT02488824|12262776|P1|STARTED|Overall Study||21
4984991|NCT02488681|12262790|P1|NOT COMPLETED|Overall Study||7
4984992|NCT02488681|12262790|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
4984993|NCT02488681|12262790|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
4984994|NCT02488330|12262794|P1|NOT COMPLETED|Overall Study||12
4984995|NCT02488330|12262794|P1|COMPLETED|Overall Study||0
4984996|NCT02488330|12262794|P1|STARTED|Overall Study||12
4984997|NCT02488317|12262800|P2|NOT COMPLETED|Overall Study||47
4984998|NCT02488317|12262801|P1|NOT COMPLETED|Overall Study||54
4984999|NCT02488317|12262800|P2|COMPLETED|Overall Study||70
4985000|NCT02488317|12262801|P1|COMPLETED|Overall Study||63
4985001|NCT02488317|12262800|P2|STARTED|Overall Study||117
4985002|NCT02488317|12262801|P1|STARTED|Overall Study||117
4985003|NCT02488239|12262815|P1|NOT COMPLETED|Overall Study||10
4985004|NCT02488239|12262815|P1|COMPLETED|Overall Study||54
4985005|NCT02488239|12262815|P1|STARTED|Overall Study||64
4985006|NCT02488070|12262820|P1|NOT COMPLETED|Overall Study||0
4985007|NCT02488070|12262820|P1|COMPLETED|Overall Study||10
4985008|NCT02488070|12262820|P1|STARTED|Overall Study||10
4985009|NCT02488018|12262828|P1|NOT COMPLETED|Overall Study||0
4985010|NCT02488018|12262828|P1|COMPLETED|Overall Study||10
4985011|NCT02488018|12262828|P1|STARTED|Overall Study||10
4985012|NCT02488005|12262832|P1|NOT COMPLETED|Overall Study||2
4985013|NCT02488005|12262832|P1|COMPLETED|Overall Study||13
4985014|NCT02488005|12262832|P1|STARTED|Overall Study||15
4985015|NCT02487979|12262842|P1|NOT COMPLETED|Overall Study||21
4985016|NCT02487979|12262842|P1|COMPLETED|Overall Study||1
4985017|NCT02487979|12262842|P1|STARTED|Overall Study||22
4985018|NCT02487810|12262854|P2|NOT COMPLETED|Overall Study||0
4985019|NCT02487810|12262855|P1|NOT COMPLETED|Overall Study||1
4985020|NCT02487810|12262854|P2|COMPLETED|Overall Study||102
4985021|NCT02487810|12262855|P1|COMPLETED|Overall Study||97
4985022|NCT02487810|12262854|P2|STARTED|Overall Study||102
4985023|NCT02487810|12262855|P1|STARTED|Overall Study||98
4985024|NCT02487771|12262887|P2|NOT COMPLETED|Overall Study||14
4985025|NCT02487771|12262888|P1|NOT COMPLETED|Overall Study||10
4985026|NCT02487771|12262887|P2|COMPLETED|Overall Study||85
4985027|NCT02487771|12262888|P1|COMPLETED|Overall Study||81
4985028|NCT02487771|12262887|P2|STARTED|Overall Study||99
4985029|NCT02487771|12262888|P1|STARTED|Overall Study||91
4985030|NCT02487563|12263041|P3|NOT COMPLETED|Overall Study||1
4985031|NCT02487563|12263042|P2|NOT COMPLETED|Overall Study||3
4985032|NCT02487563|12263043|P1|NOT COMPLETED|Overall Study||2
4985033|NCT02487563|12263041|P3|COMPLETED|Overall Study||31
4985034|NCT02487563|12263042|P2|COMPLETED|Overall Study||30
4985035|NCT02487563|12263043|P1|COMPLETED|Overall Study||30
4985036|NCT02487563|12263041|P3|STARTED|Overall Study||32
4985037|NCT02487563|12263042|P2|STARTED|Overall Study||33
4985038|NCT02487563|12263043|P1|STARTED|Overall Study||32
4985039|NCT02487498|12263054|P2|NOT COMPLETED|Period: Period 2||5
4985040|NCT02487498|12263055|P1|NOT COMPLETED|Period: Period 2||6
4985041|NCT02487498|12263054|P2|COMPLETED|Period: Period 2||154
4985042|NCT02487498|12263055|P1|COMPLETED|Period: Period 2||164
4985043|NCT02487498|12263054|P2|STARTED|Period: Period 2||159
4985044|NCT02487498|12263055|P1|STARTED|Period: Period 2||170
4985045|NCT02487498|12263054|P2|NOT COMPLETED|Period: Washout||7
4985046|NCT02487498|12263055|P1|NOT COMPLETED|Period: Washout||2
4985047|NCT02487498|12263054|P2|COMPLETED|Period: Washout||159
4985048|NCT02487498|12263055|P1|COMPLETED|Period: Washout||170
4985049|NCT02487498|12263054|P2|STARTED|Period: Washout||166
4985050|NCT02487498|12263055|P1|STARTED|Period: Washout||172
4985051|NCT02487498|12263054|P2|NOT COMPLETED|Period: Period 1||11
4985052|NCT02487498|12263055|P1|NOT COMPLETED|Period: Period 1||6
4985053|NCT02487498|12263054|P2|COMPLETED|Period: Period 1||166
4985054|NCT02487498|12263055|P1|COMPLETED|Period: Period 1||172
4985055|NCT02487498|12263054|P2|STARTED|Period: Period 1||177
4985056|NCT02487498|12263055|P1|STARTED|Period: Period 1||178
4985057|NCT02487485|12263080|P2|NOT COMPLETED|Overall Study||3
4985058|NCT02487485|12263081|P1|NOT COMPLETED|Overall Study||3
4985059|NCT02487485|12263080|P2|COMPLETED|Overall Study||8
4985060|NCT02487485|12263081|P1|COMPLETED|Overall Study||9
4985061|NCT02487485|12263080|P2|STARTED|Overall Study||11
4985062|NCT02487485|12263081|P1|STARTED|Overall Study||12
4985063|NCT02487472|12263099|P1|NOT COMPLETED|Overall Study||11
4985064|NCT02487472|12263099|P1|COMPLETED|Overall Study||90
4985065|NCT02487472|12263099|P1|STARTED|Overall Study||101
4985066|NCT02487446|12263115|P2|NOT COMPLETED|Period 2||5
4985067|NCT02487446|12263116|P1|NOT COMPLETED|Period 2||8
4985068|NCT02487446|12263115|P2|COMPLETED|Period 2||158
4985069|NCT02487446|12263116|P1|COMPLETED|Period 2||154
4985070|NCT02487446|12263115|P2|STARTED|Period 2||163
4985071|NCT02487446|12263116|P1|STARTED|Period 2||162
4985072|NCT02487446|12263115|P2|NOT COMPLETED|Washout||8
4985073|NCT02487446|12263116|P1|NOT COMPLETED|Washout||3
4985074|NCT02487446|12263115|P2|COMPLETED|Washout||163
4985075|NCT02487446|12263116|P1|COMPLETED|Washout||162
4985076|NCT02487446|12263115|P2|STARTED|Washout||171
4985077|NCT02487446|12263116|P1|STARTED|Washout||165
4985078|NCT02487446|12263115|P2|NOT COMPLETED|Period 1||8
4985079|NCT02487446|12263116|P1|NOT COMPLETED|Period 1||13
4985080|NCT02487446|12263115|P2|COMPLETED|Period 1||171
4985081|NCT02487446|12263116|P1|COMPLETED|Period 1||165
4985082|NCT02487446|12263115|P2|STARTED|Period 1||179
4985083|NCT02487446|12263116|P1|STARTED|Period 1||178
4985084|NCT02487303|12263142|P3|NOT COMPLETED|Overall Study||1
4985085|NCT02487303|12263143|P2|NOT COMPLETED|Overall Study||4
4985086|NCT02487303|12263144|P1|NOT COMPLETED|Overall Study||2
4985087|NCT02487303|12263142|P3|COMPLETED|Overall Study||47
4985088|NCT02487303|12263143|P2|COMPLETED|Overall Study||47
4985089|NCT02487303|12263144|P1|COMPLETED|Overall Study||47
4985090|NCT02487303|12263142|P3|STARTED|Overall Study||48
4985091|NCT02487303|12263143|P2|STARTED|Overall Study||51
4985092|NCT02487303|12263144|P1|STARTED|Overall Study||49
4985093|NCT02487277|12263163|P2|NOT COMPLETED|Overall Study||0
4985094|NCT02487277|12263164|P1|NOT COMPLETED|Overall Study||0
4985095|NCT02487277|12263163|P2|COMPLETED|Overall Study||0
4985096|NCT02487277|12263164|P1|COMPLETED|Overall Study||3
4985097|NCT02487277|12263163|P2|STARTED|Overall Study||0
4985098|NCT02487277|12263164|P1|STARTED|Overall Study||3
4985099|NCT02487225|12263181|P2|NOT COMPLETED|Overall Study||30
4985100|NCT02487225|12263182|P1|NOT COMPLETED|Overall Study||27
4985101|NCT02487225|12263181|P2|COMPLETED|Overall Study||8
4985102|NCT02487225|12263182|P1|COMPLETED|Overall Study||18
4985103|NCT02487225|12263181|P2|STARTED|Overall Study||38
4985104|NCT02487225|12263182|P1|STARTED|Overall Study||45
4985105|NCT02487199|12263196|P2|NOT COMPLETED|Overall Study||1
4985106|NCT02487199|12263197|P1|NOT COMPLETED|Overall Study||0
4985107|NCT02487199|12263196|P2|COMPLETED|Overall Study||4
4985108|NCT02487199|12263197|P1|COMPLETED|Overall Study||13
4985109|NCT02487199|12263196|P2|STARTED|Overall Study||5
4985110|NCT02487199|12263197|P1|STARTED|Overall Study||13
4985111|NCT02487056|12263209|P1|NOT COMPLETED|Overall Study||16
4985112|NCT02487056|12263209|P1|COMPLETED|Overall Study||1606
4985113|NCT02487056|12263209|P1|STARTED|Overall Study||1622
4985114|NCT02487030|12263222|P7|NOT COMPLETED|Overall Study||0
4985115|NCT02487030|12263223|P6|NOT COMPLETED|Overall Study||1
4985116|NCT02487030|12263224|P5|NOT COMPLETED|Overall Study||2
4985117|NCT02487030|12263225|P4|NOT COMPLETED|Overall Study||2
4985118|NCT02487030|12263226|P3|NOT COMPLETED|Overall Study||2
4985119|NCT02487030|12263227|P2|NOT COMPLETED|Overall Study||4
4985120|NCT02487030|12263228|P1|NOT COMPLETED|Overall Study||2
4985121|NCT02487030|12263222|P7|COMPLETED|Overall Study||11
4985122|NCT02487030|12263223|P6|COMPLETED|Overall Study||37
4985123|NCT02487030|12263224|P5|COMPLETED|Overall Study||34
4985124|NCT02487030|12263225|P4|COMPLETED|Overall Study||40
4985125|NCT02487030|12263226|P3|COMPLETED|Overall Study||41
4985126|NCT02487030|12263227|P2|COMPLETED|Overall Study||38
4985127|NCT02487030|12263228|P1|COMPLETED|Overall Study||41
4985128|NCT02487030|12263222|P7|STARTED|Overall Study||11
4985129|NCT02487030|12263223|P6|STARTED|Overall Study||38
4985130|NCT02487030|12263224|P5|STARTED|Overall Study||36
4985131|NCT02487030|12263225|P4|STARTED|Overall Study||42
4985132|NCT02487030|12263226|P3|STARTED|Overall Study||43
4985133|NCT02487030|12263227|P2|STARTED|Overall Study||42
4985134|NCT02487030|12263228|P1|STARTED|Overall Study||43
4985135|NCT02486952|12263259|P1|NOT COMPLETED|Overall Study||50
4985136|NCT02486952|12263259|P1|COMPLETED|Overall Study||104
4985137|NCT02486952|12263259|P1|Started Induction Therapy|Overall Study||151
4985138|NCT02486952|12263259|P1|STARTED|Overall Study||154
4985139|NCT02486939|12263266|P2|NOT COMPLETED|Overall Study||2
4985140|NCT02486939|12263267|P1|NOT COMPLETED|Overall Study||1
4985141|NCT02486939|12263266|P2|COMPLETED|Overall Study||132
4985142|NCT02486939|12263267|P1|COMPLETED|Overall Study||224
4985143|NCT02486939|12263266|P2|STARTED|Overall Study||134
4985144|NCT02486939|12263267|P1|STARTED|Overall Study||225
4985145|NCT02486796|12263277|P2|NOT COMPLETED|Overall Study||1
4985146|NCT02486796|12263278|P1|NOT COMPLETED|Overall Study||2
4985147|NCT02486796|12263277|P2|COMPLETED|Overall Study||1
4985148|NCT02486796|12263278|P1|COMPLETED|Overall Study||1
4985149|NCT02486796|12263277|P2|STARTED|Overall Study||2
4985150|NCT02486796|12263278|P1|STARTED|Overall Study||3
4985151|NCT02486757|12263290|P1|NOT COMPLETED|Overall Study||1
4985152|NCT02486757|12263290|P1|COMPLETED|Overall Study||5
4985153|NCT02486757|12263290|P1|STARTED|Overall Study||6
4985154|NCT02486692|12263296|P2|NOT COMPLETED|Overall Study||7
4985155|NCT02486692|12263297|P1|NOT COMPLETED|Overall Study||4
4985156|NCT02486692|12263296|P2|COMPLETED|Overall Study||23
4985157|NCT02486692|12263297|P1|COMPLETED|Overall Study||26
4985158|NCT02486692|12263296|P2|STARTED|Overall Study||30
4985159|NCT02486692|12263297|P1|STARTED|Overall Study||30
4985160|NCT02486653|12263309|P2|NOT COMPLETED|Overall Study||4
4985161|NCT02486653|12263310|P1|NOT COMPLETED|Overall Study||6
4985162|NCT02486653|12263309|P2|COMPLETED|Overall Study||71
4985163|NCT02486653|12263310|P1|COMPLETED|Overall Study||70
4985164|NCT02486653|12263309|P2|STARTED|Overall Study||75
4985165|NCT02486653|12263310|P1|STARTED|Overall Study||76
4985166|NCT02486627|12263334|P2|NOT COMPLETED|Overall Study||9
4985167|NCT02486627|12263335|P1|NOT COMPLETED|Overall Study||7
4985168|NCT02486627|12263334|P2|COMPLETED|Overall Study||294
4985169|NCT02486627|12263335|P1|COMPLETED|Overall Study||299
4985170|NCT02486627|12263334|P2|STARTED|Overall Study||303
4985171|NCT02486627|12263335|P1|STARTED|Overall Study||306
4985172|NCT02486588|12263358|P6|NOT COMPLETED|Overall Study||746
4985173|NCT02486588|12263359|P5|NOT COMPLETED|Overall Study||746
4985174|NCT02486588|12263360|P4|NOT COMPLETED|Overall Study||738
4985175|NCT02486588|12263361|P3|NOT COMPLETED|Overall Study||755
4985176|NCT02486588|12263362|P2|NOT COMPLETED|Overall Study||750
4985177|NCT02486588|12263363|P1|NOT COMPLETED|Overall Study||738
4985178|NCT02486588|12263358|P6|COMPLETED|Overall Study||459
4985179|NCT02486588|12263359|P5|COMPLETED|Overall Study||497
4985180|NCT02486588|12263360|P4|COMPLETED|Overall Study||468
4985181|NCT02486588|12263361|P3|COMPLETED|Overall Study||465
4985182|NCT02486588|12263362|P2|COMPLETED|Overall Study||502
4985183|NCT02486588|12263363|P1|COMPLETED|Overall Study||450
4985184|NCT02486588|12263358|P6|STARTED|Overall Study||1205
4985185|NCT02486588|12263359|P5|STARTED|Overall Study||1243
4985186|NCT02486588|12263360|P4|STARTED|Overall Study||1206
4985187|NCT02486588|12263361|P3|STARTED|Overall Study||1220
4985188|NCT02486588|12263362|P2|STARTED|Overall Study||1252
4985189|NCT02486588|12263363|P1|STARTED|Overall Study||1188
4985190|NCT02486302|12263419|P1|NOT COMPLETED|Overall Study||676
4985191|NCT02486302|12263419|P1|COMPLETED|Overall Study||858
4985192|NCT02486302|12263419|P1|Treated|Overall Study||1523
4985193|NCT02486302|12263419|P1|STARTED|Overall Study||1534
4985194|NCT02486263|12263476|P2|NOT COMPLETED|Overall Study||1
4985195|NCT02486263|12263477|P1|NOT COMPLETED|Overall Study||3
4985196|NCT02486263|12263476|P2|COMPLETED|Overall Study||35
4985197|NCT02486263|12263477|P1|COMPLETED|Overall Study||37
4985198|NCT02486263|12263476|P2|STARTED|Overall Study||36
4985199|NCT02486263|12263477|P1|STARTED|Overall Study||40
4985200|NCT02486211|12263493|P2|NOT COMPLETED|Overall Study||0
4985201|NCT02486211|12263494|P1|NOT COMPLETED|Overall Study||1
4985202|NCT02486211|12263493|P2|COMPLETED|Overall Study||7
4985203|NCT02486211|12263494|P1|COMPLETED|Overall Study||6
4985204|NCT02486211|12263493|P2|STARTED|Overall Study||7
4985205|NCT02486211|12263494|P1|STARTED|Overall Study||7
4985206|NCT02486016|12263508|P1|NOT COMPLETED|Overall Study||0
4985207|NCT02486016|12263508|P1|COMPLETED|Overall Study||10
4985208|NCT02486016|12263508|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
4985209|NCT02485925|12263516|P1|NOT COMPLETED|Overall Study||15
4985210|NCT02485925|12263516|P1|COMPLETED|Overall Study||185
4985211|NCT02485925|12263516|P1|Per-Protocol Population|Overall Study||166
4985212|NCT02485925|12263516|P1|Intent to Treat (ITT) Population|Overall Study||193
4985213|NCT02485925|12263516|P1|Safety Population|Overall Study||200
4985214|NCT02485925|12263516|P1|STARTED|Overall Study||200
4985215|NCT02485912|12263526|P2|NOT COMPLETED|Overall Study||0
4985216|NCT02485912|12263527|P1|NOT COMPLETED|Overall Study||0
4985217|NCT02485912|12263526|P2|COMPLETED|Overall Study||20
4985218|NCT02485912|12263527|P1|COMPLETED|Overall Study||20
4985219|NCT02485912|12263526|P2|STARTED|Overall Study||20
4985220|NCT02485912|12263527|P1|STARTED|Overall Study||20
4985221|NCT02485834|12263535|P2|NOT COMPLETED|Overall Study||0
4985222|NCT02485834|12263536|P1|NOT COMPLETED|Overall Study||0
4985223|NCT02485834|12263535|P2|COMPLETED|Overall Study||2
4985224|NCT02485834|12263536|P1|COMPLETED|Overall Study||3
4985225|NCT02485834|12263535|P2|STARTED|Overall Study||2
4985226|NCT02485834|12263536|P1|STARTED|Overall Study||3
4985227|NCT02485717|12263548|P3|NOT COMPLETED|Overall Study||1
4985228|NCT02485717|12263549|P2|NOT COMPLETED|Overall Study||2
4985229|NCT02485717|12263550|P1|NOT COMPLETED|Overall Study||6
4985230|NCT02485717|12263548|P3|COMPLETED|Overall Study||19
4985231|NCT02485717|12263549|P2|COMPLETED|Overall Study||127
4985232|NCT02485717|12263550|P1|COMPLETED|Overall Study||136
4985233|NCT02485717|12263548|P3|STARTED|Overall Study||20
4985234|NCT02485717|12263549|P2|STARTED|Overall Study||129
4985235|NCT02485717|12263550|P1|STARTED|Overall Study||142
4985236|NCT02485704|12263565|P2|NOT COMPLETED|Overall Study||8
4985237|NCT02485704|12263566|P1|NOT COMPLETED|Overall Study||5
4985238|NCT02485704|12263565|P2|COMPLETED|Overall Study||118
4985239|NCT02485704|12263566|P1|COMPLETED|Overall Study||149
4985240|NCT02485704|12263565|P2|STARTED|Overall Study||126
4985241|NCT02485704|12263566|P1|STARTED|Overall Study||154
4985242|NCT02485561|12263575|P3|NOT COMPLETED|Overall Study||23
4985243|NCT02485561|12263576|P2|NOT COMPLETED|Overall Study||39
4985244|NCT02485561|12263577|P1|NOT COMPLETED|Overall Study||28
4985245|NCT02485561|12263575|P3|COMPLETED|Overall Study||136
4985246|NCT02485561|12263576|P2|COMPLETED|Overall Study||118
4985247|NCT02485561|12263577|P1|COMPLETED|Overall Study||133
4985248|NCT02485561|12263575|P3|Completed 1 mo Survey|Overall Study||144
4985249|NCT02485561|12263576|P2|Completed 1 mo Survey|Overall Study||138
4985250|NCT02485561|12263577|P1|Completed 1 mo Survey|Overall Study||145
4985251|NCT02485561|12263575|P3|STARTED|Overall Study||159
4985252|NCT02485561|12263576|P2|STARTED|Overall Study||157
4985253|NCT02485561|12263577|P1|STARTED|Overall Study||161
4985254|NCT02485483|12263614|P2|NOT COMPLETED|Overall Study||0
4985255|NCT02485483|12263615|P1|NOT COMPLETED|Overall Study||54
4985256|NCT02485483|12263614|P2|COMPLETED|Overall Study||1015
4985257|NCT02485483|12263615|P1|COMPLETED|Overall Study||223
4985258|NCT02485483|12263614|P2|STARTED|Overall Study||1015
4985259|NCT02485483|12263615|P1|STARTED|Overall Study||277
4985260|NCT02485353|12263630|P1|NOT COMPLETED|Overall Study||2
4985261|NCT02485353|12263630|P1|COMPLETED|Overall Study||0
4985262|NCT02485353|12263630|P1|STARTED|Overall Study||2
4985263|NCT02485301|12263637|P2|NOT COMPLETED|Overall Study||49
4985264|NCT02485301|12263638|P1|NOT COMPLETED|Overall Study||38
4985265|NCT02485301|12263637|P2|COMPLETED|Overall Study||1455
4985266|NCT02485301|12263638|P1|COMPLETED|Overall Study||1471
4985267|NCT02485301|12263637|P2|STARTED|Overall Study||1504
4985268|NCT02485301|12263638|P1|STARTED|Overall Study||1509
4985269|NCT02485158|12263688|P1|NOT COMPLETED|Overall Study||4
4985270|NCT02485158|12263688|P1|COMPLETED|Overall Study||24
4985271|NCT02485158|12263688|P1|STARTED|Overall Study||28
4985272|NCT02484911|12263777|P2|NOT COMPLETED|Overall Study||2
4985273|NCT02484911|12263778|P1|NOT COMPLETED|Overall Study||4
4985274|NCT02484911|12263777|P2|COMPLETED|Overall Study||58
4985275|NCT02484911|12263778|P1|COMPLETED|Overall Study||56
4985276|NCT02484911|12263777|P2|STARTED|Overall Study||60
4985277|NCT02484911|12263778|P1|STARTED|Overall Study||60
4985278|NCT02484898|12263806|P1|NOT COMPLETED|Overall Study||18
4985279|NCT02484898|12263806|P1|COMPLETED|Overall Study||182
4985280|NCT02484898|12263806|P1|STARTED|Overall Study||200
4985281|NCT02484859|12263812|P2|NOT COMPLETED|Overall Study||0
4985282|NCT02484859|12263813|P1|NOT COMPLETED|Overall Study||0
4985283|NCT02484859|12263812|P2|COMPLETED|Overall Study||44
4985284|NCT02484859|12263813|P1|COMPLETED|Overall Study||44
4985285|NCT02484859|12263812|P2|STARTED|Overall Study||44
4985286|NCT02484859|12263813|P1|STARTED|Overall Study||44
4985287|NCT02484807|12263833|P6|NOT COMPLETED|Overall Study||0
4985288|NCT02484807|12263834|P5|NOT COMPLETED|Overall Study||0
4985289|NCT02484807|12263835|P4|NOT COMPLETED|Overall Study||0
4985290|NCT02484807|12263836|P3|NOT COMPLETED|Overall Study||0
4985291|NCT02484807|12263837|P2|NOT COMPLETED|Overall Study||0
4985292|NCT02484807|12263838|P1|NOT COMPLETED|Overall Study||0
4985293|NCT02484807|12263833|P6|COMPLETED|Overall Study||6
4985294|NCT02484807|12263834|P5|COMPLETED|Overall Study||33
4985295|NCT02484807|12263835|P4|COMPLETED|Overall Study||21
4985296|NCT02484807|12263836|P3|COMPLETED|Overall Study||19
4985297|NCT02484807|12263837|P2|COMPLETED|Overall Study||7
4985298|NCT02484807|12263838|P1|COMPLETED|Overall Study||39
4985299|NCT02484807|12263833|P6|STARTED|Overall Study||6
4985300|NCT02484807|12263834|P5|STARTED|Overall Study||33
4985301|NCT02484807|12263835|P4|STARTED|Overall Study||21
4985302|NCT02484807|12263836|P3|STARTED|Overall Study||19
4985303|NCT02484807|12263837|P2|STARTED|Overall Study||7
4985304|NCT02484807|12263838|P1|STARTED|Overall Study||39
4985305|NCT02484729|12263868|P10|NOT COMPLETED|Overall Study||1
4985306|NCT02484729|12263869|P9|NOT COMPLETED|Overall Study||0
4985307|NCT02484729|12263870|P8|NOT COMPLETED|Overall Study||0
4985308|NCT02484729|12263871|P7|NOT COMPLETED|Overall Study||0
4985309|NCT02484729|12263872|P6|NOT COMPLETED|Overall Study||0
4985310|NCT02484729|12263873|P5|NOT COMPLETED|Overall Study||0
4985311|NCT02484729|12263874|P4|NOT COMPLETED|Overall Study||0
4985312|NCT02484729|12263875|P3|NOT COMPLETED|Overall Study||0
4985313|NCT02484729|12263876|P2|NOT COMPLETED|Overall Study||0
4985314|NCT02484729|12263877|P1|NOT COMPLETED|Overall Study||0
4985315|NCT02484729|12263868|P10|COMPLETED|Overall Study||7
4985316|NCT02484729|12263869|P9|COMPLETED|Overall Study||6
4985317|NCT02484729|12263870|P8|COMPLETED|Overall Study||6
4985318|NCT02484729|12263871|P7|COMPLETED|Overall Study||5
4985319|NCT02484729|12263872|P6|COMPLETED|Overall Study||6
4985320|NCT02484729|12263873|P5|COMPLETED|Overall Study||5
4985321|NCT02484729|12263874|P4|COMPLETED|Overall Study||6
4985322|NCT02484729|12263875|P3|COMPLETED|Overall Study||6
4985323|NCT02484729|12263876|P2|COMPLETED|Overall Study||6
4985324|NCT02484729|12263877|P1|COMPLETED|Overall Study||16
4985325|NCT02484729|12263868|P10|STARTED|Overall Study||8
4985326|NCT02484729|12263869|P9|STARTED|Overall Study||6
4985327|NCT02484729|12263870|P8|STARTED|Overall Study||6
4985328|NCT02484729|12263871|P7|STARTED|Overall Study||5
4985329|NCT02484729|12263872|P6|STARTED|Overall Study||6
4985330|NCT02484729|12263873|P5|STARTED|Overall Study||5
4985331|NCT02484729|12263874|P4|STARTED|Overall Study||6
4985332|NCT02484729|12263875|P3|STARTED|Overall Study||6
4985333|NCT02484729|12263876|P2|STARTED|Overall Study||6
4985334|NCT02484729|12263877|P1|STARTED|Overall Study||16
4985335|NCT02484651|12264075|P2|NOT COMPLETED|Overall Study||4
4985336|NCT02484651|12264076|P1|NOT COMPLETED|Overall Study||3
4985337|NCT02484651|12264075|P2|COMPLETED|Overall Study||31
4985338|NCT02484651|12264076|P1|COMPLETED|Overall Study||32
4985339|NCT02484651|12264075|P2|Data Analysis|Overall Study||31
4985340|NCT02484651|12264076|P1|Data Analysis|Overall Study||32
4985341|NCT02484651|12264075|P2|End of Clinical Study|Overall Study||35
4985342|NCT02484651|12264076|P1|End of Clinical Study|Overall Study||35
4985343|NCT02484651|12264075|P2|STARTED|Overall Study|35 patients were randomized|35
4985344|NCT02484651|12264076|P1|STARTED|Overall Study|35 patients were randomized|35
4985345|NCT02484222|12264088|P1|NOT COMPLETED|Overall Study||3
4985346|NCT02484222|12264088|P1|COMPLETED|Overall Study||77
4985347|NCT02484222|12264088|P1|STARTED|Overall Study||80
4985348|NCT02484092|12264095|P1|NOT COMPLETED|Overall Study||0
4985349|NCT02484092|12264095|P1|COMPLETED|Overall Study||15
4985350|NCT02484092|12264095|P1|STARTED|Overall Study||15
4985351|NCT02483975|12264110|P2|NOT COMPLETED|Overall Study||2
4985352|NCT02483975|12264111|P1|NOT COMPLETED|Overall Study||2
4985353|NCT02483975|12264110|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
4985354|NCT02483975|12264111|P1|COMPLETED|Overall Study||54
4985355|NCT02483975|12264110|P2|STARTED|Overall Study||55
4985356|NCT02483975|12264111|P1|STARTED|Overall Study||56
4985357|NCT02483676|12264127|P2|NOT COMPLETED|Overall Study||5
4985358|NCT02483676|12264128|P1|NOT COMPLETED|Overall Study||6
4985359|NCT02483676|12264127|P2|COMPLETED|Overall Study||17
4985360|NCT02483676|12264128|P1|COMPLETED|Overall Study||17
4985361|NCT02483676|12264127|P2|STARTED|Overall Study||22
4985362|NCT02483676|12264128|P1|STARTED|Overall Study||23
4985363|NCT02483611|12264149|P3|NOT COMPLETED|Overall Study||1
4985364|NCT02483611|12264150|P2|NOT COMPLETED|Overall Study||0
4985365|NCT02483611|12264151|P1|NOT COMPLETED|Overall Study||0
4985366|NCT02483611|12264149|P3|COMPLETED|Overall Study|One patient required decurarization|15
4985367|NCT02483611|12264150|P2|COMPLETED|Overall Study||16
4985368|NCT02483611|12264151|P1|COMPLETED|Overall Study||16
4985369|NCT02483611|12264149|P3|STARTED|Overall Study||16
4985370|NCT02483611|12264150|P2|STARTED|Overall Study||16
4985371|NCT02483611|12264151|P1|STARTED|Overall Study||16
4985372|NCT02483585|12264248|P2|NOT COMPLETED|Open-label Treatment Phase||25
4985373|NCT02483585|12264249|P1|NOT COMPLETED|Open-label Treatment Phase||27
4985374|NCT02483585|12264248|P2|COMPLETED|Open-label Treatment Phase||243
4985375|NCT02483585|12264249|P1|COMPLETED|Open-label Treatment Phase||243
4985376|NCT02483585|12264248|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
4985377|NCT02483585|12264249|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
4985378|NCT02483585|12264248|P2|NOT COMPLETED|Double-blind Treatment Phase||15
4985379|NCT02483585|12264249|P1|NOT COMPLETED|Double-blind Treatment Phase||16
4985380|NCT02483585|12264248|P2|COMPLETED|Double-blind Treatment Phase||271
4985381|NCT02483585|12264249|P1|COMPLETED|Double-blind Treatment Phase||275
4985382|NCT02483585|12264248|P2|Received Treatment|Double-blind Treatment Phase||283
4985383|NCT02483585|12264249|P1|Received Treatment|Double-blind Treatment Phase||289
4985384|NCT02483585|12264248|P2|STARTED|Double-blind Treatment Phase||286
4985385|NCT02483585|12264249|P1|STARTED|Double-blind Treatment Phase||291
4985386|NCT02483572|12264271|P2|NOT COMPLETED|Overall Study||1
4985387|NCT02483572|12264272|P1|NOT COMPLETED|Overall Study||2
4985388|NCT02483572|12264271|P2|COMPLETED|Overall Study||1
4985389|NCT02483572|12264272|P1|COMPLETED|Overall Study||0
4985390|NCT02483572|12264271|P2|STARTED|Overall Study||2
4985391|NCT02483572|12264272|P1|STARTED|Overall Study||2
4985392|NCT02483533|12264286|P2|NOT COMPLETED|Overall Study||50
4985393|NCT02483533|12264287|P1|NOT COMPLETED|Overall Study||50
4985394|NCT02483533|12264286|P2|COMPLETED|Overall Study||0
4985395|NCT02483533|12264287|P1|COMPLETED|Overall Study||0
4985396|NCT02483533|12264286|P2|STARTED|Overall Study||50
4985397|NCT02483533|12264287|P1|STARTED|Overall Study||50
4985398|NCT02483416|12264297|P2|NOT COMPLETED|Overall Study||1
4985399|NCT02483416|12264298|P1|NOT COMPLETED|Overall Study||3
4985400|NCT02483416|12264297|P2|COMPLETED|Overall Study||6
4985401|NCT02483416|12264298|P1|COMPLETED|Overall Study||18
4985402|NCT02483416|12264297|P2|STARTED|Overall Study||7
4985403|NCT02483416|12264298|P1|STARTED|Overall Study||21
4985404|NCT02482935|12264353|P2|NOT COMPLETED|Period 2||0
4985405|NCT02482935|12264354|P1|NOT COMPLETED|Period 2||0
4985406|NCT02482935|12264353|P2|COMPLETED|Period 2||15
4985407|NCT02482935|12264354|P1|COMPLETED|Period 2||14
4985408|NCT02482935|12264353|P2|Follow-up|Period 2||15
4985409|NCT02482935|12264354|P1|Follow-up|Period 2||14
4985410|NCT02482935|12264353|P2|Received Abemaciclib|Period 2||15
4985411|NCT02482935|12264354|P1|Received Abemaciclib|Period 2||14
4985412|NCT02482935|12264353|P2|STARTED|Period 2||15
4985413|NCT02482935|12264354|P1|STARTED|Period 2||14
4985414|NCT02482935|12264353|P2|NOT COMPLETED|Period 1||0
4985415|NCT02482935|12264354|P1|NOT COMPLETED|Period 1||1
4985416|NCT02482935|12264353|P2|COMPLETED|Period 1||15
4985417|NCT02482935|12264354|P1|COMPLETED|Period 1||14
4985418|NCT02482935|12264353|P2|Washout|Period 1||15
4985419|NCT02482935|12264354|P1|Washout|Period 1||15
4985420|NCT02482935|12264353|P2|Received Abemaciclib|Period 1||15
4985421|NCT02482935|12264354|P1|Received Abemaciclib|Period 1||15
4985422|NCT02482935|12264353|P2|STARTED|Period 1||15
4985423|NCT02482935|12264354|P1|STARTED|Period 1||15
4985424|NCT02482870|12264364|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
4985425|NCT02482870|12264365|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
4985426|NCT02482870|12264364|P2|COMPLETED|Period 2 - Rest of the Study||202
4985427|NCT02482870|12264365|P1|COMPLETED|Period 2 - Rest of the Study||186
4985428|NCT02482870|12264364|P2|STARTED|Period 2 - Rest of the Study||202
4985429|NCT02482870|12264365|P1|STARTED|Period 2 - Rest of the Study||186
4985430|NCT02482870|12264364|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
4985431|NCT02482870|12264365|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
4985432|NCT02482870|12264364|P2|COMPLETED|Period 1 - First 60 Patients||30
4985433|NCT02482870|12264365|P1|COMPLETED|Period 1 - First 60 Patients||30
4985434|NCT02482870|12264364|P2|STARTED|Period 1 - First 60 Patients||30
4985435|NCT02482870|12264365|P1|STARTED|Period 1 - First 60 Patients||30
4985436|NCT02482805|12264382|P3|NOT COMPLETED|Overall Study||0
4985437|NCT02482805|12264383|P2|NOT COMPLETED|Overall Study||4
4985438|NCT02482805|12264384|P1|NOT COMPLETED|Overall Study||4
4985439|NCT02482805|12264382|P3|COMPLETED|Overall Study||20
4985440|NCT02482805|12264383|P2|COMPLETED|Overall Study||23
4985441|NCT02482805|12264384|P1|COMPLETED|Overall Study||22
4985442|NCT02482805|12264382|P3|STARTED|Overall Study||20
4985443|NCT02482805|12264383|P2|STARTED|Overall Study||27
4985444|NCT02482805|12264384|P1|STARTED|Overall Study||26
4985445|NCT02482675|12264398|P23|NOT COMPLETED|Overall Study||0
4985446|NCT02482675|12264399|P22|NOT COMPLETED|Overall Study||0
4985447|NCT02482675|12264400|P21|NOT COMPLETED|Overall Study||0
4985448|NCT02482675|12264401|P20|NOT COMPLETED|Overall Study||0
4985449|NCT02482675|12264402|P19|NOT COMPLETED|Overall Study||0
4985450|NCT02482675|12264403|P18|NOT COMPLETED|Overall Study||0
4985451|NCT02482675|12264404|P17|NOT COMPLETED|Overall Study||0
4985452|NCT02482675|12264405|P16|NOT COMPLETED|Overall Study||0
4985453|NCT02482675|12264406|P15|NOT COMPLETED|Overall Study||0
4985454|NCT02482675|12264407|P14|NOT COMPLETED|Overall Study||0
4985455|NCT02482675|12264408|P13|NOT COMPLETED|Overall Study||0
4985456|NCT02482675|12264409|P12|NOT COMPLETED|Overall Study||0
4985457|NCT02482675|12264410|P11|NOT COMPLETED|Overall Study||0
4985458|NCT02482675|12264411|P10|NOT COMPLETED|Overall Study||0
4985459|NCT02482675|12264412|P9|NOT COMPLETED|Overall Study||0
4985460|NCT02482675|12264413|P8|NOT COMPLETED|Overall Study||0
4985461|NCT02482675|12264414|P7|NOT COMPLETED|Overall Study||0
4985462|NCT02482675|12264415|P6|NOT COMPLETED|Overall Study||0
4985463|NCT02482675|12264416|P5|NOT COMPLETED|Overall Study||0
4985464|NCT02482675|12264417|P4|NOT COMPLETED|Overall Study||0
4985465|NCT02482675|12264418|P3|NOT COMPLETED|Overall Study||0
4985466|NCT02482675|12264419|P2|NOT COMPLETED|Overall Study||0
4985467|NCT02482675|12264420|P1|NOT COMPLETED|Overall Study||0
4985468|NCT02482675|12264398|P23|COMPLETED|Overall Study||1
4985469|NCT02482675|12264399|P22|COMPLETED|Overall Study||1
4985470|NCT02482675|12264400|P21|COMPLETED|Overall Study||1
4985471|NCT02482675|12264401|P20|COMPLETED|Overall Study||1
4985472|NCT02482675|12264402|P19|COMPLETED|Overall Study||1
4985473|NCT02482675|12264403|P18|COMPLETED|Overall Study||1
4985474|NCT02482675|12264404|P17|COMPLETED|Overall Study||1
4985475|NCT02482675|12264405|P16|COMPLETED|Overall Study||1
4985476|NCT02482675|12264406|P15|COMPLETED|Overall Study||1
4985477|NCT02482675|12264407|P14|COMPLETED|Overall Study||1
4985478|NCT02482675|12264408|P13|COMPLETED|Overall Study||1
4985479|NCT02482675|12264409|P12|COMPLETED|Overall Study||1
4985480|NCT02482675|12264410|P11|COMPLETED|Overall Study||1
4985481|NCT02482675|12264411|P10|COMPLETED|Overall Study||1
4985482|NCT02482675|12264412|P9|COMPLETED|Overall Study||1
4985483|NCT02482675|12264413|P8|COMPLETED|Overall Study||1
4985484|NCT02482675|12264414|P7|COMPLETED|Overall Study||1
4985485|NCT02482675|12264415|P6|COMPLETED|Overall Study||1
4985486|NCT02482675|12264416|P5|COMPLETED|Overall Study||1
4985487|NCT02482675|12264417|P4|COMPLETED|Overall Study||1
4985488|NCT02482675|12264418|P3|COMPLETED|Overall Study||1
4985489|NCT02482675|12264419|P2|COMPLETED|Overall Study||1
4985490|NCT02482675|12264420|P1|COMPLETED|Overall Study||1
4985491|NCT02482675|12264398|P23|STARTED|Overall Study||1
4985492|NCT02482675|12264399|P22|STARTED|Overall Study||1
4985493|NCT02482675|12264400|P21|STARTED|Overall Study||1
4985494|NCT02482675|12264401|P20|STARTED|Overall Study||1
4985495|NCT02482675|12264402|P19|STARTED|Overall Study||1
4985496|NCT02482675|12264403|P18|STARTED|Overall Study||1
4985497|NCT02482675|12264404|P17|STARTED|Overall Study||1
4985498|NCT02482675|12264405|P16|STARTED|Overall Study||1
4985499|NCT02482675|12264406|P15|STARTED|Overall Study||1
4985500|NCT02482675|12264407|P14|STARTED|Overall Study||1
4985501|NCT02482675|12264408|P13|STARTED|Overall Study||1
4985502|NCT02482675|12264409|P12|STARTED|Overall Study||1
4985503|NCT02482675|12264410|P11|STARTED|Overall Study||1
4985504|NCT02482675|12264411|P10|STARTED|Overall Study||1
4985505|NCT02482675|12264412|P9|STARTED|Overall Study||1
4985506|NCT02482675|12264413|P8|STARTED|Overall Study||1
4985507|NCT02482675|12264414|P7|STARTED|Overall Study||1
4985508|NCT02482675|12264415|P6|STARTED|Overall Study||1
4985509|NCT02482675|12264416|P5|STARTED|Overall Study||1
4985510|NCT02482675|12264417|P4|STARTED|Overall Study||1
4985511|NCT02482675|12264418|P3|STARTED|Overall Study||1
4985512|NCT02482675|12264419|P2|STARTED|Overall Study||1
4985513|NCT02482675|12264420|P1|STARTED|Overall Study||1
4985514|NCT02482610|12264478|P6|NOT COMPLETED|Overall Study||0
4985515|NCT02482610|12264479|P5|NOT COMPLETED|Overall Study||0
4985516|NCT02482610|12264480|P4|NOT COMPLETED|Overall Study||0
4985517|NCT02482610|12264481|P3|NOT COMPLETED|Overall Study||0
4985518|NCT02482610|12264482|P2|NOT COMPLETED|Overall Study||0
4985519|NCT02482610|12264483|P1|NOT COMPLETED|Overall Study||0
4985520|NCT02482610|12264478|P6|COMPLETED|Overall Study||5
4985521|NCT02482610|12264479|P5|COMPLETED|Overall Study||3
4985522|NCT02482610|12264480|P4|COMPLETED|Overall Study||3
4985523|NCT02482610|12264481|P3|COMPLETED|Overall Study||2
4985524|NCT02482610|12264482|P2|COMPLETED|Overall Study||5
4985525|NCT02482610|12264483|P1|COMPLETED|Overall Study||4
4985526|NCT02482610|12264478|P6|STARTED|Overall Study||5
4985527|NCT02482610|12264479|P5|STARTED|Overall Study||3
4985528|NCT02482610|12264480|P4|STARTED|Overall Study||3
4985529|NCT02482610|12264481|P3|STARTED|Overall Study||2
4985530|NCT02482610|12264482|P2|STARTED|Overall Study||5
4985531|NCT02482610|12264483|P1|STARTED|Overall Study||4
4985532|NCT02482571|12264503|P1|NOT COMPLETED|Overall Study||8
4985533|NCT02482571|12264503|P1|COMPLETED|Overall Study||17
4985534|NCT02482571|12264503|P1|STARTED|Overall Study||25
4985535|NCT02482428|12264515|P5|NOT COMPLETED|Overall Study||7
4985536|NCT02482428|12264516|P4|NOT COMPLETED|Overall Study||2
4985537|NCT02482428|12264517|P3|NOT COMPLETED|Overall Study||1
4985538|NCT02482428|12264518|P2|NOT COMPLETED|Overall Study||12
4985539|NCT02482428|12264519|P1|NOT COMPLETED|Overall Study||9
4985540|NCT02482428|12264515|P5|COMPLETED|Overall Study||15
4985541|NCT02482428|12264516|P4|COMPLETED|Overall Study||8
4985542|NCT02482428|12264517|P3|COMPLETED|Overall Study||9
4985543|NCT02482428|12264518|P2|COMPLETED|Overall Study||10
4985544|NCT02482428|12264519|P1|COMPLETED|Overall Study||15
4985545|NCT02482428|12264515|P5|STARTED|Overall Study||22
4985546|NCT02482428|12264516|P4|STARTED|Overall Study||10
4985547|NCT02482428|12264517|P3|STARTED|Overall Study||10
4985548|NCT02482428|12264518|P2|STARTED|Overall Study||22
4985549|NCT02482428|12264519|P1|STARTED|Overall Study||24
4985550|NCT02482298|12264542|P3|NOT COMPLETED|Overall Study||3
4985551|NCT02482298|12264543|P2|NOT COMPLETED|Overall Study||3
4985552|NCT02482298|12264544|P1|NOT COMPLETED|Overall Study||2
4985553|NCT02482298|12264542|P3|COMPLETED|Overall Study||27
4985554|NCT02482298|12264543|P2|COMPLETED|Overall Study||24
4985555|NCT02482298|12264544|P1|COMPLETED|Overall Study||28
4985556|NCT02482298|12264542|P3|STARTED|Overall Study||30
4985557|NCT02482298|12264543|P2|STARTED|Overall Study||27
4985558|NCT02482298|12264544|P1|STARTED|Overall Study||30
4985559|NCT02482233|12264566|P2|NOT COMPLETED|Overall Study||1
4985560|NCT02482233|12264567|P1|NOT COMPLETED|Overall Study||1
4985561|NCT02482233|12264566|P2|COMPLETED|Overall Study||19
4985562|NCT02482233|12264567|P1|COMPLETED|Overall Study||9
4985563|NCT02482233|12264566|P2|STARTED|Overall Study||20
4985564|NCT02482233|12264567|P1|STARTED|Overall Study||10
4985565|NCT02482129|12264603|P2|NOT COMPLETED|Overall Study||2
4985566|NCT02482129|12264604|P1|NOT COMPLETED|Overall Study||6
4985567|NCT02482129|12264603|P2|COMPLETED|Overall Study||9
4985568|NCT02482129|12264604|P1|COMPLETED|Overall Study||26
4985569|NCT02482129|12264603|P2|Treated, as Randomized|Overall Study||9
4985570|NCT02482129|12264604|P1|Treated, as Randomized|Overall Study||30
4985571|NCT02482129|12264603|P2|STARTED|Overall Study||11
4985572|NCT02482129|12264604|P1|STARTED|Overall Study||32
4985573|NCT02481947|12264633|P2|NOT COMPLETED|Overall Study||36
4985574|NCT02481947|12264634|P1|NOT COMPLETED|Overall Study||46
4985575|NCT02481947|12264633|P2|COMPLETED|Overall Study||193
4985576|NCT02481947|12264634|P1|COMPLETED|Overall Study||184
4985577|NCT02481947|12264633|P2|STARTED|Overall Study||229
4985578|NCT02481947|12264634|P1|STARTED|Overall Study||230
4985579|NCT02481934|12264640|P1|NOT COMPLETED|Overall Study||2
4985580|NCT02481934|12264640|P1|COMPLETED|Overall Study||3
4985581|NCT02481934|12264640|P1|STARTED|Overall Study||5
4985582|NCT02481830|12264647|P2|NOT COMPLETED|Overall Study||20
4985583|NCT02481830|12264648|P1|NOT COMPLETED|Overall Study||2
4985584|NCT02481830|12264647|P2|COMPLETED|Overall Study||265
4985585|NCT02481830|12264648|P1|COMPLETED|Overall Study||282
4985586|NCT02481830|12264647|P2|STARTED|Overall Study||285
4985587|NCT02481830|12264648|P1|STARTED|Overall Study||284
4985588|NCT02481596|12264661|P3|NOT COMPLETED|Overall Study||8
4985589|NCT02481596|12264662|P2|NOT COMPLETED|Overall Study||1
4985590|NCT02481596|12264663|P1|NOT COMPLETED|Overall Study||3
4985591|NCT02481596|12264661|P3|COMPLETED|Overall Study||245
4985592|NCT02481596|12264662|P2|COMPLETED|Overall Study||126
4985593|NCT02481596|12264663|P1|COMPLETED|Overall Study||123
4985594|NCT02481596|12264661|P3|STARTED|Overall Study||253
4985595|NCT02481596|12264662|P2|STARTED|Overall Study||127
4985596|NCT02481596|12264663|P1|STARTED|Overall Study||126
4985597|NCT02481557|12264688|P2|NOT COMPLETED|Overall Study||0
4985598|NCT02481557|12264689|P1|NOT COMPLETED|Overall Study||0
4985599|NCT02481557|12264688|P2|COMPLETED|Overall Study||19
4985600|NCT02481557|12264689|P1|COMPLETED|Overall Study||17
4985601|NCT02481557|12264688|P2|STARTED|Overall Study||19
4985602|NCT02481557|12264689|P1|STARTED|Overall Study||17
4985603|NCT02481440|12264697|P1|NOT COMPLETED|Overall Study||61
4985604|NCT02481440|12264697|P1|COMPLETED|Overall Study||41
4985605|NCT02481440|12264697|P1|STARTED|Overall Study||102
4985606|NCT02481375|12264714|P4|NOT COMPLETED|Overall Study||14
4985607|NCT02481375|12264715|P3|NOT COMPLETED|Overall Study||10
4985608|NCT02481375|12264716|P2|NOT COMPLETED|Overall Study||11
4985609|NCT02481375|12264717|P1|NOT COMPLETED|Overall Study||14
4985610|NCT02481375|12264714|P4|COMPLETED|Overall Study||186
4985611|NCT02481375|12264715|P3|COMPLETED|Overall Study||191
4985612|NCT02481375|12264716|P2|COMPLETED|Overall Study||191
4985613|NCT02481375|12264717|P1|COMPLETED|Overall Study||192
4985614|NCT02481375|12264714|P4|STARTED|Overall Study||200
4985615|NCT02481375|12264715|P3|STARTED|Overall Study||201
4985616|NCT02481375|12264716|P2|STARTED|Overall Study||202
4985617|NCT02481375|12264717|P1|STARTED|Overall Study||206
4985618|NCT02481297|12264729|P2|NOT COMPLETED|Overall Study||0
4985619|NCT02481297|12264730|P1|NOT COMPLETED|Overall Study||0
4985620|NCT02481297|12264729|P2|COMPLETED|Overall Study||6
4985621|NCT02481297|12264730|P1|COMPLETED|Overall Study||1
4985622|NCT02481297|12264729|P2|STARTED|Overall Study||6
4985623|NCT02481297|12264730|P1|STARTED|Overall Study||1
4985624|NCT02481258|12264742|P2|NOT COMPLETED|Overall Study||0
4985625|NCT02481258|12264743|P1|NOT COMPLETED|Overall Study||0
4985626|NCT02481258|12264742|P2|COMPLETED|Overall Study||11
4985627|NCT02481258|12264743|P1|COMPLETED|Overall Study||12
4985628|NCT02481258|12264742|P2|STARTED|Overall Study||11
4985629|NCT02481258|12264743|P1|STARTED|Overall Study||12
4985630|NCT02481219|12264751|P2|NOT COMPLETED|Overall Study||1
4985631|NCT02481219|12264752|P1|NOT COMPLETED|Overall Study||2
4985632|NCT02481219|12264751|P2|COMPLETED|Overall Study||61
4985633|NCT02481219|12264752|P1|COMPLETED|Overall Study||58
4985634|NCT02481219|12264751|P2|STARTED|Overall Study||62
4985635|NCT02481219|12264752|P1|STARTED|Overall Study||60
4985636|NCT02481141|12264770|P2|NOT COMPLETED|Overall Study||5
4985637|NCT02481141|12264771|P1|NOT COMPLETED|Overall Study||9
4985638|NCT02481141|12264770|P2|COMPLETED|Overall Study||13
4985639|NCT02481141|12264771|P1|COMPLETED|Overall Study||26
4985640|NCT02481141|12264770|P2|STARTED|Overall Study||18
4985641|NCT02481141|12264771|P1|STARTED|Overall Study||35
4985642|NCT02481050|12264823|P1|NOT COMPLETED|Overall Study||58
4985643|NCT02481050|12264823|P1|COMPLETED|Overall Study||0
4985644|NCT02481050|12264823|P1|STARTED|Overall Study||58
4985645|NCT02480998|12264834|P2|NOT COMPLETED|Overall Study||0
4985646|NCT02480998|12264835|P1|NOT COMPLETED|Overall Study||0
4985647|NCT02480998|12264834|P2|COMPLETED|Overall Study||28
4985648|NCT02480998|12264835|P1|COMPLETED|Overall Study||56
4985649|NCT02480998|12264834|P2|STARTED|Overall Study||28
4985650|NCT02480998|12264835|P1|STARTED|Overall Study||56
4985651|NCT02480920|12264843|P1|NOT COMPLETED|Overall Study||0
4985652|NCT02480920|12264843|P1|COMPLETED|Overall Study||2738
4985653|NCT02480920|12264843|P1|STARTED|Overall Study||2738
4985654|NCT02480764|12264850|P3|NOT COMPLETED|Overall Study||21
4985655|NCT02480764|12264851|P2|NOT COMPLETED|Overall Study||20
4985656|NCT02480764|12264852|P1|NOT COMPLETED|Overall Study||10
4985657|NCT02480764|12264850|P3|COMPLETED|Overall Study||183
4985658|NCT02480764|12264851|P2|COMPLETED|Overall Study||189
4985659|NCT02480764|12264852|P1|COMPLETED|Overall Study||189
4985660|NCT02480764|12264850|P3|STARTED|Overall Study||204
4985661|NCT02480764|12264851|P2|STARTED|Overall Study||209
4985662|NCT02480764|12264852|P1|STARTED|Overall Study||199
4985663|NCT02480712|12264878|P1|NOT COMPLETED|Overall Study||11
4985664|NCT02480712|12264878|P1|COMPLETED|Overall Study||96
4985665|NCT02480712|12264878|P1|STARTED|Overall Study||107
4985666|NCT02480621|12264897|P2|NOT COMPLETED|Follow Up||2
4985667|NCT02480621|12264898|P1|NOT COMPLETED|Follow Up||4
4985668|NCT02480621|12264897|P2|COMPLETED|Follow Up||37
4985669|NCT02480621|12264898|P1|COMPLETED|Follow Up||39
4985670|NCT02480621|12264897|P2|STARTED|Follow Up||39
4985671|NCT02480621|12264898|P1|STARTED|Follow Up||43
4985672|NCT02480621|12264897|P2|NOT COMPLETED|Randomization||1
4985673|NCT02480621|12264898|P1|NOT COMPLETED|Randomization||1
4985674|NCT02480621|12264897|P2|COMPLETED|Randomization||39
4985675|NCT02480621|12264898|P1|COMPLETED|Randomization||43
4985676|NCT02480621|12264897|P2|STARTED|Randomization||40
4985677|NCT02480621|12264898|P1|STARTED|Randomization||44
4985678|NCT02480582|12264904|P6|NOT COMPLETED|Overall Study||0
4985679|NCT02480582|12264905|P5|NOT COMPLETED|Overall Study||0
4985680|NCT02480582|12264906|P4|NOT COMPLETED|Overall Study||0
4985681|NCT02480582|12264907|P3|NOT COMPLETED|Overall Study||0
4985682|NCT02480582|12264908|P2|NOT COMPLETED|Overall Study||0
4985683|NCT02480582|12264909|P1|NOT COMPLETED|Overall Study||0
4985684|NCT02480582|12264904|P6|COMPLETED|Overall Study||7
4985685|NCT02480582|12264905|P5|COMPLETED|Overall Study||7
4985686|NCT02480582|12264906|P4|COMPLETED|Overall Study||7
4985687|NCT02480582|12264907|P3|COMPLETED|Overall Study||7
4985688|NCT02480582|12264908|P2|COMPLETED|Overall Study||7
4985689|NCT02480582|12264909|P1|COMPLETED|Overall Study||7
4985690|NCT02480582|12264904|P6|STARTED|Overall Study||7
4985691|NCT02480582|12264905|P5|STARTED|Overall Study||7
4985692|NCT02480582|12264906|P4|STARTED|Overall Study||7
4985693|NCT02480582|12264907|P3|STARTED|Overall Study||7
4985694|NCT02480582|12264908|P2|STARTED|Overall Study||7
4985695|NCT02480582|12264909|P1|STARTED|Overall Study||7
4985696|NCT02480439|12264932|P3|NOT COMPLETED|Treatment Period 3||0
4985697|NCT02480439|12264933|P2|NOT COMPLETED|Treatment Period 3||0
4985698|NCT02480439|12264934|P1|NOT COMPLETED|Treatment Period 3||0
4985699|NCT02480439|12264932|P3|COMPLETED|Treatment Period 3||7
4985700|NCT02480439|12264933|P2|COMPLETED|Treatment Period 3||7
4985701|NCT02480439|12264934|P1|COMPLETED|Treatment Period 3||8
4985702|NCT02480439|12264932|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
4985703|NCT02480439|12264933|P2|STARTED|Treatment Period 3||7
4985704|NCT02480439|12264934|P1|STARTED|Treatment Period 3||8
4985705|NCT02480439|12264932|P3|NOT COMPLETED|Treatment Period 2||0
4985706|NCT02480439|12264933|P2|NOT COMPLETED|Treatment Period 2||0
4985707|NCT02480439|12264934|P1|NOT COMPLETED|Treatment Period 2||0
4985708|NCT02480439|12264932|P3|COMPLETED|Treatment Period 2||8
4985709|NCT02480439|12264933|P2|COMPLETED|Treatment Period 2||7
4985710|NCT02480439|12264934|P1|COMPLETED|Treatment Period 2||8
4985711|NCT02480439|12264932|P3|STARTED|Treatment Period 2||8
4985712|NCT02480439|12264933|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
4985713|NCT02480439|12264934|P1|STARTED|Treatment Period 2||8
4985714|NCT02480439|12264932|P3|NOT COMPLETED|Treatment Period 1||0
4985715|NCT02480439|12264933|P2|NOT COMPLETED|Treatment Period 1||0
4985716|NCT02480439|12264934|P1|NOT COMPLETED|Treatment Period 1||0
4985717|NCT02480439|12264932|P3|COMPLETED|Treatment Period 1||8
4985718|NCT02480439|12264933|P2|COMPLETED|Treatment Period 1||8
4985719|NCT02480439|12264934|P1|COMPLETED|Treatment Period 1||8
4985720|NCT02480439|12264932|P3|STARTED|Treatment Period 1||8
4985721|NCT02480439|12264933|P2|STARTED|Treatment Period 1||8
4985722|NCT02480439|12264934|P1|STARTED|Treatment Period 1||8
4985723|NCT02480166|12264960|P3|NOT COMPLETED|Overall Study||0
4985724|NCT02480166|12264961|P2|NOT COMPLETED|Overall Study||0
4985725|NCT02480166|12264962|P1|NOT COMPLETED|Overall Study||0
4985726|NCT02480166|12264960|P3|COMPLETED|Overall Study||4
4985727|NCT02480166|12264961|P2|COMPLETED|Overall Study||36
4985728|NCT02480166|12264962|P1|COMPLETED|Overall Study||20
4985729|NCT02480166|12264960|P3|STARTED|Overall Study||4
4985730|NCT02480166|12264961|P2|STARTED|Overall Study||36
4985731|NCT02480166|12264962|P1|STARTED|Overall Study||20
4985732|NCT02480153|12264975|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
4985733|NCT02480153|12264976|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
4985734|NCT02480153|12264977|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
4985735|NCT02480153|12264975|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
4985736|NCT02480153|12264976|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
4985737|NCT02480153|12264977|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
4985738|NCT02480153|12264975|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
4985739|NCT02480153|12264976|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
4985740|NCT02480153|12264977|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
4985741|NCT02480153|12264975|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
4985742|NCT02480153|12264976|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
4985743|NCT02480153|12264977|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
4985744|NCT02480153|12264975|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
4985745|NCT02480153|12264976|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
4985746|NCT02480153|12264977|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
4985747|NCT02480153|12264975|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
4985748|NCT02480153|12264976|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
4985749|NCT02480153|12264977|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
4985750|NCT02480153|12264975|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
4985751|NCT02480153|12264976|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
4985752|NCT02480153|12264977|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
4985753|NCT02480153|12264975|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
4985754|NCT02480153|12264976|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
4985755|NCT02480153|12264977|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
4985756|NCT02480153|12264975|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
4985757|NCT02480153|12264976|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
4985758|NCT02480153|12264977|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
4985759|NCT02480153|12264975|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
4985760|NCT02480153|12264976|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
4985761|NCT02480153|12264977|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
4985762|NCT02480153|12264975|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
4985763|NCT02480153|12264976|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
4985764|NCT02480153|12264977|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
4985765|NCT02480153|12264975|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
4985766|NCT02480153|12264976|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
4985767|NCT02480153|12264977|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
4985768|NCT02480010|12265154|P2|NOT COMPLETED|Overall Study||33
4985769|NCT02480010|12265155|P1|NOT COMPLETED|Overall Study||35
4985770|NCT02480010|12265154|P2|COMPLETED|Overall Study||0
4985771|NCT02480010|12265155|P1|COMPLETED|Overall Study||0
4985772|NCT02480010|12265154|P2|STARTED|Overall Study||33
4985773|NCT02480010|12265155|P1|STARTED|Overall Study||35
4985774|NCT02479880|12265201|P2|NOT COMPLETED|Overall Study||13
4985775|NCT02479880|12265202|P1|NOT COMPLETED|Overall Study||13
4985776|NCT02479880|12265201|P2|COMPLETED|Overall Study||2
4985777|NCT02479880|12265202|P1|COMPLETED|Overall Study||2
4985778|NCT02479880|12265201|P2|STARTED|Overall Study||15
4985779|NCT02479880|12265202|P1|STARTED|Overall Study||15
4985780|NCT02479802|12265208|P1|NOT COMPLETED|Overall Study||2
4985781|NCT02479802|12265208|P1|COMPLETED|Overall Study||11
4985782|NCT02479802|12265208|P1|STARTED|Overall Study||13
4985783|NCT02479763|12265219|P2|NOT COMPLETED|Overall Study||3
4985784|NCT02479763|12265220|P1|NOT COMPLETED|Overall Study||3
4985785|NCT02479763|12265219|P2|COMPLETED|Overall Study||50
4985786|NCT02479763|12265220|P1|COMPLETED|Overall Study||50
4985787|NCT02479763|12265219|P2|STARTED|Overall Study||53
4985788|NCT02479763|12265220|P1|STARTED|Overall Study||53
4985789|NCT02479412|12265235|P9|NOT COMPLETED|Overall Study||1
4985790|NCT02479412|12265236|P8|NOT COMPLETED|Overall Study||1
4985791|NCT02479412|12265237|P7|NOT COMPLETED|Overall Study||0
4985792|NCT02479412|12265238|P6|NOT COMPLETED|Overall Study||0
4985793|NCT02479412|12265239|P5|NOT COMPLETED|Overall Study||1
4985794|NCT02479412|12265240|P4|NOT COMPLETED|Overall Study||1
4985795|NCT02479412|12265241|P3|NOT COMPLETED|Overall Study||2
4985796|NCT02479412|12265242|P2|NOT COMPLETED|Overall Study||0
4985797|NCT02479412|12265243|P1|NOT COMPLETED|Overall Study||0
4985798|NCT02479412|12265235|P9|COMPLETED|Overall Study||6
4985799|NCT02479412|12265236|P8|COMPLETED|Overall Study||4
4985800|NCT02479412|12265237|P7|COMPLETED|Overall Study||6
4985801|NCT02479412|12265238|P6|COMPLETED|Overall Study||5
4985802|NCT02479412|12265239|P5|COMPLETED|Overall Study||5
4985803|NCT02479412|12265240|P4|COMPLETED|Overall Study||6
4985804|NCT02479412|12265241|P3|COMPLETED|Overall Study||4
4985805|NCT02479412|12265242|P2|COMPLETED|Overall Study||6
4985806|NCT02479412|12265243|P1|COMPLETED|Overall Study||6
4985807|NCT02479412|12265235|P9|STARTED|Overall Study||7
4985808|NCT02479412|12265236|P8|STARTED|Overall Study||5
4985809|NCT02479412|12265237|P7|STARTED|Overall Study||6
4985810|NCT02479412|12265238|P6|STARTED|Overall Study||5
4985811|NCT02479412|12265239|P5|STARTED|Overall Study||6
4985812|NCT02479412|12265240|P4|STARTED|Overall Study||7
4985813|NCT02479412|12265241|P3|STARTED|Overall Study||6
4985814|NCT02479412|12265242|P2|STARTED|Overall Study||6
4985815|NCT02479412|12265243|P1|STARTED|Overall Study||6
4985816|NCT02479139|12265320|P6|NOT COMPLETED|Overall Study||6
4985817|NCT02479139|12265321|P5|NOT COMPLETED|Overall Study||5
4985818|NCT02479139|12265322|P4|NOT COMPLETED|Overall Study||7
4985819|NCT02479139|12265323|P3|NOT COMPLETED|Overall Study||7
4985820|NCT02479139|12265324|P2|NOT COMPLETED|Overall Study||10
4985821|NCT02479139|12265325|P1|NOT COMPLETED|Overall Study||8
4985822|NCT02479139|12265320|P6|COMPLETED|Overall Study||19
4985823|NCT02479139|12265321|P5|COMPLETED|Overall Study||17
4985824|NCT02479139|12265322|P4|COMPLETED|Overall Study||14
4985825|NCT02479139|12265323|P3|COMPLETED|Overall Study||21
4985826|NCT02479139|12265324|P2|COMPLETED|Overall Study||12
4985827|NCT02479139|12265325|P1|COMPLETED|Overall Study||19
4985828|NCT02479139|12265320|P6|STARTED|Overall Study||25
4985829|NCT02479139|12265321|P5|STARTED|Overall Study||22
4985830|NCT02479139|12265322|P4|STARTED|Overall Study||21
4985831|NCT02479139|12265323|P3|STARTED|Overall Study||28
4985832|NCT02479139|12265324|P2|STARTED|Overall Study||22
4985833|NCT02479139|12265325|P1|STARTED|Overall Study||27
4985834|NCT02478671|12265351|P1|NOT COMPLETED|Overall Study||0
4985835|NCT02478671|12265351|P1|COMPLETED|Overall Study||4
4985836|NCT02478671|12265351|P1|STARTED|Overall Study||4
4985837|NCT02478632|12265358|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
4985838|NCT02478632|12265359|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
4985839|NCT02478632|12265358|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
4985840|NCT02478632|12265359|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
4985841|NCT02478632|12265358|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
4985842|NCT02478632|12265359|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
4985843|NCT02478632|12265358|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
4985844|NCT02478632|12265359|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
4985845|NCT02478632|12265358|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
4985846|NCT02478632|12265359|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
4985847|NCT02478632|12265358|P2|STARTED|Early Switch Phase (Up to Week 52)||49
4985848|NCT02478632|12265359|P1|STARTED|Early Switch Phase (Up to Week 52)||53
4985849|NCT02478580|12265385|P2|NOT COMPLETED|Overall Study||0
4985850|NCT02478580|12265386|P1|NOT COMPLETED|Overall Study||0
4985851|NCT02478580|12265385|P2|COMPLETED|Overall Study||33
4985852|NCT02478580|12265386|P1|COMPLETED|Overall Study||34
4985853|NCT02478580|12265385|P2|STARTED|Overall Study||33
4985854|NCT02478580|12265386|P1|STARTED|Overall Study||34
4985855|NCT02478463|12265394|P1|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
4985856|NCT02478463|12265394|P1|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
4985857|NCT02478463|12265394|P1|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
4985858|NCT02478463|12265394|P1|NOT COMPLETED|Washout Period (Up to 42 Days)||1
4985859|NCT02478463|12265394|P1|COMPLETED|Washout Period (Up to 42 Days)||17
4985860|NCT02478463|12265394|P1|STARTED|Washout Period (Up to 42 Days)||18
4985861|NCT02478463|12265394|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
4985862|NCT02478463|12265394|P1|COMPLETED|Treatment Period 1 (Up to Day 29)||18
4985863|NCT02478463|12265394|P1|STARTED|Treatment Period 1 (Up to Day 29)||19
4985864|NCT02478398|12265511|P2|NOT COMPLETED|Overall Study||21
4985865|NCT02478398|12265512|P1|NOT COMPLETED|Overall Study||52
4985866|NCT02478398|12265511|P2|COMPLETED|Overall Study||491
4985867|NCT02478398|12265512|P1|COMPLETED|Overall Study||461
4985868|NCT02478398|12265511|P2|Treated|Overall Study||510
4985869|NCT02478398|12265512|P1|Treated|Overall Study||512
4985870|NCT02478398|12265511|P2|STARTED|Overall Study||512
4985871|NCT02478398|12265512|P1|STARTED|Overall Study||513
4985872|NCT02478372|12265532|P2|NOT COMPLETED|Overall Study||14
4985873|NCT02478372|12265533|P1|NOT COMPLETED|Overall Study||13
4985874|NCT02478372|12265532|P2|COMPLETED|Overall Study||107
4985875|NCT02478372|12265533|P1|COMPLETED|Overall Study||108
4985876|NCT02478372|12265532|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
4985877|NCT02478372|12265533|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
4985878|NCT02478372|12265532|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
4985879|NCT02478372|12265533|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
4985880|NCT02478372|12265532|P2|Recieved Allocation Intervention|Overall Study||113
4985881|NCT02478372|12265533|P1|Recieved Allocation Intervention|Overall Study||109
4985882|NCT02478372|12265532|P2|STARTED|Overall Study||121
4985883|NCT02478372|12265533|P1|STARTED|Overall Study||121
4985884|NCT02478359|12265557|P2|NOT COMPLETED|Overall Study||65
4985885|NCT02478359|12265558|P1|NOT COMPLETED|Overall Study||106
4985886|NCT02478359|12265557|P2|COMPLETED|Overall Study||1293
4985887|NCT02478359|12265558|P1|COMPLETED|Overall Study||1243
4985888|NCT02478359|12265557|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
4985889|NCT02478359|12265558|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
4985890|NCT02478359|12265557|P2|STARTED|Overall Study||1358
4985891|NCT02478359|12265558|P1|STARTED|Overall Study||1349
4985892|NCT02478164|12265630|P1|NOT COMPLETED|Overall Study||15
4985893|NCT02478164|12265630|P1|COMPLETED|Overall Study||0
4985894|NCT02478164|12265630|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
4985895|NCT02477709|12265637|P1|NOT COMPLETED|Overall Study||0
4985896|NCT02477709|12265637|P1|COMPLETED|Overall Study||6
4985897|NCT02477709|12265637|P1|STARTED|Overall Study||6
4985898|NCT02477618|12265643|P2|NOT COMPLETED|Overall Study||14
4985899|NCT02477618|12265644|P1|NOT COMPLETED|Overall Study||15
4985900|NCT02477618|12265643|P2|COMPLETED|Overall Study||53
4985901|NCT02477618|12265644|P1|COMPLETED|Overall Study||50
4985902|NCT02477618|12265643|P2|Intent-to-Treat Analysis Set|Overall Study||66
4985903|NCT02477618|12265644|P1|Intent-to-Treat Analysis Set|Overall Study||66
4985904|NCT02477618|12265643|P2|STARTED|Overall Study||67
4985905|NCT02477618|12265644|P1|STARTED|Overall Study||65
4985906|NCT02477605|12265668|P2|NOT COMPLETED|Overall Study||4
4985907|NCT02477605|12265669|P1|NOT COMPLETED|Overall Study||1
4985908|NCT02477605|12265668|P2|COMPLETED|Overall Study||64
4985909|NCT02477605|12265669|P1|COMPLETED|Overall Study||67
4985910|NCT02477605|12265668|P2|Randomized and Treated|Overall Study||68
4985911|NCT02477605|12265669|P1|Randomized and Treated|Overall Study||67
4985912|NCT02477605|12265668|P2|STARTED|Overall Study||68
4985913|NCT02477605|12265669|P1|STARTED|Overall Study||68
4985914|NCT02477553|12265685|P2|NOT COMPLETED|Overall Study||20
4985915|NCT02477553|12265686|P1|NOT COMPLETED|Overall Study||20
4985916|NCT02477553|12265685|P2|COMPLETED|Overall Study||344
4985917|NCT02477553|12265686|P1|COMPLETED|Overall Study||344
4985918|NCT02477553|12265685|P2|STARTED|Overall Study||364
4985919|NCT02477553|12265686|P1|STARTED|Overall Study||364
4985920|NCT02477527|12265706|P1|NOT COMPLETED|Overall Study||6
4985921|NCT02477527|12265706|P1|COMPLETED|Overall Study||21
4985922|NCT02477527|12265706|P1|STARTED|Overall Study||27
4985923|NCT02477332|12265720|P6|NOT COMPLETED|Overall Study||5
4985924|NCT02477332|12265721|P5|NOT COMPLETED|Overall Study||4
4985925|NCT02477332|12265722|P4|NOT COMPLETED|Overall Study||13
4985926|NCT02477332|12265723|P3|NOT COMPLETED|Overall Study||12
4985927|NCT02477332|12265724|P2|NOT COMPLETED|Overall Study||7
4985928|NCT02477332|12265725|P1|NOT COMPLETED|Overall Study||3
4985929|NCT02477332|12265720|P6|COMPLETED|Overall Study||37
4985930|NCT02477332|12265721|P5|COMPLETED|Overall Study||39
4985931|NCT02477332|12265722|P4|COMPLETED|Overall Study||72
4985932|NCT02477332|12265723|P3|COMPLETED|Overall Study||73
4985933|NCT02477332|12265724|P2|COMPLETED|Overall Study||77
4985934|NCT02477332|12265725|P1|COMPLETED|Overall Study||40
4985935|NCT02477332|12265720|P6|STARTED|Overall Study||42
4985936|NCT02477332|12265721|P5|STARTED|Overall Study||43
4985937|NCT02477332|12265722|P4|STARTED|Overall Study||85
4985938|NCT02477332|12265723|P3|STARTED|Overall Study||85
4985939|NCT02477332|12265724|P2|STARTED|Overall Study||84
4985940|NCT02477332|12265725|P1|STARTED|Overall Study||43
4985941|NCT02477319|12265803|P4|NOT COMPLETED|Overall Study||22
4985942|NCT02477319|12265804|P3|NOT COMPLETED|Overall Study||15
4985943|NCT02477319|12265805|P2|NOT COMPLETED|Overall Study||3
4985944|NCT02477319|12265806|P1|NOT COMPLETED|Overall Study||0
4985945|NCT02477319|12265803|P4|COMPLETED|Overall Study||171
4985946|NCT02477319|12265804|P3|COMPLETED|Overall Study||149
4985947|NCT02477319|12265805|P2|COMPLETED|Overall Study||37
4985948|NCT02477319|12265806|P1|COMPLETED|Overall Study||55
4985949|NCT02477319|12265803|P4|STARTED|Overall Study||193
4985950|NCT02477319|12265804|P3|STARTED|Overall Study||164
4985951|NCT02477319|12265805|P2|STARTED|Overall Study||40
4985952|NCT02477319|12265806|P1|STARTED|Overall Study||55
4985953|NCT02477215|12265817|P3|NOT COMPLETED|Fixed Dose Phase||0
4985954|NCT02477215|12265818|P2|NOT COMPLETED|Fixed Dose Phase||7
4985955|NCT02477215|12265819|P1|NOT COMPLETED|Fixed Dose Phase||0
4985956|NCT02477215|12265817|P3|COMPLETED|Fixed Dose Phase||0
4985957|NCT02477215|12265818|P2|COMPLETED|Fixed Dose Phase||13
4985958|NCT02477215|12265819|P1|COMPLETED|Fixed Dose Phase||0
4985959|NCT02477215|12265817|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
4985960|NCT02477215|12265818|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
4985961|NCT02477215|12265819|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
4985962|NCT02477215|12265817|P3|NOT COMPLETED|Dose Escalation Phase||0
4985963|NCT02477215|12265818|P2|NOT COMPLETED|Dose Escalation Phase||2
4985964|NCT02477215|12265819|P1|NOT COMPLETED|Dose Escalation Phase||1
4985965|NCT02477215|12265817|P3|COMPLETED|Dose Escalation Phase||6
4985966|NCT02477215|12265818|P2|COMPLETED|Dose Escalation Phase||6
4985967|NCT02477215|12265819|P1|COMPLETED|Dose Escalation Phase||3
4985968|NCT02477215|12265817|P3|STARTED|Dose Escalation Phase||6
4985969|NCT02477215|12265818|P2|STARTED|Dose Escalation Phase||8
4985970|NCT02477215|12265819|P1|STARTED|Dose Escalation Phase||4
4985971|NCT02477020|12265835|P2|NOT COMPLETED|Overall Study||28
4985972|NCT02477020|12265836|P1|NOT COMPLETED|Overall Study||30
4985973|NCT02477020|12265835|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
4985974|NCT02477020|12265836|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
4985975|NCT02477020|12265835|P2|STARTED|Overall Study||83
4985976|NCT02477020|12265836|P1|STARTED|Overall Study||81
4985977|NCT02476994|12265866|P2|NOT COMPLETED|Overall Study||0
4985978|NCT02476994|12265867|P1|NOT COMPLETED|Overall Study||1
4985979|NCT02476994|12265866|P2|COMPLETED|Overall Study||0
4985980|NCT02476994|12265867|P1|COMPLETED|Overall Study||0
4985981|NCT02476994|12265866|P2|STARTED|Overall Study||0
4985982|NCT02476994|12265867|P1|STARTED|Overall Study||1
4985983|NCT02476916|12265895|P2|NOT COMPLETED|Extension Period||18
4985984|NCT02476916|12265896|P1|NOT COMPLETED|Extension Period||18
4985985|NCT02476916|12265895|P2|COMPLETED|Extension Period||0
4985986|NCT02476916|12265896|P1|COMPLETED|Extension Period||0
4985987|NCT02476916|12265895|P2|STARTED|Extension Period||18
4985988|NCT02476916|12265896|P1|STARTED|Extension Period||18
4985989|NCT02476916|12265895|P2|NOT COMPLETED|Core Period||3
4985990|NCT02476916|12265896|P1|NOT COMPLETED|Core Period||6
4985991|NCT02476916|12265895|P2|COMPLETED|Core Period||22
4985992|NCT02476916|12265896|P1|COMPLETED|Core Period||21
4985993|NCT02476916|12265895|P2|STARTED|Core Period||25
4985994|NCT02476916|12265896|P1|STARTED|Core Period||27
4985995|NCT02476890|12265942|P4|NOT COMPLETED|Overall Study||0
4985996|NCT02476890|12265943|P3|NOT COMPLETED|Overall Study||0
4985997|NCT02476890|12265944|P2|NOT COMPLETED|Overall Study||0
4985998|NCT02476890|12265945|P1|NOT COMPLETED|Overall Study||0
4985999|NCT02476890|12265942|P4|COMPLETED|Overall Study||12
4986000|NCT02476890|12265943|P3|COMPLETED|Overall Study||12
4986001|NCT02476890|12265944|P2|COMPLETED|Overall Study||6
4986002|NCT02476890|12265945|P1|COMPLETED|Overall Study||6
4986003|NCT02476890|12265942|P4|Washout|Overall Study||12
4986004|NCT02476890|12265943|P3|Washout|Overall Study||12
4986005|NCT02476890|12265944|P2|Washout|Overall Study||6
4986006|NCT02476890|12265945|P1|Washout|Overall Study||6
4986007|NCT02476890|12265942|P4|STARTED|Overall Study|Crossover study|12
4986008|NCT02476890|12265943|P3|STARTED|Overall Study|Crossover study|12
4986009|NCT02476890|12265944|P2|STARTED|Overall Study|Crossover study|6
4986010|NCT02476890|12265945|P1|STARTED|Overall Study|Crossover study|6
4986011|NCT02476617|12265981|P1|NOT COMPLETED|Overall Study||2
4986012|NCT02476617|12265981|P1|COMPLETED|Overall Study||23
4986013|NCT02476617|12265981|P1|STARTED|Overall Study||25
4986014|NCT02476578|12265987|P2|NOT COMPLETED|Overall Study||56
4986015|NCT02476578|12265988|P1|NOT COMPLETED|Overall Study||41
4986016|NCT02476578|12265987|P2|COMPLETED|Overall Study||4218
4986017|NCT02476578|12265988|P1|COMPLETED|Overall Study||4269
4986018|NCT02476578|12265987|P2|Left Before End of Trial|Overall Study||13
4986019|NCT02476578|12265988|P1|Left Before End of Trial|Overall Study||6
4986020|NCT02476578|12265987|P2|Died Before Email Was Sent|Overall Study||43
4986021|NCT02476578|12265988|P1|Died Before Email Was Sent|Overall Study||35
4986022|NCT02476578|12265987|P2|STARTED|Overall Study||4274
4986023|NCT02476578|12265988|P1|STARTED|Overall Study||4310
4986024|NCT02476565|12266002|P2|NOT COMPLETED|Overall Study||0
4986025|NCT02476565|12266003|P1|NOT COMPLETED|Overall Study||0
4986026|NCT02476565|12266002|P2|COMPLETED|Overall Study||19
4986027|NCT02476565|12266003|P1|COMPLETED|Overall Study||20
4986028|NCT02476565|12266002|P2|STARTED|Overall Study||19
4986029|NCT02476565|12266003|P1|STARTED|Overall Study||20
4986030|NCT02476448|12266027|P4|NOT COMPLETED|Overall Study||0
4986031|NCT02476448|12266028|P3|NOT COMPLETED|Overall Study||0
4986032|NCT02476448|12266029|P2|NOT COMPLETED|Overall Study||0
4986033|NCT02476448|12266030|P1|NOT COMPLETED|Overall Study||0
4986034|NCT02476448|12266027|P4|COMPLETED|Overall Study||44
4986035|NCT02476448|12266028|P3|COMPLETED|Overall Study||44
4986036|NCT02476448|12266029|P2|COMPLETED|Overall Study||44
4986037|NCT02476448|12266030|P1|COMPLETED|Overall Study||44
4986038|NCT02476448|12266027|P4|STARTED|Overall Study||44
4986039|NCT02476448|12266028|P3|STARTED|Overall Study||44
4986040|NCT02476448|12266029|P2|STARTED|Overall Study||44
4986041|NCT02476448|12266030|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
4986042|NCT02476422|12266050|P2|NOT COMPLETED|Overall Study||1
4986043|NCT02476422|12266051|P1|NOT COMPLETED|Overall Study||0
4986044|NCT02476422|12266050|P2|COMPLETED|Overall Study||161
4986045|NCT02476422|12266051|P1|COMPLETED|Overall Study||166
4986046|NCT02476422|12266050|P2|STARTED|Overall Study||162
4986047|NCT02476422|12266051|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
4986048|NCT02476357|12266083|P2|NOT COMPLETED|Overall Study||0
4986049|NCT02476357|12266084|P1|NOT COMPLETED|Overall Study||0
4986050|NCT02476357|12266083|P2|COMPLETED|Overall Study||40
4986051|NCT02476357|12266084|P1|COMPLETED|Overall Study||40
4986052|NCT02476357|12266083|P2|STARTED|Overall Study||40
4986053|NCT02476357|12266084|P1|STARTED|Overall Study||40
4986054|NCT02476175|12266092|P1|NOT COMPLETED|Overall Study||2
4986055|NCT02476175|12266092|P1|COMPLETED|Overall Study||33
4986056|NCT02476175|12266092|P1|STARTED|Overall Study||35
4986057|NCT02476032|12266103|P3|NOT COMPLETED|Overall Study||1
4986058|NCT02476032|12266104|P2|NOT COMPLETED|Overall Study||1
4986059|NCT02476032|12266105|P1|NOT COMPLETED|Overall Study||0
4986060|NCT02476032|12266103|P3|COMPLETED|Overall Study||19
4986061|NCT02476032|12266104|P2|COMPLETED|Overall Study||19
4986062|NCT02476032|12266105|P1|COMPLETED|Overall Study||20
4986063|NCT02476032|12266103|P3|STARTED|Overall Study||20
4986064|NCT02476032|12266104|P2|STARTED|Overall Study||20
4986065|NCT02476032|12266105|P1|STARTED|Overall Study||20
4986066|NCT02476006|12266116|P1|NOT COMPLETED|Overall Study||120
4986067|NCT02476006|12266116|P1|COMPLETED|Overall Study||878
4986068|NCT02476006|12266116|P1|Treated|Overall Study||994
4986069|NCT02476006|12266116|P1|STARTED|Overall Study||998
4986070|NCT02475980|12266130|P1|NOT COMPLETED|Overall Study||5
4986071|NCT02475980|12266130|P1|COMPLETED|Overall Study||8
4986072|NCT02475980|12266130|P1|STARTED|Overall Study||13
4986073|NCT02475837|12266141|P2|NOT COMPLETED|Overall Study||0
4986074|NCT02475837|12266142|P1|NOT COMPLETED|Overall Study||0
4986075|NCT02475837|12266141|P2|COMPLETED|Overall Study||7
4986076|NCT02475837|12266142|P1|COMPLETED|Overall Study||6
4986077|NCT02475837|12266141|P2|STARTED|Overall Study||7
4986078|NCT02475837|12266142|P1|STARTED|Overall Study||6
4986079|NCT02475733|12266156|P2|NOT COMPLETED|Overall Study||0
4986080|NCT02475733|12266157|P1|NOT COMPLETED|Overall Study||2
4986081|NCT02475733|12266156|P2|COMPLETED|Overall Study||22
4986082|NCT02475733|12266157|P1|COMPLETED|Overall Study||59
4986083|NCT02475733|12266156|P2|STARTED|Overall Study||22
4986084|NCT02475733|12266157|P1|STARTED|Overall Study||61
4986085|NCT02475655|12266214|P2|NOT COMPLETED|Overall Study||1
4986086|NCT02475655|12266215|P1|NOT COMPLETED|Overall Study||0
4986087|NCT02475655|12266214|P2|COMPLETED|Overall Study||19
4986088|NCT02475655|12266215|P1|COMPLETED|Overall Study||40
4986089|NCT02475655|12266214|P2|STARTED|Overall Study||20
4986090|NCT02475655|12266215|P1|STARTED|Overall Study||40
4986091|NCT02475629|12266274|P1|NOT COMPLETED|Overall Study||9
4986092|NCT02475629|12266274|P1|COMPLETED|Overall Study||31
4986093|NCT02475629|12266274|P1|STARTED|Overall Study||40
4986094|NCT02475564|12266297|P2|NOT COMPLETED|Overall Study||1
4986095|NCT02475564|12266298|P1|NOT COMPLETED|Overall Study||4
4986096|NCT02475564|12266297|P2|COMPLETED|Overall Study||21
4986097|NCT02475564|12266298|P1|COMPLETED|Overall Study||18
4986098|NCT02475564|12266297|P2|STARTED|Overall Study||22
4986099|NCT02475564|12266298|P1|STARTED|Overall Study||22
4986100|NCT02475395|12266310|P2|NOT COMPLETED|Overall Study||3
4986101|NCT02475395|12266311|P1|NOT COMPLETED|Overall Study||30
4986102|NCT02475395|12266310|P2|COMPLETED|Overall Study||11
4986103|NCT02475395|12266311|P1|COMPLETED|Overall Study||228
4986104|NCT02475395|12266310|P2|STARTED|Overall Study||14
4986105|NCT02475395|12266311|P1|STARTED|Overall Study||258
4986106|NCT02475278|12266321|P1|NOT COMPLETED|Overall Study||2
4986107|NCT02475278|12266321|P1|COMPLETED|Overall Study||48
4986108|NCT02475278|12266321|P1|STARTED|Overall Study||50
4986109|NCT02475265|12266332|P1|NOT COMPLETED|Overall Study||3
4986110|NCT02475265|12266332|P1|COMPLETED|Overall Study||8
4986111|NCT02475265|12266332|P1|STARTED|Overall Study||11
4986112|NCT02475070|12266338|P2|NOT COMPLETED|Overall Study||0
4986113|NCT02475070|12266339|P1|NOT COMPLETED|Overall Study||0
4986114|NCT02475070|12266338|P2|COMPLETED|Overall Study||11
4986115|NCT02475070|12266339|P1|COMPLETED|Overall Study||17
4986116|NCT02475070|12266338|P2|STARTED|Overall Study||11
4986117|NCT02475070|12266339|P1|STARTED|Overall Study||17
4986118|NCT02475031|12266349|P2|NOT COMPLETED|Overall Study||0
4986119|NCT02475031|12266350|P1|NOT COMPLETED|Overall Study||0
4986120|NCT02475031|12266349|P2|COMPLETED|Overall Study||35
4986121|NCT02475031|12266350|P1|COMPLETED|Overall Study||35
4986122|NCT02475031|12266349|P2|STARTED|Overall Study||35
4986123|NCT02475031|12266350|P1|STARTED|Overall Study||35
4986124|NCT02474901|12266366|P2|NOT COMPLETED|Overall Study||0
4986125|NCT02474901|12266367|P1|NOT COMPLETED|Overall Study||1
4986126|NCT02474901|12266366|P2|COMPLETED|Overall Study||56
4986127|NCT02474901|12266367|P1|COMPLETED|Overall Study||44
4986128|NCT02474901|12266366|P2|STARTED|Overall Study||56
4986129|NCT02474901|12266367|P1|STARTED|Overall Study||45
4986130|NCT02474589|12266383|P2|NOT COMPLETED|Overall Study||5
4986131|NCT02474589|12266384|P1|NOT COMPLETED|Overall Study||25
4986132|NCT02474589|12266383|P2|COMPLETED|Overall Study||85
4986133|NCT02474589|12266384|P1|COMPLETED|Overall Study||334
4986134|NCT02474589|12266383|P2|STARTED|Overall Study||90
4986135|NCT02474589|12266384|P1|STARTED|Overall Study||359
4986136|NCT02474498|12266393|P3|NOT COMPLETED|Overall Study||0
4986137|NCT02474498|12266394|P2|NOT COMPLETED|Overall Study||0
4986138|NCT02474498|12266395|P1|NOT COMPLETED|Overall Study||0
4986139|NCT02474498|12266393|P3|COMPLETED|Overall Study||14
4986140|NCT02474498|12266394|P2|COMPLETED|Overall Study||14
4986141|NCT02474498|12266395|P1|COMPLETED|Overall Study||13
4986142|NCT02474498|12266393|P3|STARTED|Overall Study||14
4986143|NCT02474498|12266394|P2|STARTED|Overall Study||14
4986144|NCT02474498|12266395|P1|STARTED|Overall Study||13
4986145|NCT02474407|12266412|P2|NOT COMPLETED|Second Intervention (14 Days)||0
4986146|NCT02474407|12266413|P1|NOT COMPLETED|Second Intervention (14 Days)||0
4986147|NCT02474407|12266412|P2|COMPLETED|Second Intervention (14 Days)||39
4986148|NCT02474407|12266413|P1|COMPLETED|Second Intervention (14 Days)||39
4986149|NCT02474407|12266412|P2|STARTED|Second Intervention (14 Days)||39
4986150|NCT02474407|12266413|P1|STARTED|Second Intervention (14 Days)||39
4986151|NCT02474407|12266412|P2|NOT COMPLETED|Washout (14 Days)||0
4986152|NCT02474407|12266413|P1|NOT COMPLETED|Washout (14 Days)||0
4986153|NCT02474407|12266412|P2|COMPLETED|Washout (14 Days)||39
4986154|NCT02474407|12266413|P1|COMPLETED|Washout (14 Days)||39
4986155|NCT02474407|12266412|P2|STARTED|Washout (14 Days)||39
4986156|NCT02474407|12266413|P1|STARTED|Washout (14 Days)||39
4986157|NCT02474407|12266412|P2|NOT COMPLETED|First Intervention (14 Days)||0
4986158|NCT02474407|12266413|P1|NOT COMPLETED|First Intervention (14 Days)||0
4986159|NCT02474407|12266412|P2|COMPLETED|First Intervention (14 Days)||39
4986160|NCT02474407|12266413|P1|COMPLETED|First Intervention (14 Days)||39
4986161|NCT02474407|12266412|P2|STARTED|First Intervention (14 Days)||39
4986162|NCT02474407|12266413|P1|STARTED|First Intervention (14 Days)||39
4986163|NCT02474082|12266443|P2|NOT COMPLETED|Overall Study||54
4986164|NCT02474082|12266444|P1|NOT COMPLETED|Overall Study||6
4986165|NCT02474082|12266443|P2|COMPLETED|Overall Study||43
4986166|NCT02474082|12266444|P1|COMPLETED|Overall Study||99
4986167|NCT02474082|12266443|P2|Full Analysis Set (FAS)|Overall Study||95
4986168|NCT02474082|12266444|P1|Full Analysis Set (FAS)|Overall Study||105
4986169|NCT02474082|12266443|P2|STARTED|Overall Study||97
4986170|NCT02474082|12266444|P1|STARTED|Overall Study||105
4986171|NCT02474069|12266478|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
4986172|NCT02474069|12266479|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
4986173|NCT02474069|12266480|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
4986174|NCT02474069|12266478|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
4986175|NCT02474069|12266479|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
4986176|NCT02474069|12266480|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
4986177|NCT02474069|12266478|P3|STARTED|Comparative Dosing Phase (CDP)||163
4986178|NCT02474069|12266479|P2|STARTED|Comparative Dosing Phase (CDP)||162
4986179|NCT02474069|12266480|P1|STARTED|Comparative Dosing Phase (CDP)||0
4986180|NCT02474069|12266478|P3|NOT COMPLETED|Selection Phase (SP)||0
4986181|NCT02474069|12266479|P2|NOT COMPLETED|Selection Phase (SP)||0
4986182|NCT02474069|12266480|P1|NOT COMPLETED|Selection Phase (SP)||23
4986183|NCT02474069|12266478|P3|COMPLETED|Selection Phase (SP)||0
4986184|NCT02474069|12266479|P2|COMPLETED|Selection Phase (SP)||0
4986185|NCT02474069|12266480|P1|COMPLETED|Selection Phase (SP)||749
4986186|NCT02474069|12266478|P3|STARTED|Selection Phase (SP)||0
4986187|NCT02474069|12266479|P2|STARTED|Selection Phase (SP)||0
4986188|NCT02474069|12266480|P1|STARTED|Selection Phase (SP)||772
4986189|NCT02473991|12266505|P1|NOT COMPLETED|Overall Study||0
4986190|NCT02473991|12266505|P1|COMPLETED|Overall Study||395
4986191|NCT02473991|12266505|P1|STARTED|Overall Study||395
4986192|NCT02473965|12266513|P2|NOT COMPLETED|Overall Study||10
4986193|NCT02473965|12266514|P1|NOT COMPLETED|Overall Study||12
4986194|NCT02473965|12266513|P2|COMPLETED|Overall Study||20
4986195|NCT02473965|12266514|P1|COMPLETED|Overall Study||18
4986196|NCT02473965|12266513|P2|STARTED|Overall Study||30
4986197|NCT02473965|12266514|P1|STARTED|Overall Study||30
4986198|NCT02473952|12266526|P2|NOT COMPLETED|Overall Study||8
4986199|NCT02473952|12266527|P1|NOT COMPLETED|Overall Study||2
4986200|NCT02473952|12266526|P2|COMPLETED|Overall Study||24
4986201|NCT02473952|12266527|P1|COMPLETED|Overall Study||28
4986202|NCT02473952|12266526|P2|STARTED|Overall Study||32
4986203|NCT02473952|12266527|P1|STARTED|Overall Study||30
4986204|NCT02473783|12266535|P2|NOT COMPLETED|Overall Study||0
4986205|NCT02473783|12266536|P1|NOT COMPLETED|Overall Study||0
4986206|NCT02473783|12266535|P2|COMPLETED|Overall Study||17
4986207|NCT02473783|12266536|P1|COMPLETED|Overall Study||20
4986208|NCT02473783|12266535|P2|STARTED|Overall Study||17
4986209|NCT02473783|12266536|P1|STARTED|Overall Study||20
4986210|NCT02473718|12266546|P2|NOT COMPLETED|Overall Study||0
4986211|NCT02473718|12266547|P1|NOT COMPLETED|Overall Study||0
4986212|NCT02473718|12266546|P2|COMPLETED|Overall Study||41
4986213|NCT02473718|12266547|P1|COMPLETED|Overall Study||41
4986214|NCT02473718|12266546|P2|STARTED|Overall Study||41
4986215|NCT02473718|12266547|P1|STARTED|Overall Study||41
4986216|NCT02473640|12266567|P1|NOT COMPLETED|Treatment Period 2||0
4986217|NCT02473640|12266567|P1|COMPLETED|Treatment Period 2||14
4986218|NCT02473640|12266567|P1|STARTED|Treatment Period 2||14
4986219|NCT02473640|12266567|P1|NOT COMPLETED|Run-in Phase||0
4986220|NCT02473640|12266567|P1|COMPLETED|Run-in Phase||14
4986221|NCT02473640|12266567|P1|STARTED|Run-in Phase||14
4986222|NCT02473640|12266567|P1|NOT COMPLETED|Treatment Period 1||1
4986223|NCT02473640|12266567|P1|COMPLETED|Treatment Period 1||14
4986224|NCT02473640|12266567|P1|STARTED|Treatment Period 1||15
4986225|NCT02473523|12266576|P1|NOT COMPLETED|Overall Study||2
4986226|NCT02473523|12266576|P1|COMPLETED|Overall Study||0
4986227|NCT02473523|12266576|P1|STARTED|Overall Study||2
4986228|NCT02473510|12266597|P2|NOT COMPLETED|Overall Study||2
4986229|NCT02473510|12266598|P1|NOT COMPLETED|Overall Study||1
4986230|NCT02473510|12266597|P2|COMPLETED|Overall Study||238
4986231|NCT02473510|12266598|P1|COMPLETED|Overall Study||59
4986232|NCT02473510|12266597|P2|STARTED|Overall Study||240
4986233|NCT02473510|12266598|P1|STARTED|Overall Study||60
4986234|NCT02473471|12266612|P1|NOT COMPLETED|Overall Study||3
4986235|NCT02473471|12266612|P1|COMPLETED|Overall Study||32
4986236|NCT02473471|12266612|P1|Randomized Not Treated|Overall Study||2
4986237|NCT02473471|12266612|P1|Received Allocated Intervention|Overall Study||33
4986238|NCT02473471|12266612|P1|STARTED|Overall Study||35
4986239|NCT02473445|12266643|P1|NOT COMPLETED|Overall Study||22
4986240|NCT02473445|12266643|P1|COMPLETED|Overall Study||0
4986241|NCT02473445|12266643|P1|STARTED|Overall Study||22
4986242|NCT02473367|12266649|P1|NOT COMPLETED|Period 4||1
4986243|NCT02473367|12266649|P1|COMPLETED|Period 4||18
4986244|NCT02473367|12266649|P1|STARTED|Period 4||19
4986245|NCT02473367|12266649|P1|NOT COMPLETED|Wait 3||0
4986246|NCT02473367|12266649|P1|COMPLETED|Wait 3||19
4986247|NCT02473367|12266649|P1|STARTED|Wait 3||19
4986248|NCT02473367|12266649|P1|NOT COMPLETED|Period 3||0
4986249|NCT02473367|12266649|P1|COMPLETED|Period 3||19
4986250|NCT02473367|12266649|P1|STARTED|Period 3||19
4986251|NCT02473367|12266649|P1|NOT COMPLETED|Wait 2||0
4986252|NCT02473367|12266649|P1|COMPLETED|Wait 2||19
4986253|NCT02473367|12266649|P1|STARTED|Wait 2||19
4986254|NCT02473367|12266649|P1|NOT COMPLETED|Period 2||0
4986255|NCT02473367|12266649|P1|COMPLETED|Period 2||19
4986256|NCT02473367|12266649|P1|STARTED|Period 2||19
4986257|NCT02473367|12266649|P1|NOT COMPLETED|Wait 1||1
4986258|NCT02473367|12266649|P1|COMPLETED|Wait 1||19
4986259|NCT02473367|12266649|P1|STARTED|Wait 1||20
4986260|NCT02473367|12266649|P1|NOT COMPLETED|Period 1||0
4986261|NCT02473367|12266649|P1|COMPLETED|Period 1||20
4986262|NCT02473367|12266649|P1|STARTED|Period 1||20
4986263|NCT02473289|12266669|P2|NOT COMPLETED|Overall Study||13
4986264|NCT02473289|12266670|P1|NOT COMPLETED|Overall Study||11
4986265|NCT02473289|12266669|P2|COMPLETED|Overall Study||81
4986266|NCT02473289|12266670|P1|COMPLETED|Overall Study||88
4986267|NCT02473289|12266669|P2|STARTED|Overall Study||94
4986268|NCT02473289|12266670|P1|STARTED|Overall Study||99
4986269|NCT02472977|12266695|P3|NOT COMPLETED|Overall Study||8
4986270|NCT02472977|12266696|P2|NOT COMPLETED|Overall Study||27
4986271|NCT02472977|12266697|P1|NOT COMPLETED|Overall Study||6
4986272|NCT02472977|12266695|P3|COMPLETED|Overall Study||0
4986273|NCT02472977|12266696|P2|COMPLETED|Overall Study||0
4986274|NCT02472977|12266697|P1|COMPLETED|Overall Study||0
4986275|NCT02472977|12266695|P3|STARTED|Overall Study||8
4986276|NCT02472977|12266696|P2|STARTED|Overall Study||27
4986277|NCT02472977|12266697|P1|STARTED|Overall Study||6
4986278|NCT02472964|12266722|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
4986279|NCT02472964|12266723|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
4986280|NCT02472964|12266722|P2|COMPLETED|Part 2 (Week 24-week 48)||116
4986281|NCT02472964|12266723|P1|COMPLETED|Part 2 (Week 24-week 48)||98
4986282|NCT02472964|12266722|P2|STARTED|Part 2 (Week 24-week 48)||179
4986283|NCT02472964|12266723|P1|STARTED|Part 2 (Week 24-week 48)||163
4986284|NCT02472964|12266722|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
4986285|NCT02472964|12266723|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
4986286|NCT02472964|12266722|P2|COMPLETED|Part 1 (up to Week 24)||185
4986287|NCT02472964|12266723|P1|COMPLETED|Part 1 (up to Week 24)||171
4986288|NCT02472964|12266722|P2|STARTED|Part 1 (up to Week 24)||247
4986289|NCT02472964|12266723|P1|STARTED|Part 1 (up to Week 24)||246
4986290|NCT02472886|12266732|P3|NOT COMPLETED|Overall Study||1
4986291|NCT02472886|12266733|P2|NOT COMPLETED|Overall Study||2
4986292|NCT02472886|12266734|P1|NOT COMPLETED|Overall Study||0
4986293|NCT02472886|12266732|P3|COMPLETED|Overall Study||26
4986294|NCT02472886|12266733|P2|COMPLETED|Overall Study||57
4986295|NCT02472886|12266734|P1|COMPLETED|Overall Study||67
4986296|NCT02472886|12266732|P3|STARTED|Overall Study||27
4986297|NCT02472886|12266733|P2|STARTED|Overall Study||59
4986298|NCT02472886|12266734|P1|STARTED|Overall Study||67
4986299|NCT02472847|12266762|P2|NOT COMPLETED|Overall Study||5
4986300|NCT02472847|12266763|P1|NOT COMPLETED|Overall Study||1
4986301|NCT02472847|12266762|P2|COMPLETED|Overall Study||21
4986302|NCT02472847|12266763|P1|COMPLETED|Overall Study||23
4986303|NCT02472847|12266762|P2|STARTED|Overall Study||26
4986304|NCT02472847|12266763|P1|STARTED|Overall Study||24
4986305|NCT02472795|12266774|P5|NOT COMPLETED|Overall Study||3
4986306|NCT02472795|12266775|P4|NOT COMPLETED|Overall Study||0
4986307|NCT02472795|12266776|P3|NOT COMPLETED|Overall Study||0
4986308|NCT02472795|12266777|P2|NOT COMPLETED|Overall Study||1
4986309|NCT02472795|12266778|P1|NOT COMPLETED|Overall Study||0
4986310|NCT02472795|12266774|P5|COMPLETED|Overall Study||14
4986311|NCT02472795|12266775|P4|COMPLETED|Overall Study||13
4986312|NCT02472795|12266776|P3|COMPLETED|Overall Study||13
4986313|NCT02472795|12266777|P2|COMPLETED|Overall Study||11
4986314|NCT02472795|12266778|P1|COMPLETED|Overall Study||12
4986315|NCT02472795|12266774|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
4986316|NCT02472795|12266775|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
4986317|NCT02472795|12266776|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
4986318|NCT02472795|12266777|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
4986319|NCT02472795|12266778|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
4986320|NCT02472795|12266774|P5|Pharmacodynamic Set|Overall Study||16
4986321|NCT02472795|12266775|P4|Pharmacodynamic Set|Overall Study||13
4986322|NCT02472795|12266776|P3|Pharmacodynamic Set|Overall Study||13
4986323|NCT02472795|12266777|P2|Pharmacodynamic Set|Overall Study||10
4986324|NCT02472795|12266778|P1|Pharmacodynamic Set|Overall Study||12
4986325|NCT02472795|12266774|P5|STARTED|Overall Study||17
4986326|NCT02472795|12266775|P4|STARTED|Overall Study||13
4986327|NCT02472795|12266776|P3|STARTED|Overall Study||13
4986328|NCT02472795|12266777|P2|STARTED|Overall Study||12
4986329|NCT02472795|12266778|P1|STARTED|Overall Study||12
4986330|NCT02472756|12266810|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
4986331|NCT02472756|12266810|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
4986332|NCT02472756|12266810|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
4986333|NCT02472756|12266810|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
4986334|NCT02472756|12266810|P1|COMPLETED|Induction (Approximately 6 Months)||39
4986335|NCT02472756|12266810|P1|Treated|Induction (Approximately 6 Months)||40
4986336|NCT02472756|12266810|P1|STARTED|Induction (Approximately 6 Months)||41
4986337|NCT02472730|12266818|P2|NOT COMPLETED|Overall Study||7
4986338|NCT02472730|12266819|P1|NOT COMPLETED|Overall Study||9
4986339|NCT02472730|12266818|P2|COMPLETED|Overall Study||102
4986340|NCT02472730|12266819|P1|COMPLETED|Overall Study||101
4986341|NCT02472730|12266818|P2|STARTED|Overall Study||109
4986342|NCT02472730|12266819|P1|STARTED|Overall Study||110
4986343|NCT02472652|12266831|P1|NOT COMPLETED|Overall Study||1
4986344|NCT02472652|12266831|P1|COMPLETED|Overall Study||1
4986345|NCT02472652|12266831|P1|STARTED|Overall Study||2
4986346|NCT02472639|12266838|P2|NOT COMPLETED|Overall Study||3
4986347|NCT02472639|12266839|P1|NOT COMPLETED|Overall Study||4
4986348|NCT02472639|12266838|P2|COMPLETED|Overall Study||0
4986349|NCT02472639|12266839|P1|COMPLETED|Overall Study||0
4986350|NCT02472639|12266838|P2|STARTED|Overall Study||3
4986351|NCT02472639|12266839|P1|STARTED|Overall Study||4
4986352|NCT02472522|12266855|P2|NOT COMPLETED|Overall Study||0
4986353|NCT02472522|12266856|P1|NOT COMPLETED|Overall Study||0
4986354|NCT02472522|12266855|P2|COMPLETED|Overall Study||50
4986355|NCT02472522|12266856|P1|COMPLETED|Overall Study||50
4986356|NCT02472522|12266855|P2|STARTED|Overall Study||50
4986357|NCT02472522|12266856|P1|STARTED|Overall Study||50
4986358|NCT02472457|12266888|P2|NOT COMPLETED|Overall Study||1
4986359|NCT02472457|12266889|P1|NOT COMPLETED|Overall Study||0
4986360|NCT02472457|12266888|P2|COMPLETED|Overall Study||10
4986361|NCT02472457|12266889|P1|COMPLETED|Overall Study||8
4986362|NCT02472457|12266888|P2|STARTED|Overall Study||11
4986363|NCT02472457|12266889|P1|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
4986364|NCT02472405|12266895|P1|NOT COMPLETED|Overall Study||10
4986365|NCT02472405|12266895|P1|COMPLETED|Overall Study||8
4986366|NCT02472405|12266895|P1|STARTED|Overall Study||18
4986367|NCT02472366|12266903|P2|NOT COMPLETED|Overall Study||0
4986368|NCT02472366|12266904|P1|NOT COMPLETED|Overall Study||1
4986369|NCT02472366|12266903|P2|COMPLETED|Overall Study||10
4986370|NCT02472366|12266904|P1|COMPLETED|Overall Study||5
4986371|NCT02472366|12266903|P2|STARTED|Overall Study||10
4986372|NCT02472366|12266904|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
4986373|NCT02472353|12266920|P2|NOT COMPLETED|Overall Study||6
4986374|NCT02472353|12266921|P1|NOT COMPLETED|Overall Study||4
4986375|NCT02472353|12266920|P2|COMPLETED|Overall Study||10
4986376|NCT02472353|12266921|P1|COMPLETED|Overall Study||10
4986377|NCT02472353|12266920|P2|STARTED|Overall Study||16
4986378|NCT02472353|12266921|P1|STARTED|Overall Study||14
4986379|NCT02472314|12266929|P2|NOT COMPLETED|Overall Study||0
4986380|NCT02472314|12266930|P1|NOT COMPLETED|Overall Study||0
4986381|NCT02472314|12266929|P2|COMPLETED|Overall Study||36
4986382|NCT02472314|12266930|P1|COMPLETED|Overall Study||34
4986383|NCT02472314|12266929|P2|STARTED|Overall Study||36
4986384|NCT02472314|12266930|P1|STARTED|Overall Study||34
4986385|NCT02472262|12266945|P3|NOT COMPLETED|Overall Study||25
4986386|NCT02472262|12266946|P2|NOT COMPLETED|Overall Study||21
4986387|NCT02472262|12266947|P1|NOT COMPLETED|Overall Study||18
4986388|NCT02472262|12266945|P3|COMPLETED|Overall Study||93
4986389|NCT02472262|12266946|P2|COMPLETED|Overall Study||99
4986390|NCT02472262|12266947|P1|COMPLETED|Overall Study||99
4986391|NCT02472262|12266945|P3|STARTED|Overall Study||118
4986392|NCT02472262|12266946|P2|STARTED|Overall Study||120
4986393|NCT02472262|12266947|P1|STARTED|Overall Study||117
4986394|NCT02472145|12266958|P3|NOT COMPLETED|Overall Study||157
4986395|NCT02472145|12266959|P2|NOT COMPLETED|Overall Study||159
4986396|NCT02472145|12266960|P1|NOT COMPLETED|Overall Study||10
4986397|NCT02472145|12266958|P3|COMPLETED|Overall Study||0
4986398|NCT02472145|12266959|P2|COMPLETED|Overall Study||0
4986399|NCT02472145|12266960|P1|COMPLETED|Overall Study||0
4986400|NCT02472145|12266958|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
4986401|NCT02472145|12266959|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
4986402|NCT02472145|12266960|P1|Safety|Overall Study||10
4986403|NCT02472145|12266958|P3|Treated|Overall Study||156
4986404|NCT02472145|12266959|P2|Treated|Overall Study||156
4986405|NCT02472145|12266960|P1|Treated|Overall Study||10
4986406|NCT02472145|12266958|P3|STARTED|Overall Study||157
4986407|NCT02472145|12266959|P2|STARTED|Overall Study||159
4986408|NCT02472145|12266960|P1|STARTED|Overall Study||10
4986409|NCT02471755|12266981|P2|NOT COMPLETED|Overall Study||1
4986410|NCT02471755|12266982|P1|NOT COMPLETED|Overall Study||1
4986411|NCT02471755|12266981|P2|COMPLETED|Overall Study||44
4986412|NCT02471755|12266982|P1|COMPLETED|Overall Study||44
4986413|NCT02471755|12266981|P2|STARTED|Overall Study||45
4986414|NCT02471755|12266982|P1|STARTED|Overall Study||45
4986415|NCT02471651|12267000|P2|NOT COMPLETED|Overall Study||5
4986416|NCT02471651|12267001|P1|NOT COMPLETED|Overall Study||5
4986417|NCT02471651|12267000|P2|COMPLETED|Overall Study||15
4986418|NCT02471651|12267001|P1|COMPLETED|Overall Study||15
4986419|NCT02471651|12267000|P2|STARTED|Overall Study||20
4986420|NCT02471651|12267001|P1|STARTED|Overall Study||20
4986421|NCT02471612|12267011|P1|NOT COMPLETED|Overall Study||2
4986422|NCT02471612|12267011|P1|COMPLETED|Overall Study||157
4986423|NCT02471612|12267011|P1|STARTED|Overall Study||159
4986424|NCT02471521|12267030|P2|NOT COMPLETED|Overall Study||8
4986425|NCT02471521|12267031|P1|NOT COMPLETED|Overall Study||0
4986426|NCT02471521|12267030|P2|COMPLETED|Overall Study||52
4986427|NCT02471521|12267031|P1|COMPLETED|Overall Study||60
4986428|NCT02471521|12267030|P2|STARTED|Overall Study||60
4986429|NCT02471521|12267031|P1|STARTED|Overall Study||60
4986430|NCT02471404|12267042|P3|NOT COMPLETED|Overall Study||25
4986431|NCT02471404|12267043|P2|NOT COMPLETED|Overall Study||14
4986432|NCT02471404|12267044|P1|NOT COMPLETED|Overall Study||33
4986433|NCT02471404|12267042|P3|COMPLETED|Overall Study||288
4986434|NCT02471404|12267043|P2|COMPLETED|Overall Study||298
4986435|NCT02471404|12267044|P1|COMPLETED|Overall Study||281
4986436|NCT02471404|12267042|P3|STARTED|Overall Study||313
4986437|NCT02471404|12267043|P2|STARTED|Overall Study||312
4986438|NCT02471404|12267044|P1|STARTED|Overall Study||314
4986439|NCT02471326|12267067|P1|NOT COMPLETED|Overall Study||1
4986440|NCT02471326|12267067|P1|COMPLETED|Overall Study||9
4986441|NCT02471326|12267067|P1|STARTED|Overall Study||10
4986442|NCT02471313|12267072|P1|NOT COMPLETED|Overall Study||0
4986443|NCT02471313|12267072|P1|COMPLETED|Overall Study||3
4986444|NCT02471313|12267072|P1|STARTED|Overall Study||3
4986445|NCT02471183|12267076|P1|NOT COMPLETED|Extended Treatment Period||1
4986446|NCT02471183|12267076|P1|COMPLETED|Extended Treatment Period||31
4986447|NCT02471183|12267076|P1|STARTED|Extended Treatment Period||32
4986448|NCT02471183|12267076|P1|NOT COMPLETED|Main Treatment Period||2
4986449|NCT02471183|12267076|P1|COMPLETED|Main Treatment Period||32
4986450|NCT02471183|12267076|P1|STARTED|Main Treatment Period||34
4986451|NCT02470949|12267091|P2|NOT COMPLETED|Second Intervention||0
4986452|NCT02470949|12267092|P1|NOT COMPLETED|Second Intervention||0
4986453|NCT02470949|12267091|P2|COMPLETED|Second Intervention||2
4986454|NCT02470949|12267092|P1|COMPLETED|Second Intervention||4
4986455|NCT02470949|12267091|P2|STARTED|Second Intervention||2
4986456|NCT02470949|12267092|P1|STARTED|Second Intervention||4
4986457|NCT02470949|12267091|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
4986458|NCT02470949|12267092|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
4986459|NCT02470949|12267091|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
4986460|NCT02470949|12267092|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
4986461|NCT02470949|12267091|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
4986462|NCT02470949|12267092|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
4986463|NCT02470949|12267091|P2|NOT COMPLETED|First Intervention||0
4986464|NCT02470949|12267092|P1|NOT COMPLETED|First Intervention||0
4986465|NCT02470949|12267091|P2|COMPLETED|First Intervention||5
4986466|NCT02470949|12267092|P1|COMPLETED|First Intervention||4
4986467|NCT02470949|12267091|P2|STARTED|First Intervention||5
4986468|NCT02470949|12267092|P1|STARTED|First Intervention||4
4986469|NCT02470910|12267102|P1|NOT COMPLETED|Overall Study||0
4986470|NCT02470910|12267102|P1|COMPLETED|Overall Study||15
4986471|NCT02470910|12267102|P1|STARTED|Overall Study||15
4986472|NCT02470806|12267111|P2|NOT COMPLETED|Overall Study||42
4986473|NCT02470806|12267112|P1|NOT COMPLETED|Overall Study||18
4986474|NCT02470806|12267111|P2|COMPLETED|Overall Study||42
4986475|NCT02470806|12267112|P1|COMPLETED|Overall Study||62
4986476|NCT02470806|12267111|P2|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
4986477|NCT02470806|12267112|P1|STARTED|Overall Study||80
4986478|NCT02470754|12267126|P2|NOT COMPLETED|Overall Study||0
4986479|NCT02470754|12267127|P1|NOT COMPLETED|Overall Study||2
4986480|NCT02470754|12267126|P2|COMPLETED|Overall Study||19
4986481|NCT02470754|12267127|P1|COMPLETED|Overall Study||17
4986482|NCT02470754|12267126|P2|STARTED|Overall Study||19
4986483|NCT02470754|12267127|P1|STARTED|Overall Study||19
4986484|NCT02470741|12267155|P2|NOT COMPLETED|Overall Study||2
4986485|NCT02470741|12267156|P1|NOT COMPLETED|Overall Study||3
4986486|NCT02470741|12267155|P2|COMPLETED|Overall Study||4
4986487|NCT02470741|12267156|P1|COMPLETED|Overall Study||3
4986488|NCT02470741|12267155|P2|STARTED|Overall Study||6
4986489|NCT02470741|12267156|P1|STARTED|Overall Study||6
4986490|NCT02470494|12267162|P1|NOT COMPLETED|Overall Study||5
4986491|NCT02470494|12267162|P1|COMPLETED|Overall Study||41
4986492|NCT02470494|12267162|P1|STARTED|Overall Study||46
4986493|NCT02470429|12267172|P2|NOT COMPLETED|Overall Study||0
4986494|NCT02470429|12267173|P1|NOT COMPLETED|Overall Study||2
4986495|NCT02470429|12267172|P2|COMPLETED|Overall Study||49
4986496|NCT02470429|12267173|P1|COMPLETED|Overall Study||48
4986497|NCT02470429|12267172|P2|STARTED|Overall Study||49
4986498|NCT02470429|12267173|P1|STARTED|Overall Study||50
4986499|NCT02470403|12267191|P5|NOT COMPLETED|Overall Study||0
4986500|NCT02470403|12267192|P4|NOT COMPLETED|Overall Study||4
4986501|NCT02470403|12267193|P3|NOT COMPLETED|Overall Study||0
4986502|NCT02470403|12267194|P2|NOT COMPLETED|Overall Study||1
4986503|NCT02470403|12267195|P1|NOT COMPLETED|Overall Study||2
4986504|NCT02470403|12267191|P5|COMPLETED|Overall Study||10
4986505|NCT02470403|12267192|P4|COMPLETED|Overall Study||39
4986506|NCT02470403|12267193|P3|COMPLETED|Overall Study||40
4986507|NCT02470403|12267194|P2|COMPLETED|Overall Study||43
4986508|NCT02470403|12267195|P1|COMPLETED|Overall Study||42
4986509|NCT02470403|12267191|P5|Normoglycemic|Overall Study||5
4986510|NCT02470403|12267192|P4|Normoglycemic|Overall Study||23
4986511|NCT02470403|12267193|P3|Normoglycemic|Overall Study||20
4986512|NCT02470403|12267194|P2|Normoglycemic|Overall Study||20
4986513|NCT02470403|12267195|P1|Normoglycemic|Overall Study||20
4986514|NCT02470403|12267191|P5|Dysglycemic|Overall Study||5
4986515|NCT02470403|12267192|P4|Dysglycemic|Overall Study||20
4986516|NCT02470403|12267193|P3|Dysglycemic|Overall Study||20
4986517|NCT02470403|12267194|P2|Dysglycemic|Overall Study||24
4986518|NCT02470403|12267195|P1|Dysglycemic|Overall Study||24
4986519|NCT02470403|12267191|P5|STARTED|Overall Study||10
4986520|NCT02470403|12267192|P4|STARTED|Overall Study||43
4986521|NCT02470403|12267193|P3|STARTED|Overall Study||40
4986522|NCT02470403|12267194|P2|STARTED|Overall Study||44
4986523|NCT02470403|12267195|P1|STARTED|Overall Study||44
4986524|NCT02470390|12267235|P2|NOT COMPLETED|Overall Study||1
4986525|NCT02470390|12267236|P1|NOT COMPLETED|Overall Study||0
4986526|NCT02470390|12267235|P2|COMPLETED|Overall Study||6
4986527|NCT02470390|12267236|P1|COMPLETED|Overall Study||6
4986528|NCT02470390|12267235|P2|STARTED|Overall Study||7
4986529|NCT02470390|12267236|P1|STARTED|Overall Study||6
4986530|NCT02470312|12267264|P2|NOT COMPLETED|Overall Study||12
4986531|NCT02470312|12267265|P1|NOT COMPLETED|Overall Study||5
4986532|NCT02470312|12267264|P2|COMPLETED|Overall Study||419
4986533|NCT02470312|12267265|P1|COMPLETED|Overall Study||142
4986534|NCT02470312|12267264|P2|STARTED|Overall Study||431
4986535|NCT02470312|12267265|P1|STARTED|Overall Study||147
4986536|NCT02469961|12267275|P2|NOT COMPLETED|Overall Study||1
4986537|NCT02469961|12267276|P1|NOT COMPLETED|Overall Study||4
4986538|NCT02469961|12267275|P2|COMPLETED|Overall Study||24
4986539|NCT02469961|12267276|P1|COMPLETED|Overall Study||21
4986540|NCT02469961|12267275|P2|STARTED|Overall Study||25
4986541|NCT02469961|12267276|P1|STARTED|Overall Study||25
4986542|NCT02469896|12267290|P2|NOT COMPLETED|Overall Study||0
4986543|NCT02469896|12267291|P1|NOT COMPLETED|Overall Study||2
4986544|NCT02469896|12267290|P2|COMPLETED|Overall Study||14
4986545|NCT02469896|12267291|P1|COMPLETED|Overall Study||6
4986546|NCT02469896|12267290|P2|STARTED|Overall Study||14
4986547|NCT02469896|12267291|P1|STARTED|Overall Study||8
4986548|NCT02469870|12267317|P2|NOT COMPLETED|Overall Study||7
4986549|NCT02469870|12267318|P1|NOT COMPLETED|Overall Study||4
4986550|NCT02469870|12267317|P2|COMPLETED|Overall Study||72
4986551|NCT02469870|12267318|P1|COMPLETED|Overall Study||73
4986552|NCT02469870|12267317|P2|STARTED|Overall Study||79
4986553|NCT02469870|12267318|P1|STARTED|Overall Study||77
4986554|NCT02469714|12267336|P2|NOT COMPLETED|Overall Study||5
4986555|NCT02469714|12267337|P1|NOT COMPLETED|Overall Study||8
4986556|NCT02469714|12267336|P2|COMPLETED|Overall Study||50
4986557|NCT02469714|12267337|P1|COMPLETED|Overall Study||47
4986558|NCT02469714|12267336|P2|8 Month Follow-Up|Overall Study||50
4986559|NCT02469714|12267337|P1|8 Month Follow-Up|Overall Study||49
4986560|NCT02469714|12267336|P2|4 Month Follow-Up|Overall Study||51
4986561|NCT02469714|12267337|P1|4 Month Follow-Up|Overall Study||50
4986562|NCT02469714|12267336|P2|STARTED|Overall Study||55
4986563|NCT02469714|12267337|P1|STARTED|Overall Study||55
4986564|NCT02469701|12267357|P1|NOT COMPLETED|Overall Study||0
4986565|NCT02469701|12267357|P1|COMPLETED|Overall Study||10
4986566|NCT02469701|12267357|P1|STARTED|Overall Study||10
4986567|NCT02469623|12267361|P1|NOT COMPLETED|Overall Study||13
4986568|NCT02469623|12267361|P1|COMPLETED|Overall Study||72
4986569|NCT02469623|12267361|P1|STARTED|Overall Study||85
4986570|NCT02469610|12267368|P2|NOT COMPLETED|Overall Study||1
4986571|NCT02469610|12267369|P1|NOT COMPLETED|Overall Study||4
4986572|NCT02469610|12267368|P2|COMPLETED|Overall Study||30
4986573|NCT02469610|12267369|P1|COMPLETED|Overall Study||30
4986574|NCT02469610|12267368|P2|STARTED|Overall Study||31
4986575|NCT02469610|12267369|P1|STARTED|Overall Study||34
4986576|NCT02469597|12267379|P2|NOT COMPLETED|Overall Study||0
4986577|NCT02469597|12267380|P1|NOT COMPLETED|Overall Study||0
4986578|NCT02469597|12267379|P2|COMPLETED|Overall Study||24
4986579|NCT02469597|12267380|P1|COMPLETED|Overall Study||22
4986580|NCT02469597|12267379|P2|STARTED|Overall Study||24
4986581|NCT02469597|12267380|P1|STARTED|Overall Study||22
4986582|NCT02469415|12267396|P1|NOT COMPLETED|Overall Study||3
4986583|NCT02469415|12267396|P1|COMPLETED|Overall Study||0
4986584|NCT02469415|12267396|P1|STARTED|Overall Study||3
4986585|NCT02469298|12267404|P4|NOT COMPLETED|Overall Study||2
4986586|NCT02469298|12267405|P3|NOT COMPLETED|Overall Study||2
4986587|NCT02469298|12267406|P2|NOT COMPLETED|Overall Study||1
4986588|NCT02469298|12267407|P1|NOT COMPLETED|Overall Study||1
4986589|NCT02469298|12267404|P4|COMPLETED|Overall Study||5
4986590|NCT02469298|12267405|P3|COMPLETED|Overall Study||14
4986591|NCT02469298|12267406|P2|COMPLETED|Overall Study||6
4986592|NCT02469298|12267407|P1|COMPLETED|Overall Study||14
4986593|NCT02469298|12267404|P4|STARTED|Overall Study||7
4986594|NCT02469298|12267405|P3|STARTED|Overall Study||16
4986595|NCT02469298|12267406|P2|STARTED|Overall Study||7
4986596|NCT02469298|12267407|P1|STARTED|Overall Study||15
4986597|NCT02469246|12267547|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
4986598|NCT02469246|12267548|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
4986599|NCT02469246|12267547|P2|COMPLETED|Open-Label Extension (OLE)||5
4986600|NCT02469246|12267548|P1|COMPLETED|Open-Label Extension (OLE)||6
4986601|NCT02469246|12267547|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
4986602|NCT02469246|12267548|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
4986603|NCT02469246|12267547|P2|NOT COMPLETED|Double-Blind Phase||56
4986604|NCT02469246|12267548|P1|NOT COMPLETED|Double-Blind Phase||67
4986605|NCT02469246|12267547|P2|COMPLETED|Double-Blind Phase||226
4986606|NCT02469246|12267548|P1|COMPLETED|Double-Blind Phase||218
4986607|NCT02469246|12267547|P2|STARTED|Double-Blind Phase||282
4986608|NCT02469246|12267548|P1|STARTED|Double-Blind Phase||285
4986609|NCT02469168|12267580|P2|NOT COMPLETED|Overall Study||0
4986610|NCT02469168|12267581|P1|NOT COMPLETED|Overall Study||1
4986611|NCT02469168|12267580|P2|COMPLETED|Overall Study||0
4986612|NCT02469168|12267581|P1|COMPLETED|Overall Study||0
4986613|NCT02469168|12267580|P2|STARTED|Overall Study||0
4986614|NCT02469168|12267581|P1|STARTED|Overall Study||1
4986615|NCT02469116|12267589|P1|NOT COMPLETED|Overall Study||0
4986616|NCT02469116|12267589|P1|COMPLETED|Overall Study||18
4986617|NCT02469116|12267589|P1|STARTED|Overall Study||18
4986618|NCT02469090|12267601|P3|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
4986619|NCT02469090|12267602|P2|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
4986620|NCT02469090|12267603|P1|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
4986621|NCT02469090|12267601|P3|COMPLETED|Period 2: Maintenance Treatment Phase||34
4986622|NCT02469090|12267602|P2|COMPLETED|Period 2: Maintenance Treatment Phase||46
4986623|NCT02469090|12267603|P1|COMPLETED|Period 2: Maintenance Treatment Phase||0
4986624|NCT02469090|12267601|P3|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
4986625|NCT02469090|12267602|P2|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
4986626|NCT02469090|12267603|P1|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
4986627|NCT02469090|12267601|P3|NOT COMPLETED|Period 1: Dose Titration Phase||0
4986628|NCT02469090|12267602|P2|NOT COMPLETED|Period 1: Dose Titration Phase||0
4986629|NCT02469090|12267603|P1|NOT COMPLETED|Period 1: Dose Titration Phase||32
4986630|NCT02469090|12267601|P3|COMPLETED|Period 1: Dose Titration Phase||0
4986631|NCT02469090|12267602|P2|COMPLETED|Period 1: Dose Titration Phase||0
4986632|NCT02469090|12267603|P1|COMPLETED|Period 1: Dose Titration Phase||109
4986633|NCT02469090|12267601|P3|STARTED|Period 1: Dose Titration Phase||0
4986634|NCT02469090|12267602|P2|STARTED|Period 1: Dose Titration Phase||0
4986635|NCT02469090|12267603|P1|STARTED|Period 1: Dose Titration Phase||141
4986636|NCT02469064|12267630|P2|NOT COMPLETED|Overall Study||3
4986637|NCT02469064|12267631|P1|NOT COMPLETED|Overall Study||1
4986638|NCT02469064|12267630|P2|COMPLETED|Overall Study||59
4986639|NCT02469064|12267631|P1|COMPLETED|Overall Study||63
4986640|NCT02469064|12267630|P2|STARTED|Overall Study||62
4986641|NCT02469064|12267631|P1|STARTED|Overall Study||64
4986642|NCT02468934|12267639|P1|NOT COMPLETED|Overall Study||7
4986643|NCT02468934|12267639|P1|COMPLETED|Overall Study||20
4986644|NCT02468934|12267639|P1|Underwent Total Knee Arthroplasty|Overall Study||20
4986645|NCT02468934|12267639|P1|Enrolled/Received Leads|Overall Study||24
4986646|NCT02468934|12267639|P1|STARTED|Overall Study||27
4986647|NCT02468830|12267658|P1|NOT COMPLETED|Overall Study||3
4986648|NCT02468830|12267658|P1|COMPLETED|Overall Study||55
4986649|NCT02468830|12267658|P1|STARTED|Overall Study||58
4986650|NCT02468700|12267668|P2|NOT COMPLETED|Overall Study||2
4986651|NCT02468700|12267669|P1|NOT COMPLETED|Overall Study||2
4986652|NCT02468700|12267668|P2|COMPLETED|Overall Study||19
4986653|NCT02468700|12267669|P1|COMPLETED|Overall Study||20
4986654|NCT02468700|12267668|P2|STARTED|Overall Study||21
4986655|NCT02468700|12267669|P1|STARTED|Overall Study||22
4986656|NCT02468674|12267690|P9|NOT COMPLETED|Overall Study||3
4986657|NCT02468674|12267691|P8|NOT COMPLETED|Overall Study||4
4986658|NCT02468674|12267692|P7|NOT COMPLETED|Overall Study||1
4986659|NCT02468674|12267693|P6|NOT COMPLETED|Overall Study||1
4986660|NCT02468674|12267694|P5|NOT COMPLETED|Overall Study||1
4986661|NCT02468674|12267695|P4|NOT COMPLETED|Overall Study||1
4986662|NCT02468674|12267696|P3|NOT COMPLETED|Overall Study||0
4986663|NCT02468674|12267697|P2|NOT COMPLETED|Overall Study||0
4986664|NCT02468674|12267698|P1|NOT COMPLETED|Overall Study||1
4986665|NCT02468674|12267690|P9|COMPLETED|Overall Study||40
4986666|NCT02468674|12267691|P8|COMPLETED|Overall Study||65
4986667|NCT02468674|12267692|P7|COMPLETED|Overall Study||14
4986668|NCT02468674|12267693|P6|COMPLETED|Overall Study||6
4986669|NCT02468674|12267694|P5|COMPLETED|Overall Study||6
4986670|NCT02468674|12267695|P4|COMPLETED|Overall Study||3
4986671|NCT02468674|12267696|P3|COMPLETED|Overall Study||5
4986672|NCT02468674|12267697|P2|COMPLETED|Overall Study||5
4986673|NCT02468674|12267698|P1|COMPLETED|Overall Study||4
4986674|NCT02468674|12267690|P9|STARTED|Overall Study||43
4986675|NCT02468674|12267691|P8|STARTED|Overall Study||69
4986676|NCT02468674|12267692|P7|STARTED|Overall Study||15
4986677|NCT02468674|12267693|P6|STARTED|Overall Study||7
4986678|NCT02468674|12267694|P5|STARTED|Overall Study||7
4986679|NCT02468674|12267695|P4|STARTED|Overall Study||4
4986680|NCT02468674|12267696|P3|STARTED|Overall Study||5
4986681|NCT02468674|12267697|P2|STARTED|Overall Study||5
4986682|NCT02468674|12267698|P1|STARTED|Overall Study||5
4986683|NCT02468648|12267754|P1|NOT COMPLETED|Overall Study||1
4986684|NCT02468648|12267754|P1|COMPLETED|Overall Study||71
4986685|NCT02468648|12267754|P1|STARTED|Overall Study||72
4986686|NCT02468583|12267763|P2|NOT COMPLETED|Overall Study||0
4986687|NCT02468583|12267764|P1|NOT COMPLETED|Overall Study||0
4986688|NCT02468583|12267763|P2|COMPLETED|Overall Study||3
4986689|NCT02468583|12267764|P1|COMPLETED|Overall Study||3
4986690|NCT02468583|12267763|P2|STARTED|Overall Study||3
4986691|NCT02468583|12267764|P1|STARTED|Overall Study||3
4986692|NCT02468570|12267802|P2|NOT COMPLETED|Overall Study||0
4986693|NCT02468570|12267803|P1|NOT COMPLETED|Overall Study||0
4986694|NCT02468570|12267802|P2|COMPLETED|Overall Study||3
4986695|NCT02468570|12267803|P1|COMPLETED|Overall Study||6
4986696|NCT02468570|12267802|P2|STARTED|Overall Study||3
4986697|NCT02468570|12267803|P1|STARTED|Overall Study||6
4986698|NCT02468414|12267821|P2|NOT COMPLETED|Overall Study||0
4986699|NCT02468414|12267822|P1|NOT COMPLETED|Overall Study||3
4986700|NCT02468414|12267821|P2|COMPLETED|Overall Study||0
4986701|NCT02468414|12267822|P1|COMPLETED|Overall Study||0
4986702|NCT02468414|12267821|P2|Safety Follow-up|Overall Study||0
4986703|NCT02468414|12267822|P1|Safety Follow-up|Overall Study||0
4986704|NCT02468414|12267821|P2|Implantation|Overall Study||0
4986705|NCT02468414|12267822|P1|Implantation|Overall Study||1
4986706|NCT02468414|12267821|P2|Harvesting|Overall Study||0
4986707|NCT02468414|12267822|P1|Harvesting|Overall Study||1
4986708|NCT02468414|12267821|P2|Successfully Screened|Overall Study||0
4986709|NCT02468414|12267822|P1|Successfully Screened|Overall Study||2
4986710|NCT02468414|12267821|P2|STARTED|Overall Study||0
4986711|NCT02468414|12267822|P1|STARTED|Overall Study||3
4986712|NCT02468193|12267828|P1|NOT COMPLETED|Overall Study||6
4986713|NCT02468193|12267828|P1|COMPLETED|Overall Study||3
4986714|NCT02468193|12267828|P1|Discontinued Study in Optional Ext. Per.|Overall Study||2
4986715|NCT02468193|12267828|P1|Completed Optional Extension Period|Overall Study||0
4986716|NCT02468193|12267828|P1|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
4986717|NCT02468193|12267828|P1|Compl. Wk-48, Didn’t Enter Opt. Ext. Per|Overall Study||0
4986718|NCT02468193|12267828|P1|Discontinued at or Prior to Week48|Overall Study||2
4986719|NCT02468193|12267828|P1|Completed Week-48 (Study Period II)|Overall Study||2
4986720|NCT02468193|12267828|P1|Completed Week-12, Entered Study Per. II|Overall Study||4
4986721|NCT02468193|12267828|P1|Completed Week-12, Did Not Enter Per. II|Overall Study||3
4986722|NCT02468193|12267828|P1|Discontinued at or Prior to Week-12|Overall Study||2
4986723|NCT02468193|12267828|P1|Completed Week-12 (Study Period I)|Overall Study||7
4986724|NCT02468193|12267828|P1|STARTED|Overall Study||9
4986725|NCT02468154|12267922|P2|NOT COMPLETED|Overall Study||0
4986726|NCT02468154|12267923|P1|NOT COMPLETED|Overall Study||0
4986727|NCT02468154|12267922|P2|COMPLETED|Overall Study||28
4986728|NCT02468154|12267923|P1|COMPLETED|Overall Study||29
4986729|NCT02468154|12267922|P2|STARTED|Overall Study||28
4986730|NCT02468154|12267923|P1|STARTED|Overall Study||29
4986731|NCT02467842|12267938|P3|NOT COMPLETED|Overall Study||0
4986732|NCT02467842|12267939|P2|NOT COMPLETED|Overall Study||0
4986733|NCT02467842|12267940|P1|NOT COMPLETED|Overall Study||0
4986734|NCT02467842|12267938|P3|COMPLETED|Overall Study||378
4986735|NCT02467842|12267939|P2|COMPLETED|Overall Study||373
4986736|NCT02467842|12267940|P1|COMPLETED|Overall Study||752
4986737|NCT02467842|12267938|P3|STARTED|Overall Study||378
4986738|NCT02467842|12267939|P2|STARTED|Overall Study||373
4986739|NCT02467842|12267940|P1|STARTED|Overall Study||752
4986740|NCT02467777|12267965|P2|NOT COMPLETED|Overall Study||0
4986741|NCT02467777|12267966|P1|NOT COMPLETED|Overall Study||0
4986742|NCT02467777|12267965|P2|COMPLETED|Overall Study||27
4986743|NCT02467777|12267966|P1|COMPLETED|Overall Study||23
4986744|NCT02467777|12267965|P2|STARTED|Overall Study||27
4986745|NCT02467777|12267966|P1|STARTED|Overall Study||23
4986746|NCT02467621|12267974|P2|NOT COMPLETED|Overall Study||6
4986747|NCT02467621|12267975|P1|NOT COMPLETED|Overall Study||1
4986748|NCT02467621|12267974|P2|COMPLETED|Overall Study||1647
4986749|NCT02467621|12267975|P1|COMPLETED|Overall Study||1644
4986750|NCT02467621|12267974|P2|STARTED|Overall Study||1653
4986751|NCT02467621|12267975|P1|STARTED|Overall Study||1645
4986752|NCT02467504|12267995|P2|NOT COMPLETED|Overall Study||1
4986753|NCT02467504|12267996|P1|NOT COMPLETED|Overall Study||6
4986754|NCT02467504|12267995|P2|COMPLETED|Overall Study||23
4986755|NCT02467504|12267996|P1|COMPLETED|Overall Study||17
4986756|NCT02467504|12267995|P2|STARTED|Overall Study||24
4986757|NCT02467504|12267996|P1|STARTED|Overall Study||23
4986758|NCT02467491|12268040|P1|NOT COMPLETED|Overall Study||0
4986759|NCT02467491|12268040|P1|COMPLETED|Overall Study||12
4986760|NCT02467491|12268040|P1|STARTED|Overall Study||12
4986761|NCT02467387|12268049|P2|NOT COMPLETED|Second Intervention||0
4986762|NCT02467387|12268050|P1|NOT COMPLETED|Second Intervention||3
4986763|NCT02467387|12268049|P2|COMPLETED|Second Intervention||12
4986764|NCT02467387|12268050|P1|COMPLETED|Second Intervention||7
4986765|NCT02467387|12268049|P2|STARTED|Second Intervention||12
4986766|NCT02467387|12268050|P1|STARTED|Second Intervention||10
4986767|NCT02467387|12268049|P2|NOT COMPLETED|First Intervention||0
4986768|NCT02467387|12268050|P1|NOT COMPLETED|First Intervention||1
4986769|NCT02467387|12268049|P2|COMPLETED|First Intervention||12
4986770|NCT02467387|12268050|P1|COMPLETED|First Intervention||10
4986771|NCT02467387|12268049|P2|Received Treatment as Randomized|First Intervention||12
4986772|NCT02467387|12268050|P1|Received Treatment as Randomized|First Intervention||10
4986773|NCT02467387|12268049|P2|STARTED|First Intervention||12
4986774|NCT02467387|12268050|P1|STARTED|First Intervention||11
4986775|NCT02467179|12268060|P2|NOT COMPLETED|Overall Study||0
4986776|NCT02467179|12268061|P1|NOT COMPLETED|Overall Study||0
4986777|NCT02467179|12268060|P2|COMPLETED|Overall Study||25
4986778|NCT02467179|12268061|P1|COMPLETED|Overall Study||25
4986779|NCT02467179|12268060|P2|STARTED|Overall Study||25
4986780|NCT02467179|12268061|P1|STARTED|Overall Study||25
4986781|NCT02467075|12268071|P2|NOT COMPLETED|30 Day Follow-up||0
4986782|NCT02467075|12268072|P1|NOT COMPLETED|30 Day Follow-up||0
4986783|NCT02467075|12268071|P2|COMPLETED|30 Day Follow-up||1
4986784|NCT02467075|12268072|P1|COMPLETED|30 Day Follow-up||0
4986785|NCT02467075|12268071|P2|STARTED|30 Day Follow-up||1
4986786|NCT02467075|12268072|P1|STARTED|30 Day Follow-up||0
4986787|NCT02467075|12268071|P2|NOT COMPLETED|72 Hour Follow-up||0
4986788|NCT02467075|12268072|P1|NOT COMPLETED|72 Hour Follow-up||0
4986789|NCT02467075|12268071|P2|COMPLETED|72 Hour Follow-up||1
4986790|NCT02467075|12268072|P1|COMPLETED|72 Hour Follow-up||0
4986791|NCT02467075|12268071|P2|STARTED|72 Hour Follow-up||1
4986792|NCT02467075|12268072|P1|STARTED|72 Hour Follow-up||0
4986793|NCT02467075|12268071|P2|NOT COMPLETED|48 Hour Follow-up||0
4986794|NCT02467075|12268072|P1|NOT COMPLETED|48 Hour Follow-up||0
4986795|NCT02467075|12268071|P2|COMPLETED|48 Hour Follow-up||1
4986796|NCT02467075|12268072|P1|COMPLETED|48 Hour Follow-up||0
4986797|NCT02467075|12268071|P2|STARTED|48 Hour Follow-up||1
4986798|NCT02467075|12268072|P1|STARTED|48 Hour Follow-up||0
4986799|NCT02467075|12268071|P2|NOT COMPLETED|Initial CT Scan||0
4986800|NCT02467075|12268072|P1|NOT COMPLETED|Initial CT Scan||0
4986801|NCT02467075|12268071|P2|COMPLETED|Initial CT Scan||1
4986802|NCT02467075|12268072|P1|COMPLETED|Initial CT Scan||0
4986803|NCT02467075|12268071|P2|STARTED|Initial CT Scan||1
4986804|NCT02467075|12268072|P1|STARTED|Initial CT Scan||0
4986805|NCT02466958|12268090|P2|NOT COMPLETED|Overall Study||3
4986806|NCT02466958|12268091|P1|NOT COMPLETED|Overall Study||10
4986807|NCT02466958|12268090|P2|COMPLETED|Overall Study||9
4986808|NCT02466958|12268091|P1|COMPLETED|Overall Study||7
4986809|NCT02466958|12268090|P2|STARTED|Overall Study||12
4986810|NCT02466958|12268091|P1|STARTED|Overall Study||17
4986811|NCT02466659|12268103|P2|NOT COMPLETED|Overall Study||2
4986812|NCT02466659|12268104|P1|NOT COMPLETED|Overall Study||5
4986813|NCT02466659|12268103|P2|COMPLETED|Overall Study||1
4986814|NCT02466659|12268104|P1|COMPLETED|Overall Study||0
4986815|NCT02466659|12268103|P2|STARTED|Overall Study||3
4986816|NCT02466659|12268104|P1|STARTED|Overall Study||5
4986817|NCT02466646|12268115|P3|NOT COMPLETED|Overall Study||0
4986818|NCT02466646|12268116|P2|NOT COMPLETED|Overall Study||0
4986819|NCT02466646|12268117|P1|NOT COMPLETED|Overall Study||0
4986820|NCT02466646|12268115|P3|COMPLETED|Overall Study||14
4986821|NCT02466646|12268116|P2|COMPLETED|Overall Study||14
4986822|NCT02466646|12268117|P1|COMPLETED|Overall Study||14
4986823|NCT02466646|12268115|P3|STARTED|Overall Study||14
4986824|NCT02466646|12268116|P2|STARTED|Overall Study||14
4986825|NCT02466646|12268117|P1|STARTED|Overall Study||14
4986826|NCT02466555|12268158|P1|NOT COMPLETED|Overall Study||2
4986827|NCT02466555|12268158|P1|COMPLETED|Overall Study||28
4986828|NCT02466555|12268158|P1|STARTED|Overall Study||30
4986829|NCT02466516|12268170|P5|NOT COMPLETED|Overall Study||0
4986830|NCT02466516|12268171|P4|NOT COMPLETED|Overall Study||0
4986831|NCT02466516|12268172|P3|NOT COMPLETED|Overall Study||1
4986832|NCT02466516|12268173|P2|NOT COMPLETED|Overall Study||1
4986833|NCT02466516|12268174|P1|NOT COMPLETED|Overall Study||4
4986834|NCT02466516|12268170|P5|COMPLETED|Overall Study||10
4986835|NCT02466516|12268171|P4|COMPLETED|Overall Study||10
4986836|NCT02466516|12268172|P3|COMPLETED|Overall Study||9
4986837|NCT02466516|12268173|P2|COMPLETED|Overall Study||21
4986838|NCT02466516|12268174|P1|COMPLETED|Overall Study||16
4986839|NCT02466516|12268170|P5|STARTED|Overall Study||10
4986840|NCT02466516|12268171|P4|STARTED|Overall Study||10
4986841|NCT02466516|12268172|P3|STARTED|Overall Study||10
4986842|NCT02466516|12268173|P2|STARTED|Overall Study||22
4986843|NCT02466516|12268174|P1|STARTED|Overall Study||20
4986844|NCT02466425|12268193|P2|NOT COMPLETED|Overall Study||16
4986845|NCT02466425|12268194|P1|NOT COMPLETED|Overall Study||14
4986846|NCT02466425|12268193|P2|COMPLETED|Overall Study||116
4986847|NCT02466425|12268194|P1|COMPLETED|Overall Study||118
4986848|NCT02466425|12268193|P2|Treated|Overall Study||132
4986849|NCT02466425|12268194|P1|Treated|Overall Study||131
4986850|NCT02466425|12268193|P2|STARTED|Overall Study||132
4986851|NCT02466425|12268194|P1|STARTED|Overall Study||132
4986852|NCT02466412|12268204|P2|NOT COMPLETED|Second Intervention (Day 3)||0
4986853|NCT02466412|12268205|P1|NOT COMPLETED|Second Intervention (Day 3)||0
4986854|NCT02466412|12268204|P2|COMPLETED|Second Intervention (Day 3)||24
4986855|NCT02466412|12268205|P1|COMPLETED|Second Intervention (Day 3)||24
4986856|NCT02466412|12268204|P2|STARTED|Second Intervention (Day 3)||24
4986857|NCT02466412|12268205|P1|STARTED|Second Intervention (Day 3)||24
4986858|NCT02466412|12268204|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
4986859|NCT02466412|12268205|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
4986860|NCT02466412|12268204|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
4986861|NCT02466412|12268205|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
4986862|NCT02466412|12268204|P2|STARTED|Washout Period of 1 Day (Day 2)||24
4986863|NCT02466412|12268205|P1|STARTED|Washout Period of 1 Day (Day 2)||24
4986864|NCT02466412|12268204|P2|NOT COMPLETED|First Intervention (Day 1)||0
4986865|NCT02466412|12268205|P1|NOT COMPLETED|First Intervention (Day 1)||0
4986866|NCT02466412|12268204|P2|COMPLETED|First Intervention (Day 1)||24
4986867|NCT02466412|12268205|P1|COMPLETED|First Intervention (Day 1)||24
4986868|NCT02466412|12268204|P2|STARTED|First Intervention (Day 1)||24
4986869|NCT02466412|12268205|P1|STARTED|First Intervention (Day 1)||24
4986870|NCT02466412|12268204|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
4986871|NCT02466412|12268205|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
4986872|NCT02466412|12268204|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
4986873|NCT02466412|12268205|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
4986874|NCT02466412|12268204|P2|STARTED|Washout Period of 1 Day (Day -1)||24
4986875|NCT02466412|12268205|P1|STARTED|Washout Period of 1 Day (Day -1)||24
4986876|NCT02466230|12268214|P1|NOT COMPLETED|Overall Study||0
4986877|NCT02466230|12268214|P1|COMPLETED|Overall Study||28
4986878|NCT02466230|12268214|P1|STARTED|Overall Study||28
4986879|NCT02466087|12268219|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
4986880|NCT02466087|12268220|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
4986881|NCT02466087|12268219|P2|COMPLETED|Second Intervention: Weeks 7-12||57
4986882|NCT02466087|12268220|P1|COMPLETED|Second Intervention: Weeks 7-12||55
4986883|NCT02466087|12268219|P2|STARTED|Second Intervention: Weeks 7-12||57
4986884|NCT02466087|12268220|P1|STARTED|Second Intervention: Weeks 7-12||55
4986885|NCT02466087|12268219|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
4986886|NCT02466087|12268220|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
4986887|NCT02466087|12268219|P2|COMPLETED|First Intervention: Weeks 1-6||57
4986888|NCT02466087|12268220|P1|COMPLETED|First Intervention: Weeks 1-6||55
4986889|NCT02466087|12268219|P2|STARTED|First Intervention: Weeks 1-6||64
4986890|NCT02466087|12268220|P1|STARTED|First Intervention: Weeks 1-6||62
4986891|NCT02465931|12268232|P2|NOT COMPLETED|Overall Study||11
4986892|NCT02465931|12268233|P1|NOT COMPLETED|Overall Study||11
4986893|NCT02465931|12268232|P2|COMPLETED|Overall Study||45
4986894|NCT02465931|12268233|P1|COMPLETED|Overall Study||44
4986895|NCT02465931|12268232|P2|STARTED|Overall Study||56
4986896|NCT02465931|12268233|P1|STARTED|Overall Study||55
4986897|NCT02465866|12268239|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
4986898|NCT02465866|12268240|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
4986899|NCT02465866|12268241|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
4986900|NCT02465866|12268242|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
4986901|NCT02465866|12268239|P4|COMPLETED|Period 4: Washout (14 Days)||5
4986902|NCT02465866|12268240|P3|COMPLETED|Period 4: Washout (14 Days)||5
4986903|NCT02465866|12268241|P2|COMPLETED|Period 4: Washout (14 Days)||4
4986904|NCT02465866|12268242|P1|COMPLETED|Period 4: Washout (14 Days)||5
4986905|NCT02465866|12268239|P4|STARTED|Period 4: Washout (14 Days)||5
4986906|NCT02465866|12268240|P3|STARTED|Period 4: Washout (14 Days)||5
4986907|NCT02465866|12268241|P2|STARTED|Period 4: Washout (14 Days)||4
4986908|NCT02465866|12268242|P1|STARTED|Period 4: Washout (14 Days)||5
4986909|NCT02465866|12268239|P4|NOT COMPLETED|Period 4||0
4986910|NCT02465866|12268240|P3|NOT COMPLETED|Period 4||0
4986911|NCT02465866|12268241|P2|NOT COMPLETED|Period 4||0
4986912|NCT02465866|12268242|P1|NOT COMPLETED|Period 4||0
4986913|NCT02465866|12268239|P4|COMPLETED|Period 4||5
4986914|NCT02465866|12268240|P3|COMPLETED|Period 4||5
4986915|NCT02465866|12268241|P2|COMPLETED|Period 4||4
4986916|NCT02465866|12268242|P1|COMPLETED|Period 4||5
4986917|NCT02465866|12268239|P4|STARTED|Period 4||5
4986918|NCT02465866|12268240|P3|STARTED|Period 4||5
4986919|NCT02465866|12268241|P2|STARTED|Period 4||4
4986920|NCT02465866|12268242|P1|STARTED|Period 4||5
4986921|NCT02465866|12268239|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
4986922|NCT02465866|12268240|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
4986923|NCT02465866|12268241|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
4986924|NCT02465866|12268242|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
4986925|NCT02465866|12268239|P4|COMPLETED|Period 3: Washout (14 Days)||5
4986926|NCT02465866|12268240|P3|COMPLETED|Period 3: Washout (14 Days)||5
4986927|NCT02465866|12268241|P2|COMPLETED|Period 3: Washout (14 Days)||4
4986928|NCT02465866|12268242|P1|COMPLETED|Period 3: Washout (14 Days)||5
4986929|NCT02465866|12268239|P4|STARTED|Period 3: Washout (14 Days)||5
4986930|NCT02465866|12268240|P3|STARTED|Period 3: Washout (14 Days)||5
4986931|NCT02465866|12268241|P2|STARTED|Period 3: Washout (14 Days)||4
4986932|NCT02465866|12268242|P1|STARTED|Period 3: Washout (14 Days)||5
4986933|NCT02465866|12268239|P4|NOT COMPLETED|Period 3||0
4986934|NCT02465866|12268240|P3|NOT COMPLETED|Period 3||0
4986935|NCT02465866|12268241|P2|NOT COMPLETED|Period 3||1
4986936|NCT02465866|12268242|P1|NOT COMPLETED|Period 3||0
4986937|NCT02465866|12268239|P4|COMPLETED|Period 3||5
4986938|NCT02465866|12268240|P3|COMPLETED|Period 3||5
4986939|NCT02465866|12268241|P2|COMPLETED|Period 3||4
4986940|NCT02465866|12268242|P1|COMPLETED|Period 3||5
4986941|NCT02465866|12268239|P4|STARTED|Period 3||5
4986942|NCT02465866|12268240|P3|STARTED|Period 3||5
4986943|NCT02465866|12268241|P2|STARTED|Period 3||5
4986944|NCT02465866|12268242|P1|STARTED|Period 3||5
4986945|NCT02465866|12268239|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
4986946|NCT02465866|12268240|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
4986947|NCT02465866|12268241|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
4986948|NCT02465866|12268242|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
4986949|NCT02465866|12268239|P4|COMPLETED|Period 2: Washout (14 Days)||5
4986950|NCT02465866|12268240|P3|COMPLETED|Period 2: Washout (14 Days)||5
4986951|NCT02465866|12268241|P2|COMPLETED|Period 2: Washout (14 Days)||5
4986952|NCT02465866|12268242|P1|COMPLETED|Period 2: Washout (14 Days)||5
4986953|NCT02465866|12268239|P4|STARTED|Period 2: Washout (14 Days)||5
4986954|NCT02465866|12268240|P3|STARTED|Period 2: Washout (14 Days)||5
4986955|NCT02465866|12268241|P2|STARTED|Period 2: Washout (14 Days)||5
4986956|NCT02465866|12268242|P1|STARTED|Period 2: Washout (14 Days)||5
4986957|NCT02465866|12268239|P4|NOT COMPLETED|Period 2||0
4986958|NCT02465866|12268240|P3|NOT COMPLETED|Period 2||0
4986959|NCT02465866|12268241|P2|NOT COMPLETED|Period 2||0
4986960|NCT02465866|12268242|P1|NOT COMPLETED|Period 2||0
4986961|NCT02465866|12268239|P4|COMPLETED|Period 2||5
4986962|NCT02465866|12268240|P3|COMPLETED|Period 2||5
4986963|NCT02465866|12268241|P2|COMPLETED|Period 2||5
4986964|NCT02465866|12268242|P1|COMPLETED|Period 2||5
4986965|NCT02465866|12268239|P4|STARTED|Period 2||5
4986966|NCT02465866|12268240|P3|STARTED|Period 2||5
4986967|NCT02465866|12268241|P2|STARTED|Period 2||5
4986968|NCT02465866|12268242|P1|STARTED|Period 2||5
4986969|NCT02465866|12268239|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
4986970|NCT02465866|12268240|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
4986971|NCT02465866|12268241|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
4986972|NCT02465866|12268242|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
4986973|NCT02465866|12268239|P4|COMPLETED|Period 1: Washout (14 Days)||5
4986974|NCT02465866|12268240|P3|COMPLETED|Period 1: Washout (14 Days)||5
4986975|NCT02465866|12268241|P2|COMPLETED|Period 1: Washout (14 Days)||5
4986976|NCT02465866|12268242|P1|COMPLETED|Period 1: Washout (14 Days)||5
4986977|NCT02465866|12268239|P4|STARTED|Period 1: Washout (14 Days)||5
4986978|NCT02465866|12268240|P3|STARTED|Period 1: Washout (14 Days)||5
4986979|NCT02465866|12268241|P2|STARTED|Period 1: Washout (14 Days)||5
4986980|NCT02465866|12268242|P1|STARTED|Period 1: Washout (14 Days)||5
4986981|NCT02465866|12268239|P4|NOT COMPLETED|Period 1||0
4986982|NCT02465866|12268240|P3|NOT COMPLETED|Period 1||0
4986983|NCT02465866|12268241|P2|NOT COMPLETED|Period 1||0
4986984|NCT02465866|12268242|P1|NOT COMPLETED|Period 1||0
4986985|NCT02465866|12268239|P4|COMPLETED|Period 1||5
4986986|NCT02465866|12268240|P3|COMPLETED|Period 1||5
4986987|NCT02465866|12268241|P2|COMPLETED|Period 1||5
4986988|NCT02465866|12268242|P1|COMPLETED|Period 1||5
4986989|NCT02465866|12268239|P4|STARTED|Period 1||5
4986990|NCT02465866|12268240|P3|STARTED|Period 1||5
4986991|NCT02465866|12268241|P2|STARTED|Period 1||5
4986992|NCT02465866|12268242|P1|STARTED|Period 1||5
4986993|NCT02465632|12268315|P3|NOT COMPLETED|Overall Study||17
4986994|NCT02465632|12268316|P2|NOT COMPLETED|Overall Study||23
4986995|NCT02465632|12268317|P1|NOT COMPLETED|Overall Study||31
4986996|NCT02465632|12268315|P3|COMPLETED|Overall Study||203
4986997|NCT02465632|12268316|P2|COMPLETED|Overall Study||417
4986998|NCT02465632|12268317|P1|COMPLETED|Overall Study||409
4986999|NCT02465632|12268315|P3|STARTED|Overall Study||220
4987000|NCT02465632|12268316|P2|STARTED|Overall Study||440
4987001|NCT02465632|12268317|P1|STARTED|Overall Study||440
4987002|NCT02465528|12268332|P4|NOT COMPLETED|Overall Study||5
4987003|NCT02465528|12268333|P3|NOT COMPLETED|Overall Study||12
4987004|NCT02465528|12268334|P2|NOT COMPLETED|Overall Study||4
4987005|NCT02465528|12268335|P1|NOT COMPLETED|Overall Study||1
4987006|NCT02465528|12268332|P4|COMPLETED|Overall Study||0
4987007|NCT02465528|12268333|P3|COMPLETED|Overall Study||0
4987008|NCT02465528|12268334|P2|COMPLETED|Overall Study||0
4987009|NCT02465528|12268335|P1|COMPLETED|Overall Study||0
4987010|NCT02465528|12268332|P4|STARTED|Overall Study||5
4987011|NCT02465528|12268333|P3|STARTED|Overall Study||12
4987012|NCT02465528|12268334|P2|STARTED|Overall Study||4
4987013|NCT02465528|12268335|P1|STARTED|Overall Study||1
4987014|NCT02465515|12268368|P2|NOT COMPLETED|Overall Study||111
4987015|NCT02465515|12268369|P1|NOT COMPLETED|Overall Study||154
4987016|NCT02465515|12268368|P2|COMPLETED|Overall Study||4620
4987017|NCT02465515|12268369|P1|COMPLETED|Overall Study||4578
4987018|NCT02465515|12268368|P2|STARTED|Overall Study||4731
4987019|NCT02465515|12268369|P1|STARTED|Overall Study||4732
4987020|NCT02465489|12268415|P1|NOT COMPLETED|Overall Study||5
4987021|NCT02465489|12268415|P1|COMPLETED|Overall Study||15
4987022|NCT02465489|12268415|P1|STARTED|Overall Study||20
4987023|NCT02465463|12268444|P2|NOT COMPLETED|Overall Study||1
4987024|NCT02465463|12268445|P1|NOT COMPLETED|Overall Study||4
4987025|NCT02465463|12268444|P2|COMPLETED|Overall Study||4
4987026|NCT02465463|12268445|P1|COMPLETED|Overall Study||4
4987027|NCT02465463|12268444|P2|STARTED|Overall Study||5
4987028|NCT02465463|12268445|P1|STARTED|Overall Study||8
4987029|NCT02465450|12268464|P6|NOT COMPLETED|Treatment Period 2||0
4987030|NCT02465450|12268465|P5|NOT COMPLETED|Treatment Period 2||4
4987031|NCT02465450|12268466|P4|NOT COMPLETED|Treatment Period 2||3
4987032|NCT02465450|12268467|P3|NOT COMPLETED|Treatment Period 2||0
4987033|NCT02465450|12268468|P2|NOT COMPLETED|Treatment Period 2||0
4987034|NCT02465450|12268469|P1|NOT COMPLETED|Treatment Period 2||0
4987035|NCT02465450|12268464|P6|COMPLETED|Treatment Period 2||23
4987036|NCT02465450|12268465|P5|COMPLETED|Treatment Period 2||24
4987037|NCT02465450|12268466|P4|COMPLETED|Treatment Period 2||27
4987038|NCT02465450|12268467|P3|COMPLETED|Treatment Period 2||0
4987039|NCT02465450|12268468|P2|COMPLETED|Treatment Period 2||0
4987040|NCT02465450|12268469|P1|COMPLETED|Treatment Period 2||0
4987041|NCT02465450|12268464|P6|STARTED|Treatment Period 2||23
4987042|NCT02465450|12268465|P5|STARTED|Treatment Period 2||28
4987043|NCT02465450|12268466|P4|STARTED|Treatment Period 2||30
4987044|NCT02465450|12268467|P3|STARTED|Treatment Period 2||0
4987045|NCT02465450|12268468|P2|STARTED|Treatment Period 2||0
4987046|NCT02465450|12268469|P1|STARTED|Treatment Period 2||0
4987047|NCT02465450|12268464|P6|NOT COMPLETED|Treatment Period 1||0
4987048|NCT02465450|12268465|P5|NOT COMPLETED|Treatment Period 1||0
4987049|NCT02465450|12268466|P4|NOT COMPLETED|Treatment Period 1||0
4987050|NCT02465450|12268467|P3|NOT COMPLETED|Treatment Period 1||1
4987051|NCT02465450|12268468|P2|NOT COMPLETED|Treatment Period 1||1
4987052|NCT02465450|12268469|P1|NOT COMPLETED|Treatment Period 1||2
4987053|NCT02465450|12268464|P6|COMPLETED|Treatment Period 1||0
4987054|NCT02465450|12268465|P5|COMPLETED|Treatment Period 1||0
4987055|NCT02465450|12268466|P4|COMPLETED|Treatment Period 1||0
4987056|NCT02465450|12268467|P3|COMPLETED|Treatment Period 1||34
4987057|NCT02465450|12268468|P2|COMPLETED|Treatment Period 1||23
4987058|NCT02465450|12268469|P1|COMPLETED|Treatment Period 1||24
4987059|NCT02465450|12268464|P6|STARTED|Treatment Period 1||0
4987060|NCT02465450|12268465|P5|STARTED|Treatment Period 1||0
4987061|NCT02465450|12268466|P4|STARTED|Treatment Period 1||0
4987062|NCT02465450|12268467|P3|STARTED|Treatment Period 1||35
4987063|NCT02465450|12268468|P2|STARTED|Treatment Period 1||24
4987064|NCT02465450|12268469|P1|STARTED|Treatment Period 1||26
4987065|NCT02465437|12268493|P4|NOT COMPLETED|Overall Study||1
4987066|NCT02465437|12268494|P3|NOT COMPLETED|Overall Study||1
4987067|NCT02465437|12268495|P2|NOT COMPLETED|Overall Study||1
4987068|NCT02465437|12268496|P1|NOT COMPLETED|Overall Study||1
4987069|NCT02465437|12268493|P4|COMPLETED|Overall Study||14
4987070|NCT02465437|12268494|P3|COMPLETED|Overall Study||8
4987071|NCT02465437|12268495|P2|COMPLETED|Overall Study||8
4987072|NCT02465437|12268496|P1|COMPLETED|Overall Study||8
4987073|NCT02465437|12268493|P4|STARTED|Overall Study||15
4987074|NCT02465437|12268494|P3|STARTED|Overall Study||9
4987075|NCT02465437|12268495|P2|STARTED|Overall Study||9
4987076|NCT02465437|12268496|P1|STARTED|Overall Study||9
4987077|NCT02465372|12268516|P2|NOT COMPLETED|Overall Study||97
4987078|NCT02465372|12268517|P1|NOT COMPLETED|Overall Study||122
4987079|NCT02465372|12268516|P2|COMPLETED|Overall Study||153
4987080|NCT02465372|12268517|P1|COMPLETED|Overall Study||227
4987081|NCT02465372|12268516|P2|STARTED|Overall Study||250
4987082|NCT02465372|12268517|P1|STARTED|Overall Study||349
4987083|NCT02465216|12268532|P5|NOT COMPLETED|Overall Study||3
4987084|NCT02465216|12268533|P4|NOT COMPLETED|Overall Study||2
4987085|NCT02465216|12268534|P3|NOT COMPLETED|Overall Study||1
4987086|NCT02465216|12268535|P2|NOT COMPLETED|Overall Study||0
4987087|NCT02465216|12268536|P1|NOT COMPLETED|Overall Study||3
4987088|NCT02465216|12268532|P5|COMPLETED|Overall Study||9
4987089|NCT02465216|12268533|P4|COMPLETED|Overall Study||12
4987090|NCT02465216|12268534|P3|COMPLETED|Overall Study||13
4987091|NCT02465216|12268535|P2|COMPLETED|Overall Study||5
4987092|NCT02465216|12268536|P1|COMPLETED|Overall Study||12
4987093|NCT02465216|12268532|P5|STARTED|Overall Study||12
4987094|NCT02465216|12268533|P4|STARTED|Overall Study||14
4987095|NCT02465216|12268534|P3|STARTED|Overall Study||14
4987096|NCT02465216|12268535|P2|STARTED|Overall Study||5
4987097|NCT02465216|12268536|P1|STARTED|Overall Study||15
4987098|NCT02465203|12268556|P3|NOT COMPLETED|Overall Study||13
4987099|NCT02465203|12268557|P2|NOT COMPLETED|Overall Study||36
4987100|NCT02465203|12268558|P1|NOT COMPLETED|Overall Study||56
4987101|NCT02465203|12268556|P3|COMPLETED|Overall Study||0
4987102|NCT02465203|12268557|P2|COMPLETED|Overall Study||0
4987103|NCT02465203|12268558|P1|COMPLETED|Overall Study||0
4987104|NCT02465203|12268556|P3|STARTED|Overall Study||13
4987105|NCT02465203|12268557|P2|STARTED|Overall Study||36
4987106|NCT02465203|12268558|P1|STARTED|Overall Study||56
4987107|NCT02465099|12268571|P2|NOT COMPLETED|Overall Study||0
4987108|NCT02465099|12268572|P1|NOT COMPLETED|Overall Study||0
4987109|NCT02465099|12268571|P2|COMPLETED|Overall Study||19
4987110|NCT02465099|12268572|P1|COMPLETED|Overall Study||45
4987111|NCT02465099|12268571|P2|STARTED|Overall Study||19
4987112|NCT02465099|12268572|P1|STARTED|Overall Study||45
4987113|NCT02465073|12268581|P3|NOT COMPLETED|Overall Study||1
4987114|NCT02465073|12268582|P2|NOT COMPLETED|Overall Study||1
4987115|NCT02465073|12268583|P1|NOT COMPLETED|Overall Study||2
4987116|NCT02465073|12268581|P3|COMPLETED|Overall Study||15
4987117|NCT02465073|12268582|P2|COMPLETED|Overall Study||15
4987118|NCT02465073|12268583|P1|COMPLETED|Overall Study||15
4987119|NCT02465073|12268581|P3|STARTED|Overall Study||16
4987120|NCT02465073|12268582|P2|STARTED|Overall Study||16
4987121|NCT02465073|12268583|P1|STARTED|Overall Study||17
4987122|NCT02464917|12268593|P2|NOT COMPLETED|Overall Study||0
4987123|NCT02464917|12268594|P1|NOT COMPLETED|Overall Study||0
4987124|NCT02464917|12268593|P2|COMPLETED|Overall Study||35
4987125|NCT02464917|12268594|P1|COMPLETED|Overall Study||35
4987126|NCT02464917|12268593|P2|STARTED|Overall Study||35
4987127|NCT02464917|12268594|P1|STARTED|Overall Study||35
4987128|NCT02464540|12268620|P2|NOT COMPLETED|Overall Study||0
4987129|NCT02464540|12268621|P1|NOT COMPLETED|Overall Study||0
4987130|NCT02464540|12268620|P2|COMPLETED|Overall Study||11
4987131|NCT02464540|12268621|P1|COMPLETED|Overall Study||11
4987132|NCT02464540|12268620|P2|STARTED|Overall Study||11
4987133|NCT02464540|12268621|P1|STARTED|Overall Study||11
4987134|NCT02464176|12268630|P3|NOT COMPLETED|Overall Study||0
4987135|NCT02464176|12268631|P2|NOT COMPLETED|Overall Study||0
4987136|NCT02464176|12268632|P1|NOT COMPLETED|Overall Study||0
4987137|NCT02464176|12268630|P3|COMPLETED|Overall Study||15
4987138|NCT02464176|12268631|P2|COMPLETED|Overall Study||50
4987139|NCT02464176|12268632|P1|COMPLETED|Overall Study||50
4987140|NCT02464176|12268630|P3|STARTED|Overall Study||15
4987141|NCT02464176|12268631|P2|STARTED|Overall Study||50
4987142|NCT02464176|12268632|P1|STARTED|Overall Study||50
4987143|NCT02464163|12268653|P4|NOT COMPLETED|Overall Study||5
4987144|NCT02464163|12268654|P3|NOT COMPLETED|Overall Study||5
4987145|NCT02464163|12268655|P2|NOT COMPLETED|Overall Study||8
4987146|NCT02464163|12268656|P1|NOT COMPLETED|Overall Study||3
4987147|NCT02464163|12268653|P4|COMPLETED|Overall Study||96
4987148|NCT02464163|12268654|P3|COMPLETED|Overall Study||97
4987149|NCT02464163|12268655|P2|COMPLETED|Overall Study||94
4987150|NCT02464163|12268656|P1|COMPLETED|Overall Study||99
4987151|NCT02464163|12268653|P4|STARTED|Overall Study||101
4987152|NCT02464163|12268654|P3|STARTED|Overall Study||102
4987153|NCT02464163|12268655|P2|STARTED|Overall Study||102
4987154|NCT02464163|12268656|P1|STARTED|Overall Study||102
4987155|NCT02464059|12268678|P1|NOT COMPLETED|Overall Study||6
4987156|NCT02464059|12268678|P1|COMPLETED|Overall Study||17
4987157|NCT02464059|12268678|P1|STARTED|Overall Study||23
4987158|NCT02464033|12268684|P1|NOT COMPLETED|Overall Study||0
4987159|NCT02464033|12268684|P1|COMPLETED|Overall Study||20
4987160|NCT02464033|12268684|P1|STARTED|Overall Study||20
4987161|NCT02463981|12268715|P2|NOT COMPLETED|Overall Study||2
4987162|NCT02463981|12268716|P1|NOT COMPLETED|Overall Study||3
4987163|NCT02463981|12268715|P2|COMPLETED|Overall Study||14
4987164|NCT02463981|12268716|P1|COMPLETED|Overall Study||18
4987165|NCT02463981|12268715|P2|STARTED|Overall Study||16
4987166|NCT02463981|12268716|P1|STARTED|Overall Study||21
4987167|NCT02463409|12268724|P1|NOT COMPLETED|Overall Study||2
4987168|NCT02463409|12268724|P1|COMPLETED|Overall Study||4
4987169|NCT02463409|12268724|P1|STARTED|Overall Study||6
4987170|NCT02463331|12268732|P2|NOT COMPLETED|Overall Study||6
4987171|NCT02463331|12268733|P1|NOT COMPLETED|Overall Study||16
4987172|NCT02463331|12268732|P2|COMPLETED|Overall Study||25
4987173|NCT02463331|12268733|P1|COMPLETED|Overall Study||10
4987174|NCT02463331|12268732|P2|STARTED|Overall Study||31
4987175|NCT02463331|12268733|P1|STARTED|Overall Study||26
4987176|NCT02463227|12268741|P1|NOT COMPLETED|Overall Study||0
4987177|NCT02463227|12268741|P1|COMPLETED|Overall Study||14
4987178|NCT02463227|12268741|P1|STARTED|Overall Study||14
4987179|NCT02463097|12268749|P1|NOT COMPLETED|Overall Study||1
4987180|NCT02463097|12268749|P1|COMPLETED|Overall Study||123
4987181|NCT02463097|12268749|P1|STARTED|Overall Study||124
4987182|NCT02463071|12268758|P3|NOT COMPLETED|Overall Study||6
4987183|NCT02463071|12268759|P2|NOT COMPLETED|Overall Study||16
4987184|NCT02463071|12268760|P1|NOT COMPLETED|Overall Study||12
4987185|NCT02463071|12268758|P3|COMPLETED|Overall Study||71
4987186|NCT02463071|12268759|P2|COMPLETED|Overall Study||138
4987187|NCT02463071|12268760|P1|COMPLETED|Overall Study||140
4987188|NCT02463071|12268758|P3|STARTED|Overall Study||77
4987189|NCT02463071|12268759|P2|STARTED|Overall Study||154
4987190|NCT02463071|12268760|P1|STARTED|Overall Study||152
4987191|NCT02462928|12268789|P3|NOT COMPLETED|Overall Study||57
4987192|NCT02462928|12268790|P2|NOT COMPLETED|Overall Study||92
4987193|NCT02462928|12268791|P1|NOT COMPLETED|Overall Study||90
4987194|NCT02462928|12268789|P3|COMPLETED|Overall Study||255
4987195|NCT02462928|12268790|P2|COMPLETED|Overall Study||221
4987196|NCT02462928|12268791|P1|COMPLETED|Overall Study||224
4987197|NCT02462928|12268789|P3|STARTED|Overall Study||312
4987198|NCT02462928|12268790|P2|STARTED|Overall Study||313
4987199|NCT02462928|12268791|P1|STARTED|Overall Study||314
4987200|NCT02462876|12268811|P1|NOT COMPLETED|Overall Study||33
4987201|NCT02462876|12268811|P1|COMPLETED|Overall Study||27
4987202|NCT02462876|12268811|P1|STARTED|Overall Study||60
4987203|NCT02462759|12268821|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
4987204|NCT02462759|12268822|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
4987205|NCT02462759|12268823|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
4987206|NCT02462759|12268821|P3|COMPLETED|Part 2: Open-Label Phase||20
4987207|NCT02462759|12268822|P2|COMPLETED|Part 2: Open-Label Phase||0
4987208|NCT02462759|12268823|P1|COMPLETED|Part 2: Open-Label Phase||0
4987209|NCT02462759|12268821|P3|STARTED|Part 2: Open-Label Phase||20
4987210|NCT02462759|12268822|P2|STARTED|Part 2: Open-Label Phase||0
4987211|NCT02462759|12268823|P1|STARTED|Part 2: Open-Label Phase||0
4987212|NCT02462759|12268821|P3|NOT COMPLETED|Part 1: Double Blind||0
4987213|NCT02462759|12268822|P2|NOT COMPLETED|Part 1: Double Blind||0
4987214|NCT02462759|12268823|P1|NOT COMPLETED|Part 1: Double Blind||1
4987215|NCT02462759|12268821|P3|COMPLETED|Part 1: Double Blind||0
4987216|NCT02462759|12268822|P2|COMPLETED|Part 1: Double Blind||14
4987217|NCT02462759|12268823|P1|COMPLETED|Part 1: Double Blind||6
4987218|NCT02462759|12268821|P3|STARTED|Part 1: Double Blind||0
4987219|NCT02462759|12268822|P2|STARTED|Part 1: Double Blind||14
4987220|NCT02462759|12268823|P1|STARTED|Part 1: Double Blind||7
4987221|NCT02462720|12268871|P2|NOT COMPLETED|Part 2||1
4987222|NCT02462720|12268872|P1|NOT COMPLETED|Part 2||1
4987223|NCT02462720|12268871|P2|COMPLETED|Part 2||16
4987224|NCT02462720|12268872|P1|COMPLETED|Part 2||17
4987225|NCT02462720|12268871|P2|STARTED|Part 2||17
4987226|NCT02462720|12268872|P1|STARTED|Part 2||18
4987227|NCT02462720|12268871|P2|NOT COMPLETED|Part 1||0
4987228|NCT02462720|12268872|P1|NOT COMPLETED|Part 1||0
4987229|NCT02462720|12268871|P2|COMPLETED|Part 1||17
4987230|NCT02462720|12268872|P1|COMPLETED|Part 1||18
4987231|NCT02462720|12268871|P2|STARTED|Part 1||17
4987232|NCT02462720|12268872|P1|STARTED|Part 1||18
4987233|NCT02462486|12268885|P3|NOT COMPLETED|Overall Study||52
4987234|NCT02462486|12268886|P2|NOT COMPLETED|Overall Study||92
4987235|NCT02462486|12268887|P1|NOT COMPLETED|Overall Study||94
4987236|NCT02462486|12268885|P3|COMPLETED|Overall Study||266
4987237|NCT02462486|12268886|P2|COMPLETED|Overall Study||223
4987238|NCT02462486|12268887|P1|COMPLETED|Overall Study||222
4987239|NCT02462486|12268885|P3|STARTED|Overall Study||318
4987240|NCT02462486|12268886|P2|STARTED|Overall Study||315
4987241|NCT02462486|12268887|P1|STARTED|Overall Study||316
4987242|NCT02462473|12268907|P1|NOT COMPLETED|Overall Study||4
4987243|NCT02462473|12268907|P1|COMPLETED|Overall Study||5
4987244|NCT02462473|12268907|P1|STARTED|Overall Study||9
4987245|NCT02462291|12268920|P2|NOT COMPLETED|Overall Study||6
4987246|NCT02462291|12268921|P1|NOT COMPLETED|Overall Study||5
4987247|NCT02462291|12268920|P2|COMPLETED|Overall Study||75
4987248|NCT02462291|12268921|P1|COMPLETED|Overall Study||77
4987249|NCT02462291|12268920|P2|STARTED|Overall Study||81
4987250|NCT02462291|12268921|P1|STARTED|Overall Study||82
4987251|NCT02462148|12268962|P3|NOT COMPLETED|Overall Study||0
4987252|NCT02462148|12268963|P2|NOT COMPLETED|Overall Study||0
4987253|NCT02462148|12268964|P1|NOT COMPLETED|Overall Study||1
4987254|NCT02462148|12268962|P3|COMPLETED|Overall Study||12
4987255|NCT02462148|12268963|P2|COMPLETED|Overall Study||36
4987256|NCT02462148|12268964|P1|COMPLETED|Overall Study||36
4987257|NCT02462148|12268962|P3|STARTED|Overall Study||12
4987258|NCT02462148|12268963|P2|STARTED|Overall Study||36
4987259|NCT02462148|12268964|P1|STARTED|Overall Study||37
4987260|NCT02462083|12268987|P1|NOT COMPLETED|Overall Study||419
4987261|NCT02462083|12268987|P1|COMPLETED|Overall Study||136
4987262|NCT02462083|12268987|P1|Safety Population|Overall Study||550
4987263|NCT02462083|12268987|P1|STARTED|Overall Study||555
4987264|NCT02462057|12268996|P5|NOT COMPLETED|Overall Study||50
4987265|NCT02462057|12268997|P4|NOT COMPLETED|Overall Study||51
4987266|NCT02462057|12268998|P3|NOT COMPLETED|Overall Study||46
4987267|NCT02462057|12268999|P2|NOT COMPLETED|Overall Study||40
4987268|NCT02462057|12269000|P1|NOT COMPLETED|Overall Study||54
4987269|NCT02462057|12268996|P5|COMPLETED|Overall Study||708
4987270|NCT02462057|12268997|P4|COMPLETED|Overall Study||701
4987271|NCT02462057|12268998|P3|COMPLETED|Overall Study||766
4987272|NCT02462057|12268999|P2|COMPLETED|Overall Study||753
4987273|NCT02462057|12269000|P1|COMPLETED|Overall Study||737
4987274|NCT02462057|12268996|P5|STARTED|Overall Study||758
4987275|NCT02462057|12268997|P4|STARTED|Overall Study||752
4987276|NCT02462057|12268998|P3|STARTED|Overall Study||812
4987277|NCT02462057|12268999|P2|STARTED|Overall Study||793
4987278|NCT02462057|12269000|P1|STARTED|Overall Study||791
4987279|NCT02461992|12269012|P1|NOT COMPLETED|Overall Study||0
4987280|NCT02461992|12269012|P1|COMPLETED|Overall Study||13
4987281|NCT02461992|12269012|P1|STARTED|Overall Study||13
4987282|NCT02461966|12269032|P3|NOT COMPLETED|Overall Study||0
4987283|NCT02461966|12269033|P2|NOT COMPLETED|Overall Study||0
4987284|NCT02461966|12269034|P1|NOT COMPLETED|Overall Study||0
4987285|NCT02461966|12269032|P3|COMPLETED|Overall Study||60
4987286|NCT02461966|12269033|P2|COMPLETED|Overall Study||80
4987287|NCT02461966|12269034|P1|COMPLETED|Overall Study||160
4987288|NCT02461966|12269032|P3|STARTED|Overall Study||60
4987289|NCT02461966|12269033|P2|STARTED|Overall Study||80
4987290|NCT02461966|12269034|P1|STARTED|Overall Study||160
4987291|NCT02461758|12269046|P4|NOT COMPLETED|Overall Study||0
4987292|NCT02461758|12269047|P3|NOT COMPLETED|Overall Study||1
4987293|NCT02461758|12269048|P2|NOT COMPLETED|Overall Study||1
4987294|NCT02461758|12269049|P1|NOT COMPLETED|Overall Study||0
4987295|NCT02461758|12269046|P4|COMPLETED|Overall Study||15
4987296|NCT02461758|12269047|P3|COMPLETED|Overall Study||25
4987297|NCT02461758|12269048|P2|COMPLETED|Overall Study||19
4987298|NCT02461758|12269049|P1|COMPLETED|Overall Study||20
4987299|NCT02461758|12269046|P4|STARTED|Overall Study||15
4987300|NCT02461758|12269047|P3|STARTED|Overall Study||26
4987301|NCT02461758|12269048|P2|STARTED|Overall Study||20
4987302|NCT02461758|12269049|P1|STARTED|Overall Study||20
4987303|NCT02461693|12269075|P2|NOT COMPLETED|Overall Study||0
4987304|NCT02461693|12269076|P1|NOT COMPLETED|Overall Study||0
4987305|NCT02461693|12269075|P2|COMPLETED|Overall Study||102
4987306|NCT02461693|12269076|P1|COMPLETED|Overall Study||103
4987307|NCT02461693|12269075|P2|STARTED|Overall Study||102
4987308|NCT02461693|12269076|P1|STARTED|Overall Study||103
4987309|NCT02461628|12269090|P2|NOT COMPLETED|Overall Study||7
4987310|NCT02461628|12269091|P1|NOT COMPLETED|Overall Study||4
4987311|NCT02461628|12269090|P2|COMPLETED|Overall Study||3625
4987312|NCT02461628|12269091|P1|COMPLETED|Overall Study||3729
4987313|NCT02461628|12269090|P2|18 Month Survey|Overall Study||905
4987314|NCT02461628|12269091|P1|18 Month Survey|Overall Study||995
4987315|NCT02461628|12269090|P2|12 Month Survey|Overall Study||914
4987316|NCT02461628|12269091|P1|12 Month Survey|Overall Study||882
4987317|NCT02461628|12269090|P2|6 Month Survey|Overall Study||832
4987318|NCT02461628|12269091|P1|6 Month Survey|Overall Study||814
4987319|NCT02461628|12269090|P2|Baseline Survey|Overall Study||974
4987320|NCT02461628|12269091|P1|Baseline Survey|Overall Study||1038
4987321|NCT02461628|12269090|P2|STARTED|Overall Study||3632
4987322|NCT02461628|12269091|P1|STARTED|Overall Study||3733
4987323|NCT02461589|12269115|P10|NOT COMPLETED|Overall Study||5
4987324|NCT02461589|12269116|P9|NOT COMPLETED|Overall Study||6
4987325|NCT02461589|12269117|P8|NOT COMPLETED|Overall Study||5
4987326|NCT02461589|12269118|P7|NOT COMPLETED|Overall Study||6
4987327|NCT02461589|12269119|P6|NOT COMPLETED|Overall Study||3
4987328|NCT02461589|12269120|P5|NOT COMPLETED|Overall Study||2
4987329|NCT02461589|12269121|P4|NOT COMPLETED|Overall Study||5
4987330|NCT02461589|12269122|P3|NOT COMPLETED|Overall Study||5
4987331|NCT02461589|12269123|P2|NOT COMPLETED|Overall Study||2
4987332|NCT02461589|12269124|P1|NOT COMPLETED|Overall Study||6
4987333|NCT02461589|12269115|P10|COMPLETED|Overall Study||60
4987334|NCT02461589|12269116|P9|COMPLETED|Overall Study||123
4987335|NCT02461589|12269117|P8|COMPLETED|Overall Study||60
4987336|NCT02461589|12269118|P7|COMPLETED|Overall Study||58
4987337|NCT02461589|12269119|P6|COMPLETED|Overall Study||61
4987338|NCT02461589|12269120|P5|COMPLETED|Overall Study||62
4987339|NCT02461589|12269121|P4|COMPLETED|Overall Study||58
4987340|NCT02461589|12269122|P3|COMPLETED|Overall Study||60
4987341|NCT02461589|12269123|P2|COMPLETED|Overall Study||61
4987342|NCT02461589|12269124|P1|COMPLETED|Overall Study||58
4987343|NCT02461589|12269115|P10|Exposed|Overall Study||64
4987344|NCT02461589|12269116|P9|Exposed|Overall Study||129
4987345|NCT02461589|12269117|P8|Exposed|Overall Study||65
4987346|NCT02461589|12269118|P7|Exposed|Overall Study||64
4987347|NCT02461589|12269119|P6|Exposed|Overall Study||64
4987348|NCT02461589|12269120|P5|Exposed|Overall Study||64
4987349|NCT02461589|12269121|P4|Exposed|Overall Study||63
4987350|NCT02461589|12269122|P3|Exposed|Overall Study||65
4987351|NCT02461589|12269123|P2|Exposed|Overall Study||63
4987352|NCT02461589|12269124|P1|Exposed|Overall Study||64
4987353|NCT02461589|12269115|P10|STARTED|Overall Study||65
4987354|NCT02461589|12269116|P9|STARTED|Overall Study||129
4987355|NCT02461589|12269117|P8|STARTED|Overall Study||65
4987356|NCT02461589|12269118|P7|STARTED|Overall Study||64
4987357|NCT02461589|12269119|P6|STARTED|Overall Study||64
4987358|NCT02461589|12269120|P5|STARTED|Overall Study||64
4987359|NCT02461589|12269121|P4|STARTED|Overall Study||63
4987360|NCT02461589|12269122|P3|STARTED|Overall Study||65
4987361|NCT02461589|12269123|P2|STARTED|Overall Study||63
4987362|NCT02461589|12269124|P1|STARTED|Overall Study||64
4987363|NCT02461563|12269180|P4|NOT COMPLETED|Overall Study||0
4987364|NCT02461563|12269181|P3|NOT COMPLETED|Overall Study||0
4987365|NCT02461563|12269182|P2|NOT COMPLETED|Overall Study||0
4987366|NCT02461563|12269183|P1|NOT COMPLETED|Overall Study||0
4987367|NCT02461563|12269180|P4|COMPLETED|Overall Study||3
4987368|NCT02461563|12269181|P3|COMPLETED|Overall Study||3
4987369|NCT02461563|12269182|P2|COMPLETED|Overall Study||3
4987370|NCT02461563|12269183|P1|COMPLETED|Overall Study||3
4987371|NCT02461563|12269180|P4|STARTED|Overall Study||3
4987372|NCT02461563|12269181|P3|STARTED|Overall Study||3
4987373|NCT02461563|12269182|P2|STARTED|Overall Study||3
4987374|NCT02461563|12269183|P1|STARTED|Overall Study||3
4987375|NCT02461550|12269217|P1|NOT COMPLETED|Overall Study||0
4987376|NCT02461550|12269217|P1|COMPLETED|Overall Study||2
4987377|NCT02461550|12269217|P1|STARTED|Overall Study||2
4987378|NCT02461433|12269223|P2|NOT COMPLETED|Overall Study||0
4987379|NCT02461433|12269224|P1|NOT COMPLETED|Overall Study||0
4987380|NCT02461433|12269223|P2|COMPLETED|Overall Study||1
4987381|NCT02461433|12269224|P1|COMPLETED|Overall Study||1
4987382|NCT02461433|12269223|P2|STARTED|Overall Study||1
4987383|NCT02461433|12269224|P1|STARTED|Overall Study||1
4987384|NCT02461355|12269250|P1|NOT COMPLETED|Overall Study||0
4987385|NCT02461355|12269250|P1|COMPLETED|Overall Study||2
4987386|NCT02461355|12269250|P1|STARTED|Overall Study||2
4987387|NCT02461290|12269257|P1|NOT COMPLETED|Overall Study||10
4987388|NCT02461290|12269257|P1|COMPLETED|Overall Study||89
4987389|NCT02461290|12269257|P1|STARTED|Overall Study||99
4987390|NCT02461160|12269277|P13|NOT COMPLETED|Overall Study||0
4987391|NCT02461160|12269278|P12|NOT COMPLETED|Overall Study||0
4987392|NCT02461160|12269279|P11|NOT COMPLETED|Overall Study||0
4987393|NCT02461160|12269280|P10|NOT COMPLETED|Overall Study||0
4987394|NCT02461160|12269281|P9|NOT COMPLETED|Overall Study||0
4987395|NCT02461160|12269282|P8|NOT COMPLETED|Overall Study||1
4987396|NCT02461160|12269283|P7|NOT COMPLETED|Overall Study||0
4987397|NCT02461160|12269284|P6|NOT COMPLETED|Overall Study||0
4987398|NCT02461160|12269285|P5|NOT COMPLETED|Overall Study||0
4987399|NCT02461160|12269286|P4|NOT COMPLETED|Overall Study||0
4987400|NCT02461160|12269287|P3|NOT COMPLETED|Overall Study||0
4987401|NCT02461160|12269288|P2|NOT COMPLETED|Overall Study||0
4987402|NCT02461160|12269289|P1|NOT COMPLETED|Overall Study||0
4987403|NCT02461160|12269277|P13|COMPLETED|Overall Study||8
4987404|NCT02461160|12269278|P12|COMPLETED|Overall Study||4
4987405|NCT02461160|12269279|P11|COMPLETED|Overall Study||4
4987406|NCT02461160|12269280|P10|COMPLETED|Overall Study||4
4987407|NCT02461160|12269281|P9|COMPLETED|Overall Study||12
4987408|NCT02461160|12269282|P8|COMPLETED|Overall Study||5
4987409|NCT02461160|12269283|P7|COMPLETED|Overall Study||6
4987410|NCT02461160|12269284|P6|COMPLETED|Overall Study||6
4987411|NCT02461160|12269285|P5|COMPLETED|Overall Study||6
4987412|NCT02461160|12269286|P4|COMPLETED|Overall Study||12
4987413|NCT02461160|12269287|P3|COMPLETED|Overall Study||6
4987414|NCT02461160|12269288|P2|COMPLETED|Overall Study||6
4987415|NCT02461160|12269289|P1|COMPLETED|Overall Study||8
4987416|NCT02461160|12269277|P13|STARTED|Overall Study||8
4987417|NCT02461160|12269278|P12|STARTED|Overall Study||4
4987418|NCT02461160|12269279|P11|STARTED|Overall Study||4
4987419|NCT02461160|12269280|P10|STARTED|Overall Study||4
4987420|NCT02461160|12269281|P9|STARTED|Overall Study||12
4987421|NCT02461160|12269282|P8|STARTED|Overall Study||6
4987422|NCT02461160|12269283|P7|STARTED|Overall Study||6
4987423|NCT02461160|12269284|P6|STARTED|Overall Study||6
4987424|NCT02461160|12269285|P5|STARTED|Overall Study||6
4987425|NCT02461160|12269286|P4|STARTED|Overall Study||12
4987426|NCT02461160|12269287|P3|STARTED|Overall Study||6
4987427|NCT02461160|12269288|P2|STARTED|Overall Study||6
4987428|NCT02461160|12269289|P1|STARTED|Overall Study||8
4987429|NCT02461134|12269500|P1|NOT COMPLETED|Overall Study||1
4987430|NCT02461134|12269500|P1|COMPLETED|Overall Study||0
4987431|NCT02461134|12269500|P1|STARTED|Overall Study||1
4987432|NCT02460991|12269508|P2|NOT COMPLETED|Overall Study||2
4987433|NCT02460991|12269509|P1|NOT COMPLETED|Overall Study||0
4987434|NCT02460991|12269508|P2|COMPLETED|Overall Study||0
4987435|NCT02460991|12269509|P1|COMPLETED|Overall Study||0
4987436|NCT02460991|12269508|P2|STARTED|Overall Study||2
4987437|NCT02460991|12269509|P1|STARTED|Overall Study||0
4987438|NCT02460978|12269526|P3|NOT COMPLETED|Overall Study||33
4987439|NCT02460978|12269527|P2|NOT COMPLETED|Overall Study||25
4987440|NCT02460978|12269528|P1|NOT COMPLETED|Overall Study||27
4987441|NCT02460978|12269526|P3|COMPLETED|Overall Study||239
4987442|NCT02460978|12269527|P2|COMPLETED|Overall Study||245
4987443|NCT02460978|12269528|P1|COMPLETED|Overall Study||244
4987444|NCT02460978|12269526|P3|STARTED|Overall Study||272
4987445|NCT02460978|12269527|P2|STARTED|Overall Study||270
4987446|NCT02460978|12269528|P1|STARTED|Overall Study||271
4987447|NCT02460822|12269554|P1|NOT COMPLETED|Overall Study||1
4987448|NCT02460822|12269554|P1|COMPLETED|Overall Study||15
4987449|NCT02460822|12269554|P1|STARTED|Overall Study||16
4987450|NCT02460575|12269565|P2|NOT COMPLETED|Overall Study||0
4987451|NCT02460575|12269566|P1|NOT COMPLETED|Overall Study||1
4987452|NCT02460575|12269565|P2|COMPLETED|Overall Study||20
4987453|NCT02460575|12269566|P1|COMPLETED|Overall Study||39
4987454|NCT02460575|12269565|P2|STARTED|Overall Study||20
4987455|NCT02460575|12269566|P1|STARTED|Overall Study||40
4987456|NCT02460562|12269576|P2|NOT COMPLETED|Overall Study||16
4987457|NCT02460562|12269577|P1|NOT COMPLETED|Overall Study||15
4987458|NCT02460562|12269576|P2|COMPLETED|Overall Study||60
4987459|NCT02460562|12269577|P1|COMPLETED|Overall Study||59
4987460|NCT02460562|12269576|P2|STARTED|Overall Study||76
4987461|NCT02460562|12269577|P1|STARTED|Overall Study||74
4987462|NCT02460458|12269585|P1|NOT COMPLETED|Prospective Phase||0
4987463|NCT02460458|12269585|P1|COMPLETED|Prospective Phase|Information not yet available.|0
4987464|NCT02460458|12269585|P1|STARTED|Prospective Phase|Information not yet available.|0
4987465|NCT02460458|12269585|P1|NOT COMPLETED|Confirmatory Phase||266
4987466|NCT02460458|12269585|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
4987467|NCT02460458|12269585|P1|STARTED|Confirmatory Phase||266
4987468|NCT02460458|12269585|P1|NOT COMPLETED|Retrospective Phase||0
4987469|NCT02460458|12269585|P1|COMPLETED|Retrospective Phase||266
4987470|NCT02460458|12269585|P1|STARTED|Retrospective Phase||266
4987471|NCT02460380|12269593|P2|NOT COMPLETED|Overall Study||5
4987472|NCT02460380|12269594|P1|NOT COMPLETED|Overall Study||10
4987473|NCT02460380|12269593|P2|COMPLETED|Overall Study||18
4987474|NCT02460380|12269594|P1|COMPLETED|Overall Study||35
4987475|NCT02460380|12269593|P2|STARTED|Overall Study||23
4987476|NCT02460380|12269594|P1|STARTED|Overall Study||45
4987477|NCT02460263|12269614|P1|NOT COMPLETED|In-Home Period||0
4987478|NCT02460263|12269614|P1|COMPLETED|In-Home Period||28
4987479|NCT02460263|12269614|P1|STARTED|In-Home Period||28
4987480|NCT02460263|12269614|P1|NOT COMPLETED|Transition Period||2
4987481|NCT02460263|12269614|P1|COMPLETED|Transition Period||28
4987482|NCT02460263|12269614|P1|STARTED|Transition Period||30
4987483|NCT02460263|12269614|P1|NOT COMPLETED|In-Center Period||0
4987484|NCT02460263|12269614|P1|COMPLETED|In-Center Period||30
4987485|NCT02460263|12269614|P1|STARTED|In-Center Period||30
4987486|NCT02460172|12269625|P1|NOT COMPLETED|Overall Study||0
4987487|NCT02460172|12269625|P1|COMPLETED|Overall Study||25
4987488|NCT02460172|12269625|P1|STARTED|Overall Study||25
4987489|NCT02460159|12269641|P2|NOT COMPLETED|Overall Study||1
4987490|NCT02460159|12269642|P1|NOT COMPLETED|Overall Study||6
4987491|NCT02460159|12269641|P2|COMPLETED|Overall Study||17
4987492|NCT02460159|12269642|P1|COMPLETED|Overall Study||111
4987493|NCT02460159|12269641|P2|STARTED|Overall Study||18
4987494|NCT02460159|12269642|P1|STARTED|Overall Study||117
4987495|NCT02459951|12269670|P1|NOT COMPLETED|Overall Study||1
4987496|NCT02459951|12269670|P1|COMPLETED|Overall Study||9
4987497|NCT02459951|12269670|P1|STARTED|Overall Study||10
4987498|NCT02459899|12269681|P4|NOT COMPLETED|Overall Study||2
4987499|NCT02459899|12269682|P3|NOT COMPLETED|Overall Study||0
4987500|NCT02459899|12269683|P2|NOT COMPLETED|Overall Study||6
4987501|NCT02459899|12269684|P1|NOT COMPLETED|Overall Study||3
4987502|NCT02459899|12269681|P4|COMPLETED|Overall Study||33
4987503|NCT02459899|12269682|P3|COMPLETED|Overall Study||35
4987504|NCT02459899|12269683|P2|COMPLETED|Overall Study||29
4987505|NCT02459899|12269684|P1|COMPLETED|Overall Study||33
4987506|NCT02459899|12269681|P4|STARTED|Overall Study||35
4987507|NCT02459899|12269682|P3|STARTED|Overall Study||35
4987508|NCT02459899|12269683|P2|STARTED|Overall Study||35
4987509|NCT02459899|12269684|P1|STARTED|Overall Study||36
4987510|NCT02459665|12269718|P4|NOT COMPLETED|Overall Study||2
4987511|NCT02459665|12269719|P3|NOT COMPLETED|Overall Study||1
4987512|NCT02459665|12269720|P2|NOT COMPLETED|Overall Study||1
4987513|NCT02459665|12269721|P1|NOT COMPLETED|Overall Study||0
4987514|NCT02459665|12269718|P4|COMPLETED|Overall Study||15
4987515|NCT02459665|12269719|P3|COMPLETED|Overall Study||16
4987516|NCT02459665|12269720|P2|COMPLETED|Overall Study||16
4987517|NCT02459665|12269721|P1|COMPLETED|Overall Study||17
4987518|NCT02459665|12269718|P4|Month 6 Visit|Overall Study||15
4987519|NCT02459665|12269719|P3|Month 6 Visit|Overall Study||16
4987520|NCT02459665|12269720|P2|Month 6 Visit|Overall Study||16
4987521|NCT02459665|12269721|P1|Month 6 Visit|Overall Study||17
4987522|NCT02459665|12269718|P4|Month 2 Visit|Overall Study||16
4987523|NCT02459665|12269719|P3|Month 2 Visit|Overall Study||17
4987524|NCT02459665|12269720|P2|Month 2 Visit|Overall Study||16
4987525|NCT02459665|12269721|P1|Month 2 Visit|Overall Study||17
4987526|NCT02459665|12269718|P4|Month 1 Visit|Overall Study||16
4987527|NCT02459665|12269719|P3|Month 1 Visit|Overall Study||17
4987528|NCT02459665|12269720|P2|Month 1 Visit|Overall Study||17
4987529|NCT02459665|12269721|P1|Month 1 Visit|Overall Study||17
4987530|NCT02459665|12269718|P4|Day 7 Visit|Overall Study||16
4987531|NCT02459665|12269719|P3|Day 7 Visit|Overall Study||17
4987532|NCT02459665|12269720|P2|Day 7 Visit|Overall Study||17
4987533|NCT02459665|12269721|P1|Day 7 Visit|Overall Study||17
4987534|NCT02459665|12269718|P4|STARTED|Overall Study||17
4987535|NCT02459665|12269719|P3|STARTED|Overall Study||17
4987536|NCT02459665|12269720|P2|STARTED|Overall Study||17
4987537|NCT02459665|12269721|P1|STARTED|Overall Study||17
4987538|NCT02459418|12269752|P2|NOT COMPLETED|Overall Study||6
4987539|NCT02459418|12269753|P1|NOT COMPLETED|Overall Study||8
4987540|NCT02459418|12269752|P2|COMPLETED|Overall Study||15
4987541|NCT02459418|12269753|P1|COMPLETED|Overall Study||13
4987542|NCT02459418|12269752|P2|Received Second Treatment|Overall Study||15
4987543|NCT02459418|12269753|P1|Received Second Treatment|Overall Study||13
4987544|NCT02459418|12269752|P2|Received First Treatment|Overall Study||21
4987545|NCT02459418|12269753|P1|Received First Treatment|Overall Study||21
4987546|NCT02459418|12269752|P2|STARTED|Overall Study||21
4987547|NCT02459418|12269753|P1|STARTED|Overall Study||21
4987548|NCT02459197|12269775|P2|NOT COMPLETED|Overall Study||1
4987549|NCT02459197|12269776|P1|NOT COMPLETED|Overall Study||0
4987550|NCT02459197|12269775|P2|COMPLETED|Overall Study||55
4987551|NCT02459197|12269776|P1|COMPLETED|Overall Study||58
4987552|NCT02459197|12269775|P2|STARTED|Overall Study||56
4987553|NCT02459197|12269776|P1|STARTED|Overall Study||58
4987554|NCT02459119|12269790|P1|NOT COMPLETED|Overall Study||0
4987555|NCT02459119|12269790|P1|COMPLETED|Overall Study||17
4987556|NCT02459119|12269790|P1|STARTED|Overall Study||17
4987557|NCT02459093|12269800|P2|NOT COMPLETED|Overall Study||18
4987558|NCT02459093|12269801|P1|NOT COMPLETED|Overall Study||12
4987559|NCT02459093|12269800|P2|COMPLETED|Overall Study||257
4987560|NCT02459093|12269801|P1|COMPLETED|Overall Study||263
4987561|NCT02459093|12269800|P2|STARTED|Overall Study||275
4987562|NCT02459093|12269801|P1|STARTED|Overall Study||275
4987563|NCT02459080|12269812|P3|NOT COMPLETED|Overall Study||58
4987564|NCT02459080|12269813|P2|NOT COMPLETED|Overall Study||40
4987565|NCT02459080|12269814|P1|NOT COMPLETED|Overall Study||44
4987566|NCT02459080|12269812|P3|COMPLETED|Overall Study||151
4987567|NCT02459080|12269813|P2|COMPLETED|Overall Study||158
4987568|NCT02459080|12269814|P1|COMPLETED|Overall Study||168
4987569|NCT02459080|12269812|P3|STARTED|Overall Study||209
4987570|NCT02459080|12269813|P2|STARTED|Overall Study||198
4987571|NCT02459080|12269814|P1|STARTED|Overall Study||212
4987572|NCT02458768|12269839|P2|NOT COMPLETED|Overall Study||5
4987573|NCT02458768|12269840|P1|NOT COMPLETED|Overall Study||7
4987574|NCT02458768|12269839|P2|COMPLETED|Overall Study||50
4987575|NCT02458768|12269840|P1|COMPLETED|Overall Study||50
4987576|NCT02458768|12269839|P2|STARTED|Overall Study||55
4987577|NCT02458768|12269840|P1|STARTED|Overall Study||57
4987578|NCT02458469|12269846|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987579|NCT02458469|12269847|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987580|NCT02458469|12269848|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987581|NCT02458469|12269849|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987582|NCT02458469|12269850|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987583|NCT02458469|12269851|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
4987584|NCT02458469|12269846|P6|COMPLETED|Third Intervention (2 Weeks)||1
4987585|NCT02458469|12269847|P5|COMPLETED|Third Intervention (2 Weeks)||1
4987586|NCT02458469|12269848|P4|COMPLETED|Third Intervention (2 Weeks)||0
4987587|NCT02458469|12269849|P3|COMPLETED|Third Intervention (2 Weeks)||2
4987588|NCT02458469|12269850|P2|COMPLETED|Third Intervention (2 Weeks)||2
4987589|NCT02458469|12269851|P1|COMPLETED|Third Intervention (2 Weeks)||2
4987590|NCT02458469|12269846|P6|STARTED|Third Intervention (2 Weeks)||1
4987591|NCT02458469|12269847|P5|STARTED|Third Intervention (2 Weeks)||1
4987592|NCT02458469|12269848|P4|STARTED|Third Intervention (2 Weeks)||0
4987593|NCT02458469|12269849|P3|STARTED|Third Intervention (2 Weeks)||2
4987594|NCT02458469|12269850|P2|STARTED|Third Intervention (2 Weeks)||2
4987595|NCT02458469|12269851|P1|STARTED|Third Intervention (2 Weeks)||2
4987596|NCT02458469|12269846|P6|NOT COMPLETED|Second Washout (2 Weeks)||0
4987597|NCT02458469|12269847|P5|NOT COMPLETED|Second Washout (2 Weeks)||0
4987598|NCT02458469|12269848|P4|NOT COMPLETED|Second Washout (2 Weeks)||0
4987599|NCT02458469|12269849|P3|NOT COMPLETED|Second Washout (2 Weeks)||0
4987600|NCT02458469|12269850|P2|NOT COMPLETED|Second Washout (2 Weeks)||0
4987601|NCT02458469|12269851|P1|NOT COMPLETED|Second Washout (2 Weeks)||0
4987602|NCT02458469|12269846|P6|COMPLETED|Second Washout (2 Weeks)||1
4987603|NCT02458469|12269847|P5|COMPLETED|Second Washout (2 Weeks)||1
4987604|NCT02458469|12269848|P4|COMPLETED|Second Washout (2 Weeks)||0
4987605|NCT02458469|12269849|P3|COMPLETED|Second Washout (2 Weeks)||2
4987606|NCT02458469|12269850|P2|COMPLETED|Second Washout (2 Weeks)||2
4987607|NCT02458469|12269851|P1|COMPLETED|Second Washout (2 Weeks)||2
4987608|NCT02458469|12269846|P6|STARTED|Second Washout (2 Weeks)||1
4987609|NCT02458469|12269847|P5|STARTED|Second Washout (2 Weeks)||1
4987610|NCT02458469|12269848|P4|STARTED|Second Washout (2 Weeks)||0
4987611|NCT02458469|12269849|P3|STARTED|Second Washout (2 Weeks)||2
4987612|NCT02458469|12269850|P2|STARTED|Second Washout (2 Weeks)||2
4987613|NCT02458469|12269851|P1|STARTED|Second Washout (2 Weeks)||2
4987614|NCT02458469|12269846|P6|NOT COMPLETED|Second Intervention (2 Weeks)||1
4987615|NCT02458469|12269847|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
4987616|NCT02458469|12269848|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
4987617|NCT02458469|12269849|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
4987618|NCT02458469|12269850|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
4987619|NCT02458469|12269851|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4987620|NCT02458469|12269846|P6|COMPLETED|Second Intervention (2 Weeks)||1
4987621|NCT02458469|12269847|P5|COMPLETED|Second Intervention (2 Weeks)||1
4987622|NCT02458469|12269848|P4|COMPLETED|Second Intervention (2 Weeks)||0
4987623|NCT02458469|12269849|P3|COMPLETED|Second Intervention (2 Weeks)||2
4987624|NCT02458469|12269850|P2|COMPLETED|Second Intervention (2 Weeks)||2
4987625|NCT02458469|12269851|P1|COMPLETED|Second Intervention (2 Weeks)||2
4987626|NCT02458469|12269846|P6|STARTED|Second Intervention (2 Weeks)||2
4987627|NCT02458469|12269847|P5|STARTED|Second Intervention (2 Weeks)||1
4987628|NCT02458469|12269848|P4|STARTED|Second Intervention (2 Weeks)||0
4987629|NCT02458469|12269849|P3|STARTED|Second Intervention (2 Weeks)||2
4987630|NCT02458469|12269850|P2|STARTED|Second Intervention (2 Weeks)||2
4987631|NCT02458469|12269851|P1|STARTED|Second Intervention (2 Weeks)||2
4987632|NCT02458469|12269846|P6|NOT COMPLETED|First Washout (2 Weeks)||0
4987633|NCT02458469|12269847|P5|NOT COMPLETED|First Washout (2 Weeks)||0
4987634|NCT02458469|12269848|P4|NOT COMPLETED|First Washout (2 Weeks)||0
4987635|NCT02458469|12269849|P3|NOT COMPLETED|First Washout (2 Weeks)||0
4987636|NCT02458469|12269850|P2|NOT COMPLETED|First Washout (2 Weeks)||0
4987637|NCT02458469|12269851|P1|NOT COMPLETED|First Washout (2 Weeks)||0
4987638|NCT02458469|12269846|P6|COMPLETED|First Washout (2 Weeks)||2
4987639|NCT02458469|12269847|P5|COMPLETED|First Washout (2 Weeks)||1
4987640|NCT02458469|12269848|P4|COMPLETED|First Washout (2 Weeks)||0
4987641|NCT02458469|12269849|P3|COMPLETED|First Washout (2 Weeks)||2
4987642|NCT02458469|12269850|P2|COMPLETED|First Washout (2 Weeks)||2
4987643|NCT02458469|12269851|P1|COMPLETED|First Washout (2 Weeks)||2
4987644|NCT02458469|12269846|P6|STARTED|First Washout (2 Weeks)||2
4987645|NCT02458469|12269847|P5|STARTED|First Washout (2 Weeks)||1
4987646|NCT02458469|12269848|P4|STARTED|First Washout (2 Weeks)||0
4987647|NCT02458469|12269849|P3|STARTED|First Washout (2 Weeks)||2
4987648|NCT02458469|12269850|P2|STARTED|First Washout (2 Weeks)||2
4987649|NCT02458469|12269851|P1|STARTED|First Washout (2 Weeks)||2
4987650|NCT02458469|12269846|P6|NOT COMPLETED|First Intervention (2 Weeks)||0
4987651|NCT02458469|12269847|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
4987652|NCT02458469|12269848|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
4987653|NCT02458469|12269849|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
4987654|NCT02458469|12269850|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
4987655|NCT02458469|12269851|P1|NOT COMPLETED|First Intervention (2 Weeks)||1
4987656|NCT02458469|12269846|P6|COMPLETED|First Intervention (2 Weeks)||2
4987657|NCT02458469|12269847|P5|COMPLETED|First Intervention (2 Weeks)||1
4987658|NCT02458469|12269848|P4|COMPLETED|First Intervention (2 Weeks)||0
4987659|NCT02458469|12269849|P3|COMPLETED|First Intervention (2 Weeks)||2
4987660|NCT02458469|12269850|P2|COMPLETED|First Intervention (2 Weeks)||2
4987661|NCT02458469|12269851|P1|COMPLETED|First Intervention (2 Weeks)||2
4987662|NCT02458469|12269846|P6|STARTED|First Intervention (2 Weeks)||2
4987663|NCT02458469|12269847|P5|STARTED|First Intervention (2 Weeks)||1
4987664|NCT02458469|12269848|P4|STARTED|First Intervention (2 Weeks)||0
4987665|NCT02458469|12269849|P3|STARTED|First Intervention (2 Weeks)||3
4987666|NCT02458469|12269850|P2|STARTED|First Intervention (2 Weeks)||2
4987667|NCT02458469|12269851|P1|STARTED|First Intervention (2 Weeks)||3
4987668|NCT02458365|12269864|P2|NOT COMPLETED|Overall Study||294
4987669|NCT02458365|12269865|P1|NOT COMPLETED|Overall Study||277
4987670|NCT02458365|12269864|P2|COMPLETED|Overall Study||1607
4987671|NCT02458365|12269865|P1|COMPLETED|Overall Study||1723
4987672|NCT02458365|12269864|P2|STARTED|Overall Study||1901
4987673|NCT02458365|12269865|P1|STARTED|Overall Study||2000
4987674|NCT02458352|12269885|P1|NOT COMPLETED|Overall Study||0
4987675|NCT02458352|12269885|P1|COMPLETED|Overall Study||105
4987676|NCT02458352|12269885|P1|STARTED|Overall Study||105
4987677|NCT02458287|12269897|P4|NOT COMPLETED|Overall Study||3
4987678|NCT02458287|12269898|P3|NOT COMPLETED|Overall Study||3
4987679|NCT02458287|12269899|P2|NOT COMPLETED|Overall Study||4
4987680|NCT02458287|12269900|P1|NOT COMPLETED|Overall Study||0
4987681|NCT02458287|12269897|P4|COMPLETED|Overall Study||97
4987682|NCT02458287|12269898|P3|COMPLETED|Overall Study||46
4987683|NCT02458287|12269899|P2|COMPLETED|Overall Study||96
4987684|NCT02458287|12269900|P1|COMPLETED|Overall Study||50
4987685|NCT02458287|12269897|P4|STARTED|Overall Study||100
4987686|NCT02458287|12269898|P3|STARTED|Overall Study||49
4987687|NCT02458287|12269899|P2|STARTED|Overall Study||100
4987688|NCT02458287|12269900|P1|STARTED|Overall Study||50
4987689|NCT02458092|12269947|P2|NOT COMPLETED|Overall Study||0
4987690|NCT02458092|12269948|P1|NOT COMPLETED|Overall Study||1
4987691|NCT02458092|12269947|P2|COMPLETED|Overall Study||10
4987692|NCT02458092|12269948|P1|COMPLETED|Overall Study||19
4987693|NCT02458092|12269947|P2|STARTED|Overall Study||10
4987694|NCT02458092|12269948|P1|STARTED|Overall Study||20
4987695|NCT02457910|12269966|P6|NOT COMPLETED|Overall Study||11
4987696|NCT02457910|12269967|P5|NOT COMPLETED|Overall Study||5
4987697|NCT02457910|12269968|P4|NOT COMPLETED|Overall Study||2
4987698|NCT02457910|12269969|P3|NOT COMPLETED|Overall Study||3
4987699|NCT02457910|12269970|P2|NOT COMPLETED|Overall Study||5
4987700|NCT02457910|12269971|P1|NOT COMPLETED|Overall Study||3
4987701|NCT02457910|12269966|P6|COMPLETED|Overall Study||1
4987702|NCT02457910|12269967|P5|COMPLETED|Overall Study||0
4987703|NCT02457910|12269968|P4|COMPLETED|Overall Study||0
4987704|NCT02457910|12269969|P3|COMPLETED|Overall Study||0
4987705|NCT02457910|12269970|P2|COMPLETED|Overall Study||0
4987706|NCT02457910|12269971|P1|COMPLETED|Overall Study||0
4987707|NCT02457910|12269966|P6|STARTED|Overall Study||12
4987708|NCT02457910|12269967|P5|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
4987709|NCT02457910|12269968|P4|STARTED|Overall Study||2
4987710|NCT02457910|12269969|P3|STARTED|Overall Study||3
4987711|NCT02457910|12269970|P2|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
4987712|NCT02457910|12269971|P1|STARTED|Overall Study||3
4987713|NCT02457897|12269988|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
4987714|NCT02457897|12269988|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
4987715|NCT02457897|12269988|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
4987716|NCT02457897|12269988|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
4987717|NCT02457897|12269988|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
4987718|NCT02457897|12269988|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
4987719|NCT02457819|12269995|P1|NOT COMPLETED|Overall Study||99
4987720|NCT02457819|12269995|P1|COMPLETED|Overall Study||138
4987721|NCT02457819|12269995|P1|Safety Population|Overall Study||236
4987722|NCT02457819|12269995|P1|STARTED|Overall Study||237
4987723|NCT02457793|12270007|P6|NOT COMPLETED|Overall Study||6
4987724|NCT02457793|12270008|P5|NOT COMPLETED|Overall Study||4
4987725|NCT02457793|12270009|P4|NOT COMPLETED|Overall Study||5
4987726|NCT02457793|12270010|P3|NOT COMPLETED|Overall Study||3
4987727|NCT02457793|12270011|P2|NOT COMPLETED|Overall Study||4
4987728|NCT02457793|12270012|P1|NOT COMPLETED|Overall Study||1
4987729|NCT02457793|12270007|P6|COMPLETED|Overall Study||0
4987730|NCT02457793|12270008|P5|COMPLETED|Overall Study||0
4987731|NCT02457793|12270009|P4|COMPLETED|Overall Study||0
4987732|NCT02457793|12270010|P3|COMPLETED|Overall Study||0
4987733|NCT02457793|12270011|P2|COMPLETED|Overall Study||1
4987734|NCT02457793|12270012|P1|COMPLETED|Overall Study||0
4987735|NCT02457793|12270007|P6|STARTED|Overall Study||6
4987736|NCT02457793|12270008|P5|STARTED|Overall Study||4
4987737|NCT02457793|12270009|P4|STARTED|Overall Study||5
4987738|NCT02457793|12270010|P3|STARTED|Overall Study||3
4987739|NCT02457793|12270011|P2|STARTED|Overall Study||5
4987740|NCT02457793|12270012|P1|STARTED|Overall Study||1
4987741|NCT02457728|12270152|P1|NOT COMPLETED|Overall Study||0
4987742|NCT02457728|12270152|P1|COMPLETED|Overall Study||34
4987743|NCT02457728|12270152|P1|STARTED|Overall Study||34
4987744|NCT02457637|12270156|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
4987745|NCT02457637|12270156|P1|COMPLETED|Clinic or Telephone Follow-up||2529
4987746|NCT02457637|12270156|P1|One-year Death|Clinic or Telephone Follow-up||475
4987747|NCT02457637|12270156|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
4987748|NCT02457637|12270156|P1|STARTED|Clinic or Telephone Follow-up||2600
4987749|NCT02457637|12270156|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
4987750|NCT02457637|12270156|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
4987751|NCT02457637|12270156|P1|Death|28-Days Hospitalization and Observation||74
4987752|NCT02457637|12270156|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
4987753|NCT02457637|12270156|P1|STARTED|28-Days Hospitalization and Observation||2600
4987754|NCT02457637|12270156|P1|NOT COMPLETED|Recruitment||0
4987755|NCT02457637|12270156|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
4987756|NCT02457637|12270156|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
4987757|NCT02457611|12270164|P1|NOT COMPLETED|Overall Study||3
4987758|NCT02457611|12270164|P1|COMPLETED|Overall Study||23
4987759|NCT02457611|12270164|P1|STARTED|Overall Study||26
4987760|NCT02457546|12270178|P2|NOT COMPLETED|Overall Study||4
4987761|NCT02457546|12270179|P1|NOT COMPLETED|Overall Study||9
4987762|NCT02457546|12270178|P2|COMPLETED|Overall Study||116
4987763|NCT02457546|12270179|P1|COMPLETED|Overall Study||105
4987764|NCT02457546|12270178|P2|STARTED|Overall Study||120
4987765|NCT02457546|12270179|P1|STARTED|Overall Study||114
4987766|NCT02457260|12270190|P3|NOT COMPLETED|Overall Study||1
4987767|NCT02457260|12270191|P2|NOT COMPLETED|Overall Study||3
4987768|NCT02457260|12270192|P1|NOT COMPLETED|Overall Study||2
4987769|NCT02457260|12270190|P3|COMPLETED|Overall Study||1
4987770|NCT02457260|12270191|P2|COMPLETED|Overall Study||4
4987771|NCT02457260|12270192|P1|COMPLETED|Overall Study||10
4987772|NCT02457260|12270190|P3|STARTED|Overall Study||2
4987773|NCT02457260|12270191|P2|STARTED|Overall Study||7
4987774|NCT02457260|12270192|P1|STARTED|Overall Study||12
4987775|NCT02457247|12270234|P4|NOT COMPLETED|Period 2||0
4987776|NCT02457247|12270235|P3|NOT COMPLETED|Period 2||0
4987777|NCT02457247|12270236|P2|NOT COMPLETED|Period 2||3
4987778|NCT02457247|12270237|P1|NOT COMPLETED|Period 2||2
4987779|NCT02457247|12270234|P4|COMPLETED|Period 2||70
4987780|NCT02457247|12270235|P3|COMPLETED|Period 2||68
4987781|NCT02457247|12270236|P2|COMPLETED|Period 2||65
4987782|NCT02457247|12270237|P1|COMPLETED|Period 2||64
4987783|NCT02457247|12270234|P4|STARTED|Period 2||70
4987784|NCT02457247|12270235|P3|STARTED|Period 2||68
4987785|NCT02457247|12270236|P2|STARTED|Period 2||68
4987786|NCT02457247|12270237|P1|STARTED|Period 2||66
4987787|NCT02457247|12270234|P4|NOT COMPLETED|Period 1||0
4987788|NCT02457247|12270235|P3|NOT COMPLETED|Period 1||0
4987789|NCT02457247|12270236|P2|NOT COMPLETED|Period 1||2
4987790|NCT02457247|12270237|P1|NOT COMPLETED|Period 1||2
4987791|NCT02457247|12270234|P4|COMPLETED|Period 1||70
4987792|NCT02457247|12270235|P3|COMPLETED|Period 1||68
4987793|NCT02457247|12270236|P2|COMPLETED|Period 1||68
4987794|NCT02457247|12270237|P1|COMPLETED|Period 1||66
4987795|NCT02457247|12270234|P4|STARTED|Period 1||70
4987796|NCT02457247|12270235|P3|STARTED|Period 1||68
4987797|NCT02457247|12270236|P2|STARTED|Period 1||70
4987798|NCT02457247|12270237|P1|STARTED|Period 1||68
4987799|NCT02457195|12270257|P1|NOT COMPLETED|Overall Study||9
4987800|NCT02457195|12270257|P1|COMPLETED|Overall Study||41
4987801|NCT02457195|12270257|P1|STARTED|Overall Study||50
4987802|NCT02457182|12270263|P2|NOT COMPLETED|Overall Study||0
4987803|NCT02457182|12270264|P1|NOT COMPLETED|Overall Study||1
4987804|NCT02457182|12270263|P2|COMPLETED|Overall Study||11
4987805|NCT02457182|12270264|P1|COMPLETED|Overall Study||8
4987806|NCT02457182|12270263|P2|STARTED|Overall Study||11
4987807|NCT02457182|12270264|P1|STARTED|Overall Study||9
4987808|NCT02457065|12270282|P2|NOT COMPLETED|Overall Study||11
4987809|NCT02457065|12270283|P1|NOT COMPLETED|Overall Study||9
4987810|NCT02457065|12270282|P2|COMPLETED|Overall Study||16
4987811|NCT02457065|12270283|P1|COMPLETED|Overall Study||18
4987812|NCT02457065|12270282|P2|STARTED|Overall Study||27
4987813|NCT02457065|12270283|P1|STARTED|Overall Study||27
4987814|NCT02456896|12270293|P2|NOT COMPLETED|Overall Study||4
4987815|NCT02456896|12270294|P1|NOT COMPLETED|Overall Study||6
4987816|NCT02456896|12270293|P2|COMPLETED|Overall Study||21
4987817|NCT02456896|12270294|P1|COMPLETED|Overall Study||19
4987818|NCT02456896|12270293|P2|STARTED|Overall Study||25
4987819|NCT02456896|12270294|P1|STARTED|Overall Study||25
4987820|NCT02456740|12270305|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
4987821|NCT02456740|12270306|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
4987822|NCT02456740|12270307|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
4987823|NCT02456740|12270308|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
4987824|NCT02456740|12270309|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
4987825|NCT02456740|12270310|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
4987826|NCT02456740|12270311|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987827|NCT02456740|12270312|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987828|NCT02456740|12270313|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987829|NCT02456740|12270305|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
4987830|NCT02456740|12270306|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
4987831|NCT02456740|12270307|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
4987832|NCT02456740|12270308|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
4987833|NCT02456740|12270309|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
4987834|NCT02456740|12270310|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
4987835|NCT02456740|12270311|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987836|NCT02456740|12270312|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987837|NCT02456740|12270313|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
4987838|NCT02456740|12270305|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
4987839|NCT02456740|12270306|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
4987840|NCT02456740|12270307|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
4987841|NCT02456740|12270308|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
4987842|NCT02456740|12270309|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
4987843|NCT02456740|12270310|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
4987844|NCT02456740|12270311|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
4987845|NCT02456740|12270312|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
4987846|NCT02456740|12270313|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
4987847|NCT02456740|12270305|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987848|NCT02456740|12270306|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987849|NCT02456740|12270307|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987850|NCT02456740|12270308|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987851|NCT02456740|12270309|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987852|NCT02456740|12270310|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987853|NCT02456740|12270311|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
4987854|NCT02456740|12270312|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
4987855|NCT02456740|12270313|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
4987856|NCT02456740|12270305|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987857|NCT02456740|12270306|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987858|NCT02456740|12270307|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987859|NCT02456740|12270308|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987860|NCT02456740|12270309|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987861|NCT02456740|12270310|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
4987862|NCT02456740|12270311|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
4987863|NCT02456740|12270312|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
4987864|NCT02456740|12270313|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
4987865|NCT02456740|12270305|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987866|NCT02456740|12270306|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987867|NCT02456740|12270307|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987868|NCT02456740|12270308|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987869|NCT02456740|12270309|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987870|NCT02456740|12270310|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
4987871|NCT02456740|12270311|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
4987872|NCT02456740|12270312|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
4987873|NCT02456740|12270313|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
4987874|NCT02456740|12270305|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987875|NCT02456740|12270306|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987876|NCT02456740|12270307|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987877|NCT02456740|12270308|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987878|NCT02456740|12270309|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987879|NCT02456740|12270310|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
4987880|NCT02456740|12270311|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
4987881|NCT02456740|12270312|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
4987882|NCT02456740|12270313|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
4987883|NCT02456662|12270337|P2|NOT COMPLETED|Overall Study||1
4987884|NCT02456662|12270338|P1|NOT COMPLETED|Overall Study||2
4987885|NCT02456662|12270337|P2|COMPLETED|Overall Study||159
4987886|NCT02456662|12270338|P1|COMPLETED|Overall Study||157
4987887|NCT02456662|12270337|P2|STARTED|Overall Study||160
4987888|NCT02456662|12270338|P1|STARTED|Overall Study||159
4987889|NCT02456636|12270347|P3|NOT COMPLETED|Overall Study||75
4987890|NCT02456636|12270348|P2|NOT COMPLETED|Overall Study||69
4987891|NCT02456636|12270349|P1|NOT COMPLETED|Overall Study||68
4987892|NCT02456636|12270347|P3|COMPLETED|Overall Study||400
4987893|NCT02456636|12270348|P2|COMPLETED|Overall Study||410
4987894|NCT02456636|12270349|P1|COMPLETED|Overall Study||410
4987895|NCT02456636|12270347|P3|18 Month|Overall Study||461
4987896|NCT02456636|12270348|P2|18 Month|Overall Study||463
4987897|NCT02456636|12270349|P1|18 Month|Overall Study||467
4987898|NCT02456636|12270347|P3|6 Month|Overall Study||468
4987899|NCT02456636|12270348|P2|6 Month|Overall Study||474
4987900|NCT02456636|12270349|P1|6 Month|Overall Study||474
4987901|NCT02456636|12270347|P3|STARTED|Overall Study||475
4987902|NCT02456636|12270348|P2|STARTED|Overall Study||479
4987903|NCT02456636|12270349|P1|STARTED|Overall Study||478
4987904|NCT02456103|12270399|P1|NOT COMPLETED|Overall Study||246
4987905|NCT02456103|12270399|P1|COMPLETED|Overall Study||0
4987906|NCT02456103|12270399|P1|Intent-to-treat (ITT) Population|Overall Study||244
4987907|NCT02456103|12270399|P1|As-Treated Population|Overall Study||245
4987908|NCT02456103|12270399|P1|STARTED|Overall Study||246
4987909|NCT02455518|12270412|P4|NOT COMPLETED|Overall Study||3
4987910|NCT02455518|12270413|P3|NOT COMPLETED|Overall Study||1
4987911|NCT02455518|12270414|P2|NOT COMPLETED|Overall Study||1
4987912|NCT02455518|12270415|P1|NOT COMPLETED|Overall Study||0
4987913|NCT02455518|12270412|P4|COMPLETED|Overall Study||101
4987914|NCT02455518|12270413|P3|COMPLETED|Overall Study||103
4987915|NCT02455518|12270414|P2|COMPLETED|Overall Study||103
4987916|NCT02455518|12270415|P1|COMPLETED|Overall Study||104
4987917|NCT02455518|12270412|P4|STARTED|Overall Study||104
4987918|NCT02455518|12270413|P3|STARTED|Overall Study||104
4987919|NCT02455518|12270414|P2|STARTED|Overall Study||104
4987920|NCT02455518|12270415|P1|STARTED|Overall Study||104
4987921|NCT02455453|12270429|P1|NOT COMPLETED|Overall Study||0
4987922|NCT02455453|12270429|P1|COMPLETED|Overall Study||47
4987923|NCT02455453|12270429|P1|STARTED|Overall Study||47
4987924|NCT02455388|12270437|P3|NOT COMPLETED|Overall Study||11
4987925|NCT02455388|12270438|P2|NOT COMPLETED|Overall Study||0
4987926|NCT02455388|12270439|P1|NOT COMPLETED|Overall Study||1
4987927|NCT02455388|12270437|P3|COMPLETED|Overall Study||326
4987928|NCT02455388|12270438|P2|COMPLETED|Overall Study||15
4987929|NCT02455388|12270439|P1|COMPLETED|Overall Study||17
4987930|NCT02455388|12270437|P3|STARTED|Overall Study||337
4987931|NCT02455388|12270438|P2|STARTED|Overall Study||15
4987932|NCT02455388|12270439|P1|STARTED|Overall Study||18
4987933|NCT02455336|12270450|P2|NOT COMPLETED|Overall Study||2
4987934|NCT02455336|12270451|P1|NOT COMPLETED|Overall Study||5
4987935|NCT02455336|12270450|P2|COMPLETED|Overall Study||6
4987936|NCT02455336|12270451|P1|COMPLETED|Overall Study||10
4987937|NCT02455336|12270450|P2|STARTED|Overall Study||8
4987938|NCT02455336|12270451|P1|STARTED|Overall Study||15
4987939|NCT02455076|12270466|P5|NOT COMPLETED|Outpatient||12
4987940|NCT02455076|12270467|P4|NOT COMPLETED|Outpatient||6
4987941|NCT02455076|12270468|P3|NOT COMPLETED|Outpatient||0
4987942|NCT02455076|12270469|P2|NOT COMPLETED|Outpatient||0
4987943|NCT02455076|12270470|P1|NOT COMPLETED|Outpatient||0
4987944|NCT02455076|12270466|P5|COMPLETED|Outpatient||43
4987945|NCT02455076|12270467|P4|COMPLETED|Outpatient||42
4987946|NCT02455076|12270468|P3|COMPLETED|Outpatient||0
4987947|NCT02455076|12270469|P2|COMPLETED|Outpatient||0
4987948|NCT02455076|12270470|P1|COMPLETED|Outpatient||0
4987949|NCT02455076|12270466|P5|STARTED|Outpatient||55
4987950|NCT02455076|12270467|P4|STARTED|Outpatient||48
4987951|NCT02455076|12270468|P3|STARTED|Outpatient||0
4987952|NCT02455076|12270469|P2|STARTED|Outpatient||0
4987953|NCT02455076|12270470|P1|STARTED|Outpatient||0
4987954|NCT02455076|12270466|P5|NOT COMPLETED|Inpatient||0
4987955|NCT02455076|12270467|P4|NOT COMPLETED|Inpatient||0
4987956|NCT02455076|12270468|P3|NOT COMPLETED|Inpatient||0
4987957|NCT02455076|12270469|P2|NOT COMPLETED|Inpatient||1
4987958|NCT02455076|12270470|P1|NOT COMPLETED|Inpatient||4
4987959|NCT02455076|12270466|P5|COMPLETED|Inpatient||0
4987960|NCT02455076|12270467|P4|COMPLETED|Inpatient||0
4987961|NCT02455076|12270468|P3|COMPLETED|Inpatient||52
4987962|NCT02455076|12270469|P2|COMPLETED|Inpatient||50
4987963|NCT02455076|12270470|P1|COMPLETED|Inpatient||43
4987964|NCT02455076|12270466|P5|STARTED|Inpatient||0
4987965|NCT02455076|12270467|P4|STARTED|Inpatient||0
4987966|NCT02455076|12270468|P3|STARTED|Inpatient||52
4987967|NCT02455076|12270469|P2|STARTED|Inpatient||51
4987968|NCT02455076|12270470|P1|STARTED|Inpatient||47
4987969|NCT02455050|12270556|P4|NOT COMPLETED|Treatment Period 2||1
4987970|NCT02455050|12270557|P3|NOT COMPLETED|Treatment Period 2||2
4987971|NCT02455050|12270558|P2|NOT COMPLETED|Treatment Period 2||0
4987972|NCT02455050|12270559|P1|NOT COMPLETED|Treatment Period 2||1
4987973|NCT02455050|12270556|P4|COMPLETED|Treatment Period 2||17
4987974|NCT02455050|12270557|P3|COMPLETED|Treatment Period 2||17
4987975|NCT02455050|12270558|P2|COMPLETED|Treatment Period 2||18
4987976|NCT02455050|12270559|P1|COMPLETED|Treatment Period 2||18
4987977|NCT02455050|12270556|P4|STARTED|Treatment Period 2||18
4987978|NCT02455050|12270557|P3|STARTED|Treatment Period 2||19
4987979|NCT02455050|12270558|P2|STARTED|Treatment Period 2||18
4987980|NCT02455050|12270559|P1|STARTED|Treatment Period 2||19
4987981|NCT02455050|12270556|P4|NOT COMPLETED|Treatment Period 1||2
4987982|NCT02455050|12270557|P3|NOT COMPLETED|Treatment Period 1||1
4987983|NCT02455050|12270558|P2|NOT COMPLETED|Treatment Period 1||1
4987984|NCT02455050|12270559|P1|NOT COMPLETED|Treatment Period 1||1
4987985|NCT02455050|12270556|P4|COMPLETED|Treatment Period 1||18
4987986|NCT02455050|12270557|P3|COMPLETED|Treatment Period 1||19
4987987|NCT02455050|12270558|P2|COMPLETED|Treatment Period 1||18
4987988|NCT02455050|12270559|P1|COMPLETED|Treatment Period 1||19
4987989|NCT02455050|12270556|P4|STARTED|Treatment Period 1||20
4987990|NCT02455050|12270557|P3|STARTED|Treatment Period 1||20
4987991|NCT02455050|12270558|P2|STARTED|Treatment Period 1||19
4987992|NCT02455050|12270559|P1|STARTED|Treatment Period 1||20
4987993|NCT02454959|12270623|P1|NOT COMPLETED|Overall Study||9
4987994|NCT02454959|12270623|P1|COMPLETED|Overall Study||70
4987995|NCT02454959|12270623|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
4987996|NCT02454959|12270623|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
4987997|NCT02454959|12270623|P1|STARTED|Overall Study||79
4987998|NCT02454933|12270643|P2|NOT COMPLETED|Overall Study||8
4987999|NCT02454933|12270644|P1|NOT COMPLETED|Overall Study||8
4988000|NCT02454933|12270643|P2|COMPLETED|Overall Study||4
4988001|NCT02454933|12270644|P1|COMPLETED|Overall Study||9
4988002|NCT02454933|12270643|P2|Treatment Group Randomised to|Overall Study||14
4988003|NCT02454933|12270644|P1|Treatment Group Randomised to|Overall Study||15
4988004|NCT02454933|12270643|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
4988005|NCT02454933|12270644|P1|STARTED|Overall Study||17
4988006|NCT02454608|12270652|P3|NOT COMPLETED|Open Label Period||19
4988007|NCT02454608|12270653|P2|NOT COMPLETED|Open Label Period||0
4988008|NCT02454608|12270654|P1|NOT COMPLETED|Open Label Period||0
4988009|NCT02454608|12270652|P3|COMPLETED|Open Label Period||10
4988010|NCT02454608|12270653|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
4988011|NCT02454608|12270654|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
4988012|NCT02454608|12270652|P3|STARTED|Open Label Period||29
4988013|NCT02454608|12270653|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
4988014|NCT02454608|12270654|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
4988015|NCT02454608|12270652|P3|NOT COMPLETED|Double-Blind Period||0
4988016|NCT02454608|12270653|P2|NOT COMPLETED|Double-Blind Period||2
4988017|NCT02454608|12270654|P1|NOT COMPLETED|Double-Blind Period||0
4988018|NCT02454608|12270652|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
4988019|NCT02454608|12270653|P2|COMPLETED|Double-Blind Period||12
4988020|NCT02454608|12270654|P1|COMPLETED|Double-Blind Period||15
4988021|NCT02454608|12270652|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
4988022|NCT02454608|12270653|P2|STARTED|Double-Blind Period||14
4988023|NCT02454608|12270654|P1|STARTED|Double-Blind Period||15
4988024|NCT02454530|12270677|P2|NOT COMPLETED|Overall Study||127
4988025|NCT02454530|12270678|P1|NOT COMPLETED|Overall Study||70
4988026|NCT02454530|12270677|P2|COMPLETED|Overall Study||481
4988027|NCT02454530|12270678|P1|COMPLETED|Overall Study||482
4988028|NCT02454530|12270677|P2|STARTED|Overall Study||608
4988029|NCT02454530|12270678|P1|STARTED|Overall Study||552
4988030|NCT02454478|12270715|P1|NOT COMPLETED|Overall Study||1
4988031|NCT02454478|12270715|P1|COMPLETED|Overall Study||6
4988032|NCT02454478|12270715|P1|STARTED|Overall Study||7
4988033|NCT02454296|12270731|P2|NOT COMPLETED|Overall Study||0
4988034|NCT02454296|12270732|P1|NOT COMPLETED|Overall Study||0
4988035|NCT02454296|12270731|P2|COMPLETED|Overall Study||21
4988036|NCT02454296|12270732|P1|COMPLETED|Overall Study||20
4988037|NCT02454296|12270731|P2|STARTED|Overall Study||21
4988038|NCT02454296|12270732|P1|STARTED|Overall Study||20
4988039|NCT02454283|12270744|P2|NOT COMPLETED|Overall Study||0
4988040|NCT02454283|12270745|P1|NOT COMPLETED|Overall Study||0
4988041|NCT02454283|12270744|P2|COMPLETED|Overall Study||15
4988042|NCT02454283|12270745|P1|COMPLETED|Overall Study||26
4988043|NCT02454283|12270744|P2|STARTED|Overall Study||15
4988044|NCT02454283|12270745|P1|STARTED|Overall Study||26
4988045|NCT02454179|12270755|P2|NOT COMPLETED|Overall Study||39
4988046|NCT02454179|12270756|P1|NOT COMPLETED|Overall Study||39
4988047|NCT02454179|12270755|P2|COMPLETED|Overall Study||0
4988048|NCT02454179|12270756|P1|COMPLETED|Overall Study||0
4988049|NCT02454179|12270755|P2|Discontinue Study|Overall Study||39
4988050|NCT02454179|12270756|P1|Discontinue Study|Overall Study||39
4988051|NCT02454179|12270755|P2|Received Study Medication|Overall Study||37
4988052|NCT02454179|12270756|P1|Received Study Medication|Overall Study||39
4988053|NCT02454179|12270755|P2|Enrolled|Overall Study||39
4988054|NCT02454179|12270756|P1|Enrolled|Overall Study||39
4988055|NCT02454179|12270755|P2|STARTED|Overall Study||39
4988056|NCT02454179|12270756|P1|STARTED|Overall Study||39
4988057|NCT02454127|12270766|P4|NOT COMPLETED|Overall Study||20
4988058|NCT02454127|12270767|P3|NOT COMPLETED|Overall Study||14
4988059|NCT02454127|12270768|P2|NOT COMPLETED|Overall Study||14
4988060|NCT02454127|12270769|P1|NOT COMPLETED|Overall Study||19
4988061|NCT02454127|12270766|P4|COMPLETED|Overall Study||20
4988062|NCT02454127|12270767|P3|COMPLETED|Overall Study||26
4988063|NCT02454127|12270768|P2|COMPLETED|Overall Study||26
4988064|NCT02454127|12270769|P1|COMPLETED|Overall Study||21
4988065|NCT02454127|12270766|P4|STARTED|Overall Study||40
4988066|NCT02454127|12270767|P3|STARTED|Overall Study||40
4988067|NCT02454127|12270768|P2|STARTED|Overall Study||40
4988068|NCT02454127|12270769|P1|STARTED|Overall Study||40
4988069|NCT02454101|12270809|P2|NOT COMPLETED|Overall Study||7
4988070|NCT02454101|12270810|P1|NOT COMPLETED|Overall Study||5
4988071|NCT02454101|12270809|P2|COMPLETED|Overall Study||143
4988072|NCT02454101|12270810|P1|COMPLETED|Overall Study||145
4988073|NCT02454101|12270809|P2|STARTED|Overall Study||150
4988074|NCT02454101|12270810|P1|STARTED|Overall Study||150
4988075|NCT02453841|12270832|P1|NOT COMPLETED|Overall Study||3
4988076|NCT02453841|12270832|P1|COMPLETED|Overall Study||27
4988077|NCT02453841|12270832|P1|STARTED|Overall Study||30
4988078|NCT02453750|12270839|P1|NOT COMPLETED|Overall Study||0
4988079|NCT02453750|12270839|P1|COMPLETED|Overall Study||21
4988080|NCT02453750|12270839|P1|STARTED|Overall Study||21
4988081|NCT02453711|12270855|P9|NOT COMPLETED|Overall Study||13
4988082|NCT02453711|12270856|P8|NOT COMPLETED|Overall Study||7
4988083|NCT02453711|12270857|P7|NOT COMPLETED|Overall Study||3
4988084|NCT02453711|12270858|P6|NOT COMPLETED|Overall Study||6
4988085|NCT02453711|12270859|P5|NOT COMPLETED|Overall Study||2
4988086|NCT02453711|12270860|P4|NOT COMPLETED|Overall Study||7
4988087|NCT02453711|12270861|P3|NOT COMPLETED|Overall Study||9
4988088|NCT02453711|12270862|P2|NOT COMPLETED|Overall Study||7
4988089|NCT02453711|12270863|P1|NOT COMPLETED|Overall Study||11
4988090|NCT02453711|12270855|P9|COMPLETED|Overall Study||123
4988091|NCT02453711|12270856|P8|COMPLETED|Overall Study||96
4988092|NCT02453711|12270857|P7|COMPLETED|Overall Study||100
4988093|NCT02453711|12270858|P6|COMPLETED|Overall Study||96
4988094|NCT02453711|12270859|P5|COMPLETED|Overall Study||100
4988095|NCT02453711|12270860|P4|COMPLETED|Overall Study||96
4988096|NCT02453711|12270861|P3|COMPLETED|Overall Study||94
4988097|NCT02453711|12270862|P2|COMPLETED|Overall Study||95
4988098|NCT02453711|12270863|P1|COMPLETED|Overall Study||92
4988099|NCT02453711|12270855|P9|Safety Analysis Set|Overall Study||136
4988100|NCT02453711|12270856|P8|Safety Analysis Set|Overall Study||103
4988101|NCT02453711|12270857|P7|Safety Analysis Set|Overall Study||103
4988102|NCT02453711|12270858|P6|Safety Analysis Set|Overall Study||102
4988103|NCT02453711|12270859|P5|Safety Analysis Set|Overall Study||102
4988104|NCT02453711|12270860|P4|Safety Analysis Set|Overall Study||103
4988105|NCT02453711|12270861|P3|Safety Analysis Set|Overall Study||103
4988106|NCT02453711|12270862|P2|Safety Analysis Set|Overall Study||102
4988107|NCT02453711|12270863|P1|Safety Analysis Set|Overall Study||103
4988108|NCT02453711|12270855|P9|Full Analysis Set|Overall Study||136
4988109|NCT02453711|12270856|P8|Full Analysis Set|Overall Study||103
4988110|NCT02453711|12270857|P7|Full Analysis Set|Overall Study||103
4988111|NCT02453711|12270858|P6|Full Analysis Set|Overall Study||102
4988112|NCT02453711|12270859|P5|Full Analysis Set|Overall Study||102
4988113|NCT02453711|12270860|P4|Full Analysis Set|Overall Study||103
4988114|NCT02453711|12270861|P3|Full Analysis Set|Overall Study||103
4988115|NCT02453711|12270862|P2|Full Analysis Set|Overall Study||102
4988116|NCT02453711|12270863|P1|Full Analysis Set|Overall Study||103
4988117|NCT02453711|12270855|P9|STARTED|Overall Study||136
4988118|NCT02453711|12270856|P8|STARTED|Overall Study||103
4988119|NCT02453711|12270857|P7|STARTED|Overall Study||103
4988120|NCT02453711|12270858|P6|STARTED|Overall Study||102
4988121|NCT02453711|12270859|P5|STARTED|Overall Study||102
4988122|NCT02453711|12270860|P4|STARTED|Overall Study||103
4988123|NCT02453711|12270861|P3|STARTED|Overall Study||103
4988124|NCT02453711|12270862|P2|STARTED|Overall Study||102
4988125|NCT02453711|12270863|P1|STARTED|Overall Study||103
4988126|NCT02453685|12271207|P2|NOT COMPLETED|Overall Study||12
4988127|NCT02453685|12271208|P1|NOT COMPLETED|Overall Study||19
4988128|NCT02453685|12271207|P2|COMPLETED|Overall Study||155
4988129|NCT02453685|12271208|P1|COMPLETED|Overall Study||149
4988130|NCT02453685|12271207|P2|Exposed|Overall Study||166
4988131|NCT02453685|12271208|P1|Exposed|Overall Study||166
4988132|NCT02453685|12271207|P2|STARTED|Overall Study||167
4988133|NCT02453685|12271208|P1|STARTED|Overall Study||168
4988134|NCT02453672|12271223|P3|NOT COMPLETED|Overall Study||1
4988135|NCT02453672|12271224|P2|NOT COMPLETED|Overall Study||2
4988136|NCT02453672|12271225|P1|NOT COMPLETED|Overall Study||3
4988137|NCT02453672|12271223|P3|COMPLETED|Overall Study||38
4988138|NCT02453672|12271224|P2|COMPLETED|Overall Study||38
4988139|NCT02453672|12271225|P1|COMPLETED|Overall Study||37
4988140|NCT02453672|12271223|P3|STARTED|Overall Study||39
4988141|NCT02453672|12271224|P2|STARTED|Overall Study||40
4988142|NCT02453672|12271225|P1|STARTED|Overall Study||40
4988143|NCT02453581|12271242|P3|NOT COMPLETED|Overall Study||0
4988144|NCT02453581|12271243|P2|NOT COMPLETED|Overall Study||0
4988145|NCT02453581|12271244|P1|NOT COMPLETED|Overall Study||0
4988146|NCT02453581|12271242|P3|COMPLETED|Overall Study||8
4988147|NCT02453581|12271243|P2|COMPLETED|Overall Study||8
4988148|NCT02453581|12271244|P1|COMPLETED|Overall Study||8
4988149|NCT02453581|12271242|P3|STARTED|Overall Study||8
4988150|NCT02453581|12271243|P2|STARTED|Overall Study||8
4988151|NCT02453581|12271244|P1|STARTED|Overall Study||8
4988152|NCT02453555|12271266|P6|NOT COMPLETED|Extension Period||1
4988153|NCT02453555|12271267|P5|NOT COMPLETED|Extension Period||1
4988154|NCT02453555|12271268|P4|NOT COMPLETED|Extension Period||2
4988155|NCT02453555|12271269|P3|NOT COMPLETED|Extension Period||3
4988156|NCT02453555|12271270|P2|NOT COMPLETED|Extension Period||0
4988157|NCT02453555|12271271|P1|NOT COMPLETED|Extension Period||0
4988158|NCT02453555|12271266|P6|COMPLETED|Extension Period||5
4988159|NCT02453555|12271267|P5|COMPLETED|Extension Period||79
4988160|NCT02453555|12271268|P4|COMPLETED|Extension Period||49
4988161|NCT02453555|12271269|P3|COMPLETED|Extension Period||123
4988162|NCT02453555|12271270|P2|COMPLETED|Extension Period||0
4988163|NCT02453555|12271271|P1|COMPLETED|Extension Period||0
4988164|NCT02453555|12271266|P6|STARTED|Extension Period||6
4988165|NCT02453555|12271267|P5|STARTED|Extension Period||80
4988166|NCT02453555|12271268|P4|STARTED|Extension Period||51
4988167|NCT02453555|12271269|P3|STARTED|Extension Period||126
4988168|NCT02453555|12271270|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
4988169|NCT02453555|12271271|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
4988170|NCT02453555|12271266|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
4988171|NCT02453555|12271267|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
4988172|NCT02453555|12271268|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
4988173|NCT02453555|12271269|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
4988174|NCT02453555|12271270|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
4988175|NCT02453555|12271271|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
4988176|NCT02453555|12271266|P6|COMPLETED|24-week Double-blind Treatment Period||0
4988177|NCT02453555|12271267|P5|COMPLETED|24-week Double-blind Treatment Period||0
4988178|NCT02453555|12271268|P4|COMPLETED|24-week Double-blind Treatment Period||0
4988179|NCT02453555|12271269|P3|COMPLETED|24-week Double-blind Treatment Period||0
4988180|NCT02453555|12271270|P2|COMPLETED|24-week Double-blind Treatment Period||86
4988181|NCT02453555|12271271|P1|COMPLETED|24-week Double-blind Treatment Period||177
4988182|NCT02453555|12271266|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
4988183|NCT02453555|12271267|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
4988184|NCT02453555|12271268|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
4988185|NCT02453555|12271269|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
4988186|NCT02453555|12271270|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
4988187|NCT02453555|12271271|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
4988188|NCT02453386|12271287|P3|NOT COMPLETED|Overall Study||41
4988189|NCT02453386|12271288|P2|NOT COMPLETED|Overall Study||49
4988190|NCT02453386|12271289|P1|NOT COMPLETED|Overall Study||49
4988191|NCT02453386|12271287|P3|COMPLETED|Overall Study||108
4988192|NCT02453386|12271288|P2|COMPLETED|Overall Study||100
4988193|NCT02453386|12271289|P1|COMPLETED|Overall Study||102
4988194|NCT02453386|12271287|P3|STARTED|Overall Study||149
4988195|NCT02453386|12271288|P2|STARTED|Overall Study||149
4988196|NCT02453386|12271289|P1|STARTED|Overall Study||151
4988197|NCT02453360|12271315|P3|NOT COMPLETED|Overall Study||0
4988198|NCT02453360|12271316|P2|NOT COMPLETED|Overall Study||0
4988199|NCT02453360|12271317|P1|NOT COMPLETED|Overall Study||0
4988200|NCT02453360|12271315|P3|COMPLETED|Overall Study||20
4988201|NCT02453360|12271316|P2|COMPLETED|Overall Study||20
4988202|NCT02453360|12271317|P1|COMPLETED|Overall Study||20
4988203|NCT02453360|12271315|P3|STARTED|Overall Study||20
4988204|NCT02453360|12271316|P2|STARTED|Overall Study||20
4988205|NCT02453360|12271317|P1|STARTED|Overall Study||20
4988206|NCT02453347|12271337|P1|NOT COMPLETED|Overall Study||0
4988207|NCT02453347|12271337|P1|COMPLETED|Overall Study||6
4988208|NCT02453347|12271337|P1|STARTED|Overall Study||6
4988209|NCT02453321|12271353|P3|NOT COMPLETED|Overall Study||2
4988210|NCT02453321|12271354|P2|NOT COMPLETED|Overall Study||2
4988211|NCT02453321|12271355|P1|NOT COMPLETED|Overall Study||1
4988212|NCT02453321|12271353|P3|COMPLETED|Overall Study||19
4988213|NCT02453321|12271354|P2|COMPLETED|Overall Study||19
4988214|NCT02453321|12271355|P1|COMPLETED|Overall Study||19
4988215|NCT02453321|12271353|P3|STARTED|Overall Study||21
4988216|NCT02453321|12271354|P2|STARTED|Overall Study||21
4988217|NCT02453321|12271355|P1|STARTED|Overall Study||20
4988218|NCT02453282|12271375|P3|NOT COMPLETED|Overall Study||372
4988219|NCT02453282|12271376|P2|NOT COMPLETED|Overall Study||372
4988220|NCT02453282|12271377|P1|NOT COMPLETED|Overall Study||374
4988221|NCT02453282|12271375|P3|COMPLETED|Overall Study||0
4988222|NCT02453282|12271376|P2|COMPLETED|Overall Study||0
4988223|NCT02453282|12271377|P1|COMPLETED|Overall Study||0
4988224|NCT02453282|12271375|P3|Received Treatment|Overall Study||352
4988225|NCT02453282|12271376|P2|Received Treatment|Overall Study||371
4988226|NCT02453282|12271377|P1|Received Treatment|Overall Study||369
4988227|NCT02453282|12271375|P3|STARTED|Overall Study||372
4988228|NCT02453282|12271376|P2|STARTED|Overall Study||372
4988229|NCT02453282|12271377|P1|STARTED|Overall Study||374
4988230|NCT02453256|12271458|P2|NOT COMPLETED|Open Label Period||7
4988231|NCT02453256|12271459|P1|NOT COMPLETED|Open Label Period||7
4988232|NCT02453256|12271458|P2|COMPLETED|Open Label Period||85
4988233|NCT02453256|12271459|P1|COMPLETED|Open Label Period||82
4988234|NCT02453256|12271458|P2|STARTED|Open Label Period||92
4988235|NCT02453256|12271459|P1|STARTED|Open Label Period||89
4988236|NCT02453256|12271458|P2|NOT COMPLETED|Double Blind Period||9
4988237|NCT02453256|12271459|P1|NOT COMPLETED|Double Blind Period||13
4988238|NCT02453256|12271458|P2|COMPLETED|Double Blind Period||95
4988239|NCT02453256|12271459|P1|COMPLETED|Double Blind Period||93
4988240|NCT02453256|12271458|P2|STARTED|Double Blind Period||104
4988241|NCT02453256|12271459|P1|STARTED|Double Blind Period||106
4988242|NCT02453191|12271579|P1|NOT COMPLETED|Overall Study||1
4988243|NCT02453191|12271579|P1|COMPLETED|Overall Study||29
4988244|NCT02453191|12271579|P1|STARTED|Overall Study||30
4988245|NCT02453048|12271592|P5|NOT COMPLETED|Overall Study||6
4988246|NCT02453048|12271593|P4|NOT COMPLETED|Overall Study||0
4988247|NCT02453048|12271594|P3|NOT COMPLETED|Overall Study||2
4988248|NCT02453048|12271595|P2|NOT COMPLETED|Overall Study||1
4988249|NCT02453048|12271596|P1|NOT COMPLETED|Overall Study||0
4988250|NCT02453048|12271592|P5|COMPLETED|Overall Study||0
4988251|NCT02453048|12271593|P4|COMPLETED|Overall Study||12
4988252|NCT02453048|12271594|P3|COMPLETED|Overall Study||10
4988253|NCT02453048|12271595|P2|COMPLETED|Overall Study||11
4988254|NCT02453048|12271596|P1|COMPLETED|Overall Study||12
4988255|NCT02453048|12271592|P5|6-month Follow-up|Overall Study||6
4988256|NCT02453048|12271593|P4|6-month Follow-up|Overall Study||12
4988257|NCT02453048|12271594|P3|6-month Follow-up|Overall Study||12
4988258|NCT02453048|12271595|P2|6-month Follow-up|Overall Study||12
4988259|NCT02453048|12271596|P1|6-month Follow-up|Overall Study||12
4988260|NCT02453048|12271592|P5|STARTED|Overall Study||6
4988261|NCT02453048|12271593|P4|STARTED|Overall Study||12
4988262|NCT02453048|12271594|P3|STARTED|Overall Study||12
4988263|NCT02453048|12271595|P2|STARTED|Overall Study||12
4988264|NCT02453048|12271596|P1|STARTED|Overall Study||12
4988265|NCT02452944|12271620|P2|NOT COMPLETED|Overall Study||0
4988266|NCT02452944|12271621|P1|NOT COMPLETED|Overall Study||0
4988267|NCT02452944|12271620|P2|COMPLETED|Overall Study||31
4988268|NCT02452944|12271621|P1|COMPLETED|Overall Study||31
4988269|NCT02452944|12271620|P2|STARTED|Overall Study||31
4988270|NCT02452944|12271621|P1|STARTED|Overall Study||31
4988271|NCT02452931|12271629|P1|NOT COMPLETED|Overall Study||4
4988272|NCT02452931|12271629|P1|COMPLETED|Overall Study||60
4988273|NCT02452931|12271629|P1|STARTED|Overall Study||64
4988274|NCT02452892|12271656|P4|NOT COMPLETED|Follow-up||1
4988275|NCT02452892|12271657|P3|NOT COMPLETED|Follow-up||0
4988276|NCT02452892|12271658|P2|NOT COMPLETED|Follow-up||0
4988277|NCT02452892|12271659|P1|NOT COMPLETED|Follow-up||1
4988278|NCT02452892|12271656|P4|COMPLETED|Follow-up||38
4988279|NCT02452892|12271657|P3|COMPLETED|Follow-up||7
4988280|NCT02452892|12271658|P2|COMPLETED|Follow-up||7
4988281|NCT02452892|12271659|P1|COMPLETED|Follow-up||62
4988282|NCT02452892|12271656|P4|STARTED|Follow-up||39
4988283|NCT02452892|12271657|P3|STARTED|Follow-up||7
4988284|NCT02452892|12271658|P2|STARTED|Follow-up||7
4988285|NCT02452892|12271659|P1|STARTED|Follow-up||63
4988286|NCT02452892|12271656|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
4988287|NCT02452892|12271657|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
4988288|NCT02452892|12271658|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
4988289|NCT02452892|12271659|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
4988290|NCT02452892|12271656|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
4988291|NCT02452892|12271657|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
4988292|NCT02452892|12271658|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
4988293|NCT02452892|12271659|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
4988294|NCT02452892|12271656|P4|Responders|Week 2 Stratification & Re-Randomization||0
4988295|NCT02452892|12271657|P3|Responders|Week 2 Stratification & Re-Randomization||7
4988296|NCT02452892|12271658|P2|Responders|Week 2 Stratification & Re-Randomization||7
4988297|NCT02452892|12271659|P1|Responders|Week 2 Stratification & Re-Randomization||27
4988298|NCT02452892|12271656|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
4988299|NCT02452892|12271657|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
4988300|NCT02452892|12271658|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
4988301|NCT02452892|12271659|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
4988302|NCT02452892|12271656|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
4988303|NCT02452892|12271657|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
4988304|NCT02452892|12271658|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
4988305|NCT02452892|12271659|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
4988306|NCT02452892|12271656|P4|NOT COMPLETED|Week 1 Initial Randommization||0
4988307|NCT02452892|12271657|P3|NOT COMPLETED|Week 1 Initial Randommization||1
4988308|NCT02452892|12271658|P2|NOT COMPLETED|Week 1 Initial Randommization||0
4988309|NCT02452892|12271659|P1|NOT COMPLETED|Week 1 Initial Randommization||1
4988310|NCT02452892|12271656|P4|COMPLETED|Week 1 Initial Randommization||0
4988311|NCT02452892|12271657|P3|COMPLETED|Week 1 Initial Randommization||40
4988312|NCT02452892|12271658|P2|COMPLETED|Week 1 Initial Randommization||40
4988313|NCT02452892|12271659|P1|COMPLETED|Week 1 Initial Randommization||40
4988314|NCT02452892|12271656|P4|STARTED|Week 1 Initial Randommization||0
4988315|NCT02452892|12271657|P3|STARTED|Week 1 Initial Randommization||41
4988316|NCT02452892|12271658|P2|STARTED|Week 1 Initial Randommization||40
4988317|NCT02452892|12271659|P1|STARTED|Week 1 Initial Randommization||41
4988318|NCT02452554|12271694|P6|NOT COMPLETED|Overall Study||9
4988319|NCT02452554|12271695|P5|NOT COMPLETED|Overall Study||5
4988320|NCT02452554|12271696|P4|NOT COMPLETED|Overall Study||1
4988321|NCT02452554|12271697|P3|NOT COMPLETED|Overall Study||11
4988322|NCT02452554|12271698|P2|NOT COMPLETED|Overall Study||17
4988323|NCT02452554|12271699|P1|NOT COMPLETED|Overall Study||17
4988324|NCT02452554|12271694|P6|COMPLETED|Overall Study||1
4988325|NCT02452554|12271695|P5|COMPLETED|Overall Study||0
4988326|NCT02452554|12271696|P4|COMPLETED|Overall Study||0
4988327|NCT02452554|12271697|P3|COMPLETED|Overall Study||1
4988328|NCT02452554|12271698|P2|COMPLETED|Overall Study||0
4988329|NCT02452554|12271699|P1|COMPLETED|Overall Study||0
4988330|NCT02452554|12271694|P6|STARTED|Overall Study||10
4988331|NCT02452554|12271695|P5|STARTED|Overall Study||5
4988332|NCT02452554|12271696|P4|STARTED|Overall Study||1
4988333|NCT02452554|12271697|P3|STARTED|Overall Study||12
4988334|NCT02452554|12271698|P2|STARTED|Overall Study||17
4988335|NCT02452554|12271699|P1|STARTED|Overall Study||17
4988336|NCT02452528|12271716|P2|NOT COMPLETED|Overall Study||1
4988337|NCT02452528|12271717|P1|NOT COMPLETED|Overall Study||1
4988338|NCT02452528|12271716|P2|COMPLETED|Overall Study||1
4988339|NCT02452528|12271717|P1|COMPLETED|Overall Study||1
4988340|NCT02452528|12271716|P2|STARTED|Overall Study||2
4988341|NCT02452528|12271717|P1|STARTED|Overall Study||2
4988342|NCT02452463|12271752|P3|NOT COMPLETED|Overall Study||0
4988343|NCT02452463|12271753|P2|NOT COMPLETED|Overall Study||2
4988344|NCT02452463|12271754|P1|NOT COMPLETED|Overall Study||2
4988345|NCT02452463|12271752|P3|COMPLETED|Overall Study||0
4988346|NCT02452463|12271753|P2|COMPLETED|Overall Study||1
4988347|NCT02452463|12271754|P1|COMPLETED|Overall Study||3
4988348|NCT02452463|12271752|P3|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
4988349|NCT02452463|12271753|P2|STARTED|Overall Study||3
4988350|NCT02452463|12271754|P1|STARTED|Overall Study||5
4988351|NCT02452424|12271797|P11|NOT COMPLETED|Overall Study||2
4988352|NCT02452424|12271798|P10|NOT COMPLETED|Overall Study||2
4988353|NCT02452424|12271799|P9|NOT COMPLETED|Overall Study||6
4988354|NCT02452424|12271800|P8|NOT COMPLETED|Overall Study||4
4988355|NCT02452424|12271801|P7|NOT COMPLETED|Overall Study||10
4988356|NCT02452424|12271802|P6|NOT COMPLETED|Overall Study||1
4988357|NCT02452424|12271803|P5|NOT COMPLETED|Overall Study||2
4988358|NCT02452424|12271804|P4|NOT COMPLETED|Overall Study||8
4988359|NCT02452424|12271805|P3|NOT COMPLETED|Overall Study||7
4988360|NCT02452424|12271806|P2|NOT COMPLETED|Overall Study||3
4988361|NCT02452424|12271807|P1|NOT COMPLETED|Overall Study||2
4988362|NCT02452424|12271797|P11|COMPLETED|Overall Study||4
4988363|NCT02452424|12271798|P10|COMPLETED|Overall Study||1
4988364|NCT02452424|12271799|P9|COMPLETED|Overall Study||9
4988365|NCT02452424|12271800|P8|COMPLETED|Overall Study||4
4988366|NCT02452424|12271801|P7|COMPLETED|Overall Study||3
4988367|NCT02452424|12271802|P6|COMPLETED|Overall Study||5
4988368|NCT02452424|12271803|P5|COMPLETED|Overall Study||2
4988369|NCT02452424|12271804|P4|COMPLETED|Overall Study||1
4988370|NCT02452424|12271805|P3|COMPLETED|Overall Study||0
4988371|NCT02452424|12271806|P2|COMPLETED|Overall Study||0
4988372|NCT02452424|12271807|P1|COMPLETED|Overall Study||2
4988373|NCT02452424|12271797|P11|STARTED|Overall Study||6
4988374|NCT02452424|12271798|P10|STARTED|Overall Study||3
4988375|NCT02452424|12271799|P9|STARTED|Overall Study||15
4988376|NCT02452424|12271800|P8|STARTED|Overall Study||8
4988377|NCT02452424|12271801|P7|STARTED|Overall Study||13
4988378|NCT02452424|12271802|P6|STARTED|Overall Study||6
4988379|NCT02452424|12271803|P5|STARTED|Overall Study||4
4988380|NCT02452424|12271804|P4|STARTED|Overall Study||9
4988381|NCT02452424|12271805|P3|STARTED|Overall Study||7
4988382|NCT02452424|12271806|P2|STARTED|Overall Study||3
4988383|NCT02452424|12271807|P1|STARTED|Overall Study||4
4988384|NCT02452346|12271842|P1|NOT COMPLETED|Overall Study||9
4988385|NCT02452346|12271842|P1|COMPLETED|Overall Study||3
4988386|NCT02452346|12271842|P1|STARTED|Overall Study||12
4988387|NCT02452320|12271850|P2|NOT COMPLETED|Overall Study||1
4988388|NCT02452320|12271851|P1|NOT COMPLETED|Overall Study||0
4988389|NCT02452320|12271850|P2|COMPLETED|Overall Study||63
4988390|NCT02452320|12271851|P1|COMPLETED|Overall Study||64
4988391|NCT02452320|12271850|P2|STARTED|Overall Study||64
4988392|NCT02452320|12271851|P1|STARTED|Overall Study||64
4988393|NCT02452190|12271863|P2|NOT COMPLETED|Overall Study||24
4988394|NCT02452190|12271864|P1|NOT COMPLETED|Overall Study||35
4988395|NCT02452190|12271863|P2|COMPLETED|Overall Study||212
4988396|NCT02452190|12271864|P1|COMPLETED|Overall Study||197
4988397|NCT02452190|12271863|P2|Safety Population|Overall Study||237
4988398|NCT02452190|12271864|P1|Safety Population|Overall Study||231
4988399|NCT02452190|12271863|P2|Intent to Treat (ITT) Population|Overall Study||234
4988400|NCT02452190|12271864|P1|Intent to Treat (ITT) Population|Overall Study||230
4988401|NCT02452190|12271863|P2|STARTED|Overall Study||236
4988402|NCT02452190|12271864|P1|STARTED|Overall Study||232
4988403|NCT02452060|12271890|P2|NOT COMPLETED|Overall Study||0
4988404|NCT02452060|12271891|P1|NOT COMPLETED|Overall Study||0
4988405|NCT02452060|12271890|P2|COMPLETED|Overall Study||44
4988406|NCT02452060|12271891|P1|COMPLETED|Overall Study||46
4988407|NCT02452060|12271890|P2|STARTED|Overall Study||44
4988408|NCT02452060|12271891|P1|STARTED|Overall Study||46
4988409|NCT02452047|12271902|P3|NOT COMPLETED|Overall Study||2
4988410|NCT02452047|12271903|P2|NOT COMPLETED|Overall Study||5
4988411|NCT02452047|12271904|P1|NOT COMPLETED|Overall Study||4
4988412|NCT02452047|12271902|P3|COMPLETED|Overall Study||1
4988413|NCT02452047|12271903|P2|COMPLETED|Overall Study||11
4988414|NCT02452047|12271904|P1|COMPLETED|Overall Study||27
4988415|NCT02452047|12271902|P3|STARTED|Overall Study||3
4988416|NCT02452047|12271903|P2|STARTED|Overall Study||16
4988417|NCT02452047|12271904|P1|STARTED|Overall Study||31
4988418|NCT02452034|12271969|P6|NOT COMPLETED|Overall Study||3
4988419|NCT02452034|12271970|P5|NOT COMPLETED|Overall Study||1
4988420|NCT02452034|12271971|P4|NOT COMPLETED|Overall Study||1
4988421|NCT02452034|12271972|P3|NOT COMPLETED|Overall Study||1
4988422|NCT02452034|12271973|P2|NOT COMPLETED|Overall Study||1
4988423|NCT02452034|12271974|P1|NOT COMPLETED|Overall Study||2
4988424|NCT02452034|12271969|P6|COMPLETED|Overall Study||26
4988425|NCT02452034|12271970|P5|COMPLETED|Overall Study||19
4988426|NCT02452034|12271971|P4|COMPLETED|Overall Study||16
4988427|NCT02452034|12271972|P3|COMPLETED|Overall Study||14
4988428|NCT02452034|12271973|P2|COMPLETED|Overall Study||20
4988429|NCT02452034|12271974|P1|COMPLETED|Overall Study||14
4988430|NCT02452034|12271969|P6|Treated|Overall Study||29
4988431|NCT02452034|12271970|P5|Treated|Overall Study||20
4988432|NCT02452034|12271971|P4|Treated|Overall Study||16
4988433|NCT02452034|12271972|P3|Treated|Overall Study||15
4988434|NCT02452034|12271973|P2|Treated|Overall Study||21
4988435|NCT02452034|12271974|P1|Treated|Overall Study||14
4988436|NCT02452034|12271969|P6|STARTED|Overall Study||29
4988437|NCT02452034|12271970|P5|STARTED|Overall Study||20
4988438|NCT02452034|12271971|P4|STARTED|Overall Study||17
4988439|NCT02452034|12271972|P3|STARTED|Overall Study||15
4988440|NCT02452034|12271973|P2|STARTED|Overall Study||21
4988441|NCT02452034|12271974|P1|STARTED|Overall Study||16
4988442|NCT02451995|12272038|P2|NOT COMPLETED|Overall Study||0
4988443|NCT02451995|12272039|P1|NOT COMPLETED|Overall Study||0
4988444|NCT02451995|12272038|P2|COMPLETED|Overall Study||41
4988445|NCT02451995|12272039|P1|COMPLETED|Overall Study||42
4988446|NCT02451995|12272038|P2|STARTED|Overall Study||41
4988447|NCT02451995|12272039|P1|STARTED|Overall Study||42
4988448|NCT02451943|12272047|P2|NOT COMPLETED|Overall Study||24
4988449|NCT02451943|12272048|P1|NOT COMPLETED|Overall Study||20
4988450|NCT02451943|12272047|P2|COMPLETED|Overall Study||227
4988451|NCT02451943|12272048|P1|COMPLETED|Overall Study||238
4988452|NCT02451943|12272047|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
4988453|NCT02451943|12272048|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
4988454|NCT02451943|12272047|P2|Received at Least One Dose of Study Drug|Overall Study||249
4988455|NCT02451943|12272048|P1|Received at Least One Dose of Study Drug|Overall Study||257
4988456|NCT02451943|12272047|P2|STARTED|Overall Study||251
4988457|NCT02451943|12272048|P1|STARTED|Overall Study||258
4988458|NCT02451917|12272076|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
4988459|NCT02451917|12272077|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
4988460|NCT02451917|12272076|P2|COMPLETED|Second Intervention (24 Weeks)||15
4988461|NCT02451917|12272077|P1|COMPLETED|Second Intervention (24 Weeks)||14
4988462|NCT02451917|12272076|P2|STARTED|Second Intervention (24 Weeks)||15
4988463|NCT02451917|12272077|P1|STARTED|Second Intervention (24 Weeks)||14
4988464|NCT02451917|12272076|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
4988465|NCT02451917|12272077|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
4988466|NCT02451917|12272076|P2|COMPLETED|First Intervention (24 Weeks)||15
4988467|NCT02451917|12272077|P1|COMPLETED|First Intervention (24 Weeks)||14
4988468|NCT02451917|12272076|P2|STARTED|First Intervention (24 Weeks)||18
4988469|NCT02451917|12272077|P1|STARTED|First Intervention (24 Weeks)||16
4988470|NCT02451839|12272095|P3|NOT COMPLETED|Overall Study||7
4988471|NCT02451839|12272096|P2|NOT COMPLETED|Overall Study||19
4988472|NCT02451839|12272097|P1|NOT COMPLETED|Overall Study||28
4988473|NCT02451839|12272095|P3|COMPLETED|Overall Study||30
4988474|NCT02451839|12272096|P2|COMPLETED|Overall Study||40
4988475|NCT02451839|12272097|P1|COMPLETED|Overall Study||44
4988476|NCT02451839|12272095|P3|Baseline WHODAS Data Recorded|Overall Study||37
4988477|NCT02451839|12272096|P2|Baseline WHODAS Data Recorded|Overall Study||57
4988478|NCT02451839|12272097|P1|Baseline WHODAS Data Recorded|Overall Study||70
4988479|NCT02451839|12272095|P3|STARTED|Overall Study||37
4988480|NCT02451839|12272096|P2|STARTED|Overall Study||59
4988481|NCT02451839|12272097|P1|STARTED|Overall Study||72
4988482|NCT02451670|12272119|P2|NOT COMPLETED|Overall Study||696
4988483|NCT02451670|12272120|P1|NOT COMPLETED|Overall Study||714
4988484|NCT02451670|12272119|P2|COMPLETED|Overall Study||4387
4988485|NCT02451670|12272120|P1|COMPLETED|Overall Study||4550
4988486|NCT02451670|12272119|P2|STARTED|Overall Study||5083
4988487|NCT02451670|12272120|P1|STARTED|Overall Study||5264
4988488|NCT02451514|12272129|P3|NOT COMPLETED|Overall Study||0
4988489|NCT02451514|12272130|P2|NOT COMPLETED|Overall Study||0
4988490|NCT02451514|12272131|P1|NOT COMPLETED|Overall Study||0
4988491|NCT02451514|12272129|P3|COMPLETED|Overall Study||50
4988492|NCT02451514|12272130|P2|COMPLETED|Overall Study||46
4988493|NCT02451514|12272131|P1|COMPLETED|Overall Study||33
4988494|NCT02451514|12272129|P3|STARTED|Overall Study||50
4988495|NCT02451514|12272130|P2|STARTED|Overall Study||46
4988496|NCT02451514|12272131|P1|STARTED|Overall Study||33
4988497|NCT02451488|12272219|P2|NOT COMPLETED|Overall Study||0
4988498|NCT02451488|12272220|P1|NOT COMPLETED|Overall Study||0
4988499|NCT02451488|12272219|P2|COMPLETED|Overall Study||4
4988500|NCT02451488|12272220|P1|COMPLETED|Overall Study||4
4988501|NCT02451488|12272219|P2|STARTED|Overall Study||4
4988502|NCT02451488|12272220|P1|STARTED|Overall Study||4
4988503|NCT02451358|12272230|P4|NOT COMPLETED|Overall Study||0
4988504|NCT02451358|12272231|P3|NOT COMPLETED|Overall Study||1
4988505|NCT02451358|12272232|P2|NOT COMPLETED|Overall Study||2
4988506|NCT02451358|12272233|P1|NOT COMPLETED|Overall Study||1
4988507|NCT02451358|12272230|P4|COMPLETED|Overall Study||100
4988508|NCT02451358|12272231|P3|COMPLETED|Overall Study||99
4988509|NCT02451358|12272232|P2|COMPLETED|Overall Study||98
4988510|NCT02451358|12272233|P1|COMPLETED|Overall Study||99
4988511|NCT02451358|12272230|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
4988512|NCT02451358|12272231|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
4988513|NCT02451358|12272232|P2|Vaccinated at Day 28|Overall Study||98
4988514|NCT02451358|12272233|P1|Vaccinated at Day 28|Overall Study||99
4988515|NCT02451358|12272230|P4|Vaccinated at Day 0|Overall Study||100
4988516|NCT02451358|12272231|P3|Vaccinated at Day 0|Overall Study||100
4988517|NCT02451358|12272232|P2|Vaccinated at Day 0|Overall Study||100
4988518|NCT02451358|12272233|P1|Vaccinated at Day 0|Overall Study||100
4988519|NCT02451358|12272230|P4|STARTED|Overall Study||100
4988520|NCT02451358|12272231|P3|STARTED|Overall Study||100
4988521|NCT02451358|12272232|P2|STARTED|Overall Study||100
4988522|NCT02451358|12272233|P1|STARTED|Overall Study||100
4988523|NCT02451202|12272257|P2|NOT COMPLETED|Overall Study||3
4988524|NCT02451202|12272258|P1|NOT COMPLETED|Overall Study||2
4988525|NCT02451202|12272257|P2|COMPLETED|Overall Study||48
4988526|NCT02451202|12272258|P1|COMPLETED|Overall Study||49
4988527|NCT02451202|12272257|P2|STARTED|Overall Study||51
4988528|NCT02451202|12272258|P1|STARTED|Overall Study||51
4988529|NCT02451150|12272268|P2|NOT COMPLETED|Overall Study||0
4988530|NCT02451150|12272269|P1|NOT COMPLETED|Overall Study||0
4988531|NCT02451150|12272268|P2|COMPLETED|Overall Study||3
4988532|NCT02451150|12272269|P1|COMPLETED|Overall Study||3
4988533|NCT02451150|12272268|P2|STARTED|Overall Study||3
4988534|NCT02451150|12272269|P1|STARTED|Overall Study||3
4988535|NCT02451137|12272321|P2|NOT COMPLETED|Overall Study||298
4988536|NCT02451137|12272322|P1|NOT COMPLETED|Overall Study||246
4988537|NCT02451137|12272321|P2|COMPLETED|Overall Study||1355
4988538|NCT02451137|12272322|P1|COMPLETED|Overall Study||1405
4988539|NCT02451137|12272321|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
4988540|NCT02451137|12272322|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
4988541|NCT02451137|12272321|P2|Treated|Overall Study||1626
4988542|NCT02451137|12272322|P1|Treated|Overall Study||1632
4988543|NCT02451137|12272321|P2|STARTED|Overall Study||1653
4988544|NCT02451137|12272322|P1|STARTED|Overall Study||1651
4988545|NCT02451124|12272352|P1|NOT COMPLETED|Overall Study||1
4988546|NCT02451124|12272352|P1|COMPLETED|Overall Study||155
4988547|NCT02451124|12272352|P1|STARTED|Overall Study||156
4988548|NCT02451007|12272363|P1|NOT COMPLETED|Overall Study||7
4988549|NCT02451007|12272363|P1|COMPLETED|Overall Study||32
4988550|NCT02451007|12272363|P1|STARTED|Overall Study||39
4988551|NCT02450799|12272373|P3|NOT COMPLETED|Overall Study||0
4988552|NCT02450799|12272374|P2|NOT COMPLETED|Overall Study||0
4988553|NCT02450799|12272375|P1|NOT COMPLETED|Overall Study||0
4988554|NCT02450799|12272373|P3|COMPLETED|Overall Study||30
4988555|NCT02450799|12272374|P2|COMPLETED|Overall Study||37
4988556|NCT02450799|12272375|P1|COMPLETED|Overall Study||31
4988557|NCT02450799|12272373|P3|STARTED|Overall Study||30
4988558|NCT02450799|12272374|P2|STARTED|Overall Study||37
4988559|NCT02450799|12272375|P1|STARTED|Overall Study||31
4988560|NCT02450747|12272386|P1|NOT COMPLETED|Overall Study||0
4988561|NCT02450747|12272386|P1|COMPLETED|Overall Study||39
4988562|NCT02450747|12272386|P1|STARTED|Overall Study||39
4988563|NCT02450591|12272395|P1|NOT COMPLETED|Overall Study||0
4988564|NCT02450591|12272395|P1|COMPLETED|Overall Study||4
4988565|NCT02450591|12272395|P1|STARTED|Overall Study||4
4988566|NCT02450552|12272402|P3|NOT COMPLETED|Overall Study||5
4988567|NCT02450552|12272403|P2|NOT COMPLETED|Overall Study||0
4988568|NCT02450552|12272404|P1|NOT COMPLETED|Overall Study||5
4988569|NCT02450552|12272402|P3|COMPLETED|Overall Study||18
4988570|NCT02450552|12272403|P2|COMPLETED|Overall Study||23
4988571|NCT02450552|12272404|P1|COMPLETED|Overall Study||14
4988572|NCT02450552|12272402|P3|STARTED|Overall Study||23
4988573|NCT02450552|12272403|P2|STARTED|Overall Study||23
4988574|NCT02450552|12272404|P1|STARTED|Overall Study||19
4988575|NCT02450539|12272447|P2|NOT COMPLETED|Overall Study||33
4988576|NCT02450539|12272448|P1|NOT COMPLETED|Overall Study||50
4988577|NCT02450539|12272447|P2|COMPLETED|Overall Study||20
4988578|NCT02450539|12272448|P1|COMPLETED|Overall Study||56
4988579|NCT02450539|12272447|P2|Death|Overall Study||20
4988580|NCT02450539|12272448|P1|Death|Overall Study||56
4988581|NCT02450539|12272447|P2|Received at Least One Dose of Study Drug|Overall Study||52
4988582|NCT02450539|12272448|P1|Received at Least One Dose of Study Drug|Overall Study||106
4988583|NCT02450539|12272447|P2|STARTED|Overall Study||53
4988584|NCT02450539|12272448|P1|STARTED|Overall Study||106
4988585|NCT02450526|12272472|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
4988586|NCT02450526|12272473|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
4988587|NCT02450526|12272474|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
4988588|NCT02450526|12272475|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
4988589|NCT02450526|12272476|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
4988590|NCT02450526|12272472|P5|COMPLETED|OL Period (Cycles 2-5)||424
4988591|NCT02450526|12272473|P4|COMPLETED|OL Period (Cycles 2-5)||0
4988592|NCT02450526|12272474|P3|COMPLETED|OL Period (Cycles 2-5)||0
4988593|NCT02450526|12272475|P2|COMPLETED|OL Period (Cycles 2-5)||0
4988594|NCT02450526|12272476|P1|COMPLETED|OL Period (Cycles 2-5)||0
4988595|NCT02450526|12272472|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
4988596|NCT02450526|12272473|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
4988597|NCT02450526|12272474|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
4988598|NCT02450526|12272475|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
4988599|NCT02450526|12272476|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
4988600|NCT02450526|12272472|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
4988601|NCT02450526|12272473|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
4988602|NCT02450526|12272474|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
4988603|NCT02450526|12272475|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
4988604|NCT02450526|12272476|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
4988605|NCT02450526|12272472|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
4988606|NCT02450526|12272473|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
4988607|NCT02450526|12272474|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
4988608|NCT02450526|12272475|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
4988609|NCT02450526|12272476|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
4988610|NCT02450526|12272472|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
4988611|NCT02450526|12272473|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
4988612|NCT02450526|12272474|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
4988613|NCT02450526|12272475|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
4988614|NCT02450526|12272476|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
4988615|NCT02450526|12272472|P5|Safety Population|OL Period (Cycles 2-5)||465
4988616|NCT02450526|12272473|P4|Safety Population|OL Period (Cycles 2-5)||0
4988617|NCT02450526|12272474|P3|Safety Population|OL Period (Cycles 2-5)||0
4988618|NCT02450526|12272475|P2|Safety Population|OL Period (Cycles 2-5)||0
4988619|NCT02450526|12272476|P1|Safety Population|OL Period (Cycles 2-5)||0
4988620|NCT02450526|12272472|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
4988621|NCT02450526|12272473|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
4988622|NCT02450526|12272474|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
4988623|NCT02450526|12272475|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
4988624|NCT02450526|12272476|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
4988625|NCT02450526|12272472|P5|NOT COMPLETED|DB Period (Cycle 1)||0
4988626|NCT02450526|12272473|P4|NOT COMPLETED|DB Period (Cycle 1)||2
4988627|NCT02450526|12272474|P3|NOT COMPLETED|DB Period (Cycle 1)||10
4988628|NCT02450526|12272475|P2|NOT COMPLETED|DB Period (Cycle 1)||3
4988629|NCT02450526|12272476|P1|NOT COMPLETED|DB Period (Cycle 1)||31
4988630|NCT02450526|12272472|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
4988631|NCT02450526|12272473|P4|COMPLETED|DB Period (Cycle 1)||20
4988632|NCT02450526|12272474|P3|COMPLETED|DB Period (Cycle 1)||97
4988633|NCT02450526|12272475|P2|COMPLETED|DB Period (Cycle 1)||63
4988634|NCT02450526|12272476|P1|COMPLETED|DB Period (Cycle 1)||294
4988635|NCT02450526|12272472|P5|Safety Population|DB Period (Cycle 1)||0
4988636|NCT02450526|12272473|P4|Safety Population|DB Period (Cycle 1)||21
4988637|NCT02450526|12272474|P3|Safety Population|DB Period (Cycle 1)||107
4988638|NCT02450526|12272475|P2|Safety Population|DB Period (Cycle 1)||66
4988639|NCT02450526|12272476|P1|Safety Population|DB Period (Cycle 1)||326
4988640|NCT02450526|12272472|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
4988641|NCT02450526|12272473|P4|STARTED|DB Period (Cycle 1)||22
4988642|NCT02450526|12272474|P3|STARTED|DB Period (Cycle 1)||107
4988643|NCT02450526|12272475|P2|STARTED|DB Period (Cycle 1)||66
4988644|NCT02450526|12272476|P1|STARTED|DB Period (Cycle 1)||325
4988645|NCT02450383|12272563|P2|NOT COMPLETED|Overall Study||0
4988646|NCT02450383|12272564|P1|NOT COMPLETED|Overall Study||0
4988647|NCT02450383|12272563|P2|COMPLETED|Overall Study||10
4988648|NCT02450383|12272564|P1|COMPLETED|Overall Study||10
4988649|NCT02450383|12272563|P2|STARTED|Overall Study||10
4988650|NCT02450383|12272564|P1|STARTED|Overall Study||10
4988651|NCT02449915|12272578|P2|NOT COMPLETED|Overall Study||4
4988652|NCT02449915|12272579|P1|NOT COMPLETED|Overall Study||2
4988653|NCT02449915|12272578|P2|COMPLETED|Overall Study||31
4988654|NCT02449915|12272579|P1|COMPLETED|Overall Study||33
4988655|NCT02449915|12272578|P2|STARTED|Overall Study||35
4988656|NCT02449915|12272579|P1|STARTED|Overall Study||35
4988657|NCT02449902|12272587|P2|NOT COMPLETED|Overall Study||2
4988658|NCT02449902|12272588|P1|NOT COMPLETED|Overall Study||0
4988659|NCT02449902|12272587|P2|COMPLETED|Overall Study||24
4988660|NCT02449902|12272588|P1|COMPLETED|Overall Study||24
4988661|NCT02449902|12272587|P2|STARTED|Overall Study||26
4988662|NCT02449902|12272588|P1|STARTED|Overall Study||24
4988663|NCT02449889|12272615|P3|NOT COMPLETED|Overall Study||1
4988664|NCT02449889|12272616|P2|NOT COMPLETED|Overall Study||6
4988665|NCT02449889|12272617|P1|NOT COMPLETED|Overall Study||1
4988666|NCT02449889|12272615|P3|COMPLETED|Overall Study||59
4988667|NCT02449889|12272616|P2|COMPLETED|Overall Study||52
4988668|NCT02449889|12272617|P1|COMPLETED|Overall Study||57
4988669|NCT02449889|12272615|P3|STARTED|Overall Study||60
4988670|NCT02449889|12272616|P2|STARTED|Overall Study||58
4988671|NCT02449889|12272617|P1|STARTED|Overall Study||58
4988672|NCT02449798|12272643|P1|NOT COMPLETED|Overall Study||0
4988673|NCT02449798|12272643|P1|COMPLETED|Overall Study||120
4988674|NCT02449798|12272643|P1|STARTED|Overall Study||120
4988675|NCT02449473|12272657|P2|NOT COMPLETED|Overall Study||0
4988676|NCT02449473|12272658|P1|NOT COMPLETED|Overall Study||0
4988677|NCT02449473|12272657|P2|COMPLETED|Overall Study||40
4988678|NCT02449473|12272658|P1|COMPLETED|Overall Study||39
4988679|NCT02449473|12272657|P2|STARTED|Overall Study||40
4988680|NCT02449473|12272658|P1|STARTED|Overall Study||39
4988681|NCT02449356|12272674|P2|NOT COMPLETED|Overall Study||0
4988682|NCT02449356|12272675|P1|NOT COMPLETED|Overall Study||0
4988683|NCT02449356|12272674|P2|COMPLETED|Overall Study||30
4988684|NCT02449356|12272675|P1|COMPLETED|Overall Study||30
4988685|NCT02449356|12272674|P2|STARTED|Overall Study||30
4988686|NCT02449356|12272675|P1|STARTED|Overall Study||30
4988687|NCT02449291|12272694|P3|NOT COMPLETED|Overall Study||1
4988688|NCT02449291|12272695|P2|NOT COMPLETED|Overall Study||2
4988689|NCT02449291|12272696|P1|NOT COMPLETED|Overall Study||5
4988690|NCT02449291|12272694|P3|COMPLETED|Overall Study||180
4988691|NCT02449291|12272695|P2|COMPLETED|Overall Study||186
4988692|NCT02449291|12272696|P1|COMPLETED|Overall Study||186
4988693|NCT02449291|12272694|P3|STARTED|Overall Study||181
4988694|NCT02449291|12272695|P2|STARTED|Overall Study||188
4988695|NCT02449291|12272696|P1|STARTED|Overall Study||191
4988696|NCT02449174|12272733|P2|NOT COMPLETED|Overall Study||0
4988697|NCT02449174|12272734|P1|NOT COMPLETED|Overall Study||0
4988698|NCT02449174|12272733|P2|COMPLETED|Overall Study||32
4988699|NCT02449174|12272734|P1|COMPLETED|Overall Study||36
4988700|NCT02449174|12272733|P2|STARTED|Overall Study||32
4988701|NCT02449174|12272734|P1|STARTED|Overall Study||36
4988702|NCT02449044|12272742|P1|NOT COMPLETED|Overall Study||64
4988703|NCT02449044|12272742|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
4988704|NCT02449044|12272742|P1|STARTED|Overall Study||111
4988705|NCT02449018|12272763|P2|NOT COMPLETED|Overall Study||2
4988706|NCT02449018|12272764|P1|NOT COMPLETED|Overall Study||12
4988707|NCT02449018|12272763|P2|COMPLETED|Overall Study||26
4988708|NCT02449018|12272764|P1|COMPLETED|Overall Study||52
4988709|NCT02449018|12272763|P2|STARTED|Overall Study||28
4988710|NCT02449018|12272764|P1|STARTED|Overall Study||64
4988711|NCT02448914|12272791|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4988712|NCT02448914|12272792|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4988713|NCT02448914|12272791|P2|COMPLETED|Second Intervention (1 Day)||5
4988714|NCT02448914|12272792|P1|COMPLETED|Second Intervention (1 Day)||6
4988715|NCT02448914|12272791|P2|STARTED|Second Intervention (1 Day)||5
4988716|NCT02448914|12272792|P1|STARTED|Second Intervention (1 Day)||6
4988717|NCT02448914|12272791|P2|NOT COMPLETED|First Intervention (1 Day)||0
4988718|NCT02448914|12272792|P1|NOT COMPLETED|First Intervention (1 Day)||0
4988719|NCT02448914|12272791|P2|COMPLETED|First Intervention (1 Day)||5
4988720|NCT02448914|12272792|P1|COMPLETED|First Intervention (1 Day)||6
4988721|NCT02448914|12272791|P2|STARTED|First Intervention (1 Day)||5
4988722|NCT02448914|12272792|P1|STARTED|First Intervention (1 Day)||6
4988723|NCT02448875|12272811|P3|NOT COMPLETED|Overall Study||1
4988724|NCT02448875|12272812|P2|NOT COMPLETED|Overall Study||1
4988725|NCT02448875|12272813|P1|NOT COMPLETED|Overall Study||7
4988726|NCT02448875|12272811|P3|COMPLETED|Overall Study||60
4988727|NCT02448875|12272812|P2|COMPLETED|Overall Study||20
4988728|NCT02448875|12272813|P1|COMPLETED|Overall Study||53
4988729|NCT02448875|12272811|P3|Safety Analysis Set|Overall Study||61
4988730|NCT02448875|12272812|P2|Safety Analysis Set|Overall Study||21
4988731|NCT02448875|12272813|P1|Safety Analysis Set|Overall Study||60
4988732|NCT02448875|12272811|P3|Full Analysis Set|Overall Study||61
4988733|NCT02448875|12272812|P2|Full Analysis Set|Overall Study||21
4988734|NCT02448875|12272813|P1|Full Analysis Set|Overall Study||60
4988735|NCT02448875|12272811|P3|Completed Dose Selection Phase|Overall Study||20
4988736|NCT02448875|12272812|P2|Completed Dose Selection Phase|Overall Study||21
4988737|NCT02448875|12272813|P1|Completed Dose Selection Phase|Overall Study||20
4988738|NCT02448875|12272811|P3|STARTED|Overall Study||61
4988739|NCT02448875|12272812|P2|STARTED|Overall Study||21
4988740|NCT02448875|12272813|P1|STARTED|Overall Study||60
4988741|NCT02448862|12272838|P2|NOT COMPLETED|Overall Study||0
4988742|NCT02448862|12272839|P1|NOT COMPLETED|Overall Study||0
4988743|NCT02448862|12272838|P2|COMPLETED|Overall Study||6050
4988744|NCT02448862|12272839|P1|COMPLETED|Overall Study||4525
4988745|NCT02448862|12272838|P2|STARTED|Overall Study||6050
4988746|NCT02448862|12272839|P1|STARTED|Overall Study||4525
4988747|NCT02448810|12272861|P8|NOT COMPLETED|Overall Study||8
4988748|NCT02448810|12272862|P7|NOT COMPLETED|Overall Study||18
4988749|NCT02448810|12272863|P6|NOT COMPLETED|Overall Study||16
4988750|NCT02448810|12272864|P5|NOT COMPLETED|Overall Study||31
4988751|NCT02448810|12272865|P4|NOT COMPLETED|Overall Study||3
4988752|NCT02448810|12272866|P3|NOT COMPLETED|Overall Study||3
4988753|NCT02448810|12272867|P2|NOT COMPLETED|Overall Study||3
4988754|NCT02448810|12272868|P1|NOT COMPLETED|Overall Study||3
4988755|NCT02448810|12272861|P8|COMPLETED|Overall Study||0
4988756|NCT02448810|12272862|P7|COMPLETED|Overall Study||0
4988757|NCT02448810|12272863|P6|COMPLETED|Overall Study||0
4988758|NCT02448810|12272864|P5|COMPLETED|Overall Study||0
4988759|NCT02448810|12272865|P4|COMPLETED|Overall Study||0
4988760|NCT02448810|12272866|P3|COMPLETED|Overall Study||0
4988761|NCT02448810|12272867|P2|COMPLETED|Overall Study||0
4988762|NCT02448810|12272868|P1|COMPLETED|Overall Study||0
4988763|NCT02448810|12272861|P8|Treated|Overall Study||7
4988764|NCT02448810|12272862|P7|Treated|Overall Study||18
4988765|NCT02448810|12272863|P6|Treated|Overall Study||13
4988766|NCT02448810|12272864|P5|Treated|Overall Study||29
4988767|NCT02448810|12272865|P4|Treated|Overall Study||3
4988768|NCT02448810|12272866|P3|Treated|Overall Study||3
4988769|NCT02448810|12272867|P2|Treated|Overall Study||3
4988770|NCT02448810|12272868|P1|Treated|Overall Study||3
4988771|NCT02448810|12272861|P8|STARTED|Overall Study||8
4988772|NCT02448810|12272862|P7|STARTED|Overall Study||18
4988773|NCT02448810|12272863|P6|STARTED|Overall Study||16
4988774|NCT02448810|12272864|P5|STARTED|Overall Study||31
4988775|NCT02448810|12272865|P4|STARTED|Overall Study||3
4988776|NCT02448810|12272866|P3|STARTED|Overall Study||3
4988777|NCT02448810|12272867|P2|STARTED|Overall Study||3
4988778|NCT02448810|12272868|P1|STARTED|Overall Study||3
4988779|NCT02448719|12272945|P11|NOT COMPLETED|Overall Study||0
4988780|NCT02448719|12272946|P10|NOT COMPLETED|Overall Study||0
4988781|NCT02448719|12272947|P9|NOT COMPLETED|Overall Study||0
4988782|NCT02448719|12272948|P8|NOT COMPLETED|Overall Study||0
4988783|NCT02448719|12272949|P7|NOT COMPLETED|Overall Study||0
4988784|NCT02448719|12272950|P6|NOT COMPLETED|Overall Study||0
4988785|NCT02448719|12272951|P5|NOT COMPLETED|Overall Study||1
4988786|NCT02448719|12272952|P4|NOT COMPLETED|Overall Study||0
4988787|NCT02448719|12272953|P3|NOT COMPLETED|Overall Study||0
4988788|NCT02448719|12272954|P2|NOT COMPLETED|Overall Study||0
4988789|NCT02448719|12272955|P1|NOT COMPLETED|Overall Study||0
4988790|NCT02448719|12272945|P11|COMPLETED|Overall Study||6
4988791|NCT02448719|12272946|P10|COMPLETED|Overall Study||6
4988792|NCT02448719|12272947|P9|COMPLETED|Overall Study||6
4988793|NCT02448719|12272948|P8|COMPLETED|Overall Study||6
4988794|NCT02448719|12272949|P7|COMPLETED|Overall Study||6
4988795|NCT02448719|12272950|P6|COMPLETED|Overall Study||6
4988796|NCT02448719|12272951|P5|COMPLETED|Overall Study||5
4988797|NCT02448719|12272952|P4|COMPLETED|Overall Study||6
4988798|NCT02448719|12272953|P3|COMPLETED|Overall Study||6
4988799|NCT02448719|12272954|P2|COMPLETED|Overall Study||6
4988800|NCT02448719|12272955|P1|COMPLETED|Overall Study||12
4988801|NCT02448719|12272945|P11|STARTED|Overall Study||6
4988802|NCT02448719|12272946|P10|STARTED|Overall Study||6
4988803|NCT02448719|12272947|P9|STARTED|Overall Study||6
4988804|NCT02448719|12272948|P8|STARTED|Overall Study||6
4988805|NCT02448719|12272949|P7|STARTED|Overall Study||6
4988806|NCT02448719|12272950|P6|STARTED|Overall Study||6
4988807|NCT02448719|12272951|P5|STARTED|Overall Study||6
4988808|NCT02448719|12272952|P4|STARTED|Overall Study||6
4988809|NCT02448719|12272953|P3|STARTED|Overall Study||6
4988810|NCT02448719|12272954|P2|STARTED|Overall Study||6
4988811|NCT02448719|12272955|P1|STARTED|Overall Study||12
4988812|NCT02448706|12273179|P2|NOT COMPLETED|Overall Study||4
4988813|NCT02448706|12273180|P1|NOT COMPLETED|Overall Study||5
4988814|NCT02448706|12273179|P2|COMPLETED|Overall Study||20
4988815|NCT02448706|12273180|P1|COMPLETED|Overall Study||20
4988816|NCT02448706|12273179|P2|Completed Baseline Testing|Overall Study||23
4988817|NCT02448706|12273180|P1|Completed Baseline Testing|Overall Study||24
4988818|NCT02448706|12273179|P2|Withdrew for Personal Reasons|Overall Study||1
4988819|NCT02448706|12273180|P1|Withdrew for Personal Reasons|Overall Study||1
4988820|NCT02448706|12273179|P2|STARTED|Overall Study||24
4988821|NCT02448706|12273180|P1|STARTED|Overall Study||25
4988822|NCT02448641|12273195|P3|NOT COMPLETED|Overall Study||4
4988823|NCT02448641|12273196|P2|NOT COMPLETED|Overall Study||5
4988824|NCT02448641|12273197|P1|NOT COMPLETED|Overall Study||1
4988825|NCT02448641|12273195|P3|COMPLETED|Overall Study||48
4988826|NCT02448641|12273196|P2|COMPLETED|Overall Study||51
4988827|NCT02448641|12273197|P1|COMPLETED|Overall Study||54
4988828|NCT02448641|12273195|P3|STARTED|Overall Study||52
4988829|NCT02448641|12273196|P2|STARTED|Overall Study||56
4988830|NCT02448641|12273197|P1|STARTED|Overall Study||55
4988831|NCT02448563|12273230|P2|NOT COMPLETED|Overall Study||11
4988832|NCT02448563|12273231|P1|NOT COMPLETED|Overall Study||16
4988833|NCT02448563|12273230|P2|COMPLETED|Overall Study||19
4988834|NCT02448563|12273231|P1|COMPLETED|Overall Study||16
4988835|NCT02448563|12273230|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
4988836|NCT02448563|12273231|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
4988837|NCT02448537|12273253|P3|NOT COMPLETED|Overall Study||1
4988838|NCT02448537|12273254|P2|NOT COMPLETED|Overall Study||1
4988839|NCT02448537|12273255|P1|NOT COMPLETED|Overall Study||1
4988840|NCT02448537|12273253|P3|COMPLETED|Overall Study||11
4988841|NCT02448537|12273254|P2|COMPLETED|Overall Study||9
4988842|NCT02448537|12273255|P1|COMPLETED|Overall Study||19
4988843|NCT02448537|12273253|P3|STARTED|Overall Study||12
4988844|NCT02448537|12273254|P2|STARTED|Overall Study||10
4988845|NCT02448537|12273255|P1|STARTED|Overall Study||20
4988846|NCT02448368|12273271|P13|NOT COMPLETED|Overall Study||0
4988847|NCT02448368|12273272|P12|NOT COMPLETED|Overall Study||0
4988848|NCT02448368|12273273|P11|NOT COMPLETED|Overall Study||0
4988849|NCT02448368|12273274|P10|NOT COMPLETED|Overall Study||0
4988850|NCT02448368|12273275|P9|NOT COMPLETED|Overall Study||0
4988851|NCT02448368|12273276|P8|NOT COMPLETED|Overall Study||0
4988852|NCT02448368|12273277|P7|NOT COMPLETED|Overall Study||0
4988853|NCT02448368|12273278|P6|NOT COMPLETED|Overall Study||0
4988854|NCT02448368|12273279|P5|NOT COMPLETED|Overall Study||0
4988855|NCT02448368|12273280|P4|NOT COMPLETED|Overall Study||0
4988856|NCT02448368|12273281|P3|NOT COMPLETED|Overall Study||0
4988857|NCT02448368|12273282|P2|NOT COMPLETED|Overall Study||0
4988858|NCT02448368|12273283|P1|NOT COMPLETED|Overall Study||0
4988859|NCT02448368|12273271|P13|COMPLETED|Overall Study||5
4988860|NCT02448368|12273272|P12|COMPLETED|Overall Study||5
4988861|NCT02448368|12273273|P11|COMPLETED|Overall Study||5
4988862|NCT02448368|12273274|P10|COMPLETED|Overall Study||2
4988863|NCT02448368|12273275|P9|COMPLETED|Overall Study||2
4988864|NCT02448368|12273276|P8|COMPLETED|Overall Study||2
4988865|NCT02448368|12273277|P7|COMPLETED|Overall Study||2
4988866|NCT02448368|12273278|P6|COMPLETED|Overall Study||2
4988867|NCT02448368|12273279|P5|COMPLETED|Overall Study||2
4988868|NCT02448368|12273280|P4|COMPLETED|Overall Study||2
4988869|NCT02448368|12273281|P3|COMPLETED|Overall Study||2
4988870|NCT02448368|12273282|P2|COMPLETED|Overall Study||2
4988871|NCT02448368|12273283|P1|COMPLETED|Overall Study||2
4988872|NCT02448368|12273271|P13|STARTED|Overall Study||5
4988873|NCT02448368|12273272|P12|STARTED|Overall Study||5
4988874|NCT02448368|12273273|P11|STARTED|Overall Study||5
4988875|NCT02448368|12273274|P10|STARTED|Overall Study||2
4988876|NCT02448368|12273275|P9|STARTED|Overall Study||2
4988877|NCT02448368|12273276|P8|STARTED|Overall Study||2
4988878|NCT02448368|12273277|P7|STARTED|Overall Study||2
4988879|NCT02448368|12273278|P6|STARTED|Overall Study||2
4988880|NCT02448368|12273279|P5|STARTED|Overall Study||2
4988881|NCT02448368|12273280|P4|STARTED|Overall Study||2
4988882|NCT02448368|12273281|P3|STARTED|Overall Study||2
4988883|NCT02448368|12273282|P2|STARTED|Overall Study||2
4988884|NCT02448368|12273283|P1|STARTED|Overall Study||2
4988885|NCT02448303|12273360|P2|NOT COMPLETED|Overall Study||36
4988886|NCT02448303|12273361|P1|NOT COMPLETED|Overall Study||38
4988887|NCT02448303|12273360|P2|COMPLETED|Overall Study||0
4988888|NCT02448303|12273361|P1|COMPLETED|Overall Study||0
4988889|NCT02448303|12273360|P2|Discontinued Study|Overall Study||36
4988890|NCT02448303|12273361|P1|Discontinued Study|Overall Study||38
4988891|NCT02448303|12273360|P2|Received Study Medication|Overall Study||35
4988892|NCT02448303|12273361|P1|Received Study Medication|Overall Study||33
4988893|NCT02448303|12273360|P2|Enrolled|Overall Study||36
4988894|NCT02448303|12273361|P1|Enrolled|Overall Study||38
4988895|NCT02448303|12273360|P2|STARTED|Overall Study||36
4988896|NCT02448303|12273361|P1|STARTED|Overall Study||38
4988897|NCT02448043|12273369|P2|NOT COMPLETED|Overall Study||4
4988898|NCT02448043|12273370|P1|NOT COMPLETED|Overall Study||3
4988899|NCT02448043|12273369|P2|COMPLETED|Overall Study||18
4988900|NCT02448043|12273370|P1|COMPLETED|Overall Study||20
4988901|NCT02448043|12273369|P2|STARTED|Overall Study||22
4988902|NCT02448043|12273370|P1|STARTED|Overall Study||23
4988903|NCT02447952|12273388|P1|NOT COMPLETED|Overall Study||7
4988904|NCT02447952|12273388|P1|COMPLETED|Overall Study||18
4988905|NCT02447952|12273388|P1|STARTED|Overall Study||25
4988906|NCT02447926|12273440|P1|NOT COMPLETED|Overall Study||0
4988907|NCT02447926|12273440|P1|COMPLETED|Overall Study||1
4988908|NCT02447926|12273440|P1|STARTED|Overall Study||1
4988909|NCT02447887|12273445|P1|NOT COMPLETED|Overall Study||3
4988910|NCT02447887|12273445|P1|COMPLETED|Overall Study||0
4988911|NCT02447887|12273445|P1|STARTED|Overall Study||3
4988912|NCT02447848|12273458|P1|NOT COMPLETED|Overall Study||11
4988913|NCT02447848|12273458|P1|COMPLETED|Overall Study||65
4988914|NCT02447848|12273458|P1|STARTED|Overall Study||76
4988915|NCT02447458|12273470|P6|NOT COMPLETED|Overall Study||0
4988916|NCT02447458|12273471|P5|NOT COMPLETED|Overall Study||0
4988917|NCT02447458|12273472|P4|NOT COMPLETED|Overall Study||0
4988918|NCT02447458|12273473|P3|NOT COMPLETED|Overall Study||1
4988919|NCT02447458|12273474|P2|NOT COMPLETED|Overall Study||0
4988920|NCT02447458|12273475|P1|NOT COMPLETED|Overall Study||0
4988921|NCT02447458|12273470|P6|COMPLETED|Overall Study||10
4988922|NCT02447458|12273471|P5|COMPLETED|Overall Study||6
4988923|NCT02447458|12273472|P4|COMPLETED|Overall Study||6
4988924|NCT02447458|12273473|P3|COMPLETED|Overall Study||5
4988925|NCT02447458|12273474|P2|COMPLETED|Overall Study||6
4988926|NCT02447458|12273475|P1|COMPLETED|Overall Study||5
4988927|NCT02447458|12273470|P6|STARTED|Overall Study||10
4988928|NCT02447458|12273471|P5|STARTED|Overall Study||6
4988929|NCT02447458|12273472|P4|STARTED|Overall Study||6
4988930|NCT02447458|12273473|P3|STARTED|Overall Study||6
4988931|NCT02447458|12273474|P2|STARTED|Overall Study||6
4988932|NCT02447458|12273475|P1|STARTED|Overall Study||5
4988933|NCT02447432|12273573|P2|NOT COMPLETED|Epoch 002||0
4988934|NCT02447432|12273574|P1|NOT COMPLETED|Epoch 002||0
4988935|NCT02447432|12273573|P2|COMPLETED|Epoch 002||145
4988936|NCT02447432|12273574|P1|COMPLETED|Epoch 002||152
4988937|NCT02447432|12273573|P2|STARTED|Epoch 002||145
4988938|NCT02447432|12273574|P1|STARTED|Epoch 002||152
4988939|NCT02447432|12273573|P2|NOT COMPLETED|Epoch 001||13
4988940|NCT02447432|12273574|P1|NOT COMPLETED|Epoch 001||5
4988941|NCT02447432|12273573|P2|COMPLETED|Epoch 001||147
4988942|NCT02447432|12273574|P1|COMPLETED|Epoch 001||155
4988943|NCT02447432|12273573|P2|STARTED|Epoch 001||160
4988944|NCT02447432|12273574|P1|STARTED|Epoch 001||160
4988945|NCT02447328|12273606|P1|NOT COMPLETED|Overall Study||1
4988946|NCT02447328|12273606|P1|COMPLETED|Overall Study||82
4988947|NCT02447328|12273606|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
4988948|NCT02447250|12273610|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
4988949|NCT02447250|12273610|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
4988950|NCT02447250|12273610|P1|STARTED|Third Dose (360 mcg Albuterol)||13
4988951|NCT02447250|12273610|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
4988952|NCT02447250|12273610|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
4988953|NCT02447250|12273610|P1|STARTED|Second Dose (270 mcg Albuterol)||14
4988954|NCT02447250|12273610|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
4988955|NCT02447250|12273610|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
4988956|NCT02447250|12273610|P1|STARTED|First Dose (180 mcg Albuterol)||14
4988957|NCT02447133|12273621|P1|NOT COMPLETED|Overall Study||0
4988958|NCT02447133|12273621|P1|COMPLETED|Overall Study||12
4988959|NCT02447133|12273621|P1|STARTED|Overall Study||12
4988960|NCT02447081|12273627|P1|NOT COMPLETED|Overall Study||224
4988961|NCT02447081|12273627|P1|COMPLETED|Overall Study||864
4988962|NCT02447081|12273627|P1|STARTED|Overall Study||1088
4988963|NCT02447029|12273643|P2|NOT COMPLETED|Overall Study||2
4988964|NCT02447029|12273644|P1|NOT COMPLETED|Overall Study||3
4988965|NCT02447029|12273643|P2|COMPLETED|Overall Study||68
4988966|NCT02447029|12273644|P1|COMPLETED|Overall Study||69
4988967|NCT02447029|12273643|P2|Treated|Overall Study||68
4988968|NCT02447029|12273644|P1|Treated|Overall Study||69
4988969|NCT02447029|12273643|P2|STARTED|Overall Study||70
4988970|NCT02447029|12273644|P1|STARTED|Overall Study||72
4988971|NCT02446990|12273664|P2|NOT COMPLETED|Overall Study||658
4988972|NCT02446990|12273665|P1|NOT COMPLETED|Overall Study||720
4988973|NCT02446990|12273664|P2|COMPLETED|Overall Study||8894
4988974|NCT02446990|12273665|P1|COMPLETED|Overall Study||8830
4988975|NCT02446990|12273664|P2|STARTED|Overall Study||9552
4988976|NCT02446990|12273665|P1|STARTED|Overall Study||9550
4988977|NCT02446912|12273700|P3|NOT COMPLETED|Overall Study||35
4988978|NCT02446912|12273701|P2|NOT COMPLETED|Overall Study||35
4988979|NCT02446912|12273702|P1|NOT COMPLETED|Overall Study||18
4988980|NCT02446912|12273700|P3|COMPLETED|Overall Study||149
4988981|NCT02446912|12273701|P2|COMPLETED|Overall Study||145
4988982|NCT02446912|12273702|P1|COMPLETED|Overall Study||75
4988983|NCT02446912|12273700|P3|Participants Who Completed Week 52|Overall Study||157
4988984|NCT02446912|12273701|P2|Participants Who Completed Week 52|Overall Study||153
4988985|NCT02446912|12273702|P1|Participants Who Completed Week 52|Overall Study||80
4988986|NCT02446912|12273700|P3|STARTED|Overall Study||184
4988987|NCT02446912|12273701|P2|STARTED|Overall Study||180
4988988|NCT02446912|12273702|P1|STARTED|Overall Study||93
4988989|NCT02446899|12273775|P2|NOT COMPLETED|Overall Study||48
4988990|NCT02446899|12273776|P1|NOT COMPLETED|Overall Study||25
4988991|NCT02446899|12273775|P2|COMPLETED|Overall Study||136
4988992|NCT02446899|12273776|P1|COMPLETED|Overall Study||156
4988993|NCT02446899|12273775|P2|Received Study Drug|Overall Study||182
4988994|NCT02446899|12273776|P1|Received Study Drug|Overall Study||180
4988995|NCT02446899|12273775|P2|STARTED|Overall Study||184
4988996|NCT02446899|12273776|P1|STARTED|Overall Study||181
4988997|NCT02446847|12273802|P2|NOT COMPLETED|Overall Study||2
4988998|NCT02446847|12273803|P1|NOT COMPLETED|Overall Study||0
4988999|NCT02446847|12273802|P2|COMPLETED|Overall Study||6
4989000|NCT02446847|12273803|P1|COMPLETED|Overall Study||8
4989001|NCT02446847|12273802|P2|STARTED|Overall Study||8
4989002|NCT02446847|12273803|P1|STARTED|Overall Study||8
4989003|NCT02446769|12273813|P3|NOT COMPLETED|Study Period||0
4989004|NCT02446769|12273814|P2|NOT COMPLETED|Study Period||2
4989005|NCT02446769|12273815|P1|NOT COMPLETED|Study Period||0
4989006|NCT02446769|12273813|P3|COMPLETED|Study Period||3
4989007|NCT02446769|12273814|P2|COMPLETED|Study Period||2
4989008|NCT02446769|12273815|P1|COMPLETED|Study Period||0
4989009|NCT02446769|12273813|P3|STARTED|Study Period||3
4989010|NCT02446769|12273814|P2|STARTED|Study Period||4
4989011|NCT02446769|12273815|P1|STARTED|Study Period||0
4989012|NCT02446769|12273813|P3|NOT COMPLETED|Screening Period||0
4989013|NCT02446769|12273814|P2|NOT COMPLETED|Screening Period||0
4989014|NCT02446769|12273815|P1|NOT COMPLETED|Screening Period||11
4989015|NCT02446769|12273813|P3|COMPLETED|Screening Period||0
4989016|NCT02446769|12273814|P2|COMPLETED|Screening Period||0
4989017|NCT02446769|12273815|P1|COMPLETED|Screening Period||7
4989018|NCT02446769|12273813|P3|STARTED|Screening Period||0
4989019|NCT02446769|12273814|P2|STARTED|Screening Period||0
4989020|NCT02446769|12273815|P1|STARTED|Screening Period||18
4989021|NCT02446743|12273836|P2|NOT COMPLETED|Overall Study||5
4989022|NCT02446743|12273837|P1|NOT COMPLETED|Overall Study||5
4989023|NCT02446743|12273836|P2|COMPLETED|Overall Study||250
4989024|NCT02446743|12273837|P1|COMPLETED|Overall Study||271
4989025|NCT02446743|12273836|P2|STARTED|Overall Study||255
4989026|NCT02446743|12273837|P1|STARTED|Overall Study||276
4989027|NCT02446717|12273992|P5|NOT COMPLETED|Overall Study||1
4989028|NCT02446717|12273993|P4|NOT COMPLETED|Overall Study||1
4989029|NCT02446717|12273994|P3|NOT COMPLETED|Overall Study||2
4989030|NCT02446717|12273995|P2|NOT COMPLETED|Overall Study||1
4989031|NCT02446717|12273996|P1|NOT COMPLETED|Overall Study||0
4989032|NCT02446717|12273992|P5|COMPLETED|Overall Study||46
4989033|NCT02446717|12273993|P4|COMPLETED|Overall Study||43
4989034|NCT02446717|12273994|P3|COMPLETED|Overall Study||20
4989035|NCT02446717|12273995|P2|COMPLETED|Overall Study||21
4989036|NCT02446717|12273996|P1|COMPLETED|Overall Study||6
4989037|NCT02446717|12273992|P5|STARTED|Overall Study||47
4989038|NCT02446717|12273993|P4|STARTED|Overall Study||44
4989039|NCT02446717|12273994|P3|STARTED|Overall Study||22
4989040|NCT02446717|12273995|P2|STARTED|Overall Study||22
4989041|NCT02446717|12273996|P1|STARTED|Overall Study||6
4989042|NCT02446691|12274023|P1|NOT COMPLETED|Overall Study||11
4989043|NCT02446691|12274023|P1|COMPLETED|Overall Study||117
4989044|NCT02446691|12274023|P1|STARTED|Overall Study||128
4989045|NCT02446613|12274043|P2|NOT COMPLETED|Overall Study||0
4989046|NCT02446613|12274044|P1|NOT COMPLETED|Overall Study||0
4989047|NCT02446613|12274043|P2|COMPLETED|Overall Study||10
4989048|NCT02446613|12274044|P1|COMPLETED|Overall Study||6
4989049|NCT02446613|12274043|P2|STARTED|Overall Study||10
4989050|NCT02446613|12274044|P1|STARTED|Overall Study||6
4989051|NCT02446496|12274066|P1|NOT COMPLETED|Overall Study||0
4989052|NCT02446496|12274066|P1|COMPLETED|Overall Study||24
4989053|NCT02446496|12274066|P1|STARTED|Overall Study||24
4989054|NCT02446483|12274078|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
4989055|NCT02446483|12274079|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
4989056|NCT02446483|12274078|P2|COMPLETED|Period 3: Intervention Period 2||30
4989057|NCT02446483|12274079|P1|COMPLETED|Period 3: Intervention Period 2||30
4989058|NCT02446483|12274078|P2|STARTED|Period 3: Intervention Period 2||30
4989059|NCT02446483|12274079|P1|STARTED|Period 3: Intervention Period 2||30
4989060|NCT02446483|12274078|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
4989061|NCT02446483|12274079|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
4989062|NCT02446483|12274078|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
4989063|NCT02446483|12274079|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
4989064|NCT02446483|12274078|P2|STARTED|Period 2: Washout Period (7 Days)||30
4989065|NCT02446483|12274079|P1|STARTED|Period 2: Washout Period (7 Days)||30
4989066|NCT02446483|12274078|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
4989067|NCT02446483|12274079|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
4989068|NCT02446483|12274078|P2|COMPLETED|Period 1: Intervention Period 1||30
4989069|NCT02446483|12274079|P1|COMPLETED|Period 1: Intervention Period 1||30
4989070|NCT02446483|12274078|P2|STARTED|Period 1: Intervention Period 1||30
4989071|NCT02446483|12274079|P1|STARTED|Period 1: Intervention Period 1||30
4989072|NCT02446418|12274093|P2|NOT COMPLETED|Overall Study||16
4989073|NCT02446418|12274094|P1|NOT COMPLETED|Overall Study||18
4989074|NCT02446418|12274093|P2|COMPLETED|Overall Study||194
4989075|NCT02446418|12274094|P1|COMPLETED|Overall Study||192
4989076|NCT02446418|12274093|P2|STARTED|Overall Study||210
4989077|NCT02446418|12274094|P1|STARTED|Overall Study||210
4989078|NCT02446314|12274108|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
4989079|NCT02446314|12274109|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
4989080|NCT02446314|12274110|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
4989081|NCT02446314|12274111|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
4989082|NCT02446314|12274108|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
4989083|NCT02446314|12274109|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
4989084|NCT02446314|12274110|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
4989085|NCT02446314|12274111|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
4989086|NCT02446314|12274108|P4|STARTED|Thirteen to Twenty Four Weeks||29
4989087|NCT02446314|12274109|P3|STARTED|Thirteen to Twenty Four Weeks||31
4989088|NCT02446314|12274110|P2|STARTED|Thirteen to Twenty Four Weeks||29
4989089|NCT02446314|12274111|P1|STARTED|Thirteen to Twenty Four Weeks||27
4989090|NCT02446314|12274108|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
4989091|NCT02446314|12274109|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
4989092|NCT02446314|12274110|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
4989093|NCT02446314|12274111|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
4989094|NCT02446314|12274108|P4|COMPLETED|Zero to Twelve Weeks.||29
4989095|NCT02446314|12274109|P3|COMPLETED|Zero to Twelve Weeks.||31
4989096|NCT02446314|12274110|P2|COMPLETED|Zero to Twelve Weeks.||29
4989097|NCT02446314|12274111|P1|COMPLETED|Zero to Twelve Weeks.||27
4989098|NCT02446314|12274108|P4|STARTED|Zero to Twelve Weeks.||31
4989099|NCT02446314|12274109|P3|STARTED|Zero to Twelve Weeks.||31
4989100|NCT02446314|12274110|P2|STARTED|Zero to Twelve Weeks.||30
4989101|NCT02446314|12274111|P1|STARTED|Zero to Twelve Weeks.||30
4989102|NCT02446223|12274157|P1|NOT COMPLETED|Overall Study||1
4989103|NCT02446223|12274157|P1|COMPLETED|Overall Study||20
4989104|NCT02446223|12274157|P1|STARTED|Overall Study||21
4989105|NCT02446171|12274165|P4|NOT COMPLETED|Overall Study||0
4989106|NCT02446171|12274166|P3|NOT COMPLETED|Overall Study||2
4989107|NCT02446171|12274167|P2|NOT COMPLETED|Overall Study||0
4989108|NCT02446171|12274168|P1|NOT COMPLETED|Overall Study||0
4989109|NCT02446171|12274165|P4|COMPLETED|Overall Study||11
4989110|NCT02446171|12274166|P3|COMPLETED|Overall Study||9
4989111|NCT02446171|12274167|P2|COMPLETED|Overall Study||11
4989112|NCT02446171|12274168|P1|COMPLETED|Overall Study||11
4989113|NCT02446171|12274165|P4|STARTED|Overall Study||11
4989114|NCT02446171|12274166|P3|STARTED|Overall Study||11
4989115|NCT02446171|12274167|P2|STARTED|Overall Study||11
4989116|NCT02446171|12274168|P1|STARTED|Overall Study||11
4989117|NCT02446015|12274239|P2|NOT COMPLETED|Overall Study||1
4989118|NCT02446015|12274240|P1|NOT COMPLETED|Overall Study||1
4989119|NCT02446015|12274239|P2|COMPLETED|Overall Study||62
4989120|NCT02446015|12274240|P1|COMPLETED|Overall Study||33
4989121|NCT02446015|12274239|P2|STARTED|Overall Study||63
4989122|NCT02446015|12274240|P1|STARTED|Overall Study||34
4989123|NCT02445963|12274255|P4|NOT COMPLETED|Overall Study||0
4989124|NCT02445963|12274256|P3|NOT COMPLETED|Overall Study||1
4989125|NCT02445963|12274257|P2|NOT COMPLETED|Overall Study||0
4989126|NCT02445963|12274258|P1|NOT COMPLETED|Overall Study||2
4989127|NCT02445963|12274255|P4|COMPLETED|Overall Study||10
4989128|NCT02445963|12274256|P3|COMPLETED|Overall Study||9
4989129|NCT02445963|12274257|P2|COMPLETED|Overall Study||9
4989130|NCT02445963|12274258|P1|COMPLETED|Overall Study||7
4989131|NCT02445963|12274255|P4|STARTED|Overall Study||10
4989132|NCT02445963|12274256|P3|STARTED|Overall Study||10
4989133|NCT02445963|12274257|P2|STARTED|Overall Study||9
4989134|NCT02445963|12274258|P1|STARTED|Overall Study||9
4989135|NCT02445911|12274284|P4|NOT COMPLETED|Overall Study||0
4989136|NCT02445911|12274285|P3|NOT COMPLETED|Overall Study||0
4989137|NCT02445911|12274286|P2|NOT COMPLETED|Overall Study||0
4989138|NCT02445911|12274287|P1|NOT COMPLETED|Overall Study||0
4989139|NCT02445911|12274284|P4|COMPLETED|Overall Study||20
4989140|NCT02445911|12274285|P3|COMPLETED|Overall Study||21
4989141|NCT02445911|12274286|P2|COMPLETED|Overall Study||20
4989142|NCT02445911|12274287|P1|COMPLETED|Overall Study||20
4989143|NCT02445911|12274284|P4|STARTED|Overall Study||20
4989144|NCT02445911|12274285|P3|STARTED|Overall Study||21
4989145|NCT02445911|12274286|P2|STARTED|Overall Study||20
4989146|NCT02445911|12274287|P1|STARTED|Overall Study||20
4989147|NCT02445859|12274359|P2|NOT COMPLETED|Overall Study||3
4989148|NCT02445859|12274360|P1|NOT COMPLETED|Overall Study||2
4989149|NCT02445859|12274359|P2|COMPLETED|Overall Study||42
4989150|NCT02445859|12274360|P1|COMPLETED|Overall Study||43
4989151|NCT02445859|12274359|P2|STARTED|Overall Study||45
4989152|NCT02445859|12274360|P1|STARTED|Overall Study||45
4989153|NCT02445807|12274368|P2|NOT COMPLETED|Overall Study||0
4989154|NCT02445807|12274369|P1|NOT COMPLETED|Overall Study||0
4989155|NCT02445807|12274368|P2|COMPLETED|Overall Study||89
4989156|NCT02445807|12274369|P1|COMPLETED|Overall Study||176
4989157|NCT02445807|12274368|P2|STARTED|Overall Study||89
4989158|NCT02445807|12274369|P1|STARTED|Overall Study||176
4989159|NCT02445755|12274379|P1|NOT COMPLETED|Overall Study||13
4989160|NCT02445755|12274379|P1|COMPLETED|Overall Study||100
4989161|NCT02445755|12274379|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
4989162|NCT02445625|12274386|P1|NOT COMPLETED|Overall Study||0
4989163|NCT02445625|12274386|P1|COMPLETED|Overall Study||15
4989164|NCT02445625|12274386|P1|STARTED|Overall Study||15
4989165|NCT02445586|12274393|P1|NOT COMPLETED|Overall Study||39
4989166|NCT02445586|12274393|P1|COMPLETED|Overall Study||13
4989167|NCT02445586|12274393|P1|Received at Least One Dose of Study Drug|Overall Study||52
4989168|NCT02445586|12274393|P1|STARTED|Overall Study||52
4989169|NCT02445573|12274433|P2|NOT COMPLETED|Overall Study||2
4989170|NCT02445573|12274434|P1|NOT COMPLETED|Overall Study||1
4989171|NCT02445573|12274433|P2|COMPLETED|Overall Study||38
4989172|NCT02445573|12274434|P1|COMPLETED|Overall Study||39
4989173|NCT02445573|12274433|P2|STARTED|Overall Study||40
4989174|NCT02445573|12274434|P1|STARTED|Overall Study||40
4989175|NCT02445326|12274450|P2|NOT COMPLETED|Overall Study||1
4989176|NCT02445326|12274451|P1|NOT COMPLETED|Overall Study||2
4989177|NCT02445326|12274450|P2|COMPLETED|Overall Study||37
4989178|NCT02445326|12274451|P1|COMPLETED|Overall Study||33
4989179|NCT02445326|12274450|P2|STARTED|Overall Study||38
4989180|NCT02445326|12274451|P1|STARTED|Overall Study||35
4989181|NCT02445287|12274469|P2|NOT COMPLETED|Overall Study||0
4989182|NCT02445287|12274470|P1|NOT COMPLETED|Overall Study||0
4989183|NCT02445287|12274469|P2|COMPLETED|Overall Study||13
4989184|NCT02445287|12274470|P1|COMPLETED|Overall Study||35
4989185|NCT02445287|12274469|P2|STARTED|Overall Study||13
4989186|NCT02445287|12274470|P1|STARTED|Overall Study||35
4989187|NCT02445196|12274485|P2|NOT COMPLETED|Overall Study||6
4989188|NCT02445196|12274486|P1|NOT COMPLETED|Overall Study||11
4989189|NCT02445196|12274485|P2|COMPLETED|Overall Study||52
4989190|NCT02445196|12274486|P1|COMPLETED|Overall Study||51
4989191|NCT02445196|12274485|P2|STARTED|Overall Study||58
4989192|NCT02445196|12274486|P1|STARTED|Overall Study||62
4989193|NCT02445027|12274499|P1|NOT COMPLETED|Overall Study||15
4989194|NCT02445027|12274499|P1|COMPLETED|Overall Study||45
4989195|NCT02445027|12274499|P1|STARTED|Overall Study||60
4989196|NCT02445014|12274503|P1|NOT COMPLETED|Overall Study||0
4989197|NCT02445014|12274503|P1|COMPLETED|Overall Study||3
4989198|NCT02445014|12274503|P1|STARTED|Overall Study||3
4989199|NCT02444988|12274509|P2|NOT COMPLETED|Overall Study||0
4989200|NCT02444988|12274510|P1|NOT COMPLETED|Overall Study||0
4989201|NCT02444988|12274509|P2|COMPLETED|Overall Study||2735
4989202|NCT02444988|12274510|P1|COMPLETED|Overall Study||2646
4989203|NCT02444988|12274509|P2|STARTED|Overall Study||2735
4989204|NCT02444988|12274510|P1|STARTED|Overall Study||2646
4989205|NCT02444936|12274520|P2|NOT COMPLETED|Overall Study||0
4989206|NCT02444936|12274521|P1|NOT COMPLETED|Overall Study||0
4989207|NCT02444936|12274520|P2|COMPLETED|Overall Study||12
4989208|NCT02444936|12274521|P1|COMPLETED|Overall Study||10
4989209|NCT02444936|12274520|P2|STARTED|Overall Study||12
4989210|NCT02444936|12274521|P1|STARTED|Overall Study||10
4989211|NCT02444793|12274531|P4|NOT COMPLETED|Overall Study||3
4989212|NCT02444793|12274532|P3|NOT COMPLETED|Overall Study||4
4989213|NCT02444793|12274533|P2|NOT COMPLETED|Overall Study||6
4989214|NCT02444793|12274534|P1|NOT COMPLETED|Overall Study||11
4989215|NCT02444793|12274531|P4|COMPLETED|Overall Study||0
4989216|NCT02444793|12274532|P3|COMPLETED|Overall Study||0
4989217|NCT02444793|12274533|P2|COMPLETED|Overall Study||0
4989218|NCT02444793|12274534|P1|COMPLETED|Overall Study||0
4989219|NCT02444793|12274531|P4|STARTED|Overall Study||3
4989220|NCT02444793|12274532|P3|STARTED|Overall Study||4
4989221|NCT02444793|12274533|P2|STARTED|Overall Study||6
4989222|NCT02444793|12274534|P1|STARTED|Overall Study||11
4989223|NCT02444715|12274661|P2|NOT COMPLETED|Overall Study||16
4989224|NCT02444715|12274662|P1|NOT COMPLETED|Overall Study||10
4989225|NCT02444715|12274661|P2|COMPLETED|Overall Study||32
4989226|NCT02444715|12274662|P1|COMPLETED|Overall Study||36
4989227|NCT02444715|12274661|P2|STARTED|Overall Study||48
4989228|NCT02444715|12274662|P1|STARTED|Overall Study||46
4989229|NCT02444533|12274693|P2|NOT COMPLETED|Overall Study||4
4989230|NCT02444533|12274694|P1|NOT COMPLETED|Overall Study||2
4989231|NCT02444533|12274693|P2|COMPLETED|Overall Study||18
4989232|NCT02444533|12274694|P1|COMPLETED|Overall Study||15
4989233|NCT02444533|12274693|P2|STARTED|Overall Study||22
4989234|NCT02444533|12274694|P1|STARTED|Overall Study||17
4989235|NCT02444234|12274708|P2|NOT COMPLETED|Second Intervention (3 Days)||0
4989236|NCT02444234|12274709|P1|NOT COMPLETED|Second Intervention (3 Days)||0
4989237|NCT02444234|12274708|P2|COMPLETED|Second Intervention (3 Days)||5
4989238|NCT02444234|12274709|P1|COMPLETED|Second Intervention (3 Days)||6
4989239|NCT02444234|12274708|P2|STARTED|Second Intervention (3 Days)||5
4989240|NCT02444234|12274709|P1|STARTED|Second Intervention (3 Days)||6
4989241|NCT02444234|12274708|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
4989242|NCT02444234|12274709|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
4989243|NCT02444234|12274708|P2|COMPLETED|Washout (2 Day Minimum)||5
4989244|NCT02444234|12274709|P1|COMPLETED|Washout (2 Day Minimum)||6
4989245|NCT02444234|12274708|P2|STARTED|Washout (2 Day Minimum)||5
4989246|NCT02444234|12274709|P1|STARTED|Washout (2 Day Minimum)||6
4989247|NCT02444234|12274708|P2|NOT COMPLETED|First Intervention (3 Days)||0
4989248|NCT02444234|12274709|P1|NOT COMPLETED|First Intervention (3 Days)||0
4989249|NCT02444234|12274708|P2|COMPLETED|First Intervention (3 Days)||5
4989250|NCT02444234|12274709|P1|COMPLETED|First Intervention (3 Days)||6
4989251|NCT02444234|12274708|P2|STARTED|First Intervention (3 Days)||5
4989252|NCT02444234|12274709|P1|STARTED|First Intervention (3 Days)||6
4989253|NCT02444182|12274727|P2|NOT COMPLETED|Overall Study||5
4989254|NCT02444182|12274728|P1|NOT COMPLETED|Overall Study||2
4989255|NCT02444182|12274727|P2|COMPLETED|Overall Study||49
4989256|NCT02444182|12274728|P1|COMPLETED|Overall Study||52
4989257|NCT02444182|12274727|P2|STARTED|Overall Study||54
4989258|NCT02444182|12274728|P1|STARTED|Overall Study||54
4989259|NCT02444143|12274738|P2|NOT COMPLETED|Overall Study||1
4989260|NCT02444143|12274739|P1|NOT COMPLETED|Overall Study||0
4989261|NCT02444143|12274738|P2|COMPLETED|Overall Study|1 patient withdrawal|9
4989262|NCT02444143|12274739|P1|COMPLETED|Overall Study||10
4989263|NCT02444143|12274738|P2|STARTED|Overall Study||10
4989264|NCT02444143|12274739|P1|STARTED|Overall Study||10
4989265|NCT02443883|12274751|P4|NOT COMPLETED|Overall Study||5
4989266|NCT02443883|12274752|P3|NOT COMPLETED|Overall Study||1
4989267|NCT02443883|12274753|P2|NOT COMPLETED|Overall Study||4
4989268|NCT02443883|12274754|P1|NOT COMPLETED|Overall Study||6
4989269|NCT02443883|12274751|P4|COMPLETED|Overall Study||36
4989270|NCT02443883|12274752|P3|COMPLETED|Overall Study||40
4989271|NCT02443883|12274753|P2|COMPLETED|Overall Study||38
4989272|NCT02443883|12274754|P1|COMPLETED|Overall Study||34
4989273|NCT02443883|12274751|P4|Received at Least One Dose of Study Drug|Overall Study||40
4989274|NCT02443883|12274752|P3|Received at Least One Dose of Study Drug|Overall Study||41
4989275|NCT02443883|12274753|P2|Received at Least One Dose of Study Drug|Overall Study||42
4989276|NCT02443883|12274754|P1|Received at Least One Dose of Study Drug|Overall Study||38
4989277|NCT02443883|12274751|P4|STARTED|Overall Study||41
4989278|NCT02443883|12274752|P3|STARTED|Overall Study||41
4989279|NCT02443883|12274753|P2|STARTED|Overall Study||42
4989280|NCT02443883|12274754|P1|STARTED|Overall Study||40
4989281|NCT02443805|12274774|P2|NOT COMPLETED|Overall Study||127
4989282|NCT02443805|12274775|P1|NOT COMPLETED|Overall Study||213
4989283|NCT02443805|12274774|P2|COMPLETED|Overall Study||678
4989284|NCT02443805|12274775|P1|COMPLETED|Overall Study||589
4989285|NCT02443805|12274774|P2|STARTED|Overall Study||805
4989286|NCT02443805|12274775|P1|STARTED|Overall Study||802
4989287|NCT02443792|12274787|P2|NOT COMPLETED|Overall Study||2
4989288|NCT02443792|12274788|P1|NOT COMPLETED|Overall Study||7
4989289|NCT02443792|12274787|P2|COMPLETED|Overall Study||23
4989290|NCT02443792|12274788|P1|COMPLETED|Overall Study||43
4989291|NCT02443792|12274787|P2|STARTED|Overall Study||25
4989292|NCT02443792|12274788|P1|STARTED|Overall Study||50
4989293|NCT02443740|12274806|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989294|NCT02443740|12274807|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989295|NCT02443740|12274808|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989296|NCT02443740|12274809|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989297|NCT02443740|12274810|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989298|NCT02443740|12274811|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989299|NCT02443740|12274812|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989300|NCT02443740|12274813|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989301|NCT02443740|12274814|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989302|NCT02443740|12274815|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989303|NCT02443740|12274816|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4989304|NCT02443740|12274806|P11|COMPLETED|Intervention Period 4 (3 Days)||0
4989305|NCT02443740|12274807|P10|COMPLETED|Intervention Period 4 (3 Days)||0
4989306|NCT02443740|12274808|P9|COMPLETED|Intervention Period 4 (3 Days)||0
4989307|NCT02443740|12274809|P8|COMPLETED|Intervention Period 4 (3 Days)||2
4989308|NCT02443740|12274810|P7|COMPLETED|Intervention Period 4 (3 Days)||2
4989309|NCT02443740|12274811|P6|COMPLETED|Intervention Period 4 (3 Days)||2
4989310|NCT02443740|12274812|P5|COMPLETED|Intervention Period 4 (3 Days)||2
4989311|NCT02443740|12274813|P4|COMPLETED|Intervention Period 4 (3 Days)||3
4989312|NCT02443740|12274814|P3|COMPLETED|Intervention Period 4 (3 Days)||2
4989313|NCT02443740|12274815|P2|COMPLETED|Intervention Period 4 (3 Days)||2
4989314|NCT02443740|12274816|P1|COMPLETED|Intervention Period 4 (3 Days)||1
4989315|NCT02443740|12274806|P11|STARTED|Intervention Period 4 (3 Days)||0
4989316|NCT02443740|12274807|P10|STARTED|Intervention Period 4 (3 Days)||0
4989317|NCT02443740|12274808|P9|STARTED|Intervention Period 4 (3 Days)||0
4989318|NCT02443740|12274809|P8|STARTED|Intervention Period 4 (3 Days)||2
4989319|NCT02443740|12274810|P7|STARTED|Intervention Period 4 (3 Days)||2
4989320|NCT02443740|12274811|P6|STARTED|Intervention Period 4 (3 Days)||2
4989321|NCT02443740|12274812|P5|STARTED|Intervention Period 4 (3 Days)||2
4989322|NCT02443740|12274813|P4|STARTED|Intervention Period 4 (3 Days)||3
4989323|NCT02443740|12274814|P3|STARTED|Intervention Period 4 (3 Days)||2
4989324|NCT02443740|12274815|P2|STARTED|Intervention Period 4 (3 Days)||2
4989325|NCT02443740|12274816|P1|STARTED|Intervention Period 4 (3 Days)||1
4989326|NCT02443740|12274806|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989327|NCT02443740|12274807|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989328|NCT02443740|12274808|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989329|NCT02443740|12274809|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989330|NCT02443740|12274810|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989331|NCT02443740|12274811|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989332|NCT02443740|12274812|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989333|NCT02443740|12274813|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989334|NCT02443740|12274814|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989335|NCT02443740|12274815|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989336|NCT02443740|12274816|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
4989337|NCT02443740|12274806|P11|COMPLETED|Washout Period 3 (7 Days)||0
4989338|NCT02443740|12274807|P10|COMPLETED|Washout Period 3 (7 Days)||0
4989339|NCT02443740|12274808|P9|COMPLETED|Washout Period 3 (7 Days)||0
4989340|NCT02443740|12274809|P8|COMPLETED|Washout Period 3 (7 Days)||2
4989341|NCT02443740|12274810|P7|COMPLETED|Washout Period 3 (7 Days)||2
4989342|NCT02443740|12274811|P6|COMPLETED|Washout Period 3 (7 Days)||2
4989343|NCT02443740|12274812|P5|COMPLETED|Washout Period 3 (7 Days)||2
4989344|NCT02443740|12274813|P4|COMPLETED|Washout Period 3 (7 Days)||3
4989345|NCT02443740|12274814|P3|COMPLETED|Washout Period 3 (7 Days)||2
4989346|NCT02443740|12274815|P2|COMPLETED|Washout Period 3 (7 Days)||2
4989347|NCT02443740|12274816|P1|COMPLETED|Washout Period 3 (7 Days)||1
4989348|NCT02443740|12274806|P11|STARTED|Washout Period 3 (7 Days)||0
4989349|NCT02443740|12274807|P10|STARTED|Washout Period 3 (7 Days)||0
4989350|NCT02443740|12274808|P9|STARTED|Washout Period 3 (7 Days)||0
4989351|NCT02443740|12274809|P8|STARTED|Washout Period 3 (7 Days)||2
4989352|NCT02443740|12274810|P7|STARTED|Washout Period 3 (7 Days)||2
4989353|NCT02443740|12274811|P6|STARTED|Washout Period 3 (7 Days)||2
4989354|NCT02443740|12274812|P5|STARTED|Washout Period 3 (7 Days)||2
4989355|NCT02443740|12274813|P4|STARTED|Washout Period 3 (7 Days)||3
4989356|NCT02443740|12274814|P3|STARTED|Washout Period 3 (7 Days)||2
4989357|NCT02443740|12274815|P2|STARTED|Washout Period 3 (7 Days)||2
4989358|NCT02443740|12274816|P1|STARTED|Washout Period 3 (7 Days)||1
4989359|NCT02443740|12274806|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989360|NCT02443740|12274807|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989361|NCT02443740|12274808|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989362|NCT02443740|12274809|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989363|NCT02443740|12274810|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989364|NCT02443740|12274811|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989365|NCT02443740|12274812|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989366|NCT02443740|12274813|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989367|NCT02443740|12274814|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989368|NCT02443740|12274815|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989369|NCT02443740|12274816|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4989370|NCT02443740|12274806|P11|COMPLETED|Intervention Period 3 (3 Days)||0
4989371|NCT02443740|12274807|P10|COMPLETED|Intervention Period 3 (3 Days)||0
4989372|NCT02443740|12274808|P9|COMPLETED|Intervention Period 3 (3 Days)||0
4989373|NCT02443740|12274809|P8|COMPLETED|Intervention Period 3 (3 Days)||2
4989374|NCT02443740|12274810|P7|COMPLETED|Intervention Period 3 (3 Days)||2
4989375|NCT02443740|12274811|P6|COMPLETED|Intervention Period 3 (3 Days)||2
4989376|NCT02443740|12274812|P5|COMPLETED|Intervention Period 3 (3 Days)||2
4989377|NCT02443740|12274813|P4|COMPLETED|Intervention Period 3 (3 Days)||3
4989378|NCT02443740|12274814|P3|COMPLETED|Intervention Period 3 (3 Days)||2
4989379|NCT02443740|12274815|P2|COMPLETED|Intervention Period 3 (3 Days)||2
4989380|NCT02443740|12274816|P1|COMPLETED|Intervention Period 3 (3 Days)||1
4989381|NCT02443740|12274806|P11|STARTED|Intervention Period 3 (3 Days)||0
4989382|NCT02443740|12274807|P10|STARTED|Intervention Period 3 (3 Days)||0
4989383|NCT02443740|12274808|P9|STARTED|Intervention Period 3 (3 Days)||0
4989384|NCT02443740|12274809|P8|STARTED|Intervention Period 3 (3 Days)||2
4989385|NCT02443740|12274810|P7|STARTED|Intervention Period 3 (3 Days)||2
4989386|NCT02443740|12274811|P6|STARTED|Intervention Period 3 (3 Days)||2
4989387|NCT02443740|12274812|P5|STARTED|Intervention Period 3 (3 Days)||2
4989388|NCT02443740|12274813|P4|STARTED|Intervention Period 3 (3 Days)||3
4989389|NCT02443740|12274814|P3|STARTED|Intervention Period 3 (3 Days)||2
4989390|NCT02443740|12274815|P2|STARTED|Intervention Period 3 (3 Days)||2
4989391|NCT02443740|12274816|P1|STARTED|Intervention Period 3 (3 Days)||1
4989392|NCT02443740|12274806|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989393|NCT02443740|12274807|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989394|NCT02443740|12274808|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989395|NCT02443740|12274809|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989396|NCT02443740|12274810|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989397|NCT02443740|12274811|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989398|NCT02443740|12274812|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989399|NCT02443740|12274813|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989400|NCT02443740|12274814|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989401|NCT02443740|12274815|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989402|NCT02443740|12274816|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4989403|NCT02443740|12274806|P11|COMPLETED|Washout Period 2 (7 Days)||0
4989404|NCT02443740|12274807|P10|COMPLETED|Washout Period 2 (7 Days)||0
4989405|NCT02443740|12274808|P9|COMPLETED|Washout Period 2 (7 Days)||0
4989406|NCT02443740|12274809|P8|COMPLETED|Washout Period 2 (7 Days)||2
4989407|NCT02443740|12274810|P7|COMPLETED|Washout Period 2 (7 Days)||2
4989408|NCT02443740|12274811|P6|COMPLETED|Washout Period 2 (7 Days)||2
4989409|NCT02443740|12274812|P5|COMPLETED|Washout Period 2 (7 Days)||2
4989410|NCT02443740|12274813|P4|COMPLETED|Washout Period 2 (7 Days)||3
4989411|NCT02443740|12274814|P3|COMPLETED|Washout Period 2 (7 Days)||2
4989412|NCT02443740|12274815|P2|COMPLETED|Washout Period 2 (7 Days)||2
4989413|NCT02443740|12274816|P1|COMPLETED|Washout Period 2 (7 Days)||1
4989414|NCT02443740|12274806|P11|STARTED|Washout Period 2 (7 Days)||0
4989415|NCT02443740|12274807|P10|STARTED|Washout Period 2 (7 Days)||0
4989416|NCT02443740|12274808|P9|STARTED|Washout Period 2 (7 Days)||0
4989417|NCT02443740|12274809|P8|STARTED|Washout Period 2 (7 Days)||2
4989418|NCT02443740|12274810|P7|STARTED|Washout Period 2 (7 Days)||2
4989419|NCT02443740|12274811|P6|STARTED|Washout Period 2 (7 Days)||2
4989420|NCT02443740|12274812|P5|STARTED|Washout Period 2 (7 Days)||2
4989421|NCT02443740|12274813|P4|STARTED|Washout Period 2 (7 Days)||3
4989422|NCT02443740|12274814|P3|STARTED|Washout Period 2 (7 Days)||2
4989423|NCT02443740|12274815|P2|STARTED|Washout Period 2 (7 Days)||2
4989424|NCT02443740|12274816|P1|STARTED|Washout Period 2 (7 Days)||1
4989425|NCT02443740|12274806|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989426|NCT02443740|12274807|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989427|NCT02443740|12274808|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989428|NCT02443740|12274809|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989429|NCT02443740|12274810|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989430|NCT02443740|12274811|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989431|NCT02443740|12274812|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989432|NCT02443740|12274813|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989433|NCT02443740|12274814|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989434|NCT02443740|12274815|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989435|NCT02443740|12274816|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4989436|NCT02443740|12274806|P11|COMPLETED|Intervention Period 2 (3 Days)||3
4989437|NCT02443740|12274807|P10|COMPLETED|Intervention Period 2 (3 Days)||3
4989438|NCT02443740|12274808|P9|COMPLETED|Intervention Period 2 (3 Days)||0
4989439|NCT02443740|12274809|P8|COMPLETED|Intervention Period 2 (3 Days)||2
4989440|NCT02443740|12274810|P7|COMPLETED|Intervention Period 2 (3 Days)||2
4989441|NCT02443740|12274811|P6|COMPLETED|Intervention Period 2 (3 Days)||2
4989442|NCT02443740|12274812|P5|COMPLETED|Intervention Period 2 (3 Days)||2
4989443|NCT02443740|12274813|P4|COMPLETED|Intervention Period 2 (3 Days)||3
4989444|NCT02443740|12274814|P3|COMPLETED|Intervention Period 2 (3 Days)||2
4989445|NCT02443740|12274815|P2|COMPLETED|Intervention Period 2 (3 Days)||2
4989446|NCT02443740|12274816|P1|COMPLETED|Intervention Period 2 (3 Days)||1
4989447|NCT02443740|12274806|P11|STARTED|Intervention Period 2 (3 Days)||3
4989448|NCT02443740|12274807|P10|STARTED|Intervention Period 2 (3 Days)||3
4989449|NCT02443740|12274808|P9|STARTED|Intervention Period 2 (3 Days)||0
4989450|NCT02443740|12274809|P8|STARTED|Intervention Period 2 (3 Days)||2
4989451|NCT02443740|12274810|P7|STARTED|Intervention Period 2 (3 Days)||2
4989452|NCT02443740|12274811|P6|STARTED|Intervention Period 2 (3 Days)||2
4989453|NCT02443740|12274812|P5|STARTED|Intervention Period 2 (3 Days)||2
4989454|NCT02443740|12274813|P4|STARTED|Intervention Period 2 (3 Days)||3
4989455|NCT02443740|12274814|P3|STARTED|Intervention Period 2 (3 Days)||2
4989456|NCT02443740|12274815|P2|STARTED|Intervention Period 2 (3 Days)||2
4989457|NCT02443740|12274816|P1|STARTED|Intervention Period 2 (3 Days)||1
4989458|NCT02443740|12274806|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989459|NCT02443740|12274807|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989460|NCT02443740|12274808|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989461|NCT02443740|12274809|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989462|NCT02443740|12274810|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989463|NCT02443740|12274811|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989464|NCT02443740|12274812|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989465|NCT02443740|12274813|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989466|NCT02443740|12274814|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989467|NCT02443740|12274815|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989468|NCT02443740|12274816|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4989469|NCT02443740|12274806|P11|COMPLETED|Washout Period 1 (7 Days)||3
4989470|NCT02443740|12274807|P10|COMPLETED|Washout Period 1 (7 Days)||3
4989471|NCT02443740|12274808|P9|COMPLETED|Washout Period 1 (7 Days)||0
4989472|NCT02443740|12274809|P8|COMPLETED|Washout Period 1 (7 Days)||2
4989473|NCT02443740|12274810|P7|COMPLETED|Washout Period 1 (7 Days)||2
4989474|NCT02443740|12274811|P6|COMPLETED|Washout Period 1 (7 Days)||2
4989475|NCT02443740|12274812|P5|COMPLETED|Washout Period 1 (7 Days)||2
4989476|NCT02443740|12274813|P4|COMPLETED|Washout Period 1 (7 Days)||3
4989477|NCT02443740|12274814|P3|COMPLETED|Washout Period 1 (7 Days)||2
4989478|NCT02443740|12274815|P2|COMPLETED|Washout Period 1 (7 Days)||2
4989479|NCT02443740|12274816|P1|COMPLETED|Washout Period 1 (7 Days)||1
4989480|NCT02443740|12274806|P11|STARTED|Washout Period 1 (7 Days)||3
4989481|NCT02443740|12274807|P10|STARTED|Washout Period 1 (7 Days)||3
4989482|NCT02443740|12274808|P9|STARTED|Washout Period 1 (7 Days)||0
4989483|NCT02443740|12274809|P8|STARTED|Washout Period 1 (7 Days)||2
4989484|NCT02443740|12274810|P7|STARTED|Washout Period 1 (7 Days)||2
4989485|NCT02443740|12274811|P6|STARTED|Washout Period 1 (7 Days)||2
4989486|NCT02443740|12274812|P5|STARTED|Washout Period 1 (7 Days)||2
4989487|NCT02443740|12274813|P4|STARTED|Washout Period 1 (7 Days)||3
4989488|NCT02443740|12274814|P3|STARTED|Washout Period 1 (7 Days)||2
4989489|NCT02443740|12274815|P2|STARTED|Washout Period 1 (7 Days)||2
4989490|NCT02443740|12274816|P1|STARTED|Washout Period 1 (7 Days)||1
4989491|NCT02443740|12274806|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989492|NCT02443740|12274807|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989493|NCT02443740|12274808|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989494|NCT02443740|12274809|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989495|NCT02443740|12274810|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
4989496|NCT02443740|12274811|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
4989497|NCT02443740|12274812|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989498|NCT02443740|12274813|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989499|NCT02443740|12274814|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989500|NCT02443740|12274815|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4989501|NCT02443740|12274816|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
4989502|NCT02443740|12274806|P11|COMPLETED|Intervention Period 1 (3 Days)||3
4989503|NCT02443740|12274807|P10|COMPLETED|Intervention Period 1 (3 Days)||3
4989504|NCT02443740|12274808|P9|COMPLETED|Intervention Period 1 (3 Days)||6
4989505|NCT02443740|12274809|P8|COMPLETED|Intervention Period 1 (3 Days)||2
4989506|NCT02443740|12274810|P7|COMPLETED|Intervention Period 1 (3 Days)||2
4989507|NCT02443740|12274811|P6|COMPLETED|Intervention Period 1 (3 Days)||2
4989508|NCT02443740|12274812|P5|COMPLETED|Intervention Period 1 (3 Days)||2
4989509|NCT02443740|12274813|P4|COMPLETED|Intervention Period 1 (3 Days)||3
4989510|NCT02443740|12274814|P3|COMPLETED|Intervention Period 1 (3 Days)||2
4989511|NCT02443740|12274815|P2|COMPLETED|Intervention Period 1 (3 Days)||2
4989512|NCT02443740|12274816|P1|COMPLETED|Intervention Period 1 (3 Days)||1
4989513|NCT02443740|12274806|P11|STARTED|Intervention Period 1 (3 Days)||3
4989514|NCT02443740|12274807|P10|STARTED|Intervention Period 1 (3 Days)||3
4989515|NCT02443740|12274808|P9|STARTED|Intervention Period 1 (3 Days)||6
4989516|NCT02443740|12274809|P8|STARTED|Intervention Period 1 (3 Days)||2
4989517|NCT02443740|12274810|P7|STARTED|Intervention Period 1 (3 Days)||3
4989518|NCT02443740|12274811|P6|STARTED|Intervention Period 1 (3 Days)||4
4989519|NCT02443740|12274812|P5|STARTED|Intervention Period 1 (3 Days)||2
4989520|NCT02443740|12274813|P4|STARTED|Intervention Period 1 (3 Days)||3
4989521|NCT02443740|12274814|P3|STARTED|Intervention Period 1 (3 Days)||2
4989522|NCT02443740|12274815|P2|STARTED|Intervention Period 1 (3 Days)||2
4989523|NCT02443740|12274816|P1|STARTED|Intervention Period 1 (3 Days)||2
4989524|NCT02443688|12274998|P3|NOT COMPLETED|Overall Study||12
4989525|NCT02443688|12274999|P2|NOT COMPLETED|Overall Study||9
4989526|NCT02443688|12275000|P1|NOT COMPLETED|Overall Study||12
4989527|NCT02443688|12274998|P3|COMPLETED|Overall Study||55
4989528|NCT02443688|12274999|P2|COMPLETED|Overall Study||58
4989529|NCT02443688|12275000|P1|COMPLETED|Overall Study||54
4989530|NCT02443688|12274998|P3|STARTED|Overall Study||67
4989531|NCT02443688|12274999|P2|STARTED|Overall Study||67
4989532|NCT02443688|12275000|P1|STARTED|Overall Study||66
4989533|NCT02443571|12275065|P3|NOT COMPLETED|Overall Study||0
4989534|NCT02443571|12275066|P2|NOT COMPLETED|Overall Study||0
4989535|NCT02443571|12275067|P1|NOT COMPLETED|Overall Study||0
4989536|NCT02443571|12275065|P3|COMPLETED|Overall Study||23
4989537|NCT02443571|12275066|P2|COMPLETED|Overall Study||95
4989538|NCT02443571|12275067|P1|COMPLETED|Overall Study||596
4989539|NCT02443571|12275065|P3|STARTED|Overall Study||23
4989540|NCT02443571|12275066|P2|STARTED|Overall Study||95
4989541|NCT02443571|12275067|P1|STARTED|Overall Study||596
4989542|NCT02443402|12275079|P2|NOT COMPLETED|Overall Study||3
4989543|NCT02443402|12275080|P1|NOT COMPLETED|Overall Study||4
4989544|NCT02443402|12275079|P2|COMPLETED|Overall Study||28
4989545|NCT02443402|12275080|P1|COMPLETED|Overall Study||32
4989546|NCT02443402|12275079|P2|STARTED|Overall Study||31
4989547|NCT02443402|12275080|P1|STARTED|Overall Study||36
4989548|NCT02443298|12275142|P2|NOT COMPLETED|Overall Study||5
4989549|NCT02443298|12275143|P1|NOT COMPLETED|Overall Study||4
4989550|NCT02443298|12275142|P2|COMPLETED|Overall Study||104
4989551|NCT02443298|12275143|P1|COMPLETED|Overall Study||101
4989552|NCT02443298|12275142|P2|STARTED|Overall Study||109
4989553|NCT02443298|12275143|P1|STARTED|Overall Study||105
4989554|NCT02443103|12275163|P1|NOT COMPLETED|Overall Study||3
4989555|NCT02443103|12275163|P1|COMPLETED|Overall Study||1
4989556|NCT02443103|12275163|P1|STARTED|Overall Study||4
4989557|NCT02442856|12275168|P1|NOT COMPLETED|Overall Study||0
4989558|NCT02442856|12275168|P1|COMPLETED|Overall Study||21
4989559|NCT02442856|12275168|P1|STARTED|Overall Study||21
4989560|NCT02442830|12275176|P2|NOT COMPLETED|Overall Study||1
4989561|NCT02442830|12275177|P1|NOT COMPLETED|Overall Study||0
4989562|NCT02442830|12275176|P2|COMPLETED|Overall Study||44
4989563|NCT02442830|12275177|P1|COMPLETED|Overall Study||42
4989564|NCT02442830|12275176|P2|STARTED|Overall Study||45
4989565|NCT02442830|12275177|P1|STARTED|Overall Study||42
4989566|NCT02442804|12275187|P2|NOT COMPLETED|Overall Study||1
4989567|NCT02442804|12275188|P1|NOT COMPLETED|Overall Study||1
4989568|NCT02442804|12275187|P2|COMPLETED|Overall Study||7
4989569|NCT02442804|12275188|P1|COMPLETED|Overall Study||7
4989570|NCT02442804|12275187|P2|STARTED|Overall Study||8
4989571|NCT02442804|12275188|P1|STARTED|Overall Study||8
4989572|NCT02442700|12275218|P2|NOT COMPLETED|Later 12 Weeks||0
4989573|NCT02442700|12275219|P1|NOT COMPLETED|Later 12 Weeks||0
4989574|NCT02442700|12275218|P2|COMPLETED|Later 12 Weeks||12
4989575|NCT02442700|12275219|P1|COMPLETED|Later 12 Weeks||12
4989576|NCT02442700|12275218|P2|STARTED|Later 12 Weeks||12
4989577|NCT02442700|12275219|P1|STARTED|Later 12 Weeks||12
4989578|NCT02442700|12275218|P2|NOT COMPLETED|First 12 Weeks||0
4989579|NCT02442700|12275219|P1|NOT COMPLETED|First 12 Weeks||0
4989580|NCT02442700|12275218|P2|COMPLETED|First 12 Weeks||12
4989581|NCT02442700|12275219|P1|COMPLETED|First 12 Weeks||12
4989582|NCT02442700|12275218|P2|STARTED|First 12 Weeks||12
4989583|NCT02442700|12275219|P1|STARTED|First 12 Weeks||12
4989584|NCT02442687|12275230|P3|NOT COMPLETED|Overall Study||3
4989585|NCT02442687|12275231|P2|NOT COMPLETED|Overall Study||11
4989586|NCT02442687|12275232|P1|NOT COMPLETED|Overall Study||8
4989587|NCT02442687|12275230|P3|COMPLETED|Overall Study||19
4989588|NCT02442687|12275231|P2|COMPLETED|Overall Study||11
4989589|NCT02442687|12275232|P1|COMPLETED|Overall Study||13
4989590|NCT02442687|12275230|P3|STARTED|Overall Study||22
4989591|NCT02442687|12275231|P2|STARTED|Overall Study||22
4989592|NCT02442687|12275232|P1|STARTED|Overall Study||21
4989593|NCT02442349|12275293|P1|NOT COMPLETED|Overall Study||171
4989594|NCT02442349|12275293|P1|COMPLETED|Overall Study||0
4989595|NCT02442349|12275293|P1|STARTED|Overall Study||171
4989596|NCT02442310|12275298|P1|NOT COMPLETED|Overall Study||3
4989597|NCT02442310|12275298|P1|COMPLETED|Overall Study||17
4989598|NCT02442310|12275298|P1|STARTED|Overall Study||20
4989599|NCT02442284|12275320|P1|NOT COMPLETED|Overall Study||7
4989600|NCT02442284|12275320|P1|COMPLETED|Overall Study||92
4989601|NCT02442284|12275320|P1|STARTED|Overall Study||99
4989602|NCT02442271|12275327|P1|NOT COMPLETED|Overall Study||4
4989603|NCT02442271|12275327|P1|COMPLETED|Overall Study||218
4989604|NCT02442271|12275327|P1|STARTED|Overall Study||222
4989605|NCT02442206|12275353|P2|NOT COMPLETED|Period 2||0
4989606|NCT02442206|12275354|P1|NOT COMPLETED|Period 2||1
4989607|NCT02442206|12275353|P2|COMPLETED|Period 2||29
4989608|NCT02442206|12275354|P1|COMPLETED|Period 2||28
4989609|NCT02442206|12275353|P2|STARTED|Period 2||29
4989610|NCT02442206|12275354|P1|STARTED|Period 2||29
4989611|NCT02442206|12275353|P2|NOT COMPLETED|Period 1||3
4989612|NCT02442206|12275354|P1|NOT COMPLETED|Period 1||1
4989613|NCT02442206|12275353|P2|COMPLETED|Period 1||29
4989614|NCT02442206|12275354|P1|COMPLETED|Period 1||29
4989615|NCT02442206|12275353|P2|STARTED|Period 1||32
4989616|NCT02442206|12275354|P1|STARTED|Period 1||30
4989617|NCT02441946|12275386|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
4989618|NCT02441946|12275387|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
4989619|NCT02441946|12275388|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
4989620|NCT02441946|12275386|P3|COMPLETED|Extension Period (8 Weeks)||0
4989621|NCT02441946|12275387|P2|COMPLETED|Extension Period (8 Weeks)||0
4989622|NCT02441946|12275388|P1|COMPLETED|Extension Period (8 Weeks)||40
4989623|NCT02441946|12275386|P3|STARTED|Extension Period (8 Weeks)||0
4989624|NCT02441946|12275387|P2|STARTED|Extension Period (8 Weeks)||0
4989625|NCT02441946|12275388|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
4989626|NCT02441946|12275386|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
4989627|NCT02441946|12275387|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
4989628|NCT02441946|12275388|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
4989629|NCT02441946|12275386|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
4989630|NCT02441946|12275387|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
4989631|NCT02441946|12275388|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
4989632|NCT02441946|12275386|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
4989633|NCT02441946|12275387|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
4989634|NCT02441946|12275388|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
4989635|NCT02441946|12275386|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
4989636|NCT02441946|12275387|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
4989637|NCT02441946|12275388|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
4989638|NCT02441946|12275386|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
4989639|NCT02441946|12275387|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
4989640|NCT02441946|12275388|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
4989641|NCT02441946|12275386|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
4989642|NCT02441946|12275387|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
4989643|NCT02441946|12275388|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
4989644|NCT02441946|12275386|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
4989645|NCT02441946|12275387|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
4989646|NCT02441946|12275388|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
4989647|NCT02441946|12275386|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
4989648|NCT02441946|12275387|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
4989649|NCT02441946|12275388|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
4989650|NCT02441946|12275386|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
4989651|NCT02441946|12275387|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
4989652|NCT02441946|12275388|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
4989653|NCT02441517|12275409|P1|NOT COMPLETED|Overall Study||4
4989654|NCT02441517|12275409|P1|COMPLETED|Overall Study||0
4989655|NCT02441517|12275409|P1|Received Treatment|Overall Study||4
4989656|NCT02441517|12275409|P1|STARTED|Overall Study||4
4989657|NCT02441309|12275422|P3|NOT COMPLETED|Overall Study||3
4989658|NCT02441309|12275423|P2|NOT COMPLETED|Overall Study||2
4989659|NCT02441309|12275424|P1|NOT COMPLETED|Overall Study||3
4989660|NCT02441309|12275422|P3|COMPLETED|Overall Study||0
4989661|NCT02441309|12275423|P2|COMPLETED|Overall Study||0
4989662|NCT02441309|12275424|P1|COMPLETED|Overall Study||0
4989663|NCT02441309|12275422|P3|Received Allocated Intervention|Overall Study||3
4989664|NCT02441309|12275423|P2|Received Allocated Intervention|Overall Study||2
4989665|NCT02441309|12275424|P1|Received Allocated Intervention|Overall Study||1
4989666|NCT02441309|12275422|P3|STARTED|Overall Study||3
4989667|NCT02441309|12275423|P2|STARTED|Overall Study||2
4989668|NCT02441309|12275424|P1|STARTED|Overall Study||3
4989669|NCT02441218|12275455|P2|NOT COMPLETED|Overall Study||612
4989670|NCT02441218|12275456|P1|NOT COMPLETED|Overall Study||578
4989671|NCT02441218|12275455|P2|COMPLETED|Overall Study||2652
4989672|NCT02441218|12275456|P1|COMPLETED|Overall Study||2663
4989673|NCT02441218|12275455|P2|STARTED|Overall Study||3264
4989674|NCT02441218|12275456|P1|STARTED|Overall Study||3241
4989675|NCT02441179|12275482|P2|NOT COMPLETED|Overall Study||1
4989676|NCT02441179|12275483|P1|NOT COMPLETED|Overall Study||1
4989677|NCT02441179|12275482|P2|COMPLETED|Overall Study||16
4989678|NCT02441179|12275483|P1|COMPLETED|Overall Study||17
4989679|NCT02441179|12275482|P2|STARTED|Overall Study||17
4989680|NCT02441179|12275483|P1|STARTED|Overall Study||18
4989681|NCT02441114|12275501|P1|NOT COMPLETED|Period3||0
4989682|NCT02441114|12275501|P1|COMPLETED|Period3||6
4989683|NCT02441114|12275501|P1|STARTED|Period3||6
4989684|NCT02441114|12275501|P1|NOT COMPLETED|Washout2||4
4989685|NCT02441114|12275501|P1|COMPLETED|Washout2||6
4989686|NCT02441114|12275501|P1|STARTED|Washout2||10
4989687|NCT02441114|12275501|P1|NOT COMPLETED|Period2||0
4989688|NCT02441114|12275501|P1|COMPLETED|Period2||10
4989689|NCT02441114|12275501|P1|STARTED|Period2||10
4989690|NCT02441114|12275501|P1|NOT COMPLETED|Washout1||0
4989691|NCT02441114|12275501|P1|COMPLETED|Washout1||10
4989692|NCT02441114|12275501|P1|STARTED|Washout1||10
4989693|NCT02441114|12275501|P1|NOT COMPLETED|Period1||0
4989694|NCT02441114|12275501|P1|COMPLETED|Period1||10
4989695|NCT02441114|12275501|P1|STARTED|Period1||10
4989696|NCT02441036|12275512|P5|NOT COMPLETED|Overall Study||0
4989697|NCT02441036|12275513|P4|NOT COMPLETED|Overall Study||1
4989698|NCT02441036|12275514|P3|NOT COMPLETED|Overall Study||0
4989699|NCT02441036|12275515|P2|NOT COMPLETED|Overall Study||1
4989700|NCT02441036|12275516|P1|NOT COMPLETED|Overall Study||0
4989701|NCT02441036|12275512|P5|COMPLETED|Overall Study||1
4989702|NCT02441036|12275513|P4|COMPLETED|Overall Study||3
4989703|NCT02441036|12275514|P3|COMPLETED|Overall Study||3
4989704|NCT02441036|12275515|P2|COMPLETED|Overall Study||4
4989705|NCT02441036|12275516|P1|COMPLETED|Overall Study||3
4989706|NCT02441036|12275512|P5|Tissue Resected|Overall Study||1
4989707|NCT02441036|12275513|P4|Tissue Resected|Overall Study||3
4989708|NCT02441036|12275514|P3|Tissue Resected|Overall Study||3
4989709|NCT02441036|12275515|P2|Tissue Resected|Overall Study||4
4989710|NCT02441036|12275516|P1|Tissue Resected|Overall Study||3
4989711|NCT02441036|12275512|P5|Treated|Overall Study||1
4989712|NCT02441036|12275513|P4|Treated|Overall Study||4
4989713|NCT02441036|12275514|P3|Treated|Overall Study||3
4989714|NCT02441036|12275515|P2|Treated|Overall Study||5
4989715|NCT02441036|12275516|P1|Treated|Overall Study||3
4989716|NCT02441036|12275512|P5|STARTED|Overall Study||1
4989717|NCT02441036|12275513|P4|STARTED|Overall Study||4
4989718|NCT02441036|12275514|P3|STARTED|Overall Study||3
4989719|NCT02441036|12275515|P2|STARTED|Overall Study||5
4989720|NCT02441036|12275516|P1|STARTED|Overall Study||3
4989721|NCT02440789|12275543|P1|NOT COMPLETED|Overall Study||4
4989722|NCT02440789|12275543|P1|COMPLETED|Overall Study||28
4989723|NCT02440789|12275543|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
4989724|NCT02440789|12275543|P1|Initiated Sirolimus|Overall Study||30
4989725|NCT02440789|12275543|P1|STARTED|Overall Study||32
4989726|NCT02440659|12275594|P2|NOT COMPLETED|Overall Study||335
4989727|NCT02440659|12275595|P1|NOT COMPLETED|Overall Study||651
4989728|NCT02440659|12275594|P2|COMPLETED|Overall Study||614
4989729|NCT02440659|12275595|P1|COMPLETED|Overall Study||1346
4989730|NCT02440659|12275594|P2|STARTED|Overall Study||949
4989731|NCT02440659|12275595|P1|STARTED|Overall Study||1997
4989732|NCT02440633|12275601|P1|NOT COMPLETED|Overall Study||0
4989733|NCT02440633|12275601|P1|COMPLETED|Overall Study||8
4989734|NCT02440633|12275601|P1|STARTED|Overall Study||8
4989735|NCT02440594|12275618|P8|NOT COMPLETED|Overall Study||56
4989736|NCT02440594|12275619|P7|NOT COMPLETED|Overall Study||37
4989737|NCT02440594|12275620|P6|NOT COMPLETED|Overall Study||7
4989738|NCT02440594|12275621|P5|NOT COMPLETED|Overall Study||9
4989739|NCT02440594|12275622|P4|NOT COMPLETED|Overall Study||89
4989740|NCT02440594|12275623|P3|NOT COMPLETED|Overall Study||117
4989741|NCT02440594|12275624|P2|NOT COMPLETED|Overall Study||108
4989742|NCT02440594|12275625|P1|NOT COMPLETED|Overall Study||132
4989743|NCT02440594|12275618|P8|COMPLETED|Overall Study||234
4989744|NCT02440594|12275619|P7|COMPLETED|Overall Study||113
4989745|NCT02440594|12275620|P6|COMPLETED|Overall Study||47
4989746|NCT02440594|12275621|P5|COMPLETED|Overall Study||46
4989747|NCT02440594|12275622|P4|COMPLETED|Overall Study||340
4989748|NCT02440594|12275623|P3|COMPLETED|Overall Study||319
4989749|NCT02440594|12275624|P2|COMPLETED|Overall Study||401
4989750|NCT02440594|12275625|P1|COMPLETED|Overall Study||377
4989751|NCT02440594|12275618|P8|STARTED|Overall Study||290
4989752|NCT02440594|12275619|P7|STARTED|Overall Study||150
4989753|NCT02440594|12275620|P6|STARTED|Overall Study||54
4989754|NCT02440594|12275621|P5|STARTED|Overall Study||55
4989755|NCT02440594|12275622|P4|STARTED|Overall Study||429
4989756|NCT02440594|12275623|P3|STARTED|Overall Study||436
4989757|NCT02440594|12275624|P2|STARTED|Overall Study||509
4989758|NCT02440594|12275625|P1|STARTED|Overall Study||509
4989759|NCT02440451|12275657|P1|NOT COMPLETED|Overall Study||0
4989760|NCT02440451|12275657|P1|COMPLETED|Overall Study||15
4989761|NCT02440451|12275657|P1|STARTED|Overall Study||15
4989762|NCT02440334|12275663|P1|NOT COMPLETED|Overall Study||0
4989763|NCT02440334|12275663|P1|COMPLETED|Overall Study||53
4989764|NCT02440334|12275663|P1|STARTED|Overall Study||53
4989765|NCT02440308|12275667|P1|NOT COMPLETED|Overall Study||0
4989766|NCT02440308|12275667|P1|COMPLETED|Overall Study||10
4989767|NCT02440308|12275667|P1|STARTED|Overall Study||10
4989768|NCT02440204|12275675|P3|NOT COMPLETED|Overall Study||0
4989769|NCT02440204|12275676|P2|NOT COMPLETED|Overall Study||0
4989770|NCT02440204|12275677|P1|NOT COMPLETED|Overall Study||0
4989771|NCT02440204|12275675|P3|COMPLETED|Overall Study||22
4989772|NCT02440204|12275676|P2|COMPLETED|Overall Study||24
4989773|NCT02440204|12275677|P1|COMPLETED|Overall Study||22
4989774|NCT02440204|12275675|P3|STARTED|Overall Study||22
4989775|NCT02440204|12275676|P2|STARTED|Overall Study||24
4989776|NCT02440204|12275677|P1|STARTED|Overall Study||22
4989777|NCT02440022|12275690|P2|NOT COMPLETED|Overall Study||13
4989778|NCT02440022|12275691|P1|NOT COMPLETED|Overall Study||27
4989779|NCT02440022|12275690|P2|COMPLETED|Overall Study||131
4989780|NCT02440022|12275691|P1|COMPLETED|Overall Study||114
4989781|NCT02440022|12275690|P2|STARTED|Overall Study||144
4989782|NCT02440022|12275691|P1|STARTED|Overall Study||141
4989783|NCT02439879|12275717|P2|NOT COMPLETED|Overall Study||0
4989784|NCT02439879|12275718|P1|NOT COMPLETED|Overall Study||0
4989785|NCT02439879|12275717|P2|COMPLETED|Overall Study||17
4989786|NCT02439879|12275718|P1|COMPLETED|Overall Study||16
4989787|NCT02439879|12275717|P2|STARTED|Overall Study||17
4989788|NCT02439879|12275718|P1|STARTED|Overall Study||16
4989789|NCT02439814|12275726|P2|NOT COMPLETED|Overall Study||0
4989790|NCT02439814|12275727|P1|NOT COMPLETED|Overall Study||0
4989791|NCT02439814|12275726|P2|COMPLETED|Overall Study||10
4989792|NCT02439814|12275727|P1|COMPLETED|Overall Study||11
4989793|NCT02439814|12275726|P2|STARTED|Overall Study||10
4989794|NCT02439814|12275727|P1|STARTED|Overall Study||11
4989795|NCT02439710|12275733|P1|NOT COMPLETED|Overall Study||0
4989796|NCT02439710|12275733|P1|COMPLETED|Overall Study||656
4989797|NCT02439710|12275733|P1|STARTED|Overall Study||656
4989798|NCT02439320|12275742|P3|NOT COMPLETED|Overall Study||99
4989799|NCT02439320|12275743|P2|NOT COMPLETED|Overall Study||114
4989800|NCT02439320|12275744|P1|NOT COMPLETED|Overall Study||96
4989801|NCT02439320|12275742|P3|COMPLETED|Overall Study||643
4989802|NCT02439320|12275743|P2|COMPLETED|Overall Study||631
4989803|NCT02439320|12275744|P1|COMPLETED|Overall Study||648
4989804|NCT02439320|12275742|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
4989805|NCT02439320|12275743|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
4989806|NCT02439320|12275744|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
4989807|NCT02439320|12275742|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
4989808|NCT02439320|12275743|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
4989809|NCT02439320|12275744|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
4989810|NCT02439320|12275742|P3|Confirmed Eligibility|Overall Study||705
4989811|NCT02439320|12275743|P2|Confirmed Eligibility|Overall Study||695
4989812|NCT02439320|12275744|P1|Confirmed Eligibility|Overall Study||710
4989813|NCT02439320|12275742|P3|STARTED|Overall Study||742
4989814|NCT02439320|12275743|P2|STARTED|Overall Study||745
4989815|NCT02439320|12275744|P1|STARTED|Overall Study||744
4989816|NCT02439281|12275789|P2|NOT COMPLETED|Overall Study||0
4989817|NCT02439281|12275790|P1|NOT COMPLETED|Overall Study||0
4989818|NCT02439281|12275789|P2|COMPLETED|Overall Study||26
4989819|NCT02439281|12275790|P1|COMPLETED|Overall Study||24
4989820|NCT02439281|12275789|P2|STARTED|Overall Study||26
4989821|NCT02439281|12275790|P1|STARTED|Overall Study||24
4989822|NCT02439164|12275810|P2|NOT COMPLETED|Overall Study||0
4989823|NCT02439164|12275811|P1|NOT COMPLETED|Overall Study||0
4989824|NCT02439164|12275810|P2|COMPLETED|Overall Study||18
4989825|NCT02439164|12275811|P1|COMPLETED|Overall Study||18
4989826|NCT02439164|12275810|P2|STARTED|Overall Study||18
4989827|NCT02439164|12275811|P1|STARTED|Overall Study||18
4989828|NCT02439138|12275824|P1|NOT COMPLETED|Overall Study||3
4989829|NCT02439138|12275824|P1|COMPLETED|Overall Study||2
4989830|NCT02439138|12275824|P1|STARTED|Overall Study||5
4989831|NCT02438826|12275837|P2|NOT COMPLETED|Overall Study||4
4989832|NCT02438826|12275838|P1|NOT COMPLETED|Overall Study||6
4989833|NCT02438826|12275837|P2|COMPLETED|Overall Study||113
4989834|NCT02438826|12275838|P1|COMPLETED|Overall Study||117
4989835|NCT02438826|12275837|P2|Received at Least 1 Dose of Study Drug|Overall Study||117
4989836|NCT02438826|12275838|P1|Received at Least 1 Dose of Study Drug|Overall Study||120
4989837|NCT02438826|12275837|P2|STARTED|Overall Study||117
4989838|NCT02438826|12275838|P1|STARTED|Overall Study||123
4989839|NCT02438813|12275866|P1|NOT COMPLETED|Overall Study||525
4989840|NCT02438813|12275866|P1|COMPLETED|Overall Study||504
4989841|NCT02438813|12275866|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
4989842|NCT02438813|12275866|P1|Received Treatment for SMF|Overall Study||676
4989843|NCT02438813|12275866|P1|STARTED|Overall Study||1029
4989844|NCT02438787|12275918|P3|NOT COMPLETED|Overall Study||83
4989845|NCT02438787|12275919|P2|NOT COMPLETED|Overall Study||83
4989846|NCT02438787|12275920|P1|NOT COMPLETED|Overall Study||81
4989847|NCT02438787|12275918|P3|COMPLETED|Overall Study||22
4989848|NCT02438787|12275919|P2|COMPLETED|Overall Study||23
4989849|NCT02438787|12275920|P1|COMPLETED|Overall Study||23
4989850|NCT02438787|12275918|P3|Cross Over at Week 24|Overall Study||0
4989851|NCT02438787|12275919|P2|Cross Over at Week 24|Overall Study||0
4989852|NCT02438787|12275920|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
4989853|NCT02438787|12275918|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
4989854|NCT02438787|12275919|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
4989855|NCT02438787|12275920|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
4989856|NCT02438787|12275918|P3|STARTED|Overall Study||105
4989857|NCT02438787|12275919|P2|STARTED|Overall Study||106
4989858|NCT02438787|12275920|P1|STARTED|Overall Study||104
4989859|NCT02438540|12275965|P2|NOT COMPLETED|Overall Study||0
4989860|NCT02438540|12275966|P1|NOT COMPLETED|Overall Study||0
4989861|NCT02438540|12275965|P2|COMPLETED|Overall Study||20
4989862|NCT02438540|12275966|P1|COMPLETED|Overall Study||19
4989863|NCT02438540|12275965|P2|STARTED|Overall Study||20
4989864|NCT02438540|12275966|P1|STARTED|Overall Study||19
4989865|NCT02438423|12276010|P4|NOT COMPLETED|Overall Study||0
4989866|NCT02438423|12276011|P3|NOT COMPLETED|Overall Study||0
4989867|NCT02438423|12276012|P2|NOT COMPLETED|Overall Study||0
4989868|NCT02438423|12276013|P1|NOT COMPLETED|Overall Study||0
4989869|NCT02438423|12276010|P4|COMPLETED|Overall Study||25
4989870|NCT02438423|12276011|P3|COMPLETED|Overall Study||25
4989871|NCT02438423|12276012|P2|COMPLETED|Overall Study||25
4989872|NCT02438423|12276013|P1|COMPLETED|Overall Study||25
4989873|NCT02438423|12276010|P4|STARTED|Overall Study||25
4989874|NCT02438423|12276011|P3|STARTED|Overall Study||25
4989875|NCT02438423|12276012|P2|STARTED|Overall Study||25
4989876|NCT02438423|12276013|P1|STARTED|Overall Study||25
4989877|NCT02438384|12276040|P3|NOT COMPLETED|Overall Study||4
4989878|NCT02438384|12276041|P2|NOT COMPLETED|Overall Study||6
4989879|NCT02438384|12276042|P1|NOT COMPLETED|Overall Study||8
4989880|NCT02438384|12276040|P3|COMPLETED|Overall Study||21
4989881|NCT02438384|12276041|P2|COMPLETED|Overall Study||19
4989882|NCT02438384|12276042|P1|COMPLETED|Overall Study||17
4989883|NCT02438384|12276040|P3|STARTED|Overall Study||25
4989884|NCT02438384|12276041|P2|STARTED|Overall Study||25
4989885|NCT02438384|12276042|P1|STARTED|Overall Study||25
4989886|NCT02438280|12276061|P2|NOT COMPLETED|Overall Study||0
4989887|NCT02438280|12276062|P1|NOT COMPLETED|Overall Study||1
4989888|NCT02438280|12276061|P2|COMPLETED|Overall Study||13
4989889|NCT02438280|12276062|P1|COMPLETED|Overall Study||13
4989890|NCT02438280|12276061|P2|STARTED|Overall Study||13
4989891|NCT02438280|12276062|P1|STARTED|Overall Study||14
4989892|NCT02438137|12276072|P2|NOT COMPLETED|Overall Study||6
4989893|NCT02438137|12276073|P1|NOT COMPLETED|Overall Study||8
4989894|NCT02438137|12276072|P2|COMPLETED|Overall Study||15
4989895|NCT02438137|12276073|P1|COMPLETED|Overall Study||36
4989896|NCT02438137|12276072|P2|STARTED|Overall Study||21
4989897|NCT02438137|12276073|P1|STARTED|Overall Study||44
4989898|NCT02437903|12276081|P1|NOT COMPLETED|Overall Study||5
4989899|NCT02437903|12276081|P1|COMPLETED|Overall Study||25
4989900|NCT02437903|12276081|P1|STARTED|Overall Study||30
4989901|NCT02437890|12276094|P5|NOT COMPLETED|Overall Study||16
4989902|NCT02437890|12276095|P4|NOT COMPLETED|Overall Study||22
4989903|NCT02437890|12276096|P3|NOT COMPLETED|Overall Study||15
4989904|NCT02437890|12276097|P2|NOT COMPLETED|Overall Study||16
4989905|NCT02437890|12276098|P1|NOT COMPLETED|Overall Study||8
4989906|NCT02437890|12276094|P5|COMPLETED|Overall Study||46
4989907|NCT02437890|12276095|P4|COMPLETED|Overall Study||40
4989908|NCT02437890|12276096|P3|COMPLETED|Overall Study||47
4989909|NCT02437890|12276097|P2|COMPLETED|Overall Study||48
4989910|NCT02437890|12276098|P1|COMPLETED|Overall Study||54
4989911|NCT02437890|12276094|P5|STARTED|Overall Study||62
4989912|NCT02437890|12276095|P4|STARTED|Overall Study||62
4989913|NCT02437890|12276096|P3|STARTED|Overall Study||62
4989914|NCT02437890|12276097|P2|STARTED|Overall Study||64
4989915|NCT02437890|12276098|P1|STARTED|Overall Study||62
4989916|NCT02437864|12276311|P2|NOT COMPLETED|Overall Study||0
4989917|NCT02437864|12276312|P1|NOT COMPLETED|Overall Study||4
4989918|NCT02437864|12276311|P2|COMPLETED|Overall Study||160
4989919|NCT02437864|12276312|P1|COMPLETED|Overall Study||196
4989920|NCT02437864|12276311|P2|STARTED|Overall Study||160
4989921|NCT02437864|12276312|P1|STARTED|Overall Study||200
4989922|NCT02437669|12276326|P1|NOT COMPLETED|Overall Study||0
4989923|NCT02437669|12276326|P1|COMPLETED|Overall Study||35
4989924|NCT02437669|12276326|P1|STARTED|Overall Study||35
4989925|NCT02437513|12276333|P1|NOT COMPLETED|Overall Study||2
4989926|NCT02437513|12276333|P1|COMPLETED|Overall Study||0
4989927|NCT02437513|12276333|P1|STARTED|Overall Study||2
4989928|NCT02437487|12276343|P2|NOT COMPLETED|Overall Study||14
4989929|NCT02437487|12276344|P1|NOT COMPLETED|Overall Study||27
4989930|NCT02437487|12276343|P2|COMPLETED|Overall Study||16
4989931|NCT02437487|12276344|P1|COMPLETED|Overall Study||32
4989932|NCT02437487|12276343|P2|Intention-to-Treat Population|Overall Study||30
4989933|NCT02437487|12276344|P1|Intention-to-Treat Population|Overall Study||59
4989934|NCT02437487|12276343|P2|Actual Treatment Received|Overall Study||29
4989935|NCT02437487|12276344|P1|Actual Treatment Received|Overall Study||60
4989936|NCT02437487|12276343|P2|STARTED|Overall Study||30
4989937|NCT02437487|12276344|P1|STARTED|Overall Study||59
4989938|NCT02437409|12276358|P1|NOT COMPLETED|Overall Study||15
4989939|NCT02437409|12276358|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
4989940|NCT02437409|12276358|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
4989941|NCT02437383|12276369|P2|NOT COMPLETED|Overall Study||13
4989942|NCT02437383|12276370|P1|NOT COMPLETED|Overall Study||13
4989943|NCT02437383|12276369|P2|COMPLETED|Overall Study||87
4989944|NCT02437383|12276370|P1|COMPLETED|Overall Study||87
4989945|NCT02437383|12276369|P2|STARTED|Overall Study||100
4989946|NCT02437383|12276370|P1|STARTED|Overall Study||100
4989947|NCT02437344|12276444|P1|NOT COMPLETED|Overall Study||1
4989948|NCT02437344|12276444|P1|COMPLETED|Overall Study||15
4989949|NCT02437344|12276444|P1|STARTED|Overall Study||16
4989950|NCT02437318|12276451|P2|NOT COMPLETED|Overall Study||242
4989951|NCT02437318|12276452|P1|NOT COMPLETED|Overall Study||229
4989952|NCT02437318|12276451|P2|COMPLETED|Overall Study||46
4989953|NCT02437318|12276452|P1|COMPLETED|Overall Study||55
4989954|NCT02437318|12276451|P2|Untreated (Protocol Deviation)|Overall Study||1
4989955|NCT02437318|12276452|P1|Untreated (Protocol Deviation)|Overall Study||0
4989956|NCT02437318|12276451|P2|End of Treatment (Didn't Complete)|Overall Study||241
4989957|NCT02437318|12276452|P1|End of Treatment (Didn't Complete)|Overall Study||229
4989958|NCT02437318|12276451|P2|STARTED|Overall Study||288
4989959|NCT02437318|12276452|P1|STARTED|Overall Study||284
4989960|NCT02437305|12276460|P2|NOT COMPLETED|Overall Study||12
4989961|NCT02437305|12276461|P1|NOT COMPLETED|Overall Study||18
4989962|NCT02437305|12276460|P2|COMPLETED|Overall Study||38
4989963|NCT02437305|12276461|P1|COMPLETED|Overall Study||32
4989964|NCT02437305|12276460|P2|STARTED|Overall Study||50
4989965|NCT02437305|12276461|P1|STARTED|Overall Study||50
4989966|NCT02437253|12276471|P2|NOT COMPLETED|Overall Study||0
4989967|NCT02437253|12276472|P1|NOT COMPLETED|Overall Study||0
4989968|NCT02437253|12276471|P2|COMPLETED|Overall Study||1
4989969|NCT02437253|12276472|P1|COMPLETED|Overall Study||1
4989970|NCT02437253|12276471|P2|STARTED|Overall Study||1
4989971|NCT02437253|12276472|P1|STARTED|Overall Study||1
4989972|NCT02437188|12276488|P2|NOT COMPLETED|Overall Study||9
4989973|NCT02437188|12276489|P1|NOT COMPLETED|Overall Study||4
4989974|NCT02437188|12276488|P2|COMPLETED|Overall Study||35
4989975|NCT02437188|12276489|P1|COMPLETED|Overall Study||40
4989976|NCT02437188|12276488|P2|STARTED|Overall Study||44
4989977|NCT02437188|12276489|P1|STARTED|Overall Study||44
4989978|NCT02437162|12276506|P3|NOT COMPLETED|Overall Study||109
4989979|NCT02437162|12276507|P2|NOT COMPLETED|Overall Study||108
4989980|NCT02437162|12276508|P1|NOT COMPLETED|Overall Study||107
4989981|NCT02437162|12276506|P3|COMPLETED|Overall Study||6
4989982|NCT02437162|12276507|P2|COMPLETED|Overall Study||8
4989983|NCT02437162|12276508|P1|COMPLETED|Overall Study||9
4989984|NCT02437162|12276506|P3|Cross Over at Week 24|Overall Study||0
4989985|NCT02437162|12276507|P2|Cross Over at Week 24|Overall Study||0
4989986|NCT02437162|12276508|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
4989987|NCT02437162|12276506|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
4989988|NCT02437162|12276507|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
4989989|NCT02437162|12276508|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
4989990|NCT02437162|12276506|P3|Treated|Overall Study||114
4989991|NCT02437162|12276507|P2|Treated|Overall Study||116
4989992|NCT02437162|12276508|P1|Treated|Overall Study||116
4989993|NCT02437162|12276506|P3|STARTED|Overall Study||115
4989994|NCT02437162|12276507|P2|STARTED|Overall Study||116
4989995|NCT02437162|12276508|P1|STARTED|Overall Study||116
4989996|NCT02436915|12276628|P2|NOT COMPLETED|Overall Study||1
4989997|NCT02436915|12276629|P1|NOT COMPLETED|Overall Study||0
4989998|NCT02436915|12276628|P2|COMPLETED|Overall Study||9
4989999|NCT02436915|12276629|P1|COMPLETED|Overall Study||9
4990000|NCT02436915|12276628|P2|STARTED|Overall Study||10
4990001|NCT02436915|12276629|P1|STARTED|Overall Study||9
4990002|NCT02436889|12276651|P2|NOT COMPLETED|Overall Study||1
4990003|NCT02436889|12276652|P1|NOT COMPLETED|Overall Study||1
4990004|NCT02436889|12276651|P2|COMPLETED|Overall Study||10
4990005|NCT02436889|12276652|P1|COMPLETED|Overall Study||11
4990006|NCT02436889|12276651|P2|STARTED|Overall Study||11
4990007|NCT02436889|12276652|P1|STARTED|Overall Study||12
4990008|NCT02436811|12276671|P3|NOT COMPLETED|Overall Study||7
4990009|NCT02436811|12276672|P2|NOT COMPLETED|Overall Study||9
4990010|NCT02436811|12276673|P1|NOT COMPLETED|Overall Study||2
4990011|NCT02436811|12276671|P3|COMPLETED|Overall Study||53
4990012|NCT02436811|12276672|P2|COMPLETED|Overall Study||51
4990013|NCT02436811|12276673|P1|COMPLETED|Overall Study||58
4990014|NCT02436811|12276671|P3|STARTED|Overall Study||60
4990015|NCT02436811|12276672|P2|STARTED|Overall Study||60
4990016|NCT02436811|12276673|P1|STARTED|Overall Study||60
4990017|NCT02436681|12276681|P1|NOT COMPLETED|Overall Study||14
4990018|NCT02436681|12276681|P1|COMPLETED|Overall Study||27
4990019|NCT02436681|12276681|P1|STARTED|Overall Study||41
4990020|NCT02436577|12276698|P6|NOT COMPLETED|Overall Study||0
4990021|NCT02436577|12276699|P5|NOT COMPLETED|Overall Study||0
4990022|NCT02436577|12276700|P4|NOT COMPLETED|Overall Study||0
4990023|NCT02436577|12276701|P3|NOT COMPLETED|Overall Study||0
4990024|NCT02436577|12276702|P2|NOT COMPLETED|Overall Study||1
4990025|NCT02436577|12276703|P1|NOT COMPLETED|Overall Study||0
4990026|NCT02436577|12276698|P6|COMPLETED|Overall Study||7
4990027|NCT02436577|12276699|P5|COMPLETED|Overall Study||7
4990028|NCT02436577|12276700|P4|COMPLETED|Overall Study||7
4990029|NCT02436577|12276701|P3|COMPLETED|Overall Study||7
4990030|NCT02436577|12276702|P2|COMPLETED|Overall Study||6
4990031|NCT02436577|12276703|P1|COMPLETED|Overall Study||7
4990032|NCT02436577|12276698|P6|STARTED|Overall Study||7
4990033|NCT02436577|12276699|P5|STARTED|Overall Study||7
4990034|NCT02436577|12276700|P4|STARTED|Overall Study||7
4990035|NCT02436577|12276701|P3|STARTED|Overall Study||7
4990036|NCT02436577|12276702|P2|STARTED|Overall Study||7
4990037|NCT02436577|12276703|P1|STARTED|Overall Study||7
4990038|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 6||1
4990039|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 6||3
4990040|NCT02436330|12276758|P2|COMPLETED|Cohort 6||4
4990041|NCT02436330|12276759|P1|COMPLETED|Cohort 6||1
4990042|NCT02436330|12276758|P2|STARTED|Cohort 6||5
4990043|NCT02436330|12276759|P1|STARTED|Cohort 6||4
4990044|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 5||4
4990045|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 5||6
4990046|NCT02436330|12276758|P2|COMPLETED|Cohort 5||1
4990047|NCT02436330|12276759|P1|COMPLETED|Cohort 5||4
4990048|NCT02436330|12276758|P2|STARTED|Cohort 5||5
4990049|NCT02436330|12276759|P1|STARTED|Cohort 5||10
4990050|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 4||0
4990051|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 4||2
4990052|NCT02436330|12276758|P2|COMPLETED|Cohort 4||0
4990053|NCT02436330|12276759|P1|COMPLETED|Cohort 4||4
4990054|NCT02436330|12276758|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
4990055|NCT02436330|12276759|P1|STARTED|Cohort 4||6
4990056|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 3||0
4990057|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 3||5
4990058|NCT02436330|12276758|P2|COMPLETED|Cohort 3||0
4990059|NCT02436330|12276759|P1|COMPLETED|Cohort 3||7
4990060|NCT02436330|12276758|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
4990061|NCT02436330|12276759|P1|STARTED|Cohort 3||12
4990062|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 2||3
4990063|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 2||4
4990064|NCT02436330|12276758|P2|COMPLETED|Cohort 2||7
4990065|NCT02436330|12276759|P1|COMPLETED|Cohort 2||10
4990066|NCT02436330|12276758|P2|STARTED|Cohort 2||10
4990067|NCT02436330|12276759|P1|STARTED|Cohort 2||14
4990068|NCT02436330|12276758|P2|NOT COMPLETED|Cohort 1||3
4990069|NCT02436330|12276759|P1|NOT COMPLETED|Cohort 1||5
4990070|NCT02436330|12276758|P2|COMPLETED|Cohort 1||1
4990071|NCT02436330|12276759|P1|COMPLETED|Cohort 1||9
4990072|NCT02436330|12276758|P2|STARTED|Cohort 1||4
4990073|NCT02436330|12276759|P1|STARTED|Cohort 1||14
4990074|NCT02436304|12276804|P3|NOT COMPLETED|Overall Study||1
4990075|NCT02436304|12276805|P2|NOT COMPLETED|Overall Study||2
4990076|NCT02436304|12276806|P1|NOT COMPLETED|Overall Study||0
4990077|NCT02436304|12276804|P3|COMPLETED|Overall Study||100
4990078|NCT02436304|12276805|P2|COMPLETED|Overall Study||100
4990079|NCT02436304|12276806|P1|COMPLETED|Overall Study||153
4990080|NCT02436304|12276804|P3|STARTED|Overall Study||101
4990081|NCT02436304|12276805|P2|STARTED|Overall Study||102
4990082|NCT02436304|12276806|P1|STARTED|Overall Study||153
4990083|NCT02436239|12276825|P4|NOT COMPLETED|Down-Taper Period||2
4990084|NCT02436239|12276826|P3|NOT COMPLETED|Down-Taper Period||1
4990085|NCT02436239|12276827|P2|NOT COMPLETED|Down-Taper Period||4
4990086|NCT02436239|12276828|P1|NOT COMPLETED|Down-Taper Period||4
4990087|NCT02436239|12276825|P4|COMPLETED|Down-Taper Period||4
4990088|NCT02436239|12276826|P3|COMPLETED|Down-Taper Period||43
4990089|NCT02436239|12276827|P2|COMPLETED|Down-Taper Period||99
4990090|NCT02436239|12276828|P1|COMPLETED|Down-Taper Period||86
4990091|NCT02436239|12276825|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
4990092|NCT02436239|12276826|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
4990093|NCT02436239|12276827|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
4990094|NCT02436239|12276828|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
4990095|NCT02436239|12276825|P4|NOT COMPLETED|Open-Lable Treatment Period||5
4990096|NCT02436239|12276826|P3|NOT COMPLETED|Open-Lable Treatment Period||27
4990097|NCT02436239|12276827|P2|NOT COMPLETED|Open-Lable Treatment Period||34
4990098|NCT02436239|12276828|P1|NOT COMPLETED|Open-Lable Treatment Period||33
4990099|NCT02436239|12276825|P4|COMPLETED|Open-Lable Treatment Period||7
4990100|NCT02436239|12276826|P3|COMPLETED|Open-Lable Treatment Period||38
4990101|NCT02436239|12276827|P2|COMPLETED|Open-Lable Treatment Period||97
4990102|NCT02436239|12276828|P1|COMPLETED|Open-Lable Treatment Period||89
4990103|NCT02436239|12276825|P4|STARTED|Open-Lable Treatment Period||12
4990104|NCT02436239|12276826|P3|STARTED|Open-Lable Treatment Period||65
4990105|NCT02436239|12276827|P2|STARTED|Open-Lable Treatment Period||131
4990106|NCT02436239|12276828|P1|STARTED|Open-Lable Treatment Period||122
4990107|NCT02436200|12276850|P1|NOT COMPLETED|Overall Study||1
4990108|NCT02436200|12276850|P1|COMPLETED|Overall Study||20
4990109|NCT02436200|12276850|P1|STARTED|Overall Study||21
4990110|NCT02436031|12276855|P2|NOT COMPLETED|Second Study Night||0
4990111|NCT02436031|12276856|P1|NOT COMPLETED|Second Study Night||0
4990112|NCT02436031|12276855|P2|COMPLETED|Second Study Night||8
4990113|NCT02436031|12276856|P1|COMPLETED|Second Study Night||7
4990114|NCT02436031|12276855|P2|STARTED|Second Study Night||8
4990115|NCT02436031|12276856|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
4990116|NCT02436031|12276855|P2|NOT COMPLETED|First Study Night||0
4990117|NCT02436031|12276856|P1|NOT COMPLETED|First Study Night||0
4990118|NCT02436031|12276855|P2|COMPLETED|First Study Night||8
4990119|NCT02436031|12276856|P1|COMPLETED|First Study Night||8
4990120|NCT02436031|12276855|P2|STARTED|First Study Night||8
4990121|NCT02436031|12276856|P1|STARTED|First Study Night||8
4990122|NCT02435966|12276869|P3|NOT COMPLETED|Overall Study||0
4990123|NCT02435966|12276870|P2|NOT COMPLETED|Overall Study||1
4990124|NCT02435966|12276871|P1|NOT COMPLETED|Overall Study||0
4990125|NCT02435966|12276869|P3|COMPLETED|Overall Study||30
4990126|NCT02435966|12276870|P2|COMPLETED|Overall Study||53
4990127|NCT02435966|12276871|P1|COMPLETED|Overall Study||47
4990128|NCT02435966|12276869|P3|Follow-up|Overall Study||30
4990129|NCT02435966|12276870|P2|Follow-up|Overall Study||53
4990130|NCT02435966|12276871|P1|Follow-up|Overall Study||47
4990131|NCT02435966|12276869|P3|Second Intervention|Overall Study||30
4990132|NCT02435966|12276870|P2|Second Intervention|Overall Study||53
4990133|NCT02435966|12276871|P1|Second Intervention|Overall Study||47
4990134|NCT02435966|12276869|P3|First Intervention|Overall Study||30
4990135|NCT02435966|12276870|P2|First Intervention|Overall Study||54
4990136|NCT02435966|12276871|P1|First Intervention|Overall Study||47
4990137|NCT02435966|12276869|P3|STARTED|Overall Study||30
4990138|NCT02435966|12276870|P2|STARTED|Overall Study||54
4990139|NCT02435966|12276871|P1|STARTED|Overall Study||47
4990140|NCT02435914|12276883|P4|NOT COMPLETED|Overall Study||0
4990141|NCT02435914|12276884|P3|NOT COMPLETED|Overall Study||1
4990142|NCT02435914|12276885|P2|NOT COMPLETED|Overall Study||1
4990143|NCT02435914|12276886|P1|NOT COMPLETED|Overall Study||1
4990144|NCT02435914|12276883|P4|COMPLETED|Overall Study||59
4990145|NCT02435914|12276884|P3|COMPLETED|Overall Study||59
4990146|NCT02435914|12276885|P2|COMPLETED|Overall Study||58
4990147|NCT02435914|12276886|P1|COMPLETED|Overall Study||57
4990148|NCT02435914|12276883|P4|STARTED|Overall Study||59
4990149|NCT02435914|12276884|P3|STARTED|Overall Study||60
4990150|NCT02435914|12276885|P2|STARTED|Overall Study||59
4990151|NCT02435914|12276886|P1|STARTED|Overall Study||58
4990152|NCT02435836|12276908|P1|NOT COMPLETED|Overall Study||631
4990153|NCT02435836|12276908|P1|COMPLETED|Overall Study||0
4990154|NCT02435836|12276908|P1|STARTED|Overall Study||631
4990155|NCT02435706|12276926|P2|NOT COMPLETED|Overall Study||1
4990156|NCT02435706|12276927|P1|NOT COMPLETED|Overall Study||2
4990157|NCT02435706|12276926|P2|COMPLETED|Overall Study||20
4990158|NCT02435706|12276927|P1|COMPLETED|Overall Study||16
4990159|NCT02435706|12276926|P2|STARTED|Overall Study||21
4990160|NCT02435706|12276927|P1|STARTED|Overall Study||18
4990161|NCT02435524|12276941|P2|NOT COMPLETED|Endline Survey||0
4990162|NCT02435524|12276942|P1|NOT COMPLETED|Endline Survey||0
4990163|NCT02435524|12276941|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
4990164|NCT02435524|12276942|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
4990165|NCT02435524|12276941|P2|STARTED|Endline Survey||1161
4990166|NCT02435524|12276942|P1|STARTED|Endline Survey||1092
4990167|NCT02435524|12276941|P2|NOT COMPLETED|Baseline Survey||0
4990168|NCT02435524|12276942|P1|NOT COMPLETED|Baseline Survey||0
4990169|NCT02435524|12276941|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
4990170|NCT02435524|12276942|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
4990171|NCT02435524|12276941|P2|STARTED|Baseline Survey||1177
4990172|NCT02435524|12276942|P1|STARTED|Baseline Survey||1111
4990173|NCT02435511|12276950|P2|NOT COMPLETED|Overall Study||35
4990174|NCT02435511|12276951|P1|NOT COMPLETED|Overall Study||44
4990175|NCT02435511|12276950|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
4990176|NCT02435511|12276951|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
4990177|NCT02435511|12276950|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
4990178|NCT02435511|12276951|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
4990179|NCT02435433|12276967|P5|NOT COMPLETED|Overall Study||0
4990180|NCT02435433|12276968|P4|NOT COMPLETED|Overall Study||0
4990181|NCT02435433|12276969|P3|NOT COMPLETED|Overall Study||0
4990182|NCT02435433|12276970|P2|NOT COMPLETED|Overall Study||5
4990183|NCT02435433|12276971|P1|NOT COMPLETED|Overall Study||15
4990184|NCT02435433|12276967|P5|COMPLETED|Overall Study||0
4990185|NCT02435433|12276968|P4|COMPLETED|Overall Study||0
4990186|NCT02435433|12276969|P3|COMPLETED|Overall Study||0
4990187|NCT02435433|12276970|P2|COMPLETED|Overall Study||90
4990188|NCT02435433|12276971|P1|COMPLETED|Overall Study||182
4990189|NCT02435433|12276967|P5|Participants Who Received Study Drug|Overall Study||0
4990190|NCT02435433|12276968|P4|Participants Who Received Study Drug|Overall Study||0
4990191|NCT02435433|12276969|P3|Participants Who Received Study Drug|Overall Study||0
4990192|NCT02435433|12276970|P2|Participants Who Received Study Drug|Overall Study||95
4990193|NCT02435433|12276971|P1|Participants Who Received Study Drug|Overall Study||197
4990194|NCT02435433|12276967|P5|STARTED|Overall Study||0
4990195|NCT02435433|12276968|P4|STARTED|Overall Study||0
4990196|NCT02435433|12276969|P3|STARTED|Overall Study||0
4990197|NCT02435433|12276970|P2|STARTED|Overall Study||95
4990198|NCT02435433|12276971|P1|STARTED|Overall Study||197
4990199|NCT02435277|12276997|P4|NOT COMPLETED|Overall Study||0
4990200|NCT02435277|12276998|P3|NOT COMPLETED|Overall Study||0
4990201|NCT02435277|12276999|P2|NOT COMPLETED|Overall Study||1
4990202|NCT02435277|12277000|P1|NOT COMPLETED|Overall Study||2
4990203|NCT02435277|12276997|P4|COMPLETED|Overall Study||11
4990204|NCT02435277|12276998|P3|COMPLETED|Overall Study||11
4990205|NCT02435277|12276999|P2|COMPLETED|Overall Study||15
4990206|NCT02435277|12277000|P1|COMPLETED|Overall Study||10
4990207|NCT02435277|12276997|P4|STARTED|Overall Study||11
4990208|NCT02435277|12276998|P3|STARTED|Overall Study||11
4990209|NCT02435277|12276999|P2|STARTED|Overall Study||16
4990210|NCT02435277|12277000|P1|STARTED|Overall Study||12
4990211|NCT02435147|12277014|P1|NOT COMPLETED|Overall Study||11
4990212|NCT02435147|12277014|P1|COMPLETED|Overall Study||75
4990213|NCT02435147|12277014|P1|STARTED|Overall Study||86
4990214|NCT02435069|12277019|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
4990215|NCT02435069|12277020|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
4990216|NCT02435069|12277021|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
4990217|NCT02435069|12277022|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
4990218|NCT02435069|12277023|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
4990219|NCT02435069|12277019|P5|COMPLETED|Effectiveness - Second Intervention||0
4990220|NCT02435069|12277020|P4|COMPLETED|Effectiveness - Second Intervention||1
4990221|NCT02435069|12277021|P3|COMPLETED|Effectiveness - Second Intervention||0
4990222|NCT02435069|12277022|P2|COMPLETED|Effectiveness - Second Intervention||0
4990223|NCT02435069|12277023|P1|COMPLETED|Effectiveness - Second Intervention||0
4990224|NCT02435069|12277019|P5|STARTED|Effectiveness - Second Intervention||1
4990225|NCT02435069|12277020|P4|STARTED|Effectiveness - Second Intervention||1
4990226|NCT02435069|12277021|P3|STARTED|Effectiveness - Second Intervention||0
4990227|NCT02435069|12277022|P2|STARTED|Effectiveness - Second Intervention||0
4990228|NCT02435069|12277023|P1|STARTED|Effectiveness - Second Intervention||0
4990229|NCT02435069|12277019|P5|NOT COMPLETED|Dose Response - First Intervention||0
4990230|NCT02435069|12277020|P4|NOT COMPLETED|Dose Response - First Intervention||0
4990231|NCT02435069|12277021|P3|NOT COMPLETED|Dose Response - First Intervention||1
4990232|NCT02435069|12277022|P2|NOT COMPLETED|Dose Response - First Intervention||1
4990233|NCT02435069|12277023|P1|NOT COMPLETED|Dose Response - First Intervention||0
4990234|NCT02435069|12277019|P5|COMPLETED|Dose Response - First Intervention||0
4990235|NCT02435069|12277020|P4|COMPLETED|Dose Response - First Intervention||0
4990236|NCT02435069|12277021|P3|COMPLETED|Dose Response - First Intervention||1
4990237|NCT02435069|12277022|P2|COMPLETED|Dose Response - First Intervention||2
4990238|NCT02435069|12277023|P1|COMPLETED|Dose Response - First Intervention||0
4990239|NCT02435069|12277019|P5|STARTED|Dose Response - First Intervention||0
4990240|NCT02435069|12277020|P4|STARTED|Dose Response - First Intervention||0
4990241|NCT02435069|12277021|P3|STARTED|Dose Response - First Intervention||2
4990242|NCT02435069|12277022|P2|STARTED|Dose Response - First Intervention||3
4990243|NCT02435069|12277023|P1|STARTED|Dose Response - First Intervention||0
4990244|NCT02435069|12277019|P5|NOT COMPLETED|Preoperative Baseline Phase||0
4990245|NCT02435069|12277020|P4|NOT COMPLETED|Preoperative Baseline Phase||0
4990246|NCT02435069|12277021|P3|NOT COMPLETED|Preoperative Baseline Phase||0
4990247|NCT02435069|12277022|P2|NOT COMPLETED|Preoperative Baseline Phase||0
4990248|NCT02435069|12277023|P1|NOT COMPLETED|Preoperative Baseline Phase||0
4990249|NCT02435069|12277019|P5|COMPLETED|Preoperative Baseline Phase||0
4990250|NCT02435069|12277020|P4|COMPLETED|Preoperative Baseline Phase||0
4990251|NCT02435069|12277021|P3|COMPLETED|Preoperative Baseline Phase||0
4990252|NCT02435069|12277022|P2|COMPLETED|Preoperative Baseline Phase||0
4990253|NCT02435069|12277023|P1|COMPLETED|Preoperative Baseline Phase||5
4990254|NCT02435069|12277019|P5|STARTED|Preoperative Baseline Phase||0
4990255|NCT02435069|12277020|P4|STARTED|Preoperative Baseline Phase||0
4990256|NCT02435069|12277021|P3|STARTED|Preoperative Baseline Phase||0
4990257|NCT02435069|12277022|P2|STARTED|Preoperative Baseline Phase||0
4990258|NCT02435069|12277023|P1|STARTED|Preoperative Baseline Phase||5
4990259|NCT02434939|12277045|P2|NOT COMPLETED|Overall Study||49
4990260|NCT02434939|12277046|P1|NOT COMPLETED|Overall Study||37
4990261|NCT02434939|12277045|P2|COMPLETED|Overall Study||71
4990262|NCT02434939|12277046|P1|COMPLETED|Overall Study||83
4990263|NCT02434939|12277045|P2|STARTED|Overall Study||120
4990264|NCT02434939|12277046|P1|STARTED|Overall Study||120
4990265|NCT02434770|12277061|P3|NOT COMPLETED|Week 18 to Week||6
4990266|NCT02434770|12277062|P2|NOT COMPLETED|Week 18 to Week||8
4990267|NCT02434770|12277063|P1|NOT COMPLETED|Week 18 to Week||8
4990268|NCT02434770|12277061|P3|COMPLETED|Week 18 to Week||227
4990269|NCT02434770|12277062|P2|COMPLETED|Week 18 to Week||220
4990270|NCT02434770|12277063|P1|COMPLETED|Week 18 to Week||227
4990271|NCT02434770|12277061|P3|STARTED|Week 18 to Week||233
4990272|NCT02434770|12277062|P2|STARTED|Week 18 to Week||228
4990273|NCT02434770|12277063|P1|STARTED|Week 18 to Week||235
4990274|NCT02434770|12277061|P3|NOT COMPLETED|Week 1 to Week 18||17
4990275|NCT02434770|12277062|P2|NOT COMPLETED|Week 1 to Week 18||22
4990276|NCT02434770|12277063|P1|NOT COMPLETED|Week 1 to Week 18||15
4990277|NCT02434770|12277061|P3|COMPLETED|Week 1 to Week 18||233
4990278|NCT02434770|12277062|P2|COMPLETED|Week 1 to Week 18||228
4990279|NCT02434770|12277063|P1|COMPLETED|Week 1 to Week 18||235
4990280|NCT02434770|12277061|P3|Received at Least One Vaccination|Week 1 to Week 18||250
4990281|NCT02434770|12277062|P2|Received at Least One Vaccination|Week 1 to Week 18||250
4990282|NCT02434770|12277063|P1|Received at Least One Vaccination|Week 1 to Week 18||249
4990283|NCT02434770|12277061|P3|STARTED|Week 1 to Week 18||250
4990284|NCT02434770|12277062|P2|STARTED|Week 1 to Week 18||250
4990285|NCT02434770|12277063|P1|STARTED|Week 1 to Week 18||250
4990286|NCT02434523|12277100|P2|NOT COMPLETED|Overall Study||6
4990287|NCT02434523|12277101|P1|NOT COMPLETED|Overall Study||5
4990288|NCT02434523|12277100|P2|COMPLETED|Overall Study||9
4990289|NCT02434523|12277101|P1|COMPLETED|Overall Study||10
4990290|NCT02434523|12277100|P2|STARTED|Overall Study||15
4990291|NCT02434523|12277101|P1|STARTED|Overall Study||15
4990292|NCT02434497|12277113|P1|NOT COMPLETED|Overall Study||5
4990293|NCT02434497|12277113|P1|COMPLETED|Overall Study||4
4990294|NCT02434497|12277113|P1|STARTED|Overall Study||9
4990295|NCT02434471|12277213|P1|NOT COMPLETED|Overall Study||9
4990296|NCT02434471|12277213|P1|COMPLETED|Overall Study||25
4990297|NCT02434471|12277213|P1|STARTED|Overall Study||34
4990298|NCT02434328|12277222|P2|NOT COMPLETED|Overall Study||42
4990299|NCT02434328|12277223|P1|NOT COMPLETED|Overall Study||30
4990300|NCT02434328|12277222|P2|COMPLETED|Overall Study||329
4990301|NCT02434328|12277223|P1|COMPLETED|Overall Study||342
4990302|NCT02434328|12277222|P2|Randomized and Treated|Overall Study||369
4990303|NCT02434328|12277223|P1|Randomized and Treated|Overall Study||370
4990304|NCT02434328|12277222|P2|STARTED|Overall Study||371
4990305|NCT02434328|12277223|P1|STARTED|Overall Study||372
4990306|NCT02434146|12277286|P1|NOT COMPLETED|Overall Study||0
4990307|NCT02434146|12277286|P1|COMPLETED|Overall Study||3
4990308|NCT02434146|12277286|P1|STARTED|Overall Study||3
4990309|NCT02433834|12277298|P1|NOT COMPLETED|Overall Study||37
4990310|NCT02433834|12277298|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
4990311|NCT02433834|12277298|P1|SAL 50 µg|Overall Study||167
4990312|NCT02433834|12277298|P1|Placebo MDI|Overall Study||174
4990313|NCT02433834|12277298|P1|GP MDI 1.9 µg|Overall Study||107
4990314|NCT02433834|12277298|P1|GP MDI 3.6 µg|Overall Study||118
4990315|NCT02433834|12277298|P1|GP MDI 7.2 µg|Overall Study||228
4990316|NCT02433834|12277298|P1|GP MDI 14.4 µg|Overall Study||230
4990317|NCT02433834|12277298|P1|GP MDI 28.8 µg|Overall Study||112
4990318|NCT02433834|12277298|P1|STARTED|Overall Study||248
4990319|NCT02433678|12277358|P2|NOT COMPLETED|Overall Study||2
4990320|NCT02433678|12277359|P1|NOT COMPLETED|Overall Study||1
4990321|NCT02433678|12277358|P2|COMPLETED|Overall Study||24
4990322|NCT02433678|12277359|P1|COMPLETED|Overall Study||25
4990323|NCT02433678|12277358|P2|STARTED|Overall Study||26
4990324|NCT02433678|12277359|P1|STARTED|Overall Study||26
4990325|NCT02433665|12277393|P2|NOT COMPLETED|Overall Study||0
4990326|NCT02433665|12277394|P1|NOT COMPLETED|Overall Study||0
4990327|NCT02433665|12277393|P2|COMPLETED|Overall Study||79
4990328|NCT02433665|12277394|P1|COMPLETED|Overall Study||77
4990329|NCT02433665|12277393|P2|STARTED|Overall Study||79
4990330|NCT02433665|12277394|P1|STARTED|Overall Study||77
4990331|NCT02433613|12277400|P1|NOT COMPLETED|Overall Study||17
4990332|NCT02433613|12277400|P1|COMPLETED|Overall Study||1054
4990333|NCT02433613|12277400|P1|STARTED|Overall Study||1071
4990334|NCT02433496|12277420|P3|NOT COMPLETED|Overall Study||0
4990335|NCT02433496|12277421|P2|NOT COMPLETED|Overall Study||0
4990336|NCT02433496|12277422|P1|NOT COMPLETED|Overall Study||0
4990337|NCT02433496|12277420|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
4990338|NCT02433496|12277421|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
4990339|NCT02433496|12277422|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
4990340|NCT02433496|12277420|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
4990341|NCT02433496|12277421|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
4990342|NCT02433496|12277422|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
4990343|NCT02433483|12277452|P1|NOT COMPLETED|Overall Study||2
4990344|NCT02433483|12277452|P1|COMPLETED|Overall Study||0
4990345|NCT02433483|12277452|P1|STARTED|Overall Study||2
4990346|NCT02433366|12277466|P2|NOT COMPLETED|Overall Study||0
4990347|NCT02433366|12277467|P1|NOT COMPLETED|Overall Study||0
4990348|NCT02433366|12277466|P2|COMPLETED|Overall Study||802
4990349|NCT02433366|12277467|P1|COMPLETED|Overall Study||411
4990350|NCT02433366|12277466|P2|STARTED|Overall Study||802
4990351|NCT02433366|12277467|P1|STARTED|Overall Study||411
4990352|NCT02433340|12277479|P4|NOT COMPLETED|Overall Study||2
4990353|NCT02433340|12277480|P3|NOT COMPLETED|Overall Study||2
4990354|NCT02433340|12277481|P2|NOT COMPLETED|Overall Study||2
4990355|NCT02433340|12277482|P1|NOT COMPLETED|Overall Study||2
4990356|NCT02433340|12277479|P4|COMPLETED|Overall Study||38
4990357|NCT02433340|12277480|P3|COMPLETED|Overall Study||37
4990358|NCT02433340|12277481|P2|COMPLETED|Overall Study||35
4990359|NCT02433340|12277482|P1|COMPLETED|Overall Study||40
4990360|NCT02433340|12277479|P4|STARTED|Overall Study||40
4990361|NCT02433340|12277480|P3|STARTED|Overall Study||39
4990362|NCT02433340|12277481|P2|STARTED|Overall Study||37
4990363|NCT02433340|12277482|P1|STARTED|Overall Study||42
4990364|NCT02433288|12278376|P2|NOT COMPLETED|Overall Study||126
4990365|NCT02433288|12278377|P1|NOT COMPLETED|Overall Study||123
4990366|NCT02433288|12278376|P2|COMPLETED|Overall Study||316
4990367|NCT02433288|12278377|P1|COMPLETED|Overall Study||320
4990368|NCT02433288|12278376|P2|STARTED|Overall Study||442
4990369|NCT02433288|12278377|P1|STARTED|Overall Study||443
4990370|NCT02433080|12278393|P2|NOT COMPLETED|Overall Study||4
4990371|NCT02433080|12278394|P1|NOT COMPLETED|Overall Study||1
4990372|NCT02433080|12278393|P2|COMPLETED|Overall Study||24
4990373|NCT02433080|12278394|P1|COMPLETED|Overall Study||25
4990374|NCT02433080|12278393|P2|8 Weeks|Overall Study||24
4990375|NCT02433080|12278394|P1|8 Weeks|Overall Study||25
4990376|NCT02433080|12278393|P2|STARTED|Overall Study||28
4990377|NCT02433080|12278394|P1|STARTED|Overall Study||26
4990378|NCT02432729|12278420|P1|NOT COMPLETED|Month 12 Visit||196
4990379|NCT02432729|12278420|P1|COMPLETED|Month 12 Visit||436
4990380|NCT02432729|12278420|P1|STARTED|Month 12 Visit||632
4990381|NCT02432729|12278420|P1|NOT COMPLETED|Month 6 Visit||86
4990382|NCT02432729|12278420|P1|COMPLETED|Month 6 Visit||632
4990383|NCT02432729|12278420|P1|STARTED|Month 6 Visit||718
4990384|NCT02432729|12278420|P1|NOT COMPLETED|Month 3 Visit||2
4990385|NCT02432729|12278420|P1|COMPLETED|Month 3 Visit||718
4990386|NCT02432729|12278420|P1|STARTED|Month 3 Visit||720
4990387|NCT02432716|12278448|P2|NOT COMPLETED|Overall Study||0
4990388|NCT02432716|12278449|P1|NOT COMPLETED|Overall Study||0
4990389|NCT02432716|12278448|P2|COMPLETED|Overall Study||6
4990390|NCT02432716|12278449|P1|COMPLETED|Overall Study||6
4990391|NCT02432716|12278448|P2|STARTED|Overall Study||6
4990392|NCT02432716|12278449|P1|STARTED|Overall Study||6
4990393|NCT02432456|12278465|P2|NOT COMPLETED|Overall Study||0
4990394|NCT02432456|12278466|P1|NOT COMPLETED|Overall Study||0
4990395|NCT02432456|12278465|P2|COMPLETED|Overall Study||75
4990396|NCT02432456|12278466|P1|COMPLETED|Overall Study||75
4990397|NCT02432456|12278465|P2|STARTED|Overall Study||75
4990398|NCT02432456|12278466|P1|STARTED|Overall Study||75
4990399|NCT02432300|12278488|P1|NOT COMPLETED|Overall Study||4
4990400|NCT02432300|12278488|P1|COMPLETED|Overall Study||13
4990401|NCT02432300|12278488|P1|STARTED|Overall Study||17
4990402|NCT02432287|12278497|P2|NOT COMPLETED|Second Intervention||0
4990403|NCT02432287|12278498|P1|NOT COMPLETED|Second Intervention||0
4990404|NCT02432287|12278497|P2|COMPLETED|Second Intervention||7
4990405|NCT02432287|12278498|P1|COMPLETED|Second Intervention||7
4990406|NCT02432287|12278497|P2|STARTED|Second Intervention||7
4990407|NCT02432287|12278498|P1|STARTED|Second Intervention||7
4990408|NCT02432287|12278497|P2|NOT COMPLETED|Washout Period||0
4990409|NCT02432287|12278498|P1|NOT COMPLETED|Washout Period||0
4990410|NCT02432287|12278497|P2|COMPLETED|Washout Period||7
4990411|NCT02432287|12278498|P1|COMPLETED|Washout Period||7
4990412|NCT02432287|12278497|P2|STARTED|Washout Period||7
4990413|NCT02432287|12278498|P1|STARTED|Washout Period||7
4990414|NCT02432287|12278497|P2|NOT COMPLETED|First Intervention||1
4990415|NCT02432287|12278498|P1|NOT COMPLETED|First Intervention||0
4990416|NCT02432287|12278497|P2|COMPLETED|First Intervention||7
4990417|NCT02432287|12278498|P1|COMPLETED|First Intervention||8
4990418|NCT02432287|12278497|P2|STARTED|First Intervention||8
4990419|NCT02432287|12278498|P1|STARTED|First Intervention||8
4990420|NCT02432196|12278506|P1|NOT COMPLETED|Overall Study||26
4990421|NCT02432196|12278506|P1|COMPLETED|Overall Study||0
4990422|NCT02432196|12278506|P1|Implanted With Device|Overall Study||25
4990423|NCT02432196|12278506|P1|STARTED|Overall Study||26
4990424|NCT02432144|12278514|P1|NOT COMPLETED|Overall Study||1
4990425|NCT02432144|12278514|P1|COMPLETED|Overall Study||11
4990426|NCT02432144|12278514|P1|STARTED|Overall Study||12
4990427|NCT02432105|12278522|P3|NOT COMPLETED|Overall Study||3
4990428|NCT02432105|12278523|P2|NOT COMPLETED|Overall Study||2
4990429|NCT02432105|12278524|P1|NOT COMPLETED|Overall Study||2
4990430|NCT02432105|12278522|P3|COMPLETED|Overall Study||108
4990431|NCT02432105|12278523|P2|COMPLETED|Overall Study||108
4990432|NCT02432105|12278524|P1|COMPLETED|Overall Study||162
4990433|NCT02432105|12278522|P3|STARTED|Overall Study||111
4990434|NCT02432105|12278523|P2|STARTED|Overall Study||110
4990435|NCT02432105|12278524|P1|STARTED|Overall Study||164
4990436|NCT02432040|12278541|P2|NOT COMPLETED|Overall Study||6
4990437|NCT02432040|12278542|P1|NOT COMPLETED|Overall Study||8
4990438|NCT02432040|12278541|P2|COMPLETED|Overall Study||8
4990439|NCT02432040|12278542|P1|COMPLETED|Overall Study||6
4990440|NCT02432040|12278541|P2|STARTED|Overall Study||14
4990441|NCT02432040|12278542|P1|STARTED|Overall Study||14
4990442|NCT02431793|12278565|P3|NOT COMPLETED|Overall Study||117
4990443|NCT02431793|12278566|P2|NOT COMPLETED|Overall Study||134
4990444|NCT02431793|12278567|P1|NOT COMPLETED|Overall Study||119
4990445|NCT02431793|12278565|P3|COMPLETED|Overall Study||90
4990446|NCT02431793|12278566|P2|COMPLETED|Overall Study||109
4990447|NCT02431793|12278567|P1|COMPLETED|Overall Study||83
4990448|NCT02431793|12278565|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
4990449|NCT02431793|12278566|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
4990450|NCT02431793|12278567|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
4990451|NCT02431793|12278565|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
4990452|NCT02431793|12278566|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
4990453|NCT02431793|12278567|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
4990454|NCT02431793|12278565|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
4990455|NCT02431793|12278566|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
4990456|NCT02431793|12278567|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
4990457|NCT02431793|12278565|P3|STARTED|Overall Study||207
4990458|NCT02431793|12278566|P2|STARTED|Overall Study||243
4990459|NCT02431793|12278567|P1|STARTED|Overall Study||202
4990460|NCT02431754|12278589|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
4990461|NCT02431754|12278590|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
4990462|NCT02431754|12278589|P2|COMPLETED|Period 2 (8 Weeks)||78
4990463|NCT02431754|12278590|P1|COMPLETED|Period 2 (8 Weeks)||74
4990464|NCT02431754|12278589|P2|STARTED|Period 2 (8 Weeks)||82
4990465|NCT02431754|12278590|P1|STARTED|Period 2 (8 Weeks)||75
4990466|NCT02431754|12278589|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
4990467|NCT02431754|12278590|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
4990468|NCT02431754|12278589|P2|COMPLETED|Wash-out Period (4 Weeks)||82
4990469|NCT02431754|12278590|P1|COMPLETED|Wash-out Period (4 Weeks)||75
4990470|NCT02431754|12278589|P2|STARTED|Wash-out Period (4 Weeks)||82
4990471|NCT02431754|12278590|P1|STARTED|Wash-out Period (4 Weeks)||79
4990472|NCT02431754|12278589|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
4990473|NCT02431754|12278590|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
4990474|NCT02431754|12278589|P2|COMPLETED|Period 1 (8 Weeks)||82
4990475|NCT02431754|12278590|P1|COMPLETED|Period 1 (8 Weeks)||79
4990476|NCT02431754|12278589|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
4990477|NCT02431754|12278590|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
4990478|NCT02431754|12278589|P2|STARTED|Period 1 (8 Weeks)||86
4990479|NCT02431754|12278590|P1|STARTED|Period 1 (8 Weeks)||85
4990480|NCT02431741|12278608|P1|NOT COMPLETED|Overall Study||0
4990481|NCT02431741|12278608|P1|COMPLETED|Overall Study||14
4990482|NCT02431741|12278608|P1|STARTED|Overall Study||14
4990483|NCT02431650|12278614|P2|NOT COMPLETED|Overall Study||0
4990484|NCT02431650|12278615|P1|NOT COMPLETED|Overall Study||0
4990485|NCT02431650|12278614|P2|COMPLETED|Overall Study||6
4990486|NCT02431650|12278615|P1|COMPLETED|Overall Study||5
4990487|NCT02431650|12278614|P2|STARTED|Overall Study||6
4990488|NCT02431650|12278615|P1|STARTED|Overall Study||5
4990489|NCT02431637|12278623|P1|NOT COMPLETED|Overall Study||0
4990490|NCT02431637|12278623|P1|COMPLETED|Overall Study||6
4990491|NCT02431637|12278623|P1|STARTED|Overall Study||6
4990492|NCT02431598|12278628|P6|NOT COMPLETED|Overall Study||0
4990493|NCT02431598|12278629|P5|NOT COMPLETED|Overall Study||0
4990494|NCT02431598|12278630|P4|NOT COMPLETED|Overall Study||0
4990495|NCT02431598|12278631|P3|NOT COMPLETED|Overall Study||0
4990496|NCT02431598|12278632|P2|NOT COMPLETED|Overall Study||0
4990497|NCT02431598|12278633|P1|NOT COMPLETED|Overall Study||0
4990498|NCT02431598|12278628|P6|COMPLETED|Overall Study||6
4990499|NCT02431598|12278629|P5|COMPLETED|Overall Study||7
4990500|NCT02431598|12278630|P4|COMPLETED|Overall Study||7
4990501|NCT02431598|12278631|P3|COMPLETED|Overall Study||9
4990502|NCT02431598|12278632|P2|COMPLETED|Overall Study||9
4990503|NCT02431598|12278633|P1|COMPLETED|Overall Study||6
4990504|NCT02431598|12278628|P6|STARTED|Overall Study||6
4990505|NCT02431598|12278629|P5|STARTED|Overall Study||7
4990506|NCT02431598|12278630|P4|STARTED|Overall Study||7
4990507|NCT02431598|12278631|P3|STARTED|Overall Study||9
4990508|NCT02431598|12278632|P2|STARTED|Overall Study||9
4990509|NCT02431598|12278633|P1|STARTED|Overall Study||6
4990510|NCT02431572|12278660|P3|NOT COMPLETED|Overall Study||0
4990511|NCT02431572|12278661|P2|NOT COMPLETED|Overall Study||0
4990512|NCT02431572|12278662|P1|NOT COMPLETED|Overall Study||1
4990513|NCT02431572|12278660|P3|COMPLETED|Overall Study||9
4990514|NCT02431572|12278661|P2|COMPLETED|Overall Study||1
4990515|NCT02431572|12278662|P1|COMPLETED|Overall Study||0
4990516|NCT02431572|12278660|P3|STARTED|Overall Study||9
4990517|NCT02431572|12278661|P2|STARTED|Overall Study||1
4990518|NCT02431572|12278662|P1|STARTED|Overall Study||1
4990519|NCT02431559|12278674|P4|NOT COMPLETED|Overall Study||31
4990520|NCT02431559|12278675|P3|NOT COMPLETED|Overall Study||4
4990521|NCT02431559|12278676|P2|NOT COMPLETED|Overall Study||3
4990522|NCT02431559|12278677|P1|NOT COMPLETED|Overall Study||2
4990523|NCT02431559|12278674|P4|COMPLETED|Overall Study||9
4990524|NCT02431559|12278675|P3|COMPLETED|Overall Study||2
4990525|NCT02431559|12278676|P2|COMPLETED|Overall Study||1
4990526|NCT02431559|12278677|P1|COMPLETED|Overall Study||1
4990527|NCT02431559|12278674|P4|STARTED|Overall Study||40
4990528|NCT02431559|12278675|P3|STARTED|Overall Study||6
4990529|NCT02431559|12278676|P2|STARTED|Overall Study||4
4990530|NCT02431559|12278677|P1|STARTED|Overall Study||3
4990531|NCT02431533|12278701|P2|NOT COMPLETED|Overall Study||3
4990532|NCT02431533|12278702|P1|NOT COMPLETED|Overall Study||2
4990533|NCT02431533|12278701|P2|COMPLETED|Overall Study||22
4990534|NCT02431533|12278702|P1|COMPLETED|Overall Study||23
4990535|NCT02431533|12278701|P2|STARTED|Overall Study||25
4990536|NCT02431533|12278702|P1|STARTED|Overall Study||25
4990537|NCT02431494|12278737|P3|NOT COMPLETED|Overall Study||0
4990538|NCT02431494|12278738|P2|NOT COMPLETED|Overall Study||0
4990539|NCT02431494|12278739|P1|NOT COMPLETED|Overall Study||0
4990540|NCT02431494|12278737|P3|COMPLETED|Overall Study||0
4990541|NCT02431494|12278738|P2|COMPLETED|Overall Study||0
4990542|NCT02431494|12278739|P1|COMPLETED|Overall Study||0
4990543|NCT02431494|12278737|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
4990544|NCT02431494|12278738|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
4990545|NCT02431494|12278739|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
4990546|NCT02431468|12278768|P3|NOT COMPLETED|Overall Study||9
4990547|NCT02431468|12278769|P2|NOT COMPLETED|Overall Study||18
4990548|NCT02431468|12278770|P1|NOT COMPLETED|Overall Study||8
4990549|NCT02431468|12278768|P3|COMPLETED|Overall Study||39
4990550|NCT02431468|12278769|P2|COMPLETED|Overall Study||29
4990551|NCT02431468|12278770|P1|COMPLETED|Overall Study||38
4990552|NCT02431468|12278768|P3|STARTED|Overall Study||48
4990553|NCT02431468|12278769|P2|STARTED|Overall Study||47
4990554|NCT02431468|12278770|P1|STARTED|Overall Study||46
4990555|NCT02431455|12278792|P2|NOT COMPLETED|Overall Study||0
4990556|NCT02431455|12278793|P1|NOT COMPLETED|Overall Study||0
4990557|NCT02431455|12278792|P2|COMPLETED|Overall Study||112
4990558|NCT02431455|12278793|P1|COMPLETED|Overall Study||112
4990559|NCT02431455|12278792|P2|STARTED|Overall Study||112
4990560|NCT02431455|12278793|P1|STARTED|Overall Study||112
4990561|NCT02431299|12278807|P2|NOT COMPLETED|Overall Study||1
4990562|NCT02431299|12278808|P1|NOT COMPLETED|Overall Study||53
4990563|NCT02431299|12278807|P2|COMPLETED|Overall Study||62
4990564|NCT02431299|12278808|P1|COMPLETED|Overall Study||183
4990565|NCT02431299|12278807|P2|STARTED|Overall Study||63
4990566|NCT02431299|12278808|P1|STARTED|Overall Study||236
4990567|NCT02431273|12278821|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
4990568|NCT02431273|12278821|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
4990569|NCT02431273|12278821|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
4990570|NCT02431273|12278821|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
4990571|NCT02431273|12278821|P1|COMPLETED|TDF-FTC (Dual IVR)||6
4990572|NCT02431273|12278821|P1|STARTED|TDF-FTC (Dual IVR)||6
4990573|NCT02431273|12278821|P1|NOT COMPLETED|TDF (Single IVR)||0
4990574|NCT02431273|12278821|P1|COMPLETED|TDF (Single IVR)||6
4990575|NCT02431273|12278821|P1|STARTED|TDF (Single IVR)||6
4990576|NCT02431260|12278861|P14|NOT COMPLETED|Overall Study||1
4990577|NCT02431260|12278862|P13|NOT COMPLETED|Overall Study||10
4990578|NCT02431260|12278863|P12|NOT COMPLETED|Overall Study||4
4990579|NCT02431260|12278864|P11|NOT COMPLETED|Overall Study||4
4990580|NCT02431260|12278865|P10|NOT COMPLETED|Overall Study||8
4990581|NCT02431260|12278866|P9|NOT COMPLETED|Overall Study||8
4990582|NCT02431260|12278867|P8|NOT COMPLETED|Overall Study||3
4990583|NCT02431260|12278868|P7|NOT COMPLETED|Overall Study||4
4990584|NCT02431260|12278869|P6|NOT COMPLETED|Overall Study||4
4990585|NCT02431260|12278870|P5|NOT COMPLETED|Overall Study||3
4990586|NCT02431260|12278871|P4|NOT COMPLETED|Overall Study||5
4990587|NCT02431260|12278872|P3|NOT COMPLETED|Overall Study||6
4990588|NCT02431260|12278873|P2|NOT COMPLETED|Overall Study||5
4990589|NCT02431260|12278874|P1|NOT COMPLETED|Overall Study||4
4990590|NCT02431260|12278861|P14|COMPLETED|Overall Study||0
4990591|NCT02431260|12278862|P13|COMPLETED|Overall Study||0
4990592|NCT02431260|12278863|P12|COMPLETED|Overall Study||0
4990593|NCT02431260|12278864|P11|COMPLETED|Overall Study||0
4990594|NCT02431260|12278865|P10|COMPLETED|Overall Study||0
4990595|NCT02431260|12278866|P9|COMPLETED|Overall Study||0
4990596|NCT02431260|12278867|P8|COMPLETED|Overall Study||0
4990597|NCT02431260|12278868|P7|COMPLETED|Overall Study||0
4990598|NCT02431260|12278869|P6|COMPLETED|Overall Study||0
4990599|NCT02431260|12278870|P5|COMPLETED|Overall Study||0
4990600|NCT02431260|12278871|P4|COMPLETED|Overall Study||0
4990601|NCT02431260|12278872|P3|COMPLETED|Overall Study||0
4990602|NCT02431260|12278873|P2|COMPLETED|Overall Study||0
4990603|NCT02431260|12278874|P1|COMPLETED|Overall Study||0
4990604|NCT02431260|12278861|P14|STARTED|Overall Study||1
4990605|NCT02431260|12278862|P13|STARTED|Overall Study||10
4990606|NCT02431260|12278863|P12|STARTED|Overall Study||4
4990607|NCT02431260|12278864|P11|STARTED|Overall Study||4
4990608|NCT02431260|12278865|P10|STARTED|Overall Study||8
4990609|NCT02431260|12278866|P9|STARTED|Overall Study||8
4990610|NCT02431260|12278867|P8|STARTED|Overall Study||3
4990611|NCT02431260|12278868|P7|STARTED|Overall Study||4
4990612|NCT02431260|12278869|P6|STARTED|Overall Study||4
4990613|NCT02431260|12278870|P5|STARTED|Overall Study||3
4990614|NCT02431260|12278871|P4|STARTED|Overall Study||5
4990615|NCT02431260|12278872|P3|STARTED|Overall Study||6
4990616|NCT02431260|12278873|P2|STARTED|Overall Study||5
4990617|NCT02431260|12278874|P1|STARTED|Overall Study||4
4990618|NCT02431247|12278967|P2|NOT COMPLETED|Overall Study||363
4990619|NCT02431247|12278968|P1|NOT COMPLETED|Overall Study||362
4990620|NCT02431247|12278967|P2|COMPLETED|Overall Study||0
4990621|NCT02431247|12278968|P1|COMPLETED|Overall Study||0
4990622|NCT02431247|12278967|P2|STARTED|Overall Study||363
4990623|NCT02431247|12278968|P1|STARTED|Overall Study||362
4990624|NCT02431052|12279027|P5|NOT COMPLETED|Overall Study||15
4990625|NCT02431052|12279028|P4|NOT COMPLETED|Overall Study||16
4990626|NCT02431052|12279029|P3|NOT COMPLETED|Overall Study||12
4990627|NCT02431052|12279030|P2|NOT COMPLETED|Overall Study||4
4990628|NCT02431052|12279031|P1|NOT COMPLETED|Overall Study||11
4990629|NCT02431052|12279027|P5|COMPLETED|Overall Study||86
4990630|NCT02431052|12279028|P4|COMPLETED|Overall Study||94
4990631|NCT02431052|12279029|P3|COMPLETED|Overall Study||94
4990632|NCT02431052|12279030|P2|COMPLETED|Overall Study||46
4990633|NCT02431052|12279031|P1|COMPLETED|Overall Study||42
4990634|NCT02431052|12279027|P5|STARTED|Overall Study||101
4990635|NCT02431052|12279028|P4|STARTED|Overall Study||110
4990636|NCT02431052|12279029|P3|STARTED|Overall Study||106
4990637|NCT02431052|12279030|P2|STARTED|Overall Study||50
4990638|NCT02431052|12279031|P1|STARTED|Overall Study||53
4990639|NCT02430870|12279061|P8|NOT COMPLETED|Part 2||1
4990640|NCT02430870|12279062|P7|NOT COMPLETED|Part 2||1
4990641|NCT02430870|12279063|P6|NOT COMPLETED|Part 2||0
4990642|NCT02430870|12279064|P5|NOT COMPLETED|Part 2||0
4990643|NCT02430870|12279065|P4|NOT COMPLETED|Part 2||0
4990644|NCT02430870|12279066|P3|NOT COMPLETED|Part 2||0
4990645|NCT02430870|12279067|P2|NOT COMPLETED|Part 2||0
4990646|NCT02430870|12279068|P1|NOT COMPLETED|Part 2||0
4990647|NCT02430870|12279061|P8|COMPLETED|Part 2||7
4990648|NCT02430870|12279062|P7|COMPLETED|Part 2||5
4990649|NCT02430870|12279063|P6|COMPLETED|Part 2||6
4990650|NCT02430870|12279064|P5|COMPLETED|Part 2||6
4990651|NCT02430870|12279065|P4|COMPLETED|Part 2||6
4990652|NCT02430870|12279066|P3|COMPLETED|Part 2||0
4990653|NCT02430870|12279067|P2|COMPLETED|Part 2||0
4990654|NCT02430870|12279068|P1|COMPLETED|Part 2||0
4990655|NCT02430870|12279061|P8|STARTED|Part 2||8
4990656|NCT02430870|12279062|P7|STARTED|Part 2||6
4990657|NCT02430870|12279063|P6|STARTED|Part 2||6
4990658|NCT02430870|12279064|P5|STARTED|Part 2||6
4990659|NCT02430870|12279065|P4|STARTED|Part 2||6
4990660|NCT02430870|12279066|P3|STARTED|Part 2||0
4990661|NCT02430870|12279067|P2|STARTED|Part 2||0
4990662|NCT02430870|12279068|P1|STARTED|Part 2||0
4990663|NCT02430870|12279061|P8|NOT COMPLETED|Part 1||0
4990664|NCT02430870|12279062|P7|NOT COMPLETED|Part 1||0
4990665|NCT02430870|12279063|P6|NOT COMPLETED|Part 1||0
4990666|NCT02430870|12279064|P5|NOT COMPLETED|Part 1||0
4990667|NCT02430870|12279065|P4|NOT COMPLETED|Part 1||0
4990668|NCT02430870|12279066|P3|NOT COMPLETED|Part 1||0
4990669|NCT02430870|12279067|P2|NOT COMPLETED|Part 1||0
4990670|NCT02430870|12279068|P1|NOT COMPLETED|Part 1||0
4990671|NCT02430870|12279061|P8|COMPLETED|Part 1||0
4990672|NCT02430870|12279062|P7|COMPLETED|Part 1||0
4990673|NCT02430870|12279063|P6|COMPLETED|Part 1||0
4990674|NCT02430870|12279064|P5|COMPLETED|Part 1||0
4990675|NCT02430870|12279065|P4|COMPLETED|Part 1||0
4990676|NCT02430870|12279066|P3|COMPLETED|Part 1||4
4990677|NCT02430870|12279067|P2|COMPLETED|Part 1||6
4990678|NCT02430870|12279068|P1|COMPLETED|Part 1||6
4990679|NCT02430870|12279061|P8|STARTED|Part 1||0
4990680|NCT02430870|12279062|P7|STARTED|Part 1||0
4990681|NCT02430870|12279063|P6|STARTED|Part 1||0
4990682|NCT02430870|12279064|P5|STARTED|Part 1||0
4990683|NCT02430870|12279065|P4|STARTED|Part 1||0
4990684|NCT02430870|12279066|P3|STARTED|Part 1||4
4990685|NCT02430870|12279067|P2|STARTED|Part 1||6
4990686|NCT02430870|12279068|P1|STARTED|Part 1||6
4990687|NCT02430818|12279142|P2|NOT COMPLETED|Overall Study||0
4990688|NCT02430818|12279143|P1|NOT COMPLETED|Overall Study||0
4990689|NCT02430818|12279142|P2|COMPLETED|Overall Study||6
4990690|NCT02430818|12279143|P1|COMPLETED|Overall Study||7
4990691|NCT02430818|12279142|P2|STARTED|Overall Study||6
4990692|NCT02430818|12279143|P1|STARTED|Overall Study||7
4990693|NCT02430532|12279155|P2|NOT COMPLETED|Overall Study||28
4990694|NCT02430532|12279156|P1|NOT COMPLETED|Overall Study||30
4990695|NCT02430532|12279155|P2|COMPLETED|Overall Study||0
4990696|NCT02430532|12279156|P1|COMPLETED|Overall Study||0
4990697|NCT02430532|12279155|P2|STARTED|Overall Study||28
4990698|NCT02430532|12279156|P1|STARTED|Overall Study||30
4990699|NCT02430389|12279172|P2|NOT COMPLETED|Overall Study||0
4990700|NCT02430389|12279173|P1|NOT COMPLETED|Overall Study||0
4990701|NCT02430389|12279172|P2|COMPLETED|Overall Study||10
4990702|NCT02430389|12279173|P1|COMPLETED|Overall Study||10
4990703|NCT02430389|12279172|P2|STARTED|Overall Study||10
4990704|NCT02430389|12279173|P1|STARTED|Overall Study||10
4990705|NCT02430337|12279183|P2|NOT COMPLETED|Overall Study||0
4990706|NCT02430337|12279184|P1|NOT COMPLETED|Overall Study||0
4990707|NCT02430337|12279183|P2|COMPLETED|Overall Study||20
4990708|NCT02430337|12279184|P1|COMPLETED|Overall Study||11
4990709|NCT02430337|12279183|P2|STARTED|Overall Study||20
4990710|NCT02430337|12279184|P1|STARTED|Overall Study||11
4990711|NCT02430311|12279197|P2|NOT COMPLETED|Part B||8
4990712|NCT02430311|12279198|P1|NOT COMPLETED|Part B||10
4990713|NCT02430311|12279197|P2|COMPLETED|Part B||7
4990714|NCT02430311|12279198|P1|COMPLETED|Part B||9
4990715|NCT02430311|12279197|P2|Received Paclitaxel|Part B||14
4990716|NCT02430311|12279198|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
4990717|NCT02430311|12279197|P2|Received Olaparib|Part B||15
4990718|NCT02430311|12279198|P1|Received Olaparib|Part B||19
4990719|NCT02430311|12279197|P2|STARTED|Part B||15
4990720|NCT02430311|12279198|P1|STARTED|Part B||19
4990721|NCT02430311|12279197|P2|NOT COMPLETED|Part A||1
4990722|NCT02430311|12279198|P1|NOT COMPLETED|Part A||1
4990723|NCT02430311|12279197|P2|COMPLETED|Part A||15
4990724|NCT02430311|12279198|P1|COMPLETED|Part A||19
4990725|NCT02430311|12279197|P2|Received Paclitaxel|Part A||16
4990726|NCT02430311|12279198|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
4990727|NCT02430311|12279197|P2|Received Olaparib|Part A||16
4990728|NCT02430311|12279198|P1|Received Olaparib|Part A||20
4990729|NCT02430311|12279197|P2|STARTED|Part A||16
4990730|NCT02430311|12279198|P1|STARTED|Part A||20
4990731|NCT02430090|12279234|P3|NOT COMPLETED|Overall Study||0
4990732|NCT02430090|12279235|P2|NOT COMPLETED|Overall Study||0
4990733|NCT02430090|12279236|P1|NOT COMPLETED|Overall Study||0
4990734|NCT02430090|12279234|P3|COMPLETED|Overall Study||15
4990735|NCT02430090|12279235|P2|COMPLETED|Overall Study||15
4990736|NCT02430090|12279236|P1|COMPLETED|Overall Study||15
4990737|NCT02430090|12279234|P3|STARTED|Overall Study||15
4990738|NCT02430090|12279235|P2|STARTED|Overall Study||15
4990739|NCT02430090|12279236|P1|STARTED|Overall Study||15
4990740|NCT02429869|12279244|P1|NOT COMPLETED|Overall Study||0
4990741|NCT02429869|12279244|P1|COMPLETED|Overall Study||10
4990742|NCT02429869|12279244|P1|STARTED|Overall Study||10
4990743|NCT02429856|12279252|P2|NOT COMPLETED|Overall Study||19
4990744|NCT02429856|12279253|P1|NOT COMPLETED|Overall Study||19
4990745|NCT02429856|12279252|P2|COMPLETED|Overall Study||32
4990746|NCT02429856|12279253|P1|COMPLETED|Overall Study||30
4990747|NCT02429856|12279252|P2|STARTED|Overall Study||51
4990748|NCT02429856|12279253|P1|STARTED|Overall Study||49
4990749|NCT02429791|12279271|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
4990750|NCT02429791|12279272|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
4990751|NCT02429791|12279271|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
4990752|NCT02429791|12279272|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
4990753|NCT02429791|12279271|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
4990754|NCT02429791|12279272|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
4990755|NCT02429791|12279271|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
4990756|NCT02429791|12279272|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
4990757|NCT02429791|12279271|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
4990758|NCT02429791|12279272|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
4990759|NCT02429791|12279271|P2|STARTED|Early Switch Phase (Up to Week 52)||256
4990760|NCT02429791|12279272|P1|STARTED|Early Switch Phase (Up to Week 52)||252
4990761|NCT02429778|12279360|P2|NOT COMPLETED|Overall Study||0
4990762|NCT02429778|12279361|P1|NOT COMPLETED|Overall Study||7
4990763|NCT02429778|12279360|P2|COMPLETED|Overall Study||20
4990764|NCT02429778|12279361|P1|COMPLETED|Overall Study||13
4990765|NCT02429778|12279360|P2|STARTED|Overall Study||20
4990766|NCT02429778|12279361|P1|STARTED|Overall Study||20
4990767|NCT02429583|12279375|P2|NOT COMPLETED|Overall Study||20
4990768|NCT02429583|12279376|P1|NOT COMPLETED|Overall Study||0
4990769|NCT02429583|12279375|P2|COMPLETED|Overall Study||3
4990770|NCT02429583|12279376|P1|COMPLETED|Overall Study||1
4990771|NCT02429583|12279375|P2|STARTED|Overall Study||23
4990772|NCT02429583|12279376|P1|STARTED|Overall Study||1
4990773|NCT02429427|12279392|P2|NOT COMPLETED|Overall Study||179
4990774|NCT02429427|12279393|P1|NOT COMPLETED|Overall Study||371
4990775|NCT02429427|12279392|P2|COMPLETED|Overall Study||697
4990776|NCT02429427|12279393|P1|COMPLETED|Overall Study||1392
4990777|NCT02429427|12279392|P2|STARTED|Overall Study||876
4990778|NCT02429427|12279393|P1|STARTED|Overall Study||1763
4990779|NCT02429310|12279407|P2|NOT COMPLETED|Overall Study||3
4990780|NCT02429310|12279408|P1|NOT COMPLETED|Overall Study||2
4990781|NCT02429310|12279407|P2|COMPLETED|Overall Study||17
4990782|NCT02429310|12279408|P1|COMPLETED|Overall Study||20
4990783|NCT02429310|12279407|P2|STARTED|Overall Study||20
4990784|NCT02429310|12279408|P1|STARTED|Overall Study||22
4990785|NCT02429258|12279418|P2|NOT COMPLETED|Overall Study||1
4990786|NCT02429258|12279419|P1|NOT COMPLETED|Overall Study||2
4990787|NCT02429258|12279418|P2|COMPLETED|Overall Study||49
4990788|NCT02429258|12279419|P1|COMPLETED|Overall Study||48
4990789|NCT02429258|12279418|P2|STARTED|Overall Study||50
4990790|NCT02429258|12279419|P1|STARTED|Overall Study||50
4990791|NCT02429115|12279451|P6|NOT COMPLETED|Overall Study||1
4990792|NCT02429115|12279452|P5|NOT COMPLETED|Overall Study||7
4990793|NCT02429115|12279453|P4|NOT COMPLETED|Overall Study||8
4990794|NCT02429115|12279454|P3|NOT COMPLETED|Overall Study||16
4990795|NCT02429115|12279455|P2|NOT COMPLETED|Overall Study||10
4990796|NCT02429115|12279456|P1|NOT COMPLETED|Overall Study||12
4990797|NCT02429115|12279451|P6|COMPLETED|Overall Study||27
4990798|NCT02429115|12279452|P5|COMPLETED|Overall Study||22
4990799|NCT02429115|12279453|P4|COMPLETED|Overall Study||21
4990800|NCT02429115|12279454|P3|COMPLETED|Overall Study||35
4990801|NCT02429115|12279455|P2|COMPLETED|Overall Study||42
4990802|NCT02429115|12279456|P1|COMPLETED|Overall Study||40
4990803|NCT02429115|12279451|P6|STARTED|Overall Study||28
4990804|NCT02429115|12279452|P5|STARTED|Overall Study||29
4990805|NCT02429115|12279453|P4|STARTED|Overall Study||29
4990806|NCT02429115|12279454|P3|STARTED|Overall Study||51
4990807|NCT02429115|12279455|P2|STARTED|Overall Study||52
4990808|NCT02429115|12279456|P1|STARTED|Overall Study||52
4990809|NCT02428855|12279473|P1|NOT COMPLETED|Overall Study||2
4990810|NCT02428855|12279473|P1|COMPLETED|Overall Study||6
4990811|NCT02428855|12279473|P1|STARTED|Overall Study||8
4990812|NCT02428699|12279480|P2|NOT COMPLETED|Period 2||0
4990813|NCT02428699|12279481|P1|NOT COMPLETED|Period 2||0
4990814|NCT02428699|12279480|P2|COMPLETED|Period 2||23
4990815|NCT02428699|12279481|P1|COMPLETED|Period 2||24
4990816|NCT02428699|12279480|P2|STARTED|Period 2||23
4990817|NCT02428699|12279481|P1|STARTED|Period 2||24
4990818|NCT02428699|12279480|P2|NOT COMPLETED|Washout Period 1||2
4990819|NCT02428699|12279481|P1|NOT COMPLETED|Washout Period 1||1
4990820|NCT02428699|12279480|P2|COMPLETED|Washout Period 1||23
4990821|NCT02428699|12279481|P1|COMPLETED|Washout Period 1||24
4990822|NCT02428699|12279480|P2|STARTED|Washout Period 1||25
4990823|NCT02428699|12279481|P1|STARTED|Washout Period 1||25
4990824|NCT02428699|12279480|P2|NOT COMPLETED|Period 1||0
4990825|NCT02428699|12279481|P1|NOT COMPLETED|Period 1||0
4990826|NCT02428699|12279480|P2|COMPLETED|Period 1||25
4990827|NCT02428699|12279481|P1|COMPLETED|Period 1||25
4990828|NCT02428699|12279480|P2|STARTED|Period 1||25
4990829|NCT02428699|12279481|P1|STARTED|Period 1||25
4990830|NCT02428608|12279509|P1|NOT COMPLETED|Overall Study||83
4990831|NCT02428608|12279509|P1|COMPLETED|Overall Study||487
4990832|NCT02428608|12279509|P1|STARTED|Overall Study||570
4990833|NCT02428595|12279514|P1|NOT COMPLETED|Treatment||19
4990834|NCT02428595|12279514|P1|COMPLETED|Treatment||54
4990835|NCT02428595|12279514|P1|STARTED|Treatment||73
4990836|NCT02428595|12279514|P1|NOT COMPLETED|Fitting||64
4990837|NCT02428595|12279514|P1|COMPLETED|Fitting||73
4990838|NCT02428595|12279514|P1|STARTED|Fitting||137
4990839|NCT02428478|12279530|P2|NOT COMPLETED|Second Study Night||0
4990840|NCT02428478|12279531|P1|NOT COMPLETED|Second Study Night||0
4990841|NCT02428478|12279530|P2|COMPLETED|Second Study Night||6
4990842|NCT02428478|12279531|P1|COMPLETED|Second Study Night||8
4990843|NCT02428478|12279530|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
4990844|NCT02428478|12279531|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
4990845|NCT02428478|12279530|P2|NOT COMPLETED|First Study Night||0
4990846|NCT02428478|12279531|P1|NOT COMPLETED|First Study Night||0
4990847|NCT02428478|12279530|P2|COMPLETED|First Study Night||8
4990848|NCT02428478|12279531|P1|COMPLETED|First Study Night||9
4990849|NCT02428478|12279530|P2|STARTED|First Study Night||8
4990850|NCT02428478|12279531|P1|STARTED|First Study Night||9
4990851|NCT02428413|12279541|P2|NOT COMPLETED|Overall Study||9
4990852|NCT02428413|12279542|P1|NOT COMPLETED|Overall Study||8
4990853|NCT02428413|12279541|P2|COMPLETED|Overall Study||52
4990854|NCT02428413|12279542|P1|COMPLETED|Overall Study||56
4990855|NCT02428413|12279541|P2|STARTED|Overall Study||61
4990856|NCT02428413|12279542|P1|STARTED|Overall Study||64
4990857|NCT02428309|12279554|P1|NOT COMPLETED|Overall Study||0
4990858|NCT02428309|12279554|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
4990859|NCT02428309|12279554|P1|STARTED|Overall Study||1
4990860|NCT02428296|12279577|P1|NOT COMPLETED|Overall Study||9
4990861|NCT02428296|12279577|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
4990862|NCT02428296|12279577|P1|Treated|Overall Study||39
4990863|NCT02428296|12279577|P1|STARTED|Overall Study||39
4990864|NCT02428231|12279589|P2|NOT COMPLETED|Overall Study||17
4990865|NCT02428231|12279590|P1|NOT COMPLETED|Overall Study||13
4990866|NCT02428231|12279589|P2|COMPLETED|Overall Study||15
4990867|NCT02428231|12279590|P1|COMPLETED|Overall Study||17
4990868|NCT02428231|12279589|P2|STARTED|Overall Study||32
4990869|NCT02428231|12279590|P1|STARTED|Overall Study||30
4990870|NCT02428192|12279606|P2|NOT COMPLETED|Overall Study||1
4990871|NCT02428192|12279607|P1|NOT COMPLETED|Overall Study||12
4990872|NCT02428192|12279606|P2|COMPLETED|Overall Study||7
4990873|NCT02428192|12279607|P1|COMPLETED|Overall Study||0
4990874|NCT02428192|12279606|P2|STARTED|Overall Study||8
4990875|NCT02428192|12279607|P1|STARTED|Overall Study||12
4990876|NCT02427984|12279622|P3|NOT COMPLETED|Overall Study||18
4990877|NCT02427984|12279623|P2|NOT COMPLETED|Overall Study||5
4990878|NCT02427984|12279624|P1|NOT COMPLETED|Overall Study||13
4990879|NCT02427984|12279622|P3|COMPLETED|Overall Study||32
4990880|NCT02427984|12279623|P2|COMPLETED|Overall Study||40
4990881|NCT02427984|12279624|P1|COMPLETED|Overall Study||40
4990882|NCT02427984|12279622|P3|STARTED|Overall Study||50
4990883|NCT02427984|12279623|P2|STARTED|Overall Study||45
4990884|NCT02427984|12279624|P1|STARTED|Overall Study||53
4990885|NCT02427958|12279638|P1|NOT COMPLETED|Overall Study||24
4990886|NCT02427958|12279638|P1|COMPLETED|Overall Study||283
4990887|NCT02427958|12279638|P1|STARTED|Overall Study||307
4990888|NCT02427750|12279645|P2|NOT COMPLETED|Overall Study||0
4990889|NCT02427750|12279646|P1|NOT COMPLETED|Overall Study||0
4990890|NCT02427750|12279645|P2|COMPLETED|Overall Study||63
4990891|NCT02427750|12279646|P1|COMPLETED|Overall Study||63
4990892|NCT02427750|12279645|P2|STARTED|Overall Study||63
4990893|NCT02427750|12279646|P1|STARTED|Overall Study||63
4990894|NCT02427737|12279671|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
4990895|NCT02427737|12279672|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
4990896|NCT02427737|12279671|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
4990897|NCT02427737|12279672|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
4990898|NCT02427737|12279671|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
4990899|NCT02427737|12279672|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
4990900|NCT02427737|12279671|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
4990901|NCT02427737|12279672|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
4990902|NCT02427737|12279671|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
4990903|NCT02427737|12279672|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
4990904|NCT02427737|12279671|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
4990905|NCT02427737|12279672|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
4990906|NCT02427737|12279671|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
4990907|NCT02427737|12279672|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
4990908|NCT02427737|12279671|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
4990909|NCT02427737|12279672|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
4990910|NCT02427737|12279671|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
4990911|NCT02427737|12279672|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
4990912|NCT02427737|12279671|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
4990913|NCT02427737|12279672|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
4990914|NCT02427737|12279671|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
4990915|NCT02427737|12279672|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
4990916|NCT02427737|12279671|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
4990917|NCT02427737|12279672|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
4990918|NCT02427737|12279671|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
4990919|NCT02427737|12279672|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
4990920|NCT02427737|12279671|P2|COMPLETED|OSU Baseline Q4FY15||3230
4990921|NCT02427737|12279672|P1|COMPLETED|OSU Baseline Q4FY15||3940
4990922|NCT02427737|12279671|P2|STARTED|OSU Baseline Q4FY15||3446
4990923|NCT02427737|12279672|P1|STARTED|OSU Baseline Q4FY15||4158
4990924|NCT02427672|12279720|P2|NOT COMPLETED|Overall Study||2
4990925|NCT02427672|12279721|P1|NOT COMPLETED|Overall Study||1
4990926|NCT02427672|12279720|P2|COMPLETED|Overall Study||42
4990927|NCT02427672|12279721|P1|COMPLETED|Overall Study||39
4990928|NCT02427672|12279720|P2|STARTED|Overall Study||44
4990929|NCT02427672|12279721|P1|STARTED|Overall Study||40
4990930|NCT02427646|12279731|P2|NOT COMPLETED|Overall Study||14
4990931|NCT02427646|12279732|P1|NOT COMPLETED|Overall Study||8
4990932|NCT02427646|12279731|P2|COMPLETED|Overall Study||14
4990933|NCT02427646|12279732|P1|COMPLETED|Overall Study||16
4990934|NCT02427646|12279731|P2|STARTED|Overall Study||28
4990935|NCT02427646|12279732|P1|STARTED|Overall Study||24
4990936|NCT02427607|12279740|P1|NOT COMPLETED|Overall Study||1
4990937|NCT02427607|12279740|P1|COMPLETED|Overall Study||6
4990938|NCT02427607|12279740|P1|STARTED|Overall Study||7
4990939|NCT02427477|12279746|P2|NOT COMPLETED|Period 3||0
4990940|NCT02427477|12279747|P1|NOT COMPLETED|Period 3||0
4990941|NCT02427477|12279746|P2|COMPLETED|Period 3||60
4990942|NCT02427477|12279747|P1|COMPLETED|Period 3||59
4990943|NCT02427477|12279746|P2|STARTED|Period 3||60
4990944|NCT02427477|12279747|P1|STARTED|Period 3||59
4990945|NCT02427477|12279746|P2|NOT COMPLETED|Period 2||0
4990946|NCT02427477|12279747|P1|NOT COMPLETED|Period 2||0
4990947|NCT02427477|12279746|P2|COMPLETED|Period 2||60
4990948|NCT02427477|12279747|P1|COMPLETED|Period 2||59
4990949|NCT02427477|12279746|P2|STARTED|Period 2||60
4990950|NCT02427477|12279747|P1|STARTED|Period 2||59
4990951|NCT02427477|12279746|P2|NOT COMPLETED|Period 1||0
4990952|NCT02427477|12279747|P1|NOT COMPLETED|Period 1||1
4990953|NCT02427477|12279746|P2|COMPLETED|Period 1||60
4990954|NCT02427477|12279747|P1|COMPLETED|Period 1||59
4990955|NCT02427477|12279746|P2|STARTED|Period 1||60
4990956|NCT02427477|12279747|P1|STARTED|Period 1||60
4990957|NCT02427399|12279760|P5|NOT COMPLETED|Overall Study||15
4990958|NCT02427399|12279761|P4|NOT COMPLETED|Overall Study||18
4990959|NCT02427399|12279762|P3|NOT COMPLETED|Overall Study||12
4990960|NCT02427399|12279763|P2|NOT COMPLETED|Overall Study||16
4990961|NCT02427399|12279764|P1|NOT COMPLETED|Overall Study||14
4990962|NCT02427399|12279760|P5|COMPLETED|Overall Study||205
4990963|NCT02427399|12279761|P4|COMPLETED|Overall Study||202
4990964|NCT02427399|12279762|P3|COMPLETED|Overall Study||208
4990965|NCT02427399|12279763|P2|COMPLETED|Overall Study||204
4990966|NCT02427399|12279764|P1|COMPLETED|Overall Study||206
4990967|NCT02427399|12279760|P5|STARTED|Overall Study||220
4990968|NCT02427399|12279761|P4|STARTED|Overall Study||220
4990969|NCT02427399|12279762|P3|STARTED|Overall Study||220
4990970|NCT02427399|12279763|P2|STARTED|Overall Study||220
4990971|NCT02427399|12279764|P1|STARTED|Overall Study||220
4990972|NCT02427100|12279788|P2|NOT COMPLETED|Overall Study||2
4990973|NCT02427100|12279789|P1|NOT COMPLETED|Overall Study||0
4990974|NCT02427100|12279788|P2|COMPLETED|Overall Study||15
4990975|NCT02427100|12279789|P1|COMPLETED|Overall Study||15
4990976|NCT02427100|12279788|P2|STARTED|Overall Study||17
4990977|NCT02427100|12279789|P1|STARTED|Overall Study||15
4990978|NCT02426918|12279800|P3|NOT COMPLETED|Overall Study||14
4990979|NCT02426918|12279801|P2|NOT COMPLETED|Overall Study||19
4990980|NCT02426918|12279802|P1|NOT COMPLETED|Overall Study||17
4990981|NCT02426918|12279800|P3|COMPLETED|Overall Study||97
4990982|NCT02426918|12279801|P2|COMPLETED|Overall Study||90
4990983|NCT02426918|12279802|P1|COMPLETED|Overall Study||93
4990984|NCT02426918|12279800|P3|Safety Population|Overall Study||107
4990985|NCT02426918|12279801|P2|Safety Population|Overall Study||107
4990986|NCT02426918|12279802|P1|Safety Population|Overall Study||110
4990987|NCT02426918|12279800|P3|STARTED|Overall Study||111
4990988|NCT02426918|12279801|P2|STARTED|Overall Study||109
4990989|NCT02426918|12279802|P1|STARTED|Overall Study||110
4990990|NCT02426749|12279824|P2|NOT COMPLETED|Overall Study||1
4990991|NCT02426749|12279825|P1|NOT COMPLETED|Overall Study||3
4990992|NCT02426749|12279824|P2|COMPLETED|Overall Study||9
4990993|NCT02426749|12279825|P1|COMPLETED|Overall Study||9
4990994|NCT02426749|12279824|P2|STARTED|Overall Study||10
4990995|NCT02426749|12279825|P1|STARTED|Overall Study||12
4990996|NCT02426658|12279837|P1|NOT COMPLETED|Overall Study||3
4990997|NCT02426658|12279837|P1|COMPLETED|Overall Study||13
4990998|NCT02426658|12279837|P1|STARTED|Overall Study||16
4990999|NCT02426580|12279844|P2|NOT COMPLETED|Overall Study||16
4991000|NCT02426580|12279845|P1|NOT COMPLETED|Overall Study||11
4991001|NCT02426580|12279844|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
4991002|NCT02426580|12279845|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
4991003|NCT02426580|12279844|P2|STARTED|Overall Study|January 2014|70
4991004|NCT02426580|12279845|P1|STARTED|Overall Study|April 2015|70
4991005|NCT02426541|12279853|P2|NOT COMPLETED|Overall Study||0
4991006|NCT02426541|12279854|P1|NOT COMPLETED|Overall Study||1
4991007|NCT02426541|12279853|P2|COMPLETED|Overall Study||16
4991008|NCT02426541|12279854|P1|COMPLETED|Overall Study||15
4991009|NCT02426541|12279853|P2|STARTED|Overall Study||16
4991010|NCT02426541|12279854|P1|STARTED|Overall Study||16
4991011|NCT02426138|12279866|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
4991012|NCT02426138|12279867|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
4991013|NCT02426138|12279866|P2|COMPLETED|Intent to Treat Population Milestone||22
4991014|NCT02426138|12279867|P1|COMPLETED|Intent to Treat Population Milestone||20
4991015|NCT02426138|12279866|P2|STARTED|Intent to Treat Population Milestone||22
4991016|NCT02426138|12279867|P1|STARTED|Intent to Treat Population Milestone||20
4991017|NCT02426138|12279866|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
4991018|NCT02426138|12279867|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
4991019|NCT02426138|12279866|P2|COMPLETED|Second Intervention (12 Weeks)||22
4991020|NCT02426138|12279867|P1|COMPLETED|Second Intervention (12 Weeks)||20
4991021|NCT02426138|12279866|P2|STARTED|Second Intervention (12 Weeks)||22
4991022|NCT02426138|12279867|P1|STARTED|Second Intervention (12 Weeks)||20
4991023|NCT02426138|12279866|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
4991024|NCT02426138|12279867|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
4991025|NCT02426138|12279866|P2|COMPLETED|First Intervention (12 Weeks)||22
4991026|NCT02426138|12279867|P1|COMPLETED|First Intervention (12 Weeks)||20
4991027|NCT02426138|12279866|P2|STARTED|First Intervention (12 Weeks)||23
4991028|NCT02426138|12279867|P1|STARTED|First Intervention (12 Weeks)||21
4991029|NCT02426125|12279907|P2|NOT COMPLETED|Overall Study||26
4991030|NCT02426125|12279908|P1|NOT COMPLETED|Overall Study||29
4991031|NCT02426125|12279907|P2|COMPLETED|Overall Study||241
4991032|NCT02426125|12279908|P1|COMPLETED|Overall Study||234
4991033|NCT02426125|12279907|P2|First Randomized Participants|Overall Study||221
4991034|NCT02426125|12279908|P1|First Randomized Participants|Overall Study||216
4991035|NCT02426125|12279907|P2|Received at Least One Dose of Study Drug|Overall Study||265
4991036|NCT02426125|12279908|P1|Received at Least One Dose of Study Drug|Overall Study||258
4991037|NCT02426125|12279907|P2|STARTED|Overall Study||267
4991038|NCT02426125|12279908|P1|STARTED|Overall Study||263
4991039|NCT02425956|12279932|P1|NOT COMPLETED|Overall Study||0
4991040|NCT02425956|12279932|P1|COMPLETED|Overall Study||21
4991041|NCT02425956|12279932|P1|STARTED|Overall Study||21
4991042|NCT02425826|12279939|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
4991043|NCT02425826|12279940|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
4991044|NCT02425826|12279941|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
4991045|NCT02425826|12279939|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
4991046|NCT02425826|12279940|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
4991047|NCT02425826|12279941|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
4991048|NCT02425826|12279939|P3|STARTED|Post-Treatment Observational Follow-Up||49
4991049|NCT02425826|12279940|P2|STARTED|Post-Treatment Observational Follow-Up||0
4991050|NCT02425826|12279941|P1|STARTED|Post-Treatment Observational Follow-Up||81
4991051|NCT02425826|12279939|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
4991052|NCT02425826|12279940|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
4991053|NCT02425826|12279941|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
4991054|NCT02425826|12279939|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
4991055|NCT02425826|12279940|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
4991056|NCT02425826|12279941|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
4991057|NCT02425826|12279939|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
4991058|NCT02425826|12279940|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
4991059|NCT02425826|12279941|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
4991060|NCT02425826|12279939|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
4991061|NCT02425826|12279940|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
4991062|NCT02425826|12279941|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
4991063|NCT02425826|12279939|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
4991064|NCT02425826|12279940|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
4991065|NCT02425826|12279941|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
4991066|NCT02425826|12279939|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
4991067|NCT02425826|12279940|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
4991068|NCT02425826|12279941|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
4991069|NCT02425826|12279939|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
4991070|NCT02425826|12279940|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
4991071|NCT02425826|12279941|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
4991072|NCT02425826|12279939|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
4991073|NCT02425826|12279940|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
4991074|NCT02425826|12279941|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
4991075|NCT02425449|12279979|P5|NOT COMPLETED|Overall Study||0
4991076|NCT02425449|12279980|P4|NOT COMPLETED|Overall Study||0
4991077|NCT02425449|12279981|P3|NOT COMPLETED|Overall Study||0
4991078|NCT02425449|12279982|P2|NOT COMPLETED|Overall Study||0
4991079|NCT02425449|12279983|P1|NOT COMPLETED|Overall Study||0
4991080|NCT02425449|12279979|P5|COMPLETED|Overall Study||5
4991081|NCT02425449|12279980|P4|COMPLETED|Overall Study||5
4991082|NCT02425449|12279981|P3|COMPLETED|Overall Study||5
4991083|NCT02425449|12279982|P2|COMPLETED|Overall Study||4
4991084|NCT02425449|12279983|P1|COMPLETED|Overall Study||0
4991085|NCT02425449|12279979|P5|STARTED|Overall Study||5
4991086|NCT02425449|12279980|P4|STARTED|Overall Study||5
4991087|NCT02425449|12279981|P3|STARTED|Overall Study||5
4991088|NCT02425449|12279982|P2|STARTED|Overall Study||4
4991089|NCT02425449|12279983|P1|STARTED|Overall Study||0
4991090|NCT02425111|12279995|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
4991091|NCT02425111|12279995|P1|COMPLETED|Part B: Treatment Extension Period||46
4991092|NCT02425111|12279995|P1|STARTED|Part B: Treatment Extension Period||56
4991093|NCT02425111|12279995|P1|NOT COMPLETED|Part A: Treatment Period||23
4991094|NCT02425111|12279995|P1|COMPLETED|Part A: Treatment Period||78
4991095|NCT02425111|12279995|P1|STARTED|Part A: Treatment Period||101
4991096|NCT02425098|12280016|P2|NOT COMPLETED|Overall Study||16
4991097|NCT02425098|12280017|P1|NOT COMPLETED|Overall Study||13
4991098|NCT02425098|12280016|P2|COMPLETED|Overall Study||159
4991099|NCT02425098|12280017|P1|COMPLETED|Overall Study||163
4991100|NCT02425098|12280016|P2|STARTED|Overall Study||175
4991101|NCT02425098|12280017|P1|STARTED|Overall Study||176
4991102|NCT02424799|12280065|P6|NOT COMPLETED|Part C (Up to Day 23)||0
4991103|NCT02424799|12280066|P5|NOT COMPLETED|Part C (Up to Day 23)||0
4991104|NCT02424799|12280067|P4|NOT COMPLETED|Part C (Up to Day 23)||0
4991105|NCT02424799|12280068|P3|NOT COMPLETED|Part C (Up to Day 23)||0
4991106|NCT02424799|12280069|P2|NOT COMPLETED|Part C (Up to Day 23)||0
4991107|NCT02424799|12280070|P1|NOT COMPLETED|Part C (Up to Day 23)||0
4991108|NCT02424799|12280065|P6|COMPLETED|Part C (Up to Day 23)||4
4991109|NCT02424799|12280066|P5|COMPLETED|Part C (Up to Day 23)||1
4991110|NCT02424799|12280067|P4|COMPLETED|Part C (Up to Day 23)||0
4991111|NCT02424799|12280068|P3|COMPLETED|Part C (Up to Day 23)||0
4991112|NCT02424799|12280069|P2|COMPLETED|Part C (Up to Day 23)||0
4991113|NCT02424799|12280070|P1|COMPLETED|Part C (Up to Day 23)||0
4991114|NCT02424799|12280065|P6|STARTED|Part C (Up to Day 23)||4
4991115|NCT02424799|12280066|P5|STARTED|Part C (Up to Day 23)||1
4991116|NCT02424799|12280067|P4|STARTED|Part C (Up to Day 23)||0
4991117|NCT02424799|12280068|P3|STARTED|Part C (Up to Day 23)||0
4991118|NCT02424799|12280069|P2|STARTED|Part C (Up to Day 23)||0
4991119|NCT02424799|12280070|P1|STARTED|Part C (Up to Day 23)||0
4991120|NCT02424799|12280065|P6|NOT COMPLETED|Part B (Up to Day 19)||0
4991121|NCT02424799|12280066|P5|NOT COMPLETED|Part B (Up to Day 19)||0
4991122|NCT02424799|12280067|P4|NOT COMPLETED|Part B (Up to Day 19)||0
4991123|NCT02424799|12280068|P3|NOT COMPLETED|Part B (Up to Day 19)||0
4991124|NCT02424799|12280069|P2|NOT COMPLETED|Part B (Up to Day 19)||0
4991125|NCT02424799|12280070|P1|NOT COMPLETED|Part B (Up to Day 19)||0
4991126|NCT02424799|12280065|P6|COMPLETED|Part B (Up to Day 19)||0
4991127|NCT02424799|12280066|P5|COMPLETED|Part B (Up to Day 19)||0
4991128|NCT02424799|12280067|P4|COMPLETED|Part B (Up to Day 19)||9
4991129|NCT02424799|12280068|P3|COMPLETED|Part B (Up to Day 19)||3
4991130|NCT02424799|12280069|P2|COMPLETED|Part B (Up to Day 19)||0
4991131|NCT02424799|12280070|P1|COMPLETED|Part B (Up to Day 19)||0
4991132|NCT02424799|12280065|P6|STARTED|Part B (Up to Day 19)||0
4991133|NCT02424799|12280066|P5|STARTED|Part B (Up to Day 19)||0
4991134|NCT02424799|12280067|P4|STARTED|Part B (Up to Day 19)||9
4991135|NCT02424799|12280068|P3|STARTED|Part B (Up to Day 19)||3
4991136|NCT02424799|12280069|P2|STARTED|Part B (Up to Day 19)||0
4991137|NCT02424799|12280070|P1|STARTED|Part B (Up to Day 19)||0
4991138|NCT02424799|12280065|P6|NOT COMPLETED|Part A (Up to Day 11)||0
4991139|NCT02424799|12280066|P5|NOT COMPLETED|Part A (Up to Day 11)||0
4991140|NCT02424799|12280067|P4|NOT COMPLETED|Part A (Up to Day 11)||0
4991141|NCT02424799|12280068|P3|NOT COMPLETED|Part A (Up to Day 11)||0
4991142|NCT02424799|12280069|P2|NOT COMPLETED|Part A (Up to Day 11)||0
4991143|NCT02424799|12280070|P1|NOT COMPLETED|Part A (Up to Day 11)||0
4991144|NCT02424799|12280065|P6|COMPLETED|Part A (Up to Day 11)||0
4991145|NCT02424799|12280066|P5|COMPLETED|Part A (Up to Day 11)||0
4991146|NCT02424799|12280067|P4|COMPLETED|Part A (Up to Day 11)||0
4991147|NCT02424799|12280068|P3|COMPLETED|Part A (Up to Day 11)||0
4991148|NCT02424799|12280069|P2|COMPLETED|Part A (Up to Day 11)||8
4991149|NCT02424799|12280070|P1|COMPLETED|Part A (Up to Day 11)||9
4991150|NCT02424799|12280065|P6|STARTED|Part A (Up to Day 11)||0
4991151|NCT02424799|12280066|P5|STARTED|Part A (Up to Day 11)||0
4991152|NCT02424799|12280067|P4|STARTED|Part A (Up to Day 11)||0
4991153|NCT02424799|12280068|P3|STARTED|Part A (Up to Day 11)||0
4991154|NCT02424799|12280069|P2|STARTED|Part A (Up to Day 11)||8
4991155|NCT02424799|12280070|P1|STARTED|Part A (Up to Day 11)||9
4991156|NCT02424734|12280169|P3|NOT COMPLETED|Overall Study||0
4991157|NCT02424734|12280170|P2|NOT COMPLETED|Overall Study||2
4991158|NCT02424734|12280171|P1|NOT COMPLETED|Overall Study||2
4991159|NCT02424734|12280169|P3|COMPLETED|Overall Study||2
4991160|NCT02424734|12280170|P2|COMPLETED|Overall Study||3
4991161|NCT02424734|12280171|P1|COMPLETED|Overall Study||2
4991162|NCT02424734|12280169|P3|Treated|Overall Study||2
4991163|NCT02424734|12280170|P2|Treated|Overall Study||5
4991164|NCT02424734|12280171|P1|Treated|Overall Study||4
4991165|NCT02424734|12280169|P3|STARTED|Overall Study||2
4991166|NCT02424734|12280170|P2|STARTED|Overall Study||5
4991167|NCT02424734|12280171|P1|STARTED|Overall Study||4
4991168|NCT02424591|12280190|P2|NOT COMPLETED|Overall Study||3
4991169|NCT02424591|12280191|P1|NOT COMPLETED|Overall Study||2
4991170|NCT02424591|12280190|P2|COMPLETED|Overall Study||20
4991171|NCT02424591|12280191|P1|COMPLETED|Overall Study||20
4991172|NCT02424591|12280190|P2|STARTED|Overall Study||23
4991173|NCT02424591|12280191|P1|STARTED|Overall Study||22
4991174|NCT02424578|12280203|P2|NOT COMPLETED|Overall Study||1
4991175|NCT02424578|12280204|P1|NOT COMPLETED|Overall Study||0
4991176|NCT02424578|12280203|P2|COMPLETED|Overall Study||14
4991177|NCT02424578|12280204|P1|COMPLETED|Overall Study||15
4991178|NCT02424578|12280203|P2|STARTED|Overall Study||15
4991179|NCT02424578|12280204|P1|STARTED|Overall Study||15
4991180|NCT02424565|12280210|P2|NOT COMPLETED|Period 2 (D3)||0
4991181|NCT02424565|12280211|P1|NOT COMPLETED|Period 2 (D3)||0
4991182|NCT02424565|12280210|P2|COMPLETED|Period 2 (D3)||6
4991183|NCT02424565|12280211|P1|COMPLETED|Period 2 (D3)||8
4991184|NCT02424565|12280210|P2|STARTED|Period 2 (D3)||6
4991185|NCT02424565|12280211|P1|STARTED|Period 2 (D3)||8
4991186|NCT02424565|12280210|P2|NOT COMPLETED|Washout Period||0
4991187|NCT02424565|12280211|P1|NOT COMPLETED|Washout Period||0
4991188|NCT02424565|12280210|P2|COMPLETED|Washout Period||6
4991189|NCT02424565|12280211|P1|COMPLETED|Washout Period||8
4991190|NCT02424565|12280210|P2|STARTED|Washout Period||6
4991191|NCT02424565|12280211|P1|STARTED|Washout Period||8
4991192|NCT02424565|12280210|P2|NOT COMPLETED|Period 1 (D0)||1
4991193|NCT02424565|12280211|P1|NOT COMPLETED|Period 1 (D0)||0
4991194|NCT02424565|12280210|P2|COMPLETED|Period 1 (D0)||6
4991195|NCT02424565|12280211|P1|COMPLETED|Period 1 (D0)||8
4991196|NCT02424565|12280210|P2|STARTED|Period 1 (D0)||7
4991197|NCT02424565|12280211|P1|STARTED|Period 1 (D0)||8
4991198|NCT02424539|12280220|P3|NOT COMPLETED|Overall Study||8
4991199|NCT02424539|12280221|P2|NOT COMPLETED|Overall Study||8
4991200|NCT02424539|12280222|P1|NOT COMPLETED|Overall Study||14
4991201|NCT02424539|12280220|P3|COMPLETED|Overall Study||111
4991202|NCT02424539|12280221|P2|COMPLETED|Overall Study||111
4991203|NCT02424539|12280222|P1|COMPLETED|Overall Study||106
4991204|NCT02424539|12280220|P3|STARTED|Overall Study||119
4991205|NCT02424539|12280221|P2|STARTED|Overall Study||119
4991206|NCT02424539|12280222|P1|STARTED|Overall Study||120
4991207|NCT02424526|12280286|P2|NOT COMPLETED|Overall Study||0
4991208|NCT02424526|12280287|P1|NOT COMPLETED|Overall Study||0
4991209|NCT02424526|12280286|P2|COMPLETED|Overall Study||10
4991210|NCT02424526|12280287|P1|COMPLETED|Overall Study||9
4991211|NCT02424526|12280286|P2|STARTED|Overall Study||10
4991212|NCT02424526|12280287|P1|STARTED|Overall Study||9
4991213|NCT02424383|12280305|P1|NOT COMPLETED|Overall Study||376
4991214|NCT02424383|12280305|P1|COMPLETED|Overall Study||629
4991215|NCT02424383|12280305|P1|Per-Protocol Population|Overall Study||966
4991216|NCT02424383|12280305|P1|STARTED|Overall Study||1005
4991217|NCT02424357|12280318|P2|NOT COMPLETED|Overall Study||0
4991218|NCT02424357|12280319|P1|NOT COMPLETED|Overall Study||0
4991219|NCT02424357|12280318|P2|COMPLETED|Overall Study||30
4991220|NCT02424357|12280319|P1|COMPLETED|Overall Study||35
4991221|NCT02424357|12280318|P2|STARTED|Overall Study||30
4991222|NCT02424357|12280319|P1|STARTED|Overall Study||35
4991223|NCT02424344|12280329|P2|NOT COMPLETED|Overall Study||10
4991224|NCT02424344|12280330|P1|NOT COMPLETED|Overall Study||7
4991225|NCT02424344|12280329|P2|COMPLETED|Overall Study||123
4991226|NCT02424344|12280330|P1|COMPLETED|Overall Study||127
4991227|NCT02424344|12280329|P2|STARTED|Overall Study||133
4991228|NCT02424344|12280330|P1|STARTED|Overall Study||134
4991229|NCT02424175|12280340|P1|NOT COMPLETED|Overall Study||0
4991230|NCT02424175|12280340|P1|COMPLETED|Overall Study||10
4991231|NCT02424175|12280340|P1|STARTED|Overall Study||10
4991232|NCT02424149|12280348|P2|NOT COMPLETED|Overall Study||1
4991233|NCT02424149|12280349|P1|NOT COMPLETED|Overall Study||2
4991234|NCT02424149|12280348|P2|COMPLETED|Overall Study||52
4991235|NCT02424149|12280349|P1|COMPLETED|Overall Study||52
4991236|NCT02424149|12280348|P2|STARTED|Overall Study||53
4991237|NCT02424149|12280349|P1|STARTED|Overall Study||54
4991238|NCT02424097|12280365|P2|NOT COMPLETED|Overall Study||2
4991239|NCT02424097|12280366|P1|NOT COMPLETED|Overall Study||1
4991240|NCT02424097|12280365|P2|COMPLETED|Overall Study||18
4991241|NCT02424097|12280366|P1|COMPLETED|Overall Study||19
4991242|NCT02424097|12280365|P2|STARTED|Overall Study||20
4991243|NCT02424097|12280366|P1|STARTED|Overall Study||20
4991244|NCT02423993|12280378|P4|NOT COMPLETED|Overall Study||0
4991245|NCT02423993|12280379|P3|NOT COMPLETED|Overall Study||0
4991246|NCT02423993|12280380|P2|NOT COMPLETED|Overall Study||0
4991247|NCT02423993|12280381|P1|NOT COMPLETED|Overall Study||0
4991248|NCT02423993|12280378|P4|COMPLETED|Overall Study||19
4991249|NCT02423993|12280379|P3|COMPLETED|Overall Study||23
4991250|NCT02423993|12280380|P2|COMPLETED|Overall Study||16
4991251|NCT02423993|12280381|P1|COMPLETED|Overall Study||19
4991252|NCT02423993|12280378|P4|STARTED|Overall Study||19
4991253|NCT02423993|12280379|P3|STARTED|Overall Study||23
4991254|NCT02423993|12280380|P2|STARTED|Overall Study||16
4991255|NCT02423993|12280381|P1|STARTED|Overall Study||19
4991256|NCT02423980|12280411|P1|NOT COMPLETED|Overall Study||0
4991257|NCT02423980|12280411|P1|COMPLETED|Overall Study||7
4991258|NCT02423980|12280411|P1|STARTED|Overall Study||7
4991259|NCT02423798|12280421|P1|NOT COMPLETED|Overall Study||3
4991260|NCT02423798|12280421|P1|COMPLETED|Overall Study||21
4991261|NCT02423798|12280421|P1|STARTED|Overall Study||24
4991262|NCT02423577|12280429|P2|NOT COMPLETED|Overall Study||0
4991263|NCT02423577|12280430|P1|NOT COMPLETED|Overall Study||0
4991264|NCT02423577|12280429|P2|COMPLETED|Overall Study||26
4991265|NCT02423577|12280430|P1|COMPLETED|Overall Study||53
4991266|NCT02423577|12280429|P2|STARTED|Overall Study||26
4991267|NCT02423577|12280430|P1|STARTED|Overall Study||53
4991268|NCT02423447|12280436|P2|NOT COMPLETED|Overall Study||0
4991269|NCT02423447|12280437|P1|NOT COMPLETED|Overall Study||0
4991270|NCT02423447|12280436|P2|COMPLETED|Overall Study||12
4991271|NCT02423447|12280437|P1|COMPLETED|Overall Study||13
4991272|NCT02423447|12280436|P2|STARTED|Overall Study||12
4991273|NCT02423447|12280437|P1|STARTED|Overall Study||13
4991274|NCT02423408|12280453|P2|NOT COMPLETED|Overall Study||2
4991275|NCT02423408|12280454|P1|NOT COMPLETED|Overall Study||1
4991276|NCT02423408|12280453|P2|COMPLETED|Overall Study||80
4991277|NCT02423408|12280454|P1|COMPLETED|Overall Study||82
4991278|NCT02423408|12280453|P2|STARTED|Overall Study||82
4991279|NCT02423408|12280454|P1|STARTED|Overall Study||83
4991280|NCT02423317|12280468|P2|NOT COMPLETED|Overall Study||0
4991281|NCT02423317|12280469|P1|NOT COMPLETED|Overall Study||0
4991282|NCT02423317|12280468|P2|COMPLETED|Overall Study||30
4991283|NCT02423317|12280469|P1|COMPLETED|Overall Study||30
4991284|NCT02423317|12280468|P2|STARTED|Overall Study||30
4991285|NCT02423317|12280469|P1|STARTED|Overall Study||30
4991286|NCT02423291|12280487|P1|NOT COMPLETED|Overall Study||15
4991287|NCT02423291|12280487|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
4991288|NCT02423291|12280487|P1|STARTED|Overall Study|Patients enrolled|15
4991289|NCT02423200|12280493|P2|NOT COMPLETED|Overall Study||0
4991290|NCT02423200|12280494|P1|NOT COMPLETED|Overall Study||1
4991291|NCT02423200|12280493|P2|COMPLETED|Overall Study||1
4991292|NCT02423200|12280494|P1|COMPLETED|Overall Study||7
4991293|NCT02423200|12280493|P2|STARTED|Overall Study||1
4991294|NCT02423200|12280494|P1|STARTED|Overall Study||8
4991295|NCT02423122|12280504|P2|NOT COMPLETED|Overall Study||0
4991296|NCT02423122|12280505|P1|NOT COMPLETED|Overall Study||0
4991297|NCT02423122|12280504|P2|COMPLETED|Overall Study||7
4991298|NCT02423122|12280505|P1|COMPLETED|Overall Study||9
4991299|NCT02423122|12280504|P2|STARTED|Overall Study||7
4991300|NCT02423122|12280505|P1|STARTED|Overall Study||9
4991301|NCT02423109|12280517|P2|NOT COMPLETED|Lens 2||0
4991302|NCT02423109|12280518|P1|NOT COMPLETED|Lens 2||0
4991303|NCT02423109|12280517|P2|COMPLETED|Lens 2||14
4991304|NCT02423109|12280518|P1|COMPLETED|Lens 2||18
4991305|NCT02423109|12280517|P2|STARTED|Lens 2||14
4991306|NCT02423109|12280518|P1|STARTED|Lens 2||18
4991307|NCT02423109|12280517|P2|NOT COMPLETED|Lens 1||0
4991308|NCT02423109|12280518|P1|NOT COMPLETED|Lens 1||1
4991309|NCT02423109|12280517|P2|COMPLETED|Lens 1||14
4991310|NCT02423109|12280518|P1|COMPLETED|Lens 1||18
4991311|NCT02423109|12280517|P2|STARTED|Lens 1||14
4991312|NCT02423109|12280518|P1|STARTED|Lens 1||19
4991313|NCT02422940|12280528|P2|NOT COMPLETED|Overall Study||121
4991314|NCT02422940|12280529|P1|NOT COMPLETED|Overall Study||121
4991315|NCT02422940|12280528|P2|COMPLETED|Overall Study||21
4991316|NCT02422940|12280529|P1|COMPLETED|Overall Study||31
4991317|NCT02422940|12280528|P2|STARTED|Overall Study||142
4991318|NCT02422940|12280529|P1|STARTED|Overall Study||152
4991319|NCT02422797|12280551|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
4991320|NCT02422797|12280552|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
4991321|NCT02422797|12280551|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
4991322|NCT02422797|12280552|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
4991323|NCT02422797|12280551|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
4991324|NCT02422797|12280552|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
4991325|NCT02422797|12280551|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
4991416|NCT02421419|12280860|P3|STARTED|Overall Study||9
4991326|NCT02422797|12280552|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
4991327|NCT02422797|12280551|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
4991328|NCT02422797|12280552|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
4991329|NCT02422797|12280551|P2|STARTED|Early Switch Phase (Up to Week 52)||255
4991330|NCT02422797|12280552|P1|STARTED|Early Switch Phase (Up to Week 52)||261
4991331|NCT02422615|12280640|P2|NOT COMPLETED|Overall Study||166
4991332|NCT02422615|12280641|P1|NOT COMPLETED|Overall Study||280
4991333|NCT02422615|12280640|P2|COMPLETED|Overall Study||76
4991334|NCT02422615|12280641|P1|COMPLETED|Overall Study||204
4991335|NCT02422615|12280640|P2|Untreated|Overall Study||1
4991336|NCT02422615|12280641|P1|Untreated|Overall Study||1
4991337|NCT02422615|12280640|P2|STARTED|Overall Study||242
4991338|NCT02422615|12280641|P1|STARTED|Overall Study||484
4991339|NCT02422446|12280649|P2|NOT COMPLETED|Overall Study||0
4991340|NCT02422446|12280650|P1|NOT COMPLETED|Overall Study||0
4991341|NCT02422446|12280649|P2|COMPLETED|Overall Study||1
4991342|NCT02422446|12280650|P1|COMPLETED|Overall Study||1
4991343|NCT02422446|12280649|P2|STARTED|Overall Study||1
4991344|NCT02422446|12280650|P1|STARTED|Overall Study||1
4991345|NCT02422303|12280658|P2|NOT COMPLETED|Overall Study||1
4991346|NCT02422303|12280659|P1|NOT COMPLETED|Overall Study||1
4991347|NCT02422303|12280658|P2|COMPLETED|Overall Study||5
4991348|NCT02422303|12280659|P1|COMPLETED|Overall Study||5
4991349|NCT02422303|12280658|P2|STARTED|Overall Study||6
4991350|NCT02422303|12280659|P1|STARTED|Overall Study||6
4991351|NCT02422264|12280667|P2|NOT COMPLETED|Overall Study||4
4991352|NCT02422264|12280668|P1|NOT COMPLETED|Overall Study||5
4991353|NCT02422264|12280667|P2|COMPLETED|Overall Study||301
4991354|NCT02422264|12280668|P1|COMPLETED|Overall Study||291
4991355|NCT02422264|12280667|P2|STARTED|Overall Study||305
4991356|NCT02422264|12280668|P1|STARTED|Overall Study||296
4991357|NCT02422186|12280714|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
4991358|NCT02422186|12280715|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
4991359|NCT02422186|12280714|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
4991360|NCT02422186|12280715|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
4991361|NCT02422186|12280714|P2|STARTED|Follow-up Phase (2 Weeks)||3
4991362|NCT02422186|12280715|P1|STARTED|Follow-up Phase (2 Weeks)||12
4991363|NCT02422186|12280714|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
4991364|NCT02422186|12280715|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
4991365|NCT02422186|12280714|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
4991366|NCT02422186|12280715|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
4991367|NCT02422186|12280714|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
4991368|NCT02422186|12280715|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
4991369|NCT02422186|12280714|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
4991370|NCT02422186|12280715|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
4991371|NCT02422186|12280714|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
4991372|NCT02422186|12280715|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
4991373|NCT02421952|12280737|P1|NOT COMPLETED|Overall Study||109
4991374|NCT02421952|12280737|P1|COMPLETED|Overall Study||99
4991375|NCT02421952|12280737|P1|Included in PACU Analysis|Overall Study||192
4991376|NCT02421952|12280737|P1|Excluded From PACU and Post-Analysis|Overall Study||16
4991377|NCT02421952|12280737|P1|STARTED|Overall Study||208
4991378|NCT02421939|12280746|P2|NOT COMPLETED|Overall Study||124
4991379|NCT02421939|12280747|P1|NOT COMPLETED|Overall Study||209
4991380|NCT02421939|12280746|P2|COMPLETED|Overall Study||0
4991381|NCT02421939|12280747|P1|COMPLETED|Overall Study||38
4991382|NCT02421939|12280746|P2|Treated|Overall Study||109
4991383|NCT02421939|12280747|P1|Treated|Overall Study||246
4991384|NCT02421939|12280746|P2|STARTED|Overall Study||124
4991385|NCT02421939|12280747|P1|STARTED|Overall Study||247
4991386|NCT02421887|12280775|P2|NOT COMPLETED|Overall Study||9
4991387|NCT02421887|12280776|P1|NOT COMPLETED|Overall Study||17
4991388|NCT02421887|12280775|P2|COMPLETED|Overall Study||77
4991389|NCT02421887|12280776|P1|COMPLETED|Overall Study||68
4991390|NCT02421887|12280775|P2|STARTED|Overall Study||86
4991391|NCT02421887|12280776|P1|STARTED|Overall Study||85
4991392|NCT02421588|12280802|P2|NOT COMPLETED|Overall Study||221
4991393|NCT02421588|12280803|P1|NOT COMPLETED|Overall Study||221
4991394|NCT02421588|12280802|P2|COMPLETED|Overall Study||0
4991395|NCT02421588|12280803|P1|COMPLETED|Overall Study||0
4991396|NCT02421588|12280802|P2|STARTED|Overall Study||221
4991397|NCT02421588|12280803|P1|STARTED|Overall Study||221
4991398|NCT02421510|12280826|P3|NOT COMPLETED|Overall Study||36
4991399|NCT02421510|12280827|P2|NOT COMPLETED|Overall Study||35
4991400|NCT02421510|12280828|P1|NOT COMPLETED|Overall Study||33
4991401|NCT02421510|12280826|P3|COMPLETED|Overall Study||227
4991402|NCT02421510|12280827|P2|COMPLETED|Overall Study||226
4991403|NCT02421510|12280828|P1|COMPLETED|Overall Study||225
4991404|NCT02421510|12280826|P3|Completed the 24 Week Treatment Period|Overall Study||240
4991405|NCT02421510|12280827|P2|Completed the 24 Week Treatment Period|Overall Study||239
4991406|NCT02421510|12280828|P1|Completed the 24 Week Treatment Period|Overall Study||236
4991407|NCT02421510|12280826|P3|STARTED|Overall Study||263
4991408|NCT02421510|12280827|P2|STARTED|Overall Study||261
4991409|NCT02421510|12280828|P1|STARTED|Overall Study||258
4991410|NCT02421419|12280860|P3|NOT COMPLETED|Overall Study||1
4991411|NCT02421419|12280861|P2|NOT COMPLETED|Overall Study||0
4991412|NCT02421419|12280862|P1|NOT COMPLETED|Overall Study||0
4991413|NCT02421419|12280860|P3|COMPLETED|Overall Study||8
4991414|NCT02421419|12280861|P2|COMPLETED|Overall Study||11
4991415|NCT02421419|12280862|P1|COMPLETED|Overall Study||6
4991417|NCT02421419|12280861|P2|STARTED|Overall Study||11
4991418|NCT02421419|12280862|P1|STARTED|Overall Study||6
4991419|NCT02421354|12280879|P1|NOT COMPLETED|Overall Study||0
4991420|NCT02421354|12280879|P1|COMPLETED|Overall Study||8
4991421|NCT02421354|12280879|P1|STARTED|Overall Study||8
4991422|NCT02421211|12280885|P2|NOT COMPLETED|Overall Study||0
4991423|NCT02421211|12280886|P1|NOT COMPLETED|Overall Study||0
4991424|NCT02421211|12280885|P2|COMPLETED|Overall Study||20
4991425|NCT02421211|12280886|P1|COMPLETED|Overall Study||20
4991426|NCT02421211|12280885|P2|STARTED|Overall Study||20
4991427|NCT02421211|12280886|P1|STARTED|Overall Study||20
4991428|NCT02421172|12280932|P5|NOT COMPLETED|Period 2||1
4991429|NCT02421172|12280933|P4|NOT COMPLETED|Period 2||3
4991430|NCT02421172|12280934|P3|NOT COMPLETED|Period 2||7
4991431|NCT02421172|12280935|P2|NOT COMPLETED|Period 2||0
4991432|NCT02421172|12280936|P1|NOT COMPLETED|Period 2||0
4991433|NCT02421172|12280932|P5|COMPLETED|Period 2||14
4991434|NCT02421172|12280933|P4|COMPLETED|Period 2||13
4991435|NCT02421172|12280934|P3|COMPLETED|Period 2||22
4991436|NCT02421172|12280935|P2|COMPLETED|Period 2||0
4991437|NCT02421172|12280936|P1|COMPLETED|Period 2||0
4991438|NCT02421172|12280932|P5|STARTED|Period 2||15
4991439|NCT02421172|12280933|P4|STARTED|Period 2||16
4991440|NCT02421172|12280934|P3|STARTED|Period 2||29
4991441|NCT02421172|12280935|P2|STARTED|Period 2||0
4991442|NCT02421172|12280936|P1|STARTED|Period 2||0
4991443|NCT02421172|12280932|P5|NOT COMPLETED|Period 1||0
4991444|NCT02421172|12280933|P4|NOT COMPLETED|Period 1||0
4991445|NCT02421172|12280934|P3|NOT COMPLETED|Period 1||0
4991446|NCT02421172|12280935|P2|NOT COMPLETED|Period 1||2
4991447|NCT02421172|12280936|P1|NOT COMPLETED|Period 1||4
4991448|NCT02421172|12280932|P5|COMPLETED|Period 1||0
4991449|NCT02421172|12280933|P4|COMPLETED|Period 1||0
4991450|NCT02421172|12280934|P3|COMPLETED|Period 1||0
4991451|NCT02421172|12280935|P2|COMPLETED|Period 1||31
4991452|NCT02421172|12280936|P1|COMPLETED|Period 1||29
4991453|NCT02421172|12280932|P5|PK Analysis Set Period 1|Period 1||0
4991454|NCT02421172|12280933|P4|PK Analysis Set Period 1|Period 1||0
4991455|NCT02421172|12280934|P3|PK Analysis Set Period 1|Period 1||0
4991456|NCT02421172|12280935|P2|PK Analysis Set Period 1|Period 1||0
4991457|NCT02421172|12280936|P1|PK Analysis Set Period 1|Period 1||33
4991458|NCT02421172|12280932|P5|PD Analysis Set Period 1|Period 1||0
4991459|NCT02421172|12280933|P4|PD Analysis Set Period 1|Period 1||0
4991460|NCT02421172|12280934|P3|PD Analysis Set Period 1|Period 1||0
4991461|NCT02421172|12280935|P2|PD Analysis Set Period 1|Period 1||33
4991462|NCT02421172|12280936|P1|PD Analysis Set Period 1|Period 1||31
4991463|NCT02421172|12280932|P5|STARTED|Period 1||0
4991464|NCT02421172|12280933|P4|STARTED|Period 1||0
4991465|NCT02421172|12280934|P3|STARTED|Period 1||0
4991466|NCT02421172|12280935|P2|STARTED|Period 1||33
4991467|NCT02421172|12280936|P1|STARTED|Period 1||33
4991468|NCT02421146|12280963|P4|NOT COMPLETED|Overall Study||0
4991469|NCT02421146|12280964|P3|NOT COMPLETED|Overall Study||0
4991470|NCT02421146|12280965|P2|NOT COMPLETED|Overall Study||0
4991471|NCT02421146|12280966|P1|NOT COMPLETED|Overall Study||0
4991472|NCT02421146|12280963|P4|COMPLETED|Overall Study||3
4991473|NCT02421146|12280964|P3|COMPLETED|Overall Study||3
4991474|NCT02421146|12280965|P2|COMPLETED|Overall Study||4
4991475|NCT02421146|12280966|P1|COMPLETED|Overall Study||2
4991476|NCT02421146|12280963|P4|STARTED|Overall Study||3
4991477|NCT02421146|12280964|P3|STARTED|Overall Study||3
4991478|NCT02421146|12280965|P2|STARTED|Overall Study||4
4991479|NCT02421146|12280966|P1|STARTED|Overall Study||2
4991480|NCT02421120|12280980|P1|NOT COMPLETED|Overall Study||1
4991481|NCT02421120|12280980|P1|COMPLETED|Overall Study||20
4991482|NCT02421120|12280980|P1|STARTED|Overall Study||21
4991483|NCT02420951|12280990|P2|NOT COMPLETED|Overall Study||0
4991484|NCT02420951|12280991|P1|NOT COMPLETED|Overall Study||0
4991485|NCT02420951|12280990|P2|COMPLETED|Overall Study||25
4991486|NCT02420951|12280991|P1|COMPLETED|Overall Study||25
4991487|NCT02420951|12280990|P2|STARTED|Overall Study||25
4991488|NCT02420951|12280991|P1|STARTED|Overall Study||25
4991489|NCT02420873|12281010|P3|NOT COMPLETED|Overall Study||0
4991490|NCT02420873|12281011|P2|NOT COMPLETED|Overall Study||0
4991491|NCT02420873|12281012|P1|NOT COMPLETED|Overall Study||0
4991492|NCT02420873|12281010|P3|COMPLETED|Overall Study||0
4991493|NCT02420873|12281011|P2|COMPLETED|Overall Study||0
4991494|NCT02420873|12281012|P1|COMPLETED|Overall Study||9
4991495|NCT02420873|12281010|P3|STARTED|Overall Study||0
4991496|NCT02420873|12281011|P2|STARTED|Overall Study||0
4991497|NCT02420873|12281012|P1|STARTED|Overall Study||9
4991498|NCT02420821|12281022|P2|NOT COMPLETED|Overall Study||137
4991499|NCT02420821|12281023|P1|NOT COMPLETED|Overall Study||168
4991500|NCT02420821|12281022|P2|COMPLETED|Overall Study||317
4991501|NCT02420821|12281023|P1|COMPLETED|Overall Study||293
4991502|NCT02420821|12281022|P2|STARTED|Overall Study||454
4991503|NCT02420821|12281023|P1|STARTED|Overall Study||461
4991504|NCT02420379|12281093|P2|NOT COMPLETED|Overall Study||4
4991505|NCT02420379|12281094|P1|NOT COMPLETED|Overall Study||1
4991506|NCT02420379|12281093|P2|COMPLETED|Overall Study||3
4991507|NCT02420379|12281094|P1|COMPLETED|Overall Study||25
4991508|NCT02420379|12281093|P2|STARTED|Overall Study||7
4991509|NCT02420379|12281094|P1|STARTED|Overall Study||26
4991510|NCT02420353|12281112|P2|NOT COMPLETED|Overall Study||1
4991511|NCT02420353|12281113|P1|NOT COMPLETED|Overall Study||0
4991512|NCT02420353|12281112|P2|COMPLETED|Overall Study||9
4991513|NCT02420353|12281113|P1|COMPLETED|Overall Study||10
4991514|NCT02420353|12281112|P2|Allocation to Intervention|Overall Study||10
4991515|NCT02420353|12281113|P1|Allocation to Intervention|Overall Study||10
4991516|NCT02420353|12281112|P2|STARTED|Overall Study||10
4991517|NCT02420353|12281113|P1|STARTED|Overall Study||10
4991518|NCT02420327|12281205|P1|NOT COMPLETED|Overall Study||16
4991519|NCT02420327|12281205|P1|COMPLETED|Overall Study||27
4991520|NCT02420327|12281205|P1|STARTED|Overall Study||43
4991521|NCT02420262|12281241|P2|NOT COMPLETED|Overall Study||5
4991522|NCT02420262|12281242|P1|NOT COMPLETED|Overall Study||2
4991523|NCT02420262|12281241|P2|COMPLETED|Overall Study||249
4991524|NCT02420262|12281242|P1|COMPLETED|Overall Study||250
4991525|NCT02420262|12281241|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
4991526|NCT02420262|12281242|P1|Exposed|Overall Study||252
4991527|NCT02420262|12281241|P2|STARTED|Overall Study||254
4991528|NCT02420262|12281242|P1|STARTED|Overall Study||252
4991529|NCT02420210|12281256|P1|NOT COMPLETED|Overall Study||0
4991530|NCT02420210|12281256|P1|COMPLETED|Overall Study||2
4991531|NCT02420210|12281256|P1|STARTED|Overall Study||2
4991532|NCT02420093|12281268|P2|NOT COMPLETED|Overall Study||1
4991533|NCT02420093|12281269|P1|NOT COMPLETED|Overall Study||1
4991534|NCT02420093|12281268|P2|COMPLETED|Overall Study||7
4991535|NCT02420093|12281269|P1|COMPLETED|Overall Study||8
4991536|NCT02420093|12281268|P2|STARTED|Overall Study||8
4991537|NCT02420093|12281269|P1|STARTED|Overall Study||9
4991538|NCT02420041|12281285|P2|NOT COMPLETED|Overall Study||0
4991539|NCT02420041|12281286|P1|NOT COMPLETED|Overall Study||0
4991540|NCT02420041|12281285|P2|COMPLETED|Overall Study||14
4991541|NCT02420041|12281286|P1|COMPLETED|Overall Study||14
4991542|NCT02420041|12281285|P2|STARTED|Overall Study||14
4991543|NCT02420041|12281286|P1|STARTED|Overall Study||14
4991544|NCT02420015|12281312|P2|NOT COMPLETED|Overall Study||0
4991545|NCT02420015|12281313|P1|NOT COMPLETED|Overall Study||0
4991546|NCT02420015|12281312|P2|COMPLETED|Overall Study||13
4991547|NCT02420015|12281313|P1|COMPLETED|Overall Study||21
4991548|NCT02420015|12281312|P2|STARTED|Overall Study||13
4991549|NCT02420015|12281313|P1|STARTED|Overall Study||21
4991550|NCT02419937|12281331|P2|NOT COMPLETED|Overall Study||0
4991551|NCT02419937|12281332|P1|NOT COMPLETED|Overall Study||1
4991552|NCT02419937|12281331|P2|COMPLETED|Overall Study||16
4991553|NCT02419937|12281332|P1|COMPLETED|Overall Study||11
4991554|NCT02419937|12281331|P2|STARTED|Overall Study||16
4991555|NCT02419937|12281332|P1|STARTED|Overall Study||12
4991556|NCT02419755|12281340|P2|NOT COMPLETED|Overall Study||4
4991557|NCT02419755|12281341|P1|NOT COMPLETED|Overall Study||3
4991558|NCT02419755|12281340|P2|COMPLETED|Overall Study||2
4991559|NCT02419755|12281341|P1|COMPLETED|Overall Study||3
4991560|NCT02419755|12281340|P2|STARTED|Overall Study||6
4991561|NCT02419755|12281341|P1|STARTED|Overall Study||6
4991562|NCT02419612|12281367|P2|NOT COMPLETED|Long-term Treatment Period||22
4991563|NCT02419612|12281368|P1|NOT COMPLETED|Long-term Treatment Period||22
4991564|NCT02419612|12281367|P2|COMPLETED|Long-term Treatment Period||164
4991565|NCT02419612|12281368|P1|COMPLETED|Long-term Treatment Period||174
4991566|NCT02419612|12281367|P2|Received Treatment|Long-term Treatment Period||183
4991567|NCT02419612|12281368|P1|Received Treatment|Long-term Treatment Period||196
4991568|NCT02419612|12281367|P2|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
4991569|NCT02419612|12281368|P1|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
4991570|NCT02419612|12281367|P2|NOT COMPLETED|Short-term Treatment Period||23
4991571|NCT02419612|12281368|P1|NOT COMPLETED|Short-term Treatment Period||17
4991572|NCT02419612|12281367|P2|COMPLETED|Short-term Treatment Period||194
4991573|NCT02419612|12281368|P1|COMPLETED|Short-term Treatment Period||210
4991574|NCT02419612|12281367|P2|Recevied Treatment|Short-term Treatment Period||216
4991575|NCT02419612|12281368|P1|Recevied Treatment|Short-term Treatment Period||227
4991576|NCT02419612|12281367|P2|STARTED|Short-term Treatment Period||217
4991577|NCT02419612|12281368|P1|STARTED|Short-term Treatment Period||227
4991578|NCT02419573|12281390|P2|NOT COMPLETED|Overall Study||0
4991579|NCT02419573|12281391|P1|NOT COMPLETED|Overall Study||4
4991580|NCT02419573|12281390|P2|COMPLETED|Overall Study||1505
4991581|NCT02419573|12281391|P1|COMPLETED|Overall Study||1495
4991582|NCT02419573|12281390|P2|STARTED|Overall Study||1505
4991583|NCT02419573|12281391|P1|STARTED|Overall Study||1499
4991584|NCT02419547|12281403|P1|NOT COMPLETED|Overall Study||0
4991585|NCT02419547|12281403|P1|COMPLETED|Overall Study||11
4991586|NCT02419547|12281403|P1|STARTED|Overall Study||11
4991587|NCT02419521|12281407|P1|NOT COMPLETED|Overall Study||1
4991588|NCT02419521|12281407|P1|COMPLETED|Overall Study||74
4991589|NCT02419521|12281407|P1|STARTED|Overall Study||75
4991590|NCT02419508|12281421|P2|NOT COMPLETED|Overall Study||4
4991591|NCT02419508|12281422|P1|NOT COMPLETED|Overall Study||10
4991592|NCT02419508|12281421|P2|COMPLETED|Overall Study||88
4991593|NCT02419508|12281422|P1|COMPLETED|Overall Study||86
4991594|NCT02419508|12281421|P2|Safety Analysis Set|Overall Study||92
4991595|NCT02419508|12281422|P1|Safety Analysis Set|Overall Study||95
4991596|NCT02419508|12281421|P2|Full Analysis Set|Overall Study||92
4991597|NCT02419508|12281422|P1|Full Analysis Set|Overall Study||95
4991598|NCT02419508|12281421|P2|STARTED|Overall Study||92
4991599|NCT02419508|12281422|P1|STARTED|Overall Study||96
4991600|NCT02419469|12281440|P1|NOT COMPLETED|Overall Study||1
4991601|NCT02419469|12281440|P1|COMPLETED|Overall Study||0
4991602|NCT02419469|12281440|P1|STARTED|Overall Study||1
4991603|NCT02419313|12281444|P2|NOT COMPLETED|Second Intervention||0
4991604|NCT02419313|12281445|P1|NOT COMPLETED|Second Intervention||1
4991605|NCT02419313|12281444|P2|COMPLETED|Second Intervention||15
4991606|NCT02419313|12281445|P1|COMPLETED|Second Intervention||15
4991607|NCT02419313|12281444|P2|STARTED|Second Intervention||15
4991608|NCT02419313|12281445|P1|STARTED|Second Intervention||16
4991609|NCT02419313|12281444|P2|NOT COMPLETED|First Intervention||0
4991610|NCT02419313|12281445|P1|NOT COMPLETED|First Intervention||2
4991611|NCT02419313|12281444|P2|COMPLETED|First Intervention||15
4991612|NCT02419313|12281445|P1|COMPLETED|First Intervention||16
4991613|NCT02419313|12281444|P2|STARTED|First Intervention||15
4991614|NCT02419313|12281445|P1|STARTED|First Intervention||18
4991615|NCT02419001|12281457|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
4991616|NCT02419001|12281458|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
4991617|NCT02419001|12281457|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
4991618|NCT02419001|12281458|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
4991619|NCT02419001|12281457|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
4991620|NCT02419001|12281458|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
4991621|NCT02419001|12281457|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
4991622|NCT02419001|12281458|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
4991623|NCT02419001|12281457|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
4991624|NCT02419001|12281458|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
4991625|NCT02419001|12281457|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
4991626|NCT02419001|12281458|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
4991627|NCT02418910|12281468|P1|NOT COMPLETED|Overall Study||7
4991628|NCT02418910|12281468|P1|COMPLETED|Overall Study||43
4991629|NCT02418910|12281468|P1|STARTED|Overall Study||50
4991630|NCT02418819|12281476|P4|NOT COMPLETED|Overall Study||1
4991631|NCT02418819|12281477|P3|NOT COMPLETED|Overall Study||4
4991632|NCT02418819|12281478|P2|NOT COMPLETED|Overall Study||0
4991633|NCT02418819|12281479|P1|NOT COMPLETED|Overall Study||1
4991634|NCT02418819|12281476|P4|COMPLETED|Overall Study||28
4991635|NCT02418819|12281477|P3|COMPLETED|Overall Study||29
4991636|NCT02418819|12281478|P2|COMPLETED|Overall Study||16
4991637|NCT02418819|12281479|P1|COMPLETED|Overall Study||21
4991638|NCT02418819|12281476|P4|STARTED|Overall Study||29
4991639|NCT02418819|12281477|P3|STARTED|Overall Study||33
4991640|NCT02418819|12281478|P2|STARTED|Overall Study||16
4991641|NCT02418819|12281479|P1|STARTED|Overall Study||22
4991642|NCT02418676|12281522|P3|NOT COMPLETED|Overall Study||0
4991643|NCT02418676|12281523|P2|NOT COMPLETED|Overall Study||0
4991644|NCT02418676|12281524|P1|NOT COMPLETED|Overall Study||0
4991645|NCT02418676|12281522|P3|COMPLETED|Overall Study||5
4991646|NCT02418676|12281523|P2|COMPLETED|Overall Study||5
4991647|NCT02418676|12281524|P1|COMPLETED|Overall Study||5
4991648|NCT02418676|12281522|P3|STARTED|Overall Study||5
4991649|NCT02418676|12281523|P2|STARTED|Overall Study||5
4991650|NCT02418676|12281524|P1|STARTED|Overall Study||5
4991651|NCT02418585|12281537|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
4991652|NCT02418585|12281538|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
4991653|NCT02418585|12281537|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
4991654|NCT02418585|12281538|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
4991655|NCT02418585|12281537|P2|STARTED|Follow-up Phase (24 Weeks)||52
4991656|NCT02418585|12281538|P1|STARTED|Follow-up Phase (24 Weeks)||34
4991657|NCT02418585|12281537|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
4991658|NCT02418585|12281538|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
4991659|NCT02418585|12281537|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
4991660|NCT02418585|12281538|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
4991661|NCT02418585|12281537|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
4991662|NCT02418585|12281538|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
4991663|NCT02418585|12281537|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
4991664|NCT02418585|12281538|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
4991665|NCT02418585|12281537|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
4991666|NCT02418585|12281538|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
4991667|NCT02418546|12281579|P3|NOT COMPLETED|Overall Study||3
4991668|NCT02418546|12281580|P2|NOT COMPLETED|Overall Study||6
4991669|NCT02418546|12281581|P1|NOT COMPLETED|Overall Study||7
4991670|NCT02418546|12281579|P3|COMPLETED|Overall Study||23
4991671|NCT02418546|12281580|P2|COMPLETED|Overall Study||20
4991672|NCT02418546|12281581|P1|COMPLETED|Overall Study||19
4991673|NCT02418546|12281579|P3|STARTED|Overall Study||26
4991674|NCT02418546|12281580|P2|STARTED|Overall Study||26
4991675|NCT02418546|12281581|P1|STARTED|Overall Study||26
4991676|NCT02418468|12281594|P2|NOT COMPLETED|Overall Study||1
4991677|NCT02418468|12281595|P1|NOT COMPLETED|Overall Study||2
4991678|NCT02418468|12281594|P2|COMPLETED|Overall Study||10
4991679|NCT02418468|12281595|P1|COMPLETED|Overall Study||11
4991680|NCT02418468|12281594|P2|STARTED|Overall Study||11
4991681|NCT02418468|12281595|P1|STARTED|Overall Study||13
4991682|NCT02418455|12281601|P1|NOT COMPLETED|Continuation Period||7
4991683|NCT02418455|12281601|P1|COMPLETED|Continuation Period||0
4991684|NCT02418455|12281601|P1|STARTED|Continuation Period||7
4991685|NCT02418455|12281601|P1|NOT COMPLETED|48-Week Treatment Period||1
4991686|NCT02418455|12281601|P1|COMPLETED|48-Week Treatment Period||7
4991687|NCT02418455|12281601|P1|Emergency IND (eIND)|48-Week Treatment Period||1
4991688|NCT02418455|12281601|P1|STARTED|48-Week Treatment Period||8
4991689|NCT02418312|12281624|P2|NOT COMPLETED|Overall Study||0
4991690|NCT02418312|12281625|P1|NOT COMPLETED|Overall Study||0
4991691|NCT02418312|12281624|P2|COMPLETED|Overall Study||114
4991692|NCT02418312|12281625|P1|COMPLETED|Overall Study||114
4991693|NCT02418312|12281624|P2|STARTED|Overall Study||114
4991694|NCT02418312|12281625|P1|STARTED|Overall Study||114
4991695|NCT02418234|12281631|P1|NOT COMPLETED|Overall Study||0
4991696|NCT02418234|12281631|P1|COMPLETED|Overall Study||314
4991697|NCT02418234|12281631|P1|STARTED|Overall Study||314
4991698|NCT02418182|12281644|P2|NOT COMPLETED|Overall Study||17
4991699|NCT02418182|12281645|P1|NOT COMPLETED|Overall Study||18
4991700|NCT02418182|12281644|P2|COMPLETED|Overall Study||33
4991701|NCT02418182|12281645|P1|COMPLETED|Overall Study||31
4991702|NCT02418182|12281644|P2|STARTED|Overall Study||50
4991703|NCT02418182|12281645|P1|STARTED|Overall Study||49
4991704|NCT02418156|12281657|P1|NOT COMPLETED|Overall Study||17
4991705|NCT02418156|12281657|P1|COMPLETED|Overall Study||21
4991706|NCT02418156|12281657|P1|STARTED|Overall Study||38
4991707|NCT02418026|12281663|P2|NOT COMPLETED|Overall Study||0
4991708|NCT02418026|12281664|P1|NOT COMPLETED|Overall Study||0
4991709|NCT02418026|12281663|P2|COMPLETED|Overall Study||35
4991710|NCT02418026|12281664|P1|COMPLETED|Overall Study||44
4991711|NCT02418026|12281663|P2|STARTED|Overall Study||35
4991712|NCT02418026|12281664|P1|STARTED|Overall Study||44
4991713|NCT02418000|12281699|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
4991714|NCT02418000|12281700|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991715|NCT02418000|12281701|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991716|NCT02418000|12281702|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991717|NCT02418000|12281703|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991718|NCT02418000|12281699|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991719|NCT02418000|12281700|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991720|NCT02418000|12281701|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991721|NCT02418000|12281702|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991722|NCT02418000|12281703|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991723|NCT02418000|12281699|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
4991724|NCT02418000|12281700|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991725|NCT02418000|12281701|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991726|NCT02418000|12281702|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991727|NCT02418000|12281703|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
4991728|NCT02418000|12281699|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991729|NCT02418000|12281700|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
4991730|NCT02418000|12281701|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991731|NCT02418000|12281702|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991732|NCT02418000|12281703|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991733|NCT02418000|12281699|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991734|NCT02418000|12281700|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991735|NCT02418000|12281701|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991736|NCT02418000|12281702|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991737|NCT02418000|12281703|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991738|NCT02418000|12281699|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991739|NCT02418000|12281700|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
4991740|NCT02418000|12281701|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991741|NCT02418000|12281702|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991742|NCT02418000|12281703|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
4991743|NCT02418000|12281699|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991744|NCT02418000|12281700|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991745|NCT02418000|12281701|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
4991746|NCT02418000|12281702|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991747|NCT02418000|12281703|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991748|NCT02418000|12281699|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991749|NCT02418000|12281700|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991750|NCT02418000|12281701|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991751|NCT02418000|12281702|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991752|NCT02418000|12281703|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991753|NCT02418000|12281699|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991754|NCT02418000|12281700|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991755|NCT02418000|12281701|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
4991756|NCT02418000|12281702|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991757|NCT02418000|12281703|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
4991758|NCT02418000|12281699|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991759|NCT02418000|12281700|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991760|NCT02418000|12281701|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991761|NCT02418000|12281702|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
4991762|NCT02418000|12281703|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991763|NCT02418000|12281699|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991764|NCT02418000|12281700|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991765|NCT02418000|12281701|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991766|NCT02418000|12281702|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991767|NCT02418000|12281703|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991768|NCT02418000|12281699|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991769|NCT02418000|12281700|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991770|NCT02418000|12281701|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991771|NCT02418000|12281702|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
4991772|NCT02418000|12281703|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
4991773|NCT02418000|12281699|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991774|NCT02418000|12281700|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991775|NCT02418000|12281701|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991776|NCT02418000|12281702|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991777|NCT02418000|12281703|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
4991778|NCT02418000|12281699|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991779|NCT02418000|12281700|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991780|NCT02418000|12281701|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991781|NCT02418000|12281702|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991782|NCT02418000|12281703|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991783|NCT02418000|12281699|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991784|NCT02418000|12281700|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991785|NCT02418000|12281701|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991786|NCT02418000|12281702|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
4991787|NCT02418000|12281703|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
4991788|NCT02417961|12281821|P1|NOT COMPLETED|Overall Study||4
4991789|NCT02417961|12281821|P1|COMPLETED|Overall Study||112
4991790|NCT02417961|12281821|P1|STARTED|Overall Study||116
4991791|NCT02417935|12281833|P2|NOT COMPLETED|Tapering Period||0
4991792|NCT02417935|12281834|P1|NOT COMPLETED|Tapering Period||0
4991793|NCT02417935|12281833|P2|COMPLETED|Tapering Period||142
4991794|NCT02417935|12281834|P1|COMPLETED|Tapering Period||134
4991795|NCT02417935|12281833|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
4991796|NCT02417935|12281834|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
4991797|NCT02417935|12281833|P2|NOT COMPLETED|Treatment Period||16
4991798|NCT02417935|12281834|P1|NOT COMPLETED|Treatment Period||21
4991799|NCT02417935|12281833|P2|COMPLETED|Treatment Period||137
4991800|NCT02417935|12281834|P1|COMPLETED|Treatment Period||130
4991801|NCT02417935|12281833|P2|Received at Least One Dose of Study Drug|Treatment Period||152
4991802|NCT02417935|12281834|P1|Received at Least One Dose of Study Drug|Treatment Period||151
4991803|NCT02417935|12281833|P2|STARTED|Treatment Period||153
4991804|NCT02417935|12281834|P1|STARTED|Treatment Period||151
4991805|NCT02417844|12281858|P2|NOT COMPLETED|Overall Study||0
4991806|NCT02417844|12281859|P1|NOT COMPLETED|Overall Study||0
4991807|NCT02417844|12281858|P2|COMPLETED|Overall Study||17
4991808|NCT02417844|12281859|P1|COMPLETED|Overall Study||17
4991809|NCT02417844|12281858|P2|STARTED|Overall Study||17
4991810|NCT02417844|12281859|P1|STARTED|Overall Study||17
4991811|NCT02417831|12281875|P2|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
4991812|NCT02417831|12281876|P1|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
4991813|NCT02417831|12281875|P2|COMPLETED|Period 2: Treatment Period 2 + Washout||17
4991814|NCT02417831|12281876|P1|COMPLETED|Period 2: Treatment Period 2 + Washout||17
4991815|NCT02417831|12281875|P2|STARTED|Period 2: Treatment Period 2 + Washout||17
4991816|NCT02417831|12281876|P1|STARTED|Period 2: Treatment Period 2 + Washout||17
4991817|NCT02417831|12281875|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
4991818|NCT02417831|12281876|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
4991819|NCT02417831|12281875|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||17
4991820|NCT02417831|12281876|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||17
4991821|NCT02417831|12281875|P2|STARTED|Period 1: Treatment Period 1 + Washout||17
4991822|NCT02417831|12281876|P1|STARTED|Period 1: Treatment Period 1 + Washout||17
4991823|NCT02417753|12281892|P1|NOT COMPLETED|Overall Study||1
4991824|NCT02417753|12281892|P1|COMPLETED|Overall Study||0
4991825|NCT02417753|12281892|P1|STARTED|Overall Study||1
4991826|NCT02417532|12281902|P1|NOT COMPLETED|Overall Study||0
4991827|NCT02417532|12281902|P1|COMPLETED|Overall Study||56
4991828|NCT02417532|12281902|P1|STARTED|Overall Study||56
4991829|NCT02417441|12281912|P2|NOT COMPLETED|Overall Study||19
4991830|NCT02417441|12281913|P1|NOT COMPLETED|Overall Study||52
4991831|NCT02417441|12281912|P2|COMPLETED|Overall Study||306
4991832|NCT02417441|12281913|P1|COMPLETED|Overall Study||593
4991833|NCT02417441|12281912|P2|STARTED|Overall Study||325
4991834|NCT02417441|12281913|P1|STARTED|Overall Study||645
4991835|NCT02417376|12281934|P2|NOT COMPLETED|Overall Study||10
4991836|NCT02417376|12281935|P1|NOT COMPLETED|Overall Study||5
4991837|NCT02417376|12281934|P2|COMPLETED|Overall Study||25
4991838|NCT02417376|12281935|P1|COMPLETED|Overall Study||30
4991839|NCT02417376|12281934|P2|STARTED|Overall Study||35
4991840|NCT02417376|12281935|P1|STARTED|Overall Study||35
4991841|NCT02417246|12281981|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
4991842|NCT02417246|12281982|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
4991843|NCT02417246|12281981|P2|COMPLETED|Phase 4 2nd Generic Administered||20
4991844|NCT02417246|12281982|P1|COMPLETED|Phase 4 2nd Generic Administered||18
4991845|NCT02417246|12281981|P2|STARTED|Phase 4 2nd Generic Administered||20
4991846|NCT02417246|12281982|P1|STARTED|Phase 4 2nd Generic Administered||18
4991847|NCT02417246|12281981|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
4991848|NCT02417246|12281982|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
4991849|NCT02417246|12281981|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
4991850|NCT02417246|12281982|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
4991851|NCT02417246|12281981|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
4991852|NCT02417246|12281982|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
4991853|NCT02417246|12281981|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
4991854|NCT02417246|12281982|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
4991855|NCT02417246|12281981|P2|COMPLETED|Phase 2 1st Generic Administered||20
4991856|NCT02417246|12281982|P1|COMPLETED|Phase 2 1st Generic Administered||19
4991857|NCT02417246|12281981|P2|STARTED|Phase 2 1st Generic Administered||20
4991858|NCT02417246|12281982|P1|STARTED|Phase 2 1st Generic Administered||20
4991859|NCT02417246|12281981|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
4991860|NCT02417246|12281982|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
4991861|NCT02417246|12281981|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
4991862|NCT02417246|12281982|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
4991863|NCT02417246|12281981|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
4991864|NCT02417246|12281982|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
4991865|NCT02417233|12282005|P3|NOT COMPLETED|Overall Study||59
4991866|NCT02417233|12282006|P2|NOT COMPLETED|Overall Study||51
4991867|NCT02417233|12282007|P1|NOT COMPLETED|Overall Study||36
4991868|NCT02417233|12282005|P3|COMPLETED|Overall Study||239
4991869|NCT02417233|12282006|P2|COMPLETED|Overall Study||238
4991870|NCT02417233|12282007|P1|COMPLETED|Overall Study||133
4991871|NCT02417233|12282005|P3|STARTED|Overall Study||298
4991872|NCT02417233|12282006|P2|STARTED|Overall Study||289
4991873|NCT02417233|12282007|P1|STARTED|Overall Study||169
4991874|NCT02417129|12282030|P2|NOT COMPLETED|Overall Study||0
4991875|NCT02417129|12282031|P1|NOT COMPLETED|Overall Study||0
4991876|NCT02417129|12282030|P2|COMPLETED|Overall Study||0
4991877|NCT02417129|12282031|P1|COMPLETED|Overall Study||2
4991878|NCT02417129|12282030|P2|STARTED|Overall Study||0
4991879|NCT02417129|12282031|P1|STARTED|Overall Study||2
4991880|NCT02417064|12282044|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
4991881|NCT02417064|12282045|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
4991882|NCT02417064|12282046|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
4991883|NCT02417064|12282044|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
4991884|NCT02417064|12282045|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
4991885|NCT02417064|12282046|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
4991886|NCT02417064|12282044|P3|STARTED|Follow-up Phase (24 Weeks)||69
4991887|NCT02417064|12282045|P2|STARTED|Follow-up Phase (24 Weeks)||52
4991888|NCT02417064|12282046|P1|STARTED|Follow-up Phase (24 Weeks)||47
4991889|NCT02417064|12282044|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
4991890|NCT02417064|12282045|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
4991891|NCT02417064|12282046|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
4991892|NCT02417064|12282044|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
4991893|NCT02417064|12282045|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
4991894|NCT02417064|12282046|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
4991895|NCT02417064|12282044|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
4991896|NCT02417064|12282045|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
4991897|NCT02417064|12282046|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
4991898|NCT02417064|12282044|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
4991899|NCT02417064|12282045|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
4991900|NCT02417064|12282046|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
4991901|NCT02417064|12282044|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
4991902|NCT02417064|12282045|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
4991903|NCT02417064|12282046|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
4991904|NCT02416973|12282105|P3|NOT COMPLETED|Overall Study||1
4991905|NCT02416973|12282106|P2|NOT COMPLETED|Overall Study||3
4991906|NCT02416973|12282107|P1|NOT COMPLETED|Overall Study||1
4991907|NCT02416973|12282105|P3|COMPLETED|Overall Study||13
4991908|NCT02416973|12282106|P2|COMPLETED|Overall Study||10
4991909|NCT02416973|12282107|P1|COMPLETED|Overall Study||13
4991910|NCT02416973|12282105|P3|STARTED|Overall Study||14
4991911|NCT02416973|12282106|P2|STARTED|Overall Study||13
4991912|NCT02416973|12282107|P1|STARTED|Overall Study||14
4991913|NCT02416934|12282117|P2|NOT COMPLETED|Overall Study||7
4991914|NCT02416934|12282118|P1|NOT COMPLETED|Overall Study||3
4991915|NCT02416934|12282117|P2|COMPLETED|Overall Study||31
4991916|NCT02416934|12282118|P1|COMPLETED|Overall Study||33
4991917|NCT02416934|12282117|P2|Last Participant Completed 1 yr|Overall Study||31
4991918|NCT02416934|12282118|P1|Last Participant Completed 1 yr|Overall Study||33
4991919|NCT02416934|12282117|P2|Double Blind (0-52 Weeks)|Overall Study||38
4991920|NCT02416934|12282118|P1|Double Blind (0-52 Weeks)|Overall Study||36
4991921|NCT02416934|12282117|P2|STARTED|Overall Study||38
4991922|NCT02416934|12282118|P1|STARTED|Overall Study||36
4991923|NCT02416908|12282133|P4|NOT COMPLETED|Maintenance Phase||0
4991924|NCT02416908|12282134|P3|NOT COMPLETED|Maintenance Phase||0
4991925|NCT02416908|12282135|P2|NOT COMPLETED|Maintenance Phase||0
4991926|NCT02416908|12282136|P1|NOT COMPLETED|Maintenance Phase||0
4991927|NCT02416908|12282133|P4|COMPLETED|Maintenance Phase||2
4991928|NCT02416908|12282134|P3|COMPLETED|Maintenance Phase||0
4991929|NCT02416908|12282135|P2|COMPLETED|Maintenance Phase||0
4991930|NCT02416908|12282136|P1|COMPLETED|Maintenance Phase||0
4991931|NCT02416908|12282133|P4|STARTED|Maintenance Phase||2
4991932|NCT02416908|12282134|P3|STARTED|Maintenance Phase||0
4991933|NCT02416908|12282135|P2|STARTED|Maintenance Phase||0
4991934|NCT02416908|12282136|P1|STARTED|Maintenance Phase||0
4991935|NCT02416908|12282133|P4|NOT COMPLETED|Dose Escalation Phase||0
4991936|NCT02416908|12282134|P3|NOT COMPLETED|Dose Escalation Phase||4
4991937|NCT02416908|12282135|P2|NOT COMPLETED|Dose Escalation Phase||0
4991938|NCT02416908|12282136|P1|NOT COMPLETED|Dose Escalation Phase||0
4991939|NCT02416908|12282133|P4|COMPLETED|Dose Escalation Phase||0
4991940|NCT02416908|12282134|P3|COMPLETED|Dose Escalation Phase||30
4991941|NCT02416908|12282135|P2|COMPLETED|Dose Escalation Phase||0
4991942|NCT02416908|12282136|P1|COMPLETED|Dose Escalation Phase||6
4991943|NCT02416908|12282133|P4|STARTED|Dose Escalation Phase||0
4991944|NCT02416908|12282134|P3|STARTED|Dose Escalation Phase||34
4991945|NCT02416908|12282135|P2|STARTED|Dose Escalation Phase||0
4991946|NCT02416908|12282136|P1|STARTED|Dose Escalation Phase||6
4991947|NCT02416713|12282155|P4|NOT COMPLETED|Overall Study||0
4991948|NCT02416713|12282156|P3|NOT COMPLETED|Overall Study||0
4991949|NCT02416713|12282157|P2|NOT COMPLETED|Overall Study||0
4991950|NCT02416713|12282158|P1|NOT COMPLETED|Overall Study||0
4991951|NCT02416713|12282155|P4|COMPLETED|Overall Study||10
4991952|NCT02416713|12282156|P3|COMPLETED|Overall Study||8
4991953|NCT02416713|12282157|P2|COMPLETED|Overall Study||9
4991954|NCT02416713|12282158|P1|COMPLETED|Overall Study||8
4991955|NCT02416713|12282155|P4|STARTED|Overall Study||10
4991956|NCT02416713|12282156|P3|STARTED|Overall Study||8
4991957|NCT02416713|12282157|P2|STARTED|Overall Study||9
4991958|NCT02416713|12282158|P1|STARTED|Overall Study||8
4991959|NCT02416622|12282171|P3|NOT COMPLETED|Overall Study||13
4991960|NCT02416622|12282172|P2|NOT COMPLETED|Overall Study||8
4991961|NCT02416622|12282173|P1|NOT COMPLETED|Overall Study||6
4991962|NCT02416622|12282171|P3|COMPLETED|Overall Study||0
4991963|NCT02416622|12282172|P2|COMPLETED|Overall Study||0
4991964|NCT02416622|12282173|P1|COMPLETED|Overall Study||0
4991965|NCT02416622|12282171|P3|Started Long-Term Follow-Up|Overall Study||13
4991966|NCT02416622|12282172|P2|Started Long-Term Follow-Up|Overall Study||8
4991967|NCT02416622|12282173|P1|Started Long-Term Follow-Up|Overall Study||6
4991968|NCT02416622|12282171|P3|Completed Month 12|Overall Study||13
4991969|NCT02416622|12282172|P2|Completed Month 12|Overall Study||8
4991970|NCT02416622|12282173|P1|Completed Month 12|Overall Study||6
4991971|NCT02416622|12282171|P3|STARTED|Overall Study||13
4991972|NCT02416622|12282172|P2|STARTED|Overall Study||8
4991973|NCT02416622|12282173|P1|STARTED|Overall Study||6
4991974|NCT02416180|12282190|P1|NOT COMPLETED|Overall Study||1
4991975|NCT02416180|12282190|P1|COMPLETED|Overall Study||110
4991976|NCT02416180|12282190|P1|STARTED|Overall Study||111
4991977|NCT02415998|12282197|P1|NOT COMPLETED|Overall Study||5
4991978|NCT02415998|12282197|P1|COMPLETED|Overall Study||20
4991979|NCT02415998|12282197|P1|STARTED|Overall Study||25
4991980|NCT02415959|12282206|P5|NOT COMPLETED|Overall Study||0
4991981|NCT02415959|12282207|P4|NOT COMPLETED|Overall Study||1
4991982|NCT02415959|12282208|P3|NOT COMPLETED|Overall Study||0
4991983|NCT02415959|12282209|P2|NOT COMPLETED|Overall Study||1
4991984|NCT02415959|12282210|P1|NOT COMPLETED|Overall Study||0
4991985|NCT02415959|12282206|P5|COMPLETED|Overall Study||14
4991986|NCT02415959|12282207|P4|COMPLETED|Overall Study||13
4991987|NCT02415959|12282208|P3|COMPLETED|Overall Study||14
4991988|NCT02415959|12282209|P2|COMPLETED|Overall Study||13
4991989|NCT02415959|12282210|P1|COMPLETED|Overall Study||14
4991990|NCT02415959|12282206|P5|STARTED|Overall Study||14
4991991|NCT02415959|12282207|P4|STARTED|Overall Study||14
4991992|NCT02415959|12282208|P3|STARTED|Overall Study||14
4991993|NCT02415959|12282209|P2|STARTED|Overall Study||14
4991994|NCT02415959|12282210|P1|STARTED|Overall Study||14
4991995|NCT02415855|12282244|P2|NOT COMPLETED|Overall Study||2
4991996|NCT02415855|12282245|P1|NOT COMPLETED|Overall Study||3
4991997|NCT02415855|12282244|P2|COMPLETED|Overall Study||62
4991998|NCT02415855|12282245|P1|COMPLETED|Overall Study||34
4991999|NCT02415855|12282244|P2|STARTED|Overall Study||64
4992000|NCT02415855|12282245|P1|STARTED|Overall Study||37
4992001|NCT02415842|12282272|P13|NOT COMPLETED|Overall Study||0
4992002|NCT02415842|12282273|P12|NOT COMPLETED|Overall Study||0
4992003|NCT02415842|12282274|P11|NOT COMPLETED|Overall Study||0
4992004|NCT02415842|12282275|P10|NOT COMPLETED|Overall Study||0
4992005|NCT02415842|12282276|P9|NOT COMPLETED|Overall Study||0
4992006|NCT02415842|12282277|P8|NOT COMPLETED|Overall Study||0
4992007|NCT02415842|12282278|P7|NOT COMPLETED|Overall Study||0
4992008|NCT02415842|12282279|P6|NOT COMPLETED|Overall Study||0
4992009|NCT02415842|12282280|P5|NOT COMPLETED|Overall Study||0
4992010|NCT02415842|12282281|P4|NOT COMPLETED|Overall Study||0
4992011|NCT02415842|12282282|P3|NOT COMPLETED|Overall Study||0
4992012|NCT02415842|12282283|P2|NOT COMPLETED|Overall Study||0
4992013|NCT02415842|12282284|P1|NOT COMPLETED|Overall Study||0
4992014|NCT02415842|12282272|P13|COMPLETED|Overall Study||20
4992015|NCT02415842|12282273|P12|COMPLETED|Overall Study||33
4992016|NCT02415842|12282274|P11|COMPLETED|Overall Study||49
4992017|NCT02415842|12282275|P10|COMPLETED|Overall Study||53
4992018|NCT02415842|12282276|P9|COMPLETED|Overall Study||29
4992019|NCT02415842|12282277|P8|COMPLETED|Overall Study||26
4992020|NCT02415842|12282278|P7|COMPLETED|Overall Study||30
4992021|NCT02415842|12282279|P6|COMPLETED|Overall Study||30
4992022|NCT02415842|12282280|P5|COMPLETED|Overall Study||30
4992023|NCT02415842|12282281|P4|COMPLETED|Overall Study||27
4992024|NCT02415842|12282282|P3|COMPLETED|Overall Study||29
4992025|NCT02415842|12282283|P2|COMPLETED|Overall Study||29
4992026|NCT02415842|12282284|P1|COMPLETED|Overall Study||29
4992027|NCT02415842|12282272|P13|STARTED|Overall Study||20
4992028|NCT02415842|12282273|P12|STARTED|Overall Study||33
4992029|NCT02415842|12282274|P11|STARTED|Overall Study||49
4992030|NCT02415842|12282275|P10|STARTED|Overall Study||53
4992031|NCT02415842|12282276|P9|STARTED|Overall Study||29
4992032|NCT02415842|12282277|P8|STARTED|Overall Study||26
4992033|NCT02415842|12282278|P7|STARTED|Overall Study||30
4992034|NCT02415842|12282279|P6|STARTED|Overall Study||30
4992035|NCT02415842|12282280|P5|STARTED|Overall Study||30
4992036|NCT02415842|12282281|P4|STARTED|Overall Study||27
4992037|NCT02415842|12282282|P3|STARTED|Overall Study||29
4992038|NCT02415842|12282283|P2|STARTED|Overall Study||29
4992039|NCT02415842|12282284|P1|STARTED|Overall Study||29
4992040|NCT02415608|12282625|P2|NOT COMPLETED|Overall Study||0
4992041|NCT02415608|12282626|P1|NOT COMPLETED|Overall Study||0
4992042|NCT02415608|12282625|P2|COMPLETED|Overall Study||1
4992043|NCT02415608|12282626|P1|COMPLETED|Overall Study||3
4992044|NCT02415608|12282625|P2|STARTED|Overall Study||1
4992045|NCT02415608|12282626|P1|STARTED|Overall Study||3
4992046|NCT02415595|12282656|P4|NOT COMPLETED|Overall Study||53
4992047|NCT02415595|12282657|P3|NOT COMPLETED|Overall Study||51
4992048|NCT02415595|12282658|P2|NOT COMPLETED|Overall Study||52
4992049|NCT02415595|12282659|P1|NOT COMPLETED|Overall Study||50
4992050|NCT02415595|12282656|P4|COMPLETED|Overall Study||0
4992051|NCT02415595|12282657|P3|COMPLETED|Overall Study||0
4992052|NCT02415595|12282658|P2|COMPLETED|Overall Study||0
4992053|NCT02415595|12282659|P1|COMPLETED|Overall Study||0
4992054|NCT02415595|12282656|P4|STARTED|Overall Study||53
4992055|NCT02415595|12282657|P3|STARTED|Overall Study||51
4992056|NCT02415595|12282658|P2|STARTED|Overall Study||52
4992057|NCT02415595|12282659|P1|STARTED|Overall Study||50
4992058|NCT02415439|12282731|P13|NOT COMPLETED|Overall Study||0
4992059|NCT02415439|12282732|P12|NOT COMPLETED|Overall Study||0
4992060|NCT02415439|12282733|P11|NOT COMPLETED|Overall Study||0
4992061|NCT02415439|12282734|P10|NOT COMPLETED|Overall Study||0
4992062|NCT02415439|12282735|P9|NOT COMPLETED|Overall Study||1
4992063|NCT02415439|12282736|P8|NOT COMPLETED|Overall Study||0
4992064|NCT02415439|12282737|P7|NOT COMPLETED|Overall Study||0
4992065|NCT02415439|12282738|P6|NOT COMPLETED|Overall Study||0
4992066|NCT02415439|12282739|P5|NOT COMPLETED|Overall Study||0
4992067|NCT02415439|12282740|P4|NOT COMPLETED|Overall Study||0
4992068|NCT02415439|12282741|P3|NOT COMPLETED|Overall Study||0
4992069|NCT02415439|12282742|P2|NOT COMPLETED|Overall Study||0
4992070|NCT02415439|12282743|P1|NOT COMPLETED|Overall Study||0
4992071|NCT02415439|12282731|P13|COMPLETED|Overall Study||8
4992072|NCT02415439|12282732|P12|COMPLETED|Overall Study||6
4992073|NCT02415439|12282733|P11|COMPLETED|Overall Study||6
4992074|NCT02415439|12282734|P10|COMPLETED|Overall Study||6
4992075|NCT02415439|12282735|P9|COMPLETED|Overall Study||5
4992076|NCT02415439|12282736|P8|COMPLETED|Overall Study||12
4992077|NCT02415439|12282737|P7|COMPLETED|Overall Study||6
4992078|NCT02415439|12282738|P6|COMPLETED|Overall Study||6
4992079|NCT02415439|12282739|P5|COMPLETED|Overall Study||6
4992080|NCT02415439|12282740|P4|COMPLETED|Overall Study||6
4992081|NCT02415439|12282741|P3|COMPLETED|Overall Study||6
4992082|NCT02415439|12282742|P2|COMPLETED|Overall Study||6
4992083|NCT02415439|12282743|P1|COMPLETED|Overall Study||6
4992084|NCT02415439|12282731|P13|STARTED|Overall Study||8
4992085|NCT02415439|12282732|P12|STARTED|Overall Study||6
4992086|NCT02415439|12282733|P11|STARTED|Overall Study||6
4992087|NCT02415439|12282734|P10|STARTED|Overall Study||6
4992088|NCT02415439|12282735|P9|STARTED|Overall Study||6
4992089|NCT02415439|12282736|P8|STARTED|Overall Study||12
4992090|NCT02415439|12282737|P7|STARTED|Overall Study||6
4992091|NCT02415439|12282738|P6|STARTED|Overall Study||6
4992092|NCT02415439|12282739|P5|STARTED|Overall Study||6
4992093|NCT02415439|12282740|P4|STARTED|Overall Study||6
4992094|NCT02415439|12282741|P3|STARTED|Overall Study||6
4992095|NCT02415439|12282742|P2|STARTED|Overall Study||6
4992096|NCT02415439|12282743|P1|STARTED|Overall Study||6
4992097|NCT02415400|12282801|P4|NOT COMPLETED|Overall Study||83
4992098|NCT02415400|12282802|P3|NOT COMPLETED|Overall Study||85
4992099|NCT02415400|12282803|P2|NOT COMPLETED|Overall Study||62
4992100|NCT02415400|12282804|P1|NOT COMPLETED|Overall Study||66
4992101|NCT02415400|12282801|P4|COMPLETED|Overall Study||1071
4992102|NCT02415400|12282802|P3|COMPLETED|Overall Study||1069
4992103|NCT02415400|12282803|P2|COMPLETED|Overall Study||1091
4992104|NCT02415400|12282804|P1|COMPLETED|Overall Study||1087
4992105|NCT02415400|12282801|P4|STARTED|Overall Study||1154
4992106|NCT02415400|12282802|P3|STARTED|Overall Study||1154
4992107|NCT02415400|12282803|P2|STARTED|Overall Study||1153
4992108|NCT02415400|12282804|P1|STARTED|Overall Study||1153
4992109|NCT02415244|12282830|P2|NOT COMPLETED|Overall Study||0
4992110|NCT02415244|12282831|P1|NOT COMPLETED|Overall Study||0
4992111|NCT02415244|12282830|P2|COMPLETED|Overall Study||25
4992112|NCT02415244|12282831|P1|COMPLETED|Overall Study||50
4992113|NCT02415244|12282830|P2|STARTED|Overall Study||25
4992114|NCT02415244|12282831|P1|STARTED|Overall Study||50
4992115|NCT02415166|12282841|P4|NOT COMPLETED|Overall Study||0
4992116|NCT02415166|12282842|P3|NOT COMPLETED|Overall Study||0
4992117|NCT02415166|12282843|P2|NOT COMPLETED|Overall Study||0
4992118|NCT02415166|12282844|P1|NOT COMPLETED|Overall Study||0
4992119|NCT02415166|12282841|P4|COMPLETED|Overall Study||0
4992120|NCT02415166|12282842|P3|COMPLETED|Overall Study||0
4992121|NCT02415166|12282843|P2|COMPLETED|Overall Study||0
4992122|NCT02415166|12282844|P1|COMPLETED|Overall Study||6
4992123|NCT02415166|12282841|P4|STARTED|Overall Study||0
4992124|NCT02415166|12282842|P3|STARTED|Overall Study||0
4992125|NCT02415166|12282843|P2|STARTED|Overall Study||0
4992126|NCT02415166|12282844|P1|STARTED|Overall Study||6
4992127|NCT02415127|12282872|P2|NOT COMPLETED|Overall Study||0
4992128|NCT02415127|12282873|P1|NOT COMPLETED|Overall Study||1
4992129|NCT02415127|12282872|P2|COMPLETED|Overall Study||45
4992130|NCT02415127|12282873|P1|COMPLETED|Overall Study||46
4992131|NCT02415127|12282872|P2|STARTED|Overall Study||45
4992132|NCT02415127|12282873|P1|STARTED|Overall Study||47
4992133|NCT02414958|12282890|P3|NOT COMPLETED|Overall Study||14
4992134|NCT02414958|12282891|P2|NOT COMPLETED|Overall Study||20
4992135|NCT02414958|12282892|P1|NOT COMPLETED|Overall Study||32
4992136|NCT02414958|12282890|P3|COMPLETED|Overall Study||230
4992137|NCT02414958|12282891|P2|COMPLETED|Overall Study||223
4992138|NCT02414958|12282892|P1|COMPLETED|Overall Study||211
4992139|NCT02414958|12282890|P3|STARTED|Overall Study||244
4992140|NCT02414958|12282891|P2|STARTED|Overall Study||243
4992141|NCT02414958|12282892|P1|STARTED|Overall Study||243
4992142|NCT02414854|12282925|P4|NOT COMPLETED|Overall Study||51
4992143|NCT02414854|12282926|P3|NOT COMPLETED|Overall Study||20
4992144|NCT02414854|12282927|P2|NOT COMPLETED|Overall Study||45
4992145|NCT02414854|12282928|P1|NOT COMPLETED|Overall Study||22
4992146|NCT02414854|12282925|P4|COMPLETED|Overall Study||582
4992147|NCT02414854|12282926|P3|COMPLETED|Overall Study||301
4992148|NCT02414854|12282927|P2|COMPLETED|Overall Study||586
4992149|NCT02414854|12282928|P1|COMPLETED|Overall Study||295
4992150|NCT02414854|12282925|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
4992151|NCT02414854|12282926|P3|Treated|Overall Study||321
4992152|NCT02414854|12282927|P2|Treated|Overall Study||629
4992153|NCT02414854|12282928|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
4992154|NCT02414854|12282925|P4|STARTED|Overall Study||633
4992155|NCT02414854|12282926|P3|STARTED|Overall Study||321
4992156|NCT02414854|12282927|P2|STARTED|Overall Study||631
4992157|NCT02414854|12282928|P1|STARTED|Overall Study||317
4992158|NCT02414841|12283092|P2|NOT COMPLETED|Overall Study||33
4992159|NCT02414841|12283093|P1|NOT COMPLETED|Overall Study||56
4992160|NCT02414841|12283092|P2|COMPLETED|Overall Study||175
4992161|NCT02414841|12283093|P1|COMPLETED|Overall Study||349
4992162|NCT02414841|12283092|P2|STARTED|Overall Study||208
4992163|NCT02414841|12283093|P1|STARTED|Overall Study||405
4992164|NCT02414828|12283105|P4|NOT COMPLETED|Overall Study||2
4992165|NCT02414828|12283106|P3|NOT COMPLETED|Overall Study||1
4992166|NCT02414828|12283107|P2|NOT COMPLETED|Overall Study||1
4992167|NCT02414828|12283108|P1|NOT COMPLETED|Overall Study||0
4992168|NCT02414828|12283105|P4|COMPLETED|Overall Study||29
4992169|NCT02414828|12283106|P3|COMPLETED|Overall Study||19
4992170|NCT02414828|12283107|P2|COMPLETED|Overall Study||9
4992171|NCT02414828|12283108|P1|COMPLETED|Overall Study||11
4992172|NCT02414828|12283105|P4|STARTED|Overall Study||31
4992173|NCT02414828|12283106|P3|STARTED|Overall Study||20
4992174|NCT02414828|12283107|P2|STARTED|Overall Study||10
4992175|NCT02414828|12283108|P1|STARTED|Overall Study||11
4992176|NCT02414698|12283148|P2|NOT COMPLETED|Overall Study||0
4992177|NCT02414698|12283149|P1|NOT COMPLETED|Overall Study||0
4992178|NCT02414698|12283148|P2|COMPLETED|Overall Study||1
4992179|NCT02414698|12283149|P1|COMPLETED|Overall Study||3
4992180|NCT02414698|12283148|P2|STARTED|Overall Study||1
4992181|NCT02414698|12283149|P1|STARTED|Overall Study||3
4992182|NCT02414633|12283159|P1|NOT COMPLETED|Overall Study||0
4992183|NCT02414633|12283159|P1|COMPLETED|Overall Study||148
4992184|NCT02414633|12283159|P1|STARTED|Overall Study||148
4992185|NCT02414243|12283182|P2|NOT COMPLETED|Overall Study||4
4992186|NCT02414243|12283183|P1|NOT COMPLETED|Overall Study||6
4992187|NCT02414243|12283182|P2|COMPLETED|Overall Study||17
4992188|NCT02414243|12283183|P1|COMPLETED|Overall Study||13
4992189|NCT02414243|12283182|P2|Entered Open Challenge at Home|Overall Study||20
4992190|NCT02414243|12283183|P1|Entered Open Challenge at Home|Overall Study||17
4992191|NCT02414243|12283182|P2|Moved to the Other Group|Overall Study||20
4992192|NCT02414243|12283183|P1|Moved to the Other Group|Overall Study||17
4992193|NCT02414243|12283182|P2|STARTED|Overall Study||21
4992194|NCT02414243|12283183|P1|STARTED|Overall Study||19
4992195|NCT02414204|12283192|P2|NOT COMPLETED|Overall Study||0
4992196|NCT02414204|12283193|P1|NOT COMPLETED|Overall Study||0
4992197|NCT02414204|12283192|P2|COMPLETED|Overall Study||2
4992198|NCT02414204|12283193|P1|COMPLETED|Overall Study||2
4992199|NCT02414204|12283192|P2|STARTED|Overall Study||2
4992200|NCT02414204|12283193|P1|STARTED|Overall Study||2
4992201|NCT02414152|12283201|P1|NOT COMPLETED|Overall Study||2
4992202|NCT02414152|12283201|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
4992203|NCT02414152|12283201|P1|STARTED|Overall Study||2
4992204|NCT02413996|12283207|P2|NOT COMPLETED|Overall Study||2
4992205|NCT02413996|12283208|P1|NOT COMPLETED|Overall Study||9
4992206|NCT02413996|12283207|P2|COMPLETED|Overall Study||39
4992207|NCT02413996|12283208|P1|COMPLETED|Overall Study||35
4992208|NCT02413996|12283207|P2|STARTED|Overall Study||41
4992209|NCT02413996|12283208|P1|STARTED|Overall Study||44
4992210|NCT02413918|12283230|P1|NOT COMPLETED|Overall Study||25
4992211|NCT02413918|12283230|P1|COMPLETED|Overall Study||16
4992212|NCT02413918|12283230|P1|STARTED|Overall Study||41
4992213|NCT02413879|12283237|P1|NOT COMPLETED|Overall Study||0
4992214|NCT02413879|12283237|P1|COMPLETED|Overall Study||86
4992215|NCT02413879|12283237|P1|STARTED|Overall Study||86
4992216|NCT02413684|12283243|P1|NOT COMPLETED|Overall Study||13
4992217|NCT02413684|12283243|P1|COMPLETED|Overall Study||40
4992218|NCT02413684|12283243|P1|STARTED|Overall Study||53
4992219|NCT02413593|12283253|P1|NOT COMPLETED|Overall Study||4
4992220|NCT02413593|12283253|P1|COMPLETED|Overall Study||107
4992221|NCT02413593|12283253|P1|STARTED|Overall Study||111
4992222|NCT02413580|12283262|P1|NOT COMPLETED|Overall Study||3
4992223|NCT02413580|12283262|P1|COMPLETED|Overall Study||46
4992224|NCT02413580|12283262|P1|STARTED|Overall Study||49
4992225|NCT02413489|12283272|P3|NOT COMPLETED|Overall Study||5
4992226|NCT02413489|12283273|P2|NOT COMPLETED|Overall Study||16
4992227|NCT02413489|12283274|P1|NOT COMPLETED|Overall Study||15
4992228|NCT02413489|12283272|P3|COMPLETED|Overall Study||0
4992229|NCT02413489|12283273|P2|COMPLETED|Overall Study||0
4992230|NCT02413489|12283274|P1|COMPLETED|Overall Study||0
4992231|NCT02413489|12283272|P3|STARTED|Overall Study||5
4992232|NCT02413489|12283273|P2|STARTED|Overall Study||16
4992233|NCT02413489|12283274|P1|STARTED|Overall Study||15
4992234|NCT02413463|12283296|P2|NOT COMPLETED|Overall Study||2
4992235|NCT02413463|12283297|P1|NOT COMPLETED|Overall Study||5
4992236|NCT02413463|12283296|P2|COMPLETED|Overall Study||28
4992237|NCT02413463|12283297|P1|COMPLETED|Overall Study||25
4992238|NCT02413463|12283296|P2|STARTED|Overall Study||30
4992239|NCT02413463|12283297|P1|STARTED|Overall Study||30
4992240|NCT02413398|12283315|P2|NOT COMPLETED|Overall Study||7
4992241|NCT02413398|12283316|P1|NOT COMPLETED|Overall Study||4
4992242|NCT02413398|12283315|P2|COMPLETED|Overall Study||154
4992243|NCT02413398|12283316|P1|COMPLETED|Overall Study||156
4992244|NCT02413398|12283315|P2|STARTED|Overall Study||161
4992245|NCT02413398|12283316|P1|STARTED|Overall Study||160
4992246|NCT02413372|12283331|P3|NOT COMPLETED|Follow-up||2
4992247|NCT02413372|12283332|P2|NOT COMPLETED|Follow-up||1
4992248|NCT02413372|12283333|P1|NOT COMPLETED|Follow-up||2
4992249|NCT02413372|12283331|P3|COMPLETED|Follow-up||23
4992250|NCT02413372|12283332|P2|COMPLETED|Follow-up||20
4992251|NCT02413372|12283333|P1|COMPLETED|Follow-up||20
4992252|NCT02413372|12283331|P3|STARTED|Follow-up||25
4992253|NCT02413372|12283332|P2|STARTED|Follow-up||21
4992254|NCT02413372|12283333|P1|STARTED|Follow-up||22
4992255|NCT02413372|12283331|P3|NOT COMPLETED|Treatment||1
4992256|NCT02413372|12283332|P2|NOT COMPLETED|Treatment||2
4992257|NCT02413372|12283333|P1|NOT COMPLETED|Treatment||1
4992258|NCT02413372|12283331|P3|COMPLETED|Treatment||25
4992259|NCT02413372|12283332|P2|COMPLETED|Treatment||22
4992260|NCT02413372|12283333|P1|COMPLETED|Treatment||24
4992261|NCT02413372|12283331|P3|STARTED|Treatment||26
4992262|NCT02413372|12283332|P2|STARTED|Treatment||24
4992263|NCT02413372|12283333|P1|STARTED|Treatment||25
4992264|NCT02413346|12283382|P2|NOT COMPLETED|Overall Study||70
4992265|NCT02413346|12283383|P1|NOT COMPLETED|Overall Study||59
4992266|NCT02413346|12283382|P2|COMPLETED|Overall Study||177
4992267|NCT02413346|12283383|P1|COMPLETED|Overall Study||177
4992268|NCT02413346|12283382|P2|STARTED|Overall Study||247
4992269|NCT02413346|12283383|P1|STARTED|Overall Study||236
4992270|NCT02413333|12283393|P2|NOT COMPLETED|Period 2||0
4992271|NCT02413333|12283394|P1|NOT COMPLETED|Period 2||1
4992272|NCT02413333|12283393|P2|COMPLETED|Period 2||65
4992273|NCT02413333|12283394|P1|COMPLETED|Period 2||64
4992274|NCT02413333|12283393|P2|STARTED|Period 2||65
4992275|NCT02413333|12283394|P1|STARTED|Period 2||65
4992276|NCT02413333|12283393|P2|NOT COMPLETED|Period 1||1
4992277|NCT02413333|12283394|P1|NOT COMPLETED|Period 1||1
4992278|NCT02413333|12283393|P2|COMPLETED|Period 1||65
4992279|NCT02413333|12283394|P1|COMPLETED|Period 1||65
4992280|NCT02413333|12283393|P2|Randomized and Treated|Period 1||66
4992281|NCT02413333|12283394|P1|Randomized and Treated|Period 1||66
4992282|NCT02413333|12283393|P2|STARTED|Period 1||66
4992283|NCT02413333|12283394|P1|STARTED|Period 1||66
4992284|NCT02413294|12283402|P1|NOT COMPLETED|Overall Study||1
4992285|NCT02413294|12283402|P1|COMPLETED|Overall Study||11
4992286|NCT02413294|12283402|P1|STARTED|Overall Study||12
4992287|NCT02413255|12283437|P17|NOT COMPLETED|Overall Study||0
4992288|NCT02413255|12283438|P16|NOT COMPLETED|Overall Study||0
4992289|NCT02413255|12283439|P15|NOT COMPLETED|Overall Study||1
4992290|NCT02413255|12283440|P14|NOT COMPLETED|Overall Study||0
4992291|NCT02413255|12283441|P13|NOT COMPLETED|Overall Study||0
4992292|NCT02413255|12283442|P12|NOT COMPLETED|Overall Study||0
4992293|NCT02413255|12283443|P11|NOT COMPLETED|Overall Study||0
4992294|NCT02413255|12283444|P10|NOT COMPLETED|Overall Study||0
4992295|NCT02413255|12283445|P9|NOT COMPLETED|Overall Study||0
4992296|NCT02413255|12283446|P8|NOT COMPLETED|Overall Study||0
4992297|NCT02413255|12283447|P7|NOT COMPLETED|Overall Study||0
4992298|NCT02413255|12283448|P6|NOT COMPLETED|Overall Study||0
4992299|NCT02413255|12283449|P5|NOT COMPLETED|Overall Study||0
4992300|NCT02413255|12283450|P4|NOT COMPLETED|Overall Study||0
4992301|NCT02413255|12283451|P3|NOT COMPLETED|Overall Study||0
4992302|NCT02413255|12283452|P2|NOT COMPLETED|Overall Study||0
4992303|NCT02413255|12283453|P1|NOT COMPLETED|Overall Study||0
4992304|NCT02413255|12283437|P17|COMPLETED|Overall Study||6
4992305|NCT02413255|12283438|P16|COMPLETED|Overall Study||6
4992306|NCT02413255|12283439|P15|COMPLETED|Overall Study||5
4992307|NCT02413255|12283440|P14|COMPLETED|Overall Study||6
4992308|NCT02413255|12283441|P13|COMPLETED|Overall Study||6
4992309|NCT02413255|12283442|P12|COMPLETED|Overall Study||6
4992310|NCT02413255|12283443|P11|COMPLETED|Overall Study||12
4992311|NCT02413255|12283444|P10|COMPLETED|Overall Study||6
4992312|NCT02413255|12283445|P9|COMPLETED|Overall Study||6
4992313|NCT02413255|12283446|P8|COMPLETED|Overall Study||6
4992314|NCT02413255|12283447|P7|COMPLETED|Overall Study||6
4992315|NCT02413255|12283448|P6|COMPLETED|Overall Study||6
4992316|NCT02413255|12283449|P5|COMPLETED|Overall Study||6
4992317|NCT02413255|12283450|P4|COMPLETED|Overall Study||6
4992318|NCT02413255|12283451|P3|COMPLETED|Overall Study||6
4992319|NCT02413255|12283452|P2|COMPLETED|Overall Study||6
4992320|NCT02413255|12283453|P1|COMPLETED|Overall Study||18
4992321|NCT02413255|12283437|P17|STARTED|Overall Study||6
4992322|NCT02413255|12283438|P16|STARTED|Overall Study||6
4992323|NCT02413255|12283439|P15|STARTED|Overall Study||6
4992324|NCT02413255|12283440|P14|STARTED|Overall Study||6
4992325|NCT02413255|12283441|P13|STARTED|Overall Study||6
4992326|NCT02413255|12283442|P12|STARTED|Overall Study||6
4992327|NCT02413255|12283443|P11|STARTED|Overall Study||12
4992328|NCT02413255|12283444|P10|STARTED|Overall Study||6
4992329|NCT02413255|12283445|P9|STARTED|Overall Study||6
4992330|NCT02413255|12283446|P8|STARTED|Overall Study||6
4992331|NCT02413255|12283447|P7|STARTED|Overall Study||6
4992332|NCT02413255|12283448|P6|STARTED|Overall Study||6
4992333|NCT02413255|12283449|P5|STARTED|Overall Study||6
4992334|NCT02413255|12283450|P4|STARTED|Overall Study||6
4992335|NCT02413255|12283451|P3|STARTED|Overall Study||6
4992336|NCT02413255|12283452|P2|STARTED|Overall Study||6
4992337|NCT02413255|12283453|P1|STARTED|Overall Study||18
4992338|NCT02413229|12283809|P8|NOT COMPLETED|Overall Study||4
4992339|NCT02413229|12283810|P7|NOT COMPLETED|Overall Study||0
4992340|NCT02413229|12283811|P6|NOT COMPLETED|Overall Study||0
4992341|NCT02413229|12283812|P5|NOT COMPLETED|Overall Study||3
4992342|NCT02413229|12283813|P4|NOT COMPLETED|Overall Study||1
4992343|NCT02413229|12283814|P3|NOT COMPLETED|Overall Study||1
4992344|NCT02413229|12283815|P2|NOT COMPLETED|Overall Study||1
4992345|NCT02413229|12283816|P1|NOT COMPLETED|Overall Study||1
4992346|NCT02413229|12283809|P8|COMPLETED|Overall Study||11
4992347|NCT02413229|12283810|P7|COMPLETED|Overall Study||25
4992348|NCT02413229|12283811|P6|COMPLETED|Overall Study||12
4992349|NCT02413229|12283812|P5|COMPLETED|Overall Study||21
4992350|NCT02413229|12283813|P4|COMPLETED|Overall Study||11
4992351|NCT02413229|12283814|P3|COMPLETED|Overall Study||25
4992352|NCT02413229|12283815|P2|COMPLETED|Overall Study||11
4992353|NCT02413229|12283816|P1|COMPLETED|Overall Study||24
4992354|NCT02413229|12283809|P8|STARTED|Overall Study||15
4992355|NCT02413229|12283810|P7|STARTED|Overall Study||25
4992356|NCT02413229|12283811|P6|STARTED|Overall Study||12
4992357|NCT02413229|12283812|P5|STARTED|Overall Study||24
4992358|NCT02413229|12283813|P4|STARTED|Overall Study||12
4992359|NCT02413229|12283814|P3|STARTED|Overall Study||26
4992360|NCT02413229|12283815|P2|STARTED|Overall Study||12
4992361|NCT02413229|12283816|P1|STARTED|Overall Study||25
4992362|NCT02413203|12283836|P2|NOT COMPLETED|Overall Study||0
4992363|NCT02413203|12283837|P1|NOT COMPLETED|Overall Study||0
4992364|NCT02413203|12283836|P2|COMPLETED|Overall Study||10
4992365|NCT02413203|12283837|P1|COMPLETED|Overall Study||10
4992366|NCT02413203|12283836|P2|STARTED|Overall Study||10
4992367|NCT02413203|12283837|P1|STARTED|Overall Study||10
4992368|NCT02413190|12283857|P1|NOT COMPLETED|Overall Study||0
4992369|NCT02413190|12283857|P1|COMPLETED|Overall Study||94
4992370|NCT02413190|12283857|P1|STARTED|Overall Study||94
4992371|NCT02413151|12283863|P2|NOT COMPLETED|Overall Study||2
4992372|NCT02413151|12283864|P1|NOT COMPLETED|Overall Study||10
4992373|NCT02413151|12283863|P2|COMPLETED|Overall Study||28
4992374|NCT02413151|12283864|P1|COMPLETED|Overall Study||22
4992375|NCT02413151|12283863|P2|STARTED|Overall Study||30
4992376|NCT02413151|12283864|P1|STARTED|Overall Study||32
4992377|NCT02413047|12283892|P1|NOT COMPLETED|Overall Study||0
4992378|NCT02413047|12283892|P1|COMPLETED|Overall Study||3
4992379|NCT02413047|12283892|P1|Participants on Adalimumab|Overall Study||1
4992380|NCT02413047|12283892|P1|Participants on Infliximab|Overall Study||2
4992381|NCT02413047|12283892|P1|STARTED|Overall Study||3
4992382|NCT02413034|12283905|P2|NOT COMPLETED|Overall Study||0
4992383|NCT02413034|12283906|P1|NOT COMPLETED|Overall Study||0
4992384|NCT02413034|12283905|P2|COMPLETED|Overall Study||14
4992385|NCT02413034|12283906|P1|COMPLETED|Overall Study||14
4992386|NCT02413034|12283905|P2|STARTED|Overall Study||14
4992387|NCT02413034|12283906|P1|STARTED|Overall Study||14
4992388|NCT02413008|12283916|P2|NOT COMPLETED|Overall Study||2
4992389|NCT02413008|12283917|P1|NOT COMPLETED|Overall Study||7
4992390|NCT02413008|12283916|P2|COMPLETED|Overall Study||9
4992391|NCT02413008|12283917|P1|COMPLETED|Overall Study||43
4992392|NCT02413008|12283916|P2|STARTED|Overall Study||11
4992393|NCT02413008|12283917|P1|STARTED|Overall Study||50
4992394|NCT02412878|12283955|P2|NOT COMPLETED|Overall Study||13
4992395|NCT02412878|12283956|P1|NOT COMPLETED|Overall Study||21
4992396|NCT02412878|12283955|P2|COMPLETED|Overall Study||227
4992397|NCT02412878|12283956|P1|COMPLETED|Overall Study||217
4992398|NCT02412878|12283955|P2|Received Carfilzomib|Overall Study||238
4992399|NCT02412878|12283956|P1|Received Carfilzomib|Overall Study||235
4992400|NCT02412878|12283955|P2|STARTED|Overall Study||240
4992401|NCT02412878|12283956|P1|STARTED|Overall Study||238
4992402|NCT02412852|12283974|P4|NOT COMPLETED|Overall Study||1
4992403|NCT02412852|12283975|P3|NOT COMPLETED|Overall Study||0
4992404|NCT02412852|12283976|P2|NOT COMPLETED|Overall Study||1
4992405|NCT02412852|12283977|P1|NOT COMPLETED|Overall Study||0
4992406|NCT02412852|12283974|P4|COMPLETED|Overall Study||8
4992407|NCT02412852|12283975|P3|COMPLETED|Overall Study||5
4992408|NCT02412852|12283976|P2|COMPLETED|Overall Study||7
4992409|NCT02412852|12283977|P1|COMPLETED|Overall Study||4
4992410|NCT02412852|12283974|P4|STARTED|Overall Study||9
4992411|NCT02412852|12283975|P3|STARTED|Overall Study||5
4992412|NCT02412852|12283976|P2|STARTED|Overall Study||8
4992413|NCT02412852|12283977|P1|STARTED|Overall Study||4
4992414|NCT02412761|12284003|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992415|NCT02412761|12284004|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992416|NCT02412761|12284005|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992417|NCT02412761|12284006|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992418|NCT02412761|12284007|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992419|NCT02412761|12284008|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
4992420|NCT02412761|12284003|P6|COMPLETED|Third Intervention (2 Weeks)||6
4992421|NCT02412761|12284004|P5|COMPLETED|Third Intervention (2 Weeks)||4
4992422|NCT02412761|12284005|P4|COMPLETED|Third Intervention (2 Weeks)||8
4992423|NCT02412761|12284006|P3|COMPLETED|Third Intervention (2 Weeks)||4
4992424|NCT02412761|12284007|P2|COMPLETED|Third Intervention (2 Weeks)||5
4992425|NCT02412761|12284008|P1|COMPLETED|Third Intervention (2 Weeks)||5
4992426|NCT02412761|12284003|P6|STARTED|Third Intervention (2 Weeks)||6
4992427|NCT02412761|12284004|P5|STARTED|Third Intervention (2 Weeks)||4
4992428|NCT02412761|12284005|P4|STARTED|Third Intervention (2 Weeks)||8
4992429|NCT02412761|12284006|P3|STARTED|Third Intervention (2 Weeks)||4
4992430|NCT02412761|12284007|P2|STARTED|Third Intervention (2 Weeks)||5
4992431|NCT02412761|12284008|P1|STARTED|Third Intervention (2 Weeks)||5
4992432|NCT02412761|12284003|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992433|NCT02412761|12284004|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992434|NCT02412761|12284005|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992435|NCT02412761|12284006|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992436|NCT02412761|12284007|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992437|NCT02412761|12284008|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
4992438|NCT02412761|12284003|P6|COMPLETED|Second Intervention (2 Weeks)||6
4992439|NCT02412761|12284004|P5|COMPLETED|Second Intervention (2 Weeks)||4
4992440|NCT02412761|12284005|P4|COMPLETED|Second Intervention (2 Weeks)||8
4992441|NCT02412761|12284006|P3|COMPLETED|Second Intervention (2 Weeks)||4
4992442|NCT02412761|12284007|P2|COMPLETED|Second Intervention (2 Weeks)||5
4992443|NCT02412761|12284008|P1|COMPLETED|Second Intervention (2 Weeks)||5
4992444|NCT02412761|12284003|P6|STARTED|Second Intervention (2 Weeks)||6
4992445|NCT02412761|12284004|P5|STARTED|Second Intervention (2 Weeks)||4
4992446|NCT02412761|12284005|P4|STARTED|Second Intervention (2 Weeks)||8
4992447|NCT02412761|12284006|P3|STARTED|Second Intervention (2 Weeks)||4
4992448|NCT02412761|12284007|P2|STARTED|Second Intervention (2 Weeks)||5
4992449|NCT02412761|12284008|P1|STARTED|Second Intervention (2 Weeks)||5
4992450|NCT02412761|12284003|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
4992451|NCT02412761|12284004|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
4992452|NCT02412761|12284005|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
4992453|NCT02412761|12284006|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
4992454|NCT02412761|12284007|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
4992455|NCT02412761|12284008|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
4992456|NCT02412761|12284003|P6|COMPLETED|First Intervention (2 Weeks)||6
4992457|NCT02412761|12284004|P5|COMPLETED|First Intervention (2 Weeks)||4
4992458|NCT02412761|12284005|P4|COMPLETED|First Intervention (2 Weeks)||8
4992459|NCT02412761|12284006|P3|COMPLETED|First Intervention (2 Weeks)||4
4992460|NCT02412761|12284007|P2|COMPLETED|First Intervention (2 Weeks)||5
4992461|NCT02412761|12284008|P1|COMPLETED|First Intervention (2 Weeks)||5
4992462|NCT02412761|12284003|P6|STARTED|First Intervention (2 Weeks)||7
4992463|NCT02412761|12284004|P5|STARTED|First Intervention (2 Weeks)||4
4992464|NCT02412761|12284005|P4|STARTED|First Intervention (2 Weeks)||8
4992465|NCT02412761|12284006|P3|STARTED|First Intervention (2 Weeks)||5
4992466|NCT02412761|12284007|P2|STARTED|First Intervention (2 Weeks)||6
4992467|NCT02412761|12284008|P1|STARTED|First Intervention (2 Weeks)||5
4992468|NCT02412722|12284022|P6|NOT COMPLETED|Overall Study||13
4992469|NCT02412722|12284023|P5|NOT COMPLETED|Overall Study||7
4992470|NCT02412722|12284024|P4|NOT COMPLETED|Overall Study||15
4992471|NCT02412722|12284025|P3|NOT COMPLETED|Overall Study||7
4992472|NCT02412722|12284026|P2|NOT COMPLETED|Overall Study||8
4992473|NCT02412722|12284027|P1|NOT COMPLETED|Overall Study||11
4992474|NCT02412722|12284022|P6|COMPLETED|Overall Study||0
4992475|NCT02412722|12284023|P5|COMPLETED|Overall Study||0
4992476|NCT02412722|12284024|P4|COMPLETED|Overall Study||0
4992477|NCT02412722|12284025|P3|COMPLETED|Overall Study||0
4992478|NCT02412722|12284026|P2|COMPLETED|Overall Study||0
4992479|NCT02412722|12284027|P1|COMPLETED|Overall Study||0
4992480|NCT02412722|12284022|P6|Safety Population|Overall Study||13
4992481|NCT02412722|12284023|P5|Safety Population|Overall Study||7
4992482|NCT02412722|12284024|P4|Safety Population|Overall Study||15
4992483|NCT02412722|12284025|P3|Safety Population|Overall Study||7
4992484|NCT02412722|12284026|P2|Safety Population|Overall Study||6
4992485|NCT02412722|12284027|P1|Safety Population|Overall Study||11
4992486|NCT02412722|12284022|P6|STARTED|Overall Study||13
4992487|NCT02412722|12284023|P5|STARTED|Overall Study||7
4992488|NCT02412722|12284024|P4|STARTED|Overall Study||15
4992489|NCT02412722|12284025|P3|STARTED|Overall Study||7
4992490|NCT02412722|12284026|P2|STARTED|Overall Study||8
4992491|NCT02412722|12284027|P1|STARTED|Overall Study||11
4992492|NCT02412657|12284098|P3|NOT COMPLETED|Overall Study||3
4992493|NCT02412657|12284099|P2|NOT COMPLETED|Overall Study||2
4992494|NCT02412657|12284100|P1|NOT COMPLETED|Overall Study||1
4992495|NCT02412657|12284098|P3|COMPLETED|Overall Study||22
4992496|NCT02412657|12284099|P2|COMPLETED|Overall Study||23
4992497|NCT02412657|12284100|P1|COMPLETED|Overall Study||24
4992498|NCT02412657|12284098|P3|STARTED|Overall Study||25
4992499|NCT02412657|12284099|P2|STARTED|Overall Study||25
4992500|NCT02412657|12284100|P1|STARTED|Overall Study||25
4992501|NCT02412644|12284110|P2|NOT COMPLETED|Overall Study||4
4992502|NCT02412644|12284111|P1|NOT COMPLETED|Overall Study||15
4992503|NCT02412644|12284110|P2|COMPLETED|Overall Study||4
4992504|NCT02412644|12284111|P1|COMPLETED|Overall Study||6
4992505|NCT02412644|12284110|P2|STARTED|Overall Study||8
4992506|NCT02412644|12284111|P1|STARTED|Overall Study||21
4992507|NCT02412501|12284123|P1|NOT COMPLETED|Overall Study||0
4992508|NCT02412501|12284123|P1|COMPLETED|Overall Study||101
4992509|NCT02412501|12284123|P1|STARTED|Overall Study||101
4992510|NCT02412488|12284144|P1|NOT COMPLETED|Overall Study||18
4992511|NCT02412488|12284144|P1|COMPLETED|Overall Study||174
4992512|NCT02412488|12284144|P1|Reveal LINQ Implanted|Overall Study||191
4992513|NCT02412488|12284144|P1|STARTED|Overall Study||192
4992514|NCT02412436|12284148|P1|NOT COMPLETED|Overall Study||18
4992515|NCT02412436|12284148|P1|COMPLETED|Overall Study||44
4992516|NCT02412436|12284148|P1|STARTED|Overall Study||62
4992517|NCT02412371|12284168|P6|NOT COMPLETED|Overall Study||5
4992518|NCT02412371|12284169|P5|NOT COMPLETED|Overall Study||12
4992519|NCT02412371|12284170|P4|NOT COMPLETED|Overall Study||8
4992520|NCT02412371|12284171|P3|NOT COMPLETED|Overall Study||7
4992521|NCT02412371|12284172|P2|NOT COMPLETED|Overall Study||9
4992522|NCT02412371|12284173|P1|NOT COMPLETED|Overall Study||7
4992523|NCT02412371|12284168|P6|COMPLETED|Overall Study||0
4992524|NCT02412371|12284169|P5|COMPLETED|Overall Study||0
4992525|NCT02412371|12284170|P4|COMPLETED|Overall Study||0
4992526|NCT02412371|12284171|P3|COMPLETED|Overall Study||0
4992527|NCT02412371|12284172|P2|COMPLETED|Overall Study||0
4992528|NCT02412371|12284173|P1|COMPLETED|Overall Study||0
4992529|NCT02412371|12284168|P6|STARTED|Overall Study||5
4992530|NCT02412371|12284169|P5|STARTED|Overall Study||12
4992531|NCT02412371|12284170|P4|STARTED|Overall Study||8
4992532|NCT02412371|12284171|P3|STARTED|Overall Study||7
4992533|NCT02412371|12284172|P2|STARTED|Overall Study||9
4992534|NCT02412371|12284173|P1|STARTED|Overall Study||7
4992535|NCT02412306|12284201|P5|NOT COMPLETED|Overall Study||2
4992536|NCT02412306|12284202|P4|NOT COMPLETED|Overall Study||0
4992537|NCT02412306|12284203|P3|NOT COMPLETED|Overall Study||16
4992538|NCT02412306|12284204|P2|NOT COMPLETED|Overall Study||8
4992539|NCT02412306|12284205|P1|NOT COMPLETED|Overall Study||5
4992540|NCT02412306|12284201|P5|COMPLETED|Overall Study||15
4992541|NCT02412306|12284202|P4|COMPLETED|Overall Study||14
4992542|NCT02412306|12284203|P3|COMPLETED|Overall Study||5
4992543|NCT02412306|12284204|P2|COMPLETED|Overall Study||1
4992544|NCT02412306|12284205|P1|COMPLETED|Overall Study||0
4992545|NCT02412306|12284201|P5|STARTED|Overall Study||17
4992546|NCT02412306|12284202|P4|STARTED|Overall Study||14
4992547|NCT02412306|12284203|P3|STARTED|Overall Study||21
4992548|NCT02412306|12284204|P2|STARTED|Overall Study||9
4992549|NCT02412306|12284205|P1|STARTED|Overall Study||5
4992550|NCT02412111|12284267|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
4992551|NCT02412111|12284268|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
4992552|NCT02412111|12284269|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
4992553|NCT02412111|12284267|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
4992554|NCT02412111|12284268|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
4992555|NCT02412111|12284269|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
4992556|NCT02412111|12284267|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
4992557|NCT02412111|12284268|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
4992558|NCT02412111|12284269|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
4992559|NCT02412111|12284267|P3|STARTED|Active Comparator Period (8 Weeks)||75
4992560|NCT02412111|12284268|P2|STARTED|Active Comparator Period (8 Weeks)||76
4992561|NCT02412111|12284269|P1|STARTED|Active Comparator Period (8 Weeks)||0
4992562|NCT02412111|12284267|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
4992563|NCT02412111|12284268|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
4992564|NCT02412111|12284269|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
4992565|NCT02412111|12284267|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
4992566|NCT02412111|12284268|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
4992567|NCT02412111|12284269|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
4992568|NCT02412111|12284267|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
4992569|NCT02412111|12284268|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
4992570|NCT02412111|12284269|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
4992571|NCT02412098|12284291|P3|NOT COMPLETED|Overall Study||0
4992572|NCT02412098|12284292|P2|NOT COMPLETED|Overall Study||0
4992573|NCT02412098|12284293|P1|NOT COMPLETED|Overall Study||0
4992574|NCT02412098|12284291|P3|COMPLETED|Overall Study||21
4992575|NCT02412098|12284292|P2|COMPLETED|Overall Study||14
4992576|NCT02412098|12284293|P1|COMPLETED|Overall Study||14
4992577|NCT02412098|12284291|P3|STARTED|Overall Study||21
4992578|NCT02412098|12284292|P2|STARTED|Overall Study||14
4992579|NCT02412098|12284293|P1|STARTED|Overall Study||14
4992580|NCT02411929|12284320|P1|NOT COMPLETED|Period 2||0
4992581|NCT02411929|12284320|P1|COMPLETED|Period 2||8
4992582|NCT02411929|12284320|P1|STARTED|Period 2||8
4992583|NCT02411929|12284320|P1|NOT COMPLETED|Washout Period||0
4992584|NCT02411929|12284320|P1|COMPLETED|Washout Period||8
4992585|NCT02411929|12284320|P1|STARTED|Washout Period||8
4992586|NCT02411929|12284320|P1|NOT COMPLETED|Period 1||0
4992587|NCT02411929|12284320|P1|COMPLETED|Period 1||8
4992588|NCT02411929|12284320|P1|STARTED|Period 1||8
4992589|NCT02411747|12284352|P2|NOT COMPLETED|Overall Study||4
4992590|NCT02411747|12284353|P1|NOT COMPLETED|Overall Study||3
4992591|NCT02411747|12284352|P2|COMPLETED|Overall Study||12
4992592|NCT02411747|12284353|P1|COMPLETED|Overall Study||13
4992593|NCT02411747|12284352|P2|Simulation Training Completed|Overall Study||16
4992594|NCT02411747|12284353|P1|Simulation Training Completed|Overall Study||16
4992595|NCT02411747|12284352|P2|STARTED|Overall Study||16
4992596|NCT02411747|12284353|P1|STARTED|Overall Study||16
4992597|NCT02411643|12284359|P1|NOT COMPLETED|Overall Study||0
4992598|NCT02411643|12284359|P1|COMPLETED|Overall Study||2
4992599|NCT02411643|12284359|P1|STARTED|Overall Study||2
4992600|NCT02411591|12284369|P3|NOT COMPLETED|Overall Study||3
4992601|NCT02411591|12284370|P2|NOT COMPLETED|Overall Study||10
4992602|NCT02411591|12284371|P1|NOT COMPLETED|Overall Study||0
4992603|NCT02411591|12284369|P3|COMPLETED|Overall Study||3
4992604|NCT02411591|12284370|P2|COMPLETED|Overall Study||47
4992605|NCT02411591|12284371|P1|COMPLETED|Overall Study||3
4992606|NCT02411591|12284369|P3|Death|Overall Study||0
4992607|NCT02411591|12284370|P2|Death|Overall Study||2
4992608|NCT02411591|12284371|P1|Death|Overall Study||0
4992609|NCT02411591|12284369|P3|Progressive Disease|Overall Study||3
4992610|NCT02411591|12284370|P2|Progressive Disease|Overall Study||42
4992611|NCT02411591|12284371|P1|Progressive Disease|Overall Study||3
4992612|NCT02411591|12284369|P3|Expansion Cohort Part B|Overall Study||0
4992613|NCT02411591|12284370|P2|Expansion Cohort Part B|Overall Study||51
4992614|NCT02411591|12284371|P1|Expansion Cohort Part B|Overall Study||0
4992615|NCT02411591|12284369|P3|Part A|Overall Study||6
4992616|NCT02411591|12284370|P2|Part A|Overall Study||6
4992617|NCT02411591|12284371|P1|Part A|Overall Study||3
4992618|NCT02411591|12284369|P3|STARTED|Overall Study||6
4992619|NCT02411591|12284370|P2|STARTED|Overall Study||57
4992620|NCT02411591|12284371|P1|STARTED|Overall Study||3
4992621|NCT02411578|12284403|P2|NOT COMPLETED|Extension Phase||0
4992622|NCT02411578|12284404|P1|NOT COMPLETED|Extension Phase||0
4992623|NCT02411578|12284403|P2|COMPLETED|Extension Phase||9
4992624|NCT02411578|12284404|P1|COMPLETED|Extension Phase||8
4992625|NCT02411578|12284403|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
4992626|NCT02411578|12284404|P1|STARTED|Extension Phase||8
4992627|NCT02411578|12284403|P2|NOT COMPLETED|Crossover Trial Phase||1
4992628|NCT02411578|12284404|P1|NOT COMPLETED|Crossover Trial Phase||0
4992629|NCT02411578|12284403|P2|COMPLETED|Crossover Trial Phase||11
4992630|NCT02411578|12284404|P1|COMPLETED|Crossover Trial Phase||8
4992631|NCT02411578|12284403|P2|STARTED|Crossover Trial Phase||12
4992632|NCT02411578|12284404|P1|STARTED|Crossover Trial Phase||8
4992633|NCT02411565|12284446|P2|NOT COMPLETED|Overall Study||0
4992634|NCT02411565|12284447|P1|NOT COMPLETED|Overall Study||0
4992635|NCT02411565|12284446|P2|COMPLETED|Overall Study||2
4992636|NCT02411565|12284447|P1|COMPLETED|Overall Study||1
4992637|NCT02411565|12284446|P2|STARTED|Overall Study||2
4992638|NCT02411565|12284447|P1|STARTED|Overall Study||1
4992639|NCT02411539|12284461|P2|NOT COMPLETED|Overall Study||1
4992640|NCT02411539|12284462|P1|NOT COMPLETED|Overall Study||2
4992641|NCT02411539|12284461|P2|COMPLETED|Overall Study||19
4992642|NCT02411539|12284462|P1|COMPLETED|Overall Study||18
4992643|NCT02411539|12284461|P2|STARTED|Overall Study||20
4992644|NCT02411539|12284462|P1|STARTED|Overall Study||20
4992645|NCT02411461|12284540|P3|NOT COMPLETED|Overall Study||0
4992646|NCT02411461|12284541|P2|NOT COMPLETED|Overall Study||0
4992647|NCT02411461|12284542|P1|NOT COMPLETED|Overall Study||0
4992648|NCT02411461|12284540|P3|COMPLETED|Overall Study||15
4992649|NCT02411461|12284541|P2|COMPLETED|Overall Study||8
4992650|NCT02411461|12284542|P1|COMPLETED|Overall Study||16
4992651|NCT02411461|12284540|P3|STARTED|Overall Study||15
4992652|NCT02411461|12284541|P2|STARTED|Overall Study||8
4992653|NCT02411461|12284542|P1|STARTED|Overall Study||16
4992654|NCT02411448|12284553|P3|NOT COMPLETED|Overall Study||52
4992655|NCT02411448|12284554|P2|NOT COMPLETED|Overall Study||83
4992656|NCT02411448|12284555|P1|NOT COMPLETED|Overall Study||4
4992657|NCT02411448|12284553|P3|COMPLETED|Overall Study||173
4992658|NCT02411448|12284554|P2|COMPLETED|Overall Study||141
4992659|NCT02411448|12284555|P1|COMPLETED|Overall Study||10
4992660|NCT02411448|12284553|P3|Received at Least One Dose of Study Drug|Overall Study||225
4992661|NCT02411448|12284554|P2|Received at Least One Dose of Study Drug|Overall Study||221
4992662|NCT02411448|12284555|P1|Received at Least One Dose of Study Drug|Overall Study||14
4992663|NCT02411448|12284553|P3|STARTED|Overall Study||225
4992664|NCT02411448|12284554|P2|STARTED|Overall Study||224
4992665|NCT02411448|12284555|P1|STARTED|Overall Study||14
4992666|NCT02411396|12284584|P1|NOT COMPLETED|Overall Study||41
4992667|NCT02411396|12284584|P1|COMPLETED|Overall Study||442
4992668|NCT02411396|12284584|P1|STARTED|Overall Study||483
4992669|NCT02411292|12284597|P1|NOT COMPLETED|Overall Study||21
4992670|NCT02411292|12284597|P1|COMPLETED|Overall Study||89
4992671|NCT02411292|12284597|P1|STARTED|Overall Study||110
4992672|NCT02411201|12284603|P1|NOT COMPLETED|Overall Study||6
4992673|NCT02411201|12284603|P1|COMPLETED|Overall Study||45
4992674|NCT02411201|12284603|P1|STARTED|Overall Study||51
4992675|NCT02411110|12284616|P2|NOT COMPLETED|Treatment Period 2||4
4992676|NCT02411110|12284617|P1|NOT COMPLETED|Treatment Period 2||1
4992677|NCT02411110|12284616|P2|COMPLETED|Treatment Period 2||44
4992678|NCT02411110|12284617|P1|COMPLETED|Treatment Period 2||49
4992679|NCT02411110|12284616|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
4992680|NCT02411110|12284617|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
4992681|NCT02411110|12284616|P2|NOT COMPLETED|Treatment Period 1||7
4992682|NCT02411110|12284617|P1|NOT COMPLETED|Treatment Period 1||9
4992683|NCT02411110|12284616|P2|COMPLETED|Treatment Period 1||59
4992684|NCT02411110|12284617|P1|COMPLETED|Treatment Period 1||56
4992685|NCT02411110|12284616|P2|STARTED|Treatment Period 1||66
4992686|NCT02411110|12284617|P1|STARTED|Treatment Period 1||65
4992687|NCT02411084|12284627|P2|NOT COMPLETED|Overall Study||13
4992688|NCT02411084|12284628|P1|NOT COMPLETED|Overall Study||13
4992689|NCT02411084|12284627|P2|COMPLETED|Overall Study||5
4992690|NCT02411084|12284628|P1|COMPLETED|Overall Study||5
4992691|NCT02411084|12284627|P2|STARTED|Overall Study||18
4992692|NCT02411084|12284628|P1|STARTED|Overall Study||18
4992693|NCT02410967|12284643|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
4992694|NCT02410967|12284644|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
4992695|NCT02410967|12284643|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
4992696|NCT02410967|12284644|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
4992697|NCT02410967|12284643|P2|STARTED|Follow-up Phase (8 Weeks)||22
4992698|NCT02410967|12284644|P1|STARTED|Follow-up Phase (8 Weeks)||26
4992699|NCT02410967|12284643|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
4992700|NCT02410967|12284644|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
4992701|NCT02410967|12284643|P2|COMPLETED|Treatment Phase (4 Weeks)||22
4992702|NCT02410967|12284644|P1|COMPLETED|Treatment Phase (4 Weeks)||26
4992703|NCT02410967|12284643|P2|STARTED|Treatment Phase (4 Weeks)||26
4992704|NCT02410967|12284644|P1|STARTED|Treatment Phase (4 Weeks)||27
4992705|NCT02410824|12284660|P2|NOT COMPLETED|Second Intervention (One Week)||0
4992706|NCT02410824|12284661|P1|NOT COMPLETED|Second Intervention (One Week)||0
4992707|NCT02410824|12284660|P2|COMPLETED|Second Intervention (One Week)||22
4992708|NCT02410824|12284661|P1|COMPLETED|Second Intervention (One Week)||22
4992709|NCT02410824|12284660|P2|STARTED|Second Intervention (One Week)||22
4992710|NCT02410824|12284661|P1|STARTED|Second Intervention (One Week)||22
4992711|NCT02410824|12284660|P2|NOT COMPLETED|First Intervention (One Week)||1
4992712|NCT02410824|12284661|P1|NOT COMPLETED|First Intervention (One Week)||0
4992713|NCT02410824|12284660|P2|COMPLETED|First Intervention (One Week)||22
4992714|NCT02410824|12284661|P1|COMPLETED|First Intervention (One Week)||22
4992715|NCT02410824|12284660|P2|STARTED|First Intervention (One Week)||23
4992716|NCT02410824|12284661|P1|STARTED|First Intervention (One Week)||22
4992717|NCT02410707|12284693|P1|NOT COMPLETED|Overall Study||0
4992718|NCT02410707|12284693|P1|COMPLETED|Overall Study||43
4992719|NCT02410707|12284693|P1|STARTED|Overall Study||43
4992720|NCT02410629|12284706|P2|NOT COMPLETED|Overall Study||3
4992721|NCT02410629|12284707|P1|NOT COMPLETED|Overall Study||3
4992722|NCT02410629|12284706|P2|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
4992723|NCT02410629|12284707|P1|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
4992724|NCT02410629|12284706|P2|STARTED|Overall Study||9
4992725|NCT02410629|12284707|P1|STARTED|Overall Study||8
4992726|NCT02410577|12284719|P1|NOT COMPLETED|Overall Study||0
4992727|NCT02410577|12284719|P1|COMPLETED|Overall Study||2
4992728|NCT02410577|12284719|P1|STARTED|Overall Study||2
4992729|NCT02410551|12284723|P1|NOT COMPLETED|Overall Study||4
4992730|NCT02410551|12284723|P1|COMPLETED|Overall Study||0
4992731|NCT02410551|12284723|P1|STARTED|Overall Study||4
4992732|NCT02410382|12284730|P2|NOT COMPLETED|Overall Study||0
4992733|NCT02410382|12284731|P1|NOT COMPLETED|Overall Study||0
4992734|NCT02410382|12284730|P2|COMPLETED|Overall Study||0
4992735|NCT02410382|12284731|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
4992736|NCT02410382|12284730|P2|STARTED|Overall Study||0
4992737|NCT02410382|12284731|P1|STARTED|Overall Study||0
4992738|NCT02410343|12284741|P2|NOT COMPLETED|Extension Period (12 Months)||1
4992739|NCT02410343|12284742|P1|NOT COMPLETED|Extension Period (12 Months)||1
4992740|NCT02410343|12284741|P2|COMPLETED|Extension Period (12 Months)||0
4992741|NCT02410343|12284742|P1|COMPLETED|Extension Period (12 Months)||0
4992742|NCT02410343|12284741|P2|STARTED|Extension Period (12 Months)||1
4992743|NCT02410343|12284742|P1|STARTED|Extension Period (12 Months)||1
4992744|NCT02410343|12284741|P2|NOT COMPLETED|Core Period (24 Weeks)||7
4992745|NCT02410343|12284742|P1|NOT COMPLETED|Core Period (24 Weeks)||5
4992746|NCT02410343|12284741|P2|COMPLETED|Core Period (24 Weeks)||1
4992747|NCT02410343|12284742|P1|COMPLETED|Core Period (24 Weeks)||1
4992748|NCT02410343|12284741|P2|STARTED|Core Period (24 Weeks)||8
4992749|NCT02410343|12284742|P1|STARTED|Core Period (24 Weeks)||6
4992750|NCT02410291|12284779|P2|NOT COMPLETED|Overall Study||0
4992751|NCT02410291|12284780|P1|NOT COMPLETED|Overall Study||0
4992752|NCT02410291|12284779|P2|COMPLETED|Overall Study||29
4992753|NCT02410291|12284780|P1|COMPLETED|Overall Study||29
4992754|NCT02410291|12284779|P2|STARTED|Overall Study||29
4992755|NCT02410291|12284780|P1|STARTED|Overall Study||29
4992756|NCT02410278|12284788|P3|NOT COMPLETED|Study Treatment Period||4
4992757|NCT02410278|12284789|P2|NOT COMPLETED|Study Treatment Period||11
4992758|NCT02410278|12284790|P1|NOT COMPLETED|Study Treatment Period||0
4992759|NCT02410278|12284788|P3|COMPLETED|Study Treatment Period||29
4992760|NCT02410278|12284789|P2|COMPLETED|Study Treatment Period||20
4992761|NCT02410278|12284790|P1|COMPLETED|Study Treatment Period||0
4992762|NCT02410278|12284788|P3|Completed Randomized Study Treatment|Study Treatment Period||29
4992763|NCT02410278|12284789|P2|Completed Randomized Study Treatment|Study Treatment Period||20
4992764|NCT02410278|12284790|P1|Completed Randomized Study Treatment|Study Treatment Period||0
4992765|NCT02410278|12284788|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
4992766|NCT02410278|12284789|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
4992767|NCT02410278|12284790|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
4992768|NCT02410278|12284788|P3|STARTED|Study Treatment Period||33
4992769|NCT02410278|12284789|P2|STARTED|Study Treatment Period||31
4992770|NCT02410278|12284790|P1|STARTED|Study Treatment Period||0
4992771|NCT02410278|12284788|P3|NOT COMPLETED|Run-in Period||0
4992772|NCT02410278|12284789|P2|NOT COMPLETED|Run-in Period||0
4992773|NCT02410278|12284790|P1|NOT COMPLETED|Run-in Period||38
4992774|NCT02410278|12284788|P3|COMPLETED|Run-in Period||0
4992775|NCT02410278|12284789|P2|COMPLETED|Run-in Period||0
4992776|NCT02410278|12284790|P1|COMPLETED|Run-in Period||64
4992777|NCT02410278|12284788|P3|Received at Least 1 Dose of DMF|Run-in Period||0
4992778|NCT02410278|12284789|P2|Received at Least 1 Dose of DMF|Run-in Period||0
4992779|NCT02410278|12284790|P1|Received at Least 1 Dose of DMF|Run-in Period||98
4992780|NCT02410278|12284788|P3|STARTED|Run-in Period||0
4992781|NCT02410278|12284789|P2|STARTED|Run-in Period||0
4992782|NCT02410278|12284790|P1|STARTED|Run-in Period||102
4992783|NCT02410252|12284815|P1|NOT COMPLETED|Overall Study||6
4992784|NCT02410252|12284815|P1|COMPLETED|Overall Study||19
4992785|NCT02410252|12284815|P1|STARTED|Overall Study||25
4992786|NCT02410213|12284821|P2|NOT COMPLETED|Overall Study||0
4992787|NCT02410213|12284822|P1|NOT COMPLETED|Overall Study||0
4992788|NCT02410213|12284821|P2|COMPLETED|Overall Study||19
4992789|NCT02410213|12284822|P1|COMPLETED|Overall Study||16
4992790|NCT02410213|12284821|P2|STARTED|Overall Study||19
4992791|NCT02410213|12284822|P1|STARTED|Overall Study||16
4992792|NCT02410200|12284828|P1|NOT COMPLETED|Overall Study||2
4992793|NCT02410200|12284828|P1|COMPLETED|Overall Study||20
4992794|NCT02410200|12284828|P1|STARTED|Overall Study||22
4992795|NCT02410161|12284841|P2|NOT COMPLETED|Overall Study||0
4992796|NCT02410161|12284842|P1|NOT COMPLETED|Overall Study||0
4992797|NCT02410161|12284841|P2|COMPLETED|Overall Study||10
4992798|NCT02410161|12284842|P1|COMPLETED|Overall Study||10
4992799|NCT02410161|12284841|P2|STARTED|Overall Study||10
4992800|NCT02410161|12284842|P1|STARTED|Overall Study||10
4992801|NCT02410018|12284858|P2|NOT COMPLETED|Overall Study||0
4992802|NCT02410018|12284859|P1|NOT COMPLETED|Overall Study||0
4992803|NCT02410018|12284858|P2|COMPLETED|Overall Study||1
4992804|NCT02410018|12284859|P1|COMPLETED|Overall Study||2
4992805|NCT02410018|12284858|P2|STARTED|Overall Study||1
4992806|NCT02410018|12284859|P1|STARTED|Overall Study||2
4992807|NCT02409927|12284879|P1|NOT COMPLETED|Overall Study||0
4992808|NCT02409927|12284879|P1|COMPLETED|Overall Study||10
4992809|NCT02409927|12284879|P1|STARTED|Overall Study||10
4992810|NCT02409914|12284887|P1|NOT COMPLETED|Overall Study||0
4992811|NCT02409914|12284887|P1|COMPLETED|Overall Study||7
4992812|NCT02409914|12284887|P1|STARTED|Overall Study||7
4992813|NCT02409784|12284893|P1|NOT COMPLETED|Overall Study||0
4992814|NCT02409784|12284893|P1|COMPLETED|Overall Study||10
4992815|NCT02409784|12284893|P1|STARTED|Overall Study||10
4992816|NCT02409732|12284898|P1|NOT COMPLETED|Overall Study||6
4992817|NCT02409732|12284898|P1|COMPLETED|Overall Study||14
4992818|NCT02409732|12284898|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
4992819|NCT02409719|12284908|P2|NOT COMPLETED|Overall Study||3
4992820|NCT02409719|12284909|P1|NOT COMPLETED|Overall Study||3
4992821|NCT02409719|12284908|P2|COMPLETED|Overall Study||42
4992822|NCT02409719|12284909|P1|COMPLETED|Overall Study||28
4992823|NCT02409719|12284908|P2|12 Months|Overall Study||42
4992824|NCT02409719|12284909|P1|12 Months|Overall Study||28
4992825|NCT02409719|12284908|P2|6 Months|Overall Study||42
4992826|NCT02409719|12284909|P1|6 Months|Overall Study||28
4992827|NCT02409719|12284908|P2|3 Months|Overall Study||42
4992828|NCT02409719|12284909|P1|3 Months|Overall Study||28
4992829|NCT02409719|12284908|P2|6 Weeks|Overall Study||42
4992830|NCT02409719|12284909|P1|6 Weeks|Overall Study||28
4992831|NCT02409719|12284908|P2|4 Weeks|Overall Study||42
4992832|NCT02409719|12284909|P1|4 Weeks|Overall Study||28
4992833|NCT02409719|12284908|P2|2 Weeks|Overall Study||42
4992834|NCT02409719|12284909|P1|2 Weeks|Overall Study||28
4992835|NCT02409719|12284908|P2|STARTED|Overall Study||45
4992836|NCT02409719|12284909|P1|STARTED|Overall Study||31
4992837|NCT02409667|12284919|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
4992838|NCT02409667|12284920|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
4992839|NCT02409667|12284921|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
4992840|NCT02409667|12284922|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
4992841|NCT02409667|12284923|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
4992842|NCT02409667|12284919|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
4992843|NCT02409667|12284920|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
4992844|NCT02409667|12284921|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
4992845|NCT02409667|12284922|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
4992846|NCT02409667|12284923|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
4992847|NCT02409667|12284919|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
4992848|NCT02409667|12284920|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
4992849|NCT02409667|12284921|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
4992850|NCT02409667|12284922|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
4992851|NCT02409667|12284923|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
4992852|NCT02409667|12284919|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992853|NCT02409667|12284920|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992854|NCT02409667|12284921|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992855|NCT02409667|12284922|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992856|NCT02409667|12284923|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
4992857|NCT02409667|12284919|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992858|NCT02409667|12284920|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992859|NCT02409667|12284921|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992860|NCT02409667|12284922|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
4992861|NCT02409667|12284923|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
4992862|NCT02409667|12284919|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
4992863|NCT02409667|12284920|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
4992864|NCT02409667|12284921|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
4992865|NCT02409667|12284922|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
4992866|NCT02409667|12284923|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
4992867|NCT02409459|12284964|P2|NOT COMPLETED|Overall Study||1
4992868|NCT02409459|12284965|P1|NOT COMPLETED|Overall Study||1
4992869|NCT02409459|12284964|P2|COMPLETED|Overall Study||39
4992870|NCT02409459|12284965|P1|COMPLETED|Overall Study||40
4992871|NCT02409459|12284964|P2|STARTED|Overall Study||40
4992872|NCT02409459|12284965|P1|STARTED|Overall Study||41
4992873|NCT02409355|12284985|P2|NOT COMPLETED|Overall Study||4
4992874|NCT02409355|12284986|P1|NOT COMPLETED|Overall Study||4
4992875|NCT02409355|12284985|P2|COMPLETED|Overall Study||0
4992876|NCT02409355|12284986|P1|COMPLETED|Overall Study||0
4992877|NCT02409355|12284985|P2|STARTED|Overall Study||4
4992878|NCT02409355|12284986|P1|STARTED|Overall Study||4
4992879|NCT02409277|12284995|P3|NOT COMPLETED|Overall Study||0
4992880|NCT02409277|12284996|P2|NOT COMPLETED|Overall Study||17
4992881|NCT02409277|12284997|P1|NOT COMPLETED|Overall Study||100
4992882|NCT02409277|12284995|P3|COMPLETED|Overall Study||599
4992883|NCT02409277|12284996|P2|COMPLETED|Overall Study||43
4992884|NCT02409277|12284997|P1|COMPLETED|Overall Study||167
4992885|NCT02409277|12284995|P3|12 Months Follow-up|Overall Study||599
4992886|NCT02409277|12284996|P2|12 Months Follow-up|Overall Study||43
4992887|NCT02409277|12284997|P1|12 Months Follow-up|Overall Study||167
4992888|NCT02409277|12284995|P3|6 Months Follow-up|Overall Study||599
4992889|NCT02409277|12284996|P2|6 Months Follow-up|Overall Study||42
4992890|NCT02409277|12284997|P1|6 Months Follow-up|Overall Study||182
4992891|NCT02409277|12284995|P3|3 Months Follow-up|Overall Study||599
4992892|NCT02409277|12284996|P2|3 Months Follow-up|Overall Study||40
4992893|NCT02409277|12284997|P1|3 Months Follow-up|Overall Study||178
4992894|NCT02409277|12284995|P3|STARTED|Overall Study||599
4992895|NCT02409277|12284996|P2|STARTED|Overall Study||60
4992896|NCT02409277|12284997|P1|STARTED|Overall Study||267
4992897|NCT02408965|12285037|P2|NOT COMPLETED|Overall Study||0
4992898|NCT02408965|12285038|P1|NOT COMPLETED|Overall Study||0
4992899|NCT02408965|12285037|P2|COMPLETED|Overall Study||144
4992900|NCT02408965|12285038|P1|COMPLETED|Overall Study||140
4992901|NCT02408965|12285037|P2|STARTED|Overall Study||144
4992902|NCT02408965|12285038|P1|STARTED|Overall Study||140
4992903|NCT02408692|12285063|P3|NOT COMPLETED|Overall Study||0
4992904|NCT02408692|12285064|P2|NOT COMPLETED|Overall Study||0
4992905|NCT02408692|12285065|P1|NOT COMPLETED|Overall Study||0
4992906|NCT02408692|12285063|P3|COMPLETED|Overall Study||5
4992907|NCT02408692|12285064|P2|COMPLETED|Overall Study||5
4992908|NCT02408692|12285065|P1|COMPLETED|Overall Study||5
4992909|NCT02408692|12285063|P3|STARTED|Overall Study||5
4992910|NCT02408692|12285064|P2|STARTED|Overall Study||5
4992911|NCT02408692|12285065|P1|STARTED|Overall Study||5
4992912|NCT02408523|12285078|P2|NOT COMPLETED|Overall Study||18
4992913|NCT02408523|12285079|P1|NOT COMPLETED|Overall Study||11
4992914|NCT02408523|12285078|P2|COMPLETED|Overall Study||103
4992915|NCT02408523|12285079|P1|COMPLETED|Overall Study||110
4992916|NCT02408523|12285078|P2|Enrolled Safety Folllow-up Period|Overall Study||11
4992917|NCT02408523|12285079|P1|Enrolled Safety Folllow-up Period|Overall Study||10
4992918|NCT02408523|12285078|P2|Enrolled Taper Period|Overall Study||9
4992919|NCT02408523|12285079|P1|Enrolled Taper Period|Overall Study||7
4992920|NCT02408523|12285078|P2|Enrolled Transition Period|Overall Study||101
4992921|NCT02408523|12285079|P1|Enrolled Transition Period|Overall Study||108
4992922|NCT02408523|12285078|P2|Completed Treatment Period|Overall Study||103
4992923|NCT02408523|12285079|P1|Completed Treatment Period|Overall Study||110
4992924|NCT02408523|12285078|P2|STARTED|Overall Study||121
4992925|NCT02408523|12285079|P1|STARTED|Overall Study||121
4992926|NCT02408484|12285099|P1|NOT COMPLETED|Overall Study||4
4992927|NCT02408484|12285099|P1|COMPLETED|Overall Study||11
4992928|NCT02408484|12285099|P1|SURG Population|Overall Study||3
4992929|NCT02408484|12285099|P1|BLEED Population|Overall Study||8
4992930|NCT02408484|12285099|P1|firstBLEED Population|Overall Study||8
4992931|NCT02408484|12285099|P1|PK Population|Overall Study||13
4992932|NCT02408484|12285099|P1|FAS Population|Overall Study||14
4992933|NCT02408484|12285099|P1|SAF Population|Overall Study||14
4992934|NCT02408484|12285099|P1|STARTED|Overall Study||15
4992935|NCT02408445|12285133|P2|NOT COMPLETED|Overall Study||0
4992936|NCT02408445|12285134|P1|NOT COMPLETED|Overall Study||0
4992937|NCT02408445|12285133|P2|COMPLETED|Overall Study||10
4992938|NCT02408445|12285134|P1|COMPLETED|Overall Study||10
4992939|NCT02408445|12285133|P2|STARTED|Overall Study||10
4992940|NCT02408445|12285134|P1|STARTED|Overall Study||10
4992941|NCT02408315|12285163|P2|NOT COMPLETED|Overall Study||0
4992942|NCT02408315|12285164|P1|NOT COMPLETED|Overall Study||0
4992943|NCT02408315|12285163|P2|COMPLETED|Overall Study||152
4992944|NCT02408315|12285164|P1|COMPLETED|Overall Study||148
4992945|NCT02408315|12285163|P2|STARTED|Overall Study||152
4992946|NCT02408315|12285164|P1|STARTED|Overall Study||148
4992947|NCT02408263|12285186|P2|NOT COMPLETED|Overall Study||0
4992948|NCT02408263|12285187|P1|NOT COMPLETED|Overall Study||0
4992949|NCT02408263|12285186|P2|COMPLETED|Overall Study||25
4992950|NCT02408263|12285187|P1|COMPLETED|Overall Study||25
4992951|NCT02408263|12285186|P2|STARTED|Overall Study||25
4992952|NCT02408263|12285187|P1|STARTED|Overall Study||25
4992953|NCT02408198|12285195|P2|NOT COMPLETED|Overall Study||0
4992954|NCT02408198|12285196|P1|NOT COMPLETED|Overall Study||3
4992955|NCT02408198|12285195|P2|COMPLETED|Overall Study||5
4992956|NCT02408198|12285196|P1|COMPLETED|Overall Study||10
4992957|NCT02408198|12285195|P2|STARTED|Overall Study||5
4992958|NCT02408198|12285196|P1|STARTED|Overall Study||13
4992959|NCT02408068|12285202|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
4992960|NCT02408068|12285203|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
4992961|NCT02408068|12285204|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
4992962|NCT02408068|12285205|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
4992963|NCT02408068|12285206|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
4992964|NCT02408068|12285207|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
4992965|NCT02408068|12285202|P6|COMPLETED|Treatment 3 (1.5 Days)||3
4992966|NCT02408068|12285203|P5|COMPLETED|Treatment 3 (1.5 Days)||3
4992967|NCT02408068|12285204|P4|COMPLETED|Treatment 3 (1.5 Days)||3
4992968|NCT02408068|12285205|P3|COMPLETED|Treatment 3 (1.5 Days)||2
4992969|NCT02408068|12285206|P2|COMPLETED|Treatment 3 (1.5 Days)||3
4992970|NCT02408068|12285207|P1|COMPLETED|Treatment 3 (1.5 Days)||3
4992971|NCT02408068|12285202|P6|STARTED|Treatment 3 (1.5 Days)||3
4992972|NCT02408068|12285203|P5|STARTED|Treatment 3 (1.5 Days)||3
4992973|NCT02408068|12285204|P4|STARTED|Treatment 3 (1.5 Days)||3
4992974|NCT02408068|12285205|P3|STARTED|Treatment 3 (1.5 Days)||3
4992975|NCT02408068|12285206|P2|STARTED|Treatment 3 (1.5 Days)||3
4992976|NCT02408068|12285207|P1|STARTED|Treatment 3 (1.5 Days)||3
4992977|NCT02408068|12285202|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992978|NCT02408068|12285203|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992979|NCT02408068|12285204|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992980|NCT02408068|12285205|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992981|NCT02408068|12285206|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992982|NCT02408068|12285207|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4992983|NCT02408068|12285202|P6|COMPLETED|Washout Period 2 (7 Days)||3
4992984|NCT02408068|12285203|P5|COMPLETED|Washout Period 2 (7 Days)||3
4992985|NCT02408068|12285204|P4|COMPLETED|Washout Period 2 (7 Days)||3
4992986|NCT02408068|12285205|P3|COMPLETED|Washout Period 2 (7 Days)||3
4992987|NCT02408068|12285206|P2|COMPLETED|Washout Period 2 (7 Days)||3
4992988|NCT02408068|12285207|P1|COMPLETED|Washout Period 2 (7 Days)||3
4992989|NCT02408068|12285202|P6|STARTED|Washout Period 2 (7 Days)||3
4992990|NCT02408068|12285203|P5|STARTED|Washout Period 2 (7 Days)||3
4992991|NCT02408068|12285204|P4|STARTED|Washout Period 2 (7 Days)||3
4992992|NCT02408068|12285205|P3|STARTED|Washout Period 2 (7 Days)||3
4992993|NCT02408068|12285206|P2|STARTED|Washout Period 2 (7 Days)||3
4992994|NCT02408068|12285207|P1|STARTED|Washout Period 2 (7 Days)||3
4992995|NCT02408068|12285202|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4992996|NCT02408068|12285203|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4992997|NCT02408068|12285204|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4992998|NCT02408068|12285205|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4992999|NCT02408068|12285206|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4993000|NCT02408068|12285207|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
4993001|NCT02408068|12285202|P6|COMPLETED|Treatment 2 (1.5 Days)||3
4993002|NCT02408068|12285203|P5|COMPLETED|Treatment 2 (1.5 Days)||3
4993003|NCT02408068|12285204|P4|COMPLETED|Treatment 2 (1.5 Days)||3
4993004|NCT02408068|12285205|P3|COMPLETED|Treatment 2 (1.5 Days)||3
4993005|NCT02408068|12285206|P2|COMPLETED|Treatment 2 (1.5 Days)||3
4993006|NCT02408068|12285207|P1|COMPLETED|Treatment 2 (1.5 Days)||3
4993007|NCT02408068|12285202|P6|STARTED|Treatment 2 (1.5 Days)||3
4993008|NCT02408068|12285203|P5|STARTED|Treatment 2 (1.5 Days)||3
4993009|NCT02408068|12285204|P4|STARTED|Treatment 2 (1.5 Days)||3
4993010|NCT02408068|12285205|P3|STARTED|Treatment 2 (1.5 Days)||3
4993011|NCT02408068|12285206|P2|STARTED|Treatment 2 (1.5 Days)||3
4993012|NCT02408068|12285207|P1|STARTED|Treatment 2 (1.5 Days)||3
4993013|NCT02408068|12285202|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993014|NCT02408068|12285203|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993015|NCT02408068|12285204|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993016|NCT02408068|12285205|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993017|NCT02408068|12285206|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993018|NCT02408068|12285207|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4993019|NCT02408068|12285202|P6|COMPLETED|Washout Period 1 (7 Days)||3
4993020|NCT02408068|12285203|P5|COMPLETED|Washout Period 1 (7 Days)||3
4993021|NCT02408068|12285204|P4|COMPLETED|Washout Period 1 (7 Days)||3
4993022|NCT02408068|12285205|P3|COMPLETED|Washout Period 1 (7 Days)||3
4993023|NCT02408068|12285206|P2|COMPLETED|Washout Period 1 (7 Days)||3
4993024|NCT02408068|12285207|P1|COMPLETED|Washout Period 1 (7 Days)||3
4993025|NCT02408068|12285202|P6|STARTED|Washout Period 1 (7 Days)||3
4993026|NCT02408068|12285203|P5|STARTED|Washout Period 1 (7 Days)||3
4993027|NCT02408068|12285204|P4|STARTED|Washout Period 1 (7 Days)||3
4993028|NCT02408068|12285205|P3|STARTED|Washout Period 1 (7 Days)||3
4993029|NCT02408068|12285206|P2|STARTED|Washout Period 1 (7 Days)||3
4993030|NCT02408068|12285207|P1|STARTED|Washout Period 1 (7 Days)||3
4993031|NCT02408068|12285202|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993032|NCT02408068|12285203|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993033|NCT02408068|12285204|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993034|NCT02408068|12285205|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993035|NCT02408068|12285206|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993036|NCT02408068|12285207|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
4993037|NCT02408068|12285202|P6|COMPLETED|Treatment 1 (1.5 Days)||3
4993038|NCT02408068|12285203|P5|COMPLETED|Treatment 1 (1.5 Days)||3
4993039|NCT02408068|12285204|P4|COMPLETED|Treatment 1 (1.5 Days)||3
4993040|NCT02408068|12285205|P3|COMPLETED|Treatment 1 (1.5 Days)||3
4993041|NCT02408068|12285206|P2|COMPLETED|Treatment 1 (1.5 Days)||3
4993042|NCT02408068|12285207|P1|COMPLETED|Treatment 1 (1.5 Days)||3
4993043|NCT02408068|12285202|P6|STARTED|Treatment 1 (1.5 Days)||3
4993044|NCT02408068|12285203|P5|STARTED|Treatment 1 (1.5 Days)||3
4993045|NCT02408068|12285204|P4|STARTED|Treatment 1 (1.5 Days)||3
4993046|NCT02408068|12285205|P3|STARTED|Treatment 1 (1.5 Days)||3
4993047|NCT02408068|12285206|P2|STARTED|Treatment 1 (1.5 Days)||3
4993048|NCT02408068|12285207|P1|STARTED|Treatment 1 (1.5 Days)||3
4993049|NCT02407704|12285234|P4|NOT COMPLETED|Overall Study||3
4993050|NCT02407704|12285235|P3|NOT COMPLETED|Overall Study||1
4993051|NCT02407704|12285236|P2|NOT COMPLETED|Overall Study||0
4993052|NCT02407704|12285237|P1|NOT COMPLETED|Overall Study||0
4993053|NCT02407704|12285234|P4|COMPLETED|Overall Study||2
4993054|NCT02407704|12285235|P3|COMPLETED|Overall Study||4
4993055|NCT02407704|12285236|P2|COMPLETED|Overall Study||3
4993056|NCT02407704|12285237|P1|COMPLETED|Overall Study||2
4993057|NCT02407704|12285234|P4|STARTED|Overall Study||5
4993058|NCT02407704|12285235|P3|STARTED|Overall Study||5
4993059|NCT02407704|12285236|P2|STARTED|Overall Study||3
4993060|NCT02407704|12285237|P1|STARTED|Overall Study||2
4993061|NCT02407249|12285271|P1|NOT COMPLETED|Overall Study||26
4993062|NCT02407249|12285271|P1|COMPLETED|Overall Study||47
4993063|NCT02407249|12285271|P1|Treated|Overall Study||60
4993064|NCT02407249|12285271|P1|STARTED|Overall Study||73
4993065|NCT02407236|12285287|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
4993066|NCT02407236|12285288|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
4993067|NCT02407236|12285289|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
4993068|NCT02407236|12285290|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
4993069|NCT02407236|12285291|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
4993070|NCT02407236|12285292|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
4993071|NCT02407236|12285293|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
4993072|NCT02407236|12285294|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
4993073|NCT02407236|12285287|P8|COMPLETED|Maintenance Study (44 Weeks)||149
4993074|NCT02407236|12285288|P7|COMPLETED|Maintenance Study (44 Weeks)||94
4993075|NCT02407236|12285289|P6|COMPLETED|Maintenance Study (44 Weeks)||168
4993076|NCT02407236|12285290|P5|COMPLETED|Maintenance Study (44 Weeks)||161
4993077|NCT02407236|12285291|P4|COMPLETED|Maintenance Study (44 Weeks)||165
4993078|NCT02407236|12285292|P3|COMPLETED|Maintenance Study (44 Weeks)||0
4993079|NCT02407236|12285293|P2|COMPLETED|Maintenance Study (44 Weeks)||0
4993080|NCT02407236|12285294|P1|COMPLETED|Maintenance Study (44 Weeks)||0
4993081|NCT02407236|12285287|P8|STARTED|Maintenance Study (44 Weeks)||157
4993082|NCT02407236|12285288|P7|STARTED|Maintenance Study (44 Weeks)||103
4993083|NCT02407236|12285289|P6|STARTED|Maintenance Study (44 Weeks)||176
4993084|NCT02407236|12285290|P5|STARTED|Maintenance Study (44 Weeks)||172
4993085|NCT02407236|12285291|P4|STARTED|Maintenance Study (44 Weeks)||175
4993086|NCT02407236|12285292|P3|STARTED|Maintenance Study (44 Weeks)||0
4993087|NCT02407236|12285293|P2|STARTED|Maintenance Study (44 Weeks)||0
4993088|NCT02407236|12285294|P1|STARTED|Maintenance Study (44 Weeks)||0
4993089|NCT02407236|12285287|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
4993090|NCT02407236|12285288|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
4993091|NCT02407236|12285289|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
4993092|NCT02407236|12285290|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
4993093|NCT02407236|12285291|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
4993094|NCT02407236|12285292|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
4993095|NCT02407236|12285293|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
4993096|NCT02407236|12285294|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
4993097|NCT02407236|12285287|P8|COMPLETED|Induction Study (8 Weeks)||0
4993098|NCT02407236|12285288|P7|COMPLETED|Induction Study (8 Weeks)||0
4993099|NCT02407236|12285289|P6|COMPLETED|Induction Study (8 Weeks)||0
4993100|NCT02407236|12285290|P5|COMPLETED|Induction Study (8 Weeks)||0
4993101|NCT02407236|12285291|P4|COMPLETED|Induction Study (8 Weeks)||0
4993102|NCT02407236|12285292|P3|COMPLETED|Induction Study (8 Weeks)||307
4993103|NCT02407236|12285293|P2|COMPLETED|Induction Study (8 Weeks)||309
4993104|NCT02407236|12285294|P1|COMPLETED|Induction Study (8 Weeks)||296
4993105|NCT02407236|12285287|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
4993106|NCT02407236|12285288|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
4993107|NCT02407236|12285289|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
4993108|NCT02407236|12285290|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
4993109|NCT02407236|12285291|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
4993110|NCT02407236|12285292|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
4993111|NCT02407236|12285293|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
4993112|NCT02407236|12285294|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
4993113|NCT02407236|12285287|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
4993114|NCT02407236|12285288|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
4993115|NCT02407236|12285289|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
4993116|NCT02407236|12285290|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
4993117|NCT02407236|12285291|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
4993118|NCT02407236|12285292|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
4993119|NCT02407236|12285293|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
4993120|NCT02407236|12285294|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
4993121|NCT02407236|12285287|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
4993122|NCT02407236|12285288|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
4993123|NCT02407236|12285289|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
4993124|NCT02407236|12285290|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
4993125|NCT02407236|12285291|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
4993126|NCT02407236|12285292|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
4993127|NCT02407236|12285293|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
4993128|NCT02407236|12285294|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
4993129|NCT02407236|12285287|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
4993130|NCT02407236|12285288|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
4993131|NCT02407236|12285289|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
4993132|NCT02407236|12285290|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
4993133|NCT02407236|12285291|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
4993134|NCT02407236|12285292|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
4993135|NCT02407236|12285293|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
4993136|NCT02407236|12285294|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
4993137|NCT02407236|12285287|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
4993138|NCT02407236|12285288|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
4993139|NCT02407236|12285289|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
4993140|NCT02407236|12285290|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
4993141|NCT02407236|12285291|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
4993142|NCT02407236|12285292|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
4993143|NCT02407236|12285293|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
4993144|NCT02407236|12285294|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
4993145|NCT02407236|12285287|P8|STARTED|Induction Study (8 Weeks)||0
4993146|NCT02407236|12285288|P7|STARTED|Induction Study (8 Weeks)||0
4993147|NCT02407236|12285289|P6|STARTED|Induction Study (8 Weeks)||0
4993148|NCT02407236|12285290|P5|STARTED|Induction Study (8 Weeks)||0
4993149|NCT02407236|12285291|P4|STARTED|Induction Study (8 Weeks)||0
4993150|NCT02407236|12285292|P3|STARTED|Induction Study (8 Weeks)||322
4993151|NCT02407236|12285293|P2|STARTED|Induction Study (8 Weeks)||320
4993152|NCT02407236|12285294|P1|STARTED|Induction Study (8 Weeks)||319
4993153|NCT02407223|12285534|P3|NOT COMPLETED|Overall Study||122
4993154|NCT02407223|12285535|P2|NOT COMPLETED|Overall Study||118
4993155|NCT02407223|12285536|P1|NOT COMPLETED|Overall Study||116
4993156|NCT02407223|12285534|P3|COMPLETED|Overall Study||0
4993157|NCT02407223|12285535|P2|COMPLETED|Overall Study||0
4993158|NCT02407223|12285536|P1|COMPLETED|Overall Study||0
4993159|NCT02407223|12285534|P3|Qualified Re-randomization at Week 52|Overall Study||2
4993160|NCT02407223|12285535|P2|Qualified Re-randomization at Week 52|Overall Study||3
4993161|NCT02407223|12285536|P1|Qualified Re-randomization at Week 52|Overall Study||0
4993162|NCT02407223|12285534|P3|Cross Over at Week 24|Overall Study||0
4993163|NCT02407223|12285535|P2|Cross Over at Week 24|Overall Study||0
4993164|NCT02407223|12285536|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
4993165|NCT02407223|12285534|P3|Early Escape at Week 16|Overall Study||0
4993166|NCT02407223|12285535|P2|Early Escape at Week 16|Overall Study||0
4993167|NCT02407223|12285536|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
4993168|NCT02407223|12285534|P3|STARTED|Overall Study||122
4993169|NCT02407223|12285535|P2|STARTED|Overall Study||118
4993170|NCT02407223|12285536|P1|STARTED|Overall Study||116
4993171|NCT02407132|12285581|P2|NOT COMPLETED|12 Months Post-intervention||2
4993172|NCT02407132|12285582|P1|NOT COMPLETED|12 Months Post-intervention||13
4993173|NCT02407132|12285581|P2|COMPLETED|12 Months Post-intervention||90
4993174|NCT02407132|12285582|P1|COMPLETED|12 Months Post-intervention||83
4993175|NCT02407132|12285581|P2|STARTED|12 Months Post-intervention||92
4993176|NCT02407132|12285582|P1|STARTED|12 Months Post-intervention||96
4993177|NCT02407132|12285581|P2|NOT COMPLETED|6 Months Post-intervention||9
4993178|NCT02407132|12285582|P1|NOT COMPLETED|6 Months Post-intervention||11
4993179|NCT02407132|12285581|P2|COMPLETED|6 Months Post-intervention||92
4993180|NCT02407132|12285582|P1|COMPLETED|6 Months Post-intervention||96
4993181|NCT02407132|12285581|P2|STARTED|6 Months Post-intervention||101
4993182|NCT02407132|12285582|P1|STARTED|6 Months Post-intervention||107
4993183|NCT02407132|12285581|P2|NOT COMPLETED|Immediate Post-intervention||10
4993184|NCT02407132|12285582|P1|NOT COMPLETED|Immediate Post-intervention||3
4993185|NCT02407132|12285581|P2|COMPLETED|Immediate Post-intervention||101
4993186|NCT02407132|12285582|P1|COMPLETED|Immediate Post-intervention||107
4993187|NCT02407132|12285581|P2|STARTED|Immediate Post-intervention||111
4993188|NCT02407132|12285582|P1|STARTED|Immediate Post-intervention||110
4993189|NCT02406937|12285609|P3|NOT COMPLETED|Overall Study||2
4993190|NCT02406937|12285610|P2|NOT COMPLETED|Overall Study||1
4993191|NCT02406937|12285611|P1|NOT COMPLETED|Overall Study||1
4993192|NCT02406937|12285609|P3|COMPLETED|Overall Study||58
4993193|NCT02406937|12285610|P2|COMPLETED|Overall Study||59
4993194|NCT02406937|12285611|P1|COMPLETED|Overall Study||59
4993195|NCT02406937|12285609|P3|STARTED|Overall Study||60
4993196|NCT02406937|12285610|P2|STARTED|Overall Study||60
4993197|NCT02406937|12285611|P1|STARTED|Overall Study||60
4993198|NCT02406677|12285669|P2|NOT COMPLETED|Overall Study||598
4993199|NCT02406677|12285670|P1|NOT COMPLETED|Overall Study||301
4993200|NCT02406677|12285669|P2|COMPLETED|Overall Study||3967
4993201|NCT02406677|12285670|P1|COMPLETED|Overall Study||6135
4993202|NCT02406677|12285669|P2|STARTED|Overall Study||4565
4993203|NCT02406677|12285670|P1|STARTED|Overall Study||6436
4993204|NCT02406612|12285684|P2|NOT COMPLETED|Overall Study||4
4993205|NCT02406612|12285685|P1|NOT COMPLETED|Overall Study||4
4993206|NCT02406612|12285684|P2|COMPLETED|Overall Study||17
4993207|NCT02406612|12285685|P1|COMPLETED|Overall Study||22
4993208|NCT02406612|12285684|P2|STARTED|Overall Study||21
4993209|NCT02406612|12285685|P1|STARTED|Overall Study||26
4993210|NCT02406586|12285700|P3|NOT COMPLETED|Overall Study||2
4993211|NCT02406586|12285701|P2|NOT COMPLETED|Overall Study||4
4993212|NCT02406586|12285702|P1|NOT COMPLETED|Overall Study||1
4993213|NCT02406586|12285700|P3|COMPLETED|Overall Study||10
4993214|NCT02406586|12285701|P2|COMPLETED|Overall Study||8
4993215|NCT02406586|12285702|P1|COMPLETED|Overall Study||11
4993216|NCT02406586|12285700|P3|STARTED|Overall Study||12
4993217|NCT02406586|12285701|P2|STARTED|Overall Study||12
4993218|NCT02406586|12285702|P1|STARTED|Overall Study||12
4993219|NCT02406573|12285776|P1|NOT COMPLETED|Overall Study||0
4993220|NCT02406573|12285776|P1|COMPLETED|Overall Study||30
4993221|NCT02406573|12285776|P1|STARTED|Overall Study||30
4993222|NCT02406495|12285782|P1|NOT COMPLETED|Overall Study||0
4993223|NCT02406495|12285782|P1|COMPLETED|Overall Study||40
4993224|NCT02406495|12285782|P1|STARTED|Overall Study||40
4993225|NCT02406443|12285823|P2|NOT COMPLETED|Overall Study||2
4993226|NCT02406443|12285824|P1|NOT COMPLETED|Overall Study||2
4993227|NCT02406443|12285823|P2|COMPLETED|Overall Study||16
4993228|NCT02406443|12285824|P1|COMPLETED|Overall Study||16
4993229|NCT02406443|12285823|P2|STARTED|Overall Study||18
4993230|NCT02406443|12285824|P1|STARTED|Overall Study||18
4993231|NCT02406261|12285844|P2|NOT COMPLETED|Period 2||3
4993232|NCT02406261|12285845|P1|NOT COMPLETED|Period 2||0
4993233|NCT02406261|12285844|P2|COMPLETED|Period 2||29
4993234|NCT02406261|12285845|P1|COMPLETED|Period 2||0
4993235|NCT02406261|12285844|P2|STARTED|Period 2||32
4993236|NCT02406261|12285845|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
4993237|NCT02406261|12285844|P2|NOT COMPLETED|Period 1||0
4993238|NCT02406261|12285845|P1|NOT COMPLETED|Period 1||3
4993239|NCT02406261|12285844|P2|COMPLETED|Period 1||32
4993240|NCT02406261|12285845|P1|COMPLETED|Period 1||47
4993241|NCT02406261|12285844|P2|Received at Least One Dose of Study Drug|Period 1||32
4993242|NCT02406261|12285845|P1|Received at Least One Dose of Study Drug|Period 1||50
4993243|NCT02406261|12285844|P2|STARTED|Period 1||32
4993244|NCT02406261|12285845|P1|STARTED|Period 1||50
4993245|NCT02406248|12285857|P1|NOT COMPLETED|Overall Study||9
4993246|NCT02406248|12285857|P1|COMPLETED|Overall Study||99
4993247|NCT02406248|12285857|P1|STARTED|Overall Study||108
4993248|NCT02406027|12285868|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
4993249|NCT02406027|12285869|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
4993250|NCT02406027|12285870|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
4993251|NCT02406027|12285871|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
4993252|NCT02406027|12285872|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
4993253|NCT02406027|12285873|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
4993254|NCT02406027|12285874|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
4993255|NCT02406027|12285868|P7|COMPLETED|Open-label Phase (Period 2)||0
4993256|NCT02406027|12285869|P6|COMPLETED|Open-label Phase (Period 2)||0
4993257|NCT02406027|12285870|P5|COMPLETED|Open-label Phase (Period 2)||0
4993258|NCT02406027|12285871|P4|COMPLETED|Open-label Phase (Period 2)||0
4993259|NCT02406027|12285872|P3|COMPLETED|Open-label Phase (Period 2)||0
4993260|NCT02406027|12285873|P2|COMPLETED|Open-label Phase (Period 2)||0
4993261|NCT02406027|12285874|P1|COMPLETED|Open-label Phase (Period 2)||0
4993262|NCT02406027|12285868|P7|STARTED|Open-label Phase (Period 2)||22
4993263|NCT02406027|12285869|P6|STARTED|Open-label Phase (Period 2)||26
4993264|NCT02406027|12285870|P5|STARTED|Open-label Phase (Period 2)||14
4993265|NCT02406027|12285871|P4|STARTED|Open-label Phase (Period 2)||15
4993266|NCT02406027|12285872|P3|STARTED|Open-label Phase (Period 2)||0
4993267|NCT02406027|12285873|P2|STARTED|Open-label Phase (Period 2)||0
4993268|NCT02406027|12285874|P1|STARTED|Open-label Phase (Period 2)||0
4993269|NCT02406027|12285868|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993270|NCT02406027|12285869|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993271|NCT02406027|12285870|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993272|NCT02406027|12285871|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993273|NCT02406027|12285872|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
4993274|NCT02406027|12285873|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
4993275|NCT02406027|12285874|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
4993276|NCT02406027|12285868|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993277|NCT02406027|12285869|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993278|NCT02406027|12285870|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993279|NCT02406027|12285871|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
4993280|NCT02406027|12285872|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
4993281|NCT02406027|12285873|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
4993282|NCT02406027|12285874|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
4993283|NCT02406027|12285868|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
4993284|NCT02406027|12285869|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
4993285|NCT02406027|12285870|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
4993286|NCT02406027|12285871|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
4993287|NCT02406027|12285872|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
4993288|NCT02406027|12285873|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
4993369|NCT02405442|12286012|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
4993289|NCT02406027|12285874|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
4993290|NCT02406027|12285868|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
4993291|NCT02406027|12285869|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
4993292|NCT02406027|12285870|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
4993293|NCT02406027|12285871|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
4993294|NCT02406027|12285872|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
4993295|NCT02406027|12285873|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
4993296|NCT02406027|12285874|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
4993297|NCT02406027|12285868|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
4993298|NCT02406027|12285869|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
4993299|NCT02406027|12285870|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
4993300|NCT02406027|12285871|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
4993301|NCT02406027|12285872|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
4993302|NCT02406027|12285873|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
4993303|NCT02406027|12285874|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
4993304|NCT02405962|12285904|P2|NOT COMPLETED|Overall Study||5
4993305|NCT02405962|12285905|P1|NOT COMPLETED|Overall Study||1
4993306|NCT02405962|12285904|P2|COMPLETED|Overall Study||79
4993307|NCT02405962|12285905|P1|COMPLETED|Overall Study||83
4993308|NCT02405962|12285904|P2|3 Months After the Intervention|Overall Study||79
4993309|NCT02405962|12285905|P1|3 Months After the Intervention|Overall Study||80
4993310|NCT02405962|12285904|P2|Post-intervention|Overall Study||81
4993311|NCT02405962|12285905|P1|Post-intervention|Overall Study||80
4993312|NCT02405962|12285904|P2|STARTED|Overall Study||84
4993313|NCT02405962|12285905|P1|STARTED|Overall Study||84
4993314|NCT02405780|12285943|P4|NOT COMPLETED|Period II||18
4993315|NCT02405780|12285944|P3|NOT COMPLETED|Period II||12
4993316|NCT02405780|12285945|P2|NOT COMPLETED|Period II||12
4993317|NCT02405780|12285946|P1|NOT COMPLETED|Period II||15
4993318|NCT02405780|12285943|P4|COMPLETED|Period II||172
4993319|NCT02405780|12285944|P3|COMPLETED|Period II||81
4993320|NCT02405780|12285945|P2|COMPLETED|Period II||88
4993321|NCT02405780|12285946|P1|COMPLETED|Period II||174
4993322|NCT02405780|12285943|P4|STARTED|Period II||190
4993323|NCT02405780|12285944|P3|STARTED|Period II||93
4993324|NCT02405780|12285945|P2|STARTED|Period II||100
4993325|NCT02405780|12285946|P1|STARTED|Period II||189
4993326|NCT02405780|12285943|P4|NOT COMPLETED|Period I||23
4993327|NCT02405780|12285944|P3|NOT COMPLETED|Period I||15
4993328|NCT02405780|12285945|P2|NOT COMPLETED|Period I||8
4993329|NCT02405780|12285946|P1|NOT COMPLETED|Period I||27
4993330|NCT02405780|12285943|P4|COMPLETED|Period I||190
4993331|NCT02405780|12285944|P3|COMPLETED|Period I||93
4993332|NCT02405780|12285945|P2|COMPLETED|Period I||100
4993333|NCT02405780|12285946|P1|COMPLETED|Period I||189
4993334|NCT02405780|12285943|P4|STARTED|Period I||213
4993335|NCT02405780|12285944|P3|STARTED|Period I||108
4993336|NCT02405780|12285945|P2|STARTED|Period I||108
4993337|NCT02405780|12285946|P1|STARTED|Period I||216
4993338|NCT02405442|12286009|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
4993339|NCT02405442|12286010|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
4993340|NCT02405442|12286011|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
4993341|NCT02405442|12286012|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
4993342|NCT02405442|12286009|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
4993343|NCT02405442|12286010|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
4993344|NCT02405442|12286011|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
4993345|NCT02405442|12286012|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
4993346|NCT02405442|12286009|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
4993347|NCT02405442|12286010|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
4993348|NCT02405442|12286011|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
4993349|NCT02405442|12286012|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
4993350|NCT02405442|12286009|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
4993351|NCT02405442|12286010|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
4993352|NCT02405442|12286011|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
4993353|NCT02405442|12286012|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
4993354|NCT02405442|12286009|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
4993355|NCT02405442|12286010|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
4993356|NCT02405442|12286011|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
4993357|NCT02405442|12286012|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
4993358|NCT02405442|12286009|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
4993359|NCT02405442|12286010|P3|STARTED|Open-Label Phase (up to Week 52)||47
4993360|NCT02405442|12286011|P2|STARTED|Open-Label Phase (up to Week 52)||48
4993361|NCT02405442|12286012|P1|STARTED|Open-Label Phase (up to Week 52)||52
4993362|NCT02405442|12286009|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
4993363|NCT02405442|12286010|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
4993364|NCT02405442|12286011|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
4993365|NCT02405442|12286012|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
4993366|NCT02405442|12286009|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
4993367|NCT02405442|12286010|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
4993368|NCT02405442|12286011|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
4993370|NCT02405442|12286009|P4|STARTED|Double-Blind Phase (up to Week 8)||28
4993371|NCT02405442|12286010|P3|STARTED|Double-Blind Phase (up to Week 8)||53
4993372|NCT02405442|12286011|P2|STARTED|Double-Blind Phase (up to Week 8)||53
4993373|NCT02405442|12286012|P1|STARTED|Double-Blind Phase (up to Week 8)||53
4993374|NCT02405429|12286038|P1|NOT COMPLETED|Overall Study||0
4993375|NCT02405429|12286038|P1|COMPLETED|Overall Study||49
4993376|NCT02405429|12286038|P1|STARTED|Overall Study||49
4993377|NCT02405390|12286048|P2|NOT COMPLETED|Overall Study||0
4993378|NCT02405390|12286049|P1|NOT COMPLETED|Overall Study||0
4993379|NCT02405390|12286048|P2|COMPLETED|Overall Study||46
4993380|NCT02405390|12286049|P1|COMPLETED|Overall Study||46
4993381|NCT02405390|12286048|P2|STARTED|Overall Study||46
4993382|NCT02405390|12286049|P1|STARTED|Overall Study||46
4993383|NCT02405195|12286057|P1|NOT COMPLETED|Overall Study||0
4993384|NCT02405195|12286057|P1|COMPLETED|Overall Study||18
4993385|NCT02405195|12286057|P1|STARTED|Overall Study||18
4993386|NCT02405091|12286066|P3|NOT COMPLETED|Overall Study||2
4993387|NCT02405091|12286067|P2|NOT COMPLETED|Overall Study||33
4993388|NCT02405091|12286068|P1|NOT COMPLETED|Overall Study||29
4993389|NCT02405091|12286066|P3|COMPLETED|Overall Study||9
4993390|NCT02405091|12286067|P2|COMPLETED|Overall Study||74
4993391|NCT02405091|12286068|P1|COMPLETED|Overall Study||20
4993392|NCT02405091|12286066|P3|STARTED|Overall Study||11
4993393|NCT02405091|12286067|P2|STARTED|Overall Study||107
4993394|NCT02405091|12286068|P1|STARTED|Overall Study||49
4993395|NCT02404792|12286091|P2|NOT COMPLETED|Overall Study||8
4993396|NCT02404792|12286092|P1|NOT COMPLETED|Overall Study||5
4993397|NCT02404792|12286091|P2|COMPLETED|Overall Study||29
4993398|NCT02404792|12286092|P1|COMPLETED|Overall Study||27
4993399|NCT02404792|12286091|P2|STARTED|Overall Study||37
4993400|NCT02404792|12286092|P1|STARTED|Overall Study||32
4993401|NCT02404649|12286104|P2|NOT COMPLETED|Overall Study||2
4993402|NCT02404649|12286105|P1|NOT COMPLETED|Overall Study||1
4993403|NCT02404649|12286104|P2|COMPLETED|Overall Study||14
4993404|NCT02404649|12286105|P1|COMPLETED|Overall Study||16
4993405|NCT02404649|12286104|P2|STARTED|Overall Study||16
4993406|NCT02404649|12286105|P1|STARTED|Overall Study||17
4993407|NCT02404610|12286115|P2|NOT COMPLETED|Overall Study||0
4993408|NCT02404610|12286116|P1|NOT COMPLETED|Overall Study||0
4993409|NCT02404610|12286115|P2|COMPLETED|Overall Study||53
4993410|NCT02404610|12286116|P1|COMPLETED|Overall Study||54
4993411|NCT02404610|12286115|P2|STARTED|Overall Study||53
4993412|NCT02404610|12286116|P1|STARTED|Overall Study||54
4993413|NCT02404545|12286124|P2|NOT COMPLETED|Overall Study||6
4993414|NCT02404545|12286125|P1|NOT COMPLETED|Overall Study||6
4993415|NCT02404545|12286124|P2|COMPLETED|Overall Study||0
4993416|NCT02404545|12286125|P1|COMPLETED|Overall Study||0
4993417|NCT02404545|12286124|P2|STARTED|Overall Study||6
4993418|NCT02404545|12286125|P1|STARTED|Overall Study||6
4993419|NCT02404532|12286132|P1|NOT COMPLETED|Overall Study||0
4993420|NCT02404532|12286132|P1|COMPLETED|Overall Study||29
4993421|NCT02404532|12286132|P1|STARTED|Overall Study||29
4993422|NCT02404493|12286144|P2|NOT COMPLETED|Overall Study||1
4993423|NCT02404493|12286145|P1|NOT COMPLETED|Overall Study||1
4993424|NCT02404493|12286144|P2|COMPLETED|Overall Study||5
4993425|NCT02404493|12286145|P1|COMPLETED|Overall Study||16
4993426|NCT02404493|12286144|P2|STARTED|Overall Study||6
4993427|NCT02404493|12286145|P1|STARTED|Overall Study||17
4993428|NCT02404389|12286390|P5|NOT COMPLETED|Overall Study||3
4993429|NCT02404389|12286391|P4|NOT COMPLETED|Overall Study||1
4993430|NCT02404389|12286392|P3|NOT COMPLETED|Overall Study||1
4993431|NCT02404389|12286393|P2|NOT COMPLETED|Overall Study||0
4993432|NCT02404389|12286394|P1|NOT COMPLETED|Overall Study||2
4993433|NCT02404389|12286390|P5|COMPLETED|Overall Study||18
4993434|NCT02404389|12286391|P4|COMPLETED|Overall Study||9
4993435|NCT02404389|12286392|P3|COMPLETED|Overall Study||10
4993436|NCT02404389|12286393|P2|COMPLETED|Overall Study||20
4993437|NCT02404389|12286394|P1|COMPLETED|Overall Study||18
4993438|NCT02404389|12286390|P5|STARTED|Overall Study||21
4993439|NCT02404389|12286391|P4|STARTED|Overall Study||10
4993440|NCT02404389|12286392|P3|STARTED|Overall Study||11
4993441|NCT02404389|12286393|P2|STARTED|Overall Study||20
4993442|NCT02404389|12286394|P1|STARTED|Overall Study||20
4993443|NCT02404350|12286434|P4|NOT COMPLETED|Overall Study||37
4993444|NCT02404350|12286435|P3|NOT COMPLETED|Overall Study||6
4993445|NCT02404350|12286436|P2|NOT COMPLETED|Overall Study||6
4993446|NCT02404350|12286437|P1|NOT COMPLETED|Overall Study||15
4993447|NCT02404350|12286434|P4|COMPLETED|Overall Study||295
4993448|NCT02404350|12286435|P3|COMPLETED|Overall Study||216
4993449|NCT02404350|12286436|P2|COMPLETED|Overall Study||214
4993450|NCT02404350|12286437|P1|COMPLETED|Overall Study||207
4993451|NCT02404350|12286434|P4|STARTED|Overall Study||332
4993452|NCT02404350|12286435|P3|STARTED|Overall Study||222
4993453|NCT02404350|12286436|P2|STARTED|Overall Study||220
4993454|NCT02404350|12286437|P1|STARTED|Overall Study||222
4993455|NCT02404285|12286482|P2|NOT COMPLETED|Overall Study||2
4993456|NCT02404285|12286483|P1|NOT COMPLETED|Overall Study||2
4993457|NCT02404285|12286482|P2|COMPLETED|Overall Study||33
4993458|NCT02404285|12286483|P1|COMPLETED|Overall Study||31
4993459|NCT02404285|12286482|P2|STARTED|Overall Study||35
4993460|NCT02404285|12286483|P1|STARTED|Overall Study||33
4993461|NCT02404220|12286519|P4|NOT COMPLETED|Overall Study||10
4993462|NCT02404220|12286520|P3|NOT COMPLETED|Overall Study||7
4993463|NCT02404220|12286521|P2|NOT COMPLETED|Overall Study||8
4993464|NCT02404220|12286522|P1|NOT COMPLETED|Overall Study||5
4993465|NCT02404220|12286519|P4|COMPLETED|Overall Study||0
4993466|NCT02404220|12286520|P3|COMPLETED|Overall Study||0
4993467|NCT02404220|12286521|P2|COMPLETED|Overall Study||0
4993468|NCT02404220|12286522|P1|COMPLETED|Overall Study||0
4993469|NCT02404220|12286519|P4|STARTED|Overall Study||10
4993470|NCT02404220|12286520|P3|STARTED|Overall Study||7
4993471|NCT02404220|12286521|P2|STARTED|Overall Study||8
4993472|NCT02404220|12286522|P1|STARTED|Overall Study||5
4993473|NCT02404168|12286548|P1|NOT COMPLETED|Overall Study||0
4993474|NCT02404168|12286548|P1|COMPLETED|Overall Study||4
4993475|NCT02404168|12286548|P1|STARTED|Overall Study||4
4993476|NCT02404103|12286558|P2|NOT COMPLETED|Overall Study||3
4993477|NCT02404103|12286559|P1|NOT COMPLETED|Overall Study||4
4993478|NCT02404103|12286558|P2|COMPLETED|Overall Study||9
4993479|NCT02404103|12286559|P1|COMPLETED|Overall Study||10
4993480|NCT02404103|12286558|P2|STARTED|Overall Study||12
4993481|NCT02404103|12286559|P1|STARTED|Overall Study||14
4993482|NCT02404025|12286579|P1|NOT COMPLETED|Overall Study||4
4993483|NCT02404025|12286579|P1|COMPLETED|Overall Study||6
4993484|NCT02404025|12286579|P1|STARTED|Overall Study||10
4993485|NCT02403999|12286611|P3|NOT COMPLETED|Overall Study||0
4993486|NCT02403999|12286612|P2|NOT COMPLETED|Overall Study||0
4993487|NCT02403999|12286613|P1|NOT COMPLETED|Overall Study||0
4993488|NCT02403999|12286611|P3|COMPLETED|Overall Study||11
4993489|NCT02403999|12286612|P2|COMPLETED|Overall Study||10
4993490|NCT02403999|12286613|P1|COMPLETED|Overall Study||10
4993491|NCT02403999|12286611|P3|STARTED|Overall Study||11
4993492|NCT02403999|12286612|P2|STARTED|Overall Study||10
4993493|NCT02403999|12286613|P1|STARTED|Overall Study||10
4993494|NCT02403986|12286626|P2|NOT COMPLETED|Overall Study||4
4993495|NCT02403986|12286627|P1|NOT COMPLETED|Overall Study||5
4993496|NCT02403986|12286626|P2|COMPLETED|Overall Study||23
4993497|NCT02403986|12286627|P1|COMPLETED|Overall Study||21
4993498|NCT02403986|12286626|P2|STARTED|Overall Study||27
4993499|NCT02403986|12286627|P1|STARTED|Overall Study||26
4993500|NCT02403895|12286635|P1|NOT COMPLETED|Overall Study||0
4993501|NCT02403895|12286635|P1|COMPLETED|Overall Study||11
4993502|NCT02403895|12286635|P1|STARTED|Overall Study||11
4993503|NCT02403830|12286648|P2|NOT COMPLETED|Visit 2||0
4993504|NCT02403830|12286649|P1|NOT COMPLETED|Visit 2||0
4993505|NCT02403830|12286648|P2|COMPLETED|Visit 2||15
4993506|NCT02403830|12286649|P1|COMPLETED|Visit 2||14
4993507|NCT02403830|12286648|P2|STARTED|Visit 2||15
4993508|NCT02403830|12286649|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
4993509|NCT02403830|12286648|P2|NOT COMPLETED|Visit 1||0
4993510|NCT02403830|12286649|P1|NOT COMPLETED|Visit 1||0
4993511|NCT02403830|12286648|P2|COMPLETED|Visit 1||15
4993512|NCT02403830|12286649|P1|COMPLETED|Visit 1||15
4993513|NCT02403830|12286648|P2|STARTED|Visit 1||15
4993514|NCT02403830|12286649|P1|STARTED|Visit 1||15
4993515|NCT02403817|12286661|P2|NOT COMPLETED|Overall Study||0
4993516|NCT02403817|12286662|P1|NOT COMPLETED|Overall Study||5
4993517|NCT02403817|12286661|P2|COMPLETED|Overall Study||2
4993518|NCT02403817|12286662|P1|COMPLETED|Overall Study||23
4993519|NCT02403817|12286661|P2|STARTED|Overall Study||2
4993520|NCT02403817|12286662|P1|STARTED|Overall Study||28
4993521|NCT02403778|12286676|P2|NOT COMPLETED|Overall Study||0
4993522|NCT02403778|12286677|P1|NOT COMPLETED|Overall Study||0
4993523|NCT02403778|12286676|P2|COMPLETED|Overall Study||4
4993524|NCT02403778|12286677|P1|COMPLETED|Overall Study||6
4993525|NCT02403778|12286676|P2|STARTED|Overall Study||4
4993526|NCT02403778|12286677|P1|STARTED|Overall Study||6
4993527|NCT02403674|12286693|P2|NOT COMPLETED|Overall Study||63
4993528|NCT02403674|12286694|P1|NOT COMPLETED|Overall Study||55
4993529|NCT02403674|12286693|P2|COMPLETED|Overall Study||303
4993530|NCT02403674|12286694|P1|COMPLETED|Overall Study||313
4993531|NCT02403674|12286693|P2|Treated|Overall Study||364
4993532|NCT02403674|12286694|P1|Treated|Overall Study||364
4993533|NCT02403674|12286693|P2|STARTED|Overall Study||366
4993534|NCT02403674|12286694|P1|STARTED|Overall Study||368
4993535|NCT02403635|12286733|P1|NOT COMPLETED|Overall Study||9
4993536|NCT02403635|12286733|P1|COMPLETED|Overall Study||18
4993537|NCT02403635|12286733|P1|Received the First Dose|Overall Study||18
4993538|NCT02403635|12286733|P1|Screening (28 Days)|Overall Study||27
4993539|NCT02403635|12286733|P1|STARTED|Overall Study||27
4993540|NCT02403479|12286801|P2|NOT COMPLETED|Overall Study||0
4993541|NCT02403479|12286802|P1|NOT COMPLETED|Overall Study||2
4993542|NCT02403479|12286801|P2|COMPLETED|Overall Study||12
4993543|NCT02403479|12286802|P1|COMPLETED|Overall Study||8
4993544|NCT02403479|12286801|P2|STARTED|Overall Study||12
4993545|NCT02403479|12286802|P1|STARTED|Overall Study||10
4993546|NCT02403271|12286810|P2|NOT COMPLETED|Period 2||124
4993547|NCT02403271|12286811|P1|NOT COMPLETED|Period 2||0
4993548|NCT02403271|12286810|P2|COMPLETED|Period 2||0
4993549|NCT02403271|12286811|P1|COMPLETED|Period 2||0
4993550|NCT02403271|12286810|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
4993551|NCT02403271|12286811|P1|STARTED|Period 2||0
4993552|NCT02403271|12286810|P2|NOT COMPLETED|Period 1||0
4993553|NCT02403271|12286811|P1|NOT COMPLETED|Period 1||1
4993554|NCT02403271|12286810|P2|COMPLETED|Period 1||0
4993555|NCT02403271|12286811|P1|COMPLETED|Period 1||6
4993556|NCT02403271|12286810|P2|STARTED|Period 1||0
4993557|NCT02403271|12286811|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
4993558|NCT02403206|12286825|P2|NOT COMPLETED|Overall Study||10
4993559|NCT02403206|12286826|P1|NOT COMPLETED|Overall Study||11
4993560|NCT02403206|12286825|P2|COMPLETED|Overall Study||186
4993561|NCT02403206|12286826|P1|COMPLETED|Overall Study||183
4993562|NCT02403206|12286825|P2|Randomized and Treated|Overall Study||190
4993563|NCT02403206|12286826|P1|Randomized and Treated|Overall Study||188
4993564|NCT02403206|12286825|P2|Treated Prior to Randomization|Overall Study||1
4993565|NCT02403206|12286826|P1|Treated Prior to Randomization|Overall Study||0
4993566|NCT02403206|12286825|P2|STARTED|Overall Study||196
4993567|NCT02403206|12286826|P1|STARTED|Overall Study||194
4993568|NCT02403180|12286837|P2|NOT COMPLETED|Period 2 (5 Days)||1
4993569|NCT02403180|12286838|P1|NOT COMPLETED|Period 2 (5 Days)||0
4993570|NCT02403180|12286837|P2|COMPLETED|Period 2 (5 Days)||32
4993571|NCT02403180|12286838|P1|COMPLETED|Period 2 (5 Days)||36
4993572|NCT02403180|12286837|P2|STARTED|Period 2 (5 Days)||33
4993573|NCT02403180|12286838|P1|STARTED|Period 2 (5 Days)||36
4993574|NCT02403180|12286837|P2|NOT COMPLETED|Period 1 (5 Days)||0
4993575|NCT02403180|12286838|P1|NOT COMPLETED|Period 1 (5 Days)||0
4993576|NCT02403180|12286837|P2|COMPLETED|Period 1 (5 Days)||33
4993577|NCT02403180|12286838|P1|COMPLETED|Period 1 (5 Days)||36
4993578|NCT02403180|12286837|P2|Randomized|Period 1 (5 Days)||33
4993579|NCT02403180|12286838|P1|Randomized|Period 1 (5 Days)||36
4993580|NCT02403180|12286837|P2|STARTED|Period 1 (5 Days)||33
4993581|NCT02403180|12286838|P1|STARTED|Period 1 (5 Days)||36
4993582|NCT02403180|12286837|P2|NOT COMPLETED|Pre-Treatment Period||1
4993583|NCT02403180|12286838|P1|NOT COMPLETED|Pre-Treatment Period||0
4993584|NCT02403180|12286837|P2|COMPLETED|Pre-Treatment Period||33
4993585|NCT02403180|12286838|P1|COMPLETED|Pre-Treatment Period||36
4993586|NCT02403180|12286837|P2|STARTED|Pre-Treatment Period||34
4993587|NCT02403180|12286838|P1|STARTED|Pre-Treatment Period||36
4993588|NCT02403154|12286850|P4|NOT COMPLETED|Overall Study||1
4993589|NCT02403154|12286851|P3|NOT COMPLETED|Overall Study||1
4993590|NCT02403154|12286852|P2|NOT COMPLETED|Overall Study||0
4993591|NCT02403154|12286853|P1|NOT COMPLETED|Overall Study||2
4993592|NCT02403154|12286850|P4|COMPLETED|Overall Study||0
4993593|NCT02403154|12286851|P3|COMPLETED|Overall Study||0
4993594|NCT02403154|12286852|P2|COMPLETED|Overall Study||0
4993595|NCT02403154|12286853|P1|COMPLETED|Overall Study||0
4993596|NCT02403154|12286850|P4|STARTED|Overall Study||1
4993597|NCT02403154|12286851|P3|STARTED|Overall Study||1
4993598|NCT02403154|12286852|P2|STARTED|Overall Study||0
4993599|NCT02403154|12286853|P1|STARTED|Overall Study||2
4993600|NCT02402933|12286867|P1|NOT COMPLETED|Overall Study||14
4993601|NCT02402933|12286867|P1|COMPLETED|Overall Study||12
4993602|NCT02402933|12286867|P1|Received at Least One Dose of Study Drug|Overall Study||22
4993603|NCT02402933|12286867|P1|STARTED|Overall Study||26
4993604|NCT02402881|12286876|P2|NOT COMPLETED|Post-Intervention Study Period||0
4993605|NCT02402881|12286877|P1|NOT COMPLETED|Post-Intervention Study Period||0
4993606|NCT02402881|12286876|P2|COMPLETED|Post-Intervention Study Period||8662
4993607|NCT02402881|12286877|P1|COMPLETED|Post-Intervention Study Period||3111
4993608|NCT02402881|12286876|P2|STARTED|Post-Intervention Study Period||8662
4993609|NCT02402881|12286877|P1|STARTED|Post-Intervention Study Period||3111
4993610|NCT02402881|12286876|P2|NOT COMPLETED|Pre-Intervention Study Period||0
4993611|NCT02402881|12286877|P1|NOT COMPLETED|Pre-Intervention Study Period||0
4993612|NCT02402881|12286876|P2|COMPLETED|Pre-Intervention Study Period||5657
4993613|NCT02402881|12286877|P1|COMPLETED|Pre-Intervention Study Period||2222
4993614|NCT02402881|12286876|P2|STARTED|Pre-Intervention Study Period||5657
4993615|NCT02402881|12286877|P1|STARTED|Pre-Intervention Study Period||2222
4993616|NCT02402764|12286885|P1|NOT COMPLETED|Overall Study||0
4993617|NCT02402764|12286885|P1|COMPLETED|Overall Study||10
4993618|NCT02402764|12286885|P1|STARTED|Overall Study||10
4993619|NCT02402452|12286895|P2|NOT COMPLETED|Overall Study||0
4993620|NCT02402452|12286896|P1|NOT COMPLETED|Overall Study||0
4993621|NCT02402452|12286895|P2|COMPLETED|Overall Study||10
4993622|NCT02402452|12286896|P1|COMPLETED|Overall Study||10
4993623|NCT02402452|12286895|P2|STARTED|Overall Study||10
4993624|NCT02402452|12286896|P1|STARTED|Overall Study||10
4993625|NCT02402322|12286911|P3|NOT COMPLETED|Follow-up||24
4993626|NCT02402322|12286912|P2|NOT COMPLETED|Follow-up||3
4993627|NCT02402322|12286913|P1|NOT COMPLETED|Follow-up||6
4993628|NCT02402322|12286911|P3|COMPLETED|Follow-up||0
4993629|NCT02402322|12286912|P2|COMPLETED|Follow-up||21
4993630|NCT02402322|12286913|P1|COMPLETED|Follow-up||18
4993631|NCT02402322|12286911|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
4993632|NCT02402322|12286912|P2|STARTED|Follow-up||24
4993633|NCT02402322|12286913|P1|STARTED|Follow-up||24
4993634|NCT02402322|12286911|P3|NOT COMPLETED|Pretreatment||1
4993635|NCT02402322|12286912|P2|NOT COMPLETED|Pretreatment||1
4993636|NCT02402322|12286913|P1|NOT COMPLETED|Pretreatment||3
4993637|NCT02402322|12286911|P3|COMPLETED|Pretreatment||24
4993638|NCT02402322|12286912|P2|COMPLETED|Pretreatment||24
4993639|NCT02402322|12286913|P1|COMPLETED|Pretreatment||24
4993640|NCT02402322|12286911|P3|Posttreatment Measures|Pretreatment||24
4993641|NCT02402322|12286912|P2|Posttreatment Measures|Pretreatment||24
4993642|NCT02402322|12286913|P1|Posttreatment Measures|Pretreatment||24
4993643|NCT02402322|12286911|P3|STARTED|Pretreatment||25
4993644|NCT02402322|12286912|P2|STARTED|Pretreatment||25
4993645|NCT02402322|12286913|P1|STARTED|Pretreatment||27
4993646|NCT02402296|12286947|P2|NOT COMPLETED|Overall Study||0
4993647|NCT02402296|12286948|P1|NOT COMPLETED|Overall Study||0
4993648|NCT02402296|12286947|P2|COMPLETED|Overall Study||15
4993649|NCT02402296|12286948|P1|COMPLETED|Overall Study||15
4993650|NCT02402296|12286947|P2|STARTED|Overall Study||15
4993651|NCT02402296|12286948|P1|STARTED|Overall Study||15
4993652|NCT02402218|12286963|P3|NOT COMPLETED|Overall Study||17
4993653|NCT02402218|12286964|P2|NOT COMPLETED|Overall Study||13
4993654|NCT02402218|12286965|P1|NOT COMPLETED|Overall Study||14
4993655|NCT02402218|12286963|P3|COMPLETED|Overall Study||37
4993656|NCT02402218|12286964|P2|COMPLETED|Overall Study||41
4993657|NCT02402218|12286965|P1|COMPLETED|Overall Study||22
4993658|NCT02402218|12286963|P3|Achieved Sustained Virologic Response|Overall Study||37
4993659|NCT02402218|12286964|P2|Achieved Sustained Virologic Response|Overall Study||41
4993660|NCT02402218|12286965|P1|Achieved Sustained Virologic Response|Overall Study||22
4993661|NCT02402218|12286963|P3|Completed Treatment With LDV/SOF|Overall Study||39
4993662|NCT02402218|12286964|P2|Completed Treatment With LDV/SOF|Overall Study||42
4993663|NCT02402218|12286965|P1|Completed Treatment With LDV/SOF|Overall Study||23
4993664|NCT02402218|12286963|P3|Initiated Treatment With LDV/SOF|Overall Study||41
4993665|NCT02402218|12286964|P2|Initiated Treatment With LDV/SOF|Overall Study||45
4993666|NCT02402218|12286965|P1|Initiated Treatment With LDV/SOF|Overall Study||24
4993667|NCT02402218|12286963|P3|STARTED|Overall Study||54
4993668|NCT02402218|12286964|P2|STARTED|Overall Study||54
4993669|NCT02402218|12286965|P1|STARTED|Overall Study||36
4993670|NCT02402166|12286988|P1|NOT COMPLETED|Overall Study||5
4993671|NCT02402166|12286988|P1|COMPLETED|Overall Study||19
4993672|NCT02402166|12286988|P1|STARTED|Overall Study||24
4993673|NCT02402153|12287009|P1|NOT COMPLETED|Overall Study||0
4993674|NCT02402153|12287009|P1|COMPLETED|Overall Study||18
4993675|NCT02402153|12287009|P1|STARTED|Overall Study||18
4993676|NCT02402127|12287025|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
4993677|NCT02402127|12287026|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
4993678|NCT02402127|12287027|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
4993679|NCT02402127|12287028|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
4993680|NCT02402127|12287029|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
4993681|NCT02402127|12287030|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
4993682|NCT02402127|12287025|P6|COMPLETED|Third Wear Period (1 Day)||4
4993683|NCT02402127|12287026|P5|COMPLETED|Third Wear Period (1 Day)||4
4993684|NCT02402127|12287027|P4|COMPLETED|Third Wear Period (1 Day)||4
4993685|NCT02402127|12287028|P3|COMPLETED|Third Wear Period (1 Day)||4
4993686|NCT02402127|12287029|P2|COMPLETED|Third Wear Period (1 Day)||4
4993687|NCT02402127|12287030|P1|COMPLETED|Third Wear Period (1 Day)||4
4993688|NCT02402127|12287025|P6|STARTED|Third Wear Period (1 Day)||4
4993689|NCT02402127|12287026|P5|STARTED|Third Wear Period (1 Day)||4
4993690|NCT02402127|12287027|P4|STARTED|Third Wear Period (1 Day)||4
4993691|NCT02402127|12287028|P3|STARTED|Third Wear Period (1 Day)||4
4993692|NCT02402127|12287029|P2|STARTED|Third Wear Period (1 Day)||4
4993693|NCT02402127|12287030|P1|STARTED|Third Wear Period (1 Day)||4
4993694|NCT02402127|12287025|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
4993695|NCT02402127|12287026|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
4993696|NCT02402127|12287027|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
4993697|NCT02402127|12287028|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
4993698|NCT02402127|12287029|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
4993699|NCT02402127|12287030|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
4993700|NCT02402127|12287025|P6|COMPLETED|Second Wear Period (1 Day)||4
4993701|NCT02402127|12287026|P5|COMPLETED|Second Wear Period (1 Day)||4
4993702|NCT02402127|12287027|P4|COMPLETED|Second Wear Period (1 Day)||4
4993703|NCT02402127|12287028|P3|COMPLETED|Second Wear Period (1 Day)||4
4993704|NCT02402127|12287029|P2|COMPLETED|Second Wear Period (1 Day)||4
4993705|NCT02402127|12287030|P1|COMPLETED|Second Wear Period (1 Day)||4
4993706|NCT02402127|12287025|P6|STARTED|Second Wear Period (1 Day)||4
4993707|NCT02402127|12287026|P5|STARTED|Second Wear Period (1 Day)||4
4993708|NCT02402127|12287027|P4|STARTED|Second Wear Period (1 Day)||4
4993709|NCT02402127|12287028|P3|STARTED|Second Wear Period (1 Day)||4
4993710|NCT02402127|12287029|P2|STARTED|Second Wear Period (1 Day)||4
4993711|NCT02402127|12287030|P1|STARTED|Second Wear Period (1 Day)||4
4993712|NCT02402127|12287025|P6|NOT COMPLETED|First Wear Period (1 Day)||0
4993713|NCT02402127|12287026|P5|NOT COMPLETED|First Wear Period (1 Day)||0
4993714|NCT02402127|12287027|P4|NOT COMPLETED|First Wear Period (1 Day)||0
4993715|NCT02402127|12287028|P3|NOT COMPLETED|First Wear Period (1 Day)||0
4993716|NCT02402127|12287029|P2|NOT COMPLETED|First Wear Period (1 Day)||0
4993717|NCT02402127|12287030|P1|NOT COMPLETED|First Wear Period (1 Day)||0
4993718|NCT02402127|12287025|P6|COMPLETED|First Wear Period (1 Day)||4
4993719|NCT02402127|12287026|P5|COMPLETED|First Wear Period (1 Day)||4
4993720|NCT02402127|12287027|P4|COMPLETED|First Wear Period (1 Day)||4
4993721|NCT02402127|12287028|P3|COMPLETED|First Wear Period (1 Day)||4
4993722|NCT02402127|12287029|P2|COMPLETED|First Wear Period (1 Day)||4
4993723|NCT02402127|12287030|P1|COMPLETED|First Wear Period (1 Day)||4
4993724|NCT02402127|12287025|P6|Randomized and Treated|First Wear Period (1 Day)||4
4993725|NCT02402127|12287026|P5|Randomized and Treated|First Wear Period (1 Day)||4
4993726|NCT02402127|12287027|P4|Randomized and Treated|First Wear Period (1 Day)||4
4993727|NCT02402127|12287028|P3|Randomized and Treated|First Wear Period (1 Day)||4
4993728|NCT02402127|12287029|P2|Randomized and Treated|First Wear Period (1 Day)||4
4993729|NCT02402127|12287030|P1|Randomized and Treated|First Wear Period (1 Day)||4
4993730|NCT02402127|12287025|P6|STARTED|First Wear Period (1 Day)||4
4993731|NCT02402127|12287026|P5|STARTED|First Wear Period (1 Day)||4
4993732|NCT02402127|12287027|P4|STARTED|First Wear Period (1 Day)||4
4993733|NCT02402127|12287028|P3|STARTED|First Wear Period (1 Day)||4
4993734|NCT02402127|12287029|P2|STARTED|First Wear Period (1 Day)||4
4993735|NCT02402127|12287030|P1|STARTED|First Wear Period (1 Day)||4
4993736|NCT02402062|12287041|P1|NOT COMPLETED|Overall Study||0
4993737|NCT02402062|12287041|P1|COMPLETED|Overall Study||17
4993738|NCT02402062|12287041|P1|STARTED|Overall Study||17
4993739|NCT02402036|12287051|P1|NOT COMPLETED|Overall Study||0
4993740|NCT02402036|12287051|P1|COMPLETED|Overall Study||10
4993741|NCT02402036|12287051|P1|STARTED|Overall Study||10
4993742|NCT02401867|12287055|P1|NOT COMPLETED|Analysis||9
4993743|NCT02401867|12287055|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
4993744|NCT02401867|12287055|P1|STARTED|Analysis||140
4993745|NCT02401867|12287055|P1|NOT COMPLETED|Specimen Collection||10
4993746|NCT02401867|12287055|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
4993747|NCT02401867|12287055|P1|STARTED|Specimen Collection||150
4993748|NCT02401867|12287055|P1|NOT COMPLETED|Enrolled||0
4993749|NCT02401867|12287055|P1|COMPLETED|Enrolled||150
4993750|NCT02401867|12287055|P1|STARTED|Enrolled||150
4993751|NCT02401555|12287063|P3|NOT COMPLETED|Overall Study||0
4993752|NCT02401555|12287064|P2|NOT COMPLETED|Overall Study||0
4993753|NCT02401555|12287065|P1|NOT COMPLETED|Overall Study||0
4993754|NCT02401555|12287063|P3|COMPLETED|Overall Study||120
4993755|NCT02401555|12287064|P2|COMPLETED|Overall Study||212
4993756|NCT02401555|12287065|P1|COMPLETED|Overall Study||87
4993757|NCT02401555|12287063|P3|STARTED|Overall Study||120
4993758|NCT02401555|12287064|P2|STARTED|Overall Study||212
4993759|NCT02401555|12287065|P1|STARTED|Overall Study||87
4993760|NCT02401542|12287076|P3|NOT COMPLETED|Overall Study||0
4993761|NCT02401542|12287077|P2|NOT COMPLETED|Overall Study||0
4993762|NCT02401542|12287078|P1|NOT COMPLETED|Overall Study||1
4993763|NCT02401542|12287076|P3|COMPLETED|Overall Study||0
4993764|NCT02401542|12287077|P2|COMPLETED|Overall Study||30
4993765|NCT02401542|12287078|P1|COMPLETED|Overall Study||40
4993766|NCT02401542|12287076|P3|STARTED|Overall Study||0
4993767|NCT02401542|12287077|P2|STARTED|Overall Study||30
4993768|NCT02401542|12287078|P1|STARTED|Overall Study||41
4993769|NCT02401529|12287090|P2|NOT COMPLETED|Overall Study||7
4993770|NCT02401529|12287091|P1|NOT COMPLETED|Overall Study||9
4993771|NCT02401529|12287090|P2|COMPLETED|Overall Study||50
4993772|NCT02401529|12287091|P1|COMPLETED|Overall Study||50
4993773|NCT02401529|12287090|P2|STARTED|Overall Study||57
4993774|NCT02401529|12287091|P1|STARTED|Overall Study||59
4993775|NCT02401464|12287119|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4993776|NCT02401464|12287120|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4993777|NCT02401464|12287121|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4993778|NCT02401464|12287122|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
4993779|NCT02401464|12287119|P4|COMPLETED|Intervention Period 2 (6 Days)||13
4993780|NCT02401464|12287120|P3|COMPLETED|Intervention Period 2 (6 Days)||13
4993781|NCT02401464|12287121|P2|COMPLETED|Intervention Period 2 (6 Days)||13
4993782|NCT02401464|12287122|P1|COMPLETED|Intervention Period 2 (6 Days)||13
4993783|NCT02401464|12287119|P4|STARTED|Intervention Period 2 (6 Days)||13
4993784|NCT02401464|12287120|P3|STARTED|Intervention Period 2 (6 Days)||13
4993785|NCT02401464|12287121|P2|STARTED|Intervention Period 2 (6 Days)||13
4993786|NCT02401464|12287122|P1|STARTED|Intervention Period 2 (6 Days)||13
4993787|NCT02401464|12287119|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
4993788|NCT02401464|12287120|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
4993789|NCT02401464|12287121|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
4993790|NCT02401464|12287122|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
4993791|NCT02401464|12287119|P4|COMPLETED|Washout Period (At Least 6 Days)||13
4993792|NCT02401464|12287120|P3|COMPLETED|Washout Period (At Least 6 Days)||13
4993793|NCT02401464|12287121|P2|COMPLETED|Washout Period (At Least 6 Days)||13
4993794|NCT02401464|12287122|P1|COMPLETED|Washout Period (At Least 6 Days)||13
4993795|NCT02401464|12287119|P4|STARTED|Washout Period (At Least 6 Days)||13
4993796|NCT02401464|12287120|P3|STARTED|Washout Period (At Least 6 Days)||13
4993797|NCT02401464|12287121|P2|STARTED|Washout Period (At Least 6 Days)||13
4993798|NCT02401464|12287122|P1|STARTED|Washout Period (At Least 6 Days)||13
4993799|NCT02401464|12287119|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4993800|NCT02401464|12287120|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4993801|NCT02401464|12287121|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4993802|NCT02401464|12287122|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
4993803|NCT02401464|12287119|P4|COMPLETED|Intervention Period 1 (6 Days)||13
4993804|NCT02401464|12287120|P3|COMPLETED|Intervention Period 1 (6 Days)||13
4993805|NCT02401464|12287121|P2|COMPLETED|Intervention Period 1 (6 Days)||13
4993806|NCT02401464|12287122|P1|COMPLETED|Intervention Period 1 (6 Days)||13
4993807|NCT02401464|12287119|P4|STARTED|Intervention Period 1 (6 Days)||13
4993808|NCT02401464|12287120|P3|STARTED|Intervention Period 1 (6 Days)||13
4993809|NCT02401464|12287121|P2|STARTED|Intervention Period 1 (6 Days)||13
4993810|NCT02401464|12287122|P1|STARTED|Intervention Period 1 (6 Days)||13
4993811|NCT02401412|12287158|P2|NOT COMPLETED|Overall Study||32
4993812|NCT02401412|12287159|P1|NOT COMPLETED|Overall Study||30
4993813|NCT02401412|12287158|P2|COMPLETED|Overall Study||49
4993814|NCT02401412|12287159|P1|COMPLETED|Overall Study||59
4993815|NCT02401412|12287158|P2|Received Study Device|Overall Study||80
4993816|NCT02401412|12287159|P1|Received Study Device|Overall Study||89
4993817|NCT02401412|12287158|P2|STARTED|Overall Study||81
4993818|NCT02401412|12287159|P1|STARTED|Overall Study||89
4993819|NCT02401256|12287167|P1|NOT COMPLETED|Overall Study||17
4993820|NCT02401256|12287167|P1|COMPLETED|Overall Study||53
4993821|NCT02401256|12287167|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
4993822|NCT02401256|12287167|P1|Finished Phase 3|Overall Study||53
4993823|NCT02401256|12287167|P1|Finished Phase 2|Overall Study||58
4993824|NCT02401256|12287167|P1|Finished Phase 1|Overall Study||64
4993825|NCT02401256|12287167|P1|STARTED|Overall Study||70
4993826|NCT02401230|12287176|P3|NOT COMPLETED|Overall Study||4
4993827|NCT02401230|12287177|P2|NOT COMPLETED|Overall Study||6
4993828|NCT02401230|12287178|P1|NOT COMPLETED|Overall Study||6
4993829|NCT02401230|12287176|P3|COMPLETED|Overall Study||21
4993830|NCT02401230|12287177|P2|COMPLETED|Overall Study||19
4993831|NCT02401230|12287178|P1|COMPLETED|Overall Study||20
4993832|NCT02401230|12287176|P3|STARTED|Overall Study||25
4993833|NCT02401230|12287177|P2|STARTED|Overall Study||25
4993834|NCT02401230|12287178|P1|STARTED|Overall Study||26
4993835|NCT02401048|12287213|P2|NOT COMPLETED|Overall Study||30
4993836|NCT02401048|12287214|P1|NOT COMPLETED|Overall Study||22
4993837|NCT02401048|12287213|P2|COMPLETED|Overall Study||4
4993838|NCT02401048|12287214|P1|COMPLETED|Overall Study||5
4993839|NCT02401048|12287213|P2|STARTED|Overall Study||34
4993840|NCT02401048|12287214|P1|STARTED|Overall Study||27
4993841|NCT02401022|12287246|P2|NOT COMPLETED|Overall Study||20
4993842|NCT02401022|12287247|P1|NOT COMPLETED|Overall Study||15
4993843|NCT02401022|12287246|P2|COMPLETED|Overall Study||90
4993844|NCT02401022|12287247|P1|COMPLETED|Overall Study||89
4993845|NCT02401022|12287246|P2|STARTED|Overall Study||110
4993846|NCT02401022|12287247|P1|STARTED|Overall Study||104
4993847|NCT02400996|12287253|P1|NOT COMPLETED|Overall Study||0
4993848|NCT02400996|12287253|P1|COMPLETED|Overall Study||40
4993849|NCT02400996|12287253|P1|STARTED|Overall Study||40
4993850|NCT02400905|12287257|P1|NOT COMPLETED|Overall Study||271
4993851|NCT02400905|12287257|P1|COMPLETED|Overall Study||0
4993852|NCT02400905|12287257|P1|12-month Follow-up|Overall Study||256
4993853|NCT02400905|12287257|P1|STARTED|Overall Study||271
4993854|NCT02400749|12287267|P2|NOT COMPLETED|Week 17 - 32||3
4993855|NCT02400749|12287268|P1|NOT COMPLETED|Week 17 - 32||5
4993856|NCT02400749|12287267|P2|COMPLETED|Week 17 - 32||41
4993857|NCT02400749|12287268|P1|COMPLETED|Week 17 - 32||34
4993858|NCT02400749|12287267|P2|STARTED|Week 17 - 32||44
4993859|NCT02400749|12287268|P1|STARTED|Week 17 - 32||39
4993860|NCT02400749|12287267|P2|NOT COMPLETED|Week 0 -16||6
4993861|NCT02400749|12287268|P1|NOT COMPLETED|Week 0 -16||11
4993862|NCT02400749|12287267|P2|COMPLETED|Week 0 -16||44
4993863|NCT02400749|12287268|P1|COMPLETED|Week 0 -16||39
4993864|NCT02400749|12287267|P2|STARTED|Week 0 -16||50
4993865|NCT02400749|12287268|P1|STARTED|Week 0 -16||50
4993866|NCT02400710|12287284|P2|NOT COMPLETED|Overall Study||0
4993867|NCT02400710|12287285|P1|NOT COMPLETED|Overall Study||0
4993868|NCT02400710|12287284|P2|COMPLETED|Overall Study||10
4993869|NCT02400710|12287285|P1|COMPLETED|Overall Study||10
4993870|NCT02400710|12287284|P2|STARTED|Overall Study||10
4993871|NCT02400710|12287285|P1|STARTED|Overall Study||10
4993872|NCT02400580|12287295|P2|NOT COMPLETED|Overall Study||1
4993873|NCT02400580|12287296|P1|NOT COMPLETED|Overall Study||2
4993874|NCT02400580|12287295|P2|COMPLETED|Overall Study||91
4993875|NCT02400580|12287296|P1|COMPLETED|Overall Study||89
4993876|NCT02400580|12287295|P2|STARTED|Overall Study||92
4993877|NCT02400580|12287296|P1|STARTED|Overall Study||91
4993878|NCT02400346|12287312|P1|NOT COMPLETED|Overall Study||44
4993879|NCT02400346|12287312|P1|COMPLETED|Overall Study||88
4993880|NCT02400346|12287312|P1|STARTED|Overall Study||132
4993881|NCT02400333|12287320|P4|NOT COMPLETED|Overall Study||2
4993882|NCT02400333|12287321|P3|NOT COMPLETED|Overall Study||2
4993883|NCT02400333|12287322|P2|NOT COMPLETED|Overall Study||1
4993884|NCT02400333|12287323|P1|NOT COMPLETED|Overall Study||1
4993885|NCT02400333|12287320|P4|COMPLETED|Overall Study||7
4993886|NCT02400333|12287321|P3|COMPLETED|Overall Study||7
4993887|NCT02400333|12287322|P2|COMPLETED|Overall Study||8
4993888|NCT02400333|12287323|P1|COMPLETED|Overall Study||8
4993889|NCT02400333|12287320|P4|STARTED|Overall Study||9
4993890|NCT02400333|12287321|P3|STARTED|Overall Study||9
4993891|NCT02400333|12287322|P2|STARTED|Overall Study||9
4993892|NCT02400333|12287323|P1|STARTED|Overall Study||9
4993893|NCT02400307|12287383|P2|NOT COMPLETED|Overall Study||0
4993894|NCT02400307|12287384|P1|NOT COMPLETED|Overall Study||1
4993895|NCT02400307|12287383|P2|COMPLETED|Overall Study||8
4993896|NCT02400307|12287384|P1|COMPLETED|Overall Study||10
4993897|NCT02400307|12287383|P2|STARTED|Overall Study||8
4993898|NCT02400307|12287384|P1|STARTED|Overall Study||11
4993899|NCT02400073|12287404|P1|NOT COMPLETED|Overall Study||11
4993900|NCT02400073|12287404|P1|COMPLETED|Overall Study||111
4993901|NCT02400073|12287404|P1|STARTED|Overall Study||122
4993902|NCT02399917|12287412|P3|NOT COMPLETED|Overall Study||0
4993903|NCT02399917|12287413|P2|NOT COMPLETED|Overall Study||0
4993904|NCT02399917|12287414|P1|NOT COMPLETED|Overall Study||0
4993905|NCT02399917|12287412|P3|COMPLETED|Overall Study||24
4993906|NCT02399917|12287413|P2|COMPLETED|Overall Study||6
4993907|NCT02399917|12287414|P1|COMPLETED|Overall Study||6
4993908|NCT02399917|12287412|P3|STARTED|Overall Study||24
4993909|NCT02399917|12287413|P2|STARTED|Overall Study||6
4993910|NCT02399917|12287414|P1|STARTED|Overall Study||6
4993911|NCT02399345|12287432|P1|NOT COMPLETED|Overall Study||0
4993912|NCT02399345|12287432|P1|COMPLETED|Overall Study||10
4993913|NCT02399345|12287432|P1|STARTED|Overall Study||10
4993914|NCT02399254|12287438|P1|NOT COMPLETED|Overall Study||2
4993915|NCT02399254|12287438|P1|COMPLETED|Overall Study||19
4993916|NCT02399254|12287438|P1|STARTED|Overall Study||21
4993917|NCT02399163|12287445|P1|NOT COMPLETED|Overall Study||9
4993918|NCT02399163|12287445|P1|COMPLETED|Overall Study||53
4993919|NCT02399163|12287445|P1|STARTED|Overall Study||62
4993920|NCT02399111|12287473|P4|NOT COMPLETED|Overall Study||0
4993921|NCT02399111|12287474|P3|NOT COMPLETED|Overall Study||0
4993922|NCT02399111|12287475|P2|NOT COMPLETED|Overall Study||0
4993923|NCT02399111|12287476|P1|NOT COMPLETED|Overall Study||0
4993924|NCT02399111|12287473|P4|COMPLETED|Overall Study||0
4993925|NCT02399111|12287474|P3|COMPLETED|Overall Study||4
4993926|NCT02399111|12287475|P2|COMPLETED|Overall Study||1
4993927|NCT02399111|12287476|P1|COMPLETED|Overall Study||4
4993928|NCT02399111|12287473|P4|STARTED|Overall Study||0
4993929|NCT02399111|12287474|P3|STARTED|Overall Study||4
4993930|NCT02399111|12287475|P2|STARTED|Overall Study||1
4993931|NCT02399111|12287476|P1|STARTED|Overall Study||4
4993932|NCT02399085|12287490|P1|NOT COMPLETED|Overall Study||51
4993933|NCT02399085|12287490|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
4993934|NCT02399085|12287490|P1|STARTED|Overall Study||81
4993935|NCT02398409|12287500|P2|NOT COMPLETED|Overall Study||5
4993936|NCT02398409|12287501|P1|NOT COMPLETED|Overall Study||2
4993937|NCT02398409|12287500|P2|COMPLETED|Overall Study||63
4993938|NCT02398409|12287501|P1|COMPLETED|Overall Study||67
4993939|NCT02398409|12287500|P2|STARTED|Overall Study||68
4993940|NCT02398409|12287501|P1|STARTED|Overall Study||69
4993941|NCT02398227|12287515|P2|NOT COMPLETED|Overall Study||18
4993942|NCT02398227|12287516|P1|NOT COMPLETED|Overall Study||27
4993943|NCT02398227|12287515|P2|COMPLETED|Overall Study||71
4993944|NCT02398227|12287516|P1|COMPLETED|Overall Study||56
4993945|NCT02398227|12287515|P2|STARTED|Overall Study||89
4993946|NCT02398227|12287516|P1|STARTED|Overall Study||83
4993947|NCT02398188|12287526|P2|NOT COMPLETED|Overall Study||34
4993948|NCT02398188|12287527|P1|NOT COMPLETED|Overall Study||27
4993949|NCT02398188|12287526|P2|COMPLETED|Overall Study||361
4993950|NCT02398188|12287527|P1|COMPLETED|Overall Study||371
4993951|NCT02398188|12287526|P2|STARTED|Overall Study||395
4993952|NCT02398188|12287527|P1|STARTED|Overall Study||398
4993953|NCT02397954|12287537|P1|NOT COMPLETED|Overall Study||0
4993954|NCT02397954|12287537|P1|COMPLETED|Overall Study||4
4993955|NCT02397954|12287537|P1|STARTED|Overall Study||4
4993956|NCT02397915|12287545|P4|NOT COMPLETED|Period 2||0
4993957|NCT02397915|12287546|P3|NOT COMPLETED|Period 2||0
4993958|NCT02397915|12287547|P2|NOT COMPLETED|Period 2||0
4993959|NCT02397915|12287548|P1|NOT COMPLETED|Period 2||0
4993960|NCT02397915|12287545|P4|COMPLETED|Period 2||149
4993961|NCT02397915|12287546|P3|COMPLETED|Period 2||149
4993962|NCT02397915|12287547|P2|COMPLETED|Period 2||0
4993963|NCT02397915|12287548|P1|COMPLETED|Period 2||0
4993964|NCT02397915|12287545|P4|STARTED|Period 2||149
4993965|NCT02397915|12287546|P3|STARTED|Period 2||149
4993966|NCT02397915|12287547|P2|STARTED|Period 2||0
4993967|NCT02397915|12287548|P1|STARTED|Period 2||0
4993968|NCT02397915|12287545|P4|NOT COMPLETED|Period 1||0
4993969|NCT02397915|12287546|P3|NOT COMPLETED|Period 1||0
4993970|NCT02397915|12287547|P2|NOT COMPLETED|Period 1||1
4993971|NCT02397915|12287548|P1|NOT COMPLETED|Period 1||1
4993972|NCT02397915|12287545|P4|COMPLETED|Period 1||0
4993973|NCT02397915|12287546|P3|COMPLETED|Period 1||0
4993974|NCT02397915|12287547|P2|COMPLETED|Period 1||149
4993975|NCT02397915|12287548|P1|COMPLETED|Period 1||149
4993976|NCT02397915|12287545|P4|STARTED|Period 1||0
4993977|NCT02397915|12287546|P3|STARTED|Period 1||0
4993978|NCT02397915|12287547|P2|STARTED|Period 1||150
4993979|NCT02397915|12287548|P1|STARTED|Period 1||150
4993980|NCT02397837|12287600|P2|NOT COMPLETED|Overall Study||6
4993981|NCT02397837|12287601|P1|NOT COMPLETED|Overall Study||7
4993982|NCT02397837|12287600|P2|COMPLETED|Overall Study||24
4993983|NCT02397837|12287601|P1|COMPLETED|Overall Study||26
4993984|NCT02397837|12287600|P2|STARTED|Overall Study||30
4993985|NCT02397837|12287601|P1|STARTED|Overall Study||33
4993986|NCT02397785|12287627|P2|NOT COMPLETED|Overall Study||9
4993987|NCT02397785|12287628|P1|NOT COMPLETED|Overall Study||2
4993988|NCT02397785|12287627|P2|COMPLETED|Overall Study||25
4993989|NCT02397785|12287628|P1|COMPLETED|Overall Study||22
4993990|NCT02397785|12287627|P2|STARTED|Overall Study||34
4993991|NCT02397785|12287628|P1|STARTED|Overall Study||24
4993992|NCT02397707|12287675|P3|NOT COMPLETED|Overall Study||0
4993993|NCT02397707|12287676|P2|NOT COMPLETED|Overall Study||0
4993994|NCT02397707|12287677|P1|NOT COMPLETED|Overall Study||0
4993995|NCT02397707|12287675|P3|COMPLETED|Overall Study||9
4993996|NCT02397707|12287676|P2|COMPLETED|Overall Study||10
4993997|NCT02397707|12287677|P1|COMPLETED|Overall Study||14
4993998|NCT02397707|12287675|P3|STARTED|Overall Study||9
4993999|NCT02397707|12287676|P2|STARTED|Overall Study||10
4994000|NCT02397707|12287677|P1|STARTED|Overall Study||14
4994001|NCT02397694|12287696|P2|NOT COMPLETED|Open Label Extension Phase||1
4994002|NCT02397694|12287697|P1|NOT COMPLETED|Open Label Extension Phase||8
4994003|NCT02397694|12287696|P2|COMPLETED|Open Label Extension Phase||29
4994004|NCT02397694|12287697|P1|COMPLETED|Open Label Extension Phase||54
4994005|NCT02397694|12287696|P2|STARTED|Open Label Extension Phase||30
4994006|NCT02397694|12287697|P1|STARTED|Open Label Extension Phase||62
4994007|NCT02397694|12287696|P2|NOT COMPLETED|Double-Blinded Phase||3
4994008|NCT02397694|12287697|P1|NOT COMPLETED|Double-Blinded Phase||3
4994009|NCT02397694|12287696|P2|COMPLETED|Double-Blinded Phase||30
4994010|NCT02397694|12287697|P1|COMPLETED|Double-Blinded Phase||62
4994011|NCT02397694|12287696|P2|STARTED|Double-Blinded Phase||33
4994012|NCT02397694|12287697|P1|STARTED|Double-Blinded Phase||65
4994013|NCT02397655|12287735|P1|NOT COMPLETED|Overall Study||1301
4994014|NCT02397655|12287735|P1|COMPLETED|Overall Study||10711
4994015|NCT02397655|12287735|P1|STARTED|Overall Study||12012
4994016|NCT02397564|12287739|P1|NOT COMPLETED|Overall Study||4
4994017|NCT02397564|12287739|P1|COMPLETED|Overall Study||16
4994018|NCT02397564|12287739|P1|STARTED|Overall Study||20
4994019|NCT02397473|12287746|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
4994020|NCT02397473|12287747|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
4994021|NCT02397473|12287746|P2|COMPLETED|Post Treatment Follow-up Phase||45
4994022|NCT02397473|12287747|P1|COMPLETED|Post Treatment Follow-up Phase||47
4994023|NCT02397473|12287746|P2|STARTED|Post Treatment Follow-up Phase||47
4994024|NCT02397473|12287747|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
4994025|NCT02397473|12287746|P2|NOT COMPLETED|Treatment Phase||7
4994026|NCT02397473|12287747|P1|NOT COMPLETED|Treatment Phase||12
4994027|NCT02397473|12287746|P2|COMPLETED|Treatment Phase||45
4994028|NCT02397473|12287747|P1|COMPLETED|Treatment Phase||45
4994029|NCT02397473|12287746|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
4994030|NCT02397473|12287747|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
4994031|NCT02397473|12287746|P2|STARTED|Treatment Phase||52
4994032|NCT02397473|12287747|P1|STARTED|Treatment Phase||57
4994033|NCT02397265|12287775|P3|NOT COMPLETED|Third Intervention of Three||0
4994034|NCT02397265|12287776|P2|NOT COMPLETED|Third Intervention of Three||0
4994035|NCT02397265|12287777|P1|NOT COMPLETED|Third Intervention of Three||0
4994036|NCT02397265|12287775|P3|COMPLETED|Third Intervention of Three||2
4994037|NCT02397265|12287776|P2|COMPLETED|Third Intervention of Three||2
4994038|NCT02397265|12287777|P1|COMPLETED|Third Intervention of Three||2
4994039|NCT02397265|12287775|P3|STARTED|Third Intervention of Three||2
4994040|NCT02397265|12287776|P2|STARTED|Third Intervention of Three||2
4994041|NCT02397265|12287777|P1|STARTED|Third Intervention of Three||2
4994042|NCT02397265|12287775|P3|NOT COMPLETED|Second Intervention of Three||0
4994043|NCT02397265|12287776|P2|NOT COMPLETED|Second Intervention of Three||0
4994044|NCT02397265|12287777|P1|NOT COMPLETED|Second Intervention of Three||0
4994045|NCT02397265|12287775|P3|COMPLETED|Second Intervention of Three||2
4994046|NCT02397265|12287776|P2|COMPLETED|Second Intervention of Three||2
4994047|NCT02397265|12287777|P1|COMPLETED|Second Intervention of Three||2
4994048|NCT02397265|12287775|P3|STARTED|Second Intervention of Three||2
4994049|NCT02397265|12287776|P2|STARTED|Second Intervention of Three||2
4994050|NCT02397265|12287777|P1|STARTED|Second Intervention of Three||2
4994051|NCT02397265|12287775|P3|NOT COMPLETED|First Intervention of Three||0
4994052|NCT02397265|12287776|P2|NOT COMPLETED|First Intervention of Three||0
4994053|NCT02397265|12287777|P1|NOT COMPLETED|First Intervention of Three||0
4994054|NCT02397265|12287775|P3|COMPLETED|First Intervention of Three||2
4994055|NCT02397265|12287776|P2|COMPLETED|First Intervention of Three||2
4994056|NCT02397265|12287777|P1|COMPLETED|First Intervention of Three||2
4994057|NCT02397265|12287775|P3|STARTED|First Intervention of Three||2
4994058|NCT02397265|12287776|P2|STARTED|First Intervention of Three||2
4994059|NCT02397265|12287777|P1|STARTED|First Intervention of Three||2
4994060|NCT02397122|12287787|P2|NOT COMPLETED|Overall Study||0
4994061|NCT02397122|12287788|P1|NOT COMPLETED|Overall Study||0
4994062|NCT02397122|12287787|P2|COMPLETED|Overall Study||20
4994063|NCT02397122|12287788|P1|COMPLETED|Overall Study||20
4994064|NCT02397122|12287787|P2|STARTED|Overall Study||20
4994065|NCT02397122|12287788|P1|STARTED|Overall Study||20
4994066|NCT02397096|12287806|P2|NOT COMPLETED|Study Extensions||202
4994067|NCT02397096|12287807|P1|NOT COMPLETED|Study Extensions||399
4994068|NCT02397096|12287806|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
4994069|NCT02397096|12287807|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
4994070|NCT02397096|12287806|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
4994071|NCT02397096|12287807|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
4994072|NCT02397096|12287806|P2|NOT COMPLETED|Week 24 to Week 48||7
4994073|NCT02397096|12287807|P1|NOT COMPLETED|Week 24 to Week 48||20
4994074|NCT02397096|12287806|P2|COMPLETED|Week 24 to Week 48||202
4994075|NCT02397096|12287807|P1|COMPLETED|Week 24 to Week 48||407
4994076|NCT02397096|12287806|P2|STARTED|Week 24 to Week 48||209
4994077|NCT02397096|12287807|P1|STARTED|Week 24 to Week 48||427
4994078|NCT02397096|12287806|P2|NOT COMPLETED|Day 1 to Week 24||14
4994079|NCT02397096|12287807|P1|NOT COMPLETED|Day 1 to Week 24||20
4994080|NCT02397096|12287806|P2|COMPLETED|Day 1 to Week 24||209
4994081|NCT02397096|12287807|P1|COMPLETED|Day 1 to Week 24||427
4994082|NCT02397096|12287806|P2|STARTED|Day 1 to Week 24||223
4994083|NCT02397096|12287807|P1|STARTED|Day 1 to Week 24||447
4994084|NCT02396953|12287840|P3|NOT COMPLETED|Overall Study||3
4994085|NCT02396953|12287841|P2|NOT COMPLETED|Overall Study||3
4994086|NCT02396953|12287842|P1|NOT COMPLETED|Overall Study||4
4994087|NCT02396953|12287840|P3|COMPLETED|Overall Study||7
4994088|NCT02396953|12287841|P2|COMPLETED|Overall Study||6
4994089|NCT02396953|12287842|P1|COMPLETED|Overall Study||5
4994090|NCT02396953|12287840|P3|STARTED|Overall Study||10
4994091|NCT02396953|12287841|P2|STARTED|Overall Study||9
4994092|NCT02396953|12287842|P1|STARTED|Overall Study||9
4994093|NCT02396745|12287892|P1|NOT COMPLETED|Overall Study||0
4994094|NCT02396745|12287892|P1|COMPLETED|Overall Study||1
4994095|NCT02396745|12287892|P1|STARTED|Overall Study||1
4994096|NCT02396732|12287904|P2|NOT COMPLETED|Overall Study||0
4994097|NCT02396732|12287905|P1|NOT COMPLETED|Overall Study||0
4994098|NCT02396732|12287904|P2|COMPLETED|Overall Study||17
4994099|NCT02396732|12287905|P1|COMPLETED|Overall Study||14
4994100|NCT02396732|12287904|P2|STARTED|Overall Study||17
4994101|NCT02396732|12287905|P1|STARTED|Overall Study||14
4994102|NCT02396537|12287917|P2|NOT COMPLETED|Overall Study||1
4994103|NCT02396537|12287918|P1|NOT COMPLETED|Overall Study||0
4994104|NCT02396537|12287917|P2|COMPLETED|Overall Study||36
4994105|NCT02396537|12287918|P1|COMPLETED|Overall Study||40
4994106|NCT02396537|12287917|P2|STARTED|Overall Study||37
4994107|NCT02396537|12287918|P1|STARTED|Overall Study||40
4994108|NCT02396511|12287924|P1|NOT COMPLETED|Overall Study||0
4994109|NCT02396511|12287924|P1|COMPLETED|Overall Study||2
4994110|NCT02396511|12287924|P1|STARTED|Overall Study||2
4994111|NCT02396420|12287930|P1|NOT COMPLETED|Overall Study||1
4994112|NCT02396420|12287930|P1|COMPLETED|Overall Study||1
4994113|NCT02396420|12287930|P1|6 Months Post PAE|Overall Study||2
4994114|NCT02396420|12287930|P1|3 Months Post PAE|Overall Study||2
4994115|NCT02396420|12287930|P1|1 Month Post PAE|Overall Study||2
4994116|NCT02396420|12287930|P1|STARTED|Overall Study||2
4994117|NCT02396381|12287954|P2|NOT COMPLETED|Overall Study||74
4994118|NCT02396381|12287955|P1|NOT COMPLETED|Overall Study||107
4994119|NCT02396381|12287954|P2|COMPLETED|Overall Study||422
4994120|NCT02396381|12287955|P1|COMPLETED|Overall Study||381
4994121|NCT02396381|12287954|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
4994122|NCT02396381|12287955|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
4994123|NCT02396381|12287954|P2|STARTED|Overall Study||496
4994124|NCT02396381|12287955|P1|STARTED|Overall Study||488
4994125|NCT02396316|12287994|P2|NOT COMPLETED|Overall Study||5
4994126|NCT02396316|12287995|P1|NOT COMPLETED|Overall Study||7
4994127|NCT02396316|12287994|P2|COMPLETED|Overall Study||22
4994128|NCT02396316|12287995|P1|COMPLETED|Overall Study||20
4994129|NCT02396316|12287994|P2|Received Active Injection at Week 9|Overall Study||1
4994130|NCT02396316|12287995|P1|Received Active Injection at Week 9|Overall Study||2
4994131|NCT02396316|12287994|P2|Received Active Injection at Week 5|Overall Study||4
4994132|NCT02396316|12287995|P1|Received Active Injection at Week 5|Overall Study||4
4994133|NCT02396316|12287994|P2|Received AFL Injection at Week 1|Overall Study||22
4994134|NCT02396316|12287995|P1|Received AFL Injection at Week 1|Overall Study||0
4994135|NCT02396316|12287994|P2|Received Sham Injection at Week 1|Overall Study||0
4994136|NCT02396316|12287995|P1|Received Sham Injection at Week 1|Overall Study||10
4994137|NCT02396316|12287994|P2|Treated|Overall Study||27
4994138|NCT02396316|12287995|P1|Treated|Overall Study||27
4994139|NCT02396316|12287994|P2|STARTED|Overall Study||27
4994140|NCT02396316|12287995|P1|STARTED|Overall Study||27
4994141|NCT02396251|12288007|P2|NOT COMPLETED|Overall Study||5
4994142|NCT02396251|12288008|P1|NOT COMPLETED|Overall Study||13
4994143|NCT02396251|12288007|P2|COMPLETED|Overall Study||7
4994144|NCT02396251|12288008|P1|COMPLETED|Overall Study||23
4994145|NCT02396251|12288007|P2|STARTED|Overall Study||12
4994146|NCT02396251|12288008|P1|STARTED|Overall Study||36
4994147|NCT02396212|12288014|P1|NOT COMPLETED|Overall Study||3
4994148|NCT02396212|12288014|P1|COMPLETED|Overall Study||16
4994149|NCT02396212|12288014|P1|STARTED|Overall Study||19
4994150|NCT02396160|12288035|P2|NOT COMPLETED|Overall Study||2
4994151|NCT02396160|12288036|P1|NOT COMPLETED|Overall Study||6
4994152|NCT02396160|12288035|P2|COMPLETED|Overall Study||73
4994153|NCT02396160|12288036|P1|COMPLETED|Overall Study||69
4994154|NCT02396160|12288035|P2|STARTED|Overall Study||75
4994155|NCT02396160|12288036|P1|STARTED|Overall Study||75
4994156|NCT02396147|12288052|P2|NOT COMPLETED|Period 3||0
4994157|NCT02396147|12288053|P1|NOT COMPLETED|Period 3||0
4994158|NCT02396147|12288052|P2|COMPLETED|Period 3||27
4994159|NCT02396147|12288053|P1|COMPLETED|Period 3||27
4994160|NCT02396147|12288052|P2|STARTED|Period 3||27
4994161|NCT02396147|12288053|P1|STARTED|Period 3||27
4994162|NCT02396147|12288052|P2|NOT COMPLETED|Period 2||0
4994163|NCT02396147|12288053|P1|NOT COMPLETED|Period 2||0
4994164|NCT02396147|12288052|P2|COMPLETED|Period 2||27
4994165|NCT02396147|12288053|P1|COMPLETED|Period 2||27
4994166|NCT02396147|12288052|P2|STARTED|Period 2||27
4994167|NCT02396147|12288053|P1|STARTED|Period 2||27
4994168|NCT02396147|12288052|P2|NOT COMPLETED|Period 1||0
4994169|NCT02396147|12288053|P1|NOT COMPLETED|Period 1||0
4994170|NCT02396147|12288052|P2|COMPLETED|Period 1||27
4994171|NCT02396147|12288053|P1|COMPLETED|Period 1||27
4994172|NCT02396147|12288052|P2|STARTED|Period 1||27
4994173|NCT02396147|12288053|P1|STARTED|Period 1||27
4994174|NCT02395822|12288121|P1|NOT COMPLETED|Overall Study||2
4994175|NCT02395822|12288121|P1|COMPLETED|Overall Study||15
4994176|NCT02395822|12288121|P1|STARTED|Overall Study||17
4994177|NCT02395692|12288129|P2|NOT COMPLETED|Overall Study||0
4994178|NCT02395692|12288130|P1|NOT COMPLETED|Overall Study||0
4994179|NCT02395692|12288129|P2|COMPLETED|Overall Study||0
4994180|NCT02395692|12288130|P1|COMPLETED|Overall Study||19
4994181|NCT02395692|12288129|P2|STARTED|Overall Study||0
4994182|NCT02395692|12288130|P1|STARTED|Overall Study||19
4994183|NCT02395666|12288142|P2|NOT COMPLETED|Overall Study||1
4994184|NCT02395666|12288143|P1|NOT COMPLETED|Overall Study||6
4994185|NCT02395666|12288142|P2|COMPLETED|Overall Study||38
4994186|NCT02395666|12288143|P1|COMPLETED|Overall Study||95
4994187|NCT02395666|12288142|P2|STARTED|Overall Study||39
4994188|NCT02395666|12288143|P1|STARTED|Overall Study||101
4994189|NCT02395653|12288157|P1|NOT COMPLETED|Overall Study||12
4994190|NCT02395653|12288157|P1|COMPLETED|Overall Study||59
4994191|NCT02395653|12288157|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
4994192|NCT02395653|12288157|P1|STARTED|Overall Study||71
4994193|NCT02395627|12288167|P3|NOT COMPLETED|Overall Study||0
4994194|NCT02395627|12288168|P2|NOT COMPLETED|Overall Study||3
4994195|NCT02395627|12288169|P1|NOT COMPLETED|Overall Study||3
4994196|NCT02395627|12288167|P3|COMPLETED|Overall Study||4
4994197|NCT02395627|12288168|P2|COMPLETED|Overall Study||13
4994198|NCT02395627|12288169|P1|COMPLETED|Overall Study||15
4994199|NCT02395627|12288167|P3|STARTED|Overall Study||4
4994200|NCT02395627|12288168|P2|STARTED|Overall Study||16
4994201|NCT02395627|12288169|P1|STARTED|Overall Study||18
4994202|NCT02395536|12288197|P2|NOT COMPLETED|Overall Study||30
4994203|NCT02395536|12288198|P1|NOT COMPLETED|Overall Study||20
4994204|NCT02395536|12288197|P2|COMPLETED|Overall Study||227
4994205|NCT02395536|12288198|P1|COMPLETED|Overall Study||244
4994206|NCT02395536|12288197|P2|REVEAL LINQ Insertion|Overall Study||231
4994207|NCT02395536|12288198|P1|REVEAL LINQ Insertion|Overall Study||251
4994208|NCT02395536|12288197|P2|STARTED|Overall Study||257
4994209|NCT02395536|12288198|P1|STARTED|Overall Study||264
4994210|NCT02395471|12288206|P2|NOT COMPLETED|Overall Study||3
4994211|NCT02395471|12288207|P1|NOT COMPLETED|Overall Study||7
4994212|NCT02395471|12288206|P2|COMPLETED|Overall Study||59
4994213|NCT02395471|12288207|P1|COMPLETED|Overall Study||122
4994214|NCT02395471|12288206|P2|STARTED|Overall Study||62
4994215|NCT02395471|12288207|P1|STARTED|Overall Study||129
4994216|NCT02395302|12288222|P1|NOT COMPLETED|Overall Study||14
4994217|NCT02395302|12288222|P1|COMPLETED|Overall Study||14
4994218|NCT02395302|12288222|P1|STARTED|Overall Study||28
4994219|NCT02395185|12288226|P1|NOT COMPLETED|Overall Study||0
4994220|NCT02395185|12288226|P1|COMPLETED|Overall Study||33
4994221|NCT02395185|12288226|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
4994222|NCT02395185|12288226|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
4994223|NCT02395185|12288226|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
4994224|NCT02395185|12288226|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
4994225|NCT02395185|12288226|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
4994226|NCT02395185|12288226|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
4994227|NCT02395185|12288226|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
4994228|NCT02395185|12288226|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
4994229|NCT02395185|12288226|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
4994230|NCT02395185|12288226|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
4994231|NCT02395185|12288226|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
4994232|NCT02395185|12288226|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
4994233|NCT02395185|12288226|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
4994234|NCT02395185|12288226|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
4994235|NCT02395185|12288226|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
4994236|NCT02395185|12288226|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
4994237|NCT02395185|12288226|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
4994238|NCT02395185|12288226|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
4994239|NCT02395185|12288226|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
4994240|NCT02395172|12288242|P2|NOT COMPLETED|Overall Study||36
4994241|NCT02395172|12288243|P1|NOT COMPLETED|Overall Study||52
4994242|NCT02395172|12288242|P2|COMPLETED|Overall Study||360
4994243|NCT02395172|12288243|P1|COMPLETED|Overall Study||344
4994244|NCT02395172|12288242|P2|Treated|Overall Study||365
4994245|NCT02395172|12288243|P1|Treated|Overall Study||393
4994246|NCT02395172|12288242|P2|STARTED|Overall Study||396
4994247|NCT02395172|12288243|P1|STARTED|Overall Study||396
4994248|NCT02395133|12288282|P4|NOT COMPLETED|Overall Study||14
4994249|NCT02395133|12288283|P3|NOT COMPLETED|Overall Study||10
4994250|NCT02395133|12288284|P2|NOT COMPLETED|Overall Study||9
4994251|NCT02395133|12288285|P1|NOT COMPLETED|Overall Study||14
4994252|NCT02395133|12288282|P4|COMPLETED|Overall Study||155
4994253|NCT02395133|12288283|P3|COMPLETED|Overall Study||76
4994254|NCT02395133|12288284|P2|COMPLETED|Overall Study||75
4994255|NCT02395133|12288285|P1|COMPLETED|Overall Study||69
4994256|NCT02395133|12288282|P4|STARTED|Overall Study||169
4994257|NCT02395133|12288283|P3|STARTED|Overall Study||86
4994258|NCT02395133|12288284|P2|STARTED|Overall Study||84
4994259|NCT02395133|12288285|P1|STARTED|Overall Study||83
4994260|NCT02395055|12288373|P2|NOT COMPLETED|Overall Study||3
4994261|NCT02395055|12288374|P1|NOT COMPLETED|Overall Study||7
4994262|NCT02395055|12288373|P2|COMPLETED|Overall Study||44
4994263|NCT02395055|12288374|P1|COMPLETED|Overall Study||40
4994264|NCT02395055|12288373|P2|STARTED|Overall Study||47
4994265|NCT02395055|12288374|P1|STARTED|Overall Study||47
4994266|NCT02395042|12288387|P3|NOT COMPLETED|Treatment 2 Period||0
4994267|NCT02395042|12288388|P2|NOT COMPLETED|Treatment 2 Period||1
4994268|NCT02395042|12288389|P1|NOT COMPLETED|Treatment 2 Period||1
4994269|NCT02395042|12288387|P3|COMPLETED|Treatment 2 Period||13
4994270|NCT02395042|12288388|P2|COMPLETED|Treatment 2 Period||23
4994271|NCT02395042|12288389|P1|COMPLETED|Treatment 2 Period||9
4994272|NCT02395042|12288387|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
4994273|NCT02395042|12288388|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
4994274|NCT02395042|12288389|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
4994275|NCT02395042|12288387|P3|NOT COMPLETED|Treatment 1 Period||2
4994276|NCT02395042|12288388|P2|NOT COMPLETED|Treatment 1 Period||6
4994277|NCT02395042|12288389|P1|NOT COMPLETED|Treatment 1 Period||3
4994278|NCT02395042|12288387|P3|COMPLETED|Treatment 1 Period||14
4994279|NCT02395042|12288388|P2|COMPLETED|Treatment 1 Period||25
4994280|NCT02395042|12288389|P1|COMPLETED|Treatment 1 Period||9
4994281|NCT02395042|12288387|P3|STARTED|Treatment 1 Period||16
4994282|NCT02395042|12288388|P2|STARTED|Treatment 1 Period||31
4994283|NCT02395042|12288389|P1|STARTED|Treatment 1 Period||12
4994284|NCT02394951|12288408|P2|NOT COMPLETED|Period II||4
4994285|NCT02394951|12288409|P1|NOT COMPLETED|Period II||0
4994286|NCT02394951|12288408|P2|COMPLETED|Period II||9
4994287|NCT02394951|12288409|P1|COMPLETED|Period II||11
4994288|NCT02394951|12288408|P2|STARTED|Period II||13
4994289|NCT02394951|12288409|P1|STARTED|Period II||11
4994290|NCT02394951|12288408|P2|NOT COMPLETED|Period I||1
4994291|NCT02394951|12288409|P1|NOT COMPLETED|Period I||1
4994292|NCT02394951|12288408|P2|COMPLETED|Period I||13
4994293|NCT02394951|12288409|P1|COMPLETED|Period I||11
4994294|NCT02394951|12288408|P2|STARTED|Period I||14
4994295|NCT02394951|12288409|P1|STARTED|Period I||12
4994296|NCT02394925|12288427|P1|NOT COMPLETED|Overall Study||29
4994297|NCT02394925|12288427|P1|COMPLETED|Overall Study||79
4994298|NCT02394925|12288427|P1|STARTED|Overall Study||108
4994299|NCT02394912|12288431|P1|NOT COMPLETED|Overall Study||0
4994300|NCT02394912|12288431|P1|COMPLETED|Overall Study||21
4994301|NCT02394912|12288431|P1|STARTED|Overall Study||21
4994302|NCT02394808|12288437|P2|NOT COMPLETED|Period 2||0
4994303|NCT02394808|12288438|P1|NOT COMPLETED|Period 2||1
4994304|NCT02394808|12288437|P2|COMPLETED|Period 2||28
4994305|NCT02394808|12288438|P1|COMPLETED|Period 2||24
4994306|NCT02394808|12288437|P2|STARTED|Period 2||28
4994307|NCT02394808|12288438|P1|STARTED|Period 2||25
4994308|NCT02394808|12288437|P2|NOT COMPLETED|Period 1||1
4994309|NCT02394808|12288438|P1|NOT COMPLETED|Period 1||0
4994310|NCT02394808|12288437|P2|COMPLETED|Period 1||28
4994311|NCT02394808|12288438|P1|COMPLETED|Period 1||25
4994312|NCT02394808|12288437|P2|STARTED|Period 1||29
4994313|NCT02394808|12288438|P1|STARTED|Period 1||25
4994314|NCT02394756|12288446|P6|NOT COMPLETED|Period 3||0
4994315|NCT02394756|12288447|P5|NOT COMPLETED|Period 3||0
4994316|NCT02394756|12288448|P4|NOT COMPLETED|Period 3||0
4994317|NCT02394756|12288449|P3|NOT COMPLETED|Period 3||0
4994318|NCT02394756|12288450|P2|NOT COMPLETED|Period 3||0
4994319|NCT02394756|12288451|P1|NOT COMPLETED|Period 3||0
4994320|NCT02394756|12288446|P6|COMPLETED|Period 3||6
4994321|NCT02394756|12288447|P5|COMPLETED|Period 3||6
4994322|NCT02394756|12288448|P4|COMPLETED|Period 3||6
4994323|NCT02394756|12288449|P3|COMPLETED|Period 3||6
4994324|NCT02394756|12288450|P2|COMPLETED|Period 3||6
4994325|NCT02394756|12288451|P1|COMPLETED|Period 3||7
4994326|NCT02394756|12288446|P6|STARTED|Period 3||6
4994327|NCT02394756|12288447|P5|STARTED|Period 3||6
4994328|NCT02394756|12288448|P4|STARTED|Period 3||6
4994329|NCT02394756|12288449|P3|STARTED|Period 3||6
4994330|NCT02394756|12288450|P2|STARTED|Period 3||6
4994331|NCT02394756|12288451|P1|STARTED|Period 3||7
4994332|NCT02394756|12288446|P6|NOT COMPLETED|Period 2||0
4994333|NCT02394756|12288447|P5|NOT COMPLETED|Period 2||1
4994334|NCT02394756|12288448|P4|NOT COMPLETED|Period 2||0
4994335|NCT02394756|12288449|P3|NOT COMPLETED|Period 2||0
4994336|NCT02394756|12288450|P2|NOT COMPLETED|Period 2||0
4994337|NCT02394756|12288451|P1|NOT COMPLETED|Period 2||0
4994338|NCT02394756|12288446|P6|COMPLETED|Period 2||6
4994339|NCT02394756|12288447|P5|COMPLETED|Period 2||6
4994340|NCT02394756|12288448|P4|COMPLETED|Period 2||6
4994341|NCT02394756|12288449|P3|COMPLETED|Period 2||6
4994342|NCT02394756|12288450|P2|COMPLETED|Period 2||6
4994343|NCT02394756|12288451|P1|COMPLETED|Period 2||7
4994344|NCT02394756|12288446|P6|STARTED|Period 2||6
4994345|NCT02394756|12288447|P5|STARTED|Period 2||7
4994346|NCT02394756|12288448|P4|STARTED|Period 2||6
4994347|NCT02394756|12288449|P3|STARTED|Period 2||6
4994348|NCT02394756|12288450|P2|STARTED|Period 2||6
4994349|NCT02394756|12288451|P1|STARTED|Period 2||7
4994350|NCT02394756|12288446|P6|NOT COMPLETED|Period 1||1
4994351|NCT02394756|12288447|P5|NOT COMPLETED|Period 1||0
4994352|NCT02394756|12288448|P4|NOT COMPLETED|Period 1||1
4994353|NCT02394756|12288449|P3|NOT COMPLETED|Period 1||1
4994354|NCT02394756|12288450|P2|NOT COMPLETED|Period 1||1
4994355|NCT02394756|12288451|P1|NOT COMPLETED|Period 1||0
4994356|NCT02394756|12288446|P6|COMPLETED|Period 1||6
4994357|NCT02394756|12288447|P5|COMPLETED|Period 1||7
4994358|NCT02394756|12288448|P4|COMPLETED|Period 1||6
4994359|NCT02394756|12288449|P3|COMPLETED|Period 1||6
4994360|NCT02394756|12288450|P2|COMPLETED|Period 1||6
4994361|NCT02394756|12288451|P1|COMPLETED|Period 1||7
4994362|NCT02394756|12288446|P6|STARTED|Period 1||7
4994363|NCT02394756|12288447|P5|STARTED|Period 1||7
4994364|NCT02394756|12288448|P4|STARTED|Period 1||7
4994365|NCT02394756|12288449|P3|STARTED|Period 1||7
4994366|NCT02394756|12288450|P2|STARTED|Period 1||7
4994367|NCT02394756|12288451|P1|STARTED|Period 1||7
4994368|NCT02394730|12288464|P2|NOT COMPLETED|Overall Study||1
4994369|NCT02394730|12288465|P1|NOT COMPLETED|Overall Study||1
4994370|NCT02394730|12288464|P2|COMPLETED|Overall Study||30
4994371|NCT02394730|12288465|P1|COMPLETED|Overall Study||33
4994372|NCT02394730|12288464|P2|STARTED|Overall Study||31
4994373|NCT02394730|12288465|P1|STARTED|Overall Study||34
4994374|NCT02394665|12288502|P3|NOT COMPLETED|Overall Study||0
4994375|NCT02394665|12288503|P2|NOT COMPLETED|Overall Study||0
4994376|NCT02394665|12288504|P1|NOT COMPLETED|Overall Study||1
4994377|NCT02394665|12288502|P3|COMPLETED|Overall Study||0
4994378|NCT02394665|12288503|P2|COMPLETED|Overall Study||0
4994379|NCT02394665|12288504|P1|COMPLETED|Overall Study||0
4994380|NCT02394665|12288502|P3|STARTED|Overall Study||0
4994381|NCT02394665|12288503|P2|STARTED|Overall Study||0
4994382|NCT02394665|12288504|P1|STARTED|Overall Study||1
4994383|NCT02394600|12288526|P2|NOT COMPLETED|Overall Study||2
4994384|NCT02394600|12288527|P1|NOT COMPLETED|Overall Study||4
4994385|NCT02394600|12288526|P2|COMPLETED|Overall Study||44
4994386|NCT02394600|12288527|P1|COMPLETED|Overall Study||43
4994387|NCT02394600|12288526|P2|STARTED|Overall Study||46
4994388|NCT02394600|12288527|P1|STARTED|Overall Study||47
4994389|NCT02394561|12288537|P2|NOT COMPLETED|Extension Phase||12
4994390|NCT02394561|12288538|P1|NOT COMPLETED|Extension Phase||11
4994391|NCT02394561|12288537|P2|COMPLETED|Extension Phase||207
4994392|NCT02394561|12288538|P1|COMPLETED|Extension Phase||151
4994393|NCT02394561|12288537|P2|STARTED|Extension Phase||219
4994394|NCT02394561|12288538|P1|STARTED|Extension Phase||162
4994395|NCT02394561|12288537|P2|NOT COMPLETED|CORE Phase||19
4994396|NCT02394561|12288538|P1|NOT COMPLETED|CORE Phase||13
4994397|NCT02394561|12288537|P2|COMPLETED|CORE Phase||227
4994398|NCT02394561|12288538|P1|COMPLETED|CORE Phase||172
4994399|NCT02394561|12288537|P2|ITT Set|CORE Phase||246
4994400|NCT02394561|12288538|P1|ITT Set|CORE Phase||184
4994401|NCT02394561|12288537|P2|Safety Set|CORE Phase||246
4994402|NCT02394561|12288538|P1|Safety Set|CORE Phase||185
4994403|NCT02394561|12288537|P2|Full Analysis Set|CORE Phase||246
4994404|NCT02394561|12288538|P1|Full Analysis Set|CORE Phase||185
4994405|NCT02394561|12288537|P2|STARTED|CORE Phase||246
4994406|NCT02394561|12288538|P1|STARTED|CORE Phase||185
4994407|NCT02394548|12288560|P1|NOT COMPLETED|Overall Study||1
4994408|NCT02394548|12288560|P1|COMPLETED|Overall Study||25
4994409|NCT02394548|12288560|P1|STARTED|Overall Study||26
4994410|NCT02394457|12288568|P2|NOT COMPLETED|Overall Study||0
4994411|NCT02394457|12288569|P1|NOT COMPLETED|Overall Study||0
4994412|NCT02394457|12288568|P2|COMPLETED|Overall Study||13
4994413|NCT02394457|12288569|P1|COMPLETED|Overall Study||15
4994414|NCT02394457|12288568|P2|STARTED|Overall Study||13
4994415|NCT02394457|12288569|P1|STARTED|Overall Study||15
4994416|NCT02394340|12288585|P1|NOT COMPLETED|Overall Study||2
4994417|NCT02394340|12288585|P1|COMPLETED|Overall Study||18
4994418|NCT02394340|12288585|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
4994419|NCT02394340|12288585|P1|STARTED|Overall Study||20
4994420|NCT02393950|12288592|P2|NOT COMPLETED|Overall Study||1
4994421|NCT02393950|12288593|P1|NOT COMPLETED|Overall Study||1
4994422|NCT02393950|12288592|P2|COMPLETED|Overall Study||8
4994423|NCT02393950|12288593|P1|COMPLETED|Overall Study||8
4994424|NCT02393950|12288592|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
4994425|NCT02393950|12288593|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
4994426|NCT02393950|12288592|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
4994427|NCT02393950|12288593|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
4994428|NCT02393950|12288592|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
4994429|NCT02393950|12288593|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
4994430|NCT02393950|12288592|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
4994431|NCT02393950|12288593|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
4994432|NCT02393950|12288592|P2|STARTED|Overall Study||9
4994433|NCT02393950|12288593|P1|STARTED|Overall Study||9
4994434|NCT02393859|12288660|P2|NOT COMPLETED|Overall Study||54
4994435|NCT02393859|12288661|P1|NOT COMPLETED|Overall Study||54
4994436|NCT02393859|12288660|P2|COMPLETED|Overall Study||0
4994437|NCT02393859|12288661|P1|COMPLETED|Overall Study||0
4994438|NCT02393859|12288660|P2|STARTED|Overall Study||54
4994439|NCT02393859|12288661|P1|STARTED|Overall Study||54
4994440|NCT02393755|12288686|P2|NOT COMPLETED|Overall Study||7
4994441|NCT02393755|12288687|P1|NOT COMPLETED|Overall Study||0
4994442|NCT02393755|12288686|P2|COMPLETED|Overall Study||32
4994443|NCT02393755|12288687|P1|COMPLETED|Overall Study||3
4994444|NCT02393755|12288686|P2|STARTED|Overall Study||39
4994445|NCT02393755|12288687|P1|STARTED|Overall Study||3
4994446|NCT02393677|12288699|P2|NOT COMPLETED|Overall Study||0
4994447|NCT02393677|12288700|P1|NOT COMPLETED|Overall Study||0
4994448|NCT02393677|12288699|P2|COMPLETED|Overall Study||40
4994449|NCT02393677|12288700|P1|COMPLETED|Overall Study||40
4994450|NCT02393677|12288699|P2|STARTED|Overall Study||40
4994451|NCT02393677|12288700|P1|STARTED|Overall Study||40
4994452|NCT02393547|12288706|P1|NOT COMPLETED|Overall Study||6
4994453|NCT02393547|12288706|P1|COMPLETED|Overall Study||14
4994454|NCT02393547|12288706|P1|STARTED|Overall Study||20
4994455|NCT02393417|12288717|P4|NOT COMPLETED|Overall Study||12
4994456|NCT02393417|12288718|P3|NOT COMPLETED|Overall Study||10
4994457|NCT02393417|12288719|P2|NOT COMPLETED|Overall Study||13
4994458|NCT02393417|12288720|P1|NOT COMPLETED|Overall Study||15
4994459|NCT02393417|12288717|P4|COMPLETED|Overall Study||29
4994460|NCT02393417|12288718|P3|COMPLETED|Overall Study||30
4994461|NCT02393417|12288719|P2|COMPLETED|Overall Study||32
4994462|NCT02393417|12288720|P1|COMPLETED|Overall Study||28
4994463|NCT02393417|12288717|P4|Completed Treatment|Overall Study||30
4994464|NCT02393417|12288718|P3|Completed Treatment|Overall Study||32
4994465|NCT02393417|12288719|P2|Completed Treatment|Overall Study||34
4994466|NCT02393417|12288720|P1|Completed Treatment|Overall Study||30
4994467|NCT02393417|12288717|P4|STARTED|Overall Study||41
4994468|NCT02393417|12288718|P3|STARTED|Overall Study||40
4994469|NCT02393417|12288719|P2|STARTED|Overall Study||45
4994470|NCT02393417|12288720|P1|STARTED|Overall Study||43
4994471|NCT02393378|12288778|P2|NOT COMPLETED|Overall Study||0
4994472|NCT02393378|12288779|P1|NOT COMPLETED|Overall Study||0
4994473|NCT02393378|12288778|P2|COMPLETED|Overall Study||4
4994474|NCT02393378|12288779|P1|COMPLETED|Overall Study||3
4994475|NCT02393378|12288778|P2|STARTED|Overall Study||4
4994476|NCT02393378|12288779|P1|STARTED|Overall Study||3
4994477|NCT02393209|12288797|P4|NOT COMPLETED|Overall Study||0
4994478|NCT02393209|12288798|P3|NOT COMPLETED|Overall Study||0
4994479|NCT02393209|12288799|P2|NOT COMPLETED|Overall Study||8
4994480|NCT02393209|12288800|P1|NOT COMPLETED|Overall Study||6
4994481|NCT02393209|12288797|P4|COMPLETED|Overall Study||0
4994482|NCT02393209|12288798|P3|COMPLETED|Overall Study||0
4994483|NCT02393209|12288799|P2|COMPLETED|Overall Study||0
4994484|NCT02393209|12288800|P1|COMPLETED|Overall Study||0
4994485|NCT02393209|12288797|P4|STARTED|Overall Study||0
4994486|NCT02393209|12288798|P3|STARTED|Overall Study||0
4994487|NCT02393209|12288799|P2|STARTED|Overall Study||8
4994488|NCT02393209|12288800|P1|STARTED|Overall Study||6
4994489|NCT02392806|12288858|P2|NOT COMPLETED|Overall Study||0
4994490|NCT02392806|12288859|P1|NOT COMPLETED|Overall Study||0
4994491|NCT02392806|12288858|P2|COMPLETED|Overall Study||21
4994492|NCT02392806|12288859|P1|COMPLETED|Overall Study||22
4994493|NCT02392806|12288858|P2|STARTED|Overall Study||21
4994494|NCT02392806|12288859|P1|STARTED|Overall Study||22
4994495|NCT02392767|12288869|P2|NOT COMPLETED|Overall Study||0
4994496|NCT02392767|12288870|P1|NOT COMPLETED|Overall Study||0
4994497|NCT02392767|12288869|P2|COMPLETED|Overall Study||13
4994498|NCT02392767|12288870|P1|COMPLETED|Overall Study||12
4994499|NCT02392767|12288869|P2|STARTED|Overall Study||13
4994500|NCT02392767|12288870|P1|STARTED|Overall Study||12
4994501|NCT02392624|12288889|P3|NOT COMPLETED|Overall Study||13
4994502|NCT02392624|12288890|P2|NOT COMPLETED|Overall Study||15
4994503|NCT02392624|12288891|P1|NOT COMPLETED|Overall Study||71
4994504|NCT02392624|12288889|P3|COMPLETED|Overall Study||40
4994505|NCT02392624|12288890|P2|COMPLETED|Overall Study||66
4994506|NCT02392624|12288891|P1|COMPLETED|Overall Study||0
4994507|NCT02392624|12288889|P3|STARTED|Overall Study||53
4994508|NCT02392624|12288890|P2|STARTED|Overall Study||81
4994509|NCT02392624|12288891|P1|STARTED|Overall Study||71
4994510|NCT02392559|12288906|P2|NOT COMPLETED|Overall Study||1
4994511|NCT02392559|12288907|P1|NOT COMPLETED|Overall Study||0
4994512|NCT02392559|12288906|P2|COMPLETED|Overall Study||104
4994513|NCT02392559|12288907|P1|COMPLETED|Overall Study||53
4994514|NCT02392559|12288906|P2|Randomized and Dosed|Overall Study||104
4994515|NCT02392559|12288907|P1|Randomized and Dosed|Overall Study||53
4994516|NCT02392559|12288906|P2|STARTED|Overall Study||105
4994517|NCT02392559|12288907|P1|STARTED|Overall Study||53
4994518|NCT02392507|12288938|P1|NOT COMPLETED|Maintenance Regimen||12
4994519|NCT02392507|12288938|P1|COMPLETED|Maintenance Regimen||22
4994520|NCT02392507|12288938|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
4994521|NCT02392507|12288938|P1|NOT COMPLETED|Induction Regimen||17
4994522|NCT02392507|12288938|P1|COMPLETED|Induction Regimen||37
4994523|NCT02392507|12288938|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
4994524|NCT02392507|12288938|P1|STARTED|Induction Regimen||54
4994525|NCT02392494|12288956|P4|NOT COMPLETED|Overall Study||0
4994526|NCT02392494|12288957|P3|NOT COMPLETED|Overall Study||0
4994527|NCT02392494|12288958|P2|NOT COMPLETED|Overall Study||0
4994528|NCT02392494|12288959|P1|NOT COMPLETED|Overall Study||0
4994529|NCT02392494|12288956|P4|COMPLETED|Overall Study||0
4994530|NCT02392494|12288957|P3|COMPLETED|Overall Study||3
4994531|NCT02392494|12288958|P2|COMPLETED|Overall Study||3
4994532|NCT02392494|12288959|P1|COMPLETED|Overall Study||3
4994533|NCT02392494|12288956|P4|STARTED|Overall Study||0
4994534|NCT02392494|12288957|P3|STARTED|Overall Study||3
4994535|NCT02392494|12288958|P2|STARTED|Overall Study||3
4994536|NCT02392494|12288959|P1|STARTED|Overall Study||3
4994537|NCT02392481|12288977|P4|NOT COMPLETED|Overall Study||2
4994538|NCT02392481|12288978|P3|NOT COMPLETED|Overall Study||2
4994539|NCT02392481|12288979|P2|NOT COMPLETED|Overall Study||0
4994540|NCT02392481|12288980|P1|NOT COMPLETED|Overall Study||0
4994541|NCT02392481|12288977|P4|COMPLETED|Overall Study||25
4994542|NCT02392481|12288978|P3|COMPLETED|Overall Study||18
4994543|NCT02392481|12288979|P2|COMPLETED|Overall Study||12
4994544|NCT02392481|12288980|P1|COMPLETED|Overall Study||10
4994545|NCT02392481|12288977|P4|STARTED|Overall Study||27
4994546|NCT02392481|12288978|P3|STARTED|Overall Study||20
4994547|NCT02392481|12288979|P2|STARTED|Overall Study||12
4994548|NCT02392481|12288980|P1|STARTED|Overall Study||10
4994549|NCT02392403|12289002|P1|NOT COMPLETED|Overall Study||3
4994550|NCT02392403|12289002|P1|COMPLETED|Overall Study||42
4994551|NCT02392403|12289002|P1|STARTED|Overall Study||45
4994552|NCT02392377|12289016|P2|NOT COMPLETED|Overall Study||1
4994553|NCT02392377|12289017|P1|NOT COMPLETED|Overall Study||0
4994554|NCT02392377|12289016|P2|COMPLETED|Overall Study||0
4994555|NCT02392377|12289017|P1|COMPLETED|Overall Study||0
4994556|NCT02392377|12289016|P2|STARTED|Overall Study||1
4994557|NCT02392377|12289017|P1|STARTED|Overall Study||0
4994558|NCT02392351|12289043|P2|NOT COMPLETED|Overall Study||17
4994559|NCT02392351|12289044|P1|NOT COMPLETED|Overall Study||34
4994560|NCT02392351|12289043|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
4994561|NCT02392351|12289044|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
4994562|NCT02392351|12289043|P2|STARTED|Overall Study||17
4994563|NCT02392351|12289044|P1|STARTED|Overall Study||34
4994564|NCT02392286|12289092|P2|NOT COMPLETED|Overall Study||2
4994565|NCT02392286|12289093|P1|NOT COMPLETED|Overall Study||3
4994566|NCT02392286|12289092|P2|COMPLETED|Overall Study||6
4994567|NCT02392286|12289093|P1|COMPLETED|Overall Study||4
4994568|NCT02392286|12289092|P2|STARTED|Overall Study||8
4994569|NCT02392286|12289093|P1|STARTED|Overall Study||7
4994570|NCT02392247|12289109|P1|NOT COMPLETED|Overall Study||2
4994571|NCT02392247|12289109|P1|COMPLETED|Overall Study||50
4994572|NCT02392247|12289109|P1|STARTED|Overall Study||52
4994573|NCT02392234|12289120|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4994574|NCT02392234|12289121|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4994575|NCT02392234|12289122|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4994576|NCT02392234|12289123|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4994577|NCT02392234|12289124|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
4994578|NCT02392234|12289125|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
4994579|NCT02392234|12289120|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
4994580|NCT02392234|12289121|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
4994581|NCT02392234|12289122|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
4994582|NCT02392234|12289123|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
4994583|NCT02392234|12289124|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
4994584|NCT02392234|12289125|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
4994585|NCT02392234|12289120|P6|STARTED|Treatment Period 2 (8 Weeks)||38
4994586|NCT02392234|12289121|P5|STARTED|Treatment Period 2 (8 Weeks)||37
4994587|NCT02392234|12289122|P4|STARTED|Treatment Period 2 (8 Weeks)||41
4994588|NCT02392234|12289123|P3|STARTED|Treatment Period 2 (8 Weeks)||38
4994589|NCT02392234|12289124|P2|STARTED|Treatment Period 2 (8 Weeks)||43
4994590|NCT02392234|12289125|P1|STARTED|Treatment Period 2 (8 Weeks)||38
4994591|NCT02392234|12289120|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
4994592|NCT02392234|12289121|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
4994593|NCT02392234|12289122|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
4994594|NCT02392234|12289123|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
4994595|NCT02392234|12289124|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
4994596|NCT02392234|12289125|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
4994597|NCT02392234|12289120|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
4994598|NCT02392234|12289121|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
4994599|NCT02392234|12289122|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
4994600|NCT02392234|12289123|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
4994601|NCT02392234|12289124|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
4994602|NCT02392234|12289125|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
4994603|NCT02392234|12289120|P6|Treated|Treatment Period 1 (8 Weeks)||41
4994604|NCT02392234|12289121|P5|Treated|Treatment Period 1 (8 Weeks)||40
4994605|NCT02392234|12289122|P4|Treated|Treatment Period 1 (8 Weeks)||42
4994606|NCT02392234|12289123|P3|Treated|Treatment Period 1 (8 Weeks)||39
4994607|NCT02392234|12289124|P2|Treated|Treatment Period 1 (8 Weeks)||43
4994608|NCT02392234|12289125|P1|Treated|Treatment Period 1 (8 Weeks)||41
4994609|NCT02392234|12289120|P6|STARTED|Treatment Period 1 (8 Weeks)||41
4994610|NCT02392234|12289121|P5|STARTED|Treatment Period 1 (8 Weeks)||41
4994611|NCT02392234|12289122|P4|STARTED|Treatment Period 1 (8 Weeks)||42
4994612|NCT02392234|12289123|P3|STARTED|Treatment Period 1 (8 Weeks)||40
4994613|NCT02392234|12289124|P2|STARTED|Treatment Period 1 (8 Weeks)||43
4994614|NCT02392234|12289125|P1|STARTED|Treatment Period 1 (8 Weeks)||41
4994615|NCT02392208|12289147|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
4994616|NCT02392208|12289147|P1|COMPLETED|Telavancin After Hemodialysis||8
4994617|NCT02392208|12289147|P1|STARTED|Telavancin After Hemodialysis||8
4994618|NCT02392208|12289147|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
4994619|NCT02392208|12289147|P1|COMPLETED|Telavancin Before Hemodialysis||8
4994620|NCT02392208|12289147|P1|STARTED|Telavancin Before Hemodialysis||8
4994621|NCT02392104|12289157|P1|NOT COMPLETED|Overall Study||11
4994622|NCT02392104|12289157|P1|COMPLETED|Overall Study||39
4994623|NCT02392104|12289157|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
4994624|NCT02392000|12289168|P1|NOT COMPLETED|Overall Study||27
4994625|NCT02392000|12289168|P1|COMPLETED|Overall Study||11
4994626|NCT02392000|12289168|P1|STARTED|Overall Study||38
4994627|NCT02391987|12289178|P2|NOT COMPLETED|Overall Study||0
4994628|NCT02391987|12289179|P1|NOT COMPLETED|Overall Study||0
4994629|NCT02391987|12289178|P2|COMPLETED|Overall Study||58
4994630|NCT02391987|12289179|P1|COMPLETED|Overall Study||54
4994631|NCT02391987|12289178|P2|STARTED|Overall Study||58
4994632|NCT02391987|12289179|P1|STARTED|Overall Study||54
4994633|NCT02391948|12289194|P5|NOT COMPLETED|24-month Assessment||10
4994634|NCT02391948|12289195|P4|NOT COMPLETED|24-month Assessment||9
4994635|NCT02391948|12289196|P3|NOT COMPLETED|24-month Assessment||3
4994636|NCT02391948|12289197|P2|NOT COMPLETED|24-month Assessment||10
4994637|NCT02391948|12289198|P1|NOT COMPLETED|24-month Assessment||14
4994638|NCT02391948|12289194|P5|COMPLETED|24-month Assessment||69
4994639|NCT02391948|12289195|P4|COMPLETED|24-month Assessment||75
4994640|NCT02391948|12289196|P3|COMPLETED|24-month Assessment||48
4994641|NCT02391948|12289197|P2|COMPLETED|24-month Assessment||97
4994642|NCT02391948|12289198|P1|COMPLETED|24-month Assessment||135
4994643|NCT02391948|12289194|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
4994644|NCT02391948|12289195|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
4994645|NCT02391948|12289196|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
4994646|NCT02391948|12289197|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
4994647|NCT02391948|12289198|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
4994648|NCT02391948|12289194|P5|NOT COMPLETED|18-month Assessment||30
4994649|NCT02391948|12289195|P4|NOT COMPLETED|18-month Assessment||36
4994650|NCT02391948|12289196|P3|NOT COMPLETED|18-month Assessment||26
4994651|NCT02391948|12289197|P2|NOT COMPLETED|18-month Assessment||50
4994652|NCT02391948|12289198|P1|NOT COMPLETED|18-month Assessment||72
4994653|NCT02391948|12289194|P5|COMPLETED|18-month Assessment||75
4994654|NCT02391948|12289195|P4|COMPLETED|18-month Assessment||83
4994655|NCT02391948|12289196|P3|COMPLETED|18-month Assessment||48
4994656|NCT02391948|12289197|P2|COMPLETED|18-month Assessment||101
4994657|NCT02391948|12289198|P1|COMPLETED|18-month Assessment||147
4994658|NCT02391948|12289194|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
4994659|NCT02391948|12289195|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
4994660|NCT02391948|12289196|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
4994661|NCT02391948|12289197|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
4994662|NCT02391948|12289198|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
4994663|NCT02391948|12289194|P5|NOT COMPLETED|12-month Assessment||6
4994664|NCT02391948|12289195|P4|NOT COMPLETED|12-month Assessment||9
4994665|NCT02391948|12289196|P3|NOT COMPLETED|12-month Assessment||4
4994666|NCT02391948|12289197|P2|NOT COMPLETED|12-month Assessment||9
4994667|NCT02391948|12289198|P1|NOT COMPLETED|12-month Assessment||8
4994668|NCT02391948|12289194|P5|COMPLETED|12-month Assessment||103
4994669|NCT02391948|12289195|P4|COMPLETED|12-month Assessment||116
4994670|NCT02391948|12289196|P3|COMPLETED|12-month Assessment||73
4994671|NCT02391948|12289197|P2|COMPLETED|12-month Assessment||147
4994672|NCT02391948|12289198|P1|COMPLETED|12-month Assessment||217
4994673|NCT02391948|12289194|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
4994674|NCT02391948|12289195|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
4994675|NCT02391948|12289196|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
4994676|NCT02391948|12289197|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
4994677|NCT02391948|12289198|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
4994678|NCT02391948|12289194|P5|NOT COMPLETED|6-month Assessment||26
4994679|NCT02391948|12289195|P4|NOT COMPLETED|6-month Assessment||45
4994680|NCT02391948|12289196|P3|NOT COMPLETED|6-month Assessment||31
4994681|NCT02391948|12289197|P2|NOT COMPLETED|6-month Assessment||56
4994682|NCT02391948|12289198|P1|NOT COMPLETED|6-month Assessment||79
4994683|NCT02391948|12289194|P5|COMPLETED|6-month Assessment||85
4994684|NCT02391948|12289195|P4|COMPLETED|6-month Assessment||84
4994685|NCT02391948|12289196|P3|COMPLETED|6-month Assessment||49
4994686|NCT02391948|12289197|P2|COMPLETED|6-month Assessment||105
4994687|NCT02391948|12289198|P1|COMPLETED|6-month Assessment||148
4994688|NCT02391948|12289194|P5|STARTED|6-month Assessment||111
4994689|NCT02391948|12289195|P4|STARTED|6-month Assessment||129
4994690|NCT02391948|12289196|P3|STARTED|6-month Assessment||80
4994691|NCT02391948|12289197|P2|STARTED|6-month Assessment||161
4994692|NCT02391948|12289198|P1|STARTED|6-month Assessment||227
4994693|NCT02391948|12289194|P5|NOT COMPLETED|Baseline||0
4994694|NCT02391948|12289195|P4|NOT COMPLETED|Baseline||0
4994695|NCT02391948|12289196|P3|NOT COMPLETED|Baseline||0
4994696|NCT02391948|12289197|P2|NOT COMPLETED|Baseline||0
4994697|NCT02391948|12289198|P1|NOT COMPLETED|Baseline||0
4994698|NCT02391948|12289194|P5|COMPLETED|Baseline||111
4994699|NCT02391948|12289195|P4|COMPLETED|Baseline||129
4994700|NCT02391948|12289196|P3|COMPLETED|Baseline||80
4994701|NCT02391948|12289197|P2|COMPLETED|Baseline||161
4994702|NCT02391948|12289198|P1|COMPLETED|Baseline||227
4994703|NCT02391948|12289194|P5|STARTED|Baseline||111
4994704|NCT02391948|12289195|P4|STARTED|Baseline||129
4994705|NCT02391948|12289196|P3|STARTED|Baseline||80
4994706|NCT02391948|12289197|P2|STARTED|Baseline||161
4994707|NCT02391948|12289198|P1|STARTED|Baseline||227
4994708|NCT02391714|12289292|P2|NOT COMPLETED|Overall Study||0
4994709|NCT02391714|12289293|P1|NOT COMPLETED|Overall Study||0
4994710|NCT02391714|12289292|P2|COMPLETED|Overall Study||40
4994711|NCT02391714|12289293|P1|COMPLETED|Overall Study||40
4994712|NCT02391714|12289292|P2|STARTED|Overall Study||40
4994713|NCT02391714|12289293|P1|STARTED|Overall Study||40
4994714|NCT02391701|12289305|P2|NOT COMPLETED|Overall Study||38
4994715|NCT02391701|12289306|P1|NOT COMPLETED|Overall Study||21
4994716|NCT02391701|12289305|P2|COMPLETED|Overall Study||315
4994717|NCT02391701|12289306|P1|COMPLETED|Overall Study||346
4994718|NCT02391701|12289305|P2|STARTED|Overall Study||353
4994719|NCT02391701|12289306|P1|STARTED|Overall Study||367
4994720|NCT02391584|12289322|P2|NOT COMPLETED|12 Month (End of Study)||0
4994721|NCT02391584|12289323|P1|NOT COMPLETED|12 Month (End of Study)||2
4994722|NCT02391584|12289322|P2|COMPLETED|12 Month (End of Study)||0
4994723|NCT02391584|12289323|P1|COMPLETED|12 Month (End of Study)||49
4994724|NCT02391584|12289322|P2|STARTED|12 Month (End of Study)||0
4994725|NCT02391584|12289323|P1|STARTED|12 Month (End of Study)||51
4994726|NCT02391584|12289322|P2|NOT COMPLETED|6 Month||0
4994727|NCT02391584|12289323|P1|NOT COMPLETED|6 Month||1
4994728|NCT02391584|12289322|P2|COMPLETED|6 Month||0
4994729|NCT02391584|12289323|P1|COMPLETED|6 Month||51
4994730|NCT02391584|12289322|P2|STARTED|6 Month||0
4994731|NCT02391584|12289323|P1|STARTED|6 Month||52
4994732|NCT02391584|12289322|P2|NOT COMPLETED|3 Month||0
4994733|NCT02391584|12289323|P1|NOT COMPLETED|3 Month||1
4994734|NCT02391584|12289322|P2|COMPLETED|3 Month||0
4994735|NCT02391584|12289323|P1|COMPLETED|3 Month||52
4994736|NCT02391584|12289322|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
4994737|NCT02391584|12289323|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
4994738|NCT02391584|12289322|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
4994739|NCT02391584|12289323|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
4994740|NCT02391584|12289322|P2|COMPLETED|Primary Endpoint (6-weeks)||27
4994741|NCT02391584|12289323|P1|COMPLETED|Primary Endpoint (6-weeks)||29
4994742|NCT02391584|12289322|P2|STARTED|Primary Endpoint (6-weeks)||29
4994743|NCT02391584|12289323|P1|STARTED|Primary Endpoint (6-weeks)||31
4994744|NCT02391545|12289340|P2|NOT COMPLETED|Overall Study||28
4994745|NCT02391545|12289341|P1|NOT COMPLETED|Overall Study||26
4994746|NCT02391545|12289340|P2|COMPLETED|Overall Study||0
4994747|NCT02391545|12289341|P1|COMPLETED|Overall Study||1
4994748|NCT02391545|12289340|P2|STARTED|Overall Study||28
4994749|NCT02391545|12289341|P1|STARTED|Overall Study||27
4994750|NCT02391363|12289361|P2|NOT COMPLETED|Overall Study||8
4994751|NCT02391363|12289362|P1|NOT COMPLETED|Overall Study||11
4994752|NCT02391363|12289361|P2|COMPLETED|Overall Study||56
4994753|NCT02391363|12289362|P1|COMPLETED|Overall Study||59
4994754|NCT02391363|12289361|P2|STARTED|Overall Study||64
4994755|NCT02391363|12289362|P1|STARTED|Overall Study||70
4994756|NCT02391311|12289428|P2|NOT COMPLETED|Overall Study||2
4994757|NCT02391311|12289429|P1|NOT COMPLETED|Overall Study||3
4994758|NCT02391311|12289428|P2|COMPLETED|Overall Study||19
4994759|NCT02391311|12289429|P1|COMPLETED|Overall Study||18
4994760|NCT02391311|12289428|P2|STARTED|Overall Study||21
4994761|NCT02391311|12289429|P1|STARTED|Overall Study||21
4994762|NCT02391116|12289437|P1|NOT COMPLETED|Survival Follow-up||4
4994763|NCT02391116|12289437|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
4994764|NCT02391116|12289437|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
4994765|NCT02391116|12289437|P1|NOT COMPLETED|Active Follow-up||3
4994766|NCT02391116|12289437|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
4994767|NCT02391116|12289437|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
4994768|NCT02391116|12289437|P1|NOT COMPLETED|Safety Follow-up||13
4994769|NCT02391116|12289437|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
4994770|NCT02391116|12289437|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
4994771|NCT02391116|12289437|P1|NOT COMPLETED|Treatment||14
4994772|NCT02391116|12289437|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
4994773|NCT02391116|12289437|P1|Included in Per Protocol Set|Treatment||40
4994774|NCT02391116|12289437|P1|STARTED|Treatment||67
4994775|NCT02391038|12289491|P3|NOT COMPLETED|Overall Study||6
4994776|NCT02391038|12289492|P2|NOT COMPLETED|Overall Study||3
4994777|NCT02391038|12289493|P1|NOT COMPLETED|Overall Study||3
4994778|NCT02391038|12289491|P3|COMPLETED|Overall Study||0
4994779|NCT02391038|12289492|P2|COMPLETED|Overall Study||0
4994780|NCT02391038|12289493|P1|COMPLETED|Overall Study||0
4994781|NCT02391038|12289491|P3|STARTED|Overall Study||6
4994782|NCT02391038|12289492|P2|STARTED|Overall Study||3
4994783|NCT02391038|12289493|P1|STARTED|Overall Study||3
4994784|NCT02390791|12289609|P2|NOT COMPLETED|Overall Study||0
4994785|NCT02390791|12289610|P1|NOT COMPLETED|Overall Study||0
4994786|NCT02390791|12289609|P2|COMPLETED|Overall Study||45
4994787|NCT02390791|12289610|P1|COMPLETED|Overall Study||40
4994788|NCT02390791|12289609|P2|STARTED|Overall Study||45
4994789|NCT02390791|12289610|P1|STARTED|Overall Study||40
4994790|NCT02390557|12289637|P3|NOT COMPLETED|Wave 2||23
4994791|NCT02390557|12289638|P2|NOT COMPLETED|Wave 2||41
4994792|NCT02390557|12289639|P1|NOT COMPLETED|Wave 2||72
4994793|NCT02390557|12289637|P3|COMPLETED|Wave 2||112
4994794|NCT02390557|12289638|P2|COMPLETED|Wave 2||115
4994795|NCT02390557|12289639|P1|COMPLETED|Wave 2||88
4994796|NCT02390557|12289637|P3|STARTED|Wave 2||135
4994797|NCT02390557|12289638|P2|STARTED|Wave 2||156
4994798|NCT02390557|12289639|P1|STARTED|Wave 2||160
4994799|NCT02390557|12289637|P3|NOT COMPLETED|Wave 1||0
4994800|NCT02390557|12289638|P2|NOT COMPLETED|Wave 1||0
4994801|NCT02390557|12289639|P1|NOT COMPLETED|Wave 1||0
4994802|NCT02390557|12289637|P3|COMPLETED|Wave 1||135
4994803|NCT02390557|12289638|P2|COMPLETED|Wave 1||156
4994804|NCT02390557|12289639|P1|COMPLETED|Wave 1||160
4994805|NCT02390557|12289637|P3|STARTED|Wave 1||135
4994806|NCT02390557|12289638|P2|STARTED|Wave 1||156
4994807|NCT02390557|12289639|P1|STARTED|Wave 1||160
4994808|NCT02390362|12289649|P2|NOT COMPLETED|Overall Study||1
4994809|NCT02390362|12289650|P1|NOT COMPLETED|Overall Study||0
4994810|NCT02390362|12289649|P2|COMPLETED|Overall Study||1
4994811|NCT02390362|12289650|P1|COMPLETED|Overall Study||1
4994812|NCT02390362|12289649|P2|STARTED|Overall Study||2
4994813|NCT02390362|12289650|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
4994814|NCT02390219|12289658|P1|NOT COMPLETED|Overall Study||13
4994815|NCT02390219|12289658|P1|COMPLETED|Overall Study||33
4994816|NCT02390219|12289658|P1|STARTED|Overall Study||46
4994817|NCT02390167|12289668|P1|NOT COMPLETED|Overall Study||1
4994818|NCT02390167|12289668|P1|COMPLETED|Overall Study||375
4994819|NCT02390167|12289668|P1|Without Diabetes|Overall Study||43
4994820|NCT02390167|12289668|P1|With Diabetes|Overall Study||333
4994821|NCT02390167|12289668|P1|STARTED|Overall Study||376
4994822|NCT02390076|12289690|P3|NOT COMPLETED|Overall Study||4
4994823|NCT02390076|12289691|P2|NOT COMPLETED|Overall Study||1
4994824|NCT02390076|12289692|P1|NOT COMPLETED|Overall Study||2
4994825|NCT02390076|12289690|P3|COMPLETED|Overall Study||11
4994826|NCT02390076|12289691|P2|COMPLETED|Overall Study||17
4994827|NCT02390076|12289692|P1|COMPLETED|Overall Study||16
4994828|NCT02390076|12289690|P3|STARTED|Overall Study||15
4994829|NCT02390076|12289691|P2|STARTED|Overall Study||18
4994830|NCT02390076|12289692|P1|STARTED|Overall Study||18
4994831|NCT02389946|12289705|P2|NOT COMPLETED|Overall Study||15
4994832|NCT02389946|12289706|P1|NOT COMPLETED|Overall Study||24
4994833|NCT02389946|12289705|P2|COMPLETED|Overall Study||435
4994834|NCT02389946|12289706|P1|COMPLETED|Overall Study||860
4994835|NCT02389946|12289705|P2|STARTED|Overall Study||450
4994836|NCT02389946|12289706|P1|STARTED|Overall Study||884
4994837|NCT02389894|12289721|P3|NOT COMPLETED|Overall Study||9
4994838|NCT02389894|12289722|P2|NOT COMPLETED|Overall Study||10
4994839|NCT02389894|12289723|P1|NOT COMPLETED|Overall Study||8
4994840|NCT02389894|12289721|P3|COMPLETED|Overall Study||123
4994841|NCT02389894|12289722|P2|COMPLETED|Overall Study||108
4994842|NCT02389894|12289723|P1|COMPLETED|Overall Study||125
4994843|NCT02389894|12289721|P3|STARTED|Overall Study||132
4994844|NCT02389894|12289722|P2|STARTED|Overall Study||118
4994845|NCT02389894|12289723|P1|STARTED|Overall Study||133
4994846|NCT02389881|12289798|P7|NOT COMPLETED|Overall Study||0
4994847|NCT02389881|12289799|P6|NOT COMPLETED|Overall Study||0
4994848|NCT02389881|12289800|P5|NOT COMPLETED|Overall Study||0
4994849|NCT02389881|12289801|P4|NOT COMPLETED|Overall Study||0
4994850|NCT02389881|12289802|P3|NOT COMPLETED|Overall Study||0
4994851|NCT02389881|12289803|P2|NOT COMPLETED|Overall Study||0
4994852|NCT02389881|12289804|P1|NOT COMPLETED|Overall Study||0
4994853|NCT02389881|12289798|P7|COMPLETED|Overall Study||2
4994854|NCT02389881|12289799|P6|COMPLETED|Overall Study||8
4994855|NCT02389881|12289800|P5|COMPLETED|Overall Study||6
4994856|NCT02389881|12289801|P4|COMPLETED|Overall Study||6
4994857|NCT02389881|12289802|P3|COMPLETED|Overall Study||6
4994858|NCT02389881|12289803|P2|COMPLETED|Overall Study||6
4994859|NCT02389881|12289804|P1|COMPLETED|Overall Study||6
4994860|NCT02389881|12289798|P7|STARTED|Overall Study||2
4994861|NCT02389881|12289799|P6|STARTED|Overall Study||8
4994862|NCT02389881|12289800|P5|STARTED|Overall Study||6
4994863|NCT02389881|12289801|P4|STARTED|Overall Study||6
4994864|NCT02389881|12289802|P3|STARTED|Overall Study||6
4994865|NCT02389881|12289803|P2|STARTED|Overall Study||6
4994866|NCT02389881|12289804|P1|STARTED|Overall Study||6
4994867|NCT02389829|12289855|P2|NOT COMPLETED|Overall Study||1
4994868|NCT02389829|12289856|P1|NOT COMPLETED|Overall Study||0
4994869|NCT02389829|12289855|P2|COMPLETED|Overall Study||62
4994870|NCT02389829|12289856|P1|COMPLETED|Overall Study||64
4994871|NCT02389829|12289855|P2|STARTED|Overall Study||63
4994872|NCT02389829|12289856|P1|STARTED|Overall Study||64
4994873|NCT02389816|12289871|P3|NOT COMPLETED|Overall Study||12
4994874|NCT02389816|12289872|P2|NOT COMPLETED|Overall Study||13
4994875|NCT02389816|12289873|P1|NOT COMPLETED|Overall Study||15
4994876|NCT02389816|12289871|P3|COMPLETED|Overall Study||152
4994877|NCT02389816|12289872|P2|COMPLETED|Overall Study||152
4994878|NCT02389816|12289873|P1|COMPLETED|Overall Study||149
4994879|NCT02389816|12289871|P3|STARTED|Overall Study||164
4994880|NCT02389816|12289872|P2|STARTED|Overall Study||165
4994881|NCT02389816|12289873|P1|STARTED|Overall Study||164
4994882|NCT02389764|12289905|P1|NOT COMPLETED|Overall Study||9
4994883|NCT02389764|12289905|P1|COMPLETED|Overall Study||0
4994884|NCT02389764|12289905|P1|STARTED|Overall Study||9
4994885|NCT02389738|12289910|P1|NOT COMPLETED|Overall Study||1
4994886|NCT02389738|12289910|P1|COMPLETED|Overall Study||5
4994887|NCT02389738|12289910|P1|STARTED|Overall Study||6
4994888|NCT02389725|12289916|P2|NOT COMPLETED|Overall Study||0
4994889|NCT02389725|12289917|P1|NOT COMPLETED|Overall Study||0
4994890|NCT02389725|12289916|P2|COMPLETED|Overall Study||60
4994891|NCT02389725|12289917|P1|COMPLETED|Overall Study||59
4994892|NCT02389725|12289916|P2|STARTED|Overall Study||60
4994893|NCT02389725|12289917|P1|STARTED|Overall Study||59
4994894|NCT02389712|12289931|P2|NOT COMPLETED|Overall Study||0
4994895|NCT02389712|12289932|P1|NOT COMPLETED|Overall Study||0
4994896|NCT02389712|12289931|P2|COMPLETED|Overall Study||1
4994897|NCT02389712|12289932|P1|COMPLETED|Overall Study||1
4994898|NCT02389712|12289931|P2|STARTED|Overall Study||1
4994899|NCT02389712|12289932|P1|STARTED|Overall Study||1
4994900|NCT02389621|12289940|P2|NOT COMPLETED|Posttreatment Period||4
4994901|NCT02389621|12289941|P1|NOT COMPLETED|Posttreatment Period||9
4994902|NCT02389621|12289940|P2|COMPLETED|Posttreatment Period||102
4994903|NCT02389621|12289941|P1|COMPLETED|Posttreatment Period||98
4994904|NCT02389621|12289940|P2|STARTED|Posttreatment Period||106
4994905|NCT02389621|12289941|P1|STARTED|Posttreatment Period||107
4994906|NCT02389621|12289940|P2|NOT COMPLETED|Treatment Period||1
4994907|NCT02389621|12289941|P1|NOT COMPLETED|Treatment Period||1
4994908|NCT02389621|12289940|P2|COMPLETED|Treatment Period||106
4994909|NCT02389621|12289941|P1|COMPLETED|Treatment Period||107
4994910|NCT02389621|12289940|P2|Received Study Drug|Treatment Period||107
4994911|NCT02389621|12289941|P1|Received Study Drug|Treatment Period||107
4994912|NCT02389621|12289940|P2|STARTED|Treatment Period||107
4994913|NCT02389621|12289941|P1|STARTED|Treatment Period||108
4994914|NCT02389452|12289971|P1|NOT COMPLETED|Overall Study||25
4994915|NCT02389452|12289971|P1|COMPLETED|Overall Study||369
4994916|NCT02389452|12289971|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
4994917|NCT02389452|12289971|P1|STARTED|Overall Study||394
4994918|NCT02389374|12289992|P3|NOT COMPLETED|Overall Study||1
4994919|NCT02389374|12289993|P2|NOT COMPLETED|Overall Study||28
4994920|NCT02389374|12289994|P1|NOT COMPLETED|Overall Study||9
4994921|NCT02389374|12289992|P3|COMPLETED|Overall Study||10
4994922|NCT02389374|12289993|P2|COMPLETED|Overall Study||87
4994923|NCT02389374|12289994|P1|COMPLETED|Overall Study||46
4994924|NCT02389374|12289992|P3|STARTED|Overall Study||11
4994925|NCT02389374|12289993|P2|STARTED|Overall Study||115
4994926|NCT02389374|12289994|P1|STARTED|Overall Study||55
4994927|NCT02389361|12290026|P2|NOT COMPLETED|Overall Study||0
4994928|NCT02389361|12290027|P1|NOT COMPLETED|Overall Study||0
4994929|NCT02389361|12290026|P2|COMPLETED|Overall Study||27
4994930|NCT02389361|12290027|P1|COMPLETED|Overall Study||24
4994931|NCT02389361|12290026|P2|STARTED|Overall Study||27
4994932|NCT02389361|12290027|P1|STARTED|Overall Study||24
4994933|NCT02389101|12290033|P1|NOT COMPLETED|Overall Study||0
4994934|NCT02389101|12290033|P1|COMPLETED|Overall Study||21
4994935|NCT02389101|12290033|P1|STARTED|Overall Study||21
4994936|NCT02389088|12290037|P1|NOT COMPLETED|Phase II - All Study Participants||0
4994937|NCT02389088|12290037|P1|COMPLETED|Phase II - All Study Participants||9
4994938|NCT02389088|12290037|P1|STARTED|Phase II - All Study Participants||9
4994939|NCT02389088|12290037|P1|NOT COMPLETED|Overall Study - Phase I||0
4994940|NCT02389088|12290037|P1|COMPLETED|Overall Study - Phase I||9
4994941|NCT02389088|12290037|P1|STARTED|Overall Study - Phase I||9
4994942|NCT02388997|12290083|P2|NOT COMPLETED|Overall Study||6
4994943|NCT02388997|12290084|P1|NOT COMPLETED|Overall Study||3
4994944|NCT02388997|12290083|P2|COMPLETED|Overall Study||10
4994945|NCT02388997|12290084|P1|COMPLETED|Overall Study||12
4994946|NCT02388997|12290083|P2|STARTED|Overall Study||16
4994947|NCT02388997|12290084|P1|STARTED|Overall Study||15
4994948|NCT02388932|12290102|P1|NOT COMPLETED|Overall Study||1
4994949|NCT02388932|12290102|P1|COMPLETED|Overall Study||2
4994950|NCT02388932|12290102|P1|STARTED|Overall Study||3
4994951|NCT02388880|12290112|P1|NOT COMPLETED|Overall Study||0
4994952|NCT02388880|12290112|P1|COMPLETED|Overall Study||3
4994953|NCT02388880|12290112|P1|STARTED|Overall Study||3
4994954|NCT02388815|12290119|P1|NOT COMPLETED|Overall Study||4
4994955|NCT02388815|12290119|P1|COMPLETED|Overall Study||85
4994956|NCT02388815|12290119|P1|STARTED|Overall Study||89
4994957|NCT02388776|12290123|P1|NOT COMPLETED|Overall Study||2
4994958|NCT02388776|12290123|P1|COMPLETED|Overall Study||0
4994959|NCT02388776|12290123|P1|STARTED|Overall Study||2
4994960|NCT02388763|12290128|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
4994961|NCT02388763|12290129|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
4994962|NCT02388763|12290128|P2|COMPLETED|Period 2, 10 Days of Wear||30
4994963|NCT02388763|12290129|P1|COMPLETED|Period 2, 10 Days of Wear||30
4994964|NCT02388763|12290128|P2|STARTED|Period 2, 10 Days of Wear||30
4994965|NCT02388763|12290129|P1|STARTED|Period 2, 10 Days of Wear||30
4994966|NCT02388763|12290128|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
4994967|NCT02388763|12290129|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
4994968|NCT02388763|12290128|P2|COMPLETED|Period 1, 10 Days of Wear||30
4994969|NCT02388763|12290129|P1|COMPLETED|Period 1, 10 Days of Wear||30
4994970|NCT02388763|12290128|P2|STARTED|Period 1, 10 Days of Wear||31
4994971|NCT02388763|12290129|P1|STARTED|Period 1, 10 Days of Wear||31
4994972|NCT02388763|12290128|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
4994973|NCT02388763|12290129|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
4994974|NCT02388763|12290128|P2|COMPLETED|Habitual, 10 Days of Wear||31
4994975|NCT02388763|12290129|P1|COMPLETED|Habitual, 10 Days of Wear||31
4994976|NCT02388763|12290128|P2|STARTED|Habitual, 10 Days of Wear||32
4994977|NCT02388763|12290129|P1|STARTED|Habitual, 10 Days of Wear||32
4994978|NCT02388737|12290143|P3|NOT COMPLETED|Overall Study||62
4994979|NCT02388737|12290144|P2|NOT COMPLETED|Overall Study||60
4994980|NCT02388737|12290145|P1|NOT COMPLETED|Overall Study||54
4994981|NCT02388737|12290143|P3|COMPLETED|Overall Study||180
4994982|NCT02388737|12290144|P2|COMPLETED|Overall Study||166
4994983|NCT02388737|12290145|P1|COMPLETED|Overall Study||181
4994984|NCT02388737|12290143|P3|STARTED|Overall Study||242
4994985|NCT02388737|12290144|P2|STARTED|Overall Study||226
4994986|NCT02388737|12290145|P1|STARTED|Overall Study||235
4994987|NCT02388724|12290179|P2|NOT COMPLETED|Overall Study||13
4994988|NCT02388724|12290180|P1|NOT COMPLETED|Overall Study||12
4994989|NCT02388724|12290179|P2|COMPLETED|Overall Study||224
4994990|NCT02388724|12290180|P1|COMPLETED|Overall Study||232
4994991|NCT02388724|12290179|P2|Safety Set: Randomized But Not Treated|Overall Study||2
4994992|NCT02388724|12290180|P1|Safety Set: Randomized But Not Treated|Overall Study||0
4994993|NCT02388724|12290179|P2|STARTED|Overall Study||237
4994994|NCT02388724|12290180|P1|STARTED|Overall Study||244
4994995|NCT02388568|12290204|P2|NOT COMPLETED|Overall Study||15
4994996|NCT02388568|12290205|P1|NOT COMPLETED|Overall Study||10
4994997|NCT02388568|12290204|P2|COMPLETED|Overall Study||53
4994998|NCT02388568|12290205|P1|COMPLETED|Overall Study||59
4994999|NCT02388568|12290204|P2|STARTED|Overall Study||68
4995000|NCT02388568|12290205|P1|STARTED|Overall Study||69
4995001|NCT02388347|12290226|P5|NOT COMPLETED|Overall Study||0
4995002|NCT02388347|12290227|P4|NOT COMPLETED|Overall Study||0
4995003|NCT02388347|12290228|P3|NOT COMPLETED|Overall Study||1
4995004|NCT02388347|12290229|P2|NOT COMPLETED|Overall Study||0
4995005|NCT02388347|12290230|P1|NOT COMPLETED|Overall Study||0
4995006|NCT02388347|12290226|P5|COMPLETED|Overall Study||6
4995007|NCT02388347|12290227|P4|COMPLETED|Overall Study||6
4995008|NCT02388347|12290228|P3|COMPLETED|Overall Study||5
4995009|NCT02388347|12290229|P2|COMPLETED|Overall Study||6
4995010|NCT02388347|12290230|P1|COMPLETED|Overall Study||8
4995011|NCT02388347|12290226|P5|STARTED|Overall Study||6
4995012|NCT02388347|12290227|P4|STARTED|Overall Study||6
4995013|NCT02388347|12290228|P3|STARTED|Overall Study||6
4995014|NCT02388347|12290229|P2|STARTED|Overall Study||6
4995015|NCT02388347|12290230|P1|STARTED|Overall Study||8
4995016|NCT02388321|12290297|P2|NOT COMPLETED|Overall Study||0
4995017|NCT02388321|12290298|P1|NOT COMPLETED|Overall Study||0
4995018|NCT02388321|12290297|P2|COMPLETED|Overall Study||11
4995019|NCT02388321|12290298|P1|COMPLETED|Overall Study||11
4995020|NCT02388321|12290297|P2|STARTED|Overall Study||11
4995021|NCT02388321|12290298|P1|STARTED|Overall Study||11
4995022|NCT02388295|12290309|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
4995023|NCT02388295|12290310|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
4995024|NCT02388295|12290311|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
4995025|NCT02388295|12290309|P3|COMPLETED|Treatment Weeks 3 to 12||17
4995026|NCT02388295|12290310|P2|COMPLETED|Treatment Weeks 3 to 12||13
4995027|NCT02388295|12290311|P1|COMPLETED|Treatment Weeks 3 to 12||15
4995028|NCT02388295|12290309|P3|STARTED|Treatment Weeks 3 to 12||17
4995029|NCT02388295|12290310|P2|STARTED|Treatment Weeks 3 to 12||14
4995030|NCT02388295|12290311|P1|STARTED|Treatment Weeks 3 to 12||16
4995031|NCT02388295|12290309|P3|NOT COMPLETED|Dose Escalation Week 2||1
4995032|NCT02388295|12290310|P2|NOT COMPLETED|Dose Escalation Week 2||2
4995033|NCT02388295|12290311|P1|NOT COMPLETED|Dose Escalation Week 2||1
4995034|NCT02388295|12290309|P3|COMPLETED|Dose Escalation Week 2||17
4995035|NCT02388295|12290310|P2|COMPLETED|Dose Escalation Week 2||14
4995036|NCT02388295|12290311|P1|COMPLETED|Dose Escalation Week 2||16
4995037|NCT02388295|12290309|P3|STARTED|Dose Escalation Week 2||18
4995038|NCT02388295|12290310|P2|STARTED|Dose Escalation Week 2||16
4995039|NCT02388295|12290311|P1|STARTED|Dose Escalation Week 2||17
4995040|NCT02388295|12290309|P3|NOT COMPLETED|Dose Escalation Week 1||2
4995041|NCT02388295|12290310|P2|NOT COMPLETED|Dose Escalation Week 1||3
4995042|NCT02388295|12290311|P1|NOT COMPLETED|Dose Escalation Week 1||2
4995043|NCT02388295|12290309|P3|COMPLETED|Dose Escalation Week 1||18
4995044|NCT02388295|12290310|P2|COMPLETED|Dose Escalation Week 1||16
4995045|NCT02388295|12290311|P1|COMPLETED|Dose Escalation Week 1||17
4995046|NCT02388295|12290309|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
4995047|NCT02388295|12290310|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
4995048|NCT02388295|12290311|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
4995049|NCT02388269|12290329|P3|NOT COMPLETED|Overall Study||10
4995050|NCT02388269|12290330|P2|NOT COMPLETED|Overall Study||2
4995051|NCT02388269|12290331|P1|NOT COMPLETED|Overall Study||9
4995052|NCT02388269|12290329|P3|COMPLETED|Overall Study||0
4995053|NCT02388269|12290330|P2|COMPLETED|Overall Study||38
4995054|NCT02388269|12290331|P1|COMPLETED|Overall Study||32
4995055|NCT02388269|12290329|P3|Open Label|Overall Study||0
4995056|NCT02388269|12290330|P2|Open Label|Overall Study||38
4995057|NCT02388269|12290331|P1|Open Label|Overall Study||37
4995058|NCT02388269|12290329|P3|Randomised Period|Overall Study||0
4995059|NCT02388269|12290330|P2|Randomised Period|Overall Study||40
4995060|NCT02388269|12290331|P1|Randomised Period|Overall Study||41
4995061|NCT02388269|12290329|P3|STARTED|Overall Study||10
4995062|NCT02388269|12290330|P2|STARTED|Overall Study||40
4995063|NCT02388269|12290331|P1|STARTED|Overall Study||41
4995064|NCT02388191|12290363|P2|NOT COMPLETED|Overall Study||0
4995065|NCT02388191|12290364|P1|NOT COMPLETED|Overall Study||1
4995066|NCT02388191|12290363|P2|COMPLETED|Overall Study||60
4995067|NCT02388191|12290364|P1|COMPLETED|Overall Study||58
4995068|NCT02388191|12290363|P2|STARTED|Overall Study||60
4995069|NCT02388191|12290364|P1|STARTED|Overall Study||59
4995070|NCT02388074|12290378|P1|NOT COMPLETED|Overall Study||3
4995071|NCT02388074|12290378|P1|COMPLETED|Overall Study||22
4995072|NCT02388074|12290378|P1|STARTED|Overall Study||25
4995073|NCT02387996|12290382|P1|NOT COMPLETED|Overall Study||204
4995074|NCT02387996|12290382|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
4995075|NCT02387996|12290382|P1|STARTED|Overall Study||270
4995076|NCT02387983|12290393|P1|NOT COMPLETED|Overall Study||7
4995077|NCT02387983|12290393|P1|COMPLETED|Overall Study||58
4995078|NCT02387983|12290393|P1|STARTED|Overall Study||65
4995079|NCT02387970|12290407|P2|NOT COMPLETED|Overall Study||2
4995080|NCT02387970|12290408|P1|NOT COMPLETED|Overall Study||1
4995081|NCT02387970|12290407|P2|COMPLETED|Overall Study||23
4995082|NCT02387970|12290408|P1|COMPLETED|Overall Study||26
4995083|NCT02387970|12290407|P2|STARTED|Overall Study||25
4995084|NCT02387970|12290408|P1|STARTED|Overall Study||27
4995085|NCT02387957|12290429|P3|NOT COMPLETED|Overall Study||20
4995086|NCT02387957|12290430|P2|NOT COMPLETED|Overall Study||21
4995087|NCT02387957|12290431|P1|NOT COMPLETED|Overall Study||21
4995088|NCT02387957|12290429|P3|COMPLETED|Overall Study|The study was discontinued|1
4995089|NCT02387957|12290430|P2|COMPLETED|Overall Study|The study was discontinued|0
4995090|NCT02387957|12290431|P1|COMPLETED|Overall Study|The study was discontinued|0
4995091|NCT02387957|12290429|P3|STARTED|Overall Study||21
4995092|NCT02387957|12290430|P2|STARTED|Overall Study||21
4995093|NCT02387957|12290431|P1|STARTED|Overall Study||21
4995094|NCT02387853|12290442|P1|NOT COMPLETED|Overall Study||3
4995095|NCT02387853|12290442|P1|COMPLETED|Overall Study||103
4995096|NCT02387853|12290442|P1|STARTED|Overall Study||106
4995097|NCT02387814|12290462|P4|NOT COMPLETED|Overall Study||0
4995098|NCT02387814|12290463|P3|NOT COMPLETED|Overall Study||0
4995099|NCT02387814|12290464|P2|NOT COMPLETED|Overall Study||0
4995100|NCT02387814|12290465|P1|NOT COMPLETED|Overall Study||0
4995101|NCT02387814|12290462|P4|COMPLETED|Overall Study||6
4995102|NCT02387814|12290463|P3|COMPLETED|Overall Study||10
4995103|NCT02387814|12290464|P2|COMPLETED|Overall Study||9
4995104|NCT02387814|12290465|P1|COMPLETED|Overall Study||10
4995105|NCT02387814|12290462|P4|Received Abemaciclib|Overall Study||6
4995106|NCT02387814|12290463|P3|Received Abemaciclib|Overall Study||10
4995107|NCT02387814|12290464|P2|Received Abemaciclib|Overall Study||9
4995108|NCT02387814|12290465|P1|Received Abemaciclib|Overall Study||10
4995109|NCT02387814|12290462|P4|STARTED|Overall Study||6
4995110|NCT02387814|12290463|P3|STARTED|Overall Study||10
4995111|NCT02387814|12290464|P2|STARTED|Overall Study||9
4995112|NCT02387814|12290465|P1|STARTED|Overall Study||10
4995113|NCT02387801|12290481|P2|NOT COMPLETED|Post-Treatment Follow-up||0
4995114|NCT02387801|12290482|P1|NOT COMPLETED|Post-Treatment Follow-up||0
4995115|NCT02387801|12290481|P2|COMPLETED|Post-Treatment Follow-up||12
4995116|NCT02387801|12290482|P1|COMPLETED|Post-Treatment Follow-up||0
4995117|NCT02387801|12290481|P2|STARTED|Post-Treatment Follow-up||12
4995118|NCT02387801|12290482|P1|STARTED|Post-Treatment Follow-up||0
4995119|NCT02387801|12290481|P2|NOT COMPLETED|Maintenance Dosing Period||0
4995120|NCT02387801|12290482|P1|NOT COMPLETED|Maintenance Dosing Period||0
4995121|NCT02387801|12290481|P2|COMPLETED|Maintenance Dosing Period||12
4995122|NCT02387801|12290482|P1|COMPLETED|Maintenance Dosing Period||0
4995123|NCT02387801|12290481|P2|STARTED|Maintenance Dosing Period||12
4995124|NCT02387801|12290482|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
4995125|NCT02387801|12290481|P2|NOT COMPLETED|Induction Dosing Period||0
4995126|NCT02387801|12290482|P1|NOT COMPLETED|Induction Dosing Period||0
4995127|NCT02387801|12290481|P2|COMPLETED|Induction Dosing Period||6
4995128|NCT02387801|12290482|P1|COMPLETED|Induction Dosing Period||6
4995129|NCT02387801|12290481|P2|STARTED|Induction Dosing Period||6
4995130|NCT02387801|12290482|P1|STARTED|Induction Dosing Period||6
4995131|NCT02387762|12290502|P2|NOT COMPLETED|Overall Study||0
4995132|NCT02387762|12290503|P1|NOT COMPLETED|Overall Study||1
4995133|NCT02387762|12290502|P2|COMPLETED|Overall Study||15
4995134|NCT02387762|12290503|P1|COMPLETED|Overall Study||15
4995135|NCT02387762|12290502|P2|STARTED|Overall Study||15
4995136|NCT02387762|12290503|P1|STARTED|Overall Study||16
4995137|NCT02387749|12290509|P1|NOT COMPLETED|Overall Study||0
4995138|NCT02387749|12290509|P1|COMPLETED|Overall Study||10
4995139|NCT02387749|12290509|P1|STARTED|Overall Study||10
4995140|NCT02387710|12290518|P2|NOT COMPLETED|Second Study Night||0
4995141|NCT02387710|12290519|P1|NOT COMPLETED|Second Study Night||0
4995142|NCT02387710|12290518|P2|COMPLETED|Second Study Night||7
4995143|NCT02387710|12290519|P1|COMPLETED|Second Study Night||9
4995144|NCT02387710|12290518|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
4995145|NCT02387710|12290519|P1|STARTED|Second Study Night||9
4995146|NCT02387710|12290518|P2|NOT COMPLETED|First Study Night||0
4995147|NCT02387710|12290519|P1|NOT COMPLETED|First Study Night||0
4995148|NCT02387710|12290518|P2|COMPLETED|First Study Night||9
4995149|NCT02387710|12290519|P1|COMPLETED|First Study Night||9
4995150|NCT02387710|12290518|P2|STARTED|First Study Night||9
4995151|NCT02387710|12290519|P1|STARTED|First Study Night||9
4995152|NCT02387580|12290535|P6|NOT COMPLETED|Overall Study||0
4995153|NCT02387580|12290536|P5|NOT COMPLETED|Overall Study||0
4995154|NCT02387580|12290537|P4|NOT COMPLETED|Overall Study||1
4995155|NCT02387580|12290538|P3|NOT COMPLETED|Overall Study||0
4995156|NCT02387580|12290539|P2|NOT COMPLETED|Overall Study||0
4995157|NCT02387580|12290540|P1|NOT COMPLETED|Overall Study||0
4995158|NCT02387580|12290535|P6|COMPLETED|Overall Study||8
4995159|NCT02387580|12290536|P5|COMPLETED|Overall Study||8
4995160|NCT02387580|12290537|P4|COMPLETED|Overall Study||7
4995161|NCT02387580|12290538|P3|COMPLETED|Overall Study||8
4995162|NCT02387580|12290539|P2|COMPLETED|Overall Study||8
4995163|NCT02387580|12290540|P1|COMPLETED|Overall Study||8
4995164|NCT02387580|12290535|P6|STARTED|Overall Study||8
4995165|NCT02387580|12290536|P5|STARTED|Overall Study||8
4995166|NCT02387580|12290537|P4|STARTED|Overall Study||8
4995167|NCT02387580|12290538|P3|STARTED|Overall Study||8
4995168|NCT02387580|12290539|P2|STARTED|Overall Study||8
4995169|NCT02387580|12290540|P1|STARTED|Overall Study||8
4995170|NCT02387554|12290576|P4|NOT COMPLETED|Overall Study||2
4995171|NCT02387554|12290577|P3|NOT COMPLETED|Overall Study||2
4995172|NCT02387554|12290578|P2|NOT COMPLETED|Overall Study||0
4995173|NCT02387554|12290579|P1|NOT COMPLETED|Overall Study||3
4995174|NCT02387554|12290576|P4|COMPLETED|Overall Study||6
4995175|NCT02387554|12290577|P3|COMPLETED|Overall Study||6
4995176|NCT02387554|12290578|P2|COMPLETED|Overall Study||7
4995177|NCT02387554|12290579|P1|COMPLETED|Overall Study||7
4995178|NCT02387554|12290576|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
4995179|NCT02387554|12290577|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
4995180|NCT02387554|12290578|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
4995181|NCT02387554|12290579|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
4995182|NCT02387502|12290592|P3|NOT COMPLETED|Overall Study||0
4995183|NCT02387502|12290593|P2|NOT COMPLETED|Overall Study||0
4995184|NCT02387502|12290594|P1|NOT COMPLETED|Overall Study||0
4995185|NCT02387502|12290592|P3|COMPLETED|Overall Study||40
4995186|NCT02387502|12290593|P2|COMPLETED|Overall Study||40
4995187|NCT02387502|12290594|P1|COMPLETED|Overall Study||40
4995188|NCT02387502|12290592|P3|STARTED|Overall Study||40
4995189|NCT02387502|12290593|P2|STARTED|Overall Study||40
4995190|NCT02387502|12290594|P1|STARTED|Overall Study||40
4995191|NCT02387476|12290604|P2|NOT COMPLETED|Overall Study||5
4995192|NCT02387476|12290605|P1|NOT COMPLETED|Overall Study||6
4995193|NCT02387476|12290604|P2|COMPLETED|Overall Study||17
4995194|NCT02387476|12290605|P1|COMPLETED|Overall Study||19
4995195|NCT02387476|12290604|P2|STARTED|Overall Study||22
4995196|NCT02387476|12290605|P1|STARTED|Overall Study||25
4995197|NCT02387372|12290633|P2|NOT COMPLETED|Overall Study||0
4995198|NCT02387372|12290634|P1|NOT COMPLETED|Overall Study||1
4995199|NCT02387372|12290633|P2|COMPLETED|Overall Study||10
4995200|NCT02387372|12290634|P1|COMPLETED|Overall Study||26
4995201|NCT02387372|12290633|P2|Treated|Overall Study||10
4995202|NCT02387372|12290634|P1|Treated|Overall Study||26
4995203|NCT02387372|12290633|P2|STARTED|Overall Study||10
4995204|NCT02387372|12290634|P1|STARTED|Overall Study||27
4995205|NCT02387359|12290683|P3|NOT COMPLETED|Overall Study||56
4995206|NCT02387359|12290684|P2|NOT COMPLETED|Overall Study||42
4995207|NCT02387359|12290685|P1|NOT COMPLETED|Overall Study||59
4995208|NCT02387359|12290683|P3|COMPLETED|Overall Study||293
4995209|NCT02387359|12290684|P2|COMPLETED|Overall Study||309
4995210|NCT02387359|12290685|P1|COMPLETED|Overall Study||295
4995211|NCT02387359|12290683|P3|STARTED|Overall Study||349
4995212|NCT02387359|12290684|P2|STARTED|Overall Study||351
4995213|NCT02387359|12290685|P1|STARTED|Overall Study||354
4995214|NCT02387268|12290717|P1|NOT COMPLETED|Overall Study||1
4995215|NCT02387268|12290717|P1|COMPLETED|Overall Study||9
4995216|NCT02387268|12290717|P1|STARTED|Overall Study||10
4995217|NCT02387008|12290725|P3|NOT COMPLETED|Overall Study||0
4995218|NCT02387008|12290726|P2|NOT COMPLETED|Overall Study||0
4995219|NCT02387008|12290727|P1|NOT COMPLETED|Overall Study||0
4995220|NCT02387008|12290725|P3|COMPLETED|Overall Study||4
4995221|NCT02387008|12290726|P2|COMPLETED|Overall Study||0
4995222|NCT02387008|12290727|P1|COMPLETED|Overall Study||2
4995223|NCT02387008|12290725|P3|STARTED|Overall Study||4
4995224|NCT02387008|12290726|P2|STARTED|Overall Study||0
4995225|NCT02387008|12290727|P1|STARTED|Overall Study||2
4995226|NCT02386345|12290744|P1|NOT COMPLETED|Overall Study||102
4995227|NCT02386345|12290744|P1|COMPLETED|Overall Study||197
4995228|NCT02386345|12290744|P1|STARTED|Overall Study||299
4995229|NCT02386189|12290754|P2|NOT COMPLETED|Overall Study||3
4995230|NCT02386189|12290755|P1|NOT COMPLETED|Overall Study||4
4995231|NCT02386189|12290754|P2|COMPLETED|Overall Study||30
4995232|NCT02386189|12290755|P1|COMPLETED|Overall Study||26
4995233|NCT02386189|12290754|P2|STARTED|Overall Study||33
4995234|NCT02386189|12290755|P1|STARTED|Overall Study||30
4995235|NCT02386098|12290778|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
4995236|NCT02386098|12290779|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
4995237|NCT02386098|12290780|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
4995238|NCT02386098|12290781|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
4995239|NCT02386098|12290782|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
4995240|NCT02386098|12290778|P5|COMPLETED|Stage 2 (96 Weeks)||0
4995241|NCT02386098|12290779|P4|COMPLETED|Stage 2 (96 Weeks)||0
4995242|NCT02386098|12290780|P3|COMPLETED|Stage 2 (96 Weeks)||0
4995243|NCT02386098|12290781|P2|COMPLETED|Stage 2 (96 Weeks)||0
4995244|NCT02386098|12290782|P1|COMPLETED|Stage 2 (96 Weeks)||0
4995245|NCT02386098|12290778|P5|STARTED|Stage 2 (96 Weeks)||0
4995246|NCT02386098|12290779|P4|STARTED|Stage 2 (96 Weeks)||0
4995247|NCT02386098|12290780|P3|STARTED|Stage 2 (96 Weeks)||0
4995248|NCT02386098|12290781|P2|STARTED|Stage 2 (96 Weeks)||0
4995249|NCT02386098|12290782|P1|STARTED|Stage 2 (96 Weeks)||0
4995250|NCT02386098|12290778|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
4995251|NCT02386098|12290779|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
4995252|NCT02386098|12290780|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
4995253|NCT02386098|12290781|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
4995254|NCT02386098|12290782|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
4995255|NCT02386098|12290778|P5|COMPLETED|Stage 1 (96 Weeks)||0
4995256|NCT02386098|12290779|P4|COMPLETED|Stage 1 (96 Weeks)||0
4995257|NCT02386098|12290780|P3|COMPLETED|Stage 1 (96 Weeks)||0
4995258|NCT02386098|12290781|P2|COMPLETED|Stage 1 (96 Weeks)||0
4995259|NCT02386098|12290782|P1|COMPLETED|Stage 1 (96 Weeks)||0
4995260|NCT02386098|12290778|P5|STARTED|Stage 1 (96 Weeks)||0
4995261|NCT02386098|12290779|P4|STARTED|Stage 1 (96 Weeks)||0
4995262|NCT02386098|12290780|P3|STARTED|Stage 1 (96 Weeks)||0
4995263|NCT02386098|12290781|P2|STARTED|Stage 1 (96 Weeks)||43
4995264|NCT02386098|12290782|P1|STARTED|Stage 1 (96 Weeks)||43
4995265|NCT02385799|12290861|P2|NOT COMPLETED|Overall Study||8
4995266|NCT02385799|12290862|P1|NOT COMPLETED|Overall Study||5
4995267|NCT02385799|12290861|P2|COMPLETED|Overall Study||24
4995268|NCT02385799|12290862|P1|COMPLETED|Overall Study||21
4995269|NCT02385799|12290861|P2|Completed End-of-Treatment Visit|Overall Study||26
4995270|NCT02385799|12290862|P1|Completed End-of-Treatment Visit|Overall Study||21
4995271|NCT02385799|12290861|P2|STARTED|Overall Study||32
4995272|NCT02385799|12290862|P1|STARTED|Overall Study||26
4995273|NCT02385721|12290896|P1|NOT COMPLETED|Overall Study||230
4995274|NCT02385721|12290896|P1|COMPLETED|Overall Study||371
4995275|NCT02385721|12290896|P1|STARTED|Overall Study||601
4995276|NCT02385708|12290903|P2|NOT COMPLETED|Overall Study||15
4995277|NCT02385708|12290904|P1|NOT COMPLETED|Overall Study||8
4995278|NCT02385708|12290903|P2|COMPLETED|Overall Study||67
4995279|NCT02385708|12290904|P1|COMPLETED|Overall Study||73
4995280|NCT02385708|12290903|P2|Intervention Started|Overall Study||82
4995281|NCT02385708|12290904|P1|Intervention Started|Overall Study||81
4995282|NCT02385708|12290903|P2|STARTED|Overall Study||82
4995283|NCT02385708|12290904|P1|STARTED|Overall Study||81
4995284|NCT02385669|12290910|P1|NOT COMPLETED|Overall Study||2
4995285|NCT02385669|12290910|P1|COMPLETED|Overall Study||1
4995286|NCT02385669|12290910|P1|STARTED|Overall Study||3
4995287|NCT02385526|12290918|P3|NOT COMPLETED|Overall Study||0
4995288|NCT02385526|12290919|P2|NOT COMPLETED|Overall Study||3
4995289|NCT02385526|12290920|P1|NOT COMPLETED|Overall Study||2
4995290|NCT02385526|12290918|P3|COMPLETED|Overall Study||20
4995291|NCT02385526|12290919|P2|COMPLETED|Overall Study||17
4995292|NCT02385526|12290920|P1|COMPLETED|Overall Study||20
4995293|NCT02385526|12290918|P3|STARTED|Overall Study||20
4995294|NCT02385526|12290919|P2|STARTED|Overall Study||20
4995295|NCT02385526|12290920|P1|STARTED|Overall Study||22
4995296|NCT02385084|12290928|P6|NOT COMPLETED|Period 3||0
4995297|NCT02385084|12290929|P5|NOT COMPLETED|Period 3||0
4995298|NCT02385084|12290930|P4|NOT COMPLETED|Period 3||0
4995299|NCT02385084|12290931|P3|NOT COMPLETED|Period 3||0
4995300|NCT02385084|12290932|P2|NOT COMPLETED|Period 3||0
4995301|NCT02385084|12290933|P1|NOT COMPLETED|Period 3||0
4995302|NCT02385084|12290928|P6|COMPLETED|Period 3||3
4995303|NCT02385084|12290929|P5|COMPLETED|Period 3||2
4995304|NCT02385084|12290930|P4|COMPLETED|Period 3||3
4995305|NCT02385084|12290931|P3|COMPLETED|Period 3||1
4995306|NCT02385084|12290932|P2|COMPLETED|Period 3||3
4995307|NCT02385084|12290933|P1|COMPLETED|Period 3||2
4995308|NCT02385084|12290928|P6|Washout|Period 3||3
4995309|NCT02385084|12290929|P5|Washout|Period 3||2
4995310|NCT02385084|12290930|P4|Washout|Period 3||3
4995311|NCT02385084|12290931|P3|Washout|Period 3||1
4995312|NCT02385084|12290932|P2|Washout|Period 3||3
4995313|NCT02385084|12290933|P1|Washout|Period 3||2
4995314|NCT02385084|12290928|P6|Received LY2409021|Period 3||3
4995315|NCT02385084|12290929|P5|Received LY2409021|Period 3||2
4995316|NCT02385084|12290930|P4|Received LY2409021|Period 3||3
4995317|NCT02385084|12290931|P3|Received LY2409021|Period 3||1
4995318|NCT02385084|12290932|P2|Received LY2409021|Period 3||3
4995319|NCT02385084|12290933|P1|Received LY2409021|Period 3||2
4995320|NCT02385084|12290928|P6|STARTED|Period 3||3
4995321|NCT02385084|12290929|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
4995322|NCT02385084|12290930|P4|STARTED|Period 3||3
4995323|NCT02385084|12290931|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
4995324|NCT02385084|12290932|P2|STARTED|Period 3||3
4995325|NCT02385084|12290933|P1|STARTED|Period 3||2
4995326|NCT02385084|12290928|P6|NOT COMPLETED|Period 2||0
4995327|NCT02385084|12290929|P5|NOT COMPLETED|Period 2||0
4995328|NCT02385084|12290930|P4|NOT COMPLETED|Period 2||0
4995329|NCT02385084|12290931|P3|NOT COMPLETED|Period 2||1
4995330|NCT02385084|12290932|P2|NOT COMPLETED|Period 2||0
4995331|NCT02385084|12290933|P1|NOT COMPLETED|Period 2||0
4995332|NCT02385084|12290928|P6|COMPLETED|Period 2||3
4995333|NCT02385084|12290929|P5|COMPLETED|Period 2||3
4995334|NCT02385084|12290930|P4|COMPLETED|Period 2||3
4995335|NCT02385084|12290931|P3|COMPLETED|Period 2||2
4995336|NCT02385084|12290932|P2|COMPLETED|Period 2||3
4995337|NCT02385084|12290933|P1|COMPLETED|Period 2||2
4995338|NCT02385084|12290928|P6|Washout|Period 2||3
4995339|NCT02385084|12290929|P5|Washout|Period 2||3
4995340|NCT02385084|12290930|P4|Washout|Period 2||3
4995341|NCT02385084|12290931|P3|Washout|Period 2||3
4995342|NCT02385084|12290932|P2|Washout|Period 2||3
4995343|NCT02385084|12290933|P1|Washout|Period 2||2
4995344|NCT02385084|12290928|P6|Received LY2409021|Period 2||3
4995345|NCT02385084|12290929|P5|Received LY2409021|Period 2||3
4995346|NCT02385084|12290930|P4|Received LY2409021|Period 2||3
4995347|NCT02385084|12290931|P3|Received LY2409021|Period 2||3
4995348|NCT02385084|12290932|P2|Received LY2409021|Period 2||3
4995349|NCT02385084|12290933|P1|Received LY2409021|Period 2||2
4995350|NCT02385084|12290928|P6|STARTED|Period 2||3
4995351|NCT02385084|12290929|P5|STARTED|Period 2||3
4995352|NCT02385084|12290930|P4|STARTED|Period 2||3
4995353|NCT02385084|12290931|P3|STARTED|Period 2||3
4995354|NCT02385084|12290932|P2|STARTED|Period 2||3
4995355|NCT02385084|12290933|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
4995356|NCT02385084|12290928|P6|NOT COMPLETED|Period 1||0
4995357|NCT02385084|12290929|P5|NOT COMPLETED|Period 1||0
4995358|NCT02385084|12290930|P4|NOT COMPLETED|Period 1||0
4995359|NCT02385084|12290931|P3|NOT COMPLETED|Period 1||0
4995360|NCT02385084|12290932|P2|NOT COMPLETED|Period 1||0
4995361|NCT02385084|12290933|P1|NOT COMPLETED|Period 1||0
4995362|NCT02385084|12290928|P6|COMPLETED|Period 1||3
4995363|NCT02385084|12290929|P5|COMPLETED|Period 1||3
4995364|NCT02385084|12290930|P4|COMPLETED|Period 1||3
4995365|NCT02385084|12290931|P3|COMPLETED|Period 1||3
4995366|NCT02385084|12290932|P2|COMPLETED|Period 1||3
4995367|NCT02385084|12290933|P1|COMPLETED|Period 1||3
4995368|NCT02385084|12290928|P6|Washout|Period 1||3
4995369|NCT02385084|12290929|P5|Washout|Period 1||3
4995370|NCT02385084|12290930|P4|Washout|Period 1||3
4995371|NCT02385084|12290931|P3|Washout|Period 1||3
4995372|NCT02385084|12290932|P2|Washout|Period 1||3
4995373|NCT02385084|12290933|P1|Washout|Period 1||3
4995374|NCT02385084|12290928|P6|Received LY2409021|Period 1||3
4995375|NCT02385084|12290929|P5|Received LY2409021|Period 1||3
4995376|NCT02385084|12290930|P4|Received LY2409021|Period 1||3
4995377|NCT02385084|12290931|P3|Received LY2409021|Period 1||3
4995378|NCT02385084|12290932|P2|Received LY2409021|Period 1||3
4995379|NCT02385084|12290933|P1|Received LY2409021|Period 1||3
4995380|NCT02385084|12290928|P6|STARTED|Period 1||3
4995381|NCT02385084|12290929|P5|STARTED|Period 1||3
4995382|NCT02385084|12290930|P4|STARTED|Period 1||3
4995383|NCT02385084|12290931|P3|STARTED|Period 1||3
4995384|NCT02385084|12290932|P2|STARTED|Period 1||3
4995385|NCT02385084|12290933|P1|STARTED|Period 1||3
4995386|NCT02384993|12290946|P2|NOT COMPLETED|Overall Study||1
4995387|NCT02384993|12290947|P1|NOT COMPLETED|Overall Study||0
4995388|NCT02384993|12290946|P2|COMPLETED|Overall Study||11
4995389|NCT02384993|12290947|P1|COMPLETED|Overall Study||12
4995390|NCT02384993|12290946|P2|STARTED|Overall Study||12
4995391|NCT02384993|12290947|P1|STARTED|Overall Study||12
4995392|NCT02384941|12290973|P3|NOT COMPLETED|Overall Study||41
4995393|NCT02384941|12290974|P2|NOT COMPLETED|Overall Study||35
4995394|NCT02384941|12290975|P1|NOT COMPLETED|Overall Study||50
4995395|NCT02384941|12290973|P3|COMPLETED|Overall Study||221
4995396|NCT02384941|12290974|P2|COMPLETED|Overall Study||228
4995397|NCT02384941|12290975|P1|COMPLETED|Overall Study||218
4995398|NCT02384941|12290973|P3|STARTED|Overall Study||262
4995399|NCT02384941|12290974|P2|STARTED|Overall Study||263
4995400|NCT02384941|12290975|P1|STARTED|Overall Study||268
4995401|NCT02384538|12291006|P2|NOT COMPLETED|Overall Study||15
4995402|NCT02384538|12291007|P1|NOT COMPLETED|Overall Study||6
4995403|NCT02384538|12291006|P2|COMPLETED|Overall Study||49
4995404|NCT02384538|12291007|P1|COMPLETED|Overall Study||61
4995405|NCT02384538|12291006|P2|STARTED|Overall Study||64
4995406|NCT02384538|12291007|P1|STARTED|Overall Study||67
4995407|NCT02384460|12291027|P2|NOT COMPLETED|Overall Study||7
4995408|NCT02384460|12291028|P1|NOT COMPLETED|Overall Study||7
4995409|NCT02384460|12291027|P2|COMPLETED|Overall Study||80
4995410|NCT02384460|12291028|P1|COMPLETED|Overall Study||75
4995411|NCT02384460|12291027|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
4995412|NCT02384460|12291028|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
4995413|NCT02384460|12291027|P2|STARTED|Overall Study||87
4995414|NCT02384460|12291028|P1|STARTED|Overall Study||82
4995415|NCT02384382|12291046|P1|NOT COMPLETED|Overall Study||23
4995416|NCT02384382|12291046|P1|COMPLETED|Overall Study||0
4995417|NCT02384382|12291046|P1|STARTED|Overall Study||23
4995418|NCT02384200|12291053|P2|NOT COMPLETED|Overall Study||0
4995419|NCT02384200|12291054|P1|NOT COMPLETED|Overall Study||0
4995420|NCT02384200|12291053|P2|COMPLETED|Overall Study||43
4995421|NCT02384200|12291054|P1|COMPLETED|Overall Study||43
4995422|NCT02384200|12291053|P2|STARTED|Overall Study||43
4995423|NCT02384200|12291054|P1|STARTED|Overall Study||43
4995424|NCT02384096|12291080|P2|NOT COMPLETED|Second Intervention (7 Days)||1
4995425|NCT02384096|12291081|P1|NOT COMPLETED|Second Intervention (7 Days)||0
4995426|NCT02384096|12291080|P2|COMPLETED|Second Intervention (7 Days)||6
4995427|NCT02384096|12291081|P1|COMPLETED|Second Intervention (7 Days)||4
4995428|NCT02384096|12291080|P2|STARTED|Second Intervention (7 Days)||7
4995429|NCT02384096|12291081|P1|STARTED|Second Intervention (7 Days)||4
4995430|NCT02384096|12291080|P2|NOT COMPLETED|First Intervention (7 Days)||0
4995431|NCT02384096|12291081|P1|NOT COMPLETED|First Intervention (7 Days)||1
4995432|NCT02384096|12291080|P2|COMPLETED|First Intervention (7 Days)||7
4995433|NCT02384096|12291081|P1|COMPLETED|First Intervention (7 Days)||4
4995434|NCT02384096|12291080|P2|STARTED|First Intervention (7 Days)||7
4995435|NCT02384096|12291081|P1|STARTED|First Intervention (7 Days)||5
4995436|NCT02384070|12291089|P3|NOT COMPLETED|Overall Study||0
4995437|NCT02384070|12291090|P2|NOT COMPLETED|Overall Study||0
4995438|NCT02384070|12291091|P1|NOT COMPLETED|Overall Study||0
4995439|NCT02384070|12291089|P3|COMPLETED|Overall Study||100
4995440|NCT02384070|12291090|P2|COMPLETED|Overall Study||100
4995441|NCT02384070|12291091|P1|COMPLETED|Overall Study||100
4995442|NCT02384070|12291089|P3|STARTED|Overall Study||100
4995443|NCT02384070|12291090|P2|STARTED|Overall Study||100
4995444|NCT02384070|12291091|P1|STARTED|Overall Study||100
4995445|NCT02384044|12291107|P2|NOT COMPLETED|Overall Study||0
4995446|NCT02384044|12291108|P1|NOT COMPLETED|Overall Study||0
4995447|NCT02384044|12291107|P2|COMPLETED|Overall Study||15
4995448|NCT02384044|12291108|P1|COMPLETED|Overall Study||15
4995449|NCT02384044|12291107|P2|STARTED|Overall Study||15
4995450|NCT02384044|12291108|P1|STARTED|Overall Study||15
4995451|NCT02383966|12291118|P2|NOT COMPLETED|Overall Study||7
4995452|NCT02383966|12291119|P1|NOT COMPLETED|Overall Study||26
4995453|NCT02383966|12291118|P2|COMPLETED|Overall Study||72
4995454|NCT02383966|12291119|P1|COMPLETED|Overall Study||138
4995455|NCT02383966|12291118|P2|STARTED|Overall Study||79
4995456|NCT02383966|12291119|P1|STARTED|Overall Study||164
4995457|NCT02383940|12291139|P2|NOT COMPLETED|Overall Study||3
4995458|NCT02383940|12291140|P1|NOT COMPLETED|Overall Study||9
4995459|NCT02383940|12291139|P2|COMPLETED|Overall Study||40
4995460|NCT02383940|12291140|P1|COMPLETED|Overall Study||35
4995461|NCT02383940|12291139|P2|Treated|Overall Study||43
4995462|NCT02383940|12291140|P1|Treated|Overall Study||42
4995463|NCT02383940|12291139|P2|STARTED|Overall Study||43
4995464|NCT02383940|12291140|P1|STARTED|Overall Study||44
4995465|NCT02383862|12291156|P2|NOT COMPLETED|3 Month Follow up||21
4995466|NCT02383862|12291157|P1|NOT COMPLETED|3 Month Follow up||23
4995467|NCT02383862|12291156|P2|COMPLETED|3 Month Follow up||128
4995468|NCT02383862|12291157|P1|COMPLETED|3 Month Follow up||128
4995469|NCT02383862|12291156|P2|STARTED|3 Month Follow up||149
4995470|NCT02383862|12291157|P1|STARTED|3 Month Follow up||151
4995471|NCT02383862|12291156|P2|NOT COMPLETED|Baseline||0
4995472|NCT02383862|12291157|P1|NOT COMPLETED|Baseline||0
4995473|NCT02383862|12291156|P2|COMPLETED|Baseline||149
4995474|NCT02383862|12291157|P1|COMPLETED|Baseline||151
4995475|NCT02383862|12291156|P2|STARTED|Baseline||149
4995476|NCT02383862|12291157|P1|STARTED|Baseline||151
4995477|NCT02383758|12291190|P2|NOT COMPLETED|Overall Study||2
4995478|NCT02383758|12291191|P1|NOT COMPLETED|Overall Study||0
4995479|NCT02383758|12291190|P2|COMPLETED|Overall Study||8
4995480|NCT02383758|12291191|P1|COMPLETED|Overall Study||10
4995481|NCT02383758|12291190|P2|STARTED|Overall Study||10
4995482|NCT02383758|12291191|P1|STARTED|Overall Study||10
4995483|NCT02383719|12291203|P1|NOT COMPLETED|Overall Study||0
4995484|NCT02383719|12291203|P1|COMPLETED|Overall Study||18
4995485|NCT02383719|12291203|P1|STARTED|Overall Study||18
4995486|NCT02383706|12291207|P1|NOT COMPLETED|Overall Study||28
4995487|NCT02383706|12291207|P1|COMPLETED|Overall Study||80
4995488|NCT02383706|12291207|P1|STARTED|Overall Study||108
4995489|NCT02383667|12291213|P1|NOT COMPLETED|Overall Study||0
4995490|NCT02383667|12291213|P1|COMPLETED|Overall Study||20
4995491|NCT02383667|12291213|P1|STARTED|Overall Study||20
4995492|NCT02383589|12291219|P2|NOT COMPLETED|Overall Study||10
4995493|NCT02383589|12291220|P1|NOT COMPLETED|Overall Study||1
4995494|NCT02383589|12291219|P2|COMPLETED|Overall Study||58
4995495|NCT02383589|12291220|P1|COMPLETED|Overall Study||66
4995496|NCT02383589|12291219|P2|STARTED|Overall Study||68
4995497|NCT02383589|12291220|P1|STARTED|Overall Study||67
4995498|NCT02383576|12291243|P2|NOT COMPLETED|Overall Study||45
4995499|NCT02383576|12291244|P1|NOT COMPLETED|Overall Study||63
4995500|NCT02383576|12291243|P2|COMPLETED|Overall Study||46
4995501|NCT02383576|12291244|P1|COMPLETED|Overall Study||31
4995502|NCT02383576|12291243|P2|STARTED|Overall Study||91
4995503|NCT02383576|12291244|P1|STARTED|Overall Study||94
4995504|NCT02383472|12291260|P2|NOT COMPLETED|Overall Study||1
4995505|NCT02383472|12291261|P1|NOT COMPLETED|Overall Study||1
4995506|NCT02383472|12291260|P2|COMPLETED|Overall Study||29
4995507|NCT02383472|12291261|P1|COMPLETED|Overall Study||22
4995508|NCT02383472|12291260|P2|STARTED|Overall Study||30
4995509|NCT02383472|12291261|P1|STARTED|Overall Study||23
4995510|NCT02383433|12291275|P1|NOT COMPLETED|Overall Study||2
4995511|NCT02383433|12291275|P1|COMPLETED|Overall Study||0
4995512|NCT02383433|12291275|P1|STARTED|Overall Study||2
4995513|NCT02383420|12291282|P3|NOT COMPLETED|Overall Study||0
4995514|NCT02383420|12291283|P2|NOT COMPLETED|Overall Study||0
4995515|NCT02383420|12291284|P1|NOT COMPLETED|Overall Study||2
4995516|NCT02383420|12291282|P3|COMPLETED|Overall Study||3
4995517|NCT02383420|12291283|P2|COMPLETED|Overall Study||10
4995518|NCT02383420|12291284|P1|COMPLETED|Overall Study||8
4995519|NCT02383420|12291282|P3|STARTED|Overall Study||3
4995520|NCT02383420|12291283|P2|STARTED|Overall Study||10
4995521|NCT02383420|12291284|P1|STARTED|Overall Study||10
4995522|NCT02383355|12291294|P2|NOT COMPLETED|Overall Study||0
4995523|NCT02383355|12291295|P1|NOT COMPLETED|Overall Study||2
4995524|NCT02383355|12291294|P2|COMPLETED|Overall Study||21
4995525|NCT02383355|12291295|P1|COMPLETED|Overall Study||17
4995526|NCT02383355|12291294|P2|STARTED|Overall Study||21
4995527|NCT02383355|12291295|P1|STARTED|Overall Study||19
4995528|NCT02383056|12291311|P2|NOT COMPLETED|Overall Study||2
4995529|NCT02383056|12291312|P1|NOT COMPLETED|Overall Study||1
4995530|NCT02383056|12291311|P2|COMPLETED|Overall Study||5
4995531|NCT02383056|12291312|P1|COMPLETED|Overall Study||6
4995532|NCT02383056|12291311|P2|STARTED|Overall Study||7
4995533|NCT02383056|12291312|P1|STARTED|Overall Study||7
4995534|NCT02383043|12291325|P3|NOT COMPLETED|Overall Study||0
4995535|NCT02383043|12291326|P2|NOT COMPLETED|Overall Study||0
4995536|NCT02383043|12291327|P1|NOT COMPLETED|Overall Study||2
4995537|NCT02383043|12291325|P3|COMPLETED|Overall Study||4
4995538|NCT02383043|12291326|P2|COMPLETED|Overall Study||5
4995539|NCT02383043|12291327|P1|COMPLETED|Overall Study||7
4995540|NCT02383043|12291325|P3|STARTED|Overall Study||4
4995541|NCT02383043|12291326|P2|STARTED|Overall Study||5
4995542|NCT02383043|12291327|P1|STARTED|Overall Study||9
4995543|NCT02382991|12291338|P2|NOT COMPLETED|Overall Study||3
4995544|NCT02382991|12291339|P1|NOT COMPLETED|Overall Study||2
4995545|NCT02382991|12291338|P2|COMPLETED|Overall Study||15
4995546|NCT02382991|12291339|P1|COMPLETED|Overall Study||15
4995547|NCT02382991|12291338|P2|STARTED|Overall Study||18
4995548|NCT02382991|12291339|P1|STARTED|Overall Study||17
4995549|NCT02382939|12291351|P2|NOT COMPLETED|Overall Study||3
4995550|NCT02382939|12291352|P1|NOT COMPLETED|Overall Study||3
4995551|NCT02382939|12291351|P2|COMPLETED|Overall Study||58
4995552|NCT02382939|12291352|P1|COMPLETED|Overall Study||28
4995553|NCT02382939|12291351|P2|Exposed|Overall Study||61
4995554|NCT02382939|12291352|P1|Exposed|Overall Study||31
4995555|NCT02382939|12291351|P2|STARTED|Overall Study||61
4995556|NCT02382939|12291352|P1|STARTED|Overall Study||31
4995557|NCT02382913|12291373|P10|NOT COMPLETED|Overall Study||0
4995558|NCT02382913|12291374|P9|NOT COMPLETED|Overall Study||0
4995559|NCT02382913|12291375|P8|NOT COMPLETED|Overall Study||0
4995560|NCT02382913|12291376|P7|NOT COMPLETED|Overall Study||0
4995561|NCT02382913|12291377|P6|NOT COMPLETED|Overall Study||0
4995562|NCT02382913|12291378|P5|NOT COMPLETED|Overall Study||0
4995563|NCT02382913|12291379|P4|NOT COMPLETED|Overall Study||0
4995564|NCT02382913|12291380|P3|NOT COMPLETED|Overall Study||0
4995565|NCT02382913|12291381|P2|NOT COMPLETED|Overall Study||0
4995566|NCT02382913|12291382|P1|NOT COMPLETED|Overall Study||0
4995567|NCT02382913|12291373|P10|COMPLETED|Overall Study||33
4995568|NCT02382913|12291374|P9|COMPLETED|Overall Study||30
4995569|NCT02382913|12291375|P8|COMPLETED|Overall Study||30
4995570|NCT02382913|12291376|P7|COMPLETED|Overall Study||37
4995571|NCT02382913|12291377|P6|COMPLETED|Overall Study||30
4995572|NCT02382913|12291378|P5|COMPLETED|Overall Study||33
4995573|NCT02382913|12291379|P4|COMPLETED|Overall Study||27
4995574|NCT02382913|12291380|P3|COMPLETED|Overall Study||32
4995575|NCT02382913|12291381|P2|COMPLETED|Overall Study||36
4995576|NCT02382913|12291382|P1|COMPLETED|Overall Study||27
4995577|NCT02382913|12291373|P10|STARTED|Overall Study||33
4995578|NCT02382913|12291374|P9|STARTED|Overall Study||30
4995579|NCT02382913|12291375|P8|STARTED|Overall Study||30
4995580|NCT02382913|12291376|P7|STARTED|Overall Study||37
4995581|NCT02382913|12291377|P6|STARTED|Overall Study||30
4995582|NCT02382913|12291378|P5|STARTED|Overall Study||33
4995583|NCT02382913|12291379|P4|STARTED|Overall Study||27
4995584|NCT02382913|12291380|P3|STARTED|Overall Study||32
4995585|NCT02382913|12291381|P2|STARTED|Overall Study||36
4995586|NCT02382913|12291382|P1|STARTED|Overall Study||27
4995587|NCT02382848|12291418|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
4995588|NCT02382848|12291419|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
4995589|NCT02382848|12291418|P2|COMPLETED|Second Intervention (3 Weeks)||5
4995590|NCT02382848|12291419|P1|COMPLETED|Second Intervention (3 Weeks)||3
4995591|NCT02382848|12291418|P2|STARTED|Second Intervention (3 Weeks)||5
4995592|NCT02382848|12291419|P1|STARTED|Second Intervention (3 Weeks)||3
4995593|NCT02382848|12291418|P2|NOT COMPLETED|Washout (1 Week)||0
4995594|NCT02382848|12291419|P1|NOT COMPLETED|Washout (1 Week)||0
4995595|NCT02382848|12291418|P2|COMPLETED|Washout (1 Week)||5
4995596|NCT02382848|12291419|P1|COMPLETED|Washout (1 Week)||3
4995597|NCT02382848|12291418|P2|STARTED|Washout (1 Week)||5
4995598|NCT02382848|12291419|P1|STARTED|Washout (1 Week)||3
4995599|NCT02382848|12291418|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
4995600|NCT02382848|12291419|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
4995601|NCT02382848|12291418|P2|COMPLETED|First Intervention (3 Weeks)||5
4995602|NCT02382848|12291419|P1|COMPLETED|First Intervention (3 Weeks)||3
4995603|NCT02382848|12291418|P2|STARTED|First Intervention (3 Weeks)||5
4995604|NCT02382848|12291419|P1|STARTED|First Intervention (3 Weeks)||3
4995605|NCT02382796|12291435|P1|NOT COMPLETED|Overall Study||7
4995606|NCT02382796|12291435|P1|COMPLETED|Overall Study||0
4995607|NCT02382796|12291435|P1|STARTED|Overall Study||7
4995608|NCT02382744|12291442|P2|NOT COMPLETED|Overall Study||0
4995609|NCT02382744|12291443|P1|NOT COMPLETED|Overall Study||0
4995610|NCT02382744|12291442|P2|COMPLETED|Overall Study||40
4995611|NCT02382744|12291443|P1|COMPLETED|Overall Study||40
4995612|NCT02382744|12291442|P2|Analyzed|Overall Study||40
4995613|NCT02382744|12291443|P1|Analyzed|Overall Study||40
4995614|NCT02382744|12291442|P2|Allocated|Overall Study||40
4995615|NCT02382744|12291443|P1|Allocated|Overall Study||40
4995616|NCT02382744|12291442|P2|STARTED|Overall Study||40
4995617|NCT02382744|12291443|P1|STARTED|Overall Study||40
4995618|NCT02382705|12291474|P1|NOT COMPLETED|Overall Study||24
4995619|NCT02382705|12291474|P1|COMPLETED|Overall Study||33
4995620|NCT02382705|12291474|P1|STARTED|Overall Study||57
4995621|NCT02382640|12291485|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4995622|NCT02382640|12291486|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4995623|NCT02382640|12291487|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
4995624|NCT02382640|12291488|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
4995625|NCT02382640|12291485|P4|COMPLETED|Intervention Period 4 (3 Days)||9
4995626|NCT02382640|12291486|P3|COMPLETED|Intervention Period 4 (3 Days)||9
4995627|NCT02382640|12291487|P2|COMPLETED|Intervention Period 4 (3 Days)||9
4995628|NCT02382640|12291488|P1|COMPLETED|Intervention Period 4 (3 Days)||8
4995629|NCT02382640|12291485|P4|STARTED|Intervention Period 4 (3 Days)||9
4995630|NCT02382640|12291486|P3|STARTED|Intervention Period 4 (3 Days)||9
4995631|NCT02382640|12291487|P2|STARTED|Intervention Period 4 (3 Days)||9
4995632|NCT02382640|12291488|P1|STARTED|Intervention Period 4 (3 Days)||9
4995633|NCT02382640|12291485|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
4995634|NCT02382640|12291486|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
4995635|NCT02382640|12291487|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
4995636|NCT02382640|12291488|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
4995637|NCT02382640|12291485|P4|COMPLETED|Washout Period 3 (7 Days)||9
4995638|NCT02382640|12291486|P3|COMPLETED|Washout Period 3 (7 Days)||9
4995639|NCT02382640|12291487|P2|COMPLETED|Washout Period 3 (7 Days)||9
4995640|NCT02382640|12291488|P1|COMPLETED|Washout Period 3 (7 Days)||9
4995641|NCT02382640|12291485|P4|STARTED|Washout Period 3 (7 Days)||9
4995642|NCT02382640|12291486|P3|STARTED|Washout Period 3 (7 Days)||9
4995643|NCT02382640|12291487|P2|STARTED|Washout Period 3 (7 Days)||9
4995644|NCT02382640|12291488|P1|STARTED|Washout Period 3 (7 Days)||9
4995645|NCT02382640|12291485|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4995646|NCT02382640|12291486|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4995647|NCT02382640|12291487|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4995648|NCT02382640|12291488|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
4995649|NCT02382640|12291485|P4|COMPLETED|Intervention Period 3 (3 Days)||9
4995650|NCT02382640|12291486|P3|COMPLETED|Intervention Period 3 (3 Days)||9
4995651|NCT02382640|12291487|P2|COMPLETED|Intervention Period 3 (3 Days)||9
4995652|NCT02382640|12291488|P1|COMPLETED|Intervention Period 3 (3 Days)||9
4995653|NCT02382640|12291485|P4|STARTED|Intervention Period 3 (3 Days)||9
4995654|NCT02382640|12291486|P3|STARTED|Intervention Period 3 (3 Days)||9
4995655|NCT02382640|12291487|P2|STARTED|Intervention Period 3 (3 Days)||9
4995656|NCT02382640|12291488|P1|STARTED|Intervention Period 3 (3 Days)||9
4995657|NCT02382640|12291485|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
4995658|NCT02382640|12291486|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
4995659|NCT02382640|12291487|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
4995660|NCT02382640|12291488|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
4995661|NCT02382640|12291485|P4|COMPLETED|Washout Period 2 (7 Days)||9
4995662|NCT02382640|12291486|P3|COMPLETED|Washout Period 2 (7 Days)||9
4995663|NCT02382640|12291487|P2|COMPLETED|Washout Period 2 (7 Days)||9
4995664|NCT02382640|12291488|P1|COMPLETED|Washout Period 2 (7 Days)||9
4995665|NCT02382640|12291485|P4|STARTED|Washout Period 2 (7 Days)||9
4995666|NCT02382640|12291486|P3|STARTED|Washout Period 2 (7 Days)||9
4995667|NCT02382640|12291487|P2|STARTED|Washout Period 2 (7 Days)||9
4995668|NCT02382640|12291488|P1|STARTED|Washout Period 2 (7 Days)||9
4995669|NCT02382640|12291485|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4995670|NCT02382640|12291486|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4995671|NCT02382640|12291487|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4995672|NCT02382640|12291488|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
4995673|NCT02382640|12291485|P4|COMPLETED|Intervention Period 2 (3 Days)||9
4995674|NCT02382640|12291486|P3|COMPLETED|Intervention Period 2 (3 Days)||9
4995675|NCT02382640|12291487|P2|COMPLETED|Intervention Period 2 (3 Days)||9
4995676|NCT02382640|12291488|P1|COMPLETED|Intervention Period 2 (3 Days)||9
4995677|NCT02382640|12291485|P4|STARTED|Intervention Period 2 (3 Days)||9
4995678|NCT02382640|12291486|P3|STARTED|Intervention Period 2 (3 Days)||9
4995679|NCT02382640|12291487|P2|STARTED|Intervention Period 2 (3 Days)||9
4995680|NCT02382640|12291488|P1|STARTED|Intervention Period 2 (3 Days)||9
4995681|NCT02382640|12291485|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
4995682|NCT02382640|12291486|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
4995683|NCT02382640|12291487|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
4995684|NCT02382640|12291488|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
4995685|NCT02382640|12291485|P4|COMPLETED|Washout Period 1 (7 Days)||9
4995686|NCT02382640|12291486|P3|COMPLETED|Washout Period 1 (7 Days)||9
4995687|NCT02382640|12291487|P2|COMPLETED|Washout Period 1 (7 Days)||9
4995688|NCT02382640|12291488|P1|COMPLETED|Washout Period 1 (7 Days)||9
4995689|NCT02382640|12291485|P4|STARTED|Washout Period 1 (7 Days)||9
4995690|NCT02382640|12291486|P3|STARTED|Washout Period 1 (7 Days)||9
4995691|NCT02382640|12291487|P2|STARTED|Washout Period 1 (7 Days)||9
4995692|NCT02382640|12291488|P1|STARTED|Washout Period 1 (7 Days)||9
4995693|NCT02382640|12291485|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4995694|NCT02382640|12291486|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4995695|NCT02382640|12291487|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4995696|NCT02382640|12291488|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
4995697|NCT02382640|12291485|P4|COMPLETED|Intervention Period 1 (3 Days)||9
4995698|NCT02382640|12291486|P3|COMPLETED|Intervention Period 1 (3 Days)||9
4995699|NCT02382640|12291487|P2|COMPLETED|Intervention Period 1 (3 Days)||9
4995700|NCT02382640|12291488|P1|COMPLETED|Intervention Period 1 (3 Days)||9
4995701|NCT02382640|12291485|P4|STARTED|Intervention Period 1 (3 Days)||9
4995702|NCT02382640|12291486|P3|STARTED|Intervention Period 1 (3 Days)||9
4995703|NCT02382640|12291487|P2|STARTED|Intervention Period 1 (3 Days)||9
4995704|NCT02382640|12291488|P1|STARTED|Intervention Period 1 (3 Days)||9
4995705|NCT02382276|12291529|P3|NOT COMPLETED|Overall Study||39
4995706|NCT02382276|12291530|P2|NOT COMPLETED|Overall Study||10
4995707|NCT02382276|12291531|P1|NOT COMPLETED|Overall Study||11
4995708|NCT02382276|12291529|P3|COMPLETED|Overall Study||133
4995709|NCT02382276|12291530|P2|COMPLETED|Overall Study||84
4995710|NCT02382276|12291531|P1|COMPLETED|Overall Study||126
4995711|NCT02382276|12291529|P3|STARTED|Overall Study||172
4995712|NCT02382276|12291530|P2|STARTED|Overall Study||94
4995713|NCT02382276|12291531|P1|STARTED|Overall Study||137
4995714|NCT02382133|12291543|P1|NOT COMPLETED|Overall Study||33
4995715|NCT02382133|12291543|P1|COMPLETED|Overall Study||10
4995716|NCT02382133|12291543|P1|STARTED|Overall Study||43
4995717|NCT02382016|12291550|P2|NOT COMPLETED|OL Extension Period||0
4995718|NCT02382016|12291551|P1|NOT COMPLETED|OL Extension Period||6
4995719|NCT02382016|12291550|P2|COMPLETED|OL Extension Period||0
4995720|NCT02382016|12291551|P1|COMPLETED|OL Extension Period||27
4995721|NCT02382016|12291550|P2|STARTED|OL Extension Period||0
4995722|NCT02382016|12291551|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
4995723|NCT02382016|12291550|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
4995724|NCT02382016|12291551|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
4995725|NCT02382016|12291550|P2|COMPLETED|Open-label (OL) Treatment Period||0
4995726|NCT02382016|12291551|P1|COMPLETED|Open-label (OL) Treatment Period||71
4995727|NCT02382016|12291550|P2|STARTED|Open-label (OL) Treatment Period||0
4995728|NCT02382016|12291551|P1|STARTED|Open-label (OL) Treatment Period||80
4995729|NCT02382016|12291550|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
4995730|NCT02382016|12291551|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
4995731|NCT02382016|12291550|P2|COMPLETED|Double-blind (DB) Treatment Period||41
4995732|NCT02382016|12291551|P1|COMPLETED|Double-blind (DB) Treatment Period||39
4995733|NCT02382016|12291550|P2|STARTED|Double-blind (DB) Treatment Period||42
4995734|NCT02382016|12291551|P1|STARTED|Double-blind (DB) Treatment Period||43
4995735|NCT02381795|12291575|P1|NOT COMPLETED|Overall Study||3
4995736|NCT02381795|12291575|P1|COMPLETED|Overall Study||7
4995737|NCT02381795|12291575|P1|STARTED|Overall Study||10
4995738|NCT02381678|12291579|P3|NOT COMPLETED|Overall Study||0
4995739|NCT02381678|12291580|P2|NOT COMPLETED|Overall Study||0
4995740|NCT02381678|12291581|P1|NOT COMPLETED|Overall Study||0
4995741|NCT02381678|12291579|P3|COMPLETED|Overall Study||32
4995742|NCT02381678|12291580|P2|COMPLETED|Overall Study||139
4995743|NCT02381678|12291581|P1|COMPLETED|Overall Study||54
4995744|NCT02381678|12291579|P3|STARTED|Overall Study||32
4995745|NCT02381678|12291580|P2|STARTED|Overall Study||139
4995746|NCT02381678|12291581|P1|STARTED|Overall Study||54
4995747|NCT02381418|12291587|P1|NOT COMPLETED|Overall Study||0
4995748|NCT02381418|12291587|P1|COMPLETED|Overall Study||120
4995749|NCT02381418|12291587|P1|STARTED|Overall Study||120
4995750|NCT02381392|12291595|P2|NOT COMPLETED|Overall Study||0
4995751|NCT02381392|12291596|P1|NOT COMPLETED|Overall Study||0
4995752|NCT02381392|12291595|P2|COMPLETED|Overall Study||12
4995753|NCT02381392|12291596|P1|COMPLETED|Overall Study||11
4995754|NCT02381392|12291595|P2|STARTED|Overall Study||12
4995755|NCT02381392|12291596|P1|STARTED|Overall Study||11
4995756|NCT02381288|12291614|P4|NOT COMPLETED|Overall Study||0
4995757|NCT02381288|12291615|P3|NOT COMPLETED|Overall Study||0
4995758|NCT02381288|12291616|P2|NOT COMPLETED|Overall Study||0
4995759|NCT02381288|12291617|P1|NOT COMPLETED|Overall Study||0
4995760|NCT02381288|12291614|P4|COMPLETED|Overall Study||5
4995761|NCT02381288|12291615|P3|COMPLETED|Overall Study||5
4995762|NCT02381288|12291616|P2|COMPLETED|Overall Study||2
4995763|NCT02381288|12291617|P1|COMPLETED|Overall Study||5
4995764|NCT02381288|12291614|P4|STARTED|Overall Study||5
4995765|NCT02381288|12291615|P3|STARTED|Overall Study||5
4995766|NCT02381288|12291616|P2|STARTED|Overall Study||2
4995767|NCT02381288|12291617|P1|STARTED|Overall Study||5
4995768|NCT02381015|12291648|P4|NOT COMPLETED|Year 3 Chart Review||51
4995769|NCT02381015|12291649|P3|NOT COMPLETED|Year 3 Chart Review||58
4995770|NCT02381015|12291650|P2|NOT COMPLETED|Year 3 Chart Review||34
4995771|NCT02381015|12291651|P1|NOT COMPLETED|Year 3 Chart Review||47
4995772|NCT02381015|12291648|P4|COMPLETED|Year 3 Chart Review||118
4995773|NCT02381015|12291649|P3|COMPLETED|Year 3 Chart Review||115
4995774|NCT02381015|12291650|P2|COMPLETED|Year 3 Chart Review||134
4995775|NCT02381015|12291651|P1|COMPLETED|Year 3 Chart Review||125
4995776|NCT02381015|12291648|P4|STARTED|Year 3 Chart Review||169
4995777|NCT02381015|12291649|P3|STARTED|Year 3 Chart Review||173
4995778|NCT02381015|12291650|P2|STARTED|Year 3 Chart Review||168
4995779|NCT02381015|12291651|P1|STARTED|Year 3 Chart Review||172
4995780|NCT02381015|12291648|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
4995781|NCT02381015|12291649|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
4995782|NCT02381015|12291650|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
4995783|NCT02381015|12291651|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
4995784|NCT02381015|12291648|P4|COMPLETED|Visit 3 - 3 Months Followup||169
4995785|NCT02381015|12291649|P3|COMPLETED|Visit 3 - 3 Months Followup||173
4995786|NCT02381015|12291650|P2|COMPLETED|Visit 3 - 3 Months Followup||168
4995787|NCT02381015|12291651|P1|COMPLETED|Visit 3 - 3 Months Followup||172
4995788|NCT02381015|12291648|P4|STARTED|Visit 3 - 3 Months Followup||169
4995789|NCT02381015|12291649|P3|STARTED|Visit 3 - 3 Months Followup||173
4995790|NCT02381015|12291650|P2|STARTED|Visit 3 - 3 Months Followup||168
4995791|NCT02381015|12291651|P1|STARTED|Visit 3 - 3 Months Followup||172
4995792|NCT02381015|12291648|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
4995793|NCT02381015|12291649|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
4995794|NCT02381015|12291650|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
4995795|NCT02381015|12291651|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
4995796|NCT02381015|12291648|P4|COMPLETED|Visit 2 - Results DIsclosure||169
4995797|NCT02381015|12291649|P3|COMPLETED|Visit 2 - Results DIsclosure||173
4995798|NCT02381015|12291650|P2|COMPLETED|Visit 2 - Results DIsclosure||168
4995799|NCT02381015|12291651|P1|COMPLETED|Visit 2 - Results DIsclosure||172
4995800|NCT02381015|12291648|P4|STARTED|Visit 2 - Results DIsclosure||172
4995801|NCT02381015|12291649|P3|STARTED|Visit 2 - Results DIsclosure||175
4995802|NCT02381015|12291650|P2|STARTED|Visit 2 - Results DIsclosure||173
4995803|NCT02381015|12291651|P1|STARTED|Visit 2 - Results DIsclosure||175
4995804|NCT02381015|12291648|P4|NOT COMPLETED|Visit 1 - Enrollment||3
4995805|NCT02381015|12291649|P3|NOT COMPLETED|Visit 1 - Enrollment||0
4995806|NCT02381015|12291650|P2|NOT COMPLETED|Visit 1 - Enrollment||2
4995807|NCT02381015|12291651|P1|NOT COMPLETED|Visit 1 - Enrollment||0
4995808|NCT02381015|12291648|P4|COMPLETED|Visit 1 - Enrollment||172
4995809|NCT02381015|12291649|P3|COMPLETED|Visit 1 - Enrollment||175
4995810|NCT02381015|12291650|P2|COMPLETED|Visit 1 - Enrollment||173
4995811|NCT02381015|12291651|P1|COMPLETED|Visit 1 - Enrollment||175
4995812|NCT02381015|12291648|P4|STARTED|Visit 1 - Enrollment||175
4995813|NCT02381015|12291649|P3|STARTED|Visit 1 - Enrollment||175
4995814|NCT02381015|12291650|P2|STARTED|Visit 1 - Enrollment||175
4995815|NCT02381015|12291651|P1|STARTED|Visit 1 - Enrollment||175
4995816|NCT02380859|12291683|P2|NOT COMPLETED|Overall Study||0
4995817|NCT02380859|12291684|P1|NOT COMPLETED|Overall Study||2
4995818|NCT02380859|12291683|P2|COMPLETED|Overall Study||13
4995819|NCT02380859|12291684|P1|COMPLETED|Overall Study||17
4995820|NCT02380859|12291683|P2|STARTED|Overall Study||13
4995821|NCT02380859|12291684|P1|STARTED|Overall Study||19
4995822|NCT02380742|12291720|P2|NOT COMPLETED|Overall Study||0
4995823|NCT02380742|12291721|P1|NOT COMPLETED|Overall Study||1
4995824|NCT02380742|12291720|P2|COMPLETED|Overall Study||26
4995825|NCT02380742|12291721|P1|COMPLETED|Overall Study||27
4995826|NCT02380742|12291720|P2|STARTED|Overall Study||26
4995827|NCT02380742|12291721|P1|STARTED|Overall Study||28
4995828|NCT02380677|12291745|P12|NOT COMPLETED|Overall Study||5
4995829|NCT02380677|12291746|P11|NOT COMPLETED|Overall Study||4
4995830|NCT02380677|12291747|P10|NOT COMPLETED|Overall Study||2
4995831|NCT02380677|12291748|P9|NOT COMPLETED|Overall Study||4
4995832|NCT02380677|12291749|P8|NOT COMPLETED|Overall Study||4
4995833|NCT02380677|12291750|P7|NOT COMPLETED|Overall Study||3
4995834|NCT02380677|12291751|P6|NOT COMPLETED|Overall Study||6
4995835|NCT02380677|12291752|P5|NOT COMPLETED|Overall Study||6
4995836|NCT02380677|12291753|P4|NOT COMPLETED|Overall Study||3
4995837|NCT02380677|12291754|P3|NOT COMPLETED|Overall Study||3
4995838|NCT02380677|12291755|P2|NOT COMPLETED|Overall Study||1
4995839|NCT02380677|12291756|P1|NOT COMPLETED|Overall Study||1
4995840|NCT02380677|12291745|P12|COMPLETED|Overall Study||0
4995841|NCT02380677|12291746|P11|COMPLETED|Overall Study||0
4995842|NCT02380677|12291747|P10|COMPLETED|Overall Study||0
4995843|NCT02380677|12291748|P9|COMPLETED|Overall Study||0
4995844|NCT02380677|12291749|P8|COMPLETED|Overall Study||0
4995845|NCT02380677|12291750|P7|COMPLETED|Overall Study||0
4995846|NCT02380677|12291751|P6|COMPLETED|Overall Study||0
4995847|NCT02380677|12291752|P5|COMPLETED|Overall Study||0
4995848|NCT02380677|12291753|P4|COMPLETED|Overall Study||0
4995849|NCT02380677|12291754|P3|COMPLETED|Overall Study||0
4995850|NCT02380677|12291755|P2|COMPLETED|Overall Study||0
4995851|NCT02380677|12291756|P1|COMPLETED|Overall Study||0
4995852|NCT02380677|12291745|P12|STARTED|Overall Study||5
4995853|NCT02380677|12291746|P11|STARTED|Overall Study||4
4995854|NCT02380677|12291747|P10|STARTED|Overall Study||2
4995855|NCT02380677|12291748|P9|STARTED|Overall Study||4
4995856|NCT02380677|12291749|P8|STARTED|Overall Study||4
4995857|NCT02380677|12291750|P7|STARTED|Overall Study||3
4995858|NCT02380677|12291751|P6|STARTED|Overall Study||6
4995859|NCT02380677|12291752|P5|STARTED|Overall Study||6
4995860|NCT02380677|12291753|P4|STARTED|Overall Study||3
4995861|NCT02380677|12291754|P3|STARTED|Overall Study||3
4995862|NCT02380677|12291755|P2|STARTED|Overall Study||1
4995863|NCT02380677|12291756|P1|STARTED|Overall Study||1
4995864|NCT02380287|12291812|P8|NOT COMPLETED|Overall Study||0
4995865|NCT02380287|12291813|P7|NOT COMPLETED|Overall Study||0
4995866|NCT02380287|12291814|P6|NOT COMPLETED|Overall Study||0
4995867|NCT02380287|12291815|P5|NOT COMPLETED|Overall Study||0
4995868|NCT02380287|12291816|P4|NOT COMPLETED|Overall Study||0
4995869|NCT02380287|12291817|P3|NOT COMPLETED|Overall Study||1
4995870|NCT02380287|12291818|P2|NOT COMPLETED|Overall Study||0
4995871|NCT02380287|12291819|P1|NOT COMPLETED|Overall Study||0
4995872|NCT02380287|12291812|P8|COMPLETED|Overall Study||3
4995873|NCT02380287|12291813|P7|COMPLETED|Overall Study||3
4995874|NCT02380287|12291814|P6|COMPLETED|Overall Study||3
4995875|NCT02380287|12291815|P5|COMPLETED|Overall Study||3
4995876|NCT02380287|12291816|P4|COMPLETED|Overall Study||3
4995877|NCT02380287|12291817|P3|COMPLETED|Overall Study||2
4995878|NCT02380287|12291818|P2|COMPLETED|Overall Study||3
4995879|NCT02380287|12291819|P1|COMPLETED|Overall Study||1
4995880|NCT02380287|12291812|P8|STARTED|Overall Study||3
4995881|NCT02380287|12291813|P7|STARTED|Overall Study||3
4995882|NCT02380287|12291814|P6|STARTED|Overall Study||3
4995883|NCT02380287|12291815|P5|STARTED|Overall Study||3
4995884|NCT02380287|12291816|P4|STARTED|Overall Study||3
4995885|NCT02380287|12291817|P3|STARTED|Overall Study||3
4995886|NCT02380287|12291818|P2|STARTED|Overall Study||3
4995887|NCT02380287|12291819|P1|STARTED|Overall Study||1
4995888|NCT02380261|12291830|P1|NOT COMPLETED|Overall Study||0
4995889|NCT02380261|12291830|P1|COMPLETED|Overall Study||35
4995890|NCT02380261|12291830|P1|STARTED|Overall Study||35
4995891|NCT02380248|12291835|P1|NOT COMPLETED|Overall Study||14
4995892|NCT02380248|12291835|P1|COMPLETED|Overall Study||186
4995893|NCT02380248|12291835|P1|STARTED|Overall Study||200
4995894|NCT02380183|12291842|P2|NOT COMPLETED|Overall Study||0
4995895|NCT02380183|12291843|P1|NOT COMPLETED|Overall Study||0
4995896|NCT02380183|12291842|P2|COMPLETED|Overall Study||34
4995897|NCT02380183|12291843|P1|COMPLETED|Overall Study||36
4995898|NCT02380183|12291842|P2|STARTED|Overall Study||34
4995899|NCT02380183|12291843|P1|STARTED|Overall Study||36
4995900|NCT02379923|12291851|P1|NOT COMPLETED|Overall Study||5
4995901|NCT02379923|12291851|P1|COMPLETED|Overall Study||158
4995902|NCT02379923|12291851|P1|STARTED|Overall Study||163
4995903|NCT02379858|12291867|P2|NOT COMPLETED|Overall Study||0
4995904|NCT02379858|12291868|P1|NOT COMPLETED|Overall Study||0
4995905|NCT02379858|12291867|P2|COMPLETED|Overall Study||4
4995906|NCT02379858|12291868|P1|COMPLETED|Overall Study||6
4995907|NCT02379858|12291867|P2|STARTED|Overall Study||4
4995908|NCT02379858|12291868|P1|STARTED|Overall Study||6
4995909|NCT02379728|12291880|P4|NOT COMPLETED|Overall Study||3
4995910|NCT02379728|12291881|P3|NOT COMPLETED|Overall Study||10
4995911|NCT02379728|12291882|P2|NOT COMPLETED|Overall Study||0
4995912|NCT02379728|12291883|P1|NOT COMPLETED|Overall Study||6
4995913|NCT02379728|12291880|P4|COMPLETED|Overall Study||13
4995914|NCT02379728|12291881|P3|COMPLETED|Overall Study||74
4995915|NCT02379728|12291882|P2|COMPLETED|Overall Study||16
4995916|NCT02379728|12291883|P1|COMPLETED|Overall Study||78
4995917|NCT02379728|12291880|P4|STARTED|Overall Study||16
4995918|NCT02379728|12291881|P3|STARTED|Overall Study||84
4995919|NCT02379728|12291882|P2|STARTED|Overall Study||16
4995920|NCT02379728|12291883|P1|STARTED|Overall Study||84
4995921|NCT02379637|12291939|P2|NOT COMPLETED|Overall Study||1
4995922|NCT02379637|12291940|P1|NOT COMPLETED|Overall Study||2
4995923|NCT02379637|12291939|P2|COMPLETED|Overall Study||34
4995924|NCT02379637|12291940|P1|COMPLETED|Overall Study||33
4995925|NCT02379637|12291939|P2|STARTED|Overall Study||35
4995926|NCT02379637|12291940|P1|STARTED|Overall Study||35
4995927|NCT02379585|12291950|P2|NOT COMPLETED|Overall Study||5
4995928|NCT02379585|12291951|P1|NOT COMPLETED|Overall Study||3
4995929|NCT02379585|12291950|P2|COMPLETED|Overall Study||0
4995930|NCT02379585|12291951|P1|COMPLETED|Overall Study||0
4995931|NCT02379585|12291950|P2|STARTED|Overall Study||5
4995932|NCT02379585|12291951|P1|STARTED|Overall Study||3
4995933|NCT02379442|12291973|P1|NOT COMPLETED|Overall Study||0
4995934|NCT02379442|12291973|P1|COMPLETED|Overall Study||1
4995935|NCT02379442|12291973|P1|STARTED|Overall Study||1
4995936|NCT02379390|12291979|P2|NOT COMPLETED|Overall Study||2
4995937|NCT02379390|12291980|P1|NOT COMPLETED|Overall Study||2
4995938|NCT02379390|12291979|P2|COMPLETED|Overall Study||2
4995939|NCT02379390|12291980|P1|COMPLETED|Overall Study||2
4995940|NCT02379390|12291979|P2|STARTED|Overall Study||4
4995941|NCT02379390|12291980|P1|STARTED|Overall Study||4
4995942|NCT02379221|12292008|P1|NOT COMPLETED|Overall Study||1
4995943|NCT02379221|12292008|P1|COMPLETED|Overall Study||48
4995944|NCT02379221|12292008|P1|STARTED|Overall Study||49
4995945|NCT02379195|12292023|P1|NOT COMPLETED|Overall Study||0
4995946|NCT02379195|12292023|P1|COMPLETED|Overall Study||12
4995947|NCT02379195|12292023|P1|STARTED|Overall Study||12
4995948|NCT02379117|12292033|P2|NOT COMPLETED|Overall Study||0
4995949|NCT02379117|12292034|P1|NOT COMPLETED|Overall Study||0
4995950|NCT02379117|12292033|P2|COMPLETED|Overall Study||31
4995951|NCT02379117|12292034|P1|COMPLETED|Overall Study||30
4995952|NCT02379117|12292033|P2|STARTED|Overall Study||31
4995953|NCT02379117|12292034|P1|STARTED|Overall Study||30
4995954|NCT02379091|12292044|P4|NOT COMPLETED|Overall Study||14
4995955|NCT02379091|12292045|P3|NOT COMPLETED|Overall Study||7
4995956|NCT02379091|12292046|P2|NOT COMPLETED|Overall Study||10
4995957|NCT02379091|12292047|P1|NOT COMPLETED|Overall Study||12
4995958|NCT02379091|12292044|P4|COMPLETED|Overall Study||14
4995959|NCT02379091|12292045|P3|COMPLETED|Overall Study||18
4995960|NCT02379091|12292046|P2|COMPLETED|Overall Study||18
4995961|NCT02379091|12292047|P1|COMPLETED|Overall Study||15
4995962|NCT02379091|12292044|P4|Full Analysis Set|Overall Study||28
4995963|NCT02379091|12292045|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
4995964|NCT02379091|12292046|P2|Full Analysis Set|Overall Study||28
4995965|NCT02379091|12292047|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
4995966|NCT02379091|12292044|P4|STARTED|Overall Study||28
4995967|NCT02379091|12292045|P3|STARTED|Overall Study||25
4995968|NCT02379091|12292046|P2|STARTED|Overall Study||28
4995969|NCT02379091|12292047|P1|STARTED|Overall Study||27
4995970|NCT02379052|12292085|P2|NOT COMPLETED|Overall Study||5
4995971|NCT02379052|12292086|P1|NOT COMPLETED|Overall Study||6
4995972|NCT02379052|12292085|P2|COMPLETED|Overall Study||18
4995973|NCT02379052|12292086|P1|COMPLETED|Overall Study||18
4995974|NCT02379052|12292085|P2|STARTED|Overall Study||23
4995975|NCT02379052|12292086|P1|STARTED|Overall Study||24
4995976|NCT02378961|12292128|P4|NOT COMPLETED|Overall Study||1
4995977|NCT02378961|12292129|P3|NOT COMPLETED|Overall Study||1
4995978|NCT02378961|12292130|P2|NOT COMPLETED|Overall Study||2
4995979|NCT02378961|12292131|P1|NOT COMPLETED|Overall Study||4
4995980|NCT02378961|12292128|P4|COMPLETED|Overall Study||28
4995981|NCT02378961|12292129|P3|COMPLETED|Overall Study||35
4995982|NCT02378961|12292130|P2|COMPLETED|Overall Study||28
4995983|NCT02378961|12292131|P1|COMPLETED|Overall Study||29
4995984|NCT02378961|12292128|P4|STARTED|Overall Study||29
4995985|NCT02378961|12292129|P3|STARTED|Overall Study||36
4995986|NCT02378961|12292130|P2|STARTED|Overall Study||30
4995987|NCT02378961|12292131|P1|STARTED|Overall Study||33
4995988|NCT02378935|12292168|P7|NOT COMPLETED|Overall Study||0
4995989|NCT02378935|12292169|P6|NOT COMPLETED|Overall Study||0
4995990|NCT02378935|12292170|P5|NOT COMPLETED|Overall Study||0
4995991|NCT02378935|12292171|P4|NOT COMPLETED|Overall Study||6
4995992|NCT02378935|12292172|P3|NOT COMPLETED|Overall Study||3
4995993|NCT02378935|12292173|P2|NOT COMPLETED|Overall Study||0
4995994|NCT02378935|12292174|P1|NOT COMPLETED|Overall Study||10
4995995|NCT02378935|12292168|P7|COMPLETED|Overall Study||8
4995996|NCT02378935|12292169|P6|COMPLETED|Overall Study||32
4995997|NCT02378935|12292170|P5|COMPLETED|Overall Study||31
4995998|NCT02378935|12292171|P4|COMPLETED|Overall Study||25
4995999|NCT02378935|12292172|P3|COMPLETED|Overall Study||30
4996000|NCT02378935|12292173|P2|COMPLETED|Overall Study||36
4996001|NCT02378935|12292174|P1|COMPLETED|Overall Study||24
4996002|NCT02378935|12292168|P7|STARTED|Overall Study||8
4996003|NCT02378935|12292169|P6|STARTED|Overall Study||32
4996004|NCT02378935|12292170|P5|STARTED|Overall Study||31
4996005|NCT02378935|12292171|P4|STARTED|Overall Study||31
4996006|NCT02378935|12292172|P3|STARTED|Overall Study||33
4996007|NCT02378935|12292173|P2|STARTED|Overall Study||36
4996008|NCT02378935|12292174|P1|STARTED|Overall Study||34
4996009|NCT02378883|12292225|P1|NOT COMPLETED|12 Months Follow-Up||5
4996010|NCT02378883|12292225|P1|COMPLETED|12 Months Follow-Up||41
4996011|NCT02378883|12292225|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
4996012|NCT02378883|12292225|P1|NOT COMPLETED|30 Day Follow-Up||6
4996013|NCT02378883|12292225|P1|COMPLETED|30 Day Follow-Up||106
4996014|NCT02378883|12292225|P1|STARTED|30 Day Follow-Up||112
4996015|NCT02378883|12292225|P1|NOT COMPLETED|Discharge||0
4996016|NCT02378883|12292225|P1|COMPLETED|Discharge||112
4996017|NCT02378883|12292225|P1|STARTED|Discharge||112
4996018|NCT02378883|12292225|P1|NOT COMPLETED|Enrollment||9
4996019|NCT02378883|12292225|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
4996020|NCT02378883|12292225|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
4996021|NCT02378844|12292238|P3|NOT COMPLETED|Open Label Period||0
4996022|NCT02378844|12292239|P2|NOT COMPLETED|Open Label Period||48
4996023|NCT02378844|12292240|P1|NOT COMPLETED|Open Label Period||43
4996024|NCT02378844|12292238|P3|COMPLETED|Open Label Period||0
4996025|NCT02378844|12292239|P2|COMPLETED|Open Label Period||87
4996026|NCT02378844|12292240|P1|COMPLETED|Open Label Period||99
4996027|NCT02378844|12292238|P3|STARTED|Open Label Period||0
4996028|NCT02378844|12292239|P2|STARTED|Open Label Period||135
4996029|NCT02378844|12292240|P1|STARTED|Open Label Period||142
4996030|NCT02378844|12292238|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
4996031|NCT02378844|12292239|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
4996032|NCT02378844|12292240|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
4996033|NCT02378844|12292238|P3|COMPLETED|Randomized Period (Double Blind)||0
4996034|NCT02378844|12292239|P2|COMPLETED|Randomized Period (Double Blind)||135
4996035|NCT02378844|12292240|P1|COMPLETED|Randomized Period (Double Blind)||142
4996036|NCT02378844|12292238|P3|STARTED|Randomized Period (Double Blind)||0
4996037|NCT02378844|12292239|P2|STARTED|Randomized Period (Double Blind)||167
4996038|NCT02378844|12292240|P1|STARTED|Randomized Period (Double Blind)||165
4996039|NCT02378844|12292238|P3|NOT COMPLETED|Run-in Period||136
4996040|NCT02378844|12292239|P2|NOT COMPLETED|Run-in Period||5
4996041|NCT02378844|12292240|P1|NOT COMPLETED|Run-in Period||4
4996042|NCT02378844|12292238|P3|COMPLETED|Run-in Period||0
4996043|NCT02378844|12292239|P2|COMPLETED|Run-in Period||167
4996044|NCT02378844|12292240|P1|COMPLETED|Run-in Period||165
4996045|NCT02378844|12292238|P3|STARTED|Run-in Period||136
4996046|NCT02378844|12292239|P2|STARTED|Run-in Period||172
4996047|NCT02378844|12292240|P1|STARTED|Run-in Period||169
4996048|NCT02378753|12292270|P2|NOT COMPLETED|Overall Study||695
4996049|NCT02378753|12292271|P1|NOT COMPLETED|Overall Study||218
4996050|NCT02378753|12292270|P2|COMPLETED|Overall Study||3637
4996051|NCT02378753|12292271|P1|COMPLETED|Overall Study||4101
4996052|NCT02378753|12292270|P2|STARTED|Overall Study||4332
4996053|NCT02378753|12292271|P1|STARTED|Overall Study||4319
4996054|NCT02378662|12292291|P2|NOT COMPLETED|Overall Study||0
4996055|NCT02378662|12292292|P1|NOT COMPLETED|Overall Study||2
4996056|NCT02378662|12292291|P2|COMPLETED|Overall Study||0
4996057|NCT02378662|12292292|P1|COMPLETED|Overall Study||0
4996058|NCT02378662|12292291|P2|Implantation|Overall Study||0
4996059|NCT02378662|12292292|P1|Implantation|Overall Study||2
4996060|NCT02378662|12292291|P2|Harvesting|Overall Study||0
4996061|NCT02378662|12292292|P1|Harvesting|Overall Study||2
4996062|NCT02378662|12292291|P2|STARTED|Overall Study||0
4996063|NCT02378662|12292292|P1|STARTED|Overall Study||2
4996064|NCT02378506|12292298|P1|NOT COMPLETED|Overall Study||25
4996065|NCT02378506|12292298|P1|COMPLETED|Overall Study||163
4996066|NCT02378506|12292298|P1|Treated|Overall Study||187
4996067|NCT02378506|12292298|P1|STARTED|Overall Study||188
4996068|NCT02378480|12292317|P2|NOT COMPLETED|Overall Study||32
4996069|NCT02378480|12292318|P1|NOT COMPLETED|Overall Study||28
4996070|NCT02378480|12292317|P2|COMPLETED|Overall Study||294
4996071|NCT02378480|12292318|P1|COMPLETED|Overall Study||301
4996072|NCT02378480|12292317|P2|STARTED|Overall Study||326
4996073|NCT02378480|12292318|P1|STARTED|Overall Study||329
4996074|NCT02378402|12292333|P3|NOT COMPLETED|Overall Study||0
4996075|NCT02378402|12292334|P2|NOT COMPLETED|Overall Study||2
4996076|NCT02378402|12292335|P1|NOT COMPLETED|Overall Study||0
4996077|NCT02378402|12292333|P3|COMPLETED|Overall Study||21
4996078|NCT02378402|12292334|P2|COMPLETED|Overall Study||23
4996079|NCT02378402|12292335|P1|COMPLETED|Overall Study||25
4996080|NCT02378402|12292333|P3|STARTED|Overall Study||21
4996081|NCT02378402|12292334|P2|STARTED|Overall Study||25
4996082|NCT02378402|12292335|P1|STARTED|Overall Study||25
4996083|NCT02378220|12292345|P2|NOT COMPLETED|Overall Study||1
4996084|NCT02378220|12292346|P1|NOT COMPLETED|Overall Study||6
4996085|NCT02378220|12292345|P2|COMPLETED|Overall Study||56
4996086|NCT02378220|12292346|P1|COMPLETED|Overall Study||47
4996087|NCT02378220|12292345|P2|STARTED|Overall Study||57
4996088|NCT02378220|12292346|P1|STARTED|Overall Study||53
4996089|NCT02378207|12292380|P4|NOT COMPLETED|Overall Study||1
4996090|NCT02378207|12292381|P3|NOT COMPLETED|Overall Study||2
4996091|NCT02378207|12292382|P2|NOT COMPLETED|Overall Study||3
4996092|NCT02378207|12292383|P1|NOT COMPLETED|Overall Study||0
4996093|NCT02378207|12292380|P4|COMPLETED|Overall Study||11
4996094|NCT02378207|12292381|P3|COMPLETED|Overall Study||22
4996095|NCT02378207|12292382|P2|COMPLETED|Overall Study||21
4996096|NCT02378207|12292383|P1|COMPLETED|Overall Study||24
4996097|NCT02378207|12292380|P4|STARTED|Overall Study||12
4996098|NCT02378207|12292381|P3|STARTED|Overall Study||24
4996099|NCT02378207|12292382|P2|STARTED|Overall Study||24
4996100|NCT02378207|12292383|P1|STARTED|Overall Study||24
4996101|NCT02378038|12292397|P1|NOT COMPLETED|Overall Study||5
4996102|NCT02378038|12292397|P1|COMPLETED|Overall Study||0
4996103|NCT02378038|12292397|P1|STARTED|Overall Study||5
4996104|NCT02378025|12292409|P2|NOT COMPLETED|Overall Study||21
4996105|NCT02378025|12292410|P1|NOT COMPLETED|Overall Study||13
4996106|NCT02378025|12292409|P2|COMPLETED|Overall Study||15
4996107|NCT02378025|12292410|P1|COMPLETED|Overall Study||26
4996108|NCT02378025|12292409|P2|STARTED|Overall Study||36
4996109|NCT02378025|12292410|P1|STARTED|Overall Study||39
4996110|NCT02377986|12292426|P1|NOT COMPLETED|Overall Study||0
4996111|NCT02377986|12292426|P1|COMPLETED|Overall Study||5
4996112|NCT02377986|12292426|P1|STARTED|Overall Study||5
4996113|NCT02377947|12292431|P1|NOT COMPLETED|Overall Study||0
4996114|NCT02377947|12292431|P1|COMPLETED|Overall Study||50
4996115|NCT02377947|12292431|P1|STARTED|Overall Study||50
4996116|NCT02377921|12292444|P2|NOT COMPLETED|Overall Study||1
4996117|NCT02377921|12292445|P1|NOT COMPLETED|Overall Study||1
4996118|NCT02377921|12292444|P2|COMPLETED|Overall Study||43
4996119|NCT02377921|12292445|P1|COMPLETED|Overall Study||44
4996120|NCT02377921|12292444|P2|STARTED|Overall Study||44
4996121|NCT02377921|12292445|P1|STARTED|Overall Study||45
4996122|NCT02377817|12292469|P2|NOT COMPLETED|Overall Study||0
4996123|NCT02377817|12292470|P1|NOT COMPLETED|Overall Study||3
4996124|NCT02377817|12292469|P2|COMPLETED|Overall Study||10
4996125|NCT02377817|12292470|P1|COMPLETED|Overall Study||10
4996126|NCT02377817|12292469|P2|STARTED|Overall Study||10
4996127|NCT02377817|12292470|P1|STARTED|Overall Study||13
4996128|NCT02377466|12292534|P2|NOT COMPLETED|Overall Study||2
4996129|NCT02377466|12292535|P1|NOT COMPLETED|Overall Study||0
4996130|NCT02377466|12292534|P2|COMPLETED|Overall Study||10
4996131|NCT02377466|12292535|P1|COMPLETED|Overall Study||13
4996132|NCT02377466|12292534|P2|Treated|Overall Study||10
4996133|NCT02377466|12292535|P1|Treated|Overall Study||13
4996134|NCT02377466|12292534|P2|STARTED|Overall Study||12
4996135|NCT02377466|12292535|P1|STARTED|Overall Study||13
4996136|NCT02377427|12292653|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996137|NCT02377427|12292654|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996138|NCT02377427|12292655|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
4996139|NCT02377427|12292656|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996140|NCT02377427|12292657|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996141|NCT02377427|12292653|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
4996142|NCT02377427|12292654|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
4996143|NCT02377427|12292655|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
4996144|NCT02377427|12292656|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996145|NCT02377427|12292657|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
4996146|NCT02377427|12292653|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
4996147|NCT02377427|12292654|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
4996148|NCT02377427|12292655|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
4996149|NCT02377427|12292656|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
4996150|NCT02377427|12292657|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
4996151|NCT02377427|12292653|P5|NOT COMPLETED|Part A (Up to Week 20)||0
4996152|NCT02377427|12292654|P4|NOT COMPLETED|Part A (Up to Week 20)||0
4996153|NCT02377427|12292655|P3|NOT COMPLETED|Part A (Up to Week 20)||0
4996154|NCT02377427|12292656|P2|NOT COMPLETED|Part A (Up to Week 20)||0
4996155|NCT02377427|12292657|P1|NOT COMPLETED|Part A (Up to Week 20)||4
4996156|NCT02377427|12292653|P5|COMPLETED|Part A (Up to Week 20)||0
4996157|NCT02377427|12292654|P4|COMPLETED|Part A (Up to Week 20)||0
4996158|NCT02377427|12292655|P3|COMPLETED|Part A (Up to Week 20)||0
4996159|NCT02377427|12292656|P2|COMPLETED|Part A (Up to Week 20)||10
4996160|NCT02377427|12292657|P1|COMPLETED|Part A (Up to Week 20)||22
4996161|NCT02377427|12292653|P5|STARTED|Part A (Up to Week 20)||0
4996162|NCT02377427|12292654|P4|STARTED|Part A (Up to Week 20)||0
4996163|NCT02377427|12292655|P3|STARTED|Part A (Up to Week 20)||0
4996164|NCT02377427|12292656|P2|STARTED|Part A (Up to Week 20)||10
4996165|NCT02377427|12292657|P1|STARTED|Part A (Up to Week 20)||26
4996166|NCT02377362|12292730|P13|NOT COMPLETED|Part B Overall||0
4996167|NCT02377362|12292731|P12|NOT COMPLETED|Part B Overall||1
4996168|NCT02377362|12292732|P11|NOT COMPLETED|Part B Overall||0
4996169|NCT02377362|12292733|P10|NOT COMPLETED|Part B Overall||1
4996170|NCT02377362|12292734|P9|NOT COMPLETED|Part B Overall||0
4996171|NCT02377362|12292735|P8|NOT COMPLETED|Part B Overall||1
4996172|NCT02377362|12292736|P7|NOT COMPLETED|Part B Overall||2
4996173|NCT02377362|12292737|P6|NOT COMPLETED|Part B Overall||0
4996174|NCT02377362|12292738|P5|NOT COMPLETED|Part B Overall||0
4996175|NCT02377362|12292739|P4|NOT COMPLETED|Part B Overall||0
4996176|NCT02377362|12292740|P3|NOT COMPLETED|Part B Overall||0
4996177|NCT02377362|12292741|P2|NOT COMPLETED|Part B Overall||0
4996178|NCT02377362|12292742|P1|NOT COMPLETED|Part B Overall||0
4996179|NCT02377362|12292730|P13|COMPLETED|Part B Overall||12
4996180|NCT02377362|12292731|P12|COMPLETED|Part B Overall||6
4996181|NCT02377362|12292732|P11|COMPLETED|Part B Overall||6
4996182|NCT02377362|12292733|P10|COMPLETED|Part B Overall||6
4996183|NCT02377362|12292734|P9|COMPLETED|Part B Overall||6
4996184|NCT02377362|12292735|P8|COMPLETED|Part B Overall||5
4996185|NCT02377362|12292736|P7|COMPLETED|Part B Overall||4
4996186|NCT02377362|12292737|P6|COMPLETED|Part B Overall||0
4996187|NCT02377362|12292738|P5|COMPLETED|Part B Overall||0
4996188|NCT02377362|12292739|P4|COMPLETED|Part B Overall||0
4996189|NCT02377362|12292740|P3|COMPLETED|Part B Overall||0
4996190|NCT02377362|12292741|P2|COMPLETED|Part B Overall||0
4996191|NCT02377362|12292742|P1|COMPLETED|Part B Overall||0
4996192|NCT02377362|12292730|P13|STARTED|Part B Overall||12
4996193|NCT02377362|12292731|P12|STARTED|Part B Overall||7
4996194|NCT02377362|12292732|P11|STARTED|Part B Overall||6
4996195|NCT02377362|12292733|P10|STARTED|Part B Overall||7
4996196|NCT02377362|12292734|P9|STARTED|Part B Overall||6
4996197|NCT02377362|12292735|P8|STARTED|Part B Overall||6
4996198|NCT02377362|12292736|P7|STARTED|Part B Overall||6
4996199|NCT02377362|12292737|P6|STARTED|Part B Overall||0
4996200|NCT02377362|12292738|P5|STARTED|Part B Overall||0
4996201|NCT02377362|12292739|P4|STARTED|Part B Overall||0
4996202|NCT02377362|12292740|P3|STARTED|Part B Overall||0
4996203|NCT02377362|12292741|P2|STARTED|Part B Overall||0
4996204|NCT02377362|12292742|P1|STARTED|Part B Overall||0
4996205|NCT02377362|12292730|P13|NOT COMPLETED|Part A Third Treatment||0
4996206|NCT02377362|12292731|P12|NOT COMPLETED|Part A Third Treatment||0
4996207|NCT02377362|12292732|P11|NOT COMPLETED|Part A Third Treatment||0
4996208|NCT02377362|12292733|P10|NOT COMPLETED|Part A Third Treatment||0
4996209|NCT02377362|12292734|P9|NOT COMPLETED|Part A Third Treatment||0
4996210|NCT02377362|12292735|P8|NOT COMPLETED|Part A Third Treatment||0
4996211|NCT02377362|12292736|P7|NOT COMPLETED|Part A Third Treatment||0
4996212|NCT02377362|12292737|P6|NOT COMPLETED|Part A Third Treatment||4
4996213|NCT02377362|12292738|P5|NOT COMPLETED|Part A Third Treatment||3
4996214|NCT02377362|12292739|P4|NOT COMPLETED|Part A Third Treatment||4
4996215|NCT02377362|12292740|P3|NOT COMPLETED|Part A Third Treatment||0
4996216|NCT02377362|12292741|P2|NOT COMPLETED|Part A Third Treatment||0
4996217|NCT02377362|12292742|P1|NOT COMPLETED|Part A Third Treatment||0
4996218|NCT02377362|12292730|P13|COMPLETED|Part A Third Treatment||0
4996219|NCT02377362|12292731|P12|COMPLETED|Part A Third Treatment||0
4996220|NCT02377362|12292732|P11|COMPLETED|Part A Third Treatment||0
4996221|NCT02377362|12292733|P10|COMPLETED|Part A Third Treatment||0
4996222|NCT02377362|12292734|P9|COMPLETED|Part A Third Treatment||0
4996223|NCT02377362|12292735|P8|COMPLETED|Part A Third Treatment||0
4996224|NCT02377362|12292736|P7|COMPLETED|Part A Third Treatment||0
4996225|NCT02377362|12292737|P6|COMPLETED|Part A Third Treatment||0
4996226|NCT02377362|12292738|P5|COMPLETED|Part A Third Treatment||0
4996227|NCT02377362|12292739|P4|COMPLETED|Part A Third Treatment||0
4996228|NCT02377362|12292740|P3|COMPLETED|Part A Third Treatment||4
4996229|NCT02377362|12292741|P2|COMPLETED|Part A Third Treatment||4
4996230|NCT02377362|12292742|P1|COMPLETED|Part A Third Treatment||4
4996231|NCT02377362|12292730|P13|STARTED|Part A Third Treatment||0
4996232|NCT02377362|12292731|P12|STARTED|Part A Third Treatment||0
4996233|NCT02377362|12292732|P11|STARTED|Part A Third Treatment||0
4996234|NCT02377362|12292733|P10|STARTED|Part A Third Treatment||0
4996235|NCT02377362|12292734|P9|STARTED|Part A Third Treatment||0
4996236|NCT02377362|12292735|P8|STARTED|Part A Third Treatment||0
4996237|NCT02377362|12292736|P7|STARTED|Part A Third Treatment||0
4996238|NCT02377362|12292737|P6|STARTED|Part A Third Treatment||4
4996239|NCT02377362|12292738|P5|STARTED|Part A Third Treatment||3
4996240|NCT02377362|12292739|P4|STARTED|Part A Third Treatment||4
4996241|NCT02377362|12292740|P3|STARTED|Part A Third Treatment||4
4996242|NCT02377362|12292741|P2|STARTED|Part A Third Treatment||4
4996243|NCT02377362|12292742|P1|STARTED|Part A Third Treatment||4
4996244|NCT02377362|12292730|P13|NOT COMPLETED|Part A Second Treatment||0
4996245|NCT02377362|12292731|P12|NOT COMPLETED|Part A Second Treatment||0
4996246|NCT02377362|12292732|P11|NOT COMPLETED|Part A Second Treatment||0
4996247|NCT02377362|12292733|P10|NOT COMPLETED|Part A Second Treatment||0
4996248|NCT02377362|12292734|P9|NOT COMPLETED|Part A Second Treatment||0
4996249|NCT02377362|12292735|P8|NOT COMPLETED|Part A Second Treatment||0
4996250|NCT02377362|12292736|P7|NOT COMPLETED|Part A Second Treatment||0
4996251|NCT02377362|12292737|P6|NOT COMPLETED|Part A Second Treatment||0
4996252|NCT02377362|12292738|P5|NOT COMPLETED|Part A Second Treatment||1
4996253|NCT02377362|12292739|P4|NOT COMPLETED|Part A Second Treatment||0
4996254|NCT02377362|12292740|P3|NOT COMPLETED|Part A Second Treatment||0
4996255|NCT02377362|12292741|P2|NOT COMPLETED|Part A Second Treatment||0
4996256|NCT02377362|12292742|P1|NOT COMPLETED|Part A Second Treatment||0
4996257|NCT02377362|12292730|P13|COMPLETED|Part A Second Treatment||0
4996258|NCT02377362|12292731|P12|COMPLETED|Part A Second Treatment||0
4996259|NCT02377362|12292732|P11|COMPLETED|Part A Second Treatment||0
4996260|NCT02377362|12292733|P10|COMPLETED|Part A Second Treatment||0
4996261|NCT02377362|12292734|P9|COMPLETED|Part A Second Treatment||0
4996262|NCT02377362|12292735|P8|COMPLETED|Part A Second Treatment||0
4996263|NCT02377362|12292736|P7|COMPLETED|Part A Second Treatment||0
4996264|NCT02377362|12292737|P6|COMPLETED|Part A Second Treatment||4
4996265|NCT02377362|12292738|P5|COMPLETED|Part A Second Treatment||3
4996266|NCT02377362|12292739|P4|COMPLETED|Part A Second Treatment||4
4996267|NCT02377362|12292740|P3|COMPLETED|Part A Second Treatment||4
4996268|NCT02377362|12292741|P2|COMPLETED|Part A Second Treatment||4
4996269|NCT02377362|12292742|P1|COMPLETED|Part A Second Treatment||4
4996270|NCT02377362|12292730|P13|STARTED|Part A Second Treatment||0
4996271|NCT02377362|12292731|P12|STARTED|Part A Second Treatment||0
4996272|NCT02377362|12292732|P11|STARTED|Part A Second Treatment||0
4996273|NCT02377362|12292733|P10|STARTED|Part A Second Treatment||0
4996274|NCT02377362|12292734|P9|STARTED|Part A Second Treatment||0
4996275|NCT02377362|12292735|P8|STARTED|Part A Second Treatment||0
4996276|NCT02377362|12292736|P7|STARTED|Part A Second Treatment||0
4996277|NCT02377362|12292737|P6|STARTED|Part A Second Treatment||4
4996278|NCT02377362|12292738|P5|STARTED|Part A Second Treatment||4
4996279|NCT02377362|12292739|P4|STARTED|Part A Second Treatment||4
4996280|NCT02377362|12292740|P3|STARTED|Part A Second Treatment||4
4996281|NCT02377362|12292741|P2|STARTED|Part A Second Treatment||4
4996282|NCT02377362|12292742|P1|STARTED|Part A Second Treatment||4
4996283|NCT02377362|12292730|P13|NOT COMPLETED|Part A First Treatment||0
4996284|NCT02377362|12292731|P12|NOT COMPLETED|Part A First Treatment||0
4996285|NCT02377362|12292732|P11|NOT COMPLETED|Part A First Treatment||0
4996286|NCT02377362|12292733|P10|NOT COMPLETED|Part A First Treatment||0
4996287|NCT02377362|12292734|P9|NOT COMPLETED|Part A First Treatment||0
4996288|NCT02377362|12292735|P8|NOT COMPLETED|Part A First Treatment||0
4996289|NCT02377362|12292736|P7|NOT COMPLETED|Part A First Treatment||0
4996290|NCT02377362|12292737|P6|NOT COMPLETED|Part A First Treatment||0
4996291|NCT02377362|12292738|P5|NOT COMPLETED|Part A First Treatment||0
4996292|NCT02377362|12292739|P4|NOT COMPLETED|Part A First Treatment||0
4996293|NCT02377362|12292740|P3|NOT COMPLETED|Part A First Treatment||0
4996294|NCT02377362|12292741|P2|NOT COMPLETED|Part A First Treatment||0
4996295|NCT02377362|12292742|P1|NOT COMPLETED|Part A First Treatment||0
4996296|NCT02377362|12292730|P13|COMPLETED|Part A First Treatment||0
4996297|NCT02377362|12292731|P12|COMPLETED|Part A First Treatment||0
4996298|NCT02377362|12292732|P11|COMPLETED|Part A First Treatment||0
4996299|NCT02377362|12292733|P10|COMPLETED|Part A First Treatment||0
4996300|NCT02377362|12292734|P9|COMPLETED|Part A First Treatment||0
4996301|NCT02377362|12292735|P8|COMPLETED|Part A First Treatment||0
4996302|NCT02377362|12292736|P7|COMPLETED|Part A First Treatment||0
4996303|NCT02377362|12292737|P6|COMPLETED|Part A First Treatment||4
4996304|NCT02377362|12292738|P5|COMPLETED|Part A First Treatment||4
4996305|NCT02377362|12292739|P4|COMPLETED|Part A First Treatment||4
4996306|NCT02377362|12292740|P3|COMPLETED|Part A First Treatment||4
4996307|NCT02377362|12292741|P2|COMPLETED|Part A First Treatment||4
4996308|NCT02377362|12292742|P1|COMPLETED|Part A First Treatment||4
4996309|NCT02377362|12292730|P13|STARTED|Part A First Treatment||0
4996310|NCT02377362|12292731|P12|STARTED|Part A First Treatment||0
4996311|NCT02377362|12292732|P11|STARTED|Part A First Treatment||0
4996312|NCT02377362|12292733|P10|STARTED|Part A First Treatment||0
4996313|NCT02377362|12292734|P9|STARTED|Part A First Treatment||0
4996314|NCT02377362|12292735|P8|STARTED|Part A First Treatment||0
4996315|NCT02377362|12292736|P7|STARTED|Part A First Treatment||0
4996316|NCT02377362|12292737|P6|STARTED|Part A First Treatment||4
4996317|NCT02377362|12292738|P5|STARTED|Part A First Treatment||4
4996318|NCT02377362|12292739|P4|STARTED|Part A First Treatment||4
4996319|NCT02377362|12292740|P3|STARTED|Part A First Treatment||4
4996320|NCT02377362|12292741|P2|STARTED|Part A First Treatment||4
4996321|NCT02377362|12292742|P1|STARTED|Part A First Treatment||4
4996322|NCT02377349|12292951|P2|NOT COMPLETED|Overall Study||11
4996323|NCT02377349|12292952|P1|NOT COMPLETED|Overall Study||16
4996324|NCT02377349|12292951|P2|COMPLETED|Overall Study||335
4996325|NCT02377349|12292952|P1|COMPLETED|Overall Study||325
4996326|NCT02377349|12292951|P2|STARTED|Overall Study||346
4996327|NCT02377349|12292952|P1|STARTED|Overall Study||341
4996328|NCT02377063|12292990|P1|NOT COMPLETED|Overall Study||5
4996329|NCT02377063|12292990|P1|COMPLETED|Overall Study||20
4996330|NCT02377063|12292990|P1|STARTED|Overall Study||25
4996331|NCT02376998|12292994|P1|NOT COMPLETED|Overall Study||9
4996332|NCT02376998|12292994|P1|COMPLETED|Overall Study||11
4996333|NCT02376998|12292994|P1|STARTED|Overall Study||20
4996334|NCT02376933|12292998|P1|NOT COMPLETED|Overall Study||2
4996335|NCT02376933|12292998|P1|COMPLETED|Overall Study||8
4996336|NCT02376933|12292998|P1|STARTED|Overall Study||10
4996337|NCT02376790|12293008|P3|NOT COMPLETED|Overall Study||53
4996338|NCT02376790|12293009|P2|NOT COMPLETED|Overall Study||47
4996339|NCT02376790|12293010|P1|NOT COMPLETED|Overall Study||60
4996340|NCT02376790|12293008|P3|COMPLETED|Overall Study||230
4996341|NCT02376790|12293009|P2|COMPLETED|Overall Study||237
4996342|NCT02376790|12293010|P1|COMPLETED|Overall Study||224
4996343|NCT02376790|12293008|P3|Received Treatment|Overall Study||282
4996344|NCT02376790|12293009|P2|Received Treatment|Overall Study||284
4996345|NCT02376790|12293010|P1|Received Treatment|Overall Study||282
4996346|NCT02376790|12293008|P3|STARTED|Overall Study||283
4996347|NCT02376790|12293009|P2|STARTED|Overall Study||284
4996348|NCT02376790|12293010|P1|STARTED|Overall Study||284
4996349|NCT02376530|12293130|P4|NOT COMPLETED|Overall Study||0
4996350|NCT02376530|12293131|P3|NOT COMPLETED|Overall Study||0
4996351|NCT02376530|12293132|P2|NOT COMPLETED|Overall Study||0
4996352|NCT02376530|12293133|P1|NOT COMPLETED|Overall Study||0
4996353|NCT02376530|12293130|P4|COMPLETED|Overall Study||197
4996354|NCT02376530|12293131|P3|COMPLETED|Overall Study||197
4996355|NCT02376530|12293132|P2|COMPLETED|Overall Study||198
4996356|NCT02376530|12293133|P1|COMPLETED|Overall Study||196
4996357|NCT02376530|12293130|P4|STARTED|Overall Study||197
4996358|NCT02376530|12293131|P3|STARTED|Overall Study||197
4996359|NCT02376530|12293132|P2|STARTED|Overall Study||198
4996360|NCT02376530|12293133|P1|STARTED|Overall Study||196
4996361|NCT02376283|12293146|P3|NOT COMPLETED|Overall Study||0
4996362|NCT02376283|12293147|P2|NOT COMPLETED|Overall Study||0
4996363|NCT02376283|12293148|P1|NOT COMPLETED|Overall Study||0
4996364|NCT02376283|12293146|P3|COMPLETED|Overall Study||30
4996365|NCT02376283|12293147|P2|COMPLETED|Overall Study||30
4996366|NCT02376283|12293148|P1|COMPLETED|Overall Study||27
4996367|NCT02376283|12293146|P3|STARTED|Overall Study||30
4996368|NCT02376283|12293147|P2|STARTED|Overall Study||30
4996369|NCT02376283|12293148|P1|STARTED|Overall Study||27
4996370|NCT02376257|12293166|P3|NOT COMPLETED|Overall Study||0
4996371|NCT02376257|12293167|P2|NOT COMPLETED|Overall Study||0
4996372|NCT02376257|12293168|P1|NOT COMPLETED|Overall Study||0
4996373|NCT02376257|12293166|P3|COMPLETED|Overall Study||11
4996374|NCT02376257|12293167|P2|COMPLETED|Overall Study||12
4996375|NCT02376257|12293168|P1|COMPLETED|Overall Study||13
4996376|NCT02376257|12293166|P3|STARTED|Overall Study||11
4996377|NCT02376257|12293167|P2|STARTED|Overall Study||12
4996378|NCT02376257|12293168|P1|STARTED|Overall Study||13
4996379|NCT02376179|12293197|P1|NOT COMPLETED|Overall Study||0
4996380|NCT02376179|12293197|P1|COMPLETED|Overall Study||84
4996381|NCT02376179|12293197|P1|STARTED|Overall Study||84
4996382|NCT02376166|12293201|P1|NOT COMPLETED|Overall Study||3
4996383|NCT02376166|12293201|P1|COMPLETED|Overall Study||12
4996384|NCT02376166|12293201|P1|STARTED|Overall Study||15
4996385|NCT02375971|12293229|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
4996386|NCT02375971|12293230|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
4996387|NCT02375971|12293231|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
4996388|NCT02375971|12293229|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
4996389|NCT02375971|12293230|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
4996390|NCT02375971|12293231|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
4996391|NCT02375971|12293229|P3|STARTED|Follow-Up Phase (up to Day 169)||69
4996392|NCT02375971|12293230|P2|STARTED|Follow-Up Phase (up to Day 169)||76
4996393|NCT02375971|12293231|P1|STARTED|Follow-Up Phase (up to Day 169)||73
4996394|NCT02375971|12293229|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
4996395|NCT02375971|12293230|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
4996396|NCT02375971|12293231|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
4996397|NCT02375971|12293229|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
4996398|NCT02375971|12293230|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
4996399|NCT02375971|12293231|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
4996400|NCT02375971|12293229|P3|PK Set|Treatment (Day 1 - Baseline)||0
4996401|NCT02375971|12293230|P2|PK Set|Treatment (Day 1 - Baseline)||46
4996402|NCT02375971|12293231|P1|PK Set|Treatment (Day 1 - Baseline)||49
4996403|NCT02375971|12293229|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
4996404|NCT02375971|12293230|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
4996405|NCT02375971|12293231|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
4996406|NCT02375971|12293229|P3|Safety Set|Treatment (Day 1 - Baseline)||69
4996407|NCT02375971|12293230|P2|Safety Set|Treatment (Day 1 - Baseline)||76
4996408|NCT02375971|12293231|P1|Safety Set|Treatment (Day 1 - Baseline)||73
4996409|NCT02375971|12293229|P3|STARTED|Treatment (Day 1 - Baseline)||74
4996410|NCT02375971|12293230|P2|STARTED|Treatment (Day 1 - Baseline)||77
4996411|NCT02375971|12293231|P1|STARTED|Treatment (Day 1 - Baseline)||74
4996412|NCT02375724|12293273|P2|NOT COMPLETED|Overall Study||6
4996413|NCT02375724|12293274|P1|NOT COMPLETED|Overall Study||6
4996414|NCT02375724|12293273|P2|COMPLETED|Overall Study||128
4996415|NCT02375724|12293274|P1|COMPLETED|Overall Study||129
4996416|NCT02375724|12293273|P2|STARTED|Overall Study||134
4996417|NCT02375724|12293274|P1|STARTED|Overall Study||135
4996418|NCT02375698|12293286|P2|NOT COMPLETED|Overall Study||2
4996419|NCT02375698|12293287|P1|NOT COMPLETED|Overall Study||2
4996420|NCT02375698|12293286|P2|COMPLETED|Overall Study||4
4996421|NCT02375698|12293287|P1|COMPLETED|Overall Study||14
4996422|NCT02375698|12293286|P2|STARTED|Overall Study||6
4996423|NCT02375698|12293287|P1|STARTED|Overall Study||16
4996424|NCT02375373|12293295|P1|NOT COMPLETED|Overall Study||11
4996425|NCT02375373|12293295|P1|COMPLETED|Overall Study||1
4996426|NCT02375373|12293295|P1|STARTED|Overall Study||12
4996427|NCT02375347|12293299|P1|NOT COMPLETED|Overall Study||1
4996428|NCT02375347|12293299|P1|COMPLETED|Overall Study||12
4996429|NCT02375347|12293299|P1|STARTED|Overall Study||13
4996430|NCT02374957|12293305|P2|NOT COMPLETED|Overall Study||0
4996431|NCT02374957|12293306|P1|NOT COMPLETED|Overall Study||1
4996432|NCT02374957|12293305|P2|COMPLETED|Overall Study||9
4996433|NCT02374957|12293306|P1|COMPLETED|Overall Study||10
4996434|NCT02374957|12293305|P2|STARTED|Overall Study||9
4996435|NCT02374957|12293306|P1|STARTED|Overall Study||11
4996436|NCT02374671|12293335|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
4996437|NCT02374671|12293336|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
4996438|NCT02374671|12293337|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
4996439|NCT02374671|12293335|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
4996440|NCT02374671|12293336|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
4996441|NCT02374671|12293337|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
4996442|NCT02374671|12293335|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
4996443|NCT02374671|12293336|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
4996444|NCT02374671|12293337|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
4996445|NCT02374671|12293335|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
4996446|NCT02374671|12293336|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
4996447|NCT02374671|12293337|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
4996448|NCT02374671|12293335|P3|COMPLETED|Observation (Deferred Implantation)||26
4996449|NCT02374671|12293336|P2|COMPLETED|Observation (Deferred Implantation)||0
4996450|NCT02374671|12293337|P1|COMPLETED|Observation (Deferred Implantation)||0
4996451|NCT02374671|12293335|P3|STARTED|Observation (Deferred Implantation)||31
4996452|NCT02374671|12293336|P2|STARTED|Observation (Deferred Implantation)||0
4996453|NCT02374671|12293337|P1|STARTED|Observation (Deferred Implantation)||0
4996454|NCT02374593|12293345|P2|NOT COMPLETED|Overall Study||0
4996455|NCT02374593|12293346|P1|NOT COMPLETED|Overall Study||2
4996456|NCT02374593|12293345|P2|COMPLETED|Overall Study||44
4996457|NCT02374593|12293346|P1|COMPLETED|Overall Study||22
4996458|NCT02374593|12293345|P2|STARTED|Overall Study||44
4996459|NCT02374593|12293346|P1|STARTED|Overall Study||24
4996460|NCT02374463|12293358|P2|NOT COMPLETED|Overall Study||3
4996461|NCT02374463|12293359|P1|NOT COMPLETED|Overall Study||3
4996462|NCT02374463|12293358|P2|COMPLETED|Overall Study||9
4996463|NCT02374463|12293359|P1|COMPLETED|Overall Study||12
4996464|NCT02374463|12293358|P2|STARTED|Overall Study||12
4996465|NCT02374463|12293359|P1|STARTED|Overall Study||15
4996466|NCT02374398|12293379|P4|NOT COMPLETED|Overall Study||0
4996467|NCT02374398|12293380|P3|NOT COMPLETED|Overall Study||3
4996468|NCT02374398|12293381|P2|NOT COMPLETED|Overall Study||1
4996469|NCT02374398|12293382|P1|NOT COMPLETED|Overall Study||2
4996470|NCT02374398|12293379|P4|COMPLETED|Overall Study||32
4996471|NCT02374398|12293380|P3|COMPLETED|Overall Study||29
4996472|NCT02374398|12293381|P2|COMPLETED|Overall Study||31
4996473|NCT02374398|12293382|P1|COMPLETED|Overall Study||29
4996474|NCT02374398|12293379|P4|STARTED|Overall Study||32
4996475|NCT02374398|12293380|P3|STARTED|Overall Study||32
4996476|NCT02374398|12293381|P2|STARTED|Overall Study||32
4996477|NCT02374398|12293382|P1|STARTED|Overall Study||31
4996478|NCT02374346|12293408|P1|NOT COMPLETED|Overall Study||48
4996479|NCT02374346|12293408|P1|COMPLETED|Overall Study||446
4996480|NCT02374346|12293408|P1|STARTED|Overall Study||494
4996481|NCT02374307|12293416|P2|NOT COMPLETED|6-months Follow-up||6
4996482|NCT02374307|12293417|P1|NOT COMPLETED|6-months Follow-up||3
4996483|NCT02374307|12293416|P2|COMPLETED|6-months Follow-up||64
4996484|NCT02374307|12293417|P1|COMPLETED|6-months Follow-up||71
4996485|NCT02374307|12293416|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
4996486|NCT02374307|12293417|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
4996487|NCT02374307|12293416|P2|NOT COMPLETED|3-months Follow-up||9
4996488|NCT02374307|12293417|P1|NOT COMPLETED|3-months Follow-up||8
4996489|NCT02374307|12293416|P2|COMPLETED|3-months Follow-up||69
4996490|NCT02374307|12293417|P1|COMPLETED|3-months Follow-up||69
4996491|NCT02374307|12293416|P2|STARTED|3-months Follow-up||78
4996492|NCT02374307|12293417|P1|STARTED|3-months Follow-up||77
4996493|NCT02374255|12293448|P4|NOT COMPLETED|Overall Study||0
4996494|NCT02374255|12293449|P3|NOT COMPLETED|Overall Study||0
4996495|NCT02374255|12293450|P2|NOT COMPLETED|Overall Study||0
4996496|NCT02374255|12293451|P1|NOT COMPLETED|Overall Study||2
4996497|NCT02374255|12293448|P4|COMPLETED|Overall Study||11
4996498|NCT02374255|12293449|P3|COMPLETED|Overall Study||11
4996499|NCT02374255|12293450|P2|COMPLETED|Overall Study||110
4996500|NCT02374255|12293451|P1|COMPLETED|Overall Study||153
4996501|NCT02374255|12293448|P4|STARTED|Overall Study||11
4996502|NCT02374255|12293449|P3|STARTED|Overall Study||11
4996503|NCT02374255|12293450|P2|STARTED|Overall Study||110
4996504|NCT02374255|12293451|P1|STARTED|Overall Study||155
4996505|NCT02374164|12293472|P3|NOT COMPLETED|Treatment Period 3||0
4996506|NCT02374164|12293473|P2|NOT COMPLETED|Treatment Period 3||0
4996507|NCT02374164|12293474|P1|NOT COMPLETED|Treatment Period 3||0
4996508|NCT02374164|12293472|P3|COMPLETED|Treatment Period 3||12
4996509|NCT02374164|12293473|P2|COMPLETED|Treatment Period 3||11
4996510|NCT02374164|12293474|P1|COMPLETED|Treatment Period 3||12
4996511|NCT02374164|12293472|P3|STARTED|Treatment Period 3||12
4996512|NCT02374164|12293473|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
4996513|NCT02374164|12293474|P1|STARTED|Treatment Period 3||12
4996514|NCT02374164|12293472|P3|NOT COMPLETED|Treatment Period 2||0
4996515|NCT02374164|12293473|P2|NOT COMPLETED|Treatment Period 2||0
4996516|NCT02374164|12293474|P1|NOT COMPLETED|Treatment Period 2||0
4996517|NCT02374164|12293472|P3|COMPLETED|Treatment Period 2||12
4996518|NCT02374164|12293473|P2|COMPLETED|Treatment Period 2||12
4996519|NCT02374164|12293474|P1|COMPLETED|Treatment Period 2||12
4996520|NCT02374164|12293472|P3|STARTED|Treatment Period 2||12
4996521|NCT02374164|12293473|P2|STARTED|Treatment Period 2||12
4996522|NCT02374164|12293474|P1|STARTED|Treatment Period 2||12
4996523|NCT02374164|12293472|P3|NOT COMPLETED|Treatment Period 1||0
4996524|NCT02374164|12293473|P2|NOT COMPLETED|Treatment Period 1||0
4996525|NCT02374164|12293474|P1|NOT COMPLETED|Treatment Period 1||0
4996526|NCT02374164|12293472|P3|COMPLETED|Treatment Period 1||12
4996527|NCT02374164|12293473|P2|COMPLETED|Treatment Period 1||12
4996528|NCT02374164|12293474|P1|COMPLETED|Treatment Period 1||12
4996529|NCT02374164|12293472|P3|STARTED|Treatment Period 1||12
4996530|NCT02374164|12293473|P2|STARTED|Treatment Period 1||12
4996531|NCT02374164|12293474|P1|STARTED|Treatment Period 1||12
4996532|NCT02374138|12293493|P2|NOT COMPLETED|Twelve Month FollowUp||12
4996533|NCT02374138|12293494|P1|NOT COMPLETED|Twelve Month FollowUp||9
4996534|NCT02374138|12293493|P2|COMPLETED|Twelve Month FollowUp||95
4996535|NCT02374138|12293494|P1|COMPLETED|Twelve Month FollowUp||101
4996536|NCT02374138|12293493|P2|STARTED|Twelve Month FollowUp||107
4996537|NCT02374138|12293494|P1|STARTED|Twelve Month FollowUp||110
4996538|NCT02374138|12293493|P2|NOT COMPLETED|Six Month Follow Up||14
4996539|NCT02374138|12293494|P1|NOT COMPLETED|Six Month Follow Up||8
4996540|NCT02374138|12293493|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
4996541|NCT02374138|12293494|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
4996542|NCT02374138|12293493|P2|STARTED|Six Month Follow Up||107
4996543|NCT02374138|12293494|P1|STARTED|Six Month Follow Up||110
4996544|NCT02374099|12293552|P2|NOT COMPLETED|Overall Study||49
4996545|NCT02374099|12293553|P1|NOT COMPLETED|Overall Study||48
4996546|NCT02374099|12293552|P2|COMPLETED|Overall Study||0
4996547|NCT02374099|12293553|P1|COMPLETED|Overall Study||0
4996548|NCT02374099|12293552|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
4996549|NCT02374099|12293553|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
4996550|NCT02374099|12293552|P2|STARTED|Overall Study||49
4996551|NCT02374099|12293553|P1|STARTED|Overall Study||48
4996552|NCT02374060|12293572|P3|NOT COMPLETED|Overall Study||3
4996553|NCT02374060|12293573|P2|NOT COMPLETED|Overall Study||1
4996554|NCT02374060|12293574|P1|NOT COMPLETED|Overall Study||2
4996555|NCT02374060|12293572|P3|COMPLETED|Overall Study||61
4996556|NCT02374060|12293573|P2|COMPLETED|Overall Study||62
4996557|NCT02374060|12293574|P1|COMPLETED|Overall Study||63
4996558|NCT02374060|12293572|P3|STARTED|Overall Study||64
4996559|NCT02374060|12293573|P2|STARTED|Overall Study||63
4996560|NCT02374060|12293574|P1|STARTED|Overall Study||65
4996561|NCT02373865|12293626|P2|NOT COMPLETED|Overall Study||0
4996562|NCT02373865|12293627|P1|NOT COMPLETED|Overall Study||0
4996563|NCT02373865|12293626|P2|COMPLETED|Overall Study||2
4996564|NCT02373865|12293627|P1|COMPLETED|Overall Study||2
4996565|NCT02373865|12293626|P2|STARTED|Overall Study||2
4996566|NCT02373865|12293627|P1|STARTED|Overall Study||2
4996567|NCT02373852|12293637|P1|NOT COMPLETED|Overall Study||1
4996568|NCT02373852|12293637|P1|COMPLETED|Overall Study||11
4996569|NCT02373852|12293637|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
4996570|NCT02373371|12293644|P2|NOT COMPLETED|Overall Study||0
4996571|NCT02373371|12293645|P1|NOT COMPLETED|Overall Study||0
4996572|NCT02373371|12293644|P2|COMPLETED|Overall Study||13
4996573|NCT02373371|12293645|P1|COMPLETED|Overall Study||13
4996574|NCT02373371|12293644|P2|STARTED|Overall Study||13
4996575|NCT02373371|12293645|P1|STARTED|Overall Study||13
4996576|NCT02373202|12293661|P4|NOT COMPLETED|Overall Study||1
4996577|NCT02373202|12293662|P3|NOT COMPLETED|Overall Study||3
4996578|NCT02373202|12293663|P2|NOT COMPLETED|Overall Study||6
4996579|NCT02373202|12293664|P1|NOT COMPLETED|Overall Study||2
4996580|NCT02373202|12293661|P4|COMPLETED|Overall Study||30
4996581|NCT02373202|12293662|P3|COMPLETED|Overall Study||27
4996582|NCT02373202|12293663|P2|COMPLETED|Overall Study||9
4996583|NCT02373202|12293664|P1|COMPLETED|Overall Study||13
4996584|NCT02373202|12293661|P4|STARTED|Overall Study||31
4996585|NCT02373202|12293662|P3|STARTED|Overall Study||30
4996586|NCT02373202|12293663|P2|STARTED|Overall Study||15
4996587|NCT02373202|12293664|P1|STARTED|Overall Study||15
4996588|NCT02373137|12293716|P2|NOT COMPLETED|Overall Study||1
4996589|NCT02373137|12293717|P1|NOT COMPLETED|Overall Study||1
4996590|NCT02373137|12293716|P2|COMPLETED|Overall Study||18
4996591|NCT02373137|12293717|P1|COMPLETED|Overall Study||18
4996592|NCT02373137|12293716|P2|12-Month Follow-Up|Overall Study||19
4996593|NCT02373137|12293717|P1|12-Month Follow-Up|Overall Study||19
4996594|NCT02373137|12293716|P2|6-Month Follow-Up|Overall Study||18
4996595|NCT02373137|12293717|P1|6-Month Follow-Up|Overall Study||19
4996596|NCT02373137|12293716|P2|3-Month Follow-Up|Overall Study||19
4996597|NCT02373137|12293717|P1|3-Month Follow-Up|Overall Study||19
4996598|NCT02373137|12293716|P2|STARTED|Overall Study||19
4996599|NCT02373137|12293717|P1|STARTED|Overall Study||19
4996600|NCT02373124|12293733|P1|NOT COMPLETED|Overall Study||1
4996601|NCT02373124|12293733|P1|COMPLETED|Overall Study||3
4996602|NCT02373124|12293733|P1|STARTED|Overall Study||4
4996603|NCT02373098|12293739|P2|NOT COMPLETED|Overall Study||0
4996604|NCT02373098|12293740|P1|NOT COMPLETED|Overall Study||12
4996605|NCT02373098|12293739|P2|COMPLETED|Overall Study||60
4996606|NCT02373098|12293740|P1|COMPLETED|Overall Study||54
4996607|NCT02373098|12293739|P2|STARTED|Overall Study||60
4996608|NCT02373098|12293740|P1|STARTED|Overall Study||66
4996609|NCT02372799|12293768|P3|NOT COMPLETED|Down-taper Period||2
4996610|NCT02372799|12293769|P2|NOT COMPLETED|Down-taper Period||2
4996611|NCT02372799|12293770|P1|NOT COMPLETED|Down-taper Period||1
4996612|NCT02372799|12293768|P3|COMPLETED|Down-taper Period||80
4996613|NCT02372799|12293769|P2|COMPLETED|Down-taper Period||157
4996614|NCT02372799|12293770|P1|COMPLETED|Down-taper Period||151
4996615|NCT02372799|12293768|P3|STARTED|Down-taper Period||82
4996616|NCT02372799|12293769|P2|STARTED|Down-taper Period||159
4996617|NCT02372799|12293770|P1|STARTED|Down-taper Period||152
4996618|NCT02372799|12293768|P3|NOT COMPLETED|Treatment Period||15
4996619|NCT02372799|12293769|P2|NOT COMPLETED|Treatment Period||32
4996620|NCT02372799|12293770|P1|NOT COMPLETED|Treatment Period||34
4996621|NCT02372799|12293768|P3|COMPLETED|Treatment Period||82
4996622|NCT02372799|12293769|P2|COMPLETED|Treatment Period||155
4996623|NCT02372799|12293770|P1|COMPLETED|Treatment Period||152
4996624|NCT02372799|12293768|P3|STARTED|Treatment Period||97
4996625|NCT02372799|12293769|P2|STARTED|Treatment Period||187
4996626|NCT02372799|12293770|P1|STARTED|Treatment Period||186
4996627|NCT02372682|12293783|P2|NOT COMPLETED|Overall Study||14
4996628|NCT02372682|12293784|P1|NOT COMPLETED|Overall Study||8
4996629|NCT02372682|12293783|P2|COMPLETED|Overall Study||79
4996630|NCT02372682|12293784|P1|COMPLETED|Overall Study||70
4996631|NCT02372682|12293783|P2|STARTED|Overall Study||93
4996632|NCT02372682|12293784|P1|STARTED|Overall Study||78
4996633|NCT02372396|12293799|P2|NOT COMPLETED|Overall Study||9
4996634|NCT02372396|12293800|P1|NOT COMPLETED|Overall Study||7
4996635|NCT02372396|12293799|P2|COMPLETED|Overall Study||11
4996636|NCT02372396|12293800|P1|COMPLETED|Overall Study||10
4996637|NCT02372396|12293799|P2|Began Intervention|Overall Study||14
4996638|NCT02372396|12293800|P1|Began Intervention|Overall Study||14
4996639|NCT02372396|12293799|P2|STARTED|Overall Study||20
4996640|NCT02372396|12293800|P1|STARTED|Overall Study||17
4996641|NCT02372344|12293806|P3|NOT COMPLETED|Period 3 (Visit 4)||0
4996642|NCT02372344|12293807|P2|NOT COMPLETED|Period 3 (Visit 4)||0
4996643|NCT02372344|12293808|P1|NOT COMPLETED|Period 3 (Visit 4)||0
4996644|NCT02372344|12293806|P3|COMPLETED|Period 3 (Visit 4)||14
4996645|NCT02372344|12293807|P2|COMPLETED|Period 3 (Visit 4)||14
4996646|NCT02372344|12293808|P1|COMPLETED|Period 3 (Visit 4)||14
4996647|NCT02372344|12293806|P3|STARTED|Period 3 (Visit 4)||14
4996648|NCT02372344|12293807|P2|STARTED|Period 3 (Visit 4)||14
4996649|NCT02372344|12293808|P1|STARTED|Period 3 (Visit 4)||14
4996650|NCT02372344|12293806|P3|NOT COMPLETED|Period 2 (Visit 3)||0
4996651|NCT02372344|12293807|P2|NOT COMPLETED|Period 2 (Visit 3)||0
4996652|NCT02372344|12293808|P1|NOT COMPLETED|Period 2 (Visit 3)||0
4996653|NCT02372344|12293806|P3|COMPLETED|Period 2 (Visit 3)||14
4996654|NCT02372344|12293807|P2|COMPLETED|Period 2 (Visit 3)||14
4996655|NCT02372344|12293808|P1|COMPLETED|Period 2 (Visit 3)||14
4996656|NCT02372344|12293806|P3|STARTED|Period 2 (Visit 3)||14
4996657|NCT02372344|12293807|P2|STARTED|Period 2 (Visit 3)||14
4996658|NCT02372344|12293808|P1|STARTED|Period 2 (Visit 3)||14
4996659|NCT02372344|12293806|P3|NOT COMPLETED|Period 1 (Visit 2)||0
4996660|NCT02372344|12293807|P2|NOT COMPLETED|Period 1 (Visit 2)||0
4996661|NCT02372344|12293808|P1|NOT COMPLETED|Period 1 (Visit 2)||0
4996662|NCT02372344|12293806|P3|COMPLETED|Period 1 (Visit 2)||14
4996663|NCT02372344|12293807|P2|COMPLETED|Period 1 (Visit 2)||14
4996664|NCT02372344|12293808|P1|COMPLETED|Period 1 (Visit 2)||14
4996665|NCT02372344|12293806|P3|STARTED|Period 1 (Visit 2)||14
4996666|NCT02372344|12293807|P2|STARTED|Period 1 (Visit 2)||14
4996667|NCT02372344|12293808|P1|STARTED|Period 1 (Visit 2)||14
4996668|NCT02372253|12293824|P2|NOT COMPLETED|Overall Study||0
4996669|NCT02372253|12293825|P1|NOT COMPLETED|Overall Study||2
4996670|NCT02372253|12293824|P2|COMPLETED|Overall Study||13
4996671|NCT02372253|12293825|P1|COMPLETED|Overall Study||11
4996672|NCT02372253|12293824|P2|STARTED|Overall Study||13
4996673|NCT02372253|12293825|P1|STARTED|Overall Study||13
4996674|NCT02372097|12293843|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
4996675|NCT02372097|12293844|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
4996676|NCT02372097|12293843|P2|COMPLETED|Second Intervention Period (8 Days)||12
4996677|NCT02372097|12293844|P1|COMPLETED|Second Intervention Period (8 Days)||12
4996678|NCT02372097|12293843|P2|STARTED|Second Intervention Period (8 Days)||12
4996679|NCT02372097|12293844|P1|STARTED|Second Intervention Period (8 Days)||12
4996680|NCT02372097|12293843|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
4996681|NCT02372097|12293844|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
4996682|NCT02372097|12293843|P2|COMPLETED|Wash Out Period (13 Days)||12
4996683|NCT02372097|12293844|P1|COMPLETED|Wash Out Period (13 Days)||12
4996684|NCT02372097|12293843|P2|STARTED|Wash Out Period (13 Days)||12
4996685|NCT02372097|12293844|P1|STARTED|Wash Out Period (13 Days)||12
4996686|NCT02372097|12293843|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
4996687|NCT02372097|12293844|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
4996688|NCT02372097|12293843|P2|COMPLETED|First Intervention Period (8 Days)||12
4996689|NCT02372097|12293844|P1|COMPLETED|First Intervention Period (8 Days)||12
4996690|NCT02372097|12293843|P2|STARTED|First Intervention Period (8 Days)||12
4996691|NCT02372097|12293844|P1|STARTED|First Intervention Period (8 Days)||12
4996692|NCT02372071|12293870|P1|NOT COMPLETED|Overall Study||18
4996693|NCT02372071|12293870|P1|COMPLETED|Overall Study||93
4996694|NCT02372071|12293870|P1|STARTED|Overall Study||111
4996695|NCT02372058|12293875|P1|NOT COMPLETED|Overall Study||3
4996696|NCT02372058|12293875|P1|COMPLETED|Overall Study||100
4996697|NCT02372058|12293875|P1|STARTED|Overall Study||103
4996698|NCT02371980|12293881|P5|NOT COMPLETED|Double-blind Period||58
4996699|NCT02371980|12293882|P4|NOT COMPLETED|Double-blind Period||49
4996700|NCT02371980|12293883|P3|NOT COMPLETED|Double-blind Period||56
4996701|NCT02371980|12293884|P2|NOT COMPLETED|Double-blind Period||81
4996702|NCT02371980|12293885|P1|NOT COMPLETED|Double-blind Period||0
4996703|NCT02371980|12293881|P5|COMPLETED|Double-blind Period||86
4996704|NCT02371980|12293882|P4|COMPLETED|Double-blind Period||96
4996705|NCT02371980|12293883|P3|COMPLETED|Double-blind Period||84
4996706|NCT02371980|12293884|P2|COMPLETED|Double-blind Period||70
4996707|NCT02371980|12293885|P1|COMPLETED|Double-blind Period||0
4996708|NCT02371980|12293881|P5|STARTED|Double-blind Period||144
4996709|NCT02371980|12293882|P4|STARTED|Double-blind Period||145
4996710|NCT02371980|12293883|P3|STARTED|Double-blind Period||140
4996711|NCT02371980|12293884|P2|STARTED|Double-blind Period||151
4996712|NCT02371980|12293885|P1|STARTED|Double-blind Period||0
4996713|NCT02371980|12293881|P5|NOT COMPLETED|Open-label Period||0
4996714|NCT02371980|12293882|P4|NOT COMPLETED|Open-label Period||0
4996715|NCT02371980|12293883|P3|NOT COMPLETED|Open-label Period||0
4996716|NCT02371980|12293884|P2|NOT COMPLETED|Open-label Period||0
4996717|NCT02371980|12293885|P1|NOT COMPLETED|Open-label Period||526
4996718|NCT02371980|12293881|P5|COMPLETED|Open-label Period||0
4996719|NCT02371980|12293882|P4|COMPLETED|Open-label Period||0
4996720|NCT02371980|12293883|P3|COMPLETED|Open-label Period||0
4996721|NCT02371980|12293884|P2|COMPLETED|Open-label Period||0
4996722|NCT02371980|12293885|P1|COMPLETED|Open-label Period||580
4996723|NCT02371980|12293881|P5|STARTED|Open-label Period||0
4996724|NCT02371980|12293882|P4|STARTED|Open-label Period||0
4996725|NCT02371980|12293883|P3|STARTED|Open-label Period||0
4996726|NCT02371980|12293884|P2|STARTED|Open-label Period||0
4996727|NCT02371980|12293885|P1|STARTED|Open-label Period||1106
4996728|NCT02371876|12293912|P1|NOT COMPLETED|Overall Study||0
4996729|NCT02371876|12293912|P1|COMPLETED|Overall Study||134
4996730|NCT02371876|12293912|P1|STARTED|Overall Study||134
4996731|NCT02371850|12293922|P1|NOT COMPLETED|Overall Study||0
4996732|NCT02371850|12293922|P1|COMPLETED|Overall Study||10
4996733|NCT02371850|12293922|P1|STARTED|Overall Study||10
4996734|NCT02371785|12293927|P1|NOT COMPLETED|Overall Study||0
4996735|NCT02371785|12293927|P1|COMPLETED|Overall Study||20
4996736|NCT02371785|12293927|P1|STARTED|Overall Study||20
4996737|NCT02371759|12293945|P8|NOT COMPLETED|Overall Study||4
4996738|NCT02371759|12293946|P7|NOT COMPLETED|Overall Study||0
4996739|NCT02371759|12293947|P6|NOT COMPLETED|Overall Study||1
4996740|NCT02371759|12293948|P5|NOT COMPLETED|Overall Study||3
4996741|NCT02371759|12293949|P4|NOT COMPLETED|Overall Study||0
4996742|NCT02371759|12293950|P3|NOT COMPLETED|Overall Study||1
4996743|NCT02371759|12293951|P2|NOT COMPLETED|Overall Study||1
4996744|NCT02371759|12293952|P1|NOT COMPLETED|Overall Study||3
4996745|NCT02371759|12293945|P8|COMPLETED|Overall Study||24
4996746|NCT02371759|12293946|P7|COMPLETED|Overall Study||25
4996747|NCT02371759|12293947|P6|COMPLETED|Overall Study||25
4996748|NCT02371759|12293948|P5|COMPLETED|Overall Study||24
4996749|NCT02371759|12293949|P4|COMPLETED|Overall Study||31
4996750|NCT02371759|12293950|P3|COMPLETED|Overall Study||32
4996751|NCT02371759|12293951|P2|COMPLETED|Overall Study||30
4996752|NCT02371759|12293952|P1|COMPLETED|Overall Study||29
4996753|NCT02371759|12293945|P8|STARTED|Overall Study||28
4996754|NCT02371759|12293946|P7|STARTED|Overall Study||25
4996755|NCT02371759|12293947|P6|STARTED|Overall Study||26
4996756|NCT02371759|12293948|P5|STARTED|Overall Study||27
4996757|NCT02371759|12293949|P4|STARTED|Overall Study||31
4996758|NCT02371759|12293950|P3|STARTED|Overall Study||33
4996759|NCT02371759|12293951|P2|STARTED|Overall Study||31
4996760|NCT02371759|12293952|P1|STARTED|Overall Study||32
4996761|NCT02371746|12294169|P7|NOT COMPLETED|Overall Study||1
4996762|NCT02371746|12294170|P6|NOT COMPLETED|Overall Study||0
4996763|NCT02371746|12294171|P5|NOT COMPLETED|Overall Study||0
4996764|NCT02371746|12294172|P4|NOT COMPLETED|Overall Study||0
4996765|NCT02371746|12294173|P3|NOT COMPLETED|Overall Study||0
4996766|NCT02371746|12294174|P2|NOT COMPLETED|Overall Study||0
4996767|NCT02371746|12294175|P1|NOT COMPLETED|Overall Study||0
4996768|NCT02371746|12294169|P7|COMPLETED|Overall Study||8
4996769|NCT02371746|12294170|P6|COMPLETED|Overall Study||6
4996770|NCT02371746|12294171|P5|COMPLETED|Overall Study||5
4996771|NCT02371746|12294172|P4|COMPLETED|Overall Study||2
4996772|NCT02371746|12294173|P3|COMPLETED|Overall Study||2
4996773|NCT02371746|12294174|P2|COMPLETED|Overall Study||10
4996774|NCT02371746|12294175|P1|COMPLETED|Overall Study||7
4996775|NCT02371746|12294169|P7|STARTED|Overall Study||9
4996776|NCT02371746|12294170|P6|STARTED|Overall Study||6
4996777|NCT02371746|12294171|P5|STARTED|Overall Study||5
4996778|NCT02371746|12294172|P4|STARTED|Overall Study||2
4996779|NCT02371746|12294173|P3|STARTED|Overall Study||2
4996780|NCT02371746|12294174|P2|STARTED|Overall Study||10
4996781|NCT02371746|12294175|P1|STARTED|Overall Study||7
4996782|NCT02371668|12294193|P2|NOT COMPLETED|Overall Study||0
4996783|NCT02371668|12294194|P1|NOT COMPLETED|Overall Study||0
4996784|NCT02371668|12294193|P2|COMPLETED|Overall Study||42
4996785|NCT02371668|12294194|P1|COMPLETED|Overall Study||49
4996786|NCT02371668|12294193|P2|STARTED|Overall Study||42
4996787|NCT02371668|12294194|P1|STARTED|Overall Study||49
4996788|NCT02371629|12294218|P2|NOT COMPLETED|Overall Study||25
4996789|NCT02371629|12294219|P1|NOT COMPLETED|Overall Study||26
4996790|NCT02371629|12294218|P2|COMPLETED|Overall Study||363
4996791|NCT02371629|12294219|P1|COMPLETED|Overall Study||362
4996792|NCT02371629|12294218|P2|STARTED|Overall Study||388
4996793|NCT02371629|12294219|P1|STARTED|Overall Study||388
4996794|NCT02371616|12294255|P2|NOT COMPLETED|Overall Study||7
4996795|NCT02371616|12294256|P1|NOT COMPLETED|Overall Study||4
4996796|NCT02371616|12294255|P2|COMPLETED|Overall Study||147
4996797|NCT02371616|12294256|P1|COMPLETED|Overall Study||146
4996798|NCT02371616|12294255|P2|STARTED|Overall Study||154
4996799|NCT02371616|12294256|P1|STARTED|Overall Study||150
4996800|NCT02371395|12294268|P1|NOT COMPLETED|Overall Study||0
4996801|NCT02371395|12294268|P1|COMPLETED|Overall Study||1000
4996802|NCT02371395|12294268|P1|STARTED|Overall Study||1000
4996803|NCT02371369|12294274|P2|NOT COMPLETED|Part 2||4
4996804|NCT02371369|12294275|P1|NOT COMPLETED|Part 2||9
4996805|NCT02371369|12294274|P2|COMPLETED|Part 2||26
4996806|NCT02371369|12294275|P1|COMPLETED|Part 2||39
4996807|NCT02371369|12294274|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
4996808|NCT02371369|12294275|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
4996809|NCT02371369|12294274|P2|NOT COMPLETED|Part 1||11
4996810|NCT02371369|12294275|P1|NOT COMPLETED|Part 1||9
4996811|NCT02371369|12294274|P2|COMPLETED|Part 1||48
4996812|NCT02371369|12294275|P1|COMPLETED|Part 1||52
4996813|NCT02371369|12294274|P2|STARTED|Part 1||59
4996814|NCT02371369|12294275|P1|STARTED|Part 1||61
4996815|NCT02371356|12294328|P5|NOT COMPLETED|Overall Study||0
4996816|NCT02371356|12294329|P4|NOT COMPLETED|Overall Study||0
4996817|NCT02371356|12294330|P3|NOT COMPLETED|Overall Study||0
4996818|NCT02371356|12294331|P2|NOT COMPLETED|Overall Study||0
4996819|NCT02371356|12294332|P1|NOT COMPLETED|Overall Study||0
4996820|NCT02371356|12294328|P5|COMPLETED|Overall Study||72183
4996821|NCT02371356|12294329|P4|COMPLETED|Overall Study||7423
4996822|NCT02371356|12294330|P3|COMPLETED|Overall Study||2804
4996823|NCT02371356|12294331|P2|COMPLETED|Overall Study||7354
4996824|NCT02371356|12294332|P1|COMPLETED|Overall Study||1320
4996825|NCT02371356|12294328|P5|STARTED|Overall Study||72183
4996826|NCT02371356|12294329|P4|STARTED|Overall Study||7423
4996827|NCT02371356|12294330|P3|STARTED|Overall Study||2804
4996828|NCT02371356|12294331|P2|STARTED|Overall Study||7354
4996829|NCT02371356|12294332|P1|STARTED|Overall Study||1320
4996830|NCT02371187|12294351|P2|NOT COMPLETED|Overall Study||4
4996831|NCT02371187|12294352|P1|NOT COMPLETED|Overall Study||3
4996832|NCT02371187|12294351|P2|COMPLETED|Overall Study||15
4996833|NCT02371187|12294352|P1|COMPLETED|Overall Study||15
4996834|NCT02371187|12294351|P2|STARTED|Overall Study||19
4996835|NCT02371187|12294352|P1|STARTED|Overall Study||18
4996836|NCT02370914|12294366|P1|NOT COMPLETED|Overall Study||2
4996837|NCT02370914|12294366|P1|COMPLETED|Overall Study||82
4996838|NCT02370914|12294366|P1|STARTED|Overall Study||84
4996839|NCT02370888|12294374|P1|NOT COMPLETED|Overall Study||8
4996840|NCT02370888|12294374|P1|COMPLETED|Overall Study||1
4996841|NCT02370888|12294374|P1|Proceed to Treatment|Overall Study||3
4996842|NCT02370888|12294374|P1|STARTED|Overall Study||9
4996843|NCT02370667|12294385|P3|NOT COMPLETED|Overall Study||0
4996844|NCT02370667|12294386|P2|NOT COMPLETED|Overall Study||1
4996845|NCT02370667|12294387|P1|NOT COMPLETED|Overall Study||0
4996846|NCT02370667|12294385|P3|COMPLETED|Overall Study||10
4996847|NCT02370667|12294386|P2|COMPLETED|Overall Study||10
4996848|NCT02370667|12294387|P1|COMPLETED|Overall Study||10
4996849|NCT02370667|12294385|P3|STARTED|Overall Study||10
4996850|NCT02370667|12294386|P2|STARTED|Overall Study||11
4996851|NCT02370667|12294387|P1|STARTED|Overall Study||10
4996852|NCT02370641|12294451|P2|NOT COMPLETED|Overall Study||2
4996853|NCT02370641|12294452|P1|NOT COMPLETED|Overall Study||4
4996854|NCT02370641|12294451|P2|COMPLETED|Overall Study||6
4996855|NCT02370641|12294452|P1|COMPLETED|Overall Study||14
4996856|NCT02370641|12294451|P2|STARTED|Overall Study||8
4996857|NCT02370641|12294452|P1|STARTED|Overall Study||18
4996858|NCT02370615|12294460|P2|NOT COMPLETED|Overall Study||0
4996859|NCT02370615|12294461|P1|NOT COMPLETED|Overall Study||1
4996860|NCT02370615|12294460|P2|COMPLETED|Overall Study||18
4996861|NCT02370615|12294461|P1|COMPLETED|Overall Study||15
4996862|NCT02370615|12294460|P2|STARTED|Overall Study||18
4996863|NCT02370615|12294461|P1|STARTED|Overall Study||16
4996864|NCT02370602|12294504|P6|NOT COMPLETED|Overall Study||0
4996865|NCT02370602|12294505|P5|NOT COMPLETED|Overall Study||0
4996866|NCT02370602|12294506|P4|NOT COMPLETED|Overall Study||0
4996867|NCT02370602|12294507|P3|NOT COMPLETED|Overall Study||0
4996868|NCT02370602|12294508|P2|NOT COMPLETED|Overall Study||0
4996869|NCT02370602|12294509|P1|NOT COMPLETED|Overall Study||1
4996870|NCT02370602|12294504|P6|COMPLETED|Overall Study||2
4996871|NCT02370602|12294505|P5|COMPLETED|Overall Study||3
4996872|NCT02370602|12294506|P4|COMPLETED|Overall Study||3
4996873|NCT02370602|12294507|P3|COMPLETED|Overall Study||2
4996874|NCT02370602|12294508|P2|COMPLETED|Overall Study||2
4996875|NCT02370602|12294509|P1|COMPLETED|Overall Study||0
4996876|NCT02370602|12294504|P6|STARTED|Overall Study||2
4996877|NCT02370602|12294505|P5|STARTED|Overall Study||3
4996878|NCT02370602|12294506|P4|STARTED|Overall Study||3
4996879|NCT02370602|12294507|P3|STARTED|Overall Study||2
4996880|NCT02370602|12294508|P2|STARTED|Overall Study||2
4996881|NCT02370602|12294509|P1|STARTED|Overall Study||1
4996882|NCT02370537|12294603|P3|NOT COMPLETED|Part B||259
4996883|NCT02370537|12294604|P2|NOT COMPLETED|Part B||3
4996884|NCT02370537|12294605|P1|NOT COMPLETED|Part B||1
4996885|NCT02370537|12294603|P3|COMPLETED|Part B||23
4996886|NCT02370537|12294604|P2|COMPLETED|Part B||12
4996887|NCT02370537|12294605|P1|COMPLETED|Part B||15
4996888|NCT02370537|12294603|P3|Period 2 Sequence BA|Part B||12
4996889|NCT02370537|12294604|P2|Period 2 Sequence BA|Part B||7
4996890|NCT02370537|12294605|P1|Period 2 Sequence BA|Part B||7
4996891|NCT02370537|12294603|P3|Period 2 Sequence AB|Part B||11
4996892|NCT02370537|12294604|P2|Period 2 Sequence AB|Part B||5
4996893|NCT02370537|12294605|P1|Period 2 Sequence AB|Part B||8
4996894|NCT02370537|12294603|P3|Period 1 Sequence BA|Part B||12
4996895|NCT02370537|12294604|P2|Period 1 Sequence BA|Part B||7
4996896|NCT02370537|12294605|P1|Period 1 Sequence BA|Part B||7
4996897|NCT02370537|12294603|P3|Period 1 Sequence AB|Part B||11
4996898|NCT02370537|12294604|P2|Period 1 Sequence AB|Part B||6
4996899|NCT02370537|12294605|P1|Period 1 Sequence AB|Part B||8
4996900|NCT02370537|12294603|P3|Eligible for Randomisation|Part B||23
4996901|NCT02370537|12294604|P2|Eligible for Randomisation|Part B||13
4996902|NCT02370537|12294605|P1|Eligible for Randomisation|Part B||15
4996903|NCT02370537|12294603|P3|STARTED|Part B||282
4996904|NCT02370537|12294604|P2|STARTED|Part B||15
4996905|NCT02370537|12294605|P1|STARTED|Part B||16
4996906|NCT02370537|12294603|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
4996907|NCT02370537|12294604|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
4996908|NCT02370537|12294605|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
4996909|NCT02370537|12294603|P3|COMPLETED|Part A (Open-label Recruitment)||282
4996910|NCT02370537|12294604|P2|COMPLETED|Part A (Open-label Recruitment)||15
4996911|NCT02370537|12294605|P1|COMPLETED|Part A (Open-label Recruitment)||16
4996912|NCT02370537|12294603|P3|STARTED|Part A (Open-label Recruitment)||283
4996913|NCT02370537|12294604|P2|STARTED|Part A (Open-label Recruitment)||16
4996914|NCT02370537|12294605|P1|STARTED|Part A (Open-label Recruitment)||16
4996915|NCT02370498|12294654|P2|NOT COMPLETED|Overall Study||296
4996916|NCT02370498|12294655|P1|NOT COMPLETED|Overall Study||296
4996917|NCT02370498|12294654|P2|COMPLETED|Overall Study||0
4996918|NCT02370498|12294655|P1|COMPLETED|Overall Study||0
4996919|NCT02370498|12294654|P2|PD-L1 Positive Participants|Overall Study||199
4996920|NCT02370498|12294655|P1|PD-L1 Positive Participants|Overall Study||196
4996921|NCT02370498|12294654|P2|Treated|Overall Study||276
4996922|NCT02370498|12294655|P1|Treated|Overall Study||294
4996923|NCT02370498|12294654|P2|STARTED|Overall Study||296
4996924|NCT02370498|12294655|P1|STARTED|Overall Study||296
4996925|NCT02370420|12294709|P2|NOT COMPLETED|Overall Study||12
4996926|NCT02370420|12294710|P1|NOT COMPLETED|Overall Study||14
4996927|NCT02370420|12294709|P2|COMPLETED|Overall Study||15
4996928|NCT02370420|12294710|P1|COMPLETED|Overall Study||15
4996929|NCT02370420|12294709|P2|STARTED|Overall Study||27
4996930|NCT02370420|12294710|P1|STARTED|Overall Study||29
4996931|NCT02370407|12294722|P2|NOT COMPLETED|Overall Study||0
4996932|NCT02370407|12294723|P1|NOT COMPLETED|Overall Study||0
4996933|NCT02370407|12294722|P2|COMPLETED|Overall Study||20
4996934|NCT02370407|12294723|P1|COMPLETED|Overall Study||20
4996935|NCT02370407|12294722|P2|STARTED|Overall Study||20
4996936|NCT02370407|12294723|P1|STARTED|Overall Study||20
4996937|NCT02370394|12294747|P2|NOT COMPLETED|Overall Study||2
4996938|NCT02370394|12294748|P1|NOT COMPLETED|Overall Study||2
4996939|NCT02370394|12294747|P2|COMPLETED|Overall Study||23
4996940|NCT02370394|12294748|P1|COMPLETED|Overall Study||26
4996941|NCT02370394|12294747|P2|STARTED|Overall Study||25
4996942|NCT02370394|12294748|P1|STARTED|Overall Study||28
4996943|NCT02370368|12294764|P2|NOT COMPLETED|Overall Study||6
4996944|NCT02370368|12294765|P1|NOT COMPLETED|Overall Study||6
4996945|NCT02370368|12294764|P2|COMPLETED|Overall Study||7
4996946|NCT02370368|12294765|P1|COMPLETED|Overall Study||8
4996947|NCT02370368|12294764|P2|STARTED|Overall Study||13
4996948|NCT02370368|12294765|P1|STARTED|Overall Study||14
4996949|NCT02370251|12294775|P1|NOT COMPLETED|Overall Study||11
4996950|NCT02370251|12294775|P1|COMPLETED|Overall Study||52
4996951|NCT02370251|12294775|P1|STARTED|Overall Study||63
4996952|NCT02370160|12294781|P3|NOT COMPLETED|Overall Study||1
4996953|NCT02370160|12294782|P2|NOT COMPLETED|Overall Study||4
4996954|NCT02370160|12294783|P1|NOT COMPLETED|Overall Study||3
4996955|NCT02370160|12294781|P3|COMPLETED|Overall Study||2
4996956|NCT02370160|12294782|P2|COMPLETED|Overall Study||2
4996957|NCT02370160|12294783|P1|COMPLETED|Overall Study||6
4996958|NCT02370160|12294781|P3|STARTED|Overall Study||3
4996959|NCT02370160|12294782|P2|STARTED|Overall Study||6
4996960|NCT02370160|12294783|P1|STARTED|Overall Study||9
4996961|NCT02370121|12294807|P2|NOT COMPLETED|Overall Study||1
4996962|NCT02370121|12294808|P1|NOT COMPLETED|Overall Study||1
4996963|NCT02370121|12294807|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
4996964|NCT02370121|12294808|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
4996965|NCT02370121|12294807|P2|STARTED|Overall Study||12
4996966|NCT02370121|12294808|P1|STARTED|Overall Study||12
4996967|NCT02370095|12294848|P2|NOT COMPLETED|Overall Study||1
4996968|NCT02370095|12294849|P1|NOT COMPLETED|Overall Study||0
4996969|NCT02370095|12294848|P2|COMPLETED|Overall Study||3
4996970|NCT02370095|12294849|P1|COMPLETED|Overall Study||10
4996971|NCT02370095|12294848|P2|STARTED|Overall Study||4
4996972|NCT02370095|12294849|P1|STARTED|Overall Study||10
4996973|NCT02370043|12294879|P6|NOT COMPLETED|Overall Study||1
4996974|NCT02370043|12294880|P5|NOT COMPLETED|Overall Study||1
4996975|NCT02370043|12294881|P4|NOT COMPLETED|Overall Study||0
4996976|NCT02370043|12294882|P3|NOT COMPLETED|Overall Study||0
4996977|NCT02370043|12294883|P2|NOT COMPLETED|Overall Study||0
4996978|NCT02370043|12294884|P1|NOT COMPLETED|Overall Study||0
4996979|NCT02370043|12294879|P6|COMPLETED|Overall Study||3
4996980|NCT02370043|12294880|P5|COMPLETED|Overall Study||2
4996981|NCT02370043|12294881|P4|COMPLETED|Overall Study||3
4996982|NCT02370043|12294882|P3|COMPLETED|Overall Study||3
4996983|NCT02370043|12294883|P2|COMPLETED|Overall Study||3
4996984|NCT02370043|12294884|P1|COMPLETED|Overall Study||3
4996985|NCT02370043|12294879|P6|STARTED|Overall Study||4
4996986|NCT02370043|12294880|P5|STARTED|Overall Study||3
4996987|NCT02370043|12294881|P4|STARTED|Overall Study||3
4996988|NCT02370043|12294882|P3|STARTED|Overall Study||3
4996989|NCT02370043|12294883|P2|STARTED|Overall Study||3
4996990|NCT02370043|12294884|P1|STARTED|Overall Study||3
4996991|NCT02370004|12295013|P1|NOT COMPLETED|Overall Study||1
4996992|NCT02370004|12295013|P1|COMPLETED|Overall Study||10
4996993|NCT02370004|12295013|P1|STARTED|Overall Study||11
4996994|NCT02369874|12295025|P3|NOT COMPLETED|Overall Study||61
4996995|NCT02369874|12295026|P2|NOT COMPLETED|Overall Study||57
4996996|NCT02369874|12295027|P1|NOT COMPLETED|Overall Study||44
4996997|NCT02369874|12295025|P3|COMPLETED|Overall Study||188
4996998|NCT02369874|12295026|P2|COMPLETED|Overall Study||183
4996999|NCT02369874|12295027|P1|COMPLETED|Overall Study||203
4997000|NCT02369874|12295025|P3|Received Treatment|Overall Study||240
4997001|NCT02369874|12295026|P2|Received Treatment|Overall Study||237
4997002|NCT02369874|12295027|P1|Received Treatment|Overall Study||246
4997003|NCT02369874|12295025|P3|STARTED|Overall Study||249
4997004|NCT02369874|12295026|P2|STARTED|Overall Study||240
4997005|NCT02369874|12295027|P1|STARTED|Overall Study||247
4997006|NCT02369848|12295074|P1|NOT COMPLETED|Overall Study||4
4997007|NCT02369848|12295074|P1|COMPLETED|Overall Study||56
4997008|NCT02369848|12295074|P1|12 Month Primary Endpoint|Overall Study||30
4997009|NCT02369848|12295074|P1|30 Day Primary Safety Endpoint|Overall Study||58
4997010|NCT02369848|12295074|P1|STARTED|Overall Study||60
4997011|NCT02369835|12295090|P2|NOT COMPLETED|Overall Study||13
4997012|NCT02369835|12295091|P1|NOT COMPLETED|Overall Study||11
4997013|NCT02369835|12295090|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
4997014|NCT02369835|12295091|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
4997015|NCT02369835|12295090|P2|STARTED|Overall Study||68
4997016|NCT02369835|12295091|P1|STARTED|Overall Study||64
4997017|NCT02369796|12295106|P5|NOT COMPLETED|Overall Study||0
4997018|NCT02369796|12295107|P4|NOT COMPLETED|Overall Study||0
4997019|NCT02369796|12295108|P3|NOT COMPLETED|Overall Study||0
4997020|NCT02369796|12295109|P2|NOT COMPLETED|Overall Study||0
4997021|NCT02369796|12295110|P1|NOT COMPLETED|Overall Study||0
4997022|NCT02369796|12295106|P5|COMPLETED|Overall Study||3
4997023|NCT02369796|12295107|P4|COMPLETED|Overall Study||3
4997024|NCT02369796|12295108|P3|COMPLETED|Overall Study||3
4997025|NCT02369796|12295109|P2|COMPLETED|Overall Study||3
4997026|NCT02369796|12295110|P1|COMPLETED|Overall Study||3
4997027|NCT02369796|12295106|P5|STARTED|Overall Study||3
4997028|NCT02369796|12295107|P4|STARTED|Overall Study||3
4997029|NCT02369796|12295108|P3|STARTED|Overall Study||3
4997030|NCT02369796|12295109|P2|STARTED|Overall Study||3
4997031|NCT02369796|12295110|P1|STARTED|Overall Study||3
4997032|NCT02369744|12295151|P2|NOT COMPLETED|Overall Study||0
4997033|NCT02369744|12295152|P1|NOT COMPLETED|Overall Study||0
4997034|NCT02369744|12295151|P2|COMPLETED|Overall Study||0
4997035|NCT02369744|12295152|P1|COMPLETED|Overall Study||0
4997036|NCT02369744|12295151|P2|STARTED|Overall Study||0
4997037|NCT02369744|12295152|P1|STARTED|Overall Study||0
4997038|NCT02369510|12295167|P3|NOT COMPLETED|Overall Study||6
4997039|NCT02369510|12295168|P2|NOT COMPLETED|Overall Study||3
4997040|NCT02369510|12295169|P1|NOT COMPLETED|Overall Study||2
4997041|NCT02369510|12295167|P3|COMPLETED|Overall Study||17
4997042|NCT02369510|12295168|P2|COMPLETED|Overall Study||19
4997043|NCT02369510|12295169|P1|COMPLETED|Overall Study||21
4997044|NCT02369510|12295167|P3|STARTED|Overall Study||23
4997045|NCT02369510|12295168|P2|STARTED|Overall Study||22
4997046|NCT02369510|12295169|P1|STARTED|Overall Study||23
4997047|NCT02369484|12295198|P1|NOT COMPLETED|Overall Study||0
4997048|NCT02369484|12295198|P1|COMPLETED|Overall Study||13
4997049|NCT02369484|12295198|P1|STARTED|Overall Study||13
4997050|NCT02369341|12295208|P2|NOT COMPLETED|Overall Study||0
4997051|NCT02369341|12295209|P1|NOT COMPLETED|Overall Study||1
4997052|NCT02369341|12295208|P2|COMPLETED|Overall Study||57
4997053|NCT02369341|12295209|P1|COMPLETED|Overall Study||62
4997054|NCT02369341|12295208|P2|STARTED|Overall Study||57
4997055|NCT02369341|12295209|P1|STARTED|Overall Study||63
4997056|NCT02369211|12295265|P2|NOT COMPLETED|Overall Study||2
4997057|NCT02369211|12295266|P1|NOT COMPLETED|Overall Study||0
4997058|NCT02369211|12295265|P2|COMPLETED|Overall Study||41
4997059|NCT02369211|12295266|P1|COMPLETED|Overall Study||43
4997060|NCT02369211|12295265|P2|STARTED|Overall Study||43
4997061|NCT02369211|12295266|P1|STARTED|Overall Study||43
4997062|NCT02369172|12295278|P1|NOT COMPLETED|Overall Study||0
4997063|NCT02369172|12295278|P1|COMPLETED|Overall Study||24
4997064|NCT02369172|12295278|P1|STARTED|Overall Study||24
4997065|NCT02369068|12295352|P2|NOT COMPLETED|6 Months||1
4997066|NCT02369068|12295353|P1|NOT COMPLETED|6 Months||0
4997067|NCT02369068|12295352|P2|COMPLETED|6 Months||7
4997068|NCT02369068|12295353|P1|COMPLETED|6 Months||9
4997069|NCT02369068|12295352|P2|STARTED|6 Months||8
4997070|NCT02369068|12295353|P1|STARTED|6 Months||9
4997071|NCT02369068|12295352|P2|NOT COMPLETED|3 Months||2
4997072|NCT02369068|12295353|P1|NOT COMPLETED|3 Months||0
4997073|NCT02369068|12295352|P2|COMPLETED|3 Months||8
4997074|NCT02369068|12295353|P1|COMPLETED|3 Months||9
4997075|NCT02369068|12295352|P2|STARTED|3 Months||10
4997076|NCT02369068|12295353|P1|STARTED|3 Months||9
4997077|NCT02369068|12295352|P2|NOT COMPLETED|1 Month||1
4997078|NCT02369068|12295353|P1|NOT COMPLETED|1 Month||1
4997079|NCT02369068|12295352|P2|COMPLETED|1 Month||10
4997080|NCT02369068|12295353|P1|COMPLETED|1 Month||9
4997081|NCT02369068|12295352|P2|STARTED|1 Month||11
4997082|NCT02369068|12295353|P1|STARTED|1 Month||10
4997083|NCT02368886|12295385|P4|NOT COMPLETED|Overall Study||4
4997084|NCT02368886|12295386|P3|NOT COMPLETED|Overall Study||1
4997085|NCT02368886|12295387|P2|NOT COMPLETED|Overall Study||1
4997086|NCT02368886|12295388|P1|NOT COMPLETED|Overall Study||1
4997087|NCT02368886|12295385|P4|COMPLETED|Overall Study||29
4997088|NCT02368886|12295386|P3|COMPLETED|Overall Study||33
4997089|NCT02368886|12295387|P2|COMPLETED|Overall Study||26
4997090|NCT02368886|12295388|P1|COMPLETED|Overall Study||28
4997091|NCT02368886|12295385|P4|STARTED|Overall Study||33
4997092|NCT02368886|12295386|P3|STARTED|Overall Study||34
4997093|NCT02368886|12295387|P2|STARTED|Overall Study||27
4997094|NCT02368886|12295388|P1|STARTED|Overall Study||29
4997095|NCT02368457|12295408|P2|NOT COMPLETED|Overall Study||0
4997096|NCT02368457|12295409|P1|NOT COMPLETED|Overall Study||0
4997097|NCT02368457|12295408|P2|COMPLETED|Overall Study||12
4997098|NCT02368457|12295409|P1|COMPLETED|Overall Study||12
4997099|NCT02368457|12295408|P2|STARTED|Overall Study||12
4997100|NCT02368457|12295409|P1|STARTED|Overall Study||12
4997101|NCT02368431|12295419|P2|NOT COMPLETED|Overall Study||19
4997102|NCT02368431|12295420|P1|NOT COMPLETED|Overall Study||24
4997103|NCT02368431|12295419|P2|COMPLETED|Overall Study||27
4997104|NCT02368431|12295420|P1|COMPLETED|Overall Study||22
4997105|NCT02368431|12295419|P2|STARTED|Overall Study||46
4997106|NCT02368431|12295420|P1|STARTED|Overall Study||46
4997107|NCT02368314|12295440|P2|NOT COMPLETED|Overall Study||3
4997108|NCT02368314|12295441|P1|NOT COMPLETED|Overall Study||3
4997109|NCT02368314|12295440|P2|COMPLETED|Overall Study||57
4997110|NCT02368314|12295441|P1|COMPLETED|Overall Study||61
4997111|NCT02368314|12295440|P2|STARTED|Overall Study||60
4997112|NCT02368314|12295441|P1|STARTED|Overall Study||64
4997113|NCT02368210|12295453|P2|NOT COMPLETED|Overall Study||1
4997114|NCT02368210|12295454|P1|NOT COMPLETED|Overall Study||1
4997115|NCT02368210|12295453|P2|COMPLETED|Overall Study||75
4997116|NCT02368210|12295454|P1|COMPLETED|Overall Study||74
4997117|NCT02368210|12295453|P2|STARTED|Overall Study||76
4997118|NCT02368210|12295454|P1|STARTED|Overall Study||75
4997119|NCT02368093|12295472|P2|NOT COMPLETED|Overall Study||0
4997120|NCT02368093|12295473|P1|NOT COMPLETED|Overall Study||0
4997121|NCT02368093|12295472|P2|COMPLETED|Overall Study||24
4997122|NCT02368093|12295473|P1|COMPLETED|Overall Study||24
4997123|NCT02368093|12295472|P2|STARTED|Overall Study||24
4997124|NCT02368093|12295473|P1|STARTED|Overall Study||24
4997125|NCT02367911|12295481|P2|NOT COMPLETED|Overall Study||4
4997126|NCT02367911|12295482|P1|NOT COMPLETED|Overall Study||5
4997127|NCT02367911|12295481|P2|COMPLETED|Overall Study||69
4997128|NCT02367911|12295482|P1|COMPLETED|Overall Study||66
4997129|NCT02367911|12295481|P2|STARTED|Overall Study||73
4997130|NCT02367911|12295482|P1|STARTED|Overall Study||71
4997131|NCT02367885|12295493|P3|NOT COMPLETED|Overall Study||0
4997132|NCT02367885|12295494|P2|NOT COMPLETED|Overall Study||0
4997133|NCT02367885|12295495|P1|NOT COMPLETED|Overall Study||2
4997134|NCT02367885|12295493|P3|COMPLETED|Overall Study||33
4997135|NCT02367885|12295494|P2|COMPLETED|Overall Study||33
4997136|NCT02367885|12295495|P1|COMPLETED|Overall Study||31
4997137|NCT02367885|12295493|P3|STARTED|Overall Study||33
4997138|NCT02367885|12295494|P2|STARTED|Overall Study||33
4997139|NCT02367885|12295495|P1|STARTED|Overall Study||33
4997140|NCT02367872|12295568|P8|NOT COMPLETED|Overall Study||0
4997141|NCT02367872|12295569|P7|NOT COMPLETED|Overall Study||0
4997142|NCT02367872|12295570|P6|NOT COMPLETED|Overall Study||0
4997143|NCT02367872|12295571|P5|NOT COMPLETED|Overall Study||0
4997144|NCT02367872|12295572|P4|NOT COMPLETED|Overall Study||0
4997145|NCT02367872|12295573|P3|NOT COMPLETED|Overall Study||0
4997146|NCT02367872|12295574|P2|NOT COMPLETED|Overall Study||0
4997147|NCT02367872|12295575|P1|NOT COMPLETED|Overall Study||0
4997148|NCT02367872|12295568|P8|COMPLETED|Overall Study||6
4997149|NCT02367872|12295569|P7|COMPLETED|Overall Study||6
4997150|NCT02367872|12295570|P6|COMPLETED|Overall Study||6
4997151|NCT02367872|12295571|P5|COMPLETED|Overall Study||6
4997152|NCT02367872|12295572|P4|COMPLETED|Overall Study||6
4997153|NCT02367872|12295573|P3|COMPLETED|Overall Study||6
4997154|NCT02367872|12295574|P2|COMPLETED|Overall Study||6
4997155|NCT02367872|12295575|P1|COMPLETED|Overall Study||6
4997156|NCT02367872|12295568|P8|STARTED|Overall Study||6
4997157|NCT02367872|12295569|P7|STARTED|Overall Study||6
4997158|NCT02367872|12295570|P6|STARTED|Overall Study||6
4997159|NCT02367872|12295571|P5|STARTED|Overall Study||6
4997160|NCT02367872|12295572|P4|STARTED|Overall Study||6
4997161|NCT02367872|12295573|P3|STARTED|Overall Study||6
4997162|NCT02367872|12295574|P2|STARTED|Overall Study||6
4997163|NCT02367872|12295575|P1|STARTED|Overall Study||6
4997164|NCT02367859|12295728|P1|NOT COMPLETED|Overall Study||0
4997165|NCT02367859|12295728|P1|COMPLETED|Overall Study||1
4997166|NCT02367859|12295728|P1|STARTED|Overall Study||1
4997167|NCT02367833|12295738|P3|NOT COMPLETED|Overall Study||0
4997168|NCT02367833|12295739|P2|NOT COMPLETED|Overall Study||1
4997169|NCT02367833|12295740|P1|NOT COMPLETED|Overall Study||1
4997170|NCT02367833|12295738|P3|COMPLETED|Overall Study||8
4997171|NCT02367833|12295739|P2|COMPLETED|Overall Study||8
4997172|NCT02367833|12295740|P1|COMPLETED|Overall Study||8
4997173|NCT02367833|12295738|P3|STARTED|Overall Study||8
4997174|NCT02367833|12295739|P2|STARTED|Overall Study||9
4997175|NCT02367833|12295740|P1|STARTED|Overall Study||9
4997176|NCT02367794|12295757|P3|NOT COMPLETED|Overall Study||249
4997177|NCT02367794|12295758|P2|NOT COMPLETED|Overall Study||240
4997178|NCT02367794|12295759|P1|NOT COMPLETED|Overall Study||258
4997179|NCT02367794|12295757|P3|COMPLETED|Overall Study||89
4997180|NCT02367794|12295758|P2|COMPLETED|Overall Study||103
4997181|NCT02367794|12295759|P1|COMPLETED|Overall Study||82
4997182|NCT02367794|12295757|P3|STARTED|Overall Study||338
4997183|NCT02367794|12295758|P2|STARTED|Overall Study||343
4997184|NCT02367794|12295759|P1|STARTED|Overall Study||340
4997185|NCT02367781|12295772|P2|NOT COMPLETED|Overall Study||240
4997186|NCT02367781|12295773|P1|NOT COMPLETED|Overall Study||483
4997187|NCT02367781|12295772|P2|COMPLETED|Overall Study||0
4997188|NCT02367781|12295773|P1|COMPLETED|Overall Study||0
4997189|NCT02367781|12295772|P2|STARTED|Overall Study||240
4997190|NCT02367781|12295773|P1|STARTED|Overall Study||483
4997191|NCT02367729|12295783|P2|NOT COMPLETED|Overall Study||8
4997192|NCT02367729|12295784|P1|NOT COMPLETED|Overall Study||3
4997193|NCT02367729|12295783|P2|COMPLETED|Overall Study||47
4997194|NCT02367729|12295784|P1|COMPLETED|Overall Study||57
4997195|NCT02367729|12295783|P2|STARTED|Overall Study||55
4997196|NCT02367729|12295784|P1|STARTED|Overall Study||60
4997197|NCT02367599|12295802|P2|NOT COMPLETED|Overall Study||0
4997198|NCT02367599|12295803|P1|NOT COMPLETED|Overall Study||0
4997199|NCT02367599|12295802|P2|COMPLETED|Overall Study||48
4997200|NCT02367599|12295803|P1|COMPLETED|Overall Study||48
4997201|NCT02367599|12295802|P2|STARTED|Overall Study||48
4997202|NCT02367599|12295803|P1|STARTED|Overall Study||48
4997203|NCT02367521|12295817|P2|NOT COMPLETED|Overall Study||0
4997204|NCT02367521|12295818|P1|NOT COMPLETED|Overall Study||4
4997205|NCT02367521|12295817|P2|COMPLETED|Overall Study||17
4997206|NCT02367521|12295818|P1|COMPLETED|Overall Study||13
4997207|NCT02367521|12295817|P2|STARTED|Overall Study||17
4997208|NCT02367521|12295818|P1|STARTED|Overall Study||17
4997209|NCT02367430|12295870|P1|NOT COMPLETED|Overall Study||3
4997210|NCT02367430|12295870|P1|COMPLETED|Overall Study||11
4997211|NCT02367430|12295870|P1|STARTED|Overall Study||14
4997212|NCT02367391|12295877|P2|NOT COMPLETED|Overall Study||0
4997213|NCT02367391|12295878|P1|NOT COMPLETED|Overall Study||2
4997214|NCT02367391|12295877|P2|COMPLETED|Overall Study||76
4997215|NCT02367391|12295878|P1|COMPLETED|Overall Study||74
4997216|NCT02367391|12295877|P2|STARTED|Overall Study||76
4997217|NCT02367391|12295878|P1|STARTED|Overall Study||76
4997218|NCT02367352|12295896|P3|NOT COMPLETED|Overall Study||0
4997219|NCT02367352|12295897|P2|NOT COMPLETED|Overall Study||0
4997220|NCT02367352|12295898|P1|NOT COMPLETED|Overall Study||9
4997221|NCT02367352|12295896|P3|COMPLETED|Overall Study||0
4997222|NCT02367352|12295897|P2|COMPLETED|Overall Study||0
4997223|NCT02367352|12295898|P1|COMPLETED|Overall Study||0
4997224|NCT02367352|12295896|P3|STARTED|Overall Study||0
4997225|NCT02367352|12295897|P2|STARTED|Overall Study||0
4997226|NCT02367352|12295898|P1|STARTED|Overall Study||9
4997227|NCT02367170|12295937|P2|NOT COMPLETED|Overall Study||0
4997228|NCT02367170|12295938|P1|NOT COMPLETED|Overall Study||0
4997229|NCT02367170|12295937|P2|COMPLETED|Overall Study||0
4997230|NCT02367170|12295938|P1|COMPLETED|Overall Study||1
4997231|NCT02367170|12295937|P2|STARTED|Overall Study||0
4997232|NCT02367170|12295938|P1|STARTED|Overall Study||1
4997233|NCT02367131|12295948|P1|NOT COMPLETED|Overall Study||222
4997234|NCT02367131|12295948|P1|COMPLETED|Overall Study||201
4997235|NCT02367131|12295948|P1|STARTED|Overall Study|Started are the treated patients|423
4997236|NCT02367066|12295956|P2|NOT COMPLETED|Overall Study||0
4997237|NCT02367066|12295957|P1|NOT COMPLETED|Overall Study||0
4997238|NCT02367066|12295956|P2|COMPLETED|Overall Study||10
4997239|NCT02367066|12295957|P1|COMPLETED|Overall Study||10
4997240|NCT02367066|12295956|P2|STARTED|Overall Study||10
4997241|NCT02367066|12295957|P1|STARTED|Overall Study||10
4997242|NCT02367014|12296019|P4|NOT COMPLETED|Overall Study||0
4997243|NCT02367014|12296020|P3|NOT COMPLETED|Overall Study||0
4997244|NCT02367014|12296021|P2|NOT COMPLETED|Overall Study||0
4997245|NCT02367014|12296022|P1|NOT COMPLETED|Overall Study||0
4997246|NCT02367014|12296019|P4|COMPLETED|Overall Study||9
4997247|NCT02367014|12296020|P3|COMPLETED|Overall Study||9
4997248|NCT02367014|12296021|P2|COMPLETED|Overall Study||9
4997249|NCT02367014|12296022|P1|COMPLETED|Overall Study||9
4997250|NCT02367014|12296019|P4|STARTED|Overall Study||9
4997251|NCT02367014|12296020|P3|STARTED|Overall Study||9
4997252|NCT02367014|12296021|P2|STARTED|Overall Study||9
4997253|NCT02367014|12296022|P1|STARTED|Overall Study||9
4997254|NCT02366936|12296140|P1|NOT COMPLETED|Overall Study||8
4997255|NCT02366936|12296140|P1|COMPLETED|Overall Study||24
4997256|NCT02366936|12296140|P1|STARTED|Overall Study||32
4997257|NCT02366923|12296145|P1|NOT COMPLETED|Overall Study||6
4997258|NCT02366923|12296145|P1|COMPLETED|Overall Study||22
4997259|NCT02366923|12296145|P1|STARTED|Overall Study||28
4997260|NCT02366910|12296158|P1|NOT COMPLETED|Overall Study||5
4997261|NCT02366910|12296158|P1|COMPLETED|Overall Study||21
4997262|NCT02366910|12296158|P1|STARTED|Overall Study||26
4997263|NCT02366871|12296172|P2|NOT COMPLETED|Overall Study||0
4997264|NCT02366871|12296173|P1|NOT COMPLETED|Overall Study||0
4997265|NCT02366871|12296172|P2|COMPLETED|Overall Study||196
4997266|NCT02366871|12296173|P1|COMPLETED|Overall Study||204
4997267|NCT02366871|12296172|P2|STARTED|Overall Study||196
4997268|NCT02366871|12296173|P1|STARTED|Overall Study||204
4997269|NCT02366845|12296191|P2|NOT COMPLETED|Overall Study||0
4997270|NCT02366845|12296192|P1|NOT COMPLETED|Overall Study||0
4997271|NCT02366845|12296191|P2|COMPLETED|Overall Study||25
4997272|NCT02366845|12296192|P1|COMPLETED|Overall Study||25
4997273|NCT02366845|12296191|P2|STARTED|Overall Study||25
4997274|NCT02366845|12296192|P1|STARTED|Overall Study||25
4997275|NCT02366767|12296206|P2|NOT COMPLETED|Overall Study||0
4997276|NCT02366767|12296207|P1|NOT COMPLETED|Overall Study||1
4997277|NCT02366767|12296206|P2|COMPLETED|Overall Study||10
4997278|NCT02366767|12296207|P1|COMPLETED|Overall Study||10
4997279|NCT02366767|12296206|P2|STARTED|Overall Study||10
4997280|NCT02366767|12296207|P1|STARTED|Overall Study||11
4997281|NCT02366689|12296220|P3|NOT COMPLETED|Overall Study||2
4997282|NCT02366689|12296221|P2|NOT COMPLETED|Overall Study||3
4997283|NCT02366689|12296222|P1|NOT COMPLETED|Overall Study||4
4997284|NCT02366689|12296220|P3|COMPLETED|Overall Study||59
4997285|NCT02366689|12296221|P2|COMPLETED|Overall Study||55
4997286|NCT02366689|12296222|P1|COMPLETED|Overall Study||56
4997287|NCT02366689|12296220|P3|STARTED|Overall Study||61
4997288|NCT02366689|12296221|P2|STARTED|Overall Study||58
4997289|NCT02366689|12296222|P1|STARTED|Overall Study||60
4997290|NCT02366663|12296247|P2|NOT COMPLETED|Overall Study||0
4997291|NCT02366663|12296248|P1|NOT COMPLETED|Overall Study||0
4997292|NCT02366663|12296247|P2|COMPLETED|Overall Study||1
4997293|NCT02366663|12296248|P1|COMPLETED|Overall Study||2
4997294|NCT02366663|12296247|P2|STARTED|Overall Study||1
4997295|NCT02366663|12296248|P1|STARTED|Overall Study||2
4997296|NCT02366637|12296274|P2|NOT COMPLETED|Second Intervention Period||1
4997297|NCT02366637|12296275|P1|NOT COMPLETED|Second Intervention Period||1
4997298|NCT02366637|12296274|P2|COMPLETED|Second Intervention Period||0
4997299|NCT02366637|12296275|P1|COMPLETED|Second Intervention Period||0
4997300|NCT02366637|12296274|P2|STARTED|Second Intervention Period||1
4997301|NCT02366637|12296275|P1|STARTED|Second Intervention Period||1
4997302|NCT02366637|12296274|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
4997303|NCT02366637|12296275|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
4997304|NCT02366637|12296274|P2|COMPLETED|Washout Period 28 to 49 Days||1
4997305|NCT02366637|12296275|P1|COMPLETED|Washout Period 28 to 49 Days||1
4997306|NCT02366637|12296274|P2|STARTED|Washout Period 28 to 49 Days||1
4997307|NCT02366637|12296275|P1|STARTED|Washout Period 28 to 49 Days||1
4997308|NCT02366637|12296274|P2|NOT COMPLETED|First Intervention Period||5
4997309|NCT02366637|12296275|P1|NOT COMPLETED|First Intervention Period||6
4997310|NCT02366637|12296274|P2|COMPLETED|First Intervention Period||1
4997311|NCT02366637|12296275|P1|COMPLETED|First Intervention Period||1
4997312|NCT02366637|12296274|P2|STARTED|First Intervention Period||6
4997313|NCT02366637|12296275|P1|STARTED|First Intervention Period||7
4997314|NCT02366468|12296301|P2|NOT COMPLETED|Overall Study||9
4997315|NCT02366468|12296302|P1|NOT COMPLETED|Overall Study||6
4997316|NCT02366468|12296301|P2|COMPLETED|Overall Study||58
4997317|NCT02366468|12296302|P1|COMPLETED|Overall Study||62
4997318|NCT02366468|12296301|P2|Per Protocol Set (PPS)|Overall Study||61
4997319|NCT02366468|12296302|P1|Per Protocol Set (PPS)|Overall Study||62
4997320|NCT02366468|12296301|P2|Full Analysis Set (FAS)|Overall Study||66
4997321|NCT02366468|12296302|P1|Full Analysis Set (FAS)|Overall Study||67
4997322|NCT02366468|12296301|P2|STARTED|Overall Study||67
4997323|NCT02366468|12296302|P1|STARTED|Overall Study||68
4997324|NCT02366338|12296323|P3|NOT COMPLETED|Overall Study||0
4997325|NCT02366338|12296324|P2|NOT COMPLETED|Overall Study||0
4997326|NCT02366338|12296325|P1|NOT COMPLETED|Overall Study||0
4997327|NCT02366338|12296323|P3|COMPLETED|Overall Study||36
4997328|NCT02366338|12296324|P2|COMPLETED|Overall Study||39
4997329|NCT02366338|12296325|P1|COMPLETED|Overall Study||73
4997330|NCT02366338|12296323|P3|STARTED|Overall Study||36
4997331|NCT02366338|12296324|P2|STARTED|Overall Study||39
4997332|NCT02366338|12296325|P1|STARTED|Overall Study||73
4997333|NCT02366195|12296333|P1|NOT COMPLETED|Overall Study||112
4997334|NCT02366195|12296333|P1|COMPLETED|Overall Study||0
4997335|NCT02366195|12296333|P1|Received Study Drug|Overall Study||111
4997336|NCT02366195|12296333|P1|STARTED|Overall Study||112
4997337|NCT02365961|12296353|P2|NOT COMPLETED|Overall Study||0
4997338|NCT02365961|12296354|P1|NOT COMPLETED|Overall Study||0
4997339|NCT02365961|12296353|P2|COMPLETED|Overall Study||43
4997340|NCT02365961|12296354|P1|COMPLETED|Overall Study||41
4997341|NCT02365961|12296353|P2|STARTED|Overall Study||43
4997342|NCT02365961|12296354|P1|STARTED|Overall Study||41
4997343|NCT02365870|12296370|P2|NOT COMPLETED|Overall Study||0
4997344|NCT02365870|12296371|P1|NOT COMPLETED|Overall Study||0
4997345|NCT02365870|12296370|P2|COMPLETED|Overall Study||3
4997346|NCT02365870|12296371|P1|COMPLETED|Overall Study||1
4997347|NCT02365870|12296370|P2|STARTED|Overall Study||3
4997348|NCT02365870|12296371|P1|STARTED|Overall Study||1
4997349|NCT02365714|12296379|P1|NOT COMPLETED|Overall Study||0
4997350|NCT02365714|12296379|P1|COMPLETED|Overall Study||2
4997351|NCT02365714|12296379|P1|STARTED|Overall Study||2
4997352|NCT02365688|12296385|P1|NOT COMPLETED|Overall Study||0
4997353|NCT02365688|12296385|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
4997354|NCT02365688|12296385|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
4997355|NCT02365636|12296392|P3|NOT COMPLETED|Overall Study||3
4997356|NCT02365636|12296393|P2|NOT COMPLETED|Overall Study||7
4997357|NCT02365636|12296394|P1|NOT COMPLETED|Overall Study||6
4997358|NCT02365636|12296392|P3|COMPLETED|Overall Study||97
4997359|NCT02365636|12296393|P2|COMPLETED|Overall Study||93
4997360|NCT02365636|12296394|P1|COMPLETED|Overall Study||94
4997361|NCT02365636|12296392|P3|Full Analysis Set|Overall Study||100
4997362|NCT02365636|12296393|P2|Full Analysis Set|Overall Study||98
4997363|NCT02365636|12296394|P1|Full Analysis Set|Overall Study||100
4997364|NCT02365636|12296392|P3|Safety Population|Overall Study||100
4997365|NCT02365636|12296393|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
4997366|NCT02365636|12296394|P1|Safety Population|Overall Study||100
4997367|NCT02365636|12296392|P3|STARTED|Overall Study||100
4997368|NCT02365636|12296393|P2|STARTED|Overall Study||100
4997369|NCT02365636|12296394|P1|STARTED|Overall Study||100
4997370|NCT02365584|12296440|P2|NOT COMPLETED|Overall Study||14
4997371|NCT02365584|12296441|P1|NOT COMPLETED|Overall Study||12
4997372|NCT02365584|12296440|P2|COMPLETED|Overall Study||8
4997373|NCT02365584|12296441|P1|COMPLETED|Overall Study||9
4997374|NCT02365584|12296440|P2|STARTED|Overall Study||22
4997375|NCT02365584|12296441|P1|STARTED|Overall Study||21
4997376|NCT02365558|12296465|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
4997377|NCT02365558|12296466|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
4997378|NCT02365558|12296465|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
4997379|NCT02365558|12296466|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
4997380|NCT02365558|12296465|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
4997381|NCT02365558|12296466|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
4997382|NCT02365558|12296465|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
4997383|NCT02365558|12296466|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
4997384|NCT02365558|12296465|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
4997385|NCT02365558|12296466|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
4997386|NCT02365558|12296465|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
4997387|NCT02365558|12296466|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
4997388|NCT02365558|12296465|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
4997389|NCT02365558|12296466|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
4997390|NCT02365519|12296479|P3|NOT COMPLETED|Randomized and Treated||1
4997391|NCT02365519|12296480|P2|NOT COMPLETED|Randomized and Treated||2
4997392|NCT02365519|12296481|P1|NOT COMPLETED|Randomized and Treated||0
4997393|NCT02365519|12296479|P3|COMPLETED|Randomized and Treated||64
4997394|NCT02365519|12296480|P2|COMPLETED|Randomized and Treated||67
4997395|NCT02365519|12296481|P1|COMPLETED|Randomized and Treated||0
4997396|NCT02365519|12296479|P3|STARTED|Randomized and Treated||65
4997397|NCT02365519|12296480|P2|STARTED|Randomized and Treated||69
4997398|NCT02365519|12296481|P1|STARTED|Randomized and Treated||0
4997399|NCT02365519|12296479|P3|NOT COMPLETED|Vehicle Run-In||0
4997400|NCT02365519|12296480|P2|NOT COMPLETED|Vehicle Run-In||0
4997401|NCT02365519|12296481|P1|NOT COMPLETED|Vehicle Run-In||79
4997402|NCT02365519|12296479|P3|COMPLETED|Vehicle Run-In||0
4997403|NCT02365519|12296480|P2|COMPLETED|Vehicle Run-In||0
4997404|NCT02365519|12296481|P1|COMPLETED|Vehicle Run-In||134
4997405|NCT02365519|12296479|P3|STARTED|Vehicle Run-In||0
4997406|NCT02365519|12296480|P2|STARTED|Vehicle Run-In||0
4997407|NCT02365519|12296481|P1|STARTED|Vehicle Run-In||213
4997408|NCT02365298|12296502|P2|NOT COMPLETED|Period 2||2
4997409|NCT02365298|12296503|P1|NOT COMPLETED|Period 2||2
4997410|NCT02365298|12296502|P2|COMPLETED|Period 2||12
4997411|NCT02365298|12296503|P1|COMPLETED|Period 2||12
4997412|NCT02365298|12296502|P2|STARTED|Period 2||14
4997413|NCT02365298|12296503|P1|STARTED|Period 2||14
4997414|NCT02365298|12296502|P2|NOT COMPLETED|Period 1||0
4997415|NCT02365298|12296503|P1|NOT COMPLETED|Period 1||0
4997416|NCT02365298|12296502|P2|COMPLETED|Period 1||14
4997417|NCT02365298|12296503|P1|COMPLETED|Period 1||14
4997418|NCT02365298|12296502|P2|STARTED|Period 1||14
4997419|NCT02365298|12296503|P1|STARTED|Period 1||14
4997420|NCT02365285|12296523|P4|NOT COMPLETED|Overall Study||2
4997421|NCT02365285|12296524|P3|NOT COMPLETED|Overall Study||1
4997422|NCT02365285|12296525|P2|NOT COMPLETED|Overall Study||1
4997423|NCT02365285|12296526|P1|NOT COMPLETED|Overall Study||0
4997424|NCT02365285|12296523|P4|COMPLETED|Overall Study||1
4997425|NCT02365285|12296524|P3|COMPLETED|Overall Study||6
4997426|NCT02365285|12296525|P2|COMPLETED|Overall Study||5
4997427|NCT02365285|12296526|P1|COMPLETED|Overall Study||7
4997428|NCT02365285|12296523|P4|STARTED|Overall Study||3
4997429|NCT02365285|12296524|P3|STARTED|Overall Study||7
4997430|NCT02365285|12296525|P2|STARTED|Overall Study||6
4997431|NCT02365285|12296526|P1|STARTED|Overall Study||7
4997432|NCT02365233|12296543|P3|NOT COMPLETED|Overall Study||2
4997433|NCT02365233|12296544|P2|NOT COMPLETED|Overall Study||2
4997434|NCT02365233|12296545|P1|NOT COMPLETED|Overall Study||1
4997435|NCT02365233|12296543|P3|COMPLETED|Overall Study||0
4997436|NCT02365233|12296544|P2|COMPLETED|Overall Study||0
4997437|NCT02365233|12296545|P1|COMPLETED|Overall Study||0
4997438|NCT02365233|12296543|P3|STARTED|Overall Study||2
4997439|NCT02365233|12296544|P2|STARTED|Overall Study||2
4997440|NCT02365233|12296545|P1|STARTED|Overall Study||1
4997441|NCT02365207|12296553|P1|NOT COMPLETED|Overall Study||2
4997442|NCT02365207|12296553|P1|COMPLETED|Overall Study||4
4997443|NCT02365207|12296553|P1|STARTED|Overall Study||6
4997444|NCT02364999|12296559|P2|NOT COMPLETED|Overall Study||173
4997445|NCT02364999|12296560|P1|NOT COMPLETED|Overall Study||165
4997446|NCT02364999|12296559|P2|COMPLETED|Overall Study||188
4997447|NCT02364999|12296560|P1|COMPLETED|Overall Study||193
4997448|NCT02364999|12296559|P2|Received Treatment|Overall Study||358
4997449|NCT02364999|12296560|P1|Received Treatment|Overall Study||356
4997450|NCT02364999|12296559|P2|STARTED|Overall Study||361
4997451|NCT02364999|12296560|P1|STARTED|Overall Study||358
4997452|NCT02364947|12296586|P3|NOT COMPLETED|Overall Study||26
4997453|NCT02364947|12296587|P2|NOT COMPLETED|Overall Study||45
4997454|NCT02364947|12296588|P1|NOT COMPLETED|Overall Study||59
4997455|NCT02364947|12296586|P3|COMPLETED|Overall Study||219
4997456|NCT02364947|12296587|P2|COMPLETED|Overall Study||139
4997457|NCT02364947|12296588|P1|COMPLETED|Overall Study||189
4997458|NCT02364947|12296586|P3|STARTED|Overall Study||245
4997459|NCT02364947|12296587|P2|STARTED|Overall Study||184
4997460|NCT02364947|12296588|P1|STARTED|Overall Study||248
4997461|NCT02364778|12296655|P1|NOT COMPLETED|Overall Study||0
4997462|NCT02364778|12296655|P1|COMPLETED|Overall Study||30
4997463|NCT02364778|12296655|P1|STARTED|Overall Study||30
4997464|NCT02364700|12296667|P1|NOT COMPLETED|Overall Study||0
4997465|NCT02364700|12296667|P1|COMPLETED|Overall Study||12
4997466|NCT02364700|12296667|P1|STARTED|Overall Study||12
4997467|NCT02364570|12296676|P16|NOT COMPLETED|Overall Study||0
4997468|NCT02364570|12296677|P15|NOT COMPLETED|Overall Study||0
4997469|NCT02364570|12296678|P14|NOT COMPLETED|Overall Study||0
4997470|NCT02364570|12296679|P13|NOT COMPLETED|Overall Study||0
4997471|NCT02364570|12296680|P12|NOT COMPLETED|Overall Study||0
4997472|NCT02364570|12296681|P11|NOT COMPLETED|Overall Study||0
4997473|NCT02364570|12296682|P10|NOT COMPLETED|Overall Study||0
4997474|NCT02364570|12296683|P9|NOT COMPLETED|Overall Study||0
4997475|NCT02364570|12296684|P8|NOT COMPLETED|Overall Study||0
4997476|NCT02364570|12296685|P7|NOT COMPLETED|Overall Study||0
4997477|NCT02364570|12296686|P6|NOT COMPLETED|Overall Study||0
4997478|NCT02364570|12296687|P5|NOT COMPLETED|Overall Study||0
4997479|NCT02364570|12296688|P4|NOT COMPLETED|Overall Study||0
4997480|NCT02364570|12296689|P3|NOT COMPLETED|Overall Study||0
4997481|NCT02364570|12296690|P2|NOT COMPLETED|Overall Study||0
4997482|NCT02364570|12296691|P1|NOT COMPLETED|Overall Study||0
4997483|NCT02364570|12296676|P16|COMPLETED|Overall Study||1
4997484|NCT02364570|12296677|P15|COMPLETED|Overall Study||1
4997485|NCT02364570|12296678|P14|COMPLETED|Overall Study||2
4997486|NCT02364570|12296679|P13|COMPLETED|Overall Study||1
4997487|NCT02364570|12296680|P12|COMPLETED|Overall Study||1
4997488|NCT02364570|12296681|P11|COMPLETED|Overall Study||1
4997489|NCT02364570|12296682|P10|COMPLETED|Overall Study||1
4997490|NCT02364570|12296683|P9|COMPLETED|Overall Study||2
4997491|NCT02364570|12296684|P8|COMPLETED|Overall Study||1
4997492|NCT02364570|12296685|P7|COMPLETED|Overall Study||2
4997493|NCT02364570|12296686|P6|COMPLETED|Overall Study||1
4997494|NCT02364570|12296687|P5|COMPLETED|Overall Study||1
4997495|NCT02364570|12296688|P4|COMPLETED|Overall Study||1
4997496|NCT02364570|12296689|P3|COMPLETED|Overall Study||2
4997497|NCT02364570|12296690|P2|COMPLETED|Overall Study||1
4997498|NCT02364570|12296691|P1|COMPLETED|Overall Study||1
4997499|NCT02364570|12296676|P16|STARTED|Overall Study||1
4997500|NCT02364570|12296677|P15|STARTED|Overall Study||1
4997501|NCT02364570|12296678|P14|STARTED|Overall Study||2
4997502|NCT02364570|12296679|P13|STARTED|Overall Study||1
4997503|NCT02364570|12296680|P12|STARTED|Overall Study||1
4997504|NCT02364570|12296681|P11|STARTED|Overall Study||1
4997505|NCT02364570|12296682|P10|STARTED|Overall Study||1
4997506|NCT02364570|12296683|P9|STARTED|Overall Study||2
4997507|NCT02364570|12296684|P8|STARTED|Overall Study||1
4997508|NCT02364570|12296685|P7|STARTED|Overall Study||2
4997509|NCT02364570|12296686|P6|STARTED|Overall Study||1
4997510|NCT02364570|12296687|P5|STARTED|Overall Study||1
4997511|NCT02364570|12296688|P4|STARTED|Overall Study||1
4997512|NCT02364570|12296689|P3|STARTED|Overall Study||2
4997513|NCT02364570|12296690|P2|STARTED|Overall Study||1
4997514|NCT02364570|12296691|P1|STARTED|Overall Study||1
4997515|NCT02364388|12296757|P1|NOT COMPLETED|Overall Study||8
4997516|NCT02364388|12296757|P1|COMPLETED|Overall Study||209
4997517|NCT02364388|12296757|P1|Excluded|Overall Study||8
4997518|NCT02364388|12296757|P1|Biopsied|Overall Study||209
4997519|NCT02364388|12296757|P1|STARTED|Overall Study||217
4997520|NCT02364336|12296764|P2|NOT COMPLETED|Overall Study||1
4997521|NCT02364336|12296765|P1|NOT COMPLETED|Overall Study||0
4997522|NCT02364336|12296764|P2|COMPLETED|Overall Study||11
4997523|NCT02364336|12296765|P1|COMPLETED|Overall Study||1
4997524|NCT02364336|12296764|P2|48 Weeks After End of Peginterferon|Overall Study||10
4997525|NCT02364336|12296765|P1|48 Weeks After End of Peginterferon|Overall Study||1
4997526|NCT02364336|12296764|P2|24 Weeks After End of Peginterferon|Overall Study||11
4997527|NCT02364336|12296765|P1|24 Weeks After End of Peginterferon|Overall Study||1
4997528|NCT02364336|12296764|P2|End of Peginterferon Treatment|Overall Study||11
4997529|NCT02364336|12296765|P1|End of Peginterferon Treatment|Overall Study||1
4997530|NCT02364336|12296764|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
4997531|NCT02364336|12296765|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
4997532|NCT02364336|12296764|P2|STARTED|Overall Study||12
4997533|NCT02364336|12296765|P1|STARTED|Overall Study||1
4997534|NCT02364180|12296778|P1|NOT COMPLETED|Overall Study||1
4997535|NCT02364180|12296778|P1|COMPLETED|Overall Study||10
4997536|NCT02364180|12296778|P1|STARTED|Overall Study||11
4997537|NCT02364076|12296782|P1|NOT COMPLETED|Overall Study||5
4997538|NCT02364076|12296782|P1|COMPLETED|Overall Study||40
4997539|NCT02364076|12296782|P1|STARTED|Overall Study||45
4997540|NCT02364037|12296791|P2|NOT COMPLETED|Overall Study||53
4997541|NCT02364037|12296792|P1|NOT COMPLETED|Overall Study||44
4997542|NCT02364037|12296791|P2|COMPLETED|Overall Study||453
4997543|NCT02364037|12296792|P1|COMPLETED|Overall Study||458
4997544|NCT02364037|12296791|P2|STARTED|Overall Study||506
4997545|NCT02364037|12296792|P1|STARTED|Overall Study||502
4997546|NCT02363959|12296808|P2|NOT COMPLETED|Overall Study||0
4997547|NCT02363959|12296809|P1|NOT COMPLETED|Overall Study||1
4997548|NCT02363959|12296808|P2|COMPLETED|Overall Study||10
4997549|NCT02363959|12296809|P1|COMPLETED|Overall Study||9
4997550|NCT02363959|12296808|P2|STARTED|Overall Study||10
4997551|NCT02363959|12296809|P1|STARTED|Overall Study||10
4997552|NCT02363946|12296838|P13|NOT COMPLETED|Overall Study||0
4997553|NCT02363946|12296839|P12|NOT COMPLETED|Overall Study||0
4997554|NCT02363946|12296840|P11|NOT COMPLETED|Overall Study||0
4997555|NCT02363946|12296841|P10|NOT COMPLETED|Overall Study||0
4997556|NCT02363946|12296842|P9|NOT COMPLETED|Overall Study||0
4997557|NCT02363946|12296843|P8|NOT COMPLETED|Overall Study||1
4997558|NCT02363946|12296844|P7|NOT COMPLETED|Overall Study||0
4997559|NCT02363946|12296845|P6|NOT COMPLETED|Overall Study||0
4997560|NCT02363946|12296846|P5|NOT COMPLETED|Overall Study||0
4997561|NCT02363946|12296847|P4|NOT COMPLETED|Overall Study||0
4997562|NCT02363946|12296848|P3|NOT COMPLETED|Overall Study||0
4997563|NCT02363946|12296849|P2|NOT COMPLETED|Overall Study||0
4997564|NCT02363946|12296850|P1|NOT COMPLETED|Overall Study||0
4997565|NCT02363946|12296838|P13|COMPLETED|Overall Study||4
4997566|NCT02363946|12296839|P12|COMPLETED|Overall Study||3
4997567|NCT02363946|12296840|P11|COMPLETED|Overall Study||4
4997568|NCT02363946|12296841|P10|COMPLETED|Overall Study||18
4997569|NCT02363946|12296842|P9|COMPLETED|Overall Study||4
4997570|NCT02363946|12296843|P8|COMPLETED|Overall Study||3
4997571|NCT02363946|12296844|P7|COMPLETED|Overall Study||4
4997572|NCT02363946|12296845|P6|COMPLETED|Overall Study||4
4997573|NCT02363946|12296846|P5|COMPLETED|Overall Study||4
4997574|NCT02363946|12296847|P4|COMPLETED|Overall Study||4
4997575|NCT02363946|12296848|P3|COMPLETED|Overall Study||4
4997576|NCT02363946|12296849|P2|COMPLETED|Overall Study||4
4997577|NCT02363946|12296850|P1|COMPLETED|Overall Study||4
4997578|NCT02363946|12296838|P13|STARTED|Overall Study||4
4997579|NCT02363946|12296839|P12|STARTED|Overall Study||3
4997580|NCT02363946|12296840|P11|STARTED|Overall Study||4
4997581|NCT02363946|12296841|P10|STARTED|Overall Study||18
4997582|NCT02363946|12296842|P9|STARTED|Overall Study||4
4997583|NCT02363946|12296843|P8|STARTED|Overall Study||4
4997584|NCT02363946|12296844|P7|STARTED|Overall Study||4
4997585|NCT02363946|12296845|P6|STARTED|Overall Study||4
4997586|NCT02363946|12296846|P5|STARTED|Overall Study||4
4997587|NCT02363946|12296847|P4|STARTED|Overall Study||4
4997588|NCT02363946|12296848|P3|STARTED|Overall Study||4
4997589|NCT02363946|12296849|P2|STARTED|Overall Study||4
4997590|NCT02363946|12296850|P1|STARTED|Overall Study||4
4997591|NCT02363933|12297036|P1|NOT COMPLETED|Overall Study||6
4997592|NCT02363933|12297036|P1|COMPLETED|Overall Study||2
4997593|NCT02363933|12297036|P1|STARTED|Overall Study||8
4997594|NCT02363907|12297041|P1|NOT COMPLETED|Overall Study||0
4997595|NCT02363907|12297041|P1|COMPLETED|Overall Study||30
4997596|NCT02363907|12297041|P1|STARTED|Overall Study||30
4997597|NCT02363803|12297047|P2|NOT COMPLETED|Period 2||0
4997598|NCT02363803|12297048|P1|NOT COMPLETED|Period 2||0
4997599|NCT02363803|12297047|P2|COMPLETED|Period 2||16
4997600|NCT02363803|12297048|P1|COMPLETED|Period 2||17
4997601|NCT02363803|12297047|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
4997602|NCT02363803|12297048|P1|STARTED|Period 2||17
4997603|NCT02363803|12297047|P2|NOT COMPLETED|Period 1||0
4997604|NCT02363803|12297048|P1|NOT COMPLETED|Period 1||0
4997605|NCT02363803|12297047|P2|COMPLETED|Period 1||17
4997606|NCT02363803|12297048|P1|COMPLETED|Period 1||17
4997607|NCT02363803|12297047|P2|STARTED|Period 1||17
4997608|NCT02363803|12297048|P1|STARTED|Period 1||17
4997609|NCT02363621|12297068|P2|NOT COMPLETED|Overall Study||0
4997610|NCT02363621|12297069|P1|NOT COMPLETED|Overall Study||1
4997611|NCT02363621|12297068|P2|COMPLETED|Overall Study||50
4997612|NCT02363621|12297069|P1|COMPLETED|Overall Study||50
4997613|NCT02363621|12297068|P2|STARTED|Overall Study||50
4997614|NCT02363621|12297069|P1|STARTED|Overall Study||51
4997615|NCT02363478|12297079|P1|NOT COMPLETED|Overall Study||8
4997616|NCT02363478|12297079|P1|COMPLETED|Overall Study||22
4997617|NCT02363478|12297079|P1|STARTED|Overall Study||30
4997618|NCT02363439|12297086|P1|NOT COMPLETED|Overall Study||4
4997619|NCT02363439|12297086|P1|COMPLETED|Overall Study||1
4997620|NCT02363439|12297086|P1|STARTED|Overall Study||5
4997621|NCT02363322|12297092|P2|NOT COMPLETED|Overall Study||0
4997622|NCT02363322|12297093|P1|NOT COMPLETED|Overall Study||1
4997623|NCT02363322|12297092|P2|COMPLETED|Overall Study||36
4997624|NCT02363322|12297093|P1|COMPLETED|Overall Study||35
4997625|NCT02363322|12297092|P2|STARTED|Overall Study||36
4997626|NCT02363322|12297093|P1|STARTED|Overall Study||36
4997627|NCT02363270|12297105|P2|NOT COMPLETED|Overall Study||0
4997628|NCT02363270|12297106|P1|NOT COMPLETED|Overall Study||0
4997629|NCT02363270|12297105|P2|COMPLETED|Overall Study||24
4997630|NCT02363270|12297106|P1|COMPLETED|Overall Study||24
4997631|NCT02363270|12297105|P2|STARTED|Overall Study||24
4997632|NCT02363270|12297106|P1|STARTED|Overall Study||24
4997633|NCT02362789|12297114|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
4997634|NCT02362789|12297115|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
4997635|NCT02362789|12297116|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
4997636|NCT02362789|12297114|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
4997637|NCT02362789|12297115|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
4997638|NCT02362789|12297116|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
4997639|NCT02362789|12297114|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
4997640|NCT02362789|12297115|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
4997641|NCT02362789|12297116|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
4997642|NCT02362789|12297114|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
4997643|NCT02362789|12297115|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
4997644|NCT02362789|12297116|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
4997645|NCT02362789|12297114|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
4997646|NCT02362789|12297115|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
4997647|NCT02362789|12297116|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
4997648|NCT02362789|12297114|P3|STARTED|Run-in Phase (Week 0 to 16)||0
4997649|NCT02362789|12297115|P2|STARTED|Run-in Phase (Week 0 to 16)||0
4997650|NCT02362789|12297116|P1|STARTED|Run-in Phase (Week 0 to 16)||130
4997651|NCT02362646|12297125|P2|NOT COMPLETED|Overall Study||24
4997652|NCT02362646|12297126|P1|NOT COMPLETED|Overall Study||38
4997653|NCT02362646|12297125|P2|COMPLETED|Overall Study||29
4997654|NCT02362646|12297126|P1|COMPLETED|Overall Study||68
4997655|NCT02362646|12297125|P2|STARTED|Overall Study||53
4997656|NCT02362646|12297126|P1|STARTED|Overall Study||106
4997657|NCT02362594|12297136|P2|NOT COMPLETED|Overall Study||225
4997658|NCT02362594|12297137|P1|NOT COMPLETED|Overall Study||250
4997659|NCT02362594|12297136|P2|COMPLETED|Overall Study||280
4997660|NCT02362594|12297137|P1|COMPLETED|Overall Study||264
4997661|NCT02362594|12297136|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
4997662|NCT02362594|12297137|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
4997663|NCT02362594|12297136|P2|Treated|Overall Study||502
4997664|NCT02362594|12297137|P1|Treated|Overall Study||509
4997665|NCT02362594|12297136|P2|STARTED|Overall Study||505
4997666|NCT02362594|12297137|P1|STARTED|Overall Study||514
4997667|NCT02362503|12297158|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
4997668|NCT02362503|12297159|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
4997669|NCT02362503|12297160|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
4997670|NCT02362503|12297158|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
4997671|NCT02362503|12297159|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
4997672|NCT02362503|12297160|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
4997673|NCT02362503|12297158|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
4997674|NCT02362503|12297159|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
4997675|NCT02362503|12297160|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
4997676|NCT02362503|12297158|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
4997677|NCT02362503|12297159|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
4997678|NCT02362503|12297160|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
4997679|NCT02362503|12297158|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
4997680|NCT02362503|12297159|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
4997681|NCT02362503|12297160|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
4997682|NCT02362503|12297158|P3|STARTED|Double-blind Period-Up to 8 Days||0
4997683|NCT02362503|12297159|P2|STARTED|Double-blind Period-Up to 8 Days||203
4997684|NCT02362503|12297160|P1|STARTED|Double-blind Period-Up to 8 Days||69
4997685|NCT02362425|12297189|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
4997686|NCT02362425|12297190|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
4997687|NCT02362425|12297191|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
4997688|NCT02362425|12297192|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
4997689|NCT02362425|12297189|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
4997690|NCT02362425|12297190|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
4997691|NCT02362425|12297191|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
4997692|NCT02362425|12297192|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
4997693|NCT02362425|12297189|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
4997694|NCT02362425|12297190|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
4997695|NCT02362425|12297191|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
4997696|NCT02362425|12297192|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
4997697|NCT02362425|12297189|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
4997698|NCT02362425|12297190|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
4997699|NCT02362425|12297191|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
4997700|NCT02362425|12297192|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
4997701|NCT02362425|12297189|P4|COMPLETED|Phase 1 (up to 6 Months)||0
4997702|NCT02362425|12297190|P3|COMPLETED|Phase 1 (up to 6 Months)||0
4997703|NCT02362425|12297191|P2|COMPLETED|Phase 1 (up to 6 Months)||10
4997704|NCT02362425|12297192|P1|COMPLETED|Phase 1 (up to 6 Months)||37
4997705|NCT02362425|12297189|P4|STARTED|Phase 1 (up to 6 Months)||0
4997706|NCT02362425|12297190|P3|STARTED|Phase 1 (up to 6 Months)||0
4997707|NCT02362425|12297191|P2|STARTED|Phase 1 (up to 6 Months)||10
4997708|NCT02362425|12297192|P1|STARTED|Phase 1 (up to 6 Months)||53
4997709|NCT02362412|12297310|P2|NOT COMPLETED|Treatment Period III||1
4997710|NCT02362412|12297311|P1|NOT COMPLETED|Treatment Period III||0
4997711|NCT02362412|12297310|P2|COMPLETED|Treatment Period III||10
4997712|NCT02362412|12297311|P1|COMPLETED|Treatment Period III||9
4997713|NCT02362412|12297310|P2|TREATED|Treatment Period III||11
4997714|NCT02362412|12297311|P1|TREATED|Treatment Period III||9
4997715|NCT02362412|12297310|P2|STARTED|Treatment Period III||11
4997716|NCT02362412|12297311|P1|STARTED|Treatment Period III||9
4997717|NCT02362412|12297310|P2|NOT COMPLETED|Treatment Period II||0
4997718|NCT02362412|12297311|P1|NOT COMPLETED|Treatment Period II||0
4997719|NCT02362412|12297310|P2|COMPLETED|Treatment Period II||11
4997720|NCT02362412|12297311|P1|COMPLETED|Treatment Period II||9
4997721|NCT02362412|12297310|P2|TREATED|Treatment Period II||11
4997722|NCT02362412|12297311|P1|TREATED|Treatment Period II||9
4997723|NCT02362412|12297310|P2|STARTED|Treatment Period II||11
4997724|NCT02362412|12297311|P1|STARTED|Treatment Period II||9
4997725|NCT02362373|12297337|P1|NOT COMPLETED|Overall Study||0
4997726|NCT02362373|12297337|P1|COMPLETED|Overall Study||20
4997727|NCT02362373|12297337|P1|STARTED|Overall Study||20
4997728|NCT02362360|12297345|P2|NOT COMPLETED|Period 2||0
4997729|NCT02362360|12297346|P1|NOT COMPLETED|Period 2||0
4997730|NCT02362360|12297345|P2|COMPLETED|Period 2||25
4997731|NCT02362360|12297346|P1|COMPLETED|Period 2||23
4997732|NCT02362360|12297345|P2|STARTED|Period 2||25
4997733|NCT02362360|12297346|P1|STARTED|Period 2||23
4997734|NCT02362360|12297345|P2|NOT COMPLETED|Period 1||1
4997735|NCT02362360|12297346|P1|NOT COMPLETED|Period 1||3
4997736|NCT02362360|12297345|P2|COMPLETED|Period 1||25
4997737|NCT02362360|12297346|P1|COMPLETED|Period 1||23
4997738|NCT02362360|12297345|P2|STARTED|Period 1||26
4997739|NCT02362360|12297346|P1|STARTED|Period 1||26
4997740|NCT02362321|12297354|P2|NOT COMPLETED|Overall Study||0
4997741|NCT02362321|12297355|P1|NOT COMPLETED|Overall Study||4
4997742|NCT02362321|12297354|P2|COMPLETED|Overall Study||10
4997743|NCT02362321|12297355|P1|COMPLETED|Overall Study||6
4997744|NCT02362321|12297354|P2|STARTED|Overall Study||10
4997745|NCT02362321|12297355|P1|STARTED|Overall Study||10
4997746|NCT02362282|12297363|P2|NOT COMPLETED|Overall Study||0
4997747|NCT02362282|12297364|P1|NOT COMPLETED|Overall Study||1
4997748|NCT02362282|12297363|P2|COMPLETED|Overall Study||7
4997749|NCT02362282|12297364|P1|COMPLETED|Overall Study||4
4997750|NCT02362282|12297363|P2|STARTED|Overall Study||7
4997751|NCT02362282|12297364|P1|STARTED|Overall Study||5
4997752|NCT02362048|12297372|P2|NOT COMPLETED|Overall Study||40
4997753|NCT02362048|12297373|P1|NOT COMPLETED|Overall Study||37
4997754|NCT02362048|12297372|P2|COMPLETED|Overall Study||0
4997755|NCT02362048|12297373|P1|COMPLETED|Overall Study||0
4997756|NCT02362048|12297372|P2|Discontinued Study|Overall Study||40
4997757|NCT02362048|12297373|P1|Discontinued Study|Overall Study||37
4997758|NCT02362048|12297372|P2|Received Study Medication|Overall Study||38
4997759|NCT02362048|12297373|P1|Received Study Medication|Overall Study||35
4997760|NCT02362048|12297372|P2|Enrolled|Overall Study||40
4997761|NCT02362048|12297373|P1|Enrolled|Overall Study||37
4997762|NCT02362048|12297372|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
4997763|NCT02362048|12297373|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
4997764|NCT02361762|12297381|P2|NOT COMPLETED|Overall Study||2
4997765|NCT02361762|12297382|P1|NOT COMPLETED|Overall Study||0
4997766|NCT02361762|12297381|P2|COMPLETED|Overall Study||33
4997767|NCT02361762|12297382|P1|COMPLETED|Overall Study||35
4997768|NCT02361762|12297381|P2|STARTED|Overall Study||35
4997769|NCT02361762|12297382|P1|STARTED|Overall Study||35
4997770|NCT02361736|12297412|P2|NOT COMPLETED|Overall Study||1
4997771|NCT02361736|12297413|P1|NOT COMPLETED|Overall Study||1
4997772|NCT02361736|12297412|P2|COMPLETED|Overall Study||59
4997773|NCT02361736|12297413|P1|COMPLETED|Overall Study||59
4997774|NCT02361736|12297412|P2|STARTED|Overall Study||60
4997775|NCT02361736|12297413|P1|STARTED|Overall Study||60
4997776|NCT02361580|12297433|P2|NOT COMPLETED|Overall Study||3
4997777|NCT02361580|12297434|P1|NOT COMPLETED|Overall Study||6
4997778|NCT02361580|12297433|P2|COMPLETED|Overall Study||0
4997779|NCT02361580|12297434|P1|COMPLETED|Overall Study||0
4997780|NCT02361580|12297433|P2|STARTED|Overall Study||3
4997781|NCT02361580|12297434|P1|STARTED|Overall Study||6
4997782|NCT02361476|12297446|P2|NOT COMPLETED|Overall Study||0
4997783|NCT02361476|12297447|P1|NOT COMPLETED|Overall Study||0
4997784|NCT02361476|12297446|P2|COMPLETED|Overall Study||188
4997785|NCT02361476|12297447|P1|COMPLETED|Overall Study||191
4997786|NCT02361476|12297446|P2|STARTED|Overall Study||188
4997787|NCT02361476|12297447|P1|STARTED|Overall Study||191
4997788|NCT02361216|12297463|P2|NOT COMPLETED|12-month Follow-up||27
4997789|NCT02361216|12297464|P1|NOT COMPLETED|12-month Follow-up||52
4997790|NCT02361216|12297463|P2|COMPLETED|12-month Follow-up||130
4997791|NCT02361216|12297464|P1|COMPLETED|12-month Follow-up||489
4997792|NCT02361216|12297463|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
4997793|NCT02361216|12297464|P1|STARTED|12-month Follow-up||541
4997794|NCT02361216|12297463|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
4997795|NCT02361216|12297464|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
4997796|NCT02361216|12297463|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
4997797|NCT02361216|12297464|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
4997798|NCT02361216|12297463|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
4997799|NCT02361216|12297464|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
4997800|NCT02360995|12297479|P3|NOT COMPLETED|Overall Study||2
4997801|NCT02360995|12297480|P2|NOT COMPLETED|Overall Study||1
4997802|NCT02360995|12297481|P1|NOT COMPLETED|Overall Study||2
4997803|NCT02360995|12297479|P3|COMPLETED|Overall Study||41
4997804|NCT02360995|12297480|P2|COMPLETED|Overall Study||42
4997805|NCT02360995|12297481|P1|COMPLETED|Overall Study||41
4997806|NCT02360995|12297479|P3|STARTED|Overall Study||43
4997807|NCT02360995|12297480|P2|STARTED|Overall Study||43
4997808|NCT02360995|12297481|P1|STARTED|Overall Study||43
4997809|NCT02360774|12297506|P2|NOT COMPLETED|Overall Study||2
4997810|NCT02360774|12297507|P1|NOT COMPLETED|Overall Study||3
4997811|NCT02360774|12297506|P2|COMPLETED|Overall Study||13
4997812|NCT02360774|12297507|P1|COMPLETED|Overall Study||12
4997813|NCT02360774|12297506|P2|STARTED|Overall Study||15
4997814|NCT02360774|12297507|P1|STARTED|Overall Study||15
4997815|NCT02360631|12297521|P2|NOT COMPLETED|Overall Study||26
4997816|NCT02360631|12297522|P1|NOT COMPLETED|Overall Study||33
4997817|NCT02360631|12297521|P2|COMPLETED|Overall Study||174
4997818|NCT02360631|12297522|P1|COMPLETED|Overall Study||267
4997819|NCT02360631|12297521|P2|Week 12|Overall Study||165
4997820|NCT02360631|12297522|P1|Week 12|Overall Study||249
4997821|NCT02360631|12297521|P2|STARTED|Overall Study||200
4997822|NCT02360631|12297522|P1|STARTED|Overall Study||300
4997823|NCT02360488|12297534|P2|NOT COMPLETED|Overall Study||7
4997824|NCT02360488|12297535|P1|NOT COMPLETED|Overall Study||3
4997825|NCT02360488|12297534|P2|COMPLETED|Overall Study||55
4997826|NCT02360488|12297535|P1|COMPLETED|Overall Study||59
4997827|NCT02360488|12297534|P2|STARTED|Overall Study||62
4997828|NCT02360488|12297535|P1|STARTED|Overall Study||62
4997829|NCT02360475|12297545|P4|NOT COMPLETED|Overall Study||5
4997830|NCT02360475|12297546|P3|NOT COMPLETED|Overall Study||8
4997831|NCT02360475|12297547|P2|NOT COMPLETED|Overall Study||13
4997832|NCT02360475|12297548|P1|NOT COMPLETED|Overall Study||4
4997833|NCT02360475|12297545|P4|COMPLETED|Overall Study||120
4997834|NCT02360475|12297546|P3|COMPLETED|Overall Study||117
4997835|NCT02360475|12297547|P2|COMPLETED|Overall Study||111
4997836|NCT02360475|12297548|P1|COMPLETED|Overall Study||122
4997837|NCT02360475|12297545|P4|STARTED|Overall Study||125
4997838|NCT02360475|12297546|P3|STARTED|Overall Study||125
4997839|NCT02360475|12297547|P2|STARTED|Overall Study||124
4997840|NCT02360475|12297548|P1|STARTED|Overall Study||126
4997841|NCT02360397|12297606|P1|NOT COMPLETED|Overall Study||4
4997842|NCT02360397|12297606|P1|COMPLETED|Overall Study||2
4997843|NCT02360397|12297606|P1|STARTED|Overall Study||6
4997844|NCT02360293|12297615|P2|NOT COMPLETED|Overall Study||96
4997845|NCT02360293|12297616|P1|NOT COMPLETED|Overall Study||76
4997846|NCT02360293|12297615|P2|COMPLETED|Overall Study||83
4997847|NCT02360293|12297616|P1|COMPLETED|Overall Study||102
4997848|NCT02360293|12297615|P2|12month Physical Activity|Overall Study||59
4997849|NCT02360293|12297616|P1|12month Physical Activity|Overall Study||68
4997850|NCT02360293|12297615|P2|12month f/u Survey|Overall Study||83
4997851|NCT02360293|12297616|P1|12month f/u Survey|Overall Study||102
4997852|NCT02360293|12297615|P2|6month Physical Activity|Overall Study||108
4997853|NCT02360293|12297616|P1|6month Physical Activity|Overall Study||122
4997854|NCT02360293|12297615|P2|6month f/u Survey|Overall Study||105
4997855|NCT02360293|12297616|P1|6month f/u Survey|Overall Study||110
4997856|NCT02360293|12297615|P2|STARTED|Overall Study||179
4997857|NCT02360293|12297616|P1|STARTED|Overall Study||178
4997858|NCT02360280|12297630|P2|NOT COMPLETED|Overall Study||1
4997859|NCT02360280|12297631|P1|NOT COMPLETED|Overall Study||3
4997860|NCT02360280|12297630|P2|COMPLETED|Overall Study||29
4997861|NCT02360280|12297631|P1|COMPLETED|Overall Study||25
4997862|NCT02360280|12297630|P2|STARTED|Overall Study||30
4997863|NCT02360280|12297631|P1|STARTED|Overall Study||28
4997864|NCT02360228|12297646|P3|NOT COMPLETED|Overall Study||1
4997865|NCT02360228|12297647|P2|NOT COMPLETED|Overall Study||1
4997866|NCT02360228|12297648|P1|NOT COMPLETED|Overall Study||1
4997867|NCT02360228|12297646|P3|COMPLETED|Overall Study||7
4997868|NCT02360228|12297647|P2|COMPLETED|Overall Study||7
4997869|NCT02360228|12297648|P1|COMPLETED|Overall Study||8
4997870|NCT02360228|12297646|P3|STARTED|Overall Study||8
4997871|NCT02360228|12297647|P2|STARTED|Overall Study||8
4997872|NCT02360228|12297648|P1|STARTED|Overall Study||9
4997873|NCT02360215|12297676|P2|NOT COMPLETED|Overall Study||0
4997874|NCT02360215|12297677|P1|NOT COMPLETED|Overall Study||0
4997875|NCT02360215|12297676|P2|COMPLETED|Overall Study||261
4997876|NCT02360215|12297677|P1|COMPLETED|Overall Study||257
4997877|NCT02360215|12297676|P2|EQ-5D-5L VAS at 12 Months|Overall Study||48
4997878|NCT02360215|12297677|P1|EQ-5D-5L VAS at 12 Months|Overall Study||57
4997879|NCT02360215|12297676|P2|EQ-5D-5L VAS at 6 Months|Overall Study||69
4997880|NCT02360215|12297677|P1|EQ-5D-5L VAS at 6 Months|Overall Study||76
4997881|NCT02360215|12297676|P2|EQ-5D-5L VAS at 4 Months|Overall Study||193
4997882|NCT02360215|12297677|P1|EQ-5D-5L VAS at 4 Months|Overall Study||104
4997883|NCT02360215|12297676|P2|EQ-5D-5L VAS at 2 Months|Overall Study||123
4997884|NCT02360215|12297677|P1|EQ-5D-5L VAS at 2 Months|Overall Study||139
4997885|NCT02360215|12297676|P2|EQ-5D-5L Index at 12 Months|Overall Study||45
4997886|NCT02360215|12297677|P1|EQ-5D-5L Index at 12 Months|Overall Study||56
4997887|NCT02360215|12297676|P2|EQ-5D-5L Index at 6 Months|Overall Study||70
4997888|NCT02360215|12297677|P1|EQ-5D-5L Index at 6 Months|Overall Study||79
4997889|NCT02360215|12297676|P2|EQ-5D-5L Index at 4 Months|Overall Study||96
4997890|NCT02360215|12297677|P1|EQ-5D-5L Index at 4 Months|Overall Study||110
4997891|NCT02360215|12297676|P2|EQ-5D-5L Index at 2 Months|Overall Study||125
4997892|NCT02360215|12297677|P1|EQ-5D-5L Index at 2 Months|Overall Study||142
4997893|NCT02360215|12297676|P2|Clinical Trial Battery Composite Score|Overall Study||259
4997894|NCT02360215|12297677|P1|Clinical Trial Battery Composite Score|Overall Study||255
4997895|NCT02360215|12297676|P2|Controlled Oral Word Association (COWA)|Overall Study||261
4997896|NCT02360215|12297677|P1|Controlled Oral Word Association (COWA)|Overall Study||257
4997897|NCT02360215|12297676|P2|TMT Part B|Overall Study||257
4997898|NCT02360215|12297677|P1|TMT Part B|Overall Study||250
4997899|NCT02360215|12297676|P2|Trail Making Test (TMT) Part A|Overall Study||260
4997900|NCT02360215|12297677|P1|Trail Making Test (TMT) Part A|Overall Study||256
4997901|NCT02360215|12297676|P2|HVLT-R Recognition|Overall Study||259
4997902|NCT02360215|12297677|P1|HVLT-R Recognition|Overall Study||255
4997903|NCT02360215|12297676|P2|HVLT-R Delayed Recall|Overall Study||259
4997904|NCT02360215|12297677|P1|HVLT-R Delayed Recall|Overall Study||256
4997905|NCT02360215|12297676|P2|HVLT-R Total Recall|Overall Study||259
4997906|NCT02360215|12297677|P1|HVLT-R Total Recall|Overall Study||256
4997907|NCT02360215|12297676|P2|MDASI-BT Neurologic Factor Score|Overall Study||251
4997908|NCT02360215|12297677|P1|MDASI-BT Neurologic Factor Score|Overall Study||249
4997909|NCT02360215|12297676|P2|MDASI-BT Cognitive Factor Score|Overall Study||251
4997910|NCT02360215|12297677|P1|MDASI-BT Cognitive Factor Score|Overall Study||249
4997911|NCT02360215|12297676|P2|MDASI-BT Intererence Score|Overall Study||251
4997912|NCT02360215|12297677|P1|MDASI-BT Intererence Score|Overall Study||248
4997913|NCT02360215|12297676|P2|MDASI-BT Symptom Score|Overall Study||251
4997914|NCT02360215|12297677|P1|MDASI-BT Symptom Score|Overall Study||249
4997915|NCT02360215|12297676|P2|Started Protocol Treatment|Overall Study||223
4997916|NCT02360215|12297677|P1|Started Protocol Treatment|Overall Study||232
4997917|NCT02360215|12297676|P2|All Randomized Participants|Overall Study||261
4997918|NCT02360215|12297677|P1|All Randomized Participants|Overall Study||257
4997919|NCT02360215|12297676|P2|STARTED|Overall Study||261
4997920|NCT02360215|12297677|P1|STARTED|Overall Study||257
4997921|NCT02360124|12297730|P3|NOT COMPLETED|Overall Study||26
4997922|NCT02360124|12297731|P2|NOT COMPLETED|Overall Study||12
4997923|NCT02360124|12297732|P1|NOT COMPLETED|Overall Study||28
4997924|NCT02360124|12297730|P3|COMPLETED|Overall Study||82
4997925|NCT02360124|12297731|P2|COMPLETED|Overall Study||95
4997926|NCT02360124|12297732|P1|COMPLETED|Overall Study||80
4997927|NCT02360124|12297730|P3|STARTED|Overall Study||108
4997928|NCT02360124|12297731|P2|STARTED|Overall Study||107
4997929|NCT02360124|12297732|P1|STARTED|Overall Study||108
4997930|NCT02360111|12297743|P1|NOT COMPLETED|Overall Study||2
4997931|NCT02360111|12297743|P1|COMPLETED|Overall Study||1
4997932|NCT02360111|12297743|P1|STARTED|Overall Study||3
4997933|NCT02360098|12297753|P1|NOT COMPLETED|Overall Study||7
4997934|NCT02360098|12297753|P1|COMPLETED|Overall Study||29
4997935|NCT02360098|12297753|P1|STARTED|Overall Study||36
4997936|NCT02360059|12297760|P2|NOT COMPLETED|Overall Study||0
4997937|NCT02360059|12297761|P1|NOT COMPLETED|Overall Study||0
4997938|NCT02360059|12297760|P2|COMPLETED|Overall Study||0
4997939|NCT02360059|12297761|P1|COMPLETED|Overall Study||1
4997940|NCT02360059|12297760|P2|STARTED|Overall Study||0
4997941|NCT02360059|12297761|P1|STARTED|Overall Study||1
4997942|NCT02359955|12297769|P2|NOT COMPLETED|Overall Study||0
4997943|NCT02359955|12297770|P1|NOT COMPLETED|Overall Study||0
4997944|NCT02359955|12297769|P2|COMPLETED|Overall Study||10
4997945|NCT02359955|12297770|P1|COMPLETED|Overall Study||10
4997946|NCT02359955|12297769|P2|STARTED|Overall Study||10
4997947|NCT02359955|12297770|P1|STARTED|Overall Study||10
4997948|NCT02359916|12297793|P7|NOT COMPLETED|Overall Study||0
4997949|NCT02359916|12297794|P6|NOT COMPLETED|Overall Study||0
4997950|NCT02359916|12297795|P5|NOT COMPLETED|Overall Study||0
4997951|NCT02359916|12297796|P4|NOT COMPLETED|Overall Study||0
4997952|NCT02359916|12297797|P3|NOT COMPLETED|Overall Study||0
4997953|NCT02359916|12297798|P2|NOT COMPLETED|Overall Study||0
4997954|NCT02359916|12297799|P1|NOT COMPLETED|Overall Study||0
4997955|NCT02359916|12297793|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997956|NCT02359916|12297794|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997957|NCT02359916|12297795|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997958|NCT02359916|12297796|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997959|NCT02359916|12297797|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997960|NCT02359916|12297798|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997961|NCT02359916|12297799|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
4997962|NCT02359916|12297793|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997963|NCT02359916|12297794|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997964|NCT02359916|12297795|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997965|NCT02359916|12297796|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997966|NCT02359916|12297797|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997967|NCT02359916|12297798|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997968|NCT02359916|12297799|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
4997969|NCT02359903|12297821|P2|NOT COMPLETED|Overall Study||2
4997970|NCT02359903|12297822|P1|NOT COMPLETED|Overall Study||0
4997971|NCT02359903|12297821|P2|COMPLETED|Overall Study||43
4997972|NCT02359903|12297822|P1|COMPLETED|Overall Study||45
4997973|NCT02359903|12297821|P2|STARTED|Overall Study||45
4997974|NCT02359903|12297822|P1|STARTED|Overall Study||45
4997975|NCT02359890|12297830|P1|NOT COMPLETED|Overall Study||10
4997976|NCT02359890|12297830|P1|COMPLETED|Overall Study||155
4997977|NCT02359890|12297830|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
4997978|NCT02359890|12297830|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
4997979|NCT02359890|12297830|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
4997980|NCT02359890|12297830|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
4997981|NCT02359877|12297841|P4|NOT COMPLETED|Overall Study||3
4997982|NCT02359877|12297842|P3|NOT COMPLETED|Overall Study||0
4997983|NCT02359877|12297843|P2|NOT COMPLETED|Overall Study||0
4997984|NCT02359877|12297844|P1|NOT COMPLETED|Overall Study||1
4997985|NCT02359877|12297841|P4|COMPLETED|Overall Study||11
4997986|NCT02359877|12297842|P3|COMPLETED|Overall Study||6
4997987|NCT02359877|12297843|P2|COMPLETED|Overall Study||6
4997988|NCT02359877|12297844|P1|COMPLETED|Overall Study||33
4997989|NCT02359877|12297841|P4|STARTED|Overall Study||14
4997990|NCT02359877|12297842|P3|STARTED|Overall Study||6
4997991|NCT02359877|12297843|P2|STARTED|Overall Study||6
4997992|NCT02359877|12297844|P1|STARTED|Overall Study||34
4997993|NCT02359851|12297894|P1|NOT COMPLETED|Overall Study||2
4997994|NCT02359851|12297894|P1|COMPLETED|Overall Study||3
4997995|NCT02359851|12297894|P1|STARTED|Overall Study||5
4997996|NCT02359435|12297904|P2|NOT COMPLETED|Overall Study||4
4997997|NCT02359435|12297905|P1|NOT COMPLETED|Overall Study||4
4997998|NCT02359435|12297904|P2|COMPLETED|Overall Study||216
4997999|NCT02359435|12297905|P1|COMPLETED|Overall Study||216
4998000|NCT02359435|12297904|P2|STARTED|Overall Study||220
4998001|NCT02359435|12297905|P1|STARTED|Overall Study||220
4998002|NCT02359305|12297913|P2|NOT COMPLETED|Overall Study||0
4998003|NCT02359305|12297914|P1|NOT COMPLETED|Overall Study||0
4998004|NCT02359305|12297913|P2|COMPLETED|Overall Study||34
4998005|NCT02359305|12297914|P1|COMPLETED|Overall Study||34
4998006|NCT02359305|12297913|P2|STARTED|Overall Study||34
4998007|NCT02359305|12297914|P1|STARTED|Overall Study||34
4998008|NCT02359110|12297926|P2|NOT COMPLETED|Overall Study||0
4998009|NCT02359110|12297927|P1|NOT COMPLETED|Overall Study||0
4998010|NCT02359110|12297926|P2|COMPLETED|Overall Study||54
4998011|NCT02359110|12297927|P1|COMPLETED|Overall Study||55
4998012|NCT02359110|12297926|P2|STARTED|Overall Study||54
4998013|NCT02359110|12297927|P1|STARTED|Overall Study||55
4998014|NCT02359058|12297940|P3|NOT COMPLETED|Overall Study||0
4998015|NCT02359058|12297941|P2|NOT COMPLETED|Overall Study||0
4998016|NCT02359058|12297942|P1|NOT COMPLETED|Overall Study||0
4998017|NCT02359058|12297940|P3|COMPLETED|Overall Study||6
4998018|NCT02359058|12297941|P2|COMPLETED|Overall Study||6
4998019|NCT02359058|12297942|P1|COMPLETED|Overall Study||6
4998020|NCT02359058|12297940|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
4998021|NCT02359058|12297941|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
4998022|NCT02359058|12297942|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
4998023|NCT02359058|12297940|P3|STARTED|Overall Study||6
4998024|NCT02359058|12297941|P2|STARTED|Overall Study||6
4998025|NCT02359058|12297942|P1|STARTED|Overall Study||6
4998026|NCT02359045|12297965|P2|NOT COMPLETED|Overall Study||3
4998027|NCT02359045|12297966|P1|NOT COMPLETED|Overall Study||4
4998028|NCT02359045|12297965|P2|COMPLETED|Overall Study||39
4998029|NCT02359045|12297966|P1|COMPLETED|Overall Study||36
4998030|NCT02359045|12297965|P2|STARTED|Overall Study||42
4998031|NCT02359045|12297966|P1|STARTED|Overall Study||40
4998032|NCT02359006|12298201|P2|NOT COMPLETED|Overall Study||3
4998033|NCT02359006|12298202|P1|NOT COMPLETED|Overall Study||4
4998034|NCT02359006|12298201|P2|COMPLETED|Overall Study||10
4998035|NCT02359006|12298202|P1|COMPLETED|Overall Study||10
4998036|NCT02359006|12298201|P2|STARTED|Overall Study||13
4998037|NCT02359006|12298202|P1|STARTED|Overall Study||14
4998038|NCT02358876|12298242|P1|NOT COMPLETED|Overall Study||2
4998039|NCT02358876|12298242|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
4998040|NCT02358876|12298242|P1|STARTED|Overall Study||32
4998041|NCT02358863|12298246|P1|NOT COMPLETED|Overall Study||3
4998042|NCT02358863|12298246|P1|COMPLETED|Overall Study||10
4998043|NCT02358863|12298246|P1|STARTED|Overall Study||13
4998044|NCT02358668|12298253|P3|NOT COMPLETED|Overall Study||0
4998045|NCT02358668|12298254|P2|NOT COMPLETED|Overall Study||1
4998046|NCT02358668|12298255|P1|NOT COMPLETED|Overall Study||2
4998047|NCT02358668|12298253|P3|COMPLETED|Overall Study||12
4998048|NCT02358668|12298254|P2|COMPLETED|Overall Study||23
4998049|NCT02358668|12298255|P1|COMPLETED|Overall Study||22
4998050|NCT02358668|12298253|P3|STARTED|Overall Study||12
4998051|NCT02358668|12298254|P2|STARTED|Overall Study||24
4998052|NCT02358668|12298255|P1|STARTED|Overall Study||24
4998053|NCT02358603|12298397|P2|NOT COMPLETED|Overall Study||0
4998054|NCT02358603|12298398|P1|NOT COMPLETED|Overall Study||0
4998055|NCT02358603|12298397|P2|COMPLETED|Overall Study||8
4998056|NCT02358603|12298398|P1|COMPLETED|Overall Study||40
4998057|NCT02358603|12298397|P2|STARTED|Overall Study||8
4998058|NCT02358603|12298398|P1|STARTED|Overall Study||40
4998059|NCT02358473|12298404|P1|NOT COMPLETED|Overall Study||13
4998060|NCT02358473|12298404|P1|COMPLETED|Overall Study||0
4998061|NCT02358473|12298404|P1|STARTED|Overall Study||13
4998062|NCT02358369|12298416|P5|NOT COMPLETED|Treatment Period C||7
4998063|NCT02358369|12298417|P4|NOT COMPLETED|Treatment Period C||0
4998064|NCT02358369|12298418|P3|NOT COMPLETED|Treatment Period C||0
4998065|NCT02358369|12298419|P2|NOT COMPLETED|Treatment Period C||0
4998066|NCT02358369|12298420|P1|NOT COMPLETED|Treatment Period C||0
4998067|NCT02358369|12298416|P5|COMPLETED|Treatment Period C||106
4998068|NCT02358369|12298417|P4|COMPLETED|Treatment Period C||0
4998069|NCT02358369|12298418|P3|COMPLETED|Treatment Period C||0
4998070|NCT02358369|12298419|P2|COMPLETED|Treatment Period C||0
4998071|NCT02358369|12298420|P1|COMPLETED|Treatment Period C||0
4998072|NCT02358369|12298416|P5|STARTED|Treatment Period C||113
4998073|NCT02358369|12298417|P4|STARTED|Treatment Period C||0
4998074|NCT02358369|12298418|P3|STARTED|Treatment Period C||0
4998075|NCT02358369|12298419|P2|STARTED|Treatment Period C||0
4998076|NCT02358369|12298420|P1|STARTED|Treatment Period C||0
4998077|NCT02358369|12298416|P5|NOT COMPLETED|Treatment Period A/B||0
4998078|NCT02358369|12298417|P4|NOT COMPLETED|Treatment Period A/B||4
4998079|NCT02358369|12298418|P3|NOT COMPLETED|Treatment Period A/B||2
4998080|NCT02358369|12298419|P2|NOT COMPLETED|Treatment Period A/B||2
4998081|NCT02358369|12298420|P1|NOT COMPLETED|Treatment Period A/B||0
4998082|NCT02358369|12298416|P5|COMPLETED|Treatment Period A/B||0
4998083|NCT02358369|12298417|P4|COMPLETED|Treatment Period A/B||37
4998084|NCT02358369|12298418|P3|COMPLETED|Treatment Period A/B||38
4998085|NCT02358369|12298419|P2|COMPLETED|Treatment Period A/B||38
4998086|NCT02358369|12298420|P1|COMPLETED|Treatment Period A/B||0
4998087|NCT02358369|12298416|P5|STARTED|Treatment Period A/B||0
4998088|NCT02358369|12298417|P4|STARTED|Treatment Period A/B||41
4998089|NCT02358369|12298418|P3|STARTED|Treatment Period A/B||40
4998090|NCT02358369|12298419|P2|STARTED|Treatment Period A/B||40
4998091|NCT02358369|12298420|P1|STARTED|Treatment Period A/B||0
4998092|NCT02358369|12298416|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
4998093|NCT02358369|12298417|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
4998094|NCT02358369|12298418|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
4998095|NCT02358369|12298419|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
4998096|NCT02358369|12298420|P1|NOT COMPLETED|Pre-Randomization Washout Period||35
4998097|NCT02358369|12298416|P5|COMPLETED|Pre-Randomization Washout Period||0
4998098|NCT02358369|12298417|P4|COMPLETED|Pre-Randomization Washout Period||0
4998099|NCT02358369|12298418|P3|COMPLETED|Pre-Randomization Washout Period||0
4998100|NCT02358369|12298419|P2|COMPLETED|Pre-Randomization Washout Period||0
4998101|NCT02358369|12298420|P1|COMPLETED|Pre-Randomization Washout Period||121
4998102|NCT02358369|12298416|P5|STARTED|Pre-Randomization Washout Period||0
4998103|NCT02358369|12298417|P4|STARTED|Pre-Randomization Washout Period||0
4998104|NCT02358369|12298418|P3|STARTED|Pre-Randomization Washout Period||0
4998105|NCT02358369|12298419|P2|STARTED|Pre-Randomization Washout Period||0
4998106|NCT02358369|12298420|P1|STARTED|Pre-Randomization Washout Period||156
4998107|NCT02358343|12298466|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
4998108|NCT02358343|12298467|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
4998109|NCT02358343|12298468|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
4998110|NCT02358343|12298469|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
4998111|NCT02358343|12298470|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
4998112|NCT02358343|12298466|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
4998113|NCT02358343|12298467|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
4998114|NCT02358343|12298468|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
4998115|NCT02358343|12298469|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
4998116|NCT02358343|12298470|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
4998117|NCT02358343|12298466|P5|STARTED|Comparative Efficacy Trial / Observation||20
4998118|NCT02358343|12298467|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
4998119|NCT02358343|12298468|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
4998120|NCT02358343|12298469|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
4998121|NCT02358343|12298470|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
4998122|NCT02358343|12298466|P5|NOT COMPLETED|Screening Intervention||0
4998123|NCT02358343|12298467|P4|NOT COMPLETED|Screening Intervention||0
4998124|NCT02358343|12298468|P3|NOT COMPLETED|Screening Intervention||0
4998125|NCT02358343|12298469|P2|NOT COMPLETED|Screening Intervention||8
4998126|NCT02358343|12298470|P1|NOT COMPLETED|Screening Intervention||6
4998127|NCT02358343|12298466|P5|COMPLETED|Screening Intervention||0
4998128|NCT02358343|12298467|P4|COMPLETED|Screening Intervention||0
4998129|NCT02358343|12298468|P3|COMPLETED|Screening Intervention||0
4998130|NCT02358343|12298469|P2|COMPLETED|Screening Intervention||84
4998131|NCT02358343|12298470|P1|COMPLETED|Screening Intervention||86
4998132|NCT02358343|12298466|P5|STARTED|Screening Intervention||0
4998133|NCT02358343|12298467|P4|STARTED|Screening Intervention||0
4998134|NCT02358343|12298468|P3|STARTED|Screening Intervention||0
4998135|NCT02358343|12298469|P2|STARTED|Screening Intervention|89 completed control visit|92
4998136|NCT02358343|12298470|P1|STARTED|Screening Intervention|90 completed engagement interview|92
4998137|NCT02358135|12298507|P2|NOT COMPLETED|Overall Study||19
4998138|NCT02358135|12298508|P1|NOT COMPLETED|Overall Study||15
4998139|NCT02358135|12298507|P2|COMPLETED|Overall Study||131
4998140|NCT02358135|12298508|P1|COMPLETED|Overall Study||135
4998141|NCT02358135|12298507|P2|Randomized|Overall Study||148
4998142|NCT02358135|12298508|P1|Randomized|Overall Study||148
4998143|NCT02358135|12298507|P2|STARTED|Overall Study||150
4998144|NCT02358135|12298508|P1|STARTED|Overall Study||150
4998145|NCT02358044|12298526|P2|NOT COMPLETED|Overall Study||7
4998146|NCT02358044|12298527|P1|NOT COMPLETED|Overall Study||2
4998147|NCT02358044|12298526|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
4998148|NCT02358044|12298527|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
4998149|NCT02358044|12298526|P2|Treated|Overall Study||126
4998150|NCT02358044|12298527|P1|Treated|Overall Study||129
4998151|NCT02358044|12298526|P2|STARTED|Overall Study||128
4998152|NCT02358044|12298527|P1|STARTED|Overall Study||129
4998153|NCT02358031|12298546|P3|NOT COMPLETED|Overall Study||300
4998154|NCT02358031|12298547|P2|NOT COMPLETED|Overall Study||281
4998155|NCT02358031|12298548|P1|NOT COMPLETED|Overall Study||301
4998156|NCT02358031|12298546|P3|COMPLETED|Overall Study||0
4998157|NCT02358031|12298547|P2|COMPLETED|Overall Study||0
4998158|NCT02358031|12298548|P1|COMPLETED|Overall Study||0
4998159|NCT02358031|12298546|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
4998160|NCT02358031|12298547|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
4998161|NCT02358031|12298548|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
4998162|NCT02358031|12298546|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
4998163|NCT02358031|12298547|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
4998164|NCT02358031|12298548|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
4998165|NCT02358031|12298546|P3|Treated|Overall Study||287
4998166|NCT02358031|12298547|P2|Treated|Overall Study||276
4998167|NCT02358031|12298548|P1|Treated|Overall Study||300
4998168|NCT02358031|12298546|P3|STARTED|Overall Study||300
4998169|NCT02358031|12298547|P2|STARTED|Overall Study||281
4998170|NCT02358031|12298548|P1|STARTED|Overall Study||301
4998171|NCT02357940|12298675|P2|NOT COMPLETED|Overall Study||2
4998172|NCT02357940|12298676|P1|NOT COMPLETED|Overall Study||0
4998173|NCT02357940|12298675|P2|COMPLETED|Overall Study||30
4998174|NCT02357940|12298676|P1|COMPLETED|Overall Study||9
4998175|NCT02357940|12298675|P2|STARTED|Overall Study||32
4998176|NCT02357940|12298676|P1|STARTED|Overall Study||9
4998177|NCT02357901|12298803|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
4998178|NCT02357901|12298804|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
4998179|NCT02357901|12298805|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
4998180|NCT02357901|12298806|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
4998181|NCT02357901|12298803|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
4998182|NCT02357901|12298804|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
4998183|NCT02357901|12298805|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
4998184|NCT02357901|12298806|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
4998185|NCT02357901|12298803|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
4998186|NCT02357901|12298804|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
4998187|NCT02357901|12298805|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
4998188|NCT02357901|12298806|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
4998189|NCT02357901|12298803|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
4998190|NCT02357901|12298804|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
4998191|NCT02357901|12298805|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
4998192|NCT02357901|12298806|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
4998193|NCT02357901|12298803|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
4998194|NCT02357901|12298804|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
4998195|NCT02357901|12298805|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
4998196|NCT02357901|12298806|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
4998197|NCT02357901|12298803|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998198|NCT02357901|12298804|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998199|NCT02357901|12298805|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998200|NCT02357901|12298806|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
4998201|NCT02357901|12298803|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998202|NCT02357901|12298804|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998203|NCT02357901|12298805|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
4998204|NCT02357901|12298806|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
4998205|NCT02357901|12298803|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
4998206|NCT02357901|12298804|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
4998207|NCT02357901|12298805|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
4998208|NCT02357901|12298806|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
4998209|NCT02357758|12298859|P3|NOT COMPLETED|Overall Study||7
4998210|NCT02357758|12298860|P2|NOT COMPLETED|Overall Study||0
4998211|NCT02357758|12298861|P1|NOT COMPLETED|Overall Study||16
4998212|NCT02357758|12298859|P3|COMPLETED|Overall Study||5
4998213|NCT02357758|12298860|P2|COMPLETED|Overall Study||20
4998214|NCT02357758|12298861|P1|COMPLETED|Overall Study||9
4998215|NCT02357758|12298859|P3|STARTED|Overall Study||12
4998216|NCT02357758|12298860|P2|STARTED|Overall Study||20
4998217|NCT02357758|12298861|P1|STARTED|Overall Study||25
4998218|NCT02357706|12298869|P2|NOT COMPLETED|Overall Study||0
4998219|NCT02357706|12298870|P1|NOT COMPLETED|Overall Study||0
4998220|NCT02357706|12298869|P2|COMPLETED|Overall Study||10
4998221|NCT02357706|12298870|P1|COMPLETED|Overall Study||10
4998222|NCT02357706|12298869|P2|STARTED|Overall Study||10
4998223|NCT02357706|12298870|P1|STARTED|Overall Study||10
4998224|NCT02357576|12298894|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
4998225|NCT02357576|12298895|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
4998226|NCT02357576|12298894|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
4998227|NCT02357576|12298895|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
4998228|NCT02357576|12298894|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
4998229|NCT02357576|12298895|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
4998230|NCT02357576|12298894|P2|NOT COMPLETED|Treatment Period||2
4998231|NCT02357576|12298895|P1|NOT COMPLETED|Treatment Period||0
4998232|NCT02357576|12298894|P2|COMPLETED|Treatment Period||7
4998233|NCT02357576|12298895|P1|COMPLETED|Treatment Period||12
4998234|NCT02357576|12298894|P2|STARTED|Treatment Period||9
4998235|NCT02357576|12298895|P1|STARTED|Treatment Period||12
4998236|NCT02357485|12298925|P1|NOT COMPLETED|Overall Study||0
4998237|NCT02357485|12298925|P1|COMPLETED|Overall Study||6
4998238|NCT02357485|12298925|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
4998239|NCT02357459|12298936|P3|NOT COMPLETED|Overall Study||12
4998240|NCT02357459|12298937|P2|NOT COMPLETED|Overall Study||14
4998241|NCT02357459|12298938|P1|NOT COMPLETED|Overall Study||17
4998242|NCT02357459|12298936|P3|COMPLETED|Overall Study||150
4998243|NCT02357459|12298937|P2|COMPLETED|Overall Study||149
4998244|NCT02357459|12298938|P1|COMPLETED|Overall Study||144
4998245|NCT02357459|12298936|P3|STARTED|Overall Study||162
4998246|NCT02357459|12298937|P2|STARTED|Overall Study||163
4998247|NCT02357459|12298938|P1|STARTED|Overall Study||161
4998248|NCT02357420|12298984|P4|NOT COMPLETED|Overall Study||19
4998249|NCT02357420|12298985|P3|NOT COMPLETED|Overall Study||16
4998250|NCT02357420|12298986|P2|NOT COMPLETED|Overall Study||12
4998251|NCT02357420|12298987|P1|NOT COMPLETED|Overall Study||12
4998252|NCT02357420|12298984|P4|COMPLETED|Overall Study||63
4998253|NCT02357420|12298985|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
4998254|NCT02357420|12298986|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
4998255|NCT02357420|12298987|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
4998256|NCT02357420|12298984|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
4998257|NCT02357420|12298985|P3|Full Analysis Set (FAS)|Overall Study||109
4998258|NCT02357420|12298986|P2|Full Analysis Set (FAS)|Overall Study||98
4998259|NCT02357420|12298987|P1|Full Analysis Set (FAS)|Overall Study||104
4998260|NCT02357420|12298984|P4|STARTED|Overall Study||82
4998261|NCT02357420|12298985|P3|STARTED|Overall Study||109
4998262|NCT02357420|12298986|P2|STARTED|Overall Study||98
4998263|NCT02357420|12298987|P1|STARTED|Overall Study||104
4998264|NCT02357394|12299007|P2|NOT COMPLETED|Overall Study||0
4998265|NCT02357394|12299008|P1|NOT COMPLETED|Overall Study||0
4998266|NCT02357394|12299007|P2|COMPLETED|Overall Study||3
4998267|NCT02357394|12299008|P1|COMPLETED|Overall Study||4
4998268|NCT02357394|12299007|P2|STARTED|Overall Study||3
4998269|NCT02357394|12299008|P1|STARTED|Overall Study||4
4998270|NCT02357342|12299048|P2|NOT COMPLETED|Extension Study||0
4998271|NCT02357342|12299049|P1|NOT COMPLETED|Extension Study||0
4998272|NCT02357342|12299048|P2|COMPLETED|Extension Study||9
4998273|NCT02357342|12299049|P1|COMPLETED|Extension Study||4
4998274|NCT02357342|12299048|P2|STARTED|Extension Study||9
4998275|NCT02357342|12299049|P1|STARTED|Extension Study||4
4998276|NCT02357342|12299048|P2|NOT COMPLETED|First 6 Months||0
4998277|NCT02357342|12299049|P1|NOT COMPLETED|First 6 Months||2
4998278|NCT02357342|12299048|P2|COMPLETED|First 6 Months||20
4998279|NCT02357342|12299049|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
4998280|NCT02357342|12299048|P2|STARTED|First 6 Months||20
4998281|NCT02357342|12299049|P1|STARTED|First 6 Months||20
4998282|NCT02357290|12299059|P1|NOT COMPLETED|Overall Study||26
4998283|NCT02357290|12299059|P1|COMPLETED|Overall Study||14
4998284|NCT02357290|12299059|P1|Exposed|Overall Study||26
4998285|NCT02357290|12299059|P1|STARTED|Overall Study||40
4998286|NCT02357264|12299066|P2|NOT COMPLETED|Overall Study||0
4998287|NCT02357264|12299067|P1|NOT COMPLETED|Overall Study||0
4998288|NCT02357264|12299066|P2|COMPLETED|Overall Study||130
4998289|NCT02357264|12299067|P1|COMPLETED|Overall Study||56
4998290|NCT02357264|12299066|P2|STARTED|Overall Study||130
4998291|NCT02357264|12299067|P1|STARTED|Overall Study||56
4998292|NCT02357173|12299076|P3|NOT COMPLETED|Overall Study||6
4998293|NCT02357173|12299077|P2|NOT COMPLETED|Overall Study||6
4998294|NCT02357173|12299078|P1|NOT COMPLETED|Overall Study||6
4998295|NCT02357173|12299076|P3|COMPLETED|Overall Study||16
4998296|NCT02357173|12299077|P2|COMPLETED|Overall Study||15
4998297|NCT02357173|12299078|P1|COMPLETED|Overall Study||19
4998298|NCT02357173|12299076|P3|STARTED|Overall Study||22
4998299|NCT02357173|12299077|P2|STARTED|Overall Study||21
4998300|NCT02357173|12299078|P1|STARTED|Overall Study||25
4998301|NCT02357147|12299097|P2|NOT COMPLETED|Maintenance Treatment Phase||29
4998302|NCT02357147|12299098|P1|NOT COMPLETED|Maintenance Treatment Phase||26
4998303|NCT02357147|12299097|P2|COMPLETED|Maintenance Treatment Phase||0
4998304|NCT02357147|12299098|P1|COMPLETED|Maintenance Treatment Phase||0
4998305|NCT02357147|12299097|P2|Treated|Maintenance Treatment Phase||29
4998306|NCT02357147|12299098|P1|Treated|Maintenance Treatment Phase||25
4998307|NCT02357147|12299097|P2|STARTED|Maintenance Treatment Phase||29
4998308|NCT02357147|12299098|P1|STARTED|Maintenance Treatment Phase||26
4998309|NCT02357147|12299097|P2|NOT COMPLETED|Combination Treatment Phase||27
4998310|NCT02357147|12299098|P1|NOT COMPLETED|Combination Treatment Phase||26
4998311|NCT02357147|12299097|P2|COMPLETED|Combination Treatment Phase||29
4998312|NCT02357147|12299098|P1|COMPLETED|Combination Treatment Phase||26
4998313|NCT02357147|12299097|P2|Treated|Combination Treatment Phase||54
4998314|NCT02357147|12299098|P1|Treated|Combination Treatment Phase||52
4998315|NCT02357147|12299097|P2|STARTED|Combination Treatment Phase||56
4998316|NCT02357147|12299098|P1|STARTED|Combination Treatment Phase||52
4998317|NCT02356900|12299110|P2|NOT COMPLETED|Overall Study||0
4998318|NCT02356900|12299111|P1|NOT COMPLETED|Overall Study||0
4998319|NCT02356900|12299110|P2|COMPLETED|Overall Study||10
4998320|NCT02356900|12299111|P1|COMPLETED|Overall Study||11
4998321|NCT02356900|12299110|P2|STARTED|Overall Study||10
4998322|NCT02356900|12299111|P1|STARTED|Overall Study||11
4998323|NCT02356887|12299129|P1|NOT COMPLETED|Overall Study||2
4998324|NCT02356887|12299129|P1|COMPLETED|Overall Study||10
4998325|NCT02356887|12299129|P1|STARTED|Overall Study||12
4998326|NCT02356783|12299146|P2|NOT COMPLETED|Overall Study||3
4998327|NCT02356783|12299147|P1|NOT COMPLETED|Overall Study||1
4998328|NCT02356783|12299146|P2|COMPLETED|Overall Study||14
4998329|NCT02356783|12299147|P1|COMPLETED|Overall Study||15
4998330|NCT02356783|12299146|P2|STARTED|Overall Study||17
4998331|NCT02356783|12299147|P1|STARTED|Overall Study||16
4998332|NCT02356588|12299157|P2|NOT COMPLETED|Overall Study||13
4998333|NCT02356588|12299158|P1|NOT COMPLETED|Overall Study||5
4998334|NCT02356588|12299157|P2|COMPLETED|Overall Study||41
4998335|NCT02356588|12299158|P1|COMPLETED|Overall Study||102
4998336|NCT02356588|12299157|P2|STARTED|Overall Study||54
4998337|NCT02356588|12299158|P1|STARTED|Overall Study||107
4998338|NCT02356575|12299192|P2|NOT COMPLETED|Overall Study||0
4998339|NCT02356575|12299193|P1|NOT COMPLETED|Overall Study||0
4998340|NCT02356575|12299192|P2|COMPLETED|Overall Study||80
4998341|NCT02356575|12299193|P1|COMPLETED|Overall Study||80
4998342|NCT02356575|12299192|P2|STARTED|Overall Study||80
4998343|NCT02356575|12299193|P1|STARTED|Overall Study||80
4998344|NCT02356562|12299275|P2|NOT COMPLETED|Overall Study||1
4998345|NCT02356562|12299276|P1|NOT COMPLETED|Overall Study||2
4998346|NCT02356562|12299275|P2|COMPLETED|Overall Study||6
4998347|NCT02356562|12299276|P1|COMPLETED|Overall Study||20
4998348|NCT02356562|12299275|P2|STARTED|Overall Study||7
4998349|NCT02356562|12299276|P1|STARTED|Overall Study||22
4998350|NCT02356484|12299286|P1|NOT COMPLETED|Overall Study||0
4998351|NCT02356484|12299286|P1|COMPLETED|Overall Study||138
4998352|NCT02356484|12299286|P1|STARTED|Overall Study||138
4998353|NCT02356471|12299290|P1|NOT COMPLETED|Overall Study||6
4998354|NCT02356471|12299290|P1|COMPLETED|Overall Study||28
4998355|NCT02356471|12299290|P1|STARTED|Overall Study||34
4998356|NCT02356211|12299305|P2|NOT COMPLETED|Overall Study||10
4998357|NCT02356211|12299306|P1|NOT COMPLETED|Overall Study||3
4998358|NCT02356211|12299305|P2|COMPLETED|Overall Study||42
4998359|NCT02356211|12299306|P1|COMPLETED|Overall Study||54
4998360|NCT02356211|12299305|P2|STARTED|Overall Study||52
4998361|NCT02356211|12299306|P1|STARTED|Overall Study||57
4998362|NCT02356198|12299314|P2|NOT COMPLETED|Overall Study||7
4998363|NCT02356198|12299315|P1|NOT COMPLETED|Overall Study||2
4998364|NCT02356198|12299314|P2|COMPLETED|Overall Study||98
4998365|NCT02356198|12299315|P1|COMPLETED|Overall Study||102
4998366|NCT02356198|12299314|P2|STARTED|Overall Study||105
4998367|NCT02356198|12299315|P1|STARTED|Overall Study||104
4998368|NCT02356107|12299329|P1|NOT COMPLETED|Overall Study||3
4998369|NCT02356107|12299329|P1|COMPLETED|Overall Study||12
4998370|NCT02356107|12299329|P1|STARTED|Overall Study||15
4998371|NCT02356003|12299333|P1|NOT COMPLETED|Overall Study||0
4998372|NCT02356003|12299333|P1|COMPLETED|Overall Study||10
4998373|NCT02356003|12299333|P1|STARTED|Overall Study||10
4998374|NCT02355977|12299341|P3|NOT COMPLETED|Overall Study||0
4998375|NCT02355977|12299342|P2|NOT COMPLETED|Overall Study||0
4998376|NCT02355977|12299343|P1|NOT COMPLETED|Overall Study||0
4998377|NCT02355977|12299341|P3|COMPLETED|Overall Study||23
4998378|NCT02355977|12299342|P2|COMPLETED|Overall Study||26
4998379|NCT02355977|12299343|P1|COMPLETED|Overall Study||21
4998380|NCT02355977|12299341|P3|STARTED|Overall Study||23
4998381|NCT02355977|12299342|P2|STARTED|Overall Study||26
4998382|NCT02355977|12299343|P1|STARTED|Overall Study||21
4998383|NCT02355886|12299359|P2|NOT COMPLETED|Overall Study||0
4998384|NCT02355886|12299360|P1|NOT COMPLETED|Overall Study||0
4998385|NCT02355886|12299359|P2|COMPLETED|Overall Study||12
4998386|NCT02355886|12299360|P1|COMPLETED|Overall Study||13
4998387|NCT02355886|12299359|P2|STARTED|Overall Study||12
4998388|NCT02355886|12299360|P1|STARTED|Overall Study||13
4998389|NCT02355743|12299370|P1|NOT COMPLETED|Overall Study||2
4998390|NCT02355743|12299370|P1|COMPLETED|Overall Study||6
4998391|NCT02355743|12299370|P1|STARTED|Overall Study||8
4998392|NCT02355691|12299378|P2|NOT COMPLETED|Overall Study||9
4998393|NCT02355691|12299379|P1|NOT COMPLETED|Overall Study||7
4998394|NCT02355691|12299378|P2|COMPLETED|Overall Study||0
4998395|NCT02355691|12299379|P1|COMPLETED|Overall Study||0
4998396|NCT02355691|12299378|P2|2nd Postop Visit|Overall Study||9
4998397|NCT02355691|12299379|P1|2nd Postop Visit|Overall Study||7
4998398|NCT02355691|12299378|P2|1st Postop Visit|Overall Study||9
4998399|NCT02355691|12299379|P1|1st Postop Visit|Overall Study||7
4998400|NCT02355691|12299378|P2|STARTED|Overall Study||9
4998401|NCT02355691|12299379|P1|STARTED|Overall Study||7
4998402|NCT02355665|12299389|P2|NOT COMPLETED|Overall Study||232
4998403|NCT02355665|12299390|P1|NOT COMPLETED|Overall Study||249
4998404|NCT02355665|12299389|P2|COMPLETED|Overall Study||365
4998405|NCT02355665|12299390|P1|COMPLETED|Overall Study||352
4998406|NCT02355665|12299389|P2|STARTED|Overall Study||597
4998407|NCT02355665|12299390|P1|STARTED|Overall Study||601
4998408|NCT02355275|12299822|P1|NOT COMPLETED|Overall Study||8
4998409|NCT02355275|12299822|P1|COMPLETED|Overall Study||14
4998410|NCT02355275|12299822|P1|STARTED|Overall Study||22
4998411|NCT02355158|12299827|P1|NOT COMPLETED|Overall Study||150
4998412|NCT02355158|12299827|P1|COMPLETED|Overall Study||47
4998413|NCT02355158|12299827|P1|STARTED|Overall Study||197
4998414|NCT02355067|12299833|P2|NOT COMPLETED|Overall Study||8
4998415|NCT02355067|12299834|P1|NOT COMPLETED|Overall Study||8
4998416|NCT02355067|12299833|P2|COMPLETED|Overall Study||12
4998417|NCT02355067|12299834|P1|COMPLETED|Overall Study||12
4998418|NCT02355067|12299833|P2|STARTED|Overall Study||20
4998419|NCT02355067|12299834|P1|STARTED|Overall Study||20
4998420|NCT02355028|12299848|P2|NOT COMPLETED|Overall Study||5
4998421|NCT02355028|12299849|P1|NOT COMPLETED|Overall Study||11
4998422|NCT02355028|12299848|P2|COMPLETED|Overall Study||41
4998423|NCT02355028|12299849|P1|COMPLETED|Overall Study||36
4998424|NCT02355028|12299848|P2|Treated|Overall Study||45
4998425|NCT02355028|12299849|P1|Treated|Overall Study||46
4998426|NCT02355028|12299848|P2|STARTED|Overall Study||46
4998427|NCT02355028|12299849|P1|STARTED|Overall Study||47
4998428|NCT02354976|12299885|P3|NOT COMPLETED|Overall Study||3
4998429|NCT02354976|12299886|P2|NOT COMPLETED|Overall Study||1
4998430|NCT02354976|12299887|P1|NOT COMPLETED|Overall Study||2
4998431|NCT02354976|12299885|P3|COMPLETED|Overall Study||23
4998432|NCT02354976|12299886|P2|COMPLETED|Overall Study||26
4998433|NCT02354976|12299887|P1|COMPLETED|Overall Study||23
4998434|NCT02354976|12299885|P3|STARTED|Overall Study||26
4998435|NCT02354976|12299886|P2|STARTED|Overall Study||27
4998436|NCT02354976|12299887|P1|STARTED|Overall Study||25
4998437|NCT02354924|12299898|P2|NOT COMPLETED|Overall Study||0
4998438|NCT02354924|12299899|P1|NOT COMPLETED|Overall Study||0
4998439|NCT02354924|12299898|P2|COMPLETED|Overall Study||20
4998440|NCT02354924|12299899|P1|COMPLETED|Overall Study||40
4998441|NCT02354924|12299898|P2|STARTED|Overall Study||20
4998442|NCT02354924|12299899|P1|STARTED|Overall Study||40
4998443|NCT02354859|12299911|P2|NOT COMPLETED|Overall Study||2
4998444|NCT02354859|12299912|P1|NOT COMPLETED|Overall Study||0
4998445|NCT02354859|12299911|P2|COMPLETED|Overall Study||57
4998446|NCT02354859|12299912|P1|COMPLETED|Overall Study||60
4998447|NCT02354859|12299911|P2|STARTED|Overall Study||59
4998448|NCT02354859|12299912|P1|STARTED|Overall Study||60
4998449|NCT02354833|12299930|P2|NOT COMPLETED|Overall Study||0
4998450|NCT02354833|12299931|P1|NOT COMPLETED|Overall Study||0
4998451|NCT02354833|12299930|P2|COMPLETED|Overall Study||43
4998452|NCT02354833|12299931|P1|COMPLETED|Overall Study||38
4998453|NCT02354833|12299930|P2|STARTED|Overall Study||43
4998454|NCT02354833|12299931|P1|STARTED|Overall Study||38
4998455|NCT02354781|12299943|P1|NOT COMPLETED|Overall Study||0
4998456|NCT02354781|12299943|P1|COMPLETED|Overall Study||3
4998457|NCT02354781|12299943|P1|STARTED|Overall Study||3
4998458|NCT02354690|12299950|P1|NOT COMPLETED|Overall Study||1
4998459|NCT02354690|12299950|P1|COMPLETED|Overall Study||12
4998460|NCT02354690|12299950|P1|STARTED|Overall Study||13
4998461|NCT02354599|12299964|P6|NOT COMPLETED|Overall Study||1
4998462|NCT02354599|12299965|P5|NOT COMPLETED|Overall Study||0
4998463|NCT02354599|12299966|P4|NOT COMPLETED|Overall Study||0
4998464|NCT02354599|12299967|P3|NOT COMPLETED|Overall Study||0
4998465|NCT02354599|12299968|P2|NOT COMPLETED|Overall Study||1
4998466|NCT02354599|12299969|P1|NOT COMPLETED|Overall Study||1
4998467|NCT02354599|12299964|P6|COMPLETED|Overall Study||5
4998468|NCT02354599|12299965|P5|COMPLETED|Overall Study||2
4998469|NCT02354599|12299966|P4|COMPLETED|Overall Study||6
4998470|NCT02354599|12299967|P3|COMPLETED|Overall Study||6
4998471|NCT02354599|12299968|P2|COMPLETED|Overall Study||5
4998472|NCT02354599|12299969|P1|COMPLETED|Overall Study||5
4998473|NCT02354599|12299964|P6|STARTED|Overall Study||6
4998474|NCT02354599|12299965|P5|STARTED|Overall Study||2
4998475|NCT02354599|12299966|P4|STARTED|Overall Study||6
4998476|NCT02354599|12299967|P3|STARTED|Overall Study||6
4998477|NCT02354599|12299968|P2|STARTED|Overall Study||6
4998478|NCT02354599|12299969|P1|STARTED|Overall Study||6
4998479|NCT02354586|12300039|P1|NOT COMPLETED|Overall Study||341
4998480|NCT02354586|12300039|P1|COMPLETED|Overall Study||122
4998481|NCT02354586|12300039|P1|Ongoing in Study|Overall Study||21
4998482|NCT02354586|12300039|P1|STARTED|Overall Study||463
4998483|NCT02354508|12300058|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
4998484|NCT02354508|12300059|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
4998485|NCT02354508|12300060|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
4998486|NCT02354508|12300058|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
4998487|NCT02354508|12300059|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
4998488|NCT02354508|12300060|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
4998489|NCT02354508|12300058|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
4998490|NCT02354508|12300059|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
4998491|NCT02354508|12300060|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
4998492|NCT02354508|12300058|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
4998493|NCT02354508|12300059|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
4998494|NCT02354508|12300060|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
4998495|NCT02354508|12300058|P3|NOT COMPLETED|Period 2: Extension Phase||3
4998496|NCT02354508|12300059|P2|NOT COMPLETED|Period 2: Extension Phase||4
4998497|NCT02354508|12300060|P1|NOT COMPLETED|Period 2: Extension Phase||6
4998498|NCT02354508|12300058|P3|COMPLETED|Period 2: Extension Phase||36
4998499|NCT02354508|12300059|P2|COMPLETED|Period 2: Extension Phase||19
4998500|NCT02354508|12300060|P1|COMPLETED|Period 2: Extension Phase||20
4998501|NCT02354508|12300058|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
4998502|NCT02354508|12300059|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
4998503|NCT02354508|12300060|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
4998504|NCT02354508|12300058|P3|NOT COMPLETED|Period 1: Core Phase||6
4998505|NCT02354508|12300059|P2|NOT COMPLETED|Period 1: Core Phase||2
4998506|NCT02354508|12300060|P1|NOT COMPLETED|Period 1: Core Phase||2
4998507|NCT02354508|12300058|P3|COMPLETED|Period 1: Core Phase||47
4998508|NCT02354508|12300059|P2|COMPLETED|Period 1: Core Phase||27
4998509|NCT02354508|12300060|P1|COMPLETED|Period 1: Core Phase||39
4998510|NCT02354508|12300058|P3|STARTED|Period 1: Core Phase||53
4998511|NCT02354508|12300059|P2|STARTED|Period 1: Core Phase||29
4998512|NCT02354508|12300060|P1|STARTED|Period 1: Core Phase||41
4998513|NCT02354482|12300138|P1|NOT COMPLETED|Reference||0
4998514|NCT02354482|12300138|P1|COMPLETED|Reference||2042
4998515|NCT02354482|12300138|P1|STARTED|Reference||2042
4998516|NCT02354482|12300138|P1|NOT COMPLETED|Assessment and Teach Back||0
4998517|NCT02354482|12300138|P1|COMPLETED|Assessment and Teach Back||508
4998518|NCT02354482|12300138|P1|STARTED|Assessment and Teach Back||508
4998519|NCT02354482|12300138|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
4998520|NCT02354482|12300138|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
4998521|NCT02354482|12300138|P1|STARTED|Patient/Family Caregiver Assessment||3093
4998522|NCT02354482|12300138|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
4998523|NCT02354482|12300138|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
4998524|NCT02354482|12300138|P1|STARTED|Hospital-Based Trust and Plain Language||2090
4998525|NCT02354482|12300138|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
4998526|NCT02354482|12300138|P1|COMPLETED|Home-Based Trust and Plain Language||1979
4998527|NCT02354482|12300138|P1|STARTED|Home-Based Trust and Plain Language||1979
4998528|NCT02354482|12300138|P1|NOT COMPLETED|Patient Communication and Care||0
4998529|NCT02354482|12300138|P1|COMPLETED|Patient Communication and Care||2158
4998530|NCT02354482|12300138|P1|STARTED|Patient Communication and Care||2158
4998531|NCT02354443|12300158|P1|NOT COMPLETED|Overall Study||0
4998532|NCT02354443|12300158|P1|COMPLETED|Overall Study||1
4998533|NCT02354443|12300158|P1|STARTED|Overall Study||1
4998534|NCT02354417|12300162|P1|NOT COMPLETED|Overall Study||1
4998535|NCT02354417|12300162|P1|COMPLETED|Overall Study||2
4998536|NCT02354417|12300162|P1|STARTED|Overall Study||3
4998537|NCT02354378|12300168|P2|NOT COMPLETED|Overall Study||4
4998538|NCT02354378|12300169|P1|NOT COMPLETED|Overall Study||34
4998539|NCT02354378|12300168|P2|COMPLETED|Overall Study||16
4998540|NCT02354378|12300169|P1|COMPLETED|Overall Study||30
4998541|NCT02354378|12300168|P2|STARTED|Overall Study||20
4998542|NCT02354378|12300169|P1|STARTED|Overall Study||64
4998543|NCT02354352|12300179|P2|NOT COMPLETED|Overall Study||3
4998544|NCT02354352|12300180|P1|NOT COMPLETED|Overall Study||3
4998545|NCT02354352|12300179|P2|COMPLETED|Overall Study||23
4998546|NCT02354352|12300180|P1|COMPLETED|Overall Study||23
4998547|NCT02354352|12300179|P2|9 Months|Overall Study||23
4998548|NCT02354352|12300180|P1|9 Months|Overall Study||25
4998549|NCT02354352|12300179|P2|6 Months|Overall Study||23
4998550|NCT02354352|12300180|P1|6 Months|Overall Study||25
4998551|NCT02354352|12300179|P2|3 Months|Overall Study||23
4998552|NCT02354352|12300180|P1|3 Months|Overall Study||25
4998553|NCT02354352|12300179|P2|2 Months|Overall Study||22
4998554|NCT02354352|12300180|P1|2 Months|Overall Study||24
4998555|NCT02354352|12300179|P2|1 Month|Overall Study||23
4998556|NCT02354352|12300180|P1|1 Month|Overall Study||24
4998557|NCT02354352|12300179|P2|2 Weeks|Overall Study||25
4998558|NCT02354352|12300180|P1|2 Weeks|Overall Study||26
4998559|NCT02354352|12300179|P2|STARTED|Overall Study||26
4998560|NCT02354352|12300180|P1|STARTED|Overall Study||26
4998561|NCT02354235|12300188|P2|NOT COMPLETED|Overall Study||7
4998562|NCT02354235|12300189|P1|NOT COMPLETED|Overall Study||3
4998563|NCT02354235|12300188|P2|COMPLETED|Overall Study||61
4998564|NCT02354235|12300189|P1|COMPLETED|Overall Study||67
4998565|NCT02354235|12300188|P2|STARTED|Overall Study||68
4998566|NCT02354235|12300189|P1|STARTED|Overall Study||70
4998567|NCT02354222|12300205|P2|NOT COMPLETED|Overall Study||11
4998568|NCT02354222|12300206|P1|NOT COMPLETED|Overall Study||4
4998569|NCT02354222|12300205|P2|COMPLETED|Overall Study||66
4998570|NCT02354222|12300206|P1|COMPLETED|Overall Study||73
4998571|NCT02354222|12300205|P2|STARTED|Overall Study||77
4998572|NCT02354222|12300206|P1|STARTED|Overall Study||77
4998573|NCT02354092|12300222|P2|NOT COMPLETED|Overall Study||0
4998574|NCT02354092|12300223|P1|NOT COMPLETED|Overall Study||0
4998575|NCT02354092|12300222|P2|COMPLETED|Overall Study||7
4998576|NCT02354092|12300223|P1|COMPLETED|Overall Study||7
4998577|NCT02354092|12300222|P2|STARTED|Overall Study||7
4998578|NCT02354092|12300223|P1|STARTED|Overall Study||7
4998579|NCT02353871|12300237|P2|NOT COMPLETED|Overall Study||9
4998580|NCT02353871|12300238|P1|NOT COMPLETED|Overall Study||3
4998581|NCT02353871|12300237|P2|COMPLETED|Overall Study||51
4998582|NCT02353871|12300238|P1|COMPLETED|Overall Study||122
4998583|NCT02353871|12300237|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
4998584|NCT02353871|12300238|P1|STARTED|Overall Study|Randomised.|125
4998585|NCT02353832|12300258|P1|NOT COMPLETED|Overall Study||0
4998586|NCT02353832|12300258|P1|COMPLETED|Overall Study||44
4998587|NCT02353832|12300258|P1|STARTED|Overall Study||44
4998588|NCT02353806|12300263|P1|NOT COMPLETED|Overall Study||10
4998589|NCT02353806|12300263|P1|COMPLETED|Overall Study||6
4998590|NCT02353806|12300263|P1|STARTED|Overall Study||16
4998591|NCT02353754|12300280|P2|NOT COMPLETED|Overall Study||0
4998592|NCT02353754|12300281|P1|NOT COMPLETED|Overall Study||2
4998593|NCT02353754|12300280|P2|COMPLETED|Overall Study||0
4998594|NCT02353754|12300281|P1|COMPLETED|Overall Study||10
4998595|NCT02353754|12300280|P2|STARTED|Overall Study||0
4998596|NCT02353754|12300281|P1|STARTED|Overall Study||12
4998597|NCT02353572|12300291|P1|NOT COMPLETED|Overall Study||3
4998598|NCT02353572|12300291|P1|COMPLETED|Overall Study||0
4998599|NCT02353572|12300291|P1|STARTED|Overall Study||3
4998600|NCT02353468|12300295|P1|NOT COMPLETED|Overall Study||3
4998601|NCT02353468|12300295|P1|COMPLETED|Overall Study||0
4998602|NCT02353468|12300295|P1|STARTED|Overall Study||3
4998603|NCT02353442|12300301|P2|NOT COMPLETED|Overall Study||4
4998604|NCT02353442|12300302|P1|NOT COMPLETED|Overall Study||3
4998605|NCT02353442|12300301|P2|COMPLETED|Overall Study||27
4998606|NCT02353442|12300302|P1|COMPLETED|Overall Study||25
4998607|NCT02353442|12300301|P2|STARTED|Overall Study||31
4998608|NCT02353442|12300302|P1|STARTED|Overall Study||28
4998609|NCT02353299|12300316|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
4998610|NCT02353299|12300317|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
4998611|NCT02353299|12300318|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
4998612|NCT02353299|12300319|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
4998613|NCT02353299|12300316|P4|COMPLETED|Fourth Intervention (1 Night)||13
4998614|NCT02353299|12300317|P3|COMPLETED|Fourth Intervention (1 Night)||13
4998615|NCT02353299|12300318|P2|COMPLETED|Fourth Intervention (1 Night)||12
4998616|NCT02353299|12300319|P1|COMPLETED|Fourth Intervention (1 Night)||13
4998617|NCT02353299|12300316|P4|STARTED|Fourth Intervention (1 Night)||13
4998618|NCT02353299|12300317|P3|STARTED|Fourth Intervention (1 Night)||13
4998619|NCT02353299|12300318|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
4998620|NCT02353299|12300319|P1|STARTED|Fourth Intervention (1 Night)||13
4998621|NCT02353299|12300316|P4|NOT COMPLETED|Third Intervention (1 Night)||0
4998622|NCT02353299|12300317|P3|NOT COMPLETED|Third Intervention (1 Night)||0
4998623|NCT02353299|12300318|P2|NOT COMPLETED|Third Intervention (1 Night)||0
4998624|NCT02353299|12300319|P1|NOT COMPLETED|Third Intervention (1 Night)||0
4998625|NCT02353299|12300316|P4|COMPLETED|Third Intervention (1 Night)||13
4998626|NCT02353299|12300317|P3|COMPLETED|Third Intervention (1 Night)||13
4998627|NCT02353299|12300318|P2|COMPLETED|Third Intervention (1 Night)||13
4998628|NCT02353299|12300319|P1|COMPLETED|Third Intervention (1 Night)||13
4998629|NCT02353299|12300316|P4|STARTED|Third Intervention (1 Night)||13
4998630|NCT02353299|12300317|P3|STARTED|Third Intervention (1 Night)||13
4998631|NCT02353299|12300318|P2|STARTED|Third Intervention (1 Night)||13
4998632|NCT02353299|12300319|P1|STARTED|Third Intervention (1 Night)||13
4998633|NCT02353299|12300316|P4|NOT COMPLETED|Second Intervention (1 Night)||0
4998634|NCT02353299|12300317|P3|NOT COMPLETED|Second Intervention (1 Night)||0
4998635|NCT02353299|12300318|P2|NOT COMPLETED|Second Intervention (1 Night)||0
4998636|NCT02353299|12300319|P1|NOT COMPLETED|Second Intervention (1 Night)||0
4998637|NCT02353299|12300316|P4|COMPLETED|Second Intervention (1 Night)||13
4998638|NCT02353299|12300317|P3|COMPLETED|Second Intervention (1 Night)||13
4998639|NCT02353299|12300318|P2|COMPLETED|Second Intervention (1 Night)||13
4998640|NCT02353299|12300319|P1|COMPLETED|Second Intervention (1 Night)||13
4998641|NCT02353299|12300316|P4|STARTED|Second Intervention (1 Night)||13
4998642|NCT02353299|12300317|P3|STARTED|Second Intervention (1 Night)||13
4998643|NCT02353299|12300318|P2|STARTED|Second Intervention (1 Night)||13
4998644|NCT02353299|12300319|P1|STARTED|Second Intervention (1 Night)||13
4998645|NCT02353299|12300316|P4|NOT COMPLETED|First Intervention (1 Night)||0
4998646|NCT02353299|12300317|P3|NOT COMPLETED|First Intervention (1 Night)||0
4998647|NCT02353299|12300318|P2|NOT COMPLETED|First Intervention (1 Night)||0
4998648|NCT02353299|12300319|P1|NOT COMPLETED|First Intervention (1 Night)||0
4998649|NCT02353299|12300316|P4|COMPLETED|First Intervention (1 Night)||13
4998650|NCT02353299|12300317|P3|COMPLETED|First Intervention (1 Night)||13
4998651|NCT02353299|12300318|P2|COMPLETED|First Intervention (1 Night)||13
4998652|NCT02353299|12300319|P1|COMPLETED|First Intervention (1 Night)||13
4998653|NCT02353299|12300316|P4|STARTED|First Intervention (1 Night)||13
4998654|NCT02353299|12300317|P3|STARTED|First Intervention (1 Night)||13
4998655|NCT02353299|12300318|P2|STARTED|First Intervention (1 Night)||13
4998656|NCT02353299|12300319|P1|STARTED|First Intervention (1 Night)||13
4998657|NCT02353169|12300357|P4|NOT COMPLETED|Overall Study||3
4998658|NCT02353169|12300358|P3|NOT COMPLETED|Overall Study||4
4998659|NCT02353169|12300359|P2|NOT COMPLETED|Overall Study||6
4998660|NCT02353169|12300360|P1|NOT COMPLETED|Overall Study||3
4998661|NCT02353169|12300357|P4|COMPLETED|Overall Study||12
4998662|NCT02353169|12300358|P3|COMPLETED|Overall Study||12
4998663|NCT02353169|12300359|P2|COMPLETED|Overall Study||12
4998664|NCT02353169|12300360|P1|COMPLETED|Overall Study||12
4998665|NCT02353169|12300357|P4|STARTED|Overall Study||15
4998666|NCT02353169|12300358|P3|STARTED|Overall Study||16
4998667|NCT02353169|12300359|P2|STARTED|Overall Study||18
4998668|NCT02353169|12300360|P1|STARTED|Overall Study||15
4998669|NCT02353091|12300380|P2|NOT COMPLETED|Overall Study||0
4998670|NCT02353091|12300381|P1|NOT COMPLETED|Overall Study||0
4998671|NCT02353091|12300380|P2|COMPLETED|Overall Study||13
4998672|NCT02353091|12300381|P1|COMPLETED|Overall Study||13
4998673|NCT02353091|12300380|P2|STARTED|Overall Study||13
4998674|NCT02353091|12300381|P1|STARTED|Overall Study||13
4998675|NCT02352974|12300419|P1|NOT COMPLETED|Extension||0
4998676|NCT02352974|12300419|P1|COMPLETED|Extension||3
4998677|NCT02352974|12300419|P1|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
4998678|NCT02352974|12300419|P1|NOT COMPLETED|Main Study||0
4998679|NCT02352974|12300419|P1|COMPLETED|Main Study||12
4998680|NCT02352974|12300419|P1|STARTED|Main Study||12
4998681|NCT02352948|12300452|P6|NOT COMPLETED|Overall Study||49
4998682|NCT02352948|12300453|P5|NOT COMPLETED|Overall Study||88
4998683|NCT02352948|12300454|P4|NOT COMPLETED|Overall Study||99
4998684|NCT02352948|12300455|P3|NOT COMPLETED|Overall Study||129
4998685|NCT02352948|12300456|P2|NOT COMPLETED|Overall Study||59
4998686|NCT02352948|12300457|P1|NOT COMPLETED|Overall Study||49
4998687|NCT02352948|12300452|P6|COMPLETED|Overall Study||11
4998688|NCT02352948|12300453|P5|COMPLETED|Overall Study||29
4998689|NCT02352948|12300454|P4|COMPLETED|Overall Study||19
4998690|NCT02352948|12300455|P3|COMPLETED|Overall Study||45
4998691|NCT02352948|12300456|P2|COMPLETED|Overall Study||5
4998692|NCT02352948|12300457|P1|COMPLETED|Overall Study||13
4998693|NCT02352948|12300452|P6|Completed Study Treatment|Overall Study||4
4998694|NCT02352948|12300453|P5|Completed Study Treatment|Overall Study||23
4998695|NCT02352948|12300454|P4|Completed Study Treatment|Overall Study||0
4998696|NCT02352948|12300455|P3|Completed Study Treatment|Overall Study||36
4998697|NCT02352948|12300456|P2|Completed Study Treatment|Overall Study||0
4998698|NCT02352948|12300457|P1|Completed Study Treatment|Overall Study||15
4998699|NCT02352948|12300452|P6|Received Treatment|Overall Study||60
4998700|NCT02352948|12300453|P5|Received Treatment|Overall Study||117
4998701|NCT02352948|12300454|P4|Received Treatment|Overall Study||110
4998702|NCT02352948|12300455|P3|Received Treatment|Overall Study||173
4998703|NCT02352948|12300456|P2|Received Treatment|Overall Study||63
4998704|NCT02352948|12300457|P1|Received Treatment|Overall Study||62
4998705|NCT02352948|12300452|P6|STARTED|Overall Study||60
4998706|NCT02352948|12300453|P5|STARTED|Overall Study||117
4998707|NCT02352948|12300454|P4|STARTED|Overall Study||118
4998708|NCT02352948|12300455|P3|STARTED|Overall Study||174
4998709|NCT02352948|12300456|P2|STARTED|Overall Study||64
4998710|NCT02352948|12300457|P1|STARTED|Overall Study||62
4998711|NCT02352844|12300513|P1|NOT COMPLETED|Overall Study||0
4998712|NCT02352844|12300513|P1|COMPLETED|Overall Study||12
4998713|NCT02352844|12300513|P1|STARTED|Overall Study||12
4998714|NCT02352831|12300521|P2|NOT COMPLETED|Overall Study||0
4998715|NCT02352831|12300522|P1|NOT COMPLETED|Overall Study||0
4998716|NCT02352831|12300521|P2|COMPLETED|Overall Study||10
4998717|NCT02352831|12300522|P1|COMPLETED|Overall Study||6
4998718|NCT02352831|12300521|P2|STARTED|Overall Study||10
4998719|NCT02352831|12300522|P1|STARTED|Overall Study||6
4998720|NCT02352779|12300545|P3|NOT COMPLETED|Overall Study||2
4998721|NCT02352779|12300546|P2|NOT COMPLETED|Overall Study||1
4998722|NCT02352779|12300547|P1|NOT COMPLETED|Overall Study||8
4998723|NCT02352779|12300545|P3|COMPLETED|Overall Study||33
4998724|NCT02352779|12300546|P2|COMPLETED|Overall Study||35
4998725|NCT02352779|12300547|P1|COMPLETED|Overall Study||29
4998726|NCT02352779|12300545|P3|STARTED|Overall Study||35
4998727|NCT02352779|12300546|P2|STARTED|Overall Study||36
4998728|NCT02352779|12300547|P1|STARTED|Overall Study||37
4998729|NCT02352493|12300573|P18|NOT COMPLETED|Overall Study||0
4998730|NCT02352493|12300574|P17|NOT COMPLETED|Overall Study||0
4998731|NCT02352493|12300575|P16|NOT COMPLETED|Overall Study||0
4998732|NCT02352493|12300576|P15|NOT COMPLETED|Overall Study||1
4998733|NCT02352493|12300577|P14|NOT COMPLETED|Overall Study||2
4998734|NCT02352493|12300578|P13|NOT COMPLETED|Overall Study||1
4998735|NCT02352493|12300579|P12|NOT COMPLETED|Overall Study||0
4998736|NCT02352493|12300580|P11|NOT COMPLETED|Overall Study||0
4998737|NCT02352493|12300581|P10|NOT COMPLETED|Overall Study||1
4998738|NCT02352493|12300582|P9|NOT COMPLETED|Overall Study||2
4998739|NCT02352493|12300583|P8|NOT COMPLETED|Overall Study||0
4998740|NCT02352493|12300584|P7|NOT COMPLETED|Overall Study||1
4998741|NCT02352493|12300585|P6|NOT COMPLETED|Overall Study||0
4998742|NCT02352493|12300586|P5|NOT COMPLETED|Overall Study||0
4998743|NCT02352493|12300587|P4|NOT COMPLETED|Overall Study||0
4998744|NCT02352493|12300588|P3|NOT COMPLETED|Overall Study||0
4998745|NCT02352493|12300589|P2|NOT COMPLETED|Overall Study||0
4998746|NCT02352493|12300590|P1|NOT COMPLETED|Overall Study||0
4998747|NCT02352493|12300573|P18|COMPLETED|Overall Study||3
4998748|NCT02352493|12300574|P17|COMPLETED|Overall Study||3
4998749|NCT02352493|12300575|P16|COMPLETED|Overall Study||3
4998750|NCT02352493|12300576|P15|COMPLETED|Overall Study||2
4998751|NCT02352493|12300577|P14|COMPLETED|Overall Study||1
4998752|NCT02352493|12300578|P13|COMPLETED|Overall Study||2
4998753|NCT02352493|12300579|P12|COMPLETED|Overall Study||3
4998754|NCT02352493|12300580|P11|COMPLETED|Overall Study||3
4998755|NCT02352493|12300581|P10|COMPLETED|Overall Study||5
4998756|NCT02352493|12300582|P9|COMPLETED|Overall Study||1
4998757|NCT02352493|12300583|P8|COMPLETED|Overall Study||3
4998758|NCT02352493|12300584|P7|COMPLETED|Overall Study||2
4998759|NCT02352493|12300585|P6|COMPLETED|Overall Study||3
4998760|NCT02352493|12300586|P5|COMPLETED|Overall Study||3
4998761|NCT02352493|12300587|P4|COMPLETED|Overall Study||3
4998762|NCT02352493|12300588|P3|COMPLETED|Overall Study||3
4998763|NCT02352493|12300589|P2|COMPLETED|Overall Study||3
4998764|NCT02352493|12300590|P1|COMPLETED|Overall Study||8
4998765|NCT02352493|12300573|P18|STARTED|Overall Study||3
4998766|NCT02352493|12300574|P17|STARTED|Overall Study||3
4998767|NCT02352493|12300575|P16|STARTED|Overall Study||3
4998768|NCT02352493|12300576|P15|STARTED|Overall Study||3
4998769|NCT02352493|12300577|P14|STARTED|Overall Study||3
4998770|NCT02352493|12300578|P13|STARTED|Overall Study||3
4998771|NCT02352493|12300579|P12|STARTED|Overall Study||3
4998772|NCT02352493|12300580|P11|STARTED|Overall Study||3
4998773|NCT02352493|12300581|P10|STARTED|Overall Study||6
4998774|NCT02352493|12300582|P9|STARTED|Overall Study||3
4998775|NCT02352493|12300583|P8|STARTED|Overall Study||3
4998776|NCT02352493|12300584|P7|STARTED|Overall Study||3
4998777|NCT02352493|12300585|P6|STARTED|Overall Study||3
4998778|NCT02352493|12300586|P5|STARTED|Overall Study||3
4998779|NCT02352493|12300587|P4|STARTED|Overall Study||3
4998780|NCT02352493|12300588|P3|STARTED|Overall Study||3
4998781|NCT02352493|12300589|P2|STARTED|Overall Study||3
4998782|NCT02352493|12300590|P1|STARTED|Overall Study||8
4998783|NCT02352363|12300780|P2|NOT COMPLETED|Overall Study||3
4998784|NCT02352363|12300781|P1|NOT COMPLETED|Overall Study||7
4998785|NCT02352363|12300780|P2|COMPLETED|Overall Study||127
4998786|NCT02352363|12300781|P1|COMPLETED|Overall Study||271
4998787|NCT02352363|12300780|P2|STARTED|Overall Study||130
4998788|NCT02352363|12300781|P1|STARTED|Overall Study||278
4998789|NCT02352298|12300793|P1|NOT COMPLETED|Overall Study||0
4998790|NCT02352298|12300793|P1|COMPLETED|Overall Study||52
4998791|NCT02352298|12300793|P1|STARTED|Overall Study||52
4998792|NCT02352103|12300800|P2|NOT COMPLETED|Overall Study||1
4998793|NCT02352103|12300801|P1|NOT COMPLETED|Overall Study||0
4998794|NCT02352103|12300800|P2|COMPLETED|Overall Study||59
4998795|NCT02352103|12300801|P1|COMPLETED|Overall Study||60
4998796|NCT02352103|12300800|P2|STARTED|Overall Study||60
4998797|NCT02352103|12300801|P1|STARTED|Overall Study||60
4998798|NCT02351960|12300823|P2|NOT COMPLETED|Overall Study||12
4998799|NCT02351960|12300824|P1|NOT COMPLETED|Overall Study||11
4998800|NCT02351960|12300823|P2|COMPLETED|Overall Study||76
4998801|NCT02351960|12300824|P1|COMPLETED|Overall Study||197
4998802|NCT02351960|12300823|P2|STARTED|Overall Study||88
4998803|NCT02351960|12300824|P1|STARTED|Overall Study||208
4998804|NCT02351934|12300845|P2|NOT COMPLETED|Follow-Up||10
4998805|NCT02351934|12300846|P1|NOT COMPLETED|Follow-Up||12
4998806|NCT02351934|12300845|P2|COMPLETED|Follow-Up||51
4998807|NCT02351934|12300846|P1|COMPLETED|Follow-Up||44
4998808|NCT02351934|12300845|P2|STARTED|Follow-Up||61
4998809|NCT02351934|12300846|P1|STARTED|Follow-Up||56
4998810|NCT02351934|12300845|P2|NOT COMPLETED|Allocation||0
4998811|NCT02351934|12300846|P1|NOT COMPLETED|Allocation||6
4998812|NCT02351934|12300845|P2|COMPLETED|Allocation||61
4998813|NCT02351934|12300846|P1|COMPLETED|Allocation||56
4998814|NCT02351934|12300845|P2|Received Allocation|Allocation||61
4998815|NCT02351934|12300846|P1|Received Allocation|Allocation||56
4998816|NCT02351934|12300845|P2|STARTED|Allocation||61
4998817|NCT02351934|12300846|P1|STARTED|Allocation||62
4998818|NCT02351817|12300862|P2|NOT COMPLETED|Period 2||2
4998819|NCT02351817|12300863|P1|NOT COMPLETED|Period 2||1
4998820|NCT02351817|12300862|P2|COMPLETED|Period 2||3
4998821|NCT02351817|12300863|P1|COMPLETED|Period 2||4
4998822|NCT02351817|12300862|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
4998823|NCT02351817|12300863|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
4998824|NCT02351817|12300862|P2|NOT COMPLETED|Period 1||3
4998825|NCT02351817|12300863|P1|NOT COMPLETED|Period 1||1
4998826|NCT02351817|12300862|P2|COMPLETED|Period 1||2
4998827|NCT02351817|12300863|P1|COMPLETED|Period 1||4
4998828|NCT02351817|12300862|P2|STARTED|Period 1||5
4998829|NCT02351817|12300863|P1|STARTED|Period 1||5
4998830|NCT02351817|12300862|P2|NOT COMPLETED|Baseline Period||0
4998831|NCT02351817|12300863|P1|NOT COMPLETED|Baseline Period||0
4998832|NCT02351817|12300862|P2|COMPLETED|Baseline Period||5
4998833|NCT02351817|12300863|P1|COMPLETED|Baseline Period||5
4998834|NCT02351817|12300862|P2|STARTED|Baseline Period||5
4998835|NCT02351817|12300863|P1|STARTED|Baseline Period||5
4998836|NCT02351739|12300872|P2|NOT COMPLETED|Overall Study||40
4998837|NCT02351739|12300873|P1|NOT COMPLETED|Overall Study||38
4998838|NCT02351739|12300872|P2|COMPLETED|Overall Study||0
4998839|NCT02351739|12300873|P1|COMPLETED|Overall Study||0
4998840|NCT02351739|12300872|P2|Discontinued Study|Overall Study||40
4998841|NCT02351739|12300873|P1|Discontinued Study|Overall Study||38
4998842|NCT02351739|12300872|P2|Received Study Medication|Overall Study||40
4998843|NCT02351739|12300873|P1|Received Study Medication|Overall Study||35
4998844|NCT02351739|12300872|P2|Enrolled|Overall Study||40
4998845|NCT02351739|12300873|P1|Enrolled|Overall Study||38
4998846|NCT02351739|12300872|P2|STARTED|Overall Study||40
4998847|NCT02351739|12300873|P1|STARTED|Overall Study||38
4998848|NCT02351505|12300879|P1|NOT COMPLETED|Overall Study||0
4998849|NCT02351505|12300879|P1|COMPLETED|Overall Study||1
4998850|NCT02351505|12300879|P1|STARTED|Overall Study||1
4998851|NCT02351271|12300892|P2|NOT COMPLETED|Overall Study||0
4998852|NCT02351271|12300893|P1|NOT COMPLETED|Overall Study||0
4998853|NCT02351271|12300892|P2|COMPLETED|Overall Study||62
4998854|NCT02351271|12300893|P1|COMPLETED|Overall Study||68
4998855|NCT02351271|12300892|P2|STARTED|Overall Study||62
4998856|NCT02351271|12300893|P1|STARTED|Overall Study||68
4998857|NCT02351258|12300905|P2|NOT COMPLETED|Intervention 2 (12 Months)||0
4998858|NCT02351258|12300906|P1|NOT COMPLETED|Intervention 2 (12 Months)||0
4998859|NCT02351258|12300905|P2|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998860|NCT02351258|12300906|P1|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998861|NCT02351258|12300905|P2|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998862|NCT02351258|12300906|P1|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998863|NCT02351258|12300905|P2|NOT COMPLETED|Washout (2-3 Months)||0
4998864|NCT02351258|12300906|P1|NOT COMPLETED|Washout (2-3 Months)||0
4998865|NCT02351258|12300905|P2|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998866|NCT02351258|12300906|P1|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998867|NCT02351258|12300905|P2|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998868|NCT02351258|12300906|P1|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998869|NCT02351258|12300905|P2|NOT COMPLETED|Intervention 1 (12 Months)||0
4998870|NCT02351258|12300906|P1|NOT COMPLETED|Intervention 1 (12 Months)||0
4998871|NCT02351258|12300905|P2|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998872|NCT02351258|12300906|P1|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998873|NCT02351258|12300905|P2|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998874|NCT02351258|12300906|P1|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
4998875|NCT02351167|12300924|P3|NOT COMPLETED|Overall Study||21
4998876|NCT02351167|12300925|P2|NOT COMPLETED|Overall Study||18
4998877|NCT02351167|12300926|P1|NOT COMPLETED|Overall Study||19
4998878|NCT02351167|12300924|P3|COMPLETED|Overall Study||252
4998879|NCT02351167|12300925|P2|COMPLETED|Overall Study||256
4998880|NCT02351167|12300926|P1|COMPLETED|Overall Study||256
4998881|NCT02351167|12300924|P3|STARTED|Overall Study||273
4998882|NCT02351167|12300925|P2|STARTED|Overall Study||274
4998883|NCT02351167|12300926|P1|STARTED|Overall Study||275
4998884|NCT02351063|12300952|P1|NOT COMPLETED|Overall Study||0
4998885|NCT02351063|12300952|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
4998886|NCT02351063|12300952|P1|STARTED|Overall Study||1
4998887|NCT02351037|12300959|P3|NOT COMPLETED|Overall Study||0
4998888|NCT02351037|12300960|P2|NOT COMPLETED|Overall Study||0
4998889|NCT02351037|12300961|P1|NOT COMPLETED|Overall Study||0
4998890|NCT02351037|12300959|P3|COMPLETED|Overall Study||8
4998891|NCT02351037|12300960|P2|COMPLETED|Overall Study||21
4998892|NCT02351037|12300961|P1|COMPLETED|Overall Study||7
4998893|NCT02351037|12300959|P3|STARTED|Overall Study||8
4998894|NCT02351037|12300960|P2|STARTED|Overall Study||21
4998895|NCT02351037|12300961|P1|STARTED|Overall Study||7
4998896|NCT02350881|12300969|P1|NOT COMPLETED|Overall Study||0
4998897|NCT02350881|12300969|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
4998898|NCT02350881|12300969|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
4998899|NCT02350816|12301001|P4|NOT COMPLETED|Overall Study||0
4998900|NCT02350816|12301002|P3|NOT COMPLETED|Overall Study||0
4998901|NCT02350816|12301003|P2|NOT COMPLETED|Overall Study||0
4998902|NCT02350816|12301004|P1|NOT COMPLETED|Overall Study||0
4998903|NCT02350816|12301001|P4|COMPLETED|Overall Study||2
4998904|NCT02350816|12301002|P3|COMPLETED|Overall Study||2
4998905|NCT02350816|12301003|P2|COMPLETED|Overall Study||6
4998906|NCT02350816|12301004|P1|COMPLETED|Overall Study||7
4998907|NCT02350816|12301001|P4|STARTED|Overall Study||2
4998908|NCT02350816|12301002|P3|STARTED|Overall Study||2
4998909|NCT02350816|12301003|P2|STARTED|Overall Study||6
4998910|NCT02350816|12301004|P1|STARTED|Overall Study||7
4998911|NCT02350777|12301048|P2|NOT COMPLETED|Overall Study||0
4998912|NCT02350777|12301049|P1|NOT COMPLETED|Overall Study||0
4998913|NCT02350777|12301048|P2|COMPLETED|Overall Study||2
4998914|NCT02350777|12301049|P1|COMPLETED|Overall Study||2
4998915|NCT02350777|12301048|P2|STARTED|Overall Study||2
4998916|NCT02350777|12301049|P1|STARTED|Overall Study||2
4998917|NCT02350647|12301057|P2|NOT COMPLETED|Overall Study||6
4998918|NCT02350647|12301058|P1|NOT COMPLETED|Overall Study||6
4998919|NCT02350647|12301057|P2|COMPLETED|Overall Study||26
4998920|NCT02350647|12301058|P1|COMPLETED|Overall Study||26
4998921|NCT02350647|12301057|P2|STARTED|Overall Study||32
4998922|NCT02350647|12301058|P1|STARTED|Overall Study||32
4998923|NCT02350569|12301070|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
4998924|NCT02350569|12301070|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
4998925|NCT02350569|12301070|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
4998926|NCT02350569|12301070|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
4998927|NCT02350569|12301070|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
4998928|NCT02350569|12301070|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
4998929|NCT02350478|12301082|P2|NOT COMPLETED|Overall Study||1
4998930|NCT02350478|12301083|P1|NOT COMPLETED|Overall Study||5
4998931|NCT02350478|12301082|P2|COMPLETED|Overall Study||23
4998932|NCT02350478|12301083|P1|COMPLETED|Overall Study||20
4998933|NCT02350478|12301082|P2|STARTED|Overall Study||24
4998934|NCT02350478|12301083|P1|STARTED|Overall Study||25
4998935|NCT02350309|12301105|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
4998936|NCT02350309|12301106|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4998937|NCT02350309|12301107|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4998938|NCT02350309|12301108|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4998939|NCT02350309|12301109|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4998940|NCT02350309|12301110|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
4998941|NCT02350309|12301105|P6|COMPLETED|Treatment Period 4 (2 Days)||11
4998942|NCT02350309|12301106|P5|COMPLETED|Treatment Period 4 (2 Days)||12
4998943|NCT02350309|12301107|P4|COMPLETED|Treatment Period 4 (2 Days)||11
4998944|NCT02350309|12301108|P3|COMPLETED|Treatment Period 4 (2 Days)||10
4998945|NCT02350309|12301109|P2|COMPLETED|Treatment Period 4 (2 Days)||11
4998946|NCT02350309|12301110|P1|COMPLETED|Treatment Period 4 (2 Days)||12
4998947|NCT02350309|12301105|P6|STARTED|Treatment Period 4 (2 Days)||12
4998948|NCT02350309|12301106|P5|STARTED|Treatment Period 4 (2 Days)||12
4998949|NCT02350309|12301107|P4|STARTED|Treatment Period 4 (2 Days)||11
4998950|NCT02350309|12301108|P3|STARTED|Treatment Period 4 (2 Days)||10
4998951|NCT02350309|12301109|P2|STARTED|Treatment Period 4 (2 Days)||11
4998952|NCT02350309|12301110|P1|STARTED|Treatment Period 4 (2 Days)||12
4998953|NCT02350309|12301105|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998954|NCT02350309|12301106|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998955|NCT02350309|12301107|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998956|NCT02350309|12301108|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998957|NCT02350309|12301109|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998958|NCT02350309|12301110|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
4998959|NCT02350309|12301105|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
4998960|NCT02350309|12301106|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
4998961|NCT02350309|12301107|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
4998962|NCT02350309|12301108|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
4998963|NCT02350309|12301109|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
4998964|NCT02350309|12301110|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
4998965|NCT02350309|12301105|P6|STARTED|Washout Period 3 (12-16 Days)||12
4998966|NCT02350309|12301106|P5|STARTED|Washout Period 3 (12-16 Days)||12
4998967|NCT02350309|12301107|P4|STARTED|Washout Period 3 (12-16 Days)||11
4998968|NCT02350309|12301108|P3|STARTED|Washout Period 3 (12-16 Days)||10
4998969|NCT02350309|12301109|P2|STARTED|Washout Period 3 (12-16 Days)||11
4998970|NCT02350309|12301110|P1|STARTED|Washout Period 3 (12-16 Days)||12
4998971|NCT02350309|12301105|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998972|NCT02350309|12301106|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998973|NCT02350309|12301107|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998974|NCT02350309|12301108|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998975|NCT02350309|12301109|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998976|NCT02350309|12301110|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
4998977|NCT02350309|12301105|P6|COMPLETED|Treatment Period 3 (2 Days)||12
4998978|NCT02350309|12301106|P5|COMPLETED|Treatment Period 3 (2 Days)||12
4998979|NCT02350309|12301107|P4|COMPLETED|Treatment Period 3 (2 Days)||11
4998980|NCT02350309|12301108|P3|COMPLETED|Treatment Period 3 (2 Days)||10
4998981|NCT02350309|12301109|P2|COMPLETED|Treatment Period 3 (2 Days)||11
4998982|NCT02350309|12301110|P1|COMPLETED|Treatment Period 3 (2 Days)||12
4998983|NCT02350309|12301105|P6|STARTED|Treatment Period 3 (2 Days)||12
4998984|NCT02350309|12301106|P5|STARTED|Treatment Period 3 (2 Days)||12
4998985|NCT02350309|12301107|P4|STARTED|Treatment Period 3 (2 Days)||11
4998986|NCT02350309|12301108|P3|STARTED|Treatment Period 3 (2 Days)||10
4998987|NCT02350309|12301109|P2|STARTED|Treatment Period 3 (2 Days)||11
4998988|NCT02350309|12301110|P1|STARTED|Treatment Period 3 (2 Days)||12
4998989|NCT02350309|12301105|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998990|NCT02350309|12301106|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998991|NCT02350309|12301107|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998992|NCT02350309|12301108|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998993|NCT02350309|12301109|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998994|NCT02350309|12301110|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
4998995|NCT02350309|12301105|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
4998996|NCT02350309|12301106|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
4998997|NCT02350309|12301107|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
4998998|NCT02350309|12301108|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
4998999|NCT02350309|12301109|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
4999000|NCT02350309|12301110|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
4999001|NCT02350309|12301105|P6|STARTED|Washout Period 2 (12-16 Days)||12
4999002|NCT02350309|12301106|P5|STARTED|Washout Period 2 (12-16 Days)||12
4999003|NCT02350309|12301107|P4|STARTED|Washout Period 2 (12-16 Days)||11
4999004|NCT02350309|12301108|P3|STARTED|Washout Period 2 (12-16 Days)||10
4999005|NCT02350309|12301109|P2|STARTED|Washout Period 2 (12-16 Days)||11
4999006|NCT02350309|12301110|P1|STARTED|Washout Period 2 (12-16 Days)||12
4999007|NCT02350309|12301105|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999008|NCT02350309|12301106|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999009|NCT02350309|12301107|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999010|NCT02350309|12301108|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999011|NCT02350309|12301109|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999012|NCT02350309|12301110|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
4999013|NCT02350309|12301105|P6|COMPLETED|Treatment Period 2 (2 Days)||12
4999014|NCT02350309|12301106|P5|COMPLETED|Treatment Period 2 (2 Days)||12
4999015|NCT02350309|12301107|P4|COMPLETED|Treatment Period 2 (2 Days)||11
4999016|NCT02350309|12301108|P3|COMPLETED|Treatment Period 2 (2 Days)||10
4999017|NCT02350309|12301109|P2|COMPLETED|Treatment Period 2 (2 Days)||11
4999018|NCT02350309|12301110|P1|COMPLETED|Treatment Period 2 (2 Days)||12
4999019|NCT02350309|12301105|P6|STARTED|Treatment Period 2 (2 Days)||12
4999020|NCT02350309|12301106|P5|STARTED|Treatment Period 2 (2 Days)||12
4999021|NCT02350309|12301107|P4|STARTED|Treatment Period 2 (2 Days)||11
4999022|NCT02350309|12301108|P3|STARTED|Treatment Period 2 (2 Days)||10
4999023|NCT02350309|12301109|P2|STARTED|Treatment Period 2 (2 Days)||11
4999024|NCT02350309|12301110|P1|STARTED|Treatment Period 2 (2 Days)||12
4999025|NCT02350309|12301105|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999026|NCT02350309|12301106|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999027|NCT02350309|12301107|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999028|NCT02350309|12301108|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999029|NCT02350309|12301109|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999030|NCT02350309|12301110|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
4999031|NCT02350309|12301105|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
4999032|NCT02350309|12301106|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
4999033|NCT02350309|12301107|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
4999034|NCT02350309|12301108|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
4999035|NCT02350309|12301109|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
4999036|NCT02350309|12301110|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
4999037|NCT02350309|12301105|P6|STARTED|Washout Period 1 (12-16 Days)||12
4999038|NCT02350309|12301106|P5|STARTED|Washout Period 1 (12-16 Days)||12
4999039|NCT02350309|12301107|P4|STARTED|Washout Period 1 (12-16 Days)||11
4999040|NCT02350309|12301108|P3|STARTED|Washout Period 1 (12-16 Days)||10
4999041|NCT02350309|12301109|P2|STARTED|Washout Period 1 (12-16 Days)||11
4999042|NCT02350309|12301110|P1|STARTED|Washout Period 1 (12-16 Days)||12
4999043|NCT02350309|12301105|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4999044|NCT02350309|12301106|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4999045|NCT02350309|12301107|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4999046|NCT02350309|12301108|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
4999047|NCT02350309|12301109|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4999048|NCT02350309|12301110|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
4999049|NCT02350309|12301105|P6|COMPLETED|Treatment Period 1 (2 Days)||12
4999050|NCT02350309|12301106|P5|COMPLETED|Treatment Period 1 (2 Days)||12
4999051|NCT02350309|12301107|P4|COMPLETED|Treatment Period 1 (2 Days)||11
4999052|NCT02350309|12301108|P3|COMPLETED|Treatment Period 1 (2 Days)||10
4999053|NCT02350309|12301109|P2|COMPLETED|Treatment Period 1 (2 Days)||11
4999054|NCT02350309|12301110|P1|COMPLETED|Treatment Period 1 (2 Days)||12
4999055|NCT02350309|12301105|P6|STARTED|Treatment Period 1 (2 Days)||12
4999056|NCT02350309|12301106|P5|STARTED|Treatment Period 1 (2 Days)||12
4999057|NCT02350309|12301107|P4|STARTED|Treatment Period 1 (2 Days)||11
4999058|NCT02350309|12301108|P3|STARTED|Treatment Period 1 (2 Days)||11
4999059|NCT02350309|12301109|P2|STARTED|Treatment Period 1 (2 Days)||11
4999060|NCT02350309|12301110|P1|STARTED|Treatment Period 1 (2 Days)||12
4999061|NCT02350127|12301151|P2|NOT COMPLETED|8-Month Assessment||9
4999062|NCT02350127|12301152|P1|NOT COMPLETED|8-Month Assessment||6
4999063|NCT02350127|12301151|P2|COMPLETED|8-Month Assessment||26
4999064|NCT02350127|12301152|P1|COMPLETED|8-Month Assessment||27
4999065|NCT02350127|12301151|P2|STARTED|8-Month Assessment||35
4999066|NCT02350127|12301152|P1|STARTED|8-Month Assessment||33
4999067|NCT02350127|12301151|P2|NOT COMPLETED|4-Month Assessment||9
4999068|NCT02350127|12301152|P1|NOT COMPLETED|4-Month Assessment||11
4999069|NCT02350127|12301151|P2|COMPLETED|4-Month Assessment||35
4999070|NCT02350127|12301152|P1|COMPLETED|4-Month Assessment||33
4999071|NCT02350127|12301151|P2|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
4999072|NCT02350127|12301152|P1|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
4999073|NCT02350127|12301151|P2|STARTED|4-Month Assessment||44
4999074|NCT02350127|12301152|P1|STARTED|4-Month Assessment||44
4999075|NCT02349789|12301191|P1|NOT COMPLETED|Overall Study||2
4999076|NCT02349789|12301191|P1|COMPLETED|Overall Study||9
4999077|NCT02349789|12301191|P1|STARTED|Overall Study||11
4999078|NCT02349711|12301202|P2|NOT COMPLETED|Overall Study||2
4999079|NCT02349711|12301203|P1|NOT COMPLETED|Overall Study||3
4999080|NCT02349711|12301202|P2|COMPLETED|Overall Study||84
4999081|NCT02349711|12301203|P1|COMPLETED|Overall Study||84
4999082|NCT02349711|12301202|P2|STARTED|Overall Study||86
4999083|NCT02349711|12301203|P1|STARTED|Overall Study||87
4999084|NCT02349685|12301218|P3|NOT COMPLETED|Overall Study||4
4999085|NCT02349685|12301219|P2|NOT COMPLETED|Overall Study||2
4999086|NCT02349685|12301220|P1|NOT COMPLETED|Overall Study||5
4999087|NCT02349685|12301218|P3|COMPLETED|Overall Study||37
4999088|NCT02349685|12301219|P2|COMPLETED|Overall Study||87
4999089|NCT02349685|12301220|P1|COMPLETED|Overall Study||84
4999090|NCT02349685|12301218|P3|STARTED|Overall Study||41
4999091|NCT02349685|12301219|P2|STARTED|Overall Study||89
4999092|NCT02349685|12301220|P1|STARTED|Overall Study||89
4999093|NCT02349646|12301231|P1|NOT COMPLETED|Overall Study||17
4999094|NCT02349646|12301231|P1|COMPLETED|Overall Study||16
4999095|NCT02349646|12301231|P1|Receive Permanent System|Overall Study||27
4999096|NCT02349646|12301231|P1|Received Trial System|Overall Study||24
4999097|NCT02349646|12301231|P1|STARTED|Overall Study||33
4999098|NCT02349542|12301236|P1|NOT COMPLETED|Overall Study||5
4999099|NCT02349542|12301236|P1|COMPLETED|Overall Study||15
4999100|NCT02349542|12301236|P1|STARTED|Overall Study||20
4999101|NCT02349477|12301243|P2|NOT COMPLETED|Overall Study||18
4999102|NCT02349477|12301244|P1|NOT COMPLETED|Overall Study||13
4999103|NCT02349477|12301243|P2|COMPLETED|Overall Study||28
4999104|NCT02349477|12301244|P1|COMPLETED|Overall Study||31
4999105|NCT02349477|12301243|P2|STARTED|Overall Study||46
4999106|NCT02349477|12301244|P1|STARTED|Overall Study||44
4999107|NCT02349451|12301260|P4|NOT COMPLETED|Overall Study||1
4999108|NCT02349451|12301261|P3|NOT COMPLETED|Overall Study||2
4999109|NCT02349451|12301262|P2|NOT COMPLETED|Overall Study||1
4999110|NCT02349451|12301263|P1|NOT COMPLETED|Overall Study||0
4999111|NCT02349451|12301260|P4|COMPLETED|Overall Study||72
4999112|NCT02349451|12301261|P3|COMPLETED|Overall Study||69
4999113|NCT02349451|12301262|P2|COMPLETED|Overall Study||71
4999114|NCT02349451|12301263|P1|COMPLETED|Overall Study||24
4999115|NCT02349451|12301260|P4|STARTED|Overall Study||73
4999116|NCT02349451|12301261|P3|STARTED|Overall Study||71
4999117|NCT02349451|12301262|P2|STARTED|Overall Study||72
4999118|NCT02349451|12301263|P1|STARTED|Overall Study||24
4999119|NCT02349438|12301299|P2|NOT COMPLETED|Period 2||0
4999120|NCT02349438|12301300|P1|NOT COMPLETED|Period 2||0
4999121|NCT02349438|12301299|P2|COMPLETED|Period 2||10
4999122|NCT02349438|12301300|P1|COMPLETED|Period 2||11
4999123|NCT02349438|12301299|P2|STARTED|Period 2||10
4999124|NCT02349438|12301300|P1|STARTED|Period 2||11
4999125|NCT02349438|12301299|P2|NOT COMPLETED|Period 1||0
4999126|NCT02349438|12301300|P1|NOT COMPLETED|Period 1||0
4999127|NCT02349438|12301299|P2|COMPLETED|Period 1||10
4999128|NCT02349438|12301300|P1|COMPLETED|Period 1||11
4999129|NCT02349438|12301299|P2|STARTED|Period 1||10
4999130|NCT02349438|12301300|P1|STARTED|Period 1||11
4999131|NCT02349412|12301312|P2|NOT COMPLETED|Overall Study||7
4999132|NCT02349412|12301313|P1|NOT COMPLETED|Overall Study||7
4999133|NCT02349412|12301312|P2|COMPLETED|Overall Study||196
4999134|NCT02349412|12301313|P1|COMPLETED|Overall Study||195
4999135|NCT02349412|12301312|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
4999136|NCT02349412|12301313|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
4999137|NCT02349412|12301312|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
4999138|NCT02349412|12301313|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
4999139|NCT02349412|12301312|P2|STARTED|Overall Study||203
4999140|NCT02349412|12301313|P1|STARTED|Overall Study||202
4999141|NCT02349360|12301329|P2|NOT COMPLETED|Overall Study||1
4999142|NCT02349360|12301330|P1|NOT COMPLETED|Overall Study||0
4999143|NCT02349360|12301329|P2|COMPLETED|Overall Study||20
4999144|NCT02349360|12301330|P1|COMPLETED|Overall Study||21
4999145|NCT02349360|12301329|P2|STARTED|Overall Study||21
4999146|NCT02349360|12301330|P1|STARTED|Overall Study||21
4999147|NCT02349295|12301341|P14|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
4999148|NCT02349295|12301342|P13|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
4999149|NCT02349295|12301343|P12|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
4999150|NCT02349295|12301344|P11|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999151|NCT02349295|12301345|P10|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999152|NCT02349295|12301346|P9|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999153|NCT02349295|12301347|P8|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999154|NCT02349295|12301348|P7|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999155|NCT02349295|12301349|P6|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999156|NCT02349295|12301350|P5|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999157|NCT02349295|12301351|P4|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999158|NCT02349295|12301352|P3|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999159|NCT02349295|12301353|P2|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999160|NCT02349295|12301354|P1|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999161|NCT02349295|12301341|P14|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
4999162|NCT02349295|12301342|P13|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
4999163|NCT02349295|12301343|P12|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
4999164|NCT02349295|12301344|P11|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999165|NCT02349295|12301345|P10|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999166|NCT02349295|12301346|P9|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999167|NCT02349295|12301347|P8|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999168|NCT02349295|12301348|P7|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999169|NCT02349295|12301349|P6|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999170|NCT02349295|12301350|P5|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999171|NCT02349295|12301351|P4|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999172|NCT02349295|12301352|P3|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999173|NCT02349295|12301353|P2|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999174|NCT02349295|12301354|P1|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
4999175|NCT02349295|12301341|P14|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
4999176|NCT02349295|12301342|P13|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
4999177|NCT02349295|12301343|P12|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
4999178|NCT02349295|12301344|P11|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
4999179|NCT02349295|12301345|P10|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
4999180|NCT02349295|12301346|P9|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
4999181|NCT02349295|12301347|P8|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
4999182|NCT02349295|12301348|P7|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999183|NCT02349295|12301349|P6|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999184|NCT02349295|12301350|P5|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999185|NCT02349295|12301351|P4|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999186|NCT02349295|12301352|P3|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999187|NCT02349295|12301353|P2|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999188|NCT02349295|12301354|P1|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
4999189|NCT02349295|12301341|P14|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999190|NCT02349295|12301342|P13|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999191|NCT02349295|12301343|P12|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999192|NCT02349295|12301344|P11|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
4999193|NCT02349295|12301345|P10|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
4999194|NCT02349295|12301346|P9|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
4999195|NCT02349295|12301347|P8|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
4999196|NCT02349295|12301348|P7|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999197|NCT02349295|12301349|P6|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999198|NCT02349295|12301350|P5|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999199|NCT02349295|12301351|P4|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999200|NCT02349295|12301352|P3|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999201|NCT02349295|12301353|P2|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999202|NCT02349295|12301354|P1|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999203|NCT02349295|12301341|P14|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999204|NCT02349295|12301342|P13|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999205|NCT02349295|12301343|P12|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999206|NCT02349295|12301344|P11|COMPLETED|Long-Term Extension Period (Week 24-156)||23
4999207|NCT02349295|12301345|P10|COMPLETED|Long-Term Extension Period (Week 24-156)||20
4999208|NCT02349295|12301346|P9|COMPLETED|Long-Term Extension Period (Week 24-156)||70
4999209|NCT02349295|12301347|P8|COMPLETED|Long-Term Extension Period (Week 24-156)||55
4999210|NCT02349295|12301348|P7|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999211|NCT02349295|12301349|P6|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999212|NCT02349295|12301350|P5|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999213|NCT02349295|12301351|P4|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999214|NCT02349295|12301352|P3|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999215|NCT02349295|12301353|P2|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999216|NCT02349295|12301354|P1|COMPLETED|Long-Term Extension Period (Week 24-156)||0
4999217|NCT02349295|12301341|P14|STARTED|Long-Term Extension Period (Week 24-156)||0
4999218|NCT02349295|12301342|P13|STARTED|Long-Term Extension Period (Week 24-156)||0
4999219|NCT02349295|12301343|P12|STARTED|Long-Term Extension Period (Week 24-156)||0
4999220|NCT02349295|12301344|P11|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
4999221|NCT02349295|12301345|P10|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
4999378|NCT02348918|12301553|P2|NOT COMPLETED|Overall Study||0
4999222|NCT02349295|12301346|P9|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
4999223|NCT02349295|12301347|P8|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
4999224|NCT02349295|12301348|P7|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
4999225|NCT02349295|12301349|P6|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
4999226|NCT02349295|12301350|P5|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
4999227|NCT02349295|12301351|P4|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
4999228|NCT02349295|12301352|P3|STARTED|Long-Term Extension Period (Week 24-156)||0
4999229|NCT02349295|12301353|P2|STARTED|Long-Term Extension Period (Week 24-156)||0
4999230|NCT02349295|12301354|P1|STARTED|Long-Term Extension Period (Week 24-156)||0
4999231|NCT02349295|12301341|P14|NOT COMPLETED|IR (Week 16-24)||0
4999232|NCT02349295|12301342|P13|NOT COMPLETED|IR (Week 16-24)||0
4999233|NCT02349295|12301343|P12|NOT COMPLETED|IR (Week 16-24)||0
4999234|NCT02349295|12301344|P11|NOT COMPLETED|IR (Week 16-24)||0
4999235|NCT02349295|12301345|P10|NOT COMPLETED|IR (Week 16-24)||0
4999236|NCT02349295|12301346|P9|NOT COMPLETED|IR (Week 16-24)||0
4999237|NCT02349295|12301347|P8|NOT COMPLETED|IR (Week 16-24)||0
4999238|NCT02349295|12301348|P7|NOT COMPLETED|IR (Week 16-24)||0
4999239|NCT02349295|12301349|P6|NOT COMPLETED|IR (Week 16-24)||0
4999240|NCT02349295|12301350|P5|NOT COMPLETED|IR (Week 16-24)||0
4999241|NCT02349295|12301351|P4|NOT COMPLETED|IR (Week 16-24)||1
4999242|NCT02349295|12301352|P3|NOT COMPLETED|IR (Week 16-24)||0
4999243|NCT02349295|12301353|P2|NOT COMPLETED|IR (Week 16-24)||0
4999244|NCT02349295|12301354|P1|NOT COMPLETED|IR (Week 16-24)||0
4999245|NCT02349295|12301341|P14|COMPLETED|IR (Week 16-24)||0
4999246|NCT02349295|12301342|P13|COMPLETED|IR (Week 16-24)||0
4999247|NCT02349295|12301343|P12|COMPLETED|IR (Week 16-24)||0
4999248|NCT02349295|12301344|P11|COMPLETED|IR (Week 16-24)||0
4999249|NCT02349295|12301345|P10|COMPLETED|IR (Week 16-24)||0
4999250|NCT02349295|12301346|P9|COMPLETED|IR (Week 16-24)||0
4999251|NCT02349295|12301347|P8|COMPLETED|IR (Week 16-24)||0
4999252|NCT02349295|12301348|P7|COMPLETED|IR (Week 16-24)||16
4999253|NCT02349295|12301349|P6|COMPLETED|IR (Week 16-24)||16
4999254|NCT02349295|12301350|P5|COMPLETED|IR (Week 16-24)||15
4999255|NCT02349295|12301351|P4|COMPLETED|IR (Week 16-24)||16
4999256|NCT02349295|12301352|P3|COMPLETED|IR (Week 16-24)||0
4999257|NCT02349295|12301353|P2|COMPLETED|IR (Week 16-24)||0
4999258|NCT02349295|12301354|P1|COMPLETED|IR (Week 16-24)||0
4999259|NCT02349295|12301341|P14|STARTED|IR (Week 16-24)||0
4999260|NCT02349295|12301342|P13|STARTED|IR (Week 16-24)||0
4999261|NCT02349295|12301343|P12|STARTED|IR (Week 16-24)||0
4999262|NCT02349295|12301344|P11|STARTED|IR (Week 16-24)||0
4999263|NCT02349295|12301345|P10|STARTED|IR (Week 16-24)||0
4999264|NCT02349295|12301346|P9|STARTED|IR (Week 16-24)||0
4999265|NCT02349295|12301347|P8|STARTED|IR (Week 16-24)||0
4999266|NCT02349295|12301348|P7|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
4999267|NCT02349295|12301349|P6|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
4999268|NCT02349295|12301350|P5|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
4999269|NCT02349295|12301351|P4|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
4999270|NCT02349295|12301352|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
4999271|NCT02349295|12301353|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
4999272|NCT02349295|12301354|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
4999273|NCT02349295|12301341|P14|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999274|NCT02349295|12301342|P13|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999275|NCT02349295|12301343|P12|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999276|NCT02349295|12301344|P11|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999277|NCT02349295|12301345|P10|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999278|NCT02349295|12301346|P9|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999279|NCT02349295|12301347|P8|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999280|NCT02349295|12301348|P7|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999281|NCT02349295|12301349|P6|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999282|NCT02349295|12301350|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999283|NCT02349295|12301351|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
4999284|NCT02349295|12301352|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
4999285|NCT02349295|12301353|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
4999286|NCT02349295|12301354|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
4999287|NCT02349295|12301341|P14|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999288|NCT02349295|12301342|P13|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999289|NCT02349295|12301343|P12|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999290|NCT02349295|12301344|P11|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999291|NCT02349295|12301345|P10|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999292|NCT02349295|12301346|P9|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999293|NCT02349295|12301347|P8|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999294|NCT02349295|12301348|P7|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999295|NCT02349295|12301349|P6|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999296|NCT02349295|12301350|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999297|NCT02349295|12301351|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
4999298|NCT02349295|12301352|P3|COMPLETED|Double Blind Treatment (Week 0-24)||94
4999299|NCT02349295|12301353|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
4999300|NCT02349295|12301354|P1|COMPLETED|Double Blind Treatment (Week 0-24)||109
4999301|NCT02349295|12301341|P14|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999302|NCT02349295|12301342|P13|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999303|NCT02349295|12301343|P12|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999304|NCT02349295|12301344|P11|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999305|NCT02349295|12301345|P10|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999306|NCT02349295|12301346|P9|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999307|NCT02349295|12301347|P8|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999308|NCT02349295|12301348|P7|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999309|NCT02349295|12301349|P6|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999310|NCT02349295|12301350|P5|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999311|NCT02349295|12301351|P4|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
4999312|NCT02349295|12301352|P3|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
4999313|NCT02349295|12301353|P2|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
4999314|NCT02349295|12301354|P1|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
4999315|NCT02349295|12301341|P14|STARTED|Double Blind Treatment (Week 0-24)||0
4999316|NCT02349295|12301342|P13|STARTED|Double Blind Treatment (Week 0-24)||0
4999317|NCT02349295|12301343|P12|STARTED|Double Blind Treatment (Week 0-24)||0
4999318|NCT02349295|12301344|P11|STARTED|Double Blind Treatment (Week 0-24)||0
4999319|NCT02349295|12301345|P10|STARTED|Double Blind Treatment (Week 0-24)||0
4999320|NCT02349295|12301346|P9|STARTED|Double Blind Treatment (Week 0-24)||0
4999321|NCT02349295|12301347|P8|STARTED|Double Blind Treatment (Week 0-24)||0
4999322|NCT02349295|12301348|P7|STARTED|Double Blind Treatment (Week 0-24)||0
4999323|NCT02349295|12301349|P6|STARTED|Double Blind Treatment (Week 0-24)||0
4999324|NCT02349295|12301350|P5|STARTED|Double Blind Treatment (Week 0-24)||0
4999325|NCT02349295|12301351|P4|STARTED|Double Blind Treatment (Week 0-24)||0
4999326|NCT02349295|12301352|P3|STARTED|Double Blind Treatment (Week 0-24)||118
4999327|NCT02349295|12301353|P2|STARTED|Double Blind Treatment (Week 0-24)||122
4999328|NCT02349295|12301354|P1|STARTED|Double Blind Treatment (Week 0-24)||123
4999329|NCT02349178|12301449|P1|NOT COMPLETED|Overall Study||0
4999330|NCT02349178|12301449|P1|COMPLETED|Overall Study||6
4999331|NCT02349178|12301449|P1|STARTED|Overall Study||6
4999332|NCT02349152|12301455|P2|NOT COMPLETED|Overall Study||4
4999333|NCT02349152|12301456|P1|NOT COMPLETED|Overall Study||6
4999334|NCT02349152|12301455|P2|COMPLETED|Overall Study||52
4999335|NCT02349152|12301456|P1|COMPLETED|Overall Study||54
4999336|NCT02349152|12301455|P2|STARTED|Overall Study||56
4999337|NCT02349152|12301456|P1|STARTED|Overall Study||60
4999338|NCT02349061|12301494|P3|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
4999339|NCT02349061|12301495|P2|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
4999340|NCT02349061|12301496|P1|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
4999341|NCT02349061|12301494|P3|COMPLETED|Study Extension (Week 56 to Week 120)||14
4999342|NCT02349061|12301495|P2|COMPLETED|Study Extension (Week 56 to Week 120)||24
4999343|NCT02349061|12301496|P1|COMPLETED|Study Extension (Week 56 to Week 120)||0
4999344|NCT02349061|12301494|P3|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
4999345|NCT02349061|12301495|P2|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
4999346|NCT02349061|12301496|P1|STARTED|Study Extension (Week 56 to Week 120)||0
4999347|NCT02349061|12301494|P3|NOT COMPLETED|Main Study: Week 24 to 56||3
4999348|NCT02349061|12301495|P2|NOT COMPLETED|Main Study: Week 24 to 56||3
4999349|NCT02349061|12301496|P1|NOT COMPLETED|Main Study: Week 24 to 56||0
4999350|NCT02349061|12301494|P3|COMPLETED|Main Study: Week 24 to 56||30
4999351|NCT02349061|12301495|P2|COMPLETED|Main Study: Week 24 to 56||53
4999352|NCT02349061|12301496|P1|COMPLETED|Main Study: Week 24 to 56||0
4999353|NCT02349061|12301494|P3|STARTED|Main Study: Week 24 to 56||33
4999354|NCT02349061|12301495|P2|STARTED|Main Study: Week 24 to 56||56
4999355|NCT02349061|12301496|P1|STARTED|Main Study: Week 24 to 56||0
4999356|NCT02349061|12301494|P3|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
4999357|NCT02349061|12301495|P2|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
4999358|NCT02349061|12301496|P1|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
4999359|NCT02349061|12301494|P3|COMPLETED|Main Study: PCP (Up to Week 24)||0
4999360|NCT02349061|12301495|P2|COMPLETED|Main Study: PCP (Up to Week 24)||56
4999361|NCT02349061|12301496|P1|COMPLETED|Main Study: PCP (Up to Week 24)||33
4999362|NCT02349061|12301494|P3|STARTED|Main Study: PCP (Up to Week 24)||0
4999363|NCT02349061|12301495|P2|STARTED|Main Study: PCP (Up to Week 24)||60
4999364|NCT02349061|12301496|P1|STARTED|Main Study: PCP (Up to Week 24)||42
4999365|NCT02349048|12301516|P2|NOT COMPLETED|Overall Study||0
4999366|NCT02349048|12301517|P1|NOT COMPLETED|Overall Study||5
4999367|NCT02349048|12301516|P2|COMPLETED|Overall Study||9
4999368|NCT02349048|12301517|P1|COMPLETED|Overall Study||54
4999369|NCT02349048|12301516|P2|STARTED|Overall Study||9
4999370|NCT02349048|12301517|P1|STARTED|Overall Study||59
4999371|NCT02348918|12301546|P9|NOT COMPLETED|Overall Study||0
4999372|NCT02348918|12301547|P8|NOT COMPLETED|Overall Study||0
4999373|NCT02348918|12301548|P7|NOT COMPLETED|Overall Study||0
4999374|NCT02348918|12301549|P6|NOT COMPLETED|Overall Study||0
4999375|NCT02348918|12301550|P5|NOT COMPLETED|Overall Study||0
4999376|NCT02348918|12301551|P4|NOT COMPLETED|Overall Study||0
4999377|NCT02348918|12301552|P3|NOT COMPLETED|Overall Study||0
4999379|NCT02348918|12301554|P1|NOT COMPLETED|Overall Study||0
4999380|NCT02348918|12301546|P9|COMPLETED|Overall Study||15
4999381|NCT02348918|12301547|P8|COMPLETED|Overall Study||16
4999382|NCT02348918|12301548|P7|COMPLETED|Overall Study||13
4999383|NCT02348918|12301549|P6|COMPLETED|Overall Study||17
4999384|NCT02348918|12301550|P5|COMPLETED|Overall Study||19
4999385|NCT02348918|12301551|P4|COMPLETED|Overall Study||24
4999386|NCT02348918|12301552|P3|COMPLETED|Overall Study||42
4999387|NCT02348918|12301553|P2|COMPLETED|Overall Study||33
4999388|NCT02348918|12301554|P1|COMPLETED|Overall Study||39
4999389|NCT02348918|12301546|P9|STARTED|Overall Study||15
4999390|NCT02348918|12301547|P8|STARTED|Overall Study||16
4999391|NCT02348918|12301548|P7|STARTED|Overall Study||13
4999392|NCT02348918|12301549|P6|STARTED|Overall Study||17
4999393|NCT02348918|12301550|P5|STARTED|Overall Study||19
4999394|NCT02348918|12301551|P4|STARTED|Overall Study||24
4999395|NCT02348918|12301552|P3|STARTED|Overall Study||42
4999396|NCT02348918|12301553|P2|STARTED|Overall Study||33
4999397|NCT02348918|12301554|P1|STARTED|Overall Study||39
4999398|NCT02348840|12301578|P4|NOT COMPLETED|Overall Study||0
4999399|NCT02348840|12301579|P3|NOT COMPLETED|Overall Study||0
4999400|NCT02348840|12301580|P2|NOT COMPLETED|Overall Study||1
4999401|NCT02348840|12301581|P1|NOT COMPLETED|Overall Study||2
4999402|NCT02348840|12301578|P4|COMPLETED|Overall Study||374
4999403|NCT02348840|12301579|P3|COMPLETED|Overall Study||425
4999404|NCT02348840|12301580|P2|COMPLETED|Overall Study||20
4999405|NCT02348840|12301581|P1|COMPLETED|Overall Study||21
4999406|NCT02348840|12301578|P4|STARTED|Overall Study||374
4999407|NCT02348840|12301579|P3|STARTED|Overall Study||425
4999408|NCT02348840|12301580|P2|STARTED|Overall Study||21
4999409|NCT02348840|12301581|P1|STARTED|Overall Study||23
4999410|NCT02348723|12301595|P2|NOT COMPLETED|Overall Study||26
4999411|NCT02348723|12301596|P1|NOT COMPLETED|Overall Study||28
4999412|NCT02348723|12301595|P2|COMPLETED|Overall Study||312
4999413|NCT02348723|12301596|P1|COMPLETED|Overall Study||310
4999414|NCT02348723|12301595|P2|STARTED|Overall Study||338
4999415|NCT02348723|12301596|P1|STARTED|Overall Study||338
4999416|NCT02348684|12301608|P1|NOT COMPLETED|Overall Study||0
4999417|NCT02348684|12301608|P1|COMPLETED|Overall Study||20
4999418|NCT02348684|12301608|P1|STARTED|Overall Study||20
4999419|NCT02348658|12301612|P2|NOT COMPLETED|Period 2 (7 Days)||0
4999420|NCT02348658|12301613|P1|NOT COMPLETED|Period 2 (7 Days)||0
4999421|NCT02348658|12301612|P2|COMPLETED|Period 2 (7 Days)||6
4999422|NCT02348658|12301613|P1|COMPLETED|Period 2 (7 Days)||6
4999423|NCT02348658|12301612|P2|STARTED|Period 2 (7 Days)||6
4999424|NCT02348658|12301613|P1|STARTED|Period 2 (7 Days)||6
4999425|NCT02348658|12301612|P2|NOT COMPLETED|Washout Period (22 Days)||0
4999426|NCT02348658|12301613|P1|NOT COMPLETED|Washout Period (22 Days)||0
4999427|NCT02348658|12301612|P2|COMPLETED|Washout Period (22 Days)||6
4999428|NCT02348658|12301613|P1|COMPLETED|Washout Period (22 Days)||6
4999429|NCT02348658|12301612|P2|STARTED|Washout Period (22 Days)||6
4999430|NCT02348658|12301613|P1|STARTED|Washout Period (22 Days)||6
4999431|NCT02348658|12301612|P2|NOT COMPLETED|Period 1 (7 Days)||0
4999432|NCT02348658|12301613|P1|NOT COMPLETED|Period 1 (7 Days)||0
4999433|NCT02348658|12301612|P2|COMPLETED|Period 1 (7 Days)||6
4999434|NCT02348658|12301613|P1|COMPLETED|Period 1 (7 Days)||6
4999435|NCT02348658|12301612|P2|STARTED|Period 1 (7 Days)||6
4999436|NCT02348658|12301613|P1|STARTED|Period 1 (7 Days)||6
4999437|NCT02348632|12301647|P2|NOT COMPLETED|Randomized Withdrawal Period||1
4999438|NCT02348632|12301648|P1|NOT COMPLETED|Randomized Withdrawal Period||3
4999439|NCT02348632|12301647|P2|COMPLETED|Randomized Withdrawal Period||141
4999440|NCT02348632|12301648|P1|COMPLETED|Randomized Withdrawal Period||137
4999441|NCT02348632|12301647|P2|STARTED|Randomized Withdrawal Period||142
4999442|NCT02348632|12301648|P1|STARTED|Randomized Withdrawal Period||140
4999443|NCT02348632|12301647|P2|NOT COMPLETED|Open-label Period||0
4999444|NCT02348632|12301648|P1|NOT COMPLETED|Open-label Period||185
4999445|NCT02348632|12301647|P2|COMPLETED|Open-label Period||0
4999446|NCT02348632|12301648|P1|COMPLETED|Open-label Period||458
4999447|NCT02348632|12301647|P2|STARTED|Open-label Period||0
4999448|NCT02348632|12301648|P1|STARTED|Open-label Period||643
4999449|NCT02348619|12301658|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
4999450|NCT02348619|12301659|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
4999451|NCT02348619|12301658|P2|COMPLETED|Double-Blind Withdrawal Phase||62
4999452|NCT02348619|12301659|P1|COMPLETED|Double-Blind Withdrawal Phase||60
4999453|NCT02348619|12301658|P2|STARTED|Double-Blind Withdrawal Phase||62
4999454|NCT02348619|12301659|P1|STARTED|Double-Blind Withdrawal Phase||62
4999455|NCT02348619|12301658|P2|NOT COMPLETED|Stable-Dose Phase||0
4999456|NCT02348619|12301659|P1|NOT COMPLETED|Stable-Dose Phase||33
4999457|NCT02348619|12301658|P2|COMPLETED|Stable-Dose Phase||0
4999458|NCT02348619|12301659|P1|COMPLETED|Stable-Dose Phase||124
4999459|NCT02348619|12301658|P2|STARTED|Stable-Dose Phase||0
4999460|NCT02348619|12301659|P1|STARTED|Stable-Dose Phase||157
4999461|NCT02348619|12301658|P2|NOT COMPLETED|Titration Phase||0
4999462|NCT02348619|12301659|P1|NOT COMPLETED|Titration Phase||17
4999463|NCT02348619|12301658|P2|COMPLETED|Titration Phase||0
4999464|NCT02348619|12301659|P1|COMPLETED|Titration Phase||157
4999465|NCT02348619|12301658|P2|STARTED|Titration Phase||0
4999466|NCT02348619|12301659|P1|STARTED|Titration Phase||174
4999467|NCT02348606|12301678|P5|NOT COMPLETED|Overall Study||18
4999468|NCT02348606|12301679|P4|NOT COMPLETED|Overall Study||24
4999469|NCT02348606|12301680|P3|NOT COMPLETED|Overall Study||11
4999470|NCT02348606|12301681|P2|NOT COMPLETED|Overall Study||8
4999471|NCT02348606|12301682|P1|NOT COMPLETED|Overall Study||9
4999472|NCT02348606|12301678|P5|COMPLETED|Overall Study||101
4999473|NCT02348606|12301679|P4|COMPLETED|Overall Study||94
4999474|NCT02348606|12301680|P3|COMPLETED|Overall Study||106
4999475|NCT02348606|12301681|P2|COMPLETED|Overall Study||54
4999476|NCT02348606|12301682|P1|COMPLETED|Overall Study||49
4999477|NCT02348606|12301678|P5|STARTED|Overall Study||119
4999478|NCT02348606|12301679|P4|STARTED|Overall Study||118
4999479|NCT02348606|12301680|P3|STARTED|Overall Study||117
4999480|NCT02348606|12301681|P2|STARTED|Overall Study||62
4999481|NCT02348606|12301682|P1|STARTED|Overall Study||58
4999482|NCT02348593|12301738|P4|NOT COMPLETED|Overall Study||7
4999483|NCT02348593|12301739|P3|NOT COMPLETED|Overall Study||16
4999484|NCT02348593|12301740|P2|NOT COMPLETED|Overall Study||8
4999485|NCT02348593|12301741|P1|NOT COMPLETED|Overall Study||10
4999486|NCT02348593|12301738|P4|COMPLETED|Overall Study||52
4999487|NCT02348593|12301739|P3|COMPLETED|Overall Study||43
4999488|NCT02348593|12301740|P2|COMPLETED|Overall Study||51
4999489|NCT02348593|12301741|P1|COMPLETED|Overall Study||49
4999490|NCT02348593|12301738|P4|STARTED|Overall Study||59
4999491|NCT02348593|12301739|P3|STARTED|Overall Study||59
4999492|NCT02348593|12301740|P2|STARTED|Overall Study||59
4999493|NCT02348593|12301741|P1|STARTED|Overall Study||59
4999494|NCT02348385|12301785|P2|NOT COMPLETED|Overall Study||0
4999495|NCT02348385|12301786|P1|NOT COMPLETED|Overall Study||0
4999496|NCT02348385|12301785|P2|COMPLETED|Overall Study||25
4999497|NCT02348385|12301786|P1|COMPLETED|Overall Study||24
4999498|NCT02348385|12301785|P2|STARTED|Overall Study||25
4999499|NCT02348385|12301786|P1|STARTED|Overall Study||24
4999500|NCT02348359|12301798|P4|NOT COMPLETED|Overall Study||12
4999501|NCT02348359|12301799|P3|NOT COMPLETED|Overall Study||14
4999502|NCT02348359|12301800|P2|NOT COMPLETED|Overall Study||17
4999503|NCT02348359|12301801|P1|NOT COMPLETED|Overall Study||11
4999504|NCT02348359|12301798|P4|COMPLETED|Overall Study||27
4999505|NCT02348359|12301799|P3|COMPLETED|Overall Study||25
4999506|NCT02348359|12301800|P2|COMPLETED|Overall Study||22
4999507|NCT02348359|12301801|P1|COMPLETED|Overall Study||29
4999508|NCT02348359|12301798|P4|STARTED|Overall Study||39
4999509|NCT02348359|12301799|P3|STARTED|Overall Study||39
4999510|NCT02348359|12301800|P2|STARTED|Overall Study||39
4999511|NCT02348359|12301801|P1|STARTED|Overall Study||40
4999512|NCT02348203|12301813|P2|NOT COMPLETED|Overall Study||10
4999513|NCT02348203|12301814|P1|NOT COMPLETED|Overall Study||10
4999514|NCT02348203|12301813|P2|COMPLETED|Overall Study||22
4999515|NCT02348203|12301814|P1|COMPLETED|Overall Study||21
4999516|NCT02348203|12301813|P2|STARTED|Overall Study||32
4999517|NCT02348203|12301814|P1|STARTED|Overall Study||31
4999518|NCT02348008|12301822|P3|NOT COMPLETED|Overall Study||19
4999519|NCT02348008|12301823|P2|NOT COMPLETED|Overall Study||10
4999520|NCT02348008|12301824|P1|NOT COMPLETED|Overall Study||3
4999521|NCT02348008|12301822|P3|COMPLETED|Overall Study||29
4999522|NCT02348008|12301823|P2|COMPLETED|Overall Study||0
4999523|NCT02348008|12301824|P1|COMPLETED|Overall Study||0
4999524|NCT02348008|12301822|P3|STARTED|Overall Study||48
4999525|NCT02348008|12301823|P2|STARTED|Overall Study||10
4999526|NCT02348008|12301824|P1|STARTED|Overall Study||3
4999527|NCT02347943|12301840|P3|NOT COMPLETED|Overall Study||45
4999528|NCT02347943|12301841|P2|NOT COMPLETED|Overall Study||67
4999529|NCT02347943|12301842|P1|NOT COMPLETED|Overall Study||140
4999530|NCT02347943|12301840|P3|COMPLETED|Overall Study||0
4999531|NCT02347943|12301841|P2|COMPLETED|Overall Study||0
4999532|NCT02347943|12301842|P1|COMPLETED|Overall Study||0
4999533|NCT02347943|12301840|P3|STARTED|Overall Study||45
4999534|NCT02347943|12301841|P2|STARTED|Overall Study||67
4999535|NCT02347943|12301842|P1|STARTED|Overall Study||140
4999536|NCT02347813|12301852|P2|NOT COMPLETED|Second Intervention, 24 Weeks||0
4999537|NCT02347813|12301853|P1|NOT COMPLETED|Second Intervention, 24 Weeks||0
4999538|NCT02347813|12301852|P2|COMPLETED|Second Intervention, 24 Weeks||4
4999539|NCT02347813|12301853|P1|COMPLETED|Second Intervention, 24 Weeks||4
4999540|NCT02347813|12301852|P2|STARTED|Second Intervention, 24 Weeks||4
4999541|NCT02347813|12301853|P1|STARTED|Second Intervention, 24 Weeks||4
4999542|NCT02347813|12301852|P2|NOT COMPLETED|First Intervention, 24 Weeks||2
4999543|NCT02347813|12301853|P1|NOT COMPLETED|First Intervention, 24 Weeks||2
4999544|NCT02347813|12301852|P2|COMPLETED|First Intervention, 24 Weeks||4
4999545|NCT02347813|12301853|P1|COMPLETED|First Intervention, 24 Weeks||4
4999546|NCT02347813|12301852|P2|STARTED|First Intervention, 24 Weeks||6
4999547|NCT02347813|12301853|P1|STARTED|First Intervention, 24 Weeks||6
4999548|NCT02347787|12301863|P2|NOT COMPLETED|9 Month Follow-Up||71
4999549|NCT02347787|12301864|P1|NOT COMPLETED|9 Month Follow-Up||61
4999550|NCT02347787|12301863|P2|COMPLETED|9 Month Follow-Up||233
4999551|NCT02347787|12301864|P1|COMPLETED|9 Month Follow-Up||227
4999552|NCT02347787|12301863|P2|STARTED|9 Month Follow-Up||304
4999553|NCT02347787|12301864|P1|STARTED|9 Month Follow-Up||288
4999554|NCT02347787|12301863|P2|NOT COMPLETED|6 Month Follow-Up||56
4999555|NCT02347787|12301864|P1|NOT COMPLETED|6 Month Follow-Up||66
4999556|NCT02347787|12301863|P2|COMPLETED|6 Month Follow-Up||248
4999557|NCT02347787|12301864|P1|COMPLETED|6 Month Follow-Up||222
4999558|NCT02347787|12301863|P2|STARTED|6 Month Follow-Up||304
4999559|NCT02347787|12301864|P1|STARTED|6 Month Follow-Up||288
4999560|NCT02347774|12301926|P3|NOT COMPLETED|On Study Treatment||36
4999561|NCT02347774|12301927|P2|NOT COMPLETED|On Study Treatment||31
4999562|NCT02347774|12301928|P1|NOT COMPLETED|On Study Treatment||24
4999563|NCT02347774|12301926|P3|COMPLETED|On Study Treatment||177
4999564|NCT02347774|12301927|P2|COMPLETED|On Study Treatment||183
4999565|NCT02347774|12301928|P1|COMPLETED|On Study Treatment||190
4999566|NCT02347774|12301926|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
4999567|NCT02347774|12301927|P2|STARTED|On Study Treatment||214
4999568|NCT02347774|12301928|P1|STARTED|On Study Treatment||214
4999569|NCT02347774|12301926|P3|NOT COMPLETED|Study Participation||25
4999570|NCT02347774|12301927|P2|NOT COMPLETED|Study Participation||21
4999571|NCT02347774|12301928|P1|NOT COMPLETED|Study Participation||15
4999572|NCT02347774|12301926|P3|COMPLETED|Study Participation||188
4999573|NCT02347774|12301927|P2|COMPLETED|Study Participation||193
4999574|NCT02347774|12301928|P1|COMPLETED|Study Participation||199
4999575|NCT02347774|12301926|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
4999576|NCT02347774|12301927|P2|STARTED|Study Participation||214
4999577|NCT02347774|12301928|P1|STARTED|Study Participation||214
4999578|NCT02347761|12301984|P3|NOT COMPLETED|On Study Treatment||42
4999579|NCT02347761|12301985|P2|NOT COMPLETED|On Study Treatment||23
4999580|NCT02347761|12301986|P1|NOT COMPLETED|On Study Treatment||27
4999581|NCT02347761|12301984|P3|COMPLETED|On Study Treatment||176
4999582|NCT02347761|12301985|P2|COMPLETED|On Study Treatment||194
4999583|NCT02347761|12301986|P1|COMPLETED|On Study Treatment||191
4999584|NCT02347761|12301984|P3|STARTED|On Study Treatment||218
4999585|NCT02347761|12301985|P2|STARTED|On Study Treatment||217
4999586|NCT02347761|12301986|P1|STARTED|On Study Treatment||218
4999587|NCT02347761|12301984|P3|NOT COMPLETED|All Collected||27
4999588|NCT02347761|12301985|P2|NOT COMPLETED|All Collected||14
4999589|NCT02347761|12301986|P1|NOT COMPLETED|All Collected||17
4999590|NCT02347761|12301984|P3|COMPLETED|All Collected||191
4999591|NCT02347761|12301985|P2|COMPLETED|All Collected||203
4999592|NCT02347761|12301986|P1|COMPLETED|All Collected||201
4999593|NCT02347761|12301984|P3|STARTED|All Collected||218
4999594|NCT02347761|12301985|P2|STARTED|All Collected||217
4999595|NCT02347761|12301986|P1|STARTED|All Collected||218
4999596|NCT02347657|12302047|P2|NOT COMPLETED|Overall Study||15
4999597|NCT02347657|12302048|P1|NOT COMPLETED|Overall Study||18
4999598|NCT02347657|12302047|P2|COMPLETED|Overall Study||236
4999599|NCT02347657|12302048|P1|COMPLETED|Overall Study||241
4999600|NCT02347657|12302047|P2|Treated|Overall Study||251
4999601|NCT02347657|12302048|P1|Treated|Overall Study||258
4999602|NCT02347657|12302047|P2|STARTED|Overall Study||251
4999603|NCT02347657|12302048|P1|STARTED|Overall Study||259
4999604|NCT02347605|12302079|P6|NOT COMPLETED|Overall Study||2
4999605|NCT02347605|12302080|P5|NOT COMPLETED|Overall Study||3
4999606|NCT02347605|12302081|P4|NOT COMPLETED|Overall Study||4
4999607|NCT02347605|12302082|P3|NOT COMPLETED|Overall Study||1
4999608|NCT02347605|12302083|P2|NOT COMPLETED|Overall Study||3
4999609|NCT02347605|12302084|P1|NOT COMPLETED|Overall Study||3
4999610|NCT02347605|12302079|P6|COMPLETED|Overall Study||7
4999611|NCT02347605|12302080|P5|COMPLETED|Overall Study||6
4999612|NCT02347605|12302081|P4|COMPLETED|Overall Study||6
4999613|NCT02347605|12302082|P3|COMPLETED|Overall Study||7
4999614|NCT02347605|12302083|P2|COMPLETED|Overall Study||7
4999615|NCT02347605|12302084|P1|COMPLETED|Overall Study||7
4999616|NCT02347605|12302079|P6|Completed Lab 2|Overall Study||8
4999617|NCT02347605|12302080|P5|Completed Lab 2|Overall Study||6
4999618|NCT02347605|12302081|P4|Completed Lab 2|Overall Study||7
4999619|NCT02347605|12302082|P3|Completed Lab 2|Overall Study||7
4999620|NCT02347605|12302083|P2|Completed Lab 2|Overall Study||7
4999621|NCT02347605|12302084|P1|Completed Lab 2|Overall Study||7
4999622|NCT02347605|12302079|P6|Completed Lab 1|Overall Study||9
4999623|NCT02347605|12302080|P5|Completed Lab 1|Overall Study||8
4999624|NCT02347605|12302081|P4|Completed Lab 1|Overall Study||10
4999625|NCT02347605|12302082|P3|Completed Lab 1|Overall Study||8
4999626|NCT02347605|12302083|P2|Completed Lab 1|Overall Study||10
4999627|NCT02347605|12302084|P1|Completed Lab 1|Overall Study||10
4999628|NCT02347605|12302079|P6|STARTED|Overall Study||9
4999629|NCT02347605|12302080|P5|STARTED|Overall Study||9
4999630|NCT02347605|12302081|P4|STARTED|Overall Study||10
4999631|NCT02347605|12302082|P3|STARTED|Overall Study||8
4999632|NCT02347605|12302083|P2|STARTED|Overall Study||10
4999633|NCT02347605|12302084|P1|STARTED|Overall Study||10
4999634|NCT02347488|12302095|P1|NOT COMPLETED|Overall Study||0
4999635|NCT02347488|12302095|P1|COMPLETED|Overall Study||30
4999636|NCT02347488|12302095|P1|STARTED|Overall Study||30
4999637|NCT02347345|12302108|P3|NOT COMPLETED|Overall Study||0
4999638|NCT02347345|12302109|P2|NOT COMPLETED|Overall Study||0
4999639|NCT02347345|12302110|P1|NOT COMPLETED|Overall Study||0
4999640|NCT02347345|12302108|P3|COMPLETED|Overall Study||12
4999641|NCT02347345|12302109|P2|COMPLETED|Overall Study||12
4999642|NCT02347345|12302110|P1|COMPLETED|Overall Study||10
4999643|NCT02347345|12302108|P3|STARTED|Overall Study||12
4999644|NCT02347345|12302109|P2|STARTED|Overall Study||12
4999645|NCT02347345|12302110|P1|STARTED|Overall Study||10
4999646|NCT02347332|12302126|P2|NOT COMPLETED|Overall Study||229
4999647|NCT02347332|12302127|P1|NOT COMPLETED|Overall Study||230
4999648|NCT02347332|12302126|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
4999649|NCT02347332|12302127|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
4999650|NCT02347332|12302126|P2|STARTED|Overall Study||229
4999651|NCT02347332|12302127|P1|STARTED|Overall Study||230
4999652|NCT02347189|12302141|P1|NOT COMPLETED|Overall Study||11
4999653|NCT02347189|12302141|P1|COMPLETED|Overall Study||28
4999654|NCT02347189|12302141|P1|Implanted > 24 Hours|Overall Study||30
4999655|NCT02347189|12302141|P1|Implanted|Overall Study||30
4999656|NCT02347189|12302141|P1|Catheterized|Overall Study||39
4999657|NCT02347189|12302141|P1|STARTED|Overall Study||39
4999658|NCT02347176|12302160|P4|NOT COMPLETED|Overall Study||4
4999659|NCT02347176|12302161|P3|NOT COMPLETED|Overall Study||8
4999660|NCT02347176|12302162|P2|NOT COMPLETED|Overall Study||10
4999661|NCT02347176|12302163|P1|NOT COMPLETED|Overall Study||12
4999662|NCT02347176|12302160|P4|COMPLETED|Overall Study||48
4999663|NCT02347176|12302161|P3|COMPLETED|Overall Study||43
4999664|NCT02347176|12302162|P2|COMPLETED|Overall Study||40
4999665|NCT02347176|12302163|P1|COMPLETED|Overall Study||39
4999666|NCT02347176|12302160|P4|STARTED|Overall Study||52
4999667|NCT02347176|12302161|P3|STARTED|Overall Study||51
4999668|NCT02347176|12302162|P2|STARTED|Overall Study||50
4999669|NCT02347176|12302163|P1|STARTED|Overall Study||51
4999670|NCT02347124|12302211|P2|NOT COMPLETED|Overall Study||99
4999671|NCT02347124|12302212|P1|NOT COMPLETED|Overall Study||93
4999672|NCT02347124|12302211|P2|COMPLETED|Overall Study||259
4999673|NCT02347124|12302212|P1|COMPLETED|Overall Study||267
4999674|NCT02347124|12302211|P2|2 Month Follow-up|Overall Study||275
4999675|NCT02347124|12302212|P1|2 Month Follow-up|Overall Study||298
4999676|NCT02347124|12302211|P2|STARTED|Overall Study||358
4999677|NCT02347124|12302212|P1|STARTED|Overall Study||360
4999678|NCT02347098|12302248|P2|NOT COMPLETED|Overall Study||8
4999679|NCT02347098|12302249|P1|NOT COMPLETED|Overall Study||7
4999680|NCT02347098|12302248|P2|COMPLETED|Overall Study||58
4999681|NCT02347098|12302249|P1|COMPLETED|Overall Study||56
4999682|NCT02347098|12302248|P2|STARTED|Overall Study||66
4999683|NCT02347098|12302249|P1|STARTED|Overall Study||63
4999684|NCT02347085|12302261|P1|NOT COMPLETED|Overall Study||10
4999685|NCT02347085|12302261|P1|COMPLETED|Overall Study||33
4999686|NCT02347085|12302261|P1|Placebo MDI|Overall Study||40
4999687|NCT02347085|12302261|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
4999688|NCT02347085|12302261|P1|STARTED|Overall Study||43
4999689|NCT02347072|12302283|P1|NOT COMPLETED|Overall Study||18
4999690|NCT02347072|12302283|P1|COMPLETED|Overall Study||62
4999691|NCT02347072|12302283|P1|Spiriva Respimat 5 µg|Overall Study||73
4999692|NCT02347072|12302283|P1|Placebo MDI|Overall Study||72
4999693|NCT02347072|12302283|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
4999694|NCT02347072|12302283|P1|STARTED|Overall Study||80
4999695|NCT02346877|12302317|P2|NOT COMPLETED|Overall Study||0
4999696|NCT02346877|12302318|P1|NOT COMPLETED|Overall Study||19
4999697|NCT02346877|12302317|P2|COMPLETED|Overall Study||0
4999698|NCT02346877|12302318|P1|COMPLETED|Overall Study||0
4999699|NCT02346877|12302317|P2|STARTED|Overall Study||0
4999700|NCT02346877|12302318|P1|STARTED|Overall Study||19
4999701|NCT02346721|12302328|P1|NOT COMPLETED|Overall Study||4
4999702|NCT02346721|12302328|P1|COMPLETED|Overall Study||107
4999703|NCT02346721|12302328|P1|STARTED|Overall Study||111
4999704|NCT02346643|12302337|P1|NOT COMPLETED|Overall Study||35
4999705|NCT02346643|12302337|P1|COMPLETED|Overall Study||6
4999706|NCT02346643|12302337|P1|Received Permanent System|Overall Study||31
4999707|NCT02346643|12302337|P1|Received Trial System|Overall Study||29
4999708|NCT02346643|12302337|P1|STARTED|Overall Study||41
4999709|NCT02346461|12302344|P2|NOT COMPLETED|Overall Study||0
4999710|NCT02346461|12302345|P1|NOT COMPLETED|Overall Study||0
4999711|NCT02346461|12302344|P2|COMPLETED|Overall Study||6
4999712|NCT02346461|12302345|P1|COMPLETED|Overall Study||6
4999713|NCT02346461|12302344|P2|STARTED|Overall Study||6
4999714|NCT02346461|12302345|P1|STARTED|Overall Study||6
4999715|NCT02346370|12302367|P3|NOT COMPLETED|Overall Study||4
4999716|NCT02346370|12302368|P2|NOT COMPLETED|Overall Study||4
4999717|NCT02346370|12302369|P1|NOT COMPLETED|Overall Study||8
4999718|NCT02346370|12302367|P3|COMPLETED|Overall Study||0
4999719|NCT02346370|12302368|P2|COMPLETED|Overall Study||0
4999720|NCT02346370|12302369|P1|COMPLETED|Overall Study||0
4999721|NCT02346370|12302367|P3|STARTED|Overall Study||4
4999722|NCT02346370|12302368|P2|STARTED|Overall Study||4
4999723|NCT02346370|12302369|P1|STARTED|Overall Study||8
4999724|NCT02346240|12302418|P24|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
4999725|NCT02346240|12302419|P23|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
4999726|NCT02346240|12302420|P22|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
4999727|NCT02346240|12302421|P21|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
4999728|NCT02346240|12302422|P20|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
4999729|NCT02346240|12302423|P19|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
4999730|NCT02346240|12302424|P18|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
4999731|NCT02346240|12302425|P17|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999732|NCT02346240|12302426|P16|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999733|NCT02346240|12302427|P15|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999734|NCT02346240|12302428|P14|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999735|NCT02346240|12302429|P13|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999736|NCT02346240|12302430|P12|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999737|NCT02346240|12302431|P11|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999738|NCT02346240|12302432|P10|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999739|NCT02346240|12302433|P9|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999740|NCT02346240|12302434|P8|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999741|NCT02346240|12302435|P7|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999742|NCT02346240|12302436|P6|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999743|NCT02346240|12302437|P5|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999744|NCT02346240|12302438|P4|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999745|NCT02346240|12302439|P3|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999746|NCT02346240|12302440|P2|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999747|NCT02346240|12302441|P1|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999748|NCT02346240|12302418|P24|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
4999749|NCT02346240|12302419|P23|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
4999750|NCT02346240|12302420|P22|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
4999751|NCT02346240|12302421|P21|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
4999752|NCT02346240|12302422|P20|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
4999753|NCT02346240|12302423|P19|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
4999754|NCT02346240|12302424|P18|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
4999755|NCT02346240|12302425|P17|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999756|NCT02346240|12302426|P16|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999757|NCT02346240|12302427|P15|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999758|NCT02346240|12302428|P14|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999759|NCT02346240|12302429|P13|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999760|NCT02346240|12302430|P12|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999761|NCT02346240|12302431|P11|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999762|NCT02346240|12302432|P10|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999763|NCT02346240|12302433|P9|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999764|NCT02346240|12302434|P8|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999765|NCT02346240|12302435|P7|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999766|NCT02346240|12302436|P6|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999767|NCT02346240|12302437|P5|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999768|NCT02346240|12302438|P4|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999769|NCT02346240|12302439|P3|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999770|NCT02346240|12302440|P2|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999771|NCT02346240|12302441|P1|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
4999772|NCT02346240|12302418|P24|STARTED|Open-Label Period (Week 48 to Week 144)||16
4999773|NCT02346240|12302419|P23|STARTED|Open-Label Period (Week 48 to Week 144)||34
4999774|NCT02346240|12302420|P22|STARTED|Open-Label Period (Week 48 to Week 144)||177
4999775|NCT02346240|12302421|P21|STARTED|Open-Label Period (Week 48 to Week 144)||48
4999776|NCT02346240|12302422|P20|STARTED|Open-Label Period (Week 48 to Week 144)||41
4999777|NCT02346240|12302423|P19|STARTED|Open-Label Period (Week 48 to Week 144)||122
4999778|NCT02346240|12302424|P18|STARTED|Open-Label Period (Week 48 to Week 144)||34
4999779|NCT02346240|12302425|P17|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999780|NCT02346240|12302426|P16|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999781|NCT02346240|12302427|P15|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999782|NCT02346240|12302428|P14|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999783|NCT02346240|12302429|P13|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999784|NCT02346240|12302430|P12|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999785|NCT02346240|12302431|P11|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999786|NCT02346240|12302432|P10|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999787|NCT02346240|12302433|P9|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999788|NCT02346240|12302434|P8|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999789|NCT02346240|12302435|P7|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999790|NCT02346240|12302436|P6|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999791|NCT02346240|12302437|P5|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999792|NCT02346240|12302438|P4|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999793|NCT02346240|12302439|P3|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999794|NCT02346240|12302440|P2|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999795|NCT02346240|12302441|P1|STARTED|Open-Label Period (Week 48 to Week 144)||0
4999796|NCT02346240|12302418|P24|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999797|NCT02346240|12302419|P23|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999798|NCT02346240|12302420|P22|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999799|NCT02346240|12302421|P21|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999800|NCT02346240|12302422|P20|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999801|NCT02346240|12302423|P19|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999802|NCT02346240|12302424|P18|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999803|NCT02346240|12302425|P17|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
4999804|NCT02346240|12302426|P16|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
4999805|NCT02346240|12302427|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
4999806|NCT02346240|12302428|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
4999807|NCT02346240|12302429|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999808|NCT02346240|12302430|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
4999809|NCT02346240|12302431|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
4999810|NCT02346240|12302432|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
4999811|NCT02346240|12302433|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
4999812|NCT02346240|12302434|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
4999813|NCT02346240|12302435|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
4999814|NCT02346240|12302436|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
4999815|NCT02346240|12302437|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999816|NCT02346240|12302438|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999817|NCT02346240|12302439|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999818|NCT02346240|12302440|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999819|NCT02346240|12302441|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999820|NCT02346240|12302418|P24|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999821|NCT02346240|12302419|P23|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999822|NCT02346240|12302420|P22|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999823|NCT02346240|12302421|P21|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999824|NCT02346240|12302422|P20|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999825|NCT02346240|12302423|P19|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999826|NCT02346240|12302424|P18|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999827|NCT02346240|12302425|P17|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
4999828|NCT02346240|12302426|P16|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
4999829|NCT02346240|12302427|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
4999830|NCT02346240|12302428|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
4999831|NCT02346240|12302429|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
4999832|NCT02346240|12302430|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
4999833|NCT02346240|12302431|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
4999834|NCT02346240|12302432|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
4999835|NCT02346240|12302433|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
4999836|NCT02346240|12302434|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
4999837|NCT02346240|12302435|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
4999838|NCT02346240|12302436|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
4999839|NCT02346240|12302437|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
4999840|NCT02346240|12302438|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999841|NCT02346240|12302439|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999842|NCT02346240|12302440|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999843|NCT02346240|12302441|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
4999844|NCT02346240|12302418|P24|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999845|NCT02346240|12302419|P23|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999846|NCT02346240|12302420|P22|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999847|NCT02346240|12302421|P21|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999848|NCT02346240|12302422|P20|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999849|NCT02346240|12302423|P19|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999850|NCT02346240|12302424|P18|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999851|NCT02346240|12302425|P17|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
4999852|NCT02346240|12302426|P16|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
4999853|NCT02346240|12302427|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
4999854|NCT02346240|12302428|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
4999855|NCT02346240|12302429|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
4999856|NCT02346240|12302430|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
4999857|NCT02346240|12302431|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
4999858|NCT02346240|12302432|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
4999859|NCT02346240|12302433|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
4999860|NCT02346240|12302434|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
4999861|NCT02346240|12302435|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
4999862|NCT02346240|12302436|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
4999863|NCT02346240|12302437|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
4999864|NCT02346240|12302438|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999865|NCT02346240|12302439|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999866|NCT02346240|12302440|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999867|NCT02346240|12302441|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
4999868|NCT02346240|12302418|P24|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999869|NCT02346240|12302419|P23|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999870|NCT02346240|12302420|P22|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999871|NCT02346240|12302421|P21|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999872|NCT02346240|12302422|P20|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999873|NCT02346240|12302423|P19|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999874|NCT02346240|12302424|P18|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999875|NCT02346240|12302425|P17|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
4999876|NCT02346240|12302426|P16|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
4999877|NCT02346240|12302427|P15|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
4999878|NCT02346240|12302428|P14|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
4999879|NCT02346240|12302429|P13|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
4999880|NCT02346240|12302430|P12|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
4999881|NCT02346240|12302431|P11|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
4999882|NCT02346240|12302432|P10|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
4999883|NCT02346240|12302433|P9|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
4999884|NCT02346240|12302434|P8|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
4999885|NCT02346240|12302435|P7|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
4999886|NCT02346240|12302436|P6|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
4999887|NCT02346240|12302437|P5|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
4999888|NCT02346240|12302438|P4|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999889|NCT02346240|12302439|P3|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999890|NCT02346240|12302440|P2|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999891|NCT02346240|12302441|P1|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
4999892|NCT02346240|12302418|P24|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999893|NCT02346240|12302419|P23|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999894|NCT02346240|12302420|P22|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999895|NCT02346240|12302421|P21|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999896|NCT02346240|12302422|P20|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999897|NCT02346240|12302423|P19|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999898|NCT02346240|12302424|P18|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999899|NCT02346240|12302425|P17|STARTED|Maintenance Period (Week 16 to Week 48)||36
4999900|NCT02346240|12302426|P16|STARTED|Maintenance Period (Week 16 to Week 48)||49
4999901|NCT02346240|12302427|P15|STARTED|Maintenance Period (Week 16 to Week 48)||85
4999902|NCT02346240|12302428|P14|STARTED|Maintenance Period (Week 16 to Week 48)||53
4999903|NCT02346240|12302429|P13|STARTED|Maintenance Period (Week 16 to Week 48)||49
4999904|NCT02346240|12302430|P12|STARTED|Maintenance Period (Week 16 to Week 48)||50
4999905|NCT02346240|12302431|P11|STARTED|Maintenance Period (Week 16 to Week 48)||25
4999906|NCT02346240|12302432|P10|STARTED|Maintenance Period (Week 16 to Week 48)||44
4999907|NCT02346240|12302433|P9|STARTED|Maintenance Period (Week 16 to Week 48)||44
4999908|NCT02346240|12302434|P8|STARTED|Maintenance Period (Week 16 to Week 48)||22
4999909|NCT02346240|12302435|P7|STARTED|Maintenance Period (Week 16 to Week 48)||50
4999910|NCT02346240|12302436|P6|STARTED|Maintenance Period (Week 16 to Week 48)||24
4999911|NCT02346240|12302437|P5|STARTED|Maintenance Period (Week 16 to Week 48)||2
4999912|NCT02346240|12302438|P4|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999913|NCT02346240|12302439|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999914|NCT02346240|12302440|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999915|NCT02346240|12302441|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
4999916|NCT02346240|12302418|P24|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999917|NCT02346240|12302419|P23|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999918|NCT02346240|12302420|P22|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999919|NCT02346240|12302421|P21|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999920|NCT02346240|12302422|P20|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999921|NCT02346240|12302423|P19|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999922|NCT02346240|12302424|P18|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999923|NCT02346240|12302425|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999924|NCT02346240|12302426|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999925|NCT02346240|12302427|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999926|NCT02346240|12302428|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999927|NCT02346240|12302429|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999928|NCT02346240|12302430|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999929|NCT02346240|12302431|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999930|NCT02346240|12302432|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999931|NCT02346240|12302433|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999932|NCT02346240|12302434|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999933|NCT02346240|12302435|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999934|NCT02346240|12302436|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999935|NCT02346240|12302437|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
4999936|NCT02346240|12302438|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
4999937|NCT02346240|12302439|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
4999938|NCT02346240|12302440|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
4999939|NCT02346240|12302441|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
4999940|NCT02346240|12302418|P24|COMPLETED|Initial Period (Baseline to Week 16)||0
4999941|NCT02346240|12302419|P23|COMPLETED|Initial Period (Baseline to Week 16)||0
4999942|NCT02346240|12302420|P22|COMPLETED|Initial Period (Baseline to Week 16)||0
4999943|NCT02346240|12302421|P21|COMPLETED|Initial Period (Baseline to Week 16)||0
4999944|NCT02346240|12302422|P20|COMPLETED|Initial Period (Baseline to Week 16)||0
4999945|NCT02346240|12302423|P19|COMPLETED|Initial Period (Baseline to Week 16)||0
4999946|NCT02346240|12302424|P18|COMPLETED|Initial Period (Baseline to Week 16)||0
4999947|NCT02346240|12302425|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
4999948|NCT02346240|12302426|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
4999949|NCT02346240|12302427|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
4999950|NCT02346240|12302428|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
4999951|NCT02346240|12302429|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
5000183|NCT02344576|12302946|P4|Completed 1-Month Survey|1-Month Follow-Up||53
4999952|NCT02346240|12302430|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
4999953|NCT02346240|12302431|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
4999954|NCT02346240|12302432|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
4999955|NCT02346240|12302433|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
4999956|NCT02346240|12302434|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
4999957|NCT02346240|12302435|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
4999958|NCT02346240|12302436|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
4999959|NCT02346240|12302437|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
4999960|NCT02346240|12302438|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
4999961|NCT02346240|12302439|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
4999962|NCT02346240|12302440|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
4999963|NCT02346240|12302441|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
4999964|NCT02346240|12302418|P24|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999965|NCT02346240|12302419|P23|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999966|NCT02346240|12302420|P22|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999967|NCT02346240|12302421|P21|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999968|NCT02346240|12302422|P20|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999969|NCT02346240|12302423|P19|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999970|NCT02346240|12302424|P18|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999971|NCT02346240|12302425|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999972|NCT02346240|12302426|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999973|NCT02346240|12302427|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999974|NCT02346240|12302428|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999975|NCT02346240|12302429|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999976|NCT02346240|12302430|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999977|NCT02346240|12302431|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999978|NCT02346240|12302432|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999979|NCT02346240|12302433|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999980|NCT02346240|12302434|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999981|NCT02346240|12302435|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999982|NCT02346240|12302436|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999983|NCT02346240|12302437|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
4999984|NCT02346240|12302438|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
4999985|NCT02346240|12302439|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
4999986|NCT02346240|12302440|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
4999987|NCT02346240|12302441|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
4999988|NCT02346240|12302418|P24|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999989|NCT02346240|12302419|P23|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999990|NCT02346240|12302420|P22|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999991|NCT02346240|12302421|P21|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999992|NCT02346240|12302422|P20|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999993|NCT02346240|12302423|P19|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999994|NCT02346240|12302424|P18|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999995|NCT02346240|12302425|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999996|NCT02346240|12302426|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999997|NCT02346240|12302427|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999998|NCT02346240|12302428|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
4999999|NCT02346240|12302429|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000000|NCT02346240|12302430|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000001|NCT02346240|12302431|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000002|NCT02346240|12302432|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000003|NCT02346240|12302433|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000004|NCT02346240|12302434|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000005|NCT02346240|12302435|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000006|NCT02346240|12302436|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000007|NCT02346240|12302437|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
5000008|NCT02346240|12302438|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
5000009|NCT02346240|12302439|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
5000010|NCT02346240|12302440|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
5000011|NCT02346240|12302441|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
5000012|NCT02346240|12302418|P24|STARTED|Initial Period (Baseline to Week 16)||0
5000013|NCT02346240|12302419|P23|STARTED|Initial Period (Baseline to Week 16)||0
5000014|NCT02346240|12302420|P22|STARTED|Initial Period (Baseline to Week 16)||0
5000015|NCT02346240|12302421|P21|STARTED|Initial Period (Baseline to Week 16)||0
5000016|NCT02346240|12302422|P20|STARTED|Initial Period (Baseline to Week 16)||0
5000017|NCT02346240|12302423|P19|STARTED|Initial Period (Baseline to Week 16)||0
5000018|NCT02346240|12302424|P18|STARTED|Initial Period (Baseline to Week 16)||0
5000019|NCT02346240|12302425|P17|STARTED|Initial Period (Baseline to Week 16)||0
5000020|NCT02346240|12302426|P16|STARTED|Initial Period (Baseline to Week 16)||0
5000021|NCT02346240|12302427|P15|STARTED|Initial Period (Baseline to Week 16)||0
5000022|NCT02346240|12302428|P14|STARTED|Initial Period (Baseline to Week 16)||0
5000023|NCT02346240|12302429|P13|STARTED|Initial Period (Baseline to Week 16)||0
5000024|NCT02346240|12302430|P12|STARTED|Initial Period (Baseline to Week 16)||0
5000025|NCT02346240|12302431|P11|STARTED|Initial Period (Baseline to Week 16)||0
5000026|NCT02346240|12302432|P10|STARTED|Initial Period (Baseline to Week 16)||0
5000027|NCT02346240|12302433|P9|STARTED|Initial Period (Baseline to Week 16)||0
5000028|NCT02346240|12302434|P8|STARTED|Initial Period (Baseline to Week 16)||0
5000029|NCT02346240|12302435|P7|STARTED|Initial Period (Baseline to Week 16)||0
5000030|NCT02346240|12302436|P6|STARTED|Initial Period (Baseline to Week 16)||0
5000031|NCT02346240|12302437|P5|STARTED|Initial Period (Baseline to Week 16)||0
5000032|NCT02346240|12302438|P4|STARTED|Initial Period (Baseline to Week 16)||167
5000033|NCT02346240|12302439|P3|STARTED|Initial Period (Baseline to Week 16)||165
5000034|NCT02346240|12302440|P2|STARTED|Initial Period (Baseline to Week 16)||170
5000035|NCT02346240|12302441|P1|STARTED|Initial Period (Baseline to Week 16)||57
5000036|NCT02346136|12302480|P2|NOT COMPLETED|Overall Study||23
5000037|NCT02346136|12302481|P1|NOT COMPLETED|Overall Study||22
5000038|NCT02346136|12302480|P2|COMPLETED|Overall Study||64
5000039|NCT02346136|12302481|P1|COMPLETED|Overall Study||71
5000040|NCT02346136|12302480|P2|STARTED|Overall Study||87
5000041|NCT02346136|12302481|P1|STARTED|Overall Study||93
5000042|NCT02345889|12302517|P4|NOT COMPLETED|Overall Study||16
5000043|NCT02345889|12302518|P3|NOT COMPLETED|Overall Study||20
5000044|NCT02345889|12302519|P2|NOT COMPLETED|Overall Study||17
5000045|NCT02345889|12302520|P1|NOT COMPLETED|Overall Study||21
5000046|NCT02345889|12302517|P4|COMPLETED|Overall Study||299
5000047|NCT02345889|12302518|P3|COMPLETED|Overall Study||295
5000048|NCT02345889|12302519|P2|COMPLETED|Overall Study||299
5000049|NCT02345889|12302520|P1|COMPLETED|Overall Study||295
5000050|NCT02345889|12302517|P4|STARTED|Overall Study||315
5000051|NCT02345889|12302518|P3|STARTED|Overall Study||315
5000052|NCT02345889|12302519|P2|STARTED|Overall Study||316
5000053|NCT02345889|12302520|P1|STARTED|Overall Study||316
5000054|NCT02345772|12302586|P1|NOT COMPLETED|Overall Study||4
5000055|NCT02345772|12302586|P1|COMPLETED|Overall Study||0
5000056|NCT02345772|12302586|P1|STARTED|Overall Study||4
5000057|NCT02345720|12302592|P1|NOT COMPLETED|Overall Study||0
5000058|NCT02345720|12302592|P1|COMPLETED|Overall Study||20
5000059|NCT02345720|12302592|P1|STARTED|Overall Study||20
5000060|NCT02345642|12302600|P2|NOT COMPLETED|Overall Study||0
5000061|NCT02345642|12302601|P1|NOT COMPLETED|Overall Study||0
5000062|NCT02345642|12302600|P2|COMPLETED|Overall Study||10
5000063|NCT02345642|12302601|P1|COMPLETED|Overall Study||10
5000064|NCT02345642|12302600|P2|STARTED|Overall Study||10
5000065|NCT02345642|12302601|P1|STARTED|Overall Study||10
5000066|NCT02345512|12302607|P1|NOT COMPLETED|Overall Study||2
5000067|NCT02345512|12302607|P1|COMPLETED|Overall Study||9
5000068|NCT02345512|12302607|P1|STARTED|Overall Study||11
5000069|NCT02345486|12302628|P2|NOT COMPLETED|Overall Study||0
5000070|NCT02345486|12302629|P1|NOT COMPLETED|Overall Study||0
5000071|NCT02345486|12302628|P2|COMPLETED|Overall Study||520
5000072|NCT02345486|12302629|P1|COMPLETED|Overall Study||454
5000073|NCT02345486|12302628|P2|STARTED|Overall Study||520
5000074|NCT02345486|12302629|P1|STARTED|Overall Study||454
5000075|NCT02345460|12302677|P1|NOT COMPLETED|Overall Study||0
5000076|NCT02345460|12302677|P1|COMPLETED|Overall Study||1
5000077|NCT02345460|12302677|P1|STARTED|Overall Study||1
5000078|NCT02345369|12302690|P2|NOT COMPLETED|Overall Study||0
5000079|NCT02345369|12302691|P1|NOT COMPLETED|Overall Study||0
5000080|NCT02345369|12302690|P2|COMPLETED|Overall Study||0
5000081|NCT02345369|12302691|P1|COMPLETED|Overall Study||0
5000082|NCT02345369|12302690|P2|STARTED|Overall Study||0
5000083|NCT02345369|12302691|P1|STARTED|Overall Study||0
5000084|NCT02345330|12302701|P1|NOT COMPLETED|Overall Study||3
5000085|NCT02345330|12302701|P1|COMPLETED|Overall Study||1
5000086|NCT02345330|12302701|P1|STARTED|Overall Study||4
5000087|NCT02345252|12302713|P2|NOT COMPLETED|Open-Label Extension Phase||0
5000088|NCT02345252|12302714|P1|NOT COMPLETED|Open-Label Extension Phase||0
5000089|NCT02345252|12302713|P2|COMPLETED|Open-Label Extension Phase||17
5000090|NCT02345252|12302714|P1|COMPLETED|Open-Label Extension Phase||19
5000091|NCT02345252|12302713|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
5000092|NCT02345252|12302714|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
5000093|NCT02345252|12302713|P2|NOT COMPLETED|Double-Blind Phase||49
5000094|NCT02345252|12302714|P1|NOT COMPLETED|Double-Blind Phase||40
5000095|NCT02345252|12302713|P2|COMPLETED|Double-Blind Phase||267
5000096|NCT02345252|12302714|P1|COMPLETED|Double-Blind Phase||276
5000097|NCT02345252|12302713|P2|STARTED|Double-Blind Phase||316
5000098|NCT02345252|12302714|P1|STARTED|Double-Blind Phase||316
5000099|NCT02345226|12302742|P2|NOT COMPLETED|Open-Label Extension Phase||1
5000100|NCT02345226|12302743|P1|NOT COMPLETED|Open-Label Extension Phase||0
5000101|NCT02345226|12302742|P2|COMPLETED|Open-Label Extension Phase||20
5000102|NCT02345226|12302743|P1|COMPLETED|Open-Label Extension Phase||25
5000103|NCT02345226|12302742|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
5000104|NCT02345226|12302743|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
5000105|NCT02345226|12302742|P2|NOT COMPLETED|Double-Blind Phase||71
5000106|NCT02345226|12302743|P1|NOT COMPLETED|Double-Blind Phase||69
5000107|NCT02345226|12302742|P2|COMPLETED|Double-Blind Phase||370
5000108|NCT02345226|12302743|P1|COMPLETED|Double-Blind Phase||371
5000109|NCT02345226|12302742|P2|STARTED|Double-Blind Phase||441
5000110|NCT02345226|12302743|P1|STARTED|Double-Blind Phase||440
5000111|NCT02345161|12302775|P2|NOT COMPLETED|Overall Study||57
5000112|NCT02345161|12302776|P1|NOT COMPLETED|Overall Study||45
5000113|NCT02345161|12302775|P2|COMPLETED|Overall Study||842
5000114|NCT02345161|12302776|P1|COMPLETED|Overall Study||866
5000115|NCT02345161|12302775|P2|STARTED|Overall Study||899
5000116|NCT02345161|12302776|P1|STARTED|Overall Study||911
5000117|NCT02345070|12302881|P3|NOT COMPLETED|Overall Study||23
5000118|NCT02345070|12302882|P2|NOT COMPLETED|Overall Study||11
5000119|NCT02345070|12302883|P1|NOT COMPLETED|Overall Study||20
5000120|NCT02345070|12302881|P3|COMPLETED|Overall Study||85
5000121|NCT02345070|12302882|P2|COMPLETED|Overall Study||98
5000122|NCT02345070|12302883|P1|COMPLETED|Overall Study||90
5000123|NCT02345070|12302881|P3|Treated|Overall Study||108
5000124|NCT02345070|12302882|P2|Treated|Overall Study||108
5000125|NCT02345070|12302883|P1|Treated|Overall Study||109
5000126|NCT02345070|12302881|P3|STARTED|Overall Study||108
5000127|NCT02345070|12302882|P2|STARTED|Overall Study||109
5000128|NCT02345070|12302883|P1|STARTED|Overall Study||110
5000129|NCT02345031|12302899|P2|NOT COMPLETED|Overall Study||1
5000130|NCT02345031|12302900|P1|NOT COMPLETED|Overall Study||1
5000131|NCT02345031|12302899|P2|COMPLETED|Overall Study||39
5000132|NCT02345031|12302900|P1|COMPLETED|Overall Study||37
5000133|NCT02345031|12302899|P2|STARTED|Overall Study||40
5000134|NCT02345031|12302900|P1|STARTED|Overall Study||38
5000135|NCT02344745|12302916|P2|NOT COMPLETED|Overall Study||0
5000136|NCT02344745|12302917|P1|NOT COMPLETED|Overall Study||2
5000137|NCT02344745|12302916|P2|COMPLETED|Overall Study||40
5000138|NCT02344745|12302917|P1|COMPLETED|Overall Study||38
5000139|NCT02344745|12302916|P2|STARTED|Overall Study||40
5000140|NCT02344745|12302917|P1|STARTED|Overall Study||40
5000141|NCT02344628|12302931|P2|NOT COMPLETED|Overall Study||86
5000142|NCT02344628|12302932|P1|NOT COMPLETED|Overall Study||91
5000143|NCT02344628|12302931|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
5000144|NCT02344628|12302932|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
5000145|NCT02344628|12302931|P2|STARTED|Overall Study||292
5000146|NCT02344628|12302932|P1|STARTED|Overall Study||291
5000147|NCT02344576|12302946|P4|NOT COMPLETED|12-Month Medical Record Follow-Up||0
5000148|NCT02344576|12302947|P3|NOT COMPLETED|12-Month Medical Record Follow-Up||0
5000149|NCT02344576|12302948|P2|NOT COMPLETED|12-Month Medical Record Follow-Up||0
5000150|NCT02344576|12302949|P1|NOT COMPLETED|12-Month Medical Record Follow-Up||0
5000151|NCT02344576|12302946|P4|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
5000152|NCT02344576|12302947|P3|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
5000153|NCT02344576|12302948|P2|COMPLETED|12-Month Medical Record Follow-Up||67
5000154|NCT02344576|12302949|P1|COMPLETED|12-Month Medical Record Follow-Up||98
5000155|NCT02344576|12302946|P4|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
5000156|NCT02344576|12302947|P3|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
5000157|NCT02344576|12302948|P2|STARTED|12-Month Medical Record Follow-Up||67
5000158|NCT02344576|12302949|P1|STARTED|12-Month Medical Record Follow-Up||98
5000159|NCT02344576|12302946|P4|NOT COMPLETED|6-Month Follow-Up||8
5000160|NCT02344576|12302947|P3|NOT COMPLETED|6-Month Follow-Up||14
5000161|NCT02344576|12302948|P2|NOT COMPLETED|6-Month Follow-Up||19
5000162|NCT02344576|12302949|P1|NOT COMPLETED|6-Month Follow-Up||19
5000163|NCT02344576|12302946|P4|COMPLETED|6-Month Follow-Up||50
5000164|NCT02344576|12302947|P3|COMPLETED|6-Month Follow-Up||78
5000165|NCT02344576|12302948|P2|COMPLETED|6-Month Follow-Up||67
5000166|NCT02344576|12302949|P1|COMPLETED|6-Month Follow-Up||98
5000167|NCT02344576|12302946|P4|Completed 6-Month Survey|6-Month Follow-Up||50
5000168|NCT02344576|12302947|P3|Completed 6-Month Survey|6-Month Follow-Up||78
5000169|NCT02344576|12302948|P2|Completed 6-Month Survey|6-Month Follow-Up||67
5000170|NCT02344576|12302949|P1|Completed 6-Month Survey|6-Month Follow-Up||98
5000171|NCT02344576|12302946|P4|STARTED|6-Month Follow-Up||58
5000172|NCT02344576|12302947|P3|STARTED|6-Month Follow-Up||92
5000173|NCT02344576|12302948|P2|STARTED|6-Month Follow-Up||86
5000174|NCT02344576|12302949|P1|STARTED|6-Month Follow-Up||117
5000175|NCT02344576|12302946|P4|NOT COMPLETED|1-Month Follow-Up||13
5000176|NCT02344576|12302947|P3|NOT COMPLETED|1-Month Follow-Up||19
5000177|NCT02344576|12302948|P2|NOT COMPLETED|1-Month Follow-Up||27
5000178|NCT02344576|12302949|P1|NOT COMPLETED|1-Month Follow-Up||18
5000179|NCT02344576|12302946|P4|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
5000180|NCT02344576|12302947|P3|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
5000181|NCT02344576|12302948|P2|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
5000182|NCT02344576|12302949|P1|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
5000184|NCT02344576|12302947|P3|Completed 1-Month Survey|1-Month Follow-Up||89
5000185|NCT02344576|12302948|P2|Completed 1-Month Survey|1-Month Follow-Up||79
5000186|NCT02344576|12302949|P1|Completed 1-Month Survey|1-Month Follow-Up||104
5000187|NCT02344576|12302946|P4|STARTED|1-Month Follow-Up||71
5000188|NCT02344576|12302947|P3|STARTED|1-Month Follow-Up||111
5000189|NCT02344576|12302948|P2|STARTED|1-Month Follow-Up||113
5000190|NCT02344576|12302949|P1|STARTED|1-Month Follow-Up||135
5000191|NCT02344576|12302946|P4|NOT COMPLETED|Enrollment||0
5000192|NCT02344576|12302947|P3|NOT COMPLETED|Enrollment||0
5000193|NCT02344576|12302948|P2|NOT COMPLETED|Enrollment||8
5000194|NCT02344576|12302949|P1|NOT COMPLETED|Enrollment||7
5000195|NCT02344576|12302946|P4|COMPLETED|Enrollment||71
5000196|NCT02344576|12302947|P3|COMPLETED|Enrollment||111
5000197|NCT02344576|12302948|P2|COMPLETED|Enrollment||113
5000198|NCT02344576|12302949|P1|COMPLETED|Enrollment||135
5000199|NCT02344576|12302946|P4|Agreed to Survey Data Collection|Enrollment||71
5000200|NCT02344576|12302947|P3|Agreed to Survey Data Collection|Enrollment||111
5000201|NCT02344576|12302948|P2|Agreed to Survey Data Collection|Enrollment||113
5000202|NCT02344576|12302949|P1|Agreed to Survey Data Collection|Enrollment||135
5000203|NCT02344576|12302946|P4|STARTED|Enrollment||71
5000204|NCT02344576|12302947|P3|STARTED|Enrollment||111
5000205|NCT02344576|12302948|P2|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
5000206|NCT02344576|12302949|P1|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
5000207|NCT02344407|12302995|P3|NOT COMPLETED|Overall Study||6
5000208|NCT02344407|12302996|P2|NOT COMPLETED|Overall Study||9
5000209|NCT02344407|12302997|P1|NOT COMPLETED|Overall Study||8
5000210|NCT02344407|12302995|P3|COMPLETED|Overall Study||494
5000211|NCT02344407|12302996|P2|COMPLETED|Overall Study||491
5000212|NCT02344407|12302997|P1|COMPLETED|Overall Study||492
5000213|NCT02344407|12302995|P3|STARTED|Overall Study||500
5000214|NCT02344407|12302996|P2|STARTED|Overall Study||500
5000215|NCT02344407|12302997|P1|STARTED|Overall Study||500
5000216|NCT02344342|12303012|P4|NOT COMPLETED|Overall Study||10
5000217|NCT02344342|12303013|P3|NOT COMPLETED|Overall Study||14
5000218|NCT02344342|12303014|P2|NOT COMPLETED|Overall Study||9
5000219|NCT02344342|12303015|P1|NOT COMPLETED|Overall Study||11
5000220|NCT02344342|12303012|P4|COMPLETED|Overall Study||3
5000221|NCT02344342|12303013|P3|COMPLETED|Overall Study||0
5000222|NCT02344342|12303014|P2|COMPLETED|Overall Study||2
5000223|NCT02344342|12303015|P1|COMPLETED|Overall Study||2
5000224|NCT02344342|12303012|P4|STARTED|Overall Study||13
5000225|NCT02344342|12303013|P3|STARTED|Overall Study||14
5000226|NCT02344342|12303014|P2|STARTED|Overall Study||11
5000227|NCT02344342|12303015|P1|STARTED|Overall Study||13
5000228|NCT02344251|12303039|P2|NOT COMPLETED|Overall Study||0
5000229|NCT02344251|12303040|P1|NOT COMPLETED|Overall Study||0
5000230|NCT02344251|12303039|P2|COMPLETED|Overall Study||20
5000231|NCT02344251|12303040|P1|COMPLETED|Overall Study||20
5000232|NCT02344251|12303039|P2|STARTED|Overall Study||20
5000233|NCT02344251|12303040|P1|STARTED|Overall Study||20
5000234|NCT02344238|12303051|P3|NOT COMPLETED|Overall Study||0
5000235|NCT02344238|12303052|P2|NOT COMPLETED|Overall Study||0
5000236|NCT02344238|12303053|P1|NOT COMPLETED|Overall Study||0
5000237|NCT02344238|12303051|P3|COMPLETED|Overall Study||20
5000238|NCT02344238|12303052|P2|COMPLETED|Overall Study||20
5000239|NCT02344238|12303053|P1|COMPLETED|Overall Study||20
5000240|NCT02344238|12303051|P3|STARTED|Overall Study||20
5000241|NCT02344238|12303052|P2|STARTED|Overall Study||20
5000242|NCT02344238|12303053|P1|STARTED|Overall Study||20
5000243|NCT02344225|12303065|P3|NOT COMPLETED|Overall Study||0
5000244|NCT02344225|12303066|P2|NOT COMPLETED|Overall Study||0
5000245|NCT02344225|12303067|P1|NOT COMPLETED|Overall Study||0
5000246|NCT02344225|12303065|P3|COMPLETED|Overall Study||5
5000247|NCT02344225|12303066|P2|COMPLETED|Overall Study||3
5000248|NCT02344225|12303067|P1|COMPLETED|Overall Study||6
5000249|NCT02344225|12303065|P3|STARTED|Overall Study||5
5000250|NCT02344225|12303066|P2|STARTED|Overall Study||3
5000251|NCT02344225|12303067|P1|STARTED|Overall Study||6
5000252|NCT02344173|12303081|P1|NOT COMPLETED|12-month Visit||96
5000253|NCT02344173|12303081|P1|COMPLETED|12-month Visit||1932
5000254|NCT02344173|12303081|P1|STARTED|12-month Visit||2028
5000255|NCT02344173|12303081|P1|NOT COMPLETED|Procedure||7
5000256|NCT02344173|12303081|P1|COMPLETED|Procedure||2028
5000257|NCT02344173|12303081|P1|STARTED|Procedure||2035
5000258|NCT02344173|12303081|P1|NOT COMPLETED|Enrollment||0
5000259|NCT02344173|12303081|P1|COMPLETED|Enrollment||2035
5000260|NCT02344173|12303081|P1|STARTED|Enrollment||2035
5000261|NCT02344004|12303089|P2|NOT COMPLETED|Overall Study||14
5000262|NCT02344004|12303090|P1|NOT COMPLETED|Overall Study||61
5000263|NCT02344004|12303089|P2|COMPLETED|Overall Study||98
5000264|NCT02344004|12303090|P1|COMPLETED|Overall Study||163
5000265|NCT02344004|12303089|P2|STARTED|Overall Study||112
5000266|NCT02344004|12303090|P1|STARTED|Overall Study||224
5000267|NCT02343939|12303117|P9|NOT COMPLETED|Overall Study||7
5000268|NCT02343939|12303118|P8|NOT COMPLETED|Overall Study||37
5000269|NCT02343939|12303119|P7|NOT COMPLETED|Overall Study||15
5000270|NCT02343939|12303120|P6|NOT COMPLETED|Overall Study||17
5000271|NCT02343939|12303121|P5|NOT COMPLETED|Overall Study||8
5000272|NCT02343939|12303122|P4|NOT COMPLETED|Overall Study||6
5000273|NCT02343939|12303123|P3|NOT COMPLETED|Overall Study||5
5000274|NCT02343939|12303124|P2|NOT COMPLETED|Overall Study||48
5000275|NCT02343939|12303125|P1|NOT COMPLETED|Overall Study||3
5000276|NCT02343939|12303117|P9|COMPLETED|Overall Study||0
5000277|NCT02343939|12303118|P8|COMPLETED|Overall Study||0
5000278|NCT02343939|12303119|P7|COMPLETED|Overall Study||0
5000279|NCT02343939|12303120|P6|COMPLETED|Overall Study||0
5000280|NCT02343939|12303121|P5|COMPLETED|Overall Study||0
5000281|NCT02343939|12303122|P4|COMPLETED|Overall Study||0
5000282|NCT02343939|12303123|P3|COMPLETED|Overall Study||0
5000283|NCT02343939|12303124|P2|COMPLETED|Overall Study||2
5000284|NCT02343939|12303125|P1|COMPLETED|Overall Study||0
5000285|NCT02343939|12303117|P9|STARTED|Overall Study||7
5000286|NCT02343939|12303118|P8|STARTED|Overall Study||37
5000287|NCT02343939|12303119|P7|STARTED|Overall Study||15
5000288|NCT02343939|12303120|P6|STARTED|Overall Study||17
5000289|NCT02343939|12303121|P5|STARTED|Overall Study||8
5000290|NCT02343939|12303122|P4|STARTED|Overall Study||6
5000291|NCT02343939|12303123|P3|STARTED|Overall Study||5
5000292|NCT02343939|12303124|P2|STARTED|Overall Study||50
5000293|NCT02343939|12303125|P1|STARTED|Overall Study||3
5000294|NCT02343627|12303237|P2|NOT COMPLETED|Overall Study||1
5000295|NCT02343627|12303238|P1|NOT COMPLETED|Overall Study||12
5000296|NCT02343627|12303237|P2|COMPLETED|Overall Study||11
5000297|NCT02343627|12303238|P1|COMPLETED|Overall Study||23
5000298|NCT02343627|12303237|P2|STARTED|Overall Study||12
5000299|NCT02343627|12303238|P1|STARTED|Overall Study||35
5000300|NCT02343575|12303246|P2|NOT COMPLETED|Overall Study||0
5000301|NCT02343575|12303247|P1|NOT COMPLETED|Overall Study||0
5000302|NCT02343575|12303246|P2|COMPLETED|Overall Study||2
5000303|NCT02343575|12303247|P1|COMPLETED|Overall Study||1
5000304|NCT02343575|12303246|P2|STARTED|Overall Study||2
5000305|NCT02343575|12303247|P1|STARTED|Overall Study||1
5000306|NCT02343458|12303267|P4|NOT COMPLETED|Overall Study||38
5000307|NCT02343458|12303268|P3|NOT COMPLETED|Overall Study||63
5000308|NCT02343458|12303269|P2|NOT COMPLETED|Overall Study||66
5000309|NCT02343458|12303270|P1|NOT COMPLETED|Overall Study||61
5000310|NCT02343458|12303267|P4|COMPLETED|Overall Study||200
5000311|NCT02343458|12303268|P3|COMPLETED|Overall Study||417
5000312|NCT02343458|12303269|P2|COMPLETED|Overall Study||417
5000313|NCT02343458|12303270|P1|COMPLETED|Overall Study||494
5000314|NCT02343458|12303267|P4|STARTED|Overall Study||238
5000315|NCT02343458|12303268|P3|STARTED|Overall Study||480
5000316|NCT02343458|12303269|P2|STARTED|Overall Study||483
5000317|NCT02343458|12303270|P1|STARTED|Overall Study||555
5000318|NCT02343406|12303349|P5|NOT COMPLETED|Overall Study||5
5000319|NCT02343406|12303350|P4|NOT COMPLETED|Overall Study||26
5000320|NCT02343406|12303351|P3|NOT COMPLETED|Overall Study||58
5000321|NCT02343406|12303352|P2|NOT COMPLETED|Overall Study||86
5000322|NCT02343406|12303353|P1|NOT COMPLETED|Overall Study||88
5000323|NCT02343406|12303349|P5|COMPLETED|Overall Study||1
5000324|NCT02343406|12303350|P4|COMPLETED|Overall Study||0
5000325|NCT02343406|12303351|P3|COMPLETED|Overall Study||2
5000326|NCT02343406|12303352|P2|COMPLETED|Overall Study||0
5000327|NCT02343406|12303353|P1|COMPLETED|Overall Study||0
5000328|NCT02343406|12303349|P5|STARTED|Overall Study||6
5000329|NCT02343406|12303350|P4|STARTED|Overall Study||26
5000330|NCT02343406|12303351|P3|STARTED|Overall Study||60
5000331|NCT02343406|12303352|P2|STARTED|Overall Study||86
5000332|NCT02343406|12303353|P1|STARTED|Overall Study||88
5000333|NCT02343380|12303388|P2|NOT COMPLETED|Overall Study||0
5000334|NCT02343380|12303389|P1|NOT COMPLETED|Overall Study||0
5000335|NCT02343380|12303388|P2|COMPLETED|Overall Study|Morning test (second week)|10
5000336|NCT02343380|12303389|P1|COMPLETED|Overall Study|Evening test (second week)|10
5000337|NCT02343380|12303388|P2|STARTED|Overall Study|Evening test (first week)|10
5000338|NCT02343380|12303389|P1|STARTED|Overall Study|Morning test (first week)|10
5000339|NCT02343276|12303407|P2|NOT COMPLETED|Overall Study||0
5000340|NCT02343276|12303408|P1|NOT COMPLETED|Overall Study||0
5000341|NCT02343276|12303407|P2|COMPLETED|Overall Study||164
5000342|NCT02343276|12303408|P1|COMPLETED|Overall Study||164
5000343|NCT02343276|12303407|P2|STARTED|Overall Study||164
5000344|NCT02343276|12303408|P1|STARTED|Overall Study||164
5000345|NCT02343263|12303421|P3|NOT COMPLETED|Overall Study||1
5000346|NCT02343263|12303422|P2|NOT COMPLETED|Overall Study||3
5000347|NCT02343263|12303423|P1|NOT COMPLETED|Overall Study||5
5000348|NCT02343263|12303421|P3|COMPLETED|Overall Study||0
5000349|NCT02343263|12303422|P2|COMPLETED|Overall Study||0
5000350|NCT02343263|12303423|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
5000351|NCT02343263|12303421|P3|STARTED|Overall Study||1
5000352|NCT02343263|12303422|P2|STARTED|Overall Study||3
5000353|NCT02343263|12303423|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
5000354|NCT02343159|12303452|P3|NOT COMPLETED|Overall Study||30
5000355|NCT02343159|12303453|P2|NOT COMPLETED|Overall Study||26
5000356|NCT02343159|12303454|P1|NOT COMPLETED|Overall Study||26
5000357|NCT02343159|12303452|P3|COMPLETED|Overall Study||0
5000358|NCT02343159|12303453|P2|COMPLETED|Overall Study||1
5000359|NCT02343159|12303454|P1|COMPLETED|Overall Study||1
5000360|NCT02343159|12303452|P3|STARTED|Overall Study||30
5000361|NCT02343159|12303453|P2|STARTED|Overall Study||27
5000362|NCT02343159|12303454|P1|STARTED|Overall Study||27
5000363|NCT02343081|12303481|P2|NOT COMPLETED|Second Intervention (Day 4)||0
5000364|NCT02343081|12303482|P1|NOT COMPLETED|Second Intervention (Day 4)||0
5000365|NCT02343081|12303481|P2|COMPLETED|Second Intervention (Day 4)||8
5000366|NCT02343081|12303482|P1|COMPLETED|Second Intervention (Day 4)||8
5000367|NCT02343081|12303481|P2|Received Intervention|Second Intervention (Day 4)||8
5000368|NCT02343081|12303482|P1|Received Intervention|Second Intervention (Day 4)||8
5000369|NCT02343081|12303481|P2|STARTED|Second Intervention (Day 4)||8
5000370|NCT02343081|12303482|P1|STARTED|Second Intervention (Day 4)||8
5000371|NCT02343081|12303481|P2|NOT COMPLETED|Washout (10 Hours)||0
5000372|NCT02343081|12303482|P1|NOT COMPLETED|Washout (10 Hours)||0
5000373|NCT02343081|12303481|P2|COMPLETED|Washout (10 Hours)||8
5000374|NCT02343081|12303482|P1|COMPLETED|Washout (10 Hours)||8
5000375|NCT02343081|12303481|P2|STARTED|Washout (10 Hours)||8
5000376|NCT02343081|12303482|P1|STARTED|Washout (10 Hours)||8
5000377|NCT02343081|12303481|P2|NOT COMPLETED|First Intervention (Day 3)||0
5000378|NCT02343081|12303482|P1|NOT COMPLETED|First Intervention (Day 3)||0
5000379|NCT02343081|12303481|P2|COMPLETED|First Intervention (Day 3)||8
5000380|NCT02343081|12303482|P1|COMPLETED|First Intervention (Day 3)||8
5000381|NCT02343081|12303481|P2|Received Intervention|First Intervention (Day 3)||8
5000382|NCT02343081|12303482|P1|Received Intervention|First Intervention (Day 3)||8
5000383|NCT02343081|12303481|P2|STARTED|First Intervention (Day 3)||8
5000384|NCT02343081|12303482|P1|STARTED|First Intervention (Day 3)||8
5000385|NCT02343003|12303498|P2|NOT COMPLETED|Overall Study||7
5000386|NCT02343003|12303499|P1|NOT COMPLETED|Overall Study||18
5000387|NCT02343003|12303498|P2|COMPLETED|Overall Study||68
5000388|NCT02343003|12303499|P1|COMPLETED|Overall Study||58
5000389|NCT02343003|12303498|P2|STARTED|Overall Study||75
5000390|NCT02343003|12303499|P1|STARTED|Overall Study||76
5000391|NCT02342886|12303520|P5|NOT COMPLETED|Overall Study||3
5000392|NCT02342886|12303521|P4|NOT COMPLETED|Overall Study||9
5000393|NCT02342886|12303522|P3|NOT COMPLETED|Overall Study||15
5000394|NCT02342886|12303523|P2|NOT COMPLETED|Overall Study||8
5000395|NCT02342886|12303524|P1|NOT COMPLETED|Overall Study||8
5000396|NCT02342886|12303520|P5|COMPLETED|Overall Study||10
5000397|NCT02342886|12303521|P4|COMPLETED|Overall Study||59
5000398|NCT02342886|12303522|P3|COMPLETED|Overall Study||52
5000399|NCT02342886|12303523|P2|COMPLETED|Overall Study||63
5000400|NCT02342886|12303524|P1|COMPLETED|Overall Study||57
5000401|NCT02342886|12303520|P5|Completed Month 24 Follow-Up|Overall Study||10
5000402|NCT02342886|12303521|P4|Completed Month 24 Follow-Up|Overall Study||53
5000403|NCT02342886|12303522|P3|Completed Month 24 Follow-Up|Overall Study||46
5000404|NCT02342886|12303523|P2|Completed Month 24 Follow-Up|Overall Study||47
5000405|NCT02342886|12303524|P1|Completed Month 24 Follow-Up|Overall Study||40
5000406|NCT02342886|12303520|P5|Completed Month 12 Follow-Up|Overall Study||10
5000407|NCT02342886|12303521|P4|Completed Month 12 Follow-Up|Overall Study||57
5000408|NCT02342886|12303522|P3|Completed Month 12 Follow-Up|Overall Study||49
5000409|NCT02342886|12303523|P2|Completed Month 12 Follow-Up|Overall Study||52
5000410|NCT02342886|12303524|P1|Completed Month 12 Follow-Up|Overall Study||43
5000411|NCT02342886|12303520|P5|STARTED|Overall Study||13
5000412|NCT02342886|12303521|P4|STARTED|Overall Study||68
5000413|NCT02342886|12303522|P3|STARTED|Overall Study||67
5000414|NCT02342886|12303523|P2|STARTED|Overall Study||71
5000415|NCT02342886|12303524|P1|STARTED|Overall Study||65
5000416|NCT02342743|12303541|P1|NOT COMPLETED|Treatment Period||11
5000417|NCT02342743|12303541|P1|COMPLETED|Treatment Period||47
5000418|NCT02342743|12303541|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
5000419|NCT02342743|12303541|P1|NOT COMPLETED|Baseline Period||15
5000420|NCT02342743|12303541|P1|COMPLETED|Baseline Period||58
5000421|NCT02342743|12303541|P1|STARTED|Baseline Period||73
5000422|NCT02342704|12303554|P2|NOT COMPLETED|Overall Study||51
5000423|NCT02342704|12303555|P1|NOT COMPLETED|Overall Study||53
5000424|NCT02342704|12303554|P2|COMPLETED|Overall Study||3
5000425|NCT02342704|12303555|P1|COMPLETED|Overall Study||1
5000426|NCT02342704|12303554|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
5000427|NCT02342704|12303555|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
5000428|NCT02342678|12303583|P2|NOT COMPLETED|Overall Study||5
5000429|NCT02342678|12303584|P1|NOT COMPLETED|Overall Study||1
5000430|NCT02342678|12303583|P2|COMPLETED|Overall Study||23
5000431|NCT02342678|12303584|P1|COMPLETED|Overall Study||27
5000432|NCT02342678|12303583|P2|STARTED|Overall Study||28
5000433|NCT02342678|12303584|P1|STARTED|Overall Study||28
5000434|NCT02342561|12303604|P1|NOT COMPLETED|Overall Study||0
5000435|NCT02342561|12303604|P1|COMPLETED|Overall Study||20
5000436|NCT02342561|12303604|P1|STARTED|Overall Study||20
5000437|NCT02342548|12303615|P3|NOT COMPLETED|Overall Study||43
5000438|NCT02342548|12303616|P2|NOT COMPLETED|Overall Study||62
5000439|NCT02342548|12303617|P1|NOT COMPLETED|Overall Study||34
5000440|NCT02342548|12303615|P3|COMPLETED|Overall Study||23
5000441|NCT02342548|12303616|P2|COMPLETED|Overall Study||9
5000442|NCT02342548|12303617|P1|COMPLETED|Overall Study||17
5000443|NCT02342548|12303615|P3|STARTED|Overall Study||66
5000444|NCT02342548|12303616|P2|STARTED|Overall Study||71
5000445|NCT02342548|12303617|P1|STARTED|Overall Study||51
5000446|NCT02342535|12303655|P1|NOT COMPLETED|Overall Study||0
5000447|NCT02342535|12303655|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
5000448|NCT02342535|12303655|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
5000449|NCT02342418|12303661|P2|NOT COMPLETED|Overall Study||1
5000450|NCT02342418|12303662|P1|NOT COMPLETED|Overall Study||0
5000451|NCT02342418|12303661|P2|COMPLETED|Overall Study||9
5000452|NCT02342418|12303662|P1|COMPLETED|Overall Study||9
5000453|NCT02342418|12303661|P2|STARTED|Overall Study||10
5000454|NCT02342418|12303662|P1|STARTED|Overall Study||9
5000455|NCT02342379|12303670|P1|NOT COMPLETED|Overall Study||0
5000456|NCT02342379|12303670|P1|COMPLETED|Overall Study||35
5000457|NCT02342379|12303670|P1|STARTED|Overall Study||35
5000458|NCT02342314|12303677|P17|NOT COMPLETED|Part B||0
5000459|NCT02342314|12303678|P16|NOT COMPLETED|Part B||0
5000460|NCT02342314|12303679|P15|NOT COMPLETED|Part B||0
5000461|NCT02342314|12303680|P14|NOT COMPLETED|Part B||0
5000462|NCT02342314|12303681|P13|NOT COMPLETED|Part B||0
5000463|NCT02342314|12303682|P12|NOT COMPLETED|Part B||0
5000464|NCT02342314|12303683|P11|NOT COMPLETED|Part B||0
5000465|NCT02342314|12303684|P10|NOT COMPLETED|Part B||0
5000466|NCT02342314|12303685|P9|NOT COMPLETED|Part B||0
5000467|NCT02342314|12303686|P8|NOT COMPLETED|Part B||0
5000468|NCT02342314|12303687|P7|NOT COMPLETED|Part B||0
5000469|NCT02342314|12303688|P6|NOT COMPLETED|Part B||0
5000470|NCT02342314|12303689|P5|NOT COMPLETED|Part B||0
5000471|NCT02342314|12303690|P4|NOT COMPLETED|Part B||0
5000472|NCT02342314|12303691|P3|NOT COMPLETED|Part B||0
5000473|NCT02342314|12303692|P2|NOT COMPLETED|Part B||0
5000474|NCT02342314|12303693|P1|NOT COMPLETED|Part B||0
5000475|NCT02342314|12303677|P17|COMPLETED|Part B||6
5000476|NCT02342314|12303678|P16|COMPLETED|Part B||3
5000477|NCT02342314|12303679|P15|COMPLETED|Part B||3
5000478|NCT02342314|12303680|P14|COMPLETED|Part B||3
5000479|NCT02342314|12303681|P13|COMPLETED|Part B||3
5000480|NCT02342314|12303682|P12|COMPLETED|Part B||3
5000481|NCT02342314|12303683|P11|COMPLETED|Part B||3
5000482|NCT02342314|12303684|P10|COMPLETED|Part B||3
5000483|NCT02342314|12303685|P9|COMPLETED|Part B||3
5000484|NCT02342314|12303686|P8|COMPLETED|Part B||3
5000485|NCT02342314|12303687|P7|COMPLETED|Part B||11
5000486|NCT02342314|12303688|P6|COMPLETED|Part B||0
5000487|NCT02342314|12303689|P5|COMPLETED|Part B||0
5000488|NCT02342314|12303690|P4|COMPLETED|Part B||0
5000489|NCT02342314|12303691|P3|COMPLETED|Part B||0
5000490|NCT02342314|12303692|P2|COMPLETED|Part B||0
5000491|NCT02342314|12303693|P1|COMPLETED|Part B||0
5000492|NCT02342314|12303677|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
5000493|NCT02342314|12303678|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000494|NCT02342314|12303679|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000495|NCT02342314|12303680|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000496|NCT02342314|12303681|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000497|NCT02342314|12303682|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000498|NCT02342314|12303683|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000499|NCT02342314|12303684|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000500|NCT02342314|12303685|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000501|NCT02342314|12303686|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
5000502|NCT02342314|12303687|P7|STARTED|Part B|Participants received placebo in Part B.|11
5000503|NCT02342314|12303688|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
5000504|NCT02342314|12303689|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
5000505|NCT02342314|12303690|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
5000506|NCT02342314|12303691|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
5000507|NCT02342314|12303692|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
5000508|NCT02342314|12303693|P1|STARTED|Part B|Participants received placebo in Part A.|0
5000509|NCT02342314|12303677|P17|NOT COMPLETED|Part A||0
5000510|NCT02342314|12303678|P16|NOT COMPLETED|Part A||0
5000511|NCT02342314|12303679|P15|NOT COMPLETED|Part A||0
5000512|NCT02342314|12303680|P14|NOT COMPLETED|Part A||0
5000513|NCT02342314|12303681|P13|NOT COMPLETED|Part A||0
5000514|NCT02342314|12303682|P12|NOT COMPLETED|Part A||0
5000515|NCT02342314|12303683|P11|NOT COMPLETED|Part A||0
5000516|NCT02342314|12303684|P10|NOT COMPLETED|Part A||0
5000517|NCT02342314|12303685|P9|NOT COMPLETED|Part A||0
5000518|NCT02342314|12303686|P8|NOT COMPLETED|Part A||0
5000519|NCT02342314|12303687|P7|NOT COMPLETED|Part A||0
5000520|NCT02342314|12303688|P6|NOT COMPLETED|Part A||0
5000521|NCT02342314|12303689|P5|NOT COMPLETED|Part A||0
5000522|NCT02342314|12303690|P4|NOT COMPLETED|Part A||0
5000523|NCT02342314|12303691|P3|NOT COMPLETED|Part A||0
5000524|NCT02342314|12303692|P2|NOT COMPLETED|Part A||0
5000525|NCT02342314|12303693|P1|NOT COMPLETED|Part A||0
5000526|NCT02342314|12303677|P17|COMPLETED|Part A||0
5000527|NCT02342314|12303678|P16|COMPLETED|Part A||0
5000528|NCT02342314|12303679|P15|COMPLETED|Part A||0
5000529|NCT02342314|12303680|P14|COMPLETED|Part A||0
5000530|NCT02342314|12303681|P13|COMPLETED|Part A||0
5000531|NCT02342314|12303682|P12|COMPLETED|Part A||0
5000532|NCT02342314|12303683|P11|COMPLETED|Part A||0
5000533|NCT02342314|12303684|P10|COMPLETED|Part A||0
5000534|NCT02342314|12303685|P9|COMPLETED|Part A||0
5000535|NCT02342314|12303686|P8|COMPLETED|Part A||0
5000536|NCT02342314|12303687|P7|COMPLETED|Part A||0
5000537|NCT02342314|12303688|P6|COMPLETED|Part A||3
5000538|NCT02342314|12303689|P5|COMPLETED|Part A||6
5000539|NCT02342314|12303690|P4|COMPLETED|Part A||3
5000540|NCT02342314|12303691|P3|COMPLETED|Part A||3
5000541|NCT02342314|12303692|P2|COMPLETED|Part A||3
5000542|NCT02342314|12303693|P1|COMPLETED|Part A||6
5000543|NCT02342314|12303677|P17|STARTED|Part A||0
5000544|NCT02342314|12303678|P16|STARTED|Part A||0
5000545|NCT02342314|12303679|P15|STARTED|Part A||0
5000546|NCT02342314|12303680|P14|STARTED|Part A||0
5000547|NCT02342314|12303681|P13|STARTED|Part A||0
5000548|NCT02342314|12303682|P12|STARTED|Part A||0
5000549|NCT02342314|12303683|P11|STARTED|Part A||0
5000550|NCT02342314|12303684|P10|STARTED|Part A||0
5000551|NCT02342314|12303685|P9|STARTED|Part A||0
5000552|NCT02342314|12303686|P8|STARTED|Part A||0
5000553|NCT02342314|12303687|P7|STARTED|Part A||0
5000554|NCT02342314|12303688|P6|STARTED|Part A||3
5000555|NCT02342314|12303689|P5|STARTED|Part A||6
5000556|NCT02342314|12303690|P4|STARTED|Part A||3
5000557|NCT02342314|12303691|P3|STARTED|Part A||3
5000558|NCT02342314|12303692|P2|STARTED|Part A||3
5000559|NCT02342314|12303693|P1|STARTED|Part A||6
5000560|NCT02342288|12303841|P2|NOT COMPLETED|Overall Study||6
5000561|NCT02342288|12303842|P1|NOT COMPLETED|Overall Study||5
5000562|NCT02342288|12303841|P2|COMPLETED|Overall Study||27
5000563|NCT02342288|12303842|P1|COMPLETED|Overall Study||25
5000564|NCT02342288|12303841|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
5000565|NCT02342288|12303842|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
5000566|NCT02342223|12303848|P1|NOT COMPLETED|Overall Study||1
5000567|NCT02342223|12303848|P1|COMPLETED|Overall Study||19
5000568|NCT02342223|12303848|P1|STARTED|Overall Study||20
5000569|NCT02342197|12303859|P2|NOT COMPLETED|Overall Study||2
5000570|NCT02342197|12303860|P1|NOT COMPLETED|Overall Study||3
5000571|NCT02342197|12303859|P2|COMPLETED|Overall Study||28
5000572|NCT02342197|12303860|P1|COMPLETED|Overall Study||27
5000573|NCT02342197|12303859|P2|STARTED|Overall Study||30
5000574|NCT02342197|12303860|P1|STARTED|Overall Study||30
5000575|NCT02342171|12303868|P2|NOT COMPLETED|Overall Study||89
5000576|NCT02342171|12303869|P1|NOT COMPLETED|Overall Study||15
5000577|NCT02342171|12303868|P2|COMPLETED|Overall Study||418
5000578|NCT02342171|12303869|P1|COMPLETED|Overall Study||84
5000579|NCT02342171|12303868|P2|STARTED|Overall Study||507
5000580|NCT02342171|12303869|P1|STARTED|Overall Study||99
5000581|NCT02341859|12303885|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5000582|NCT02341859|12303886|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5000583|NCT02341859|12303885|P2|COMPLETED|Second Intervention (1 Day)||9
5000584|NCT02341859|12303886|P1|COMPLETED|Second Intervention (1 Day)||10
5000585|NCT02341859|12303885|P2|STARTED|Second Intervention (1 Day)||9
5000586|NCT02341859|12303886|P1|STARTED|Second Intervention (1 Day)||10
5000587|NCT02341859|12303885|P2|NOT COMPLETED|First Intervention (1 Day)||0
5000588|NCT02341859|12303886|P1|NOT COMPLETED|First Intervention (1 Day)||0
5000589|NCT02341859|12303885|P2|COMPLETED|First Intervention (1 Day)||9
5000590|NCT02341859|12303886|P1|COMPLETED|First Intervention (1 Day)||10
5000591|NCT02341859|12303885|P2|STARTED|First Intervention (1 Day)||9
5000592|NCT02341859|12303886|P1|STARTED|First Intervention (1 Day)||10
5000593|NCT02341599|12304044|P5|NOT COMPLETED|Overall Study||0
5000594|NCT02341599|12304045|P4|NOT COMPLETED|Overall Study||0
5000595|NCT02341599|12304046|P3|NOT COMPLETED|Overall Study||0
5000596|NCT02341599|12304047|P2|NOT COMPLETED|Overall Study||0
5000597|NCT02341599|12304048|P1|NOT COMPLETED|Overall Study||0
5000598|NCT02341599|12304044|P5|COMPLETED|Overall Study||8
5000599|NCT02341599|12304045|P4|COMPLETED|Overall Study||8
5000600|NCT02341599|12304046|P3|COMPLETED|Overall Study||8
5000601|NCT02341599|12304047|P2|COMPLETED|Overall Study||8
5000602|NCT02341599|12304048|P1|COMPLETED|Overall Study||8
5000603|NCT02341599|12304044|P5|STARTED|Overall Study||8
5000604|NCT02341599|12304045|P4|STARTED|Overall Study||8
5000605|NCT02341599|12304046|P3|STARTED|Overall Study||8
5000606|NCT02341599|12304047|P2|STARTED|Overall Study||8
5000607|NCT02341599|12304048|P1|STARTED|Overall Study||8
5000608|NCT02341495|12304116|P1|NOT COMPLETED|Overall Study||0
5000609|NCT02341495|12304116|P1|COMPLETED|Overall Study||4
5000610|NCT02341495|12304116|P1|STARTED|Overall Study||4
5000611|NCT02341482|12304123|P1|NOT COMPLETED|Overall Study||1
5000612|NCT02341482|12304123|P1|COMPLETED|Overall Study||12
5000613|NCT02341482|12304123|P1|STARTED|Overall Study||13
5000614|NCT02341456|12304152|P3|NOT COMPLETED|Overall Study||4
5000615|NCT02341456|12304153|P2|NOT COMPLETED|Overall Study||6
5000616|NCT02341456|12304154|P1|NOT COMPLETED|Overall Study||4
5000617|NCT02341456|12304152|P3|COMPLETED|Overall Study||2
5000618|NCT02341456|12304153|P2|COMPLETED|Overall Study||0
5000619|NCT02341456|12304154|P1|COMPLETED|Overall Study||3
5000620|NCT02341456|12304152|P3|STARTED|Overall Study||6
5000621|NCT02341456|12304153|P2|STARTED|Overall Study||6
5000622|NCT02341456|12304154|P1|STARTED|Overall Study||7
5000623|NCT02341417|12304279|P3|NOT COMPLETED|Overall Study||1
5000624|NCT02341417|12304280|P2|NOT COMPLETED|Overall Study||2
5000625|NCT02341417|12304281|P1|NOT COMPLETED|Overall Study||2
5000626|NCT02341417|12304279|P3|COMPLETED|Overall Study||0
5000627|NCT02341417|12304280|P2|COMPLETED|Overall Study||12
5000628|NCT02341417|12304281|P1|COMPLETED|Overall Study||11
5000629|NCT02341417|12304279|P3|STARTED|Overall Study||1
5000630|NCT02341417|12304280|P2|STARTED|Overall Study||14
5000631|NCT02341417|12304281|P1|STARTED|Overall Study||13
5000632|NCT02341144|12304325|P2|NOT COMPLETED|Overall Study||1
5000633|NCT02341144|12304326|P1|NOT COMPLETED|Overall Study||2
5000634|NCT02341144|12304325|P2|COMPLETED|Overall Study||30
5000635|NCT02341144|12304326|P1|COMPLETED|Overall Study||28
5000636|NCT02341144|12304325|P2|STARTED|Overall Study||31
5000637|NCT02341144|12304326|P1|STARTED|Overall Study||30
5000638|NCT02340975|12304346|P6|NOT COMPLETED|Overall Study||19
5000639|NCT02340975|12304347|P5|NOT COMPLETED|Overall Study||25
5000640|NCT02340975|12304348|P4|NOT COMPLETED|Overall Study||12
5000641|NCT02340975|12304349|P3|NOT COMPLETED|Overall Study||24
5000642|NCT02340975|12304350|P2|NOT COMPLETED|Overall Study||27
5000643|NCT02340975|12304351|P1|NOT COMPLETED|Overall Study||6
5000644|NCT02340975|12304346|P6|COMPLETED|Overall Study||0
5000645|NCT02340975|12304347|P5|COMPLETED|Overall Study||0
5000646|NCT02340975|12304348|P4|COMPLETED|Overall Study||0
5000647|NCT02340975|12304349|P3|COMPLETED|Overall Study||0
5000648|NCT02340975|12304350|P2|COMPLETED|Overall Study||0
5000649|NCT02340975|12304351|P1|COMPLETED|Overall Study||0
5000650|NCT02340975|12304346|P6|STARTED|Overall Study||19
5000651|NCT02340975|12304347|P5|STARTED|Overall Study||25
5000652|NCT02340975|12304348|P4|STARTED|Overall Study||12
5000653|NCT02340975|12304349|P3|STARTED|Overall Study||24
5000654|NCT02340975|12304350|P2|STARTED|Overall Study||27
5000655|NCT02340975|12304351|P1|STARTED|Overall Study||6
5000656|NCT02340962|12304465|P2|NOT COMPLETED|Overall Study||0
5000657|NCT02340962|12304466|P1|NOT COMPLETED|Overall Study||1
5000658|NCT02340962|12304465|P2|COMPLETED|Overall Study||12
5000659|NCT02340962|12304466|P1|COMPLETED|Overall Study||12
5000660|NCT02340962|12304465|P2|STARTED|Overall Study||12
5000661|NCT02340962|12304466|P1|STARTED|Overall Study||13
5000662|NCT02340819|12304486|P1|NOT COMPLETED|Overall Study||4
5000663|NCT02340819|12304486|P1|COMPLETED|Overall Study||7
5000664|NCT02340819|12304486|P1|Completed Stage 4|Overall Study||7
5000665|NCT02340819|12304486|P1|Started Stage 4|Overall Study||7
5000666|NCT02340819|12304486|P1|Completed Stage 3|Overall Study||7
5000667|NCT02340819|12304486|P1|Started Stage 3|Overall Study||8
5000668|NCT02340819|12304486|P1|Completed Stage 2|Overall Study||9
5000669|NCT02340819|12304486|P1|Started Stage 2|Overall Study||11
5000670|NCT02340819|12304486|P1|STARTED|Overall Study||11
5000671|NCT02340806|12304515|P2|NOT COMPLETED|Overall Study||4
5000672|NCT02340806|12304516|P1|NOT COMPLETED|Overall Study||6
5000673|NCT02340806|12304515|P2|COMPLETED|Overall Study||108
5000674|NCT02340806|12304516|P1|COMPLETED|Overall Study||102
5000675|NCT02340806|12304515|P2|STARTED|Overall Study||112
5000676|NCT02340806|12304516|P1|STARTED|Overall Study||108
5000677|NCT02340780|12304542|P1|NOT COMPLETED|Overall Study||1
5000678|NCT02340780|12304542|P1|COMPLETED|Overall Study||13
5000679|NCT02340780|12304542|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
5000680|NCT02340767|12304556|P9|NOT COMPLETED|Overall Study||0
5000681|NCT02340767|12304557|P8|NOT COMPLETED|Overall Study||0
5000682|NCT02340767|12304558|P7|NOT COMPLETED|Overall Study||0
5000683|NCT02340767|12304559|P6|NOT COMPLETED|Overall Study||0
5000684|NCT02340767|12304560|P5|NOT COMPLETED|Overall Study||0
5000685|NCT02340767|12304561|P4|NOT COMPLETED|Overall Study||0
5000686|NCT02340767|12304562|P3|NOT COMPLETED|Overall Study||0
5000687|NCT02340767|12304563|P2|NOT COMPLETED|Overall Study||0
5000688|NCT02340767|12304564|P1|NOT COMPLETED|Overall Study||0
5000689|NCT02340767|12304556|P9|COMPLETED|Overall Study||531
5000690|NCT02340767|12304557|P8|COMPLETED|Overall Study||444
5000691|NCT02340767|12304558|P7|COMPLETED|Overall Study||525
5000692|NCT02340767|12304559|P6|COMPLETED|Overall Study||526
5000693|NCT02340767|12304560|P5|COMPLETED|Overall Study||474
5000694|NCT02340767|12304561|P4|COMPLETED|Overall Study||500
5000695|NCT02340767|12304562|P3|COMPLETED|Overall Study||29
5000696|NCT02340767|12304563|P2|COMPLETED|Overall Study||28
5000697|NCT02340767|12304564|P1|COMPLETED|Overall Study||28
5000698|NCT02340767|12304556|P9|STARTED|Overall Study||531
5000699|NCT02340767|12304557|P8|STARTED|Overall Study||444
5000700|NCT02340767|12304558|P7|STARTED|Overall Study||525
5000701|NCT02340767|12304559|P6|STARTED|Overall Study||526
5000702|NCT02340767|12304560|P5|STARTED|Overall Study||474
5000703|NCT02340767|12304561|P4|STARTED|Overall Study||500
5000704|NCT02340767|12304562|P3|STARTED|Overall Study||29
5000705|NCT02340767|12304563|P2|STARTED|Overall Study||28
5000706|NCT02340767|12304564|P1|STARTED|Overall Study||28
5000707|NCT02340715|12304580|P1|NOT COMPLETED|Overall Study||0
5000708|NCT02340715|12304580|P1|COMPLETED|Overall Study|158|158
5000709|NCT02340715|12304580|P1|STARTED|Overall Study|158|158
5000710|NCT02340676|12304584|P1|NOT COMPLETED|Overall Study||0
5000711|NCT02340676|12304584|P1|COMPLETED|Overall Study||25
5000712|NCT02340676|12304584|P1|STARTED|Overall Study||25
5000713|NCT02340663|12304597|P2|NOT COMPLETED|Overall Study||1
5000714|NCT02340663|12304598|P1|NOT COMPLETED|Overall Study||5
5000715|NCT02340663|12304597|P2|COMPLETED|Overall Study||31
5000716|NCT02340663|12304598|P1|COMPLETED|Overall Study||30
5000717|NCT02340663|12304597|P2|4 Month Follow-up, Assessments|Overall Study||31
5000718|NCT02340663|12304598|P1|4 Month Follow-up, Assessments|Overall Study||30
5000719|NCT02340663|12304597|P2|1 Week Follow-up, Assessments|Overall Study||31
5000720|NCT02340663|12304598|P1|1 Week Follow-up, Assessments|Overall Study||33
5000721|NCT02340663|12304597|P2|Splint Delivery, Assessments|Overall Study||31
5000722|NCT02340663|12304598|P1|Splint Delivery, Assessments|Overall Study||33
5000723|NCT02340663|12304597|P2|Clinical Exam, Impressions|Overall Study||32
5000724|NCT02340663|12304598|P1|Clinical Exam, Impressions|Overall Study||35
5000725|NCT02340663|12304597|P2|STARTED|Overall Study||32
5000726|NCT02340663|12304598|P1|STARTED|Overall Study||35
5000727|NCT02340520|12304654|P1|NOT COMPLETED|Overall Study||3
5000728|NCT02340520|12304654|P1|COMPLETED|Overall Study||8
5000729|NCT02340520|12304654|P1|STARTED|Overall Study||11
5000730|NCT02340338|12304666|P7|NOT COMPLETED|Overall Study||0
5000731|NCT02340338|12304667|P6|NOT COMPLETED|Overall Study||0
5000732|NCT02340338|12304668|P5|NOT COMPLETED|Overall Study||0
5000733|NCT02340338|12304669|P4|NOT COMPLETED|Overall Study||0
5000734|NCT02340338|12304670|P3|NOT COMPLETED|Overall Study||0
5000735|NCT02340338|12304671|P2|NOT COMPLETED|Overall Study||0
5000736|NCT02340338|12304672|P1|NOT COMPLETED|Overall Study||0
5000737|NCT02340338|12304666|P7|COMPLETED|Overall Study||12
5000738|NCT02340338|12304667|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
5000739|NCT02340338|12304668|P5|COMPLETED|Overall Study||9
5000740|NCT02340338|12304669|P4|COMPLETED|Overall Study||9
5000741|NCT02340338|12304670|P3|COMPLETED|Overall Study||3
5000742|NCT02340338|12304671|P2|COMPLETED|Overall Study||2
5000743|NCT02340338|12304672|P1|COMPLETED|Overall Study||2
5000744|NCT02340338|12304666|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
5000745|NCT02340338|12304667|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
5000746|NCT02340338|12304668|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
5000747|NCT02340338|12304669|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
5000748|NCT02340338|12304670|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
5000749|NCT02340338|12304671|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
5000750|NCT02340338|12304672|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
5000751|NCT02340221|12304697|P2|NOT COMPLETED|Overall Study||417
5000752|NCT02340221|12304698|P1|NOT COMPLETED|Overall Study||214
5000753|NCT02340221|12304697|P2|COMPLETED|Overall Study||0
5000754|NCT02340221|12304698|P1|COMPLETED|Overall Study||0
5000755|NCT02340221|12304697|P2|STARTED|Overall Study||417
5000756|NCT02340221|12304698|P1|STARTED|Overall Study||214
5000757|NCT02340104|12304722|P1|NOT COMPLETED|Overall Study||0
5000758|NCT02340104|12304722|P1|COMPLETED|Overall Study||8
5000759|NCT02340104|12304722|P1|STARTED|Overall Study||8
5000760|NCT02340091|12304727|P1|NOT COMPLETED|Overall Study||2
5000761|NCT02340091|12304727|P1|COMPLETED|Overall Study||60
5000762|NCT02340091|12304727|P1|STARTED|Overall Study|All Study Participants|62
5000763|NCT02340078|12304732|P1|NOT COMPLETED|Overall Study||1
5000764|NCT02340078|12304732|P1|COMPLETED|Overall Study||61
5000765|NCT02340078|12304732|P1|STARTED|Overall Study||62
5000766|NCT02340000|12304739|P2|NOT COMPLETED|Time Period 2||15
5000767|NCT02340000|12304740|P1|NOT COMPLETED|Time Period 2||19
5000768|NCT02340000|12304739|P2|COMPLETED|Time Period 2||52
5000769|NCT02340000|12304740|P1|COMPLETED|Time Period 2||50
5000770|NCT02340000|12304739|P2|STARTED|Time Period 2||67
5000771|NCT02340000|12304740|P1|STARTED|Time Period 2||69
5000772|NCT02340000|12304739|P2|NOT COMPLETED|Time Period 1||15
5000773|NCT02340000|12304740|P1|NOT COMPLETED|Time Period 1||12
5000774|NCT02340000|12304739|P2|COMPLETED|Time Period 1||74
5000775|NCT02340000|12304740|P1|COMPLETED|Time Period 1||78
5000776|NCT02340000|12304739|P2|STARTED|Time Period 1||89
5000777|NCT02340000|12304740|P1|STARTED|Time Period 1||90
5000778|NCT02339909|12304770|P3|NOT COMPLETED|Overall Study||71
5000779|NCT02339909|12304771|P2|NOT COMPLETED|Overall Study||63
5000780|NCT02339909|12304772|P1|NOT COMPLETED|Overall Study||89
5000781|NCT02339909|12304770|P3|COMPLETED|Overall Study||304
5000782|NCT02339909|12304771|P2|COMPLETED|Overall Study||312
5000783|NCT02339909|12304772|P1|COMPLETED|Overall Study||435
5000784|NCT02339909|12304770|P3|STARTED|Overall Study||375
5000785|NCT02339909|12304771|P2|STARTED|Overall Study||375
5000786|NCT02339909|12304772|P1|STARTED|Overall Study||524
5000787|NCT02339831|12304785|P2|NOT COMPLETED|Overall Study||7
5000788|NCT02339831|12304786|P1|NOT COMPLETED|Overall Study||20
5000789|NCT02339831|12304785|P2|COMPLETED|Overall Study||45
5000790|NCT02339831|12304786|P1|COMPLETED|Overall Study||38
5000791|NCT02339831|12304785|P2|Lost to Follow Up|Overall Study||7
5000792|NCT02339831|12304786|P1|Lost to Follow Up|Overall Study||20
5000793|NCT02339831|12304785|P2|STARTED|Overall Study||52
5000794|NCT02339831|12304786|P1|STARTED|Overall Study||58
5000795|NCT02339584|12304810|P2|NOT COMPLETED|Overall Study||15
5000796|NCT02339584|12304811|P1|NOT COMPLETED|Overall Study||15
5000797|NCT02339584|12304810|P2|COMPLETED|Overall Study||176
5000798|NCT02339584|12304811|P1|COMPLETED|Overall Study||173
5000799|NCT02339584|12304810|P2|STARTED|Overall Study||191
5000800|NCT02339584|12304811|P1|STARTED|Overall Study||188
5000801|NCT02339558|12304817|P1|NOT COMPLETED|Overall Study||0
5000802|NCT02339558|12304817|P1|COMPLETED|Overall Study||45
5000803|NCT02339558|12304817|P1|STARTED|Overall Study||45
5000804|NCT02339545|12304826|P1|NOT COMPLETED|Overall Study||0
5000805|NCT02339545|12304826|P1|COMPLETED|Overall Study||15
5000806|NCT02339545|12304826|P1|STARTED|Overall Study||15
5000807|NCT02339506|12304831|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
5000808|NCT02339506|12304832|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
5000809|NCT02339506|12304831|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
5000810|NCT02339506|12304832|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
5000811|NCT02339506|12304831|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
5000812|NCT02339506|12304832|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
5000813|NCT02339506|12304831|P2|NOT COMPLETED|Washout (Period 2)||0
5000814|NCT02339506|12304832|P1|NOT COMPLETED|Washout (Period 2)||2
5000815|NCT02339506|12304831|P2|COMPLETED|Washout (Period 2)||10
5000816|NCT02339506|12304832|P1|COMPLETED|Washout (Period 2)||10
5000817|NCT02339506|12304831|P2|STARTED|Washout (Period 2)||10
5000818|NCT02339506|12304832|P1|STARTED|Washout (Period 2)||12
5000819|NCT02339506|12304831|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
5000820|NCT02339506|12304832|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
5000821|NCT02339506|12304831|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
5000822|NCT02339506|12304832|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
5000823|NCT02339506|12304831|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
5000824|NCT02339506|12304832|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
5000825|NCT02339415|12304842|P2|NOT COMPLETED|Second Period||2
5000826|NCT02339415|12304843|P1|NOT COMPLETED|Second Period||1
5000827|NCT02339415|12304842|P2|COMPLETED|Second Period||18
5000828|NCT02339415|12304843|P1|COMPLETED|Second Period||19
5000829|NCT02339415|12304842|P2|STARTED|Second Period||20
5000830|NCT02339415|12304843|P1|STARTED|Second Period||20
5000831|NCT02339415|12304842|P2|NOT COMPLETED|Washout||0
5000832|NCT02339415|12304843|P1|NOT COMPLETED|Washout||0
5000833|NCT02339415|12304842|P2|COMPLETED|Washout||20
5000834|NCT02339415|12304843|P1|COMPLETED|Washout||20
5000835|NCT02339415|12304842|P2|STARTED|Washout||20
5000836|NCT02339415|12304843|P1|STARTED|Washout||20
5000837|NCT02339415|12304842|P2|NOT COMPLETED|First Period||2
5000838|NCT02339415|12304843|P1|NOT COMPLETED|First Period||2
5000839|NCT02339415|12304842|P2|COMPLETED|First Period||20
5000840|NCT02339415|12304843|P1|COMPLETED|First Period||20
5000841|NCT02339415|12304842|P2|Received at Least One Dose|First Period||20
5000842|NCT02339415|12304843|P1|Received at Least One Dose|First Period||21
5000843|NCT02339415|12304842|P2|STARTED|First Period||22
5000844|NCT02339415|12304843|P1|STARTED|First Period||22
5000845|NCT02339389|12304853|P1|NOT COMPLETED|Overall Study||16
5000846|NCT02339389|12304853|P1|COMPLETED|Overall Study||41
5000847|NCT02339389|12304853|P1|STARTED|Overall Study||57
5000848|NCT02339285|12304861|P3|NOT COMPLETED|Overall Study||2
5000849|NCT02339285|12304862|P2|NOT COMPLETED|Overall Study||3
5000850|NCT02339285|12304863|P1|NOT COMPLETED|Overall Study||1
5000851|NCT02339285|12304861|P3|COMPLETED|Overall Study||9
5000852|NCT02339285|12304862|P2|COMPLETED|Overall Study||8
5000853|NCT02339285|12304863|P1|COMPLETED|Overall Study||9
5000854|NCT02339285|12304861|P3|4 Week Follow-up Visit|Overall Study||9
5000855|NCT02339285|12304862|P2|4 Week Follow-up Visit|Overall Study||8
5000856|NCT02339285|12304863|P1|4 Week Follow-up Visit|Overall Study||9
5000857|NCT02339285|12304861|P3|2 Week Follow-up|Overall Study||10
5000858|NCT02339285|12304862|P2|2 Week Follow-up|Overall Study||10
5000859|NCT02339285|12304863|P1|2 Week Follow-up|Overall Study||9
5000860|NCT02339285|12304861|P3|Completed Intervention|Overall Study||10
5000861|NCT02339285|12304862|P2|Completed Intervention|Overall Study||10
5000862|NCT02339285|12304863|P1|Completed Intervention|Overall Study||10
5000863|NCT02339285|12304861|P3|STARTED|Overall Study||11
5000864|NCT02339285|12304862|P2|STARTED|Overall Study||11
5000865|NCT02339285|12304863|P1|STARTED|Overall Study||10
5000866|NCT02339246|12304891|P3|NOT COMPLETED|Third Period (7 Days)||0
5000867|NCT02339246|12304892|P2|NOT COMPLETED|Third Period (7 Days)||0
5000868|NCT02339246|12304893|P1|NOT COMPLETED|Third Period (7 Days)||0
5000869|NCT02339246|12304891|P3|COMPLETED|Third Period (7 Days)||0
5000870|NCT02339246|12304892|P2|COMPLETED|Third Period (7 Days)||16
5000871|NCT02339246|12304893|P1|COMPLETED|Third Period (7 Days)||15
5000872|NCT02339246|12304891|P3|STARTED|Third Period (7 Days)||0
5000873|NCT02339246|12304892|P2|STARTED|Third Period (7 Days)||16
5000874|NCT02339246|12304893|P1|STARTED|Third Period (7 Days)||15
5000875|NCT02339246|12304891|P3|NOT COMPLETED|Second Intervention (7 Days)||0
5000876|NCT02339246|12304892|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5000877|NCT02339246|12304893|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5000878|NCT02339246|12304891|P3|COMPLETED|Second Intervention (7 Days)||0
5000879|NCT02339246|12304892|P2|COMPLETED|Second Intervention (7 Days)||15
5000880|NCT02339246|12304893|P1|COMPLETED|Second Intervention (7 Days)||16
5000881|NCT02339246|12304891|P3|STARTED|Second Intervention (7 Days)||0
5000882|NCT02339246|12304892|P2|STARTED|Second Intervention (7 Days)||15
5000883|NCT02339246|12304893|P1|STARTED|Second Intervention (7 Days)||16
5000884|NCT02339246|12304891|P3|NOT COMPLETED|First Intervention (7 Days)||0
5000885|NCT02339246|12304892|P2|NOT COMPLETED|First Intervention (7 Days)||0
5000886|NCT02339246|12304893|P1|NOT COMPLETED|First Intervention (7 Days)||0
5000887|NCT02339246|12304891|P3|COMPLETED|First Intervention (7 Days)||31
5000888|NCT02339246|12304892|P2|COMPLETED|First Intervention (7 Days)||0
5000889|NCT02339246|12304893|P1|COMPLETED|First Intervention (7 Days)||0
5000890|NCT02339246|12304891|P3|STARTED|First Intervention (7 Days)||31
5000891|NCT02339246|12304892|P2|STARTED|First Intervention (7 Days)||0
5000892|NCT02339246|12304893|P1|STARTED|First Intervention (7 Days)||0
5000893|NCT02339155|12304909|P2|NOT COMPLETED|Overall Study||21
5000894|NCT02339155|12304910|P1|NOT COMPLETED|Overall Study||15
5000895|NCT02339155|12304909|P2|COMPLETED|Overall Study||266
5000896|NCT02339155|12304910|P1|COMPLETED|Overall Study||271
5000897|NCT02339155|12304909|P2|Received Study Treatment|Overall Study||281
5000898|NCT02339155|12304910|P1|Received Study Treatment|Overall Study||285
5000899|NCT02339155|12304909|P2|STARTED|Overall Study||287
5000900|NCT02339155|12304910|P1|STARTED|Overall Study||286
5000901|NCT02339038|12304936|P1|NOT COMPLETED|Overall Study||600
5000902|NCT02339038|12304936|P1|COMPLETED|Overall Study||0
5000903|NCT02339038|12304936|P1|STARTED|Overall Study||600
5000904|NCT02338973|12304940|P1|NOT COMPLETED|Overall Study||0
5000905|NCT02338973|12304940|P1|COMPLETED|Overall Study||4
5000906|NCT02338973|12304940|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
5000907|NCT02338973|12304940|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
5000908|NCT02338973|12304940|P1|STARTED|Overall Study||4
5000909|NCT02338882|12305116|P2|NOT COMPLETED|Overall Study||3
5000910|NCT02338882|12305117|P1|NOT COMPLETED|Overall Study||7
5000911|NCT02338882|12305116|P2|COMPLETED|Overall Study||47
5000912|NCT02338882|12305117|P1|COMPLETED|Overall Study||43
5000913|NCT02338882|12305116|P2|STARTED|Overall Study||50
5000914|NCT02338882|12305117|P1|STARTED|Overall Study||50
5000915|NCT02338843|12305155|P2|NOT COMPLETED|Overall Study||58
5000916|NCT02338843|12305156|P1|NOT COMPLETED|Overall Study||44
5000917|NCT02338843|12305155|P2|COMPLETED|Overall Study||100
5000918|NCT02338843|12305156|P1|COMPLETED|Overall Study||119
5000919|NCT02338843|12305155|P2|STARTED|Overall Study||158
5000920|NCT02338843|12305156|P1|STARTED|Overall Study||163
5000921|NCT02338713|12305162|P1|NOT COMPLETED|Overall Study||0
5000922|NCT02338713|12305162|P1|COMPLETED|Overall Study||27
5000923|NCT02338713|12305162|P1|STARTED|Overall Study||27
5000924|NCT02338492|12305184|P1|NOT COMPLETED|Overall Study||45
5000925|NCT02338492|12305184|P1|COMPLETED|Overall Study||36
5000926|NCT02338492|12305184|P1|Treatment Failure|Overall Study||2
5000927|NCT02338492|12305184|P1|Device Implanted|Overall Study||79
5000928|NCT02338492|12305184|P1|Enrolled|Overall Study||81
5000929|NCT02338492|12305184|P1|STARTED|Overall Study||81
5000930|NCT02338362|12305200|P2|NOT COMPLETED|Overall Study||1
5000931|NCT02338362|12305201|P1|NOT COMPLETED|Overall Study||1
5000932|NCT02338362|12305200|P2|COMPLETED|Overall Study||10
5000933|NCT02338362|12305201|P1|COMPLETED|Overall Study||10
5000934|NCT02338362|12305200|P2|STARTED|Overall Study||11
5000935|NCT02338362|12305201|P1|STARTED|Overall Study||11
5000936|NCT02338336|12305217|P4|NOT COMPLETED|Overall Study||0
5000937|NCT02338336|12305218|P3|NOT COMPLETED|Overall Study||0
5000938|NCT02338336|12305219|P2|NOT COMPLETED|Overall Study||0
5000939|NCT02338336|12305220|P1|NOT COMPLETED|Overall Study||2
5000940|NCT02338336|12305217|P4|COMPLETED|Overall Study||4
5000941|NCT02338336|12305218|P3|COMPLETED|Overall Study||7
5000942|NCT02338336|12305219|P2|COMPLETED|Overall Study||17
5000943|NCT02338336|12305220|P1|COMPLETED|Overall Study||24
5000944|NCT02338336|12305217|P4|STARTED|Overall Study||4
5000945|NCT02338336|12305218|P3|STARTED|Overall Study||7
5000946|NCT02338336|12305219|P2|STARTED|Overall Study||17
5000947|NCT02338336|12305220|P1|STARTED|Overall Study||26
5000948|NCT02338193|12305231|P3|NOT COMPLETED|Overall Study||10
5000949|NCT02338193|12305232|P2|NOT COMPLETED|Overall Study||4
5000950|NCT02338193|12305233|P1|NOT COMPLETED|Overall Study||3
5000951|NCT02338193|12305231|P3|COMPLETED|Overall Study||15
5000952|NCT02338193|12305232|P2|COMPLETED|Overall Study||17
5000953|NCT02338193|12305233|P1|COMPLETED|Overall Study||17
5000954|NCT02338193|12305231|P3|STARTED|Overall Study||25
5000955|NCT02338193|12305232|P2|STARTED|Overall Study||21
5000956|NCT02338193|12305233|P1|STARTED|Overall Study||20
5000957|NCT02338154|12305286|P1|NOT COMPLETED|Overall Study||143
5000958|NCT02338154|12305286|P1|COMPLETED|Overall Study||373
5000959|NCT02338154|12305286|P1|INTUITY (Study Valve Cohort)|Overall Study||493
5000960|NCT02338154|12305286|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
5000961|NCT02338154|12305286|P1|STARTED|Overall Study||516
5000962|NCT02338076|12305382|P1|NOT COMPLETED|Overall Study||0
5000963|NCT02338076|12305382|P1|COMPLETED|Overall Study||20
5000964|NCT02338076|12305382|P1|STARTED|Overall Study||20
5000965|NCT02337959|12305400|P3|NOT COMPLETED|Overall Study||0
5000966|NCT02337959|12305401|P2|NOT COMPLETED|Overall Study||3
5000967|NCT02337959|12305402|P1|NOT COMPLETED|Overall Study||0
5000968|NCT02337959|12305400|P3|COMPLETED|Overall Study||7
5000969|NCT02337959|12305401|P2|COMPLETED|Overall Study||7
5000970|NCT02337959|12305402|P1|COMPLETED|Overall Study||10
5000971|NCT02337959|12305400|P3|STARTED|Overall Study||7
5000972|NCT02337959|12305401|P2|STARTED|Overall Study||10
5000973|NCT02337959|12305402|P1|STARTED|Overall Study||10
5000974|NCT02337946|12305410|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
5000975|NCT02337946|12305411|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
5000976|NCT02337946|12305412|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
5000977|NCT02337946|12305410|P3|COMPLETED|Protocol Treatment 2 Period||7
5000978|NCT02337946|12305411|P2|COMPLETED|Protocol Treatment 2 Period||5
5000979|NCT02337946|12305412|P1|COMPLETED|Protocol Treatment 2 Period||0
5000980|NCT02337946|12305410|P3|Safety Population|Protocol Treatment 2 Period||54
5000981|NCT02337946|12305411|P2|Safety Population|Protocol Treatment 2 Period||56
5000982|NCT02337946|12305412|P1|Safety Population|Protocol Treatment 2 Period||0
5000983|NCT02337946|12305410|P3|STARTED|Protocol Treatment 2 Period||57
5000984|NCT02337946|12305411|P2|STARTED|Protocol Treatment 2 Period||56
5000985|NCT02337946|12305412|P1|STARTED|Protocol Treatment 2 Period||0
5000986|NCT02337946|12305410|P3|NOT COMPLETED|In-between Period||0
5000987|NCT02337946|12305411|P2|NOT COMPLETED|In-between Period||0
5000988|NCT02337946|12305412|P1|NOT COMPLETED|In-between Period||1
5000989|NCT02337946|12305410|P3|COMPLETED|In-between Period||0
5000990|NCT02337946|12305411|P2|COMPLETED|In-between Period||0
5000991|NCT02337946|12305412|P1|COMPLETED|In-between Period||113
5000992|NCT02337946|12305410|P3|STARTED|In-between Period||0
5000993|NCT02337946|12305411|P2|STARTED|In-between Period||0
5000994|NCT02337946|12305412|P1|STARTED|In-between Period||114
5000995|NCT02337946|12305410|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
5000996|NCT02337946|12305411|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
5000997|NCT02337946|12305412|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
5000998|NCT02337946|12305410|P3|COMPLETED|Protocol Treatment 1 Period||0
5000999|NCT02337946|12305411|P2|COMPLETED|Protocol Treatment 1 Period||0
5001000|NCT02337946|12305412|P1|COMPLETED|Protocol Treatment 1 Period||114
5001001|NCT02337946|12305410|P3|STARTED|Protocol Treatment 1 Period||0
5001002|NCT02337946|12305411|P2|STARTED|Protocol Treatment 1 Period||0
5001003|NCT02337946|12305412|P1|STARTED|Protocol Treatment 1 Period||164
5001004|NCT02337907|12305440|P6|NOT COMPLETED|Overall Study||1
5001005|NCT02337907|12305441|P5|NOT COMPLETED|Overall Study||10
5001006|NCT02337907|12305442|P4|NOT COMPLETED|Overall Study||4
5001007|NCT02337907|12305443|P3|NOT COMPLETED|Overall Study||1
5001008|NCT02337907|12305444|P2|NOT COMPLETED|Overall Study||4
5001009|NCT02337907|12305445|P1|NOT COMPLETED|Overall Study||4
5001010|NCT02337907|12305440|P6|COMPLETED|Overall Study||4
5001011|NCT02337907|12305441|P5|COMPLETED|Overall Study||96
5001012|NCT02337907|12305442|P4|COMPLETED|Overall Study||51
5001013|NCT02337907|12305443|P3|COMPLETED|Overall Study||54
5001014|NCT02337907|12305444|P2|COMPLETED|Overall Study||49
5001015|NCT02337907|12305445|P1|COMPLETED|Overall Study||51
5001016|NCT02337907|12305440|P6|STARTED|Overall Study||5
5001017|NCT02337907|12305441|P5|STARTED|Overall Study||106
5001018|NCT02337907|12305442|P4|STARTED|Overall Study||55
5001019|NCT02337907|12305443|P3|STARTED|Overall Study||55
5001020|NCT02337907|12305444|P2|STARTED|Overall Study||53
5001021|NCT02337907|12305445|P1|STARTED|Overall Study||55
5001022|NCT02337764|12305480|P1|NOT COMPLETED|Overall Study||60
5001023|NCT02337764|12305480|P1|COMPLETED|Overall Study||162
5001024|NCT02337764|12305480|P1|STARTED|Overall Study||222
5001025|NCT02337751|12305493|P2|NOT COMPLETED|Overall Study||16
5001026|NCT02337751|12305494|P1|NOT COMPLETED|Overall Study||11
5001027|NCT02337751|12305493|P2|COMPLETED|Overall Study||87
5001028|NCT02337751|12305494|P1|COMPLETED|Overall Study||84
5001029|NCT02337751|12305493|P2|STARTED|Overall Study||103
5001030|NCT02337751|12305494|P1|STARTED|Overall Study||95
5001031|NCT02337738|12305513|P3|NOT COMPLETED|Overall Study||26
5001032|NCT02337738|12305514|P2|NOT COMPLETED|Overall Study||30
5001033|NCT02337738|12305515|P1|NOT COMPLETED|Overall Study||22
5001034|NCT02337738|12305513|P3|COMPLETED|Overall Study||103
5001035|NCT02337738|12305514|P2|COMPLETED|Overall Study||104
5001036|NCT02337738|12305515|P1|COMPLETED|Overall Study||119
5001037|NCT02337738|12305513|P3|STARTED|Overall Study||129
5001038|NCT02337738|12305514|P2|STARTED|Overall Study||134
5001039|NCT02337738|12305515|P1|STARTED|Overall Study||141
5001040|NCT02337725|12305555|P2|NOT COMPLETED|Overall Study||8
5001041|NCT02337725|12305556|P1|NOT COMPLETED|Overall Study||26
5001042|NCT02337725|12305555|P2|COMPLETED|Overall Study||110
5001043|NCT02337725|12305556|P1|COMPLETED|Overall Study||100
5001044|NCT02337725|12305555|P2|STARTED|Overall Study||118
5001045|NCT02337725|12305556|P1|STARTED|Overall Study||126
5001046|NCT02337491|12305580|P2|NOT COMPLETED|Overall Study||30
5001047|NCT02337491|12305581|P1|NOT COMPLETED|Overall Study||50
5001048|NCT02337491|12305580|P2|COMPLETED|Overall Study||0
5001049|NCT02337491|12305581|P1|COMPLETED|Overall Study||0
5001050|NCT02337491|12305580|P2|STARTED|Overall Study||30
5001051|NCT02337491|12305581|P1|STARTED|Overall Study||50
5001052|NCT02337478|12305595|P1|NOT COMPLETED|Overall Study||5
5001053|NCT02337478|12305595|P1|COMPLETED|Overall Study||0
5001054|NCT02337478|12305595|P1|STARTED|Overall Study||5
5001055|NCT02337387|12305605|P4|NOT COMPLETED|Overall Study||3
5001056|NCT02337387|12305606|P3|NOT COMPLETED|Overall Study||3
5001057|NCT02337387|12305607|P2|NOT COMPLETED|Overall Study||8
5001058|NCT02337387|12305608|P1|NOT COMPLETED|Overall Study||14
5001059|NCT02337387|12305605|P4|COMPLETED|Overall Study||0
5001060|NCT02337387|12305606|P3|COMPLETED|Overall Study||0
5001061|NCT02337387|12305607|P2|COMPLETED|Overall Study||0
5001062|NCT02337387|12305608|P1|COMPLETED|Overall Study||0
5001063|NCT02337387|12305605|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5001064|NCT02337387|12305606|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5001065|NCT02337387|12305607|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
5001066|NCT02337387|12305608|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
5001067|NCT02337387|12305605|P4|STARTED|Overall Study||3
5001068|NCT02337387|12305606|P3|STARTED|Overall Study||3
5001069|NCT02337387|12305607|P2|STARTED|Overall Study||8
5001070|NCT02337387|12305608|P1|STARTED|Overall Study||14
5001071|NCT02337361|12305626|P2|NOT COMPLETED|6-month Follow-up||4
5001072|NCT02337361|12305627|P1|NOT COMPLETED|6-month Follow-up||2
5001073|NCT02337361|12305626|P2|COMPLETED|6-month Follow-up||68
5001074|NCT02337361|12305627|P1|COMPLETED|6-month Follow-up||78
5001075|NCT02337361|12305626|P2|STARTED|6-month Follow-up||72
5001076|NCT02337361|12305627|P1|STARTED|6-month Follow-up||80
5001077|NCT02337361|12305626|P2|NOT COMPLETED|3-month Follow-up||14
5001078|NCT02337361|12305627|P1|NOT COMPLETED|3-month Follow-up||19
5001079|NCT02337361|12305626|P2|COMPLETED|3-month Follow-up||72
5001080|NCT02337361|12305627|P1|COMPLETED|3-month Follow-up||80
5001081|NCT02337361|12305626|P2|STARTED|3-month Follow-up||86
5001082|NCT02337361|12305627|P1|STARTED|3-month Follow-up||99
5001083|NCT02337361|12305626|P2|NOT COMPLETED|Baseline Assessment||0
5001084|NCT02337361|12305627|P1|NOT COMPLETED|Baseline Assessment||0
5001085|NCT02337361|12305626|P2|COMPLETED|Baseline Assessment||86
5001086|NCT02337361|12305627|P1|COMPLETED|Baseline Assessment||99
5001087|NCT02337361|12305626|P2|STARTED|Baseline Assessment||86
5001088|NCT02337361|12305627|P1|STARTED|Baseline Assessment||99
5001089|NCT02337062|12305647|P2|NOT COMPLETED|Overall Study||19
5001090|NCT02337062|12305648|P1|NOT COMPLETED|Overall Study||17
5001091|NCT02337062|12305647|P2|COMPLETED|Overall Study||556
5001092|NCT02337062|12305648|P1|COMPLETED|Overall Study||555
5001093|NCT02337062|12305647|P2|STARTED|Overall Study||575
5001094|NCT02337062|12305648|P1|STARTED|Overall Study||572
5001095|NCT02336958|12305666|P2|NOT COMPLETED|Overall Study||0
5001096|NCT02336958|12305667|P1|NOT COMPLETED|Overall Study||0
5001097|NCT02336958|12305666|P2|COMPLETED|Overall Study||20
5001098|NCT02336958|12305667|P1|COMPLETED|Overall Study||20
5001099|NCT02336958|12305666|P2|STARTED|Overall Study||20
5001100|NCT02336958|12305667|P1|STARTED|Overall Study||20
5001101|NCT02336763|12305675|P1|NOT COMPLETED|Overall Study||0
5001102|NCT02336763|12305675|P1|COMPLETED|Overall Study||2
5001103|NCT02336763|12305675|P1|STARTED|Overall Study||2
5001104|NCT02336607|12305689|P4|NOT COMPLETED|Overall Study||87
5001105|NCT02336607|12305690|P3|NOT COMPLETED|Overall Study||6
5001106|NCT02336607|12305691|P2|NOT COMPLETED|Overall Study||10
5001107|NCT02336607|12305692|P1|NOT COMPLETED|Overall Study||4
5001108|NCT02336607|12305689|P4|COMPLETED|Overall Study||180
5001109|NCT02336607|12305690|P3|COMPLETED|Overall Study||86
5001110|NCT02336607|12305691|P2|COMPLETED|Overall Study||75
5001111|NCT02336607|12305692|P1|COMPLETED|Overall Study||81
5001112|NCT02336607|12305689|P4|Patients Included in Safety Population|Overall Study||260
5001113|NCT02336607|12305690|P3|Patients Included in Safety Population|Overall Study||92
5001114|NCT02336607|12305691|P2|Patients Included in Safety Population|Overall Study||85
5001115|NCT02336607|12305692|P1|Patients Included in Safety Population|Overall Study||85
5001116|NCT02336607|12305689|P4|Patients Included in PP Population|Overall Study||162
5001117|NCT02336607|12305690|P3|Patients Included in PP Population|Overall Study||75
5001118|NCT02336607|12305691|P2|Patients Included in PP Population|Overall Study||75
5001119|NCT02336607|12305692|P1|Patients Included in PP Population|Overall Study||78
5001120|NCT02336607|12305689|P4|Patients Included in ITT Population|Overall Study||222
5001121|NCT02336607|12305690|P3|Patients Included in ITT Population|Overall Study||91
5001122|NCT02336607|12305691|P2|Patients Included in ITT Population|Overall Study||84
5001123|NCT02336607|12305692|P1|Patients Included in ITT Population|Overall Study||84
5001124|NCT02336607|12305689|P4|STARTED|Overall Study||267
5001125|NCT02336607|12305690|P3|STARTED|Overall Study||92
5001126|NCT02336607|12305691|P2|STARTED|Overall Study||85
5001127|NCT02336607|12305692|P1|STARTED|Overall Study||85
5001128|NCT02336594|12305750|P4|NOT COMPLETED|Overall Study||0
5001129|NCT02336594|12305751|P3|NOT COMPLETED|Overall Study||0
5001130|NCT02336594|12305752|P2|NOT COMPLETED|Overall Study||0
5001131|NCT02336594|12305753|P1|NOT COMPLETED|Overall Study||0
5001132|NCT02336594|12305750|P4|COMPLETED|Overall Study||4
5001133|NCT02336594|12305751|P3|COMPLETED|Overall Study||4
5001134|NCT02336594|12305752|P2|COMPLETED|Overall Study||4
5001135|NCT02336594|12305753|P1|COMPLETED|Overall Study||3
5001136|NCT02336594|12305750|P4|STARTED|Overall Study||4
5001137|NCT02336594|12305751|P3|STARTED|Overall Study||4
5001138|NCT02336594|12305752|P2|STARTED|Overall Study||4
5001139|NCT02336594|12305753|P1|STARTED|Overall Study||3
5001140|NCT02336555|12305795|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
5001141|NCT02336555|12305796|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5001142|NCT02336555|12305795|P2|COMPLETED|Treatment Period 2 (28 Days)||15
5001143|NCT02336555|12305796|P1|COMPLETED|Treatment Period 2 (28 Days)||16
5001144|NCT02336555|12305795|P2|STARTED|Treatment Period 2 (28 Days)||16
5001145|NCT02336555|12305796|P1|STARTED|Treatment Period 2 (28 Days)||16
5001146|NCT02336555|12305795|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5001147|NCT02336555|12305796|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
5001148|NCT02336555|12305795|P2|COMPLETED|Treatment Period 1 (28 Days)||16
5001149|NCT02336555|12305796|P1|COMPLETED|Treatment Period 1 (28 Days)||16
5001150|NCT02336555|12305795|P2|STARTED|Treatment Period 1 (28 Days)||17
5001151|NCT02336555|12305796|P1|STARTED|Treatment Period 1 (28 Days)||18
5001152|NCT02336451|12305809|P5|NOT COMPLETED|Overall Study||18
5001153|NCT02336451|12305810|P4|NOT COMPLETED|Overall Study||44
5001154|NCT02336451|12305811|P3|NOT COMPLETED|Overall Study||12
5001155|NCT02336451|12305812|P2|NOT COMPLETED|Overall Study||40
5001156|NCT02336451|12305813|P1|NOT COMPLETED|Overall Study||42
5001157|NCT02336451|12305809|P5|COMPLETED|Overall Study||0
5001158|NCT02336451|12305810|P4|COMPLETED|Overall Study||0
5001159|NCT02336451|12305811|P3|COMPLETED|Overall Study||0
5001160|NCT02336451|12305812|P2|COMPLETED|Overall Study||0
5001161|NCT02336451|12305813|P1|COMPLETED|Overall Study||0
5001162|NCT02336451|12305809|P5|STARTED|Overall Study||18
5001163|NCT02336451|12305810|P4|STARTED|Overall Study||44
5001164|NCT02336451|12305811|P3|STARTED|Overall Study||12
5001165|NCT02336451|12305812|P2|STARTED|Overall Study||40
5001166|NCT02336451|12305813|P1|STARTED|Overall Study||42
5001167|NCT02336438|12305957|P1|NOT COMPLETED|Overall Study||1
5001168|NCT02336438|12305957|P1|COMPLETED|Overall Study||10
5001169|NCT02336438|12305957|P1|STARTED|Overall Study||11
5001170|NCT02336425|12305970|P4|NOT COMPLETED|Overall Study||3
5001171|NCT02336425|12305971|P3|NOT COMPLETED|Overall Study||3
5001172|NCT02336425|12305972|P2|NOT COMPLETED|Overall Study||2
5001173|NCT02336425|12305973|P1|NOT COMPLETED|Overall Study||2
5001174|NCT02336425|12305970|P4|COMPLETED|Overall Study||0
5001175|NCT02336425|12305971|P3|COMPLETED|Overall Study||0
5001176|NCT02336425|12305972|P2|COMPLETED|Overall Study||0
5001177|NCT02336425|12305973|P1|COMPLETED|Overall Study||0
5001178|NCT02336425|12305970|P4|STARTED|Overall Study||3
5001179|NCT02336425|12305971|P3|STARTED|Overall Study||3
5001180|NCT02336425|12305972|P2|STARTED|Overall Study||2
5001181|NCT02336425|12305973|P1|STARTED|Overall Study||2
5001182|NCT02336282|12306023|P1|NOT COMPLETED|Overall Study||5
5001183|NCT02336282|12306023|P1|COMPLETED|Overall Study||28
5001184|NCT02336282|12306023|P1|STARTED|Overall Study||33
5001185|NCT02336178|12306047|P1|NOT COMPLETED|Overall Study||4
5001186|NCT02336178|12306047|P1|COMPLETED|Overall Study||66
5001187|NCT02336178|12306047|P1|STARTED|Overall Study||70
5001188|NCT02336165|12306138|P5|NOT COMPLETED|Overall Study||22
5001189|NCT02336165|12306139|P4|NOT COMPLETED|Overall Study||31
5001190|NCT02336165|12306140|P3|NOT COMPLETED|Overall Study||31
5001191|NCT02336165|12306141|P2|NOT COMPLETED|Overall Study||25
5001192|NCT02336165|12306142|P1|NOT COMPLETED|Overall Study||34
5001193|NCT02336165|12306138|P5|COMPLETED|Overall Study||0
5001194|NCT02336165|12306139|P4|COMPLETED|Overall Study||2
5001195|NCT02336165|12306140|P3|COMPLETED|Overall Study||2
5001196|NCT02336165|12306141|P2|COMPLETED|Overall Study||6
5001197|NCT02336165|12306142|P1|COMPLETED|Overall Study||6
5001198|NCT02336165|12306138|P5|STARTED|Overall Study||22
5001199|NCT02336165|12306139|P4|STARTED|Overall Study||33
5001200|NCT02336165|12306140|P3|STARTED|Overall Study||33
5001201|NCT02336165|12306141|P2|STARTED|Overall Study||31
5001202|NCT02336165|12306142|P1|STARTED|Overall Study||40
5001203|NCT02336074|12306176|P2|NOT COMPLETED|Overall Study||2
5001204|NCT02336074|12306177|P1|NOT COMPLETED|Overall Study||0
5001205|NCT02336074|12306176|P2|COMPLETED|Overall Study||28
5001206|NCT02336074|12306177|P1|COMPLETED|Overall Study||30
5001207|NCT02336074|12306176|P2|STARTED|Overall Study||30
5001208|NCT02336074|12306177|P1|STARTED|Overall Study||30
5001209|NCT02335710|12306196|P2|NOT COMPLETED|Overall Study||0
5001210|NCT02335710|12306197|P1|NOT COMPLETED|Overall Study||0
5001211|NCT02335710|12306196|P2|COMPLETED|Overall Study||10
5001212|NCT02335710|12306197|P1|COMPLETED|Overall Study||40
5001213|NCT02335710|12306196|P2|STARTED|Overall Study||10
5001214|NCT02335710|12306197|P1|STARTED|Overall Study||40
5001215|NCT02335502|12306217|P1|NOT COMPLETED|Overall Study||17
5001216|NCT02335502|12306217|P1|COMPLETED|Overall Study||49
5001217|NCT02335502|12306217|P1|Receiving Permanent System|Overall Study||56
5001218|NCT02335502|12306217|P1|Received Trial System|Overall Study||65
5001219|NCT02335502|12306217|P1|STARTED|Overall Study||66
5001220|NCT02335489|12306222|P1|NOT COMPLETED|Overall Study||10
5001221|NCT02335489|12306222|P1|COMPLETED|Overall Study||0
5001222|NCT02335489|12306222|P1|Receiving Permanent System|Overall Study||8
5001223|NCT02335489|12306222|P1|Received Trial System|Overall Study||9
5001224|NCT02335489|12306222|P1|STARTED|Overall Study||10
5001225|NCT02335424|12306226|P1|NOT COMPLETED|Overall Study||374
5001226|NCT02335424|12306226|P1|COMPLETED|Overall Study||0
5001227|NCT02335424|12306226|P1|Treated|Overall Study||370
5001228|NCT02335424|12306226|P1|STARTED|Overall Study||374
5001229|NCT02335346|12306259|P1|NOT COMPLETED|Overall Study||12
5001230|NCT02335346|12306259|P1|COMPLETED|Overall Study||81
5001231|NCT02335346|12306259|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
5001232|NCT02335346|12306259|P1|STARTED|Overall Study||93
5001233|NCT02335229|12306271|P1|NOT COMPLETED|Overall Study||7
5001234|NCT02335229|12306271|P1|COMPLETED|Overall Study||23
5001235|NCT02335229|12306271|P1|Received Permanent System|Overall Study||26
5001236|NCT02335229|12306271|P1|Received Trial System|Overall Study||10
5001237|NCT02335229|12306271|P1|STARTED|Overall Study||30
5001238|NCT02335216|12306276|P1|NOT COMPLETED|Overall Study||13
5001239|NCT02335216|12306276|P1|COMPLETED|Overall Study||9
5001240|NCT02335216|12306276|P1|Received Permanent System|Overall Study||13
5001241|NCT02335216|12306276|P1|Received Trial System|Overall Study||16
5001242|NCT02335216|12306276|P1|STARTED|Overall Study||22
5001243|NCT02334982|12306288|P7|NOT COMPLETED|Overall Study||0
5001244|NCT02334982|12306289|P6|NOT COMPLETED|Overall Study||0
5001245|NCT02334982|12306290|P5|NOT COMPLETED|Overall Study||0
5001246|NCT02334982|12306291|P4|NOT COMPLETED|Overall Study||0
5001247|NCT02334982|12306292|P3|NOT COMPLETED|Overall Study||0
5001248|NCT02334982|12306293|P2|NOT COMPLETED|Overall Study||0
5001249|NCT02334982|12306294|P1|NOT COMPLETED|Overall Study||0
5001250|NCT02334982|12306288|P7|COMPLETED|Overall Study||12
5001251|NCT02334982|12306289|P6|COMPLETED|Overall Study||6
5001252|NCT02334982|12306290|P5|COMPLETED|Overall Study||6
5001253|NCT02334982|12306291|P4|COMPLETED|Overall Study||6
5001254|NCT02334982|12306292|P3|COMPLETED|Overall Study||6
5001255|NCT02334982|12306293|P2|COMPLETED|Overall Study||5
5001256|NCT02334982|12306294|P1|COMPLETED|Overall Study||6
5001257|NCT02334982|12306288|P7|STARTED|Overall Study||12
5001258|NCT02334982|12306289|P6|STARTED|Overall Study||6
5001259|NCT02334982|12306290|P5|STARTED|Overall Study||6
5001260|NCT02334982|12306291|P4|STARTED|Overall Study||6
5001261|NCT02334982|12306292|P3|STARTED|Overall Study||6
5001262|NCT02334982|12306293|P2|STARTED|Overall Study||5
5001263|NCT02334982|12306294|P1|STARTED|Overall Study||6
5001264|NCT02334813|12306400|P2|NOT COMPLETED|Overall Study||1
5001265|NCT02334813|12306401|P1|NOT COMPLETED|Overall Study||3
5001266|NCT02334813|12306400|P2|COMPLETED|Overall Study||13
5001267|NCT02334813|12306401|P1|COMPLETED|Overall Study||9
5001268|NCT02334813|12306400|P2|STARTED|Overall Study||14
5001269|NCT02334813|12306401|P1|STARTED|Overall Study||12
5001270|NCT02334800|12306411|P4|NOT COMPLETED|Overall Study||0
5001271|NCT02334800|12306412|P3|NOT COMPLETED|Overall Study||0
5001272|NCT02334800|12306413|P2|NOT COMPLETED|Overall Study||0
5001273|NCT02334800|12306414|P1|NOT COMPLETED|Overall Study||0
5001274|NCT02334800|12306411|P4|COMPLETED|Overall Study||7
5001275|NCT02334800|12306412|P3|COMPLETED|Overall Study||7
5001276|NCT02334800|12306413|P2|COMPLETED|Overall Study||7
5001277|NCT02334800|12306414|P1|COMPLETED|Overall Study||7
5001278|NCT02334800|12306411|P4|Received Treatment|Overall Study||7
5001279|NCT02334800|12306412|P3|Received Treatment|Overall Study||7
5001280|NCT02334800|12306413|P2|Received Treatment|Overall Study||7
5001281|NCT02334800|12306414|P1|Received Treatment|Overall Study||7
5001282|NCT02334800|12306411|P4|STARTED|Overall Study||7
5001283|NCT02334800|12306412|P3|STARTED|Overall Study||7
5001284|NCT02334800|12306413|P2|STARTED|Overall Study||7
5001285|NCT02334800|12306414|P1|STARTED|Overall Study||7
5001286|NCT02334787|12306508|P4|NOT COMPLETED|Overall Study||0
5001287|NCT02334787|12306509|P3|NOT COMPLETED|Overall Study||0
5001288|NCT02334787|12306510|P2|NOT COMPLETED|Overall Study||0
5001289|NCT02334787|12306511|P1|NOT COMPLETED|Overall Study||0
5001290|NCT02334787|12306508|P4|COMPLETED|Overall Study||8
5001291|NCT02334787|12306509|P3|COMPLETED|Overall Study||8
5001292|NCT02334787|12306510|P2|COMPLETED|Overall Study||8
5001293|NCT02334787|12306511|P1|COMPLETED|Overall Study||8
5001294|NCT02334787|12306508|P4|STARTED|Overall Study||8
5001295|NCT02334787|12306509|P3|STARTED|Overall Study||8
5001296|NCT02334787|12306510|P2|STARTED|Overall Study||8
5001297|NCT02334787|12306511|P1|STARTED|Overall Study||8
5001298|NCT02334748|12306533|P1|NOT COMPLETED|Overall Study||8
5001299|NCT02334748|12306533|P1|COMPLETED|Overall Study||23
5001300|NCT02334748|12306533|P1|STARTED|Overall Study||31
5001301|NCT02334527|12306538|P1|NOT COMPLETED|Overall Study||0
5001302|NCT02334527|12306538|P1|COMPLETED|Overall Study||12
5001303|NCT02334527|12306538|P1|STARTED|Overall Study||12
5001304|NCT02334436|12306549|P2|NOT COMPLETED|Overall Study||1
5001305|NCT02334436|12306550|P1|NOT COMPLETED|Overall Study||9
5001306|NCT02334436|12306549|P2|COMPLETED|Overall Study||77
5001307|NCT02334436|12306550|P1|COMPLETED|Overall Study||237
5001308|NCT02334436|12306549|P2|STARTED|Overall Study||78
5001309|NCT02334436|12306550|P1|STARTED|Overall Study||246
5001310|NCT02334423|12306564|P2|NOT COMPLETED|Overall Study||3
5001311|NCT02334423|12306565|P1|NOT COMPLETED|Overall Study||10
5001312|NCT02334423|12306564|P2|COMPLETED|Overall Study||81
5001313|NCT02334423|12306565|P1|COMPLETED|Overall Study||236
5001314|NCT02334423|12306564|P2|STARTED|Overall Study||84
5001315|NCT02334423|12306565|P1|STARTED|Overall Study||246
5001316|NCT02334384|12306579|P2|NOT COMPLETED|Overall Study||1
5001317|NCT02334384|12306580|P1|NOT COMPLETED|Overall Study||1
5001318|NCT02334384|12306579|P2|COMPLETED|Overall Study||1
5001319|NCT02334384|12306580|P1|COMPLETED|Overall Study||3
5001320|NCT02334384|12306579|P2|STARTED|Overall Study||2
5001321|NCT02334384|12306580|P1|STARTED|Overall Study||4
5001322|NCT02334358|12306586|P1|NOT COMPLETED|Overall Study||9
5001323|NCT02334358|12306586|P1|COMPLETED|Overall Study||494
5001324|NCT02334358|12306586|P1|STARTED|Overall Study||503
5001325|NCT02334306|12306592|P2|NOT COMPLETED|Open-label Period||0
5001326|NCT02334306|12306593|P1|NOT COMPLETED|Open-label Period||0
5001327|NCT02334306|12306592|P2|COMPLETED|Open-label Period||14
5001328|NCT02334306|12306593|P1|COMPLETED|Open-label Period||15
5001329|NCT02334306|12306592|P2|STARTED|Open-label Period||14
5001330|NCT02334306|12306593|P1|STARTED|Open-label Period||15
5001331|NCT02334306|12306592|P2|NOT COMPLETED|Double-blind Period||2
5001332|NCT02334306|12306593|P1|NOT COMPLETED|Double-blind Period||1
5001333|NCT02334306|12306592|P2|COMPLETED|Double-blind Period||14
5001334|NCT02334306|12306593|P1|COMPLETED|Double-blind Period||15
5001335|NCT02334306|12306592|P2|STARTED|Double-blind Period||16
5001336|NCT02334306|12306593|P1|STARTED|Double-blind Period||16
5001337|NCT02334267|12306615|P2|NOT COMPLETED|Overall Study||0
5001338|NCT02334267|12306616|P1|NOT COMPLETED|Overall Study||1
5001339|NCT02334267|12306615|P2|COMPLETED|Overall Study||5
5001340|NCT02334267|12306616|P1|COMPLETED|Overall Study||5
5001341|NCT02334267|12306615|P2|STARTED|Overall Study||5
5001342|NCT02334267|12306616|P1|STARTED|Overall Study||6
5001343|NCT02334059|12306631|P3|NOT COMPLETED|Overall Study||0
5001344|NCT02334059|12306632|P2|NOT COMPLETED|Overall Study||0
5001345|NCT02334059|12306633|P1|NOT COMPLETED|Overall Study||0
5001346|NCT02334059|12306631|P3|COMPLETED|Overall Study||37
5001347|NCT02334059|12306632|P2|COMPLETED|Overall Study||34
5001348|NCT02334059|12306633|P1|COMPLETED|Overall Study||37
5001349|NCT02334059|12306631|P3|STARTED|Overall Study||37
5001350|NCT02334059|12306632|P2|STARTED|Overall Study||34
5001351|NCT02334059|12306633|P1|STARTED|Overall Study||37
5001352|NCT02333630|12306649|P2|NOT COMPLETED|Overall Study||2
5001353|NCT02333630|12306650|P1|NOT COMPLETED|Overall Study||5
5001354|NCT02333630|12306649|P2|COMPLETED|Overall Study||98
5001355|NCT02333630|12306650|P1|COMPLETED|Overall Study||95
5001356|NCT02333630|12306649|P2|STARTED|Overall Study||100
5001357|NCT02333630|12306650|P1|STARTED|Overall Study||100
5001358|NCT02333487|12306665|P3|NOT COMPLETED|Overall Study||0
5001359|NCT02333487|12306666|P2|NOT COMPLETED|Overall Study||2
5001360|NCT02333487|12306667|P1|NOT COMPLETED|Overall Study||0
5001361|NCT02333487|12306665|P3|COMPLETED|Overall Study||8
5001362|NCT02333487|12306666|P2|COMPLETED|Overall Study||6
5001363|NCT02333487|12306667|P1|COMPLETED|Overall Study||6
5001364|NCT02333487|12306665|P3|STARTED|Overall Study||8
5001365|NCT02333487|12306666|P2|STARTED|Overall Study||8
5001366|NCT02333487|12306667|P1|STARTED|Overall Study||6
5001367|NCT02333383|12306678|P1|NOT COMPLETED|Overall Study||41
5001368|NCT02333383|12306678|P1|COMPLETED|Overall Study||160
5001369|NCT02333383|12306678|P1|STARTED|Overall Study||201
5001370|NCT02333331|12306692|P4|NOT COMPLETED|Overall Study||3
5001371|NCT02333331|12306693|P3|NOT COMPLETED|Overall Study||18
5001372|NCT02333331|12306694|P2|NOT COMPLETED|Overall Study||6
5001373|NCT02333331|12306695|P1|NOT COMPLETED|Overall Study||2
5001374|NCT02333331|12306692|P4|COMPLETED|Overall Study||64
5001375|NCT02333331|12306693|P3|COMPLETED|Overall Study||95
5001376|NCT02333331|12306694|P2|COMPLETED|Overall Study||12
5001377|NCT02333331|12306695|P1|COMPLETED|Overall Study||17
5001378|NCT02333331|12306692|P4|STARTED|Overall Study||67
5001379|NCT02333331|12306693|P3|STARTED|Overall Study||113
5001380|NCT02333331|12306694|P2|STARTED|Overall Study||18
5001381|NCT02333331|12306695|P1|STARTED|Overall Study||19
5001382|NCT02333045|12306723|P2|NOT COMPLETED|Overall Study||0
5001383|NCT02333045|12306724|P1|NOT COMPLETED|Overall Study||0
5001384|NCT02333045|12306723|P2|COMPLETED|Overall Study||3
5001385|NCT02333045|12306724|P1|COMPLETED|Overall Study||1
5001386|NCT02333045|12306723|P2|STARTED|Overall Study||3
5001387|NCT02333045|12306724|P1|STARTED|Overall Study||1
5001388|NCT02332902|12306734|P1|NOT COMPLETED|Overall Study||7
5001389|NCT02332902|12306734|P1|COMPLETED|Overall Study||17
5001390|NCT02332902|12306734|P1|STARTED|Overall Study||24
5001391|NCT02332889|12306739|P1|NOT COMPLETED|Overall Study||1
5001392|NCT02332889|12306739|P1|COMPLETED|Overall Study||0
5001393|NCT02332889|12306739|P1|STARTED|Overall Study||1
5001394|NCT02332876|12306745|P2|NOT COMPLETED|Overall Study||1
5001395|NCT02332876|12306746|P1|NOT COMPLETED|Overall Study||1
5001396|NCT02332876|12306745|P2|COMPLETED|Overall Study||43
5001397|NCT02332876|12306746|P1|COMPLETED|Overall Study||42
5001398|NCT02332876|12306745|P2|STARTED|Overall Study||44
5001399|NCT02332876|12306746|P1|STARTED|Overall Study||43
5001400|NCT02332824|12306758|P6|NOT COMPLETED|Overall Study||1
5001401|NCT02332824|12306759|P5|NOT COMPLETED|Overall Study||4
5001402|NCT02332824|12306760|P4|NOT COMPLETED|Overall Study||2
5001403|NCT02332824|12306761|P3|NOT COMPLETED|Overall Study||2
5001404|NCT02332824|12306762|P2|NOT COMPLETED|Overall Study||1
5001405|NCT02332824|12306763|P1|NOT COMPLETED|Overall Study||6
5001406|NCT02332824|12306758|P6|COMPLETED|Overall Study||69
5001407|NCT02332824|12306759|P5|COMPLETED|Overall Study||65
5001408|NCT02332824|12306760|P4|COMPLETED|Overall Study||66
5001409|NCT02332824|12306761|P3|COMPLETED|Overall Study||72
5001410|NCT02332824|12306762|P2|COMPLETED|Overall Study||66
5001411|NCT02332824|12306763|P1|COMPLETED|Overall Study||61
5001412|NCT02332824|12306758|P6|STARTED|Overall Study||70
5001413|NCT02332824|12306759|P5|STARTED|Overall Study||69
5001414|NCT02332824|12306760|P4|STARTED|Overall Study||68
5001415|NCT02332824|12306761|P3|STARTED|Overall Study||74
5001416|NCT02332824|12306762|P2|STARTED|Overall Study||67
5001417|NCT02332824|12306763|P1|STARTED|Overall Study||67
5001418|NCT02332798|12306804|P3|NOT COMPLETED|Overall Study||1
5001419|NCT02332798|12306805|P2|NOT COMPLETED|Overall Study||2
5001420|NCT02332798|12306806|P1|NOT COMPLETED|Overall Study||1
5001421|NCT02332798|12306804|P3|COMPLETED|Overall Study||11
5001422|NCT02332798|12306805|P2|COMPLETED|Overall Study||12
5001423|NCT02332798|12306806|P1|COMPLETED|Overall Study||12
5001424|NCT02332798|12306804|P3|STARTED|Overall Study||12
5001425|NCT02332798|12306805|P2|STARTED|Overall Study||14
5001426|NCT02332798|12306806|P1|STARTED|Overall Study||13
5001427|NCT02332720|12306879|P23|NOT COMPLETED|Part C||0
5001428|NCT02332720|12306880|P22|NOT COMPLETED|Part C||0
5001429|NCT02332720|12306881|P21|NOT COMPLETED|Part C||0
5001430|NCT02332720|12306882|P20|NOT COMPLETED|Part C||0
5001431|NCT02332720|12306883|P19|NOT COMPLETED|Part C||0
5001432|NCT02332720|12306884|P18|NOT COMPLETED|Part C||0
5001433|NCT02332720|12306885|P17|NOT COMPLETED|Part C||0
5001434|NCT02332720|12306886|P16|NOT COMPLETED|Part C||0
5001435|NCT02332720|12306887|P15|NOT COMPLETED|Part C||0
5001436|NCT02332720|12306888|P14|NOT COMPLETED|Part C||0
5001437|NCT02332720|12306889|P13|NOT COMPLETED|Part C||0
5001438|NCT02332720|12306890|P12|NOT COMPLETED|Part C||0
5001439|NCT02332720|12306891|P11|NOT COMPLETED|Part C||0
5001440|NCT02332720|12306892|P10|NOT COMPLETED|Part C||0
5001441|NCT02332720|12306893|P9|NOT COMPLETED|Part C||0
5001442|NCT02332720|12306894|P8|NOT COMPLETED|Part C||0
5001443|NCT02332720|12306895|P7|NOT COMPLETED|Part C||0
5001444|NCT02332720|12306896|P6|NOT COMPLETED|Part C||0
5001445|NCT02332720|12306897|P5|NOT COMPLETED|Part C||0
5001446|NCT02332720|12306898|P4|NOT COMPLETED|Part C||0
5001447|NCT02332720|12306899|P3|NOT COMPLETED|Part C||0
5001448|NCT02332720|12306900|P2|NOT COMPLETED|Part C||0
5001449|NCT02332720|12306901|P1|NOT COMPLETED|Part C||0
5001450|NCT02332720|12306879|P23|COMPLETED|Part C||0
5001451|NCT02332720|12306880|P22|COMPLETED|Part C||0
5001452|NCT02332720|12306881|P21|COMPLETED|Part C||0
5001453|NCT02332720|12306882|P20|COMPLETED|Part C||0
5001454|NCT02332720|12306883|P19|COMPLETED|Part C||0
5001455|NCT02332720|12306884|P18|COMPLETED|Part C||0
5001456|NCT02332720|12306885|P17|COMPLETED|Part C||0
5001457|NCT02332720|12306886|P16|COMPLETED|Part C||0
5001458|NCT02332720|12306887|P15|COMPLETED|Part C||0
5001459|NCT02332720|12306888|P14|COMPLETED|Part C||0
5001460|NCT02332720|12306889|P13|COMPLETED|Part C||0
5001461|NCT02332720|12306890|P12|COMPLETED|Part C||0
5001462|NCT02332720|12306891|P11|COMPLETED|Part C||0
5001463|NCT02332720|12306892|P10|COMPLETED|Part C||0
5001464|NCT02332720|12306893|P9|COMPLETED|Part C||0
5001465|NCT02332720|12306894|P8|COMPLETED|Part C||0
5001466|NCT02332720|12306895|P7|COMPLETED|Part C||0
5001467|NCT02332720|12306896|P6|COMPLETED|Part C||0
5001468|NCT02332720|12306897|P5|COMPLETED|Part C||0
5001469|NCT02332720|12306898|P4|COMPLETED|Part C||2
5001470|NCT02332720|12306899|P3|COMPLETED|Part C||3
5001471|NCT02332720|12306900|P2|COMPLETED|Part C||1
5001472|NCT02332720|12306901|P1|COMPLETED|Part C||2
5001473|NCT02332720|12306879|P23|STARTED|Part C|Part B participants were not included in Part C.|0
5001474|NCT02332720|12306880|P22|STARTED|Part C||0
5001475|NCT02332720|12306881|P21|STARTED|Part C|Part B participants were not included in Part C.|0
5001476|NCT02332720|12306882|P20|STARTED|Part C|Part B participants were not included in Part C.|0
5001477|NCT02332720|12306883|P19|STARTED|Part C|Part B participants were not included in Part C.|0
5001478|NCT02332720|12306884|P18|STARTED|Part C|Part B participants were not included in Part C.|0
5001479|NCT02332720|12306885|P17|STARTED|Part C|Part B participants were not included in Part C.|0
5001480|NCT02332720|12306886|P16|STARTED|Part C|Part B participants were not included in Part C.|0
5001481|NCT02332720|12306887|P15|STARTED|Part C|Part B participants were not included in Part C.|0
5001482|NCT02332720|12306888|P14|STARTED|Part C|Part B participants were not included in Part C.|0
5001568|NCT02332720|12306882|P20|STARTED|Part A and Part B||25
5001483|NCT02332720|12306889|P13|STARTED|Part C|Part B participants were not included in Part C.|0
5001484|NCT02332720|12306890|P12|STARTED|Part C|Part B participants were not included in Part C.|0
5001485|NCT02332720|12306891|P11|STARTED|Part C|Part B participants were not included in Part C.|0
5001486|NCT02332720|12306892|P10|STARTED|Part C|Part B participants were not included in Part C.|0
5001487|NCT02332720|12306893|P9|STARTED|Part C|Part B participants were not included in Part C.|0
5001488|NCT02332720|12306894|P8|STARTED|Part C|Part B participants were not included in Part C.|0
5001489|NCT02332720|12306895|P7|STARTED|Part C|Part B participants were not included in Part C.|0
5001490|NCT02332720|12306896|P6|STARTED|Part C|Part B participants were not included in Part C.|0
5001491|NCT02332720|12306897|P5|STARTED|Part C|Part B participants were not included in Part C.|0
5001492|NCT02332720|12306898|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
5001493|NCT02332720|12306899|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
5001494|NCT02332720|12306900|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
5001495|NCT02332720|12306901|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
5001496|NCT02332720|12306879|P23|NOT COMPLETED|Part A and Part B||0
5001497|NCT02332720|12306880|P22|NOT COMPLETED|Part A and Part B||0
5001498|NCT02332720|12306881|P21|NOT COMPLETED|Part A and Part B||0
5001499|NCT02332720|12306882|P20|NOT COMPLETED|Part A and Part B||1
5001500|NCT02332720|12306883|P19|NOT COMPLETED|Part A and Part B||1
5001501|NCT02332720|12306884|P18|NOT COMPLETED|Part A and Part B||1
5001502|NCT02332720|12306885|P17|NOT COMPLETED|Part A and Part B||0
5001503|NCT02332720|12306886|P16|NOT COMPLETED|Part A and Part B||1
5001504|NCT02332720|12306887|P15|NOT COMPLETED|Part A and Part B||0
5001505|NCT02332720|12306888|P14|NOT COMPLETED|Part A and Part B||0
5001506|NCT02332720|12306889|P13|NOT COMPLETED|Part A and Part B||0
5001507|NCT02332720|12306890|P12|NOT COMPLETED|Part A and Part B||0
5001508|NCT02332720|12306891|P11|NOT COMPLETED|Part A and Part B||0
5001509|NCT02332720|12306892|P10|NOT COMPLETED|Part A and Part B||0
5001510|NCT02332720|12306893|P9|NOT COMPLETED|Part A and Part B||0
5001511|NCT02332720|12306894|P8|NOT COMPLETED|Part A and Part B||1
5001512|NCT02332720|12306895|P7|NOT COMPLETED|Part A and Part B||1
5001513|NCT02332720|12306896|P6|NOT COMPLETED|Part A and Part B||3
5001514|NCT02332720|12306897|P5|NOT COMPLETED|Part A and Part B||0
5001515|NCT02332720|12306898|P4|NOT COMPLETED|Part A and Part B||0
5001516|NCT02332720|12306899|P3|NOT COMPLETED|Part A and Part B||0
5001517|NCT02332720|12306900|P2|NOT COMPLETED|Part A and Part B||0
5001518|NCT02332720|12306901|P1|NOT COMPLETED|Part A and Part B||1
5001519|NCT02332720|12306879|P23|COMPLETED|Part A and Part B||4
5001520|NCT02332720|12306880|P22|COMPLETED|Part A and Part B||0
5001521|NCT02332720|12306881|P21|COMPLETED|Part A and Part B||7
5001522|NCT02332720|12306882|P20|COMPLETED|Part A and Part B||24
5001523|NCT02332720|12306883|P19|COMPLETED|Part A and Part B||20
5001524|NCT02332720|12306884|P18|COMPLETED|Part A and Part B||13
5001525|NCT02332720|12306885|P17|COMPLETED|Part A and Part B||15
5001526|NCT02332720|12306886|P16|COMPLETED|Part A and Part B||13
5001527|NCT02332720|12306887|P15|COMPLETED|Part A and Part B||16
5001528|NCT02332720|12306888|P14|COMPLETED|Part A and Part B||13
5001529|NCT02332720|12306889|P13|COMPLETED|Part A and Part B||16
5001530|NCT02332720|12306890|P12|COMPLETED|Part A and Part B||15
5001531|NCT02332720|12306891|P11|COMPLETED|Part A and Part B||14
5001532|NCT02332720|12306892|P10|COMPLETED|Part A and Part B||14
5001533|NCT02332720|12306893|P9|COMPLETED|Part A and Part B||15
5001534|NCT02332720|12306894|P8|COMPLETED|Part A and Part B||34
5001535|NCT02332720|12306895|P7|COMPLETED|Part A and Part B||36
5001536|NCT02332720|12306896|P6|COMPLETED|Part A and Part B||33
5001537|NCT02332720|12306897|P5|COMPLETED|Part A and Part B||16
5001538|NCT02332720|12306898|P4|COMPLETED|Part A and Part B||22
5001539|NCT02332720|12306899|P3|COMPLETED|Part A and Part B||22
5001540|NCT02332720|12306900|P2|COMPLETED|Part A and Part B||21
5001541|NCT02332720|12306901|P1|COMPLETED|Part A and Part B||20
5001542|NCT02332720|12306879|P23|Treated|Part A and Part B||4
5001543|NCT02332720|12306880|P22|Treated|Part A and Part B||0
5001544|NCT02332720|12306881|P21|Treated|Part A and Part B||7
5001545|NCT02332720|12306882|P20|Treated|Part A and Part B||25
5001546|NCT02332720|12306883|P19|Treated|Part A and Part B||20
5001547|NCT02332720|12306884|P18|Treated|Part A and Part B||14
5001548|NCT02332720|12306885|P17|Treated|Part A and Part B||15
5001549|NCT02332720|12306886|P16|Treated|Part A and Part B||14
5001550|NCT02332720|12306887|P15|Treated|Part A and Part B||16
5001551|NCT02332720|12306888|P14|Treated|Part A and Part B||13
5001552|NCT02332720|12306889|P13|Treated|Part A and Part B||16
5001553|NCT02332720|12306890|P12|Treated|Part A and Part B||15
5001554|NCT02332720|12306891|P11|Treated|Part A and Part B||14
5001555|NCT02332720|12306892|P10|Treated|Part A and Part B||14
5001556|NCT02332720|12306893|P9|Treated|Part A and Part B||15
5001557|NCT02332720|12306894|P8|Treated|Part A and Part B||35
5001558|NCT02332720|12306895|P7|Treated|Part A and Part B||37
5001559|NCT02332720|12306896|P6|Treated|Part A and Part B||36
5001560|NCT02332720|12306897|P5|Treated|Part A and Part B||16
5001561|NCT02332720|12306898|P4|Treated|Part A and Part B||22
5001562|NCT02332720|12306899|P3|Treated|Part A and Part B||22
5001563|NCT02332720|12306900|P2|Treated|Part A and Part B||21
5001564|NCT02332720|12306901|P1|Treated|Part A and Part B||21
5001565|NCT02332720|12306879|P23|STARTED|Part A and Part B||4
5001566|NCT02332720|12306880|P22|STARTED|Part A and Part B||0
5001567|NCT02332720|12306881|P21|STARTED|Part A and Part B||7
5001569|NCT02332720|12306883|P19|STARTED|Part A and Part B||21
5001570|NCT02332720|12306884|P18|STARTED|Part A and Part B||14
5001571|NCT02332720|12306885|P17|STARTED|Part A and Part B||15
5001572|NCT02332720|12306886|P16|STARTED|Part A and Part B||14
5001573|NCT02332720|12306887|P15|STARTED|Part A and Part B||16
5001574|NCT02332720|12306888|P14|STARTED|Part A and Part B||13
5001575|NCT02332720|12306889|P13|STARTED|Part A and Part B||16
5001576|NCT02332720|12306890|P12|STARTED|Part A and Part B||15
5001577|NCT02332720|12306891|P11|STARTED|Part A and Part B||14
5001578|NCT02332720|12306892|P10|STARTED|Part A and Part B||14
5001579|NCT02332720|12306893|P9|STARTED|Part A and Part B||15
5001580|NCT02332720|12306894|P8|STARTED|Part A and Part B||35
5001581|NCT02332720|12306895|P7|STARTED|Part A and Part B||37
5001582|NCT02332720|12306896|P6|STARTED|Part A and Part B||36
5001583|NCT02332720|12306897|P5|STARTED|Part A and Part B||16
5001584|NCT02332720|12306898|P4|STARTED|Part A and Part B||22
5001585|NCT02332720|12306899|P3|STARTED|Part A and Part B||22
5001586|NCT02332720|12306900|P2|STARTED|Part A and Part B||21
5001587|NCT02332720|12306901|P1|STARTED|Part A and Part B||21
5001588|NCT02332707|12307037|P18|NOT COMPLETED|Overall Study||0
5001589|NCT02332707|12307038|P17|NOT COMPLETED|Overall Study||0
5001590|NCT02332707|12307039|P16|NOT COMPLETED|Overall Study||0
5001591|NCT02332707|12307040|P15|NOT COMPLETED|Overall Study||0
5001592|NCT02332707|12307041|P14|NOT COMPLETED|Overall Study||0
5001593|NCT02332707|12307042|P13|NOT COMPLETED|Overall Study||5
5001594|NCT02332707|12307043|P12|NOT COMPLETED|Overall Study||0
5001595|NCT02332707|12307044|P11|NOT COMPLETED|Overall Study||2
5001596|NCT02332707|12307045|P10|NOT COMPLETED|Overall Study||3
5001597|NCT02332707|12307046|P9|NOT COMPLETED|Overall Study||0
5001598|NCT02332707|12307047|P8|NOT COMPLETED|Overall Study||0
5001599|NCT02332707|12307048|P7|NOT COMPLETED|Overall Study||0
5001600|NCT02332707|12307049|P6|NOT COMPLETED|Overall Study||1
5001601|NCT02332707|12307050|P5|NOT COMPLETED|Overall Study||0
5001602|NCT02332707|12307051|P4|NOT COMPLETED|Overall Study||1
5001603|NCT02332707|12307052|P3|NOT COMPLETED|Overall Study||1
5001604|NCT02332707|12307053|P2|NOT COMPLETED|Overall Study||0
5001605|NCT02332707|12307054|P1|NOT COMPLETED|Overall Study||0
5001606|NCT02332707|12307037|P18|COMPLETED|Overall Study||16
5001607|NCT02332707|12307038|P17|COMPLETED|Overall Study||30
5001608|NCT02332707|12307039|P16|COMPLETED|Overall Study||26
5001609|NCT02332707|12307040|P15|COMPLETED|Overall Study||16
5001610|NCT02332707|12307041|P14|COMPLETED|Overall Study||15
5001611|NCT02332707|12307042|P13|COMPLETED|Overall Study||35
5001612|NCT02332707|12307043|P12|COMPLETED|Overall Study||35
5001613|NCT02332707|12307044|P11|COMPLETED|Overall Study||29
5001614|NCT02332707|12307045|P10|COMPLETED|Overall Study||28
5001615|NCT02332707|12307046|P9|COMPLETED|Overall Study||48
5001616|NCT02332707|12307047|P8|COMPLETED|Overall Study||16
5001617|NCT02332707|12307048|P7|COMPLETED|Overall Study||15
5001618|NCT02332707|12307049|P6|COMPLETED|Overall Study||22
5001619|NCT02332707|12307050|P5|COMPLETED|Overall Study||23
5001620|NCT02332707|12307051|P4|COMPLETED|Overall Study||13
5001621|NCT02332707|12307052|P3|COMPLETED|Overall Study||15
5001622|NCT02332707|12307053|P2|COMPLETED|Overall Study||24
5001623|NCT02332707|12307054|P1|COMPLETED|Overall Study||23
5001624|NCT02332707|12307037|P18|STARTED|Overall Study||16
5001625|NCT02332707|12307038|P17|STARTED|Overall Study||30
5001626|NCT02332707|12307039|P16|STARTED|Overall Study||26
5001627|NCT02332707|12307040|P15|STARTED|Overall Study||16
5001628|NCT02332707|12307041|P14|STARTED|Overall Study||15
5001629|NCT02332707|12307042|P13|STARTED|Overall Study||40
5001630|NCT02332707|12307043|P12|STARTED|Overall Study||35
5001631|NCT02332707|12307044|P11|STARTED|Overall Study||31
5001632|NCT02332707|12307045|P10|STARTED|Overall Study||31
5001633|NCT02332707|12307046|P9|STARTED|Overall Study||48
5001634|NCT02332707|12307047|P8|STARTED|Overall Study||16
5001635|NCT02332707|12307048|P7|STARTED|Overall Study||15
5001636|NCT02332707|12307049|P6|STARTED|Overall Study||23
5001637|NCT02332707|12307050|P5|STARTED|Overall Study||23
5001638|NCT02332707|12307051|P4|STARTED|Overall Study||14
5001639|NCT02332707|12307052|P3|STARTED|Overall Study||16
5001640|NCT02332707|12307053|P2|STARTED|Overall Study||24
5001641|NCT02332707|12307054|P1|STARTED|Overall Study||23
5001642|NCT02332590|12307148|P2|NOT COMPLETED|Overall Study||19
5001643|NCT02332590|12307149|P1|NOT COMPLETED|Overall Study||29
5001644|NCT02332590|12307148|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
5001645|NCT02332590|12307149|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
5001646|NCT02332590|12307148|P2|Treated|Overall Study||184
5001647|NCT02332590|12307149|P1|Treated|Overall Study||184
5001648|NCT02332590|12307148|P2|STARTED|Overall Study||184
5001649|NCT02332590|12307149|P1|STARTED|Overall Study||185
5001650|NCT02332239|12307213|P2|NOT COMPLETED|Overall Study||6
5001651|NCT02332239|12307214|P1|NOT COMPLETED|Overall Study||4
5001652|NCT02332239|12307213|P2|COMPLETED|Overall Study||52
5001653|NCT02332239|12307214|P1|COMPLETED|Overall Study||54
5001654|NCT02332239|12307213|P2|STARTED|Overall Study||58
5001655|NCT02332239|12307214|P1|STARTED|Overall Study||58
5001656|NCT02331992|12307227|P1|NOT COMPLETED|Overall Study||0
5001657|NCT02331992|12307227|P1|COMPLETED|Overall Study||34
5001658|NCT02331992|12307227|P1|STARTED|Overall Study||34
5001659|NCT02331940|12307234|P2|NOT COMPLETED|Overall Study||5
5001660|NCT02331940|12307235|P1|NOT COMPLETED|Overall Study||7
5001661|NCT02331940|12307234|P2|COMPLETED|Overall Study||95
5001662|NCT02331940|12307235|P1|COMPLETED|Overall Study||93
5001663|NCT02331940|12307234|P2|STARTED|Overall Study||100
5001664|NCT02331940|12307235|P1|STARTED|Overall Study||100
5001665|NCT02331680|12307250|P3|NOT COMPLETED|Overall Study||15
5001666|NCT02331680|12307251|P2|NOT COMPLETED|Overall Study||4
5001667|NCT02331680|12307252|P1|NOT COMPLETED|Overall Study||6
5001668|NCT02331680|12307250|P3|COMPLETED|Overall Study||29
5001669|NCT02331680|12307251|P2|COMPLETED|Overall Study||36
5001670|NCT02331680|12307252|P1|COMPLETED|Overall Study||34
5001671|NCT02331680|12307250|P3|STARTED|Overall Study||44
5001672|NCT02331680|12307251|P2|STARTED|Overall Study||40
5001673|NCT02331680|12307252|P1|STARTED|Overall Study||40
5001674|NCT02331589|12307265|P2|NOT COMPLETED|Overall Study||5
5001675|NCT02331589|12307266|P1|NOT COMPLETED|Overall Study||5
5001676|NCT02331589|12307265|P2|COMPLETED|Overall Study||31
5001677|NCT02331589|12307266|P1|COMPLETED|Overall Study||34
5001678|NCT02331589|12307265|P2|STARTED|Overall Study||36
5001679|NCT02331589|12307266|P1|STARTED|Overall Study||39
5001680|NCT02331446|12307282|P4|NOT COMPLETED|Overall Study||3
5001681|NCT02331446|12307283|P3|NOT COMPLETED|Overall Study||3
5001682|NCT02331446|12307284|P2|NOT COMPLETED|Overall Study||5
5001683|NCT02331446|12307285|P1|NOT COMPLETED|Overall Study||4
5001684|NCT02331446|12307282|P4|COMPLETED|Overall Study||8
5001685|NCT02331446|12307283|P3|COMPLETED|Overall Study||8
5001686|NCT02331446|12307284|P2|COMPLETED|Overall Study||6
5001687|NCT02331446|12307285|P1|COMPLETED|Overall Study||5
5001688|NCT02331446|12307282|P4|STARTED|Overall Study||11
5001689|NCT02331446|12307283|P3|STARTED|Overall Study||11
5001690|NCT02331446|12307284|P2|STARTED|Overall Study||11
5001691|NCT02331446|12307285|P1|STARTED|Overall Study||9
5001692|NCT02331407|12307355|P1|NOT COMPLETED|Overall Study||0
5001693|NCT02331407|12307355|P1|COMPLETED|Overall Study||9
5001694|NCT02331407|12307355|P1|STARTED|Overall Study||9
5001695|NCT02331394|12307361|P1|NOT COMPLETED|Overall Study||1
5001696|NCT02331394|12307361|P1|COMPLETED|Overall Study|14 patients, 1 dropped out|14
5001697|NCT02331394|12307361|P1|STARTED|Overall Study||15
5001698|NCT02331368|12307372|P1|NOT COMPLETED|Overall Study||3
5001699|NCT02331368|12307372|P1|COMPLETED|Overall Study||29
5001700|NCT02331368|12307372|P1|STARTED|Overall Study||32
5001701|NCT02331108|12307384|P6|NOT COMPLETED|Overall Study||2
5001702|NCT02331108|12307385|P5|NOT COMPLETED|Overall Study||2
5001703|NCT02331108|12307386|P4|NOT COMPLETED|Overall Study||1
5001704|NCT02331108|12307387|P3|NOT COMPLETED|Overall Study||1
5001705|NCT02331108|12307388|P2|NOT COMPLETED|Overall Study||2
5001706|NCT02331108|12307389|P1|NOT COMPLETED|Overall Study||1
5001707|NCT02331108|12307384|P6|COMPLETED|Overall Study||50
5001708|NCT02331108|12307385|P5|COMPLETED|Overall Study||50
5001709|NCT02331108|12307386|P4|COMPLETED|Overall Study||50
5001710|NCT02331108|12307387|P3|COMPLETED|Overall Study||50
5001711|NCT02331108|12307388|P2|COMPLETED|Overall Study||50
5001712|NCT02331108|12307389|P1|COMPLETED|Overall Study||50
5001713|NCT02331108|12307384|P6|STARTED|Overall Study||52
5001714|NCT02331108|12307385|P5|STARTED|Overall Study||52
5001715|NCT02331108|12307386|P4|STARTED|Overall Study||51
5001716|NCT02331108|12307387|P3|STARTED|Overall Study||51
5001717|NCT02331108|12307388|P2|STARTED|Overall Study||52
5001718|NCT02331108|12307389|P1|STARTED|Overall Study||51
5001719|NCT02330978|12307411|P1|NOT COMPLETED|The Second Patient Included at Study||0
5001720|NCT02330978|12307411|P1|COMPLETED|The Second Patient Included at Study||1
5001721|NCT02330978|12307411|P1|STARTED|The Second Patient Included at Study||1
5001722|NCT02330978|12307411|P1|NOT COMPLETED|The First Patient Included at Study||0
5001723|NCT02330978|12307411|P1|COMPLETED|The First Patient Included at Study||1
5001724|NCT02330978|12307411|P1|STARTED|The First Patient Included at Study||1
5001725|NCT02330627|12307417|P2|NOT COMPLETED|Overall Study||1
5001726|NCT02330627|12307418|P1|NOT COMPLETED|Overall Study||1
5001727|NCT02330627|12307417|P2|COMPLETED|Overall Study||12
5001728|NCT02330627|12307418|P1|COMPLETED|Overall Study||15
5001729|NCT02330627|12307417|P2|STARTED|Overall Study||13
5001730|NCT02330627|12307418|P1|STARTED|Overall Study||16
5001731|NCT02330588|12307437|P5|NOT COMPLETED|Overall Study||19
5001732|NCT02330588|12307438|P4|NOT COMPLETED|Overall Study||22
5001733|NCT02330588|12307439|P3|NOT COMPLETED|Overall Study||15
5001734|NCT02330588|12307440|P2|NOT COMPLETED|Overall Study||18
5001735|NCT02330588|12307441|P1|NOT COMPLETED|Overall Study||16
5001736|NCT02330588|12307437|P5|COMPLETED|Overall Study||28
5001737|NCT02330588|12307438|P4|COMPLETED|Overall Study||24
5001738|NCT02330588|12307439|P3|COMPLETED|Overall Study||31
5001739|NCT02330588|12307440|P2|COMPLETED|Overall Study||25
5001740|NCT02330588|12307441|P1|COMPLETED|Overall Study||28
5001741|NCT02330588|12307437|P5|STARTED|Overall Study||47
5001742|NCT02330588|12307438|P4|STARTED|Overall Study||46
5001743|NCT02330588|12307439|P3|STARTED|Overall Study||46
5001744|NCT02330588|12307440|P2|STARTED|Overall Study||43
5001745|NCT02330588|12307441|P1|STARTED|Overall Study||44
5001746|NCT02330549|12307468|P2|NOT COMPLETED|Overall Study||1
5001747|NCT02330549|12307469|P1|NOT COMPLETED|Overall Study||4
5001748|NCT02330549|12307468|P2|COMPLETED|Overall Study||24
5001749|NCT02330549|12307469|P1|COMPLETED|Overall Study||16
5001750|NCT02330549|12307468|P2|STARTED|Overall Study||25
5001751|NCT02330549|12307469|P1|STARTED|Overall Study||20
5001752|NCT02330523|12307584|P2|NOT COMPLETED|Overall Study||0
5001753|NCT02330523|12307585|P1|NOT COMPLETED|Overall Study||0
5001754|NCT02330523|12307584|P2|COMPLETED|Overall Study||19
5001755|NCT02330523|12307585|P1|COMPLETED|Overall Study||21
5001756|NCT02330523|12307584|P2|STARTED|Overall Study||19
5001757|NCT02330523|12307585|P1|STARTED|Overall Study||21
5001758|NCT02330276|12307598|P3|NOT COMPLETED|Overall Study||0
5001759|NCT02330276|12307599|P2|NOT COMPLETED|Overall Study||0
5001760|NCT02330276|12307600|P1|NOT COMPLETED|Overall Study||0
5001761|NCT02330276|12307598|P3|COMPLETED|Overall Study||4
5001762|NCT02330276|12307599|P2|COMPLETED|Overall Study||4
5001763|NCT02330276|12307600|P1|COMPLETED|Overall Study||4
5001764|NCT02330276|12307598|P3|STARTED|Overall Study||4
5001765|NCT02330276|12307599|P2|STARTED|Overall Study||4
5001766|NCT02330276|12307600|P1|STARTED|Overall Study||4
5001767|NCT02330172|12307622|P2|NOT COMPLETED|Overall Study||1
5001768|NCT02330172|12307623|P1|NOT COMPLETED|Overall Study||3
5001769|NCT02330172|12307622|P2|COMPLETED|Overall Study||21
5001770|NCT02330172|12307623|P1|COMPLETED|Overall Study||19
5001771|NCT02330172|12307622|P2|STARTED|Overall Study||22
5001772|NCT02330172|12307623|P1|STARTED|Overall Study||22
5001773|NCT02330094|12307633|P2|NOT COMPLETED|Overall Study||0
5001774|NCT02330094|12307634|P1|NOT COMPLETED|Overall Study||0
5001775|NCT02330094|12307633|P2|COMPLETED|Overall Study||8
5001776|NCT02330094|12307634|P1|COMPLETED|Overall Study||8
5001777|NCT02330094|12307633|P2|STARTED|Overall Study||8
5001778|NCT02330094|12307634|P1|STARTED|Overall Study||8
5001779|NCT02330081|12307644|P1|NOT COMPLETED|Overall Study||8
5001780|NCT02330081|12307644|P1|COMPLETED|Overall Study||14
5001781|NCT02330081|12307644|P1|STARTED|Overall Study||22
5001782|NCT02330055|12307665|P2|NOT COMPLETED|Overall Study||9
5001783|NCT02330055|12307666|P1|NOT COMPLETED|Overall Study||10
5001784|NCT02330055|12307665|P2|COMPLETED|Overall Study||40
5001785|NCT02330055|12307666|P1|COMPLETED|Overall Study||40
5001786|NCT02330055|12307665|P2|STARTED|Overall Study||49
5001787|NCT02330055|12307666|P1|STARTED|Overall Study||50
5001788|NCT02329964|12307686|P2|NOT COMPLETED|Overall Study||0
5001789|NCT02329964|12307687|P1|NOT COMPLETED|Overall Study||0
5001790|NCT02329964|12307686|P2|COMPLETED|Overall Study||40
5001791|NCT02329964|12307687|P1|COMPLETED|Overall Study||40
5001792|NCT02329964|12307686|P2|STARTED|Overall Study||40
5001793|NCT02329964|12307687|P1|STARTED|Overall Study||40
5001794|NCT02329743|12307712|P3|NOT COMPLETED|Overall Study||8
5001795|NCT02329743|12307713|P2|NOT COMPLETED|Overall Study||7
5001796|NCT02329743|12307714|P1|NOT COMPLETED|Overall Study||6
5001797|NCT02329743|12307712|P3|COMPLETED|Overall Study||77
5001798|NCT02329743|12307713|P2|COMPLETED|Overall Study||80
5001799|NCT02329743|12307714|P1|COMPLETED|Overall Study||78
5001800|NCT02329743|12307712|P3|STARTED|Overall Study||85
5001801|NCT02329743|12307713|P2|STARTED|Overall Study||87
5001802|NCT02329743|12307714|P1|STARTED|Overall Study||84
5001803|NCT02329730|12307729|P12|NOT COMPLETED|Overall Study||0
5001804|NCT02329730|12307730|P11|NOT COMPLETED|Overall Study||0
5001805|NCT02329730|12307731|P10|NOT COMPLETED|Overall Study||1
5001806|NCT02329730|12307732|P9|NOT COMPLETED|Overall Study||1
5001807|NCT02329730|12307733|P8|NOT COMPLETED|Overall Study||1
5001808|NCT02329730|12307734|P7|NOT COMPLETED|Overall Study||1
5001809|NCT02329730|12307735|P6|NOT COMPLETED|Overall Study||2
5001810|NCT02329730|12307736|P5|NOT COMPLETED|Overall Study||3
5001811|NCT02329730|12307737|P4|NOT COMPLETED|Overall Study||0
5001812|NCT02329730|12307738|P3|NOT COMPLETED|Overall Study||0
5001813|NCT02329730|12307739|P2|NOT COMPLETED|Overall Study||0
5001814|NCT02329730|12307740|P1|NOT COMPLETED|Overall Study||0
5001815|NCT02329730|12307729|P12|COMPLETED|Overall Study||8
5001816|NCT02329730|12307730|P11|COMPLETED|Overall Study||8
5001817|NCT02329730|12307731|P10|COMPLETED|Overall Study||7
5001818|NCT02329730|12307732|P9|COMPLETED|Overall Study||7
5001819|NCT02329730|12307733|P8|COMPLETED|Overall Study||13
5001820|NCT02329730|12307734|P7|COMPLETED|Overall Study||13
5001821|NCT02329730|12307735|P6|COMPLETED|Overall Study||12
5001822|NCT02329730|12307736|P5|COMPLETED|Overall Study||11
5001823|NCT02329730|12307737|P4|COMPLETED|Overall Study||14
5001824|NCT02329730|12307738|P3|COMPLETED|Overall Study||14
5001825|NCT02329730|12307739|P2|COMPLETED|Overall Study||14
5001826|NCT02329730|12307740|P1|COMPLETED|Overall Study||14
5001827|NCT02329730|12307729|P12|STARTED|Overall Study||8
5001828|NCT02329730|12307730|P11|STARTED|Overall Study||8
5001829|NCT02329730|12307731|P10|STARTED|Overall Study||8
5001830|NCT02329730|12307732|P9|STARTED|Overall Study||8
5001831|NCT02329730|12307733|P8|STARTED|Overall Study||14
5001832|NCT02329730|12307734|P7|STARTED|Overall Study||14
5001833|NCT02329730|12307735|P6|STARTED|Overall Study||14
5001834|NCT02329730|12307736|P5|STARTED|Overall Study||14
5001835|NCT02329730|12307737|P4|STARTED|Overall Study||14
5001836|NCT02329730|12307738|P3|STARTED|Overall Study||14
5001837|NCT02329730|12307739|P2|STARTED|Overall Study||14
5001838|NCT02329730|12307740|P1|STARTED|Overall Study||14
5001839|NCT02329600|12307817|P3|NOT COMPLETED|Overall Study||0
5001840|NCT02329600|12307818|P2|NOT COMPLETED|Overall Study||0
5001841|NCT02329600|12307819|P1|NOT COMPLETED|Overall Study||0
5001842|NCT02329600|12307817|P3|COMPLETED|Overall Study||15
5001843|NCT02329600|12307818|P2|COMPLETED|Overall Study||15
5001844|NCT02329600|12307819|P1|COMPLETED|Overall Study||10
5001845|NCT02329600|12307817|P3|STARTED|Overall Study||15
5001846|NCT02329600|12307818|P2|STARTED|Overall Study||15
5001847|NCT02329600|12307819|P1|STARTED|Overall Study||10
5001848|NCT02329587|12307832|P2|NOT COMPLETED|1-month Follow-up||1
5001849|NCT02329587|12307833|P1|NOT COMPLETED|1-month Follow-up||0
5001850|NCT02329587|12307832|P2|COMPLETED|1-month Follow-up||5
5001851|NCT02329587|12307833|P1|COMPLETED|1-month Follow-up||4
5001852|NCT02329587|12307832|P2|STARTED|1-month Follow-up||6
5001853|NCT02329587|12307833|P1|STARTED|1-month Follow-up||4
5001854|NCT02329587|12307832|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
5001855|NCT02329587|12307833|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
5001856|NCT02329587|12307832|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
5001857|NCT02329587|12307833|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
5001858|NCT02329587|12307832|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
5001859|NCT02329587|12307833|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
5001860|NCT02329587|12307832|P2|STARTED|Baseline Thru Post-treatment Assessment||7
5001861|NCT02329587|12307833|P1|STARTED|Baseline Thru Post-treatment Assessment||5
5001862|NCT02329431|12307851|P2|NOT COMPLETED|Overall Study||13
5001863|NCT02329431|12307852|P1|NOT COMPLETED|Overall Study||20
5001864|NCT02329431|12307851|P2|COMPLETED|Overall Study||76
5001865|NCT02329431|12307852|P1|COMPLETED|Overall Study||72
5001866|NCT02329431|12307851|P2|Baseline Interview|Overall Study||85
5001867|NCT02329431|12307852|P1|Baseline Interview|Overall Study||87
5001868|NCT02329431|12307851|P2|STARTED|Overall Study||89
5001869|NCT02329431|12307852|P1|STARTED|Overall Study||92
5001870|NCT02329223|12307871|P3|NOT COMPLETED|Overall Study||6
5001871|NCT02329223|12307872|P2|NOT COMPLETED|Overall Study||3
5001872|NCT02329223|12307873|P1|NOT COMPLETED|Overall Study||1
5001873|NCT02329223|12307871|P3|COMPLETED|Overall Study||68
5001874|NCT02329223|12307872|P2|COMPLETED|Overall Study||68
5001875|NCT02329223|12307873|P1|COMPLETED|Overall Study||72
5001876|NCT02329223|12307871|P3|Safety Set|Overall Study||74
5001877|NCT02329223|12307872|P2|Safety Set|Overall Study||71
5001878|NCT02329223|12307873|P1|Safety Set|Overall Study||73
5001879|NCT02329223|12307871|P3|Full Analysis Set|Overall Study||74
5001880|NCT02329223|12307872|P2|Full Analysis Set|Overall Study||70
5001881|NCT02329223|12307873|P1|Full Analysis Set|Overall Study||73
5001882|NCT02329223|12307871|P3|STARTED|Overall Study||74
5001883|NCT02329223|12307872|P2|STARTED|Overall Study||71
5001884|NCT02329223|12307873|P1|STARTED|Overall Study||73
5001885|NCT02329015|12307906|P2|NOT COMPLETED|Overall Study||0
5001886|NCT02329015|12307907|P1|NOT COMPLETED|Overall Study||0
5001887|NCT02329015|12307906|P2|COMPLETED|Overall Study||64
5001888|NCT02329015|12307907|P1|COMPLETED|Overall Study||48
5001889|NCT02329015|12307906|P2|STARTED|Overall Study||64
5001890|NCT02329015|12307907|P1|STARTED|Overall Study||48
5001891|NCT02328937|12307923|P6|NOT COMPLETED|Period 3||0
5001892|NCT02328937|12307924|P5|NOT COMPLETED|Period 3||0
5001893|NCT02328937|12307925|P4|NOT COMPLETED|Period 3||0
5001894|NCT02328937|12307926|P3|NOT COMPLETED|Period 3||0
5001895|NCT02328937|12307927|P2|NOT COMPLETED|Period 3||0
5001896|NCT02328937|12307928|P1|NOT COMPLETED|Period 3||0
5001897|NCT02328937|12307923|P6|COMPLETED|Period 3||6
5001898|NCT02328937|12307924|P5|COMPLETED|Period 3||6
5001899|NCT02328937|12307925|P4|COMPLETED|Period 3||5
5001900|NCT02328937|12307926|P3|COMPLETED|Period 3||6
5001901|NCT02328937|12307927|P2|COMPLETED|Period 3||6
5001902|NCT02328937|12307928|P1|COMPLETED|Period 3||7
5001903|NCT02328937|12307923|P6|STARTED|Period 3||6
5001904|NCT02328937|12307924|P5|STARTED|Period 3||6
5001905|NCT02328937|12307925|P4|STARTED|Period 3||5
5001906|NCT02328937|12307926|P3|STARTED|Period 3||6
5001907|NCT02328937|12307927|P2|STARTED|Period 3||6
5001908|NCT02328937|12307928|P1|STARTED|Period 3||7
5001909|NCT02328937|12307923|P6|NOT COMPLETED|Period 2||0
5001910|NCT02328937|12307924|P5|NOT COMPLETED|Period 2||0
5001911|NCT02328937|12307925|P4|NOT COMPLETED|Period 2||0
5001912|NCT02328937|12307926|P3|NOT COMPLETED|Period 2||1
5001913|NCT02328937|12307927|P2|NOT COMPLETED|Period 2||0
5001914|NCT02328937|12307928|P1|NOT COMPLETED|Period 2||0
5001915|NCT02328937|12307923|P6|COMPLETED|Period 2||6
5001916|NCT02328937|12307924|P5|COMPLETED|Period 2||6
5001917|NCT02328937|12307925|P4|COMPLETED|Period 2||5
5001918|NCT02328937|12307926|P3|COMPLETED|Period 2||6
5001919|NCT02328937|12307927|P2|COMPLETED|Period 2||6
5001920|NCT02328937|12307928|P1|COMPLETED|Period 2||7
5001921|NCT02328937|12307923|P6|STARTED|Period 2||6
5001922|NCT02328937|12307924|P5|STARTED|Period 2||6
5001923|NCT02328937|12307925|P4|STARTED|Period 2||5
5001924|NCT02328937|12307926|P3|STARTED|Period 2||7
5001925|NCT02328937|12307927|P2|STARTED|Period 2||6
5001926|NCT02328937|12307928|P1|STARTED|Period 2||7
5001927|NCT02328937|12307923|P6|NOT COMPLETED|Period 1||0
5001928|NCT02328937|12307924|P5|NOT COMPLETED|Period 1||0
5001929|NCT02328937|12307925|P4|NOT COMPLETED|Period 1||1
5001930|NCT02328937|12307926|P3|NOT COMPLETED|Period 1||0
5001931|NCT02328937|12307927|P2|NOT COMPLETED|Period 1||0
5001932|NCT02328937|12307928|P1|NOT COMPLETED|Period 1||0
5001933|NCT02328937|12307923|P6|COMPLETED|Period 1||6
5001934|NCT02328937|12307924|P5|COMPLETED|Period 1||6
5001935|NCT02328937|12307925|P4|COMPLETED|Period 1||5
5001936|NCT02328937|12307926|P3|COMPLETED|Period 1||7
5001937|NCT02328937|12307927|P2|COMPLETED|Period 1||6
5001938|NCT02328937|12307928|P1|COMPLETED|Period 1||7
5001939|NCT02328937|12307923|P6|STARTED|Period 1||6
5001940|NCT02328937|12307924|P5|STARTED|Period 1||6
5001941|NCT02328937|12307925|P4|STARTED|Period 1||6
5001942|NCT02328937|12307926|P3|STARTED|Period 1||7
5001943|NCT02328937|12307927|P2|STARTED|Period 1||6
5001944|NCT02328937|12307928|P1|STARTED|Period 1||7
5001945|NCT02328807|12307939|P1|NOT COMPLETED|Overall Study||0
5001946|NCT02328807|12307939|P1|COMPLETED|Overall Study||6
5001947|NCT02328807|12307939|P1|STARTED|Overall Study||6
5001948|NCT02328547|12307948|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
5001949|NCT02328547|12307949|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
5001950|NCT02328547|12307948|P2|COMPLETED|Second Intervention (12 Weeks)||23
5001951|NCT02328547|12307949|P1|COMPLETED|Second Intervention (12 Weeks)||22
5001952|NCT02328547|12307948|P2|STARTED|Second Intervention (12 Weeks)||23
5001953|NCT02328547|12307949|P1|STARTED|Second Intervention (12 Weeks)||22
5001954|NCT02328547|12307948|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
5001955|NCT02328547|12307949|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
5001956|NCT02328547|12307948|P2|COMPLETED|First Intervention (12 Weeks)||23
5001957|NCT02328547|12307949|P1|COMPLETED|First Intervention (12 Weeks)||22
5001958|NCT02328547|12307948|P2|STARTED|First Intervention (12 Weeks)||23
5001959|NCT02328547|12307949|P1|STARTED|First Intervention (12 Weeks)||25
5001960|NCT02328404|12307989|P2|NOT COMPLETED|Overall Study||1
5001961|NCT02328404|12307990|P1|NOT COMPLETED|Overall Study||1
5001962|NCT02328404|12307989|P2|COMPLETED|Overall Study||29
5001963|NCT02328404|12307990|P1|COMPLETED|Overall Study||29
5001964|NCT02328404|12307989|P2|STARTED|Overall Study||30
5001965|NCT02328404|12307990|P1|STARTED|Overall Study||30
5001966|NCT02328326|12308026|P2|NOT COMPLETED|Overall Study||8
5001967|NCT02328326|12308027|P1|NOT COMPLETED|Overall Study||22
5001968|NCT02328326|12308026|P2|COMPLETED|Overall Study||224
5001969|NCT02328326|12308027|P1|COMPLETED|Overall Study||224
5001970|NCT02328326|12308026|P2|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
5001971|NCT02328326|12308027|P1|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
5001972|NCT02328326|12308026|P2|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
5001973|NCT02328326|12308027|P1|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
5001974|NCT02328105|12308035|P1|NOT COMPLETED|Overall Study||11
5001975|NCT02328105|12308035|P1|COMPLETED|Overall Study||0
5001976|NCT02328105|12308035|P1|STARTED|Overall Study||11
5001977|NCT02328040|12308040|P2|NOT COMPLETED|Second Intervention (2 Days)||0
5001978|NCT02328040|12308041|P1|NOT COMPLETED|Second Intervention (2 Days)||0
5001979|NCT02328040|12308040|P2|COMPLETED|Second Intervention (2 Days)||8
5001980|NCT02328040|12308041|P1|COMPLETED|Second Intervention (2 Days)||7
5001981|NCT02328040|12308040|P2|STARTED|Second Intervention (2 Days)||8
5001982|NCT02328040|12308041|P1|STARTED|Second Intervention (2 Days)||7
5001983|NCT02328040|12308040|P2|NOT COMPLETED|First Intervention (2 Days)||1
5001984|NCT02328040|12308041|P1|NOT COMPLETED|First Intervention (2 Days)||1
5001985|NCT02328040|12308040|P2|COMPLETED|First Intervention (2 Days)||8
5001986|NCT02328040|12308041|P1|COMPLETED|First Intervention (2 Days)||7
5001987|NCT02328040|12308040|P2|STARTED|First Intervention (2 Days)||9
5001988|NCT02328040|12308041|P1|STARTED|First Intervention (2 Days)||8
5001989|NCT02328027|12308051|P2|NOT COMPLETED|Overall Study||1
5001990|NCT02328027|12308052|P1|NOT COMPLETED|Overall Study||0
5001991|NCT02328027|12308051|P2|COMPLETED|Overall Study||10
5001992|NCT02328027|12308052|P1|COMPLETED|Overall Study||5
5001993|NCT02328027|12308051|P2|STARTED|Overall Study||11
5001994|NCT02328027|12308052|P1|STARTED|Overall Study||5
5001995|NCT02327741|12308068|P2|NOT COMPLETED|Overall Study||0
5001996|NCT02327741|12308069|P1|NOT COMPLETED|Overall Study||0
5001997|NCT02327741|12308068|P2|COMPLETED|Overall Study||508
5001998|NCT02327741|12308069|P1|COMPLETED|Overall Study||502
5001999|NCT02327741|12308068|P2|STARTED|Overall Study||508
5002000|NCT02327741|12308069|P1|STARTED|Overall Study||502
5002001|NCT02327429|12308087|P1|NOT COMPLETED|Overall Study||2
5002002|NCT02327429|12308087|P1|COMPLETED|Overall Study||17
5002003|NCT02327429|12308087|P1|STARTED|Overall Study||19
5002004|NCT02327325|12308110|P3|NOT COMPLETED|Overall Study||5
5002005|NCT02327325|12308111|P2|NOT COMPLETED|Overall Study||4
5002006|NCT02327325|12308112|P1|NOT COMPLETED|Overall Study||1
5002007|NCT02327325|12308110|P3|COMPLETED|Overall Study||15
5002008|NCT02327325|12308111|P2|COMPLETED|Overall Study||16
5002009|NCT02327325|12308112|P1|COMPLETED|Overall Study||19
5002010|NCT02327325|12308110|P3|STARTED|Overall Study||20
5002011|NCT02327325|12308111|P2|STARTED|Overall Study||20
5002012|NCT02327325|12308112|P1|STARTED|Overall Study||20
5002013|NCT02327260|12308135|P3|NOT COMPLETED|Overall Study||2
5002014|NCT02327260|12308136|P2|NOT COMPLETED|Overall Study||4
5002015|NCT02327260|12308137|P1|NOT COMPLETED|Overall Study||6
5002016|NCT02327260|12308135|P3|COMPLETED|Overall Study||15
5002017|NCT02327260|12308136|P2|COMPLETED|Overall Study||20
5002018|NCT02327260|12308137|P1|COMPLETED|Overall Study||14
5002019|NCT02327260|12308135|P3|STARTED|Overall Study||17
5002020|NCT02327260|12308136|P2|STARTED|Overall Study||24
5002021|NCT02327260|12308137|P1|STARTED|Overall Study||20
5002022|NCT02327169|12308184|P15|NOT COMPLETED|Overall Study||10
5002023|NCT02327169|12308185|P14|NOT COMPLETED|Overall Study||7
5002024|NCT02327169|12308186|P13|NOT COMPLETED|Overall Study||1
5002025|NCT02327169|12308187|P12|NOT COMPLETED|Overall Study||7
5002026|NCT02327169|12308188|P11|NOT COMPLETED|Overall Study||6
5002027|NCT02327169|12308189|P10|NOT COMPLETED|Overall Study||8
5002028|NCT02327169|12308190|P9|NOT COMPLETED|Overall Study||6
5002029|NCT02327169|12308191|P8|NOT COMPLETED|Overall Study||4
5002030|NCT02327169|12308192|P7|NOT COMPLETED|Overall Study||3
5002031|NCT02327169|12308193|P6|NOT COMPLETED|Overall Study||4
5002032|NCT02327169|12308194|P5|NOT COMPLETED|Overall Study||8
5002033|NCT02327169|12308195|P4|NOT COMPLETED|Overall Study||3
5002034|NCT02327169|12308196|P3|NOT COMPLETED|Overall Study||7
5002035|NCT02327169|12308197|P2|NOT COMPLETED|Overall Study||3
5002036|NCT02327169|12308198|P1|NOT COMPLETED|Overall Study||4
5002037|NCT02327169|12308184|P15|COMPLETED|Overall Study||0
5002038|NCT02327169|12308185|P14|COMPLETED|Overall Study||0
5002039|NCT02327169|12308186|P13|COMPLETED|Overall Study||0
5002040|NCT02327169|12308187|P12|COMPLETED|Overall Study||0
5002041|NCT02327169|12308188|P11|COMPLETED|Overall Study||0
5002042|NCT02327169|12308189|P10|COMPLETED|Overall Study||0
5002043|NCT02327169|12308190|P9|COMPLETED|Overall Study||0
5002044|NCT02327169|12308191|P8|COMPLETED|Overall Study||0
5002045|NCT02327169|12308192|P7|COMPLETED|Overall Study||0
5002046|NCT02327169|12308193|P6|COMPLETED|Overall Study||0
5002047|NCT02327169|12308194|P5|COMPLETED|Overall Study||0
5002048|NCT02327169|12308195|P4|COMPLETED|Overall Study||0
5002049|NCT02327169|12308196|P3|COMPLETED|Overall Study||0
5002050|NCT02327169|12308197|P2|COMPLETED|Overall Study||0
5002051|NCT02327169|12308198|P1|COMPLETED|Overall Study||0
5002052|NCT02327169|12308184|P15|STARTED|Overall Study||10
5002053|NCT02327169|12308185|P14|STARTED|Overall Study||7
5002054|NCT02327169|12308186|P13|STARTED|Overall Study||1
5002055|NCT02327169|12308187|P12|STARTED|Overall Study||7
5002056|NCT02327169|12308188|P11|STARTED|Overall Study||6
5002057|NCT02327169|12308189|P10|STARTED|Overall Study||8
5002058|NCT02327169|12308190|P9|STARTED|Overall Study||6
5002059|NCT02327169|12308191|P8|STARTED|Overall Study||4
5002060|NCT02327169|12308192|P7|STARTED|Overall Study||3
5002061|NCT02327169|12308193|P6|STARTED|Overall Study||4
5002062|NCT02327169|12308194|P5|STARTED|Overall Study||8
5002063|NCT02327169|12308195|P4|STARTED|Overall Study||3
5002064|NCT02327169|12308196|P3|STARTED|Overall Study||7
5002065|NCT02327169|12308197|P2|STARTED|Overall Study||3
5002066|NCT02327169|12308198|P1|STARTED|Overall Study||4
5002067|NCT02327143|12308419|P2|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
5002068|NCT02327143|12308420|P1|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
5002069|NCT02327143|12308419|P2|COMPLETED|Day 1: Time 6 Hrs – to Day 9||11
5002070|NCT02327143|12308420|P1|COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
5002071|NCT02327143|12308419|P2|STARTED|Day 1: Time 6 Hrs – to Day 9||11
5002072|NCT02327143|12308420|P1|STARTED|Day 1: Time 6 Hrs – to Day 9||0
5002073|NCT02327143|12308419|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
5002074|NCT02327143|12308420|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
5002075|NCT02327143|12308419|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
5002076|NCT02327143|12308420|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
5002077|NCT02327143|12308419|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
5002078|NCT02327143|12308420|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
5002079|NCT02327130|12308428|P1|NOT COMPLETED|Overall Study||12
5002080|NCT02327130|12308428|P1|COMPLETED|Overall Study||20
5002081|NCT02327130|12308428|P1|STARTED|Overall Study||32
5002082|NCT02327117|12308437|P2|NOT COMPLETED|Overall Study||0
5002083|NCT02327117|12308438|P1|NOT COMPLETED|Overall Study||0
5002084|NCT02327117|12308437|P2|COMPLETED|Overall Study||45
5002085|NCT02327117|12308438|P1|COMPLETED|Overall Study||45
5002086|NCT02327117|12308437|P2|STARTED|Overall Study||45
5002087|NCT02327117|12308438|P1|STARTED|Overall Study||45
5002088|NCT02327013|12308447|P5|NOT COMPLETED|Overall Study||4
5002089|NCT02327013|12308448|P4|NOT COMPLETED|Overall Study||1
5002090|NCT02327013|12308449|P3|NOT COMPLETED|Overall Study||42
5002091|NCT02327013|12308450|P2|NOT COMPLETED|Overall Study||16
5002092|NCT02327013|12308451|P1|NOT COMPLETED|Overall Study||13
5002093|NCT02327013|12308447|P5|COMPLETED|Overall Study||12
5002094|NCT02327013|12308448|P4|COMPLETED|Overall Study||20
5002095|NCT02327013|12308449|P3|COMPLETED|Overall Study||54
5002096|NCT02327013|12308450|P2|COMPLETED|Overall Study||29
5002097|NCT02327013|12308451|P1|COMPLETED|Overall Study||36
5002098|NCT02327013|12308447|P5|STARTED|Overall Study||16
5002099|NCT02327013|12308448|P4|STARTED|Overall Study||21
5002100|NCT02327013|12308449|P3|STARTED|Overall Study||96
5002101|NCT02327013|12308450|P2|STARTED|Overall Study||45
5002102|NCT02327013|12308451|P1|STARTED|Overall Study||49
5002103|NCT02326844|12308624|P1|NOT COMPLETED|Overall Study||0
5002104|NCT02326844|12308624|P1|COMPLETED|Overall Study||3
5002105|NCT02326844|12308624|P1|STARTED|Overall Study||3
5002106|NCT02326649|12308631|P1|NOT COMPLETED|Overall Study||12
5002107|NCT02326649|12308631|P1|COMPLETED|Overall Study||21
5002108|NCT02326649|12308631|P1|STARTED|Overall Study||33
5002109|NCT02326597|12308637|P2|NOT COMPLETED|Overall Study||32
5002110|NCT02326597|12308638|P1|NOT COMPLETED|Overall Study||42
5002111|NCT02326597|12308637|P2|COMPLETED|Overall Study||28
5002112|NCT02326597|12308638|P1|COMPLETED|Overall Study||18
5002113|NCT02326597|12308637|P2|STARTED|Overall Study||60
5002114|NCT02326597|12308638|P1|STARTED|Overall Study||60
5002115|NCT02326363|12308658|P2|NOT COMPLETED|Overall Study||56
5002116|NCT02326363|12308659|P1|NOT COMPLETED|Overall Study||51
5002117|NCT02326363|12308658|P2|COMPLETED|Overall Study||50
5002118|NCT02326363|12308659|P1|COMPLETED|Overall Study||47
5002119|NCT02326363|12308658|P2|STARTED|Overall Study||106
5002120|NCT02326363|12308659|P1|STARTED|Overall Study||98
5002121|NCT02326298|12308684|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
5002122|NCT02326298|12308685|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
5002123|NCT02326298|12308686|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
5002124|NCT02326298|12308687|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002125|NCT02326298|12308688|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002126|NCT02326298|12308689|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002127|NCT02326298|12308690|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002642|NCT02325713|12308926|P2|STARTED|Intervention Period 3 (2 Days)||2
5002128|NCT02326298|12308691|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002129|NCT02326298|12308692|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002130|NCT02326298|12308693|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002131|NCT02326298|12308694|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002132|NCT02326298|12308695|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002133|NCT02326298|12308696|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002134|NCT02326298|12308697|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002135|NCT02326298|12308684|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
5002136|NCT02326298|12308685|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
5002137|NCT02326298|12308686|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
5002138|NCT02326298|12308687|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
5002139|NCT02326298|12308688|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002140|NCT02326298|12308689|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002141|NCT02326298|12308690|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002142|NCT02326298|12308691|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002143|NCT02326298|12308692|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002144|NCT02326298|12308693|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002145|NCT02326298|12308694|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002146|NCT02326298|12308695|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002147|NCT02326298|12308696|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002148|NCT02326298|12308697|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002149|NCT02326298|12308684|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
5002150|NCT02326298|12308685|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
5002151|NCT02326298|12308686|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
5002152|NCT02326298|12308687|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
5002153|NCT02326298|12308688|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
5002154|NCT02326298|12308689|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
5002155|NCT02326298|12308690|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
5002156|NCT02326298|12308691|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
5002157|NCT02326298|12308692|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
5002158|NCT02326298|12308693|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
5002159|NCT02326298|12308694|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
5002160|NCT02326298|12308695|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
5002161|NCT02326298|12308696|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
5002162|NCT02326298|12308697|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
5002163|NCT02326298|12308684|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002164|NCT02326298|12308685|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002165|NCT02326298|12308686|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002166|NCT02326298|12308687|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002167|NCT02326298|12308688|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
5002168|NCT02326298|12308689|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002169|NCT02326298|12308690|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002170|NCT02326298|12308691|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
5002171|NCT02326298|12308692|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002172|NCT02326298|12308693|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002173|NCT02326298|12308694|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002174|NCT02326298|12308695|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002175|NCT02326298|12308696|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002176|NCT02326298|12308697|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002177|NCT02326298|12308684|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002178|NCT02326298|12308685|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002179|NCT02326298|12308686|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002180|NCT02326298|12308687|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002181|NCT02326298|12308688|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
5002182|NCT02326298|12308689|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
5002183|NCT02326298|12308690|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
5002184|NCT02326298|12308691|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
5002185|NCT02326298|12308692|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
5002186|NCT02326298|12308693|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002187|NCT02326298|12308694|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
5002188|NCT02326298|12308695|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002189|NCT02326298|12308696|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002190|NCT02326298|12308697|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002191|NCT02326298|12308684|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002192|NCT02326298|12308685|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002193|NCT02326298|12308686|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002194|NCT02326298|12308687|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002195|NCT02326298|12308688|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
5002196|NCT02326298|12308689|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
5002197|NCT02326298|12308690|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
5002198|NCT02326298|12308691|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
5002199|NCT02326298|12308692|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
5002200|NCT02326298|12308693|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
5002201|NCT02326298|12308694|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
5002202|NCT02326298|12308695|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002203|NCT02326298|12308696|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002204|NCT02326298|12308697|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002205|NCT02326298|12308684|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002206|NCT02326298|12308685|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002207|NCT02326298|12308686|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002208|NCT02326298|12308687|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002209|NCT02326298|12308688|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
5002210|NCT02326298|12308689|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
5002211|NCT02326298|12308690|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
5002212|NCT02326298|12308691|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
5002213|NCT02326298|12308692|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
5002214|NCT02326298|12308693|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
5002215|NCT02326298|12308694|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
5002216|NCT02326298|12308695|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002217|NCT02326298|12308696|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002218|NCT02326298|12308697|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002219|NCT02326298|12308684|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002220|NCT02326298|12308685|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002221|NCT02326298|12308686|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002222|NCT02326298|12308687|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002223|NCT02326298|12308688|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
5002224|NCT02326298|12308689|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
5002225|NCT02326298|12308690|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
5002226|NCT02326298|12308691|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
5002227|NCT02326298|12308692|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
5002228|NCT02326298|12308693|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
5002229|NCT02326298|12308694|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
5002230|NCT02326298|12308695|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002231|NCT02326298|12308696|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002232|NCT02326298|12308697|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002233|NCT02326298|12308684|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002234|NCT02326298|12308685|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002235|NCT02326298|12308686|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002236|NCT02326298|12308687|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002237|NCT02326298|12308688|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002238|NCT02326298|12308689|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002239|NCT02326298|12308690|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002240|NCT02326298|12308691|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002241|NCT02326298|12308692|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002242|NCT02326298|12308693|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002243|NCT02326298|12308694|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002244|NCT02326298|12308695|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
5002245|NCT02326298|12308696|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
5002246|NCT02326298|12308697|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
5002247|NCT02326298|12308684|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002248|NCT02326298|12308685|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002249|NCT02326298|12308686|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002250|NCT02326298|12308687|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002251|NCT02326298|12308688|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002252|NCT02326298|12308689|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002253|NCT02326298|12308690|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002254|NCT02326298|12308691|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002255|NCT02326298|12308692|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002256|NCT02326298|12308693|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002257|NCT02326298|12308694|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002258|NCT02326298|12308695|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
5002259|NCT02326298|12308696|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
5002260|NCT02326298|12308697|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
5002261|NCT02326298|12308684|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002262|NCT02326298|12308685|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002263|NCT02326298|12308686|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002264|NCT02326298|12308687|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002265|NCT02326298|12308688|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002266|NCT02326298|12308689|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002267|NCT02326298|12308690|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002268|NCT02326298|12308691|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002269|NCT02326298|12308692|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002270|NCT02326298|12308693|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002271|NCT02326298|12308694|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002272|NCT02326298|12308695|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
5002273|NCT02326298|12308696|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
5002274|NCT02326298|12308697|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
5002275|NCT02326298|12308684|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002276|NCT02326298|12308685|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002277|NCT02326298|12308686|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002278|NCT02326298|12308687|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002279|NCT02326298|12308688|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002280|NCT02326298|12308689|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002281|NCT02326298|12308690|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002282|NCT02326298|12308691|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002283|NCT02326298|12308692|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002284|NCT02326298|12308693|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002285|NCT02326298|12308694|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002286|NCT02326298|12308695|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
5002287|NCT02326298|12308696|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
5002288|NCT02326298|12308697|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
5002289|NCT02326298|12308684|P14|STARTED|Initial Period (Week 0 to Week 16)||0
5002290|NCT02326298|12308685|P13|STARTED|Initial Period (Week 0 to Week 16)||0
5002291|NCT02326298|12308686|P12|STARTED|Initial Period (Week 0 to Week 16)||0
5002292|NCT02326298|12308687|P11|STARTED|Initial Period (Week 0 to Week 16)||0
5002293|NCT02326298|12308688|P10|STARTED|Initial Period (Week 0 to Week 16)||0
5002294|NCT02326298|12308689|P9|STARTED|Initial Period (Week 0 to Week 16)||0
5002295|NCT02326298|12308690|P8|STARTED|Initial Period (Week 0 to Week 16)||0
5002296|NCT02326298|12308691|P7|STARTED|Initial Period (Week 0 to Week 16)||0
5002297|NCT02326298|12308692|P6|STARTED|Initial Period (Week 0 to Week 16)||0
5002298|NCT02326298|12308693|P5|STARTED|Initial Period (Week 0 to Week 16)||0
5002299|NCT02326298|12308694|P4|STARTED|Initial Period (Week 0 to Week 16)||0
5002300|NCT02326298|12308695|P3|STARTED|Initial Period (Week 0 to Week 16)||88
5002301|NCT02326298|12308696|P2|STARTED|Initial Period (Week 0 to Week 16)||95
5002302|NCT02326298|12308697|P1|STARTED|Initial Period (Week 0 to Week 16)||51
5002303|NCT02326272|12308720|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
5002304|NCT02326272|12308721|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002305|NCT02326272|12308722|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
5002306|NCT02326272|12308723|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
5002307|NCT02326272|12308724|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
5002308|NCT02326272|12308725|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002309|NCT02326272|12308726|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002310|NCT02326272|12308727|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002311|NCT02326272|12308728|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002312|NCT02326272|12308729|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002313|NCT02326272|12308730|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002314|NCT02326272|12308731|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002315|NCT02326272|12308732|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002316|NCT02326272|12308733|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002317|NCT02326272|12308734|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002318|NCT02326272|12308720|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
5002319|NCT02326272|12308721|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
5002320|NCT02326272|12308722|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
5002321|NCT02326272|12308723|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
5002322|NCT02326272|12308724|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
5002323|NCT02326272|12308725|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002324|NCT02326272|12308726|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002325|NCT02326272|12308727|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002326|NCT02326272|12308728|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002327|NCT02326272|12308729|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002328|NCT02326272|12308730|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002329|NCT02326272|12308731|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002330|NCT02326272|12308732|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002331|NCT02326272|12308733|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002332|NCT02326272|12308734|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
5002333|NCT02326272|12308720|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
5002334|NCT02326272|12308721|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
5002335|NCT02326272|12308722|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
5002336|NCT02326272|12308723|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
5002337|NCT02326272|12308724|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
5002338|NCT02326272|12308725|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
5002339|NCT02326272|12308726|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
5002340|NCT02326272|12308727|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
5002341|NCT02326272|12308728|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
5002342|NCT02326272|12308729|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
5002343|NCT02326272|12308730|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
5002344|NCT02326272|12308731|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
5002345|NCT02326272|12308732|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
5002346|NCT02326272|12308733|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
5002347|NCT02326272|12308734|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
5002348|NCT02326272|12308720|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002349|NCT02326272|12308721|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002350|NCT02326272|12308722|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002351|NCT02326272|12308723|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002352|NCT02326272|12308724|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002353|NCT02326272|12308725|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
5002354|NCT02326272|12308726|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002355|NCT02326272|12308727|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
5002356|NCT02326272|12308728|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
5002357|NCT02326272|12308729|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
5002358|NCT02326272|12308730|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
5002359|NCT02326272|12308731|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
5002360|NCT02326272|12308732|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002361|NCT02326272|12308733|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002362|NCT02326272|12308734|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002363|NCT02326272|12308720|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002364|NCT02326272|12308721|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002365|NCT02326272|12308722|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002366|NCT02326272|12308723|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002367|NCT02326272|12308724|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002368|NCT02326272|12308725|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
5002369|NCT02326272|12308726|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
5002370|NCT02326272|12308727|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
5002371|NCT02326272|12308728|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
5002372|NCT02326272|12308729|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
5002373|NCT02326272|12308730|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
5002374|NCT02326272|12308731|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
5002375|NCT02326272|12308732|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002376|NCT02326272|12308733|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002377|NCT02326272|12308734|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
5002378|NCT02326272|12308720|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002379|NCT02326272|12308721|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002380|NCT02326272|12308722|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002381|NCT02326272|12308723|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002382|NCT02326272|12308724|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002383|NCT02326272|12308725|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
5002384|NCT02326272|12308726|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
5002385|NCT02326272|12308727|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
5002386|NCT02326272|12308728|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
5002387|NCT02326272|12308729|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
5002388|NCT02326272|12308730|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
5002389|NCT02326272|12308731|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
5002390|NCT02326272|12308732|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002391|NCT02326272|12308733|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002392|NCT02326272|12308734|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
5002393|NCT02326272|12308720|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002394|NCT02326272|12308721|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002395|NCT02326272|12308722|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002396|NCT02326272|12308723|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002397|NCT02326272|12308724|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002398|NCT02326272|12308725|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
5002399|NCT02326272|12308726|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
5002400|NCT02326272|12308727|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
5002401|NCT02326272|12308728|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
5002402|NCT02326272|12308729|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
5002403|NCT02326272|12308730|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
5002404|NCT02326272|12308731|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
5002405|NCT02326272|12308732|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002406|NCT02326272|12308733|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002407|NCT02326272|12308734|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
5002408|NCT02326272|12308720|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002409|NCT02326272|12308721|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002643|NCT02325713|12308927|P1|STARTED|Intervention Period 3 (2 Days)||1
5002410|NCT02326272|12308722|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002411|NCT02326272|12308723|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002412|NCT02326272|12308724|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002413|NCT02326272|12308725|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
5002414|NCT02326272|12308726|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
5002415|NCT02326272|12308727|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
5002416|NCT02326272|12308728|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
5002417|NCT02326272|12308729|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
5002418|NCT02326272|12308730|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
5002419|NCT02326272|12308731|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
5002420|NCT02326272|12308732|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002421|NCT02326272|12308733|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002422|NCT02326272|12308734|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
5002423|NCT02326272|12308720|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002424|NCT02326272|12308721|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002425|NCT02326272|12308722|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002426|NCT02326272|12308723|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002427|NCT02326272|12308724|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002428|NCT02326272|12308725|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002429|NCT02326272|12308726|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002430|NCT02326272|12308727|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002431|NCT02326272|12308728|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002432|NCT02326272|12308729|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002433|NCT02326272|12308730|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002434|NCT02326272|12308731|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
5002435|NCT02326272|12308732|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
5002436|NCT02326272|12308733|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
5002437|NCT02326272|12308734|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
5002438|NCT02326272|12308720|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002439|NCT02326272|12308721|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002440|NCT02326272|12308722|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002441|NCT02326272|12308723|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002442|NCT02326272|12308724|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002443|NCT02326272|12308725|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002444|NCT02326272|12308726|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002445|NCT02326272|12308727|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002446|NCT02326272|12308728|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002447|NCT02326272|12308729|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002448|NCT02326272|12308730|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002449|NCT02326272|12308731|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
5002450|NCT02326272|12308732|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
5002451|NCT02326272|12308733|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
5002452|NCT02326272|12308734|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
5002453|NCT02326272|12308720|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002454|NCT02326272|12308721|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002455|NCT02326272|12308722|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002456|NCT02326272|12308723|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002457|NCT02326272|12308724|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002458|NCT02326272|12308725|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002459|NCT02326272|12308726|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002460|NCT02326272|12308727|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002461|NCT02326272|12308728|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002462|NCT02326272|12308729|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002463|NCT02326272|12308730|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002464|NCT02326272|12308731|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
5002465|NCT02326272|12308732|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
5002466|NCT02326272|12308733|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
5002467|NCT02326272|12308734|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
5002468|NCT02326272|12308720|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002469|NCT02326272|12308721|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002470|NCT02326272|12308722|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002471|NCT02326272|12308723|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002472|NCT02326272|12308724|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002473|NCT02326272|12308725|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002474|NCT02326272|12308726|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002475|NCT02326272|12308727|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002476|NCT02326272|12308728|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002477|NCT02326272|12308729|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002478|NCT02326272|12308730|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002479|NCT02326272|12308731|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
5002723|NCT02325713|12308927|P1|COMPLETED|Intervention Period 1 (2 Days)||2
5002480|NCT02326272|12308732|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
5002481|NCT02326272|12308733|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
5002482|NCT02326272|12308734|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
5002483|NCT02326272|12308720|P15|STARTED|Initial Period (Week 0 to Week 16)||0
5002484|NCT02326272|12308721|P14|STARTED|Initial Period (Week 0 to Week 16)||0
5002485|NCT02326272|12308722|P13|STARTED|Initial Period (Week 0 to Week 16)||0
5002486|NCT02326272|12308723|P12|STARTED|Initial Period (Week 0 to Week 16)||0
5002487|NCT02326272|12308724|P11|STARTED|Initial Period (Week 0 to Week 16)||0
5002488|NCT02326272|12308725|P10|STARTED|Initial Period (Week 0 to Week 16)||0
5002489|NCT02326272|12308726|P9|STARTED|Initial Period (Week 0 to Week 16)||0
5002490|NCT02326272|12308727|P8|STARTED|Initial Period (Week 0 to Week 16)||0
5002491|NCT02326272|12308728|P7|STARTED|Initial Period (Week 0 to Week 16)||0
5002492|NCT02326272|12308729|P6|STARTED|Initial Period (Week 0 to Week 16)||0
5002493|NCT02326272|12308730|P5|STARTED|Initial Period (Week 0 to Week 16)||0
5002494|NCT02326272|12308731|P4|STARTED|Initial Period (Week 0 to Week 16)||0
5002495|NCT02326272|12308732|P3|STARTED|Initial Period (Week 0 to Week 16)||87
5002496|NCT02326272|12308733|P2|STARTED|Initial Period (Week 0 to Week 16)||91
5002497|NCT02326272|12308734|P1|STARTED|Initial Period (Week 0 to Week 16)||49
5002498|NCT02326233|12308756|P2|NOT COMPLETED|Overall Study||1
5002499|NCT02326233|12308757|P1|NOT COMPLETED|Overall Study||0
5002500|NCT02326233|12308756|P2|COMPLETED|Overall Study||94
5002501|NCT02326233|12308757|P1|COMPLETED|Overall Study||95
5002502|NCT02326233|12308756|P2|STARTED|Overall Study||95
5002503|NCT02326233|12308757|P1|STARTED|Overall Study||95
5002504|NCT02326220|12308771|P3|NOT COMPLETED|Open-label Treatment Period||2
5002505|NCT02326220|12308772|P2|NOT COMPLETED|Open-label Treatment Period||0
5002506|NCT02326220|12308773|P1|NOT COMPLETED|Open-label Treatment Period||0
5002507|NCT02326220|12308771|P3|COMPLETED|Open-label Treatment Period||27
5002508|NCT02326220|12308772|P2|COMPLETED|Open-label Treatment Period||0
5002509|NCT02326220|12308773|P1|COMPLETED|Open-label Treatment Period||0
5002510|NCT02326220|12308771|P3|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
5002511|NCT02326220|12308772|P2|STARTED|Open-label Treatment Period||0
5002512|NCT02326220|12308773|P1|STARTED|Open-label Treatment Period||0
5002513|NCT02326220|12308771|P3|NOT COMPLETED|Double-blind Treatment Period||0
5002514|NCT02326220|12308772|P2|NOT COMPLETED|Double-blind Treatment Period||4
5002515|NCT02326220|12308773|P1|NOT COMPLETED|Double-blind Treatment Period||1
5002516|NCT02326220|12308771|P3|COMPLETED|Double-blind Treatment Period||0
5002517|NCT02326220|12308772|P2|COMPLETED|Double-blind Treatment Period||37
5002518|NCT02326220|12308773|P1|COMPLETED|Double-blind Treatment Period||20
5002519|NCT02326220|12308771|P3|STARTED|Double-blind Treatment Period||0
5002520|NCT02326220|12308772|P2|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
5002521|NCT02326220|12308773|P1|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
5002522|NCT02326025|12308826|P2|NOT COMPLETED|Overall Study||5
5002523|NCT02326025|12308827|P1|NOT COMPLETED|Overall Study||5
5002524|NCT02326025|12308826|P2|COMPLETED|Overall Study||19
5002525|NCT02326025|12308827|P1|COMPLETED|Overall Study||20
5002526|NCT02326025|12308826|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
5002527|NCT02326025|12308827|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
5002528|NCT02326025|12308826|P2|STARTED|Overall Study||24
5002529|NCT02326025|12308827|P1|STARTED|Overall Study||25
5002530|NCT02325856|12308861|P2|NOT COMPLETED|Overall Study||27
5002531|NCT02325856|12308862|P1|NOT COMPLETED|Overall Study||20
5002532|NCT02325856|12308861|P2|COMPLETED|Overall Study||123
5002533|NCT02325856|12308862|P1|COMPLETED|Overall Study||128
5002534|NCT02325856|12308861|P2|STARTED|Overall Study||150
5002535|NCT02325856|12308862|P1|STARTED|Overall Study||148
5002536|NCT02325791|12308874|P4|NOT COMPLETED|Overall Study||26
5002537|NCT02325791|12308875|P3|NOT COMPLETED|Overall Study||25
5002538|NCT02325791|12308876|P2|NOT COMPLETED|Overall Study||25
5002539|NCT02325791|12308877|P1|NOT COMPLETED|Overall Study||0
5002540|NCT02325791|12308874|P4|COMPLETED|Overall Study||355
5002541|NCT02325791|12308875|P3|COMPLETED|Overall Study||360
5002542|NCT02325791|12308876|P2|COMPLETED|Overall Study||358
5002543|NCT02325791|12308877|P1|COMPLETED|Overall Study||23
5002544|NCT02325791|12308874|P4|STARTED|Overall Study||381
5002545|NCT02325791|12308875|P3|STARTED|Overall Study||385
5002546|NCT02325791|12308876|P2|STARTED|Overall Study||383
5002547|NCT02325791|12308877|P1|STARTED|Overall Study||23
5002548|NCT02325713|12308912|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002549|NCT02325713|12308913|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002550|NCT02325713|12308914|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002551|NCT02325713|12308915|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002552|NCT02325713|12308916|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002553|NCT02325713|12308917|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002554|NCT02325713|12308918|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002555|NCT02325713|12308919|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002556|NCT02325713|12308920|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002557|NCT02325713|12308921|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002558|NCT02325713|12308922|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002559|NCT02325713|12308923|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002560|NCT02325713|12308924|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002561|NCT02325713|12308925|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002562|NCT02325713|12308926|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002563|NCT02325713|12308927|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
5002564|NCT02325713|12308912|P16|COMPLETED|Intervention Period 4 (2 Days)||2
5002565|NCT02325713|12308913|P15|COMPLETED|Intervention Period 4 (2 Days)||2
5002566|NCT02325713|12308914|P14|COMPLETED|Intervention Period 4 (2 Days)||2
5002567|NCT02325713|12308915|P13|COMPLETED|Intervention Period 4 (2 Days)||2
5002568|NCT02325713|12308916|P12|COMPLETED|Intervention Period 4 (2 Days)||2
5002569|NCT02325713|12308917|P11|COMPLETED|Intervention Period 4 (2 Days)||1
5002570|NCT02325713|12308918|P10|COMPLETED|Intervention Period 4 (2 Days)||1
5002571|NCT02325713|12308919|P9|COMPLETED|Intervention Period 4 (2 Days)||2
5002572|NCT02325713|12308920|P8|COMPLETED|Intervention Period 4 (2 Days)||2
5002573|NCT02325713|12308921|P7|COMPLETED|Intervention Period 4 (2 Days)||2
5002574|NCT02325713|12308922|P6|COMPLETED|Intervention Period 4 (2 Days)||2
5002575|NCT02325713|12308923|P5|COMPLETED|Intervention Period 4 (2 Days)||2
5002576|NCT02325713|12308924|P4|COMPLETED|Intervention Period 4 (2 Days)||2
5002577|NCT02325713|12308925|P3|COMPLETED|Intervention Period 4 (2 Days)||2
5002578|NCT02325713|12308926|P2|COMPLETED|Intervention Period 4 (2 Days)||2
5002579|NCT02325713|12308927|P1|COMPLETED|Intervention Period 4 (2 Days)||1
5002580|NCT02325713|12308912|P16|STARTED|Intervention Period 4 (2 Days)||2
5002581|NCT02325713|12308913|P15|STARTED|Intervention Period 4 (2 Days)||2
5002582|NCT02325713|12308914|P14|STARTED|Intervention Period 4 (2 Days)||2
5002583|NCT02325713|12308915|P13|STARTED|Intervention Period 4 (2 Days)||2
5002584|NCT02325713|12308916|P12|STARTED|Intervention Period 4 (2 Days)||2
5002585|NCT02325713|12308917|P11|STARTED|Intervention Period 4 (2 Days)||1
5002586|NCT02325713|12308918|P10|STARTED|Intervention Period 4 (2 Days)||1
5002587|NCT02325713|12308919|P9|STARTED|Intervention Period 4 (2 Days)||2
5002588|NCT02325713|12308920|P8|STARTED|Intervention Period 4 (2 Days)||2
5002589|NCT02325713|12308921|P7|STARTED|Intervention Period 4 (2 Days)||2
5002590|NCT02325713|12308922|P6|STARTED|Intervention Period 4 (2 Days)||2
5002591|NCT02325713|12308923|P5|STARTED|Intervention Period 4 (2 Days)||2
5002592|NCT02325713|12308924|P4|STARTED|Intervention Period 4 (2 Days)||2
5002593|NCT02325713|12308925|P3|STARTED|Intervention Period 4 (2 Days)||2
5002594|NCT02325713|12308926|P2|STARTED|Intervention Period 4 (2 Days)||2
5002595|NCT02325713|12308927|P1|STARTED|Intervention Period 4 (2 Days)||1
5002596|NCT02325713|12308912|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002597|NCT02325713|12308913|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002598|NCT02325713|12308914|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002599|NCT02325713|12308915|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002600|NCT02325713|12308916|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002601|NCT02325713|12308917|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002602|NCT02325713|12308918|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
5002603|NCT02325713|12308919|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002604|NCT02325713|12308920|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002605|NCT02325713|12308921|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002606|NCT02325713|12308922|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002607|NCT02325713|12308923|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002608|NCT02325713|12308924|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002609|NCT02325713|12308925|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002610|NCT02325713|12308926|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002611|NCT02325713|12308927|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
5002612|NCT02325713|12308912|P16|COMPLETED|Intervention Period 3 (2 Days)||2
5002613|NCT02325713|12308913|P15|COMPLETED|Intervention Period 3 (2 Days)||2
5002614|NCT02325713|12308914|P14|COMPLETED|Intervention Period 3 (2 Days)||2
5002615|NCT02325713|12308915|P13|COMPLETED|Intervention Period 3 (2 Days)||2
5002616|NCT02325713|12308916|P12|COMPLETED|Intervention Period 3 (2 Days)||2
5002617|NCT02325713|12308917|P11|COMPLETED|Intervention Period 3 (2 Days)||1
5002618|NCT02325713|12308918|P10|COMPLETED|Intervention Period 3 (2 Days)||1
5002619|NCT02325713|12308919|P9|COMPLETED|Intervention Period 3 (2 Days)||2
5002620|NCT02325713|12308920|P8|COMPLETED|Intervention Period 3 (2 Days)||2
5002621|NCT02325713|12308921|P7|COMPLETED|Intervention Period 3 (2 Days)||2
5002622|NCT02325713|12308922|P6|COMPLETED|Intervention Period 3 (2 Days)||2
5002623|NCT02325713|12308923|P5|COMPLETED|Intervention Period 3 (2 Days)||2
5002624|NCT02325713|12308924|P4|COMPLETED|Intervention Period 3 (2 Days)||2
5002625|NCT02325713|12308925|P3|COMPLETED|Intervention Period 3 (2 Days)||2
5002626|NCT02325713|12308926|P2|COMPLETED|Intervention Period 3 (2 Days)||2
5002627|NCT02325713|12308927|P1|COMPLETED|Intervention Period 3 (2 Days)||1
5002628|NCT02325713|12308912|P16|STARTED|Intervention Period 3 (2 Days)||2
5002629|NCT02325713|12308913|P15|STARTED|Intervention Period 3 (2 Days)||2
5002630|NCT02325713|12308914|P14|STARTED|Intervention Period 3 (2 Days)||2
5002631|NCT02325713|12308915|P13|STARTED|Intervention Period 3 (2 Days)||2
5002632|NCT02325713|12308916|P12|STARTED|Intervention Period 3 (2 Days)||2
5002633|NCT02325713|12308917|P11|STARTED|Intervention Period 3 (2 Days)||1
5002634|NCT02325713|12308918|P10|STARTED|Intervention Period 3 (2 Days)||2
5002635|NCT02325713|12308919|P9|STARTED|Intervention Period 3 (2 Days)||2
5002636|NCT02325713|12308920|P8|STARTED|Intervention Period 3 (2 Days)||2
5002637|NCT02325713|12308921|P7|STARTED|Intervention Period 3 (2 Days)||2
5002638|NCT02325713|12308922|P6|STARTED|Intervention Period 3 (2 Days)||2
5002639|NCT02325713|12308923|P5|STARTED|Intervention Period 3 (2 Days)||2
5002640|NCT02325713|12308924|P4|STARTED|Intervention Period 3 (2 Days)||2
5002641|NCT02325713|12308925|P3|STARTED|Intervention Period 3 (2 Days)||2
5002644|NCT02325713|12308912|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002645|NCT02325713|12308913|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002646|NCT02325713|12308914|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002647|NCT02325713|12308915|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002648|NCT02325713|12308916|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002649|NCT02325713|12308917|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002650|NCT02325713|12308918|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002651|NCT02325713|12308919|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002652|NCT02325713|12308920|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002653|NCT02325713|12308921|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002654|NCT02325713|12308922|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002655|NCT02325713|12308923|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002656|NCT02325713|12308924|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002657|NCT02325713|12308925|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002658|NCT02325713|12308926|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
5002659|NCT02325713|12308927|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
5002660|NCT02325713|12308912|P16|COMPLETED|Intervention Period 2 (2 Days)||2
5002661|NCT02325713|12308913|P15|COMPLETED|Intervention Period 2 (2 Days)||2
5002662|NCT02325713|12308914|P14|COMPLETED|Intervention Period 2 (2 Days)||2
5002663|NCT02325713|12308915|P13|COMPLETED|Intervention Period 2 (2 Days)||2
5002664|NCT02325713|12308916|P12|COMPLETED|Intervention Period 2 (2 Days)||2
5002665|NCT02325713|12308917|P11|COMPLETED|Intervention Period 2 (2 Days)||1
5002666|NCT02325713|12308918|P10|COMPLETED|Intervention Period 2 (2 Days)||2
5002667|NCT02325713|12308919|P9|COMPLETED|Intervention Period 2 (2 Days)||2
5002668|NCT02325713|12308920|P8|COMPLETED|Intervention Period 2 (2 Days)||2
5002669|NCT02325713|12308921|P7|COMPLETED|Intervention Period 2 (2 Days)||2
5002670|NCT02325713|12308922|P6|COMPLETED|Intervention Period 2 (2 Days)||2
5002671|NCT02325713|12308923|P5|COMPLETED|Intervention Period 2 (2 Days)||2
5002672|NCT02325713|12308924|P4|COMPLETED|Intervention Period 2 (2 Days)||2
5002673|NCT02325713|12308925|P3|COMPLETED|Intervention Period 2 (2 Days)||2
5002674|NCT02325713|12308926|P2|COMPLETED|Intervention Period 2 (2 Days)||2
5002675|NCT02325713|12308927|P1|COMPLETED|Intervention Period 2 (2 Days)||1
5002676|NCT02325713|12308912|P16|STARTED|Intervention Period 2 (2 Days)||2
5002677|NCT02325713|12308913|P15|STARTED|Intervention Period 2 (2 Days)||2
5002678|NCT02325713|12308914|P14|STARTED|Intervention Period 2 (2 Days)||2
5002679|NCT02325713|12308915|P13|STARTED|Intervention Period 2 (2 Days)||2
5002680|NCT02325713|12308916|P12|STARTED|Intervention Period 2 (2 Days)||2
5002681|NCT02325713|12308917|P11|STARTED|Intervention Period 2 (2 Days)||1
5002682|NCT02325713|12308918|P10|STARTED|Intervention Period 2 (2 Days)||2
5002683|NCT02325713|12308919|P9|STARTED|Intervention Period 2 (2 Days)||2
5002684|NCT02325713|12308920|P8|STARTED|Intervention Period 2 (2 Days)||2
5002685|NCT02325713|12308921|P7|STARTED|Intervention Period 2 (2 Days)||2
5002686|NCT02325713|12308922|P6|STARTED|Intervention Period 2 (2 Days)||2
5002687|NCT02325713|12308923|P5|STARTED|Intervention Period 2 (2 Days)||2
5002688|NCT02325713|12308924|P4|STARTED|Intervention Period 2 (2 Days)||2
5002689|NCT02325713|12308925|P3|STARTED|Intervention Period 2 (2 Days)||2
5002690|NCT02325713|12308926|P2|STARTED|Intervention Period 2 (2 Days)||2
5002691|NCT02325713|12308927|P1|STARTED|Intervention Period 2 (2 Days)||2
5002692|NCT02325713|12308912|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002693|NCT02325713|12308913|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002694|NCT02325713|12308914|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002695|NCT02325713|12308915|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002696|NCT02325713|12308916|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002697|NCT02325713|12308917|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
5002698|NCT02325713|12308918|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002699|NCT02325713|12308919|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002700|NCT02325713|12308920|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002701|NCT02325713|12308921|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002702|NCT02325713|12308922|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002703|NCT02325713|12308923|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002704|NCT02325713|12308924|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002705|NCT02325713|12308925|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002706|NCT02325713|12308926|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002707|NCT02325713|12308927|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
5002708|NCT02325713|12308912|P16|COMPLETED|Intervention Period 1 (2 Days)||2
5002709|NCT02325713|12308913|P15|COMPLETED|Intervention Period 1 (2 Days)||2
5002710|NCT02325713|12308914|P14|COMPLETED|Intervention Period 1 (2 Days)||2
5002711|NCT02325713|12308915|P13|COMPLETED|Intervention Period 1 (2 Days)||2
5002712|NCT02325713|12308916|P12|COMPLETED|Intervention Period 1 (2 Days)||2
5002713|NCT02325713|12308917|P11|COMPLETED|Intervention Period 1 (2 Days)||1
5002714|NCT02325713|12308918|P10|COMPLETED|Intervention Period 1 (2 Days)||2
5002715|NCT02325713|12308919|P9|COMPLETED|Intervention Period 1 (2 Days)||2
5002716|NCT02325713|12308920|P8|COMPLETED|Intervention Period 1 (2 Days)||2
5002717|NCT02325713|12308921|P7|COMPLETED|Intervention Period 1 (2 Days)||2
5002718|NCT02325713|12308922|P6|COMPLETED|Intervention Period 1 (2 Days)||2
5002719|NCT02325713|12308923|P5|COMPLETED|Intervention Period 1 (2 Days)||2
5002720|NCT02325713|12308924|P4|COMPLETED|Intervention Period 1 (2 Days)||2
5002721|NCT02325713|12308925|P3|COMPLETED|Intervention Period 1 (2 Days)||2
5002722|NCT02325713|12308926|P2|COMPLETED|Intervention Period 1 (2 Days)||2
5002724|NCT02325713|12308912|P16|STARTED|Intervention Period 1 (2 Days)||2
5002725|NCT02325713|12308913|P15|STARTED|Intervention Period 1 (2 Days)||2
5002726|NCT02325713|12308914|P14|STARTED|Intervention Period 1 (2 Days)||2
5002727|NCT02325713|12308915|P13|STARTED|Intervention Period 1 (2 Days)||2
5002728|NCT02325713|12308916|P12|STARTED|Intervention Period 1 (2 Days)||2
5002729|NCT02325713|12308917|P11|STARTED|Intervention Period 1 (2 Days)||2
5002730|NCT02325713|12308918|P10|STARTED|Intervention Period 1 (2 Days)||2
5002731|NCT02325713|12308919|P9|STARTED|Intervention Period 1 (2 Days)||2
5002732|NCT02325713|12308920|P8|STARTED|Intervention Period 1 (2 Days)||2
5002733|NCT02325713|12308921|P7|STARTED|Intervention Period 1 (2 Days)||2
5002734|NCT02325713|12308922|P6|STARTED|Intervention Period 1 (2 Days)||2
5002735|NCT02325713|12308923|P5|STARTED|Intervention Period 1 (2 Days)||2
5002736|NCT02325713|12308924|P4|STARTED|Intervention Period 1 (2 Days)||2
5002737|NCT02325713|12308925|P3|STARTED|Intervention Period 1 (2 Days)||2
5002738|NCT02325713|12308926|P2|STARTED|Intervention Period 1 (2 Days)||2
5002739|NCT02325713|12308927|P1|STARTED|Intervention Period 1 (2 Days)||2
5002740|NCT02325687|12309023|P3|NOT COMPLETED|Overall Study||6
5002741|NCT02325687|12309024|P2|NOT COMPLETED|Overall Study||3
5002742|NCT02325687|12309025|P1|NOT COMPLETED|Overall Study||4
5002743|NCT02325687|12309023|P3|COMPLETED|Overall Study||13
5002744|NCT02325687|12309024|P2|COMPLETED|Overall Study||12
5002745|NCT02325687|12309025|P1|COMPLETED|Overall Study||12
5002746|NCT02325687|12309023|P3|STARTED|Overall Study||19
5002747|NCT02325687|12309024|P2|STARTED|Overall Study||15
5002748|NCT02325687|12309025|P1|STARTED|Overall Study||16
5002749|NCT02325518|12309041|P2|NOT COMPLETED|Overall Study||3
5002750|NCT02325518|12309042|P1|NOT COMPLETED|Overall Study||4
5002751|NCT02325518|12309041|P2|COMPLETED|Overall Study||100
5002752|NCT02325518|12309042|P1|COMPLETED|Overall Study||94
5002753|NCT02325518|12309041|P2|Per Protocol Set (PPS)|Overall Study||97
5002754|NCT02325518|12309042|P1|Per Protocol Set (PPS)|Overall Study||92
5002755|NCT02325518|12309041|P2|Full Analysis Set (FAS)|Overall Study||101
5002756|NCT02325518|12309042|P1|Full Analysis Set (FAS)|Overall Study||98
5002757|NCT02325518|12309041|P2|Safety Set|Overall Study||103
5002758|NCT02325518|12309042|P1|Safety Set|Overall Study||98
5002759|NCT02325518|12309041|P2|STARTED|Overall Study||103
5002760|NCT02325518|12309042|P1|STARTED|Overall Study||98
5002761|NCT02325401|12309051|P3|NOT COMPLETED|Overall Study||1
5002762|NCT02325401|12309052|P2|NOT COMPLETED|Overall Study||1
5002763|NCT02325401|12309053|P1|NOT COMPLETED|Overall Study||0
5002764|NCT02325401|12309051|P3|COMPLETED|Overall Study||4
5002765|NCT02325401|12309052|P2|COMPLETED|Overall Study||8
5002766|NCT02325401|12309053|P1|COMPLETED|Overall Study||6
5002767|NCT02325401|12309051|P3|STARTED|Overall Study||5
5002768|NCT02325401|12309052|P2|STARTED|Overall Study||9
5002769|NCT02325401|12309053|P1|STARTED|Overall Study||6
5002770|NCT02325219|12309076|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
5002771|NCT02325219|12309077|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
5002772|NCT02325219|12309078|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
5002773|NCT02325219|12309079|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
5002774|NCT02325219|12309080|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
5002775|NCT02325219|12309076|P5|COMPLETED|After Controlled Period (Week 16 - 52)||25
5002776|NCT02325219|12309077|P4|COMPLETED|After Controlled Period (Week 16 - 52)||26
5002777|NCT02325219|12309078|P3|COMPLETED|After Controlled Period (Week 16 - 52)||62
5002778|NCT02325219|12309079|P2|COMPLETED|After Controlled Period (Week 16 - 52)||60
5002779|NCT02325219|12309080|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
5002780|NCT02325219|12309076|P5|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
5002781|NCT02325219|12309077|P4|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
5002782|NCT02325219|12309078|P3|STARTED|After Controlled Period (Week 16 - 52)||62
5002783|NCT02325219|12309079|P2|STARTED|After Controlled Period (Week 16 - 52)||63
5002784|NCT02325219|12309080|P1|STARTED|After Controlled Period (Week 16 - 52)||0
5002785|NCT02325219|12309076|P5|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
5002786|NCT02325219|12309077|P4|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
5002787|NCT02325219|12309078|P3|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
5002788|NCT02325219|12309079|P2|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
5002789|NCT02325219|12309080|P1|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
5002790|NCT02325219|12309076|P5|COMPLETED|Controlled Period (Week 0 - 16)||0
5002791|NCT02325219|12309077|P4|COMPLETED|Controlled Period (Week 0 - 16)||0
5002792|NCT02325219|12309078|P3|COMPLETED|Controlled Period (Week 0 - 16)||62
5002793|NCT02325219|12309079|P2|COMPLETED|Controlled Period (Week 0 - 16)||63
5002794|NCT02325219|12309080|P1|COMPLETED|Controlled Period (Week 0 - 16)||52
5002795|NCT02325219|12309076|P5|STARTED|Controlled Period (Week 0 - 16)||0
5002796|NCT02325219|12309077|P4|STARTED|Controlled Period (Week 0 - 16)||0
5002797|NCT02325219|12309078|P3|STARTED|Controlled Period (Week 0 - 16)||63
5002798|NCT02325219|12309079|P2|STARTED|Controlled Period (Week 0 - 16)||65
5002799|NCT02325219|12309080|P1|STARTED|Controlled Period (Week 0 - 16)||64
5002800|NCT02324972|12309254|P2|NOT COMPLETED|Overall Study||5
5002801|NCT02324972|12309255|P1|NOT COMPLETED|Overall Study||7
5002802|NCT02324972|12309254|P2|COMPLETED|Overall Study||23
5002803|NCT02324972|12309255|P1|COMPLETED|Overall Study||19
5002804|NCT02324972|12309254|P2|STARTED|Overall Study||28
5002805|NCT02324972|12309255|P1|STARTED|Overall Study||26
5002806|NCT02324842|12309272|P3|NOT COMPLETED|Overall Study||2
5002807|NCT02324842|12309273|P2|NOT COMPLETED|Overall Study||1
5002808|NCT02324842|12309274|P1|NOT COMPLETED|Overall Study||1
5002809|NCT02324842|12309272|P3|COMPLETED|Overall Study||13
5002810|NCT02324842|12309273|P2|COMPLETED|Overall Study||14
5002811|NCT02324842|12309274|P1|COMPLETED|Overall Study||14
5002812|NCT02324842|12309272|P3|STARTED|Overall Study||15
5002813|NCT02324842|12309273|P2|STARTED|Overall Study||15
5002814|NCT02324842|12309274|P1|STARTED|Overall Study||15
5002815|NCT02324699|12309303|P1|NOT COMPLETED|Overall Study||1
5002816|NCT02324699|12309303|P1|COMPLETED|Overall Study||0
5002817|NCT02324699|12309303|P1|STARTED|Overall Study||1
5002818|NCT02324673|12309313|P3|NOT COMPLETED|Overall Study||0
5002819|NCT02324673|12309314|P2|NOT COMPLETED|Overall Study||0
5002820|NCT02324673|12309315|P1|NOT COMPLETED|Overall Study||0
5002821|NCT02324673|12309313|P3|COMPLETED|Overall Study||21
5002822|NCT02324673|12309314|P2|COMPLETED|Overall Study||20
5002823|NCT02324673|12309315|P1|COMPLETED|Overall Study||20
5002824|NCT02324673|12309313|P3|STARTED|Overall Study||21
5002825|NCT02324673|12309314|P2|STARTED|Overall Study||20
5002826|NCT02324673|12309315|P1|STARTED|Overall Study||20
5002827|NCT02324660|12309416|P1|NOT COMPLETED|Overall Study||32
5002828|NCT02324660|12309416|P1|COMPLETED|Overall Study||137
5002829|NCT02324660|12309416|P1|STARTED|Overall Study||169
5002830|NCT02324569|12309423|P2|NOT COMPLETED|Overall Study||21
5002831|NCT02324569|12309424|P1|NOT COMPLETED|Overall Study||16
5002832|NCT02324569|12309423|P2|COMPLETED|Overall Study||103
5002833|NCT02324569|12309424|P1|COMPLETED|Overall Study||100
5002834|NCT02324569|12309423|P2|STARTED|Overall Study||124
5002835|NCT02324569|12309424|P1|STARTED|Overall Study||116
5002836|NCT02324504|12309448|P1|NOT COMPLETED|Overall Study||0
5002837|NCT02324504|12309448|P1|COMPLETED|Overall Study||60
5002838|NCT02324504|12309448|P1|STARTED|Overall Study||60
5002839|NCT02324465|12309457|P2|NOT COMPLETED|Overall Study||1
5002840|NCT02324465|12309458|P1|NOT COMPLETED|Overall Study||0
5002841|NCT02324465|12309457|P2|COMPLETED|Overall Study||21
5002842|NCT02324465|12309458|P1|COMPLETED|Overall Study||18
5002843|NCT02324465|12309457|P2|STARTED|Overall Study||22
5002844|NCT02324465|12309458|P1|STARTED|Overall Study||18
5002845|NCT02324335|12309472|P2|NOT COMPLETED|Overall Study||9
5002846|NCT02324335|12309473|P1|NOT COMPLETED|Overall Study||9
5002847|NCT02324335|12309472|P2|COMPLETED|Overall Study||20
5002848|NCT02324335|12309473|P1|COMPLETED|Overall Study||21
5002849|NCT02324335|12309472|P2|STARTED|Overall Study||29
5002850|NCT02324335|12309473|P1|STARTED|Overall Study||30
5002851|NCT02324270|12309488|P3|NOT COMPLETED|Overall Study||5
5002852|NCT02324270|12309489|P2|NOT COMPLETED|Overall Study||7
5002853|NCT02324270|12309490|P1|NOT COMPLETED|Overall Study||5
5002854|NCT02324270|12309488|P3|COMPLETED|Overall Study||216
5002855|NCT02324270|12309489|P2|COMPLETED|Overall Study||212
5002856|NCT02324270|12309490|P1|COMPLETED|Overall Study||213
5002857|NCT02324270|12309488|P3|PP Population|Overall Study||171
5002858|NCT02324270|12309489|P2|PP Population|Overall Study||177
5002859|NCT02324270|12309490|P1|PP Population|Overall Study||180
5002860|NCT02324270|12309488|P3|mITT Population|Overall Study||217
5002861|NCT02324270|12309489|P2|mITT Population|Overall Study||216
5002862|NCT02324270|12309490|P1|mITT Population|Overall Study||214
5002863|NCT02324270|12309488|P3|Safety Population|Overall Study||217
5002864|NCT02324270|12309489|P2|Safety Population|Overall Study||216
5002865|NCT02324270|12309490|P1|Safety Population|Overall Study||214
5002866|NCT02324270|12309488|P3|STARTED|Overall Study||221
5002867|NCT02324270|12309489|P2|STARTED|Overall Study||219
5002868|NCT02324270|12309490|P1|STARTED|Overall Study||218
5002869|NCT02324205|12309500|P1|NOT COMPLETED|Overall Study||37
5002870|NCT02324205|12309500|P1|COMPLETED|Overall Study||159
5002871|NCT02324205|12309500|P1|STARTED|Overall Study||196
5002872|NCT02324153|12309512|P2|NOT COMPLETED|Overall Study||1
5002873|NCT02324153|12309513|P1|NOT COMPLETED|Overall Study||8
5002874|NCT02324153|12309512|P2|COMPLETED|Overall Study||38
5002875|NCT02324153|12309513|P1|COMPLETED|Overall Study||33
5002876|NCT02324153|12309512|P2|STARTED|Overall Study||39
5002877|NCT02324153|12309513|P1|STARTED|Overall Study||41
5002878|NCT02324075|12309525|P2|NOT COMPLETED|Overall Study||9
5002879|NCT02324075|12309526|P1|NOT COMPLETED|Overall Study||3
5002880|NCT02324075|12309525|P2|COMPLETED|Overall Study||605
5002881|NCT02324075|12309526|P1|COMPLETED|Overall Study||609
5002882|NCT02324075|12309525|P2|STARTED|Overall Study||614
5002883|NCT02324075|12309526|P1|STARTED|Overall Study||612
5002884|NCT02324049|12309544|P1|NOT COMPLETED|Part C||11
5002885|NCT02324049|12309544|P1|COMPLETED|Part C||0
5002886|NCT02324049|12309544|P1|Safety Analysis Set|Part C||11
5002887|NCT02324049|12309544|P1|STARTED|Part C||11
5002888|NCT02324049|12309544|P1|NOT COMPLETED|Part B||0
5002889|NCT02324049|12309544|P1|COMPLETED|Part B||11
5002890|NCT02324049|12309544|P1|Safety Analysis Set|Part B||11
5002891|NCT02324049|12309544|P1|STARTED|Part B||11
5002892|NCT02324049|12309544|P1|NOT COMPLETED|Part A||0
5002893|NCT02324049|12309544|P1|COMPLETED|Part A||11
5002894|NCT02324049|12309544|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
5002895|NCT02324049|12309544|P1|STARTED|Part A||11
5002896|NCT02323854|12309548|P1|NOT COMPLETED|Overall Study||0
5002897|NCT02323854|12309548|P1|COMPLETED|Overall Study||15
5002898|NCT02323854|12309548|P1|STARTED|Overall Study||15
5002899|NCT02323646|12309557|P3|NOT COMPLETED|Treatment Course 2||3
5002900|NCT02323646|12309558|P2|NOT COMPLETED|Treatment Course 2||1
5002901|NCT02323646|12309559|P1|NOT COMPLETED|Treatment Course 2||1
5002902|NCT02323646|12309557|P3|COMPLETED|Treatment Course 2||9
5002903|NCT02323646|12309558|P2|COMPLETED|Treatment Course 2||9
5002904|NCT02323646|12309559|P1|COMPLETED|Treatment Course 2||10
5002905|NCT02323646|12309557|P3|STARTED|Treatment Course 2||12
5002906|NCT02323646|12309558|P2|STARTED|Treatment Course 2||10
5002907|NCT02323646|12309559|P1|STARTED|Treatment Course 2||11
5002908|NCT02323646|12309557|P3|NOT COMPLETED|Treatment Course 1||3
5002909|NCT02323646|12309558|P2|NOT COMPLETED|Treatment Course 1||3
5002910|NCT02323646|12309559|P1|NOT COMPLETED|Treatment Course 1||3
5002911|NCT02323646|12309557|P3|COMPLETED|Treatment Course 1||12
5002912|NCT02323646|12309558|P2|COMPLETED|Treatment Course 1||10
5002913|NCT02323646|12309559|P1|COMPLETED|Treatment Course 1||11
5002914|NCT02323646|12309557|P3|STARTED|Treatment Course 1||15
5002915|NCT02323646|12309558|P2|STARTED|Treatment Course 1||13
5002916|NCT02323646|12309559|P1|STARTED|Treatment Course 1||14
5002917|NCT02323204|12309607|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
5002918|NCT02323204|12309608|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
5002919|NCT02323204|12309609|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
5002920|NCT02323204|12309610|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
5002921|NCT02323204|12309607|P4|COMPLETED|6-month Follow-up Survey Completion||112
5002922|NCT02323204|12309608|P3|COMPLETED|6-month Follow-up Survey Completion||113
5002923|NCT02323204|12309609|P2|COMPLETED|6-month Follow-up Survey Completion||96
5002924|NCT02323204|12309610|P1|COMPLETED|6-month Follow-up Survey Completion||96
5002925|NCT02323204|12309607|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
5002926|NCT02323204|12309608|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
5002927|NCT02323204|12309609|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
5002928|NCT02323204|12309610|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
5002929|NCT02323204|12309607|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
5002930|NCT02323204|12309608|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
5002931|NCT02323204|12309609|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
5002932|NCT02323204|12309610|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
5002933|NCT02323204|12309607|P4|COMPLETED|3-month Follow-up Survey Completion||112
5002934|NCT02323204|12309608|P3|COMPLETED|3-month Follow-up Survey Completion||113
5002935|NCT02323204|12309609|P2|COMPLETED|3-month Follow-up Survey Completion||99
5002936|NCT02323204|12309610|P1|COMPLETED|3-month Follow-up Survey Completion||91
5002937|NCT02323204|12309607|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
5002938|NCT02323204|12309608|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
5002939|NCT02323204|12309609|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
5002940|NCT02323204|12309610|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
5002941|NCT02323204|12309607|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
5002942|NCT02323204|12309608|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
5002943|NCT02323204|12309609|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
5002944|NCT02323204|12309610|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
5002945|NCT02323204|12309607|P4|COMPLETED|6-week Follow-up Intervention Booster||120
5002946|NCT02323204|12309608|P3|COMPLETED|6-week Follow-up Intervention Booster||0
5002947|NCT02323204|12309609|P2|COMPLETED|6-week Follow-up Intervention Booster||103
5002948|NCT02323204|12309610|P1|COMPLETED|6-week Follow-up Intervention Booster||0
5002949|NCT02323204|12309607|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
5002950|NCT02323204|12309608|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
5002951|NCT02323204|12309609|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
5002952|NCT02323204|12309610|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
5002953|NCT02323204|12309607|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
5002954|NCT02323204|12309608|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
5002955|NCT02323204|12309609|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
5002956|NCT02323204|12309610|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
5002957|NCT02323204|12309607|P4|COMPLETED|6-week Follow-up Survey Completion||119
5002958|NCT02323204|12309608|P3|COMPLETED|6-week Follow-up Survey Completion||112
5002959|NCT02323204|12309609|P2|COMPLETED|6-week Follow-up Survey Completion||110
5002960|NCT02323204|12309610|P1|COMPLETED|6-week Follow-up Survey Completion||104
5002961|NCT02323204|12309607|P4|STARTED|6-week Follow-up Survey Completion||156
5002962|NCT02323204|12309608|P3|STARTED|6-week Follow-up Survey Completion||154
5002963|NCT02323204|12309609|P2|STARTED|6-week Follow-up Survey Completion||146
5002964|NCT02323204|12309610|P1|STARTED|6-week Follow-up Survey Completion||145
5002965|NCT02323204|12309607|P4|NOT COMPLETED|Baseline Survey Completion||3
5002966|NCT02323204|12309608|P3|NOT COMPLETED|Baseline Survey Completion||5
5002967|NCT02323204|12309609|P2|NOT COMPLETED|Baseline Survey Completion||9
5002968|NCT02323204|12309610|P1|NOT COMPLETED|Baseline Survey Completion||10
5002969|NCT02323204|12309607|P4|COMPLETED|Baseline Survey Completion||156
5002970|NCT02323204|12309608|P3|COMPLETED|Baseline Survey Completion||154
5002971|NCT02323204|12309609|P2|COMPLETED|Baseline Survey Completion||146
5002972|NCT02323204|12309610|P1|COMPLETED|Baseline Survey Completion||145
5002973|NCT02323204|12309607|P4|STARTED|Baseline Survey Completion||159
5002974|NCT02323204|12309608|P3|STARTED|Baseline Survey Completion||159
5002975|NCT02323204|12309609|P2|STARTED|Baseline Survey Completion||155
5002976|NCT02323204|12309610|P1|STARTED|Baseline Survey Completion||155
5002977|NCT02323048|12309665|P5|NOT COMPLETED|Overall Study||0
5002978|NCT02323048|12309666|P4|NOT COMPLETED|Overall Study||0
5002979|NCT02323048|12309667|P3|NOT COMPLETED|Overall Study||0
5002980|NCT02323048|12309668|P2|NOT COMPLETED|Overall Study||2
5002981|NCT02323048|12309669|P1|NOT COMPLETED|Overall Study||1
5002982|NCT02323048|12309665|P5|COMPLETED|Overall Study||9
5002983|NCT02323048|12309666|P4|COMPLETED|Overall Study||7
5002984|NCT02323048|12309667|P3|COMPLETED|Overall Study||23
5002985|NCT02323048|12309668|P2|COMPLETED|Overall Study||24
5002986|NCT02323048|12309669|P1|COMPLETED|Overall Study||24
5002987|NCT02323048|12309665|P5|STARTED|Overall Study||9
5002988|NCT02323048|12309666|P4|STARTED|Overall Study||7
5002989|NCT02323048|12309667|P3|STARTED|Overall Study||23
5002990|NCT02323048|12309668|P2|STARTED|Overall Study||26
5002991|NCT02323048|12309669|P1|STARTED|Overall Study||25
5002992|NCT02322892|12309683|P2|NOT COMPLETED|Overall Study||3
5002993|NCT02322892|12309684|P1|NOT COMPLETED|Overall Study||2
5002994|NCT02322892|12309683|P2|COMPLETED|Overall Study|Received thiamine|31
5002995|NCT02322892|12309684|P1|COMPLETED|Overall Study|Received placebo|33
5002996|NCT02322892|12309683|P2|STARTED|Overall Study|Number randomized|34
5002997|NCT02322892|12309684|P1|STARTED|Overall Study|Number randomized|35
5002998|NCT02322879|12309700|P2|NOT COMPLETED|Second Intervention||0
5002999|NCT02322879|12309701|P1|NOT COMPLETED|Second Intervention||0
5003000|NCT02322879|12309700|P2|COMPLETED|Second Intervention||10
5003001|NCT02322879|12309701|P1|COMPLETED|Second Intervention||10
5003002|NCT02322879|12309700|P2|STARTED|Second Intervention||10
5003003|NCT02322879|12309701|P1|STARTED|Second Intervention||10
5003004|NCT02322879|12309700|P2|NOT COMPLETED|Washout||0
5003005|NCT02322879|12309701|P1|NOT COMPLETED|Washout||0
5003006|NCT02322879|12309700|P2|COMPLETED|Washout||10
5003007|NCT02322879|12309701|P1|COMPLETED|Washout||10
5003008|NCT02322879|12309700|P2|STARTED|Washout||10
5003009|NCT02322879|12309701|P1|STARTED|Washout||10
5003010|NCT02322879|12309700|P2|NOT COMPLETED|First Intervention||0
5003011|NCT02322879|12309701|P1|NOT COMPLETED|First Intervention||1
5003012|NCT02322879|12309700|P2|COMPLETED|First Intervention||10
5003013|NCT02322879|12309701|P1|COMPLETED|First Intervention||10
5003014|NCT02322879|12309700|P2|STARTED|First Intervention||10
5003015|NCT02322879|12309701|P1|STARTED|First Intervention||11
5003016|NCT02322866|12309709|P2|NOT COMPLETED|Overall Study||86
5003017|NCT02322866|12309710|P1|NOT COMPLETED|Overall Study||71
5003018|NCT02322866|12309709|P2|COMPLETED|Overall Study||433
5003019|NCT02322866|12309710|P1|COMPLETED|Overall Study||444
5003020|NCT02322866|12309709|P2|STARTED|Overall Study||519
5003021|NCT02322866|12309710|P1|STARTED|Overall Study||515
5003022|NCT02322814|12309737|P5|NOT COMPLETED|Overall Study||31
5003023|NCT02322814|12309738|P4|NOT COMPLETED|Overall Study||32
5003024|NCT02322814|12309739|P3|NOT COMPLETED|Overall Study||47
5003025|NCT02322814|12309740|P2|NOT COMPLETED|Overall Study||43
5003026|NCT02322814|12309741|P1|NOT COMPLETED|Overall Study||16
5003027|NCT02322814|12309737|P5|COMPLETED|Overall Study||0
5003028|NCT02322814|12309738|P4|COMPLETED|Overall Study||0
5003029|NCT02322814|12309739|P3|COMPLETED|Overall Study||0
5003030|NCT02322814|12309740|P2|COMPLETED|Overall Study||0
5003031|NCT02322814|12309741|P1|COMPLETED|Overall Study||0
5003032|NCT02322814|12309737|P5|STARTED|Overall Study||31
5003033|NCT02322814|12309738|P4|STARTED|Overall Study||32
5003034|NCT02322814|12309739|P3|STARTED|Overall Study||47
5003035|NCT02322814|12309740|P2|STARTED|Overall Study||43
5003036|NCT02322814|12309741|P1|STARTED|Overall Study||16
5003037|NCT02322788|12309752|P4|NOT COMPLETED|Visit 6||0
5003038|NCT02322788|12309753|P3|NOT COMPLETED|Visit 6||0
5003039|NCT02322788|12309754|P2|NOT COMPLETED|Visit 6||0
5003040|NCT02322788|12309755|P1|NOT COMPLETED|Visit 6||0
5003041|NCT02322788|12309752|P4|COMPLETED|Visit 6||15
5003042|NCT02322788|12309753|P3|COMPLETED|Visit 6||15
5003043|NCT02322788|12309754|P2|COMPLETED|Visit 6||16
5003044|NCT02322788|12309755|P1|COMPLETED|Visit 6||14
5003045|NCT02322788|12309752|P4|STARTED|Visit 6||15
5003046|NCT02322788|12309753|P3|STARTED|Visit 6||15
5003047|NCT02322788|12309754|P2|STARTED|Visit 6||16
5003048|NCT02322788|12309755|P1|STARTED|Visit 6||14
5003049|NCT02322788|12309752|P4|NOT COMPLETED|Visit 5||0
5003050|NCT02322788|12309753|P3|NOT COMPLETED|Visit 5||0
5003051|NCT02322788|12309754|P2|NOT COMPLETED|Visit 5||0
5003052|NCT02322788|12309755|P1|NOT COMPLETED|Visit 5||0
5003053|NCT02322788|12309752|P4|COMPLETED|Visit 5||14
5003054|NCT02322788|12309753|P3|COMPLETED|Visit 5||15
5003055|NCT02322788|12309754|P2|COMPLETED|Visit 5||15
5003056|NCT02322788|12309755|P1|COMPLETED|Visit 5||16
5003057|NCT02322788|12309752|P4|STARTED|Visit 5||14
5003058|NCT02322788|12309753|P3|STARTED|Visit 5||15
5003059|NCT02322788|12309754|P2|STARTED|Visit 5||15
5003060|NCT02322788|12309755|P1|STARTED|Visit 5||16
5003061|NCT02322788|12309752|P4|NOT COMPLETED|Visit 4||0
5003062|NCT02322788|12309753|P3|NOT COMPLETED|Visit 4||0
5003063|NCT02322788|12309754|P2|NOT COMPLETED|Visit 4||0
5003064|NCT02322788|12309755|P1|NOT COMPLETED|Visit 4||0
5003065|NCT02322788|12309752|P4|COMPLETED|Visit 4||15
5003066|NCT02322788|12309753|P3|COMPLETED|Visit 4||16
5003067|NCT02322788|12309754|P2|COMPLETED|Visit 4||14
5003068|NCT02322788|12309755|P1|COMPLETED|Visit 4||15
5003069|NCT02322788|12309752|P4|STARTED|Visit 4||15
5003070|NCT02322788|12309753|P3|STARTED|Visit 4||16
5003071|NCT02322788|12309754|P2|STARTED|Visit 4||14
5003072|NCT02322788|12309755|P1|STARTED|Visit 4||15
5003073|NCT02322788|12309752|P4|NOT COMPLETED|Visit 3||0
5003074|NCT02322788|12309753|P3|NOT COMPLETED|Visit 3||0
5003075|NCT02322788|12309754|P2|NOT COMPLETED|Visit 3||0
5003076|NCT02322788|12309755|P1|NOT COMPLETED|Visit 3||0
5003077|NCT02322788|12309752|P4|COMPLETED|Visit 3||16
5003078|NCT02322788|12309753|P3|COMPLETED|Visit 3||14
5003079|NCT02322788|12309754|P2|COMPLETED|Visit 3||15
5003080|NCT02322788|12309755|P1|COMPLETED|Visit 3||15
5003081|NCT02322788|12309752|P4|STARTED|Visit 3||16
5003082|NCT02322788|12309753|P3|STARTED|Visit 3||14
5003083|NCT02322788|12309754|P2|STARTED|Visit 3||15
5003084|NCT02322788|12309755|P1|STARTED|Visit 3||15
5003085|NCT02322775|12309767|P2|NOT COMPLETED|Overall Study||6
5003086|NCT02322775|12309768|P1|NOT COMPLETED|Overall Study||5
5003087|NCT02322775|12309767|P2|COMPLETED|Overall Study||99
5003088|NCT02322775|12309768|P1|COMPLETED|Overall Study||101
5003089|NCT02322775|12309767|P2|STARTED|Overall Study||105
5003090|NCT02322775|12309768|P1|STARTED|Overall Study||106
5003091|NCT02322749|12309794|P6|NOT COMPLETED|Period 3||0
5003092|NCT02322749|12309795|P5|NOT COMPLETED|Period 3||0
5003093|NCT02322749|12309796|P4|NOT COMPLETED|Period 3||0
5003094|NCT02322749|12309797|P3|NOT COMPLETED|Period 3||1
5003095|NCT02322749|12309798|P2|NOT COMPLETED|Period 3||0
5003096|NCT02322749|12309799|P1|NOT COMPLETED|Period 3||0
5003097|NCT02322749|12309794|P6|COMPLETED|Period 3||8
5003098|NCT02322749|12309795|P5|COMPLETED|Period 3||8
5003099|NCT02322749|12309796|P4|COMPLETED|Period 3||6
5003100|NCT02322749|12309797|P3|COMPLETED|Period 3||7
5003101|NCT02322749|12309798|P2|COMPLETED|Period 3||8
5003102|NCT02322749|12309799|P1|COMPLETED|Period 3||8
5003103|NCT02322749|12309794|P6|STARTED|Period 3||8
5003104|NCT02322749|12309795|P5|STARTED|Period 3||8
5003105|NCT02322749|12309796|P4|STARTED|Period 3||6
5003106|NCT02322749|12309797|P3|STARTED|Period 3||8
5003107|NCT02322749|12309798|P2|STARTED|Period 3||8
5003108|NCT02322749|12309799|P1|STARTED|Period 3||8
5003109|NCT02322749|12309794|P6|NOT COMPLETED|Period 2||0
5003110|NCT02322749|12309795|P5|NOT COMPLETED|Period 2||0
5003111|NCT02322749|12309796|P4|NOT COMPLETED|Period 2||2
5003112|NCT02322749|12309797|P3|NOT COMPLETED|Period 2||0
5003113|NCT02322749|12309798|P2|NOT COMPLETED|Period 2||0
5003114|NCT02322749|12309799|P1|NOT COMPLETED|Period 2||0
5003115|NCT02322749|12309794|P6|COMPLETED|Period 2||8
5003116|NCT02322749|12309795|P5|COMPLETED|Period 2||8
5003117|NCT02322749|12309796|P4|COMPLETED|Period 2||6
5003118|NCT02322749|12309797|P3|COMPLETED|Period 2||8
5003119|NCT02322749|12309798|P2|COMPLETED|Period 2||8
5003120|NCT02322749|12309799|P1|COMPLETED|Period 2||8
5003121|NCT02322749|12309794|P6|STARTED|Period 2||8
5003122|NCT02322749|12309795|P5|STARTED|Period 2||8
5003123|NCT02322749|12309796|P4|STARTED|Period 2||8
5003124|NCT02322749|12309797|P3|STARTED|Period 2||8
5003125|NCT02322749|12309798|P2|STARTED|Period 2||8
5003126|NCT02322749|12309799|P1|STARTED|Period 2||8
5003127|NCT02322749|12309794|P6|NOT COMPLETED|Period 1||0
5003128|NCT02322749|12309795|P5|NOT COMPLETED|Period 1||0
5003129|NCT02322749|12309796|P4|NOT COMPLETED|Period 1||0
5003130|NCT02322749|12309797|P3|NOT COMPLETED|Period 1||0
5003131|NCT02322749|12309798|P2|NOT COMPLETED|Period 1||0
5003132|NCT02322749|12309799|P1|NOT COMPLETED|Period 1||0
5003133|NCT02322749|12309794|P6|COMPLETED|Period 1||8
5003134|NCT02322749|12309795|P5|COMPLETED|Period 1||8
5003135|NCT02322749|12309796|P4|COMPLETED|Period 1||8
5003136|NCT02322749|12309797|P3|COMPLETED|Period 1||8
5003137|NCT02322749|12309798|P2|COMPLETED|Period 1||8
5003138|NCT02322749|12309799|P1|COMPLETED|Period 1||8
5003139|NCT02322749|12309794|P6|STARTED|Period 1||8
5003140|NCT02322749|12309795|P5|STARTED|Period 1||8
5003141|NCT02322749|12309796|P4|STARTED|Period 1||8
5003142|NCT02322749|12309797|P3|STARTED|Period 1||8
5003143|NCT02322749|12309798|P2|STARTED|Period 1||8
5003144|NCT02322749|12309799|P1|STARTED|Period 1||8
5003145|NCT02322710|12309824|P2|NOT COMPLETED|Overall Study||26
5003146|NCT02322710|12309825|P1|NOT COMPLETED|Overall Study||20
5003147|NCT02322710|12309824|P2|COMPLETED|Overall Study||73
5003148|NCT02322710|12309825|P1|COMPLETED|Overall Study||85
5003149|NCT02322710|12309824|P2|Full Analysis Population|Overall Study||98
5003150|NCT02322710|12309825|P1|Full Analysis Population|Overall Study||105
5003151|NCT02322710|12309824|P2|Safety Population|Overall Study||99
5003152|NCT02322710|12309825|P1|Safety Population|Overall Study||105
5003153|NCT02322710|12309824|P2|STARTED|Overall Study||99
5003154|NCT02322710|12309825|P1|STARTED|Overall Study||105
5003155|NCT02322528|12309831|P1|NOT COMPLETED|Overall Study||0
5003156|NCT02322528|12309831|P1|COMPLETED|Overall Study||10
5003157|NCT02322528|12309831|P1|STARTED|Overall Study||10
5003158|NCT02322411|12309838|P2|NOT COMPLETED|Overall Study||7
5003159|NCT02322411|12309839|P1|NOT COMPLETED|Overall Study||5
5003160|NCT02322411|12309838|P2|COMPLETED|Overall Study||9
5003161|NCT02322411|12309839|P1|COMPLETED|Overall Study||9
5003162|NCT02322411|12309838|P2|All Baseline Measures Analyzed|Overall Study||16
5003163|NCT02322411|12309839|P1|All Baseline Measures Analyzed|Overall Study||13
5003164|NCT02322411|12309838|P2|Randomized|Overall Study||16
5003165|NCT02322411|12309839|P1|Randomized|Overall Study||14
5003166|NCT02322411|12309838|P2|STARTED|Overall Study||16
5003167|NCT02322411|12309839|P1|STARTED|Overall Study||14
5003168|NCT02322320|12309860|P3|NOT COMPLETED|Overall Study||0
5003169|NCT02322320|12309861|P2|NOT COMPLETED|Overall Study||0
5003170|NCT02322320|12309862|P1|NOT COMPLETED|Overall Study||0
5003171|NCT02322320|12309860|P3|COMPLETED|Overall Study||89
5003172|NCT02322320|12309861|P2|COMPLETED|Overall Study||86
5003173|NCT02322320|12309862|P1|COMPLETED|Overall Study||98
5003174|NCT02322320|12309860|P3|STARTED|Overall Study||89
5003175|NCT02322320|12309861|P2|STARTED|Overall Study||86
5003176|NCT02322320|12309862|P1|STARTED|Overall Study||98
5003177|NCT02322281|12309885|P3|NOT COMPLETED|Overall Study||74
5003178|NCT02322281|12309886|P2|NOT COMPLETED|Overall Study||22
5003179|NCT02322281|12309887|P1|NOT COMPLETED|Overall Study||53
5003180|NCT02322281|12309885|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5003181|NCT02322281|12309886|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5003182|NCT02322281|12309887|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5003183|NCT02322281|12309885|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
5003184|NCT02322281|12309886|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
5003185|NCT02322281|12309887|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
5003186|NCT02322281|12309885|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
5003187|NCT02322281|12309886|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
5003188|NCT02322281|12309887|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
5003189|NCT02322281|12309885|P3|STARTED|Overall Study||74
5003190|NCT02322281|12309886|P2|STARTED|Overall Study||22
5003191|NCT02322281|12309887|P1|STARTED|Overall Study||53
5003192|NCT02322242|12309910|P2|NOT COMPLETED|Overall Study||0
5003193|NCT02322242|12309911|P1|NOT COMPLETED|Overall Study||0
5003194|NCT02322242|12309910|P2|COMPLETED|Overall Study||90
5003195|NCT02322242|12309911|P1|COMPLETED|Overall Study||92
5003196|NCT02322242|12309910|P2|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
5003197|NCT02322242|12309911|P1|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
5003198|NCT02322242|12309910|P2|Primary Outcome|Overall Study||90
5003199|NCT02322242|12309911|P1|Primary Outcome|Overall Study||92
5003200|NCT02322242|12309910|P2|STARTED|Overall Study||90
5003201|NCT02322242|12309911|P1|STARTED|Overall Study||92
5003202|NCT02322229|12309935|P1|NOT COMPLETED|Overall Study||2
5003203|NCT02322229|12309935|P1|COMPLETED|Overall Study||50
5003204|NCT02322229|12309935|P1|STARTED|Overall Study||52
5003205|NCT02322216|12309947|P2|NOT COMPLETED|Overall Study||4
5003206|NCT02322216|12309948|P1|NOT COMPLETED|Overall Study||2
5003207|NCT02322216|12309947|P2|COMPLETED|Overall Study||123
5003208|NCT02322216|12309948|P1|COMPLETED|Overall Study||124
5003209|NCT02322216|12309947|P2|Per Protocol Set (PPS)|Overall Study||122
5003210|NCT02322216|12309948|P1|Per Protocol Set (PPS)|Overall Study||123
5003211|NCT02322216|12309947|P2|Treated (Safety Set)|Overall Study||126
5003212|NCT02322216|12309948|P1|Treated (Safety Set)|Overall Study||126
5003213|NCT02322216|12309947|P2|STARTED|Overall Study||127
5003214|NCT02322216|12309948|P1|STARTED|Overall Study||126
5003215|NCT02322190|12309955|P2|NOT COMPLETED|Overall Study||0
5003216|NCT02322190|12309956|P1|NOT COMPLETED|Overall Study||1
5003217|NCT02322190|12309955|P2|COMPLETED|Overall Study||0
5003218|NCT02322190|12309956|P1|COMPLETED|Overall Study||4
5003219|NCT02322190|12309955|P2|STARTED|Overall Study||0
5003220|NCT02322190|12309956|P1|STARTED|Overall Study||5
5003221|NCT02321930|12309964|P1|NOT COMPLETED|Overall Study||1
5003222|NCT02321930|12309964|P1|COMPLETED|Overall Study||24
5003223|NCT02321930|12309964|P1|STARTED|Overall Study||25
5003224|NCT02321800|12309974|P2|NOT COMPLETED|Overall Study||11
5003225|NCT02321800|12309975|P1|NOT COMPLETED|Overall Study||20
5003226|NCT02321800|12309974|P2|COMPLETED|Overall Study||138
5003227|NCT02321800|12309975|P1|COMPLETED|Overall Study||283
5003228|NCT02321800|12309974|P2|Received Study Drug|Overall Study||148
5003229|NCT02321800|12309975|P1|Received Study Drug|Overall Study||300
5003230|NCT02321800|12309974|P2|STARTED|Overall Study||149
5003231|NCT02321800|12309975|P1|STARTED|Overall Study||303
5003232|NCT02321748|12310025|P2|NOT COMPLETED|Overall Study||0
5003233|NCT02321748|12310026|P1|NOT COMPLETED|Overall Study||0
5003234|NCT02321748|12310025|P2|COMPLETED|Overall Study||12
5003235|NCT02321748|12310026|P1|COMPLETED|Overall Study||12
5003236|NCT02321748|12310025|P2|Second Intervention (4 Days)|Overall Study||12
5003237|NCT02321748|12310026|P1|Second Intervention (4 Days)|Overall Study||12
5003238|NCT02321748|12310025|P2|Wasout (2weeks)|Overall Study||12
5003239|NCT02321748|12310026|P1|Wasout (2weeks)|Overall Study||12
5003240|NCT02321748|12310025|P2|First Intervention (4 Days)|Overall Study||12
5003241|NCT02321748|12310026|P1|First Intervention (4 Days)|Overall Study||12
5003242|NCT02321748|12310025|P2|STARTED|Overall Study||12
5003243|NCT02321748|12310026|P1|STARTED|Overall Study||12
5003244|NCT02321527|12310058|P1|NOT COMPLETED|Overall Study||1
5003245|NCT02321527|12310058|P1|COMPLETED|Overall Study||20
5003246|NCT02321527|12310058|P1|STARTED|Overall Study||21
5003247|NCT02321462|12310064|P2|NOT COMPLETED|Overall Study||3
5003248|NCT02321462|12310065|P1|NOT COMPLETED|Overall Study||6
5003249|NCT02321462|12310064|P2|COMPLETED|Overall Study||146
5003250|NCT02321462|12310065|P1|COMPLETED|Overall Study||141
5003251|NCT02321462|12310064|P2|Safety Population|Overall Study||147
5003252|NCT02321462|12310065|P1|Safety Population|Overall Study||147
5003253|NCT02321462|12310064|P2|Treated Patients|Overall Study||147
5003254|NCT02321462|12310065|P1|Treated Patients|Overall Study||147
5003255|NCT02321462|12310064|P2|ITT Population|Overall Study||148
5003256|NCT02321462|12310065|P1|ITT Population|Overall Study||146
5003257|NCT02321462|12310064|P2|STARTED|Overall Study||149
5003258|NCT02321462|12310065|P1|STARTED|Overall Study||147
5003259|NCT02321436|12310087|P2|NOT COMPLETED|Overall Study||1
5003260|NCT02321436|12310088|P1|NOT COMPLETED|Overall Study||1
5003261|NCT02321436|12310087|P2|COMPLETED|Overall Study||13
5003262|NCT02321436|12310088|P1|COMPLETED|Overall Study||27
5003263|NCT02321436|12310087|P2|STARTED|Overall Study||14
5003264|NCT02321436|12310088|P1|STARTED|Overall Study||28
5003265|NCT02321319|12310104|P1|NOT COMPLETED|Overall Study||5
5003266|NCT02321319|12310104|P1|COMPLETED|Overall Study||0
5003267|NCT02321319|12310104|P1|STARTED|Overall Study||5
5003268|NCT02321111|12310108|P6|NOT COMPLETED|Infusion3||0
5003269|NCT02321111|12310109|P5|NOT COMPLETED|Infusion3||0
5003270|NCT02321111|12310110|P4|NOT COMPLETED|Infusion3||0
5003271|NCT02321111|12310111|P3|NOT COMPLETED|Infusion3||0
5003272|NCT02321111|12310112|P2|NOT COMPLETED|Infusion3||0
5003273|NCT02321111|12310113|P1|NOT COMPLETED|Infusion3||0
5003274|NCT02321111|12310108|P6|COMPLETED|Infusion3||0
5003275|NCT02321111|12310109|P5|COMPLETED|Infusion3||0
5003276|NCT02321111|12310110|P4|COMPLETED|Infusion3||1
5003277|NCT02321111|12310111|P3|COMPLETED|Infusion3||4
5003278|NCT02321111|12310112|P2|COMPLETED|Infusion3||4
5003279|NCT02321111|12310113|P1|COMPLETED|Infusion3||1
5003280|NCT02321111|12310108|P6|STARTED|Infusion3||0
5003281|NCT02321111|12310109|P5|STARTED|Infusion3||0
5003282|NCT02321111|12310110|P4|STARTED|Infusion3||1
5003283|NCT02321111|12310111|P3|STARTED|Infusion3||4
5003284|NCT02321111|12310112|P2|STARTED|Infusion3||4
5003285|NCT02321111|12310113|P1|STARTED|Infusion3||1
5003286|NCT02321111|12310108|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003287|NCT02321111|12310109|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003288|NCT02321111|12310110|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003289|NCT02321111|12310111|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003290|NCT02321111|12310112|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003291|NCT02321111|12310113|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003292|NCT02321111|12310108|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003293|NCT02321111|12310109|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
5003294|NCT02321111|12310110|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
5003295|NCT02321111|12310111|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
5003296|NCT02321111|12310112|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
5003297|NCT02321111|12310113|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
5003298|NCT02321111|12310108|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
5003299|NCT02321111|12310109|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
5003300|NCT02321111|12310110|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
5003301|NCT02321111|12310111|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
5003302|NCT02321111|12310112|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
5003303|NCT02321111|12310113|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
5003304|NCT02321111|12310108|P6|NOT COMPLETED|Infusion2||0
5003305|NCT02321111|12310109|P5|NOT COMPLETED|Infusion2||0
5003306|NCT02321111|12310110|P4|NOT COMPLETED|Infusion2||0
5003307|NCT02321111|12310111|P3|NOT COMPLETED|Infusion2||0
5003308|NCT02321111|12310112|P2|NOT COMPLETED|Infusion2||0
5003309|NCT02321111|12310113|P1|NOT COMPLETED|Infusion2||0
5003310|NCT02321111|12310108|P6|COMPLETED|Infusion2||0
5003311|NCT02321111|12310109|P5|COMPLETED|Infusion2||0
5003312|NCT02321111|12310110|P4|COMPLETED|Infusion2||1
5003313|NCT02321111|12310111|P3|COMPLETED|Infusion2||4
5003314|NCT02321111|12310112|P2|COMPLETED|Infusion2||4
5003315|NCT02321111|12310113|P1|COMPLETED|Infusion2||1
5003316|NCT02321111|12310108|P6|STARTED|Infusion2||0
5003317|NCT02321111|12310109|P5|STARTED|Infusion2||0
5003318|NCT02321111|12310110|P4|STARTED|Infusion2||1
5003319|NCT02321111|12310111|P3|STARTED|Infusion2||4
5003320|NCT02321111|12310112|P2|STARTED|Infusion2||4
5003321|NCT02321111|12310113|P1|STARTED|Infusion2||1
5003322|NCT02321111|12310108|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003323|NCT02321111|12310109|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003324|NCT02321111|12310110|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003325|NCT02321111|12310111|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003326|NCT02321111|12310112|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003327|NCT02321111|12310113|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003328|NCT02321111|12310108|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003329|NCT02321111|12310109|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
5003330|NCT02321111|12310110|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
5003331|NCT02321111|12310111|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
5003332|NCT02321111|12310112|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
5003333|NCT02321111|12310113|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
5003334|NCT02321111|12310108|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
5003335|NCT02321111|12310109|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
5003336|NCT02321111|12310110|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
5003337|NCT02321111|12310111|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
5003338|NCT02321111|12310112|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
5003339|NCT02321111|12310113|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
5003340|NCT02321111|12310108|P6|NOT COMPLETED|Infusion1||0
5003341|NCT02321111|12310109|P5|NOT COMPLETED|Infusion1||0
5003342|NCT02321111|12310110|P4|NOT COMPLETED|Infusion1||0
5003343|NCT02321111|12310111|P3|NOT COMPLETED|Infusion1||0
5003344|NCT02321111|12310112|P2|NOT COMPLETED|Infusion1||0
5003345|NCT02321111|12310113|P1|NOT COMPLETED|Infusion1||0
5003346|NCT02321111|12310108|P6|COMPLETED|Infusion1||0
5003347|NCT02321111|12310109|P5|COMPLETED|Infusion1||0
5003348|NCT02321111|12310110|P4|COMPLETED|Infusion1||1
5003349|NCT02321111|12310111|P3|COMPLETED|Infusion1||4
5003350|NCT02321111|12310112|P2|COMPLETED|Infusion1||4
5003351|NCT02321111|12310113|P1|COMPLETED|Infusion1||1
5003352|NCT02321111|12310108|P6|STARTED|Infusion1||0
5003353|NCT02321111|12310109|P5|STARTED|Infusion1||0
5003354|NCT02321111|12310110|P4|STARTED|Infusion1||1
5003355|NCT02321111|12310111|P3|STARTED|Infusion1||4
5003356|NCT02321111|12310112|P2|STARTED|Infusion1||4
5003357|NCT02321111|12310113|P1|STARTED|Infusion1||1
5003358|NCT02321098|12310136|P3|NOT COMPLETED|Additional 15 Months Treatment||8
5003359|NCT02321098|12310137|P2|NOT COMPLETED|Additional 15 Months Treatment||0
5003360|NCT02321098|12310138|P1|NOT COMPLETED|Additional 15 Months Treatment||0
5003361|NCT02321098|12310136|P3|COMPLETED|Additional 15 Months Treatment||21
5003362|NCT02321098|12310137|P2|COMPLETED|Additional 15 Months Treatment||0
5003363|NCT02321098|12310138|P1|COMPLETED|Additional 15 Months Treatment||0
5003364|NCT02321098|12310136|P3|STARTED|Additional 15 Months Treatment||29
5003365|NCT02321098|12310137|P2|STARTED|Additional 15 Months Treatment||0
5003366|NCT02321098|12310138|P1|STARTED|Additional 15 Months Treatment||0
5003367|NCT02321098|12310136|P3|NOT COMPLETED|12 Weeks Treament||0
5003368|NCT02321098|12310137|P2|NOT COMPLETED|12 Weeks Treament||1
5003369|NCT02321098|12310138|P1|NOT COMPLETED|12 Weeks Treament||1
5003370|NCT02321098|12310136|P3|COMPLETED|12 Weeks Treament||0
5003371|NCT02321098|12310137|P2|COMPLETED|12 Weeks Treament||23
5003372|NCT02321098|12310138|P1|COMPLETED|12 Weeks Treament||25
5003373|NCT02321098|12310136|P3|STARTED|12 Weeks Treament||0
5003374|NCT02321098|12310137|P2|STARTED|12 Weeks Treament||24
5003375|NCT02321098|12310138|P1|STARTED|12 Weeks Treament||26
5003376|NCT02320903|12310150|P3|NOT COMPLETED|Overall Study||16
5003377|NCT02320903|12310151|P2|NOT COMPLETED|Overall Study||16
5003378|NCT02320903|12310152|P1|NOT COMPLETED|Overall Study||8
5003379|NCT02320903|12310150|P3|COMPLETED|Overall Study||16
5003380|NCT02320903|12310151|P2|COMPLETED|Overall Study||16
5003381|NCT02320903|12310152|P1|COMPLETED|Overall Study||16
5003382|NCT02320903|12310150|P3|STARTED|Overall Study||32
5003383|NCT02320903|12310151|P2|STARTED|Overall Study||32
5003384|NCT02320903|12310152|P1|STARTED|Overall Study||24
5003385|NCT02320838|12310185|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5003386|NCT02320838|12310186|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5003387|NCT02320838|12310187|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5003388|NCT02320838|12310188|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5003389|NCT02320838|12310189|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5003390|NCT02320838|12310185|P5|COMPLETED|Third Intervention (1 Day)||7
5003391|NCT02320838|12310186|P4|COMPLETED|Third Intervention (1 Day)||7
5003392|NCT02320838|12310187|P3|COMPLETED|Third Intervention (1 Day)||8
5003393|NCT02320838|12310188|P2|COMPLETED|Third Intervention (1 Day)||8
5003394|NCT02320838|12310189|P1|COMPLETED|Third Intervention (1 Day)||8
5003395|NCT02320838|12310185|P5|STARTED|Third Intervention (1 Day)||7
5003396|NCT02320838|12310186|P4|STARTED|Third Intervention (1 Day)||7
5003397|NCT02320838|12310187|P3|STARTED|Third Intervention (1 Day)||8
5003398|NCT02320838|12310188|P2|STARTED|Third Intervention (1 Day)||8
5003399|NCT02320838|12310189|P1|STARTED|Third Intervention (1 Day)||8
5003400|NCT02320838|12310185|P5|NOT COMPLETED|Washout (1 Day)||0
5003401|NCT02320838|12310186|P4|NOT COMPLETED|Washout (1 Day)||0
5003402|NCT02320838|12310187|P3|NOT COMPLETED|Washout (1 Day)||0
5003403|NCT02320838|12310188|P2|NOT COMPLETED|Washout (1 Day)||0
5003404|NCT02320838|12310189|P1|NOT COMPLETED|Washout (1 Day)||0
5003405|NCT02320838|12310185|P5|COMPLETED|Washout (1 Day)||7
5003406|NCT02320838|12310186|P4|COMPLETED|Washout (1 Day)||7
5003407|NCT02320838|12310187|P3|COMPLETED|Washout (1 Day)||8
5003408|NCT02320838|12310188|P2|COMPLETED|Washout (1 Day)||8
5003409|NCT02320838|12310189|P1|COMPLETED|Washout (1 Day)||8
5003410|NCT02320838|12310185|P5|STARTED|Washout (1 Day)||7
5003411|NCT02320838|12310186|P4|STARTED|Washout (1 Day)||7
5003412|NCT02320838|12310187|P3|STARTED|Washout (1 Day)||8
5003413|NCT02320838|12310188|P2|STARTED|Washout (1 Day)||8
5003414|NCT02320838|12310189|P1|STARTED|Washout (1 Day)||8
5003415|NCT02320838|12310185|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5003416|NCT02320838|12310186|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5003417|NCT02320838|12310187|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5003418|NCT02320838|12310188|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5003419|NCT02320838|12310189|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5003420|NCT02320838|12310185|P5|COMPLETED|Second Intervention (1 Day)||7
5003421|NCT02320838|12310186|P4|COMPLETED|Second Intervention (1 Day)||7
5003422|NCT02320838|12310187|P3|COMPLETED|Second Intervention (1 Day)||8
5003423|NCT02320838|12310188|P2|COMPLETED|Second Intervention (1 Day)||8
5003424|NCT02320838|12310189|P1|COMPLETED|Second Intervention (1 Day)||8
5003425|NCT02320838|12310185|P5|STARTED|Second Intervention (1 Day)||7
5003426|NCT02320838|12310186|P4|STARTED|Second Intervention (1 Day)||7
5003427|NCT02320838|12310187|P3|STARTED|Second Intervention (1 Day)||8
5003428|NCT02320838|12310188|P2|STARTED|Second Intervention (1 Day)||8
5003429|NCT02320838|12310189|P1|STARTED|Second Intervention (1 Day)||8
5003430|NCT02320838|12310185|P5|NOT COMPLETED|Washout (1 Day)||0
5003431|NCT02320838|12310186|P4|NOT COMPLETED|Washout (1 Day)||0
5003432|NCT02320838|12310187|P3|NOT COMPLETED|Washout (1 Day)||0
5003433|NCT02320838|12310188|P2|NOT COMPLETED|Washout (1 Day)||0
5003434|NCT02320838|12310189|P1|NOT COMPLETED|Washout (1 Day)||0
5003435|NCT02320838|12310185|P5|COMPLETED|Washout (1 Day)||7
5003436|NCT02320838|12310186|P4|COMPLETED|Washout (1 Day)||7
5003437|NCT02320838|12310187|P3|COMPLETED|Washout (1 Day)||8
5003438|NCT02320838|12310188|P2|COMPLETED|Washout (1 Day)||8
5003439|NCT02320838|12310189|P1|COMPLETED|Washout (1 Day)||8
5003440|NCT02320838|12310185|P5|STARTED|Washout (1 Day)||7
5003441|NCT02320838|12310186|P4|STARTED|Washout (1 Day)||7
5003442|NCT02320838|12310187|P3|STARTED|Washout (1 Day)||8
5003443|NCT02320838|12310188|P2|STARTED|Washout (1 Day)||8
5003444|NCT02320838|12310189|P1|STARTED|Washout (1 Day)||8
5003445|NCT02320838|12310185|P5|NOT COMPLETED|First Intervention (1 Day)||0
5003446|NCT02320838|12310186|P4|NOT COMPLETED|First Intervention (1 Day)||0
5003447|NCT02320838|12310187|P3|NOT COMPLETED|First Intervention (1 Day)||0
5003448|NCT02320838|12310188|P2|NOT COMPLETED|First Intervention (1 Day)||0
5003449|NCT02320838|12310189|P1|NOT COMPLETED|First Intervention (1 Day)||0
5003450|NCT02320838|12310185|P5|COMPLETED|First Intervention (1 Day)||7
5003451|NCT02320838|12310186|P4|COMPLETED|First Intervention (1 Day)||7
5003452|NCT02320838|12310187|P3|COMPLETED|First Intervention (1 Day)||8
5003453|NCT02320838|12310188|P2|COMPLETED|First Intervention (1 Day)||8
5003454|NCT02320838|12310189|P1|COMPLETED|First Intervention (1 Day)||8
5003455|NCT02320838|12310185|P5|STARTED|First Intervention (1 Day)||7
5003456|NCT02320838|12310186|P4|STARTED|First Intervention (1 Day)||7
5003457|NCT02320838|12310187|P3|STARTED|First Intervention (1 Day)||8
5003458|NCT02320838|12310188|P2|STARTED|First Intervention (1 Day)||8
5003459|NCT02320838|12310189|P1|STARTED|First Intervention (1 Day)||8
5003460|NCT02320825|12310256|P2|NOT COMPLETED|Overall Study||0
5003461|NCT02320825|12310257|P1|NOT COMPLETED|Overall Study||0
5003462|NCT02320825|12310256|P2|COMPLETED|Overall Study||8
5003463|NCT02320825|12310257|P1|COMPLETED|Overall Study||8
5003464|NCT02320825|12310256|P2|STARTED|Overall Study||8
5003465|NCT02320825|12310257|P1|STARTED|Overall Study||8
5003466|NCT02320812|12310267|P1|NOT COMPLETED|Overall Study||0
5003467|NCT02320812|12310267|P1|COMPLETED|Overall Study||28
5003468|NCT02320812|12310267|P1|STARTED|Overall Study||28
5003469|NCT02320721|12310277|P2|NOT COMPLETED|Overall Study||34
5003470|NCT02320721|12310278|P1|NOT COMPLETED|Overall Study||27
5003471|NCT02320721|12310277|P2|COMPLETED|Overall Study||472
5003472|NCT02320721|12310278|P1|COMPLETED|Overall Study||481
5003473|NCT02320721|12310277|P2|Treated (Safety Population)|Overall Study||505
5003474|NCT02320721|12310278|P1|Treated (Safety Population)|Overall Study||508
5003475|NCT02320721|12310277|P2|STARTED|Overall Study||506
5003476|NCT02320721|12310278|P1|STARTED|Overall Study||508
5003477|NCT02320695|12310306|P1|NOT COMPLETED|Overall Study||0
5003478|NCT02320695|12310306|P1|COMPLETED|Overall Study||60
5003479|NCT02320695|12310306|P1|Pain Relief Ointment|Overall Study||60
5003480|NCT02320695|12310306|P1|Original Ointment|Overall Study||60
5003481|NCT02320695|12310306|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
5003482|NCT02320695|12310306|P1|Pain Relieving Cream|Overall Study||59
5003483|NCT02320695|12310306|P1|Alcohol|Overall Study||60
5003484|NCT02320695|12310306|P1|Saline|Overall Study||60
5003485|NCT02320695|12310306|P1|STARTED|Overall Study||60
5003486|NCT02320487|12310333|P1|NOT COMPLETED|Overall Study||21
5003487|NCT02320487|12310333|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
5003488|NCT02320487|12310333|P1|STARTED|Overall Study||102
5003489|NCT02320396|12310353|P2|NOT COMPLETED|Overall Study||4
5003490|NCT02320396|12310354|P1|NOT COMPLETED|Overall Study||4
5003491|NCT02320396|12310353|P2|COMPLETED|Overall Study||221
5003492|NCT02320396|12310354|P1|COMPLETED|Overall Study||220
5003493|NCT02320396|12310353|P2|Treated (Full Analysis Set)|Overall Study||225
5003494|NCT02320396|12310354|P1|Treated (Full Analysis Set)|Overall Study||223
5003495|NCT02320396|12310353|P2|STARTED|Overall Study||225
5003496|NCT02320396|12310354|P1|STARTED|Overall Study||224
5003497|NCT02320227|12310384|P1|NOT COMPLETED|Overall Study||0
5003498|NCT02320227|12310384|P1|COMPLETED|Overall Study||30
5003499|NCT02320227|12310384|P1|STARTED|Overall Study||30
5003500|NCT02320214|12310389|P1|NOT COMPLETED|Overall Study||0
5003501|NCT02320214|12310389|P1|COMPLETED|Overall Study||30
5003502|NCT02320214|12310389|P1|STARTED|Overall Study||30
5003503|NCT02320149|12310396|P2|NOT COMPLETED|Overall Study||80
5003504|NCT02320149|12310397|P1|NOT COMPLETED|Overall Study||63
5003505|NCT02320149|12310396|P2|COMPLETED|Overall Study||405
5003506|NCT02320149|12310397|P1|COMPLETED|Overall Study||420
5003507|NCT02320149|12310396|P2|STARTED|Overall Study||485
5003508|NCT02320149|12310397|P1|STARTED|Overall Study||483
5003509|NCT02319967|12310438|P3|NOT COMPLETED|Overall Study||45
5003510|NCT02319967|12310439|P2|NOT COMPLETED|Overall Study||44
5003511|NCT02319967|12310440|P1|NOT COMPLETED|Overall Study||48
5003512|NCT02319967|12310438|P3|COMPLETED|Overall Study||76
5003513|NCT02319967|12310439|P2|COMPLETED|Overall Study||82
5003514|NCT02319967|12310440|P1|COMPLETED|Overall Study||78
5003515|NCT02319967|12310438|P3|STARTED|Overall Study||121
5003516|NCT02319967|12310439|P2|STARTED|Overall Study||126
5003517|NCT02319967|12310440|P1|STARTED|Overall Study||126
5003518|NCT02319824|12310496|P1|NOT COMPLETED|Overall Study||0
5003519|NCT02319824|12310496|P1|COMPLETED|Overall Study||2
5003520|NCT02319824|12310496|P1|STARTED|Overall Study||2
5003521|NCT02319668|12310504|P2|NOT COMPLETED|Overall Study||2
5003522|NCT02319668|12310505|P1|NOT COMPLETED|Overall Study||0
5003523|NCT02319668|12310504|P2|COMPLETED|Overall Study||17
5003524|NCT02319668|12310505|P1|COMPLETED|Overall Study||19
5003525|NCT02319668|12310504|P2|STARTED|Overall Study||19
5003526|NCT02319668|12310505|P1|STARTED|Overall Study||19
5003527|NCT02319642|12310519|P2|NOT COMPLETED|Overall Study||6
5003528|NCT02319642|12310520|P1|NOT COMPLETED|Overall Study||4
5003529|NCT02319642|12310519|P2|COMPLETED|Overall Study||245
5003530|NCT02319642|12310520|P1|COMPLETED|Overall Study||91
5003531|NCT02319642|12310519|P2|STARTED|Overall Study||251
5003532|NCT02319642|12310520|P1|STARTED|Overall Study||95
5003533|NCT02319525|12310540|P2|NOT COMPLETED|Overall Study||1
5003534|NCT02319525|12310541|P1|NOT COMPLETED|Overall Study||2
5003535|NCT02319525|12310540|P2|COMPLETED|Overall Study||147
5003536|NCT02319525|12310541|P1|COMPLETED|Overall Study||151
5003537|NCT02319525|12310540|P2|Primary Research Completion|Overall Study||147
5003538|NCT02319525|12310541|P1|Primary Research Completion|Overall Study||151
5003539|NCT02319525|12310540|P2|STARTED|Overall Study||148
5003540|NCT02319525|12310541|P1|STARTED|Overall Study||153
5003541|NCT02319486|12310559|P1|NOT COMPLETED|Overall Study||0
5003542|NCT02319486|12310559|P1|COMPLETED|Overall Study||26
5003543|NCT02319486|12310559|P1|STARTED|Overall Study||26
5003544|NCT02319317|12310567|P2|NOT COMPLETED|Overall Study||0
5003545|NCT02319317|12310568|P1|NOT COMPLETED|Overall Study||0
5003546|NCT02319317|12310567|P2|COMPLETED|Overall Study||29
5003547|NCT02319317|12310568|P1|COMPLETED|Overall Study||31
5003548|NCT02319317|12310567|P2|STARTED|Overall Study||29
5003549|NCT02319317|12310568|P1|STARTED|Overall Study||31
5003550|NCT02319174|12310574|P1|NOT COMPLETED|Overall Study||1
5003551|NCT02319174|12310574|P1|COMPLETED|Overall Study||42
5003552|NCT02319174|12310574|P1|STARTED|Overall Study||43
5003553|NCT02319148|12310583|P4|NOT COMPLETED|Second Intervention Period||2
5003554|NCT02319148|12310584|P3|NOT COMPLETED|Second Intervention Period||1
5003555|NCT02319148|12310585|P2|NOT COMPLETED|Second Intervention Period||1
5003556|NCT02319148|12310586|P1|NOT COMPLETED|Second Intervention Period||0
5003557|NCT02319148|12310583|P4|COMPLETED|Second Intervention Period||6
5003558|NCT02319148|12310584|P3|COMPLETED|Second Intervention Period||6
5003559|NCT02319148|12310585|P2|COMPLETED|Second Intervention Period||6
5003560|NCT02319148|12310586|P1|COMPLETED|Second Intervention Period||0
5003561|NCT02319148|12310583|P4|STARTED|Second Intervention Period||8
5003562|NCT02319148|12310584|P3|STARTED|Second Intervention Period||7
5003563|NCT02319148|12310585|P2|STARTED|Second Intervention Period||7
5003564|NCT02319148|12310586|P1|STARTED|Second Intervention Period||0
5003565|NCT02319148|12310583|P4|NOT COMPLETED|Washout Period 4 Days||0
5003566|NCT02319148|12310584|P3|NOT COMPLETED|Washout Period 4 Days||0
5003567|NCT02319148|12310585|P2|NOT COMPLETED|Washout Period 4 Days||0
5003568|NCT02319148|12310586|P1|NOT COMPLETED|Washout Period 4 Days||0
5003569|NCT02319148|12310583|P4|COMPLETED|Washout Period 4 Days||0
5003570|NCT02319148|12310584|P3|COMPLETED|Washout Period 4 Days||0
5003571|NCT02319148|12310585|P2|COMPLETED|Washout Period 4 Days||0
5003572|NCT02319148|12310586|P1|COMPLETED|Washout Period 4 Days||22
5003573|NCT02319148|12310583|P4|STARTED|Washout Period 4 Days||0
5003574|NCT02319148|12310584|P3|STARTED|Washout Period 4 Days||0
5003575|NCT02319148|12310585|P2|STARTED|Washout Period 4 Days||0
5003576|NCT02319148|12310586|P1|STARTED|Washout Period 4 Days||22
5003577|NCT02319148|12310583|P4|NOT COMPLETED|First Intervention Period||0
5003578|NCT02319148|12310584|P3|NOT COMPLETED|First Intervention Period||0
5003579|NCT02319148|12310585|P2|NOT COMPLETED|First Intervention Period||0
5003580|NCT02319148|12310586|P1|NOT COMPLETED|First Intervention Period||0
5003581|NCT02319148|12310583|P4|COMPLETED|First Intervention Period||0
5003582|NCT02319148|12310584|P3|COMPLETED|First Intervention Period||0
5003583|NCT02319148|12310585|P2|COMPLETED|First Intervention Period||0
5003584|NCT02319148|12310586|P1|COMPLETED|First Intervention Period||22
5003585|NCT02319148|12310583|P4|STARTED|First Intervention Period||0
5003586|NCT02319148|12310584|P3|STARTED|First Intervention Period||0
5003587|NCT02319148|12310585|P2|STARTED|First Intervention Period||0
5003588|NCT02319148|12310586|P1|STARTED|First Intervention Period||22
5003589|NCT02319044|12310649|P3|NOT COMPLETED|Overall Study||67
5003590|NCT02319044|12310650|P2|NOT COMPLETED|Overall Study||60
5003591|NCT02319044|12310651|P1|NOT COMPLETED|Overall Study||122
5003592|NCT02319044|12310649|P3|COMPLETED|Overall Study||0
5003593|NCT02319044|12310650|P2|COMPLETED|Overall Study||7
5003594|NCT02319044|12310651|P1|COMPLETED|Overall Study||11
5003595|NCT02319044|12310649|P3|STARTED|Overall Study||67
5003596|NCT02319044|12310650|P2|STARTED|Overall Study||67
5003597|NCT02319044|12310651|P1|STARTED|Overall Study||133
5003598|NCT02319031|12310707|P2|NOT COMPLETED|Follow-Up Period||0
5003599|NCT02319031|12310708|P1|NOT COMPLETED|Follow-Up Period||0
5003600|NCT02319031|12310707|P2|COMPLETED|Follow-Up Period||26
5003601|NCT02319031|12310708|P1|COMPLETED|Follow-Up Period||23
5003602|NCT02319031|12310707|P2|STARTED|Follow-Up Period||26
5003603|NCT02319031|12310708|P1|STARTED|Follow-Up Period||23
5003604|NCT02319031|12310707|P2|NOT COMPLETED|Treatment Period||0
5003605|NCT02319031|12310708|P1|NOT COMPLETED|Treatment Period||1
5003606|NCT02319031|12310707|P2|COMPLETED|Treatment Period||26
5003607|NCT02319031|12310708|P1|COMPLETED|Treatment Period||23
5003608|NCT02319031|12310707|P2|STARTED|Treatment Period||26
5003609|NCT02319031|12310708|P1|STARTED|Treatment Period||24
5003610|NCT02319005|12310720|P2|NOT COMPLETED|Overall Study||15
5003611|NCT02319005|12310721|P1|NOT COMPLETED|Overall Study||48
5003612|NCT02319005|12310720|P2|COMPLETED|Overall Study||51
5003613|NCT02319005|12310721|P1|COMPLETED|Overall Study||92
5003614|NCT02319005|12310720|P2|STARTED|Overall Study||66
5003615|NCT02319005|12310721|P1|STARTED|Overall Study||140
5003616|NCT02318992|12310744|P3|NOT COMPLETED|Overall Study||4
5003617|NCT02318992|12310745|P2|NOT COMPLETED|Overall Study||2
5003618|NCT02318992|12310746|P1|NOT COMPLETED|Overall Study||2
5003619|NCT02318992|12310744|P3|COMPLETED|Overall Study||20
5003620|NCT02318992|12310745|P2|COMPLETED|Overall Study||25
5003621|NCT02318992|12310746|P1|COMPLETED|Overall Study||25
5003622|NCT02318992|12310744|P3|STARTED|Overall Study||24
5003623|NCT02318992|12310745|P2|STARTED|Overall Study||27
5003624|NCT02318992|12310746|P1|STARTED|Overall Study||27
5003625|NCT02318979|12310759|P2|NOT COMPLETED|Overall Study||0
5003626|NCT02318979|12310760|P1|NOT COMPLETED|Overall Study||0
5003627|NCT02318979|12310759|P2|COMPLETED|Overall Study||15
5003628|NCT02318979|12310760|P1|COMPLETED|Overall Study||15
5003629|NCT02318979|12310759|P2|STARTED|Overall Study||15
5003630|NCT02318979|12310760|P1|STARTED|Overall Study||15
5003631|NCT02318940|12310772|P2|NOT COMPLETED|Overall Study||0
5003632|NCT02318940|12310773|P1|NOT COMPLETED|Overall Study||1
5003633|NCT02318940|12310772|P2|COMPLETED|Overall Study||50
5003634|NCT02318940|12310773|P1|COMPLETED|Overall Study||49
5003635|NCT02318940|12310772|P2|STARTED|Overall Study||50
5003636|NCT02318940|12310773|P1|STARTED|Overall Study|in the last patient we lost the record.|50
5003637|NCT02318901|12310788|P3|NOT COMPLETED|Overall Study||10
5003638|NCT02318901|12310789|P2|NOT COMPLETED|Overall Study||1
5003639|NCT02318901|12310790|P1|NOT COMPLETED|Overall Study||5
5003640|NCT02318901|12310788|P3|COMPLETED|Overall Study||0
5003641|NCT02318901|12310789|P2|COMPLETED|Overall Study||0
5003642|NCT02318901|12310790|P1|COMPLETED|Overall Study||0
5003643|NCT02318901|12310788|P3|STARTED|Overall Study||10
5003644|NCT02318901|12310789|P2|STARTED|Overall Study||1
5003645|NCT02318901|12310790|P1|STARTED|Overall Study||5
5003646|NCT02318797|12310815|P2|NOT COMPLETED|Overall Study||102
5003647|NCT02318797|12310816|P1|NOT COMPLETED|Overall Study||88
5003648|NCT02318797|12310815|P2|COMPLETED|Overall Study||611
5003649|NCT02318797|12310816|P1|COMPLETED|Overall Study||428
5003650|NCT02318797|12310815|P2|STARTED|Overall Study||713
5003651|NCT02318797|12310816|P1|STARTED|Overall Study||516
5003652|NCT02318693|12310856|P2|NOT COMPLETED|Overall Study||1
5003653|NCT02318693|12310857|P1|NOT COMPLETED|Overall Study||0
5003654|NCT02318693|12310856|P2|COMPLETED|Overall Study||26
5003655|NCT02318693|12310857|P1|COMPLETED|Overall Study||26
5003656|NCT02318693|12310856|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
5003657|NCT02318693|12310857|P1|Treated|Overall Study||26
5003658|NCT02318693|12310856|P2|STARTED|Overall Study||27
5003659|NCT02318693|12310857|P1|STARTED|Overall Study||26
5003660|NCT02318667|12310871|P1|NOT COMPLETED|Overall Study||9
5003661|NCT02318667|12310871|P1|COMPLETED|Overall Study||29
5003662|NCT02318667|12310871|P1|STARTED|Overall Study||38
5003663|NCT02318602|12310890|P3|NOT COMPLETED|Overall Study||2
5003664|NCT02318602|12310891|P2|NOT COMPLETED|Overall Study||4
5003665|NCT02318602|12310892|P1|NOT COMPLETED|Overall Study||1
5003666|NCT02318602|12310890|P3|COMPLETED|Overall Study||15
5003667|NCT02318602|12310891|P2|COMPLETED|Overall Study||22
5003668|NCT02318602|12310892|P1|COMPLETED|Overall Study||8
5003669|NCT02318602|12310890|P3|STARTED|Overall Study||17
5003670|NCT02318602|12310891|P2|STARTED|Overall Study||26
5003671|NCT02318602|12310892|P1|STARTED|Overall Study||9
5003672|NCT02318329|12310933|P10|NOT COMPLETED|Overall Study||52
5003673|NCT02318329|12310934|P9|NOT COMPLETED|Overall Study||6
5003674|NCT02318329|12310935|P8|NOT COMPLETED|Overall Study||1
5003675|NCT02318329|12310936|P7|NOT COMPLETED|Overall Study||1
5003676|NCT02318329|12310937|P6|NOT COMPLETED|Overall Study||3
5003677|NCT02318329|12310938|P5|NOT COMPLETED|Overall Study||3
5003678|NCT02318329|12310939|P4|NOT COMPLETED|Overall Study||3
5003679|NCT02318329|12310940|P3|NOT COMPLETED|Overall Study||3
5003680|NCT02318329|12310941|P2|NOT COMPLETED|Overall Study||4
5003681|NCT02318329|12310942|P1|NOT COMPLETED|Overall Study||3
5003682|NCT02318329|12310933|P10|COMPLETED|Overall Study||0
5003683|NCT02318329|12310934|P9|COMPLETED|Overall Study||0
5003684|NCT02318329|12310935|P8|COMPLETED|Overall Study||0
5003685|NCT02318329|12310936|P7|COMPLETED|Overall Study||0
5003686|NCT02318329|12310937|P6|COMPLETED|Overall Study||0
5003687|NCT02318329|12310938|P5|COMPLETED|Overall Study||0
5003688|NCT02318329|12310939|P4|COMPLETED|Overall Study||0
5003689|NCT02318329|12310940|P3|COMPLETED|Overall Study||0
5003690|NCT02318329|12310941|P2|COMPLETED|Overall Study||0
5003691|NCT02318329|12310942|P1|COMPLETED|Overall Study||0
5003692|NCT02318329|12310933|P10|STARTED|Overall Study||52
5003693|NCT02318329|12310934|P9|STARTED|Overall Study||6
5003694|NCT02318329|12310935|P8|STARTED|Overall Study||1
5003695|NCT02318329|12310936|P7|STARTED|Overall Study||1
5003696|NCT02318329|12310937|P6|STARTED|Overall Study||3
5003697|NCT02318329|12310938|P5|STARTED|Overall Study||3
5003698|NCT02318329|12310939|P4|STARTED|Overall Study||3
5003699|NCT02318329|12310940|P3|STARTED|Overall Study||3
5003700|NCT02318329|12310941|P2|STARTED|Overall Study||4
5003701|NCT02318329|12310942|P1|STARTED|Overall Study||3
5003702|NCT02318303|12311005|P7|NOT COMPLETED|Overall Study||2
5003703|NCT02318303|12311006|P6|NOT COMPLETED|Overall Study||6
5003704|NCT02318303|12311007|P5|NOT COMPLETED|Overall Study||5
5003705|NCT02318303|12311008|P4|NOT COMPLETED|Overall Study||3
5003706|NCT02318303|12311009|P3|NOT COMPLETED|Overall Study||3
5003707|NCT02318303|12311010|P2|NOT COMPLETED|Overall Study||3
5003708|NCT02318303|12311011|P1|NOT COMPLETED|Overall Study||4
5003709|NCT02318303|12311005|P7|COMPLETED|Overall Study||158
5003710|NCT02318303|12311006|P6|COMPLETED|Overall Study||153
5003711|NCT02318303|12311007|P5|COMPLETED|Overall Study||152
5003712|NCT02318303|12311008|P4|COMPLETED|Overall Study||155
5003713|NCT02318303|12311009|P3|COMPLETED|Overall Study||157
5003714|NCT02318303|12311010|P2|COMPLETED|Overall Study||155
5003715|NCT02318303|12311011|P1|COMPLETED|Overall Study||155
5003716|NCT02318303|12311005|P7|STARTED|Overall Study||160
5003717|NCT02318303|12311006|P6|STARTED|Overall Study||159
5003718|NCT02318303|12311007|P5|STARTED|Overall Study||157
5003719|NCT02318303|12311008|P4|STARTED|Overall Study||158
5003720|NCT02318303|12311009|P3|STARTED|Overall Study||160
5003721|NCT02318303|12311010|P2|STARTED|Overall Study||158
5003722|NCT02318303|12311011|P1|STARTED|Overall Study||159
5003723|NCT02317809|12311027|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
5003724|NCT02317809|12311028|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
5003725|NCT02317809|12311027|P2|COMPLETED|Second Intervention Period (8 Days)||17
5003726|NCT02317809|12311028|P1|COMPLETED|Second Intervention Period (8 Days)||14
5003727|NCT02317809|12311027|P2|STARTED|Second Intervention Period (8 Days)||17
5003728|NCT02317809|12311028|P1|STARTED|Second Intervention Period (8 Days)||14
5003729|NCT02317809|12311027|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
5003730|NCT02317809|12311028|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
5003731|NCT02317809|12311027|P2|COMPLETED|First Intervention Period (8 Days)||17
5003732|NCT02317809|12311028|P1|COMPLETED|First Intervention Period (8 Days)||14
5003733|NCT02317809|12311027|P2|STARTED|First Intervention Period (8 Days)||17
5003734|NCT02317809|12311028|P1|STARTED|First Intervention Period (8 Days)||17
5003735|NCT02317744|12311080|P2|NOT COMPLETED|Overall Study||2
5003736|NCT02317744|12311081|P1|NOT COMPLETED|Overall Study||1
5003737|NCT02317744|12311080|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
5003738|NCT02317744|12311081|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
5003739|NCT02317744|12311080|P2|Completed Treatment|Overall Study||7
5003740|NCT02317744|12311081|P1|Completed Treatment|Overall Study||10
5003741|NCT02317744|12311080|P2|STARTED|Overall Study||10
5003742|NCT02317744|12311081|P1|STARTED|Overall Study||12
5003743|NCT02317692|12311095|P2|NOT COMPLETED|Overall Study||0
5003744|NCT02317692|12311096|P1|NOT COMPLETED|Overall Study||6
5003745|NCT02317692|12311095|P2|COMPLETED|Overall Study||77
5003746|NCT02317692|12311096|P1|COMPLETED|Overall Study||63
5003747|NCT02317692|12311095|P2|STARTED|Overall Study||77
5003748|NCT02317692|12311096|P1|STARTED|Overall Study||69
5003749|NCT02317614|12311116|P2|NOT COMPLETED|Overall Study||2
5003750|NCT02317614|12311117|P1|NOT COMPLETED|Overall Study||3
5003751|NCT02317614|12311116|P2|COMPLETED|Overall Study||23
5003752|NCT02317614|12311117|P1|COMPLETED|Overall Study||23
5003753|NCT02317614|12311116|P2|STARTED|Overall Study||25
5003754|NCT02317614|12311117|P1|STARTED|Overall Study||26
5003755|NCT02317575|12311133|P5|NOT COMPLETED|Period 5||0
5003756|NCT02317575|12311134|P4|NOT COMPLETED|Period 5||0
5003757|NCT02317575|12311135|P3|NOT COMPLETED|Period 5||0
5003758|NCT02317575|12311136|P2|NOT COMPLETED|Period 5||0
5003759|NCT02317575|12311137|P1|NOT COMPLETED|Period 5||0
5003760|NCT02317575|12311133|P5|COMPLETED|Period 5||6
5003761|NCT02317575|12311134|P4|COMPLETED|Period 5||6
5003762|NCT02317575|12311135|P3|COMPLETED|Period 5||6
5003763|NCT02317575|12311136|P2|COMPLETED|Period 5||5
5003764|NCT02317575|12311137|P1|COMPLETED|Period 5||4
5003765|NCT02317575|12311133|P5|STARTED|Period 5||6
5003766|NCT02317575|12311134|P4|STARTED|Period 5||6
5003767|NCT02317575|12311135|P3|STARTED|Period 5||6
5003768|NCT02317575|12311136|P2|STARTED|Period 5||5
5003769|NCT02317575|12311137|P1|STARTED|Period 5||4
5003770|NCT02317575|12311133|P5|NOT COMPLETED|Period 4||0
5003771|NCT02317575|12311134|P4|NOT COMPLETED|Period 4||0
5003772|NCT02317575|12311135|P3|NOT COMPLETED|Period 4||0
5003773|NCT02317575|12311136|P2|NOT COMPLETED|Period 4||0
5003774|NCT02317575|12311137|P1|NOT COMPLETED|Period 4||0
5003775|NCT02317575|12311133|P5|COMPLETED|Period 4||6
5003776|NCT02317575|12311134|P4|COMPLETED|Period 4||6
5003777|NCT02317575|12311135|P3|COMPLETED|Period 4||6
5003778|NCT02317575|12311136|P2|COMPLETED|Period 4||5
5003779|NCT02317575|12311137|P1|COMPLETED|Period 4||4
5003780|NCT02317575|12311133|P5|STARTED|Period 4||6
5003781|NCT02317575|12311134|P4|STARTED|Period 4||6
5003782|NCT02317575|12311135|P3|STARTED|Period 4||6
5003783|NCT02317575|12311136|P2|STARTED|Period 4||5
5003784|NCT02317575|12311137|P1|STARTED|Period 4||4
5003785|NCT02317575|12311133|P5|NOT COMPLETED|Period 3||0
5003786|NCT02317575|12311134|P4|NOT COMPLETED|Period 3||0
5003787|NCT02317575|12311135|P3|NOT COMPLETED|Period 3||0
5003788|NCT02317575|12311136|P2|NOT COMPLETED|Period 3||0
5003789|NCT02317575|12311137|P1|NOT COMPLETED|Period 3||0
5003790|NCT02317575|12311133|P5|COMPLETED|Period 3||6
5003791|NCT02317575|12311134|P4|COMPLETED|Period 3||6
5003792|NCT02317575|12311135|P3|COMPLETED|Period 3||6
5003793|NCT02317575|12311136|P2|COMPLETED|Period 3||5
5003794|NCT02317575|12311137|P1|COMPLETED|Period 3||4
5003795|NCT02317575|12311133|P5|STARTED|Period 3||6
5003796|NCT02317575|12311134|P4|STARTED|Period 3||6
5003797|NCT02317575|12311135|P3|STARTED|Period 3||6
5003798|NCT02317575|12311136|P2|STARTED|Period 3||5
5003799|NCT02317575|12311137|P1|STARTED|Period 3||4
5003800|NCT02317575|12311133|P5|NOT COMPLETED|Period 2||0
5003801|NCT02317575|12311134|P4|NOT COMPLETED|Period 2||0
5003802|NCT02317575|12311135|P3|NOT COMPLETED|Period 2||0
5003803|NCT02317575|12311136|P2|NOT COMPLETED|Period 2||0
5003804|NCT02317575|12311137|P1|NOT COMPLETED|Period 2||0
5003805|NCT02317575|12311133|P5|COMPLETED|Period 2||6
5003806|NCT02317575|12311134|P4|COMPLETED|Period 2||6
5003807|NCT02317575|12311135|P3|COMPLETED|Period 2||6
5003808|NCT02317575|12311136|P2|COMPLETED|Period 2||5
5003809|NCT02317575|12311137|P1|COMPLETED|Period 2||4
5003810|NCT02317575|12311133|P5|STARTED|Period 2||6
5003811|NCT02317575|12311134|P4|STARTED|Period 2||6
5003812|NCT02317575|12311135|P3|STARTED|Period 2||6
5003813|NCT02317575|12311136|P2|STARTED|Period 2||5
5003814|NCT02317575|12311137|P1|STARTED|Period 2||4
5003815|NCT02317575|12311133|P5|NOT COMPLETED|Period 1||0
5003816|NCT02317575|12311134|P4|NOT COMPLETED|Period 1||0
5003817|NCT02317575|12311135|P3|NOT COMPLETED|Period 1||0
5003818|NCT02317575|12311136|P2|NOT COMPLETED|Period 1||1
5003819|NCT02317575|12311137|P1|NOT COMPLETED|Period 1||1
5003820|NCT02317575|12311133|P5|COMPLETED|Period 1||6
5003821|NCT02317575|12311134|P4|COMPLETED|Period 1||6
5003822|NCT02317575|12311135|P3|COMPLETED|Period 1||6
5003823|NCT02317575|12311136|P2|COMPLETED|Period 1||5
5003824|NCT02317575|12311137|P1|COMPLETED|Period 1||4
5003825|NCT02317575|12311133|P5|Received at Least 1 Dose of Study Drug|Period 1||6
5003826|NCT02317575|12311134|P4|Received at Least 1 Dose of Study Drug|Period 1||6
5003827|NCT02317575|12311135|P3|Received at Least 1 Dose of Study Drug|Period 1||6
5003828|NCT02317575|12311136|P2|Received at Least 1 Dose of Study Drug|Period 1||5
5003829|NCT02317575|12311137|P1|Received at Least 1 Dose of Study Drug|Period 1||5
5003830|NCT02317575|12311133|P5|STARTED|Period 1||6
5003831|NCT02317575|12311134|P4|STARTED|Period 1||6
5003832|NCT02317575|12311135|P3|STARTED|Period 1||6
5003833|NCT02317575|12311136|P2|STARTED|Period 1||6
5003834|NCT02317575|12311137|P1|STARTED|Period 1||5
5003835|NCT02317549|12311163|P2|NOT COMPLETED|Overall Study||0
5003836|NCT02317549|12311164|P1|NOT COMPLETED|Overall Study||0
5003837|NCT02317549|12311163|P2|COMPLETED|Overall Study||3
5003838|NCT02317549|12311164|P1|COMPLETED|Overall Study||5
5003839|NCT02317549|12311163|P2|STARTED|Overall Study||3
5003840|NCT02317549|12311164|P1|STARTED|Overall Study||5
5003841|NCT02317510|12311172|P2|NOT COMPLETED|Overall Study||1
5003842|NCT02317510|12311173|P1|NOT COMPLETED|Overall Study||0
5003843|NCT02317510|12311172|P2|COMPLETED|Overall Study||24
5003844|NCT02317510|12311173|P1|COMPLETED|Overall Study||25
5003845|NCT02317510|12311172|P2|STARTED|Overall Study||25
5003846|NCT02317510|12311173|P1|STARTED|Overall Study||25
5003847|NCT02317276|12311201|P1|NOT COMPLETED|Overall Study||6
5003848|NCT02317276|12311201|P1|COMPLETED|Overall Study||5
5003849|NCT02317276|12311201|P1|STARTED|Overall Study||11
5003850|NCT02317016|12311205|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
5003851|NCT02317016|12311205|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
5003852|NCT02317016|12311205|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
5003853|NCT02317016|12311205|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
5003854|NCT02317016|12311205|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
5003855|NCT02317016|12311205|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
5003856|NCT02317016|12311205|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
5003857|NCT02317016|12311205|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
5003858|NCT02317016|12311205|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
5003859|NCT02317016|12311205|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
5003860|NCT02317016|12311205|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
5003861|NCT02317016|12311205|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
5003862|NCT02316847|12311233|P2|NOT COMPLETED|Overall Study||86
5003863|NCT02316847|12311234|P1|NOT COMPLETED|Overall Study||9
5003864|NCT02316847|12311233|P2|COMPLETED|Overall Study||13
5003865|NCT02316847|12311234|P1|COMPLETED|Overall Study||0
5003866|NCT02316847|12311233|P2|STARTED|Overall Study||99
5003867|NCT02316847|12311234|P1|STARTED|Overall Study||9
5003868|NCT02316769|12311245|P2|NOT COMPLETED|Overall Study||0
5003869|NCT02316769|12311246|P1|NOT COMPLETED|Overall Study||2
5003870|NCT02316769|12311245|P2|COMPLETED|Overall Study||33
5003871|NCT02316769|12311246|P1|COMPLETED|Overall Study||31
5003872|NCT02316769|12311245|P2|STARTED|Overall Study||33
5003873|NCT02316769|12311246|P1|STARTED|Overall Study||33
5003874|NCT02316717|12311257|P3|NOT COMPLETED|Overall Study||3
5003875|NCT02316717|12311258|P2|NOT COMPLETED|Overall Study||7
5003876|NCT02316717|12311259|P1|NOT COMPLETED|Overall Study||11
5003877|NCT02316717|12311257|P3|COMPLETED|Overall Study||41
5003878|NCT02316717|12311258|P2|COMPLETED|Overall Study||39
5003879|NCT02316717|12311259|P1|COMPLETED|Overall Study||32
5003880|NCT02316717|12311257|P3|STARTED|Overall Study||44
5003881|NCT02316717|12311258|P2|STARTED|Overall Study||46
5003882|NCT02316717|12311259|P1|STARTED|Overall Study||43
5003883|NCT02316678|12311389|P2|NOT COMPLETED|Overall Study||0
5003884|NCT02316678|12311390|P1|NOT COMPLETED|Overall Study||0
5003885|NCT02316678|12311389|P2|COMPLETED|Overall Study||7694
5003886|NCT02316678|12311390|P1|COMPLETED|Overall Study||1879
5003887|NCT02316678|12311389|P2|STARTED|Overall Study||7694
5003888|NCT02316678|12311390|P1|STARTED|Overall Study||1879
5003889|NCT02316613|12311396|P1|NOT COMPLETED|Overall Study||104
5003890|NCT02316613|12311396|P1|COMPLETED|Overall Study||156
5003891|NCT02316613|12311396|P1|Overall Population|Overall Study||241
5003892|NCT02316613|12311396|P1|Safety Population|Overall Study||255
5003893|NCT02316613|12311396|P1|STARTED|Overall Study||260
5003894|NCT02316548|12311435|P2|NOT COMPLETED|Overall Study||1
5003895|NCT02316548|12311436|P1|NOT COMPLETED|Overall Study||0
5003896|NCT02316548|12311435|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
5003897|NCT02316548|12311436|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
5003898|NCT02316548|12311435|P2|Eligible With Adverse Event Data|Overall Study||2
5003899|NCT02316548|12311436|P1|Eligible With Adverse Event Data|Overall Study||4
5003900|NCT02316548|12311435|P2|Eligible With Disease Assessment|Overall Study||1
5003901|NCT02316548|12311436|P1|Eligible With Disease Assessment|Overall Study||4
5003902|NCT02316548|12311435|P2|Eligible Population|Overall Study||6
5003903|NCT02316548|12311436|P1|Eligible Population|Overall Study||6
5003904|NCT02316548|12311435|P2|STARTED|Overall Study|Randomized|7
5003905|NCT02316548|12311436|P1|STARTED|Overall Study|Randomized|6
5003906|NCT02316470|12311450|P4|NOT COMPLETED|Overall Study||2
5003907|NCT02316470|12311451|P3|NOT COMPLETED|Overall Study||5
5003908|NCT02316470|12311452|P2|NOT COMPLETED|Overall Study||6
5003909|NCT02316470|12311453|P1|NOT COMPLETED|Overall Study||5
5003910|NCT02316470|12311450|P4|COMPLETED|Overall Study||46
5003911|NCT02316470|12311451|P3|COMPLETED|Overall Study||147
5003912|NCT02316470|12311452|P2|COMPLETED|Overall Study||146
5003913|NCT02316470|12311453|P1|COMPLETED|Overall Study||143
5003914|NCT02316470|12311450|P4|STARTED|Overall Study||48
5003915|NCT02316470|12311451|P3|STARTED|Overall Study||152
5003916|NCT02316470|12311452|P2|STARTED|Overall Study||152
5003917|NCT02316470|12311453|P1|STARTED|Overall Study||148
5003918|NCT02316366|12311549|P2|NOT COMPLETED|Overall Study||0
5003919|NCT02316366|12311550|P1|NOT COMPLETED|Overall Study||0
5003920|NCT02316366|12311549|P2|COMPLETED|Overall Study||40
5003921|NCT02316366|12311550|P1|COMPLETED|Overall Study||40
5003922|NCT02316366|12311549|P2|STARTED|Overall Study||40
5003923|NCT02316366|12311550|P1|STARTED|Overall Study||40
5003924|NCT02316353|12311566|P2|NOT COMPLETED|Overall Study||8
5003925|NCT02316353|12311567|P1|NOT COMPLETED|Overall Study||8
5003926|NCT02316353|12311566|P2|COMPLETED|Overall Study||55
5003927|NCT02316353|12311567|P1|COMPLETED|Overall Study||55
5003928|NCT02316353|12311566|P2|STARTED|Overall Study||63
5003929|NCT02316353|12311567|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
5003930|NCT02316171|12311587|P4|NOT COMPLETED|Overall Study||0
5003931|NCT02316171|12311588|P3|NOT COMPLETED|Overall Study||0
5003932|NCT02316171|12311589|P2|NOT COMPLETED|Overall Study||0
5003933|NCT02316171|12311590|P1|NOT COMPLETED|Overall Study||1
5003934|NCT02316171|12311587|P4|COMPLETED|Overall Study||3
5003935|NCT02316171|12311588|P3|COMPLETED|Overall Study||3
5003936|NCT02316171|12311589|P2|COMPLETED|Overall Study||6
5003937|NCT02316171|12311590|P1|COMPLETED|Overall Study||3
5003938|NCT02316171|12311587|P4|STARTED|Overall Study||3
5003939|NCT02316171|12311588|P3|STARTED|Overall Study||3
5003940|NCT02316171|12311589|P2|STARTED|Overall Study||6
5003941|NCT02316171|12311590|P1|STARTED|Overall Study||4
5003942|NCT02316002|12311596|P1|NOT COMPLETED|Overall Study||6
5003943|NCT02316002|12311596|P1|COMPLETED|Overall Study||45
5003944|NCT02316002|12311596|P1|STARTED|Overall Study||51
5003945|NCT02315989|12311600|P1|NOT COMPLETED|Overall Study||0
5003946|NCT02315989|12311600|P1|COMPLETED|Overall Study||6
5003947|NCT02315989|12311600|P1|STARTED|Overall Study||6
5003948|NCT02315872|12311610|P2|NOT COMPLETED|Overall Study||1
5003949|NCT02315872|12311611|P1|NOT COMPLETED|Overall Study||3
5003950|NCT02315872|12311610|P2|COMPLETED|Overall Study||3
5003951|NCT02315872|12311611|P1|COMPLETED|Overall Study||1
5003952|NCT02315872|12311610|P2|STARTED|Overall Study||4
5003953|NCT02315872|12311611|P1|STARTED|Overall Study||4
5003954|NCT02315755|12311623|P1|NOT COMPLETED|Overall Study||0
5003955|NCT02315755|12311623|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
5003956|NCT02315755|12311623|P1|STARTED|Overall Study||102
5003957|NCT02315664|12311654|P2|NOT COMPLETED|Overall Study||4
5003958|NCT02315664|12311655|P1|NOT COMPLETED|Overall Study||1
5003959|NCT02315664|12311654|P2|COMPLETED|Overall Study||27
5003960|NCT02315664|12311655|P1|COMPLETED|Overall Study||29
5003961|NCT02315664|12311654|P2|STARTED|Overall Study||31
5003962|NCT02315664|12311655|P1|STARTED|Overall Study||30
5003963|NCT02315560|12311675|P1|NOT COMPLETED|Overall Study||3
5003964|NCT02315560|12311675|P1|COMPLETED|Overall Study||22
5003965|NCT02315560|12311675|P1|STARTED|Overall Study||25
5003966|NCT02315430|12311680|P1|NOT COMPLETED|Overall Study||0
5003967|NCT02315430|12311680|P1|COMPLETED|Overall Study||13
5003968|NCT02315430|12311680|P1|STARTED|Overall Study||13
5003969|NCT02315352|12311690|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003970|NCT02315352|12311691|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003971|NCT02315352|12311692|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003972|NCT02315352|12311693|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003973|NCT02315352|12311694|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003974|NCT02315352|12311695|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003975|NCT02315352|12311696|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003976|NCT02315352|12311697|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
5003977|NCT02315352|12311690|P8|COMPLETED|Fifth Intervention (Day 2)||8
5003978|NCT02315352|12311691|P7|COMPLETED|Fifth Intervention (Day 2)||9
5003979|NCT02315352|12311692|P6|COMPLETED|Fifth Intervention (Day 2)||7
5003980|NCT02315352|12311693|P5|COMPLETED|Fifth Intervention (Day 2)||8
5003981|NCT02315352|12311694|P4|COMPLETED|Fifth Intervention (Day 2)||8
5003982|NCT02315352|12311695|P3|COMPLETED|Fifth Intervention (Day 2)||7
5003983|NCT02315352|12311696|P2|COMPLETED|Fifth Intervention (Day 2)||0
5003984|NCT02315352|12311697|P1|COMPLETED|Fifth Intervention (Day 2)||0
5003985|NCT02315352|12311690|P8|STARTED|Fifth Intervention (Day 2)||8
5003986|NCT02315352|12311691|P7|STARTED|Fifth Intervention (Day 2)||9
5003987|NCT02315352|12311692|P6|STARTED|Fifth Intervention (Day 2)||7
5003988|NCT02315352|12311693|P5|STARTED|Fifth Intervention (Day 2)||8
5003989|NCT02315352|12311694|P4|STARTED|Fifth Intervention (Day 2)||8
5003990|NCT02315352|12311695|P3|STARTED|Fifth Intervention (Day 2)||7
5003991|NCT02315352|12311696|P2|STARTED|Fifth Intervention (Day 2)||0
5003992|NCT02315352|12311697|P1|STARTED|Fifth Intervention (Day 2)||0
5003993|NCT02315352|12311690|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003994|NCT02315352|12311691|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003995|NCT02315352|12311692|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003996|NCT02315352|12311693|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003997|NCT02315352|12311694|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003998|NCT02315352|12311695|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
5003999|NCT02315352|12311696|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
5004000|NCT02315352|12311697|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
5004001|NCT02315352|12311690|P8|COMPLETED|Fourth Intervention (Day 2)||8
5004002|NCT02315352|12311691|P7|COMPLETED|Fourth Intervention (Day 2)||9
5004003|NCT02315352|12311692|P6|COMPLETED|Fourth Intervention (Day 2)||7
5004004|NCT02315352|12311693|P5|COMPLETED|Fourth Intervention (Day 2)||8
5004005|NCT02315352|12311694|P4|COMPLETED|Fourth Intervention (Day 2)||8
5004006|NCT02315352|12311695|P3|COMPLETED|Fourth Intervention (Day 2)||7
5004007|NCT02315352|12311696|P2|COMPLETED|Fourth Intervention (Day 2)||0
5004008|NCT02315352|12311697|P1|COMPLETED|Fourth Intervention (Day 2)||0
5004009|NCT02315352|12311690|P8|STARTED|Fourth Intervention (Day 2)||8
5004010|NCT02315352|12311691|P7|STARTED|Fourth Intervention (Day 2)||9
5004011|NCT02315352|12311692|P6|STARTED|Fourth Intervention (Day 2)||7
5004012|NCT02315352|12311693|P5|STARTED|Fourth Intervention (Day 2)||8
5004013|NCT02315352|12311694|P4|STARTED|Fourth Intervention (Day 2)||8
5004014|NCT02315352|12311695|P3|STARTED|Fourth Intervention (Day 2)||7
5004015|NCT02315352|12311696|P2|STARTED|Fourth Intervention (Day 2)||0
5004016|NCT02315352|12311697|P1|STARTED|Fourth Intervention (Day 2)||0
5004017|NCT02315352|12311690|P8|NOT COMPLETED|Third Intervention (Day 2)||0
5004018|NCT02315352|12311691|P7|NOT COMPLETED|Third Intervention (Day 2)||0
5004019|NCT02315352|12311692|P6|NOT COMPLETED|Third Intervention (Day 2)||0
5004020|NCT02315352|12311693|P5|NOT COMPLETED|Third Intervention (Day 2)||0
5004021|NCT02315352|12311694|P4|NOT COMPLETED|Third Intervention (Day 2)||0
5004022|NCT02315352|12311695|P3|NOT COMPLETED|Third Intervention (Day 2)||0
5004023|NCT02315352|12311696|P2|NOT COMPLETED|Third Intervention (Day 2)||0
5004024|NCT02315352|12311697|P1|NOT COMPLETED|Third Intervention (Day 2)||0
5004025|NCT02315352|12311690|P8|COMPLETED|Third Intervention (Day 2)||8
5004026|NCT02315352|12311691|P7|COMPLETED|Third Intervention (Day 2)||9
5004027|NCT02315352|12311692|P6|COMPLETED|Third Intervention (Day 2)||7
5004028|NCT02315352|12311693|P5|COMPLETED|Third Intervention (Day 2)||8
5004029|NCT02315352|12311694|P4|COMPLETED|Third Intervention (Day 2)||8
5004030|NCT02315352|12311695|P3|COMPLETED|Third Intervention (Day 2)||7
5004031|NCT02315352|12311696|P2|COMPLETED|Third Intervention (Day 2)||0
5004032|NCT02315352|12311697|P1|COMPLETED|Third Intervention (Day 2)||0
5004033|NCT02315352|12311690|P8|STARTED|Third Intervention (Day 2)||8
5004034|NCT02315352|12311691|P7|STARTED|Third Intervention (Day 2)||9
5004035|NCT02315352|12311692|P6|STARTED|Third Intervention (Day 2)||7
5004036|NCT02315352|12311693|P5|STARTED|Third Intervention (Day 2)||8
5004037|NCT02315352|12311694|P4|STARTED|Third Intervention (Day 2)||8
5004038|NCT02315352|12311695|P3|STARTED|Third Intervention (Day 2)||7
5004039|NCT02315352|12311696|P2|STARTED|Third Intervention (Day 2)||0
5004040|NCT02315352|12311697|P1|STARTED|Third Intervention (Day 2)||0
5004041|NCT02315352|12311690|P8|NOT COMPLETED|Second Intervention (Day 1)||0
5004042|NCT02315352|12311691|P7|NOT COMPLETED|Second Intervention (Day 1)||0
5004043|NCT02315352|12311692|P6|NOT COMPLETED|Second Intervention (Day 1)||0
5004044|NCT02315352|12311693|P5|NOT COMPLETED|Second Intervention (Day 1)||0
5004045|NCT02315352|12311694|P4|NOT COMPLETED|Second Intervention (Day 1)||0
5004046|NCT02315352|12311695|P3|NOT COMPLETED|Second Intervention (Day 1)||0
5004047|NCT02315352|12311696|P2|NOT COMPLETED|Second Intervention (Day 1)||0
5004048|NCT02315352|12311697|P1|NOT COMPLETED|Second Intervention (Day 1)||0
5004049|NCT02315352|12311690|P8|COMPLETED|Second Intervention (Day 1)||0
5004050|NCT02315352|12311691|P7|COMPLETED|Second Intervention (Day 1)||0
5004051|NCT02315352|12311692|P6|COMPLETED|Second Intervention (Day 1)||0
5004052|NCT02315352|12311693|P5|COMPLETED|Second Intervention (Day 1)||0
5004053|NCT02315352|12311694|P4|COMPLETED|Second Intervention (Day 1)||0
5004054|NCT02315352|12311695|P3|COMPLETED|Second Intervention (Day 1)||0
5004055|NCT02315352|12311696|P2|COMPLETED|Second Intervention (Day 1)||24
5004056|NCT02315352|12311697|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
5004057|NCT02315352|12311690|P8|STARTED|Second Intervention (Day 1)||0
5004058|NCT02315352|12311691|P7|STARTED|Second Intervention (Day 1)||0
5004059|NCT02315352|12311692|P6|STARTED|Second Intervention (Day 1)||0
5004060|NCT02315352|12311693|P5|STARTED|Second Intervention (Day 1)||0
5004061|NCT02315352|12311694|P4|STARTED|Second Intervention (Day 1)||0
5004062|NCT02315352|12311695|P3|STARTED|Second Intervention (Day 1)||0
5004063|NCT02315352|12311696|P2|STARTED|Second Intervention (Day 1)||24
5004064|NCT02315352|12311697|P1|STARTED|Second Intervention (Day 1)||24
5004065|NCT02315352|12311690|P8|NOT COMPLETED|First Intervention (Day 1)||0
5004066|NCT02315352|12311691|P7|NOT COMPLETED|First Intervention (Day 1)||0
5004067|NCT02315352|12311692|P6|NOT COMPLETED|First Intervention (Day 1)||0
5004068|NCT02315352|12311693|P5|NOT COMPLETED|First Intervention (Day 1)||0
5004069|NCT02315352|12311694|P4|NOT COMPLETED|First Intervention (Day 1)||0
5004070|NCT02315352|12311695|P3|NOT COMPLETED|First Intervention (Day 1)||0
5004071|NCT02315352|12311696|P2|NOT COMPLETED|First Intervention (Day 1)||0
5004072|NCT02315352|12311697|P1|NOT COMPLETED|First Intervention (Day 1)||0
5004073|NCT02315352|12311690|P8|COMPLETED|First Intervention (Day 1)||0
5004074|NCT02315352|12311691|P7|COMPLETED|First Intervention (Day 1)||0
5004075|NCT02315352|12311692|P6|COMPLETED|First Intervention (Day 1)||0
5004076|NCT02315352|12311693|P5|COMPLETED|First Intervention (Day 1)||0
5004077|NCT02315352|12311694|P4|COMPLETED|First Intervention (Day 1)||0
5004078|NCT02315352|12311695|P3|COMPLETED|First Intervention (Day 1)||0
5004079|NCT02315352|12311696|P2|COMPLETED|First Intervention (Day 1)||24
5004080|NCT02315352|12311697|P1|COMPLETED|First Intervention (Day 1)||24
5004081|NCT02315352|12311690|P8|STARTED|First Intervention (Day 1)||0
5004082|NCT02315352|12311691|P7|STARTED|First Intervention (Day 1)||0
5004083|NCT02315352|12311692|P6|STARTED|First Intervention (Day 1)||0
5004084|NCT02315352|12311693|P5|STARTED|First Intervention (Day 1)||0
5004085|NCT02315352|12311694|P4|STARTED|First Intervention (Day 1)||0
5004086|NCT02315352|12311695|P3|STARTED|First Intervention (Day 1)||0
5004087|NCT02315352|12311696|P2|STARTED|First Intervention (Day 1)||24
5004088|NCT02315352|12311697|P1|STARTED|First Intervention (Day 1)||24
5004089|NCT02315261|12311724|P1|NOT COMPLETED|Overall Study||0
5004090|NCT02315261|12311724|P1|COMPLETED|Overall Study||364
5004091|NCT02315261|12311724|P1|STARTED|Overall Study||364
5004092|NCT02314936|12311735|P4|NOT COMPLETED|Overall Study||0
5004093|NCT02314936|12311736|P3|NOT COMPLETED|Overall Study||2
5004094|NCT02314936|12311737|P2|NOT COMPLETED|Overall Study||0
5004095|NCT02314936|12311738|P1|NOT COMPLETED|Overall Study||0
5004096|NCT02314936|12311735|P4|COMPLETED|Overall Study||48
5004097|NCT02314936|12311736|P3|COMPLETED|Overall Study||46
5004098|NCT02314936|12311737|P2|COMPLETED|Overall Study||48
5004099|NCT02314936|12311738|P1|COMPLETED|Overall Study||48
5004100|NCT02314936|12311735|P4|STARTED|Overall Study||48
5004101|NCT02314936|12311736|P3|STARTED|Overall Study||48
5004102|NCT02314936|12311737|P2|STARTED|Overall Study||48
5004103|NCT02314936|12311738|P1|STARTED|Overall Study||48
5004104|NCT02314923|12311934|P10|NOT COMPLETED|Overall Study||0
5004105|NCT02314923|12311935|P9|NOT COMPLETED|Overall Study||2
5004106|NCT02314923|12311936|P8|NOT COMPLETED|Overall Study||5
5004107|NCT02314923|12311937|P7|NOT COMPLETED|Overall Study||5
5004108|NCT02314923|12311938|P6|NOT COMPLETED|Overall Study||1
5004109|NCT02314923|12311939|P5|NOT COMPLETED|Overall Study||1
5004110|NCT02314923|12311940|P4|NOT COMPLETED|Overall Study||1
5004111|NCT02314923|12311941|P3|NOT COMPLETED|Overall Study||2
5004112|NCT02314923|12311942|P2|NOT COMPLETED|Overall Study||4
5004113|NCT02314923|12311943|P1|NOT COMPLETED|Overall Study||3
5004114|NCT02314923|12311934|P10|COMPLETED|Overall Study||20
5004115|NCT02314923|12311935|P9|COMPLETED|Overall Study||46
5004116|NCT02314923|12311936|P8|COMPLETED|Overall Study||42
5004117|NCT02314923|12311937|P7|COMPLETED|Overall Study||43
5004118|NCT02314923|12311938|P6|COMPLETED|Overall Study||19
5004119|NCT02314923|12311939|P5|COMPLETED|Overall Study||73
5004120|NCT02314923|12311940|P4|COMPLETED|Overall Study||63
5004121|NCT02314923|12311941|P3|COMPLETED|Overall Study||62
5004122|NCT02314923|12311942|P2|COMPLETED|Overall Study||60
5004123|NCT02314923|12311943|P1|COMPLETED|Overall Study||61
5004124|NCT02314923|12311934|P10|Treated|Overall Study||20
5004125|NCT02314923|12311935|P9|Treated|Overall Study||48
5004126|NCT02314923|12311936|P8|Treated|Overall Study||47
5004127|NCT02314923|12311937|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
5004128|NCT02314923|12311938|P6|Treated|Overall Study||20
5004129|NCT02314923|12311939|P5|Treated|Overall Study||74
5004130|NCT02314923|12311940|P4|Treated|Overall Study||64
5004131|NCT02314923|12311941|P3|Treated|Overall Study||64
5004132|NCT02314923|12311942|P2|Treated|Overall Study||64
5004133|NCT02314923|12311943|P1|Treated|Overall Study||64
5004134|NCT02314923|12311934|P10|STARTED|Overall Study||20
5004135|NCT02314923|12311935|P9|STARTED|Overall Study||48
5004136|NCT02314923|12311936|P8|STARTED|Overall Study||47
5004137|NCT02314923|12311937|P7|STARTED|Overall Study||48
5004138|NCT02314923|12311938|P6|STARTED|Overall Study||20
5004139|NCT02314923|12311939|P5|STARTED|Overall Study||74
5004140|NCT02314923|12311940|P4|STARTED|Overall Study||64
5004141|NCT02314923|12311941|P3|STARTED|Overall Study||64
5004142|NCT02314923|12311942|P2|STARTED|Overall Study||64
5004143|NCT02314923|12311943|P1|STARTED|Overall Study||64
5004144|NCT02314689|12312036|P1|NOT COMPLETED|Overall Study||0
5004145|NCT02314689|12312036|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
5004146|NCT02314689|12312036|P1|STARTED|Overall Study||4
5004147|NCT02314637|12312042|P2|NOT COMPLETED|Overall Study||14
5004148|NCT02314637|12312043|P1|NOT COMPLETED|Overall Study||16
5004149|NCT02314637|12312042|P2|COMPLETED|Overall Study||75
5004150|NCT02314637|12312043|P1|COMPLETED|Overall Study||135
5004151|NCT02314637|12312042|P2|STARTED|Overall Study||89
5004152|NCT02314637|12312043|P1|STARTED|Overall Study||151
5004153|NCT02314598|12312053|P1|NOT COMPLETED|Overall Study||0
5004154|NCT02314598|12312053|P1|COMPLETED|Overall Study||46
5004155|NCT02314598|12312053|P1|STARTED|Overall Study||46
5004156|NCT02314546|12312062|P3|NOT COMPLETED|Overall Study||0
5004157|NCT02314546|12312063|P2|NOT COMPLETED|Overall Study||0
5004158|NCT02314546|12312064|P1|NOT COMPLETED|Overall Study||0
5004159|NCT02314546|12312062|P3|COMPLETED|Overall Study||5
5004160|NCT02314546|12312063|P2|COMPLETED|Overall Study||5
5004161|NCT02314546|12312064|P1|COMPLETED|Overall Study||5
5004162|NCT02314546|12312062|P3|STARTED|Overall Study||5
5004163|NCT02314546|12312063|P2|STARTED|Overall Study||5
5004164|NCT02314546|12312064|P1|STARTED|Overall Study||5
5004165|NCT02314520|12312092|P2|NOT COMPLETED|Overall Study||0
5004166|NCT02314520|12312093|P1|NOT COMPLETED|Overall Study||0
5004167|NCT02314520|12312092|P2|COMPLETED|Overall Study||80
5004168|NCT02314520|12312093|P1|COMPLETED|Overall Study||72
5004169|NCT02314520|12312092|P2|STARTED|Overall Study||80
5004170|NCT02314520|12312093|P1|STARTED|Overall Study||72
5004171|NCT02314260|12312105|P1|NOT COMPLETED|Overall Study||0
5004172|NCT02314260|12312105|P1|COMPLETED|Overall Study||80
5004173|NCT02314260|12312105|P1|STARTED|Overall Study||80
5004174|NCT02314247|12312114|P3|NOT COMPLETED|Overall Study||1
5004175|NCT02314247|12312115|P2|NOT COMPLETED|Overall Study||6
5004176|NCT02314247|12312116|P1|NOT COMPLETED|Overall Study||9
5004177|NCT02314247|12312114|P3|COMPLETED|Overall Study||0
5004178|NCT02314247|12312115|P2|COMPLETED|Overall Study||0
5004179|NCT02314247|12312116|P1|COMPLETED|Overall Study||0
5004180|NCT02314247|12312114|P3|STARTED|Overall Study||1
5004181|NCT02314247|12312115|P2|STARTED|Overall Study||6
5004182|NCT02314247|12312116|P1|STARTED|Overall Study||9
5004183|NCT02314143|12312141|P3|NOT COMPLETED|Overall Study||9
5004184|NCT02314143|12312142|P2|NOT COMPLETED|Overall Study||10
5004185|NCT02314143|12312143|P1|NOT COMPLETED|Overall Study||8
5004186|NCT02314143|12312141|P3|COMPLETED|Overall Study||7
5004187|NCT02314143|12312142|P2|COMPLETED|Overall Study||6
5004188|NCT02314143|12312143|P1|COMPLETED|Overall Study||8
5004189|NCT02314143|12312141|P3|STARTED|Overall Study||16
5004190|NCT02314143|12312142|P2|STARTED|Overall Study||16
5004191|NCT02314143|12312143|P1|STARTED|Overall Study||16
5004192|NCT02314117|12312189|P2|NOT COMPLETED|Overall Study||38
5004193|NCT02314117|12312190|P1|NOT COMPLETED|Overall Study||41
5004194|NCT02314117|12312189|P2|COMPLETED|Overall Study||281
5004195|NCT02314117|12312190|P1|COMPLETED|Overall Study||285
5004196|NCT02314117|12312189|P2|Alive But Off Treatment|Overall Study||50
5004197|NCT02314117|12312190|P1|Alive But Off Treatment|Overall Study||46
5004198|NCT02314117|12312189|P2|Death|Overall Study||231
5004199|NCT02314117|12312190|P1|Death|Overall Study||239
5004200|NCT02314117|12312189|P2|Received at Least One Dose of Study Drug|Overall Study||315
5004201|NCT02314117|12312190|P1|Received at Least One Dose of Study Drug|Overall Study||323
5004202|NCT02314117|12312189|P2|STARTED|Overall Study||319
5004203|NCT02314117|12312190|P1|STARTED|Overall Study||326
5004204|NCT02314104|12312221|P3|NOT COMPLETED|Overall Study||18
5004205|NCT02314104|12312222|P2|NOT COMPLETED|Overall Study||20
5004206|NCT02314104|12312223|P1|NOT COMPLETED|Overall Study||14
5004207|NCT02314104|12312221|P3|COMPLETED|Overall Study||53
5004208|NCT02314104|12312222|P2|COMPLETED|Overall Study||58
5004209|NCT02314104|12312223|P1|COMPLETED|Overall Study||57
5004210|NCT02314104|12312221|P3|STARTED|Overall Study||71
5004211|NCT02314104|12312222|P2|STARTED|Overall Study||78
5004212|NCT02314104|12312223|P1|STARTED|Overall Study||71
5004213|NCT02314052|12312243|P6|NOT COMPLETED|Cycles 6 -10.5||0
5004214|NCT02314052|12312244|P5|NOT COMPLETED|Cycles 6 -10.5||0
5004215|NCT02314052|12312245|P4|NOT COMPLETED|Cycles 6 -10.5||0
5004216|NCT02314052|12312246|P3|NOT COMPLETED|Cycles 6 -10.5||0
5004217|NCT02314052|12312247|P2|NOT COMPLETED|Cycles 6 -10.5||0
5004218|NCT02314052|12312248|P1|NOT COMPLETED|Cycles 6 -10.5||0
5004219|NCT02314052|12312243|P6|COMPLETED|Cycles 6 -10.5||0
5004220|NCT02314052|12312244|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
5004221|NCT02314052|12312245|P4|COMPLETED|Cycles 6 -10.5||1
5004222|NCT02314052|12312246|P3|COMPLETED|Cycles 6 -10.5||0
5004223|NCT02314052|12312247|P2|COMPLETED|Cycles 6 -10.5||0
5004224|NCT02314052|12312248|P1|COMPLETED|Cycles 6 -10.5||0
5004225|NCT02314052|12312243|P6|STARTED|Cycles 6 -10.5||0
5004226|NCT02314052|12312244|P5|STARTED|Cycles 6 -10.5||2
5004227|NCT02314052|12312245|P4|STARTED|Cycles 6 -10.5||1
5004228|NCT02314052|12312246|P3|STARTED|Cycles 6 -10.5||0
5004229|NCT02314052|12312247|P2|STARTED|Cycles 6 -10.5||0
5004230|NCT02314052|12312248|P1|STARTED|Cycles 6 -10.5||0
5004231|NCT02314052|12312243|P6|NOT COMPLETED|Cycle Five||0
5004232|NCT02314052|12312244|P5|NOT COMPLETED|Cycle Five||0
5004233|NCT02314052|12312245|P4|NOT COMPLETED|Cycle Five||0
5004234|NCT02314052|12312246|P3|NOT COMPLETED|Cycle Five||1
5004235|NCT02314052|12312247|P2|NOT COMPLETED|Cycle Five||2
5004236|NCT02314052|12312248|P1|NOT COMPLETED|Cycle Five||0
5004237|NCT02314052|12312243|P6|COMPLETED|Cycle Five||0
5004238|NCT02314052|12312244|P5|COMPLETED|Cycle Five||2
5004239|NCT02314052|12312245|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
5004240|NCT02314052|12312246|P3|COMPLETED|Cycle Five||0
5004241|NCT02314052|12312247|P2|COMPLETED|Cycle Five||0
5004242|NCT02314052|12312248|P1|COMPLETED|Cycle Five||0
5004243|NCT02314052|12312243|P6|STARTED|Cycle Five||0
5004244|NCT02314052|12312244|P5|STARTED|Cycle Five||2
5004245|NCT02314052|12312245|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
5004246|NCT02314052|12312246|P3|STARTED|Cycle Five||1
5004247|NCT02314052|12312247|P2|STARTED|Cycle Five||2
5004248|NCT02314052|12312248|P1|STARTED|Cycle Five||0
5004249|NCT02314052|12312243|P6|NOT COMPLETED|Cycle Four||3
5004250|NCT02314052|12312244|P5|NOT COMPLETED|Cycle Four||0
5004251|NCT02314052|12312245|P4|NOT COMPLETED|Cycle Four||1
5004252|NCT02314052|12312246|P3|NOT COMPLETED|Cycle Four||1
5004253|NCT02314052|12312247|P2|NOT COMPLETED|Cycle Four||0
5004254|NCT02314052|12312248|P1|NOT COMPLETED|Cycle Four||3
5004255|NCT02314052|12312243|P6|COMPLETED|Cycle Four||0
5004256|NCT02314052|12312244|P5|COMPLETED|Cycle Four||2
5004257|NCT02314052|12312245|P4|COMPLETED|Cycle Four||0
5004258|NCT02314052|12312246|P3|COMPLETED|Cycle Four||1
5004259|NCT02314052|12312247|P2|COMPLETED|Cycle Four||2
5004260|NCT02314052|12312248|P1|COMPLETED|Cycle Four||0
5004261|NCT02314052|12312243|P6|STARTED|Cycle Four||3
5004262|NCT02314052|12312244|P5|STARTED|Cycle Four||2
5004263|NCT02314052|12312245|P4|STARTED|Cycle Four||1
5004264|NCT02314052|12312246|P3|STARTED|Cycle Four||2
5004265|NCT02314052|12312247|P2|STARTED|Cycle Four||2
5004266|NCT02314052|12312248|P1|STARTED|Cycle Four||3
5004267|NCT02314052|12312243|P6|NOT COMPLETED|Cycle Three||0
5004268|NCT02314052|12312244|P5|NOT COMPLETED|Cycle Three||0
5004269|NCT02314052|12312245|P4|NOT COMPLETED|Cycle Three||0
5004270|NCT02314052|12312246|P3|NOT COMPLETED|Cycle Three||0
5004271|NCT02314052|12312247|P2|NOT COMPLETED|Cycle Three||0
5004272|NCT02314052|12312248|P1|NOT COMPLETED|Cycle Three||0
5004273|NCT02314052|12312243|P6|COMPLETED|Cycle Three||3
5004274|NCT02314052|12312244|P5|COMPLETED|Cycle Three||2
5004275|NCT02314052|12312245|P4|COMPLETED|Cycle Three||1
5004276|NCT02314052|12312246|P3|COMPLETED|Cycle Three||2
5004277|NCT02314052|12312247|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
5004278|NCT02314052|12312248|P1|COMPLETED|Cycle Three||3
5004279|NCT02314052|12312243|P6|STARTED|Cycle Three||3
5004280|NCT02314052|12312244|P5|STARTED|Cycle Three||2
5004281|NCT02314052|12312245|P4|STARTED|Cycle Three||1
5004282|NCT02314052|12312246|P3|STARTED|Cycle Three||2
5004283|NCT02314052|12312247|P2|STARTED|Cycle Three||2
5004284|NCT02314052|12312248|P1|STARTED|Cycle Three||3
5004285|NCT02314052|12312243|P6|NOT COMPLETED|Cycle Two||0
5004286|NCT02314052|12312244|P5|NOT COMPLETED|Cycle Two||4
5004287|NCT02314052|12312245|P4|NOT COMPLETED|Cycle Two||1
5004288|NCT02314052|12312246|P3|NOT COMPLETED|Cycle Two||1
5004289|NCT02314052|12312247|P2|NOT COMPLETED|Cycle Two||1
5004290|NCT02314052|12312248|P1|NOT COMPLETED|Cycle Two||0
5004291|NCT02314052|12312243|P6|COMPLETED|Cycle Two||3
5004292|NCT02314052|12312244|P5|COMPLETED|Cycle Two||2
5004293|NCT02314052|12312245|P4|COMPLETED|Cycle Two||1
5004294|NCT02314052|12312246|P3|COMPLETED|Cycle Two||2
5004295|NCT02314052|12312247|P2|COMPLETED|Cycle Two||2
5004296|NCT02314052|12312248|P1|COMPLETED|Cycle Two||3
5004297|NCT02314052|12312243|P6|STARTED|Cycle Two||3
5004298|NCT02314052|12312244|P5|STARTED|Cycle Two||6
5004299|NCT02314052|12312245|P4|STARTED|Cycle Two||2
5004300|NCT02314052|12312246|P3|STARTED|Cycle Two||3
5004301|NCT02314052|12312247|P2|STARTED|Cycle Two||3
5004302|NCT02314052|12312248|P1|STARTED|Cycle Two||3
5004303|NCT02314052|12312243|P6|NOT COMPLETED|Cycle One||0
5004304|NCT02314052|12312244|P5|NOT COMPLETED|Cycle One||0
5004305|NCT02314052|12312245|P4|NOT COMPLETED|Cycle One||1
5004306|NCT02314052|12312246|P3|NOT COMPLETED|Cycle One||0
5004307|NCT02314052|12312247|P2|NOT COMPLETED|Cycle One||0
5004308|NCT02314052|12312248|P1|NOT COMPLETED|Cycle One||0
5004309|NCT02314052|12312243|P6|COMPLETED|Cycle One||3
5004310|NCT02314052|12312244|P5|COMPLETED|Cycle One||6
5004311|NCT02314052|12312245|P4|COMPLETED|Cycle One||2
5004312|NCT02314052|12312246|P3|COMPLETED|Cycle One||3
5004313|NCT02314052|12312247|P2|COMPLETED|Cycle One||3
5004314|NCT02314052|12312248|P1|COMPLETED|Cycle One||3
5004315|NCT02314052|12312243|P6|STARTED|Cycle One||3
5004316|NCT02314052|12312244|P5|STARTED|Cycle One||6
5004317|NCT02314052|12312245|P4|STARTED|Cycle One||3
5004318|NCT02314052|12312246|P3|STARTED|Cycle One||3
5004319|NCT02314052|12312247|P2|STARTED|Cycle One||3
5004320|NCT02314052|12312248|P1|STARTED|Cycle One||3
5004321|NCT02314026|12312316|P1|NOT COMPLETED|Overall Study||28
5004322|NCT02314026|12312316|P1|COMPLETED|Overall Study||107
5004323|NCT02314026|12312316|P1|STARTED|Overall Study||135
5004324|NCT02314000|12312324|P2|NOT COMPLETED|Overall Study||8
5004325|NCT02314000|12312325|P1|NOT COMPLETED|Overall Study||13
5004326|NCT02314000|12312324|P2|COMPLETED|Overall Study||57
5004327|NCT02314000|12312325|P1|COMPLETED|Overall Study||62
5004328|NCT02314000|12312324|P2|STARTED|Overall Study||65
5004329|NCT02314000|12312325|P1|STARTED|Overall Study||75
5004330|NCT02313909|12312334|P2|NOT COMPLETED|Overall Study||50
5004331|NCT02313909|12312335|P1|NOT COMPLETED|Overall Study||57
5004332|NCT02313909|12312334|P2|COMPLETED|Overall Study||3554
5004333|NCT02313909|12312335|P1|COMPLETED|Overall Study||3552
5004334|NCT02313909|12312334|P2|Treated|Overall Study||3559
5004335|NCT02313909|12312335|P1|Treated|Overall Study||3562
5004336|NCT02313909|12312334|P2|STARTED|Overall Study||3604
5004337|NCT02313909|12312335|P1|STARTED|Overall Study||3609
5004338|NCT02313766|12312358|P3|NOT COMPLETED|Overall Study||0
5004339|NCT02313766|12312359|P2|NOT COMPLETED|Overall Study||3
5004340|NCT02313766|12312360|P1|NOT COMPLETED|Overall Study||1
5004341|NCT02313766|12312358|P3|COMPLETED|Overall Study||50
5004342|NCT02313766|12312359|P2|COMPLETED|Overall Study||47
5004343|NCT02313766|12312360|P1|COMPLETED|Overall Study||49
5004344|NCT02313766|12312358|P3|STARTED|Overall Study||50
5004345|NCT02313766|12312359|P2|STARTED|Overall Study||50
5004346|NCT02313766|12312360|P1|STARTED|Overall Study||50
5004347|NCT02313675|12312378|P4|NOT COMPLETED|Overall Study||0
5004348|NCT02313675|12312379|P3|NOT COMPLETED|Overall Study||0
5004349|NCT02313675|12312380|P2|NOT COMPLETED|Overall Study||0
5004350|NCT02313675|12312381|P1|NOT COMPLETED|Overall Study||0
5004351|NCT02313675|12312378|P4|COMPLETED|Overall Study||11
5004352|NCT02313675|12312379|P3|COMPLETED|Overall Study||11
5004353|NCT02313675|12312380|P2|COMPLETED|Overall Study||11
5004354|NCT02313675|12312381|P1|COMPLETED|Overall Study||11
5004355|NCT02313675|12312378|P4|STARTED|Overall Study||11
5004356|NCT02313675|12312379|P3|STARTED|Overall Study||11
5004357|NCT02313675|12312380|P2|STARTED|Overall Study||11
5004358|NCT02313675|12312381|P1|STARTED|Overall Study||11
5004359|NCT02313558|12312397|P2|NOT COMPLETED|Overall Study||4
5004360|NCT02313558|12312398|P1|NOT COMPLETED|Overall Study||6
5004361|NCT02313558|12312397|P2|COMPLETED|Overall Study||46
5004362|NCT02313558|12312398|P1|COMPLETED|Overall Study||44
5004363|NCT02313558|12312397|P2|STARTED|Overall Study||50
5004364|NCT02313558|12312398|P1|STARTED|Overall Study||50
5004365|NCT02313506|12312412|P2|NOT COMPLETED|Overall Study||0
5004366|NCT02313506|12312413|P1|NOT COMPLETED|Overall Study||0
5004367|NCT02313506|12312412|P2|COMPLETED|Overall Study||17
5004368|NCT02313506|12312413|P1|COMPLETED|Overall Study||17
5004369|NCT02313506|12312412|P2|STARTED|Overall Study||17
5004370|NCT02313506|12312413|P1|STARTED|Overall Study||17
5004371|NCT02313454|12312433|P2|NOT COMPLETED|Treatment 2||0
5004372|NCT02313454|12312434|P1|NOT COMPLETED|Treatment 2||0
5004373|NCT02313454|12312433|P2|COMPLETED|Treatment 2||10
5004374|NCT02313454|12312434|P1|COMPLETED|Treatment 2||8
5004375|NCT02313454|12312433|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
5004376|NCT02313454|12312434|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
5004377|NCT02313454|12312433|P2|NOT COMPLETED|Treatment 1||0
5004378|NCT02313454|12312434|P1|NOT COMPLETED|Treatment 1||0
5004379|NCT02313454|12312433|P2|COMPLETED|Treatment 1||11
5004380|NCT02313454|12312434|P1|COMPLETED|Treatment 1||9
5004381|NCT02313454|12312433|P2|STARTED|Treatment 1||11
5004382|NCT02313454|12312434|P1|STARTED|Treatment 1||9
5004383|NCT02313233|12312444|P2|NOT COMPLETED|Overall Study||3
5004384|NCT02313233|12312445|P1|NOT COMPLETED|Overall Study||2
5004385|NCT02313233|12312444|P2|COMPLETED|Overall Study||18
5004386|NCT02313233|12312445|P1|COMPLETED|Overall Study||18
5004387|NCT02313233|12312444|P2|STARTED|Overall Study||21
5004388|NCT02313233|12312445|P1|STARTED|Overall Study||20
5004389|NCT02313155|12312467|P2|NOT COMPLETED|Overall Study||1
5004390|NCT02313155|12312468|P1|NOT COMPLETED|Overall Study||0
5004391|NCT02313155|12312467|P2|COMPLETED|Overall Study||54
5004392|NCT02313155|12312468|P1|COMPLETED|Overall Study||55
5004393|NCT02313155|12312467|P2|STARTED|Overall Study||55
5004394|NCT02313155|12312468|P1|STARTED|Overall Study||55
5004395|NCT02312934|12312518|P2|NOT COMPLETED|Overall Study||0
5004396|NCT02312934|12312519|P1|NOT COMPLETED|Overall Study||2
5004397|NCT02312934|12312518|P2|COMPLETED|Overall Study||11
5004398|NCT02312934|12312519|P1|COMPLETED|Overall Study||9
5004399|NCT02312934|12312518|P2|STARTED|Overall Study||11
5004400|NCT02312934|12312519|P1|STARTED|Overall Study||11
5004401|NCT02312882|12312527|P1|NOT COMPLETED|Overall Study||4
5004402|NCT02312882|12312527|P1|COMPLETED|Overall Study||36
5004403|NCT02312882|12312527|P1|STARTED|Overall Study||40
5004404|NCT02312856|12312531|P1|NOT COMPLETED|Overall Study||4
5004405|NCT02312856|12312531|P1|COMPLETED|Overall Study||30
5004406|NCT02312856|12312531|P1|STARTED|Overall Study||34
5004407|NCT02312739|12312537|P2|NOT COMPLETED|Overall Study||2
5004408|NCT02312739|12312538|P1|NOT COMPLETED|Overall Study||6
5004409|NCT02312739|12312537|P2|COMPLETED|Overall Study||34
5004410|NCT02312739|12312538|P1|COMPLETED|Overall Study||30
5004411|NCT02312739|12312537|P2|Withdrawn Prior to Procedure|Overall Study||2
5004412|NCT02312739|12312538|P1|Withdrawn Prior to Procedure|Overall Study||6
5004413|NCT02312739|12312537|P2|STARTED|Overall Study||36
5004414|NCT02312739|12312538|P1|STARTED|Overall Study||36
5004415|NCT02312726|12312552|P3|NOT COMPLETED|Overall Study||67
5004416|NCT02312726|12312553|P2|NOT COMPLETED|Overall Study||0
5004417|NCT02312726|12312554|P1|NOT COMPLETED|Overall Study||0
5004418|NCT02312726|12312552|P3|COMPLETED|Overall Study||0
5004419|NCT02312726|12312553|P2|COMPLETED|Overall Study||30
5004420|NCT02312726|12312554|P1|COMPLETED|Overall Study||38
5004421|NCT02312726|12312552|P3|STARTED|Overall Study||67
5004422|NCT02312726|12312553|P2|STARTED|Overall Study||30
5004423|NCT02312726|12312554|P1|STARTED|Overall Study||38
5004424|NCT02312713|12312569|P3|NOT COMPLETED|Overall Study||5
5004425|NCT02312713|12312570|P2|NOT COMPLETED|Overall Study||30
5004426|NCT02312713|12312571|P1|NOT COMPLETED|Overall Study||11
5004427|NCT02312713|12312569|P3|COMPLETED|Overall Study||63
5004428|NCT02312713|12312570|P2|COMPLETED|Overall Study||112
5004429|NCT02312713|12312571|P1|COMPLETED|Overall Study||129
5004430|NCT02312713|12312569|P3|STARTED|Overall Study||68
5004431|NCT02312713|12312570|P2|STARTED|Overall Study||142
5004432|NCT02312713|12312571|P1|STARTED|Overall Study||140
5004433|NCT02312687|12312615|P1|NOT COMPLETED|Overall Study||1
5004434|NCT02312687|12312615|P1|COMPLETED|Overall Study||19
5004435|NCT02312687|12312615|P1|STARTED|Overall Study||20
5004436|NCT02312622|12312646|P3|NOT COMPLETED|Overall Study||0
5004437|NCT02312622|12312647|P2|NOT COMPLETED|Overall Study||0
5004438|NCT02312622|12312648|P1|NOT COMPLETED|Overall Study||0
5004439|NCT02312622|12312646|P3|COMPLETED|Overall Study||12
5004440|NCT02312622|12312647|P2|COMPLETED|Overall Study||3
5004441|NCT02312622|12312648|P1|COMPLETED|Overall Study||12
5004442|NCT02312622|12312646|P3|STARTED|Overall Study||12
5004443|NCT02312622|12312647|P2|STARTED|Overall Study||3
5004444|NCT02312622|12312648|P1|STARTED|Overall Study||12
5004445|NCT02312310|12312676|P4|NOT COMPLETED|Overall Study||0
5004446|NCT02312310|12312677|P3|NOT COMPLETED|Overall Study||3
5004447|NCT02312310|12312678|P2|NOT COMPLETED|Overall Study||2
5004448|NCT02312310|12312679|P1|NOT COMPLETED|Overall Study||2
5004449|NCT02312310|12312676|P4|COMPLETED|Overall Study||52
5004450|NCT02312310|12312677|P3|COMPLETED|Overall Study||50
5004451|NCT02312310|12312678|P2|COMPLETED|Overall Study||51
5004452|NCT02312310|12312679|P1|COMPLETED|Overall Study||51
5004453|NCT02312310|12312676|P4|STARTED|Overall Study||52
5004454|NCT02312310|12312677|P3|STARTED|Overall Study||53
5004455|NCT02312310|12312678|P2|STARTED|Overall Study||53
5004456|NCT02312310|12312679|P1|STARTED|Overall Study||53
5004457|NCT02312219|12312707|P2|NOT COMPLETED|Overall Study||6
5004458|NCT02312219|12312708|P1|NOT COMPLETED|Overall Study||1
5004459|NCT02312219|12312707|P2|COMPLETED|Overall Study||16
5004460|NCT02312219|12312708|P1|COMPLETED|Overall Study||12
5004461|NCT02312219|12312707|P2|STARTED|Overall Study||22
5004462|NCT02312219|12312708|P1|STARTED|Overall Study||13
5004463|NCT02312206|12312718|P2|NOT COMPLETED|Overall Study||130
5004464|NCT02312206|12312719|P1|NOT COMPLETED|Overall Study||130
5004465|NCT02312206|12312718|P2|COMPLETED|Overall Study||0
5004466|NCT02312206|12312719|P1|COMPLETED|Overall Study||0
5004467|NCT02312206|12312718|P2|Informed Consent Obtained|Overall Study||130
5004468|NCT02312206|12312719|P1|Informed Consent Obtained|Overall Study||130
5004469|NCT02312206|12312718|P2|STARTED|Overall Study||130
5004470|NCT02312206|12312719|P1|STARTED|Overall Study||130
5004471|NCT02312154|12312725|P1|NOT COMPLETED|Overall Study||1
5004472|NCT02312154|12312725|P1|COMPLETED|Overall Study||24
5004473|NCT02312154|12312725|P1|STARTED|Overall Study||25
5004474|NCT02312063|12312742|P2|NOT COMPLETED|Overall Study||1
5004475|NCT02312063|12312743|P1|NOT COMPLETED|Overall Study||0
5004476|NCT02312063|12312742|P2|COMPLETED|Overall Study||24
5004477|NCT02312063|12312743|P1|COMPLETED|Overall Study||23
5004478|NCT02312063|12312742|P2|STARTED|Overall Study||25
5004479|NCT02312063|12312743|P1|STARTED|Overall Study||23
5004480|NCT02311972|12312753|P2|NOT COMPLETED|Overall Study||0
5004481|NCT02311972|12312754|P1|NOT COMPLETED|Overall Study||0
5004482|NCT02311972|12312753|P2|COMPLETED|Overall Study||8
5004483|NCT02311972|12312754|P1|COMPLETED|Overall Study||12
5004484|NCT02311972|12312753|P2|STARTED|Overall Study||8
5004485|NCT02311972|12312754|P1|STARTED|Overall Study||12
5004486|NCT02311907|12312773|P2|NOT COMPLETED|Overall Study||0
5004487|NCT02311907|12312774|P1|NOT COMPLETED|Overall Study||0
5004488|NCT02311907|12312773|P2|COMPLETED|Overall Study||91
5004489|NCT02311907|12312774|P1|COMPLETED|Overall Study||94
5004490|NCT02311907|12312773|P2|STARTED|Overall Study||91
5004491|NCT02311907|12312774|P1|STARTED|Overall Study||94
5004492|NCT02311894|12312796|P1|NOT COMPLETED|Overall Study||4
5004493|NCT02311894|12312796|P1|COMPLETED|Overall Study||78
5004494|NCT02311894|12312796|P1|Modified ITT Population|Overall Study||81
5004495|NCT02311894|12312796|P1|STARTED|Overall Study||82
5004496|NCT02311881|12312808|P3|NOT COMPLETED|Overall Study||41
5004497|NCT02311881|12312809|P2|NOT COMPLETED|Overall Study||43
5004498|NCT02311881|12312810|P1|NOT COMPLETED|Overall Study||35
5004499|NCT02311881|12312808|P3|COMPLETED|Overall Study||196
5004500|NCT02311881|12312809|P2|COMPLETED|Overall Study||193
5004501|NCT02311881|12312810|P1|COMPLETED|Overall Study||200
5004502|NCT02311881|12312808|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
5004503|NCT02311881|12312809|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
5004504|NCT02311881|12312810|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
5004505|NCT02311881|12312808|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
5004506|NCT02311881|12312809|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
5004507|NCT02311881|12312810|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
5004508|NCT02311478|12312845|P1|NOT COMPLETED|Overall Study||7
5004509|NCT02311478|12312845|P1|COMPLETED|Overall Study||72
5004510|NCT02311478|12312845|P1|IUD Insertion|Overall Study||78
5004511|NCT02311478|12312845|P1|STARTED|Overall Study||79
5004512|NCT02311361|12312854|P4|NOT COMPLETED|Overall Study||1
5004513|NCT02311361|12312855|P3|NOT COMPLETED|Overall Study||0
5004514|NCT02311361|12312856|P2|NOT COMPLETED|Overall Study||1
5004515|NCT02311361|12312857|P1|NOT COMPLETED|Overall Study||0
5004516|NCT02311361|12312854|P4|COMPLETED|Overall Study||20
5004517|NCT02311361|12312855|P3|COMPLETED|Overall Study||19
5004518|NCT02311361|12312856|P2|COMPLETED|Overall Study||10
5004519|NCT02311361|12312857|P1|COMPLETED|Overall Study||14
5004520|NCT02311361|12312854|P4|Received Radiation Therapy Only|Overall Study||1
5004521|NCT02311361|12312855|P3|Received Radiation Therapy Only|Overall Study||1
5004522|NCT02311361|12312856|P2|Received Radiation Therapy Only|Overall Study||1
5004523|NCT02311361|12312857|P1|Received Radiation Therapy Only|Overall Study||0
5004524|NCT02311361|12312854|P4|STARTED|Overall Study||21
5004525|NCT02311361|12312855|P3|STARTED|Overall Study||19
5004526|NCT02311361|12312856|P2|STARTED|Overall Study||11
5004527|NCT02311361|12312857|P1|STARTED|Overall Study||14
5004528|NCT02311309|12312894|P3|NOT COMPLETED|Overall Study||0
5004529|NCT02311309|12312895|P2|NOT COMPLETED|Overall Study||0
5004530|NCT02311309|12312896|P1|NOT COMPLETED|Overall Study||0
5004531|NCT02311309|12312894|P3|COMPLETED|Overall Study||863
5004532|NCT02311309|12312895|P2|COMPLETED|Overall Study||35
5004533|NCT02311309|12312896|P1|COMPLETED|Overall Study||541
5004534|NCT02311309|12312894|P3|STARTED|Overall Study||863
5004535|NCT02311309|12312895|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
5004536|NCT02311309|12312896|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
5004537|NCT02311153|12312909|P2|NOT COMPLETED|Overall Study||7
5004538|NCT02311153|12312910|P1|NOT COMPLETED|Overall Study||5
5004539|NCT02311153|12312909|P2|COMPLETED|Overall Study||42
5004540|NCT02311153|12312910|P1|COMPLETED|Overall Study||48
5004541|NCT02311153|12312909|P2|STARTED|Overall Study||49
5004542|NCT02311153|12312910|P1|STARTED|Overall Study||53
5004543|NCT02310789|12312926|P1|NOT COMPLETED|Overall Study||1
5004544|NCT02310789|12312926|P1|COMPLETED|Overall Study||7
5004545|NCT02310789|12312926|P1|STARTED|Overall Study||8
5004546|NCT02310776|12312931|P1|NOT COMPLETED|Overall Study||0
5004547|NCT02310776|12312931|P1|COMPLETED|Overall Study||501
5004548|NCT02310776|12312931|P1|STARTED|Overall Study||501
5004549|NCT02310763|12312938|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
5004550|NCT02310763|12312939|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
5004551|NCT02310763|12312940|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
5004552|NCT02310763|12312938|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
5004553|NCT02310763|12312939|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
5004554|NCT02310763|12312940|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
5004555|NCT02310763|12312938|P3|STARTED|Period 2 (Weeks 49 to 96)||38
5004556|NCT02310763|12312939|P2|STARTED|Period 2 (Weeks 49 to 96)||37
5004557|NCT02310763|12312940|P1|STARTED|Period 2 (Weeks 49 to 96)||38
5004558|NCT02310763|12312938|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
5004559|NCT02310763|12312939|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
5004560|NCT02310763|12312940|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
5004561|NCT02310763|12312938|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
5004562|NCT02310763|12312939|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
5004563|NCT02310763|12312940|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
5004564|NCT02310763|12312938|P3|STARTED|Period 1 (Weeks 1 to 48)||40
5004565|NCT02310763|12312939|P2|STARTED|Period 1 (Weeks 1 to 48)||39
5004566|NCT02310763|12312940|P1|STARTED|Period 1 (Weeks 1 to 48)||41
5004567|NCT02310750|12313143|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004568|NCT02310750|12313144|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004569|NCT02310750|12313145|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004570|NCT02310750|12313146|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004571|NCT02310750|12313147|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004572|NCT02310750|12313148|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004573|NCT02310750|12313149|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004574|NCT02310750|12313150|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004575|NCT02310750|12313151|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004576|NCT02310750|12313152|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004577|NCT02310750|12313153|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004578|NCT02310750|12313154|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
5004579|NCT02310750|12313155|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004580|NCT02310750|12313156|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004581|NCT02310750|12313157|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004582|NCT02310750|12313158|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
5004583|NCT02310750|12313143|P16|COMPLETED|HP MAD and Fasted/Fed||2
5004584|NCT02310750|12313144|P15|COMPLETED|HP MAD and Fasted/Fed||2
5004585|NCT02310750|12313145|P14|COMPLETED|HP MAD and Fasted/Fed||2
5004586|NCT02310750|12313146|P13|COMPLETED|HP MAD and Fasted/Fed||2
5004587|NCT02310750|12313147|P12|COMPLETED|HP MAD and Fasted/Fed||2
5004588|NCT02310750|12313148|P11|COMPLETED|HP MAD and Fasted/Fed||2
5004589|NCT02310750|12313149|P10|COMPLETED|HP MAD and Fasted/Fed||0
5004590|NCT02310750|12313150|P9|COMPLETED|HP MAD and Fasted/Fed||0
5004591|NCT02310750|12313151|P8|COMPLETED|HP MAD and Fasted/Fed||0
5004592|NCT02310750|12313152|P7|COMPLETED|HP MAD and Fasted/Fed||2
5004593|NCT02310750|12313153|P6|COMPLETED|HP MAD and Fasted/Fed||0
5004594|NCT02310750|12313154|P5|COMPLETED|HP MAD and Fasted/Fed||4
5004595|NCT02310750|12313155|P4|COMPLETED|HP MAD and Fasted/Fed||0
5004596|NCT02310750|12313156|P3|COMPLETED|HP MAD and Fasted/Fed||0
5004597|NCT02310750|12313157|P2|COMPLETED|HP MAD and Fasted/Fed||0
5004598|NCT02310750|12313158|P1|COMPLETED|HP MAD and Fasted/Fed||0
5004599|NCT02310750|12313143|P16|STARTED|HP MAD and Fasted/Fed||2
5004600|NCT02310750|12313144|P15|STARTED|HP MAD and Fasted/Fed||2
5004601|NCT02310750|12313145|P14|STARTED|HP MAD and Fasted/Fed||2
5004602|NCT02310750|12313146|P13|STARTED|HP MAD and Fasted/Fed||2
5004603|NCT02310750|12313147|P12|STARTED|HP MAD and Fasted/Fed||2
5004604|NCT02310750|12313148|P11|STARTED|HP MAD and Fasted/Fed||2
5004605|NCT02310750|12313149|P10|STARTED|HP MAD and Fasted/Fed||0
5004606|NCT02310750|12313150|P9|STARTED|HP MAD and Fasted/Fed||0
5004607|NCT02310750|12313151|P8|STARTED|HP MAD and Fasted/Fed||0
5004608|NCT02310750|12313152|P7|STARTED|HP MAD and Fasted/Fed||2
5004609|NCT02310750|12313153|P6|STARTED|HP MAD and Fasted/Fed||0
5004610|NCT02310750|12313154|P5|STARTED|HP MAD and Fasted/Fed||5
5004611|NCT02310750|12313155|P4|STARTED|HP MAD and Fasted/Fed||0
5004612|NCT02310750|12313156|P3|STARTED|HP MAD and Fasted/Fed||0
5004613|NCT02310750|12313157|P2|STARTED|HP MAD and Fasted/Fed||0
5004614|NCT02310750|12313158|P1|STARTED|HP MAD and Fasted/Fed||0
5004615|NCT02310750|12313143|P16|NOT COMPLETED|HP Washout 2||0
5004616|NCT02310750|12313144|P15|NOT COMPLETED|HP Washout 2||0
5004617|NCT02310750|12313145|P14|NOT COMPLETED|HP Washout 2||0
5004618|NCT02310750|12313146|P13|NOT COMPLETED|HP Washout 2||0
5004619|NCT02310750|12313147|P12|NOT COMPLETED|HP Washout 2||0
5004620|NCT02310750|12313148|P11|NOT COMPLETED|HP Washout 2||0
5004621|NCT02310750|12313149|P10|NOT COMPLETED|HP Washout 2||0
5004622|NCT02310750|12313150|P9|NOT COMPLETED|HP Washout 2||0
5004623|NCT02310750|12313151|P8|NOT COMPLETED|HP Washout 2||0
5004624|NCT02310750|12313152|P7|NOT COMPLETED|HP Washout 2||7
5004625|NCT02310750|12313153|P6|NOT COMPLETED|HP Washout 2||0
5004626|NCT02310750|12313154|P5|NOT COMPLETED|HP Washout 2||1
5004627|NCT02310750|12313155|P4|NOT COMPLETED|HP Washout 2||0
5004628|NCT02310750|12313156|P3|NOT COMPLETED|HP Washout 2||0
5004629|NCT02310750|12313157|P2|NOT COMPLETED|HP Washout 2||0
5004630|NCT02310750|12313158|P1|NOT COMPLETED|HP Washout 2||0
5004631|NCT02310750|12313143|P16|COMPLETED|HP Washout 2||2
5004632|NCT02310750|12313144|P15|COMPLETED|HP Washout 2||2
5004633|NCT02310750|12313145|P14|COMPLETED|HP Washout 2||2
5004634|NCT02310750|12313146|P13|COMPLETED|HP Washout 2||2
5004635|NCT02310750|12313147|P12|COMPLETED|HP Washout 2||2
5004636|NCT02310750|12313148|P11|COMPLETED|HP Washout 2||2
5004637|NCT02310750|12313149|P10|COMPLETED|HP Washout 2||0
5004638|NCT02310750|12313150|P9|COMPLETED|HP Washout 2||0
5004639|NCT02310750|12313151|P8|COMPLETED|HP Washout 2||0
5004640|NCT02310750|12313152|P7|COMPLETED|HP Washout 2||2
5004641|NCT02310750|12313153|P6|COMPLETED|HP Washout 2||0
5004642|NCT02310750|12313154|P5|COMPLETED|HP Washout 2||5
5004643|NCT02310750|12313155|P4|COMPLETED|HP Washout 2||0
5004644|NCT02310750|12313156|P3|COMPLETED|HP Washout 2||0
5004645|NCT02310750|12313157|P2|COMPLETED|HP Washout 2||0
5004646|NCT02310750|12313158|P1|COMPLETED|HP Washout 2||0
5004647|NCT02310750|12313143|P16|STARTED|HP Washout 2||2
5004648|NCT02310750|12313144|P15|STARTED|HP Washout 2||2
5004649|NCT02310750|12313145|P14|STARTED|HP Washout 2||2
5004650|NCT02310750|12313146|P13|STARTED|HP Washout 2||2
5004651|NCT02310750|12313147|P12|STARTED|HP Washout 2||2
5004652|NCT02310750|12313148|P11|STARTED|HP Washout 2||2
5004653|NCT02310750|12313149|P10|STARTED|HP Washout 2||0
5004654|NCT02310750|12313150|P9|STARTED|HP Washout 2||0
5004655|NCT02310750|12313151|P8|STARTED|HP Washout 2||0
5004656|NCT02310750|12313152|P7|STARTED|HP Washout 2||9
5004657|NCT02310750|12313153|P6|STARTED|HP Washout 2||0
5004658|NCT02310750|12313154|P5|STARTED|HP Washout 2||6
5004659|NCT02310750|12313155|P4|STARTED|HP Washout 2||0
5004660|NCT02310750|12313156|P3|STARTED|HP Washout 2||0
5004661|NCT02310750|12313157|P2|STARTED|HP Washout 2||0
5004662|NCT02310750|12313158|P1|STARTED|HP Washout 2||0
5004663|NCT02310750|12313143|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004664|NCT02310750|12313144|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004665|NCT02310750|12313145|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004666|NCT02310750|12313146|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004667|NCT02310750|12313147|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004668|NCT02310750|12313148|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004669|NCT02310750|12313149|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
5004670|NCT02310750|12313150|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
5004671|NCT02310750|12313151|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004672|NCT02310750|12313152|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004673|NCT02310750|12313153|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004674|NCT02310750|12313154|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004675|NCT02310750|12313155|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
5004676|NCT02310750|12313156|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004677|NCT02310750|12313157|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004678|NCT02310750|12313158|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004679|NCT02310750|12313143|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004680|NCT02310750|12313144|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004681|NCT02310750|12313145|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004682|NCT02310750|12313146|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004683|NCT02310750|12313147|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004684|NCT02310750|12313148|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004685|NCT02310750|12313149|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
5004686|NCT02310750|12313150|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
5004687|NCT02310750|12313151|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
5004688|NCT02310750|12313152|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
5004689|NCT02310750|12313153|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
5004690|NCT02310750|12313154|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
5004691|NCT02310750|12313155|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
5004692|NCT02310750|12313156|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
5004693|NCT02310750|12313157|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004694|NCT02310750|12313158|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004695|NCT02310750|12313143|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004696|NCT02310750|12313144|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004697|NCT02310750|12313145|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004698|NCT02310750|12313146|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004699|NCT02310750|12313147|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004700|NCT02310750|12313148|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
5004701|NCT02310750|12313149|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
5004702|NCT02310750|12313150|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
5004703|NCT02310750|12313151|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
5004704|NCT02310750|12313152|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
5004705|NCT02310750|12313153|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
5004706|NCT02310750|12313154|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
5004707|NCT02310750|12313155|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
5004708|NCT02310750|12313156|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
5004709|NCT02310750|12313157|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004710|NCT02310750|12313158|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
5004711|NCT02310750|12313143|P16|NOT COMPLETED|HP Washout 1||0
5004712|NCT02310750|12313144|P15|NOT COMPLETED|HP Washout 1||0
5004713|NCT02310750|12313145|P14|NOT COMPLETED|HP Washout 1||0
5004714|NCT02310750|12313146|P13|NOT COMPLETED|HP Washout 1||0
5004715|NCT02310750|12313147|P12|NOT COMPLETED|HP Washout 1||0
5004716|NCT02310750|12313148|P11|NOT COMPLETED|HP Washout 1||0
5004717|NCT02310750|12313149|P10|NOT COMPLETED|HP Washout 1||0
5004718|NCT02310750|12313150|P9|NOT COMPLETED|HP Washout 1||0
5004719|NCT02310750|12313151|P8|NOT COMPLETED|HP Washout 1||0
5004720|NCT02310750|12313152|P7|NOT COMPLETED|HP Washout 1||3
5004721|NCT02310750|12313153|P6|NOT COMPLETED|HP Washout 1||2
5004722|NCT02310750|12313154|P5|NOT COMPLETED|HP Washout 1||2
5004723|NCT02310750|12313155|P4|NOT COMPLETED|HP Washout 1||1
5004724|NCT02310750|12313156|P3|NOT COMPLETED|HP Washout 1||1
5004725|NCT02310750|12313157|P2|NOT COMPLETED|HP Washout 1||0
5004726|NCT02310750|12313158|P1|NOT COMPLETED|HP Washout 1||0
5004727|NCT02310750|12313143|P16|COMPLETED|HP Washout 1||2
5004728|NCT02310750|12313144|P15|COMPLETED|HP Washout 1||2
5004729|NCT02310750|12313145|P14|COMPLETED|HP Washout 1||2
5004730|NCT02310750|12313146|P13|COMPLETED|HP Washout 1||2
5004731|NCT02310750|12313147|P12|COMPLETED|HP Washout 1||2
5004732|NCT02310750|12313148|P11|COMPLETED|HP Washout 1||2
5004733|NCT02310750|12313149|P10|COMPLETED|HP Washout 1||0
5004734|NCT02310750|12313150|P9|COMPLETED|HP Washout 1||0
5004735|NCT02310750|12313151|P8|COMPLETED|HP Washout 1||0
5004736|NCT02310750|12313152|P7|COMPLETED|HP Washout 1||9
5004737|NCT02310750|12313153|P6|COMPLETED|HP Washout 1||6
5004738|NCT02310750|12313154|P5|COMPLETED|HP Washout 1||6
5004739|NCT02310750|12313155|P4|COMPLETED|HP Washout 1||4
5004740|NCT02310750|12313156|P3|COMPLETED|HP Washout 1||5
5004741|NCT02310750|12313157|P2|COMPLETED|HP Washout 1||0
5004742|NCT02310750|12313158|P1|COMPLETED|HP Washout 1||0
5004743|NCT02310750|12313143|P16|STARTED|HP Washout 1||2
5004744|NCT02310750|12313144|P15|STARTED|HP Washout 1||2
5004745|NCT02310750|12313145|P14|STARTED|HP Washout 1||2
5004746|NCT02310750|12313146|P13|STARTED|HP Washout 1||2
5004747|NCT02310750|12313147|P12|STARTED|HP Washout 1||2
5004748|NCT02310750|12313148|P11|STARTED|HP Washout 1||2
5004749|NCT02310750|12313149|P10|STARTED|HP Washout 1||0
5004750|NCT02310750|12313150|P9|STARTED|HP Washout 1||0
5004751|NCT02310750|12313151|P8|STARTED|HP Washout 1||0
5004752|NCT02310750|12313152|P7|STARTED|HP Washout 1||12
5004753|NCT02310750|12313153|P6|STARTED|HP Washout 1||8
5004754|NCT02310750|12313154|P5|STARTED|HP Washout 1||8
5004755|NCT02310750|12313155|P4|STARTED|HP Washout 1||5
5004756|NCT02310750|12313156|P3|STARTED|HP Washout 1||6
5004757|NCT02310750|12313157|P2|STARTED|HP Washout 1||0
5004758|NCT02310750|12313158|P1|STARTED|HP Washout 1||0
5004759|NCT02310750|12313143|P16|NOT COMPLETED|HP Period 1||0
5004760|NCT02310750|12313144|P15|NOT COMPLETED|HP Period 1||0
5004761|NCT02310750|12313145|P14|NOT COMPLETED|HP Period 1||0
5004762|NCT02310750|12313146|P13|NOT COMPLETED|HP Period 1||0
5004763|NCT02310750|12313147|P12|NOT COMPLETED|HP Period 1||0
5004764|NCT02310750|12313148|P11|NOT COMPLETED|HP Period 1||0
5004765|NCT02310750|12313149|P10|NOT COMPLETED|HP Period 1||0
5004766|NCT02310750|12313150|P9|NOT COMPLETED|HP Period 1||0
5004767|NCT02310750|12313151|P8|NOT COMPLETED|HP Period 1||0
5004768|NCT02310750|12313152|P7|NOT COMPLETED|HP Period 1||1
5004769|NCT02310750|12313153|P6|NOT COMPLETED|HP Period 1||0
5004770|NCT02310750|12313154|P5|NOT COMPLETED|HP Period 1||0
5004771|NCT02310750|12313155|P4|NOT COMPLETED|HP Period 1||1
5004772|NCT02310750|12313156|P3|NOT COMPLETED|HP Period 1||0
5004773|NCT02310750|12313157|P2|NOT COMPLETED|HP Period 1||0
5004774|NCT02310750|12313158|P1|NOT COMPLETED|HP Period 1||1
5004775|NCT02310750|12313143|P16|COMPLETED|HP Period 1||2
5004776|NCT02310750|12313144|P15|COMPLETED|HP Period 1||2
5004777|NCT02310750|12313145|P14|COMPLETED|HP Period 1||2
5004778|NCT02310750|12313146|P13|COMPLETED|HP Period 1||2
5004779|NCT02310750|12313147|P12|COMPLETED|HP Period 1||2
5004780|NCT02310750|12313148|P11|COMPLETED|HP Period 1||2
5004781|NCT02310750|12313149|P10|COMPLETED|HP Period 1||0
5004782|NCT02310750|12313150|P9|COMPLETED|HP Period 1||0
5004783|NCT02310750|12313151|P8|COMPLETED|HP Period 1||0
5004784|NCT02310750|12313152|P7|COMPLETED|HP Period 1||12
5004785|NCT02310750|12313153|P6|COMPLETED|HP Period 1||8
5004786|NCT02310750|12313154|P5|COMPLETED|HP Period 1||8
5004787|NCT02310750|12313155|P4|COMPLETED|HP Period 1||5
5004788|NCT02310750|12313156|P3|COMPLETED|HP Period 1||6
5004789|NCT02310750|12313157|P2|COMPLETED|HP Period 1||6
5004790|NCT02310750|12313158|P1|COMPLETED|HP Period 1||6
5004791|NCT02310750|12313143|P16|STARTED|HP Period 1||2
5004792|NCT02310750|12313144|P15|STARTED|HP Period 1||2
5004793|NCT02310750|12313145|P14|STARTED|HP Period 1||2
5004794|NCT02310750|12313146|P13|STARTED|HP Period 1||2
5004795|NCT02310750|12313147|P12|STARTED|HP Period 1||2
5004796|NCT02310750|12313148|P11|STARTED|HP Period 1||2
5004797|NCT02310750|12313149|P10|STARTED|HP Period 1||0
5004798|NCT02310750|12313150|P9|STARTED|HP Period 1||0
5004799|NCT02310750|12313151|P8|STARTED|HP Period 1||0
5004800|NCT02310750|12313152|P7|STARTED|HP Period 1||13
5004801|NCT02310750|12313153|P6|STARTED|HP Period 1||8
5004802|NCT02310750|12313154|P5|STARTED|HP Period 1||8
5004803|NCT02310750|12313155|P4|STARTED|HP Period 1||6
5004804|NCT02310750|12313156|P3|STARTED|HP Period 1||6
5004805|NCT02310750|12313157|P2|STARTED|HP Period 1||6
5004806|NCT02310750|12313158|P1|STARTED|HP Period 1||7
5004807|NCT02310646|12313599|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
5004808|NCT02310646|12313600|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
5004809|NCT02310646|12313599|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
5004810|NCT02310646|12313600|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
5004811|NCT02310646|12313599|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
5004812|NCT02310646|12313600|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
5004813|NCT02310646|12313599|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
5004814|NCT02310646|12313600|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
5004815|NCT02310646|12313599|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
5004816|NCT02310646|12313600|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
5004817|NCT02310646|12313599|P2|STARTED|First Intervention (Day 1 - Day 7)||104
5004818|NCT02310646|12313600|P1|STARTED|First Intervention (Day 1 - Day 7)||109
5004819|NCT02310581|12313628|P4|NOT COMPLETED|Overall Study||1
5004820|NCT02310581|12313629|P3|NOT COMPLETED|Overall Study||1
5004821|NCT02310581|12313630|P2|NOT COMPLETED|Overall Study||2
5004822|NCT02310581|12313631|P1|NOT COMPLETED|Overall Study||3
5004823|NCT02310581|12313628|P4|COMPLETED|Overall Study||9
5004824|NCT02310581|12313629|P3|COMPLETED|Overall Study||9
5004825|NCT02310581|12313630|P2|COMPLETED|Overall Study||9
5004826|NCT02310581|12313631|P1|COMPLETED|Overall Study||6
5004827|NCT02310581|12313628|P4|STARTED|Overall Study||10
5004828|NCT02310581|12313629|P3|STARTED|Overall Study||10
5004829|NCT02310581|12313630|P2|STARTED|Overall Study||11
5004830|NCT02310581|12313631|P1|STARTED|Overall Study||9
5004831|NCT02310568|12313670|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
5004832|NCT02310568|12313671|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
5004833|NCT02310568|12313672|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
5004834|NCT02310568|12313673|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
5004835|NCT02310568|12313674|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
5004836|NCT02310568|12313670|P5|COMPLETED|Stage 2 (4 Weeks)||19
5004837|NCT02310568|12313671|P4|COMPLETED|Stage 2 (4 Weeks)||17
5004838|NCT02310568|12313672|P3|COMPLETED|Stage 2 (4 Weeks)||13
5004839|NCT02310568|12313673|P2|COMPLETED|Stage 2 (4 Weeks)||12
5004840|NCT02310568|12313674|P1|COMPLETED|Stage 2 (4 Weeks)||11
5004841|NCT02310568|12313670|P5|STARTED|Stage 2 (4 Weeks)||20
5004842|NCT02310568|12313671|P4|STARTED|Stage 2 (4 Weeks)||22
5004843|NCT02310568|12313672|P3|STARTED|Stage 2 (4 Weeks)||14
5004844|NCT02310568|12313673|P2|STARTED|Stage 2 (4 Weeks)||13
5004845|NCT02310568|12313674|P1|STARTED|Stage 2 (4 Weeks)||12
5004846|NCT02310568|12313670|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
5004847|NCT02310568|12313671|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
5004848|NCT02310568|12313672|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
5004849|NCT02310568|12313673|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
5004850|NCT02310568|12313674|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
5004851|NCT02310568|12313670|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
5004852|NCT02310568|12313671|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
5004853|NCT02310568|12313672|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
5004854|NCT02310568|12313673|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
5004855|NCT02310568|12313674|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
5004856|NCT02310568|12313670|P5|STARTED|Stage 1 ( 4 Weeks)||21
5004857|NCT02310568|12313671|P4|STARTED|Stage 1 ( 4 Weeks)||24
5004858|NCT02310568|12313672|P3|STARTED|Stage 1 ( 4 Weeks)||15
5004859|NCT02310568|12313673|P2|STARTED|Stage 1 ( 4 Weeks)||15
5004860|NCT02310568|12313674|P1|STARTED|Stage 1 ( 4 Weeks)||15
5004861|NCT02310126|12313754|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
5004862|NCT02310126|12313755|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
5004863|NCT02310126|12313754|P2|COMPLETED|Period 2 (15 Minutes)||95
5004864|NCT02310126|12313755|P1|COMPLETED|Period 2 (15 Minutes)||94
5004865|NCT02310126|12313754|P2|Myopes|Period 2 (15 Minutes)||63
5004866|NCT02310126|12313755|P1|Myopes|Period 2 (15 Minutes)||56
5004867|NCT02310126|12313754|P2|Hyperopes|Period 2 (15 Minutes)||32
5004868|NCT02310126|12313755|P1|Hyperopes|Period 2 (15 Minutes)||38
5004869|NCT02310126|12313754|P2|STARTED|Period 2 (15 Minutes)||95
5004870|NCT02310126|12313755|P1|STARTED|Period 2 (15 Minutes)||94
5004871|NCT02310126|12313754|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
5004872|NCT02310126|12313755|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
5004873|NCT02310126|12313754|P2|COMPLETED|Period 1 (15 Minutes)||95
5004874|NCT02310126|12313755|P1|COMPLETED|Period 1 (15 Minutes)||94
5004875|NCT02310126|12313754|P2|Myopes|Period 1 (15 Minutes)||64
5004876|NCT02310126|12313755|P1|Myopes|Period 1 (15 Minutes)||56
5004877|NCT02310126|12313754|P2|Hyperopes|Period 1 (15 Minutes)||33
5004878|NCT02310126|12313755|P1|Hyperopes|Period 1 (15 Minutes)||38
5004879|NCT02310126|12313754|P2|STARTED|Period 1 (15 Minutes)||97
5004880|NCT02310126|12313755|P1|STARTED|Period 1 (15 Minutes)||94
5004881|NCT02310100|12313761|P1|NOT COMPLETED|Overall Study||18
5004882|NCT02310100|12313761|P1|COMPLETED|Overall Study||160
5004883|NCT02310100|12313761|P1|STARTED|Overall Study|First enrollment|178
5004884|NCT02309944|12313768|P2|NOT COMPLETED|Overall Study||0
5004885|NCT02309944|12313769|P1|NOT COMPLETED|Overall Study||0
5004886|NCT02309944|12313768|P2|COMPLETED|Overall Study||43
5004887|NCT02309944|12313769|P1|COMPLETED|Overall Study||38
5004888|NCT02309944|12313768|P2|STARTED|Overall Study||43
5004889|NCT02309944|12313769|P1|STARTED|Overall Study||38
5004890|NCT02309723|12313780|P3|NOT COMPLETED|Overall Study||24
5004891|NCT02309723|12313781|P2|NOT COMPLETED|Overall Study||23
5004892|NCT02309723|12313782|P1|NOT COMPLETED|Overall Study||24
5004893|NCT02309723|12313780|P3|COMPLETED|Overall Study||105
5004894|NCT02309723|12313781|P2|COMPLETED|Overall Study||105
5004895|NCT02309723|12313782|P1|COMPLETED|Overall Study||105
5004896|NCT02309723|12313780|P3|STARTED|Overall Study||129
5004897|NCT02309723|12313781|P2|STARTED|Overall Study||128
5004898|NCT02309723|12313782|P1|STARTED|Overall Study||129
5004899|NCT02309489|12313798|P2|NOT COMPLETED|Overall Study||14
5004900|NCT02309489|12313799|P1|NOT COMPLETED|Overall Study||15
5004901|NCT02309489|12313798|P2|COMPLETED|Overall Study||547
5004902|NCT02309489|12313799|P1|COMPLETED|Overall Study||568
5004903|NCT02309489|12313798|P2|Follow-up at 3 Months Postpartum|Overall Study||541
5004904|NCT02309489|12313799|P1|Follow-up at 3 Months Postpartum|Overall Study||560
5004905|NCT02309489|12313798|P2|STARTED|Overall Study||561
5004906|NCT02309489|12313799|P1|STARTED|Overall Study||583
5004907|NCT02309411|12313825|P3|NOT COMPLETED|Overall Study||0
5004908|NCT02309411|12313826|P2|NOT COMPLETED|Overall Study||1
5004909|NCT02309411|12313827|P1|NOT COMPLETED|Overall Study||2
5004910|NCT02309411|12313825|P3|COMPLETED|Overall Study||6
5004911|NCT02309411|12313826|P2|COMPLETED|Overall Study||14
5004912|NCT02309411|12313827|P1|COMPLETED|Overall Study||23
5004913|NCT02309411|12313825|P3|STARTED|Overall Study||6
5004914|NCT02309411|12313826|P2|STARTED|Overall Study||15
5004915|NCT02309411|12313827|P1|STARTED|Overall Study||25
5004916|NCT02309372|12313848|P2|NOT COMPLETED|Overall Study||2
5004917|NCT02309372|12313849|P1|NOT COMPLETED|Overall Study||3
5004918|NCT02309372|12313848|P2|COMPLETED|Overall Study||25
5004919|NCT02309372|12313849|P1|COMPLETED|Overall Study||24
5004920|NCT02309372|12313848|P2|STARTED|Overall Study||27
5004921|NCT02309372|12313849|P1|STARTED|Overall Study||27
5004922|NCT02309359|12313866|P5|NOT COMPLETED|Overall Study||9
5004923|NCT02309359|12313867|P4|NOT COMPLETED|Overall Study||12
5004924|NCT02309359|12313868|P3|NOT COMPLETED|Overall Study||11
5004925|NCT02309359|12313869|P2|NOT COMPLETED|Overall Study||8
5004926|NCT02309359|12313870|P1|NOT COMPLETED|Overall Study||12
5004927|NCT02309359|12313866|P5|COMPLETED|Overall Study||60
5004928|NCT02309359|12313867|P4|COMPLETED|Overall Study||57
5004929|NCT02309359|12313868|P3|COMPLETED|Overall Study||57
5004930|NCT02309359|12313869|P2|COMPLETED|Overall Study||62
5004931|NCT02309359|12313870|P1|COMPLETED|Overall Study||57
5004932|NCT02309359|12313866|P5|STARTED|Overall Study||69
5004933|NCT02309359|12313867|P4|STARTED|Overall Study||69
5004934|NCT02309359|12313868|P3|STARTED|Overall Study||68
5004935|NCT02309359|12313869|P2|STARTED|Overall Study||70
5004936|NCT02309359|12313870|P1|STARTED|Overall Study||69
5004937|NCT02309294|12313997|P1|NOT COMPLETED|Overall Study||2
5004938|NCT02309294|12313997|P1|COMPLETED|Overall Study||41
5004939|NCT02309294|12313997|P1|STARTED|Overall Study||43
5004940|NCT02309138|12314003|P2|NOT COMPLETED|Overall Study||18
5004941|NCT02309138|12314004|P1|NOT COMPLETED|Overall Study||48
5004942|NCT02309138|12314003|P2|COMPLETED|Overall Study||443
5004943|NCT02309138|12314004|P1|COMPLETED|Overall Study||412
5004944|NCT02309138|12314003|P2|STARTED|Overall Study||461
5004945|NCT02309138|12314004|P1|STARTED|Overall Study||460
5004946|NCT02309112|12314027|P3|NOT COMPLETED|Overall Study||1
5004947|NCT02309112|12314028|P2|NOT COMPLETED|Overall Study||1
5004948|NCT02309112|12314029|P1|NOT COMPLETED|Overall Study||1
5004949|NCT02309112|12314027|P3|COMPLETED|Overall Study||4
5004950|NCT02309112|12314028|P2|COMPLETED|Overall Study||4
5004951|NCT02309112|12314029|P1|COMPLETED|Overall Study||4
5004952|NCT02309112|12314027|P3|Completed Yoga Intervention|Overall Study||4
5004953|NCT02309112|12314028|P2|Completed Yoga Intervention|Overall Study||5
5004954|NCT02309112|12314029|P1|Completed Yoga Intervention|Overall Study||4
5004955|NCT02309112|12314027|P3|STARTED|Overall Study||5
5004956|NCT02309112|12314028|P2|STARTED|Overall Study||5
5004957|NCT02309112|12314029|P1|STARTED|Overall Study||5
5004958|NCT02309099|12314052|P2|NOT COMPLETED|Overall Study||0
5004959|NCT02309099|12314053|P1|NOT COMPLETED|Overall Study||2
5004960|NCT02309099|12314052|P2|COMPLETED|Overall Study||3
5004961|NCT02309099|12314053|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
5004962|NCT02309099|12314052|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
5004963|NCT02309099|12314053|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
5004964|NCT02309099|12314052|P2|Initial Activation|Overall Study||3
5004965|NCT02309099|12314053|P1|Initial Activation|Overall Study||7
5004966|NCT02309099|12314052|P2|Cochlear Implantation|Overall Study||3
5004967|NCT02309099|12314053|P1|Cochlear Implantation|Overall Study||7
5004968|NCT02309099|12314052|P2|STARTED|Overall Study||3
5004969|NCT02309099|12314053|P1|STARTED|Overall Study||7
5004970|NCT02308839|12314099|P1|NOT COMPLETED|Overall Study||109
5004971|NCT02308839|12314099|P1|COMPLETED|Overall Study||72
5004972|NCT02308839|12314099|P1|STARTED|Overall Study||181
5004973|NCT02308787|12314109|P1|NOT COMPLETED|Overall Study||0
5004974|NCT02308787|12314109|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
5004975|NCT02308787|12314109|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
5004976|NCT02308748|12314124|P10|NOT COMPLETED|Period 5||0
5004977|NCT02308748|12314125|P9|NOT COMPLETED|Period 5||1
5004978|NCT02308748|12314126|P8|NOT COMPLETED|Period 5||0
5004979|NCT02308748|12314127|P7|NOT COMPLETED|Period 5||0
5004980|NCT02308748|12314128|P6|NOT COMPLETED|Period 5||0
5004981|NCT02308748|12314129|P5|NOT COMPLETED|Period 5||0
5004982|NCT02308748|12314130|P4|NOT COMPLETED|Period 5||0
5004983|NCT02308748|12314131|P3|NOT COMPLETED|Period 5||0
5004984|NCT02308748|12314132|P2|NOT COMPLETED|Period 5||0
5004985|NCT02308748|12314133|P1|NOT COMPLETED|Period 5||1
5004986|NCT02308748|12314124|P10|COMPLETED|Period 5||2
5004987|NCT02308748|12314125|P9|COMPLETED|Period 5||1
5004988|NCT02308748|12314126|P8|COMPLETED|Period 5||1
5004989|NCT02308748|12314127|P7|COMPLETED|Period 5||2
5004990|NCT02308748|12314128|P6|COMPLETED|Period 5||3
5004991|NCT02308748|12314129|P5|COMPLETED|Period 5||2
5004992|NCT02308748|12314130|P4|COMPLETED|Period 5||2
5004993|NCT02308748|12314131|P3|COMPLETED|Period 5||1
5004994|NCT02308748|12314132|P2|COMPLETED|Period 5||2
5004995|NCT02308748|12314133|P1|COMPLETED|Period 5||1
5004996|NCT02308748|12314124|P10|STARTED|Period 5||2
5004997|NCT02308748|12314125|P9|STARTED|Period 5||2
5004998|NCT02308748|12314126|P8|STARTED|Period 5||1
5004999|NCT02308748|12314127|P7|STARTED|Period 5||2
5005000|NCT02308748|12314128|P6|STARTED|Period 5||3
5005001|NCT02308748|12314129|P5|STARTED|Period 5||2
5005002|NCT02308748|12314130|P4|STARTED|Period 5||2
5005003|NCT02308748|12314131|P3|STARTED|Period 5||1
5005004|NCT02308748|12314132|P2|STARTED|Period 5||2
5005005|NCT02308748|12314133|P1|STARTED|Period 5||2
5005006|NCT02308748|12314124|P10|NOT COMPLETED|Period 4||0
5005007|NCT02308748|12314125|P9|NOT COMPLETED|Period 4||0
5005008|NCT02308748|12314126|P8|NOT COMPLETED|Period 4||0
5005009|NCT02308748|12314127|P7|NOT COMPLETED|Period 4||0
5005010|NCT02308748|12314128|P6|NOT COMPLETED|Period 4||0
5005011|NCT02308748|12314129|P5|NOT COMPLETED|Period 4||0
5005012|NCT02308748|12314130|P4|NOT COMPLETED|Period 4||0
5005013|NCT02308748|12314131|P3|NOT COMPLETED|Period 4||0
5005014|NCT02308748|12314132|P2|NOT COMPLETED|Period 4||0
5005015|NCT02308748|12314133|P1|NOT COMPLETED|Period 4||0
5005016|NCT02308748|12314124|P10|COMPLETED|Period 4||2
5005017|NCT02308748|12314125|P9|COMPLETED|Period 4||2
5005018|NCT02308748|12314126|P8|COMPLETED|Period 4||1
5005019|NCT02308748|12314127|P7|COMPLETED|Period 4||2
5005020|NCT02308748|12314128|P6|COMPLETED|Period 4||3
5005021|NCT02308748|12314129|P5|COMPLETED|Period 4||2
5005022|NCT02308748|12314130|P4|COMPLETED|Period 4||2
5005023|NCT02308748|12314131|P3|COMPLETED|Period 4||1
5005024|NCT02308748|12314132|P2|COMPLETED|Period 4||2
5005025|NCT02308748|12314133|P1|COMPLETED|Period 4||2
5005026|NCT02308748|12314124|P10|STARTED|Period 4||2
5005027|NCT02308748|12314125|P9|STARTED|Period 4||2
5005028|NCT02308748|12314126|P8|STARTED|Period 4||1
5005029|NCT02308748|12314127|P7|STARTED|Period 4||2
5005030|NCT02308748|12314128|P6|STARTED|Period 4||3
5005031|NCT02308748|12314129|P5|STARTED|Period 4||2
5005032|NCT02308748|12314130|P4|STARTED|Period 4||2
5005033|NCT02308748|12314131|P3|STARTED|Period 4||1
5005034|NCT02308748|12314132|P2|STARTED|Period 4||2
5005035|NCT02308748|12314133|P1|STARTED|Period 4||2
5005036|NCT02308748|12314124|P10|NOT COMPLETED|Period 3||1
5005037|NCT02308748|12314125|P9|NOT COMPLETED|Period 3||0
5005038|NCT02308748|12314126|P8|NOT COMPLETED|Period 3||0
5005039|NCT02308748|12314127|P7|NOT COMPLETED|Period 3||0
5005040|NCT02308748|12314128|P6|NOT COMPLETED|Period 3||0
5005041|NCT02308748|12314129|P5|NOT COMPLETED|Period 3||0
5005042|NCT02308748|12314130|P4|NOT COMPLETED|Period 3||0
5005043|NCT02308748|12314131|P3|NOT COMPLETED|Period 3||0
5005044|NCT02308748|12314132|P2|NOT COMPLETED|Period 3||0
5005045|NCT02308748|12314133|P1|NOT COMPLETED|Period 3||0
5005046|NCT02308748|12314124|P10|COMPLETED|Period 3||2
5005047|NCT02308748|12314125|P9|COMPLETED|Period 3||2
5005048|NCT02308748|12314126|P8|COMPLETED|Period 3||1
5005049|NCT02308748|12314127|P7|COMPLETED|Period 3||2
5005050|NCT02308748|12314128|P6|COMPLETED|Period 3||3
5005051|NCT02308748|12314129|P5|COMPLETED|Period 3||2
5005052|NCT02308748|12314130|P4|COMPLETED|Period 3||2
5005053|NCT02308748|12314131|P3|COMPLETED|Period 3||1
5005054|NCT02308748|12314132|P2|COMPLETED|Period 3||2
5005055|NCT02308748|12314133|P1|COMPLETED|Period 3||2
5005056|NCT02308748|12314124|P10|STARTED|Period 3||3
5005057|NCT02308748|12314125|P9|STARTED|Period 3||2
5005058|NCT02308748|12314126|P8|STARTED|Period 3||1
5005059|NCT02308748|12314127|P7|STARTED|Period 3||2
5005060|NCT02308748|12314128|P6|STARTED|Period 3||3
5005061|NCT02308748|12314129|P5|STARTED|Period 3||2
5005062|NCT02308748|12314130|P4|STARTED|Period 3||2
5005063|NCT02308748|12314131|P3|STARTED|Period 3||1
5005064|NCT02308748|12314132|P2|STARTED|Period 3||2
5005065|NCT02308748|12314133|P1|STARTED|Period 3||2
5005066|NCT02308748|12314124|P10|NOT COMPLETED|Period 2||0
5005067|NCT02308748|12314125|P9|NOT COMPLETED|Period 2||0
5005068|NCT02308748|12314126|P8|NOT COMPLETED|Period 2||1
5005069|NCT02308748|12314127|P7|NOT COMPLETED|Period 2||0
5005070|NCT02308748|12314128|P6|NOT COMPLETED|Period 2||0
5005071|NCT02308748|12314129|P5|NOT COMPLETED|Period 2||0
5005072|NCT02308748|12314130|P4|NOT COMPLETED|Period 2||0
5005073|NCT02308748|12314131|P3|NOT COMPLETED|Period 2||0
5005074|NCT02308748|12314132|P2|NOT COMPLETED|Period 2||0
5005075|NCT02308748|12314133|P1|NOT COMPLETED|Period 2||0
5005076|NCT02308748|12314124|P10|COMPLETED|Period 2||3
5005077|NCT02308748|12314125|P9|COMPLETED|Period 2||2
5005078|NCT02308748|12314126|P8|COMPLETED|Period 2||1
5005079|NCT02308748|12314127|P7|COMPLETED|Period 2||2
5005080|NCT02308748|12314128|P6|COMPLETED|Period 2||3
5005081|NCT02308748|12314129|P5|COMPLETED|Period 2||2
5005082|NCT02308748|12314130|P4|COMPLETED|Period 2||2
5005083|NCT02308748|12314131|P3|COMPLETED|Period 2||1
5005084|NCT02308748|12314132|P2|COMPLETED|Period 2||2
5005085|NCT02308748|12314133|P1|COMPLETED|Period 2||2
5005086|NCT02308748|12314124|P10|STARTED|Period 2||3
5005087|NCT02308748|12314125|P9|STARTED|Period 2||2
5005088|NCT02308748|12314126|P8|STARTED|Period 2||2
5005089|NCT02308748|12314127|P7|STARTED|Period 2||2
5005090|NCT02308748|12314128|P6|STARTED|Period 2||3
5005091|NCT02308748|12314129|P5|STARTED|Period 2||2
5005092|NCT02308748|12314130|P4|STARTED|Period 2||2
5005093|NCT02308748|12314131|P3|STARTED|Period 2||1
5005094|NCT02308748|12314132|P2|STARTED|Period 2||2
5005095|NCT02308748|12314133|P1|STARTED|Period 2||2
5005096|NCT02308748|12314124|P10|NOT COMPLETED|Period 1||0
5005097|NCT02308748|12314125|P9|NOT COMPLETED|Period 1||0
5005098|NCT02308748|12314126|P8|NOT COMPLETED|Period 1||0
5005099|NCT02308748|12314127|P7|NOT COMPLETED|Period 1||0
5005100|NCT02308748|12314128|P6|NOT COMPLETED|Period 1||0
5005101|NCT02308748|12314129|P5|NOT COMPLETED|Period 1||0
5005102|NCT02308748|12314130|P4|NOT COMPLETED|Period 1||0
5005103|NCT02308748|12314131|P3|NOT COMPLETED|Period 1||1
5005104|NCT02308748|12314132|P2|NOT COMPLETED|Period 1||0
5005105|NCT02308748|12314133|P1|NOT COMPLETED|Period 1||0
5005106|NCT02308748|12314124|P10|COMPLETED|Period 1||3
5005107|NCT02308748|12314125|P9|COMPLETED|Period 1||2
5005108|NCT02308748|12314126|P8|COMPLETED|Period 1||2
5005109|NCT02308748|12314127|P7|COMPLETED|Period 1||2
5005110|NCT02308748|12314128|P6|COMPLETED|Period 1||3
5005111|NCT02308748|12314129|P5|COMPLETED|Period 1||2
5005112|NCT02308748|12314130|P4|COMPLETED|Period 1||2
5005113|NCT02308748|12314131|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
5005114|NCT02308748|12314132|P2|COMPLETED|Period 1||2
5005115|NCT02308748|12314133|P1|COMPLETED|Period 1||2
5005116|NCT02308748|12314124|P10|STARTED|Period 1||3
5005117|NCT02308748|12314125|P9|STARTED|Period 1||2
5005118|NCT02308748|12314126|P8|STARTED|Period 1||2
5005119|NCT02308748|12314127|P7|STARTED|Period 1||2
5005120|NCT02308748|12314128|P6|STARTED|Period 1||3
5005121|NCT02308748|12314129|P5|STARTED|Period 1||2
5005122|NCT02308748|12314130|P4|STARTED|Period 1||2
5005123|NCT02308748|12314131|P3|STARTED|Period 1||2
5005124|NCT02308748|12314132|P2|STARTED|Period 1||2
5005125|NCT02308748|12314133|P1|STARTED|Period 1||2
5005126|NCT02308696|12314147|P2|NOT COMPLETED|Overall Study||31
5005127|NCT02308696|12314148|P1|NOT COMPLETED|Overall Study||53
5005128|NCT02308696|12314147|P2|COMPLETED|Overall Study||203
5005129|NCT02308696|12314148|P1|COMPLETED|Overall Study||169
5005130|NCT02308696|12314147|P2|STARTED|Overall Study||234
5005131|NCT02308696|12314148|P1|STARTED|Overall Study||222
5005132|NCT02308540|12314182|P6|NOT COMPLETED|Overall Study||1
5005133|NCT02308540|12314183|P5|NOT COMPLETED|Overall Study||0
5005134|NCT02308540|12314184|P4|NOT COMPLETED|Overall Study||0
5005135|NCT02308540|12314185|P3|NOT COMPLETED|Overall Study||0
5005136|NCT02308540|12314186|P2|NOT COMPLETED|Overall Study||0
5005137|NCT02308540|12314187|P1|NOT COMPLETED|Overall Study||0
5005138|NCT02308540|12314182|P6|COMPLETED|Overall Study||99
5005139|NCT02308540|12314183|P5|COMPLETED|Overall Study||100
5005140|NCT02308540|12314184|P4|COMPLETED|Overall Study||56
5005141|NCT02308540|12314185|P3|COMPLETED|Overall Study||56
5005142|NCT02308540|12314186|P2|COMPLETED|Overall Study||17
5005143|NCT02308540|12314187|P1|COMPLETED|Overall Study||17
5005144|NCT02308540|12314182|P6|Vaccinated|Overall Study||100
5005145|NCT02308540|12314183|P5|Vaccinated|Overall Study||100
5005146|NCT02308540|12314184|P4|Vaccinated|Overall Study||56
5005147|NCT02308540|12314185|P3|Vaccinated|Overall Study||56
5005148|NCT02308540|12314186|P2|Vaccinated|Overall Study||17
5005149|NCT02308540|12314187|P1|Vaccinated|Overall Study||17
5005150|NCT02308540|12314182|P6|Randomized|Overall Study||100
5005151|NCT02308540|12314183|P5|Randomized|Overall Study||100
5005152|NCT02308540|12314184|P4|Randomized|Overall Study||56
5005153|NCT02308540|12314185|P3|Randomized|Overall Study||56
5005154|NCT02308540|12314186|P2|Randomized|Overall Study||17
5005155|NCT02308540|12314187|P1|Randomized|Overall Study||17
5005156|NCT02308540|12314182|P6|STARTED|Overall Study||100
5005157|NCT02308540|12314183|P5|STARTED|Overall Study||100
5005158|NCT02308540|12314184|P4|STARTED|Overall Study||56
5005159|NCT02308540|12314185|P3|STARTED|Overall Study||56
5005160|NCT02308540|12314186|P2|STARTED|Overall Study||17
5005161|NCT02308540|12314187|P1|STARTED|Overall Study||17
5005162|NCT02308475|12314251|P1|NOT COMPLETED|Overall Study||0
5005163|NCT02308475|12314251|P1|COMPLETED|Overall Study||2
5005164|NCT02308475|12314251|P1|STARTED|Overall Study||2
5005165|NCT02308371|12314259|P2|NOT COMPLETED|Overall Study||0
5005166|NCT02308371|12314260|P1|NOT COMPLETED|Overall Study||0
5005167|NCT02308371|12314259|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
5005168|NCT02308371|12314260|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
5005169|NCT02308371|12314259|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
5005170|NCT02308371|12314260|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
5005171|NCT02308228|12314276|P2|NOT COMPLETED|Overall Study||7
5005172|NCT02308228|12314277|P1|NOT COMPLETED|Overall Study||8
5005173|NCT02308228|12314276|P2|COMPLETED|Overall Study||48
5005174|NCT02308228|12314277|P1|COMPLETED|Overall Study||46
5005175|NCT02308228|12314276|P2|STARTED|Overall Study||55
5005176|NCT02308228|12314277|P1|STARTED|Overall Study||54
5005177|NCT02308189|12314291|P2|NOT COMPLETED|Overall Study||1
5005178|NCT02308189|12314292|P1|NOT COMPLETED|Overall Study||1
5005179|NCT02308189|12314291|P2|COMPLETED|Overall Study||14
5005180|NCT02308189|12314292|P1|COMPLETED|Overall Study||16
5005181|NCT02308189|12314291|P2|STARTED|Overall Study||15
5005182|NCT02308189|12314292|P1|STARTED|Overall Study||17
5005183|NCT02308163|12314306|P5|NOT COMPLETED|Overall Study||34
5005184|NCT02308163|12314307|P4|NOT COMPLETED|Overall Study||13
5005185|NCT02308163|12314308|P3|NOT COMPLETED|Overall Study||14
5005186|NCT02308163|12314309|P2|NOT COMPLETED|Overall Study||18
5005187|NCT02308163|12314310|P1|NOT COMPLETED|Overall Study||31
5005188|NCT02308163|12314306|P5|COMPLETED|Overall Study||167
5005189|NCT02308163|12314307|P4|COMPLETED|Overall Study||39
5005190|NCT02308163|12314308|P3|COMPLETED|Overall Study||36
5005191|NCT02308163|12314309|P2|COMPLETED|Overall Study||84
5005192|NCT02308163|12314310|P1|COMPLETED|Overall Study||73
5005193|NCT02308163|12314306|P5|STARTED|Overall Study||201
5005194|NCT02308163|12314307|P4|STARTED|Overall Study||52
5005195|NCT02308163|12314308|P3|STARTED|Overall Study||50
5005196|NCT02308163|12314309|P2|STARTED|Overall Study||102
5005197|NCT02308163|12314310|P1|STARTED|Overall Study||104
5005198|NCT02308124|12314620|P3|NOT COMPLETED|Overall Study||8
5005199|NCT02308124|12314621|P2|NOT COMPLETED|Overall Study||8
5005200|NCT02308124|12314622|P1|NOT COMPLETED|Overall Study||6
5005201|NCT02308124|12314620|P3|COMPLETED|Overall Study||21
5005202|NCT02308124|12314621|P2|COMPLETED|Overall Study||21
5005203|NCT02308124|12314622|P1|COMPLETED|Overall Study||23
5005204|NCT02308124|12314620|P3|STARTED|Overall Study||29
5005205|NCT02308124|12314621|P2|STARTED|Overall Study||29
5005206|NCT02308124|12314622|P1|STARTED|Overall Study||29
5005207|NCT02308046|12314644|P2|NOT COMPLETED|Overall Study||38
5005208|NCT02308046|12314645|P1|NOT COMPLETED|Overall Study||34
5005209|NCT02308046|12314644|P2|COMPLETED|Overall Study||67
5005210|NCT02308046|12314645|P1|COMPLETED|Overall Study||73
5005211|NCT02308046|12314644|P2|STARTED|Overall Study||105
5005212|NCT02308046|12314645|P1|STARTED|Overall Study||107
5005213|NCT02308033|12314661|P2|NOT COMPLETED|Overall Study||19
5005214|NCT02308033|12314662|P1|NOT COMPLETED|Overall Study||26
5005215|NCT02308033|12314661|P2|COMPLETED|Overall Study||83
5005216|NCT02308033|12314662|P1|COMPLETED|Overall Study||76
5005217|NCT02308033|12314661|P2|STARTED|Overall Study||102
5005218|NCT02308033|12314662|P1|STARTED|Overall Study||102
5005219|NCT02308020|12314682|P6|NOT COMPLETED|Overall Study||2
5005220|NCT02308020|12314683|P5|NOT COMPLETED|Overall Study||2
5005221|NCT02308020|12314684|P4|NOT COMPLETED|Overall Study||4
5005222|NCT02308020|12314685|P3|NOT COMPLETED|Overall Study||1
5005223|NCT02308020|12314686|P2|NOT COMPLETED|Overall Study||12
5005224|NCT02308020|12314687|P1|NOT COMPLETED|Overall Study||3
5005225|NCT02308020|12314682|P6|COMPLETED|Overall Study||15
5005226|NCT02308020|12314683|P5|COMPLETED|Overall Study||21
5005227|NCT02308020|12314684|P4|COMPLETED|Overall Study||24
5005228|NCT02308020|12314685|P3|COMPLETED|Overall Study||8
5005229|NCT02308020|12314686|P2|COMPLETED|Overall Study||46
5005230|NCT02308020|12314687|P1|COMPLETED|Overall Study||24
5005231|NCT02308020|12314682|P6|Progressive Disease|Overall Study||13
5005232|NCT02308020|12314683|P5|Progressive Disease|Overall Study||16
5005233|NCT02308020|12314684|P4|Progressive Disease|Overall Study||20
5005234|NCT02308020|12314685|P3|Progressive Disease|Overall Study||6
5005235|NCT02308020|12314686|P2|Progressive Disease|Overall Study||43
5005236|NCT02308020|12314687|P1|Progressive Disease|Overall Study||23
5005237|NCT02308020|12314682|P6|Received at Least One Dose of Study Drug|Overall Study||17
5005238|NCT02308020|12314683|P5|Received at Least One Dose of Study Drug|Overall Study||23
5005239|NCT02308020|12314684|P4|Received at Least One Dose of Study Drug|Overall Study||28
5005240|NCT02308020|12314685|P3|Received at Least One Dose of Study Drug|Overall Study||9
5005241|NCT02308020|12314686|P2|Received at Least One Dose of Study Drug|Overall Study||58
5005242|NCT02308020|12314687|P1|Received at Least One Dose of Study Drug|Overall Study||27
5005243|NCT02308020|12314682|P6|STARTED|Overall Study||17
5005244|NCT02308020|12314683|P5|STARTED|Overall Study||23
5005245|NCT02308020|12314684|P4|STARTED|Overall Study||28
5005246|NCT02308020|12314685|P3|STARTED|Overall Study||9
5005247|NCT02308020|12314686|P2|STARTED|Overall Study||58
5005248|NCT02308020|12314687|P1|STARTED|Overall Study||27
5005249|NCT02307916|12314739|P2|NOT COMPLETED|Overall Study||1
5005250|NCT02307916|12314740|P1|NOT COMPLETED|Overall Study||2
5005251|NCT02307916|12314739|P2|COMPLETED|Overall Study||14
5005252|NCT02307916|12314740|P1|COMPLETED|Overall Study||40
5005253|NCT02307916|12314739|P2|STARTED|Overall Study||15
5005254|NCT02307916|12314740|P1|STARTED|Overall Study||42
5005255|NCT02307838|12314757|P3|NOT COMPLETED|Overall Study||0
5005256|NCT02307838|12314758|P2|NOT COMPLETED|Overall Study||0
5005257|NCT02307838|12314759|P1|NOT COMPLETED|Overall Study||0
5005258|NCT02307838|12314757|P3|COMPLETED|Overall Study||55
5005259|NCT02307838|12314758|P2|COMPLETED|Overall Study||64
5005260|NCT02307838|12314759|P1|COMPLETED|Overall Study||56
5005261|NCT02307838|12314757|P3|STARTED|Overall Study||55
5005262|NCT02307838|12314758|P2|STARTED|Overall Study||64
5005263|NCT02307838|12314759|P1|STARTED|Overall Study||56
5005264|NCT02307682|12314805|P3|NOT COMPLETED|Overall Study||64
5005265|NCT02307682|12314806|P2|NOT COMPLETED|Overall Study||57
5005266|NCT02307682|12314807|P1|NOT COMPLETED|Overall Study||50
5005267|NCT02307682|12314805|P3|COMPLETED|Overall Study||297
5005268|NCT02307682|12314806|P2|COMPLETED|Overall Study||304
5005269|NCT02307682|12314807|P1|COMPLETED|Overall Study||310
5005270|NCT02307682|12314805|P3|Randomized and Treated|Overall Study||360
5005271|NCT02307682|12314806|P2|Randomized and Treated|Overall Study||360
5005272|NCT02307682|12314807|P1|Randomized and Treated|Overall Study||358
5005273|NCT02307682|12314805|P3|STARTED|Overall Study||361
5005274|NCT02307682|12314806|P2|STARTED|Overall Study||361
5005275|NCT02307682|12314807|P1|STARTED|Overall Study||360
5005276|NCT02307552|12314907|P1|NOT COMPLETED|Overall Study||0
5005277|NCT02307552|12314907|P1|COMPLETED|Overall Study||1
5005278|NCT02307552|12314907|P1|STARTED|Overall Study||1
5005279|NCT02307526|12314911|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
5005280|NCT02307526|12314911|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
5005281|NCT02307526|12314911|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
5005282|NCT02307526|12314911|P1|NOT COMPLETED|Day 1 - No Drug||0
5005283|NCT02307526|12314911|P1|COMPLETED|Day 1 - No Drug||10
5005284|NCT02307526|12314911|P1|STARTED|Day 1 - No Drug||10
5005285|NCT02307513|12314923|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
5005286|NCT02307513|12314924|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
5005287|NCT02307513|12314923|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
5005288|NCT02307513|12314924|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
5005289|NCT02307513|12314923|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
5005290|NCT02307513|12314924|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
5005291|NCT02307513|12314923|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
5005292|NCT02307513|12314924|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
5005293|NCT02307513|12314923|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
5005294|NCT02307513|12314924|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
5005295|NCT02307513|12314923|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
5005296|NCT02307513|12314924|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
5005297|NCT02307318|12314965|P1|NOT COMPLETED|Overall Study||0
5005298|NCT02307318|12314965|P1|COMPLETED|Overall Study||51
5005299|NCT02307318|12314965|P1|STARTED|Overall Study||51
5005300|NCT02307266|12314975|P3|NOT COMPLETED|Overall Study||6
5005301|NCT02307266|12314976|P2|NOT COMPLETED|Overall Study||1
5005302|NCT02307266|12314977|P1|NOT COMPLETED|Overall Study||8
5005303|NCT02307266|12314975|P3|COMPLETED|Overall Study||25
5005304|NCT02307266|12314976|P2|COMPLETED|Overall Study||32
5005305|NCT02307266|12314977|P1|COMPLETED|Overall Study||25
5005306|NCT02307266|12314975|P3|STARTED|Overall Study||31
5005307|NCT02307266|12314976|P2|STARTED|Overall Study||33
5005308|NCT02307266|12314977|P1|STARTED|Overall Study||33
5005309|NCT02307188|12314985|P1|NOT COMPLETED|Overall Study||4
5005310|NCT02307188|12314985|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
5005311|NCT02307188|12314985|P1|STARTED|Overall Study||5
5005312|NCT02307123|12314989|P1|NOT COMPLETED|Overall Study||0
5005313|NCT02307123|12314989|P1|COMPLETED|Overall Study||483
5005314|NCT02307123|12314989|P1|STARTED|Overall Study||483
5005315|NCT02306928|12314994|P1|NOT COMPLETED|Overall Study||0
5005316|NCT02306928|12314994|P1|COMPLETED|Overall Study||15
5005317|NCT02306928|12314994|P1|STARTED|Overall Study||15
5005318|NCT02306850|12315002|P1|NOT COMPLETED|Overall Study||2
5005319|NCT02306850|12315002|P1|COMPLETED|Overall Study||8
5005320|NCT02306850|12315002|P1|STARTED|Overall Study||10
5005321|NCT02306759|12315009|P2|NOT COMPLETED|Overall Study||0
5005322|NCT02306759|12315010|P1|NOT COMPLETED|Overall Study||0
5005323|NCT02306759|12315009|P2|COMPLETED|Overall Study||30
5005324|NCT02306759|12315010|P1|COMPLETED|Overall Study||30
5005325|NCT02306759|12315009|P2|STARTED|Overall Study||30
5005326|NCT02306759|12315010|P1|STARTED|Overall Study||30
5005327|NCT02306694|12315024|P1|NOT COMPLETED|Overall Study||4
5005328|NCT02306694|12315024|P1|COMPLETED|Overall Study||12
5005329|NCT02306694|12315024|P1|STARTED|Overall Study||16
5005330|NCT02306265|12315034|P1|NOT COMPLETED|Overall Study||1
5005331|NCT02306265|12315034|P1|COMPLETED|Overall Study||249
5005332|NCT02306265|12315034|P1|STARTED|Overall Study||250
5005333|NCT02305888|12315043|P3|NOT COMPLETED|Overall Study||1
5005334|NCT02305888|12315044|P2|NOT COMPLETED|Overall Study||1
5005335|NCT02305888|12315045|P1|NOT COMPLETED|Overall Study||0
5005336|NCT02305888|12315043|P3|COMPLETED|Overall Study||62
5005337|NCT02305888|12315044|P2|COMPLETED|Overall Study||62
5005338|NCT02305888|12315045|P1|COMPLETED|Overall Study||63
5005339|NCT02305888|12315043|P3|STARTED|Overall Study||63
5005340|NCT02305888|12315044|P2|STARTED|Overall Study||63
5005341|NCT02305888|12315045|P1|STARTED|Overall Study||63
5005342|NCT02305797|12315064|P2|NOT COMPLETED|Overall Study||38
5005343|NCT02305797|12315065|P1|NOT COMPLETED|Overall Study||45
5005344|NCT02305797|12315064|P2|COMPLETED|Overall Study||210
5005345|NCT02305797|12315065|P1|COMPLETED|Overall Study||202
5005346|NCT02305797|12315064|P2|STARTED|Overall Study||248
5005347|NCT02305797|12315065|P1|STARTED|Overall Study||247
5005348|NCT02305758|12315075|P2|NOT COMPLETED|Overall Study||65
5005349|NCT02305758|12315076|P1|NOT COMPLETED|Overall Study||65
5005350|NCT02305758|12315075|P2|COMPLETED|Overall Study||0
5005351|NCT02305758|12315076|P1|COMPLETED|Overall Study||0
5005352|NCT02305758|12315075|P2|STARTED|Overall Study||65
5005353|NCT02305758|12315076|P1|STARTED|Overall Study||65
5005354|NCT02305732|12315086|P1|NOT COMPLETED|Overall Study||18
5005355|NCT02305732|12315086|P1|COMPLETED|Overall Study||72
5005356|NCT02305732|12315086|P1|STARTED|Overall Study||90
5005357|NCT02305446|12315094|P1|NOT COMPLETED|Overall Study||1
5005358|NCT02305446|12315094|P1|COMPLETED|Overall Study||54
5005359|NCT02305446|12315094|P1|STARTED|Overall Study||55
5005360|NCT02305381|12315102|P3|NOT COMPLETED|Overall Study||7
5005361|NCT02305381|12315103|P2|NOT COMPLETED|Overall Study||5
5005362|NCT02305381|12315104|P1|NOT COMPLETED|Overall Study||5
5005363|NCT02305381|12315102|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
5005364|NCT02305381|12315103|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
5005365|NCT02305381|12315104|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
5005366|NCT02305381|12315102|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
5005367|NCT02305381|12315103|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
5005368|NCT02305381|12315104|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
5005369|NCT02305381|12315102|P3|Exposed|Overall Study||133
5005370|NCT02305381|12315103|P2|Exposed|Overall Study||131
5005371|NCT02305381|12315104|P1|Exposed|Overall Study||132
5005372|NCT02305381|12315102|P3|STARTED|Overall Study||133
5005373|NCT02305381|12315103|P2|STARTED|Overall Study||132
5005374|NCT02305381|12315104|P1|STARTED|Overall Study||132
5005375|NCT02305329|12315137|P4|NOT COMPLETED|Overall Study||0
5005376|NCT02305329|12315138|P3|NOT COMPLETED|Overall Study||0
5005377|NCT02305329|12315139|P2|NOT COMPLETED|Overall Study||1
5005378|NCT02305329|12315140|P1|NOT COMPLETED|Overall Study||0
5005379|NCT02305329|12315137|P4|COMPLETED|Overall Study||14
5005380|NCT02305329|12315138|P3|COMPLETED|Overall Study||14
5005381|NCT02305329|12315139|P2|COMPLETED|Overall Study||13
5005382|NCT02305329|12315140|P1|COMPLETED|Overall Study||14
5005383|NCT02305329|12315137|P4|Period 2|Overall Study||14
5005384|NCT02305329|12315138|P3|Period 2|Overall Study||14
5005385|NCT02305329|12315139|P2|Period 2|Overall Study||13
5005386|NCT02305329|12315140|P1|Period 2|Overall Study||14
5005387|NCT02305329|12315137|P4|Period 1|Overall Study||14
5005388|NCT02305329|12315138|P3|Period 1|Overall Study||14
5005389|NCT02305329|12315139|P2|Period 1|Overall Study||14
5005390|NCT02305329|12315140|P1|Period 1|Overall Study||14
5005391|NCT02305329|12315137|P4|STARTED|Overall Study||14
5005392|NCT02305329|12315138|P3|STARTED|Overall Study||14
5005393|NCT02305329|12315139|P2|STARTED|Overall Study||14
5005394|NCT02305329|12315140|P1|STARTED|Overall Study||14
5005395|NCT02305316|12315164|P2|NOT COMPLETED|Overall Study||0
5005396|NCT02305316|12315165|P1|NOT COMPLETED|Overall Study||0
5005397|NCT02305316|12315164|P2|COMPLETED|Overall Study||14
5005398|NCT02305316|12315165|P1|COMPLETED|Overall Study||14
5005399|NCT02305316|12315164|P2|STARTED|Overall Study||14
5005400|NCT02305316|12315165|P1|STARTED|Overall Study||14
5005401|NCT02305277|12315183|P6|NOT COMPLETED|Overall Study||0
5005402|NCT02305277|12315184|P5|NOT COMPLETED|Overall Study||1
5005403|NCT02305277|12315185|P4|NOT COMPLETED|Overall Study||0
5005404|NCT02305277|12315186|P3|NOT COMPLETED|Overall Study||0
5005405|NCT02305277|12315187|P2|NOT COMPLETED|Overall Study||0
5005406|NCT02305277|12315188|P1|NOT COMPLETED|Overall Study||1
5005407|NCT02305277|12315183|P6|COMPLETED|Overall Study||14
5005408|NCT02305277|12315184|P5|COMPLETED|Overall Study||13
5005409|NCT02305277|12315185|P4|COMPLETED|Overall Study||14
5005410|NCT02305277|12315186|P3|COMPLETED|Overall Study||14
5005411|NCT02305277|12315187|P2|COMPLETED|Overall Study||14
5005412|NCT02305277|12315188|P1|COMPLETED|Overall Study||14
5005413|NCT02305277|12315183|P6|Received TBM|Overall Study||14
5005414|NCT02305277|12315184|P5|Received TBM|Overall Study||14
5005415|NCT02305277|12315185|P4|Received TBM|Overall Study||14
5005416|NCT02305277|12315186|P3|Received TBM|Overall Study||14
5005417|NCT02305277|12315187|P2|Received TBM|Overall Study||14
5005418|NCT02305277|12315188|P1|Received TBM|Overall Study||15
5005419|NCT02305277|12315183|P6|Received CM|Overall Study||14
5005420|NCT02305277|12315184|P5|Received CM|Overall Study||14
5005421|NCT02305277|12315185|P4|Received CM|Overall Study||14
5005422|NCT02305277|12315186|P3|Received CM|Overall Study||14
5005423|NCT02305277|12315187|P2|Received CM|Overall Study||14
5005424|NCT02305277|12315188|P1|Received CM|Overall Study||15
5005425|NCT02305277|12315183|P6|STARTED|Overall Study||14
5005426|NCT02305277|12315184|P5|STARTED|Overall Study||14
5005427|NCT02305277|12315185|P4|STARTED|Overall Study||14
5005428|NCT02305277|12315186|P3|STARTED|Overall Study||14
5005429|NCT02305277|12315187|P2|STARTED|Overall Study||14
5005430|NCT02305277|12315188|P1|STARTED|Overall Study||15
5005431|NCT02305238|12315217|P3|NOT COMPLETED|Overall Study||8
5005432|NCT02305238|12315218|P2|NOT COMPLETED|Overall Study||19
5005433|NCT02305238|12315219|P1|NOT COMPLETED|Overall Study||16
5005434|NCT02305238|12315217|P3|COMPLETED|Overall Study||0
5005435|NCT02305238|12315218|P2|COMPLETED|Overall Study||104
5005436|NCT02305238|12315219|P1|COMPLETED|Overall Study||108
5005437|NCT02305238|12315217|P3|BCVA Post-randomization Assessment|Overall Study||0
5005438|NCT02305238|12315218|P2|BCVA Post-randomization Assessment|Overall Study||123
5005439|NCT02305238|12315219|P1|BCVA Post-randomization Assessment|Overall Study||123
5005440|NCT02305238|12315217|P3|Randomized|Overall Study||0
5005441|NCT02305238|12315218|P2|Randomized|Overall Study||123
5005442|NCT02305238|12315219|P1|Randomized|Overall Study||124
5005443|NCT02305238|12315217|P3|Treated|Overall Study||7
5005444|NCT02305238|12315218|P2|Treated|Overall Study||123
5005445|NCT02305238|12315219|P1|Treated|Overall Study||124
5005446|NCT02305238|12315217|P3|STARTED|Overall Study||8
5005447|NCT02305238|12315218|P2|STARTED|Overall Study||123
5005448|NCT02305238|12315219|P1|STARTED|Overall Study||124
5005449|NCT02305017|12315236|P2|NOT COMPLETED|Overall Study||0
5005450|NCT02305017|12315237|P1|NOT COMPLETED|Overall Study||0
5005451|NCT02305017|12315236|P2|COMPLETED|Overall Study||14
5005452|NCT02305017|12315237|P1|COMPLETED|Overall Study||14
5005453|NCT02305017|12315236|P2|STARTED|Overall Study||14
5005454|NCT02305017|12315237|P1|STARTED|Overall Study||14
5005455|NCT02304926|12315251|P2|NOT COMPLETED|Overall Study||1
5005456|NCT02304926|12315252|P1|NOT COMPLETED|Overall Study||2
5005457|NCT02304926|12315251|P2|COMPLETED|Overall Study||19
5005458|NCT02304926|12315252|P1|COMPLETED|Overall Study||20
5005459|NCT02304926|12315251|P2|STARTED|Overall Study||20
5005460|NCT02304926|12315252|P1|STARTED|Overall Study||22
5005461|NCT02304705|12315298|P2|NOT COMPLETED|Overall Study||7
5005462|NCT02304705|12315299|P1|NOT COMPLETED|Overall Study||4
5005463|NCT02304705|12315298|P2|COMPLETED|Overall Study||10
5005464|NCT02304705|12315299|P1|COMPLETED|Overall Study||12
5005465|NCT02304705|12315298|P2|STARTED|Overall Study||17
5005466|NCT02304705|12315299|P1|STARTED|Overall Study||16
5005467|NCT02304484|12315305|P1|NOT COMPLETED|Overall Study||25
5005468|NCT02304484|12315305|P1|COMPLETED|Overall Study||745
5005469|NCT02304484|12315305|P1|STARTED|Overall Study||770
5005470|NCT02304432|12315310|P4|NOT COMPLETED|Second Open Label DCS||0
5005471|NCT02304432|12315311|P3|NOT COMPLETED|Second Open Label DCS||0
5005472|NCT02304432|12315312|P2|NOT COMPLETED|Second Open Label DCS||0
5005473|NCT02304432|12315313|P1|NOT COMPLETED|Second Open Label DCS||0
5005474|NCT02304432|12315310|P4|COMPLETED|Second Open Label DCS||2
5005475|NCT02304432|12315311|P3|COMPLETED|Second Open Label DCS||0
5005476|NCT02304432|12315312|P2|COMPLETED|Second Open Label DCS||0
5005477|NCT02304432|12315313|P1|COMPLETED|Second Open Label DCS||0
5005478|NCT02304432|12315310|P4|STARTED|Second Open Label DCS||2
5005479|NCT02304432|12315311|P3|STARTED|Second Open Label DCS||0
5005480|NCT02304432|12315312|P2|STARTED|Second Open Label DCS||0
5005481|NCT02304432|12315313|P1|STARTED|Second Open Label DCS||0
5005482|NCT02304432|12315310|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
5005483|NCT02304432|12315311|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
5005484|NCT02304432|12315312|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
5005485|NCT02304432|12315313|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
5005486|NCT02304432|12315310|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
5005487|NCT02304432|12315311|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
5005488|NCT02304432|12315312|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
5005489|NCT02304432|12315313|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
5005490|NCT02304432|12315310|P4|STARTED|Double-Blind DCS Placebo Crossover||0
5005491|NCT02304432|12315311|P3|STARTED|Double-Blind DCS Placebo Crossover||1
5005492|NCT02304432|12315312|P2|STARTED|Double-Blind DCS Placebo Crossover||1
5005493|NCT02304432|12315313|P1|STARTED|Double-Blind DCS Placebo Crossover||0
5005494|NCT02304432|12315310|P4|NOT COMPLETED|Open Label DCS||0
5005495|NCT02304432|12315311|P3|NOT COMPLETED|Open Label DCS||0
5005496|NCT02304432|12315312|P2|NOT COMPLETED|Open Label DCS||0
5005497|NCT02304432|12315313|P1|NOT COMPLETED|Open Label DCS||0
5005498|NCT02304432|12315310|P4|COMPLETED|Open Label DCS||0
5005499|NCT02304432|12315311|P3|COMPLETED|Open Label DCS||0
5005500|NCT02304432|12315312|P2|COMPLETED|Open Label DCS||0
5005501|NCT02304432|12315313|P1|COMPLETED|Open Label DCS||2
5005502|NCT02304432|12315310|P4|STARTED|Open Label DCS||0
5005503|NCT02304432|12315311|P3|STARTED|Open Label DCS||0
5005504|NCT02304432|12315312|P2|STARTED|Open Label DCS||0
5005505|NCT02304432|12315313|P1|STARTED|Open Label DCS||2
5005506|NCT02304406|12315345|P1|NOT COMPLETED|Overall Study||0
5005507|NCT02304406|12315345|P1|COMPLETED|Overall Study||449
5005508|NCT02304406|12315345|P1|STARTED|Overall Study||449
5005509|NCT02304380|12315368|P6|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005510|NCT02304380|12315369|P5|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005511|NCT02304380|12315370|P4|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005512|NCT02304380|12315371|P3|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005513|NCT02304380|12315372|P2|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005514|NCT02304380|12315373|P1|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005515|NCT02304380|12315368|P6|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005516|NCT02304380|12315369|P5|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005517|NCT02304380|12315370|P4|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005518|NCT02304380|12315371|P3|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005519|NCT02304380|12315372|P2|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
5005520|NCT02304380|12315373|P1|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
5005521|NCT02304380|12315368|P6|STARTED|ACO Stakeholder Interviews (Aim 1)||0
5005522|NCT02304380|12315369|P5|STARTED|ACO Stakeholder Interviews (Aim 1)||0
5005523|NCT02304380|12315370|P4|STARTED|ACO Stakeholder Interviews (Aim 1)||0
5005524|NCT02304380|12315371|P3|STARTED|ACO Stakeholder Interviews (Aim 1)||0
5005525|NCT02304380|12315372|P2|STARTED|ACO Stakeholder Interviews (Aim 1)||0
5005526|NCT02304380|12315373|P1|STARTED|ACO Stakeholder Interviews (Aim 1)||24
5005527|NCT02304380|12315368|P6|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005528|NCT02304380|12315369|P5|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005529|NCT02304380|12315370|P4|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005530|NCT02304380|12315371|P3|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005531|NCT02304380|12315372|P2|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005532|NCT02304380|12315373|P1|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005533|NCT02304380|12315368|P6|COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005534|NCT02304380|12315369|P5|COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005535|NCT02304380|12315370|P4|COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005536|NCT02304380|12315371|P3|COMPLETED|Interviews & Focus Groups (Aim 1)||33
5005537|NCT02304380|12315372|P2|COMPLETED|Interviews & Focus Groups (Aim 1)||35
5005538|NCT02304380|12315373|P1|COMPLETED|Interviews & Focus Groups (Aim 1)||0
5005539|NCT02304380|12315368|P6|STARTED|Interviews & Focus Groups (Aim 1)||0
5005540|NCT02304380|12315369|P5|STARTED|Interviews & Focus Groups (Aim 1)||0
5005541|NCT02304380|12315370|P4|STARTED|Interviews & Focus Groups (Aim 1)||0
5005542|NCT02304380|12315371|P3|STARTED|Interviews & Focus Groups (Aim 1)||33
5005543|NCT02304380|12315372|P2|STARTED|Interviews & Focus Groups (Aim 1)||35
5005544|NCT02304380|12315373|P1|STARTED|Interviews & Focus Groups (Aim 1)||0
5005545|NCT02304380|12315368|P6|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005546|NCT02304380|12315369|P5|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005547|NCT02304380|12315370|P4|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
5005548|NCT02304380|12315371|P3|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005549|NCT02304380|12315372|P2|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005550|NCT02304380|12315373|P1|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005551|NCT02304380|12315368|P6|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005552|NCT02304380|12315369|P5|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005553|NCT02304380|12315370|P4|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
5005554|NCT02304380|12315371|P3|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005555|NCT02304380|12315372|P2|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005556|NCT02304380|12315373|P1|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005557|NCT02304380|12315368|P6|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005558|NCT02304380|12315369|P5|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005559|NCT02304380|12315370|P4|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
5005560|NCT02304380|12315371|P3|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005561|NCT02304380|12315372|P2|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005562|NCT02304380|12315373|P1|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
5005563|NCT02304380|12315368|P6|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005564|NCT02304380|12315369|P5|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005565|NCT02304380|12315370|P4|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005566|NCT02304380|12315371|P3|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005567|NCT02304380|12315372|P2|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005568|NCT02304380|12315373|P1|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005569|NCT02304380|12315368|P6|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
5005570|NCT02304380|12315369|P5|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
5005571|NCT02304380|12315370|P4|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005572|NCT02304380|12315371|P3|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005573|NCT02304380|12315372|P2|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005574|NCT02304380|12315373|P1|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
5005575|NCT02304380|12315368|P6|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
5005576|NCT02304380|12315369|P5|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
5005577|NCT02304380|12315370|P4|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
5005578|NCT02304380|12315371|P3|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
5005579|NCT02304380|12315372|P2|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
5005580|NCT02304380|12315373|P1|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
5005581|NCT02304367|12315423|P1|NOT COMPLETED|Overall Study||17
5005582|NCT02304367|12315423|P1|COMPLETED|Overall Study||0
5005583|NCT02304367|12315423|P1|Completed 144 Weeks of Study Drug|Overall Study||11
5005584|NCT02304367|12315423|P1|Completed 48 Weeks of Study Drug|Overall Study||16
5005585|NCT02304367|12315423|P1|STARTED|Overall Study||17
5005586|NCT02304159|12315483|P2|NOT COMPLETED|Overall Study||2
5005587|NCT02304159|12315484|P1|NOT COMPLETED|Overall Study||2
5005588|NCT02304159|12315483|P2|COMPLETED|Overall Study||16
5005589|NCT02304159|12315484|P1|COMPLETED|Overall Study||19
5005590|NCT02304159|12315483|P2|STARTED|Overall Study||18
5005591|NCT02304159|12315484|P1|STARTED|Overall Study||21
5005592|NCT02303743|12315496|P2|NOT COMPLETED|Overall Study||0
5005593|NCT02303743|12315497|P1|NOT COMPLETED|Overall Study||0
5005594|NCT02303743|12315496|P2|COMPLETED|Overall Study||152
5005595|NCT02303743|12315497|P1|COMPLETED|Overall Study||108
5005596|NCT02303743|12315496|P2|STARTED|Overall Study||152
5005597|NCT02303743|12315497|P1|STARTED|Overall Study||108
5005598|NCT02303704|12315507|P2|NOT COMPLETED|Overall Study||9
5005599|NCT02303704|12315508|P1|NOT COMPLETED|Overall Study||5
5005600|NCT02303704|12315507|P2|COMPLETED|Overall Study||219
5005601|NCT02303704|12315508|P1|COMPLETED|Overall Study||215
5005602|NCT02303704|12315507|P2|STARTED|Overall Study||228
5005603|NCT02303704|12315508|P1|STARTED|Overall Study||220
5005604|NCT02303574|12315536|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005605|NCT02303574|12315537|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005606|NCT02303574|12315538|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
5005607|NCT02303574|12315539|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005608|NCT02303574|12315540|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005609|NCT02303574|12315541|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005610|NCT02303574|12315542|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005611|NCT02303574|12315543|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005612|NCT02303574|12315544|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005613|NCT02303574|12315545|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005614|NCT02303574|12315536|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
5005615|NCT02303574|12315537|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
5005616|NCT02303574|12315538|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
5005617|NCT02303574|12315539|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
5005618|NCT02303574|12315540|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005619|NCT02303574|12315541|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005620|NCT02303574|12315542|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005621|NCT02303574|12315543|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005622|NCT02303574|12315544|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005623|NCT02303574|12315545|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
5005624|NCT02303574|12315536|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
5005625|NCT02303574|12315537|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
5005626|NCT02303574|12315538|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
5005627|NCT02303574|12315539|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
5005628|NCT02303574|12315540|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005629|NCT02303574|12315541|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005630|NCT02303574|12315542|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005631|NCT02303574|12315543|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005632|NCT02303574|12315544|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005633|NCT02303574|12315545|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
5005634|NCT02303574|12315536|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005635|NCT02303574|12315537|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005636|NCT02303574|12315538|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005637|NCT02303574|12315539|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005638|NCT02303574|12315540|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005639|NCT02303574|12315541|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005640|NCT02303574|12315542|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005641|NCT02303574|12315543|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005642|NCT02303574|12315544|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005643|NCT02303574|12315545|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
5005644|NCT02303574|12315536|P10|COMPLETED|Part 1b (Fed State) - SAD||3
5005645|NCT02303574|12315537|P9|COMPLETED|Part 1b (Fed State) - SAD||0
5005646|NCT02303574|12315538|P8|COMPLETED|Part 1b (Fed State) - SAD||0
5005647|NCT02303574|12315539|P7|COMPLETED|Part 1b (Fed State) - SAD||0
5005648|NCT02303574|12315540|P6|COMPLETED|Part 1b (Fed State) - SAD||5
5005649|NCT02303574|12315541|P5|COMPLETED|Part 1b (Fed State) - SAD||0
5005650|NCT02303574|12315542|P4|COMPLETED|Part 1b (Fed State) - SAD||0
5005651|NCT02303574|12315543|P3|COMPLETED|Part 1b (Fed State) - SAD||0
5005652|NCT02303574|12315544|P2|COMPLETED|Part 1b (Fed State) - SAD||0
5005653|NCT02303574|12315545|P1|COMPLETED|Part 1b (Fed State) - SAD||0
5005654|NCT02303574|12315536|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
5005655|NCT02303574|12315537|P9|STARTED|Part 1b (Fed State) - SAD||0
5005656|NCT02303574|12315538|P8|STARTED|Part 1b (Fed State) - SAD||0
5005657|NCT02303574|12315539|P7|STARTED|Part 1b (Fed State) - SAD||0
5005658|NCT02303574|12315540|P6|STARTED|Part 1b (Fed State) - SAD||5
5005659|NCT02303574|12315541|P5|STARTED|Part 1b (Fed State) - SAD||0
5005660|NCT02303574|12315542|P4|STARTED|Part 1b (Fed State) - SAD||0
5005661|NCT02303574|12315543|P3|STARTED|Part 1b (Fed State) - SAD||0
5005662|NCT02303574|12315544|P2|STARTED|Part 1b (Fed State) - SAD||0
5005663|NCT02303574|12315545|P1|STARTED|Part 1b (Fed State) - SAD||0
5005664|NCT02303574|12315536|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005665|NCT02303574|12315537|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005666|NCT02303574|12315538|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005667|NCT02303574|12315539|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005668|NCT02303574|12315540|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005669|NCT02303574|12315541|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005670|NCT02303574|12315542|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005671|NCT02303574|12315543|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
5005672|NCT02303574|12315544|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005673|NCT02303574|12315545|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
5005674|NCT02303574|12315536|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
5005675|NCT02303574|12315537|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
5005676|NCT02303574|12315538|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
5005677|NCT02303574|12315539|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
5005678|NCT02303574|12315540|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
5005679|NCT02303574|12315541|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
5005680|NCT02303574|12315542|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
5005681|NCT02303574|12315543|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
5005682|NCT02303574|12315544|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
5005683|NCT02303574|12315545|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
5005684|NCT02303574|12315536|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
5005685|NCT02303574|12315537|P9|STARTED|Part 1a (Fasted State)- SAD||0
5005686|NCT02303574|12315538|P8|STARTED|Part 1a (Fasted State)- SAD||0
5005687|NCT02303574|12315539|P7|STARTED|Part 1a (Fasted State)- SAD||0
5005688|NCT02303574|12315540|P6|STARTED|Part 1a (Fasted State)- SAD||0
5005689|NCT02303574|12315541|P5|STARTED|Part 1a (Fasted State)- SAD||6
5005690|NCT02303574|12315542|P4|STARTED|Part 1a (Fasted State)- SAD||6
5005691|NCT02303574|12315543|P3|STARTED|Part 1a (Fasted State)- SAD||6
5005692|NCT02303574|12315544|P2|STARTED|Part 1a (Fasted State)- SAD||6
5005693|NCT02303574|12315545|P1|STARTED|Part 1a (Fasted State)- SAD||6
5005694|NCT02303548|12315759|P2|NOT COMPLETED|Overall Study||0
5005695|NCT02303548|12315760|P1|NOT COMPLETED|Overall Study||0
5005696|NCT02303548|12315759|P2|COMPLETED|Overall Study||25
5005697|NCT02303548|12315760|P1|COMPLETED|Overall Study||25
5005698|NCT02303548|12315759|P2|STARTED|Overall Study||25
5005699|NCT02303548|12315760|P1|STARTED|Overall Study||25
5005700|NCT02303262|12315766|P1|NOT COMPLETED|Overall Study||2
5005701|NCT02303262|12315766|P1|COMPLETED|Overall Study||18
5005702|NCT02303262|12315766|P1|STARTED|Overall Study||20
5005703|NCT02303041|12315774|P2|NOT COMPLETED|Overall Study||2
5005704|NCT02303041|12315775|P1|NOT COMPLETED|Overall Study||1
5005705|NCT02303041|12315774|P2|COMPLETED|Overall Study||4
5005706|NCT02303041|12315775|P1|COMPLETED|Overall Study||3
5005707|NCT02303041|12315774|P2|STARTED|Overall Study||6
5005708|NCT02303041|12315775|P1|STARTED|Overall Study||4
5005709|NCT02302859|12315791|P2|NOT COMPLETED|Overall Study||2
5005710|NCT02302859|12315792|P1|NOT COMPLETED|Overall Study||1
5005711|NCT02302859|12315791|P2|COMPLETED|Overall Study||4
5005712|NCT02302859|12315792|P1|COMPLETED|Overall Study||1
5005713|NCT02302859|12315791|P2|STARTED|Overall Study||6
5005714|NCT02302859|12315792|P1|STARTED|Overall Study||2
5005715|NCT02302846|12315798|P1|NOT COMPLETED|Overall Study||1
5005716|NCT02302846|12315798|P1|COMPLETED|Overall Study||4
5005717|NCT02302846|12315798|P1|STARTED|Overall Study||5
5005718|NCT02302807|12315804|P2|NOT COMPLETED|Overall Study||467
5005719|NCT02302807|12315805|P1|NOT COMPLETED|Overall Study||464
5005720|NCT02302807|12315804|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
5005721|NCT02302807|12315805|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
5005722|NCT02302807|12315804|P2|Received Treatment|Overall Study||459
5005723|NCT02302807|12315805|P1|Received Treatment|Overall Study||443
5005724|NCT02302807|12315804|P2|STARTED|Overall Study||467
5005725|NCT02302807|12315805|P1|STARTED|Overall Study||464
5005726|NCT02302716|12315852|P2|NOT COMPLETED|Overall Study||19
5005727|NCT02302716|12315853|P1|NOT COMPLETED|Overall Study||19
5005728|NCT02302716|12315852|P2|COMPLETED|Overall Study||225
5005729|NCT02302716|12315853|P1|COMPLETED|Overall Study||230
5005730|NCT02302716|12315852|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
5005731|NCT02302716|12315853|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
5005732|NCT02302716|12315852|P2|STARTED|Overall Study||244
5005733|NCT02302716|12315853|P1|STARTED|Overall Study||249
5005734|NCT02302365|12315879|P1|NOT COMPLETED|0-24 Hour Period||0
5005735|NCT02302365|12315879|P1|COMPLETED|0-24 Hour Period||32
5005736|NCT02302365|12315879|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
5005737|NCT02302365|12315879|P1|NOT COMPLETED|0-2 Hour Period||2
5005738|NCT02302365|12315879|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
5005739|NCT02302365|12315879|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
5005740|NCT02302339|12315901|P4|NOT COMPLETED|Overall Study||0
5005741|NCT02302339|12315902|P3|NOT COMPLETED|Overall Study||1
5005742|NCT02302339|12315903|P2|NOT COMPLETED|Overall Study||2
5005743|NCT02302339|12315904|P1|NOT COMPLETED|Overall Study||1
5005744|NCT02302339|12315901|P4|COMPLETED|Overall Study||7
5005745|NCT02302339|12315902|P3|COMPLETED|Overall Study||28
5005746|NCT02302339|12315903|P2|COMPLETED|Overall Study||32
5005747|NCT02302339|12315904|P1|COMPLETED|Overall Study||61
5005748|NCT02302339|12315901|P4|STARTED|Overall Study||7
5005749|NCT02302339|12315902|P3|STARTED|Overall Study||29
5005750|NCT02302339|12315903|P2|STARTED|Overall Study||34
5005751|NCT02302339|12315904|P1|STARTED|Overall Study||62
5005752|NCT02302222|12315937|P2|NOT COMPLETED|Overall Study||6
5005753|NCT02302222|12315938|P1|NOT COMPLETED|Overall Study||1
5005754|NCT02302222|12315937|P2|COMPLETED|Overall Study||31
5005755|NCT02302222|12315938|P1|COMPLETED|Overall Study||33
5005756|NCT02302222|12315937|P2|STARTED|Overall Study||37
5005757|NCT02302222|12315938|P1|STARTED|Overall Study||34
5005758|NCT02302092|12315946|P2|NOT COMPLETED|Overall Study||0
5005759|NCT02302092|12315947|P1|NOT COMPLETED|Overall Study||0
5005760|NCT02302092|12315946|P2|COMPLETED|Overall Study||7
5005761|NCT02302092|12315947|P1|COMPLETED|Overall Study||6
5005762|NCT02302092|12315946|P2|STARTED|Overall Study||7
5005763|NCT02302092|12315947|P1|STARTED|Overall Study||6
5005764|NCT02302066|12315977|P4|NOT COMPLETED|Overall Study||41
5005765|NCT02302066|12315978|P3|NOT COMPLETED|Overall Study||172
5005766|NCT02302066|12315979|P2|NOT COMPLETED|Overall Study||75
5005767|NCT02302066|12315980|P1|NOT COMPLETED|Overall Study||33
5005768|NCT02302066|12315977|P4|COMPLETED|Overall Study||158
5005769|NCT02302066|12315978|P3|COMPLETED|Overall Study||830
5005770|NCT02302066|12315979|P2|COMPLETED|Overall Study||323
5005771|NCT02302066|12315980|P1|COMPLETED|Overall Study||168
5005772|NCT02302066|12315977|P4|Per-Protocol Set (PPS)|Overall Study||81
5005773|NCT02302066|12315978|P3|Per-Protocol Set (PPS)|Overall Study||174
5005774|NCT02302066|12315979|P2|Per-Protocol Set (PPS)|Overall Study||171
5005775|NCT02302066|12315980|P1|Per-Protocol Set (PPS)|Overall Study||83
5005776|NCT02302066|12315977|P4|Immunogenicity Subset|Overall Study||94
5005777|NCT02302066|12315978|P3|Immunogenicity Subset|Overall Study||192
5005778|NCT02302066|12315979|P2|Immunogenicity Subset|Overall Study||187
5005779|NCT02302066|12315980|P1|Immunogenicity Subset|Overall Study||92
5005780|NCT02302066|12315977|P4|Safety Analysis Set|Overall Study||198
5005781|NCT02302066|12315978|P3|Safety Analysis Set|Overall Study||998
5005782|NCT02302066|12315979|P2|Safety Analysis Set|Overall Study||398
5005783|NCT02302066|12315980|P1|Safety Analysis Set|Overall Study||200
5005784|NCT02302066|12315977|P4|STARTED|Overall Study||199
5005785|NCT02302066|12315978|P3|STARTED|Overall Study||1002
5005786|NCT02302066|12315979|P2|STARTED|Overall Study||398
5005787|NCT02302066|12315980|P1|STARTED|Overall Study||201
5005788|NCT02301988|12316024|P2|NOT COMPLETED|Overall Study||9
5005789|NCT02301988|12316025|P1|NOT COMPLETED|Overall Study||10
5005790|NCT02301988|12316024|P2|COMPLETED|Overall Study||66
5005791|NCT02301988|12316025|P1|COMPLETED|Overall Study||66
5005792|NCT02301988|12316024|P2|STARTED|Overall Study||75
5005793|NCT02301988|12316025|P1|STARTED|Overall Study||76
5005794|NCT02301975|12316058|P3|NOT COMPLETED|Overall Study||22
5005795|NCT02301975|12316059|P2|NOT COMPLETED|Overall Study||25
5005796|NCT02301975|12316060|P1|NOT COMPLETED|Overall Study||31
5005797|NCT02301975|12316058|P3|COMPLETED|Overall Study||477
5005798|NCT02301975|12316059|P2|COMPLETED|Overall Study||476
5005799|NCT02301975|12316060|P1|COMPLETED|Overall Study||473
5005800|NCT02301975|12316058|P3|STARTED|Overall Study||499
5005801|NCT02301975|12316059|P2|STARTED|Overall Study||501
5005802|NCT02301975|12316060|P1|STARTED|Overall Study||504
5005803|NCT02301936|12316088|P2|NOT COMPLETED|Overall Study||0
5005804|NCT02301936|12316089|P1|NOT COMPLETED|Overall Study||1
5005805|NCT02301936|12316088|P2|COMPLETED|Overall Study||1
5005806|NCT02301936|12316089|P1|COMPLETED|Overall Study||8
5005807|NCT02301936|12316088|P2|STARTED|Overall Study||1
5005808|NCT02301936|12316089|P1|STARTED|Overall Study||9
5005809|NCT02301897|12316114|P3|NOT COMPLETED|Treatment Course 2||1
5005810|NCT02301897|12316115|P2|NOT COMPLETED|Treatment Course 2||5
5005811|NCT02301897|12316116|P1|NOT COMPLETED|Treatment Course 2||1
5005812|NCT02301897|12316114|P3|COMPLETED|Treatment Course 2||7
5005813|NCT02301897|12316115|P2|COMPLETED|Treatment Course 2||9
5005814|NCT02301897|12316116|P1|COMPLETED|Treatment Course 2||8
5005815|NCT02301897|12316114|P3|STARTED|Treatment Course 2||8
5005816|NCT02301897|12316115|P2|STARTED|Treatment Course 2||14
5005817|NCT02301897|12316116|P1|STARTED|Treatment Course 2||9
5005818|NCT02301897|12316114|P3|NOT COMPLETED|Treatment Course 1||6
5005819|NCT02301897|12316115|P2|NOT COMPLETED|Treatment Course 1||3
5005820|NCT02301897|12316116|P1|NOT COMPLETED|Treatment Course 1||3
5005821|NCT02301897|12316114|P3|COMPLETED|Treatment Course 1||8
5005822|NCT02301897|12316115|P2|COMPLETED|Treatment Course 1||14
5005823|NCT02301897|12316116|P1|COMPLETED|Treatment Course 1||9
5005824|NCT02301897|12316114|P3|STARTED|Treatment Course 1||14
5005825|NCT02301897|12316115|P2|STARTED|Treatment Course 1||17
5005826|NCT02301897|12316116|P1|STARTED|Treatment Course 1||12
5005827|NCT02301793|12316165|P2|NOT COMPLETED|During and Post Education Study Period||49
5005828|NCT02301793|12316166|P1|NOT COMPLETED|During and Post Education Study Period||83
5005829|NCT02301793|12316165|P2|COMPLETED|During and Post Education Study Period||396
5005830|NCT02301793|12316166|P1|COMPLETED|During and Post Education Study Period||405
5005831|NCT02301793|12316165|P2|STARTED|During and Post Education Study Period||445
5005832|NCT02301793|12316166|P1|STARTED|During and Post Education Study Period||488
5005833|NCT02301793|12316165|P2|NOT COMPLETED|Pre Education Study Period||0
5005834|NCT02301793|12316166|P1|NOT COMPLETED|Pre Education Study Period||0
5005835|NCT02301793|12316165|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
5005836|NCT02301793|12316166|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
5005837|NCT02301793|12316165|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
5005838|NCT02301793|12316166|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
5005839|NCT02301624|12316182|P2|NOT COMPLETED|Open-label Maintenance Phase||17
5005840|NCT02301624|12316183|P1|NOT COMPLETED|Open-label Maintenance Phase||12
5005841|NCT02301624|12316182|P2|COMPLETED|Open-label Maintenance Phase||44
5005842|NCT02301624|12316183|P1|COMPLETED|Open-label Maintenance Phase||43
5005843|NCT02301624|12316182|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
5005844|NCT02301624|12316183|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
5005845|NCT02301624|12316182|P2|STARTED|Open-label Maintenance Phase||61
5005846|NCT02301624|12316183|P1|STARTED|Open-label Maintenance Phase||55
5005847|NCT02301624|12316182|P2|NOT COMPLETED|Blind Induction Phase||0
5005848|NCT02301624|12316183|P1|NOT COMPLETED|Blind Induction Phase||1
5005849|NCT02301624|12316182|P2|COMPLETED|Blind Induction Phase||61
5005850|NCT02301624|12316183|P1|COMPLETED|Blind Induction Phase||55
5005851|NCT02301624|12316182|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
5005852|NCT02301624|12316183|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
5005853|NCT02301624|12316182|P2|STARTED|Blind Induction Phase||61
5005854|NCT02301624|12316183|P1|STARTED|Blind Induction Phase||56
5005855|NCT02301546|12316194|P2|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
5005856|NCT02301546|12316195|P1|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
5005857|NCT02301546|12316194|P2|COMPLETED|Long Term Effectiveness (~1 Year)||51
5005858|NCT02301546|12316195|P1|COMPLETED|Long Term Effectiveness (~1 Year)||43
5005859|NCT02301546|12316194|P2|STARTED|Long Term Effectiveness (~1 Year)||58
5005860|NCT02301546|12316195|P1|STARTED|Long Term Effectiveness (~1 Year)||55
5005861|NCT02301546|12316194|P2|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
5005862|NCT02301546|12316195|P1|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
5005863|NCT02301546|12316194|P2|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
5005864|NCT02301546|12316195|P1|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
5005865|NCT02301546|12316194|P2|STARTED|Short-term Effectiveness (~13 Weeks)||73
5005866|NCT02301546|12316195|P1|STARTED|Short-term Effectiveness (~13 Weeks)||73
5005867|NCT02301429|12316201|P1|NOT COMPLETED|Overall Study||3
5005868|NCT02301429|12316201|P1|COMPLETED|Overall Study||13
5005869|NCT02301429|12316201|P1|STARTED|Overall Study||16
5005870|NCT02301416|12316207|P2|NOT COMPLETED|Overall Study||0
5005871|NCT02301416|12316208|P1|NOT COMPLETED|Overall Study||10
5005872|NCT02301416|12316207|P2|COMPLETED|Overall Study||40
5005873|NCT02301416|12316208|P1|COMPLETED|Overall Study||15
5005874|NCT02301416|12316207|P2|STARTED|Overall Study||40
5005875|NCT02301416|12316208|P1|STARTED|Overall Study||25
5005876|NCT02301403|12316247|P2|NOT COMPLETED|Overall Study||41
5005877|NCT02301403|12316248|P1|NOT COMPLETED|Overall Study||28
5005878|NCT02301403|12316247|P2|COMPLETED|Overall Study||267
5005879|NCT02301403|12316248|P1|COMPLETED|Overall Study||287
5005880|NCT02301403|12316247|P2|STARTED|Overall Study||308
5005881|NCT02301403|12316248|P1|STARTED|Overall Study||315
5005882|NCT02301390|12316256|P2|NOT COMPLETED|Overall Study||13
5005883|NCT02301390|12316257|P1|NOT COMPLETED|Overall Study||10
5005884|NCT02301390|12316256|P2|COMPLETED|Overall Study||13
5005885|NCT02301390|12316257|P1|COMPLETED|Overall Study||17
5005886|NCT02301390|12316256|P2|STARTED|Overall Study||26
5005887|NCT02301390|12316257|P1|STARTED|Overall Study||27
5005888|NCT02301377|12316271|P2|NOT COMPLETED|Overall Study||0
5005889|NCT02301377|12316272|P1|NOT COMPLETED|Overall Study||0
5005890|NCT02301377|12316271|P2|COMPLETED|Overall Study||2
5005891|NCT02301377|12316272|P1|COMPLETED|Overall Study||3
5005892|NCT02301377|12316271|P2|STARTED|Overall Study||2
5005893|NCT02301377|12316272|P1|STARTED|Overall Study||3
5005894|NCT02301364|12316282|P1|NOT COMPLETED|Overall Study||0
5005895|NCT02301364|12316282|P1|COMPLETED|Overall Study||4
5005896|NCT02301364|12316282|P1|STARTED|Overall Study||4
5005897|NCT02301299|12316289|P1|NOT COMPLETED|Overall Study||0
5005898|NCT02301299|12316289|P1|COMPLETED|Overall Study||1322
5005899|NCT02301299|12316289|P1|STARTED|Overall Study||1322
5005900|NCT02301169|12316298|P2|NOT COMPLETED|Overall Study||0
5005901|NCT02301169|12316299|P1|NOT COMPLETED|Overall Study||1
5005902|NCT02301169|12316298|P2|COMPLETED|Overall Study||21
5005903|NCT02301169|12316299|P1|COMPLETED|Overall Study||20
5005904|NCT02301169|12316298|P2|STARTED|Overall Study||21
5005905|NCT02301169|12316299|P1|STARTED|Overall Study||21
5005906|NCT02301143|12316313|P2|NOT COMPLETED|Investigator's Choice||10
5005907|NCT02301143|12316314|P1|NOT COMPLETED|Investigator's Choice||0
5005908|NCT02301143|12316313|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
5005909|NCT02301143|12316314|P1|COMPLETED|Investigator's Choice||0
5005910|NCT02301143|12316313|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
5005911|NCT02301143|12316314|P1|STARTED|Investigator's Choice||0
5005912|NCT02301143|12316313|P2|NOT COMPLETED|Induction Period||0
5005913|NCT02301143|12316314|P1|NOT COMPLETED|Induction Period||45
5005914|NCT02301143|12316313|P2|COMPLETED|Induction Period||0
5005915|NCT02301143|12316314|P1|COMPLETED|Induction Period||62
5005916|NCT02301143|12316313|P2|STARTED|Induction Period||0
5005917|NCT02301143|12316314|P1|STARTED|Induction Period||107
5005918|NCT02300727|12316336|P6|NOT COMPLETED|Overall Study||0
5005919|NCT02300727|12316337|P5|NOT COMPLETED|Overall Study||0
5005920|NCT02300727|12316338|P4|NOT COMPLETED|Overall Study||1
5005921|NCT02300727|12316339|P3|NOT COMPLETED|Overall Study||0
5005922|NCT02300727|12316340|P2|NOT COMPLETED|Overall Study||0
5005923|NCT02300727|12316341|P1|NOT COMPLETED|Overall Study||0
5005924|NCT02300727|12316336|P6|COMPLETED|Overall Study||0
5005925|NCT02300727|12316337|P5|COMPLETED|Overall Study||0
5005926|NCT02300727|12316338|P4|COMPLETED|Overall Study||2
5005927|NCT02300727|12316339|P3|COMPLETED|Overall Study||3
5005928|NCT02300727|12316340|P2|COMPLETED|Overall Study||0
5005929|NCT02300727|12316341|P1|COMPLETED|Overall Study||0
5005930|NCT02300727|12316336|P6|STARTED|Overall Study||0
5005931|NCT02300727|12316337|P5|STARTED|Overall Study||0
5005932|NCT02300727|12316338|P4|STARTED|Overall Study||3
5005933|NCT02300727|12316339|P3|STARTED|Overall Study||3
5005934|NCT02300727|12316340|P2|STARTED|Overall Study||0
5005935|NCT02300727|12316341|P1|STARTED|Overall Study||0
5005936|NCT02300610|12316358|P3|NOT COMPLETED|Overall Study||1
5005937|NCT02300610|12316359|P2|NOT COMPLETED|Overall Study||0
5005938|NCT02300610|12316360|P1|NOT COMPLETED|Overall Study||1
5005939|NCT02300610|12316358|P3|COMPLETED|Overall Study||3
5005940|NCT02300610|12316359|P2|COMPLETED|Overall Study||3
5005941|NCT02300610|12316360|P1|COMPLETED|Overall Study||2
5005942|NCT02300610|12316358|P3|STARTED|Overall Study||4
5005943|NCT02300610|12316359|P2|STARTED|Overall Study||3
5005944|NCT02300610|12316360|P1|STARTED|Overall Study||3
5005945|NCT02300558|12316375|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
5005946|NCT02300558|12316375|P1|COMPLETED|Open-Label (OL) Extension Phase||0
5005947|NCT02300558|12316375|P1|STARTED|Open-Label (OL) Extension Phase||32
5005948|NCT02300558|12316375|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
5005949|NCT02300558|12316375|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
5005950|NCT02300558|12316375|P1|STARTED|Single Blind Phase (24 Weeks)||41
5005951|NCT02300545|12316386|P1|NOT COMPLETED|Overall Study||0
5005952|NCT02300545|12316386|P1|COMPLETED|Overall Study||56
5005953|NCT02300545|12316386|P1|STARTED|Overall Study||56
5005954|NCT02300311|12316395|P2|NOT COMPLETED|Overall Study||0
5005955|NCT02300311|12316396|P1|NOT COMPLETED|Overall Study||19
5005956|NCT02300311|12316395|P2|COMPLETED|Overall Study||69
5005957|NCT02300311|12316396|P1|COMPLETED|Overall Study||50
5005958|NCT02300311|12316395|P2|STARTED|Overall Study||69
5005959|NCT02300311|12316396|P1|STARTED|Overall Study||69
5005960|NCT02300298|12316408|P2|NOT COMPLETED|Disposition for Docetaxel||10
5005961|NCT02300298|12316409|P1|NOT COMPLETED|Disposition for Docetaxel||0
5005962|NCT02300298|12316408|P2|COMPLETED|Disposition for Docetaxel||0
5005963|NCT02300298|12316409|P1|COMPLETED|Disposition for Docetaxel||0
5005964|NCT02300298|12316408|P2|STARTED|Disposition for Docetaxel||10
5005965|NCT02300298|12316409|P1|STARTED|Disposition for Docetaxel||0
5005966|NCT02300298|12316408|P2|NOT COMPLETED|Disposition for Nintedanib||0
5005967|NCT02300298|12316409|P1|NOT COMPLETED|Disposition for Nintedanib||10
5005968|NCT02300298|12316408|P2|COMPLETED|Disposition for Nintedanib||0
5005969|NCT02300298|12316409|P1|COMPLETED|Disposition for Nintedanib||0
5005970|NCT02300298|12316408|P2|STARTED|Disposition for Nintedanib||0
5005971|NCT02300298|12316409|P1|STARTED|Disposition for Nintedanib||10
5005972|NCT02300259|12316422|P3|NOT COMPLETED|Period 2||1
5005973|NCT02300259|12316423|P2|NOT COMPLETED|Period 2||0
5005974|NCT02300259|12316424|P1|NOT COMPLETED|Period 2||1
5005975|NCT02300259|12316422|P3|COMPLETED|Period 2||13
5005976|NCT02300259|12316423|P2|COMPLETED|Period 2||0
5005977|NCT02300259|12316424|P1|COMPLETED|Period 2||15
5005978|NCT02300259|12316422|P3|STARTED|Period 2||14
5005979|NCT02300259|12316423|P2|STARTED|Period 2|There was no period 2 for Group 2.|0
5005980|NCT02300259|12316424|P1|STARTED|Period 2||16
5005981|NCT02300259|12316422|P3|NOT COMPLETED|Period 1||2
5005982|NCT02300259|12316423|P2|NOT COMPLETED|Period 1||0
5005983|NCT02300259|12316424|P1|NOT COMPLETED|Period 1||0
5005984|NCT02300259|12316422|P3|COMPLETED|Period 1||14
5005985|NCT02300259|12316423|P2|COMPLETED|Period 1||16
5005986|NCT02300259|12316424|P1|COMPLETED|Period 1||16
5005987|NCT02300259|12316422|P3|Received at Least One Dose of Study Drug|Period 1||16
5005988|NCT02300259|12316423|P2|Received at Least One Dose of Study Drug|Period 1||16
5005989|NCT02300259|12316424|P1|Received at Least One Dose of Study Drug|Period 1||16
5005990|NCT02300259|12316422|P3|STARTED|Period 1||16
5005991|NCT02300259|12316423|P2|STARTED|Period 1||16
5005992|NCT02300259|12316424|P1|STARTED|Period 1||16
5005993|NCT02300129|12316453|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5005994|NCT02300129|12316454|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5005995|NCT02300129|12316455|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5005996|NCT02300129|12316456|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5005997|NCT02300129|12316453|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
5005998|NCT02300129|12316454|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
5005999|NCT02300129|12316455|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
5006000|NCT02300129|12316456|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
5006001|NCT02300129|12316453|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
5006002|NCT02300129|12316454|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
5006003|NCT02300129|12316455|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
5006004|NCT02300129|12316456|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
5006005|NCT02300129|12316453|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
5006006|NCT02300129|12316454|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
5006007|NCT02300129|12316455|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
5006008|NCT02300129|12316456|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
5006009|NCT02300129|12316453|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
5006010|NCT02300129|12316454|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
5006011|NCT02300129|12316455|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
5006012|NCT02300129|12316456|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
5006013|NCT02300129|12316453|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
5006014|NCT02300129|12316454|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
5006015|NCT02300129|12316455|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
5006016|NCT02300129|12316456|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
5006017|NCT02300129|12316453|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5006018|NCT02300129|12316454|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5006019|NCT02300129|12316455|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5006020|NCT02300129|12316456|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5006021|NCT02300129|12316453|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
5006022|NCT02300129|12316454|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
5006023|NCT02300129|12316455|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
5006024|NCT02300129|12316456|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
5006025|NCT02300129|12316453|P4|STARTED|Period 1 Session 3 (Day 5)||11
5006026|NCT02300129|12316454|P3|STARTED|Period 1 Session 3 (Day 5)||7
5006027|NCT02300129|12316455|P2|STARTED|Period 1 Session 3 (Day 5)||4
5006028|NCT02300129|12316456|P1|STARTED|Period 1 Session 3 (Day 5)||11
5006029|NCT02300129|12316453|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5006030|NCT02300129|12316454|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5006031|NCT02300129|12316455|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
5006032|NCT02300129|12316456|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5006033|NCT02300129|12316453|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
5006034|NCT02300129|12316454|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
5006035|NCT02300129|12316455|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
5006036|NCT02300129|12316456|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
5006037|NCT02300129|12316453|P4|STARTED|Period 1 Session 2 (Day 3)||11
5006038|NCT02300129|12316454|P3|STARTED|Period 1 Session 2 (Day 3)||7
5006039|NCT02300129|12316455|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
5006040|NCT02300129|12316456|P1|STARTED|Period 1 Session 2 (Day 3)||11
5006041|NCT02300129|12316453|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5006042|NCT02300129|12316454|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5006043|NCT02300129|12316455|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5006044|NCT02300129|12316456|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5006045|NCT02300129|12316453|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
5006046|NCT02300129|12316454|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
5006047|NCT02300129|12316455|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
5006048|NCT02300129|12316456|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
5006049|NCT02300129|12316453|P4|STARTED|Period 1 Session 1 (Day 1)||11
5006050|NCT02300129|12316454|P3|STARTED|Period 1 Session 1 (Day 1)||7
5006051|NCT02300129|12316455|P2|STARTED|Period 1 Session 1 (Day 1)||5
5006052|NCT02300129|12316456|P1|STARTED|Period 1 Session 1 (Day 1)||11
5006053|NCT02300103|12316466|P1|NOT COMPLETED|Overall Study||6
5006054|NCT02300103|12316466|P1|COMPLETED|Overall Study||63
5006055|NCT02300103|12316466|P1|STARTED|Overall Study||69
5006056|NCT02300077|12316478|P3|NOT COMPLETED|Overall Study||0
5006057|NCT02300077|12316479|P2|NOT COMPLETED|Overall Study||0
5006058|NCT02300077|12316480|P1|NOT COMPLETED|Overall Study||0
5006059|NCT02300077|12316478|P3|COMPLETED|Overall Study||21
5006060|NCT02300077|12316479|P2|COMPLETED|Overall Study||18
5006061|NCT02300077|12316480|P1|COMPLETED|Overall Study||21
5006062|NCT02300077|12316478|P3|STARTED|Overall Study||21
5006063|NCT02300077|12316479|P2|STARTED|Overall Study||18
5006064|NCT02300077|12316480|P1|STARTED|Overall Study||21
5006065|NCT02300025|12316501|P4|NOT COMPLETED|Overall Study||0
5006066|NCT02300025|12316502|P3|NOT COMPLETED|Overall Study||0
5006067|NCT02300025|12316503|P2|NOT COMPLETED|Overall Study||0
5006068|NCT02300025|12316504|P1|NOT COMPLETED|Overall Study||0
5006069|NCT02300025|12316501|P4|COMPLETED|Overall Study||6
5006070|NCT02300025|12316502|P3|COMPLETED|Overall Study||6
5006071|NCT02300025|12316503|P2|COMPLETED|Overall Study||6
5006072|NCT02300025|12316504|P1|COMPLETED|Overall Study||10
5006073|NCT02300025|12316501|P4|STARTED|Overall Study||6
5006074|NCT02300025|12316502|P3|STARTED|Overall Study||6
5006075|NCT02300025|12316503|P2|STARTED|Overall Study||6
5006076|NCT02300025|12316504|P1|STARTED|Overall Study||10
5006077|NCT02299934|12316546|P1|NOT COMPLETED|Overall Study||13
5006078|NCT02299934|12316546|P1|COMPLETED|Overall Study||0
5006079|NCT02299934|12316546|P1|STARTED|Overall Study||13
5006080|NCT02299869|12316561|P4|NOT COMPLETED|Overall Study||0
5006081|NCT02299869|12316562|P3|NOT COMPLETED|Overall Study||0
5006082|NCT02299869|12316563|P2|NOT COMPLETED|Overall Study||0
5006083|NCT02299869|12316564|P1|NOT COMPLETED|Overall Study||0
5006084|NCT02299869|12316561|P4|COMPLETED|Overall Study||10
5006085|NCT02299869|12316562|P3|COMPLETED|Overall Study||10
5006086|NCT02299869|12316563|P2|COMPLETED|Overall Study||10
5006087|NCT02299869|12316564|P1|COMPLETED|Overall Study||10
5006088|NCT02299869|12316561|P4|STARTED|Overall Study||10
5006089|NCT02299869|12316562|P3|STARTED|Overall Study||10
5006090|NCT02299869|12316563|P2|STARTED|Overall Study||10
5006091|NCT02299869|12316564|P1|STARTED|Overall Study||10
5006092|NCT02299791|12316589|P2|NOT COMPLETED|Overall Study||0
5006093|NCT02299791|12316590|P1|NOT COMPLETED|Overall Study||0
5006094|NCT02299791|12316589|P2|COMPLETED|Overall Study||2803
5006095|NCT02299791|12316590|P1|COMPLETED|Overall Study||2053
5006096|NCT02299791|12316589|P2|STARTED|Overall Study||2803
5006097|NCT02299791|12316590|P1|STARTED|Overall Study||2053
5006098|NCT02299635|12316596|P1|NOT COMPLETED|Overall Study||19
5006099|NCT02299635|12316596|P1|COMPLETED|Overall Study||0
5006100|NCT02299635|12316596|P1|STARTED|Overall Study||19
5006101|NCT02299570|12316618|P3|NOT COMPLETED|Overall Study||2
5006102|NCT02299570|12316619|P2|NOT COMPLETED|Overall Study||0
5006103|NCT02299570|12316620|P1|NOT COMPLETED|Overall Study||4
5006104|NCT02299570|12316618|P3|COMPLETED|Overall Study||42
5006105|NCT02299570|12316619|P2|COMPLETED|Overall Study||44
5006106|NCT02299570|12316620|P1|COMPLETED|Overall Study||41
5006107|NCT02299570|12316618|P3|STARTED|Overall Study||44
5006108|NCT02299570|12316619|P2|STARTED|Overall Study||44
5006109|NCT02299570|12316620|P1|STARTED|Overall Study||45
5006110|NCT02299479|12316628|P1|NOT COMPLETED|Overall Study||2
5006111|NCT02299479|12316628|P1|COMPLETED|Overall Study||18
5006112|NCT02299479|12316628|P1|STARTED|Overall Study||20
5006113|NCT02299427|12316636|P2|NOT COMPLETED|Overall Study||3
5006114|NCT02299427|12316637|P1|NOT COMPLETED|Overall Study||23
5006115|NCT02299427|12316636|P2|COMPLETED|Overall Study||31
5006116|NCT02299427|12316637|P1|COMPLETED|Overall Study||12
5006117|NCT02299427|12316636|P2|STARTED|Overall Study||34
5006118|NCT02299427|12316637|P1|STARTED|Overall Study||35
5006119|NCT02299388|12316647|P2|NOT COMPLETED|Overall Study||1
5006120|NCT02299388|12316648|P1|NOT COMPLETED|Overall Study||0
5006121|NCT02299388|12316647|P2|COMPLETED|Overall Study||4
5006122|NCT02299388|12316648|P1|COMPLETED|Overall Study||6
5006123|NCT02299388|12316647|P2|STARTED|Overall Study||5
5006124|NCT02299388|12316648|P1|STARTED|Overall Study||6
5006125|NCT02299375|12316658|P2|NOT COMPLETED|Overall Study||80
5006126|NCT02299375|12316659|P1|NOT COMPLETED|Overall Study||80
5006127|NCT02299375|12316658|P2|COMPLETED|Overall Study||10
5006128|NCT02299375|12316659|P1|COMPLETED|Overall Study||14
5006129|NCT02299375|12316658|P2|STARTED|Overall Study||90
5006130|NCT02299375|12316659|P1|STARTED|Overall Study||94
5006131|NCT02299349|12316709|P2|NOT COMPLETED|Overall Study||0
5006132|NCT02299349|12316710|P1|NOT COMPLETED|Overall Study||0
5006133|NCT02299349|12316709|P2|COMPLETED|Overall Study||35
5006134|NCT02299349|12316710|P1|COMPLETED|Overall Study||35
5006135|NCT02299349|12316709|P2|STARTED|Overall Study||35
5006136|NCT02299349|12316710|P1|STARTED|Overall Study||35
5006137|NCT02299336|12316718|P1|NOT COMPLETED|Overall Study||14
5006138|NCT02299336|12316718|P1|COMPLETED|Overall Study||46
5006139|NCT02299336|12316718|P1|STARTED|Overall Study||60
5006140|NCT02299297|12316734|P1|NOT COMPLETED|Overall Study||1
5006141|NCT02299297|12316734|P1|COMPLETED|Overall Study||11
5006142|NCT02299297|12316734|P1|STARTED|Overall Study||12
5006143|NCT02299258|12316744|P2|NOT COMPLETED|Overall Study||1
5006144|NCT02299258|12316745|P1|NOT COMPLETED|Overall Study||1
5006145|NCT02299258|12316744|P2|COMPLETED|Overall Study||30
5006146|NCT02299258|12316745|P1|COMPLETED|Overall Study||31
5006147|NCT02299258|12316744|P2|STARTED|Overall Study||31
5006148|NCT02299258|12316745|P1|STARTED|Overall Study||32
5006149|NCT02299206|12316753|P1|NOT COMPLETED|Overall Study||2
5006150|NCT02299206|12316753|P1|COMPLETED|Overall Study||2
5006151|NCT02299206|12316753|P1|STARTED|Overall Study||4
5006152|NCT02299089|12316765|P4|NOT COMPLETED|Overall Study||0
5006153|NCT02299089|12316766|P3|NOT COMPLETED|Overall Study||0
5006154|NCT02299089|12316767|P2|NOT COMPLETED|Overall Study||0
5006155|NCT02299089|12316768|P1|NOT COMPLETED|Overall Study||0
5006156|NCT02299089|12316765|P4|COMPLETED|Overall Study||4
5006157|NCT02299089|12316766|P3|COMPLETED|Overall Study||1
5006158|NCT02299089|12316767|P2|COMPLETED|Overall Study||4
5006159|NCT02299089|12316768|P1|COMPLETED|Overall Study||3
5006160|NCT02299089|12316765|P4|STARTED|Overall Study||4
5006161|NCT02299089|12316766|P3|STARTED|Overall Study||1
5006162|NCT02299089|12316767|P2|STARTED|Overall Study||4
5006163|NCT02299089|12316768|P1|STARTED|Overall Study||3
5006164|NCT02299076|12316814|P2|NOT COMPLETED|Overall Study||14
5006165|NCT02299076|12316815|P1|NOT COMPLETED|Overall Study||20
5006166|NCT02299076|12316814|P2|COMPLETED|Overall Study||212
5006167|NCT02299076|12316815|P1|COMPLETED|Overall Study||210
5006168|NCT02299076|12316814|P2|STARTED|Overall Study||226
5006169|NCT02299076|12316815|P1|STARTED|Overall Study||230
5006170|NCT02299050|12316823|P1|NOT COMPLETED|Overall Study||8
5006171|NCT02299050|12316823|P1|COMPLETED|Overall Study||15
5006172|NCT02299050|12316823|P1|STARTED|Overall Study||23
5006173|NCT02298946|12316836|P2|NOT COMPLETED|Overall Study||1
5006174|NCT02298946|12316837|P1|NOT COMPLETED|Overall Study||4
5006175|NCT02298946|12316836|P2|COMPLETED|Overall Study||8
5006176|NCT02298946|12316837|P1|COMPLETED|Overall Study||4
5006177|NCT02298946|12316836|P2|STARTED|Overall Study||9
5006178|NCT02298946|12316837|P1|STARTED|Overall Study||8
5006179|NCT02298933|12316861|P1|NOT COMPLETED|Overall Study||0
5006180|NCT02298933|12316861|P1|COMPLETED|Overall Study||10
5006181|NCT02298933|12316861|P1|STARTED|Overall Study||10
5006182|NCT02298868|12316865|P1|NOT COMPLETED|Overall Study||3
5006183|NCT02298868|12316865|P1|COMPLETED|Overall Study||7
5006184|NCT02298868|12316865|P1|STARTED|Overall Study||10
5006185|NCT02298842|12316879|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
5006186|NCT02298842|12316880|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
5006187|NCT02298842|12316879|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
5006188|NCT02298842|12316880|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
5006189|NCT02298842|12316879|P2|STARTED|Second Platelet Donation (Day 6-8)||36
5006190|NCT02298842|12316880|P1|STARTED|Second Platelet Donation (Day 6-8)||38
5006191|NCT02298842|12316879|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
5006192|NCT02298842|12316880|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
5006193|NCT02298842|12316879|P2|COMPLETED|First Platelet Donation (Day 0)||36
5006194|NCT02298842|12316880|P1|COMPLETED|First Platelet Donation (Day 0)||38
5006195|NCT02298842|12316879|P2|STARTED|First Platelet Donation (Day 0)||41
5006196|NCT02298842|12316880|P1|STARTED|First Platelet Donation (Day 0)||44
5006197|NCT02298803|12316906|P1|NOT COMPLETED|Overall Study||0
5006198|NCT02298803|12316906|P1|COMPLETED|Overall Study||30
5006199|NCT02298803|12316906|P1|STARTED|Overall Study||30
5006200|NCT02298361|12316918|P3|NOT COMPLETED|Overall Study||0
5006201|NCT02298361|12316919|P2|NOT COMPLETED|Overall Study||0
5006202|NCT02298361|12316920|P1|NOT COMPLETED|Overall Study||0
5006203|NCT02298361|12316918|P3|COMPLETED|Overall Study||12227
5006204|NCT02298361|12316919|P2|COMPLETED|Overall Study||12784
5006205|NCT02298361|12316920|P1|COMPLETED|Overall Study||2240
5006206|NCT02298361|12316918|P3|STARTED|Overall Study||12227
5006207|NCT02298361|12316919|P2|STARTED|Overall Study||12784
5006208|NCT02298361|12316920|P1|STARTED|Overall Study||2240
5006209|NCT02298192|12316936|P2|NOT COMPLETED|Overall Study||6
5006210|NCT02298192|12316937|P1|NOT COMPLETED|Overall Study||19
5006211|NCT02298192|12316936|P2|COMPLETED|Overall Study||204
5006212|NCT02298192|12316937|P1|COMPLETED|Overall Study||191
5006213|NCT02298192|12316936|P2|STARTED|Overall Study||210
5006214|NCT02298192|12316937|P1|STARTED|Overall Study||210
5006215|NCT02298179|12316961|P12|NOT COMPLETED|Overall Study||0
5006216|NCT02298179|12316962|P11|NOT COMPLETED|Overall Study||0
5006217|NCT02298179|12316963|P10|NOT COMPLETED|Overall Study||0
5006218|NCT02298179|12316964|P9|NOT COMPLETED|Overall Study||0
5006219|NCT02298179|12316965|P8|NOT COMPLETED|Overall Study||1
5006220|NCT02298179|12316966|P7|NOT COMPLETED|Overall Study||0
5006221|NCT02298179|12316967|P6|NOT COMPLETED|Overall Study||0
5006222|NCT02298179|12316968|P5|NOT COMPLETED|Overall Study||0
5006223|NCT02298179|12316969|P4|NOT COMPLETED|Overall Study||0
5006224|NCT02298179|12316970|P3|NOT COMPLETED|Overall Study||1
5006225|NCT02298179|12316971|P2|NOT COMPLETED|Overall Study||0
5006226|NCT02298179|12316972|P1|NOT COMPLETED|Overall Study||0
5006227|NCT02298179|12316961|P12|COMPLETED|Overall Study||24
5006228|NCT02298179|12316962|P11|COMPLETED|Overall Study||24
5006229|NCT02298179|12316963|P10|COMPLETED|Overall Study||24
5006230|NCT02298179|12316964|P9|COMPLETED|Overall Study||24
5006231|NCT02298179|12316965|P8|COMPLETED|Overall Study||23
5006232|NCT02298179|12316966|P7|COMPLETED|Overall Study||24
5006233|NCT02298179|12316967|P6|COMPLETED|Overall Study||24
5006234|NCT02298179|12316968|P5|COMPLETED|Overall Study||24
5006235|NCT02298179|12316969|P4|COMPLETED|Overall Study||24
5006236|NCT02298179|12316970|P3|COMPLETED|Overall Study||23
5006237|NCT02298179|12316971|P2|COMPLETED|Overall Study||24
5006238|NCT02298179|12316972|P1|COMPLETED|Overall Study||24
5006239|NCT02298179|12316961|P12|STARTED|Overall Study||24
5006240|NCT02298179|12316962|P11|STARTED|Overall Study||24
5006241|NCT02298179|12316963|P10|STARTED|Overall Study||24
5006242|NCT02298179|12316964|P9|STARTED|Overall Study||24
5006243|NCT02298179|12316965|P8|STARTED|Overall Study||24
5006244|NCT02298179|12316966|P7|STARTED|Overall Study||24
5006245|NCT02298179|12316967|P6|STARTED|Overall Study||24
5006246|NCT02298179|12316968|P5|STARTED|Overall Study||24
5006247|NCT02298179|12316969|P4|STARTED|Overall Study||24
5006248|NCT02298179|12316970|P3|STARTED|Overall Study||24
5006249|NCT02298179|12316971|P2|STARTED|Overall Study||24
5006250|NCT02298179|12316972|P1|STARTED|Overall Study||24
5006251|NCT02297841|12317214|P1|NOT COMPLETED|Overall Study||8
5006252|NCT02297841|12317214|P1|COMPLETED|Overall Study||201
5006253|NCT02297841|12317214|P1|Challenge Phase|Overall Study||201
5006254|NCT02297841|12317214|P1|Induction Phase|Overall Study||209
5006255|NCT02297841|12317214|P1|STARTED|Overall Study||209
5006256|NCT02297815|12317220|P2|NOT COMPLETED|Overall Study||140
5006257|NCT02297815|12317221|P1|NOT COMPLETED|Overall Study||236
5006258|NCT02297815|12317220|P2|COMPLETED|Overall Study||728
5006259|NCT02297815|12317221|P1|COMPLETED|Overall Study||1368
5006260|NCT02297815|12317220|P2|14-20 Day Interview|Overall Study||728
5006261|NCT02297815|12317221|P1|14-20 Day Interview|Overall Study||1368
5006262|NCT02297815|12317220|P2|5-10 Day Interview|Overall Study||868
5006263|NCT02297815|12317221|P1|5-10 Day Interview|Overall Study||1604
5006264|NCT02297815|12317220|P2|STARTED|Overall Study||868
5006265|NCT02297815|12317221|P1|STARTED|Overall Study||1604
5006266|NCT02297516|12317239|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
5006267|NCT02297516|12317240|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
5006268|NCT02297516|12317239|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
5006269|NCT02297516|12317240|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
5006270|NCT02297516|12317239|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
5006271|NCT02297516|12317240|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
5006272|NCT02297516|12317239|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
5006273|NCT02297516|12317240|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
5006274|NCT02297516|12317239|P2|COMPLETED|Single Treatment Phase (6 Months)||31
5006275|NCT02297516|12317240|P1|COMPLETED|Single Treatment Phase (6 Months)||31
5006276|NCT02297516|12317239|P2|STARTED|Single Treatment Phase (6 Months)||33
5006277|NCT02297516|12317240|P1|STARTED|Single Treatment Phase (6 Months)||32
5006278|NCT02297503|12317261|P2|NOT COMPLETED|Overall Study||4
5006279|NCT02297503|12317262|P1|NOT COMPLETED|Overall Study||2
5006280|NCT02297503|12317261|P2|COMPLETED|Overall Study||27
5006281|NCT02297503|12317262|P1|COMPLETED|Overall Study||28
5006282|NCT02297503|12317261|P2|Second Combined Treatment|Overall Study||28
5006283|NCT02297503|12317262|P1|Second Combined Treatment|Overall Study||28
5006284|NCT02297503|12317261|P2|First Combined Treatment|Overall Study||28
5006285|NCT02297503|12317262|P1|First Combined Treatment|Overall Study||28
5006286|NCT02297503|12317261|P2|Initial Single Treatment|Overall Study||31
5006287|NCT02297503|12317262|P1|Initial Single Treatment|Overall Study||29
5006288|NCT02297503|12317261|P2|STARTED|Overall Study||31
5006289|NCT02297503|12317262|P1|STARTED|Overall Study||30
5006290|NCT02297412|12317289|P2|NOT COMPLETED|Overall Study||1
5006291|NCT02297412|12317290|P1|NOT COMPLETED|Overall Study||1
5006292|NCT02297412|12317289|P2|COMPLETED|Overall Study||23
5006293|NCT02297412|12317290|P1|COMPLETED|Overall Study||22
5006294|NCT02297412|12317289|P2|STARTED|Overall Study||24
5006295|NCT02297412|12317290|P1|STARTED|Overall Study||23
5006296|NCT02297308|12317300|P1|NOT COMPLETED|Overall Study||0
5006297|NCT02297308|12317300|P1|COMPLETED|Overall Study||90
5006298|NCT02297308|12317300|P1|STARTED|Overall Study||90
5006299|NCT02297230|12317309|P4|NOT COMPLETED|Overall Study||0
5006300|NCT02297230|12317310|P3|NOT COMPLETED|Overall Study||0
5006301|NCT02297230|12317311|P2|NOT COMPLETED|Overall Study||0
5006302|NCT02297230|12317312|P1|NOT COMPLETED|Overall Study||0
5006303|NCT02297230|12317309|P4|COMPLETED|Overall Study||11
5006304|NCT02297230|12317310|P3|COMPLETED|Overall Study||11
5006305|NCT02297230|12317311|P2|COMPLETED|Overall Study||11
5006306|NCT02297230|12317312|P1|COMPLETED|Overall Study||11
5006307|NCT02297230|12317309|P4|STARTED|Overall Study||11
5006308|NCT02297230|12317310|P3|STARTED|Overall Study||11
5006309|NCT02297230|12317311|P2|STARTED|Overall Study||11
5006310|NCT02297230|12317312|P1|STARTED|Overall Study||11
5006311|NCT02297100|12317336|P2|NOT COMPLETED|Overall Study||0
5006312|NCT02297100|12317337|P1|NOT COMPLETED|Overall Study||0
5006313|NCT02297100|12317336|P2|COMPLETED|Overall Study||14
5006314|NCT02297100|12317337|P1|COMPLETED|Overall Study||13
5006315|NCT02297100|12317336|P2|STARTED|Overall Study||14
5006316|NCT02297100|12317337|P1|STARTED|Overall Study||13
5006317|NCT02296931|12317351|P2|NOT COMPLETED|Overall Study||2
5006318|NCT02296931|12317352|P1|NOT COMPLETED|Overall Study||0
5006319|NCT02296931|12317351|P2|COMPLETED|Overall Study||22
5006320|NCT02296931|12317352|P1|COMPLETED|Overall Study||10
5006321|NCT02296931|12317351|P2|STARTED|Overall Study||24
5006322|NCT02296931|12317352|P1|STARTED|Overall Study||10
5006323|NCT02296892|12317361|P3|NOT COMPLETED|Overall Study||5
5006324|NCT02296892|12317362|P2|NOT COMPLETED|Overall Study||4
5006325|NCT02296892|12317363|P1|NOT COMPLETED|Overall Study||12
5006326|NCT02296892|12317361|P3|COMPLETED|Overall Study||68
5006327|NCT02296892|12317362|P2|COMPLETED|Overall Study||59
5006328|NCT02296892|12317363|P1|COMPLETED|Overall Study||298
5006329|NCT02296892|12317361|P3|Complete Trial Treatment Period|Overall Study||69
5006330|NCT02296892|12317362|P2|Complete Trial Treatment Period|Overall Study||59
5006331|NCT02296892|12317363|P1|Complete Trial Treatment Period|Overall Study||303
5006332|NCT02296892|12317361|P3|Safety Population|Overall Study||69
5006333|NCT02296892|12317362|P2|Safety Population|Overall Study||59
5006334|NCT02296892|12317363|P1|Safety Population|Overall Study||303
5006335|NCT02296892|12317361|P3|STARTED|Overall Study||73
5006336|NCT02296892|12317362|P2|STARTED|Overall Study||63
5006337|NCT02296892|12317363|P1|STARTED|Overall Study||310
5006338|NCT02296840|12317382|P2|NOT COMPLETED|Overall Study||19
5006339|NCT02296840|12317383|P1|NOT COMPLETED|Overall Study||9
5006340|NCT02296840|12317382|P2|COMPLETED|Overall Study||8
5006341|NCT02296840|12317383|P1|COMPLETED|Overall Study||9
5006342|NCT02296840|12317382|P2|STARTED|Overall Study||27
5006343|NCT02296840|12317383|P1|STARTED|Overall Study||18
5006344|NCT02296775|12317394|P3|NOT COMPLETED|Recovery and Follow-up||4
5006345|NCT02296775|12317395|P2|NOT COMPLETED|Recovery and Follow-up||5
5006346|NCT02296775|12317396|P1|NOT COMPLETED|Recovery and Follow-up||5
5006347|NCT02296775|12317394|P3|COMPLETED|Recovery and Follow-up||79
5006348|NCT02296775|12317395|P2|COMPLETED|Recovery and Follow-up||79
5006349|NCT02296775|12317396|P1|COMPLETED|Recovery and Follow-up||82
5006350|NCT02296775|12317394|P3|STARTED|Recovery and Follow-up||83
5006351|NCT02296775|12317395|P2|STARTED|Recovery and Follow-up||84
5006352|NCT02296775|12317396|P1|STARTED|Recovery and Follow-up||87
5006353|NCT02296775|12317394|P3|NOT COMPLETED|Treatment and Evaluation||10
5006354|NCT02296775|12317395|P2|NOT COMPLETED|Treatment and Evaluation||8
5006355|NCT02296775|12317396|P1|NOT COMPLETED|Treatment and Evaluation||4
5006356|NCT02296775|12317394|P3|COMPLETED|Treatment and Evaluation||83
5006357|NCT02296775|12317395|P2|COMPLETED|Treatment and Evaluation||84
5006358|NCT02296775|12317396|P1|COMPLETED|Treatment and Evaluation||87
5006359|NCT02296775|12317394|P3|STARTED|Treatment and Evaluation||93
5006360|NCT02296775|12317395|P2|STARTED|Treatment and Evaluation||92
5006361|NCT02296775|12317396|P1|STARTED|Treatment and Evaluation||91
5006362|NCT02296606|12317464|P1|NOT COMPLETED|Overall Study||0
5006363|NCT02296606|12317464|P1|COMPLETED|Overall Study||127
5006364|NCT02296606|12317464|P1|STARTED|Overall Study||127
5006365|NCT02296502|12317472|P4|NOT COMPLETED|Overall Study||0
5006366|NCT02296502|12317473|P3|NOT COMPLETED|Overall Study||0
5006367|NCT02296502|12317474|P2|NOT COMPLETED|Overall Study||0
5006368|NCT02296502|12317475|P1|NOT COMPLETED|Overall Study||0
5006369|NCT02296502|12317472|P4|COMPLETED|Overall Study||160
5006370|NCT02296502|12317473|P3|COMPLETED|Overall Study||30
5006371|NCT02296502|12317474|P2|COMPLETED|Overall Study||1
5006372|NCT02296502|12317475|P1|COMPLETED|Overall Study||248
5006373|NCT02296502|12317472|P4|STARTED|Overall Study||160
5006374|NCT02296502|12317473|P3|STARTED|Overall Study||30
5006375|NCT02296502|12317474|P2|STARTED|Overall Study||1
5006376|NCT02296502|12317475|P1|STARTED|Overall Study||248
5006377|NCT02296476|12317491|P3|NOT COMPLETED|Overall Study||2
5006378|NCT02296476|12317492|P2|NOT COMPLETED|Overall Study||4
5006379|NCT02296476|12317493|P1|NOT COMPLETED|Overall Study||6
5006380|NCT02296476|12317491|P3|COMPLETED|Overall Study||0
5006381|NCT02296476|12317492|P2|COMPLETED|Overall Study||0
5006382|NCT02296476|12317493|P1|COMPLETED|Overall Study||0
5006383|NCT02296476|12317491|P3|STARTED|Overall Study||2
5006384|NCT02296476|12317492|P2|STARTED|Overall Study||4
5006385|NCT02296476|12317493|P1|STARTED|Overall Study||6
5006386|NCT02296424|12317548|P4|NOT COMPLETED|Part 2||0
5006387|NCT02296424|12317549|P3|NOT COMPLETED|Part 2||3
5006388|NCT02296424|12317550|P2|NOT COMPLETED|Part 2||0
5006389|NCT02296424|12317551|P1|NOT COMPLETED|Part 2||0
5006390|NCT02296424|12317548|P4|COMPLETED|Part 2||37
5006391|NCT02296424|12317549|P3|COMPLETED|Part 2||35
5006392|NCT02296424|12317550|P2|COMPLETED|Part 2||0
5006393|NCT02296424|12317551|P1|COMPLETED|Part 2||0
5006394|NCT02296424|12317548|P4|STARTED|Part 2||37
5006395|NCT02296424|12317549|P3|STARTED|Part 2||38
5006396|NCT02296424|12317550|P2|STARTED|Part 2||0
5006397|NCT02296424|12317551|P1|STARTED|Part 2||0
5006398|NCT02296424|12317548|P4|NOT COMPLETED|Part 1||0
5006399|NCT02296424|12317549|P3|NOT COMPLETED|Part 1||0
5006400|NCT02296424|12317550|P2|NOT COMPLETED|Part 1||33
5006401|NCT02296424|12317551|P1|NOT COMPLETED|Part 1||23
5006402|NCT02296424|12317548|P4|COMPLETED|Part 1||0
5006403|NCT02296424|12317549|P3|COMPLETED|Part 1||0
5006404|NCT02296424|12317550|P2|COMPLETED|Part 1||65
5006405|NCT02296424|12317551|P1|COMPLETED|Part 1||61
5006406|NCT02296424|12317548|P4|STARTED|Part 1||0
5006407|NCT02296424|12317549|P3|STARTED|Part 1||0
5006408|NCT02296424|12317550|P2|STARTED|Part 1||98
5006409|NCT02296424|12317551|P1|STARTED|Part 1|16 patients immediately went into Part II|84
5006410|NCT02296346|12317564|P2|NOT COMPLETED|Overall Study||6
5006411|NCT02296346|12317565|P1|NOT COMPLETED|Overall Study||5
5006412|NCT02296346|12317564|P2|COMPLETED|Overall Study||0
5006413|NCT02296346|12317565|P1|COMPLETED|Overall Study||2
5006414|NCT02296346|12317564|P2|STARTED|Overall Study||6
5006415|NCT02296346|12317565|P1|STARTED|Overall Study||7
5006416|NCT02296320|12317576|P3|NOT COMPLETED|Overall Study||37
5006417|NCT02296320|12317577|P2|NOT COMPLETED|Overall Study||5
5006418|NCT02296320|12317578|P1|NOT COMPLETED|Overall Study||35
5006419|NCT02296320|12317576|P3|COMPLETED|Overall Study||59
5006420|NCT02296320|12317577|P2|COMPLETED|Overall Study||10
5006421|NCT02296320|12317578|P1|COMPLETED|Overall Study||67
5006422|NCT02296320|12317576|P3|Treated|Overall Study||96
5006423|NCT02296320|12317577|P2|Treated|Overall Study||15
5006424|NCT02296320|12317578|P1|Treated|Overall Study||100
5006425|NCT02296320|12317576|P3|STARTED|Overall Study||96
5006426|NCT02296320|12317577|P2|STARTED|Overall Study||15
5006427|NCT02296320|12317578|P1|STARTED|Overall Study||102
5006428|NCT02296242|12317617|P5|NOT COMPLETED|Overall Study||21
5006429|NCT02296242|12317618|P4|NOT COMPLETED|Overall Study||14
5006430|NCT02296242|12317619|P3|NOT COMPLETED|Overall Study||7
5006431|NCT02296242|12317620|P2|NOT COMPLETED|Overall Study||6
5006432|NCT02296242|12317621|P1|NOT COMPLETED|Overall Study||5
5006433|NCT02296242|12317617|P5|COMPLETED|Overall Study||0
5006434|NCT02296242|12317618|P4|COMPLETED|Overall Study||0
5006435|NCT02296242|12317619|P3|COMPLETED|Overall Study||0
5006436|NCT02296242|12317620|P2|COMPLETED|Overall Study||0
5006437|NCT02296242|12317621|P1|COMPLETED|Overall Study||0
5006438|NCT02296242|12317617|P5|STARTED|Overall Study||21
5006439|NCT02296242|12317618|P4|STARTED|Overall Study||14
5006440|NCT02296242|12317619|P3|STARTED|Overall Study||7
5006441|NCT02296242|12317620|P2|STARTED|Overall Study||6
5006442|NCT02296242|12317621|P1|STARTED|Overall Study||5
5006443|NCT02296164|12317643|P1|NOT COMPLETED|Overall Study||110
5006444|NCT02296164|12317643|P1|COMPLETED|Overall Study||188
5006445|NCT02296164|12317643|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
5006446|NCT02296138|12317649|P2|NOT COMPLETED|Overall Study||500
5006447|NCT02296138|12317650|P1|NOT COMPLETED|Overall Study||661
5006448|NCT02296138|12317649|P2|COMPLETED|Overall Study||3451
5006449|NCT02296138|12317650|P1|COMPLETED|Overall Study||3291
5006450|NCT02296138|12317649|P2|Treated|Overall Study||3939
5006451|NCT02296138|12317650|P1|Treated|Overall Study||3941
5006452|NCT02296138|12317649|P2|STARTED|Overall Study||3951
5006453|NCT02296138|12317650|P1|STARTED|Overall Study||3952
5006454|NCT02296125|12317666|P4|NOT COMPLETED|Overall Study||44
5006455|NCT02296125|12317667|P3|NOT COMPLETED|Overall Study||38
5006456|NCT02296125|12317668|P2|NOT COMPLETED|Overall Study||213
5006457|NCT02296125|12317669|P1|NOT COMPLETED|Overall Study||138
5006458|NCT02296125|12317666|P4|COMPLETED|Overall Study||21
5006459|NCT02296125|12317667|P3|COMPLETED|Overall Study||33
5006460|NCT02296125|12317668|P2|COMPLETED|Overall Study||64
5006461|NCT02296125|12317669|P1|COMPLETED|Overall Study||141
5006462|NCT02296125|12317666|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
5006463|NCT02296125|12317667|P3|STARTED|Overall Study||71
5006464|NCT02296125|12317668|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
5006465|NCT02296125|12317669|P1|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|279
5006466|NCT02296112|12317721|P1|NOT COMPLETED|Overall Study||9
5006467|NCT02296112|12317721|P1|COMPLETED|Overall Study||0
5006468|NCT02296112|12317721|P1|STARTED|Overall Study||9
5006469|NCT02296099|12317736|P2|NOT COMPLETED|Overall Study||2
5006470|NCT02296099|12317737|P1|NOT COMPLETED|Overall Study||3
5006471|NCT02296099|12317736|P2|COMPLETED|Overall Study||55
5006472|NCT02296099|12317737|P1|COMPLETED|Overall Study||54
5006473|NCT02296099|12317736|P2|STARTED|Overall Study||57
5006474|NCT02296099|12317737|P1|STARTED|Overall Study||57
5006475|NCT02295995|12317763|P2|NOT COMPLETED|Overall Study||1
5006476|NCT02295995|12317764|P1|NOT COMPLETED|Overall Study||5
5006477|NCT02295995|12317763|P2|COMPLETED|Overall Study||17
5006478|NCT02295995|12317764|P1|COMPLETED|Overall Study||31
5006479|NCT02295995|12317763|P2|STARTED|Overall Study||18
5006480|NCT02295995|12317764|P1|STARTED|Overall Study||36
5006481|NCT02295774|12317775|P1|NOT COMPLETED|Overall Study||3
5006482|NCT02295774|12317775|P1|COMPLETED|Overall Study||10
5006483|NCT02295774|12317775|P1|STARTED|Overall Study||13
5006484|NCT02295735|12317782|P2|NOT COMPLETED|Overall Study||27
5006485|NCT02295735|12317783|P1|NOT COMPLETED|Overall Study||26
5006486|NCT02295735|12317782|P2|COMPLETED|Overall Study||210
5006487|NCT02295735|12317783|P1|COMPLETED|Overall Study||212
5006488|NCT02295735|12317782|P2|STARTED|Overall Study||237
5006489|NCT02295735|12317783|P1|STARTED|Overall Study||238
5006490|NCT02295644|12317815|P4|NOT COMPLETED|Overall Study||2
5006491|NCT02295644|12317816|P3|NOT COMPLETED|Overall Study||1
5006492|NCT02295644|12317817|P2|NOT COMPLETED|Overall Study||0
5006493|NCT02295644|12317818|P1|NOT COMPLETED|Overall Study||0
5006494|NCT02295644|12317815|P4|COMPLETED|Overall Study||5
5006495|NCT02295644|12317816|P3|COMPLETED|Overall Study||6
5006496|NCT02295644|12317817|P2|COMPLETED|Overall Study||7
5006497|NCT02295644|12317818|P1|COMPLETED|Overall Study||7
5006498|NCT02295644|12317815|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5006499|NCT02295644|12317816|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5006500|NCT02295644|12317817|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5006501|NCT02295644|12317818|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5006502|NCT02295553|12317840|P4|NOT COMPLETED|Overall Study||1
5006503|NCT02295553|12317841|P3|NOT COMPLETED|Overall Study||1
5006504|NCT02295553|12317842|P2|NOT COMPLETED|Overall Study||0
5006505|NCT02295553|12317843|P1|NOT COMPLETED|Overall Study||0
5006506|NCT02295553|12317840|P4|COMPLETED|Overall Study||13
5006507|NCT02295553|12317841|P3|COMPLETED|Overall Study||13
5006508|NCT02295553|12317842|P2|COMPLETED|Overall Study||14
5006509|NCT02295553|12317843|P1|COMPLETED|Overall Study||14
5006510|NCT02295553|12317840|P4|STARTED|Overall Study||14
5006511|NCT02295553|12317841|P3|STARTED|Overall Study||14
5006512|NCT02295553|12317842|P2|STARTED|Overall Study||14
5006513|NCT02295553|12317843|P1|STARTED|Overall Study||14
5006514|NCT02295280|12317867|P2|NOT COMPLETED|Overall Study||1
5006515|NCT02295280|12317868|P1|NOT COMPLETED|Overall Study||0
5006516|NCT02295280|12317867|P2|COMPLETED|Overall Study||34
5006517|NCT02295280|12317868|P1|COMPLETED|Overall Study||35
5006518|NCT02295280|12317867|P2|STARTED|Overall Study||35
5006519|NCT02295280|12317868|P1|STARTED|Overall Study||35
5006520|NCT02295020|12317876|P2|NOT COMPLETED|Overall Study||3
5006521|NCT02295020|12317877|P1|NOT COMPLETED|Overall Study||3
5006522|NCT02295020|12317876|P2|COMPLETED|Overall Study||17
5006523|NCT02295020|12317877|P1|COMPLETED|Overall Study||17
5006524|NCT02295020|12317876|P2|STARTED|Overall Study||20
5006525|NCT02295020|12317877|P1|STARTED|Overall Study||20
5006526|NCT02294981|12317907|P1|NOT COMPLETED|Overall Study||1
5006527|NCT02294981|12317907|P1|COMPLETED|Overall Study||3
5006528|NCT02294981|12317907|P1|STARTED|Overall Study||4
5006529|NCT02294786|12317913|P2|NOT COMPLETED|Overall Study||14
5006530|NCT02294786|12317914|P1|NOT COMPLETED|Overall Study||11
5006531|NCT02294786|12317913|P2|COMPLETED|Overall Study||18
5006532|NCT02294786|12317914|P1|COMPLETED|Overall Study||19
5006533|NCT02294786|12317913|P2|ITT Population|Overall Study||32
5006534|NCT02294786|12317914|P1|ITT Population|Overall Study||30
5006535|NCT02294786|12317913|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
5006536|NCT02294786|12317914|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
5006537|NCT02294786|12317913|P2|STARTED|Overall Study||32
5006538|NCT02294786|12317914|P1|STARTED|Overall Study||30
5006539|NCT02294773|12317961|P2|NOT COMPLETED|Overall Study||2
5006540|NCT02294773|12317962|P1|NOT COMPLETED|Overall Study||0
5006541|NCT02294773|12317961|P2|COMPLETED|Overall Study||4
5006542|NCT02294773|12317962|P1|COMPLETED|Overall Study||7
5006543|NCT02294773|12317961|P2|STARTED|Overall Study||6
5006544|NCT02294773|12317962|P1|STARTED|Overall Study||7
5006545|NCT02294734|12317978|P2|NOT COMPLETED|Overall Study||8
5006546|NCT02294734|12317979|P1|NOT COMPLETED|Overall Study||14
5006547|NCT02294734|12317978|P2|COMPLETED|Overall Study||55
5006548|NCT02294734|12317979|P1|COMPLETED|Overall Study||49
5006549|NCT02294734|12317978|P2|STARTED|Overall Study||63
5006550|NCT02294734|12317979|P1|STARTED|Overall Study||63
5006551|NCT02294682|12318031|P2|NOT COMPLETED|Overall Study||0
5006552|NCT02294682|12318032|P1|NOT COMPLETED|Overall Study||1
5006553|NCT02294682|12318031|P2|COMPLETED|Overall Study||53
5006554|NCT02294682|12318032|P1|COMPLETED|Overall Study||52
5006555|NCT02294682|12318031|P2|STARTED|Overall Study||53
5006556|NCT02294682|12318032|P1|STARTED|Overall Study||53
5006557|NCT02294604|12318075|P3|NOT COMPLETED|Overall Study||0
5006558|NCT02294604|12318076|P2|NOT COMPLETED|Overall Study||3
5006559|NCT02294604|12318077|P1|NOT COMPLETED|Overall Study||1
5006560|NCT02294604|12318075|P3|COMPLETED|Overall Study||80
5006561|NCT02294604|12318076|P2|COMPLETED|Overall Study||77
5006562|NCT02294604|12318077|P1|COMPLETED|Overall Study||79
5006563|NCT02294604|12318075|P3|STARTED|Overall Study||80
5006564|NCT02294604|12318076|P2|STARTED|Overall Study||80
5006565|NCT02294604|12318077|P1|STARTED|Overall Study||80
5006566|NCT02294474|12318096|P2|NOT COMPLETED|Overall Study||22
5006567|NCT02294474|12318097|P1|NOT COMPLETED|Overall Study||25
5006568|NCT02294474|12318096|P2|COMPLETED|Overall Study||230
5006569|NCT02294474|12318097|P1|COMPLETED|Overall Study||228
5006570|NCT02294474|12318096|P2|STARTED|Overall Study||252
5006571|NCT02294474|12318097|P1|STARTED|Overall Study||253
5006572|NCT02294461|12318121|P2|NOT COMPLETED|Overall Study||131
5006573|NCT02294461|12318122|P1|NOT COMPLETED|Overall Study||62
5006574|NCT02294461|12318121|P2|COMPLETED|Overall Study||59
5006575|NCT02294461|12318122|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
5006576|NCT02294461|12318121|P2|Treated/Received Study Drug|Overall Study||190
5006577|NCT02294461|12318122|P1|Treated/Received Study Drug|Overall Study||198
5006578|NCT02294461|12318121|P2|STARTED|Overall Study||190
5006579|NCT02294461|12318122|P1|STARTED|Overall Study||198
5006580|NCT02294396|12318178|P4|NOT COMPLETED|Overall Study||37
5006581|NCT02294396|12318179|P3|NOT COMPLETED|Overall Study||35
5006582|NCT02294396|12318180|P2|NOT COMPLETED|Overall Study||33
5006583|NCT02294396|12318181|P1|NOT COMPLETED|Overall Study||40
5006584|NCT02294396|12318178|P4|COMPLETED|Overall Study||123
5006585|NCT02294396|12318179|P3|COMPLETED|Overall Study||126
5006586|NCT02294396|12318180|P2|COMPLETED|Overall Study||128
5006587|NCT02294396|12318181|P1|COMPLETED|Overall Study||127
5006588|NCT02294396|12318178|P4|STARTED|Overall Study||160
5006589|NCT02294396|12318179|P3|STARTED|Overall Study||161
5006590|NCT02294396|12318180|P2|STARTED|Overall Study||161
5006591|NCT02294396|12318181|P1|STARTED|Overall Study||167
5006592|NCT02294318|12318253|P2|NOT COMPLETED|Overall Study||2
5006593|NCT02294318|12318254|P1|NOT COMPLETED|Overall Study||3
5006594|NCT02294318|12318253|P2|COMPLETED|Overall Study||21
5006595|NCT02294318|12318254|P1|COMPLETED|Overall Study||21
5006596|NCT02294318|12318253|P2|STARTED|Overall Study||23
5006597|NCT02294318|12318254|P1|STARTED|Overall Study||24
5006598|NCT02294253|12318266|P1|NOT COMPLETED|Overall Study||15
5006599|NCT02294253|12318266|P1|COMPLETED|Overall Study||15
5006600|NCT02294253|12318266|P1|STARTED|Overall Study||30
5006601|NCT02294227|12318273|P3|NOT COMPLETED|Overall Study||19
5006602|NCT02294227|12318274|P2|NOT COMPLETED|Overall Study||25
5006603|NCT02294227|12318275|P1|NOT COMPLETED|Overall Study||25
5006604|NCT02294227|12318273|P3|COMPLETED|Overall Study||95
5006605|NCT02294227|12318274|P2|COMPLETED|Overall Study||88
5006606|NCT02294227|12318275|P1|COMPLETED|Overall Study||89
5006607|NCT02294227|12318273|P3|STARTED|Overall Study||114
5006608|NCT02294227|12318274|P2|STARTED|Overall Study||113
5006609|NCT02294227|12318275|P1|STARTED|Overall Study||114
5006610|NCT02294175|12318301|P2|NOT COMPLETED|Overall Study||6
5006611|NCT02294175|12318302|P1|NOT COMPLETED|Overall Study||5
5006612|NCT02294175|12318301|P2|COMPLETED|Overall Study||16
5006613|NCT02294175|12318302|P1|COMPLETED|Overall Study||18
5006614|NCT02294175|12318301|P2|STARTED|Overall Study||22
5006615|NCT02294175|12318302|P1|STARTED|Overall Study||23
5006616|NCT02294019|12318326|P1|NOT COMPLETED|Overall Study||103
5006617|NCT02294019|12318326|P1|COMPLETED|Overall Study||635
5006618|NCT02294019|12318326|P1|STARTED|Overall Study||738
5006619|NCT02293902|12318334|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
5006620|NCT02293902|12318335|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
5006621|NCT02293902|12318336|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
5006622|NCT02293902|12318337|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
5006623|NCT02293902|12318338|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
5006624|NCT02293902|12318334|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
5006625|NCT02293902|12318335|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
5006626|NCT02293902|12318336|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
5006627|NCT02293902|12318337|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
5006628|NCT02293902|12318338|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
5006629|NCT02293902|12318334|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
5006630|NCT02293902|12318335|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
5006631|NCT02293902|12318336|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
5006632|NCT02293902|12318337|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
5006633|NCT02293902|12318338|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
5006634|NCT02293902|12318334|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
5006635|NCT02293902|12318335|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
5006636|NCT02293902|12318336|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
5006637|NCT02293902|12318337|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
5006638|NCT02293902|12318338|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
5006639|NCT02293902|12318334|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
5006640|NCT02293902|12318335|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
5006641|NCT02293902|12318336|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
5006642|NCT02293902|12318337|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
5006643|NCT02293902|12318338|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
5006644|NCT02293902|12318334|P5|Rescued|Double-Blind Period (Up to Week 24)||0
5006645|NCT02293902|12318335|P4|Rescued|Double-Blind Period (Up to Week 24)||0
5006646|NCT02293902|12318336|P3|Rescued|Double-Blind Period (Up to Week 24)||8
5006647|NCT02293902|12318337|P2|Rescued|Double-Blind Period (Up to Week 24)||6
5006648|NCT02293902|12318338|P1|Rescued|Double-Blind Period (Up to Week 24)||44
5006649|NCT02293902|12318334|P5|Treated|Double-Blind Period (Up to Week 24)||0
5006650|NCT02293902|12318335|P4|Treated|Double-Blind Period (Up to Week 24)||0
5006651|NCT02293902|12318336|P3|Treated|Double-Blind Period (Up to Week 24)||80
5006652|NCT02293902|12318337|P2|Treated|Double-Blind Period (Up to Week 24)||81
5006653|NCT02293902|12318338|P1|Treated|Double-Blind Period (Up to Week 24)||81
5006654|NCT02293902|12318334|P5|STARTED|Double-Blind Period (Up to Week 24)||0
5006655|NCT02293902|12318335|P4|STARTED|Double-Blind Period (Up to Week 24)||0
5006656|NCT02293902|12318336|P3|STARTED|Double-Blind Period (Up to Week 24)||80
5006657|NCT02293902|12318337|P2|STARTED|Double-Blind Period (Up to Week 24)||81
5006658|NCT02293902|12318338|P1|STARTED|Double-Blind Period (Up to Week 24)||82
5006659|NCT02293863|12318400|P3|NOT COMPLETED|Overall Study||9
5006660|NCT02293863|12318401|P2|NOT COMPLETED|Overall Study||13
5006661|NCT02293863|12318402|P1|NOT COMPLETED|Overall Study||9
5006662|NCT02293863|12318400|P3|COMPLETED|Overall Study||38
5006663|NCT02293863|12318401|P2|COMPLETED|Overall Study||42
5006664|NCT02293863|12318402|P1|COMPLETED|Overall Study||47
5006665|NCT02293863|12318400|P3|STARTED|Overall Study||47
5006666|NCT02293863|12318401|P2|STARTED|Overall Study||55
5006667|NCT02293863|12318402|P1|STARTED|Overall Study||56
5006668|NCT02293798|12318465|P1|NOT COMPLETED|Overall Study||0
5006669|NCT02293798|12318465|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
5006670|NCT02293798|12318465|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
5006671|NCT02293538|12318471|P2|NOT COMPLETED|Overall Study||2
5006672|NCT02293538|12318472|P1|NOT COMPLETED|Overall Study||1
5006673|NCT02293538|12318471|P2|COMPLETED|Overall Study||69
5006674|NCT02293538|12318472|P1|COMPLETED|Overall Study||72
5006675|NCT02293538|12318471|P2|STARTED|Overall Study||71
5006676|NCT02293538|12318472|P1|STARTED|Overall Study||73
5006677|NCT02293512|12318489|P4|NOT COMPLETED|Overall Study||2
5006678|NCT02293512|12318490|P3|NOT COMPLETED|Overall Study||3
5006679|NCT02293512|12318491|P2|NOT COMPLETED|Overall Study||6
5006680|NCT02293512|12318492|P1|NOT COMPLETED|Overall Study||4
5006681|NCT02293512|12318489|P4|COMPLETED|Overall Study||8
5006682|NCT02293512|12318490|P3|COMPLETED|Overall Study||7
5006683|NCT02293512|12318491|P2|COMPLETED|Overall Study||4
5006684|NCT02293512|12318492|P1|COMPLETED|Overall Study||6
5006685|NCT02293512|12318489|P4|STARTED|Overall Study||10
5006686|NCT02293512|12318490|P3|STARTED|Overall Study||10
5006687|NCT02293512|12318491|P2|STARTED|Overall Study||10
5006688|NCT02293512|12318492|P1|STARTED|Overall Study||10
5006689|NCT02293460|12318502|P1|NOT COMPLETED|Overall Study||6
5006690|NCT02293460|12318502|P1|COMPLETED|Overall Study||37
5006691|NCT02293460|12318502|P1|STARTED|Overall Study||43
5006692|NCT02293395|12318508|P2|NOT COMPLETED|Overall Study||7
5006693|NCT02293395|12318509|P1|NOT COMPLETED|Overall Study||9
5006694|NCT02293395|12318508|P2|COMPLETED|Overall Study||1511
5006695|NCT02293395|12318509|P1|COMPLETED|Overall Study||1510
5006696|NCT02293395|12318508|P2|Treated|Overall Study||1506
5006697|NCT02293395|12318509|P1|Treated|Overall Study||1510
5006698|NCT02293395|12318508|P2|STARTED|Overall Study||1518
5006699|NCT02293395|12318509|P1|STARTED|Overall Study||1519
5006700|NCT02293044|12318515|P1|NOT COMPLETED|Overall Study||0
5006701|NCT02293044|12318515|P1|COMPLETED|Overall Study||15
5006702|NCT02293044|12318515|P1|STARTED|Overall Study||15
5006703|NCT02292927|12318522|P2|NOT COMPLETED|Overall Study||7
5006704|NCT02292927|12318523|P1|NOT COMPLETED|Overall Study||13
5006705|NCT02292927|12318522|P2|COMPLETED|Overall Study||5
5006706|NCT02292927|12318523|P1|COMPLETED|Overall Study||0
5006707|NCT02292927|12318522|P2|STARTED|Overall Study||12
5006708|NCT02292927|12318523|P1|STARTED|Overall Study||13
5006709|NCT02292849|12318540|P3|NOT COMPLETED|Overall Study||2
5006710|NCT02292849|12318541|P2|NOT COMPLETED|Overall Study||2
5006711|NCT02292849|12318542|P1|NOT COMPLETED|Overall Study||4
5006712|NCT02292849|12318540|P3|COMPLETED|Overall Study||8
5006713|NCT02292849|12318541|P2|COMPLETED|Overall Study||6
5006714|NCT02292849|12318542|P1|COMPLETED|Overall Study||7
5006715|NCT02292849|12318540|P3|STARTED|Overall Study||10
5006716|NCT02292849|12318541|P2|STARTED|Overall Study||8
5006717|NCT02292849|12318542|P1|STARTED|Overall Study||11
5006718|NCT02292784|12318553|P3|NOT COMPLETED|Overall Study||21
5006719|NCT02292784|12318554|P2|NOT COMPLETED|Overall Study||20
5006720|NCT02292784|12318555|P1|NOT COMPLETED|Overall Study||1
5006721|NCT02292784|12318553|P3|COMPLETED|Overall Study||28
5006722|NCT02292784|12318554|P2|COMPLETED|Overall Study||24
5006723|NCT02292784|12318555|P1|COMPLETED|Overall Study||4
5006724|NCT02292784|12318553|P3|STARTED|Overall Study||49
5006725|NCT02292784|12318554|P2|STARTED|Overall Study||44
5006726|NCT02292784|12318555|P1|STARTED|Overall Study||5
5006727|NCT02292771|12318622|P2|NOT COMPLETED|Overall Study||2
5006728|NCT02292771|12318623|P1|NOT COMPLETED|Overall Study||4
5006729|NCT02292771|12318622|P2|COMPLETED|Overall Study||48
5006730|NCT02292771|12318623|P1|COMPLETED|Overall Study||43
5006731|NCT02292771|12318622|P2|STARTED|Overall Study||50
5006732|NCT02292771|12318623|P1|STARTED|Overall Study||47
5006733|NCT02292758|12318715|P2|NOT COMPLETED|Overall Study||0
5006734|NCT02292758|12318716|P1|NOT COMPLETED|Overall Study||0
5006735|NCT02292758|12318715|P2|COMPLETED|Overall Study||17
5006736|NCT02292758|12318716|P1|COMPLETED|Overall Study||19
5006737|NCT02292758|12318715|P2|STARTED|Overall Study||17
5006738|NCT02292758|12318716|P1|STARTED|Overall Study||19
5006739|NCT02292719|12318746|P6|NOT COMPLETED|Overall Study||0
5006740|NCT02292719|12318747|P5|NOT COMPLETED|Overall Study||1
5006741|NCT02292719|12318748|P4|NOT COMPLETED|Overall Study||1
5006742|NCT02292719|12318749|P3|NOT COMPLETED|Overall Study||1
5006743|NCT02292719|12318750|P2|NOT COMPLETED|Overall Study||0
5006744|NCT02292719|12318751|P1|NOT COMPLETED|Overall Study||0
5006745|NCT02292719|12318746|P6|COMPLETED|Overall Study||10
5006746|NCT02292719|12318747|P5|COMPLETED|Overall Study||20
5006747|NCT02292719|12318748|P4|COMPLETED|Overall Study||8
5006748|NCT02292719|12318749|P3|COMPLETED|Overall Study||9
5006749|NCT02292719|12318750|P2|COMPLETED|Overall Study||11
5006750|NCT02292719|12318751|P1|COMPLETED|Overall Study||9
5006751|NCT02292719|12318746|P6|STARTED|Overall Study||10
5006752|NCT02292719|12318747|P5|STARTED|Overall Study||21
5006753|NCT02292719|12318748|P4|STARTED|Overall Study||9
5006754|NCT02292719|12318749|P3|STARTED|Overall Study||10
5006755|NCT02292719|12318750|P2|STARTED|Overall Study||11
5006756|NCT02292719|12318751|P1|STARTED|Overall Study||9
5006757|NCT02292537|12318779|P2|NOT COMPLETED|Overall Study||0
5006758|NCT02292537|12318780|P1|NOT COMPLETED|Overall Study||0
5006759|NCT02292537|12318779|P2|COMPLETED|Overall Study||84
5006760|NCT02292537|12318780|P1|COMPLETED|Overall Study||42
5006761|NCT02292537|12318779|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
5006762|NCT02292537|12318780|P1|Completed Treatment|Overall Study||42
5006763|NCT02292537|12318779|P2|STARTED|Overall Study||84
5006764|NCT02292537|12318780|P1|STARTED|Overall Study||42
5006765|NCT02292446|12318814|P1|NOT COMPLETED|Overall Study||20
5006766|NCT02292446|12318814|P1|COMPLETED|Overall Study||141
5006767|NCT02292446|12318814|P1|STARTED|Overall Study||161
5006768|NCT02292433|12318830|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
5006769|NCT02292433|12318831|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
5006770|NCT02292433|12318832|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
5006771|NCT02292433|12318830|P3|COMPLETED|Third Intervention Period (7 Days)||4
5006772|NCT02292433|12318831|P2|COMPLETED|Third Intervention Period (7 Days)||4
5006773|NCT02292433|12318832|P1|COMPLETED|Third Intervention Period (7 Days)||4
5006774|NCT02292433|12318830|P3|STARTED|Third Intervention Period (7 Days)||4
5006775|NCT02292433|12318831|P2|STARTED|Third Intervention Period (7 Days)||4
5006776|NCT02292433|12318832|P1|STARTED|Third Intervention Period (7 Days)||4
5006777|NCT02292433|12318830|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5006778|NCT02292433|12318831|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5006779|NCT02292433|12318832|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5006780|NCT02292433|12318830|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
5006781|NCT02292433|12318831|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
5006782|NCT02292433|12318832|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
5006783|NCT02292433|12318830|P3|STARTED|Second Washout Period (7 to 14 Days)||4
5006784|NCT02292433|12318831|P2|STARTED|Second Washout Period (7 to 14 Days)||4
5006785|NCT02292433|12318832|P1|STARTED|Second Washout Period (7 to 14 Days)||4
5006786|NCT02292433|12318830|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
5006787|NCT02292433|12318831|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
5006788|NCT02292433|12318832|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
5006789|NCT02292433|12318830|P3|COMPLETED|Second Intervention Period (7 Days)||4
5006790|NCT02292433|12318831|P2|COMPLETED|Second Intervention Period (7 Days)||4
5006791|NCT02292433|12318832|P1|COMPLETED|Second Intervention Period (7 Days)||4
5006792|NCT02292433|12318830|P3|STARTED|Second Intervention Period (7 Days)||4
5006793|NCT02292433|12318831|P2|STARTED|Second Intervention Period (7 Days)||4
5006794|NCT02292433|12318832|P1|STARTED|Second Intervention Period (7 Days)||4
5006795|NCT02292433|12318830|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5006796|NCT02292433|12318831|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5006797|NCT02292433|12318832|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5006798|NCT02292433|12318830|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
5006799|NCT02292433|12318831|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
5006800|NCT02292433|12318832|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
5006801|NCT02292433|12318830|P3|STARTED|First Washout Period (7 to 14 Days)||4
5006802|NCT02292433|12318831|P2|STARTED|First Washout Period (7 to 14 Days)||4
5006803|NCT02292433|12318832|P1|STARTED|First Washout Period (7 to 14 Days)||4
5006804|NCT02292433|12318830|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
5006805|NCT02292433|12318831|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
5006806|NCT02292433|12318832|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
5006807|NCT02292433|12318830|P3|COMPLETED|First Intervention Period (7 Days)||4
5006808|NCT02292433|12318831|P2|COMPLETED|First Intervention Period (7 Days)||4
5006809|NCT02292433|12318832|P1|COMPLETED|First Intervention Period (7 Days)||4
5006810|NCT02292433|12318830|P3|STARTED|First Intervention Period (7 Days)||4
5006811|NCT02292433|12318831|P2|STARTED|First Intervention Period (7 Days)||4
5006812|NCT02292433|12318832|P1|STARTED|First Intervention Period (7 Days)||4
5006813|NCT02292212|12318903|P1|NOT COMPLETED|Post-ViE Phase||0
5006814|NCT02292212|12318903|P1|COMPLETED|Post-ViE Phase||14
5006815|NCT02292212|12318903|P1|STARTED|Post-ViE Phase||14
5006816|NCT02292212|12318903|P1|NOT COMPLETED|ViE Phase||3
5006817|NCT02292212|12318903|P1|COMPLETED|ViE Phase||14
5006818|NCT02292212|12318903|P1|STARTED|ViE Phase||17
5006819|NCT02292212|12318903|P1|NOT COMPLETED|Pre-ViE Phase||0
5006820|NCT02292212|12318903|P1|COMPLETED|Pre-ViE Phase||17
5006821|NCT02292212|12318903|P1|STARTED|Pre-ViE Phase||17
5006822|NCT02292186|12318935|P1|NOT COMPLETED|Overall Study||18
5006823|NCT02292186|12318935|P1|COMPLETED|Overall Study||7
5006824|NCT02292186|12318935|P1|STARTED|Overall Study||25
5006825|NCT02292082|12318945|P2|NOT COMPLETED|Overall Study||0
5006826|NCT02292082|12318946|P1|NOT COMPLETED|Overall Study||0
5006827|NCT02292082|12318945|P2|COMPLETED|Overall Study||55
5006828|NCT02292082|12318946|P1|COMPLETED|Overall Study||56
5006829|NCT02292082|12318945|P2|STARTED|Overall Study||55
5006830|NCT02292082|12318946|P1|STARTED|Overall Study||56
5006831|NCT02291913|12318972|P1|NOT COMPLETED|Overall Study||48
5006832|NCT02291913|12318972|P1|COMPLETED|Overall Study||0
5006833|NCT02291913|12318972|P1|STARTED|Overall Study||48
5006834|NCT02291861|12318985|P4|NOT COMPLETED|Overall Study||10
5006835|NCT02291861|12318986|P3|NOT COMPLETED|Overall Study||9
5006836|NCT02291861|12318987|P2|NOT COMPLETED|Overall Study||8
5006837|NCT02291861|12318988|P1|NOT COMPLETED|Overall Study||7
5006838|NCT02291861|12318985|P4|COMPLETED|Overall Study||65
5006839|NCT02291861|12318986|P3|COMPLETED|Overall Study||65
5006840|NCT02291861|12318987|P2|COMPLETED|Overall Study||67
5006841|NCT02291861|12318988|P1|COMPLETED|Overall Study||67
5006842|NCT02291861|12318985|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
5006843|NCT02291861|12318986|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
5006844|NCT02291861|12318987|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
5006845|NCT02291861|12318988|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
5006846|NCT02291861|12318985|P4|Safety Population|Overall Study||74
5006847|NCT02291861|12318986|P3|Safety Population|Overall Study||73
5006848|NCT02291861|12318987|P2|Safety Population|Overall Study||74
5006849|NCT02291861|12318988|P1|Safety Population|Overall Study||72
5006850|NCT02291861|12318985|P4|STARTED|Overall Study||75
5006851|NCT02291861|12318986|P3|STARTED|Overall Study||74
5006852|NCT02291861|12318987|P2|STARTED|Overall Study||75
5006853|NCT02291861|12318988|P1|STARTED|Overall Study||74
5006854|NCT02291718|12319029|P3|NOT COMPLETED|Overall Study||0
5006855|NCT02291718|12319030|P2|NOT COMPLETED|Overall Study||0
5006856|NCT02291718|12319031|P1|NOT COMPLETED|Overall Study||0
5006857|NCT02291718|12319029|P3|COMPLETED|Overall Study||50
5006858|NCT02291718|12319030|P2|COMPLETED|Overall Study||50
5006859|NCT02291718|12319031|P1|COMPLETED|Overall Study||50
5006860|NCT02291718|12319029|P3|STARTED|Overall Study||50
5006861|NCT02291718|12319030|P2|STARTED|Overall Study||50
5006862|NCT02291718|12319031|P1|STARTED|Overall Study||50
5006863|NCT02291679|12319051|P3|NOT COMPLETED|Overall Study||59
5006864|NCT02291679|12319052|P2|NOT COMPLETED|Overall Study||42
5006865|NCT02291679|12319053|P1|NOT COMPLETED|Overall Study||44
5006866|NCT02291679|12319051|P3|COMPLETED|Overall Study||352
5006867|NCT02291679|12319052|P2|COMPLETED|Overall Study||369
5006868|NCT02291679|12319053|P1|COMPLETED|Overall Study||357
5006869|NCT02291679|12319051|P3|STARTED|Overall Study||411
5006870|NCT02291679|12319052|P2|STARTED|Overall Study||411
5006871|NCT02291679|12319053|P1|STARTED|Overall Study||401
5006872|NCT02291549|12319084|P2|NOT COMPLETED|Overall Study||1
5006873|NCT02291549|12319085|P1|NOT COMPLETED|Overall Study||1
5006874|NCT02291549|12319084|P2|COMPLETED|Overall Study||98
5006875|NCT02291549|12319085|P1|COMPLETED|Overall Study||200
5006876|NCT02291549|12319084|P2|STARTED|Overall Study||99
5006877|NCT02291549|12319085|P1|STARTED|Overall Study||201
5006878|NCT02291510|12319107|P4|NOT COMPLETED|Overall Study||1
5006879|NCT02291510|12319108|P3|NOT COMPLETED|Overall Study||0
5006880|NCT02291510|12319109|P2|NOT COMPLETED|Overall Study||0
5006881|NCT02291510|12319110|P1|NOT COMPLETED|Overall Study||0
5006882|NCT02291510|12319107|P4|COMPLETED|Overall Study||4
5006883|NCT02291510|12319108|P3|COMPLETED|Overall Study||5
5006884|NCT02291510|12319109|P2|COMPLETED|Overall Study||5
5006885|NCT02291510|12319110|P1|COMPLETED|Overall Study||5
5006886|NCT02291510|12319107|P4|Completed Treatment D|Overall Study||5
5006887|NCT02291510|12319108|P3|Completed Treatment D|Overall Study||5
5006888|NCT02291510|12319109|P2|Completed Treatment D|Overall Study||5
5006889|NCT02291510|12319110|P1|Completed Treatment D|Overall Study||5
5006890|NCT02291510|12319107|P4|Completed Treatment C|Overall Study||4
5006891|NCT02291510|12319108|P3|Completed Treatment C|Overall Study||5
5006892|NCT02291510|12319109|P2|Completed Treatment C|Overall Study||5
5006893|NCT02291510|12319110|P1|Completed Treatment C|Overall Study||5
5006894|NCT02291510|12319107|P4|Completed Treatment B|Overall Study||4
5006895|NCT02291510|12319108|P3|Completed Treatment B|Overall Study||5
5006896|NCT02291510|12319109|P2|Completed Treatment B|Overall Study||5
5006897|NCT02291510|12319110|P1|Completed Treatment B|Overall Study||5
5006898|NCT02291510|12319107|P4|Completed Treatment A|Overall Study||5
5006899|NCT02291510|12319108|P3|Completed Treatment A|Overall Study||5
5006900|NCT02291510|12319109|P2|Completed Treatment A|Overall Study||5
5006901|NCT02291510|12319110|P1|Completed Treatment A|Overall Study||5
5006902|NCT02291510|12319107|P4|STARTED|Overall Study||5
5006903|NCT02291510|12319108|P3|STARTED|Overall Study||5
5006904|NCT02291510|12319109|P2|STARTED|Overall Study||5
5006905|NCT02291510|12319110|P1|STARTED|Overall Study||5
5006906|NCT02291419|12319126|P2|NOT COMPLETED|Overall Study||5
5006907|NCT02291419|12319127|P1|NOT COMPLETED|Overall Study||1
5006908|NCT02291419|12319126|P2|COMPLETED|Overall Study||0
5006909|NCT02291419|12319127|P1|COMPLETED|Overall Study||0
5006910|NCT02291419|12319126|P2|STARTED|Overall Study||5
5006911|NCT02291419|12319127|P1|STARTED|Overall Study||1
5006912|NCT02291289|12319147|P12|NOT COMPLETED|Maintenance Treatment Phase||16
5006913|NCT02291289|12319148|P11|NOT COMPLETED|Maintenance Treatment Phase||31
5006914|NCT02291289|12319149|P10|NOT COMPLETED|Maintenance Treatment Phase||0
5006915|NCT02291289|12319150|P9|NOT COMPLETED|Maintenance Treatment Phase||2
5006916|NCT02291289|12319151|P8|NOT COMPLETED|Maintenance Treatment Phase||2
5006917|NCT02291289|12319152|P7|NOT COMPLETED|Maintenance Treatment Phase||0
5006918|NCT02291289|12319153|P6|NOT COMPLETED|Maintenance Treatment Phase||129
5006919|NCT02291289|12319154|P5|NOT COMPLETED|Maintenance Treatment Phase||252
5006920|NCT02291289|12319155|P4|NOT COMPLETED|Maintenance Treatment Phase||0
5006921|NCT02291289|12319156|P3|NOT COMPLETED|Maintenance Treatment Phase||16
5006922|NCT02291289|12319157|P2|NOT COMPLETED|Maintenance Treatment Phase||24
5006923|NCT02291289|12319158|P1|NOT COMPLETED|Maintenance Treatment Phase||0
5006924|NCT02291289|12319147|P12|COMPLETED|Maintenance Treatment Phase||18
5006925|NCT02291289|12319148|P11|COMPLETED|Maintenance Treatment Phase||34
5006926|NCT02291289|12319149|P10|COMPLETED|Maintenance Treatment Phase||0
5006927|NCT02291289|12319150|P9|COMPLETED|Maintenance Treatment Phase||0
5006928|NCT02291289|12319151|P8|COMPLETED|Maintenance Treatment Phase||1
5006929|NCT02291289|12319152|P7|COMPLETED|Maintenance Treatment Phase||0
5006930|NCT02291289|12319153|P6|COMPLETED|Maintenance Treatment Phase||19
5006931|NCT02291289|12319154|P5|COMPLETED|Maintenance Treatment Phase||45
5006932|NCT02291289|12319155|P4|COMPLETED|Maintenance Treatment Phase||0
5006933|NCT02291289|12319156|P3|COMPLETED|Maintenance Treatment Phase||4
5006934|NCT02291289|12319157|P2|COMPLETED|Maintenance Treatment Phase||16
5006935|NCT02291289|12319158|P1|COMPLETED|Maintenance Treatment Phase||0
5006936|NCT02291289|12319147|P12|Dosed|Maintenance Treatment Phase||34
5006937|NCT02291289|12319148|P11|Dosed|Maintenance Treatment Phase||64
5006938|NCT02291289|12319149|P10|Dosed|Maintenance Treatment Phase||0
5006939|NCT02291289|12319150|P9|Dosed|Maintenance Treatment Phase||2
5006940|NCT02291289|12319151|P8|Dosed|Maintenance Treatment Phase||3
5006941|NCT02291289|12319152|P7|Dosed|Maintenance Treatment Phase||0
5006942|NCT02291289|12319153|P6|Dosed|Maintenance Treatment Phase||143
5006943|NCT02291289|12319154|P5|Dosed|Maintenance Treatment Phase||293
5006944|NCT02291289|12319155|P4|Dosed|Maintenance Treatment Phase||0
5006945|NCT02291289|12319156|P3|Dosed|Maintenance Treatment Phase||18
5006946|NCT02291289|12319157|P2|Dosed|Maintenance Treatment Phase||40
5006947|NCT02291289|12319158|P1|Dosed|Maintenance Treatment Phase||0
5006948|NCT02291289|12319147|P12|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
5006949|NCT02291289|12319148|P11|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
5006950|NCT02291289|12319149|P10|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
5006951|NCT02291289|12319150|P9|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
5006952|NCT02291289|12319151|P8|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
5006953|NCT02291289|12319152|P7|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
5007039|NCT02290925|12319322|P1|NOT COMPLETED|First Period of Three Months||4
5006954|NCT02291289|12319153|P6|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
5006955|NCT02291289|12319154|P5|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
5006956|NCT02291289|12319155|P4|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
5006957|NCT02291289|12319156|P3|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
5006958|NCT02291289|12319157|P2|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
5006959|NCT02291289|12319158|P1|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
5006960|NCT02291289|12319147|P12|NOT COMPLETED|Induction Treatment||0
5006961|NCT02291289|12319148|P11|NOT COMPLETED|Induction Treatment||0
5006962|NCT02291289|12319149|P10|NOT COMPLETED|Induction Treatment||1
5006963|NCT02291289|12319150|P9|NOT COMPLETED|Induction Treatment||0
5006964|NCT02291289|12319151|P8|NOT COMPLETED|Induction Treatment||0
5006965|NCT02291289|12319152|P7|NOT COMPLETED|Induction Treatment||0
5006966|NCT02291289|12319153|P6|NOT COMPLETED|Induction Treatment||0
5006967|NCT02291289|12319154|P5|NOT COMPLETED|Induction Treatment||0
5006968|NCT02291289|12319155|P4|NOT COMPLETED|Induction Treatment||9
5006969|NCT02291289|12319156|P3|NOT COMPLETED|Induction Treatment||0
5006970|NCT02291289|12319157|P2|NOT COMPLETED|Induction Treatment||0
5006971|NCT02291289|12319158|P1|NOT COMPLETED|Induction Treatment||2
5006972|NCT02291289|12319147|P12|COMPLETED|Induction Treatment||0
5006973|NCT02291289|12319148|P11|COMPLETED|Induction Treatment||0
5006974|NCT02291289|12319149|P10|COMPLETED|Induction Treatment||98
5006975|NCT02291289|12319150|P9|COMPLETED|Induction Treatment||0
5006976|NCT02291289|12319151|P8|COMPLETED|Induction Treatment||0
5006977|NCT02291289|12319152|P7|COMPLETED|Induction Treatment||5
5006978|NCT02291289|12319153|P6|COMPLETED|Induction Treatment||0
5006979|NCT02291289|12319154|P5|COMPLETED|Induction Treatment||0
5006980|NCT02291289|12319155|P4|COMPLETED|Induction Treatment||436
5006981|NCT02291289|12319156|P3|COMPLETED|Induction Treatment||0
5006982|NCT02291289|12319157|P2|COMPLETED|Induction Treatment||0
5006983|NCT02291289|12319158|P1|COMPLETED|Induction Treatment||58
5006984|NCT02291289|12319147|P12|STARTED|Induction Treatment||0
5006985|NCT02291289|12319148|P11|STARTED|Induction Treatment||0
5006986|NCT02291289|12319149|P10|STARTED|Induction Treatment||99
5006987|NCT02291289|12319150|P9|STARTED|Induction Treatment||0
5006988|NCT02291289|12319151|P8|STARTED|Induction Treatment||0
5006989|NCT02291289|12319152|P7|STARTED|Induction Treatment||5
5006990|NCT02291289|12319153|P6|STARTED|Induction Treatment||0
5006991|NCT02291289|12319154|P5|STARTED|Induction Treatment||0
5006992|NCT02291289|12319155|P4|STARTED|Induction Treatment||445
5006993|NCT02291289|12319156|P3|STARTED|Induction Treatment||0
5006994|NCT02291289|12319157|P2|STARTED|Induction Treatment||0
5006995|NCT02291289|12319158|P1|STARTED|Induction Treatment||60
5006996|NCT02291237|12319222|P2|NOT COMPLETED|Overall Study||86
5006997|NCT02291237|12319223|P1|NOT COMPLETED|Overall Study||86
5006998|NCT02291237|12319222|P2|COMPLETED|Overall Study||0
5006999|NCT02291237|12319223|P1|COMPLETED|Overall Study||0
5007000|NCT02291237|12319222|P2|STARTED|Overall Study||86
5007001|NCT02291237|12319223|P1|STARTED|Overall Study||86
5007002|NCT02291029|12319245|P6|NOT COMPLETED|Overall Study||0
5007003|NCT02291029|12319246|P5|NOT COMPLETED|Overall Study||0
5007004|NCT02291029|12319247|P4|NOT COMPLETED|Overall Study||0
5007005|NCT02291029|12319248|P3|NOT COMPLETED|Overall Study||1
5007006|NCT02291029|12319249|P2|NOT COMPLETED|Overall Study||1
5007007|NCT02291029|12319250|P1|NOT COMPLETED|Overall Study||0
5007008|NCT02291029|12319245|P6|COMPLETED|Overall Study||12
5007009|NCT02291029|12319246|P5|COMPLETED|Overall Study||13
5007010|NCT02291029|12319247|P4|COMPLETED|Overall Study||11
5007011|NCT02291029|12319248|P3|COMPLETED|Overall Study||20
5007012|NCT02291029|12319249|P2|COMPLETED|Overall Study||3
5007013|NCT02291029|12319250|P1|COMPLETED|Overall Study||8
5007014|NCT02291029|12319245|P6|STARTED|Overall Study||12
5007015|NCT02291029|12319246|P5|STARTED|Overall Study||13
5007016|NCT02291029|12319247|P4|STARTED|Overall Study||11
5007017|NCT02291029|12319248|P3|STARTED|Overall Study||21
5007018|NCT02291029|12319249|P2|STARTED|Overall Study||4
5007019|NCT02291029|12319250|P1|STARTED|Overall Study||8
5007020|NCT02291016|12319296|P2|NOT COMPLETED|Visit 2||0
5007021|NCT02291016|12319297|P1|NOT COMPLETED|Visit 2||1
5007022|NCT02291016|12319296|P2|COMPLETED|Visit 2||5
5007023|NCT02291016|12319297|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
5007024|NCT02291016|12319296|P2|STARTED|Visit 2||5
5007025|NCT02291016|12319297|P1|STARTED|Visit 2||2
5007026|NCT02291016|12319296|P2|NOT COMPLETED|Visit 1||0
5007027|NCT02291016|12319297|P1|NOT COMPLETED|Visit 1||0
5007028|NCT02291016|12319296|P2|COMPLETED|Visit 1||5
5007029|NCT02291016|12319297|P1|COMPLETED|Visit 1||2
5007030|NCT02291016|12319296|P2|STARTED|Visit 1||5
5007031|NCT02291016|12319297|P1|STARTED|Visit 1||2
5007032|NCT02290925|12319321|P2|NOT COMPLETED|Second Period of 3 Months||4
5007033|NCT02290925|12319322|P1|NOT COMPLETED|Second Period of 3 Months||1
5007034|NCT02290925|12319321|P2|COMPLETED|Second Period of 3 Months||65
5007035|NCT02290925|12319322|P1|COMPLETED|Second Period of 3 Months||57
5007036|NCT02290925|12319321|P2|STARTED|Second Period of 3 Months||69
5007037|NCT02290925|12319322|P1|STARTED|Second Period of 3 Months||58
5007038|NCT02290925|12319321|P2|NOT COMPLETED|First Period of Three Months||2
5007040|NCT02290925|12319321|P2|COMPLETED|First Period of Three Months||69
5007041|NCT02290925|12319322|P1|COMPLETED|First Period of Three Months||58
5007042|NCT02290925|12319321|P2|STARTED|First Period of Three Months||71
5007043|NCT02290925|12319322|P1|STARTED|First Period of Three Months||62
5007044|NCT02290873|12319337|P3|NOT COMPLETED|Overall Study||2
5007045|NCT02290873|12319338|P2|NOT COMPLETED|Overall Study||1
5007046|NCT02290873|12319339|P1|NOT COMPLETED|Overall Study||2
5007047|NCT02290873|12319337|P3|COMPLETED|Overall Study||101
5007048|NCT02290873|12319338|P2|COMPLETED|Overall Study||59
5007049|NCT02290873|12319339|P1|COMPLETED|Overall Study||296
5007050|NCT02290873|12319337|P3|Safety Population|Overall Study||102
5007051|NCT02290873|12319338|P2|Safety Population|Overall Study||60
5007052|NCT02290873|12319339|P1|Safety Population|Overall Study||296
5007053|NCT02290873|12319337|P3|Modified Intention to Treat (mITT)|Overall Study||102
5007054|NCT02290873|12319338|P2|Modified Intention to Treat (mITT)|Overall Study||60
5007055|NCT02290873|12319339|P1|Modified Intention to Treat (mITT)|Overall Study||296
5007056|NCT02290873|12319337|P3|STARTED|Overall Study||103
5007057|NCT02290873|12319338|P2|STARTED|Overall Study||60
5007058|NCT02290873|12319339|P1|STARTED|Overall Study||298
5007059|NCT02290821|12319358|P2|NOT COMPLETED|Overall Study||3
5007060|NCT02290821|12319359|P1|NOT COMPLETED|Overall Study||6
5007061|NCT02290821|12319358|P2|COMPLETED|Overall Study||103
5007062|NCT02290821|12319359|P1|COMPLETED|Overall Study||103
5007063|NCT02290821|12319358|P2|STARTED|Overall Study||106
5007064|NCT02290821|12319359|P1|STARTED|Overall Study||109
5007065|NCT02290691|12319367|P2|NOT COMPLETED|Overall Study||9
5007066|NCT02290691|12319368|P1|NOT COMPLETED|Overall Study||8
5007067|NCT02290691|12319367|P2|COMPLETED|Overall Study||479
5007068|NCT02290691|12319368|P1|COMPLETED|Overall Study||488
5007069|NCT02290691|12319367|P2|STARTED|Overall Study||488
5007070|NCT02290691|12319368|P1|STARTED|Overall Study||496
5007071|NCT02290613|12319384|P2|NOT COMPLETED|Overall Study||4
5007072|NCT02290613|12319385|P1|NOT COMPLETED|Overall Study||2
5007073|NCT02290613|12319384|P2|COMPLETED|Overall Study||15
5007074|NCT02290613|12319385|P1|COMPLETED|Overall Study||17
5007075|NCT02290613|12319384|P2|STARTED|Overall Study||19
5007076|NCT02290613|12319385|P1|STARTED|Overall Study||19
5007077|NCT02290574|12319433|P1|NOT COMPLETED|Overall Study||1
5007078|NCT02290574|12319433|P1|COMPLETED|Overall Study||13
5007079|NCT02290574|12319433|P1|STARTED|Overall Study||14
5007080|NCT02290509|12319443|P2|NOT COMPLETED|Overall Study||14
5007081|NCT02290509|12319444|P1|NOT COMPLETED|Overall Study||49
5007082|NCT02290509|12319443|P2|COMPLETED|Overall Study||325
5007083|NCT02290509|12319444|P1|COMPLETED|Overall Study||962
5007084|NCT02290509|12319443|P2|STARTED|Overall Study||339
5007085|NCT02290509|12319444|P1|STARTED|Overall Study||1011
5007086|NCT02290444|12319458|P2|NOT COMPLETED|Overall Study||2
5007087|NCT02290444|12319459|P1|NOT COMPLETED|Overall Study||1
5007088|NCT02290444|12319458|P2|COMPLETED|Overall Study||32
5007089|NCT02290444|12319459|P1|COMPLETED|Overall Study||29
5007090|NCT02290444|12319458|P2|STARTED|Overall Study||34
5007091|NCT02290444|12319459|P1|STARTED|Overall Study||30
5007092|NCT02290431|12319481|P1|NOT COMPLETED|Overall Study||27
5007093|NCT02290431|12319481|P1|COMPLETED|Overall Study||4
5007094|NCT02290431|12319481|P1|Entered Treatment Phase 2|Overall Study||17
5007095|NCT02290431|12319481|P1|Subjects Entered Survival f/u Phase|Overall Study||24
5007096|NCT02290431|12319481|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
5007097|NCT02290431|12319481|P1|Subjects Completed Study Per Protocol|Overall Study||8
5007098|NCT02290431|12319481|P1|Subjects. Discont. Prematurely|Overall Study||27
5007099|NCT02290431|12319481|P1|STARTED|Overall Study||31
5007100|NCT02290340|12319504|P4|NOT COMPLETED|Overall Study||2
5007101|NCT02290340|12319505|P3|NOT COMPLETED|Overall Study||0
5007102|NCT02290340|12319506|P2|NOT COMPLETED|Overall Study||0
5007103|NCT02290340|12319507|P1|NOT COMPLETED|Overall Study||2
5007104|NCT02290340|12319504|P4|COMPLETED|Overall Study||30
5007105|NCT02290340|12319505|P3|COMPLETED|Overall Study||31
5007106|NCT02290340|12319506|P2|COMPLETED|Overall Study||8
5007107|NCT02290340|12319507|P1|COMPLETED|Overall Study||16
5007108|NCT02290340|12319504|P4|STARTED|Overall Study||32
5007109|NCT02290340|12319505|P3|STARTED|Overall Study||31
5007110|NCT02290340|12319506|P2|STARTED|Overall Study||8
5007111|NCT02290340|12319507|P1|STARTED|Overall Study||18
5007112|NCT02290223|12319552|P2|NOT COMPLETED|12 Months||11
5007113|NCT02290223|12319553|P1|NOT COMPLETED|12 Months||16
5007114|NCT02290223|12319552|P2|COMPLETED|12 Months||176
5007115|NCT02290223|12319553|P1|COMPLETED|12 Months||166
5007116|NCT02290223|12319552|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
5007117|NCT02290223|12319553|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
5007118|NCT02290223|12319552|P2|NOT COMPLETED|6 Months||6
5007119|NCT02290223|12319553|P1|NOT COMPLETED|6 Months||16
5007120|NCT02290223|12319552|P2|COMPLETED|6 Months||181
5007121|NCT02290223|12319553|P1|COMPLETED|6 Months||173
5007122|NCT02290223|12319552|P2|STARTED|6 Months||187
5007123|NCT02290223|12319553|P1|STARTED|6 Months||189
5007124|NCT02290223|12319552|P2|NOT COMPLETED|Baseline||0
5007125|NCT02290223|12319553|P1|NOT COMPLETED|Baseline||0
5007126|NCT02290223|12319552|P2|COMPLETED|Baseline||187
5007127|NCT02290223|12319553|P1|COMPLETED|Baseline||189
5007128|NCT02290223|12319552|P2|STARTED|Baseline||187
5007129|NCT02290223|12319553|P1|STARTED|Baseline||189
5007130|NCT02290184|12319613|P2|NOT COMPLETED|Overall Study||0
5007131|NCT02290184|12319614|P1|NOT COMPLETED|Overall Study||0
5007132|NCT02290184|12319613|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
5007133|NCT02290184|12319614|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
5007134|NCT02290184|12319613|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
5007135|NCT02290184|12319614|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
5007136|NCT02290184|12319613|P2|STARTED|Overall Study||23
5007137|NCT02290184|12319614|P1|STARTED|Overall Study||22
5007138|NCT02290106|12319628|P2|NOT COMPLETED|Overall Study||2
5007139|NCT02290106|12319629|P1|NOT COMPLETED|Overall Study||1
5007140|NCT02290106|12319628|P2|COMPLETED|Overall Study||23
5007141|NCT02290106|12319629|P1|COMPLETED|Overall Study||24
5007142|NCT02290106|12319628|P2|STARTED|Overall Study||25
5007143|NCT02290106|12319629|P1|STARTED|Overall Study||25
5007144|NCT02289989|12319649|P2|NOT COMPLETED|Overall Study||0
5007145|NCT02289989|12319650|P1|NOT COMPLETED|Overall Study||0
5007146|NCT02289989|12319649|P2|COMPLETED|Overall Study||1
5007147|NCT02289989|12319650|P1|COMPLETED|Overall Study||0
5007148|NCT02289989|12319649|P2|STARTED|Overall Study||1
5007149|NCT02289989|12319650|P1|STARTED|Overall Study||0
5007150|NCT02289963|12319668|P2|NOT COMPLETED|Overall Study||10
5007151|NCT02289963|12319669|P1|NOT COMPLETED|Overall Study||5
5007152|NCT02289963|12319668|P2|COMPLETED|Overall Study||87
5007153|NCT02289963|12319669|P1|COMPLETED|Overall Study||97
5007154|NCT02289963|12319668|P2|Treated|Overall Study||97
5007155|NCT02289963|12319669|P1|Treated|Overall Study||102
5007156|NCT02289963|12319668|P2|STARTED|Overall Study|Randomized|97
5007157|NCT02289963|12319669|P1|STARTED|Overall Study|Randomized|102
5007158|NCT02289898|12319720|P3|NOT COMPLETED|Overall Study||56
5007159|NCT02289898|12319721|P2|NOT COMPLETED|Overall Study||53
5007160|NCT02289898|12319722|P1|NOT COMPLETED|Overall Study||52
5007161|NCT02289898|12319720|P3|COMPLETED|Overall Study||9
5007162|NCT02289898|12319721|P2|COMPLETED|Overall Study||18
5007163|NCT02289898|12319722|P1|COMPLETED|Overall Study||16
5007164|NCT02289898|12319720|P3|STARTED|Overall Study||65
5007165|NCT02289898|12319721|P2|STARTED|Overall Study||71
5007166|NCT02289898|12319722|P1|STARTED|Overall Study||68
5007167|NCT02289833|12319731|P2|NOT COMPLETED|Overall Study||17
5007168|NCT02289833|12319732|P1|NOT COMPLETED|Overall Study||27
5007169|NCT02289833|12319731|P2|COMPLETED|Overall Study||3
5007170|NCT02289833|12319732|P1|COMPLETED|Overall Study||2
5007171|NCT02289833|12319731|P2|STARTED|Overall Study||20
5007172|NCT02289833|12319732|P1|STARTED|Overall Study||29
5007173|NCT02289820|12319768|P7|NOT COMPLETED|Overall Study||2
5007174|NCT02289820|12319769|P6|NOT COMPLETED|Overall Study||1
5007175|NCT02289820|12319770|P5|NOT COMPLETED|Overall Study||0
5007176|NCT02289820|12319771|P4|NOT COMPLETED|Overall Study||2
5007177|NCT02289820|12319772|P3|NOT COMPLETED|Overall Study||6
5007178|NCT02289820|12319773|P2|NOT COMPLETED|Overall Study||2
5007179|NCT02289820|12319774|P1|NOT COMPLETED|Overall Study||2
5007180|NCT02289820|12319768|P7|COMPLETED|Overall Study||37
5007181|NCT02289820|12319769|P6|COMPLETED|Overall Study||39
5007182|NCT02289820|12319770|P5|COMPLETED|Overall Study||40
5007183|NCT02289820|12319771|P4|COMPLETED|Overall Study||37
5007184|NCT02289820|12319772|P3|COMPLETED|Overall Study||38
5007185|NCT02289820|12319773|P2|COMPLETED|Overall Study||18
5007186|NCT02289820|12319774|P1|COMPLETED|Overall Study||37
5007187|NCT02289820|12319768|P7|STARTED|Overall Study||39
5007188|NCT02289820|12319769|P6|STARTED|Overall Study||40
5007189|NCT02289820|12319770|P5|STARTED|Overall Study||40
5007190|NCT02289820|12319771|P4|STARTED|Overall Study||39
5007191|NCT02289820|12319772|P3|STARTED|Overall Study||44
5007192|NCT02289820|12319773|P2|STARTED|Overall Study||20
5007193|NCT02289820|12319774|P1|STARTED|Overall Study||39
5007194|NCT02289755|12319885|P1|NOT COMPLETED|Follow up Period [4 Days]||0
5007195|NCT02289755|12319885|P1|COMPLETED|Follow up Period [4 Days]||16
5007196|NCT02289755|12319885|P1|STARTED|Follow up Period [4 Days]||16
5007197|NCT02289755|12319885|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
5007198|NCT02289755|12319885|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
5007199|NCT02289755|12319885|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
5007200|NCT02289755|12319885|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
5007201|NCT02289755|12319885|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
5007202|NCT02289755|12319885|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
5007203|NCT02289742|12319892|P4|NOT COMPLETED|Third Wear Period||1
5007204|NCT02289742|12319893|P3|NOT COMPLETED|Third Wear Period||0
5007205|NCT02289742|12319894|P2|NOT COMPLETED|Third Wear Period||1
5007206|NCT02289742|12319895|P1|NOT COMPLETED|Third Wear Period||0
5007207|NCT02289742|12319892|P4|COMPLETED|Third Wear Period||8
5007208|NCT02289742|12319893|P3|COMPLETED|Third Wear Period||11
5007209|NCT02289742|12319894|P2|COMPLETED|Third Wear Period||10
5007210|NCT02289742|12319895|P1|COMPLETED|Third Wear Period||11
5007211|NCT02289742|12319892|P4|STARTED|Third Wear Period||9
5007212|NCT02289742|12319893|P3|STARTED|Third Wear Period||11
5007213|NCT02289742|12319894|P2|STARTED|Third Wear Period||11
5007214|NCT02289742|12319895|P1|STARTED|Third Wear Period||11
5007215|NCT02289742|12319892|P4|NOT COMPLETED|Second Wear Period||0
5007216|NCT02289742|12319893|P3|NOT COMPLETED|Second Wear Period||0
5007217|NCT02289742|12319894|P2|NOT COMPLETED|Second Wear Period||0
5007218|NCT02289742|12319895|P1|NOT COMPLETED|Second Wear Period||0
5007219|NCT02289742|12319892|P4|COMPLETED|Second Wear Period||9
5007220|NCT02289742|12319893|P3|COMPLETED|Second Wear Period||11
5007221|NCT02289742|12319894|P2|COMPLETED|Second Wear Period||11
5007222|NCT02289742|12319895|P1|COMPLETED|Second Wear Period||11
5007223|NCT02289742|12319892|P4|STARTED|Second Wear Period||9
5007224|NCT02289742|12319893|P3|STARTED|Second Wear Period||11
5007225|NCT02289742|12319894|P2|STARTED|Second Wear Period||11
5007226|NCT02289742|12319895|P1|STARTED|Second Wear Period||11
5007227|NCT02289742|12319892|P4|NOT COMPLETED|First Wear Period||1
5007228|NCT02289742|12319893|P3|NOT COMPLETED|First Wear Period||1
5007229|NCT02289742|12319894|P2|NOT COMPLETED|First Wear Period||1
5007230|NCT02289742|12319895|P1|NOT COMPLETED|First Wear Period||0
5007231|NCT02289742|12319892|P4|COMPLETED|First Wear Period||9
5007232|NCT02289742|12319893|P3|COMPLETED|First Wear Period||11
5007233|NCT02289742|12319894|P2|COMPLETED|First Wear Period||11
5007234|NCT02289742|12319895|P1|COMPLETED|First Wear Period||11
5007235|NCT02289742|12319892|P4|Treated|First Wear Period||9
5007236|NCT02289742|12319893|P3|Treated|First Wear Period||12
5007237|NCT02289742|12319894|P2|Treated|First Wear Period||11
5007238|NCT02289742|12319895|P1|Treated|First Wear Period||11
5007239|NCT02289742|12319892|P4|STARTED|First Wear Period||10
5007240|NCT02289742|12319893|P3|STARTED|First Wear Period||12
5007241|NCT02289742|12319894|P2|STARTED|First Wear Period||12
5007242|NCT02289742|12319895|P1|STARTED|First Wear Period||11
5007243|NCT02289729|12319912|P1|NOT COMPLETED|Overall Study||6
5007244|NCT02289729|12319912|P1|COMPLETED|Overall Study||53
5007245|NCT02289729|12319912|P1|STARTED|Overall Study||59
5007246|NCT02289690|12319976|P10|NOT COMPLETED|Overall Study||61
5007247|NCT02289690|12319977|P9|NOT COMPLETED|Overall Study||59
5007248|NCT02289690|12319978|P8|NOT COMPLETED|Overall Study||61
5007249|NCT02289690|12319979|P7|NOT COMPLETED|Overall Study||4
5007250|NCT02289690|12319980|P6|NOT COMPLETED|Overall Study||14
5007251|NCT02289690|12319981|P5|NOT COMPLETED|Overall Study||8
5007252|NCT02289690|12319982|P4|NOT COMPLETED|Overall Study||3
5007253|NCT02289690|12319983|P3|NOT COMPLETED|Overall Study||4
5007254|NCT02289690|12319984|P2|NOT COMPLETED|Overall Study||3
5007255|NCT02289690|12319985|P1|NOT COMPLETED|Overall Study||4
5007256|NCT02289690|12319976|P10|COMPLETED|Overall Study||0
5007257|NCT02289690|12319977|P9|COMPLETED|Overall Study||0
5007258|NCT02289690|12319978|P8|COMPLETED|Overall Study||0
5007259|NCT02289690|12319979|P7|COMPLETED|Overall Study||0
5007260|NCT02289690|12319980|P6|COMPLETED|Overall Study||0
5007261|NCT02289690|12319981|P5|COMPLETED|Overall Study||0
5007262|NCT02289690|12319982|P4|COMPLETED|Overall Study||0
5007263|NCT02289690|12319983|P3|COMPLETED|Overall Study||0
5007264|NCT02289690|12319984|P2|COMPLETED|Overall Study||0
5007265|NCT02289690|12319985|P1|COMPLETED|Overall Study||0
5007266|NCT02289690|12319976|P10|Received Study Drug|Overall Study||60
5007267|NCT02289690|12319977|P9|Received Study Drug|Overall Study||58
5007268|NCT02289690|12319978|P8|Received Study Drug|Overall Study||60
5007269|NCT02289690|12319979|P7|Received Study Drug|Overall Study||4
5007270|NCT02289690|12319980|P6|Received Study Drug|Overall Study||14
5007271|NCT02289690|12319981|P5|Received Study Drug|Overall Study||8
5007272|NCT02289690|12319982|P4|Received Study Drug|Overall Study||3
5007273|NCT02289690|12319983|P3|Received Study Drug|Overall Study||4
5007274|NCT02289690|12319984|P2|Received Study Drug|Overall Study||3
5007275|NCT02289690|12319985|P1|Received Study Drug|Overall Study||4
5007276|NCT02289690|12319976|P10|STARTED|Overall Study||61
5007277|NCT02289690|12319977|P9|STARTED|Overall Study||59
5007278|NCT02289690|12319978|P8|STARTED|Overall Study||61
5007279|NCT02289690|12319979|P7|STARTED|Overall Study||4
5007280|NCT02289690|12319980|P6|STARTED|Overall Study||14
5007281|NCT02289690|12319981|P5|STARTED|Overall Study||8
5007282|NCT02289690|12319982|P4|STARTED|Overall Study||3
5007283|NCT02289690|12319983|P3|STARTED|Overall Study||4
5007284|NCT02289690|12319984|P2|STARTED|Overall Study||3
5007285|NCT02289690|12319985|P1|STARTED|Overall Study||4
5007286|NCT02289469|12320073|P2|NOT COMPLETED|Overall Study||0
5007287|NCT02289469|12320074|P1|NOT COMPLETED|Overall Study||6
5007288|NCT02289469|12320073|P2|COMPLETED|Overall Study||244
5007289|NCT02289469|12320074|P1|COMPLETED|Overall Study||244
5007290|NCT02289469|12320073|P2|STARTED|Overall Study||244
5007291|NCT02289469|12320074|P1|STARTED|Overall Study||250
5007292|NCT02289456|12320082|P1|NOT COMPLETED|Monotherapy Period||16
5007293|NCT02289456|12320082|P1|COMPLETED|Monotherapy Period||0
5007294|NCT02289456|12320082|P1|STARTED|Monotherapy Period||16
5007295|NCT02289456|12320082|P1|NOT COMPLETED|Induction Period||24
5007296|NCT02289456|12320082|P1|COMPLETED|Induction Period||16
5007297|NCT02289456|12320082|P1|Treated Population|Induction Period||40
5007298|NCT02289456|12320082|P1|STARTED|Induction Period||40
5007299|NCT02289417|12320105|P9|NOT COMPLETED|Extension Phase Weeks 52-104||6
5007300|NCT02289417|12320106|P8|NOT COMPLETED|Extension Phase Weeks 52-104||7
5007301|NCT02289417|12320107|P7|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007302|NCT02289417|12320108|P6|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007303|NCT02289417|12320109|P5|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007304|NCT02289417|12320110|P4|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007305|NCT02289417|12320111|P3|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007306|NCT02289417|12320112|P2|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007307|NCT02289417|12320113|P1|NOT COMPLETED|Extension Phase Weeks 52-104||0
5007308|NCT02289417|12320105|P9|COMPLETED|Extension Phase Weeks 52-104||48
5007309|NCT02289417|12320106|P8|COMPLETED|Extension Phase Weeks 52-104||38
5007310|NCT02289417|12320107|P7|COMPLETED|Extension Phase Weeks 52-104||0
5007311|NCT02289417|12320108|P6|COMPLETED|Extension Phase Weeks 52-104||0
5007312|NCT02289417|12320109|P5|COMPLETED|Extension Phase Weeks 52-104||0
5007313|NCT02289417|12320110|P4|COMPLETED|Extension Phase Weeks 52-104||0
5007314|NCT02289417|12320111|P3|COMPLETED|Extension Phase Weeks 52-104||0
5007315|NCT02289417|12320112|P2|COMPLETED|Extension Phase Weeks 52-104||0
5007316|NCT02289417|12320113|P1|COMPLETED|Extension Phase Weeks 52-104||0
5007317|NCT02289417|12320105|P9|STARTED|Extension Phase Weeks 52-104||54
5007318|NCT02289417|12320106|P8|STARTED|Extension Phase Weeks 52-104||45
5007319|NCT02289417|12320107|P7|STARTED|Extension Phase Weeks 52-104||0
5007320|NCT02289417|12320108|P6|STARTED|Extension Phase Weeks 52-104||0
5007321|NCT02289417|12320109|P5|STARTED|Extension Phase Weeks 52-104||0
5007322|NCT02289417|12320110|P4|STARTED|Extension Phase Weeks 52-104||0
5007323|NCT02289417|12320111|P3|STARTED|Extension Phase Weeks 52-104||0
5007324|NCT02289417|12320112|P2|STARTED|Extension Phase Weeks 52-104||0
5007325|NCT02289417|12320113|P1|STARTED|Extension Phase Weeks 52-104||0
5007326|NCT02289417|12320105|P9|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
5007327|NCT02289417|12320106|P8|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
5007328|NCT02289417|12320107|P7|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
5007329|NCT02289417|12320108|P6|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
5007330|NCT02289417|12320109|P5|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
5007331|NCT02289417|12320110|P4|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
5007332|NCT02289417|12320111|P3|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
5007333|NCT02289417|12320112|P2|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
5007334|NCT02289417|12320113|P1|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
5007335|NCT02289417|12320105|P9|COMPLETED|Active Treatment Phase Weeks 12-52||0
5007336|NCT02289417|12320106|P8|COMPLETED|Active Treatment Phase Weeks 12-52||0
5007337|NCT02289417|12320107|P7|COMPLETED|Active Treatment Phase Weeks 12-52||5
5007338|NCT02289417|12320108|P6|COMPLETED|Active Treatment Phase Weeks 12-52||7
5007339|NCT02289417|12320109|P5|COMPLETED|Active Treatment Phase Weeks 12-52||20
5007340|NCT02289417|12320110|P4|COMPLETED|Active Treatment Phase Weeks 12-52||17
5007341|NCT02289417|12320111|P3|COMPLETED|Active Treatment Phase Weeks 12-52||32
5007342|NCT02289417|12320112|P2|COMPLETED|Active Treatment Phase Weeks 12-52||39
5007343|NCT02289417|12320113|P1|COMPLETED|Active Treatment Phase Weeks 12-52||0
5007344|NCT02289417|12320105|P9|STARTED|Active Treatment Phase Weeks 12-52||0
5007345|NCT02289417|12320106|P8|STARTED|Active Treatment Phase Weeks 12-52||0
5007346|NCT02289417|12320107|P7|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
5007347|NCT02289417|12320108|P6|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
5007348|NCT02289417|12320109|P5|STARTED|Active Treatment Phase Weeks 12-52||25
5007349|NCT02289417|12320110|P4|STARTED|Active Treatment Phase Weeks 12-52||26
5007350|NCT02289417|12320111|P3|STARTED|Active Treatment Phase Weeks 12-52||42
5007351|NCT02289417|12320112|P2|STARTED|Active Treatment Phase Weeks 12-52||41
5007352|NCT02289417|12320113|P1|STARTED|Active Treatment Phase Weeks 12-52||0
5007353|NCT02289417|12320105|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007354|NCT02289417|12320106|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007355|NCT02289417|12320107|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007356|NCT02289417|12320108|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007357|NCT02289417|12320109|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007358|NCT02289417|12320110|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007359|NCT02289417|12320111|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
5007360|NCT02289417|12320112|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
5007361|NCT02289417|12320113|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
5007362|NCT02289417|12320105|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007363|NCT02289417|12320106|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007364|NCT02289417|12320107|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007365|NCT02289417|12320108|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007366|NCT02289417|12320109|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007367|NCT02289417|12320110|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
5007368|NCT02289417|12320111|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
5007369|NCT02289417|12320112|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
5007370|NCT02289417|12320113|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
5007371|NCT02289417|12320105|P9|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007372|NCT02289417|12320106|P8|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007373|NCT02289417|12320107|P7|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007374|NCT02289417|12320108|P6|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007375|NCT02289417|12320109|P5|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007376|NCT02289417|12320110|P4|STARTED|Placebo-Controlled Phase Weeks 0-12||0
5007377|NCT02289417|12320111|P3|STARTED|Placebo-Controlled Phase Weeks 0-12||55
5007378|NCT02289417|12320112|P2|STARTED|Placebo-Controlled Phase Weeks 0-12||57
5007379|NCT02289417|12320113|P1|STARTED|Placebo-Controlled Phase Weeks 0-12||58
5007380|NCT02289352|12320162|P3|NOT COMPLETED|Overall Study||0
5007381|NCT02289352|12320163|P2|NOT COMPLETED|Overall Study||1
5007382|NCT02289352|12320164|P1|NOT COMPLETED|Overall Study||1
5007383|NCT02289352|12320162|P3|COMPLETED|Overall Study||64
5007384|NCT02289352|12320163|P2|COMPLETED|Overall Study||198
5007385|NCT02289352|12320164|P1|COMPLETED|Overall Study||198
5007386|NCT02289352|12320162|P3|PP Population|Overall Study||54
5007387|NCT02289352|12320163|P2|PP Population|Overall Study||173
5007388|NCT02289352|12320164|P1|PP Population|Overall Study||173
5007389|NCT02289352|12320162|P3|mITT Population|Overall Study||58
5007390|NCT02289352|12320163|P2|mITT Population|Overall Study||193
5007391|NCT02289352|12320164|P1|mITT Population|Overall Study||191
5007392|NCT02289352|12320162|P3|Safety Population|Overall Study||64
5007393|NCT02289352|12320163|P2|Safety Population|Overall Study||199
5007394|NCT02289352|12320164|P1|Safety Population|Overall Study||199
5007395|NCT02289352|12320162|P3|STARTED|Overall Study||64
5007396|NCT02289352|12320163|P2|STARTED|Overall Study||199
5007397|NCT02289352|12320164|P1|STARTED|Overall Study||199
5007398|NCT02289222|12320175|P1|NOT COMPLETED|Overall Study||0
5007399|NCT02289222|12320175|P1|COMPLETED|Overall Study||48
5007400|NCT02289222|12320175|P1|STARTED|Overall Study||48
5007401|NCT02289157|12320183|P2|NOT COMPLETED|Overall Study||0
5007402|NCT02289157|12320184|P1|NOT COMPLETED|Overall Study||0
5007403|NCT02289157|12320183|P2|COMPLETED|Overall Study||219
5007404|NCT02289157|12320184|P1|COMPLETED|Overall Study||222
5007405|NCT02289157|12320183|P2|No Post op Check or Follow up Phone Call|Overall Study||4
5007406|NCT02289157|12320184|P1|No Post op Check or Follow up Phone Call|Overall Study||2
5007407|NCT02289157|12320183|P2|STARTED|Overall Study||219
5007408|NCT02289157|12320184|P1|STARTED|Overall Study||222
5007409|NCT02289105|12320218|P2|NOT COMPLETED|Overall Study||0
5007410|NCT02289105|12320219|P1|NOT COMPLETED|Overall Study||0
5007411|NCT02289105|12320218|P2|COMPLETED|Overall Study||637
5007412|NCT02289105|12320219|P1|COMPLETED|Overall Study||642
5007413|NCT02289105|12320218|P2|STARTED|Overall Study||637
5007414|NCT02289105|12320219|P1|STARTED|Overall Study||642
5007415|NCT02289079|12320231|P2|NOT COMPLETED|Overall Study||1
5007416|NCT02289079|12320232|P1|NOT COMPLETED|Overall Study||2
5007417|NCT02289079|12320231|P2|COMPLETED|Overall Study||29
5007418|NCT02289079|12320232|P1|COMPLETED|Overall Study||28
5007419|NCT02289079|12320231|P2|STARTED|Overall Study||30
5007420|NCT02289079|12320232|P1|STARTED|Overall Study||30
5007421|NCT02288819|12320244|P1|NOT COMPLETED|Overall Study||0
5007422|NCT02288819|12320244|P1|COMPLETED|Overall Study||50
5007423|NCT02288819|12320244|P1|STARTED|Overall Study||50
5007424|NCT02288559|12320261|P4|NOT COMPLETED|Overall Study||2
5007425|NCT02288559|12320262|P3|NOT COMPLETED|Overall Study||11
5007426|NCT02288559|12320263|P2|NOT COMPLETED|Overall Study||1
5007427|NCT02288559|12320264|P1|NOT COMPLETED|Overall Study||1
5007428|NCT02288559|12320261|P4|COMPLETED|Overall Study||20
5007429|NCT02288559|12320262|P3|COMPLETED|Overall Study||35
5007430|NCT02288559|12320263|P2|COMPLETED|Overall Study||10
5007431|NCT02288559|12320264|P1|COMPLETED|Overall Study||9
5007432|NCT02288559|12320261|P4|STARTED|Overall Study||22
5007433|NCT02288559|12320262|P3|STARTED|Overall Study||46
5007434|NCT02288559|12320263|P2|STARTED|Overall Study||11
5007435|NCT02288559|12320264|P1|STARTED|Overall Study||10
5007436|NCT02288364|12320290|P2|NOT COMPLETED|Overall Study||0
5007437|NCT02288364|12320291|P1|NOT COMPLETED|Overall Study||0
5007438|NCT02288364|12320290|P2|COMPLETED|Overall Study||44
5007439|NCT02288364|12320291|P1|COMPLETED|Overall Study||42
5007440|NCT02288364|12320290|P2|STARTED|Overall Study||44
5007441|NCT02288364|12320291|P1|STARTED|Overall Study||42
5007442|NCT02288325|12320315|P3|NOT COMPLETED|Double-blind Treatment Period||26
5007443|NCT02288325|12320316|P2|NOT COMPLETED|Double-blind Treatment Period||24
5007444|NCT02288325|12320317|P1|NOT COMPLETED|Double-blind Treatment Period||0
5007445|NCT02288325|12320315|P3|COMPLETED|Double-blind Treatment Period||139
5007446|NCT02288325|12320316|P2|COMPLETED|Double-blind Treatment Period||135
5007447|NCT02288325|12320317|P1|COMPLETED|Double-blind Treatment Period||0
5007448|NCT02288325|12320315|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
5007449|NCT02288325|12320316|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
5007450|NCT02288325|12320317|P1|STARTED|Double-blind Treatment Period||0
5007451|NCT02288325|12320315|P3|NOT COMPLETED|Stabilization Period||0
5007452|NCT02288325|12320316|P2|NOT COMPLETED|Stabilization Period||0
5007453|NCT02288325|12320317|P1|NOT COMPLETED|Stabilization Period||98
5007454|NCT02288325|12320315|P3|COMPLETED|Stabilization Period||0
5007455|NCT02288325|12320316|P2|COMPLETED|Stabilization Period||0
5007456|NCT02288325|12320317|P1|COMPLETED|Stabilization Period||331
5007457|NCT02288325|12320315|P3|STARTED|Stabilization Period||0
5007458|NCT02288325|12320316|P2|STARTED|Stabilization Period||0
5007459|NCT02288325|12320317|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
5007460|NCT02288325|12320315|P3|NOT COMPLETED|Run-in Period||0
5007461|NCT02288325|12320316|P2|NOT COMPLETED|Run-in Period||0
5007462|NCT02288325|12320317|P1|NOT COMPLETED|Run-in Period||145
5007463|NCT02288325|12320315|P3|COMPLETED|Run-in Period||0
5007464|NCT02288325|12320316|P2|COMPLETED|Run-in Period||0
5007465|NCT02288325|12320317|P1|COMPLETED|Run-in Period||499
5007466|NCT02288325|12320315|P3|STARTED|Run-in Period||0
5007467|NCT02288325|12320316|P2|STARTED|Run-in Period||0
5007468|NCT02288325|12320317|P1|STARTED|Run-in Period||644
5007469|NCT02288312|12320327|P3|NOT COMPLETED|Overall Study||0
5007470|NCT02288312|12320328|P2|NOT COMPLETED|Overall Study||0
5007471|NCT02288312|12320329|P1|NOT COMPLETED|Overall Study||1
5007472|NCT02288312|12320327|P3|COMPLETED|Overall Study||6
5007473|NCT02288312|12320328|P2|COMPLETED|Overall Study||6
5007474|NCT02288312|12320329|P1|COMPLETED|Overall Study||5
5007475|NCT02288312|12320327|P3|STARTED|Overall Study||6
5007476|NCT02288312|12320328|P2|STARTED|Overall Study||6
5007477|NCT02288312|12320329|P1|STARTED|Overall Study||6
5007478|NCT02288273|12320348|P2|NOT COMPLETED|Overall Study||8
5007479|NCT02288273|12320349|P1|NOT COMPLETED|Overall Study||8
5007480|NCT02288273|12320348|P2|COMPLETED|Overall Study||48
5007481|NCT02288273|12320349|P1|COMPLETED|Overall Study||53
5007482|NCT02288273|12320348|P2|STARTED|Overall Study||56
5007483|NCT02288273|12320349|P1|STARTED|Overall Study||61
5007484|NCT02288182|12320369|P2|NOT COMPLETED|Overall Study||2
5007485|NCT02288182|12320370|P1|NOT COMPLETED|Overall Study||0
5007486|NCT02288182|12320369|P2|COMPLETED|Overall Study||25
5007487|NCT02288182|12320370|P1|COMPLETED|Overall Study||25
5007488|NCT02288182|12320369|P2|STARTED|Overall Study||27
5007489|NCT02288182|12320370|P1|STARTED|Overall Study||25
5007490|NCT02288091|12320382|P1|NOT COMPLETED|Overall Study||8
5007491|NCT02288091|12320382|P1|COMPLETED|Overall Study||24
5007492|NCT02288091|12320382|P1|Randomized/Treated|Overall Study||25
5007493|NCT02288091|12320382|P1|STARTED|Overall Study||32
5007494|NCT02287922|12320394|P4|NOT COMPLETED|Overall Study||7
5007495|NCT02287922|12320395|P3|NOT COMPLETED|Overall Study||7
5007496|NCT02287922|12320396|P2|NOT COMPLETED|Overall Study||2
5007497|NCT02287922|12320397|P1|NOT COMPLETED|Overall Study||3
5007498|NCT02287922|12320394|P4|COMPLETED|Overall Study||57
5007499|NCT02287922|12320395|P3|COMPLETED|Overall Study||56
5007500|NCT02287922|12320396|P2|COMPLETED|Overall Study||60
5007501|NCT02287922|12320397|P1|COMPLETED|Overall Study||59
5007502|NCT02287922|12320394|P4|STARTED|Overall Study||64
5007503|NCT02287922|12320395|P3|STARTED|Overall Study||63
5007504|NCT02287922|12320396|P2|STARTED|Overall Study||62
5007505|NCT02287922|12320397|P1|STARTED|Overall Study||62
5007506|NCT02287896|12320488|P2|NOT COMPLETED|Second Injection Visit||1
5007507|NCT02287896|12320489|P1|NOT COMPLETED|Second Injection Visit||0
5007508|NCT02287896|12320488|P2|COMPLETED|Second Injection Visit||25
5007509|NCT02287896|12320489|P1|COMPLETED|Second Injection Visit||36
5007510|NCT02287896|12320488|P2|STARTED|Second Injection Visit||26
5007511|NCT02287896|12320489|P1|STARTED|Second Injection Visit||36
5007512|NCT02287896|12320488|P2|NOT COMPLETED|First Injection Visit||0
5007513|NCT02287896|12320489|P1|NOT COMPLETED|First Injection Visit||0
5007514|NCT02287896|12320488|P2|COMPLETED|First Injection Visit||26
5007515|NCT02287896|12320489|P1|COMPLETED|First Injection Visit||36
5007516|NCT02287896|12320488|P2|STARTED|First Injection Visit||26
5007517|NCT02287896|12320489|P1|STARTED|First Injection Visit||36
5007518|NCT02287896|12320488|P2|NOT COMPLETED|Screening Visit V1||0
5007519|NCT02287896|12320489|P1|NOT COMPLETED|Screening Visit V1||0
5007520|NCT02287896|12320488|P2|COMPLETED|Screening Visit V1||26
5007521|NCT02287896|12320489|P1|COMPLETED|Screening Visit V1||36
5007522|NCT02287896|12320488|P2|STARTED|Screening Visit V1||26
5007523|NCT02287896|12320489|P1|STARTED|Screening Visit V1||36
5007524|NCT02287883|12320507|P2|NOT COMPLETED|Overall Study||426
5007525|NCT02287883|12320508|P1|NOT COMPLETED|Overall Study||459
5007526|NCT02287883|12320507|P2|COMPLETED|Overall Study||669
5007527|NCT02287883|12320508|P1|COMPLETED|Overall Study||622
5007528|NCT02287883|12320507|P2|One-year Follow-up Survey|Overall Study||669
5007529|NCT02287883|12320508|P1|One-year Follow-up Survey|Overall Study||622
5007530|NCT02287883|12320507|P2|STARTED|Overall Study||1095
5007531|NCT02287883|12320508|P1|STARTED|Overall Study||1081
5007532|NCT02287779|12320526|P8|NOT COMPLETED|Overall Study||0
5007533|NCT02287779|12320527|P7|NOT COMPLETED|Overall Study||0
5007534|NCT02287779|12320528|P6|NOT COMPLETED|Overall Study||0
5007535|NCT02287779|12320529|P5|NOT COMPLETED|Overall Study||0
5007536|NCT02287779|12320530|P4|NOT COMPLETED|Overall Study||0
5007537|NCT02287779|12320531|P3|NOT COMPLETED|Overall Study||0
5007538|NCT02287779|12320532|P2|NOT COMPLETED|Overall Study||0
5007539|NCT02287779|12320533|P1|NOT COMPLETED|Overall Study||0
5007540|NCT02287779|12320526|P8|COMPLETED|Overall Study||9
5007541|NCT02287779|12320527|P7|COMPLETED|Overall Study||9
5007542|NCT02287779|12320528|P6|COMPLETED|Overall Study||9
5007543|NCT02287779|12320529|P5|COMPLETED|Overall Study||9
5007544|NCT02287779|12320530|P4|COMPLETED|Overall Study||9
5007545|NCT02287779|12320531|P3|COMPLETED|Overall Study||9
5007546|NCT02287779|12320532|P2|COMPLETED|Overall Study||9
5007547|NCT02287779|12320533|P1|COMPLETED|Overall Study||21
5007548|NCT02287779|12320526|P8|STARTED|Overall Study||9
5007549|NCT02287779|12320527|P7|STARTED|Overall Study||9
5007550|NCT02287779|12320528|P6|STARTED|Overall Study||9
5007551|NCT02287779|12320529|P5|STARTED|Overall Study||9
5007552|NCT02287779|12320530|P4|STARTED|Overall Study||9
5007553|NCT02287779|12320531|P3|STARTED|Overall Study||9
5007554|NCT02287779|12320532|P2|STARTED|Overall Study||9
5007555|NCT02287779|12320533|P1|STARTED|Overall Study||21
5007556|NCT02287688|12320671|P1|NOT COMPLETED|Overall Study||0
5007557|NCT02287688|12320671|P1|COMPLETED|Overall Study||138
5007558|NCT02287688|12320671|P1|STARTED|Overall Study||138
5007559|NCT02287675|12320682|P2|NOT COMPLETED|Overall Study||0
5007560|NCT02287675|12320683|P1|NOT COMPLETED|Overall Study||0
5007561|NCT02287675|12320682|P2|COMPLETED|Overall Study||18
5007562|NCT02287675|12320683|P1|COMPLETED|Overall Study||22
5007563|NCT02287675|12320682|P2|STARTED|Overall Study||18
5007564|NCT02287675|12320683|P1|STARTED|Overall Study||22
5007565|NCT02287636|12320699|P1|NOT COMPLETED|Overall Study||0
5007566|NCT02287636|12320699|P1|COMPLETED|Overall Study||13
5007567|NCT02287636|12320699|P1|STARTED|Overall Study||13
5007568|NCT02287623|12320710|P2|NOT COMPLETED|Overall Study||1
5007569|NCT02287623|12320711|P1|NOT COMPLETED|Overall Study||0
5007570|NCT02287623|12320710|P2|COMPLETED|Overall Study||29
5007571|NCT02287623|12320711|P1|COMPLETED|Overall Study||30
5007572|NCT02287623|12320710|P2|STARTED|Overall Study||30
5007573|NCT02287623|12320711|P1|STARTED|Overall Study||30
5007574|NCT02287610|12320727|P1|NOT COMPLETED|Overall Study||16
5007575|NCT02287610|12320727|P1|COMPLETED|Overall Study||48
5007576|NCT02287610|12320727|P1|Per Protocol Follow-Up|Overall Study||56
5007577|NCT02287610|12320727|P1|STARTED|Overall Study||64
5007578|NCT02287467|12320762|P2|NOT COMPLETED|Overall Study||9
5007579|NCT02287467|12320763|P1|NOT COMPLETED|Overall Study||12
5007580|NCT02287467|12320762|P2|COMPLETED|Overall Study||152
5007581|NCT02287467|12320763|P1|COMPLETED|Overall Study||156
5007582|NCT02287467|12320762|P2|STARTED|Overall Study||161
5007583|NCT02287467|12320763|P1|STARTED|Overall Study||168
5007584|NCT02287415|12320805|P1|NOT COMPLETED|Overall Study||0
5007585|NCT02287415|12320805|P1|COMPLETED|Overall Study||13
5007586|NCT02287415|12320805|P1|STARTED|Overall Study||13
5007587|NCT02287402|12320811|P1|NOT COMPLETED|Follow-up||3
5007588|NCT02287402|12320811|P1|COMPLETED|Follow-up||103
5007589|NCT02287402|12320811|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
5007590|NCT02287402|12320811|P1|NOT COMPLETED|Treatment Period||27
5007591|NCT02287402|12320811|P1|COMPLETED|Treatment Period||170
5007592|NCT02287402|12320811|P1|STARTED|Treatment Period||197
5007593|NCT02287376|12320826|P1|NOT COMPLETED|Overall Study||0
5007594|NCT02287376|12320826|P1|COMPLETED|Overall Study||25
5007595|NCT02287376|12320826|P1|STARTED|Overall Study||25
5007596|NCT02287350|12320869|P1|NOT COMPLETED|Overall Study||3
5007597|NCT02287350|12320869|P1|COMPLETED|Overall Study||48
5007598|NCT02287350|12320869|P1|STARTED|Overall Study||51
5007599|NCT02287038|12320916|P2|NOT COMPLETED|Overall Study||3
5007600|NCT02287038|12320917|P1|NOT COMPLETED|Overall Study||5
5007601|NCT02287038|12320916|P2|COMPLETED|Overall Study||18
5007602|NCT02287038|12320917|P1|COMPLETED|Overall Study||18
5007603|NCT02287038|12320916|P2|STARTED|Overall Study||21
5007604|NCT02287038|12320917|P1|STARTED|Overall Study||23
5007605|NCT02287025|12320927|P2|NOT COMPLETED|Overall Study||9
5007606|NCT02287025|12320928|P1|NOT COMPLETED|Overall Study||10
5007607|NCT02287025|12320927|P2|COMPLETED|Overall Study||2
5007608|NCT02287025|12320928|P1|COMPLETED|Overall Study||2
5007609|NCT02287025|12320927|P2|STARTED|Overall Study||11
5007610|NCT02287025|12320928|P1|STARTED|Overall Study||12
5007611|NCT02286960|12320939|P2|NOT COMPLETED|Overall Study||3
5007612|NCT02286960|12320940|P1|NOT COMPLETED|Overall Study||3
5007613|NCT02286960|12320939|P2|COMPLETED|Overall Study||14
5007614|NCT02286960|12320940|P1|COMPLETED|Overall Study||16
5007615|NCT02286960|12320939|P2|STARTED|Overall Study||17
5007616|NCT02286960|12320940|P1|STARTED|Overall Study||19
5007617|NCT02286947|12320952|P1|NOT COMPLETED|Overall Study||2
5007618|NCT02286947|12320952|P1|COMPLETED|Overall Study||22
5007619|NCT02286947|12320952|P1|STARTED|Overall Study||24
5007620|NCT02286921|12320963|P2|NOT COMPLETED|Overall Study||0
5007621|NCT02286921|12320964|P1|NOT COMPLETED|Overall Study||0
5007622|NCT02286921|12320963|P2|COMPLETED|Overall Study||101
5007623|NCT02286921|12320964|P1|COMPLETED|Overall Study||94
5007624|NCT02286921|12320963|P2|STARTED|Overall Study||101
5007625|NCT02286921|12320964|P1|STARTED|Overall Study||94
5007626|NCT02286895|12320994|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
5007627|NCT02286895|12320995|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
5007628|NCT02286895|12320994|P2|COMPLETED|Assessed for Measles Seroconversion||261
5007629|NCT02286895|12320995|P1|COMPLETED|Assessed for Measles Seroconversion||252
5007630|NCT02286895|12320994|P2|STARTED|Assessed for Measles Seroconversion||300
5007631|NCT02286895|12320995|P1|STARTED|Assessed for Measles Seroconversion||300
5007632|NCT02286895|12320994|P2|NOT COMPLETED|Randomized and Vaccinated||0
5007633|NCT02286895|12320995|P1|NOT COMPLETED|Randomized and Vaccinated||0
5007634|NCT02286895|12320994|P2|COMPLETED|Randomized and Vaccinated||300
5007635|NCT02286895|12320995|P1|COMPLETED|Randomized and Vaccinated||300
5007636|NCT02286895|12320994|P2|STARTED|Randomized and Vaccinated||300
5007637|NCT02286895|12320995|P1|STARTED|Randomized and Vaccinated||300
5007638|NCT02286713|12321039|P2|NOT COMPLETED|Six Month Follow-Up||27
5007639|NCT02286713|12321040|P1|NOT COMPLETED|Six Month Follow-Up||32
5007640|NCT02286713|12321039|P2|COMPLETED|Six Month Follow-Up||225
5007641|NCT02286713|12321040|P1|COMPLETED|Six Month Follow-Up||218
5007642|NCT02286713|12321039|P2|STARTED|Six Month Follow-Up||252
5007643|NCT02286713|12321040|P1|STARTED|Six Month Follow-Up||250
5007644|NCT02286713|12321039|P2|NOT COMPLETED|Three Month Follow-Up||26
5007645|NCT02286713|12321040|P1|NOT COMPLETED|Three Month Follow-Up||28
5007646|NCT02286713|12321039|P2|COMPLETED|Three Month Follow-Up||228
5007647|NCT02286713|12321040|P1|COMPLETED|Three Month Follow-Up||224
5007648|NCT02286713|12321039|P2|STARTED|Three Month Follow-Up||254
5007649|NCT02286713|12321040|P1|STARTED|Three Month Follow-Up||252
5007650|NCT02286713|12321039|P2|NOT COMPLETED|One Week Follow-Up||24
5007651|NCT02286713|12321040|P1|NOT COMPLETED|One Week Follow-Up||24
5007652|NCT02286713|12321039|P2|COMPLETED|One Week Follow-Up||233
5007653|NCT02286713|12321040|P1|COMPLETED|One Week Follow-Up||235
5007654|NCT02286713|12321039|P2|STARTED|One Week Follow-Up||257
5007655|NCT02286713|12321040|P1|STARTED|One Week Follow-Up||259
5007656|NCT02286518|12321066|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007657|NCT02286518|12321067|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007658|NCT02286518|12321068|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007659|NCT02286518|12321069|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007660|NCT02286518|12321070|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007661|NCT02286518|12321071|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007662|NCT02286518|12321072|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007663|NCT02286518|12321073|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007664|NCT02286518|12321074|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007665|NCT02286518|12321075|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007666|NCT02286518|12321076|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007667|NCT02286518|12321077|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007668|NCT02286518|12321078|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007669|NCT02286518|12321079|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007670|NCT02286518|12321066|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007671|NCT02286518|12321067|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007672|NCT02286518|12321068|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007673|NCT02286518|12321069|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007674|NCT02286518|12321070|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007675|NCT02286518|12321071|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
5007676|NCT02286518|12321072|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
5007677|NCT02286518|12321073|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007678|NCT02286518|12321074|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007679|NCT02286518|12321075|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007680|NCT02286518|12321076|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007681|NCT02286518|12321077|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007682|NCT02286518|12321078|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007683|NCT02286518|12321079|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
5007684|NCT02286518|12321066|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007685|NCT02286518|12321067|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007686|NCT02286518|12321068|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007687|NCT02286518|12321069|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007688|NCT02286518|12321070|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007689|NCT02286518|12321071|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
5007690|NCT02286518|12321072|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
5007691|NCT02286518|12321073|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007692|NCT02286518|12321074|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007693|NCT02286518|12321075|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007694|NCT02286518|12321076|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007695|NCT02286518|12321077|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007696|NCT02286518|12321078|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007697|NCT02286518|12321079|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
5007698|NCT02286518|12321066|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007699|NCT02286518|12321067|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007700|NCT02286518|12321068|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007701|NCT02286518|12321069|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007702|NCT02286518|12321070|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007703|NCT02286518|12321071|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007704|NCT02286518|12321072|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007705|NCT02286518|12321073|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007706|NCT02286518|12321074|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007707|NCT02286518|12321075|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007708|NCT02286518|12321076|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007709|NCT02286518|12321077|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007710|NCT02286518|12321078|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007711|NCT02286518|12321079|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007712|NCT02286518|12321066|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007713|NCT02286518|12321067|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007714|NCT02286518|12321068|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007715|NCT02286518|12321069|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007716|NCT02286518|12321070|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007717|NCT02286518|12321071|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
5007718|NCT02286518|12321072|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
5007719|NCT02286518|12321073|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007720|NCT02286518|12321074|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007721|NCT02286518|12321075|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007722|NCT02286518|12321076|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007723|NCT02286518|12321077|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007724|NCT02286518|12321078|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007725|NCT02286518|12321079|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
5007726|NCT02286518|12321066|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007727|NCT02286518|12321067|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007728|NCT02286518|12321068|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007729|NCT02286518|12321069|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007730|NCT02286518|12321070|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007731|NCT02286518|12321071|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
5007732|NCT02286518|12321072|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
5007733|NCT02286518|12321073|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007734|NCT02286518|12321074|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007735|NCT02286518|12321075|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007736|NCT02286518|12321076|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007737|NCT02286518|12321077|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007738|NCT02286518|12321078|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007739|NCT02286518|12321079|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
5007740|NCT02286518|12321066|P14|NOT COMPLETED|All Parts (16 Days)||0
5007741|NCT02286518|12321067|P13|NOT COMPLETED|All Parts (16 Days)||0
5007742|NCT02286518|12321068|P12|NOT COMPLETED|All Parts (16 Days)||0
5007743|NCT02286518|12321069|P11|NOT COMPLETED|All Parts (16 Days)||0
5007744|NCT02286518|12321070|P10|NOT COMPLETED|All Parts (16 Days)||0
5007745|NCT02286518|12321071|P9|NOT COMPLETED|All Parts (16 Days)||0
5007746|NCT02286518|12321072|P8|NOT COMPLETED|All Parts (16 Days)||0
5007747|NCT02286518|12321073|P7|NOT COMPLETED|All Parts (16 Days)||0
5007748|NCT02286518|12321074|P6|NOT COMPLETED|All Parts (16 Days)||0
5007749|NCT02286518|12321075|P5|NOT COMPLETED|All Parts (16 Days)||0
5007750|NCT02286518|12321076|P4|NOT COMPLETED|All Parts (16 Days)||0
5007751|NCT02286518|12321077|P3|NOT COMPLETED|All Parts (16 Days)||0
5007752|NCT02286518|12321078|P2|NOT COMPLETED|All Parts (16 Days)||0
5007753|NCT02286518|12321079|P1|NOT COMPLETED|All Parts (16 Days)||0
5007754|NCT02286518|12321066|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007755|NCT02286518|12321067|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007756|NCT02286518|12321068|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007757|NCT02286518|12321069|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007758|NCT02286518|12321070|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
5007759|NCT02286518|12321071|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
5007760|NCT02286518|12321072|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
5007761|NCT02286518|12321073|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007762|NCT02286518|12321074|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007763|NCT02286518|12321075|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007764|NCT02286518|12321076|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007765|NCT02286518|12321077|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007766|NCT02286518|12321078|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007767|NCT02286518|12321079|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
5007768|NCT02286518|12321066|P14|STARTED|All Parts (16 Days)||6
5007769|NCT02286518|12321067|P13|STARTED|All Parts (16 Days)||6
5007770|NCT02286518|12321068|P12|STARTED|All Parts (16 Days)||6
5007771|NCT02286518|12321069|P11|STARTED|All Parts (16 Days)||6
5007772|NCT02286518|12321070|P10|STARTED|All Parts (16 Days)||4
5007773|NCT02286518|12321071|P9|STARTED|All Parts (16 Days)||6
5007774|NCT02286518|12321072|P8|STARTED|All Parts (16 Days)||6
5007775|NCT02286518|12321073|P7|STARTED|All Parts (16 Days)||6
5007776|NCT02286518|12321074|P6|STARTED|All Parts (16 Days)||6
5007777|NCT02286518|12321075|P5|STARTED|All Parts (16 Days)||6
5007778|NCT02286518|12321076|P4|STARTED|All Parts (16 Days)||6
5007779|NCT02286518|12321077|P3|STARTED|All Parts (16 Days)||6
5007780|NCT02286518|12321078|P2|STARTED|All Parts (16 Days)||6
5007781|NCT02286518|12321079|P1|STARTED|All Parts (16 Days)||6
5007782|NCT02286466|12321221|P2|NOT COMPLETED|Overall Study||10
5007783|NCT02286466|12321222|P1|NOT COMPLETED|Overall Study||7
5007784|NCT02286466|12321221|P2|COMPLETED|Overall Study||63
5007785|NCT02286466|12321222|P1|COMPLETED|Overall Study||65
5007786|NCT02286466|12321221|P2|Post Self-report|Overall Study||68
5007787|NCT02286466|12321222|P1|Post Self-report|Overall Study||67
5007788|NCT02286466|12321221|P2|Baseline Clinician Assessment|Overall Study||72
5007789|NCT02286466|12321222|P1|Baseline Clinician Assessment|Overall Study||72
5007790|NCT02286466|12321221|P2|STARTED|Overall Study||73
5007791|NCT02286466|12321222|P1|STARTED|Overall Study||72
5007792|NCT02286193|12321234|P1|NOT COMPLETED|Overall Study||204
5007793|NCT02286193|12321234|P1|COMPLETED|Overall Study||418
5007794|NCT02286193|12321234|P1|STARTED|Overall Study||622
5007795|NCT02286102|12321241|P2|NOT COMPLETED|Overall Study||1
5007796|NCT02286102|12321242|P1|NOT COMPLETED|Overall Study||1
5007797|NCT02286102|12321241|P2|COMPLETED|Overall Study||33
5007798|NCT02286102|12321242|P1|COMPLETED|Overall Study||35
5007799|NCT02286102|12321241|P2|STARTED|Overall Study||34
5007800|NCT02286102|12321242|P1|STARTED|Overall Study||36
5007801|NCT02285998|12321254|P2|NOT COMPLETED|Overall Study||253
5007802|NCT02285998|12321255|P1|NOT COMPLETED|Overall Study||246
5007803|NCT02285998|12321254|P2|COMPLETED|Overall Study||4236
5007804|NCT02285998|12321255|P1|COMPLETED|Overall Study||4228
5007805|NCT02285998|12321254|P2|STARTED|Overall Study||4489
5007806|NCT02285998|12321255|P1|STARTED|Overall Study||4474
5007807|NCT02285920|12321283|P4|NOT COMPLETED|Overall Study||1
5007808|NCT02285920|12321284|P3|NOT COMPLETED|Overall Study||5
5007809|NCT02285920|12321285|P2|NOT COMPLETED|Overall Study||4
5007810|NCT02285920|12321286|P1|NOT COMPLETED|Overall Study||4
5007811|NCT02285920|12321283|P4|COMPLETED|Overall Study||24
5007812|NCT02285920|12321284|P3|COMPLETED|Overall Study||21
5007813|NCT02285920|12321285|P2|COMPLETED|Overall Study||23
5007814|NCT02285920|12321286|P1|COMPLETED|Overall Study||47
5007815|NCT02285920|12321283|P4|STARTED|Overall Study||25
5007816|NCT02285920|12321284|P3|STARTED|Overall Study||26
5007817|NCT02285920|12321285|P2|STARTED|Overall Study||27
5007818|NCT02285920|12321286|P1|STARTED|Overall Study||51
5007819|NCT02285907|12321348|P1|NOT COMPLETED|Overall Study||0
5007820|NCT02285907|12321348|P1|COMPLETED|Overall Study||21
5007821|NCT02285907|12321348|P1|Began 4th Intervention|Overall Study||21
5007822|NCT02285907|12321348|P1|Began 3rd Intervention|Overall Study||21
5007823|NCT02285907|12321348|P1|Began 2nd Intervention|Overall Study||21
5007824|NCT02285907|12321348|P1|Began 1st Intervention|Overall Study||21
5007825|NCT02285907|12321348|P1|STARTED|Overall Study||21
5007826|NCT02285855|12321376|P2|NOT COMPLETED|Overall Study||1
5007827|NCT02285855|12321377|P1|NOT COMPLETED|Overall Study||2
5007828|NCT02285855|12321376|P2|COMPLETED|Overall Study||1
5007829|NCT02285855|12321377|P1|COMPLETED|Overall Study||14
5007830|NCT02285855|12321376|P2|Randomized|Overall Study||2
5007831|NCT02285855|12321377|P1|Randomized|Overall Study||16
5007832|NCT02285855|12321376|P2|STARTED|Overall Study||2
5007833|NCT02285855|12321377|P1|STARTED|Overall Study||16
5007834|NCT02285777|12321385|P2|NOT COMPLETED|Overall Study||3
5007835|NCT02285777|12321386|P1|NOT COMPLETED|Overall Study||5
5007836|NCT02285777|12321385|P2|COMPLETED|Overall Study||91
5007837|NCT02285777|12321386|P1|COMPLETED|Overall Study||90
5007838|NCT02285777|12321385|P2|STARTED|Overall Study||94
5007839|NCT02285777|12321386|P1|STARTED|Overall Study||95
5007840|NCT02285634|12321442|P4|NOT COMPLETED|Overall Study||1
5007841|NCT02285634|12321443|P3|NOT COMPLETED|Overall Study||4
5007842|NCT02285634|12321444|P2|NOT COMPLETED|Overall Study||0
5007843|NCT02285634|12321445|P1|NOT COMPLETED|Overall Study||0
5007844|NCT02285634|12321442|P4|COMPLETED|Overall Study||17
5007845|NCT02285634|12321443|P3|COMPLETED|Overall Study||11
5007846|NCT02285634|12321444|P2|COMPLETED|Overall Study||20
5007847|NCT02285634|12321445|P1|COMPLETED|Overall Study||15
5007848|NCT02285634|12321442|P4|STARTED|Overall Study||18
5007849|NCT02285634|12321443|P3|STARTED|Overall Study||15
5007850|NCT02285634|12321444|P2|STARTED|Overall Study||20
5007851|NCT02285634|12321445|P1|STARTED|Overall Study||15
5007852|NCT02285270|12321467|P1|NOT COMPLETED|Overall Study||5
5007853|NCT02285270|12321467|P1|COMPLETED|Overall Study||5
5007854|NCT02285270|12321467|P1|STARTED|Overall Study||10
5007855|NCT02285153|12321475|P2|NOT COMPLETED|Overall Study||0
5007856|NCT02285153|12321476|P1|NOT COMPLETED|Overall Study||1
5007857|NCT02285153|12321475|P2|COMPLETED|Overall Study||8
5007858|NCT02285153|12321476|P1|COMPLETED|Overall Study||6
5007859|NCT02285153|12321475|P2|STARTED|Overall Study||8
5007860|NCT02285153|12321476|P1|STARTED|Overall Study||7
5007861|NCT02285062|12321490|P2|NOT COMPLETED|Overall Study||84
5007862|NCT02285062|12321491|P1|NOT COMPLETED|Overall Study||78
5007863|NCT02285062|12321490|P2|COMPLETED|Overall Study||201
5007864|NCT02285062|12321491|P1|COMPLETED|Overall Study||207
5007865|NCT02285062|12321490|P2|Ongoing Study Treatment|Overall Study||0
5007866|NCT02285062|12321491|P1|Ongoing Study Treatment|Overall Study||0
5007867|NCT02285062|12321490|P2|Received Study Treatment|Overall Study||284
5007868|NCT02285062|12321491|P1|Received Study Treatment|Overall Study||283
5007869|NCT02285062|12321490|P2|STARTED|Overall Study||285
5007870|NCT02285062|12321491|P1|STARTED|Overall Study||285
5007871|NCT02285023|12321527|P1|NOT COMPLETED|Overall Study||0
5007872|NCT02285023|12321527|P1|COMPLETED|Overall Study||166
5007873|NCT02285023|12321527|P1|STARTED|Overall Study||166
5007874|NCT02285010|12321539|P2|NOT COMPLETED|Overall Study||1
5007875|NCT02285010|12321540|P1|NOT COMPLETED|Overall Study||5
5007876|NCT02285010|12321539|P2|COMPLETED|Overall Study||61
5007877|NCT02285010|12321540|P1|COMPLETED|Overall Study||58
5007878|NCT02285010|12321539|P2|STARTED|Overall Study||62
5007879|NCT02285010|12321540|P1|STARTED|Overall Study||63
5007880|NCT02284906|12321557|P3|NOT COMPLETED|Overall Study||19
5007881|NCT02284906|12321558|P2|NOT COMPLETED|Overall Study||18
5007882|NCT02284906|12321559|P1|NOT COMPLETED|Overall Study||3
5007883|NCT02284906|12321557|P3|COMPLETED|Overall Study||0
5007884|NCT02284906|12321558|P2|COMPLETED|Overall Study||0
5007885|NCT02284906|12321559|P1|COMPLETED|Overall Study||0
5007886|NCT02284906|12321557|P3|STARTED|Overall Study||19
5007887|NCT02284906|12321558|P2|STARTED|Overall Study||18
5007888|NCT02284906|12321559|P1|STARTED|Overall Study||3
5007889|NCT02284893|12321572|P2|NOT COMPLETED|52 Week (Long Term)||13
5007890|NCT02284893|12321573|P1|NOT COMPLETED|52 Week (Long Term)||11
5007891|NCT02284893|12321572|P2|COMPLETED|52 Week (Long Term)||180
5007892|NCT02284893|12321573|P1|COMPLETED|52 Week (Long Term)||198
5007893|NCT02284893|12321572|P2|STARTED|52 Week (Long Term)||193
5007894|NCT02284893|12321573|P1|STARTED|52 Week (Long Term)||209
5007895|NCT02284893|12321572|P2|NOT COMPLETED|26 Week (Short Term)||31
5007896|NCT02284893|12321573|P1|NOT COMPLETED|26 Week (Short Term)||19
5007897|NCT02284893|12321572|P2|COMPLETED|26 Week (Short Term)||198
5007898|NCT02284893|12321573|P1|COMPLETED|26 Week (Short Term)||213
5007899|NCT02284893|12321572|P2|STARTED|26 Week (Short Term)||229
5007900|NCT02284893|12321573|P1|STARTED|26 Week (Short Term)||232
5007901|NCT02284880|12321587|P4|NOT COMPLETED|Overall Study||0
5007902|NCT02284880|12321588|P3|NOT COMPLETED|Overall Study||2
5007903|NCT02284880|12321589|P2|NOT COMPLETED|Overall Study||0
5007904|NCT02284880|12321590|P1|NOT COMPLETED|Overall Study||0
5007905|NCT02284880|12321587|P4|COMPLETED|Overall Study||10
5007906|NCT02284880|12321588|P3|COMPLETED|Overall Study||8
5007907|NCT02284880|12321589|P2|COMPLETED|Overall Study||9
5007908|NCT02284880|12321590|P1|COMPLETED|Overall Study||11
5007909|NCT02284880|12321587|P4|Second Period (4 Days)|Overall Study||10
5007910|NCT02284880|12321588|P3|Second Period (4 Days)|Overall Study||8
5007911|NCT02284880|12321589|P2|Second Period (4 Days)|Overall Study||9
5007912|NCT02284880|12321590|P1|Second Period (4 Days)|Overall Study||11
5007913|NCT02284880|12321587|P4|Wash-out Period (7 Days)|Overall Study||10
5007914|NCT02284880|12321588|P3|Wash-out Period (7 Days)|Overall Study||10
5007915|NCT02284880|12321589|P2|Wash-out Period (7 Days)|Overall Study||9
5007916|NCT02284880|12321590|P1|Wash-out Period (7 Days)|Overall Study||11
5007917|NCT02284880|12321587|P4|First Period (4 Days)|Overall Study||10
5007918|NCT02284880|12321588|P3|First Period (4 Days)|Overall Study||10
5007919|NCT02284880|12321589|P2|First Period (4 Days)|Overall Study||9
5007920|NCT02284880|12321590|P1|First Period (4 Days)|Overall Study||11
5007921|NCT02284880|12321587|P4|STARTED|Overall Study||10
5007922|NCT02284880|12321588|P3|STARTED|Overall Study||10
5007923|NCT02284880|12321589|P2|STARTED|Overall Study||9
5007924|NCT02284880|12321590|P1|STARTED|Overall Study||11
5007925|NCT02284867|12321606|P2|NOT COMPLETED|Overall Study||0
5007926|NCT02284867|12321607|P1|NOT COMPLETED|Overall Study||0
5007927|NCT02284867|12321606|P2|COMPLETED|Overall Study||30
5007928|NCT02284867|12321607|P1|COMPLETED|Overall Study||30
5007929|NCT02284867|12321606|P2|STARTED|Overall Study||30
5007930|NCT02284867|12321607|P1|STARTED|Overall Study||30
5007931|NCT02284854|12321617|P2|NOT COMPLETED|Overall Study||0
5007932|NCT02284854|12321618|P1|NOT COMPLETED|Overall Study||5
5007933|NCT02284854|12321617|P2|COMPLETED|Overall Study||20
5007934|NCT02284854|12321618|P1|COMPLETED|Overall Study||18
5007935|NCT02284854|12321617|P2|STARTED|Overall Study||20
5007936|NCT02284854|12321618|P1|STARTED|Overall Study||23
5007937|NCT02284828|12321635|P1|NOT COMPLETED|Overall Study||4
5007938|NCT02284828|12321635|P1|COMPLETED|Overall Study||22
5007939|NCT02284828|12321635|P1|STARTED|Overall Study||26
5007940|NCT02284568|12321650|P3|NOT COMPLETED|Overall Study||95
5007941|NCT02284568|12321651|P2|NOT COMPLETED|Overall Study||46
5007942|NCT02284568|12321652|P1|NOT COMPLETED|Overall Study||31
5007943|NCT02284568|12321650|P3|COMPLETED|Overall Study||0
5007944|NCT02284568|12321651|P2|COMPLETED|Overall Study||93
5007945|NCT02284568|12321652|P1|COMPLETED|Overall Study||109
5007946|NCT02284568|12321650|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
5007947|NCT02284568|12321651|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
5007948|NCT02284568|12321652|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
5007949|NCT02284568|12321650|P3|Safety Population|Overall Study||95
5007950|NCT02284568|12321651|P2|Safety Population|Overall Study||138
5007951|NCT02284568|12321652|P1|Safety Population|Overall Study||140
5007952|NCT02284568|12321650|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
5007953|NCT02284568|12321651|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
5007954|NCT02284568|12321652|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
5007955|NCT02284555|12321678|P1|NOT COMPLETED|Overall Study||0
5007956|NCT02284555|12321678|P1|COMPLETED|Overall Study||12
5007957|NCT02284555|12321678|P1|STARTED|Overall Study||12
5007958|NCT02284516|12321685|P2|NOT COMPLETED|Overall Study||36
5007959|NCT02284516|12321686|P1|NOT COMPLETED|Overall Study||38
5007960|NCT02284516|12321685|P2|COMPLETED|Overall Study||319
5007961|NCT02284516|12321686|P1|COMPLETED|Overall Study||318
5007962|NCT02284516|12321685|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
5007963|NCT02284516|12321686|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
5007964|NCT02284516|12321685|P2|STARTED|Overall Study||355
5007965|NCT02284516|12321686|P1|STARTED|Overall Study||356
5007966|NCT02284464|12321696|P2|NOT COMPLETED|Overall Study||17
5007967|NCT02284464|12321697|P1|NOT COMPLETED|Overall Study||13
5007968|NCT02284464|12321696|P2|COMPLETED|Overall Study||36
5007969|NCT02284464|12321697|P1|COMPLETED|Overall Study||39
5007970|NCT02284464|12321696|P2|STARTED|Overall Study||53
5007971|NCT02284464|12321697|P1|STARTED|Overall Study||52
5007972|NCT02284399|12321725|P2|NOT COMPLETED|Overall Study||0
5007973|NCT02284399|12321726|P1|NOT COMPLETED|Overall Study||0
5007974|NCT02284399|12321725|P2|COMPLETED|Overall Study||3074
5007975|NCT02284399|12321726|P1|COMPLETED|Overall Study||1414
5007976|NCT02284399|12321725|P2|STARTED|Overall Study||3074
5007977|NCT02284399|12321726|P1|STARTED|Overall Study||1414
5007978|NCT02284386|12321734|P1|NOT COMPLETED|Overall Study||0
5007979|NCT02284386|12321734|P1|COMPLETED|Overall Study||15
5007980|NCT02284386|12321734|P1|STARTED|Overall Study||15
5007981|NCT02284373|12321746|P3|NOT COMPLETED|Overall Study||0
5007982|NCT02284373|12321747|P2|NOT COMPLETED|Overall Study||3
5007983|NCT02284373|12321748|P1|NOT COMPLETED|Overall Study||0
5007984|NCT02284373|12321746|P3|COMPLETED|Overall Study||29
5007985|NCT02284373|12321747|P2|COMPLETED|Overall Study||2
5007986|NCT02284373|12321748|P1|COMPLETED|Overall Study||5
5007987|NCT02284373|12321746|P3|STARTED|Overall Study||29
5007988|NCT02284373|12321747|P2|STARTED|Overall Study||5
5007989|NCT02284373|12321748|P1|STARTED|Overall Study||5
5007990|NCT02284347|12321756|P1|NOT COMPLETED|Overall Study||3
5007991|NCT02284347|12321756|P1|COMPLETED|Overall Study||48
5007992|NCT02284347|12321756|P1|STARTED|Overall Study||51
5007993|NCT02284243|12321764|P2|NOT COMPLETED|Overall Study||3
5007994|NCT02284243|12321765|P1|NOT COMPLETED|Overall Study||4
5007995|NCT02284243|12321764|P2|COMPLETED|Overall Study||81
5007996|NCT02284243|12321765|P1|COMPLETED|Overall Study||80
5007997|NCT02284243|12321764|P2|STARTED|Overall Study||84
5007998|NCT02284243|12321765|P1|STARTED|Overall Study||84
5007999|NCT02284178|12321785|P2|NOT COMPLETED|Overall Study||54
5008000|NCT02284178|12321786|P1|NOT COMPLETED|Overall Study||49
5008001|NCT02284178|12321785|P2|COMPLETED|Overall Study||204
5008002|NCT02284178|12321786|P1|COMPLETED|Overall Study||206
5008003|NCT02284178|12321785|P2|STARTED|Overall Study||258
5008004|NCT02284178|12321786|P1|STARTED|Overall Study||255
5008005|NCT02284165|12321809|P3|NOT COMPLETED|Overall Study||0
5008006|NCT02284165|12321810|P2|NOT COMPLETED|Overall Study||0
5008007|NCT02284165|12321811|P1|NOT COMPLETED|Overall Study||0
5008008|NCT02284165|12321809|P3|COMPLETED|Overall Study||70996
5008009|NCT02284165|12321810|P2|COMPLETED|Overall Study||40272
5008010|NCT02284165|12321811|P1|COMPLETED|Overall Study||36448
5008011|NCT02284165|12321809|P3|STARTED|Overall Study||70996
5008012|NCT02284165|12321810|P2|STARTED|Overall Study||40272
5008013|NCT02284165|12321811|P1|STARTED|Overall Study||36448
5008014|NCT02284009|12321829|P2|NOT COMPLETED|Overall Study||10
5008015|NCT02284009|12321830|P1|NOT COMPLETED|Overall Study||6
5008016|NCT02284009|12321829|P2|COMPLETED|Overall Study||40
5008017|NCT02284009|12321830|P1|COMPLETED|Overall Study||11
5008018|NCT02284009|12321829|P2|STARTED|Overall Study||50
5008019|NCT02284009|12321830|P1|STARTED|Overall Study||17
5008020|NCT02283840|12321875|P3|NOT COMPLETED|Overall Study||0
5008021|NCT02283840|12321876|P2|NOT COMPLETED|Overall Study||1
5008022|NCT02283840|12321877|P1|NOT COMPLETED|Overall Study||0
5008023|NCT02283840|12321875|P3|COMPLETED|Overall Study||20
5008024|NCT02283840|12321876|P2|COMPLETED|Overall Study||19
5008025|NCT02283840|12321877|P1|COMPLETED|Overall Study||20
5008026|NCT02283840|12321875|P3|STARTED|Overall Study||20
5008027|NCT02283840|12321876|P2|STARTED|Overall Study||20
5008028|NCT02283840|12321877|P1|STARTED|Overall Study||20
5008029|NCT02283827|12321896|P2|NOT COMPLETED|Overall Study||3
5008030|NCT02283827|12321897|P1|NOT COMPLETED|Overall Study||1
5008031|NCT02283827|12321896|P2|COMPLETED|Overall Study||13
5008032|NCT02283827|12321897|P1|COMPLETED|Overall Study||15
5008033|NCT02283827|12321896|P2|STARTED|Overall Study||16
5008034|NCT02283827|12321897|P1|STARTED|Overall Study||16
5008035|NCT02283814|12321914|P2|NOT COMPLETED|Overall Study||2
5008036|NCT02283814|12321915|P1|NOT COMPLETED|Overall Study||3
5008037|NCT02283814|12321914|P2|COMPLETED|Overall Study||14
5008038|NCT02283814|12321915|P1|COMPLETED|Overall Study||13
5008039|NCT02283814|12321914|P2|STARTED|Overall Study||16
5008040|NCT02283814|12321915|P1|STARTED|Overall Study||16
5008041|NCT02283788|12321929|P4|NOT COMPLETED|Overall Study||2
5008042|NCT02283788|12321930|P3|NOT COMPLETED|Overall Study||5
5008043|NCT02283788|12321931|P2|NOT COMPLETED|Overall Study||4
5008044|NCT02283788|12321932|P1|NOT COMPLETED|Overall Study||1
5008045|NCT02283788|12321929|P4|COMPLETED|Overall Study||14
5008046|NCT02283788|12321930|P3|COMPLETED|Overall Study||12
5008047|NCT02283788|12321931|P2|COMPLETED|Overall Study||13
5008048|NCT02283788|12321932|P1|COMPLETED|Overall Study||16
5008049|NCT02283788|12321929|P4|STARTED|Overall Study||16
5008050|NCT02283788|12321930|P3|STARTED|Overall Study||17
5008051|NCT02283788|12321931|P2|STARTED|Overall Study||17
5008052|NCT02283788|12321932|P1|STARTED|Overall Study||17
5008053|NCT02283762|12321944|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
5008054|NCT02283762|12321945|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
5008055|NCT02283762|12321944|P2|COMPLETED|Long-term Extension Phase (LTE)||31
5008056|NCT02283762|12321945|P1|COMPLETED|Long-term Extension Phase (LTE)||32
5008057|NCT02283762|12321944|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
5008058|NCT02283762|12321945|P1|STARTED|Long-term Extension Phase (LTE)||42
5008059|NCT02283762|12321944|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
5008060|NCT02283762|12321945|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
5008061|NCT02283762|12321944|P2|COMPLETED|Main Treatment Phase (MT)||46
5008062|NCT02283762|12321945|P1|COMPLETED|Main Treatment Phase (MT)||42
5008063|NCT02283762|12321944|P2|STARTED|Main Treatment Phase (MT)||61
5008064|NCT02283762|12321945|P1|STARTED|Main Treatment Phase (MT)||60
5008065|NCT02283749|12321963|P1|NOT COMPLETED|Overall Study||0
5008066|NCT02283749|12321963|P1|COMPLETED|Overall Study||5
5008067|NCT02283749|12321963|P1|STARTED|Overall Study||5
5008068|NCT02283658|12321969|P1|NOT COMPLETED|Overall Study||1
5008069|NCT02283658|12321969|P1|COMPLETED|Overall Study||19
5008070|NCT02283658|12321969|P1|STARTED|Overall Study||20
5008071|NCT02283528|12321980|P2|NOT COMPLETED|Overall Study||0
5008072|NCT02283528|12321981|P1|NOT COMPLETED|Overall Study||0
5008073|NCT02283528|12321980|P2|COMPLETED|Overall Study||24
5008074|NCT02283528|12321981|P1|COMPLETED|Overall Study||26
5008075|NCT02283528|12321980|P2|STARTED|Overall Study||24
5008076|NCT02283528|12321981|P1|STARTED|Overall Study||26
5008077|NCT02283411|12321991|P1|NOT COMPLETED|Overall Study||31
5008078|NCT02283411|12321991|P1|COMPLETED|Overall Study||125
5008079|NCT02283411|12321991|P1|STARTED|Overall Study||156
5008080|NCT02283268|12321999|P1|NOT COMPLETED|Overall Study||1
5008081|NCT02283268|12321999|P1|COMPLETED|Overall Study||14
5008082|NCT02283268|12321999|P1|STARTED|Overall Study||15
5008083|NCT02282982|12322060|P1|NOT COMPLETED|Overall Study||206
5008084|NCT02282982|12322060|P1|COMPLETED|Overall Study||153
5008085|NCT02282982|12322060|P1|Attended Follow-up Visit|Overall Study||349
5008086|NCT02282982|12322060|P1|Attended Visit 5|Overall Study||83
5008087|NCT02282982|12322060|P1|Attended Visit 4|Overall Study||194
5008088|NCT02282982|12322060|P1|Attended Visit 3|Overall Study||298
5008089|NCT02282982|12322060|P1|Attended Visit 2|Overall Study||341
5008090|NCT02282982|12322060|P1|Attended Visit 1|Overall Study||359
5008091|NCT02282982|12322060|P1|STARTED|Overall Study||359
5008092|NCT02282930|12322075|P1|NOT COMPLETED|Overall Study||1
5008093|NCT02282930|12322075|P1|COMPLETED|Overall Study||19
5008094|NCT02282930|12322075|P1|STARTED|Overall Study||20
5008095|NCT02282904|12322080|P1|NOT COMPLETED|Overall Study||0
5008096|NCT02282904|12322080|P1|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
5008097|NCT02282904|12322080|P1|STARTED|Overall Study||7
5008098|NCT02282813|12322088|P3|NOT COMPLETED|Overall Study||3
5008099|NCT02282813|12322089|P2|NOT COMPLETED|Overall Study||23
5008100|NCT02282813|12322090|P1|NOT COMPLETED|Overall Study||12
5008101|NCT02282813|12322088|P3|COMPLETED|Overall Study||39
5008102|NCT02282813|12322089|P2|COMPLETED|Overall Study||130
5008103|NCT02282813|12322090|P1|COMPLETED|Overall Study||91
5008104|NCT02282813|12322088|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
5008105|NCT02282813|12322089|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
5008106|NCT02282813|12322090|P1|STARTED|Overall Study|ITT Population|103
5008107|NCT02282722|12322109|P2|NOT COMPLETED|Overall Study||19
5008108|NCT02282722|12322110|P1|NOT COMPLETED|Overall Study||23
5008109|NCT02282722|12322109|P2|COMPLETED|Overall Study||73
5008110|NCT02282722|12322110|P1|COMPLETED|Overall Study||71
5008111|NCT02282722|12322109|P2|3-month Assessment|Overall Study||73
5008112|NCT02282722|12322110|P1|3-month Assessment|Overall Study||71
5008113|NCT02282722|12322109|P2|2-week Assessment|Overall Study||75
5008114|NCT02282722|12322110|P1|2-week Assessment|Overall Study||79
5008115|NCT02282722|12322109|P2|STARTED|Overall Study||92
5008116|NCT02282722|12322110|P1|STARTED|Overall Study||94
5008117|NCT02282631|12322136|P2|NOT COMPLETED|Overall Study||0
5008118|NCT02282631|12322137|P1|NOT COMPLETED|Overall Study||2
5008119|NCT02282631|12322136|P2|COMPLETED|Overall Study||15
5008120|NCT02282631|12322137|P1|COMPLETED|Overall Study||12
5008121|NCT02282631|12322136|P2|STARTED|Overall Study||15
5008122|NCT02282631|12322137|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
5008123|NCT02282605|12322178|P3|NOT COMPLETED|Overall Study||0
5008124|NCT02282605|12322179|P2|NOT COMPLETED|Overall Study||0
5008125|NCT02282605|12322180|P1|NOT COMPLETED|Overall Study||3
5008126|NCT02282605|12322178|P3|COMPLETED|Overall Study||24
5008127|NCT02282605|12322179|P2|COMPLETED|Overall Study||12
5008128|NCT02282605|12322180|P1|COMPLETED|Overall Study||24
5008129|NCT02282605|12322178|P3|STARTED|Overall Study||24
5008130|NCT02282605|12322179|P2|STARTED|Overall Study||12
5008131|NCT02282605|12322180|P1|STARTED|Overall Study||27
5008132|NCT02282527|12322202|P2|NOT COMPLETED|Overall Study||1
5008133|NCT02282527|12322203|P1|NOT COMPLETED|Overall Study||1
5008134|NCT02282527|12322202|P2|COMPLETED|Overall Study||15
5008135|NCT02282527|12322203|P1|COMPLETED|Overall Study||15
5008136|NCT02282527|12322202|P2|STARTED|Overall Study||16
5008137|NCT02282527|12322203|P1|STARTED|Overall Study||16
5008138|NCT02282293|12322215|P2|NOT COMPLETED|Overall Study||3
5008139|NCT02282293|12322216|P1|NOT COMPLETED|Overall Study||3
5008140|NCT02282293|12322215|P2|COMPLETED|Overall Study||97
5008141|NCT02282293|12322216|P1|COMPLETED|Overall Study||97
5008142|NCT02282293|12322215|P2|STARTED|Overall Study||100
5008143|NCT02282293|12322216|P1|STARTED|Overall Study||100
5008144|NCT02282163|12322234|P1|NOT COMPLETED|Overall Study||1
5008145|NCT02282163|12322234|P1|COMPLETED|Overall Study||12
5008146|NCT02282163|12322234|P1|STARTED|Overall Study||13
5008147|NCT02282111|12322249|P2|NOT COMPLETED|Overall Study||8
5008148|NCT02282111|12322250|P1|NOT COMPLETED|Overall Study||7
5008149|NCT02282111|12322249|P2|COMPLETED|Overall Study||22
5008150|NCT02282111|12322250|P1|COMPLETED|Overall Study||19
5008151|NCT02282111|12322249|P2|STARTED|Overall Study||30
5008152|NCT02282111|12322250|P1|STARTED|Overall Study||26
5008153|NCT02282020|12322266|P2|NOT COMPLETED|Overall Study||87
5008154|NCT02282020|12322267|P1|NOT COMPLETED|Overall Study||135
5008155|NCT02282020|12322266|P2|COMPLETED|Overall Study||1
5008156|NCT02282020|12322267|P1|COMPLETED|Overall Study||43
5008157|NCT02282020|12322266|P2|Received Treatment|Overall Study||76
5008158|NCT02282020|12322267|P1|Received Treatment|Overall Study||178
5008159|NCT02282020|12322266|P2|STARTED|Overall Study||88
5008160|NCT02282020|12322267|P1|STARTED|Overall Study||178
5008161|NCT02281851|12322314|P2|NOT COMPLETED|Overall Study||0
5008162|NCT02281851|12322315|P1|NOT COMPLETED|Overall Study||0
5008163|NCT02281851|12322314|P2|COMPLETED|Overall Study||10
5008164|NCT02281851|12322315|P1|COMPLETED|Overall Study||4
5008165|NCT02281851|12322314|P2|STARTED|Overall Study||10
5008166|NCT02281851|12322315|P1|STARTED|Overall Study||4
5008167|NCT02281773|12322326|P5|NOT COMPLETED|Overall Study||30
5008168|NCT02281773|12322327|P4|NOT COMPLETED|Overall Study||21
5008169|NCT02281773|12322328|P3|NOT COMPLETED|Overall Study||18
5008170|NCT02281773|12322329|P2|NOT COMPLETED|Overall Study||15
5008171|NCT02281773|12322330|P1|NOT COMPLETED|Overall Study||11
5008172|NCT02281773|12322326|P5|COMPLETED|Overall Study||143
5008173|NCT02281773|12322327|P4|COMPLETED|Overall Study||65
5008174|NCT02281773|12322328|P3|COMPLETED|Overall Study||67
5008175|NCT02281773|12322329|P2|COMPLETED|Overall Study||70
5008176|NCT02281773|12322330|P1|COMPLETED|Overall Study||76
5008177|NCT02281773|12322326|P5|STARTED|Overall Study|Started are the treated patients|173
5008178|NCT02281773|12322327|P4|STARTED|Overall Study||86
5008179|NCT02281773|12322328|P3|STARTED|Overall Study||85
5008180|NCT02281773|12322329|P2|STARTED|Overall Study|Started are the treated patients|85
5008181|NCT02281773|12322330|P1|STARTED|Overall Study||87
5008182|NCT02281591|12322391|P4|NOT COMPLETED|Overall Study||0
5008183|NCT02281591|12322392|P3|NOT COMPLETED|Overall Study||0
5008184|NCT02281591|12322393|P2|NOT COMPLETED|Overall Study||0
5008185|NCT02281591|12322394|P1|NOT COMPLETED|Overall Study||0
5008186|NCT02281591|12322391|P4|COMPLETED|Overall Study||8
5008187|NCT02281591|12322392|P3|COMPLETED|Overall Study||8
5008188|NCT02281591|12322393|P2|COMPLETED|Overall Study||8
5008189|NCT02281591|12322394|P1|COMPLETED|Overall Study||8
5008190|NCT02281591|12322391|P4|STARTED|Overall Study||8
5008191|NCT02281591|12322392|P3|STARTED|Overall Study||8
5008192|NCT02281591|12322393|P2|STARTED|Overall Study||8
5008193|NCT02281591|12322394|P1|STARTED|Overall Study||8
5008194|NCT02281552|12322418|P2|NOT COMPLETED|Overall Study||10
5008195|NCT02281552|12322419|P1|NOT COMPLETED|Overall Study||4
5008196|NCT02281552|12322418|P2|COMPLETED|Overall Study||95
5008197|NCT02281552|12322419|P1|COMPLETED|Overall Study||100
5008198|NCT02281552|12322418|P2|STARTED|Overall Study||105
5008199|NCT02281552|12322419|P1|STARTED|Overall Study||104
5008200|NCT02281526|12322459|P2|NOT COMPLETED|Overall Study||0
5008201|NCT02281526|12322460|P1|NOT COMPLETED|Overall Study||1
5008202|NCT02281526|12322459|P2|COMPLETED|Overall Study||8
5008203|NCT02281526|12322460|P1|COMPLETED|Overall Study||8
5008204|NCT02281526|12322459|P2|STARTED|Overall Study||8
5008205|NCT02281526|12322460|P1|STARTED|Overall Study||9
5008206|NCT02281448|12322470|P2|NOT COMPLETED|Overall Study||1
5008207|NCT02281448|12322471|P1|NOT COMPLETED|Overall Study||2
5008208|NCT02281448|12322470|P2|COMPLETED|Overall Study||9
5008209|NCT02281448|12322471|P1|COMPLETED|Overall Study||8
5008210|NCT02281448|12322470|P2|STARTED|Overall Study||10
5008211|NCT02281448|12322471|P1|STARTED|Overall Study||10
5008212|NCT02281422|12322484|P5|NOT COMPLETED|Overall Study||0
5008213|NCT02281422|12322485|P4|NOT COMPLETED|Overall Study||0
5008214|NCT02281422|12322486|P3|NOT COMPLETED|Overall Study||0
5008215|NCT02281422|12322487|P2|NOT COMPLETED|Overall Study||0
5008216|NCT02281422|12322488|P1|NOT COMPLETED|Overall Study||0
5008217|NCT02281422|12322484|P5|COMPLETED|Overall Study||8
5008218|NCT02281422|12322485|P4|COMPLETED|Overall Study||8
5008219|NCT02281422|12322486|P3|COMPLETED|Overall Study||8
5008220|NCT02281422|12322487|P2|COMPLETED|Overall Study||8
5008221|NCT02281422|12322488|P1|COMPLETED|Overall Study||8
5008222|NCT02281422|12322484|P5|STARTED|Overall Study||8
5008223|NCT02281422|12322485|P4|STARTED|Overall Study||8
5008224|NCT02281422|12322486|P3|STARTED|Overall Study||8
5008225|NCT02281422|12322487|P2|STARTED|Overall Study||8
5008226|NCT02281422|12322488|P1|STARTED|Overall Study||8
5008227|NCT02281357|12322512|P2|NOT COMPLETED|Overall Study||4
5008228|NCT02281357|12322513|P1|NOT COMPLETED|Overall Study||7
5008229|NCT02281357|12322512|P2|COMPLETED|Overall Study||66
5008230|NCT02281357|12322513|P1|COMPLETED|Overall Study||63
5008231|NCT02281357|12322512|P2|STARTED|Overall Study||70
5008232|NCT02281357|12322513|P1|STARTED|Overall Study||70
5008233|NCT02281344|12322525|P1|NOT COMPLETED|Overall Study||0
5008234|NCT02281344|12322525|P1|COMPLETED|Overall Study||6
5008235|NCT02281344|12322525|P1|STARTED|Overall Study||6
5008236|NCT02281318|12322532|P2|NOT COMPLETED|Overall Study||5
5008237|NCT02281318|12322533|P1|NOT COMPLETED|Overall Study||14
5008238|NCT02281318|12322532|P2|COMPLETED|Overall Study||269
5008239|NCT02281318|12322533|P1|COMPLETED|Overall Study||263
5008240|NCT02281318|12322532|P2|STARTED|Overall Study||274
5008241|NCT02281318|12322533|P1|STARTED|Overall Study||277
5008242|NCT02281136|12322545|P1|NOT COMPLETED|Overall Study||0
5008243|NCT02281136|12322545|P1|COMPLETED|Overall Study||29
5008244|NCT02281136|12322545|P1|STARTED|Overall Study||29
5008245|NCT02281084|12322581|P4|NOT COMPLETED|Overall Study||5
5008246|NCT02281084|12322582|P3|NOT COMPLETED|Overall Study||4
5008247|NCT02281084|12322583|P2|NOT COMPLETED|Overall Study||18
5008248|NCT02281084|12322584|P1|NOT COMPLETED|Overall Study||22
5008249|NCT02281084|12322581|P4|COMPLETED|Overall Study||0
5008250|NCT02281084|12322582|P3|COMPLETED|Overall Study||2
5008251|NCT02281084|12322583|P2|COMPLETED|Overall Study||4
5008252|NCT02281084|12322584|P1|COMPLETED|Overall Study||10
5008253|NCT02281084|12322581|P4|STARTED|Overall Study||5
5008254|NCT02281084|12322582|P3|STARTED|Overall Study||6
5008255|NCT02281084|12322583|P2|STARTED|Overall Study||22
5008256|NCT02281084|12322584|P1|STARTED|Overall Study||32
5008257|NCT02280863|12322640|P2|NOT COMPLETED|Integrated Platform||1
5008258|NCT02280863|12322641|P1|NOT COMPLETED|Integrated Platform||0
5008259|NCT02280863|12322640|P2|COMPLETED|Integrated Platform||14
5008260|NCT02280863|12322641|P1|COMPLETED|Integrated Platform||9
5008261|NCT02280863|12322640|P2|STARTED|Integrated Platform||15
5008262|NCT02280863|12322641|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
5008263|NCT02280863|12322640|P2|NOT COMPLETED|Android Platform||0
5008264|NCT02280863|12322641|P1|NOT COMPLETED|Android Platform||0
5008265|NCT02280863|12322640|P2|COMPLETED|Android Platform||0
5008266|NCT02280863|12322641|P1|COMPLETED|Android Platform||8
5008267|NCT02280863|12322640|P2|STARTED|Android Platform||0
5008268|NCT02280863|12322641|P1|STARTED|Android Platform||8
5008269|NCT02280811|12322671|P5|NOT COMPLETED|Retreated at the MTD||0
5008270|NCT02280811|12322672|P4|NOT COMPLETED|Retreated at the MTD||0
5008271|NCT02280811|12322673|P3|NOT COMPLETED|Retreated at the MTD||0
5008272|NCT02280811|12322674|P2|NOT COMPLETED|Retreated at the MTD||0
5008273|NCT02280811|12322675|P1|NOT COMPLETED|Retreated at the MTD||0
5008274|NCT02280811|12322671|P5|COMPLETED|Retreated at the MTD||1
5008275|NCT02280811|12322672|P4|COMPLETED|Retreated at the MTD||0
5008276|NCT02280811|12322673|P3|COMPLETED|Retreated at the MTD||0
5008277|NCT02280811|12322674|P2|COMPLETED|Retreated at the MTD||0
5008278|NCT02280811|12322675|P1|COMPLETED|Retreated at the MTD||0
5008279|NCT02280811|12322671|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
5008280|NCT02280811|12322672|P4|STARTED|Retreated at the MTD||0
5008281|NCT02280811|12322673|P3|STARTED|Retreated at the MTD||0
5008282|NCT02280811|12322674|P2|STARTED|Retreated at the MTD||0
5008283|NCT02280811|12322675|P1|STARTED|Retreated at the MTD||0
5008284|NCT02280811|12322671|P5|NOT COMPLETED|Drug Administration||0
5008285|NCT02280811|12322672|P4|NOT COMPLETED|Drug Administration||0
5008286|NCT02280811|12322673|P3|NOT COMPLETED|Drug Administration||0
5008287|NCT02280811|12322674|P2|NOT COMPLETED|Drug Administration||0
5008288|NCT02280811|12322675|P1|NOT COMPLETED|Drug Administration||0
5008289|NCT02280811|12322671|P5|COMPLETED|Drug Administration||2
5008290|NCT02280811|12322672|P4|COMPLETED|Drug Administration||6
5008291|NCT02280811|12322673|P3|COMPLETED|Drug Administration||1
5008292|NCT02280811|12322674|P2|COMPLETED|Drug Administration||2
5008293|NCT02280811|12322675|P1|COMPLETED|Drug Administration||1
5008294|NCT02280811|12322671|P5|STARTED|Drug Administration||2
5008295|NCT02280811|12322672|P4|STARTED|Drug Administration||6
5008296|NCT02280811|12322673|P3|STARTED|Drug Administration||1
5008297|NCT02280811|12322674|P2|STARTED|Drug Administration||2
5008298|NCT02280811|12322675|P1|STARTED|Drug Administration||1
5008299|NCT02280655|12322716|P2|NOT COMPLETED|Overall Study||0
5008300|NCT02280655|12322717|P1|NOT COMPLETED|Overall Study||0
5008301|NCT02280655|12322716|P2|COMPLETED|Overall Study||18
5008302|NCT02280655|12322717|P1|COMPLETED|Overall Study||25
5008303|NCT02280655|12322716|P2|STARTED|Overall Study||18
5008304|NCT02280655|12322717|P1|STARTED|Overall Study||25
5008305|NCT02280499|12322725|P1|NOT COMPLETED|Overall Study||61
5008306|NCT02280499|12322725|P1|COMPLETED|Overall Study||26
5008307|NCT02280499|12322725|P1|STARTED|Overall Study||87
5008308|NCT02280473|12322733|P2|NOT COMPLETED|Overall Study||3
5008309|NCT02280473|12322734|P1|NOT COMPLETED|Overall Study||1
5008310|NCT02280473|12322733|P2|COMPLETED|Overall Study||91
5008311|NCT02280473|12322734|P1|COMPLETED|Overall Study||93
5008312|NCT02280473|12322733|P2|STARTED|Overall Study||94
5008313|NCT02280473|12322734|P1|STARTED|Overall Study||94
5008314|NCT02280421|12322750|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
5008315|NCT02280421|12322751|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
5008316|NCT02280421|12322750|P2|COMPLETED|Second Intervention(2 Weeks)||12
5008317|NCT02280421|12322751|P1|COMPLETED|Second Intervention(2 Weeks)||12
5008318|NCT02280421|12322750|P2|Received Intervention|Second Intervention(2 Weeks)||12
5008319|NCT02280421|12322751|P1|Received Intervention|Second Intervention(2 Weeks)||12
5008320|NCT02280421|12322750|P2|STARTED|Second Intervention(2 Weeks)||12
5008321|NCT02280421|12322751|P1|STARTED|Second Intervention(2 Weeks)||12
5008322|NCT02280421|12322750|P2|NOT COMPLETED|Washout (2 Weeks)||1
5008323|NCT02280421|12322751|P1|NOT COMPLETED|Washout (2 Weeks)||1
5008324|NCT02280421|12322750|P2|COMPLETED|Washout (2 Weeks)||11
5008325|NCT02280421|12322751|P1|COMPLETED|Washout (2 Weeks)||11
5008326|NCT02280421|12322750|P2|STARTED|Washout (2 Weeks)||12
5008327|NCT02280421|12322751|P1|STARTED|Washout (2 Weeks)||12
5008328|NCT02280421|12322750|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
5008329|NCT02280421|12322751|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
5008330|NCT02280421|12322750|P2|COMPLETED|First Intervention(2 Weeks)||12
5008331|NCT02280421|12322751|P1|COMPLETED|First Intervention(2 Weeks)||12
5008332|NCT02280421|12322750|P2|Received Intervention|First Intervention(2 Weeks)||12
5008333|NCT02280421|12322751|P1|Received Intervention|First Intervention(2 Weeks)||12
5008334|NCT02280421|12322750|P2|STARTED|First Intervention(2 Weeks)||12
5008335|NCT02280421|12322751|P1|STARTED|First Intervention(2 Weeks)||12
5008336|NCT02280408|12322817|P4|NOT COMPLETED|Overall Study||0
5008337|NCT02280408|12322818|P3|NOT COMPLETED|Overall Study||0
5008338|NCT02280408|12322819|P2|NOT COMPLETED|Overall Study||2
5008339|NCT02280408|12322820|P1|NOT COMPLETED|Overall Study||0
5008340|NCT02280408|12322817|P4|COMPLETED|Overall Study||9
5008341|NCT02280408|12322818|P3|COMPLETED|Overall Study||10
5008342|NCT02280408|12322819|P2|COMPLETED|Overall Study||8
5008343|NCT02280408|12322820|P1|COMPLETED|Overall Study||10
5008344|NCT02280408|12322817|P4|Vaccination 2|Overall Study||9
5008345|NCT02280408|12322818|P3|Vaccination 2|Overall Study||10
5008346|NCT02280408|12322819|P2|Vaccination 2|Overall Study||10
5008347|NCT02280408|12322820|P1|Vaccination 2|Overall Study||10
5008348|NCT02280408|12322817|P4|Vaccination 1|Overall Study||9
5008349|NCT02280408|12322818|P3|Vaccination 1|Overall Study||10
5008350|NCT02280408|12322819|P2|Vaccination 1|Overall Study||10
5008351|NCT02280408|12322820|P1|Vaccination 1|Overall Study||10
5008352|NCT02280408|12322817|P4|STARTED|Overall Study||9
5008353|NCT02280408|12322818|P3|STARTED|Overall Study||10
5008354|NCT02280408|12322819|P2|STARTED|Overall Study||10
5008355|NCT02280408|12322820|P1|STARTED|Overall Study||10
5008356|NCT02280304|12322892|P2|NOT COMPLETED|Overall Study||8
5008357|NCT02280304|12322893|P1|NOT COMPLETED|Overall Study||7
5008358|NCT02280304|12322892|P2|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
5008359|NCT02280304|12322893|P1|COMPLETED|Overall Study||12
5008360|NCT02280304|12322892|P2|STARTED|Overall Study||18
5008361|NCT02280304|12322893|P1|STARTED|Overall Study||19
5008362|NCT02280291|12322914|P4|NOT COMPLETED|Overall Study||8
5008363|NCT02280291|12322915|P3|NOT COMPLETED|Overall Study||3
5008364|NCT02280291|12322916|P2|NOT COMPLETED|Overall Study||2
5008365|NCT02280291|12322917|P1|NOT COMPLETED|Overall Study||4
5008366|NCT02280291|12322914|P4|COMPLETED|Overall Study||18
5008367|NCT02280291|12322915|P3|COMPLETED|Overall Study||21
5008368|NCT02280291|12322916|P2|COMPLETED|Overall Study||23
5008369|NCT02280291|12322917|P1|COMPLETED|Overall Study||21
5008370|NCT02280291|12322914|P4|STARTED|Overall Study||26
5008371|NCT02280291|12322915|P3|STARTED|Overall Study||24
5008372|NCT02280291|12322916|P2|STARTED|Overall Study||25
5008373|NCT02280291|12322917|P1|STARTED|Overall Study||25
5008374|NCT02280226|12322929|P1|NOT COMPLETED|Overall Study||0
5008375|NCT02280226|12322929|P1|COMPLETED|Overall Study||17
5008376|NCT02280226|12322929|P1|STARTED|Overall Study||17
5008377|NCT02280200|12322936|P2|NOT COMPLETED|Overall Study||3
5008378|NCT02280200|12322937|P1|NOT COMPLETED|Overall Study||3
5008379|NCT02280200|12322936|P2|COMPLETED|Overall Study||10
5008380|NCT02280200|12322937|P1|COMPLETED|Overall Study||12
5008381|NCT02280200|12322936|P2|STARTED|Overall Study||13
5008382|NCT02280200|12322937|P1|STARTED|Overall Study||15
5008383|NCT02280187|12322951|P1|NOT COMPLETED|Overall Study||218
5008384|NCT02280187|12322951|P1|COMPLETED|Overall Study||182
5008385|NCT02280187|12322951|P1|STARTED|Overall Study||400
5008386|NCT02280122|12322969|P3|NOT COMPLETED|Overall Study||0
5008387|NCT02280122|12322970|P2|NOT COMPLETED|Overall Study||0
5008388|NCT02280122|12322971|P1|NOT COMPLETED|Overall Study||0
5008389|NCT02280122|12322969|P3|COMPLETED|Overall Study||30
5008390|NCT02280122|12322970|P2|COMPLETED|Overall Study||15
5008391|NCT02280122|12322971|P1|COMPLETED|Overall Study||15
5008392|NCT02280122|12322969|P3|STARTED|Overall Study||30
5008393|NCT02280122|12322970|P2|STARTED|Overall Study||15
5008394|NCT02280122|12322971|P1|STARTED|Overall Study||15
5008395|NCT02280096|12322979|P2|NOT COMPLETED|Overall Study||1
5008396|NCT02280096|12322980|P1|NOT COMPLETED|Overall Study||2
5008397|NCT02280096|12322979|P2|COMPLETED|Overall Study||10
5008398|NCT02280096|12322980|P1|COMPLETED|Overall Study||11
5008399|NCT02280096|12322979|P2|STARTED|Overall Study||11
5008400|NCT02280096|12322980|P1|STARTED|Overall Study||13
5008401|NCT02280044|12323010|P2|NOT COMPLETED|Overall Study||2
5008402|NCT02280044|12323011|P1|NOT COMPLETED|Overall Study||0
5008403|NCT02280044|12323010|P2|COMPLETED|Overall Study||13
5008404|NCT02280044|12323011|P1|COMPLETED|Overall Study||15
5008405|NCT02280044|12323010|P2|STARTED|Overall Study||15
5008406|NCT02280044|12323011|P1|STARTED|Overall Study||15
5008407|NCT02279862|12323021|P2|NOT COMPLETED|Overall Study||25
5008408|NCT02279862|12323022|P1|NOT COMPLETED|Overall Study||26
5008409|NCT02279862|12323021|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
5008410|NCT02279862|12323022|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
5008411|NCT02279862|12323021|P2|Treated|Overall Study||26
5008412|NCT02279862|12323022|P1|Treated|Overall Study||25
5008413|NCT02279862|12323021|P2|STARTED|Overall Study||27
5008414|NCT02279862|12323022|P1|STARTED|Overall Study||26
5008415|NCT02279732|12323040|P2|NOT COMPLETED|Overall Study||106
5008416|NCT02279732|12323041|P1|NOT COMPLETED|Overall Study||98
5008417|NCT02279732|12323040|P2|COMPLETED|Overall Study||0
5008418|NCT02279732|12323041|P1|COMPLETED|Overall Study||0
5008419|NCT02279732|12323040|P2|STARTED|Overall Study||106
5008420|NCT02279732|12323041|P1|STARTED|Overall Study||98
5008421|NCT02279667|12323054|P3|NOT COMPLETED|Overall Study||0
5008422|NCT02279667|12323055|P2|NOT COMPLETED|Overall Study||0
5008423|NCT02279667|12323056|P1|NOT COMPLETED|Overall Study||0
5008424|NCT02279667|12323054|P3|COMPLETED|Overall Study||6
5008425|NCT02279667|12323055|P2|COMPLETED|Overall Study||6
5008426|NCT02279667|12323056|P1|COMPLETED|Overall Study||6
5008427|NCT02279667|12323054|P3|STARTED|Overall Study||6
5008428|NCT02279667|12323055|P2|STARTED|Overall Study||6
5008429|NCT02279667|12323056|P1|STARTED|Overall Study||6
5008430|NCT02279641|12323076|P2|NOT COMPLETED|Overall Study||0
5008431|NCT02279641|12323077|P1|NOT COMPLETED|Overall Study||0
5008432|NCT02279641|12323076|P2|COMPLETED|Overall Study||6
5008433|NCT02279641|12323077|P1|COMPLETED|Overall Study||6
5008434|NCT02279641|12323076|P2|STARTED|Overall Study||6
5008435|NCT02279641|12323077|P1|STARTED|Overall Study||6
5008436|NCT02279498|12323133|P2|NOT COMPLETED|Overall Study||4
5008437|NCT02279498|12323134|P1|NOT COMPLETED|Overall Study||18
5008438|NCT02279498|12323133|P2|COMPLETED|Overall Study||59
5008439|NCT02279498|12323134|P1|COMPLETED|Overall Study||47
5008440|NCT02279498|12323133|P2|STARTED|Overall Study||63
5008441|NCT02279498|12323134|P1|STARTED|Overall Study||65
5008442|NCT02279420|12323143|P1|NOT COMPLETED|Overall Study||23
5008443|NCT02279420|12323143|P1|COMPLETED|Overall Study||50
5008444|NCT02279420|12323143|P1|STARTED|Overall Study||73
5008445|NCT02279407|12323151|P4|NOT COMPLETED|Overall Study||1
5008446|NCT02279407|12323152|P3|NOT COMPLETED|Overall Study||5
5008447|NCT02279407|12323153|P2|NOT COMPLETED|Overall Study||1
5008448|NCT02279407|12323154|P1|NOT COMPLETED|Overall Study||2
5008449|NCT02279407|12323151|P4|COMPLETED|Overall Study||20
5008450|NCT02279407|12323152|P3|COMPLETED|Overall Study||15
5008451|NCT02279407|12323153|P2|COMPLETED|Overall Study||20
5008452|NCT02279407|12323154|P1|COMPLETED|Overall Study||20
5008453|NCT02279407|12323151|P4|STARTED|Overall Study||21
5008454|NCT02279407|12323152|P3|STARTED|Overall Study||20
5008455|NCT02279407|12323153|P2|STARTED|Overall Study||21
5008456|NCT02279407|12323154|P1|STARTED|Overall Study||22
5008457|NCT02279173|12323165|P1|NOT COMPLETED|Overall Study||167
5008458|NCT02279173|12323165|P1|COMPLETED|Overall Study||37
5008459|NCT02279173|12323165|P1|Enrolled Under Protocol Supplement|Overall Study||79
5008460|NCT02279173|12323165|P1|Received Treatment|Overall Study||203
5008461|NCT02279173|12323165|P1|STARTED|Overall Study||204
5008462|NCT02279160|12323184|P2|NOT COMPLETED|Overall Study||2
5008463|NCT02279160|12323185|P1|NOT COMPLETED|Overall Study||6
5008464|NCT02279160|12323184|P2|COMPLETED|Overall Study||19
5008465|NCT02279160|12323185|P1|COMPLETED|Overall Study||34
5008466|NCT02279160|12323184|P2|STARTED|Overall Study||21
5008467|NCT02279160|12323185|P1|STARTED|Overall Study||40
5008468|NCT02279108|12323195|P2|NOT COMPLETED|Overall Study||1
5008469|NCT02279108|12323196|P1|NOT COMPLETED|Overall Study||0
5008470|NCT02279108|12323195|P2|COMPLETED|Overall Study||49
5008471|NCT02279108|12323196|P1|COMPLETED|Overall Study||50
5008472|NCT02279108|12323195|P2|STARTED|Overall Study||50
5008473|NCT02279108|12323196|P1|STARTED|Overall Study||50
5008474|NCT02279082|12323218|P1|NOT COMPLETED|Overall Study||33
5008475|NCT02279082|12323218|P1|COMPLETED|Overall Study||134
5008476|NCT02279082|12323218|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
5008477|NCT02279043|12323225|P3|NOT COMPLETED|Overall Study||0
5008478|NCT02279043|12323226|P2|NOT COMPLETED|Overall Study||89
5008479|NCT02279043|12323227|P1|NOT COMPLETED|Overall Study||47
5008480|NCT02279043|12323225|P3|COMPLETED|Overall Study||140
5008481|NCT02279043|12323226|P2|COMPLETED|Overall Study||226
5008482|NCT02279043|12323227|P1|COMPLETED|Overall Study||128
5008483|NCT02279043|12323225|P3|STARTED|Overall Study||140
5008484|NCT02279043|12323226|P2|STARTED|Overall Study||315
5008485|NCT02279043|12323227|P1|STARTED|Overall Study||175
5008486|NCT02278952|12323257|P1|NOT COMPLETED|Overall Study||6
5008487|NCT02278952|12323257|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
5008488|NCT02278952|12323257|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
5008489|NCT02278939|12323269|P2|NOT COMPLETED|Overall Study||1
5008490|NCT02278939|12323270|P1|NOT COMPLETED|Overall Study||5
5008491|NCT02278939|12323269|P2|COMPLETED|Overall Study||33
5008492|NCT02278939|12323270|P1|COMPLETED|Overall Study||28
5008493|NCT02278939|12323269|P2|STARTED|Overall Study||34
5008494|NCT02278939|12323270|P1|STARTED|Overall Study||33
5008495|NCT02278783|12323282|P1|NOT COMPLETED|Overall Study||0
5008496|NCT02278783|12323282|P1|COMPLETED|Overall Study||1
5008497|NCT02278783|12323282|P1|STARTED|Overall Study||1
5008498|NCT02278640|12323289|P1|NOT COMPLETED|Overall Study||0
5008499|NCT02278640|12323289|P1|COMPLETED|Overall Study||40
5008500|NCT02278640|12323289|P1|STARTED|Overall Study||40
5008501|NCT02278614|12323298|P2|NOT COMPLETED|Overall Study||5
5008502|NCT02278614|12323299|P1|NOT COMPLETED|Overall Study||5
5008503|NCT02278614|12323298|P2|COMPLETED|Overall Study||110
5008504|NCT02278614|12323299|P1|COMPLETED|Overall Study||122
5008505|NCT02278614|12323298|P2|STARTED|Overall Study||115
5008506|NCT02278614|12323299|P1|STARTED|Overall Study||127
5008507|NCT02278562|12323308|P3|NOT COMPLETED|Overall Study||0
5008508|NCT02278562|12323309|P2|NOT COMPLETED|Overall Study||0
5008509|NCT02278562|12323310|P1|NOT COMPLETED|Overall Study||0
5008510|NCT02278562|12323308|P3|COMPLETED|Overall Study||8
5008511|NCT02278562|12323309|P2|COMPLETED|Overall Study||7
5008512|NCT02278562|12323310|P1|COMPLETED|Overall Study||9
5008513|NCT02278562|12323308|P3|STARTED|Overall Study||8
5008514|NCT02278562|12323309|P2|STARTED|Overall Study||7
5008515|NCT02278562|12323310|P1|STARTED|Overall Study||9
5008516|NCT02278484|12323324|P1|NOT COMPLETED|Overall Study||0
5008517|NCT02278484|12323324|P1|COMPLETED|Overall Study||50
5008518|NCT02278484|12323324|P1|STARTED|Overall Study||50
5008519|NCT02278471|12323333|P2|NOT COMPLETED|Overall Study||20
5008520|NCT02278471|12323334|P1|NOT COMPLETED|Overall Study||8
5008521|NCT02278471|12323333|P2|COMPLETED|Overall Study||128
5008522|NCT02278471|12323334|P1|COMPLETED|Overall Study||147
5008523|NCT02278471|12323333|P2|STARTED|Overall Study||148
5008524|NCT02278471|12323334|P1|STARTED|Overall Study||155
5008525|NCT02278328|12323350|P3|NOT COMPLETED|Third Washout (1 Week)||0
5008526|NCT02278328|12323351|P2|NOT COMPLETED|Third Washout (1 Week)||0
5008527|NCT02278328|12323352|P1|NOT COMPLETED|Third Washout (1 Week)||0
5008528|NCT02278328|12323350|P3|COMPLETED|Third Washout (1 Week)||6
5008529|NCT02278328|12323351|P2|COMPLETED|Third Washout (1 Week)||6
5008530|NCT02278328|12323352|P1|COMPLETED|Third Washout (1 Week)||9
5008531|NCT02278328|12323350|P3|STARTED|Third Washout (1 Week)||6
5008532|NCT02278328|12323351|P2|STARTED|Third Washout (1 Week)||6
5008533|NCT02278328|12323352|P1|STARTED|Third Washout (1 Week)||9
5008534|NCT02278328|12323350|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5008535|NCT02278328|12323351|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5008536|NCT02278328|12323352|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5008537|NCT02278328|12323350|P3|COMPLETED|Third Intervention (1 Day)||6
5008538|NCT02278328|12323351|P2|COMPLETED|Third Intervention (1 Day)||6
5008539|NCT02278328|12323352|P1|COMPLETED|Third Intervention (1 Day)||9
5008540|NCT02278328|12323350|P3|STARTED|Third Intervention (1 Day)||6
5008541|NCT02278328|12323351|P2|STARTED|Third Intervention (1 Day)||6
5008542|NCT02278328|12323352|P1|STARTED|Third Intervention (1 Day)||9
5008543|NCT02278328|12323350|P3|NOT COMPLETED|Second Washout (1 Week)||0
5008544|NCT02278328|12323351|P2|NOT COMPLETED|Second Washout (1 Week)||0
5008545|NCT02278328|12323352|P1|NOT COMPLETED|Second Washout (1 Week)||0
5008546|NCT02278328|12323350|P3|COMPLETED|Second Washout (1 Week)||6
5008547|NCT02278328|12323351|P2|COMPLETED|Second Washout (1 Week)||6
5008548|NCT02278328|12323352|P1|COMPLETED|Second Washout (1 Week)||9
5008549|NCT02278328|12323350|P3|STARTED|Second Washout (1 Week)||6
5008550|NCT02278328|12323351|P2|STARTED|Second Washout (1 Week)||6
5008551|NCT02278328|12323352|P1|STARTED|Second Washout (1 Week)||9
5008552|NCT02278328|12323350|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5008553|NCT02278328|12323351|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5008554|NCT02278328|12323352|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5008555|NCT02278328|12323350|P3|COMPLETED|Second Intervention (1 Day)||6
5008556|NCT02278328|12323351|P2|COMPLETED|Second Intervention (1 Day)||6
5008557|NCT02278328|12323352|P1|COMPLETED|Second Intervention (1 Day)||9
5008558|NCT02278328|12323350|P3|STARTED|Second Intervention (1 Day)||6
5008559|NCT02278328|12323351|P2|STARTED|Second Intervention (1 Day)||6
5008560|NCT02278328|12323352|P1|STARTED|Second Intervention (1 Day)||9
5008561|NCT02278328|12323350|P3|NOT COMPLETED|Washout (1 Week)||0
5008562|NCT02278328|12323351|P2|NOT COMPLETED|Washout (1 Week)||0
5008563|NCT02278328|12323352|P1|NOT COMPLETED|Washout (1 Week)||0
5008564|NCT02278328|12323350|P3|COMPLETED|Washout (1 Week)||6
5008565|NCT02278328|12323351|P2|COMPLETED|Washout (1 Week)||6
5008566|NCT02278328|12323352|P1|COMPLETED|Washout (1 Week)||9
5008567|NCT02278328|12323350|P3|STARTED|Washout (1 Week)||6
5008568|NCT02278328|12323351|P2|STARTED|Washout (1 Week)||6
5008569|NCT02278328|12323352|P1|STARTED|Washout (1 Week)||9
5008570|NCT02278328|12323350|P3|NOT COMPLETED|First Intervention (1 Day)||0
5008571|NCT02278328|12323351|P2|NOT COMPLETED|First Intervention (1 Day)||0
5008572|NCT02278328|12323352|P1|NOT COMPLETED|First Intervention (1 Day)||0
5008573|NCT02278328|12323350|P3|COMPLETED|First Intervention (1 Day)||6
5008574|NCT02278328|12323351|P2|COMPLETED|First Intervention (1 Day)||6
5008575|NCT02278328|12323352|P1|COMPLETED|First Intervention (1 Day)||9
5008576|NCT02278328|12323350|P3|STARTED|First Intervention (1 Day)||6
5008577|NCT02278328|12323351|P2|STARTED|First Intervention (1 Day)||6
5008578|NCT02278328|12323352|P1|STARTED|First Intervention (1 Day)||9
5008579|NCT02278328|12323350|P3|NOT COMPLETED|Neuropsych Screening||2
5008580|NCT02278328|12323351|P2|NOT COMPLETED|Neuropsych Screening||1
5008581|NCT02278328|12323352|P1|NOT COMPLETED|Neuropsych Screening||1
5008582|NCT02278328|12323350|P3|COMPLETED|Neuropsych Screening||6
5008583|NCT02278328|12323351|P2|COMPLETED|Neuropsych Screening||6
5008584|NCT02278328|12323352|P1|COMPLETED|Neuropsych Screening||9
5008585|NCT02278328|12323350|P3|STARTED|Neuropsych Screening||8
5008586|NCT02278328|12323351|P2|STARTED|Neuropsych Screening||7
5008587|NCT02278328|12323352|P1|STARTED|Neuropsych Screening||10
5008588|NCT02278263|12323365|P3|NOT COMPLETED|Overall Study||9
5008589|NCT02278263|12323366|P2|NOT COMPLETED|Overall Study||0
5008590|NCT02278263|12323367|P1|NOT COMPLETED|Overall Study||7
5008591|NCT02278263|12323365|P3|COMPLETED|Overall Study||51
5008592|NCT02278263|12323366|P2|COMPLETED|Overall Study|Correction|60
5008593|NCT02278263|12323367|P1|COMPLETED|Overall Study||23
5008594|NCT02278263|12323365|P3|STARTED|Overall Study||60
5008595|NCT02278263|12323366|P2|STARTED|Overall Study||60
5008596|NCT02278263|12323367|P1|STARTED|Overall Study||30
5008597|NCT02278237|12323393|P1|NOT COMPLETED|Overall Study||7
5008598|NCT02278237|12323393|P1|COMPLETED|Overall Study||83
5008599|NCT02278237|12323393|P1|STARTED|Overall Study||90
5008600|NCT02278146|12323399|P2|NOT COMPLETED|Overall Study||2
5008601|NCT02278146|12323400|P1|NOT COMPLETED|Overall Study||0
5008602|NCT02278146|12323399|P2|COMPLETED|Overall Study||8
5008603|NCT02278146|12323400|P1|COMPLETED|Overall Study||6
5008604|NCT02278146|12323399|P2|STARTED|Overall Study||10
5008605|NCT02278146|12323400|P1|STARTED|Overall Study||6
5008606|NCT02278120|12323412|P2|NOT COMPLETED|Overall Study||216
5008607|NCT02278120|12323413|P1|NOT COMPLETED|Overall Study||161
5008608|NCT02278120|12323412|P2|COMPLETED|Overall Study||121
5008609|NCT02278120|12323413|P1|COMPLETED|Overall Study||174
5008610|NCT02278120|12323412|P2|STARTED|Overall Study||337
5008611|NCT02278120|12323413|P1|STARTED|Overall Study||335
5008612|NCT02278003|12323429|P2|NOT COMPLETED|Overall Study||0
5008613|NCT02278003|12323430|P1|NOT COMPLETED|Overall Study||19
5008614|NCT02278003|12323429|P2|COMPLETED|Overall Study||20
5008615|NCT02278003|12323430|P1|COMPLETED|Overall Study||30
5008616|NCT02278003|12323429|P2|STARTED|Overall Study||20
5008617|NCT02278003|12323430|P1|STARTED|Overall Study||49
5008618|NCT02277990|12323440|P2|NOT COMPLETED|Overall Study||376
5008619|NCT02277990|12323441|P1|NOT COMPLETED|Overall Study||366
5008620|NCT02277990|12323440|P2|COMPLETED|Overall Study||3112
5008621|NCT02277990|12323441|P1|COMPLETED|Overall Study||3129
5008622|NCT02277990|12323440|P2|STARTED|Overall Study||3488
5008623|NCT02277990|12323441|P1|STARTED|Overall Study||3495
5008624|NCT02277925|12323455|P2|NOT COMPLETED|Overall Study||15
5008625|NCT02277925|12323456|P1|NOT COMPLETED|Overall Study||7
5008626|NCT02277925|12323455|P2|COMPLETED|Overall Study||87
5008627|NCT02277925|12323456|P1|COMPLETED|Overall Study||95
5008628|NCT02277925|12323455|P2|Surgery|Overall Study||101
5008629|NCT02277925|12323456|P1|Surgery|Overall Study||99
5008630|NCT02277925|12323455|P2|STARTED|Overall Study||102
5008631|NCT02277925|12323456|P1|STARTED|Overall Study||102
5008632|NCT02277769|12323469|P3|NOT COMPLETED|Overall Study||18
5008633|NCT02277769|12323470|P2|NOT COMPLETED|Overall Study||13
5008634|NCT02277769|12323471|P1|NOT COMPLETED|Overall Study||46
5008635|NCT02277769|12323469|P3|COMPLETED|Overall Study||221
5008636|NCT02277769|12323470|P2|COMPLETED|Overall Study||220
5008637|NCT02277769|12323471|P1|COMPLETED|Overall Study||190
5008638|NCT02277769|12323469|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
5008639|NCT02277769|12323470|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
5008640|NCT02277769|12323471|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
5008641|NCT02277769|12323469|P3|Treated|Overall Study||239
5008642|NCT02277769|12323470|P2|Treated|Overall Study||233
5008643|NCT02277769|12323471|P1|Treated|Overall Study||235
5008644|NCT02277769|12323469|P3|STARTED|Overall Study||239
5008645|NCT02277769|12323470|P2|STARTED|Overall Study||233
5008646|NCT02277769|12323471|P1|STARTED|Overall Study||236
5008647|NCT02277743|12323542|P3|NOT COMPLETED|Overall Study||26
5008648|NCT02277743|12323543|P2|NOT COMPLETED|Overall Study||16
5008649|NCT02277743|12323544|P1|NOT COMPLETED|Overall Study||40
5008650|NCT02277743|12323542|P3|COMPLETED|Overall Study||197
5008651|NCT02277743|12323543|P2|COMPLETED|Overall Study||208
5008652|NCT02277743|12323544|P1|COMPLETED|Overall Study||184
5008653|NCT02277743|12323542|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
5008654|NCT02277743|12323543|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
5008655|NCT02277743|12323544|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
5008656|NCT02277743|12323542|P3|Treated|Overall Study||223
5008657|NCT02277743|12323543|P2|Treated|Overall Study||223
5008658|NCT02277743|12323544|P1|Treated|Overall Study||223
5008659|NCT02277743|12323542|P3|STARTED|Overall Study||223
5008660|NCT02277743|12323543|P2|STARTED|Overall Study||224
5008661|NCT02277743|12323544|P1|STARTED|Overall Study||224
5008662|NCT02277691|12323612|P1|NOT COMPLETED|Overall Study||46
5008663|NCT02277691|12323612|P1|COMPLETED|Overall Study||295
5008664|NCT02277691|12323612|P1|STARTED|Overall Study||341
5008665|NCT02277665|12323624|P2|NOT COMPLETED|Overall Study||0
5008666|NCT02277665|12323625|P1|NOT COMPLETED|Overall Study||0
5008667|NCT02277665|12323624|P2|COMPLETED|Overall Study||34
5008668|NCT02277665|12323625|P1|COMPLETED|Overall Study||33
5008669|NCT02277665|12323624|P2|STARTED|Overall Study||34
5008670|NCT02277665|12323625|P1|STARTED|Overall Study||33
5008671|NCT02277639|12323643|P2|NOT COMPLETED|Overall Study||0
5008672|NCT02277639|12323644|P1|NOT COMPLETED|Overall Study||0
5008673|NCT02277639|12323643|P2|COMPLETED|Overall Study||2
5008674|NCT02277639|12323644|P1|COMPLETED|Overall Study||0
5008675|NCT02277639|12323643|P2|STARTED|Overall Study||2
5008676|NCT02277639|12323644|P1|STARTED|Overall Study||0
5008677|NCT02277626|12323650|P2|NOT COMPLETED|Overall Study||0
5008678|NCT02277626|12323651|P1|NOT COMPLETED|Overall Study||0
5008679|NCT02277626|12323650|P2|COMPLETED|Overall Study||9
5008680|NCT02277626|12323651|P1|COMPLETED|Overall Study||6
5008681|NCT02277626|12323650|P2|STARTED|Overall Study||9
5008682|NCT02277626|12323651|P1|STARTED|Overall Study||6
5008683|NCT02277548|12323667|P2|NOT COMPLETED|Overall Study||2
5008684|NCT02277548|12323668|P1|NOT COMPLETED|Overall Study||0
5008685|NCT02277548|12323667|P2|COMPLETED|Overall Study||9
5008686|NCT02277548|12323668|P1|COMPLETED|Overall Study||9
5008687|NCT02277548|12323667|P2|STARTED|Overall Study||11
5008688|NCT02277548|12323668|P1|STARTED|Overall Study||9
5008689|NCT02277249|12323676|P2|NOT COMPLETED|Overall Study||0
5008690|NCT02277249|12323677|P1|NOT COMPLETED|Overall Study||0
5008691|NCT02277249|12323676|P2|COMPLETED|Overall Study||30
5008692|NCT02277249|12323677|P1|COMPLETED|Overall Study||30
5008693|NCT02277249|12323676|P2|STARTED|Overall Study||30
5008694|NCT02277249|12323677|P1|STARTED|Overall Study||30
5008695|NCT02277119|12323686|P3|NOT COMPLETED|Overall Study||8
5008696|NCT02277119|12323687|P2|NOT COMPLETED|Overall Study||4
5008697|NCT02277119|12323688|P1|NOT COMPLETED|Overall Study||3
5008698|NCT02277119|12323686|P3|COMPLETED|Overall Study||19
5008699|NCT02277119|12323687|P2|COMPLETED|Overall Study||20
5008700|NCT02277119|12323688|P1|COMPLETED|Overall Study||55
5008701|NCT02277119|12323686|P3|STARTED|Overall Study||27
5008702|NCT02277119|12323687|P2|STARTED|Overall Study||24
5008703|NCT02277119|12323688|P1|STARTED|Overall Study||58
5008704|NCT02277093|12323705|P1|NOT COMPLETED|Overall Study||0
5008705|NCT02277093|12323705|P1|COMPLETED|Overall Study||11
5008706|NCT02277093|12323705|P1|STARTED|Overall Study||11
5008707|NCT02277054|12323713|P1|NOT COMPLETED|Overall Study||0
5008708|NCT02277054|12323713|P1|COMPLETED|Overall Study||5
5008709|NCT02277054|12323713|P1|STARTED|Overall Study||5
5008710|NCT02276963|12323719|P1|NOT COMPLETED|Overall Study||3
5008711|NCT02276963|12323719|P1|COMPLETED|Overall Study||3
5008712|NCT02276963|12323719|P1|STARTED|Overall Study||6
5008713|NCT02276872|12323726|P3|NOT COMPLETED|Overall Study||0
5008714|NCT02276872|12323727|P2|NOT COMPLETED|Overall Study||0
5008715|NCT02276872|12323728|P1|NOT COMPLETED|Overall Study||1
5008716|NCT02276872|12323726|P3|COMPLETED|Overall Study||12
5008717|NCT02276872|12323727|P2|COMPLETED|Overall Study||10
5008718|NCT02276872|12323728|P1|COMPLETED|Overall Study||9
5008719|NCT02276872|12323726|P3|STARTED|Overall Study||12
5008720|NCT02276872|12323727|P2|STARTED|Overall Study||10
5008721|NCT02276872|12323728|P1|STARTED|Overall Study||10
5008722|NCT02276807|12323804|P2|NOT COMPLETED|Overall Study||17
5008723|NCT02276807|12323805|P1|NOT COMPLETED|Overall Study||18
5008724|NCT02276807|12323804|P2|COMPLETED|Overall Study||55
5008725|NCT02276807|12323805|P1|COMPLETED|Overall Study||50
5008726|NCT02276807|12323804|P2|12-week Assessment|Overall Study||63
5008727|NCT02276807|12323805|P1|12-week Assessment|Overall Study||57
5008728|NCT02276807|12323804|P2|STARTED|Overall Study||72
5008729|NCT02276807|12323805|P1|STARTED|Overall Study||68
5008730|NCT02276638|12323822|P3|NOT COMPLETED|Overall Study||0
5008731|NCT02276638|12323823|P2|NOT COMPLETED|Overall Study||0
5008732|NCT02276638|12323824|P1|NOT COMPLETED|Overall Study||0
5008733|NCT02276638|12323822|P3|COMPLETED|Overall Study||23
5008734|NCT02276638|12323823|P2|COMPLETED|Overall Study||28
5008735|NCT02276638|12323824|P1|COMPLETED|Overall Study||28
5008736|NCT02276638|12323822|P3|STARTED|Overall Study||23
5008737|NCT02276638|12323823|P2|STARTED|Overall Study||28
5008738|NCT02276638|12323824|P1|STARTED|Overall Study||28
5008739|NCT02276612|12323840|P2|NOT COMPLETED|Overall Study||0
5008740|NCT02276612|12323841|P1|NOT COMPLETED|Overall Study||4
5008741|NCT02276612|12323840|P2|COMPLETED|Overall Study||10
5008742|NCT02276612|12323841|P1|COMPLETED|Overall Study||46
5008743|NCT02276612|12323840|P2|STARTED|Overall Study||10
5008744|NCT02276612|12323841|P1|STARTED|Overall Study||50
5008745|NCT02276560|12323864|P3|NOT COMPLETED|Overall Study||0
5008746|NCT02276560|12323865|P2|NOT COMPLETED|Overall Study||0
5008747|NCT02276560|12323866|P1|NOT COMPLETED|Overall Study||1
5008748|NCT02276560|12323864|P3|COMPLETED|Overall Study||0
5008749|NCT02276560|12323865|P2|COMPLETED|Overall Study||0
5008750|NCT02276560|12323866|P1|COMPLETED|Overall Study||0
5008751|NCT02276560|12323864|P3|STARTED|Overall Study||0
5008752|NCT02276560|12323865|P2|STARTED|Overall Study||0
5008753|NCT02276560|12323866|P1|STARTED|Overall Study||1
5008754|NCT02276482|12323876|P2|NOT COMPLETED|Overall Study||1
5008755|NCT02276482|12323877|P1|NOT COMPLETED|Overall Study||3
5008756|NCT02276482|12323876|P2|COMPLETED|Overall Study||28
5008757|NCT02276482|12323877|P1|COMPLETED|Overall Study||88
5008758|NCT02276482|12323876|P2|STARTED|Overall Study||29
5008759|NCT02276482|12323877|P1|STARTED|Overall Study||91
5008760|NCT02276274|12323901|P2|NOT COMPLETED|Second Intervention Period||0
5008761|NCT02276274|12323902|P1|NOT COMPLETED|Second Intervention Period||0
5008762|NCT02276274|12323901|P2|COMPLETED|Second Intervention Period||6
5008763|NCT02276274|12323902|P1|COMPLETED|Second Intervention Period||6
5008764|NCT02276274|12323901|P2|STARTED|Second Intervention Period||6
5008765|NCT02276274|12323902|P1|STARTED|Second Intervention Period||6
5008766|NCT02276274|12323901|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
5008767|NCT02276274|12323902|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
5008768|NCT02276274|12323901|P2|COMPLETED|Washout Period (at Least 15 Days)||6
5008769|NCT02276274|12323902|P1|COMPLETED|Washout Period (at Least 15 Days)||6
5008770|NCT02276274|12323901|P2|STARTED|Washout Period (at Least 15 Days)||6
5008771|NCT02276274|12323902|P1|STARTED|Washout Period (at Least 15 Days)||6
5008772|NCT02276274|12323901|P2|NOT COMPLETED|First Intervention Period||0
5008773|NCT02276274|12323902|P1|NOT COMPLETED|First Intervention Period||0
5008774|NCT02276274|12323901|P2|COMPLETED|First Intervention Period||6
5008775|NCT02276274|12323902|P1|COMPLETED|First Intervention Period||6
5008776|NCT02276274|12323901|P2|STARTED|First Intervention Period||6
5008777|NCT02276274|12323902|P1|STARTED|First Intervention Period||6
5008778|NCT02276222|12324012|P2|NOT COMPLETED|Overall Study||64
5008779|NCT02276222|12324013|P1|NOT COMPLETED|Overall Study||185
5008780|NCT02276222|12324012|P2|COMPLETED|Overall Study||402
5008781|NCT02276222|12324013|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
5008782|NCT02276222|12324012|P2|STARTED|Overall Study||466
5008783|NCT02276222|12324013|P1|STARTED|Overall Study||621
5008784|NCT02276053|12324037|P1|NOT COMPLETED|Overall Study||14
5008785|NCT02276053|12324037|P1|COMPLETED|Overall Study||79
5008786|NCT02276053|12324037|P1|STARTED|Overall Study||93
5008787|NCT02276040|12324053|P1|NOT COMPLETED|Overall Study||15
5008788|NCT02276040|12324053|P1|COMPLETED|Overall Study||11
5008789|NCT02276040|12324053|P1|STARTED|Overall Study||26
5008790|NCT02275923|12324057|P1|NOT COMPLETED|Overall Study||2
5008791|NCT02275923|12324057|P1|COMPLETED|Overall Study||7
5008792|NCT02275923|12324057|P1|STARTED|Overall Study||9
5008793|NCT02275780|12324064|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
5008794|NCT02275780|12324065|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
5008795|NCT02275780|12324064|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
5008796|NCT02275780|12324065|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
5008797|NCT02275780|12324064|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
5008798|NCT02275780|12324065|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
5008799|NCT02275780|12324064|P2|NOT COMPLETED|Base Study: 96 Weeks||111
5008800|NCT02275780|12324065|P1|NOT COMPLETED|Base Study: 96 Weeks||93
5008801|NCT02275780|12324064|P2|COMPLETED|Base Study: 96 Weeks||273
5008802|NCT02275780|12324065|P1|COMPLETED|Base Study: 96 Weeks||292
5008803|NCT02275780|12324064|P2|Treated|Base Study: 96 Weeks||383
5008804|NCT02275780|12324065|P1|Treated|Base Study: 96 Weeks||383
5008805|NCT02275780|12324064|P2|STARTED|Base Study: 96 Weeks||384
5008806|NCT02275780|12324065|P1|STARTED|Base Study: 96 Weeks||385
5008807|NCT02275767|12324104|P3|NOT COMPLETED|Overall Study||3
5008808|NCT02275767|12324105|P2|NOT COMPLETED|Overall Study||4
5008809|NCT02275767|12324106|P1|NOT COMPLETED|Overall Study||2
5008810|NCT02275767|12324104|P3|COMPLETED|Overall Study||19
5008811|NCT02275767|12324105|P2|COMPLETED|Overall Study||18
5008812|NCT02275767|12324106|P1|COMPLETED|Overall Study||20
5008813|NCT02275767|12324104|P3|STARTED|Overall Study||22
5008814|NCT02275767|12324105|P2|STARTED|Overall Study||22
5008815|NCT02275767|12324106|P1|STARTED|Overall Study||22
5008816|NCT02275611|12324121|P4|NOT COMPLETED|Outpatient Drinking||0
5008817|NCT02275611|12324122|P3|NOT COMPLETED|Outpatient Drinking||0
5008818|NCT02275611|12324123|P2|NOT COMPLETED|Outpatient Drinking||0
5008819|NCT02275611|12324124|P1|NOT COMPLETED|Outpatient Drinking||0
5008820|NCT02275611|12324121|P4|COMPLETED|Outpatient Drinking||3
5008821|NCT02275611|12324122|P3|COMPLETED|Outpatient Drinking||6
5008822|NCT02275611|12324123|P2|COMPLETED|Outpatient Drinking||0
5008823|NCT02275611|12324124|P1|COMPLETED|Outpatient Drinking||0
5008824|NCT02275611|12324121|P4|STARTED|Outpatient Drinking||3
5008825|NCT02275611|12324122|P3|STARTED|Outpatient Drinking||6
5008826|NCT02275611|12324123|P2|STARTED|Outpatient Drinking||0
5008827|NCT02275611|12324124|P1|STARTED|Outpatient Drinking||0
5008828|NCT02275611|12324121|P4|NOT COMPLETED|Inpatient Withdrawal||0
5008829|NCT02275611|12324122|P3|NOT COMPLETED|Inpatient Withdrawal||0
5008830|NCT02275611|12324123|P2|NOT COMPLETED|Inpatient Withdrawal||0
5008831|NCT02275611|12324124|P1|NOT COMPLETED|Inpatient Withdrawal||1
5008832|NCT02275611|12324121|P4|COMPLETED|Inpatient Withdrawal||0
5008833|NCT02275611|12324122|P3|COMPLETED|Inpatient Withdrawal||0
5008834|NCT02275611|12324123|P2|COMPLETED|Inpatient Withdrawal||4
5008835|NCT02275611|12324124|P1|COMPLETED|Inpatient Withdrawal||4
5008836|NCT02275611|12324121|P4|STARTED|Inpatient Withdrawal||0
5008837|NCT02275611|12324122|P3|STARTED|Inpatient Withdrawal||0
5008838|NCT02275611|12324123|P2|STARTED|Inpatient Withdrawal||4
5008839|NCT02275611|12324124|P1|STARTED|Inpatient Withdrawal||5
5008840|NCT02275546|12324136|P2|NOT COMPLETED|Treatment Period 2||2
5008841|NCT02275546|12324137|P1|NOT COMPLETED|Treatment Period 2||2
5008842|NCT02275546|12324136|P2|COMPLETED|Treatment Period 2||81
5008843|NCT02275546|12324137|P1|COMPLETED|Treatment Period 2||79
5008844|NCT02275546|12324136|P2|STARTED|Treatment Period 2||83
5008845|NCT02275546|12324137|P1|STARTED|Treatment Period 2||81
5008846|NCT02275546|12324136|P2|NOT COMPLETED|Treatment Period 1||0
5008847|NCT02275546|12324137|P1|NOT COMPLETED|Treatment Period 1||0
5008848|NCT02275546|12324136|P2|COMPLETED|Treatment Period 1||83
5008849|NCT02275546|12324137|P1|COMPLETED|Treatment Period 1||81
5008850|NCT02275546|12324136|P2|STARTED|Treatment Period 1||83
5008851|NCT02275546|12324137|P1|STARTED|Treatment Period 1||81
5008852|NCT02275481|12324147|P2|NOT COMPLETED|Overall Study||3
5008853|NCT02275481|12324148|P1|NOT COMPLETED|Overall Study||9
5008854|NCT02275481|12324147|P2|COMPLETED|Overall Study||31
5008855|NCT02275481|12324148|P1|COMPLETED|Overall Study||23
5008856|NCT02275481|12324147|P2|STARTED|Overall Study||34
5008857|NCT02275481|12324148|P1|STARTED|Overall Study||32
5008858|NCT02275364|12324154|P2|NOT COMPLETED|Period 4||0
5008859|NCT02275364|12324155|P1|NOT COMPLETED|Period 4||0
5008860|NCT02275364|12324154|P2|COMPLETED|Period 4||14
5008861|NCT02275364|12324155|P1|COMPLETED|Period 4||12
5008862|NCT02275364|12324154|P2|STARTED|Period 4||14
5008863|NCT02275364|12324155|P1|STARTED|Period 4||12
5008864|NCT02275364|12324154|P2|NOT COMPLETED|Period 3||0
5008865|NCT02275364|12324155|P1|NOT COMPLETED|Period 3||0
5008866|NCT02275364|12324154|P2|COMPLETED|Period 3||14
5008867|NCT02275364|12324155|P1|COMPLETED|Period 3||12
5008868|NCT02275364|12324154|P2|STARTED|Period 3||14
5008869|NCT02275364|12324155|P1|STARTED|Period 3||12
5008870|NCT02275364|12324154|P2|NOT COMPLETED|Washout Period 2||0
5008871|NCT02275364|12324155|P1|NOT COMPLETED|Washout Period 2||0
5008872|NCT02275364|12324154|P2|COMPLETED|Washout Period 2||14
5008873|NCT02275364|12324155|P1|COMPLETED|Washout Period 2||12
5008874|NCT02275364|12324154|P2|STARTED|Washout Period 2||14
5008875|NCT02275364|12324155|P1|STARTED|Washout Period 2||12
5008876|NCT02275364|12324154|P2|NOT COMPLETED|Period 2||0
5008877|NCT02275364|12324155|P1|NOT COMPLETED|Period 2||0
5008878|NCT02275364|12324154|P2|COMPLETED|Period 2||14
5008879|NCT02275364|12324155|P1|COMPLETED|Period 2||12
5008880|NCT02275364|12324154|P2|STARTED|Period 2||14
5008881|NCT02275364|12324155|P1|STARTED|Period 2||12
5008882|NCT02275364|12324154|P2|NOT COMPLETED|Washout Period 1||0
5008883|NCT02275364|12324155|P1|NOT COMPLETED|Washout Period 1||0
5008884|NCT02275364|12324154|P2|COMPLETED|Washout Period 1||14
5008885|NCT02275364|12324155|P1|COMPLETED|Washout Period 1||12
5008886|NCT02275364|12324154|P2|STARTED|Washout Period 1||14
5008887|NCT02275364|12324155|P1|STARTED|Washout Period 1||12
5008888|NCT02275364|12324154|P2|NOT COMPLETED|Period 1||0
5008889|NCT02275364|12324155|P1|NOT COMPLETED|Period 1||2
5008890|NCT02275364|12324154|P2|COMPLETED|Period 1||14
5008891|NCT02275364|12324155|P1|COMPLETED|Period 1||12
5008892|NCT02275364|12324154|P2|STARTED|Period 1||14
5008893|NCT02275364|12324155|P1|STARTED|Period 1||14
5008894|NCT02275338|12324184|P1|NOT COMPLETED|Overall Study||33
5008895|NCT02275338|12324184|P1|COMPLETED|Overall Study||19
5008896|NCT02275338|12324184|P1|Started Phase 2|Overall Study||21
5008897|NCT02275338|12324184|P1|Completed Phase 1|Overall Study||25
5008898|NCT02275338|12324184|P1|STARTED|Overall Study||52
5008899|NCT02275156|12324199|P3|NOT COMPLETED|Overall Study||0
5008900|NCT02275156|12324200|P2|NOT COMPLETED|Overall Study||0
5008901|NCT02275156|12324201|P1|NOT COMPLETED|Overall Study||0
5008902|NCT02275156|12324199|P3|COMPLETED|Overall Study||6
5008903|NCT02275156|12324200|P2|COMPLETED|Overall Study||6
5008904|NCT02275156|12324201|P1|COMPLETED|Overall Study||6
5008905|NCT02275156|12324199|P3|STARTED|Overall Study||6
5008906|NCT02275156|12324200|P2|STARTED|Overall Study||6
5008907|NCT02275156|12324201|P1|STARTED|Overall Study||6
5008908|NCT02275117|12324233|P5|NOT COMPLETED|Overall Study||36
5008909|NCT02275117|12324234|P4|NOT COMPLETED|Overall Study||33
5008910|NCT02275117|12324235|P3|NOT COMPLETED|Overall Study||42
5008911|NCT02275117|12324236|P2|NOT COMPLETED|Overall Study||37
5008912|NCT02275117|12324237|P1|NOT COMPLETED|Overall Study||34
5008913|NCT02275117|12324233|P5|COMPLETED|Overall Study||98
5008914|NCT02275117|12324234|P4|COMPLETED|Overall Study||100
5008915|NCT02275117|12324235|P3|COMPLETED|Overall Study||92
5008916|NCT02275117|12324236|P2|COMPLETED|Overall Study||96
5008917|NCT02275117|12324237|P1|COMPLETED|Overall Study||97
5008918|NCT02275117|12324233|P5|Randomized and Treated|Overall Study||121
5008919|NCT02275117|12324234|P4|Randomized and Treated|Overall Study||130
5008920|NCT02275117|12324235|P3|Randomized and Treated|Overall Study||122
5008921|NCT02275117|12324236|P2|Randomized and Treated|Overall Study||123
5008922|NCT02275117|12324237|P1|Randomized and Treated|Overall Study||120
5008923|NCT02275117|12324233|P5|STARTED|Overall Study||134
5008924|NCT02275117|12324234|P4|STARTED|Overall Study||133
5008925|NCT02275117|12324235|P3|STARTED|Overall Study||134
5008926|NCT02275117|12324236|P2|STARTED|Overall Study||133
5008927|NCT02275117|12324237|P1|STARTED|Overall Study||131
5008928|NCT02275052|12324344|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
5008929|NCT02275052|12324345|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
5008930|NCT02275052|12324346|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
5008931|NCT02275052|12324347|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
5008932|NCT02275052|12324344|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
5008933|NCT02275052|12324345|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
5008934|NCT02275052|12324346|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
5008935|NCT02275052|12324347|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
5008936|NCT02275052|12324344|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
5008937|NCT02275052|12324345|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
5008938|NCT02275052|12324346|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
5008939|NCT02275052|12324347|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
5008940|NCT02275052|12324344|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
5008941|NCT02275052|12324345|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
5008942|NCT02275052|12324346|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
5008943|NCT02275052|12324347|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
5008944|NCT02275052|12324344|P4|COMPLETED|Washout Period (12-17 Days)||0
5008945|NCT02275052|12324345|P3|COMPLETED|Washout Period (12-17 Days)||0
5008946|NCT02275052|12324346|P2|COMPLETED|Washout Period (12-17 Days)||93
5008947|NCT02275052|12324347|P1|COMPLETED|Washout Period (12-17 Days)||86
5008948|NCT02275052|12324344|P4|STARTED|Washout Period (12-17 Days)||0
5008949|NCT02275052|12324345|P3|STARTED|Washout Period (12-17 Days)||0
5008950|NCT02275052|12324346|P2|STARTED|Washout Period (12-17 Days)||93
5008951|NCT02275052|12324347|P1|STARTED|Washout Period (12-17 Days)||90
5008952|NCT02275052|12324344|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
5008953|NCT02275052|12324345|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
5008954|NCT02275052|12324346|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
5008955|NCT02275052|12324347|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
5008956|NCT02275052|12324344|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
5008957|NCT02275052|12324345|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
5008958|NCT02275052|12324346|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
5008959|NCT02275052|12324347|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
5008960|NCT02275052|12324344|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
5008961|NCT02275052|12324345|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
5008962|NCT02275052|12324346|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
5008963|NCT02275052|12324347|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
5008964|NCT02274948|12324361|P2|NOT COMPLETED|Overall Study||91
5008965|NCT02274948|12324362|P1|NOT COMPLETED|Overall Study||98
5008966|NCT02274948|12324361|P2|COMPLETED|Overall Study||82
5008967|NCT02274948|12324362|P1|COMPLETED|Overall Study||68
5008968|NCT02274948|12324361|P2|STARTED|Overall Study||173
5008969|NCT02274948|12324362|P1|STARTED|Overall Study||166
5008970|NCT02274870|12324378|P2|NOT COMPLETED|Overall Study||0
5008971|NCT02274870|12324379|P1|NOT COMPLETED|Overall Study||0
5008972|NCT02274870|12324378|P2|COMPLETED|Overall Study||33
5008973|NCT02274870|12324379|P1|COMPLETED|Overall Study||32
5008974|NCT02274870|12324378|P2|STARTED|Overall Study||33
5008975|NCT02274870|12324379|P1|STARTED|Overall Study||32
5008976|NCT02274857|12324405|P2|NOT COMPLETED|Overall Study||6
5008977|NCT02274857|12324406|P1|NOT COMPLETED|Overall Study||20
5008978|NCT02274857|12324405|P2|COMPLETED|Overall Study||165
5008979|NCT02274857|12324406|P1|COMPLETED|Overall Study||159
5008980|NCT02274857|12324405|P2|Completed Per Protocol|Overall Study||114
5008981|NCT02274857|12324406|P1|Completed Per Protocol|Overall Study||102
5008982|NCT02274857|12324405|P2|STARTED|Overall Study||171
5008983|NCT02274857|12324406|P1|STARTED|Overall Study||179
5008984|NCT02274792|12324419|P1|NOT COMPLETED|Overall Study||25
5008985|NCT02274792|12324419|P1|COMPLETED|Overall Study||107
5008986|NCT02274792|12324419|P1|Received Treatment|Overall Study||131
5008987|NCT02274792|12324419|P1|STARTED|Overall Study||132
5008988|NCT02274766|12324429|P2|NOT COMPLETED|Overall Study||9
5008989|NCT02274766|12324430|P1|NOT COMPLETED|Overall Study||4
5008990|NCT02274766|12324429|P2|COMPLETED|Overall Study||29
5008991|NCT02274766|12324430|P1|COMPLETED|Overall Study||35
5008992|NCT02274766|12324429|P2|Received Study Drug|Overall Study||37
5008993|NCT02274766|12324430|P1|Received Study Drug|Overall Study||38
5008994|NCT02274766|12324429|P2|STARTED|Overall Study||38
5008995|NCT02274766|12324430|P1|STARTED|Overall Study||39
5008996|NCT02274688|12324440|P2|NOT COMPLETED|Overall Study||13
5008997|NCT02274688|12324441|P1|NOT COMPLETED|Overall Study||14
5008998|NCT02274688|12324440|P2|COMPLETED|Overall Study||72
5008999|NCT02274688|12324441|P1|COMPLETED|Overall Study||72
5009000|NCT02274688|12324440|P2|STARTED|Overall Study||85
5009001|NCT02274688|12324441|P1|STARTED|Overall Study||86
5009002|NCT02274675|12324463|P1|NOT COMPLETED|Overall Study||0
5009003|NCT02274675|12324463|P1|COMPLETED|Overall Study||7
5009004|NCT02274675|12324463|P1|STARTED|Overall Study||7
5009005|NCT02274649|12324475|P2|NOT COMPLETED|Overall Study||12
5009006|NCT02274649|12324476|P1|NOT COMPLETED|Overall Study||24
5009007|NCT02274649|12324475|P2|COMPLETED|Overall Study||81
5009008|NCT02274649|12324476|P1|COMPLETED|Overall Study||77
5009009|NCT02274649|12324475|P2|STARTED|Overall Study||93
5009010|NCT02274649|12324476|P1|STARTED|Overall Study||101
5009011|NCT02274558|12324497|P3|NOT COMPLETED|Overall Study||9
5009012|NCT02274558|12324498|P2|NOT COMPLETED|Overall Study||13
5009013|NCT02274558|12324499|P1|NOT COMPLETED|Overall Study||7
5009014|NCT02274558|12324497|P3|COMPLETED|Overall Study||71
5009015|NCT02274558|12324498|P2|COMPLETED|Overall Study||63
5009016|NCT02274558|12324499|P1|COMPLETED|Overall Study||71
5009017|NCT02274558|12324497|P3|Included in the Safety Analysis Set|Overall Study||79
5009018|NCT02274558|12324498|P2|Included in the Safety Analysis Set|Overall Study||72
5009019|NCT02274558|12324499|P1|Included in the Safety Analysis Set|Overall Study||76
5009020|NCT02274558|12324497|P3|STARTED|Overall Study||80
5009021|NCT02274558|12324498|P2|STARTED|Overall Study||76
5009022|NCT02274558|12324499|P1|STARTED|Overall Study||78
5009023|NCT02274493|12324513|P1|NOT COMPLETED|Overall Study||1
5009024|NCT02274493|12324513|P1|COMPLETED|Overall Study||14
5009025|NCT02274493|12324513|P1|STARTED|Overall Study||15
5009026|NCT02274311|12324520|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
5009027|NCT02274311|12324520|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
5009028|NCT02274311|12324520|P1|STARTED|Three Months of Clomiphene Wash-out||16
5009029|NCT02274311|12324520|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
5009030|NCT02274311|12324520|P1|COMPLETED|Three Months of Clomiphene Treatment||16
5009031|NCT02274311|12324520|P1|STARTED|Three Months of Clomiphene Treatment||16
5009032|NCT02273973|12324528|P2|NOT COMPLETED|Overall Study||8
5009033|NCT02273973|12324529|P1|NOT COMPLETED|Overall Study||9
5009034|NCT02273973|12324528|P2|COMPLETED|Overall Study||160
5009035|NCT02273973|12324529|P1|COMPLETED|Overall Study||157
5009036|NCT02273973|12324528|P2|STARTED|Overall Study||168
5009037|NCT02273973|12324529|P1|STARTED|Overall Study||166
5009038|NCT02273960|12324573|P4|NOT COMPLETED|Long Term Extension||1
5009039|NCT02273960|12324574|P3|NOT COMPLETED|Long Term Extension||0
5009040|NCT02273960|12324575|P2|NOT COMPLETED|Long Term Extension||0
5009041|NCT02273960|12324576|P1|NOT COMPLETED|Long Term Extension||0
5009042|NCT02273960|12324573|P4|COMPLETED|Long Term Extension||3
5009043|NCT02273960|12324574|P3|COMPLETED|Long Term Extension||1
5009044|NCT02273960|12324575|P2|COMPLETED|Long Term Extension||0
5009045|NCT02273960|12324576|P1|COMPLETED|Long Term Extension||0
5009046|NCT02273960|12324573|P4|STARTED|Long Term Extension||4
5009047|NCT02273960|12324574|P3|STARTED|Long Term Extension||1
5009048|NCT02273960|12324575|P2|STARTED|Long Term Extension||0
5009049|NCT02273960|12324576|P1|STARTED|Long Term Extension||0
5009050|NCT02273960|12324573|P4|NOT COMPLETED|Short Term Period||6
5009051|NCT02273960|12324574|P3|NOT COMPLETED|Short Term Period||4
5009052|NCT02273960|12324575|P2|NOT COMPLETED|Short Term Period||6
5009053|NCT02273960|12324576|P1|NOT COMPLETED|Short Term Period||5
5009054|NCT02273960|12324573|P4|COMPLETED|Short Term Period||4
5009055|NCT02273960|12324574|P3|COMPLETED|Short Term Period||1
5009056|NCT02273960|12324575|P2|COMPLETED|Short Term Period||0
5009057|NCT02273960|12324576|P1|COMPLETED|Short Term Period||0
5009058|NCT02273960|12324573|P4|STARTED|Short Term Period||10
5009059|NCT02273960|12324574|P3|STARTED|Short Term Period||5
5009060|NCT02273960|12324575|P2|STARTED|Short Term Period||6
5009061|NCT02273960|12324576|P1|STARTED|Short Term Period||5
5009062|NCT02273908|12324620|P2|NOT COMPLETED|Overall Study||5
5009063|NCT02273908|12324621|P1|NOT COMPLETED|Overall Study||33
5009064|NCT02273908|12324620|P2|COMPLETED|Overall Study||169
5009065|NCT02273908|12324621|P1|COMPLETED|Overall Study||124
5009066|NCT02273908|12324620|P2|STARTED|Overall Study||174
5009067|NCT02273908|12324621|P1|STARTED|Overall Study||157
5009068|NCT02273752|12324643|P1|NOT COMPLETED|Overall Study||2
5009069|NCT02273752|12324643|P1|COMPLETED|Overall Study||0
5009070|NCT02273752|12324643|P1|STARTED|Overall Study||2
5009071|NCT02273323|12324654|P2|NOT COMPLETED|Overall Study||0
5009072|NCT02273323|12324655|P1|NOT COMPLETED|Overall Study||0
5009073|NCT02273323|12324654|P2|COMPLETED|Overall Study||15
5009074|NCT02273323|12324655|P1|COMPLETED|Overall Study||15
5009075|NCT02273323|12324654|P2|STARTED|Overall Study||15
5009076|NCT02273323|12324655|P1|STARTED|Overall Study||15
5009077|NCT02273310|12324673|P2|NOT COMPLETED|Overall Study||3
5009078|NCT02273310|12324674|P1|NOT COMPLETED|Overall Study||18
5009079|NCT02273310|12324673|P2|COMPLETED|Overall Study||38
5009080|NCT02273310|12324674|P1|COMPLETED|Overall Study||24
5009081|NCT02273310|12324673|P2|STARTED|Overall Study||41
5009082|NCT02273310|12324674|P1|STARTED|Overall Study||42
5009083|NCT02273206|12324687|P2|NOT COMPLETED|Overall Study||42
5009084|NCT02273206|12324688|P1|NOT COMPLETED|Overall Study||25
5009085|NCT02273206|12324687|P2|COMPLETED|Overall Study||337
5009086|NCT02273206|12324688|P1|COMPLETED|Overall Study||353
5009087|NCT02273206|12324687|P2|STARTED|Overall Study||379
5009088|NCT02273206|12324688|P1|STARTED|Overall Study||378
5009089|NCT02273180|12324734|P2|NOT COMPLETED|Overall Study||19
5009090|NCT02273180|12324735|P1|NOT COMPLETED|Overall Study||27
5009091|NCT02273180|12324734|P2|COMPLETED|Overall Study||235
5009092|NCT02273180|12324735|P1|COMPLETED|Overall Study||226
5009093|NCT02273180|12324734|P2|Treated|Overall Study||254
5009094|NCT02273180|12324735|P1|Treated|Overall Study||252
5009095|NCT02273180|12324734|P2|STARTED|Overall Study||254
5009096|NCT02273180|12324735|P1|STARTED|Overall Study||253
5009097|NCT02273167|12324760|P3|NOT COMPLETED|Overall Study||21
5009098|NCT02273167|12324761|P2|NOT COMPLETED|Overall Study||23
5009099|NCT02273167|12324762|P1|NOT COMPLETED|Overall Study||24
5009100|NCT02273167|12324760|P3|COMPLETED|Overall Study||262
5009101|NCT02273167|12324761|P2|COMPLETED|Overall Study||260
5009102|NCT02273167|12324762|P1|COMPLETED|Overall Study||259
5009103|NCT02273167|12324760|P3|STARTED|Overall Study||283
5009104|NCT02273167|12324761|P2|STARTED|Overall Study||283
5009105|NCT02273167|12324762|P1|STARTED|Overall Study||283
5009106|NCT02273141|12324787|P2|NOT COMPLETED|Overall Study||25
5009107|NCT02273141|12324788|P1|NOT COMPLETED|Overall Study||17
5009108|NCT02273141|12324787|P2|COMPLETED|Overall Study||233
5009109|NCT02273141|12324788|P1|COMPLETED|Overall Study||240
5009110|NCT02273141|12324787|P2|STARTED|Overall Study||258
5009111|NCT02273141|12324788|P1|STARTED|Overall Study||257
5009112|NCT02273115|12324808|P4|NOT COMPLETED|Overall Study||1
5009113|NCT02273115|12324809|P3|NOT COMPLETED|Overall Study||0
5009114|NCT02273115|12324810|P2|NOT COMPLETED|Overall Study||0
5009115|NCT02273115|12324811|P1|NOT COMPLETED|Overall Study||0
5009116|NCT02273115|12324808|P4|COMPLETED|Overall Study||71
5009117|NCT02273115|12324809|P3|COMPLETED|Overall Study||67
5009118|NCT02273115|12324810|P2|COMPLETED|Overall Study||90
5009119|NCT02273115|12324811|P1|COMPLETED|Overall Study||94
5009120|NCT02273115|12324808|P4|STARTED|Overall Study||72
5009121|NCT02273115|12324809|P3|STARTED|Overall Study||67
5009122|NCT02273115|12324810|P2|STARTED|Overall Study||90
5009123|NCT02273115|12324811|P1|STARTED|Overall Study||94
5009124|NCT02273063|12324853|P1|NOT COMPLETED|Overall Study||5
5009125|NCT02273063|12324853|P1|COMPLETED|Overall Study||35
5009126|NCT02273063|12324853|P1|STARTED|Overall Study||40
5009127|NCT02273050|12324861|P3|NOT COMPLETED|Overall Study||29
5009128|NCT02273050|12324862|P2|NOT COMPLETED|Overall Study||22
5009129|NCT02273050|12324863|P1|NOT COMPLETED|Overall Study||24
5009130|NCT02273050|12324861|P3|COMPLETED|Overall Study||185
5009131|NCT02273050|12324862|P2|COMPLETED|Overall Study||194
5009132|NCT02273050|12324863|P1|COMPLETED|Overall Study||186
5009133|NCT02273050|12324861|P3|STARTED|Overall Study||214
5009134|NCT02273050|12324862|P2|STARTED|Overall Study||216
5009135|NCT02273050|12324863|P1|STARTED|Overall Study||210
5009136|NCT02273037|12324891|P2|NOT COMPLETED|Overall Study||8
5009137|NCT02273037|12324892|P1|NOT COMPLETED|Overall Study||8
5009138|NCT02273037|12324891|P2|COMPLETED|Overall Study||992
5009139|NCT02273037|12324892|P1|COMPLETED|Overall Study||979
5009140|NCT02273037|12324891|P2|STARTED|Overall Study||1000
5009141|NCT02273037|12324892|P1|STARTED|Overall Study||987
5009142|NCT02272985|12324902|P1|NOT COMPLETED|Overall Study||3
5009143|NCT02272985|12324902|P1|COMPLETED|Overall Study||12
5009144|NCT02272985|12324902|P1|STARTED|Overall Study||15
5009145|NCT02272816|12324907|P1|NOT COMPLETED|Overall Study||1
5009146|NCT02272816|12324907|P1|COMPLETED|Overall Study||47
5009147|NCT02272816|12324907|P1|STARTED|Overall Study||48
5009148|NCT02272803|12324915|P2|NOT COMPLETED|Overall Study||17
5009149|NCT02272803|12324916|P1|NOT COMPLETED|Overall Study||9
5009150|NCT02272803|12324915|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
5009151|NCT02272803|12324916|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
5009152|NCT02272803|12324915|P2|STARTED|Overall Study||42
5009153|NCT02272803|12324916|P1|STARTED|Overall Study||40
5009154|NCT02272790|12324933|P6|NOT COMPLETED|Overall Study||0
5009155|NCT02272790|12324934|P5|NOT COMPLETED|Overall Study||0
5009156|NCT02272790|12324935|P4|NOT COMPLETED|Overall Study||0
5009157|NCT02272790|12324936|P3|NOT COMPLETED|Overall Study||0
5009158|NCT02272790|12324937|P2|NOT COMPLETED|Overall Study||1
5009159|NCT02272790|12324938|P1|NOT COMPLETED|Overall Study||0
5009160|NCT02272790|12324933|P6|COMPLETED|Overall Study||6
5009161|NCT02272790|12324934|P5|COMPLETED|Overall Study||6
5009162|NCT02272790|12324935|P4|COMPLETED|Overall Study||12
5009163|NCT02272790|12324936|P3|COMPLETED|Overall Study||23
5009164|NCT02272790|12324937|P2|COMPLETED|Overall Study||38
5009165|NCT02272790|12324938|P1|COMPLETED|Overall Study||9
5009166|NCT02272790|12324933|P6|STARTED|Overall Study||6
5009167|NCT02272790|12324934|P5|STARTED|Overall Study||6
5009168|NCT02272790|12324935|P4|STARTED|Overall Study||12
5009169|NCT02272790|12324936|P3|STARTED|Overall Study||23
5009170|NCT02272790|12324937|P2|STARTED|Overall Study||39
5009171|NCT02272790|12324938|P1|STARTED|Overall Study||9
5009172|NCT02272777|12325074|P2|NOT COMPLETED|Overall Study||4
5009173|NCT02272777|12325075|P1|NOT COMPLETED|Overall Study||4
5009174|NCT02272777|12325074|P2|COMPLETED|Overall Study||109
5009175|NCT02272777|12325075|P1|COMPLETED|Overall Study||108
5009176|NCT02272777|12325074|P2|STARTED|Overall Study||113
5009177|NCT02272777|12325075|P1|STARTED|Overall Study||112
5009178|NCT02272725|12325083|P2|NOT COMPLETED|Overall Study||0
5009179|NCT02272725|12325084|P1|NOT COMPLETED|Overall Study||2
5009180|NCT02272725|12325083|P2|COMPLETED|Overall Study||42
5009181|NCT02272725|12325084|P1|COMPLETED|Overall Study||47
5009182|NCT02272725|12325083|P2|STARTED|Overall Study||42
5009183|NCT02272725|12325084|P1|STARTED|Overall Study||49
5009184|NCT02272686|12325094|P1|NOT COMPLETED|Overall Study||0
5009185|NCT02272686|12325094|P1|COMPLETED|Overall Study||1
5009186|NCT02272686|12325094|P1|STARTED|Overall Study||1
5009187|NCT02272413|12325101|P2|NOT COMPLETED|Post-switch Period||46
5009188|NCT02272413|12325102|P1|NOT COMPLETED|Post-switch Period||42
5009189|NCT02272413|12325101|P2|COMPLETED|Post-switch Period||0
5009190|NCT02272413|12325102|P1|COMPLETED|Post-switch Period||0
5009191|NCT02272413|12325101|P2|STARTED|Post-switch Period|Started for this period|46
5009192|NCT02272413|12325102|P1|STARTED|Post-switch Period|Started for this period|42
5009193|NCT02272413|12325101|P2|NOT COMPLETED|Pre-switch Period||282
5009194|NCT02272413|12325102|P1|NOT COMPLETED|Pre-switch Period||293
5009195|NCT02272413|12325101|P2|COMPLETED|Pre-switch Period||46
5009196|NCT02272413|12325102|P1|COMPLETED|Pre-switch Period||42
5009197|NCT02272413|12325101|P2|STARTED|Pre-switch Period|Started for this period|328
5009198|NCT02272413|12325102|P1|STARTED|Pre-switch Period|Started for this period|335
5009199|NCT02272413|12325101|P2|NOT COMPLETED|Randomized Through Treatment Start||5
5009200|NCT02272413|12325102|P1|NOT COMPLETED|Randomized Through Treatment Start||3
5009201|NCT02272413|12325101|P2|COMPLETED|Randomized Through Treatment Start||328
5009202|NCT02272413|12325102|P1|COMPLETED|Randomized Through Treatment Start||335
5009203|NCT02272413|12325101|P2|Treated|Randomized Through Treatment Start||328
5009204|NCT02272413|12325102|P1|Treated|Randomized Through Treatment Start||335
5009205|NCT02272413|12325101|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
5009206|NCT02272413|12325102|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
5009207|NCT02272244|12325120|P2|NOT COMPLETED|Overall Study||0
5009208|NCT02272244|12325121|P1|NOT COMPLETED|Overall Study||0
5009209|NCT02272244|12325120|P2|COMPLETED|Overall Study||197
5009210|NCT02272244|12325121|P1|COMPLETED|Overall Study||203
5009211|NCT02272244|12325120|P2|STARTED|Overall Study||197
5009212|NCT02272244|12325121|P1|STARTED|Overall Study||203
5009213|NCT02271984|12325133|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009214|NCT02271984|12325134|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009215|NCT02271984|12325135|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009216|NCT02271984|12325136|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009217|NCT02271984|12325137|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009218|NCT02271984|12325138|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009219|NCT02271984|12325139|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009220|NCT02271984|12325140|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009221|NCT02271984|12325141|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009222|NCT02271984|12325142|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009223|NCT02271984|12325143|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009224|NCT02271984|12325144|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
5009225|NCT02271984|12325133|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
5009226|NCT02271984|12325134|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
5009227|NCT02271984|12325135|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
5009228|NCT02271984|12325136|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
5009229|NCT02271984|12325137|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
5009230|NCT02271984|12325138|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
5009231|NCT02271984|12325139|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
5009232|NCT02271984|12325140|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
5009233|NCT02271984|12325141|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
5009234|NCT02271984|12325142|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
5009235|NCT02271984|12325143|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
5009236|NCT02271984|12325144|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
5009237|NCT02271984|12325133|P12|STARTED|Fifth Intervention Period (1 Day)||3
5009238|NCT02271984|12325134|P11|STARTED|Fifth Intervention Period (1 Day)||3
5009239|NCT02271984|12325135|P10|STARTED|Fifth Intervention Period (1 Day)||3
5009240|NCT02271984|12325136|P9|STARTED|Fifth Intervention Period (1 Day)||3
5009241|NCT02271984|12325137|P8|STARTED|Fifth Intervention Period (1 Day)||2
5009242|NCT02271984|12325138|P7|STARTED|Fifth Intervention Period (1 Day)||3
5009243|NCT02271984|12325139|P6|STARTED|Fifth Intervention Period (1 Day)||2
5009244|NCT02271984|12325140|P5|STARTED|Fifth Intervention Period (1 Day)||3
5009245|NCT02271984|12325141|P4|STARTED|Fifth Intervention Period (1 Day)||3
5009246|NCT02271984|12325142|P3|STARTED|Fifth Intervention Period (1 Day)||3
5009247|NCT02271984|12325143|P2|STARTED|Fifth Intervention Period (1 Day)||3
5009248|NCT02271984|12325144|P1|STARTED|Fifth Intervention Period (1 Day)||3
5009249|NCT02271984|12325133|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009250|NCT02271984|12325134|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009251|NCT02271984|12325135|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009252|NCT02271984|12325136|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009253|NCT02271984|12325137|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
5009254|NCT02271984|12325138|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009255|NCT02271984|12325139|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
5009256|NCT02271984|12325140|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009257|NCT02271984|12325141|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009258|NCT02271984|12325142|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009259|NCT02271984|12325143|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009260|NCT02271984|12325144|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
5009261|NCT02271984|12325133|P12|COMPLETED|Washout Period 4 (7 Days)||3
5009262|NCT02271984|12325134|P11|COMPLETED|Washout Period 4 (7 Days)||3
5009263|NCT02271984|12325135|P10|COMPLETED|Washout Period 4 (7 Days)||3
5009264|NCT02271984|12325136|P9|COMPLETED|Washout Period 4 (7 Days)||3
5009265|NCT02271984|12325137|P8|COMPLETED|Washout Period 4 (7 Days)||2
5009266|NCT02271984|12325138|P7|COMPLETED|Washout Period 4 (7 Days)||3
5009267|NCT02271984|12325139|P6|COMPLETED|Washout Period 4 (7 Days)||2
5009268|NCT02271984|12325140|P5|COMPLETED|Washout Period 4 (7 Days)||3
5009269|NCT02271984|12325141|P4|COMPLETED|Washout Period 4 (7 Days)||3
5009270|NCT02271984|12325142|P3|COMPLETED|Washout Period 4 (7 Days)||3
5009271|NCT02271984|12325143|P2|COMPLETED|Washout Period 4 (7 Days)||3
5009272|NCT02271984|12325144|P1|COMPLETED|Washout Period 4 (7 Days)||3
5009273|NCT02271984|12325133|P12|STARTED|Washout Period 4 (7 Days)||3
5009274|NCT02271984|12325134|P11|STARTED|Washout Period 4 (7 Days)||3
5009275|NCT02271984|12325135|P10|STARTED|Washout Period 4 (7 Days)||3
5009276|NCT02271984|12325136|P9|STARTED|Washout Period 4 (7 Days)||3
5009277|NCT02271984|12325137|P8|STARTED|Washout Period 4 (7 Days)||3
5009278|NCT02271984|12325138|P7|STARTED|Washout Period 4 (7 Days)||3
5009279|NCT02271984|12325139|P6|STARTED|Washout Period 4 (7 Days)||3
5009280|NCT02271984|12325140|P5|STARTED|Washout Period 4 (7 Days)||3
5009281|NCT02271984|12325141|P4|STARTED|Washout Period 4 (7 Days)||3
5009282|NCT02271984|12325142|P3|STARTED|Washout Period 4 (7 Days)||3
5009283|NCT02271984|12325143|P2|STARTED|Washout Period 4 (7 Days)||3
5009284|NCT02271984|12325144|P1|STARTED|Washout Period 4 (7 Days)||3
5009285|NCT02271984|12325133|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009286|NCT02271984|12325134|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009287|NCT02271984|12325135|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009288|NCT02271984|12325136|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009289|NCT02271984|12325137|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009290|NCT02271984|12325138|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009291|NCT02271984|12325139|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009292|NCT02271984|12325140|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009293|NCT02271984|12325141|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009294|NCT02271984|12325142|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009295|NCT02271984|12325143|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009296|NCT02271984|12325144|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
5009297|NCT02271984|12325133|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
5009298|NCT02271984|12325134|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
5009299|NCT02271984|12325135|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
5009300|NCT02271984|12325136|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
5009301|NCT02271984|12325137|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
5009302|NCT02271984|12325138|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
5009303|NCT02271984|12325139|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
5009304|NCT02271984|12325140|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
5009305|NCT02271984|12325141|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
5009306|NCT02271984|12325142|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
5009307|NCT02271984|12325143|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
5009308|NCT02271984|12325144|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
5009309|NCT02271984|12325133|P12|STARTED|Fourth Intervention Period (Day 1)||3
5009310|NCT02271984|12325134|P11|STARTED|Fourth Intervention Period (Day 1)||3
5009311|NCT02271984|12325135|P10|STARTED|Fourth Intervention Period (Day 1)||3
5009312|NCT02271984|12325136|P9|STARTED|Fourth Intervention Period (Day 1)||3
5009313|NCT02271984|12325137|P8|STARTED|Fourth Intervention Period (Day 1)||3
5009314|NCT02271984|12325138|P7|STARTED|Fourth Intervention Period (Day 1)||3
5009315|NCT02271984|12325139|P6|STARTED|Fourth Intervention Period (Day 1)||3
5009316|NCT02271984|12325140|P5|STARTED|Fourth Intervention Period (Day 1)||3
5009317|NCT02271984|12325141|P4|STARTED|Fourth Intervention Period (Day 1)||3
5009318|NCT02271984|12325142|P3|STARTED|Fourth Intervention Period (Day 1)||3
5009319|NCT02271984|12325143|P2|STARTED|Fourth Intervention Period (Day 1)||3
5009320|NCT02271984|12325144|P1|STARTED|Fourth Intervention Period (Day 1)||3
5009321|NCT02271984|12325133|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009322|NCT02271984|12325134|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009323|NCT02271984|12325135|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009324|NCT02271984|12325136|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009325|NCT02271984|12325137|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009326|NCT02271984|12325138|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009327|NCT02271984|12325139|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009328|NCT02271984|12325140|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009329|NCT02271984|12325141|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009330|NCT02271984|12325142|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009331|NCT02271984|12325143|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009332|NCT02271984|12325144|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
5009333|NCT02271984|12325133|P12|COMPLETED|Washout Period 3 (7 Days)||3
5009334|NCT02271984|12325134|P11|COMPLETED|Washout Period 3 (7 Days)||3
5009335|NCT02271984|12325135|P10|COMPLETED|Washout Period 3 (7 Days)||3
5009336|NCT02271984|12325136|P9|COMPLETED|Washout Period 3 (7 Days)||3
5009337|NCT02271984|12325137|P8|COMPLETED|Washout Period 3 (7 Days)||3
5009338|NCT02271984|12325138|P7|COMPLETED|Washout Period 3 (7 Days)||3
5009339|NCT02271984|12325139|P6|COMPLETED|Washout Period 3 (7 Days)||3
5009340|NCT02271984|12325140|P5|COMPLETED|Washout Period 3 (7 Days)||3
5009341|NCT02271984|12325141|P4|COMPLETED|Washout Period 3 (7 Days)||3
5009342|NCT02271984|12325142|P3|COMPLETED|Washout Period 3 (7 Days)||3
5009343|NCT02271984|12325143|P2|COMPLETED|Washout Period 3 (7 Days)||3
5009344|NCT02271984|12325144|P1|COMPLETED|Washout Period 3 (7 Days)||3
5009345|NCT02271984|12325133|P12|STARTED|Washout Period 3 (7 Days)||3
5009346|NCT02271984|12325134|P11|STARTED|Washout Period 3 (7 Days)||3
5009347|NCT02271984|12325135|P10|STARTED|Washout Period 3 (7 Days)||3
5009348|NCT02271984|12325136|P9|STARTED|Washout Period 3 (7 Days)||3
5009349|NCT02271984|12325137|P8|STARTED|Washout Period 3 (7 Days)||3
5009350|NCT02271984|12325138|P7|STARTED|Washout Period 3 (7 Days)||3
5009351|NCT02271984|12325139|P6|STARTED|Washout Period 3 (7 Days)||3
5009352|NCT02271984|12325140|P5|STARTED|Washout Period 3 (7 Days)||3
5009353|NCT02271984|12325141|P4|STARTED|Washout Period 3 (7 Days)||3
5009354|NCT02271984|12325142|P3|STARTED|Washout Period 3 (7 Days)||3
5009355|NCT02271984|12325143|P2|STARTED|Washout Period 3 (7 Days)||3
5009356|NCT02271984|12325144|P1|STARTED|Washout Period 3 (7 Days)||3
5009357|NCT02271984|12325133|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009358|NCT02271984|12325134|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009359|NCT02271984|12325135|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009360|NCT02271984|12325136|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009361|NCT02271984|12325137|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009362|NCT02271984|12325138|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009363|NCT02271984|12325139|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009364|NCT02271984|12325140|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009365|NCT02271984|12325141|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009366|NCT02271984|12325142|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009367|NCT02271984|12325143|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009368|NCT02271984|12325144|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
5009369|NCT02271984|12325133|P12|COMPLETED|Third Intervention Period (1 Day)||3
5009370|NCT02271984|12325134|P11|COMPLETED|Third Intervention Period (1 Day)||3
5009371|NCT02271984|12325135|P10|COMPLETED|Third Intervention Period (1 Day)||3
5009372|NCT02271984|12325136|P9|COMPLETED|Third Intervention Period (1 Day)||3
5009373|NCT02271984|12325137|P8|COMPLETED|Third Intervention Period (1 Day)||3
5009374|NCT02271984|12325138|P7|COMPLETED|Third Intervention Period (1 Day)||3
5009375|NCT02271984|12325139|P6|COMPLETED|Third Intervention Period (1 Day)||3
5009376|NCT02271984|12325140|P5|COMPLETED|Third Intervention Period (1 Day)||3
5009377|NCT02271984|12325141|P4|COMPLETED|Third Intervention Period (1 Day)||3
5009378|NCT02271984|12325142|P3|COMPLETED|Third Intervention Period (1 Day)||3
5009379|NCT02271984|12325143|P2|COMPLETED|Third Intervention Period (1 Day)||3
5009380|NCT02271984|12325144|P1|COMPLETED|Third Intervention Period (1 Day)||3
5009381|NCT02271984|12325133|P12|STARTED|Third Intervention Period (1 Day)||3
5009382|NCT02271984|12325134|P11|STARTED|Third Intervention Period (1 Day)||3
5009383|NCT02271984|12325135|P10|STARTED|Third Intervention Period (1 Day)||3
5009384|NCT02271984|12325136|P9|STARTED|Third Intervention Period (1 Day)||3
5009385|NCT02271984|12325137|P8|STARTED|Third Intervention Period (1 Day)||3
5009386|NCT02271984|12325138|P7|STARTED|Third Intervention Period (1 Day)||3
5009387|NCT02271984|12325139|P6|STARTED|Third Intervention Period (1 Day)||3
5009388|NCT02271984|12325140|P5|STARTED|Third Intervention Period (1 Day)||3
5009389|NCT02271984|12325141|P4|STARTED|Third Intervention Period (1 Day)||3
5009390|NCT02271984|12325142|P3|STARTED|Third Intervention Period (1 Day)||3
5009391|NCT02271984|12325143|P2|STARTED|Third Intervention Period (1 Day)||3
5009392|NCT02271984|12325144|P1|STARTED|Third Intervention Period (1 Day)||3
5009393|NCT02271984|12325133|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009394|NCT02271984|12325134|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009395|NCT02271984|12325135|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009396|NCT02271984|12325136|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009397|NCT02271984|12325137|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009398|NCT02271984|12325138|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009399|NCT02271984|12325139|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009400|NCT02271984|12325140|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009401|NCT02271984|12325141|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009402|NCT02271984|12325142|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009403|NCT02271984|12325143|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009404|NCT02271984|12325144|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5009405|NCT02271984|12325133|P12|COMPLETED|Washout Period 2 (7 Days)||3
5009406|NCT02271984|12325134|P11|COMPLETED|Washout Period 2 (7 Days)||3
5009407|NCT02271984|12325135|P10|COMPLETED|Washout Period 2 (7 Days)||3
5009408|NCT02271984|12325136|P9|COMPLETED|Washout Period 2 (7 Days)||3
5009409|NCT02271984|12325137|P8|COMPLETED|Washout Period 2 (7 Days)||3
5009410|NCT02271984|12325138|P7|COMPLETED|Washout Period 2 (7 Days)||3
5009411|NCT02271984|12325139|P6|COMPLETED|Washout Period 2 (7 Days)||3
5009412|NCT02271984|12325140|P5|COMPLETED|Washout Period 2 (7 Days)||3
5009413|NCT02271984|12325141|P4|COMPLETED|Washout Period 2 (7 Days)||3
5009414|NCT02271984|12325142|P3|COMPLETED|Washout Period 2 (7 Days)||3
5009415|NCT02271984|12325143|P2|COMPLETED|Washout Period 2 (7 Days)||3
5009416|NCT02271984|12325144|P1|COMPLETED|Washout Period 2 (7 Days)||3
5009417|NCT02271984|12325133|P12|STARTED|Washout Period 2 (7 Days)||3
5009418|NCT02271984|12325134|P11|STARTED|Washout Period 2 (7 Days)||3
5009419|NCT02271984|12325135|P10|STARTED|Washout Period 2 (7 Days)||3
5009420|NCT02271984|12325136|P9|STARTED|Washout Period 2 (7 Days)||3
5009421|NCT02271984|12325137|P8|STARTED|Washout Period 2 (7 Days)||3
5009422|NCT02271984|12325138|P7|STARTED|Washout Period 2 (7 Days)||3
5009423|NCT02271984|12325139|P6|STARTED|Washout Period 2 (7 Days)||3
5009424|NCT02271984|12325140|P5|STARTED|Washout Period 2 (7 Days)||3
5009425|NCT02271984|12325141|P4|STARTED|Washout Period 2 (7 Days)||3
5009426|NCT02271984|12325142|P3|STARTED|Washout Period 2 (7 Days)||3
5009427|NCT02271984|12325143|P2|STARTED|Washout Period 2 (7 Days)||3
5009428|NCT02271984|12325144|P1|STARTED|Washout Period 2 (7 Days)||3
5009429|NCT02271984|12325133|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009430|NCT02271984|12325134|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009431|NCT02271984|12325135|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009432|NCT02271984|12325136|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009433|NCT02271984|12325137|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009434|NCT02271984|12325138|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009435|NCT02271984|12325139|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009436|NCT02271984|12325140|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009437|NCT02271984|12325141|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009438|NCT02271984|12325142|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009439|NCT02271984|12325143|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009440|NCT02271984|12325144|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
5009441|NCT02271984|12325133|P12|COMPLETED|Second Intervention Period (1 Day)||3
5009442|NCT02271984|12325134|P11|COMPLETED|Second Intervention Period (1 Day)||3
5009443|NCT02271984|12325135|P10|COMPLETED|Second Intervention Period (1 Day)||3
5009444|NCT02271984|12325136|P9|COMPLETED|Second Intervention Period (1 Day)||3
5009445|NCT02271984|12325137|P8|COMPLETED|Second Intervention Period (1 Day)||3
5009446|NCT02271984|12325138|P7|COMPLETED|Second Intervention Period (1 Day)||3
5009447|NCT02271984|12325139|P6|COMPLETED|Second Intervention Period (1 Day)||3
5009448|NCT02271984|12325140|P5|COMPLETED|Second Intervention Period (1 Day)||3
5009449|NCT02271984|12325141|P4|COMPLETED|Second Intervention Period (1 Day)||3
5009450|NCT02271984|12325142|P3|COMPLETED|Second Intervention Period (1 Day)||3
5009451|NCT02271984|12325143|P2|COMPLETED|Second Intervention Period (1 Day)||3
5009452|NCT02271984|12325144|P1|COMPLETED|Second Intervention Period (1 Day)||3
5009453|NCT02271984|12325133|P12|STARTED|Second Intervention Period (1 Day)||3
5009454|NCT02271984|12325134|P11|STARTED|Second Intervention Period (1 Day)||3
5009455|NCT02271984|12325135|P10|STARTED|Second Intervention Period (1 Day)||3
5009456|NCT02271984|12325136|P9|STARTED|Second Intervention Period (1 Day)||3
5009457|NCT02271984|12325137|P8|STARTED|Second Intervention Period (1 Day)||3
5009458|NCT02271984|12325138|P7|STARTED|Second Intervention Period (1 Day)||3
5009459|NCT02271984|12325139|P6|STARTED|Second Intervention Period (1 Day)||3
5009460|NCT02271984|12325140|P5|STARTED|Second Intervention Period (1 Day)||3
5009461|NCT02271984|12325141|P4|STARTED|Second Intervention Period (1 Day)||3
5009462|NCT02271984|12325142|P3|STARTED|Second Intervention Period (1 Day)||3
5009463|NCT02271984|12325143|P2|STARTED|Second Intervention Period (1 Day)||3
5009464|NCT02271984|12325144|P1|STARTED|Second Intervention Period (1 Day)||3
5009465|NCT02271984|12325133|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009466|NCT02271984|12325134|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009467|NCT02271984|12325135|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009468|NCT02271984|12325136|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009469|NCT02271984|12325137|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009470|NCT02271984|12325138|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009471|NCT02271984|12325139|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009472|NCT02271984|12325140|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009473|NCT02271984|12325141|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009474|NCT02271984|12325142|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009475|NCT02271984|12325143|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009476|NCT02271984|12325144|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5009477|NCT02271984|12325133|P12|COMPLETED|Washout Period 1 (7 Days)||3
5009478|NCT02271984|12325134|P11|COMPLETED|Washout Period 1 (7 Days)||3
5009479|NCT02271984|12325135|P10|COMPLETED|Washout Period 1 (7 Days)||3
5009480|NCT02271984|12325136|P9|COMPLETED|Washout Period 1 (7 Days)||3
5009481|NCT02271984|12325137|P8|COMPLETED|Washout Period 1 (7 Days)||3
5009482|NCT02271984|12325138|P7|COMPLETED|Washout Period 1 (7 Days)||3
5009483|NCT02271984|12325139|P6|COMPLETED|Washout Period 1 (7 Days)||3
5009484|NCT02271984|12325140|P5|COMPLETED|Washout Period 1 (7 Days)||3
5009485|NCT02271984|12325141|P4|COMPLETED|Washout Period 1 (7 Days)||3
5009486|NCT02271984|12325142|P3|COMPLETED|Washout Period 1 (7 Days)||3
5009487|NCT02271984|12325143|P2|COMPLETED|Washout Period 1 (7 Days)||3
5009488|NCT02271984|12325144|P1|COMPLETED|Washout Period 1 (7 Days)||3
5009489|NCT02271984|12325133|P12|STARTED|Washout Period 1 (7 Days)||3
5009490|NCT02271984|12325134|P11|STARTED|Washout Period 1 (7 Days)||3
5009491|NCT02271984|12325135|P10|STARTED|Washout Period 1 (7 Days)||3
5009492|NCT02271984|12325136|P9|STARTED|Washout Period 1 (7 Days)||3
5009493|NCT02271984|12325137|P8|STARTED|Washout Period 1 (7 Days)||3
5009494|NCT02271984|12325138|P7|STARTED|Washout Period 1 (7 Days)||3
5009495|NCT02271984|12325139|P6|STARTED|Washout Period 1 (7 Days)||3
5009496|NCT02271984|12325140|P5|STARTED|Washout Period 1 (7 Days)||3
5009497|NCT02271984|12325141|P4|STARTED|Washout Period 1 (7 Days)||3
5009498|NCT02271984|12325142|P3|STARTED|Washout Period 1 (7 Days)||3
5009499|NCT02271984|12325143|P2|STARTED|Washout Period 1 (7 Days)||3
5009500|NCT02271984|12325144|P1|STARTED|Washout Period 1 (7 Days)||3
5009501|NCT02271984|12325133|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
5009502|NCT02271984|12325134|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
5009503|NCT02271984|12325135|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
5009504|NCT02271984|12325136|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
5009505|NCT02271984|12325137|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
5009506|NCT02271984|12325138|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
5009507|NCT02271984|12325139|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
5009508|NCT02271984|12325140|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
5009509|NCT02271984|12325141|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
5009510|NCT02271984|12325142|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
5009511|NCT02271984|12325143|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
5009512|NCT02271984|12325144|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
5009513|NCT02271984|12325133|P12|COMPLETED|First Intervention Period (1 Day)||3
5009514|NCT02271984|12325134|P11|COMPLETED|First Intervention Period (1 Day)||3
5009515|NCT02271984|12325135|P10|COMPLETED|First Intervention Period (1 Day)||3
5009516|NCT02271984|12325136|P9|COMPLETED|First Intervention Period (1 Day)||3
5009517|NCT02271984|12325137|P8|COMPLETED|First Intervention Period (1 Day)||3
5009518|NCT02271984|12325138|P7|COMPLETED|First Intervention Period (1 Day)||3
5009519|NCT02271984|12325139|P6|COMPLETED|First Intervention Period (1 Day)||3
5009520|NCT02271984|12325140|P5|COMPLETED|First Intervention Period (1 Day)||3
5009521|NCT02271984|12325141|P4|COMPLETED|First Intervention Period (1 Day)||3
5009522|NCT02271984|12325142|P3|COMPLETED|First Intervention Period (1 Day)||3
5009523|NCT02271984|12325143|P2|COMPLETED|First Intervention Period (1 Day)||3
5009524|NCT02271984|12325144|P1|COMPLETED|First Intervention Period (1 Day)||3
5009525|NCT02271984|12325133|P12|STARTED|First Intervention Period (1 Day)||3
5009526|NCT02271984|12325134|P11|STARTED|First Intervention Period (1 Day)||3
5009527|NCT02271984|12325135|P10|STARTED|First Intervention Period (1 Day)||3
5009528|NCT02271984|12325136|P9|STARTED|First Intervention Period (1 Day)||3
5009529|NCT02271984|12325137|P8|STARTED|First Intervention Period (1 Day)||3
5009530|NCT02271984|12325138|P7|STARTED|First Intervention Period (1 Day)||3
5009531|NCT02271984|12325139|P6|STARTED|First Intervention Period (1 Day)||3
5009532|NCT02271984|12325140|P5|STARTED|First Intervention Period (1 Day)||3
5009533|NCT02271984|12325141|P4|STARTED|First Intervention Period (1 Day)||3
5009534|NCT02271984|12325142|P3|STARTED|First Intervention Period (1 Day)||3
5009535|NCT02271984|12325143|P2|STARTED|First Intervention Period (1 Day)||3
5009536|NCT02271984|12325144|P1|STARTED|First Intervention Period (1 Day)||3
5009537|NCT02271945|12325233|P2|NOT COMPLETED|Overall Study||5
5009538|NCT02271945|12325234|P1|NOT COMPLETED|Overall Study||5
5009539|NCT02271945|12325233|P2|COMPLETED|Overall Study||0
5009540|NCT02271945|12325234|P1|COMPLETED|Overall Study||0
5009541|NCT02271945|12325233|P2|STARTED|Overall Study||5
5009542|NCT02271945|12325234|P1|STARTED|Overall Study||5
5009543|NCT02271906|12325270|P1|NOT COMPLETED|Overall Study||0
5009544|NCT02271906|12325270|P1|COMPLETED|Overall Study||2
5009545|NCT02271906|12325270|P1|STARTED|Overall Study||2
5009546|NCT02271880|12325277|P2|NOT COMPLETED|Overall Study||4
5009547|NCT02271880|12325278|P1|NOT COMPLETED|Overall Study||3
5009548|NCT02271880|12325277|P2|COMPLETED|Overall Study||0
5009549|NCT02271880|12325278|P1|COMPLETED|Overall Study||0
5009550|NCT02271880|12325277|P2|STARTED|Overall Study||4
5009551|NCT02271880|12325278|P1|STARTED|Overall Study||3
5009552|NCT02271854|12325308|P1|NOT COMPLETED|Overall Study||4
5009553|NCT02271854|12325308|P1|COMPLETED|Overall Study||98
5009554|NCT02271854|12325308|P1|STARTED|Overall Study||102
5009555|NCT02271698|12325319|P4|NOT COMPLETED|Overall Study||0
5009556|NCT02271698|12325320|P3|NOT COMPLETED|Overall Study||0
5009557|NCT02271698|12325321|P2|NOT COMPLETED|Overall Study||0
5009558|NCT02271698|12325322|P1|NOT COMPLETED|Overall Study||0
5009559|NCT02271698|12325319|P4|COMPLETED|Overall Study||11
5009560|NCT02271698|12325320|P3|COMPLETED|Overall Study||10
5009561|NCT02271698|12325321|P2|COMPLETED|Overall Study||10
5009562|NCT02271698|12325322|P1|COMPLETED|Overall Study||11
5009563|NCT02271698|12325319|P4|STARTED|Overall Study||11
5009564|NCT02271698|12325320|P3|STARTED|Overall Study||10
5009565|NCT02271698|12325321|P2|STARTED|Overall Study||10
5009566|NCT02271698|12325322|P1|STARTED|Overall Study||11
5009567|NCT02271529|12325348|P1|NOT COMPLETED|Overall Study||1
5009568|NCT02271529|12325348|P1|COMPLETED|Overall Study||39
5009569|NCT02271529|12325348|P1|STARTED|Overall Study||40
5009570|NCT02271477|12325354|P2|NOT COMPLETED|Overall Study||0
5009571|NCT02271477|12325355|P1|NOT COMPLETED|Overall Study||0
5009572|NCT02271477|12325354|P2|COMPLETED|Overall Study||80
5009573|NCT02271477|12325355|P1|COMPLETED|Overall Study||80
5009574|NCT02271477|12325354|P2|STARTED|Overall Study||80
5009575|NCT02271477|12325355|P1|STARTED|Overall Study||80
5009576|NCT02271451|12325369|P2|NOT COMPLETED|Overall Study||1
5009577|NCT02271451|12325370|P1|NOT COMPLETED|Overall Study||0
5009578|NCT02271451|12325369|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
5009579|NCT02271451|12325370|P1|COMPLETED|Overall Study||7
5009580|NCT02271451|12325369|P2|STARTED|Overall Study||8
5009581|NCT02271451|12325370|P1|STARTED|Overall Study||7
5009582|NCT02271425|12325376|P1|NOT COMPLETED|Overall Study||0
5009583|NCT02271425|12325376|P1|COMPLETED|Overall Study||8
5009584|NCT02271425|12325376|P1|STARTED|Overall Study||8
5009585|NCT02271386|12325385|P4|NOT COMPLETED|Intervention Period- 8 Months||0
5009586|NCT02271386|12325386|P3|NOT COMPLETED|Intervention Period- 8 Months||0
5009587|NCT02271386|12325387|P2|NOT COMPLETED|Intervention Period- 8 Months||0
5009588|NCT02271386|12325388|P1|NOT COMPLETED|Intervention Period- 8 Months||0
5009589|NCT02271386|12325385|P4|COMPLETED|Intervention Period- 8 Months||197
5009590|NCT02271386|12325386|P3|COMPLETED|Intervention Period- 8 Months||202
5009591|NCT02271386|12325387|P2|COMPLETED|Intervention Period- 8 Months||52
5009592|NCT02271386|12325388|P1|COMPLETED|Intervention Period- 8 Months||53
5009593|NCT02271386|12325385|P4|STARTED|Intervention Period- 8 Months||197
5009594|NCT02271386|12325386|P3|STARTED|Intervention Period- 8 Months||202
5009595|NCT02271386|12325387|P2|STARTED|Intervention Period- 8 Months||52
5009596|NCT02271386|12325388|P1|STARTED|Intervention Period- 8 Months||53
5009597|NCT02271386|12325385|P4|NOT COMPLETED|Baseline Period- 8 Months||0
5009598|NCT02271386|12325386|P3|NOT COMPLETED|Baseline Period- 8 Months||0
5009599|NCT02271386|12325387|P2|NOT COMPLETED|Baseline Period- 8 Months||0
5009600|NCT02271386|12325388|P1|NOT COMPLETED|Baseline Period- 8 Months||0
5009601|NCT02271386|12325385|P4|COMPLETED|Baseline Period- 8 Months||191
5009602|NCT02271386|12325386|P3|COMPLETED|Baseline Period- 8 Months||200
5009603|NCT02271386|12325387|P2|COMPLETED|Baseline Period- 8 Months||52
5009604|NCT02271386|12325388|P1|COMPLETED|Baseline Period- 8 Months||53
5009605|NCT02271386|12325385|P4|STARTED|Baseline Period- 8 Months||191
5009606|NCT02271386|12325386|P3|STARTED|Baseline Period- 8 Months||200
5009607|NCT02271386|12325387|P2|STARTED|Baseline Period- 8 Months||52
5009608|NCT02271386|12325388|P1|STARTED|Baseline Period- 8 Months||53
5009609|NCT02271217|12325453|P3|NOT COMPLETED|Overall Study||12
5009610|NCT02271217|12325454|P2|NOT COMPLETED|Overall Study||13
5009611|NCT02271217|12325455|P1|NOT COMPLETED|Overall Study||11
5009612|NCT02271217|12325453|P3|COMPLETED|Overall Study||113
5009613|NCT02271217|12325454|P2|COMPLETED|Overall Study||113
5009614|NCT02271217|12325455|P1|COMPLETED|Overall Study||115
5009615|NCT02271217|12325453|P3|STARTED|Overall Study||125
5009616|NCT02271217|12325454|P2|STARTED|Overall Study||126
5009617|NCT02271217|12325455|P1|STARTED|Overall Study||126
5009618|NCT02270983|12325469|P3|NOT COMPLETED|Overall Study||12
5009619|NCT02270983|12325470|P2|NOT COMPLETED|Overall Study||7
5009620|NCT02270983|12325471|P1|NOT COMPLETED|Overall Study||9
5009621|NCT02270983|12325469|P3|COMPLETED|Overall Study||76
5009622|NCT02270983|12325470|P2|COMPLETED|Overall Study||80
5009623|NCT02270983|12325471|P1|COMPLETED|Overall Study||70
5009624|NCT02270983|12325469|P3|STARTED|Overall Study||88
5009625|NCT02270983|12325470|P2|STARTED|Overall Study||87
5009626|NCT02270983|12325471|P1|STARTED|Overall Study||79
5009627|NCT02270944|12325496|P2|NOT COMPLETED|Overall Study||5
5009628|NCT02270944|12325497|P1|NOT COMPLETED|Overall Study||11
5009629|NCT02270944|12325496|P2|COMPLETED|Overall Study||516
5009630|NCT02270944|12325497|P1|COMPLETED|Overall Study||518
5009631|NCT02270944|12325496|P2|STARTED|Overall Study||521
5009632|NCT02270944|12325497|P1|STARTED|Overall Study||529
5009633|NCT02270684|12325515|P2|NOT COMPLETED|Overall Study||3
5009634|NCT02270684|12325516|P1|NOT COMPLETED|Overall Study||1
5009635|NCT02270684|12325515|P2|COMPLETED|Overall Study||0
5009636|NCT02270684|12325516|P1|COMPLETED|Overall Study||0
5009637|NCT02270684|12325515|P2|STARTED|Overall Study||3
5009638|NCT02270684|12325516|P1|STARTED|Overall Study||1
5009639|NCT02270671|12325524|P2|NOT COMPLETED|Overall Study||5
5009640|NCT02270671|12325525|P1|NOT COMPLETED|Overall Study||5
5009641|NCT02270671|12325524|P2|COMPLETED|Overall Study||61
5009642|NCT02270671|12325525|P1|COMPLETED|Overall Study||59
5009643|NCT02270671|12325524|P2|STARTED|Overall Study||66
5009644|NCT02270671|12325525|P1|STARTED|Overall Study||64
5009645|NCT02270645|12325541|P2|NOT COMPLETED|Overall Study||0
5009646|NCT02270645|12325542|P1|NOT COMPLETED|Overall Study||2
5009647|NCT02270645|12325541|P2|COMPLETED|Overall Study||4
5009648|NCT02270645|12325542|P1|COMPLETED|Overall Study||6
5009649|NCT02270645|12325541|P2|STARTED|Overall Study||4
5009650|NCT02270645|12325542|P1|STARTED|Overall Study||8
5009651|NCT02270515|12325550|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
5009652|NCT02270515|12325550|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
5009653|NCT02270515|12325550|P1|STARTED|Intervention Period 3: 12-18 Months||127
5009654|NCT02270515|12325550|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
5009655|NCT02270515|12325550|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
5009656|NCT02270515|12325550|P1|STARTED|Intervention Period 2: 6-12 Months||159
5009657|NCT02270515|12325550|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
5009658|NCT02270515|12325550|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
5009659|NCT02270515|12325550|P1|STARTED|Intervention Period 1: 0-6 Months||175
5009660|NCT02270255|12325567|P2|NOT COMPLETED|Overall Study||0
5009661|NCT02270255|12325568|P1|NOT COMPLETED|Overall Study||1
5009662|NCT02270255|12325567|P2|COMPLETED|Overall Study||22
5009663|NCT02270255|12325568|P1|COMPLETED|Overall Study||21
5009664|NCT02270255|12325567|P2|Complete Data From Home Survey|Overall Study||22
5009665|NCT02270255|12325568|P1|Complete Data From Home Survey|Overall Study||21
5009666|NCT02270255|12325567|P2|Complete Data at Discharge PACU|Overall Study||22
5009667|NCT02270255|12325568|P1|Complete Data at Discharge PACU|Overall Study||22
5009668|NCT02270255|12325567|P2|STARTED|Overall Study||22
5009669|NCT02270255|12325568|P1|STARTED|Overall Study||22
5009670|NCT02270060|12325579|P3|NOT COMPLETED|Overall Study||0
5009671|NCT02270060|12325580|P2|NOT COMPLETED|Overall Study||0
5009672|NCT02270060|12325581|P1|NOT COMPLETED|Overall Study||0
5009673|NCT02270060|12325579|P3|COMPLETED|Overall Study||20
5009674|NCT02270060|12325580|P2|COMPLETED|Overall Study||20
5009675|NCT02270060|12325581|P1|COMPLETED|Overall Study||20
5009676|NCT02270060|12325579|P3|STARTED|Overall Study||20
5009677|NCT02270060|12325580|P2|STARTED|Overall Study||20
5009678|NCT02270060|12325581|P1|STARTED|Overall Study||20
5009679|NCT02269943|12325609|P2|NOT COMPLETED|Follow-Up Survival Period||26
5009680|NCT02269943|12325610|P1|NOT COMPLETED|Follow-Up Survival Period||5
5009681|NCT02269943|12325609|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
5009682|NCT02269943|12325610|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
5009683|NCT02269943|12325609|P2|STARTED|Follow-Up Survival Period||26
5009684|NCT02269943|12325610|P1|STARTED|Follow-Up Survival Period||5
5009685|NCT02269943|12325609|P2|NOT COMPLETED|Treatment Period||30
5009686|NCT02269943|12325610|P1|NOT COMPLETED|Treatment Period||6
5009687|NCT02269943|12325609|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
5009688|NCT02269943|12325610|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
5009689|NCT02269943|12325609|P2|Investigational Product (IP) Stopped|Treatment Period||30
5009690|NCT02269943|12325610|P1|Investigational Product (IP) Stopped|Treatment Period||6
5009691|NCT02269943|12325609|P2|STARTED|Treatment Period||30
5009692|NCT02269943|12325610|P1|STARTED|Treatment Period||6
5009693|NCT02269917|12325640|P2|NOT COMPLETED|Overall Study||383
5009694|NCT02269917|12325641|P1|NOT COMPLETED|Overall Study||766
5009695|NCT02269917|12325640|P2|COMPLETED|Overall Study||0
5009696|NCT02269917|12325641|P1|COMPLETED|Overall Study||0
5009697|NCT02269917|12325640|P2|Treated|Overall Study||378
5009698|NCT02269917|12325641|P1|Treated|Overall Study||763
5009699|NCT02269917|12325640|P2|STARTED|Overall Study||383
5009700|NCT02269917|12325641|P1|STARTED|Overall Study||766
5009701|NCT02269787|12325694|P2|NOT COMPLETED|Overall Study||10
5009702|NCT02269787|12325695|P1|NOT COMPLETED|Overall Study||22
5009703|NCT02269787|12325694|P2|COMPLETED|Overall Study||140
5009704|NCT02269787|12325695|P1|COMPLETED|Overall Study||126
5009705|NCT02269787|12325694|P2|STARTED|Overall Study||150
5009706|NCT02269787|12325695|P1|STARTED|Overall Study||148
5009707|NCT02269709|12325701|P1|NOT COMPLETED|Six Month Follow-up||12
5009708|NCT02269709|12325701|P1|COMPLETED|Six Month Follow-up||5
5009709|NCT02269709|12325701|P1|STARTED|Six Month Follow-up||17
5009710|NCT02269709|12325701|P1|NOT COMPLETED|Prior to Hospital Discharge||0
5009711|NCT02269709|12325701|P1|COMPLETED|Prior to Hospital Discharge||17
5009712|NCT02269709|12325701|P1|STARTED|Prior to Hospital Discharge||17
5009713|NCT02269709|12325701|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
5009714|NCT02269709|12325701|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
5009715|NCT02269709|12325701|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
5009716|NCT02269709|12325701|P1|NOT COMPLETED|Time of Enrollment||3
5009717|NCT02269709|12325701|P1|COMPLETED|Time of Enrollment||18
5009718|NCT02269709|12325701|P1|STARTED|Time of Enrollment||21
5009719|NCT02269657|12325706|P1|NOT COMPLETED|Overall Study||3
5009720|NCT02269657|12325706|P1|COMPLETED|Overall Study||37
5009721|NCT02269657|12325706|P1|STARTED|Overall Study||40
5009722|NCT02269631|12325722|P2|NOT COMPLETED|Overall Study||0
5009723|NCT02269631|12325723|P1|NOT COMPLETED|Overall Study||0
5009724|NCT02269631|12325722|P2|COMPLETED|Overall Study||5
5009725|NCT02269631|12325723|P1|COMPLETED|Overall Study||7
5009726|NCT02269631|12325722|P2|STARTED|Overall Study||5
5009727|NCT02269631|12325723|P1|STARTED|Overall Study||7
5009728|NCT02269488|12325737|P1|NOT COMPLETED|Overall Study||0
5009729|NCT02269488|12325737|P1|COMPLETED|Overall Study||100
5009730|NCT02269488|12325737|P1|STARTED|Overall Study||100
5009731|NCT02269475|12325743|P2|NOT COMPLETED|Overall Study||1
5009732|NCT02269475|12325744|P1|NOT COMPLETED|Overall Study||3
5009733|NCT02269475|12325743|P2|COMPLETED|Overall Study||432
5009734|NCT02269475|12325744|P1|COMPLETED|Overall Study||865
5009735|NCT02269475|12325743|P2|Per Protocol Population|Overall Study||430
5009736|NCT02269475|12325744|P1|Per Protocol Population|Overall Study||849
5009737|NCT02269475|12325743|P2|Received IP (Safety Population)|Overall Study||433
5009738|NCT02269475|12325744|P1|Received IP (Safety Population)|Overall Study||868
5009739|NCT02269475|12325743|P2|STARTED|Overall Study||433
5009740|NCT02269475|12325744|P1|STARTED|Overall Study||868
5009741|NCT02269423|12325759|P4|NOT COMPLETED|Overall Study||1
5009742|NCT02269423|12325760|P3|NOT COMPLETED|Overall Study||0
5009743|NCT02269423|12325761|P2|NOT COMPLETED|Overall Study||1
5009744|NCT02269423|12325762|P1|NOT COMPLETED|Overall Study||0
5009745|NCT02269423|12325759|P4|COMPLETED|Overall Study||8
5009746|NCT02269423|12325760|P3|COMPLETED|Overall Study||10
5009747|NCT02269423|12325761|P2|COMPLETED|Overall Study||9
5009748|NCT02269423|12325762|P1|COMPLETED|Overall Study||10
5009749|NCT02269423|12325759|P4|STARTED|Overall Study||9
5009750|NCT02269423|12325760|P3|STARTED|Overall Study||10
5009751|NCT02269423|12325761|P2|STARTED|Overall Study||10
5009752|NCT02269423|12325762|P1|STARTED|Overall Study||10
5009753|NCT02269241|12325824|P1|NOT COMPLETED|Overall Study||1200
5009754|NCT02269241|12325824|P1|COMPLETED|Overall Study||352
5009755|NCT02269241|12325824|P1|STARTED|Overall Study||1552
5009756|NCT02269098|12325838|P2|NOT COMPLETED|Overall Study||9
5009757|NCT02269098|12325839|P1|NOT COMPLETED|Overall Study||14
5009758|NCT02269098|12325838|P2|COMPLETED|Overall Study||41
5009759|NCT02269098|12325839|P1|COMPLETED|Overall Study||37
5009760|NCT02269098|12325838|P2|STARTED|Overall Study||50
5009761|NCT02269098|12325839|P1|STARTED|Overall Study||51
5009762|NCT02268994|12325855|P2|NOT COMPLETED|Overall Study||35
5009763|NCT02268994|12325856|P1|NOT COMPLETED|Overall Study||31
5009764|NCT02268994|12325855|P2|COMPLETED|Overall Study||81
5009765|NCT02268994|12325856|P1|COMPLETED|Overall Study||86
5009766|NCT02268994|12325855|P2|STARTED|Overall Study||116
5009767|NCT02268994|12325856|P1|STARTED|Overall Study||117
5009768|NCT02268955|12325874|P2|NOT COMPLETED|Overall Study||2
5009769|NCT02268955|12325875|P1|NOT COMPLETED|Overall Study||2
5009770|NCT02268955|12325874|P2|COMPLETED|Overall Study||9
5009771|NCT02268955|12325875|P1|COMPLETED|Overall Study||9
5009772|NCT02268955|12325874|P2|STARTED|Overall Study||11
5009773|NCT02268955|12325875|P1|STARTED|Overall Study||11
5009774|NCT02268942|12325881|P1|NOT COMPLETED|Overall Study||0
5009775|NCT02268942|12325881|P1|COMPLETED|Overall Study||144
5009776|NCT02268942|12325881|P1|STARTED|Overall Study||144
5009777|NCT02268877|12325888|P2|NOT COMPLETED|Overall Study||5
5009778|NCT02268877|12325889|P1|NOT COMPLETED|Overall Study||4
5009779|NCT02268877|12325888|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
5009780|NCT02268877|12325889|P1|COMPLETED|Overall Study||118
5009781|NCT02268877|12325888|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
5009782|NCT02268877|12325889|P1|STARTED|Overall Study||122
5009783|NCT02268864|12325900|P3|NOT COMPLETED|Overall Study||0
5009784|NCT02268864|12325901|P2|NOT COMPLETED|Overall Study||1
5009785|NCT02268864|12325902|P1|NOT COMPLETED|Overall Study||2
5009786|NCT02268864|12325900|P3|COMPLETED|Overall Study||64
5009787|NCT02268864|12325901|P2|COMPLETED|Overall Study||24
5009788|NCT02268864|12325902|P1|COMPLETED|Overall Study||15
5009789|NCT02268864|12325900|P3|STARTED|Overall Study||64
5009790|NCT02268864|12325901|P2|STARTED|Overall Study||25
5009791|NCT02268864|12325902|P1|STARTED|Overall Study||17
5009792|NCT02268851|12325930|P6|NOT COMPLETED|Overall Study||11
5009793|NCT02268851|12325931|P5|NOT COMPLETED|Overall Study||7
5009794|NCT02268851|12325932|P4|NOT COMPLETED|Overall Study||3
5009795|NCT02268851|12325933|P3|NOT COMPLETED|Overall Study||1
5009796|NCT02268851|12325934|P2|NOT COMPLETED|Overall Study||3
5009797|NCT02268851|12325935|P1|NOT COMPLETED|Overall Study||1
5009798|NCT02268851|12325930|P6|COMPLETED|Overall Study||4
5009799|NCT02268851|12325931|P5|COMPLETED|Overall Study||8
5009800|NCT02268851|12325932|P4|COMPLETED|Overall Study||0
5009801|NCT02268851|12325933|P3|COMPLETED|Overall Study||3
5009802|NCT02268851|12325934|P2|COMPLETED|Overall Study||0
5009803|NCT02268851|12325935|P1|COMPLETED|Overall Study||2
5009804|NCT02268851|12325930|P6|STARTED|Overall Study||15
5009805|NCT02268851|12325931|P5|STARTED|Overall Study||15
5009806|NCT02268851|12325932|P4|STARTED|Overall Study||3
5009807|NCT02268851|12325933|P3|STARTED|Overall Study||4
5009808|NCT02268851|12325934|P2|STARTED|Overall Study||3
5009809|NCT02268851|12325935|P1|STARTED|Overall Study||3
5009810|NCT02268812|12325953|P4|NOT COMPLETED|Overall Study||14
5009811|NCT02268812|12325954|P3|NOT COMPLETED|Overall Study||9
5009812|NCT02268812|12325955|P2|NOT COMPLETED|Overall Study||32
5009813|NCT02268812|12325956|P1|NOT COMPLETED|Overall Study||16
5009814|NCT02268812|12325953|P4|COMPLETED|Overall Study||26
5009815|NCT02268812|12325954|P3|COMPLETED|Overall Study||21
5009816|NCT02268812|12325955|P2|COMPLETED|Overall Study||40
5009817|NCT02268812|12325956|P1|COMPLETED|Overall Study||61
5009818|NCT02268812|12325953|P4|STARTED|Overall Study||40
5009819|NCT02268812|12325954|P3|STARTED|Overall Study||30
5009820|NCT02268812|12325955|P2|STARTED|Overall Study||72
5009821|NCT02268812|12325956|P1|STARTED|Overall Study||77
5009822|NCT02268786|12325988|P2|NOT COMPLETED|Overall Study||18
5009823|NCT02268786|12325989|P1|NOT COMPLETED|Overall Study||56
5009824|NCT02268786|12325988|P2|COMPLETED|Overall Study||313
5009825|NCT02268786|12325989|P1|COMPLETED|Overall Study||274
5009826|NCT02268786|12325988|P2|STARTED|Overall Study||331
5009827|NCT02268786|12325989|P1|STARTED|Overall Study||330
5009828|NCT02268526|12325998|P3|NOT COMPLETED|Overall Study||5
5009829|NCT02268526|12325999|P2|NOT COMPLETED|Overall Study||21
5009830|NCT02268526|12326000|P1|NOT COMPLETED|Overall Study||1
5009831|NCT02268526|12325998|P3|COMPLETED|Overall Study||16
5009832|NCT02268526|12325999|P2|COMPLETED|Overall Study||38
5009833|NCT02268526|12326000|P1|COMPLETED|Overall Study||5
5009834|NCT02268526|12325998|P3|PD Analysis Set (Cohort 2)|Overall Study||17
5009835|NCT02268526|12325999|P2|PD Analysis Set (Cohort 2)|Overall Study||42
5009836|NCT02268526|12326000|P1|PD Analysis Set (Cohort 2)|Overall Study||0
5009837|NCT02268526|12325998|P3|STARTED|Overall Study||21
5009838|NCT02268526|12325999|P2|STARTED|Overall Study||59
5009839|NCT02268526|12326000|P1|STARTED|Overall Study||6
5009840|NCT02268396|12326021|P1|NOT COMPLETED|Overall Study||12
5009841|NCT02268396|12326021|P1|COMPLETED|Overall Study||126
5009842|NCT02268396|12326021|P1|STARTED|Overall Study||138
5009843|NCT02268214|12326033|P3|NOT COMPLETED|Overall Study||42
5009844|NCT02268214|12326034|P2|NOT COMPLETED|Overall Study||41
5009845|NCT02268214|12326035|P1|NOT COMPLETED|Overall Study||42
5009846|NCT02268214|12326033|P3|COMPLETED|Overall Study||218
5009847|NCT02268214|12326034|P2|COMPLETED|Overall Study||255
5009848|NCT02268214|12326035|P1|COMPLETED|Overall Study||235
5009849|NCT02268214|12326033|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
5009850|NCT02268214|12326034|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
5009851|NCT02268214|12326035|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
5009852|NCT02268214|12326033|P3|STARTED|Overall Study||260
5009853|NCT02268214|12326034|P2|STARTED|Overall Study||296
5009854|NCT02268214|12326035|P1|STARTED|Overall Study||277
5009855|NCT02268175|12326063|P2|NOT COMPLETED|Overall Study||0
5009856|NCT02268175|12326064|P1|NOT COMPLETED|Overall Study||0
5009857|NCT02268175|12326063|P2|COMPLETED|Overall Study||25
5009858|NCT02268175|12326064|P1|COMPLETED|Overall Study||50
5009859|NCT02268175|12326063|P2|STARTED|Overall Study||25
5009860|NCT02268175|12326064|P1|STARTED|Overall Study||50
5009861|NCT02268058|12326082|P4|NOT COMPLETED|Overall Study||0
5009862|NCT02268058|12326083|P3|NOT COMPLETED|Overall Study||0
5009863|NCT02268058|12326084|P2|NOT COMPLETED|Overall Study||0
5009864|NCT02268058|12326085|P1|NOT COMPLETED|Overall Study||1
5009865|NCT02268058|12326082|P4|COMPLETED|Overall Study||20
5009866|NCT02268058|12326083|P3|COMPLETED|Overall Study||20
5009867|NCT02268058|12326084|P2|COMPLETED|Overall Study||20
5009868|NCT02268058|12326085|P1|COMPLETED|Overall Study||19
5009869|NCT02268058|12326082|P4|STARTED|Overall Study||20
5009870|NCT02268058|12326083|P3|STARTED|Overall Study||20
5009871|NCT02268058|12326084|P2|STARTED|Overall Study||20
5009872|NCT02268058|12326085|P1|STARTED|Overall Study||20
5009873|NCT02268045|12326109|P2|NOT COMPLETED|Overall Study||20
5009874|NCT02268045|12326110|P1|NOT COMPLETED|Overall Study||16
5009875|NCT02268045|12326109|P2|COMPLETED|Overall Study||116
5009876|NCT02268045|12326110|P1|COMPLETED|Overall Study||120
5009877|NCT02268045|12326109|P2|STARTED|Overall Study||136
5009878|NCT02268045|12326110|P1|STARTED|Overall Study||136
5009879|NCT02267850|12326134|P2|NOT COMPLETED|Overall Study||2
5009880|NCT02267850|12326135|P1|NOT COMPLETED|Overall Study||1
5009881|NCT02267850|12326134|P2|COMPLETED|Overall Study||12
5009882|NCT02267850|12326135|P1|COMPLETED|Overall Study||14
5009883|NCT02267850|12326134|P2|STARTED|Overall Study||14
5009884|NCT02267850|12326135|P1|STARTED|Overall Study||15
5009885|NCT02267837|12326143|P2|NOT COMPLETED|Overall Study||0
5009886|NCT02267837|12326144|P1|NOT COMPLETED|Overall Study||0
5009887|NCT02267837|12326143|P2|COMPLETED|Overall Study||9
5009888|NCT02267837|12326144|P1|COMPLETED|Overall Study||11
5009889|NCT02267837|12326143|P2|STARTED|Overall Study||9
5009890|NCT02267837|12326144|P1|STARTED|Overall Study||11
5009891|NCT02267824|12326152|P2|NOT COMPLETED|Overall Study||1
5009892|NCT02267824|12326153|P1|NOT COMPLETED|Overall Study||10
5009893|NCT02267824|12326152|P2|COMPLETED|Overall Study||17
5009894|NCT02267824|12326153|P1|COMPLETED|Overall Study||73
5009895|NCT02267824|12326152|P2|STARTED|Overall Study||18
5009896|NCT02267824|12326153|P1|STARTED|Overall Study||83
5009897|NCT02267811|12326161|P2|NOT COMPLETED|Overall Study||2
5009898|NCT02267811|12326162|P1|NOT COMPLETED|Overall Study||1
5009899|NCT02267811|12326161|P2|COMPLETED|Overall Study||15
5009900|NCT02267811|12326162|P1|COMPLETED|Overall Study||15
5009901|NCT02267811|12326161|P2|STARTED|Overall Study||17
5009902|NCT02267811|12326162|P1|STARTED|Overall Study||16
5009903|NCT02267746|12326175|P3|NOT COMPLETED|Overall Study||21
5009904|NCT02267746|12326176|P2|NOT COMPLETED|Overall Study||22
5009905|NCT02267746|12326177|P1|NOT COMPLETED|Overall Study||21
5009906|NCT02267746|12326175|P3|COMPLETED|Overall Study||278
5009907|NCT02267746|12326176|P2|COMPLETED|Overall Study||274
5009908|NCT02267746|12326177|P1|COMPLETED|Overall Study||277
5009909|NCT02267746|12326175|P3|STARTED|Overall Study||299
5009910|NCT02267746|12326176|P2|STARTED|Overall Study||296
5009911|NCT02267746|12326177|P1|STARTED|Overall Study||298
5009912|NCT02267629|12326191|P1|NOT COMPLETED|Overall Study||0
5009913|NCT02267629|12326191|P1|COMPLETED|Overall Study||7
5009914|NCT02267629|12326191|P1|STARTED|Overall Study||7
5009915|NCT02267603|12326196|P1|NOT COMPLETED|Overall Study||44
5009916|NCT02267603|12326196|P1|COMPLETED|Overall Study||6
5009917|NCT02267603|12326196|P1|STARTED|Overall Study||50
5009918|NCT02267577|12326200|P1|NOT COMPLETED|Overall Study||4
5009919|NCT02267577|12326200|P1|COMPLETED|Overall Study||81
5009920|NCT02267577|12326200|P1|STARTED|Overall Study||85
5009921|NCT02267538|12326207|P2|NOT COMPLETED|Overall Study||0
5009922|NCT02267538|12326208|P1|NOT COMPLETED|Overall Study||0
5009923|NCT02267538|12326207|P2|COMPLETED|Overall Study||143
5009924|NCT02267538|12326208|P1|COMPLETED|Overall Study||142
5009925|NCT02267538|12326207|P2|STARTED|Overall Study||143
5009926|NCT02267538|12326208|P1|STARTED|Overall Study||142
5009927|NCT02267447|12326228|P2|NOT COMPLETED|Overall Study||0
5009928|NCT02267447|12326229|P1|NOT COMPLETED|Overall Study||0
5009929|NCT02267447|12326228|P2|COMPLETED|Overall Study||26968
5009930|NCT02267447|12326229|P1|COMPLETED|Overall Study||77251
5009931|NCT02267447|12326228|P2|STARTED|Overall Study||26968
5009932|NCT02267447|12326229|P1|STARTED|Overall Study||77251
5009933|NCT02267382|12326242|P5|NOT COMPLETED|Overall Study||7
5009934|NCT02267382|12326243|P4|NOT COMPLETED|Overall Study||6
5009935|NCT02267382|12326244|P3|NOT COMPLETED|Overall Study||9
5009936|NCT02267382|12326245|P2|NOT COMPLETED|Overall Study||10
5009937|NCT02267382|12326246|P1|NOT COMPLETED|Overall Study||7
5009938|NCT02267382|12326242|P5|COMPLETED|Overall Study||39
5009939|NCT02267382|12326243|P4|COMPLETED|Overall Study||35
5009940|NCT02267382|12326244|P3|COMPLETED|Overall Study||34
5009941|NCT02267382|12326245|P2|COMPLETED|Overall Study||33
5009942|NCT02267382|12326246|P1|COMPLETED|Overall Study||35
5009943|NCT02267382|12326242|P5|STARTED|Overall Study||46
5009944|NCT02267382|12326243|P4|STARTED|Overall Study||41
5009945|NCT02267382|12326244|P3|STARTED|Overall Study||43
5009946|NCT02267382|12326245|P2|STARTED|Overall Study||43
5009947|NCT02267382|12326246|P1|STARTED|Overall Study||42
5009948|NCT02267317|12326261|P6|NOT COMPLETED|Infusion2||0
5009949|NCT02267317|12326262|P5|NOT COMPLETED|Infusion2||0
5009950|NCT02267317|12326263|P4|NOT COMPLETED|Infusion2||0
5009951|NCT02267317|12326264|P3|NOT COMPLETED|Infusion2||0
5009952|NCT02267317|12326265|P2|NOT COMPLETED|Infusion2||0
5009953|NCT02267317|12326266|P1|NOT COMPLETED|Infusion2||0
5009954|NCT02267317|12326261|P6|COMPLETED|Infusion2||1
5009955|NCT02267317|12326262|P5|COMPLETED|Infusion2||0
5009956|NCT02267317|12326263|P4|COMPLETED|Infusion2||2
5009957|NCT02267317|12326264|P3|COMPLETED|Infusion2||1
5009958|NCT02267317|12326265|P2|COMPLETED|Infusion2||3
5009959|NCT02267317|12326266|P1|COMPLETED|Infusion2||6
5009960|NCT02267317|12326261|P6|STARTED|Infusion2||1
5009961|NCT02267317|12326262|P5|STARTED|Infusion2||0
5009962|NCT02267317|12326263|P4|STARTED|Infusion2||2
5009963|NCT02267317|12326264|P3|STARTED|Infusion2||1
5009964|NCT02267317|12326265|P2|STARTED|Infusion2||3
5009965|NCT02267317|12326266|P1|STARTED|Infusion2||6
5009966|NCT02267317|12326261|P6|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
5009967|NCT02267317|12326262|P5|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
5009968|NCT02267317|12326263|P4|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
5009969|NCT02267317|12326264|P3|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
5009970|NCT02267317|12326265|P2|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
5009971|NCT02267317|12326266|P1|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
5009972|NCT02267317|12326261|P6|COMPLETED|Washout (3-4weeks Between Infusions)||1
5009973|NCT02267317|12326262|P5|COMPLETED|Washout (3-4weeks Between Infusions)||0
5009974|NCT02267317|12326263|P4|COMPLETED|Washout (3-4weeks Between Infusions)||2
5009975|NCT02267317|12326264|P3|COMPLETED|Washout (3-4weeks Between Infusions)||1
5009976|NCT02267317|12326265|P2|COMPLETED|Washout (3-4weeks Between Infusions)||3
5009977|NCT02267317|12326266|P1|COMPLETED|Washout (3-4weeks Between Infusions)||6
5009978|NCT02267317|12326261|P6|STARTED|Washout (3-4weeks Between Infusions)||1
5009979|NCT02267317|12326262|P5|STARTED|Washout (3-4weeks Between Infusions)||0
5009980|NCT02267317|12326263|P4|STARTED|Washout (3-4weeks Between Infusions)||2
5009981|NCT02267317|12326264|P3|STARTED|Washout (3-4weeks Between Infusions)||1
5009982|NCT02267317|12326265|P2|STARTED|Washout (3-4weeks Between Infusions)||3
5009983|NCT02267317|12326266|P1|STARTED|Washout (3-4weeks Between Infusions)||8
5009984|NCT02267317|12326261|P6|NOT COMPLETED|Infusion1||0
5009985|NCT02267317|12326262|P5|NOT COMPLETED|Infusion1||0
5009986|NCT02267317|12326263|P4|NOT COMPLETED|Infusion1||0
5009987|NCT02267317|12326264|P3|NOT COMPLETED|Infusion1||0
5009988|NCT02267317|12326265|P2|NOT COMPLETED|Infusion1||0
5009989|NCT02267317|12326266|P1|NOT COMPLETED|Infusion1||0
5009990|NCT02267317|12326261|P6|COMPLETED|Infusion1||1
5009991|NCT02267317|12326262|P5|COMPLETED|Infusion1||0
5009992|NCT02267317|12326263|P4|COMPLETED|Infusion1||2
5009993|NCT02267317|12326264|P3|COMPLETED|Infusion1||1
5009994|NCT02267317|12326265|P2|COMPLETED|Infusion1||3
5009995|NCT02267317|12326266|P1|COMPLETED|Infusion1||8
5009996|NCT02267317|12326261|P6|STARTED|Infusion1||1
5009997|NCT02267317|12326262|P5|STARTED|Infusion1||0
5009998|NCT02267317|12326263|P4|STARTED|Infusion1||2
5009999|NCT02267317|12326264|P3|STARTED|Infusion1||1
5010000|NCT02267317|12326265|P2|STARTED|Infusion1||3
5010001|NCT02267317|12326266|P1|STARTED|Infusion1||8
5010002|NCT02267278|12326316|P1|NOT COMPLETED|Overall Study||5
5010003|NCT02267278|12326316|P1|COMPLETED|Overall Study||20
5010004|NCT02267278|12326316|P1|STARTED|Overall Study||25
5010005|NCT02267226|12326321|P1|NOT COMPLETED|Overall Study||7
5010006|NCT02267226|12326321|P1|COMPLETED|Overall Study||18
5010007|NCT02267226|12326321|P1|Surgical Prophylaxis Population|Overall Study||9
5010008|NCT02267226|12326321|P1|FAS-Bleeding Population|Overall Study||24
5010009|NCT02267226|12326321|P1|SAFETY Population|Overall Study||25
5010010|NCT02267226|12326321|P1|STARTED|Overall Study||25
5010011|NCT02267187|12326340|P1|NOT COMPLETED|Overall Study||5
5010012|NCT02267187|12326340|P1|COMPLETED|Overall Study||10
5010013|NCT02267187|12326340|P1|STARTED|Overall Study||15
5010014|NCT02267135|12326348|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
5010015|NCT02267135|12326349|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
5010016|NCT02267135|12326348|P2|COMPLETED|Period 2 (Randomized Set)||46
5010017|NCT02267135|12326349|P1|COMPLETED|Period 2 (Randomized Set)||46
5010018|NCT02267135|12326348|P2|STARTED|Period 2 (Randomized Set)||47
5010019|NCT02267135|12326349|P1|STARTED|Period 2 (Randomized Set)||50
5010020|NCT02267135|12326348|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
5010021|NCT02267135|12326349|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
5010022|NCT02267135|12326348|P2|COMPLETED|Period 1 (Randomized Set)||47
5010023|NCT02267135|12326349|P1|COMPLETED|Period 1 (Randomized Set)||50
5010024|NCT02267135|12326348|P2|STARTED|Period 1 (Randomized Set)||51
5010025|NCT02267135|12326349|P1|STARTED|Period 1 (Randomized Set)||51
5010026|NCT02267083|12326380|P1|NOT COMPLETED|Overall Study||19
5010027|NCT02267083|12326380|P1|COMPLETED|Overall Study||3
5010028|NCT02267083|12326380|P1|STARTED|Overall Study||22
5010029|NCT02266914|12326387|P1|NOT COMPLETED|Overall Study||9
5010030|NCT02266914|12326387|P1|COMPLETED|Overall Study||0
5010031|NCT02266914|12326387|P1|STARTED|Overall Study||9
5010032|NCT02266888|12326393|P4|NOT COMPLETED|Overall Study||7
5010033|NCT02266888|12326394|P3|NOT COMPLETED|Overall Study||11
5010034|NCT02266888|12326395|P2|NOT COMPLETED|Overall Study||4
5010035|NCT02266888|12326396|P1|NOT COMPLETED|Overall Study||7
5010036|NCT02266888|12326393|P4|COMPLETED|Overall Study||0
5010037|NCT02266888|12326394|P3|COMPLETED|Overall Study||0
5010038|NCT02266888|12326395|P2|COMPLETED|Overall Study||8
5010039|NCT02266888|12326396|P1|COMPLETED|Overall Study||8
5010040|NCT02266888|12326393|P4|STARTED|Overall Study||7
5010041|NCT02266888|12326394|P3|STARTED|Overall Study||11
5010042|NCT02266888|12326395|P2|STARTED|Overall Study||12
5010043|NCT02266888|12326396|P1|STARTED|Overall Study||15
5010044|NCT02266875|12326430|P2|NOT COMPLETED|Overall Study||0
5010045|NCT02266875|12326431|P1|NOT COMPLETED|Overall Study||11
5010046|NCT02266875|12326430|P2|COMPLETED|Overall Study||30
5010047|NCT02266875|12326431|P1|COMPLETED|Overall Study||29
5010048|NCT02266875|12326430|P2|STARTED|Overall Study||30
5010049|NCT02266875|12326431|P1|STARTED|Overall Study||40
5010050|NCT02266810|12326443|P2|NOT COMPLETED|Overall Study||1
5010051|NCT02266810|12326444|P1|NOT COMPLETED|Overall Study||1
5010052|NCT02266810|12326443|P2|COMPLETED|Overall Study|sinus sides|79
5010053|NCT02266810|12326444|P1|COMPLETED|Overall Study|sinus sides|79
5010054|NCT02266810|12326443|P2|STARTED|Overall Study|sinus sides|80
5010055|NCT02266810|12326444|P1|STARTED|Overall Study|sinus sides|80
5010056|NCT02266797|12326470|P2|NOT COMPLETED|Overall Study||1
5010057|NCT02266797|12326471|P1|NOT COMPLETED|Overall Study||0
5010058|NCT02266797|12326470|P2|COMPLETED|Overall Study||2
5010059|NCT02266797|12326471|P1|COMPLETED|Overall Study||1
5010060|NCT02266797|12326470|P2|STARTED|Overall Study||3
5010061|NCT02266797|12326471|P1|STARTED|Overall Study||1
5010062|NCT02266706|12326496|P9|NOT COMPLETED|Overall Study||0
5010063|NCT02266706|12326497|P8|NOT COMPLETED|Overall Study||0
5010064|NCT02266706|12326498|P7|NOT COMPLETED|Overall Study||1
5010065|NCT02266706|12326499|P6|NOT COMPLETED|Overall Study||2
5010066|NCT02266706|12326500|P5|NOT COMPLETED|Overall Study||0
5010067|NCT02266706|12326501|P4|NOT COMPLETED|Overall Study||1
5010068|NCT02266706|12326502|P3|NOT COMPLETED|Overall Study||1
5010069|NCT02266706|12326503|P2|NOT COMPLETED|Overall Study||1
5010070|NCT02266706|12326504|P1|NOT COMPLETED|Overall Study||0
5010071|NCT02266706|12326496|P9|COMPLETED|Overall Study||4
5010072|NCT02266706|12326497|P8|COMPLETED|Overall Study||2
5010073|NCT02266706|12326498|P7|COMPLETED|Overall Study||7
5010074|NCT02266706|12326499|P6|COMPLETED|Overall Study||5
5010075|NCT02266706|12326500|P5|COMPLETED|Overall Study||1
5010076|NCT02266706|12326501|P4|COMPLETED|Overall Study||3
5010077|NCT02266706|12326502|P3|COMPLETED|Overall Study||3
5010078|NCT02266706|12326503|P2|COMPLETED|Overall Study||6
5010079|NCT02266706|12326504|P1|COMPLETED|Overall Study||6
5010080|NCT02266706|12326496|P9|Treated|Overall Study||4
5010081|NCT02266706|12326497|P8|Treated|Overall Study||2
5010082|NCT02266706|12326498|P7|Treated|Overall Study||7
5010083|NCT02266706|12326499|P6|Treated|Overall Study||5
5010084|NCT02266706|12326500|P5|Treated|Overall Study||1
5010085|NCT02266706|12326501|P4|Treated|Overall Study||3
5010086|NCT02266706|12326502|P3|Treated|Overall Study||3
5010087|NCT02266706|12326503|P2|Treated|Overall Study||6
5010088|NCT02266706|12326504|P1|Treated|Overall Study||6
5010089|NCT02266706|12326496|P9|STARTED|Overall Study||4
5010090|NCT02266706|12326497|P8|STARTED|Overall Study||2
5010091|NCT02266706|12326498|P7|STARTED|Overall Study||8
5010092|NCT02266706|12326499|P6|STARTED|Overall Study||7
5010093|NCT02266706|12326500|P5|STARTED|Overall Study||1
5010094|NCT02266706|12326501|P4|STARTED|Overall Study||4
5010095|NCT02266706|12326502|P3|STARTED|Overall Study||4
5010096|NCT02266706|12326503|P2|STARTED|Overall Study||7
5010097|NCT02266706|12326504|P1|STARTED|Overall Study||6
5010098|NCT02266576|12326697|P2|NOT COMPLETED|Overall Study||15
5010099|NCT02266576|12326698|P1|NOT COMPLETED|Overall Study||17
5010100|NCT02266576|12326697|P2|COMPLETED|Overall Study||90
5010101|NCT02266576|12326698|P1|COMPLETED|Overall Study||85
5010102|NCT02266576|12326697|P2|STARTED|Overall Study||105
5010103|NCT02266576|12326698|P1|STARTED|Overall Study||102
5010104|NCT02266472|12326716|P2|NOT COMPLETED|Period 2+ Washout||0
5010105|NCT02266472|12326717|P1|NOT COMPLETED|Period 2+ Washout||0
5010106|NCT02266472|12326716|P2|COMPLETED|Period 2+ Washout||15
5010107|NCT02266472|12326717|P1|COMPLETED|Period 2+ Washout||15
5010108|NCT02266472|12326716|P2|STARTED|Period 2+ Washout||15
5010109|NCT02266472|12326717|P1|STARTED|Period 2+ Washout||15
5010110|NCT02266472|12326716|P2|NOT COMPLETED|Period 1+ Washout||0
5010111|NCT02266472|12326717|P1|NOT COMPLETED|Period 1+ Washout||0
5010112|NCT02266472|12326716|P2|COMPLETED|Period 1+ Washout||15
5010113|NCT02266472|12326717|P1|COMPLETED|Period 1+ Washout||15
5010114|NCT02266472|12326716|P2|STARTED|Period 1+ Washout||15
5010115|NCT02266472|12326717|P1|STARTED|Period 1+ Washout||15
5010116|NCT02266381|12326736|P3|NOT COMPLETED|Overall Study||4
5010117|NCT02266381|12326737|P2|NOT COMPLETED|Overall Study||5
5010118|NCT02266381|12326738|P1|NOT COMPLETED|Overall Study||3
5010119|NCT02266381|12326736|P3|COMPLETED|Overall Study||146
5010120|NCT02266381|12326737|P2|COMPLETED|Overall Study||145
5010121|NCT02266381|12326738|P1|COMPLETED|Overall Study||147
5010122|NCT02266381|12326736|P3|STARTED|Overall Study||150
5010123|NCT02266381|12326737|P2|STARTED|Overall Study||150
5010124|NCT02266381|12326738|P1|STARTED|Overall Study||150
5010125|NCT02266277|12326761|P6|NOT COMPLETED|Overall Study||0
5010126|NCT02266277|12326762|P5|NOT COMPLETED|Overall Study||0
5010127|NCT02266277|12326763|P4|NOT COMPLETED|Overall Study||0
5010128|NCT02266277|12326764|P3|NOT COMPLETED|Overall Study||0
5010129|NCT02266277|12326765|P2|NOT COMPLETED|Overall Study||0
5010130|NCT02266277|12326766|P1|NOT COMPLETED|Overall Study||0
5010131|NCT02266277|12326761|P6|COMPLETED|Overall Study||5000
5010132|NCT02266277|12326762|P5|COMPLETED|Overall Study||5000
5010133|NCT02266277|12326763|P4|COMPLETED|Overall Study||5000
5010134|NCT02266277|12326764|P3|COMPLETED|Overall Study||5000
5010135|NCT02266277|12326765|P2|COMPLETED|Overall Study||5000
5010136|NCT02266277|12326766|P1|COMPLETED|Overall Study||5000
5010137|NCT02266277|12326761|P6|STARTED|Overall Study||5000
5010138|NCT02266277|12326762|P5|STARTED|Overall Study||5000
5010139|NCT02266277|12326763|P4|STARTED|Overall Study||5000
5010140|NCT02266277|12326764|P3|STARTED|Overall Study||5000
5010141|NCT02266277|12326765|P2|STARTED|Overall Study||5000
5010142|NCT02266277|12326766|P1|STARTED|Overall Study||5000
5010143|NCT02266225|12326788|P1|NOT COMPLETED|Overall Study||16
5010144|NCT02266225|12326788|P1|COMPLETED|Overall Study||32
5010145|NCT02266225|12326788|P1|Enrolled in Intervention|Overall Study||44
5010146|NCT02266225|12326788|P1|STARTED|Overall Study||48
5010147|NCT02266108|12326811|P2|NOT COMPLETED|Overall Study||0
5010148|NCT02266108|12326812|P1|NOT COMPLETED|Overall Study||0
5010149|NCT02266108|12326811|P2|COMPLETED|Overall Study||71
5010150|NCT02266108|12326812|P1|COMPLETED|Overall Study||80
5010151|NCT02266108|12326811|P2|STARTED|Overall Study||71
5010152|NCT02266108|12326812|P1|STARTED|Overall Study||80
5010153|NCT02266004|12326822|P1|NOT COMPLETED|Overall Study||2
5010154|NCT02266004|12326822|P1|COMPLETED|Overall Study||7
5010155|NCT02266004|12326822|P1|STARTED|Overall Study||9
5010156|NCT02265965|12326839|P2|NOT COMPLETED|Overall Study||0
5010157|NCT02265965|12326840|P1|NOT COMPLETED|Overall Study||0
5010158|NCT02265965|12326839|P2|COMPLETED|Overall Study||11
5010159|NCT02265965|12326840|P1|COMPLETED|Overall Study||7
5010160|NCT02265965|12326839|P2|STARTED|Overall Study||11
5010161|NCT02265965|12326840|P1|STARTED|Overall Study||7
5010162|NCT02265952|12326860|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
5010163|NCT02265952|12326861|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
5010164|NCT02265952|12326860|P2|COMPLETED|Open Label Extension (OLE) Period||0
5010165|NCT02265952|12326861|P1|COMPLETED|Open Label Extension (OLE) Period||0
5010166|NCT02265952|12326860|P2|STARTED|Open Label Extension (OLE) Period||8
5010167|NCT02265952|12326861|P1|STARTED|Open Label Extension (OLE) Period||0
5010168|NCT02265952|12326860|P2|NOT COMPLETED|Main Study Period||0
5010169|NCT02265952|12326861|P1|NOT COMPLETED|Main Study Period||0
5010170|NCT02265952|12326860|P2|COMPLETED|Main Study Period||0
5010171|NCT02265952|12326861|P1|COMPLETED|Main Study Period||9
5010172|NCT02265952|12326860|P2|STARTED|Main Study Period||0
5010173|NCT02265952|12326861|P1|STARTED|Main Study Period||9
5010174|NCT02265848|12326889|P2|NOT COMPLETED|Overall Study||0
5010175|NCT02265848|12326890|P1|NOT COMPLETED|Overall Study||0
5010176|NCT02265848|12326889|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
5010177|NCT02265848|12326890|P1|COMPLETED|Overall Study||11
5010178|NCT02265848|12326889|P2|STARTED|Overall Study||11
5010179|NCT02265848|12326890|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
5010180|NCT02265796|12326904|P2|NOT COMPLETED|Overall Study||1
5010181|NCT02265796|12326905|P1|NOT COMPLETED|Overall Study||3
5010182|NCT02265796|12326904|P2|COMPLETED|Overall Study||24
5010183|NCT02265796|12326905|P1|COMPLETED|Overall Study||22
5010184|NCT02265796|12326904|P2|STARTED|Overall Study||25
5010185|NCT02265796|12326905|P1|STARTED|Overall Study||25
5010186|NCT02265783|12326915|P1|NOT COMPLETED|Overall Study||0
5010187|NCT02265783|12326915|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
5010188|NCT02265783|12326915|P1|STARTED|Overall Study||20
5010189|NCT02265744|12326924|P5|NOT COMPLETED|Overall Study||13
5010190|NCT02265744|12326925|P4|NOT COMPLETED|Overall Study||23
5010191|NCT02265744|12326926|P3|NOT COMPLETED|Overall Study||17
5010192|NCT02265744|12326927|P2|NOT COMPLETED|Overall Study||15
5010193|NCT02265744|12326928|P1|NOT COMPLETED|Overall Study||20
5010194|NCT02265744|12326924|P5|COMPLETED|Overall Study||58
5010195|NCT02265744|12326925|P4|COMPLETED|Overall Study||47
5010196|NCT02265744|12326926|P3|COMPLETED|Overall Study||51
5010197|NCT02265744|12326927|P2|COMPLETED|Overall Study||53
5010198|NCT02265744|12326928|P1|COMPLETED|Overall Study||49
5010199|NCT02265744|12326924|P5|STARTED|Overall Study||71
5010200|NCT02265744|12326925|P4|STARTED|Overall Study||70
5010201|NCT02265744|12326926|P3|STARTED|Overall Study||68
5010202|NCT02265744|12326927|P2|STARTED|Overall Study||68
5010203|NCT02265744|12326928|P1|STARTED|Overall Study||69
5010204|NCT02265705|12327107|P7|NOT COMPLETED|Follow-up Period||11
5010205|NCT02265705|12327108|P6|NOT COMPLETED|Follow-up Period||1
5010206|NCT02265705|12327109|P5|NOT COMPLETED|Follow-up Period||0
5010207|NCT02265705|12327110|P4|NOT COMPLETED|Follow-up Period||0
5010208|NCT02265705|12327111|P3|NOT COMPLETED|Follow-up Period||0
5010209|NCT02265705|12327112|P2|NOT COMPLETED|Follow-up Period||0
5010210|NCT02265705|12327113|P1|NOT COMPLETED|Follow-up Period||0
5010211|NCT02265705|12327107|P7|COMPLETED|Follow-up Period||47
5010212|NCT02265705|12327108|P6|COMPLETED|Follow-up Period||1
5010213|NCT02265705|12327109|P5|COMPLETED|Follow-up Period||0
5010214|NCT02265705|12327110|P4|COMPLETED|Follow-up Period||0
5010215|NCT02265705|12327111|P3|COMPLETED|Follow-up Period||0
5010216|NCT02265705|12327112|P2|COMPLETED|Follow-up Period||0
5010217|NCT02265705|12327113|P1|COMPLETED|Follow-up Period||0
5010218|NCT02265705|12327107|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
5010219|NCT02265705|12327108|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
5010220|NCT02265705|12327109|P5|STARTED|Follow-up Period||0
5010221|NCT02265705|12327110|P4|STARTED|Follow-up Period||0
5010222|NCT02265705|12327111|P3|STARTED|Follow-up Period||0
5010223|NCT02265705|12327112|P2|STARTED|Follow-up Period||0
5010224|NCT02265705|12327113|P1|STARTED|Follow-up Period||0
5010225|NCT02265705|12327107|P7|NOT COMPLETED|Open Label Period||0
5010226|NCT02265705|12327108|P6|NOT COMPLETED|Open Label Period||0
5010227|NCT02265705|12327109|P5|NOT COMPLETED|Open Label Period||5
5010228|NCT02265705|12327110|P4|NOT COMPLETED|Open Label Period||2
5010229|NCT02265705|12327111|P3|NOT COMPLETED|Open Label Period||0
5010230|NCT02265705|12327112|P2|NOT COMPLETED|Open Label Period||0
5010231|NCT02265705|12327113|P1|NOT COMPLETED|Open Label Period||0
5010232|NCT02265705|12327107|P7|COMPLETED|Open Label Period||0
5010233|NCT02265705|12327108|P6|COMPLETED|Open Label Period||0
5010234|NCT02265705|12327109|P5|COMPLETED|Open Label Period||115
5010235|NCT02265705|12327110|P4|COMPLETED|Open Label Period||72
5010236|NCT02265705|12327111|P3|COMPLETED|Open Label Period||0
5010237|NCT02265705|12327112|P2|COMPLETED|Open Label Period||0
5010238|NCT02265705|12327113|P1|COMPLETED|Open Label Period||0
5010239|NCT02265705|12327107|P7|STARTED|Open Label Period||0
5010240|NCT02265705|12327108|P6|STARTED|Open Label Period||0
5010241|NCT02265705|12327109|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
5010242|NCT02265705|12327110|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
5010243|NCT02265705|12327111|P3|STARTED|Open Label Period||0
5010244|NCT02265705|12327112|P2|STARTED|Open Label Period||0
5010245|NCT02265705|12327113|P1|STARTED|Open Label Period||0
5010246|NCT02265705|12327107|P7|NOT COMPLETED|Rescue Period||0
5010247|NCT02265705|12327108|P6|NOT COMPLETED|Rescue Period||0
5010248|NCT02265705|12327109|P5|NOT COMPLETED|Rescue Period||0
5010249|NCT02265705|12327110|P4|NOT COMPLETED|Rescue Period||0
5010250|NCT02265705|12327111|P3|NOT COMPLETED|Rescue Period||3
5010251|NCT02265705|12327112|P2|NOT COMPLETED|Rescue Period||0
5010252|NCT02265705|12327113|P1|NOT COMPLETED|Rescue Period||0
5010253|NCT02265705|12327107|P7|COMPLETED|Rescue Period||0
5010254|NCT02265705|12327108|P6|COMPLETED|Rescue Period||0
5010255|NCT02265705|12327109|P5|COMPLETED|Rescue Period||0
5010256|NCT02265705|12327110|P4|COMPLETED|Rescue Period||0
5010257|NCT02265705|12327111|P3|COMPLETED|Rescue Period||74
5010258|NCT02265705|12327112|P2|COMPLETED|Rescue Period||0
5010259|NCT02265705|12327113|P1|COMPLETED|Rescue Period||0
5010260|NCT02265705|12327107|P7|STARTED|Rescue Period||0
5010261|NCT02265705|12327108|P6|STARTED|Rescue Period||0
5010262|NCT02265705|12327109|P5|STARTED|Rescue Period||0
5010263|NCT02265705|12327110|P4|STARTED|Rescue Period||0
5010264|NCT02265705|12327111|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
5010265|NCT02265705|12327112|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5010266|NCT02265705|12327113|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5010267|NCT02265705|12327107|P7|NOT COMPLETED|Treatment Period Week 0-24||0
5010268|NCT02265705|12327108|P6|NOT COMPLETED|Treatment Period Week 0-24||0
5010269|NCT02265705|12327109|P5|NOT COMPLETED|Treatment Period Week 0-24||0
5010270|NCT02265705|12327110|P4|NOT COMPLETED|Treatment Period Week 0-24||0
5010271|NCT02265705|12327111|P3|NOT COMPLETED|Treatment Period Week 0-24||0
5010272|NCT02265705|12327112|P2|NOT COMPLETED|Treatment Period Week 0-24||9
5010273|NCT02265705|12327113|P1|NOT COMPLETED|Treatment Period Week 0-24||12
5010274|NCT02265705|12327107|P7|COMPLETED|Treatment Period Week 0-24||0
5010275|NCT02265705|12327108|P6|COMPLETED|Treatment Period Week 0-24||0
5010276|NCT02265705|12327109|P5|COMPLETED|Treatment Period Week 0-24||0
5010277|NCT02265705|12327110|P4|COMPLETED|Treatment Period Week 0-24||0
5010278|NCT02265705|12327111|P3|COMPLETED|Treatment Period Week 0-24||0
5010279|NCT02265705|12327112|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
5010280|NCT02265705|12327113|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
5010281|NCT02265705|12327107|P7|Rescued|Treatment Period Week 0-24||0
5010282|NCT02265705|12327108|P6|Rescued|Treatment Period Week 0-24||0
5010283|NCT02265705|12327109|P5|Rescued|Treatment Period Week 0-24||0
5010284|NCT02265705|12327110|P4|Rescued|Treatment Period Week 0-24||0
5010285|NCT02265705|12327111|P3|Rescued|Treatment Period Week 0-24||0
5010286|NCT02265705|12327112|P2|Rescued|Treatment Period Week 0-24||17
5010287|NCT02265705|12327113|P1|Rescued|Treatment Period Week 0-24||59
5010288|NCT02265705|12327107|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
5010289|NCT02265705|12327108|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
5010290|NCT02265705|12327109|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
5010291|NCT02265705|12327110|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
5010292|NCT02265705|12327111|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
5010293|NCT02265705|12327112|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
5010294|NCT02265705|12327113|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
5010295|NCT02265705|12327107|P7|STARTED|Treatment Period Week 0-24||0
5010296|NCT02265705|12327108|P6|STARTED|Treatment Period Week 0-24||0
5010297|NCT02265705|12327109|P5|STARTED|Treatment Period Week 0-24||0
5010298|NCT02265705|12327110|P4|STARTED|Treatment Period Week 0-24||0
5010299|NCT02265705|12327111|P3|STARTED|Treatment Period Week 0-24||0
5010300|NCT02265705|12327112|P2|STARTED|Treatment Period Week 0-24||145
5010301|NCT02265705|12327113|P1|STARTED|Treatment Period Week 0-24||145
5010302|NCT02265510|12327152|P14|NOT COMPLETED|Overall Study||10
5010303|NCT02265510|12327153|P13|NOT COMPLETED|Overall Study||9
5010304|NCT02265510|12327154|P12|NOT COMPLETED|Overall Study||16
5010305|NCT02265510|12327155|P11|NOT COMPLETED|Overall Study||5
5010306|NCT02265510|12327156|P10|NOT COMPLETED|Overall Study||7
5010307|NCT02265510|12327157|P9|NOT COMPLETED|Overall Study||4
5010308|NCT02265510|12327158|P8|NOT COMPLETED|Overall Study||4
5010309|NCT02265510|12327159|P7|NOT COMPLETED|Overall Study||3
5010310|NCT02265510|12327160|P6|NOT COMPLETED|Overall Study||6
5010311|NCT02265510|12327161|P5|NOT COMPLETED|Overall Study||3
5010312|NCT02265510|12327162|P4|NOT COMPLETED|Overall Study||4
5010313|NCT02265510|12327163|P3|NOT COMPLETED|Overall Study||6
5010314|NCT02265510|12327164|P2|NOT COMPLETED|Overall Study||3
5010315|NCT02265510|12327165|P1|NOT COMPLETED|Overall Study||3
5010316|NCT02265510|12327152|P14|COMPLETED|Overall Study||0
5010317|NCT02265510|12327153|P13|COMPLETED|Overall Study||0
5010318|NCT02265510|12327154|P12|COMPLETED|Overall Study||0
5010319|NCT02265510|12327155|P11|COMPLETED|Overall Study||0
5010320|NCT02265510|12327156|P10|COMPLETED|Overall Study||0
5010321|NCT02265510|12327157|P9|COMPLETED|Overall Study||0
5010322|NCT02265510|12327158|P8|COMPLETED|Overall Study||0
5010323|NCT02265510|12327159|P7|COMPLETED|Overall Study||0
5010324|NCT02265510|12327160|P6|COMPLETED|Overall Study||0
5010325|NCT02265510|12327161|P5|COMPLETED|Overall Study||0
5010326|NCT02265510|12327162|P4|COMPLETED|Overall Study||0
5010327|NCT02265510|12327163|P3|COMPLETED|Overall Study||0
5010328|NCT02265510|12327164|P2|COMPLETED|Overall Study||0
5010329|NCT02265510|12327165|P1|COMPLETED|Overall Study||0
5010330|NCT02265510|12327152|P14|STARTED|Overall Study||10
5010331|NCT02265510|12327153|P13|STARTED|Overall Study||9
5010332|NCT02265510|12327154|P12|STARTED|Overall Study||16
5010333|NCT02265510|12327155|P11|STARTED|Overall Study||5
5010334|NCT02265510|12327156|P10|STARTED|Overall Study||7
5010335|NCT02265510|12327157|P9|STARTED|Overall Study||4
5010336|NCT02265510|12327158|P8|STARTED|Overall Study||4
5010337|NCT02265510|12327159|P7|STARTED|Overall Study||3
5010338|NCT02265510|12327160|P6|STARTED|Overall Study||6
5010339|NCT02265510|12327161|P5|STARTED|Overall Study||3
5010340|NCT02265510|12327162|P4|STARTED|Overall Study||4
5010341|NCT02265510|12327163|P3|STARTED|Overall Study||6
5010342|NCT02265510|12327164|P2|STARTED|Overall Study||3
5010343|NCT02265510|12327165|P1|STARTED|Overall Study||3
5010344|NCT02265341|12327253|P1|NOT COMPLETED|Overall Study||0
5010345|NCT02265341|12327253|P1|COMPLETED|Overall Study||12
5010346|NCT02265341|12327253|P1|STARTED|Overall Study||12
5010347|NCT02265237|12327265|P4|NOT COMPLETED|As Treated (Overall Study)||1
5010348|NCT02265237|12327266|P3|NOT COMPLETED|As Treated (Overall Study)||10
5010349|NCT02265237|12327267|P2|NOT COMPLETED|As Treated (Overall Study)||3
5010350|NCT02265237|12327268|P1|NOT COMPLETED|As Treated (Overall Study)||5
5010351|NCT02265237|12327265|P4|COMPLETED|As Treated (Overall Study)||2
5010352|NCT02265237|12327266|P3|COMPLETED|As Treated (Overall Study)||51
5010353|NCT02265237|12327267|P2|COMPLETED|As Treated (Overall Study)||57
5010354|NCT02265237|12327268|P1|COMPLETED|As Treated (Overall Study)||55
5010355|NCT02265237|12327265|P4|STARTED|As Treated (Overall Study)||3
5010356|NCT02265237|12327266|P3|STARTED|As Treated (Overall Study)||61
5010357|NCT02265237|12327267|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
5010358|NCT02265237|12327268|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
5010359|NCT02265237|12327265|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
5010360|NCT02265237|12327266|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
5010361|NCT02265237|12327267|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
5010362|NCT02265237|12327268|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
5010363|NCT02265237|12327265|P4|COMPLETED|As Enrolled (Overall Study)||2
5010364|NCT02265237|12327266|P3|COMPLETED|As Enrolled (Overall Study)||51
5010365|NCT02265237|12327267|P2|COMPLETED|As Enrolled (Overall Study)||58
5010366|NCT02265237|12327268|P1|COMPLETED|As Enrolled (Overall Study)||54
5010367|NCT02265237|12327265|P4|STARTED|As Enrolled (Overall Study)||3
5010368|NCT02265237|12327266|P3|STARTED|As Enrolled (Overall Study)||61
5010369|NCT02265237|12327267|P2|STARTED|As Enrolled (Overall Study)||61
5010370|NCT02265237|12327268|P1|STARTED|As Enrolled (Overall Study)||59
5010371|NCT02264977|12327287|P1|NOT COMPLETED|Overall Study||6
5010372|NCT02264977|12327287|P1|COMPLETED|Overall Study||3
5010373|NCT02264977|12327287|P1|STARTED|Overall Study||9
5010374|NCT02264821|12327298|P3|NOT COMPLETED|Overall Study||6
5010375|NCT02264821|12327299|P2|NOT COMPLETED|Overall Study||3
5010376|NCT02264821|12327300|P1|NOT COMPLETED|Overall Study||1
5010377|NCT02264821|12327298|P3|COMPLETED|Overall Study||58
5010378|NCT02264821|12327299|P2|COMPLETED|Overall Study||61
5010379|NCT02264821|12327300|P1|COMPLETED|Overall Study||63
5010380|NCT02264821|12327298|P3|STARTED|Overall Study|Double Blind|64
5010381|NCT02264821|12327299|P2|STARTED|Overall Study|Double Blind|64
5010382|NCT02264821|12327300|P1|STARTED|Overall Study|Double Blind|64
5010383|NCT02264574|12327313|P2|NOT COMPLETED|Overall Study||8
5010384|NCT02264574|12327314|P1|NOT COMPLETED|Overall Study||6
5010385|NCT02264574|12327313|P2|COMPLETED|Overall Study||108
5010386|NCT02264574|12327314|P1|COMPLETED|Overall Study||107
5010387|NCT02264574|12327313|P2|STARTED|Overall Study||116
5010388|NCT02264574|12327314|P1|STARTED|Overall Study||113
5010389|NCT02264353|12327324|P2|NOT COMPLETED|Overall Study||0
5010390|NCT02264353|12327325|P1|NOT COMPLETED|Overall Study||3
5010391|NCT02264353|12327324|P2|COMPLETED|Overall Study||24
5010392|NCT02264353|12327325|P1|COMPLETED|Overall Study||17
5010393|NCT02264353|12327324|P2|STARTED|Overall Study||24
5010394|NCT02264353|12327325|P1|STARTED|Overall Study||20
5010395|NCT02264249|12327338|P3|NOT COMPLETED|Overall Study||0
5010396|NCT02264249|12327339|P2|NOT COMPLETED|Overall Study||0
5010397|NCT02264249|12327340|P1|NOT COMPLETED|Overall Study||0
5010398|NCT02264249|12327338|P3|COMPLETED|Overall Study||241
5010399|NCT02264249|12327339|P2|COMPLETED|Overall Study||187
5010400|NCT02264249|12327340|P1|COMPLETED|Overall Study||21
5010401|NCT02264249|12327338|P3|STARTED|Overall Study||241
5010402|NCT02264249|12327339|P2|STARTED|Overall Study||187
5010403|NCT02264249|12327340|P1|STARTED|Overall Study||21
5010404|NCT02263911|12327354|P4|NOT COMPLETED|Period 5||0
5010405|NCT02263911|12327355|P3|NOT COMPLETED|Period 5||0
5010406|NCT02263911|12327356|P2|NOT COMPLETED|Period 5||0
5010407|NCT02263911|12327357|P1|NOT COMPLETED|Period 5||0
5010408|NCT02263911|12327354|P4|COMPLETED|Period 5||4
5010409|NCT02263911|12327355|P3|COMPLETED|Period 5||4
5010410|NCT02263911|12327356|P2|COMPLETED|Period 5||4
5010411|NCT02263911|12327357|P1|COMPLETED|Period 5||4
5010412|NCT02263911|12327354|P4|STARTED|Period 5||4
5010413|NCT02263911|12327355|P3|STARTED|Period 5||4
5010414|NCT02263911|12327356|P2|STARTED|Period 5||4
5010415|NCT02263911|12327357|P1|STARTED|Period 5||4
5010416|NCT02263911|12327354|P4|NOT COMPLETED|Period 4 Washout||0
5010417|NCT02263911|12327355|P3|NOT COMPLETED|Period 4 Washout||0
5010418|NCT02263911|12327356|P2|NOT COMPLETED|Period 4 Washout||0
5010419|NCT02263911|12327357|P1|NOT COMPLETED|Period 4 Washout||0
5010420|NCT02263911|12327354|P4|COMPLETED|Period 4 Washout||4
5010421|NCT02263911|12327355|P3|COMPLETED|Period 4 Washout||4
5010422|NCT02263911|12327356|P2|COMPLETED|Period 4 Washout||4
5010423|NCT02263911|12327357|P1|COMPLETED|Period 4 Washout||4
5010424|NCT02263911|12327354|P4|STARTED|Period 4 Washout||4
5010425|NCT02263911|12327355|P3|STARTED|Period 4 Washout||4
5010426|NCT02263911|12327356|P2|STARTED|Period 4 Washout||4
5010427|NCT02263911|12327357|P1|STARTED|Period 4 Washout||4
5010428|NCT02263911|12327354|P4|NOT COMPLETED|Period 4||0
5010429|NCT02263911|12327355|P3|NOT COMPLETED|Period 4||0
5010430|NCT02263911|12327356|P2|NOT COMPLETED|Period 4||0
5010431|NCT02263911|12327357|P1|NOT COMPLETED|Period 4||0
5010432|NCT02263911|12327354|P4|COMPLETED|Period 4||4
5010433|NCT02263911|12327355|P3|COMPLETED|Period 4||4
5010434|NCT02263911|12327356|P2|COMPLETED|Period 4||4
5010435|NCT02263911|12327357|P1|COMPLETED|Period 4||4
5010436|NCT02263911|12327354|P4|STARTED|Period 4||4
5010437|NCT02263911|12327355|P3|STARTED|Period 4||4
5010438|NCT02263911|12327356|P2|STARTED|Period 4||4
5010439|NCT02263911|12327357|P1|STARTED|Period 4||4
5010440|NCT02263911|12327354|P4|NOT COMPLETED|Period 3 Washout||0
5010441|NCT02263911|12327355|P3|NOT COMPLETED|Period 3 Washout||0
5010442|NCT02263911|12327356|P2|NOT COMPLETED|Period 3 Washout||0
5010443|NCT02263911|12327357|P1|NOT COMPLETED|Period 3 Washout||0
5010444|NCT02263911|12327354|P4|COMPLETED|Period 3 Washout||4
5010445|NCT02263911|12327355|P3|COMPLETED|Period 3 Washout||4
5010446|NCT02263911|12327356|P2|COMPLETED|Period 3 Washout||4
5010447|NCT02263911|12327357|P1|COMPLETED|Period 3 Washout||4
5010448|NCT02263911|12327354|P4|STARTED|Period 3 Washout||4
5010449|NCT02263911|12327355|P3|STARTED|Period 3 Washout||4
5010450|NCT02263911|12327356|P2|STARTED|Period 3 Washout||4
5010451|NCT02263911|12327357|P1|STARTED|Period 3 Washout||4
5010452|NCT02263911|12327354|P4|NOT COMPLETED|Period 3||0
5010453|NCT02263911|12327355|P3|NOT COMPLETED|Period 3||0
5010454|NCT02263911|12327356|P2|NOT COMPLETED|Period 3||0
5010455|NCT02263911|12327357|P1|NOT COMPLETED|Period 3||0
5010456|NCT02263911|12327354|P4|COMPLETED|Period 3||4
5010457|NCT02263911|12327355|P3|COMPLETED|Period 3||4
5010458|NCT02263911|12327356|P2|COMPLETED|Period 3||4
5010459|NCT02263911|12327357|P1|COMPLETED|Period 3||4
5010460|NCT02263911|12327354|P4|STARTED|Period 3||4
5010461|NCT02263911|12327355|P3|STARTED|Period 3||4
5010462|NCT02263911|12327356|P2|STARTED|Period 3||4
5010463|NCT02263911|12327357|P1|STARTED|Period 3||4
5010464|NCT02263911|12327354|P4|NOT COMPLETED|Period 2 Washout||0
5010465|NCT02263911|12327355|P3|NOT COMPLETED|Period 2 Washout||0
5010466|NCT02263911|12327356|P2|NOT COMPLETED|Period 2 Washout||0
5010467|NCT02263911|12327357|P1|NOT COMPLETED|Period 2 Washout||0
5010468|NCT02263911|12327354|P4|COMPLETED|Period 2 Washout||4
5010469|NCT02263911|12327355|P3|COMPLETED|Period 2 Washout||4
5010470|NCT02263911|12327356|P2|COMPLETED|Period 2 Washout||4
5010471|NCT02263911|12327357|P1|COMPLETED|Period 2 Washout||4
5010472|NCT02263911|12327354|P4|STARTED|Period 2 Washout||4
5010473|NCT02263911|12327355|P3|STARTED|Period 2 Washout||4
5010474|NCT02263911|12327356|P2|STARTED|Period 2 Washout||4
5010475|NCT02263911|12327357|P1|STARTED|Period 2 Washout||4
5010476|NCT02263911|12327354|P4|NOT COMPLETED|Period 2||0
5010477|NCT02263911|12327355|P3|NOT COMPLETED|Period 2||0
5010478|NCT02263911|12327356|P2|NOT COMPLETED|Period 2||0
5010479|NCT02263911|12327357|P1|NOT COMPLETED|Period 2||0
5010480|NCT02263911|12327354|P4|COMPLETED|Period 2||4
5010481|NCT02263911|12327355|P3|COMPLETED|Period 2||4
5010482|NCT02263911|12327356|P2|COMPLETED|Period 2||4
5010483|NCT02263911|12327357|P1|COMPLETED|Period 2||4
5010484|NCT02263911|12327354|P4|STARTED|Period 2||4
5010485|NCT02263911|12327355|P3|STARTED|Period 2||4
5010486|NCT02263911|12327356|P2|STARTED|Period 2||4
5010487|NCT02263911|12327357|P1|STARTED|Period 2||4
5010488|NCT02263911|12327354|P4|NOT COMPLETED|Period 1 Washout||0
5010489|NCT02263911|12327355|P3|NOT COMPLETED|Period 1 Washout||0
5010490|NCT02263911|12327356|P2|NOT COMPLETED|Period 1 Washout||0
5010491|NCT02263911|12327357|P1|NOT COMPLETED|Period 1 Washout||0
5010492|NCT02263911|12327354|P4|COMPLETED|Period 1 Washout||4
5010493|NCT02263911|12327355|P3|COMPLETED|Period 1 Washout||4
5010494|NCT02263911|12327356|P2|COMPLETED|Period 1 Washout||4
5010495|NCT02263911|12327357|P1|COMPLETED|Period 1 Washout||4
5010496|NCT02263911|12327354|P4|STARTED|Period 1 Washout||4
5010497|NCT02263911|12327355|P3|STARTED|Period 1 Washout||4
5010498|NCT02263911|12327356|P2|STARTED|Period 1 Washout||4
5010499|NCT02263911|12327357|P1|STARTED|Period 1 Washout||4
5010500|NCT02263911|12327354|P4|NOT COMPLETED|Period 1||0
5010501|NCT02263911|12327355|P3|NOT COMPLETED|Period 1||0
5010502|NCT02263911|12327356|P2|NOT COMPLETED|Period 1||0
5010503|NCT02263911|12327357|P1|NOT COMPLETED|Period 1||0
5010504|NCT02263911|12327354|P4|COMPLETED|Period 1||4
5010505|NCT02263911|12327355|P3|COMPLETED|Period 1||4
5010506|NCT02263911|12327356|P2|COMPLETED|Period 1||4
5010507|NCT02263911|12327357|P1|COMPLETED|Period 1||4
5010508|NCT02263911|12327354|P4|STARTED|Period 1||4
5010509|NCT02263911|12327355|P3|STARTED|Period 1||4
5010510|NCT02263911|12327356|P2|STARTED|Period 1||4
5010511|NCT02263911|12327357|P1|STARTED|Period 1||4
5010512|NCT02263833|12327379|P1|NOT COMPLETED|Overall Study||0
5010513|NCT02263833|12327379|P1|COMPLETED|Overall Study||742
5010514|NCT02263833|12327379|P1|STARTED|Overall Study||742
5010515|NCT02263547|12327384|P1|NOT COMPLETED|Overall Study||3
5010516|NCT02263547|12327384|P1|COMPLETED|Overall Study||11
5010517|NCT02263547|12327384|P1|STARTED|Overall Study||14
5010518|NCT02263365|12327391|P2|NOT COMPLETED|Overall Study||18
5010519|NCT02263365|12327392|P1|NOT COMPLETED|Overall Study||22
5010520|NCT02263365|12327391|P2|COMPLETED|Overall Study||0
5010521|NCT02263365|12327392|P1|COMPLETED|Overall Study||0
5010522|NCT02263365|12327391|P2|STARTED|Overall Study||18
5010523|NCT02263365|12327392|P1|STARTED|Overall Study||22
5010524|NCT02263326|12327406|P2|NOT COMPLETED|Overall Study||1
5010525|NCT02263326|12327407|P1|NOT COMPLETED|Overall Study||1
5010526|NCT02263326|12327406|P2|COMPLETED|Overall Study||44
5010527|NCT02263326|12327407|P1|COMPLETED|Overall Study||43
5010528|NCT02263326|12327406|P2|STARTED|Overall Study||45
5010529|NCT02263326|12327407|P1|STARTED|Overall Study||44
5010530|NCT02263131|12327429|P2|NOT COMPLETED|Overall Study||1
5010531|NCT02263131|12327430|P1|NOT COMPLETED|Overall Study||10
5010532|NCT02263131|12327429|P2|COMPLETED|Overall Study||68
5010533|NCT02263131|12327430|P1|COMPLETED|Overall Study||337
5010534|NCT02263131|12327429|P2|STARTED|Overall Study||69
5010535|NCT02263131|12327430|P1|STARTED|Overall Study||347
5010536|NCT02263118|12327452|P4|NOT COMPLETED|Overall Study||2
5010537|NCT02263118|12327453|P3|NOT COMPLETED|Overall Study||8
5010538|NCT02263118|12327454|P2|NOT COMPLETED|Overall Study||8
5010539|NCT02263118|12327455|P1|NOT COMPLETED|Overall Study||4
5010540|NCT02263118|12327452|P4|COMPLETED|Overall Study||12
5010541|NCT02263118|12327453|P3|COMPLETED|Overall Study||22
5010542|NCT02263118|12327454|P2|COMPLETED|Overall Study||24
5010543|NCT02263118|12327455|P1|COMPLETED|Overall Study||20
5010544|NCT02263118|12327452|P4|STARTED|Overall Study||14
5010545|NCT02263118|12327453|P3|STARTED|Overall Study||30
5010546|NCT02263118|12327454|P2|STARTED|Overall Study||32
5010547|NCT02263118|12327455|P1|STARTED|Overall Study||24
5010548|NCT02263040|12327479|P2|NOT COMPLETED|Overall Study||0
5010549|NCT02263040|12327480|P1|NOT COMPLETED|Overall Study||0
5010550|NCT02263040|12327479|P2|COMPLETED|Overall Study||83
5010551|NCT02263040|12327480|P1|COMPLETED|Overall Study||87
5010552|NCT02263040|12327479|P2|STARTED|Overall Study||83
5010553|NCT02263040|12327480|P1|STARTED|Overall Study||87
5010554|NCT02262754|12327511|P3|NOT COMPLETED|Overall Study||9
5010555|NCT02262754|12327512|P2|NOT COMPLETED|Overall Study||9
5010556|NCT02262754|12327513|P1|NOT COMPLETED|Overall Study||16
5010557|NCT02262754|12327511|P3|COMPLETED|Overall Study||65
5010558|NCT02262754|12327512|P2|COMPLETED|Overall Study||65
5010559|NCT02262754|12327513|P1|COMPLETED|Overall Study||58
5010560|NCT02262754|12327511|P3|STARTED|Overall Study||74
5010561|NCT02262754|12327512|P2|STARTED|Overall Study||74
5010562|NCT02262754|12327513|P1|STARTED|Overall Study||74
5010563|NCT02262728|12327588|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
5010564|NCT02262728|12327589|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
5010565|NCT02262728|12327588|P2|COMPLETED|Follow-up Phase (3 Years)||18
5010566|NCT02262728|12327589|P1|COMPLETED|Follow-up Phase (3 Years)||15
5010567|NCT02262728|12327588|P2|STARTED|Follow-up Phase (3 Years)||21
5010568|NCT02262728|12327589|P1|STARTED|Follow-up Phase (3 Years)||19
5010569|NCT02262728|12327588|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
5010570|NCT02262728|12327589|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
5010571|NCT02262728|12327588|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
5010572|NCT02262728|12327589|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
5010573|NCT02262728|12327588|P2|STARTED|Treatment Period (12 Weeks)||21
5010574|NCT02262728|12327589|P1|STARTED|Treatment Period (12 Weeks)||19
5010575|NCT02262377|12327621|P2|NOT COMPLETED|Overall Study||6
5010576|NCT02262377|12327622|P1|NOT COMPLETED|Overall Study||12
5010577|NCT02262377|12327621|P2|COMPLETED|Overall Study||73
5010578|NCT02262377|12327622|P1|COMPLETED|Overall Study||68
5010579|NCT02262377|12327621|P2|STARTED|Overall Study||79
5010580|NCT02262377|12327622|P1|STARTED|Overall Study||80
5010581|NCT02262364|12327637|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
5010582|NCT02262364|12327637|P1|COMPLETED|Follow-Up Through 12 Months||10
5010583|NCT02262364|12327637|P1|STARTED|Follow-Up Through 12 Months||10
5010584|NCT02262364|12327637|P1|NOT COMPLETED|Injection With APS||0
5010585|NCT02262364|12327637|P1|COMPLETED|Injection With APS||10
5010586|NCT02262364|12327637|P1|STARTED|Injection With APS||10
5010587|NCT02262364|12327637|P1|NOT COMPLETED|Blood Draw for Device Processing||1
5010588|NCT02262364|12327637|P1|COMPLETED|Blood Draw for Device Processing||10
5010589|NCT02262364|12327637|P1|STARTED|Blood Draw for Device Processing||11
5010590|NCT02262364|12327637|P1|NOT COMPLETED|Study Enrollment||0
5010591|NCT02262364|12327637|P1|COMPLETED|Study Enrollment||11
5010592|NCT02262364|12327637|P1|STARTED|Study Enrollment||11
5010593|NCT02262260|12327646|P2|NOT COMPLETED|Overall Study||10
5010594|NCT02262260|12327647|P1|NOT COMPLETED|Overall Study||11
5010595|NCT02262260|12327646|P2|COMPLETED|Overall Study||32
5010596|NCT02262260|12327647|P1|COMPLETED|Overall Study||34
5010597|NCT02262260|12327646|P2|STARTED|Overall Study||42
5010598|NCT02262260|12327647|P1|STARTED|Overall Study||45
5010599|NCT02262130|12327665|P1|NOT COMPLETED|Overall Study||0
5010600|NCT02262130|12327665|P1|COMPLETED|Overall Study||10
5010601|NCT02262130|12327665|P1|STARTED|Overall Study||10
5010602|NCT02262078|12327675|P2|NOT COMPLETED|Overall Study||0
5010603|NCT02262078|12327676|P1|NOT COMPLETED|Overall Study||0
5010604|NCT02262078|12327675|P2|COMPLETED|Overall Study||13
5010605|NCT02262078|12327676|P1|COMPLETED|Overall Study||13
5010606|NCT02262078|12327675|P2|STARTED|Overall Study||13
5010607|NCT02262078|12327676|P1|STARTED|Overall Study||13
5010608|NCT02262039|12327684|P2|NOT COMPLETED|Overall Study||0
5010609|NCT02262039|12327685|P1|NOT COMPLETED|Overall Study||0
5010610|NCT02262039|12327684|P2|COMPLETED|Overall Study||27
5010611|NCT02262039|12327685|P1|COMPLETED|Overall Study||14
5010612|NCT02262039|12327684|P2|STARTED|Overall Study||27
5010613|NCT02262039|12327685|P1|STARTED|Overall Study||14
5010614|NCT02261974|12327705|P2|NOT COMPLETED|Overall Study||7
5010615|NCT02261974|12327706|P1|NOT COMPLETED|Overall Study||15
5010616|NCT02261974|12327705|P2|COMPLETED|Overall Study||56
5010617|NCT02261974|12327706|P1|COMPLETED|Overall Study||108
5010618|NCT02261974|12327705|P2|Treated|Overall Study||57
5010619|NCT02261974|12327706|P1|Treated|Overall Study||117
5010620|NCT02261974|12327705|P2|STARTED|Overall Study||63
5010621|NCT02261974|12327706|P1|STARTED|Overall Study||123
5010622|NCT02261948|12327722|P2|NOT COMPLETED|Overall Study||0
5010623|NCT02261948|12327723|P1|NOT COMPLETED|Overall Study||0
5010624|NCT02261948|12327722|P2|COMPLETED|Overall Study||19
5010625|NCT02261948|12327723|P1|COMPLETED|Overall Study||23
5010626|NCT02261948|12327722|P2|STARTED|Overall Study||19
5010627|NCT02261948|12327723|P1|STARTED|Overall Study||23
5010628|NCT02261818|12327733|P1|NOT COMPLETED|Overall Study||3
5010629|NCT02261818|12327733|P1|COMPLETED|Overall Study||27
5010630|NCT02261818|12327733|P1|STARTED|Overall Study||30
5010631|NCT02261805|12327737|P3|NOT COMPLETED|Overall Study||0
5010632|NCT02261805|12327738|P2|NOT COMPLETED|Overall Study||0
5010633|NCT02261805|12327739|P1|NOT COMPLETED|Overall Study||0
5010634|NCT02261805|12327737|P3|COMPLETED|Overall Study||2
5010635|NCT02261805|12327738|P2|COMPLETED|Overall Study||6
5010636|NCT02261805|12327739|P1|COMPLETED|Overall Study||3
5010637|NCT02261805|12327737|P3|STARTED|Overall Study||2
5010638|NCT02261805|12327738|P2|STARTED|Overall Study||6
5010639|NCT02261805|12327739|P1|STARTED|Overall Study||3
5010640|NCT02261714|12327747|P1|NOT COMPLETED|Overall Study||28
5010641|NCT02261714|12327747|P1|COMPLETED|Overall Study||4
5010642|NCT02261714|12327747|P1|STARTED|Overall Study||32
5010643|NCT02261597|12327756|P2|NOT COMPLETED|Overall Study||0
5010644|NCT02261597|12327757|P1|NOT COMPLETED|Overall Study||0
5010645|NCT02261597|12327756|P2|COMPLETED|Overall Study||22
5010646|NCT02261597|12327757|P1|COMPLETED|Overall Study||22
5010647|NCT02261597|12327756|P2|STARTED|Overall Study||22
5010648|NCT02261597|12327757|P1|STARTED|Overall Study||22
5010649|NCT02261493|12327770|P3|NOT COMPLETED|Overall Study||26
5010650|NCT02261493|12327771|P2|NOT COMPLETED|Overall Study||47
5010651|NCT02261493|12327772|P1|NOT COMPLETED|Overall Study||30
5010652|NCT02261493|12327770|P3|COMPLETED|Overall Study||287
5010653|NCT02261493|12327771|P2|COMPLETED|Overall Study||271
5010654|NCT02261493|12327772|P1|COMPLETED|Overall Study||126
5010655|NCT02261493|12327770|P3|STARTED|Overall Study||313
5010656|NCT02261493|12327771|P2|STARTED|Overall Study||318
5010657|NCT02261493|12327772|P1|STARTED|Overall Study||156
5010658|NCT02261467|12327800|P2|NOT COMPLETED|Overall Study||37
5010659|NCT02261467|12327801|P1|NOT COMPLETED|Overall Study||21
5010660|NCT02261467|12327800|P2|COMPLETED|Overall Study||253
5010661|NCT02261467|12327801|P1|COMPLETED|Overall Study||80
5010662|NCT02261467|12327800|P2|STARTED|Overall Study||290
5010663|NCT02261467|12327801|P1|STARTED|Overall Study||101
5010664|NCT02261428|12327821|P2|NOT COMPLETED|Overall Study||0
5010665|NCT02261428|12327822|P1|NOT COMPLETED|Overall Study||0
5010666|NCT02261428|12327821|P2|COMPLETED|Overall Study||10
5010667|NCT02261428|12327822|P1|COMPLETED|Overall Study||10
5010668|NCT02261428|12327821|P2|STARTED|Overall Study|Washout (30 minutes)|10
5010669|NCT02261428|12327822|P1|STARTED|Overall Study|Washout (30 minutes)|10
5010670|NCT02260986|12327843|P3|NOT COMPLETED|Overall Study||41
5010671|NCT02260986|12327844|P2|NOT COMPLETED|Overall Study||13
5010672|NCT02260986|12327845|P1|NOT COMPLETED|Overall Study||90
5010673|NCT02260986|12327843|P3|COMPLETED|Overall Study||278
5010674|NCT02260986|12327844|P2|COMPLETED|Overall Study||93
5010675|NCT02260986|12327845|P1|COMPLETED|Overall Study||225
5010676|NCT02260986|12327843|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
5010677|NCT02260986|12327844|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
5010678|NCT02260986|12327845|P1|Safety Population|Overall Study||315
5010679|NCT02260986|12327843|P3|STARTED|Overall Study||319
5010680|NCT02260986|12327844|P2|STARTED|Overall Study||106
5010681|NCT02260986|12327845|P1|STARTED|Overall Study||315
5010682|NCT02260934|12327963|P2|NOT COMPLETED|Overall Study||4
5010683|NCT02260934|12327964|P1|NOT COMPLETED|Overall Study||3
5010684|NCT02260934|12327963|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
5010685|NCT02260934|12327964|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
5010686|NCT02260934|12327963|P2|STARTED|Overall Study||21
5010687|NCT02260934|12327964|P1|STARTED|Overall Study||22
5010688|NCT02260882|12328002|P2|NOT COMPLETED|Overall Study||1
5010689|NCT02260882|12328003|P1|NOT COMPLETED|Overall Study||0
5010690|NCT02260882|12328002|P2|COMPLETED|Overall Study||81
5010691|NCT02260882|12328003|P1|COMPLETED|Overall Study||161
5010692|NCT02260882|12328002|P2|STARTED|Overall Study||82
5010693|NCT02260882|12328003|P1|STARTED|Overall Study||161
5010694|NCT02260817|12328027|P2|NOT COMPLETED|Overall Study||37
5010695|NCT02260817|12328028|P1|NOT COMPLETED|Overall Study||0
5010696|NCT02260817|12328027|P2|COMPLETED|Overall Study||58
5010697|NCT02260817|12328028|P1|COMPLETED|Overall Study||14
5010698|NCT02260817|12328027|P2|STARTED|Overall Study||95
5010699|NCT02260817|12328028|P1|STARTED|Overall Study||14
5010700|NCT02260791|12328076|P2|NOT COMPLETED|Overall Study||34
5010701|NCT02260791|12328077|P1|NOT COMPLETED|Overall Study||33
5010702|NCT02260791|12328076|P2|COMPLETED|Overall Study||328
5010703|NCT02260791|12328077|P1|COMPLETED|Overall Study||333
5010704|NCT02260791|12328076|P2|STARTED|Overall Study||362
5010705|NCT02260791|12328077|P1|STARTED|Overall Study||366
5010706|NCT02260648|12328116|P3|NOT COMPLETED|Overall Study||8
5010707|NCT02260648|12328117|P2|NOT COMPLETED|Overall Study||13
5010708|NCT02260648|12328118|P1|NOT COMPLETED|Overall Study||18
5010709|NCT02260648|12328116|P3|COMPLETED|Overall Study||42
5010710|NCT02260648|12328117|P2|COMPLETED|Overall Study||33
5010711|NCT02260648|12328118|P1|COMPLETED|Overall Study||35
5010712|NCT02260648|12328116|P3|Received at Least One Dose of Study Drug|Overall Study||50
5010713|NCT02260648|12328117|P2|Received at Least One Dose of Study Drug|Overall Study||46
5010714|NCT02260648|12328118|P1|Received at Least One Dose of Study Drug|Overall Study||53
5010715|NCT02260648|12328116|P3|STARTED|Overall Study||50
5010716|NCT02260648|12328117|P2|STARTED|Overall Study||46
5010717|NCT02260648|12328118|P1|STARTED|Overall Study||53
5010718|NCT02260635|12328146|P2|NOT COMPLETED|Open-Label Extension||25
5010719|NCT02260635|12328147|P1|NOT COMPLETED|Open-Label Extension||26
5010720|NCT02260635|12328146|P2|COMPLETED|Open-Label Extension||0
5010721|NCT02260635|12328147|P1|COMPLETED|Open-Label Extension||0
5010722|NCT02260635|12328146|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
5010723|NCT02260635|12328147|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
5010724|NCT02260635|12328146|P2|STARTED|Open-Label Extension||25
5010725|NCT02260635|12328147|P1|STARTED|Open-Label Extension||26
5010726|NCT02260635|12328146|P2|NOT COMPLETED|Double-Blind Treatment Period||2
5010727|NCT02260635|12328147|P1|NOT COMPLETED|Double-Blind Treatment Period||1
5010728|NCT02260635|12328146|P2|COMPLETED|Double-Blind Treatment Period||25
5010729|NCT02260635|12328147|P1|COMPLETED|Double-Blind Treatment Period||26
5010730|NCT02260635|12328146|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
5010731|NCT02260635|12328147|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
5010732|NCT02260635|12328146|P2|STARTED|Double-Blind Treatment Period||27
5010733|NCT02260635|12328147|P1|STARTED|Double-Blind Treatment Period||27
5010734|NCT02260622|12328169|P2|NOT COMPLETED|Overall Study||0
5010735|NCT02260622|12328170|P1|NOT COMPLETED|Overall Study||0
5010736|NCT02260622|12328169|P2|COMPLETED|Overall Study||9
5010737|NCT02260622|12328170|P1|COMPLETED|Overall Study||11
5010738|NCT02260622|12328169|P2|STARTED|Overall Study||9
5010739|NCT02260622|12328170|P1|STARTED|Overall Study||11
5010740|NCT02260492|12328199|P3|NOT COMPLETED|Overall Study||5
5010741|NCT02260492|12328200|P2|NOT COMPLETED|Overall Study||13
5010742|NCT02260492|12328201|P1|NOT COMPLETED|Overall Study||23
5010743|NCT02260492|12328199|P3|COMPLETED|Overall Study||37
5010744|NCT02260492|12328200|P2|COMPLETED|Overall Study||406
5010745|NCT02260492|12328201|P1|COMPLETED|Overall Study||395
5010746|NCT02260492|12328199|P3|Completed Day 1|Overall Study||42
5010747|NCT02260492|12328200|P2|Completed Day 1|Overall Study||419
5010748|NCT02260492|12328201|P1|Completed Day 1|Overall Study||418
5010749|NCT02260492|12328199|P3|STARTED|Overall Study||42
5010750|NCT02260492|12328200|P2|STARTED|Overall Study||419
5010751|NCT02260492|12328201|P1|STARTED|Overall Study||418
5010752|NCT02260440|12328215|P1|NOT COMPLETED|Overall Study||0
5010753|NCT02260440|12328215|P1|COMPLETED|Overall Study||31
5010754|NCT02260440|12328215|P1|STARTED|Overall Study||31
5010755|NCT02260401|12328223|P2|NOT COMPLETED|Overall Study||12
5010756|NCT02260401|12328224|P1|NOT COMPLETED|Overall Study||5
5010757|NCT02260401|12328223|P2|COMPLETED|Overall Study||73
5010758|NCT02260401|12328224|P1|COMPLETED|Overall Study||75
5010759|NCT02260401|12328223|P2|STARTED|Overall Study||85
5010760|NCT02260401|12328224|P1|STARTED|Overall Study||80
5010761|NCT02260388|12328234|P4|NOT COMPLETED|Overall Study||4
5010762|NCT02260388|12328235|P3|NOT COMPLETED|Overall Study||3
5010763|NCT02260388|12328236|P2|NOT COMPLETED|Overall Study||8
5010764|NCT02260388|12328237|P1|NOT COMPLETED|Overall Study||2
5010765|NCT02260388|12328234|P4|COMPLETED|Overall Study||65
5010766|NCT02260388|12328235|P3|COMPLETED|Overall Study||70
5010767|NCT02260388|12328236|P2|COMPLETED|Overall Study||118
5010768|NCT02260388|12328237|P1|COMPLETED|Overall Study||132
5010769|NCT02260388|12328234|P4|STARTED|Overall Study||69
5010770|NCT02260388|12328235|P3|STARTED|Overall Study||73
5010771|NCT02260388|12328236|P2|STARTED|Overall Study||126
5010772|NCT02260388|12328237|P1|STARTED|Overall Study||134
5010773|NCT02260180|12328266|P3|NOT COMPLETED|Overall Study||1
5010774|NCT02260180|12328267|P2|NOT COMPLETED|Overall Study||0
5010775|NCT02260180|12328268|P1|NOT COMPLETED|Overall Study||2
5010776|NCT02260180|12328266|P3|COMPLETED|Overall Study||40
5010777|NCT02260180|12328267|P2|COMPLETED|Overall Study||39
5010778|NCT02260180|12328268|P1|COMPLETED|Overall Study||37
5010779|NCT02260180|12328266|P3|STARTED|Overall Study||41
5010780|NCT02260180|12328267|P2|STARTED|Overall Study||39
5010781|NCT02260180|12328268|P1|STARTED|Overall Study||39
5010782|NCT02260154|12328279|P1|NOT COMPLETED|Overall Study||2
5010783|NCT02260154|12328279|P1|COMPLETED|Overall Study||218
5010784|NCT02260154|12328279|P1|STARTED|Overall Study||220
5010785|NCT02259699|12328295|P2|NOT COMPLETED|Overall Study||20
5010786|NCT02259699|12328296|P1|NOT COMPLETED|Overall Study||27
5010787|NCT02259699|12328295|P2|COMPLETED|Overall Study||40
5010788|NCT02259699|12328296|P1|COMPLETED|Overall Study||37
5010789|NCT02259699|12328295|P2|STARTED|Overall Study||60
5010790|NCT02259699|12328296|P1|STARTED|Overall Study||64
5010791|NCT02259608|12328311|P1|NOT COMPLETED|Overall Study||0
5010792|NCT02259608|12328311|P1|COMPLETED|Overall Study||15
5010793|NCT02259608|12328311|P1|STARTED|Overall Study||15
5010794|NCT02259582|12328319|P3|NOT COMPLETED|Overall Study||21
5010795|NCT02259582|12328320|P2|NOT COMPLETED|Overall Study||17
5010796|NCT02259582|12328321|P1|NOT COMPLETED|Overall Study||16
5010797|NCT02259582|12328319|P3|COMPLETED|Overall Study||8
5010798|NCT02259582|12328320|P2|COMPLETED|Overall Study||11
5010799|NCT02259582|12328321|P1|COMPLETED|Overall Study||9
5010800|NCT02259582|12328319|P3|STARTED|Overall Study||29
5010801|NCT02259582|12328320|P2|STARTED|Overall Study||28
5010802|NCT02259582|12328321|P1|STARTED|Overall Study||25
5010803|NCT02259400|12328331|P2|NOT COMPLETED|Overall Study||2
5010804|NCT02259400|12328332|P1|NOT COMPLETED|Overall Study||0
5010805|NCT02259400|12328331|P2|COMPLETED|Overall Study||60
5010806|NCT02259400|12328332|P1|COMPLETED|Overall Study||62
5010807|NCT02259400|12328331|P2|STARTED|Overall Study||62
5010808|NCT02259400|12328332|P1|STARTED|Overall Study||62
5010809|NCT02259348|12328364|P1|NOT COMPLETED|Overall Study||10
5010810|NCT02259348|12328364|P1|COMPLETED|Overall Study||2
5010811|NCT02259348|12328364|P1|One Year Post-transplant|Overall Study||2
5010812|NCT02259348|12328364|P1|STARTED|Overall Study||12
5010813|NCT02259114|12328381|P5|NOT COMPLETED|Overall Study||6
5010814|NCT02259114|12328382|P4|NOT COMPLETED|Overall Study||3
5010815|NCT02259114|12328383|P3|NOT COMPLETED|Overall Study||13
5010816|NCT02259114|12328384|P2|NOT COMPLETED|Overall Study||4
5010817|NCT02259114|12328385|P1|NOT COMPLETED|Overall Study||21
5010818|NCT02259114|12328381|P5|COMPLETED|Overall Study||0
5010819|NCT02259114|12328382|P4|COMPLETED|Overall Study||0
5010820|NCT02259114|12328383|P3|COMPLETED|Overall Study||0
5010821|NCT02259114|12328384|P2|COMPLETED|Overall Study||0
5010822|NCT02259114|12328385|P1|COMPLETED|Overall Study||0
5010823|NCT02259114|12328381|P5|Treated|Overall Study||6
5010824|NCT02259114|12328382|P4|Treated|Overall Study||3
5010825|NCT02259114|12328383|P3|Treated|Overall Study||13
5010826|NCT02259114|12328384|P2|Treated|Overall Study||4
5010827|NCT02259114|12328385|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
5010828|NCT02259114|12328381|P5|STARTED|Overall Study||6
5010829|NCT02259114|12328382|P4|STARTED|Overall Study||3
5010830|NCT02259114|12328383|P3|STARTED|Overall Study||13
5010831|NCT02259114|12328384|P2|STARTED|Overall Study||4
5010832|NCT02259114|12328385|P1|STARTED|Overall Study||21
5010833|NCT02259088|12328444|P2|NOT COMPLETED|Overall Study||14
5010834|NCT02259088|12328445|P1|NOT COMPLETED|Overall Study||28
5010835|NCT02259088|12328444|P2|COMPLETED|Overall Study||63
5010836|NCT02259088|12328445|P1|COMPLETED|Overall Study||279
5010837|NCT02259088|12328444|P2|Treated (Safety Analysis Set)|Overall Study||75
5010838|NCT02259088|12328445|P1|Treated (Safety Analysis Set)|Overall Study||307
5010839|NCT02259088|12328444|P2|Full Analysis Set|Overall Study||77
5010840|NCT02259088|12328445|P1|Full Analysis Set|Overall Study||307
5010841|NCT02259088|12328444|P2|STARTED|Overall Study||77
5010842|NCT02259088|12328445|P1|STARTED|Overall Study||307
5010843|NCT02259010|12328490|P1|NOT COMPLETED|Overall Study||5
5010844|NCT02259010|12328490|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
5010845|NCT02259010|12328490|P1|STARTED|Overall Study||24
5010846|NCT02258542|12328519|P4|NOT COMPLETED|Overall Study||5
5010847|NCT02258542|12328520|P3|NOT COMPLETED|Overall Study||8
5010848|NCT02258542|12328521|P2|NOT COMPLETED|Overall Study||49
5010849|NCT02258542|12328522|P1|NOT COMPLETED|Overall Study||42
5010850|NCT02258542|12328519|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
5010851|NCT02258542|12328520|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
5010852|NCT02258542|12328521|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
5010853|NCT02258542|12328522|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
5010854|NCT02258542|12328519|P4|Adolescents Only|Overall Study||0
5010855|NCT02258542|12328520|P3|Adolescents Only|Overall Study||0
5010856|NCT02258542|12328521|P2|Adolescents Only|Overall Study||61
5010857|NCT02258542|12328522|P1|Adolescents Only|Overall Study||25
5010858|NCT02258542|12328519|P4|Treated|Overall Study||97
5010859|NCT02258542|12328520|P3|Treated|Overall Study||100
5010860|NCT02258542|12328521|P2|Treated|Overall Study||971
5010861|NCT02258542|12328522|P1|Treated|Overall Study||953
5010862|NCT02258542|12328519|P4|STARTED|Overall Study||97
5010863|NCT02258542|12328520|P3|STARTED|Overall Study||100
5010864|NCT02258542|12328521|P2|STARTED|Overall Study||973
5010865|NCT02258542|12328522|P1|STARTED|Overall Study||953
5010866|NCT02258529|12328746|P1|NOT COMPLETED|Overall Study||10
5010867|NCT02258529|12328746|P1|COMPLETED|Overall Study||0
5010868|NCT02258529|12328746|P1|STARTED|Overall Study||10
5010869|NCT02258477|12328758|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
5010870|NCT02258477|12328759|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
5010871|NCT02258477|12328760|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
5010872|NCT02258477|12328761|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
5010873|NCT02258477|12328758|P4|COMPLETED|Fourth Intervention (1 Week)||8
5010874|NCT02258477|12328759|P3|COMPLETED|Fourth Intervention (1 Week)||8
5010875|NCT02258477|12328760|P2|COMPLETED|Fourth Intervention (1 Week)||8
5010876|NCT02258477|12328761|P1|COMPLETED|Fourth Intervention (1 Week)||9
5010877|NCT02258477|12328758|P4|STARTED|Fourth Intervention (1 Week)||8
5010878|NCT02258477|12328759|P3|STARTED|Fourth Intervention (1 Week)||8
5010879|NCT02258477|12328760|P2|STARTED|Fourth Intervention (1 Week)||8
5010880|NCT02258477|12328761|P1|STARTED|Fourth Intervention (1 Week)||9
5010881|NCT02258477|12328758|P4|NOT COMPLETED|Third Intervention (1 Week)||0
5010882|NCT02258477|12328759|P3|NOT COMPLETED|Third Intervention (1 Week)||0
5010883|NCT02258477|12328760|P2|NOT COMPLETED|Third Intervention (1 Week)||0
5010884|NCT02258477|12328761|P1|NOT COMPLETED|Third Intervention (1 Week)||0
5010885|NCT02258477|12328758|P4|COMPLETED|Third Intervention (1 Week)||8
5010886|NCT02258477|12328759|P3|COMPLETED|Third Intervention (1 Week)||8
5010887|NCT02258477|12328760|P2|COMPLETED|Third Intervention (1 Week)||8
5010888|NCT02258477|12328761|P1|COMPLETED|Third Intervention (1 Week)||9
5010889|NCT02258477|12328758|P4|STARTED|Third Intervention (1 Week)||8
5010890|NCT02258477|12328759|P3|STARTED|Third Intervention (1 Week)||8
5010891|NCT02258477|12328760|P2|STARTED|Third Intervention (1 Week)||8
5010892|NCT02258477|12328761|P1|STARTED|Third Intervention (1 Week)||9
5010893|NCT02258477|12328758|P4|NOT COMPLETED|Second Intervention (1 Week)||1
5010894|NCT02258477|12328759|P3|NOT COMPLETED|Second Intervention (1 Week)||1
5010895|NCT02258477|12328760|P2|NOT COMPLETED|Second Intervention (1 Week)||0
5010896|NCT02258477|12328761|P1|NOT COMPLETED|Second Intervention (1 Week)||0
5010897|NCT02258477|12328758|P4|COMPLETED|Second Intervention (1 Week)||8
5010898|NCT02258477|12328759|P3|COMPLETED|Second Intervention (1 Week)||8
5010899|NCT02258477|12328760|P2|COMPLETED|Second Intervention (1 Week)||8
5010900|NCT02258477|12328761|P1|COMPLETED|Second Intervention (1 Week)||9
5010901|NCT02258477|12328758|P4|STARTED|Second Intervention (1 Week)||9
5010902|NCT02258477|12328759|P3|STARTED|Second Intervention (1 Week)||9
5010903|NCT02258477|12328760|P2|STARTED|Second Intervention (1 Week)||8
5010904|NCT02258477|12328761|P1|STARTED|Second Intervention (1 Week)||9
5010905|NCT02258477|12328758|P4|NOT COMPLETED|First Intervention (1 Week)||0
5010906|NCT02258477|12328759|P3|NOT COMPLETED|First Intervention (1 Week)||0
5010907|NCT02258477|12328760|P2|NOT COMPLETED|First Intervention (1 Week)||1
5010908|NCT02258477|12328761|P1|NOT COMPLETED|First Intervention (1 Week)||1
5010909|NCT02258477|12328758|P4|COMPLETED|First Intervention (1 Week)||9
5010910|NCT02258477|12328759|P3|COMPLETED|First Intervention (1 Week)||9
5010911|NCT02258477|12328760|P2|COMPLETED|First Intervention (1 Week)||8
5010912|NCT02258477|12328761|P1|COMPLETED|First Intervention (1 Week)||9
5010913|NCT02258477|12328758|P4|STARTED|First Intervention (1 Week)||9
5010914|NCT02258477|12328759|P3|STARTED|First Intervention (1 Week)||9
5010915|NCT02258477|12328760|P2|STARTED|First Intervention (1 Week)||9
5010916|NCT02258477|12328761|P1|STARTED|First Intervention (1 Week)||10
5010917|NCT02258412|12328779|P3|NOT COMPLETED|Overall Study||0
5010918|NCT02258412|12328780|P2|NOT COMPLETED|Overall Study||0
5010919|NCT02258412|12328781|P1|NOT COMPLETED|Overall Study||0
5010920|NCT02258412|12328779|P3|COMPLETED|Overall Study||61
5010921|NCT02258412|12328780|P2|COMPLETED|Overall Study||25
5010922|NCT02258412|12328781|P1|COMPLETED|Overall Study||26
5010923|NCT02258412|12328779|P3|STARTED|Overall Study||61
5010924|NCT02258412|12328780|P2|STARTED|Overall Study||25
5010925|NCT02258412|12328781|P1|STARTED|Overall Study||26
5010926|NCT02258373|12328790|P2|NOT COMPLETED|Overall Study||2
5010927|NCT02258373|12328791|P1|NOT COMPLETED|Overall Study||7
5010928|NCT02258373|12328790|P2|COMPLETED|Overall Study||75
5010929|NCT02258373|12328791|P1|COMPLETED|Overall Study||142
5010930|NCT02258373|12328790|P2|STARTED|Overall Study||77
5010931|NCT02258373|12328791|P1|STARTED|Overall Study||149
5010932|NCT02258334|12328835|P4|NOT COMPLETED|Overall Study||0
5010933|NCT02258334|12328836|P3|NOT COMPLETED|Overall Study||0
5010934|NCT02258334|12328837|P2|NOT COMPLETED|Overall Study||0
5010935|NCT02258334|12328838|P1|NOT COMPLETED|Overall Study||1
5010936|NCT02258334|12328835|P4|COMPLETED|Overall Study||52
5010937|NCT02258334|12328836|P3|COMPLETED|Overall Study||52
5010938|NCT02258334|12328837|P2|COMPLETED|Overall Study||54
5010939|NCT02258334|12328838|P1|COMPLETED|Overall Study||49
5010940|NCT02258334|12328835|P4|STARTED|Overall Study||52
5010941|NCT02258334|12328836|P3|STARTED|Overall Study||52
5010942|NCT02258334|12328837|P2|STARTED|Overall Study||54
5010943|NCT02258334|12328838|P1|STARTED|Overall Study||50
5010944|NCT02258256|12328864|P1|NOT COMPLETED|Overall Study||0
5010945|NCT02258256|12328864|P1|COMPLETED|Overall Study||11
5010946|NCT02258256|12328864|P1|STARTED|Overall Study||11
5010947|NCT02258152|12328870|P2|NOT COMPLETED|Overall Study||4
5010948|NCT02258152|12328871|P1|NOT COMPLETED|Overall Study||6
5010949|NCT02258152|12328870|P2|COMPLETED|Overall Study||34
5010950|NCT02258152|12328871|P1|COMPLETED|Overall Study||38
5010951|NCT02258152|12328870|P2|STARTED|Overall Study||38
5010952|NCT02258152|12328871|P1|STARTED|Overall Study||44
5010953|NCT02257970|12328883|P4|NOT COMPLETED|Part 3||7
5010954|NCT02257970|12328884|P3|NOT COMPLETED|Part 3||7
5010955|NCT02257970|12328885|P2|NOT COMPLETED|Part 3||0
5010956|NCT02257970|12328886|P1|NOT COMPLETED|Part 3||0
5010957|NCT02257970|12328883|P4|COMPLETED|Part 3||14
5010958|NCT02257970|12328884|P3|COMPLETED|Part 3||16
5010959|NCT02257970|12328885|P2|COMPLETED|Part 3||0
5010960|NCT02257970|12328886|P1|COMPLETED|Part 3||0
5010961|NCT02257970|12328883|P4|STARTED|Part 3||21
5010962|NCT02257970|12328884|P3|STARTED|Part 3||23
5010963|NCT02257970|12328885|P2|STARTED|Part 3||0
5010964|NCT02257970|12328886|P1|STARTED|Part 3||0
5010965|NCT02257970|12328883|P4|NOT COMPLETED|Part 2||0
5010966|NCT02257970|12328884|P3|NOT COMPLETED|Part 2||0
5010967|NCT02257970|12328885|P2|NOT COMPLETED|Part 2||7
5010968|NCT02257970|12328886|P1|NOT COMPLETED|Part 2||0
5010969|NCT02257970|12328883|P4|COMPLETED|Part 2||0
5010970|NCT02257970|12328884|P3|COMPLETED|Part 2||0
5010971|NCT02257970|12328885|P2|COMPLETED|Part 2||16
5010972|NCT02257970|12328886|P1|COMPLETED|Part 2||0
5010973|NCT02257970|12328883|P4|STARTED|Part 2||0
5010974|NCT02257970|12328884|P3|STARTED|Part 2||0
5010975|NCT02257970|12328885|P2|STARTED|Part 2||23
5010976|NCT02257970|12328886|P1|STARTED|Part 2||0
5010977|NCT02257970|12328883|P4|NOT COMPLETED|Part 1||0
5010978|NCT02257970|12328884|P3|NOT COMPLETED|Part 1||0
5010979|NCT02257970|12328885|P2|NOT COMPLETED|Part 1||0
5010980|NCT02257970|12328886|P1|NOT COMPLETED|Part 1||0
5010981|NCT02257970|12328883|P4|COMPLETED|Part 1||0
5010982|NCT02257970|12328884|P3|COMPLETED|Part 1||0
5010983|NCT02257970|12328885|P2|COMPLETED|Part 1||0
5010984|NCT02257970|12328886|P1|COMPLETED|Part 1||50
5010985|NCT02257970|12328883|P4|STARTED|Part 1||0
5010986|NCT02257970|12328884|P3|STARTED|Part 1||0
5010987|NCT02257970|12328885|P2|STARTED|Part 1||0
5010988|NCT02257970|12328886|P1|STARTED|Part 1||50
5010989|NCT02257918|12328912|P3|NOT COMPLETED|Overall Study||2
5010990|NCT02257918|12328913|P2|NOT COMPLETED|Overall Study||1
5010991|NCT02257918|12328914|P1|NOT COMPLETED|Overall Study||4
5010992|NCT02257918|12328912|P3|COMPLETED|Overall Study||39
5010993|NCT02257918|12328913|P2|COMPLETED|Overall Study||66
5010994|NCT02257918|12328914|P1|COMPLETED|Overall Study||68
5010995|NCT02257918|12328912|P3|Test of Cure Visit|Overall Study||40
5010996|NCT02257918|12328913|P2|Test of Cure Visit|Overall Study||67
5010997|NCT02257918|12328914|P1|Test of Cure Visit|Overall Study||72
5010998|NCT02257918|12328912|P3|STARTED|Overall Study||41
5010999|NCT02257918|12328913|P2|STARTED|Overall Study||67
5011000|NCT02257918|12328914|P1|STARTED|Overall Study||72
5011001|NCT02257684|12328964|P1|NOT COMPLETED|Overall Study||4
5011002|NCT02257684|12328964|P1|COMPLETED|Overall Study||0
5011003|NCT02257684|12328964|P1|STARTED|Overall Study||4
5011004|NCT02257632|12328974|P2|NOT COMPLETED|Overall Study||3
5011005|NCT02257632|12328975|P1|NOT COMPLETED|Overall Study||1
5011006|NCT02257632|12328974|P2|COMPLETED|Overall Study||19
5011007|NCT02257632|12328975|P1|COMPLETED|Overall Study||18
5011008|NCT02257632|12328974|P2|Per-Protocol Set (PPS)|Overall Study||20
5011009|NCT02257632|12328975|P1|Per-Protocol Set (PPS)|Overall Study||17
5011010|NCT02257632|12328974|P2|Safety Set (SAF)|Overall Study||21
5011011|NCT02257632|12328975|P1|Safety Set (SAF)|Overall Study||19
5011012|NCT02257632|12328974|P2|Full Analysis Set (FAS)|Overall Study||21
5011013|NCT02257632|12328975|P1|Full Analysis Set (FAS)|Overall Study||19
5011014|NCT02257632|12328974|P2|STARTED|Overall Study||22
5011015|NCT02257632|12328975|P1|STARTED|Overall Study||19
5011016|NCT02257541|12328992|P5|NOT COMPLETED|Overall Study||0
5011017|NCT02257541|12328993|P4|NOT COMPLETED|Overall Study||0
5011018|NCT02257541|12328994|P3|NOT COMPLETED|Overall Study||0
5011019|NCT02257541|12328995|P2|NOT COMPLETED|Overall Study||0
5011020|NCT02257541|12328996|P1|NOT COMPLETED|Overall Study||0
5011021|NCT02257541|12328992|P5|COMPLETED|Overall Study||1
5011022|NCT02257541|12328993|P4|COMPLETED|Overall Study||3
5011023|NCT02257541|12328994|P3|COMPLETED|Overall Study||1
5011024|NCT02257541|12328995|P2|COMPLETED|Overall Study||8
5011025|NCT02257541|12328996|P1|COMPLETED|Overall Study||3
5011026|NCT02257541|12328992|P5|STARTED|Overall Study||1
5011027|NCT02257541|12328993|P4|STARTED|Overall Study||3
5011028|NCT02257541|12328994|P3|STARTED|Overall Study||1
5011029|NCT02257541|12328995|P2|STARTED|Overall Study||8
5011030|NCT02257541|12328996|P1|STARTED|Overall Study||3
5011031|NCT02257489|12329024|P9|NOT COMPLETED|Overall Study||0
5011032|NCT02257489|12329025|P8|NOT COMPLETED|Overall Study||0
5011033|NCT02257489|12329026|P7|NOT COMPLETED|Overall Study||0
5011034|NCT02257489|12329027|P6|NOT COMPLETED|Overall Study||0
5011035|NCT02257489|12329028|P5|NOT COMPLETED|Overall Study||0
5011036|NCT02257489|12329029|P4|NOT COMPLETED|Overall Study||1
5011037|NCT02257489|12329030|P3|NOT COMPLETED|Overall Study||0
5011038|NCT02257489|12329031|P2|NOT COMPLETED|Overall Study||0
5011039|NCT02257489|12329032|P1|NOT COMPLETED|Overall Study||0
5011040|NCT02257489|12329024|P9|COMPLETED|Overall Study||6
5011041|NCT02257489|12329025|P8|COMPLETED|Overall Study||10
5011042|NCT02257489|12329026|P7|COMPLETED|Overall Study||6
5011043|NCT02257489|12329027|P6|COMPLETED|Overall Study||6
5011044|NCT02257489|12329028|P5|COMPLETED|Overall Study||6
5011045|NCT02257489|12329029|P4|COMPLETED|Overall Study||5
5011046|NCT02257489|12329030|P3|COMPLETED|Overall Study||6
5011047|NCT02257489|12329031|P2|COMPLETED|Overall Study||6
5011048|NCT02257489|12329032|P1|COMPLETED|Overall Study||6
5011049|NCT02257489|12329024|P9|STARTED|Overall Study||6
5011050|NCT02257489|12329025|P8|STARTED|Overall Study||10
5011051|NCT02257489|12329026|P7|STARTED|Overall Study||6
5011052|NCT02257489|12329027|P6|STARTED|Overall Study||6
5011053|NCT02257489|12329028|P5|STARTED|Overall Study||6
5011054|NCT02257489|12329029|P4|STARTED|Overall Study||6
5011055|NCT02257489|12329030|P3|STARTED|Overall Study||6
5011056|NCT02257489|12329031|P2|STARTED|Overall Study||6
5011057|NCT02257489|12329032|P1|STARTED|Overall Study||6
5011058|NCT02257385|12329068|P2|NOT COMPLETED|Overall Study||22
5011059|NCT02257385|12329069|P1|NOT COMPLETED|Overall Study||22
5011060|NCT02257385|12329068|P2|COMPLETED|Overall Study||457
5011061|NCT02257385|12329069|P1|COMPLETED|Overall Study||460
5011062|NCT02257385|12329068|P2|STARTED|Overall Study||479
5011063|NCT02257385|12329069|P1|STARTED|Overall Study||482
5011064|NCT02257372|12329079|P2|NOT COMPLETED|Overall Study||10
5011065|NCT02257372|12329080|P1|NOT COMPLETED|Overall Study||7
5011066|NCT02257372|12329079|P2|COMPLETED|Overall Study||109
5011067|NCT02257372|12329080|P1|COMPLETED|Overall Study||110
5011068|NCT02257372|12329079|P2|STARTED|Overall Study||119
5011069|NCT02257372|12329080|P1|STARTED|Overall Study||117
5011070|NCT02257099|12329088|P1|NOT COMPLETED|Overall Study||0
5011071|NCT02257099|12329088|P1|COMPLETED|Overall Study||20
5011072|NCT02257099|12329088|P1|STARTED|Overall Study||20
5011073|NCT02256982|12329097|P2|NOT COMPLETED|Overall Study||1
5011074|NCT02256982|12329098|P1|NOT COMPLETED|Overall Study||0
5011075|NCT02256982|12329097|P2|COMPLETED|Overall Study||1
5011076|NCT02256982|12329098|P1|COMPLETED|Overall Study||1
5011077|NCT02256982|12329097|P2|STARTED|Overall Study||2
5011078|NCT02256982|12329098|P1|STARTED|Overall Study||1
5011079|NCT02256969|12329107|P3|NOT COMPLETED|Overall Study||1
5011080|NCT02256969|12329108|P2|NOT COMPLETED|Overall Study||1
5011081|NCT02256969|12329109|P1|NOT COMPLETED|Overall Study||2
5011082|NCT02256969|12329107|P3|COMPLETED|Overall Study||14
5011083|NCT02256969|12329108|P2|COMPLETED|Overall Study||14
5011084|NCT02256969|12329109|P1|COMPLETED|Overall Study||13
5011085|NCT02256969|12329107|P3|STARTED|Overall Study||15
5011086|NCT02256969|12329108|P2|STARTED|Overall Study||15
5011087|NCT02256969|12329109|P1|STARTED|Overall Study||15
5011088|NCT02256917|12329126|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
5011089|NCT02256917|12329126|P1|COMPLETED|Prophylactic Treatment Phase II||52
5011090|NCT02256917|12329126|P1|STARTED|Prophylactic Treatment Phase II||56
5011091|NCT02256917|12329126|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
5011092|NCT02256917|12329126|P1|COMPLETED|Prophylactic Treatment Phase I||56
5011093|NCT02256917|12329126|P1|STARTED|Prophylactic Treatment Phase I||57
5011094|NCT02256917|12329126|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
5011095|NCT02256917|12329126|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
5011096|NCT02256917|12329126|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
5011097|NCT02256891|12329147|P2|NOT COMPLETED|Overall Study||13
5011098|NCT02256891|12329148|P1|NOT COMPLETED|Overall Study||12
5011099|NCT02256891|12329147|P2|COMPLETED|Overall Study||29
5011100|NCT02256891|12329148|P1|COMPLETED|Overall Study||43
5011101|NCT02256891|12329147|P2|STARTED|Overall Study||42
5011102|NCT02256891|12329148|P1|STARTED|Overall Study||55
5011103|NCT02256839|12329174|P2|NOT COMPLETED|Overall Study||3
5011104|NCT02256839|12329175|P1|NOT COMPLETED|Overall Study||2
5011105|NCT02256839|12329174|P2|COMPLETED|Overall Study||212
5011106|NCT02256839|12329175|P1|COMPLETED|Overall Study||51
5011107|NCT02256839|12329174|P2|STARTED|Overall Study||215
5011108|NCT02256839|12329175|P1|STARTED|Overall Study||53
5011109|NCT02256553|12329181|P1|NOT COMPLETED|Period III||3
5011110|NCT02256553|12329181|P1|COMPLETED|Period III||91
5011111|NCT02256553|12329181|P1|STARTED|Period III||94
5011112|NCT02256553|12329181|P1|NOT COMPLETED|Period II||2
5011113|NCT02256553|12329181|P1|COMPLETED|Period II||94
5011114|NCT02256553|12329181|P1|STARTED|Period II||96
5011115|NCT02256553|12329181|P1|NOT COMPLETED|Period I||6
5011116|NCT02256553|12329181|P1|COMPLETED|Period I||96
5011117|NCT02256553|12329181|P1|STARTED|Period I||102
5011118|NCT02256540|12329190|P3|NOT COMPLETED|Overall Study||2
5011119|NCT02256540|12329191|P2|NOT COMPLETED|Overall Study||1
5011120|NCT02256540|12329192|P1|NOT COMPLETED|Overall Study||0
5011121|NCT02256540|12329190|P3|COMPLETED|Overall Study||4
5011122|NCT02256540|12329191|P2|COMPLETED|Overall Study||5
5011123|NCT02256540|12329192|P1|COMPLETED|Overall Study||6
5011124|NCT02256540|12329190|P3|STARTED|Overall Study||6
5011125|NCT02256540|12329191|P2|STARTED|Overall Study||6
5011126|NCT02256540|12329192|P1|STARTED|Overall Study||6
5011127|NCT02256488|12329210|P4|NOT COMPLETED|Overall Study||6
5011128|NCT02256488|12329211|P3|NOT COMPLETED|Overall Study||10
5011129|NCT02256488|12329212|P2|NOT COMPLETED|Overall Study||6
5011130|NCT02256488|12329213|P1|NOT COMPLETED|Overall Study||8
5011131|NCT02256488|12329210|P4|COMPLETED|Overall Study||384
5011132|NCT02256488|12329211|P3|COMPLETED|Overall Study||382
5011133|NCT02256488|12329212|P2|COMPLETED|Overall Study||386
5011134|NCT02256488|12329213|P1|COMPLETED|Overall Study||379
5011135|NCT02256488|12329210|P4|STARTED|Overall Study||390
5011136|NCT02256488|12329211|P3|STARTED|Overall Study||392
5011137|NCT02256488|12329212|P2|STARTED|Overall Study||392
5011138|NCT02256488|12329213|P1|STARTED|Overall Study||387
5011139|NCT02256436|12329229|P2|NOT COMPLETED|Overall Study||272
5011140|NCT02256436|12329230|P1|NOT COMPLETED|Overall Study||270
5011141|NCT02256436|12329229|P2|COMPLETED|Overall Study||0
5011142|NCT02256436|12329230|P1|COMPLETED|Overall Study||0
5011143|NCT02256436|12329229|P2|Treated|Overall Study||255
5011144|NCT02256436|12329230|P1|Treated|Overall Study||266
5011145|NCT02256436|12329229|P2|STARTED|Overall Study||272
5011146|NCT02256436|12329230|P1|STARTED|Overall Study||270
5011147|NCT02256358|12329268|P2|NOT COMPLETED|Overall Study||1
5011148|NCT02256358|12329269|P1|NOT COMPLETED|Overall Study||0
5011149|NCT02256358|12329268|P2|COMPLETED|Overall Study||33
5011150|NCT02256358|12329269|P1|COMPLETED|Overall Study||34
5011151|NCT02256358|12329268|P2|STARTED|Overall Study||34
5011152|NCT02256358|12329269|P1|STARTED|Overall Study||34
5011153|NCT02256345|12329277|P2|NOT COMPLETED|Overall Study||0
5011154|NCT02256345|12329278|P1|NOT COMPLETED|Overall Study||0
5011155|NCT02256345|12329277|P2|COMPLETED|Overall Study||3
5011156|NCT02256345|12329278|P1|COMPLETED|Overall Study||9
5011157|NCT02256345|12329277|P2|STARTED|Overall Study||3
5011158|NCT02256345|12329278|P1|STARTED|Overall Study||9
5011159|NCT02256267|12329290|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
5011160|NCT02256267|12329290|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
5011161|NCT02256267|12329290|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
5011162|NCT02256267|12329290|P1|STARTED|Period 2 (Day 7 to Day 14)||23
5011163|NCT02256267|12329290|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
5011164|NCT02256267|12329290|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
5011165|NCT02256267|12329290|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
5011166|NCT02256267|12329290|P1|STARTED|Period 2 (Day 1 to Day 6)||23
5011167|NCT02256267|12329290|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
5011168|NCT02256267|12329290|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
5011169|NCT02256267|12329290|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
5011170|NCT02256267|12329290|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
5011171|NCT02256189|12329301|P2|NOT COMPLETED|Overall Study||0
5011172|NCT02256189|12329302|P1|NOT COMPLETED|Overall Study||0
5011173|NCT02256189|12329301|P2|COMPLETED|Overall Study||13
5011174|NCT02256189|12329302|P1|COMPLETED|Overall Study||15
5011175|NCT02256189|12329301|P2|STARTED|Overall Study||13
5011176|NCT02256189|12329302|P1|STARTED|Overall Study||15
5011177|NCT02256111|12329312|P2|NOT COMPLETED|Overall Study||0
5011178|NCT02256111|12329313|P1|NOT COMPLETED|Overall Study||0
5011179|NCT02256111|12329312|P2|COMPLETED|Overall Study||13
5011180|NCT02256111|12329313|P1|COMPLETED|Overall Study||13
5011181|NCT02256111|12329312|P2|STARTED|Overall Study||13
5011182|NCT02256111|12329313|P1|STARTED|Overall Study||13
5011183|NCT02256072|12329348|P2|NOT COMPLETED|Overall Study||29
5011184|NCT02256072|12329349|P1|NOT COMPLETED|Overall Study||42
5011185|NCT02256072|12329348|P2|COMPLETED|Overall Study||162
5011186|NCT02256072|12329349|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
5011187|NCT02256072|12329348|P2|Completed 1 Month Follow-Up|Overall Study||179
5011188|NCT02256072|12329349|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
5011189|NCT02256072|12329348|P2|STARTED|Overall Study||191
5011190|NCT02256072|12329349|P1|STARTED|Overall Study||194
5011191|NCT02255981|12329363|P1|NOT COMPLETED|Overall Study||4
5011192|NCT02255981|12329363|P1|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
5011193|NCT02255981|12329363|P1|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
5011194|NCT02255760|12329378|P5|NOT COMPLETED|Overall Study||0
5011195|NCT02255760|12329379|P4|NOT COMPLETED|Overall Study||0
5011196|NCT02255760|12329380|P3|NOT COMPLETED|Overall Study||0
5011197|NCT02255760|12329381|P2|NOT COMPLETED|Overall Study||1
5011198|NCT02255760|12329382|P1|NOT COMPLETED|Overall Study||0
5011199|NCT02255760|12329378|P5|COMPLETED|Overall Study||9
5011200|NCT02255760|12329379|P4|COMPLETED|Overall Study||15
5011201|NCT02255760|12329380|P3|COMPLETED|Overall Study||15
5011202|NCT02255760|12329381|P2|COMPLETED|Overall Study||2
5011203|NCT02255760|12329382|P1|COMPLETED|Overall Study||14
5011204|NCT02255760|12329378|P5|STARTED|Overall Study||9
5011205|NCT02255760|12329379|P4|STARTED|Overall Study||15
5011206|NCT02255760|12329380|P3|STARTED|Overall Study||15
5011207|NCT02255760|12329381|P2|STARTED|Overall Study||3
5011208|NCT02255760|12329382|P1|STARTED|Overall Study||14
5011209|NCT02255565|12329437|P3|NOT COMPLETED|Overall Study||0
5011210|NCT02255565|12329438|P2|NOT COMPLETED|Overall Study||1
5011211|NCT02255565|12329439|P1|NOT COMPLETED|Overall Study||0
5011212|NCT02255565|12329437|P3|COMPLETED|Overall Study||9
5011213|NCT02255565|12329438|P2|COMPLETED|Overall Study||8
5011214|NCT02255565|12329439|P1|COMPLETED|Overall Study||9
5011215|NCT02255565|12329437|P3|STARTED|Overall Study||9
5011216|NCT02255565|12329438|P2|STARTED|Overall Study||9
5011217|NCT02255565|12329439|P1|STARTED|Overall Study||9
5011218|NCT02255552|12329500|P2|NOT COMPLETED|Overall Study||15
5011219|NCT02255552|12329501|P1|NOT COMPLETED|Overall Study||1
5011220|NCT02255552|12329500|P2|COMPLETED|Overall Study||15
5011221|NCT02255552|12329501|P1|COMPLETED|Overall Study||78
5011222|NCT02255552|12329500|P2|STARTED|Overall Study||30
5011223|NCT02255552|12329501|P1|STARTED|Overall Study||79
5011224|NCT02255461|12329521|P5|NOT COMPLETED|Overall Study||2
5011225|NCT02255461|12329522|P4|NOT COMPLETED|Overall Study||0
5011226|NCT02255461|12329523|P3|NOT COMPLETED|Overall Study||1
5011227|NCT02255461|12329524|P2|NOT COMPLETED|Overall Study||2
5011228|NCT02255461|12329525|P1|NOT COMPLETED|Overall Study||0
5011229|NCT02255461|12329521|P5|COMPLETED|Overall Study||8
5011230|NCT02255461|12329522|P4|COMPLETED|Overall Study||4
5011231|NCT02255461|12329523|P3|COMPLETED|Overall Study||5
5011232|NCT02255461|12329524|P2|COMPLETED|Overall Study||10
5011233|NCT02255461|12329525|P1|COMPLETED|Overall Study||3
5011234|NCT02255461|12329521|P5|STARTED|Overall Study||10
5011235|NCT02255461|12329522|P4|STARTED|Overall Study||4
5011236|NCT02255461|12329523|P3|STARTED|Overall Study||6
5011237|NCT02255461|12329524|P2|STARTED|Overall Study||12
5011238|NCT02255461|12329525|P1|STARTED|Overall Study||3
5011239|NCT02255357|12329599|P2|NOT COMPLETED|Overall Study||10
5011240|NCT02255357|12329600|P1|NOT COMPLETED|Overall Study||7
5011241|NCT02255357|12329599|P2|COMPLETED|Overall Study||5
5011242|NCT02255357|12329600|P1|COMPLETED|Overall Study||4
5011243|NCT02255357|12329599|P2|STARTED|Overall Study||15
5011244|NCT02255357|12329600|P1|STARTED|Overall Study||11
5011245|NCT02255279|12329608|P2|NOT COMPLETED|Overall Study||9
5011246|NCT02255279|12329609|P1|NOT COMPLETED|Overall Study||5
5011247|NCT02255279|12329608|P2|COMPLETED|Overall Study||134
5011248|NCT02255279|12329609|P1|COMPLETED|Overall Study||139
5011249|NCT02255279|12329608|P2|STARTED|Overall Study||143
5011250|NCT02255279|12329609|P1|STARTED|Overall Study||144
5011251|NCT02255175|12329637|P2|NOT COMPLETED|Overall Study||12
5011252|NCT02255175|12329638|P1|NOT COMPLETED|Overall Study||17
5011253|NCT02255175|12329637|P2|COMPLETED|Overall Study||19
5011254|NCT02255175|12329638|P1|COMPLETED|Overall Study||16
5011255|NCT02255175|12329637|P2|STARTED|Overall Study||31
5011256|NCT02255175|12329638|P1|STARTED|Overall Study||33
5011257|NCT02255149|12329662|P1|NOT COMPLETED|Overall Study||5
5011258|NCT02255149|12329662|P1|COMPLETED|Overall Study||5
5011259|NCT02255149|12329662|P1|STARTED|Overall Study||10
5011260|NCT02255110|12329666|P1|NOT COMPLETED|Overall Study||0
5011261|NCT02255110|12329666|P1|COMPLETED|Overall Study||6
5011262|NCT02255110|12329666|P1|STARTED|Overall Study||6
5011263|NCT02255097|12329678|P1|NOT COMPLETED|Overall Study||172
5011264|NCT02255097|12329678|P1|COMPLETED|Overall Study||0
5011265|NCT02255097|12329678|P1|Treated|Overall Study||171
5011266|NCT02255097|12329678|P1|STARTED|Overall Study||172
5011267|NCT02254772|12329699|P1|NOT COMPLETED|Overall Study||2
5011268|NCT02254772|12329699|P1|COMPLETED|Overall Study||7
5011269|NCT02254772|12329699|P1|STARTED|Overall Study||9
5011270|NCT02254681|12329705|P1|NOT COMPLETED|Overall Study||6
5011271|NCT02254681|12329705|P1|COMPLETED|Overall Study||0
5011272|NCT02254681|12329705|P1|STARTED|Overall Study||6
5011273|NCT02254551|12329715|P1|NOT COMPLETED|Maintenance||0
5011274|NCT02254551|12329715|P1|COMPLETED|Maintenance||0
5011275|NCT02254551|12329715|P1|STARTED|Maintenance||0
5011276|NCT02254551|12329715|P1|NOT COMPLETED|Expansion||0
5011277|NCT02254551|12329715|P1|COMPLETED|Expansion||0
5011278|NCT02254551|12329715|P1|STARTED|Expansion||0
5011279|NCT02254551|12329715|P1|NOT COMPLETED|Dose Escalation||3
5011280|NCT02254551|12329715|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
5011281|NCT02254551|12329715|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
5011282|NCT02254551|12329715|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
5011283|NCT02254551|12329715|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
5011284|NCT02254551|12329715|P1|STARTED|Dose Escalation||7
5011285|NCT02254486|12329725|P2|NOT COMPLETED|Overall Study||55
5011286|NCT02254486|12329726|P1|NOT COMPLETED|Overall Study||50
5011287|NCT02254486|12329725|P2|COMPLETED|Overall Study||255
5011288|NCT02254486|12329726|P1|COMPLETED|Overall Study||261
5011289|NCT02254486|12329725|P2|STARTED|Overall Study||310
5011290|NCT02254486|12329726|P1|STARTED|Overall Study||311
5011291|NCT02254473|12329744|P2|NOT COMPLETED|Overall Study||1
5011292|NCT02254473|12329745|P1|NOT COMPLETED|Overall Study||2
5011293|NCT02254473|12329744|P2|COMPLETED|Overall Study||2
5011294|NCT02254473|12329745|P1|COMPLETED|Overall Study||7
5011295|NCT02254473|12329744|P2|STARTED|Overall Study||3
5011296|NCT02254473|12329745|P1|STARTED|Overall Study||9
5011297|NCT02254460|12329765|P2|NOT COMPLETED|Overall Study||0
5011298|NCT02254460|12329766|P1|NOT COMPLETED|Overall Study||1
5011299|NCT02254460|12329765|P2|COMPLETED|Overall Study||12
5011300|NCT02254460|12329766|P1|COMPLETED|Overall Study||12
5011301|NCT02254460|12329765|P2|STARTED|Overall Study||12
5011302|NCT02254460|12329766|P1|STARTED|Overall Study||13
5011303|NCT02254421|12329774|P2|NOT COMPLETED|Overall Study||3
5011304|NCT02254421|12329775|P1|NOT COMPLETED|Overall Study||2
5011305|NCT02254421|12329774|P2|COMPLETED|Overall Study||26
5011306|NCT02254421|12329775|P1|COMPLETED|Overall Study||29
5011307|NCT02254421|12329774|P2|STARTED|Overall Study||29
5011308|NCT02254421|12329775|P1|STARTED|Overall Study||31
5011309|NCT02254408|12329789|P2|NOT COMPLETED|Overall Study||10
5011310|NCT02254408|12329790|P1|NOT COMPLETED|Overall Study||8
5011311|NCT02254408|12329789|P2|COMPLETED|Overall Study||83
5011312|NCT02254408|12329790|P1|COMPLETED|Overall Study||88
5011313|NCT02254408|12329789|P2|STARTED|Overall Study||93
5011314|NCT02254408|12329790|P1|STARTED|Overall Study||96
5011315|NCT02254304|12329802|P2|NOT COMPLETED|Overall Study||4
5011316|NCT02254304|12329803|P1|NOT COMPLETED|Overall Study||14
5011317|NCT02254304|12329802|P2|COMPLETED|Overall Study||13
5011318|NCT02254304|12329803|P1|COMPLETED|Overall Study||75
5011319|NCT02254304|12329802|P2|STARTED|Overall Study||17
5011320|NCT02254304|12329803|P1|STARTED|Overall Study||89
5011321|NCT02254291|12329863|P3|NOT COMPLETED|Overall Study||2
5011322|NCT02254291|12329864|P2|NOT COMPLETED|Overall Study||3
5011323|NCT02254291|12329865|P1|NOT COMPLETED|Overall Study||0
5011324|NCT02254291|12329863|P3|COMPLETED|Overall Study||101
5011325|NCT02254291|12329864|P2|COMPLETED|Overall Study||99
5011326|NCT02254291|12329865|P1|COMPLETED|Overall Study||103
5011327|NCT02254291|12329863|P3|Exposed|Overall Study||103
5011328|NCT02254291|12329864|P2|Exposed|Overall Study||102
5011329|NCT02254291|12329865|P1|Exposed|Overall Study||103
5011330|NCT02254291|12329863|P3|STARTED|Overall Study||103
5011331|NCT02254291|12329864|P2|STARTED|Overall Study||102
5011332|NCT02254291|12329865|P1|STARTED|Overall Study||103
5011333|NCT02254265|12329882|P3|NOT COMPLETED|Overall Study||8
5011334|NCT02254265|12329883|P2|NOT COMPLETED|Overall Study||12
5011335|NCT02254265|12329884|P1|NOT COMPLETED|Overall Study||9
5011336|NCT02254265|12329882|P3|COMPLETED|Overall Study||144
5011337|NCT02254265|12329883|P2|COMPLETED|Overall Study||140
5011338|NCT02254265|12329884|P1|COMPLETED|Overall Study||142
5011339|NCT02254265|12329882|P3|STARTED|Overall Study||152
5011340|NCT02254265|12329883|P2|STARTED|Overall Study||152
5011341|NCT02254265|12329884|P1|STARTED|Overall Study||151
5011342|NCT02254252|12329909|P2|NOT COMPLETED|Overall Study||2
5011343|NCT02254252|12329910|P1|NOT COMPLETED|Overall Study||3
5011344|NCT02254252|12329909|P2|COMPLETED|Overall Study||25
5011345|NCT02254252|12329910|P1|COMPLETED|Overall Study||24
5011346|NCT02254252|12329909|P2|STARTED|Overall Study||27
5011347|NCT02254252|12329910|P1|STARTED|Overall Study||27
5011348|NCT02253654|12329922|P2|NOT COMPLETED|Overall Study||18
5011349|NCT02253654|12329923|P1|NOT COMPLETED|Overall Study||23
5011350|NCT02253654|12329922|P2|COMPLETED|Overall Study||90
5011351|NCT02253654|12329923|P1|COMPLETED|Overall Study||85
5011352|NCT02253654|12329922|P2|Received Treatment|Overall Study||107
5011353|NCT02253654|12329923|P1|Received Treatment|Overall Study||104
5011354|NCT02253654|12329922|P2|STARTED|Overall Study||108
5011355|NCT02253654|12329923|P1|STARTED|Overall Study||108
5011356|NCT02253537|12329943|P1|NOT COMPLETED|Overall Study||0
5011357|NCT02253537|12329943|P1|COMPLETED|Overall Study||15
5011358|NCT02253537|12329943|P1|STARTED|Overall Study||15
5011359|NCT02253433|12329949|P2|NOT COMPLETED|Overall Study||55
5011360|NCT02253433|12329950|P1|NOT COMPLETED|Overall Study||16
5011361|NCT02253433|12329949|P2|COMPLETED|Overall Study||79
5011362|NCT02253433|12329950|P1|COMPLETED|Overall Study||114
5011363|NCT02253433|12329949|P2|STARTED|Overall Study||134
5011364|NCT02253433|12329950|P1|STARTED|Overall Study||130
5011365|NCT02253394|12329960|P2|NOT COMPLETED|Overall Study||0
5011366|NCT02253394|12329961|P1|NOT COMPLETED|Overall Study||0
5011367|NCT02253394|12329960|P2|COMPLETED|Overall Study||2
5011368|NCT02253394|12329961|P1|COMPLETED|Overall Study||0
5011369|NCT02253394|12329960|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
5011370|NCT02253394|12329961|P1|STARTED|Overall Study||0
5011371|NCT02253173|12329971|P4|NOT COMPLETED|Overall Study||14
5011372|NCT02253173|12329972|P3|NOT COMPLETED|Overall Study||13
5011373|NCT02253173|12329973|P2|NOT COMPLETED|Overall Study||17
5011374|NCT02253173|12329974|P1|NOT COMPLETED|Overall Study||16
5011375|NCT02253173|12329971|P4|COMPLETED|Overall Study||178
5011376|NCT02253173|12329972|P3|COMPLETED|Overall Study||177
5011377|NCT02253173|12329973|P2|COMPLETED|Overall Study||174
5011378|NCT02253173|12329974|P1|COMPLETED|Overall Study||175
5011379|NCT02253173|12329971|P4|STARTED|Overall Study||192
5011380|NCT02253173|12329972|P3|STARTED|Overall Study||190
5011381|NCT02253173|12329973|P2|STARTED|Overall Study||191
5011382|NCT02253173|12329974|P1|STARTED|Overall Study||191
5011383|NCT02253160|12330171|P3|NOT COMPLETED|Overall Study||0
5011384|NCT02253160|12330172|P2|NOT COMPLETED|Overall Study||0
5011385|NCT02253160|12330173|P1|NOT COMPLETED|Overall Study||0
5011386|NCT02253160|12330171|P3|COMPLETED|Overall Study||10
5011387|NCT02253160|12330172|P2|COMPLETED|Overall Study||12
5011388|NCT02253160|12330173|P1|COMPLETED|Overall Study||1
5011389|NCT02253160|12330171|P3|STARTED|Overall Study||10
5011390|NCT02253160|12330172|P2|STARTED|Overall Study||12
5011391|NCT02253160|12330173|P1|STARTED|Overall Study||1
5011392|NCT02253147|12330209|P1|NOT COMPLETED|Overall Study||47
5011393|NCT02253147|12330209|P1|COMPLETED|Overall Study||71
5011394|NCT02253147|12330209|P1|N Patients at W52|Overall Study||84
5011395|NCT02253147|12330209|P1|N Patients at W36|Overall Study||86
5011396|NCT02253147|12330209|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
5011397|NCT02253147|12330209|P1|STARTED|Overall Study||118
5011398|NCT02252965|12330243|P2|NOT COMPLETED|Overall Study||43
5011399|NCT02252965|12330244|P1|NOT COMPLETED|Overall Study||40
5011400|NCT02252965|12330243|P2|COMPLETED|Overall Study||222
5011401|NCT02252965|12330244|P1|COMPLETED|Overall Study||227
5011402|NCT02252965|12330243|P2|Safety Population|Overall Study||264
5011403|NCT02252965|12330244|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
5011404|NCT02252965|12330243|P2|STARTED|Overall Study||265
5011405|NCT02252965|12330244|P1|STARTED|Overall Study||267
5011406|NCT02252939|12330271|P1|NOT COMPLETED|Overall Study||3
5011407|NCT02252939|12330271|P1|COMPLETED|Overall Study||59
5011408|NCT02252939|12330271|P1|STARTED|Overall Study||62
5011409|NCT02252744|12330280|P1|NOT COMPLETED|Overall Study||0
5011410|NCT02252744|12330280|P1|COMPLETED|Overall Study||286
5011411|NCT02252744|12330280|P1|STARTED|Overall Study||286
5011412|NCT02252718|12330284|P1|NOT COMPLETED|Overall Study||0
5011413|NCT02252718|12330284|P1|COMPLETED|Overall Study||100
5011414|NCT02252718|12330284|P1|STARTED|Overall Study||100
5011415|NCT02252666|12330288|P1|NOT COMPLETED|Overall Study||0
5011416|NCT02252666|12330288|P1|COMPLETED|Overall Study||6
5011417|NCT02252666|12330288|P1|STARTED|Overall Study||6
5011418|NCT02252562|12330312|P2|NOT COMPLETED|Overall Study||0
5011419|NCT02252562|12330313|P1|NOT COMPLETED|Overall Study||0
5011420|NCT02252562|12330312|P2|COMPLETED|Overall Study||1636
5011421|NCT02252562|12330313|P1|COMPLETED|Overall Study||1620
5011422|NCT02252562|12330312|P2|STARTED|Overall Study||1636
5011423|NCT02252562|12330313|P1|STARTED|Overall Study||1620
5011424|NCT02252536|12330328|P2|NOT COMPLETED|Overall Study||3
5011425|NCT02252536|12330329|P1|NOT COMPLETED|Overall Study||5
5011426|NCT02252536|12330328|P2|COMPLETED|Overall Study||170
5011427|NCT02252536|12330329|P1|COMPLETED|Overall Study||168
5011428|NCT02252536|12330328|P2|STARTED|Overall Study||173
5011429|NCT02252536|12330329|P1|STARTED|Overall Study||173
5011430|NCT02252445|12330363|P2|NOT COMPLETED|Overall Study||0
5011431|NCT02252445|12330364|P1|NOT COMPLETED|Overall Study||0
5011432|NCT02252445|12330363|P2|COMPLETED|Overall Study||41
5011433|NCT02252445|12330364|P1|COMPLETED|Overall Study||41
5011434|NCT02252445|12330363|P2|STARTED|Overall Study||41
5011435|NCT02252445|12330364|P1|STARTED|Overall Study||41
5011436|NCT02252406|12330390|P2|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
5011437|NCT02252406|12330391|P1|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
5011438|NCT02252406|12330390|P2|COMPLETED|Titrated to Ranolazine 1000mg BID||13
5011439|NCT02252406|12330391|P1|COMPLETED|Titrated to Ranolazine 1000mg BID||9
5011440|NCT02252406|12330390|P2|STARTED|Titrated to Ranolazine 1000mg BID||14
5011441|NCT02252406|12330391|P1|STARTED|Titrated to Ranolazine 1000mg BID||12
5011442|NCT02252406|12330390|P2|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
5011443|NCT02252406|12330391|P1|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
5011444|NCT02252406|12330390|P2|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
5011445|NCT02252406|12330391|P1|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
5011446|NCT02252406|12330390|P2|STARTED|Starting Dose Ranolazine 500 mg BID||17
5011447|NCT02252406|12330391|P1|STARTED|Starting Dose Ranolazine 500 mg BID||16
5011448|NCT02252354|12330401|P2|NOT COMPLETED|Overall Study||0
5011449|NCT02252354|12330402|P1|NOT COMPLETED|Overall Study||0
5011450|NCT02252354|12330401|P2|COMPLETED|Overall Study||6
5011451|NCT02252354|12330402|P1|COMPLETED|Overall Study||6
5011452|NCT02252354|12330401|P2|STARTED|Overall Study||6
5011453|NCT02252354|12330402|P1|STARTED|Overall Study||6
5011454|NCT02252211|12330449|P3|NOT COMPLETED|Overall Study||1
5011455|NCT02252211|12330450|P2|NOT COMPLETED|Overall Study||3
5011456|NCT02252211|12330451|P1|NOT COMPLETED|Overall Study||5
5011457|NCT02252211|12330449|P3|COMPLETED|Overall Study||0
5011458|NCT02252211|12330450|P2|COMPLETED|Overall Study||0
5011459|NCT02252211|12330451|P1|COMPLETED|Overall Study||0
5011460|NCT02252211|12330449|P3|Received Further Doses (Through Dose 24)|Overall Study||0
5011461|NCT02252211|12330450|P2|Received Further Doses (Through Dose 24)|Overall Study||0
5011462|NCT02252211|12330451|P1|Received Further Doses (Through Dose 24)|Overall Study||1
5011463|NCT02252211|12330449|P3|Received Dose 4 (Day 36)|Overall Study||0
5011464|NCT02252211|12330450|P2|Received Dose 4 (Day 36)|Overall Study||1
5011465|NCT02252211|12330451|P1|Received Dose 4 (Day 36)|Overall Study||1
5011466|NCT02252211|12330449|P3|Received Dose 3 (Day 22)|Overall Study||0
5011467|NCT02252211|12330450|P2|Received Dose 3 (Day 22)|Overall Study||3
5011468|NCT02252211|12330451|P1|Received Dose 3 (Day 22)|Overall Study||3
5011469|NCT02252211|12330449|P3|Received Dose 2 (Day 8)|Overall Study||0
5011470|NCT02252211|12330450|P2|Received Dose 2 (Day 8)|Overall Study||3
5011471|NCT02252211|12330451|P1|Received Dose 2 (Day 8)|Overall Study||4
5011472|NCT02252211|12330449|P3|Received Dose 1 (Day 1)|Overall Study||0
5011473|NCT02252211|12330450|P2|Received Dose 1 (Day 1)|Overall Study||3
5011474|NCT02252211|12330451|P1|Received Dose 1 (Day 1)|Overall Study||4
5011475|NCT02252211|12330449|P3|STARTED|Overall Study||1
5011476|NCT02252211|12330450|P2|STARTED|Overall Study||3
5011477|NCT02252211|12330451|P1|STARTED|Overall Study||5
5011478|NCT02252172|12330488|P2|NOT COMPLETED|Overall Study||299
5011479|NCT02252172|12330489|P1|NOT COMPLETED|Overall Study||279
5011480|NCT02252172|12330488|P2|COMPLETED|Overall Study||69
5011481|NCT02252172|12330489|P1|COMPLETED|Overall Study||90
5011482|NCT02252172|12330488|P2|Treated|Overall Study||364
5011483|NCT02252172|12330489|P1|Treated|Overall Study||365
5011484|NCT02252172|12330488|P2|STARTED|Overall Study||368
5011485|NCT02252172|12330489|P1|STARTED|Overall Study||369
5011486|NCT02252146|12330501|P1|NOT COMPLETED|Overall Study||6
5011487|NCT02252146|12330501|P1|COMPLETED|Overall Study||0
5011488|NCT02252146|12330501|P1|STARTED|Overall Study||6
5011489|NCT02252133|12330505|P2|NOT COMPLETED|Period 2||0
5011490|NCT02252133|12330506|P1|NOT COMPLETED|Period 2||0
5011491|NCT02252133|12330505|P2|COMPLETED|Period 2||24
5011492|NCT02252133|12330506|P1|COMPLETED|Period 2||23
5011493|NCT02252133|12330505|P2|STARTED|Period 2||24
5011494|NCT02252133|12330506|P1|STARTED|Period 2||23
5011495|NCT02252133|12330505|P2|NOT COMPLETED|Period 1||0
5011496|NCT02252133|12330506|P1|NOT COMPLETED|Period 1||0
5011497|NCT02252133|12330505|P2|COMPLETED|Period 1||24
5011498|NCT02252133|12330506|P1|COMPLETED|Period 1||23
5011499|NCT02252133|12330505|P2|STARTED|Period 1||24
5011500|NCT02252133|12330506|P1|STARTED|Period 1||23
5011501|NCT02252042|12330514|P2|NOT COMPLETED|Overall Study||248
5011502|NCT02252042|12330515|P1|NOT COMPLETED|Overall Study||247
5011503|NCT02252042|12330514|P2|COMPLETED|Overall Study||0
5011504|NCT02252042|12330515|P1|COMPLETED|Overall Study||0
5011505|NCT02252042|12330514|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
5011506|NCT02252042|12330515|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
5011507|NCT02252042|12330514|P2|STARTED|Overall Study||248
5011508|NCT02252042|12330515|P1|STARTED|Overall Study||247
5011509|NCT02252016|12330555|P2|NOT COMPLETED|Overall Study||3
5011510|NCT02252016|12330556|P1|NOT COMPLETED|Overall Study||3
5011511|NCT02252016|12330555|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
5011512|NCT02252016|12330556|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
5011513|NCT02252016|12330555|P2|STARTED|Overall Study||52
5011514|NCT02252016|12330556|P1|STARTED|Overall Study||107
5011515|NCT02251990|12330570|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
5011516|NCT02251990|12330571|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
5011517|NCT02251990|12330570|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
5011518|NCT02251990|12330571|P1|COMPLETED|Period 3 (DTG Follow-up)||0
5011519|NCT02251990|12330570|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
5011520|NCT02251990|12330571|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
5011521|NCT02251990|12330570|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
5011522|NCT02251990|12330571|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
5011523|NCT02251990|12330570|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
5011524|NCT02251990|12330571|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
5011525|NCT02251990|12330570|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
5011526|NCT02251990|12330571|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
5011527|NCT02251990|12330570|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
5011528|NCT02251990|12330571|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
5011529|NCT02251990|12330570|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
5011530|NCT02251990|12330571|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
5011531|NCT02251990|12330570|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
5011532|NCT02251990|12330571|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
5011533|NCT02251990|12330570|P2|STARTED|Period 1 (Double-blind [DB])||123
5011534|NCT02251990|12330571|P1|STARTED|Period 1 (Double-blind [DB])||366
5011535|NCT02251938|12330586|P1|NOT COMPLETED|Overall Study||17
5011536|NCT02251938|12330586|P1|COMPLETED|Overall Study||43
5011537|NCT02251938|12330586|P1|STARTED|Overall Study||60
5011538|NCT02251912|12330599|P2|NOT COMPLETED|Overall Study||5
5011539|NCT02251912|12330600|P1|NOT COMPLETED|Overall Study||2
5011540|NCT02251912|12330599|P2|COMPLETED|Overall Study||5
5011541|NCT02251912|12330600|P1|COMPLETED|Overall Study||10
5011542|NCT02251912|12330599|P2|STARTED|Overall Study||10
5011543|NCT02251912|12330600|P1|STARTED|Overall Study||12
5011544|NCT02251886|12330614|P4|NOT COMPLETED|Overall Study||0
5011545|NCT02251886|12330615|P3|NOT COMPLETED|Overall Study||0
5011546|NCT02251886|12330616|P2|NOT COMPLETED|Overall Study||0
5011547|NCT02251886|12330617|P1|NOT COMPLETED|Overall Study||0
5011548|NCT02251886|12330614|P4|COMPLETED|Overall Study||54
5011549|NCT02251886|12330615|P3|COMPLETED|Overall Study||44
5011550|NCT02251886|12330616|P2|COMPLETED|Overall Study||54
5011551|NCT02251886|12330617|P1|COMPLETED|Overall Study||48
5011552|NCT02251886|12330614|P4|STARTED|Overall Study||54
5011553|NCT02251886|12330615|P3|STARTED|Overall Study||44
5011554|NCT02251886|12330616|P2|STARTED|Overall Study||54
5011555|NCT02251886|12330617|P1|STARTED|Overall Study||48
5011556|NCT02251717|12330629|P2|NOT COMPLETED|Overall Study||1
5011557|NCT02251717|12330630|P1|NOT COMPLETED|Overall Study||1
5011558|NCT02251717|12330629|P2|COMPLETED|Overall Study||56
5011559|NCT02251717|12330630|P1|COMPLETED|Overall Study||56
5011560|NCT02251717|12330629|P2|STARTED|Overall Study||57
5011561|NCT02251717|12330630|P1|STARTED|Overall Study||57
5011562|NCT02251652|12330642|P1|NOT COMPLETED|Overall Study||1
5011563|NCT02251652|12330642|P1|COMPLETED|Overall Study||16
5011564|NCT02251652|12330642|P1|STARTED|Overall Study||17
5011565|NCT02251613|12330652|P1|NOT COMPLETED|Overall Study||0
5011566|NCT02251613|12330652|P1|COMPLETED|Overall Study||50
5011567|NCT02251613|12330652|P1|STARTED|Overall Study||50
5011568|NCT02251561|12330660|P1|NOT COMPLETED|Overall Study||0
5011569|NCT02251561|12330660|P1|COMPLETED|Overall Study||28
5011570|NCT02251561|12330660|P1|STARTED|Overall Study||28
5011571|NCT02251548|12330668|P1|NOT COMPLETED|Overall Study||85
5011572|NCT02251548|12330668|P1|COMPLETED|Overall Study||0
5011573|NCT02251548|12330668|P1|STARTED|Overall Study||85
5011574|NCT02251379|12330676|P2|NOT COMPLETED|Overall Study||20
5011575|NCT02251379|12330677|P1|NOT COMPLETED|Overall Study||20
5011576|NCT02251379|12330676|P2|COMPLETED|Overall Study||58
5011577|NCT02251379|12330677|P1|COMPLETED|Overall Study||57
5011578|NCT02251379|12330676|P2|STARTED|Overall Study||78
5011579|NCT02251379|12330677|P1|STARTED|Overall Study||77
5011580|NCT02251275|12330698|P5|NOT COMPLETED|Overall Study||1
5011581|NCT02251275|12330699|P4|NOT COMPLETED|Overall Study||1
5011582|NCT02251275|12330700|P3|NOT COMPLETED|Overall Study||94
5011583|NCT02251275|12330701|P2|NOT COMPLETED|Overall Study||147
5011584|NCT02251275|12330702|P1|NOT COMPLETED|Overall Study||72
5011585|NCT02251275|12330698|P5|COMPLETED|Overall Study||2
5011586|NCT02251275|12330699|P4|COMPLETED|Overall Study||5
5011587|NCT02251275|12330700|P3|COMPLETED|Overall Study||624
5011588|NCT02251275|12330701|P2|COMPLETED|Overall Study||423
5011589|NCT02251275|12330702|P1|COMPLETED|Overall Study||434
5011590|NCT02251275|12330698|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5011591|NCT02251275|12330699|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5011592|NCT02251275|12330700|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
5011593|NCT02251275|12330701|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
5011594|NCT02251275|12330702|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
5011595|NCT02251275|12330698|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
5011596|NCT02251275|12330699|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
5011597|NCT02251275|12330700|P3|STARTED|Overall Study||718
5011598|NCT02251275|12330701|P2|STARTED|Overall Study||570
5011599|NCT02251275|12330702|P1|STARTED|Overall Study||506
5011600|NCT02251236|12330717|P3|NOT COMPLETED|Overall Study||0
5011601|NCT02251236|12330718|P2|NOT COMPLETED|Overall Study||0
5011602|NCT02251236|12330719|P1|NOT COMPLETED|Overall Study||0
5011603|NCT02251236|12330717|P3|COMPLETED|Overall Study||0
5011604|NCT02251236|12330718|P2|COMPLETED|Overall Study||5
5011605|NCT02251236|12330719|P1|COMPLETED|Overall Study||9
5011606|NCT02251236|12330717|P3|STARTED|Overall Study||0
5011607|NCT02251236|12330718|P2|STARTED|Overall Study||5
5011608|NCT02251236|12330719|P1|STARTED|Overall Study||9
5011609|NCT02250807|12330736|P1|NOT COMPLETED|Overall Study||0
5011610|NCT02250807|12330736|P1|COMPLETED|Overall Study||40
5011611|NCT02250807|12330736|P1|STARTED|Overall Study||40
5011612|NCT02250703|12330748|P2|NOT COMPLETED|Overall Study||1
5011613|NCT02250703|12330749|P1|NOT COMPLETED|Overall Study||1
5011614|NCT02250703|12330748|P2|COMPLETED|Overall Study||36
5011615|NCT02250703|12330749|P1|COMPLETED|Overall Study||37
5011616|NCT02250703|12330748|P2|STARTED|Overall Study||37
5011617|NCT02250703|12330749|P1|STARTED|Overall Study||38
5011618|NCT02250521|12330761|P1|NOT COMPLETED|Overall Study||1
5011619|NCT02250521|12330761|P1|COMPLETED|Overall Study||99
5011620|NCT02250521|12330761|P1|STARTED|Overall Study||100
5011621|NCT02250443|12330775|P1|NOT COMPLETED|Overall Study||10
5011622|NCT02250443|12330775|P1|COMPLETED|Overall Study||0
5011623|NCT02250443|12330775|P1|STARTED|Overall Study||10
5011624|NCT02250417|12330788|P2|NOT COMPLETED|Second Intervention (1 Night)||0
5011625|NCT02250417|12330789|P1|NOT COMPLETED|Second Intervention (1 Night)||0
5011626|NCT02250417|12330788|P2|COMPLETED|Second Intervention (1 Night)||6
5011627|NCT02250417|12330789|P1|COMPLETED|Second Intervention (1 Night)||6
5011628|NCT02250417|12330788|P2|STARTED|Second Intervention (1 Night)||6
5011629|NCT02250417|12330789|P1|STARTED|Second Intervention (1 Night)||6
5011630|NCT02250417|12330788|P2|NOT COMPLETED|First Intervention (1 Night)||0
5011631|NCT02250417|12330789|P1|NOT COMPLETED|First Intervention (1 Night)||0
5011632|NCT02250417|12330788|P2|COMPLETED|First Intervention (1 Night)||6
5011633|NCT02250417|12330789|P1|COMPLETED|First Intervention (1 Night)||6
5011634|NCT02250417|12330788|P2|STARTED|First Intervention (1 Night)||6
5011635|NCT02250417|12330789|P1|STARTED|First Intervention (1 Night)||6
5011636|NCT02250326|12330804|P3|NOT COMPLETED|Follow-Up Period||38
5011637|NCT02250326|12330805|P2|NOT COMPLETED|Follow-Up Period||30
5011638|NCT02250326|12330806|P1|NOT COMPLETED|Follow-Up Period||49
5011639|NCT02250326|12330804|P3|COMPLETED|Follow-Up Period||26
5011640|NCT02250326|12330805|P2|COMPLETED|Follow-Up Period||13
5011641|NCT02250326|12330806|P1|COMPLETED|Follow-Up Period||18
5011642|NCT02250326|12330804|P3|STARTED|Follow-Up Period||64
5011643|NCT02250326|12330805|P2|STARTED|Follow-Up Period||43
5011644|NCT02250326|12330806|P1|STARTED|Follow-Up Period||67
5011645|NCT02250326|12330804|P3|NOT COMPLETED|Treatment Period||77
5011646|NCT02250326|12330805|P2|NOT COMPLETED|Treatment Period||64
5011647|NCT02250326|12330806|P1|NOT COMPLETED|Treatment Period||81
5011648|NCT02250326|12330804|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
5011649|NCT02250326|12330805|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
5011650|NCT02250326|12330806|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
5011651|NCT02250326|12330804|P3|Treated Population|Treatment Period||79
5011652|NCT02250326|12330805|P2|Treated Population|Treatment Period||78
5011653|NCT02250326|12330806|P1|Treated Population|Treatment Period||79
5011654|NCT02250326|12330804|P3|STARTED|Treatment Period||80
5011655|NCT02250326|12330805|P2|STARTED|Treatment Period||79
5011656|NCT02250326|12330806|P1|STARTED|Treatment Period||81
5011657|NCT02250274|12330839|P2|NOT COMPLETED|Overall Study||6
5011658|NCT02250274|12330840|P1|NOT COMPLETED|Overall Study||7
5011659|NCT02250274|12330839|P2|COMPLETED|Overall Study||40
5011660|NCT02250274|12330840|P1|COMPLETED|Overall Study||78
5011661|NCT02250274|12330839|P2|STARTED|Overall Study||46
5011662|NCT02250274|12330840|P1|STARTED|Overall Study||85
5011663|NCT02250183|12330856|P1|NOT COMPLETED|Overall Study||8
5011664|NCT02250183|12330856|P1|COMPLETED|Overall Study||13
5011665|NCT02250183|12330856|P1|STARTED|Overall Study||21
5011666|NCT02249949|12330865|P1|NOT COMPLETED|Overall Study||2
5011667|NCT02249949|12330865|P1|COMPLETED|Overall Study||11
5011668|NCT02249949|12330865|P1|STARTED|Overall Study||13
5011669|NCT02249832|12330872|P1|NOT COMPLETED|Overall Study||13
5011670|NCT02249832|12330872|P1|COMPLETED|Overall Study||42
5011671|NCT02249832|12330872|P1|STARTED|Overall Study||55
5011672|NCT02249819|12330884|P2|NOT COMPLETED|Overall Study||0
5011673|NCT02249819|12330885|P1|NOT COMPLETED|Overall Study||0
5011674|NCT02249819|12330884|P2|COMPLETED|Overall Study||7
5011675|NCT02249819|12330885|P1|COMPLETED|Overall Study||8
5011676|NCT02249819|12330884|P2|STARTED|Overall Study||7
5011677|NCT02249819|12330885|P1|STARTED|Overall Study||8
5011678|NCT02249793|12330891|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
5011679|NCT02249793|12330891|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
5011680|NCT02249793|12330891|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
5011681|NCT02249793|12330891|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
5011682|NCT02249793|12330891|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
5011683|NCT02249793|12330891|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
5011684|NCT02249767|12330916|P3|NOT COMPLETED|Overall Study||8
5011685|NCT02249767|12330917|P2|NOT COMPLETED|Overall Study||9
5011686|NCT02249767|12330918|P1|NOT COMPLETED|Overall Study||8
5011687|NCT02249767|12330916|P3|COMPLETED|Overall Study||107
5011688|NCT02249767|12330917|P2|COMPLETED|Overall Study||220
5011689|NCT02249767|12330918|P1|COMPLETED|Overall Study||222
5011690|NCT02249767|12330916|P3|STARTED|Overall Study||115
5011691|NCT02249767|12330917|P2|STARTED|Overall Study||229
5011692|NCT02249767|12330918|P1|STARTED|Overall Study||230
5011693|NCT02249728|12330926|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
5011694|NCT02249728|12330926|P1|COMPLETED|Part Two (up to 6 Days)||6
5011695|NCT02249728|12330926|P1|STARTED|Part Two (up to 6 Days)||6
5011696|NCT02249728|12330926|P1|NOT COMPLETED|Part One (4 Days)||0
5011697|NCT02249728|12330926|P1|COMPLETED|Part One (4 Days)||6
5011698|NCT02249728|12330926|P1|STARTED|Part One (4 Days)||6
5011699|NCT02249585|12330939|P3|NOT COMPLETED|Overall Study||0
5011700|NCT02249585|12330940|P2|NOT COMPLETED|Overall Study||0
5011701|NCT02249585|12330941|P1|NOT COMPLETED|Overall Study||0
5011702|NCT02249585|12330939|P3|COMPLETED|Overall Study||44
5011703|NCT02249585|12330940|P2|COMPLETED|Overall Study||44
5011704|NCT02249585|12330941|P1|COMPLETED|Overall Study||43
5011705|NCT02249585|12330939|P3|STARTED|Overall Study||44
5011706|NCT02249585|12330940|P2|STARTED|Overall Study||44
5011707|NCT02249585|12330941|P1|STARTED|Overall Study||43
5011708|NCT02249377|12330966|P2|NOT COMPLETED|Overall Study||24
5011709|NCT02249377|12330967|P1|NOT COMPLETED|Overall Study||25
5011710|NCT02249377|12330966|P2|COMPLETED|Overall Study||1
5011711|NCT02249377|12330967|P1|COMPLETED|Overall Study||0
5011712|NCT02249377|12330966|P2|STARTED|Overall Study||25
5011713|NCT02249377|12330967|P1|STARTED|Overall Study||25
5011714|NCT02249182|12330984|P5|NOT COMPLETED|Treatment Phase||0
5011715|NCT02249182|12330985|P4|NOT COMPLETED|Treatment Phase||0
5011716|NCT02249182|12330986|P3|NOT COMPLETED|Treatment Phase||0
5011717|NCT02249182|12330987|P2|NOT COMPLETED|Treatment Phase||0
5011718|NCT02249182|12330988|P1|NOT COMPLETED|Treatment Phase||4
5011719|NCT02249182|12330984|P5|COMPLETED|Treatment Phase||34
5011720|NCT02249182|12330985|P4|COMPLETED|Treatment Phase||2
5011721|NCT02249182|12330986|P3|COMPLETED|Treatment Phase||1
5011722|NCT02249182|12330987|P2|COMPLETED|Treatment Phase||89
5011723|NCT02249182|12330988|P1|COMPLETED|Treatment Phase||96
5011724|NCT02249182|12330984|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
5011725|NCT02249182|12330985|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
5011726|NCT02249182|12330986|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
5011727|NCT02249182|12330987|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
5011728|NCT02249182|12330988|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
5011729|NCT02249182|12330984|P5|NOT COMPLETED|PK Lead-In Phase||0
5011730|NCT02249182|12330985|P4|NOT COMPLETED|PK Lead-In Phase||0
5011731|NCT02249182|12330986|P3|NOT COMPLETED|PK Lead-In Phase||0
5011732|NCT02249182|12330987|P2|NOT COMPLETED|PK Lead-In Phase||0
5011733|NCT02249182|12330988|P1|NOT COMPLETED|PK Lead-In Phase||0
5011734|NCT02249182|12330984|P5|COMPLETED|PK Lead-In Phase||17
5011735|NCT02249182|12330985|P4|COMPLETED|PK Lead-In Phase||0
5011736|NCT02249182|12330986|P3|COMPLETED|PK Lead-In Phase||0
5011737|NCT02249182|12330987|P2|COMPLETED|PK Lead-In Phase||12
5011738|NCT02249182|12330988|P1|COMPLETED|PK Lead-In Phase||10
5011739|NCT02249182|12330984|P5|STARTED|PK Lead-In Phase||17
5011740|NCT02249182|12330985|P4|STARTED|PK Lead-In Phase||0
5011741|NCT02249182|12330986|P3|STARTED|PK Lead-In Phase||0
5011742|NCT02249182|12330987|P2|STARTED|PK Lead-In Phase||12
5011743|NCT02249182|12330988|P1|STARTED|PK Lead-In Phase||10
5011744|NCT02249143|12331076|P2|NOT COMPLETED|Overall Study||4
5011745|NCT02249143|12331077|P1|NOT COMPLETED|Overall Study||2
5011746|NCT02249143|12331076|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
5011747|NCT02249143|12331077|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
5011748|NCT02249143|12331076|P2|STARTED|Overall Study|randomized|26
5011749|NCT02249143|12331077|P1|STARTED|Overall Study||24
5011750|NCT02249104|12331103|P1|NOT COMPLETED|Overall Study||3
5011751|NCT02249104|12331103|P1|COMPLETED|Overall Study||25
5011752|NCT02249104|12331103|P1|STARTED|Overall Study||28
5011753|NCT02249065|12331112|P1|NOT COMPLETED|Overall Study||29
5011754|NCT02249065|12331112|P1|COMPLETED|Overall Study||176
5011755|NCT02249065|12331112|P1|Treated|Overall Study||181
5011756|NCT02249065|12331112|P1|STARTED|Overall Study||205
5011757|NCT02249052|12331120|P1|NOT COMPLETED|Overall Study||0
5011758|NCT02249052|12331120|P1|COMPLETED|Overall Study||19
5011759|NCT02249052|12331120|P1|STARTED|Overall Study||19
5011760|NCT02248974|12331138|P2|NOT COMPLETED|1-Month Follow-Up||3
5011761|NCT02248974|12331139|P1|NOT COMPLETED|1-Month Follow-Up||2
5011762|NCT02248974|12331138|P2|COMPLETED|1-Month Follow-Up||31
5011763|NCT02248974|12331139|P1|COMPLETED|1-Month Follow-Up||27
5011764|NCT02248974|12331138|P2|STARTED|1-Month Follow-Up||34
5011765|NCT02248974|12331139|P1|STARTED|1-Month Follow-Up||29
5011766|NCT02248974|12331138|P2|NOT COMPLETED|1-Week Follow-Up||17
5011767|NCT02248974|12331139|P1|NOT COMPLETED|1-Week Follow-Up||8
5011768|NCT02248974|12331138|P2|COMPLETED|1-Week Follow-Up||34
5011769|NCT02248974|12331139|P1|COMPLETED|1-Week Follow-Up||29
5011770|NCT02248974|12331138|P2|STARTED|1-Week Follow-Up||51
5011771|NCT02248974|12331139|P1|STARTED|1-Week Follow-Up||37
5011772|NCT02248974|12331138|P2|NOT COMPLETED|1-Day Follow-Up||0
5011773|NCT02248974|12331139|P1|NOT COMPLETED|1-Day Follow-Up||10
5011774|NCT02248974|12331138|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
5011775|NCT02248974|12331139|P1|COMPLETED|1-Day Follow-Up||37
5011776|NCT02248974|12331138|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
5011777|NCT02248974|12331139|P1|STARTED|1-Day Follow-Up||47
5011778|NCT02248974|12331138|P2|NOT COMPLETED|Baseline||0
5011779|NCT02248974|12331139|P1|NOT COMPLETED|Baseline||0
5011780|NCT02248974|12331138|P2|COMPLETED|Baseline||51
5011781|NCT02248974|12331139|P1|COMPLETED|Baseline||47
5011782|NCT02248974|12331138|P2|STARTED|Baseline||51
5011783|NCT02248974|12331139|P1|STARTED|Baseline||47
5011784|NCT02248961|12331217|P2|NOT COMPLETED|Overall Study||2
5011785|NCT02248961|12331218|P1|NOT COMPLETED|Overall Study||3
5011786|NCT02248961|12331217|P2|COMPLETED|Overall Study||88
5011787|NCT02248961|12331218|P1|COMPLETED|Overall Study||86
5011788|NCT02248961|12331217|P2|STARTED|Overall Study||90
5011789|NCT02248961|12331218|P1|STARTED|Overall Study||89
5011790|NCT02248922|12331238|P2|NOT COMPLETED|Overall Study||0
5011791|NCT02248922|12331239|P1|NOT COMPLETED|Overall Study||0
5011792|NCT02248922|12331238|P2|COMPLETED|Overall Study||12
5011793|NCT02248922|12331239|P1|COMPLETED|Overall Study||5
5011794|NCT02248922|12331238|P2|STARTED|Overall Study||12
5011795|NCT02248922|12331239|P1|STARTED|Overall Study||5
5011796|NCT02248857|12331253|P3|NOT COMPLETED|6 Month||17
5011797|NCT02248857|12331254|P2|NOT COMPLETED|6 Month||29
5011798|NCT02248857|12331255|P1|NOT COMPLETED|6 Month||28
5011799|NCT02248857|12331253|P3|COMPLETED|6 Month||106
5011800|NCT02248857|12331254|P2|COMPLETED|6 Month||136
5011801|NCT02248857|12331255|P1|COMPLETED|6 Month||120
5011802|NCT02248857|12331253|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
5011803|NCT02248857|12331254|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
5011804|NCT02248857|12331255|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
5011805|NCT02248857|12331253|P3|NOT COMPLETED|3 Month||31
5011806|NCT02248857|12331254|P2|NOT COMPLETED|3 Month||34
5011807|NCT02248857|12331255|P1|NOT COMPLETED|3 Month||46
5011808|NCT02248857|12331253|P3|COMPLETED|3 Month||96
5011809|NCT02248857|12331254|P2|COMPLETED|3 Month||134
5011810|NCT02248857|12331255|P1|COMPLETED|3 Month||111
5011811|NCT02248857|12331253|P3|STARTED|3 Month||127
5011812|NCT02248857|12331254|P2|STARTED|3 Month||168
5011813|NCT02248857|12331255|P1|STARTED|3 Month||157
5011814|NCT02248857|12331253|P3|NOT COMPLETED|Baseline||0
5011815|NCT02248857|12331254|P2|NOT COMPLETED|Baseline||0
5011816|NCT02248857|12331255|P1|NOT COMPLETED|Baseline||0
5011817|NCT02248857|12331253|P3|COMPLETED|Baseline||127
5011818|NCT02248857|12331254|P2|COMPLETED|Baseline||168
5011819|NCT02248857|12331255|P1|COMPLETED|Baseline||157
5011820|NCT02248857|12331253|P3|STARTED|Baseline||127
5011821|NCT02248857|12331254|P2|STARTED|Baseline||168
5011822|NCT02248857|12331255|P1|STARTED|Baseline||157
5011823|NCT02248818|12331292|P9|NOT COMPLETED|Randomised Study||0
5011824|NCT02248818|12331293|P8|NOT COMPLETED|Randomised Study||0
5011825|NCT02248818|12331294|P7|NOT COMPLETED|Randomised Study||0
5011826|NCT02248818|12331295|P6|NOT COMPLETED|Randomised Study||8
5011827|NCT02248818|12331296|P5|NOT COMPLETED|Randomised Study||0
5011828|NCT02248818|12331297|P4|NOT COMPLETED|Randomised Study||0
5011829|NCT02248818|12331298|P3|NOT COMPLETED|Randomised Study||0
5011830|NCT02248818|12331299|P2|NOT COMPLETED|Randomised Study||0
5011831|NCT02248818|12331300|P1|NOT COMPLETED|Randomised Study||0
5011832|NCT02248818|12331292|P9|COMPLETED|Randomised Study||0
5011833|NCT02248818|12331293|P8|COMPLETED|Randomised Study||4
5011834|NCT02248818|12331294|P7|COMPLETED|Randomised Study||6
5011835|NCT02248818|12331295|P6|COMPLETED|Randomised Study||0
5011836|NCT02248818|12331296|P5|COMPLETED|Randomised Study||6
5011837|NCT02248818|12331297|P4|COMPLETED|Randomised Study||6
5011838|NCT02248818|12331298|P3|COMPLETED|Randomised Study||6
5011839|NCT02248818|12331299|P2|COMPLETED|Randomised Study||6
5011840|NCT02248818|12331300|P1|COMPLETED|Randomised Study||6
5011841|NCT02248818|12331292|P9|STARTED|Randomised Study||0
5011842|NCT02248818|12331293|P8|STARTED|Randomised Study||4
5011843|NCT02248818|12331294|P7|STARTED|Randomised Study||6
5011844|NCT02248818|12331295|P6|STARTED|Randomised Study||8
5011845|NCT02248818|12331296|P5|STARTED|Randomised Study||6
5011846|NCT02248818|12331297|P4|STARTED|Randomised Study||6
5011847|NCT02248818|12331298|P3|STARTED|Randomised Study||6
5011848|NCT02248818|12331299|P2|STARTED|Randomised Study||6
5011849|NCT02248818|12331300|P1|STARTED|Randomised Study||6
5011850|NCT02248818|12331292|P9|NOT COMPLETED|Screening||107
5011851|NCT02248818|12331293|P8|NOT COMPLETED|Screening||0
5011852|NCT02248818|12331294|P7|NOT COMPLETED|Screening||0
5011853|NCT02248818|12331295|P6|NOT COMPLETED|Screening||0
5011854|NCT02248818|12331296|P5|NOT COMPLETED|Screening||0
5011855|NCT02248818|12331297|P4|NOT COMPLETED|Screening||0
5011856|NCT02248818|12331298|P3|NOT COMPLETED|Screening||0
5011857|NCT02248818|12331299|P2|NOT COMPLETED|Screening||0
5011858|NCT02248818|12331300|P1|NOT COMPLETED|Screening||0
5011859|NCT02248818|12331292|P9|COMPLETED|Screening||48
5011860|NCT02248818|12331293|P8|COMPLETED|Screening||0
5011861|NCT02248818|12331294|P7|COMPLETED|Screening||0
5011862|NCT02248818|12331295|P6|COMPLETED|Screening||0
5011863|NCT02248818|12331296|P5|COMPLETED|Screening||0
5011864|NCT02248818|12331297|P4|COMPLETED|Screening||0
5011865|NCT02248818|12331298|P3|COMPLETED|Screening||0
5011866|NCT02248818|12331299|P2|COMPLETED|Screening||0
5011867|NCT02248818|12331300|P1|COMPLETED|Screening||0
5011868|NCT02248818|12331292|P9|STARTED|Screening||155
5011869|NCT02248818|12331293|P8|STARTED|Screening||0
5011870|NCT02248818|12331294|P7|STARTED|Screening||0
5011871|NCT02248818|12331295|P6|STARTED|Screening||0
5011872|NCT02248818|12331296|P5|STARTED|Screening||0
5011873|NCT02248818|12331297|P4|STARTED|Screening||0
5011874|NCT02248818|12331298|P3|STARTED|Screening||0
5011875|NCT02248818|12331299|P2|STARTED|Screening||0
5011876|NCT02248818|12331300|P1|STARTED|Screening||0
5011877|NCT02248766|12331438|P1|NOT COMPLETED|Overall Study||0
5011878|NCT02248766|12331438|P1|COMPLETED|Overall Study||30
5011879|NCT02248766|12331438|P1|STARTED|Overall Study||30
5011880|NCT02248740|12331452|P2|NOT COMPLETED|Overall Study||18
5011881|NCT02248740|12331453|P1|NOT COMPLETED|Overall Study||18
5011882|NCT02248740|12331452|P2|COMPLETED|Overall Study||0
5011883|NCT02248740|12331453|P1|COMPLETED|Overall Study||0
5011884|NCT02248740|12331452|P2|STARTED|Overall Study||18
5011885|NCT02248740|12331453|P1|STARTED|Overall Study||18
5011886|NCT02248727|12331463|P1|NOT COMPLETED|Overall Study||0
5011887|NCT02248727|12331463|P1|COMPLETED|Overall Study||30
5011888|NCT02248727|12331463|P1|STARTED|Overall Study||30
5011889|NCT02248714|12331476|P2|NOT COMPLETED|Overall Study||4
5011890|NCT02248714|12331477|P1|NOT COMPLETED|Overall Study||4
5011891|NCT02248714|12331476|P2|COMPLETED|Overall Study||61
5011892|NCT02248714|12331477|P1|COMPLETED|Overall Study||62
5011893|NCT02248714|12331476|P2|STARTED|Overall Study||65
5011894|NCT02248714|12331477|P1|STARTED|Overall Study||66
5011895|NCT02248675|12331515|P2|NOT COMPLETED|Overall Study||1
5011896|NCT02248675|12331516|P1|NOT COMPLETED|Overall Study||3
5011897|NCT02248675|12331515|P2|COMPLETED|Overall Study||27
5011898|NCT02248675|12331516|P1|COMPLETED|Overall Study||23
5011899|NCT02248675|12331515|P2|STARTED|Overall Study||28
5011900|NCT02248675|12331516|P1|STARTED|Overall Study||26
5011901|NCT02248662|12331530|P2|NOT COMPLETED|Overall Study||30515
5011902|NCT02248662|12331531|P1|NOT COMPLETED|Overall Study||4563
5011903|NCT02248662|12331530|P2|COMPLETED|Overall Study||2679
5011904|NCT02248662|12331531|P1|COMPLETED|Overall Study||757
5011905|NCT02248662|12331530|P2|STARTED|Overall Study||33194
5011906|NCT02248662|12331531|P1|STARTED|Overall Study||5320
5011907|NCT02248649|12331543|P2|NOT COMPLETED|Overall Study||21
5011908|NCT02248649|12331544|P1|NOT COMPLETED|Overall Study||21
5011909|NCT02248649|12331543|P2|COMPLETED|Overall Study||59
5011910|NCT02248649|12331544|P1|COMPLETED|Overall Study||59
5011911|NCT02248649|12331543|P2|STARTED|Overall Study||80
5011912|NCT02248649|12331544|P1|STARTED|Overall Study||80
5011913|NCT02248558|12331556|P2|NOT COMPLETED|Overall Study||45
5011914|NCT02248558|12331557|P1|NOT COMPLETED|Overall Study||52
5011915|NCT02248558|12331556|P2|COMPLETED|Overall Study||307
5011916|NCT02248558|12331557|P1|COMPLETED|Overall Study||317
5011917|NCT02248558|12331556|P2|STARTED|Overall Study||352
5011918|NCT02248558|12331557|P1|STARTED|Overall Study||369
5011919|NCT02248480|12331569|P2|NOT COMPLETED|Overall Study||14
5011920|NCT02248480|12331570|P1|NOT COMPLETED|Overall Study||17
5011921|NCT02248480|12331569|P2|COMPLETED|Overall Study||162
5011922|NCT02248480|12331570|P1|COMPLETED|Overall Study||161
5011923|NCT02248480|12331569|P2|Efficacy Population|Overall Study||176
5011924|NCT02248480|12331570|P1|Efficacy Population|Overall Study||177
5011925|NCT02248480|12331569|P2|STARTED|Overall Study||176
5011926|NCT02248480|12331570|P1|STARTED|Overall Study||178
5011927|NCT02248285|12331610|P2|NOT COMPLETED|Overall Study||287
5011928|NCT02248285|12331611|P1|NOT COMPLETED|Overall Study||101
5011929|NCT02248285|12331610|P2|COMPLETED|Overall Study||571
5011930|NCT02248285|12331611|P1|COMPLETED|Overall Study||586
5011931|NCT02248285|12331610|P2|STARTED|Overall Study||858
5011932|NCT02248285|12331611|P1|STARTED|Overall Study||687
5011933|NCT02248246|12331617|P1|NOT COMPLETED|Overall Study||0
5011934|NCT02248246|12331617|P1|COMPLETED|Overall Study||40
5011935|NCT02248246|12331617|P1|STARTED|Overall Study||40
5011936|NCT02248103|12331624|P2|NOT COMPLETED|Overall Study||0
5011937|NCT02248103|12331625|P1|NOT COMPLETED|Overall Study||0
5011938|NCT02248103|12331624|P2|COMPLETED|Overall Study||10
5011939|NCT02248103|12331625|P1|COMPLETED|Overall Study||10
5011940|NCT02248103|12331624|P2|STARTED|Overall Study||10
5011941|NCT02248103|12331625|P1|STARTED|Overall Study||10
5011942|NCT02247960|12331637|P2|NOT COMPLETED|Catheter Removed||10
5011943|NCT02247960|12331638|P1|NOT COMPLETED|Catheter Removed||7
5011944|NCT02247960|12331637|P2|COMPLETED|Catheter Removed||74
5011945|NCT02247960|12331638|P1|COMPLETED|Catheter Removed||76
5011946|NCT02247960|12331637|P2|STARTED|Catheter Removed||84
5011947|NCT02247960|12331638|P1|STARTED|Catheter Removed||83
5011948|NCT02247960|12331637|P2|NOT COMPLETED|Patient Consent and Randomization||6
5011949|NCT02247960|12331638|P1|NOT COMPLETED|Patient Consent and Randomization||2
5011950|NCT02247960|12331637|P2|COMPLETED|Patient Consent and Randomization||84
5011951|NCT02247960|12331638|P1|COMPLETED|Patient Consent and Randomization||83
5011952|NCT02247960|12331637|P2|STARTED|Patient Consent and Randomization||90
5011953|NCT02247960|12331638|P1|STARTED|Patient Consent and Randomization||85
5011954|NCT02247804|12331651|P3|NOT COMPLETED|Treatment Period 3||10
5011955|NCT02247804|12331652|P2|NOT COMPLETED|Treatment Period 3||10
5011956|NCT02247804|12331653|P1|NOT COMPLETED|Treatment Period 3||11
5011957|NCT02247804|12331651|P3|COMPLETED|Treatment Period 3||167
5011958|NCT02247804|12331652|P2|COMPLETED|Treatment Period 3||173
5011959|NCT02247804|12331653|P1|COMPLETED|Treatment Period 3||147
5011960|NCT02247804|12331651|P3|STARTED|Treatment Period 3||177
5011961|NCT02247804|12331652|P2|STARTED|Treatment Period 3||183
5011962|NCT02247804|12331653|P1|STARTED|Treatment Period 3||158
5011963|NCT02247804|12331651|P3|NOT COMPLETED|Treatment Period 2||8
5011964|NCT02247804|12331652|P2|NOT COMPLETED|Treatment Period 2||5
5011965|NCT02247804|12331653|P1|NOT COMPLETED|Treatment Period 2||8
5011966|NCT02247804|12331651|P3|COMPLETED|Treatment Period 2||179
5011967|NCT02247804|12331652|P2|COMPLETED|Treatment Period 2||186
5011968|NCT02247804|12331653|P1|COMPLETED|Treatment Period 2||164
5011969|NCT02247804|12331651|P3|STARTED|Treatment Period 2||187
5011970|NCT02247804|12331652|P2|STARTED|Treatment Period 2||191
5011971|NCT02247804|12331653|P1|STARTED|Treatment Period 2||172
5011972|NCT02247804|12331651|P3|NOT COMPLETED|Treatment Period 1||8
5011973|NCT02247804|12331652|P2|NOT COMPLETED|Treatment Period 1||4
5011974|NCT02247804|12331653|P1|NOT COMPLETED|Treatment Period 1||22
5011975|NCT02247804|12331651|P3|COMPLETED|Treatment Period 1||190
5011976|NCT02247804|12331652|P2|COMPLETED|Treatment Period 1||194
5011977|NCT02247804|12331653|P1|COMPLETED|Treatment Period 1||176
5011978|NCT02247804|12331651|P3|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
5011979|NCT02247804|12331652|P2|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
5011980|NCT02247804|12331653|P1|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
5011981|NCT02247804|12331651|P3|STARTED|Treatment Period 1||198
5011982|NCT02247804|12331652|P2|STARTED|Treatment Period 1||198
5011983|NCT02247804|12331653|P1|STARTED|Treatment Period 1||198
5011984|NCT02247765|12331682|P1|NOT COMPLETED|Overall Study||0
5011985|NCT02247765|12331682|P1|COMPLETED|Overall Study||18
5011986|NCT02247765|12331682|P1|STARTED|Overall Study||18
5011987|NCT02247739|12331687|P6|NOT COMPLETED|Overall Study||1
5011988|NCT02247739|12331688|P5|NOT COMPLETED|Overall Study||1
5011989|NCT02247739|12331689|P4|NOT COMPLETED|Overall Study||0
5011990|NCT02247739|12331690|P3|NOT COMPLETED|Overall Study||1
5011991|NCT02247739|12331691|P2|NOT COMPLETED|Overall Study||3
5011992|NCT02247739|12331692|P1|NOT COMPLETED|Overall Study||0
5011993|NCT02247739|12331687|P6|COMPLETED|Overall Study||4
5011994|NCT02247739|12331688|P5|COMPLETED|Overall Study||5
5011995|NCT02247739|12331689|P4|COMPLETED|Overall Study||5
5011996|NCT02247739|12331690|P3|COMPLETED|Overall Study||4
5011997|NCT02247739|12331691|P2|COMPLETED|Overall Study||3
5011998|NCT02247739|12331692|P1|COMPLETED|Overall Study||5
5011999|NCT02247739|12331687|P6|STARTED|Overall Study||5
5012000|NCT02247739|12331688|P5|STARTED|Overall Study||6
5012001|NCT02247739|12331689|P4|STARTED|Overall Study||5
5012002|NCT02247739|12331690|P3|STARTED|Overall Study||5
5012003|NCT02247739|12331691|P2|STARTED|Overall Study||6
5012004|NCT02247739|12331692|P1|STARTED|Overall Study||5
5012005|NCT02247531|12331711|P3|NOT COMPLETED|Overall Study||110
5012006|NCT02247531|12331712|P2|NOT COMPLETED|Overall Study||125
5012007|NCT02247531|12331713|P1|NOT COMPLETED|Overall Study||106
5012008|NCT02247531|12331711|P3|COMPLETED|Overall Study||214
5012009|NCT02247531|12331712|P2|COMPLETED|Overall Study||205
5012010|NCT02247531|12331713|P1|COMPLETED|Overall Study||215
5012011|NCT02247531|12331711|P3|STARTED|Overall Study||324
5012012|NCT02247531|12331712|P2|STARTED|Overall Study||330
5012013|NCT02247531|12331713|P1|STARTED|Overall Study||321
5012014|NCT02247479|12331763|P3|NOT COMPLETED|Overall Study||138
5012015|NCT02247479|12331764|P2|NOT COMPLETED|Overall Study||138
5012016|NCT02247479|12331765|P1|NOT COMPLETED|Overall Study||142
5012017|NCT02247479|12331763|P3|COMPLETED|Overall Study||165
5012018|NCT02247479|12331764|P2|COMPLETED|Overall Study||160
5012019|NCT02247479|12331765|P1|COMPLETED|Overall Study||163
5012020|NCT02247479|12331763|P3|STARTED|Overall Study||303
5012021|NCT02247479|12331764|P2|STARTED|Overall Study||298
5012022|NCT02247479|12331765|P1|STARTED|Overall Study||305
5012023|NCT02247466|12331814|P2|NOT COMPLETED|Overall Study||3
5012024|NCT02247466|12331815|P1|NOT COMPLETED|Overall Study||0
5012025|NCT02247466|12331814|P2|COMPLETED|Overall Study||15
5012026|NCT02247466|12331815|P1|COMPLETED|Overall Study||19
5012027|NCT02247466|12331814|P2|STARTED|Overall Study||18
5012028|NCT02247466|12331815|P1|STARTED|Overall Study||19
5012029|NCT02247440|12331833|P1|NOT COMPLETED|Overall Study||4
5012030|NCT02247440|12331833|P1|COMPLETED|Overall Study||14
5012031|NCT02247440|12331833|P1|STARTED|Overall Study||18
5012032|NCT02247401|12331846|P3|NOT COMPLETED|Overall Study||2
5012033|NCT02247401|12331847|P2|NOT COMPLETED|Overall Study||2
5012034|NCT02247401|12331848|P1|NOT COMPLETED|Overall Study||6
5012035|NCT02247401|12331846|P3|COMPLETED|Overall Study||27
5012036|NCT02247401|12331847|P2|COMPLETED|Overall Study||29
5012037|NCT02247401|12331848|P1|COMPLETED|Overall Study||94
5012038|NCT02247401|12331846|P3|STARTED|Overall Study||29
5012039|NCT02247401|12331847|P2|STARTED|Overall Study||31
5012040|NCT02247401|12331848|P1|STARTED|Overall Study||100
5012041|NCT02247245|12331869|P4|NOT COMPLETED|Overall Study||0
5012042|NCT02247245|12331870|P3|NOT COMPLETED|Overall Study||0
5012043|NCT02247245|12331871|P2|NOT COMPLETED|Overall Study||0
5012044|NCT02247245|12331872|P1|NOT COMPLETED|Overall Study||0
5012045|NCT02247245|12331869|P4|COMPLETED|Overall Study||7
5012046|NCT02247245|12331870|P3|COMPLETED|Overall Study||7
5012047|NCT02247245|12331871|P2|COMPLETED|Overall Study||13
5012048|NCT02247245|12331872|P1|COMPLETED|Overall Study||13
5012049|NCT02247245|12331869|P4|STARTED|Overall Study||7
5012050|NCT02247245|12331870|P3|STARTED|Overall Study||7
5012051|NCT02247245|12331871|P2|STARTED|Overall Study||13
5012052|NCT02247245|12331872|P1|STARTED|Overall Study||13
5012053|NCT02247063|12331884|P2|NOT COMPLETED|Overall Study||0
5012054|NCT02247063|12331885|P1|NOT COMPLETED|Overall Study||0
5012055|NCT02247063|12331884|P2|COMPLETED|Overall Study||12
5012056|NCT02247063|12331885|P1|COMPLETED|Overall Study||12
5012057|NCT02247063|12331884|P2|STARTED|Overall Study||12
5012058|NCT02247063|12331885|P1|STARTED|Overall Study||12
5012059|NCT02247011|12331895|P1|NOT COMPLETED|Overall Study||125
5012060|NCT02247011|12331895|P1|COMPLETED|Overall Study||975
5012061|NCT02247011|12331895|P1|STARTED|Overall Study||1100
5012062|NCT02246998|12331916|P4|NOT COMPLETED|Overall Study||2
5012063|NCT02246998|12331917|P3|NOT COMPLETED|Overall Study||3
5012064|NCT02246998|12331918|P2|NOT COMPLETED|Overall Study||3
5012065|NCT02246998|12331919|P1|NOT COMPLETED|Overall Study||2
5012066|NCT02246998|12331916|P4|COMPLETED|Overall Study||16
5012067|NCT02246998|12331917|P3|COMPLETED|Overall Study||15
5012068|NCT02246998|12331918|P2|COMPLETED|Overall Study||15
5012069|NCT02246998|12331919|P1|COMPLETED|Overall Study||16
5012070|NCT02246998|12331916|P4|STARTED|Overall Study||18
5012071|NCT02246998|12331917|P3|STARTED|Overall Study||18
5012072|NCT02246998|12331918|P2|STARTED|Overall Study||18
5012073|NCT02246998|12331919|P1|STARTED|Overall Study||18
5012074|NCT02246777|12332029|P1|NOT COMPLETED|Overall Study||3
5012075|NCT02246777|12332029|P1|COMPLETED|Overall Study||29
5012076|NCT02246777|12332029|P1|STARTED|Overall Study||32
5012077|NCT02246764|12332045|P3|NOT COMPLETED|Overall Study||4
5012078|NCT02246764|12332046|P2|NOT COMPLETED|Overall Study||32
5012079|NCT02246764|12332047|P1|NOT COMPLETED|Overall Study||18
5012080|NCT02246764|12332045|P3|COMPLETED|Overall Study||19
5012081|NCT02246764|12332046|P2|COMPLETED|Overall Study||4
5012082|NCT02246764|12332047|P1|COMPLETED|Overall Study||16
5012083|NCT02246764|12332045|P3|STARTED|Overall Study||23
5012084|NCT02246764|12332046|P2|STARTED|Overall Study||36
5012085|NCT02246764|12332047|P1|STARTED|Overall Study||34
5012086|NCT02246673|12332060|P5|NOT COMPLETED|Overall Study||1
5012087|NCT02246673|12332061|P4|NOT COMPLETED|Overall Study||2
5012088|NCT02246673|12332062|P3|NOT COMPLETED|Overall Study||0
5012089|NCT02246673|12332063|P2|NOT COMPLETED|Overall Study||0
5012090|NCT02246673|12332064|P1|NOT COMPLETED|Overall Study||1
5012091|NCT02246673|12332060|P5|COMPLETED|Overall Study||11
5012092|NCT02246673|12332061|P4|COMPLETED|Overall Study||12
5012093|NCT02246673|12332062|P3|COMPLETED|Overall Study||12
5012094|NCT02246673|12332063|P2|COMPLETED|Overall Study||12
5012095|NCT02246673|12332064|P1|COMPLETED|Overall Study||13
5012096|NCT02246673|12332060|P5|STARTED|Overall Study||12
5012097|NCT02246673|12332061|P4|STARTED|Overall Study||14
5012098|NCT02246673|12332062|P3|STARTED|Overall Study||12
5012099|NCT02246673|12332063|P2|STARTED|Overall Study||12
5012100|NCT02246673|12332064|P1|STARTED|Overall Study||14
5012101|NCT02246660|12332172|P3|NOT COMPLETED|Overall Study||1
5012102|NCT02246660|12332173|P2|NOT COMPLETED|Overall Study||1
5012103|NCT02246660|12332174|P1|NOT COMPLETED|Overall Study||0
5012104|NCT02246660|12332172|P3|COMPLETED|Overall Study||21
5012105|NCT02246660|12332173|P2|COMPLETED|Overall Study||20
5012106|NCT02246660|12332174|P1|COMPLETED|Overall Study||23
5012107|NCT02246660|12332172|P3|STARTED|Overall Study||22
5012108|NCT02246660|12332173|P2|STARTED|Overall Study||21
5012109|NCT02246660|12332174|P1|STARTED|Overall Study||23
5012110|NCT02246647|12332184|P2|NOT COMPLETED|Overall Study||1
5012111|NCT02246647|12332185|P1|NOT COMPLETED|Overall Study||1
5012112|NCT02246647|12332184|P2|COMPLETED|Overall Study||19
5012113|NCT02246647|12332185|P1|COMPLETED|Overall Study||18
5012114|NCT02246647|12332184|P2|STARTED|Overall Study||20
5012115|NCT02246647|12332185|P1|STARTED|Overall Study||19
5012116|NCT02246621|12332219|P2|NOT COMPLETED|Overall Study||148
5012117|NCT02246621|12332220|P1|NOT COMPLETED|Overall Study||296
5012118|NCT02246621|12332219|P2|COMPLETED|Overall Study||17
5012119|NCT02246621|12332220|P1|COMPLETED|Overall Study||32
5012120|NCT02246621|12332219|P2|Received At Least One Dose of Study Drug|Overall Study||162
5012121|NCT02246621|12332220|P1|Received At Least One Dose of Study Drug|Overall Study||326
5012122|NCT02246621|12332219|P2|STARTED|Overall Study||165
5012123|NCT02246621|12332220|P1|STARTED|Overall Study||328
5012124|NCT02246608|12332248|P2|NOT COMPLETED|Overall Study||10
5012125|NCT02246608|12332249|P1|NOT COMPLETED|Overall Study||12
5012126|NCT02246608|12332248|P2|COMPLETED|Overall Study||11
5012127|NCT02246608|12332249|P1|COMPLETED|Overall Study||10
5012128|NCT02246608|12332248|P2|STARTED|Overall Study||21
5012129|NCT02246608|12332249|P1|STARTED|Overall Study||22
5012130|NCT02246582|12332257|P2|NOT COMPLETED|Overall Study||4
5012131|NCT02246582|12332258|P1|NOT COMPLETED|Overall Study||3
5012132|NCT02246582|12332257|P2|COMPLETED|Overall Study||41
5012133|NCT02246582|12332258|P1|COMPLETED|Overall Study||41
5012134|NCT02246582|12332257|P2|STARTED|Overall Study||45
5012135|NCT02246582|12332258|P1|STARTED|Overall Study||44
5012136|NCT02246439|12332266|P2|NOT COMPLETED|Overall Study||11
5012137|NCT02246439|12332267|P1|NOT COMPLETED|Overall Study||12
5012138|NCT02246439|12332266|P2|COMPLETED|Overall Study||118
5012139|NCT02246439|12332267|P1|COMPLETED|Overall Study||180
5012140|NCT02246439|12332266|P2|Randomized|Overall Study||132
5012141|NCT02246439|12332267|P1|Randomized|Overall Study||198
5012142|NCT02246439|12332266|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
5012143|NCT02246439|12332267|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
5012144|NCT02246413|12332305|P2|NOT COMPLETED|24-months (Secondary Outcome)||32
5012145|NCT02246413|12332306|P1|NOT COMPLETED|24-months (Secondary Outcome)||51
5012146|NCT02246413|12332305|P2|COMPLETED|24-months (Secondary Outcome)||173
5012147|NCT02246413|12332306|P1|COMPLETED|24-months (Secondary Outcome)||153
5012148|NCT02246413|12332305|P2|STARTED|24-months (Secondary Outcome)||205
5012149|NCT02246413|12332306|P1|STARTED|24-months (Secondary Outcome)||204
5012150|NCT02246413|12332305|P2|NOT COMPLETED|12-months (Primary Outcome)||30
5012151|NCT02246413|12332306|P1|NOT COMPLETED|12-months (Primary Outcome)||35
5012152|NCT02246413|12332305|P2|COMPLETED|12-months (Primary Outcome)||175
5012153|NCT02246413|12332306|P1|COMPLETED|12-months (Primary Outcome)||169
5012154|NCT02246413|12332305|P2|STARTED|12-months (Primary Outcome)||205
5012155|NCT02246413|12332306|P1|STARTED|12-months (Primary Outcome)||204
5012156|NCT02246309|12332386|P2|NOT COMPLETED|Overall Study||0
5012157|NCT02246309|12332387|P1|NOT COMPLETED|Overall Study||0
5012158|NCT02246309|12332386|P2|COMPLETED|Overall Study||15
5012159|NCT02246309|12332387|P1|COMPLETED|Overall Study||16
5012160|NCT02246309|12332386|P2|STARTED|Overall Study||15
5012161|NCT02246309|12332387|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
5012162|NCT02246218|12332399|P2|NOT COMPLETED|Overall Study||6
5012163|NCT02246218|12332400|P1|NOT COMPLETED|Overall Study||4
5012164|NCT02246218|12332399|P2|COMPLETED|Overall Study||10
5012165|NCT02246218|12332400|P1|COMPLETED|Overall Study||6
5012166|NCT02246218|12332399|P2|STARTED|Overall Study||16
5012167|NCT02246218|12332400|P1|STARTED|Overall Study||10
5012168|NCT02246166|12332460|P2|NOT COMPLETED|Overall Study||0
5012169|NCT02246166|12332461|P1|NOT COMPLETED|Overall Study||1
5012170|NCT02246166|12332460|P2|COMPLETED|Overall Study||27
5012171|NCT02246166|12332461|P1|COMPLETED|Overall Study||25
5012172|NCT02246166|12332460|P2|STARTED|Overall Study||27
5012173|NCT02246166|12332461|P1|STARTED|Overall Study||26
5012174|NCT02246114|12332497|P2|NOT COMPLETED|Overall Study||0
5012175|NCT02246114|12332498|P1|NOT COMPLETED|Overall Study||1
5012176|NCT02246114|12332497|P2|COMPLETED|Overall Study||0
5012177|NCT02246114|12332498|P1|COMPLETED|Overall Study||0
5012178|NCT02246114|12332497|P2|STARTED|Overall Study||0
5012179|NCT02246114|12332498|P1|STARTED|Overall Study||1
5012180|NCT02246062|12332508|P4|NOT COMPLETED|Overall Study||0
5012181|NCT02246062|12332509|P3|NOT COMPLETED|Overall Study||0
5012182|NCT02246062|12332510|P2|NOT COMPLETED|Overall Study||0
5012183|NCT02246062|12332511|P1|NOT COMPLETED|Overall Study||0
5012184|NCT02246062|12332508|P4|COMPLETED|Overall Study||21
5012185|NCT02246062|12332509|P3|COMPLETED|Overall Study||21
5012186|NCT02246062|12332510|P2|COMPLETED|Overall Study||21
5012187|NCT02246062|12332511|P1|COMPLETED|Overall Study||21
5012188|NCT02246062|12332508|P4|STARTED|Overall Study||21
5012189|NCT02246062|12332509|P3|STARTED|Overall Study||21
5012190|NCT02246062|12332510|P2|STARTED|Overall Study||21
5012191|NCT02246062|12332511|P1|STARTED|Overall Study||21
5012192|NCT02246010|12332531|P2|NOT COMPLETED|Overall Study||0
5012193|NCT02246010|12332532|P1|NOT COMPLETED|Overall Study||0
5012194|NCT02246010|12332531|P2|COMPLETED|Overall Study||2
5012195|NCT02246010|12332532|P1|COMPLETED|Overall Study||4
5012196|NCT02246010|12332531|P2|STARTED|Overall Study||2
5012197|NCT02246010|12332532|P1|STARTED|Overall Study||4
5012198|NCT02245737|12332549|P3|NOT COMPLETED|Overall Study||571
5012199|NCT02245737|12332550|P2|NOT COMPLETED|Overall Study||555
5012200|NCT02245737|12332551|P1|NOT COMPLETED|Overall Study||553
5012201|NCT02245737|12332549|P3|COMPLETED|Overall Study||168
5012202|NCT02245737|12332550|P2|COMPLETED|Overall Study||184
5012203|NCT02245737|12332551|P1|COMPLETED|Overall Study||187
5012204|NCT02245737|12332549|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
5012205|NCT02245737|12332550|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
5012206|NCT02245737|12332551|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
5012207|NCT02245737|12332549|P3|STARTED|Overall Study||739
5012208|NCT02245737|12332550|P2|STARTED|Overall Study||739
5012209|NCT02245737|12332551|P1|STARTED|Overall Study||740
5012210|NCT02245620|12332608|P2|NOT COMPLETED|Overall Study||1
5012211|NCT02245620|12332609|P1|NOT COMPLETED|Overall Study||1
5012212|NCT02245620|12332608|P2|COMPLETED|Overall Study||20
5012213|NCT02245620|12332609|P1|COMPLETED|Overall Study||19
5012214|NCT02245620|12332608|P2|STARTED|Overall Study||21
5012215|NCT02245620|12332609|P1|STARTED|Overall Study||20
5012216|NCT02245568|12332621|P1|NOT COMPLETED|Overall Study||853
5012217|NCT02245568|12332621|P1|COMPLETED|Overall Study||60
5012218|NCT02245568|12332621|P1|STARTED|Overall Study||913
5012219|NCT02245412|12332628|P3|NOT COMPLETED|Follow-Up Period||2
5012220|NCT02245412|12332629|P2|NOT COMPLETED|Follow-Up Period||2
5012221|NCT02245412|12332630|P1|NOT COMPLETED|Follow-Up Period||5
5012222|NCT02245412|12332628|P3|COMPLETED|Follow-Up Period||0
5012223|NCT02245412|12332629|P2|COMPLETED|Follow-Up Period||2
5012224|NCT02245412|12332630|P1|COMPLETED|Follow-Up Period||8
5012225|NCT02245412|12332628|P3|STARTED|Follow-Up Period||2
5012226|NCT02245412|12332629|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
5012227|NCT02245412|12332630|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
5012228|NCT02245412|12332628|P3|NOT COMPLETED|Treatment Period||0
5012229|NCT02245412|12332629|P2|NOT COMPLETED|Treatment Period||3
5012230|NCT02245412|12332630|P1|NOT COMPLETED|Treatment Period||5
5012231|NCT02245412|12332628|P3|COMPLETED|Treatment Period||2
5012232|NCT02245412|12332629|P2|COMPLETED|Treatment Period||3
5012233|NCT02245412|12332630|P1|COMPLETED|Treatment Period||12
5012234|NCT02245412|12332628|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
5012235|NCT02245412|12332629|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
5012236|NCT02245412|12332630|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
5012237|NCT02245412|12332628|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
5012238|NCT02245412|12332629|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
5012239|NCT02245412|12332630|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
5012240|NCT02245412|12332628|P3|STARTED|Treatment Period||2
5012241|NCT02245412|12332629|P2|STARTED|Treatment Period||6
5012242|NCT02245412|12332630|P1|STARTED|Treatment Period||17
5012243|NCT02245360|12332649|P2|NOT COMPLETED|Overall Study||2
5012244|NCT02245360|12332650|P1|NOT COMPLETED|Overall Study||5
5012245|NCT02245360|12332649|P2|COMPLETED|Overall Study||52
5012246|NCT02245360|12332650|P1|COMPLETED|Overall Study||48
5012247|NCT02245360|12332649|P2|STARTED|Overall Study||54
5012248|NCT02245360|12332650|P1|STARTED|Overall Study||53
5012249|NCT02245308|12332660|P2|NOT COMPLETED|Overall Study||0
5012250|NCT02245308|12332661|P1|NOT COMPLETED|Overall Study||0
5012251|NCT02245308|12332660|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
5012252|NCT02245308|12332661|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
5012253|NCT02245308|12332660|P2|STARTED|Overall Study||64
5012254|NCT02245308|12332661|P1|STARTED|Overall Study||63
5012255|NCT02245217|12332669|P1|NOT COMPLETED|Overall Study||2
5012256|NCT02245217|12332669|P1|COMPLETED|Overall Study||7
5012257|NCT02245217|12332669|P1|STARTED|Overall Study||9
5012258|NCT02244996|12332677|P2|NOT COMPLETED|Overall Study||6
5012259|NCT02244996|12332678|P1|NOT COMPLETED|Overall Study||2
5012260|NCT02244996|12332677|P2|COMPLETED|Overall Study||19
5012261|NCT02244996|12332678|P1|COMPLETED|Overall Study||23
5012262|NCT02244996|12332677|P2|STARTED|Overall Study||25
5012263|NCT02244996|12332678|P1|STARTED|Overall Study||25
5012264|NCT02244957|12332692|P2|NOT COMPLETED|Overall Study||0
5012265|NCT02244957|12332693|P1|NOT COMPLETED|Overall Study||1
5012266|NCT02244957|12332692|P2|COMPLETED|Overall Study||16
5012267|NCT02244957|12332693|P1|COMPLETED|Overall Study||6
5012268|NCT02244957|12332692|P2|STARTED|Overall Study||16
5012269|NCT02244957|12332693|P1|STARTED|Overall Study||7
5012270|NCT02244944|12332737|P1|NOT COMPLETED|Overall Study||2
5012271|NCT02244944|12332737|P1|COMPLETED|Overall Study||0
5012272|NCT02244944|12332737|P1|STARTED|Overall Study||2
5012273|NCT02244918|12332745|P2|NOT COMPLETED|Overall Study||0
5012274|NCT02244918|12332746|P1|NOT COMPLETED|Overall Study||0
5012275|NCT02244918|12332745|P2|COMPLETED|Overall Study||93
5012276|NCT02244918|12332746|P1|COMPLETED|Overall Study||185
5012277|NCT02244918|12332745|P2|Week 12|Overall Study||83
5012278|NCT02244918|12332746|P1|Week 12|Overall Study||160
5012279|NCT02244918|12332745|P2|STARTED|Overall Study||93
5012280|NCT02244918|12332746|P1|STARTED|Overall Study||185
5012281|NCT02244840|12332762|P1|NOT COMPLETED|Overall Study||0
5012282|NCT02244840|12332762|P1|COMPLETED|Overall Study||40
5012283|NCT02244840|12332762|P1|STARTED|Overall Study||40
5012284|NCT02244619|12332768|P2|NOT COMPLETED|Overall Study||21
5012285|NCT02244619|12332769|P1|NOT COMPLETED|Overall Study||8
5012286|NCT02244619|12332768|P2|COMPLETED|Overall Study||245
5012287|NCT02244619|12332769|P1|COMPLETED|Overall Study||241
5012288|NCT02244619|12332768|P2|STARTED|Overall Study||266
5012289|NCT02244619|12332769|P1|STARTED|Overall Study||249
5012290|NCT02244580|12332787|P1|NOT COMPLETED|Overall Study||241
5012291|NCT02244580|12332787|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
5012292|NCT02244580|12332787|P1|STARTED|Overall Study||1010
5012293|NCT02244424|12332797|P2|NOT COMPLETED|Overall Study||10
5012294|NCT02244424|12332798|P1|NOT COMPLETED|Overall Study||20
5012295|NCT02244424|12332797|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
5012296|NCT02244424|12332798|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
5012297|NCT02244424|12332797|P2|Mothers|Overall Study||31
5012298|NCT02244424|12332798|P1|Mothers|Overall Study||51
5012299|NCT02244424|12332797|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
5012300|NCT02244424|12332798|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
5012301|NCT02244424|12332797|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
5012302|NCT02244424|12332798|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
5012303|NCT02243943|12332806|P2|NOT COMPLETED|Overall Study||0
5012304|NCT02243943|12332807|P1|NOT COMPLETED|Overall Study||0
5012305|NCT02243943|12332806|P2|COMPLETED|Overall Study||50
5012306|NCT02243943|12332807|P1|COMPLETED|Overall Study||50
5012307|NCT02243943|12332806|P2|STARTED|Overall Study||50
5012308|NCT02243943|12332807|P1|STARTED|Overall Study||50
5012309|NCT02243696|12332817|P1|NOT COMPLETED|Overall Study||1694
5012310|NCT02243696|12332817|P1|COMPLETED|Overall Study||0
5012311|NCT02243696|12332817|P1|STARTED|Overall Study||1694
5012312|NCT02243579|12332827|P1|NOT COMPLETED|Overall Study||20
5012313|NCT02243579|12332827|P1|COMPLETED|Overall Study||4
5012314|NCT02243579|12332827|P1|STARTED|Overall Study||24
5012315|NCT02243527|12332838|P2|NOT COMPLETED|Overall Study||0
5012316|NCT02243527|12332839|P1|NOT COMPLETED|Overall Study||0
5012317|NCT02243527|12332838|P2|COMPLETED|Overall Study||13
5012318|NCT02243527|12332839|P1|COMPLETED|Overall Study||12
5012319|NCT02243527|12332838|P2|STARTED|Overall Study||13
5012320|NCT02243527|12332839|P1|STARTED|Overall Study||12
5012321|NCT02243371|12332853|P2|NOT COMPLETED|Overall Study||32
5012322|NCT02243371|12332854|P1|NOT COMPLETED|Overall Study||37
5012323|NCT02243371|12332853|P2|COMPLETED|Overall Study||10
5012324|NCT02243371|12332854|P1|COMPLETED|Overall Study||14
5012325|NCT02243371|12332853|P2|STARTED|Overall Study||42
5012326|NCT02243371|12332854|P1|STARTED|Overall Study||51
5012327|NCT02243306|12332874|P2|NOT COMPLETED|Overall Study||3
5012328|NCT02243306|12332875|P1|NOT COMPLETED|Overall Study||0
5012329|NCT02243306|12332874|P2|COMPLETED|Overall Study||4
5012330|NCT02243306|12332875|P1|COMPLETED|Overall Study||1
5012331|NCT02243306|12332874|P2|STARTED|Overall Study||7
5012332|NCT02243306|12332875|P1|STARTED|Overall Study||1
5012333|NCT02243293|12332950|P22|NOT COMPLETED|Overall Study||3
5012334|NCT02243293|12332951|P21|NOT COMPLETED|Overall Study||2
5012335|NCT02243293|12332952|P20|NOT COMPLETED|Overall Study||1
5012336|NCT02243293|12332953|P19|NOT COMPLETED|Overall Study||0
5012337|NCT02243293|12332954|P18|NOT COMPLETED|Overall Study||1
5012338|NCT02243293|12332955|P17|NOT COMPLETED|Overall Study||3
5012339|NCT02243293|12332956|P16|NOT COMPLETED|Overall Study||1
5012340|NCT02243293|12332957|P15|NOT COMPLETED|Overall Study||1
5012341|NCT02243293|12332958|P14|NOT COMPLETED|Overall Study||0
5012342|NCT02243293|12332959|P13|NOT COMPLETED|Overall Study||0
5012343|NCT02243293|12332960|P12|NOT COMPLETED|Overall Study||3
5012344|NCT02243293|12332961|P11|NOT COMPLETED|Overall Study||0
5012345|NCT02243293|12332962|P10|NOT COMPLETED|Overall Study||2
5012346|NCT02243293|12332963|P9|NOT COMPLETED|Overall Study||0
5012347|NCT02243293|12332964|P8|NOT COMPLETED|Overall Study||0
5012348|NCT02243293|12332965|P7|NOT COMPLETED|Overall Study||3
5012349|NCT02243293|12332966|P6|NOT COMPLETED|Overall Study||0
5012350|NCT02243293|12332967|P5|NOT COMPLETED|Overall Study||1
5012351|NCT02243293|12332968|P4|NOT COMPLETED|Overall Study||1
5012352|NCT02243293|12332969|P3|NOT COMPLETED|Overall Study||1
5012353|NCT02243293|12332970|P2|NOT COMPLETED|Overall Study||1
5012354|NCT02243293|12332971|P1|NOT COMPLETED|Overall Study||2
5012355|NCT02243293|12332950|P22|COMPLETED|Overall Study||55
5012356|NCT02243293|12332951|P21|COMPLETED|Overall Study||143
5012357|NCT02243293|12332952|P20|COMPLETED|Overall Study||47
5012358|NCT02243293|12332953|P19|COMPLETED|Overall Study||22
5012359|NCT02243293|12332954|P18|COMPLETED|Overall Study||21
5012360|NCT02243293|12332955|P17|COMPLETED|Overall Study||37
5012361|NCT02243293|12332956|P16|COMPLETED|Overall Study||26
5012362|NCT02243293|12332957|P15|COMPLETED|Overall Study||27
5012363|NCT02243293|12332958|P14|COMPLETED|Overall Study||0
5012364|NCT02243293|12332959|P13|COMPLETED|Overall Study||0
5012365|NCT02243293|12332960|P12|COMPLETED|Overall Study||50
5012366|NCT02243293|12332961|P11|COMPLETED|Overall Study||0
5012367|NCT02243293|12332962|P10|COMPLETED|Overall Study||53
5012368|NCT02243293|12332963|P9|COMPLETED|Overall Study||0
5012369|NCT02243293|12332964|P8|COMPLETED|Overall Study||0
5012370|NCT02243293|12332965|P7|COMPLETED|Overall Study||27
5012371|NCT02243293|12332966|P6|COMPLETED|Overall Study||31
5012372|NCT02243293|12332967|P5|COMPLETED|Overall Study||30
5012373|NCT02243293|12332968|P4|COMPLETED|Overall Study||29
5012374|NCT02243293|12332969|P3|COMPLETED|Overall Study||24
5012375|NCT02243293|12332970|P2|COMPLETED|Overall Study||23
5012376|NCT02243293|12332971|P1|COMPLETED|Overall Study||23
5012377|NCT02243293|12332950|P22|STARTED|Overall Study||58
5012378|NCT02243293|12332951|P21|STARTED|Overall Study||145
5012379|NCT02243293|12332952|P20|STARTED|Overall Study||48
5012380|NCT02243293|12332953|P19|STARTED|Overall Study||22
5012381|NCT02243293|12332954|P18|STARTED|Overall Study||22
5012382|NCT02243293|12332955|P17|STARTED|Overall Study||40
5012383|NCT02243293|12332956|P16|STARTED|Overall Study||27
5012384|NCT02243293|12332957|P15|STARTED|Overall Study||28
5012385|NCT02243293|12332958|P14|STARTED|Overall Study||0
5012386|NCT02243293|12332959|P13|STARTED|Overall Study||0
5012387|NCT02243293|12332960|P12|STARTED|Overall Study||53
5012388|NCT02243293|12332961|P11|STARTED|Overall Study||0
5012389|NCT02243293|12332962|P10|STARTED|Overall Study||55
5012390|NCT02243293|12332963|P9|STARTED|Overall Study||0
5012391|NCT02243293|12332964|P8|STARTED|Overall Study||0
5012392|NCT02243293|12332965|P7|STARTED|Overall Study||30
5012393|NCT02243293|12332966|P6|STARTED|Overall Study||31
5012394|NCT02243293|12332967|P5|STARTED|Overall Study||31
5012395|NCT02243293|12332968|P4|STARTED|Overall Study||30
5012396|NCT02243293|12332969|P3|STARTED|Overall Study||25
5012397|NCT02243293|12332970|P2|STARTED|Overall Study||24
5012398|NCT02243293|12332971|P1|STARTED|Overall Study||25
5012399|NCT02243280|12333070|P11|NOT COMPLETED|Treated||3
5012400|NCT02243280|12333071|P10|NOT COMPLETED|Treated||0
5012401|NCT02243280|12333072|P9|NOT COMPLETED|Treated||1
5012402|NCT02243280|12333073|P8|NOT COMPLETED|Treated||0
5012403|NCT02243280|12333074|P7|NOT COMPLETED|Treated||0
5012404|NCT02243280|12333075|P6|NOT COMPLETED|Treated||0
5012405|NCT02243280|12333076|P5|NOT COMPLETED|Treated||0
5012406|NCT02243280|12333077|P4|NOT COMPLETED|Treated||0
5012407|NCT02243280|12333078|P3|NOT COMPLETED|Treated||0
5012408|NCT02243280|12333079|P2|NOT COMPLETED|Treated||0
5012409|NCT02243280|12333080|P1|NOT COMPLETED|Treated||1
5012410|NCT02243280|12333070|P11|COMPLETED|Treated||31
5012411|NCT02243280|12333071|P10|COMPLETED|Treated||0
5012412|NCT02243280|12333072|P9|COMPLETED|Treated||31
5012413|NCT02243280|12333073|P8|COMPLETED|Treated||0
5012414|NCT02243280|12333074|P7|COMPLETED|Treated||0
5012415|NCT02243280|12333075|P6|COMPLETED|Treated||27
5012416|NCT02243280|12333076|P5|COMPLETED|Treated||0
5012417|NCT02243280|12333077|P4|COMPLETED|Treated||0
5012418|NCT02243280|12333078|P3|COMPLETED|Treated||0
5012419|NCT02243280|12333079|P2|COMPLETED|Treated||39
5012420|NCT02243280|12333080|P1|COMPLETED|Treated||41
5012421|NCT02243280|12333070|P11|Completed Treatment|Treated||33
5012422|NCT02243280|12333071|P10|Completed Treatment|Treated||0
5012423|NCT02243280|12333072|P9|Completed Treatment|Treated||32
5012424|NCT02243280|12333073|P8|Completed Treatment|Treated||0
5012425|NCT02243280|12333074|P7|Completed Treatment|Treated||0
5012426|NCT02243280|12333075|P6|Completed Treatment|Treated||27
5012427|NCT02243280|12333076|P5|Completed Treatment|Treated||0
5012428|NCT02243280|12333077|P4|Completed Treatment|Treated||0
5012429|NCT02243280|12333078|P3|Completed Treatment|Treated||0
5012430|NCT02243280|12333079|P2|Completed Treatment|Treated||38
5012431|NCT02243280|12333080|P1|Completed Treatment|Treated||42
5012432|NCT02243280|12333070|P11|STARTED|Treated||34
5012433|NCT02243280|12333071|P10|STARTED|Treated||0
5012434|NCT02243280|12333072|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
5012435|NCT02243280|12333073|P8|STARTED|Treated||0
5012436|NCT02243280|12333074|P7|STARTED|Treated||0
5012437|NCT02243280|12333075|P6|STARTED|Treated||27
5012438|NCT02243280|12333076|P5|STARTED|Treated||0
5012439|NCT02243280|12333077|P4|STARTED|Treated||0
5012440|NCT02243280|12333078|P3|STARTED|Treated||0
5012441|NCT02243280|12333079|P2|STARTED|Treated||39
5012442|NCT02243280|12333080|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
5012443|NCT02243280|12333070|P11|NOT COMPLETED|Enrolled||0
5012444|NCT02243280|12333071|P10|NOT COMPLETED|Enrolled||0
5012445|NCT02243280|12333072|P9|NOT COMPLETED|Enrolled||0
5012446|NCT02243280|12333073|P8|NOT COMPLETED|Enrolled||0
5012447|NCT02243280|12333074|P7|NOT COMPLETED|Enrolled||0
5012448|NCT02243280|12333075|P6|NOT COMPLETED|Enrolled||0
5012449|NCT02243280|12333076|P5|NOT COMPLETED|Enrolled||0
5012450|NCT02243280|12333077|P4|NOT COMPLETED|Enrolled||0
5012451|NCT02243280|12333078|P3|NOT COMPLETED|Enrolled||0
5012452|NCT02243280|12333079|P2|NOT COMPLETED|Enrolled||0
5012453|NCT02243280|12333080|P1|NOT COMPLETED|Enrolled||0
5012454|NCT02243280|12333070|P11|COMPLETED|Enrolled||34
5012455|NCT02243280|12333071|P10|COMPLETED|Enrolled||0
5012456|NCT02243280|12333072|P9|COMPLETED|Enrolled||34
5012457|NCT02243280|12333073|P8|COMPLETED|Enrolled||0
5012458|NCT02243280|12333074|P7|COMPLETED|Enrolled||0
5012459|NCT02243280|12333075|P6|COMPLETED|Enrolled||27
5012460|NCT02243280|12333076|P5|COMPLETED|Enrolled||0
5012461|NCT02243280|12333077|P4|COMPLETED|Enrolled||0
5012462|NCT02243280|12333078|P3|COMPLETED|Enrolled||0
5012463|NCT02243280|12333079|P2|COMPLETED|Enrolled||39
5012464|NCT02243280|12333080|P1|COMPLETED|Enrolled||40
5012465|NCT02243280|12333070|P11|STARTED|Enrolled||34
5012466|NCT02243280|12333071|P10|STARTED|Enrolled||0
5012467|NCT02243280|12333072|P9|STARTED|Enrolled||34
5012468|NCT02243280|12333073|P8|STARTED|Enrolled||0
5012469|NCT02243280|12333074|P7|STARTED|Enrolled||0
5012470|NCT02243280|12333075|P6|STARTED|Enrolled||27
5012471|NCT02243280|12333076|P5|STARTED|Enrolled||0
5012472|NCT02243280|12333077|P4|STARTED|Enrolled||0
5012473|NCT02243280|12333078|P3|STARTED|Enrolled||0
5012474|NCT02243280|12333079|P2|STARTED|Enrolled||39
5012475|NCT02243280|12333080|P1|STARTED|Enrolled||40
5012476|NCT02243202|12333135|P4|NOT COMPLETED|Overall Study||23
5012477|NCT02243202|12333136|P3|NOT COMPLETED|Overall Study||31
5012478|NCT02243202|12333137|P2|NOT COMPLETED|Overall Study||25
5012479|NCT02243202|12333138|P1|NOT COMPLETED|Overall Study||25
5012480|NCT02243202|12333135|P4|COMPLETED|Overall Study||61
5012481|NCT02243202|12333136|P3|COMPLETED|Overall Study||53
5012482|NCT02243202|12333137|P2|COMPLETED|Overall Study||60
5012483|NCT02243202|12333138|P1|COMPLETED|Overall Study||57
5012484|NCT02243202|12333135|P4|Treated|Overall Study||83
5012485|NCT02243202|12333136|P3|Treated|Overall Study||84
5012486|NCT02243202|12333137|P2|Treated|Overall Study||85
5012487|NCT02243202|12333138|P1|Treated|Overall Study||82
5012488|NCT02243202|12333135|P4|STARTED|Overall Study||84
5012489|NCT02243202|12333136|P3|STARTED|Overall Study||84
5012490|NCT02243202|12333137|P2|STARTED|Overall Study||85
5012491|NCT02243202|12333138|P1|STARTED|Overall Study||82
5012492|NCT02243176|12333174|P2|NOT COMPLETED|Overall Study||15
5012493|NCT02243176|12333175|P1|NOT COMPLETED|Overall Study||14
5012494|NCT02243176|12333174|P2|COMPLETED|Overall Study||229
5012495|NCT02243176|12333175|P1|COMPLETED|Overall Study||230
5012496|NCT02243176|12333174|P2|STARTED|Overall Study||244
5012497|NCT02243176|12333175|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
5012498|NCT02243046|12333200|P3|NOT COMPLETED|Overall Study||4
5012499|NCT02243046|12333201|P2|NOT COMPLETED|Overall Study||1
5012500|NCT02243046|12333202|P1|NOT COMPLETED|Overall Study||1
5012501|NCT02243046|12333200|P3|COMPLETED|Overall Study||49
5012502|NCT02243046|12333201|P2|COMPLETED|Overall Study||53
5012503|NCT02243046|12333202|P1|COMPLETED|Overall Study||54
5012504|NCT02243046|12333200|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
5012505|NCT02243046|12333201|P2|6 Month|Overall Study||53
5012506|NCT02243046|12333202|P1|6 Month|Overall Study||54
5012507|NCT02243046|12333200|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
5012508|NCT02243046|12333201|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
5012509|NCT02243046|12333202|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
5012510|NCT02243046|12333200|P3|STARTED|Overall Study||53
5012511|NCT02243046|12333201|P2|STARTED|Overall Study||54
5012512|NCT02243046|12333202|P1|STARTED|Overall Study||55
5012513|NCT02243020|12333227|P2|NOT COMPLETED|Overall Study||0
5012514|NCT02243020|12333228|P1|NOT COMPLETED|Overall Study||0
5012515|NCT02243020|12333227|P2|COMPLETED|Overall Study||9
5012516|NCT02243020|12333228|P1|COMPLETED|Overall Study||8
5012517|NCT02243020|12333227|P2|STARTED|Overall Study||9
5012518|NCT02243020|12333228|P1|STARTED|Overall Study||8
5012519|NCT02243007|12333238|P2|NOT COMPLETED|Overall Study||0
5012520|NCT02243007|12333239|P1|NOT COMPLETED|Overall Study||0
5012521|NCT02243007|12333238|P2|COMPLETED|Overall Study||3
5012522|NCT02243007|12333239|P1|COMPLETED|Overall Study||4
5012523|NCT02243007|12333238|P2|STARTED|Overall Study||3
5012524|NCT02243007|12333239|P1|STARTED|Overall Study||4
5012525|NCT02242994|12333261|P1|NOT COMPLETED|Overall Study||0
5012526|NCT02242994|12333261|P1|COMPLETED|Overall Study||5
5012527|NCT02242994|12333261|P1|STARTED|Overall Study||5
5012528|NCT02242981|12333266|P1|NOT COMPLETED|Overall Study||1
5012529|NCT02242981|12333266|P1|COMPLETED|Overall Study||5
5012530|NCT02242981|12333266|P1|Received Study Drug|Overall Study||6
5012531|NCT02242981|12333266|P1|STARTED|Overall Study||6
5012532|NCT02242942|12333277|P3|NOT COMPLETED|Overall Study||13
5012533|NCT02242942|12333278|P2|NOT COMPLETED|Overall Study||216
5012534|NCT02242942|12333279|P1|NOT COMPLETED|Overall Study||216
5012535|NCT02242942|12333277|P3|COMPLETED|Overall Study||0
5012536|NCT02242942|12333278|P2|COMPLETED|Overall Study||0
5012537|NCT02242942|12333279|P1|COMPLETED|Overall Study||0
5012538|NCT02242942|12333277|P3|Treated|Overall Study||13
5012539|NCT02242942|12333278|P2|Treated|Overall Study||212
5012540|NCT02242942|12333279|P1|Treated|Overall Study||214
5012541|NCT02242942|12333277|P3|STARTED|Overall Study||13
5012542|NCT02242942|12333278|P2|STARTED|Overall Study||216
5012543|NCT02242942|12333279|P1|STARTED|Overall Study||216
5012544|NCT02242903|12333313|P7|NOT COMPLETED|Overall Study||0
5012545|NCT02242903|12333314|P6|NOT COMPLETED|Overall Study||0
5012546|NCT02242903|12333315|P5|NOT COMPLETED|Overall Study||0
5012547|NCT02242903|12333316|P4|NOT COMPLETED|Overall Study||0
5012548|NCT02242903|12333317|P3|NOT COMPLETED|Overall Study||0
5012549|NCT02242903|12333318|P2|NOT COMPLETED|Overall Study||0
5012550|NCT02242903|12333319|P1|NOT COMPLETED|Overall Study||1
5012551|NCT02242903|12333313|P7|COMPLETED|Overall Study||6
5012552|NCT02242903|12333314|P6|COMPLETED|Overall Study||6
5012553|NCT02242903|12333315|P5|COMPLETED|Overall Study||6
5012554|NCT02242903|12333316|P4|COMPLETED|Overall Study||6
5012555|NCT02242903|12333317|P3|COMPLETED|Overall Study||6
5012556|NCT02242903|12333318|P2|COMPLETED|Overall Study||6
5012557|NCT02242903|12333319|P1|COMPLETED|Overall Study||11
5012558|NCT02242903|12333313|P7|Received at Least One Dose of Study Drug|Overall Study||6
5012559|NCT02242903|12333314|P6|Received at Least One Dose of Study Drug|Overall Study||6
5012560|NCT02242903|12333315|P5|Received at Least One Dose of Study Drug|Overall Study||6
5012561|NCT02242903|12333316|P4|Received at Least One Dose of Study Drug|Overall Study||6
5012562|NCT02242903|12333317|P3|Received at Least One Dose of Study Drug|Overall Study||6
5012563|NCT02242903|12333318|P2|Received at Least One Dose of Study Drug|Overall Study||6
5012564|NCT02242903|12333319|P1|Received at Least One Dose of Study Drug|Overall Study||12
5012565|NCT02242903|12333313|P7|STARTED|Overall Study||6
5012566|NCT02242903|12333314|P6|STARTED|Overall Study||6
5012567|NCT02242903|12333315|P5|STARTED|Overall Study||6
5012568|NCT02242903|12333316|P4|STARTED|Overall Study||6
5012569|NCT02242903|12333317|P3|STARTED|Overall Study||6
5012570|NCT02242903|12333318|P2|STARTED|Overall Study||6
5012571|NCT02242903|12333319|P1|STARTED|Overall Study||12
5012572|NCT02242643|12333349|P2|NOT COMPLETED|Overall Study||78
5012573|NCT02242643|12333350|P1|NOT COMPLETED|Overall Study||75
5012574|NCT02242643|12333349|P2|COMPLETED|Overall Study||1139
5012575|NCT02242643|12333350|P1|COMPLETED|Overall Study||1132
5012576|NCT02242643|12333349|P2|STARTED|Overall Study||1217
5012577|NCT02242643|12333350|P1|STARTED|Overall Study||1207
5012578|NCT02242630|12333386|P4|NOT COMPLETED|Overall Study||0
5012579|NCT02242630|12333387|P3|NOT COMPLETED|Overall Study||0
5012580|NCT02242630|12333388|P2|NOT COMPLETED|Overall Study||0
5012581|NCT02242630|12333389|P1|NOT COMPLETED|Overall Study||0
5012582|NCT02242630|12333386|P4|COMPLETED|Overall Study||16
5012583|NCT02242630|12333387|P3|COMPLETED|Overall Study||15
5012584|NCT02242630|12333388|P2|COMPLETED|Overall Study||15
5012585|NCT02242630|12333389|P1|COMPLETED|Overall Study||15
5012586|NCT02242630|12333386|P4|STARTED|Overall Study||16
5012587|NCT02242630|12333387|P3|STARTED|Overall Study||15
5012588|NCT02242630|12333388|P2|STARTED|Overall Study||15
5012589|NCT02242630|12333389|P1|STARTED|Overall Study||15
5012590|NCT02242487|12333405|P2|NOT COMPLETED|Overall Study||47
5012591|NCT02242487|12333406|P1|NOT COMPLETED|Overall Study||62
5012592|NCT02242487|12333405|P2|COMPLETED|Overall Study||117
5012593|NCT02242487|12333406|P1|COMPLETED|Overall Study||99
5012594|NCT02242487|12333405|P2|STARTED|Overall Study||164
5012595|NCT02242487|12333406|P1|STARTED|Overall Study||161
5012596|NCT02242305|12333422|P2|NOT COMPLETED|Overall Study||10
5012597|NCT02242305|12333423|P1|NOT COMPLETED|Overall Study||6
5012598|NCT02242305|12333422|P2|COMPLETED|Overall Study||141
5012599|NCT02242305|12333423|P1|COMPLETED|Overall Study||145
5012600|NCT02242305|12333422|P2|STARTED|Overall Study||151
5012601|NCT02242305|12333423|P1|STARTED|Overall Study||151
5012602|NCT02242201|12333444|P3|NOT COMPLETED|Overall Study||1
5012603|NCT02242201|12333445|P2|NOT COMPLETED|Overall Study||1
5012604|NCT02242201|12333446|P1|NOT COMPLETED|Overall Study||4
5012605|NCT02242201|12333444|P3|COMPLETED|Overall Study||54
5012606|NCT02242201|12333445|P2|COMPLETED|Overall Study||54
5012607|NCT02242201|12333446|P1|COMPLETED|Overall Study||51
5012608|NCT02242201|12333444|P3|STARTED|Overall Study||55
5012609|NCT02242201|12333445|P2|STARTED|Overall Study||55
5012610|NCT02242201|12333446|P1|STARTED|Overall Study||55
5012611|NCT02242019|12333478|P1|NOT COMPLETED|Overall Study||0
5012612|NCT02242019|12333478|P1|COMPLETED|Overall Study||109
5012613|NCT02242019|12333478|P1|STARTED|Overall Study||109
5012614|NCT02241889|12333484|P6|NOT COMPLETED|Overall Study||1
5012615|NCT02241889|12333485|P5|NOT COMPLETED|Overall Study||0
5012616|NCT02241889|12333486|P4|NOT COMPLETED|Overall Study||0
5012617|NCT02241889|12333487|P3|NOT COMPLETED|Overall Study||1
5012618|NCT02241889|12333488|P2|NOT COMPLETED|Overall Study||0
5012619|NCT02241889|12333489|P1|NOT COMPLETED|Overall Study||0
5012620|NCT02241889|12333484|P6|COMPLETED|Overall Study||3
5012621|NCT02241889|12333485|P5|COMPLETED|Overall Study||5
5012622|NCT02241889|12333486|P4|COMPLETED|Overall Study||3
5012623|NCT02241889|12333487|P3|COMPLETED|Overall Study||2
5012624|NCT02241889|12333488|P2|COMPLETED|Overall Study||4
5012625|NCT02241889|12333489|P1|COMPLETED|Overall Study||4
5012626|NCT02241889|12333484|P6|STARTED|Overall Study||4
5012627|NCT02241889|12333485|P5|STARTED|Overall Study||5
5012628|NCT02241889|12333486|P4|STARTED|Overall Study||3
5012629|NCT02241889|12333487|P3|STARTED|Overall Study||3
5012630|NCT02241889|12333488|P2|STARTED|Overall Study||4
5012631|NCT02241889|12333489|P1|STARTED|Overall Study||4
5012632|NCT02241785|12333524|P1|NOT COMPLETED|Overall Study||47
5012633|NCT02241785|12333524|P1|COMPLETED|Overall Study||0
5012634|NCT02241785|12333524|P1|STARTED|Overall Study||47
5012635|NCT02241733|12333534|P2|NOT COMPLETED|Overall Study||10
5012636|NCT02241733|12333535|P1|NOT COMPLETED|Overall Study||15
5012637|NCT02241733|12333534|P2|COMPLETED|Overall Study||30
5012638|NCT02241733|12333535|P1|COMPLETED|Overall Study||25
5012639|NCT02241733|12333534|P2|STARTED|Overall Study||40
5012640|NCT02241733|12333535|P1|STARTED|Overall Study||40
5012641|NCT02241720|12333547|P1|NOT COMPLETED|Overall Study||4
5012642|NCT02241720|12333547|P1|COMPLETED|Overall Study||1
5012643|NCT02241720|12333547|P1|STARTED|Overall Study||5
5012644|NCT02241655|12333553|P2|NOT COMPLETED|Overall Study||0
5012645|NCT02241655|12333554|P1|NOT COMPLETED|Overall Study||0
5012646|NCT02241655|12333553|P2|COMPLETED|Overall Study||618
5012647|NCT02241655|12333554|P1|COMPLETED|Overall Study||614
5012648|NCT02241655|12333553|P2|STARTED|Overall Study||618
5012649|NCT02241655|12333554|P1|STARTED|Overall Study||614
5012650|NCT02241551|12333574|P2|NOT COMPLETED|Overall Study||0
5012651|NCT02241551|12333575|P1|NOT COMPLETED|Overall Study||1
5012652|NCT02241551|12333574|P2|COMPLETED|Overall Study||0
5012653|NCT02241551|12333575|P1|COMPLETED|Overall Study||0
5012654|NCT02241551|12333574|P2|STARTED|Overall Study||0
5012655|NCT02241551|12333575|P1|STARTED|Overall Study||1
5012656|NCT02241512|12333597|P2|NOT COMPLETED|Overall Study||0
5012657|NCT02241512|12333598|P1|NOT COMPLETED|Overall Study||1
5012658|NCT02241512|12333597|P2|COMPLETED|Overall Study||29
5012659|NCT02241512|12333598|P1|COMPLETED|Overall Study||29
5012660|NCT02241512|12333597|P2|STARTED|Overall Study||29
5012661|NCT02241512|12333598|P1|STARTED|Overall Study||30
5012662|NCT02241486|12333610|P1|NOT COMPLETED|Overall Study||0
5012663|NCT02241486|12333610|P1|COMPLETED|Overall Study||2
5012664|NCT02241486|12333610|P1|STARTED|Overall Study||2
5012665|NCT02241187|12333614|P1|NOT COMPLETED|Overall Study||2
5012666|NCT02241187|12333614|P1|COMPLETED|Overall Study||0
5012667|NCT02241187|12333614|P1|STARTED|Overall Study||2
5012668|NCT02240810|12333621|P2|NOT COMPLETED|Overall Study||60
5012669|NCT02240810|12333622|P1|NOT COMPLETED|Overall Study||60
5012670|NCT02240810|12333621|P2|COMPLETED|Overall Study||2621
5012671|NCT02240810|12333622|P1|COMPLETED|Overall Study||1441
5012672|NCT02240810|12333621|P2|STARTED|Overall Study|correct typo|2681
5012673|NCT02240810|12333622|P1|STARTED|Overall Study||1501
5012674|NCT02240693|12333646|P5|NOT COMPLETED|Overall Study||1
5012675|NCT02240693|12333647|P4|NOT COMPLETED|Overall Study||1
5012676|NCT02240693|12333648|P3|NOT COMPLETED|Overall Study||4
5012677|NCT02240693|12333649|P2|NOT COMPLETED|Overall Study||0
5012678|NCT02240693|12333650|P1|NOT COMPLETED|Overall Study||0
5012679|NCT02240693|12333646|P5|COMPLETED|Overall Study||42
5012680|NCT02240693|12333647|P4|COMPLETED|Overall Study||20
5012681|NCT02240693|12333648|P3|COMPLETED|Overall Study||17
5012682|NCT02240693|12333649|P2|COMPLETED|Overall Study||21
5012683|NCT02240693|12333650|P1|COMPLETED|Overall Study||22
5012684|NCT02240693|12333646|P5|STARTED|Overall Study||43
5012685|NCT02240693|12333647|P4|STARTED|Overall Study||21
5012686|NCT02240693|12333648|P3|STARTED|Overall Study||21
5012687|NCT02240693|12333649|P2|STARTED|Overall Study||21
5012688|NCT02240693|12333650|P1|STARTED|Overall Study||22
5012689|NCT02240680|12333686|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
5012690|NCT02240680|12333687|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
5012691|NCT02240680|12333688|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
5012692|NCT02240680|12333689|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
5012693|NCT02240680|12333686|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
5012694|NCT02240680|12333687|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
5012695|NCT02240680|12333688|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
5012696|NCT02240680|12333689|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
5012697|NCT02240680|12333686|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
5012698|NCT02240680|12333687|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
5012699|NCT02240680|12333688|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
5012700|NCT02240680|12333689|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
5012701|NCT02240680|12333686|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
5012702|NCT02240680|12333687|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
5012703|NCT02240680|12333688|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
5012704|NCT02240680|12333689|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
5012705|NCT02240680|12333686|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
5012706|NCT02240680|12333687|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
5012707|NCT02240680|12333688|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
5012708|NCT02240680|12333689|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
5012709|NCT02240680|12333686|P4|STARTED|Overall Study (Up to 24 Weeks)||0
5012710|NCT02240680|12333687|P3|STARTED|Overall Study (Up to 24 Weeks)||0
5012711|NCT02240680|12333688|P2|STARTED|Overall Study (Up to 24 Weeks)||151
5012712|NCT02240680|12333689|P1|STARTED|Overall Study (Up to 24 Weeks)||151
5012713|NCT02240667|12333709|P2|NOT COMPLETED|Overall Study||0
5012714|NCT02240667|12333710|P1|NOT COMPLETED|Overall Study||0
5012715|NCT02240667|12333709|P2|COMPLETED|Overall Study||650
5012716|NCT02240667|12333710|P1|COMPLETED|Overall Study||771
5012717|NCT02240667|12333709|P2|STARTED|Overall Study||650
5012718|NCT02240667|12333710|P1|STARTED|Overall Study||771
5012719|NCT02240654|12333725|P5|NOT COMPLETED|Overall Study||0
5012720|NCT02240654|12333726|P4|NOT COMPLETED|Overall Study||0
5012721|NCT02240654|12333727|P3|NOT COMPLETED|Overall Study||0
5012722|NCT02240654|12333728|P2|NOT COMPLETED|Overall Study||0
5012723|NCT02240654|12333729|P1|NOT COMPLETED|Overall Study||0
5012724|NCT02240654|12333725|P5|COMPLETED|Overall Study||1285
5012725|NCT02240654|12333726|P4|COMPLETED|Overall Study||2150
5012726|NCT02240654|12333727|P3|COMPLETED|Overall Study||28619
5012727|NCT02240654|12333728|P2|COMPLETED|Overall Study||2813
5012728|NCT02240654|12333729|P1|COMPLETED|Overall Study||1706
5012729|NCT02240654|12333725|P5|STARTED|Overall Study||1285
5012730|NCT02240654|12333726|P4|STARTED|Overall Study||2150
5012731|NCT02240654|12333727|P3|STARTED|Overall Study||28619
5012732|NCT02240654|12333728|P2|STARTED|Overall Study||2813
5012733|NCT02240654|12333729|P1|STARTED|Overall Study||1706
5012734|NCT02240628|12333743|P2|NOT COMPLETED|Overall Study||5
5012735|NCT02240628|12333744|P1|NOT COMPLETED|Overall Study||6
5012736|NCT02240628|12333743|P2|COMPLETED|Overall Study||33
5012737|NCT02240628|12333744|P1|COMPLETED|Overall Study||32
5012738|NCT02240628|12333743|P2|STARTED|Overall Study||38
5012739|NCT02240628|12333744|P1|STARTED|Overall Study||38
5012740|NCT02240589|12333754|P2|NOT COMPLETED|Overall Study||2
5012741|NCT02240589|12333755|P1|NOT COMPLETED|Overall Study||2
5012742|NCT02240589|12333754|P2|COMPLETED|Overall Study||4
5012743|NCT02240589|12333755|P1|COMPLETED|Overall Study||3
5012744|NCT02240589|12333754|P2|STARTED|Overall Study||6
5012745|NCT02240589|12333755|P1|STARTED|Overall Study||5
5012746|NCT02240368|12333778|P3|NOT COMPLETED|Overall Study||1
5012747|NCT02240368|12333779|P2|NOT COMPLETED|Overall Study||0
5012748|NCT02240368|12333780|P1|NOT COMPLETED|Overall Study||1
5012749|NCT02240368|12333778|P3|COMPLETED|Overall Study||18
5012750|NCT02240368|12333779|P2|COMPLETED|Overall Study||22
5012751|NCT02240368|12333780|P1|COMPLETED|Overall Study||8
5012752|NCT02240368|12333778|P3|STARTED|Overall Study||19
5012753|NCT02240368|12333779|P2|STARTED|Overall Study||22
5012754|NCT02240368|12333780|P1|STARTED|Overall Study||9
5012755|NCT02240329|12333797|P1|NOT COMPLETED|Overall Study||0
5012756|NCT02240329|12333797|P1|COMPLETED|Overall Study||4
5012757|NCT02240329|12333797|P1|Determination of Urge to Cough|Overall Study||4
5012758|NCT02240329|12333797|P1|STARTED|Overall Study||4
5012759|NCT02240186|12333802|P1|NOT COMPLETED|Overall Study||27
5012760|NCT02240186|12333802|P1|COMPLETED|Overall Study||23
5012761|NCT02240186|12333802|P1|STARTED|Overall Study||50
5012762|NCT02240121|12333812|P2|NOT COMPLETED|Overall Study||20
5012763|NCT02240121|12333813|P1|NOT COMPLETED|Overall Study||18
5012764|NCT02240121|12333812|P2|COMPLETED|Overall Study||20
5012765|NCT02240121|12333813|P1|COMPLETED|Overall Study||22
5012766|NCT02240121|12333812|P2|STARTED|Overall Study||40
5012767|NCT02240121|12333813|P1|STARTED|Overall Study||40
5012768|NCT02240108|12333841|P2|NOT COMPLETED|Overall Study||25
5012769|NCT02240108|12333842|P1|NOT COMPLETED|Overall Study||14
5012770|NCT02240108|12333841|P2|COMPLETED|Overall Study||21
5012771|NCT02240108|12333842|P1|COMPLETED|Overall Study||21
5012772|NCT02240108|12333841|P2|Intent-to-treat (ITT) Population|Overall Study||45
5012773|NCT02240108|12333842|P1|Intent-to-treat (ITT) Population|Overall Study||35
5012774|NCT02240108|12333841|P2|STARTED|Overall Study||46
5012775|NCT02240108|12333842|P1|STARTED|Overall Study||35
5012776|NCT02240030|12333871|P3|NOT COMPLETED|Overall Study||15
5012777|NCT02240030|12333872|P2|NOT COMPLETED|Overall Study||17
5012778|NCT02240030|12333873|P1|NOT COMPLETED|Overall Study||17
5012779|NCT02240030|12333871|P3|COMPLETED|Overall Study||97
5012780|NCT02240030|12333872|P2|COMPLETED|Overall Study||97
5012781|NCT02240030|12333873|P1|COMPLETED|Overall Study||96
5012782|NCT02240030|12333871|P3|STARTED|Overall Study||112
5012783|NCT02240030|12333872|P2|STARTED|Overall Study||114
5012784|NCT02240030|12333873|P1|STARTED|Overall Study||113
5012785|NCT02239978|12333897|P2|NOT COMPLETED|Overall Study||0
5012786|NCT02239978|12333898|P1|NOT COMPLETED|Overall Study||2
5012787|NCT02239978|12333897|P2|COMPLETED|Overall Study||12
5012788|NCT02239978|12333898|P1|COMPLETED|Overall Study||28
5012789|NCT02239978|12333897|P2|STARTED|Overall Study||12
5012790|NCT02239978|12333898|P1|STARTED|Overall Study||30
5012791|NCT02239939|12333915|P2|NOT COMPLETED|Overall Study||2
5012792|NCT02239939|12333916|P1|NOT COMPLETED|Overall Study||2
5012793|NCT02239939|12333915|P2|COMPLETED|Overall Study||15
5012794|NCT02239939|12333916|P1|COMPLETED|Overall Study||18
5012795|NCT02239939|12333915|P2|STARTED|Overall Study||17
5012796|NCT02239939|12333916|P1|STARTED|Overall Study||20
5012797|NCT02239926|12333932|P2|NOT COMPLETED|Overall Study||1
5012798|NCT02239926|12333933|P1|NOT COMPLETED|Overall Study||0
5012799|NCT02239926|12333932|P2|COMPLETED|Overall Study||1
5012800|NCT02239926|12333933|P1|COMPLETED|Overall Study||0
5012801|NCT02239926|12333932|P2|STARTED|Overall Study||2
5012802|NCT02239926|12333933|P1|STARTED|Overall Study||0
5012803|NCT02239770|12333947|P6|NOT COMPLETED|Part 2||0
5012804|NCT02239770|12333948|P5|NOT COMPLETED|Part 2||0
5012805|NCT02239770|12333949|P4|NOT COMPLETED|Part 2||0
5012806|NCT02239770|12333950|P3|NOT COMPLETED|Part 2||0
5012807|NCT02239770|12333951|P2|NOT COMPLETED|Part 2||0
5012808|NCT02239770|12333952|P1|NOT COMPLETED|Part 2||0
5012809|NCT02239770|12333947|P6|COMPLETED|Part 2||4
5012810|NCT02239770|12333948|P5|COMPLETED|Part 2||4
5012811|NCT02239770|12333949|P4|COMPLETED|Part 2||4
5012812|NCT02239770|12333950|P3|COMPLETED|Part 2||0
5012813|NCT02239770|12333951|P2|COMPLETED|Part 2||0
5012814|NCT02239770|12333952|P1|COMPLETED|Part 2||0
5012815|NCT02239770|12333947|P6|STARTED|Part 2||4
5012816|NCT02239770|12333948|P5|STARTED|Part 2||4
5012817|NCT02239770|12333949|P4|STARTED|Part 2||4
5012818|NCT02239770|12333950|P3|STARTED|Part 2||0
5012819|NCT02239770|12333951|P2|STARTED|Part 2||0
5012820|NCT02239770|12333952|P1|STARTED|Part 2||0
5012821|NCT02239770|12333947|P6|NOT COMPLETED|Part 1||0
5012822|NCT02239770|12333948|P5|NOT COMPLETED|Part 1||0
5012823|NCT02239770|12333949|P4|NOT COMPLETED|Part 1||0
5012824|NCT02239770|12333950|P3|NOT COMPLETED|Part 1||0
5012825|NCT02239770|12333951|P2|NOT COMPLETED|Part 1||0
5012826|NCT02239770|12333952|P1|NOT COMPLETED|Part 1||0
5012827|NCT02239770|12333947|P6|COMPLETED|Part 1||0
5012828|NCT02239770|12333948|P5|COMPLETED|Part 1||0
5012829|NCT02239770|12333949|P4|COMPLETED|Part 1||0
5012830|NCT02239770|12333950|P3|COMPLETED|Part 1||4
5012831|NCT02239770|12333951|P2|COMPLETED|Part 1||4
5012832|NCT02239770|12333952|P1|COMPLETED|Part 1||4
5012833|NCT02239770|12333947|P6|STARTED|Part 1||0
5012834|NCT02239770|12333948|P5|STARTED|Part 1||0
5012835|NCT02239770|12333949|P4|STARTED|Part 1||0
5012836|NCT02239770|12333950|P3|STARTED|Part 1||4
5012837|NCT02239770|12333951|P2|STARTED|Part 1||4
5012838|NCT02239770|12333952|P1|STARTED|Part 1||4
5012839|NCT02239744|12333980|P2|NOT COMPLETED|Period 2||0
5012840|NCT02239744|12333981|P1|NOT COMPLETED|Period 2||0
5012841|NCT02239744|12333980|P2|COMPLETED|Period 2||18
5012842|NCT02239744|12333981|P1|COMPLETED|Period 2||17
5012843|NCT02239744|12333980|P2|STARTED|Period 2||18
5012844|NCT02239744|12333981|P1|STARTED|Period 2||17
5012845|NCT02239744|12333980|P2|NOT COMPLETED|Period 1||0
5012846|NCT02239744|12333981|P1|NOT COMPLETED|Period 1||0
5012847|NCT02239744|12333980|P2|COMPLETED|Period 1||18
5012848|NCT02239744|12333981|P1|COMPLETED|Period 1||17
5012849|NCT02239744|12333980|P2|STARTED|Period 1||18
5012850|NCT02239744|12333981|P1|STARTED|Period 1||17
5012851|NCT02239692|12333995|P2|NOT COMPLETED|Overall Study||13
5012852|NCT02239692|12333996|P1|NOT COMPLETED|Overall Study||6
5012853|NCT02239692|12333995|P2|COMPLETED|Overall Study||118
5012854|NCT02239692|12333996|P1|COMPLETED|Overall Study||67
5012855|NCT02239692|12333995|P2|Safety Analysis Set|Overall Study||125
5012856|NCT02239692|12333996|P1|Safety Analysis Set|Overall Study||70
5012857|NCT02239692|12333995|P2|Per-protocol Analysis Set|Overall Study||120
5012858|NCT02239692|12333996|P1|Per-protocol Analysis Set|Overall Study||66
5012859|NCT02239692|12333995|P2|Intention-to-treat Analysis Set|Overall Study||131
5012860|NCT02239692|12333996|P1|Intention-to-treat Analysis Set|Overall Study||73
5012861|NCT02239692|12333995|P2|STARTED|Overall Study||131
5012862|NCT02239692|12333996|P1|STARTED|Overall Study||73
5012863|NCT02239679|12334015|P3|NOT COMPLETED|Overall Study||1
5012864|NCT02239679|12334016|P2|NOT COMPLETED|Overall Study||3
5012865|NCT02239679|12334017|P1|NOT COMPLETED|Overall Study||3
5012866|NCT02239679|12334015|P3|COMPLETED|Overall Study||53
5012867|NCT02239679|12334016|P2|COMPLETED|Overall Study||56
5012868|NCT02239679|12334017|P1|COMPLETED|Overall Study||50
5012869|NCT02239679|12334015|P3|STARTED|Overall Study||54
5012870|NCT02239679|12334016|P2|STARTED|Overall Study||59
5012871|NCT02239679|12334017|P1|STARTED|Overall Study||53
5012872|NCT02239640|12334229|P1|NOT COMPLETED|Overall Study||217
5012873|NCT02239640|12334229|P1|COMPLETED|Overall Study||767
5012874|NCT02239640|12334229|P1|STARTED|Overall Study||984
5012875|NCT02239601|12334241|P2|NOT COMPLETED|Overall Study||6
5012876|NCT02239601|12334242|P1|NOT COMPLETED|Overall Study||7
5012877|NCT02239601|12334241|P2|COMPLETED|Overall Study||26
5012878|NCT02239601|12334242|P1|COMPLETED|Overall Study||22
5012879|NCT02239601|12334241|P2|STARTED|Overall Study||32
5012880|NCT02239601|12334242|P1|STARTED|Overall Study||29
5012881|NCT02239562|12334266|P6|NOT COMPLETED|Overall Study||0
5012882|NCT02239562|12334267|P5|NOT COMPLETED|Overall Study||0
5012883|NCT02239562|12334268|P4|NOT COMPLETED|Overall Study||0
5012884|NCT02239562|12334269|P3|NOT COMPLETED|Overall Study||0
5012885|NCT02239562|12334270|P2|NOT COMPLETED|Overall Study||0
5012886|NCT02239562|12334271|P1|NOT COMPLETED|Overall Study||0
5012887|NCT02239562|12334266|P6|COMPLETED|Overall Study||6
5012888|NCT02239562|12334267|P5|COMPLETED|Overall Study||6
5012889|NCT02239562|12334268|P4|COMPLETED|Overall Study||6
5012890|NCT02239562|12334269|P3|COMPLETED|Overall Study||6
5012891|NCT02239562|12334270|P2|COMPLETED|Overall Study||6
5012892|NCT02239562|12334271|P1|COMPLETED|Overall Study||6
5012893|NCT02239562|12334266|P6|STARTED|Overall Study||6
5012894|NCT02239562|12334267|P5|STARTED|Overall Study||6
5012895|NCT02239562|12334268|P4|STARTED|Overall Study||6
5012896|NCT02239562|12334269|P3|STARTED|Overall Study||6
5012897|NCT02239562|12334270|P2|STARTED|Overall Study||6
5012898|NCT02239562|12334271|P1|STARTED|Overall Study||6
5012899|NCT02239536|12334295|P2|NOT COMPLETED|Overall Study||17
5012900|NCT02239536|12334296|P1|NOT COMPLETED|Overall Study||23
5012901|NCT02239536|12334295|P2|COMPLETED|Overall Study||155
5012902|NCT02239536|12334296|P1|COMPLETED|Overall Study||167
5012903|NCT02239536|12334295|P2|STARTED|Overall Study||172
5012904|NCT02239536|12334296|P1|STARTED|Overall Study||190
5012905|NCT02239510|12334306|P2|NOT COMPLETED|Overall Study||1
5012906|NCT02239510|12334307|P1|NOT COMPLETED|Overall Study||2
5012907|NCT02239510|12334306|P2|COMPLETED|Overall Study||3
5012908|NCT02239510|12334307|P1|COMPLETED|Overall Study||3
5012909|NCT02239510|12334306|P2|STARTED|Overall Study||4
5012910|NCT02239510|12334307|P1|STARTED|Overall Study||5
5012911|NCT02239380|12334319|P1|NOT COMPLETED|Overall Study||0
5012912|NCT02239380|12334319|P1|COMPLETED|Overall Study||26
5012913|NCT02239380|12334319|P1|STARTED|Overall Study||26
5012914|NCT02239328|12334329|P1|NOT COMPLETED|Overall Study||8
5012915|NCT02239328|12334329|P1|COMPLETED|Overall Study||174
5012916|NCT02239328|12334329|P1|STARTED|Overall Study||182
5012917|NCT02239289|12334333|P1|NOT COMPLETED|Overall Study||0
5012918|NCT02239289|12334333|P1|COMPLETED|Overall Study||21
5012919|NCT02239289|12334333|P1|STARTED|Overall Study||21
5012920|NCT02239120|12334354|P2|NOT COMPLETED|Overall Study||72
5012921|NCT02239120|12334355|P1|NOT COMPLETED|Overall Study||75
5012922|NCT02239120|12334354|P2|COMPLETED|Overall Study||2623
5012923|NCT02239120|12334355|P1|COMPLETED|Overall Study||2620
5012924|NCT02239120|12334354|P2|STARTED|Overall Study||2695
5012925|NCT02239120|12334355|P1|STARTED|Overall Study||2695
5012926|NCT02239094|12334379|P1|NOT COMPLETED|Overall Study||2
5012927|NCT02239094|12334379|P1|COMPLETED|Overall Study||18
5012928|NCT02239094|12334379|P1|STARTED|Overall Study||20
5012929|NCT02238977|12334386|P2|NOT COMPLETED|Overall Study||0
5012930|NCT02238977|12334387|P1|NOT COMPLETED|Overall Study||0
5012931|NCT02238977|12334386|P2|COMPLETED|Overall Study||1
5012932|NCT02238977|12334387|P1|COMPLETED|Overall Study||0
5012933|NCT02238977|12334386|P2|STARTED|Overall Study||1
5012934|NCT02238977|12334387|P1|STARTED|Overall Study||0
5012935|NCT02238925|12334393|P1|NOT COMPLETED|Overall Study||25
5012936|NCT02238925|12334393|P1|COMPLETED|Overall Study||1
5012937|NCT02238925|12334393|P1|STARTED|Overall Study||26
5012938|NCT02238847|12334403|P2|NOT COMPLETED|Overall Study||24
5012939|NCT02238847|12334404|P1|NOT COMPLETED|Overall Study||22
5012940|NCT02238847|12334403|P2|COMPLETED|Overall Study||36
5012941|NCT02238847|12334404|P1|COMPLETED|Overall Study||37
5012942|NCT02238847|12334403|P2|STARTED|Overall Study||60
5012943|NCT02238847|12334404|P1|STARTED|Overall Study||59
5012944|NCT02238782|12334428|P1|NOT COMPLETED|Overall Study||0
5012945|NCT02238782|12334428|P1|COMPLETED|Overall Study||12
5012946|NCT02238782|12334428|P1|Subjects Treated|Overall Study||12
5012947|NCT02238782|12334428|P1|STARTED|Overall Study||12
5012948|NCT02238483|12334434|P2|NOT COMPLETED|Overall Study||14
5012949|NCT02238483|12334435|P1|NOT COMPLETED|Overall Study||15
5012950|NCT02238483|12334434|P2|COMPLETED|Overall Study||91
5012951|NCT02238483|12334435|P1|COMPLETED|Overall Study||93
5012952|NCT02238483|12334434|P2|STARTED|Overall Study||105
5012953|NCT02238483|12334435|P1|STARTED|Overall Study||108
5012954|NCT02238379|12334473|P2|NOT COMPLETED|Overall Study||0
5012955|NCT02238379|12334474|P1|NOT COMPLETED|Overall Study||1
5012956|NCT02238379|12334473|P2|COMPLETED|Overall Study||14
5012957|NCT02238379|12334474|P1|COMPLETED|Overall Study||11
5012958|NCT02238379|12334473|P2|STARTED|Overall Study||14
5012959|NCT02238379|12334474|P1|STARTED|Overall Study||12
5012960|NCT02238080|12334500|P1|NOT COMPLETED|Overall Study||25
5012961|NCT02238080|12334500|P1|COMPLETED|Overall Study||172
5012962|NCT02238080|12334500|P1|STARTED|Overall Study||197
5012963|NCT02238067|12334514|P1|NOT COMPLETED|Overall Study||45
5012964|NCT02238067|12334514|P1|COMPLETED|Overall Study||151
5012965|NCT02238067|12334514|P1|STARTED|Overall Study||196
5012966|NCT02238028|12334537|P2|NOT COMPLETED|Overall Study||2
5012967|NCT02238028|12334538|P1|NOT COMPLETED|Overall Study||2
5012968|NCT02238028|12334537|P2|COMPLETED|Overall Study||12
5012969|NCT02238028|12334538|P1|COMPLETED|Overall Study||12
5012970|NCT02238028|12334537|P2|STARTED|Overall Study||14
5012971|NCT02238028|12334538|P1|STARTED|Overall Study||14
5012972|NCT02237950|12334559|P2|NOT COMPLETED|Overall Study||48
5012973|NCT02237950|12334560|P1|NOT COMPLETED|Overall Study||48
5012974|NCT02237950|12334559|P2|COMPLETED|Overall Study||243
5012975|NCT02237950|12334560|P1|COMPLETED|Overall Study||247
5012976|NCT02237950|12334559|P2|STARTED|Overall Study||291
5012977|NCT02237950|12334560|P1|STARTED|Overall Study||295
5012978|NCT02237911|12334585|P3|NOT COMPLETED|Overall Study||3
5012979|NCT02237911|12334586|P2|NOT COMPLETED|Overall Study||8
5012980|NCT02237911|12334587|P1|NOT COMPLETED|Overall Study||7
5012981|NCT02237911|12334585|P3|COMPLETED|Overall Study||45
5012982|NCT02237911|12334586|P2|COMPLETED|Overall Study||88
5012983|NCT02237911|12334587|P1|COMPLETED|Overall Study||89
5012984|NCT02237911|12334585|P3|6 Months|Overall Study||45
5012985|NCT02237911|12334586|P2|6 Months|Overall Study||88
5012986|NCT02237911|12334587|P1|6 Months|Overall Study||89
5012987|NCT02237911|12334585|P3|3 Months|Overall Study||44
5012988|NCT02237911|12334586|P2|3 Months|Overall Study||87
5012989|NCT02237911|12334587|P1|3 Months|Overall Study||90
5012990|NCT02237911|12334585|P3|STARTED|Overall Study||48
5012991|NCT02237911|12334586|P2|STARTED|Overall Study||96
5012992|NCT02237911|12334587|P1|STARTED|Overall Study||96
5012993|NCT02237898|12334603|P2|NOT COMPLETED|Overall Study||12
5012994|NCT02237898|12334604|P1|NOT COMPLETED|Overall Study||7
5012995|NCT02237898|12334603|P2|COMPLETED|Overall Study||2
5012996|NCT02237898|12334604|P1|COMPLETED|Overall Study||5
5012997|NCT02237898|12334603|P2|Completed 15 Month Follow-up|Overall Study||8
5012998|NCT02237898|12334604|P1|Completed 15 Month Follow-up|Overall Study||8
5012999|NCT02237898|12334603|P2|Completed 9 Month Follow-up|Overall Study||7
5013000|NCT02237898|12334604|P1|Completed 9 Month Follow-up|Overall Study||6
5013001|NCT02237898|12334603|P2|Completed 3 Month Follow-up|Overall Study||6
5013002|NCT02237898|12334604|P1|Completed 3 Month Follow-up|Overall Study||6
5013003|NCT02237898|12334603|P2|Completed 12 Weeks of CM|Overall Study||2
5013004|NCT02237898|12334604|P1|Completed 12 Weeks of CM|Overall Study||7
5013005|NCT02237898|12334603|P2|STARTED|Overall Study||14
5013006|NCT02237898|12334604|P1|STARTED|Overall Study||12
5013007|NCT02237196|12334627|P4|NOT COMPLETED|Overall Study||11
5013008|NCT02237196|12334628|P3|NOT COMPLETED|Overall Study||10
5013009|NCT02237196|12334629|P2|NOT COMPLETED|Overall Study||6
5013010|NCT02237196|12334630|P1|NOT COMPLETED|Overall Study||8
5013011|NCT02237196|12334627|P4|COMPLETED|Overall Study||17
5013012|NCT02237196|12334628|P3|COMPLETED|Overall Study||20
5013013|NCT02237196|12334629|P2|COMPLETED|Overall Study||25
5013014|NCT02237196|12334630|P1|COMPLETED|Overall Study||24
5013015|NCT02237196|12334627|P4|STARTED|Overall Study||28
5013016|NCT02237196|12334628|P3|STARTED|Overall Study||30
5013017|NCT02237196|12334629|P2|STARTED|Overall Study||31
5013018|NCT02237196|12334630|P1|STARTED|Overall Study||32
5013019|NCT02237118|12334674|P2|NOT COMPLETED|Overall Study||1
5013020|NCT02237118|12334675|P1|NOT COMPLETED|Overall Study||1
5013021|NCT02237118|12334674|P2|COMPLETED|Overall Study||62
5013022|NCT02237118|12334675|P1|COMPLETED|Overall Study||59
5013023|NCT02237118|12334674|P2|STARTED|Overall Study||63
5013024|NCT02237118|12334675|P1|STARTED|Overall Study||60
5013025|NCT02237092|12334689|P1|NOT COMPLETED|Overall Study||0
5013026|NCT02237092|12334689|P1|COMPLETED|Overall Study||196
5013027|NCT02237092|12334689|P1|STARTED|Overall Study||196
5013028|NCT02236767|12334706|P1|NOT COMPLETED|Overall Study||0
5013029|NCT02236767|12334706|P1|COMPLETED|Overall Study||1
5013030|NCT02236767|12334706|P1|STARTED|Overall Study||1
5013031|NCT02236611|12334712|P2|NOT COMPLETED|Overall Study||34
5013032|NCT02236611|12334713|P1|NOT COMPLETED|Overall Study||26
5013033|NCT02236611|12334712|P2|COMPLETED|Overall Study||484
5013034|NCT02236611|12334713|P1|COMPLETED|Overall Study||490
5013035|NCT02236611|12334712|P2|STARTED|Overall Study||518
5013036|NCT02236611|12334713|P1|STARTED|Overall Study||516
5013037|NCT02236598|12334721|P2|NOT COMPLETED|Overall Study||2
5013038|NCT02236598|12334722|P1|NOT COMPLETED|Overall Study||0
5013039|NCT02236598|12334721|P2|COMPLETED|Overall Study||12
5013040|NCT02236598|12334722|P1|COMPLETED|Overall Study||15
5013041|NCT02236598|12334721|P2|STARTED|Overall Study||14
5013042|NCT02236598|12334722|P1|STARTED|Overall Study||15
5013043|NCT02236559|12334736|P2|NOT COMPLETED|Overall Study||12
5013044|NCT02236559|12334737|P1|NOT COMPLETED|Overall Study||12
5013045|NCT02236559|12334736|P2|COMPLETED|Overall Study||104
5013046|NCT02236559|12334737|P1|COMPLETED|Overall Study||100
5013047|NCT02236559|12334736|P2|STARTED|Overall Study||116
5013048|NCT02236559|12334737|P1|STARTED|Overall Study||112
5013049|NCT02236546|12334763|P1|NOT COMPLETED|Overall Study||0
5013050|NCT02236546|12334763|P1|COMPLETED|Overall Study||3
5013051|NCT02236546|12334763|P1|STARTED|Overall Study||3
5013052|NCT02236520|12334774|P4|NOT COMPLETED|Overall Study||1
5013053|NCT02236520|12334775|P3|NOT COMPLETED|Overall Study||0
5013054|NCT02236520|12334776|P2|NOT COMPLETED|Overall Study||5
5013055|NCT02236520|12334777|P1|NOT COMPLETED|Overall Study||2
5013056|NCT02236520|12334774|P4|COMPLETED|Overall Study||14
5013057|NCT02236520|12334775|P3|COMPLETED|Overall Study||15
5013058|NCT02236520|12334776|P2|COMPLETED|Overall Study||8
5013059|NCT02236520|12334777|P1|COMPLETED|Overall Study||14
5013060|NCT02236520|12334774|P4|STARTED|Overall Study||15
5013061|NCT02236520|12334775|P3|STARTED|Overall Study||15
5013062|NCT02236520|12334776|P2|STARTED|Overall Study||13
5013063|NCT02236520|12334777|P1|STARTED|Overall Study||16
5013064|NCT02236338|12334789|P2|NOT COMPLETED|Overall Study||0
5013065|NCT02236338|12334790|P1|NOT COMPLETED|Overall Study||0
5013066|NCT02236338|12334789|P2|COMPLETED|Overall Study||100
5013067|NCT02236338|12334790|P1|COMPLETED|Overall Study||100
5013068|NCT02236338|12334789|P2|STARTED|Overall Study||100
5013069|NCT02236338|12334790|P1|STARTED|Overall Study||100
5013070|NCT02236130|12334804|P2|NOT COMPLETED|Overall Study||12
5013071|NCT02236130|12334805|P1|NOT COMPLETED|Overall Study||7
5013072|NCT02236130|12334804|P2|COMPLETED|Overall Study||15
5013073|NCT02236130|12334805|P1|COMPLETED|Overall Study||15
5013074|NCT02236130|12334804|P2|STARTED|Overall Study||27
5013075|NCT02236130|12334805|P1|STARTED|Overall Study||22
5013076|NCT02235987|12334813|P1|NOT COMPLETED|Overall Study||1
5013077|NCT02235987|12334813|P1|COMPLETED|Overall Study||19
5013078|NCT02235987|12334813|P1|Received 1800 µg DG3173|Overall Study||19
5013079|NCT02235987|12334813|P1|Received 900 µg DG3173|Overall Study||19
5013080|NCT02235987|12334813|P1|Received 300 µg DG3173|Overall Study||20
5013081|NCT02235987|12334813|P1|Received 100 µg DG3173|Overall Study||20
5013082|NCT02235987|12334813|P1|Received Octreotide|Overall Study||20
5013083|NCT02235987|12334813|P1|STARTED|Overall Study||20
5013084|NCT02235870|12334828|P2|NOT COMPLETED|Overall Study||61
5013085|NCT02235870|12334829|P1|NOT COMPLETED|Overall Study||38
5013086|NCT02235870|12334828|P2|COMPLETED|Overall Study||128
5013087|NCT02235870|12334829|P1|COMPLETED|Overall Study||160
5013088|NCT02235870|12334828|P2|Crossover (Week 24)|Overall Study||138
5013089|NCT02235870|12334829|P1|Crossover (Week 24)|Overall Study||170
5013090|NCT02235870|12334828|P2|Completed Phase I (Week 24)|Overall Study||179
5013091|NCT02235870|12334829|P1|Completed Phase I (Week 24)|Overall Study||182
5013092|NCT02235870|12334828|P2|STARTED|Overall Study||189
5013093|NCT02235870|12334829|P1|STARTED|Overall Study||198
5013094|NCT02235831|12334838|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013095|NCT02235831|12334839|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013096|NCT02235831|12334840|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013097|NCT02235831|12334841|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013098|NCT02235831|12334842|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013099|NCT02235831|12334843|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
5013100|NCT02235831|12334838|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
5013101|NCT02235831|12334839|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
5013102|NCT02235831|12334840|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
5013103|NCT02235831|12334841|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
5013104|NCT02235831|12334842|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
5013105|NCT02235831|12334843|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
5013106|NCT02235831|12334838|P6|STARTED|Period 3, Third 5 Days of Wear||4
5013107|NCT02235831|12334839|P5|STARTED|Period 3, Third 5 Days of Wear||4
5013108|NCT02235831|12334840|P4|STARTED|Period 3, Third 5 Days of Wear||4
5013109|NCT02235831|12334841|P3|STARTED|Period 3, Third 5 Days of Wear||4
5013110|NCT02235831|12334842|P2|STARTED|Period 3, Third 5 Days of Wear||4
5013111|NCT02235831|12334843|P1|STARTED|Period 3, Third 5 Days of Wear||4
5013112|NCT02235831|12334838|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013113|NCT02235831|12334839|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013114|NCT02235831|12334840|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013115|NCT02235831|12334841|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013116|NCT02235831|12334842|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013117|NCT02235831|12334843|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
5013118|NCT02235831|12334838|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
5013119|NCT02235831|12334839|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
5013120|NCT02235831|12334840|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
5013121|NCT02235831|12334841|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
5013122|NCT02235831|12334842|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
5013123|NCT02235831|12334843|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
5013124|NCT02235831|12334838|P6|STARTED|Period 2, Second 5 Days of Wear||4
5013125|NCT02235831|12334839|P5|STARTED|Period 2, Second 5 Days of Wear||4
5013126|NCT02235831|12334840|P4|STARTED|Period 2, Second 5 Days of Wear||4
5013127|NCT02235831|12334841|P3|STARTED|Period 2, Second 5 Days of Wear||4
5013128|NCT02235831|12334842|P2|STARTED|Period 2, Second 5 Days of Wear||4
5013129|NCT02235831|12334843|P1|STARTED|Period 2, Second 5 Days of Wear||4
5013130|NCT02235831|12334838|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013131|NCT02235831|12334839|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013132|NCT02235831|12334840|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013133|NCT02235831|12334841|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013134|NCT02235831|12334842|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013135|NCT02235831|12334843|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
5013136|NCT02235831|12334838|P6|COMPLETED|Period 1, First 5 Days of Wear||4
5013137|NCT02235831|12334839|P5|COMPLETED|Period 1, First 5 Days of Wear||4
5013138|NCT02235831|12334840|P4|COMPLETED|Period 1, First 5 Days of Wear||4
5013139|NCT02235831|12334841|P3|COMPLETED|Period 1, First 5 Days of Wear||4
5013140|NCT02235831|12334842|P2|COMPLETED|Period 1, First 5 Days of Wear||4
5013141|NCT02235831|12334843|P1|COMPLETED|Period 1, First 5 Days of Wear||4
5013142|NCT02235831|12334838|P6|STARTED|Period 1, First 5 Days of Wear||4
5013143|NCT02235831|12334839|P5|STARTED|Period 1, First 5 Days of Wear||4
5013144|NCT02235831|12334840|P4|STARTED|Period 1, First 5 Days of Wear||4
5013145|NCT02235831|12334841|P3|STARTED|Period 1, First 5 Days of Wear||4
5013146|NCT02235831|12334842|P2|STARTED|Period 1, First 5 Days of Wear||4
5013147|NCT02235831|12334843|P1|STARTED|Period 1, First 5 Days of Wear||4
5013148|NCT02235493|12334850|P1|NOT COMPLETED|Overall Study||0
5013149|NCT02235493|12334850|P1|COMPLETED|Overall Study||6
5013150|NCT02235493|12334850|P1|STARTED|Overall Study||6
5013151|NCT02235454|12334855|P1|NOT COMPLETED|Overall Study||2
5013152|NCT02235454|12334855|P1|COMPLETED|Overall Study||55
5013153|NCT02235454|12334855|P1|STARTED|Overall Study||57
5013154|NCT02235311|12334861|P2|NOT COMPLETED|Overall Study||2
5013155|NCT02235311|12334862|P1|NOT COMPLETED|Overall Study||0
5013156|NCT02235311|12334861|P2|COMPLETED|Overall Study||0
5013157|NCT02235311|12334862|P1|COMPLETED|Overall Study||1
5013158|NCT02235311|12334861|P2|STARTED|Overall Study||2
5013159|NCT02235311|12334862|P1|STARTED|Overall Study||1
5013160|NCT02235285|12334874|P1|NOT COMPLETED|Overall Study||13
5013161|NCT02235285|12334874|P1|COMPLETED|Overall Study||149
5013162|NCT02235285|12334874|P1|STARTED|Overall Study||162
5013163|NCT02235077|12334880|P2|NOT COMPLETED|Overall Study||19
5013164|NCT02235077|12334881|P1|NOT COMPLETED|Overall Study||18
5013165|NCT02235077|12334880|P2|COMPLETED|Overall Study||159
5013166|NCT02235077|12334881|P1|COMPLETED|Overall Study||164
5013167|NCT02235077|12334880|P2|STARTED|Overall Study||178
5013168|NCT02235077|12334881|P1|STARTED|Overall Study||182
5013169|NCT02235064|12334909|P2|NOT COMPLETED|Overall Study||0
5013170|NCT02235064|12334910|P1|NOT COMPLETED|Overall Study||0
5013171|NCT02235064|12334909|P2|COMPLETED|Overall Study||1
5013172|NCT02235064|12334910|P1|COMPLETED|Overall Study||1
5013173|NCT02235064|12334909|P2|STARTED|Overall Study||1
5013174|NCT02235064|12334910|P1|STARTED|Overall Study||1
5013175|NCT02234843|12334946|P10|NOT COMPLETED|Overall Study||0
5013176|NCT02234843|12334947|P9|NOT COMPLETED|Overall Study||1
5013177|NCT02234843|12334948|P8|NOT COMPLETED|Overall Study||2
5013178|NCT02234843|12334949|P7|NOT COMPLETED|Overall Study||2
5013179|NCT02234843|12334950|P6|NOT COMPLETED|Overall Study||13
5013180|NCT02234843|12334951|P5|NOT COMPLETED|Overall Study||2
5013181|NCT02234843|12334952|P4|NOT COMPLETED|Overall Study||5
5013182|NCT02234843|12334953|P3|NOT COMPLETED|Overall Study||3
5013183|NCT02234843|12334954|P2|NOT COMPLETED|Overall Study||6
5013184|NCT02234843|12334955|P1|NOT COMPLETED|Overall Study||22
5013185|NCT02234843|12334946|P10|COMPLETED|Overall Study||8
5013186|NCT02234843|12334947|P9|COMPLETED|Overall Study||8
5013187|NCT02234843|12334948|P8|COMPLETED|Overall Study||20
5013188|NCT02234843|12334949|P7|COMPLETED|Overall Study||32
5013189|NCT02234843|12334950|P6|COMPLETED|Overall Study||79
5013190|NCT02234843|12334951|P5|COMPLETED|Overall Study||14
5013191|NCT02234843|12334952|P4|COMPLETED|Overall Study||16
5013192|NCT02234843|12334953|P3|COMPLETED|Overall Study||44
5013193|NCT02234843|12334954|P2|COMPLETED|Overall Study||61
5013194|NCT02234843|12334955|P1|COMPLETED|Overall Study||162
5013195|NCT02234843|12334946|P10|STARTED|Overall Study||8
5013196|NCT02234843|12334947|P9|STARTED|Overall Study||9
5013197|NCT02234843|12334948|P8|STARTED|Overall Study||22
5013198|NCT02234843|12334949|P7|STARTED|Overall Study||34
5013199|NCT02234843|12334950|P6|STARTED|Overall Study||92
5013200|NCT02234843|12334951|P5|STARTED|Overall Study||16
5013201|NCT02234843|12334952|P4|STARTED|Overall Study||21
5013202|NCT02234843|12334953|P3|STARTED|Overall Study||47
5013203|NCT02234843|12334954|P2|STARTED|Overall Study||67
5013204|NCT02234843|12334955|P1|STARTED|Overall Study||184
5013205|NCT02234752|12335062|P1|NOT COMPLETED|Overall Study||1
5013206|NCT02234752|12335062|P1|COMPLETED|Overall Study||2
5013207|NCT02234752|12335062|P1|STARTED|Overall Study||3
5013208|NCT02234713|12335075|P2|NOT COMPLETED|Overall Study||5
5013209|NCT02234713|12335076|P1|NOT COMPLETED|Overall Study||6
5013210|NCT02234713|12335075|P2|COMPLETED|Overall Study||27
5013211|NCT02234713|12335076|P1|COMPLETED|Overall Study||25
5013212|NCT02234713|12335075|P2|STARTED|Overall Study||32
5013213|NCT02234713|12335076|P1|STARTED|Overall Study||31
5013214|NCT02234687|12335101|P3|NOT COMPLETED|Overall Study||4
5013215|NCT02234687|12335102|P2|NOT COMPLETED|Overall Study||4
5013216|NCT02234687|12335103|P1|NOT COMPLETED|Overall Study||6
5013217|NCT02234687|12335101|P3|COMPLETED|Overall Study||0
5013218|NCT02234687|12335102|P2|COMPLETED|Overall Study||0
5013219|NCT02234687|12335103|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
5013220|NCT02234687|12335101|P3|STARTED|Overall Study||4
5013221|NCT02234687|12335102|P2|STARTED|Overall Study||4
5013222|NCT02234687|12335103|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
5013223|NCT02234622|12335113|P2|NOT COMPLETED|Overall Study||36
5013224|NCT02234622|12335114|P1|NOT COMPLETED|Overall Study||43
5013225|NCT02234622|12335113|P2|COMPLETED|Overall Study||68
5013226|NCT02234622|12335114|P1|COMPLETED|Overall Study||65
5013227|NCT02234622|12335113|P2|STARTED|Overall Study||104
5013228|NCT02234622|12335114|P1|STARTED|Overall Study||108
5013229|NCT02234583|12335134|P2|NOT COMPLETED|Overall Study||556
5013230|NCT02234583|12335135|P1|NOT COMPLETED|Overall Study||413
5013231|NCT02234583|12335134|P2|COMPLETED|Overall Study||685
5013232|NCT02234583|12335135|P1|COMPLETED|Overall Study||434
5013233|NCT02234583|12335134|P2|STARTED|Overall Study||1241
5013234|NCT02234583|12335135|P1|STARTED|Overall Study||847
5013235|NCT02234570|12335171|P8|NOT COMPLETED|Overall Study||0
5013236|NCT02234570|12335172|P7|NOT COMPLETED|Overall Study||0
5013237|NCT02234570|12335173|P6|NOT COMPLETED|Overall Study||0
5013238|NCT02234570|12335174|P5|NOT COMPLETED|Overall Study||0
5013239|NCT02234570|12335175|P4|NOT COMPLETED|Overall Study||0
5013240|NCT02234570|12335176|P3|NOT COMPLETED|Overall Study||0
5013241|NCT02234570|12335177|P2|NOT COMPLETED|Overall Study||0
5013242|NCT02234570|12335178|P1|NOT COMPLETED|Overall Study||0
5013243|NCT02234570|12335171|P8|COMPLETED|Overall Study||14
5013244|NCT02234570|12335172|P7|COMPLETED|Overall Study||8
5013245|NCT02234570|12335173|P6|COMPLETED|Overall Study||8
5013246|NCT02234570|12335174|P5|COMPLETED|Overall Study||8
5013247|NCT02234570|12335175|P4|COMPLETED|Overall Study||8
5013248|NCT02234570|12335176|P3|COMPLETED|Overall Study||8
5013249|NCT02234570|12335177|P2|COMPLETED|Overall Study||8
5013250|NCT02234570|12335178|P1|COMPLETED|Overall Study||8
5013251|NCT02234570|12335171|P8|STARTED|Overall Study||14
5013252|NCT02234570|12335172|P7|STARTED|Overall Study||8
5013253|NCT02234570|12335173|P6|STARTED|Overall Study||8
5013254|NCT02234570|12335174|P5|STARTED|Overall Study||8
5013255|NCT02234570|12335175|P4|STARTED|Overall Study||8
5013256|NCT02234570|12335176|P3|STARTED|Overall Study||8
5013257|NCT02234570|12335177|P2|STARTED|Overall Study||8
5013258|NCT02234570|12335178|P1|STARTED|Overall Study||8
5013259|NCT02234479|12335254|P2|NOT COMPLETED|Overall Study||3
5013260|NCT02234479|12335255|P1|NOT COMPLETED|Overall Study||1
5013261|NCT02234479|12335254|P2|COMPLETED|Overall Study||15
5013262|NCT02234479|12335255|P1|COMPLETED|Overall Study||15
5013263|NCT02234479|12335254|P2|STARTED|Overall Study||18
5013264|NCT02234479|12335255|P1|STARTED|Overall Study||16
5013265|NCT02234427|12335261|P1|NOT COMPLETED|Overall Study||1
5013266|NCT02234427|12335261|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
5013267|NCT02234427|12335261|P1|STARTED|Overall Study||34
5013268|NCT02234362|12335265|P1|NOT COMPLETED|Overall Study||26
5013269|NCT02234362|12335265|P1|COMPLETED|Overall Study||21
5013270|NCT02234362|12335265|P1|Received at Least One Dose of Medication|Overall Study||27
5013271|NCT02234362|12335265|P1|STARTED|Overall Study||47
5013272|NCT02234310|12335282|P1|NOT COMPLETED|Overall Study||6
5013273|NCT02234310|12335282|P1|COMPLETED|Overall Study||27
5013274|NCT02234310|12335282|P1|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
5013275|NCT02234310|12335282|P1|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
5013276|NCT02234310|12335282|P1|STARTED|Overall Study||33
5013277|NCT02234284|12335296|P2|NOT COMPLETED|Overall Study||9
5013278|NCT02234284|12335297|P1|NOT COMPLETED|Overall Study||25
5013279|NCT02234284|12335296|P2|COMPLETED|Overall Study||83
5013280|NCT02234284|12335297|P1|COMPLETED|Overall Study||75
5013281|NCT02234284|12335296|P2|STARTED|Overall Study||92
5013282|NCT02234284|12335297|P1|STARTED|Overall Study||100
5013283|NCT02234180|12335345|P2|NOT COMPLETED|Overall Study||0
5013284|NCT02234180|12335346|P1|NOT COMPLETED|Overall Study||0
5013285|NCT02234180|12335345|P2|COMPLETED|Overall Study||1
5013286|NCT02234180|12335346|P1|COMPLETED|Overall Study||2
5013287|NCT02234180|12335345|P2|STARTED|Overall Study||1
5013288|NCT02234180|12335346|P1|STARTED|Overall Study||2
5013289|NCT02234141|12335356|P7|NOT COMPLETED|Long-Term Treatment Period||10
5013290|NCT02234141|12335357|P6|NOT COMPLETED|Long-Term Treatment Period||12
5013291|NCT02234141|12335358|P5|NOT COMPLETED|Long-Term Treatment Period||10
5013292|NCT02234141|12335359|P4|NOT COMPLETED|Long-Term Treatment Period||0
5013293|NCT02234141|12335360|P3|NOT COMPLETED|Long-Term Treatment Period||33
5013294|NCT02234141|12335361|P2|NOT COMPLETED|Long-Term Treatment Period||31
5013295|NCT02234141|12335362|P1|NOT COMPLETED|Long-Term Treatment Period||33
5013296|NCT02234141|12335356|P7|COMPLETED|Long-Term Treatment Period||0
5013297|NCT02234141|12335357|P6|COMPLETED|Long-Term Treatment Period||0
5013298|NCT02234141|12335358|P5|COMPLETED|Long-Term Treatment Period||0
5013299|NCT02234141|12335359|P4|COMPLETED|Long-Term Treatment Period||0
5013300|NCT02234141|12335360|P3|COMPLETED|Long-Term Treatment Period||0
5013301|NCT02234141|12335361|P2|COMPLETED|Long-Term Treatment Period||0
5013302|NCT02234141|12335362|P1|COMPLETED|Long-Term Treatment Period||0
5013303|NCT02234141|12335356|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
5013304|NCT02234141|12335357|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
5013305|NCT02234141|12335358|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
5013306|NCT02234141|12335359|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
5013307|NCT02234141|12335360|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
5013308|NCT02234141|12335361|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
5013309|NCT02234141|12335362|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
5013310|NCT02234141|12335356|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
5013311|NCT02234141|12335357|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
5013312|NCT02234141|12335358|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
5013313|NCT02234141|12335359|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
5013314|NCT02234141|12335360|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
5013315|NCT02234141|12335361|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
5013316|NCT02234141|12335362|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
5013317|NCT02234141|12335356|P7|COMPLETED|Treatment Period (24 Weeks)||0
5013318|NCT02234141|12335357|P6|COMPLETED|Treatment Period (24 Weeks)||0
5013319|NCT02234141|12335358|P5|COMPLETED|Treatment Period (24 Weeks)||0
5013320|NCT02234141|12335359|P4|COMPLETED|Treatment Period (24 Weeks)||32
5013321|NCT02234141|12335360|P3|COMPLETED|Treatment Period (24 Weeks)||35
5013322|NCT02234141|12335361|P2|COMPLETED|Treatment Period (24 Weeks)||32
5013323|NCT02234141|12335362|P1|COMPLETED|Treatment Period (24 Weeks)||35
5013324|NCT02234141|12335356|P7|STARTED|Treatment Period (24 Weeks)||0
5013325|NCT02234141|12335357|P6|STARTED|Treatment Period (24 Weeks)||0
5013326|NCT02234141|12335358|P5|STARTED|Treatment Period (24 Weeks)||0
5013327|NCT02234141|12335359|P4|STARTED|Treatment Period (24 Weeks)||37
5013328|NCT02234141|12335360|P3|STARTED|Treatment Period (24 Weeks)||37
5013329|NCT02234141|12335361|P2|STARTED|Treatment Period (24 Weeks)||38
5013330|NCT02234141|12335362|P1|STARTED|Treatment Period (24 Weeks)||39
5013331|NCT02234115|12335444|P1|NOT COMPLETED|Overall Study||15
5013332|NCT02234115|12335444|P1|COMPLETED|Overall Study||122
5013333|NCT02234115|12335444|P1|PK Subgroup|Overall Study||31
5013334|NCT02234115|12335444|P1|PP|Overall Study||124
5013335|NCT02234115|12335444|P1|ITT|Overall Study||137
5013336|NCT02234115|12335444|P1|STARTED|Overall Study||137
5013337|NCT02234011|12335449|P1|NOT COMPLETED|Overall Study||0
5013338|NCT02234011|12335449|P1|COMPLETED|Overall Study||0
5013339|NCT02234011|12335449|P1|STARTED|Overall Study||0
5013340|NCT02233998|12335456|P3|NOT COMPLETED|Overall Study||0
5013341|NCT02233998|12335457|P2|NOT COMPLETED|Overall Study||0
5013342|NCT02233998|12335458|P1|NOT COMPLETED|Overall Study||0
5013343|NCT02233998|12335456|P3|COMPLETED|Overall Study||53
5013344|NCT02233998|12335457|P2|COMPLETED|Overall Study||52
5013345|NCT02233998|12335458|P1|COMPLETED|Overall Study||53
5013346|NCT02233998|12335456|P3|STARTED|Overall Study||53
5013347|NCT02233998|12335457|P2|STARTED|Overall Study||52
5013348|NCT02233998|12335458|P1|STARTED|Overall Study||53
5013349|NCT02233985|12335492|P2|NOT COMPLETED|Overall Study||0
5013350|NCT02233985|12335493|P1|NOT COMPLETED|Overall Study||0
5013351|NCT02233985|12335492|P2|COMPLETED|Overall Study||31
5013352|NCT02233985|12335493|P1|COMPLETED|Overall Study||33
5013353|NCT02233985|12335492|P2|STARTED|Overall Study||31
5013354|NCT02233985|12335493|P1|STARTED|Overall Study||33
5013355|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
5013356|NCT02233842|12335501|P1|COMPLETED|Questionnaire 3 Version 2||5
5013357|NCT02233842|12335501|P1|STARTED|Questionnaire 3 Version 2||5
5013358|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
5013359|NCT02233842|12335501|P1|COMPLETED|Questionnaire 3 Version 1||5
5013360|NCT02233842|12335501|P1|STARTED|Questionnaire 3 Version 1||5
5013361|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
5013362|NCT02233842|12335501|P1|COMPLETED|Questionnaire 2 Version 2||5
5013363|NCT02233842|12335501|P1|STARTED|Questionnaire 2 Version 2||5
5013364|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
5013365|NCT02233842|12335501|P1|COMPLETED|Questionnaire 2 Version 1||5
5013366|NCT02233842|12335501|P1|STARTED|Questionnaire 2 Version 1||5
5013367|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
5013368|NCT02233842|12335501|P1|COMPLETED|Questionnaire 1 Version 2||5
5013369|NCT02233842|12335501|P1|STARTED|Questionnaire 1 Version 2||5
5013370|NCT02233842|12335501|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
5013371|NCT02233842|12335501|P1|COMPLETED|Questionnaire 1 Version 1||5
5013372|NCT02233842|12335501|P1|STARTED|Questionnaire 1 Version 1||5
5013373|NCT02233803|12335508|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
5013374|NCT02233803|12335509|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
5013375|NCT02233803|12335508|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
5013376|NCT02233803|12335509|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
5013377|NCT02233803|12335508|P2|STARTED|Treatment Period 2 (4-Wks)||93
5013378|NCT02233803|12335509|P1|STARTED|Treatment Period 2 (4-Wks)||95
5013379|NCT02233803|12335508|P2|NOT COMPLETED|Washout Period (4-Wks)||2
5013380|NCT02233803|12335509|P1|NOT COMPLETED|Washout Period (4-Wks)||2
5013381|NCT02233803|12335508|P2|COMPLETED|Washout Period (4-Wks)||93
5013382|NCT02233803|12335509|P1|COMPLETED|Washout Period (4-Wks)||95
5013383|NCT02233803|12335508|P2|STARTED|Washout Period (4-Wks)||95
5013384|NCT02233803|12335509|P1|STARTED|Washout Period (4-Wks)||97
5013385|NCT02233803|12335508|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
5013386|NCT02233803|12335509|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
5013387|NCT02233803|12335508|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
5013388|NCT02233803|12335509|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
5013389|NCT02233803|12335508|P2|STARTED|Treatment Period 1 (4-Wks)||99
5013390|NCT02233803|12335509|P1|STARTED|Treatment Period 1 (4-Wks)||100
5013391|NCT02233751|12335521|P2|NOT COMPLETED|Overall Study||0
5013392|NCT02233751|12335522|P1|NOT COMPLETED|Overall Study||0
5013393|NCT02233751|12335521|P2|COMPLETED|Overall Study||6
5013394|NCT02233751|12335522|P1|COMPLETED|Overall Study||6
5013395|NCT02233751|12335521|P2|STARTED|Overall Study||6
5013396|NCT02233751|12335522|P1|STARTED|Overall Study||6
5013397|NCT02233738|12335542|P2|NOT COMPLETED|Overall Study||16
5013398|NCT02233738|12335543|P1|NOT COMPLETED|Overall Study||8
5013399|NCT02233738|12335542|P2|COMPLETED|Overall Study||75
5013400|NCT02233738|12335543|P1|COMPLETED|Overall Study||85
5013401|NCT02233738|12335542|P2|6 Month Follow-Up|Overall Study||75
5013402|NCT02233738|12335543|P1|6 Month Follow-Up|Overall Study||85
5013403|NCT02233738|12335542|P2|3 Month Follow-Up|Overall Study||77
5013404|NCT02233738|12335543|P1|3 Month Follow-Up|Overall Study||87
5013405|NCT02233738|12335542|P2|1 Month Follow-Up|Overall Study||82
5013406|NCT02233738|12335543|P1|1 Month Follow-Up|Overall Study||89
5013407|NCT02233738|12335542|P2|STARTED|Overall Study||91
5013408|NCT02233738|12335543|P1|STARTED|Overall Study||93
5013409|NCT02233647|12335713|P1|NOT COMPLETED|Overall Study||1
5013410|NCT02233647|12335713|P1|COMPLETED|Overall Study||10
5013411|NCT02233647|12335713|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
5013412|NCT02233647|12335713|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
5013413|NCT02233647|12335713|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
5013414|NCT02233647|12335713|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
5013415|NCT02233647|12335713|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
5013416|NCT02233647|12335713|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
5013417|NCT02233647|12335713|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
5013418|NCT02233647|12335713|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
5013419|NCT02233647|12335713|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
5013420|NCT02233647|12335713|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
5013421|NCT02233647|12335713|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
5013422|NCT02233647|12335713|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
5013423|NCT02233647|12335713|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
5013424|NCT02233647|12335713|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
5013425|NCT02233647|12335713|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
5013426|NCT02233647|12335713|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
5013427|NCT02233647|12335713|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
5013428|NCT02233647|12335713|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
5013429|NCT02233647|12335713|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
5013430|NCT02233647|12335713|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
5013431|NCT02233647|12335713|P1|STARTED|Overall Study||11
5013432|NCT02233543|12335742|P2|NOT COMPLETED|Period 2||1
5013433|NCT02233543|12335743|P1|NOT COMPLETED|Period 2||2
5013434|NCT02233543|12335742|P2|COMPLETED|Period 2||12
5013435|NCT02233543|12335743|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
5013436|NCT02233543|12335742|P2|STARTED|Period 2||13
5013437|NCT02233543|12335743|P1|STARTED|Period 2||19
5013438|NCT02233543|12335742|P2|NOT COMPLETED|Period 1||3
5013439|NCT02233543|12335743|P1|NOT COMPLETED|Period 1||3
5013440|NCT02233543|12335742|P2|COMPLETED|Period 1||13
5013441|NCT02233543|12335743|P1|COMPLETED|Period 1||19
5013442|NCT02233543|12335742|P2|STARTED|Period 1||16
5013443|NCT02233543|12335743|P1|STARTED|Period 1||22
5013444|NCT02233517|12335753|P2|NOT COMPLETED|Overall Study||4
5013445|NCT02233517|12335754|P1|NOT COMPLETED|Overall Study||7
5013446|NCT02233517|12335753|P2|COMPLETED|Overall Study||13
5013447|NCT02233517|12335754|P1|COMPLETED|Overall Study||12
5013448|NCT02233517|12335753|P2|STARTED|Overall Study||17
5013449|NCT02233517|12335754|P1|STARTED|Overall Study||19
5013450|NCT02233478|12335780|P6|NOT COMPLETED|Third Intervention (1 Day)||0
5013451|NCT02233478|12335781|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5013452|NCT02233478|12335782|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5013453|NCT02233478|12335783|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5013454|NCT02233478|12335784|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5013455|NCT02233478|12335785|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5013456|NCT02233478|12335780|P6|COMPLETED|Third Intervention (1 Day)||3
5013457|NCT02233478|12335781|P5|COMPLETED|Third Intervention (1 Day)||3
5013458|NCT02233478|12335782|P4|COMPLETED|Third Intervention (1 Day)||3
5013459|NCT02233478|12335783|P3|COMPLETED|Third Intervention (1 Day)||3
5013460|NCT02233478|12335784|P2|COMPLETED|Third Intervention (1 Day)||3
5013461|NCT02233478|12335785|P1|COMPLETED|Third Intervention (1 Day)||3
5013462|NCT02233478|12335780|P6|STARTED|Third Intervention (1 Day)||3
5013463|NCT02233478|12335781|P5|STARTED|Third Intervention (1 Day)||3
5013464|NCT02233478|12335782|P4|STARTED|Third Intervention (1 Day)||3
5013465|NCT02233478|12335783|P3|STARTED|Third Intervention (1 Day)||3
5013466|NCT02233478|12335784|P2|STARTED|Third Intervention (1 Day)||3
5013467|NCT02233478|12335785|P1|STARTED|Third Intervention (1 Day)||3
5013468|NCT02233478|12335780|P6|NOT COMPLETED|Washout (7 Days)||0
5013469|NCT02233478|12335781|P5|NOT COMPLETED|Washout (7 Days)||0
5013470|NCT02233478|12335782|P4|NOT COMPLETED|Washout (7 Days)||0
5013471|NCT02233478|12335783|P3|NOT COMPLETED|Washout (7 Days)||0
5013472|NCT02233478|12335784|P2|NOT COMPLETED|Washout (7 Days)||0
5013473|NCT02233478|12335785|P1|NOT COMPLETED|Washout (7 Days)||0
5013474|NCT02233478|12335780|P6|COMPLETED|Washout (7 Days)||3
5013475|NCT02233478|12335781|P5|COMPLETED|Washout (7 Days)||3
5013476|NCT02233478|12335782|P4|COMPLETED|Washout (7 Days)||3
5013477|NCT02233478|12335783|P3|COMPLETED|Washout (7 Days)||3
5013478|NCT02233478|12335784|P2|COMPLETED|Washout (7 Days)||3
5013479|NCT02233478|12335785|P1|COMPLETED|Washout (7 Days)||3
5013480|NCT02233478|12335780|P6|STARTED|Washout (7 Days)||3
5013481|NCT02233478|12335781|P5|STARTED|Washout (7 Days)||3
5013482|NCT02233478|12335782|P4|STARTED|Washout (7 Days)||3
5013483|NCT02233478|12335783|P3|STARTED|Washout (7 Days)||3
5013484|NCT02233478|12335784|P2|STARTED|Washout (7 Days)||3
5013485|NCT02233478|12335785|P1|STARTED|Washout (7 Days)||3
5013486|NCT02233478|12335780|P6|NOT COMPLETED|Second Intervention (1 Day)||0
5013487|NCT02233478|12335781|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5013488|NCT02233478|12335782|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5013489|NCT02233478|12335783|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5013490|NCT02233478|12335784|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5013491|NCT02233478|12335785|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5013492|NCT02233478|12335780|P6|COMPLETED|Second Intervention (1 Day)||3
5013493|NCT02233478|12335781|P5|COMPLETED|Second Intervention (1 Day)||3
5013494|NCT02233478|12335782|P4|COMPLETED|Second Intervention (1 Day)||3
5013495|NCT02233478|12335783|P3|COMPLETED|Second Intervention (1 Day)||3
5013496|NCT02233478|12335784|P2|COMPLETED|Second Intervention (1 Day)||3
5013497|NCT02233478|12335785|P1|COMPLETED|Second Intervention (1 Day)||3
5013498|NCT02233478|12335780|P6|STARTED|Second Intervention (1 Day)||3
5013499|NCT02233478|12335781|P5|STARTED|Second Intervention (1 Day)||3
5013500|NCT02233478|12335782|P4|STARTED|Second Intervention (1 Day)||3
5013501|NCT02233478|12335783|P3|STARTED|Second Intervention (1 Day)||3
5013502|NCT02233478|12335784|P2|STARTED|Second Intervention (1 Day)||3
5013503|NCT02233478|12335785|P1|STARTED|Second Intervention (1 Day)||3
5013504|NCT02233478|12335780|P6|NOT COMPLETED|Washout (7 Days)||0
5013505|NCT02233478|12335781|P5|NOT COMPLETED|Washout (7 Days)||0
5013506|NCT02233478|12335782|P4|NOT COMPLETED|Washout (7 Days)||0
5013507|NCT02233478|12335783|P3|NOT COMPLETED|Washout (7 Days)||0
5013508|NCT02233478|12335784|P2|NOT COMPLETED|Washout (7 Days)||0
5013509|NCT02233478|12335785|P1|NOT COMPLETED|Washout (7 Days)||0
5013510|NCT02233478|12335780|P6|COMPLETED|Washout (7 Days)||3
5013511|NCT02233478|12335781|P5|COMPLETED|Washout (7 Days)||3
5013512|NCT02233478|12335782|P4|COMPLETED|Washout (7 Days)||3
5013513|NCT02233478|12335783|P3|COMPLETED|Washout (7 Days)||3
5013514|NCT02233478|12335784|P2|COMPLETED|Washout (7 Days)||3
5013515|NCT02233478|12335785|P1|COMPLETED|Washout (7 Days)||3
5013516|NCT02233478|12335780|P6|STARTED|Washout (7 Days)||3
5013517|NCT02233478|12335781|P5|STARTED|Washout (7 Days)||3
5013518|NCT02233478|12335782|P4|STARTED|Washout (7 Days)||3
5013519|NCT02233478|12335783|P3|STARTED|Washout (7 Days)||3
5013520|NCT02233478|12335784|P2|STARTED|Washout (7 Days)||3
5013521|NCT02233478|12335785|P1|STARTED|Washout (7 Days)||3
5013522|NCT02233478|12335780|P6|NOT COMPLETED|First Intervention (1 Day)||0
5013523|NCT02233478|12335781|P5|NOT COMPLETED|First Intervention (1 Day)||0
5013524|NCT02233478|12335782|P4|NOT COMPLETED|First Intervention (1 Day)||0
5013525|NCT02233478|12335783|P3|NOT COMPLETED|First Intervention (1 Day)||0
5013526|NCT02233478|12335784|P2|NOT COMPLETED|First Intervention (1 Day)||0
5013527|NCT02233478|12335785|P1|NOT COMPLETED|First Intervention (1 Day)||0
5013528|NCT02233478|12335780|P6|COMPLETED|First Intervention (1 Day)||3
5013529|NCT02233478|12335781|P5|COMPLETED|First Intervention (1 Day)||3
5013530|NCT02233478|12335782|P4|COMPLETED|First Intervention (1 Day)||3
5013531|NCT02233478|12335783|P3|COMPLETED|First Intervention (1 Day)||3
5013532|NCT02233478|12335784|P2|COMPLETED|First Intervention (1 Day)||3
5013533|NCT02233478|12335785|P1|COMPLETED|First Intervention (1 Day)||3
5013534|NCT02233478|12335780|P6|STARTED|First Intervention (1 Day)||3
5013535|NCT02233478|12335781|P5|STARTED|First Intervention (1 Day)||3
5013536|NCT02233478|12335782|P4|STARTED|First Intervention (1 Day)||3
5013537|NCT02233478|12335783|P3|STARTED|First Intervention (1 Day)||3
5013538|NCT02233478|12335784|P2|STARTED|First Intervention (1 Day)||3
5013539|NCT02233478|12335785|P1|STARTED|First Intervention (1 Day)||3
5013540|NCT02233309|12335793|P1|NOT COMPLETED|Overall Study||5
5013541|NCT02233309|12335793|P1|COMPLETED|Overall Study||31
5013542|NCT02233309|12335793|P1|STARTED|Overall Study||36
5013543|NCT02233296|12335799|P2|NOT COMPLETED|Overall Study||0
5013544|NCT02233296|12335800|P1|NOT COMPLETED|Overall Study||0
5013545|NCT02233296|12335799|P2|COMPLETED|Overall Study||14
5013546|NCT02233296|12335800|P1|COMPLETED|Overall Study||16
5013547|NCT02233296|12335799|P2|STARTED|Overall Study||14
5013548|NCT02233296|12335800|P1|STARTED|Overall Study||16
5013549|NCT02233101|12335818|P2|NOT COMPLETED|Overall Study||1
5013550|NCT02233101|12335819|P1|NOT COMPLETED|Overall Study||12
5013551|NCT02233101|12335818|P2|COMPLETED|Overall Study||80
5013552|NCT02233101|12335819|P1|COMPLETED|Overall Study||74
5013553|NCT02233101|12335818|P2|STARTED|Overall Study||81
5013554|NCT02233101|12335819|P1|STARTED|Overall Study||86
5013555|NCT02232984|12335827|P1|NOT COMPLETED|Overall Study||77
5013639|NCT02232022|12336005|P1|COMPLETED|Overall Study||51
5013556|NCT02232984|12335827|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
5013557|NCT02232984|12335827|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
5013558|NCT02232984|12335827|P1|STARTED|Overall Study|Enrolled subjects|749
5013559|NCT02232893|12335838|P2|NOT COMPLETED|Overall Study||7
5013560|NCT02232893|12335839|P1|NOT COMPLETED|Overall Study||4
5013561|NCT02232893|12335838|P2|COMPLETED|Overall Study||27
5013562|NCT02232893|12335839|P1|COMPLETED|Overall Study||31
5013563|NCT02232893|12335838|P2|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
5013564|NCT02232893|12335839|P1|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
5013565|NCT02232893|12335838|P2|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
5013566|NCT02232893|12335839|P1|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
5013567|NCT02232893|12335838|P2|STARTED|Overall Study||34
5013568|NCT02232893|12335839|P1|STARTED|Overall Study||35
5013569|NCT02232880|12335845|P1|NOT COMPLETED|Overall Study||1
5013570|NCT02232880|12335845|P1|COMPLETED|Overall Study||0
5013571|NCT02232880|12335845|P1|STARTED|Overall Study||1
5013572|NCT02232698|12335854|P2|NOT COMPLETED|Overall Study||20
5013573|NCT02232698|12335855|P1|NOT COMPLETED|Overall Study||10
5013574|NCT02232698|12335854|P2|COMPLETED|Overall Study||101
5013575|NCT02232698|12335855|P1|COMPLETED|Overall Study||110
5013576|NCT02232698|12335854|P2|STARTED|Overall Study||121
5013577|NCT02232698|12335855|P1|STARTED|Overall Study||120
5013578|NCT02232425|12335878|P2|NOT COMPLETED|Overall Study||8
5013579|NCT02232425|12335879|P1|NOT COMPLETED|Overall Study||14
5013580|NCT02232425|12335878|P2|COMPLETED|Overall Study||22
5013581|NCT02232425|12335879|P1|COMPLETED|Overall Study||44
5013582|NCT02232425|12335878|P2|STARTED|Overall Study||30
5013583|NCT02232425|12335879|P1|STARTED|Overall Study||58
5013584|NCT02232243|12335912|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
5013585|NCT02232243|12335913|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
5013586|NCT02232243|12335914|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
5013587|NCT02232243|12335912|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
5013588|NCT02232243|12335913|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
5013589|NCT02232243|12335914|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
5013590|NCT02232243|12335912|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
5013591|NCT02232243|12335913|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
5013592|NCT02232243|12335914|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
5013593|NCT02232243|12335912|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
5013594|NCT02232243|12335913|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
5013595|NCT02232243|12335914|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
5013596|NCT02232243|12335912|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
5013597|NCT02232243|12335913|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
5013598|NCT02232243|12335914|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
5013599|NCT02232243|12335912|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
5013600|NCT02232243|12335913|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
5013601|NCT02232243|12335914|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
5013602|NCT02232243|12335912|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
5013603|NCT02232243|12335913|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
5013604|NCT02232243|12335914|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
5013605|NCT02232243|12335912|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
5013606|NCT02232243|12335913|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
5013607|NCT02232243|12335914|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
5013608|NCT02232243|12335912|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
5013609|NCT02232243|12335913|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
5013610|NCT02232243|12335914|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
5013611|NCT02232178|12335926|P3|NOT COMPLETED|Overall Study||1
5013612|NCT02232178|12335927|P2|NOT COMPLETED|Overall Study||1
5013613|NCT02232178|12335928|P1|NOT COMPLETED|Overall Study||1
5013614|NCT02232178|12335926|P3|COMPLETED|Overall Study||12
5013615|NCT02232178|12335927|P2|COMPLETED|Overall Study||24
5013616|NCT02232178|12335928|P1|COMPLETED|Overall Study||25
5013617|NCT02232178|12335926|P3|Safety Population|Overall Study||12
5013618|NCT02232178|12335927|P2|Safety Population|Overall Study||24
5013619|NCT02232178|12335928|P1|Safety Population|Overall Study||26
5013620|NCT02232178|12335926|P3|Per Protocol PK Population|Overall Study||11
5013621|NCT02232178|12335927|P2|Per Protocol PK Population|Overall Study||24
5013622|NCT02232178|12335928|P1|Per Protocol PK Population|Overall Study||26
5013623|NCT02232178|12335926|P3|STARTED|Overall Study||13
5013624|NCT02232178|12335927|P2|STARTED|Overall Study||25
5013625|NCT02232178|12335928|P1|STARTED|Overall Study||26
5013626|NCT02232126|12335947|P2|NOT COMPLETED|Overall Study||0
5013627|NCT02232126|12335948|P1|NOT COMPLETED|Overall Study||0
5013628|NCT02232126|12335947|P2|COMPLETED|Overall Study||90
5013629|NCT02232126|12335948|P1|COMPLETED|Overall Study||91
5013630|NCT02232126|12335947|P2|STARTED|Overall Study||90
5013631|NCT02232126|12335948|P1|STARTED|Overall Study||91
5013632|NCT02232074|12335958|P2|NOT COMPLETED|Overall Study||45
5013633|NCT02232074|12335959|P1|NOT COMPLETED|Overall Study||41
5013634|NCT02232074|12335958|P2|COMPLETED|Overall Study||107
5013635|NCT02232074|12335959|P1|COMPLETED|Overall Study||113
5013636|NCT02232074|12335958|P2|STARTED|Overall Study||152
5013637|NCT02232074|12335959|P1|STARTED|Overall Study||154
5013638|NCT02232022|12336005|P1|NOT COMPLETED|Overall Study||2
5013640|NCT02232022|12336005|P1|STARTED|Overall Study||53
5013641|NCT02232009|12336014|P1|NOT COMPLETED|Overall Study||0
5013642|NCT02232009|12336014|P1|COMPLETED|Overall Study||9
5013643|NCT02232009|12336014|P1|STARTED|Overall Study||9
5013644|NCT02231918|12336026|P3|NOT COMPLETED|Overall Study||1
5013645|NCT02231918|12336027|P2|NOT COMPLETED|Overall Study||1
5013646|NCT02231918|12336028|P1|NOT COMPLETED|Overall Study||0
5013647|NCT02231918|12336026|P3|COMPLETED|Overall Study||1
5013648|NCT02231918|12336027|P2|COMPLETED|Overall Study||14
5013649|NCT02231918|12336028|P1|COMPLETED|Overall Study||9
5013650|NCT02231918|12336026|P3|STARTED|Overall Study||2
5013651|NCT02231918|12336027|P2|STARTED|Overall Study||15
5013652|NCT02231918|12336028|P1|STARTED|Overall Study||9
5013653|NCT02231892|12336093|P3|NOT COMPLETED|Overall Study||45
5013654|NCT02231892|12336094|P2|NOT COMPLETED|Overall Study||12
5013655|NCT02231892|12336095|P1|NOT COMPLETED|Overall Study||11
5013656|NCT02231892|12336093|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
5013657|NCT02231892|12336094|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
5013658|NCT02231892|12336095|P1|COMPLETED|Overall Study||6
5013659|NCT02231892|12336093|P3|110% MT|Overall Study||27
5013660|NCT02231892|12336094|P2|110% MT|Overall Study||5
5013661|NCT02231892|12336095|P1|110% MT|Overall Study||7
5013662|NCT02231892|12336093|P3|100% MT|Overall Study||25
5013663|NCT02231892|12336094|P2|100% MT|Overall Study||6
5013664|NCT02231892|12336095|P1|100% MT|Overall Study||7
5013665|NCT02231892|12336093|P3|Sham|Overall Study||26
5013666|NCT02231892|12336094|P2|Sham|Overall Study||5
5013667|NCT02231892|12336095|P1|Sham|Overall Study||8
5013668|NCT02231892|12336093|P3|STARTED|Overall Study||70
5013669|NCT02231892|12336094|P2|STARTED|Overall Study||17
5013670|NCT02231892|12336095|P1|STARTED|Overall Study||17
5013671|NCT02231762|12336112|P4|NOT COMPLETED|Maintenance Phase||5
5013672|NCT02231762|12336113|P3|NOT COMPLETED|Maintenance Phase||5
5013673|NCT02231762|12336114|P2|NOT COMPLETED|Maintenance Phase||3
5013674|NCT02231762|12336115|P1|NOT COMPLETED|Maintenance Phase||0
5013675|NCT02231762|12336112|P4|COMPLETED|Maintenance Phase||7
5013676|NCT02231762|12336113|P3|COMPLETED|Maintenance Phase||9
5013677|NCT02231762|12336114|P2|COMPLETED|Maintenance Phase||8
5013678|NCT02231762|12336115|P1|COMPLETED|Maintenance Phase||0
5013679|NCT02231762|12336112|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
5013680|NCT02231762|12336113|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
5013681|NCT02231762|12336114|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
5013682|NCT02231762|12336115|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
5013683|NCT02231762|12336112|P4|NOT COMPLETED|Combination Phase||0
5013684|NCT02231762|12336113|P3|NOT COMPLETED|Combination Phase||0
5013685|NCT02231762|12336114|P2|NOT COMPLETED|Combination Phase||0
5013686|NCT02231762|12336115|P1|NOT COMPLETED|Combination Phase||20
5013687|NCT02231762|12336112|P4|COMPLETED|Combination Phase||0
5013688|NCT02231762|12336113|P3|COMPLETED|Combination Phase||0
5013689|NCT02231762|12336114|P2|COMPLETED|Combination Phase||0
5013690|NCT02231762|12336115|P1|COMPLETED|Combination Phase||37
5013691|NCT02231762|12336112|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
5013692|NCT02231762|12336113|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
5013693|NCT02231762|12336114|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
5013694|NCT02231762|12336115|P1|STARTED|Combination Phase||57
5013695|NCT02231749|12336148|P2|NOT COMPLETED|Overall Study||449
5013696|NCT02231749|12336149|P1|NOT COMPLETED|Overall Study||422
5013697|NCT02231749|12336148|P2|COMPLETED|Overall Study||97
5013698|NCT02231749|12336149|P1|COMPLETED|Overall Study||128
5013699|NCT02231749|12336148|P2|Received Treatment|Overall Study||535
5013700|NCT02231749|12336149|P1|Received Treatment|Overall Study||547
5013701|NCT02231749|12336148|P2|STARTED|Overall Study||546
5013702|NCT02231749|12336149|P1|STARTED|Overall Study||550
5013703|NCT02231580|12336167|P2|NOT COMPLETED|Overall Study||0
5013704|NCT02231580|12336168|P1|NOT COMPLETED|Overall Study||5
5013705|NCT02231580|12336167|P2|COMPLETED|Overall Study||3
5013706|NCT02231580|12336168|P1|COMPLETED|Overall Study||9
5013707|NCT02231580|12336167|P2|Cohort 2|Overall Study||1
5013708|NCT02231580|12336168|P1|Cohort 2|Overall Study||6
5013709|NCT02231580|12336167|P2|Cohort 1|Overall Study||2
5013710|NCT02231580|12336168|P1|Cohort 1|Overall Study||8
5013711|NCT02231580|12336167|P2|STARTED|Overall Study||3
5013712|NCT02231580|12336168|P1|STARTED|Overall Study||14
5013713|NCT02231177|12336224|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013714|NCT02231177|12336225|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013715|NCT02231177|12336226|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013716|NCT02231177|12336227|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013717|NCT02231177|12336228|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013718|NCT02231177|12336229|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
5013719|NCT02231177|12336224|P6|COMPLETED|Treatment Period 3 (21 Days)||9
5013720|NCT02231177|12336225|P5|COMPLETED|Treatment Period 3 (21 Days)||8
5013721|NCT02231177|12336226|P4|COMPLETED|Treatment Period 3 (21 Days)||7
5013722|NCT02231177|12336227|P3|COMPLETED|Treatment Period 3 (21 Days)||8
5013723|NCT02231177|12336228|P2|COMPLETED|Treatment Period 3 (21 Days)||7
5013724|NCT02231177|12336229|P1|COMPLETED|Treatment Period 3 (21 Days)||8
5013725|NCT02231177|12336224|P6|STARTED|Treatment Period 3 (21 Days)||9
5013726|NCT02231177|12336225|P5|STARTED|Treatment Period 3 (21 Days)||8
5013727|NCT02231177|12336226|P4|STARTED|Treatment Period 3 (21 Days)||7
5013728|NCT02231177|12336227|P3|STARTED|Treatment Period 3 (21 Days)||8
5013729|NCT02231177|12336228|P2|STARTED|Treatment Period 3 (21 Days)||7
5013730|NCT02231177|12336229|P1|STARTED|Treatment Period 3 (21 Days)||8
5013731|NCT02231177|12336224|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013732|NCT02231177|12336225|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013733|NCT02231177|12336226|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013734|NCT02231177|12336227|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013735|NCT02231177|12336228|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013736|NCT02231177|12336229|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5013737|NCT02231177|12336224|P6|COMPLETED|Treatment Period 2 (21 Days)||9
5013738|NCT02231177|12336225|P5|COMPLETED|Treatment Period 2 (21 Days)||8
5013739|NCT02231177|12336226|P4|COMPLETED|Treatment Period 2 (21 Days)||7
5013740|NCT02231177|12336227|P3|COMPLETED|Treatment Period 2 (21 Days)||8
5013741|NCT02231177|12336228|P2|COMPLETED|Treatment Period 2 (21 Days)||7
5013742|NCT02231177|12336229|P1|COMPLETED|Treatment Period 2 (21 Days)||8
5013743|NCT02231177|12336224|P6|STARTED|Treatment Period 2 (21 Days)||9
5013744|NCT02231177|12336225|P5|STARTED|Treatment Period 2 (21 Days)||8
5013745|NCT02231177|12336226|P4|STARTED|Treatment Period 2 (21 Days)||7
5013746|NCT02231177|12336227|P3|STARTED|Treatment Period 2 (21 Days)||8
5013747|NCT02231177|12336228|P2|STARTED|Treatment Period 2 (21 Days)||7
5013748|NCT02231177|12336229|P1|STARTED|Treatment Period 2 (21 Days)||8
5013749|NCT02231177|12336224|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013750|NCT02231177|12336225|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013751|NCT02231177|12336226|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013752|NCT02231177|12336227|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013753|NCT02231177|12336228|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013754|NCT02231177|12336229|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5013755|NCT02231177|12336224|P6|COMPLETED|Treatment Period 1 (21 Days)||9
5013756|NCT02231177|12336225|P5|COMPLETED|Treatment Period 1 (21 Days)||8
5013757|NCT02231177|12336226|P4|COMPLETED|Treatment Period 1 (21 Days)||7
5013758|NCT02231177|12336227|P3|COMPLETED|Treatment Period 1 (21 Days)||8
5013759|NCT02231177|12336228|P2|COMPLETED|Treatment Period 1 (21 Days)||7
5013760|NCT02231177|12336229|P1|COMPLETED|Treatment Period 1 (21 Days)||8
5013761|NCT02231177|12336224|P6|STARTED|Treatment Period 1 (21 Days)||9
5013762|NCT02231177|12336225|P5|STARTED|Treatment Period 1 (21 Days)||8
5013763|NCT02231177|12336226|P4|STARTED|Treatment Period 1 (21 Days)||7
5013764|NCT02231177|12336227|P3|STARTED|Treatment Period 1 (21 Days)||8
5013765|NCT02231177|12336228|P2|STARTED|Treatment Period 1 (21 Days)||7
5013766|NCT02231177|12336229|P1|STARTED|Treatment Period 1 (21 Days)||8
5013767|NCT02231164|12336285|P2|NOT COMPLETED|Overall Study||6
5013768|NCT02231164|12336286|P1|NOT COMPLETED|Overall Study||6
5013769|NCT02231164|12336285|P2|COMPLETED|Overall Study||0
5013770|NCT02231164|12336286|P1|COMPLETED|Overall Study||0
5013771|NCT02231164|12336285|P2|STARTED|Overall Study||6
5013772|NCT02231164|12336286|P1|STARTED|Overall Study||6
5013773|NCT02230995|12336294|P2|NOT COMPLETED|Period 2 + Washout||0
5013774|NCT02230995|12336295|P1|NOT COMPLETED|Period 2 + Washout||0
5013775|NCT02230995|12336294|P2|COMPLETED|Period 2 + Washout||15
5013776|NCT02230995|12336295|P1|COMPLETED|Period 2 + Washout||15
5013777|NCT02230995|12336294|P2|STARTED|Period 2 + Washout||15
5013778|NCT02230995|12336295|P1|STARTED|Period 2 + Washout||15
5013779|NCT02230995|12336294|P2|NOT COMPLETED|Period 1 + Washout||0
5013780|NCT02230995|12336295|P1|NOT COMPLETED|Period 1 + Washout||0
5013781|NCT02230995|12336294|P2|COMPLETED|Period 1 + Washout||15
5013782|NCT02230995|12336295|P1|COMPLETED|Period 1 + Washout||15
5013783|NCT02230995|12336294|P2|STARTED|Period 1 + Washout||15
5013784|NCT02230995|12336295|P1|STARTED|Period 1 + Washout||15
5013785|NCT02230956|12336314|P3|NOT COMPLETED|Overall Study||7
5013786|NCT02230956|12336315|P2|NOT COMPLETED|Overall Study||6
5013787|NCT02230956|12336316|P1|NOT COMPLETED|Overall Study||5
5013788|NCT02230956|12336314|P3|COMPLETED|Overall Study||82
5013789|NCT02230956|12336315|P2|COMPLETED|Overall Study||37
5013790|NCT02230956|12336316|P1|COMPLETED|Overall Study||39
5013791|NCT02230956|12336314|P3|STARTED|Overall Study||89
5013792|NCT02230956|12336315|P2|STARTED|Overall Study||43
5013793|NCT02230956|12336316|P1|STARTED|Overall Study||44
5013794|NCT02230904|12336338|P2|NOT COMPLETED|Overall Study||1
5013795|NCT02230904|12336339|P1|NOT COMPLETED|Overall Study||0
5013796|NCT02230904|12336338|P2|COMPLETED|Overall Study||27
5013797|NCT02230904|12336339|P1|COMPLETED|Overall Study||29
5013798|NCT02230904|12336338|P2|STARTED|Overall Study||28
5013799|NCT02230904|12336339|P1|STARTED|Overall Study||29
5013800|NCT02230761|12336361|P2|NOT COMPLETED|Overall Study||1
5013801|NCT02230761|12336362|P1|NOT COMPLETED|Overall Study||0
5013802|NCT02230761|12336361|P2|COMPLETED|Overall Study||29
5013803|NCT02230761|12336362|P1|COMPLETED|Overall Study||60
5013804|NCT02230761|12336361|P2|STARTED|Overall Study||30
5013805|NCT02230761|12336362|P1|STARTED|Overall Study||60
5013806|NCT02230683|12336372|P1|NOT COMPLETED|Overall Study||1
5013807|NCT02230683|12336372|P1|COMPLETED|Overall Study||22
5013808|NCT02230683|12336372|P1|STARTED|Overall Study||23
5013809|NCT02230670|12336389|P2|NOT COMPLETED|Overall Study||8
5013810|NCT02230670|12336390|P1|NOT COMPLETED|Overall Study||4
5013811|NCT02230670|12336389|P2|COMPLETED|Overall Study||34
5013812|NCT02230670|12336390|P1|COMPLETED|Overall Study||40
5013905|NCT02229851|12336584|P7|NOT COMPLETED|Extension Phase (Open-label Phase)||3
5013813|NCT02230670|12336389|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
5013814|NCT02230670|12336390|P1|STARTED|Overall Study||44
5013815|NCT02230579|12336407|P7|NOT COMPLETED|Overall Study||0
5013816|NCT02230579|12336408|P6|NOT COMPLETED|Overall Study||0
5013817|NCT02230579|12336409|P5|NOT COMPLETED|Overall Study||0
5013818|NCT02230579|12336410|P4|NOT COMPLETED|Overall Study||0
5013819|NCT02230579|12336411|P3|NOT COMPLETED|Overall Study||0
5013820|NCT02230579|12336412|P2|NOT COMPLETED|Overall Study||0
5013821|NCT02230579|12336413|P1|NOT COMPLETED|Overall Study||0
5013822|NCT02230579|12336407|P7|COMPLETED|Overall Study||12
5013823|NCT02230579|12336408|P6|COMPLETED|Overall Study||6
5013824|NCT02230579|12336409|P5|COMPLETED|Overall Study||6
5013825|NCT02230579|12336410|P4|COMPLETED|Overall Study||6
5013826|NCT02230579|12336411|P3|COMPLETED|Overall Study||6
5013827|NCT02230579|12336412|P2|COMPLETED|Overall Study||6
5013828|NCT02230579|12336413|P1|COMPLETED|Overall Study||6
5013829|NCT02230579|12336407|P7|STARTED|Overall Study||12
5013830|NCT02230579|12336408|P6|STARTED|Overall Study||6
5013831|NCT02230579|12336409|P5|STARTED|Overall Study||6
5013832|NCT02230579|12336410|P4|STARTED|Overall Study||6
5013833|NCT02230579|12336411|P3|STARTED|Overall Study||6
5013834|NCT02230579|12336412|P2|STARTED|Overall Study||6
5013835|NCT02230579|12336413|P1|STARTED|Overall Study||6
5013836|NCT02230566|12336451|P4|NOT COMPLETED|Overall Study||0
5013837|NCT02230566|12336452|P3|NOT COMPLETED|Overall Study||0
5013838|NCT02230566|12336453|P2|NOT COMPLETED|Overall Study||0
5013839|NCT02230566|12336454|P1|NOT COMPLETED|Overall Study||0
5013840|NCT02230566|12336451|P4|COMPLETED|Overall Study||3
5013841|NCT02230566|12336452|P3|COMPLETED|Overall Study||3
5013842|NCT02230566|12336453|P2|COMPLETED|Overall Study||3
5013843|NCT02230566|12336454|P1|COMPLETED|Overall Study||3
5013844|NCT02230566|12336451|P4|STARTED|Overall Study||3
5013845|NCT02230566|12336452|P3|STARTED|Overall Study||3
5013846|NCT02230566|12336453|P2|STARTED|Overall Study||3
5013847|NCT02230566|12336454|P1|STARTED|Overall Study||3
5013848|NCT02230540|12336469|P2|NOT COMPLETED|Overall Study||0
5013849|NCT02230540|12336470|P1|NOT COMPLETED|Overall Study||0
5013850|NCT02230540|12336469|P2|COMPLETED|Overall Study||0
5013851|NCT02230540|12336470|P1|COMPLETED|Overall Study||8
5013852|NCT02230540|12336469|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
5013853|NCT02230540|12336470|P1|STARTED|Overall Study||8
5013854|NCT02230384|12336476|P2|NOT COMPLETED|Phase 2 Wash Out||0
5013855|NCT02230384|12336477|P1|NOT COMPLETED|Phase 2 Wash Out||0
5013856|NCT02230384|12336476|P2|COMPLETED|Phase 2 Wash Out||30
5013857|NCT02230384|12336477|P1|COMPLETED|Phase 2 Wash Out||26
5013858|NCT02230384|12336476|P2|STARTED|Phase 2 Wash Out||30
5013859|NCT02230384|12336477|P1|STARTED|Phase 2 Wash Out||26
5013860|NCT02230384|12336476|P2|NOT COMPLETED|Phase 2 - Switch||1
5013861|NCT02230384|12336477|P1|NOT COMPLETED|Phase 2 - Switch||3
5013862|NCT02230384|12336476|P2|COMPLETED|Phase 2 - Switch||30
5013863|NCT02230384|12336477|P1|COMPLETED|Phase 2 - Switch||26
5013864|NCT02230384|12336476|P2|STARTED|Phase 2 - Switch||31
5013865|NCT02230384|12336477|P1|STARTED|Phase 2 - Switch||29
5013866|NCT02230384|12336476|P2|NOT COMPLETED|Phase 1 Wash Out||0
5013867|NCT02230384|12336477|P1|NOT COMPLETED|Phase 1 Wash Out||0
5013868|NCT02230384|12336476|P2|COMPLETED|Phase 1 Wash Out||31
5013869|NCT02230384|12336477|P1|COMPLETED|Phase 1 Wash Out||29
5013870|NCT02230384|12336476|P2|STARTED|Phase 1 Wash Out||31
5013871|NCT02230384|12336477|P1|STARTED|Phase 1 Wash Out||29
5013872|NCT02230384|12336476|P2|NOT COMPLETED|Phase 1||1
5013873|NCT02230384|12336477|P1|NOT COMPLETED|Phase 1||1
5013874|NCT02230384|12336476|P2|COMPLETED|Phase 1||31
5013875|NCT02230384|12336477|P1|COMPLETED|Phase 1||29
5013876|NCT02230384|12336476|P2|STARTED|Phase 1||32
5013877|NCT02230384|12336477|P1|STARTED|Phase 1||30
5013878|NCT02230332|12336497|P2|NOT COMPLETED|Overall Study||1
5013879|NCT02230332|12336498|P1|NOT COMPLETED|Overall Study||4
5013880|NCT02230332|12336497|P2|COMPLETED|Overall Study||39
5013881|NCT02230332|12336498|P1|COMPLETED|Overall Study||34
5013882|NCT02230332|12336497|P2|STARTED|Overall Study||40
5013883|NCT02230332|12336498|P1|STARTED|Overall Study||38
5013884|NCT02230306|12336514|P1|NOT COMPLETED|Overall Study||1
5013885|NCT02230306|12336514|P1|COMPLETED|Overall Study||4
5013886|NCT02230306|12336514|P1|STARTED|Overall Study||5
5013887|NCT02230085|12336525|P1|NOT COMPLETED|Overall Study||4
5013888|NCT02230085|12336525|P1|COMPLETED|Overall Study||106
5013889|NCT02230085|12336525|P1|STARTED|Overall Study||110
5013890|NCT02229864|12336529|P1|NOT COMPLETED|3 - Year Visit||2
5013891|NCT02229864|12336529|P1|COMPLETED|3 - Year Visit||10
5013892|NCT02229864|12336529|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
5013893|NCT02229864|12336529|P1|NOT COMPLETED|2 - Year Visit||1
5013894|NCT02229864|12336529|P1|COMPLETED|2 - Year Visit||11
5013895|NCT02229864|12336529|P1|STARTED|2 - Year Visit||12
5013896|NCT02229864|12336529|P1|NOT COMPLETED|1 - Year Visit||0
5013897|NCT02229864|12336529|P1|COMPLETED|1 - Year Visit||12
5013898|NCT02229864|12336529|P1|STARTED|1 - Year Visit||12
5013899|NCT02229864|12336529|P1|NOT COMPLETED|6 - Month Visit||0
5013900|NCT02229864|12336529|P1|COMPLETED|6 - Month Visit||12
5013901|NCT02229864|12336529|P1|STARTED|6 - Month Visit||12
5013902|NCT02229864|12336529|P1|NOT COMPLETED|1 - Month Visit||0
5013903|NCT02229864|12336529|P1|COMPLETED|1 - Month Visit||12
5013904|NCT02229864|12336529|P1|STARTED|1 - Month Visit||12
5013980|NCT02229513|12337038|P1|NOT COMPLETED|Overall Study||0
5013906|NCT02229851|12336585|P6|NOT COMPLETED|Extension Phase (Open-label Phase)||5
5013907|NCT02229851|12336586|P5|NOT COMPLETED|Extension Phase (Open-label Phase)||5
5013908|NCT02229851|12336587|P4|NOT COMPLETED|Extension Phase (Open-label Phase)||2
5013909|NCT02229851|12336588|P3|NOT COMPLETED|Extension Phase (Open-label Phase)||0
5013910|NCT02229851|12336589|P2|NOT COMPLETED|Extension Phase (Open-label Phase)||0
5013911|NCT02229851|12336590|P1|NOT COMPLETED|Extension Phase (Open-label Phase)||0
5013912|NCT02229851|12336584|P7|COMPLETED|Extension Phase (Open-label Phase)||48
5013913|NCT02229851|12336585|P6|COMPLETED|Extension Phase (Open-label Phase)||47
5013914|NCT02229851|12336586|P5|COMPLETED|Extension Phase (Open-label Phase)||109
5013915|NCT02229851|12336587|P4|COMPLETED|Extension Phase (Open-label Phase)||53
5013916|NCT02229851|12336588|P3|COMPLETED|Extension Phase (Open-label Phase)||0
5013917|NCT02229851|12336589|P2|COMPLETED|Extension Phase (Open-label Phase)||0
5013918|NCT02229851|12336590|P1|COMPLETED|Extension Phase (Open-label Phase)||0
5013919|NCT02229851|12336584|P7|STARTED|Extension Phase (Open-label Phase)||51
5013920|NCT02229851|12336585|P6|STARTED|Extension Phase (Open-label Phase)||52
5013921|NCT02229851|12336586|P5|STARTED|Extension Phase (Open-label Phase)||114
5013922|NCT02229851|12336587|P4|STARTED|Extension Phase (Open-label Phase)||55
5013923|NCT02229851|12336588|P3|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
5013924|NCT02229851|12336589|P2|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
5013925|NCT02229851|12336590|P1|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
5013926|NCT02229851|12336584|P7|NOT COMPLETED|Main Phase (Double-blind Phase)||0
5013927|NCT02229851|12336585|P6|NOT COMPLETED|Main Phase (Double-blind Phase)||0
5013928|NCT02229851|12336586|P5|NOT COMPLETED|Main Phase (Double-blind Phase)||0
5013929|NCT02229851|12336587|P4|NOT COMPLETED|Main Phase (Double-blind Phase)||0
5013930|NCT02229851|12336588|P3|NOT COMPLETED|Main Phase (Double-blind Phase)||6
5013931|NCT02229851|12336589|P2|NOT COMPLETED|Main Phase (Double-blind Phase)||16
5013932|NCT02229851|12336590|P1|NOT COMPLETED|Main Phase (Double-blind Phase)||6
5013933|NCT02229851|12336584|P7|COMPLETED|Main Phase (Double-blind Phase)||0
5013934|NCT02229851|12336585|P6|COMPLETED|Main Phase (Double-blind Phase)||0
5013935|NCT02229851|12336586|P5|COMPLETED|Main Phase (Double-blind Phase)||0
5013936|NCT02229851|12336587|P4|COMPLETED|Main Phase (Double-blind Phase)||0
5013937|NCT02229851|12336588|P3|COMPLETED|Main Phase (Double-blind Phase)||114
5013938|NCT02229851|12336589|P2|COMPLETED|Main Phase (Double-blind Phase)||103
5013939|NCT02229851|12336590|P1|COMPLETED|Main Phase (Double-blind Phase)||55
5013940|NCT02229851|12336584|P7|Safety Analysis Set|Main Phase (Double-blind Phase)||0
5013941|NCT02229851|12336585|P6|Safety Analysis Set|Main Phase (Double-blind Phase)||0
5013942|NCT02229851|12336586|P5|Safety Analysis Set|Main Phase (Double-blind Phase)||0
5013943|NCT02229851|12336587|P4|Safety Analysis Set|Main Phase (Double-blind Phase)||0
5013944|NCT02229851|12336588|P3|Safety Analysis Set|Main Phase (Double-blind Phase)||120
5013945|NCT02229851|12336589|P2|Safety Analysis Set|Main Phase (Double-blind Phase)||119
5013946|NCT02229851|12336590|P1|Safety Analysis Set|Main Phase (Double-blind Phase)||61
5013947|NCT02229851|12336584|P7|Full Analysis Set|Main Phase (Double-blind Phase)||0
5013948|NCT02229851|12336585|P6|Full Analysis Set|Main Phase (Double-blind Phase)||0
5013949|NCT02229851|12336586|P5|Full Analysis Set|Main Phase (Double-blind Phase)||0
5013950|NCT02229851|12336587|P4|Full Analysis Set|Main Phase (Double-blind Phase)||0
5013951|NCT02229851|12336588|P3|Full Analysis Set|Main Phase (Double-blind Phase)||120
5013952|NCT02229851|12336589|P2|Full Analysis Set|Main Phase (Double-blind Phase)||119
5013953|NCT02229851|12336590|P1|Full Analysis Set|Main Phase (Double-blind Phase)||61
5013954|NCT02229851|12336584|P7|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
5013955|NCT02229851|12336585|P6|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
5013956|NCT02229851|12336586|P5|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
5013957|NCT02229851|12336587|P4|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
5013958|NCT02229851|12336588|P3|STARTED|Main Phase (Double-blind Phase)||120
5013959|NCT02229851|12336589|P2|STARTED|Main Phase (Double-blind Phase)||119
5013960|NCT02229851|12336590|P1|STARTED|Main Phase (Double-blind Phase)||61
5013961|NCT02229539|12337025|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
5013962|NCT02229539|12337026|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
5013963|NCT02229539|12337027|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
5013964|NCT02229539|12337025|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
5013965|NCT02229539|12337026|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
5013966|NCT02229539|12337027|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
5013967|NCT02229539|12337025|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
5013968|NCT02229539|12337026|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
5013969|NCT02229539|12337027|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
5013970|NCT02229539|12337025|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
5013971|NCT02229539|12337026|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
5013972|NCT02229539|12337027|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
5013973|NCT02229539|12337025|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
5013974|NCT02229539|12337026|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
5013975|NCT02229539|12337027|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
5013976|NCT02229539|12337025|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
5013977|NCT02229539|12337026|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
5013978|NCT02229539|12337027|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
5013979|NCT02229513|12337037|P2|NOT COMPLETED|Overall Study||0
5013981|NCT02229513|12337037|P2|COMPLETED|Overall Study||100
5013982|NCT02229513|12337038|P1|COMPLETED|Overall Study||100
5013983|NCT02229513|12337037|P2|STARTED|Overall Study||100
5013984|NCT02229513|12337038|P1|STARTED|Overall Study||100
5013985|NCT02229487|12337074|P2|NOT COMPLETED|Overall Study||0
5013986|NCT02229487|12337075|P1|NOT COMPLETED|Overall Study||0
5013987|NCT02229487|12337074|P2|COMPLETED|Overall Study||27
5013988|NCT02229487|12337075|P1|COMPLETED|Overall Study||24
5013989|NCT02229487|12337074|P2|STARTED|Overall Study||27
5013990|NCT02229487|12337075|P1|STARTED|Overall Study||24
5013991|NCT02229474|12337083|P2|NOT COMPLETED|Overall Study||3
5013992|NCT02229474|12337084|P1|NOT COMPLETED|Overall Study||0
5013993|NCT02229474|12337083|P2|COMPLETED|Overall Study||15
5013994|NCT02229474|12337084|P1|COMPLETED|Overall Study||16
5013995|NCT02229474|12337083|P2|STARTED|Overall Study||18
5013996|NCT02229474|12337084|P1|STARTED|Overall Study||16
5013997|NCT02229461|12337117|P6|NOT COMPLETED|Overall Study||0
5013998|NCT02229461|12337118|P5|NOT COMPLETED|Overall Study||0
5013999|NCT02229461|12337119|P4|NOT COMPLETED|Overall Study||0
5014000|NCT02229461|12337120|P3|NOT COMPLETED|Overall Study||0
5014001|NCT02229461|12337121|P2|NOT COMPLETED|Overall Study||0
5014002|NCT02229461|12337122|P1|NOT COMPLETED|Overall Study||0
5014003|NCT02229461|12337117|P6|COMPLETED|Overall Study||17
5014004|NCT02229461|12337118|P5|COMPLETED|Overall Study||17
5014005|NCT02229461|12337119|P4|COMPLETED|Overall Study||17
5014006|NCT02229461|12337120|P3|COMPLETED|Overall Study||17
5014007|NCT02229461|12337121|P2|COMPLETED|Overall Study||17
5014008|NCT02229461|12337122|P1|COMPLETED|Overall Study||17
5014009|NCT02229461|12337117|P6|STARTED|Overall Study|Randomized and received treatment|17
5014010|NCT02229461|12337118|P5|STARTED|Overall Study|Randomized and received treatment|17
5014011|NCT02229461|12337119|P4|STARTED|Overall Study|Randomized and received treatment|17
5014012|NCT02229461|12337120|P3|STARTED|Overall Study|Randomized and received treatment|17
5014013|NCT02229461|12337121|P2|STARTED|Overall Study|Randomized and received treatment|17
5014014|NCT02229461|12337122|P1|STARTED|Overall Study|Randomized and received treatment|17
5014015|NCT02229396|12337158|P3|NOT COMPLETED|Overall Study||95
5014016|NCT02229396|12337159|P2|NOT COMPLETED|Overall Study||77
5014017|NCT02229396|12337160|P1|NOT COMPLETED|Overall Study||78
5014018|NCT02229396|12337158|P3|COMPLETED|Overall Study||136
5014019|NCT02229396|12337159|P2|COMPLETED|Overall Study||154
5014020|NCT02229396|12337160|P1|COMPLETED|Overall Study||155
5014021|NCT02229396|12337158|P3|Completed 52-Week Study Period|Overall Study||177
5014022|NCT02229396|12337159|P2|Completed 52-Week Study Period|Overall Study||193
5014023|NCT02229396|12337160|P1|Completed 52-Week Study Period|Overall Study||194
5014024|NCT02229396|12337158|P3|Completed 28-Week Study Period|Overall Study||193
5014025|NCT02229396|12337159|P2|Completed 28-Week Study Period|Overall Study||202
5014026|NCT02229396|12337160|P1|Completed 28-Week Study Period|Overall Study||208
5014027|NCT02229396|12337158|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
5014028|NCT02229396|12337159|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
5014029|NCT02229396|12337160|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
5014030|NCT02229396|12337158|P3|Safety Analysis Set|Overall Study||230
5014031|NCT02229396|12337159|P2|Safety Analysis Set|Overall Study||231
5014032|NCT02229396|12337160|P1|Safety Analysis Set|Overall Study||233
5014033|NCT02229396|12337158|P3|Randomization Code Allocated|Overall Study||231
5014034|NCT02229396|12337159|P2|Randomization Code Allocated|Overall Study||231
5014035|NCT02229396|12337160|P1|Randomization Code Allocated|Overall Study||233
5014036|NCT02229396|12337158|P3|STARTED|Overall Study||231
5014037|NCT02229396|12337159|P2|STARTED|Overall Study||231
5014038|NCT02229396|12337160|P1|STARTED|Overall Study||233
5014039|NCT02229383|12337191|P2|NOT COMPLETED|Overall Study||22
5014040|NCT02229383|12337192|P1|NOT COMPLETED|Overall Study||20
5014041|NCT02229383|12337191|P2|COMPLETED|Overall Study||207
5014042|NCT02229383|12337192|P1|COMPLETED|Overall Study||212
5014043|NCT02229383|12337191|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
5014044|NCT02229383|12337192|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
5014045|NCT02229383|12337191|P2|Safety Analysis Set|Overall Study||229
5014046|NCT02229383|12337192|P1|Safety Analysis Set|Overall Study||231
5014047|NCT02229383|12337191|P2|Received Treatment|Overall Study||229
5014048|NCT02229383|12337192|P1|Received Treatment|Overall Study||231
5014049|NCT02229383|12337191|P2|STARTED|Overall Study||229
5014050|NCT02229383|12337192|P1|STARTED|Overall Study||232
5014051|NCT02229318|12337210|P1|NOT COMPLETED|Overall Study||0
5014052|NCT02229318|12337210|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
5014053|NCT02229318|12337210|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
5014054|NCT02229227|12337217|P2|NOT COMPLETED|Overall Study||62
5014055|NCT02229227|12337218|P1|NOT COMPLETED|Overall Study||51
5014056|NCT02229227|12337217|P2|COMPLETED|Overall Study||350
5014057|NCT02229227|12337218|P1|COMPLETED|Overall Study||351
5014058|NCT02229227|12337217|P2|STARTED|Overall Study||412
5014059|NCT02229227|12337218|P1|STARTED|Overall Study||402
5014060|NCT02229214|12337303|P2|NOT COMPLETED|Overall Study||0
5014061|NCT02229214|12337304|P1|NOT COMPLETED|Overall Study||6
5014062|NCT02229214|12337303|P2|COMPLETED|Overall Study||10
5014063|NCT02229214|12337304|P1|COMPLETED|Overall Study||35
5014064|NCT02229214|12337303|P2|STARTED|Overall Study||10
5014065|NCT02229214|12337304|P1|STARTED|Overall Study||41
5014066|NCT02228980|12337328|P4|NOT COMPLETED|Overall Study||3
5014067|NCT02228980|12337329|P3|NOT COMPLETED|Overall Study||2
5014068|NCT02228980|12337330|P2|NOT COMPLETED|Overall Study||3
5014069|NCT02228980|12337331|P1|NOT COMPLETED|Overall Study||24
5014070|NCT02228980|12337328|P4|COMPLETED|Overall Study||148
5014071|NCT02228980|12337329|P3|COMPLETED|Overall Study||149
5014072|NCT02228980|12337330|P2|COMPLETED|Overall Study||147
5014073|NCT02228980|12337331|P1|COMPLETED|Overall Study||126
5014074|NCT02228980|12337328|P4|STARTED|Overall Study||151
5014075|NCT02228980|12337329|P3|STARTED|Overall Study||151
5014076|NCT02228980|12337330|P2|STARTED|Overall Study||150
5014077|NCT02228980|12337331|P1|STARTED|Overall Study||150
5014078|NCT02228967|12337355|P2|NOT COMPLETED|Overall Study||160
5014079|NCT02228967|12337356|P1|NOT COMPLETED|Overall Study||159
5014080|NCT02228967|12337355|P2|COMPLETED|Overall Study||228
5014081|NCT02228967|12337356|P1|COMPLETED|Overall Study||244
5014082|NCT02228967|12337355|P2|STARTED|Overall Study||388
5014083|NCT02228967|12337356|P1|STARTED|Overall Study||403
5014084|NCT02228824|12337386|P2|NOT COMPLETED|Overall Study||22
5014085|NCT02228824|12337387|P1|NOT COMPLETED|Overall Study||29
5014086|NCT02228824|12337386|P2|COMPLETED|Overall Study||98
5014087|NCT02228824|12337387|P1|COMPLETED|Overall Study||89
5014088|NCT02228824|12337386|P2|STARTED|Overall Study||120
5014089|NCT02228824|12337387|P1|STARTED|Overall Study||118
5014090|NCT02228720|12337401|P1|NOT COMPLETED|Open Label - Day 90||0
5014091|NCT02228720|12337401|P1|COMPLETED|Open Label - Day 90||14
5014092|NCT02228720|12337401|P1|STARTED|Open Label - Day 90||14
5014093|NCT02228720|12337401|P1|NOT COMPLETED|Open Label - Day 30||1
5014094|NCT02228720|12337401|P1|COMPLETED|Open Label - Day 30||14
5014095|NCT02228720|12337401|P1|STARTED|Open Label - Day 30||15
5014096|NCT02228720|12337401|P1|NOT COMPLETED|Open Label - Baseline||0
5014097|NCT02228720|12337401|P1|COMPLETED|Open Label - Baseline||15
5014098|NCT02228720|12337401|P1|STARTED|Open Label - Baseline||15
5014099|NCT02228681|12337411|P2|NOT COMPLETED|Overall Study||0
5014100|NCT02228681|12337412|P1|NOT COMPLETED|Overall Study||0
5014101|NCT02228681|12337411|P2|COMPLETED|Overall Study||37
5014102|NCT02228681|12337412|P1|COMPLETED|Overall Study||37
5014103|NCT02228681|12337411|P2|STARTED|Overall Study||37
5014104|NCT02228681|12337412|P1|STARTED|Overall Study||37
5014105|NCT02228590|12337424|P1|NOT COMPLETED|Overall Study||1
5014106|NCT02228590|12337424|P1|COMPLETED|Overall Study||19
5014107|NCT02228590|12337424|P1|STARTED|Overall Study||20
5014108|NCT02228499|12337439|P2|NOT COMPLETED|Overall Study||26
5014109|NCT02228499|12337440|P1|NOT COMPLETED|Overall Study||23
5014110|NCT02228499|12337439|P2|COMPLETED|Overall Study||10
5014111|NCT02228499|12337440|P1|COMPLETED|Overall Study||7
5014112|NCT02228499|12337439|P2|STARTED|Overall Study||36
5014113|NCT02228499|12337440|P1|STARTED|Overall Study||30
5014114|NCT02228460|12337446|P1|NOT COMPLETED|Overall Study||2
5014115|NCT02228460|12337446|P1|COMPLETED|Overall Study||9
5014116|NCT02228460|12337446|P1|STARTED|Overall Study||11
5014117|NCT02228395|12337469|P3|NOT COMPLETED|Third Intervention Period||0
5014118|NCT02228395|12337470|P2|NOT COMPLETED|Third Intervention Period||0
5014119|NCT02228395|12337471|P1|NOT COMPLETED|Third Intervention Period||0
5014120|NCT02228395|12337469|P3|COMPLETED|Third Intervention Period||3
5014121|NCT02228395|12337470|P2|COMPLETED|Third Intervention Period||3
5014122|NCT02228395|12337471|P1|COMPLETED|Third Intervention Period||3
5014123|NCT02228395|12337469|P3|STARTED|Third Intervention Period||3
5014124|NCT02228395|12337470|P2|STARTED|Third Intervention Period||3
5014125|NCT02228395|12337471|P1|STARTED|Third Intervention Period||3
5014126|NCT02228395|12337469|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014127|NCT02228395|12337470|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014128|NCT02228395|12337471|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014129|NCT02228395|12337469|P3|COMPLETED|Washout Period (at Least 10 Days)||3
5014130|NCT02228395|12337470|P2|COMPLETED|Washout Period (at Least 10 Days)||3
5014131|NCT02228395|12337471|P1|COMPLETED|Washout Period (at Least 10 Days)||3
5014132|NCT02228395|12337469|P3|STARTED|Washout Period (at Least 10 Days)||3
5014133|NCT02228395|12337470|P2|STARTED|Washout Period (at Least 10 Days)||3
5014134|NCT02228395|12337471|P1|STARTED|Washout Period (at Least 10 Days)||3
5014135|NCT02228395|12337469|P3|NOT COMPLETED|Second Intervention Period||0
5014136|NCT02228395|12337470|P2|NOT COMPLETED|Second Intervention Period||0
5014137|NCT02228395|12337471|P1|NOT COMPLETED|Second Intervention Period||0
5014138|NCT02228395|12337469|P3|COMPLETED|Second Intervention Period||3
5014139|NCT02228395|12337470|P2|COMPLETED|Second Intervention Period||3
5014140|NCT02228395|12337471|P1|COMPLETED|Second Intervention Period||3
5014141|NCT02228395|12337469|P3|STARTED|Second Intervention Period||3
5014142|NCT02228395|12337470|P2|STARTED|Second Intervention Period||3
5014143|NCT02228395|12337471|P1|STARTED|Second Intervention Period||3
5014144|NCT02228395|12337469|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014145|NCT02228395|12337470|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014146|NCT02228395|12337471|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
5014147|NCT02228395|12337469|P3|COMPLETED|Washout Period (at Least 10 Days)||3
5014148|NCT02228395|12337470|P2|COMPLETED|Washout Period (at Least 10 Days)||3
5014149|NCT02228395|12337471|P1|COMPLETED|Washout Period (at Least 10 Days)||3
5014150|NCT02228395|12337469|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
5014151|NCT02228395|12337470|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
5014152|NCT02228395|12337471|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
5014153|NCT02228395|12337469|P3|NOT COMPLETED|First Intervention Period||1
5014154|NCT02228395|12337470|P2|NOT COMPLETED|First Intervention Period||1
5014155|NCT02228395|12337471|P1|NOT COMPLETED|First Intervention Period||1
5014156|NCT02228395|12337469|P3|COMPLETED|First Intervention Period||2
5014157|NCT02228395|12337470|P2|COMPLETED|First Intervention Period||2
5014158|NCT02228395|12337471|P1|COMPLETED|First Intervention Period||2
5014159|NCT02228395|12337469|P3|STARTED|First Intervention Period||3
5014160|NCT02228395|12337470|P2|STARTED|First Intervention Period||3
5014161|NCT02228395|12337471|P1|STARTED|First Intervention Period||3
5014162|NCT02228174|12337535|P1|NOT COMPLETED|Overall Study||5
5014163|NCT02228174|12337535|P1|COMPLETED|Overall Study||142
5014164|NCT02228174|12337535|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
5014165|NCT02228174|12337535|P1|STARTED|Overall Study||147
5014166|NCT02227862|12337557|P2|NOT COMPLETED|Overall Study||22
5014167|NCT02227862|12337558|P1|NOT COMPLETED|Overall Study||19
5014168|NCT02227862|12337557|P2|COMPLETED|Overall Study||256
5014169|NCT02227862|12337558|P1|COMPLETED|Overall Study||261
5014170|NCT02227862|12337557|P2|Week 24|Overall Study||263
5014171|NCT02227862|12337558|P1|Week 24|Overall Study||269
5014172|NCT02227862|12337557|P2|STARTED|Overall Study||278
5014173|NCT02227862|12337558|P1|STARTED|Overall Study||280
5014174|NCT02227849|12337588|P1|NOT COMPLETED|Overall Study||8
5014175|NCT02227849|12337588|P1|COMPLETED|Overall Study||63
5014176|NCT02227849|12337588|P1|STARTED|Overall Study||71
5014177|NCT02227836|12337596|P1|NOT COMPLETED|Overall Study||0
5014178|NCT02227836|12337596|P1|COMPLETED|Overall Study||8
5014179|NCT02227836|12337596|P1|STARTED|Overall Study||8
5014180|NCT02227810|12337602|P2|NOT COMPLETED|Overall Study||5
5014181|NCT02227810|12337603|P1|NOT COMPLETED|Overall Study||2
5014182|NCT02227810|12337602|P2|COMPLETED|Overall Study||29
5014183|NCT02227810|12337603|P1|COMPLETED|Overall Study||17
5014184|NCT02227810|12337602|P2|STARTED|Overall Study||34
5014185|NCT02227810|12337603|P1|STARTED|Overall Study||19
5014186|NCT02227784|12337619|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
5014187|NCT02227784|12337620|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
5014188|NCT02227784|12337621|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
5014189|NCT02227784|12337622|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
5014190|NCT02227784|12337623|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
5014191|NCT02227784|12337619|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
5014192|NCT02227784|12337620|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
5014193|NCT02227784|12337621|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
5014194|NCT02227784|12337622|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
5014195|NCT02227784|12337623|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
5014196|NCT02227784|12337619|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
5014197|NCT02227784|12337620|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
5014198|NCT02227784|12337621|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
5014199|NCT02227784|12337622|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
5014200|NCT02227784|12337623|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
5014201|NCT02227784|12337619|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
5014202|NCT02227784|12337620|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
5014203|NCT02227784|12337621|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
5014204|NCT02227784|12337622|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
5014205|NCT02227784|12337623|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
5014206|NCT02227784|12337619|P5|NOT COMPLETED|Double-Blind Phase||0
5014207|NCT02227784|12337620|P4|NOT COMPLETED|Double-Blind Phase||39
5014208|NCT02227784|12337621|P3|NOT COMPLETED|Double-Blind Phase||21
5014209|NCT02227784|12337622|P2|NOT COMPLETED|Double-Blind Phase||18
5014210|NCT02227784|12337623|P1|NOT COMPLETED|Double-Blind Phase||40
5014211|NCT02227784|12337619|P5|COMPLETED|Double-Blind Phase||0
5014212|NCT02227784|12337620|P4|COMPLETED|Double-Blind Phase||88
5014213|NCT02227784|12337621|P3|COMPLETED|Double-Blind Phase||41
5014214|NCT02227784|12337622|P2|COMPLETED|Double-Blind Phase||36
5014215|NCT02227784|12337623|P1|COMPLETED|Double-Blind Phase||83
5014216|NCT02227784|12337619|P5|STARTED|Double-Blind Phase||0
5014217|NCT02227784|12337620|P4|STARTED|Double-Blind Phase||127
5014218|NCT02227784|12337621|P3|STARTED|Double-Blind Phase||62
5014219|NCT02227784|12337622|P2|STARTED|Double-Blind Phase||54
5014220|NCT02227784|12337623|P1|STARTED|Double-Blind Phase||123
5014221|NCT02227758|12337658|P1|NOT COMPLETED|Overall Study||67
5014222|NCT02227758|12337658|P1|COMPLETED|Overall Study||45
5014223|NCT02227758|12337658|P1|STARTED|Overall Study||112
5014224|NCT02227693|12337674|P4|NOT COMPLETED|Overall Study||0
5014225|NCT02227693|12337675|P3|NOT COMPLETED|Overall Study||0
5014226|NCT02227693|12337676|P2|NOT COMPLETED|Overall Study||0
5014227|NCT02227693|12337677|P1|NOT COMPLETED|Overall Study||0
5014228|NCT02227693|12337674|P4|COMPLETED|Overall Study||10
5014229|NCT02227693|12337675|P3|COMPLETED|Overall Study||11
5014230|NCT02227693|12337676|P2|COMPLETED|Overall Study||7
5014231|NCT02227693|12337677|P1|COMPLETED|Overall Study||11
5014232|NCT02227693|12337674|P4|STARTED|Overall Study||10
5014233|NCT02227693|12337675|P3|STARTED|Overall Study||11
5014234|NCT02227693|12337676|P2|STARTED|Overall Study||7
5014235|NCT02227693|12337677|P1|STARTED|Overall Study||11
5014236|NCT02227485|12337733|P2|NOT COMPLETED|Second Follow-up||2
5014237|NCT02227485|12337734|P1|NOT COMPLETED|Second Follow-up||2
5014238|NCT02227485|12337733|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
5014239|NCT02227485|12337734|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
5014240|NCT02227485|12337733|P2|STARTED|Second Follow-up||38
5014241|NCT02227485|12337734|P1|STARTED|Second Follow-up||36
5014242|NCT02227485|12337733|P2|NOT COMPLETED|First Follow-up||2
5014243|NCT02227485|12337734|P1|NOT COMPLETED|First Follow-up||4
5014244|NCT02227485|12337733|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
5014245|NCT02227485|12337734|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
5014246|NCT02227485|12337733|P2|STARTED|First Follow-up||40
5014247|NCT02227485|12337734|P1|STARTED|First Follow-up||40
5014248|NCT02227368|12337752|P2|NOT COMPLETED|Overall Study||4
5014249|NCT02227368|12337753|P1|NOT COMPLETED|Overall Study||2
5014250|NCT02227368|12337752|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
5014251|NCT02227368|12337753|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
5014252|NCT02227368|12337752|P2|Sujects Who Completed Treatment|Overall Study||17
5014253|NCT02227368|12337753|P1|Sujects Who Completed Treatment|Overall Study||10
5014254|NCT02227368|12337752|P2|Sujects Who Received Treatment|Overall Study||24
5014255|NCT02227368|12337753|P1|Sujects Who Received Treatment|Overall Study||16
5014256|NCT02227368|12337752|P2|STARTED|Overall Study||24
5014257|NCT02227368|12337753|P1|STARTED|Overall Study||16
5014258|NCT02227329|12337763|P2|NOT COMPLETED|Overall Study||0
5014259|NCT02227329|12337764|P1|NOT COMPLETED|Overall Study||0
5014260|NCT02227329|12337763|P2|COMPLETED|Overall Study||20
5014261|NCT02227329|12337764|P1|COMPLETED|Overall Study||18
5014262|NCT02227329|12337763|P2|STARTED|Overall Study||20
5014263|NCT02227329|12337764|P1|STARTED|Overall Study||18
5014264|NCT02227316|12337774|P4|NOT COMPLETED|Overall Study||0
5014265|NCT02227316|12337775|P3|NOT COMPLETED|Overall Study||0
5014266|NCT02227316|12337776|P2|NOT COMPLETED|Overall Study||0
5014267|NCT02227316|12337777|P1|NOT COMPLETED|Overall Study||0
5014268|NCT02227316|12337774|P4|COMPLETED|Overall Study||16
5014269|NCT02227316|12337775|P3|COMPLETED|Overall Study||16
5014270|NCT02227316|12337776|P2|COMPLETED|Overall Study||4
5014271|NCT02227316|12337777|P1|COMPLETED|Overall Study||4
5014272|NCT02227316|12337774|P4|STARTED|Overall Study||16
5014273|NCT02227316|12337775|P3|STARTED|Overall Study||16
5014274|NCT02227316|12337776|P2|STARTED|Overall Study||4
5014275|NCT02227316|12337777|P1|STARTED|Overall Study||4
5014276|NCT02227238|12337809|P2|NOT COMPLETED|Overall Study||67
5014277|NCT02227238|12337810|P1|NOT COMPLETED|Overall Study||37
5014278|NCT02227238|12337809|P2|COMPLETED|Overall Study||245
5014279|NCT02227238|12337810|P1|COMPLETED|Overall Study||275
5014280|NCT02227238|12337809|P2|STARTED|Overall Study||312
5014281|NCT02227238|12337810|P1|STARTED|Overall Study||312
5014282|NCT02227147|12337876|P2|NOT COMPLETED|Follow-up Period||5
5014283|NCT02227147|12337877|P1|NOT COMPLETED|Follow-up Period||3
5014284|NCT02227147|12337876|P2|COMPLETED|Follow-up Period||16
5014285|NCT02227147|12337877|P1|COMPLETED|Follow-up Period||15
5014286|NCT02227147|12337876|P2|STARTED|Follow-up Period||21
5014287|NCT02227147|12337877|P1|STARTED|Follow-up Period||18
5014288|NCT02227147|12337876|P2|NOT COMPLETED|Controlled Treatment Period||3
5014289|NCT02227147|12337877|P1|NOT COMPLETED|Controlled Treatment Period||6
5014290|NCT02227147|12337876|P2|COMPLETED|Controlled Treatment Period||21
5014291|NCT02227147|12337877|P1|COMPLETED|Controlled Treatment Period||18
5014292|NCT02227147|12337876|P2|STARTED|Controlled Treatment Period||24
5014293|NCT02227147|12337877|P1|STARTED|Controlled Treatment Period||24
5014294|NCT02227121|12337900|P1|NOT COMPLETED|Overall Study||0
5014295|NCT02227121|12337900|P1|COMPLETED|Overall Study||16
5014296|NCT02227121|12337900|P1|STARTED|Overall Study||16
5014297|NCT02227108|12337904|P1|NOT COMPLETED|Overall Study||31
5014298|NCT02227108|12337904|P1|COMPLETED|Overall Study||1
5014299|NCT02227108|12337904|P1|Treated|Overall Study||30
5014300|NCT02227108|12337904|P1|STARTED|Overall Study||32
5014301|NCT02226965|12337931|P1|NOT COMPLETED|Overall Study||41
5014302|NCT02226965|12337931|P1|COMPLETED|Overall Study||4
5014303|NCT02226965|12337931|P1|STARTED|Overall Study||45
5014304|NCT02226653|12337943|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
5014305|NCT02226653|12337944|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
5014306|NCT02226653|12337943|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
5014307|NCT02226653|12337944|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
5014308|NCT02226653|12337943|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
5014309|NCT02226653|12337944|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
5014310|NCT02226653|12337943|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
5014311|NCT02226653|12337944|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
5014312|NCT02226653|12337943|P2|COMPLETED|Treatment Period 5 Fed State||23
5014313|NCT02226653|12337944|P1|COMPLETED|Treatment Period 5 Fed State||23
5014314|NCT02226653|12337943|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
5014315|NCT02226653|12337944|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
5014316|NCT02226653|12337943|P2|STARTED|Treatment Period 5 Fed State||24
5014317|NCT02226653|12337944|P1|STARTED|Treatment Period 5 Fed State||23
5014318|NCT02226653|12337943|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
5014319|NCT02226653|12337944|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
5014320|NCT02226653|12337943|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
5014321|NCT02226653|12337944|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
5014322|NCT02226653|12337943|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
5014323|NCT02226653|12337944|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
5014324|NCT02226653|12337943|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
5014325|NCT02226653|12337944|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
5014326|NCT02226653|12337943|P2|COMPLETED|Treatment Period 4 Fasted State||24
5014327|NCT02226653|12337944|P1|COMPLETED|Treatment Period 4 Fasted State||23
5014328|NCT02226653|12337943|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
5014329|NCT02226653|12337944|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
5014330|NCT02226653|12337943|P2|STARTED|Treatment Period 4 Fasted State||24
5014331|NCT02226653|12337944|P1|STARTED|Treatment Period 4 Fasted State||23
5014332|NCT02226653|12337943|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
5014333|NCT02226653|12337944|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
5014334|NCT02226653|12337943|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
5014335|NCT02226653|12337944|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
5014336|NCT02226653|12337943|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
5014337|NCT02226653|12337944|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
5014338|NCT02226653|12337943|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
5014339|NCT02226653|12337944|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
5014340|NCT02226653|12337943|P2|COMPLETED|Treatment Period 3 Fasted State||24
5014341|NCT02226653|12337944|P1|COMPLETED|Treatment Period 3 Fasted State||23
5014342|NCT02226653|12337943|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
5014343|NCT02226653|12337944|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
5014344|NCT02226653|12337943|P2|STARTED|Treatment Period 3 Fasted State||24
5014345|NCT02226653|12337944|P1|STARTED|Treatment Period 3 Fasted State||23
5014346|NCT02226653|12337943|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
5014347|NCT02226653|12337944|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
5014348|NCT02226653|12337943|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
5014349|NCT02226653|12337944|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
5014350|NCT02226653|12337943|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
5014351|NCT02226653|12337944|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
5014352|NCT02226653|12337943|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
5014353|NCT02226653|12337944|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
5014354|NCT02226653|12337943|P2|COMPLETED|Treatment Period 2 Fasted State||24
5014355|NCT02226653|12337944|P1|COMPLETED|Treatment Period 2 Fasted State||23
5014356|NCT02226653|12337943|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
5014357|NCT02226653|12337944|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
5014358|NCT02226653|12337943|P2|STARTED|Treatment Period 2 Fasted State||24
5014359|NCT02226653|12337944|P1|STARTED|Treatment Period 2 Fasted State||24
5014360|NCT02226653|12337943|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
5014361|NCT02226653|12337944|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
5014362|NCT02226653|12337943|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
5014363|NCT02226653|12337944|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
5014364|NCT02226653|12337943|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
5014365|NCT02226653|12337944|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
5014366|NCT02226653|12337943|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
5014367|NCT02226653|12337944|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
5014368|NCT02226653|12337943|P2|COMPLETED|Treatment Period 1 Fasted State||24
5014369|NCT02226653|12337944|P1|COMPLETED|Treatment Period 1 Fasted State||24
5014370|NCT02226653|12337943|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
5014371|NCT02226653|12337944|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
5014372|NCT02226653|12337943|P2|STARTED|Treatment Period 1 Fasted State||24
5014373|NCT02226653|12337944|P1|STARTED|Treatment Period 1 Fasted State||24
5014374|NCT02226562|12337968|P2|NOT COMPLETED|Overall Study||1
5014375|NCT02226562|12337969|P1|NOT COMPLETED|Overall Study||0
5014376|NCT02226562|12337968|P2|COMPLETED|Overall Study|Lost to follow up|95
5014377|NCT02226562|12337969|P1|COMPLETED|Overall Study||95
5014378|NCT02226562|12337968|P2|STARTED|Overall Study||96
5014379|NCT02226562|12337969|P1|STARTED|Overall Study||95
5014380|NCT02226549|12337987|P2|NOT COMPLETED|Overall Study||1
5014381|NCT02226549|12337988|P1|NOT COMPLETED|Overall Study||1
5014382|NCT02226549|12337987|P2|COMPLETED|Overall Study||23
5014383|NCT02226549|12337988|P1|COMPLETED|Overall Study||22
5014384|NCT02226549|12337987|P2|STARTED|Overall Study||24
5014385|NCT02226549|12337988|P1|STARTED|Overall Study||23
5014386|NCT02226198|12337998|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
5014387|NCT02226198|12337999|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
5014388|NCT02226198|12338000|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
5014389|NCT02226198|12337998|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
5014390|NCT02226198|12337999|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
5014391|NCT02226198|12338000|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
5014392|NCT02226198|12337998|P3|STARTED|Maintenance Phase (12 Weeks)||0
5014393|NCT02226198|12337999|P2|STARTED|Maintenance Phase (12 Weeks)||0
5014394|NCT02226198|12338000|P1|STARTED|Maintenance Phase (12 Weeks)||13
5014395|NCT02226198|12337998|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
5014396|NCT02226198|12337999|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
5014397|NCT02226198|12338000|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
5014398|NCT02226198|12337998|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
5014399|NCT02226198|12337999|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
5014400|NCT02226198|12338000|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
5014401|NCT02226198|12337998|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
5014402|NCT02226198|12337999|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
5014403|NCT02226198|12338000|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
5014404|NCT02226198|12337998|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
5014405|NCT02226198|12337999|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
5014406|NCT02226198|12338000|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
5014407|NCT02226198|12337998|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
5014408|NCT02226198|12337999|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
5014409|NCT02226198|12338000|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
5014410|NCT02226198|12337998|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
5014411|NCT02226198|12337999|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
5014412|NCT02226198|12338000|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
5014413|NCT02226198|12337998|P3|NOT COMPLETED|Lead-in Phase||0
5014414|NCT02226198|12337999|P2|NOT COMPLETED|Lead-in Phase||0
5014415|NCT02226198|12338000|P1|NOT COMPLETED|Lead-in Phase||1
5014416|NCT02226198|12337998|P3|COMPLETED|Lead-in Phase||0
5014417|NCT02226198|12337999|P2|COMPLETED|Lead-in Phase||0
5014418|NCT02226198|12338000|P1|COMPLETED|Lead-in Phase||10
5014419|NCT02226198|12337998|P3|STARTED|Lead-in Phase||0
5014420|NCT02226198|12337999|P2|STARTED|Lead-in Phase||0
5014421|NCT02226198|12338000|P1|STARTED|Lead-in Phase||11
5014422|NCT02226172|12338073|P1|NOT COMPLETED|Overall Study||17
5014423|NCT02226172|12338073|P1|COMPLETED|Overall Study||4
5014424|NCT02226172|12338073|P1|STARTED|Overall Study||21
5014425|NCT02226120|12338104|P1|NOT COMPLETED|Overall Study||320
5014426|NCT02226120|12338104|P1|COMPLETED|Overall Study||1660
5014427|NCT02226120|12338104|P1|STARTED|Overall Study||1980
5014428|NCT02226003|12338111|P3|NOT COMPLETED|Overall Study||6
5014429|NCT02226003|12338112|P2|NOT COMPLETED|Overall Study||1
5014430|NCT02226003|12338113|P1|NOT COMPLETED|Overall Study||2
5014431|NCT02226003|12338111|P3|COMPLETED|Overall Study||91
5014432|NCT02226003|12338112|P2|COMPLETED|Overall Study||95
5014433|NCT02226003|12338113|P1|COMPLETED|Overall Study||96
5014434|NCT02226003|12338111|P3|STARTED|Overall Study||97
5014435|NCT02226003|12338112|P2|STARTED|Overall Study||96
5014436|NCT02226003|12338113|P1|STARTED|Overall Study||98
5014437|NCT02225925|12338145|P1|NOT COMPLETED|Overall Study||0
5014438|NCT02225925|12338145|P1|COMPLETED|Overall Study||45
5014439|NCT02225925|12338145|P1|STARTED|Overall Study||45
5014440|NCT02225860|12338158|P2|NOT COMPLETED|Overall Study||0
5014441|NCT02225860|12338159|P1|NOT COMPLETED|Overall Study||1
5014442|NCT02225860|12338158|P2|COMPLETED|Overall Study||17
5014443|NCT02225860|12338159|P1|COMPLETED|Overall Study||16
5014444|NCT02225860|12338158|P2|STARTED|Overall Study||17
5014445|NCT02225860|12338159|P1|STARTED|Overall Study||17
5014446|NCT02225743|12338169|P1|NOT COMPLETED|Overall Study||18
5014447|NCT02225743|12338169|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
5014448|NCT02225743|12338169|P1|STARTED|Overall Study||120
5014449|NCT02225587|12338175|P2|NOT COMPLETED|Overall Study||38
5014450|NCT02225587|12338176|P1|NOT COMPLETED|Overall Study||28
5014451|NCT02225587|12338175|P2|COMPLETED|Overall Study||162
5014452|NCT02225587|12338176|P1|COMPLETED|Overall Study||172
5014453|NCT02225587|12338175|P2|Vaccination 3|Overall Study||164
5014454|NCT02225587|12338176|P1|Vaccination 3|Overall Study||172
5014455|NCT02225587|12338175|P2|Vaccination 2|Overall Study||185
5014456|NCT02225587|12338176|P1|Vaccination 2|Overall Study||188
5014457|NCT02225587|12338175|P2|STARTED|Overall Study||200
5014458|NCT02225587|12338176|P1|STARTED|Overall Study||200
5014459|NCT02225353|12338205|P3|NOT COMPLETED|Overall Study||15
5014460|NCT02225353|12338206|P2|NOT COMPLETED|Overall Study||6
5014461|NCT02225353|12338207|P1|NOT COMPLETED|Overall Study||4
5014462|NCT02225353|12338205|P3|COMPLETED|Overall Study||75
5014463|NCT02225353|12338206|P2|COMPLETED|Overall Study||84
5014464|NCT02225353|12338207|P1|COMPLETED|Overall Study||87
5014465|NCT02225353|12338205|P3|STARTED|Overall Study||90
5014466|NCT02225353|12338206|P2|STARTED|Overall Study||90
5014467|NCT02225353|12338207|P1|STARTED|Overall Study||91
5014468|NCT02225132|12338230|P1|NOT COMPLETED|Overall Study||0
5014469|NCT02225132|12338230|P1|COMPLETED|Overall Study||10
5014470|NCT02225132|12338230|P1|STARTED|Overall Study||10
5014471|NCT02225106|12338235|P1|NOT COMPLETED|Overall Study||0
5014472|NCT02225106|12338235|P1|COMPLETED|Overall Study||11
5014473|NCT02225106|12338235|P1|STARTED|Overall Study||11
5014474|NCT02225080|12338239|P1|NOT COMPLETED|Overall Study||0
5014475|NCT02225080|12338239|P1|COMPLETED|Overall Study||100
5014476|NCT02225080|12338239|P1|STARTED|Overall Study||100
5014477|NCT02224846|12338248|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
5014478|NCT02224846|12338249|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
5014479|NCT02224846|12338248|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
5014480|NCT02224846|12338249|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
5014481|NCT02224846|12338248|P2|STARTED|Period 2 (Month 12 to Month 24)||357
5014482|NCT02224846|12338249|P1|STARTED|Period 2 (Month 12 to Month 24)||173
5014483|NCT02224846|12338248|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
5014484|NCT02224846|12338249|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
5014485|NCT02224846|12338248|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
5014486|NCT02224846|12338249|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
5014487|NCT02224846|12338248|P2|STARTED|Period 2 (Month 3 to Month 12)||388
5014488|NCT02224846|12338249|P1|STARTED|Period 2 (Month 3 to Month 12)||192
5014489|NCT02224846|12338248|P2|NOT COMPLETED|Period 1 (Month 3)||36
5014490|NCT02224846|12338249|P1|NOT COMPLETED|Period 1 (Month 3)||19
5014491|NCT02224846|12338248|P2|COMPLETED|Period 1 (Month 3)||388
5014492|NCT02224846|12338249|P1|COMPLETED|Period 1 (Month 3)||192
5014493|NCT02224846|12338248|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
5014494|NCT02224846|12338249|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
5014495|NCT02224846|12338248|P2|STARTED|Period 1 (Month 3)||424
5014496|NCT02224846|12338249|P1|STARTED|Period 1 (Month 3)||211
5014497|NCT02224820|12338269|P1|NOT COMPLETED|Overall Study||0
5014498|NCT02224820|12338269|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
5014499|NCT02224820|12338269|P1|STARTED|Overall Study||8
5014500|NCT02224755|12338279|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
5014501|NCT02224755|12338280|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
5014502|NCT02224755|12338279|P2|COMPLETED|Two Year Follow up Post-implant||289
5014503|NCT02224755|12338280|P1|COMPLETED|Two Year Follow up Post-implant||247
5014504|NCT02224755|12338279|P2|STARTED|Two Year Follow up Post-implant||515
5014505|NCT02224755|12338280|P1|STARTED|Two Year Follow up Post-implant||505
5014506|NCT02224755|12338279|P2|NOT COMPLETED|Randomization to Device Implant||1
5014507|NCT02224755|12338280|P1|NOT COMPLETED|Randomization to Device Implant||7
5014508|NCT02224755|12338279|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
5014509|NCT02224755|12338280|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
5014510|NCT02224755|12338279|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
5014511|NCT02224755|12338280|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
5014512|NCT02224729|12338304|P1|NOT COMPLETED|Overall Study||0
5014513|NCT02224729|12338304|P1|COMPLETED|Overall Study||24
5014514|NCT02224729|12338304|P1|STARTED|Overall Study||24
5014515|NCT02224703|12338315|P3|NOT COMPLETED|Overall Study||0
5014516|NCT02224703|12338316|P2|NOT COMPLETED|Overall Study||6
5014517|NCT02224703|12338317|P1|NOT COMPLETED|Overall Study||3
5014518|NCT02224703|12338315|P3|COMPLETED|Overall Study||65
5014519|NCT02224703|12338316|P2|COMPLETED|Overall Study||61
5014520|NCT02224703|12338317|P1|COMPLETED|Overall Study||64
5014521|NCT02224703|12338315|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
5014522|NCT02224703|12338316|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
5014523|NCT02224703|12338317|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
5014524|NCT02224703|12338315|P3|Safety Analysis Set|Overall Study||65
5014525|NCT02224703|12338316|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
5014526|NCT02224703|12338317|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
5014527|NCT02224703|12338315|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
5014528|NCT02224703|12338316|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
5014529|NCT02224703|12338317|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
5014530|NCT02224703|12338315|P3|STARTED|Overall Study||65
5014531|NCT02224703|12338316|P2|STARTED|Overall Study||67
5014532|NCT02224703|12338317|P1|STARTED|Overall Study||67
5014533|NCT02224690|12338336|P2|NOT COMPLETED|Overall Study||1
5014534|NCT02224690|12338337|P1|NOT COMPLETED|Overall Study||14
5014535|NCT02224690|12338336|P2|COMPLETED|Overall Study||84
5014536|NCT02224690|12338337|P1|COMPLETED|Overall Study||72
5014537|NCT02224690|12338336|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
5014538|NCT02224690|12338337|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
5014539|NCT02224690|12338336|P2|Safety Analysis Set|Overall Study||85
5014540|NCT02224690|12338337|P1|Safety Analysis Set|Overall Study||86
5014541|NCT02224690|12338336|P2|STARTED|Overall Study||85
5014542|NCT02224690|12338337|P1|STARTED|Overall Study||86
5014543|NCT02224664|12338349|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
5014544|NCT02224664|12338350|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
5014545|NCT02224664|12338351|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
5014546|NCT02224664|12338352|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
5014547|NCT02224664|12338353|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
5014548|NCT02224664|12338349|P5|COMPLETED|Dose Escalation Period (21 Days)||8
5014549|NCT02224664|12338350|P4|COMPLETED|Dose Escalation Period (21 Days)||3
5014550|NCT02224664|12338351|P3|COMPLETED|Dose Escalation Period (21 Days)||9
5014551|NCT02224664|12338352|P2|COMPLETED|Dose Escalation Period (21 Days)||9
5014552|NCT02224664|12338353|P1|COMPLETED|Dose Escalation Period (21 Days)||0
5014553|NCT02224664|12338349|P5|STARTED|Dose Escalation Period (21 Days)||19
5014554|NCT02224664|12338350|P4|STARTED|Dose Escalation Period (21 Days)||6
5014555|NCT02224664|12338351|P3|STARTED|Dose Escalation Period (21 Days)||11
5014556|NCT02224664|12338352|P2|STARTED|Dose Escalation Period (21 Days)||9
5014557|NCT02224664|12338353|P1|STARTED|Dose Escalation Period (21 Days)||0
5014558|NCT02224664|12338349|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
5014559|NCT02224664|12338350|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
5014560|NCT02224664|12338351|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
5014561|NCT02224664|12338352|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
5014562|NCT02224664|12338353|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
5014563|NCT02224664|12338349|P5|COMPLETED|Lead-in Period (3 Days)||0
5014564|NCT02224664|12338350|P4|COMPLETED|Lead-in Period (3 Days)||0
5014565|NCT02224664|12338351|P3|COMPLETED|Lead-in Period (3 Days)||0
5014566|NCT02224664|12338352|P2|COMPLETED|Lead-in Period (3 Days)||0
5014567|NCT02224664|12338353|P1|COMPLETED|Lead-in Period (3 Days)||45
5014568|NCT02224664|12338349|P5|STARTED|Lead-in Period (3 Days)||0
5014569|NCT02224664|12338350|P4|STARTED|Lead-in Period (3 Days)||0
5014570|NCT02224664|12338351|P3|STARTED|Lead-in Period (3 Days)||0
5014571|NCT02224664|12338352|P2|STARTED|Lead-in Period (3 Days)||0
5014572|NCT02224664|12338353|P1|STARTED|Lead-in Period (3 Days)||50
5014573|NCT02224638|12338435|P2|NOT COMPLETED|Overall Study||1
5014574|NCT02224638|12338436|P1|NOT COMPLETED|Overall Study||1
5014575|NCT02224638|12338435|P2|COMPLETED|Overall Study||9
5014576|NCT02224638|12338436|P1|COMPLETED|Overall Study||10
5014577|NCT02224638|12338435|P2|STARTED|Overall Study||10
5014578|NCT02224638|12338436|P1|STARTED|Overall Study||11
5014579|NCT02224625|12338444|P1|NOT COMPLETED|Sensitization||55
5014580|NCT02224625|12338444|P1|COMPLETED|Sensitization||194
5014581|NCT02224625|12338444|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
5014582|NCT02224625|12338444|P1|NOT COMPLETED|Irritation||6
5014583|NCT02224625|12338444|P1|COMPLETED|Irritation||33
5014584|NCT02224625|12338444|P1|STARTED|Irritation||39
5014585|NCT02224612|12338456|P2|NOT COMPLETED|Overall Study||0
5014586|NCT02224612|12338457|P1|NOT COMPLETED|Overall Study||0
5014587|NCT02224612|12338456|P2|COMPLETED|Overall Study||48
5014588|NCT02224612|12338457|P1|COMPLETED|Overall Study||48
5014589|NCT02224612|12338456|P2|STARTED|Overall Study||48
5014590|NCT02224612|12338457|P1|STARTED|Overall Study||48
5014591|NCT02224599|12338465|P1|NOT COMPLETED|Overall Study||2
5014592|NCT02224599|12338465|P1|COMPLETED|Overall Study||1
5014593|NCT02224599|12338465|P1|STARTED|Overall Study||3
5014594|NCT02224560|12338474|P3|NOT COMPLETED|Overall Study||2
5014595|NCT02224560|12338475|P2|NOT COMPLETED|Overall Study||2
5014596|NCT02224560|12338476|P1|NOT COMPLETED|Overall Study||9
5014597|NCT02224560|12338474|P3|COMPLETED|Overall Study||74
5014598|NCT02224560|12338475|P2|COMPLETED|Overall Study||71
5014599|NCT02224560|12338476|P1|COMPLETED|Overall Study||67
5014600|NCT02224560|12338474|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
5014601|NCT02224560|12338475|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
5014602|NCT02224560|12338476|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
5014603|NCT02224560|12338474|P3|Safety Analysis Set|Overall Study||76
5014604|NCT02224560|12338475|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
5014605|NCT02224560|12338476|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
5014606|NCT02224560|12338474|P3|STARTED|Overall Study||76
5014607|NCT02224560|12338475|P2|STARTED|Overall Study||73
5014608|NCT02224560|12338476|P1|STARTED|Overall Study||76
5014609|NCT02224508|12338495|P2|NOT COMPLETED|Overall Study||0
5014610|NCT02224508|12338496|P1|NOT COMPLETED|Overall Study||0
5014611|NCT02224508|12338495|P2|COMPLETED|Overall Study||653
5014612|NCT02224508|12338496|P1|COMPLETED|Overall Study||935
5014613|NCT02224508|12338495|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
5014614|NCT02224508|12338496|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
5014615|NCT02224404|12338506|P1|NOT COMPLETED|Overall Study||0
5014616|NCT02224404|12338506|P1|COMPLETED|Overall Study||21
5014617|NCT02224404|12338506|P1|STARTED|Overall Study||21
5014618|NCT02224313|12338513|P2|NOT COMPLETED|Overall Study||1
5014619|NCT02224313|12338514|P1|NOT COMPLETED|Overall Study||3
5014620|NCT02224313|12338513|P2|COMPLETED|Overall Study||9
5014621|NCT02224313|12338514|P1|COMPLETED|Overall Study||7
5014622|NCT02224313|12338513|P2|STARTED|Overall Study||10
5014623|NCT02224313|12338514|P1|STARTED|Overall Study||10
5014624|NCT02224274|12338524|P2|NOT COMPLETED|Overall Study||0
5014625|NCT02224274|12338525|P1|NOT COMPLETED|Overall Study||1
5014626|NCT02224274|12338524|P2|COMPLETED|Overall Study||20
5014627|NCT02224274|12338525|P1|COMPLETED|Overall Study||16
5014628|NCT02224274|12338524|P2|STARTED|Overall Study||20
5014629|NCT02224274|12338525|P1|STARTED|Overall Study||17
5014630|NCT02224157|12338537|P2|NOT COMPLETED|Overall Study||111
5014631|NCT02224157|12338538|P1|NOT COMPLETED|Overall Study||110
5014632|NCT02224157|12338537|P2|COMPLETED|Overall Study||1983
5014633|NCT02224157|12338538|P1|COMPLETED|Overall Study||1985
5014634|NCT02224157|12338537|P2|Patients Who Completed Treatment|Overall Study||1903
5014635|NCT02224157|12338538|P1|Patients Who Completed Treatment|Overall Study||1924
5014636|NCT02224157|12338537|P2|STARTED|Overall Study||2094
5014637|NCT02224157|12338538|P1|STARTED|Overall Study||2095
5014638|NCT02224053|12338562|P1|NOT COMPLETED|AZD9291 Alone||0
5014639|NCT02224053|12338562|P1|COMPLETED|AZD9291 Alone||47
5014640|NCT02224053|12338562|P1|STARTED|AZD9291 Alone||47
5014641|NCT02224053|12338562|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
5014642|NCT02224053|12338562|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
5014643|NCT02224053|12338562|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
5014644|NCT02223871|12338594|P1|NOT COMPLETED|Overall Study||0
5014645|NCT02223871|12338594|P1|COMPLETED|Overall Study||8
5014646|NCT02223871|12338594|P1|STARTED|Overall Study||8
5014647|NCT02223858|12338608|P2|NOT COMPLETED|Overall Study||26
5014648|NCT02223858|12338609|P1|NOT COMPLETED|Overall Study||24
5014649|NCT02223858|12338608|P2|COMPLETED|Overall Study||154
5014650|NCT02223858|12338609|P1|COMPLETED|Overall Study||156
5014651|NCT02223858|12338608|P2|6-month Follow-up|Overall Study||154
5014652|NCT02223858|12338609|P1|6-month Follow-up|Overall Study||156
5014653|NCT02223858|12338608|P2|3-month Follow-up|Overall Study||154
5014654|NCT02223858|12338609|P1|3-month Follow-up|Overall Study||155
5014655|NCT02223858|12338608|P2|1-month Follow-up|Overall Study||150
5014656|NCT02223858|12338609|P1|1-month Follow-up|Overall Study||156
5014657|NCT02223858|12338608|P2|STARTED|Overall Study||180
5014658|NCT02223858|12338609|P1|STARTED|Overall Study||180
5014659|NCT02223793|12338622|P3|NOT COMPLETED|Overall Study||13
5014660|NCT02223793|12338623|P2|NOT COMPLETED|Overall Study||9
5014661|NCT02223793|12338624|P1|NOT COMPLETED|Overall Study||17
5014662|NCT02223793|12338622|P3|COMPLETED|Overall Study||185
5014663|NCT02223793|12338623|P2|COMPLETED|Overall Study||190
5014664|NCT02223793|12338624|P1|COMPLETED|Overall Study||168
5014665|NCT02223793|12338622|P3|STARTED|Overall Study||198
5014666|NCT02223793|12338623|P2|STARTED|Overall Study||199
5014667|NCT02223793|12338624|P1|STARTED|Overall Study||185
5014668|NCT02223754|12338637|P2|NOT COMPLETED|Period 2||3
5014669|NCT02223754|12338638|P1|NOT COMPLETED|Period 2||3
5014670|NCT02223754|12338637|P2|COMPLETED|Period 2||141
5014671|NCT02223754|12338638|P1|COMPLETED|Period 2||156
5014672|NCT02223754|12338637|P2|STARTED|Period 2||144
5014673|NCT02223754|12338638|P1|STARTED|Period 2||159
5014674|NCT02223754|12338637|P2|NOT COMPLETED|Period 1||15
5014675|NCT02223754|12338638|P1|NOT COMPLETED|Period 1||4
5014676|NCT02223754|12338637|P2|COMPLETED|Period 1||144
5014677|NCT02223754|12338638|P1|COMPLETED|Period 1||159
5014678|NCT02223754|12338637|P2|STARTED|Period 1||159
5014679|NCT02223754|12338638|P1|STARTED|Period 1||163
5014680|NCT02223715|12338658|P1|NOT COMPLETED|Overall Study||104
5014681|NCT02223715|12338658|P1|COMPLETED|Overall Study||496
5014682|NCT02223715|12338658|P1|STARTED|Overall Study||600
5014683|NCT02223702|12338667|P2|NOT COMPLETED|Overall Study||4
5014684|NCT02223702|12338668|P1|NOT COMPLETED|Overall Study||1
5014685|NCT02223702|12338667|P2|COMPLETED|Overall Study||15
5014686|NCT02223702|12338668|P1|COMPLETED|Overall Study||19
5014687|NCT02223702|12338667|P2|STARTED|Overall Study||19
5014688|NCT02223702|12338668|P1|STARTED|Overall Study||20
5014689|NCT02223689|12338676|P1|NOT COMPLETED|Overall Study||0
5014690|NCT02223689|12338676|P1|COMPLETED|Overall Study||35
5014691|NCT02223689|12338676|P1|STARTED|Overall Study||35
5014692|NCT02223650|12338683|P2|NOT COMPLETED|Overall Study||0
5014693|NCT02223650|12338684|P1|NOT COMPLETED|Overall Study||0
5014694|NCT02223650|12338683|P2|COMPLETED|Overall Study||31
5014695|NCT02223650|12338684|P1|COMPLETED|Overall Study||27
5014696|NCT02223650|12338683|P2|STARTED|Overall Study||31
5014697|NCT02223650|12338684|P1|STARTED|Overall Study||27
5014698|NCT02223637|12338714|P1|NOT COMPLETED|Overall Study||0
5014699|NCT02223637|12338714|P1|COMPLETED|Overall Study||82
5014700|NCT02223637|12338714|P1|STARTED|Overall Study||82
5014701|NCT02223520|12338739|P2|NOT COMPLETED|Overall Study||0
5014702|NCT02223520|12338740|P1|NOT COMPLETED|Overall Study||0
5014703|NCT02223520|12338739|P2|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
5014704|NCT02223520|12338740|P1|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
5014705|NCT02223520|12338739|P2|STARTED|Overall Study||160
5014706|NCT02223520|12338740|P1|STARTED|Overall Study||147
5014707|NCT02223455|12338749|P3|NOT COMPLETED|Overall Study||0
5014708|NCT02223455|12338750|P2|NOT COMPLETED|Overall Study||0
5014709|NCT02223455|12338751|P1|NOT COMPLETED|Overall Study||0
5014710|NCT02223455|12338749|P3|COMPLETED|Overall Study|Participant level data not collected.|0
5014711|NCT02223455|12338750|P2|COMPLETED|Overall Study|Participant level data not collected.|0
5014712|NCT02223455|12338751|P1|COMPLETED|Overall Study|Participant level data not collected.|0
5014713|NCT02223455|12338749|P3|STARTED|Overall Study|Participant level data not collected.|0
5014714|NCT02223455|12338750|P2|STARTED|Overall Study|Participant level data not collected.|0
5014715|NCT02223455|12338751|P1|STARTED|Overall Study|Participant level data not collected.|0
5014716|NCT02223429|12338763|P4|NOT COMPLETED|Overall Study||0
5014717|NCT02223429|12338764|P3|NOT COMPLETED|Overall Study||0
5014718|NCT02223429|12338765|P2|NOT COMPLETED|Overall Study||0
5014719|NCT02223429|12338766|P1|NOT COMPLETED|Overall Study||1
5014720|NCT02223429|12338763|P4|COMPLETED|Overall Study||8
5014721|NCT02223429|12338764|P3|COMPLETED|Overall Study||8
5014722|NCT02223429|12338765|P2|COMPLETED|Overall Study||8
5014723|NCT02223429|12338766|P1|COMPLETED|Overall Study||7
5014724|NCT02223429|12338763|P4|STARTED|Overall Study||8
5014725|NCT02223429|12338764|P3|STARTED|Overall Study||8
5014726|NCT02223429|12338765|P2|STARTED|Overall Study||8
5014727|NCT02223429|12338766|P1|STARTED|Overall Study||8
5014728|NCT02223390|12338796|P2|NOT COMPLETED|Overall Study||4
5014729|NCT02223390|12338797|P1|NOT COMPLETED|Overall Study||9
5014730|NCT02223390|12338796|P2|COMPLETED|Overall Study||28
5014731|NCT02223390|12338797|P1|COMPLETED|Overall Study||23
5014732|NCT02223390|12338796|P2|STARTED|Overall Study||32
5014733|NCT02223390|12338797|P1|STARTED|Overall Study||32
5014734|NCT02223364|12338808|P3|NOT COMPLETED|Overall Study||3
5014735|NCT02223364|12338809|P2|NOT COMPLETED|Overall Study||0
5014736|NCT02223364|12338810|P1|NOT COMPLETED|Overall Study||5
5014737|NCT02223364|12338808|P3|COMPLETED|Overall Study||52
5014738|NCT02223364|12338809|P2|COMPLETED|Overall Study||55
5014739|NCT02223364|12338810|P1|COMPLETED|Overall Study||50
5014740|NCT02223364|12338808|P3|STARTED|Overall Study||55
5014741|NCT02223364|12338809|P2|STARTED|Overall Study||55
5014742|NCT02223364|12338810|P1|STARTED|Overall Study||55
5014743|NCT02223351|12338862|P2|NOT COMPLETED|Overall Study||0
5014744|NCT02223351|12338863|P1|NOT COMPLETED|Overall Study||0
5014745|NCT02223351|12338862|P2|COMPLETED|Overall Study||24
5014746|NCT02223351|12338863|P1|COMPLETED|Overall Study||24
5014747|NCT02223351|12338862|P2|Second Intervention (8 Days)|Overall Study||24
5014748|NCT02223351|12338863|P1|Second Intervention (8 Days)|Overall Study||24
5014749|NCT02223351|12338862|P2|Wasout (2weeks)|Overall Study||24
5014750|NCT02223351|12338863|P1|Wasout (2weeks)|Overall Study||24
5014751|NCT02223351|12338862|P2|First Intervention (8 Days)|Overall Study||24
5014752|NCT02223351|12338863|P1|First Intervention (8 Days)|Overall Study||24
5014753|NCT02223351|12338862|P2|STARTED|Overall Study||24
5014754|NCT02223351|12338863|P1|STARTED|Overall Study||24
5014755|NCT02223338|12338923|P2|NOT COMPLETED|Overall Study||0
5014756|NCT02223338|12338924|P1|NOT COMPLETED|Overall Study||0
5014757|NCT02223338|12338923|P2|COMPLETED|Overall Study||60
5014758|NCT02223338|12338924|P1|COMPLETED|Overall Study||60
5014759|NCT02223338|12338923|P2|STARTED|Overall Study||60
5014760|NCT02223338|12338924|P1|STARTED|Overall Study||60
5014761|NCT02223260|12338932|P1|NOT COMPLETED|Overall Study||0
5014762|NCT02223260|12338932|P1|COMPLETED|Overall Study||8
5014763|NCT02223260|12338932|P1|STARTED|Overall Study||8
5014764|NCT02223065|12338950|P2|NOT COMPLETED|Overall Study||0
5014765|NCT02223065|12338951|P1|NOT COMPLETED|Overall Study||0
5014766|NCT02223065|12338950|P2|COMPLETED|Overall Study||18
5014767|NCT02223065|12338951|P1|COMPLETED|Overall Study||18
5014768|NCT02223065|12338950|P2|STARTED|Overall Study||18
5014769|NCT02223065|12338951|P1|STARTED|Overall Study||18
5014770|NCT02222870|12338969|P2|NOT COMPLETED|Overall Study||0
5014771|NCT02222870|12338970|P1|NOT COMPLETED|Overall Study||0
5014772|NCT02222870|12338969|P2|COMPLETED|Overall Study||30
5014773|NCT02222870|12338970|P1|COMPLETED|Overall Study||30
5014774|NCT02222870|12338969|P2|STARTED|Overall Study||30
5014775|NCT02222870|12338970|P1|STARTED|Overall Study||30
5014776|NCT02222818|12338986|P2|NOT COMPLETED|Period 2||0
5014777|NCT02222818|12338987|P1|NOT COMPLETED|Period 2||0
5014778|NCT02222818|12338986|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
5014779|NCT02222818|12338987|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
5014780|NCT02222818|12338986|P2|STARTED|Period 2|Start of CAFR evaluation period|30
5014781|NCT02222818|12338987|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
5014782|NCT02222818|12338986|P2|NOT COMPLETED|Period 1||3
5014783|NCT02222818|12338987|P1|NOT COMPLETED|Period 1||0
5014784|NCT02222818|12338986|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
5014785|NCT02222818|12338987|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
5014786|NCT02222818|12338986|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
5014787|NCT02222818|12338987|P1|STARTED|Period 1|Start of CAFR evaluation period|33
5014788|NCT02222714|12338999|P5|NOT COMPLETED|Overall Study||7
5014789|NCT02222714|12339000|P4|NOT COMPLETED|Overall Study||4
5014790|NCT02222714|12339001|P3|NOT COMPLETED|Overall Study||4
5014791|NCT02222714|12339002|P2|NOT COMPLETED|Overall Study||2
5014792|NCT02222714|12339003|P1|NOT COMPLETED|Overall Study||0
5014793|NCT02222714|12338999|P5|COMPLETED|Overall Study||37
5014794|NCT02222714|12339000|P4|COMPLETED|Overall Study||11
5014795|NCT02222714|12339001|P3|COMPLETED|Overall Study||8
5014796|NCT02222714|12339002|P2|COMPLETED|Overall Study||22
5014797|NCT02222714|12339003|P1|COMPLETED|Overall Study||15
5014798|NCT02222714|12338999|P5|STARTED|Overall Study||44
5014799|NCT02222714|12339000|P4|STARTED|Overall Study||15
5014800|NCT02222714|12339001|P3|STARTED|Overall Study||12
5014801|NCT02222714|12339002|P2|STARTED|Overall Study||24
5014802|NCT02222714|12339003|P1|STARTED|Overall Study||15
5014803|NCT02222558|12339042|P6|NOT COMPLETED|Period 3||1
5014804|NCT02222558|12339043|P5|NOT COMPLETED|Period 3||0
5014805|NCT02222558|12339044|P4|NOT COMPLETED|Period 3||0
5014806|NCT02222558|12339045|P3|NOT COMPLETED|Period 3||0
5014807|NCT02222558|12339046|P2|NOT COMPLETED|Period 3||0
5014808|NCT02222558|12339047|P1|NOT COMPLETED|Period 3||0
5014809|NCT02222558|12339042|P6|COMPLETED|Period 3||7
5014810|NCT02222558|12339043|P5|COMPLETED|Period 3||8
5014811|NCT02222558|12339044|P4|COMPLETED|Period 3||1
5014812|NCT02222558|12339045|P3|COMPLETED|Period 3||4
5014813|NCT02222558|12339046|P2|COMPLETED|Period 3||0
5014814|NCT02222558|12339047|P1|COMPLETED|Period 3||0
5014815|NCT02222558|12339042|P6|STARTED|Period 3||8
5014816|NCT02222558|12339043|P5|STARTED|Period 3||8
5014817|NCT02222558|12339044|P4|STARTED|Period 3||1
5014818|NCT02222558|12339045|P3|STARTED|Period 3||4
5014819|NCT02222558|12339046|P2|STARTED|Period 3||0
5014820|NCT02222558|12339047|P1|STARTED|Period 3||0
5014821|NCT02222558|12339042|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014822|NCT02222558|12339043|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014823|NCT02222558|12339044|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014824|NCT02222558|12339045|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014825|NCT02222558|12339046|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014826|NCT02222558|12339047|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014827|NCT02222558|12339042|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014828|NCT02222558|12339043|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014829|NCT02222558|12339044|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014830|NCT02222558|12339045|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014831|NCT02222558|12339046|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
5014832|NCT02222558|12339047|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
5014833|NCT02222558|12339042|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
5014834|NCT02222558|12339043|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
5014835|NCT02222558|12339044|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
5014836|NCT02222558|12339045|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
5014837|NCT02222558|12339046|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
5014838|NCT02222558|12339047|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
5014839|NCT02222558|12339042|P6|NOT COMPLETED|Period 1: Single Dose||0
5014840|NCT02222558|12339043|P5|NOT COMPLETED|Period 1: Single Dose||0
5014841|NCT02222558|12339044|P4|NOT COMPLETED|Period 1: Single Dose||0
5014842|NCT02222558|12339045|P3|NOT COMPLETED|Period 1: Single Dose||0
5014843|NCT02222558|12339046|P2|NOT COMPLETED|Period 1: Single Dose||0
5014844|NCT02222558|12339047|P1|NOT COMPLETED|Period 1: Single Dose||4
5014845|NCT02222558|12339042|P6|COMPLETED|Period 1: Single Dose||0
5014846|NCT02222558|12339043|P5|COMPLETED|Period 1: Single Dose||0
5014847|NCT02222558|12339044|P4|COMPLETED|Period 1: Single Dose||0
5014848|NCT02222558|12339045|P3|COMPLETED|Period 1: Single Dose||0
5014849|NCT02222558|12339046|P2|COMPLETED|Period 1: Single Dose||0
5014850|NCT02222558|12339047|P1|COMPLETED|Period 1: Single Dose||21
5014851|NCT02222558|12339042|P6|STARTED|Period 1: Single Dose||0
5014852|NCT02222558|12339043|P5|STARTED|Period 1: Single Dose||0
5014853|NCT02222558|12339044|P4|STARTED|Period 1: Single Dose||0
5014854|NCT02222558|12339045|P3|STARTED|Period 1: Single Dose||0
5014855|NCT02222558|12339046|P2|STARTED|Period 1: Single Dose||0
5014856|NCT02222558|12339047|P1|STARTED|Period 1: Single Dose||25
5014857|NCT02222493|12339063|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
5014858|NCT02222493|12339064|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
5014859|NCT02222493|12339063|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
5014860|NCT02222493|12339064|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
5014861|NCT02222493|12339063|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
5014862|NCT02222493|12339064|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
5014863|NCT02222493|12339063|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
5014864|NCT02222493|12339064|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
5014865|NCT02222493|12339063|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
5014866|NCT02222493|12339064|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
5014867|NCT02222493|12339063|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
5014868|NCT02222493|12339064|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
5014869|NCT02222493|12339063|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
5014870|NCT02222493|12339064|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
5014871|NCT02222493|12339063|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
5014872|NCT02222493|12339064|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
5014873|NCT02222493|12339063|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
5014874|NCT02222493|12339064|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
5014875|NCT02222493|12339063|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
5014876|NCT02222493|12339064|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
5014877|NCT02222337|12339182|P2|NOT COMPLETED|Overall Study||24
5014878|NCT02222337|12339183|P1|NOT COMPLETED|Overall Study||26
5014879|NCT02222337|12339182|P2|COMPLETED|Overall Study||108
5014880|NCT02222337|12339183|P1|COMPLETED|Overall Study||114
5014881|NCT02222337|12339182|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
5014882|NCT02222337|12339183|P1|STARTED|Overall Study||140
5014883|NCT02222246|12339215|P2|NOT COMPLETED|Overall Study||27
5014884|NCT02222246|12339216|P1|NOT COMPLETED|Overall Study||27
5014885|NCT02222246|12339215|P2|COMPLETED|Overall Study||26
5014886|NCT02222246|12339216|P1|COMPLETED|Overall Study||26
5014887|NCT02222246|12339215|P2|STARTED|Overall Study||53
5014888|NCT02222246|12339216|P1|STARTED|Overall Study||53
5014889|NCT02222207|12339244|P1|NOT COMPLETED|Overall Study||4
5014890|NCT02222207|12339244|P1|COMPLETED|Overall Study||48
5014891|NCT02222207|12339244|P1|Treated and Valid for Full Analysis Set|Overall Study||51
5014892|NCT02222207|12339244|P1|STARTED|Overall Study||52
5014893|NCT02222181|12339251|P1|NOT COMPLETED|Overall Study||108
5014894|NCT02222181|12339251|P1|COMPLETED|Overall Study||55
5014895|NCT02222181|12339251|P1|STARTED|Overall Study||163
5014896|NCT02222129|12339263|P2|NOT COMPLETED|Overall Study||0
5014897|NCT02222129|12339264|P1|NOT COMPLETED|Overall Study||0
5014898|NCT02222129|12339263|P2|COMPLETED|Overall Study||106
5014899|NCT02222129|12339264|P1|COMPLETED|Overall Study||100
5014900|NCT02222129|12339263|P2|STARTED|Overall Study||106
5014901|NCT02222129|12339264|P1|STARTED|Overall Study||100
5014902|NCT02221947|12339272|P2|NOT COMPLETED|Overall Study||0
5014903|NCT02221947|12339273|P1|NOT COMPLETED|Overall Study||0
5014904|NCT02221947|12339272|P2|COMPLETED|Overall Study||3
5014905|NCT02221947|12339273|P1|COMPLETED|Overall Study||6
5014906|NCT02221947|12339272|P2|STARTED|Overall Study||3
5014907|NCT02221947|12339273|P1|STARTED|Overall Study||6
5014908|NCT02221882|12339291|P6|NOT COMPLETED|Overall Study||2
5014909|NCT02221882|12339292|P5|NOT COMPLETED|Overall Study||2
5014910|NCT02221882|12339293|P4|NOT COMPLETED|Overall Study||2
5014911|NCT02221882|12339294|P3|NOT COMPLETED|Overall Study||4
5014912|NCT02221882|12339295|P2|NOT COMPLETED|Overall Study||1
5014913|NCT02221882|12339296|P1|NOT COMPLETED|Overall Study||0
5014914|NCT02221882|12339291|P6|COMPLETED|Overall Study||2
5014915|NCT02221882|12339292|P5|COMPLETED|Overall Study||3
5014916|NCT02221882|12339293|P4|COMPLETED|Overall Study||1
5014917|NCT02221882|12339294|P3|COMPLETED|Overall Study||7
5014918|NCT02221882|12339295|P2|COMPLETED|Overall Study||2
5014919|NCT02221882|12339296|P1|COMPLETED|Overall Study||3
5014920|NCT02221882|12339291|P6|Received at Least One Dose of Study Drug|Overall Study||4
5014921|NCT02221882|12339292|P5|Received at Least One Dose of Study Drug|Overall Study||5
5014922|NCT02221882|12339293|P4|Received at Least One Dose of Study Drug|Overall Study||3
5014923|NCT02221882|12339294|P3|Received at Least One Dose of Study Drug|Overall Study||11
5014924|NCT02221882|12339295|P2|Received at Least One Dose of Study Drug|Overall Study||3
5014925|NCT02221882|12339296|P1|Received at Least One Dose of Study Drug|Overall Study||3
5014926|NCT02221882|12339291|P6|STARTED|Overall Study||4
5014927|NCT02221882|12339292|P5|STARTED|Overall Study||5
5014928|NCT02221882|12339293|P4|STARTED|Overall Study||3
5014929|NCT02221882|12339294|P3|STARTED|Overall Study||11
5014930|NCT02221882|12339295|P2|STARTED|Overall Study||3
5014931|NCT02221882|12339296|P1|STARTED|Overall Study||3
5014932|NCT02221869|12339339|P3|NOT COMPLETED|Overall Study||10
5014933|NCT02221869|12339340|P2|NOT COMPLETED|Overall Study||0
5014934|NCT02221869|12339341|P1|NOT COMPLETED|Overall Study||1
5014935|NCT02221869|12339339|P3|COMPLETED|Overall Study||33
5014936|NCT02221869|12339340|P2|COMPLETED|Overall Study||32
5014937|NCT02221869|12339341|P1|COMPLETED|Overall Study||30
5014938|NCT02221869|12339339|P3|STARTED|Overall Study||43
5014939|NCT02221869|12339340|P2|STARTED|Overall Study||32
5014940|NCT02221869|12339341|P1|STARTED|Overall Study||31
5014941|NCT02221739|12339355|P1|NOT COMPLETED|Overall Study||18
5014942|NCT02221739|12339355|P1|COMPLETED|Overall Study||21
5014943|NCT02221739|12339355|P1|STARTED|Overall Study||39
5014944|NCT02221674|12339363|P3|NOT COMPLETED|Overall Study||0
5014945|NCT02221674|12339364|P2|NOT COMPLETED|Overall Study||0
5014946|NCT02221674|12339365|P1|NOT COMPLETED|Overall Study||1
5014947|NCT02221674|12339363|P3|COMPLETED|Overall Study||5
5014948|NCT02221674|12339364|P2|COMPLETED|Overall Study||6
5014949|NCT02221674|12339365|P1|COMPLETED|Overall Study||7
5014950|NCT02221674|12339363|P3|STARTED|Overall Study||5
5014951|NCT02221674|12339364|P2|STARTED|Overall Study||6
5014952|NCT02221674|12339365|P1|STARTED|Overall Study||8
5014953|NCT02221648|12339381|P2|NOT COMPLETED|Overall Study||3
5014954|NCT02221648|12339382|P1|NOT COMPLETED|Overall Study||3
5014955|NCT02221648|12339381|P2|COMPLETED|Overall Study||18
5014956|NCT02221648|12339382|P1|COMPLETED|Overall Study||19
5014957|NCT02221648|12339381|P2|STARTED|Overall Study||21
5014958|NCT02221648|12339382|P1|STARTED|Overall Study||22
5014959|NCT02221557|12339392|P1|NOT COMPLETED|Overall Study||3
5014960|NCT02221557|12339392|P1|COMPLETED|Overall Study||5
5014961|NCT02221557|12339392|P1|STARTED|Overall Study||8
5014962|NCT02221284|12339400|P1|NOT COMPLETED|Overall Study||61
5014963|NCT02221284|12339400|P1|COMPLETED|Overall Study||903
5014964|NCT02221284|12339400|P1|STARTED|Overall Study||964
5014965|NCT02221037|12339432|P4|NOT COMPLETED|Overall Study||0
5014966|NCT02221037|12339433|P3|NOT COMPLETED|Overall Study||1
5014967|NCT02221037|12339434|P2|NOT COMPLETED|Overall Study||0
5014968|NCT02221037|12339435|P1|NOT COMPLETED|Overall Study||0
5014969|NCT02221037|12339432|P4|COMPLETED|Overall Study||9
5014970|NCT02221037|12339433|P3|COMPLETED|Overall Study||7
5014971|NCT02221037|12339434|P2|COMPLETED|Overall Study||11
5014972|NCT02221037|12339435|P1|COMPLETED|Overall Study||5
5014973|NCT02221037|12339432|P4|STARTED|Overall Study||9
5014974|NCT02221037|12339433|P3|STARTED|Overall Study||8
5014975|NCT02221037|12339434|P2|STARTED|Overall Study||11
5014976|NCT02221037|12339435|P1|STARTED|Overall Study||5
5014977|NCT02220998|12339521|P2|NOT COMPLETED|Overall Study||11
5014978|NCT02220998|12339522|P1|NOT COMPLETED|Overall Study||7
5014979|NCT02220998|12339521|P2|COMPLETED|Overall Study||123
5014980|NCT02220998|12339522|P1|COMPLETED|Overall Study||128
5014981|NCT02220998|12339521|P2|STARTED|Overall Study||134
5014982|NCT02220998|12339522|P1|STARTED|Overall Study||135
5014983|NCT02220920|12339540|P2|NOT COMPLETED|Overall Study||3
5014984|NCT02220920|12339541|P1|NOT COMPLETED|Overall Study||3
5014985|NCT02220920|12339540|P2|COMPLETED|Overall Study||67
5014986|NCT02220920|12339541|P1|COMPLETED|Overall Study||73
5014987|NCT02220920|12339540|P2|STARTED|Overall Study||70
5014988|NCT02220920|12339541|P1|STARTED|Overall Study||76
5014989|NCT02220907|12339555|P1|NOT COMPLETED|Overall Study||11
5014990|NCT02220907|12339555|P1|COMPLETED|Overall Study||142
5014991|NCT02220907|12339555|P1|STARTED|Overall Study||153
5014992|NCT02220894|12339564|P2|NOT COMPLETED|Overall Study||637
5014993|NCT02220894|12339565|P1|NOT COMPLETED|Overall Study||637
5014994|NCT02220894|12339564|P2|COMPLETED|Overall Study||0
5014995|NCT02220894|12339565|P1|COMPLETED|Overall Study||0
5014996|NCT02220894|12339564|P2|Treated|Overall Study||615
5014997|NCT02220894|12339565|P1|Treated|Overall Study||636
5014998|NCT02220894|12339564|P2|STARTED|Overall Study||637
5014999|NCT02220894|12339565|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
5015000|NCT02220855|12339591|P1|NOT COMPLETED|Overall Study||14
5015001|NCT02220855|12339591|P1|COMPLETED|Overall Study||0
5015002|NCT02220855|12339591|P1|STARTED|Overall Study||14
5015003|NCT02220764|12339601|P2|NOT COMPLETED|Overall Study||1
5015004|NCT02220764|12339602|P1|NOT COMPLETED|Overall Study||4
5015005|NCT02220764|12339601|P2|COMPLETED|Overall Study||7
5015006|NCT02220764|12339602|P1|COMPLETED|Overall Study||20
5015007|NCT02220764|12339601|P2|STARTED|Overall Study||8
5015008|NCT02220764|12339602|P1|STARTED|Overall Study||24
5015009|NCT02220725|12339616|P4|NOT COMPLETED|Overall Study||2
5015010|NCT02220725|12339617|P3|NOT COMPLETED|Overall Study||0
5015011|NCT02220725|12339618|P2|NOT COMPLETED|Overall Study||0
5015012|NCT02220725|12339619|P1|NOT COMPLETED|Overall Study||0
5015013|NCT02220725|12339616|P4|COMPLETED|Overall Study||24
5015014|NCT02220725|12339617|P3|COMPLETED|Overall Study||13
5015015|NCT02220725|12339618|P2|COMPLETED|Overall Study||27
5015016|NCT02220725|12339619|P1|COMPLETED|Overall Study||14
5015017|NCT02220725|12339616|P4|STARTED|Overall Study||26
5015018|NCT02220725|12339617|P3|STARTED|Overall Study||13
5015019|NCT02220725|12339618|P2|STARTED|Overall Study||27
5015020|NCT02220725|12339619|P1|STARTED|Overall Study||14
5015021|NCT02220205|12339649|P2|NOT COMPLETED|Overall Study||0
5015022|NCT02220205|12339650|P1|NOT COMPLETED|Overall Study||1
5015023|NCT02220205|12339649|P2|COMPLETED|Overall Study||30
5015024|NCT02220205|12339650|P1|COMPLETED|Overall Study||29
5015025|NCT02220205|12339649|P2|STARTED|Overall Study||30
5015026|NCT02220205|12339650|P1|STARTED|Overall Study||30
5015027|NCT02219997|12339660|P3|NOT COMPLETED|Second Filter||0
5015028|NCT02219997|12339661|P2|NOT COMPLETED|Second Filter||0
5015029|NCT02219997|12339662|P1|NOT COMPLETED|Second Filter||0
5015030|NCT02219997|12339660|P3|COMPLETED|Second Filter||18
5015031|NCT02219997|12339661|P2|COMPLETED|Second Filter||17
5015032|NCT02219997|12339662|P1|COMPLETED|Second Filter||0
5015033|NCT02219997|12339660|P3|STARTED|Second Filter||18
5015034|NCT02219997|12339661|P2|STARTED|Second Filter||17
5015035|NCT02219997|12339662|P1|STARTED|Second Filter||0
5015036|NCT02219997|12339660|P3|NOT COMPLETED|First Filter||0
5015037|NCT02219997|12339661|P2|NOT COMPLETED|First Filter||0
5015038|NCT02219997|12339662|P1|NOT COMPLETED|First Filter||0
5015039|NCT02219997|12339660|P3|COMPLETED|First Filter||18
5015040|NCT02219997|12339661|P2|COMPLETED|First Filter||17
5015041|NCT02219997|12339662|P1|COMPLETED|First Filter||33
5015042|NCT02219997|12339660|P3|STARTED|First Filter||18
5015043|NCT02219997|12339661|P2|STARTED|First Filter||17
5015044|NCT02219997|12339662|P1|STARTED|First Filter||33
5015045|NCT02219932|12339675|P2|NOT COMPLETED|Overall Study||51
5015046|NCT02219932|12339676|P1|NOT COMPLETED|Overall Study||65
5015047|NCT02219932|12339675|P2|COMPLETED|Overall Study||266
5015048|NCT02219932|12339676|P1|COMPLETED|Overall Study||254
5015049|NCT02219932|12339675|P2|Randomized, Not Treated|Overall Study||1
5015050|NCT02219932|12339676|P1|Randomized, Not Treated|Overall Study||0
5015051|NCT02219932|12339675|P2|STARTED|Overall Study||317
5015052|NCT02219932|12339676|P1|STARTED|Overall Study||319
5015053|NCT02219685|12339692|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
5015054|NCT02219685|12339693|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
5015055|NCT02219685|12339692|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
5015056|NCT02219685|12339693|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
5015057|NCT02219685|12339692|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
5015058|NCT02219685|12339693|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
5015059|NCT02219685|12339692|P2|NOT COMPLETED|Blinded Treatment Phase||0
5015060|NCT02219685|12339693|P1|NOT COMPLETED|Blinded Treatment Phase||2
5015061|NCT02219685|12339692|P2|COMPLETED|Blinded Treatment Phase||14
5015062|NCT02219685|12339693|P1|COMPLETED|Blinded Treatment Phase||24
5015063|NCT02219685|12339692|P2|STARTED|Blinded Treatment Phase||14
5015064|NCT02219685|12339693|P1|STARTED|Blinded Treatment Phase||26
5015065|NCT02219516|12339741|P4|NOT COMPLETED|Overall Study||0
5015066|NCT02219516|12339742|P3|NOT COMPLETED|Overall Study||0
5015067|NCT02219516|12339743|P2|NOT COMPLETED|Overall Study||0
5015068|NCT02219516|12339744|P1|NOT COMPLETED|Overall Study||0
5015069|NCT02219516|12339741|P4|COMPLETED|Overall Study||8
5015070|NCT02219516|12339742|P3|COMPLETED|Overall Study||7
5015071|NCT02219516|12339743|P2|COMPLETED|Overall Study||8
5015072|NCT02219516|12339744|P1|COMPLETED|Overall Study||8
5015073|NCT02219516|12339741|P4|STARTED|Overall Study||8
5015074|NCT02219516|12339742|P3|STARTED|Overall Study||7
5015075|NCT02219516|12339743|P2|STARTED|Overall Study||8
5015076|NCT02219516|12339744|P1|STARTED|Overall Study||8
5015077|NCT02219503|12339790|P1|NOT COMPLETED|Overall Study||0
5015078|NCT02219503|12339790|P1|COMPLETED|Overall Study||60
5015079|NCT02219503|12339790|P1|STARTED|Overall Study||60
5015080|NCT02219477|12339799|P3|NOT COMPLETED|Overall Study||1
5015081|NCT02219477|12339800|P2|NOT COMPLETED|Overall Study||2
5015082|NCT02219477|12339801|P1|NOT COMPLETED|Overall Study||0
5015083|NCT02219477|12339799|P3|COMPLETED|Overall Study||2
5015084|NCT02219477|12339800|P2|COMPLETED|Overall Study||22
5015085|NCT02219477|12339801|P1|COMPLETED|Overall Study||9
5015086|NCT02219477|12339799|P3|STARTED|Overall Study||3
5015087|NCT02219477|12339800|P2|STARTED|Overall Study||24
5015088|NCT02219477|12339801|P1|STARTED|Overall Study||9
5015089|NCT02219464|12339829|P2|NOT COMPLETED|Overall Study||0
5015090|NCT02219464|12339830|P1|NOT COMPLETED|Overall Study||3
5015091|NCT02219464|12339829|P2|COMPLETED|Overall Study||30
5015092|NCT02219464|12339830|P1|COMPLETED|Overall Study||27
5015093|NCT02219464|12339829|P2|STARTED|Overall Study||30
5015094|NCT02219464|12339830|P1|STARTED|Overall Study||30
5015095|NCT02219321|12339840|P2|NOT COMPLETED|Overall Study||0
5015096|NCT02219321|12339841|P1|NOT COMPLETED|Overall Study||0
5015097|NCT02219321|12339840|P2|COMPLETED|Overall Study||2
5015098|NCT02219321|12339841|P1|COMPLETED|Overall Study||1
5015099|NCT02219321|12339840|P2|STARTED|Overall Study||2
5015100|NCT02219321|12339841|P1|STARTED|Overall Study||1
5015101|NCT02219308|12339851|P2|NOT COMPLETED|Overall Study||2
5015102|NCT02219308|12339852|P1|NOT COMPLETED|Overall Study||1
5015103|NCT02219308|12339851|P2|COMPLETED|Overall Study||33
5015104|NCT02219308|12339852|P1|COMPLETED|Overall Study||31
5015105|NCT02219308|12339851|P2|STARTED|Overall Study||35
5015106|NCT02219308|12339852|P1|STARTED|Overall Study||32
5015107|NCT02219282|12339862|P2|NOT COMPLETED|Overall Study||1
5015108|NCT02219282|12339863|P1|NOT COMPLETED|Overall Study||1
5015109|NCT02219282|12339862|P2|COMPLETED|Overall Study||32
5015110|NCT02219282|12339863|P1|COMPLETED|Overall Study||32
5015111|NCT02219282|12339862|P2|STARTED|Overall Study||33
5015112|NCT02219282|12339863|P1|STARTED|Overall Study||33
5015113|NCT02219256|12339889|P12|NOT COMPLETED|Overall Study||0
5015114|NCT02219256|12339890|P11|NOT COMPLETED|Overall Study||0
5015115|NCT02219256|12339891|P10|NOT COMPLETED|Overall Study||0
5015116|NCT02219256|12339892|P9|NOT COMPLETED|Overall Study||0
5015117|NCT02219256|12339893|P8|NOT COMPLETED|Overall Study||0
5015118|NCT02219256|12339894|P7|NOT COMPLETED|Overall Study||0
5015119|NCT02219256|12339895|P6|NOT COMPLETED|Overall Study||0
5015120|NCT02219256|12339896|P5|NOT COMPLETED|Overall Study||0
5015121|NCT02219256|12339897|P4|NOT COMPLETED|Overall Study||0
5015122|NCT02219256|12339898|P3|NOT COMPLETED|Overall Study||0
5015123|NCT02219256|12339899|P2|NOT COMPLETED|Overall Study||0
5015124|NCT02219256|12339900|P1|NOT COMPLETED|Overall Study||0
5015125|NCT02219256|12339889|P12|COMPLETED|Overall Study||6
5015126|NCT02219256|12339890|P11|COMPLETED|Overall Study||6
5015127|NCT02219256|12339891|P10|COMPLETED|Overall Study||6
5015128|NCT02219256|12339892|P9|COMPLETED|Overall Study||6
5015129|NCT02219256|12339893|P8|COMPLETED|Overall Study||8
5015130|NCT02219256|12339894|P7|COMPLETED|Overall Study||6
5015131|NCT02219256|12339895|P6|COMPLETED|Overall Study||6
5015132|NCT02219256|12339896|P5|COMPLETED|Overall Study||6
5015133|NCT02219256|12339897|P4|COMPLETED|Overall Study||4
5015134|NCT02219256|12339898|P3|COMPLETED|Overall Study||4
5015135|NCT02219256|12339899|P2|COMPLETED|Overall Study||4
5015136|NCT02219256|12339900|P1|COMPLETED|Overall Study||12
5015137|NCT02219256|12339889|P12|STARTED|Overall Study||6
5015138|NCT02219256|12339890|P11|STARTED|Overall Study||6
5015139|NCT02219256|12339891|P10|STARTED|Overall Study||6
5015140|NCT02219256|12339892|P9|STARTED|Overall Study||6
5015141|NCT02219256|12339893|P8|STARTED|Overall Study||8
5015142|NCT02219256|12339894|P7|STARTED|Overall Study||6
5015143|NCT02219256|12339895|P6|STARTED|Overall Study||6
5015144|NCT02219256|12339896|P5|STARTED|Overall Study||6
5015145|NCT02219256|12339897|P4|STARTED|Overall Study||4
5015146|NCT02219256|12339898|P3|STARTED|Overall Study||4
5015147|NCT02219256|12339899|P2|STARTED|Overall Study||4
5015148|NCT02219256|12339900|P1|STARTED|Overall Study||12
5015149|NCT02219087|12340012|P2|NOT COMPLETED|Overall Study||1
5015150|NCT02219087|12340013|P1|NOT COMPLETED|Overall Study||0
5015151|NCT02219087|12340012|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
5015152|NCT02219087|12340013|P1|COMPLETED|Overall Study||30
5015153|NCT02219087|12340012|P2|STARTED|Overall Study||30
5015154|NCT02219087|12340013|P1|STARTED|Overall Study||30
5015155|NCT02219048|12340033|P2|NOT COMPLETED|Overall Study||21
5015156|NCT02219048|12340034|P1|NOT COMPLETED|Overall Study||21
5015157|NCT02219048|12340033|P2|COMPLETED|Overall Study||4
5015158|NCT02219048|12340034|P1|COMPLETED|Overall Study||5
5015159|NCT02219048|12340033|P2|STARTED|Overall Study||25
5015160|NCT02219048|12340034|P1|STARTED|Overall Study||26
5015161|NCT02219009|12340060|P2|NOT COMPLETED|Overall Study||8
5015162|NCT02219009|12340061|P1|NOT COMPLETED|Overall Study||10
5015163|NCT02219009|12340060|P2|COMPLETED|Overall Study||22
5015164|NCT02219009|12340061|P1|COMPLETED|Overall Study||27
5015165|NCT02219009|12340060|P2|STARTED|Overall Study||30
5015166|NCT02219009|12340061|P1|STARTED|Overall Study||37
5015167|NCT02218736|12340073|P2|NOT COMPLETED|Overall Study||9
5015168|NCT02218736|12340074|P1|NOT COMPLETED|Overall Study||12
5015169|NCT02218736|12340073|P2|COMPLETED|Overall Study||35
5015170|NCT02218736|12340074|P1|COMPLETED|Overall Study||33
5015171|NCT02218736|12340073|P2|STARTED|Overall Study||44
5015172|NCT02218736|12340074|P1|STARTED|Overall Study||45
5015173|NCT02218697|12340086|P2|NOT COMPLETED|Overall Study||6
5015174|NCT02218697|12340087|P1|NOT COMPLETED|Overall Study||2
5015175|NCT02218697|12340086|P2|COMPLETED|Overall Study||171
5015176|NCT02218697|12340087|P1|COMPLETED|Overall Study||177
5015177|NCT02218697|12340086|P2|STARTED|Overall Study||177
5015178|NCT02218697|12340087|P1|STARTED|Overall Study||179
5015179|NCT02218541|12340127|P2|NOT COMPLETED|Overall Study||2
5015180|NCT02218541|12340128|P1|NOT COMPLETED|Overall Study||6
5015181|NCT02218541|12340127|P2|COMPLETED|Overall Study||9
5015182|NCT02218541|12340128|P1|COMPLETED|Overall Study||5
5015183|NCT02218541|12340127|P2|STARTED|Overall Study||11
5015184|NCT02218541|12340128|P1|STARTED|Overall Study||11
5015185|NCT02218463|12340140|P2|NOT COMPLETED|Overall Study||3
5015186|NCT02218463|12340141|P1|NOT COMPLETED|Overall Study||3
5015187|NCT02218463|12340140|P2|COMPLETED|Overall Study||19
5015188|NCT02218463|12340141|P1|COMPLETED|Overall Study||18
5015189|NCT02218463|12340140|P2|STARTED|Overall Study||22
5015190|NCT02218463|12340141|P1|STARTED|Overall Study||21
5015191|NCT02218424|12340151|P2|NOT COMPLETED|Overall Study||0
5015192|NCT02218424|12340152|P1|NOT COMPLETED|Overall Study||0
5015193|NCT02218424|12340151|P2|COMPLETED|Overall Study||30
5015194|NCT02218424|12340152|P1|COMPLETED|Overall Study||30
5015195|NCT02218424|12340151|P2|STARTED|Overall Study||30
5015196|NCT02218424|12340152|P1|STARTED|Overall Study||30
5015197|NCT02218372|12340174|P2|NOT COMPLETED|Overall Study||6
5015198|NCT02218372|12340175|P1|NOT COMPLETED|Overall Study||5
5015199|NCT02218372|12340174|P2|COMPLETED|Overall Study||42
5015200|NCT02218372|12340175|P1|COMPLETED|Overall Study||95
5015201|NCT02218372|12340174|P2|Treated|Overall Study||44
5015202|NCT02218372|12340175|P1|Treated|Overall Study||98
5015203|NCT02218372|12340174|P2|STARTED|Overall Study||48
5015204|NCT02218372|12340175|P1|STARTED|Overall Study||100
5015205|NCT02218320|12340233|P2|NOT COMPLETED|Overall Study||0
5015206|NCT02218320|12340234|P1|NOT COMPLETED|Overall Study||0
5015207|NCT02218320|12340233|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
5015296|NCT02218008|12340326|P3|NOT COMPLETED|Stage 1 (S1)||15
5015208|NCT02218320|12340234|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
5015209|NCT02218320|12340233|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
5015210|NCT02218320|12340234|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
5015211|NCT02218307|12340246|P2|NOT COMPLETED|Overall Study||1
5015212|NCT02218307|12340247|P1|NOT COMPLETED|Overall Study||9
5015213|NCT02218307|12340246|P2|COMPLETED|Overall Study||33
5015214|NCT02218307|12340247|P1|COMPLETED|Overall Study||25
5015215|NCT02218307|12340246|P2|STARTED|Overall Study||34
5015216|NCT02218307|12340247|P1|STARTED|Overall Study||34
5015217|NCT02218268|12340255|P2|NOT COMPLETED|Final Phase (2 Hours)||0
5015218|NCT02218268|12340256|P1|NOT COMPLETED|Final Phase (2 Hours)||0
5015219|NCT02218268|12340255|P2|COMPLETED|Final Phase (2 Hours)||21
5015220|NCT02218268|12340256|P1|COMPLETED|Final Phase (2 Hours)||19
5015221|NCT02218268|12340255|P2|STARTED|Final Phase (2 Hours)||21
5015222|NCT02218268|12340256|P1|STARTED|Final Phase (2 Hours)||19
5015223|NCT02218268|12340255|P2|NOT COMPLETED|24 Hour Washout||9
5015224|NCT02218268|12340256|P1|NOT COMPLETED|24 Hour Washout||11
5015225|NCT02218268|12340255|P2|COMPLETED|24 Hour Washout||21
5015226|NCT02218268|12340256|P1|COMPLETED|24 Hour Washout||19
5015227|NCT02218268|12340255|P2|STARTED|24 Hour Washout||30
5015228|NCT02218268|12340256|P1|STARTED|24 Hour Washout||30
5015229|NCT02218268|12340255|P2|NOT COMPLETED|First Phase (2 Hours)||0
5015230|NCT02218268|12340256|P1|NOT COMPLETED|First Phase (2 Hours)||0
5015231|NCT02218268|12340255|P2|COMPLETED|First Phase (2 Hours)||30
5015232|NCT02218268|12340256|P1|COMPLETED|First Phase (2 Hours)||30
5015233|NCT02218268|12340255|P2|STARTED|First Phase (2 Hours)||30
5015234|NCT02218268|12340256|P1|STARTED|First Phase (2 Hours)||30
5015235|NCT02218242|12340262|P1|NOT COMPLETED|Overall Study||0
5015236|NCT02218242|12340262|P1|COMPLETED|Overall Study||9
5015237|NCT02218242|12340262|P1|STARTED|Overall Study||9
5015238|NCT02218216|12340268|P3|NOT COMPLETED|Overall Study||0
5015239|NCT02218216|12340269|P2|NOT COMPLETED|Overall Study||0
5015240|NCT02218216|12340270|P1|NOT COMPLETED|Overall Study||6
5015241|NCT02218216|12340268|P3|COMPLETED|Overall Study||3
5015242|NCT02218216|12340269|P2|COMPLETED|Overall Study||2
5015243|NCT02218216|12340270|P1|COMPLETED|Overall Study||8
5015244|NCT02218216|12340268|P3|STARTED|Overall Study||3
5015245|NCT02218216|12340269|P2|STARTED|Overall Study||2
5015246|NCT02218216|12340270|P1|STARTED|Overall Study||14
5015247|NCT02218203|12340278|P1|NOT COMPLETED|Overall Study||0
5015248|NCT02218203|12340278|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
5015249|NCT02218203|12340278|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
5015250|NCT02218203|12340278|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
5015251|NCT02218203|12340278|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
5015252|NCT02218203|12340278|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
5015253|NCT02218203|12340278|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
5015254|NCT02218203|12340278|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
5015255|NCT02218203|12340278|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
5015256|NCT02218203|12340278|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
5015257|NCT02218203|12340278|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
5015258|NCT02218203|12340278|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
5015259|NCT02218203|12340278|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
5015260|NCT02218203|12340278|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
5015261|NCT02218203|12340278|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
5015262|NCT02218203|12340278|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
5015263|NCT02218203|12340278|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
5015264|NCT02218203|12340278|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
5015265|NCT02218203|12340278|P1|STARTED|Overall Study||26
5015266|NCT02218190|12340302|P2|NOT COMPLETED|Overall Study||0
5015267|NCT02218190|12340303|P1|NOT COMPLETED|Overall Study||0
5015268|NCT02218190|12340302|P2|COMPLETED|Overall Study||13
5015269|NCT02218190|12340303|P1|COMPLETED|Overall Study||13
5015270|NCT02218190|12340302|P2|STARTED|Overall Study||13
5015271|NCT02218190|12340303|P1|STARTED|Overall Study||13
5015272|NCT02218164|12340313|P1|NOT COMPLETED|Overall Study||0
5015273|NCT02218164|12340313|P1|COMPLETED|Overall Study||8
5015274|NCT02218164|12340313|P1|STARTED|Overall Study||8
5015275|NCT02218008|12340323|P6|NOT COMPLETED|Stage 2 (S2)||6
5015276|NCT02218008|12340324|P5|NOT COMPLETED|Stage 2 (S2)||4
5015277|NCT02218008|12340325|P4|NOT COMPLETED|Stage 2 (S2)||4
5015278|NCT02218008|12340326|P3|NOT COMPLETED|Stage 2 (S2)||0
5015279|NCT02218008|12340327|P2|NOT COMPLETED|Stage 2 (S2)||0
5015280|NCT02218008|12340328|P1|NOT COMPLETED|Stage 2 (S2)||0
5015281|NCT02218008|12340323|P6|COMPLETED|Stage 2 (S2)||57
5015282|NCT02218008|12340324|P5|COMPLETED|Stage 2 (S2)||58
5015283|NCT02218008|12340325|P4|COMPLETED|Stage 2 (S2)||58
5015284|NCT02218008|12340326|P3|COMPLETED|Stage 2 (S2)||0
5015285|NCT02218008|12340327|P2|COMPLETED|Stage 2 (S2)||0
5015286|NCT02218008|12340328|P1|COMPLETED|Stage 2 (S2)||0
5015287|NCT02218008|12340323|P6|STARTED|Stage 2 (S2)||63
5015288|NCT02218008|12340324|P5|STARTED|Stage 2 (S2)||62
5015289|NCT02218008|12340325|P4|STARTED|Stage 2 (S2)||62
5015290|NCT02218008|12340326|P3|STARTED|Stage 2 (S2)||0
5015291|NCT02218008|12340327|P2|STARTED|Stage 2 (S2)||0
5015292|NCT02218008|12340328|P1|STARTED|Stage 2 (S2)||0
5015293|NCT02218008|12340323|P6|NOT COMPLETED|Stage 1 (S1)||0
5015294|NCT02218008|12340324|P5|NOT COMPLETED|Stage 1 (S1)||0
5015295|NCT02218008|12340325|P4|NOT COMPLETED|Stage 1 (S1)||0
5015297|NCT02218008|12340327|P2|NOT COMPLETED|Stage 1 (S1)||7
5015298|NCT02218008|12340328|P1|NOT COMPLETED|Stage 1 (S1)||22
5015299|NCT02218008|12340323|P6|COMPLETED|Stage 1 (S1)||0
5015300|NCT02218008|12340324|P5|COMPLETED|Stage 1 (S1)||0
5015301|NCT02218008|12340325|P4|COMPLETED|Stage 1 (S1)||0
5015302|NCT02218008|12340326|P3|COMPLETED|Stage 1 (S1)||48
5015303|NCT02218008|12340327|P2|COMPLETED|Stage 1 (S1)||56
5015304|NCT02218008|12340328|P1|COMPLETED|Stage 1 (S1)||258
5015305|NCT02218008|12340323|P6|STARTED|Stage 1 (S1)||0
5015306|NCT02218008|12340324|P5|STARTED|Stage 1 (S1)||0
5015307|NCT02218008|12340325|P4|STARTED|Stage 1 (S1)||0
5015308|NCT02218008|12340326|P3|STARTED|Stage 1 (S1)||63
5015309|NCT02218008|12340327|P2|STARTED|Stage 1 (S1)||63
5015310|NCT02218008|12340328|P1|STARTED|Stage 1 (S1)||280
5015311|NCT02217982|12340374|P2|NOT COMPLETED|Overall Study||1
5015312|NCT02217982|12340375|P1|NOT COMPLETED|Overall Study||1
5015313|NCT02217982|12340374|P2|COMPLETED|Overall Study||3
5015314|NCT02217982|12340375|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
5015315|NCT02217982|12340374|P2|STARTED|Overall Study||4
5015316|NCT02217982|12340375|P1|STARTED|Overall Study||1
5015317|NCT02217904|12340388|P7|NOT COMPLETED|Overall Study||0
5015318|NCT02217904|12340389|P6|NOT COMPLETED|Overall Study||0
5015319|NCT02217904|12340390|P5|NOT COMPLETED|Overall Study||0
5015320|NCT02217904|12340391|P4|NOT COMPLETED|Overall Study||0
5015321|NCT02217904|12340392|P3|NOT COMPLETED|Overall Study||0
5015322|NCT02217904|12340393|P2|NOT COMPLETED|Overall Study||0
5015323|NCT02217904|12340394|P1|NOT COMPLETED|Overall Study||0
5015324|NCT02217904|12340388|P7|COMPLETED|Overall Study||0
5015325|NCT02217904|12340389|P6|COMPLETED|Overall Study||0
5015326|NCT02217904|12340390|P5|COMPLETED|Overall Study||6
5015327|NCT02217904|12340391|P4|COMPLETED|Overall Study||6
5015328|NCT02217904|12340392|P3|COMPLETED|Overall Study||6
5015329|NCT02217904|12340393|P2|COMPLETED|Overall Study||6
5015330|NCT02217904|12340394|P1|COMPLETED|Overall Study||6
5015331|NCT02217904|12340388|P7|STARTED|Overall Study||0
5015332|NCT02217904|12340389|P6|STARTED|Overall Study||0
5015333|NCT02217904|12340390|P5|STARTED|Overall Study||6
5015334|NCT02217904|12340391|P4|STARTED|Overall Study||6
5015335|NCT02217904|12340392|P3|STARTED|Overall Study||6
5015336|NCT02217904|12340393|P2|STARTED|Overall Study||6
5015337|NCT02217904|12340394|P1|STARTED|Overall Study||6
5015338|NCT02217878|12340458|P2|NOT COMPLETED|Overall Study||2
5015339|NCT02217878|12340459|P1|NOT COMPLETED|Overall Study||2
5015340|NCT02217878|12340458|P2|COMPLETED|Overall Study||35
5015341|NCT02217878|12340459|P1|COMPLETED|Overall Study||35
5015342|NCT02217878|12340458|P2|STARTED|Overall Study||37
5015343|NCT02217878|12340459|P1|STARTED|Overall Study||37
5015344|NCT02217800|12340539|P1|NOT COMPLETED|Overall Study||0
5015345|NCT02217800|12340539|P1|COMPLETED|Overall Study||8
5015346|NCT02217800|12340539|P1|STARTED|Overall Study||8
5015347|NCT02217618|12340551|P1|NOT COMPLETED|Overall Study||0
5015348|NCT02217618|12340551|P1|COMPLETED|Overall Study||16
5015349|NCT02217618|12340551|P1|Received Study Drug|Overall Study||16
5015350|NCT02217618|12340551|P1|STARTED|Overall Study||16
5015351|NCT02217566|12340557|P1|NOT COMPLETED|Overall Study||11
5015352|NCT02217566|12340557|P1|COMPLETED|Overall Study||35
5015353|NCT02217566|12340557|P1|STARTED|Overall Study||46
5015354|NCT02217527|12340568|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
5015355|NCT02217527|12340569|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
5015356|NCT02217527|12340568|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
5015357|NCT02217527|12340569|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
5015358|NCT02217527|12340568|P2|STARTED|Drug Condition 2: Second Study Phase||15
5015359|NCT02217527|12340569|P1|STARTED|Drug Condition 2: Second Study Phase||17
5015360|NCT02217527|12340568|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
5015361|NCT02217527|12340569|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
5015362|NCT02217527|12340568|P2|COMPLETED|Drug Condition 1: First Study Phase||15
5015363|NCT02217527|12340569|P1|COMPLETED|Drug Condition 1: First Study Phase||17
5015364|NCT02217527|12340568|P2|STARTED|Drug Condition 1: First Study Phase||18
5015365|NCT02217527|12340569|P1|STARTED|Drug Condition 1: First Study Phase||18
5015366|NCT02217475|12340582|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
5015367|NCT02217475|12340583|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
5015368|NCT02217475|12340584|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
5015369|NCT02217475|12340582|P3|COMPLETED|Treatment Period 2 (Year 2)||109
5015370|NCT02217475|12340583|P2|COMPLETED|Treatment Period 2 (Year 2)||59
5015371|NCT02217475|12340584|P1|COMPLETED|Treatment Period 2 (Year 2)||58
5015372|NCT02217475|12340582|P3|STARTED|Treatment Period 2 (Year 2)||121
5015373|NCT02217475|12340583|P2|STARTED|Treatment Period 2 (Year 2)||61
5015374|NCT02217475|12340584|P1|STARTED|Treatment Period 2 (Year 2)||60
5015375|NCT02217475|12340582|P3|NOT COMPLETED|Discontinued After Period 1||3
5015376|NCT02217475|12340583|P2|NOT COMPLETED|Discontinued After Period 1||3
5015377|NCT02217475|12340584|P1|NOT COMPLETED|Discontinued After Period 1||2
5015378|NCT02217475|12340582|P3|COMPLETED|Discontinued After Period 1||121
5015379|NCT02217475|12340583|P2|COMPLETED|Discontinued After Period 1||61
5015380|NCT02217475|12340584|P1|COMPLETED|Discontinued After Period 1||60
5015381|NCT02217475|12340582|P3|STARTED|Discontinued After Period 1||124
5015382|NCT02217475|12340583|P2|STARTED|Discontinued After Period 1||64
5015383|NCT02217475|12340584|P1|STARTED|Discontinued After Period 1||62
5015384|NCT02217475|12340582|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
5015385|NCT02217475|12340583|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
5015386|NCT02217475|12340584|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
5015387|NCT02217475|12340582|P3|COMPLETED|Treatment Period 1 (Year 1)||124
5015388|NCT02217475|12340583|P2|COMPLETED|Treatment Period 1 (Year 1)||64
5015389|NCT02217475|12340584|P1|COMPLETED|Treatment Period 1 (Year 1)||62
5015390|NCT02217475|12340582|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
5015391|NCT02217475|12340583|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
5015392|NCT02217475|12340584|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
5015393|NCT02217475|12340582|P3|STARTED|Treatment Period 1 (Year 1)||145
5015394|NCT02217475|12340583|P2|STARTED|Treatment Period 1 (Year 1)||72
5015395|NCT02217475|12340584|P1|STARTED|Treatment Period 1 (Year 1)||72
5015396|NCT02217436|12340701|P2|NOT COMPLETED|Overall Study||2
5015397|NCT02217436|12340702|P1|NOT COMPLETED|Overall Study||1
5015398|NCT02217436|12340701|P2|COMPLETED|Overall Study||38
5015399|NCT02217436|12340702|P1|COMPLETED|Overall Study||39
5015400|NCT02217436|12340701|P2|STARTED|Overall Study||40
5015401|NCT02217436|12340702|P1|STARTED|Overall Study||40
5015402|NCT02217410|12340713|P3|NOT COMPLETED|Overall Study||5
5015403|NCT02217410|12340714|P2|NOT COMPLETED|Overall Study||4
5015404|NCT02217410|12340715|P1|NOT COMPLETED|Overall Study||1
5015405|NCT02217410|12340713|P3|COMPLETED|Overall Study||13
5015406|NCT02217410|12340714|P2|COMPLETED|Overall Study||30
5015407|NCT02217410|12340715|P1|COMPLETED|Overall Study||6
5015408|NCT02217410|12340713|P3|STARTED|Overall Study||18
5015409|NCT02217410|12340714|P2|STARTED|Overall Study||34
5015410|NCT02217410|12340715|P1|STARTED|Overall Study||7
5015411|NCT02217280|12340738|P1|NOT COMPLETED|Overall Study||4
5015412|NCT02217280|12340738|P1|COMPLETED|Overall Study||16
5015413|NCT02217280|12340738|P1|STARTED|Overall Study||20
5015414|NCT02216812|12340745|P2|NOT COMPLETED|Overall Study||5
5015415|NCT02216812|12340746|P1|NOT COMPLETED|Overall Study||10
5015416|NCT02216812|12340745|P2|COMPLETED|Overall Study||62
5015417|NCT02216812|12340746|P1|COMPLETED|Overall Study||57
5015418|NCT02216812|12340745|P2|STARTED|Overall Study||67
5015419|NCT02216812|12340746|P1|STARTED|Overall Study||67
5015420|NCT02216773|12340762|P2|NOT COMPLETED|Overall Study||5
5015421|NCT02216773|12340763|P1|NOT COMPLETED|Overall Study||12
5015422|NCT02216773|12340762|P2|COMPLETED|Overall Study||24
5015423|NCT02216773|12340763|P1|COMPLETED|Overall Study||16
5015424|NCT02216773|12340762|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
5015425|NCT02216773|12340763|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
5015426|NCT02216773|12340762|P2|STARTED|Overall Study||29
5015427|NCT02216773|12340763|P1|STARTED|Overall Study||28
5015428|NCT02216695|12340773|P1|NOT COMPLETED|Overall Study||0
5015429|NCT02216695|12340773|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
5015430|NCT02216695|12340773|P1|STARTED|Overall Study||64882
5015431|NCT02216591|12340784|P2|NOT COMPLETED|Overall Study||1
5015432|NCT02216591|12340785|P1|NOT COMPLETED|Overall Study||0
5015433|NCT02216591|12340784|P2|COMPLETED|Overall Study||9
5015434|NCT02216591|12340785|P1|COMPLETED|Overall Study||11
5015435|NCT02216591|12340784|P2|STARTED|Overall Study||10
5015436|NCT02216591|12340785|P1|STARTED|Overall Study||11
5015437|NCT02216526|12340798|P3|NOT COMPLETED|Overall Study||8
5015438|NCT02216526|12340799|P2|NOT COMPLETED|Overall Study||3
5015439|NCT02216526|12340800|P1|NOT COMPLETED|Overall Study||5
5015440|NCT02216526|12340798|P3|COMPLETED|Overall Study||36
5015441|NCT02216526|12340799|P2|COMPLETED|Overall Study||41
5015442|NCT02216526|12340800|P1|COMPLETED|Overall Study||40
5015443|NCT02216526|12340798|P3|STARTED|Overall Study||44
5015444|NCT02216526|12340799|P2|STARTED|Overall Study||44
5015445|NCT02216526|12340800|P1|STARTED|Overall Study||45
5015446|NCT02216422|12340910|P1|NOT COMPLETED|Overall Study||0
5015447|NCT02216422|12340910|P1|COMPLETED|Overall Study||36
5015448|NCT02216422|12340910|P1|STARTED|Overall Study||36
5015449|NCT02216357|12340918|P2|NOT COMPLETED|Overall Study||1
5015450|NCT02216357|12340919|P1|NOT COMPLETED|Overall Study||2
5015451|NCT02216357|12340918|P2|COMPLETED|Overall Study||4
5015452|NCT02216357|12340919|P1|COMPLETED|Overall Study||12
5015453|NCT02216357|12340918|P2|STARTED|Overall Study||5
5015454|NCT02216357|12340919|P1|STARTED|Overall Study||14
5015455|NCT02216214|12340945|P2|NOT COMPLETED|Overall Study||36
5015456|NCT02216214|12340946|P1|NOT COMPLETED|Overall Study||43
5015457|NCT02216214|12340945|P2|COMPLETED|Overall Study||409
5015458|NCT02216214|12340946|P1|COMPLETED|Overall Study||400
5015459|NCT02216214|12340945|P2|Treated|Overall Study||445
5015460|NCT02216214|12340946|P1|Treated|Overall Study||442
5015461|NCT02216214|12340945|P2|STARTED|Overall Study||445
5015462|NCT02216214|12340946|P1|STARTED|Overall Study||443
5015463|NCT02216136|12341005|P3|NOT COMPLETED|Overall Study||0
5015464|NCT02216136|12341006|P2|NOT COMPLETED|Overall Study||0
5015465|NCT02216136|12341007|P1|NOT COMPLETED|Overall Study||0
5015466|NCT02216136|12341005|P3|COMPLETED|Overall Study||0
5015467|NCT02216136|12341006|P2|COMPLETED|Overall Study||90
5015468|NCT02216136|12341007|P1|COMPLETED|Overall Study||72
5015469|NCT02216136|12341005|P3|STARTED|Overall Study||0
5015470|NCT02216136|12341006|P2|STARTED|Overall Study||90
5015471|NCT02216136|12341007|P1|STARTED|Overall Study||72
5015472|NCT02216123|12341017|P2|NOT COMPLETED|Overall Study||2
5015473|NCT02216123|12341018|P1|NOT COMPLETED|Overall Study||6
5015474|NCT02216123|12341017|P2|COMPLETED|Overall Study||83
5015475|NCT02216123|12341018|P1|COMPLETED|Overall Study||160
5015476|NCT02216123|12341017|P2|STARTED|Overall Study||85
5015477|NCT02216123|12341018|P1|STARTED|Overall Study||166
5015478|NCT02216097|12341084|P2|NOT COMPLETED|Overall Study||0
5015479|NCT02216097|12341085|P1|NOT COMPLETED|Overall Study||0
5015480|NCT02216097|12341084|P2|COMPLETED|Overall Study||6
5015481|NCT02216097|12341085|P1|COMPLETED|Overall Study||8
5015482|NCT02216097|12341084|P2|STARTED|Overall Study||6
5015483|NCT02216097|12341085|P1|STARTED|Overall Study||8
5015484|NCT02215967|12341111|P4|NOT COMPLETED|Overall Study||3
5015485|NCT02215967|12341112|P3|NOT COMPLETED|Overall Study||1
5015486|NCT02215967|12341113|P2|NOT COMPLETED|Overall Study||0
5015487|NCT02215967|12341114|P1|NOT COMPLETED|Overall Study||0
5015488|NCT02215967|12341111|P4|COMPLETED|Overall Study||16
5015489|NCT02215967|12341112|P3|COMPLETED|Overall Study||4
5015490|NCT02215967|12341113|P2|COMPLETED|Overall Study||3
5015491|NCT02215967|12341114|P1|COMPLETED|Overall Study||3
5015492|NCT02215967|12341111|P4|STARTED|Overall Study||19
5015493|NCT02215967|12341112|P3|STARTED|Overall Study||5
5015494|NCT02215967|12341113|P2|STARTED|Overall Study||3
5015495|NCT02215967|12341114|P1|STARTED|Overall Study||3
5015496|NCT02215954|12341135|P3|NOT COMPLETED|Overall Study||6
5015497|NCT02215954|12341136|P2|NOT COMPLETED|Overall Study||1
5015498|NCT02215954|12341137|P1|NOT COMPLETED|Overall Study||1
5015499|NCT02215954|12341135|P3|COMPLETED|Overall Study||205
5015500|NCT02215954|12341136|P2|COMPLETED|Overall Study||211
5015501|NCT02215954|12341137|P1|COMPLETED|Overall Study||213
5015502|NCT02215954|12341135|P3|Safety Analysis Set|Overall Study||208
5015503|NCT02215954|12341136|P2|Safety Analysis Set|Overall Study||211
5015504|NCT02215954|12341137|P1|Safety Analysis Set|Overall Study||213
5015505|NCT02215954|12341135|P3|Per Protocol (PP) Analysis Set|Overall Study||205
5015506|NCT02215954|12341136|P2|Per Protocol (PP) Analysis Set|Overall Study||208
5015507|NCT02215954|12341137|P1|Per Protocol (PP) Analysis Set|Overall Study||212
5015508|NCT02215954|12341135|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
5015509|NCT02215954|12341136|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
5015510|NCT02215954|12341137|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
5015511|NCT02215954|12341135|P3|STARTED|Overall Study||211
5015512|NCT02215954|12341136|P2|STARTED|Overall Study||212
5015513|NCT02215954|12341137|P1|STARTED|Overall Study||214
5015514|NCT02215616|12341161|P4|NOT COMPLETED|Overall Study||13
5015515|NCT02215616|12341162|P3|NOT COMPLETED|Overall Study||14
5015516|NCT02215616|12341163|P2|NOT COMPLETED|Overall Study||17
5015517|NCT02215616|12341164|P1|NOT COMPLETED|Overall Study||11
5015518|NCT02215616|12341161|P4|COMPLETED|Overall Study||17
5015519|NCT02215616|12341162|P3|COMPLETED|Overall Study||93
5015520|NCT02215616|12341163|P2|COMPLETED|Overall Study||90
5015521|NCT02215616|12341164|P1|COMPLETED|Overall Study||97
5015522|NCT02215616|12341161|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
5015523|NCT02215616|12341162|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
5015524|NCT02215616|12341163|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
5015525|NCT02215616|12341164|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
5015526|NCT02215616|12341161|P4|STARTED|Overall Study||30
5015527|NCT02215616|12341162|P3|STARTED|Overall Study||107
5015528|NCT02215616|12341163|P2|STARTED|Overall Study||107
5015529|NCT02215616|12341164|P1|STARTED|Overall Study||108
5015530|NCT02215369|12341178|P1|NOT COMPLETED|Overall Study||42
5015531|NCT02215369|12341178|P1|COMPLETED|Overall Study||70
5015532|NCT02215369|12341178|P1|STARTED|Overall Study||112
5015533|NCT02215252|12341186|P3|NOT COMPLETED|Overall Study||4
5015534|NCT02215252|12341187|P2|NOT COMPLETED|Overall Study||8
5015535|NCT02215252|12341188|P1|NOT COMPLETED|Overall Study||2
5015536|NCT02215252|12341186|P3|COMPLETED|Overall Study||41
5015537|NCT02215252|12341187|P2|COMPLETED|Overall Study||38
5015538|NCT02215252|12341188|P1|COMPLETED|Overall Study||42
5015539|NCT02215252|12341186|P3|STARTED|Overall Study||45
5015540|NCT02215252|12341187|P2|STARTED|Overall Study||46
5015541|NCT02215252|12341188|P1|STARTED|Overall Study||44
5015542|NCT02215200|12341248|P3|NOT COMPLETED|Overall Study||1
5015543|NCT02215200|12341249|P2|NOT COMPLETED|Overall Study||1
5015544|NCT02215200|12341250|P1|NOT COMPLETED|Overall Study||0
5015545|NCT02215200|12341248|P3|COMPLETED|Overall Study||30
5015546|NCT02215200|12341249|P2|COMPLETED|Overall Study||28
5015547|NCT02215200|12341250|P1|COMPLETED|Overall Study||29
5015548|NCT02215200|12341248|P3|STARTED|Overall Study||31
5015549|NCT02215200|12341249|P2|STARTED|Overall Study||29
5015550|NCT02215200|12341250|P1|STARTED|Overall Study||29
5015551|NCT02215161|12341258|P1|NOT COMPLETED|Overall Study||0
5015552|NCT02215161|12341258|P1|COMPLETED|Overall Study||14
5015553|NCT02215161|12341258|P1|STARTED|Overall Study||14
5015554|NCT02215070|12341276|P1|NOT COMPLETED|Overall Study||6
5015555|NCT02215070|12341276|P1|COMPLETED|Overall Study||20
5015556|NCT02215070|12341276|P1|STARTED|Overall Study||26
5015557|NCT02214628|12341284|P2|NOT COMPLETED|Overall Study||29
5015558|NCT02214628|12341285|P1|NOT COMPLETED|Overall Study||27
5015559|NCT02214628|12341284|P2|COMPLETED|Overall Study||9
5015560|NCT02214628|12341285|P1|COMPLETED|Overall Study||36
5015561|NCT02214628|12341284|P2|STARTED|Overall Study||38
5015562|NCT02214628|12341285|P1|STARTED|Overall Study||63
5015563|NCT02214615|12341295|P2|NOT COMPLETED|Second Intervention||0
5015564|NCT02214615|12341296|P1|NOT COMPLETED|Second Intervention||0
5015565|NCT02214615|12341295|P2|COMPLETED|Second Intervention||1
5015566|NCT02214615|12341296|P1|COMPLETED|Second Intervention||1
5015567|NCT02214615|12341295|P2|STARTED|Second Intervention||1
5015568|NCT02214615|12341296|P1|STARTED|Second Intervention||1
5015569|NCT02214615|12341295|P2|NOT COMPLETED|Washout||0
5015570|NCT02214615|12341296|P1|NOT COMPLETED|Washout||0
5015571|NCT02214615|12341295|P2|COMPLETED|Washout||1
5015572|NCT02214615|12341296|P1|COMPLETED|Washout||1
5015573|NCT02214615|12341295|P2|STARTED|Washout||1
5015574|NCT02214615|12341296|P1|STARTED|Washout||1
5015575|NCT02214615|12341295|P2|NOT COMPLETED|First Intervention||0
5015576|NCT02214615|12341296|P1|NOT COMPLETED|First Intervention||0
5015577|NCT02214615|12341295|P2|COMPLETED|First Intervention||1
5015578|NCT02214615|12341296|P1|COMPLETED|First Intervention||1
5015579|NCT02214615|12341295|P2|STARTED|First Intervention||1
5015580|NCT02214615|12341296|P1|STARTED|First Intervention||1
5015581|NCT02214420|12341306|P2|NOT COMPLETED|Overall Study||0
5015582|NCT02214420|12341307|P1|NOT COMPLETED|Overall Study||1
5015583|NCT02214420|12341306|P2|COMPLETED|Overall Study||10
5015584|NCT02214420|12341307|P1|COMPLETED|Overall Study||13
5015585|NCT02214420|12341306|P2|STARTED|Overall Study||10
5015586|NCT02214420|12341307|P1|STARTED|Overall Study||14
5015587|NCT02214277|12341316|P3|NOT COMPLETED|Overall Study||34
5015588|NCT02214277|12341317|P2|NOT COMPLETED|Overall Study||25
5015589|NCT02214277|12341318|P1|NOT COMPLETED|Overall Study||19
5015590|NCT02214277|12341316|P3|COMPLETED|Overall Study||85
5015591|NCT02214277|12341317|P2|COMPLETED|Overall Study||96
5015592|NCT02214277|12341318|P1|COMPLETED|Overall Study||104
5015593|NCT02214277|12341316|P3|STARTED|Overall Study||119
5015594|NCT02214277|12341317|P2|STARTED|Overall Study||121
5015595|NCT02214277|12341318|P1|STARTED|Overall Study||123
5015596|NCT02214238|12341328|P2|NOT COMPLETED|Overall Study||6
5015597|NCT02214238|12341329|P1|NOT COMPLETED|Overall Study||6
5015598|NCT02214238|12341328|P2|COMPLETED|Overall Study||17
5015599|NCT02214238|12341329|P1|COMPLETED|Overall Study||20
5015600|NCT02214238|12341328|P2|STARTED|Overall Study||23
5015601|NCT02214238|12341329|P1|STARTED|Overall Study||26
5015602|NCT02214225|12341342|P3|NOT COMPLETED|Overall Study||22
5015603|NCT02214225|12341343|P2|NOT COMPLETED|Overall Study||19
5015604|NCT02214225|12341344|P1|NOT COMPLETED|Overall Study||55
5015605|NCT02214225|12341342|P3|COMPLETED|Overall Study||850
5015606|NCT02214225|12341343|P2|COMPLETED|Overall Study||852
5015607|NCT02214225|12341344|P1|COMPLETED|Overall Study||1686
5015608|NCT02214225|12341342|P3|STARTED|Overall Study||872
5015609|NCT02214225|12341343|P2|STARTED|Overall Study||871
5015610|NCT02214225|12341344|P1|STARTED|Overall Study||1741
5015611|NCT02214186|12341403|P2|NOT COMPLETED|Overall Study||2
5015612|NCT02214186|12341404|P1|NOT COMPLETED|Overall Study||2
5015613|NCT02214186|12341403|P2|COMPLETED|Overall Study||21
5015614|NCT02214186|12341404|P1|COMPLETED|Overall Study||21
5015615|NCT02214186|12341403|P2|STARTED|Overall Study||23
5015616|NCT02214186|12341404|P1|STARTED|Overall Study||23
5015617|NCT02214147|12341429|P3|NOT COMPLETED|Overall Study||0
5015618|NCT02214147|12341430|P2|NOT COMPLETED|Overall Study||0
5015619|NCT02214147|12341431|P1|NOT COMPLETED|Overall Study||0
5015620|NCT02214147|12341429|P3|COMPLETED|Overall Study||8
5015621|NCT02214147|12341430|P2|COMPLETED|Overall Study||12
5015622|NCT02214147|12341431|P1|COMPLETED|Overall Study||16
5015623|NCT02214147|12341429|P3|STARTED|Overall Study||8
5015624|NCT02214147|12341430|P2|STARTED|Overall Study||12
5015625|NCT02214147|12341431|P1|STARTED|Overall Study||16
5015626|NCT02214121|12341472|P3|NOT COMPLETED|Part B||1
5015627|NCT02214121|12341473|P2|NOT COMPLETED|Part B||3
5015628|NCT02214121|12341474|P1|NOT COMPLETED|Part B||0
5015629|NCT02214121|12341472|P3|COMPLETED|Part B||7
5015630|NCT02214121|12341473|P2|COMPLETED|Part B||14
5015631|NCT02214121|12341474|P1|COMPLETED|Part B||0
5015632|NCT02214121|12341472|P3|STARTED|Part B||8
5015633|NCT02214121|12341473|P2|STARTED|Part B||17
5015634|NCT02214121|12341474|P1|STARTED|Part B||0
5015635|NCT02214121|12341472|P3|NOT COMPLETED|Part A||0
5015636|NCT02214121|12341473|P2|NOT COMPLETED|Part A||0
5015637|NCT02214121|12341474|P1|NOT COMPLETED|Part A||7
5015638|NCT02214121|12341472|P3|COMPLETED|Part A||0
5015639|NCT02214121|12341473|P2|COMPLETED|Part A||0
5015640|NCT02214121|12341474|P1|COMPLETED|Part A||39
5015641|NCT02214121|12341472|P3|STARTED|Part A||0
5015642|NCT02214121|12341473|P2|STARTED|Part A||0
5015643|NCT02214121|12341474|P1|STARTED|Part A||46
5015644|NCT02214017|12341553|P2|NOT COMPLETED|Overall Study||0
5015645|NCT02214017|12341554|P1|NOT COMPLETED|Overall Study||0
5015646|NCT02214017|12341553|P2|COMPLETED|Overall Study||18
5015647|NCT02214017|12341554|P1|COMPLETED|Overall Study||22
5015648|NCT02214017|12341553|P2|STARTED|Overall Study||18
5015649|NCT02214017|12341554|P1|STARTED|Overall Study||22
5015650|NCT02213926|12341564|P1|NOT COMPLETED|Overall Study||70
5015651|NCT02213926|12341564|P1|COMPLETED|Overall Study||54
5015652|NCT02213926|12341564|P1|STARTED|Overall Study||124
5015653|NCT02213900|12341570|P2|NOT COMPLETED|Overall Study||0
5015654|NCT02213900|12341571|P1|NOT COMPLETED|Overall Study||0
5015655|NCT02213900|12341570|P2|COMPLETED|Overall Study||67
5015656|NCT02213900|12341571|P1|COMPLETED|Overall Study||68
5015657|NCT02213900|12341570|P2|STARTED|Overall Study||67
5015658|NCT02213900|12341571|P1|STARTED|Overall Study||68
5015659|NCT02213666|12341583|P1|NOT COMPLETED|Overall Study||1
5015660|NCT02213666|12341583|P1|COMPLETED|Overall Study||71
5015661|NCT02213666|12341583|P1|STARTED|Overall Study||72
5015662|NCT02213510|12341589|P2|NOT COMPLETED|Overall Study||1
5015663|NCT02213510|12341590|P1|NOT COMPLETED|Overall Study||1
5015664|NCT02213510|12341589|P2|COMPLETED|Overall Study||18
5015665|NCT02213510|12341590|P1|COMPLETED|Overall Study||20
5015666|NCT02213510|12341589|P2|STARTED|Overall Study||19
5015667|NCT02213510|12341590|P1|STARTED|Overall Study||21
5015668|NCT02213263|12341618|P2|NOT COMPLETED|Overall Study||26
5015669|NCT02213263|12341619|P1|NOT COMPLETED|Overall Study||28
5015670|NCT02213263|12341618|P2|COMPLETED|Overall Study||170
5015671|NCT02213263|12341619|P1|COMPLETED|Overall Study||170
5015672|NCT02213263|12341618|P2|Treated|Overall Study||196
5015673|NCT02213263|12341619|P1|Treated|Overall Study||197
5015674|NCT02213263|12341618|P2|STARTED|Overall Study||196
5015675|NCT02213263|12341619|P1|STARTED|Overall Study||198
5015676|NCT02213250|12341655|P2|NOT COMPLETED|Overall Study||0
5015677|NCT02213250|12341656|P1|NOT COMPLETED|Overall Study||0
5015678|NCT02213250|12341655|P2|COMPLETED|Overall Study||8
5015679|NCT02213250|12341656|P1|COMPLETED|Overall Study||4
5015680|NCT02213250|12341655|P2|STARTED|Overall Study||8
5015681|NCT02213250|12341656|P1|STARTED|Overall Study||4
5015682|NCT02213198|12341687|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
5015683|NCT02213198|12341688|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
5015684|NCT02213198|12341687|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
5015685|NCT02213198|12341688|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
5015686|NCT02213198|12341687|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
5015687|NCT02213198|12341688|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
5015688|NCT02213198|12341687|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
5015689|NCT02213198|12341688|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
5015690|NCT02213198|12341687|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
5015691|NCT02213198|12341688|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
5015692|NCT02213198|12341687|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
5015693|NCT02213198|12341688|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
5015694|NCT02213198|12341687|P2|NOT COMPLETED|Baseline||51
5015695|NCT02213198|12341688|P1|NOT COMPLETED|Baseline||88
5015696|NCT02213198|12341687|P2|COMPLETED|Baseline||108
5015697|NCT02213198|12341688|P1|COMPLETED|Baseline||218
5015698|NCT02213198|12341687|P2|STARTED|Baseline||159
5015699|NCT02213198|12341688|P1|STARTED|Baseline||306
5015700|NCT02213094|12341698|P2|NOT COMPLETED|Overall Study||0
5015701|NCT02213094|12341699|P1|NOT COMPLETED|Overall Study||1
5015702|NCT02213094|12341698|P2|COMPLETED|Overall Study||5
5015703|NCT02213094|12341699|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
5015704|NCT02213094|12341698|P2|STARTED|Overall Study||5
5015705|NCT02213094|12341699|P1|STARTED|Overall Study||5
5015706|NCT02213055|12341707|P2|NOT COMPLETED|Overall Study||0
5015707|NCT02213055|12341708|P1|NOT COMPLETED|Overall Study||39
5015708|NCT02213055|12341707|P2|COMPLETED|Overall Study||0
5015709|NCT02213055|12341708|P1|COMPLETED|Overall Study||58
5015710|NCT02213055|12341707|P2|STARTED|Overall Study||0
5015711|NCT02213055|12341708|P1|STARTED|Overall Study||97
5015712|NCT02212977|12341716|P2|NOT COMPLETED|Overall Study||6
5015713|NCT02212977|12341717|P1|NOT COMPLETED|Overall Study||5
5015714|NCT02212977|12341716|P2|COMPLETED|Overall Study||48
5015715|NCT02212977|12341717|P1|COMPLETED|Overall Study||50
5015716|NCT02212977|12341716|P2|STARTED|Overall Study||54
5015717|NCT02212977|12341717|P1|STARTED|Overall Study||55
5015718|NCT02212834|12341733|P2|NOT COMPLETED|Overall Study||0
5015719|NCT02212834|12341734|P1|NOT COMPLETED|Overall Study||0
5015720|NCT02212834|12341733|P2|COMPLETED|Overall Study||2506
5015721|NCT02212834|12341734|P1|COMPLETED|Overall Study||33938
5015722|NCT02212834|12341733|P2|STARTED|Overall Study||2506
5015723|NCT02212834|12341734|P1|STARTED|Overall Study||33938
5015724|NCT02212730|12341742|P2|NOT COMPLETED|Overall Study||1
5015725|NCT02212730|12341743|P1|NOT COMPLETED|Overall Study||2
5015726|NCT02212730|12341742|P2|COMPLETED|Overall Study||3
5015727|NCT02212730|12341743|P1|COMPLETED|Overall Study||4
5015728|NCT02212730|12341742|P2|Received Post-RCC Pembrolizumab|Overall Study||1
5015729|NCT02212730|12341743|P1|Received Post-RCC Pembrolizumab|Overall Study||1
5015730|NCT02212730|12341742|P2|Underwent RCC|Overall Study||3
5015731|NCT02212730|12341743|P1|Underwent RCC|Overall Study||4
5015732|NCT02212730|12341742|P2|Received Neoadjuvant Pembrolizumab|Overall Study||0
5015733|NCT02212730|12341743|P1|Received Neoadjuvant Pembrolizumab|Overall Study||4
5015734|NCT02212730|12341742|P2|STARTED|Overall Study||4
5015735|NCT02212730|12341743|P1|STARTED|Overall Study||6
5015736|NCT02212678|12341765|P1|NOT COMPLETED|Overall Study||1
5015737|NCT02212678|12341765|P1|COMPLETED|Overall Study||7
5015738|NCT02212678|12341765|P1|STARTED|Overall Study||8
5015739|NCT02212457|12341775|P6|NOT COMPLETED|Overall Study||13
5015740|NCT02212457|12341776|P5|NOT COMPLETED|Overall Study||15
5015741|NCT02212457|12341777|P4|NOT COMPLETED|Overall Study||11
5015742|NCT02212457|12341778|P3|NOT COMPLETED|Overall Study||16
5015743|NCT02212457|12341779|P2|NOT COMPLETED|Overall Study||21
5015744|NCT02212457|12341780|P1|NOT COMPLETED|Overall Study||19
5015745|NCT02212457|12341775|P6|COMPLETED|Overall Study||147
5015746|NCT02212457|12341776|P5|COMPLETED|Overall Study||137
5015747|NCT02212457|12341777|P4|COMPLETED|Overall Study||123
5015748|NCT02212457|12341778|P3|COMPLETED|Overall Study||141
5015749|NCT02212457|12341779|P2|COMPLETED|Overall Study||211
5015750|NCT02212457|12341780|P1|COMPLETED|Overall Study||209
5015751|NCT02212457|12341775|P6|STARTED|Overall Study||160
5015752|NCT02212457|12341776|P5|STARTED|Overall Study||152
5015753|NCT02212457|12341777|P4|STARTED|Overall Study||134
5015754|NCT02212457|12341778|P3|STARTED|Overall Study||157
5015755|NCT02212457|12341779|P2|STARTED|Overall Study||232
5015756|NCT02212457|12341780|P1|STARTED|Overall Study||228
5015757|NCT02212301|12341904|P2|NOT COMPLETED|Period 2||0
5015758|NCT02212301|12341905|P1|NOT COMPLETED|Period 2||0
5015759|NCT02212301|12341904|P2|COMPLETED|Period 2||21
5015760|NCT02212301|12341905|P1|COMPLETED|Period 2||21
5015761|NCT02212301|12341904|P2|STARTED|Period 2||21
5015762|NCT02212301|12341905|P1|STARTED|Period 2||21
5015763|NCT02212301|12341904|P2|NOT COMPLETED|Period 1||1
5015764|NCT02212301|12341905|P1|NOT COMPLETED|Period 1||0
5015765|NCT02212301|12341904|P2|COMPLETED|Period 1||21
5015766|NCT02212301|12341905|P1|COMPLETED|Period 1||21
5015767|NCT02212301|12341904|P2|STARTED|Period 1||22
5015768|NCT02212301|12341905|P1|STARTED|Period 1||21
5015769|NCT02212197|12341916|P3|NOT COMPLETED|Overall Study||0
5015770|NCT02212197|12341917|P2|NOT COMPLETED|Overall Study||0
5015771|NCT02212197|12341918|P1|NOT COMPLETED|Overall Study||1
5015772|NCT02212197|12341916|P3|COMPLETED|Overall Study||17
5015773|NCT02212197|12341917|P2|COMPLETED|Overall Study||15
5015774|NCT02212197|12341918|P1|COMPLETED|Overall Study||18
5015775|NCT02212197|12341916|P3|STARTED|Overall Study||17
5015776|NCT02212197|12341917|P2|STARTED|Overall Study||15
5015777|NCT02212197|12341918|P1|STARTED|Overall Study||19
5015778|NCT02212106|12341943|P2|NOT COMPLETED|Overall Study||4
5015779|NCT02212106|12341944|P1|NOT COMPLETED|Overall Study||10
5015780|NCT02212106|12341943|P2|COMPLETED|Overall Study||96
5015781|NCT02212106|12341944|P1|COMPLETED|Overall Study||292
5015782|NCT02212106|12341943|P2|STARTED|Overall Study||100
5015783|NCT02212106|12341944|P1|STARTED|Overall Study||302
5015784|NCT02212028|12341962|P2|NOT COMPLETED|Overall Study||0
5015785|NCT02212028|12341963|P1|NOT COMPLETED|Overall Study||0
5015786|NCT02212028|12341962|P2|COMPLETED|Overall Study||26
5015787|NCT02212028|12341963|P1|COMPLETED|Overall Study||26
5015788|NCT02212028|12341962|P2|STARTED|Overall Study||26
5015789|NCT02212028|12341963|P1|STARTED|Overall Study||26
5015790|NCT02211638|12341971|P1|NOT COMPLETED|Overall Study||983
5015791|NCT02211638|12341971|P1|COMPLETED|Overall Study||17130
5015792|NCT02211638|12341971|P1|STARTED|Overall Study||18113
5015793|NCT02211534|12341982|P2|NOT COMPLETED|Overall Study||5
5015794|NCT02211534|12341983|P1|NOT COMPLETED|Overall Study||13
5015795|NCT02211534|12341982|P2|COMPLETED|Overall Study||6
5015796|NCT02211534|12341983|P1|COMPLETED|Overall Study||11
5015797|NCT02211534|12341982|P2|STARTED|Overall Study||11
5015798|NCT02211534|12341983|P1|STARTED|Overall Study||24
5015799|NCT02211313|12342005|P2|NOT COMPLETED|Overall Study||3
5015800|NCT02211313|12342006|P1|NOT COMPLETED|Overall Study||6
5015801|NCT02211313|12342005|P2|COMPLETED|Overall Study||20
5015802|NCT02211313|12342006|P1|COMPLETED|Overall Study||12
5015803|NCT02211313|12342005|P2|STARTED|Overall Study||23
5015804|NCT02211313|12342006|P1|STARTED|Overall Study||18
5015805|NCT02211261|12342023|P11|NOT COMPLETED|Overall Study||0
5015806|NCT02211261|12342024|P10|NOT COMPLETED|Overall Study||2
5015807|NCT02211261|12342025|P9|NOT COMPLETED|Overall Study||0
5015808|NCT02211261|12342026|P8|NOT COMPLETED|Overall Study||1
5015809|NCT02211261|12342027|P7|NOT COMPLETED|Overall Study||0
5015810|NCT02211261|12342028|P6|NOT COMPLETED|Overall Study||1
5015811|NCT02211261|12342029|P5|NOT COMPLETED|Overall Study||2
5015812|NCT02211261|12342030|P4|NOT COMPLETED|Overall Study||0
5015813|NCT02211261|12342031|P3|NOT COMPLETED|Overall Study||1
5015814|NCT02211261|12342032|P2|NOT COMPLETED|Overall Study||0
5015815|NCT02211261|12342033|P1|NOT COMPLETED|Overall Study||0
5015816|NCT02211261|12342023|P11|COMPLETED|Overall Study||8
5015817|NCT02211261|12342024|P10|COMPLETED|Overall Study||14
5015818|NCT02211261|12342025|P9|COMPLETED|Overall Study||8
5015819|NCT02211261|12342026|P8|COMPLETED|Overall Study||7
5015820|NCT02211261|12342027|P7|COMPLETED|Overall Study||6
5015821|NCT02211261|12342028|P6|COMPLETED|Overall Study||1
5015822|NCT02211261|12342029|P5|COMPLETED|Overall Study||7
5015823|NCT02211261|12342030|P4|COMPLETED|Overall Study||6
5015824|NCT02211261|12342031|P3|COMPLETED|Overall Study||5
5015825|NCT02211261|12342032|P2|COMPLETED|Overall Study||6
5015826|NCT02211261|12342033|P1|COMPLETED|Overall Study||9
5015827|NCT02211261|12342023|P11|STARTED|Overall Study||8
5015828|NCT02211261|12342024|P10|STARTED|Overall Study||16
5015829|NCT02211261|12342025|P9|STARTED|Overall Study||8
5015830|NCT02211261|12342026|P8|STARTED|Overall Study||8
5015831|NCT02211261|12342027|P7|STARTED|Overall Study||6
5015832|NCT02211261|12342028|P6|STARTED|Overall Study||2
5015833|NCT02211261|12342029|P5|STARTED|Overall Study||9
5015834|NCT02211261|12342030|P4|STARTED|Overall Study||6
5015835|NCT02211261|12342031|P3|STARTED|Overall Study||6
5015836|NCT02211261|12342032|P2|STARTED|Overall Study||6
5015837|NCT02211261|12342033|P1|STARTED|Overall Study||9
5015838|NCT02211131|12342156|P2|NOT COMPLETED|Overall Study||76
5015839|NCT02211131|12342157|P1|NOT COMPLETED|Overall Study||74
5015840|NCT02211131|12342156|P2|COMPLETED|Overall Study||0
5015841|NCT02211131|12342157|P1|COMPLETED|Overall Study||0
5015842|NCT02211131|12342156|P2|STARTED|Overall Study||76
5015843|NCT02211131|12342157|P1|STARTED|Overall Study||74
5015844|NCT02211014|12342191|P2|NOT COMPLETED|Overall Study||6
5015845|NCT02211014|12342192|P1|NOT COMPLETED|Overall Study||2
5015846|NCT02211014|12342191|P2|COMPLETED|Overall Study||8
5015847|NCT02211014|12342192|P1|COMPLETED|Overall Study||11
5015848|NCT02211014|12342191|P2|STARTED|Overall Study||14
5015849|NCT02211014|12342192|P1|STARTED|Overall Study||13
5015850|NCT02210780|12342218|P2|NOT COMPLETED|Overall Study||8
5015851|NCT02210780|12342219|P1|NOT COMPLETED|Overall Study||5
5015852|NCT02210780|12342218|P2|COMPLETED|Overall Study||89
5015853|NCT02210780|12342219|P1|COMPLETED|Overall Study||92
5015854|NCT02210780|12342218|P2|STARTED|Overall Study||97
5015855|NCT02210780|12342219|P1|STARTED|Overall Study||97
5015856|NCT02210689|12342248|P3|NOT COMPLETED|Overall Study||23
5015857|NCT02210689|12342249|P2|NOT COMPLETED|Overall Study||47
5015858|NCT02210689|12342250|P1|NOT COMPLETED|Overall Study||52
5015859|NCT02210689|12342248|P3|COMPLETED|Overall Study||99
5015860|NCT02210689|12342249|P2|COMPLETED|Overall Study||193
5015861|NCT02210689|12342250|P1|COMPLETED|Overall Study||190
5015862|NCT02210689|12342248|P3|PP Population|Overall Study||84
5015863|NCT02210689|12342249|P2|PP Population|Overall Study||169
5015864|NCT02210689|12342250|P1|PP Population|Overall Study||164
5015865|NCT02210689|12342248|P3|mITT Population|Overall Study||107
5015866|NCT02210689|12342249|P2|mITT Population|Overall Study||207
5015867|NCT02210689|12342250|P1|mITT Population|Overall Study||199
5015868|NCT02210689|12342248|P3|Safety Population|Overall Study||122
5015869|NCT02210689|12342249|P2|Safety Population|Overall Study||236
5015870|NCT02210689|12342250|P1|Safety Population|Overall Study||233
5015871|NCT02210689|12342248|P3|STARTED|Overall Study||122
5015872|NCT02210689|12342249|P2|STARTED|Overall Study||240
5015873|NCT02210689|12342250|P1|STARTED|Overall Study||242
5015874|NCT02210208|12342258|P1|NOT COMPLETED|Period B (Donor Site)||7
5015875|NCT02210208|12342258|P1|COMPLETED|Period B (Donor Site)||12
5015876|NCT02210208|12342258|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
5015877|NCT02210208|12342258|P1|NOT COMPLETED|Period A (Graft Site)||2
5015878|NCT02210208|12342258|P1|COMPLETED|Period A (Graft Site)||23
5015879|NCT02210208|12342258|P1|STARTED|Period A (Graft Site)||25
5015880|NCT02210195|12342267|P2|NOT COMPLETED|Overall Study||0
5015881|NCT02210195|12342268|P1|NOT COMPLETED|Overall Study||4
5015882|NCT02210195|12342267|P2|COMPLETED|Overall Study||10
5015883|NCT02210195|12342268|P1|COMPLETED|Overall Study||6
5015884|NCT02210195|12342267|P2|STARTED|Overall Study||10
5015885|NCT02210195|12342268|P1|STARTED|Overall Study||10
5015886|NCT02210091|12342278|P2|NOT COMPLETED|Overall Study||2
5015887|NCT02210091|12342279|P1|NOT COMPLETED|Overall Study||0
5015888|NCT02210091|12342278|P2|COMPLETED|Overall Study||32
5015889|NCT02210091|12342279|P1|COMPLETED|Overall Study||32
5015890|NCT02210091|12342278|P2|STARTED|Overall Study||34
5015891|NCT02210091|12342279|P1|STARTED|Overall Study||32
5015892|NCT02210065|12342351|P1|NOT COMPLETED|Overall Study||0
5015893|NCT02210065|12342351|P1|COMPLETED|Overall Study||1
5015894|NCT02210065|12342351|P1|STARTED|Overall Study||1
5015895|NCT02210052|12342356|P1|NOT COMPLETED|Overall Study||0
5015896|NCT02210052|12342356|P1|COMPLETED|Overall Study||6
5015897|NCT02210052|12342356|P1|STARTED|Overall Study||6
5015898|NCT02210039|12342360|P1|NOT COMPLETED|Overall Study||0
5015899|NCT02210039|12342360|P1|COMPLETED|Overall Study||6
5015900|NCT02210039|12342360|P1|STARTED|Overall Study||6
5015901|NCT02210000|12342366|P2|NOT COMPLETED|Overall Study||21
5015902|NCT02210000|12342367|P1|NOT COMPLETED|Overall Study||19
5015903|NCT02210000|12342366|P2|COMPLETED|Overall Study||36
5015904|NCT02210000|12342367|P1|COMPLETED|Overall Study||38
5015905|NCT02210000|12342366|P2|STARTED|Overall Study||57
5015906|NCT02210000|12342367|P1|STARTED|Overall Study||57
5015907|NCT02209766|12342393|P5|NOT COMPLETED|Overall Study||0
5015908|NCT02209766|12342394|P4|NOT COMPLETED|Overall Study||1
5015909|NCT02209766|12342395|P3|NOT COMPLETED|Overall Study||0
5015910|NCT02209766|12342396|P2|NOT COMPLETED|Overall Study||0
5015911|NCT02209766|12342397|P1|NOT COMPLETED|Overall Study||0
5015912|NCT02209766|12342393|P5|COMPLETED|Overall Study||6
5015913|NCT02209766|12342394|P4|COMPLETED|Overall Study||2
5015914|NCT02209766|12342395|P3|COMPLETED|Overall Study||6
5015915|NCT02209766|12342396|P2|COMPLETED|Overall Study||3
5015916|NCT02209766|12342397|P1|COMPLETED|Overall Study||6
5015917|NCT02209766|12342393|P5|STARTED|Overall Study||6
5015918|NCT02209766|12342394|P4|STARTED|Overall Study||3
5015919|NCT02209766|12342395|P3|STARTED|Overall Study||6
5015920|NCT02209766|12342396|P2|STARTED|Overall Study||3
5015921|NCT02209766|12342397|P1|STARTED|Overall Study||6
5015922|NCT02209610|12342445|P2|NOT COMPLETED|Overall Study||0
5015923|NCT02209610|12342446|P1|NOT COMPLETED|Overall Study||0
5015924|NCT02209610|12342445|P2|COMPLETED|Overall Study||16
5015925|NCT02209610|12342446|P1|COMPLETED|Overall Study||16
5015926|NCT02209610|12342445|P2|STARTED|Overall Study||16
5015927|NCT02209610|12342446|P1|STARTED|Overall Study||16
5015928|NCT02209597|12342456|P1|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
5015929|NCT02209597|12342456|P1|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
5015930|NCT02209597|12342456|P1|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
5015931|NCT02209597|12342456|P1|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
5015932|NCT02209597|12342456|P1|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
5015933|NCT02209597|12342456|P1|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
5015934|NCT02209597|12342456|P1|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
5015935|NCT02209597|12342456|P1|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
5015936|NCT02209597|12342456|P1|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
5015937|NCT02209597|12342456|P1|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
5015938|NCT02209597|12342456|P1|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
5015939|NCT02209597|12342456|P1|STARTED|Phase 1 Current Tx (Non-randomized)||74
5015940|NCT02209532|12342468|P2|NOT COMPLETED|Overall Study||1
5015941|NCT02209532|12342469|P1|NOT COMPLETED|Overall Study||3
5015942|NCT02209532|12342468|P2|COMPLETED|Overall Study||89
5015943|NCT02209532|12342469|P1|COMPLETED|Overall Study||87
5015944|NCT02209532|12342468|P2|STARTED|Overall Study||90
5015945|NCT02209532|12342469|P1|STARTED|Overall Study||90
5015946|NCT02209519|12342487|P2|NOT COMPLETED|Overall Study||0
5015947|NCT02209519|12342488|P1|NOT COMPLETED|Overall Study||0
5015948|NCT02209519|12342487|P2|COMPLETED|Overall Study||107
5015949|NCT02209519|12342488|P1|COMPLETED|Overall Study||107
5015950|NCT02209519|12342487|P2|STARTED|Overall Study||107
5015951|NCT02209519|12342488|P1|STARTED|Overall Study||107
5015952|NCT02209506|12342501|P5|NOT COMPLETED|Overall Study||1
5015953|NCT02209506|12342502|P4|NOT COMPLETED|Overall Study||0
5015954|NCT02209506|12342503|P3|NOT COMPLETED|Overall Study||0
5015955|NCT02209506|12342504|P2|NOT COMPLETED|Overall Study||0
5015956|NCT02209506|12342505|P1|NOT COMPLETED|Overall Study||0
5015957|NCT02209506|12342501|P5|COMPLETED|Overall Study||5
5015958|NCT02209506|12342502|P4|COMPLETED|Overall Study||2
5015959|NCT02209506|12342503|P3|COMPLETED|Overall Study||6
5015960|NCT02209506|12342504|P2|COMPLETED|Overall Study||6
5015961|NCT02209506|12342505|P1|COMPLETED|Overall Study||3
5015962|NCT02209506|12342501|P5|STARTED|Overall Study||6
5015963|NCT02209506|12342502|P4|STARTED|Overall Study||2
5015964|NCT02209506|12342503|P3|STARTED|Overall Study||6
5015965|NCT02209506|12342504|P2|STARTED|Overall Study||6
5015966|NCT02209506|12342505|P1|STARTED|Overall Study||3
5015967|NCT02209454|12342580|P2|NOT COMPLETED|Second Period||0
5015968|NCT02209454|12342581|P1|NOT COMPLETED|Second Period||1
5015969|NCT02209454|12342580|P2|COMPLETED|Second Period||13
5015970|NCT02209454|12342581|P1|COMPLETED|Second Period||12
5015971|NCT02209454|12342580|P2|STARTED|Second Period||13
5015972|NCT02209454|12342581|P1|STARTED|Second Period||13
5015973|NCT02209454|12342580|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
5015974|NCT02209454|12342581|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
5015975|NCT02209454|12342580|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
5015976|NCT02209454|12342581|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
5015977|NCT02209454|12342580|P2|STARTED|Washout Period a Minimum of a 7 Day||13
5015978|NCT02209454|12342581|P1|STARTED|Washout Period a Minimum of a 7 Day||13
5015979|NCT02209454|12342580|P2|NOT COMPLETED|First Period||0
5015980|NCT02209454|12342581|P1|NOT COMPLETED|First Period||0
5015981|NCT02209454|12342580|P2|COMPLETED|First Period||13
5015982|NCT02209454|12342581|P1|COMPLETED|First Period||13
5015983|NCT02209454|12342580|P2|STARTED|First Period||13
5015984|NCT02209454|12342581|P1|STARTED|First Period||13
5015985|NCT02209272|12342597|P2|NOT COMPLETED|Overall Study||0
5015986|NCT02209272|12342598|P1|NOT COMPLETED|Overall Study||0
5015987|NCT02209272|12342597|P2|COMPLETED|Overall Study||36
5015988|NCT02209272|12342598|P1|COMPLETED|Overall Study||32
5015989|NCT02209272|12342597|P2|STARTED|Overall Study||36
5015990|NCT02209272|12342598|P1|STARTED|Overall Study||32
5015991|NCT02209259|12342611|P3|NOT COMPLETED|Overall Study||0
5015992|NCT02209259|12342612|P2|NOT COMPLETED|Overall Study||0
5015993|NCT02209259|12342613|P1|NOT COMPLETED|Overall Study||0
5015994|NCT02209259|12342611|P3|COMPLETED|Overall Study||56
5015995|NCT02209259|12342612|P2|COMPLETED|Overall Study||56
5015996|NCT02209259|12342613|P1|COMPLETED|Overall Study||56
5015997|NCT02209259|12342611|P3|STARTED|Overall Study||56
5015998|NCT02209259|12342612|P2|STARTED|Overall Study||56
5015999|NCT02209259|12342613|P1|STARTED|Overall Study||56
5016000|NCT02209181|12342631|P4|NOT COMPLETED|Overall Study||0
5016001|NCT02209181|12342632|P3|NOT COMPLETED|Overall Study||1
5016002|NCT02209181|12342633|P2|NOT COMPLETED|Overall Study||1
5016003|NCT02209181|12342634|P1|NOT COMPLETED|Overall Study||1
5016004|NCT02209181|12342631|P4|COMPLETED|Overall Study||66
5016005|NCT02209181|12342632|P3|COMPLETED|Overall Study||68
5016006|NCT02209181|12342633|P2|COMPLETED|Overall Study||66
5016007|NCT02209181|12342634|P1|COMPLETED|Overall Study||66
5016008|NCT02209181|12342631|P4|STARTED|Overall Study||66
5016009|NCT02209181|12342632|P3|STARTED|Overall Study||69
5016010|NCT02209181|12342633|P2|STARTED|Overall Study||67
5016011|NCT02209181|12342634|P1|STARTED|Overall Study||67
5016012|NCT02209064|12342796|P1|NOT COMPLETED|Overall Study||0
5016013|NCT02209064|12342796|P1|COMPLETED|Overall Study||25
5016014|NCT02209064|12342796|P1|STARTED|Overall Study||25
5016015|NCT02208999|12342805|P1|NOT COMPLETED|Overall Study||1
5016016|NCT02208999|12342805|P1|COMPLETED|Overall Study||105
5016017|NCT02208999|12342805|P1|STARTED|Overall Study||106
5016018|NCT02208843|12342827|P1|NOT COMPLETED|Overall Study||60
5016019|NCT02208843|12342827|P1|COMPLETED|Overall Study||0
5016020|NCT02208843|12342827|P1|STARTED|Overall Study||60
5016021|NCT02208349|12342835|P2|NOT COMPLETED|Sixth 6 Month||0
5016022|NCT02208349|12342836|P1|NOT COMPLETED|Sixth 6 Month||0
5016023|NCT02208349|12342835|P2|COMPLETED|Sixth 6 Month||2
5016024|NCT02208349|12342836|P1|COMPLETED|Sixth 6 Month||3
5016025|NCT02208349|12342835|P2|STARTED|Sixth 6 Month||2
5016026|NCT02208349|12342836|P1|STARTED|Sixth 6 Month||3
5016027|NCT02208349|12342835|P2|NOT COMPLETED|Fifth 6 Month||0
5016028|NCT02208349|12342836|P1|NOT COMPLETED|Fifth 6 Month||0
5016029|NCT02208349|12342835|P2|COMPLETED|Fifth 6 Month||2
5016030|NCT02208349|12342836|P1|COMPLETED|Fifth 6 Month||7
5016031|NCT02208349|12342835|P2|STARTED|Fifth 6 Month||2
5016032|NCT02208349|12342836|P1|STARTED|Fifth 6 Month||7
5016033|NCT02208349|12342835|P2|NOT COMPLETED|Fourth 6 Month||0
5016034|NCT02208349|12342836|P1|NOT COMPLETED|Fourth 6 Month||0
5016035|NCT02208349|12342835|P2|COMPLETED|Fourth 6 Month||2
5016036|NCT02208349|12342836|P1|COMPLETED|Fourth 6 Month||14
5016037|NCT02208349|12342835|P2|STARTED|Fourth 6 Month||2
5016038|NCT02208349|12342836|P1|STARTED|Fourth 6 Month||14
5016039|NCT02208349|12342835|P2|NOT COMPLETED|Third 6 Month||0
5016040|NCT02208349|12342836|P1|NOT COMPLETED|Third 6 Month||0
5016041|NCT02208349|12342835|P2|COMPLETED|Third 6 Month||3
5016042|NCT02208349|12342836|P1|COMPLETED|Third 6 Month||6
5016043|NCT02208349|12342835|P2|STARTED|Third 6 Month||3
5016044|NCT02208349|12342836|P1|STARTED|Third 6 Month||6
5016045|NCT02208349|12342835|P2|NOT COMPLETED|Second 6 Months||0
5016046|NCT02208349|12342836|P1|NOT COMPLETED|Second 6 Months||0
5016047|NCT02208349|12342835|P2|COMPLETED|Second 6 Months||7
5016048|NCT02208349|12342836|P1|COMPLETED|Second 6 Months||11
5016049|NCT02208349|12342835|P2|STARTED|Second 6 Months||7
5016050|NCT02208349|12342836|P1|STARTED|Second 6 Months||11
5016051|NCT02208349|12342835|P2|NOT COMPLETED|Initial 6 Months||0
5016052|NCT02208349|12342836|P1|NOT COMPLETED|Initial 6 Months||0
5016053|NCT02208349|12342835|P2|COMPLETED|Initial 6 Months||9
5016054|NCT02208349|12342836|P1|COMPLETED|Initial 6 Months||16
5016055|NCT02208349|12342835|P2|STARTED|Initial 6 Months||9
5016056|NCT02208349|12342836|P1|STARTED|Initial 6 Months||16
5016057|NCT02208310|12342846|P2|NOT COMPLETED|Overall Study||5
5016058|NCT02208310|12342847|P1|NOT COMPLETED|Overall Study||6
5016059|NCT02208310|12342846|P2|COMPLETED|Overall Study||0
5016060|NCT02208310|12342847|P1|COMPLETED|Overall Study||0
5016061|NCT02208310|12342846|P2|Day 180|Overall Study||1
5016062|NCT02208310|12342847|P1|Day 180|Overall Study||0
5016063|NCT02208310|12342846|P2|STARTED|Overall Study||5
5016064|NCT02208310|12342847|P1|STARTED|Overall Study||6
5016065|NCT02208089|12342879|P2|NOT COMPLETED|Overall Study||0
5016066|NCT02208089|12342880|P1|NOT COMPLETED|Overall Study||7
5016067|NCT02208089|12342879|P2|COMPLETED|Overall Study||47
5016068|NCT02208089|12342880|P1|COMPLETED|Overall Study||40
5016069|NCT02208089|12342879|P2|STARTED|Overall Study||47
5016070|NCT02208089|12342880|P1|STARTED|Overall Study||47
5016071|NCT02208063|12342896|P2|NOT COMPLETED|Overall Study||11
5016072|NCT02208063|12342897|P1|NOT COMPLETED|Overall Study||12
5016073|NCT02208063|12342896|P2|COMPLETED|Overall Study||50
5016074|NCT02208063|12342897|P1|COMPLETED|Overall Study||48
5016075|NCT02208063|12342896|P2|Microbiological All Treated|Overall Study||52
5016076|NCT02208063|12342897|P1|Microbiological All Treated|Overall Study||47
5016077|NCT02208063|12342896|P2|Randomized and Treated|Overall Study||60
5016078|NCT02208063|12342897|P1|Randomized and Treated|Overall Study||58
5016079|NCT02208063|12342896|P2|STARTED|Overall Study||61
5016080|NCT02208063|12342897|P1|STARTED|Overall Study||60
5016081|NCT02208037|12342912|P3|NOT COMPLETED|Overall Study||1
5016082|NCT02208037|12342913|P2|NOT COMPLETED|Overall Study||1
5016083|NCT02208037|12342914|P1|NOT COMPLETED|Overall Study||4
5016084|NCT02208037|12342912|P3|COMPLETED|Overall Study||92
5016085|NCT02208037|12342913|P2|COMPLETED|Overall Study||92
5016086|NCT02208037|12342914|P1|COMPLETED|Overall Study||89
5016087|NCT02208037|12342912|P3|STARTED|Overall Study||93
5016088|NCT02208037|12342913|P2|STARTED|Overall Study||93
5016089|NCT02208037|12342914|P1|STARTED|Overall Study||93
5016090|NCT02207972|12342963|P2|NOT COMPLETED|Overall Study||0
5016091|NCT02207972|12342964|P1|NOT COMPLETED|Overall Study||0
5016092|NCT02207972|12342963|P2|COMPLETED|Overall Study||24
5016093|NCT02207972|12342964|P1|COMPLETED|Overall Study||22
5016094|NCT02207972|12342963|P2|STARTED|Overall Study||24
5016095|NCT02207972|12342964|P1|STARTED|Overall Study||22
5016096|NCT02207907|12342976|P2|NOT COMPLETED|Overall Study||8
5016097|NCT02207907|12342977|P1|NOT COMPLETED|Overall Study||11
5016098|NCT02207907|12342976|P2|COMPLETED|Overall Study||115
5016099|NCT02207907|12342977|P1|COMPLETED|Overall Study||113
5016100|NCT02207907|12342976|P2|STARTED|Overall Study||123
5016101|NCT02207907|12342977|P1|STARTED|Overall Study||124
5016102|NCT02207829|12342995|P2|NOT COMPLETED|Overall Study||34
5016103|NCT02207829|12342996|P1|NOT COMPLETED|Overall Study||42
5016104|NCT02207829|12342995|P2|COMPLETED|Overall Study||474
5016105|NCT02207829|12342996|P1|COMPLETED|Overall Study||467
5016106|NCT02207829|12342995|P2|STARTED|Overall Study||508
5016107|NCT02207829|12342996|P1|STARTED|Overall Study||509
5016108|NCT02207816|12343005|P3|NOT COMPLETED|Overall Study||67
5016109|NCT02207816|12343006|P2|NOT COMPLETED|Overall Study||86
5016110|NCT02207816|12343007|P1|NOT COMPLETED|Overall Study||51
5016111|NCT02207816|12343005|P3|COMPLETED|Overall Study||961
5016112|NCT02207816|12343006|P2|COMPLETED|Overall Study||924
5016113|NCT02207816|12343007|P1|COMPLETED|Overall Study||995
5016114|NCT02207816|12343005|P3|STARTED|Overall Study||1028
5016115|NCT02207816|12343006|P2|STARTED|Overall Study||1010
5016116|NCT02207816|12343007|P1|STARTED|Overall Study||1046
5016117|NCT02207803|12343152|P2|NOT COMPLETED|Overall Study||17
5016118|NCT02207803|12343153|P1|NOT COMPLETED|Overall Study||15
5016119|NCT02207803|12343152|P2|COMPLETED|Overall Study||108
5016120|NCT02207803|12343153|P1|COMPLETED|Overall Study||110
5016121|NCT02207803|12343152|P2|STARTED|Overall Study||125
5016122|NCT02207803|12343153|P1|STARTED|Overall Study||125
5016123|NCT02207725|12343165|P4|NOT COMPLETED|Overall Study||1
5016124|NCT02207725|12343166|P3|NOT COMPLETED|Overall Study||1
5016125|NCT02207725|12343167|P2|NOT COMPLETED|Overall Study||1
5016126|NCT02207725|12343168|P1|NOT COMPLETED|Overall Study||0
5016127|NCT02207725|12343165|P4|COMPLETED|Overall Study||24
5016128|NCT02207725|12343166|P3|COMPLETED|Overall Study||8
5016129|NCT02207725|12343167|P2|COMPLETED|Overall Study||24
5016130|NCT02207725|12343168|P1|COMPLETED|Overall Study||9
5016131|NCT02207725|12343165|P4|STARTED|Overall Study||25
5016132|NCT02207725|12343166|P3|STARTED|Overall Study||9
5016133|NCT02207725|12343167|P2|STARTED|Overall Study||25
5016134|NCT02207725|12343168|P1|STARTED|Overall Study||9
5016135|NCT02207634|12343198|P2|NOT COMPLETED|Overall Study||31
5016136|NCT02207634|12343199|P1|NOT COMPLETED|Overall Study||22
5016137|NCT02207634|12343198|P2|COMPLETED|Overall Study||953
5016138|NCT02207634|12343199|P1|COMPLETED|Overall Study||968
5016139|NCT02207634|12343198|P2|Received Treatment|Overall Study||983
5016140|NCT02207634|12343199|P1|Received Treatment|Overall Study||990
5016141|NCT02207634|12343198|P2|STARTED|Overall Study||984
5016142|NCT02207634|12343199|P1|STARTED|Overall Study||990
5016143|NCT02207621|12343214|P3|NOT COMPLETED|Overall Study||168
5016144|NCT02207621|12343215|P2|NOT COMPLETED|Overall Study||47
5016145|NCT02207621|12343216|P1|NOT COMPLETED|Overall Study||105
5016146|NCT02207621|12343214|P3|COMPLETED|Overall Study||86
5016147|NCT02207621|12343215|P2|COMPLETED|Overall Study||204
5016148|NCT02207621|12343216|P1|COMPLETED|Overall Study||146
5016149|NCT02207621|12343214|P3|STARTED|Overall Study||254
5016150|NCT02207621|12343215|P2|STARTED|Overall Study||251
5016151|NCT02207621|12343216|P1|STARTED|Overall Study||251
5016152|NCT02207608|12343229|P2|NOT COMPLETED|Overall Study||0
5016153|NCT02207608|12343230|P1|NOT COMPLETED|Overall Study||1
5016154|NCT02207608|12343229|P2|COMPLETED|Overall Study||15
5016155|NCT02207608|12343230|P1|COMPLETED|Overall Study||14
5016156|NCT02207608|12343229|P2|STARTED|Overall Study||15
5016157|NCT02207608|12343230|P1|STARTED|Overall Study||15
5016158|NCT02207569|12343236|P1|NOT COMPLETED|6 Months - 1 Year||9
5016159|NCT02207569|12343236|P1|COMPLETED|6 Months - 1 Year||213
5016160|NCT02207569|12343236|P1|STARTED|6 Months - 1 Year||222
5016161|NCT02207569|12343236|P1|NOT COMPLETED|30 Days to 6 Months||11
5016162|NCT02207569|12343236|P1|COMPLETED|30 Days to 6 Months||222
5016163|NCT02207569|12343236|P1|STARTED|30 Days to 6 Months||233
5016164|NCT02207569|12343236|P1|NOT COMPLETED|Implant to 30 Days||4
5016165|NCT02207569|12343236|P1|COMPLETED|Implant to 30 Days||233
5016166|NCT02207569|12343236|P1|STARTED|Implant to 30 Days||237
5016167|NCT02207569|12343236|P1|NOT COMPLETED|Enrolled to Implant||4
5016168|NCT02207569|12343236|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
5016169|NCT02207569|12343236|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
5016170|NCT02207556|12343256|P2|NOT COMPLETED|Overall Study||5
5016171|NCT02207556|12343257|P1|NOT COMPLETED|Overall Study||2
5016172|NCT02207556|12343256|P2|COMPLETED|Overall Study||20
5016173|NCT02207556|12343257|P1|COMPLETED|Overall Study||5
5016174|NCT02207556|12343256|P2|STARTED|Overall Study||25
5016175|NCT02207556|12343257|P1|STARTED|Overall Study||7
5016176|NCT02207530|12343262|P1|NOT COMPLETED|Overall Study||91
5016177|NCT02207530|12343262|P1|COMPLETED|Overall Study||21
5016178|NCT02207530|12343262|P1|STARTED|Overall Study||112
5016179|NCT02207491|12343276|P2|NOT COMPLETED|Overall Study||13
5016180|NCT02207491|12343277|P1|NOT COMPLETED|Overall Study||31
5016181|NCT02207491|12343276|P2|COMPLETED|Overall Study||196
5016182|NCT02207491|12343277|P1|COMPLETED|Overall Study||171
5016183|NCT02207491|12343276|P2|STARTED|Overall Study||209
5016184|NCT02207491|12343277|P1|STARTED|Overall Study||202
5016185|NCT02207478|12343287|P2|NOT COMPLETED|Overall Study||0
5016186|NCT02207478|12343288|P1|NOT COMPLETED|Overall Study||0
5016187|NCT02207478|12343287|P2|COMPLETED|Overall Study||46
5016188|NCT02207478|12343288|P1|COMPLETED|Overall Study||40
5016189|NCT02207478|12343287|P2|STARTED|Overall Study||46
5016190|NCT02207478|12343288|P1|STARTED|Overall Study||40
5016191|NCT02207413|12343302|P6|NOT COMPLETED|Overall Study||13
5016192|NCT02207413|12343303|P5|NOT COMPLETED|Overall Study||7
5016193|NCT02207413|12343304|P4|NOT COMPLETED|Overall Study||1
5016194|NCT02207413|12343305|P3|NOT COMPLETED|Overall Study||0
5016195|NCT02207413|12343306|P2|NOT COMPLETED|Overall Study||0
5016196|NCT02207413|12343307|P1|NOT COMPLETED|Overall Study||1
5016197|NCT02207413|12343302|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
5016198|NCT02207413|12343303|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
5016199|NCT02207413|12343304|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
5016200|NCT02207413|12343305|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
5016201|NCT02207413|12343306|P2|COMPLETED|Overall Study||60
5016202|NCT02207413|12343307|P1|COMPLETED|Overall Study||59
5016203|NCT02207413|12343302|P6|STARTED|Overall Study||474
5016204|NCT02207413|12343303|P5|STARTED|Overall Study||466
5016205|NCT02207413|12343304|P4|STARTED|Overall Study||411
5016206|NCT02207413|12343305|P3|STARTED|Overall Study||410
5016207|NCT02207413|12343306|P2|STARTED|Overall Study||60
5016208|NCT02207413|12343307|P1|STARTED|Overall Study||60
5016209|NCT02207400|12343403|P2|NOT COMPLETED|Overall Study||14
5016210|NCT02207400|12343404|P1|NOT COMPLETED|Overall Study||16
5016211|NCT02207400|12343403|P2|COMPLETED|Overall Study||109
5016212|NCT02207400|12343404|P1|COMPLETED|Overall Study||107
5016213|NCT02207400|12343403|P2|STARTED|Overall Study||123
5016214|NCT02207400|12343404|P1|STARTED|Overall Study||123
5016215|NCT02207374|12343425|P3|NOT COMPLETED|Overall Study||6
5016216|NCT02207374|12343426|P2|NOT COMPLETED|Overall Study||10
5016217|NCT02207374|12343427|P1|NOT COMPLETED|Overall Study||6
5016218|NCT02207374|12343425|P3|COMPLETED|Overall Study||115
5016219|NCT02207374|12343426|P2|COMPLETED|Overall Study||231
5016220|NCT02207374|12343427|P1|COMPLETED|Overall Study||233
5016221|NCT02207374|12343425|P3|Exposed|Overall Study||120
5016222|NCT02207374|12343426|P2|Exposed|Overall Study||241
5016223|NCT02207374|12343427|P1|Exposed|Overall Study||239
5016224|NCT02207374|12343425|P3|STARTED|Overall Study||121
5016225|NCT02207374|12343426|P2|STARTED|Overall Study||241
5016226|NCT02207374|12343427|P1|STARTED|Overall Study||239
5016227|NCT02207322|12343443|P2|NOT COMPLETED|Overall Study||10
5016228|NCT02207322|12343444|P1|NOT COMPLETED|Overall Study||9
5016229|NCT02207322|12343443|P2|COMPLETED|Overall Study|6-month|71
5016230|NCT02207322|12343444|P1|COMPLETED|Overall Study|6-month|70
5016231|NCT02207322|12343443|P2|3-month|Overall Study||75
5016232|NCT02207322|12343444|P1|3-month|Overall Study||74
5016233|NCT02207322|12343443|P2|Week-2|Overall Study||80
5016234|NCT02207322|12343444|P1|Week-2|Overall Study||77
5016235|NCT02207322|12343443|P2|STARTED|Overall Study||81
5016236|NCT02207322|12343444|P1|STARTED|Overall Study||79
5016237|NCT02207244|12343491|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
5016238|NCT02207244|12343492|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
5016239|NCT02207244|12343493|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
5016240|NCT02207244|12343494|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016241|NCT02207244|12343495|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016242|NCT02207244|12343496|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016243|NCT02207244|12343497|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016244|NCT02207244|12343498|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016245|NCT02207244|12343499|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016246|NCT02207244|12343491|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
5016247|NCT02207244|12343492|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
5016248|NCT02207244|12343493|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
5016249|NCT02207244|12343494|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016250|NCT02207244|12343495|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016251|NCT02207244|12343496|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016252|NCT02207244|12343497|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016253|NCT02207244|12343498|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016254|NCT02207244|12343499|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
5016255|NCT02207244|12343491|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
5016256|NCT02207244|12343492|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
5016257|NCT02207244|12343493|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
5016258|NCT02207244|12343494|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016259|NCT02207244|12343495|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016260|NCT02207244|12343496|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016261|NCT02207244|12343497|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016262|NCT02207244|12343498|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016263|NCT02207244|12343499|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
5016264|NCT02207244|12343491|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016265|NCT02207244|12343492|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
5016266|NCT02207244|12343493|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016267|NCT02207244|12343494|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016268|NCT02207244|12343495|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016269|NCT02207244|12343496|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016270|NCT02207244|12343497|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016271|NCT02207244|12343498|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016272|NCT02207244|12343499|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016273|NCT02207244|12343491|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
5016274|NCT02207244|12343492|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
5016275|NCT02207244|12343493|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
5016276|NCT02207244|12343494|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016277|NCT02207244|12343495|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016278|NCT02207244|12343496|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016279|NCT02207244|12343497|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016280|NCT02207244|12343498|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016281|NCT02207244|12343499|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
5016282|NCT02207244|12343491|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
5016283|NCT02207244|12343492|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
5016284|NCT02207244|12343493|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
5016285|NCT02207244|12343494|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016286|NCT02207244|12343495|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016287|NCT02207244|12343496|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016288|NCT02207244|12343497|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016289|NCT02207244|12343498|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016290|NCT02207244|12343499|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
5016291|NCT02207244|12343491|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
5016292|NCT02207244|12343492|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
5016293|NCT02207244|12343493|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
5016294|NCT02207244|12343494|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016295|NCT02207244|12343495|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016296|NCT02207244|12343496|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016297|NCT02207244|12343497|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016298|NCT02207244|12343498|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016299|NCT02207244|12343499|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
5016300|NCT02207244|12343491|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016301|NCT02207244|12343492|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016302|NCT02207244|12343493|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016303|NCT02207244|12343494|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
5016304|NCT02207244|12343495|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
5016305|NCT02207244|12343496|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
5016306|NCT02207244|12343497|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016307|NCT02207244|12343498|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016308|NCT02207244|12343499|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016309|NCT02207244|12343491|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016310|NCT02207244|12343492|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016311|NCT02207244|12343493|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016312|NCT02207244|12343494|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
5016313|NCT02207244|12343495|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
5016314|NCT02207244|12343496|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
5016315|NCT02207244|12343497|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016316|NCT02207244|12343498|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016317|NCT02207244|12343499|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
5016318|NCT02207244|12343491|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016319|NCT02207244|12343492|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016320|NCT02207244|12343493|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016321|NCT02207244|12343494|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
5016322|NCT02207244|12343495|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
5016323|NCT02207244|12343496|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
5016324|NCT02207244|12343497|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016325|NCT02207244|12343498|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016326|NCT02207244|12343499|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
5016327|NCT02207244|12343491|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016328|NCT02207244|12343492|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016329|NCT02207244|12343493|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016330|NCT02207244|12343494|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016331|NCT02207244|12343495|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016332|NCT02207244|12343496|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016333|NCT02207244|12343497|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
5016334|NCT02207244|12343498|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
5016335|NCT02207244|12343499|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
5016336|NCT02207244|12343491|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016337|NCT02207244|12343492|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016338|NCT02207244|12343493|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016339|NCT02207244|12343494|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016340|NCT02207244|12343495|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016341|NCT02207244|12343496|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
5016342|NCT02207244|12343497|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
5016343|NCT02207244|12343498|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
5016344|NCT02207244|12343499|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
5016345|NCT02207244|12343491|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
5016346|NCT02207244|12343492|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
5016347|NCT02207244|12343493|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
5016348|NCT02207244|12343494|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
5016349|NCT02207244|12343495|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
5016350|NCT02207244|12343496|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
5016351|NCT02207244|12343497|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
5016352|NCT02207244|12343498|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
5016353|NCT02207244|12343499|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
5016354|NCT02207244|12343491|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016355|NCT02207244|12343492|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016356|NCT02207244|12343493|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016357|NCT02207244|12343494|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016358|NCT02207244|12343495|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016359|NCT02207244|12343496|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
5016360|NCT02207244|12343497|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
5016361|NCT02207244|12343498|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
5016362|NCT02207244|12343499|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
5016363|NCT02207231|12343540|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
5016364|NCT02207231|12343541|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
5016365|NCT02207231|12343542|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
5016366|NCT02207231|12343540|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
5016367|NCT02207231|12343541|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
5016368|NCT02207231|12343542|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
5016369|NCT02207231|12343540|P3|STARTED|Active Controlled Period: Week 16 - 48||324
5016370|NCT02207231|12343541|P2|STARTED|Active Controlled Period: Week 16 - 48||322
5016371|NCT02207231|12343542|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
5016372|NCT02207231|12343540|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
5016373|NCT02207231|12343541|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
5016374|NCT02207231|12343542|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
5016375|NCT02207231|12343540|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
5016376|NCT02207231|12343541|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
5016377|NCT02207231|12343542|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
5016378|NCT02207231|12343540|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
5016379|NCT02207231|12343541|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
5016380|NCT02207231|12343542|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
5016381|NCT02207231|12343540|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
5016382|NCT02207231|12343541|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
5016383|NCT02207231|12343542|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
5016384|NCT02207088|12343574|P1|NOT COMPLETED|Overall Study||2
5016385|NCT02207088|12343574|P1|COMPLETED|Overall Study||66
5016386|NCT02207088|12343574|P1|STARTED|Overall Study||68
5016387|NCT02206828|12343580|P1|NOT COMPLETED|Overall Study||7
5016388|NCT02206828|12343580|P1|COMPLETED|Overall Study||93
5016389|NCT02206828|12343580|P1|STARTED|Overall Study||100
5016390|NCT02206776|12343609|P2|NOT COMPLETED|Overall Study||0
5016391|NCT02206776|12343610|P1|NOT COMPLETED|Overall Study||0
5016392|NCT02206776|12343609|P2|COMPLETED|Overall Study||1
5016393|NCT02206776|12343610|P1|COMPLETED|Overall Study||1
5016394|NCT02206776|12343609|P2|STARTED|Overall Study||1
5016395|NCT02206776|12343610|P1|STARTED|Overall Study||1
5016396|NCT02206620|12343616|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
5016397|NCT02206620|12343617|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
5016398|NCT02206620|12343616|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
5016399|NCT02206620|12343617|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
5016400|NCT02206620|12343616|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
5016401|NCT02206620|12343617|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
5016402|NCT02206620|12343616|P2|NOT COMPLETED|Washout (6 Weeks)||0
5016403|NCT02206620|12343617|P1|NOT COMPLETED|Washout (6 Weeks)||0
5016404|NCT02206620|12343616|P2|COMPLETED|Washout (6 Weeks)||26
5016405|NCT02206620|12343617|P1|COMPLETED|Washout (6 Weeks)||21
5016406|NCT02206620|12343616|P2|STARTED|Washout (6 Weeks)||26
5016407|NCT02206620|12343617|P1|STARTED|Washout (6 Weeks)||21
5016408|NCT02206620|12343616|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
5016409|NCT02206620|12343617|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
5016410|NCT02206620|12343616|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
5016411|NCT02206620|12343617|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
5016412|NCT02206620|12343616|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
5016413|NCT02206620|12343617|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
5016414|NCT02206607|12343633|P5|NOT COMPLETED|Fourth Intervention Period||0
5016415|NCT02206607|12343634|P4|NOT COMPLETED|Fourth Intervention Period||0
5016416|NCT02206607|12343635|P3|NOT COMPLETED|Fourth Intervention Period||0
5016417|NCT02206607|12343636|P2|NOT COMPLETED|Fourth Intervention Period||0
5016418|NCT02206607|12343637|P1|NOT COMPLETED|Fourth Intervention Period||0
5016419|NCT02206607|12343633|P5|COMPLETED|Fourth Intervention Period||10
5016420|NCT02206607|12343634|P4|COMPLETED|Fourth Intervention Period||10
5016421|NCT02206607|12343635|P3|COMPLETED|Fourth Intervention Period||9
5016422|NCT02206607|12343636|P2|COMPLETED|Fourth Intervention Period||9
5016423|NCT02206607|12343637|P1|COMPLETED|Fourth Intervention Period||0
5016424|NCT02206607|12343633|P5|STARTED|Fourth Intervention Period||10
5016425|NCT02206607|12343634|P4|STARTED|Fourth Intervention Period||10
5016426|NCT02206607|12343635|P3|STARTED|Fourth Intervention Period||9
5016427|NCT02206607|12343636|P2|STARTED|Fourth Intervention Period||9
5016428|NCT02206607|12343637|P1|STARTED|Fourth Intervention Period||0
5016429|NCT02206607|12343633|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
5016430|NCT02206607|12343634|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
5016431|NCT02206607|12343635|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
5016432|NCT02206607|12343636|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
5016433|NCT02206607|12343637|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
5016434|NCT02206607|12343633|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
5016435|NCT02206607|12343634|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
5016436|NCT02206607|12343635|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
5016437|NCT02206607|12343636|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
5016438|NCT02206607|12343637|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
5016439|NCT02206607|12343633|P5|STARTED|Third Washout Period 5 to 10 Days||10
5016440|NCT02206607|12343634|P4|STARTED|Third Washout Period 5 to 10 Days||10
5016441|NCT02206607|12343635|P3|STARTED|Third Washout Period 5 to 10 Days||9
5016442|NCT02206607|12343636|P2|STARTED|Third Washout Period 5 to 10 Days||9
5016443|NCT02206607|12343637|P1|STARTED|Third Washout Period 5 to 10 Days||0
5016444|NCT02206607|12343633|P5|NOT COMPLETED|Third Intervention Period||0
5016445|NCT02206607|12343634|P4|NOT COMPLETED|Third Intervention Period||0
5016446|NCT02206607|12343635|P3|NOT COMPLETED|Third Intervention Period||0
5016447|NCT02206607|12343636|P2|NOT COMPLETED|Third Intervention Period||0
5016448|NCT02206607|12343637|P1|NOT COMPLETED|Third Intervention Period||0
5016449|NCT02206607|12343633|P5|COMPLETED|Third Intervention Period||10
5016450|NCT02206607|12343634|P4|COMPLETED|Third Intervention Period||10
5016451|NCT02206607|12343635|P3|COMPLETED|Third Intervention Period||9
5016452|NCT02206607|12343636|P2|COMPLETED|Third Intervention Period||9
5016453|NCT02206607|12343637|P1|COMPLETED|Third Intervention Period||0
5016454|NCT02206607|12343633|P5|STARTED|Third Intervention Period||10
5016455|NCT02206607|12343634|P4|STARTED|Third Intervention Period||10
5016456|NCT02206607|12343635|P3|STARTED|Third Intervention Period||9
5016457|NCT02206607|12343636|P2|STARTED|Third Intervention Period||9
5016458|NCT02206607|12343637|P1|STARTED|Third Intervention Period||0
5016459|NCT02206607|12343633|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
5016460|NCT02206607|12343634|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
5016461|NCT02206607|12343635|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
5016462|NCT02206607|12343636|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
5016463|NCT02206607|12343637|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
5016464|NCT02206607|12343633|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
5016465|NCT02206607|12343634|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
5016466|NCT02206607|12343635|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
5016467|NCT02206607|12343636|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
5016468|NCT02206607|12343637|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
5016469|NCT02206607|12343633|P5|STARTED|Second Washout Period 5 to 10 Days||10
5016470|NCT02206607|12343634|P4|STARTED|Second Washout Period 5 to 10 Days||10
5016471|NCT02206607|12343635|P3|STARTED|Second Washout Period 5 to 10 Days||9
5016472|NCT02206607|12343636|P2|STARTED|Second Washout Period 5 to 10 Days||9
5016473|NCT02206607|12343637|P1|STARTED|Second Washout Period 5 to 10 Days||0
5016474|NCT02206607|12343633|P5|NOT COMPLETED|Second Intervention Period||0
5016475|NCT02206607|12343634|P4|NOT COMPLETED|Second Intervention Period||1
5016476|NCT02206607|12343635|P3|NOT COMPLETED|Second Intervention Period||0
5016477|NCT02206607|12343636|P2|NOT COMPLETED|Second Intervention Period||0
5016478|NCT02206607|12343637|P1|NOT COMPLETED|Second Intervention Period||0
5016479|NCT02206607|12343633|P5|COMPLETED|Second Intervention Period||10
5016480|NCT02206607|12343634|P4|COMPLETED|Second Intervention Period||10
5016481|NCT02206607|12343635|P3|COMPLETED|Second Intervention Period||9
5016482|NCT02206607|12343636|P2|COMPLETED|Second Intervention Period||9
5016483|NCT02206607|12343637|P1|COMPLETED|Second Intervention Period||0
5016484|NCT02206607|12343633|P5|STARTED|Second Intervention Period||10
5016485|NCT02206607|12343634|P4|STARTED|Second Intervention Period||11
5016486|NCT02206607|12343635|P3|STARTED|Second Intervention Period||9
5016487|NCT02206607|12343636|P2|STARTED|Second Intervention Period||9
5016488|NCT02206607|12343637|P1|STARTED|Second Intervention Period||0
5016489|NCT02206607|12343633|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
5016490|NCT02206607|12343634|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
5016491|NCT02206607|12343635|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
5016492|NCT02206607|12343636|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
5016493|NCT02206607|12343637|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
5016494|NCT02206607|12343633|P5|COMPLETED|First Washout Period 5 to 10 Days||10
5016495|NCT02206607|12343634|P4|COMPLETED|First Washout Period 5 to 10 Days||11
5016496|NCT02206607|12343635|P3|COMPLETED|First Washout Period 5 to 10 Days||9
5016497|NCT02206607|12343636|P2|COMPLETED|First Washout Period 5 to 10 Days||9
5016498|NCT02206607|12343637|P1|COMPLETED|First Washout Period 5 to 10 Days||0
5016499|NCT02206607|12343633|P5|STARTED|First Washout Period 5 to 10 Days||10
5016500|NCT02206607|12343634|P4|STARTED|First Washout Period 5 to 10 Days||11
5016501|NCT02206607|12343635|P3|STARTED|First Washout Period 5 to 10 Days||9
5016502|NCT02206607|12343636|P2|STARTED|First Washout Period 5 to 10 Days||9
5016503|NCT02206607|12343637|P1|STARTED|First Washout Period 5 to 10 Days||0
5016504|NCT02206607|12343633|P5|NOT COMPLETED|First Intervention Period||0
5016505|NCT02206607|12343634|P4|NOT COMPLETED|First Intervention Period||0
5016506|NCT02206607|12343635|P3|NOT COMPLETED|First Intervention Period||0
5016507|NCT02206607|12343636|P2|NOT COMPLETED|First Intervention Period||0
5016508|NCT02206607|12343637|P1|NOT COMPLETED|First Intervention Period||0
5016509|NCT02206607|12343633|P5|COMPLETED|First Intervention Period||10
5016510|NCT02206607|12343634|P4|COMPLETED|First Intervention Period||11
5016511|NCT02206607|12343635|P3|COMPLETED|First Intervention Period||9
5016512|NCT02206607|12343636|P2|COMPLETED|First Intervention Period||9
5016513|NCT02206607|12343637|P1|COMPLETED|First Intervention Period||0
5016514|NCT02206607|12343633|P5|STARTED|First Intervention Period||10
5016515|NCT02206607|12343634|P4|STARTED|First Intervention Period||11
5016516|NCT02206607|12343635|P3|STARTED|First Intervention Period||9
5016517|NCT02206607|12343636|P2|STARTED|First Intervention Period||9
5016518|NCT02206607|12343637|P1|STARTED|First Intervention Period||0
5016519|NCT02206607|12343633|P5|NOT COMPLETED|Open-Label Run-In||0
5016520|NCT02206607|12343634|P4|NOT COMPLETED|Open-Label Run-In||0
5016521|NCT02206607|12343635|P3|NOT COMPLETED|Open-Label Run-In||0
5016522|NCT02206607|12343636|P2|NOT COMPLETED|Open-Label Run-In||0
5016523|NCT02206607|12343637|P1|NOT COMPLETED|Open-Label Run-In||3
5016524|NCT02206607|12343633|P5|COMPLETED|Open-Label Run-In||0
5016525|NCT02206607|12343634|P4|COMPLETED|Open-Label Run-In||0
5016526|NCT02206607|12343635|P3|COMPLETED|Open-Label Run-In||0
5016527|NCT02206607|12343636|P2|COMPLETED|Open-Label Run-In||0
5016528|NCT02206607|12343637|P1|COMPLETED|Open-Label Run-In||39
5016529|NCT02206607|12343633|P5|STARTED|Open-Label Run-In||0
5016530|NCT02206607|12343634|P4|STARTED|Open-Label Run-In||0
5016531|NCT02206607|12343635|P3|STARTED|Open-Label Run-In||0
5016532|NCT02206607|12343636|P2|STARTED|Open-Label Run-In||0
5016533|NCT02206607|12343637|P1|STARTED|Open-Label Run-In||42
5016534|NCT02206217|12343691|P2|NOT COMPLETED|Overall Study||14
5016535|NCT02206217|12343692|P1|NOT COMPLETED|Overall Study||9
5016536|NCT02206217|12343691|P2|COMPLETED|Overall Study||79
5016537|NCT02206217|12343692|P1|COMPLETED|Overall Study||81
5016538|NCT02206217|12343691|P2|STARTED|Overall Study||93
5016539|NCT02206217|12343692|P1|STARTED|Overall Study||90
5016540|NCT02206152|12343700|P1|NOT COMPLETED|NAC, Then Placebo||0
5016541|NCT02206152|12343700|P1|COMPLETED|NAC, Then Placebo||10
5016542|NCT02206152|12343700|P1|STARTED|NAC, Then Placebo||10
5016543|NCT02206152|12343700|P1|NOT COMPLETED|Placebo, Then NAC||0
5016544|NCT02206152|12343700|P1|COMPLETED|Placebo, Then NAC||10
5016545|NCT02206152|12343700|P1|STARTED|Placebo, Then NAC||10
5016546|NCT02206152|12343700|P1|NOT COMPLETED|Pre-Randomization||2
5016547|NCT02206152|12343700|P1|COMPLETED|Pre-Randomization||20
5016548|NCT02206152|12343700|P1|STARTED|Pre-Randomization||22
5016549|NCT02205983|12343710|P4|NOT COMPLETED|Overall Study||0
5016550|NCT02205983|12343711|P3|NOT COMPLETED|Overall Study||0
5016551|NCT02205983|12343712|P2|NOT COMPLETED|Overall Study||0
5016552|NCT02205983|12343713|P1|NOT COMPLETED|Overall Study||0
5016553|NCT02205983|12343710|P4|COMPLETED|Overall Study||13
5016554|NCT02205983|12343711|P3|COMPLETED|Overall Study||13
5016555|NCT02205983|12343712|P2|COMPLETED|Overall Study||12
5016556|NCT02205983|12343713|P1|COMPLETED|Overall Study||12
5016557|NCT02205983|12343710|P4|STARTED|Overall Study||13
5016558|NCT02205983|12343711|P3|STARTED|Overall Study||13
5016559|NCT02205983|12343712|P2|STARTED|Overall Study||12
5016560|NCT02205983|12343713|P1|STARTED|Overall Study||12
5016561|NCT02205814|12343727|P4|NOT COMPLETED|Overall Study||4
5016562|NCT02205814|12343728|P3|NOT COMPLETED|Overall Study||5
5016563|NCT02205814|12343729|P2|NOT COMPLETED|Overall Study||1
5016564|NCT02205814|12343730|P1|NOT COMPLETED|Overall Study||2
5016565|NCT02205814|12343727|P4|COMPLETED|Overall Study||104
5016566|NCT02205814|12343728|P3|COMPLETED|Overall Study||103
5016567|NCT02205814|12343729|P2|COMPLETED|Overall Study||109
5016568|NCT02205814|12343730|P1|COMPLETED|Overall Study||108
5016569|NCT02205814|12343727|P4|STARTED|Overall Study||108
5016570|NCT02205814|12343728|P3|STARTED|Overall Study||108
5016571|NCT02205814|12343729|P2|STARTED|Overall Study||110
5016572|NCT02205814|12343730|P1|STARTED|Overall Study||110
5016573|NCT02205801|12343756|P4|NOT COMPLETED|Overall Study||0
5016574|NCT02205801|12343757|P3|NOT COMPLETED|Overall Study||0
5016575|NCT02205801|12343758|P2|NOT COMPLETED|Overall Study||0
5016576|NCT02205801|12343759|P1|NOT COMPLETED|Overall Study||0
5016577|NCT02205801|12343756|P4|COMPLETED|Overall Study||8
5016578|NCT02205801|12343757|P3|COMPLETED|Overall Study||9
5016579|NCT02205801|12343758|P2|COMPLETED|Overall Study||8
5016580|NCT02205801|12343759|P1|COMPLETED|Overall Study||11
5016581|NCT02205801|12343756|P4|STARTED|Overall Study||8
5016582|NCT02205801|12343757|P3|STARTED|Overall Study||9
5016583|NCT02205801|12343758|P2|STARTED|Overall Study||8
5016584|NCT02205801|12343759|P1|STARTED|Overall Study||11
5016585|NCT02205476|12343783|P2|NOT COMPLETED|Overall Study||3
5016586|NCT02205476|12343784|P1|NOT COMPLETED|Overall Study||7
5016587|NCT02205476|12343783|P2|COMPLETED|Overall Study||0
5016588|NCT02205476|12343784|P1|COMPLETED|Overall Study||0
5016589|NCT02205476|12343783|P2|STARTED|Overall Study||3
5016590|NCT02205476|12343784|P1|STARTED|Overall Study||7
5016591|NCT02205333|12343823|P9|NOT COMPLETED|Overall Study||0
5016592|NCT02205333|12343824|P8|NOT COMPLETED|Overall Study||2
5016593|NCT02205333|12343825|P7|NOT COMPLETED|Overall Study||5
5016594|NCT02205333|12343826|P6|NOT COMPLETED|Overall Study||3
5016595|NCT02205333|12343827|P5|NOT COMPLETED|Overall Study||5
5016596|NCT02205333|12343828|P4|NOT COMPLETED|Overall Study||7
5016597|NCT02205333|12343829|P3|NOT COMPLETED|Overall Study||2
5016598|NCT02205333|12343830|P2|NOT COMPLETED|Overall Study||6
5016599|NCT02205333|12343831|P1|NOT COMPLETED|Overall Study||6
5016600|NCT02205333|12343823|P9|COMPLETED|Overall Study||1
5016601|NCT02205333|12343824|P8|COMPLETED|Overall Study||1
5016602|NCT02205333|12343825|P7|COMPLETED|Overall Study||2
5016603|NCT02205333|12343826|P6|COMPLETED|Overall Study||4
5016604|NCT02205333|12343827|P5|COMPLETED|Overall Study||1
5016605|NCT02205333|12343828|P4|COMPLETED|Overall Study||0
5016606|NCT02205333|12343829|P3|COMPLETED|Overall Study||1
5016607|NCT02205333|12343830|P2|COMPLETED|Overall Study||0
5016608|NCT02205333|12343831|P1|COMPLETED|Overall Study||2
5016609|NCT02205333|12343823|P9|STARTED|Overall Study||1
5016610|NCT02205333|12343824|P8|STARTED|Overall Study||3
5016611|NCT02205333|12343825|P7|STARTED|Overall Study||7
5016612|NCT02205333|12343826|P6|STARTED|Overall Study||7
5016613|NCT02205333|12343827|P5|STARTED|Overall Study||6
5016614|NCT02205333|12343828|P4|STARTED|Overall Study||7
5016615|NCT02205333|12343829|P3|STARTED|Overall Study||3
5016616|NCT02205333|12343830|P2|STARTED|Overall Study||6
5016617|NCT02205333|12343831|P1|STARTED|Overall Study||8
5016618|NCT02205307|12344006|P2|NOT COMPLETED|Overall Study||6
5016619|NCT02205307|12344007|P1|NOT COMPLETED|Overall Study||17
5016620|NCT02205307|12344006|P2|COMPLETED|Overall Study||163
5016621|NCT02205307|12344007|P1|COMPLETED|Overall Study||161
5016622|NCT02205307|12344006|P2|STARTED|Overall Study||169
5016623|NCT02205307|12344007|P1|STARTED|Overall Study||178
5016624|NCT02205177|12344019|P2|NOT COMPLETED|Overall Study||0
5016625|NCT02205177|12344020|P1|NOT COMPLETED|Overall Study||2
5016626|NCT02205177|12344019|P2|COMPLETED|Overall Study||2
5016627|NCT02205177|12344020|P1|COMPLETED|Overall Study||6
5016628|NCT02205177|12344019|P2|STARTED|Overall Study||2
5016629|NCT02205177|12344020|P1|STARTED|Overall Study||8
5016630|NCT02204982|12344030|P2|NOT COMPLETED|Overall Study||7
5016631|NCT02204982|12344031|P1|NOT COMPLETED|Overall Study||4
5016632|NCT02204982|12344030|P2|COMPLETED|Overall Study||0
5016633|NCT02204982|12344031|P1|COMPLETED|Overall Study||2
5016634|NCT02204982|12344030|P2|STARTED|Overall Study||7
5016635|NCT02204982|12344031|P1|STARTED|Overall Study||6
5016636|NCT02204917|12344039|P1|NOT COMPLETED|Overall Study||1
5016637|NCT02204917|12344039|P1|COMPLETED|Overall Study||30
5016638|NCT02204917|12344039|P1|STARTED|Overall Study||31
5016639|NCT02204761|12344046|P1|NOT COMPLETED|Overall Study||0
5016640|NCT02204761|12344046|P1|COMPLETED|Overall Study||6
5016641|NCT02204761|12344046|P1|STARTED|Overall Study||6
5016642|NCT02204748|12344053|P1|NOT COMPLETED|Overall Study||0
5016643|NCT02204748|12344053|P1|COMPLETED|Overall Study||5
5016644|NCT02204748|12344053|P1|STARTED|Overall Study||5
5016645|NCT02204657|12344067|P2|NOT COMPLETED|Overall Study||0
5016646|NCT02204657|12344068|P1|NOT COMPLETED|Overall Study||7
5016647|NCT02204657|12344067|P2|COMPLETED|Overall Study||25
5016648|NCT02204657|12344068|P1|COMPLETED|Overall Study||25
5016649|NCT02204657|12344067|P2|STARTED|Overall Study||25
5016650|NCT02204657|12344068|P1|STARTED|Overall Study||32
5016651|NCT02204579|12344076|P1|NOT COMPLETED|Overall Study||2
5016652|NCT02204579|12344076|P1|COMPLETED|Overall Study||5
5016653|NCT02204579|12344076|P1|Treated|Overall Study||5
5016654|NCT02204579|12344076|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
5016655|NCT02204579|12344076|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
5016656|NCT02204579|12344076|P1|STARTED|Overall Study||7
5016657|NCT02204566|12344128|P1|NOT COMPLETED|Overall Study||4
5016658|NCT02204566|12344128|P1|COMPLETED|Overall Study||1
5016659|NCT02204566|12344128|P1|STARTED|Overall Study||5
5016660|NCT02204449|12344134|P2|NOT COMPLETED|Overall Study||11
5016661|NCT02204449|12344135|P1|NOT COMPLETED|Overall Study||7
5016662|NCT02204449|12344134|P2|COMPLETED|Overall Study||37
5016663|NCT02204449|12344135|P1|COMPLETED|Overall Study||39
5016664|NCT02204449|12344134|P2|STARTED|Overall Study||48
5016665|NCT02204449|12344135|P1|STARTED|Overall Study||46
5016666|NCT02204410|12344145|P1|NOT COMPLETED|Overall Study||11
5016667|NCT02204410|12344145|P1|COMPLETED|Overall Study||10
5016668|NCT02204410|12344145|P1|STARTED|Overall Study||21
5016669|NCT02204371|12344150|P1|NOT COMPLETED|Overall Study||1
5016670|NCT02204371|12344150|P1|COMPLETED|Overall Study||6
5016671|NCT02204371|12344150|P1|STARTED|Overall Study||7
5016672|NCT02204319|12344173|P1|NOT COMPLETED|Overall Study||3
5016673|NCT02204319|12344173|P1|COMPLETED|Overall Study|3 did not complete study.|7
5016674|NCT02204319|12344173|P1|STARTED|Overall Study||10
5016675|NCT02204176|12344182|P3|NOT COMPLETED|Overall Study||16
5016676|NCT02204176|12344183|P2|NOT COMPLETED|Overall Study||12
5016677|NCT02204176|12344184|P1|NOT COMPLETED|Overall Study||10
5016678|NCT02204176|12344182|P3|COMPLETED|Overall Study||58
5016679|NCT02204176|12344183|P2|COMPLETED|Overall Study||61
5016680|NCT02204176|12344184|P1|COMPLETED|Overall Study||64
5016681|NCT02204176|12344182|P3|STARTED|Overall Study||74
5016682|NCT02204176|12344183|P2|STARTED|Overall Study||73
5016683|NCT02204176|12344184|P1|STARTED|Overall Study||74
5016684|NCT02204150|12344207|P1|NOT COMPLETED|Overall Study||0
5016685|NCT02204150|12344207|P1|COMPLETED|Overall Study||56
5016686|NCT02204150|12344207|P1|STARTED|Overall Study||56
5016687|NCT02204124|12344213|P2|NOT COMPLETED|Overall Study||0
5016688|NCT02204124|12344214|P1|NOT COMPLETED|Overall Study||0
5016689|NCT02204124|12344213|P2|COMPLETED|Overall Study||19
5016690|NCT02204124|12344214|P1|COMPLETED|Overall Study||13
5016691|NCT02204124|12344213|P2|STARTED|Overall Study||19
5016692|NCT02204124|12344214|P1|STARTED|Overall Study||13
5016693|NCT02204007|12344234|P2|NOT COMPLETED|Overall Study||1
5016694|NCT02204007|12344235|P1|NOT COMPLETED|Overall Study||1
5016695|NCT02204007|12344234|P2|COMPLETED|Overall Study||17
5016696|NCT02204007|12344235|P1|COMPLETED|Overall Study||17
5016697|NCT02204007|12344234|P2|STARTED|Overall Study||18
5016698|NCT02204007|12344235|P1|STARTED|Overall Study||18
5016699|NCT02203916|12344246|P3|NOT COMPLETED|Overall Study||11
5016700|NCT02203916|12344247|P2|NOT COMPLETED|Overall Study||10
5016701|NCT02203916|12344248|P1|NOT COMPLETED|Overall Study||8
5016702|NCT02203916|12344246|P3|COMPLETED|Overall Study||120
5016703|NCT02203916|12344247|P2|COMPLETED|Overall Study||122
5016704|NCT02203916|12344248|P1|COMPLETED|Overall Study||57
5016705|NCT02203916|12344246|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
5016706|NCT02203916|12344247|P2|Safety Analysis Set (SAS)|Overall Study||132
5016707|NCT02203916|12344248|P1|Safety Analysis Set (SAS)|Overall Study||65
5016708|NCT02203916|12344246|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
5016709|NCT02203916|12344247|P2|Full Analysis Set (FAS)|Overall Study||132
5016710|NCT02203916|12344248|P1|Full Analysis Set (FAS)|Overall Study||65
5016711|NCT02203916|12344246|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
5016712|NCT02203916|12344247|P2|STARTED|Overall Study||132
5016713|NCT02203916|12344248|P1|STARTED|Overall Study||65
5016714|NCT02203851|12344268|P1|NOT COMPLETED|Overall Study||11
5016715|NCT02203851|12344268|P1|COMPLETED|Overall Study||99
5016716|NCT02203851|12344268|P1|STARTED|Overall Study||110
5016717|NCT02203838|12344306|P4|NOT COMPLETED|Overall Study||18
5016718|NCT02203838|12344307|P3|NOT COMPLETED|Overall Study||16
5016719|NCT02203838|12344308|P2|NOT COMPLETED|Overall Study||22
5016720|NCT02203838|12344309|P1|NOT COMPLETED|Overall Study||210
5016721|NCT02203838|12344306|P4|COMPLETED|Overall Study||15
5016722|NCT02203838|12344307|P3|COMPLETED|Overall Study||15
5016723|NCT02203838|12344308|P2|COMPLETED|Overall Study||6
5016724|NCT02203838|12344309|P1|COMPLETED|Overall Study||198
5016725|NCT02203838|12344306|P4|STARTED|Overall Study||33
5016726|NCT02203838|12344307|P3|STARTED|Overall Study||31
5016727|NCT02203838|12344308|P2|STARTED|Overall Study||28
5016728|NCT02203838|12344309|P1|STARTED|Overall Study||408
5016729|NCT02203786|12344343|P4|NOT COMPLETED|Overall Study||0
5016730|NCT02203786|12344344|P3|NOT COMPLETED|Overall Study||2
5016731|NCT02203786|12344345|P2|NOT COMPLETED|Overall Study||0
5016732|NCT02203786|12344346|P1|NOT COMPLETED|Overall Study||0
5016733|NCT02203786|12344343|P4|COMPLETED|Overall Study||15
5016734|NCT02203786|12344344|P3|COMPLETED|Overall Study||15
5016735|NCT02203786|12344345|P2|COMPLETED|Overall Study||15
5016736|NCT02203786|12344346|P1|COMPLETED|Overall Study||15
5016737|NCT02203786|12344343|P4|STARTED|Overall Study||15
5016738|NCT02203786|12344344|P3|STARTED|Overall Study||17
5016739|NCT02203786|12344345|P2|STARTED|Overall Study||15
5016740|NCT02203786|12344346|P1|STARTED|Overall Study||15
5016741|NCT02203747|12344378|P2|NOT COMPLETED|Overall Study||0
5016742|NCT02203747|12344379|P1|NOT COMPLETED|Overall Study||0
5016743|NCT02203747|12344378|P2|COMPLETED|Overall Study||34
5016744|NCT02203747|12344379|P1|COMPLETED|Overall Study||45
5016745|NCT02203747|12344378|P2|STARTED|Overall Study||34
5016746|NCT02203747|12344379|P1|STARTED|Overall Study||45
5016747|NCT02203721|12344389|P2|NOT COMPLETED|Overall Study||3
5016748|NCT02203721|12344390|P1|NOT COMPLETED|Overall Study||1
5016749|NCT02203721|12344389|P2|COMPLETED|Overall Study||148
5016750|NCT02203721|12344390|P1|COMPLETED|Overall Study||147
5016751|NCT02203721|12344389|P2|STARTED|Overall Study||151
5016752|NCT02203721|12344390|P1|STARTED|Overall Study||148
5016753|NCT02203630|12344400|P2|NOT COMPLETED|Overall Study||0
5016754|NCT02203630|12344401|P1|NOT COMPLETED|Overall Study||0
5016755|NCT02203630|12344400|P2|COMPLETED|Overall Study||9
5016756|NCT02203630|12344401|P1|COMPLETED|Overall Study||8
5016757|NCT02203630|12344400|P2|STARTED|Overall Study||9
5016758|NCT02203630|12344401|P1|STARTED|Overall Study||8
5016759|NCT02203578|12344471|P1|NOT COMPLETED|Overall Study||0
5016760|NCT02203578|12344471|P1|COMPLETED|Overall Study||1
5016761|NCT02203578|12344471|P1|STARTED|Overall Study||1
5016762|NCT02203565|12344483|P1|NOT COMPLETED|Overall Study||1
5016763|NCT02203565|12344483|P1|COMPLETED|Overall Study||19
5016764|NCT02203565|12344483|P1|STARTED|Overall Study||20
5016765|NCT02203357|12344490|P3|NOT COMPLETED|Overall Study||70
5016766|NCT02203357|12344491|P2|NOT COMPLETED|Overall Study||66
5016767|NCT02203357|12344492|P1|NOT COMPLETED|Overall Study||58
5016768|NCT02203357|12344490|P3|COMPLETED|Overall Study||55
5016769|NCT02203357|12344491|P2|COMPLETED|Overall Study||45
5016770|NCT02203357|12344492|P1|COMPLETED|Overall Study||59
5016771|NCT02203357|12344490|P3|mon24|Overall Study||55
5016772|NCT02203357|12344491|P2|mon24|Overall Study||45
5016773|NCT02203357|12344492|P1|mon24|Overall Study||59
5016774|NCT02203357|12344490|P3|mon12|Overall Study||122
5016775|NCT02203357|12344491|P2|mon12|Overall Study||101
5016776|NCT02203357|12344492|P1|mon12|Overall Study||113
5016777|NCT02203357|12344490|P3|mon7/2/3|Overall Study||124
5016778|NCT02203357|12344491|P2|mon7/2/3|Overall Study||110
5016779|NCT02203357|12344492|P1|mon7/2/3|Overall Study||114
5016780|NCT02203357|12344490|P3|STARTED|Overall Study||125
5016781|NCT02203357|12344491|P2|STARTED|Overall Study||111
5016782|NCT02203357|12344492|P1|STARTED|Overall Study||117
5016783|NCT02203331|12344515|P6|NOT COMPLETED|Overall Study||7
5016784|NCT02203331|12344516|P5|NOT COMPLETED|Overall Study||7
5016785|NCT02203331|12344517|P4|NOT COMPLETED|Overall Study||7
5016786|NCT02203331|12344518|P3|NOT COMPLETED|Overall Study||5
5016787|NCT02203331|12344519|P2|NOT COMPLETED|Overall Study||14
5016788|NCT02203331|12344520|P1|NOT COMPLETED|Overall Study||7
5016789|NCT02203331|12344515|P6|COMPLETED|Overall Study||46
5016790|NCT02203331|12344516|P5|COMPLETED|Overall Study||46
5016791|NCT02203331|12344517|P4|COMPLETED|Overall Study||46
5016792|NCT02203331|12344518|P3|COMPLETED|Overall Study||50
5016793|NCT02203331|12344519|P2|COMPLETED|Overall Study||39
5016794|NCT02203331|12344520|P1|COMPLETED|Overall Study||45
5016795|NCT02203331|12344515|P6|Treated|Overall Study||53
5016796|NCT02203331|12344516|P5|Treated|Overall Study||50
5016797|NCT02203331|12344517|P4|Treated|Overall Study||49
5016798|NCT02203331|12344518|P3|Treated|Overall Study||54
5016799|NCT02203331|12344519|P2|Treated|Overall Study||50
5016800|NCT02203331|12344520|P1|Treated|Overall Study||49
5016801|NCT02203331|12344515|P6|STARTED|Overall Study||53
5016802|NCT02203331|12344516|P5|STARTED|Overall Study||53
5016803|NCT02203331|12344517|P4|STARTED|Overall Study||53
5016804|NCT02203331|12344518|P3|STARTED|Overall Study||55
5016805|NCT02203331|12344519|P2|STARTED|Overall Study||53
5016806|NCT02203331|12344520|P1|STARTED|Overall Study||52
5016807|NCT02203162|12344570|P1|NOT COMPLETED|Overall Study||0
5016808|NCT02203162|12344570|P1|COMPLETED|Overall Study||30
5016809|NCT02203162|12344570|P1|STARTED|Overall Study||30
5016810|NCT02203149|12344579|P5|NOT COMPLETED|Part 2||1
5016811|NCT02203149|12344580|P4|NOT COMPLETED|Part 2||3
5016812|NCT02203149|12344581|P3|NOT COMPLETED|Part 2||1
5016813|NCT02203149|12344582|P2|NOT COMPLETED|Part 2||0
5016814|NCT02203149|12344583|P1|NOT COMPLETED|Part 2||0
5016815|NCT02203149|12344579|P5|COMPLETED|Part 2||34
5016816|NCT02203149|12344580|P4|COMPLETED|Part 2||71
5016817|NCT02203149|12344581|P3|COMPLETED|Part 2||226
5016818|NCT02203149|12344582|P2|COMPLETED|Part 2||0
5016819|NCT02203149|12344583|P1|COMPLETED|Part 2||0
5016820|NCT02203149|12344579|P5|Started Deferred Active Treatment|Part 2||0
5016821|NCT02203149|12344580|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
5016822|NCT02203149|12344581|P3|Started Deferred Active Treatment|Part 2||0
5016823|NCT02203149|12344582|P2|Started Deferred Active Treatment|Part 2||0
5016824|NCT02203149|12344583|P1|Started Deferred Active Treatment|Part 2||0
5016825|NCT02203149|12344579|P5|STARTED|Part 2||35
5016826|NCT02203149|12344580|P4|STARTED|Part 2||74
5016827|NCT02203149|12344581|P3|STARTED|Part 2||227
5016828|NCT02203149|12344582|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
5016829|NCT02203149|12344583|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
5016830|NCT02203149|12344579|P5|NOT COMPLETED|Part 1||0
5016831|NCT02203149|12344580|P4|NOT COMPLETED|Part 1||0
5016832|NCT02203149|12344581|P3|NOT COMPLETED|Part 1||0
5016833|NCT02203149|12344582|P2|NOT COMPLETED|Part 1||1
5016834|NCT02203149|12344583|P1|NOT COMPLETED|Part 1||0
5016835|NCT02203149|12344579|P5|COMPLETED|Part 1||0
5016836|NCT02203149|12344580|P4|COMPLETED|Part 1||0
5016837|NCT02203149|12344581|P3|COMPLETED|Part 1||0
5016838|NCT02203149|12344582|P2|COMPLETED|Part 1||31
5016839|NCT02203149|12344583|P1|COMPLETED|Part 1||31
5016840|NCT02203149|12344579|P5|STARTED|Part 1||0
5016841|NCT02203149|12344580|P4|STARTED|Part 1||0
5016842|NCT02203149|12344581|P3|STARTED|Part 1||0
5016843|NCT02203149|12344582|P2|STARTED|Part 1||32
5016844|NCT02203149|12344583|P1|STARTED|Part 1||31
5016845|NCT02203071|12344618|P2|NOT COMPLETED|Overall Study||1
5016846|NCT02203071|12344619|P1|NOT COMPLETED|Overall Study||3
5016847|NCT02203071|12344618|P2|COMPLETED|Overall Study||5
5016848|NCT02203071|12344619|P1|COMPLETED|Overall Study||10
5016849|NCT02203071|12344618|P2|STARTED|Overall Study||6
5016850|NCT02203071|12344619|P1|STARTED|Overall Study||13
5016851|NCT02203032|12344635|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
5016852|NCT02203032|12344636|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
5016853|NCT02203032|12344637|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
5016854|NCT02203032|12344638|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
5016855|NCT02203032|12344635|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
5016856|NCT02203032|12344636|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
5016857|NCT02203032|12344637|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
5016858|NCT02203032|12344638|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
5016859|NCT02203032|12344635|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
5016860|NCT02203032|12344636|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
5016861|NCT02203032|12344637|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
5016862|NCT02203032|12344638|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
5016863|NCT02203032|12344635|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016864|NCT02203032|12344636|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016865|NCT02203032|12344637|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016866|NCT02203032|12344638|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
5016867|NCT02203032|12344635|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016868|NCT02203032|12344636|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016869|NCT02203032|12344637|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
5016870|NCT02203032|12344638|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
5016871|NCT02203032|12344635|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
5016872|NCT02203032|12344636|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
5016873|NCT02203032|12344637|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
5016874|NCT02203032|12344638|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
5016875|NCT02203032|12344635|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
5016876|NCT02203032|12344636|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
5016877|NCT02203032|12344637|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
5016878|NCT02203032|12344638|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
5016879|NCT02203019|12344654|P2|NOT COMPLETED|Overall Study||0
5016880|NCT02203019|12344655|P1|NOT COMPLETED|Overall Study||0
5016881|NCT02203019|12344654|P2|COMPLETED|Overall Study||17
5016882|NCT02203019|12344655|P1|COMPLETED|Overall Study||19
5016883|NCT02203019|12344654|P2|STARTED|Overall Study||17
5016884|NCT02203019|12344655|P1|STARTED|Overall Study||19
5016885|NCT02202980|12344681|P14|NOT COMPLETED|Overall Study||0
5016886|NCT02202980|12344682|P13|NOT COMPLETED|Overall Study||11
5016887|NCT02202980|12344683|P12|NOT COMPLETED|Overall Study||3
5016888|NCT02202980|12344684|P11|NOT COMPLETED|Overall Study||0
5016889|NCT02202980|12344685|P10|NOT COMPLETED|Overall Study||0
5016890|NCT02202980|12344686|P9|NOT COMPLETED|Overall Study||4
5016891|NCT02202980|12344687|P8|NOT COMPLETED|Overall Study||3
5016892|NCT02202980|12344688|P7|NOT COMPLETED|Overall Study||11
5016893|NCT02202980|12344689|P6|NOT COMPLETED|Overall Study||1
5016894|NCT02202980|12344690|P5|NOT COMPLETED|Overall Study||6
5016895|NCT02202980|12344691|P4|NOT COMPLETED|Overall Study||4
5016896|NCT02202980|12344692|P3|NOT COMPLETED|Overall Study||10
5016897|NCT02202980|12344693|P2|NOT COMPLETED|Overall Study||2
5016898|NCT02202980|12344694|P1|NOT COMPLETED|Overall Study||1
5016899|NCT02202980|12344681|P14|COMPLETED|Overall Study||4
5016900|NCT02202980|12344682|P13|COMPLETED|Overall Study||19
5016901|NCT02202980|12344683|P12|COMPLETED|Overall Study||25
5016902|NCT02202980|12344684|P11|COMPLETED|Overall Study||19
5016903|NCT02202980|12344685|P10|COMPLETED|Overall Study||17
5016904|NCT02202980|12344686|P9|COMPLETED|Overall Study||14
5016905|NCT02202980|12344687|P8|COMPLETED|Overall Study||12
5016906|NCT02202980|12344688|P7|COMPLETED|Overall Study||4
5016907|NCT02202980|12344689|P6|COMPLETED|Overall Study||14
5016908|NCT02202980|12344690|P5|COMPLETED|Overall Study||7
5016909|NCT02202980|12344691|P4|COMPLETED|Overall Study||28
5016910|NCT02202980|12344692|P3|COMPLETED|Overall Study||17
5016911|NCT02202980|12344693|P2|COMPLETED|Overall Study||24
5016912|NCT02202980|12344694|P1|COMPLETED|Overall Study||13
5016913|NCT02202980|12344681|P14|STARTED|Overall Study||4
5016914|NCT02202980|12344682|P13|STARTED|Overall Study||30
5016915|NCT02202980|12344683|P12|STARTED|Overall Study||28
5016916|NCT02202980|12344684|P11|STARTED|Overall Study||19
5016917|NCT02202980|12344685|P10|STARTED|Overall Study||17
5016918|NCT02202980|12344686|P9|STARTED|Overall Study||18
5016919|NCT02202980|12344687|P8|STARTED|Overall Study||15
5016920|NCT02202980|12344688|P7|STARTED|Overall Study||15
5016921|NCT02202980|12344689|P6|STARTED|Overall Study||15
5016922|NCT02202980|12344690|P5|STARTED|Overall Study||13
5016923|NCT02202980|12344691|P4|STARTED|Overall Study||32
5016924|NCT02202980|12344692|P3|STARTED|Overall Study||27
5016925|NCT02202980|12344693|P2|STARTED|Overall Study||26
5016926|NCT02202980|12344694|P1|STARTED|Overall Study||14
5016927|NCT02202850|12344782|P2|NOT COMPLETED|Overall Study||6
5016928|NCT02202850|12344783|P1|NOT COMPLETED|Overall Study||24
5016929|NCT02202850|12344782|P2|COMPLETED|Overall Study||8
5016930|NCT02202850|12344783|P1|COMPLETED|Overall Study||46
5016931|NCT02202850|12344782|P2|STARTED|Overall Study||14
5016932|NCT02202850|12344783|P1|STARTED|Overall Study||70
5016933|NCT02202837|12344835|P2|NOT COMPLETED|Overall Study||5
5016934|NCT02202837|12344836|P1|NOT COMPLETED|Overall Study||53
5016935|NCT02202837|12344835|P2|COMPLETED|Overall Study||12
5016936|NCT02202837|12344836|P1|COMPLETED|Overall Study||87
5016937|NCT02202837|12344835|P2|STARTED|Overall Study||17
5016938|NCT02202837|12344836|P1|STARTED|Overall Study||140
5016939|NCT02202785|12344887|P3|NOT COMPLETED|Overall Study||17
5016940|NCT02202785|12344888|P2|NOT COMPLETED|Overall Study||15
5016941|NCT02202785|12344889|P1|NOT COMPLETED|Overall Study||11
5016942|NCT02202785|12344887|P3|COMPLETED|Overall Study||0
5016943|NCT02202785|12344888|P2|COMPLETED|Overall Study||0
5016944|NCT02202785|12344889|P1|COMPLETED|Overall Study||0
5016945|NCT02202785|12344887|P3|STARTED|Overall Study||17
5016946|NCT02202785|12344888|P2|STARTED|Overall Study||15
5016947|NCT02202785|12344889|P1|STARTED|Overall Study||11
5016948|NCT02202759|12344926|P3|NOT COMPLETED|Overall Study||14
5016949|NCT02202759|12344927|P2|NOT COMPLETED|Overall Study||15
5016950|NCT02202759|12344928|P1|NOT COMPLETED|Overall Study||9
5016951|NCT02202759|12344926|P3|COMPLETED|Overall Study||0
5016952|NCT02202759|12344927|P2|COMPLETED|Overall Study||0
5016953|NCT02202759|12344928|P1|COMPLETED|Overall Study||0
5016954|NCT02202759|12344926|P3|STARTED|Overall Study||14
5016955|NCT02202759|12344927|P2|STARTED|Overall Study||15
5016956|NCT02202759|12344928|P1|STARTED|Overall Study||9
5016957|NCT02202746|12344964|P2|NOT COMPLETED|Overall Study||0
5016958|NCT02202746|12344965|P1|NOT COMPLETED|Overall Study||0
5016959|NCT02202746|12344964|P2|COMPLETED|Overall Study||69
5016960|NCT02202746|12344965|P1|COMPLETED|Overall Study||109
5016961|NCT02202746|12344964|P2|STARTED|Overall Study||69
5016962|NCT02202746|12344965|P1|STARTED|Overall Study||109
5016963|NCT02202616|12344995|P1|NOT COMPLETED|Overall Study||100
5016964|NCT02202616|12344995|P1|COMPLETED|Overall Study||301
5016965|NCT02202616|12344995|P1|Intent to Treat Set (ITT)|Overall Study||338
5016966|NCT02202616|12344995|P1|STARTED|Overall Study||401
5016967|NCT02202538|12345006|P1|NOT COMPLETED|Overall Study||8
5016968|NCT02202538|12345006|P1|COMPLETED|Overall Study||45
5016969|NCT02202538|12345006|P1|Screen Failure|Overall Study||2
5016970|NCT02202538|12345006|P1|STARTED|Overall Study||53
5016971|NCT02202499|12345020|P3|NOT COMPLETED|Overall Study||2
5016972|NCT02202499|12345021|P2|NOT COMPLETED|Overall Study||0
5016973|NCT02202499|12345022|P1|NOT COMPLETED|Overall Study||2
5016974|NCT02202499|12345020|P3|COMPLETED|Overall Study||19
5016975|NCT02202499|12345021|P2|COMPLETED|Overall Study||20
5016976|NCT02202499|12345022|P1|COMPLETED|Overall Study||19
5016977|NCT02202499|12345020|P3|STARTED|Overall Study||21
5016978|NCT02202499|12345021|P2|STARTED|Overall Study||20
5016979|NCT02202499|12345022|P1|STARTED|Overall Study||21
5016980|NCT02202434|12345049|P4|NOT COMPLETED|Overall Study||37
5016981|NCT02202434|12345050|P3|NOT COMPLETED|Overall Study||15
5016982|NCT02202434|12345051|P2|NOT COMPLETED|Overall Study||69
5016983|NCT02202434|12345052|P1|NOT COMPLETED|Overall Study||109
5016984|NCT02202434|12345049|P4|COMPLETED|Overall Study||258
5016985|NCT02202434|12345050|P3|COMPLETED|Overall Study||87
5016986|NCT02202434|12345051|P2|COMPLETED|Overall Study||236
5016987|NCT02202434|12345052|P1|COMPLETED|Overall Study||498
5016988|NCT02202434|12345049|P4|STARTED|Overall Study||295
5016989|NCT02202434|12345050|P3|STARTED|Overall Study||102
5016990|NCT02202434|12345051|P2|STARTED|Overall Study||305
5016991|NCT02202434|12345052|P1|STARTED|Overall Study||607
5016992|NCT02202317|12345176|P1|NOT COMPLETED|Overall Study||1
5016993|NCT02202317|12345176|P1|COMPLETED|Overall Study||8
5016994|NCT02202317|12345176|P1|STARTED|Overall Study||9
5016995|NCT02202252|12345184|P2|NOT COMPLETED|Overall Study||0
5016996|NCT02202252|12345185|P1|NOT COMPLETED|Overall Study||0
5016997|NCT02202252|12345184|P2|COMPLETED|Overall Study||30
5016998|NCT02202252|12345185|P1|COMPLETED|Overall Study||30
5016999|NCT02202252|12345184|P2|STARTED|Overall Study||30
5017000|NCT02202252|12345185|P1|STARTED|Overall Study||30
5017001|NCT02202161|12345203|P8|NOT COMPLETED|Overall Study||6
5017002|NCT02202161|12345204|P7|NOT COMPLETED|Overall Study||0
5017003|NCT02202161|12345205|P6|NOT COMPLETED|Overall Study||1
5017004|NCT02202161|12345206|P5|NOT COMPLETED|Overall Study||1
5017005|NCT02202161|12345207|P4|NOT COMPLETED|Overall Study||0
5017006|NCT02202161|12345208|P3|NOT COMPLETED|Overall Study||0
5017007|NCT02202161|12345209|P2|NOT COMPLETED|Overall Study||1
5017008|NCT02202161|12345210|P1|NOT COMPLETED|Overall Study||1
5017009|NCT02202161|12345203|P8|COMPLETED|Overall Study||0
5017010|NCT02202161|12345204|P7|COMPLETED|Overall Study||13
5017011|NCT02202161|12345205|P6|COMPLETED|Overall Study||9
5017012|NCT02202161|12345206|P5|COMPLETED|Overall Study||8
5017013|NCT02202161|12345207|P4|COMPLETED|Overall Study||9
5017014|NCT02202161|12345208|P3|COMPLETED|Overall Study||5
5017015|NCT02202161|12345209|P2|COMPLETED|Overall Study||4
5017016|NCT02202161|12345210|P1|COMPLETED|Overall Study||12
5017017|NCT02202161|12345203|P8|STARTED|Overall Study||6
5017018|NCT02202161|12345204|P7|STARTED|Overall Study||13
5017019|NCT02202161|12345205|P6|STARTED|Overall Study||10
5017020|NCT02202161|12345206|P5|STARTED|Overall Study||9
5017021|NCT02202161|12345207|P4|STARTED|Overall Study||9
5017022|NCT02202161|12345208|P3|STARTED|Overall Study||5
5017023|NCT02202161|12345209|P2|STARTED|Overall Study||5
5017024|NCT02202161|12345210|P1|STARTED|Overall Study||13
5017025|NCT02202135|12345364|P1|NOT COMPLETED|Overall Study||0
5017026|NCT02202135|12345364|P1|COMPLETED|Overall Study||4
5017027|NCT02202135|12345364|P1|STARTED|Overall Study||4
5017028|NCT02202109|12345370|P2|NOT COMPLETED|Overall Study||87
5017029|NCT02202109|12345371|P1|NOT COMPLETED|Overall Study||90
5017030|NCT02202109|12345370|P2|COMPLETED|Overall Study||213
5017031|NCT02202109|12345371|P1|COMPLETED|Overall Study||212
5017032|NCT02202109|12345370|P2|STARTED|Overall Study||300
5017033|NCT02202109|12345371|P1|STARTED|Overall Study||302
5017034|NCT02202044|12345381|P1|NOT COMPLETED|Overall Study||0
5017035|NCT02202044|12345381|P1|COMPLETED|Overall Study||0
5017036|NCT02202044|12345381|P1|STARTED|Overall Study||0
5017037|NCT02202031|12345388|P2|NOT COMPLETED|Overall Study||5
5017038|NCT02202031|12345389|P1|NOT COMPLETED|Overall Study||5
5017039|NCT02202031|12345388|P2|COMPLETED|Overall Study||74
5017040|NCT02202031|12345389|P1|COMPLETED|Overall Study||77
5017041|NCT02202031|12345388|P2|STARTED|Overall Study||79
5017042|NCT02202031|12345389|P1|STARTED|Overall Study||82
5017043|NCT02201953|12345437|P2|NOT COMPLETED|Overall Study||56
5017044|NCT02201953|12345438|P1|NOT COMPLETED|Overall Study||20
5017045|NCT02201953|12345437|P2|COMPLETED|Overall Study||224
5017046|NCT02201953|12345438|P1|COMPLETED|Overall Study||258
5017047|NCT02201953|12345437|P2|STARTED|Overall Study||280
5017048|NCT02201953|12345438|P1|STARTED|Overall Study||278
5017049|NCT02201940|12345456|P2|NOT COMPLETED|Overall Study||116
5017050|NCT02201940|12345457|P1|NOT COMPLETED|Overall Study||12
5017051|NCT02201940|12345456|P2|COMPLETED|Overall Study||0
5017052|NCT02201940|12345457|P1|COMPLETED|Overall Study||613
5017053|NCT02201940|12345456|P2|STARTED|Overall Study||116
5017054|NCT02201940|12345457|P1|STARTED|Overall Study||625
5017055|NCT02201901|12345476|P3|NOT COMPLETED|Overall Study||13
5017056|NCT02201901|12345477|P2|NOT COMPLETED|Overall Study||9
5017057|NCT02201901|12345478|P1|NOT COMPLETED|Overall Study||15
5017058|NCT02201901|12345476|P3|COMPLETED|Overall Study||77
5017059|NCT02201901|12345477|P2|COMPLETED|Overall Study||79
5017060|NCT02201901|12345478|P1|COMPLETED|Overall Study||75
5017061|NCT02201901|12345476|P3|STARTED|Overall Study||90
5017062|NCT02201901|12345477|P2|STARTED|Overall Study||88
5017063|NCT02201901|12345478|P1|STARTED|Overall Study||90
5017064|NCT02201784|12345509|P2|NOT COMPLETED|Overall Study||0
5017065|NCT02201784|12345510|P1|NOT COMPLETED|Overall Study||2
5017066|NCT02201784|12345509|P2|COMPLETED|Overall Study||30
5017067|NCT02201784|12345510|P1|COMPLETED|Overall Study||28
5017068|NCT02201784|12345509|P2|STARTED|Overall Study||30
5017069|NCT02201784|12345510|P1|STARTED|Overall Study||30
5017070|NCT02201771|12345527|P3|NOT COMPLETED|Overall Study||10
5017071|NCT02201771|12345528|P2|NOT COMPLETED|Overall Study||10
5017072|NCT02201771|12345529|P1|NOT COMPLETED|Overall Study||13
5017073|NCT02201771|12345527|P3|COMPLETED|Overall Study||156
5017074|NCT02201771|12345528|P2|COMPLETED|Overall Study||158
5017075|NCT02201771|12345529|P1|COMPLETED|Overall Study||153
5017076|NCT02201771|12345527|P3|STARTED|Overall Study||166
5017077|NCT02201771|12345528|P2|STARTED|Overall Study||168
5017078|NCT02201771|12345529|P1|STARTED|Overall Study||166
5017079|NCT02201524|12345556|P4|NOT COMPLETED|Overall Study||4
5017080|NCT02201524|12345557|P3|NOT COMPLETED|Overall Study||4
5017081|NCT02201524|12345558|P2|NOT COMPLETED|Overall Study||3
5017082|NCT02201524|12345559|P1|NOT COMPLETED|Overall Study||2
5017083|NCT02201524|12345556|P4|COMPLETED|Overall Study||10
5017084|NCT02201524|12345557|P3|COMPLETED|Overall Study||12
5017085|NCT02201524|12345558|P2|COMPLETED|Overall Study||12
5017086|NCT02201524|12345559|P1|COMPLETED|Overall Study||12
5017087|NCT02201524|12345556|P4|STARTED|Overall Study||14
5017088|NCT02201524|12345557|P3|STARTED|Overall Study||16
5017089|NCT02201524|12345558|P2|STARTED|Overall Study||15
5017090|NCT02201524|12345559|P1|STARTED|Overall Study||14
5017091|NCT02201446|12345643|P2|NOT COMPLETED|Overall Study||0
5017092|NCT02201446|12345644|P1|NOT COMPLETED|Overall Study||0
5017093|NCT02201446|12345643|P2|COMPLETED|Overall Study||58
5017094|NCT02201446|12345644|P1|COMPLETED|Overall Study||81
5017095|NCT02201446|12345643|P2|STARTED|Overall Study||58
5017096|NCT02201446|12345644|P1|STARTED|Overall Study||81
5017097|NCT02201420|12345672|P1|NOT COMPLETED|Overall Study||0
5017098|NCT02201420|12345672|P1|COMPLETED|Overall Study||5
5017099|NCT02201420|12345672|P1|STARTED|Overall Study||5
5017100|NCT02201394|12345677|P1|NOT COMPLETED|Maintenance Dose||0
5017101|NCT02201394|12345677|P1|COMPLETED|Maintenance Dose||20
5017102|NCT02201394|12345677|P1|STARTED|Maintenance Dose||20
5017103|NCT02201394|12345677|P1|NOT COMPLETED|Loading Dose||0
5017104|NCT02201394|12345677|P1|COMPLETED|Loading Dose||20
5017105|NCT02201394|12345677|P1|STARTED|Loading Dose||20
5017106|NCT02201329|12345684|P1|NOT COMPLETED|Overall Study||5
5017107|NCT02201329|12345684|P1|COMPLETED|Overall Study||0
5017108|NCT02201329|12345684|P1|STARTED|Overall Study||5
5017109|NCT02201290|12345692|P1|NOT COMPLETED|Overall Study||5
5017110|NCT02201290|12345692|P1|COMPLETED|Overall Study||4
5017111|NCT02201290|12345692|P1|STARTED|Overall Study||9
5017112|NCT02201277|12345698|P2|NOT COMPLETED|Overall Study||5
5017113|NCT02201277|12345699|P1|NOT COMPLETED|Overall Study||7
5017114|NCT02201277|12345698|P2|COMPLETED|Overall Study||16
5017115|NCT02201277|12345699|P1|COMPLETED|Overall Study||17
5017116|NCT02201277|12345698|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
5017117|NCT02201277|12345699|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
5017118|NCT02201277|12345698|P2|Complicated Retrieval|Overall Study||0
5017119|NCT02201277|12345699|P1|Complicated Retrieval|Overall Study||2
5017120|NCT02201277|12345698|P2|Death (Before Removal)|Overall Study||4
5017121|NCT02201277|12345699|P1|Death (Before Removal)|Overall Study||3
5017122|NCT02201277|12345698|P2|Lost to Follow up|Overall Study||1
5017123|NCT02201277|12345699|P1|Lost to Follow up|Overall Study||2
5017124|NCT02201277|12345698|P2|Filter Ruled to be Permanent|Overall Study||2
5017125|NCT02201277|12345699|P1|Filter Ruled to be Permanent|Overall Study||2
5017126|NCT02201277|12345698|P2|Signed ICF But Did Not Enroll|Overall Study||1
5017127|NCT02201277|12345699|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
5017128|NCT02201277|12345698|P2|Filter Retrieval|Overall Study||16
5017129|NCT02201277|12345699|P1|Filter Retrieval|Overall Study||17
5017130|NCT02201277|12345698|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
5017131|NCT02201277|12345699|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
5017132|NCT02201056|12345726|P7|NOT COMPLETED|Overall Study||0
5017133|NCT02201056|12345727|P6|NOT COMPLETED|Overall Study||0
5017134|NCT02201056|12345728|P5|NOT COMPLETED|Overall Study||0
5017135|NCT02201056|12345729|P4|NOT COMPLETED|Overall Study||0
5017136|NCT02201056|12345730|P3|NOT COMPLETED|Overall Study||0
5017137|NCT02201056|12345731|P2|NOT COMPLETED|Overall Study||0
5017138|NCT02201056|12345732|P1|NOT COMPLETED|Overall Study||0
5017139|NCT02201056|12345726|P7|COMPLETED|Overall Study||6
5017140|NCT02201056|12345727|P6|COMPLETED|Overall Study||6
5017141|NCT02201056|12345728|P5|COMPLETED|Overall Study||6
5017142|NCT02201056|12345729|P4|COMPLETED|Overall Study||6
5017143|NCT02201056|12345730|P3|COMPLETED|Overall Study||6
5017144|NCT02201056|12345731|P2|COMPLETED|Overall Study||6
5017145|NCT02201056|12345732|P1|COMPLETED|Overall Study||12
5017146|NCT02201056|12345726|P7|STARTED|Overall Study||6
5017147|NCT02201056|12345727|P6|STARTED|Overall Study||6
5017148|NCT02201056|12345728|P5|STARTED|Overall Study||6
5017149|NCT02201056|12345729|P4|STARTED|Overall Study||6
5017150|NCT02201056|12345730|P3|STARTED|Overall Study||6
5017151|NCT02201056|12345731|P2|STARTED|Overall Study||6
5017152|NCT02201056|12345732|P1|STARTED|Overall Study||12
5017153|NCT02200770|12345789|P2|NOT COMPLETED|Open-label Period (OLP)||162
5017154|NCT02200770|12345790|P1|NOT COMPLETED|Open-label Period (OLP)||51
5017155|NCT02200770|12345789|P2|COMPLETED|Open-label Period (OLP)||0
5017156|NCT02200770|12345790|P1|COMPLETED|Open-label Period (OLP)||0
5017157|NCT02200770|12345789|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
5017158|NCT02200770|12345790|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
5017159|NCT02200770|12345789|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
5017160|NCT02200770|12345790|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
5017161|NCT02200770|12345789|P2|COMPLETED|Randomized-controlled Period (RCP)||169
5017162|NCT02200770|12345790|P1|COMPLETED|Randomized-controlled Period (RCP)||54
5017163|NCT02200770|12345789|P2|Treated|Randomized-controlled Period (RCP)||174
5017164|NCT02200770|12345790|P1|Treated|Randomized-controlled Period (RCP)||56
5017165|NCT02200770|12345789|P2|STARTED|Randomized-controlled Period (RCP)||175
5017166|NCT02200770|12345790|P1|STARTED|Randomized-controlled Period (RCP)||56
5017167|NCT02200614|12345821|P2|NOT COMPLETED|Follow-up Period||163
5017168|NCT02200614|12345822|P1|NOT COMPLETED|Follow-up Period||174
5017169|NCT02200614|12345821|P2|COMPLETED|Follow-up Period||169
5017170|NCT02200614|12345822|P1|COMPLETED|Follow-up Period||117
5017171|NCT02200614|12345821|P2|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|332
5017172|NCT02200614|12345822|P1|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|291
5017173|NCT02200614|12345821|P2|NOT COMPLETED|Treatment Period to Primary Completion||354
5017174|NCT02200614|12345822|P1|NOT COMPLETED|Treatment Period to Primary Completion||340
5017175|NCT02200614|12345821|P2|COMPLETED|Treatment Period to Primary Completion||200
5017176|NCT02200614|12345822|P1|COMPLETED|Treatment Period to Primary Completion||615
5017177|NCT02200614|12345821|P2|Treated|Treatment Period to Primary Completion|Safety population|554
5017178|NCT02200614|12345822|P1|Treated|Treatment Period to Primary Completion|Safety population|954
5017179|NCT02200614|12345821|P2|Ongoing|Treatment Period to Primary Completion||200
5017180|NCT02200614|12345822|P1|Ongoing|Treatment Period to Primary Completion||615
5017181|NCT02200614|12345821|P2|STARTED|Treatment Period to Primary Completion||554
5017182|NCT02200614|12345822|P1|STARTED|Treatment Period to Primary Completion||955
5017183|NCT02200536|12345839|P3|NOT COMPLETED|Overall Study||0
5017184|NCT02200536|12345840|P2|NOT COMPLETED|Overall Study||0
5017185|NCT02200536|12345841|P1|NOT COMPLETED|Overall Study||0
5017186|NCT02200536|12345839|P3|COMPLETED|Overall Study||30
5017187|NCT02200536|12345840|P2|COMPLETED|Overall Study||30
5017188|NCT02200536|12345841|P1|COMPLETED|Overall Study||32
5017189|NCT02200536|12345839|P3|STARTED|Overall Study||30
5017190|NCT02200536|12345840|P2|STARTED|Overall Study||30
5017191|NCT02200536|12345841|P1|STARTED|Overall Study||32
5017192|NCT02200510|12345854|P2|NOT COMPLETED|Overall Study||3
5017193|NCT02200510|12345855|P1|NOT COMPLETED|Overall Study||9
5017194|NCT02200510|12345854|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
5017195|NCT02200510|12345855|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
5017196|NCT02200510|12345854|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
5017197|NCT02200510|12345855|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
5017198|NCT02200458|12345861|P1|NOT COMPLETED|Overall Study||0
5017199|NCT02200458|12345861|P1|COMPLETED|Overall Study||62
5017200|NCT02200458|12345861|P1|STARTED|Overall Study||62
5017201|NCT02200328|12345867|P2|NOT COMPLETED|Overall Study||33
5017202|NCT02200328|12345868|P1|NOT COMPLETED|Overall Study||43
5017203|NCT02200328|12345867|P2|COMPLETED|Overall Study||0
5017204|NCT02200328|12345868|P1|COMPLETED|Overall Study||0
5017205|NCT02200328|12345867|P2|STARTED|Overall Study||33
5017206|NCT02200328|12345868|P1|STARTED|Overall Study||43
5017207|NCT02200211|12345880|P4|NOT COMPLETED|Overall Study||2
5017208|NCT02200211|12345881|P3|NOT COMPLETED|Overall Study||1
5017209|NCT02200211|12345882|P2|NOT COMPLETED|Overall Study||7
5017210|NCT02200211|12345883|P1|NOT COMPLETED|Overall Study||8
5017211|NCT02200211|12345880|P4|COMPLETED|Overall Study||58
5017212|NCT02200211|12345881|P3|COMPLETED|Overall Study||39
5017213|NCT02200211|12345882|P2|COMPLETED|Overall Study||188
5017214|NCT02200211|12345883|P1|COMPLETED|Overall Study||182
5017215|NCT02200211|12345880|P4|Included in 16-week Primary Analysis|Overall Study||56
5017216|NCT02200211|12345881|P3|Included in 16-week Primary Analysis|Overall Study||39
5017217|NCT02200211|12345882|P2|Included in 16-week Primary Analysis|Overall Study||186
5017218|NCT02200211|12345883|P1|Included in 16-week Primary Analysis|Overall Study||177
5017219|NCT02200211|12345880|P4|STARTED|Overall Study||60
5017220|NCT02200211|12345881|P3|STARTED|Overall Study||40
5017221|NCT02200211|12345882|P2|STARTED|Overall Study||195
5017222|NCT02200211|12345883|P1|STARTED|Overall Study||190
5017223|NCT02200055|12345979|P1|NOT COMPLETED|Overall Study||0
5017224|NCT02200055|12345979|P1|COMPLETED|Overall Study||86
5017225|NCT02200055|12345979|P1|STARTED|Overall Study||86
5017226|NCT02200042|12345996|P2|NOT COMPLETED|Overall Study||1
5017227|NCT02200042|12345997|P1|NOT COMPLETED|Overall Study||0
5017228|NCT02200042|12345996|P2|COMPLETED|Overall Study||0
5017229|NCT02200042|12345997|P1|COMPLETED|Overall Study||0
5017230|NCT02200042|12345996|P2|STARTED|Overall Study||1
5017231|NCT02200042|12345997|P1|STARTED|Overall Study||0
5017232|NCT02199964|12346015|P2|NOT COMPLETED|Overall Study||0
5017233|NCT02199964|12346016|P1|NOT COMPLETED|Overall Study||0
5017234|NCT02199964|12346015|P2|COMPLETED|Overall Study||2
5017235|NCT02199964|12346016|P1|COMPLETED|Overall Study||2
5017236|NCT02199964|12346015|P2|STARTED|Overall Study||2
5017237|NCT02199964|12346016|P1|STARTED|Overall Study||2
5017238|NCT02199795|12346026|P2|NOT COMPLETED|Overall Study||0
5017239|NCT02199795|12346027|P1|NOT COMPLETED|Overall Study||2
5017240|NCT02199795|12346026|P2|COMPLETED|Overall Study||3
5017241|NCT02199795|12346027|P1|COMPLETED|Overall Study||2
5017242|NCT02199795|12346026|P2|STARTED|Overall Study||3
5017243|NCT02199795|12346027|P1|STARTED|Overall Study||4
5017244|NCT02199717|12346039|P1|NOT COMPLETED|Overall Study||0
5017245|NCT02199717|12346039|P1|COMPLETED|Overall Study||66
5017246|NCT02199717|12346039|P1|STARTED|Overall Study||66
5017247|NCT02199691|12346050|P4|NOT COMPLETED|Overall Study||30
5017248|NCT02199691|12346051|P3|NOT COMPLETED|Overall Study||27
5017249|NCT02199691|12346052|P2|NOT COMPLETED|Overall Study||7
5017250|NCT02199691|12346053|P1|NOT COMPLETED|Overall Study||10
5017251|NCT02199691|12346050|P4|COMPLETED|Overall Study||270
5017252|NCT02199691|12346051|P3|COMPLETED|Overall Study||376
5017253|NCT02199691|12346052|P2|COMPLETED|Overall Study||500
5017254|NCT02199691|12346053|P1|COMPLETED|Overall Study||495
5017255|NCT02199691|12346050|P4|Safety Analysis Set (SafAS)|Overall Study||296
5017256|NCT02199691|12346051|P3|Safety Analysis Set (SafAS)|Overall Study||392
5017257|NCT02199691|12346052|P2|Safety Analysis Set (SafAS)|Overall Study||501
5017258|NCT02199691|12346053|P1|Safety Analysis Set (SafAS)|Overall Study||503
5017259|NCT02199691|12346050|P4|STARTED|Overall Study||300
5017260|NCT02199691|12346051|P3|STARTED|Overall Study||403
5017261|NCT02199691|12346052|P2|STARTED|Overall Study||507
5017262|NCT02199691|12346053|P1|STARTED|Overall Study||505
5017263|NCT02199652|12346075|P2|NOT COMPLETED|Overall Study||7
5017264|NCT02199652|12346076|P1|NOT COMPLETED|Overall Study||7
5017265|NCT02199652|12346075|P2|COMPLETED|Overall Study||3
5017266|NCT02199652|12346076|P1|COMPLETED|Overall Study||3
5017267|NCT02199652|12346075|P2|STARTED|Overall Study||10
5017268|NCT02199652|12346076|P1|STARTED|Overall Study||10
5017269|NCT02199574|12346086|P1|NOT COMPLETED|Overall Study||0
5017270|NCT02199574|12346086|P1|COMPLETED|Overall Study||12
5017271|NCT02199574|12346086|P1|STARTED|Overall Study||12
5017272|NCT02199509|12346095|P2|NOT COMPLETED|Overall Study||1
5017273|NCT02199509|12346096|P1|NOT COMPLETED|Overall Study||1
5017274|NCT02199509|12346095|P2|COMPLETED|Overall Study||3
5017275|NCT02199509|12346096|P1|COMPLETED|Overall Study||2
5017276|NCT02199509|12346095|P2|STARTED|Overall Study||4
5017277|NCT02199509|12346096|P1|STARTED|Overall Study||3
5017278|NCT02199197|12346110|P2|NOT COMPLETED|Overall Study||2
5017279|NCT02199197|12346111|P1|NOT COMPLETED|Overall Study||0
5017280|NCT02199197|12346110|P2|COMPLETED|Overall Study||12
5017281|NCT02199197|12346111|P1|COMPLETED|Overall Study||35
5017282|NCT02199197|12346110|P2|STARTED|Overall Study||14
5017283|NCT02199197|12346111|P1|STARTED|Overall Study||35
5017284|NCT02199080|12346119|P1|NOT COMPLETED|Overall Study||12
5017285|NCT02199080|12346119|P1|COMPLETED|Overall Study||2494
5017286|NCT02199080|12346119|P1|STARTED|Overall Study||2506
5017287|NCT02199041|12346129|P1|NOT COMPLETED|Overall Study||0
5017288|NCT02199041|12346129|P1|COMPLETED|Overall Study||12
5017289|NCT02199041|12346129|P1|STARTED|Overall Study||12
5017290|NCT02199028|12346144|P2|NOT COMPLETED|Week 4||0
5017291|NCT02199028|12346145|P1|NOT COMPLETED|Week 4||0
5017292|NCT02199028|12346144|P2|COMPLETED|Week 4||15
5017293|NCT02199028|12346145|P1|COMPLETED|Week 4||13
5017294|NCT02199028|12346144|P2|STARTED|Week 4||15
5017295|NCT02199028|12346145|P1|STARTED|Week 4||13
5017296|NCT02199028|12346144|P2|NOT COMPLETED|Week 3||0
5017297|NCT02199028|12346145|P1|NOT COMPLETED|Week 3||1
5017298|NCT02199028|12346144|P2|COMPLETED|Week 3||15
5017299|NCT02199028|12346145|P1|COMPLETED|Week 3||13
5017300|NCT02199028|12346144|P2|STARTED|Week 3||15
5017301|NCT02199028|12346145|P1|STARTED|Week 3||14
5017302|NCT02199028|12346144|P2|NOT COMPLETED|Week 2||0
5017303|NCT02199028|12346145|P1|NOT COMPLETED|Week 2||0
5017304|NCT02199028|12346144|P2|COMPLETED|Week 2||15
5017305|NCT02199028|12346145|P1|COMPLETED|Week 2||14
5017306|NCT02199028|12346144|P2|STARTED|Week 2||15
5017307|NCT02199028|12346145|P1|STARTED|Week 2||14
5017308|NCT02199028|12346144|P2|NOT COMPLETED|Week 1||0
5017309|NCT02199028|12346145|P1|NOT COMPLETED|Week 1||1
5017310|NCT02199028|12346144|P2|COMPLETED|Week 1||15
5017311|NCT02199028|12346145|P1|COMPLETED|Week 1||14
5017312|NCT02199028|12346144|P2|STARTED|Week 1||15
5017313|NCT02199028|12346145|P1|STARTED|Week 1||15
5017314|NCT02198963|12346154|P1|NOT COMPLETED|Overall Study||7
5017315|NCT02198963|12346154|P1|COMPLETED|Overall Study||36
5017316|NCT02198963|12346154|P1|STARTED|Overall Study||43
5017317|NCT02198833|12346165|P2|NOT COMPLETED|Overall Study||0
5017318|NCT02198833|12346166|P1|NOT COMPLETED|Overall Study||0
5017319|NCT02198833|12346165|P2|COMPLETED|Overall Study||1
5017320|NCT02198833|12346166|P1|COMPLETED|Overall Study||1
5017321|NCT02198833|12346165|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
5017322|NCT02198833|12346166|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
5017323|NCT02198651|12346178|P5|NOT COMPLETED|Open-label Rescue Period||0
5017324|NCT02198651|12346179|P4|NOT COMPLETED|Open-label Rescue Period||3
5017325|NCT02198651|12346180|P3|NOT COMPLETED|Open-label Rescue Period||0
5017326|NCT02198651|12346181|P2|NOT COMPLETED|Open-label Rescue Period||0
5017327|NCT02198651|12346182|P1|NOT COMPLETED|Open-label Rescue Period||0
5017328|NCT02198651|12346178|P5|COMPLETED|Open-label Rescue Period||8
5017329|NCT02198651|12346179|P4|COMPLETED|Open-label Rescue Period||28
5017330|NCT02198651|12346180|P3|COMPLETED|Open-label Rescue Period||0
5017331|NCT02198651|12346181|P2|COMPLETED|Open-label Rescue Period||0
5017332|NCT02198651|12346182|P1|COMPLETED|Open-label Rescue Period||0
5017333|NCT02198651|12346178|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
5017334|NCT02198651|12346179|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
5017335|NCT02198651|12346180|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
5017336|NCT02198651|12346181|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
5017337|NCT02198651|12346182|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
5017338|NCT02198651|12346178|P5|STARTED|Open-label Rescue Period||8
5017339|NCT02198651|12346179|P4|STARTED|Open-label Rescue Period||31
5017340|NCT02198651|12346180|P3|STARTED|Open-label Rescue Period||0
5017341|NCT02198651|12346181|P2|STARTED|Open-label Rescue Period||0
5017342|NCT02198651|12346182|P1|STARTED|Open-label Rescue Period||0
5017343|NCT02198651|12346178|P5|NOT COMPLETED|Double-blind Period||0
5017344|NCT02198651|12346179|P4|NOT COMPLETED|Double-blind Period||0
5017345|NCT02198651|12346180|P3|NOT COMPLETED|Double-blind Period||1
5017346|NCT02198651|12346181|P2|NOT COMPLETED|Double-blind Period||9
5017347|NCT02198651|12346182|P1|NOT COMPLETED|Double-blind Period||0
5017348|NCT02198651|12346178|P5|COMPLETED|Double-blind Period||0
5017349|NCT02198651|12346179|P4|COMPLETED|Double-blind Period||0
5017350|NCT02198651|12346180|P3|COMPLETED|Double-blind Period||19
5017351|NCT02198651|12346181|P2|COMPLETED|Double-blind Period||93
5017352|NCT02198651|12346182|P1|COMPLETED|Double-blind Period||0
5017353|NCT02198651|12346178|P5|STARTED|Double-blind Period||0
5017354|NCT02198651|12346179|P4|STARTED|Double-blind Period||0
5017355|NCT02198651|12346180|P3|STARTED|Double-blind Period||20
5017356|NCT02198651|12346181|P2|STARTED|Double-blind Period||102
5017357|NCT02198651|12346182|P1|STARTED|Double-blind Period||0
5017358|NCT02198651|12346178|P5|NOT COMPLETED|Lead-in Period||0
5017359|NCT02198651|12346179|P4|NOT COMPLETED|Lead-in Period||0
5017360|NCT02198651|12346180|P3|NOT COMPLETED|Lead-in Period||0
5017361|NCT02198651|12346181|P2|NOT COMPLETED|Lead-in Period||0
5017362|NCT02198651|12346182|P1|NOT COMPLETED|Lead-in Period||37
5017363|NCT02198651|12346178|P5|COMPLETED|Lead-in Period||0
5017364|NCT02198651|12346179|P4|COMPLETED|Lead-in Period||0
5017365|NCT02198651|12346180|P3|COMPLETED|Lead-in Period||0
5017366|NCT02198651|12346181|P2|COMPLETED|Lead-in Period||0
5017367|NCT02198651|12346182|P1|COMPLETED|Lead-in Period||112
5017368|NCT02198651|12346178|P5|Participants Treated in Lead-In Period|Lead-in Period||0
5017369|NCT02198651|12346179|P4|Participants Treated in Lead-In Period|Lead-in Period||0
5017370|NCT02198651|12346180|P3|Participants Treated in Lead-In Period|Lead-in Period||0
5017371|NCT02198651|12346181|P2|Participants Treated in Lead-In Period|Lead-in Period||0
5017372|NCT02198651|12346182|P1|Participants Treated in Lead-In Period|Lead-in Period||146
5017373|NCT02198651|12346178|P5|STARTED|Lead-in Period||0
5017374|NCT02198651|12346179|P4|STARTED|Lead-in Period||0
5017375|NCT02198651|12346180|P3|STARTED|Lead-in Period||0
5017376|NCT02198651|12346181|P2|STARTED|Lead-in Period||0
5017377|NCT02198651|12346182|P1|STARTED|Lead-in Period||149
5017378|NCT02198430|12346267|P2|NOT COMPLETED|Overall Study||0
5017379|NCT02198430|12346268|P1|NOT COMPLETED|Overall Study||0
5017380|NCT02198430|12346267|P2|COMPLETED|Overall Study||51
5017381|NCT02198430|12346268|P1|COMPLETED|Overall Study||53
5017382|NCT02198430|12346267|P2|STARTED|Overall Study||51
5017383|NCT02198430|12346268|P1|STARTED|Overall Study||53
5017384|NCT02198235|12346283|P3|NOT COMPLETED|Overall Study||2
5017385|NCT02198235|12346284|P2|NOT COMPLETED|Overall Study||2
5017386|NCT02198235|12346285|P1|NOT COMPLETED|Overall Study||3
5017387|NCT02198235|12346283|P3|COMPLETED|Overall Study||28
5017388|NCT02198235|12346284|P2|COMPLETED|Overall Study||28
5017389|NCT02198235|12346285|P1|COMPLETED|Overall Study||27
5017390|NCT02198235|12346283|P3|STARTED|Overall Study||30
5017391|NCT02198235|12346284|P2|STARTED|Overall Study||30
5017392|NCT02198235|12346285|P1|STARTED|Overall Study||30
5017393|NCT02198040|12346305|P3|NOT COMPLETED|Overall Study||1
5017394|NCT02198040|12346306|P2|NOT COMPLETED|Overall Study||1
5017395|NCT02198040|12346307|P1|NOT COMPLETED|Overall Study||0
5017396|NCT02198040|12346305|P3|COMPLETED|Overall Study||8
5017397|NCT02198040|12346306|P2|COMPLETED|Overall Study||8
5017398|NCT02198040|12346307|P1|COMPLETED|Overall Study||9
5017399|NCT02198040|12346305|P3|STARTED|Overall Study||9
5017400|NCT02198040|12346306|P2|STARTED|Overall Study||9
5017401|NCT02198040|12346307|P1|STARTED|Overall Study||9
5017402|NCT02197806|12346337|P4|NOT COMPLETED|Overall Study||1
5017403|NCT02197806|12346338|P3|NOT COMPLETED|Overall Study||0
5017404|NCT02197806|12346339|P2|NOT COMPLETED|Overall Study||1
5017405|NCT02197806|12346340|P1|NOT COMPLETED|Overall Study||0
5017406|NCT02197806|12346337|P4|COMPLETED|Overall Study||16
5017407|NCT02197806|12346338|P3|COMPLETED|Overall Study||16
5017408|NCT02197806|12346339|P2|COMPLETED|Overall Study||16
5017409|NCT02197806|12346340|P1|COMPLETED|Overall Study||15
5017410|NCT02197806|12346337|P4|STARTED|Overall Study||17
5017411|NCT02197806|12346338|P3|STARTED|Overall Study||16
5017412|NCT02197806|12346339|P2|STARTED|Overall Study||17
5017413|NCT02197806|12346340|P1|STARTED|Overall Study||15
5017414|NCT02197767|12346350|P1|NOT COMPLETED|Overall Study||0
5017415|NCT02197767|12346350|P1|COMPLETED|Overall Study||11
5017416|NCT02197767|12346350|P1|STARTED|Overall Study||11
5017417|NCT02197572|12346355|P1|NOT COMPLETED|Overall Study||44
5017418|NCT02197572|12346355|P1|COMPLETED|Overall Study||0
5017419|NCT02197572|12346355|P1|STARTED|Overall Study||44
5017420|NCT02197520|12346372|P2|NOT COMPLETED|Period 2||2
5017421|NCT02197520|12346373|P1|NOT COMPLETED|Period 2||1
5017422|NCT02197520|12346372|P2|COMPLETED|Period 2||10
5017423|NCT02197520|12346373|P1|COMPLETED|Period 2||10
5017424|NCT02197520|12346372|P2|STARTED|Period 2||12
5017425|NCT02197520|12346373|P1|STARTED|Period 2||11
5017426|NCT02197520|12346372|P2|NOT COMPLETED|Period 1||0
5017427|NCT02197520|12346373|P1|NOT COMPLETED|Period 1||1
5017428|NCT02197520|12346372|P2|COMPLETED|Period 1||12
5017429|NCT02197520|12346373|P1|COMPLETED|Period 1||11
5017430|NCT02197520|12346372|P2|STARTED|Period 1||12
5017431|NCT02197520|12346373|P1|STARTED|Period 1||12
5017432|NCT02197481|12346391|P2|NOT COMPLETED|Overall Study||0
5017433|NCT02197481|12346392|P1|NOT COMPLETED|Overall Study||0
5017434|NCT02197481|12346391|P2|COMPLETED|Overall Study||43
5017435|NCT02197481|12346392|P1|COMPLETED|Overall Study|February 2016|43
5017436|NCT02197481|12346391|P2|STARTED|Overall Study||43
5017437|NCT02197481|12346392|P1|STARTED|Overall Study|October 2014|43
5017438|NCT02197455|12346412|P1|NOT COMPLETED|Overall Study||0
5017439|NCT02197455|12346412|P1|COMPLETED|Overall Study||30
5017440|NCT02197455|12346412|P1|STARTED|Overall Study||30
5017441|NCT02197416|12346420|P3|NOT COMPLETED|Overall Study||8
5017442|NCT02197416|12346421|P2|NOT COMPLETED|Overall Study||4
5017443|NCT02197416|12346422|P1|NOT COMPLETED|Overall Study||1
5017444|NCT02197416|12346420|P3|COMPLETED|Overall Study||153
5017445|NCT02197416|12346421|P2|COMPLETED|Overall Study||39
5017446|NCT02197416|12346422|P1|COMPLETED|Overall Study||8
5017447|NCT02197416|12346420|P3|STARTED|Overall Study||161
5017448|NCT02197416|12346421|P2|STARTED|Overall Study||43
5017449|NCT02197416|12346422|P1|STARTED|Overall Study||9
5017450|NCT02197377|12346460|P2|NOT COMPLETED|Overall Study||3
5017451|NCT02197377|12346461|P1|NOT COMPLETED|Overall Study||0
5017452|NCT02197377|12346460|P2|COMPLETED|Overall Study||27
5017453|NCT02197377|12346461|P1|COMPLETED|Overall Study||30
5017454|NCT02197377|12346460|P2|STARTED|Overall Study||30
5017455|NCT02197377|12346461|P1|STARTED|Overall Study||30
5017456|NCT02197273|12346471|P2|NOT COMPLETED|Overall Study||0
5017457|NCT02197273|12346472|P1|NOT COMPLETED|Overall Study||0
5017458|NCT02197273|12346471|P2|COMPLETED|Overall Study||104
5017459|NCT02197273|12346472|P1|COMPLETED|Overall Study||107
5017460|NCT02197273|12346471|P2|STARTED|Overall Study||104
5017461|NCT02197273|12346472|P1|STARTED|Overall Study||107
5017462|NCT02197247|12346482|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
5017463|NCT02197247|12346482|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
5017552|NCT02196831|12346767|P1|COMPLETED|Overall Study||21
5017464|NCT02197247|12346482|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
5017465|NCT02197247|12346482|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
5017466|NCT02197247|12346482|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
5017467|NCT02197247|12346482|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
5017468|NCT02197247|12346482|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
5017469|NCT02197247|12346482|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
5017470|NCT02197247|12346482|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
5017471|NCT02197247|12346482|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
5017472|NCT02197247|12346482|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
5017473|NCT02197247|12346482|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
5017474|NCT02197234|12346527|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
5017475|NCT02197234|12346527|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
5017476|NCT02197234|12346527|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
5017477|NCT02197234|12346527|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
5017478|NCT02197234|12346527|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
5017479|NCT02197234|12346527|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
5017480|NCT02197234|12346527|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
5017481|NCT02197234|12346527|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
5017482|NCT02197234|12346527|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
5017483|NCT02197234|12346527|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
5017484|NCT02197234|12346527|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
5017485|NCT02197234|12346527|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
5017486|NCT02197130|12346549|P3|NOT COMPLETED|Overall Study||32
5017487|NCT02197130|12346550|P2|NOT COMPLETED|Overall Study||8
5017488|NCT02197130|12346551|P1|NOT COMPLETED|Overall Study||16
5017489|NCT02197130|12346549|P3|COMPLETED|Overall Study||56
5017490|NCT02197130|12346550|P2|COMPLETED|Overall Study||81
5017491|NCT02197130|12346551|P1|COMPLETED|Overall Study||79
5017492|NCT02197130|12346549|P3|Received Treatment|Overall Study||87
5017493|NCT02197130|12346550|P2|Received Treatment|Overall Study||88
5017494|NCT02197130|12346551|P1|Received Treatment|Overall Study||95
5017495|NCT02197130|12346549|P3|STARTED|Overall Study||88
5017496|NCT02197130|12346550|P2|STARTED|Overall Study||89
5017497|NCT02197130|12346551|P1|STARTED|Overall Study||95
5017498|NCT02197078|12346613|P12|NOT COMPLETED|Overall Study||0
5017499|NCT02197078|12346614|P11|NOT COMPLETED|Overall Study||0
5017500|NCT02197078|12346615|P10|NOT COMPLETED|Overall Study||0
5017501|NCT02197078|12346616|P9|NOT COMPLETED|Overall Study||0
5017502|NCT02197078|12346617|P8|NOT COMPLETED|Overall Study||0
5017503|NCT02197078|12346618|P7|NOT COMPLETED|Overall Study||0
5017504|NCT02197078|12346619|P6|NOT COMPLETED|Overall Study||0
5017505|NCT02197078|12346620|P5|NOT COMPLETED|Overall Study||0
5017506|NCT02197078|12346621|P4|NOT COMPLETED|Overall Study||0
5017507|NCT02197078|12346622|P3|NOT COMPLETED|Overall Study||0
5017508|NCT02197078|12346623|P2|NOT COMPLETED|Overall Study||0
5017509|NCT02197078|12346624|P1|NOT COMPLETED|Overall Study||0
5017510|NCT02197078|12346613|P12|COMPLETED|Overall Study||15742
5017511|NCT02197078|12346614|P11|COMPLETED|Overall Study||15742
5017512|NCT02197078|12346615|P10|COMPLETED|Overall Study||18996
5017513|NCT02197078|12346616|P9|COMPLETED|Overall Study||18996
5017514|NCT02197078|12346617|P8|COMPLETED|Overall Study||25135
5017515|NCT02197078|12346618|P7|COMPLETED|Overall Study||25135
5017516|NCT02197078|12346619|P6|COMPLETED|Overall Study||9538
5017517|NCT02197078|12346620|P5|COMPLETED|Overall Study||9538
5017518|NCT02197078|12346621|P4|COMPLETED|Overall Study||10614
5017519|NCT02197078|12346622|P3|COMPLETED|Overall Study||10614
5017520|NCT02197078|12346623|P2|COMPLETED|Overall Study||14688
5017521|NCT02197078|12346624|P1|COMPLETED|Overall Study||14688
5017522|NCT02197078|12346613|P12|STARTED|Overall Study||15742
5017523|NCT02197078|12346614|P11|STARTED|Overall Study||15742
5017524|NCT02197078|12346615|P10|STARTED|Overall Study||18996
5017525|NCT02197078|12346616|P9|STARTED|Overall Study||18996
5017526|NCT02197078|12346617|P8|STARTED|Overall Study||25135
5017527|NCT02197078|12346618|P7|STARTED|Overall Study||25135
5017528|NCT02197078|12346619|P6|STARTED|Overall Study||9538
5017529|NCT02197078|12346620|P5|STARTED|Overall Study||9538
5017530|NCT02197078|12346621|P4|STARTED|Overall Study||10614
5017531|NCT02197078|12346622|P3|STARTED|Overall Study||10614
5017532|NCT02197078|12346623|P2|STARTED|Overall Study||14688
5017533|NCT02197078|12346624|P1|STARTED|Overall Study||14688
5017534|NCT02197065|12346736|P2|NOT COMPLETED|Overall Study||0
5017535|NCT02197065|12346737|P1|NOT COMPLETED|Overall Study||0
5017536|NCT02197065|12346736|P2|COMPLETED|Overall Study||10
5017537|NCT02197065|12346737|P1|COMPLETED|Overall Study||10
5017538|NCT02197065|12346736|P2|STARTED|Overall Study||10
5017539|NCT02197065|12346737|P1|STARTED|Overall Study||10
5017540|NCT02196922|12346748|P2|NOT COMPLETED|Overall Study||0
5017541|NCT02196922|12346749|P1|NOT COMPLETED|Overall Study||0
5017542|NCT02196922|12346748|P2|COMPLETED|Overall Study||46
5017543|NCT02196922|12346749|P1|COMPLETED|Overall Study||58
5017544|NCT02196922|12346748|P2|STARTED|Overall Study||46
5017545|NCT02196922|12346749|P1|STARTED|Overall Study||58
5017546|NCT02196857|12346759|P1|NOT COMPLETED|Overall Study||0
5017547|NCT02196857|12346759|P1|COMPLETED|Overall Study||16
5017548|NCT02196857|12346759|P1|STARTED|Overall Study||16
5017549|NCT02196831|12346766|P2|NOT COMPLETED|Overall Study||4
5017550|NCT02196831|12346767|P1|NOT COMPLETED|Overall Study||9
5017551|NCT02196831|12346766|P2|COMPLETED|Overall Study||26
5017553|NCT02196831|12346766|P2|Received Follow-up Imaging|Overall Study||28
5017554|NCT02196831|12346767|P1|Received Follow-up Imaging|Overall Study||26
5017555|NCT02196831|12346766|P2|STARTED|Overall Study||30
5017556|NCT02196831|12346767|P1|STARTED|Overall Study||30
5017557|NCT02196766|12346780|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5017558|NCT02196766|12346781|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5017559|NCT02196766|12346780|P2|COMPLETED|Second Intervention (7 Days)||15
5017560|NCT02196766|12346781|P1|COMPLETED|Second Intervention (7 Days)||15
5017561|NCT02196766|12346780|P2|STARTED|Second Intervention (7 Days)||15
5017562|NCT02196766|12346781|P1|STARTED|Second Intervention (7 Days)||15
5017563|NCT02196766|12346780|P2|NOT COMPLETED|First Intervention (7 Days)||0
5017564|NCT02196766|12346781|P1|NOT COMPLETED|First Intervention (7 Days)||0
5017565|NCT02196766|12346780|P2|COMPLETED|First Intervention (7 Days)||15
5017566|NCT02196766|12346781|P1|COMPLETED|First Intervention (7 Days)||15
5017567|NCT02196766|12346780|P2|STARTED|First Intervention (7 Days)||15
5017568|NCT02196766|12346781|P1|STARTED|First Intervention (7 Days)||15
5017569|NCT02196714|12346797|P4|NOT COMPLETED|Overall Study||0
5017570|NCT02196714|12346798|P3|NOT COMPLETED|Overall Study||1
5017571|NCT02196714|12346799|P2|NOT COMPLETED|Overall Study||0
5017572|NCT02196714|12346800|P1|NOT COMPLETED|Overall Study||0
5017573|NCT02196714|12346797|P4|COMPLETED|Overall Study||24
5017574|NCT02196714|12346798|P3|COMPLETED|Overall Study||23
5017575|NCT02196714|12346799|P2|COMPLETED|Overall Study||23
5017576|NCT02196714|12346800|P1|COMPLETED|Overall Study||24
5017577|NCT02196714|12346797|P4|STARTED|Overall Study||24
5017578|NCT02196714|12346798|P3|STARTED|Overall Study||24
5017579|NCT02196714|12346799|P2|STARTED|Overall Study||23
5017580|NCT02196714|12346800|P1|STARTED|Overall Study||24
5017581|NCT02196701|12346922|P1|NOT COMPLETED|Overall Study||3
5017582|NCT02196701|12346922|P1|COMPLETED|Overall Study||43
5017583|NCT02196701|12346922|P1|STARTED|Overall Study||46
5017584|NCT02196688|12346980|P2|NOT COMPLETED|Overall Study||1
5017585|NCT02196688|12346981|P1|NOT COMPLETED|Overall Study||7
5017586|NCT02196688|12346980|P2|COMPLETED|Overall Study||23
5017587|NCT02196688|12346981|P1|COMPLETED|Overall Study||40
5017588|NCT02196688|12346980|P2|STARTED|Overall Study||24
5017589|NCT02196688|12346981|P1|STARTED|Overall Study||47
5017590|NCT02196675|12346996|P3|NOT COMPLETED|Overall Study||1
5017591|NCT02196675|12346997|P2|NOT COMPLETED|Overall Study||2
5017592|NCT02196675|12346998|P1|NOT COMPLETED|Overall Study||2
5017593|NCT02196675|12346996|P3|COMPLETED|Overall Study||7
5017594|NCT02196675|12346997|P2|COMPLETED|Overall Study||68
5017595|NCT02196675|12346998|P1|COMPLETED|Overall Study||25
5017596|NCT02196675|12346996|P3|STARTED|Overall Study||8
5017597|NCT02196675|12346997|P2|STARTED|Overall Study||70
5017598|NCT02196675|12346998|P1|STARTED|Overall Study||27
5017599|NCT02196506|12347020|P4|NOT COMPLETED|Phase A+||14
5017600|NCT02196506|12347021|P3|NOT COMPLETED|Phase A+||0
5017601|NCT02196506|12347022|P2|NOT COMPLETED|Phase A+||0
5017602|NCT02196506|12347023|P1|NOT COMPLETED|Phase A+||0
5017603|NCT02196506|12347020|P4|COMPLETED|Phase A+||308
5017604|NCT02196506|12347021|P3|COMPLETED|Phase A+||0
5017605|NCT02196506|12347022|P2|COMPLETED|Phase A+||0
5017606|NCT02196506|12347023|P1|COMPLETED|Phase A+||0
5017607|NCT02196506|12347020|P4|STARTED|Phase A+||322
5017608|NCT02196506|12347021|P3|STARTED|Phase A+||0
5017609|NCT02196506|12347022|P2|STARTED|Phase A+||0
5017610|NCT02196506|12347023|P1|STARTED|Phase A+||0
5017611|NCT02196506|12347020|P4|NOT COMPLETED|Phase B||0
5017612|NCT02196506|12347021|P3|NOT COMPLETED|Phase B||6
5017613|NCT02196506|12347022|P2|NOT COMPLETED|Phase B||15
5017614|NCT02196506|12347023|P1|NOT COMPLETED|Phase B||0
5017615|NCT02196506|12347020|P4|COMPLETED|Phase B||0
5017616|NCT02196506|12347021|P3|COMPLETED|Phase B||196
5017617|NCT02196506|12347022|P2|COMPLETED|Phase B||177
5017618|NCT02196506|12347023|P1|COMPLETED|Phase B||0
5017619|NCT02196506|12347020|P4|STARTED|Phase B||0
5017620|NCT02196506|12347021|P3|STARTED|Phase B||202
5017621|NCT02196506|12347022|P2|STARTED|Phase B||192
5017622|NCT02196506|12347023|P1|STARTED|Phase B||0
5017623|NCT02196506|12347020|P4|NOT COMPLETED|Phase A||0
5017624|NCT02196506|12347021|P3|NOT COMPLETED|Phase A||0
5017625|NCT02196506|12347022|P2|NOT COMPLETED|Phase A||0
5017626|NCT02196506|12347023|P1|NOT COMPLETED|Phase A||121
5017627|NCT02196506|12347020|P4|COMPLETED|Phase A||0
5017628|NCT02196506|12347021|P3|COMPLETED|Phase A||0
5017629|NCT02196506|12347022|P2|COMPLETED|Phase A||0
5017630|NCT02196506|12347023|P1|COMPLETED|Phase A||716
5017631|NCT02196506|12347020|P4|STARTED|Phase A||0
5017632|NCT02196506|12347021|P3|STARTED|Phase A||0
5017633|NCT02196506|12347022|P2|STARTED|Phase A||0
5017634|NCT02196506|12347023|P1|STARTED|Phase A||837
5017635|NCT02196259|12347038|P3|NOT COMPLETED|Overall Study||1
5017636|NCT02196259|12347039|P2|NOT COMPLETED|Overall Study||3
5017637|NCT02196259|12347040|P1|NOT COMPLETED|Overall Study||0
5017638|NCT02196259|12347038|P3|COMPLETED|Overall Study||2
5017639|NCT02196259|12347039|P2|COMPLETED|Overall Study||4
5017640|NCT02196259|12347040|P1|COMPLETED|Overall Study||3
5017641|NCT02196259|12347038|P3|STARTED|Overall Study||3
5017642|NCT02196259|12347039|P2|STARTED|Overall Study||7
5017643|NCT02196259|12347040|P1|STARTED|Overall Study||3
5017644|NCT02196168|12347049|P2|NOT COMPLETED|Overall Study||0
5017645|NCT02196168|12347050|P1|NOT COMPLETED|Overall Study||0
5017646|NCT02196168|12347049|P2|COMPLETED|Overall Study||0
5017647|NCT02196168|12347050|P1|COMPLETED|Overall Study||6
5017648|NCT02196168|12347049|P2|STARTED|Overall Study||0
5017649|NCT02196168|12347050|P1|STARTED|Overall Study||6
5017650|NCT02196077|12347068|P1|NOT COMPLETED|Overall Study||47
5017651|NCT02196077|12347068|P1|COMPLETED|Overall Study||133
5017652|NCT02196077|12347068|P1|FF MDI 9.6 μg|Overall Study||157
5017653|NCT02196077|12347068|P1|BD MDI 320 μg|Overall Study||108
5017654|NCT02196077|12347068|P1|BFF MDI 80/9.6 μg|Overall Study||103
5017655|NCT02196077|12347068|P1|BFF MDI 160/9.6 μg|Overall Study||106
5017656|NCT02196077|12347068|P1|BFF MDI 320/9.6 μg|Overall Study||155
5017657|NCT02196077|12347068|P1|STARTED|Overall Study||180
5017658|NCT02195986|12347118|P3|NOT COMPLETED|Overall Study||2
5017659|NCT02195986|12347119|P2|NOT COMPLETED|Overall Study||5
5017660|NCT02195986|12347120|P1|NOT COMPLETED|Overall Study||3
5017661|NCT02195986|12347118|P3|COMPLETED|Overall Study||71
5017662|NCT02195986|12347119|P2|COMPLETED|Overall Study||142
5017663|NCT02195986|12347120|P1|COMPLETED|Overall Study||143
5017664|NCT02195986|12347118|P3|STARTED|Overall Study||73
5017665|NCT02195986|12347119|P2|STARTED|Overall Study||147
5017666|NCT02195986|12347120|P1|STARTED|Overall Study||146
5017667|NCT02195895|12347135|P1|NOT COMPLETED|Overall Study||0
5017668|NCT02195895|12347135|P1|COMPLETED|Overall Study||17
5017669|NCT02195895|12347135|P1|STARTED|Overall Study||17
5017670|NCT02195869|12347143|P1|NOT COMPLETED|Overall Study||42
5017671|NCT02195869|12347143|P1|COMPLETED|Overall Study||0
5017672|NCT02195869|12347143|P1|All-Treated Population|Overall Study||42
5017673|NCT02195869|12347143|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
5017674|NCT02195713|12347156|P2|NOT COMPLETED|Overall Study||0
5017675|NCT02195713|12347157|P1|NOT COMPLETED|Overall Study||0
5017676|NCT02195713|12347156|P2|COMPLETED|Overall Study||10
5017677|NCT02195713|12347157|P1|COMPLETED|Overall Study||10
5017678|NCT02195713|12347156|P2|STARTED|Overall Study||10
5017679|NCT02195713|12347157|P1|STARTED|Overall Study||10
5017680|NCT02195700|12347165|P2|NOT COMPLETED|Overall Study||7
5017681|NCT02195700|12347166|P1|NOT COMPLETED|Overall Study||6
5017682|NCT02195700|12347165|P2|COMPLETED|Overall Study||52
5017683|NCT02195700|12347166|P1|COMPLETED|Overall Study||52
5017684|NCT02195700|12347165|P2|Maintenance Period|Overall Study||54
5017685|NCT02195700|12347166|P1|Maintenance Period|Overall Study||53
5017686|NCT02195700|12347165|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
5017687|NCT02195700|12347166|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
5017688|NCT02195700|12347165|P2|Safety and ITT Populations|Overall Study||59
5017689|NCT02195700|12347166|P1|Safety and ITT Populations|Overall Study||58
5017690|NCT02195700|12347165|P2|STARTED|Overall Study||59
5017691|NCT02195700|12347166|P1|STARTED|Overall Study||58
5017692|NCT02195687|12347188|P2|NOT COMPLETED|Overall Study||2
5017693|NCT02195687|12347189|P1|NOT COMPLETED|Overall Study||5
5017694|NCT02195687|12347188|P2|COMPLETED|Overall Study||99
5017695|NCT02195687|12347189|P1|COMPLETED|Overall Study||311
5017696|NCT02195687|12347188|P2|STARTED|Overall Study||101
5017697|NCT02195687|12347189|P1|STARTED|Overall Study||316
5017698|NCT02195622|12347207|P2|NOT COMPLETED|Overall Study||0
5017699|NCT02195622|12347208|P1|NOT COMPLETED|Overall Study||0
5017700|NCT02195622|12347207|P2|COMPLETED|Overall Study||37
5017701|NCT02195622|12347208|P1|COMPLETED|Overall Study||37
5017702|NCT02195622|12347207|P2|STARTED|Overall Study||37
5017703|NCT02195622|12347208|P1|STARTED|Overall Study||37
5017704|NCT02195583|12347214|P1|NOT COMPLETED|Overall Study||9
5017705|NCT02195583|12347214|P1|COMPLETED|Overall Study||53
5017706|NCT02195583|12347214|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
5017707|NCT02195583|12347214|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
5017708|NCT02195583|12347214|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
5017709|NCT02195583|12347214|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
5017710|NCT02195583|12347214|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
5017711|NCT02195583|12347214|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
5017712|NCT02195583|12347214|P1|STARTED|Overall Study||62
5017713|NCT02195531|12347249|P3|NOT COMPLETED|Overall Study||1
5017714|NCT02195531|12347250|P2|NOT COMPLETED|Overall Study||1
5017715|NCT02195531|12347251|P1|NOT COMPLETED|Overall Study||1
5017716|NCT02195531|12347249|P3|COMPLETED|Overall Study||55
5017717|NCT02195531|12347250|P2|COMPLETED|Overall Study||48
5017718|NCT02195531|12347251|P1|COMPLETED|Overall Study||63
5017719|NCT02195531|12347249|P3|STARTED|Overall Study||56
5017720|NCT02195531|12347250|P2|STARTED|Overall Study||49
5017721|NCT02195531|12347251|P1|STARTED|Overall Study||64
5017722|NCT02195518|12347276|P1|NOT COMPLETED|Overall Study||9
5017723|NCT02195518|12347276|P1|COMPLETED|Overall Study||204
5017724|NCT02195518|12347276|P1|STARTED|Overall Study||213
5017725|NCT02195479|12347299|P2|NOT COMPLETED|Overall Study||350
5017726|NCT02195479|12347300|P1|NOT COMPLETED|Overall Study||356
5017727|NCT02195479|12347299|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
5017728|NCT02195479|12347300|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
5017729|NCT02195479|12347299|P2|Treated|Overall Study||346
5017730|NCT02195479|12347300|P1|Treated|Overall Study||354
5017731|NCT02195479|12347299|P2|STARTED|Overall Study||350
5017732|NCT02195479|12347300|P1|STARTED|Overall Study||356
5017733|NCT02195427|12347338|P2|NOT COMPLETED|Overall Study||27
5017734|NCT02195427|12347339|P1|NOT COMPLETED|Overall Study||26
5017735|NCT02195427|12347338|P2|COMPLETED|Overall Study||47
5017736|NCT02195427|12347339|P1|COMPLETED|Overall Study||47
5017737|NCT02195427|12347338|P2|N Patients at W52|Overall Study||56
5017738|NCT02195427|12347339|P1|N Patients at W52|Overall Study||63
5017739|NCT02195427|12347338|P2|N Patients at W36|Overall Study||59
5017740|NCT02195427|12347339|P1|N Patients at W36|Overall Study||65
5017741|NCT02195427|12347338|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
5017742|NCT02195427|12347339|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
5017743|NCT02195427|12347338|P2|STARTED|Overall Study||74
5017744|NCT02195427|12347339|P1|STARTED|Overall Study||73
5017745|NCT02195414|12347401|P1|NOT COMPLETED|Overall Study||0
5017746|NCT02195414|12347401|P1|COMPLETED|Overall Study||31
5017747|NCT02195414|12347401|P1|Primary Endpoint|Overall Study||31
5017748|NCT02195414|12347401|P1|STARTED|Overall Study||31
5017749|NCT02195349|12347419|P11|NOT COMPLETED|Overall Study||0
5017750|NCT02195349|12347420|P10|NOT COMPLETED|Overall Study||0
5017751|NCT02195349|12347421|P9|NOT COMPLETED|Overall Study||0
5017752|NCT02195349|12347422|P8|NOT COMPLETED|Overall Study||0
5017753|NCT02195349|12347423|P7|NOT COMPLETED|Overall Study||0
5017754|NCT02195349|12347424|P6|NOT COMPLETED|Overall Study||0
5017755|NCT02195349|12347425|P5|NOT COMPLETED|Overall Study||0
5017756|NCT02195349|12347426|P4|NOT COMPLETED|Overall Study||0
5017757|NCT02195349|12347427|P3|NOT COMPLETED|Overall Study||0
5017758|NCT02195349|12347428|P2|NOT COMPLETED|Overall Study||0
5017759|NCT02195349|12347429|P1|NOT COMPLETED|Overall Study||0
5017760|NCT02195349|12347419|P11|COMPLETED|Overall Study||6
5017761|NCT02195349|12347420|P10|COMPLETED|Overall Study||6
5017762|NCT02195349|12347421|P9|COMPLETED|Overall Study||6
5017763|NCT02195349|12347422|P8|COMPLETED|Overall Study||9
5017764|NCT02195349|12347423|P7|COMPLETED|Overall Study||6
5017765|NCT02195349|12347424|P6|COMPLETED|Overall Study||6
5017766|NCT02195349|12347425|P5|COMPLETED|Overall Study||6
5017767|NCT02195349|12347426|P4|COMPLETED|Overall Study||6
5017768|NCT02195349|12347427|P3|COMPLETED|Overall Study||1
5017769|NCT02195349|12347428|P2|COMPLETED|Overall Study||1
5017770|NCT02195349|12347429|P1|COMPLETED|Overall Study||14
5017771|NCT02195349|12347419|P11|STARTED|Overall Study||6
5017772|NCT02195349|12347420|P10|STARTED|Overall Study||6
5017773|NCT02195349|12347421|P9|STARTED|Overall Study||6
5017774|NCT02195349|12347422|P8|STARTED|Overall Study||9
5017775|NCT02195349|12347423|P7|STARTED|Overall Study||6
5017776|NCT02195349|12347424|P6|STARTED|Overall Study||6
5017777|NCT02195349|12347425|P5|STARTED|Overall Study||6
5017778|NCT02195349|12347426|P4|STARTED|Overall Study||6
5017779|NCT02195349|12347427|P3|STARTED|Overall Study||1
5017780|NCT02195349|12347428|P2|STARTED|Overall Study||1
5017781|NCT02195349|12347429|P1|STARTED|Overall Study||14
5017782|NCT02195310|12347682|P2|NOT COMPLETED|Overall Study||16
5017783|NCT02195310|12347683|P1|NOT COMPLETED|Overall Study||20
5017784|NCT02195310|12347682|P2|COMPLETED|Overall Study||153
5017785|NCT02195310|12347683|P1|COMPLETED|Overall Study||153
5017786|NCT02195310|12347682|P2|STARTED|Overall Study||169
5017787|NCT02195310|12347683|P1|STARTED|Overall Study||173
5017788|NCT02195232|12347691|P2|NOT COMPLETED|Overall Study||3
5017789|NCT02195232|12347692|P1|NOT COMPLETED|Overall Study||4
5017790|NCT02195232|12347691|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
5017791|NCT02195232|12347692|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
5017792|NCT02195232|12347691|P2|STARTED|Overall Study|patients consented|32
5017793|NCT02195232|12347692|P1|STARTED|Overall Study|patients consented|32
5017794|NCT02195011|12347704|P2|NOT COMPLETED|Overall Study||1
5017795|NCT02195011|12347705|P1|NOT COMPLETED|Overall Study||25
5017796|NCT02195011|12347704|P2|COMPLETED|Overall Study||0
5017797|NCT02195011|12347705|P1|COMPLETED|Overall Study||0
5017798|NCT02195011|12347704|P2|STARTED|Overall Study||1
5017799|NCT02195011|12347705|P1|STARTED|Overall Study||25
5017800|NCT02194998|12347721|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
5017801|NCT02194998|12347722|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
5017802|NCT02194998|12347723|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
5017803|NCT02194998|12347724|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
5017804|NCT02194998|12347721|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
5017805|NCT02194998|12347722|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
5017806|NCT02194998|12347723|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
5017807|NCT02194998|12347724|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
5017808|NCT02194998|12347721|P4|STARTED|Post-HCV Treatment Follow-Up||4
5017809|NCT02194998|12347722|P3|STARTED|Post-HCV Treatment Follow-Up||15
5017810|NCT02194998|12347723|P2|STARTED|Post-HCV Treatment Follow-Up||5
5017811|NCT02194998|12347724|P1|STARTED|Post-HCV Treatment Follow-Up||21
5017812|NCT02194998|12347721|P4|NOT COMPLETED|On-HCV Treatment||0
5017813|NCT02194998|12347722|P3|NOT COMPLETED|On-HCV Treatment||0
5017814|NCT02194998|12347723|P2|NOT COMPLETED|On-HCV Treatment||1
5017815|NCT02194998|12347724|P1|NOT COMPLETED|On-HCV Treatment||0
5017816|NCT02194998|12347721|P4|COMPLETED|On-HCV Treatment||4
5017817|NCT02194998|12347722|P3|COMPLETED|On-HCV Treatment||15
5017818|NCT02194998|12347723|P2|COMPLETED|On-HCV Treatment||5
5017819|NCT02194998|12347724|P1|COMPLETED|On-HCV Treatment||21
5017820|NCT02194998|12347721|P4|STARTED|On-HCV Treatment||4
5017821|NCT02194998|12347722|P3|STARTED|On-HCV Treatment||15
5017822|NCT02194998|12347723|P2|STARTED|On-HCV Treatment||6
5017823|NCT02194998|12347724|P1|STARTED|On-HCV Treatment||21
5017824|NCT02194933|12347788|P2|NOT COMPLETED|Overall Study||9
5017825|NCT02194933|12347789|P1|NOT COMPLETED|Overall Study||3
5017826|NCT02194933|12347788|P2|COMPLETED|Overall Study||10
5017827|NCT02194933|12347789|P1|COMPLETED|Overall Study||16
5017828|NCT02194933|12347788|P2|STARTED|Overall Study||19
5017829|NCT02194933|12347789|P1|STARTED|Overall Study||19
5017830|NCT02194699|12347843|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
5017831|NCT02194699|12347844|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
5017832|NCT02194699|12347843|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
5017833|NCT02194699|12347844|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
5017834|NCT02194699|12347843|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
5017835|NCT02194699|12347844|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
5017836|NCT02194699|12347843|P2|NOT COMPLETED|Randomised||11
5017837|NCT02194699|12347844|P1|NOT COMPLETED|Randomised||8
5017838|NCT02194699|12347843|P2|COMPLETED|Randomised||417
5017839|NCT02194699|12347844|P1|COMPLETED|Randomised||420
5017840|NCT02194699|12347843|P2|STARTED|Randomised||428
5017841|NCT02194699|12347844|P1|STARTED|Randomised||428
5017842|NCT02194621|12347952|P3|NOT COMPLETED|Overall Study||9
5017843|NCT02194621|12347953|P2|NOT COMPLETED|Overall Study||6
5017844|NCT02194621|12347954|P1|NOT COMPLETED|Overall Study||6
5017845|NCT02194621|12347952|P3|COMPLETED|Overall Study||34
5017846|NCT02194621|12347953|P2|COMPLETED|Overall Study||36
5017847|NCT02194621|12347954|P1|COMPLETED|Overall Study||37
5017848|NCT02194621|12347952|P3|STARTED|Overall Study||43
5017849|NCT02194621|12347953|P2|STARTED|Overall Study||42
5017850|NCT02194621|12347954|P1|STARTED|Overall Study||43
5017851|NCT02194465|12347978|P7|NOT COMPLETED|Overall Study||2
5017852|NCT02194465|12347979|P6|NOT COMPLETED|Overall Study||4
5017853|NCT02194465|12347980|P5|NOT COMPLETED|Overall Study||9
5017854|NCT02194465|12347981|P4|NOT COMPLETED|Overall Study||8
5017855|NCT02194465|12347982|P3|NOT COMPLETED|Overall Study||8
5017856|NCT02194465|12347983|P2|NOT COMPLETED|Overall Study||7
5017857|NCT02194465|12347984|P1|NOT COMPLETED|Overall Study||9
5017858|NCT02194465|12347978|P7|COMPLETED|Overall Study||24
5017859|NCT02194465|12347979|P6|COMPLETED|Overall Study||21
5017860|NCT02194465|12347980|P5|COMPLETED|Overall Study||42
5017861|NCT02194465|12347981|P4|COMPLETED|Overall Study||41
5017862|NCT02194465|12347982|P3|COMPLETED|Overall Study||44
5017863|NCT02194465|12347983|P2|COMPLETED|Overall Study||43
5017864|NCT02194465|12347984|P1|COMPLETED|Overall Study||42
5017865|NCT02194465|12347978|P7|Received at Least 1 Dose of Study Drug|Overall Study||26
5017866|NCT02194465|12347979|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
5017867|NCT02194465|12347980|P5|Received at Least 1 Dose of Study Drug|Overall Study||51
5017868|NCT02194465|12347981|P4|Received at Least 1 Dose of Study Drug|Overall Study||49
5017869|NCT02194465|12347982|P3|Received at Least 1 Dose of Study Drug|Overall Study||51
5017870|NCT02194465|12347983|P2|Received at Least 1 Dose of Study Drug|Overall Study||50
5017871|NCT02194465|12347984|P1|Received at Least 1 Dose of Study Drug|Overall Study||51
5017872|NCT02194465|12347978|P7|STARTED|Overall Study||26
5017873|NCT02194465|12347979|P6|STARTED|Overall Study||25
5017874|NCT02194465|12347980|P5|STARTED|Overall Study||51
5017875|NCT02194465|12347981|P4|STARTED|Overall Study||49
5017876|NCT02194465|12347982|P3|STARTED|Overall Study||52
5017877|NCT02194465|12347983|P2|STARTED|Overall Study||50
5017878|NCT02194465|12347984|P1|STARTED|Overall Study||51
5017879|NCT02194088|12348027|P2|NOT COMPLETED|Overall Study||0
5017880|NCT02194088|12348028|P1|NOT COMPLETED|Overall Study||0
5017881|NCT02194088|12348027|P2|COMPLETED|Overall Study||25
5017882|NCT02194088|12348028|P1|COMPLETED|Overall Study||75
5017883|NCT02194088|12348027|P2|STARTED|Overall Study||25
5017884|NCT02194088|12348028|P1|STARTED|Overall Study||75
5017885|NCT02194062|12348041|P3|NOT COMPLETED|Overall Study||5
5017886|NCT02194062|12348042|P2|NOT COMPLETED|Overall Study||2
5017887|NCT02194062|12348043|P1|NOT COMPLETED|Overall Study||2
5017888|NCT02194062|12348041|P3|COMPLETED|Overall Study||7
5017889|NCT02194062|12348042|P2|COMPLETED|Overall Study||8
5017890|NCT02194062|12348043|P1|COMPLETED|Overall Study||8
5017891|NCT02194062|12348041|P3|STARTED|Overall Study||12
5017892|NCT02194062|12348042|P2|STARTED|Overall Study||10
5017893|NCT02194062|12348043|P1|STARTED|Overall Study||10
5017894|NCT02193880|12348054|P1|NOT COMPLETED|Overall Study||3
5017895|NCT02193880|12348054|P1|COMPLETED|Overall Study||4
5017896|NCT02193880|12348054|P1|STARTED|Overall Study||7
5017897|NCT02193867|12348059|P1|NOT COMPLETED|Overall Study||4
5017898|NCT02193867|12348059|P1|COMPLETED|Overall Study||6
5017899|NCT02193867|12348059|P1|Completed 18 Months Of Treatment|Overall Study||8
5017900|NCT02193867|12348059|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
5017901|NCT02193867|12348059|P1|STARTED|Overall Study||10
5017902|NCT02193828|12348077|P4|NOT COMPLETED|Overall Study||1
5017903|NCT02193828|12348078|P3|NOT COMPLETED|Overall Study||1
5017904|NCT02193828|12348079|P2|NOT COMPLETED|Overall Study||0
5017905|NCT02193828|12348080|P1|NOT COMPLETED|Overall Study||0
5017906|NCT02193828|12348077|P4|COMPLETED|Overall Study||16
5017907|NCT02193828|12348078|P3|COMPLETED|Overall Study||22
5017908|NCT02193828|12348079|P2|COMPLETED|Overall Study||18
5017909|NCT02193828|12348080|P1|COMPLETED|Overall Study||18
5017910|NCT02193828|12348077|P4|STARTED|Overall Study||17
5017911|NCT02193828|12348078|P3|STARTED|Overall Study||23
5017912|NCT02193828|12348079|P2|STARTED|Overall Study||18
5017913|NCT02193828|12348080|P1|STARTED|Overall Study||18
5017914|NCT02193815|12348118|P1|NOT COMPLETED|Overall Study||0
5017915|NCT02193815|12348118|P1|COMPLETED|Overall Study||15
5017916|NCT02193815|12348118|P1|STARTED|Overall Study||15
5017917|NCT02193776|12348157|P4|NOT COMPLETED|Overall Study||2
5017918|NCT02193776|12348158|P3|NOT COMPLETED|Overall Study||2
5017919|NCT02193776|12348159|P2|NOT COMPLETED|Overall Study||7
5017920|NCT02193776|12348160|P1|NOT COMPLETED|Overall Study||8
5017921|NCT02193776|12348157|P4|COMPLETED|Overall Study||58
5017922|NCT02193776|12348158|P3|COMPLETED|Overall Study||59
5017923|NCT02193776|12348159|P2|COMPLETED|Overall Study||53
5017924|NCT02193776|12348160|P1|COMPLETED|Overall Study||51
5017925|NCT02193776|12348157|P4|Completed Day 140 Follow-up|Overall Study||58
5017926|NCT02193776|12348158|P3|Completed Day 140 Follow-up|Overall Study||58
5017927|NCT02193776|12348159|P2|Completed Day 140 Follow-up|Overall Study||52
5017928|NCT02193776|12348160|P1|Completed Day 140 Follow-up|Overall Study||52
5017929|NCT02193776|12348157|P4|Completed Day 70 Follow-up|Overall Study||60
5017930|NCT02193776|12348158|P3|Completed Day 70 Follow-up|Overall Study||60
5017931|NCT02193776|12348159|P2|Completed Day 70 Follow-up|Overall Study||56
5017932|NCT02193776|12348160|P1|Completed Day 70 Follow-up|Overall Study||54
5017933|NCT02193776|12348157|P4|STARTED|Overall Study||60
5017934|NCT02193776|12348158|P3|STARTED|Overall Study||61
5017935|NCT02193776|12348159|P2|STARTED|Overall Study||60
5017936|NCT02193776|12348160|P1|STARTED|Overall Study||59
5017937|NCT02193490|12348176|P2|NOT COMPLETED|Overall Study||2
5017938|NCT02193490|12348177|P1|NOT COMPLETED|Overall Study||4
5017939|NCT02193490|12348176|P2|COMPLETED|Overall Study||20
5017940|NCT02193490|12348177|P1|COMPLETED|Overall Study||21
5017941|NCT02193490|12348176|P2|STARTED|Overall Study||22
5017942|NCT02193490|12348177|P1|STARTED|Overall Study||25
5017943|NCT02193178|12348187|P1|NOT COMPLETED|Overall Study||2
5017944|NCT02193178|12348187|P1|COMPLETED|Overall Study||13
5017945|NCT02193178|12348187|P1|STARTED|Overall Study||15
5017946|NCT02193165|12348237|P3|NOT COMPLETED|6 Week Product Use||0
5017947|NCT02193165|12348238|P2|NOT COMPLETED|6 Week Product Use||1
5017948|NCT02193165|12348239|P1|NOT COMPLETED|6 Week Product Use||0
5017949|NCT02193165|12348237|P3|COMPLETED|6 Week Product Use||39
5017950|NCT02193165|12348238|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
5017951|NCT02193165|12348239|P1|COMPLETED|6 Week Product Use||39
5017952|NCT02193165|12348237|P3|STARTED|6 Week Product Use||39
5017953|NCT02193165|12348238|P2|STARTED|6 Week Product Use||39
5017954|NCT02193165|12348239|P1|STARTED|6 Week Product Use||39
5017955|NCT02193165|12348237|P3|NOT COMPLETED|4 Week Product Use||1
5017956|NCT02193165|12348238|P2|NOT COMPLETED|4 Week Product Use||1
5017957|NCT02193165|12348239|P1|NOT COMPLETED|4 Week Product Use||1
5017958|NCT02193165|12348237|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
5017959|NCT02193165|12348238|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
5017960|NCT02193165|12348239|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
5017961|NCT02193165|12348237|P3|STARTED|4 Week Product Use||40
5017962|NCT02193165|12348238|P2|STARTED|4 Week Product Use||40
5017963|NCT02193165|12348239|P1|STARTED|4 Week Product Use||40
5017964|NCT02193152|12348262|P1|NOT COMPLETED|Overall Study||0
5017965|NCT02193152|12348262|P1|COMPLETED|Overall Study||16
5017966|NCT02193152|12348262|P1|STARTED|Overall Study||16
5017967|NCT02193087|12348274|P4|NOT COMPLETED|Overall Study||79
5017968|NCT02193087|12348275|P3|NOT COMPLETED|Overall Study||7
5017969|NCT02193087|12348276|P2|NOT COMPLETED|Overall Study||14
5017970|NCT02193087|12348277|P1|NOT COMPLETED|Overall Study||37
5017971|NCT02193087|12348274|P4|COMPLETED|Overall Study||524
5017972|NCT02193087|12348275|P3|COMPLETED|Overall Study||93
5017973|NCT02193087|12348276|P2|COMPLETED|Overall Study||86
5017974|NCT02193087|12348277|P1|COMPLETED|Overall Study||162
5017975|NCT02193087|12348274|P4|Received Vaccination|Overall Study||602
5017976|NCT02193087|12348275|P3|Received Vaccination|Overall Study||100
5017977|NCT02193087|12348276|P2|Received Vaccination|Overall Study||97
5017978|NCT02193087|12348277|P1|Received Vaccination|Overall Study||197
5017979|NCT02193087|12348274|P4|STARTED|Overall Study||603
5017980|NCT02193087|12348275|P3|STARTED|Overall Study||100
5017981|NCT02193087|12348276|P2|STARTED|Overall Study||100
5017982|NCT02193087|12348277|P1|STARTED|Overall Study||199
5017983|NCT02193074|12348322|P2|NOT COMPLETED|Overall Study||15
5017984|NCT02193074|12348323|P1|NOT COMPLETED|Overall Study||17
5017985|NCT02193074|12348322|P2|COMPLETED|Overall Study||65
5017986|NCT02193074|12348323|P1|COMPLETED|Overall Study||24
5017987|NCT02193074|12348322|P2|Completed Due to Early Study Termination|Overall Study||39
5017988|NCT02193074|12348323|P1|Completed Due to Early Study Termination|Overall Study||13
5017989|NCT02193074|12348322|P2|Completed During Follow-Up Period|Overall Study||26
5017990|NCT02193074|12348323|P1|Completed During Follow-Up Period|Overall Study||11
5017991|NCT02193074|12348322|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
5017992|NCT02193074|12348323|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
5017993|NCT02192905|12348355|P1|NOT COMPLETED|Overall Study||1
5017994|NCT02192905|12348355|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
5017995|NCT02192905|12348355|P1|STARTED|Overall Study||43
5017996|NCT02192879|12348369|P3|NOT COMPLETED|Overall Study||0
5017997|NCT02192879|12348370|P2|NOT COMPLETED|Overall Study||0
5017998|NCT02192879|12348371|P1|NOT COMPLETED|Overall Study||0
5017999|NCT02192879|12348369|P3|COMPLETED|Overall Study||3
5018000|NCT02192879|12348370|P2|COMPLETED|Overall Study||4
5018001|NCT02192879|12348371|P1|COMPLETED|Overall Study||3
5018002|NCT02192879|12348369|P3|STARTED|Overall Study||3
5018003|NCT02192879|12348370|P2|STARTED|Overall Study||4
5018004|NCT02192879|12348371|P1|STARTED|Overall Study||3
5018005|NCT02192814|12348397|P1|NOT COMPLETED|Overall Study||0
5018006|NCT02192814|12348397|P1|COMPLETED|Overall Study||9
5018007|NCT02192814|12348397|P1|STARTED|Overall Study||9
5018008|NCT02192684|12348410|P2|NOT COMPLETED|Overall Study||0
5018009|NCT02192684|12348411|P1|NOT COMPLETED|Overall Study||0
5018010|NCT02192684|12348410|P2|COMPLETED|Overall Study||15
5018011|NCT02192684|12348411|P1|COMPLETED|Overall Study||30
5018012|NCT02192684|12348410|P2|STARTED|Overall Study||15
5018013|NCT02192684|12348411|P1|STARTED|Overall Study||30
5018014|NCT02192606|12348419|P2|NOT COMPLETED|Overall Study||4
5018015|NCT02192606|12348420|P1|NOT COMPLETED|Overall Study||2
5018016|NCT02192606|12348419|P2|COMPLETED|Overall Study||24
5018017|NCT02192606|12348420|P1|COMPLETED|Overall Study||27
5018018|NCT02192606|12348419|P2|STARTED|Overall Study||28
5018019|NCT02192606|12348420|P1|STARTED|Overall Study||29
5018020|NCT02192541|12348430|P2|NOT COMPLETED|Overall Study||0
5018021|NCT02192541|12348431|P1|NOT COMPLETED|Overall Study||0
5018022|NCT02192541|12348430|P2|COMPLETED|Overall Study||3
5018023|NCT02192541|12348431|P1|COMPLETED|Overall Study||2
5018024|NCT02192541|12348430|P2|Evaluable for Response|Overall Study||3
5018025|NCT02192541|12348431|P1|Evaluable for Response|Overall Study||1
5018026|NCT02192541|12348430|P2|Treated|Overall Study||3
5018027|NCT02192541|12348431|P1|Treated|Overall Study||2
5018028|NCT02192541|12348430|P2|STARTED|Overall Study||3
5018029|NCT02192541|12348431|P1|STARTED|Overall Study||2
5018030|NCT02192307|12348453|P2|NOT COMPLETED|Overall Study||0
5018031|NCT02192307|12348454|P1|NOT COMPLETED|Overall Study||0
5018032|NCT02192307|12348453|P2|COMPLETED|Overall Study||30
5018033|NCT02192307|12348454|P1|COMPLETED|Overall Study||30
5018034|NCT02192307|12348453|P2|STARTED|Overall Study||30
5018035|NCT02192307|12348454|P1|STARTED|Overall Study||30
5018036|NCT02192190|12348468|P6|NOT COMPLETED|Overall Study||29
5018037|NCT02192190|12348469|P5|NOT COMPLETED|Overall Study||30
5018038|NCT02192190|12348470|P4|NOT COMPLETED|Overall Study||26
5018039|NCT02192190|12348471|P3|NOT COMPLETED|Overall Study||25
5018040|NCT02192190|12348472|P2|NOT COMPLETED|Overall Study||29
5018041|NCT02192190|12348473|P1|NOT COMPLETED|Overall Study||54
5018042|NCT02192190|12348468|P6|COMPLETED|Overall Study||9
5018043|NCT02192190|12348469|P5|COMPLETED|Overall Study||9
5018044|NCT02192190|12348470|P4|COMPLETED|Overall Study||12
5018045|NCT02192190|12348471|P3|COMPLETED|Overall Study||13
5018046|NCT02192190|12348472|P2|COMPLETED|Overall Study||10
5018047|NCT02192190|12348473|P1|COMPLETED|Overall Study||22
5018048|NCT02192190|12348468|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
5018049|NCT02192190|12348469|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
5018050|NCT02192190|12348470|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
5018051|NCT02192190|12348471|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
5018052|NCT02192190|12348472|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
5018053|NCT02192190|12348473|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
5018054|NCT02192190|12348468|P6|STARTED|Overall Study||38
5018055|NCT02192190|12348469|P5|STARTED|Overall Study||39
5018056|NCT02192190|12348470|P4|STARTED|Overall Study||38
5018057|NCT02192190|12348471|P3|STARTED|Overall Study||38
5018058|NCT02192190|12348472|P2|STARTED|Overall Study||39
5018059|NCT02192190|12348473|P1|STARTED|Overall Study||76
5018060|NCT02192164|12348517|P1|NOT COMPLETED|Overall Study||14
5018061|NCT02192164|12348517|P1|COMPLETED|Overall Study||112
5018062|NCT02192164|12348517|P1|Etanercept Treated Population|Overall Study||112
5018063|NCT02192164|12348517|P1|STARTED|Overall Study||126
5018064|NCT02192099|12348533|P1|NOT COMPLETED|Overall Study||61
5018065|NCT02192099|12348533|P1|COMPLETED|Overall Study||0
5018066|NCT02192099|12348533|P1|STARTED|Overall Study||61
5018067|NCT02191865|12348540|P3|NOT COMPLETED|Overall Study||0
5018068|NCT02191865|12348541|P2|NOT COMPLETED|Overall Study||0
5018069|NCT02191865|12348542|P1|NOT COMPLETED|Overall Study||0
5018070|NCT02191865|12348540|P3|COMPLETED|Overall Study||17
5018071|NCT02191865|12348541|P2|COMPLETED|Overall Study||8
5018072|NCT02191865|12348542|P1|COMPLETED|Overall Study||8
5018073|NCT02191865|12348540|P3|STARTED|Overall Study||17
5018074|NCT02191865|12348541|P2|STARTED|Overall Study||8
5018075|NCT02191865|12348542|P1|STARTED|Overall Study||8
5018076|NCT02191618|12348562|P1|NOT COMPLETED|Overall Study||7
5018077|NCT02191618|12348562|P1|COMPLETED|Overall Study||143
5018078|NCT02191618|12348562|P1|STARTED|Overall Study||150
5018079|NCT02191605|12348572|P5|NOT COMPLETED|Overall Study||4
5018080|NCT02191605|12348573|P4|NOT COMPLETED|Overall Study||3
5018081|NCT02191605|12348574|P3|NOT COMPLETED|Overall Study||7
5018082|NCT02191605|12348575|P2|NOT COMPLETED|Overall Study||4
5018083|NCT02191605|12348576|P1|NOT COMPLETED|Overall Study||9
5018084|NCT02191605|12348572|P5|COMPLETED|Overall Study||3
5018085|NCT02191605|12348573|P4|COMPLETED|Overall Study||5
5018086|NCT02191605|12348574|P3|COMPLETED|Overall Study||8
5018087|NCT02191605|12348575|P2|COMPLETED|Overall Study||11
5018088|NCT02191605|12348576|P1|COMPLETED|Overall Study||6
5018089|NCT02191605|12348572|P5|Completed Intervention Portion|Overall Study||7
5018090|NCT02191605|12348573|P4|Completed Intervention Portion|Overall Study||8
5018091|NCT02191605|12348574|P3|Completed Intervention Portion|Overall Study||15
5018092|NCT02191605|12348575|P2|Completed Intervention Portion|Overall Study||15
5018093|NCT02191605|12348576|P1|Completed Intervention Portion|Overall Study||15
5018094|NCT02191605|12348572|P5|STARTED|Overall Study||7
5018095|NCT02191605|12348573|P4|STARTED|Overall Study||8
5018096|NCT02191605|12348574|P3|STARTED|Overall Study||15
5018097|NCT02191605|12348575|P2|STARTED|Overall Study||15
5018098|NCT02191605|12348576|P1|STARTED|Overall Study||15
5018099|NCT02191579|12348595|P2|NOT COMPLETED|Treatment 2||25
5018100|NCT02191579|12348596|P1|NOT COMPLETED|Treatment 2||0
5018101|NCT02191579|12348595|P2|COMPLETED|Treatment 2||55
5018102|NCT02191579|12348596|P1|COMPLETED|Treatment 2||0
5018103|NCT02191579|12348595|P2|STARTED|Treatment 2||80
5018104|NCT02191579|12348596|P1|STARTED|Treatment 2||0
5018105|NCT02191579|12348595|P2|NOT COMPLETED|Treatment 1||58
5018106|NCT02191579|12348596|P1|NOT COMPLETED|Treatment 1||27
5018107|NCT02191579|12348595|P2|COMPLETED|Treatment 1||84
5018108|NCT02191579|12348596|P1|COMPLETED|Treatment 1||113
5018109|NCT02191579|12348595|P2|STARTED|Treatment 1||142
5018110|NCT02191579|12348596|P1|STARTED|Treatment 1||140
5018111|NCT02191397|12348610|P2|NOT COMPLETED|Overall Study||70
5018112|NCT02191397|12348611|P1|NOT COMPLETED|Overall Study||83
5018113|NCT02191397|12348610|P2|COMPLETED|Overall Study||198
5018114|NCT02191397|12348611|P1|COMPLETED|Overall Study||183
5018115|NCT02191397|12348610|P2|STARTED|Overall Study||268
5018116|NCT02191397|12348611|P1|STARTED|Overall Study||266
5018117|NCT02191267|12348672|P3|NOT COMPLETED|Overall Study||0
5018118|NCT02191267|12348673|P2|NOT COMPLETED|Overall Study||0
5018119|NCT02191267|12348674|P1|NOT COMPLETED|Overall Study||1
5018120|NCT02191267|12348672|P3|COMPLETED|Overall Study||4
5018121|NCT02191267|12348673|P2|COMPLETED|Overall Study||6
5018122|NCT02191267|12348674|P1|COMPLETED|Overall Study||19
5018123|NCT02191267|12348672|P3|STARTED|Overall Study||4
5018124|NCT02191267|12348673|P2|STARTED|Overall Study||6
5018125|NCT02191267|12348674|P1|STARTED|Overall Study||20
5018126|NCT02191137|12348685|P1|NOT COMPLETED|Follow-up||5
5018127|NCT02191137|12348685|P1|COMPLETED|Follow-up||60
5018128|NCT02191137|12348685|P1|STARTED|Follow-up||65
5018129|NCT02191137|12348685|P1|NOT COMPLETED|Treatment||10
5018130|NCT02191137|12348685|P1|COMPLETED|Treatment||65
5018131|NCT02191137|12348685|P1|STARTED|Treatment||75
5018132|NCT02191046|12348715|P2|NOT COMPLETED|Overall Study||1
5018133|NCT02191046|12348716|P1|NOT COMPLETED|Overall Study||5
5018134|NCT02191046|12348715|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
5018135|NCT02191046|12348716|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
5018136|NCT02191046|12348715|P2|STARTED|Overall Study||39
5018137|NCT02191046|12348716|P1|STARTED|Overall Study||41
5018138|NCT02191033|12348724|P2|NOT COMPLETED|Overall Study||1
5018139|NCT02191033|12348725|P1|NOT COMPLETED|Overall Study||2
5018140|NCT02191033|12348724|P2|COMPLETED|Overall Study||19
5018141|NCT02191033|12348725|P1|COMPLETED|Overall Study||18
5018142|NCT02191033|12348724|P2|STARTED|Overall Study||20
5018143|NCT02191033|12348725|P1|STARTED|Overall Study||20
5018144|NCT02190903|12348737|P2|NOT COMPLETED|Overall Study||0
5018145|NCT02190903|12348738|P1|NOT COMPLETED|Overall Study||0
5018146|NCT02190903|12348737|P2|COMPLETED|Overall Study||6
5018147|NCT02190903|12348738|P1|COMPLETED|Overall Study||6
5018148|NCT02190903|12348737|P2|STARTED|Overall Study||6
5018149|NCT02190903|12348738|P1|STARTED|Overall Study||6
5018150|NCT02190747|12348747|P3|NOT COMPLETED|Overall Study||0
5018151|NCT02190747|12348748|P2|NOT COMPLETED|Overall Study||0
5018152|NCT02190747|12348749|P1|NOT COMPLETED|Overall Study||0
5018153|NCT02190747|12348747|P3|COMPLETED|Overall Study||10
5018154|NCT02190747|12348748|P2|COMPLETED|Overall Study||9
5018155|NCT02190747|12348749|P1|COMPLETED|Overall Study||21
5018156|NCT02190747|12348747|P3|STARTED|Overall Study||10
5018157|NCT02190747|12348748|P2|STARTED|Overall Study||9
5018158|NCT02190747|12348749|P1|STARTED|Overall Study||21
5018159|NCT02190721|12348823|P3|NOT COMPLETED|Overall Study||0
5018160|NCT02190721|12348824|P2|NOT COMPLETED|Overall Study||1
5018161|NCT02190721|12348825|P1|NOT COMPLETED|Overall Study||0
5018162|NCT02190721|12348823|P3|COMPLETED|Overall Study||18
5018163|NCT02190721|12348824|P2|COMPLETED|Overall Study||29
5018164|NCT02190721|12348825|P1|COMPLETED|Overall Study||2
5018165|NCT02190721|12348823|P3|Completed 90 Day Follow-up|Overall Study||18
5018166|NCT02190721|12348824|P2|Completed 90 Day Follow-up|Overall Study||29
5018167|NCT02190721|12348825|P1|Completed 90 Day Follow-up|Overall Study||2
5018168|NCT02190721|12348823|P3|Completed 30 Day Follow-up|Overall Study||18
5018169|NCT02190721|12348824|P2|Completed 30 Day Follow-up|Overall Study||29
5018170|NCT02190721|12348825|P1|Completed 30 Day Follow-up|Overall Study||2
5018171|NCT02190721|12348823|P3|Completed Treatment|Overall Study||18
5018172|NCT02190721|12348824|P2|Completed Treatment|Overall Study||30
5018173|NCT02190721|12348825|P1|Completed Treatment|Overall Study||2
5018174|NCT02190721|12348823|P3|STARTED|Overall Study||18
5018175|NCT02190721|12348824|P2|STARTED|Overall Study||30
5018176|NCT02190721|12348825|P1|STARTED|Overall Study||2
5018177|NCT02190604|12348948|P19|NOT COMPLETED|Part 3 (Patients)||0
5018178|NCT02190604|12348949|P18|NOT COMPLETED|Part 3 (Patients)||0
5018179|NCT02190604|12348950|P17|NOT COMPLETED|Part 3 (Patients)||0
5018180|NCT02190604|12348951|P16|NOT COMPLETED|Part 3 (Patients)||0
5018181|NCT02190604|12348952|P15|NOT COMPLETED|Part 3 (Patients)||0
5018182|NCT02190604|12348953|P14|NOT COMPLETED|Part 3 (Patients)||0
5018183|NCT02190604|12348954|P13|NOT COMPLETED|Part 3 (Patients)||0
5018184|NCT02190604|12348955|P12|NOT COMPLETED|Part 3 (Patients)||0
5018185|NCT02190604|12348956|P11|NOT COMPLETED|Part 3 (Patients)||0
5018186|NCT02190604|12348957|P10|NOT COMPLETED|Part 3 (Patients)||0
5018187|NCT02190604|12348958|P9|NOT COMPLETED|Part 3 (Patients)||0
5018188|NCT02190604|12348959|P8|NOT COMPLETED|Part 3 (Patients)||0
5018189|NCT02190604|12348960|P7|NOT COMPLETED|Part 3 (Patients)||0
5018190|NCT02190604|12348961|P6|NOT COMPLETED|Part 3 (Patients)||0
5018191|NCT02190604|12348962|P5|NOT COMPLETED|Part 3 (Patients)||0
5018192|NCT02190604|12348963|P4|NOT COMPLETED|Part 3 (Patients)||0
5018193|NCT02190604|12348964|P3|NOT COMPLETED|Part 3 (Patients)||0
5018194|NCT02190604|12348965|P2|NOT COMPLETED|Part 3 (Patients)||0
5018195|NCT02190604|12348966|P1|NOT COMPLETED|Part 3 (Patients)||0
5018196|NCT02190604|12348948|P19|COMPLETED|Part 3 (Patients)||12
5018197|NCT02190604|12348949|P18|COMPLETED|Part 3 (Patients)||19
5018198|NCT02190604|12348950|P17|COMPLETED|Part 3 (Patients)||12
5018199|NCT02190604|12348951|P16|COMPLETED|Part 3 (Patients)||6
5018200|NCT02190604|12348952|P15|COMPLETED|Part 3 (Patients)||0
5018201|NCT02190604|12348953|P14|COMPLETED|Part 3 (Patients)||0
5018202|NCT02190604|12348954|P13|COMPLETED|Part 3 (Patients)||0
5018203|NCT02190604|12348955|P12|COMPLETED|Part 3 (Patients)||0
5018204|NCT02190604|12348956|P11|COMPLETED|Part 3 (Patients)||0
5018205|NCT02190604|12348957|P10|COMPLETED|Part 3 (Patients)||0
5018206|NCT02190604|12348958|P9|COMPLETED|Part 3 (Patients)||0
5018207|NCT02190604|12348959|P8|COMPLETED|Part 3 (Patients)||0
5018208|NCT02190604|12348960|P7|COMPLETED|Part 3 (Patients)||0
5018209|NCT02190604|12348961|P6|COMPLETED|Part 3 (Patients)||0
5018210|NCT02190604|12348962|P5|COMPLETED|Part 3 (Patients)||0
5018211|NCT02190604|12348963|P4|COMPLETED|Part 3 (Patients)||0
5018212|NCT02190604|12348964|P3|COMPLETED|Part 3 (Patients)||0
5018213|NCT02190604|12348965|P2|COMPLETED|Part 3 (Patients)||0
5018214|NCT02190604|12348966|P1|COMPLETED|Part 3 (Patients)||0
5018215|NCT02190604|12348948|P19|STARTED|Part 3 (Patients)||12
5018216|NCT02190604|12348949|P18|STARTED|Part 3 (Patients)||19
5018217|NCT02190604|12348950|P17|STARTED|Part 3 (Patients)||12
5018218|NCT02190604|12348951|P16|STARTED|Part 3 (Patients)||6
5018219|NCT02190604|12348952|P15|STARTED|Part 3 (Patients)||0
5018220|NCT02190604|12348953|P14|STARTED|Part 3 (Patients)||0
5018221|NCT02190604|12348954|P13|STARTED|Part 3 (Patients)||0
5018222|NCT02190604|12348955|P12|STARTED|Part 3 (Patients)||0
5018223|NCT02190604|12348956|P11|STARTED|Part 3 (Patients)||0
5018224|NCT02190604|12348957|P10|STARTED|Part 3 (Patients)||0
5018225|NCT02190604|12348958|P9|STARTED|Part 3 (Patients)||0
5018226|NCT02190604|12348959|P8|STARTED|Part 3 (Patients)||0
5018227|NCT02190604|12348960|P7|STARTED|Part 3 (Patients)||0
5018228|NCT02190604|12348961|P6|STARTED|Part 3 (Patients)||0
5018229|NCT02190604|12348962|P5|STARTED|Part 3 (Patients)||0
5018230|NCT02190604|12348963|P4|STARTED|Part 3 (Patients)||0
5018231|NCT02190604|12348964|P3|STARTED|Part 3 (Patients)||0
5018232|NCT02190604|12348965|P2|STARTED|Part 3 (Patients)||0
5018233|NCT02190604|12348966|P1|STARTED|Part 3 (Patients)||0
5018234|NCT02190604|12348948|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018235|NCT02190604|12348949|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018236|NCT02190604|12348950|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018237|NCT02190604|12348951|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018238|NCT02190604|12348952|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
5018239|NCT02190604|12348953|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
5018240|NCT02190604|12348954|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018241|NCT02190604|12348955|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018242|NCT02190604|12348956|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018243|NCT02190604|12348957|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018244|NCT02190604|12348958|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018245|NCT02190604|12348959|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018246|NCT02190604|12348960|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018247|NCT02190604|12348961|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018248|NCT02190604|12348962|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018249|NCT02190604|12348963|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018250|NCT02190604|12348964|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018251|NCT02190604|12348965|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018252|NCT02190604|12348966|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018253|NCT02190604|12348948|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018254|NCT02190604|12348949|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018255|NCT02190604|12348950|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018256|NCT02190604|12348951|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
5018257|NCT02190604|12348952|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
5018258|NCT02190604|12348953|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
5018259|NCT02190604|12348954|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018260|NCT02190604|12348955|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018261|NCT02190604|12348956|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018262|NCT02190604|12348957|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018263|NCT02190604|12348958|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
5018264|NCT02190604|12348959|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018265|NCT02190604|12348960|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018266|NCT02190604|12348961|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018267|NCT02190604|12348962|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018268|NCT02190604|12348963|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018269|NCT02190604|12348964|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018270|NCT02190604|12348965|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018271|NCT02190604|12348966|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
5018272|NCT02190604|12348948|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
5018273|NCT02190604|12348949|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
5018274|NCT02190604|12348950|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
5018275|NCT02190604|12348951|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
5018276|NCT02190604|12348952|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
5018277|NCT02190604|12348953|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018278|NCT02190604|12348954|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018279|NCT02190604|12348955|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018280|NCT02190604|12348956|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018281|NCT02190604|12348957|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018282|NCT02190604|12348958|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
5018283|NCT02190604|12348959|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018284|NCT02190604|12348960|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018285|NCT02190604|12348961|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018286|NCT02190604|12348962|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018287|NCT02190604|12348963|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018288|NCT02190604|12348964|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018289|NCT02190604|12348965|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018290|NCT02190604|12348966|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
5018291|NCT02190591|12349157|P2|NOT COMPLETED|Overall Study||11
5018292|NCT02190591|12349158|P1|NOT COMPLETED|Overall Study||2
5018293|NCT02190591|12349157|P2|COMPLETED|Overall Study||91
5018294|NCT02190591|12349158|P1|COMPLETED|Overall Study||100
5018295|NCT02190591|12349157|P2|STARTED|Overall Study||102
5018296|NCT02190591|12349158|P1|STARTED|Overall Study||102
5018297|NCT02190552|12349168|P1|NOT COMPLETED|Overall Study||4
5018298|NCT02190552|12349168|P1|COMPLETED|Overall Study||36
5018299|NCT02190552|12349168|P1|STARTED|Overall Study||40
5018300|NCT02190435|12349181|P2|NOT COMPLETED|Overall Study||0
5018301|NCT02190435|12349182|P1|NOT COMPLETED|Overall Study||15
5018302|NCT02190435|12349181|P2|COMPLETED|Overall Study||24
5018303|NCT02190435|12349182|P1|COMPLETED|Overall Study||26
5018304|NCT02190435|12349181|P2|STARTED|Overall Study||24
5018305|NCT02190435|12349182|P1|STARTED|Overall Study||41
5018306|NCT02190279|12349193|P3|NOT COMPLETED|Overall Study||3
5018307|NCT02190279|12349194|P2|NOT COMPLETED|Overall Study||0
5018308|NCT02190279|12349195|P1|NOT COMPLETED|Overall Study||3
5018309|NCT02190279|12349193|P3|COMPLETED|Overall Study||28
5018310|NCT02190279|12349194|P2|COMPLETED|Overall Study||69
5018311|NCT02190279|12349195|P1|COMPLETED|Overall Study||13
5018312|NCT02190279|12349193|P3|STARTED|Overall Study||31
5018313|NCT02190279|12349194|P2|STARTED|Overall Study||69
5018314|NCT02190279|12349195|P1|STARTED|Overall Study||16
5018315|NCT02190045|12349216|P2|NOT COMPLETED|Overall Study||0
5018316|NCT02190045|12349217|P1|NOT COMPLETED|Overall Study||3
5018317|NCT02190045|12349216|P2|COMPLETED|Overall Study||15
5018318|NCT02190045|12349217|P1|COMPLETED|Overall Study||12
5018319|NCT02190045|12349216|P2|STARTED|Overall Study||15
5018320|NCT02190045|12349217|P1|STARTED|Overall Study||15
5018321|NCT02189954|12349225|P2|NOT COMPLETED|Overall Study||0
5018322|NCT02189954|12349226|P1|NOT COMPLETED|Overall Study||0
5018323|NCT02189954|12349225|P2|COMPLETED|Overall Study||45
5018324|NCT02189954|12349226|P1|COMPLETED|Overall Study||45
5018325|NCT02189954|12349225|P2|STARTED|Overall Study||45
5018326|NCT02189954|12349226|P1|STARTED|Overall Study||45
5018327|NCT02189941|12349234|P3|NOT COMPLETED|Overall Study||1
5018328|NCT02189941|12349235|P2|NOT COMPLETED|Overall Study||0
5018329|NCT02189941|12349236|P1|NOT COMPLETED|Overall Study||0
5018330|NCT02189941|12349234|P3|COMPLETED|Overall Study||2
5018331|NCT02189941|12349235|P2|COMPLETED|Overall Study||4
5018332|NCT02189941|12349236|P1|COMPLETED|Overall Study||4
5018333|NCT02189941|12349234|P3|STARTED|Overall Study||3
5018334|NCT02189941|12349235|P2|STARTED|Overall Study||4
5018335|NCT02189941|12349236|P1|STARTED|Overall Study||4
5018336|NCT02189915|12349259|P1|NOT COMPLETED|Overall Study||3
5018337|NCT02189915|12349259|P1|COMPLETED|Overall Study||11
5018338|NCT02189915|12349259|P1|STARTED|Overall Study||14
5018339|NCT02189863|12349264|P2|NOT COMPLETED|Second 2 Weeks||0
5018340|NCT02189863|12349265|P1|NOT COMPLETED|Second 2 Weeks||0
5018341|NCT02189863|12349264|P2|COMPLETED|Second 2 Weeks||13
5018342|NCT02189863|12349265|P1|COMPLETED|Second 2 Weeks||8
5018343|NCT02189863|12349264|P2|STARTED|Second 2 Weeks||13
5018344|NCT02189863|12349265|P1|STARTED|Second 2 Weeks||8
5018345|NCT02189863|12349264|P2|NOT COMPLETED|First 2 Weeks||2
5018346|NCT02189863|12349265|P1|NOT COMPLETED|First 2 Weeks||4
5018347|NCT02189863|12349264|P2|COMPLETED|First 2 Weeks||13
5018348|NCT02189863|12349265|P1|COMPLETED|First 2 Weeks||8
5018349|NCT02189863|12349264|P2|STARTED|First 2 Weeks||15
5018350|NCT02189863|12349265|P1|STARTED|First 2 Weeks||12
5018351|NCT02189837|12349280|P4|NOT COMPLETED|Overall Study||2
5018352|NCT02189837|12349281|P3|NOT COMPLETED|Overall Study||3
5018353|NCT02189837|12349282|P2|NOT COMPLETED|Overall Study||1
5018354|NCT02189837|12349283|P1|NOT COMPLETED|Overall Study||2
5018355|NCT02189837|12349280|P4|COMPLETED|Overall Study||19
5018356|NCT02189837|12349281|P3|COMPLETED|Overall Study||20
5018357|NCT02189837|12349282|P2|COMPLETED|Overall Study||22
5018358|NCT02189837|12349283|P1|COMPLETED|Overall Study||20
5018359|NCT02189837|12349280|P4|Received Treatment|Overall Study||20
5018360|NCT02189837|12349281|P3|Received Treatment|Overall Study||22
5018361|NCT02189837|12349282|P2|Received Treatment|Overall Study||22
5018362|NCT02189837|12349283|P1|Received Treatment|Overall Study||21
5018363|NCT02189837|12349280|P4|STARTED|Overall Study||21
5018364|NCT02189837|12349281|P3|STARTED|Overall Study||23
5018365|NCT02189837|12349282|P2|STARTED|Overall Study||23
5018366|NCT02189837|12349283|P1|STARTED|Overall Study||22
5018367|NCT02189759|12349313|P4|NOT COMPLETED|Overall Study||5
5018368|NCT02189759|12349314|P3|NOT COMPLETED|Overall Study||2
5018369|NCT02189759|12349315|P2|NOT COMPLETED|Overall Study||0
5018370|NCT02189759|12349316|P1|NOT COMPLETED|Overall Study||0
5018371|NCT02189759|12349313|P4|COMPLETED|Overall Study||84
5018372|NCT02189759|12349314|P3|COMPLETED|Overall Study||81
5018373|NCT02189759|12349315|P2|COMPLETED|Overall Study||101
5018374|NCT02189759|12349316|P1|COMPLETED|Overall Study||102
5018375|NCT02189759|12349313|P4|STARTED|Overall Study||89
5018376|NCT02189759|12349314|P3|STARTED|Overall Study||83
5018377|NCT02189759|12349315|P2|STARTED|Overall Study||101
5018378|NCT02189759|12349316|P1|STARTED|Overall Study||102
5018379|NCT02189668|12349336|P2|NOT COMPLETED|Overall Study||0
5018380|NCT02189668|12349337|P1|NOT COMPLETED|Overall Study||0
5018381|NCT02189668|12349336|P2|COMPLETED|Overall Study||9
5018382|NCT02189668|12349337|P1|COMPLETED|Overall Study||5
5018383|NCT02189668|12349336|P2|STARTED|Overall Study||9
5018384|NCT02189668|12349337|P1|STARTED|Overall Study||5
5018385|NCT02189629|12349345|P1|NOT COMPLETED|Overall Study||105
5018386|NCT02189629|12349345|P1|COMPLETED|Overall Study||348
5018387|NCT02189629|12349345|P1|STARTED|Overall Study||453
5018388|NCT02189473|12349352|P2|NOT COMPLETED|Overall Study||25
5018389|NCT02189473|12349353|P1|NOT COMPLETED|Overall Study||23
5018390|NCT02189473|12349352|P2|COMPLETED|Overall Study||77
5018391|NCT02189473|12349353|P1|COMPLETED|Overall Study||78
5018392|NCT02189473|12349352|P2|STARTED|Overall Study||102
5018393|NCT02189473|12349353|P1|STARTED|Overall Study||101
5018394|NCT02189382|12349375|P2|NOT COMPLETED|Overall Study||0
5018395|NCT02189382|12349376|P1|NOT COMPLETED|Overall Study||0
5018396|NCT02189382|12349375|P2|COMPLETED|Overall Study||35
5018397|NCT02189382|12349376|P1|COMPLETED|Overall Study||35
5018398|NCT02189382|12349375|P2|STARTED|Overall Study||35
5018399|NCT02189382|12349376|P1|STARTED|Overall Study||35
5018400|NCT02189317|12349386|P2|NOT COMPLETED|Overall Study||0
5018401|NCT02189317|12349387|P1|NOT COMPLETED|Overall Study||0
5018402|NCT02189317|12349386|P2|COMPLETED|Overall Study||16
5018403|NCT02189317|12349387|P1|COMPLETED|Overall Study||16
5018404|NCT02189317|12349386|P2|STARTED|Overall Study||16
5018405|NCT02189317|12349387|P1|STARTED|Overall Study||16
5018406|NCT02189252|12349401|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
5018407|NCT02189252|12349402|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
5018408|NCT02189252|12349403|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
5018409|NCT02189252|12349404|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
5018410|NCT02189252|12349401|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
5018411|NCT02189252|12349402|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
5018412|NCT02189252|12349403|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
5018413|NCT02189252|12349404|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
5018414|NCT02189252|12349401|P4|STARTED|Period 2 (Visit6b, Week 12)||4
5018415|NCT02189252|12349402|P3|STARTED|Period 2 (Visit6b, Week 12)||3
5018416|NCT02189252|12349403|P2|STARTED|Period 2 (Visit6b, Week 12)||2
5018417|NCT02189252|12349404|P1|STARTED|Period 2 (Visit6b, Week 12)||4
5018418|NCT02189252|12349401|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
5018419|NCT02189252|12349402|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
5018420|NCT02189252|12349403|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
5018421|NCT02189252|12349404|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
5018422|NCT02189252|12349401|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
5018423|NCT02189252|12349402|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
5018424|NCT02189252|12349403|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
5018425|NCT02189252|12349404|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
5018426|NCT02189252|12349401|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
5018427|NCT02189252|12349402|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
5018428|NCT02189252|12349403|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
5018429|NCT02189252|12349404|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
5018430|NCT02189161|12349436|P1|NOT COMPLETED|Overall Study||0
5018431|NCT02189161|12349436|P1|COMPLETED|Overall Study||10
5018432|NCT02189161|12349436|P1|STARTED|Overall Study||10
5018433|NCT02189122|12349444|P2|NOT COMPLETED|Overall Study||0
5018434|NCT02189122|12349445|P1|NOT COMPLETED|Overall Study||0
5018435|NCT02189122|12349444|P2|COMPLETED|Overall Study||18
5018436|NCT02189122|12349445|P1|COMPLETED|Overall Study||18
5018437|NCT02189122|12349444|P2|STARTED|Overall Study||18
5018438|NCT02189122|12349445|P1|STARTED|Overall Study||18
5018439|NCT02188849|12349463|P2|NOT COMPLETED|Overall Study||8
5018440|NCT02188849|12349464|P1|NOT COMPLETED|Overall Study||3
5018441|NCT02188849|12349463|P2|COMPLETED|Overall Study||17
5018442|NCT02188849|12349464|P1|COMPLETED|Overall Study||22
5018443|NCT02188849|12349463|P2|STARTED|Overall Study||25
5018444|NCT02188849|12349464|P1|STARTED|Overall Study||25
5018445|NCT02188784|12349478|P2|NOT COMPLETED|Overall Study||13
5018446|NCT02188784|12349479|P1|NOT COMPLETED|Overall Study||9
5018447|NCT02188784|12349478|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
5018448|NCT02188784|12349479|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
5018449|NCT02188784|12349478|P2|STARTED|Overall Study||114
5018450|NCT02188784|12349479|P1|STARTED|Overall Study||111
5018451|NCT02188719|12349499|P4|NOT COMPLETED|Overall Study||0
5018452|NCT02188719|12349500|P3|NOT COMPLETED|Overall Study||0
5018453|NCT02188719|12349501|P2|NOT COMPLETED|Overall Study||1
5018454|NCT02188719|12349502|P1|NOT COMPLETED|Overall Study||0
5018455|NCT02188719|12349499|P4|COMPLETED|Overall Study||0
5018456|NCT02188719|12349500|P3|COMPLETED|Overall Study||0
5018457|NCT02188719|12349501|P2|COMPLETED|Overall Study||8
5018458|NCT02188719|12349502|P1|COMPLETED|Overall Study||6
5018459|NCT02188719|12349499|P4|STARTED|Overall Study||0
5018460|NCT02188719|12349500|P3|STARTED|Overall Study||0
5018461|NCT02188719|12349501|P2|STARTED|Overall Study||9
5018462|NCT02188719|12349502|P1|STARTED|Overall Study||6
5018463|NCT02188589|12349526|P1|NOT COMPLETED|Overall Study||5
5018464|NCT02188589|12349526|P1|COMPLETED|Overall Study||25
5018465|NCT02188589|12349526|P1|24 Months|Overall Study||25
5018466|NCT02188589|12349526|P1|12 Months|Overall Study||30
5018467|NCT02188589|12349526|P1|6 Months|Overall Study||30
5018468|NCT02188589|12349526|P1|STARTED|Overall Study||30
5018469|NCT02188576|12349534|P2|NOT COMPLETED|Overall Study||0
5018470|NCT02188576|12349535|P1|NOT COMPLETED|Overall Study||0
5018471|NCT02188576|12349534|P2|COMPLETED|Overall Study||34
5018472|NCT02188576|12349535|P1|COMPLETED|Overall Study||32
5018473|NCT02188576|12349534|P2|STARTED|Overall Study||34
5018474|NCT02188576|12349535|P1|STARTED|Overall Study||32
5018475|NCT02187887|12349545|P2|NOT COMPLETED|Overall Study||4
5018476|NCT02187887|12349546|P1|NOT COMPLETED|Overall Study||5
5018477|NCT02187887|12349545|P2|COMPLETED|Overall Study||396
5018478|NCT02187887|12349546|P1|COMPLETED|Overall Study||388
5018479|NCT02187887|12349545|P2|STARTED|Overall Study||400
5018480|NCT02187887|12349546|P1|STARTED|Overall Study||393
5018481|NCT02187861|12349558|P4|NOT COMPLETED|Overall Study||32
5018482|NCT02187861|12349559|P3|NOT COMPLETED|Overall Study||32
5018483|NCT02187861|12349560|P2|NOT COMPLETED|Overall Study||48
5018484|NCT02187861|12349561|P1|NOT COMPLETED|Overall Study||6
5018485|NCT02187861|12349558|P4|COMPLETED|Overall Study||19
5018486|NCT02187861|12349559|P3|COMPLETED|Overall Study||19
5018487|NCT02187861|12349560|P2|COMPLETED|Overall Study||4
5018488|NCT02187861|12349561|P1|COMPLETED|Overall Study||3
5018489|NCT02187861|12349558|P4|Treated|Overall Study||50
5018490|NCT02187861|12349559|P3|Treated|Overall Study||49
5018491|NCT02187861|12349560|P2|Treated|Overall Study||52
5018492|NCT02187861|12349561|P1|Treated|Overall Study||9
5018493|NCT02187861|12349558|P4|STARTED|Overall Study||51
5018494|NCT02187861|12349559|P3|STARTED|Overall Study||51
5018495|NCT02187861|12349560|P2|STARTED|Overall Study||52
5018496|NCT02187861|12349561|P1|STARTED|Overall Study||9
5018497|NCT02187809|12349657|P1|NOT COMPLETED|Overall Study||3
5018498|NCT02187809|12349657|P1|COMPLETED|Overall Study||0
5018499|NCT02187809|12349657|P1|Treated|Overall Study||1
5018500|NCT02187809|12349657|P1|STARTED|Overall Study||3
5018501|NCT02187783|12349667|P1|NOT COMPLETED|Overall Study||106
5018502|NCT02187783|12349667|P1|COMPLETED|Overall Study||0
5018503|NCT02187783|12349667|P1|Patients With Solid Tumors|Overall Study||105
5018504|NCT02187783|12349667|P1|STARTED|Overall Study||106
5018505|NCT02187744|12349678|P2|NOT COMPLETED|Treatment||5
5018506|NCT02187744|12349679|P1|NOT COMPLETED|Treatment||4
5018507|NCT02187744|12349678|P2|COMPLETED|Treatment||107
5018508|NCT02187744|12349679|P1|COMPLETED|Treatment||109
5018509|NCT02187744|12349678|P2|STARTED|Treatment||112
5018510|NCT02187744|12349679|P1|STARTED|Treatment||113
5018511|NCT02187744|12349678|P2|NOT COMPLETED|Study||6
5018512|NCT02187744|12349679|P1|NOT COMPLETED|Study||4
5018513|NCT02187744|12349678|P2|COMPLETED|Study||106
5018514|NCT02187744|12349679|P1|COMPLETED|Study||109
5018515|NCT02187744|12349678|P2|STARTED|Study|Received treatment|112
5018516|NCT02187744|12349679|P1|STARTED|Study|Received treatment|113
5018517|NCT02187172|12349697|P2|NOT COMPLETED|Overall Study||6
5018518|NCT02187172|12349698|P1|NOT COMPLETED|Overall Study||3
5018519|NCT02187172|12349697|P2|COMPLETED|Overall Study||15
5018520|NCT02187172|12349698|P1|COMPLETED|Overall Study||19
5018521|NCT02187172|12349697|P2|RCT Phase Completed|Overall Study||19
5018522|NCT02187172|12349698|P1|RCT Phase Completed|Overall Study||22
5018523|NCT02187172|12349697|P2|STARTED|Overall Study||21
5018524|NCT02187172|12349698|P1|STARTED|Overall Study||22
5018525|NCT02187055|12349865|P3|NOT COMPLETED|Overall Study||74
5018526|NCT02187055|12349866|P2|NOT COMPLETED|Overall Study||73
5018527|NCT02187055|12349867|P1|NOT COMPLETED|Overall Study||69
5018528|NCT02187055|12349865|P3|COMPLETED|Overall Study||312
5018529|NCT02187055|12349866|P2|COMPLETED|Overall Study||303
5018530|NCT02187055|12349867|P1|COMPLETED|Overall Study||315
5018531|NCT02187055|12349865|P3|STARTED|Overall Study|Treated|386
5018532|NCT02187055|12349866|P2|STARTED|Overall Study|Treated|376
5018533|NCT02187055|12349867|P1|STARTED|Overall Study|Treated|384
5018534|NCT02187042|12349967|P2|NOT COMPLETED|Overall Study||14
5018535|NCT02187042|12349968|P1|NOT COMPLETED|Overall Study||13
5018536|NCT02187042|12349967|P2|COMPLETED|Overall Study||13
5018537|NCT02187042|12349968|P1|COMPLETED|Overall Study||29
5018538|NCT02187042|12349967|P2|STARTED|Overall Study||27
5018539|NCT02187042|12349968|P1|STARTED|Overall Study||42
5018540|NCT02187029|12350014|P4|NOT COMPLETED|Overall Study||3
5018541|NCT02187029|12350015|P3|NOT COMPLETED|Overall Study||11
5018542|NCT02187029|12350016|P2|NOT COMPLETED|Overall Study||1
5018543|NCT02187029|12350017|P1|NOT COMPLETED|Overall Study||1
5018544|NCT02187029|12350014|P4|COMPLETED|Overall Study||6
5018545|NCT02187029|12350015|P3|COMPLETED|Overall Study||0
5018546|NCT02187029|12350016|P2|COMPLETED|Overall Study||2
5018547|NCT02187029|12350017|P1|COMPLETED|Overall Study||6
5018548|NCT02187029|12350014|P4|STARTED|Overall Study||9
5018549|NCT02187029|12350015|P3|STARTED|Overall Study||11
5018550|NCT02187029|12350016|P2|STARTED|Overall Study||3
5018551|NCT02187029|12350017|P1|STARTED|Overall Study||7
5018552|NCT02187016|12350093|P4|NOT COMPLETED|Overall Study||0
5018553|NCT02187016|12350094|P3|NOT COMPLETED|Overall Study||1
5018554|NCT02187016|12350095|P2|NOT COMPLETED|Overall Study||2
5018555|NCT02187016|12350096|P1|NOT COMPLETED|Overall Study||1
5018556|NCT02187016|12350093|P4|COMPLETED|Overall Study||51
5018557|NCT02187016|12350094|P3|COMPLETED|Overall Study||78
5018558|NCT02187016|12350095|P2|COMPLETED|Overall Study||78
5018559|NCT02187016|12350096|P1|COMPLETED|Overall Study||79
5018560|NCT02187016|12350093|P4|STARTED|Overall Study||51
5018561|NCT02187016|12350094|P3|STARTED|Overall Study||79
5018562|NCT02187016|12350095|P2|STARTED|Overall Study||80
5018563|NCT02187016|12350096|P1|STARTED|Overall Study||80
5018564|NCT02186938|12350128|P2|NOT COMPLETED|Overall Study||3
5018565|NCT02186938|12350129|P1|NOT COMPLETED|Overall Study||9
5018566|NCT02186938|12350128|P2|COMPLETED|Overall Study||44
5018567|NCT02186938|12350129|P1|COMPLETED|Overall Study||38
5018568|NCT02186938|12350128|P2|STARTED|Overall Study||47
5018569|NCT02186938|12350129|P1|STARTED|Overall Study|2012|47
5018570|NCT02186873|12350139|P2|NOT COMPLETED|Overall Study||8
5018571|NCT02186873|12350140|P1|NOT COMPLETED|Overall Study||9
5018572|NCT02186873|12350139|P2|COMPLETED|Overall Study||97
5018573|NCT02186873|12350140|P1|COMPLETED|Overall Study||94
5018574|NCT02186873|12350139|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
5018575|NCT02186873|12350140|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
5018576|NCT02186873|12350139|P2|STARTED|Overall Study||105
5018577|NCT02186873|12350140|P1|STARTED|Overall Study||103
5018578|NCT02186847|12350165|P2|NOT COMPLETED|Overall Study||0
5018579|NCT02186847|12350166|P1|NOT COMPLETED|Overall Study||3
5018580|NCT02186847|12350165|P2|COMPLETED|Overall Study||86
5018581|NCT02186847|12350166|P1|COMPLETED|Overall Study||81
5018582|NCT02186847|12350165|P2|Eligible and Started Protocol Treatment|Overall Study||82
5018583|NCT02186847|12350166|P1|Eligible and Started Protocol Treatment|Overall Study||76
5018584|NCT02186847|12350165|P2|Eligible Population|Overall Study||86
5018585|NCT02186847|12350166|P1|Eligible Population|Overall Study||81
5018586|NCT02186847|12350165|P2|STARTED|Overall Study||86
5018587|NCT02186847|12350166|P1|STARTED|Overall Study||84
5018588|NCT02186834|12350180|P6|NOT COMPLETED|Treatment at RP2D||1
5018589|NCT02186834|12350181|P5|NOT COMPLETED|Treatment at RP2D||0
5018590|NCT02186834|12350182|P4|NOT COMPLETED|Treatment at RP2D||0
5018591|NCT02186834|12350183|P3|NOT COMPLETED|Treatment at RP2D||0
5018592|NCT02186834|12350184|P2|NOT COMPLETED|Treatment at RP2D||0
5018593|NCT02186834|12350185|P1|NOT COMPLETED|Treatment at RP2D||0
5018594|NCT02186834|12350180|P6|COMPLETED|Treatment at RP2D||13
5018595|NCT02186834|12350181|P5|COMPLETED|Treatment at RP2D||0
5018596|NCT02186834|12350182|P4|COMPLETED|Treatment at RP2D||0
5018597|NCT02186834|12350183|P3|COMPLETED|Treatment at RP2D||0
5018598|NCT02186834|12350184|P2|COMPLETED|Treatment at RP2D||0
5018599|NCT02186834|12350185|P1|COMPLETED|Treatment at RP2D||0
5018600|NCT02186834|12350180|P6|STARTED|Treatment at RP2D||14
5018601|NCT02186834|12350181|P5|STARTED|Treatment at RP2D||0
5018602|NCT02186834|12350182|P4|STARTED|Treatment at RP2D||0
5018603|NCT02186834|12350183|P3|STARTED|Treatment at RP2D||0
5018604|NCT02186834|12350184|P2|STARTED|Treatment at RP2D||0
5018605|NCT02186834|12350185|P1|STARTED|Treatment at RP2D||0
5018606|NCT02186834|12350180|P6|NOT COMPLETED|Dose Escalation||0
5018607|NCT02186834|12350181|P5|NOT COMPLETED|Dose Escalation||0
5018608|NCT02186834|12350182|P4|NOT COMPLETED|Dose Escalation||1
5018609|NCT02186834|12350183|P3|NOT COMPLETED|Dose Escalation||0
5018610|NCT02186834|12350184|P2|NOT COMPLETED|Dose Escalation||0
5018611|NCT02186834|12350185|P1|NOT COMPLETED|Dose Escalation||0
5018612|NCT02186834|12350180|P6|COMPLETED|Dose Escalation||0
5018613|NCT02186834|12350181|P5|COMPLETED|Dose Escalation||4
5018614|NCT02186834|12350182|P4|COMPLETED|Dose Escalation||6
5018615|NCT02186834|12350183|P3|COMPLETED|Dose Escalation||0
5018616|NCT02186834|12350184|P2|COMPLETED|Dose Escalation||3
5018617|NCT02186834|12350185|P1|COMPLETED|Dose Escalation||6
5018618|NCT02186834|12350180|P6|STARTED|Dose Escalation||0
5018619|NCT02186834|12350181|P5|STARTED|Dose Escalation||4
5018620|NCT02186834|12350182|P4|STARTED|Dose Escalation||7
5018621|NCT02186834|12350183|P3|STARTED|Dose Escalation||0
5018622|NCT02186834|12350184|P2|STARTED|Dose Escalation||3
5018623|NCT02186834|12350185|P1|STARTED|Dose Escalation||6
5018624|NCT02186808|12350196|P1|NOT COMPLETED|Overall Study||13
5018625|NCT02186808|12350196|P1|COMPLETED|Overall Study||67
5018626|NCT02186808|12350196|P1|STARTED|Overall Study||80
5018627|NCT02186795|12350203|P2|NOT COMPLETED|Overall Study||0
5018628|NCT02186795|12350204|P1|NOT COMPLETED|Overall Study||0
5018629|NCT02186795|12350203|P2|COMPLETED|Overall Study||24
5018630|NCT02186795|12350204|P1|COMPLETED|Overall Study||24
5018631|NCT02186795|12350203|P2|STARTED|Overall Study||24
5018632|NCT02186795|12350204|P1|STARTED|Overall Study||24
5018633|NCT02186665|12350212|P2|NOT COMPLETED|Overall Study||1
5018634|NCT02186665|12350213|P1|NOT COMPLETED|Overall Study||0
5018635|NCT02186665|12350212|P2|COMPLETED|Overall Study||10
5018636|NCT02186665|12350213|P1|COMPLETED|Overall Study||8
5018637|NCT02186665|12350212|P2|STARTED|Overall Study||11
5018638|NCT02186665|12350213|P1|STARTED|Overall Study||8
5018639|NCT02186652|12350221|P2|NOT COMPLETED|Overall Study||0
5018640|NCT02186652|12350222|P1|NOT COMPLETED|Overall Study||2
5018641|NCT02186652|12350221|P2|COMPLETED|Overall Study||22
5018642|NCT02186652|12350222|P1|COMPLETED|Overall Study||17
5018643|NCT02186652|12350221|P2|STARTED|Overall Study||22
5018644|NCT02186652|12350222|P1|STARTED|Overall Study||19
5018645|NCT02186587|12350249|P2|NOT COMPLETED|Overall Study||0
5018646|NCT02186587|12350250|P1|NOT COMPLETED|Overall Study||5
5018647|NCT02186587|12350249|P2|COMPLETED|Overall Study||0
5018648|NCT02186587|12350250|P1|COMPLETED|Overall Study||23
5018649|NCT02186587|12350249|P2|STARTED|Overall Study||0
5018650|NCT02186587|12350250|P1|STARTED|Overall Study||28
5018651|NCT02186561|12350255|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
5018652|NCT02186561|12350255|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
5018653|NCT02186561|12350255|P1|STARTED|3 - Year Post Index Procedure Visit||141
5018654|NCT02186561|12350255|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
5018655|NCT02186561|12350255|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
5018656|NCT02186561|12350255|P1|STARTED|2 - Year Post Index Procedure Visit||141
5018657|NCT02186561|12350255|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
5018658|NCT02186561|12350255|P1|COMPLETED|1- Year Post Index Procedure Visit||139
5018659|NCT02186561|12350255|P1|STARTED|1- Year Post Index Procedure Visit||141
5018660|NCT02186561|12350255|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
5018661|NCT02186561|12350255|P1|COMPLETED|180- Day Post Index Procedure Visit||134
5018662|NCT02186561|12350255|P1|STARTED|180- Day Post Index Procedure Visit||141
5018663|NCT02186561|12350255|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
5018664|NCT02186561|12350255|P1|COMPLETED|30-Day Post Index Procedure Visit||140
5018665|NCT02186561|12350255|P1|STARTED|30-Day Post Index Procedure Visit||141
5018666|NCT02186561|12350255|P1|NOT COMPLETED|Subjects Implanted With Device||0
5018667|NCT02186561|12350255|P1|COMPLETED|Subjects Implanted With Device||141
5018668|NCT02186561|12350255|P1|STARTED|Subjects Implanted With Device||141
5018669|NCT02186561|12350255|P1|NOT COMPLETED|Enrollment||56
5018670|NCT02186561|12350255|P1|COMPLETED|Enrollment||141
5018671|NCT02186561|12350255|P1|STARTED|Enrollment||197
5018672|NCT02186509|12350265|P1|NOT COMPLETED|Overall Study||0
5018673|NCT02186509|12350265|P1|COMPLETED|Overall Study||17
5018674|NCT02186509|12350265|P1|STARTED|Overall Study||17
5018675|NCT02186301|12350275|P3|NOT COMPLETED|Overall Study||50
5018676|NCT02186301|12350276|P2|NOT COMPLETED|Overall Study||30
5018677|NCT02186301|12350277|P1|NOT COMPLETED|Overall Study||20
5018678|NCT02186301|12350275|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5018679|NCT02186301|12350276|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5018680|NCT02186301|12350277|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
5018681|NCT02186301|12350275|P3|STARTED|Overall Study||50
5018682|NCT02186301|12350276|P2|STARTED|Overall Study||30
5018683|NCT02186301|12350277|P1|STARTED|Overall Study||20
5018684|NCT02186223|12350293|P1|NOT COMPLETED|Overall Study||21
5018685|NCT02186223|12350293|P1|COMPLETED|Overall Study||151
5018686|NCT02186223|12350293|P1|Device Placed|Overall Study||163
5018687|NCT02186223|12350293|P1|STARTED|Overall Study||172
5018688|NCT02186210|12350304|P2|NOT COMPLETED|Overall Study||0
5018689|NCT02186210|12350305|P1|NOT COMPLETED|Overall Study||0
5018690|NCT02186210|12350304|P2|COMPLETED|Overall Study||20
5018691|NCT02186210|12350305|P1|COMPLETED|Overall Study||20
5018692|NCT02186210|12350304|P2|STARTED|Overall Study||20
5018693|NCT02186210|12350305|P1|STARTED|Overall Study||20
5018694|NCT02186171|12350315|P2|NOT COMPLETED|Overall Study||15
5018695|NCT02186171|12350316|P1|NOT COMPLETED|Overall Study||4
5018696|NCT02186171|12350315|P2|COMPLETED|Overall Study||148
5018697|NCT02186171|12350316|P1|COMPLETED|Overall Study||78
5018698|NCT02186171|12350315|P2|Received Treatment|Overall Study||163
5018699|NCT02186171|12350316|P1|Received Treatment|Overall Study||81
5018700|NCT02186171|12350315|P2|STARTED|Overall Study||163
5018701|NCT02186171|12350316|P1|STARTED|Overall Study||82
5018702|NCT02185729|12350332|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
5018703|NCT02185729|12350332|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
5018704|NCT02185729|12350332|P1|STARTED|24 Hours Into Dextrose Infusion||12
5018705|NCT02185729|12350332|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
5018706|NCT02185729|12350332|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
5018707|NCT02185729|12350332|P1|STARTED|4 Hours Into Dextrose Infusion||12
5018708|NCT02185729|12350332|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
5018709|NCT02185729|12350332|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
5018710|NCT02185729|12350332|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
5018711|NCT02185729|12350332|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
5018712|NCT02185729|12350332|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
5018713|NCT02185729|12350332|P1|STARTED|24 Hours Into ClinOleic Infusion||12
5018714|NCT02185729|12350332|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
5018715|NCT02185729|12350332|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
5018716|NCT02185729|12350332|P1|STARTED|4 Hours Into ClinOleic Infusion||12
5018717|NCT02185729|12350332|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
5018718|NCT02185729|12350332|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
5018719|NCT02185729|12350332|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
5018720|NCT02185729|12350332|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
5018721|NCT02185729|12350332|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
5018722|NCT02185729|12350332|P1|STARTED|24 Hours Into Intralipid Infusion||12
5018723|NCT02185729|12350332|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
5018724|NCT02185729|12350332|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
5018725|NCT02185729|12350332|P1|STARTED|4 Hours Into Intralipid Infusion||12
5018726|NCT02185729|12350332|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
5018727|NCT02185729|12350332|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
5018728|NCT02185729|12350332|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
5018729|NCT02185729|12350332|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
5018730|NCT02185729|12350332|P1|COMPLETED|24 Hours Into Saline Infusion||12
5018731|NCT02185729|12350332|P1|STARTED|24 Hours Into Saline Infusion||12
5018732|NCT02185729|12350332|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
5018733|NCT02185729|12350332|P1|COMPLETED|4 Hours Into Saline Infusion||12
5018734|NCT02185729|12350332|P1|STARTED|4 Hours Into Saline Infusion||12
5018735|NCT02185729|12350332|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
5018736|NCT02185729|12350332|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
5018737|NCT02185729|12350332|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
5018738|NCT02185534|12350353|P6|NOT COMPLETED|Third Period||0
5018739|NCT02185534|12350354|P5|NOT COMPLETED|Third Period||0
5018740|NCT02185534|12350355|P4|NOT COMPLETED|Third Period||0
5018741|NCT02185534|12350356|P3|NOT COMPLETED|Third Period||0
5018742|NCT02185534|12350357|P2|NOT COMPLETED|Third Period||0
5018743|NCT02185534|12350358|P1|NOT COMPLETED|Third Period||0
5018744|NCT02185534|12350353|P6|COMPLETED|Third Period||13
5018745|NCT02185534|12350354|P5|COMPLETED|Third Period||13
5018746|NCT02185534|12350355|P4|COMPLETED|Third Period||13
5018747|NCT02185534|12350356|P3|COMPLETED|Third Period||14
5018748|NCT02185534|12350357|P2|COMPLETED|Third Period||14
5018749|NCT02185534|12350358|P1|COMPLETED|Third Period||13
5018750|NCT02185534|12350353|P6|STARTED|Third Period||13
5018751|NCT02185534|12350354|P5|STARTED|Third Period||13
5018752|NCT02185534|12350355|P4|STARTED|Third Period||13
5018753|NCT02185534|12350356|P3|STARTED|Third Period||14
5018754|NCT02185534|12350357|P2|STARTED|Third Period||14
5018755|NCT02185534|12350358|P1|STARTED|Third Period||13
5018756|NCT02185534|12350353|P6|NOT COMPLETED|Second Washout Period||0
5018757|NCT02185534|12350354|P5|NOT COMPLETED|Second Washout Period||0
5018758|NCT02185534|12350355|P4|NOT COMPLETED|Second Washout Period||0
5018759|NCT02185534|12350356|P3|NOT COMPLETED|Second Washout Period||0
5018760|NCT02185534|12350357|P2|NOT COMPLETED|Second Washout Period||0
5018761|NCT02185534|12350358|P1|NOT COMPLETED|Second Washout Period||0
5018762|NCT02185534|12350353|P6|COMPLETED|Second Washout Period||13
5018763|NCT02185534|12350354|P5|COMPLETED|Second Washout Period||13
5018764|NCT02185534|12350355|P4|COMPLETED|Second Washout Period||13
5018765|NCT02185534|12350356|P3|COMPLETED|Second Washout Period||14
5018766|NCT02185534|12350357|P2|COMPLETED|Second Washout Period||14
5018767|NCT02185534|12350358|P1|COMPLETED|Second Washout Period||13
5018768|NCT02185534|12350353|P6|STARTED|Second Washout Period||13
5018769|NCT02185534|12350354|P5|STARTED|Second Washout Period||13
5018770|NCT02185534|12350355|P4|STARTED|Second Washout Period||13
5018771|NCT02185534|12350356|P3|STARTED|Second Washout Period||14
5018772|NCT02185534|12350357|P2|STARTED|Second Washout Period||14
5018773|NCT02185534|12350358|P1|STARTED|Second Washout Period||13
5018774|NCT02185534|12350353|P6|NOT COMPLETED|Second Period||0
5018775|NCT02185534|12350354|P5|NOT COMPLETED|Second Period||0
5018776|NCT02185534|12350355|P4|NOT COMPLETED|Second Period||0
5018777|NCT02185534|12350356|P3|NOT COMPLETED|Second Period||0
5018778|NCT02185534|12350357|P2|NOT COMPLETED|Second Period||0
5018779|NCT02185534|12350358|P1|NOT COMPLETED|Second Period||0
5018780|NCT02185534|12350353|P6|COMPLETED|Second Period||13
5018781|NCT02185534|12350354|P5|COMPLETED|Second Period||13
5018782|NCT02185534|12350355|P4|COMPLETED|Second Period||13
5018783|NCT02185534|12350356|P3|COMPLETED|Second Period||14
5018784|NCT02185534|12350357|P2|COMPLETED|Second Period||14
5018785|NCT02185534|12350358|P1|COMPLETED|Second Period||13
5018786|NCT02185534|12350353|P6|STARTED|Second Period||13
5018787|NCT02185534|12350354|P5|STARTED|Second Period||13
5018788|NCT02185534|12350355|P4|STARTED|Second Period||13
5018789|NCT02185534|12350356|P3|STARTED|Second Period||14
5018790|NCT02185534|12350357|P2|STARTED|Second Period||14
5018791|NCT02185534|12350358|P1|STARTED|Second Period||13
5018792|NCT02185534|12350353|P6|NOT COMPLETED|First Washout Period||1
5018793|NCT02185534|12350354|P5|NOT COMPLETED|First Washout Period||1
5018794|NCT02185534|12350355|P4|NOT COMPLETED|First Washout Period||0
5018795|NCT02185534|12350356|P3|NOT COMPLETED|First Washout Period||0
5018796|NCT02185534|12350357|P2|NOT COMPLETED|First Washout Period||0
5018797|NCT02185534|12350358|P1|NOT COMPLETED|First Washout Period||1
5018798|NCT02185534|12350353|P6|COMPLETED|First Washout Period||13
5018799|NCT02185534|12350354|P5|COMPLETED|First Washout Period||13
5018800|NCT02185534|12350355|P4|COMPLETED|First Washout Period||13
5018801|NCT02185534|12350356|P3|COMPLETED|First Washout Period||14
5018802|NCT02185534|12350357|P2|COMPLETED|First Washout Period||14
5018803|NCT02185534|12350358|P1|COMPLETED|First Washout Period||13
5018804|NCT02185534|12350353|P6|STARTED|First Washout Period||14
5018805|NCT02185534|12350354|P5|STARTED|First Washout Period||14
5018806|NCT02185534|12350355|P4|STARTED|First Washout Period||13
5018807|NCT02185534|12350356|P3|STARTED|First Washout Period||14
5018808|NCT02185534|12350357|P2|STARTED|First Washout Period||14
5018809|NCT02185534|12350358|P1|STARTED|First Washout Period||14
5018810|NCT02185534|12350353|P6|NOT COMPLETED|First Period||0
5018811|NCT02185534|12350354|P5|NOT COMPLETED|First Period||0
5018812|NCT02185534|12350355|P4|NOT COMPLETED|First Period||1
5018813|NCT02185534|12350356|P3|NOT COMPLETED|First Period||0
5018814|NCT02185534|12350357|P2|NOT COMPLETED|First Period||0
5018815|NCT02185534|12350358|P1|NOT COMPLETED|First Period||0
5018816|NCT02185534|12350353|P6|COMPLETED|First Period||14
5018817|NCT02185534|12350354|P5|COMPLETED|First Period||14
5018818|NCT02185534|12350355|P4|COMPLETED|First Period||13
5018819|NCT02185534|12350356|P3|COMPLETED|First Period||14
5018820|NCT02185534|12350357|P2|COMPLETED|First Period||14
5018821|NCT02185534|12350358|P1|COMPLETED|First Period||14
5018822|NCT02185534|12350353|P6|STARTED|First Period||14
5018823|NCT02185534|12350354|P5|STARTED|First Period||14
5018824|NCT02185534|12350355|P4|STARTED|First Period||14
5018825|NCT02185534|12350356|P3|STARTED|First Period||14
5018826|NCT02185534|12350357|P2|STARTED|First Period||14
5018827|NCT02185534|12350358|P1|STARTED|First Period||14
5018828|NCT02185521|12350373|P1|NOT COMPLETED|Overall Study||2
5018829|NCT02185521|12350373|P1|COMPLETED|Overall Study||125
5018830|NCT02185521|12350373|P1|STARTED|Overall Study||127
5018831|NCT02185339|12350380|P2|NOT COMPLETED|Overall Study||1
5018832|NCT02185339|12350381|P1|NOT COMPLETED|Overall Study||0
5018833|NCT02185339|12350380|P2|COMPLETED|Overall Study||30
5018834|NCT02185339|12350381|P1|COMPLETED|Overall Study||30
5018835|NCT02185339|12350380|P2|STARTED|Overall Study||31
5018836|NCT02185339|12350381|P1|STARTED|Overall Study||30
5018837|NCT02185183|12350403|P1|NOT COMPLETED|Overall Study||0
5018838|NCT02185183|12350403|P1|COMPLETED|Overall Study||14
5018839|NCT02185183|12350403|P1|STARTED|Overall Study||14
5018840|NCT02185131|12350409|P2|NOT COMPLETED|Overall Study||1
5018841|NCT02185131|12350410|P1|NOT COMPLETED|Overall Study||1
5018842|NCT02185131|12350409|P2|COMPLETED|Overall Study||8
5018843|NCT02185131|12350410|P1|COMPLETED|Overall Study||6
5018844|NCT02185131|12350409|P2|STARTED|Overall Study||9
5018845|NCT02185131|12350410|P1|STARTED|Overall Study||7
5018846|NCT02185105|12350418|P1|NOT COMPLETED|Overall Study||0
5018847|NCT02185105|12350418|P1|COMPLETED|Overall Study||30
5018848|NCT02185105|12350418|P1|STARTED|Overall Study||30
5018849|NCT02185053|12350461|P3|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
5018850|NCT02185053|12350462|P2|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
5018851|NCT02185053|12350463|P1|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
5018852|NCT02185053|12350461|P3|COMPLETED|Donepezil Dose Maintenance Phase||30
5018853|NCT02185053|12350462|P2|COMPLETED|Donepezil Dose Maintenance Phase||0
5018854|NCT02185053|12350463|P1|COMPLETED|Donepezil Dose Maintenance Phase||0
5018855|NCT02185053|12350461|P3|STARTED|Donepezil Dose Maintenance Phase||33
5018856|NCT02185053|12350462|P2|STARTED|Donepezil Dose Maintenance Phase||0
5018857|NCT02185053|12350463|P1|STARTED|Donepezil Dose Maintenance Phase||0
5018858|NCT02185053|12350461|P3|NOT COMPLETED|Donepezil Dose Escalation Phase||0
5018859|NCT02185053|12350462|P2|NOT COMPLETED|Donepezil Dose Escalation Phase||5
5018860|NCT02185053|12350463|P1|NOT COMPLETED|Donepezil Dose Escalation Phase||0
5018861|NCT02185053|12350461|P3|COMPLETED|Donepezil Dose Escalation Phase||0
5018862|NCT02185053|12350462|P2|COMPLETED|Donepezil Dose Escalation Phase||33
5018863|NCT02185053|12350463|P1|COMPLETED|Donepezil Dose Escalation Phase||0
5018864|NCT02185053|12350461|P3|STARTED|Donepezil Dose Escalation Phase||0
5018865|NCT02185053|12350462|P2|STARTED|Donepezil Dose Escalation Phase||38
5018866|NCT02185053|12350463|P1|STARTED|Donepezil Dose Escalation Phase||0
5018867|NCT02185053|12350461|P3|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
5018868|NCT02185053|12350462|P2|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
5018869|NCT02185053|12350463|P1|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
5018870|NCT02185053|12350461|P3|COMPLETED|Solifenacin Dose Escalation Phase||0
5018871|NCT02185053|12350462|P2|COMPLETED|Solifenacin Dose Escalation Phase||0
5018872|NCT02185053|12350463|P1|COMPLETED|Solifenacin Dose Escalation Phase||38
5018873|NCT02185053|12350461|P3|STARTED|Solifenacin Dose Escalation Phase||0
5018874|NCT02185053|12350462|P2|STARTED|Solifenacin Dose Escalation Phase||0
5018875|NCT02185053|12350463|P1|STARTED|Solifenacin Dose Escalation Phase||41
5018876|NCT02185040|12350477|P7|NOT COMPLETED|Active Treatment Extension Phase||7
5018877|NCT02185040|12350478|P6|NOT COMPLETED|Active Treatment Extension Phase||3
5018878|NCT02185040|12350479|P5|NOT COMPLETED|Active Treatment Extension Phase||0
5018879|NCT02185040|12350480|P4|NOT COMPLETED|Active Treatment Extension Phase||0
5018880|NCT02185040|12350481|P3|NOT COMPLETED|Active Treatment Extension Phase||0
5018881|NCT02185040|12350482|P2|NOT COMPLETED|Active Treatment Extension Phase||0
5018882|NCT02185040|12350483|P1|NOT COMPLETED|Active Treatment Extension Phase||0
5018883|NCT02185040|12350477|P7|COMPLETED|Active Treatment Extension Phase||1
5018884|NCT02185040|12350478|P6|COMPLETED|Active Treatment Extension Phase||6
5018885|NCT02185040|12350479|P5|COMPLETED|Active Treatment Extension Phase||0
5018886|NCT02185040|12350480|P4|COMPLETED|Active Treatment Extension Phase||0
5018887|NCT02185040|12350481|P3|COMPLETED|Active Treatment Extension Phase||0
5018888|NCT02185040|12350482|P2|COMPLETED|Active Treatment Extension Phase||0
5018889|NCT02185040|12350483|P1|COMPLETED|Active Treatment Extension Phase||0
5018890|NCT02185040|12350477|P7|STARTED|Active Treatment Extension Phase||8
5018891|NCT02185040|12350478|P6|STARTED|Active Treatment Extension Phase||9
5018892|NCT02185040|12350479|P5|STARTED|Active Treatment Extension Phase||0
5018893|NCT02185040|12350480|P4|STARTED|Active Treatment Extension Phase||0
5018894|NCT02185040|12350481|P3|STARTED|Active Treatment Extension Phase||0
5018895|NCT02185040|12350482|P2|STARTED|Active Treatment Extension Phase||0
5018896|NCT02185040|12350483|P1|STARTED|Active Treatment Extension Phase||0
5018897|NCT02185040|12350477|P7|NOT COMPLETED|Part 1 Treatment Phase||0
5018898|NCT02185040|12350478|P6|NOT COMPLETED|Part 1 Treatment Phase||0
5018899|NCT02185040|12350479|P5|NOT COMPLETED|Part 1 Treatment Phase||3
5018900|NCT02185040|12350480|P4|NOT COMPLETED|Part 1 Treatment Phase||2
5018901|NCT02185040|12350481|P3|NOT COMPLETED|Part 1 Treatment Phase||1
5018902|NCT02185040|12350482|P2|NOT COMPLETED|Part 1 Treatment Phase||2
5018903|NCT02185040|12350483|P1|NOT COMPLETED|Part 1 Treatment Phase||1
5018904|NCT02185040|12350477|P7|COMPLETED|Part 1 Treatment Phase||0
5018905|NCT02185040|12350478|P6|COMPLETED|Part 1 Treatment Phase||0
5018906|NCT02185040|12350479|P5|COMPLETED|Part 1 Treatment Phase||6
5018907|NCT02185040|12350480|P4|COMPLETED|Part 1 Treatment Phase||7
5018908|NCT02185040|12350481|P3|COMPLETED|Part 1 Treatment Phase||7
5018909|NCT02185040|12350482|P2|COMPLETED|Part 1 Treatment Phase||6
5018910|NCT02185040|12350483|P1|COMPLETED|Part 1 Treatment Phase||7
5018911|NCT02185040|12350477|P7|STARTED|Part 1 Treatment Phase||0
5018912|NCT02185040|12350478|P6|STARTED|Part 1 Treatment Phase||0
5018913|NCT02185040|12350479|P5|STARTED|Part 1 Treatment Phase||9
5018914|NCT02185040|12350480|P4|STARTED|Part 1 Treatment Phase||9
5018915|NCT02185040|12350481|P3|STARTED|Part 1 Treatment Phase||8
5018916|NCT02185040|12350482|P2|STARTED|Part 1 Treatment Phase||8
5018917|NCT02185040|12350483|P1|STARTED|Part 1 Treatment Phase||8
5018918|NCT02185014|12350537|P1|NOT COMPLETED|Overall Study||54
5018919|NCT02185014|12350537|P1|COMPLETED|Overall Study||198
5018920|NCT02185014|12350537|P1|STARTED|Overall Study||252
5018921|NCT02184988|12350541|P1|NOT COMPLETED|Overall Study||55
5018922|NCT02184988|12350541|P1|COMPLETED|Overall Study||297
5018923|NCT02184988|12350541|P1|STARTED|Overall Study||352
5018924|NCT02184624|12350551|P5|NOT COMPLETED|Overall Study||0
5018925|NCT02184624|12350552|P4|NOT COMPLETED|Overall Study||0
5018926|NCT02184624|12350553|P3|NOT COMPLETED|Overall Study||0
5018927|NCT02184624|12350554|P2|NOT COMPLETED|Overall Study||0
5018928|NCT02184624|12350555|P1|NOT COMPLETED|Overall Study||0
5018929|NCT02184624|12350551|P5|COMPLETED|Overall Study||98
5018930|NCT02184624|12350552|P4|COMPLETED|Overall Study||118
5018931|NCT02184624|12350553|P3|COMPLETED|Overall Study||100
5018932|NCT02184624|12350554|P2|COMPLETED|Overall Study||80
5018933|NCT02184624|12350555|P1|COMPLETED|Overall Study||171
5018934|NCT02184624|12350551|P5|STARTED|Overall Study||98
5018935|NCT02184624|12350552|P4|STARTED|Overall Study||118
5018936|NCT02184624|12350553|P3|STARTED|Overall Study||100
5018937|NCT02184624|12350554|P2|STARTED|Overall Study||80
5018938|NCT02184624|12350555|P1|STARTED|Overall Study||171
5018939|NCT02184611|12350599|P2|NOT COMPLETED|Overall Study||28
5018940|NCT02184611|12350600|P1|NOT COMPLETED|Overall Study||21
5018941|NCT02184611|12350599|P2|COMPLETED|Overall Study||177
5018942|NCT02184611|12350600|P1|COMPLETED|Overall Study||80
5018943|NCT02184611|12350599|P2|STARTED|Overall Study||205
5018944|NCT02184611|12350600|P1|STARTED|Overall Study||101
5018945|NCT02184572|12350636|P2|NOT COMPLETED|Overall Study||30
5018946|NCT02184572|12350637|P1|NOT COMPLETED|Overall Study||47
5018947|NCT02184572|12350636|P2|COMPLETED|Overall Study||542
5018948|NCT02184572|12350637|P1|COMPLETED|Overall Study||1117
5018949|NCT02184572|12350636|P2|STARTED|Overall Study||572
5018950|NCT02184572|12350637|P1|STARTED|Overall Study||1164
5018951|NCT02184494|12350676|P3|NOT COMPLETED|Overall Study||0
5018952|NCT02184494|12350677|P2|NOT COMPLETED|Overall Study||2
5018953|NCT02184494|12350678|P1|NOT COMPLETED|Overall Study||1
5018954|NCT02184494|12350676|P3|COMPLETED|Overall Study||8
5018955|NCT02184494|12350677|P2|COMPLETED|Overall Study||11
5018956|NCT02184494|12350678|P1|COMPLETED|Overall Study||12
5018957|NCT02184494|12350676|P3|STARTED|Overall Study||8
5018958|NCT02184494|12350677|P2|STARTED|Overall Study||13
5018959|NCT02184494|12350678|P1|STARTED|Overall Study||13
5018960|NCT02184455|12350698|P1|NOT COMPLETED|Overall Study||1
5018961|NCT02184455|12350698|P1|COMPLETED|Overall Study||10
5018962|NCT02184455|12350698|P1|STARTED|Overall Study||11
5018963|NCT02184442|12350709|P2|NOT COMPLETED|Overall Study||76
5018964|NCT02184442|12350710|P1|NOT COMPLETED|Overall Study||64
5018965|NCT02184442|12350709|P2|COMPLETED|Overall Study||200
5018966|NCT02184442|12350710|P1|COMPLETED|Overall Study||220
5018967|NCT02184442|12350709|P2|Valve-Implant|Overall Study||263
5018968|NCT02184442|12350710|P1|Valve-Implant|Overall Study||280
5018969|NCT02184442|12350709|P2|As-Treated|Overall Study||271
5018970|NCT02184442|12350710|P1|As-Treated|Overall Study||282
5018971|NCT02184442|12350709|P2|STARTED|Overall Study||276
5018972|NCT02184442|12350710|P1|STARTED|Overall Study||284
5018973|NCT02184208|12350722|P1|NOT COMPLETED|Overall Study||56
5018974|NCT02184208|12350722|P1|COMPLETED|Overall Study||222
5018975|NCT02184208|12350722|P1|STARTED|Overall Study||278
5018976|NCT02184195|12350730|P2|NOT COMPLETED|Overall Study||35
5018977|NCT02184195|12350731|P1|NOT COMPLETED|Overall Study||43
5018978|NCT02184195|12350730|P2|COMPLETED|Overall Study||27
5018979|NCT02184195|12350731|P1|COMPLETED|Overall Study||49
5018980|NCT02184195|12350730|P2|STARTED|Overall Study||62
5018981|NCT02184195|12350731|P1|STARTED|Overall Study||92
5018982|NCT02184169|12350757|P2|NOT COMPLETED|Overall Study||0
5018983|NCT02184169|12350758|P1|NOT COMPLETED|Overall Study||0
5018984|NCT02184169|12350757|P2|COMPLETED|Overall Study||6
5018985|NCT02184169|12350758|P1|COMPLETED|Overall Study||21
5018986|NCT02184169|12350757|P2|STARTED|Overall Study||6
5018987|NCT02184169|12350758|P1|STARTED|Overall Study||21
5018988|NCT02184143|12350768|P2|NOT COMPLETED|Overall Study||7
5018989|NCT02184143|12350769|P1|NOT COMPLETED|Overall Study||10
5018990|NCT02184143|12350768|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
5018991|NCT02184143|12350769|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
5018992|NCT02184143|12350768|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
5018993|NCT02184143|12350769|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
5018994|NCT02183792|12350783|P2|NOT COMPLETED|Overall Study||0
5018995|NCT02183792|12350784|P1|NOT COMPLETED|Overall Study||0
5018996|NCT02183792|12350783|P2|COMPLETED|Overall Study||15
5018997|NCT02183792|12350784|P1|COMPLETED|Overall Study||18
5018998|NCT02183792|12350783|P2|STARTED|Overall Study||15
5018999|NCT02183792|12350784|P1|STARTED|Overall Study||18
5019000|NCT02183675|12350798|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019001|NCT02183675|12350799|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019002|NCT02183675|12350800|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019003|NCT02183675|12350801|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019004|NCT02183675|12350802|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019005|NCT02183675|12350803|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
5019006|NCT02183675|12350798|P6|COMPLETED|Treatment Period 3 (10 Days)||4
5019007|NCT02183675|12350799|P5|COMPLETED|Treatment Period 3 (10 Days)||6
5019008|NCT02183675|12350800|P4|COMPLETED|Treatment Period 3 (10 Days)||6
5019009|NCT02183675|12350801|P3|COMPLETED|Treatment Period 3 (10 Days)||6
5019010|NCT02183675|12350802|P2|COMPLETED|Treatment Period 3 (10 Days)||6
5019011|NCT02183675|12350803|P1|COMPLETED|Treatment Period 3 (10 Days)||6
5019012|NCT02183675|12350798|P6|STARTED|Treatment Period 3 (10 Days)||4
5019013|NCT02183675|12350799|P5|STARTED|Treatment Period 3 (10 Days)||6
5019014|NCT02183675|12350800|P4|STARTED|Treatment Period 3 (10 Days)||6
5019015|NCT02183675|12350801|P3|STARTED|Treatment Period 3 (10 Days)||6
5019016|NCT02183675|12350802|P2|STARTED|Treatment Period 3 (10 Days)||6
5019017|NCT02183675|12350803|P1|STARTED|Treatment Period 3 (10 Days)||6
5019018|NCT02183675|12350798|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
5019019|NCT02183675|12350799|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
5019020|NCT02183675|12350800|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
5019021|NCT02183675|12350801|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
5019022|NCT02183675|12350802|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
5019023|NCT02183675|12350803|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
5019024|NCT02183675|12350798|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
5019025|NCT02183675|12350799|P5|COMPLETED|Treatment Period 2 (10 Days)||6
5019026|NCT02183675|12350800|P4|COMPLETED|Treatment Period 2 (10 Days)||6
5019027|NCT02183675|12350801|P3|COMPLETED|Treatment Period 2 (10 Days)||6
5019028|NCT02183675|12350802|P2|COMPLETED|Treatment Period 2 (10 Days)||6
5019029|NCT02183675|12350803|P1|COMPLETED|Treatment Period 2 (10 Days)||6
5019030|NCT02183675|12350798|P6|STARTED|Treatment Period 2 (10 Days)||6
5019031|NCT02183675|12350799|P5|STARTED|Treatment Period 2 (10 Days)||6
5019032|NCT02183675|12350800|P4|STARTED|Treatment Period 2 (10 Days)||6
5019033|NCT02183675|12350801|P3|STARTED|Treatment Period 2 (10 Days)||6
5019034|NCT02183675|12350802|P2|STARTED|Treatment Period 2 (10 Days)||6
5019035|NCT02183675|12350803|P1|STARTED|Treatment Period 2 (10 Days)||6
5019036|NCT02183675|12350798|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019037|NCT02183675|12350799|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019038|NCT02183675|12350800|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019039|NCT02183675|12350801|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019040|NCT02183675|12350802|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019041|NCT02183675|12350803|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
5019042|NCT02183675|12350798|P6|COMPLETED|Treatment Period 1 (10 Days)||6
5019043|NCT02183675|12350799|P5|COMPLETED|Treatment Period 1 (10 Days)||6
5019044|NCT02183675|12350800|P4|COMPLETED|Treatment Period 1 (10 Days)||6
5019045|NCT02183675|12350801|P3|COMPLETED|Treatment Period 1 (10 Days)||6
5019046|NCT02183675|12350802|P2|COMPLETED|Treatment Period 1 (10 Days)||6
5019047|NCT02183675|12350803|P1|COMPLETED|Treatment Period 1 (10 Days)||6
5019048|NCT02183675|12350798|P6|STARTED|Treatment Period 1 (10 Days)||6
5019049|NCT02183675|12350799|P5|STARTED|Treatment Period 1 (10 Days)||6
5019050|NCT02183675|12350800|P4|STARTED|Treatment Period 1 (10 Days)||6
5019051|NCT02183675|12350801|P3|STARTED|Treatment Period 1 (10 Days)||6
5019052|NCT02183675|12350802|P2|STARTED|Treatment Period 1 (10 Days)||6
5019053|NCT02183675|12350803|P1|STARTED|Treatment Period 1 (10 Days)||6
5019054|NCT02183519|12350827|P2|NOT COMPLETED|Overall Study||3
5019055|NCT02183519|12350828|P1|NOT COMPLETED|Overall Study||3
5019056|NCT02183519|12350827|P2|COMPLETED|Overall Study||13
5019057|NCT02183519|12350828|P1|COMPLETED|Overall Study||25
5019058|NCT02183519|12350827|P2|STARTED|Overall Study||16
5019059|NCT02183519|12350828|P1|STARTED|Overall Study||28
5019060|NCT02182999|12350836|P2|NOT COMPLETED|Overall Study||3
5019061|NCT02182999|12350837|P1|NOT COMPLETED|Overall Study||5
5019062|NCT02182999|12350836|P2|COMPLETED|Overall Study||22
5019063|NCT02182999|12350837|P1|COMPLETED|Overall Study||20
5019064|NCT02182999|12350836|P2|STARTED|Overall Study||25
5019065|NCT02182999|12350837|P1|STARTED|Overall Study||25
5019066|NCT02182973|12350853|P2|NOT COMPLETED|Overall Study||0
5019067|NCT02182973|12350854|P1|NOT COMPLETED|Overall Study||3
5019068|NCT02182973|12350853|P2|COMPLETED|Overall Study||9
5019069|NCT02182973|12350854|P1|COMPLETED|Overall Study||9
5019070|NCT02182973|12350853|P2|STARTED|Overall Study||9
5019071|NCT02182973|12350854|P1|STARTED|Overall Study||12
5019072|NCT02182895|12350866|P2|NOT COMPLETED|Overall Study||4
5019073|NCT02182895|12350867|P1|NOT COMPLETED|Overall Study||2
5019074|NCT02182895|12350866|P2|COMPLETED|Overall Study||33
5019075|NCT02182895|12350867|P1|COMPLETED|Overall Study||33
5019076|NCT02182895|12350866|P2|STARTED|Overall Study||37
5019077|NCT02182895|12350867|P1|STARTED|Overall Study||35
5019078|NCT02182843|12350887|P1|NOT COMPLETED|Overall Study||10
5019079|NCT02182843|12350887|P1|COMPLETED|Overall Study||71
5019080|NCT02182843|12350887|P1|STARTED|Overall Study||81
5019081|NCT02182830|12350894|P2|NOT COMPLETED|Overall Study||15
5019082|NCT02182830|12350895|P1|NOT COMPLETED|Overall Study||15
5019083|NCT02182830|12350894|P2|COMPLETED|Overall Study||68
5019084|NCT02182830|12350895|P1|COMPLETED|Overall Study||68
5019085|NCT02182830|12350894|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
5019086|NCT02182830|12350895|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
5019087|NCT02182830|12350894|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
5019088|NCT02182830|12350895|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
5019089|NCT02182830|12350894|P2|STARTED|Overall Study||83
5019090|NCT02182830|12350895|P1|STARTED|Overall Study||83
5019091|NCT02182492|12350923|P2|NOT COMPLETED|Overall Study||8
5019092|NCT02182492|12350924|P1|NOT COMPLETED|Overall Study||7
5019093|NCT02182492|12350923|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
5019094|NCT02182492|12350924|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
5019095|NCT02182492|12350923|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
5019096|NCT02182492|12350924|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
5019097|NCT02182440|12350936|P4|NOT COMPLETED|Overall Study||30
5019098|NCT02182440|12350937|P3|NOT COMPLETED|Overall Study||11
5019099|NCT02182440|12350938|P2|NOT COMPLETED|Overall Study||14
5019100|NCT02182440|12350939|P1|NOT COMPLETED|Overall Study||45
5019101|NCT02182440|12350936|P4|COMPLETED|Overall Study||81
5019102|NCT02182440|12350937|P3|COMPLETED|Overall Study||24
5019103|NCT02182440|12350938|P2|COMPLETED|Overall Study||25
5019104|NCT02182440|12350939|P1|COMPLETED|Overall Study||71
5019105|NCT02182440|12350936|P4|Safety Population|Overall Study||109
5019106|NCT02182440|12350937|P3|Safety Population|Overall Study||35
5019107|NCT02182440|12350938|P2|Safety Population|Overall Study||38
5019108|NCT02182440|12350939|P1|Safety Population|Overall Study||112
5019109|NCT02182440|12350936|P4|ITTinterim|Overall Study||29
5019110|NCT02182440|12350937|P3|ITTinterim|Overall Study||32
5019111|NCT02182440|12350938|P2|ITTinterim|Overall Study||31
5019112|NCT02182440|12350939|P1|ITTinterim|Overall Study||30
5019113|NCT02182440|12350936|P4|ITTcombined|Overall Study||111
5019114|NCT02182440|12350937|P3|ITTcombined|Overall Study||32
5019115|NCT02182440|12350938|P2|ITTcombined|Overall Study||31
5019116|NCT02182440|12350939|P1|ITTcombined|Overall Study||116
5019117|NCT02182440|12350936|P4|STARTED|Overall Study||111
5019118|NCT02182440|12350937|P3|STARTED|Overall Study||35
5019119|NCT02182440|12350938|P2|STARTED|Overall Study||39
5019120|NCT02182440|12350939|P1|STARTED|Overall Study||116
5019121|NCT02182115|12350971|P2|NOT COMPLETED|Overall Study||0
5019122|NCT02182115|12350972|P1|NOT COMPLETED|Overall Study||0
5019123|NCT02182115|12350971|P2|COMPLETED|Overall Study||57
5019124|NCT02182115|12350972|P1|COMPLETED|Overall Study||53
5019125|NCT02182115|12350971|P2|STARTED|Overall Study||57
5019126|NCT02182115|12350972|P1|STARTED|Overall Study||53
5019127|NCT02181842|12350978|P1|NOT COMPLETED|Overall Study||2
5019128|NCT02181842|12350978|P1|COMPLETED|Overall Study||244
5019129|NCT02181842|12350978|P1|STARTED|Overall Study||246
5019130|NCT02181816|12350995|P1|NOT COMPLETED|Overall Study||59
5019131|NCT02181816|12350995|P1|COMPLETED|Overall Study||1031
5019132|NCT02181816|12350995|P1|STARTED|Overall Study||1090
5019133|NCT02181803|12351010|P9|NOT COMPLETED|Overall Study||0
5019134|NCT02181803|12351011|P8|NOT COMPLETED|Overall Study||1
5019135|NCT02181803|12351012|P7|NOT COMPLETED|Overall Study||1
5019136|NCT02181803|12351013|P6|NOT COMPLETED|Overall Study||0
5019137|NCT02181803|12351014|P5|NOT COMPLETED|Overall Study||0
5019138|NCT02181803|12351015|P4|NOT COMPLETED|Overall Study||2
5019139|NCT02181803|12351016|P3|NOT COMPLETED|Overall Study||0
5019140|NCT02181803|12351017|P2|NOT COMPLETED|Overall Study||4
5019141|NCT02181803|12351018|P1|NOT COMPLETED|Overall Study||0
5019142|NCT02181803|12351010|P9|COMPLETED|Overall Study||2
5019143|NCT02181803|12351011|P8|COMPLETED|Overall Study||0
5019144|NCT02181803|12351012|P7|COMPLETED|Overall Study||8
5019145|NCT02181803|12351013|P6|COMPLETED|Overall Study||6
5019146|NCT02181803|12351014|P5|COMPLETED|Overall Study||6
5019147|NCT02181803|12351015|P4|COMPLETED|Overall Study||11
5019148|NCT02181803|12351016|P3|COMPLETED|Overall Study||4
5019149|NCT02181803|12351017|P2|COMPLETED|Overall Study||9
5019150|NCT02181803|12351018|P1|COMPLETED|Overall Study||1
5019151|NCT02181803|12351010|P9|STARTED|Overall Study||2
5019152|NCT02181803|12351011|P8|STARTED|Overall Study||1
5019153|NCT02181803|12351012|P7|STARTED|Overall Study||9
5019154|NCT02181803|12351013|P6|STARTED|Overall Study||6
5019155|NCT02181803|12351014|P5|STARTED|Overall Study||6
5019156|NCT02181803|12351015|P4|STARTED|Overall Study||13
5019157|NCT02181803|12351016|P3|STARTED|Overall Study||4
5019158|NCT02181803|12351017|P2|STARTED|Overall Study||13
5019159|NCT02181803|12351018|P1|STARTED|Overall Study||1
5019160|NCT02181790|12351169|P2|NOT COMPLETED|Overall Study||0
5019161|NCT02181790|12351170|P1|NOT COMPLETED|Overall Study||2
5019162|NCT02181790|12351169|P2|COMPLETED|Overall Study||0
5019163|NCT02181790|12351170|P1|COMPLETED|Overall Study||0
5019164|NCT02181790|12351169|P2|STARTED|Overall Study||0
5019165|NCT02181790|12351170|P1|STARTED|Overall Study||2
5019166|NCT02181738|12351182|P4|NOT COMPLETED|Overall Study||2
5019167|NCT02181738|12351183|P3|NOT COMPLETED|Overall Study||10
5019168|NCT02181738|12351184|P2|NOT COMPLETED|Overall Study||9
5019169|NCT02181738|12351185|P1|NOT COMPLETED|Overall Study||2
5019170|NCT02181738|12351182|P4|COMPLETED|Overall Study||49
5019171|NCT02181738|12351183|P3|COMPLETED|Overall Study||90
5019172|NCT02181738|12351184|P2|COMPLETED|Overall Study||71
5019173|NCT02181738|12351185|P1|COMPLETED|Overall Study||61
5019174|NCT02181738|12351182|P4|STARTED|Overall Study||51
5019175|NCT02181738|12351183|P3|STARTED|Overall Study||100
5019176|NCT02181738|12351184|P2|STARTED|Overall Study||80
5019177|NCT02181738|12351185|P1|STARTED|Overall Study||63
5019178|NCT02181673|12351226|P3|NOT COMPLETED|Week 24-Week 60||17
5019179|NCT02181673|12351227|P2|NOT COMPLETED|Week 24-Week 60||8
5019180|NCT02181673|12351228|P1|NOT COMPLETED|Week 24-Week 60||0
5019181|NCT02181673|12351226|P3|COMPLETED|Week 24-Week 60||213
5019182|NCT02181673|12351227|P2|COMPLETED|Week 24-Week 60||214
5019183|NCT02181673|12351228|P1|COMPLETED|Week 24-Week 60||0
5019184|NCT02181673|12351226|P3|Treated|Week 24-Week 60||230
5019185|NCT02181673|12351227|P2|Treated|Week 24-Week 60||220
5019186|NCT02181673|12351228|P1|Treated|Week 24-Week 60||0
5019187|NCT02181673|12351226|P3|STARTED|Week 24-Week 60||230
5019188|NCT02181673|12351227|P2|STARTED|Week 24-Week 60||222
5019189|NCT02181673|12351228|P1|STARTED|Week 24-Week 60||0
5019190|NCT02181673|12351226|P3|NOT COMPLETED|Up to Week 24||11
5019191|NCT02181673|12351227|P2|NOT COMPLETED|Up to Week 24||0
5019192|NCT02181673|12351228|P1|NOT COMPLETED|Up to Week 24||17
5019193|NCT02181673|12351226|P3|COMPLETED|Up to Week 24||230
5019194|NCT02181673|12351227|P2|COMPLETED|Up to Week 24||0
5019195|NCT02181673|12351228|P1|COMPLETED|Up to Week 24||222
5019196|NCT02181673|12351226|P3|Treated|Up to Week 24||240
5019197|NCT02181673|12351227|P2|Treated|Up to Week 24||0
5019198|NCT02181673|12351228|P1|Treated|Up to Week 24||239
5019199|NCT02181673|12351226|P3|STARTED|Up to Week 24||241
5019200|NCT02181673|12351227|P2|STARTED|Up to Week 24||0
5019201|NCT02181673|12351228|P1|STARTED|Up to Week 24||239
5019202|NCT02181634|12351255|P1|NOT COMPLETED|Overall Study||72
5019203|NCT02181634|12351255|P1|COMPLETED|Overall Study||2
5019204|NCT02181634|12351255|P1|Eligible and Treated|Overall Study||73
5019205|NCT02181634|12351255|P1|STARTED|Overall Study||74
5019206|NCT02181530|12351266|P1|NOT COMPLETED|Overall Study||0
5019207|NCT02181530|12351266|P1|COMPLETED|Overall Study||43
5019208|NCT02181530|12351266|P1|STARTED|Overall Study||43
5019209|NCT02181517|12351279|P3|NOT COMPLETED|Overall Study||0
5019210|NCT02181517|12351280|P2|NOT COMPLETED|Overall Study||0
5019211|NCT02181517|12351281|P1|NOT COMPLETED|Overall Study||0
5019212|NCT02181517|12351279|P3|COMPLETED|Overall Study||5
5019213|NCT02181517|12351280|P2|COMPLETED|Overall Study||10
5019214|NCT02181517|12351281|P1|COMPLETED|Overall Study||10
5019215|NCT02181517|12351279|P3|STARTED|Overall Study||5
5019216|NCT02181517|12351280|P2|STARTED|Overall Study||10
5019217|NCT02181517|12351281|P1|STARTED|Overall Study||10
5019218|NCT02181504|12351304|P3|NOT COMPLETED|Overall Study||1
5019219|NCT02181504|12351305|P2|NOT COMPLETED|Overall Study||1
5019220|NCT02181504|12351306|P1|NOT COMPLETED|Overall Study||1
5019221|NCT02181504|12351304|P3|COMPLETED|Overall Study||4
5019222|NCT02181504|12351305|P2|COMPLETED|Overall Study||9
5019223|NCT02181504|12351306|P1|COMPLETED|Overall Study||9
5019224|NCT02181504|12351304|P3|STARTED|Overall Study||5
5019225|NCT02181504|12351305|P2|STARTED|Overall Study||10
5019226|NCT02181504|12351306|P1|STARTED|Overall Study||10
5019227|NCT02181426|12351330|P4|NOT COMPLETED|Overall Study||0
5019228|NCT02181426|12351331|P3|NOT COMPLETED|Overall Study||0
5019229|NCT02181426|12351332|P2|NOT COMPLETED|Overall Study||0
5019230|NCT02181426|12351333|P1|NOT COMPLETED|Overall Study||0
5019231|NCT02181426|12351330|P4|COMPLETED|Overall Study||28
5019232|NCT02181426|12351331|P3|COMPLETED|Overall Study||28
5019233|NCT02181426|12351332|P2|COMPLETED|Overall Study||28
5019234|NCT02181426|12351333|P1|COMPLETED|Overall Study||28
5019235|NCT02181426|12351330|P4|STARTED|Overall Study||28
5019236|NCT02181426|12351331|P3|STARTED|Overall Study||28
5019237|NCT02181426|12351332|P2|STARTED|Overall Study||28
5019238|NCT02181426|12351333|P1|STARTED|Overall Study||28
5019239|NCT02181413|12351345|P2|NOT COMPLETED|Overall Study||197
5019240|NCT02181413|12351346|P1|NOT COMPLETED|Overall Study||152
5019241|NCT02181413|12351345|P2|COMPLETED|Overall Study||198
5019242|NCT02181413|12351346|P1|COMPLETED|Overall Study||109
5019243|NCT02181413|12351345|P2|Per Protocol (PP) Population|Overall Study||387
5019244|NCT02181413|12351346|P1|Per Protocol (PP) Population|Overall Study||256
5019245|NCT02181413|12351345|P2|Safety Population|Overall Study||394
5019246|NCT02181413|12351346|P1|Safety Population|Overall Study||259
5019247|NCT02181413|12351345|P2|Intent-to-Treat (ITT) Population|Overall Study||395
5019248|NCT02181413|12351346|P1|Intent-to-Treat (ITT) Population|Overall Study||261
5019249|NCT02181413|12351345|P2|STARTED|Overall Study||395
5019250|NCT02181413|12351346|P1|STARTED|Overall Study||261
5019251|NCT02181400|12351355|P3|NOT COMPLETED|Overall Study||0
5019252|NCT02181400|12351356|P2|NOT COMPLETED|Overall Study||0
5019253|NCT02181400|12351357|P1|NOT COMPLETED|Overall Study||0
5019254|NCT02181400|12351355|P3|COMPLETED|Overall Study||7
5019255|NCT02181400|12351356|P2|COMPLETED|Overall Study||7
5019256|NCT02181400|12351357|P1|COMPLETED|Overall Study||7
5019257|NCT02181400|12351355|P3|STARTED|Overall Study||7
5019258|NCT02181400|12351356|P2|STARTED|Overall Study||7
5019259|NCT02181400|12351357|P1|STARTED|Overall Study||7
5019260|NCT02181387|12351382|P2|NOT COMPLETED|Overall Study||4
5019261|NCT02181387|12351383|P1|NOT COMPLETED|Overall Study||2
5019262|NCT02181387|12351382|P2|COMPLETED|Overall Study||15
5019263|NCT02181387|12351383|P1|COMPLETED|Overall Study||12
5019264|NCT02181387|12351382|P2|STARTED|Overall Study||19
5019265|NCT02181387|12351383|P1|STARTED|Overall Study||14
5019266|NCT02181296|12351391|P2|NOT COMPLETED|Overall Study||6
5019267|NCT02181296|12351392|P1|NOT COMPLETED|Overall Study||7
5019268|NCT02181296|12351391|P2|COMPLETED|Overall Study||19
5019269|NCT02181296|12351392|P1|COMPLETED|Overall Study||18
5019270|NCT02181296|12351391|P2|STARTED|Overall Study||25
5019271|NCT02181296|12351392|P1|STARTED|Overall Study||25
5019272|NCT02181231|12351406|P2|NOT COMPLETED|Overall Study||0
5019273|NCT02181231|12351407|P1|NOT COMPLETED|Overall Study||2
5019274|NCT02181231|12351406|P2|COMPLETED|Overall Study||6
5019275|NCT02181231|12351407|P1|COMPLETED|Overall Study||10
5019276|NCT02181231|12351406|P2|STARTED|Overall Study||6
5019277|NCT02181231|12351407|P1|STARTED|Overall Study||12
5019278|NCT02181140|12351423|P1|NOT COMPLETED|Overall Study||0
5019279|NCT02181140|12351423|P1|COMPLETED|Overall Study||56
5019280|NCT02181140|12351423|P1|STARTED|Overall Study||56
5019281|NCT02181127|12351429|P1|NOT COMPLETED|Overall Study||0
5019282|NCT02181127|12351429|P1|COMPLETED|Overall Study||22
5019283|NCT02181127|12351429|P1|STARTED|Overall Study||22
5019284|NCT02181075|12351475|P2|NOT COMPLETED|Overall Study||0
5019285|NCT02181075|12351476|P1|NOT COMPLETED|Overall Study||0
5019286|NCT02181075|12351475|P2|COMPLETED|Overall Study||4
5019287|NCT02181075|12351476|P1|COMPLETED|Overall Study||6
5019288|NCT02181075|12351475|P2|STARTED|Overall Study||4
5019289|NCT02181075|12351476|P1|STARTED|Overall Study||6
5019290|NCT02180893|12351494|P2|NOT COMPLETED|Overall Study||7
5019291|NCT02180893|12351495|P1|NOT COMPLETED|Overall Study||3
5019292|NCT02180893|12351494|P2|COMPLETED|Overall Study||23
5019293|NCT02180893|12351495|P1|COMPLETED|Overall Study||27
5019294|NCT02180893|12351494|P2|STARTED|Overall Study||30
5019295|NCT02180893|12351495|P1|STARTED|Overall Study||30
5019296|NCT02180828|12351509|P2|NOT COMPLETED|Overall Study||7
5019297|NCT02180828|12351510|P1|NOT COMPLETED|Overall Study||5
5019298|NCT02180828|12351509|P2|COMPLETED|Overall Study||113
5019299|NCT02180828|12351510|P1|COMPLETED|Overall Study||115
5019300|NCT02180828|12351509|P2|STARTED|Overall Study||120
5019301|NCT02180828|12351510|P1|STARTED|Overall Study||120
5019302|NCT02180724|12351534|P2|NOT COMPLETED|Overall Study||14
5019303|NCT02180724|12351535|P1|NOT COMPLETED|Overall Study||92
5019304|NCT02180724|12351534|P2|COMPLETED|Overall Study||0
5019305|NCT02180724|12351535|P1|COMPLETED|Overall Study||0
5019306|NCT02180724|12351534|P2|Discontinued Treatment|Overall Study||7
5019307|NCT02180724|12351535|P1|Discontinued Treatment|Overall Study||23
5019308|NCT02180724|12351534|P2|Discontinued Study|Overall Study||3
5019309|NCT02180724|12351535|P1|Discontinued Study|Overall Study||14
5019310|NCT02180724|12351534|P2|Received Study Medication|Overall Study||14
5019311|NCT02180724|12351535|P1|Received Study Medication|Overall Study||92
5019312|NCT02180724|12351534|P2|Enrolled|Overall Study||14
5019313|NCT02180724|12351535|P1|Enrolled|Overall Study||92
5019314|NCT02180724|12351534|P2|STARTED|Overall Study||14
5019315|NCT02180724|12351535|P1|STARTED|Overall Study||92
5019316|NCT02180659|12351549|P2|NOT COMPLETED|Overall Study||5
5019317|NCT02180659|12351550|P1|NOT COMPLETED|Overall Study||6
5019318|NCT02180659|12351549|P2|COMPLETED|Overall Study||84
5019319|NCT02180659|12351550|P1|COMPLETED|Overall Study||81
5019320|NCT02180659|12351549|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
5019321|NCT02180659|12351550|P1|STARTED|Overall Study||87
5019322|NCT02180646|12351572|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5019323|NCT02180646|12351573|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5019324|NCT02180646|12351572|P2|COMPLETED|Second Intervention (7 Days)||6
5019325|NCT02180646|12351573|P1|COMPLETED|Second Intervention (7 Days)||6
5019326|NCT02180646|12351572|P2|STARTED|Second Intervention (7 Days)||6
5019327|NCT02180646|12351573|P1|STARTED|Second Intervention (7 Days)||6
5019328|NCT02180646|12351572|P2|NOT COMPLETED|Washout (7 Days)||0
5019329|NCT02180646|12351573|P1|NOT COMPLETED|Washout (7 Days)||0
5019330|NCT02180646|12351572|P2|COMPLETED|Washout (7 Days)||6
5019331|NCT02180646|12351573|P1|COMPLETED|Washout (7 Days)||6
5019332|NCT02180646|12351572|P2|STARTED|Washout (7 Days)||6
5019333|NCT02180646|12351573|P1|STARTED|Washout (7 Days)||6
5019334|NCT02180646|12351572|P2|NOT COMPLETED|First Intervention (7 Days)||0
5019335|NCT02180646|12351573|P1|NOT COMPLETED|First Intervention (7 Days)||0
5019336|NCT02180646|12351572|P2|COMPLETED|First Intervention (7 Days)||6
5019337|NCT02180646|12351573|P1|COMPLETED|First Intervention (7 Days)||6
5019338|NCT02180646|12351572|P2|STARTED|First Intervention (7 Days)||6
5019339|NCT02180646|12351573|P1|STARTED|First Intervention (7 Days)||6
5019340|NCT02180438|12351585|P1|NOT COMPLETED|Overall Study||1
5019341|NCT02180438|12351585|P1|COMPLETED|Overall Study||29
5019342|NCT02180438|12351585|P1|STARTED|Overall Study||30
5019343|NCT02180230|12351600|P1|NOT COMPLETED|Overall Study||7
5019344|NCT02180230|12351600|P1|COMPLETED|Overall Study||31
5019345|NCT02180230|12351600|P1|STARTED|Overall Study||38
5019346|NCT02180217|12351608|P3|NOT COMPLETED|Overall Study||32
5019347|NCT02180217|12351609|P2|NOT COMPLETED|Overall Study||8
5019348|NCT02180217|12351610|P1|NOT COMPLETED|Overall Study||2
5019349|NCT02180217|12351608|P3|COMPLETED|Overall Study||34
5019350|NCT02180217|12351609|P2|COMPLETED|Overall Study||27
5019351|NCT02180217|12351610|P1|COMPLETED|Overall Study||34
5019352|NCT02180217|12351608|P3|Discontinued Extension Phase|Overall Study||7
5019353|NCT02180217|12351609|P2|Discontinued Extension Phase|Overall Study||3
5019354|NCT02180217|12351610|P1|Discontinued Extension Phase|Overall Study||1
5019355|NCT02180217|12351608|P3|Completed W48, Entered Ext. Phase|Overall Study||41
5019356|NCT02180217|12351609|P2|Completed W48, Entered Ext. Phase|Overall Study||30
5019357|NCT02180217|12351610|P1|Completed W48, Entered Ext. Phase|Overall Study||35
5019358|NCT02180217|12351608|P3|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
5019359|NCT02180217|12351609|P2|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
5019360|NCT02180217|12351610|P1|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
5019361|NCT02180217|12351608|P3|Completed Week 48 (Core Phase)|Overall Study||44
5019362|NCT02180217|12351609|P2|Completed Week 48 (Core Phase)|Overall Study||33
5019363|NCT02180217|12351610|P1|Completed Week 48 (Core Phase)|Overall Study||36
5019364|NCT02180217|12351608|P3|Discontinued Prior to W48 But After W26|Overall Study||1
5019365|NCT02180217|12351609|P2|Discontinued Prior to W48 But After W26|Overall Study||2
5019366|NCT02180217|12351610|P1|Discontinued Prior to W48 But After W26|Overall Study||0
5019367|NCT02180217|12351608|P3|Discont. at/Prior to W26 But After W12|Overall Study||12
5019368|NCT02180217|12351609|P2|Discont. at/Prior to W26 But After W12|Overall Study||0
5019369|NCT02180217|12351610|P1|Discont. at/Prior to W26 But After W12|Overall Study||0
5019370|NCT02180217|12351608|P3|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
5019371|NCT02180217|12351609|P2|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
5019372|NCT02180217|12351610|P1|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
5019373|NCT02180217|12351608|P3|STARTED|Overall Study||66
5019374|NCT02180217|12351609|P2|STARTED|Overall Study||35
5019375|NCT02180217|12351610|P1|STARTED|Overall Study||36
5019376|NCT02180165|12351625|P4|NOT COMPLETED|Overall Study||6
5019377|NCT02180165|12351626|P3|NOT COMPLETED|Overall Study||29
5019378|NCT02180165|12351627|P2|NOT COMPLETED|Overall Study||1
5019379|NCT02180165|12351628|P1|NOT COMPLETED|Overall Study||11
5019380|NCT02180165|12351625|P4|COMPLETED|Overall Study||25
5019381|NCT02180165|12351626|P3|COMPLETED|Overall Study||34
5019382|NCT02180165|12351627|P2|COMPLETED|Overall Study||6
5019383|NCT02180165|12351628|P1|COMPLETED|Overall Study||4
5019384|NCT02180165|12351625|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
5019385|NCT02180165|12351626|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
5019386|NCT02180165|12351627|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
5019387|NCT02180165|12351628|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
5019388|NCT02180165|12351625|P4|Treated Participants|Overall Study||31
5019389|NCT02180165|12351626|P3|Treated Participants|Overall Study||62
5019390|NCT02180165|12351627|P2|Treated Participants|Overall Study||7
5019391|NCT02180165|12351628|P1|Treated Participants|Overall Study||15
5019392|NCT02180165|12351625|P4|STARTED|Overall Study||31
5019393|NCT02180165|12351626|P3|STARTED|Overall Study||63
5019394|NCT02180165|12351627|P2|STARTED|Overall Study||7
5019395|NCT02180165|12351628|P1|STARTED|Overall Study||15
5019396|NCT02180061|12351716|P2|NOT COMPLETED|Overall Study||8
5019397|NCT02180061|12351717|P1|NOT COMPLETED|Overall Study||25
5019398|NCT02180061|12351716|P2|COMPLETED|Overall Study||0
5019399|NCT02180061|12351717|P1|COMPLETED|Overall Study||9
5019400|NCT02180061|12351716|P2|STARTED|Overall Study||8
5019401|NCT02180061|12351717|P1|STARTED|Overall Study||34
5019402|NCT02179918|12351736|P5|NOT COMPLETED|Overall Study||8
5019403|NCT02179918|12351737|P4|NOT COMPLETED|Overall Study||3
5019404|NCT02179918|12351738|P3|NOT COMPLETED|Overall Study||2
5019405|NCT02179918|12351739|P2|NOT COMPLETED|Overall Study||3
5019406|NCT02179918|12351740|P1|NOT COMPLETED|Overall Study||4
5019407|NCT02179918|12351736|P5|COMPLETED|Overall Study||1
5019408|NCT02179918|12351737|P4|COMPLETED|Overall Study||0
5019409|NCT02179918|12351738|P3|COMPLETED|Overall Study||1
5019410|NCT02179918|12351739|P2|COMPLETED|Overall Study||0
5019411|NCT02179918|12351740|P1|COMPLETED|Overall Study||1
5019412|NCT02179918|12351736|P5|STARTED|Overall Study||9
5019413|NCT02179918|12351737|P4|STARTED|Overall Study||3
5019414|NCT02179918|12351738|P3|STARTED|Overall Study||3
5019415|NCT02179918|12351739|P2|STARTED|Overall Study||3
5019416|NCT02179918|12351740|P1|STARTED|Overall Study||5
5019417|NCT02179892|12351866|P2|NOT COMPLETED|Overall Study||0
5019418|NCT02179892|12351867|P1|NOT COMPLETED|Overall Study||0
5019419|NCT02179892|12351866|P2|COMPLETED|Overall Study||4
5019420|NCT02179892|12351867|P1|COMPLETED|Overall Study||5
5019421|NCT02179892|12351866|P2|STARTED|Overall Study||4
5019422|NCT02179892|12351867|P1|STARTED|Overall Study||5
5019423|NCT02179671|12351884|P5|NOT COMPLETED|Overall Study||13
5019424|NCT02179671|12351885|P4|NOT COMPLETED|Overall Study||13
5019425|NCT02179671|12351886|P3|NOT COMPLETED|Overall Study||1
5019426|NCT02179671|12351887|P2|NOT COMPLETED|Overall Study||1
5019427|NCT02179671|12351888|P1|NOT COMPLETED|Overall Study||1
5019428|NCT02179671|12351884|P5|COMPLETED|Overall Study||1
5019429|NCT02179671|12351885|P4|COMPLETED|Overall Study||1
5019430|NCT02179671|12351886|P3|COMPLETED|Overall Study||1
5019431|NCT02179671|12351887|P2|COMPLETED|Overall Study||0
5019432|NCT02179671|12351888|P1|COMPLETED|Overall Study||0
5019433|NCT02179671|12351884|P5|STARTED|Overall Study||14
5019434|NCT02179671|12351885|P4|STARTED|Overall Study||14
5019435|NCT02179671|12351886|P3|STARTED|Overall Study||2
5019436|NCT02179671|12351887|P2|STARTED|Overall Study||1
5019437|NCT02179671|12351888|P1|STARTED|Overall Study||1
5019438|NCT02179424|12351924|P4|NOT COMPLETED|Overall Study||0
5019439|NCT02179424|12351925|P3|NOT COMPLETED|Overall Study||0
5019440|NCT02179424|12351926|P2|NOT COMPLETED|Overall Study||0
5019441|NCT02179424|12351927|P1|NOT COMPLETED|Overall Study||0
5019442|NCT02179424|12351924|P4|COMPLETED|Overall Study||39
5019443|NCT02179424|12351925|P3|COMPLETED|Overall Study||516
5019444|NCT02179424|12351926|P2|COMPLETED|Overall Study||11
5019445|NCT02179424|12351927|P1|COMPLETED|Overall Study||76
5019446|NCT02179424|12351924|P4|STARTED|Overall Study||39
5019447|NCT02179424|12351925|P3|STARTED|Overall Study||516
5019448|NCT02179424|12351926|P2|STARTED|Overall Study||11
5019449|NCT02179424|12351927|P1|STARTED|Overall Study||76
5019450|NCT02179398|12351944|P2|NOT COMPLETED|Overall Study||4
5019451|NCT02179398|12351945|P1|NOT COMPLETED|Overall Study||3
5019452|NCT02179398|12351944|P2|COMPLETED|Overall Study||140
5019453|NCT02179398|12351945|P1|COMPLETED|Overall Study||131
5019454|NCT02179398|12351944|P2|STARTED|Overall Study||144
5019455|NCT02179398|12351945|P1|STARTED|Overall Study||134
5019456|NCT02179190|12351963|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
5019457|NCT02179190|12351963|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
5019458|NCT02179190|12351963|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
5019459|NCT02179190|12351963|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
5019460|NCT02179190|12351963|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
5019461|NCT02179190|12351963|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
5019462|NCT02179190|12351963|P1|NOT COMPLETED|Enrollment||11
5019463|NCT02179190|12351963|P1|COMPLETED|Enrollment||127
5019464|NCT02179190|12351963|P1|STARTED|Enrollment||138
5019465|NCT02179177|12351976|P2|NOT COMPLETED|Overall Study||2
5019466|NCT02179177|12351977|P1|NOT COMPLETED|Overall Study||2
5019467|NCT02179177|12351976|P2|COMPLETED|Overall Study||6
5019468|NCT02179177|12351977|P1|COMPLETED|Overall Study||6
5019469|NCT02179177|12351976|P2|STARTED|Overall Study||8
5019470|NCT02179177|12351977|P1|STARTED|Overall Study||8
5019471|NCT02179047|12351991|P2|NOT COMPLETED|Overall Study||0
5019472|NCT02179047|12351992|P1|NOT COMPLETED|Overall Study||7
5019473|NCT02179047|12351991|P2|COMPLETED|Overall Study||20
5019474|NCT02179047|12351992|P1|COMPLETED|Overall Study||187
5019475|NCT02179047|12351991|P2|STARTED|Overall Study||20
5019476|NCT02179047|12351992|P1|STARTED|Overall Study||194
5019477|NCT02178995|12352017|P9|NOT COMPLETED|Open Label||0
5019478|NCT02178995|12352018|P8|NOT COMPLETED|Open Label||0
5019479|NCT02178995|12352019|P7|NOT COMPLETED|Open Label||0
5019480|NCT02178995|12352020|P6|NOT COMPLETED|Open Label||0
5019481|NCT02178995|12352021|P5|NOT COMPLETED|Open Label||0
5019482|NCT02178995|12352022|P4|NOT COMPLETED|Open Label||0
5019483|NCT02178995|12352023|P3|NOT COMPLETED|Open Label||0
5019484|NCT02178995|12352024|P2|NOT COMPLETED|Open Label||0
5019485|NCT02178995|12352025|P1|NOT COMPLETED|Open Label||2
5019486|NCT02178995|12352017|P9|COMPLETED|Open Label||0
5019487|NCT02178995|12352018|P8|COMPLETED|Open Label||0
5019488|NCT02178995|12352019|P7|COMPLETED|Open Label||0
5019489|NCT02178995|12352020|P6|COMPLETED|Open Label||0
5019490|NCT02178995|12352021|P5|COMPLETED|Open Label||0
5019491|NCT02178995|12352022|P4|COMPLETED|Open Label||0
5019492|NCT02178995|12352023|P3|COMPLETED|Open Label||0
5019493|NCT02178995|12352024|P2|COMPLETED|Open Label||14
5019494|NCT02178995|12352025|P1|COMPLETED|Open Label||28
5019495|NCT02178995|12352017|P9|STARTED|Open Label||0
5019496|NCT02178995|12352018|P8|STARTED|Open Label||0
5019497|NCT02178995|12352019|P7|STARTED|Open Label||0
5019498|NCT02178995|12352020|P6|STARTED|Open Label||0
5019499|NCT02178995|12352021|P5|STARTED|Open Label||0
5019500|NCT02178995|12352022|P4|STARTED|Open Label||0
5019501|NCT02178995|12352023|P3|STARTED|Open Label||0
5019502|NCT02178995|12352024|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
5019503|NCT02178995|12352025|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
5019504|NCT02178995|12352017|P9|NOT COMPLETED|Double Blind||1
5019505|NCT02178995|12352018|P8|NOT COMPLETED|Double Blind||2
5019506|NCT02178995|12352019|P7|NOT COMPLETED|Double Blind||0
5019507|NCT02178995|12352020|P6|NOT COMPLETED|Double Blind||1
5019508|NCT02178995|12352021|P5|NOT COMPLETED|Double Blind||0
5019509|NCT02178995|12352022|P4|NOT COMPLETED|Double Blind||0
5019510|NCT02178995|12352023|P3|NOT COMPLETED|Double Blind||0
5019511|NCT02178995|12352024|P2|NOT COMPLETED|Double Blind||1
5019512|NCT02178995|12352025|P1|NOT COMPLETED|Double Blind||0
5019513|NCT02178995|12352017|P9|COMPLETED|Double Blind||0
5019514|NCT02178995|12352018|P8|COMPLETED|Double Blind||4
5019515|NCT02178995|12352019|P7|COMPLETED|Double Blind||5
5019516|NCT02178995|12352020|P6|COMPLETED|Double Blind||5
5019517|NCT02178995|12352021|P5|COMPLETED|Double Blind||6
5019518|NCT02178995|12352022|P4|COMPLETED|Double Blind||6
5019519|NCT02178995|12352023|P3|COMPLETED|Double Blind||5
5019520|NCT02178995|12352024|P2|COMPLETED|Double Blind||15
5019521|NCT02178995|12352025|P1|COMPLETED|Double Blind||0
5019522|NCT02178995|12352017|P9|STARTED|Double Blind||1
5019523|NCT02178995|12352018|P8|STARTED|Double Blind||6
5019524|NCT02178995|12352019|P7|STARTED|Double Blind||5
5019525|NCT02178995|12352020|P6|STARTED|Double Blind||6
5019526|NCT02178995|12352021|P5|STARTED|Double Blind||6
5019527|NCT02178995|12352022|P4|STARTED|Double Blind||6
5019528|NCT02178995|12352023|P3|STARTED|Double Blind||5
5019529|NCT02178995|12352024|P2|STARTED|Double Blind||16
5019530|NCT02178995|12352025|P1|STARTED|Double Blind||0
5019531|NCT02178800|12352098|P2|NOT COMPLETED|Overall Study||6
5019532|NCT02178800|12352099|P1|NOT COMPLETED|Overall Study||20
5019533|NCT02178800|12352098|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
5019534|NCT02178800|12352099|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
5019535|NCT02178800|12352098|P2|STARTED|Overall Study||48
5019536|NCT02178800|12352099|P1|STARTED|Overall Study||151
5019537|NCT02178787|12352133|P2|NOT COMPLETED|Overall Study||9
5019538|NCT02178787|12352134|P1|NOT COMPLETED|Overall Study||5
5019539|NCT02178787|12352133|P2|COMPLETED|Overall Study||30
5019540|NCT02178787|12352134|P1|COMPLETED|Overall Study||30
5019541|NCT02178787|12352133|P2|STARTED|Overall Study||39
5019542|NCT02178787|12352134|P1|STARTED|Overall Study||35
5019543|NCT02178722|12352147|P5|NOT COMPLETED|Overall Study||382
5019544|NCT02178722|12352148|P4|NOT COMPLETED|Overall Study||20
5019545|NCT02178722|12352149|P3|NOT COMPLETED|Overall Study||18
5019546|NCT02178722|12352150|P2|NOT COMPLETED|Overall Study||20
5019547|NCT02178722|12352151|P1|NOT COMPLETED|Overall Study||4
5019548|NCT02178722|12352147|P5|COMPLETED|Overall Study||0
5019549|NCT02178722|12352148|P4|COMPLETED|Overall Study||0
5019550|NCT02178722|12352149|P3|COMPLETED|Overall Study||0
5019551|NCT02178722|12352150|P2|COMPLETED|Overall Study||0
5019552|NCT02178722|12352151|P1|COMPLETED|Overall Study||0
5019553|NCT02178722|12352147|P5|STARTED|Overall Study||382
5019554|NCT02178722|12352148|P4|STARTED|Overall Study||20
5019555|NCT02178722|12352149|P3|STARTED|Overall Study||18
5019556|NCT02178722|12352150|P2|STARTED|Overall Study||20
5019557|NCT02178722|12352151|P1|STARTED|Overall Study||4
5019558|NCT02178709|12352163|P1|NOT COMPLETED|Overall Study||16
5019559|NCT02178709|12352163|P1|COMPLETED|Overall Study||32
5019560|NCT02178709|12352163|P1|STARTED|Overall Study||48
5019561|NCT02178696|12352174|P2|NOT COMPLETED|Open-label Antidepressant||7
5019562|NCT02178696|12352175|P1|NOT COMPLETED|Open-label Antidepressant||6
5019563|NCT02178696|12352174|P2|COMPLETED|Open-label Antidepressant||13
5019564|NCT02178696|12352175|P1|COMPLETED|Open-label Antidepressant||14
5019565|NCT02178696|12352174|P2|STARTED|Open-label Antidepressant||20
5019566|NCT02178696|12352175|P1|STARTED|Open-label Antidepressant||20
5019567|NCT02178696|12352174|P2|NOT COMPLETED|Second Assignment After Crossover||0
5019568|NCT02178696|12352175|P1|NOT COMPLETED|Second Assignment After Crossover||0
5019569|NCT02178696|12352174|P2|COMPLETED|Second Assignment After Crossover||20
5019570|NCT02178696|12352175|P1|COMPLETED|Second Assignment After Crossover||20
5019571|NCT02178696|12352174|P2|STARTED|Second Assignment After Crossover||20
5019572|NCT02178696|12352175|P1|STARTED|Second Assignment After Crossover||20
5019573|NCT02178696|12352174|P2|NOT COMPLETED|First Assignment and Washout||0
5019574|NCT02178696|12352175|P1|NOT COMPLETED|First Assignment and Washout||0
5019575|NCT02178696|12352174|P2|COMPLETED|First Assignment and Washout||20
5019576|NCT02178696|12352175|P1|COMPLETED|First Assignment and Washout||20
5019577|NCT02178696|12352174|P2|STARTED|First Assignment and Washout||20
5019578|NCT02178696|12352175|P1|STARTED|First Assignment and Washout||20
5019579|NCT02178592|12352190|P2|NOT COMPLETED|Overall Study||9
5019580|NCT02178592|12352191|P1|NOT COMPLETED|Overall Study||19
5019581|NCT02178592|12352190|P2|COMPLETED|Overall Study||35
5019582|NCT02178592|12352191|P1|COMPLETED|Overall Study||50
5019583|NCT02178592|12352190|P2|STARTED|Overall Study||44
5019584|NCT02178592|12352191|P1|STARTED|Overall Study||69
5019585|NCT02178553|12352219|P2|NOT COMPLETED|Overall Study||10
5019586|NCT02178553|12352220|P1|NOT COMPLETED|Overall Study||8
5019587|NCT02178553|12352219|P2|COMPLETED|Overall Study||39
5019588|NCT02178553|12352220|P1|COMPLETED|Overall Study||45
5019589|NCT02178553|12352219|P2|STARTED|Overall Study||49
5019590|NCT02178553|12352220|P1|STARTED|Overall Study||53
5019591|NCT02178540|12352232|P1|NOT COMPLETED|Overall Study||0
5019592|NCT02178540|12352232|P1|COMPLETED|Overall Study||45
5019593|NCT02178540|12352232|P1|STARTED|Overall Study||45
5019594|NCT02178475|12352239|P1|NOT COMPLETED|Overall Study||129
5019595|NCT02178475|12352239|P1|COMPLETED|Overall Study||814
5019596|NCT02178475|12352239|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
5019597|NCT02178475|12352239|P1|STARTED|Overall Study||943
5019598|NCT02178241|12352259|P1|NOT COMPLETED|Overall Study||0
5019599|NCT02178241|12352259|P1|COMPLETED|Overall Study||24
5019600|NCT02178241|12352259|P1|STARTED|Overall Study||24
5019601|NCT02178059|12352266|P2|NOT COMPLETED|Second Intervention||0
5019602|NCT02178059|12352267|P1|NOT COMPLETED|Second Intervention||0
5019603|NCT02178059|12352266|P2|COMPLETED|Second Intervention||17
5019604|NCT02178059|12352267|P1|COMPLETED|Second Intervention||16
5019605|NCT02178059|12352266|P2|STARTED|Second Intervention||17
5019606|NCT02178059|12352267|P1|STARTED|Second Intervention||16
5019607|NCT02178059|12352266|P2|NOT COMPLETED|Washout||0
5019608|NCT02178059|12352267|P1|NOT COMPLETED|Washout||1
5019609|NCT02178059|12352266|P2|COMPLETED|Washout||17
5019610|NCT02178059|12352267|P1|COMPLETED|Washout||16
5019611|NCT02178059|12352266|P2|STARTED|Washout||17
5019612|NCT02178059|12352267|P1|STARTED|Washout||17
5019613|NCT02178059|12352266|P2|NOT COMPLETED|First Intervention||0
5019614|NCT02178059|12352267|P1|NOT COMPLETED|First Intervention||0
5019615|NCT02178059|12352266|P2|COMPLETED|First Intervention||17
5019616|NCT02178059|12352267|P1|COMPLETED|First Intervention||17
5019617|NCT02178059|12352266|P2|STARTED|First Intervention||17
5019618|NCT02178059|12352267|P1|STARTED|First Intervention||17
5019619|NCT02177942|12352285|P2|NOT COMPLETED|Overall Study||88
5019620|NCT02177942|12352286|P1|NOT COMPLETED|Overall Study||77
5019621|NCT02177942|12352285|P2|COMPLETED|Overall Study||178
5019622|NCT02177942|12352286|P1|COMPLETED|Overall Study||185
5019623|NCT02177942|12352285|P2|STARTED|Overall Study||266
5019624|NCT02177942|12352286|P1|STARTED|Overall Study||262
5019625|NCT02177812|12352317|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019626|NCT02177812|12352318|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019627|NCT02177812|12352319|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019628|NCT02177812|12352320|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019629|NCT02177812|12352321|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019630|NCT02177812|12352322|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019631|NCT02177812|12352323|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019632|NCT02177812|12352324|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019633|NCT02177812|12352325|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
5019634|NCT02177812|12352317|P9|COMPLETED|Part 2 (Up to 14 Months)||0
5019635|NCT02177812|12352318|P8|COMPLETED|Part 2 (Up to 14 Months)||0
5019636|NCT02177812|12352319|P7|COMPLETED|Part 2 (Up to 14 Months)||0
5019637|NCT02177812|12352320|P6|COMPLETED|Part 2 (Up to 14 Months)||0
5019638|NCT02177812|12352321|P5|COMPLETED|Part 2 (Up to 14 Months)||0
5019639|NCT02177812|12352322|P4|COMPLETED|Part 2 (Up to 14 Months)||0
5019640|NCT02177812|12352323|P3|COMPLETED|Part 2 (Up to 14 Months)||0
5019641|NCT02177812|12352324|P2|COMPLETED|Part 2 (Up to 14 Months)||0
5019642|NCT02177812|12352325|P1|COMPLETED|Part 2 (Up to 14 Months)||0
5019643|NCT02177812|12352317|P9|STARTED|Part 2 (Up to 14 Months)||0
5019644|NCT02177812|12352318|P8|STARTED|Part 2 (Up to 14 Months)||0
5019645|NCT02177812|12352319|P7|STARTED|Part 2 (Up to 14 Months)||0
5019646|NCT02177812|12352320|P6|STARTED|Part 2 (Up to 14 Months)||0
5019647|NCT02177812|12352321|P5|STARTED|Part 2 (Up to 14 Months)||0
5019648|NCT02177812|12352322|P4|STARTED|Part 2 (Up to 14 Months)||0
5019649|NCT02177812|12352323|P3|STARTED|Part 2 (Up to 14 Months)||0
5019650|NCT02177812|12352324|P2|STARTED|Part 2 (Up to 14 Months)||0
5019651|NCT02177812|12352325|P1|STARTED|Part 2 (Up to 14 Months)||0
5019652|NCT02177812|12352317|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
5019653|NCT02177812|12352318|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
5019654|NCT02177812|12352319|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
5019655|NCT02177812|12352320|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
5019656|NCT02177812|12352321|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
5019657|NCT02177812|12352322|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
5019658|NCT02177812|12352323|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
5019659|NCT02177812|12352324|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
5019660|NCT02177812|12352325|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
5019661|NCT02177812|12352317|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
5019662|NCT02177812|12352318|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
5019663|NCT02177812|12352319|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
5019664|NCT02177812|12352320|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
5019665|NCT02177812|12352321|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
5019666|NCT02177812|12352322|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
5019667|NCT02177812|12352323|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
5019668|NCT02177812|12352324|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
5019669|NCT02177812|12352325|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
5019670|NCT02177812|12352317|P9|STARTED|Part 1 (Median of 4 Weeks)||0
5019671|NCT02177812|12352318|P8|STARTED|Part 1 (Median of 4 Weeks)||6
5019672|NCT02177812|12352319|P7|STARTED|Part 1 (Median of 4 Weeks)||10
5019673|NCT02177812|12352320|P6|STARTED|Part 1 (Median of 4 Weeks)||4
5019674|NCT02177812|12352321|P5|STARTED|Part 1 (Median of 4 Weeks)||6
5019675|NCT02177812|12352322|P4|STARTED|Part 1 (Median of 4 Weeks)||5
5019676|NCT02177812|12352323|P3|STARTED|Part 1 (Median of 4 Weeks)||7
5019677|NCT02177812|12352324|P2|STARTED|Part 1 (Median of 4 Weeks)||2
5019678|NCT02177812|12352325|P1|STARTED|Part 1 (Median of 4 Weeks)||1
5019679|NCT02177786|12352542|P4|NOT COMPLETED|Overall Study||13
5019680|NCT02177786|12352543|P3|NOT COMPLETED|Overall Study||18
5019681|NCT02177786|12352544|P2|NOT COMPLETED|Overall Study||14
5019682|NCT02177786|12352545|P1|NOT COMPLETED|Overall Study||6
5019683|NCT02177786|12352542|P4|COMPLETED|Overall Study||72
5019684|NCT02177786|12352543|P3|COMPLETED|Overall Study||66
5019685|NCT02177786|12352544|P2|COMPLETED|Overall Study||70
5019686|NCT02177786|12352545|P1|COMPLETED|Overall Study||75
5019687|NCT02177786|12352542|P4|Randomized and Treated|Overall Study||85
5019688|NCT02177786|12352543|P3|Randomized and Treated|Overall Study||83
5019689|NCT02177786|12352544|P2|Randomized and Treated|Overall Study||84
5019690|NCT02177786|12352545|P1|Randomized and Treated|Overall Study||81
5019691|NCT02177786|12352542|P4|STARTED|Overall Study||85
5019692|NCT02177786|12352543|P3|STARTED|Overall Study||84
5019693|NCT02177786|12352544|P2|STARTED|Overall Study||84
5019694|NCT02177786|12352545|P1|STARTED|Overall Study||81
5019695|NCT02177773|12352559|P1|NOT COMPLETED|Overall Study||0
5019696|NCT02177773|12352559|P1|COMPLETED|Overall Study||300
5019697|NCT02177773|12352559|P1|STARTED|Overall Study||300
5019698|NCT02177266|12352568|P2|NOT COMPLETED|Overall Study||1
5019699|NCT02177266|12352569|P1|NOT COMPLETED|Overall Study||1
5019700|NCT02177266|12352568|P2|COMPLETED|Overall Study||0
5019701|NCT02177266|12352569|P1|COMPLETED|Overall Study||0
5019702|NCT02177266|12352568|P2|STARTED|Overall Study||1
5019703|NCT02177266|12352569|P1|STARTED|Overall Study||1
5019704|NCT02177201|12352581|P2|NOT COMPLETED|Overall Study||3
5019705|NCT02177201|12352582|P1|NOT COMPLETED|Overall Study||3
5019706|NCT02177201|12352581|P2|COMPLETED|Overall Study||77
5019707|NCT02177201|12352582|P1|COMPLETED|Overall Study||77
5019708|NCT02177201|12352581|P2|STARTED|Overall Study||80
5019709|NCT02177201|12352582|P1|STARTED|Overall Study||80
5019710|NCT02177136|12352591|P3|NOT COMPLETED|Overall Study||4
5019711|NCT02177136|12352592|P2|NOT COMPLETED|Overall Study||5
5019712|NCT02177136|12352593|P1|NOT COMPLETED|Overall Study||6
5019713|NCT02177136|12352591|P3|COMPLETED|Overall Study||21
5019714|NCT02177136|12352592|P2|COMPLETED|Overall Study||21
5019715|NCT02177136|12352593|P1|COMPLETED|Overall Study||19
5019716|NCT02177136|12352591|P3|STARTED|Overall Study||25
5019717|NCT02177136|12352592|P2|STARTED|Overall Study||26
5019718|NCT02177136|12352593|P1|STARTED|Overall Study||25
5019719|NCT02177032|12352626|P4|NOT COMPLETED|Overall Study||0
5019720|NCT02177032|12352627|P3|NOT COMPLETED|Overall Study||3
5019721|NCT02177032|12352628|P2|NOT COMPLETED|Overall Study||2
5019722|NCT02177032|12352629|P1|NOT COMPLETED|Overall Study||5
5019723|NCT02177032|12352626|P4|COMPLETED|Overall Study||88
5019724|NCT02177032|12352627|P3|COMPLETED|Overall Study||351
5019725|NCT02177032|12352628|P2|COMPLETED|Overall Study||86
5019726|NCT02177032|12352629|P1|COMPLETED|Overall Study||350
5019727|NCT02177032|12352626|P4|STARTED|Overall Study||88
5019728|NCT02177032|12352627|P3|STARTED|Overall Study||354
5019729|NCT02177032|12352628|P2|STARTED|Overall Study||88
5019730|NCT02177032|12352629|P1|STARTED|Overall Study||355
5019731|NCT02176837|12352663|P1|NOT COMPLETED|Overall Study||6
5019732|NCT02176837|12352663|P1|COMPLETED|Overall Study||0
5019733|NCT02176837|12352663|P1|STARTED|Overall Study||6
5019734|NCT02176655|12352667|P1|NOT COMPLETED|Overall Study||6
5019735|NCT02176655|12352667|P1|COMPLETED|Overall Study||25
5019736|NCT02176655|12352667|P1|STARTED|Overall Study||31
5019737|NCT02176642|12352690|P2|NOT COMPLETED|Overall Study||1
5019738|NCT02176642|12352691|P1|NOT COMPLETED|Overall Study||0
5019739|NCT02176642|12352690|P2|COMPLETED|Overall Study||16
5019740|NCT02176642|12352691|P1|COMPLETED|Overall Study||18
5019741|NCT02176642|12352690|P2|STARTED|Overall Study||17
5019742|NCT02176642|12352691|P1|STARTED|Overall Study||18
5019743|NCT02176525|12352721|P8|NOT COMPLETED|Overall Study||0
5019744|NCT02176525|12352722|P7|NOT COMPLETED|Overall Study||1
5019745|NCT02176525|12352723|P6|NOT COMPLETED|Overall Study||1
5019746|NCT02176525|12352724|P5|NOT COMPLETED|Overall Study||1
5019747|NCT02176525|12352725|P4|NOT COMPLETED|Overall Study||1
5019748|NCT02176525|12352726|P3|NOT COMPLETED|Overall Study||0
5019749|NCT02176525|12352727|P2|NOT COMPLETED|Overall Study||0
5019750|NCT02176525|12352728|P1|NOT COMPLETED|Overall Study||1
5019751|NCT02176525|12352721|P8|COMPLETED|Overall Study||10
5019752|NCT02176525|12352722|P7|COMPLETED|Overall Study||8
5019753|NCT02176525|12352723|P6|COMPLETED|Overall Study||5
5019754|NCT02176525|12352724|P5|COMPLETED|Overall Study||7
5019755|NCT02176525|12352725|P4|COMPLETED|Overall Study||8
5019756|NCT02176525|12352726|P3|COMPLETED|Overall Study||9
5019757|NCT02176525|12352727|P2|COMPLETED|Overall Study||9
5019758|NCT02176525|12352728|P1|COMPLETED|Overall Study||14
5019759|NCT02176525|12352721|P8|STARTED|Overall Study||10
5019760|NCT02176525|12352722|P7|STARTED|Overall Study||9
5019761|NCT02176525|12352723|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
5019762|NCT02176525|12352724|P5|STARTED|Overall Study||8
5019763|NCT02176525|12352725|P4|STARTED|Overall Study||9
5019764|NCT02176525|12352726|P3|STARTED|Overall Study||9
5019765|NCT02176525|12352727|P2|STARTED|Overall Study||9
5019766|NCT02176525|12352728|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
5019767|NCT02176486|12352908|P3|NOT COMPLETED|Overall Study||0
5019768|NCT02176486|12352909|P2|NOT COMPLETED|Overall Study||0
5019769|NCT02176486|12352910|P1|NOT COMPLETED|Overall Study||0
5019770|NCT02176486|12352908|P3|COMPLETED|Overall Study||4
5019771|NCT02176486|12352909|P2|COMPLETED|Overall Study||5
5019772|NCT02176486|12352910|P1|COMPLETED|Overall Study||3
5019773|NCT02176486|12352908|P3|STARTED|Overall Study||4
5019774|NCT02176486|12352909|P2|STARTED|Overall Study||5
5019775|NCT02176486|12352910|P1|STARTED|Overall Study||3
5019776|NCT02176421|12352944|P1|NOT COMPLETED|Overall Study||5
5019777|NCT02176421|12352944|P1|COMPLETED|Overall Study||75
5019778|NCT02176421|12352944|P1|STARTED|Overall Study||80
5019779|NCT02176408|12352955|P2|NOT COMPLETED|Overall Study||4
5019780|NCT02176408|12352956|P1|NOT COMPLETED|Overall Study||6
5019781|NCT02176408|12352955|P2|COMPLETED|Overall Study||12
5019782|NCT02176408|12352956|P1|COMPLETED|Overall Study||9
5019783|NCT02176408|12352955|P2|STARTED|Overall Study||16
5019784|NCT02176408|12352956|P1|STARTED|Overall Study||15
5019785|NCT02176356|12352976|P1|NOT COMPLETED|Overall Study||23
5019786|NCT02176356|12352976|P1|COMPLETED|Overall Study||93
5019787|NCT02176356|12352976|P1|Eligible and Received Treatment|Overall Study||100
5019788|NCT02176356|12352976|P1|STARTED|Overall Study||116
5019789|NCT02176343|12352993|P1|NOT COMPLETED|Overall Study||0
5019790|NCT02176343|12352993|P1|COMPLETED|Overall Study||31
5019791|NCT02176343|12352993|P1|STARTED|Overall Study||31
5019792|NCT02176291|12353006|P2|NOT COMPLETED|Overall Study||0
5019793|NCT02176291|12353007|P1|NOT COMPLETED|Overall Study||5
5019794|NCT02176291|12353006|P2|COMPLETED|Overall Study||11
5019795|NCT02176291|12353007|P1|COMPLETED|Overall Study||15
5019796|NCT02176291|12353006|P2|STARTED|Overall Study||11
5019797|NCT02176291|12353007|P1|STARTED|Overall Study||20
5019798|NCT02176226|12353015|P1|NOT COMPLETED|Overall Study||9
5019799|NCT02176226|12353015|P1|COMPLETED|Overall Study||96
5019800|NCT02176226|12353015|P1|STARTED|Overall Study||105
5019801|NCT02176083|12353023|P2|NOT COMPLETED|Overall Study||0
5019802|NCT02176083|12353024|P1|NOT COMPLETED|Overall Study||0
5019803|NCT02176083|12353023|P2|COMPLETED|Overall Study||27
5019804|NCT02176083|12353024|P1|COMPLETED|Overall Study||11
5019805|NCT02176083|12353023|P2|STARTED|Overall Study||27
5019806|NCT02176083|12353024|P1|STARTED|Overall Study||11
5019807|NCT02176031|12353030|P1|NOT COMPLETED|Overall Study||12
5019808|NCT02176031|12353030|P1|COMPLETED|Overall Study||9
5019809|NCT02176031|12353030|P1|STARTED|Overall Study||21
5019810|NCT02176018|12353041|P2|NOT COMPLETED|Overall Study||6
5019811|NCT02176018|12353042|P1|NOT COMPLETED|Overall Study||5
5019812|NCT02176018|12353041|P2|COMPLETED|Overall Study||17
5019813|NCT02176018|12353042|P1|COMPLETED|Overall Study||17
5019814|NCT02176018|12353041|P2|STARTED|Overall Study||23
5019815|NCT02176018|12353042|P1|STARTED|Overall Study||22
5019816|NCT02176005|12353070|P4|NOT COMPLETED|Overall Study||0
5019817|NCT02176005|12353071|P3|NOT COMPLETED|Overall Study||0
5019818|NCT02176005|12353072|P2|NOT COMPLETED|Overall Study||0
5019819|NCT02176005|12353073|P1|NOT COMPLETED|Overall Study||0
5019820|NCT02176005|12353070|P4|COMPLETED|Overall Study||8
5019821|NCT02176005|12353071|P3|COMPLETED|Overall Study||8
5019822|NCT02176005|12353072|P2|COMPLETED|Overall Study||14
5019823|NCT02176005|12353073|P1|COMPLETED|Overall Study||14
5019824|NCT02176005|12353070|P4|STARTED|Overall Study||8
5019825|NCT02176005|12353071|P3|STARTED|Overall Study||8
5019826|NCT02176005|12353072|P2|STARTED|Overall Study||14
5019827|NCT02176005|12353073|P1|STARTED|Overall Study||14
5019828|NCT02175979|12353101|P2|NOT COMPLETED|Overall Study||8
5019829|NCT02175979|12353102|P1|NOT COMPLETED|Overall Study||7
5019830|NCT02175979|12353101|P2|COMPLETED|Overall Study||132
5019831|NCT02175979|12353102|P1|COMPLETED|Overall Study||133
5019832|NCT02175979|12353101|P2|STARTED|Overall Study||140
5019833|NCT02175979|12353102|P1|STARTED|Overall Study||140
5019834|NCT02175966|12353126|P2|NOT COMPLETED|Follow-up Period||6
5019835|NCT02175966|12353127|P1|NOT COMPLETED|Follow-up Period||10
5019836|NCT02175966|12353126|P2|COMPLETED|Follow-up Period||8
5019837|NCT02175966|12353127|P1|COMPLETED|Follow-up Period||4
5019838|NCT02175966|12353126|P2|STARTED|Follow-up Period||14
5019839|NCT02175966|12353127|P1|STARTED|Follow-up Period||14
5019840|NCT02175966|12353126|P2|NOT COMPLETED|Treatment Period||0
5019841|NCT02175966|12353127|P1|NOT COMPLETED|Treatment Period||0
5019842|NCT02175966|12353126|P2|COMPLETED|Treatment Period||14
5019843|NCT02175966|12353127|P1|COMPLETED|Treatment Period||14
5019844|NCT02175966|12353126|P2|STARTED|Treatment Period||14
5019845|NCT02175966|12353127|P1|STARTED|Treatment Period||14
5019846|NCT02175771|12353155|P9|NOT COMPLETED|Treatment Period||6
5019847|NCT02175771|12353156|P8|NOT COMPLETED|Treatment Period||17
5019848|NCT02175771|12353157|P7|NOT COMPLETED|Treatment Period||5
5019849|NCT02175771|12353158|P6|NOT COMPLETED|Treatment Period||10
5019850|NCT02175771|12353159|P5|NOT COMPLETED|Treatment Period||5
5019851|NCT02175771|12353160|P4|NOT COMPLETED|Treatment Period||13
5019852|NCT02175771|12353161|P3|NOT COMPLETED|Treatment Period||7
5019853|NCT02175771|12353162|P2|NOT COMPLETED|Treatment Period||16
5019854|NCT02175771|12353163|P1|NOT COMPLETED|Treatment Period||0
5019855|NCT02175771|12353155|P9|COMPLETED|Treatment Period||38
5019856|NCT02175771|12353156|P8|COMPLETED|Treatment Period||116
5019857|NCT02175771|12353157|P7|COMPLETED|Treatment Period||36
5019858|NCT02175771|12353158|P6|COMPLETED|Treatment Period||110
5019859|NCT02175771|12353159|P5|COMPLETED|Treatment Period||36
5019860|NCT02175771|12353160|P4|COMPLETED|Treatment Period||113
5019861|NCT02175771|12353161|P3|COMPLETED|Treatment Period||35
5019862|NCT02175771|12353162|P2|COMPLETED|Treatment Period||111
5019863|NCT02175771|12353163|P1|COMPLETED|Treatment Period||0
5019864|NCT02175771|12353155|P9|STARTED|Treatment Period||44
5019865|NCT02175771|12353156|P8|STARTED|Treatment Period||133
5019866|NCT02175771|12353157|P7|STARTED|Treatment Period||41
5019867|NCT02175771|12353158|P6|STARTED|Treatment Period||120
5019868|NCT02175771|12353159|P5|STARTED|Treatment Period||41
5019869|NCT02175771|12353160|P4|STARTED|Treatment Period||126
5019870|NCT02175771|12353161|P3|STARTED|Treatment Period||42
5019871|NCT02175771|12353162|P2|STARTED|Treatment Period||127
5019872|NCT02175771|12353163|P1|STARTED|Treatment Period||0
5019873|NCT02175771|12353155|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019874|NCT02175771|12353156|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019875|NCT02175771|12353157|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019876|NCT02175771|12353158|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019877|NCT02175771|12353159|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019878|NCT02175771|12353160|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019879|NCT02175771|12353161|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019880|NCT02175771|12353162|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5019881|NCT02175771|12353163|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
5019882|NCT02175771|12353155|P9|COMPLETED|Run-In Period (Pre-assignment)||0
5019883|NCT02175771|12353156|P8|COMPLETED|Run-In Period (Pre-assignment)||0
5019884|NCT02175771|12353157|P7|COMPLETED|Run-In Period (Pre-assignment)||0
5019885|NCT02175771|12353158|P6|COMPLETED|Run-In Period (Pre-assignment)||0
5019886|NCT02175771|12353159|P5|COMPLETED|Run-In Period (Pre-assignment)||0
5019887|NCT02175771|12353160|P4|COMPLETED|Run-In Period (Pre-assignment)||0
5019888|NCT02175771|12353161|P3|COMPLETED|Run-In Period (Pre-assignment)||0
5019889|NCT02175771|12353162|P2|COMPLETED|Run-In Period (Pre-assignment)||0
5019890|NCT02175771|12353163|P1|COMPLETED|Run-In Period (Pre-assignment)||674
5019891|NCT02175771|12353155|P9|STARTED|Run-In Period (Pre-assignment)||0
5019892|NCT02175771|12353156|P8|STARTED|Run-In Period (Pre-assignment)||0
5019893|NCT02175771|12353157|P7|STARTED|Run-In Period (Pre-assignment)||0
5019894|NCT02175771|12353158|P6|STARTED|Run-In Period (Pre-assignment)||0
5019895|NCT02175771|12353159|P5|STARTED|Run-In Period (Pre-assignment)||0
5019896|NCT02175771|12353160|P4|STARTED|Run-In Period (Pre-assignment)||0
5019897|NCT02175771|12353161|P3|STARTED|Run-In Period (Pre-assignment)||0
5019898|NCT02175771|12353162|P2|STARTED|Run-In Period (Pre-assignment)||0
5019899|NCT02175771|12353163|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
5019900|NCT02175758|12353227|P6|NOT COMPLETED|Treatment Phase||0
5019901|NCT02175758|12353228|P5|NOT COMPLETED|Treatment Phase||1
5019902|NCT02175758|12353229|P4|NOT COMPLETED|Treatment Phase||0
5019903|NCT02175758|12353230|P3|NOT COMPLETED|Treatment Phase||0
5019904|NCT02175758|12353231|P2|NOT COMPLETED|Treatment Phase||1
5019905|NCT02175758|12353232|P1|NOT COMPLETED|Treatment Phase||0
5019906|NCT02175758|12353227|P6|COMPLETED|Treatment Phase||8
5019907|NCT02175758|12353228|P5|COMPLETED|Treatment Phase||4
5019908|NCT02175758|12353229|P4|COMPLETED|Treatment Phase||28
5019909|NCT02175758|12353230|P3|COMPLETED|Treatment Phase||13
5019910|NCT02175758|12353231|P2|COMPLETED|Treatment Phase||38
5019911|NCT02175758|12353232|P1|COMPLETED|Treatment Phase||13
5019912|NCT02175758|12353227|P6|STARTED|Treatment Phase||8
5019913|NCT02175758|12353228|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
5019914|NCT02175758|12353229|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
5019915|NCT02175758|12353230|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
5019916|NCT02175758|12353231|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
5019917|NCT02175758|12353232|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
5019918|NCT02175758|12353227|P6|NOT COMPLETED|PK Lead-in Phase||0
5019919|NCT02175758|12353228|P5|NOT COMPLETED|PK Lead-in Phase||0
5019920|NCT02175758|12353229|P4|NOT COMPLETED|PK Lead-in Phase||0
5019921|NCT02175758|12353230|P3|NOT COMPLETED|PK Lead-in Phase||0
5019922|NCT02175758|12353231|P2|NOT COMPLETED|PK Lead-in Phase||0
5019923|NCT02175758|12353232|P1|NOT COMPLETED|PK Lead-in Phase||0
5019924|NCT02175758|12353227|P6|COMPLETED|PK Lead-in Phase||8
5019925|NCT02175758|12353228|P5|COMPLETED|PK Lead-in Phase||4
5019926|NCT02175758|12353229|P4|COMPLETED|PK Lead-in Phase||10
5019927|NCT02175758|12353230|P3|COMPLETED|PK Lead-in Phase||2
5019928|NCT02175758|12353231|P2|COMPLETED|PK Lead-in Phase||6
5019929|NCT02175758|12353232|P1|COMPLETED|PK Lead-in Phase||4
5019930|NCT02175758|12353227|P6|STARTED|PK Lead-in Phase||8
5019931|NCT02175758|12353228|P5|STARTED|PK Lead-in Phase||4
5019932|NCT02175758|12353229|P4|STARTED|PK Lead-in Phase||10
5019933|NCT02175758|12353230|P3|STARTED|PK Lead-in Phase||2
5019934|NCT02175758|12353231|P2|STARTED|PK Lead-in Phase||6
5019935|NCT02175758|12353232|P1|STARTED|PK Lead-in Phase||4
5019936|NCT02175745|12353335|P1|NOT COMPLETED|Overall Study||1
5019937|NCT02175745|12353335|P1|COMPLETED|Overall Study||1
5019938|NCT02175745|12353335|P1|STARTED|Overall Study||2
5019939|NCT02175628|12353342|P2|NOT COMPLETED|Overall Study||0
5019940|NCT02175628|12353343|P1|NOT COMPLETED|Overall Study||0
5019941|NCT02175628|12353342|P2|COMPLETED|Overall Study||17
5019942|NCT02175628|12353343|P1|COMPLETED|Overall Study||6
5019943|NCT02175628|12353342|P2|STARTED|Overall Study||17
5019944|NCT02175628|12353343|P1|STARTED|Overall Study||6
5019945|NCT02175472|12353359|P2|NOT COMPLETED|Overall Study||2
5019946|NCT02175472|12353360|P1|NOT COMPLETED|Overall Study||7
5019947|NCT02175472|12353359|P2|COMPLETED|Overall Study||45
5019948|NCT02175472|12353360|P1|COMPLETED|Overall Study||38
5019949|NCT02175472|12353359|P2|STARTED|Overall Study||47
5019950|NCT02175472|12353360|P1|STARTED|Overall Study||45
5019951|NCT02175368|12353374|P1|NOT COMPLETED|Overall Study||1
5019952|NCT02175368|12353374|P1|COMPLETED|Overall Study||27
5019953|NCT02175368|12353374|P1|STARTED|Overall Study||28
5019954|NCT02175277|12353379|P1|NOT COMPLETED|Overall Study||1
5019955|NCT02175277|12353379|P1|COMPLETED|Overall Study||8
5019956|NCT02175277|12353379|P1|STARTED|Overall Study||9
5019957|NCT02175225|12353385|P2|NOT COMPLETED|Overall Study||11
5019958|NCT02175225|12353386|P1|NOT COMPLETED|Overall Study||8
5019959|NCT02175225|12353385|P2|COMPLETED|Overall Study||138
5019960|NCT02175225|12353386|P1|COMPLETED|Overall Study||137
5019961|NCT02175225|12353385|P2|180 Day Outcome Obtained|Overall Study||135
5019962|NCT02175225|12353386|P1|180 Day Outcome Obtained|Overall Study||135
5019963|NCT02175225|12353385|P2|90 Day Outcome Obtained|Overall Study||143
5019964|NCT02175225|12353386|P1|90 Day Outcome Obtained|Overall Study||140
5019965|NCT02175225|12353385|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
5019966|NCT02175225|12353386|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
5019967|NCT02175225|12353385|P2|STARTED|Overall Study||149
5019968|NCT02175225|12353386|P1|STARTED|Overall Study||145
5019969|NCT02175212|12353420|P2|NOT COMPLETED|Overall Study||147
5019970|NCT02175212|12353421|P1|NOT COMPLETED|Overall Study||163
5019971|NCT02175212|12353420|P2|COMPLETED|Overall Study||31
5019972|NCT02175212|12353421|P1|COMPLETED|Overall Study||14
5019973|NCT02175212|12353420|P2|STARTED|Overall Study||178
5019974|NCT02175212|12353421|P1|STARTED|Overall Study||177
5019975|NCT02175199|12353437|P2|NOT COMPLETED|Overall Study||5
5019976|NCT02175199|12353438|P1|NOT COMPLETED|Overall Study||3
5019977|NCT02175199|12353437|P2|COMPLETED|Overall Study||71
5019978|NCT02175199|12353438|P1|COMPLETED|Overall Study||71
5019979|NCT02175199|12353437|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
5019980|NCT02175199|12353438|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
5019981|NCT02175199|12353437|P2|STARTED|Overall Study||76
5019982|NCT02175199|12353438|P1|STARTED|Overall Study||74
5019983|NCT02175121|12353452|P5|NOT COMPLETED|Overall Study||1
5019984|NCT02175121|12353453|P4|NOT COMPLETED|Overall Study||1
5019985|NCT02175121|12353454|P3|NOT COMPLETED|Overall Study||2
5019986|NCT02175121|12353455|P2|NOT COMPLETED|Overall Study||1
5019987|NCT02175121|12353456|P1|NOT COMPLETED|Overall Study||1
5019988|NCT02175121|12353452|P5|COMPLETED|Overall Study||33
5019989|NCT02175121|12353453|P4|COMPLETED|Overall Study||34
5019990|NCT02175121|12353454|P3|COMPLETED|Overall Study||32
5019991|NCT02175121|12353455|P2|COMPLETED|Overall Study||34
5019992|NCT02175121|12353456|P1|COMPLETED|Overall Study||33
5019993|NCT02175121|12353452|P5|STARTED|Overall Study||34
5019994|NCT02175121|12353453|P4|STARTED|Overall Study||35
5019995|NCT02175121|12353454|P3|STARTED|Overall Study||34
5019996|NCT02175121|12353455|P2|STARTED|Overall Study||35
5019997|NCT02175121|12353456|P1|STARTED|Overall Study||34
5019998|NCT02174913|12353585|P2|NOT COMPLETED|Overall Study||0
5019999|NCT02174913|12353586|P1|NOT COMPLETED|Overall Study||0
5020000|NCT02174913|12353585|P2|COMPLETED|Overall Study||17
5020001|NCT02174913|12353586|P1|COMPLETED|Overall Study||17
5020002|NCT02174913|12353585|P2|STARTED|Overall Study||17
5020003|NCT02174913|12353586|P1|STARTED|Overall Study||17
5020004|NCT02174861|12353594|P1|NOT COMPLETED|Overall Study||158
5020005|NCT02174861|12353594|P1|COMPLETED|Overall Study||451
5020006|NCT02174861|12353594|P1|Enrolled in CHU Substudy|Overall Study||53
5020007|NCT02174861|12353594|P1|STARTED|Overall Study||609
5020008|NCT02174848|12353608|P2|NOT COMPLETED|Overall Study||6
5020009|NCT02174848|12353609|P1|NOT COMPLETED|Overall Study||7
5020010|NCT02174848|12353608|P2|COMPLETED|Overall Study||38
5020011|NCT02174848|12353609|P1|COMPLETED|Overall Study||17
5020012|NCT02174848|12353608|P2|Provided Post-baseline Efficacy Data|Overall Study||43
5020013|NCT02174848|12353609|P1|Provided Post-baseline Efficacy Data|Overall Study||19
5020014|NCT02174848|12353608|P2|STARTED|Overall Study||44
5020015|NCT02174848|12353609|P1|STARTED|Overall Study||24
5020016|NCT02174731|12353630|P2|NOT COMPLETED|Overall Study||65
5020017|NCT02174731|12353631|P1|NOT COMPLETED|Overall Study||69
5020018|NCT02174731|12353630|P2|COMPLETED|Overall Study||990
5020019|NCT02174731|12353631|P1|COMPLETED|Overall Study||982
5020020|NCT02174731|12353630|P2|Received Treatment|Overall Study||1053
5020021|NCT02174731|12353631|P1|Received Treatment|Overall Study||1048
5020022|NCT02174731|12353630|P2|STARTED|Overall Study||1055
5020023|NCT02174731|12353631|P1|STARTED|Overall Study||1051
5020024|NCT02174627|12353653|P2|NOT COMPLETED|Overall Study||130
5020025|NCT02174627|12353654|P1|NOT COMPLETED|Overall Study||84
5020026|NCT02174627|12353653|P2|COMPLETED|Overall Study||1247
5020027|NCT02174627|12353654|P1|COMPLETED|Overall Study||1300
5020028|NCT02174627|12353653|P2|Discontinued Treatment|Overall Study||801
5020029|NCT02174627|12353654|P1|Discontinued Treatment|Overall Study||499
5020030|NCT02174627|12353653|P2|Received Treatment|Overall Study||1376
5020031|NCT02174627|12353654|P1|Received Treatment|Overall Study||1384
5020032|NCT02174627|12353653|P2|STARTED|Overall Study||1377
5020033|NCT02174627|12353654|P1|STARTED|Overall Study||1384
5020034|NCT02174562|12353682|P2|NOT COMPLETED|Overall Study||5
5020035|NCT02174562|12353683|P1|NOT COMPLETED|Overall Study||9
5020036|NCT02174562|12353682|P2|COMPLETED|Overall Study||46
5020037|NCT02174562|12353683|P1|COMPLETED|Overall Study||41
5020038|NCT02174562|12353682|P2|STARTED|Overall Study||51
5020039|NCT02174562|12353683|P1|STARTED|Overall Study||50
5020040|NCT02174523|12353693|P2|NOT COMPLETED|Overall Study||0
5020041|NCT02174523|12353694|P1|NOT COMPLETED|Overall Study||1
5020042|NCT02174523|12353693|P2|COMPLETED|Overall Study||4
5020043|NCT02174523|12353694|P1|COMPLETED|Overall Study||9
5020044|NCT02174523|12353693|P2|STARTED|Overall Study||4
5020045|NCT02174523|12353694|P1|STARTED|Overall Study||10
5020046|NCT02174510|12353725|P4|NOT COMPLETED|Overall Study||0
5020047|NCT02174510|12353726|P3|NOT COMPLETED|Overall Study||0
5020048|NCT02174510|12353727|P2|NOT COMPLETED|Overall Study||0
5020049|NCT02174510|12353728|P1|NOT COMPLETED|Overall Study||0
5020050|NCT02174510|12353725|P4|COMPLETED|Overall Study||9
5020051|NCT02174510|12353726|P3|COMPLETED|Overall Study||12
5020052|NCT02174510|12353727|P2|COMPLETED|Overall Study||8
5020053|NCT02174510|12353728|P1|COMPLETED|Overall Study||8
5020054|NCT02174510|12353725|P4|STARTED|Overall Study||9
5020055|NCT02174510|12353726|P3|STARTED|Overall Study||12
5020056|NCT02174510|12353727|P2|STARTED|Overall Study||8
5020057|NCT02174510|12353728|P1|STARTED|Overall Study||8
5020058|NCT02174276|12353762|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
5020059|NCT02174276|12353763|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
5020060|NCT02174276|12353764|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
5020061|NCT02174276|12353765|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
5020062|NCT02174276|12353762|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
5020063|NCT02174276|12353763|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
5020064|NCT02174276|12353764|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
5020065|NCT02174276|12353765|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
5020066|NCT02174276|12353762|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
5020067|NCT02174276|12353763|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
5020068|NCT02174276|12353764|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
5020069|NCT02174276|12353765|P1|STARTED|OTEP (Weeks 48 to 144)||26
5020070|NCT02174276|12353762|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
5020071|NCT02174276|12353763|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
5020072|NCT02174276|12353764|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
5020073|NCT02174276|12353765|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
5020074|NCT02174276|12353762|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
5020075|NCT02174276|12353763|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
5020076|NCT02174276|12353764|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
5020077|NCT02174276|12353765|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
5020078|NCT02174276|12353762|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
5020079|NCT02174276|12353763|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
5020080|NCT02174276|12353764|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
5020081|NCT02174276|12353765|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
5020082|NCT02174198|12353849|P2|NOT COMPLETED|Overall Study||0
5020083|NCT02174198|12353850|P1|NOT COMPLETED|Overall Study||0
5020084|NCT02174198|12353849|P2|COMPLETED|Overall Study||16
5020085|NCT02174198|12353850|P1|COMPLETED|Overall Study||16
5020086|NCT02174198|12353849|P2|STARTED|Overall Study||16
5020087|NCT02174198|12353850|P1|STARTED|Overall Study||16
5020088|NCT02173769|12353872|P1|NOT COMPLETED|Overall Study||4
5020089|NCT02173769|12353872|P1|COMPLETED|Overall Study||1854
5020090|NCT02173769|12353872|P1|STARTED|Overall Study||1858
5020091|NCT02173704|12353885|P2|NOT COMPLETED|Overall Study||4
5020092|NCT02173704|12353886|P1|NOT COMPLETED|Overall Study||13
5020093|NCT02173704|12353885|P2|COMPLETED|Overall Study||71
5020094|NCT02173704|12353886|P1|COMPLETED|Overall Study||137
5020095|NCT02173704|12353885|P2|STARTED|Overall Study||75
5020096|NCT02173704|12353886|P1|STARTED|Overall Study||150
5020097|NCT02173548|12353912|P2|NOT COMPLETED|Overall Study||2
5020098|NCT02173548|12353913|P1|NOT COMPLETED|Overall Study||1
5020099|NCT02173548|12353912|P2|COMPLETED|Overall Study||8
5020100|NCT02173548|12353913|P1|COMPLETED|Overall Study||20
5020101|NCT02173548|12353912|P2|STARTED|Overall Study||10
5020102|NCT02173548|12353913|P1|STARTED|Overall Study||21
5020103|NCT02173535|12353953|P20|NOT COMPLETED|Period 5||0
5020104|NCT02173535|12353954|P19|NOT COMPLETED|Period 5||0
5020105|NCT02173535|12353955|P18|NOT COMPLETED|Period 5||0
5020106|NCT02173535|12353956|P17|NOT COMPLETED|Period 5||0
5020107|NCT02173535|12353957|P16|NOT COMPLETED|Period 5||0
5020108|NCT02173535|12353958|P15|NOT COMPLETED|Period 5||0
5020109|NCT02173535|12353959|P14|NOT COMPLETED|Period 5||0
5020110|NCT02173535|12353960|P13|NOT COMPLETED|Period 5||0
5020111|NCT02173535|12353961|P12|NOT COMPLETED|Period 5||0
5020112|NCT02173535|12353962|P11|NOT COMPLETED|Period 5||0
5020113|NCT02173535|12353963|P10|NOT COMPLETED|Period 5||0
5020114|NCT02173535|12353964|P9|NOT COMPLETED|Period 5||0
5020115|NCT02173535|12353965|P8|NOT COMPLETED|Period 5||0
5020116|NCT02173535|12353966|P7|NOT COMPLETED|Period 5||0
5020117|NCT02173535|12353967|P6|NOT COMPLETED|Period 5||0
5020118|NCT02173535|12353968|P5|NOT COMPLETED|Period 5||0
5020119|NCT02173535|12353969|P4|NOT COMPLETED|Period 5||0
5020120|NCT02173535|12353970|P3|NOT COMPLETED|Period 5||0
5020121|NCT02173535|12353971|P2|NOT COMPLETED|Period 5||0
5020122|NCT02173535|12353972|P1|NOT COMPLETED|Period 5||0
5020123|NCT02173535|12353953|P20|COMPLETED|Period 5||12
5020124|NCT02173535|12353954|P19|COMPLETED|Period 5||12
5020125|NCT02173535|12353955|P18|COMPLETED|Period 5||12
5020126|NCT02173535|12353956|P17|COMPLETED|Period 5||12
5020127|NCT02173535|12353957|P16|COMPLETED|Period 5||12
5020128|NCT02173535|12353958|P15|COMPLETED|Period 5||12
5020129|NCT02173535|12353959|P14|COMPLETED|Period 5||12
5020130|NCT02173535|12353960|P13|COMPLETED|Period 5||12
5020131|NCT02173535|12353961|P12|COMPLETED|Period 5||12
5020132|NCT02173535|12353962|P11|COMPLETED|Period 5||12
5020133|NCT02173535|12353963|P10|COMPLETED|Period 5||12
5020134|NCT02173535|12353964|P9|COMPLETED|Period 5||12
5020135|NCT02173535|12353965|P8|COMPLETED|Period 5||12
5020136|NCT02173535|12353966|P7|COMPLETED|Period 5||12
5020137|NCT02173535|12353967|P6|COMPLETED|Period 5||12
5020138|NCT02173535|12353968|P5|COMPLETED|Period 5||12
5020139|NCT02173535|12353969|P4|COMPLETED|Period 5||12
5020140|NCT02173535|12353970|P3|COMPLETED|Period 5||12
5020141|NCT02173535|12353971|P2|COMPLETED|Period 5||12
5020142|NCT02173535|12353972|P1|COMPLETED|Period 5||12
5020143|NCT02173535|12353953|P20|STARTED|Period 5||12
5020144|NCT02173535|12353954|P19|STARTED|Period 5||12
5020145|NCT02173535|12353955|P18|STARTED|Period 5||12
5020146|NCT02173535|12353956|P17|STARTED|Period 5||12
5020147|NCT02173535|12353957|P16|STARTED|Period 5||12
5020148|NCT02173535|12353958|P15|STARTED|Period 5||12
5020149|NCT02173535|12353959|P14|STARTED|Period 5||12
5020150|NCT02173535|12353960|P13|STARTED|Period 5||12
5020151|NCT02173535|12353961|P12|STARTED|Period 5||12
5020152|NCT02173535|12353962|P11|STARTED|Period 5||12
5020153|NCT02173535|12353963|P10|STARTED|Period 5||12
5020154|NCT02173535|12353964|P9|STARTED|Period 5||12
5020155|NCT02173535|12353965|P8|STARTED|Period 5||12
5020156|NCT02173535|12353966|P7|STARTED|Period 5||12
5020157|NCT02173535|12353967|P6|STARTED|Period 5||12
5020158|NCT02173535|12353968|P5|STARTED|Period 5||12
5020159|NCT02173535|12353969|P4|STARTED|Period 5||12
5020160|NCT02173535|12353970|P3|STARTED|Period 5||12
5020161|NCT02173535|12353971|P2|STARTED|Period 5||12
5020162|NCT02173535|12353972|P1|STARTED|Period 5||12
5020163|NCT02173535|12353953|P20|NOT COMPLETED|Period 4||0
5020164|NCT02173535|12353954|P19|NOT COMPLETED|Period 4||0
5020165|NCT02173535|12353955|P18|NOT COMPLETED|Period 4||0
5020166|NCT02173535|12353956|P17|NOT COMPLETED|Period 4||0
5020167|NCT02173535|12353957|P16|NOT COMPLETED|Period 4||0
5020168|NCT02173535|12353958|P15|NOT COMPLETED|Period 4||0
5020169|NCT02173535|12353959|P14|NOT COMPLETED|Period 4||0
5020170|NCT02173535|12353960|P13|NOT COMPLETED|Period 4||0
5020171|NCT02173535|12353961|P12|NOT COMPLETED|Period 4||0
5020172|NCT02173535|12353962|P11|NOT COMPLETED|Period 4||0
5020173|NCT02173535|12353963|P10|NOT COMPLETED|Period 4||0
5020174|NCT02173535|12353964|P9|NOT COMPLETED|Period 4||0
5020175|NCT02173535|12353965|P8|NOT COMPLETED|Period 4||0
5020176|NCT02173535|12353966|P7|NOT COMPLETED|Period 4||0
5020177|NCT02173535|12353967|P6|NOT COMPLETED|Period 4||0
5020178|NCT02173535|12353968|P5|NOT COMPLETED|Period 4||0
5020179|NCT02173535|12353969|P4|NOT COMPLETED|Period 4||0
5020180|NCT02173535|12353970|P3|NOT COMPLETED|Period 4||0
5020181|NCT02173535|12353971|P2|NOT COMPLETED|Period 4||0
5020182|NCT02173535|12353972|P1|NOT COMPLETED|Period 4||0
5020183|NCT02173535|12353953|P20|COMPLETED|Period 4||12
5020184|NCT02173535|12353954|P19|COMPLETED|Period 4||12
5020185|NCT02173535|12353955|P18|COMPLETED|Period 4||12
5020186|NCT02173535|12353956|P17|COMPLETED|Period 4||12
5020187|NCT02173535|12353957|P16|COMPLETED|Period 4||12
5020188|NCT02173535|12353958|P15|COMPLETED|Period 4||12
5020189|NCT02173535|12353959|P14|COMPLETED|Period 4||12
5020190|NCT02173535|12353960|P13|COMPLETED|Period 4||12
5020191|NCT02173535|12353961|P12|COMPLETED|Period 4||12
5020192|NCT02173535|12353962|P11|COMPLETED|Period 4||12
5020193|NCT02173535|12353963|P10|COMPLETED|Period 4||12
5020194|NCT02173535|12353964|P9|COMPLETED|Period 4||12
5020195|NCT02173535|12353965|P8|COMPLETED|Period 4||12
5020196|NCT02173535|12353966|P7|COMPLETED|Period 4||12
5020197|NCT02173535|12353967|P6|COMPLETED|Period 4||12
5020198|NCT02173535|12353968|P5|COMPLETED|Period 4||12
5020199|NCT02173535|12353969|P4|COMPLETED|Period 4||12
5020200|NCT02173535|12353970|P3|COMPLETED|Period 4||12
5020201|NCT02173535|12353971|P2|COMPLETED|Period 4||12
5020202|NCT02173535|12353972|P1|COMPLETED|Period 4||12
5020203|NCT02173535|12353953|P20|STARTED|Period 4||12
5020204|NCT02173535|12353954|P19|STARTED|Period 4||12
5020205|NCT02173535|12353955|P18|STARTED|Period 4||12
5020206|NCT02173535|12353956|P17|STARTED|Period 4||12
5020207|NCT02173535|12353957|P16|STARTED|Period 4||12
5020208|NCT02173535|12353958|P15|STARTED|Period 4||12
5020209|NCT02173535|12353959|P14|STARTED|Period 4||12
5020210|NCT02173535|12353960|P13|STARTED|Period 4||12
5020211|NCT02173535|12353961|P12|STARTED|Period 4||12
5020212|NCT02173535|12353962|P11|STARTED|Period 4||12
5020213|NCT02173535|12353963|P10|STARTED|Period 4||12
5020214|NCT02173535|12353964|P9|STARTED|Period 4||12
5020215|NCT02173535|12353965|P8|STARTED|Period 4||12
5020216|NCT02173535|12353966|P7|STARTED|Period 4||12
5020217|NCT02173535|12353967|P6|STARTED|Period 4||12
5020218|NCT02173535|12353968|P5|STARTED|Period 4||12
5020219|NCT02173535|12353969|P4|STARTED|Period 4||12
5020220|NCT02173535|12353970|P3|STARTED|Period 4||12
5020221|NCT02173535|12353971|P2|STARTED|Period 4||12
5020222|NCT02173535|12353972|P1|STARTED|Period 4||12
5020223|NCT02173535|12353953|P20|NOT COMPLETED|Period 3||0
5020224|NCT02173535|12353954|P19|NOT COMPLETED|Period 3||0
5020225|NCT02173535|12353955|P18|NOT COMPLETED|Period 3||0
5020226|NCT02173535|12353956|P17|NOT COMPLETED|Period 3||0
5020227|NCT02173535|12353957|P16|NOT COMPLETED|Period 3||0
5020228|NCT02173535|12353958|P15|NOT COMPLETED|Period 3||0
5020229|NCT02173535|12353959|P14|NOT COMPLETED|Period 3||0
5020230|NCT02173535|12353960|P13|NOT COMPLETED|Period 3||0
5020231|NCT02173535|12353961|P12|NOT COMPLETED|Period 3||0
5020232|NCT02173535|12353962|P11|NOT COMPLETED|Period 3||0
5020233|NCT02173535|12353963|P10|NOT COMPLETED|Period 3||0
5020234|NCT02173535|12353964|P9|NOT COMPLETED|Period 3||0
5020235|NCT02173535|12353965|P8|NOT COMPLETED|Period 3||0
5020236|NCT02173535|12353966|P7|NOT COMPLETED|Period 3||0
5020237|NCT02173535|12353967|P6|NOT COMPLETED|Period 3||0
5020238|NCT02173535|12353968|P5|NOT COMPLETED|Period 3||0
5020239|NCT02173535|12353969|P4|NOT COMPLETED|Period 3||0
5020240|NCT02173535|12353970|P3|NOT COMPLETED|Period 3||0
5020241|NCT02173535|12353971|P2|NOT COMPLETED|Period 3||0
5020242|NCT02173535|12353972|P1|NOT COMPLETED|Period 3||0
5020243|NCT02173535|12353953|P20|COMPLETED|Period 3||12
5020244|NCT02173535|12353954|P19|COMPLETED|Period 3||12
5020245|NCT02173535|12353955|P18|COMPLETED|Period 3||12
5020246|NCT02173535|12353956|P17|COMPLETED|Period 3||12
5020247|NCT02173535|12353957|P16|COMPLETED|Period 3||12
5020248|NCT02173535|12353958|P15|COMPLETED|Period 3||12
5020249|NCT02173535|12353959|P14|COMPLETED|Period 3||12
5020250|NCT02173535|12353960|P13|COMPLETED|Period 3||12
5020251|NCT02173535|12353961|P12|COMPLETED|Period 3||12
5020252|NCT02173535|12353962|P11|COMPLETED|Period 3||12
5020253|NCT02173535|12353963|P10|COMPLETED|Period 3||12
5020254|NCT02173535|12353964|P9|COMPLETED|Period 3||12
5020255|NCT02173535|12353965|P8|COMPLETED|Period 3||12
5020256|NCT02173535|12353966|P7|COMPLETED|Period 3||12
5020257|NCT02173535|12353967|P6|COMPLETED|Period 3||12
5020258|NCT02173535|12353968|P5|COMPLETED|Period 3||12
5020259|NCT02173535|12353969|P4|COMPLETED|Period 3||12
5020260|NCT02173535|12353970|P3|COMPLETED|Period 3||12
5020261|NCT02173535|12353971|P2|COMPLETED|Period 3||12
5020262|NCT02173535|12353972|P1|COMPLETED|Period 3||12
5020263|NCT02173535|12353953|P20|STARTED|Period 3||12
5020264|NCT02173535|12353954|P19|STARTED|Period 3||12
5020265|NCT02173535|12353955|P18|STARTED|Period 3||12
5020266|NCT02173535|12353956|P17|STARTED|Period 3||12
5020267|NCT02173535|12353957|P16|STARTED|Period 3||12
5020268|NCT02173535|12353958|P15|STARTED|Period 3||12
5020269|NCT02173535|12353959|P14|STARTED|Period 3||12
5020270|NCT02173535|12353960|P13|STARTED|Period 3||12
5020271|NCT02173535|12353961|P12|STARTED|Period 3||12
5020272|NCT02173535|12353962|P11|STARTED|Period 3||12
5020273|NCT02173535|12353963|P10|STARTED|Period 3||12
5020274|NCT02173535|12353964|P9|STARTED|Period 3||12
5020275|NCT02173535|12353965|P8|STARTED|Period 3||12
5020276|NCT02173535|12353966|P7|STARTED|Period 3||12
5020277|NCT02173535|12353967|P6|STARTED|Period 3||12
5020278|NCT02173535|12353968|P5|STARTED|Period 3||12
5020279|NCT02173535|12353969|P4|STARTED|Period 3||12
5020280|NCT02173535|12353970|P3|STARTED|Period 3||12
5020281|NCT02173535|12353971|P2|STARTED|Period 3||12
5020282|NCT02173535|12353972|P1|STARTED|Period 3||12
5020283|NCT02173535|12353953|P20|NOT COMPLETED|Period 2||0
5020284|NCT02173535|12353954|P19|NOT COMPLETED|Period 2||0
5020285|NCT02173535|12353955|P18|NOT COMPLETED|Period 2||0
5020286|NCT02173535|12353956|P17|NOT COMPLETED|Period 2||0
5020287|NCT02173535|12353957|P16|NOT COMPLETED|Period 2||0
5020288|NCT02173535|12353958|P15|NOT COMPLETED|Period 2||0
5020289|NCT02173535|12353959|P14|NOT COMPLETED|Period 2||0
5020290|NCT02173535|12353960|P13|NOT COMPLETED|Period 2||0
5020291|NCT02173535|12353961|P12|NOT COMPLETED|Period 2||0
5020292|NCT02173535|12353962|P11|NOT COMPLETED|Period 2||0
5020293|NCT02173535|12353963|P10|NOT COMPLETED|Period 2||0
5020294|NCT02173535|12353964|P9|NOT COMPLETED|Period 2||0
5020295|NCT02173535|12353965|P8|NOT COMPLETED|Period 2||0
5020296|NCT02173535|12353966|P7|NOT COMPLETED|Period 2||0
5020297|NCT02173535|12353967|P6|NOT COMPLETED|Period 2||0
5020298|NCT02173535|12353968|P5|NOT COMPLETED|Period 2||0
5020299|NCT02173535|12353969|P4|NOT COMPLETED|Period 2||0
5020300|NCT02173535|12353970|P3|NOT COMPLETED|Period 2||0
5020301|NCT02173535|12353971|P2|NOT COMPLETED|Period 2||0
5020302|NCT02173535|12353972|P1|NOT COMPLETED|Period 2||0
5020303|NCT02173535|12353953|P20|COMPLETED|Period 2||12
5020304|NCT02173535|12353954|P19|COMPLETED|Period 2||12
5020305|NCT02173535|12353955|P18|COMPLETED|Period 2||12
5020306|NCT02173535|12353956|P17|COMPLETED|Period 2||12
5020307|NCT02173535|12353957|P16|COMPLETED|Period 2||12
5020308|NCT02173535|12353958|P15|COMPLETED|Period 2||12
5020309|NCT02173535|12353959|P14|COMPLETED|Period 2||12
5020310|NCT02173535|12353960|P13|COMPLETED|Period 2||12
5020311|NCT02173535|12353961|P12|COMPLETED|Period 2||12
5020312|NCT02173535|12353962|P11|COMPLETED|Period 2||12
5020313|NCT02173535|12353963|P10|COMPLETED|Period 2||12
5020314|NCT02173535|12353964|P9|COMPLETED|Period 2||12
5020315|NCT02173535|12353965|P8|COMPLETED|Period 2||12
5020316|NCT02173535|12353966|P7|COMPLETED|Period 2||12
5020317|NCT02173535|12353967|P6|COMPLETED|Period 2||12
5020318|NCT02173535|12353968|P5|COMPLETED|Period 2||12
5020319|NCT02173535|12353969|P4|COMPLETED|Period 2||12
5020320|NCT02173535|12353970|P3|COMPLETED|Period 2||12
5020321|NCT02173535|12353971|P2|COMPLETED|Period 2||12
5020322|NCT02173535|12353972|P1|COMPLETED|Period 2||12
5020323|NCT02173535|12353953|P20|STARTED|Period 2||12
5020324|NCT02173535|12353954|P19|STARTED|Period 2||12
5020325|NCT02173535|12353955|P18|STARTED|Period 2||12
5020326|NCT02173535|12353956|P17|STARTED|Period 2||12
5020327|NCT02173535|12353957|P16|STARTED|Period 2||12
5020328|NCT02173535|12353958|P15|STARTED|Period 2||12
5020329|NCT02173535|12353959|P14|STARTED|Period 2||12
5020330|NCT02173535|12353960|P13|STARTED|Period 2||12
5020331|NCT02173535|12353961|P12|STARTED|Period 2||12
5020332|NCT02173535|12353962|P11|STARTED|Period 2||12
5020333|NCT02173535|12353963|P10|STARTED|Period 2||12
5020334|NCT02173535|12353964|P9|STARTED|Period 2||12
5020335|NCT02173535|12353965|P8|STARTED|Period 2||12
5020336|NCT02173535|12353966|P7|STARTED|Period 2||12
5020337|NCT02173535|12353967|P6|STARTED|Period 2||12
5020338|NCT02173535|12353968|P5|STARTED|Period 2||12
5020339|NCT02173535|12353969|P4|STARTED|Period 2||12
5020340|NCT02173535|12353970|P3|STARTED|Period 2||12
5020341|NCT02173535|12353971|P2|STARTED|Period 2||12
5020342|NCT02173535|12353972|P1|STARTED|Period 2||12
5020343|NCT02173535|12353953|P20|NOT COMPLETED|Period 1||0
5020344|NCT02173535|12353954|P19|NOT COMPLETED|Period 1||0
5020345|NCT02173535|12353955|P18|NOT COMPLETED|Period 1||0
5020346|NCT02173535|12353956|P17|NOT COMPLETED|Period 1||0
5020347|NCT02173535|12353957|P16|NOT COMPLETED|Period 1||0
5020348|NCT02173535|12353958|P15|NOT COMPLETED|Period 1||0
5020349|NCT02173535|12353959|P14|NOT COMPLETED|Period 1||0
5020350|NCT02173535|12353960|P13|NOT COMPLETED|Period 1||0
5020351|NCT02173535|12353961|P12|NOT COMPLETED|Period 1||0
5020352|NCT02173535|12353962|P11|NOT COMPLETED|Period 1||0
5020353|NCT02173535|12353963|P10|NOT COMPLETED|Period 1||0
5020354|NCT02173535|12353964|P9|NOT COMPLETED|Period 1||0
5020355|NCT02173535|12353965|P8|NOT COMPLETED|Period 1||0
5020356|NCT02173535|12353966|P7|NOT COMPLETED|Period 1||0
5020357|NCT02173535|12353967|P6|NOT COMPLETED|Period 1||0
5020358|NCT02173535|12353968|P5|NOT COMPLETED|Period 1||0
5020359|NCT02173535|12353969|P4|NOT COMPLETED|Period 1||0
5020360|NCT02173535|12353970|P3|NOT COMPLETED|Period 1||0
5020361|NCT02173535|12353971|P2|NOT COMPLETED|Period 1||0
5020362|NCT02173535|12353972|P1|NOT COMPLETED|Period 1||0
5020363|NCT02173535|12353953|P20|COMPLETED|Period 1||12
5020364|NCT02173535|12353954|P19|COMPLETED|Period 1||12
5020365|NCT02173535|12353955|P18|COMPLETED|Period 1||12
5020366|NCT02173535|12353956|P17|COMPLETED|Period 1||12
5020367|NCT02173535|12353957|P16|COMPLETED|Period 1||12
5020368|NCT02173535|12353958|P15|COMPLETED|Period 1||12
5020369|NCT02173535|12353959|P14|COMPLETED|Period 1||12
5020370|NCT02173535|12353960|P13|COMPLETED|Period 1||12
5020371|NCT02173535|12353961|P12|COMPLETED|Period 1||12
5020372|NCT02173535|12353962|P11|COMPLETED|Period 1||12
5020373|NCT02173535|12353963|P10|COMPLETED|Period 1||12
5020374|NCT02173535|12353964|P9|COMPLETED|Period 1||12
5020375|NCT02173535|12353965|P8|COMPLETED|Period 1||12
5020376|NCT02173535|12353966|P7|COMPLETED|Period 1||12
5020377|NCT02173535|12353967|P6|COMPLETED|Period 1||12
5020378|NCT02173535|12353968|P5|COMPLETED|Period 1||12
5020379|NCT02173535|12353969|P4|COMPLETED|Period 1||12
5020380|NCT02173535|12353970|P3|COMPLETED|Period 1||12
5020381|NCT02173535|12353971|P2|COMPLETED|Period 1||12
5020382|NCT02173535|12353972|P1|COMPLETED|Period 1||12
5020383|NCT02173535|12353953|P20|STARTED|Period 1||12
5020384|NCT02173535|12353954|P19|STARTED|Period 1||12
5020385|NCT02173535|12353955|P18|STARTED|Period 1||12
5020386|NCT02173535|12353956|P17|STARTED|Period 1||12
5020387|NCT02173535|12353957|P16|STARTED|Period 1||12
5020388|NCT02173535|12353958|P15|STARTED|Period 1||12
5020389|NCT02173535|12353959|P14|STARTED|Period 1||12
5020390|NCT02173535|12353960|P13|STARTED|Period 1||12
5020391|NCT02173535|12353961|P12|STARTED|Period 1||12
5020392|NCT02173535|12353962|P11|STARTED|Period 1||12
5020393|NCT02173535|12353963|P10|STARTED|Period 1||12
5020394|NCT02173535|12353964|P9|STARTED|Period 1||12
5020395|NCT02173535|12353965|P8|STARTED|Period 1||12
5020396|NCT02173535|12353966|P7|STARTED|Period 1||12
5020397|NCT02173535|12353967|P6|STARTED|Period 1||12
5020398|NCT02173535|12353968|P5|STARTED|Period 1||12
5020399|NCT02173535|12353969|P4|STARTED|Period 1||12
5020400|NCT02173535|12353970|P3|STARTED|Period 1||12
5020401|NCT02173535|12353971|P2|STARTED|Period 1||12
5020402|NCT02173535|12353972|P1|STARTED|Period 1||12
5020403|NCT02173522|12354011|P2|NOT COMPLETED|Overall Study||0
5020404|NCT02173522|12354012|P1|NOT COMPLETED|Overall Study||0
5020405|NCT02173522|12354011|P2|COMPLETED|Overall Study||0
5020406|NCT02173522|12354012|P1|COMPLETED|Overall Study||4
5020407|NCT02173522|12354011|P2|STARTED|Overall Study||0
5020408|NCT02173522|12354012|P1|STARTED|Overall Study||4
5020409|NCT02173392|12354032|P2|NOT COMPLETED|Overall Study||4
5020410|NCT02173392|12354033|P1|NOT COMPLETED|Overall Study||14
5020411|NCT02173392|12354032|P2|COMPLETED|Overall Study||68
5020412|NCT02173392|12354033|P1|COMPLETED|Overall Study||59
5020413|NCT02173392|12354032|P2|STARTED|Overall Study||72
5020414|NCT02173392|12354033|P1|STARTED|Overall Study||73
5020415|NCT02173379|12354045|P2|NOT COMPLETED|Overall Study||7
5020416|NCT02173379|12354046|P1|NOT COMPLETED|Overall Study||9
5020417|NCT02173379|12354045|P2|COMPLETED|Overall Study||1301
5020418|NCT02173379|12354046|P1|COMPLETED|Overall Study||1287
5020419|NCT02173379|12354045|P2|STARTED|Overall Study||1308
5020420|NCT02173379|12354046|P1|STARTED|Overall Study||1296
5020421|NCT02173158|12354112|P1|NOT COMPLETED|Safety Phase||0
5020422|NCT02173158|12354112|P1|COMPLETED|Safety Phase||8
5020423|NCT02173158|12354112|P1|STARTED|Safety Phase||8
5020424|NCT02173158|12354112|P1|NOT COMPLETED|Efficacy Phase||1
5020425|NCT02173158|12354112|P1|COMPLETED|Efficacy Phase||8
5020426|NCT02173158|12354112|P1|STARTED|Efficacy Phase||9
5020427|NCT02173054|12354129|P3|NOT COMPLETED|Overall Study||1
5020428|NCT02173054|12354130|P2|NOT COMPLETED|Overall Study||0
5020429|NCT02173054|12354131|P1|NOT COMPLETED|Overall Study||1
5020430|NCT02173054|12354129|P3|COMPLETED|Overall Study||39
5020431|NCT02173054|12354130|P2|COMPLETED|Overall Study||40
5020432|NCT02173054|12354131|P1|COMPLETED|Overall Study||39
5020433|NCT02173054|12354129|P3|STARTED|Overall Study||40
5020434|NCT02173054|12354130|P2|STARTED|Overall Study||40
5020435|NCT02173054|12354131|P1|STARTED|Overall Study||40
5020436|NCT02172820|12354153|P2|NOT COMPLETED|Overall Study||0
5020437|NCT02172820|12354154|P1|NOT COMPLETED|Overall Study||0
5020438|NCT02172820|12354153|P2|COMPLETED|Overall Study||65
5020439|NCT02172820|12354154|P1|COMPLETED|Overall Study||65
5020440|NCT02172820|12354153|P2|STARTED|Overall Study||65
5020441|NCT02172820|12354154|P1|STARTED|Overall Study||65
5020442|NCT02172755|12354166|P2|NOT COMPLETED|Overall Study||4
5020443|NCT02172755|12354167|P1|NOT COMPLETED|Overall Study||2
5020444|NCT02172755|12354166|P2|COMPLETED|Overall Study||12
5020445|NCT02172755|12354167|P1|COMPLETED|Overall Study||12
5020446|NCT02172755|12354166|P2|STARTED|Overall Study||16
5020447|NCT02172755|12354167|P1|STARTED|Overall Study||14
5020448|NCT02172742|12354179|P2|NOT COMPLETED|Overall Study||0
5020449|NCT02172742|12354180|P1|NOT COMPLETED|Overall Study||1
5020450|NCT02172742|12354179|P2|COMPLETED|Overall Study||6
5020451|NCT02172742|12354180|P1|COMPLETED|Overall Study||6
5020452|NCT02172742|12354179|P2|STARTED|Overall Study||6
5020453|NCT02172742|12354180|P1|STARTED|Overall Study||7
5020454|NCT02172664|12354187|P2|NOT COMPLETED|Overall Study||6
5020455|NCT02172664|12354188|P1|NOT COMPLETED|Overall Study||6
5020456|NCT02172664|12354187|P2|COMPLETED|Overall Study||27
5020457|NCT02172664|12354188|P1|COMPLETED|Overall Study||27
5020458|NCT02172664|12354187|P2|STARTED|Overall Study||33
5020459|NCT02172664|12354188|P1|STARTED|Overall Study||33
5020460|NCT02172625|12354197|P2|NOT COMPLETED|Overall Study||3
5020461|NCT02172625|12354198|P1|NOT COMPLETED|Overall Study||0
5020462|NCT02172625|12354197|P2|COMPLETED|Overall Study||16
5020463|NCT02172625|12354198|P1|COMPLETED|Overall Study||19
5020464|NCT02172625|12354197|P2|STARTED|Overall Study||19
5020465|NCT02172625|12354198|P1|STARTED|Overall Study||19
5020466|NCT02172040|12354220|P4|NOT COMPLETED|Overall Study||1
5020467|NCT02172040|12354221|P3|NOT COMPLETED|Overall Study||2
5020468|NCT02172040|12354222|P2|NOT COMPLETED|Overall Study||3
5020469|NCT02172040|12354223|P1|NOT COMPLETED|Overall Study||0
5020470|NCT02172040|12354220|P4|COMPLETED|Overall Study||26
5020471|NCT02172040|12354221|P3|COMPLETED|Overall Study||29
5020472|NCT02172040|12354222|P2|COMPLETED|Overall Study||42
5020473|NCT02172040|12354223|P1|COMPLETED|Overall Study||49
5020474|NCT02172040|12354220|P4|STARTED|Overall Study||27
5020475|NCT02172040|12354221|P3|STARTED|Overall Study||31
5020476|NCT02172040|12354222|P2|STARTED|Overall Study||45
5020477|NCT02172040|12354223|P1|STARTED|Overall Study||49
5020478|NCT02171819|12354272|P3|NOT COMPLETED|Overall Study||0
5020479|NCT02171819|12354273|P2|NOT COMPLETED|Overall Study||0
5020480|NCT02171819|12354274|P1|NOT COMPLETED|Overall Study||0
5020481|NCT02171819|12354272|P3|COMPLETED|Overall Study||12
5020482|NCT02171819|12354273|P2|COMPLETED|Overall Study||32
5020483|NCT02171819|12354274|P1|COMPLETED|Overall Study||31
5020484|NCT02171819|12354272|P3|STARTED|Overall Study||12
5020485|NCT02171819|12354273|P2|STARTED|Overall Study||32
5020486|NCT02171819|12354274|P1|STARTED|Overall Study||31
5020487|NCT02171611|12354309|P6|NOT COMPLETED|Overall Study||0
5020488|NCT02171611|12354310|P5|NOT COMPLETED|Overall Study||0
5020489|NCT02171611|12354311|P4|NOT COMPLETED|Overall Study||0
5020490|NCT02171611|12354312|P3|NOT COMPLETED|Overall Study||0
5020491|NCT02171611|12354313|P2|NOT COMPLETED|Overall Study||0
5020492|NCT02171611|12354314|P1|NOT COMPLETED|Overall Study||0
5020493|NCT02171611|12354309|P6|COMPLETED|Overall Study||5
5020494|NCT02171611|12354310|P5|COMPLETED|Overall Study||5
5020495|NCT02171611|12354311|P4|COMPLETED|Overall Study||5
5020496|NCT02171611|12354312|P3|COMPLETED|Overall Study||5
5020497|NCT02171611|12354313|P2|COMPLETED|Overall Study||5
5020498|NCT02171611|12354314|P1|COMPLETED|Overall Study||5
5020499|NCT02171611|12354309|P6|STARTED|Overall Study||5
5020500|NCT02171611|12354310|P5|STARTED|Overall Study||5
5020501|NCT02171611|12354311|P4|STARTED|Overall Study||5
5020502|NCT02171611|12354312|P3|STARTED|Overall Study||5
5020503|NCT02171611|12354313|P2|STARTED|Overall Study||5
5020504|NCT02171611|12354314|P1|STARTED|Overall Study||5
5020505|NCT02171260|12354386|P4|NOT COMPLETED|Overall Study||5
5020506|NCT02171260|12354387|P3|NOT COMPLETED|Overall Study||5
5020507|NCT02171260|12354388|P2|NOT COMPLETED|Overall Study||6
5020508|NCT02171260|12354389|P1|NOT COMPLETED|Overall Study||6
5020509|NCT02171260|12354386|P4|COMPLETED|Overall Study||0
5020510|NCT02171260|12354387|P3|COMPLETED|Overall Study||0
5020511|NCT02171260|12354388|P2|COMPLETED|Overall Study||0
5020512|NCT02171260|12354389|P1|COMPLETED|Overall Study||0
5020513|NCT02171260|12354386|P4|STARTED|Overall Study||5
5020514|NCT02171260|12354387|P3|STARTED|Overall Study||5
5020515|NCT02171260|12354388|P2|STARTED|Overall Study||6
5020516|NCT02171260|12354389|P1|STARTED|Overall Study||6
5020517|NCT02171247|12354446|P2|NOT COMPLETED|Overall Study||0
5020518|NCT02171247|12354447|P1|NOT COMPLETED|Overall Study||0
5020519|NCT02171247|12354446|P2|COMPLETED|Overall Study||17
5020520|NCT02171247|12354447|P1|COMPLETED|Overall Study||16
5020521|NCT02171247|12354446|P2|STARTED|Overall Study||17
5020522|NCT02171247|12354447|P1|STARTED|Overall Study||16
5020523|NCT02171234|12354464|P5|NOT COMPLETED|Overall Study||0
5020524|NCT02171234|12354465|P4|NOT COMPLETED|Overall Study||0
5020525|NCT02171234|12354466|P3|NOT COMPLETED|Overall Study||0
5020526|NCT02171234|12354467|P2|NOT COMPLETED|Overall Study||0
5020527|NCT02171234|12354468|P1|NOT COMPLETED|Overall Study||0
5020528|NCT02171234|12354464|P5|COMPLETED|Overall Study||6
5020529|NCT02171234|12354465|P4|COMPLETED|Overall Study||6
5020530|NCT02171234|12354466|P3|COMPLETED|Overall Study||6
5020531|NCT02171234|12354467|P2|COMPLETED|Overall Study||6
5020532|NCT02171234|12354468|P1|COMPLETED|Overall Study||8
5020533|NCT02171234|12354464|P5|STARTED|Overall Study||6
5020534|NCT02171234|12354465|P4|STARTED|Overall Study||6
5020535|NCT02171234|12354466|P3|STARTED|Overall Study||6
5020536|NCT02171234|12354467|P2|STARTED|Overall Study||6
5020537|NCT02171234|12354468|P1|STARTED|Overall Study||8
5020538|NCT02171195|12354497|P9|NOT COMPLETED|Overall Study||0
5020539|NCT02171195|12354498|P8|NOT COMPLETED|Overall Study||0
5020540|NCT02171195|12354499|P7|NOT COMPLETED|Overall Study||0
5020541|NCT02171195|12354500|P6|NOT COMPLETED|Overall Study||0
5020542|NCT02171195|12354501|P5|NOT COMPLETED|Overall Study||0
5020543|NCT02171195|12354502|P4|NOT COMPLETED|Overall Study||0
5020544|NCT02171195|12354503|P3|NOT COMPLETED|Overall Study||0
5020545|NCT02171195|12354504|P2|NOT COMPLETED|Overall Study||0
5020546|NCT02171195|12354505|P1|NOT COMPLETED|Overall Study||0
5020547|NCT02171195|12354497|P9|COMPLETED|Overall Study||6
5020548|NCT02171195|12354498|P8|COMPLETED|Overall Study||6
5020549|NCT02171195|12354499|P7|COMPLETED|Overall Study||6
5020550|NCT02171195|12354500|P6|COMPLETED|Overall Study||6
5020551|NCT02171195|12354501|P5|COMPLETED|Overall Study||6
5020552|NCT02171195|12354502|P4|COMPLETED|Overall Study||6
5020553|NCT02171195|12354503|P3|COMPLETED|Overall Study||6
5020554|NCT02171195|12354504|P2|COMPLETED|Overall Study||6
5020555|NCT02171195|12354505|P1|COMPLETED|Overall Study||16
5020556|NCT02171195|12354497|P9|STARTED|Overall Study||6
5020557|NCT02171195|12354498|P8|STARTED|Overall Study||6
5020558|NCT02171195|12354499|P7|STARTED|Overall Study||6
5020559|NCT02171195|12354500|P6|STARTED|Overall Study||6
5020560|NCT02171195|12354501|P5|STARTED|Overall Study||6
5020561|NCT02171195|12354502|P4|STARTED|Overall Study||6
5020562|NCT02171195|12354503|P3|STARTED|Overall Study||6
5020563|NCT02171195|12354504|P2|STARTED|Overall Study||6
5020564|NCT02171195|12354505|P1|STARTED|Overall Study||16
5020565|NCT02171130|12354525|P1|NOT COMPLETED|Overall Study||28
5020566|NCT02171130|12354525|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
5020567|NCT02171130|12354525|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
5020568|NCT02171130|12354525|P1|Received at Least One Dose of Study Drug|Overall Study||87
5020569|NCT02171130|12354525|P1|STARTED|Overall Study||129
5020570|NCT02170870|12354539|P6|NOT COMPLETED|Overall Study||0
5020571|NCT02170870|12354540|P5|NOT COMPLETED|Overall Study||0
5020572|NCT02170870|12354541|P4|NOT COMPLETED|Overall Study||0
5020573|NCT02170870|12354542|P3|NOT COMPLETED|Overall Study||0
5020574|NCT02170870|12354543|P2|NOT COMPLETED|Overall Study||0
5020575|NCT02170870|12354544|P1|NOT COMPLETED|Overall Study||0
5020576|NCT02170870|12354539|P6|COMPLETED|Overall Study||20
5020577|NCT02170870|12354540|P5|COMPLETED|Overall Study||20
5020578|NCT02170870|12354541|P4|COMPLETED|Overall Study||20
5020579|NCT02170870|12354542|P3|COMPLETED|Overall Study||20
5020580|NCT02170870|12354543|P2|COMPLETED|Overall Study||11
5020581|NCT02170870|12354544|P1|COMPLETED|Overall Study||13
5020582|NCT02170870|12354539|P6|STARTED|Overall Study||20
5020583|NCT02170870|12354540|P5|STARTED|Overall Study||20
5020584|NCT02170870|12354541|P4|STARTED|Overall Study||20
5020585|NCT02170870|12354542|P3|STARTED|Overall Study||20
5020586|NCT02170870|12354543|P2|STARTED|Overall Study||11
5020587|NCT02170870|12354544|P1|STARTED|Overall Study||13
5020588|NCT02170779|12354566|P2|NOT COMPLETED|Overall Study||1
5020589|NCT02170779|12354567|P1|NOT COMPLETED|Overall Study||1
5020590|NCT02170779|12354566|P2|COMPLETED|Overall Study||19
5020591|NCT02170779|12354567|P1|COMPLETED|Overall Study||19
5020592|NCT02170779|12354566|P2|STARTED|Overall Study||20
5020593|NCT02170779|12354567|P1|STARTED|Overall Study||20
5020594|NCT02170727|12354591|P2|NOT COMPLETED|Overall Study||0
5020595|NCT02170727|12354592|P1|NOT COMPLETED|Overall Study||3
5020596|NCT02170727|12354591|P2|COMPLETED|Overall Study||31
5020597|NCT02170727|12354592|P1|COMPLETED|Overall Study||135
5020598|NCT02170727|12354591|P2|STARTED|Overall Study||31
5020599|NCT02170727|12354592|P1|STARTED|Overall Study||138
5020600|NCT02170688|12354623|P5|NOT COMPLETED|Overall Study||0
5020601|NCT02170688|12354624|P4|NOT COMPLETED|Overall Study||2
5020602|NCT02170688|12354625|P3|NOT COMPLETED|Overall Study||4
5020603|NCT02170688|12354626|P2|NOT COMPLETED|Overall Study||3
5020604|NCT02170688|12354627|P1|NOT COMPLETED|Overall Study||4
5020605|NCT02170688|12354623|P5|COMPLETED|Overall Study||25
5020606|NCT02170688|12354624|P4|COMPLETED|Overall Study||25
5020607|NCT02170688|12354625|P3|COMPLETED|Overall Study||25
5020608|NCT02170688|12354626|P2|COMPLETED|Overall Study||26
5020609|NCT02170688|12354627|P1|COMPLETED|Overall Study||25
5020610|NCT02170688|12354623|P5|STARTED|Overall Study||25
5020611|NCT02170688|12354624|P4|STARTED|Overall Study||27
5020612|NCT02170688|12354625|P3|STARTED|Overall Study||29
5020613|NCT02170688|12354626|P2|STARTED|Overall Study||29
5020614|NCT02170688|12354627|P1|STARTED|Overall Study||29
5020615|NCT02170662|12354646|P2|NOT COMPLETED|Overall Study||0
5020616|NCT02170662|12354647|P1|NOT COMPLETED|Overall Study||0
5020617|NCT02170662|12354646|P2|COMPLETED|Overall Study||6
5020618|NCT02170662|12354647|P1|COMPLETED|Overall Study||3
5020619|NCT02170662|12354646|P2|STARTED|Overall Study||6
5020620|NCT02170662|12354647|P1|STARTED|Overall Study||3
5020621|NCT02170649|12354659|P1|NOT COMPLETED|Fed Period||0
5020622|NCT02170649|12354659|P1|COMPLETED|Fed Period||12
5020623|NCT02170649|12354659|P1|STARTED|Fed Period||12
5020624|NCT02170649|12354659|P1|NOT COMPLETED|Fasting Period||0
5020625|NCT02170649|12354659|P1|COMPLETED|Fasting Period||12
5020626|NCT02170649|12354659|P1|STARTED|Fasting Period||12
5020627|NCT02170532|12354666|P1|NOT COMPLETED|Overall Study||0
5020628|NCT02170532|12354666|P1|COMPLETED|Overall Study||10
5020629|NCT02170532|12354666|P1|STARTED|Overall Study||10
5020630|NCT02170519|12354696|P2|NOT COMPLETED|Overall Study||0
5020631|NCT02170519|12354697|P1|NOT COMPLETED|Overall Study||0
5020632|NCT02170519|12354696|P2|COMPLETED|Overall Study||5
5020633|NCT02170519|12354697|P1|COMPLETED|Overall Study||22
5020634|NCT02170519|12354696|P2|STARTED|Overall Study||5
5020635|NCT02170519|12354697|P1|STARTED|Overall Study||22
5020636|NCT02170389|12354713|P1|NOT COMPLETED|Overall Study||1
5020637|NCT02170389|12354713|P1|COMPLETED|Overall Study||4
5020638|NCT02170389|12354713|P1|STARTED|Overall Study||5
5020639|NCT02170376|12354723|P5|NOT COMPLETED|Overall Study||0
5020640|NCT02170376|12354724|P4|NOT COMPLETED|Overall Study||0
5020641|NCT02170376|12354725|P3|NOT COMPLETED|Overall Study||0
5020642|NCT02170376|12354726|P2|NOT COMPLETED|Overall Study||1
5020643|NCT02170376|12354727|P1|NOT COMPLETED|Overall Study||0
5020644|NCT02170376|12354723|P5|COMPLETED|Overall Study||16
5020645|NCT02170376|12354724|P4|COMPLETED|Overall Study||16
5020646|NCT02170376|12354725|P3|COMPLETED|Overall Study||16
5020647|NCT02170376|12354726|P2|COMPLETED|Overall Study||15
5020648|NCT02170376|12354727|P1|COMPLETED|Overall Study||16
5020649|NCT02170376|12354723|P5|Pharmacokinetic Population|Overall Study||16
5020650|NCT02170376|12354724|P4|Pharmacokinetic Population|Overall Study||16
5020651|NCT02170376|12354725|P3|Pharmacokinetic Population|Overall Study||16
5020652|NCT02170376|12354726|P2|Pharmacokinetic Population|Overall Study||15
5020653|NCT02170376|12354727|P1|Pharmacokinetic Population|Overall Study||16
5020654|NCT02170376|12354723|P5|STARTED|Overall Study||16
5020655|NCT02170376|12354724|P4|STARTED|Overall Study||16
5020656|NCT02170376|12354725|P3|STARTED|Overall Study||16
5020657|NCT02170376|12354726|P2|STARTED|Overall Study||16
5020658|NCT02170376|12354727|P1|STARTED|Overall Study||16
5020659|NCT02170363|12354764|P1|NOT COMPLETED|Overall Study||0
5020660|NCT02170363|12354764|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
5020661|NCT02170363|12354764|P1|STARTED|Overall Study||50
5020662|NCT02170298|12354778|P2|NOT COMPLETED|Overall Study||1
5020663|NCT02170298|12354779|P1|NOT COMPLETED|Overall Study||1
5020664|NCT02170298|12354778|P2|COMPLETED|Overall Study||4
5020665|NCT02170298|12354779|P1|COMPLETED|Overall Study||0
5020666|NCT02170298|12354778|P2|STARTED|Overall Study||5
5020667|NCT02170298|12354779|P1|STARTED|Overall Study||1
5020668|NCT02170220|12354789|P2|NOT COMPLETED|Overall Study||0
5020669|NCT02170220|12354790|P1|NOT COMPLETED|Overall Study||0
5020670|NCT02170220|12354789|P2|COMPLETED|Overall Study||6
5020671|NCT02170220|12354790|P1|COMPLETED|Overall Study||6
5020672|NCT02170220|12354789|P2|STARTED|Overall Study||6
5020673|NCT02170220|12354790|P1|STARTED|Overall Study||6
5020674|NCT02170207|12354816|P1|NOT COMPLETED|Overall Study||5
5020675|NCT02170207|12354816|P1|COMPLETED|Overall Study||58
5020676|NCT02170207|12354816|P1|STARTED|Overall Study||63
5020677|NCT02170077|12354827|P3|NOT COMPLETED|Overall Study||12
5020678|NCT02170077|12354828|P2|NOT COMPLETED|Overall Study||13
5020679|NCT02170077|12354829|P1|NOT COMPLETED|Overall Study||9
5020680|NCT02170077|12354827|P3|COMPLETED|Overall Study||35
5020681|NCT02170077|12354828|P2|COMPLETED|Overall Study||34
5020682|NCT02170077|12354829|P1|COMPLETED|Overall Study||41
5020683|NCT02170077|12354827|P3|Intent to Treat (ITT) Population|Overall Study||47
5020684|NCT02170077|12354828|P2|Intent to Treat (ITT) Population|Overall Study||46
5020685|NCT02170077|12354829|P1|Intent to Treat (ITT) Population|Overall Study||50
5020686|NCT02170077|12354827|P3|STARTED|Overall Study||47
5020687|NCT02170077|12354828|P2|STARTED|Overall Study||47
5020688|NCT02170077|12354829|P1|STARTED|Overall Study||50
5020689|NCT02170064|12354840|P3|NOT COMPLETED|Overall Study||1
5020690|NCT02170064|12354841|P2|NOT COMPLETED|Overall Study||2
5020691|NCT02170064|12354842|P1|NOT COMPLETED|Overall Study||6
5020692|NCT02170064|12354840|P3|COMPLETED|Overall Study||10
5020693|NCT02170064|12354841|P2|COMPLETED|Overall Study||7
5020694|NCT02170064|12354842|P1|COMPLETED|Overall Study||9
5020695|NCT02170064|12354840|P3|Efficacy Population (EP)|Overall Study||10
5020696|NCT02170064|12354841|P2|Efficacy Population (EP)|Overall Study||8
5020697|NCT02170064|12354842|P1|Efficacy Population (EP)|Overall Study||11
5020698|NCT02170064|12354840|P3|Pharmacokinetic Population (PKP)|Overall Study||10
5020699|NCT02170064|12354841|P2|Pharmacokinetic Population (PKP)|Overall Study||8
5020700|NCT02170064|12354842|P1|Pharmacokinetic Population (PKP)|Overall Study||11
5020701|NCT02170064|12354840|P3|Safety Population (SP)|Overall Study||11
5020702|NCT02170064|12354841|P2|Safety Population (SP)|Overall Study||8
5020703|NCT02170064|12354842|P1|Safety Population (SP)|Overall Study||12
5020704|NCT02170064|12354840|P3|STARTED|Overall Study||11
5020705|NCT02170064|12354841|P2|STARTED|Overall Study||9
5020706|NCT02170064|12354842|P1|STARTED|Overall Study||15
5020707|NCT02170025|12354858|P2|NOT COMPLETED|Overall Study||0
5020708|NCT02170025|12354859|P1|NOT COMPLETED|Overall Study||2
5020709|NCT02170025|12354858|P2|COMPLETED|Overall Study||7
5020710|NCT02170025|12354859|P1|COMPLETED|Overall Study||12
5020711|NCT02170025|12354858|P2|STARTED|Overall Study||7
5020712|NCT02170025|12354859|P1|STARTED|Overall Study||14
5020713|NCT02169895|12354871|P4|NOT COMPLETED|Overall Study||2
5020714|NCT02169895|12354872|P3|NOT COMPLETED|Overall Study||0
5020715|NCT02169895|12354873|P2|NOT COMPLETED|Overall Study||0
5020716|NCT02169895|12354874|P1|NOT COMPLETED|Overall Study||0
5020717|NCT02169895|12354871|P4|COMPLETED|Overall Study||2
5020718|NCT02169895|12354872|P3|COMPLETED|Overall Study||4
5020719|NCT02169895|12354873|P2|COMPLETED|Overall Study||4
5020720|NCT02169895|12354874|P1|COMPLETED|Overall Study||4
5020721|NCT02169895|12354871|P4|Placebo|Overall Study||4
5020722|NCT02169895|12354872|P3|Placebo|Overall Study||4
5020723|NCT02169895|12354873|P2|Placebo|Overall Study||4
5020724|NCT02169895|12354874|P1|Placebo|Overall Study||4
5020725|NCT02169895|12354871|P4|100 mg BIA 9-1067|Overall Study||2
5020726|NCT02169895|12354872|P3|100 mg BIA 9-1067|Overall Study||4
5020727|NCT02169895|12354873|P2|100 mg BIA 9-1067|Overall Study||4
5020728|NCT02169895|12354874|P1|100 mg BIA 9-1067|Overall Study||4
5020729|NCT02169895|12354871|P4|50 mg BIA 9-1067|Overall Study||4
5020730|NCT02169895|12354872|P3|50 mg BIA 9-1067|Overall Study||4
5020731|NCT02169895|12354873|P2|50 mg BIA 9-1067|Overall Study||4
5020732|NCT02169895|12354874|P1|50 mg BIA 9-1067|Overall Study||4
5020733|NCT02169895|12354871|P4|25 mg BIA 9-1067|Overall Study||4
5020734|NCT02169895|12354872|P3|25 mg BIA 9-1067|Overall Study||4
5020735|NCT02169895|12354873|P2|25 mg BIA 9-1067|Overall Study||4
5020736|NCT02169895|12354874|P1|25 mg BIA 9-1067|Overall Study||4
5020737|NCT02169895|12354871|P4|STARTED|Overall Study||4
5020738|NCT02169895|12354872|P3|STARTED|Overall Study||4
5020739|NCT02169895|12354873|P2|STARTED|Overall Study||4
5020740|NCT02169895|12354874|P1|STARTED|Overall Study||4
5020741|NCT02169869|12354894|P2|NOT COMPLETED|Overall Study||0
5020742|NCT02169869|12354895|P1|NOT COMPLETED|Overall Study||0
5020743|NCT02169869|12354894|P2|COMPLETED|Overall Study||16
5020744|NCT02169869|12354895|P1|COMPLETED|Overall Study||17
5020745|NCT02169869|12354894|P2|STARTED|Overall Study||16
5020746|NCT02169869|12354895|P1|STARTED|Overall Study||17
5020747|NCT02169674|12354903|P2|NOT COMPLETED|Overall Study||78
5020748|NCT02169674|12354904|P1|NOT COMPLETED|Overall Study||32
5020749|NCT02169674|12354903|P2|COMPLETED|Overall Study||135
5020750|NCT02169674|12354904|P1|COMPLETED|Overall Study||105
5020751|NCT02169674|12354903|P2|STARTED|Overall Study||213
5020752|NCT02169674|12354904|P1|STARTED|Overall Study||137
5020753|NCT02169505|12354918|P1|NOT COMPLETED|Overall Study||1
5020754|NCT02169505|12354918|P1|COMPLETED|Overall Study||1
5020755|NCT02169505|12354918|P1|STARTED|Overall Study||2
5020756|NCT02169479|12354933|P4|NOT COMPLETED|Overall Study||0
5020757|NCT02169479|12354934|P3|NOT COMPLETED|Overall Study||0
5020758|NCT02169479|12354935|P2|NOT COMPLETED|Overall Study||1
5020759|NCT02169479|12354936|P1|NOT COMPLETED|Overall Study||1
5020760|NCT02169479|12354933|P4|COMPLETED|Overall Study||4
5020761|NCT02169479|12354934|P3|COMPLETED|Overall Study||4
5020762|NCT02169479|12354935|P2|COMPLETED|Overall Study||3
5020763|NCT02169479|12354936|P1|COMPLETED|Overall Study||3
5020764|NCT02169479|12354933|P4|Placebo|Overall Study||4
5020765|NCT02169479|12354934|P3|Placebo|Overall Study||4
5020766|NCT02169479|12354935|P2|Placebo|Overall Study||3
5020767|NCT02169479|12354936|P1|Placebo|Overall Study||3
5020768|NCT02169479|12354933|P4|100 mg BIA 9-1067|Overall Study||4
5020769|NCT02169479|12354934|P3|100 mg BIA 9-1067|Overall Study||4
5020770|NCT02169479|12354935|P2|100 mg BIA 9-1067|Overall Study||4
5020771|NCT02169479|12354936|P1|100 mg BIA 9-1067|Overall Study||3
5020772|NCT02169479|12354933|P4|50 mg BIA 9-1067|Overall Study||4
5020773|NCT02169479|12354934|P3|50 mg BIA 9-1067|Overall Study||4
5020774|NCT02169479|12354935|P2|50 mg BIA 9-1067|Overall Study||4
5020775|NCT02169479|12354936|P1|50 mg BIA 9-1067|Overall Study||4
5020776|NCT02169479|12354933|P4|25 mg BIA 9-1067|Overall Study||4
5020777|NCT02169479|12354934|P3|25 mg BIA 9-1067|Overall Study||4
5020778|NCT02169479|12354935|P2|25 mg BIA 9-1067|Overall Study||3
5020779|NCT02169479|12354936|P1|25 mg BIA 9-1067|Overall Study||4
5020780|NCT02169479|12354933|P4|STARTED|Overall Study||4
5020781|NCT02169479|12354934|P3|STARTED|Overall Study||4
5020782|NCT02169479|12354935|P2|STARTED|Overall Study||4
5020783|NCT02169479|12354936|P1|STARTED|Overall Study||4
5020784|NCT02169466|12354958|P4|NOT COMPLETED|Overall Study||0
5020785|NCT02169466|12354959|P3|NOT COMPLETED|Overall Study||0
5020786|NCT02169466|12354960|P2|NOT COMPLETED|Overall Study||1
5020787|NCT02169466|12354961|P1|NOT COMPLETED|Overall Study||1
5020788|NCT02169466|12354958|P4|COMPLETED|Overall Study||5
5020789|NCT02169466|12354959|P3|COMPLETED|Overall Study||5
5020790|NCT02169466|12354960|P2|COMPLETED|Overall Study||5
5020791|NCT02169466|12354961|P1|COMPLETED|Overall Study||5
5020792|NCT02169466|12354958|P4|Placebo|Overall Study||5
5020793|NCT02169466|12354959|P3|Placebo|Overall Study||5
5020794|NCT02169466|12354960|P2|Placebo|Overall Study||6
5020795|NCT02169466|12354961|P1|Placebo|Overall Study||5
5020796|NCT02169466|12354958|P4|100 mg BIA 9-1067|Overall Study||5
5020797|NCT02169466|12354959|P3|100 mg BIA 9-1067|Overall Study||5
5020798|NCT02169466|12354960|P2|100 mg BIA 9-1067|Overall Study||6
5020799|NCT02169466|12354961|P1|100 mg BIA 9-1067|Overall Study||6
5020800|NCT02169466|12354958|P4|50 mg BIA 9-1067|Overall Study||5
5020801|NCT02169466|12354959|P3|50 mg BIA 9-1067|Overall Study||5
5020802|NCT02169466|12354960|P2|50 mg BIA 9-1067|Overall Study||6
5020803|NCT02169466|12354961|P1|50 mg BIA 9-1067|Overall Study||6
5020804|NCT02169466|12354958|P4|25 mg BIA 9-1067|Overall Study||5
5020805|NCT02169466|12354959|P3|25 mg BIA 9-1067|Overall Study||5
5020806|NCT02169466|12354960|P2|25 mg BIA 9-1067|Overall Study||5
5020807|NCT02169466|12354961|P1|25 mg BIA 9-1067|Overall Study||6
5020808|NCT02169466|12354958|P4|STARTED|Overall Study||5
5020809|NCT02169466|12354959|P3|STARTED|Overall Study||5
5020810|NCT02169466|12354960|P2|STARTED|Overall Study||6
5020811|NCT02169466|12354961|P1|STARTED|Overall Study||6
5020812|NCT02169453|12354987|P4|NOT COMPLETED|Overall Study||0
5020813|NCT02169453|12354988|P3|NOT COMPLETED|Overall Study||1
5020814|NCT02169453|12354989|P2|NOT COMPLETED|Overall Study||0
5020815|NCT02169453|12354990|P1|NOT COMPLETED|Overall Study||0
5020816|NCT02169453|12354987|P4|COMPLETED|Overall Study||3
5020817|NCT02169453|12354988|P3|COMPLETED|Overall Study||2
5020818|NCT02169453|12354989|P2|COMPLETED|Overall Study||3
5020819|NCT02169453|12354990|P1|COMPLETED|Overall Study||3
5020820|NCT02169453|12354987|P4|Placebo|Overall Study||3
5020821|NCT02169453|12354988|P3|Placebo|Overall Study||3
5020822|NCT02169453|12354989|P2|Placebo|Overall Study||3
5020823|NCT02169453|12354990|P1|Placebo|Overall Study||3
5020824|NCT02169453|12354987|P4|100 mg BIA 9-1067|Overall Study||3
5020825|NCT02169453|12354988|P3|100 mg BIA 9-1067|Overall Study||3
5020826|NCT02169453|12354989|P2|100 mg BIA 9-1067|Overall Study||3
5020827|NCT02169453|12354990|P1|100 mg BIA 9-1067|Overall Study||3
5020828|NCT02169453|12354987|P4|50 mg BIA 9-1067|Overall Study||3
5020829|NCT02169453|12354988|P3|50 mg BIA 9-1067|Overall Study||2
5020830|NCT02169453|12354989|P2|50 mg BIA 9-1067|Overall Study||3
5020831|NCT02169453|12354990|P1|50 mg BIA 9-1067|Overall Study||3
5020832|NCT02169453|12354987|P4|25 mg BIA 9-1067|Overall Study||3
5020833|NCT02169453|12354988|P3|25 mg BIA 9-1067|Overall Study||3
5020834|NCT02169453|12354989|P2|25 mg BIA 9-1067|Overall Study||3
5020835|NCT02169453|12354990|P1|25 mg BIA 9-1067|Overall Study||3
5020836|NCT02169453|12354987|P4|STARTED|Overall Study||3
5020837|NCT02169453|12354988|P3|STARTED|Overall Study||3
5020838|NCT02169453|12354989|P2|STARTED|Overall Study||3
5020839|NCT02169453|12354990|P1|STARTED|Overall Study||3
5020840|NCT02169440|12355022|P2|NOT COMPLETED|Overall Study||0
5020841|NCT02169440|12355023|P1|NOT COMPLETED|Overall Study||0
5020842|NCT02169440|12355022|P2|COMPLETED|Overall Study||10
5020843|NCT02169440|12355023|P1|COMPLETED|Overall Study||10
5020844|NCT02169440|12355022|P2|STARTED|Overall Study||10
5020845|NCT02169440|12355023|P1|STARTED|Overall Study||10
5020846|NCT02169427|12355036|P1|NOT COMPLETED|Overall Study||0
5020847|NCT02169427|12355036|P1|COMPLETED|Overall Study||6
5020848|NCT02169427|12355036|P1|STARTED|Overall Study||6
5020849|NCT02169414|12355046|P4|NOT COMPLETED|Overall Study||0
5020850|NCT02169414|12355047|P3|NOT COMPLETED|Overall Study||0
5020851|NCT02169414|12355048|P2|NOT COMPLETED|Overall Study||1
5020852|NCT02169414|12355049|P1|NOT COMPLETED|Overall Study||1
5020853|NCT02169414|12355046|P4|COMPLETED|Overall Study||18
5020854|NCT02169414|12355047|P3|COMPLETED|Overall Study||18
5020855|NCT02169414|12355048|P2|COMPLETED|Overall Study||18
5020856|NCT02169414|12355049|P1|COMPLETED|Overall Study||18
5020857|NCT02169414|12355046|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
5020858|NCT02169414|12355047|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
5020952|NCT02168660|12355425|P1|NOT COMPLETED|Overall Study||16
5020859|NCT02169414|12355048|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
5020860|NCT02169414|12355049|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
5020861|NCT02169414|12355046|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
5020862|NCT02169414|12355047|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
5020863|NCT02169414|12355048|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
5020864|NCT02169414|12355049|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
5020865|NCT02169414|12355046|P4|STARTED|Overall Study||18
5020866|NCT02169414|12355047|P3|STARTED|Overall Study||18
5020867|NCT02169414|12355048|P2|STARTED|Overall Study||19
5020868|NCT02169414|12355049|P1|STARTED|Overall Study||19
5020869|NCT02169336|12355090|P3|NOT COMPLETED|Overall Study||3
5020870|NCT02169336|12355091|P2|NOT COMPLETED|Overall Study||4
5020871|NCT02169336|12355092|P1|NOT COMPLETED|Overall Study||4
5020872|NCT02169336|12355090|P3|COMPLETED|Overall Study||29
5020873|NCT02169336|12355091|P2|COMPLETED|Overall Study||28
5020874|NCT02169336|12355092|P1|COMPLETED|Overall Study||27
5020875|NCT02169336|12355090|P3|STARTED|Overall Study||32
5020876|NCT02169336|12355091|P2|STARTED|Overall Study||32
5020877|NCT02169336|12355092|P1|STARTED|Overall Study||31
5020878|NCT02169284|12355102|P2|NOT COMPLETED|Overall Study||1
5020879|NCT02169284|12355103|P1|NOT COMPLETED|Overall Study||0
5020880|NCT02169284|12355102|P2|COMPLETED|Overall Study||12
5020881|NCT02169284|12355103|P1|COMPLETED|Overall Study||24
5020882|NCT02169284|12355102|P2|STARTED|Overall Study||13
5020883|NCT02169284|12355103|P1|STARTED|Overall Study||24
5020884|NCT02169271|12355129|P2|NOT COMPLETED|Overall Study||2
5020885|NCT02169271|12355130|P1|NOT COMPLETED|Overall Study||1
5020886|NCT02169271|12355129|P2|COMPLETED|Overall Study||47
5020887|NCT02169271|12355130|P1|COMPLETED|Overall Study||48
5020888|NCT02169271|12355129|P2|STARTED|Overall Study||49
5020889|NCT02169271|12355130|P1|STARTED|Overall Study||49
5020890|NCT02169219|12355152|P1|NOT COMPLETED|Overall Study||6
5020891|NCT02169219|12355152|P1|COMPLETED|Overall Study||14
5020892|NCT02169219|12355152|P1|STARTED|Overall Study||20
5020893|NCT02169115|12355166|P3|NOT COMPLETED|Overall Study||0
5020894|NCT02169115|12355167|P2|NOT COMPLETED|Overall Study||0
5020895|NCT02169115|12355168|P1|NOT COMPLETED|Overall Study||0
5020896|NCT02169115|12355166|P3|COMPLETED|Overall Study||21
5020897|NCT02169115|12355167|P2|COMPLETED|Overall Study||21
5020898|NCT02169115|12355168|P1|COMPLETED|Overall Study||19
5020899|NCT02169115|12355166|P3|STARTED|Overall Study||21
5020900|NCT02169115|12355167|P2|STARTED|Overall Study||21
5020901|NCT02169115|12355168|P1|STARTED|Overall Study||19
5020902|NCT02168946|12355178|P2|NOT COMPLETED|Overall Study||5
5020903|NCT02168946|12355179|P1|NOT COMPLETED|Overall Study||12
5020904|NCT02168946|12355178|P2|COMPLETED|Overall Study||20
5020905|NCT02168946|12355179|P1|COMPLETED|Overall Study||38
5020906|NCT02168946|12355178|P2|STARTED|Overall Study||25
5020907|NCT02168946|12355179|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
5020908|NCT02168933|12355215|P1|NOT COMPLETED|Overall Study||1
5020909|NCT02168933|12355215|P1|COMPLETED|Overall Study||7
5020910|NCT02168933|12355215|P1|STARTED|Overall Study||8
5020911|NCT02168855|12355225|P2|NOT COMPLETED|Overall Study||11
5020912|NCT02168855|12355226|P1|NOT COMPLETED|Overall Study||12
5020913|NCT02168855|12355225|P2|COMPLETED|Overall Study||177
5020914|NCT02168855|12355226|P1|COMPLETED|Overall Study||169
5020915|NCT02168855|12355225|P2|STARTED|Overall Study||188
5020916|NCT02168855|12355226|P1|STARTED|Overall Study||181
5020917|NCT02168842|12355238|P2|NOT COMPLETED|Overall Study||8
5020918|NCT02168842|12355239|P1|NOT COMPLETED|Overall Study||8
5020919|NCT02168842|12355238|P2|COMPLETED|Overall Study||158
5020920|NCT02168842|12355239|P1|COMPLETED|Overall Study||162
5020921|NCT02168842|12355238|P2|STARTED|Overall Study||166
5020922|NCT02168842|12355239|P1|STARTED|Overall Study||170
5020923|NCT02168816|12355297|P2|NOT COMPLETED|Overall Study||2
5020924|NCT02168816|12355298|P1|NOT COMPLETED|Overall Study||2
5020925|NCT02168816|12355297|P2|COMPLETED|Overall Study||5
5020926|NCT02168816|12355298|P1|COMPLETED|Overall Study||3
5020927|NCT02168816|12355297|P2|STARTED|Overall Study||7
5020928|NCT02168816|12355298|P1|STARTED|Overall Study||5
5020929|NCT02168803|12355309|P3|NOT COMPLETED|Overall Study||6
5020930|NCT02168803|12355310|P2|NOT COMPLETED|Overall Study||3
5020931|NCT02168803|12355311|P1|NOT COMPLETED|Overall Study||2
5020932|NCT02168803|12355309|P3|COMPLETED|Overall Study||33
5020933|NCT02168803|12355310|P2|COMPLETED|Overall Study||29
5020934|NCT02168803|12355311|P1|COMPLETED|Overall Study||28
5020935|NCT02168803|12355309|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
5020936|NCT02168803|12355310|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
5020937|NCT02168803|12355311|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
5020938|NCT02168803|12355309|P3|STARTED|Overall Study||39
5020939|NCT02168803|12355310|P2|STARTED|Overall Study||32
5020940|NCT02168803|12355311|P1|STARTED|Overall Study||30
5020941|NCT02168777|12355341|P3|NOT COMPLETED|Overall Study||11
5020942|NCT02168777|12355342|P2|NOT COMPLETED|Overall Study||7
5020943|NCT02168777|12355343|P1|NOT COMPLETED|Overall Study||2
5020944|NCT02168777|12355341|P3|COMPLETED|Overall Study||0
5020945|NCT02168777|12355342|P2|COMPLETED|Overall Study||0
5020946|NCT02168777|12355343|P1|COMPLETED|Overall Study||0
5020947|NCT02168777|12355341|P3|STARTED|Overall Study||11
5020948|NCT02168777|12355342|P2|STARTED|Overall Study||7
5020949|NCT02168777|12355343|P1|STARTED|Overall Study||2
5020950|NCT02168660|12355423|P3|NOT COMPLETED|Overall Study||15
5020951|NCT02168660|12355424|P2|NOT COMPLETED|Overall Study||17
5020953|NCT02168660|12355423|P3|COMPLETED|Overall Study||21
5020954|NCT02168660|12355424|P2|COMPLETED|Overall Study||18
5020955|NCT02168660|12355425|P1|COMPLETED|Overall Study||22
5020956|NCT02168660|12355423|P3|STARTED|Overall Study||36
5020957|NCT02168660|12355424|P2|STARTED|Overall Study||35
5020958|NCT02168660|12355425|P1|STARTED|Overall Study||38
5020959|NCT02168491|12355439|P1|NOT COMPLETED|Overall Study||1
5020960|NCT02168491|12355439|P1|COMPLETED|Overall Study||8
5020961|NCT02168491|12355439|P1|STARTED|Overall Study||9
5020962|NCT02168478|12355445|P1|NOT COMPLETED|Overall Study||4
5020963|NCT02168478|12355445|P1|COMPLETED|Overall Study||202
5020964|NCT02168478|12355445|P1|STARTED|Overall Study||206
5020965|NCT02168439|12355451|P2|NOT COMPLETED|Overall Study||2
5020966|NCT02168439|12355452|P1|NOT COMPLETED|Overall Study||0
5020967|NCT02168439|12355451|P2|COMPLETED|Overall Study||18
5020968|NCT02168439|12355452|P1|COMPLETED|Overall Study||20
5020969|NCT02168439|12355451|P2|STARTED|Overall Study||20
5020970|NCT02168439|12355452|P1|STARTED|Overall Study||20
5020971|NCT02168387|12355470|P2|NOT COMPLETED|Overall Study||3
5020972|NCT02168387|12355471|P1|NOT COMPLETED|Overall Study||7
5020973|NCT02168387|12355470|P2|COMPLETED|Overall Study||16
5020974|NCT02168387|12355471|P1|COMPLETED|Overall Study||13
5020975|NCT02168387|12355470|P2|STARTED|Overall Study||19
5020976|NCT02168387|12355471|P1|STARTED|Overall Study||20
5020977|NCT02168361|12355483|P2|NOT COMPLETED|Overall Study||10
5020978|NCT02168361|12355484|P1|NOT COMPLETED|Overall Study||5
5020979|NCT02168361|12355483|P2|COMPLETED|Overall Study||21
5020980|NCT02168361|12355484|P1|COMPLETED|Overall Study||57
5020981|NCT02168361|12355483|P2|STARTED|Overall Study||31
5020982|NCT02168361|12355484|P1|STARTED|Overall Study||62
5020983|NCT02168309|12355494|P2|NOT COMPLETED|Overall Study||0
5020984|NCT02168309|12355495|P1|NOT COMPLETED|Overall Study||0
5020985|NCT02168309|12355494|P2|COMPLETED|Overall Study||25
5020986|NCT02168309|12355495|P1|COMPLETED|Overall Study||25
5020987|NCT02168309|12355494|P2|STARTED|Overall Study||25
5020988|NCT02168309|12355495|P1|STARTED|Overall Study||25
5020989|NCT02168270|12355503|P1|NOT COMPLETED|Overall Study||4
5020990|NCT02168270|12355503|P1|COMPLETED|Overall Study||0
5020991|NCT02168270|12355503|P1|STARTED|Overall Study||4
5020992|NCT02168153|12355512|P2|NOT COMPLETED|Overall Study||0
5020993|NCT02168153|12355513|P1|NOT COMPLETED|Overall Study||3
5020994|NCT02168153|12355512|P2|COMPLETED|Overall Study||60
5020995|NCT02168153|12355513|P1|COMPLETED|Overall Study||57
5020996|NCT02168153|12355512|P2|STARTED|Overall Study||60
5020997|NCT02168153|12355513|P1|STARTED|Overall Study||60
5020998|NCT02168101|12355530|P3|NOT COMPLETED|Overall Study||1
5020999|NCT02168101|12355531|P2|NOT COMPLETED|Overall Study||2
5021000|NCT02168101|12355532|P1|NOT COMPLETED|Overall Study||2
5021001|NCT02168101|12355530|P3|COMPLETED|Overall Study||2
5021002|NCT02168101|12355531|P2|COMPLETED|Overall Study||1
5021003|NCT02168101|12355532|P1|COMPLETED|Overall Study||1
5021004|NCT02168101|12355530|P3|STARTED|Overall Study||3
5021005|NCT02168101|12355531|P2|STARTED|Overall Study||3
5021006|NCT02168101|12355532|P1|STARTED|Overall Study||3
5021007|NCT02168062|12355554|P3|NOT COMPLETED|Overall Study||0
5021008|NCT02168062|12355555|P2|NOT COMPLETED|Overall Study||0
5021009|NCT02168062|12355556|P1|NOT COMPLETED|Overall Study||0
5021010|NCT02168062|12355554|P3|COMPLETED|Overall Study||8
5021011|NCT02168062|12355555|P2|COMPLETED|Overall Study||26
5021012|NCT02168062|12355556|P1|COMPLETED|Overall Study||23
5021013|NCT02168062|12355554|P3|STARTED|Overall Study||8
5021014|NCT02168062|12355555|P2|STARTED|Overall Study||26
5021015|NCT02168062|12355556|P1|STARTED|Overall Study||23
5021016|NCT02167893|12355602|P1|NOT COMPLETED|Overall Study||163
5021017|NCT02167893|12355602|P1|COMPLETED|Overall Study||11125
5021018|NCT02167893|12355602|P1|STARTED|Overall Study||11288
5021019|NCT02167867|12355613|P2|NOT COMPLETED|Overall Study||0
5021020|NCT02167867|12355614|P1|NOT COMPLETED|Overall Study||0
5021021|NCT02167867|12355613|P2|COMPLETED|Overall Study||22
5021022|NCT02167867|12355614|P1|COMPLETED|Overall Study||22
5021023|NCT02167867|12355613|P2|STARTED|Overall Study||22
5021024|NCT02167867|12355614|P1|STARTED|Overall Study||22
5021025|NCT02167815|12355622|P2|NOT COMPLETED|Overall Study||0
5021026|NCT02167815|12355623|P1|NOT COMPLETED|Overall Study||0
5021027|NCT02167815|12355622|P2|COMPLETED|Overall Study||21
5021028|NCT02167815|12355623|P1|COMPLETED|Overall Study||9
5021029|NCT02167815|12355622|P2|STARTED|Overall Study||21
5021030|NCT02167815|12355623|P1|STARTED|Overall Study||9
5021031|NCT02167451|12355634|P1|NOT COMPLETED|Overall Study||1
5021032|NCT02167451|12355634|P1|COMPLETED|Overall Study||30
5021033|NCT02167451|12355634|P1|STARTED|Overall Study||31
5021034|NCT02167256|12355651|P2|NOT COMPLETED|Overall Study||10
5021035|NCT02167256|12355652|P1|NOT COMPLETED|Overall Study||21
5021036|NCT02167256|12355651|P2|COMPLETED|Overall Study||70
5021037|NCT02167256|12355652|P1|COMPLETED|Overall Study||58
5021038|NCT02167256|12355651|P2|STARTED|Overall Study||80
5021039|NCT02167256|12355652|P1|STARTED|Overall Study||79
5021040|NCT02167217|12355668|P1|NOT COMPLETED|Overall Study||2
5021041|NCT02167217|12355668|P1|COMPLETED|Overall Study||23
5021042|NCT02167217|12355668|P1|STARTED|Overall Study||25
5021043|NCT02167204|12355672|P1|NOT COMPLETED|Overall Study||0
5021044|NCT02167204|12355672|P1|COMPLETED|Overall Study||9
5021045|NCT02167204|12355672|P1|STARTED|Overall Study||9
5021046|NCT02167139|12355685|P4|NOT COMPLETED|Transition-extension||5
5021047|NCT02167139|12355686|P3|NOT COMPLETED|Transition-extension||8
5021048|NCT02167139|12355687|P2|NOT COMPLETED|Transition-extension||0
5021049|NCT02167139|12355688|P1|NOT COMPLETED|Transition-extension||6
5021050|NCT02167139|12355685|P4|COMPLETED|Transition-extension||124
5021051|NCT02167139|12355686|P3|COMPLETED|Transition-extension||117
5021052|NCT02167139|12355687|P2|COMPLETED|Transition-extension||0
5021053|NCT02167139|12355688|P1|COMPLETED|Transition-extension||248
5021054|NCT02167139|12355685|P4|STARTED|Transition-extension||129
5021055|NCT02167139|12355686|P3|STARTED|Transition-extension||125
5021056|NCT02167139|12355687|P2|STARTED|Transition-extension||0
5021057|NCT02167139|12355688|P1|STARTED|Transition-extension||254
5021058|NCT02167139|12355685|P4|NOT COMPLETED|Randomised, Double-blind||0
5021059|NCT02167139|12355686|P3|NOT COMPLETED|Randomised, Double-blind||0
5021060|NCT02167139|12355687|P2|NOT COMPLETED|Randomised, Double-blind||19
5021061|NCT02167139|12355688|P1|NOT COMPLETED|Randomised, Double-blind||17
5021062|NCT02167139|12355685|P4|COMPLETED|Randomised, Double-blind||0
5021063|NCT02167139|12355686|P3|COMPLETED|Randomised, Double-blind||0
5021064|NCT02167139|12355687|P2|COMPLETED|Randomised, Double-blind||254
5021065|NCT02167139|12355688|P1|COMPLETED|Randomised, Double-blind||254
5021066|NCT02167139|12355685|P4|STARTED|Randomised, Double-blind||0
5021067|NCT02167139|12355686|P3|STARTED|Randomised, Double-blind||0
5021068|NCT02167139|12355687|P2|STARTED|Randomised, Double-blind||273
5021069|NCT02167139|12355688|P1|STARTED|Randomised, Double-blind||271
5021070|NCT02167074|12355704|P2|NOT COMPLETED|Overall Study||0
5021071|NCT02167074|12355705|P1|NOT COMPLETED|Overall Study||0
5021072|NCT02167074|12355704|P2|COMPLETED|Overall Study||302
5021073|NCT02167074|12355705|P1|COMPLETED|Overall Study||306
5021074|NCT02167074|12355704|P2|STARTED|Overall Study||302
5021075|NCT02167074|12355705|P1|STARTED|Overall Study||306
5021076|NCT02167035|12355723|P2|NOT COMPLETED|Overall Study||6
5021077|NCT02167035|12355724|P1|NOT COMPLETED|Overall Study||5
5021078|NCT02167035|12355723|P2|COMPLETED|Overall Study||16
5021079|NCT02167035|12355724|P1|COMPLETED|Overall Study||16
5021080|NCT02167035|12355723|P2|STARTED|Overall Study||22
5021081|NCT02167035|12355724|P1|STARTED|Overall Study||21
5021082|NCT02166697|12355732|P1|NOT COMPLETED|Overall Study||347
5021083|NCT02166697|12355732|P1|COMPLETED|Overall Study||13804
5021084|NCT02166697|12355732|P1|STARTED|Overall Study||14151
5021085|NCT02166606|12355741|P1|NOT COMPLETED|Overall Study||78
5021086|NCT02166606|12355741|P1|COMPLETED|Overall Study||1106
5021087|NCT02166606|12355741|P1|Consent Eligible|Overall Study||1174
5021088|NCT02166606|12355741|P1|Actively Enrolled|Overall Study||1180
5021089|NCT02166606|12355741|P1|STARTED|Overall Study||1184
5021090|NCT02166476|12355748|P2|NOT COMPLETED|Overall Study||23
5021091|NCT02166476|12355749|P1|NOT COMPLETED|Overall Study||14
5021092|NCT02166476|12355748|P2|COMPLETED|Overall Study||250
5021093|NCT02166476|12355749|P1|COMPLETED|Overall Study||258
5021094|NCT02166476|12355748|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
5021095|NCT02166476|12355749|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
5021096|NCT02166476|12355748|P2|STARTED|Overall Study||273
5021097|NCT02166476|12355749|P1|STARTED|Overall Study||272
5021098|NCT02166346|12355782|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
5021099|NCT02166346|12355783|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
5021100|NCT02166346|12355782|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
5021101|NCT02166346|12355783|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
5021102|NCT02166346|12355782|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
5021103|NCT02166346|12355783|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
5021104|NCT02166346|12355782|P2|NOT COMPLETED|Intervention - Phase 1||2
5021105|NCT02166346|12355783|P1|NOT COMPLETED|Intervention - Phase 1||0
5021106|NCT02166346|12355782|P2|COMPLETED|Intervention - Phase 1||6
5021107|NCT02166346|12355783|P1|COMPLETED|Intervention - Phase 1||8
5021108|NCT02166346|12355782|P2|STARTED|Intervention - Phase 1||8
5021109|NCT02166346|12355783|P1|STARTED|Intervention - Phase 1||8
5021110|NCT02166346|12355782|P2|NOT COMPLETED|Screening and Randomization||4
5021111|NCT02166346|12355783|P1|NOT COMPLETED|Screening and Randomization||4
5021112|NCT02166346|12355782|P2|COMPLETED|Screening and Randomization||8
5021113|NCT02166346|12355783|P1|COMPLETED|Screening and Randomization||8
5021114|NCT02166346|12355782|P2|STARTED|Screening and Randomization||12
5021115|NCT02166346|12355783|P1|STARTED|Screening and Randomization||12
5021116|NCT02165904|12355791|P1|NOT COMPLETED|Overall Study||0
5021117|NCT02165904|12355791|P1|COMPLETED|Overall Study||10
5021118|NCT02165904|12355791|P1|STARTED|Overall Study||10
5021119|NCT02165826|12355813|P3|NOT COMPLETED|Down-Titration Period||7
5021120|NCT02165826|12355814|P2|NOT COMPLETED|Down-Titration Period||11
5021121|NCT02165826|12355815|P1|NOT COMPLETED|Down-Titration Period||7
5021122|NCT02165826|12355813|P3|COMPLETED|Down-Titration Period||31
5021123|NCT02165826|12355814|P2|COMPLETED|Down-Titration Period||28
5021124|NCT02165826|12355815|P1|COMPLETED|Down-Titration Period||20
5021125|NCT02165826|12355813|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
5021126|NCT02165826|12355814|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
5021127|NCT02165826|12355815|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
5021128|NCT02165826|12355813|P3|STARTED|Down-Titration Period||38
5021129|NCT02165826|12355814|P2|STARTED|Down-Titration Period||39
5021130|NCT02165826|12355815|P1|STARTED|Down-Titration Period||27
5021131|NCT02165826|12355813|P3|NOT COMPLETED|Main Treatment Period||109
5021132|NCT02165826|12355814|P2|NOT COMPLETED|Main Treatment Period||90
5021133|NCT02165826|12355815|P1|NOT COMPLETED|Main Treatment Period||81
5021134|NCT02165826|12355813|P3|COMPLETED|Main Treatment Period||334
5021135|NCT02165826|12355814|P2|COMPLETED|Main Treatment Period||349
5021136|NCT02165826|12355815|P1|COMPLETED|Main Treatment Period||360
5021137|NCT02165826|12355813|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
5021138|NCT02165826|12355814|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
5021139|NCT02165826|12355815|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
5021140|NCT02165826|12355813|P3|STARTED|Main Treatment Period||443
5021141|NCT02165826|12355814|P2|STARTED|Main Treatment Period||439
5021142|NCT02165826|12355815|P1|STARTED|Main Treatment Period||441
5021143|NCT02165761|12355874|P2|NOT COMPLETED|Overall Study||14
5021144|NCT02165761|12355875|P1|NOT COMPLETED|Overall Study||19
5021145|NCT02165761|12355874|P2|COMPLETED|Overall Study||5
5021146|NCT02165761|12355875|P1|COMPLETED|Overall Study||4
5021147|NCT02165761|12355874|P2|STARTED|Overall Study||19
5021148|NCT02165761|12355875|P1|STARTED|Overall Study||23
5021149|NCT02165735|12355883|P2|NOT COMPLETED|Overall Study||14
5021150|NCT02165735|12355884|P1|NOT COMPLETED|Overall Study||16
5021151|NCT02165735|12355883|P2|COMPLETED|Overall Study||166
5021152|NCT02165735|12355884|P1|COMPLETED|Overall Study||164
5021153|NCT02165735|12355883|P2|STARTED|Overall Study||180
5021154|NCT02165735|12355884|P1|STARTED|Overall Study||180
5021155|NCT02165722|12355912|P2|NOT COMPLETED|Overall Study||0
5021156|NCT02165722|12355913|P1|NOT COMPLETED|Overall Study||0
5021157|NCT02165722|12355912|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
5021158|NCT02165722|12355913|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
5021159|NCT02165722|12355912|P2|STARTED|Overall Study||2202
5021160|NCT02165722|12355913|P1|STARTED|Overall Study||1971
5021161|NCT02165462|12355925|P1|NOT COMPLETED|Overall Study||0
5021162|NCT02165462|12355925|P1|COMPLETED|Overall Study||17
5021163|NCT02165462|12355925|P1|STARTED|Overall Study||17
5021164|NCT02165384|12355942|P1|NOT COMPLETED|Overall Study||0
5021165|NCT02165384|12355942|P1|COMPLETED|Overall Study||199
5021166|NCT02165384|12355942|P1|STARTED|Overall Study||199
5021167|NCT02165202|12355949|P2|NOT COMPLETED|Injection Phase||6
5021168|NCT02165202|12355950|P1|NOT COMPLETED|Injection Phase||10
5021169|NCT02165202|12355949|P2|COMPLETED|Injection Phase||36
5021170|NCT02165202|12355950|P1|COMPLETED|Injection Phase||70
5021171|NCT02165202|12355949|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
5021172|NCT02165202|12355950|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
5021173|NCT02165202|12355949|P2|NOT COMPLETED|Oral Phase||3
5021174|NCT02165202|12355950|P1|NOT COMPLETED|Oral Phase||11
5021175|NCT02165202|12355949|P2|COMPLETED|Oral Phase||42
5021176|NCT02165202|12355950|P1|COMPLETED|Oral Phase||80
5021177|NCT02165202|12355949|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
5021178|NCT02165202|12355950|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
5021179|NCT02165124|12355956|P1|NOT COMPLETED|Overall Study||5
5021180|NCT02165124|12355956|P1|COMPLETED|Overall Study||15
5021181|NCT02165124|12355956|P1|STARTED|Overall Study||20
5021182|NCT02165111|12355962|P2|NOT COMPLETED|Overall Study||0
5021183|NCT02165111|12355963|P1|NOT COMPLETED|Overall Study||0
5021184|NCT02165111|12355962|P2|COMPLETED|Overall Study||40
5021185|NCT02165111|12355963|P1|COMPLETED|Overall Study||40
5021186|NCT02165111|12355962|P2|STARTED|Overall Study||40
5021187|NCT02165111|12355963|P1|STARTED|Overall Study||40
5021188|NCT02165072|12355979|P1|NOT COMPLETED|Overall Study||0
5021189|NCT02165072|12355979|P1|COMPLETED|Overall Study||30
5021190|NCT02165072|12355979|P1|STARTED|Overall Study||30
5021191|NCT02164981|12355987|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
5021192|NCT02164981|12355988|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
5021193|NCT02164981|12355989|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
5021194|NCT02164981|12355987|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
5021195|NCT02164981|12355988|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
5021196|NCT02164981|12355989|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
5021197|NCT02164981|12355987|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
5021198|NCT02164981|12355988|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
5021199|NCT02164981|12355989|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
5021200|NCT02164981|12355987|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
5021201|NCT02164981|12355988|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
5021202|NCT02164981|12355989|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
5021203|NCT02164981|12355987|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
5021204|NCT02164981|12355988|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
5021205|NCT02164981|12355989|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
5021206|NCT02164981|12355987|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
5021207|NCT02164981|12355988|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
5021208|NCT02164981|12355989|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
5021209|NCT02164981|12355987|P3|NOT COMPLETED|Started||0
5021210|NCT02164981|12355988|P2|NOT COMPLETED|Started||3
5021211|NCT02164981|12355989|P1|NOT COMPLETED|Started||5
5021212|NCT02164981|12355987|P3|COMPLETED|Started||18
5021213|NCT02164981|12355988|P2|COMPLETED|Started||16
5021214|NCT02164981|12355989|P1|COMPLETED|Started||18
5021215|NCT02164981|12355987|P3|STARTED|Started||18
5021216|NCT02164981|12355988|P2|STARTED|Started||19
5021217|NCT02164981|12355989|P1|STARTED|Started||23
5021218|NCT02164929|12356062|P4|NOT COMPLETED|Overall Study||2
5021219|NCT02164929|12356063|P3|NOT COMPLETED|Overall Study||1
5021220|NCT02164929|12356064|P2|NOT COMPLETED|Overall Study||0
5021221|NCT02164929|12356065|P1|NOT COMPLETED|Overall Study||1
5021222|NCT02164929|12356062|P4|COMPLETED|Overall Study||2
5021223|NCT02164929|12356063|P3|COMPLETED|Overall Study||4
5021224|NCT02164929|12356064|P2|COMPLETED|Overall Study||3
5021225|NCT02164929|12356065|P1|COMPLETED|Overall Study||3
5021226|NCT02164929|12356062|P4|STARTED|Overall Study||4
5021227|NCT02164929|12356063|P3|STARTED|Overall Study||5
5021228|NCT02164929|12356064|P2|STARTED|Overall Study||3
5021229|NCT02164929|12356065|P1|STARTED|Overall Study||4
5021230|NCT02164916|12356109|P2|NOT COMPLETED|Overall Study||54
5021231|NCT02164916|12356110|P1|NOT COMPLETED|Overall Study||52
5021232|NCT02164916|12356109|P2|COMPLETED|Overall Study||0
5021233|NCT02164916|12356110|P1|COMPLETED|Overall Study||0
5021234|NCT02164916|12356109|P2|Cross-over to Arm II|Overall Study||0
5021235|NCT02164916|12356110|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
5021236|NCT02164916|12356109|P2|Eligible|Overall Study||49
5021237|NCT02164916|12356110|P1|Eligible|Overall Study||50
5021238|NCT02164916|12356109|P2|STARTED|Overall Study||54
5021239|NCT02164916|12356110|P1|STARTED|Overall Study||52
5021240|NCT02164864|12356130|P3|NOT COMPLETED|Overall Study||132
5021241|NCT02164864|12356131|P2|NOT COMPLETED|Overall Study||60
5021242|NCT02164864|12356132|P1|NOT COMPLETED|Overall Study||95
5021243|NCT02164864|12356130|P3|COMPLETED|Overall Study||849
5021244|NCT02164864|12356131|P2|COMPLETED|Overall Study||703
5021245|NCT02164864|12356132|P1|COMPLETED|Overall Study||886
5021246|NCT02164864|12356130|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
5021247|NCT02164864|12356131|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
5021248|NCT02164864|12356132|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
5021249|NCT02164721|12356191|P1|NOT COMPLETED|Overall Study||0
5021250|NCT02164721|12356191|P1|COMPLETED|Overall Study||30
5021251|NCT02164721|12356191|P1|STARTED|Overall Study||30
5021252|NCT02164539|12356207|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
5021253|NCT02164539|12356208|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
5021254|NCT02164539|12356209|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
5021255|NCT02164539|12356210|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
5021256|NCT02164539|12356211|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
5021257|NCT02164539|12356212|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
5021258|NCT02164539|12356213|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
5021259|NCT02164539|12356207|P7|COMPLETED|Treatment Phase C (1 Week)||78
5021260|NCT02164539|12356208|P6|COMPLETED|Treatment Phase C (1 Week)||82
5021261|NCT02164539|12356209|P5|COMPLETED|Treatment Phase C (1 Week)||84
5021262|NCT02164539|12356210|P4|COMPLETED|Treatment Phase C (1 Week)||0
5021263|NCT02164539|12356211|P3|COMPLETED|Treatment Phase C (1 Week)||0
5021264|NCT02164539|12356212|P2|COMPLETED|Treatment Phase C (1 Week)||0
5021265|NCT02164539|12356213|P1|COMPLETED|Treatment Phase C (1 Week)||78
5021266|NCT02164539|12356207|P7|STARTED|Treatment Phase C (1 Week)||80
5021267|NCT02164539|12356208|P6|STARTED|Treatment Phase C (1 Week)||82
5021268|NCT02164539|12356209|P5|STARTED|Treatment Phase C (1 Week)||84
5021269|NCT02164539|12356210|P4|STARTED|Treatment Phase C (1 Week)||0
5021270|NCT02164539|12356211|P3|STARTED|Treatment Phase C (1 Week)||0
5021271|NCT02164539|12356212|P2|STARTED|Treatment Phase C (1 Week)||0
5021272|NCT02164539|12356213|P1|STARTED|Treatment Phase C (1 Week)||79
5021273|NCT02164539|12356207|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
5021274|NCT02164539|12356208|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
5021275|NCT02164539|12356209|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
5021276|NCT02164539|12356210|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
5021277|NCT02164539|12356211|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
5021278|NCT02164539|12356212|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
5021279|NCT02164539|12356213|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
5021280|NCT02164539|12356207|P7|COMPLETED|Treatment Phase B (1 Week)||162
5021281|NCT02164539|12356208|P6|COMPLETED|Treatment Phase B (1 Week)||0
5021282|NCT02164539|12356209|P5|COMPLETED|Treatment Phase B (1 Week)||163
5021283|NCT02164539|12356210|P4|COMPLETED|Treatment Phase B (1 Week)||0
5021284|NCT02164539|12356211|P3|COMPLETED|Treatment Phase B (1 Week)||0
5021285|NCT02164539|12356212|P2|COMPLETED|Treatment Phase B (1 Week)||0
5021286|NCT02164539|12356213|P1|COMPLETED|Treatment Phase B (1 Week)||0
5021287|NCT02164539|12356207|P7|STARTED|Treatment Phase B (1 Week)||163
5021288|NCT02164539|12356208|P6|STARTED|Treatment Phase B (1 Week)||0
5021289|NCT02164539|12356209|P5|STARTED|Treatment Phase B (1 Week)||166
5021290|NCT02164539|12356210|P4|STARTED|Treatment Phase B (1 Week)||0
5021291|NCT02164539|12356211|P3|STARTED|Treatment Phase B (1 Week)||0
5021292|NCT02164539|12356212|P2|STARTED|Treatment Phase B (1 Week)||0
5021293|NCT02164539|12356213|P1|STARTED|Treatment Phase B (1 Week)||0
5021294|NCT02164539|12356207|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
5021295|NCT02164539|12356208|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
5021296|NCT02164539|12356209|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
5021297|NCT02164539|12356210|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
5021298|NCT02164539|12356211|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
5021299|NCT02164539|12356212|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
5021300|NCT02164539|12356213|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
5021301|NCT02164539|12356207|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
5021302|NCT02164539|12356208|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
5021303|NCT02164539|12356209|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
5021304|NCT02164539|12356210|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
5021305|NCT02164539|12356211|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
5021306|NCT02164539|12356212|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
5021307|NCT02164539|12356213|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
5021308|NCT02164539|12356207|P7|STARTED|Treatment Phase A (4 Weeks)||0
5021309|NCT02164539|12356208|P6|STARTED|Treatment Phase A (4 Weeks)||84
5021310|NCT02164539|12356209|P5|STARTED|Treatment Phase A (4 Weeks)||85
5021311|NCT02164539|12356210|P4|STARTED|Treatment Phase A (4 Weeks)||46
5021312|NCT02164539|12356211|P3|STARTED|Treatment Phase A (4 Weeks)||40
5021313|NCT02164539|12356212|P2|STARTED|Treatment Phase A (4 Weeks)||42
5021314|NCT02164539|12356213|P1|STARTED|Treatment Phase A (4 Weeks)||41
5021315|NCT02164513|12356261|P3|NOT COMPLETED|Overall Study||295
5021316|NCT02164513|12356262|P2|NOT COMPLETED|Overall Study||536
5021317|NCT02164513|12356263|P1|NOT COMPLETED|Overall Study||437
5021318|NCT02164513|12356261|P3|COMPLETED|Overall Study||1775
5021319|NCT02164513|12356262|P2|COMPLETED|Overall Study||3598
5021320|NCT02164513|12356263|P1|COMPLETED|Overall Study||3714
5021321|NCT02164513|12356261|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
5021322|NCT02164513|12356262|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
5021323|NCT02164513|12356263|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
5021324|NCT02164513|12356261|P3|WIP: Withdrawal by Participant|Overall Study||153
5021325|NCT02164513|12356262|P2|WIP: Withdrawal by Participant|Overall Study||296
5021326|NCT02164513|12356263|P1|WIP: Withdrawal by Participant|Overall Study||250
5021327|NCT02164513|12356261|P3|WIP: Investigator Discretion|Overall Study||15
5021328|NCT02164513|12356262|P2|WIP: Investigator Discretion|Overall Study||36
5021329|NCT02164513|12356263|P1|WIP: Investigator Discretion|Overall Study||33
5021330|NCT02164513|12356261|P3|WIP: Lost to Follow-up|Overall Study||14
5021331|NCT02164513|12356262|P2|WIP: Lost to Follow-up|Overall Study||25
5021332|NCT02164513|12356263|P1|WIP: Lost to Follow-up|Overall Study||21
5021333|NCT02164513|12356261|P3|WIP: Study Closed/Terminated|Overall Study||5
5021334|NCT02164513|12356262|P2|WIP: Study Closed/Terminated|Overall Study||2
5021335|NCT02164513|12356263|P1|WIP: Study Closed/Terminated|Overall Study||5
5021336|NCT02164513|12356261|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
5021337|NCT02164513|12356262|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
5021338|NCT02164513|12356263|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
5021339|NCT02164513|12356261|P3|Withdrew IP: Protocol Deviation|Overall Study||19
5021340|NCT02164513|12356262|P2|Withdrew IP: Protocol Deviation|Overall Study||41
5021341|NCT02164513|12356263|P1|Withdrew IP: Protocol Deviation|Overall Study||32
5021342|NCT02164513|12356261|P3|WIP: Lack of Efficacy|Overall Study||172
5021343|NCT02164513|12356262|P2|WIP: Lack of Efficacy|Overall Study||313
5021344|NCT02164513|12356263|P1|WIP: Lack of Efficacy|Overall Study||163
5021345|NCT02164513|12356261|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
5021346|NCT02164513|12356262|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
5021347|NCT02164513|12356263|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
5021348|NCT02164513|12356261|P3|Not Completed IP|Overall Study||566
5021349|NCT02164513|12356262|P2|Not Completed IP|Overall Study||1040
5021350|NCT02164513|12356263|P1|Not Completed IP|Overall Study||758
5021351|NCT02164513|12356261|P3|Completed Investigational Product (IP)|Overall Study||1504
5021352|NCT02164513|12356262|P2|Completed Investigational Product (IP)|Overall Study||3094
5021353|NCT02164513|12356263|P1|Completed Investigational Product (IP)|Overall Study||3393
5021354|NCT02164513|12356261|P3|STARTED|Overall Study||2070
5021355|NCT02164513|12356262|P2|STARTED|Overall Study||4134
5021356|NCT02164513|12356263|P1|STARTED|Overall Study||4151
5021357|NCT02164396|12356288|P3|NOT COMPLETED|Overall Study||0
5021358|NCT02164396|12356289|P2|NOT COMPLETED|Overall Study||0
5021359|NCT02164396|12356290|P1|NOT COMPLETED|Overall Study||0
5021360|NCT02164396|12356288|P3|COMPLETED|Overall Study||10
5021361|NCT02164396|12356289|P2|COMPLETED|Overall Study||10
5021362|NCT02164396|12356290|P1|COMPLETED|Overall Study||10
5021363|NCT02164396|12356288|P3|STARTED|Overall Study||10
5021364|NCT02164396|12356289|P2|STARTED|Overall Study||10
5021365|NCT02164396|12356290|P1|STARTED|Overall Study||10
5021366|NCT02164383|12356300|P2|NOT COMPLETED|Overall Study||0
5021367|NCT02164383|12356301|P1|NOT COMPLETED|Overall Study||1
5021368|NCT02164383|12356300|P2|COMPLETED|Overall Study||14
5021369|NCT02164383|12356301|P1|COMPLETED|Overall Study||15
5021370|NCT02164383|12356300|P2|STARTED|Overall Study||14
5021371|NCT02164383|12356301|P1|STARTED|Overall Study||16
5021372|NCT02164318|12356311|P4|NOT COMPLETED|Overall Study||1
5021373|NCT02164318|12356312|P3|NOT COMPLETED|Overall Study||0
5021374|NCT02164318|12356313|P2|NOT COMPLETED|Overall Study||1
5021375|NCT02164318|12356314|P1|NOT COMPLETED|Overall Study||0
5021376|NCT02164318|12356311|P4|COMPLETED|Overall Study||2
5021377|NCT02164318|12356312|P3|COMPLETED|Overall Study||1
5021378|NCT02164318|12356313|P2|COMPLETED|Overall Study||2
5021379|NCT02164318|12356314|P1|COMPLETED|Overall Study||4
5021380|NCT02164318|12356311|P4|STARTED|Overall Study||3
5021381|NCT02164318|12356312|P3|STARTED|Overall Study||1
5021382|NCT02164318|12356313|P2|STARTED|Overall Study||3
5021383|NCT02164318|12356314|P1|STARTED|Overall Study||4
5021384|NCT02164240|12356332|P3|NOT COMPLETED|Overall Study||0
5021385|NCT02164240|12356333|P2|NOT COMPLETED|Overall Study||0
5021386|NCT02164240|12356334|P1|NOT COMPLETED|Overall Study||0
5021387|NCT02164240|12356332|P3|COMPLETED|Overall Study||4
5021388|NCT02164240|12356333|P2|COMPLETED|Overall Study||5
5021389|NCT02164240|12356334|P1|COMPLETED|Overall Study||5
5021390|NCT02164240|12356332|P3|STARTED|Overall Study||4
5021391|NCT02164240|12356333|P2|STARTED|Overall Study||5
5021392|NCT02164240|12356334|P1|STARTED|Overall Study||5
5021393|NCT02163993|12356349|P5|NOT COMPLETED|Post-treatment Period||3
5021394|NCT02163993|12356350|P4|NOT COMPLETED|Post-treatment Period||2
5021395|NCT02163993|12356351|P3|NOT COMPLETED|Post-treatment Period||4
5021396|NCT02163993|12356352|P2|NOT COMPLETED|Post-treatment Period||6
5021397|NCT02163993|12356353|P1|NOT COMPLETED|Post-treatment Period||4
5021398|NCT02163993|12356349|P5|COMPLETED|Post-treatment Period||62
5021399|NCT02163993|12356350|P4|COMPLETED|Post-treatment Period||61
5021400|NCT02163993|12356351|P3|COMPLETED|Post-treatment Period||62
5021401|NCT02163993|12356352|P2|COMPLETED|Post-treatment Period||55
5021402|NCT02163993|12356353|P1|COMPLETED|Post-treatment Period||121
5021403|NCT02163993|12356349|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
5021404|NCT02163993|12356350|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
5021405|NCT02163993|12356351|P3|STARTED|Post-treatment Period||66
5021406|NCT02163993|12356352|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
5021407|NCT02163993|12356353|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
5021408|NCT02163993|12356349|P5|NOT COMPLETED|Treatment Period||7
5021409|NCT02163993|12356350|P4|NOT COMPLETED|Treatment Period||9
5021410|NCT02163993|12356351|P3|NOT COMPLETED|Treatment Period||2
5021411|NCT02163993|12356352|P2|NOT COMPLETED|Treatment Period||9
5021412|NCT02163993|12356353|P1|NOT COMPLETED|Treatment Period||12
5021413|NCT02163993|12356349|P5|COMPLETED|Treatment Period||62
5021414|NCT02163993|12356350|P4|COMPLETED|Treatment Period||62
5021415|NCT02163993|12356351|P3|COMPLETED|Treatment Period||66
5021416|NCT02163993|12356352|P2|COMPLETED|Treatment Period||59
5021417|NCT02163993|12356353|P1|COMPLETED|Treatment Period||126
5021418|NCT02163993|12356349|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
5021419|NCT02163993|12356350|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
5021420|NCT02163993|12356351|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
5021421|NCT02163993|12356352|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
5021422|NCT02163993|12356353|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
5021423|NCT02163993|12356349|P5|STARTED|Treatment Period||69
5021424|NCT02163993|12356350|P4|STARTED|Treatment Period||71
5021425|NCT02163993|12356351|P3|STARTED|Treatment Period||68
5021426|NCT02163993|12356352|P2|STARTED|Treatment Period||68
5021427|NCT02163993|12356353|P1|STARTED|Treatment Period||138
5021428|NCT02163967|12356429|P6|NOT COMPLETED|Third Intervention/Day 3||0
5021429|NCT02163967|12356430|P5|NOT COMPLETED|Third Intervention/Day 3||0
5021430|NCT02163967|12356431|P4|NOT COMPLETED|Third Intervention/Day 3||0
5021431|NCT02163967|12356432|P3|NOT COMPLETED|Third Intervention/Day 3||0
5021432|NCT02163967|12356433|P2|NOT COMPLETED|Third Intervention/Day 3||0
5021433|NCT02163967|12356434|P1|NOT COMPLETED|Third Intervention/Day 3||0
5021434|NCT02163967|12356429|P6|COMPLETED|Third Intervention/Day 3||3
5021435|NCT02163967|12356430|P5|COMPLETED|Third Intervention/Day 3||3
5021436|NCT02163967|12356431|P4|COMPLETED|Third Intervention/Day 3||4
5021437|NCT02163967|12356432|P3|COMPLETED|Third Intervention/Day 3||2
5021438|NCT02163967|12356433|P2|COMPLETED|Third Intervention/Day 3||3
5021439|NCT02163967|12356434|P1|COMPLETED|Third Intervention/Day 3||3
5021440|NCT02163967|12356429|P6|STARTED|Third Intervention/Day 3||3
5021441|NCT02163967|12356430|P5|STARTED|Third Intervention/Day 3||3
5021442|NCT02163967|12356431|P4|STARTED|Third Intervention/Day 3||4
5021443|NCT02163967|12356432|P3|STARTED|Third Intervention/Day 3||2
5021444|NCT02163967|12356433|P2|STARTED|Third Intervention/Day 3||3
5021445|NCT02163967|12356434|P1|STARTED|Third Intervention/Day 3||3
5021446|NCT02163967|12356429|P6|NOT COMPLETED|Second Intevention/Day 2||0
5021447|NCT02163967|12356430|P5|NOT COMPLETED|Second Intevention/Day 2||0
5021448|NCT02163967|12356431|P4|NOT COMPLETED|Second Intevention/Day 2||0
5021449|NCT02163967|12356432|P3|NOT COMPLETED|Second Intevention/Day 2||0
5021450|NCT02163967|12356433|P2|NOT COMPLETED|Second Intevention/Day 2||0
5021451|NCT02163967|12356434|P1|NOT COMPLETED|Second Intevention/Day 2||0
5021452|NCT02163967|12356429|P6|COMPLETED|Second Intevention/Day 2||3
5021453|NCT02163967|12356430|P5|COMPLETED|Second Intevention/Day 2||3
5021454|NCT02163967|12356431|P4|COMPLETED|Second Intevention/Day 2||4
5021455|NCT02163967|12356432|P3|COMPLETED|Second Intevention/Day 2||2
5021456|NCT02163967|12356433|P2|COMPLETED|Second Intevention/Day 2||4
5021457|NCT02163967|12356434|P1|COMPLETED|Second Intevention/Day 2||3
5021458|NCT02163967|12356429|P6|STARTED|Second Intevention/Day 2||3
5021459|NCT02163967|12356430|P5|STARTED|Second Intevention/Day 2||3
5021460|NCT02163967|12356431|P4|STARTED|Second Intevention/Day 2||4
5021461|NCT02163967|12356432|P3|STARTED|Second Intevention/Day 2||2
5021462|NCT02163967|12356433|P2|STARTED|Second Intevention/Day 2||4
5021463|NCT02163967|12356434|P1|STARTED|Second Intevention/Day 2||3
5021464|NCT02163967|12356429|P6|NOT COMPLETED|First Intervention/ Day 1||0
5021465|NCT02163967|12356430|P5|NOT COMPLETED|First Intervention/ Day 1||0
5021466|NCT02163967|12356431|P4|NOT COMPLETED|First Intervention/ Day 1||0
5021467|NCT02163967|12356432|P3|NOT COMPLETED|First Intervention/ Day 1||0
5021468|NCT02163967|12356433|P2|NOT COMPLETED|First Intervention/ Day 1||0
5021469|NCT02163967|12356434|P1|NOT COMPLETED|First Intervention/ Day 1||0
5021470|NCT02163967|12356429|P6|COMPLETED|First Intervention/ Day 1||3
5021471|NCT02163967|12356430|P5|COMPLETED|First Intervention/ Day 1||3
5021472|NCT02163967|12356431|P4|COMPLETED|First Intervention/ Day 1||4
5021473|NCT02163967|12356432|P3|COMPLETED|First Intervention/ Day 1||3
5021474|NCT02163967|12356433|P2|COMPLETED|First Intervention/ Day 1||4
5021475|NCT02163967|12356434|P1|COMPLETED|First Intervention/ Day 1||4
5021476|NCT02163967|12356429|P6|STARTED|First Intervention/ Day 1||3
5021477|NCT02163967|12356430|P5|STARTED|First Intervention/ Day 1||3
5021478|NCT02163967|12356431|P4|STARTED|First Intervention/ Day 1||4
5021479|NCT02163967|12356432|P3|STARTED|First Intervention/ Day 1||3
5021480|NCT02163967|12356433|P2|STARTED|First Intervention/ Day 1||4
5021481|NCT02163967|12356434|P1|STARTED|First Intervention/ Day 1||4
5021482|NCT02163915|12356456|P5|NOT COMPLETED|Overall Study||4
5021483|NCT02163915|12356457|P4|NOT COMPLETED|Overall Study||3
5021484|NCT02163915|12356458|P3|NOT COMPLETED|Overall Study||2
5021485|NCT02163915|12356459|P2|NOT COMPLETED|Overall Study||0
5021486|NCT02163915|12356460|P1|NOT COMPLETED|Overall Study||3
5021487|NCT02163915|12356456|P5|COMPLETED|Overall Study||6
5021488|NCT02163915|12356457|P4|COMPLETED|Overall Study||6
5021489|NCT02163915|12356458|P3|COMPLETED|Overall Study||8
5021490|NCT02163915|12356459|P2|COMPLETED|Overall Study||8
5021491|NCT02163915|12356460|P1|COMPLETED|Overall Study||7
5021492|NCT02163915|12356456|P5|STARTED|Overall Study||10
5021493|NCT02163915|12356457|P4|STARTED|Overall Study||9
5021494|NCT02163915|12356458|P3|STARTED|Overall Study||10
5021495|NCT02163915|12356459|P2|STARTED|Overall Study||8
5021496|NCT02163915|12356460|P1|STARTED|Overall Study||10
5021497|NCT02163902|12356515|P2|NOT COMPLETED|Overall Study||13
5021498|NCT02163902|12356516|P1|NOT COMPLETED|Overall Study||11
5021499|NCT02163902|12356515|P2|COMPLETED|Overall Study||98
5021500|NCT02163902|12356516|P1|COMPLETED|Overall Study||102
5021501|NCT02163902|12356515|P2|STARTED|Overall Study||111
5021502|NCT02163902|12356516|P1|STARTED|Overall Study||113
5021503|NCT02163837|12356532|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
5021504|NCT02163837|12356532|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
5021505|NCT02163837|12356532|P1|STARTED|Day 28 of Rifaximin Treatment||15
5021506|NCT02163837|12356532|P1|NOT COMPLETED|Before Rifaximin||0
5021507|NCT02163837|12356532|P1|COMPLETED|Before Rifaximin||15
5021508|NCT02163837|12356532|P1|STARTED|Before Rifaximin||15
5021509|NCT02163733|12356542|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
5021510|NCT02163733|12356543|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
5021511|NCT02163733|12356544|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
5021512|NCT02163733|12356542|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
5021513|NCT02163733|12356543|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
5021514|NCT02163733|12356544|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
5021515|NCT02163733|12356542|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
5021516|NCT02163733|12356543|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
5021517|NCT02163733|12356544|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
5021518|NCT02163733|12356542|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
5021519|NCT02163733|12356543|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
5021520|NCT02163733|12356544|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
5021521|NCT02163733|12356542|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
5021522|NCT02163733|12356543|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
5021523|NCT02163733|12356544|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
5021524|NCT02163733|12356542|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
5021525|NCT02163733|12356543|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
5021526|NCT02163733|12356544|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
5021527|NCT02163733|12356542|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
5021528|NCT02163733|12356543|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
5021529|NCT02163733|12356544|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
5021530|NCT02163733|12356542|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
5021531|NCT02163733|12356543|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
5021532|NCT02163733|12356544|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
5021533|NCT02163733|12356542|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
5021534|NCT02163733|12356543|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
5021535|NCT02163733|12356544|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
5021536|NCT02163577|12356581|P2|NOT COMPLETED|Overall Study||0
5021537|NCT02163577|12356582|P1|NOT COMPLETED|Overall Study||0
5021538|NCT02163577|12356581|P2|COMPLETED|Overall Study||26
5021539|NCT02163577|12356582|P1|COMPLETED|Overall Study||26
5021540|NCT02163577|12356581|P2|STARTED|Overall Study||26
5021541|NCT02163577|12356582|P1|STARTED|Overall Study||26
5021542|NCT02163538|12356646|P2|NOT COMPLETED|Overall Study||1
5021543|NCT02163538|12356647|P1|NOT COMPLETED|Overall Study||1
5021544|NCT02163538|12356646|P2|COMPLETED|Overall Study||70
5021545|NCT02163538|12356647|P1|COMPLETED|Overall Study||70
5021546|NCT02163538|12356646|P2|STARTED|Overall Study||71
5021547|NCT02163538|12356647|P1|STARTED|Overall Study||71
5021548|NCT02163499|12356663|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
5021549|NCT02163499|12356663|P1|COMPLETED|Extended Dosing Phase: ZS||466
5021550|NCT02163499|12356663|P1|STARTED|Extended Dosing Phase: ZS||746
5021551|NCT02163499|12356663|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
5021552|NCT02163499|12356663|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
5021553|NCT02163499|12356663|P1|STARTED|Acute Phase: ZS 10 g TID||751
5021554|NCT02163486|12356673|P2|NOT COMPLETED|Overall Study||2
5021555|NCT02163486|12356674|P1|NOT COMPLETED|Overall Study||1
5021556|NCT02163486|12356673|P2|COMPLETED|Overall Study||50
5021557|NCT02163486|12356674|P1|COMPLETED|Overall Study||50
5021558|NCT02163486|12356673|P2|STARTED|Overall Study||52
5021559|NCT02163486|12356674|P1|STARTED|Overall Study||51
5021560|NCT02163447|12356691|P3|NOT COMPLETED|Overall Study||3
5021561|NCT02163447|12356692|P2|NOT COMPLETED|Overall Study||6
5021562|NCT02163447|12356693|P1|NOT COMPLETED|Overall Study||6
5021563|NCT02163447|12356691|P3|COMPLETED|Overall Study||97
5021564|NCT02163447|12356692|P2|COMPLETED|Overall Study||88
5021565|NCT02163447|12356693|P1|COMPLETED|Overall Study||100
5021566|NCT02163447|12356691|P3|STARTED|Overall Study||100
5021567|NCT02163447|12356692|P2|STARTED|Overall Study||94
5021568|NCT02163447|12356693|P1|STARTED|Overall Study||106
5021569|NCT02163421|12356723|P4|NOT COMPLETED|Overall Study||0
5021570|NCT02163421|12356724|P3|NOT COMPLETED|Overall Study||0
5021571|NCT02163421|12356725|P2|NOT COMPLETED|Overall Study||0
5021572|NCT02163421|12356726|P1|NOT COMPLETED|Overall Study||0
5021573|NCT02163421|12356723|P4|COMPLETED|Overall Study||12
5021574|NCT02163421|12356724|P3|COMPLETED|Overall Study||12
5021575|NCT02163421|12356725|P2|COMPLETED|Overall Study||12
5021576|NCT02163421|12356726|P1|COMPLETED|Overall Study||12
5021577|NCT02163421|12356723|P4|STARTED|Overall Study||12
5021578|NCT02163421|12356724|P3|STARTED|Overall Study||12
5021579|NCT02163421|12356725|P2|STARTED|Overall Study||12
5021580|NCT02163421|12356726|P1|STARTED|Overall Study||12
5021581|NCT02163395|12356733|P1|NOT COMPLETED|Overall Study||5
5021582|NCT02163395|12356733|P1|COMPLETED|Overall Study||39
5021583|NCT02163395|12356733|P1|STARTED|Overall Study||44
5021584|NCT02163187|12356742|P2|NOT COMPLETED|Overall Study||0
5021585|NCT02163187|12356743|P1|NOT COMPLETED|Overall Study||2
5021586|NCT02163187|12356742|P2|COMPLETED|Overall Study||0
5021587|NCT02163187|12356743|P1|COMPLETED|Overall Study||2
5021588|NCT02163187|12356742|P2|Treatment|Overall Study||0
5021589|NCT02163187|12356743|P1|Treatment|Overall Study||2
5021590|NCT02163187|12356742|P2|STARTED|Overall Study||0
5021591|NCT02163187|12356743|P1|STARTED|Overall Study||4
5021592|NCT02162992|12356753|P2|NOT COMPLETED|Overall Study||1
5021593|NCT02162992|12356754|P1|NOT COMPLETED|Overall Study||5
5021594|NCT02162992|12356753|P2|COMPLETED|Overall Study||99
5021595|NCT02162992|12356754|P1|COMPLETED|Overall Study||46
5021596|NCT02162992|12356753|P2|STARTED|Overall Study||100
5021597|NCT02162992|12356754|P1|STARTED|Overall Study||51
5021598|NCT02162979|12356764|P2|NOT COMPLETED|Overall Study||0
5021599|NCT02162979|12356765|P1|NOT COMPLETED|Overall Study||0
5021600|NCT02162979|12356764|P2|COMPLETED|Overall Study||0
5021601|NCT02162979|12356765|P1|COMPLETED|Overall Study||0
5021602|NCT02162979|12356764|P2|STARTED|Overall Study||0
5021603|NCT02162979|12356765|P1|STARTED|Overall Study||0
5021604|NCT02162862|12356778|P3|NOT COMPLETED|Overall Study||4
5021605|NCT02162862|12356779|P2|NOT COMPLETED|Overall Study||11
5021606|NCT02162862|12356780|P1|NOT COMPLETED|Overall Study||0
5021607|NCT02162862|12356778|P3|COMPLETED|Overall Study||29
5021608|NCT02162862|12356779|P2|COMPLETED|Overall Study||24
5021609|NCT02162862|12356780|P1|COMPLETED|Overall Study||31
5021610|NCT02162862|12356778|P3|STARTED|Overall Study||33
5021611|NCT02162862|12356779|P2|STARTED|Overall Study||35
5021612|NCT02162862|12356780|P1|STARTED|Overall Study||31
5021613|NCT02162771|12356793|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
5021614|NCT02162771|12356794|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
5021615|NCT02162771|12356793|P2|COMPLETED|Maintenance Study Period (Part 2)||38
5021616|NCT02162771|12356794|P1|COMPLETED|Maintenance Study Period (Part 2)||46
5021617|NCT02162771|12356793|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
5021618|NCT02162771|12356794|P1|STARTED|Maintenance Study Period (Part 2)||62
5021619|NCT02162771|12356793|P2|NOT COMPLETED|Core Study Period (Part 2)||8
5021620|NCT02162771|12356794|P1|NOT COMPLETED|Core Study Period (Part 2)||8
5021621|NCT02162771|12356793|P2|COMPLETED|Core Study Period (Part 2)||62
5021622|NCT02162771|12356794|P1|COMPLETED|Core Study Period (Part 2)||62
5021623|NCT02162771|12356793|P2|STARTED|Core Study Period (Part 2)||70
5021624|NCT02162771|12356794|P1|STARTED|Core Study Period (Part 2)||70
5021625|NCT02162758|12356808|P2|NOT COMPLETED|Overall Study||1
5021626|NCT02162758|12356809|P1|NOT COMPLETED|Overall Study||0
5021627|NCT02162758|12356808|P2|COMPLETED|Overall Study||2
5021628|NCT02162758|12356809|P1|COMPLETED|Overall Study||3
5021629|NCT02162758|12356808|P2|STARTED|Overall Study||3
5021630|NCT02162758|12356809|P1|STARTED|Overall Study||3
5021631|NCT02162680|12356824|P3|NOT COMPLETED|Overall Study||0
5021632|NCT02162680|12356825|P2|NOT COMPLETED|Overall Study||0
5021633|NCT02162680|12356826|P1|NOT COMPLETED|Overall Study||0
5021634|NCT02162680|12356824|P3|COMPLETED|Overall Study||32
5021635|NCT02162680|12356825|P2|COMPLETED|Overall Study||33
5021636|NCT02162680|12356826|P1|COMPLETED|Overall Study||33
5021637|NCT02162680|12356824|P3|STARTED|Overall Study||32
5021638|NCT02162680|12356825|P2|STARTED|Overall Study||33
5021639|NCT02162680|12356826|P1|STARTED|Overall Study||33
5021640|NCT02162667|12356836|P2|NOT COMPLETED|Adjuvant Period||13
5021641|NCT02162667|12356837|P1|NOT COMPLETED|Adjuvant Period||12
5021642|NCT02162667|12356836|P2|COMPLETED|Adjuvant Period||255
5021643|NCT02162667|12356837|P1|COMPLETED|Adjuvant Period||248
5021644|NCT02162667|12356836|P2|STARTED|Adjuvant Period||268
5021645|NCT02162667|12356837|P1|STARTED|Adjuvant Period||260
5021646|NCT02162667|12356836|P2|NOT COMPLETED|Neoadjuvant Period||17
5021647|NCT02162667|12356837|P1|NOT COMPLETED|Neoadjuvant Period||14
5021648|NCT02162667|12356836|P2|COMPLETED|Neoadjuvant Period||267
5021649|NCT02162667|12356837|P1|COMPLETED|Neoadjuvant Period||264
5021650|NCT02162667|12356836|P2|STARTED|Neoadjuvant Period||284
5021651|NCT02162667|12356837|P1|STARTED|Neoadjuvant Period||278
5021652|NCT02162576|12356863|P1|NOT COMPLETED|Overall Study||0
5021653|NCT02162576|12356863|P1|COMPLETED|Overall Study||95
5021654|NCT02162576|12356863|P1|STARTED|Overall Study||95
5021655|NCT02162446|12356869|P1|NOT COMPLETED|Overall Study||0
5021656|NCT02162446|12356869|P1|COMPLETED|Overall Study||12
5021657|NCT02162446|12356869|P1|STARTED|Overall Study||12
5021658|NCT02162433|12356904|P4|NOT COMPLETED|Overall Study||1
5021659|NCT02162433|12356905|P3|NOT COMPLETED|Overall Study||2
5021660|NCT02162433|12356906|P2|NOT COMPLETED|Overall Study||2
5021661|NCT02162433|12356907|P1|NOT COMPLETED|Overall Study||1
5021662|NCT02162433|12356904|P4|COMPLETED|Overall Study||22
5021663|NCT02162433|12356905|P3|COMPLETED|Overall Study||21
5021664|NCT02162433|12356906|P2|COMPLETED|Overall Study||21
5021665|NCT02162433|12356907|P1|COMPLETED|Overall Study||22
5021666|NCT02162433|12356904|P4|STARTED|Overall Study||23
5021667|NCT02162433|12356905|P3|STARTED|Overall Study||23
5021668|NCT02162433|12356906|P2|STARTED|Overall Study||23
5021669|NCT02162433|12356907|P1|STARTED|Overall Study||23
5021670|NCT02161757|12356944|P3|NOT COMPLETED|Treatment Through Study Completion||39
5021671|NCT02161757|12356945|P2|NOT COMPLETED|Treatment Through Study Completion||43
5021672|NCT02161757|12356946|P1|NOT COMPLETED|Treatment Through Study Completion||57
5021673|NCT02161757|12356944|P3|COMPLETED|Treatment Through Study Completion||361
5021674|NCT02161757|12356945|P2|COMPLETED|Treatment Through Study Completion||361
5021675|NCT02161757|12356946|P1|COMPLETED|Treatment Through Study Completion||341
5021676|NCT02161757|12356944|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
5021677|NCT02161757|12356945|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
5021678|NCT02161757|12356946|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
5021679|NCT02161757|12356944|P3|STARTED|Treatment Through Study Completion||400
5021680|NCT02161757|12356945|P2|STARTED|Treatment Through Study Completion||404
5021681|NCT02161757|12356946|P1|STARTED|Treatment Through Study Completion||398
5021682|NCT02161757|12356944|P3|NOT COMPLETED|Randomised Through Start Treatment||0
5021683|NCT02161757|12356945|P2|NOT COMPLETED|Randomised Through Start Treatment||2
5021684|NCT02161757|12356946|P1|NOT COMPLETED|Randomised Through Start Treatment||3
5021685|NCT02161757|12356944|P3|COMPLETED|Randomised Through Start Treatment||400
5021686|NCT02161757|12356945|P2|COMPLETED|Randomised Through Start Treatment||404
5021687|NCT02161757|12356946|P1|COMPLETED|Randomised Through Start Treatment||398
5021688|NCT02161757|12356944|P3|STARTED|Randomised Through Start Treatment||400
5021689|NCT02161757|12356945|P2|STARTED|Randomised Through Start Treatment||406
5021690|NCT02161757|12356946|P1|STARTED|Randomised Through Start Treatment||401
5021691|NCT02161731|12357004|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
5021692|NCT02161731|12357005|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
5021693|NCT02161731|12357004|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
5021694|NCT02161731|12357005|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
5021695|NCT02161731|12357004|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
5021696|NCT02161731|12357005|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
5021697|NCT02161731|12357004|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
5021698|NCT02161731|12357005|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
5021699|NCT02161731|12357004|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
5021700|NCT02161731|12357005|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
5021701|NCT02161731|12357004|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
5021702|NCT02161731|12357005|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
5021703|NCT02161731|12357004|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
5021704|NCT02161731|12357005|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
5021705|NCT02161731|12357004|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
5021706|NCT02161731|12357005|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
5021707|NCT02161705|12357024|P2|NOT COMPLETED|Overall Study||0
5021708|NCT02161705|12357025|P1|NOT COMPLETED|Overall Study||0
5021709|NCT02161705|12357024|P2|COMPLETED|Overall Study||9
5021710|NCT02161705|12357025|P1|COMPLETED|Overall Study||9
5021711|NCT02161705|12357024|P2|STARTED|Overall Study||9
5021712|NCT02161705|12357025|P1|STARTED|Overall Study||9
5021713|NCT02161575|12357033|P1|NOT COMPLETED|Overall Study||11
5021714|NCT02161575|12357033|P1|COMPLETED|Overall Study||92
5021715|NCT02161575|12357033|P1|Safety (SAF) Population|Overall Study||100
5021716|NCT02161575|12357033|P1|Full Analysis Set (FAS) Population|Overall Study||100
5021717|NCT02161575|12357033|P1|STARTED|Overall Study||103
5021718|NCT02161562|12357053|P2|NOT COMPLETED|Overall Study||17
5021719|NCT02161562|12357054|P1|NOT COMPLETED|Overall Study||26
5021720|NCT02161562|12357053|P2|COMPLETED|Overall Study||119
5021721|NCT02161562|12357054|P1|COMPLETED|Overall Study||152
5021722|NCT02161562|12357053|P2|STARTED|Overall Study||136
5021723|NCT02161562|12357054|P1|STARTED|Overall Study||178
5021724|NCT02161549|12357082|P2|NOT COMPLETED|Overall Study||2
5021725|NCT02161549|12357083|P1|NOT COMPLETED|Overall Study||6
5021726|NCT02161549|12357082|P2|COMPLETED|Overall Study||29
5021727|NCT02161549|12357083|P1|COMPLETED|Overall Study||34
5021728|NCT02161549|12357082|P2|STARTED|Overall Study||31
5021729|NCT02161549|12357083|P1|STARTED|Overall Study||40
5021730|NCT02161536|12357092|P3|NOT COMPLETED|Overall Study||0
5021731|NCT02161536|12357093|P2|NOT COMPLETED|Overall Study||0
5021732|NCT02161536|12357094|P1|NOT COMPLETED|Overall Study||0
5021733|NCT02161536|12357092|P3|COMPLETED|Overall Study||20
5021734|NCT02161536|12357093|P2|COMPLETED|Overall Study||21
5021735|NCT02161536|12357094|P1|COMPLETED|Overall Study||6
5021736|NCT02161536|12357092|P3|STARTED|Overall Study||20
5021737|NCT02161536|12357093|P2|STARTED|Overall Study||21
5021738|NCT02161536|12357094|P1|STARTED|Overall Study||6
5021739|NCT02161484|12357104|P2|NOT COMPLETED|Overall Study||3
5021740|NCT02161484|12357105|P1|NOT COMPLETED|Overall Study||4
5021741|NCT02161484|12357104|P2|COMPLETED|Overall Study||2
5021742|NCT02161484|12357105|P1|COMPLETED|Overall Study||1
5021743|NCT02161484|12357104|P2|STARTED|Overall Study||5
5021744|NCT02161484|12357105|P1|STARTED|Overall Study||5
5021745|NCT02161458|12357131|P4|NOT COMPLETED|Overall Study||0
5021746|NCT02161458|12357132|P3|NOT COMPLETED|Overall Study||5
5021747|NCT02161458|12357133|P2|NOT COMPLETED|Overall Study||6
5021748|NCT02161458|12357134|P1|NOT COMPLETED|Overall Study||0
5021749|NCT02161458|12357131|P4|COMPLETED|Overall Study||8
5021750|NCT02161458|12357132|P3|COMPLETED|Overall Study||28
5021751|NCT02161458|12357133|P2|COMPLETED|Overall Study||29
5021752|NCT02161458|12357134|P1|COMPLETED|Overall Study||22
5021753|NCT02161458|12357131|P4|STARTED|Overall Study||8
5021754|NCT02161458|12357132|P3|STARTED|Overall Study||33
5021755|NCT02161458|12357133|P2|STARTED|Overall Study||35
5021756|NCT02161458|12357134|P1|STARTED|Overall Study||22
5021757|NCT02161406|12357146|P2|NOT COMPLETED|Overall Study||9
5021758|NCT02161406|12357147|P1|NOT COMPLETED|Overall Study||10
5021759|NCT02161406|12357146|P2|COMPLETED|Overall Study||35
5021760|NCT02161406|12357147|P1|COMPLETED|Overall Study||34
5021761|NCT02161406|12357146|P2|STARTED|Overall Study||44
5021762|NCT02161406|12357147|P1|STARTED|Overall Study||44
5021763|NCT02161185|12357221|P1|NOT COMPLETED|Treatment Phase||7
5021764|NCT02161185|12357221|P1|COMPLETED|Treatment Phase||0
5021765|NCT02161185|12357221|P1|STARTED|Treatment Phase||7
5021766|NCT02161185|12357221|P1|NOT COMPLETED|Test Dose Phase||0
5021767|NCT02161185|12357221|P1|COMPLETED|Test Dose Phase||7
5021768|NCT02161185|12357221|P1|STARTED|Test Dose Phase||7
5021769|NCT02161146|12357231|P5|NOT COMPLETED|Overall Study||1
5021770|NCT02161146|12357232|P4|NOT COMPLETED|Overall Study||3
5021771|NCT02161146|12357233|P3|NOT COMPLETED|Overall Study||0
5021772|NCT02161146|12357234|P2|NOT COMPLETED|Overall Study||4
5021773|NCT02161146|12357235|P1|NOT COMPLETED|Overall Study||1
5021774|NCT02161146|12357231|P5|COMPLETED|Overall Study||48
5021775|NCT02161146|12357232|P4|COMPLETED|Overall Study||45
5021776|NCT02161146|12357233|P3|COMPLETED|Overall Study||49
5021777|NCT02161146|12357234|P2|COMPLETED|Overall Study||43
5021778|NCT02161146|12357235|P1|COMPLETED|Overall Study||46
5021779|NCT02161146|12357231|P5|STARTED|Overall Study||49
5021780|NCT02161146|12357232|P4|STARTED|Overall Study||48
5021781|NCT02161146|12357233|P3|STARTED|Overall Study||49
5021782|NCT02161146|12357234|P2|STARTED|Overall Study||47
5021783|NCT02161146|12357235|P1|STARTED|Overall Study||47
5021784|NCT02161133|12357250|P2|NOT COMPLETED|Overall Study||11
5021785|NCT02161133|12357251|P1|NOT COMPLETED|Overall Study||19
5021786|NCT02161133|12357250|P2|COMPLETED|Overall Study||122
5021787|NCT02161133|12357251|P1|COMPLETED|Overall Study||116
5021788|NCT02161133|12357250|P2|STARTED|Overall Study||133
5021789|NCT02161133|12357251|P1|STARTED|Overall Study||135
5021790|NCT02161016|12357259|P1|NOT COMPLETED|Overall Study||1
5021791|NCT02161016|12357259|P1|COMPLETED|Overall Study||0
5021792|NCT02161016|12357259|P1|STARTED|Overall Study||1
5021793|NCT02160990|12357269|P2|NOT COMPLETED|Overall Study||0
5021794|NCT02160990|12357270|P1|NOT COMPLETED|Overall Study||0
5021795|NCT02160990|12357269|P2|COMPLETED|Overall Study||10
5021796|NCT02160990|12357270|P1|COMPLETED|Overall Study||10
5021797|NCT02160990|12357269|P2|STARTED|Overall Study||10
5021798|NCT02160990|12357270|P1|STARTED|Overall Study||10
5021799|NCT02160977|12357290|P2|NOT COMPLETED|Six Months After Surgery||1
5021800|NCT02160977|12357291|P1|NOT COMPLETED|Six Months After Surgery||2
5021801|NCT02160977|12357290|P2|COMPLETED|Six Months After Surgery||42
5021802|NCT02160977|12357291|P1|COMPLETED|Six Months After Surgery||42
5021803|NCT02160977|12357290|P2|STARTED|Six Months After Surgery||43
5021804|NCT02160977|12357291|P1|STARTED|Six Months After Surgery||44
5021805|NCT02160977|12357290|P2|NOT COMPLETED|Three Months After Surgery||2
5021806|NCT02160977|12357291|P1|NOT COMPLETED|Three Months After Surgery||0
5021807|NCT02160977|12357290|P2|COMPLETED|Three Months After Surgery||43
5021808|NCT02160977|12357291|P1|COMPLETED|Three Months After Surgery||44
5021809|NCT02160977|12357290|P2|STARTED|Three Months After Surgery||45
5021810|NCT02160977|12357291|P1|STARTED|Three Months After Surgery||44
5021811|NCT02160977|12357290|P2|NOT COMPLETED|Six Weeks After Surgery||0
5021812|NCT02160977|12357291|P1|NOT COMPLETED|Six Weeks After Surgery||1
5021813|NCT02160977|12357290|P2|COMPLETED|Six Weeks After Surgery||45
5021814|NCT02160977|12357291|P1|COMPLETED|Six Weeks After Surgery||44
5021815|NCT02160977|12357290|P2|STARTED|Six Weeks After Surgery||45
5021816|NCT02160977|12357291|P1|STARTED|Six Weeks After Surgery||45
5021817|NCT02160977|12357290|P2|NOT COMPLETED|One Week After Surgery||0
5021818|NCT02160977|12357291|P1|NOT COMPLETED|One Week After Surgery||0
5021819|NCT02160977|12357290|P2|COMPLETED|One Week After Surgery||45
5021820|NCT02160977|12357291|P1|COMPLETED|One Week After Surgery||45
5021821|NCT02160977|12357290|P2|STARTED|One Week After Surgery||45
5021822|NCT02160977|12357291|P1|STARTED|One Week After Surgery||45
5021823|NCT02160899|12357307|P6|NOT COMPLETED|Overall Study||0
5021824|NCT02160899|12357308|P5|NOT COMPLETED|Overall Study||2
5021825|NCT02160899|12357309|P4|NOT COMPLETED|Overall Study||1
5021826|NCT02160899|12357310|P3|NOT COMPLETED|Overall Study||0
5021827|NCT02160899|12357311|P2|NOT COMPLETED|Overall Study||1
5021828|NCT02160899|12357312|P1|NOT COMPLETED|Overall Study||0
5021829|NCT02160899|12357307|P6|COMPLETED|Overall Study||8
5021830|NCT02160899|12357308|P5|COMPLETED|Overall Study||0
5021831|NCT02160899|12357309|P4|COMPLETED|Overall Study||2
5021832|NCT02160899|12357310|P3|COMPLETED|Overall Study||21
5021833|NCT02160899|12357311|P2|COMPLETED|Overall Study||3
5021834|NCT02160899|12357312|P1|COMPLETED|Overall Study||26
5021835|NCT02160899|12357307|P6|STARTED|Overall Study||8
5021836|NCT02160899|12357308|P5|STARTED|Overall Study||2
5021837|NCT02160899|12357309|P4|STARTED|Overall Study||3
5021838|NCT02160899|12357310|P3|STARTED|Overall Study||21
5021839|NCT02160899|12357311|P2|STARTED|Overall Study||4
5021840|NCT02160899|12357312|P1|STARTED|Overall Study||26
5021841|NCT02160873|12357334|P2|NOT COMPLETED|Overall Study||0
5021842|NCT02160873|12357335|P1|NOT COMPLETED|Overall Study||0
5021843|NCT02160873|12357334|P2|COMPLETED|Overall Study||6
5021844|NCT02160873|12357335|P1|COMPLETED|Overall Study||6
5021845|NCT02160873|12357334|P2|STARTED|Overall Study||6
5021846|NCT02160873|12357335|P1|STARTED|Overall Study||6
5021847|NCT02160847|12357349|P2|NOT COMPLETED|Overall Study||0
5021848|NCT02160847|12357350|P1|NOT COMPLETED|Overall Study||0
5021849|NCT02160847|12357349|P2|COMPLETED|Overall Study||16
5021850|NCT02160847|12357350|P1|COMPLETED|Overall Study||16
5021851|NCT02160847|12357349|P2|STARTED|Overall Study||16
5021852|NCT02160847|12357350|P1|STARTED|Overall Study||16
5021853|NCT02160808|12357360|P2|NOT COMPLETED|Overall Study||0
5021854|NCT02160808|12357361|P1|NOT COMPLETED|Overall Study||0
5021855|NCT02160808|12357360|P2|COMPLETED|Overall Study||83
5021856|NCT02160808|12357361|P1|COMPLETED|Overall Study||87
5021857|NCT02160808|12357360|P2|STARTED|Overall Study||83
5021858|NCT02160808|12357361|P1|STARTED|Overall Study||87
5021859|NCT02160626|12357374|P3|NOT COMPLETED|Overall Study||1
5021860|NCT02160626|12357375|P2|NOT COMPLETED|Overall Study||1
5021861|NCT02160626|12357376|P1|NOT COMPLETED|Overall Study||1
5021862|NCT02160626|12357374|P3|COMPLETED|Overall Study||56
5021863|NCT02160626|12357375|P2|COMPLETED|Overall Study||56
5021864|NCT02160626|12357376|P1|COMPLETED|Overall Study||57
5021865|NCT02160626|12357374|P3|STARTED|Overall Study||57
5021866|NCT02160626|12357375|P2|STARTED|Overall Study||57
5021867|NCT02160626|12357376|P1|STARTED|Overall Study||58
5021868|NCT02160535|12357390|P1|NOT COMPLETED|Overall Study||3
5021869|NCT02160535|12357390|P1|COMPLETED|Overall Study||10
5021870|NCT02160535|12357390|P1|STARTED|Overall Study||13
5021871|NCT02160314|12357399|P2|NOT COMPLETED|Overall Study||13
5021872|NCT02160314|12357400|P1|NOT COMPLETED|Overall Study||1
5021873|NCT02160314|12357399|P2|COMPLETED|Overall Study||59
5021874|NCT02160314|12357400|P1|COMPLETED|Overall Study||72
5021875|NCT02160314|12357399|P2|STARTED|Overall Study||72
5021876|NCT02160314|12357400|P1|STARTED|Overall Study||73
5021877|NCT02160288|12357408|P2|NOT COMPLETED|Overall Study||0
5021878|NCT02160288|12357409|P1|NOT COMPLETED|Overall Study||0
5021879|NCT02160288|12357408|P2|COMPLETED|Overall Study||0
5021880|NCT02160288|12357409|P1|COMPLETED|Overall Study||1
5021881|NCT02160288|12357408|P2|STARTED|Overall Study||0
5021882|NCT02160288|12357409|P1|STARTED|Overall Study||1
5021883|NCT02160145|12357435|P3|NOT COMPLETED|Randomized Double-blind Period||28
5021884|NCT02160145|12357436|P2|NOT COMPLETED|Randomized Double-blind Period||29
5021885|NCT02160145|12357437|P1|NOT COMPLETED|Randomized Double-blind Period||0
5021886|NCT02160145|12357435|P3|COMPLETED|Randomized Double-blind Period||659
5021887|NCT02160145|12357436|P2|COMPLETED|Randomized Double-blind Period||654
5021888|NCT02160145|12357437|P1|COMPLETED|Randomized Double-blind Period||0
5021889|NCT02160145|12357435|P3|Off-treatment Completers|Randomized Double-blind Period||22
5021890|NCT02160145|12357436|P2|Off-treatment Completers|Randomized Double-blind Period||76
5021891|NCT02160145|12357437|P1|Off-treatment Completers|Randomized Double-blind Period||0
5021892|NCT02160145|12357435|P3|On-treatment Completers|Randomized Double-blind Period||637
5021893|NCT02160145|12357436|P2|On-treatment Completers|Randomized Double-blind Period||578
5021894|NCT02160145|12357437|P1|On-treatment Completers|Randomized Double-blind Period||0
5021895|NCT02160145|12357435|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
5021896|NCT02160145|12357436|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
5021897|NCT02160145|12357437|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
5021898|NCT02160145|12357435|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
5021899|NCT02160145|12357436|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
5021900|NCT02160145|12357437|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
5021901|NCT02160145|12357435|P3|COMPLETED|Prerandomization Single-blind Period||0
5021902|NCT02160145|12357436|P2|COMPLETED|Prerandomization Single-blind Period||0
5021903|NCT02160145|12357437|P1|COMPLETED|Prerandomization Single-blind Period||1370
5021904|NCT02160145|12357435|P3|Randomized|Prerandomization Single-blind Period||0
5021905|NCT02160145|12357436|P2|Randomized|Prerandomization Single-blind Period||0
5021906|NCT02160145|12357437|P1|Randomized|Prerandomization Single-blind Period||1370
5021907|NCT02160145|12357435|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
5021908|NCT02160145|12357436|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
5021909|NCT02160145|12357437|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
5021910|NCT02160145|12357435|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
5021911|NCT02160145|12357436|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
5021912|NCT02160145|12357437|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
5021913|NCT02160145|12357435|P3|STARTED|Prerandomization Single-blind Period||0
5021914|NCT02160145|12357436|P2|STARTED|Prerandomization Single-blind Period||0
5021915|NCT02160145|12357437|P1|STARTED|Prerandomization Single-blind Period||1519
5021916|NCT02160041|12357450|P1|NOT COMPLETED|Overall Study||84
5021917|NCT02160041|12357450|P1|COMPLETED|Overall Study||0
5021918|NCT02160041|12357450|P1|STARTED|Overall Study||84
5021919|NCT02160002|12357462|P2|NOT COMPLETED|Overall Study||1
5021920|NCT02160002|12357463|P1|NOT COMPLETED|Overall Study||2
5021921|NCT02160002|12357462|P2|COMPLETED|Overall Study||178
5021922|NCT02160002|12357463|P1|COMPLETED|Overall Study||185
5021923|NCT02160002|12357462|P2|Primary Outcome|Overall Study||178
5021924|NCT02160002|12357463|P1|Primary Outcome|Overall Study||185
5021925|NCT02160002|12357462|P2|STARTED|Overall Study||179
5021926|NCT02160002|12357463|P1|STARTED|Overall Study||187
5021927|NCT02159976|12357495|P2|NOT COMPLETED|Overall Study||25
5021928|NCT02159976|12357496|P1|NOT COMPLETED|Overall Study||30
5021929|NCT02159976|12357495|P2|COMPLETED|Overall Study||170
5021930|NCT02159976|12357496|P1|COMPLETED|Overall Study||165
5021931|NCT02159976|12357495|P2|STARTED|Overall Study||195
5021932|NCT02159976|12357496|P1|STARTED|Overall Study||195
5021933|NCT02159950|12357510|P2|NOT COMPLETED|Overall Study||2
5021934|NCT02159950|12357511|P1|NOT COMPLETED|Overall Study||0
5021935|NCT02159950|12357510|P2|COMPLETED|Overall Study||0
5021936|NCT02159950|12357511|P1|COMPLETED|Overall Study||0
5021937|NCT02159950|12357510|P2|STARTED|Overall Study||2
5021938|NCT02159950|12357511|P1|STARTED|Overall Study||0
5021939|NCT02159898|12357545|P2|NOT COMPLETED|Overall Study||0
5021940|NCT02159898|12357546|P1|NOT COMPLETED|Overall Study||1
5021941|NCT02159898|12357545|P2|COMPLETED|Overall Study||30
5021942|NCT02159898|12357546|P1|COMPLETED|Overall Study||29
5021943|NCT02159898|12357545|P2|STARTED|Overall Study||30
5021944|NCT02159898|12357546|P1|STARTED|Overall Study||30
5021945|NCT02159859|12357554|P1|NOT COMPLETED|Overall Study||0
5021946|NCT02159859|12357554|P1|COMPLETED|Overall Study||7
5021947|NCT02159859|12357554|P1|STARTED|Overall Study||7
5021948|NCT02159807|12357570|P3|NOT COMPLETED|Overall Study||3
5021949|NCT02159807|12357571|P2|NOT COMPLETED|Overall Study||1
5021950|NCT02159807|12357572|P1|NOT COMPLETED|Overall Study||1
5021951|NCT02159807|12357570|P3|COMPLETED|Overall Study||48
5021952|NCT02159807|12357571|P2|COMPLETED|Overall Study||51
5021953|NCT02159807|12357572|P1|COMPLETED|Overall Study||66
5021954|NCT02159807|12357570|P3|STARTED|Overall Study||51
5021955|NCT02159807|12357571|P2|STARTED|Overall Study||52
5021956|NCT02159807|12357572|P1|STARTED|Overall Study||67
5021957|NCT02159768|12357586|P1|NOT COMPLETED|Overall Study||0
5021958|NCT02159768|12357586|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
5021959|NCT02159768|12357586|P1|STARTED|Overall Study|Started 16 July 2014|30
5021960|NCT02159729|12357593|P2|NOT COMPLETED|Overall Study||21
5021961|NCT02159729|12357594|P1|NOT COMPLETED|Overall Study||42
5021962|NCT02159729|12357593|P2|COMPLETED|Overall Study||44
5021963|NCT02159729|12357594|P1|COMPLETED|Overall Study||98
5021964|NCT02159729|12357593|P2|STARTED|Overall Study||65
5021965|NCT02159729|12357594|P1|STARTED|Overall Study||140
5021966|NCT02159703|12357606|P1|NOT COMPLETED|Overall Study||0
5021967|NCT02159703|12357606|P1|COMPLETED|Overall Study||60
5021968|NCT02159703|12357606|P1|STARTED|Overall Study||60
5021969|NCT02159547|12357612|P2|NOT COMPLETED|Overall Study||0
5021970|NCT02159547|12357613|P1|NOT COMPLETED|Overall Study||0
5021971|NCT02159547|12357612|P2|COMPLETED|Overall Study||112
5021972|NCT02159547|12357613|P1|COMPLETED|Overall Study||112
5021973|NCT02159547|12357612|P2|STARTED|Overall Study||112
5021974|NCT02159547|12357613|P1|STARTED|Overall Study||112
5021975|NCT02159521|12357621|P1|NOT COMPLETED|Overall Study||18
5021976|NCT02159521|12357621|P1|COMPLETED|Overall Study||63
5021977|NCT02159521|12357621|P1|Received EkoSonic® Treatment|Overall Study||78
5021978|NCT02159521|12357621|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
5021979|NCT02159482|12357642|P1|NOT COMPLETED|Overall Study||5
5021980|NCT02159482|12357642|P1|COMPLETED|Overall Study||6
5021981|NCT02159482|12357642|P1|STARTED|Overall Study||11
5021982|NCT02159469|12357647|P1|NOT COMPLETED|Overall Study||53
5021983|NCT02159469|12357647|P1|COMPLETED|Overall Study||97
5021984|NCT02159469|12357647|P1|Completed 12 Week|Overall Study||137
5021985|NCT02159469|12357647|P1|STARTED|Overall Study||150
5021986|NCT02159365|12357652|P1|NOT COMPLETED|Overall Study||70
5021987|NCT02159365|12357652|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
5021988|NCT02159365|12357652|P1|STARTED|Overall Study||70
5021989|NCT02159352|12357659|P2|NOT COMPLETED|Overall Study||2
5021990|NCT02159352|12357660|P1|NOT COMPLETED|Overall Study||3
5021991|NCT02159352|12357659|P2|COMPLETED|Overall Study||12
5021992|NCT02159352|12357660|P1|COMPLETED|Overall Study||11
5021993|NCT02159352|12357659|P2|Phase 2 (Day 5-14)|Overall Study||12
5021994|NCT02159352|12357660|P1|Phase 2 (Day 5-14)|Overall Study||11
5021995|NCT02159352|12357659|P2|Phase 1 (Day 1- 4)|Overall Study||14
5021996|NCT02159352|12357660|P1|Phase 1 (Day 1- 4)|Overall Study||14
5021997|NCT02159352|12357659|P2|STARTED|Overall Study||14
5021998|NCT02159352|12357660|P1|STARTED|Overall Study||14
5021999|NCT02159183|12357712|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
5022000|NCT02159183|12357713|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
5022001|NCT02159183|12357712|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
5022002|NCT02159183|12357713|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
5022003|NCT02159183|12357712|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
5022004|NCT02159183|12357713|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
5022005|NCT02159183|12357712|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
5022006|NCT02159183|12357713|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
5022007|NCT02159183|12357712|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
5022008|NCT02159183|12357713|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
5022009|NCT02159183|12357712|P2|STARTED|Analysis After the 36 Months Follow-up||21
5022010|NCT02159183|12357713|P1|STARTED|Analysis After the 36 Months Follow-up||22
5022011|NCT02159118|12357739|P2|NOT COMPLETED|Overall Study||0
5022012|NCT02159118|12357740|P1|NOT COMPLETED|Overall Study||0
5022013|NCT02159118|12357739|P2|COMPLETED|Overall Study||22
5022014|NCT02159118|12357740|P1|COMPLETED|Overall Study||22
5022015|NCT02159118|12357739|P2|STARTED|Overall Study||22
5022016|NCT02159118|12357740|P1|STARTED|Overall Study||22
5022017|NCT02159079|12357764|P2|NOT COMPLETED|Overall Study||0
5022018|NCT02159079|12357765|P1|NOT COMPLETED|Overall Study||0
5022019|NCT02159079|12357764|P2|COMPLETED|Overall Study||15
5022020|NCT02159079|12357765|P1|COMPLETED|Overall Study||15
5022021|NCT02159079|12357764|P2|STARTED|Overall Study||15
5022022|NCT02159079|12357765|P1|STARTED|Overall Study||15
5022023|NCT02159053|12357786|P3|NOT COMPLETED|Overall Study||20
5022024|NCT02159053|12357787|P2|NOT COMPLETED|Overall Study||21
5022025|NCT02159053|12357788|P1|NOT COMPLETED|Overall Study||20
5022026|NCT02159053|12357786|P3|COMPLETED|Overall Study||97
5022027|NCT02159053|12357787|P2|COMPLETED|Overall Study||96
5022028|NCT02159053|12357788|P1|COMPLETED|Overall Study||96
5022029|NCT02159053|12357786|P3|Paticipants Week 16 Onwards|Overall Study||113
5022030|NCT02159053|12357787|P2|Paticipants Week 16 Onwards|Overall Study||117
5022031|NCT02159053|12357788|P1|Paticipants Week 16 Onwards|Overall Study||116
5022032|NCT02159053|12357786|P3|STARTED|Overall Study||117
5022033|NCT02159053|12357787|P2|STARTED|Overall Study||117
5022034|NCT02159053|12357788|P1|STARTED|Overall Study||116
5022035|NCT02159040|12357825|P1|NOT COMPLETED|Overall Study||1
5022036|NCT02159040|12357825|P1|COMPLETED|Overall Study||0
5022037|NCT02159040|12357825|P1|STARTED|Overall Study||1
5022038|NCT02158975|12357838|P1|NOT COMPLETED|Overall Study||1
5022039|NCT02158975|12357838|P1|COMPLETED|Overall Study||12
5022040|NCT02158975|12357838|P1|STARTED|Overall Study||13
5022041|NCT02158949|12357848|P2|NOT COMPLETED|Overall Study||11
5022042|NCT02158949|12357849|P1|NOT COMPLETED|Overall Study||6
5022043|NCT02158949|12357848|P2|COMPLETED|Overall Study||13
5022044|NCT02158949|12357849|P1|COMPLETED|Overall Study||18
5022045|NCT02158949|12357848|P2|STARTED|Overall Study||24
5022046|NCT02158949|12357849|P1|STARTED|Overall Study||24
5022047|NCT02158936|12357865|P2|NOT COMPLETED|Overall Study||177
5022048|NCT02158936|12357866|P1|NOT COMPLETED|Overall Study||179
5022049|NCT02158936|12357865|P2|COMPLETED|Overall Study||0
5022050|NCT02158936|12357866|P1|COMPLETED|Overall Study||0
5022051|NCT02158936|12357865|P2|Untreated|Overall Study||0
5022052|NCT02158936|12357866|P1|Untreated|Overall Study||2
5022053|NCT02158936|12357865|P2|Treated|Overall Study||177
5022054|NCT02158936|12357866|P1|Treated|Overall Study||177
5022055|NCT02158936|12357865|P2|STARTED|Overall Study||177
5022056|NCT02158936|12357866|P1|STARTED|Overall Study||179
5022057|NCT02158884|12357908|P1|NOT COMPLETED|12 Month Assessment||17
5022058|NCT02158884|12357908|P1|COMPLETED|12 Month Assessment||64
5022059|NCT02158884|12357908|P1|STARTED|12 Month Assessment||81
5022060|NCT02158884|12357908|P1|NOT COMPLETED|6 Month Assessment||20
5022061|NCT02158884|12357908|P1|COMPLETED|6 Month Assessment||61
5022062|NCT02158884|12357908|P1|STARTED|6 Month Assessment||81
5022063|NCT02158884|12357908|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
5022064|NCT02158884|12357908|P1|COMPLETED|Post Intervention (~4 Weeks)||71
5022065|NCT02158884|12357908|P1|STARTED|Post Intervention (~4 Weeks)||81
5022066|NCT02158884|12357908|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
5022067|NCT02158884|12357908|P1|COMPLETED|Intervention: IDEO and PT Program||81
5022068|NCT02158884|12357908|P1|STARTED|Intervention: IDEO and PT Program||87
5022069|NCT02158884|12357908|P1|NOT COMPLETED|Baseline Assessment||4
5022070|NCT02158884|12357908|P1|COMPLETED|Baseline Assessment||87
5022071|NCT02158884|12357908|P1|STARTED|Baseline Assessment||91
5022072|NCT02158806|12357943|P2|NOT COMPLETED|Overall Study||5
5022073|NCT02158806|12357944|P1|NOT COMPLETED|Overall Study||4
5022074|NCT02158806|12357943|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
5022075|NCT02158806|12357944|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
5022076|NCT02158806|12357943|P2|STARTED|Overall Study||126
5022077|NCT02158806|12357944|P1|STARTED|Overall Study||125
5022078|NCT02158728|12357964|P1|NOT COMPLETED|Overall Study||27
5022079|NCT02158728|12357964|P1|COMPLETED|Overall Study||53
5022080|NCT02158728|12357964|P1|STARTED|Overall Study||80
5022081|NCT02158663|12357970|P2|NOT COMPLETED|Overall Study||4
5022082|NCT02158663|12357971|P1|NOT COMPLETED|Overall Study||5
5022083|NCT02158663|12357970|P2|COMPLETED|Overall Study||18
5022084|NCT02158663|12357971|P1|COMPLETED|Overall Study||17
5022085|NCT02158663|12357970|P2|STARTED|Overall Study||22
5022086|NCT02158663|12357971|P1|STARTED|Overall Study||22
5022087|NCT02158572|12357979|P1|NOT COMPLETED|Overall Study||1043
5022088|NCT02158572|12357979|P1|COMPLETED|Overall Study||989
5022089|NCT02158572|12357979|P1|STARTED|Overall Study||2032
5022090|NCT02158546|12357994|P4|NOT COMPLETED|Overall Study||6
5022091|NCT02158546|12357995|P3|NOT COMPLETED|Overall Study||4
5022092|NCT02158546|12357996|P2|NOT COMPLETED|Overall Study||17
5022093|NCT02158546|12357997|P1|NOT COMPLETED|Overall Study||19
5022094|NCT02158546|12357994|P4|COMPLETED|Overall Study||13
5022095|NCT02158546|12357995|P3|COMPLETED|Overall Study||14
5022096|NCT02158546|12357996|P2|COMPLETED|Overall Study||136
5022097|NCT02158546|12357997|P1|COMPLETED|Overall Study||133
5022098|NCT02158546|12357994|P4|STARTED|Overall Study||19
5022099|NCT02158546|12357995|P3|STARTED|Overall Study||18
5022100|NCT02158546|12357996|P2|STARTED|Overall Study||153
5022101|NCT02158546|12357997|P1|STARTED|Overall Study||152
5022102|NCT02158533|12358016|P6|NOT COMPLETED|Stage 2||6
5022103|NCT02158533|12358017|P5|NOT COMPLETED|Stage 2||4
5022104|NCT02158533|12358018|P4|NOT COMPLETED|Stage 2||3
5022105|NCT02158533|12358019|P3|NOT COMPLETED|Stage 2||0
5022106|NCT02158533|12358020|P2|NOT COMPLETED|Stage 2||0
5022107|NCT02158533|12358021|P1|NOT COMPLETED|Stage 2||0
5022108|NCT02158533|12358016|P6|COMPLETED|Stage 2||50
5022109|NCT02158533|12358017|P5|COMPLETED|Stage 2||52
5022110|NCT02158533|12358018|P4|COMPLETED|Stage 2||53
5022111|NCT02158533|12358019|P3|COMPLETED|Stage 2||0
5022112|NCT02158533|12358020|P2|COMPLETED|Stage 2||0
5022113|NCT02158533|12358021|P1|COMPLETED|Stage 2||0
5022114|NCT02158533|12358016|P6|STARTED|Stage 2||56
5022115|NCT02158533|12358017|P5|STARTED|Stage 2||56
5022116|NCT02158533|12358018|P4|STARTED|Stage 2||56
5022117|NCT02158533|12358019|P3|STARTED|Stage 2||0
5022118|NCT02158533|12358020|P2|STARTED|Stage 2||0
5022119|NCT02158533|12358021|P1|STARTED|Stage 2||0
5022120|NCT02158533|12358016|P6|NOT COMPLETED|Stage 1||0
5022121|NCT02158533|12358017|P5|NOT COMPLETED|Stage 1||0
5022122|NCT02158533|12358018|P4|NOT COMPLETED|Stage 1||0
5022123|NCT02158533|12358019|P3|NOT COMPLETED|Stage 1||8
5022124|NCT02158533|12358020|P2|NOT COMPLETED|Stage 1||8
5022125|NCT02158533|12358021|P1|NOT COMPLETED|Stage 1||14
5022126|NCT02158533|12358016|P6|COMPLETED|Stage 1||0
5022127|NCT02158533|12358017|P5|COMPLETED|Stage 1||0
5022128|NCT02158533|12358018|P4|COMPLETED|Stage 1||0
5022129|NCT02158533|12358019|P3|COMPLETED|Stage 1||52
5022130|NCT02158533|12358020|P2|COMPLETED|Stage 1||51
5022131|NCT02158533|12358021|P1|COMPLETED|Stage 1||251
5022132|NCT02158533|12358016|P6|STARTED|Stage 1||0
5022133|NCT02158533|12358017|P5|STARTED|Stage 1||0
5022134|NCT02158533|12358018|P4|STARTED|Stage 1||0
5022135|NCT02158533|12358019|P3|STARTED|Stage 1||60
5022136|NCT02158533|12358020|P2|STARTED|Stage 1||59
5022137|NCT02158533|12358021|P1|STARTED|Stage 1||265
5022138|NCT02158520|12358055|P2|NOT COMPLETED|Overall Study||0
5022139|NCT02158520|12358056|P1|NOT COMPLETED|Overall Study||0
5022140|NCT02158520|12358055|P2|COMPLETED|Overall Study||12
5022141|NCT02158520|12358056|P1|COMPLETED|Overall Study||12
5022142|NCT02158520|12358055|P2|Crossover Cohort|Overall Study||6
5022143|NCT02158520|12358056|P1|Crossover Cohort|Overall Study||4
5022144|NCT02158520|12358055|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
5022145|NCT02158520|12358056|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
5022146|NCT02158520|12358055|P2|Eligible for Crossover|Overall Study||8
5022147|NCT02158520|12358056|P1|Eligible for Crossover|Overall Study||8
5022148|NCT02158520|12358055|P2|AE Evaluated Prior to Crossover|Overall Study||12
5022149|NCT02158520|12358056|P1|AE Evaluated Prior to Crossover|Overall Study||12
5022150|NCT02158520|12358055|P2|STARTED|Overall Study||12
5022151|NCT02158520|12358056|P1|STARTED|Overall Study||12
5022152|NCT02158494|12358072|P2|NOT COMPLETED|Overall Study||1
5022153|NCT02158494|12358073|P1|NOT COMPLETED|Overall Study||0
5022154|NCT02158494|12358072|P2|COMPLETED|Overall Study||21
5022155|NCT02158494|12358073|P1|COMPLETED|Overall Study||22
5022156|NCT02158494|12358072|P2|STARTED|Overall Study||22
5022157|NCT02158494|12358073|P1|STARTED|Overall Study||22
5022158|NCT02158442|12358097|P2|NOT COMPLETED|Overall Study||0
5022159|NCT02158442|12358098|P1|NOT COMPLETED|Overall Study||2
5022160|NCT02158442|12358097|P2|COMPLETED|Overall Study||7
5022161|NCT02158442|12358098|P1|COMPLETED|Overall Study||6
5022162|NCT02158442|12358097|P2|STARTED|Overall Study||7
5022163|NCT02158442|12358098|P1|STARTED|Overall Study||8
5022164|NCT02158364|12358104|P1|NOT COMPLETED|Overall Study||60
5022165|NCT02158364|12358104|P1|COMPLETED|Overall Study||3271
5022166|NCT02158364|12358104|P1|STARTED|Overall Study||3331
5022167|NCT02158273|12358111|P2|NOT COMPLETED|Overall Study||3
5022168|NCT02158273|12358112|P1|NOT COMPLETED|Overall Study||3
5022169|NCT02158273|12358111|P2|COMPLETED|Overall Study||22
5022170|NCT02158273|12358112|P1|COMPLETED|Overall Study||22
5022171|NCT02158273|12358111|P2|STARTED|Overall Study||25
5022172|NCT02158273|12358112|P1|STARTED|Overall Study||25
5022173|NCT02158247|12358122|P1|NOT COMPLETED|Overall Study||5
5022174|NCT02158247|12358122|P1|COMPLETED|Overall Study||176
5022175|NCT02158247|12358122|P1|STARTED|Overall Study||181
5022176|NCT02158091|12358141|P3|NOT COMPLETED|Overall Study||0
5022177|NCT02158091|12358142|P2|NOT COMPLETED|Overall Study||1
5022178|NCT02158091|12358143|P1|NOT COMPLETED|Overall Study||2
5022179|NCT02158091|12358141|P3|COMPLETED|Overall Study||20
5022180|NCT02158091|12358142|P2|COMPLETED|Overall Study||5
5022181|NCT02158091|12358143|P1|COMPLETED|Overall Study||4
5022182|NCT02158091|12358141|P3|STARTED|Overall Study||20
5022183|NCT02158091|12358142|P2|STARTED|Overall Study||6
5022184|NCT02158091|12358143|P1|STARTED|Overall Study||6
5022185|NCT02158039|12358151|P1|NOT COMPLETED|Overall Study||10
5022186|NCT02158039|12358151|P1|COMPLETED|Overall Study||23
5022187|NCT02158039|12358151|P1|STARTED|Overall Study||33
5022188|NCT02157948|12358158|P2|NOT COMPLETED|Overall Study||9
5022189|NCT02157948|12358159|P1|NOT COMPLETED|Overall Study||9
5022190|NCT02157948|12358158|P2|COMPLETED|Overall Study||188
5022191|NCT02157948|12358159|P1|COMPLETED|Overall Study||188
5022192|NCT02157948|12358158|P2|Received Treatment|Overall Study||196
5022193|NCT02157948|12358159|P1|Received Treatment|Overall Study||196
5022194|NCT02157948|12358158|P2|STARTED|Overall Study||197
5022195|NCT02157948|12358159|P1|STARTED|Overall Study||197
5022196|NCT02157935|12358171|P2|NOT COMPLETED|Overall Study||65
5022197|NCT02157935|12358172|P1|NOT COMPLETED|Overall Study||39
5022198|NCT02157935|12358171|P2|COMPLETED|Overall Study||548
5022199|NCT02157935|12358172|P1|COMPLETED|Overall Study||567
5022200|NCT02157935|12358171|P2|STARTED|Overall Study||613
5022201|NCT02157935|12358172|P1|STARTED|Overall Study||606
5022202|NCT02157909|12358190|P2|NOT COMPLETED|Overall Study||0
5022203|NCT02157909|12358191|P1|NOT COMPLETED|Overall Study||0
5022204|NCT02157909|12358190|P2|COMPLETED|Overall Study||66
5022205|NCT02157909|12358191|P1|COMPLETED|Overall Study||66
5022206|NCT02157909|12358190|P2|STARTED|Overall Study||66
5022207|NCT02157909|12358191|P1|STARTED|Overall Study||66
5022208|NCT02157883|12358198|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
5022209|NCT02157883|12358198|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
5022210|NCT02157883|12358198|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
5022211|NCT02157883|12358198|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
5022212|NCT02157883|12358198|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
5022213|NCT02157883|12358198|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
5022214|NCT02157883|12358198|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
5022215|NCT02157883|12358198|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
5022216|NCT02157883|12358198|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
5022217|NCT02157779|12358229|P2|NOT COMPLETED|Overall Study||11
5022218|NCT02157779|12358230|P1|NOT COMPLETED|Overall Study||24
5022219|NCT02157779|12358229|P2|COMPLETED|Overall Study||34
5022220|NCT02157779|12358230|P1|COMPLETED|Overall Study||23
5022221|NCT02157779|12358229|P2|STARTED|Overall Study||45
5022222|NCT02157779|12358230|P1|STARTED|Overall Study||47
5022223|NCT02157623|12358252|P1|NOT COMPLETED|Overall Study||0
5022224|NCT02157623|12358252|P1|COMPLETED|Overall Study||3
5022225|NCT02157623|12358252|P1|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
5022226|NCT02157519|12358264|P2|NOT COMPLETED|Overall Study||1
5022227|NCT02157519|12358265|P1|NOT COMPLETED|Overall Study||11
5022228|NCT02157519|12358264|P2|COMPLETED|Overall Study||89
5022229|NCT02157519|12358265|P1|COMPLETED|Overall Study||80
5022230|NCT02157519|12358264|P2|MEMScap Collected|Overall Study||86
5022231|NCT02157519|12358265|P1|MEMScap Collected|Overall Study||84
5022232|NCT02157519|12358264|P2|STARTED|Overall Study||90
5022233|NCT02157519|12358265|P1|STARTED|Overall Study||91
5022234|NCT02157506|12358288|P5|NOT COMPLETED|Overall Study||0
5022235|NCT02157506|12358289|P4|NOT COMPLETED|Overall Study||0
5022236|NCT02157506|12358290|P3|NOT COMPLETED|Overall Study||1
5022237|NCT02157506|12358291|P2|NOT COMPLETED|Overall Study||1
5022238|NCT02157506|12358292|P1|NOT COMPLETED|Overall Study||0
5022239|NCT02157506|12358288|P5|COMPLETED|Overall Study||7
5022240|NCT02157506|12358289|P4|COMPLETED|Overall Study||12
5022241|NCT02157506|12358290|P3|COMPLETED|Overall Study||8
5022242|NCT02157506|12358291|P2|COMPLETED|Overall Study||5
5022243|NCT02157506|12358292|P1|COMPLETED|Overall Study||12
5022244|NCT02157506|12358288|P5|STARTED|Overall Study||7
5022245|NCT02157506|12358289|P4|STARTED|Overall Study||12
5022246|NCT02157506|12358290|P3|STARTED|Overall Study||9
5022247|NCT02157506|12358291|P2|STARTED|Overall Study||6
5022248|NCT02157506|12358292|P1|STARTED|Overall Study||12
5022249|NCT02157376|12358351|P2|NOT COMPLETED|Overall Study||18
5022250|NCT02157376|12358352|P1|NOT COMPLETED|Overall Study||22
5022251|NCT02157376|12358351|P2|COMPLETED|Overall Study||138
5022252|NCT02157376|12358352|P1|COMPLETED|Overall Study||133
5022253|NCT02157376|12358351|P2|STARTED|Overall Study||156
5022254|NCT02157376|12358352|P1|STARTED|Overall Study||155
5022255|NCT02157298|12358362|P2|NOT COMPLETED|Overall Study||2
5022256|NCT02157298|12358363|P1|NOT COMPLETED|Overall Study||4
5022257|NCT02157298|12358362|P2|COMPLETED|Overall Study||58
5022258|NCT02157298|12358363|P1|COMPLETED|Overall Study||119
5022259|NCT02157298|12358362|P2|STARTED|Overall Study||60
5022260|NCT02157298|12358363|P1|STARTED|Overall Study||123
5022261|NCT02157168|12358380|P3|NOT COMPLETED|Overall Study||0
5022262|NCT02157168|12358381|P2|NOT COMPLETED|Overall Study||0
5022263|NCT02157168|12358382|P1|NOT COMPLETED|Overall Study||0
5022264|NCT02157168|12358380|P3|COMPLETED|Overall Study||1362
5022265|NCT02157168|12358381|P2|COMPLETED|Overall Study||159
5022266|NCT02157168|12358382|P1|COMPLETED|Overall Study||746
5022267|NCT02157168|12358380|P3|STARTED|Overall Study||1362
5022268|NCT02157168|12358381|P2|STARTED|Overall Study||159
5022269|NCT02157168|12358382|P1|STARTED|Overall Study||746
5022270|NCT02157116|12358402|P1|NOT COMPLETED|Overall Study||9
5022271|NCT02157116|12358402|P1|COMPLETED|Overall Study||4
5022272|NCT02157116|12358402|P1|STARTED|Overall Study|signed consent form|13
5022273|NCT02157103|12358411|P1|NOT COMPLETED|Overall Study||0
5022274|NCT02157103|12358411|P1|COMPLETED|Overall Study||3
5022275|NCT02157103|12358411|P1|STARTED|Overall Study||3
5022276|NCT02156804|12358417|P1|NOT COMPLETED|Overall Study||1
5022277|NCT02156804|12358417|P1|COMPLETED|Overall Study||1008
5022278|NCT02156804|12358417|P1|STARTED|Overall Study||1009
5022279|NCT02156492|12358428|P3|NOT COMPLETED|Period 3||0
5022280|NCT02156492|12358429|P2|NOT COMPLETED|Period 3||1
5022281|NCT02156492|12358430|P1|NOT COMPLETED|Period 3||0
5022282|NCT02156492|12358428|P3|COMPLETED|Period 3||22
5022283|NCT02156492|12358429|P2|COMPLETED|Period 3||22
5022284|NCT02156492|12358430|P1|COMPLETED|Period 3||0
5022285|NCT02156492|12358428|P3|STARTED|Period 3||22
5022286|NCT02156492|12358429|P2|STARTED|Period 3||23
5022287|NCT02156492|12358430|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
5022288|NCT02156492|12358428|P3|NOT COMPLETED|Period 2||0
5022289|NCT02156492|12358429|P2|NOT COMPLETED|Period 2||0
5022290|NCT02156492|12358430|P1|NOT COMPLETED|Period 2||0
5022291|NCT02156492|12358428|P3|COMPLETED|Period 2||22
5022292|NCT02156492|12358429|P2|COMPLETED|Period 2||23
5022293|NCT02156492|12358430|P1|COMPLETED|Period 2||16
5022294|NCT02156492|12358428|P3|STARTED|Period 2||22
5022295|NCT02156492|12358429|P2|STARTED|Period 2||23
5022296|NCT02156492|12358430|P1|STARTED|Period 2||16
5022297|NCT02156492|12358428|P3|NOT COMPLETED|Period 1||0
5022298|NCT02156492|12358429|P2|NOT COMPLETED|Period 1||1
5022299|NCT02156492|12358430|P1|NOT COMPLETED|Period 1||0
5022300|NCT02156492|12358428|P3|COMPLETED|Period 1||22
5022301|NCT02156492|12358429|P2|COMPLETED|Period 1||23
5022302|NCT02156492|12358430|P1|COMPLETED|Period 1||16
5022303|NCT02156492|12358428|P3|Received at Least One Dose of Study Drug|Period 1||22
5022304|NCT02156492|12358429|P2|Received at Least One Dose of Study Drug|Period 1||24
5022305|NCT02156492|12358430|P1|Received at Least One Dose of Study Drug|Period 1||16
5022306|NCT02156492|12358428|P3|STARTED|Period 1||22
5022307|NCT02156492|12358429|P2|STARTED|Period 1||24
5022308|NCT02156492|12358430|P1|STARTED|Period 1||16
5022309|NCT02156466|12358456|P5|NOT COMPLETED|Overall Study||0
5022310|NCT02156466|12358457|P4|NOT COMPLETED|Overall Study||2
5022311|NCT02156466|12358458|P3|NOT COMPLETED|Overall Study||1
5022312|NCT02156466|12358459|P2|NOT COMPLETED|Overall Study||0
5022313|NCT02156466|12358460|P1|NOT COMPLETED|Overall Study||0
5022314|NCT02156466|12358456|P5|COMPLETED|Overall Study||8
5022315|NCT02156466|12358457|P4|COMPLETED|Overall Study||7
5022316|NCT02156466|12358458|P3|COMPLETED|Overall Study||7
5022317|NCT02156466|12358459|P2|COMPLETED|Overall Study||8
5022318|NCT02156466|12358460|P1|COMPLETED|Overall Study||8
5022319|NCT02156466|12358456|P5|STARTED|Overall Study||8
5022320|NCT02156466|12358457|P4|STARTED|Overall Study||9
5022321|NCT02156466|12358458|P3|STARTED|Overall Study||8
5022322|NCT02156466|12358459|P2|STARTED|Overall Study||8
5022323|NCT02156466|12358460|P1|STARTED|Overall Study||8
5022324|NCT02156271|12358641|P2|NOT COMPLETED|Overall Study||3
5022325|NCT02156271|12358642|P1|NOT COMPLETED|Overall Study||4
5022326|NCT02156271|12358641|P2|COMPLETED|Overall Study||10
5022327|NCT02156271|12358642|P1|COMPLETED|Overall Study||22
5022328|NCT02156271|12358641|P2|STARTED|Overall Study||13
5022329|NCT02156271|12358642|P1|STARTED|Overall Study||26
5022330|NCT02156258|12358677|P3|NOT COMPLETED|Overall Study||111
5022331|NCT02156258|12358678|P2|NOT COMPLETED|Overall Study||79
5022332|NCT02156258|12358679|P1|NOT COMPLETED|Overall Study||32
5022333|NCT02156258|12358677|P3|COMPLETED|Overall Study||244
5022334|NCT02156258|12358678|P2|COMPLETED|Overall Study||124
5022335|NCT02156258|12358679|P1|COMPLETED|Overall Study||642
5022336|NCT02156258|12358677|P3|STARTED|Overall Study||355
5022337|NCT02156258|12358678|P2|STARTED|Overall Study||203
5022338|NCT02156258|12358679|P1|STARTED|Overall Study||674
5022339|NCT02156167|12358687|P1|NOT COMPLETED|Overall Study||0
5022340|NCT02156167|12358687|P1|COMPLETED|Overall Study||15
5022341|NCT02156167|12358687|P1|STARTED|Overall Study||15
5022342|NCT02156076|12358695|P4|NOT COMPLETED|Follow-up Period||0
5022343|NCT02156076|12358696|P3|NOT COMPLETED|Follow-up Period||0
5022344|NCT02156076|12358697|P2|NOT COMPLETED|Follow-up Period||0
5022345|NCT02156076|12358698|P1|NOT COMPLETED|Follow-up Period||1
5022346|NCT02156076|12358695|P4|COMPLETED|Follow-up Period||4
5022347|NCT02156076|12358696|P3|COMPLETED|Follow-up Period||4
5022348|NCT02156076|12358697|P2|COMPLETED|Follow-up Period||5
5022349|NCT02156076|12358698|P1|COMPLETED|Follow-up Period||6
5022350|NCT02156076|12358695|P4|STARTED|Follow-up Period||4
5022351|NCT02156076|12358696|P3|STARTED|Follow-up Period||4
5022352|NCT02156076|12358697|P2|STARTED|Follow-up Period||5
5022353|NCT02156076|12358698|P1|STARTED|Follow-up Period||7
5022354|NCT02156076|12358695|P4|NOT COMPLETED|Treatment Period||2
5022355|NCT02156076|12358696|P3|NOT COMPLETED|Treatment Period||2
5022356|NCT02156076|12358697|P2|NOT COMPLETED|Treatment Period||2
5022357|NCT02156076|12358698|P1|NOT COMPLETED|Treatment Period||0
5022358|NCT02156076|12358695|P4|COMPLETED|Treatment Period||4
5022359|NCT02156076|12358696|P3|COMPLETED|Treatment Period||4
5022360|NCT02156076|12358697|P2|COMPLETED|Treatment Period||5
5022361|NCT02156076|12358698|P1|COMPLETED|Treatment Period||7
5022362|NCT02156076|12358695|P4|STARTED|Treatment Period||6
5022363|NCT02156076|12358696|P3|STARTED|Treatment Period||6
5022364|NCT02156076|12358697|P2|STARTED|Treatment Period||7
5022365|NCT02156076|12358698|P1|STARTED|Treatment Period||7
5022366|NCT02155985|12358755|P3|NOT COMPLETED|Overall Study||1
5022367|NCT02155985|12358756|P2|NOT COMPLETED|Overall Study||0
5022368|NCT02155985|12358757|P1|NOT COMPLETED|Overall Study||1
5022369|NCT02155985|12358755|P3|COMPLETED|Overall Study||39
5022370|NCT02155985|12358756|P2|COMPLETED|Overall Study||41
5022371|NCT02155985|12358757|P1|COMPLETED|Overall Study||39
5022372|NCT02155985|12358755|P3|STARTED|Overall Study||40
5022373|NCT02155985|12358756|P2|STARTED|Overall Study||41
5022374|NCT02155985|12358757|P1|STARTED|Overall Study||40
5022375|NCT02155881|12358824|P2|NOT COMPLETED|Overall Study||4
5022376|NCT02155881|12358825|P1|NOT COMPLETED|Overall Study||2
5022377|NCT02155881|12358824|P2|COMPLETED|Overall Study||36
5022378|NCT02155881|12358825|P1|COMPLETED|Overall Study||38
5022379|NCT02155881|12358824|P2|STARTED|Overall Study||40
5022380|NCT02155881|12358825|P1|STARTED|Overall Study||40
5022381|NCT02155738|12358849|P4|NOT COMPLETED|Overall Study||1
5022382|NCT02155738|12358850|P3|NOT COMPLETED|Overall Study||0
5022383|NCT02155738|12358851|P2|NOT COMPLETED|Overall Study||0
5022384|NCT02155738|12358852|P1|NOT COMPLETED|Overall Study||1
5022385|NCT02155738|12358849|P4|COMPLETED|Overall Study||50
5022386|NCT02155738|12358850|P3|COMPLETED|Overall Study||51
5022387|NCT02155738|12358851|P2|COMPLETED|Overall Study||52
5022388|NCT02155738|12358852|P1|COMPLETED|Overall Study||49
5022389|NCT02155738|12358849|P4|STARTED|Overall Study||51
5022390|NCT02155738|12358850|P3|STARTED|Overall Study||51
5022391|NCT02155738|12358851|P2|STARTED|Overall Study||52
5022392|NCT02155738|12358852|P1|STARTED|Overall Study||50
5022393|NCT02155712|12358872|P2|NOT COMPLETED|Secondary Objectives||134
5022394|NCT02155712|12358873|P1|NOT COMPLETED|Secondary Objectives||319
5022395|NCT02155712|12358872|P2|COMPLETED|Secondary Objectives||0
5022396|NCT02155712|12358873|P1|COMPLETED|Secondary Objectives||0
5022397|NCT02155712|12358872|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
5022398|NCT02155712|12358873|P1|STARTED|Secondary Objectives||319
5022399|NCT02155712|12358872|P2|NOT COMPLETED|Primary Objective||0
5022400|NCT02155712|12358873|P1|NOT COMPLETED|Primary Objective||60
5022401|NCT02155712|12358872|P2|COMPLETED|Primary Objective||0
5022402|NCT02155712|12358873|P1|COMPLETED|Primary Objective||259
5022403|NCT02155712|12358872|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
5022404|NCT02155712|12358873|P1|STARTED|Primary Objective||319
5022405|NCT02155660|12358883|P4|NOT COMPLETED|Overall Study||61
5022406|NCT02155660|12358884|P3|NOT COMPLETED|Overall Study||60
5022407|NCT02155660|12358885|P2|NOT COMPLETED|Overall Study||73
5022408|NCT02155660|12358886|P1|NOT COMPLETED|Overall Study||58
5022409|NCT02155660|12358883|P4|COMPLETED|Overall Study||507
5022410|NCT02155660|12358884|P3|COMPLETED|Overall Study||502
5022411|NCT02155660|12358885|P2|COMPLETED|Overall Study||489
5022412|NCT02155660|12358886|P1|COMPLETED|Overall Study||504
5022413|NCT02155660|12358883|P4|STARTED|Overall Study||568
5022414|NCT02155660|12358884|P3|STARTED|Overall Study||562
5022415|NCT02155660|12358885|P2|STARTED|Overall Study||562
5022416|NCT02155660|12358886|P1|STARTED|Overall Study||562
5022417|NCT02155647|12358969|P2|NOT COMPLETED|Overall Study||52
5022418|NCT02155647|12358970|P1|NOT COMPLETED|Overall Study||41
5022419|NCT02155647|12358969|P2|COMPLETED|Overall Study||64
5022420|NCT02155647|12358970|P1|COMPLETED|Overall Study||47
5022421|NCT02155647|12358969|P2|STARTED|Overall Study||116
5022422|NCT02155647|12358970|P1|STARTED|Overall Study||88
5022423|NCT02155608|12358998|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
5022424|NCT02155608|12358999|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
5022425|NCT02155608|12358998|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
5022426|NCT02155608|12358999|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
5022427|NCT02155608|12358998|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
5022428|NCT02155608|12358999|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
5022429|NCT02155608|12358998|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
5022430|NCT02155608|12358999|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
5022431|NCT02155608|12358998|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
5022432|NCT02155608|12358999|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
5022433|NCT02155608|12358998|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
5022434|NCT02155608|12358999|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
5022435|NCT02155543|12359038|P7|NOT COMPLETED|Overall Study||0
5022436|NCT02155543|12359039|P6|NOT COMPLETED|Overall Study||0
5022437|NCT02155543|12359040|P5|NOT COMPLETED|Overall Study||0
5022438|NCT02155543|12359041|P4|NOT COMPLETED|Overall Study||0
5022439|NCT02155543|12359042|P3|NOT COMPLETED|Overall Study||0
5022440|NCT02155543|12359043|P2|NOT COMPLETED|Overall Study||0
5022441|NCT02155543|12359044|P1|NOT COMPLETED|Overall Study||0
5022442|NCT02155543|12359038|P7|COMPLETED|Overall Study||9
5022443|NCT02155543|12359039|P6|COMPLETED|Overall Study||3
5022444|NCT02155543|12359040|P5|COMPLETED|Overall Study||3
5022445|NCT02155543|12359041|P4|COMPLETED|Overall Study||9
5022446|NCT02155543|12359042|P3|COMPLETED|Overall Study||9
5022447|NCT02155543|12359043|P2|COMPLETED|Overall Study||9
5022448|NCT02155543|12359044|P1|COMPLETED|Overall Study||9
5022449|NCT02155543|12359038|P7|STARTED|Overall Study||9
5022450|NCT02155543|12359039|P6|STARTED|Overall Study||3
5022451|NCT02155543|12359040|P5|STARTED|Overall Study||3
5022452|NCT02155543|12359041|P4|STARTED|Overall Study||9
5022453|NCT02155543|12359042|P3|STARTED|Overall Study||9
5022454|NCT02155543|12359043|P2|STARTED|Overall Study||9
5022455|NCT02155543|12359044|P1|STARTED|Overall Study||9
5022456|NCT02155465|12359064|P7|NOT COMPLETED|Overall Study||0
5022457|NCT02155465|12359065|P6|NOT COMPLETED|Overall Study||0
5022458|NCT02155465|12359066|P5|NOT COMPLETED|Overall Study||0
5022459|NCT02155465|12359067|P4|NOT COMPLETED|Overall Study||0
5022460|NCT02155465|12359068|P3|NOT COMPLETED|Overall Study||0
5022461|NCT02155465|12359069|P2|NOT COMPLETED|Overall Study||0
5022462|NCT02155465|12359070|P1|NOT COMPLETED|Overall Study||0
5022463|NCT02155465|12359064|P7|COMPLETED|Overall Study||5
5022464|NCT02155465|12359065|P6|COMPLETED|Overall Study||2
5022465|NCT02155465|12359066|P5|COMPLETED|Overall Study||1
5022466|NCT02155465|12359067|P4|COMPLETED|Overall Study||2
5022467|NCT02155465|12359068|P3|COMPLETED|Overall Study||6
5022468|NCT02155465|12359069|P2|COMPLETED|Overall Study||3
5022469|NCT02155465|12359070|P1|COMPLETED|Overall Study||3
5022470|NCT02155465|12359064|P7|STARTED|Overall Study||5
5022471|NCT02155465|12359065|P6|STARTED|Overall Study||2
5022472|NCT02155465|12359066|P5|STARTED|Overall Study||1
5022473|NCT02155465|12359067|P4|STARTED|Overall Study||2
5022474|NCT02155465|12359068|P3|STARTED|Overall Study||6
5022475|NCT02155465|12359069|P2|STARTED|Overall Study||3
5022476|NCT02155465|12359070|P1|STARTED|Overall Study||3
5022477|NCT02155335|12359090|P2|NOT COMPLETED|Period 2||0
5022478|NCT02155335|12359091|P1|NOT COMPLETED|Period 2||0
5022479|NCT02155335|12359090|P2|COMPLETED|Period 2||49
5022480|NCT02155335|12359091|P1|COMPLETED|Period 2||50
5022481|NCT02155335|12359090|P2|STARTED|Period 2||49
5022482|NCT02155335|12359091|P1|STARTED|Period 2||50
5022483|NCT02155335|12359090|P2|NOT COMPLETED|Period 1||1
5022484|NCT02155335|12359091|P1|NOT COMPLETED|Period 1||0
5022485|NCT02155335|12359090|P2|COMPLETED|Period 1||49
5022486|NCT02155335|12359091|P1|COMPLETED|Period 1||50
5022487|NCT02155335|12359090|P2|Treated|Period 1||49
5022488|NCT02155335|12359091|P1|Treated|Period 1||50
5022489|NCT02155335|12359090|P2|STARTED|Period 1||50
5022490|NCT02155335|12359091|P1|STARTED|Period 1||50
5022491|NCT02155322|12359096|P1|NOT COMPLETED|Overall Study||14
5022492|NCT02155322|12359096|P1|COMPLETED|Overall Study||19
5022493|NCT02155322|12359096|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
5022494|NCT02155322|12359096|P1|STARTED|Overall Study||33
5022495|NCT02155309|12359103|P3|NOT COMPLETED|Overall Study||1
5022496|NCT02155309|12359104|P2|NOT COMPLETED|Overall Study||0
5022497|NCT02155309|12359105|P1|NOT COMPLETED|Overall Study||0
5022498|NCT02155309|12359103|P3|COMPLETED|Overall Study||12
5022499|NCT02155309|12359104|P2|COMPLETED|Overall Study||10
5022500|NCT02155309|12359105|P1|COMPLETED|Overall Study||13
5022501|NCT02155309|12359103|P3|STARTED|Overall Study||13
5022502|NCT02155309|12359104|P2|STARTED|Overall Study||10
5022503|NCT02155309|12359105|P1|STARTED|Overall Study||13
5022504|NCT02155283|12359112|P1|NOT COMPLETED|Overall Study||7
5022505|NCT02155283|12359112|P1|COMPLETED|Overall Study||9
5022506|NCT02155283|12359112|P1|STARTED|Overall Study||16
5022507|NCT02155257|12359120|P3|NOT COMPLETED|Overall Study||0
5022508|NCT02155257|12359121|P2|NOT COMPLETED|Overall Study||0
5022509|NCT02155257|12359122|P1|NOT COMPLETED|Overall Study||0
5022510|NCT02155257|12359120|P3|COMPLETED|Overall Study||10
5022511|NCT02155257|12359121|P2|COMPLETED|Overall Study||10
5022512|NCT02155257|12359122|P1|COMPLETED|Overall Study||10
5022513|NCT02155257|12359120|P3|STARTED|Overall Study||10
5022514|NCT02155257|12359121|P2|STARTED|Overall Study||10
5022515|NCT02155257|12359122|P1|STARTED|Overall Study||10
5022516|NCT02155101|12359138|P2|NOT COMPLETED|Overall Study||1
5022517|NCT02155101|12359139|P1|NOT COMPLETED|Overall Study||0
5022518|NCT02155101|12359138|P2|COMPLETED|Overall Study||80
5022519|NCT02155101|12359139|P1|COMPLETED|Overall Study||39
5022520|NCT02155101|12359138|P2|STARTED|Overall Study||81
5022521|NCT02155101|12359139|P1|STARTED|Overall Study||39
5022522|NCT02155010|12359151|P2|NOT COMPLETED|Overall Study||6
5022523|NCT02155010|12359152|P1|NOT COMPLETED|Overall Study||6
5022524|NCT02155010|12359151|P2|COMPLETED|Overall Study||31
5022525|NCT02155010|12359152|P1|COMPLETED|Overall Study||31
5022526|NCT02155010|12359151|P2|STARTED|Overall Study||37
5022527|NCT02155010|12359152|P1|STARTED|Overall Study||37
5022528|NCT02154906|12359162|P2|NOT COMPLETED|Overall Study||3
5022529|NCT02154906|12359163|P1|NOT COMPLETED|Overall Study||2
5022530|NCT02154906|12359162|P2|COMPLETED|Overall Study||17
5022531|NCT02154906|12359163|P1|COMPLETED|Overall Study||19
5022532|NCT02154906|12359162|P2|STARTED|Overall Study||20
5022533|NCT02154906|12359163|P1|STARTED|Overall Study||21
5022534|NCT02154763|12359173|P2|NOT COMPLETED|Overall Study||14
5022535|NCT02154763|12359174|P1|NOT COMPLETED|Overall Study||14
5022536|NCT02154763|12359173|P2|COMPLETED|Overall Study||46
5022537|NCT02154763|12359174|P1|COMPLETED|Overall Study||46
5022538|NCT02154763|12359173|P2|STARTED|Overall Study||60
5022539|NCT02154763|12359174|P1|STARTED|Overall Study||60
5022540|NCT02154581|12359288|P2|NOT COMPLETED|Overall Study||8
5022541|NCT02154581|12359289|P1|NOT COMPLETED|Overall Study||7
5022542|NCT02154581|12359288|P2|COMPLETED|Overall Study||12
5022543|NCT02154581|12359289|P1|COMPLETED|Overall Study||14
5022544|NCT02154581|12359288|P2|STARTED|Overall Study||20
5022545|NCT02154581|12359289|P1|STARTED|Overall Study||21
5022546|NCT02154477|12359307|P2|NOT COMPLETED|Overall Study||0
5022547|NCT02154477|12359308|P1|NOT COMPLETED|Overall Study||0
5022548|NCT02154477|12359307|P2|COMPLETED|Overall Study||8
5022549|NCT02154477|12359308|P1|COMPLETED|Overall Study||6
5022550|NCT02154477|12359307|P2|STARTED|Overall Study||8
5022551|NCT02154477|12359308|P1|STARTED|Overall Study||6
5022552|NCT02154425|12359314|P1|NOT COMPLETED|Sampling Period||0
5022553|NCT02154425|12359314|P1|COMPLETED|Sampling Period||17
5022554|NCT02154425|12359314|P1|STARTED|Sampling Period||17
5022555|NCT02154425|12359314|P1|NOT COMPLETED|Screening Period||1
5022556|NCT02154425|12359314|P1|COMPLETED|Screening Period||17
5022557|NCT02154425|12359314|P1|STARTED|Screening Period||18
5022558|NCT02154386|12359346|P2|NOT COMPLETED|Overall Study||2
5022559|NCT02154386|12359347|P1|NOT COMPLETED|Overall Study||1
5022560|NCT02154386|12359346|P2|COMPLETED|Overall Study||21
5022561|NCT02154386|12359347|P1|COMPLETED|Overall Study||22
5022562|NCT02154386|12359346|P2|STARTED|Overall Study||23
5022563|NCT02154386|12359347|P1|STARTED|Overall Study||23
5022564|NCT02154347|12359359|P2|NOT COMPLETED|Open-label Period||25
5022565|NCT02154347|12359360|P1|NOT COMPLETED|Open-label Period||7
5022566|NCT02154347|12359359|P2|COMPLETED|Open-label Period||88
5022567|NCT02154347|12359360|P1|COMPLETED|Open-label Period||50
5022568|NCT02154347|12359359|P2|STARTED|Open-label Period||113
5022569|NCT02154347|12359360|P1|STARTED|Open-label Period||57
5022570|NCT02154347|12359359|P2|NOT COMPLETED|Double-blind Period||4
5022571|NCT02154347|12359360|P1|NOT COMPLETED|Double-blind Period||3
5022572|NCT02154347|12359359|P2|COMPLETED|Double-blind Period||114
5022573|NCT02154347|12359360|P1|COMPLETED|Double-blind Period||57
5022574|NCT02154347|12359359|P2|STARTED|Double-blind Period||118
5022575|NCT02154347|12359360|P1|STARTED|Double-blind Period||60
5022576|NCT02154243|12359370|P3|NOT COMPLETED|Overall Study||0
5022577|NCT02154243|12359371|P2|NOT COMPLETED|Overall Study||0
5022578|NCT02154243|12359372|P1|NOT COMPLETED|Overall Study||0
5022579|NCT02154243|12359370|P3|COMPLETED|Overall Study||4
5022580|NCT02154243|12359371|P2|COMPLETED|Overall Study||4
5022581|NCT02154243|12359372|P1|COMPLETED|Overall Study||5
5022582|NCT02154243|12359370|P3|STARTED|Overall Study||4
5022583|NCT02154243|12359371|P2|STARTED|Overall Study||4
5022584|NCT02154243|12359372|P1|STARTED|Overall Study||5
5022585|NCT02154139|12359383|P1|NOT COMPLETED|Overall Study||7
5022586|NCT02154139|12359383|P1|COMPLETED|Overall Study||644
5022587|NCT02154139|12359383|P1|STARTED|Overall Study||651
5022588|NCT02154087|12359391|P1|NOT COMPLETED|Overall Study||1
5022589|NCT02154087|12359391|P1|COMPLETED|Overall Study||0
5022590|NCT02154087|12359391|P1|STARTED|Overall Study||1
5022591|NCT02154061|12359397|P2|NOT COMPLETED|Overall Study||0
5022592|NCT02154061|12359398|P1|NOT COMPLETED|Overall Study||2
5022593|NCT02154061|12359397|P2|COMPLETED|Overall Study||17
5022594|NCT02154061|12359398|P1|COMPLETED|Overall Study||14
5022595|NCT02154061|12359397|P2|STARTED|Overall Study||17
5022596|NCT02154061|12359398|P1|STARTED|Overall Study||16
5022597|NCT02154048|12359407|P3|NOT COMPLETED|Overall Study||0
5022598|NCT02154048|12359408|P2|NOT COMPLETED|Overall Study||0
5022599|NCT02154048|12359409|P1|NOT COMPLETED|Overall Study||0
5022600|NCT02154048|12359407|P3|COMPLETED|Overall Study||1
5022601|NCT02154048|12359408|P2|COMPLETED|Overall Study||2
5022602|NCT02154048|12359409|P1|COMPLETED|Overall Study||2
5022603|NCT02154048|12359407|P3|STARTED|Overall Study||1
5022604|NCT02154048|12359408|P2|STARTED|Overall Study||2
5022605|NCT02154048|12359409|P1|STARTED|Overall Study||2
5022606|NCT02153983|12359423|P6|NOT COMPLETED|Overall Study||0
5022607|NCT02153983|12359424|P5|NOT COMPLETED|Overall Study||0
5022608|NCT02153983|12359425|P4|NOT COMPLETED|Overall Study||0
5022609|NCT02153983|12359426|P3|NOT COMPLETED|Overall Study||2
5022610|NCT02153983|12359427|P2|NOT COMPLETED|Overall Study||3
5022611|NCT02153983|12359428|P1|NOT COMPLETED|Overall Study||0
5022612|NCT02153983|12359423|P6|COMPLETED|Overall Study||1
5022613|NCT02153983|12359424|P5|COMPLETED|Overall Study||19
5022614|NCT02153983|12359425|P4|COMPLETED|Overall Study||13
5022615|NCT02153983|12359426|P3|COMPLETED|Overall Study||2
5022616|NCT02153983|12359427|P2|COMPLETED|Overall Study||18
5022617|NCT02153983|12359428|P1|COMPLETED|Overall Study||19
5022618|NCT02153983|12359423|P6|STARTED|Overall Study||1
5022619|NCT02153983|12359424|P5|STARTED|Overall Study||19
5022620|NCT02153983|12359425|P4|STARTED|Overall Study||13
5022621|NCT02153983|12359426|P3|STARTED|Overall Study||4
5022622|NCT02153983|12359427|P2|STARTED|Overall Study||21
5022623|NCT02153983|12359428|P1|STARTED|Overall Study||19
5022624|NCT02153918|12359445|P1|NOT COMPLETED|Overall Study||1
5022625|NCT02153918|12359445|P1|COMPLETED|Overall Study||26
5022626|NCT02153918|12359445|P1|STARTED|Overall Study||27
5022627|NCT02153905|12359456|P2|NOT COMPLETED|Overall Study||0
5022628|NCT02153905|12359457|P1|NOT COMPLETED|Overall Study||1
5022629|NCT02153905|12359456|P2|COMPLETED|Overall Study||2
5022630|NCT02153905|12359457|P1|COMPLETED|Overall Study||0
5022631|NCT02153905|12359456|P2|STARTED|Overall Study||2
5022632|NCT02153905|12359457|P1|STARTED|Overall Study||1
5022633|NCT02153827|12359475|P2|NOT COMPLETED|Overall Study||9
5022634|NCT02153827|12359476|P1|NOT COMPLETED|Overall Study||3
5022635|NCT02153827|12359475|P2|COMPLETED|Overall Study||14
5022636|NCT02153827|12359476|P1|COMPLETED|Overall Study||22
5022637|NCT02153827|12359475|P2|STARTED|Overall Study||23
5022638|NCT02153827|12359476|P1|STARTED|Overall Study||25
5022639|NCT02153788|12359492|P2|NOT COMPLETED|Overall Study||1
5022640|NCT02153788|12359493|P1|NOT COMPLETED|Overall Study||2
5022641|NCT02153788|12359492|P2|COMPLETED|Overall Study||18
5022642|NCT02153788|12359493|P1|COMPLETED|Overall Study||23
5022643|NCT02153788|12359492|P2|STARTED|Overall Study||19
5022644|NCT02153788|12359493|P1|STARTED|Overall Study||25
5022645|NCT02153736|12359513|P2|NOT COMPLETED|Overall Study||2
5022646|NCT02153736|12359514|P1|NOT COMPLETED|Overall Study||2
5022647|NCT02153736|12359513|P2|COMPLETED|Overall Study||5
5022648|NCT02153736|12359514|P1|COMPLETED|Overall Study||5
5022649|NCT02153736|12359513|P2|STARTED|Overall Study||7
5022650|NCT02153736|12359514|P1|STARTED|Overall Study||7
5022651|NCT02153723|12359530|P1|NOT COMPLETED|Overall Study||0
5022652|NCT02153723|12359530|P1|COMPLETED|Overall Study||10
5022653|NCT02153723|12359530|P1|STARTED|Overall Study||10
5022654|NCT02153710|12359541|P2|NOT COMPLETED|Overall Study||0
5022655|NCT02153710|12359542|P1|NOT COMPLETED|Overall Study||0
5022656|NCT02153710|12359541|P2|COMPLETED|Overall Study||30
5022657|NCT02153710|12359542|P1|COMPLETED|Overall Study||28
5022658|NCT02153710|12359541|P2|STARTED|Overall Study||30
5022659|NCT02153710|12359542|P1|STARTED|Overall Study||28
5022660|NCT02153671|12359554|P2|NOT COMPLETED|Overall Study||0
5022661|NCT02153671|12359555|P1|NOT COMPLETED|Overall Study||0
5022662|NCT02153671|12359554|P2|COMPLETED|Overall Study||24
5022663|NCT02153671|12359555|P1|COMPLETED|Overall Study||19
5022664|NCT02153671|12359554|P2|STARTED|Overall Study||24
5022665|NCT02153671|12359555|P1|STARTED|Overall Study||19
5022666|NCT02153645|12359634|P3|NOT COMPLETED|Overall Study||10
5022667|NCT02153645|12359635|P2|NOT COMPLETED|Overall Study||10
5022668|NCT02153645|12359636|P1|NOT COMPLETED|Overall Study||13
5022669|NCT02153645|12359634|P3|COMPLETED|Overall Study||18
5022670|NCT02153645|12359635|P2|COMPLETED|Overall Study||19
5022671|NCT02153645|12359636|P1|COMPLETED|Overall Study||17
5022672|NCT02153645|12359634|P3|STARTED|Overall Study||28
5022673|NCT02153645|12359635|P2|STARTED|Overall Study||29
5022674|NCT02153645|12359636|P1|STARTED|Overall Study||30
5022675|NCT02153632|12359650|P3|NOT COMPLETED|Overall Study||19
5022676|NCT02153632|12359651|P2|NOT COMPLETED|Overall Study||19
5022677|NCT02153632|12359652|P1|NOT COMPLETED|Overall Study||18
5022678|NCT02153632|12359650|P3|COMPLETED|Overall Study||25
5022679|NCT02153632|12359651|P2|COMPLETED|Overall Study||27
5022680|NCT02153632|12359652|P1|COMPLETED|Overall Study||27
5022681|NCT02153632|12359650|P3|STARTED|Overall Study||44
5022682|NCT02153632|12359651|P2|STARTED|Overall Study||46
5022683|NCT02153632|12359652|P1|STARTED|Overall Study||45
5022684|NCT02153528|12359665|P2|NOT COMPLETED|Overall Study||0
5022685|NCT02153528|12359666|P1|NOT COMPLETED|Overall Study||0
5022686|NCT02153528|12359665|P2|COMPLETED|Overall Study||353
5022687|NCT02153528|12359666|P1|COMPLETED|Overall Study||348
5022688|NCT02153528|12359665|P2|STARTED|Overall Study||353
5022689|NCT02153528|12359666|P1|STARTED|Overall Study||348
5022690|NCT02153489|12359688|P2|NOT COMPLETED|Period 2||0
5022691|NCT02153489|12359689|P1|NOT COMPLETED|Period 2||0
5022692|NCT02153489|12359688|P2|COMPLETED|Period 2||15
5022693|NCT02153489|12359689|P1|COMPLETED|Period 2||15
5022694|NCT02153489|12359688|P2|STARTED|Period 2||15
5022695|NCT02153489|12359689|P1|STARTED|Period 2||15
5022696|NCT02153489|12359688|P2|NOT COMPLETED|Period 1||0
5022697|NCT02153489|12359689|P1|NOT COMPLETED|Period 1||0
5022698|NCT02153489|12359688|P2|COMPLETED|Period 1||15
5022699|NCT02153489|12359689|P1|COMPLETED|Period 1||15
5022700|NCT02153489|12359688|P2|STARTED|Period 1||15
5022701|NCT02153489|12359689|P1|STARTED|Period 1||15
5022702|NCT02153476|12359729|P2|NOT COMPLETED|Overall Study||0
5022703|NCT02153476|12359730|P1|NOT COMPLETED|Overall Study||1
5022704|NCT02153476|12359729|P2|COMPLETED|Overall Study||22
5022705|NCT02153476|12359730|P1|COMPLETED|Overall Study||22
5022706|NCT02153476|12359729|P2|STARTED|Overall Study||22
5022707|NCT02153476|12359730|P1|STARTED|Overall Study||23
5022708|NCT02153398|12359741|P5|NOT COMPLETED|Overall Study||0
5022709|NCT02153398|12359742|P4|NOT COMPLETED|Overall Study||1
5022710|NCT02153398|12359743|P3|NOT COMPLETED|Overall Study||1
5022711|NCT02153398|12359744|P2|NOT COMPLETED|Overall Study||0
5022712|NCT02153398|12359745|P1|NOT COMPLETED|Overall Study||1
5022713|NCT02153398|12359741|P5|COMPLETED|Overall Study||10
5022714|NCT02153398|12359742|P4|COMPLETED|Overall Study||9
5022715|NCT02153398|12359743|P3|COMPLETED|Overall Study||9
5022716|NCT02153398|12359744|P2|COMPLETED|Overall Study||10
5022717|NCT02153398|12359745|P1|COMPLETED|Overall Study||9
5022718|NCT02153398|12359741|P5|STARTED|Overall Study||10
5022719|NCT02153398|12359742|P4|STARTED|Overall Study||10
5022720|NCT02153398|12359743|P3|STARTED|Overall Study||10
5022721|NCT02153398|12359744|P2|STARTED|Overall Study||10
5022722|NCT02153398|12359745|P1|STARTED|Overall Study||10
5022723|NCT02153359|12359867|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
5022724|NCT02153359|12359868|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
5022725|NCT02153359|12359867|P2|COMPLETED|Intervention 2 (1 Month)||10
5022726|NCT02153359|12359868|P1|COMPLETED|Intervention 2 (1 Month)||11
5022727|NCT02153359|12359867|P2|STARTED|Intervention 2 (1 Month)||12
5022728|NCT02153359|12359868|P1|STARTED|Intervention 2 (1 Month)||11
5022729|NCT02153359|12359867|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
5022730|NCT02153359|12359868|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
5022731|NCT02153359|12359867|P2|COMPLETED|Washout (at Least 1 Month)||12
5022732|NCT02153359|12359868|P1|COMPLETED|Washout (at Least 1 Month)||11
5022733|NCT02153359|12359867|P2|STARTED|Washout (at Least 1 Month)||12
5022734|NCT02153359|12359868|P1|STARTED|Washout (at Least 1 Month)||11
5022735|NCT02153359|12359867|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
5022736|NCT02153359|12359868|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
5022737|NCT02153359|12359867|P2|COMPLETED|Intervention 1 (1 Month)||12
5022738|NCT02153359|12359868|P1|COMPLETED|Intervention 1 (1 Month)||11
5022739|NCT02153359|12359867|P2|STARTED|Intervention 1 (1 Month)||12
5022740|NCT02153359|12359868|P1|STARTED|Intervention 1 (1 Month)||11
5022741|NCT02153346|12359902|P1|NOT COMPLETED|Overall Study||11
5022742|NCT02153346|12359902|P1|COMPLETED|Overall Study||90
5022743|NCT02153346|12359902|P1|STARTED|Overall Study||101
5022744|NCT02153112|12359919|P10|NOT COMPLETED|Overall Study||14
5022745|NCT02153112|12359920|P9|NOT COMPLETED|Overall Study||15
5022746|NCT02153112|12359921|P8|NOT COMPLETED|Overall Study||2
5022747|NCT02153112|12359922|P7|NOT COMPLETED|Overall Study||8
5022748|NCT02153112|12359923|P6|NOT COMPLETED|Overall Study||2
5022749|NCT02153112|12359924|P5|NOT COMPLETED|Overall Study||3
5022750|NCT02153112|12359925|P4|NOT COMPLETED|Overall Study||2
5022751|NCT02153112|12359926|P3|NOT COMPLETED|Overall Study||3
5022752|NCT02153112|12359927|P2|NOT COMPLETED|Overall Study||2
5022753|NCT02153112|12359928|P1|NOT COMPLETED|Overall Study||4
5022754|NCT02153112|12359919|P10|COMPLETED|Overall Study||166
5022755|NCT02153112|12359920|P9|COMPLETED|Overall Study||165
5022756|NCT02153112|12359921|P8|COMPLETED|Overall Study||58
5022757|NCT02153112|12359922|P7|COMPLETED|Overall Study||52
5022758|NCT02153112|12359923|P6|COMPLETED|Overall Study||58
5022759|NCT02153112|12359924|P5|COMPLETED|Overall Study||57
5022760|NCT02153112|12359925|P4|COMPLETED|Overall Study||57
5022761|NCT02153112|12359926|P3|COMPLETED|Overall Study||58
5022762|NCT02153112|12359927|P2|COMPLETED|Overall Study||57
5022763|NCT02153112|12359928|P1|COMPLETED|Overall Study||57
5022764|NCT02153112|12359919|P10|STARTED|Overall Study||180
5022765|NCT02153112|12359920|P9|STARTED|Overall Study||180
5022766|NCT02153112|12359921|P8|STARTED|Overall Study||60
5022767|NCT02153112|12359922|P7|STARTED|Overall Study||60
5022768|NCT02153112|12359923|P6|STARTED|Overall Study||60
5022769|NCT02153112|12359924|P5|STARTED|Overall Study||60
5022770|NCT02153112|12359925|P4|STARTED|Overall Study||59
5022771|NCT02153112|12359926|P3|STARTED|Overall Study||61
5022772|NCT02153112|12359927|P2|STARTED|Overall Study||59
5022773|NCT02153112|12359928|P1|STARTED|Overall Study||61
5022774|NCT02153099|12360207|P7|NOT COMPLETED|Overall Study||0
5022775|NCT02153099|12360208|P6|NOT COMPLETED|Overall Study||0
5022776|NCT02153099|12360209|P5|NOT COMPLETED|Overall Study||0
5022777|NCT02153099|12360210|P4|NOT COMPLETED|Overall Study||0
5022778|NCT02153099|12360211|P3|NOT COMPLETED|Overall Study||0
5022779|NCT02153099|12360212|P2|NOT COMPLETED|Overall Study||0
5022780|NCT02153099|12360213|P1|NOT COMPLETED|Overall Study||0
5022781|NCT02153099|12360207|P7|COMPLETED|Overall Study||12
5022782|NCT02153099|12360208|P6|COMPLETED|Overall Study||6
5022783|NCT02153099|12360209|P5|COMPLETED|Overall Study||6
5022784|NCT02153099|12360210|P4|COMPLETED|Overall Study||6
5022785|NCT02153099|12360211|P3|COMPLETED|Overall Study||6
5022786|NCT02153099|12360212|P2|COMPLETED|Overall Study||6
5022787|NCT02153099|12360213|P1|COMPLETED|Overall Study||6
5022788|NCT02153099|12360207|P7|STARTED|Overall Study||12
5022789|NCT02153099|12360208|P6|STARTED|Overall Study||6
5022790|NCT02153099|12360209|P5|STARTED|Overall Study||6
5022791|NCT02153099|12360210|P4|STARTED|Overall Study||6
5022792|NCT02153099|12360211|P3|STARTED|Overall Study||6
5022793|NCT02153099|12360212|P2|STARTED|Overall Study||6
5022794|NCT02153099|12360213|P1|STARTED|Overall Study||6
5022795|NCT02153086|12360267|P1|NOT COMPLETED|Overall Study||4
5022796|NCT02153086|12360267|P1|COMPLETED|Overall Study||232
5022797|NCT02153086|12360267|P1|STARTED|Overall Study||236
5022798|NCT02153073|12360281|P1|NOT COMPLETED|Overall Study||298
5022799|NCT02153073|12360281|P1|COMPLETED|Overall Study||2786
5022800|NCT02153073|12360281|P1|STARTED|Overall Study||3084
5022801|NCT02152631|12360296|P2|NOT COMPLETED|Overall Study||26
5022802|NCT02152631|12360297|P1|NOT COMPLETED|Overall Study||66
5022803|NCT02152631|12360296|P2|COMPLETED|Overall Study||157
5022804|NCT02152631|12360297|P1|COMPLETED|Overall Study||204
5022805|NCT02152631|12360296|P2|Progressive Disease|Overall Study||137
5022806|NCT02152631|12360297|P1|Progressive Disease|Overall Study||174
5022807|NCT02152631|12360296|P2|Death Due to Any Cause|Overall Study||20
5022808|NCT02152631|12360297|P1|Death Due to Any Cause|Overall Study||30
5022809|NCT02152631|12360296|P2|Off Treatment|Overall Study||172
5022810|NCT02152631|12360297|P1|Off Treatment|Overall Study||246
5022811|NCT02152631|12360296|P2|Received at Least One Dose of Study Drug|Overall Study||175
5022812|NCT02152631|12360297|P1|Received at Least One Dose of Study Drug|Overall Study||265
5022813|NCT02152631|12360296|P2|STARTED|Overall Study||183
5022814|NCT02152631|12360297|P1|STARTED|Overall Study||270
5022815|NCT02152605|12360316|P2|NOT COMPLETED|Overall Study||18
5022816|NCT02152605|12360317|P1|NOT COMPLETED|Overall Study||19
5022817|NCT02152605|12360316|P2|COMPLETED|Overall Study||230
5022818|NCT02152605|12360317|P1|COMPLETED|Overall Study||229
5022819|NCT02152605|12360316|P2|STARTED|Overall Study||248
5022820|NCT02152605|12360317|P1|STARTED|Overall Study||248
5022821|NCT02152566|12360327|P1|NOT COMPLETED|Overall Study||3
5022822|NCT02152566|12360327|P1|COMPLETED|Overall Study||3
5022823|NCT02152566|12360327|P1|STARTED|Overall Study||6
5022824|NCT02152540|12360333|P2|NOT COMPLETED|Overall Study||0
5022825|NCT02152540|12360334|P1|NOT COMPLETED|Overall Study||0
5022826|NCT02152540|12360333|P2|COMPLETED|Overall Study||16
5022827|NCT02152540|12360334|P1|COMPLETED|Overall Study||17
5022828|NCT02152540|12360333|P2|STARTED|Overall Study||16
5022829|NCT02152540|12360334|P1|STARTED|Overall Study||17
5022830|NCT02152384|12360340|P2|NOT COMPLETED|Period 2||0
5022831|NCT02152384|12360341|P1|NOT COMPLETED|Period 2||0
5022832|NCT02152384|12360340|P2|COMPLETED|Period 2||12
5022833|NCT02152384|12360341|P1|COMPLETED|Period 2||13
5022834|NCT02152384|12360340|P2|STARTED|Period 2||12
5022835|NCT02152384|12360341|P1|STARTED|Period 2||13
5022836|NCT02152384|12360340|P2|NOT COMPLETED|Period 1||2
5022837|NCT02152384|12360341|P1|NOT COMPLETED|Period 1||1
5022838|NCT02152384|12360340|P2|COMPLETED|Period 1||12
5022839|NCT02152384|12360341|P1|COMPLETED|Period 1||13
5022840|NCT02152384|12360340|P2|Received at Least 1 Dose of Study Drug|Period 1||14
5022841|NCT02152384|12360341|P1|Received at Least 1 Dose of Study Drug|Period 1||14
5022842|NCT02152384|12360340|P2|STARTED|Period 1||14
5022843|NCT02152384|12360341|P1|STARTED|Period 1||14
5022844|NCT02152384|12360340|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
5022845|NCT02152384|12360341|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
5022846|NCT02152384|12360340|P2|COMPLETED|Run In (1-5 Week Transition)||14
5022847|NCT02152384|12360341|P1|COMPLETED|Run In (1-5 Week Transition)||14
5022848|NCT02152384|12360340|P2|STARTED|Run In (1-5 Week Transition)||14
5022849|NCT02152384|12360341|P1|STARTED|Run In (1-5 Week Transition)||14
5022850|NCT02152371|12360361|P2|NOT COMPLETED|Overall Study||16
5022851|NCT02152371|12360362|P1|NOT COMPLETED|Overall Study||12
5022852|NCT02152371|12360361|P2|COMPLETED|Overall Study||134
5022853|NCT02152371|12360362|P1|COMPLETED|Overall Study||138
5022854|NCT02152371|12360361|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
5022855|NCT02152371|12360362|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
5022856|NCT02152371|12360361|P2|STARTED|Overall Study||150
5022857|NCT02152371|12360362|P1|STARTED|Overall Study||150
5022858|NCT02152345|12360400|P2|NOT COMPLETED|Overall Study||5
5022859|NCT02152345|12360401|P1|NOT COMPLETED|Overall Study||4
5022860|NCT02152345|12360400|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
5022861|NCT02152345|12360401|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
5022862|NCT02152345|12360400|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
5022863|NCT02152345|12360401|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
5022864|NCT02152137|12360413|P1|NOT COMPLETED|Overall Study||4
5022865|NCT02152137|12360413|P1|COMPLETED|Overall Study||15
5022866|NCT02152137|12360413|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
5022867|NCT02152137|12360413|P1|Originally Assigned to Arm A|Overall Study||16
5022868|NCT02152137|12360413|P1|STARTED|Overall Study||19
5022869|NCT02152007|12360421|P1|NOT COMPLETED|Overall Study||1
5022870|NCT02152007|12360421|P1|COMPLETED|Overall Study||14
5022871|NCT02152007|12360421|P1|STARTED|Overall Study||15
5022872|NCT02151994|12360430|P13|NOT COMPLETED|Food Effect (FE): Fed||0
5022873|NCT02151994|12360431|P12|NOT COMPLETED|Food Effect (FE): Fed||0
5022874|NCT02151994|12360432|P11|NOT COMPLETED|Food Effect (FE): Fed||0
5022875|NCT02151994|12360433|P10|NOT COMPLETED|Food Effect (FE): Fed||0
5022876|NCT02151994|12360434|P9|NOT COMPLETED|Food Effect (FE): Fed||0
5022877|NCT02151994|12360435|P8|NOT COMPLETED|Food Effect (FE): Fed||0
5022878|NCT02151994|12360436|P7|NOT COMPLETED|Food Effect (FE): Fed||0
5022879|NCT02151994|12360437|P6|NOT COMPLETED|Food Effect (FE): Fed||0
5022880|NCT02151994|12360438|P5|NOT COMPLETED|Food Effect (FE): Fed||0
5022881|NCT02151994|12360439|P4|NOT COMPLETED|Food Effect (FE): Fed||0
5022882|NCT02151994|12360440|P3|NOT COMPLETED|Food Effect (FE): Fed||0
5022883|NCT02151994|12360441|P2|NOT COMPLETED|Food Effect (FE): Fed||0
5022884|NCT02151994|12360442|P1|NOT COMPLETED|Food Effect (FE): Fed||0
5022885|NCT02151994|12360430|P13|COMPLETED|Food Effect (FE): Fed||12
5022886|NCT02151994|12360431|P12|COMPLETED|Food Effect (FE): Fed||0
5022887|NCT02151994|12360432|P11|COMPLETED|Food Effect (FE): Fed||0
5022888|NCT02151994|12360433|P10|COMPLETED|Food Effect (FE): Fed||0
5022889|NCT02151994|12360434|P9|COMPLETED|Food Effect (FE): Fed||0
5022890|NCT02151994|12360435|P8|COMPLETED|Food Effect (FE): Fed||0
5022891|NCT02151994|12360436|P7|COMPLETED|Food Effect (FE): Fed||0
5022892|NCT02151994|12360437|P6|COMPLETED|Food Effect (FE): Fed||0
5022893|NCT02151994|12360438|P5|COMPLETED|Food Effect (FE): Fed||0
5022894|NCT02151994|12360439|P4|COMPLETED|Food Effect (FE): Fed||0
5022895|NCT02151994|12360440|P3|COMPLETED|Food Effect (FE): Fed||0
5022896|NCT02151994|12360441|P2|COMPLETED|Food Effect (FE): Fed||0
5022897|NCT02151994|12360442|P1|COMPLETED|Food Effect (FE): Fed||0
5022898|NCT02151994|12360430|P13|STARTED|Food Effect (FE): Fed||12
5022899|NCT02151994|12360431|P12|STARTED|Food Effect (FE): Fed||0
5022900|NCT02151994|12360432|P11|STARTED|Food Effect (FE): Fed||0
5022901|NCT02151994|12360433|P10|STARTED|Food Effect (FE): Fed||0
5022902|NCT02151994|12360434|P9|STARTED|Food Effect (FE): Fed||0
5022903|NCT02151994|12360435|P8|STARTED|Food Effect (FE): Fed||0
5022904|NCT02151994|12360436|P7|STARTED|Food Effect (FE): Fed||0
5022905|NCT02151994|12360437|P6|STARTED|Food Effect (FE): Fed||0
5022906|NCT02151994|12360438|P5|STARTED|Food Effect (FE): Fed||0
5022907|NCT02151994|12360439|P4|STARTED|Food Effect (FE): Fed||0
5022908|NCT02151994|12360440|P3|STARTED|Food Effect (FE): Fed||0
5022909|NCT02151994|12360441|P2|STARTED|Food Effect (FE): Fed||0
5022910|NCT02151994|12360442|P1|STARTED|Food Effect (FE): Fed||0
5022911|NCT02151994|12360430|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
5022912|NCT02151994|12360431|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
5022913|NCT02151994|12360432|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
5022914|NCT02151994|12360433|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
5022915|NCT02151994|12360434|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
5022916|NCT02151994|12360435|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
5022917|NCT02151994|12360436|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
5022918|NCT02151994|12360437|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
5022919|NCT02151994|12360438|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
5022920|NCT02151994|12360439|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
5022921|NCT02151994|12360440|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
5022922|NCT02151994|12360441|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
5022923|NCT02151994|12360442|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
5022924|NCT02151994|12360430|P13|COMPLETED|Food Effect (FE): Fasted||0
5022925|NCT02151994|12360431|P12|COMPLETED|Food Effect (FE): Fasted||12
5022926|NCT02151994|12360432|P11|COMPLETED|Food Effect (FE): Fasted||0
5022927|NCT02151994|12360433|P10|COMPLETED|Food Effect (FE): Fasted||0
5022928|NCT02151994|12360434|P9|COMPLETED|Food Effect (FE): Fasted||0
5022929|NCT02151994|12360435|P8|COMPLETED|Food Effect (FE): Fasted||0
5022930|NCT02151994|12360436|P7|COMPLETED|Food Effect (FE): Fasted||0
5022931|NCT02151994|12360437|P6|COMPLETED|Food Effect (FE): Fasted||0
5022932|NCT02151994|12360438|P5|COMPLETED|Food Effect (FE): Fasted||0
5022933|NCT02151994|12360439|P4|COMPLETED|Food Effect (FE): Fasted||0
5022934|NCT02151994|12360440|P3|COMPLETED|Food Effect (FE): Fasted||0
5022935|NCT02151994|12360441|P2|COMPLETED|Food Effect (FE): Fasted||0
5022936|NCT02151994|12360442|P1|COMPLETED|Food Effect (FE): Fasted||0
5022937|NCT02151994|12360430|P13|STARTED|Food Effect (FE): Fasted||0
5022938|NCT02151994|12360431|P12|STARTED|Food Effect (FE): Fasted||12
5022939|NCT02151994|12360432|P11|STARTED|Food Effect (FE): Fasted||0
5022940|NCT02151994|12360433|P10|STARTED|Food Effect (FE): Fasted||0
5022941|NCT02151994|12360434|P9|STARTED|Food Effect (FE): Fasted||0
5022942|NCT02151994|12360435|P8|STARTED|Food Effect (FE): Fasted||0
5022943|NCT02151994|12360436|P7|STARTED|Food Effect (FE): Fasted||0
5022944|NCT02151994|12360437|P6|STARTED|Food Effect (FE): Fasted||0
5022945|NCT02151994|12360438|P5|STARTED|Food Effect (FE): Fasted||0
5022946|NCT02151994|12360439|P4|STARTED|Food Effect (FE): Fasted||0
5022947|NCT02151994|12360440|P3|STARTED|Food Effect (FE): Fasted||0
5022948|NCT02151994|12360441|P2|STARTED|Food Effect (FE): Fasted||0
5022949|NCT02151994|12360442|P1|STARTED|Food Effect (FE): Fasted||0
5022950|NCT02151994|12360430|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022951|NCT02151994|12360431|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022952|NCT02151994|12360432|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022953|NCT02151994|12360433|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022954|NCT02151994|12360434|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022955|NCT02151994|12360435|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022956|NCT02151994|12360436|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022957|NCT02151994|12360437|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022958|NCT02151994|12360438|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022959|NCT02151994|12360439|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022960|NCT02151994|12360440|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022961|NCT02151994|12360441|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022962|NCT02151994|12360442|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
5022963|NCT02151994|12360430|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
5022964|NCT02151994|12360431|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
5022965|NCT02151994|12360432|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
5022966|NCT02151994|12360433|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
5022967|NCT02151994|12360434|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
5022968|NCT02151994|12360435|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
5022969|NCT02151994|12360436|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
5022970|NCT02151994|12360437|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
5022971|NCT02151994|12360438|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
5022972|NCT02151994|12360439|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
5022973|NCT02151994|12360440|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
5022974|NCT02151994|12360441|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
5022975|NCT02151994|12360442|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
5022976|NCT02151994|12360430|P13|STARTED|Multiple Ascending Dose (MAD)||0
5022977|NCT02151994|12360431|P12|STARTED|Multiple Ascending Dose (MAD)||0
5022978|NCT02151994|12360432|P11|STARTED|Multiple Ascending Dose (MAD)||0
5022979|NCT02151994|12360433|P10|STARTED|Multiple Ascending Dose (MAD)||0
5022980|NCT02151994|12360434|P9|STARTED|Multiple Ascending Dose (MAD)||6
5022981|NCT02151994|12360435|P8|STARTED|Multiple Ascending Dose (MAD)||0
5022982|NCT02151994|12360436|P7|STARTED|Multiple Ascending Dose (MAD)||6
5022983|NCT02151994|12360437|P6|STARTED|Multiple Ascending Dose (MAD)||6
5022984|NCT02151994|12360438|P5|STARTED|Multiple Ascending Dose (MAD)||6
5022985|NCT02151994|12360439|P4|STARTED|Multiple Ascending Dose (MAD)||6
5022986|NCT02151994|12360440|P3|STARTED|Multiple Ascending Dose (MAD)||0
5022987|NCT02151994|12360441|P2|STARTED|Multiple Ascending Dose (MAD)||0
5022988|NCT02151994|12360442|P1|STARTED|Multiple Ascending Dose (MAD)||10
5022989|NCT02151994|12360430|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022990|NCT02151994|12360431|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022991|NCT02151994|12360432|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022992|NCT02151994|12360433|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022993|NCT02151994|12360434|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022994|NCT02151994|12360435|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022995|NCT02151994|12360436|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022996|NCT02151994|12360437|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022997|NCT02151994|12360438|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022998|NCT02151994|12360439|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
5022999|NCT02151994|12360440|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
5023000|NCT02151994|12360441|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
5023001|NCT02151994|12360442|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
5023002|NCT02151994|12360430|P13|COMPLETED|Single Ascending Dose (SAD)||0
5023003|NCT02151994|12360431|P12|COMPLETED|Single Ascending Dose (SAD)||0
5023004|NCT02151994|12360432|P11|COMPLETED|Single Ascending Dose (SAD)||6
5023005|NCT02151994|12360433|P10|COMPLETED|Single Ascending Dose (SAD)||6
5023006|NCT02151994|12360434|P9|COMPLETED|Single Ascending Dose (SAD)||0
5023007|NCT02151994|12360435|P8|COMPLETED|Single Ascending Dose (SAD)||6
5023008|NCT02151994|12360436|P7|COMPLETED|Single Ascending Dose (SAD)||6
5023009|NCT02151994|12360437|P6|COMPLETED|Single Ascending Dose (SAD)||6
5023010|NCT02151994|12360438|P5|COMPLETED|Single Ascending Dose (SAD)||6
5023011|NCT02151994|12360439|P4|COMPLETED|Single Ascending Dose (SAD)||6
5023012|NCT02151994|12360440|P3|COMPLETED|Single Ascending Dose (SAD)||6
5023013|NCT02151994|12360441|P2|COMPLETED|Single Ascending Dose (SAD)||6
5023014|NCT02151994|12360442|P1|COMPLETED|Single Ascending Dose (SAD)||18
5023015|NCT02151994|12360430|P13|STARTED|Single Ascending Dose (SAD)||0
5023016|NCT02151994|12360431|P12|STARTED|Single Ascending Dose (SAD)||0
5023017|NCT02151994|12360432|P11|STARTED|Single Ascending Dose (SAD)||6
5023018|NCT02151994|12360433|P10|STARTED|Single Ascending Dose (SAD)||6
5023019|NCT02151994|12360434|P9|STARTED|Single Ascending Dose (SAD)||0
5023020|NCT02151994|12360435|P8|STARTED|Single Ascending Dose (SAD)||6
5023021|NCT02151994|12360436|P7|STARTED|Single Ascending Dose (SAD)||6
5023022|NCT02151994|12360437|P6|STARTED|Single Ascending Dose (SAD)||6
5023023|NCT02151994|12360438|P5|STARTED|Single Ascending Dose (SAD)||6
5023024|NCT02151994|12360439|P4|STARTED|Single Ascending Dose (SAD)||6
5023025|NCT02151994|12360440|P3|STARTED|Single Ascending Dose (SAD)||6
5023026|NCT02151994|12360441|P2|STARTED|Single Ascending Dose (SAD)||6
5023027|NCT02151994|12360442|P1|STARTED|Single Ascending Dose (SAD)||18
5023028|NCT02151981|12360482|P2|NOT COMPLETED|Overall Study||140
5023029|NCT02151981|12360483|P1|NOT COMPLETED|Overall Study||279
5023030|NCT02151981|12360482|P2|COMPLETED|Overall Study||0
5023031|NCT02151981|12360483|P1|COMPLETED|Overall Study||0
5023032|NCT02151981|12360482|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
5023033|NCT02151981|12360483|P1|Crossed Over AZD9291|Overall Study||0
5023034|NCT02151981|12360482|P2|Did Not Receive Treatment|Overall Study||4
5023035|NCT02151981|12360483|P1|Did Not Receive Treatment|Overall Study||0
5023036|NCT02151981|12360482|P2|Received Randomised Treatment Only|Overall Study||54
5023037|NCT02151981|12360483|P1|Received Randomised Treatment Only|Overall Study||279
5023038|NCT02151981|12360482|P2|STARTED|Overall Study||140
5023039|NCT02151981|12360483|P1|STARTED|Overall Study||279
5023040|NCT02151877|12360501|P2|NOT COMPLETED|Overall Study||0
5023041|NCT02151877|12360502|P1|NOT COMPLETED|Overall Study||0
5023042|NCT02151877|12360501|P2|COMPLETED|Overall Study||12
5023043|NCT02151877|12360502|P1|COMPLETED|Overall Study||12
5023044|NCT02151877|12360501|P2|STARTED|Overall Study||12
5023045|NCT02151877|12360502|P1|STARTED|Overall Study||12
5023046|NCT02151851|12360520|P2|NOT COMPLETED|Overall Study||130
5023047|NCT02151851|12360521|P1|NOT COMPLETED|Overall Study||76
5023048|NCT02151851|12360520|P2|COMPLETED|Overall Study||186
5023049|NCT02151851|12360521|P1|COMPLETED|Overall Study||38
5023050|NCT02151851|12360520|P2|Included in the Safety Set|Overall Study||316
5023051|NCT02151851|12360521|P1|Included in the Safety Set|Overall Study||113
5023052|NCT02151851|12360520|P2|STARTED|Overall Study||316
5023053|NCT02151851|12360521|P1|STARTED|Overall Study||114
5023054|NCT02151786|12360533|P1|NOT COMPLETED|Overall Study||36
5023055|NCT02151786|12360533|P1|COMPLETED|Overall Study||1084
5023056|NCT02151786|12360533|P1|STARTED|Overall Study||1120
5023057|NCT02151773|12360544|P1|NOT COMPLETED|Overall Study||64
5023058|NCT02151773|12360544|P1|COMPLETED|Overall Study||3429
5023059|NCT02151773|12360544|P1|STARTED|Overall Study||3493
5023060|NCT02151682|12360551|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
5023061|NCT02151682|12360552|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023062|NCT02151682|12360553|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023063|NCT02151682|12360554|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023064|NCT02151682|12360555|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023065|NCT02151682|12360556|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023066|NCT02151682|12360551|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
5023067|NCT02151682|12360552|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023068|NCT02151682|12360553|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023069|NCT02151682|12360554|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023070|NCT02151682|12360555|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023071|NCT02151682|12360556|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
5023072|NCT02151682|12360551|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
5023073|NCT02151682|12360552|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
5023074|NCT02151682|12360553|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
5023075|NCT02151682|12360554|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
5023076|NCT02151682|12360555|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
5023077|NCT02151682|12360556|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
5023078|NCT02151682|12360551|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
5023079|NCT02151682|12360552|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
5023080|NCT02151682|12360553|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
5023081|NCT02151682|12360554|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
5023082|NCT02151682|12360555|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
5023083|NCT02151682|12360556|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
5023084|NCT02151682|12360551|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
5023085|NCT02151682|12360552|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
5023086|NCT02151682|12360553|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
5023087|NCT02151682|12360554|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
5023088|NCT02151682|12360555|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
5023089|NCT02151682|12360556|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
5023090|NCT02151682|12360551|P6|STARTED|Part 2: Tapent. Extension or Observation||0
5023091|NCT02151682|12360552|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
5023092|NCT02151682|12360553|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
5023093|NCT02151682|12360554|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
5023094|NCT02151682|12360555|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
5023095|NCT02151682|12360556|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
5023096|NCT02151682|12360551|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023097|NCT02151682|12360552|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023098|NCT02151682|12360553|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023099|NCT02151682|12360554|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023100|NCT02151682|12360555|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
5023101|NCT02151682|12360556|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
5023102|NCT02151682|12360551|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023103|NCT02151682|12360552|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023104|NCT02151682|12360553|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023105|NCT02151682|12360554|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
5023106|NCT02151682|12360555|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
5023107|NCT02151682|12360556|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
5023108|NCT02151682|12360551|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
5023109|NCT02151682|12360552|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
5023110|NCT02151682|12360553|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
5023111|NCT02151682|12360554|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
5023112|NCT02151682|12360555|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
5023113|NCT02151682|12360556|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
5023114|NCT02151643|12360606|P5|NOT COMPLETED|Overall Study||3
5023115|NCT02151643|12360607|P4|NOT COMPLETED|Overall Study||7
5023116|NCT02151643|12360608|P3|NOT COMPLETED|Overall Study||4
5023117|NCT02151643|12360609|P2|NOT COMPLETED|Overall Study||4
5023118|NCT02151643|12360610|P1|NOT COMPLETED|Overall Study||6
5023119|NCT02151643|12360606|P5|COMPLETED|Overall Study||35
5023120|NCT02151643|12360607|P4|COMPLETED|Overall Study||32
5023121|NCT02151643|12360608|P3|COMPLETED|Overall Study||21
5023122|NCT02151643|12360609|P2|COMPLETED|Overall Study||21
5023123|NCT02151643|12360610|P1|COMPLETED|Overall Study||20
5023124|NCT02151643|12360606|P5|STARTED|Overall Study||38
5023125|NCT02151643|12360607|P4|STARTED|Overall Study||39
5023126|NCT02151643|12360608|P3|STARTED|Overall Study||25
5023127|NCT02151643|12360609|P2|STARTED|Overall Study||25
5023128|NCT02151643|12360610|P1|STARTED|Overall Study||26
5023129|NCT02151591|12360649|P2|NOT COMPLETED|Overall Study||3
5023130|NCT02151591|12360650|P1|NOT COMPLETED|Overall Study||6
5023131|NCT02151591|12360649|P2|COMPLETED|Overall Study||10
5023132|NCT02151591|12360650|P1|COMPLETED|Overall Study||7
5023133|NCT02151591|12360649|P2|STARTED|Overall Study||13
5023134|NCT02151591|12360650|P1|STARTED|Overall Study||13
5023135|NCT02151526|12360662|P2|NOT COMPLETED|Overall Study||0
5023136|NCT02151526|12360663|P1|NOT COMPLETED|Overall Study||0
5023137|NCT02151526|12360662|P2|COMPLETED|Overall Study||4
5023138|NCT02151526|12360663|P1|COMPLETED|Overall Study||3
5023139|NCT02151526|12360662|P2|STARTED|Overall Study||4
5023140|NCT02151526|12360663|P1|STARTED|Overall Study||3
5023141|NCT02151487|12360700|P4|NOT COMPLETED|Overall Study||3
5023142|NCT02151487|12360701|P3|NOT COMPLETED|Overall Study||4
5023143|NCT02151487|12360702|P2|NOT COMPLETED|Overall Study||5
5023144|NCT02151487|12360703|P1|NOT COMPLETED|Overall Study||2
5023145|NCT02151487|12360700|P4|COMPLETED|Overall Study||20
5023146|NCT02151487|12360701|P3|COMPLETED|Overall Study||16
5023147|NCT02151487|12360702|P2|COMPLETED|Overall Study||22
5023148|NCT02151487|12360703|P1|COMPLETED|Overall Study||25
5023149|NCT02151487|12360700|P4|STARTED|Overall Study||23
5023150|NCT02151487|12360701|P3|STARTED|Overall Study||20
5023151|NCT02151487|12360702|P2|STARTED|Overall Study||27
5023152|NCT02151487|12360703|P1|STARTED|Overall Study||27
5023153|NCT02151461|12360721|P4|NOT COMPLETED|Overall Study||4
5023154|NCT02151461|12360722|P3|NOT COMPLETED|Overall Study||3
5023155|NCT02151461|12360723|P2|NOT COMPLETED|Overall Study||1
5023156|NCT02151461|12360724|P1|NOT COMPLETED|Overall Study||6
5023157|NCT02151461|12360721|P4|COMPLETED|Overall Study||19
5023158|NCT02151461|12360722|P3|COMPLETED|Overall Study||21
5023159|NCT02151461|12360723|P2|COMPLETED|Overall Study||24
5023160|NCT02151461|12360724|P1|COMPLETED|Overall Study||18
5023161|NCT02151461|12360721|P4|STARTED|Overall Study||23
5023162|NCT02151461|12360722|P3|STARTED|Overall Study||24
5023163|NCT02151461|12360723|P2|STARTED|Overall Study||25
5023164|NCT02151461|12360724|P1|STARTED|Overall Study||24
5023165|NCT02151448|12360762|P1|NOT COMPLETED|Phase 2||0
5023166|NCT02151448|12360762|P1|COMPLETED|Phase 2||55
5023167|NCT02151448|12360762|P1|STARTED|Phase 2||55
5023168|NCT02151448|12360762|P1|NOT COMPLETED|Phase 1||0
5023169|NCT02151448|12360762|P1|COMPLETED|Phase 1||9
5023170|NCT02151448|12360762|P1|STARTED|Phase 1||9
5023171|NCT02151383|12360780|P3|NOT COMPLETED|Overall Study||0
5023172|NCT02151383|12360781|P2|NOT COMPLETED|Overall Study||0
5023173|NCT02151383|12360782|P1|NOT COMPLETED|Overall Study||0
5023174|NCT02151383|12360780|P3|COMPLETED|Overall Study||1
5023175|NCT02151383|12360781|P2|COMPLETED|Overall Study||3
5023176|NCT02151383|12360782|P1|COMPLETED|Overall Study||8
5023177|NCT02151383|12360780|P3|High-dose|Overall Study||0
5023178|NCT02151383|12360781|P2|High-dose|Overall Study||0
5023179|NCT02151383|12360782|P1|High-dose|Overall Study||6
5023180|NCT02151383|12360780|P3|Low-dose|Overall Study||1
5023181|NCT02151383|12360781|P2|Low-dose|Overall Study||3
5023182|NCT02151383|12360782|P1|Low-dose|Overall Study||2
5023183|NCT02151383|12360780|P3|STARTED|Overall Study||1
5023184|NCT02151383|12360781|P2|STARTED|Overall Study||3
5023185|NCT02151383|12360782|P1|STARTED|Overall Study||8
5023186|NCT02151331|12360840|P2|NOT COMPLETED|Overall Study||40
5023187|NCT02151331|12360841|P1|NOT COMPLETED|Overall Study||32
5023188|NCT02151331|12360840|P2|COMPLETED|Overall Study||52
5023189|NCT02151331|12360841|P1|COMPLETED|Overall Study||45
5023190|NCT02151331|12360840|P2|STARTED|Overall Study||92
5023191|NCT02151331|12360841|P1|STARTED|Overall Study||77
5023192|NCT02151266|12360856|P3|NOT COMPLETED|Overall Study||7
5023193|NCT02151266|12360857|P2|NOT COMPLETED|Overall Study||15
5023194|NCT02151266|12360858|P1|NOT COMPLETED|Overall Study||8
5023195|NCT02151266|12360856|P3|COMPLETED|Overall Study||14
5023196|NCT02151266|12360857|P2|COMPLETED|Overall Study||14
5023197|NCT02151266|12360858|P1|COMPLETED|Overall Study||11
5023198|NCT02151266|12360856|P3|STARTED|Overall Study||21
5023199|NCT02151266|12360857|P2|STARTED|Overall Study||29
5023200|NCT02151266|12360858|P1|STARTED|Overall Study||19
5023201|NCT02151253|12360884|P2|NOT COMPLETED|Overall Study||0
5023202|NCT02151253|12360885|P1|NOT COMPLETED|Overall Study||0
5023203|NCT02151253|12360884|P2|COMPLETED|Overall Study||15
5023204|NCT02151253|12360885|P1|COMPLETED|Overall Study||13
5023205|NCT02151253|12360884|P2|STARTED|Overall Study||15
5023206|NCT02151253|12360885|P1|STARTED|Overall Study||13
5023207|NCT02151149|12360901|P2|NOT COMPLETED|Follow-Up Period||37
5023208|NCT02151149|12360902|P1|NOT COMPLETED|Follow-Up Period||39
5023209|NCT02151149|12360901|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
5023210|NCT02151149|12360902|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
5023211|NCT02151149|12360901|P2|STARTED|Follow-Up Period||55
5023212|NCT02151149|12360902|P1|STARTED|Follow-Up Period||58
5023213|NCT02151149|12360901|P2|NOT COMPLETED|Treatment Period||71
5023214|NCT02151149|12360902|P1|NOT COMPLETED|Treatment Period||70
5023215|NCT02151149|12360901|P2|COMPLETED|Treatment Period||1
5023216|NCT02151149|12360902|P1|COMPLETED|Treatment Period||1
5023217|NCT02151149|12360901|P2|Treated Population|Treatment Period||70
5023218|NCT02151149|12360902|P1|Treated Population|Treatment Period||68
5023219|NCT02151149|12360901|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
5023220|NCT02151149|12360902|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
5023221|NCT02151110|12360934|P8|NOT COMPLETED|Overall Study||3
5023222|NCT02151110|12360935|P7|NOT COMPLETED|Overall Study||0
5023223|NCT02151110|12360936|P6|NOT COMPLETED|Overall Study||0
5023224|NCT02151110|12360937|P5|NOT COMPLETED|Overall Study||0
5023225|NCT02151110|12360938|P4|NOT COMPLETED|Overall Study||0
5023226|NCT02151110|12360939|P3|NOT COMPLETED|Overall Study||0
5023227|NCT02151110|12360940|P2|NOT COMPLETED|Overall Study||0
5023228|NCT02151110|12360941|P1|NOT COMPLETED|Overall Study||0
5023229|NCT02151110|12360934|P8|COMPLETED|Overall Study||5
5023230|NCT02151110|12360935|P7|COMPLETED|Overall Study||8
5023231|NCT02151110|12360936|P6|COMPLETED|Overall Study||8
5023232|NCT02151110|12360937|P5|COMPLETED|Overall Study||8
5023233|NCT02151110|12360938|P4|COMPLETED|Overall Study||8
5023234|NCT02151110|12360939|P3|COMPLETED|Overall Study||2
5023235|NCT02151110|12360940|P2|COMPLETED|Overall Study||2
5023236|NCT02151110|12360941|P1|COMPLETED|Overall Study||12
5023237|NCT02151110|12360934|P8|STARTED|Overall Study||8
5023238|NCT02151110|12360935|P7|STARTED|Overall Study||8
5023239|NCT02151110|12360936|P6|STARTED|Overall Study||8
5023240|NCT02151110|12360937|P5|STARTED|Overall Study||8
5023241|NCT02151110|12360938|P4|STARTED|Overall Study||8
5023242|NCT02151110|12360939|P3|STARTED|Overall Study||2
5023243|NCT02151110|12360940|P2|STARTED|Overall Study||2
5023244|NCT02151110|12360941|P1|STARTED|Overall Study||12
5023245|NCT02151058|12361034|P3|NOT COMPLETED|Overall Study||5
5023246|NCT02151058|12361035|P2|NOT COMPLETED|Overall Study||1
5023247|NCT02151058|12361036|P1|NOT COMPLETED|Overall Study||2
5023248|NCT02151058|12361034|P3|COMPLETED|Overall Study||86
5023249|NCT02151058|12361035|P2|COMPLETED|Overall Study||90
5023250|NCT02151058|12361036|P1|COMPLETED|Overall Study||43
5023251|NCT02151058|12361034|P3|STARTED|Overall Study||91
5023252|NCT02151058|12361035|P2|STARTED|Overall Study||91
5023253|NCT02151058|12361036|P1|STARTED|Overall Study||45
5023254|NCT02150954|12361070|P2|NOT COMPLETED|Overall Study||0
5023255|NCT02150954|12361071|P1|NOT COMPLETED|Overall Study||1
5023256|NCT02150954|12361070|P2|COMPLETED|Overall Study||59
5023257|NCT02150954|12361071|P1|COMPLETED|Overall Study||57
5023258|NCT02150954|12361070|P2|STARTED|Overall Study||59
5023259|NCT02150954|12361071|P1|STARTED|Overall Study||58
5023260|NCT02150863|12361096|P3|NOT COMPLETED|Overall Study||0
5023261|NCT02150863|12361097|P2|NOT COMPLETED|Overall Study||1
5023262|NCT02150863|12361098|P1|NOT COMPLETED|Overall Study||0
5023263|NCT02150863|12361096|P3|COMPLETED|Overall Study||0
5023264|NCT02150863|12361097|P2|COMPLETED|Overall Study||0
5023265|NCT02150863|12361098|P1|COMPLETED|Overall Study||0
5023266|NCT02150863|12361096|P3|STARTED|Overall Study||0
5023267|NCT02150863|12361097|P2|STARTED|Overall Study||1
5023268|NCT02150863|12361098|P1|STARTED|Overall Study||0
5023269|NCT02150837|12361108|P2|NOT COMPLETED|Overall Study||125
5023270|NCT02150837|12361109|P1|NOT COMPLETED|Overall Study||25
5023271|NCT02150837|12361108|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
5023272|NCT02150837|12361109|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
5023273|NCT02150837|12361108|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
5023274|NCT02150837|12361109|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
5023275|NCT02150759|12361281|P2|NOT COMPLETED|Overall Study||2
5023276|NCT02150759|12361282|P1|NOT COMPLETED|Overall Study||1
5023277|NCT02150759|12361281|P2|COMPLETED|Overall Study||21
5023278|NCT02150759|12361282|P1|COMPLETED|Overall Study||22
5023279|NCT02150759|12361281|P2|STARTED|Overall Study||23
5023280|NCT02150759|12361282|P1|STARTED|Overall Study||23
5023281|NCT02150499|12361292|P2|NOT COMPLETED|Overall Study||0
5023282|NCT02150499|12361293|P1|NOT COMPLETED|Overall Study||0
5023283|NCT02150499|12361292|P2|COMPLETED|Overall Study||9
5023284|NCT02150499|12361293|P1|COMPLETED|Overall Study||9
5023285|NCT02150499|12361292|P2|STARTED|Overall Study||9
5023286|NCT02150499|12361293|P1|STARTED|Overall Study||9
5023287|NCT02150460|12361315|P2|NOT COMPLETED|Overall Study||0
5023288|NCT02150460|12361316|P1|NOT COMPLETED|Overall Study||0
5023289|NCT02150460|12361315|P2|COMPLETED|Overall Study||50
5023290|NCT02150460|12361316|P1|COMPLETED|Overall Study||50
5023291|NCT02150460|12361315|P2|STARTED|Overall Study||50
5023292|NCT02150460|12361316|P1|STARTED|Overall Study||50
5023293|NCT02150343|12361344|P4|NOT COMPLETED|Overall Study||10
5023294|NCT02150343|12361345|P3|NOT COMPLETED|Overall Study||12
5023295|NCT02150343|12361346|P2|NOT COMPLETED|Overall Study||20
5023296|NCT02150343|12361347|P1|NOT COMPLETED|Overall Study||21
5023297|NCT02150343|12361344|P4|COMPLETED|Overall Study||168
5023298|NCT02150343|12361345|P3|COMPLETED|Overall Study||166
5023299|NCT02150343|12361346|P2|COMPLETED|Overall Study||158
5023300|NCT02150343|12361347|P1|COMPLETED|Overall Study||159
5023301|NCT02150343|12361344|P4|STARTED|Overall Study||178
5023302|NCT02150343|12361345|P3|STARTED|Overall Study||178
5023303|NCT02150343|12361346|P2|STARTED|Overall Study||178
5023304|NCT02150343|12361347|P1|STARTED|Overall Study||180
5023305|NCT02150213|12361385|P1|NOT COMPLETED|Overall Study||2
5023306|NCT02150213|12361385|P1|COMPLETED|Overall Study||57
5023307|NCT02150213|12361385|P1|STARTED|Overall Study||59
5023308|NCT02150109|12361390|P1|NOT COMPLETED|Overall Study||0
5023309|NCT02150109|12361390|P1|COMPLETED|Overall Study||372
5023310|NCT02150109|12361390|P1|STARTED|Overall Study||372
5023311|NCT02150057|12361404|P2|NOT COMPLETED|Overall Study||4
5023312|NCT02150057|12361405|P1|NOT COMPLETED|Overall Study||6
5023313|NCT02150057|12361404|P2|COMPLETED|Overall Study||22
5023314|NCT02150057|12361405|P1|COMPLETED|Overall Study||19
5023315|NCT02150057|12361404|P2|STARTED|Overall Study||26
5023316|NCT02150057|12361405|P1|STARTED|Overall Study||25
5023317|NCT02150044|12361411|P1|NOT COMPLETED|Overall Study||0
5023318|NCT02150044|12361411|P1|COMPLETED|Overall Study||29
5023319|NCT02150044|12361411|P1|Study Cohort|Overall Study||13
5023320|NCT02150044|12361411|P1|Lead-In Subjects|Overall Study||16
5023321|NCT02150044|12361411|P1|STARTED|Overall Study||29
5023322|NCT02149875|12361420|P3|NOT COMPLETED|Overall Study||9
5023323|NCT02149875|12361421|P2|NOT COMPLETED|Overall Study||8
5023324|NCT02149875|12361422|P1|NOT COMPLETED|Overall Study||7
5023325|NCT02149875|12361420|P3|COMPLETED|Overall Study||20
5023326|NCT02149875|12361421|P2|COMPLETED|Overall Study||20
5023327|NCT02149875|12361422|P1|COMPLETED|Overall Study||20
5023328|NCT02149875|12361420|P3|STARTED|Overall Study||29
5023329|NCT02149875|12361421|P2|STARTED|Overall Study||28
5023330|NCT02149875|12361422|P1|STARTED|Overall Study||27
5023331|NCT02149836|12361433|P1|NOT COMPLETED|Overall Study||1
5023332|NCT02149836|12361433|P1|COMPLETED|Overall Study||17
5023333|NCT02149836|12361433|P1|STARTED|Overall Study||18
5023334|NCT02149524|12361442|P2|NOT COMPLETED|Overall Study||57
5023335|NCT02149524|12361443|P1|NOT COMPLETED|Overall Study||54
5023336|NCT02149524|12361442|P2|COMPLETED|Overall Study||380
5023337|NCT02149524|12361443|P1|COMPLETED|Overall Study||384
5023338|NCT02149524|12361442|P2|STARTED|Overall Study||437
5023339|NCT02149524|12361443|P1|STARTED|Overall Study||438
5023340|NCT02149420|12361460|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
5023341|NCT02149420|12361461|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
5023342|NCT02149420|12361462|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
5023343|NCT02149420|12361460|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
5023344|NCT02149420|12361461|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
5023345|NCT02149420|12361462|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
5023346|NCT02149420|12361460|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
5023347|NCT02149420|12361461|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
5023348|NCT02149420|12361462|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
5023349|NCT02149420|12361460|P3|NOT COMPLETED|Core Study||2
5023350|NCT02149420|12361461|P2|NOT COMPLETED|Core Study||1
5023351|NCT02149420|12361462|P1|NOT COMPLETED|Core Study||0
5023352|NCT02149420|12361460|P3|COMPLETED|Core Study||10
5023353|NCT02149420|12361461|P2|COMPLETED|Core Study||5
5023354|NCT02149420|12361462|P1|COMPLETED|Core Study||9
5023355|NCT02149420|12361460|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
5023356|NCT02149420|12361461|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
5023357|NCT02149420|12361462|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
5023358|NCT02149420|12361460|P3|PK Analysis Set|Core Study||12
5023359|NCT02149420|12361461|P2|PK Analysis Set|Core Study||6
5023360|NCT02149420|12361462|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
5023361|NCT02149420|12361460|P3|Safety Analysis Set|Core Study||12
5023362|NCT02149420|12361461|P2|Safety Analysis Set|Core Study||6
5023363|NCT02149420|12361462|P1|Safety Analysis Set|Core Study||9
5023364|NCT02149420|12361460|P3|STARTED|Core Study||12
5023365|NCT02149420|12361461|P2|STARTED|Core Study||6
5023366|NCT02149420|12361462|P1|STARTED|Core Study||9
5023367|NCT02149342|12361512|P1|NOT COMPLETED|Overall Study||0
5023368|NCT02149342|12361512|P1|COMPLETED|Overall Study|14 patients|14
5023369|NCT02149342|12361512|P1|STARTED|Overall Study|14 patients|14
5023370|NCT02149303|12361524|P1|NOT COMPLETED|Overall Study||0
5023371|NCT02149303|12361524|P1|COMPLETED|Overall Study||191
5023372|NCT02149303|12361524|P1|STARTED|Overall Study||191
5023373|NCT02149264|12361530|P1|NOT COMPLETED|Overall Study||20
5023374|NCT02149264|12361530|P1|COMPLETED|Overall Study||139
5023375|NCT02149264|12361530|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
5023376|NCT02149199|12361546|P3|NOT COMPLETED|Overall Study||147
5023377|NCT02149199|12361547|P2|NOT COMPLETED|Overall Study||193
5023378|NCT02149199|12361548|P1|NOT COMPLETED|Overall Study||133
5023379|NCT02149199|12361546|P3|COMPLETED|Overall Study||1135
5023380|NCT02149199|12361547|P2|COMPLETED|Overall Study||1084
5023381|NCT02149199|12361548|P1|COMPLETED|Overall Study||1144
5023382|NCT02149199|12361546|P3|STARTED|Overall Study||1282
5023383|NCT02149199|12361547|P2|STARTED|Overall Study||1277
5023384|NCT02149199|12361548|P1|STARTED|Overall Study||1277
5023385|NCT02149173|12361613|P1|NOT COMPLETED|Overall Study||0
5023386|NCT02149173|12361613|P1|COMPLETED|Overall Study||29
5023387|NCT02149173|12361613|P1|STARTED|Overall Study||29
5023388|NCT02149108|12361627|P2|NOT COMPLETED|Overall Study||383
5023389|NCT02149108|12361628|P1|NOT COMPLETED|Overall Study||380
5023390|NCT02149108|12361627|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
5023391|NCT02149108|12361628|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
5023392|NCT02149108|12361627|P2|STARTED|Overall Study|Randomised patients.|386
5023393|NCT02149108|12361628|P1|STARTED|Overall Study|Randomised patients.|382
5023394|NCT02148952|12361642|P2|NOT COMPLETED|Follow-Up||279
5023395|NCT02148952|12361643|P1|NOT COMPLETED|Follow-Up||265
5023396|NCT02148952|12361642|P2|COMPLETED|Follow-Up||77347
5023397|NCT02148952|12361643|P1|COMPLETED|Follow-Up||79798
5023398|NCT02148952|12361642|P2|STARTED|Follow-Up||77626
5023399|NCT02148952|12361643|P1|STARTED|Follow-Up||80063
5023400|NCT02148952|12361642|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
5023401|NCT02148952|12361643|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
5023402|NCT02148952|12361642|P2|COMPLETED|Assessing Eligibility and Consent||77626
5023403|NCT02148952|12361643|P1|COMPLETED|Assessing Eligibility and Consent||80063
5023404|NCT02148952|12361642|P2|STARTED|Assessing Eligibility and Consent||80773
5023405|NCT02148952|12361643|P1|STARTED|Assessing Eligibility and Consent||83166
5023406|NCT02148874|12361701|P2|NOT COMPLETED|Overall Study||2
5023407|NCT02148874|12361702|P1|NOT COMPLETED|Overall Study||7
5023408|NCT02148874|12361701|P2|COMPLETED|Overall Study||84
5023409|NCT02148874|12361702|P1|COMPLETED|Overall Study||194
5023410|NCT02148874|12361701|P2|STARTED|Overall Study||86
5023411|NCT02148874|12361702|P1|STARTED|Overall Study||201
5023412|NCT02148835|12361714|P2|NOT COMPLETED|Overall Study||0
5023413|NCT02148835|12361715|P1|NOT COMPLETED|Overall Study||0
5023414|NCT02148835|12361714|P2|COMPLETED|Overall Study||22
5023415|NCT02148835|12361715|P1|COMPLETED|Overall Study||22
5023416|NCT02148835|12361714|P2|STARTED|Overall Study||22
5023417|NCT02148835|12361715|P1|STARTED|Overall Study||22
5023418|NCT02148809|12361721|P1|NOT COMPLETED|Overall Study||0
5023419|NCT02148809|12361721|P1|COMPLETED|Overall Study||14
5023420|NCT02148809|12361721|P1|STARTED|Overall Study||14
5023421|NCT02148718|12361726|P1|NOT COMPLETED|Overall Study||31
5023422|NCT02148718|12361726|P1|COMPLETED|Overall Study||55
5023423|NCT02148718|12361726|P1|STARTED|Overall Study||86
5023424|NCT02148588|12361747|P1|NOT COMPLETED|Overall Study||0
5023425|NCT02148588|12361747|P1|COMPLETED|Overall Study||8
5023426|NCT02148588|12361747|P1|STARTED|Overall Study||8
5023427|NCT02148523|12361759|P3|NOT COMPLETED|Overall Study||0
5023428|NCT02148523|12361760|P2|NOT COMPLETED|Overall Study||0
5023429|NCT02148523|12361761|P1|NOT COMPLETED|Overall Study||0
5023430|NCT02148523|12361759|P3|COMPLETED|Overall Study||67
5023431|NCT02148523|12361760|P2|COMPLETED|Overall Study||67
5023432|NCT02148523|12361761|P1|COMPLETED|Overall Study||67
5023433|NCT02148523|12361759|P3|STARTED|Overall Study||67
5023434|NCT02148523|12361760|P2|STARTED|Overall Study||67
5023435|NCT02148523|12361761|P1|STARTED|Overall Study||67
5023436|NCT02148445|12361774|P2|NOT COMPLETED|Overall Study||3
5023437|NCT02148445|12361775|P1|NOT COMPLETED|Overall Study||1
5023438|NCT02148445|12361774|P2|COMPLETED|Overall Study||197
5023439|NCT02148445|12361775|P1|COMPLETED|Overall Study||197
5023440|NCT02148445|12361774|P2|STARTED|Overall Study||200
5023441|NCT02148445|12361775|P1|STARTED|Overall Study||198
5023442|NCT02148302|12361813|P2|NOT COMPLETED|Overall Study||0
5023443|NCT02148302|12361814|P1|NOT COMPLETED|Overall Study||0
5023444|NCT02148302|12361813|P2|COMPLETED|Overall Study||66
5023445|NCT02148302|12361814|P1|COMPLETED|Overall Study||57
5023446|NCT02148302|12361813|P2|STARTED|Overall Study||66
5023447|NCT02148302|12361814|P1|STARTED|Overall Study||57
5023448|NCT02148250|12361826|P2|NOT COMPLETED|Period 2||0
5023449|NCT02148250|12361827|P1|NOT COMPLETED|Period 2||0
5023450|NCT02148250|12361826|P2|COMPLETED|Period 2||6
5023451|NCT02148250|12361827|P1|COMPLETED|Period 2||6
5023452|NCT02148250|12361826|P2|STARTED|Period 2||6
5023453|NCT02148250|12361827|P1|STARTED|Period 2||6
5023454|NCT02148250|12361826|P2|NOT COMPLETED|Period 1||0
5023455|NCT02148250|12361827|P1|NOT COMPLETED|Period 1||0
5023456|NCT02148250|12361826|P2|COMPLETED|Period 1||6
5023457|NCT02148250|12361827|P1|COMPLETED|Period 1||6
5023458|NCT02148250|12361826|P2|STARTED|Period 1||6
5023459|NCT02148250|12361827|P1|STARTED|Period 1||6
5023460|NCT02148250|12361826|P2|NOT COMPLETED|Screening||0
5023461|NCT02148250|12361827|P1|NOT COMPLETED|Screening||5
5023462|NCT02148250|12361826|P2|COMPLETED|Screening||0
5023463|NCT02148250|12361827|P1|COMPLETED|Screening||12
5023464|NCT02148250|12361826|P2|STARTED|Screening||0
5023465|NCT02148250|12361827|P1|STARTED|Screening||17
5023466|NCT02148211|12361841|P1|NOT COMPLETED|Overall Study||352
5023467|NCT02148211|12361841|P1|COMPLETED|Overall Study||155
5023468|NCT02148211|12361841|P1|STARTED|Overall Study||507
5023469|NCT02148133|12361850|P1|NOT COMPLETED|Overall Study||5
5023470|NCT02148133|12361850|P1|COMPLETED|Overall Study||16
5023471|NCT02148133|12361850|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
5023472|NCT02148133|12361850|P1|Safety Set (SS)|Overall Study||21
5023473|NCT02148133|12361850|P1|STARTED|Overall Study||21
5023474|NCT02148107|12361872|P3|NOT COMPLETED|Overall Study||0
5023475|NCT02148107|12361873|P2|NOT COMPLETED|Overall Study||0
5023476|NCT02148107|12361874|P1|NOT COMPLETED|Overall Study||0
5023477|NCT02148107|12361872|P3|COMPLETED|Overall Study||3
5023478|NCT02148107|12361873|P2|COMPLETED|Overall Study||7
5023479|NCT02148107|12361874|P1|COMPLETED|Overall Study||8
5023480|NCT02148107|12361872|P3|STARTED|Overall Study||3
5023481|NCT02148107|12361873|P2|STARTED|Overall Study||7
5023482|NCT02148107|12361874|P1|STARTED|Overall Study||8
5023483|NCT02147899|12361893|P3|NOT COMPLETED|Overall Study||0
5023484|NCT02147899|12361894|P2|NOT COMPLETED|Overall Study||0
5023485|NCT02147899|12361895|P1|NOT COMPLETED|Overall Study||0
5023486|NCT02147899|12361893|P3|COMPLETED|Overall Study||72
5023487|NCT02147899|12361894|P2|COMPLETED|Overall Study||72
5023488|NCT02147899|12361895|P1|COMPLETED|Overall Study||71
5023489|NCT02147899|12361893|P3|STARTED|Overall Study||72
5023490|NCT02147899|12361894|P2|STARTED|Overall Study||72
5023491|NCT02147899|12361895|P1|STARTED|Overall Study||71
5023492|NCT02147834|12361908|P2|NOT COMPLETED|Overall Study||0
5023493|NCT02147834|12361909|P1|NOT COMPLETED|Overall Study||0
5023494|NCT02147834|12361908|P2|COMPLETED|Overall Study||2
5023495|NCT02147834|12361909|P1|COMPLETED|Overall Study||3
5023496|NCT02147834|12361908|P2|STARTED|Overall Study||2
5023497|NCT02147834|12361909|P1|STARTED|Overall Study||3
5023498|NCT02147769|12361919|P1|NOT COMPLETED|Overall Study||0
5023499|NCT02147769|12361919|P1|COMPLETED|Overall Study||111
5023500|NCT02147769|12361919|P1|STARTED|Overall Study||111
5023501|NCT02147691|12361926|P2|NOT COMPLETED|Overall Study||1
5023502|NCT02147691|12361927|P1|NOT COMPLETED|Overall Study||4
5023503|NCT02147691|12361926|P2|COMPLETED|Overall Study||11
5023504|NCT02147691|12361927|P1|COMPLETED|Overall Study||6
5023505|NCT02147691|12361926|P2|STARTED|Overall Study||12
5023506|NCT02147691|12361927|P1|STARTED|Overall Study||10
5023507|NCT02147613|12361973|P2|NOT COMPLETED|Overall Study||3
5023508|NCT02147613|12361974|P1|NOT COMPLETED|Overall Study||1
5023509|NCT02147613|12361973|P2|COMPLETED|Overall Study||6
5023510|NCT02147613|12361974|P1|COMPLETED|Overall Study||9
5023511|NCT02147613|12361973|P2|STARTED|Overall Study||9
5023512|NCT02147613|12361974|P1|STARTED|Overall Study||10
5023513|NCT02147587|12361986|P2|NOT COMPLETED|Overall Study||5
5023514|NCT02147587|12361987|P1|NOT COMPLETED|Overall Study||11
5023515|NCT02147587|12361986|P2|COMPLETED|Overall Study||50
5023516|NCT02147587|12361987|P1|COMPLETED|Overall Study||46
5023517|NCT02147587|12361986|P2|STARTED|Overall Study||55
5023518|NCT02147587|12361987|P1|STARTED|Overall Study||57
5023519|NCT02147561|12362007|P1|NOT COMPLETED|Overall Study||4
5023520|NCT02147561|12362007|P1|COMPLETED|Overall Study||276
5023521|NCT02147561|12362007|P1|STARTED|Overall Study||280
5023522|NCT02147522|12362015|P2|NOT COMPLETED|Overall Study||48
5023523|NCT02147522|12362016|P1|NOT COMPLETED|Overall Study||56
5023524|NCT02147522|12362015|P2|COMPLETED|Overall Study||122
5023525|NCT02147522|12362016|P1|COMPLETED|Overall Study||122
5023526|NCT02147522|12362015|P2|STARTED|Overall Study||170
5023527|NCT02147522|12362016|P1|STARTED|Overall Study||178
5023528|NCT02147353|12362028|P2|NOT COMPLETED|Overall Study||0
5023529|NCT02147353|12362029|P1|NOT COMPLETED|Overall Study||9
5023530|NCT02147353|12362028|P2|COMPLETED|Overall Study||21
5023531|NCT02147353|12362029|P1|COMPLETED|Overall Study||12
5023532|NCT02147353|12362028|P2|STARTED|Overall Study||21
5023533|NCT02147353|12362029|P1|STARTED|Overall Study||21
5023534|NCT02147301|12362047|P1|NOT COMPLETED|Overall Study||0
5023535|NCT02147301|12362047|P1|COMPLETED|Overall Study||17
5023536|NCT02147301|12362047|P1|STARTED|Overall Study||17
5023537|NCT02147288|12362062|P10|NOT COMPLETED|Overall Study||0
5023538|NCT02147288|12362063|P9|NOT COMPLETED|Overall Study||0
5023539|NCT02147288|12362064|P8|NOT COMPLETED|Overall Study||0
5023540|NCT02147288|12362065|P7|NOT COMPLETED|Overall Study||0
5023541|NCT02147288|12362066|P6|NOT COMPLETED|Overall Study||0
5023542|NCT02147288|12362067|P5|NOT COMPLETED|Overall Study||0
5023543|NCT02147288|12362068|P4|NOT COMPLETED|Overall Study||0
5023544|NCT02147288|12362069|P3|NOT COMPLETED|Overall Study||0
5023545|NCT02147288|12362070|P2|NOT COMPLETED|Overall Study||2
5023546|NCT02147288|12362071|P1|NOT COMPLETED|Overall Study||1
5023547|NCT02147288|12362062|P10|COMPLETED|Overall Study||0
5023548|NCT02147288|12362063|P9|COMPLETED|Overall Study||0
5023549|NCT02147288|12362064|P8|COMPLETED|Overall Study||0
5023550|NCT02147288|12362065|P7|COMPLETED|Overall Study||0
5023551|NCT02147288|12362066|P6|COMPLETED|Overall Study||0
5023552|NCT02147288|12362067|P5|COMPLETED|Overall Study||0
5023553|NCT02147288|12362068|P4|COMPLETED|Overall Study||0
5023554|NCT02147288|12362069|P3|COMPLETED|Overall Study||0
5023555|NCT02147288|12362070|P2|COMPLETED|Overall Study||22
5023556|NCT02147288|12362071|P1|COMPLETED|Overall Study||21
5023557|NCT02147288|12362062|P10|STARTED|Overall Study||0
5023558|NCT02147288|12362063|P9|STARTED|Overall Study||0
5023559|NCT02147288|12362064|P8|STARTED|Overall Study||0
5023560|NCT02147288|12362065|P7|STARTED|Overall Study||0
5023561|NCT02147288|12362066|P6|STARTED|Overall Study||0
5023562|NCT02147288|12362067|P5|STARTED|Overall Study||0
5023563|NCT02147288|12362068|P4|STARTED|Overall Study||0
5023564|NCT02147288|12362069|P3|STARTED|Overall Study||0
5023565|NCT02147288|12362070|P2|STARTED|Overall Study||24
5023566|NCT02147288|12362071|P1|STARTED|Overall Study||22
5023567|NCT02147197|12362080|P3|NOT COMPLETED|Overall Study||9
5023568|NCT02147197|12362081|P2|NOT COMPLETED|Overall Study||6
5023569|NCT02147197|12362082|P1|NOT COMPLETED|Overall Study||9
5023570|NCT02147197|12362080|P3|COMPLETED|Overall Study||39
5023571|NCT02147197|12362081|P2|COMPLETED|Overall Study||47
5023572|NCT02147197|12362082|P1|COMPLETED|Overall Study||47
5023573|NCT02147197|12362080|P3|STARTED|Overall Study||48
5023574|NCT02147197|12362081|P2|STARTED|Overall Study||53
5023575|NCT02147197|12362082|P1|STARTED|Overall Study||56
5023576|NCT02147184|12362101|P2|NOT COMPLETED|Overall Study||27
5023577|NCT02147184|12362102|P1|NOT COMPLETED|Overall Study||49
5023578|NCT02147184|12362101|P2|COMPLETED|Overall Study||110
5023579|NCT02147184|12362102|P1|COMPLETED|Overall Study||78
5023580|NCT02147184|12362101|P2|STARTED|Overall Study||137
5023581|NCT02147184|12362102|P1|STARTED|Overall Study||127
5023582|NCT02147158|12362126|P6|NOT COMPLETED|Off-Treatment Interval 2||4
5023583|NCT02147158|12362127|P5|NOT COMPLETED|Off-Treatment Interval 2||2
5023584|NCT02147158|12362128|P4|NOT COMPLETED|Off-Treatment Interval 2||11
5023585|NCT02147158|12362129|P3|NOT COMPLETED|Off-Treatment Interval 2||10
5023586|NCT02147158|12362130|P2|NOT COMPLETED|Off-Treatment Interval 2||4
5023587|NCT02147158|12362131|P1|NOT COMPLETED|Off-Treatment Interval 2||4
5023588|NCT02147158|12362126|P6|COMPLETED|Off-Treatment Interval 2||39
5023589|NCT02147158|12362127|P5|COMPLETED|Off-Treatment Interval 2||39
5023590|NCT02147158|12362128|P4|COMPLETED|Off-Treatment Interval 2||66
5023591|NCT02147158|12362129|P3|COMPLETED|Off-Treatment Interval 2||69
5023592|NCT02147158|12362130|P2|COMPLETED|Off-Treatment Interval 2||25
5023593|NCT02147158|12362131|P1|COMPLETED|Off-Treatment Interval 2||36
5023594|NCT02147158|12362126|P6|STARTED|Off-Treatment Interval 2||43
5023595|NCT02147158|12362127|P5|STARTED|Off-Treatment Interval 2||41
5023596|NCT02147158|12362128|P4|STARTED|Off-Treatment Interval 2||77
5023597|NCT02147158|12362129|P3|STARTED|Off-Treatment Interval 2||79
5023598|NCT02147158|12362130|P2|STARTED|Off-Treatment Interval 2||29
5023599|NCT02147158|12362131|P1|STARTED|Off-Treatment Interval 2||40
5023600|NCT02147158|12362126|P6|NOT COMPLETED|Treatment Course 2||2
5023601|NCT02147158|12362127|P5|NOT COMPLETED|Treatment Course 2||0
5023602|NCT02147158|12362128|P4|NOT COMPLETED|Treatment Course 2||5
5023603|NCT02147158|12362129|P3|NOT COMPLETED|Treatment Course 2||5
5023604|NCT02147158|12362130|P2|NOT COMPLETED|Treatment Course 2||5
5023605|NCT02147158|12362131|P1|NOT COMPLETED|Treatment Course 2||1
5023606|NCT02147158|12362126|P6|COMPLETED|Treatment Course 2||43
5023607|NCT02147158|12362127|P5|COMPLETED|Treatment Course 2||41
5023608|NCT02147158|12362128|P4|COMPLETED|Treatment Course 2||77
5023609|NCT02147158|12362129|P3|COMPLETED|Treatment Course 2||79
5023610|NCT02147158|12362130|P2|COMPLETED|Treatment Course 2||29
5023611|NCT02147158|12362131|P1|COMPLETED|Treatment Course 2||40
5023612|NCT02147158|12362126|P6|STARTED|Treatment Course 2||45
5023613|NCT02147158|12362127|P5|STARTED|Treatment Course 2||41
5023614|NCT02147158|12362128|P4|STARTED|Treatment Course 2||82
5023615|NCT02147158|12362129|P3|STARTED|Treatment Course 2||84
5023616|NCT02147158|12362130|P2|STARTED|Treatment Course 2||34
5023617|NCT02147158|12362131|P1|STARTED|Treatment Course 2||41
5023618|NCT02147158|12362126|P6|NOT COMPLETED|Off-Treatment Interval 1||5
5023619|NCT02147158|12362127|P5|NOT COMPLETED|Off-Treatment Interval 1||8
5023620|NCT02147158|12362128|P4|NOT COMPLETED|Off-Treatment Interval 1||15
5023621|NCT02147158|12362129|P3|NOT COMPLETED|Off-Treatment Interval 1||15
5023622|NCT02147158|12362130|P2|NOT COMPLETED|Off-Treatment Interval 1||4
5023623|NCT02147158|12362131|P1|NOT COMPLETED|Off-Treatment Interval 1||10
5023624|NCT02147158|12362126|P6|COMPLETED|Off-Treatment Interval 1||45
5023625|NCT02147158|12362127|P5|COMPLETED|Off-Treatment Interval 1||41
5023626|NCT02147158|12362128|P4|COMPLETED|Off-Treatment Interval 1||82
5023627|NCT02147158|12362129|P3|COMPLETED|Off-Treatment Interval 1||84
5023628|NCT02147158|12362130|P2|COMPLETED|Off-Treatment Interval 1||34
5023629|NCT02147158|12362131|P1|COMPLETED|Off-Treatment Interval 1||41
5023630|NCT02147158|12362126|P6|STARTED|Off-Treatment Interval 1||50
5023631|NCT02147158|12362127|P5|STARTED|Off-Treatment Interval 1||49
5023632|NCT02147158|12362128|P4|STARTED|Off-Treatment Interval 1||97
5023633|NCT02147158|12362129|P3|STARTED|Off-Treatment Interval 1||99
5023634|NCT02147158|12362130|P2|STARTED|Off-Treatment Interval 1||38
5023635|NCT02147158|12362131|P1|STARTED|Off-Treatment Interval 1||51
5023636|NCT02147158|12362126|P6|NOT COMPLETED|Treatment Course 1||8
5023637|NCT02147158|12362127|P5|NOT COMPLETED|Treatment Course 1||6
5023638|NCT02147158|12362128|P4|NOT COMPLETED|Treatment Course 1||13
5023639|NCT02147158|12362129|P3|NOT COMPLETED|Treatment Course 1||8
5023640|NCT02147158|12362130|P2|NOT COMPLETED|Treatment Course 1||9
5023641|NCT02147158|12362131|P1|NOT COMPLETED|Treatment Course 1||4
5023642|NCT02147158|12362126|P6|COMPLETED|Treatment Course 1||50
5023643|NCT02147158|12362127|P5|COMPLETED|Treatment Course 1||49
5023644|NCT02147158|12362128|P4|COMPLETED|Treatment Course 1||97
5023645|NCT02147158|12362129|P3|COMPLETED|Treatment Course 1||99
5023646|NCT02147158|12362130|P2|COMPLETED|Treatment Course 1||38
5023647|NCT02147158|12362131|P1|COMPLETED|Treatment Course 1||51
5023648|NCT02147158|12362126|P6|STARTED|Treatment Course 1||58
5023649|NCT02147158|12362127|P5|STARTED|Treatment Course 1||55
5023650|NCT02147158|12362128|P4|STARTED|Treatment Course 1||110
5023651|NCT02147158|12362129|P3|STARTED|Treatment Course 1||107
5023652|NCT02147158|12362130|P2|STARTED|Treatment Course 1||47
5023653|NCT02147158|12362131|P1|STARTED|Treatment Course 1||55
5023654|NCT02147132|12362160|P4|NOT COMPLETED|Overall Study||0
5023655|NCT02147132|12362161|P3|NOT COMPLETED|Overall Study||0
5023656|NCT02147132|12362162|P2|NOT COMPLETED|Overall Study||0
5023657|NCT02147132|12362163|P1|NOT COMPLETED|Overall Study||1
5023658|NCT02147132|12362160|P4|COMPLETED|Overall Study||2
5023659|NCT02147132|12362161|P3|COMPLETED|Overall Study||1
5023660|NCT02147132|12362162|P2|COMPLETED|Overall Study||2
5023661|NCT02147132|12362163|P1|COMPLETED|Overall Study||1
5023662|NCT02147132|12362160|P4|STARTED|Overall Study||2
5023663|NCT02147132|12362161|P3|STARTED|Overall Study||1
5023664|NCT02147132|12362162|P2|STARTED|Overall Study||2
5023665|NCT02147132|12362163|P1|STARTED|Overall Study||2
5023666|NCT02147093|12362183|P2|NOT COMPLETED|Period 2||0
5023667|NCT02147093|12362184|P1|NOT COMPLETED|Period 2||2
5023668|NCT02147093|12362183|P2|COMPLETED|Period 2||19
5023669|NCT02147093|12362184|P1|COMPLETED|Period 2||18
5023670|NCT02147093|12362183|P2|STARTED|Period 2||19
5023671|NCT02147093|12362184|P1|STARTED|Period 2||20
5023672|NCT02147093|12362183|P2|NOT COMPLETED|Period 1||1
5023673|NCT02147093|12362184|P1|NOT COMPLETED|Period 1||0
5023674|NCT02147093|12362183|P2|COMPLETED|Period 1||19
5023675|NCT02147093|12362184|P1|COMPLETED|Period 1||20
5023676|NCT02147093|12362183|P2|STARTED|Period 1||20
5023677|NCT02147093|12362184|P1|STARTED|Period 1||20
5023678|NCT02147067|12362194|P2|NOT COMPLETED|Overall Study||2
5023679|NCT02147067|12362195|P1|NOT COMPLETED|Overall Study||2
5023680|NCT02147067|12362194|P2|COMPLETED|Overall Study||11
5023681|NCT02147067|12362195|P1|COMPLETED|Overall Study||11
5023682|NCT02147067|12362194|P2|STARTED|Overall Study||13
5023683|NCT02147067|12362195|P1|STARTED|Overall Study||13
5023684|NCT02146599|12362221|P1|NOT COMPLETED|Overall Study||5
5023685|NCT02146599|12362221|P1|COMPLETED|Overall Study||296
5023686|NCT02146599|12362221|P1|STARTED|Overall Study||301
5023687|NCT02146482|12362227|P2|NOT COMPLETED|Overall Study||0
5023688|NCT02146482|12362228|P1|NOT COMPLETED|Overall Study||0
5023689|NCT02146482|12362227|P2|COMPLETED|Overall Study||25
5023690|NCT02146482|12362228|P1|COMPLETED|Overall Study||21
5023691|NCT02146482|12362227|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
5023692|NCT02146482|12362228|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
5023693|NCT02146365|12362240|P8|NOT COMPLETED|Overall Study||1
5023694|NCT02146365|12362241|P7|NOT COMPLETED|Overall Study||0
5023695|NCT02146365|12362242|P6|NOT COMPLETED|Overall Study||1
5023696|NCT02146365|12362243|P5|NOT COMPLETED|Overall Study||2
5023697|NCT02146365|12362244|P4|NOT COMPLETED|Overall Study||9
5023698|NCT02146365|12362245|P3|NOT COMPLETED|Overall Study||7
5023699|NCT02146365|12362246|P2|NOT COMPLETED|Overall Study||4
5023700|NCT02146365|12362247|P1|NOT COMPLETED|Overall Study||4
5023701|NCT02146365|12362240|P8|COMPLETED|Overall Study||24
5023702|NCT02146365|12362241|P7|COMPLETED|Overall Study||25
5023703|NCT02146365|12362242|P6|COMPLETED|Overall Study||24
5023704|NCT02146365|12362243|P5|COMPLETED|Overall Study||22
5023705|NCT02146365|12362244|P4|COMPLETED|Overall Study||41
5023706|NCT02146365|12362245|P3|COMPLETED|Overall Study||43
5023707|NCT02146365|12362246|P2|COMPLETED|Overall Study||45
5023708|NCT02146365|12362247|P1|COMPLETED|Overall Study||45
5023709|NCT02146365|12362240|P8|STARTED|Overall Study||25
5023710|NCT02146365|12362241|P7|STARTED|Overall Study||25
5023711|NCT02146365|12362242|P6|STARTED|Overall Study||25
5023712|NCT02146365|12362243|P5|STARTED|Overall Study||24
5023713|NCT02146365|12362244|P4|STARTED|Overall Study||50
5023714|NCT02146365|12362245|P3|STARTED|Overall Study||50
5023715|NCT02146365|12362246|P2|STARTED|Overall Study||49
5023716|NCT02146365|12362247|P1|STARTED|Overall Study||49
5023717|NCT02146352|12362373|P1|NOT COMPLETED|Overall Study||2
5023718|NCT02146352|12362373|P1|COMPLETED|Overall Study||28
5023719|NCT02146352|12362373|P1|7 Days Post-stent Removal|Overall Study||28
5023720|NCT02146352|12362373|P1|30 or 60 Days Post-procedure|Overall Study||30
5023721|NCT02146352|12362373|P1|STARTED|Overall Study||30
5023722|NCT02146326|12362391|P4|NOT COMPLETED|Overall Study||48
5023723|NCT02146326|12362392|P3|NOT COMPLETED|Overall Study||43
5023724|NCT02146326|12362393|P2|NOT COMPLETED|Overall Study||37
5023725|NCT02146326|12362394|P1|NOT COMPLETED|Overall Study||28
5023726|NCT02146326|12362391|P4|COMPLETED|Overall Study||210
5023727|NCT02146326|12362392|P3|COMPLETED|Overall Study||168
5023728|NCT02146326|12362393|P2|COMPLETED|Overall Study||66
5023729|NCT02146326|12362394|P1|COMPLETED|Overall Study||61
5023730|NCT02146326|12362391|P4|12 Months|Overall Study||210
5023731|NCT02146326|12362392|P3|12 Months|Overall Study||168
5023732|NCT02146326|12362393|P2|12 Months|Overall Study||66
5023733|NCT02146326|12362394|P1|12 Months|Overall Study||61
5023734|NCT02146326|12362391|P4|6 Months|Overall Study||235
5023735|NCT02146326|12362392|P3|6 Months|Overall Study||186
5023736|NCT02146326|12362393|P2|6 Months|Overall Study||71
5023737|NCT02146326|12362394|P1|6 Months|Overall Study||71
5023738|NCT02146326|12362391|P4|3 Months|Overall Study||0
5023739|NCT02146326|12362392|P3|3 Months|Overall Study||0
5023740|NCT02146326|12362393|P2|3 Months|Overall Study||83
5023741|NCT02146326|12362394|P1|3 Months|Overall Study||71
5023742|NCT02146326|12362391|P4|Baseline|Overall Study||258
5023743|NCT02146326|12362392|P3|Baseline|Overall Study||211
5023744|NCT02146326|12362393|P2|Baseline|Overall Study||103
5023745|NCT02146326|12362394|P1|Baseline|Overall Study||89
5023746|NCT02146326|12362391|P4|STARTED|Overall Study||258
5023747|NCT02146326|12362392|P3|STARTED|Overall Study||211
5023748|NCT02146326|12362393|P2|STARTED|Overall Study||103
5023749|NCT02146326|12362394|P1|STARTED|Overall Study||89
5023750|NCT02146274|12362556|P1|NOT COMPLETED|Overall Study||73
5023751|NCT02146274|12362556|P1|COMPLETED|Overall Study||1804
5023752|NCT02146274|12362556|P1|STARTED|Overall Study||1877
5023753|NCT02146248|12362563|P1|NOT COMPLETED|Overall Study||2
5023754|NCT02146248|12362563|P1|COMPLETED|Overall Study||9
5023755|NCT02146248|12362563|P1|HSG 5|Overall Study||1
5023756|NCT02146248|12362563|P1|HSG 4|Overall Study||7
5023757|NCT02146248|12362563|P1|HSG 3|Overall Study||9
5023758|NCT02146248|12362563|P1|HSG 2|Overall Study||10
5023759|NCT02146248|12362563|P1|HSG 1|Overall Study||10
5023760|NCT02146248|12362563|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
5023761|NCT02146248|12362563|P1|Enrolled|Overall Study||11
5023762|NCT02146248|12362563|P1|STARTED|Overall Study||11
5023763|NCT02146131|12362573|P2|NOT COMPLETED|Overall Study||56
5023764|NCT02146131|12362574|P1|NOT COMPLETED|Overall Study||61
5023765|NCT02146131|12362573|P2|COMPLETED|Overall Study||113
5023766|NCT02146131|12362574|P1|COMPLETED|Overall Study||109
5023767|NCT02146131|12362573|P2|STARTED|Overall Study||169
5023768|NCT02146131|12362574|P1|STARTED|Overall Study||170
5023769|NCT02146105|12362580|P1|NOT COMPLETED|Overall Study||6
5023770|NCT02146105|12362580|P1|COMPLETED|Overall Study||39
5023771|NCT02146105|12362580|P1|STARTED|Overall Study||45
5023772|NCT02146001|12362586|P2|NOT COMPLETED|Overall Study||0
5023773|NCT02146001|12362587|P1|NOT COMPLETED|Overall Study||0
5023774|NCT02146001|12362586|P2|COMPLETED|Overall Study||19
5023775|NCT02146001|12362587|P1|COMPLETED|Overall Study||19
5023776|NCT02146001|12362586|P2|STARTED|Overall Study||19
5023777|NCT02146001|12362587|P1|STARTED|Overall Study||19
5023778|NCT02145754|12362597|P1|NOT COMPLETED|Overall Study||0
5023779|NCT02145754|12362597|P1|COMPLETED|Overall Study||235
5023780|NCT02145754|12362597|P1|STARTED|Overall Study||235
5023781|NCT02145676|12362604|P3|NOT COMPLETED|Overall Study||0
5023782|NCT02145676|12362605|P2|NOT COMPLETED|Overall Study||0
5023783|NCT02145676|12362606|P1|NOT COMPLETED|Overall Study||0
5023784|NCT02145676|12362604|P3|COMPLETED|Overall Study||18
5023785|NCT02145676|12362605|P2|COMPLETED|Overall Study||18
5023786|NCT02145676|12362606|P1|COMPLETED|Overall Study||17
5023787|NCT02145676|12362604|P3|STARTED|Overall Study||18
5023788|NCT02145676|12362605|P2|STARTED|Overall Study||18
5023789|NCT02145676|12362606|P1|STARTED|Overall Study||17
5023790|NCT02145468|12362631|P2|NOT COMPLETED|Overall Study||8
5023791|NCT02145468|12362632|P1|NOT COMPLETED|Overall Study||5
5023792|NCT02145468|12362631|P2|COMPLETED|Overall Study||1723
5023793|NCT02145468|12362632|P1|COMPLETED|Overall Study||1753
5023794|NCT02145468|12362631|P2|STARTED|Overall Study||1731
5023795|NCT02145468|12362632|P1|STARTED|Overall Study||1758
5023796|NCT02145429|12362690|P2|NOT COMPLETED|Overall Study||11
5023797|NCT02145429|12362691|P1|NOT COMPLETED|Overall Study||16
5023798|NCT02145429|12362690|P2|COMPLETED|Overall Study||79
5023799|NCT02145429|12362691|P1|COMPLETED|Overall Study||75
5023800|NCT02145429|12362690|P2|STARTED|Overall Study||90
5023801|NCT02145429|12362691|P1|STARTED|Overall Study||91
5023802|NCT02145403|12362705|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023803|NCT02145403|12362706|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
5023804|NCT02145403|12362707|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023805|NCT02145403|12362708|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023806|NCT02145403|12362705|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023807|NCT02145403|12362706|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
5023808|NCT02145403|12362707|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023809|NCT02145403|12362708|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023810|NCT02145403|12362705|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023811|NCT02145403|12362706|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
5023812|NCT02145403|12362707|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023813|NCT02145403|12362708|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
5023814|NCT02145403|12362705|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
5023815|NCT02145403|12362706|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023816|NCT02145403|12362707|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023817|NCT02145403|12362708|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023818|NCT02145403|12362705|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
5023819|NCT02145403|12362706|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023820|NCT02145403|12362707|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023821|NCT02145403|12362708|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023822|NCT02145403|12362705|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
5023823|NCT02145403|12362706|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023824|NCT02145403|12362707|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023825|NCT02145403|12362708|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
5023826|NCT02145403|12362705|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023827|NCT02145403|12362706|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
5023828|NCT02145403|12362707|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023829|NCT02145403|12362708|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023830|NCT02145403|12362705|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023831|NCT02145403|12362706|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
5023832|NCT02145403|12362707|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023833|NCT02145403|12362708|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023834|NCT02145403|12362705|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023835|NCT02145403|12362706|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
5023836|NCT02145403|12362707|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023837|NCT02145403|12362708|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
5023838|NCT02145403|12362705|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023839|NCT02145403|12362706|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023840|NCT02145403|12362707|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023841|NCT02145403|12362708|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023842|NCT02145403|12362705|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023843|NCT02145403|12362706|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023844|NCT02145403|12362707|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
5023845|NCT02145403|12362708|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023846|NCT02145403|12362705|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023847|NCT02145403|12362706|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023848|NCT02145403|12362707|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
5023849|NCT02145403|12362708|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
5023850|NCT02145403|12362705|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023851|NCT02145403|12362706|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023852|NCT02145403|12362707|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023853|NCT02145403|12362708|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023854|NCT02145403|12362705|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023855|NCT02145403|12362706|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023856|NCT02145403|12362707|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023857|NCT02145403|12362708|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
5023858|NCT02145403|12362705|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023859|NCT02145403|12362706|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023860|NCT02145403|12362707|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
5023861|NCT02145403|12362708|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
5023862|NCT02145390|12362722|P1|NOT COMPLETED|Overall Study||1
5023863|NCT02145390|12362722|P1|COMPLETED|Overall Study||0
5023864|NCT02145390|12362722|P1|STARTED|Overall Study||1
5023865|NCT02145299|12362733|P2|NOT COMPLETED|Overall Study||0
5023866|NCT02145299|12362734|P1|NOT COMPLETED|Overall Study||0
5023867|NCT02145299|12362733|P2|COMPLETED|Overall Study||2
5023868|NCT02145299|12362734|P1|COMPLETED|Overall Study||6
5023869|NCT02145299|12362733|P2|STARTED|Overall Study||2
5023870|NCT02145299|12362734|P1|STARTED|Overall Study||6
5023871|NCT02145247|12362762|P2|NOT COMPLETED|Overall Study||0
5023872|NCT02145247|12362763|P1|NOT COMPLETED|Overall Study||0
5023873|NCT02145247|12362762|P2|COMPLETED|Overall Study||19
5023874|NCT02145247|12362763|P1|COMPLETED|Overall Study||20
5023875|NCT02145247|12362762|P2|STARTED|Overall Study||19
5023876|NCT02145247|12362763|P1|STARTED|Overall Study||20
5023877|NCT02145182|12362771|P2|NOT COMPLETED|Overall Study||16
5023878|NCT02145182|12362772|P1|NOT COMPLETED|Overall Study||18
5023879|NCT02145182|12362771|P2|COMPLETED|Overall Study||130
5023880|NCT02145182|12362772|P1|COMPLETED|Overall Study||124
5023881|NCT02145182|12362771|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
5023882|NCT02145182|12362772|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
5023883|NCT02145182|12362771|P2|STARTED|Overall Study||146
5023884|NCT02145182|12362772|P1|STARTED|Overall Study||142
5023885|NCT02145169|12362786|P1|NOT COMPLETED|Overall Study||0
5023886|NCT02145169|12362786|P1|COMPLETED|Overall Study||0
5023887|NCT02145169|12362786|P1|STARTED|Overall Study||0
5023888|NCT02145156|12362805|P3|NOT COMPLETED|Overall Study||41
5023889|NCT02145156|12362806|P2|NOT COMPLETED|Overall Study||52
5023890|NCT02145156|12362807|P1|NOT COMPLETED|Overall Study||60
5023891|NCT02145156|12362805|P3|COMPLETED|Overall Study||398
5023892|NCT02145156|12362806|P2|COMPLETED|Overall Study||373
5023893|NCT02145156|12362807|P1|COMPLETED|Overall Study||370
5023894|NCT02145156|12362805|P3|STARTED|Overall Study||439
5023895|NCT02145156|12362806|P2|STARTED|Overall Study||425
5023896|NCT02145156|12362807|P1|STARTED|Overall Study||430
5023897|NCT02145039|12362848|P1|NOT COMPLETED|Overall Study||0
5023898|NCT02145039|12362848|P1|COMPLETED|Overall Study||2
5023899|NCT02145039|12362848|P1|STARTED|Overall Study||2
5023900|NCT02145026|12362857|P1|NOT COMPLETED|Overall Study||12
5023901|NCT02145026|12362857|P1|COMPLETED|Overall Study||88
5023902|NCT02145026|12362857|P1|STARTED|Overall Study||100
5023903|NCT02144714|12362867|P3|NOT COMPLETED|Overall Study||0
5023904|NCT02144714|12362868|P2|NOT COMPLETED|Overall Study||0
5023905|NCT02144714|12362869|P1|NOT COMPLETED|Overall Study||0
5023906|NCT02144714|12362867|P3|COMPLETED|Overall Study||63
5023907|NCT02144714|12362868|P2|COMPLETED|Overall Study||63
5023908|NCT02144714|12362869|P1|COMPLETED|Overall Study||63
5023909|NCT02144714|12362867|P3|STARTED|Overall Study||63
5023910|NCT02144714|12362868|P2|STARTED|Overall Study||63
5023911|NCT02144714|12362869|P1|STARTED|Overall Study||63
5023912|NCT02144701|12362888|P2|NOT COMPLETED|Overall Study||3
5023913|NCT02144701|12362889|P1|NOT COMPLETED|Overall Study||9
5023914|NCT02144701|12362888|P2|COMPLETED|Overall Study||8
5023915|NCT02144701|12362889|P1|COMPLETED|Overall Study||13
5023916|NCT02144701|12362888|P2|STARTED|Overall Study||11
5023917|NCT02144701|12362889|P1|STARTED|Overall Study||22
5023918|NCT02144675|12362907|P2|NOT COMPLETED|Overall Study||0
5023919|NCT02144675|12362908|P1|NOT COMPLETED|Overall Study||0
5023920|NCT02144675|12362907|P2|COMPLETED|Overall Study||14
5023921|NCT02144675|12362908|P1|COMPLETED|Overall Study||13
5023922|NCT02144675|12362907|P2|STARTED|Overall Study||14
5023923|NCT02144675|12362908|P1|STARTED|Overall Study||13
5023924|NCT02144610|12362916|P2|NOT COMPLETED|Overall Study||22
5023925|NCT02144610|12362917|P1|NOT COMPLETED|Overall Study||23
5023926|NCT02144610|12362916|P2|COMPLETED|Overall Study||1
5023927|NCT02144610|12362917|P1|COMPLETED|Overall Study||0
5023928|NCT02144610|12362916|P2|STARTED|Overall Study||23
5023929|NCT02144610|12362917|P1|STARTED|Overall Study||23
5023930|NCT02144519|12362947|P2|NOT COMPLETED|Year 3||0
5023931|NCT02144519|12362948|P1|NOT COMPLETED|Year 3||0
5023932|NCT02144519|12362947|P2|COMPLETED|Year 3||760
5023933|NCT02144519|12362948|P1|COMPLETED|Year 3||894
5023934|NCT02144519|12362947|P2|STARTED|Year 3||760
5023935|NCT02144519|12362948|P1|STARTED|Year 3||894
5023936|NCT02144519|12362947|P2|NOT COMPLETED|Year 2||0
5023937|NCT02144519|12362948|P1|NOT COMPLETED|Year 2||0
5023938|NCT02144519|12362947|P2|COMPLETED|Year 2||864
5023939|NCT02144519|12362948|P1|COMPLETED|Year 2||763
5023940|NCT02144519|12362947|P2|STARTED|Year 2||864
5023941|NCT02144519|12362948|P1|STARTED|Year 2||763
5023942|NCT02144519|12362947|P2|NOT COMPLETED|Year 1||0
5023943|NCT02144519|12362948|P1|NOT COMPLETED|Year 1||0
5023944|NCT02144519|12362947|P2|COMPLETED|Year 1||870
5023945|NCT02144519|12362948|P1|COMPLETED|Year 1||895
5023946|NCT02144519|12362947|P2|STARTED|Year 1||870
5023947|NCT02144519|12362948|P1|STARTED|Year 1||895
5023948|NCT02144337|12362958|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
5023949|NCT02144337|12362959|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
5023950|NCT02144337|12362958|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
5023951|NCT02144337|12362959|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
5023952|NCT02144337|12362958|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
5023953|NCT02144337|12362959|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
5023954|NCT02144337|12362958|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
5023955|NCT02144337|12362959|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
5023956|NCT02144337|12362958|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
5023957|NCT02144337|12362959|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
5023958|NCT02144337|12362958|P2|STARTED|T2 Follow-up (Post-intervention)||5
5023959|NCT02144337|12362959|P1|STARTED|T2 Follow-up (Post-intervention)||8
5023960|NCT02144337|12362958|P2|NOT COMPLETED|Baseline 0 Months||0
5023961|NCT02144337|12362959|P1|NOT COMPLETED|Baseline 0 Months||0
5023962|NCT02144337|12362958|P2|COMPLETED|Baseline 0 Months||5
5023963|NCT02144337|12362959|P1|COMPLETED|Baseline 0 Months||8
5023964|NCT02144337|12362958|P2|STARTED|Baseline 0 Months||5
5023965|NCT02144337|12362959|P1|STARTED|Baseline 0 Months||8
5023966|NCT02144285|12362979|P10|NOT COMPLETED|Overall Study||0
5023967|NCT02144285|12362980|P9|NOT COMPLETED|Overall Study||0
5023968|NCT02144285|12362981|P8|NOT COMPLETED|Overall Study||0
5023969|NCT02144285|12362982|P7|NOT COMPLETED|Overall Study||0
5023970|NCT02144285|12362983|P6|NOT COMPLETED|Overall Study||0
5023971|NCT02144285|12362984|P5|NOT COMPLETED|Overall Study||1
5023972|NCT02144285|12362985|P4|NOT COMPLETED|Overall Study||0
5023973|NCT02144285|12362986|P3|NOT COMPLETED|Overall Study||0
5023974|NCT02144285|12362987|P2|NOT COMPLETED|Overall Study||0
5023975|NCT02144285|12362988|P1|NOT COMPLETED|Overall Study||0
5023976|NCT02144285|12362979|P10|COMPLETED|Overall Study||6
5023977|NCT02144285|12362980|P9|COMPLETED|Overall Study||2
5023978|NCT02144285|12362981|P8|COMPLETED|Overall Study||6
5023979|NCT02144285|12362982|P7|COMPLETED|Overall Study||6
5023980|NCT02144285|12362983|P6|COMPLETED|Overall Study||6
5023981|NCT02144285|12362984|P5|COMPLETED|Overall Study||5
5023982|NCT02144285|12362985|P4|COMPLETED|Overall Study||6
5023983|NCT02144285|12362986|P3|COMPLETED|Overall Study||6
5023984|NCT02144285|12362987|P2|COMPLETED|Overall Study||6
5023985|NCT02144285|12362988|P1|COMPLETED|Overall Study||14
5023986|NCT02144285|12362979|P10|Received At Least One Dose of Study Drug|Overall Study||6
5023987|NCT02144285|12362980|P9|Received At Least One Dose of Study Drug|Overall Study||2
5023988|NCT02144285|12362981|P8|Received At Least One Dose of Study Drug|Overall Study||6
5023989|NCT02144285|12362982|P7|Received At Least One Dose of Study Drug|Overall Study||6
5023990|NCT02144285|12362983|P6|Received At Least One Dose of Study Drug|Overall Study||6
5023991|NCT02144285|12362984|P5|Received At Least One Dose of Study Drug|Overall Study||6
5023992|NCT02144285|12362985|P4|Received At Least One Dose of Study Drug|Overall Study||6
5023993|NCT02144285|12362986|P3|Received At Least One Dose of Study Drug|Overall Study||6
5023994|NCT02144285|12362987|P2|Received At Least One Dose of Study Drug|Overall Study||6
5023995|NCT02144285|12362988|P1|Received At Least One Dose of Study Drug|Overall Study||14
5023996|NCT02144285|12362979|P10|STARTED|Overall Study||6
5023997|NCT02144285|12362980|P9|STARTED|Overall Study||2
5023998|NCT02144285|12362981|P8|STARTED|Overall Study||6
5023999|NCT02144285|12362982|P7|STARTED|Overall Study||6
5024000|NCT02144285|12362983|P6|STARTED|Overall Study||6
5024001|NCT02144285|12362984|P5|STARTED|Overall Study||6
5024002|NCT02144285|12362985|P4|STARTED|Overall Study||6
5024003|NCT02144285|12362986|P3|STARTED|Overall Study||6
5024004|NCT02144285|12362987|P2|STARTED|Overall Study||6
5024005|NCT02144285|12362988|P1|STARTED|Overall Study||14
5024006|NCT02144259|12363061|P3|NOT COMPLETED|Overall Study||18
5024007|NCT02144259|12363062|P2|NOT COMPLETED|Overall Study||5
5024008|NCT02144259|12363063|P1|NOT COMPLETED|Overall Study||10
5024009|NCT02144259|12363061|P3|COMPLETED|Overall Study||16
5024010|NCT02144259|12363062|P2|COMPLETED|Overall Study||28
5024011|NCT02144259|12363063|P1|COMPLETED|Overall Study||23
5024012|NCT02144259|12363061|P3|STARTED|Overall Study||34
5024013|NCT02144259|12363062|P2|STARTED|Overall Study||33
5024014|NCT02144259|12363063|P1|STARTED|Overall Study||33
5024015|NCT02144233|12363079|P2|NOT COMPLETED|Overall Study||0
5024016|NCT02144233|12363080|P1|NOT COMPLETED|Overall Study||0
5024017|NCT02144233|12363079|P2|COMPLETED|Overall Study||38
5024018|NCT02144233|12363080|P1|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
5024019|NCT02144233|12363079|P2|STARTED|Overall Study||38
5024020|NCT02144233|12363080|P1|STARTED|Overall Study||39
5024021|NCT02144220|12363114|P1|NOT COMPLETED|Overall Study||19
5024022|NCT02144220|12363114|P1|COMPLETED|Overall Study||258
5024023|NCT02144220|12363114|P1|STARTED|Overall Study||277
5024024|NCT02144155|12363122|P1|NOT COMPLETED|Overall Study||0
5024025|NCT02144155|12363122|P1|COMPLETED|Overall Study||14
5024026|NCT02144155|12363122|P1|STARTED|Overall Study||14
5024027|NCT02144077|12363133|P2|NOT COMPLETED|Overall Study||11
5024028|NCT02144077|12363134|P1|NOT COMPLETED|Overall Study||10
5024029|NCT02144077|12363133|P2|COMPLETED|Overall Study||132
5024030|NCT02144077|12363134|P1|COMPLETED|Overall Study||128
5024031|NCT02144077|12363133|P2|STARTED|Overall Study||143
5024032|NCT02144077|12363134|P1|STARTED|Overall Study||138
5024033|NCT02144012|12363152|P2|NOT COMPLETED|Overall Study||15
5024034|NCT02144012|12363153|P1|NOT COMPLETED|Overall Study||34
5024035|NCT02144012|12363152|P2|COMPLETED|Overall Study||0
5024036|NCT02144012|12363153|P1|COMPLETED|Overall Study||0
5024037|NCT02144012|12363152|P2|STARTED|Overall Study||15
5024038|NCT02144012|12363153|P1|STARTED|Overall Study||34
5024039|NCT02143947|12363190|P2|NOT COMPLETED|Overall Study||2
5024040|NCT02143947|12363191|P1|NOT COMPLETED|Overall Study||4
5024041|NCT02143947|12363190|P2|COMPLETED|Overall Study||42
5024042|NCT02143947|12363191|P1|COMPLETED|Overall Study||32
5024043|NCT02143947|12363190|P2|STARTED|Overall Study||44
5024044|NCT02143947|12363191|P1|STARTED|Overall Study||36
5024045|NCT02143843|12363203|P1|NOT COMPLETED|Overall Study||12
5024046|NCT02143843|12363203|P1|COMPLETED|Overall Study||63
5024047|NCT02143843|12363203|P1|STARTED|Overall Study||75
5024048|NCT02143778|12363208|P1|NOT COMPLETED|Overall Study||3
5024049|NCT02143778|12363208|P1|COMPLETED|Overall Study||243
5024050|NCT02143778|12363208|P1|STARTED|Overall Study||246
5024051|NCT02143713|12363217|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
5024052|NCT02143713|12363218|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
5024053|NCT02143713|12363219|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
5024054|NCT02143713|12363220|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
5024055|NCT02143713|12363217|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
5024056|NCT02143713|12363218|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
5024057|NCT02143713|12363219|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
5024058|NCT02143713|12363220|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
5024059|NCT02143713|12363217|P4|STARTED|Post-treatment Follow-up (12 Months)||122
5024060|NCT02143713|12363218|P3|STARTED|Post-treatment Follow-up (12 Months)||125
5024061|NCT02143713|12363219|P2|STARTED|Post-treatment Follow-up (12 Months)||105
5024062|NCT02143713|12363220|P1|STARTED|Post-treatment Follow-up (12 Months)||85
5024063|NCT02143713|12363217|P4|NOT COMPLETED|Treatment Period (6 Months)||28
5024064|NCT02143713|12363218|P3|NOT COMPLETED|Treatment Period (6 Months)||22
5024065|NCT02143713|12363219|P2|NOT COMPLETED|Treatment Period (6 Months)||12
5024066|NCT02143713|12363220|P1|NOT COMPLETED|Treatment Period (6 Months)||20
5024067|NCT02143713|12363217|P4|COMPLETED|Treatment Period (6 Months)||112
5024068|NCT02143713|12363218|P3|COMPLETED|Treatment Period (6 Months)||120
5024069|NCT02143713|12363219|P2|COMPLETED|Treatment Period (6 Months)||99
5024070|NCT02143713|12363220|P1|COMPLETED|Treatment Period (6 Months)||82
5024071|NCT02143713|12363217|P4|Received Elagolix|Treatment Period (6 Months)||140
5024072|NCT02143713|12363218|P3|Received Elagolix|Treatment Period (6 Months)||142
5024073|NCT02143713|12363219|P2|Received Elagolix|Treatment Period (6 Months)||111
5024074|NCT02143713|12363220|P1|Received Elagolix|Treatment Period (6 Months)||102
5024075|NCT02143713|12363217|P4|STARTED|Treatment Period (6 Months)||140
5024076|NCT02143713|12363218|P3|STARTED|Treatment Period (6 Months)||142
5024077|NCT02143713|12363219|P2|STARTED|Treatment Period (6 Months)||111
5024078|NCT02143713|12363220|P1|STARTED|Treatment Period (6 Months)||102
5024079|NCT02143583|12363301|P3|NOT COMPLETED|Overall Study||2
5024080|NCT02143583|12363302|P2|NOT COMPLETED|Overall Study||0
5024081|NCT02143583|12363303|P1|NOT COMPLETED|Overall Study||1
5024082|NCT02143583|12363301|P3|COMPLETED|Overall Study||66
5024083|NCT02143583|12363302|P2|COMPLETED|Overall Study||66
5024084|NCT02143583|12363303|P1|COMPLETED|Overall Study||61
5024085|NCT02143583|12363301|P3|STARTED|Overall Study||68
5024086|NCT02143583|12363302|P2|STARTED|Overall Study||66
5024087|NCT02143583|12363303|P1|STARTED|Overall Study||62
5024088|NCT02143310|12363314|P1|NOT COMPLETED|Overall Study||107
5024089|NCT02143310|12363314|P1|COMPLETED|Overall Study||102
5024090|NCT02143310|12363314|P1|STARTED|Overall Study||209
5024091|NCT02143141|12363326|P2|NOT COMPLETED|Overall Study||0
5024092|NCT02143141|12363327|P1|NOT COMPLETED|Overall Study||1
5024093|NCT02143141|12363326|P2|COMPLETED|Overall Study||6
5024094|NCT02143141|12363327|P1|COMPLETED|Overall Study||6
5024095|NCT02143141|12363326|P2|STARTED|Overall Study||6
5024096|NCT02143141|12363327|P1|STARTED|Overall Study||7
5024097|NCT02143102|12363339|P2|NOT COMPLETED|Overall Study||0
5024098|NCT02143102|12363340|P1|NOT COMPLETED|Overall Study||11
5024099|NCT02143102|12363339|P2|COMPLETED|Overall Study||28
5024100|NCT02143102|12363340|P1|COMPLETED|Overall Study||86
5024101|NCT02143102|12363339|P2|STARTED|Overall Study||28
5024102|NCT02143102|12363340|P1|STARTED|Overall Study||97
5024103|NCT02143024|12363350|P2|NOT COMPLETED|Overall Study||1
5024104|NCT02143024|12363351|P1|NOT COMPLETED|Overall Study||2
5024105|NCT02143024|12363350|P2|COMPLETED|Overall Study||7
5024106|NCT02143024|12363351|P1|COMPLETED|Overall Study||13
5024107|NCT02143024|12363350|P2|Received Treatment|Overall Study||7
5024108|NCT02143024|12363351|P1|Received Treatment|Overall Study||13
5024109|NCT02143024|12363350|P2|STARTED|Overall Study||8
5024110|NCT02143024|12363351|P1|STARTED|Overall Study||15
5024111|NCT02142894|12363357|P1|NOT COMPLETED|Overall Study||8
5024112|NCT02142894|12363357|P1|COMPLETED|Overall Study||25
5024113|NCT02142894|12363357|P1|STARTED|Overall Study||33
5024114|NCT02142738|12363363|P2|NOT COMPLETED|Overall Study||151
5024115|NCT02142738|12363364|P1|NOT COMPLETED|Overall Study||154
5024116|NCT02142738|12363363|P2|COMPLETED|Overall Study||0
5024117|NCT02142738|12363364|P1|COMPLETED|Overall Study||0
5024118|NCT02142738|12363363|P2|Treated|Overall Study||150
5024119|NCT02142738|12363364|P1|Treated|Overall Study||154
5024120|NCT02142738|12363363|P2|STARTED|Overall Study||151
5024121|NCT02142738|12363364|P1|STARTED|Overall Study||154
5024122|NCT02142712|12363377|P4|NOT COMPLETED|Overall Study||0
5024123|NCT02142712|12363378|P3|NOT COMPLETED|Overall Study||1
5024124|NCT02142712|12363379|P2|NOT COMPLETED|Overall Study||1
5024125|NCT02142712|12363380|P1|NOT COMPLETED|Overall Study||1
5024126|NCT02142712|12363377|P4|COMPLETED|Overall Study||0
5024127|NCT02142712|12363378|P3|COMPLETED|Overall Study||0
5024128|NCT02142712|12363379|P2|COMPLETED|Overall Study||0
5024129|NCT02142712|12363380|P1|COMPLETED|Overall Study||0
5024130|NCT02142712|12363377|P4|STARTED|Overall Study||0
5024131|NCT02142712|12363378|P3|STARTED|Overall Study||1
5024132|NCT02142712|12363379|P2|STARTED|Overall Study||1
5024133|NCT02142712|12363380|P1|STARTED|Overall Study||1
5024134|NCT02142504|12363403|P3|NOT COMPLETED|Overall Study||43
5024135|NCT02142504|12363404|P2|NOT COMPLETED|Overall Study||42
5024136|NCT02142504|12363405|P1|NOT COMPLETED|Overall Study||31
5024137|NCT02142504|12363403|P3|COMPLETED|Overall Study||111
5024138|NCT02142504|12363404|P2|COMPLETED|Overall Study||105
5024139|NCT02142504|12363405|P1|COMPLETED|Overall Study||122
5024140|NCT02142504|12363403|P3|Received Booster (Second Vaccination)|Overall Study||116
5024141|NCT02142504|12363404|P2|Received Booster (Second Vaccination)|Overall Study||109
5024142|NCT02142504|12363405|P1|Received Booster (Second Vaccination)|Overall Study||126
5024143|NCT02142504|12363403|P3|Randomized and Received Treatment|Overall Study||154
5024144|NCT02142504|12363404|P2|Randomized and Received Treatment|Overall Study||145
5024145|NCT02142504|12363405|P1|Randomized and Received Treatment|Overall Study||153
5024146|NCT02142504|12363403|P3|STARTED|Overall Study||154
5024147|NCT02142504|12363404|P2|STARTED|Overall Study||147
5024148|NCT02142504|12363405|P1|STARTED|Overall Study||153
5024149|NCT02142387|12363493|P2|NOT COMPLETED|Overall Study||7630
5024150|NCT02142387|12363494|P1|NOT COMPLETED|Overall Study||1065
5024151|NCT02142387|12363493|P2|COMPLETED|Overall Study||8641
5024152|NCT02142387|12363494|P1|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
5024153|NCT02142387|12363493|P2|STARTED|Overall Study||16271
5024154|NCT02142387|12363494|P1|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
5024155|NCT02142361|12363504|P3|NOT COMPLETED|Overall Study||0
5024156|NCT02142361|12363505|P2|NOT COMPLETED|Overall Study||0
5024157|NCT02142361|12363506|P1|NOT COMPLETED|Overall Study||0
5024158|NCT02142361|12363504|P3|COMPLETED|Overall Study||20
5024159|NCT02142361|12363505|P2|COMPLETED|Overall Study||20
5024160|NCT02142361|12363506|P1|COMPLETED|Overall Study||20
5024161|NCT02142361|12363504|P3|STARTED|Overall Study||20
5024162|NCT02142361|12363505|P2|STARTED|Overall Study||20
5024163|NCT02142361|12363506|P1|STARTED|Overall Study||20
5024164|NCT02142283|12363607|P2|NOT COMPLETED|Overall Study||21
5024165|NCT02142283|12363608|P1|NOT COMPLETED|Overall Study||21
5024166|NCT02142283|12363607|P2|COMPLETED|Overall Study||78
5024167|NCT02142283|12363608|P1|COMPLETED|Overall Study||86
5024168|NCT02142283|12363607|P2|STARTED|Overall Study||99
5024169|NCT02142283|12363608|P1|STARTED|Overall Study||107
5024170|NCT02142153|12363638|P10|NOT COMPLETED|Overall Study||0
5024171|NCT02142153|12363639|P9|NOT COMPLETED|Overall Study||0
5024172|NCT02142153|12363640|P8|NOT COMPLETED|Overall Study||0
5024173|NCT02142153|12363641|P7|NOT COMPLETED|Overall Study||0
5024174|NCT02142153|12363642|P6|NOT COMPLETED|Overall Study||0
5024175|NCT02142153|12363643|P5|NOT COMPLETED|Overall Study||0
5024176|NCT02142153|12363644|P4|NOT COMPLETED|Overall Study||0
5024177|NCT02142153|12363645|P3|NOT COMPLETED|Overall Study||0
5024178|NCT02142153|12363646|P2|NOT COMPLETED|Overall Study||0
5024179|NCT02142153|12363647|P1|NOT COMPLETED|Overall Study||0
5024180|NCT02142153|12363638|P10|COMPLETED|Overall Study||2
5024181|NCT02142153|12363639|P9|COMPLETED|Overall Study||6
5024182|NCT02142153|12363640|P8|COMPLETED|Overall Study||2
5024183|NCT02142153|12363641|P7|COMPLETED|Overall Study||6
5024184|NCT02142153|12363642|P6|COMPLETED|Overall Study||2
5024185|NCT02142153|12363643|P5|COMPLETED|Overall Study||6
5024186|NCT02142153|12363644|P4|COMPLETED|Overall Study||2
5024187|NCT02142153|12363645|P3|COMPLETED|Overall Study||6
5024188|NCT02142153|12363646|P2|COMPLETED|Overall Study||2
5024189|NCT02142153|12363647|P1|COMPLETED|Overall Study||6
5024190|NCT02142153|12363638|P10|STARTED|Overall Study||2
5024191|NCT02142153|12363639|P9|STARTED|Overall Study||6
5024192|NCT02142153|12363640|P8|STARTED|Overall Study||2
5024193|NCT02142153|12363641|P7|STARTED|Overall Study||6
5024194|NCT02142153|12363642|P6|STARTED|Overall Study||2
5024195|NCT02142153|12363643|P5|STARTED|Overall Study||6
5024196|NCT02142153|12363644|P4|STARTED|Overall Study||2
5024197|NCT02142153|12363645|P3|STARTED|Overall Study||6
5024198|NCT02142153|12363646|P2|STARTED|Overall Study||2
5024199|NCT02142153|12363647|P1|STARTED|Overall Study||6
5024200|NCT02142049|12363684|P5|NOT COMPLETED|Overall Study||0
5024201|NCT02142049|12363685|P4|NOT COMPLETED|Overall Study||0
5024202|NCT02142049|12363686|P3|NOT COMPLETED|Overall Study||0
5024203|NCT02142049|12363687|P2|NOT COMPLETED|Overall Study||0
5024204|NCT02142049|12363688|P1|NOT COMPLETED|Overall Study||0
5024205|NCT02142049|12363684|P5|COMPLETED|Overall Study||20
5024206|NCT02142049|12363685|P4|COMPLETED|Overall Study||6
5024207|NCT02142049|12363686|P3|COMPLETED|Overall Study||3
5024208|NCT02142049|12363687|P2|COMPLETED|Overall Study||3
5024209|NCT02142049|12363688|P1|COMPLETED|Overall Study||3
5024210|NCT02142049|12363684|P5|STARTED|Overall Study||20
5024211|NCT02142049|12363685|P4|STARTED|Overall Study||6
5024212|NCT02142049|12363686|P3|STARTED|Overall Study||3
5024213|NCT02142049|12363687|P2|STARTED|Overall Study||3
5024214|NCT02142049|12363688|P1|STARTED|Overall Study||3
5024215|NCT02141997|12363717|P4|NOT COMPLETED|Overall Study||1
5024216|NCT02141997|12363718|P3|NOT COMPLETED|Overall Study||3
5024217|NCT02141997|12363719|P2|NOT COMPLETED|Overall Study||6
5024218|NCT02141997|12363720|P1|NOT COMPLETED|Overall Study||3
5024219|NCT02141997|12363717|P4|COMPLETED|Overall Study||54
5024220|NCT02141997|12363718|P3|COMPLETED|Overall Study||53
5024221|NCT02141997|12363719|P2|COMPLETED|Overall Study||49
5024222|NCT02141997|12363720|P1|COMPLETED|Overall Study||53
5024223|NCT02141997|12363717|P4|STARTED|Overall Study||55
5024224|NCT02141997|12363718|P3|STARTED|Overall Study||56
5024225|NCT02141997|12363719|P2|STARTED|Overall Study||55
5024226|NCT02141997|12363720|P1|STARTED|Overall Study||56
5024227|NCT02141984|12363758|P1|NOT COMPLETED|Overall Study||2
5024228|NCT02141984|12363758|P1|COMPLETED|Overall Study||26
5024229|NCT02141984|12363758|P1|STARTED|Overall Study||28
5024230|NCT02141867|12363765|P1|NOT COMPLETED|Overall Study||94
5024231|NCT02141867|12363765|P1|COMPLETED|Overall Study||3927
5024232|NCT02141867|12363765|P1|STARTED|Overall Study||4021
5024233|NCT02141854|12363777|P6|NOT COMPLETED|Treatment Period||38
5024234|NCT02141854|12363778|P5|NOT COMPLETED|Treatment Period||10
5024235|NCT02141854|12363779|P4|NOT COMPLETED|Treatment Period||11
5024236|NCT02141854|12363780|P3|NOT COMPLETED|Treatment Period||9
5024237|NCT02141854|12363781|P2|NOT COMPLETED|Treatment Period||10
5024238|NCT02141854|12363782|P1|NOT COMPLETED|Treatment Period||0
5024239|NCT02141854|12363777|P6|COMPLETED|Treatment Period||107
5024240|NCT02141854|12363778|P5|COMPLETED|Treatment Period||136
5024241|NCT02141854|12363779|P4|COMPLETED|Treatment Period||135
5024242|NCT02141854|12363780|P3|COMPLETED|Treatment Period||136
5024243|NCT02141854|12363781|P2|COMPLETED|Treatment Period||136
5024244|NCT02141854|12363782|P1|COMPLETED|Treatment Period||0
5024245|NCT02141854|12363777|P6|Full Analysis Set|Treatment Period||143
5024246|NCT02141854|12363778|P5|Full Analysis Set|Treatment Period||145
5024247|NCT02141854|12363779|P4|Full Analysis Set|Treatment Period||146
5024248|NCT02141854|12363780|P3|Full Analysis Set|Treatment Period||141
5024249|NCT02141854|12363781|P2|Full Analysis Set|Treatment Period||145
5024250|NCT02141854|12363782|P1|Full Analysis Set|Treatment Period||0
5024251|NCT02141854|12363777|P6|Safety Population|Treatment Period||144
5024252|NCT02141854|12363778|P5|Safety Population|Treatment Period||145
5024253|NCT02141854|12363779|P4|Safety Population|Treatment Period||146
5024254|NCT02141854|12363780|P3|Safety Population|Treatment Period||143
5024255|NCT02141854|12363781|P2|Safety Population|Treatment Period||145
5024256|NCT02141854|12363782|P1|Safety Population|Treatment Period||0
5024257|NCT02141854|12363777|P6|Intent to Treat Population|Treatment Period||145
5024258|NCT02141854|12363778|P5|Intent to Treat Population|Treatment Period||146
5024259|NCT02141854|12363779|P4|Intent to Treat Population|Treatment Period||146
5024260|NCT02141854|12363780|P3|Intent to Treat Population|Treatment Period||145
5024261|NCT02141854|12363781|P2|Intent to Treat Population|Treatment Period||146
5024262|NCT02141854|12363782|P1|Intent to Treat Population|Treatment Period||0
5024263|NCT02141854|12363777|P6|STARTED|Treatment Period||145
5024264|NCT02141854|12363778|P5|STARTED|Treatment Period||146
5024265|NCT02141854|12363779|P4|STARTED|Treatment Period||146
5024266|NCT02141854|12363780|P3|STARTED|Treatment Period||145
5024267|NCT02141854|12363781|P2|STARTED|Treatment Period||146
5024268|NCT02141854|12363782|P1|STARTED|Treatment Period||0
5024269|NCT02141854|12363777|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024270|NCT02141854|12363778|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024271|NCT02141854|12363779|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024272|NCT02141854|12363780|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024273|NCT02141854|12363781|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024274|NCT02141854|12363782|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
5024275|NCT02141854|12363777|P6|COMPLETED|Run-In Period (Pre-assignment)||0
5024276|NCT02141854|12363778|P5|COMPLETED|Run-In Period (Pre-assignment)||0
5024277|NCT02141854|12363779|P4|COMPLETED|Run-In Period (Pre-assignment)||0
5024278|NCT02141854|12363780|P3|COMPLETED|Run-In Period (Pre-assignment)||0
5024279|NCT02141854|12363781|P2|COMPLETED|Run-In Period (Pre-assignment)||0
5024280|NCT02141854|12363782|P1|COMPLETED|Run-In Period (Pre-assignment)||728
5024281|NCT02141854|12363777|P6|STARTED|Run-In Period (Pre-assignment)||0
5024282|NCT02141854|12363778|P5|STARTED|Run-In Period (Pre-assignment)||0
5024283|NCT02141854|12363779|P4|STARTED|Run-In Period (Pre-assignment)||0
5024284|NCT02141854|12363780|P3|STARTED|Run-In Period (Pre-assignment)||0
5024285|NCT02141854|12363781|P2|STARTED|Run-In Period (Pre-assignment)||0
5024286|NCT02141854|12363782|P1|STARTED|Run-In Period (Pre-assignment)||882
5024287|NCT02141659|12363840|P6|NOT COMPLETED|Overall Study||2
5024288|NCT02141659|12363841|P5|NOT COMPLETED|Overall Study||2
5024289|NCT02141659|12363842|P4|NOT COMPLETED|Overall Study||0
5024290|NCT02141659|12363843|P3|NOT COMPLETED|Overall Study||0
5024291|NCT02141659|12363844|P2|NOT COMPLETED|Overall Study||1
5024292|NCT02141659|12363845|P1|NOT COMPLETED|Overall Study||0
5024293|NCT02141659|12363840|P6|COMPLETED|Overall Study||13
5024294|NCT02141659|12363841|P5|COMPLETED|Overall Study||13
5024295|NCT02141659|12363842|P4|COMPLETED|Overall Study||3
5024296|NCT02141659|12363843|P3|COMPLETED|Overall Study||3
5024297|NCT02141659|12363844|P2|COMPLETED|Overall Study||3
5024298|NCT02141659|12363845|P1|COMPLETED|Overall Study||3
5024299|NCT02141659|12363840|P6|STARTED|Overall Study||15
5024300|NCT02141659|12363841|P5|STARTED|Overall Study||15
5024301|NCT02141659|12363842|P4|STARTED|Overall Study||3
5024302|NCT02141659|12363843|P3|STARTED|Overall Study||3
5024303|NCT02141659|12363844|P2|STARTED|Overall Study||4
5024304|NCT02141659|12363845|P1|STARTED|Overall Study||3
5024305|NCT02141633|12363901|P2|NOT COMPLETED|Overall Study||0
5024306|NCT02141633|12363902|P1|NOT COMPLETED|Overall Study||1
5024307|NCT02141633|12363901|P2|COMPLETED|Overall Study||15
5024308|NCT02141633|12363902|P1|COMPLETED|Overall Study||15
5024309|NCT02141633|12363901|P2|STARTED|Overall Study||15
5024310|NCT02141633|12363902|P1|STARTED|Overall Study||16
5024311|NCT02141620|12363910|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
5024312|NCT02141620|12363911|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
5024313|NCT02141620|12363910|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
5024314|NCT02141620|12363911|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
5024315|NCT02141620|12363910|P2|STARTED|Treatment Condition 2 (7 Days)||7
5024316|NCT02141620|12363911|P1|STARTED|Treatment Condition 2 (7 Days)||7
5024317|NCT02141620|12363910|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
5024318|NCT02141620|12363911|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
5024319|NCT02141620|12363910|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
5024320|NCT02141620|12363911|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
5024321|NCT02141620|12363910|P2|STARTED|Treatment Condition 1 (7 Days)||7
5024322|NCT02141620|12363911|P1|STARTED|Treatment Condition 1 (7 Days)||8
5024323|NCT02141581|12363972|P3|NOT COMPLETED|Overall Study||0
5024324|NCT02141581|12363973|P2|NOT COMPLETED|Overall Study||0
5024325|NCT02141581|12363974|P1|NOT COMPLETED|Overall Study||0
5024326|NCT02141581|12363972|P3|COMPLETED|Overall Study||25
5024327|NCT02141581|12363973|P2|COMPLETED|Overall Study||19
5024328|NCT02141581|12363974|P1|COMPLETED|Overall Study||42
5024329|NCT02141581|12363972|P3|STARTED|Overall Study||25
5024330|NCT02141581|12363973|P2|STARTED|Overall Study||19
5024331|NCT02141581|12363974|P1|STARTED|Overall Study||42
5024332|NCT02141555|12363987|P2|NOT COMPLETED|Overall Study||0
5024333|NCT02141555|12363988|P1|NOT COMPLETED|Overall Study||0
5024334|NCT02141555|12363987|P2|COMPLETED|Overall Study||2
5024335|NCT02141555|12363988|P1|COMPLETED|Overall Study||2
5024336|NCT02141555|12363987|P2|STARTED|Overall Study||2
5024337|NCT02141555|12363988|P1|STARTED|Overall Study||2
5024338|NCT02141516|12364003|P3|NOT COMPLETED|Overall Study||0
5024339|NCT02141516|12364004|P2|NOT COMPLETED|Overall Study||5
5024340|NCT02141516|12364005|P1|NOT COMPLETED|Overall Study||0
5024341|NCT02141516|12364003|P3|COMPLETED|Overall Study||87
5024342|NCT02141516|12364004|P2|COMPLETED|Overall Study||107
5024343|NCT02141516|12364005|P1|COMPLETED|Overall Study||40
5024344|NCT02141516|12364003|P3|STARTED|Overall Study||87
5024345|NCT02141516|12364004|P2|STARTED|Overall Study||112
5024346|NCT02141516|12364005|P1|STARTED|Overall Study||40
5024347|NCT02141490|12364056|P3|NOT COMPLETED|Overall Study||0
5024348|NCT02141490|12364057|P2|NOT COMPLETED|Overall Study||0
5024349|NCT02141490|12364058|P1|NOT COMPLETED|Overall Study||4
5024350|NCT02141490|12364056|P3|COMPLETED|Overall Study||3
5024351|NCT02141490|12364057|P2|COMPLETED|Overall Study||6
5024352|NCT02141490|12364058|P1|COMPLETED|Overall Study||30
5024353|NCT02141490|12364056|P3|STARTED|Overall Study||3
5024354|NCT02141490|12364057|P2|STARTED|Overall Study||6
5024355|NCT02141490|12364058|P1|STARTED|Overall Study||34
5024356|NCT02141451|12364075|P4|NOT COMPLETED|Overall Study||9
5024357|NCT02141451|12364076|P3|NOT COMPLETED|Overall Study||5
5024358|NCT02141451|12364077|P2|NOT COMPLETED|Overall Study||2
5024359|NCT02141451|12364078|P1|NOT COMPLETED|Overall Study||0
5024360|NCT02141451|12364075|P4|COMPLETED|Overall Study||7
5024361|NCT02141451|12364076|P3|COMPLETED|Overall Study||2
5024362|NCT02141451|12364077|P2|COMPLETED|Overall Study||2
5024363|NCT02141451|12364078|P1|COMPLETED|Overall Study||3
5024364|NCT02141451|12364075|P4|STARTED|Overall Study||16
5024365|NCT02141451|12364076|P3|STARTED|Overall Study||7
5024366|NCT02141451|12364077|P2|STARTED|Overall Study||4
5024367|NCT02141451|12364078|P1|STARTED|Overall Study||3
5024368|NCT02141399|12364103|P1|NOT COMPLETED|Overall Study||744
5024369|NCT02141399|12364103|P1|COMPLETED|Overall Study||741
5024370|NCT02141399|12364103|P1|STARTED|Overall Study||1485
5024371|NCT02141360|12364109|P3|NOT COMPLETED|Overall Study||0
5024372|NCT02141360|12364110|P2|NOT COMPLETED|Overall Study||0
5024373|NCT02141360|12364111|P1|NOT COMPLETED|Overall Study||7
5024374|NCT02141360|12364109|P3|COMPLETED|Overall Study||6
5024375|NCT02141360|12364110|P2|COMPLETED|Overall Study||6
5024376|NCT02141360|12364111|P1|COMPLETED|Overall Study||4
5024377|NCT02141360|12364109|P3|STARTED|Overall Study||6
5024378|NCT02141360|12364110|P2|STARTED|Overall Study||6
5024379|NCT02141360|12364111|P1|STARTED|Overall Study||11
5024380|NCT02141295|12364122|P3|NOT COMPLETED|Overall Study||95
5024381|NCT02141295|12364123|P2|NOT COMPLETED|Overall Study||94
5024382|NCT02141295|12364124|P1|NOT COMPLETED|Overall Study||6
5024383|NCT02141295|12364122|P3|COMPLETED|Overall Study||0
5024384|NCT02141295|12364123|P2|COMPLETED|Overall Study||0
5024385|NCT02141295|12364124|P1|COMPLETED|Overall Study||2
5024386|NCT02141295|12364122|P3|STARTED|Overall Study||95
5024387|NCT02141295|12364123|P2|STARTED|Overall Study||94
5024388|NCT02141295|12364124|P1|STARTED|Overall Study||8
5024389|NCT02141217|12364160|P2|NOT COMPLETED|Overall Study||8
5024390|NCT02141217|12364161|P1|NOT COMPLETED|Overall Study||11
5024391|NCT02141217|12364160|P2|COMPLETED|Overall Study||229
5024392|NCT02141217|12364161|P1|COMPLETED|Overall Study||223
5024393|NCT02141217|12364160|P2|ITT Population-Actual Treatment Received|Overall Study||235
5024394|NCT02141217|12364161|P1|ITT Population-Actual Treatment Received|Overall Study||236
5024395|NCT02141217|12364160|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
5024396|NCT02141217|12364161|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
5024397|NCT02141217|12364160|P2|STARTED|Overall Study||237
5024398|NCT02141217|12364161|P1|STARTED|Overall Study||234
5024399|NCT02140957|12364181|P2|NOT COMPLETED|Overall Study||23
5024400|NCT02140957|12364182|P1|NOT COMPLETED|Overall Study||27
5024401|NCT02140957|12364181|P2|COMPLETED|Overall Study||99
5024402|NCT02140957|12364182|P1|COMPLETED|Overall Study||102
5024403|NCT02140957|12364181|P2|STARTED|Overall Study||122
5024404|NCT02140957|12364182|P1|STARTED|Overall Study||129
5024405|NCT02140788|12364192|P4|NOT COMPLETED|Overall Study||0
5024406|NCT02140788|12364193|P3|NOT COMPLETED|Overall Study||0
5024407|NCT02140788|12364194|P2|NOT COMPLETED|Overall Study||0
5024408|NCT02140788|12364195|P1|NOT COMPLETED|Overall Study||0
5024409|NCT02140788|12364192|P4|COMPLETED|Overall Study||0
5024410|NCT02140788|12364193|P3|COMPLETED|Overall Study||0
5024411|NCT02140788|12364194|P2|COMPLETED|Overall Study||0
5024412|NCT02140788|12364195|P1|COMPLETED|Overall Study||0
5024413|NCT02140788|12364192|P4|STARTED|Overall Study||0
5024414|NCT02140788|12364193|P3|STARTED|Overall Study||0
5024415|NCT02140788|12364194|P2|STARTED|Overall Study||0
5024416|NCT02140788|12364195|P1|STARTED|Overall Study||0
5024417|NCT02140775|12364223|P2|NOT COMPLETED|Overall Study||7
5024418|NCT02140775|12364224|P1|NOT COMPLETED|Overall Study||30
5024419|NCT02140775|12364223|P2|COMPLETED|Overall Study||22
5024420|NCT02140775|12364224|P1|COMPLETED|Overall Study||57
5024421|NCT02140775|12364223|P2|STARTED|Overall Study||29
5024422|NCT02140775|12364224|P1|STARTED|Overall Study||87
5024423|NCT02140762|12364236|P2|NOT COMPLETED|Overall Study||12
5024424|NCT02140762|12364237|P1|NOT COMPLETED|Overall Study||17
5024425|NCT02140762|12364236|P2|COMPLETED|Overall Study||139
5024426|NCT02140762|12364237|P1|COMPLETED|Overall Study||137
5024427|NCT02140762|12364236|P2|STARTED|Overall Study||151
5024428|NCT02140762|12364237|P1|STARTED|Overall Study||154
5024429|NCT02140645|12364303|P6|NOT COMPLETED|Overall Study||70896
5024430|NCT02140645|12364304|P5|NOT COMPLETED|Overall Study||3286
5024431|NCT02140645|12364305|P4|NOT COMPLETED|Overall Study||13833
5024432|NCT02140645|12364306|P3|NOT COMPLETED|Overall Study||4236
5024433|NCT02140645|12364307|P2|NOT COMPLETED|Overall Study||61654
5024434|NCT02140645|12364308|P1|NOT COMPLETED|Overall Study||5489
5024435|NCT02140645|12364303|P6|COMPLETED|Overall Study||3050
5024436|NCT02140645|12364304|P5|COMPLETED|Overall Study||150
5024437|NCT02140645|12364305|P4|COMPLETED|Overall Study||530
5024438|NCT02140645|12364306|P3|COMPLETED|Overall Study||205
5024439|NCT02140645|12364307|P2|COMPLETED|Overall Study||3041
5024440|NCT02140645|12364308|P1|COMPLETED|Overall Study||243
5024441|NCT02140645|12364303|P6|STARTED|Overall Study||73946
5024442|NCT02140645|12364304|P5|STARTED|Overall Study||3436
5024443|NCT02140645|12364305|P4|STARTED|Overall Study||14363
5024444|NCT02140645|12364306|P3|STARTED|Overall Study||4441
5024445|NCT02140645|12364307|P2|STARTED|Overall Study||64695
5024446|NCT02140645|12364308|P1|STARTED|Overall Study||5732
5024447|NCT02140593|12364397|P2|NOT COMPLETED|Overall Study||0
5024448|NCT02140593|12364398|P1|NOT COMPLETED|Overall Study||0
5024449|NCT02140593|12364397|P2|COMPLETED|Overall Study||65
5024450|NCT02140593|12364398|P1|COMPLETED|Overall Study||63
5024451|NCT02140593|12364397|P2|STARTED|Overall Study||65
5024452|NCT02140593|12364398|P1|STARTED|Overall Study||63
5024453|NCT02140567|12364406|P1|NOT COMPLETED|Overall Study||6
5024454|NCT02140567|12364406|P1|COMPLETED|Overall Study||134
5024455|NCT02140567|12364406|P1|STARTED|Overall Study||140
5024456|NCT02140411|12364411|P1|NOT COMPLETED|Overall Study||1
5024457|NCT02140411|12364411|P1|COMPLETED|Overall Study||20
5024458|NCT02140411|12364411|P1|STARTED|Overall Study||21
5024459|NCT02140372|12364420|P1|NOT COMPLETED|Overall Study||0
5024460|NCT02140372|12364420|P1|COMPLETED|Overall Study||10
5024461|NCT02140372|12364420|P1|STARTED|Overall Study||10
5024462|NCT02140164|12364431|P1|NOT COMPLETED|Overall Study||2
5024463|NCT02140164|12364431|P1|COMPLETED|Overall Study||5
5024464|NCT02140164|12364431|P1|STARTED|Overall Study||7
5024465|NCT02140060|12364452|P6|NOT COMPLETED|Overall Study||1
5024466|NCT02140060|12364453|P5|NOT COMPLETED|Overall Study||1
5024467|NCT02140060|12364454|P4|NOT COMPLETED|Overall Study||2
5024468|NCT02140060|12364455|P3|NOT COMPLETED|Overall Study||0
5024469|NCT02140060|12364456|P2|NOT COMPLETED|Overall Study||0
5024470|NCT02140060|12364457|P1|NOT COMPLETED|Overall Study||0
5024471|NCT02140060|12364452|P6|COMPLETED|Overall Study||43
5024472|NCT02140060|12364453|P5|COMPLETED|Overall Study||44
5024473|NCT02140060|12364454|P4|COMPLETED|Overall Study||43
5024474|NCT02140060|12364455|P3|COMPLETED|Overall Study||44
5024475|NCT02140060|12364456|P2|COMPLETED|Overall Study||44
5024476|NCT02140060|12364457|P1|COMPLETED|Overall Study||44
5024477|NCT02140060|12364452|P6|STARTED|Overall Study||44
5024478|NCT02140060|12364453|P5|STARTED|Overall Study||45
5024479|NCT02140060|12364454|P4|STARTED|Overall Study||45
5024480|NCT02140060|12364455|P3|STARTED|Overall Study||44
5024481|NCT02140060|12364456|P2|STARTED|Overall Study||44
5024482|NCT02140060|12364457|P1|STARTED|Overall Study||44
5024483|NCT02139982|12364482|P10|NOT COMPLETED|Overall Study||0
5024484|NCT02139982|12364483|P9|NOT COMPLETED|Overall Study||0
5024485|NCT02139982|12364484|P8|NOT COMPLETED|Overall Study||0
5024486|NCT02139982|12364485|P7|NOT COMPLETED|Overall Study||0
5024487|NCT02139982|12364486|P6|NOT COMPLETED|Overall Study||0
5024488|NCT02139982|12364487|P5|NOT COMPLETED|Overall Study||0
5024489|NCT02139982|12364488|P4|NOT COMPLETED|Overall Study||1
5024490|NCT02139982|12364489|P3|NOT COMPLETED|Overall Study||0
5024491|NCT02139982|12364490|P2|NOT COMPLETED|Overall Study||1
5024492|NCT02139982|12364491|P1|NOT COMPLETED|Overall Study||0
5024493|NCT02139982|12364482|P10|COMPLETED|Overall Study||13
5024494|NCT02139982|12364483|P9|COMPLETED|Overall Study||13
5024495|NCT02139982|12364484|P8|COMPLETED|Overall Study||13
5024496|NCT02139982|12364485|P7|COMPLETED|Overall Study||13
5024497|NCT02139982|12364486|P6|COMPLETED|Overall Study||13
5024498|NCT02139982|12364487|P5|COMPLETED|Overall Study||13
5024499|NCT02139982|12364488|P4|COMPLETED|Overall Study||7
5024500|NCT02139982|12364489|P3|COMPLETED|Overall Study||8
5024501|NCT02139982|12364490|P2|COMPLETED|Overall Study||7
5024502|NCT02139982|12364491|P1|COMPLETED|Overall Study||8
5024503|NCT02139982|12364482|P10|STARTED|Overall Study||13
5024504|NCT02139982|12364483|P9|STARTED|Overall Study||13
5024505|NCT02139982|12364484|P8|STARTED|Overall Study||13
5024506|NCT02139982|12364485|P7|STARTED|Overall Study||13
5024507|NCT02139982|12364486|P6|STARTED|Overall Study||13
5024508|NCT02139982|12364487|P5|STARTED|Overall Study||13
5024509|NCT02139982|12364488|P4|STARTED|Overall Study||8
5024510|NCT02139982|12364489|P3|STARTED|Overall Study||8
5024511|NCT02139982|12364490|P2|STARTED|Overall Study||8
5024512|NCT02139982|12364491|P1|STARTED|Overall Study||8
5024513|NCT02139943|12364536|P3|NOT COMPLETED|Overall Study||7
5024514|NCT02139943|12364537|P2|NOT COMPLETED|Overall Study||6
5024515|NCT02139943|12364538|P1|NOT COMPLETED|Overall Study||10
5024516|NCT02139943|12364536|P3|COMPLETED|Overall Study||110
5024517|NCT02139943|12364537|P2|COMPLETED|Overall Study||111
5024518|NCT02139943|12364538|P1|COMPLETED|Overall Study||107
5024519|NCT02139943|12364536|P3|STARTED|Overall Study||117
5024520|NCT02139943|12364537|P2|STARTED|Overall Study||117
5024521|NCT02139943|12364538|P1|STARTED|Overall Study||117
5024522|NCT02139878|12364549|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5024523|NCT02139878|12364550|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5024524|NCT02139878|12364549|P2|COMPLETED|Second Intervention (7 Days)||10
5024525|NCT02139878|12364550|P1|COMPLETED|Second Intervention (7 Days)||9
5024526|NCT02139878|12364549|P2|STARTED|Second Intervention (7 Days)||10
5024527|NCT02139878|12364550|P1|STARTED|Second Intervention (7 Days)||9
5024528|NCT02139878|12364549|P2|NOT COMPLETED|Washout Period (8 Days)||0
5024529|NCT02139878|12364550|P1|NOT COMPLETED|Washout Period (8 Days)||0
5024530|NCT02139878|12364549|P2|COMPLETED|Washout Period (8 Days)||10
5024531|NCT02139878|12364550|P1|COMPLETED|Washout Period (8 Days)||9
5024532|NCT02139878|12364549|P2|STARTED|Washout Period (8 Days)||10
5024533|NCT02139878|12364550|P1|STARTED|Washout Period (8 Days)||9
5024534|NCT02139878|12364549|P2|NOT COMPLETED|First Intervention (7 Days)||0
5024535|NCT02139878|12364550|P1|NOT COMPLETED|First Intervention (7 Days)||1
5024536|NCT02139878|12364549|P2|COMPLETED|First Intervention (7 Days)||10
5024537|NCT02139878|12364550|P1|COMPLETED|First Intervention (7 Days)||9
5024538|NCT02139878|12364549|P2|STARTED|First Intervention (7 Days)||10
5024539|NCT02139878|12364550|P1|STARTED|First Intervention (7 Days)||10
5024540|NCT02139800|12364560|P2|NOT COMPLETED|Overall Study||21
5024541|NCT02139800|12364561|P1|NOT COMPLETED|Overall Study||13
5024542|NCT02139800|12364560|P2|COMPLETED|Overall Study||215
5024543|NCT02139800|12364561|P1|COMPLETED|Overall Study||211
5024544|NCT02139800|12364560|P2|STARTED|Overall Study||236
5024545|NCT02139800|12364561|P1|STARTED|Overall Study||224
5024546|NCT02139644|12364572|P6|NOT COMPLETED|Treatment Period||17
5024547|NCT02139644|12364573|P5|NOT COMPLETED|Treatment Period||8
5024548|NCT02139644|12364574|P4|NOT COMPLETED|Treatment Period||9
5024549|NCT02139644|12364575|P3|NOT COMPLETED|Treatment Period||8
5024550|NCT02139644|12364576|P2|NOT COMPLETED|Treatment Period||3
5024551|NCT02139644|12364577|P1|NOT COMPLETED|Treatment Period||0
5024552|NCT02139644|12364572|P6|COMPLETED|Treatment Period||113
5024553|NCT02139644|12364573|P5|COMPLETED|Treatment Period||121
5024554|NCT02139644|12364574|P4|COMPLETED|Treatment Period||121
5024555|NCT02139644|12364575|P3|COMPLETED|Treatment Period||121
5024556|NCT02139644|12364576|P2|COMPLETED|Treatment Period||126
5024557|NCT02139644|12364577|P1|COMPLETED|Treatment Period||0
5024558|NCT02139644|12364572|P6|STARTED|Treatment Period|Randomized|130
5024559|NCT02139644|12364573|P5|STARTED|Treatment Period|Randomized|129
5024560|NCT02139644|12364574|P4|STARTED|Treatment Period|Randomized|130
5024561|NCT02139644|12364575|P3|STARTED|Treatment Period|Randomized|129
5024562|NCT02139644|12364576|P2|STARTED|Treatment Period|Randomized|129
5024563|NCT02139644|12364577|P1|STARTED|Treatment Period||0
5024564|NCT02139644|12364572|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024565|NCT02139644|12364573|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024566|NCT02139644|12364574|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024567|NCT02139644|12364575|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024568|NCT02139644|12364576|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
5024569|NCT02139644|12364577|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
5024570|NCT02139644|12364572|P6|COMPLETED|Run-In Period (Pre-assignment)||0
5024571|NCT02139644|12364573|P5|COMPLETED|Run-In Period (Pre-assignment)||0
5024572|NCT02139644|12364574|P4|COMPLETED|Run-In Period (Pre-assignment)||0
5024573|NCT02139644|12364575|P3|COMPLETED|Run-In Period (Pre-assignment)||0
5024574|NCT02139644|12364576|P2|COMPLETED|Run-In Period (Pre-assignment)||0
5024575|NCT02139644|12364577|P1|COMPLETED|Run-In Period (Pre-assignment)||647
5024576|NCT02139644|12364572|P6|STARTED|Run-In Period (Pre-assignment)||0
5024577|NCT02139644|12364573|P5|STARTED|Run-In Period (Pre-assignment)||0
5024578|NCT02139644|12364574|P4|STARTED|Run-In Period (Pre-assignment)||0
5024579|NCT02139644|12364575|P3|STARTED|Run-In Period (Pre-assignment)||0
5024580|NCT02139644|12364576|P2|STARTED|Run-In Period (Pre-assignment)||0
5024581|NCT02139644|12364577|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
5024582|NCT02139592|12364629|P1|NOT COMPLETED|Overall Study||8
5024583|NCT02139592|12364629|P1|COMPLETED|Overall Study||284
5024584|NCT02139592|12364629|P1|STARTED|Overall Study||292
5024585|NCT02139540|12364637|P2|NOT COMPLETED|Overall Study||0
5024586|NCT02139540|12364638|P1|NOT COMPLETED|Overall Study||1
5024587|NCT02139540|12364637|P2|COMPLETED|Overall Study||10
5024588|NCT02139540|12364638|P1|COMPLETED|Overall Study||10
5024589|NCT02139540|12364637|P2|STARTED|Overall Study||10
5024590|NCT02139540|12364638|P1|STARTED|Overall Study||11
5024591|NCT02139358|12364646|P1|NOT COMPLETED|Overall Study||0
5024592|NCT02139358|12364646|P1|COMPLETED|Overall Study||15
5024593|NCT02139358|12364646|P1|STARTED|Overall Study||15
5024594|NCT02139306|12364655|P2|NOT COMPLETED|Overall Study||14
5024595|NCT02139306|12364656|P1|NOT COMPLETED|Overall Study||13
5024596|NCT02139306|12364655|P2|COMPLETED|Overall Study||125
5024597|NCT02139306|12364656|P1|COMPLETED|Overall Study||127
5024598|NCT02139306|12364655|P2|STARTED|Overall Study||139
5024599|NCT02139306|12364656|P1|STARTED|Overall Study||140
5024600|NCT02139228|12364682|P2|NOT COMPLETED|Overall Study||0
5024601|NCT02139228|12364683|P1|NOT COMPLETED|Overall Study||0
5024602|NCT02139228|12364682|P2|COMPLETED|Overall Study||211
5024603|NCT02139228|12364683|P1|COMPLETED|Overall Study||215
5024604|NCT02139228|12364682|P2|STARTED|Overall Study||211
5024605|NCT02139228|12364683|P1|STARTED|Overall Study||215
5024606|NCT02139176|12364693|P2|NOT COMPLETED|Overall Study||0
5024607|NCT02139176|12364694|P1|NOT COMPLETED|Overall Study||0
5024608|NCT02139176|12364693|P2|COMPLETED|Overall Study||100
5024609|NCT02139176|12364694|P1|COMPLETED|Overall Study||100
5024610|NCT02139176|12364693|P2|STARTED|Overall Study||100
5024611|NCT02139176|12364694|P1|STARTED|Overall Study||100
5024612|NCT02139137|12364706|P2|NOT COMPLETED|Overall Study||10
5024613|NCT02139137|12364707|P1|NOT COMPLETED|Overall Study||7
5024614|NCT02139137|12364706|P2|COMPLETED|Overall Study||10
5024615|NCT02139137|12364707|P1|COMPLETED|Overall Study||15
5024616|NCT02139137|12364706|P2|STARTED|Overall Study||20
5024617|NCT02139137|12364707|P1|STARTED|Overall Study||22
5024618|NCT02139124|12364726|P5|NOT COMPLETED|Overall Study||13
5024619|NCT02139124|12364727|P4|NOT COMPLETED|Overall Study||12
5024620|NCT02139124|12364728|P3|NOT COMPLETED|Overall Study||4
5024621|NCT02139124|12364729|P2|NOT COMPLETED|Overall Study||4
5024622|NCT02139124|12364730|P1|NOT COMPLETED|Overall Study||9
5024623|NCT02139124|12364726|P5|COMPLETED|Overall Study||61
5024624|NCT02139124|12364727|P4|COMPLETED|Overall Study||61
5024625|NCT02139124|12364728|P3|COMPLETED|Overall Study||69
5024626|NCT02139124|12364729|P2|COMPLETED|Overall Study||73
5024627|NCT02139124|12364730|P1|COMPLETED|Overall Study||69
5024628|NCT02139124|12364726|P5|STARTED|Overall Study||74
5024629|NCT02139124|12364727|P4|STARTED|Overall Study||73
5024630|NCT02139124|12364728|P3|STARTED|Overall Study||73
5024631|NCT02139124|12364729|P2|STARTED|Overall Study||77
5024632|NCT02139124|12364730|P1|STARTED|Overall Study||78
5024633|NCT02139046|12364747|P5|NOT COMPLETED|Overall Study||57
5024634|NCT02139046|12364748|P4|NOT COMPLETED|Overall Study||68
5024635|NCT02139046|12364749|P3|NOT COMPLETED|Overall Study||59
5024636|NCT02139046|12364750|P2|NOT COMPLETED|Overall Study||54
5024637|NCT02139046|12364751|P1|NOT COMPLETED|Overall Study||62
5024638|NCT02139046|12364747|P5|COMPLETED|Overall Study||301
5024639|NCT02139046|12364748|P4|COMPLETED|Overall Study||290
5024640|NCT02139046|12364749|P3|COMPLETED|Overall Study||298
5024641|NCT02139046|12364750|P2|COMPLETED|Overall Study||305
5024642|NCT02139046|12364751|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
5024643|NCT02139046|12364747|P5|Full Analysis Set|Overall Study||357
5024644|NCT02139046|12364748|P4|Full Analysis Set|Overall Study||357
5024645|NCT02139046|12364749|P3|Full Analysis Set|Overall Study||355
5024646|NCT02139046|12364750|P2|Full Analysis Set|Overall Study||357
5024647|NCT02139046|12364751|P1|Full Analysis Set|Overall Study||357
5024648|NCT02139046|12364747|P5|Safety Analysis Set|Overall Study||357
5024649|NCT02139046|12364748|P4|Safety Analysis Set|Overall Study||357
5024650|NCT02139046|12364749|P3|Safety Analysis Set|Overall Study||355
5024651|NCT02139046|12364750|P2|Safety Analysis Set|Overall Study||358
5024652|NCT02139046|12364751|P1|Safety Analysis Set|Overall Study||356
5024653|NCT02139046|12364747|P5|STARTED|Overall Study||358
5024654|NCT02139046|12364748|P4|STARTED|Overall Study||358
5024655|NCT02139046|12364749|P3|STARTED|Overall Study||357
5024656|NCT02139046|12364750|P2|STARTED|Overall Study||359
5024657|NCT02139046|12364751|P1|STARTED|Overall Study||358
5024658|NCT02139007|12364775|P2|NOT COMPLETED|Patient Participant Recruitment||1
5024659|NCT02139007|12364776|P1|NOT COMPLETED|Patient Participant Recruitment||2
5024660|NCT02139007|12364775|P2|COMPLETED|Patient Participant Recruitment||13
5024661|NCT02139007|12364776|P1|COMPLETED|Patient Participant Recruitment||11
5024662|NCT02139007|12364775|P2|STARTED|Patient Participant Recruitment||14
5024663|NCT02139007|12364776|P1|STARTED|Patient Participant Recruitment||13
5024664|NCT02139007|12364775|P2|NOT COMPLETED|Study Site Recruitment||4
5024665|NCT02139007|12364776|P1|NOT COMPLETED|Study Site Recruitment||3
5024666|NCT02139007|12364775|P2|COMPLETED|Study Site Recruitment||1
5024667|NCT02139007|12364776|P1|COMPLETED|Study Site Recruitment||1
5024668|NCT02139007|12364775|P2|STARTED|Study Site Recruitment||5
5024669|NCT02139007|12364776|P1|STARTED|Study Site Recruitment||4
5024670|NCT02138916|12364792|P3|NOT COMPLETED|Overall Study||59
5024671|NCT02138916|12364793|P2|NOT COMPLETED|Overall Study||60
5024672|NCT02138916|12364794|P1|NOT COMPLETED|Overall Study||57
5024673|NCT02138916|12364792|P3|COMPLETED|Overall Study||491
5024674|NCT02138916|12364793|P2|COMPLETED|Overall Study||492
5024675|NCT02138916|12364794|P1|COMPLETED|Overall Study||497
5024676|NCT02138916|12364792|P3|STARTED|Overall Study||550
5024677|NCT02138916|12364793|P2|STARTED|Overall Study||552
5024678|NCT02138916|12364794|P1|STARTED|Overall Study||554
5024679|NCT02138890|12364857|P2|NOT COMPLETED|Overall Study||0
5024680|NCT02138890|12364858|P1|NOT COMPLETED|Overall Study||1
5024681|NCT02138890|12364857|P2|COMPLETED|Overall Study||15
5024682|NCT02138890|12364858|P1|COMPLETED|Overall Study||30
5024683|NCT02138890|12364857|P2|STARTED|Overall Study||15
5024684|NCT02138890|12364858|P1|STARTED|Overall Study||31
5024685|NCT02138838|12364900|P2|NOT COMPLETED|Overall Study||11
5024686|NCT02138838|12364901|P1|NOT COMPLETED|Overall Study||8
5024687|NCT02138838|12364900|P2|COMPLETED|Overall Study||16
5024688|NCT02138838|12364901|P1|COMPLETED|Overall Study||20
5024689|NCT02138838|12364900|P2|Received Study Drug|Overall Study||25
5024690|NCT02138838|12364901|P1|Received Study Drug|Overall Study||28
5024691|NCT02138838|12364900|P2|STARTED|Overall Study||27
5024692|NCT02138838|12364901|P1|STARTED|Overall Study||28
5024693|NCT02138825|12364919|P2|NOT COMPLETED|Safety Follow-up||17
5024694|NCT02138825|12364920|P1|NOT COMPLETED|Safety Follow-up||22
5024695|NCT02138825|12364919|P2|COMPLETED|Safety Follow-up||47
5024696|NCT02138825|12364920|P1|COMPLETED|Safety Follow-up||50
5024697|NCT02138825|12364919|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
5024698|NCT02138825|12364920|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
5024699|NCT02138825|12364919|P2|NOT COMPLETED|Long-term Extension||38
5024700|NCT02138825|12364920|P1|NOT COMPLETED|Long-term Extension||32
5024701|NCT02138825|12364919|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
5024702|NCT02138825|12364920|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
5024703|NCT02138825|12364919|P2|STARTED|Long-term Extension||38
5024704|NCT02138825|12364920|P1|STARTED|Long-term Extension||32
5024705|NCT02138825|12364919|P2|NOT COMPLETED|Main Study Treatment||35
5024706|NCT02138825|12364920|P1|NOT COMPLETED|Main Study Treatment||40
5024707|NCT02138825|12364919|P2|COMPLETED|Main Study Treatment||39
5024708|NCT02138825|12364920|P1|COMPLETED|Main Study Treatment||33
5024709|NCT02138825|12364919|P2|STARTED|Main Study Treatment|safety population|74
5024710|NCT02138825|12364920|P1|STARTED|Main Study Treatment|safety population|73
5024711|NCT02138786|12364937|P3|NOT COMPLETED|Overall Study||8
5024712|NCT02138786|12364938|P2|NOT COMPLETED|Overall Study||15
5024713|NCT02138786|12364939|P1|NOT COMPLETED|Overall Study||3
5024714|NCT02138786|12364937|P3|COMPLETED|Overall Study||0
5024715|NCT02138786|12364938|P2|COMPLETED|Overall Study||0
5024716|NCT02138786|12364939|P1|COMPLETED|Overall Study||0
5024717|NCT02138786|12364937|P3|STARTED|Overall Study||8
5024718|NCT02138786|12364938|P2|STARTED|Overall Study||15
5024719|NCT02138786|12364939|P1|STARTED|Overall Study||3
5024720|NCT02138747|12364956|P4|NOT COMPLETED|Treatment Period 2||3
5024721|NCT02138747|12364957|P3|NOT COMPLETED|Treatment Period 2||2
5024722|NCT02138747|12364958|P2|NOT COMPLETED|Treatment Period 2||7
5024723|NCT02138747|12364959|P1|NOT COMPLETED|Treatment Period 2||17
5024724|NCT02138747|12364956|P4|COMPLETED|Treatment Period 2||24
5024725|NCT02138747|12364957|P3|COMPLETED|Treatment Period 2||24
5024726|NCT02138747|12364958|P2|COMPLETED|Treatment Period 2||125
5024727|NCT02138747|12364959|P1|COMPLETED|Treatment Period 2||121
5024728|NCT02138747|12364956|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
5024729|NCT02138747|12364957|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
5024730|NCT02138747|12364958|P2|STARTED|Treatment Period 2||132
5024731|NCT02138747|12364959|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
5024732|NCT02138747|12364956|P4|NOT COMPLETED|Treatment Period 1||4
5024733|NCT02138747|12364957|P3|NOT COMPLETED|Treatment Period 1||4
5024734|NCT02138747|12364958|P2|NOT COMPLETED|Treatment Period 1||25
5024735|NCT02138747|12364959|P1|NOT COMPLETED|Treatment Period 1||20
5024736|NCT02138747|12364956|P4|COMPLETED|Treatment Period 1||28
5024737|NCT02138747|12364957|P3|COMPLETED|Treatment Period 1||27
5024738|NCT02138747|12364958|P2|COMPLETED|Treatment Period 1||132
5024739|NCT02138747|12364959|P1|COMPLETED|Treatment Period 1||136
5024740|NCT02138747|12364956|P4|STARTED|Treatment Period 1||32
5024741|NCT02138747|12364957|P3|STARTED|Treatment Period 1||31
5024742|NCT02138747|12364958|P2|STARTED|Treatment Period 1||157
5024743|NCT02138747|12364959|P1|STARTED|Treatment Period 1||156
5024744|NCT02138578|12364994|P3|NOT COMPLETED|Overall Study||0
5024745|NCT02138578|12364995|P2|NOT COMPLETED|Overall Study||0
5024746|NCT02138578|12364996|P1|NOT COMPLETED|Overall Study||0
5024747|NCT02138578|12364994|P3|COMPLETED|Overall Study||3
5024748|NCT02138578|12364995|P2|COMPLETED|Overall Study||0
5024749|NCT02138578|12364996|P1|COMPLETED|Overall Study||1
5024750|NCT02138578|12364994|P3|STARTED|Overall Study||3
5024751|NCT02138578|12364995|P2|STARTED|Overall Study||0
5024752|NCT02138578|12364996|P1|STARTED|Overall Study||1
5024753|NCT02138461|12365024|P2|NOT COMPLETED|Overall Study||0
5024754|NCT02138461|12365025|P1|NOT COMPLETED|Overall Study||0
5024755|NCT02138461|12365024|P2|COMPLETED|Overall Study||110
5024756|NCT02138461|12365025|P1|COMPLETED|Overall Study||101
5024757|NCT02138461|12365024|P2|STARTED|Overall Study||110
5024758|NCT02138461|12365025|P1|STARTED|Overall Study||101
5024759|NCT02138253|12365033|P2|NOT COMPLETED|Overall Study||4
5024760|NCT02138253|12365034|P1|NOT COMPLETED|Overall Study||9
5024761|NCT02138253|12365033|P2|COMPLETED|Overall Study||19
5024762|NCT02138253|12365034|P1|COMPLETED|Overall Study||32
5024763|NCT02138253|12365033|P2|STARTED|Overall Study||23
5024764|NCT02138253|12365034|P1|STARTED|Overall Study||41
5024765|NCT02138240|12365062|P1|NOT COMPLETED|Overall Study||0
5024766|NCT02138240|12365062|P1|COMPLETED|Overall Study||34
5024767|NCT02138240|12365062|P1|STARTED|Overall Study||34
5024768|NCT02138227|12365074|P2|NOT COMPLETED|Overall Study||0
5024769|NCT02138227|12365075|P1|NOT COMPLETED|Overall Study||0
5024770|NCT02138227|12365074|P2|COMPLETED|Overall Study||218
5024771|NCT02138227|12365075|P1|COMPLETED|Overall Study||55
5024772|NCT02138227|12365074|P2|STARTED|Overall Study||218
5024773|NCT02138227|12365075|P1|STARTED|Overall Study||55
5024774|NCT02138136|12365106|P1|NOT COMPLETED|Overall Study||139
5024775|NCT02138136|12365106|P1|COMPLETED|Overall Study||280
5024776|NCT02138136|12365106|P1|Modified Intent to Treat (mITT)|Overall Study||418
5024777|NCT02138136|12365106|P1|Safety Analysis Set|Overall Study||419
5024778|NCT02138136|12365106|P1|STARTED|Overall Study||419
5024779|NCT02138110|12365113|P1|NOT COMPLETED|Overall Scaffold Implantation||3
5024780|NCT02138110|12365113|P1|COMPLETED|Overall Scaffold Implantation||16
5024781|NCT02138110|12365113|P1|6-month Follow-Up|Overall Scaffold Implantation||16
5024782|NCT02138110|12365113|P1|STARTED|Overall Scaffold Implantation||19
5024783|NCT02138110|12365113|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
5024784|NCT02138110|12365113|P1|COMPLETED|Enrolled for Scaffold Implantation||19
5024785|NCT02138110|12365113|P1|STARTED|Enrolled for Scaffold Implantation||20
5024786|NCT02138110|12365113|P1|NOT COMPLETED|Enrolled in Study||0
5024787|NCT02138110|12365113|P1|COMPLETED|Enrolled in Study||20
5024788|NCT02138110|12365113|P1|STARTED|Enrolled in Study||20
5024789|NCT02138097|12365141|P2|NOT COMPLETED|Overall Study||0
5024790|NCT02138097|12365142|P1|NOT COMPLETED|Overall Study||0
5024791|NCT02138097|12365141|P2|COMPLETED|Overall Study||459722
5024792|NCT02138097|12365142|P1|COMPLETED|Overall Study||155345
5024793|NCT02138097|12365141|P2|STARTED|Overall Study||459722
5024794|NCT02138097|12365142|P1|STARTED|Overall Study||155345
5024795|NCT02138006|12365334|P2|NOT COMPLETED|Overall Study||0
5024796|NCT02138006|12365335|P1|NOT COMPLETED|Overall Study||0
5024797|NCT02138006|12365334|P2|COMPLETED|Overall Study||54
5024798|NCT02138006|12365335|P1|COMPLETED|Overall Study||48
5024799|NCT02138006|12365334|P2|STARTED|Overall Study||54
5024800|NCT02138006|12365335|P1|STARTED|Overall Study||48
5024801|NCT02137785|12365345|P2|NOT COMPLETED|Overall Study||4
5024802|NCT02137785|12365346|P1|NOT COMPLETED|Overall Study||3
5024803|NCT02137785|12365345|P2|COMPLETED|Overall Study||130
5024804|NCT02137785|12365346|P1|COMPLETED|Overall Study||132
5024805|NCT02137785|12365345|P2|STARTED|Overall Study||134
5024806|NCT02137785|12365346|P1|STARTED|Overall Study||135
5024807|NCT02137772|12365454|P2|NOT COMPLETED|Overall Study||75
5024808|NCT02137772|12365455|P1|NOT COMPLETED|Overall Study||132
5024809|NCT02137772|12365454|P2|COMPLETED|Overall Study||119
5024810|NCT02137772|12365455|P1|COMPLETED|Overall Study||244
5024811|NCT02137772|12365454|P2|Treated Participants|Overall Study||192
5024812|NCT02137772|12365455|P1|Treated Participants|Overall Study||373
5024813|NCT02137772|12365454|P2|STARTED|Overall Study|Randomized participants|194
5024814|NCT02137772|12365455|P1|STARTED|Overall Study|Randomized participants|376
5024815|NCT02137603|12365481|P2|NOT COMPLETED|Overall Study||0
5024816|NCT02137603|12365482|P1|NOT COMPLETED|Overall Study||2
5024817|NCT02137603|12365481|P2|COMPLETED|Overall Study||18
5024818|NCT02137603|12365482|P1|COMPLETED|Overall Study||16
5024819|NCT02137603|12365481|P2|STARTED|Overall Study||18
5024820|NCT02137603|12365482|P1|STARTED|Overall Study||18
5024821|NCT02137512|12365490|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
5024822|NCT02137512|12365490|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
5024823|NCT02137512|12365490|P1|STARTED|5-Month 24/7 Closed-Loop||14
5024824|NCT02137512|12365490|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
5024825|NCT02137512|12365490|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
5024826|NCT02137512|12365490|P1|STARTED|2-Week 24/7 Closed-Loop||30
5024827|NCT02137512|12365490|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
5024828|NCT02137512|12365490|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
5024829|NCT02137512|12365490|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
5024830|NCT02137512|12365490|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
5024831|NCT02137512|12365490|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
5024832|NCT02137512|12365490|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
5024833|NCT02137499|12365647|P4|NOT COMPLETED|Overall Study||0
5024834|NCT02137499|12365648|P3|NOT COMPLETED|Overall Study||0
5024835|NCT02137499|12365649|P2|NOT COMPLETED|Overall Study||0
5024836|NCT02137499|12365650|P1|NOT COMPLETED|Overall Study||0
5024837|NCT02137499|12365647|P4|COMPLETED|Overall Study||10
5024838|NCT02137499|12365648|P3|COMPLETED|Overall Study||10
5024839|NCT02137499|12365649|P2|COMPLETED|Overall Study||10
5024840|NCT02137499|12365650|P1|COMPLETED|Overall Study||10
5024841|NCT02137499|12365647|P4|STARTED|Overall Study||10
5024842|NCT02137499|12365648|P3|STARTED|Overall Study||10
5024843|NCT02137499|12365649|P2|STARTED|Overall Study||10
5024844|NCT02137499|12365650|P1|STARTED|Overall Study||10
5024845|NCT02137486|12365670|P2|NOT COMPLETED|Overall Study||0
5024846|NCT02137486|12365671|P1|NOT COMPLETED|Overall Study||0
5024847|NCT02137486|12365670|P2|COMPLETED|Overall Study||102
5024848|NCT02137486|12365671|P1|COMPLETED|Overall Study||112
5024849|NCT02137486|12365670|P2|STARTED|Overall Study||102
5024850|NCT02137486|12365671|P1|STARTED|Overall Study||112
5024851|NCT02137447|12365687|P1|NOT COMPLETED|Overall Study||0
5024852|NCT02137447|12365687|P1|COMPLETED|Overall Study||10
5024853|NCT02137447|12365687|P1|STARTED|Overall Study||10
5024854|NCT02137382|12365692|P2|NOT COMPLETED|Cross-over Period 2||0
5024855|NCT02137382|12365693|P1|NOT COMPLETED|Cross-over Period 2||0
5024856|NCT02137382|12365692|P2|COMPLETED|Cross-over Period 2||21
5024857|NCT02137382|12365693|P1|COMPLETED|Cross-over Period 2||18
5024858|NCT02137382|12365692|P2|STARTED|Cross-over Period 2||21
5024859|NCT02137382|12365693|P1|STARTED|Cross-over Period 2||18
5024860|NCT02137382|12365692|P2|NOT COMPLETED|Wash Out||0
5024861|NCT02137382|12365693|P1|NOT COMPLETED|Wash Out||0
5024862|NCT02137382|12365692|P2|COMPLETED|Wash Out||21
5024863|NCT02137382|12365693|P1|COMPLETED|Wash Out||18
5024864|NCT02137382|12365692|P2|STARTED|Wash Out||21
5024865|NCT02137382|12365693|P1|STARTED|Wash Out||18
5024866|NCT02137382|12365692|P2|NOT COMPLETED|Cross-over Period 1||0
5024867|NCT02137382|12365693|P1|NOT COMPLETED|Cross-over Period 1||2
5024868|NCT02137382|12365692|P2|COMPLETED|Cross-over Period 1||21
5024869|NCT02137382|12365693|P1|COMPLETED|Cross-over Period 1||18
5024870|NCT02137382|12365692|P2|STARTED|Cross-over Period 1||21
5024871|NCT02137382|12365693|P1|STARTED|Cross-over Period 1||20
5024872|NCT02137226|12365713|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
5024873|NCT02137226|12365714|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
5024874|NCT02137226|12365715|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
5024875|NCT02137226|12365716|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
5024876|NCT02137226|12365717|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
5024877|NCT02137226|12365713|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
5024878|NCT02137226|12365714|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
5024879|NCT02137226|12365715|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
5024880|NCT02137226|12365716|P2|COMPLETED|Period 2 (Re - Randomization)||0
5024881|NCT02137226|12365717|P1|COMPLETED|Period 2 (Re - Randomization)||0
5024882|NCT02137226|12365713|P5|STARTED|Period 2 (Re - Randomization)||147
5024883|NCT02137226|12365714|P4|STARTED|Period 2 (Re - Randomization)||148
5024884|NCT02137226|12365715|P3|STARTED|Period 2 (Re - Randomization)||298
5024885|NCT02137226|12365716|P2|STARTED|Period 2 (Re - Randomization)||0
5024886|NCT02137226|12365717|P1|STARTED|Period 2 (Re - Randomization)||0
5024887|NCT02137226|12365713|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
5024888|NCT02137226|12365714|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
5024889|NCT02137226|12365715|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
5024890|NCT02137226|12365716|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
5024891|NCT02137226|12365717|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
5024892|NCT02137226|12365713|P5|COMPLETED|Period 1 (Initial Randomization)||0
5024893|NCT02137226|12365714|P4|COMPLETED|Period 1 (Initial Randomization)||0
5024894|NCT02137226|12365715|P3|COMPLETED|Period 1 (Initial Randomization)||0
5024895|NCT02137226|12365716|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
5024896|NCT02137226|12365717|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
5024897|NCT02137226|12365713|P5|STARTED|Period 1 (Initial Randomization)||0
5024898|NCT02137226|12365714|P4|STARTED|Period 1 (Initial Randomization)||0
5024899|NCT02137226|12365715|P3|STARTED|Period 1 (Initial Randomization)||0
5024900|NCT02137226|12365716|P2|STARTED|Period 1 (Initial Randomization)||321
5024901|NCT02137226|12365717|P1|STARTED|Period 1 (Initial Randomization)||324
5024902|NCT02137096|12365729|P1|NOT COMPLETED|Overall Study||0
5024903|NCT02137096|12365729|P1|COMPLETED|Overall Study||1
5024904|NCT02137096|12365729|P1|STARTED|Overall Study||1
5024905|NCT02136914|12365735|P2|NOT COMPLETED|Overall Study||21
5024906|NCT02136914|12365736|P1|NOT COMPLETED|Overall Study||21
5024907|NCT02136914|12365735|P2|COMPLETED|Overall Study||42
5024908|NCT02136914|12365736|P1|COMPLETED|Overall Study||42
5024909|NCT02136914|12365735|P2|Received Study Drug|Overall Study||63
5024910|NCT02136914|12365736|P1|Received Study Drug|Overall Study||60
5024911|NCT02136914|12365735|P2|STARTED|Overall Study||63
5024912|NCT02136914|12365736|P1|STARTED|Overall Study||63
5024913|NCT02136810|12365750|P1|NOT COMPLETED|Overall Study||0
5024914|NCT02136810|12365750|P1|COMPLETED|Overall Study||200
5024915|NCT02136810|12365750|P1|STARTED|Overall Study||200
5024916|NCT02136680|12365756|P2|NOT COMPLETED|Overall Study||29
5024917|NCT02136680|12365757|P1|NOT COMPLETED|Overall Study||32
5024918|NCT02136680|12365756|P2|COMPLETED|Overall Study||56
5024919|NCT02136680|12365757|P1|COMPLETED|Overall Study||80
5024920|NCT02136680|12365756|P2|Interview 3|Overall Study||56
5024921|NCT02136680|12365757|P1|Interview 3|Overall Study||80
5024922|NCT02136680|12365756|P2|Interview 2|Overall Study||70
5024923|NCT02136680|12365757|P1|Interview 2|Overall Study||97
5024924|NCT02136680|12365756|P2|Interview 1|Overall Study||85
5024925|NCT02136680|12365757|P1|Interview 1|Overall Study||112
5024926|NCT02136680|12365756|P2|STARTED|Overall Study||85
5024927|NCT02136680|12365757|P1|STARTED|Overall Study||112
5024928|NCT02136498|12365773|P2|NOT COMPLETED|Overall Study||0
5024929|NCT02136498|12365774|P1|NOT COMPLETED|Overall Study||0
5024930|NCT02136498|12365773|P2|COMPLETED|Overall Study||33
5024931|NCT02136498|12365774|P1|COMPLETED|Overall Study||33
5024932|NCT02136498|12365773|P2|STARTED|Overall Study||33
5024933|NCT02136498|12365774|P1|STARTED|Overall Study||33
5024934|NCT02136420|12365786|P10|NOT COMPLETED|Overall Study||0
5024935|NCT02136420|12365787|P9|NOT COMPLETED|Overall Study||0
5024936|NCT02136420|12365788|P8|NOT COMPLETED|Overall Study||0
5024937|NCT02136420|12365789|P7|NOT COMPLETED|Overall Study||0
5024938|NCT02136420|12365790|P6|NOT COMPLETED|Overall Study||0
5024939|NCT02136420|12365791|P5|NOT COMPLETED|Overall Study||0
5024940|NCT02136420|12365792|P4|NOT COMPLETED|Overall Study||0
5024941|NCT02136420|12365793|P3|NOT COMPLETED|Overall Study||0
5024942|NCT02136420|12365794|P2|NOT COMPLETED|Overall Study||0
5024943|NCT02136420|12365795|P1|NOT COMPLETED|Overall Study||1
5024944|NCT02136420|12365786|P10|COMPLETED|Overall Study||5
5024945|NCT02136420|12365787|P9|COMPLETED|Overall Study||5
5024946|NCT02136420|12365788|P8|COMPLETED|Overall Study||0
5024947|NCT02136420|12365789|P7|COMPLETED|Overall Study||0
5024948|NCT02136420|12365790|P6|COMPLETED|Overall Study||0
5024949|NCT02136420|12365791|P5|COMPLETED|Overall Study||10
5024950|NCT02136420|12365792|P4|COMPLETED|Overall Study||0
5024951|NCT02136420|12365793|P3|COMPLETED|Overall Study||0
5024952|NCT02136420|12365794|P2|COMPLETED|Overall Study||0
5024953|NCT02136420|12365795|P1|COMPLETED|Overall Study||9
5024954|NCT02136420|12365786|P10|STARTED|Overall Study||5
5024955|NCT02136420|12365787|P9|STARTED|Overall Study||5
5024956|NCT02136420|12365788|P8|STARTED|Overall Study||0
5024957|NCT02136420|12365789|P7|STARTED|Overall Study||0
5024958|NCT02136420|12365790|P6|STARTED|Overall Study||0
5024959|NCT02136420|12365791|P5|STARTED|Overall Study||10
5024960|NCT02136420|12365792|P4|STARTED|Overall Study||0
5024961|NCT02136420|12365793|P3|STARTED|Overall Study||0
5024962|NCT02136420|12365794|P2|STARTED|Overall Study||0
5024963|NCT02136420|12365795|P1|STARTED|Overall Study||10
5024964|NCT02136238|12365817|P3|NOT COMPLETED|Overall Study||0
5024965|NCT02136238|12365818|P2|NOT COMPLETED|Overall Study||0
5024966|NCT02136238|12365819|P1|NOT COMPLETED|Overall Study||0
5024967|NCT02136238|12365817|P3|COMPLETED|Overall Study||10
5024968|NCT02136238|12365818|P2|COMPLETED|Overall Study||4
5024969|NCT02136238|12365819|P1|COMPLETED|Overall Study||4
5024970|NCT02136238|12365817|P3|STARTED|Overall Study||10
5024971|NCT02136238|12365818|P2|STARTED|Overall Study||4
5024972|NCT02136238|12365819|P1|STARTED|Overall Study||4
5024973|NCT02136134|12365832|P2|NOT COMPLETED|Overall Study||251
5024974|NCT02136134|12365833|P1|NOT COMPLETED|Overall Study||247
5024975|NCT02136134|12365832|P2|COMPLETED|Overall Study||0
5024976|NCT02136134|12365833|P1|COMPLETED|Overall Study||0
5024977|NCT02136134|12365832|P2|Treated|Overall Study||243
5024978|NCT02136134|12365833|P1|Treated|Overall Study||237
5024979|NCT02136134|12365832|P2|STARTED|Overall Study||251
5024980|NCT02136134|12365833|P1|STARTED|Overall Study||247
5024981|NCT02136004|12365851|P1|NOT COMPLETED|Overall Study||1
5024982|NCT02136004|12365851|P1|COMPLETED|Overall Study||219
5024983|NCT02136004|12365851|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
5024984|NCT02135900|12365862|P1|NOT COMPLETED|Overall Study||0
5024985|NCT02135900|12365862|P1|COMPLETED|Overall Study||32
5024986|NCT02135900|12365862|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
5024987|NCT02135861|12365872|P3|NOT COMPLETED|Overall Study||0
5024988|NCT02135861|12365873|P2|NOT COMPLETED|Overall Study||0
5024989|NCT02135861|12365874|P1|NOT COMPLETED|Overall Study||0
5024990|NCT02135861|12365872|P3|COMPLETED|Overall Study||3
5024991|NCT02135861|12365873|P2|COMPLETED|Overall Study||12
5024992|NCT02135861|12365874|P1|COMPLETED|Overall Study||21
5024993|NCT02135861|12365872|P3|STARTED|Overall Study||3
5024994|NCT02135861|12365873|P2|STARTED|Overall Study||12
5024995|NCT02135861|12365874|P1|STARTED|Overall Study||21
5024996|NCT02135848|12365895|P2|NOT COMPLETED|Overall Study||1
5024997|NCT02135848|12365896|P1|NOT COMPLETED|Overall Study||3
5024998|NCT02135848|12365895|P2|COMPLETED|Overall Study||19
5024999|NCT02135848|12365896|P1|COMPLETED|Overall Study||23
5025000|NCT02135848|12365895|P2|STARTED|Overall Study||20
5025001|NCT02135848|12365896|P1|STARTED|Overall Study||26
5025002|NCT02135692|12365954|P1|NOT COMPLETED|Overall Study||339
5025003|NCT02135692|12365954|P1|COMPLETED|Overall Study||0
5025004|NCT02135692|12365954|P1|STARTED|Overall Study||339
5025005|NCT02135614|12365973|P2|NOT COMPLETED|Overall Study||5
5025006|NCT02135614|12365974|P1|NOT COMPLETED|Overall Study||8
5025007|NCT02135614|12365973|P2|COMPLETED|Overall Study||90
5025008|NCT02135614|12365974|P1|COMPLETED|Overall Study||86
5025009|NCT02135614|12365973|P2|STARTED|Overall Study||95
5025010|NCT02135614|12365974|P1|STARTED|Overall Study||94
5025011|NCT02135445|12365988|P2|NOT COMPLETED|Overall Study||0
5025012|NCT02135445|12365989|P1|NOT COMPLETED|Overall Study||2
5025013|NCT02135445|12365988|P2|COMPLETED|Overall Study||38
5025014|NCT02135445|12365989|P1|COMPLETED|Overall Study||63
5025015|NCT02135445|12365988|P2|STARTED|Overall Study||38
5025016|NCT02135445|12365989|P1|STARTED|Overall Study||65
5025017|NCT02135432|12366040|P2|NOT COMPLETED|Overall Study||0
5025018|NCT02135432|12366041|P1|NOT COMPLETED|Overall Study||0
5025019|NCT02135432|12366040|P2|COMPLETED|Overall Study||4
5025020|NCT02135432|12366041|P1|COMPLETED|Overall Study||8
5025021|NCT02135432|12366040|P2|STARTED|Overall Study||4
5025022|NCT02135432|12366041|P1|STARTED|Overall Study||8
5025023|NCT02135146|12366055|P2|NOT COMPLETED|Overall Study||0
5025024|NCT02135146|12366056|P1|NOT COMPLETED|Overall Study||0
5025025|NCT02135146|12366055|P2|COMPLETED|Overall Study||20
5025026|NCT02135146|12366056|P1|COMPLETED|Overall Study||20
5025027|NCT02135146|12366055|P2|STARTED|Overall Study||20
5025028|NCT02135146|12366056|P1|STARTED|Overall Study||20
5025029|NCT02135107|12366074|P4|NOT COMPLETED|Maintenance Therapy Period||20
5025030|NCT02135107|12366075|P3|NOT COMPLETED|Maintenance Therapy Period||15
5025031|NCT02135107|12366076|P2|NOT COMPLETED|Maintenance Therapy Period||0
5025032|NCT02135107|12366077|P1|NOT COMPLETED|Maintenance Therapy Period||0
5025033|NCT02135107|12366074|P4|COMPLETED|Maintenance Therapy Period||161
5025034|NCT02135107|12366075|P3|COMPLETED|Maintenance Therapy Period||163
5025035|NCT02135107|12366076|P2|COMPLETED|Maintenance Therapy Period||0
5025036|NCT02135107|12366077|P1|COMPLETED|Maintenance Therapy Period||0
5025037|NCT02135107|12366074|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
5025038|NCT02135107|12366075|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
5025039|NCT02135107|12366076|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
5025040|NCT02135107|12366077|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
5025041|NCT02135107|12366074|P4|NOT COMPLETED|Treatment Period||0
5025042|NCT02135107|12366075|P3|NOT COMPLETED|Treatment Period||0
5025043|NCT02135107|12366076|P2|NOT COMPLETED|Treatment Period||26
5025044|NCT02135107|12366077|P1|NOT COMPLETED|Treatment Period||132
5025045|NCT02135107|12366074|P4|COMPLETED|Treatment Period||0
5025046|NCT02135107|12366075|P3|COMPLETED|Treatment Period||0
5025047|NCT02135107|12366076|P2|COMPLETED|Treatment Period||54
5025048|NCT02135107|12366077|P1|COMPLETED|Treatment Period||305
5025049|NCT02135107|12366074|P4|STARTED|Treatment Period||0
5025050|NCT02135107|12366075|P3|STARTED|Treatment Period||0
5025051|NCT02135107|12366076|P2|STARTED|Treatment Period||80
5025052|NCT02135107|12366077|P1|STARTED|Treatment Period||437
5025053|NCT02135094|12366105|P2|NOT COMPLETED|Overall Study||0
5025054|NCT02135094|12366106|P1|NOT COMPLETED|Overall Study||0
5025055|NCT02135094|12366105|P2|COMPLETED|Overall Study||8
5025056|NCT02135094|12366106|P1|COMPLETED|Overall Study||25
5025057|NCT02135094|12366105|P2|Week 4|Overall Study||8
5025058|NCT02135094|12366106|P1|Week 4|Overall Study||25
5025059|NCT02135094|12366105|P2|Week 3|Overall Study||8
5025060|NCT02135094|12366106|P1|Week 3|Overall Study||25
5025061|NCT02135094|12366105|P2|Week 2|Overall Study||8
5025062|NCT02135094|12366106|P1|Week 2|Overall Study||25
5025063|NCT02135094|12366105|P2|STARTED|Overall Study||8
5025064|NCT02135094|12366106|P1|STARTED|Overall Study||25
5025065|NCT02135029|12366123|P3|NOT COMPLETED|Overall Study||3
5025066|NCT02135029|12366124|P2|NOT COMPLETED|Overall Study||5
5025067|NCT02135029|12366125|P1|NOT COMPLETED|Overall Study||4
5025068|NCT02135029|12366123|P3|COMPLETED|Overall Study||34
5025069|NCT02135029|12366124|P2|COMPLETED|Overall Study||69
5025070|NCT02135029|12366125|P1|COMPLETED|Overall Study||69
5025071|NCT02135029|12366123|P3|Treated|Overall Study||36
5025072|NCT02135029|12366124|P2|Treated|Overall Study||74
5025073|NCT02135029|12366125|P1|Treated|Overall Study||73
5025074|NCT02135029|12366123|P3|STARTED|Overall Study||37
5025075|NCT02135029|12366124|P2|STARTED|Overall Study||74
5025076|NCT02135029|12366125|P1|STARTED|Overall Study||73
5025077|NCT02135016|12366208|P3|NOT COMPLETED|Overall Study||0
5025078|NCT02135016|12366209|P2|NOT COMPLETED|Overall Study||0
5025079|NCT02135016|12366210|P1|NOT COMPLETED|Overall Study||0
5025080|NCT02135016|12366208|P3|COMPLETED|Overall Study||15
5025081|NCT02135016|12366209|P2|COMPLETED|Overall Study||15
5025082|NCT02135016|12366210|P1|COMPLETED|Overall Study||15
5025083|NCT02135016|12366208|P3|STARTED|Overall Study||15
5025084|NCT02135016|12366209|P2|STARTED|Overall Study||15
5025085|NCT02135016|12366210|P1|STARTED|Overall Study||15
5025086|NCT02134977|12366230|P1|NOT COMPLETED|Overall Study||102
5025087|NCT02134977|12366230|P1|COMPLETED|Overall Study||2714
5025088|NCT02134977|12366230|P1|STARTED|Overall Study||2816
5025089|NCT02134951|12366253|P2|NOT COMPLETED|Overall Study||0
5025090|NCT02134951|12366254|P1|NOT COMPLETED|Overall Study||0
5025091|NCT02134951|12366253|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
5025092|NCT02134951|12366254|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
5025093|NCT02134951|12366253|P2|STARTED|Overall Study||20
5025094|NCT02134951|12366254|P1|STARTED|Overall Study||39
5025095|NCT02134925|12366264|P2|NOT COMPLETED|Overall Study||6
5025096|NCT02134925|12366265|P1|NOT COMPLETED|Overall Study||2
5025097|NCT02134925|12366264|P2|COMPLETED|Overall Study||50
5025098|NCT02134925|12366265|P1|COMPLETED|Overall Study||52
5025099|NCT02134925|12366264|P2|Received at Least One Dose of Treatment|Overall Study||50
5025100|NCT02134925|12366265|P1|Received at Least One Dose of Treatment|Overall Study||53
5025101|NCT02134925|12366264|P2|STARTED|Overall Study||56
5025102|NCT02134925|12366265|P1|STARTED|Overall Study||54
5025103|NCT02134912|12366283|P2|NOT COMPLETED|Overall Study||0
5025104|NCT02134912|12366284|P1|NOT COMPLETED|Overall Study||0
5025105|NCT02134912|12366283|P2|COMPLETED|Overall Study||0
5025106|NCT02134912|12366284|P1|COMPLETED|Overall Study||0
5025107|NCT02134912|12366283|P2|STARTED|Overall Study||0
5025108|NCT02134912|12366284|P1|STARTED|Overall Study||0
5025109|NCT02134717|12366300|P1|NOT COMPLETED|Overall Study||0
5025110|NCT02134717|12366300|P1|COMPLETED|Overall Study||3
5025111|NCT02134717|12366300|P1|STARTED|Overall Study||3
5025112|NCT02134587|12366306|P1|NOT COMPLETED|Overall Study||30
5025113|NCT02134587|12366306|P1|COMPLETED|Overall Study||173
5025114|NCT02134587|12366306|P1|STARTED|Overall Study||203
5025115|NCT02134522|12366315|P1|NOT COMPLETED|Overall Study||0
5025116|NCT02134522|12366315|P1|COMPLETED|Overall Study||1
5025117|NCT02134522|12366315|P1|STARTED|Overall Study||1
5025118|NCT02134314|12366322|P2|NOT COMPLETED|Overall Study||1
5025119|NCT02134314|12366323|P1|NOT COMPLETED|Overall Study||1
5025120|NCT02134314|12366322|P2|COMPLETED|Overall Study||34
5025121|NCT02134314|12366323|P1|COMPLETED|Overall Study||34
5025122|NCT02134314|12366322|P2|STARTED|Overall Study||35
5025123|NCT02134314|12366323|P1|STARTED|Overall Study||35
5025124|NCT02134210|12366355|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
5025125|NCT02134210|12366356|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
5025126|NCT02134210|12366355|P2|COMPLETED|Part Two: Weeks 13-48||227
5025127|NCT02134210|12366356|P1|COMPLETED|Part Two: Weeks 13-48||211
5025128|NCT02134210|12366355|P2|STARTED|Part Two: Weeks 13-48||255
5025129|NCT02134210|12366356|P1|STARTED|Part Two: Weeks 13-48||241
5025130|NCT02134210|12366355|P2|NOT COMPLETED|Part One: Weeks 0-12||6
5025131|NCT02134210|12366356|P1|NOT COMPLETED|Part One: Weeks 0-12||19
5025132|NCT02134210|12366355|P2|COMPLETED|Part One: Weeks 0-12||255
5025133|NCT02134210|12366356|P1|COMPLETED|Part One: Weeks 0-12||241
5025134|NCT02134210|12366355|P2|STARTED|Part One: Weeks 0-12||261
5025135|NCT02134210|12366356|P1|STARTED|Part One: Weeks 0-12||260
5025136|NCT02134184|12366389|P3|NOT COMPLETED|Overall Study||0
5025137|NCT02134184|12366390|P2|NOT COMPLETED|Overall Study||0
5025138|NCT02134184|12366391|P1|NOT COMPLETED|Overall Study||0
5025139|NCT02134184|12366389|P3|COMPLETED|Overall Study||8
5025140|NCT02134184|12366390|P2|COMPLETED|Overall Study||37
5025141|NCT02134184|12366391|P1|COMPLETED|Overall Study||33
5025142|NCT02134184|12366389|P3|STARTED|Overall Study||8
5025143|NCT02134184|12366390|P2|STARTED|Overall Study||37
5025144|NCT02134184|12366391|P1|STARTED|Overall Study||33
5025145|NCT02134119|12366404|P2|NOT COMPLETED|Overall Study||0
5025146|NCT02134119|12366405|P1|NOT COMPLETED|Overall Study||0
5025147|NCT02134119|12366404|P2|COMPLETED|Overall Study||15
5025148|NCT02134119|12366405|P1|COMPLETED|Overall Study||30
5025149|NCT02134119|12366404|P2|STARTED|Overall Study||15
5025150|NCT02134119|12366405|P1|STARTED|Overall Study||30
5025151|NCT02134015|12366445|P2|NOT COMPLETED|Overall Study||74
5025152|NCT02134015|12366446|P1|NOT COMPLETED|Overall Study||71
5025153|NCT02134015|12366445|P2|COMPLETED|Overall Study||0
5025154|NCT02134015|12366446|P1|COMPLETED|Overall Study||0
5025155|NCT02134015|12366445|P2|STARTED|Overall Study||74
5025156|NCT02134015|12366446|P1|STARTED|Overall Study||71
5025157|NCT02133781|12366469|P3|NOT COMPLETED|Overall Study||0
5025158|NCT02133781|12366470|P2|NOT COMPLETED|Overall Study||0
5025159|NCT02133781|12366471|P1|NOT COMPLETED|Overall Study||0
5025160|NCT02133781|12366469|P3|COMPLETED|Overall Study||21
5025161|NCT02133781|12366470|P2|COMPLETED|Overall Study||24
5025162|NCT02133781|12366471|P1|COMPLETED|Overall Study||6
5025163|NCT02133781|12366469|P3|STARTED|Overall Study||21
5025164|NCT02133781|12366470|P2|STARTED|Overall Study||24
5025165|NCT02133781|12366471|P1|STARTED|Overall Study||6
5025166|NCT02133742|12366482|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
5025167|NCT02133742|12366482|P1|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
5025168|NCT02133742|12366482|P1|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
5025169|NCT02133742|12366482|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
5025170|NCT02133742|12366482|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
5025171|NCT02133742|12366482|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
5025172|NCT02133664|12366511|P2|NOT COMPLETED|Overall Study||7
5025173|NCT02133664|12366512|P1|NOT COMPLETED|Overall Study||5
5025174|NCT02133664|12366511|P2|COMPLETED|Overall Study||21
5025175|NCT02133664|12366512|P1|COMPLETED|Overall Study||21
5025176|NCT02133664|12366511|P2|STARTED|Overall Study||28
5025177|NCT02133664|12366512|P1|STARTED|Overall Study||26
5025178|NCT02133534|12366524|P1|NOT COMPLETED|Overall Study||0
5025179|NCT02133534|12366524|P1|COMPLETED|Overall Study||1
5025180|NCT02133534|12366524|P1|STARTED|Overall Study||1
5025181|NCT02133508|12366528|P1|NOT COMPLETED|Overall Study||15
5025182|NCT02133508|12366528|P1|COMPLETED|Overall Study||141
5025183|NCT02133508|12366528|P1|STARTED|Overall Study||156
5025184|NCT02133352|12366536|P1|NOT COMPLETED|Longer Term Extension||6
5025185|NCT02133352|12366536|P1|COMPLETED|Longer Term Extension||4
5025186|NCT02133352|12366536|P1|STARTED|Longer Term Extension||10
5025187|NCT02133352|12366536|P1|NOT COMPLETED|Main Study (180 Day)||0
5025188|NCT02133352|12366536|P1|COMPLETED|Main Study (180 Day)||10
5025189|NCT02133352|12366536|P1|STARTED|Main Study (180 Day)||10
5025190|NCT02133235|12366547|P2|NOT COMPLETED|Overall Study||0
5025191|NCT02133235|12366548|P1|NOT COMPLETED|Overall Study||0
5025192|NCT02133235|12366547|P2|COMPLETED|Overall Study||57
5025193|NCT02133235|12366548|P1|COMPLETED|Overall Study||55
5025194|NCT02133235|12366547|P2|STARTED|Overall Study||57
5025195|NCT02133235|12366548|P1|STARTED|Overall Study||55
5025196|NCT02133131|12366567|P7|NOT COMPLETED|Overall Study||12
5025197|NCT02133131|12366568|P6|NOT COMPLETED|Overall Study||14
5025198|NCT02133131|12366569|P5|NOT COMPLETED|Overall Study||15
5025199|NCT02133131|12366570|P4|NOT COMPLETED|Overall Study||6
5025200|NCT02133131|12366571|P3|NOT COMPLETED|Overall Study||1
5025201|NCT02133131|12366572|P2|NOT COMPLETED|Overall Study||5
5025202|NCT02133131|12366573|P1|NOT COMPLETED|Overall Study||5
5025203|NCT02133131|12366567|P7|COMPLETED|Overall Study||0
5025204|NCT02133131|12366568|P6|COMPLETED|Overall Study||0
5025205|NCT02133131|12366569|P5|COMPLETED|Overall Study||0
5025206|NCT02133131|12366570|P4|COMPLETED|Overall Study||15
5025207|NCT02133131|12366571|P3|COMPLETED|Overall Study||19
5025208|NCT02133131|12366572|P2|COMPLETED|Overall Study||25
5025209|NCT02133131|12366573|P1|COMPLETED|Overall Study||26
5025210|NCT02133131|12366567|P7|STARTED|Overall Study||12
5025211|NCT02133131|12366568|P6|STARTED|Overall Study||14
5025212|NCT02133131|12366569|P5|STARTED|Overall Study||15
5025213|NCT02133131|12366570|P4|STARTED|Overall Study||21
5025214|NCT02133131|12366571|P3|STARTED|Overall Study||20
5025215|NCT02133131|12366572|P2|STARTED|Overall Study||30
5025216|NCT02133131|12366573|P1|STARTED|Overall Study||31
5025217|NCT02133066|12366612|P2|NOT COMPLETED|Overall Study||0
5025218|NCT02133066|12366613|P1|NOT COMPLETED|Overall Study||0
5025219|NCT02133066|12366612|P2|COMPLETED|Overall Study||64
5025220|NCT02133066|12366613|P1|COMPLETED|Overall Study||64
5025221|NCT02133066|12366612|P2|STARTED|Overall Study||64
5025222|NCT02133066|12366613|P1|STARTED|Overall Study||64
5025223|NCT02133001|12366627|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
5025224|NCT02133001|12366628|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
5025225|NCT02133001|12366627|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
5025226|NCT02133001|12366628|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
5025227|NCT02133001|12366627|P2|STARTED|Follow-Up Phase (Day 26-81)||27
5025228|NCT02133001|12366628|P1|STARTED|Follow-Up Phase (Day 26-81)||22
5025229|NCT02133001|12366627|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
5025230|NCT02133001|12366628|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
5025231|NCT02133001|12366627|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
5025232|NCT02133001|12366628|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
5025233|NCT02133001|12366627|P2|Safety|Double Blind (Day 1-25)||35
5025234|NCT02133001|12366628|P1|Safety|Double Blind (Day 1-25)||31
5025235|NCT02133001|12366627|P2|STARTED|Double Blind (Day 1-25)||36
5025236|NCT02133001|12366628|P1|STARTED|Double Blind (Day 1-25)||32
5025237|NCT02132949|12366676|P2|NOT COMPLETED|Adjuvant Treatment Period||167
5025238|NCT02132949|12366677|P1|NOT COMPLETED|Adjuvant Treatment Period||149
5025239|NCT02132949|12366676|P2|COMPLETED|Adjuvant Treatment Period||23
5025240|NCT02132949|12366677|P1|COMPLETED|Adjuvant Treatment Period||29
5025241|NCT02132949|12366676|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
5025242|NCT02132949|12366677|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
5025243|NCT02132949|12366676|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
5025244|NCT02132949|12366677|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
5025245|NCT02132949|12366676|P2|COMPLETED|Neoadjuvant Treatment Period||189
5025246|NCT02132949|12366677|P1|COMPLETED|Neoadjuvant Treatment Period||182
5025247|NCT02132949|12366676|P2|No Treatment|Neoadjuvant Treatment Period||3
5025248|NCT02132949|12366677|P1|No Treatment|Neoadjuvant Treatment Period||1
5025249|NCT02132949|12366676|P2|STARTED|Neoadjuvant Treatment Period||201
5025250|NCT02132949|12366677|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
5025251|NCT02132936|12366709|P4|NOT COMPLETED|Overall Study||14
5025252|NCT02132936|12366710|P3|NOT COMPLETED|Overall Study||14
5025253|NCT02132936|12366711|P2|NOT COMPLETED|Overall Study||9
5025254|NCT02132936|12366712|P1|NOT COMPLETED|Overall Study||10
5025255|NCT02132936|12366709|P4|COMPLETED|Overall Study||29
5025256|NCT02132936|12366710|P3|COMPLETED|Overall Study||174
5025257|NCT02132936|12366711|P2|COMPLETED|Overall Study||38
5025258|NCT02132936|12366712|P1|COMPLETED|Overall Study||175
5025259|NCT02132936|12366709|P4|STARTED|Overall Study||43
5025260|NCT02132936|12366710|P3|STARTED|Overall Study||188
5025261|NCT02132936|12366711|P2|STARTED|Overall Study||47
5025262|NCT02132936|12366712|P1|STARTED|Overall Study||185
5025263|NCT02132910|12366730|P2|NOT COMPLETED|Overall Study||0
5025264|NCT02132910|12366731|P1|NOT COMPLETED|Overall Study||0
5025265|NCT02132910|12366730|P2|COMPLETED|Overall Study||34
5025266|NCT02132910|12366731|P1|COMPLETED|Overall Study||34
5025267|NCT02132910|12366730|P2|STARTED|Overall Study||34
5025268|NCT02132910|12366731|P1|STARTED|Overall Study||34
5025269|NCT02132884|12366745|P2|NOT COMPLETED|Overall Study||0
5025270|NCT02132884|12366746|P1|NOT COMPLETED|Overall Study||0
5025271|NCT02132884|12366745|P2|COMPLETED|Overall Study||0
5025272|NCT02132884|12366746|P1|COMPLETED|Overall Study||0
5025273|NCT02132884|12366745|P2|STARTED|Overall Study||0
5025274|NCT02132884|12366746|P1|STARTED|Overall Study||0
5025275|NCT02132832|12366758|P2|NOT COMPLETED|Overall Study||7
5025276|NCT02132832|12366759|P1|NOT COMPLETED|Overall Study||3
5025277|NCT02132832|12366758|P2|COMPLETED|Overall Study||16
5025278|NCT02132832|12366759|P1|COMPLETED|Overall Study||16
5025279|NCT02132832|12366758|P2|STARTED|Overall Study||23
5025280|NCT02132832|12366759|P1|STARTED|Overall Study||19
5025281|NCT02132767|12366789|P2|NOT COMPLETED|Overall Study||15
5025282|NCT02132767|12366790|P1|NOT COMPLETED|Overall Study||17
5025283|NCT02132767|12366789|P2|COMPLETED|Overall Study||246
5025284|NCT02132767|12366790|P1|COMPLETED|Overall Study||245
5025285|NCT02132767|12366789|P2|STARTED|Overall Study||261
5025286|NCT02132767|12366790|P1|STARTED|Overall Study||262
5025287|NCT02132754|12366844|P34|NOT COMPLETED|Overall Study||23
5025288|NCT02132754|12366845|P33|NOT COMPLETED|Overall Study||4
5025289|NCT02132754|12366846|P32|NOT COMPLETED|Overall Study||3
5025290|NCT02132754|12366847|P31|NOT COMPLETED|Overall Study||3
5025291|NCT02132754|12366848|P30|NOT COMPLETED|Overall Study||3
5025292|NCT02132754|12366849|P29|NOT COMPLETED|Overall Study||3
5025293|NCT02132754|12366850|P28|NOT COMPLETED|Overall Study||3
5025294|NCT02132754|12366851|P27|NOT COMPLETED|Overall Study||4
5025295|NCT02132754|12366852|P26|NOT COMPLETED|Overall Study||3
5025296|NCT02132754|12366853|P25|NOT COMPLETED|Overall Study||3
5025297|NCT02132754|12366854|P24|NOT COMPLETED|Overall Study||3
5025298|NCT02132754|12366855|P23|NOT COMPLETED|Overall Study||3
5025299|NCT02132754|12366856|P22|NOT COMPLETED|Overall Study||5
5025300|NCT02132754|12366857|P21|NOT COMPLETED|Overall Study||3
5025301|NCT02132754|12366858|P20|NOT COMPLETED|Overall Study||4
5025302|NCT02132754|12366859|P19|NOT COMPLETED|Overall Study||3
5025303|NCT02132754|12366860|P18|NOT COMPLETED|Overall Study||3
5025304|NCT02132754|12366861|P17|NOT COMPLETED|Overall Study||4
5025305|NCT02132754|12366862|P16|NOT COMPLETED|Overall Study||5
5025306|NCT02132754|12366863|P15|NOT COMPLETED|Overall Study||3
5025307|NCT02132754|12366864|P14|NOT COMPLETED|Overall Study||3
5025308|NCT02132754|12366865|P13|NOT COMPLETED|Overall Study||4
5025309|NCT02132754|12366866|P12|NOT COMPLETED|Overall Study||3
5025310|NCT02132754|12366867|P11|NOT COMPLETED|Overall Study||3
5025311|NCT02132754|12366868|P10|NOT COMPLETED|Overall Study||6
5025312|NCT02132754|12366869|P9|NOT COMPLETED|Overall Study||1
5025313|NCT02132754|12366870|P8|NOT COMPLETED|Overall Study||1
5025314|NCT02132754|12366871|P7|NOT COMPLETED|Overall Study||1
5025315|NCT02132754|12366872|P6|NOT COMPLETED|Overall Study||1
5025316|NCT02132754|12366873|P5|NOT COMPLETED|Overall Study||1
5025317|NCT02132754|12366874|P4|NOT COMPLETED|Overall Study||1
5025318|NCT02132754|12366875|P3|NOT COMPLETED|Overall Study||1
5025319|NCT02132754|12366876|P2|NOT COMPLETED|Overall Study||1
5025320|NCT02132754|12366877|P1|NOT COMPLETED|Overall Study||1
5025321|NCT02132754|12366844|P34|COMPLETED|Overall Study||0
5025322|NCT02132754|12366845|P33|COMPLETED|Overall Study||0
5025323|NCT02132754|12366846|P32|COMPLETED|Overall Study||0
5025324|NCT02132754|12366847|P31|COMPLETED|Overall Study||0
5025325|NCT02132754|12366848|P30|COMPLETED|Overall Study||0
5025326|NCT02132754|12366849|P29|COMPLETED|Overall Study||0
5025327|NCT02132754|12366850|P28|COMPLETED|Overall Study||0
5025328|NCT02132754|12366851|P27|COMPLETED|Overall Study||0
5025329|NCT02132754|12366852|P26|COMPLETED|Overall Study||0
5025330|NCT02132754|12366853|P25|COMPLETED|Overall Study||0
5025331|NCT02132754|12366854|P24|COMPLETED|Overall Study||0
5025332|NCT02132754|12366855|P23|COMPLETED|Overall Study||0
5025333|NCT02132754|12366856|P22|COMPLETED|Overall Study||0
5025334|NCT02132754|12366857|P21|COMPLETED|Overall Study||0
5025335|NCT02132754|12366858|P20|COMPLETED|Overall Study||0
5025336|NCT02132754|12366859|P19|COMPLETED|Overall Study||0
5025337|NCT02132754|12366860|P18|COMPLETED|Overall Study||0
5025338|NCT02132754|12366861|P17|COMPLETED|Overall Study||0
5025339|NCT02132754|12366862|P16|COMPLETED|Overall Study||0
5025340|NCT02132754|12366863|P15|COMPLETED|Overall Study||0
5025341|NCT02132754|12366864|P14|COMPLETED|Overall Study||0
5025342|NCT02132754|12366865|P13|COMPLETED|Overall Study||0
5025343|NCT02132754|12366866|P12|COMPLETED|Overall Study||0
5025344|NCT02132754|12366867|P11|COMPLETED|Overall Study||0
5025345|NCT02132754|12366868|P10|COMPLETED|Overall Study||0
5025346|NCT02132754|12366869|P9|COMPLETED|Overall Study||0
5025347|NCT02132754|12366870|P8|COMPLETED|Overall Study||0
5025348|NCT02132754|12366871|P7|COMPLETED|Overall Study||0
5025349|NCT02132754|12366872|P6|COMPLETED|Overall Study||0
5025350|NCT02132754|12366873|P5|COMPLETED|Overall Study||0
5025351|NCT02132754|12366874|P4|COMPLETED|Overall Study||0
5025352|NCT02132754|12366875|P3|COMPLETED|Overall Study||0
5025353|NCT02132754|12366876|P2|COMPLETED|Overall Study||0
5025354|NCT02132754|12366877|P1|COMPLETED|Overall Study||0
5025355|NCT02132754|12366844|P34|Treated|Overall Study||23
5025356|NCT02132754|12366845|P33|Treated|Overall Study||4
5025357|NCT02132754|12366846|P32|Treated|Overall Study||3
5025358|NCT02132754|12366847|P31|Treated|Overall Study||3
5025359|NCT02132754|12366848|P30|Treated|Overall Study||3
5025360|NCT02132754|12366849|P29|Treated|Overall Study||3
5025361|NCT02132754|12366850|P28|Treated|Overall Study||3
5025362|NCT02132754|12366851|P27|Treated|Overall Study||4
5025363|NCT02132754|12366852|P26|Treated|Overall Study||3
5025364|NCT02132754|12366853|P25|Treated|Overall Study||3
5025365|NCT02132754|12366854|P24|Treated|Overall Study||3
5025366|NCT02132754|12366855|P23|Treated|Overall Study||3
5025367|NCT02132754|12366856|P22|Treated|Overall Study||4
5025368|NCT02132754|12366857|P21|Treated|Overall Study||3
5025369|NCT02132754|12366858|P20|Treated|Overall Study||3
5025370|NCT02132754|12366859|P19|Treated|Overall Study||3
5025371|NCT02132754|12366860|P18|Treated|Overall Study||3
5025372|NCT02132754|12366861|P17|Treated|Overall Study||4
5025373|NCT02132754|12366862|P16|Treated|Overall Study||5
5025374|NCT02132754|12366863|P15|Treated|Overall Study||3
5025375|NCT02132754|12366864|P14|Treated|Overall Study||3
5025376|NCT02132754|12366865|P13|Treated|Overall Study||3
5025377|NCT02132754|12366866|P12|Treated|Overall Study||3
5025378|NCT02132754|12366867|P11|Treated|Overall Study||3
5025379|NCT02132754|12366868|P10|Treated|Overall Study||6
5025380|NCT02132754|12366869|P9|Treated|Overall Study||1
5025381|NCT02132754|12366870|P8|Treated|Overall Study||1
5025382|NCT02132754|12366871|P7|Treated|Overall Study||1
5025383|NCT02132754|12366872|P6|Treated|Overall Study||1
5025384|NCT02132754|12366873|P5|Treated|Overall Study||1
5025385|NCT02132754|12366874|P4|Treated|Overall Study||1
5025386|NCT02132754|12366875|P3|Treated|Overall Study||1
5025387|NCT02132754|12366876|P2|Treated|Overall Study||1
5025388|NCT02132754|12366877|P1|Treated|Overall Study||1
5025389|NCT02132754|12366844|P34|STARTED|Overall Study||23
5025390|NCT02132754|12366845|P33|STARTED|Overall Study||4
5025391|NCT02132754|12366846|P32|STARTED|Overall Study||3
5025392|NCT02132754|12366847|P31|STARTED|Overall Study||3
5025393|NCT02132754|12366848|P30|STARTED|Overall Study||3
5025394|NCT02132754|12366849|P29|STARTED|Overall Study||3
5025395|NCT02132754|12366850|P28|STARTED|Overall Study||3
5025396|NCT02132754|12366851|P27|STARTED|Overall Study||4
5025397|NCT02132754|12366852|P26|STARTED|Overall Study||3
5025398|NCT02132754|12366853|P25|STARTED|Overall Study||3
5025399|NCT02132754|12366854|P24|STARTED|Overall Study||3
5025400|NCT02132754|12366855|P23|STARTED|Overall Study||3
5025401|NCT02132754|12366856|P22|STARTED|Overall Study||5
5025402|NCT02132754|12366857|P21|STARTED|Overall Study||3
5025403|NCT02132754|12366858|P20|STARTED|Overall Study||4
5025404|NCT02132754|12366859|P19|STARTED|Overall Study||3
5025405|NCT02132754|12366860|P18|STARTED|Overall Study||3
5025406|NCT02132754|12366861|P17|STARTED|Overall Study||4
5025407|NCT02132754|12366862|P16|STARTED|Overall Study||5
5025408|NCT02132754|12366863|P15|STARTED|Overall Study||3
5025409|NCT02132754|12366864|P14|STARTED|Overall Study||3
5025410|NCT02132754|12366865|P13|STARTED|Overall Study||4
5025411|NCT02132754|12366866|P12|STARTED|Overall Study||3
5025412|NCT02132754|12366867|P11|STARTED|Overall Study||3
5025413|NCT02132754|12366868|P10|STARTED|Overall Study||6
5025414|NCT02132754|12366869|P9|STARTED|Overall Study||1
5025415|NCT02132754|12366870|P8|STARTED|Overall Study||1
5025416|NCT02132754|12366871|P7|STARTED|Overall Study||1
5025417|NCT02132754|12366872|P6|STARTED|Overall Study||1
5025418|NCT02132754|12366873|P5|STARTED|Overall Study||1
5025419|NCT02132754|12366874|P4|STARTED|Overall Study||1
5025420|NCT02132754|12366875|P3|STARTED|Overall Study||1
5025421|NCT02132754|12366876|P2|STARTED|Overall Study||1
5025422|NCT02132754|12366877|P1|STARTED|Overall Study||1
5025423|NCT02132650|12367601|P2|NOT COMPLETED|Overall Study||4
5025424|NCT02132650|12367602|P1|NOT COMPLETED|Overall Study||3
5025425|NCT02132650|12367601|P2|COMPLETED|Overall Study||14
5025426|NCT02132650|12367602|P1|COMPLETED|Overall Study||17
5025427|NCT02132650|12367601|P2|Post-Intervention Assessment|Overall Study||17
5025428|NCT02132650|12367602|P1|Post-Intervention Assessment|Overall Study||19
5025429|NCT02132650|12367601|P2|STARTED|Overall Study||18
5025430|NCT02132650|12367602|P1|STARTED|Overall Study||20
5025431|NCT02132637|12367612|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
5025432|NCT02132637|12367613|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
5025433|NCT02132637|12367612|P2|COMPLETED|Study Period 2 (Crossover)||29
5025434|NCT02132637|12367613|P1|COMPLETED|Study Period 2 (Crossover)||31
5025435|NCT02132637|12367612|P2|STARTED|Study Period 2 (Crossover)||30
5025436|NCT02132637|12367613|P1|STARTED|Study Period 2 (Crossover)||33
5025437|NCT02132637|12367612|P2|NOT COMPLETED|Study Period 1||4
5025438|NCT02132637|12367613|P1|NOT COMPLETED|Study Period 1||1
5025439|NCT02132637|12367612|P2|COMPLETED|Study Period 1||30
5025440|NCT02132637|12367613|P1|COMPLETED|Study Period 1||33
5025441|NCT02132637|12367612|P2|Received at Least One Dose of Study Drug|Study Period 1||34
5025442|NCT02132637|12367613|P1|Received at Least One Dose of Study Drug|Study Period 1||34
5025443|NCT02132637|12367612|P2|STARTED|Study Period 1||34
5025444|NCT02132637|12367613|P1|STARTED|Study Period 1||34
5025445|NCT02132611|12367637|P1|NOT COMPLETED|Overall Study||2
5025446|NCT02132611|12367637|P1|COMPLETED|Overall Study||98
5025447|NCT02132611|12367637|P1|STARTED|Overall Study||100
5025448|NCT02132572|12367642|P1|NOT COMPLETED|Overall Study||0
5025449|NCT02132572|12367642|P1|COMPLETED|Overall Study||201
5025450|NCT02132572|12367642|P1|STARTED|Overall Study||201
5025451|NCT02132533|12367648|P2|NOT COMPLETED|Overall Study||0
5025452|NCT02132533|12367649|P1|NOT COMPLETED|Overall Study||0
5025453|NCT02132533|12367648|P2|COMPLETED|Overall Study||42
5025454|NCT02132533|12367649|P1|COMPLETED|Overall Study||46
5025455|NCT02132533|12367648|P2|STARTED|Overall Study||42
5025456|NCT02132533|12367649|P1|STARTED|Overall Study||46
5025457|NCT02132520|12367664|P3|NOT COMPLETED|Overall Study||0
5025458|NCT02132520|12367665|P2|NOT COMPLETED|Overall Study||0
5025459|NCT02132520|12367666|P1|NOT COMPLETED|Overall Study||0
5025460|NCT02132520|12367664|P3|COMPLETED|Overall Study||2
5025461|NCT02132520|12367665|P2|COMPLETED|Overall Study||1
5025462|NCT02132520|12367666|P1|COMPLETED|Overall Study||0
5025463|NCT02132520|12367664|P3|STARTED|Overall Study||2
5025464|NCT02132520|12367665|P2|STARTED|Overall Study||1
5025465|NCT02132520|12367666|P1|STARTED|Overall Study||0
5025466|NCT02132468|12367679|P1|NOT COMPLETED|Overall Study||7
5025467|NCT02132468|12367679|P1|COMPLETED|Overall Study||11
5025468|NCT02132468|12367679|P1|STARTED|Overall Study||18
5025469|NCT02132247|12367688|P2|NOT COMPLETED|Overall Study||0
5025470|NCT02132247|12367689|P1|NOT COMPLETED|Overall Study||1
5025471|NCT02132247|12367688|P2|COMPLETED|Overall Study||52
5025472|NCT02132247|12367689|P1|COMPLETED|Overall Study||51
5025473|NCT02132247|12367688|P2|STARTED|Overall Study||52
5025474|NCT02132247|12367689|P1|STARTED|Overall Study||52
5025475|NCT02132195|12367704|P3|NOT COMPLETED|Rescue Therapy||11
5025476|NCT02132195|12367705|P2|NOT COMPLETED|Rescue Therapy||0
5025477|NCT02132195|12367706|P1|NOT COMPLETED|Rescue Therapy||0
5025478|NCT02132195|12367704|P3|COMPLETED|Rescue Therapy||2
5025479|NCT02132195|12367705|P2|COMPLETED|Rescue Therapy||0
5025480|NCT02132195|12367706|P1|COMPLETED|Rescue Therapy||0
5025481|NCT02132195|12367704|P3|STARTED|Rescue Therapy||13
5025482|NCT02132195|12367705|P2|STARTED|Rescue Therapy||0
5025483|NCT02132195|12367706|P1|STARTED|Rescue Therapy||0
5025484|NCT02132195|12367704|P3|NOT COMPLETED|Initial Assignment||0
5025485|NCT02132195|12367705|P2|NOT COMPLETED|Initial Assignment||0
5025486|NCT02132195|12367706|P1|NOT COMPLETED|Initial Assignment||14
5025487|NCT02132195|12367704|P3|COMPLETED|Initial Assignment||0
5025488|NCT02132195|12367705|P2|COMPLETED|Initial Assignment||16
5025489|NCT02132195|12367706|P1|COMPLETED|Initial Assignment||1
5025490|NCT02132195|12367704|P3|STARTED|Initial Assignment||0
5025491|NCT02132195|12367705|P2|STARTED|Initial Assignment||16
5025492|NCT02132195|12367706|P1|STARTED|Initial Assignment||15
5025493|NCT02132169|12367722|P2|NOT COMPLETED|Overall Study||9
5025494|NCT02132169|12367723|P1|NOT COMPLETED|Overall Study||15
5025495|NCT02132169|12367722|P2|COMPLETED|Overall Study||162
5025496|NCT02132169|12367723|P1|COMPLETED|Overall Study||326
5025497|NCT02132169|12367722|P2|STARTED|Overall Study||171
5025498|NCT02132169|12367723|P1|STARTED|Overall Study||341
5025499|NCT02132117|12367737|P2|NOT COMPLETED|Overall Study||5
5025500|NCT02132117|12367738|P1|NOT COMPLETED|Overall Study||11
5025501|NCT02132117|12367737|P2|COMPLETED|Overall Study||216
5025502|NCT02132117|12367738|P1|COMPLETED|Overall Study||213
5025503|NCT02132117|12367737|P2|STARTED|Overall Study||221
5025504|NCT02132117|12367738|P1|STARTED|Overall Study||224
5025505|NCT02131766|12367754|P1|NOT COMPLETED|Overall Study||4
5025506|NCT02131766|12367754|P1|COMPLETED|Overall Study||40
5025507|NCT02131766|12367754|P1|STARTED|Overall Study||44
5025508|NCT02131662|12367770|P5|NOT COMPLETED|Overall Study||18
5025509|NCT02131662|12367771|P4|NOT COMPLETED|Overall Study||21
5025510|NCT02131662|12367772|P3|NOT COMPLETED|Overall Study||7
5025511|NCT02131662|12367773|P2|NOT COMPLETED|Overall Study||14
5025512|NCT02131662|12367774|P1|NOT COMPLETED|Overall Study||8
5025513|NCT02131662|12367770|P5|COMPLETED|Overall Study||43
5025514|NCT02131662|12367771|P4|COMPLETED|Overall Study||41
5025515|NCT02131662|12367772|P3|COMPLETED|Overall Study||56
5025516|NCT02131662|12367773|P2|COMPLETED|Overall Study||47
5025517|NCT02131662|12367774|P1|COMPLETED|Overall Study||54
5025518|NCT02131662|12367770|P5|Completed Follow-up|Overall Study||44
5025519|NCT02131662|12367771|P4|Completed Follow-up|Overall Study||42
5025520|NCT02131662|12367772|P3|Completed Follow-up|Overall Study||56
5025521|NCT02131662|12367773|P2|Completed Follow-up|Overall Study||47
5025522|NCT02131662|12367774|P1|Completed Follow-up|Overall Study||54
5025523|NCT02131662|12367770|P5|Completed Treatment|Overall Study||52
5025524|NCT02131662|12367771|P4|Completed Treatment|Overall Study||56
5025525|NCT02131662|12367772|P3|Completed Treatment|Overall Study||61
5025526|NCT02131662|12367773|P2|Completed Treatment|Overall Study||60
5025527|NCT02131662|12367774|P1|Completed Treatment|Overall Study||57
5025528|NCT02131662|12367770|P5|Treated|Overall Study||58
5025529|NCT02131662|12367771|P4|Treated|Overall Study||60
5025530|NCT02131662|12367772|P3|Treated|Overall Study||61
5025531|NCT02131662|12367773|P2|Treated|Overall Study||61
5025532|NCT02131662|12367774|P1|Treated|Overall Study||60
5025533|NCT02131662|12367770|P5|STARTED|Overall Study||61
5025534|NCT02131662|12367771|P4|STARTED|Overall Study||62
5025535|NCT02131662|12367772|P3|STARTED|Overall Study||63
5025536|NCT02131662|12367773|P2|STARTED|Overall Study||61
5025537|NCT02131662|12367774|P1|STARTED|Overall Study||62
5025538|NCT02131636|12367820|P2|NOT COMPLETED|Overall Study||5
5025539|NCT02131636|12367821|P1|NOT COMPLETED|Overall Study||12
5025540|NCT02131636|12367820|P2|COMPLETED|Overall Study||213
5025541|NCT02131636|12367821|P1|COMPLETED|Overall Study||210
5025542|NCT02131636|12367820|P2|STARTED|Overall Study||218
5025543|NCT02131636|12367821|P1|STARTED|Overall Study||222
5025544|NCT02131532|12367837|P1|NOT COMPLETED|Overall Study||4
5025545|NCT02131532|12367837|P1|COMPLETED|Overall Study||8
5025546|NCT02131532|12367837|P1|STARTED|Overall Study||12
5025547|NCT02131402|12367856|P1|NOT COMPLETED|Overall Study||0
5025548|NCT02131402|12367856|P1|COMPLETED|Overall Study||60
5025549|NCT02131402|12367856|P1|STARTED|Overall Study||60
5025550|NCT02131324|12367929|P2|NOT COMPLETED|Overall Study||3
5025551|NCT02131324|12367930|P1|NOT COMPLETED|Overall Study||2
5025552|NCT02131324|12367929|P2|COMPLETED|Overall Study||23
5025553|NCT02131324|12367930|P1|COMPLETED|Overall Study||22
5025554|NCT02131324|12367929|P2|Analyzed|Overall Study||24
5025555|NCT02131324|12367930|P1|Analyzed|Overall Study||22
5025556|NCT02131324|12367929|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
5025557|NCT02131324|12367930|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
5025558|NCT02131311|12367936|P1|NOT COMPLETED|Overall Study||4
5025559|NCT02131311|12367936|P1|COMPLETED|Overall Study||86
5025560|NCT02131311|12367936|P1|STARTED|Overall Study||90
5025561|NCT02131272|12367948|P2|NOT COMPLETED|Overall Study||2
5025562|NCT02131272|12367949|P1|NOT COMPLETED|Overall Study||1
5025563|NCT02131272|12367948|P2|COMPLETED|Overall Study||20
5025564|NCT02131272|12367949|P1|COMPLETED|Overall Study||19
5025565|NCT02131272|12367948|P2|STARTED|Overall Study||22
5025566|NCT02131272|12367949|P1|STARTED|Overall Study||20
5025567|NCT02131259|12367967|P1|NOT COMPLETED|Overall Study||1225
5025568|NCT02131259|12367967|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
5025569|NCT02131259|12367967|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
5025570|NCT02131233|12367974|P2|NOT COMPLETED|Overall Study||42
5025571|NCT02131233|12367975|P1|NOT COMPLETED|Overall Study||66
5025572|NCT02131233|12367974|P2|COMPLETED|Overall Study|Completed to Week 96|227
5025573|NCT02131233|12367975|P1|COMPLETED|Overall Study|Completed to Week 96|467
5025574|NCT02131233|12367974|P2|Treated|Overall Study||266
5025575|NCT02131233|12367975|P1|Treated|Overall Study||531
5025576|NCT02131233|12367974|P2|STARTED|Overall Study|Enrolled participants|269
5025577|NCT02131233|12367975|P1|STARTED|Overall Study|Enrolled participants|533
5025578|NCT02131155|12368009|P2|NOT COMPLETED|Overall Study||11
5025579|NCT02131155|12368010|P1|NOT COMPLETED|Overall Study||25
5025580|NCT02131155|12368009|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
5025581|NCT02131155|12368010|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
5025582|NCT02131155|12368009|P2|STARTED|Overall Study|Started are treated patients.|11
5025583|NCT02131155|12368010|P1|STARTED|Overall Study|Started are treated patients.|25
5025584|NCT02131129|12368024|P2|NOT COMPLETED|Overall Study||0
5025585|NCT02131129|12368025|P1|NOT COMPLETED|Overall Study||1
5025586|NCT02131129|12368024|P2|COMPLETED|Overall Study||10
5025587|NCT02131129|12368025|P1|COMPLETED|Overall Study||9
5025588|NCT02131129|12368024|P2|STARTED|Overall Study||10
5025589|NCT02131129|12368025|P1|STARTED|Overall Study||10
5025590|NCT02131064|12368043|P2|NOT COMPLETED|Overall Study||34
5025591|NCT02131064|12368044|P1|NOT COMPLETED|Overall Study||25
5025592|NCT02131064|12368043|P2|COMPLETED|Overall Study||189
5025593|NCT02131064|12368044|P1|COMPLETED|Overall Study||196
5025594|NCT02131064|12368043|P2|STARTED|Overall Study||223
5025595|NCT02131064|12368044|P1|STARTED|Overall Study||221
5025596|NCT02130999|12368084|P2|NOT COMPLETED|Overall Study||0
5025597|NCT02130999|12368085|P1|NOT COMPLETED|Overall Study||0
5025598|NCT02130999|12368084|P2|COMPLETED|Overall Study||8
5025599|NCT02130999|12368085|P1|COMPLETED|Overall Study||6
5025600|NCT02130999|12368084|P2|STARTED|Overall Study||8
5025601|NCT02130999|12368085|P1|STARTED|Overall Study||6
5025602|NCT02130986|12368113|P2|NOT COMPLETED|Overall Study||164
5025603|NCT02130986|12368114|P1|NOT COMPLETED|Overall Study||155
5025604|NCT02130986|12368113|P2|COMPLETED|Overall Study||670
5025605|NCT02130986|12368114|P1|COMPLETED|Overall Study||675
5025606|NCT02130986|12368113|P2|STARTED|Overall Study||834
5025607|NCT02130986|12368114|P1|STARTED|Overall Study||830
5025608|NCT02130765|12368128|P4|NOT COMPLETED|Overall Study||0
5025609|NCT02130765|12368129|P3|NOT COMPLETED|Overall Study||0
5025610|NCT02130765|12368130|P2|NOT COMPLETED|Overall Study||0
5025611|NCT02130765|12368131|P1|NOT COMPLETED|Overall Study||4
5025612|NCT02130765|12368128|P4|COMPLETED|Overall Study||19
5025613|NCT02130765|12368129|P3|COMPLETED|Overall Study||26
5025614|NCT02130765|12368130|P2|COMPLETED|Overall Study||8
5025615|NCT02130765|12368131|P1|COMPLETED|Overall Study||7
5025616|NCT02130765|12368128|P4|STARTED|Overall Study||19
5025617|NCT02130765|12368129|P3|STARTED|Overall Study||26
5025618|NCT02130765|12368130|P2|STARTED|Overall Study||8
5025619|NCT02130765|12368131|P1|STARTED|Overall Study||11
5025620|NCT02130635|12368159|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025621|NCT02130635|12368160|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025622|NCT02130635|12368161|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025623|NCT02130635|12368162|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025624|NCT02130635|12368163|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025625|NCT02130635|12368164|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025626|NCT02130635|12368165|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025627|NCT02130635|12368166|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025628|NCT02130635|12368167|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
5025629|NCT02130635|12368159|P9|COMPLETED|Part B-Dose-Response Relationship||5
5025630|NCT02130635|12368160|P8|COMPLETED|Part B-Dose-Response Relationship||5
5025631|NCT02130635|12368161|P7|COMPLETED|Part B-Dose-Response Relationship||6
5025632|NCT02130635|12368162|P6|COMPLETED|Part B-Dose-Response Relationship||5
5025633|NCT02130635|12368163|P5|COMPLETED|Part B-Dose-Response Relationship||5
5025634|NCT02130635|12368164|P4|COMPLETED|Part B-Dose-Response Relationship||5
5025635|NCT02130635|12368165|P3|COMPLETED|Part B-Dose-Response Relationship||5
5025636|NCT02130635|12368166|P2|COMPLETED|Part B-Dose-Response Relationship||0
5025637|NCT02130635|12368167|P1|COMPLETED|Part B-Dose-Response Relationship||0
5025638|NCT02130635|12368159|P9|STARTED|Part B-Dose-Response Relationship||5
5025639|NCT02130635|12368160|P8|STARTED|Part B-Dose-Response Relationship||5
5025640|NCT02130635|12368161|P7|STARTED|Part B-Dose-Response Relationship||6
5025641|NCT02130635|12368162|P6|STARTED|Part B-Dose-Response Relationship||5
5025642|NCT02130635|12368163|P5|STARTED|Part B-Dose-Response Relationship||5
5025643|NCT02130635|12368164|P4|STARTED|Part B-Dose-Response Relationship||5
5025644|NCT02130635|12368165|P3|STARTED|Part B-Dose-Response Relationship||5
5025645|NCT02130635|12368166|P2|STARTED|Part B-Dose-Response Relationship||0
5025646|NCT02130635|12368167|P1|STARTED|Part B-Dose-Response Relationship||0
5025647|NCT02130635|12368159|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
5025733|NCT02130063|12368523|P2|STARTED|Overall Study||169
5025648|NCT02130635|12368160|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
5025649|NCT02130635|12368161|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
5025650|NCT02130635|12368162|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
5025651|NCT02130635|12368163|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
5025652|NCT02130635|12368164|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
5025653|NCT02130635|12368165|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
5025654|NCT02130635|12368166|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
5025655|NCT02130635|12368167|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
5025656|NCT02130635|12368159|P9|COMPLETED|Part A-Safety and Tolerability||0
5025657|NCT02130635|12368160|P8|COMPLETED|Part A-Safety and Tolerability||0
5025658|NCT02130635|12368161|P7|COMPLETED|Part A-Safety and Tolerability||0
5025659|NCT02130635|12368162|P6|COMPLETED|Part A-Safety and Tolerability||0
5025660|NCT02130635|12368163|P5|COMPLETED|Part A-Safety and Tolerability||0
5025661|NCT02130635|12368164|P4|COMPLETED|Part A-Safety and Tolerability||0
5025662|NCT02130635|12368165|P3|COMPLETED|Part A-Safety and Tolerability||0
5025663|NCT02130635|12368166|P2|COMPLETED|Part A-Safety and Tolerability||21
5025664|NCT02130635|12368167|P1|COMPLETED|Part A-Safety and Tolerability||7
5025665|NCT02130635|12368159|P9|STARTED|Part A-Safety and Tolerability||0
5025666|NCT02130635|12368160|P8|STARTED|Part A-Safety and Tolerability||0
5025667|NCT02130635|12368161|P7|STARTED|Part A-Safety and Tolerability||0
5025668|NCT02130635|12368162|P6|STARTED|Part A-Safety and Tolerability||0
5025669|NCT02130635|12368163|P5|STARTED|Part A-Safety and Tolerability||0
5025670|NCT02130635|12368164|P4|STARTED|Part A-Safety and Tolerability||0
5025671|NCT02130635|12368165|P3|STARTED|Part A-Safety and Tolerability||0
5025672|NCT02130635|12368166|P2|STARTED|Part A-Safety and Tolerability||21
5025673|NCT02130635|12368167|P1|STARTED|Part A-Safety and Tolerability||7
5025674|NCT02130622|12368341|P2|NOT COMPLETED|Overall Study||0
5025675|NCT02130622|12368342|P1|NOT COMPLETED|Overall Study||0
5025676|NCT02130622|12368341|P2|COMPLETED|Overall Study||1
5025677|NCT02130622|12368342|P1|COMPLETED|Overall Study||2
5025678|NCT02130622|12368341|P2|STARTED|Overall Study||1
5025679|NCT02130622|12368342|P1|STARTED|Overall Study||2
5025680|NCT02130583|12368356|P2|NOT COMPLETED|Overall Study||7
5025681|NCT02130583|12368357|P1|NOT COMPLETED|Overall Study||9
5025682|NCT02130583|12368356|P2|COMPLETED|Overall Study||19
5025683|NCT02130583|12368357|P1|COMPLETED|Overall Study||17
5025684|NCT02130583|12368356|P2|STARTED|Overall Study||26
5025685|NCT02130583|12368357|P1|STARTED|Overall Study||26
5025686|NCT02130570|12368377|P2|NOT COMPLETED|Overall Study||13
5025687|NCT02130570|12368378|P1|NOT COMPLETED|Overall Study||9
5025688|NCT02130570|12368377|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
5025689|NCT02130570|12368378|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
5025690|NCT02130570|12368377|P2|STARTED|Overall Study||692
5025691|NCT02130570|12368378|P1|STARTED|Overall Study||987
5025692|NCT02130557|12368396|P2|NOT COMPLETED|Overall Study||268
5025693|NCT02130557|12368397|P1|NOT COMPLETED|Overall Study||268
5025694|NCT02130557|12368396|P2|COMPLETED|Overall Study||0
5025695|NCT02130557|12368397|P1|COMPLETED|Overall Study||0
5025696|NCT02130557|12368396|P2|mITT Population|Overall Study||241
5025697|NCT02130557|12368397|P1|mITT Population|Overall Study||246
5025698|NCT02130557|12368396|P2|Treated|Overall Study||265
5025699|NCT02130557|12368397|P1|Treated|Overall Study||268
5025700|NCT02130557|12368396|P2|STARTED|Overall Study||268
5025701|NCT02130557|12368397|P1|STARTED|Overall Study||268
5025702|NCT02130284|12368429|P1|NOT COMPLETED|Overall Study||9
5025703|NCT02130284|12368429|P1|COMPLETED|Overall Study||71
5025704|NCT02130284|12368429|P1|STARTED|Overall Study||80
5025705|NCT02130258|12368442|P2|NOT COMPLETED|Overall Study||0
5025706|NCT02130258|12368443|P1|NOT COMPLETED|Overall Study||0
5025707|NCT02130258|12368442|P2|COMPLETED|Overall Study||11
5025708|NCT02130258|12368443|P1|COMPLETED|Overall Study||9
5025709|NCT02130258|12368442|P2|STARTED|Overall Study||11
5025710|NCT02130258|12368443|P1|STARTED|Overall Study||9
5025711|NCT02130193|12368455|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
5025712|NCT02130193|12368456|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
5025713|NCT02130193|12368457|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
5025714|NCT02130193|12368455|P3|COMPLETED|Part B: 52-week Double-blind Period||37
5025715|NCT02130193|12368456|P2|COMPLETED|Part B: 52-week Double-blind Period||38
5025716|NCT02130193|12368457|P1|COMPLETED|Part B: 52-week Double-blind Period||0
5025717|NCT02130193|12368455|P3|STARTED|Part B: 52-week Double-blind Period||45
5025718|NCT02130193|12368456|P2|STARTED|Part B: 52-week Double-blind Period||48
5025719|NCT02130193|12368457|P1|STARTED|Part B: 52-week Double-blind Period||0
5025720|NCT02130193|12368455|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
5025721|NCT02130193|12368456|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
5025722|NCT02130193|12368457|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
5025723|NCT02130193|12368455|P3|COMPLETED|Part A: 4-week Open-label Period||0
5025724|NCT02130193|12368456|P2|COMPLETED|Part A: 4-week Open-label Period||0
5025725|NCT02130193|12368457|P1|COMPLETED|Part A: 4-week Open-label Period||9
5025726|NCT02130193|12368455|P3|STARTED|Part A: 4-week Open-label Period||0
5025727|NCT02130193|12368456|P2|STARTED|Part A: 4-week Open-label Period||0
5025728|NCT02130193|12368457|P1|STARTED|Part A: 4-week Open-label Period||9
5025729|NCT02130063|12368523|P2|NOT COMPLETED|Overall Study||17
5025730|NCT02130063|12368524|P1|NOT COMPLETED|Overall Study||25
5025731|NCT02130063|12368523|P2|COMPLETED|Overall Study||152
5025732|NCT02130063|12368524|P1|COMPLETED|Overall Study||317
5025734|NCT02130063|12368524|P1|STARTED|Overall Study||342
5025735|NCT02130024|12368538|P2|NOT COMPLETED|Overall Study||31
5025736|NCT02130024|12368539|P1|NOT COMPLETED|Overall Study||25
5025737|NCT02130024|12368538|P2|COMPLETED|Overall Study||108
5025738|NCT02130024|12368539|P1|COMPLETED|Overall Study||117
5025739|NCT02130024|12368538|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
5025740|NCT02130024|12368539|P1|Full Analysis Set (FAS)|Overall Study||141
5025741|NCT02130024|12368538|P2|Safety Set|Overall Study||139
5025742|NCT02130024|12368539|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
5025743|NCT02130024|12368538|P2|STARTED|Overall Study||139
5025744|NCT02130024|12368539|P1|STARTED|Overall Study||142
5025745|NCT02129777|12368576|P7|NOT COMPLETED|Open-Label Period||48
5025746|NCT02129777|12368577|P6|NOT COMPLETED|Open-Label Period||12
5025747|NCT02129777|12368578|P5|NOT COMPLETED|Open-Label Period||0
5025748|NCT02129777|12368579|P4|NOT COMPLETED|Open-Label Period||0
5025749|NCT02129777|12368580|P3|NOT COMPLETED|Open-Label Period||0
5025750|NCT02129777|12368581|P2|NOT COMPLETED|Open-Label Period||0
5025751|NCT02129777|12368582|P1|NOT COMPLETED|Open-Label Period||0
5025752|NCT02129777|12368576|P7|COMPLETED|Open-Label Period||0
5025753|NCT02129777|12368577|P6|COMPLETED|Open-Label Period||0
5025754|NCT02129777|12368578|P5|COMPLETED|Open-Label Period||0
5025755|NCT02129777|12368579|P4|COMPLETED|Open-Label Period||0
5025756|NCT02129777|12368580|P3|COMPLETED|Open-Label Period||0
5025757|NCT02129777|12368581|P2|COMPLETED|Open-Label Period||0
5025758|NCT02129777|12368582|P1|COMPLETED|Open-Label Period||0
5025759|NCT02129777|12368576|P7|STARTED|Open-Label Period||48
5025760|NCT02129777|12368577|P6|STARTED|Open-Label Period||12
5025761|NCT02129777|12368578|P5|STARTED|Open-Label Period||0
5025762|NCT02129777|12368579|P4|STARTED|Open-Label Period||0
5025763|NCT02129777|12368580|P3|STARTED|Open-Label Period||0
5025764|NCT02129777|12368581|P2|STARTED|Open-Label Period||0
5025765|NCT02129777|12368582|P1|STARTED|Open-Label Period||0
5025766|NCT02129777|12368576|P7|NOT COMPLETED|Double-Blind Period||0
5025767|NCT02129777|12368577|P6|NOT COMPLETED|Double-Blind Period||0
5025768|NCT02129777|12368578|P5|NOT COMPLETED|Double-Blind Period||7
5025769|NCT02129777|12368579|P4|NOT COMPLETED|Double-Blind Period||7
5025770|NCT02129777|12368580|P3|NOT COMPLETED|Double-Blind Period||4
5025771|NCT02129777|12368581|P2|NOT COMPLETED|Double-Blind Period||8
5025772|NCT02129777|12368582|P1|NOT COMPLETED|Double-Blind Period||7
5025773|NCT02129777|12368576|P7|COMPLETED|Double-Blind Period||0
5025774|NCT02129777|12368577|P6|COMPLETED|Double-Blind Period||0
5025775|NCT02129777|12368578|P5|COMPLETED|Double-Blind Period||18
5025776|NCT02129777|12368579|P4|COMPLETED|Double-Blind Period||18
5025777|NCT02129777|12368580|P3|COMPLETED|Double-Blind Period||20
5025778|NCT02129777|12368581|P2|COMPLETED|Double-Blind Period||16
5025779|NCT02129777|12368582|P1|COMPLETED|Double-Blind Period||17
5025780|NCT02129777|12368576|P7|STARTED|Double-Blind Period||0
5025781|NCT02129777|12368577|P6|STARTED|Double-Blind Period||0
5025782|NCT02129777|12368578|P5|STARTED|Double-Blind Period||25
5025783|NCT02129777|12368579|P4|STARTED|Double-Blind Period||25
5025784|NCT02129777|12368580|P3|STARTED|Double-Blind Period||24
5025785|NCT02129777|12368581|P2|STARTED|Double-Blind Period||24
5025786|NCT02129777|12368582|P1|STARTED|Double-Blind Period||24
5025787|NCT02129725|12368688|P2|NOT COMPLETED|Overall Study||3
5025788|NCT02129725|12368689|P1|NOT COMPLETED|Overall Study||2
5025789|NCT02129725|12368688|P2|COMPLETED|Overall Study||4
5025790|NCT02129725|12368689|P1|COMPLETED|Overall Study||6
5025791|NCT02129725|12368688|P2|STARTED|Overall Study||7
5025792|NCT02129725|12368689|P1|STARTED|Overall Study||8
5025793|NCT02129660|12368700|P5|NOT COMPLETED|Overall Study||2
5025794|NCT02129660|12368701|P4|NOT COMPLETED|Overall Study||0
5025795|NCT02129660|12368702|P3|NOT COMPLETED|Overall Study||1
5025796|NCT02129660|12368703|P2|NOT COMPLETED|Overall Study||0
5025797|NCT02129660|12368704|P1|NOT COMPLETED|Overall Study||2
5025798|NCT02129660|12368700|P5|COMPLETED|Overall Study||20
5025799|NCT02129660|12368701|P4|COMPLETED|Overall Study||20
5025800|NCT02129660|12368702|P3|COMPLETED|Overall Study||21
5025801|NCT02129660|12368703|P2|COMPLETED|Overall Study||20
5025802|NCT02129660|12368704|P1|COMPLETED|Overall Study||19
5025803|NCT02129660|12368700|P5|STARTED|Overall Study||22
5025804|NCT02129660|12368701|P4|STARTED|Overall Study||20
5025805|NCT02129660|12368702|P3|STARTED|Overall Study||22
5025806|NCT02129660|12368703|P2|STARTED|Overall Study||20
5025807|NCT02129660|12368704|P1|STARTED|Overall Study||21
5025808|NCT02129608|12368749|P3|NOT COMPLETED|Overall Study||3
5025809|NCT02129608|12368750|P2|NOT COMPLETED|Overall Study||1
5025810|NCT02129608|12368751|P1|NOT COMPLETED|Overall Study||0
5025811|NCT02129608|12368749|P3|COMPLETED|Overall Study||12
5025812|NCT02129608|12368750|P2|COMPLETED|Overall Study||13
5025813|NCT02129608|12368751|P1|COMPLETED|Overall Study||15
5025814|NCT02129608|12368749|P3|End of Treatment|Overall Study||12
5025815|NCT02129608|12368750|P2|End of Treatment|Overall Study||13
5025816|NCT02129608|12368751|P1|End of Treatment|Overall Study||15
5025817|NCT02129608|12368749|P3|STARTED|Overall Study||15
5025818|NCT02129608|12368750|P2|STARTED|Overall Study||14
5025819|NCT02129608|12368751|P1|STARTED|Overall Study||15
5025820|NCT02129556|12368765|P4|NOT COMPLETED|Overall Study||0
5025821|NCT02129556|12368766|P3|NOT COMPLETED|Overall Study||3
5025822|NCT02129556|12368767|P2|NOT COMPLETED|Overall Study||0
5025823|NCT02129556|12368768|P1|NOT COMPLETED|Overall Study||0
5025824|NCT02129556|12368765|P4|COMPLETED|Overall Study||12
5025825|NCT02129556|12368766|P3|COMPLETED|Overall Study||37
5025826|NCT02129556|12368767|P2|COMPLETED|Overall Study||3
5025827|NCT02129556|12368768|P1|COMPLETED|Overall Study||3
5025828|NCT02129556|12368765|P4|STARTED|Overall Study||12
5025829|NCT02129556|12368766|P3|STARTED|Overall Study||40
5025830|NCT02129556|12368767|P2|STARTED|Overall Study||3
5025831|NCT02129556|12368768|P1|STARTED|Overall Study||3
5025832|NCT02129478|12368792|P1|NOT COMPLETED|Overall Study||0
5025833|NCT02129478|12368792|P1|COMPLETED|Overall Study||15
5025834|NCT02129478|12368792|P1|STARTED|Overall Study||15
5025835|NCT02129205|12368808|P10|NOT COMPLETED|Overall Study||0
5025836|NCT02129205|12368809|P9|NOT COMPLETED|Overall Study||2
5025837|NCT02129205|12368810|P8|NOT COMPLETED|Overall Study||2
5025838|NCT02129205|12368811|P7|NOT COMPLETED|Overall Study||4
5025839|NCT02129205|12368812|P6|NOT COMPLETED|Overall Study||4
5025840|NCT02129205|12368813|P5|NOT COMPLETED|Overall Study||3
5025841|NCT02129205|12368814|P4|NOT COMPLETED|Overall Study||0
5025842|NCT02129205|12368815|P3|NOT COMPLETED|Overall Study||0
5025843|NCT02129205|12368816|P2|NOT COMPLETED|Overall Study||0
5025844|NCT02129205|12368817|P1|NOT COMPLETED|Overall Study||1
5025845|NCT02129205|12368808|P10|COMPLETED|Overall Study||0
5025846|NCT02129205|12368809|P9|COMPLETED|Overall Study||0
5025847|NCT02129205|12368810|P8|COMPLETED|Overall Study||4
5025848|NCT02129205|12368811|P7|COMPLETED|Overall Study||2
5025849|NCT02129205|12368812|P6|COMPLETED|Overall Study||7
5025850|NCT02129205|12368813|P5|COMPLETED|Overall Study||4
5025851|NCT02129205|12368814|P4|COMPLETED|Overall Study||2
5025852|NCT02129205|12368815|P3|COMPLETED|Overall Study||2
5025853|NCT02129205|12368816|P2|COMPLETED|Overall Study||2
5025854|NCT02129205|12368817|P1|COMPLETED|Overall Study||1
5025855|NCT02129205|12368808|P10|STARTED|Overall Study||0
5025856|NCT02129205|12368809|P9|STARTED|Overall Study||2
5025857|NCT02129205|12368810|P8|STARTED|Overall Study||6
5025858|NCT02129205|12368811|P7|STARTED|Overall Study||6
5025859|NCT02129205|12368812|P6|STARTED|Overall Study||11
5025860|NCT02129205|12368813|P5|STARTED|Overall Study||7
5025861|NCT02129205|12368814|P4|STARTED|Overall Study||2
5025862|NCT02129205|12368815|P3|STARTED|Overall Study||2
5025863|NCT02129205|12368816|P2|STARTED|Overall Study||2
5025864|NCT02129205|12368817|P1|STARTED|Overall Study||2
5025865|NCT02129192|12368970|P2|NOT COMPLETED|Period 5||0
5025866|NCT02129192|12368971|P1|NOT COMPLETED|Period 5||0
5025867|NCT02129192|12368970|P2|COMPLETED|Period 5||0
5025868|NCT02129192|12368971|P1|COMPLETED|Period 5||36
5025869|NCT02129192|12368970|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
5025870|NCT02129192|12368971|P1|STARTED|Period 5||36
5025871|NCT02129192|12368970|P2|NOT COMPLETED|Period 4 Including Washout Period||0
5025872|NCT02129192|12368971|P1|NOT COMPLETED|Period 4 Including Washout Period||0
5025873|NCT02129192|12368970|P2|COMPLETED|Period 4 Including Washout Period||35
5025874|NCT02129192|12368971|P1|COMPLETED|Period 4 Including Washout Period||36
5025875|NCT02129192|12368970|P2|STARTED|Period 4 Including Washout Period||35
5025876|NCT02129192|12368971|P1|STARTED|Period 4 Including Washout Period||36
5025877|NCT02129192|12368970|P2|NOT COMPLETED|Period 3 Including Washout Period||0
5025878|NCT02129192|12368971|P1|NOT COMPLETED|Period 3 Including Washout Period||0
5025879|NCT02129192|12368970|P2|COMPLETED|Period 3 Including Washout Period||35
5025880|NCT02129192|12368971|P1|COMPLETED|Period 3 Including Washout Period||36
5025881|NCT02129192|12368970|P2|STARTED|Period 3 Including Washout Period||35
5025882|NCT02129192|12368971|P1|STARTED|Period 3 Including Washout Period||36
5025883|NCT02129192|12368970|P2|NOT COMPLETED|Period 2 Including Washout Period||0
5025884|NCT02129192|12368971|P1|NOT COMPLETED|Period 2 Including Washout Period||0
5025885|NCT02129192|12368970|P2|COMPLETED|Period 2 Including Washout Period||35
5025886|NCT02129192|12368971|P1|COMPLETED|Period 2 Including Washout Period||36
5025887|NCT02129192|12368970|P2|STARTED|Period 2 Including Washout Period||35
5025888|NCT02129192|12368971|P1|STARTED|Period 2 Including Washout Period||36
5025889|NCT02129192|12368970|P2|NOT COMPLETED|Period 1 Including Washout Period||1
5025890|NCT02129192|12368971|P1|NOT COMPLETED|Period 1 Including Washout Period||0
5025891|NCT02129192|12368970|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
5025892|NCT02129192|12368971|P1|COMPLETED|Period 1 Including Washout Period||36
5025893|NCT02129192|12368970|P2|STARTED|Period 1 Including Washout Period||36
5025894|NCT02129192|12368971|P1|STARTED|Period 1 Including Washout Period||36
5025895|NCT02129062|12368988|P1|NOT COMPLETED|Overall Study||3
5025896|NCT02129062|12368988|P1|COMPLETED|Overall Study||0
5025897|NCT02129062|12368988|P1|STARTED|Overall Study||3
5025898|NCT02128997|12368995|P2|NOT COMPLETED|Overall Study||11
5025899|NCT02128997|12368996|P1|NOT COMPLETED|Overall Study||6
5025900|NCT02128997|12368995|P2|COMPLETED|Overall Study||58
5025901|NCT02128997|12368996|P1|COMPLETED|Overall Study||61
5025902|NCT02128997|12368995|P2|STARTED|Overall Study||69
5025903|NCT02128997|12368996|P1|STARTED|Overall Study||67
5025904|NCT02128932|12369011|P3|NOT COMPLETED|Overall Study||18
5025905|NCT02128932|12369012|P2|NOT COMPLETED|Overall Study||19
5025906|NCT02128932|12369013|P1|NOT COMPLETED|Overall Study||27
5025907|NCT02128932|12369011|P3|COMPLETED|Overall Study||342
5025908|NCT02128932|12369012|P2|COMPLETED|Overall Study||341
5025909|NCT02128932|12369013|P1|COMPLETED|Overall Study||335
5025910|NCT02128932|12369011|P3|STARTED|Overall Study||360
5025911|NCT02128932|12369012|P2|STARTED|Overall Study||360
5025912|NCT02128932|12369013|P1|STARTED|Overall Study||362
5025913|NCT02128919|12369044|P2|NOT COMPLETED|Overall Study||1
5025914|NCT02128919|12369045|P1|NOT COMPLETED|Overall Study||3
5025915|NCT02128919|12369044|P2|COMPLETED|Overall Study||15
5025916|NCT02128919|12369045|P1|COMPLETED|Overall Study||14
5025917|NCT02128919|12369044|P2|STARTED|Overall Study||16
5025918|NCT02128919|12369045|P1|STARTED|Overall Study||17
5025919|NCT02128867|12369058|P3|NOT COMPLETED|Overall Study||4
5025920|NCT02128867|12369059|P2|NOT COMPLETED|Overall Study||2
5025921|NCT02128867|12369060|P1|NOT COMPLETED|Overall Study||3
5025922|NCT02128867|12369058|P3|COMPLETED|Overall Study||50
5025923|NCT02128867|12369059|P2|COMPLETED|Overall Study||50
5025924|NCT02128867|12369060|P1|COMPLETED|Overall Study||50
5025925|NCT02128867|12369058|P3|STARTED|Overall Study||54
5025926|NCT02128867|12369059|P2|STARTED|Overall Study||52
5025927|NCT02128867|12369060|P1|STARTED|Overall Study||53
5025928|NCT02128763|12369070|P2|NOT COMPLETED|Overall Study||16
5025929|NCT02128763|12369071|P1|NOT COMPLETED|Overall Study||20
5025930|NCT02128763|12369070|P2|COMPLETED|Overall Study||170
5025931|NCT02128763|12369071|P1|COMPLETED|Overall Study||329
5025932|NCT02128763|12369070|P2|STARTED|Overall Study||186
5025933|NCT02128763|12369071|P1|STARTED|Overall Study||349
5025934|NCT02128724|12369117|P4|NOT COMPLETED|Overall Study||3
5025935|NCT02128724|12369118|P3|NOT COMPLETED|Overall Study||0
5025936|NCT02128724|12369119|P2|NOT COMPLETED|Overall Study||1
5025937|NCT02128724|12369120|P1|NOT COMPLETED|Overall Study||1
5025938|NCT02128724|12369117|P4|COMPLETED|Overall Study||7
5025939|NCT02128724|12369118|P3|COMPLETED|Overall Study||3
5025940|NCT02128724|12369119|P2|COMPLETED|Overall Study||3
5025941|NCT02128724|12369120|P1|COMPLETED|Overall Study||3
5025942|NCT02128724|12369117|P4|STARTED|Overall Study||10
5025943|NCT02128724|12369118|P3|STARTED|Overall Study||3
5025944|NCT02128724|12369119|P2|STARTED|Overall Study||4
5025945|NCT02128724|12369120|P1|STARTED|Overall Study||4
5025946|NCT02128542|12369175|P2|NOT COMPLETED|Overall Study||0
5025947|NCT02128542|12369176|P1|NOT COMPLETED|Overall Study||4
5025948|NCT02128542|12369175|P2|COMPLETED|Overall Study||19
5025949|NCT02128542|12369176|P1|COMPLETED|Overall Study||43
5025950|NCT02128542|12369175|P2|STARTED|Overall Study||19
5025951|NCT02128542|12369176|P1|STARTED|Overall Study||47
5025952|NCT02128490|12369194|P5|NOT COMPLETED|Overall Study||7
5025953|NCT02128490|12369195|P4|NOT COMPLETED|Overall Study||6
5025954|NCT02128490|12369196|P3|NOT COMPLETED|Overall Study||5
5025955|NCT02128490|12369197|P2|NOT COMPLETED|Overall Study||6
5025956|NCT02128490|12369198|P1|NOT COMPLETED|Overall Study||5
5025957|NCT02128490|12369194|P5|COMPLETED|Overall Study||31
5025958|NCT02128490|12369195|P4|COMPLETED|Overall Study||31
5025959|NCT02128490|12369196|P3|COMPLETED|Overall Study||34
5025960|NCT02128490|12369197|P2|COMPLETED|Overall Study||31
5025961|NCT02128490|12369198|P1|COMPLETED|Overall Study||33
5025962|NCT02128490|12369194|P5|STARTED|Overall Study||38
5025963|NCT02128490|12369195|P4|STARTED|Overall Study||37
5025964|NCT02128490|12369196|P3|STARTED|Overall Study||39
5025965|NCT02128490|12369197|P2|STARTED|Overall Study||37
5025966|NCT02128490|12369198|P1|STARTED|Overall Study||38
5025967|NCT02128269|12369220|P1|NOT COMPLETED|Follow-up||0
5025968|NCT02128269|12369220|P1|COMPLETED|Follow-up||9
5025969|NCT02128269|12369220|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
5025970|NCT02128269|12369220|P1|NOT COMPLETED|Treatment Period||2
5025971|NCT02128269|12369220|P1|COMPLETED|Treatment Period||7
5025972|NCT02128269|12369220|P1|STARTED|Treatment Period||9
5025973|NCT02128217|12369226|P2|NOT COMPLETED|Overall Study||1
5025974|NCT02128217|12369227|P1|NOT COMPLETED|Overall Study||0
5025975|NCT02128217|12369226|P2|COMPLETED|Overall Study||26
5025976|NCT02128217|12369227|P1|COMPLETED|Overall Study||17
5025977|NCT02128217|12369226|P2|STARTED|Overall Study||27
5025978|NCT02128217|12369227|P1|STARTED|Overall Study||17
5025979|NCT02128074|12369269|P1|NOT COMPLETED|Overall Study||6
5025980|NCT02128074|12369269|P1|COMPLETED|Overall Study||26
5025981|NCT02128074|12369269|P1|STARTED|Overall Study||32
5025982|NCT02127970|12369275|P2|NOT COMPLETED|Overall Study||27
5025983|NCT02127970|12369276|P1|NOT COMPLETED|Overall Study||26
5025984|NCT02127970|12369275|P2|COMPLETED|Overall Study||322
5025985|NCT02127970|12369276|P1|COMPLETED|Overall Study||323
5025986|NCT02127970|12369275|P2|STARTED|Overall Study||349
5025987|NCT02127970|12369276|P1|STARTED|Overall Study||349
5025988|NCT02127931|12369298|P1|NOT COMPLETED|Overall Study||1
5025989|NCT02127931|12369298|P1|COMPLETED|Overall Study||17
5025990|NCT02127931|12369298|P1|STARTED|Overall Study||18
5025991|NCT02127892|12369308|P4|NOT COMPLETED|Overall Study||0
5025992|NCT02127892|12369309|P3|NOT COMPLETED|Overall Study||0
5025993|NCT02127892|12369310|P2|NOT COMPLETED|Overall Study||1
5025994|NCT02127892|12369311|P1|NOT COMPLETED|Overall Study||1
5025995|NCT02127892|12369308|P4|COMPLETED|Overall Study||0
5025996|NCT02127892|12369309|P3|COMPLETED|Overall Study||0
5025997|NCT02127892|12369310|P2|COMPLETED|Overall Study||1
5025998|NCT02127892|12369311|P1|COMPLETED|Overall Study||6
5025999|NCT02127892|12369308|P4|STARTED|Overall Study||0
5026000|NCT02127892|12369309|P3|STARTED|Overall Study||0
5026001|NCT02127892|12369310|P2|STARTED|Overall Study||2
5026002|NCT02127892|12369311|P1|STARTED|Overall Study||7
5026003|NCT02127710|12369340|P3|NOT COMPLETED|Overall Study||0
5026004|NCT02127710|12369341|P2|NOT COMPLETED|Overall Study||0
5026005|NCT02127710|12369342|P1|NOT COMPLETED|Overall Study||0
5026006|NCT02127710|12369340|P3|COMPLETED|Overall Study||19
5026007|NCT02127710|12369341|P2|COMPLETED|Overall Study||46
5026008|NCT02127710|12369342|P1|COMPLETED|Overall Study||44
5026009|NCT02127710|12369340|P3|STARTED|Overall Study||19
5026010|NCT02127710|12369341|P2|STARTED|Overall Study||46
5026011|NCT02127710|12369342|P1|STARTED|Overall Study||44
5026012|NCT02127632|12369384|P2|NOT COMPLETED|Overall Study||0
5026013|NCT02127632|12369385|P1|NOT COMPLETED|Overall Study||0
5026014|NCT02127632|12369384|P2|COMPLETED|Overall Study||50
5026015|NCT02127632|12369385|P1|COMPLETED|Overall Study||50
5026016|NCT02127632|12369384|P2|STARTED|Overall Study||50
5026017|NCT02127632|12369385|P1|STARTED|Overall Study||50
5026018|NCT02127567|12369395|P1|NOT COMPLETED|Overall Study||0
5026019|NCT02127567|12369395|P1|COMPLETED|Overall Study||41
5026020|NCT02127567|12369395|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
5026021|NCT02127372|12369417|P2|NOT COMPLETED|Overall Study||0
5026022|NCT02127372|12369418|P1|NOT COMPLETED|Overall Study||1
5026023|NCT02127372|12369417|P2|COMPLETED|Overall Study||28
5026024|NCT02127372|12369418|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
5026025|NCT02127372|12369417|P2|Started Study Treatment|Overall Study||28
5026026|NCT02127372|12369418|P1|Started Study Treatment|Overall Study||15
5026027|NCT02127372|12369417|P2|STARTED|Overall Study|Signed Consent|28
5026028|NCT02127372|12369418|P1|STARTED|Overall Study|Signed Consent|15
5026029|NCT02127307|12369428|P1|NOT COMPLETED|Overall Study||308
5026030|NCT02127307|12369428|P1|COMPLETED|Overall Study||656
5026031|NCT02127307|12369428|P1|STARTED|Overall Study||964
5026032|NCT02127281|12369434|P2|NOT COMPLETED|Overall Study||0
5026033|NCT02127281|12369435|P1|NOT COMPLETED|Overall Study||1
5026034|NCT02127281|12369434|P2|COMPLETED|Overall Study||80
5026035|NCT02127281|12369435|P1|COMPLETED|Overall Study||79
5026036|NCT02127281|12369434|P2|STARTED|Overall Study||80
5026037|NCT02127281|12369435|P1|STARTED|Overall Study||80
5026038|NCT02126969|12369463|P2|NOT COMPLETED|Overall Study||2
5026039|NCT02126969|12369464|P1|NOT COMPLETED|Overall Study||1
5026040|NCT02126969|12369463|P2|COMPLETED|Overall Study||20
5026041|NCT02126969|12369464|P1|COMPLETED|Overall Study||22
5026042|NCT02126969|12369463|P2|STARTED|Overall Study||22
5026043|NCT02126969|12369464|P1|STARTED|Overall Study||23
5026044|NCT02126839|12369474|P2|NOT COMPLETED|Overall Study||14
5026045|NCT02126839|12369475|P1|NOT COMPLETED|Overall Study||10
5026046|NCT02126839|12369474|P2|COMPLETED|Overall Study||80
5026047|NCT02126839|12369475|P1|COMPLETED|Overall Study||82
5026048|NCT02126839|12369474|P2|Full Analysis Set|Overall Study||92
5026049|NCT02126839|12369475|P1|Full Analysis Set|Overall Study||92
5026050|NCT02126839|12369474|P2|Safety Population|Overall Study||93
5026051|NCT02126839|12369475|P1|Safety Population|Overall Study||92
5026052|NCT02126839|12369474|P2|STARTED|Overall Study||94
5026053|NCT02126839|12369475|P1|STARTED|Overall Study||92
5026054|NCT02126826|12369492|P7|NOT COMPLETED|Overall Study||0
5026055|NCT02126826|12369493|P6|NOT COMPLETED|Overall Study||0
5026056|NCT02126826|12369494|P5|NOT COMPLETED|Overall Study||0
5026057|NCT02126826|12369495|P4|NOT COMPLETED|Overall Study||1
5026058|NCT02126826|12369496|P3|NOT COMPLETED|Overall Study||0
5026059|NCT02126826|12369497|P2|NOT COMPLETED|Overall Study||0
5026060|NCT02126826|12369498|P1|NOT COMPLETED|Overall Study||0
5026061|NCT02126826|12369492|P7|COMPLETED|Overall Study||8
5026062|NCT02126826|12369493|P6|COMPLETED|Overall Study||9
5026063|NCT02126826|12369494|P5|COMPLETED|Overall Study||5
5026064|NCT02126826|12369495|P4|COMPLETED|Overall Study||8
5026065|NCT02126826|12369496|P3|COMPLETED|Overall Study||9
5026066|NCT02126826|12369497|P2|COMPLETED|Overall Study||9
5026067|NCT02126826|12369498|P1|COMPLETED|Overall Study||9
5026068|NCT02126826|12369492|P7|STARTED|Overall Study||8
5026069|NCT02126826|12369493|P6|STARTED|Overall Study||9
5026070|NCT02126826|12369494|P5|STARTED|Overall Study||5
5026071|NCT02126826|12369495|P4|STARTED|Overall Study||9
5026072|NCT02126826|12369496|P3|STARTED|Overall Study||9
5026073|NCT02126826|12369497|P2|STARTED|Overall Study||9
5026074|NCT02126826|12369498|P1|STARTED|Overall Study||9
5026075|NCT02126748|12369552|P3|NOT COMPLETED|Overall Study||5
5026076|NCT02126748|12369553|P2|NOT COMPLETED|Overall Study||3
5026077|NCT02126748|12369554|P1|NOT COMPLETED|Overall Study||2
5026078|NCT02126748|12369552|P3|COMPLETED|Overall Study||31
5026079|NCT02126748|12369553|P2|COMPLETED|Overall Study||31
5026080|NCT02126748|12369554|P1|COMPLETED|Overall Study||31
5026081|NCT02126748|12369552|P3|STARTED|Overall Study||36
5026082|NCT02126748|12369553|P2|STARTED|Overall Study||34
5026083|NCT02126748|12369554|P1|STARTED|Overall Study||33
5026084|NCT02126670|12369566|P4|NOT COMPLETED|Overall Study||1
5026085|NCT02126670|12369567|P3|NOT COMPLETED|Overall Study||0
5026086|NCT02126670|12369568|P2|NOT COMPLETED|Overall Study||0
5026087|NCT02126670|12369569|P1|NOT COMPLETED|Overall Study||1
5026088|NCT02126670|12369566|P4|COMPLETED|Overall Study||24
5026089|NCT02126670|12369567|P3|COMPLETED|Overall Study||25
5026090|NCT02126670|12369568|P2|COMPLETED|Overall Study||24
5026091|NCT02126670|12369569|P1|COMPLETED|Overall Study||25
5026092|NCT02126670|12369566|P4|STARTED|Overall Study||25
5026093|NCT02126670|12369567|P3|STARTED|Overall Study||25
5026094|NCT02126670|12369568|P2|STARTED|Overall Study||24
5026095|NCT02126670|12369569|P1|STARTED|Overall Study||26
5026096|NCT02126319|12369585|P2|NOT COMPLETED|Overall Study||24
5026097|NCT02126319|12369586|P1|NOT COMPLETED|Overall Study||21
5026098|NCT02126319|12369585|P2|COMPLETED|Overall Study||43
5026099|NCT02126319|12369586|P1|COMPLETED|Overall Study||40
5026100|NCT02126319|12369585|P2|STARTED|Overall Study||67
5026101|NCT02126319|12369586|P1|STARTED|Overall Study||61
5026102|NCT02126306|12369612|P2|NOT COMPLETED|Overall Study||0
5026103|NCT02126306|12369613|P1|NOT COMPLETED|Overall Study||0
5026104|NCT02126306|12369612|P2|COMPLETED|Overall Study||13
5026105|NCT02126306|12369613|P1|COMPLETED|Overall Study||10
5026106|NCT02126306|12369612|P2|STARTED|Overall Study||13
5026107|NCT02126306|12369613|P1|STARTED|Overall Study||10
5026108|NCT02125877|12369621|P2|NOT COMPLETED|Overall Study||10
5026109|NCT02125877|12369622|P1|NOT COMPLETED|Overall Study||13
5026110|NCT02125877|12369621|P2|COMPLETED|Overall Study||77
5026111|NCT02125877|12369622|P1|COMPLETED|Overall Study||73
5026112|NCT02125877|12369621|P2|Safety Set|Overall Study||87
5026113|NCT02125877|12369622|P1|Safety Set|Overall Study||86
5026114|NCT02125877|12369621|P2|Pharmacokinetic Subset A|Overall Study||15
5026115|NCT02125877|12369622|P1|Pharmacokinetic Subset A|Overall Study||16
5026116|NCT02125877|12369621|P2|Pharmacokinetic Analysis Set|Overall Study||83
5026117|NCT02125877|12369622|P1|Pharmacokinetic Analysis Set|Overall Study||83
5026118|NCT02125877|12369621|P2|STARTED|Overall Study||87
5026119|NCT02125877|12369622|P1|STARTED|Overall Study||86
5026120|NCT02125838|12369652|P2|NOT COMPLETED|Overall Study||4
5026121|NCT02125838|12369653|P1|NOT COMPLETED|Overall Study||4
5026122|NCT02125838|12369652|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
5026123|NCT02125838|12369653|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
5026124|NCT02125838|12369652|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
5026125|NCT02125838|12369653|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
5026126|NCT02125734|12369671|P2|NOT COMPLETED|Period 2||1
5026127|NCT02125734|12369672|P1|NOT COMPLETED|Period 2||0
5026128|NCT02125734|12369671|P2|COMPLETED|Period 2||47
5026129|NCT02125734|12369672|P1|COMPLETED|Period 2||40
5026130|NCT02125734|12369671|P2|STARTED|Period 2||48
5026131|NCT02125734|12369672|P1|STARTED|Period 2||40
5026132|NCT02125734|12369671|P2|NOT COMPLETED|Period 1||0
5026133|NCT02125734|12369672|P1|NOT COMPLETED|Period 1||0
5026134|NCT02125734|12369671|P2|COMPLETED|Period 1||48
5026135|NCT02125734|12369672|P1|COMPLETED|Period 1||40
5026136|NCT02125734|12369671|P2|STARTED|Period 1||48
5026137|NCT02125734|12369672|P1|STARTED|Period 1||40
5026138|NCT02125604|12369682|P1|NOT COMPLETED|Overall Study||31
5026139|NCT02125604|12369682|P1|COMPLETED|Overall Study||180
5026140|NCT02125604|12369682|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
5026141|NCT02125461|12369698|P2|NOT COMPLETED|Overall Study||129
5026142|NCT02125461|12369699|P1|NOT COMPLETED|Overall Study||203
5026143|NCT02125461|12369698|P2|COMPLETED|Overall Study||108
5026144|NCT02125461|12369699|P1|COMPLETED|Overall Study||273
5026145|NCT02125461|12369698|P2|Completed 12 Months of Treatment|Overall Study||82
5026146|NCT02125461|12369699|P1|Completed 12 Months of Treatment|Overall Study||232
5026147|NCT02125461|12369698|P2|Safety Analysis Set|Overall Study||234
5026148|NCT02125461|12369699|P1|Safety Analysis Set|Overall Study||475
5026149|NCT02125461|12369698|P2|Receieved Treatment|Overall Study||236
5026150|NCT02125461|12369699|P1|Receieved Treatment|Overall Study||473
5026151|NCT02125461|12369698|P2|Full Analysis Set (FAS)|Overall Study||237
5026152|NCT02125461|12369699|P1|Full Analysis Set (FAS)|Overall Study||476
5026153|NCT02125461|12369698|P2|STARTED|Overall Study||237
5026154|NCT02125461|12369699|P1|STARTED|Overall Study||476
5026155|NCT02125331|12369730|P2|NOT COMPLETED|Overall Study||0
5026156|NCT02125331|12369731|P1|NOT COMPLETED|Overall Study||5
5026157|NCT02125331|12369730|P2|COMPLETED|Overall Study||25
5026158|NCT02125331|12369731|P1|COMPLETED|Overall Study||53
5026159|NCT02125331|12369730|P2|STARTED|Overall Study||25
5026160|NCT02125331|12369731|P1|STARTED|Overall Study||58
5026161|NCT02125292|12369737|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
5026162|NCT02125292|12369738|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
5026163|NCT02125292|12369739|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
5026164|NCT02125292|12369740|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
5026165|NCT02125292|12369741|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
5026166|NCT02125292|12369742|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
5026167|NCT02125292|12369737|P6|COMPLETED|Third Intervention (1 Hour)||3
5026168|NCT02125292|12369738|P5|COMPLETED|Third Intervention (1 Hour)||3
5026169|NCT02125292|12369739|P4|COMPLETED|Third Intervention (1 Hour)||3
5026170|NCT02125292|12369740|P3|COMPLETED|Third Intervention (1 Hour)||3
5026171|NCT02125292|12369741|P2|COMPLETED|Third Intervention (1 Hour)||3
5026172|NCT02125292|12369742|P1|COMPLETED|Third Intervention (1 Hour)||3
5026173|NCT02125292|12369737|P6|STARTED|Third Intervention (1 Hour)||3
5026174|NCT02125292|12369738|P5|STARTED|Third Intervention (1 Hour)||3
5026175|NCT02125292|12369739|P4|STARTED|Third Intervention (1 Hour)||3
5026176|NCT02125292|12369740|P3|STARTED|Third Intervention (1 Hour)||3
5026177|NCT02125292|12369741|P2|STARTED|Third Intervention (1 Hour)||3
5026178|NCT02125292|12369742|P1|STARTED|Third Intervention (1 Hour)||3
5026179|NCT02125292|12369737|P6|NOT COMPLETED|Washout (2 Hours)||0
5026180|NCT02125292|12369738|P5|NOT COMPLETED|Washout (2 Hours)||0
5026181|NCT02125292|12369739|P4|NOT COMPLETED|Washout (2 Hours)||0
5026182|NCT02125292|12369740|P3|NOT COMPLETED|Washout (2 Hours)||0
5026183|NCT02125292|12369741|P2|NOT COMPLETED|Washout (2 Hours)||0
5026184|NCT02125292|12369742|P1|NOT COMPLETED|Washout (2 Hours)||0
5026185|NCT02125292|12369737|P6|COMPLETED|Washout (2 Hours)||3
5026186|NCT02125292|12369738|P5|COMPLETED|Washout (2 Hours)||3
5026187|NCT02125292|12369739|P4|COMPLETED|Washout (2 Hours)||3
5026188|NCT02125292|12369740|P3|COMPLETED|Washout (2 Hours)||3
5026189|NCT02125292|12369741|P2|COMPLETED|Washout (2 Hours)||3
5026190|NCT02125292|12369742|P1|COMPLETED|Washout (2 Hours)||3
5026191|NCT02125292|12369737|P6|STARTED|Washout (2 Hours)||3
5026192|NCT02125292|12369738|P5|STARTED|Washout (2 Hours)||3
5026193|NCT02125292|12369739|P4|STARTED|Washout (2 Hours)||3
5026194|NCT02125292|12369740|P3|STARTED|Washout (2 Hours)||3
5026195|NCT02125292|12369741|P2|STARTED|Washout (2 Hours)||3
5026196|NCT02125292|12369742|P1|STARTED|Washout (2 Hours)||3
5026197|NCT02125292|12369737|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
5026198|NCT02125292|12369738|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
5026199|NCT02125292|12369739|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
5026200|NCT02125292|12369740|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
5026201|NCT02125292|12369741|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
5026202|NCT02125292|12369742|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
5026203|NCT02125292|12369737|P6|COMPLETED|Second Intervention (1 Hour)||3
5026204|NCT02125292|12369738|P5|COMPLETED|Second Intervention (1 Hour)||3
5026205|NCT02125292|12369739|P4|COMPLETED|Second Intervention (1 Hour)||3
5026206|NCT02125292|12369740|P3|COMPLETED|Second Intervention (1 Hour)||3
5026207|NCT02125292|12369741|P2|COMPLETED|Second Intervention (1 Hour)||3
5026208|NCT02125292|12369742|P1|COMPLETED|Second Intervention (1 Hour)||3
5026209|NCT02125292|12369737|P6|STARTED|Second Intervention (1 Hour)||3
5026210|NCT02125292|12369738|P5|STARTED|Second Intervention (1 Hour)||3
5026211|NCT02125292|12369739|P4|STARTED|Second Intervention (1 Hour)||3
5026212|NCT02125292|12369740|P3|STARTED|Second Intervention (1 Hour)||3
5026213|NCT02125292|12369741|P2|STARTED|Second Intervention (1 Hour)||3
5026214|NCT02125292|12369742|P1|STARTED|Second Intervention (1 Hour)||3
5026215|NCT02125292|12369737|P6|NOT COMPLETED|Washout (2 Hours)||0
5026216|NCT02125292|12369738|P5|NOT COMPLETED|Washout (2 Hours)||0
5026217|NCT02125292|12369739|P4|NOT COMPLETED|Washout (2 Hours)||0
5026218|NCT02125292|12369740|P3|NOT COMPLETED|Washout (2 Hours)||0
5026219|NCT02125292|12369741|P2|NOT COMPLETED|Washout (2 Hours)||0
5026220|NCT02125292|12369742|P1|NOT COMPLETED|Washout (2 Hours)||0
5026221|NCT02125292|12369737|P6|COMPLETED|Washout (2 Hours)||3
5026222|NCT02125292|12369738|P5|COMPLETED|Washout (2 Hours)||3
5026223|NCT02125292|12369739|P4|COMPLETED|Washout (2 Hours)||3
5026224|NCT02125292|12369740|P3|COMPLETED|Washout (2 Hours)||3
5026225|NCT02125292|12369741|P2|COMPLETED|Washout (2 Hours)||3
5026226|NCT02125292|12369742|P1|COMPLETED|Washout (2 Hours)||3
5026227|NCT02125292|12369737|P6|STARTED|Washout (2 Hours)||3
5026228|NCT02125292|12369738|P5|STARTED|Washout (2 Hours)||3
5026229|NCT02125292|12369739|P4|STARTED|Washout (2 Hours)||3
5026230|NCT02125292|12369740|P3|STARTED|Washout (2 Hours)||3
5026231|NCT02125292|12369741|P2|STARTED|Washout (2 Hours)||3
5026232|NCT02125292|12369742|P1|STARTED|Washout (2 Hours)||3
5026233|NCT02125292|12369737|P6|NOT COMPLETED|First Intervention (1 Hour)||0
5026234|NCT02125292|12369738|P5|NOT COMPLETED|First Intervention (1 Hour)||0
5026235|NCT02125292|12369739|P4|NOT COMPLETED|First Intervention (1 Hour)||0
5026236|NCT02125292|12369740|P3|NOT COMPLETED|First Intervention (1 Hour)||0
5026237|NCT02125292|12369741|P2|NOT COMPLETED|First Intervention (1 Hour)||0
5026238|NCT02125292|12369742|P1|NOT COMPLETED|First Intervention (1 Hour)||0
5026239|NCT02125292|12369737|P6|COMPLETED|First Intervention (1 Hour)||3
5026240|NCT02125292|12369738|P5|COMPLETED|First Intervention (1 Hour)||3
5026241|NCT02125292|12369739|P4|COMPLETED|First Intervention (1 Hour)||3
5026242|NCT02125292|12369740|P3|COMPLETED|First Intervention (1 Hour)||3
5026243|NCT02125292|12369741|P2|COMPLETED|First Intervention (1 Hour)||3
5026244|NCT02125292|12369742|P1|COMPLETED|First Intervention (1 Hour)||3
5026245|NCT02125292|12369737|P6|STARTED|First Intervention (1 Hour)||3
5026246|NCT02125292|12369738|P5|STARTED|First Intervention (1 Hour)||3
5026247|NCT02125292|12369739|P4|STARTED|First Intervention (1 Hour)||3
5026248|NCT02125292|12369740|P3|STARTED|First Intervention (1 Hour)||3
5026249|NCT02125292|12369741|P2|STARTED|First Intervention (1 Hour)||3
5026250|NCT02125292|12369742|P1|STARTED|First Intervention (1 Hour)||3
5026251|NCT02125279|12369763|P1|NOT COMPLETED|Overall Study||13
5026252|NCT02125279|12369763|P1|COMPLETED|Overall Study||41
5026253|NCT02125279|12369763|P1|STARTED|Overall Study||54
5026254|NCT02124889|12369792|P2|NOT COMPLETED|Overall Study||0
5026255|NCT02124889|12369793|P1|NOT COMPLETED|Overall Study||0
5026256|NCT02124889|12369792|P2|COMPLETED|Overall Study||12
5026257|NCT02124889|12369793|P1|COMPLETED|Overall Study||12
5026258|NCT02124889|12369792|P2|STARTED|Overall Study||12
5026259|NCT02124889|12369793|P1|STARTED|Overall Study||12
5026260|NCT02124863|12369799|P1|NOT COMPLETED|Overall Study||17
5026261|NCT02124863|12369799|P1|COMPLETED|Overall Study||50
5026262|NCT02124863|12369799|P1|STARTED|Overall Study||67
5026263|NCT02124811|12369807|P2|NOT COMPLETED|Overall Study||2
5026264|NCT02124811|12369808|P1|NOT COMPLETED|Overall Study||3
5026265|NCT02124811|12369807|P2|COMPLETED|Overall Study||3
5026266|NCT02124811|12369808|P1|COMPLETED|Overall Study||2
5026267|NCT02124811|12369807|P2|STARTED|Overall Study||5
5026268|NCT02124811|12369808|P1|STARTED|Overall Study||5
5026269|NCT02124798|12369824|P1|NOT COMPLETED|Overall Study||4
5026270|NCT02124798|12369824|P1|COMPLETED|Overall Study||91
5026271|NCT02124798|12369824|P1|STARTED|Overall Study||95
5026272|NCT02124603|12369830|P1|NOT COMPLETED|Overall Study||0
5026273|NCT02124603|12369830|P1|COMPLETED|Overall Study||120
5026274|NCT02124603|12369830|P1|STARTED|Overall Study||120
5026275|NCT02124564|12369836|P1|NOT COMPLETED|Taper Period||0
5026276|NCT02124564|12369836|P1|COMPLETED|Taper Period||2
5026277|NCT02124564|12369836|P1|STARTED|Taper Period||2
5026278|NCT02124564|12369836|P1|NOT COMPLETED|Treatment Period||7
5026279|NCT02124564|12369836|P1|COMPLETED|Treatment Period||12
5026280|NCT02124564|12369836|P1|Started Follow-Up Period|Treatment Period||13
5026281|NCT02124564|12369836|P1|Started Evaluation Period|Treatment Period||17
5026282|NCT02124564|12369836|P1|Started Monotherapy Period|Treatment Period||17
5026283|NCT02124564|12369836|P1|Started AED Withdrawal Period|Treatment Period||19
5026284|NCT02124564|12369836|P1|Started Titration Period|Treatment Period||19
5026285|NCT02124564|12369836|P1|Started Treatment Period|Treatment Period||19
5026286|NCT02124564|12369836|P1|STARTED|Treatment Period||19
5026287|NCT02124512|12369848|P2|NOT COMPLETED|Overall Study||0
5026288|NCT02124512|12369849|P1|NOT COMPLETED|Overall Study||0
5026289|NCT02124512|12369848|P2|COMPLETED|Overall Study||6
5026290|NCT02124512|12369849|P1|COMPLETED|Overall Study||6
5026291|NCT02124512|12369848|P2|STARTED|Overall Study||6
5026292|NCT02124512|12369849|P1|STARTED|Overall Study||6
5026293|NCT02124460|12369859|P2|NOT COMPLETED|Overall Study||24
5026294|NCT02124460|12369860|P1|NOT COMPLETED|Overall Study||33
5026295|NCT02124460|12369859|P2|COMPLETED|Overall Study||336
5026296|NCT02124460|12369860|P1|COMPLETED|Overall Study||328
5026297|NCT02124460|12369859|P2|STARTED|Overall Study||360
5026298|NCT02124460|12369860|P1|STARTED|Overall Study||361
5026299|NCT02124304|12369892|P2|NOT COMPLETED|Overall Study||0
5026300|NCT02124304|12369893|P1|NOT COMPLETED|Overall Study||0
5026301|NCT02124304|12369892|P2|COMPLETED|Overall Study||15
5026302|NCT02124304|12369893|P1|COMPLETED|Overall Study||15
5026303|NCT02124304|12369892|P2|STARTED|Overall Study||15
5026304|NCT02124304|12369893|P1|STARTED|Overall Study||15
5026305|NCT02124265|12369901|P1|NOT COMPLETED|Overall Study||1
5026306|NCT02124265|12369901|P1|COMPLETED|Overall Study||2
5026307|NCT02124265|12369901|P1|STARTED|Overall Study||3
5026308|NCT02124161|12369907|P2|NOT COMPLETED|Overall Study||15
5026309|NCT02124161|12369908|P1|NOT COMPLETED|Overall Study||16
5026310|NCT02124161|12369907|P2|COMPLETED|Overall Study||426
5026311|NCT02124161|12369908|P1|COMPLETED|Overall Study||425
5026312|NCT02124161|12369907|P2|Vaccination 2|Overall Study||432
5026313|NCT02124161|12369908|P1|Vaccination 2|Overall Study||431
5026314|NCT02124161|12369907|P2|Vaccination 1|Overall Study||437
5026315|NCT02124161|12369908|P1|Vaccination 1|Overall Study||439
5026316|NCT02124161|12369907|P2|STARTED|Overall Study||441
5026317|NCT02124161|12369908|P1|STARTED|Overall Study||441
5026318|NCT02124122|12369940|P2|NOT COMPLETED|Overall Study||0
5026319|NCT02124122|12369941|P1|NOT COMPLETED|Overall Study||0
5026320|NCT02124122|12369940|P2|COMPLETED|Overall Study||19
5026321|NCT02124122|12369941|P1|COMPLETED|Overall Study||41
5026322|NCT02124122|12369940|P2|STARTED|Overall Study||19
5026323|NCT02124122|12369941|P1|STARTED|Overall Study||41
5026324|NCT02124083|12369949|P1|NOT COMPLETED|Overall Study||1
5026325|NCT02124083|12369949|P1|COMPLETED|Overall Study||11
5026326|NCT02124083|12369949|P1|STARTED|Overall Study||12
5026327|NCT02124044|12369960|P2|NOT COMPLETED|Overall Study||1
5026328|NCT02124044|12369961|P1|NOT COMPLETED|Overall Study||0
5026329|NCT02124044|12369960|P2|COMPLETED|Overall Study||9
5026330|NCT02124044|12369961|P1|COMPLETED|Overall Study||20
5026331|NCT02124044|12369960|P2|STARTED|Overall Study||10
5026332|NCT02124044|12369961|P1|STARTED|Overall Study||20
5026333|NCT02124018|12369970|P3|NOT COMPLETED|Overall Study||0
5026334|NCT02124018|12369971|P2|NOT COMPLETED|Overall Study||0
5026335|NCT02124018|12369972|P1|NOT COMPLETED|Overall Study||0
5026336|NCT02124018|12369970|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
5026337|NCT02124018|12369971|P2|COMPLETED|Overall Study||111
5026338|NCT02124018|12369972|P1|COMPLETED|Overall Study||371
5026339|NCT02124018|12369970|P3|STARTED|Overall Study||41
5026340|NCT02124018|12369971|P2|STARTED|Overall Study||111
5026341|NCT02124018|12369972|P1|STARTED|Overall Study||371
5026342|NCT02123966|12369983|P1|NOT COMPLETED|Overall Study||1
5026343|NCT02123966|12369983|P1|COMPLETED|Overall Study||9
5026344|NCT02123966|12369983|P1|STARTED|Overall Study||10
5026345|NCT02123849|12369990|P2|NOT COMPLETED|Overall Study||9
5026346|NCT02123849|12369991|P1|NOT COMPLETED|Overall Study||4
5026347|NCT02123849|12369990|P2|COMPLETED|Overall Study||18
5026348|NCT02123849|12369991|P1|COMPLETED|Overall Study||23
5026349|NCT02123849|12369990|P2|STARTED|Overall Study||27
5026350|NCT02123849|12369991|P1|STARTED|Overall Study||27
5026351|NCT02123797|12370017|P5|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
5026352|NCT02123797|12370018|P4|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
5026353|NCT02123797|12370019|P3|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
5026354|NCT02123797|12370020|P2|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
5026355|NCT02123797|12370021|P1|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
5026356|NCT02123797|12370017|P5|COMPLETED|6-month Follow up (Cumulative Counts)||5
5026357|NCT02123797|12370018|P4|COMPLETED|6-month Follow up (Cumulative Counts)||31
5026358|NCT02123797|12370019|P3|COMPLETED|6-month Follow up (Cumulative Counts)||34
5026359|NCT02123797|12370020|P2|COMPLETED|6-month Follow up (Cumulative Counts)||178
5026360|NCT02123797|12370021|P1|COMPLETED|6-month Follow up (Cumulative Counts)||101
5026361|NCT02123797|12370017|P5|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
5026362|NCT02123797|12370018|P4|STARTED|6-month Follow up (Cumulative Counts)||144
5026363|NCT02123797|12370019|P3|STARTED|6-month Follow up (Cumulative Counts)||100
5026364|NCT02123797|12370020|P2|STARTED|6-month Follow up (Cumulative Counts)||306
5026365|NCT02123797|12370021|P1|STARTED|6-month Follow up (Cumulative Counts)||156
5026366|NCT02123797|12370017|P5|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
5026367|NCT02123797|12370018|P4|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
5026368|NCT02123797|12370019|P3|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
5026369|NCT02123797|12370020|P2|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
5026370|NCT02123797|12370021|P1|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
5026371|NCT02123797|12370017|P5|COMPLETED|3-month Follow up (Cumulative Counts)||8
5026372|NCT02123797|12370018|P4|COMPLETED|3-month Follow up (Cumulative Counts)||62
5026373|NCT02123797|12370019|P3|COMPLETED|3-month Follow up (Cumulative Counts)||50
5026374|NCT02123797|12370020|P2|COMPLETED|3-month Follow up (Cumulative Counts)||189
5026375|NCT02123797|12370021|P1|COMPLETED|3-month Follow up (Cumulative Counts)||99
5026376|NCT02123797|12370017|P5|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
5026377|NCT02123797|12370018|P4|STARTED|3-month Follow up (Cumulative Counts)||144
5026378|NCT02123797|12370019|P3|STARTED|3-month Follow up (Cumulative Counts)||100
5026379|NCT02123797|12370020|P2|STARTED|3-month Follow up (Cumulative Counts)||306
5026380|NCT02123797|12370021|P1|STARTED|3-month Follow up (Cumulative Counts)||156
5026381|NCT02123797|12370017|P5|NOT COMPLETED|Baseline Intervention||0
5026382|NCT02123797|12370018|P4|NOT COMPLETED|Baseline Intervention||0
5026383|NCT02123797|12370019|P3|NOT COMPLETED|Baseline Intervention||0
5026384|NCT02123797|12370020|P2|NOT COMPLETED|Baseline Intervention||42
5026385|NCT02123797|12370021|P1|NOT COMPLETED|Baseline Intervention||22
5026386|NCT02123797|12370017|P5|COMPLETED|Baseline Intervention||11
5026387|NCT02123797|12370018|P4|COMPLETED|Baseline Intervention||144
5026388|NCT02123797|12370019|P3|COMPLETED|Baseline Intervention||100
5026389|NCT02123797|12370020|P2|COMPLETED|Baseline Intervention||306
5026390|NCT02123797|12370021|P1|COMPLETED|Baseline Intervention||156
5026391|NCT02123797|12370017|P5|STARTED|Baseline Intervention||11
5026392|NCT02123797|12370018|P4|STARTED|Baseline Intervention||144
5026393|NCT02123797|12370019|P3|STARTED|Baseline Intervention||100
5026394|NCT02123797|12370020|P2|STARTED|Baseline Intervention||348
5026395|NCT02123797|12370021|P1|STARTED|Baseline Intervention||178
5026396|NCT02123745|12370120|P1|NOT COMPLETED|Overall Study||0
5026397|NCT02123745|12370120|P1|COMPLETED|Overall Study||71
5026398|NCT02123745|12370120|P1|STARTED|Overall Study||71
5026399|NCT02123576|12370130|P2|NOT COMPLETED|Overall Study||0
5026400|NCT02123576|12370131|P1|NOT COMPLETED|Overall Study||1
5026401|NCT02123576|12370130|P2|COMPLETED|Overall Study||6
5026402|NCT02123576|12370131|P1|COMPLETED|Overall Study||5
5026403|NCT02123576|12370130|P2|STARTED|Overall Study||6
5026404|NCT02123576|12370131|P1|STARTED|Overall Study||6
5026405|NCT02123511|12370149|P2|NOT COMPLETED|Overall Study||4
5026406|NCT02123511|12370150|P1|NOT COMPLETED|Overall Study||2
5026407|NCT02123511|12370149|P2|COMPLETED|Overall Study||12
5026408|NCT02123511|12370150|P1|COMPLETED|Overall Study||16
5026409|NCT02123511|12370149|P2|Eligible Patients|Overall Study||15
5026410|NCT02123511|12370150|P1|Eligible Patients|Overall Study||17
5026411|NCT02123511|12370149|P2|STARTED|Overall Study||16
5026412|NCT02123511|12370150|P1|STARTED|Overall Study||18
5026413|NCT02123472|12370174|P2|NOT COMPLETED|Period 2 (7 Days)||1
5026414|NCT02123472|12370175|P1|NOT COMPLETED|Period 2 (7 Days)||0
5026415|NCT02123472|12370174|P2|COMPLETED|Period 2 (7 Days)||13
5026416|NCT02123472|12370175|P1|COMPLETED|Period 2 (7 Days)||14
5026417|NCT02123472|12370174|P2|STARTED|Period 2 (7 Days)||14
5026418|NCT02123472|12370175|P1|STARTED|Period 2 (7 Days)||14
5026419|NCT02123472|12370174|P2|NOT COMPLETED|Washout Period (1 Day)||0
5026420|NCT02123472|12370175|P1|NOT COMPLETED|Washout Period (1 Day)||0
5026421|NCT02123472|12370174|P2|COMPLETED|Washout Period (1 Day)||14
5026422|NCT02123472|12370175|P1|COMPLETED|Washout Period (1 Day)||14
5026423|NCT02123472|12370174|P2|STARTED|Washout Period (1 Day)||14
5026424|NCT02123472|12370175|P1|STARTED|Washout Period (1 Day)||14
5026425|NCT02123472|12370174|P2|NOT COMPLETED|Period 1 (7 Days)||0
5026426|NCT02123472|12370175|P1|NOT COMPLETED|Period 1 (7 Days)||0
5026427|NCT02123472|12370174|P2|COMPLETED|Period 1 (7 Days)||14
5026428|NCT02123472|12370175|P1|COMPLETED|Period 1 (7 Days)||14
5026429|NCT02123472|12370174|P2|STARTED|Period 1 (7 Days)||14
5026430|NCT02123472|12370175|P1|STARTED|Period 1 (7 Days)||14
5026431|NCT02123459|12370185|P2|NOT COMPLETED|Period 2 (7 Days)||0
5026432|NCT02123459|12370186|P1|NOT COMPLETED|Period 2 (7 Days)||0
5026433|NCT02123459|12370185|P2|COMPLETED|Period 2 (7 Days)||14
5026434|NCT02123459|12370186|P1|COMPLETED|Period 2 (7 Days)||13
5026435|NCT02123459|12370185|P2|STARTED|Period 2 (7 Days)||14
5026436|NCT02123459|12370186|P1|STARTED|Period 2 (7 Days)||13
5026437|NCT02123459|12370185|P2|NOT COMPLETED|Washout Period (1 Day)||0
5026438|NCT02123459|12370186|P1|NOT COMPLETED|Washout Period (1 Day)||1
5026439|NCT02123459|12370185|P2|COMPLETED|Washout Period (1 Day)||14
5026440|NCT02123459|12370186|P1|COMPLETED|Washout Period (1 Day)||13
5026441|NCT02123459|12370185|P2|STARTED|Washout Period (1 Day)||14
5026442|NCT02123459|12370186|P1|STARTED|Washout Period (1 Day)||14
5026443|NCT02123459|12370185|P2|NOT COMPLETED|Period 1 (7 Days)||0
5026444|NCT02123459|12370186|P1|NOT COMPLETED|Period 1 (7 Days)||0
5026445|NCT02123459|12370185|P2|COMPLETED|Period 1 (7 Days)||14
5026446|NCT02123459|12370186|P1|COMPLETED|Period 1 (7 Days)||14
5026447|NCT02123459|12370185|P2|STARTED|Period 1 (7 Days)||14
5026448|NCT02123459|12370186|P1|STARTED|Period 1 (7 Days)||14
5026449|NCT02123446|12370196|P2|NOT COMPLETED|Period 2 (7 Days)||0
5026450|NCT02123446|12370197|P1|NOT COMPLETED|Period 2 (7 Days)||0
5026451|NCT02123446|12370196|P2|COMPLETED|Period 2 (7 Days)||14
5026452|NCT02123446|12370197|P1|COMPLETED|Period 2 (7 Days)||13
5026453|NCT02123446|12370196|P2|STARTED|Period 2 (7 Days)||14
5026454|NCT02123446|12370197|P1|STARTED|Period 2 (7 Days)||13
5026455|NCT02123446|12370196|P2|NOT COMPLETED|Washout Period (1 Day)||0
5026456|NCT02123446|12370197|P1|NOT COMPLETED|Washout Period (1 Day)||1
5026457|NCT02123446|12370196|P2|COMPLETED|Washout Period (1 Day)||14
5026458|NCT02123446|12370197|P1|COMPLETED|Washout Period (1 Day)||13
5026459|NCT02123446|12370196|P2|STARTED|Washout Period (1 Day)||14
5026460|NCT02123446|12370197|P1|STARTED|Washout Period (1 Day)||14
5026461|NCT02123446|12370196|P2|NOT COMPLETED|Period 1 (7 Days)||0
5026462|NCT02123446|12370197|P1|NOT COMPLETED|Period 1 (7 Days)||0
5026463|NCT02123446|12370196|P2|COMPLETED|Period 1 (7 Days)||14
5026464|NCT02123446|12370197|P1|COMPLETED|Period 1 (7 Days)||14
5026465|NCT02123446|12370196|P2|STARTED|Period 1 (7 Days)||14
5026466|NCT02123446|12370197|P1|STARTED|Period 1 (7 Days)||14
5026467|NCT02123329|12370209|P2|NOT COMPLETED|12 Month Outcome Measure||79
5026468|NCT02123329|12370210|P1|NOT COMPLETED|12 Month Outcome Measure||64
5026469|NCT02123329|12370209|P2|COMPLETED|12 Month Outcome Measure||88
5026470|NCT02123329|12370210|P1|COMPLETED|12 Month Outcome Measure||83
5026471|NCT02123329|12370209|P2|STARTED|12 Month Outcome Measure||167
5026472|NCT02123329|12370210|P1|STARTED|12 Month Outcome Measure||147
5026473|NCT02123329|12370209|P2|NOT COMPLETED|6 Month Outcome Measure||67
5026474|NCT02123329|12370210|P1|NOT COMPLETED|6 Month Outcome Measure||48
5026475|NCT02123329|12370209|P2|COMPLETED|6 Month Outcome Measure||100
5026476|NCT02123329|12370210|P1|COMPLETED|6 Month Outcome Measure||99
5026477|NCT02123329|12370209|P2|STARTED|6 Month Outcome Measure||167
5026478|NCT02123329|12370210|P1|STARTED|6 Month Outcome Measure||147
5026479|NCT02123329|12370209|P2|NOT COMPLETED|3 Month Outcome Measure||66
5026480|NCT02123329|12370210|P1|NOT COMPLETED|3 Month Outcome Measure||49
5026481|NCT02123329|12370209|P2|COMPLETED|3 Month Outcome Measure||101
5026482|NCT02123329|12370210|P1|COMPLETED|3 Month Outcome Measure||98
5026483|NCT02123329|12370209|P2|STARTED|3 Month Outcome Measure||167
5026484|NCT02123329|12370210|P1|STARTED|3 Month Outcome Measure||147
5026485|NCT02123251|12370238|P2|NOT COMPLETED|Overall Study||30
5026486|NCT02123251|12370239|P1|NOT COMPLETED|Overall Study||34
5026487|NCT02123251|12370238|P2|COMPLETED|Overall Study||131
5026488|NCT02123251|12370239|P1|COMPLETED|Overall Study||125
5026489|NCT02123251|12370238|P2|STARTED|Overall Study||161
5026490|NCT02123251|12370239|P1|STARTED|Overall Study||159
5026491|NCT02123134|12370265|P2|NOT COMPLETED|Overall Study||3
5026492|NCT02123134|12370266|P1|NOT COMPLETED|Overall Study||3
5026493|NCT02123134|12370265|P2|COMPLETED|Overall Study||24
5026494|NCT02123134|12370266|P1|COMPLETED|Overall Study||25
5026495|NCT02123134|12370265|P2|STARTED|Overall Study||27
5026496|NCT02123134|12370266|P1|STARTED|Overall Study||28
5026497|NCT02123017|12370287|P3|NOT COMPLETED|Overall Study||0
5026498|NCT02123017|12370288|P2|NOT COMPLETED|Overall Study||0
5026499|NCT02123017|12370289|P1|NOT COMPLETED|Overall Study||0
5026500|NCT02123017|12370287|P3|COMPLETED|Overall Study||12
5026501|NCT02123017|12370288|P2|COMPLETED|Overall Study||12
5026502|NCT02123017|12370289|P1|COMPLETED|Overall Study||8
5026503|NCT02123017|12370287|P3|STARTED|Overall Study||12
5026504|NCT02123017|12370288|P2|STARTED|Overall Study||12
5026505|NCT02123017|12370289|P1|STARTED|Overall Study||8
5026506|NCT02122952|12370308|P2|NOT COMPLETED|Overall Study||0
5026507|NCT02122952|12370309|P1|NOT COMPLETED|Overall Study||0
5026508|NCT02122952|12370308|P2|COMPLETED|Overall Study||12
5026509|NCT02122952|12370309|P1|COMPLETED|Overall Study||3
5026510|NCT02122952|12370308|P2|STARTED|Overall Study||12
5026511|NCT02122952|12370309|P1|STARTED|Overall Study||3
5026512|NCT02122887|12370323|P2|NOT COMPLETED|Overall Study||2
5026513|NCT02122887|12370324|P1|NOT COMPLETED|Overall Study||20
5026514|NCT02122887|12370323|P2|COMPLETED|Overall Study||39
5026515|NCT02122887|12370324|P1|COMPLETED|Overall Study||40
5026516|NCT02122887|12370323|P2|STARTED|Overall Study||41
5026517|NCT02122887|12370324|P1|STARTED|Overall Study||60
5026518|NCT02122796|12370346|P2|NOT COMPLETED|Visit 2||1
5026519|NCT02122796|12370347|P1|NOT COMPLETED|Visit 2||3
5026520|NCT02122796|12370346|P2|COMPLETED|Visit 2||14
5026521|NCT02122796|12370347|P1|COMPLETED|Visit 2||12
5026522|NCT02122796|12370346|P2|STARTED|Visit 2||15
5026523|NCT02122796|12370347|P1|STARTED|Visit 2||15
5026524|NCT02122796|12370346|P2|NOT COMPLETED|Visit 1||0
5026525|NCT02122796|12370347|P1|NOT COMPLETED|Visit 1||0
5026526|NCT02122796|12370346|P2|COMPLETED|Visit 1||15
5026527|NCT02122796|12370347|P1|COMPLETED|Visit 1||15
5026528|NCT02122796|12370346|P2|STARTED|Visit 1||15
5026529|NCT02122796|12370347|P1|STARTED|Visit 1||15
5026530|NCT02122783|12370362|P2|NOT COMPLETED|Overall Study||1
5026531|NCT02122783|12370363|P1|NOT COMPLETED|Overall Study||0
5026532|NCT02122783|12370362|P2|COMPLETED|Overall Study||2
5026533|NCT02122783|12370363|P1|COMPLETED|Overall Study||2
5026534|NCT02122783|12370362|P2|STARTED|Overall Study||3
5026535|NCT02122783|12370363|P1|STARTED|Overall Study||2
5026536|NCT02122770|12370377|P6|NOT COMPLETED|Part B: Standard of Care||13
5026537|NCT02122770|12370378|P5|NOT COMPLETED|Part B: Standard of Care||23
5026538|NCT02122770|12370379|P4|NOT COMPLETED|Part B: Standard of Care||0
5026539|NCT02122770|12370380|P3|NOT COMPLETED|Part B: Standard of Care||0
5026540|NCT02122770|12370381|P2|NOT COMPLETED|Part B: Standard of Care||0
5026541|NCT02122770|12370382|P1|NOT COMPLETED|Part B: Standard of Care||0
5026542|NCT02122770|12370377|P6|COMPLETED|Part B: Standard of Care||0
5026543|NCT02122770|12370378|P5|COMPLETED|Part B: Standard of Care||0
5026544|NCT02122770|12370379|P4|COMPLETED|Part B: Standard of Care||0
5026545|NCT02122770|12370380|P3|COMPLETED|Part B: Standard of Care||0
5026546|NCT02122770|12370381|P2|COMPLETED|Part B: Standard of Care||0
5026547|NCT02122770|12370382|P1|COMPLETED|Part B: Standard of Care||0
5026548|NCT02122770|12370377|P6|STARTED|Part B: Standard of Care||13
5026549|NCT02122770|12370378|P5|STARTED|Part B: Standard of Care||23
5026550|NCT02122770|12370379|P4|STARTED|Part B: Standard of Care||0
5026551|NCT02122770|12370380|P3|STARTED|Part B: Standard of Care||0
5026552|NCT02122770|12370381|P2|STARTED|Part B: Standard of Care||0
5026553|NCT02122770|12370382|P1|STARTED|Part B: Standard of Care||0
5026554|NCT02122770|12370377|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
5026555|NCT02122770|12370378|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
5026556|NCT02122770|12370379|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
5026557|NCT02122770|12370380|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
5026558|NCT02122770|12370381|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
5026559|NCT02122770|12370382|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
5026560|NCT02122770|12370377|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
5026561|NCT02122770|12370378|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
5026562|NCT02122770|12370379|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
5026563|NCT02122770|12370380|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
5026564|NCT02122770|12370381|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
5026565|NCT02122770|12370382|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
5026566|NCT02122770|12370377|P6|STARTED|Part A: Drug-drug Interaction 2||0
5026567|NCT02122770|12370378|P5|STARTED|Part A: Drug-drug Interaction 2||0
5026568|NCT02122770|12370379|P4|STARTED|Part A: Drug-drug Interaction 2||19
5026569|NCT02122770|12370380|P3|STARTED|Part A: Drug-drug Interaction 2||6
5026570|NCT02122770|12370381|P2|STARTED|Part A: Drug-drug Interaction 2||13
5026571|NCT02122770|12370382|P1|STARTED|Part A: Drug-drug Interaction 2||13
5026572|NCT02122549|12370462|P1|NOT COMPLETED|Overall Study||0
5026573|NCT02122549|12370462|P1|COMPLETED|Overall Study||59
5026574|NCT02122549|12370462|P1|STARTED|Overall Study||59
5026575|NCT02122471|12370469|P3|NOT COMPLETED|Overall Study||44
5026576|NCT02122471|12370470|P2|NOT COMPLETED|Overall Study||51
5026577|NCT02122471|12370471|P1|NOT COMPLETED|Overall Study||39
5026578|NCT02122471|12370469|P3|COMPLETED|Overall Study||405
5026579|NCT02122471|12370470|P2|COMPLETED|Overall Study||392
5026580|NCT02122471|12370471|P1|COMPLETED|Overall Study||406
5026581|NCT02122471|12370469|P3|STARTED|Overall Study||449
5026582|NCT02122471|12370470|P2|STARTED|Overall Study||443
5026583|NCT02122471|12370471|P1|STARTED|Overall Study||445
5026584|NCT02122445|12370491|P1|NOT COMPLETED|Overall Study||0
5026585|NCT02122445|12370491|P1|COMPLETED|Overall Study||20
5026586|NCT02122445|12370491|P1|STARTED|Overall Study||20
5026587|NCT02122406|12370496|P1|NOT COMPLETED|Overall Study||0
5026588|NCT02122406|12370496|P1|COMPLETED|Overall Study||200
5026589|NCT02122406|12370496|P1|STARTED|Overall Study||200
5026590|NCT02122380|12370502|P2|NOT COMPLETED|Second Intervention (30 Days)||2
5026591|NCT02122380|12370503|P1|NOT COMPLETED|Second Intervention (30 Days)||0
5026592|NCT02122380|12370502|P2|COMPLETED|Second Intervention (30 Days)||7
5026593|NCT02122380|12370503|P1|COMPLETED|Second Intervention (30 Days)||9
5026594|NCT02122380|12370502|P2|STARTED|Second Intervention (30 Days)||9
5026595|NCT02122380|12370503|P1|STARTED|Second Intervention (30 Days)||9
5026596|NCT02122380|12370502|P2|NOT COMPLETED|Washout (8 Weeks)||2
5026597|NCT02122380|12370503|P1|NOT COMPLETED|Washout (8 Weeks)||1
5026598|NCT02122380|12370502|P2|COMPLETED|Washout (8 Weeks)||9
5026599|NCT02122380|12370503|P1|COMPLETED|Washout (8 Weeks)||9
5026600|NCT02122380|12370502|P2|STARTED|Washout (8 Weeks)||11
5026601|NCT02122380|12370503|P1|STARTED|Washout (8 Weeks)||10
5026602|NCT02122380|12370502|P2|NOT COMPLETED|First Intervention (30 Days)||1
5026603|NCT02122380|12370503|P1|NOT COMPLETED|First Intervention (30 Days)||1
5026604|NCT02122380|12370502|P2|COMPLETED|First Intervention (30 Days)||11
5026605|NCT02122380|12370503|P1|COMPLETED|First Intervention (30 Days)||10
5026606|NCT02122380|12370502|P2|STARTED|First Intervention (30 Days)||12
5026607|NCT02122380|12370503|P1|STARTED|First Intervention (30 Days)||11
5026608|NCT02122341|12370519|P2|NOT COMPLETED|Overall Study||0
5026609|NCT02122341|12370520|P1|NOT COMPLETED|Overall Study||0
5026610|NCT02122341|12370519|P2|COMPLETED|Overall Study||18
5026611|NCT02122341|12370520|P1|COMPLETED|Overall Study||17
5026612|NCT02122341|12370519|P2|STARTED|Overall Study||18
5026613|NCT02122341|12370520|P1|STARTED|Overall Study||17
5026614|NCT02122146|12370542|P8|NOT COMPLETED|Part 3: Expansion||0
5026615|NCT02122146|12370543|P7|NOT COMPLETED|Part 3: Expansion||0
5026616|NCT02122146|12370544|P6|NOT COMPLETED|Part 3: Expansion||0
5026617|NCT02122146|12370545|P5|NOT COMPLETED|Part 3: Expansion||0
5026618|NCT02122146|12370546|P4|NOT COMPLETED|Part 3: Expansion||0
5026619|NCT02122146|12370547|P3|NOT COMPLETED|Part 3: Expansion||0
5026620|NCT02122146|12370548|P2|NOT COMPLETED|Part 3: Expansion||0
5026621|NCT02122146|12370549|P1|NOT COMPLETED|Part 3: Expansion||0
5026622|NCT02122146|12370542|P8|COMPLETED|Part 3: Expansion||0
5026623|NCT02122146|12370543|P7|COMPLETED|Part 3: Expansion||0
5026624|NCT02122146|12370544|P6|COMPLETED|Part 3: Expansion||0
5026625|NCT02122146|12370545|P5|COMPLETED|Part 3: Expansion||0
5026626|NCT02122146|12370546|P4|COMPLETED|Part 3: Expansion||0
5026627|NCT02122146|12370547|P3|COMPLETED|Part 3: Expansion||0
5026628|NCT02122146|12370548|P2|COMPLETED|Part 3: Expansion||0
5026629|NCT02122146|12370549|P1|COMPLETED|Part 3: Expansion||0
5026630|NCT02122146|12370542|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026631|NCT02122146|12370543|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026632|NCT02122146|12370544|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026633|NCT02122146|12370545|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026634|NCT02122146|12370546|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026635|NCT02122146|12370547|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026636|NCT02122146|12370548|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026637|NCT02122146|12370549|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
5026638|NCT02122146|12370542|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026639|NCT02122146|12370543|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026640|NCT02122146|12370544|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026641|NCT02122146|12370545|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026642|NCT02122146|12370546|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026643|NCT02122146|12370547|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026644|NCT02122146|12370548|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026645|NCT02122146|12370549|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
5026646|NCT02122146|12370542|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026647|NCT02122146|12370543|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026648|NCT02122146|12370544|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026649|NCT02122146|12370545|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026650|NCT02122146|12370546|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026651|NCT02122146|12370547|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026652|NCT02122146|12370548|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026653|NCT02122146|12370549|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
5026654|NCT02122146|12370542|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026655|NCT02122146|12370543|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026656|NCT02122146|12370544|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026657|NCT02122146|12370545|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026658|NCT02122146|12370546|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026659|NCT02122146|12370547|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026660|NCT02122146|12370548|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026661|NCT02122146|12370549|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
5026662|NCT02122146|12370542|P8|NOT COMPLETED|Part 1: Dose Escalation||2
5026663|NCT02122146|12370543|P7|NOT COMPLETED|Part 1: Dose Escalation||1
5026664|NCT02122146|12370544|P6|NOT COMPLETED|Part 1: Dose Escalation||1
5026665|NCT02122146|12370545|P5|NOT COMPLETED|Part 1: Dose Escalation||1
5026666|NCT02122146|12370546|P4|NOT COMPLETED|Part 1: Dose Escalation||1
5026667|NCT02122146|12370547|P3|NOT COMPLETED|Part 1: Dose Escalation||2
5026668|NCT02122146|12370548|P2|NOT COMPLETED|Part 1: Dose Escalation||1
5026669|NCT02122146|12370549|P1|NOT COMPLETED|Part 1: Dose Escalation||1
5026670|NCT02122146|12370542|P8|COMPLETED|Part 1: Dose Escalation||6
5026671|NCT02122146|12370543|P7|COMPLETED|Part 1: Dose Escalation||0
5026672|NCT02122146|12370544|P6|COMPLETED|Part 1: Dose Escalation||5
5026673|NCT02122146|12370545|P5|COMPLETED|Part 1: Dose Escalation||3
5026674|NCT02122146|12370546|P4|COMPLETED|Part 1: Dose Escalation||3
5026675|NCT02122146|12370547|P3|COMPLETED|Part 1: Dose Escalation||2
5026676|NCT02122146|12370548|P2|COMPLETED|Part 1: Dose Escalation||1
5026677|NCT02122146|12370549|P1|COMPLETED|Part 1: Dose Escalation||1
5026678|NCT02122146|12370542|P8|STARTED|Part 1: Dose Escalation||8
5026679|NCT02122146|12370543|P7|STARTED|Part 1: Dose Escalation||1
5026680|NCT02122146|12370544|P6|STARTED|Part 1: Dose Escalation||6
5026681|NCT02122146|12370545|P5|STARTED|Part 1: Dose Escalation||4
5026682|NCT02122146|12370546|P4|STARTED|Part 1: Dose Escalation||4
5026683|NCT02122146|12370547|P3|STARTED|Part 1: Dose Escalation||4
5026684|NCT02122146|12370548|P2|STARTED|Part 1: Dose Escalation||2
5026685|NCT02122146|12370549|P1|STARTED|Part 1: Dose Escalation||2
5026686|NCT02121912|12370786|P2|NOT COMPLETED|Overall Study||0
5026687|NCT02121912|12370787|P1|NOT COMPLETED|Overall Study||4
5026688|NCT02121912|12370786|P2|COMPLETED|Overall Study||25
5026689|NCT02121912|12370787|P1|COMPLETED|Overall Study||21
5026690|NCT02121912|12370786|P2|STARTED|Overall Study||25
5026691|NCT02121912|12370787|P1|STARTED|Overall Study||25
5026692|NCT02121860|12370801|P4|NOT COMPLETED|Overall Study||0
5026693|NCT02121860|12370802|P3|NOT COMPLETED|Overall Study||0
5026694|NCT02121860|12370803|P2|NOT COMPLETED|Overall Study||0
5026695|NCT02121860|12370804|P1|NOT COMPLETED|Overall Study||0
5026696|NCT02121860|12370801|P4|COMPLETED|Overall Study||8
5026697|NCT02121860|12370802|P3|COMPLETED|Overall Study||8
5026698|NCT02121860|12370803|P2|COMPLETED|Overall Study||12
5026699|NCT02121860|12370804|P1|COMPLETED|Overall Study||8
5026700|NCT02121860|12370801|P4|STARTED|Overall Study||8
5026701|NCT02121860|12370802|P3|STARTED|Overall Study||8
5026702|NCT02121860|12370803|P2|STARTED|Overall Study||12
5026703|NCT02121860|12370804|P1|STARTED|Overall Study||8
5026704|NCT02121847|12370823|P1|NOT COMPLETED|Overall Study||3
5026705|NCT02121847|12370823|P1|COMPLETED|Overall Study||37
5026706|NCT02121847|12370823|P1|STARTED|Overall Study||40
5026707|NCT02121834|12370849|P7|NOT COMPLETED|Overall Study||0
5026708|NCT02121834|12370850|P6|NOT COMPLETED|Overall Study||0
5026709|NCT02121834|12370851|P5|NOT COMPLETED|Overall Study||0
5026710|NCT02121834|12370852|P4|NOT COMPLETED|Overall Study||0
5026711|NCT02121834|12370853|P3|NOT COMPLETED|Overall Study||2
5026712|NCT02121834|12370854|P2|NOT COMPLETED|Overall Study||2
5026713|NCT02121834|12370855|P1|NOT COMPLETED|Overall Study||0
5026714|NCT02121834|12370849|P7|COMPLETED|Overall Study||3
5026715|NCT02121834|12370850|P6|COMPLETED|Overall Study||9
5026716|NCT02121834|12370851|P5|COMPLETED|Overall Study||9
5026717|NCT02121834|12370852|P4|COMPLETED|Overall Study||10
5026718|NCT02121834|12370853|P3|COMPLETED|Overall Study||7
5026719|NCT02121834|12370854|P2|COMPLETED|Overall Study||9
5026720|NCT02121834|12370855|P1|COMPLETED|Overall Study||12
5026721|NCT02121834|12370849|P7|Received at Least One Dose of Study Drug|Overall Study||3
5026722|NCT02121834|12370850|P6|Received at Least One Dose of Study Drug|Overall Study||9
5026723|NCT02121834|12370851|P5|Received at Least One Dose of Study Drug|Overall Study||9
5026724|NCT02121834|12370852|P4|Received at Least One Dose of Study Drug|Overall Study||10
5026725|NCT02121834|12370853|P3|Received at Least One Dose of Study Drug|Overall Study||9
5026726|NCT02121834|12370854|P2|Received at Least One Dose of Study Drug|Overall Study||11
5026727|NCT02121834|12370855|P1|Received at Least One Dose of Study Drug|Overall Study||12
5026728|NCT02121834|12370849|P7|STARTED|Overall Study||3
5026729|NCT02121834|12370850|P6|STARTED|Overall Study||9
5026730|NCT02121834|12370851|P5|STARTED|Overall Study||9
5026731|NCT02121834|12370852|P4|STARTED|Overall Study||10
5026732|NCT02121834|12370853|P3|STARTED|Overall Study||9
5026733|NCT02121834|12370854|P2|STARTED|Overall Study||11
5026734|NCT02121834|12370855|P1|STARTED|Overall Study||12
5026735|NCT02121808|12370881|P1|NOT COMPLETED|Overall Study||3
5026736|NCT02121808|12370881|P1|COMPLETED|Overall Study||17
5026737|NCT02121808|12370881|P1|STARTED|Overall Study||20
5026738|NCT02121795|12370892|P2|NOT COMPLETED|Open-Label Phase||10
5026739|NCT02121795|12370893|P1|NOT COMPLETED|Open-Label Phase||12
5026740|NCT02121795|12370892|P2|COMPLETED|Open-Label Phase||21
5026741|NCT02121795|12370893|P1|COMPLETED|Open-Label Phase||21
5026742|NCT02121795|12370892|P2|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
5026743|NCT02121795|12370893|P1|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
5026744|NCT02121795|12370892|P2|NOT COMPLETED|Double-Blind Phase||34
5026745|NCT02121795|12370893|P1|NOT COMPLETED|Double-Blind Phase||38
5026746|NCT02121795|12370892|P2|COMPLETED|Double-Blind Phase||300
5026747|NCT02121795|12370893|P1|COMPLETED|Double-Blind Phase||296
5026748|NCT02121795|12370892|P2|Safety Analysis Set|Double-Blind Phase||330
5026749|NCT02121795|12370893|P1|Safety Analysis Set|Double-Blind Phase||333
5026750|NCT02121795|12370892|P2|STARTED|Double-Blind Phase||334
5026751|NCT02121795|12370893|P1|STARTED|Double-Blind Phase||334
5026752|NCT02121756|12370921|P2|NOT COMPLETED|Overall Study||2
5026753|NCT02121756|12370922|P1|NOT COMPLETED|Overall Study||6
5026754|NCT02121756|12370921|P2|COMPLETED|Overall Study||17
5026755|NCT02121756|12370922|P1|COMPLETED|Overall Study||15
5026756|NCT02121756|12370921|P2|STARTED|Overall Study||19
5026757|NCT02121756|12370922|P1|STARTED|Overall Study||21
5026758|NCT02121535|12370959|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
5026759|NCT02121535|12370960|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
5026760|NCT02121535|12370959|P2|COMPLETED|Period 4 (8 Trial Days)||35
5026761|NCT02121535|12370960|P1|COMPLETED|Period 4 (8 Trial Days)||35
5026762|NCT02121535|12370959|P2|STARTED|Period 4 (8 Trial Days)||35
5026763|NCT02121535|12370960|P1|STARTED|Period 4 (8 Trial Days)||35
5026764|NCT02121535|12370959|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
5026765|NCT02121535|12370960|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
5026766|NCT02121535|12370959|P2|COMPLETED|Period 3 (8 Trial Days)||35
5026767|NCT02121535|12370960|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
5026768|NCT02121535|12370959|P2|STARTED|Period 3 (8 Trial Days)||35
5026769|NCT02121535|12370960|P1|STARTED|Period 3 (8 Trial Days)||36
5026770|NCT02121535|12370959|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
5026771|NCT02121535|12370960|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
5026772|NCT02121535|12370959|P2|COMPLETED|Period 2 (8 Trial Days)||35
5026773|NCT02121535|12370960|P1|COMPLETED|Period 2 (8 Trial Days)||36
5026774|NCT02121535|12370959|P2|STARTED|Period 2 (8 Trial Days)||35
5026775|NCT02121535|12370960|P1|STARTED|Period 2 (8 Trial Days)||36
5026776|NCT02121535|12370959|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
5026777|NCT02121535|12370960|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
5026778|NCT02121535|12370959|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
5026779|NCT02121535|12370960|P1|COMPLETED|Period 1 (8 Trial Days)||36
5026780|NCT02121535|12370959|P2|STARTED|Period 1 (8 Trial Days)||36
5026781|NCT02121535|12370960|P1|STARTED|Period 1 (8 Trial Days)||36
5026782|NCT02121522|12370983|P1|NOT COMPLETED|Overall Study||1
5026783|NCT02121522|12370983|P1|COMPLETED|Overall Study||13
5026784|NCT02121522|12370983|P1|STARTED|Overall Study||14
5026785|NCT02121509|12370990|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
5026786|NCT02121509|12370991|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
5026787|NCT02121509|12370992|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
5026788|NCT02121509|12370993|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
5026789|NCT02121509|12370990|P4|COMPLETED|Treatment Period-2 (4 Days)||8
5026790|NCT02121509|12370991|P3|COMPLETED|Treatment Period-2 (4 Days)||8
5026791|NCT02121509|12370992|P2|COMPLETED|Treatment Period-2 (4 Days)||24
5026792|NCT02121509|12370993|P1|COMPLETED|Treatment Period-2 (4 Days)||28
5026793|NCT02121509|12370990|P4|STARTED|Treatment Period-2 (4 Days)||8
5026794|NCT02121509|12370991|P3|STARTED|Treatment Period-2 (4 Days)||8
5026795|NCT02121509|12370992|P2|STARTED|Treatment Period-2 (4 Days)||24
5026796|NCT02121509|12370993|P1|STARTED|Treatment Period-2 (4 Days)||28
5026797|NCT02121509|12370990|P4|NOT COMPLETED|Washout Period (35 Days)||0
5026798|NCT02121509|12370991|P3|NOT COMPLETED|Washout Period (35 Days)||0
5026799|NCT02121509|12370992|P2|NOT COMPLETED|Washout Period (35 Days)||4
5026800|NCT02121509|12370993|P1|NOT COMPLETED|Washout Period (35 Days)||2
5026801|NCT02121509|12370990|P4|COMPLETED|Washout Period (35 Days)||8
5026802|NCT02121509|12370991|P3|COMPLETED|Washout Period (35 Days)||8
5026803|NCT02121509|12370992|P2|COMPLETED|Washout Period (35 Days)||24
5026804|NCT02121509|12370993|P1|COMPLETED|Washout Period (35 Days)||28
5026805|NCT02121509|12370990|P4|STARTED|Washout Period (35 Days)||8
5026806|NCT02121509|12370991|P3|STARTED|Washout Period (35 Days)||8
5026807|NCT02121509|12370992|P2|STARTED|Washout Period (35 Days)||28
5026808|NCT02121509|12370993|P1|STARTED|Washout Period (35 Days)||30
5026809|NCT02121509|12370990|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
5026810|NCT02121509|12370991|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
5026811|NCT02121509|12370992|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
5026812|NCT02121509|12370993|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
5026813|NCT02121509|12370990|P4|COMPLETED|Treatment Period-1 (4 Days)||8
5026814|NCT02121509|12370991|P3|COMPLETED|Treatment Period-1 (4 Days)||8
5026815|NCT02121509|12370992|P2|COMPLETED|Treatment Period-1 (4 Days)||28
5026816|NCT02121509|12370993|P1|COMPLETED|Treatment Period-1 (4 Days)||30
5026817|NCT02121509|12370990|P4|STARTED|Treatment Period-1 (4 Days)||8
5026818|NCT02121509|12370991|P3|STARTED|Treatment Period-1 (4 Days)||8
5026819|NCT02121509|12370992|P2|STARTED|Treatment Period-1 (4 Days)||28
5026820|NCT02121509|12370993|P1|STARTED|Treatment Period-1 (4 Days)||30
5026821|NCT02121483|12371026|P3|NOT COMPLETED|Overall Study||0
5026822|NCT02121483|12371027|P2|NOT COMPLETED|Overall Study||0
5026823|NCT02121483|12371028|P1|NOT COMPLETED|Overall Study||0
5026824|NCT02121483|12371026|P3|COMPLETED|Overall Study||10
5026825|NCT02121483|12371027|P2|COMPLETED|Overall Study||8
5026826|NCT02121483|12371028|P1|COMPLETED|Overall Study||9
5026827|NCT02121483|12371026|P3|STARTED|Overall Study||10
5026828|NCT02121483|12371027|P2|STARTED|Overall Study||8
5026829|NCT02121483|12371028|P1|STARTED|Overall Study||9
5026830|NCT02121418|12371057|P1|NOT COMPLETED|Overall Study||0
5026831|NCT02121418|12371057|P1|COMPLETED|Overall Study||12
5026832|NCT02121418|12371057|P1|STARTED|Overall Study||12
5026833|NCT02121210|12371064|P2|NOT COMPLETED|Overall Study||9
5026834|NCT02121210|12371065|P1|NOT COMPLETED|Overall Study||7
5026835|NCT02121210|12371064|P2|COMPLETED|Overall Study||58
5026836|NCT02121210|12371065|P1|COMPLETED|Overall Study||58
5026837|NCT02121210|12371064|P2|STARTED|Overall Study||67
5026838|NCT02121210|12371065|P1|STARTED|Overall Study||65
5026839|NCT02121067|12371073|P1|NOT COMPLETED|Overall Study||0
5026840|NCT02121067|12371073|P1|COMPLETED|Overall Study||50
5026841|NCT02121067|12371073|P1|STARTED|Overall Study||50
5026842|NCT02121041|12371081|P2|NOT COMPLETED|Overall Study||6
5026843|NCT02121041|12371082|P1|NOT COMPLETED|Overall Study||1
5026844|NCT02121041|12371081|P2|COMPLETED|Overall Study||8
5026845|NCT02121041|12371082|P1|COMPLETED|Overall Study||13
5026846|NCT02121041|12371081|P2|STARTED|Overall Study||14
5026847|NCT02121041|12371082|P1|STARTED|Overall Study||14
5026848|NCT02120950|12371090|P3|NOT COMPLETED|Overall Study||15
5026849|NCT02120950|12371091|P2|NOT COMPLETED|Overall Study||14
5026850|NCT02120950|12371092|P1|NOT COMPLETED|Overall Study||20
5026851|NCT02120950|12371090|P3|COMPLETED|Overall Study||0
5026852|NCT02120950|12371091|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
5026853|NCT02120950|12371092|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
5026854|NCT02120950|12371090|P3|STARTED|Overall Study||15
5026855|NCT02120950|12371091|P2|STARTED|Overall Study||161
5026856|NCT02120950|12371092|P1|STARTED|Overall Study||157
5026857|NCT02120924|12371128|P3|NOT COMPLETED|Overall Study||29
5026858|NCT02120924|12371129|P2|NOT COMPLETED|Overall Study||46
5026859|NCT02120924|12371130|P1|NOT COMPLETED|Overall Study||42
5026860|NCT02120924|12371128|P3|COMPLETED|Overall Study||173
5026861|NCT02120924|12371129|P2|COMPLETED|Overall Study||357
5026862|NCT02120924|12371130|P1|COMPLETED|Overall Study||362
5026863|NCT02120924|12371128|P3|STARTED|Overall Study||202
5026864|NCT02120924|12371129|P2|STARTED|Overall Study||403
5026865|NCT02120924|12371130|P1|STARTED|Overall Study||404
5026866|NCT02120898|12371144|P3|NOT COMPLETED|Overall Study||4
5026867|NCT02120898|12371145|P2|NOT COMPLETED|Overall Study||6
5026868|NCT02120898|12371146|P1|NOT COMPLETED|Overall Study||9
5026869|NCT02120898|12371144|P3|COMPLETED|Overall Study||89
5026870|NCT02120898|12371145|P2|COMPLETED|Overall Study||181
5026871|NCT02120898|12371146|P1|COMPLETED|Overall Study||178
5026872|NCT02120898|12371144|P3|Intent-to-Treat (ITT) Population|Overall Study||93
5026873|NCT02120898|12371145|P2|Intent-to-Treat (ITT) Population|Overall Study||185
5026874|NCT02120898|12371146|P1|Intent-to-Treat (ITT) Population|Overall Study||183
5026875|NCT02120898|12371144|P3|Safety Population|Overall Study||93
5026876|NCT02120898|12371145|P2|Safety Population|Overall Study||187
5026877|NCT02120898|12371146|P1|Safety Population|Overall Study||187
5026878|NCT02120898|12371144|P3|STARTED|Overall Study||93
5026879|NCT02120898|12371145|P2|STARTED|Overall Study||187
5026880|NCT02120898|12371146|P1|STARTED|Overall Study||187
5026881|NCT02120833|12371168|P2|NOT COMPLETED|Overall Study||1
5026882|NCT02120833|12371169|P1|NOT COMPLETED|Overall Study||4
5026883|NCT02120833|12371168|P2|COMPLETED|Overall Study||11
5026884|NCT02120833|12371169|P1|COMPLETED|Overall Study||35
5026885|NCT02120833|12371168|P2|STARTED|Overall Study||12
5026886|NCT02120833|12371169|P1|STARTED|Overall Study||39
5026887|NCT02120794|12371323|P1|NOT COMPLETED|Overall Study||58
5026888|NCT02120794|12371323|P1|COMPLETED|Overall Study||136
5026889|NCT02120794|12371323|P1|STARTED|Overall Study||194
5026890|NCT02120716|12371332|P2|NOT COMPLETED|Overall Study||0
5026891|NCT02120716|12371333|P1|NOT COMPLETED|Overall Study||1
5026892|NCT02120716|12371332|P2|COMPLETED|Overall Study||19
5026893|NCT02120716|12371333|P1|COMPLETED|Overall Study||30
5026894|NCT02120716|12371332|P2|STARTED|Overall Study||19
5026895|NCT02120716|12371333|P1|STARTED|Overall Study||31
5026896|NCT02120664|12371347|P5|NOT COMPLETED|Overall Study||0
5026897|NCT02120664|12371348|P4|NOT COMPLETED|Overall Study||1
5026898|NCT02120664|12371349|P3|NOT COMPLETED|Overall Study||0
5026899|NCT02120664|12371350|P2|NOT COMPLETED|Overall Study||0
5026900|NCT02120664|12371351|P1|NOT COMPLETED|Overall Study||0
5026901|NCT02120664|12371347|P5|COMPLETED|Overall Study||10
5026902|NCT02120664|12371348|P4|COMPLETED|Overall Study||3
5026903|NCT02120664|12371349|P3|COMPLETED|Overall Study||7
5026904|NCT02120664|12371350|P2|COMPLETED|Overall Study||4
5026905|NCT02120664|12371351|P1|COMPLETED|Overall Study||10
5026906|NCT02120664|12371347|P5|STARTED|Overall Study||10
5026907|NCT02120664|12371348|P4|STARTED|Overall Study||4
5026908|NCT02120664|12371349|P3|STARTED|Overall Study||7
5026909|NCT02120664|12371350|P2|STARTED|Overall Study||4
5026910|NCT02120664|12371351|P1|STARTED|Overall Study||10
5026911|NCT02120625|12371369|P1|NOT COMPLETED|Overall Study||2
5026912|NCT02120625|12371369|P1|COMPLETED|Overall Study||6
5026913|NCT02120625|12371369|P1|STARTED|Overall Study||8
5026914|NCT02120456|12371385|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
5026915|NCT02120456|12371386|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
5026916|NCT02120456|12371387|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
5026917|NCT02120456|12371388|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
5026918|NCT02120456|12371389|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
5026919|NCT02120456|12371390|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
5026920|NCT02120456|12371391|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
5026921|NCT02120456|12371392|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
5026922|NCT02120456|12371393|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
5026923|NCT02120456|12371385|P9|COMPLETED|Part 2 Double-blind Phase||62
5026924|NCT02120456|12371386|P8|COMPLETED|Part 2 Double-blind Phase||60
5026925|NCT02120456|12371387|P7|COMPLETED|Part 2 Double-blind Phase||30
5026926|NCT02120456|12371388|P6|COMPLETED|Part 2 Double-blind Phase||0
5026927|NCT02120456|12371389|P5|COMPLETED|Part 2 Double-blind Phase||0
5026928|NCT02120456|12371390|P4|COMPLETED|Part 2 Double-blind Phase||0
5026929|NCT02120456|12371391|P3|COMPLETED|Part 2 Double-blind Phase||0
5026930|NCT02120456|12371392|P2|COMPLETED|Part 2 Double-blind Phase||0
5026931|NCT02120456|12371393|P1|COMPLETED|Part 2 Double-blind Phase||0
5026932|NCT02120456|12371385|P9|STARTED|Part 2 Double-blind Phase||63
5026933|NCT02120456|12371386|P8|STARTED|Part 2 Double-blind Phase||60
5026934|NCT02120456|12371387|P7|STARTED|Part 2 Double-blind Phase||32
5026935|NCT02120456|12371388|P6|STARTED|Part 2 Double-blind Phase||0
5026936|NCT02120456|12371389|P5|STARTED|Part 2 Double-blind Phase||0
5026937|NCT02120456|12371390|P4|STARTED|Part 2 Double-blind Phase||0
5026938|NCT02120456|12371391|P3|STARTED|Part 2 Double-blind Phase||0
5026939|NCT02120456|12371392|P2|STARTED|Part 2 Double-blind Phase||0
5026940|NCT02120456|12371393|P1|STARTED|Part 2 Double-blind Phase||0
5026941|NCT02120456|12371385|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026942|NCT02120456|12371386|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026943|NCT02120456|12371387|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026944|NCT02120456|12371388|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026945|NCT02120456|12371389|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026946|NCT02120456|12371390|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026947|NCT02120456|12371391|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026948|NCT02120456|12371392|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026949|NCT02120456|12371393|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026950|NCT02120456|12371385|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026951|NCT02120456|12371386|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026952|NCT02120456|12371387|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5026953|NCT02120456|12371388|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
5026954|NCT02120456|12371389|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5026955|NCT02120456|12371390|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5026956|NCT02120456|12371391|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5026957|NCT02120456|12371392|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5026958|NCT02120456|12371393|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5026959|NCT02120456|12371385|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5026960|NCT02120456|12371386|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5026961|NCT02120456|12371387|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5026962|NCT02120456|12371388|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
5026963|NCT02120456|12371389|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5026964|NCT02120456|12371390|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5026965|NCT02120456|12371391|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5026966|NCT02120456|12371392|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5026967|NCT02120456|12371393|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5026968|NCT02120443|12371419|P1|NOT COMPLETED|Overall Study||0
5026969|NCT02120443|12371419|P1|COMPLETED|Overall Study||43
5026970|NCT02120443|12371419|P1|STARTED|Overall Study||43
5026971|NCT02120417|12371427|P2|NOT COMPLETED|Overall Study||68
5026972|NCT02120417|12371428|P1|NOT COMPLETED|Overall Study||60
5026973|NCT02120417|12371427|P2|COMPLETED|Overall Study||5
5026974|NCT02120417|12371428|P1|COMPLETED|Overall Study||16
5026975|NCT02120417|12371427|P2|STARTED|Overall Study||73
5026976|NCT02120417|12371428|P1|STARTED|Overall Study||76
5026977|NCT02120300|12371450|P4|NOT COMPLETED|Overall Study||1
5026978|NCT02120300|12371451|P3|NOT COMPLETED|Overall Study||0
5026979|NCT02120300|12371452|P2|NOT COMPLETED|Overall Study||0
5026980|NCT02120300|12371453|P1|NOT COMPLETED|Overall Study||3
5026981|NCT02120300|12371450|P4|COMPLETED|Overall Study||5
5026982|NCT02120300|12371451|P3|COMPLETED|Overall Study||10
5026983|NCT02120300|12371452|P2|COMPLETED|Overall Study||5
5026984|NCT02120300|12371453|P1|COMPLETED|Overall Study||98
5026985|NCT02120300|12371450|P4|STARTED|Overall Study||6
5026986|NCT02120300|12371451|P3|STARTED|Overall Study||10
5026987|NCT02120300|12371452|P2|STARTED|Overall Study||5
5026988|NCT02120300|12371453|P1|STARTED|Overall Study||101
5026989|NCT02120287|12371489|P1|NOT COMPLETED|Overall Study||0
5026990|NCT02120287|12371489|P1|COMPLETED|Overall Study||16
5026991|NCT02120287|12371489|P1|STARTED|Overall Study||16
5026992|NCT02120261|12371509|P2|NOT COMPLETED|Overall Study||0
5026993|NCT02120261|12371510|P1|NOT COMPLETED|Overall Study||0
5026994|NCT02120261|12371509|P2|COMPLETED|Overall Study||25
5026995|NCT02120261|12371510|P1|COMPLETED|Overall Study||23
5026996|NCT02120261|12371509|P2|STARTED|Overall Study||25
5026997|NCT02120261|12371510|P1|STARTED|Overall Study||23
5026998|NCT02120157|12371524|P2|NOT COMPLETED|Overall Study||2
5026999|NCT02120157|12371525|P1|NOT COMPLETED|Overall Study||6
5027000|NCT02120157|12371524|P2|COMPLETED|Overall Study||11
5027001|NCT02120157|12371525|P1|COMPLETED|Overall Study||13
5027002|NCT02120157|12371524|P2|Undergoing Follow-up|Overall Study||8
5027003|NCT02120157|12371525|P1|Undergoing Follow-up|Overall Study||7
5027004|NCT02120157|12371524|P2|Completed 180 Days|Overall Study||3
5027005|NCT02120157|12371525|P1|Completed 180 Days|Overall Study||5
5027006|NCT02120157|12371524|P2|STARTED|Overall Study||13
5027007|NCT02120157|12371525|P1|STARTED|Overall Study||19
5027008|NCT02120027|12371535|P2|NOT COMPLETED|Overall Study||119
5027009|NCT02120027|12371536|P1|NOT COMPLETED|Overall Study||116
5027010|NCT02120027|12371535|P2|COMPLETED|Overall Study||160
5027011|NCT02120027|12371536|P1|COMPLETED|Overall Study||161
5027012|NCT02120027|12371535|P2|STARTED|Overall Study||279
5027013|NCT02120027|12371536|P1|STARTED|Overall Study||277
5027014|NCT02120001|12371552|P2|NOT COMPLETED|Overall Study||0
5027015|NCT02120001|12371553|P1|NOT COMPLETED|Overall Study||0
5027016|NCT02120001|12371552|P2|COMPLETED|Overall Study||19
5027017|NCT02120001|12371553|P1|COMPLETED|Overall Study||17
5027018|NCT02120001|12371552|P2|STARTED|Overall Study||19
5027019|NCT02120001|12371553|P1|STARTED|Overall Study||17
5027020|NCT02119936|12371561|P1|NOT COMPLETED|Overall Study||10
5027021|NCT02119936|12371561|P1|COMPLETED|Overall Study||0
5027022|NCT02119936|12371561|P1|STARTED|Overall Study||10
5027023|NCT02119871|12371572|P2|NOT COMPLETED|Overall Study||0
5027024|NCT02119871|12371573|P1|NOT COMPLETED|Overall Study||0
5027025|NCT02119871|12371572|P2|COMPLETED|Overall Study||10
5027026|NCT02119871|12371573|P1|COMPLETED|Overall Study||10
5027027|NCT02119871|12371572|P2|STARTED|Overall Study||10
5027028|NCT02119871|12371573|P1|STARTED|Overall Study||10
5027029|NCT02119676|12371595|P4|NOT COMPLETED|Overall Study||101
5027030|NCT02119676|12371596|P3|NOT COMPLETED|Overall Study||97
5027031|NCT02119676|12371597|P2|NOT COMPLETED|Overall Study||86
5027032|NCT02119676|12371598|P1|NOT COMPLETED|Overall Study||83
5027033|NCT02119676|12371595|P4|COMPLETED|Overall Study||10
5027034|NCT02119676|12371596|P3|COMPLETED|Overall Study||13
5027035|NCT02119676|12371597|P2|COMPLETED|Overall Study||2
5027036|NCT02119676|12371598|P1|COMPLETED|Overall Study||4
5027037|NCT02119676|12371595|P4|Treated Patients|Overall Study||106
5027038|NCT02119676|12371596|P3|Treated Patients|Overall Study||106
5027039|NCT02119676|12371597|P2|Treated Patients|Overall Study||86
5027040|NCT02119676|12371598|P1|Treated Patients|Overall Study||85
5027041|NCT02119676|12371595|P4|STARTED|Overall Study||111
5027042|NCT02119676|12371596|P3|STARTED|Overall Study||110
5027043|NCT02119676|12371597|P2|STARTED|Overall Study||88
5027044|NCT02119676|12371598|P1|STARTED|Overall Study||87
5027045|NCT02119663|12371630|P2|NOT COMPLETED|Overall Study||41
5027046|NCT02119663|12371631|P1|NOT COMPLETED|Overall Study||40
5027047|NCT02119663|12371630|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
5027048|NCT02119663|12371631|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
5027049|NCT02119663|12371630|P2|STARTED|Overall Study||43
5027050|NCT02119663|12371631|P1|STARTED|Overall Study||43
5027051|NCT02119650|12371649|P2|NOT COMPLETED|Overall Study||26
5027052|NCT02119650|12371650|P1|NOT COMPLETED|Overall Study||25
5027053|NCT02119650|12371649|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
5027054|NCT02119650|12371650|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
5027055|NCT02119650|12371649|P2|STARTED|Overall Study||37
5027056|NCT02119650|12371650|P1|STARTED|Overall Study||39
5027057|NCT02119455|12371666|P2|NOT COMPLETED|Overall Study||3
5027058|NCT02119455|12371667|P1|NOT COMPLETED|Overall Study||0
5027059|NCT02119455|12371666|P2|COMPLETED|Overall Study||17
5027060|NCT02119455|12371667|P1|COMPLETED|Overall Study||20
5027061|NCT02119455|12371666|P2|STARTED|Overall Study||20
5027062|NCT02119455|12371667|P1|STARTED|Overall Study||20
5027063|NCT02119442|12371681|P1|NOT COMPLETED|Overall Study||0
5027064|NCT02119442|12371681|P1|COMPLETED|Overall Study||90
5027065|NCT02119442|12371681|P1|STARTED|Overall Study||90
5027066|NCT02119325|12371685|P2|NOT COMPLETED|Period 2||0
5027067|NCT02119325|12371686|P1|NOT COMPLETED|Period 2||0
5027068|NCT02119325|12371685|P2|COMPLETED|Period 2||47
5027069|NCT02119325|12371686|P1|COMPLETED|Period 2||48
5027070|NCT02119325|12371685|P2|STARTED|Period 2||47
5027071|NCT02119325|12371686|P1|STARTED|Period 2||48
5027072|NCT02119325|12371685|P2|NOT COMPLETED|Washout Period 1||1
5027073|NCT02119325|12371686|P1|NOT COMPLETED|Washout Period 1||0
5027074|NCT02119325|12371685|P2|COMPLETED|Washout Period 1||47
5027075|NCT02119325|12371686|P1|COMPLETED|Washout Period 1||48
5027076|NCT02119325|12371685|P2|STARTED|Washout Period 1||48
5027077|NCT02119325|12371686|P1|STARTED|Washout Period 1||48
5027078|NCT02119325|12371685|P2|NOT COMPLETED|Period 1||0
5027079|NCT02119325|12371686|P1|NOT COMPLETED|Period 1||0
5027080|NCT02119325|12371685|P2|COMPLETED|Period 1||48
5027081|NCT02119325|12371686|P1|COMPLETED|Period 1||48
5027082|NCT02119325|12371685|P2|STARTED|Period 1||48
5027083|NCT02119325|12371686|P1|STARTED|Period 1||48
5027084|NCT02119299|12371730|P1|NOT COMPLETED|Overall Study||9
5027085|NCT02119299|12371730|P1|COMPLETED|Overall Study||67
5027086|NCT02119299|12371730|P1|STARTED|Overall Study||76
5027087|NCT02119286|12371744|P3|NOT COMPLETED|Overall Study||7
5027088|NCT02119286|12371745|P2|NOT COMPLETED|Overall Study||11
5027089|NCT02119286|12371746|P1|NOT COMPLETED|Overall Study||26
5027090|NCT02119286|12371744|P3|COMPLETED|Overall Study||200
5027091|NCT02119286|12371745|P2|COMPLETED|Overall Study||195
5027092|NCT02119286|12371746|P1|COMPLETED|Overall Study||180
5027093|NCT02119286|12371744|P3|STARTED|Overall Study||207
5027094|NCT02119286|12371745|P2|STARTED|Overall Study||206
5027095|NCT02119286|12371746|P1|STARTED|Overall Study||206
5027096|NCT02119260|12371764|P7|NOT COMPLETED|Overall Study||0
5027097|NCT02119260|12371765|P6|NOT COMPLETED|Overall Study||0
5027098|NCT02119260|12371766|P5|NOT COMPLETED|Overall Study||0
5027099|NCT02119260|12371767|P4|NOT COMPLETED|Overall Study||0
5027100|NCT02119260|12371768|P3|NOT COMPLETED|Overall Study||1
5027101|NCT02119260|12371769|P2|NOT COMPLETED|Overall Study||1
5027102|NCT02119260|12371770|P1|NOT COMPLETED|Overall Study||1
5027103|NCT02119260|12371764|P7|COMPLETED|Overall Study||2
5027104|NCT02119260|12371765|P6|COMPLETED|Overall Study||6
5027105|NCT02119260|12371766|P5|COMPLETED|Overall Study||13
5027106|NCT02119260|12371767|P4|COMPLETED|Overall Study||10
5027107|NCT02119260|12371768|P3|COMPLETED|Overall Study||7
5027108|NCT02119260|12371769|P2|COMPLETED|Overall Study||11
5027109|NCT02119260|12371770|P1|COMPLETED|Overall Study||8
5027110|NCT02119260|12371764|P7|STARTED|Overall Study||2
5027111|NCT02119260|12371765|P6|STARTED|Overall Study||6
5027112|NCT02119260|12371766|P5|STARTED|Overall Study||13
5027113|NCT02119260|12371767|P4|STARTED|Overall Study||10
5027114|NCT02119260|12371768|P3|STARTED|Overall Study||8
5027115|NCT02119260|12371769|P2|STARTED|Overall Study||12
5027116|NCT02119260|12371770|P1|STARTED|Overall Study||9
5027117|NCT02119156|12371843|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
5027118|NCT02119156|12371844|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
5027119|NCT02119156|12371845|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
5027120|NCT02119156|12371843|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
5027121|NCT02119156|12371844|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
5027122|NCT02119156|12371845|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
5027123|NCT02119156|12371843|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
5027124|NCT02119156|12371844|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
5027125|NCT02119156|12371845|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
5027126|NCT02119156|12371843|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
5027127|NCT02119156|12371844|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
5027128|NCT02119156|12371845|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
5027129|NCT02119156|12371843|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
5027130|NCT02119156|12371844|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
5027131|NCT02119156|12371845|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
5027132|NCT02119156|12371843|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
5027133|NCT02119156|12371844|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
5027134|NCT02119156|12371845|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
5027135|NCT02119104|12371903|P1|NOT COMPLETED|Overall Study||16
5027136|NCT02119104|12371903|P1|COMPLETED|Overall Study||1071
5027137|NCT02119104|12371903|P1|STARTED|Overall Study||1087
5027138|NCT02119026|12371909|P2|NOT COMPLETED|2nd-line Treatment||2
5027139|NCT02119026|12371910|P1|NOT COMPLETED|2nd-line Treatment||9
5027140|NCT02119026|12371909|P2|COMPLETED|2nd-line Treatment||22
5027141|NCT02119026|12371910|P1|COMPLETED|2nd-line Treatment||23
5027142|NCT02119026|12371909|P2|STARTED|2nd-line Treatment||24
5027143|NCT02119026|12371910|P1|STARTED|2nd-line Treatment||32
5027144|NCT02119026|12371909|P2|NOT COMPLETED|1st-line Treatment||38
5027145|NCT02119026|12371910|P1|NOT COMPLETED|1st-line Treatment||26
5027146|NCT02119026|12371909|P2|COMPLETED|1st-line Treatment||24
5027147|NCT02119026|12371910|P1|COMPLETED|1st-line Treatment||32
5027148|NCT02119026|12371909|P2|STARTED|1st-line Treatment||62
5027149|NCT02119026|12371910|P1|STARTED|1st-line Treatment||58
5027150|NCT02118961|12371934|P2|NOT COMPLETED|Overall Study||0
5027151|NCT02118961|12371935|P1|NOT COMPLETED|Overall Study||1
5027152|NCT02118961|12371934|P2|COMPLETED|Overall Study||222
5027153|NCT02118961|12371935|P1|COMPLETED|Overall Study||223
5027154|NCT02118961|12371934|P2|STARTED|Overall Study||222
5027155|NCT02118961|12371935|P1|STARTED|Overall Study||224
5027156|NCT02118896|12371963|P10|NOT COMPLETED|Overall Study||2
5027157|NCT02118896|12371964|P9|NOT COMPLETED|Overall Study||4
5027158|NCT02118896|12371965|P8|NOT COMPLETED|Overall Study||2
5027159|NCT02118896|12371966|P7|NOT COMPLETED|Overall Study||2
5027160|NCT02118896|12371967|P6|NOT COMPLETED|Overall Study||28
5027161|NCT02118896|12371968|P5|NOT COMPLETED|Overall Study||17
5027162|NCT02118896|12371969|P4|NOT COMPLETED|Overall Study||24
5027163|NCT02118896|12371970|P3|NOT COMPLETED|Overall Study||14
5027164|NCT02118896|12371971|P2|NOT COMPLETED|Overall Study||15
5027165|NCT02118896|12371972|P1|NOT COMPLETED|Overall Study||17
5027166|NCT02118896|12371963|P10|COMPLETED|Overall Study||7
5027167|NCT02118896|12371964|P9|COMPLETED|Overall Study||84
5027168|NCT02118896|12371965|P8|COMPLETED|Overall Study||105
5027169|NCT02118896|12371966|P7|COMPLETED|Overall Study||83
5027170|NCT02118896|12371967|P6|COMPLETED|Overall Study||163
5027171|NCT02118896|12371968|P5|COMPLETED|Overall Study||113
5027172|NCT02118896|12371969|P4|COMPLETED|Overall Study||55
5027173|NCT02118896|12371970|P3|COMPLETED|Overall Study||53
5027174|NCT02118896|12371971|P2|COMPLETED|Overall Study||32
5027175|NCT02118896|12371972|P1|COMPLETED|Overall Study||30
5027176|NCT02118896|12371963|P10|STARTED|Overall Study||9
5027177|NCT02118896|12371964|P9|STARTED|Overall Study||88
5027178|NCT02118896|12371965|P8|STARTED|Overall Study||107
5027179|NCT02118896|12371966|P7|STARTED|Overall Study||85
5027180|NCT02118896|12371967|P6|STARTED|Overall Study||191
5027181|NCT02118896|12371968|P5|STARTED|Overall Study||130
5027182|NCT02118896|12371969|P4|STARTED|Overall Study||79
5027183|NCT02118896|12371970|P3|STARTED|Overall Study||67
5027184|NCT02118896|12371971|P2|STARTED|Overall Study||47
5027185|NCT02118896|12371972|P1|STARTED|Overall Study||47
5027186|NCT02118831|12372047|P3|NOT COMPLETED|Overall Study||0
5027187|NCT02118831|12372048|P2|NOT COMPLETED|Overall Study||0
5027188|NCT02118831|12372049|P1|NOT COMPLETED|Overall Study||0
5027189|NCT02118831|12372047|P3|COMPLETED|Overall Study||20
5027190|NCT02118831|12372048|P2|COMPLETED|Overall Study||15
5027191|NCT02118831|12372049|P1|COMPLETED|Overall Study||21
5027192|NCT02118831|12372047|P3|STARTED|Overall Study||20
5027193|NCT02118831|12372048|P2|STARTED|Overall Study||15
5027194|NCT02118831|12372049|P1|STARTED|Overall Study||21
5027195|NCT02118792|12372062|P2|NOT COMPLETED|Overall Study||37
5027196|NCT02118792|12372063|P1|NOT COMPLETED|Overall Study||31
5027197|NCT02118792|12372062|P2|COMPLETED|Overall Study||213
5027198|NCT02118792|12372063|P1|COMPLETED|Overall Study||483
5027199|NCT02118792|12372062|P2|Treated|Overall Study||250
5027200|NCT02118792|12372063|P1|Treated|Overall Study||513
5027201|NCT02118792|12372062|P2|STARTED|Overall Study||250
5027202|NCT02118792|12372063|P1|STARTED|Overall Study||514
5027203|NCT02118766|12372105|P2|NOT COMPLETED|Overall Study||31
5027204|NCT02118766|12372106|P1|NOT COMPLETED|Overall Study||30
5027205|NCT02118766|12372105|P2|COMPLETED|Overall Study||225
5027206|NCT02118766|12372106|P1|COMPLETED|Overall Study||477
5027207|NCT02118766|12372105|P2|Treated|Overall Study||256
5027208|NCT02118766|12372106|P1|Treated|Overall Study||503
5027209|NCT02118766|12372105|P2|STARTED|Overall Study||256
5027210|NCT02118766|12372106|P1|STARTED|Overall Study||507
5027211|NCT02118714|12372128|P1|NOT COMPLETED|Overall Study||3
5027212|NCT02118714|12372128|P1|COMPLETED|Overall Study||17
5027213|NCT02118714|12372128|P1|STARTED|Overall Study||20
5027214|NCT02118610|12372144|P2|NOT COMPLETED|Overall Study||1
5027215|NCT02118610|12372145|P1|NOT COMPLETED|Overall Study||1
5027216|NCT02118610|12372144|P2|COMPLETED|Overall Study||32
5027217|NCT02118610|12372145|P1|COMPLETED|Overall Study||29
5027218|NCT02118610|12372144|P2|STARTED|Overall Study||33
5027219|NCT02118610|12372145|P1|STARTED|Overall Study||30
5027220|NCT02118597|12372153|P1|NOT COMPLETED|Overall Study||16
5027221|NCT02118597|12372153|P1|COMPLETED|Overall Study||3
5027222|NCT02118597|12372153|P1|STARTED|Overall Study||19
5027223|NCT02118441|12372169|P2|NOT COMPLETED|Overall Study||1
5027224|NCT02118441|12372170|P1|NOT COMPLETED|Overall Study||3
5027225|NCT02118441|12372169|P2|COMPLETED|Overall Study||63
5027226|NCT02118441|12372170|P1|COMPLETED|Overall Study||62
5027227|NCT02118441|12372169|P2|STARTED|Overall Study||64
5027228|NCT02118441|12372170|P1|STARTED|Overall Study||65
5027229|NCT02118428|12372184|P3|NOT COMPLETED|Overall Study||1
5027230|NCT02118428|12372185|P2|NOT COMPLETED|Overall Study||9
5027231|NCT02118428|12372186|P1|NOT COMPLETED|Overall Study||13
5027232|NCT02118428|12372184|P3|COMPLETED|Overall Study||0
5027233|NCT02118428|12372185|P2|COMPLETED|Overall Study||104
5027234|NCT02118428|12372186|P1|COMPLETED|Overall Study||100
5027235|NCT02118428|12372184|P3|Received Study Transfusion|Overall Study||0
5027236|NCT02118428|12372185|P2|Received Study Transfusion|Overall Study||112
5027237|NCT02118428|12372186|P1|Received Study Transfusion|Overall Study||111
5027238|NCT02118428|12372184|P3|STARTED|Overall Study||1
5027239|NCT02118428|12372185|P2|STARTED|Overall Study||113
5027240|NCT02118428|12372186|P1|STARTED|Overall Study||113
5027241|NCT02118012|12372226|P2|NOT COMPLETED|Overall Study||2
5027242|NCT02118012|12372227|P1|NOT COMPLETED|Overall Study||0
5027243|NCT02118012|12372226|P2|COMPLETED|Overall Study||10
5027244|NCT02118012|12372227|P1|COMPLETED|Overall Study||12
5027245|NCT02118012|12372226|P2|Day 14|Overall Study||10
5027246|NCT02118012|12372227|P1|Day 14|Overall Study||12
5027247|NCT02118012|12372226|P2|Day 5|Overall Study||11
5027248|NCT02118012|12372227|P1|Day 5|Overall Study||12
5027249|NCT02118012|12372226|P2|STARTED|Overall Study||12
5027250|NCT02118012|12372227|P1|STARTED|Overall Study||12
5027251|NCT02117999|12372241|P2|NOT COMPLETED|Overall Study||0
5027252|NCT02117999|12372242|P1|NOT COMPLETED|Overall Study||0
5027253|NCT02117999|12372241|P2|COMPLETED|Overall Study||10
5027254|NCT02117999|12372242|P1|COMPLETED|Overall Study||20
5027255|NCT02117999|12372241|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
5027256|NCT02117999|12372242|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
5027257|NCT02117999|12372241|P2|STARTED|Overall Study||10
5027258|NCT02117999|12372242|P1|STARTED|Overall Study||20
5027259|NCT02117934|12372260|P2|NOT COMPLETED|Overall Study||215
5027260|NCT02117934|12372261|P1|NOT COMPLETED|Overall Study||500
5027261|NCT02117934|12372260|P2|COMPLETED|Overall Study||2567
5027262|NCT02117934|12372261|P1|COMPLETED|Overall Study||5092
5027263|NCT02117934|12372260|P2|STARTED|Overall Study||2782
5027264|NCT02117934|12372261|P1|STARTED|Overall Study||5592
5027265|NCT02117687|12372271|P2|NOT COMPLETED|Overall Study||4
5027266|NCT02117687|12372272|P1|NOT COMPLETED|Overall Study||1
5027267|NCT02117687|12372271|P2|COMPLETED|Overall Study||36
5027268|NCT02117687|12372272|P1|COMPLETED|Overall Study||39
5027269|NCT02117687|12372271|P2|STARTED|Overall Study||40
5027270|NCT02117687|12372272|P1|STARTED|Overall Study||40
5027271|NCT02117648|12372304|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
5027272|NCT02117648|12372304|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
5027273|NCT02117648|12372304|P1|STARTED|Abemaciclib Safety-Extension Phase||20
5027274|NCT02117648|12372304|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
5027275|NCT02117648|12372304|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
5027276|NCT02117648|12372304|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
5027277|NCT02117648|12372304|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
5027278|NCT02117648|12372304|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
5027279|NCT02117648|12372304|P1|COMPLETED|Abemaciclib Alone Period 1||24
5027280|NCT02117648|12372304|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
5027281|NCT02117648|12372304|P1|STARTED|Abemaciclib Alone Period 1||26
5027282|NCT02117570|12372317|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
5027283|NCT02117570|12372318|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
5027284|NCT02117570|12372319|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
5027285|NCT02117570|12372317|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
5027286|NCT02117570|12372318|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
5027287|NCT02117570|12372319|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
5027288|NCT02117570|12372317|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
5027289|NCT02117570|12372318|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
5027290|NCT02117570|12372319|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
5027291|NCT02117570|12372317|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
5027292|NCT02117570|12372318|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
5027293|NCT02117570|12372319|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
5027294|NCT02117570|12372317|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
5027295|NCT02117570|12372318|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
5027296|NCT02117570|12372319|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
5027297|NCT02117570|12372317|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
5027298|NCT02117570|12372318|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
5027299|NCT02117570|12372319|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
5027300|NCT02117570|12372317|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
5027301|NCT02117570|12372318|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
5027302|NCT02117570|12372319|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
5027303|NCT02117570|12372317|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
5027304|NCT02117570|12372318|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
5027305|NCT02117570|12372319|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
5027306|NCT02117570|12372317|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
5027307|NCT02117570|12372318|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
5027308|NCT02117570|12372319|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
5027309|NCT02117570|12372317|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
5027310|NCT02117570|12372318|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
5027311|NCT02117570|12372319|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
5027312|NCT02117570|12372317|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
5027313|NCT02117570|12372318|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
5027314|NCT02117570|12372319|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
5027315|NCT02117570|12372317|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
5027316|NCT02117570|12372318|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
5027317|NCT02117570|12372319|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
5027318|NCT02117544|12372369|P2|NOT COMPLETED|Period 2||0
5027319|NCT02117544|12372370|P1|NOT COMPLETED|Period 2||0
5027320|NCT02117544|12372369|P2|COMPLETED|Period 2||55
5027321|NCT02117544|12372370|P1|COMPLETED|Period 2||52
5027322|NCT02117544|12372369|P2|STARTED|Period 2||55
5027323|NCT02117544|12372370|P1|STARTED|Period 2||52
5027324|NCT02117544|12372369|P2|NOT COMPLETED|Period 1||0
5027325|NCT02117544|12372370|P1|NOT COMPLETED|Period 1||2
5027326|NCT02117544|12372369|P2|COMPLETED|Period 1||55
5027327|NCT02117544|12372370|P1|COMPLETED|Period 1||52
5027328|NCT02117544|12372369|P2|Treated|Period 1||55
5027329|NCT02117544|12372370|P1|Treated|Period 1||52
5027330|NCT02117544|12372369|P2|STARTED|Period 1||55
5027331|NCT02117544|12372370|P1|STARTED|Period 1||54
5027332|NCT02117479|12372385|P2|NOT COMPLETED|Overall Study||156
5027333|NCT02117479|12372386|P1|NOT COMPLETED|Overall Study||156
5027334|NCT02117479|12372385|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
5027335|NCT02117479|12372386|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
5027336|NCT02117479|12372385|P2|STARTED|Overall Study||160
5027337|NCT02117479|12372386|P1|STARTED|Overall Study||161
5027338|NCT02117427|12372405|P3|NOT COMPLETED|Overall Study||0
5027339|NCT02117427|12372406|P2|NOT COMPLETED|Overall Study||5
5027340|NCT02117427|12372407|P1|NOT COMPLETED|Overall Study||5
5027341|NCT02117427|12372405|P3|COMPLETED|Overall Study||0
5027342|NCT02117427|12372406|P2|COMPLETED|Overall Study||0
5027343|NCT02117427|12372407|P1|COMPLETED|Overall Study||1
5027344|NCT02117427|12372405|P3|Long Term Safety Follow-up|Overall Study||0
5027345|NCT02117427|12372406|P2|Long Term Safety Follow-up|Overall Study||0
5027346|NCT02117427|12372407|P1|Long Term Safety Follow-up|Overall Study||1
5027347|NCT02117427|12372405|P3|Safety Follow-up|Overall Study||0
5027348|NCT02117427|12372406|P2|Safety Follow-up|Overall Study||0
5027349|NCT02117427|12372407|P1|Safety Follow-up|Overall Study||1
5027350|NCT02117427|12372405|P3|Implantation & Efficacy|Overall Study||0
5027351|NCT02117427|12372406|P2|Implantation & Efficacy|Overall Study||4
5027352|NCT02117427|12372407|P1|Implantation & Efficacy|Overall Study||6
5027353|NCT02117427|12372405|P3|Run in Phase & Harvest|Overall Study||0
5027354|NCT02117427|12372406|P2|Run in Phase & Harvest|Overall Study||4
5027355|NCT02117427|12372407|P1|Run in Phase & Harvest|Overall Study||6
5027356|NCT02117427|12372405|P3|STARTED|Overall Study||0
5027357|NCT02117427|12372406|P2|STARTED|Overall Study||5
5027358|NCT02117427|12372407|P1|STARTED|Overall Study||6
5027359|NCT02117414|12372417|P2|NOT COMPLETED|Overall Study||6
5027360|NCT02117414|12372418|P1|NOT COMPLETED|Overall Study||15
5027361|NCT02117414|12372417|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
5027362|NCT02117414|12372418|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
5027363|NCT02117414|12372417|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
5027364|NCT02117414|12372418|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
5027365|NCT02117349|12372438|P2|NOT COMPLETED|Overall Study||1
5027366|NCT02117349|12372439|P1|NOT COMPLETED|Overall Study||3
5027367|NCT02117349|12372438|P2|COMPLETED|Overall Study||17
5027368|NCT02117349|12372439|P1|COMPLETED|Overall Study||34
5027369|NCT02117349|12372438|P2|Modified Intent-to-treat (mITT)|Overall Study||18
5027370|NCT02117349|12372439|P1|Modified Intent-to-treat (mITT)|Overall Study||36
5027371|NCT02117349|12372438|P2|Safety Population|Overall Study||18
5027372|NCT02117349|12372439|P1|Safety Population|Overall Study||36
5027373|NCT02117349|12372438|P2|Intent-to-treat Population|Overall Study||18
5027374|NCT02117349|12372439|P1|Intent-to-treat Population|Overall Study||37
5027375|NCT02117349|12372438|P2|STARTED|Overall Study||18
5027376|NCT02117349|12372439|P1|STARTED|Overall Study||37
5027377|NCT02117310|12372449|P1|NOT COMPLETED|Overall Study||0
5027378|NCT02117310|12372449|P1|COMPLETED|Overall Study||5
5027379|NCT02117310|12372449|P1|STARTED|Overall Study||5
5027380|NCT02117193|12372453|P1|NOT COMPLETED|Overall Study||0
5027381|NCT02117193|12372453|P1|COMPLETED|Overall Study||10
5027382|NCT02117193|12372453|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
5027383|NCT02117193|12372453|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
5027384|NCT02117193|12372453|P1|Placebo Intake + Normal Sleep|Overall Study||10
5027385|NCT02117193|12372453|P1|Alcohol Intake + Normal Sleep|Overall Study||10
5027386|NCT02117193|12372453|P1|STARTED|Overall Study||10
5027387|NCT02117050|12372475|P1|NOT COMPLETED|Overall Study||1
5027388|NCT02117050|12372475|P1|COMPLETED|Overall Study||0
5027389|NCT02117050|12372475|P1|STARTED|Overall Study||1
5027390|NCT02117024|12372489|P2|NOT COMPLETED|Overall Study||20
5027391|NCT02117024|12372490|P1|NOT COMPLETED|Overall Study||44
5027392|NCT02117024|12372489|P2|COMPLETED|Overall Study||1
5027393|NCT02117024|12372490|P1|COMPLETED|Overall Study||1
5027394|NCT02117024|12372489|P2|STARTED|Overall Study||21
5027395|NCT02117024|12372490|P1|STARTED|Overall Study||45
5027396|NCT02116972|12372517|P3|NOT COMPLETED|Overall Study||19
5027397|NCT02116972|12372518|P2|NOT COMPLETED|Overall Study||17
5027398|NCT02116972|12372519|P1|NOT COMPLETED|Overall Study||19
5027399|NCT02116972|12372517|P3|COMPLETED|Overall Study||85
5027400|NCT02116972|12372518|P2|COMPLETED|Overall Study||87
5027401|NCT02116972|12372519|P1|COMPLETED|Overall Study||83
5027402|NCT02116972|12372517|P3|STARTED|Overall Study||104
5027403|NCT02116972|12372518|P2|STARTED|Overall Study||104
5027404|NCT02116972|12372519|P1|STARTED|Overall Study||102
5027405|NCT02116803|12372551|P2|NOT COMPLETED|Overall Study||2
5027406|NCT02116803|12372552|P1|NOT COMPLETED|Overall Study||10
5027407|NCT02116803|12372551|P2|COMPLETED|Overall Study||0
5027408|NCT02116803|12372552|P1|COMPLETED|Overall Study||0
5027409|NCT02116803|12372551|P2|STARTED|Overall Study||2
5027410|NCT02116803|12372552|P1|STARTED|Overall Study||10
5027411|NCT02116660|12372560|P2|NOT COMPLETED|Overall Study||4
5027412|NCT02116660|12372561|P1|NOT COMPLETED|Overall Study||2
5027413|NCT02116660|12372560|P2|COMPLETED|Overall Study||1
5027414|NCT02116660|12372561|P1|COMPLETED|Overall Study||4
5027415|NCT02116660|12372560|P2|STARTED|Overall Study||5
5027416|NCT02116660|12372561|P1|STARTED|Overall Study||6
5027417|NCT02116621|12372605|P2|NOT COMPLETED|Twelve Month Follow-up||12
5027418|NCT02116621|12372606|P1|NOT COMPLETED|Twelve Month Follow-up||16
5027419|NCT02116621|12372605|P2|COMPLETED|Twelve Month Follow-up||86
5027420|NCT02116621|12372606|P1|COMPLETED|Twelve Month Follow-up||84
5027421|NCT02116621|12372605|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
5027422|NCT02116621|12372606|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
5027423|NCT02116621|12372605|P2|NOT COMPLETED|Six Month Follow-up||3
5027424|NCT02116621|12372606|P1|NOT COMPLETED|Six Month Follow-up||4
5027425|NCT02116621|12372605|P2|COMPLETED|Six Month Follow-up||97
5027426|NCT02116621|12372606|P1|COMPLETED|Six Month Follow-up||99
5027519|NCT02115646|12372916|P1|COMPLETED|Overall Study||22
5027427|NCT02116621|12372605|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
5027428|NCT02116621|12372606|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
5027429|NCT02116621|12372605|P2|NOT COMPLETED|Three Month Follow-up||7
5027430|NCT02116621|12372606|P1|NOT COMPLETED|Three Month Follow-up||19
5027431|NCT02116621|12372605|P2|COMPLETED|Three Month Follow-up||96
5027432|NCT02116621|12372606|P1|COMPLETED|Three Month Follow-up||89
5027433|NCT02116621|12372605|P2|STARTED|Three Month Follow-up||103
5027434|NCT02116621|12372606|P1|STARTED|Three Month Follow-up||108
5027435|NCT02116621|12372605|P2|NOT COMPLETED|Baseline||4
5027436|NCT02116621|12372606|P1|NOT COMPLETED|Baseline||0
5027437|NCT02116621|12372605|P2|COMPLETED|Baseline||103
5027438|NCT02116621|12372606|P1|COMPLETED|Baseline||108
5027439|NCT02116621|12372605|P2|Completed Intervention Period|Baseline||103
5027440|NCT02116621|12372606|P1|Completed Intervention Period|Baseline||95
5027441|NCT02116621|12372605|P2|Completed Baseline Visit|Baseline||103
5027442|NCT02116621|12372606|P1|Completed Baseline Visit|Baseline||108
5027443|NCT02116621|12372605|P2|STARTED|Baseline||107
5027444|NCT02116621|12372606|P1|STARTED|Baseline||108
5027445|NCT02116582|12372694|P1|NOT COMPLETED|Overall Study||215
5027446|NCT02116582|12372694|P1|COMPLETED|Overall Study||0
5027447|NCT02116582|12372694|P1|Treated|Overall Study||214
5027448|NCT02116582|12372694|P1|STARTED|Overall Study||215
5027449|NCT02116530|12372704|P2|NOT COMPLETED|Overall Study||4
5027450|NCT02116530|12372705|P1|NOT COMPLETED|Overall Study||9
5027451|NCT02116530|12372704|P2|COMPLETED|Overall Study||184
5027452|NCT02116530|12372705|P1|COMPLETED|Overall Study||183
5027453|NCT02116530|12372704|P2|STARTED|Overall Study||188
5027454|NCT02116530|12372705|P1|STARTED|Overall Study||192
5027455|NCT02116361|12372723|P4|NOT COMPLETED|Overall Study||31
5027456|NCT02116361|12372724|P3|NOT COMPLETED|Overall Study||26
5027457|NCT02116361|12372725|P2|NOT COMPLETED|Overall Study||31
5027458|NCT02116361|12372726|P1|NOT COMPLETED|Overall Study||31
5027459|NCT02116361|12372723|P4|COMPLETED|Overall Study||34
5027460|NCT02116361|12372724|P3|COMPLETED|Overall Study||33
5027461|NCT02116361|12372725|P2|COMPLETED|Overall Study||34
5027462|NCT02116361|12372726|P1|COMPLETED|Overall Study||38
5027463|NCT02116361|12372723|P4|STARTED|Overall Study||65
5027464|NCT02116361|12372724|P3|STARTED|Overall Study||59
5027465|NCT02116361|12372725|P2|STARTED|Overall Study||65
5027466|NCT02116361|12372726|P1|STARTED|Overall Study||69
5027467|NCT02116322|12372756|P1|NOT COMPLETED|Overall Study||0
5027468|NCT02116322|12372756|P1|COMPLETED|Overall Study||1
5027469|NCT02116322|12372756|P1|STARTED|Overall Study||1
5027470|NCT02116309|12372763|P2|NOT COMPLETED|Overall Study||1
5027471|NCT02116309|12372764|P1|NOT COMPLETED|Overall Study||0
5027472|NCT02116309|12372763|P2|COMPLETED|Overall Study||477
5027473|NCT02116309|12372764|P1|COMPLETED|Overall Study||482
5027474|NCT02116309|12372763|P2|STARTED|Overall Study||478
5027475|NCT02116309|12372764|P1|STARTED|Overall Study||482
5027476|NCT02115984|12372774|P2|NOT COMPLETED|Overall Study||7
5027477|NCT02115984|12372775|P1|NOT COMPLETED|Overall Study||6
5027478|NCT02115984|12372774|P2|COMPLETED|Overall Study||16
5027479|NCT02115984|12372775|P1|COMPLETED|Overall Study||51
5027480|NCT02115984|12372774|P2|STARTED|Overall Study||23
5027481|NCT02115984|12372775|P1|STARTED|Overall Study||57
5027482|NCT02115828|12372781|P1|NOT COMPLETED|Overall Study||0
5027483|NCT02115828|12372781|P1|COMPLETED|Overall Study||9
5027484|NCT02115828|12372781|P1|STARTED|Overall Study||9
5027485|NCT02115815|12372796|P7|NOT COMPLETED|Overall Study||0
5027486|NCT02115815|12372797|P6|NOT COMPLETED|Overall Study||2
5027487|NCT02115815|12372798|P5|NOT COMPLETED|Overall Study||0
5027488|NCT02115815|12372799|P4|NOT COMPLETED|Overall Study||0
5027489|NCT02115815|12372800|P3|NOT COMPLETED|Overall Study||0
5027490|NCT02115815|12372801|P2|NOT COMPLETED|Overall Study||0
5027491|NCT02115815|12372802|P1|NOT COMPLETED|Overall Study||2
5027492|NCT02115815|12372796|P7|COMPLETED|Overall Study||20
5027493|NCT02115815|12372797|P6|COMPLETED|Overall Study||20
5027494|NCT02115815|12372798|P5|COMPLETED|Overall Study||20
5027495|NCT02115815|12372799|P4|COMPLETED|Overall Study||20
5027496|NCT02115815|12372800|P3|COMPLETED|Overall Study||20
5027497|NCT02115815|12372801|P2|COMPLETED|Overall Study||20
5027498|NCT02115815|12372802|P1|COMPLETED|Overall Study||22
5027499|NCT02115815|12372796|P7|STARTED|Overall Study||20
5027500|NCT02115815|12372797|P6|STARTED|Overall Study||22
5027501|NCT02115815|12372798|P5|STARTED|Overall Study||20
5027502|NCT02115815|12372799|P4|STARTED|Overall Study||20
5027503|NCT02115815|12372800|P3|STARTED|Overall Study||20
5027504|NCT02115815|12372801|P2|STARTED|Overall Study||20
5027505|NCT02115815|12372802|P1|STARTED|Overall Study||24
5027506|NCT02115750|12372897|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
5027507|NCT02115750|12372898|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
5027508|NCT02115750|12372897|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
5027509|NCT02115750|12372898|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
5027510|NCT02115750|12372897|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
5027511|NCT02115750|12372898|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
5027512|NCT02115750|12372897|P2|NOT COMPLETED|Part 1||12
5027513|NCT02115750|12372898|P1|NOT COMPLETED|Part 1||22
5027514|NCT02115750|12372897|P2|COMPLETED|Part 1||312
5027515|NCT02115750|12372898|P1|COMPLETED|Part 1||301
5027516|NCT02115750|12372897|P2|STARTED|Part 1||324
5027517|NCT02115750|12372898|P1|STARTED|Part 1||323
5027518|NCT02115646|12372916|P1|NOT COMPLETED|Overall Study||7
5027520|NCT02115646|12372916|P1|STARTED|Overall Study||29
5027521|NCT02115633|12372931|P2|NOT COMPLETED|Overall Study||0
5027522|NCT02115633|12372932|P1|NOT COMPLETED|Overall Study||0
5027523|NCT02115633|12372931|P2|COMPLETED|Overall Study||16
5027524|NCT02115633|12372932|P1|COMPLETED|Overall Study||15
5027525|NCT02115633|12372931|P2|STARTED|Overall Study||16
5027526|NCT02115633|12372932|P1|STARTED|Overall Study||15
5027527|NCT02115607|12372944|P1|NOT COMPLETED|Overall Study||1
5027528|NCT02115607|12372944|P1|COMPLETED|Overall Study||16
5027529|NCT02115607|12372944|P1|STARTED|Overall Study||17
5027530|NCT02115581|12372953|P2|NOT COMPLETED|Overall Study||0
5027531|NCT02115581|12372954|P1|NOT COMPLETED|Overall Study||0
5027532|NCT02115581|12372953|P2|COMPLETED|Overall Study||21
5027533|NCT02115581|12372954|P1|COMPLETED|Overall Study||17
5027534|NCT02115581|12372953|P2|STARTED|Overall Study||21
5027535|NCT02115581|12372954|P1|STARTED|Overall Study||17
5027536|NCT02115542|12372964|P1|NOT COMPLETED|Overall Study||0
5027537|NCT02115542|12372964|P1|COMPLETED|Overall Study||39
5027538|NCT02115542|12372964|P1|STARTED|Overall Study||39
5027539|NCT02115386|12372970|P1|NOT COMPLETED|Overall Study||7
5027540|NCT02115386|12372970|P1|COMPLETED|Overall Study||0
5027541|NCT02115386|12372970|P1|STARTED|Overall Study||7
5027542|NCT02115373|12372983|P3|NOT COMPLETED|Overall Study||0
5027543|NCT02115373|12372984|P2|NOT COMPLETED|Overall Study||0
5027544|NCT02115373|12372985|P1|NOT COMPLETED|Overall Study||0
5027545|NCT02115373|12372983|P3|COMPLETED|Overall Study||49
5027546|NCT02115373|12372984|P2|COMPLETED|Overall Study||13
5027547|NCT02115373|12372985|P1|COMPLETED|Overall Study||4
5027548|NCT02115373|12372983|P3|STARTED|Overall Study||49
5027549|NCT02115373|12372984|P2|STARTED|Overall Study||13
5027550|NCT02115373|12372985|P1|STARTED|Overall Study||4
5027551|NCT02115347|12373051|P3|NOT COMPLETED|Overall Study||0
5027552|NCT02115347|12373052|P2|NOT COMPLETED|Overall Study||0
5027553|NCT02115347|12373053|P1|NOT COMPLETED|Overall Study||0
5027554|NCT02115347|12373051|P3|COMPLETED|Overall Study||0
5027555|NCT02115347|12373052|P2|COMPLETED|Overall Study||8
5027556|NCT02115347|12373053|P1|COMPLETED|Overall Study||8
5027557|NCT02115347|12373051|P3|STARTED|Overall Study||0
5027558|NCT02115347|12373052|P2|STARTED|Overall Study||8
5027559|NCT02115347|12373053|P1|STARTED|Overall Study||8
5027560|NCT02115321|12373073|P2|NOT COMPLETED|Overall Study||0
5027561|NCT02115321|12373074|P1|NOT COMPLETED|Overall Study||1
5027562|NCT02115321|12373073|P2|COMPLETED|Overall Study||10
5027563|NCT02115321|12373074|P1|COMPLETED|Overall Study||29
5027564|NCT02115321|12373073|P2|STARTED|Overall Study||10
5027565|NCT02115321|12373074|P1|STARTED|Overall Study||30
5027566|NCT02115308|12373096|P2|NOT COMPLETED|Overall Study||2
5027567|NCT02115308|12373097|P1|NOT COMPLETED|Overall Study||2
5027568|NCT02115308|12373096|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
5027569|NCT02115308|12373097|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
5027570|NCT02115308|12373096|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
5027571|NCT02115308|12373097|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
5027572|NCT02115269|12373113|P1|NOT COMPLETED|Overall Study||57
5027573|NCT02115269|12373113|P1|COMPLETED|Overall Study||702
5027574|NCT02115269|12373113|P1|STARTED|Overall Study||759
5027575|NCT02115256|12373133|P2|NOT COMPLETED|Overall Study||1
5027576|NCT02115256|12373134|P1|NOT COMPLETED|Overall Study||0
5027577|NCT02115256|12373133|P2|COMPLETED|Overall Study||2
5027578|NCT02115256|12373134|P1|COMPLETED|Overall Study||3
5027579|NCT02115256|12373133|P2|STARTED|Overall Study||3
5027580|NCT02115256|12373134|P1|STARTED|Overall Study||3
5027581|NCT02115113|12373146|P3|NOT COMPLETED|Participants Randomized||0
5027582|NCT02115113|12373147|P2|NOT COMPLETED|Participants Randomized||0
5027583|NCT02115113|12373148|P1|NOT COMPLETED|Participants Randomized||2
5027584|NCT02115113|12373146|P3|COMPLETED|Participants Randomized||0
5027585|NCT02115113|12373147|P2|COMPLETED|Participants Randomized||26
5027586|NCT02115113|12373148|P1|COMPLETED|Participants Randomized||22
5027587|NCT02115113|12373146|P3|STARTED|Participants Randomized||0
5027588|NCT02115113|12373147|P2|STARTED|Participants Randomized||26
5027589|NCT02115113|12373148|P1|STARTED|Participants Randomized||24
5027590|NCT02115113|12373146|P3|NOT COMPLETED|Participants in Run-in Period||10
5027591|NCT02115113|12373147|P2|NOT COMPLETED|Participants in Run-in Period||0
5027592|NCT02115113|12373148|P1|NOT COMPLETED|Participants in Run-in Period||0
5027593|NCT02115113|12373146|P3|COMPLETED|Participants in Run-in Period||68
5027594|NCT02115113|12373147|P2|COMPLETED|Participants in Run-in Period||0
5027595|NCT02115113|12373148|P1|COMPLETED|Participants in Run-in Period||0
5027596|NCT02115113|12373146|P3|STARTED|Participants in Run-in Period||78
5027597|NCT02115113|12373147|P2|STARTED|Participants in Run-in Period||0
5027598|NCT02115113|12373148|P1|STARTED|Participants in Run-in Period||0
5027599|NCT02115048|12373163|P2|NOT COMPLETED|Overall Study||0
5027600|NCT02115048|12373164|P1|NOT COMPLETED|Overall Study||0
5027601|NCT02115048|12373163|P2|COMPLETED|Overall Study||21
5027602|NCT02115048|12373164|P1|COMPLETED|Overall Study||23
5027603|NCT02115048|12373163|P2|STARTED|Overall Study||21
5027604|NCT02115048|12373164|P1|STARTED|Overall Study||23
5027605|NCT02114931|12373180|P2|NOT COMPLETED|Overall Study||30
5027606|NCT02114931|12373181|P1|NOT COMPLETED|Overall Study||25
5027607|NCT02114931|12373180|P2|COMPLETED|Overall Study||207
5027608|NCT02114931|12373181|P1|COMPLETED|Overall Study||205
5027609|NCT02114931|12373180|P2|Received Treatment|Overall Study||237
5027704|NCT02113956|12373522|P2|NOT COMPLETED|3 Month Post-intervention||2
5027610|NCT02114931|12373181|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
5027611|NCT02114931|12373180|P2|STARTED|Overall Study||237
5027612|NCT02114931|12373181|P1|STARTED|Overall Study||230
5027613|NCT02114892|12373197|P2|NOT COMPLETED|Overall Study||2
5027614|NCT02114892|12373198|P1|NOT COMPLETED|Overall Study||1
5027615|NCT02114892|12373197|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
5027616|NCT02114892|12373198|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
5027617|NCT02114892|12373197|P2|STARTED|Overall Study||12
5027618|NCT02114892|12373198|P1|STARTED|Overall Study||12
5027619|NCT02114879|12373234|P2|NOT COMPLETED|Overall Study||24
5027620|NCT02114879|12373235|P1|NOT COMPLETED|Overall Study||19
5027621|NCT02114879|12373234|P2|COMPLETED|Overall Study||90
5027622|NCT02114879|12373235|P1|COMPLETED|Overall Study||96
5027623|NCT02114879|12373234|P2|STARTED|Overall Study||114
5027624|NCT02114879|12373235|P1|STARTED|Overall Study||115
5027625|NCT02114697|12373253|P2|NOT COMPLETED|Overall Study||4
5027626|NCT02114697|12373254|P1|NOT COMPLETED|Overall Study||5
5027627|NCT02114697|12373253|P2|COMPLETED|Overall Study||0
5027628|NCT02114697|12373254|P1|COMPLETED|Overall Study||0
5027629|NCT02114697|12373253|P2|Completed Month 18 Visit|Overall Study||1
5027630|NCT02114697|12373254|P1|Completed Month 18 Visit|Overall Study||0
5027631|NCT02114697|12373253|P2|STARTED|Overall Study||4
5027632|NCT02114697|12373254|P1|STARTED|Overall Study||5
5027633|NCT02114684|12373262|P2|NOT COMPLETED|Overall Study||10
5027634|NCT02114684|12373263|P1|NOT COMPLETED|Overall Study||12
5027635|NCT02114684|12373262|P2|COMPLETED|Overall Study||88
5027636|NCT02114684|12373263|P1|COMPLETED|Overall Study||86
5027637|NCT02114684|12373262|P2|STARTED|Overall Study||98
5027638|NCT02114684|12373263|P1|STARTED|Overall Study||98
5027639|NCT02114515|12373281|P2|NOT COMPLETED|Overall Study||150
5027640|NCT02114515|12373282|P1|NOT COMPLETED|Overall Study||133
5027641|NCT02114515|12373281|P2|COMPLETED|Overall Study||368
5027642|NCT02114515|12373282|P1|COMPLETED|Overall Study||378
5027643|NCT02114515|12373281|P2|STARTED|Overall Study||518
5027644|NCT02114515|12373282|P1|STARTED|Overall Study||511
5027645|NCT02114385|12373328|P2|NOT COMPLETED|Overall Study||8
5027646|NCT02114385|12373329|P1|NOT COMPLETED|Overall Study||3
5027647|NCT02114385|12373328|P2|COMPLETED|Overall Study||243
5027648|NCT02114385|12373329|P1|COMPLETED|Overall Study||246
5027649|NCT02114385|12373328|P2|Vaccinated|Overall Study||251
5027650|NCT02114385|12373329|P1|Vaccinated|Overall Study||249
5027651|NCT02114385|12373328|P2|STARTED|Overall Study||251
5027652|NCT02114385|12373329|P1|STARTED|Overall Study||249
5027653|NCT02114307|12373353|P2|NOT COMPLETED|Overall Study||0
5027654|NCT02114307|12373354|P1|NOT COMPLETED|Overall Study||1
5027655|NCT02114307|12373353|P2|COMPLETED|Overall Study||11
5027656|NCT02114307|12373354|P1|COMPLETED|Overall Study||10
5027657|NCT02114307|12373353|P2|STARTED|Overall Study||11
5027658|NCT02114307|12373354|P1|STARTED|Overall Study||11
5027659|NCT02114268|12373370|P6|NOT COMPLETED|Overall Study||3
5027660|NCT02114268|12373371|P5|NOT COMPLETED|Overall Study||0
5027661|NCT02114268|12373372|P4|NOT COMPLETED|Overall Study||0
5027662|NCT02114268|12373373|P3|NOT COMPLETED|Overall Study||1
5027663|NCT02114268|12373374|P2|NOT COMPLETED|Overall Study||1
5027664|NCT02114268|12373375|P1|NOT COMPLETED|Overall Study||6
5027665|NCT02114268|12373370|P6|COMPLETED|Overall Study||75
5027666|NCT02114268|12373371|P5|COMPLETED|Overall Study||6
5027667|NCT02114268|12373372|P4|COMPLETED|Overall Study||6
5027668|NCT02114268|12373373|P3|COMPLETED|Overall Study||5
5027669|NCT02114268|12373374|P2|COMPLETED|Overall Study||5
5027670|NCT02114268|12373375|P1|COMPLETED|Overall Study||28
5027671|NCT02114268|12373370|P6|STARTED|Overall Study||78
5027672|NCT02114268|12373371|P5|STARTED|Overall Study||6
5027673|NCT02114268|12373372|P4|STARTED|Overall Study||6
5027674|NCT02114268|12373373|P3|STARTED|Overall Study||6
5027675|NCT02114268|12373374|P2|STARTED|Overall Study||6
5027676|NCT02114268|12373375|P1|STARTED|Overall Study||34
5027677|NCT02114216|12373428|P3|NOT COMPLETED|Overall Study||0
5027678|NCT02114216|12373429|P2|NOT COMPLETED|Overall Study||0
5027679|NCT02114216|12373430|P1|NOT COMPLETED|Overall Study||0
5027680|NCT02114216|12373428|P3|COMPLETED|Overall Study||14
5027681|NCT02114216|12373429|P2|COMPLETED|Overall Study||45
5027682|NCT02114216|12373430|P1|COMPLETED|Overall Study||16
5027683|NCT02114216|12373428|P3|STARTED|Overall Study||14
5027684|NCT02114216|12373429|P2|STARTED|Overall Study||45
5027685|NCT02114216|12373430|P1|STARTED|Overall Study||16
5027686|NCT02114203|12373444|P3|NOT COMPLETED|Overall Study||0
5027687|NCT02114203|12373445|P2|NOT COMPLETED|Overall Study||2
5027688|NCT02114203|12373446|P1|NOT COMPLETED|Overall Study||0
5027689|NCT02114203|12373444|P3|COMPLETED|Overall Study||7
5027690|NCT02114203|12373445|P2|COMPLETED|Overall Study||14
5027691|NCT02114203|12373446|P1|COMPLETED|Overall Study||7
5027692|NCT02114203|12373444|P3|STARTED|Overall Study||7
5027693|NCT02114203|12373445|P2|STARTED|Overall Study||16
5027694|NCT02114203|12373446|P1|STARTED|Overall Study||7
5027695|NCT02114177|12373480|P2|NOT COMPLETED|Overall Study||4
5027696|NCT02114177|12373481|P1|NOT COMPLETED|Overall Study||9
5027697|NCT02114177|12373480|P2|COMPLETED|Overall Study||151
5027698|NCT02114177|12373481|P1|COMPLETED|Overall Study||146
5027699|NCT02114177|12373480|P2|STARTED|Overall Study||155
5027700|NCT02114177|12373481|P1|STARTED|Overall Study||155
5027701|NCT02114151|12373505|P1|NOT COMPLETED|Overall Study||7
5027702|NCT02114151|12373505|P1|COMPLETED|Overall Study||96
5027703|NCT02114151|12373505|P1|STARTED|Overall Study||103
5027705|NCT02113956|12373523|P1|NOT COMPLETED|3 Month Post-intervention||4
5027706|NCT02113956|12373522|P2|COMPLETED|3 Month Post-intervention||146
5027707|NCT02113956|12373523|P1|COMPLETED|3 Month Post-intervention||137
5027708|NCT02113956|12373522|P2|STARTED|3 Month Post-intervention||148
5027709|NCT02113956|12373523|P1|STARTED|3 Month Post-intervention||141
5027710|NCT02113956|12373522|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
5027711|NCT02113956|12373523|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
5027712|NCT02113956|12373522|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
5027713|NCT02113956|12373523|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
5027714|NCT02113956|12373522|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
5027715|NCT02113956|12373523|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
5027716|NCT02113579|12373557|P2|NOT COMPLETED|Overall Study||4
5027717|NCT02113579|12373558|P1|NOT COMPLETED|Overall Study||10
5027718|NCT02113579|12373557|P2|COMPLETED|Overall Study||185
5027719|NCT02113579|12373558|P1|COMPLETED|Overall Study||176
5027720|NCT02113579|12373557|P2|STARTED|Overall Study||189
5027721|NCT02113579|12373558|P1|STARTED|Overall Study||186
5027722|NCT02113449|12373582|P1|NOT COMPLETED|Overall Study||4
5027723|NCT02113449|12373582|P1|COMPLETED|Overall Study||143
5027724|NCT02113449|12373582|P1|STARTED|Overall Study||147
5027725|NCT02113436|12373598|P4|NOT COMPLETED|Period 2: 16 Weeks||11
5027726|NCT02113436|12373599|P3|NOT COMPLETED|Period 2: 16 Weeks||9
5027727|NCT02113436|12373600|P2|NOT COMPLETED|Period 2: 16 Weeks||0
5027728|NCT02113436|12373601|P1|NOT COMPLETED|Period 2: 16 Weeks||0
5027729|NCT02113436|12373598|P4|COMPLETED|Period 2: 16 Weeks||136
5027730|NCT02113436|12373599|P3|COMPLETED|Period 2: 16 Weeks||132
5027731|NCT02113436|12373600|P2|COMPLETED|Period 2: 16 Weeks||0
5027732|NCT02113436|12373601|P1|COMPLETED|Period 2: 16 Weeks||0
5027733|NCT02113436|12373598|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
5027734|NCT02113436|12373599|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
5027735|NCT02113436|12373600|P2|STARTED|Period 2: 16 Weeks||0
5027736|NCT02113436|12373601|P1|STARTED|Period 2: 16 Weeks||0
5027737|NCT02113436|12373598|P4|NOT COMPLETED|Period 1: 8 Weeks||0
5027738|NCT02113436|12373599|P3|NOT COMPLETED|Period 1: 8 Weeks||0
5027739|NCT02113436|12373600|P2|NOT COMPLETED|Period 1: 8 Weeks||2
5027740|NCT02113436|12373601|P1|NOT COMPLETED|Period 1: 8 Weeks||8
5027741|NCT02113436|12373598|P4|COMPLETED|Period 1: 8 Weeks||0
5027742|NCT02113436|12373599|P3|COMPLETED|Period 1: 8 Weeks||0
5027743|NCT02113436|12373600|P2|COMPLETED|Period 1: 8 Weeks||148
5027744|NCT02113436|12373601|P1|COMPLETED|Period 1: 8 Weeks||142
5027745|NCT02113436|12373598|P4|STARTED|Period 1: 8 Weeks||0
5027746|NCT02113436|12373599|P3|STARTED|Period 1: 8 Weeks||0
5027747|NCT02113436|12373600|P2|STARTED|Period 1: 8 Weeks||150
5027748|NCT02113436|12373601|P1|STARTED|Period 1: 8 Weeks||150
5027749|NCT02113410|12373624|P2|NOT COMPLETED|Overall Study||3
5027750|NCT02113410|12373625|P1|NOT COMPLETED|Overall Study||16
5027751|NCT02113410|12373624|P2|COMPLETED|Overall Study||63
5027752|NCT02113410|12373625|P1|COMPLETED|Overall Study||49
5027753|NCT02113410|12373624|P2|STARTED|Overall Study||66
5027754|NCT02113410|12373625|P1|STARTED|Overall Study||65
5027755|NCT02113189|12373652|P3|NOT COMPLETED|Overall Study||3
5027756|NCT02113189|12373653|P2|NOT COMPLETED|Overall Study||1
5027757|NCT02113189|12373654|P1|NOT COMPLETED|Overall Study||2
5027758|NCT02113189|12373652|P3|COMPLETED|Overall Study||2
5027759|NCT02113189|12373653|P2|COMPLETED|Overall Study||3
5027760|NCT02113189|12373654|P1|COMPLETED|Overall Study||2
5027761|NCT02113189|12373652|P3|STARTED|Overall Study||5
5027762|NCT02113189|12373653|P2|STARTED|Overall Study||4
5027763|NCT02113189|12373654|P1|STARTED|Overall Study||4
5027764|NCT02113124|12373670|P2|NOT COMPLETED|Overall Study||1
5027765|NCT02113124|12373671|P1|NOT COMPLETED|Overall Study||1
5027766|NCT02113124|12373670|P2|COMPLETED|Overall Study||24
5027767|NCT02113124|12373671|P1|COMPLETED|Overall Study||17
5027768|NCT02113124|12373670|P2|STARTED|Overall Study||25
5027769|NCT02113124|12373671|P1|STARTED|Overall Study||18
5027770|NCT02113007|12373677|P1|NOT COMPLETED|Overall Study||2
5027771|NCT02113007|12373677|P1|COMPLETED|Overall Study||0
5027772|NCT02113007|12373677|P1|STARTED|Overall Study||2
5027773|NCT02112994|12373683|P3|NOT COMPLETED|Overall Study||3
5027774|NCT02112994|12373684|P2|NOT COMPLETED|Overall Study||2
5027775|NCT02112994|12373685|P1|NOT COMPLETED|Overall Study||0
5027776|NCT02112994|12373683|P3|COMPLETED|Overall Study||6
5027777|NCT02112994|12373684|P2|COMPLETED|Overall Study||14
5027778|NCT02112994|12373685|P1|COMPLETED|Overall Study||6
5027779|NCT02112994|12373683|P3|Completed 96-week Treatment Period|Overall Study||8
5027780|NCT02112994|12373684|P2|Completed 96-week Treatment Period|Overall Study||14
5027781|NCT02112994|12373685|P1|Completed 96-week Treatment Period|Overall Study||6
5027782|NCT02112994|12373683|P3|Received 3 mg/kg QW|Overall Study||1
5027783|NCT02112994|12373684|P2|Received 3 mg/kg QW|Overall Study||1
5027784|NCT02112994|12373685|P1|Received 3 mg/kg QW|Overall Study||2
5027785|NCT02112994|12373683|P3|Received 3 mg/kg QOW|Overall Study||3
5027786|NCT02112994|12373684|P2|Received 3 mg/kg QOW|Overall Study||5
5027787|NCT02112994|12373685|P1|Received 3 mg/kg QOW|Overall Study||3
5027788|NCT02112994|12373683|P3|Received 1 mg/kg QW|Overall Study||0
5027789|NCT02112994|12373684|P2|Received 1 mg/kg QW|Overall Study||1
5027790|NCT02112994|12373685|P1|Received 1 mg/kg QW|Overall Study||1
5027791|NCT02112994|12373683|P3|Received 1 mg/kg QOW|Overall Study||9
5027792|NCT02112994|12373684|P2|Received 1 mg/kg QOW|Overall Study||16
5027793|NCT02112994|12373685|P1|Received 1 mg/kg QOW|Overall Study||6
5027794|NCT02112994|12373683|P3|Received 0.35 mg/kg QOW|Overall Study||1
5027795|NCT02112994|12373684|P2|Received 0.35 mg/kg QOW|Overall Study||0
5027796|NCT02112994|12373685|P1|Received 0.35 mg/kg QOW|Overall Study||0
5027797|NCT02112994|12373683|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
5027798|NCT02112994|12373684|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
5027799|NCT02112994|12373685|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5027800|NCT02112994|12373683|P3|STARTED|Overall Study||9
5027801|NCT02112994|12373684|P2|STARTED|Overall Study||16
5027802|NCT02112994|12373685|P1|STARTED|Overall Study||6
5027803|NCT02112877|12373703|P2|NOT COMPLETED|Overall Study||13
5027804|NCT02112877|12373704|P1|NOT COMPLETED|Overall Study||2
5027805|NCT02112877|12373703|P2|COMPLETED|Overall Study||157
5027806|NCT02112877|12373704|P1|COMPLETED|Overall Study||28
5027807|NCT02112877|12373703|P2|STARTED|Overall Study||170
5027808|NCT02112877|12373704|P1|STARTED|Overall Study||30
5027809|NCT02112838|12373729|P3|NOT COMPLETED|Overall Study||1
5027810|NCT02112838|12373730|P2|NOT COMPLETED|Overall Study||2
5027811|NCT02112838|12373731|P1|NOT COMPLETED|Overall Study||5
5027812|NCT02112838|12373729|P3|COMPLETED|Overall Study||24
5027813|NCT02112838|12373730|P2|COMPLETED|Overall Study||24
5027814|NCT02112838|12373731|P1|COMPLETED|Overall Study||20
5027815|NCT02112838|12373729|P3|STARTED|Overall Study||25
5027816|NCT02112838|12373730|P2|STARTED|Overall Study||26
5027817|NCT02112838|12373731|P1|STARTED|Overall Study||25
5027818|NCT02112526|12373783|P2|NOT COMPLETED|Overall Study||9
5027819|NCT02112526|12373784|P1|NOT COMPLETED|Overall Study||11
5027820|NCT02112526|12373783|P2|COMPLETED|Overall Study||1
5027821|NCT02112526|12373784|P1|COMPLETED|Overall Study||0
5027822|NCT02112526|12373783|P2|Subjects Continuing Study Medication|Overall Study||1
5027823|NCT02112526|12373784|P1|Subjects Continuing Study Medication|Overall Study||0
5027824|NCT02112526|12373783|P2|Discontinued Study|Overall Study||9
5027825|NCT02112526|12373784|P1|Discontinued Study|Overall Study||11
5027826|NCT02112526|12373783|P2|Received Study Medication|Overall Study||10
5027827|NCT02112526|12373784|P1|Received Study Medication|Overall Study||11
5027828|NCT02112526|12373783|P2|Enrolled|Overall Study||10
5027829|NCT02112526|12373784|P1|Enrolled|Overall Study||11
5027830|NCT02112526|12373783|P2|STARTED|Overall Study||10
5027831|NCT02112526|12373784|P1|STARTED|Overall Study||11
5027832|NCT02112448|12373792|P2|NOT COMPLETED|Overall Study||10
5027833|NCT02112448|12373793|P1|NOT COMPLETED|Overall Study||8
5027834|NCT02112448|12373792|P2|COMPLETED|Overall Study||30
5027835|NCT02112448|12373793|P1|COMPLETED|Overall Study||30
5027836|NCT02112448|12373792|P2|STARTED|Overall Study||40
5027837|NCT02112448|12373793|P1|STARTED|Overall Study||38
5027838|NCT02112370|12373803|P2|NOT COMPLETED|Overall Study||0
5027839|NCT02112370|12373804|P1|NOT COMPLETED|Overall Study||0
5027840|NCT02112370|12373803|P2|COMPLETED|Overall Study||74
5027841|NCT02112370|12373804|P1|COMPLETED|Overall Study||74
5027842|NCT02112370|12373803|P2|STARTED|Overall Study||74
5027843|NCT02112370|12373804|P1|STARTED|Overall Study||74
5027844|NCT02112045|12373826|P2|NOT COMPLETED|Overall Study||0
5027845|NCT02112045|12373827|P1|NOT COMPLETED|Overall Study||1
5027846|NCT02112045|12373826|P2|COMPLETED|Overall Study||45
5027847|NCT02112045|12373827|P1|COMPLETED|Overall Study||44
5027848|NCT02112045|12373826|P2|STARTED|Overall Study||45
5027849|NCT02112045|12373827|P1|STARTED|Overall Study||45
5027850|NCT02111993|12373847|P2|NOT COMPLETED|Overall Study||4
5027851|NCT02111993|12373848|P1|NOT COMPLETED|Overall Study||5
5027852|NCT02111993|12373847|P2|COMPLETED|Overall Study||26
5027853|NCT02111993|12373848|P1|COMPLETED|Overall Study||25
5027854|NCT02111993|12373847|P2|STARTED|Overall Study||30
5027855|NCT02111993|12373848|P1|STARTED|Overall Study||30
5027856|NCT02111980|12373858|P1|NOT COMPLETED|Overall Study||0
5027857|NCT02111980|12373858|P1|COMPLETED|Overall Study||50
5027858|NCT02111980|12373858|P1|STARTED|Overall Study||50
5027859|NCT02111863|12373881|P1|NOT COMPLETED|Overall Study||0
5027860|NCT02111863|12373881|P1|COMPLETED|Overall Study||6
5027861|NCT02111863|12373881|P1|STARTED|Overall Study||6
5027862|NCT02111811|12373889|P2|NOT COMPLETED|Follow up Period (Aim 2)||17
5027863|NCT02111811|12373890|P1|NOT COMPLETED|Follow up Period (Aim 2)||28
5027864|NCT02111811|12373889|P2|COMPLETED|Follow up Period (Aim 2)||97
5027865|NCT02111811|12373890|P1|COMPLETED|Follow up Period (Aim 2)||111
5027866|NCT02111811|12373889|P2|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
5027867|NCT02111811|12373890|P1|STARTED|Follow up Period (Aim 2)||139
5027868|NCT02111811|12373889|P2|NOT COMPLETED|Treatment Phase||18
5027869|NCT02111811|12373890|P1|NOT COMPLETED|Treatment Phase||24
5027870|NCT02111811|12373889|P2|COMPLETED|Treatment Phase||96
5027871|NCT02111811|12373890|P1|COMPLETED|Treatment Phase||115
5027872|NCT02111811|12373889|P2|STARTED|Treatment Phase||114
5027873|NCT02111811|12373890|P1|STARTED|Treatment Phase||139
5027874|NCT02111785|12373903|P4|NOT COMPLETED|Overall Study||0
5027875|NCT02111785|12373904|P3|NOT COMPLETED|Overall Study||0
5027876|NCT02111785|12373905|P2|NOT COMPLETED|Overall Study||1
5027877|NCT02111785|12373906|P1|NOT COMPLETED|Overall Study||0
5027878|NCT02111785|12373903|P4|COMPLETED|Overall Study||1
5027879|NCT02111785|12373904|P3|COMPLETED|Overall Study||1
5027880|NCT02111785|12373905|P2|COMPLETED|Overall Study||4
5027881|NCT02111785|12373906|P1|COMPLETED|Overall Study||3
5027882|NCT02111785|12373903|P4|STARTED|Overall Study||1
5027883|NCT02111785|12373904|P3|STARTED|Overall Study||1
5027884|NCT02111785|12373905|P2|STARTED|Overall Study||5
5027885|NCT02111785|12373906|P1|STARTED|Overall Study||3
5027886|NCT02111772|12373934|P2|NOT COMPLETED|Overall Study||0
5027887|NCT02111772|12373935|P1|NOT COMPLETED|Overall Study||0
5027888|NCT02111772|12373934|P2|COMPLETED|Overall Study||14
5027889|NCT02111772|12373935|P1|COMPLETED|Overall Study||12
5027890|NCT02111772|12373934|P2|STARTED|Overall Study||14
5027891|NCT02111772|12373935|P1|STARTED|Overall Study||12
5027892|NCT02111746|12373945|P2|NOT COMPLETED|Overall Study||2
5027893|NCT02111746|12373946|P1|NOT COMPLETED|Overall Study||3
5027894|NCT02111746|12373945|P2|COMPLETED|Overall Study||169
5027895|NCT02111746|12373946|P1|COMPLETED|Overall Study||169
5027896|NCT02111746|12373945|P2|STARTED|Overall Study||171
5027897|NCT02111746|12373946|P1|STARTED|Overall Study||172
5027898|NCT02111603|12373968|P1|NOT COMPLETED|Overall Study||1
5027899|NCT02111603|12373968|P1|COMPLETED|Overall Study||12
5027900|NCT02111603|12373968|P1|STARTED|Overall Study||13
5027901|NCT02111564|12373979|P2|NOT COMPLETED|Overall Study||143
5027902|NCT02111564|12373980|P1|NOT COMPLETED|Overall Study||131
5027903|NCT02111564|12373979|P2|COMPLETED|Overall Study||5869
5027904|NCT02111564|12373980|P1|COMPLETED|Overall Study||5876
5027905|NCT02111564|12373979|P2|Treated|Overall Study||5980
5027906|NCT02111564|12373980|P1|Treated|Overall Study||5982
5027907|NCT02111564|12373979|P2|STARTED|Overall Study||6012
5027908|NCT02111564|12373980|P1|STARTED|Overall Study||6007
5027909|NCT02111447|12374002|P4|NOT COMPLETED|Overall Study||0
5027910|NCT02111447|12374003|P3|NOT COMPLETED|Overall Study||0
5027911|NCT02111447|12374004|P2|NOT COMPLETED|Overall Study||0
5027912|NCT02111447|12374005|P1|NOT COMPLETED|Overall Study||0
5027913|NCT02111447|12374002|P4|COMPLETED|Overall Study||0
5027914|NCT02111447|12374003|P3|COMPLETED|Overall Study||1
5027915|NCT02111447|12374004|P2|COMPLETED|Overall Study||5
5027916|NCT02111447|12374005|P1|COMPLETED|Overall Study||0
5027917|NCT02111447|12374002|P4|STARTED|Overall Study||0
5027918|NCT02111447|12374003|P3|STARTED|Overall Study||1
5027919|NCT02111447|12374004|P2|STARTED|Overall Study||5
5027920|NCT02111447|12374005|P1|STARTED|Overall Study||0
5027921|NCT02111369|12374019|P1|NOT COMPLETED|Overall Study||3
5027922|NCT02111369|12374019|P1|COMPLETED|Overall Study||15
5027923|NCT02111369|12374019|P1|STARTED|Overall Study||18
5027924|NCT02111252|12374027|P1|NOT COMPLETED|Overall Study||0
5027925|NCT02111252|12374027|P1|COMPLETED|Overall Study||55
5027926|NCT02111252|12374027|P1|STARTED|Overall Study||55
5027927|NCT02111213|12374043|P2|NOT COMPLETED|Overall Study||6
5027928|NCT02111213|12374044|P1|NOT COMPLETED|Overall Study||6
5027929|NCT02111213|12374043|P2|COMPLETED|Overall Study||117
5027930|NCT02111213|12374044|P1|COMPLETED|Overall Study||116
5027931|NCT02111213|12374043|P2|STARTED|Overall Study||123
5027932|NCT02111213|12374044|P1|STARTED|Overall Study||122
5027933|NCT02111200|12374054|P4|NOT COMPLETED|Overall Study||0
5027934|NCT02111200|12374055|P3|NOT COMPLETED|Overall Study||0
5027935|NCT02111200|12374056|P2|NOT COMPLETED|Overall Study||0
5027936|NCT02111200|12374057|P1|NOT COMPLETED|Overall Study||0
5027937|NCT02111200|12374054|P4|COMPLETED|Overall Study||1
5027938|NCT02111200|12374055|P3|COMPLETED|Overall Study||1
5027939|NCT02111200|12374056|P2|COMPLETED|Overall Study||2
5027940|NCT02111200|12374057|P1|COMPLETED|Overall Study||3
5027941|NCT02111200|12374054|P4|STARTED|Overall Study||1
5027942|NCT02111200|12374055|P3|STARTED|Overall Study||1
5027943|NCT02111200|12374056|P2|STARTED|Overall Study||2
5027944|NCT02111200|12374057|P1|STARTED|Overall Study||3
5027945|NCT02111187|12374073|P2|NOT COMPLETED|Overall Study||0
5027946|NCT02111187|12374074|P1|NOT COMPLETED|Overall Study||0
5027947|NCT02111187|12374073|P2|COMPLETED|Overall Study||7
5027948|NCT02111187|12374074|P1|COMPLETED|Overall Study||7
5027949|NCT02111187|12374073|P2|STARTED|Overall Study||7
5027950|NCT02111187|12374074|P1|STARTED|Overall Study||7
5027951|NCT02111174|12374088|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
5027952|NCT02111174|12374089|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
5027953|NCT02111174|12374088|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
5027954|NCT02111174|12374089|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
5027955|NCT02111174|12374088|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
5027956|NCT02111174|12374089|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
5027957|NCT02111174|12374088|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
5027958|NCT02111174|12374089|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
5027959|NCT02111174|12374088|P2|NOT COMPLETED|Treatment and Primary Outcome||2
5027960|NCT02111174|12374089|P1|NOT COMPLETED|Treatment and Primary Outcome||3
5027961|NCT02111174|12374088|P2|COMPLETED|Treatment and Primary Outcome||16
5027962|NCT02111174|12374089|P1|COMPLETED|Treatment and Primary Outcome||15
5027963|NCT02111174|12374088|P2|STARTED|Treatment and Primary Outcome||18
5027964|NCT02111174|12374089|P1|STARTED|Treatment and Primary Outcome||18
5027965|NCT02111096|12374118|P3|NOT COMPLETED|Overall Study||66
5027966|NCT02111096|12374119|P2|NOT COMPLETED|Overall Study||41
5027967|NCT02111096|12374120|P1|NOT COMPLETED|Overall Study||64
5027968|NCT02111096|12374118|P3|COMPLETED|Overall Study||2
5027969|NCT02111096|12374119|P2|COMPLETED|Overall Study||0
5027970|NCT02111096|12374120|P1|COMPLETED|Overall Study||1
5027971|NCT02111096|12374118|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
5027972|NCT02111096|12374119|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
5027973|NCT02111096|12374120|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
5027974|NCT02111096|12374118|P3|STARTED|Overall Study||68
5027975|NCT02111096|12374119|P2|STARTED|Overall Study||41
5027976|NCT02111096|12374120|P1|STARTED|Overall Study||65
5027977|NCT02111083|12374168|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
5027978|NCT02111083|12374169|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
5027979|NCT02111083|12374168|P2|COMPLETED|Fourth Intervention (1 Day)||18
5027980|NCT02111083|12374169|P1|COMPLETED|Fourth Intervention (1 Day)||18
5027981|NCT02111083|12374168|P2|STARTED|Fourth Intervention (1 Day)||18
5027982|NCT02111083|12374169|P1|STARTED|Fourth Intervention (1 Day)||18
5027983|NCT02111083|12374168|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
5027984|NCT02111083|12374169|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
5027985|NCT02111083|12374168|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
5027986|NCT02111083|12374169|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
5027987|NCT02111083|12374168|P2|STARTED|Interval Between Dosing (7-8 Days)||19
5027988|NCT02111083|12374169|P1|STARTED|Interval Between Dosing (7-8 Days)||19
5027989|NCT02111083|12374168|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5027990|NCT02111083|12374169|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5027991|NCT02111083|12374168|P2|COMPLETED|Third Intervention (1 Day)||19
5027992|NCT02111083|12374169|P1|COMPLETED|Third Intervention (1 Day)||19
5027993|NCT02111083|12374168|P2|STARTED|Third Intervention (1 Day)||19
5027994|NCT02111083|12374169|P1|STARTED|Third Intervention (1 Day)||19
5027995|NCT02111083|12374168|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
5027996|NCT02111083|12374169|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
5027997|NCT02111083|12374168|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
5027998|NCT02111083|12374169|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
5027999|NCT02111083|12374168|P2|STARTED|Interval Between Dosing (7-8 Days)||19
5028000|NCT02111083|12374169|P1|STARTED|Interval Between Dosing (7-8 Days)||19
5028001|NCT02111083|12374168|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5028002|NCT02111083|12374169|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5028003|NCT02111083|12374168|P2|COMPLETED|Second Intervention (1 Day)||19
5028004|NCT02111083|12374169|P1|COMPLETED|Second Intervention (1 Day)||19
5028005|NCT02111083|12374168|P2|STARTED|Second Intervention (1 Day)||19
5028006|NCT02111083|12374169|P1|STARTED|Second Intervention (1 Day)||19
5028007|NCT02111083|12374168|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
5028008|NCT02111083|12374169|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
5028009|NCT02111083|12374168|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
5028010|NCT02111083|12374169|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
5028011|NCT02111083|12374168|P2|STARTED|Interval Between Dosing (7-8 Days)||19
5028012|NCT02111083|12374169|P1|STARTED|Interval Between Dosing (7-8 Days)||19
5028013|NCT02111083|12374168|P2|NOT COMPLETED|First Intervention (1 Day)||0
5028014|NCT02111083|12374169|P1|NOT COMPLETED|First Intervention (1 Day)||0
5028015|NCT02111083|12374168|P2|COMPLETED|First Intervention (1 Day)||19
5028016|NCT02111083|12374169|P1|COMPLETED|First Intervention (1 Day)||19
5028017|NCT02111083|12374168|P2|STARTED|First Intervention (1 Day)||19
5028018|NCT02111083|12374169|P1|STARTED|First Intervention (1 Day)||19
5028019|NCT02110901|12374189|P2|NOT COMPLETED|Overall Study||14
5028020|NCT02110901|12374190|P1|NOT COMPLETED|Overall Study||30
5028021|NCT02110901|12374189|P2|COMPLETED|Overall Study||88
5028022|NCT02110901|12374190|P1|COMPLETED|Overall Study||179
5028023|NCT02110901|12374189|P2|STARTED|Overall Study||102
5028024|NCT02110901|12374190|P1|STARTED|Overall Study||209
5028025|NCT02110706|12374204|P2|NOT COMPLETED|Overall Study||4
5028026|NCT02110706|12374205|P1|NOT COMPLETED|Overall Study||5
5028027|NCT02110706|12374204|P2|COMPLETED|Overall Study||23
5028028|NCT02110706|12374205|P1|COMPLETED|Overall Study||20
5028029|NCT02110706|12374204|P2|No. Completing Study Through Week 52|Overall Study||24
5028030|NCT02110706|12374205|P1|No. Completing Study Through Week 52|Overall Study||23
5028031|NCT02110706|12374204|P2|STARTED|Overall Study||27
5028032|NCT02110706|12374205|P1|STARTED|Overall Study||25
5028033|NCT02110693|12374217|P2|NOT COMPLETED|Overall Study||29
5028034|NCT02110693|12374218|P1|NOT COMPLETED|Overall Study||28
5028035|NCT02110693|12374217|P2|COMPLETED|Overall Study||1002
5028036|NCT02110693|12374218|P1|COMPLETED|Overall Study||998
5028037|NCT02110693|12374217|P2|STARTED|Overall Study||1031
5028038|NCT02110693|12374218|P1|STARTED|Overall Study||1026
5028039|NCT02110485|12374245|P2|NOT COMPLETED|Overall Study||19
5028040|NCT02110485|12374246|P1|NOT COMPLETED|Overall Study||7
5028041|NCT02110485|12374245|P2|COMPLETED|Overall Study||83
5028042|NCT02110485|12374246|P1|COMPLETED|Overall Study||91
5028043|NCT02110485|12374245|P2|STARTED|Overall Study||102
5028044|NCT02110485|12374246|P1|STARTED|Overall Study||98
5028045|NCT02110381|12374264|P2|NOT COMPLETED|Dual Modality||1
5028046|NCT02110381|12374265|P1|NOT COMPLETED|Dual Modality||2
5028047|NCT02110381|12374264|P2|COMPLETED|Dual Modality||7
5028048|NCT02110381|12374265|P1|COMPLETED|Dual Modality||5
5028049|NCT02110381|12374264|P2|Began Active Treatment|Dual Modality||7
5028050|NCT02110381|12374265|P1|Began Active Treatment|Dual Modality||7
5028051|NCT02110381|12374264|P2|STARTED|Dual Modality||8
5028052|NCT02110381|12374265|P1|STARTED|Dual Modality||7
5028053|NCT02110381|12374264|P2|NOT COMPLETED|Single Modality||1
5028054|NCT02110381|12374265|P1|NOT COMPLETED|Single Modality||2
5028055|NCT02110381|12374264|P2|COMPLETED|Single Modality||8
5028056|NCT02110381|12374265|P1|COMPLETED|Single Modality||7
5028057|NCT02110381|12374264|P2|STARTED|Single Modality||9
5028058|NCT02110381|12374265|P1|STARTED|Single Modality||9
5028059|NCT02110277|12374276|P1|NOT COMPLETED|Overall Study||2
5028060|NCT02110277|12374276|P1|COMPLETED|Overall Study||0
5028061|NCT02110277|12374276|P1|STARTED|Overall Study||2
5028062|NCT02110264|12374284|P3|NOT COMPLETED|Overall Study||9
5028063|NCT02110264|12374285|P2|NOT COMPLETED|Overall Study||12
5028064|NCT02110264|12374286|P1|NOT COMPLETED|Overall Study||18
5028065|NCT02110264|12374284|P3|COMPLETED|Overall Study||39
5028066|NCT02110264|12374285|P2|COMPLETED|Overall Study||38
5028067|NCT02110264|12374286|P1|COMPLETED|Overall Study||35
5028068|NCT02110264|12374284|P3|STARTED|Overall Study||48
5028069|NCT02110264|12374285|P2|STARTED|Overall Study||50
5028070|NCT02110264|12374286|P1|STARTED|Overall Study||53
5028071|NCT02110238|12374299|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
5028072|NCT02110238|12374300|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
5028073|NCT02110238|12374299|P2|COMPLETED|14 Week Blinded Extension Phase||188
5028074|NCT02110238|12374300|P1|COMPLETED|14 Week Blinded Extension Phase||190
5028075|NCT02110238|12374299|P2|STARTED|14 Week Blinded Extension Phase||200
5028076|NCT02110238|12374300|P1|STARTED|14 Week Blinded Extension Phase||202
5028077|NCT02110238|12374299|P2|NOT COMPLETED|12 Week Pivotal Phase||9
5028078|NCT02110238|12374300|P1|NOT COMPLETED|12 Week Pivotal Phase||10
5028079|NCT02110238|12374299|P2|COMPLETED|12 Week Pivotal Phase||200
5028080|NCT02110238|12374300|P1|COMPLETED|12 Week Pivotal Phase||202
5028081|NCT02110238|12374299|P2|STARTED|12 Week Pivotal Phase||209
5028082|NCT02110238|12374300|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
5028083|NCT02110225|12374309|P3|NOT COMPLETED|Overall Study||0
5028084|NCT02110225|12374310|P2|NOT COMPLETED|Overall Study||1
5028085|NCT02110225|12374311|P1|NOT COMPLETED|Overall Study||0
5028086|NCT02110225|12374309|P3|COMPLETED|Overall Study||10
5028087|NCT02110225|12374310|P2|COMPLETED|Overall Study||19
5028088|NCT02110225|12374311|P1|COMPLETED|Overall Study||20
5028089|NCT02110225|12374309|P3|STARTED|Overall Study||10
5028090|NCT02110225|12374310|P2|STARTED|Overall Study||20
5028091|NCT02110225|12374311|P1|STARTED|Overall Study||20
5028092|NCT02110147|12374363|P1|NOT COMPLETED|Overall Study||0
5028093|NCT02110147|12374363|P1|COMPLETED|Overall Study||4
5028094|NCT02110147|12374363|P1|STARTED|Overall Study||4
5028095|NCT02109939|12374371|P2|NOT COMPLETED|Overall Study||110
5028096|NCT02109939|12374372|P1|NOT COMPLETED|Overall Study||121
5028097|NCT02109939|12374371|P2|COMPLETED|Overall Study||607
5028098|NCT02109939|12374372|P1|COMPLETED|Overall Study||560
5028099|NCT02109939|12374371|P2|STARTED|Overall Study||717
5028100|NCT02109939|12374372|P1|STARTED|Overall Study||681
5028101|NCT02109809|12374395|P1|NOT COMPLETED|Overall Study||3
5028102|NCT02109809|12374395|P1|COMPLETED|Overall Study||1
5028103|NCT02109809|12374395|P1|STARTED|Overall Study||4
5028104|NCT02109731|12374401|P1|NOT COMPLETED|Overall Study||0
5028105|NCT02109731|12374401|P1|COMPLETED|Overall Study||15
5028106|NCT02109731|12374401|P1|STARTED|Overall Study||15
5028107|NCT02109640|12374407|P2|NOT COMPLETED|Overall Study||0
5028108|NCT02109640|12374408|P1|NOT COMPLETED|Overall Study||0
5028109|NCT02109640|12374407|P2|COMPLETED|Overall Study||23
5028110|NCT02109640|12374408|P1|COMPLETED|Overall Study||27
5028111|NCT02109640|12374407|P2|STARTED|Overall Study||23
5028112|NCT02109640|12374408|P1|STARTED|Overall Study||27
5028113|NCT02109562|12374421|P3|NOT COMPLETED|Overall Study||35
5028114|NCT02109562|12374422|P2|NOT COMPLETED|Overall Study||34
5028115|NCT02109562|12374423|P1|NOT COMPLETED|Overall Study||26
5028116|NCT02109562|12374421|P3|COMPLETED|Overall Study||84
5028117|NCT02109562|12374422|P2|COMPLETED|Overall Study||85
5028118|NCT02109562|12374423|P1|COMPLETED|Overall Study||90
5028119|NCT02109562|12374421|P3|Intent to Treat (ITT)|Overall Study||112
5028120|NCT02109562|12374422|P2|Intent to Treat (ITT)|Overall Study||114
5028121|NCT02109562|12374423|P1|Intent to Treat (ITT)|Overall Study||111
5028122|NCT02109562|12374421|P3|Safety|Overall Study||118
5028123|NCT02109562|12374422|P2|Safety|Overall Study||117
5028124|NCT02109562|12374423|P1|Safety|Overall Study||115
5028125|NCT02109562|12374421|P3|STARTED|Overall Study||119
5028126|NCT02109562|12374422|P2|STARTED|Overall Study||119
5028127|NCT02109562|12374423|P1|STARTED|Overall Study||116
5028128|NCT02109497|12374437|P1|NOT COMPLETED|Overall Study||1
5028129|NCT02109497|12374437|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
5028130|NCT02109497|12374437|P1|STARTED|Overall Study||18
5028131|NCT02109484|12374450|P8|NOT COMPLETED|Overall Study||3
5028132|NCT02109484|12374451|P7|NOT COMPLETED|Overall Study||3
5028133|NCT02109484|12374452|P6|NOT COMPLETED|Overall Study||1
5028134|NCT02109484|12374453|P5|NOT COMPLETED|Overall Study||4
5028135|NCT02109484|12374454|P4|NOT COMPLETED|Overall Study||1
5028136|NCT02109484|12374455|P3|NOT COMPLETED|Overall Study||0
5028137|NCT02109484|12374456|P2|NOT COMPLETED|Overall Study||0
5028138|NCT02109484|12374457|P1|NOT COMPLETED|Overall Study||0
5028139|NCT02109484|12374450|P8|COMPLETED|Overall Study||47
5028140|NCT02109484|12374451|P7|COMPLETED|Overall Study||47
5028141|NCT02109484|12374452|P6|COMPLETED|Overall Study||11
5028142|NCT02109484|12374453|P5|COMPLETED|Overall Study||46
5028143|NCT02109484|12374454|P4|COMPLETED|Overall Study||11
5028144|NCT02109484|12374455|P3|COMPLETED|Overall Study||12
5028145|NCT02109484|12374456|P2|COMPLETED|Overall Study||13
5028146|NCT02109484|12374457|P1|COMPLETED|Overall Study||5
5028147|NCT02109484|12374450|P8|STARTED|Overall Study||50
5028148|NCT02109484|12374451|P7|STARTED|Overall Study||50
5028149|NCT02109484|12374452|P6|STARTED|Overall Study||12
5028150|NCT02109484|12374453|P5|STARTED|Overall Study||50
5028151|NCT02109484|12374454|P4|STARTED|Overall Study||12
5028152|NCT02109484|12374455|P3|STARTED|Overall Study||12
5028153|NCT02109484|12374456|P2|STARTED|Overall Study||13
5028154|NCT02109484|12374457|P1|STARTED|Overall Study||5
5028155|NCT02109458|12374506|P1|NOT COMPLETED|Overall Study||0
5028156|NCT02109458|12374506|P1|COMPLETED|Overall Study||24
5028157|NCT02109458|12374506|P1|STARTED|Overall Study||24
5028158|NCT02109445|12374513|P1|NOT COMPLETED|Overall Study||3
5028159|NCT02109445|12374513|P1|COMPLETED|Overall Study||0
5028160|NCT02109445|12374513|P1|STARTED|Overall Study||3
5028161|NCT02109432|12374546|P1|NOT COMPLETED|Overall Study||1
5028162|NCT02109432|12374546|P1|COMPLETED|Overall Study||6
5028163|NCT02109432|12374546|P1|STARTED|Overall Study||7
5028164|NCT02109419|12374550|P1|NOT COMPLETED|Overall Study||0
5028165|NCT02109419|12374550|P1|COMPLETED|Overall Study||57
5028166|NCT02109419|12374550|P1|STARTED|Overall Study||57
5028167|NCT02109172|12374556|P6|NOT COMPLETED|Overall Study||1
5028168|NCT02109172|12374557|P5|NOT COMPLETED|Overall Study||1
5028169|NCT02109172|12374558|P4|NOT COMPLETED|Overall Study||1
5028170|NCT02109172|12374559|P3|NOT COMPLETED|Overall Study||1
5028171|NCT02109172|12374560|P2|NOT COMPLETED|Overall Study||0
5028172|NCT02109172|12374561|P1|NOT COMPLETED|Overall Study||1
5028173|NCT02109172|12374556|P6|COMPLETED|Overall Study||10
5028174|NCT02109172|12374557|P5|COMPLETED|Overall Study||9
5028175|NCT02109172|12374558|P4|COMPLETED|Overall Study||10
5028176|NCT02109172|12374559|P3|COMPLETED|Overall Study||9
5028177|NCT02109172|12374560|P2|COMPLETED|Overall Study||11
5028178|NCT02109172|12374561|P1|COMPLETED|Overall Study||10
5028179|NCT02109172|12374556|P6|STARTED|Overall Study||11
5028180|NCT02109172|12374557|P5|STARTED|Overall Study||10
5028181|NCT02109172|12374558|P4|STARTED|Overall Study||11
5028182|NCT02109172|12374559|P3|STARTED|Overall Study||10
5028183|NCT02109172|12374560|P2|STARTED|Overall Study||11
5028184|NCT02109172|12374561|P1|STARTED|Overall Study||11
5028185|NCT02109159|12374571|P2|NOT COMPLETED|Overall Study||0
5028186|NCT02109159|12374572|P1|NOT COMPLETED|Overall Study||0
5028187|NCT02109159|12374571|P2|COMPLETED|Overall Study||4175
5028188|NCT02109159|12374572|P1|COMPLETED|Overall Study||4178
5028189|NCT02109159|12374571|P2|STARTED|Overall Study||4175
5028190|NCT02109159|12374572|P1|STARTED|Overall Study||4178
5028191|NCT02109133|12374582|P2|NOT COMPLETED|Overall Study||0
5028192|NCT02109133|12374583|P1|NOT COMPLETED|Overall Study||1
5028193|NCT02109133|12374582|P2|COMPLETED|Overall Study||34
5028194|NCT02109133|12374583|P1|COMPLETED|Overall Study||32
5028195|NCT02109133|12374582|P2|STARTED|Overall Study||34
5028196|NCT02109133|12374583|P1|STARTED|Overall Study||33
5028197|NCT02109107|12374595|P1|NOT COMPLETED|Overall Study||2
5028198|NCT02109107|12374595|P1|COMPLETED|Overall Study||52
5028199|NCT02109107|12374595|P1|STARTED|Overall Study||54
5028200|NCT02109042|12374602|P1|NOT COMPLETED|Overall Study||15
5028201|NCT02109042|12374602|P1|COMPLETED|Overall Study||0
5028202|NCT02109042|12374602|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
5028203|NCT02109042|12374602|P1|Received 180 mg Loading Dose|Overall Study||15
5028204|NCT02109042|12374602|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
5028205|NCT02109042|12374602|P1|STARTED|Overall Study||15
5028206|NCT02109029|12374611|P6|NOT COMPLETED|Part B||1
5028207|NCT02109029|12374612|P5|NOT COMPLETED|Part B||1
5028208|NCT02109029|12374613|P4|NOT COMPLETED|Part B||0
5028209|NCT02109029|12374614|P3|NOT COMPLETED|Part B||0
5028210|NCT02109029|12374615|P2|NOT COMPLETED|Part B||0
5028211|NCT02109029|12374616|P1|NOT COMPLETED|Part B||0
5028212|NCT02109029|12374611|P6|COMPLETED|Part B||5
5028213|NCT02109029|12374612|P5|COMPLETED|Part B||5
5028214|NCT02109029|12374613|P4|COMPLETED|Part B||0
5028215|NCT02109029|12374614|P3|COMPLETED|Part B||0
5028216|NCT02109029|12374615|P2|COMPLETED|Part B||0
5028217|NCT02109029|12374616|P1|COMPLETED|Part B||0
5028218|NCT02109029|12374611|P6|Received at Least One Dose of Study Drug|Part B||6
5028219|NCT02109029|12374612|P5|Received at Least One Dose of Study Drug|Part B||6
5028220|NCT02109029|12374613|P4|Received at Least One Dose of Study Drug|Part B||0
5028221|NCT02109029|12374614|P3|Received at Least One Dose of Study Drug|Part B||0
5028222|NCT02109029|12374615|P2|Received at Least One Dose of Study Drug|Part B||0
5028223|NCT02109029|12374616|P1|Received at Least One Dose of Study Drug|Part B||0
5028224|NCT02109029|12374611|P6|STARTED|Part B|New participants entered Part B.|6
5028225|NCT02109029|12374612|P5|STARTED|Part B|New participants entered Part B.|6
5028226|NCT02109029|12374613|P4|STARTED|Part B||0
5028227|NCT02109029|12374614|P3|STARTED|Part B||0
5028228|NCT02109029|12374615|P2|STARTED|Part B||0
5028229|NCT02109029|12374616|P1|STARTED|Part B||0
5028230|NCT02109029|12374611|P6|NOT COMPLETED|Part A||0
5028231|NCT02109029|12374612|P5|NOT COMPLETED|Part A||0
5028232|NCT02109029|12374613|P4|NOT COMPLETED|Part A||0
5028233|NCT02109029|12374614|P3|NOT COMPLETED|Part A||0
5028234|NCT02109029|12374615|P2|NOT COMPLETED|Part A||0
5028235|NCT02109029|12374616|P1|NOT COMPLETED|Part A||0
5028236|NCT02109029|12374611|P6|COMPLETED|Part A||0
5028237|NCT02109029|12374612|P5|COMPLETED|Part A||0
5028238|NCT02109029|12374613|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
5028239|NCT02109029|12374614|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
5028240|NCT02109029|12374615|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
5028241|NCT02109029|12374616|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
5028242|NCT02109029|12374611|P6|Received One Dose of Study Drug|Part A||0
5028243|NCT02109029|12374612|P5|Received One Dose of Study Drug|Part A||0
5028244|NCT02109029|12374613|P4|Received One Dose of Study Drug|Part A||4
5028245|NCT02109029|12374614|P3|Received One Dose of Study Drug|Part A||4
5028246|NCT02109029|12374615|P2|Received One Dose of Study Drug|Part A||2
5028247|NCT02109029|12374616|P1|Received One Dose of Study Drug|Part A||2
5028248|NCT02109029|12374611|P6|STARTED|Part A||0
5028249|NCT02109029|12374612|P5|STARTED|Part A||0
5028250|NCT02109029|12374613|P4|STARTED|Part A||4
5028251|NCT02109029|12374614|P3|STARTED|Part A||4
5028252|NCT02109029|12374615|P2|STARTED|Part A||2
5028253|NCT02109029|12374616|P1|STARTED|Part A||2
5028254|NCT02108977|12374630|P2|NOT COMPLETED|Overall Study||1
5028255|NCT02108977|12374631|P1|NOT COMPLETED|Overall Study||10
5028256|NCT02108977|12374630|P2|COMPLETED|Overall Study||19
5028257|NCT02108977|12374631|P1|COMPLETED|Overall Study||8
5028258|NCT02108977|12374630|P2|STARTED|Overall Study||20
5028259|NCT02108977|12374631|P1|STARTED|Overall Study||18
5028260|NCT02108951|12374645|P1|NOT COMPLETED|Overall Study||16
5028261|NCT02108951|12374645|P1|COMPLETED|Overall Study||4
5028262|NCT02108951|12374645|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
5028263|NCT02108912|12374664|P2|NOT COMPLETED|Overall Study||1
5028264|NCT02108912|12374665|P1|NOT COMPLETED|Overall Study||3
5028265|NCT02108912|12374664|P2|COMPLETED|Overall Study||6
5028266|NCT02108912|12374665|P1|COMPLETED|Overall Study||6
5028267|NCT02108912|12374664|P2|STARTED|Overall Study||7
5028268|NCT02108912|12374665|P1|STARTED|Overall Study||9
5028269|NCT02108691|12374675|P2|NOT COMPLETED|Overall Study||9
5028270|NCT02108691|12374676|P1|NOT COMPLETED|Overall Study||8
5028271|NCT02108691|12374675|P2|COMPLETED|Overall Study||31
5028272|NCT02108691|12374676|P1|COMPLETED|Overall Study||32
5028273|NCT02108691|12374675|P2|STARTED|Overall Study||40
5028274|NCT02108691|12374676|P1|STARTED|Overall Study||40
5028275|NCT02108652|12374694|P1|NOT COMPLETED|Overall Study||310
5028276|NCT02108652|12374694|P1|COMPLETED|Overall Study||0
5028277|NCT02108652|12374694|P1|STARTED|Overall Study||310
5028278|NCT02108457|12374717|P2|NOT COMPLETED|Overall Study||2
5028279|NCT02108457|12374718|P1|NOT COMPLETED|Overall Study||0
5028280|NCT02108457|12374717|P2|COMPLETED|Overall Study||10
5028281|NCT02108457|12374718|P1|COMPLETED|Overall Study||3
5028282|NCT02108457|12374717|P2|STARTED|Overall Study||12
5028283|NCT02108457|12374718|P1|STARTED|Overall Study||3
5028284|NCT02108288|12374727|P3|NOT COMPLETED|Overall Study||0
5028285|NCT02108288|12374728|P2|NOT COMPLETED|Overall Study||0
5028286|NCT02108288|12374729|P1|NOT COMPLETED|Overall Study||0
5028287|NCT02108288|12374727|P3|COMPLETED|Overall Study||10
5028288|NCT02108288|12374728|P2|COMPLETED|Overall Study||10
5028289|NCT02108288|12374729|P1|COMPLETED|Overall Study||10
5028290|NCT02108288|12374727|P3|STARTED|Overall Study||10
5028291|NCT02108288|12374728|P2|STARTED|Overall Study||10
5028292|NCT02108288|12374729|P1|STARTED|Overall Study||10
5028293|NCT02108223|12374745|P3|NOT COMPLETED|Overall Study||0
5028294|NCT02108223|12374746|P2|NOT COMPLETED|Overall Study||0
5028295|NCT02108223|12374747|P1|NOT COMPLETED|Overall Study||0
5028296|NCT02108223|12374745|P3|COMPLETED|Overall Study||35
5028297|NCT02108223|12374746|P2|COMPLETED|Overall Study||50
5028298|NCT02108223|12374747|P1|COMPLETED|Overall Study||52
5028299|NCT02108223|12374745|P3|STARTED|Overall Study||35
5028300|NCT02108223|12374746|P2|STARTED|Overall Study||50
5028301|NCT02108223|12374747|P1|STARTED|Overall Study||52
5028302|NCT02108171|12374769|P2|NOT COMPLETED|Overall Study||0
5028303|NCT02108171|12374770|P1|NOT COMPLETED|Overall Study||0
5028304|NCT02108171|12374769|P2|COMPLETED|Overall Study||41
5028305|NCT02108171|12374770|P1|COMPLETED|Overall Study||40
5028306|NCT02108171|12374769|P2|STARTED|Overall Study||41
5028307|NCT02108171|12374770|P1|STARTED|Overall Study||40
5028308|NCT02107898|12374872|P2|NOT COMPLETED|Overall Study||12
5028309|NCT02107898|12374873|P1|NOT COMPLETED|Overall Study||6
5028310|NCT02107898|12374872|P2|COMPLETED|Overall Study||132
5028311|NCT02107898|12374873|P1|COMPLETED|Overall Study||66
5028312|NCT02107898|12374872|P2|Treated|Overall Study||143
5028313|NCT02107898|12374873|P1|Treated|Overall Study||72
5028314|NCT02107898|12374872|P2|STARTED|Overall Study|Randomized|144
5028315|NCT02107898|12374873|P1|STARTED|Overall Study|Randomized|72
5028316|NCT02107859|12374925|P1|NOT COMPLETED|Overall Study||61
5028317|NCT02107859|12374925|P1|COMPLETED|Overall Study||0
5028318|NCT02107859|12374925|P1|Intent-to-treat (ITT) Population|Overall Study||60
5028319|NCT02107859|12374925|P1|As-treated Population|Overall Study||61
5028320|NCT02107859|12374925|P1|STARTED|Overall Study||61
5028321|NCT02107703|12374941|P2|NOT COMPLETED|Overall Study||175
5028322|NCT02107703|12374942|P1|NOT COMPLETED|Overall Study||361
5028323|NCT02107703|12374941|P2|COMPLETED|Overall Study||48
5028324|NCT02107703|12374942|P1|COMPLETED|Overall Study||85
5028325|NCT02107703|12374941|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
5028326|NCT02107703|12374942|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
5028327|NCT02107703|12374941|P2|STARTED|Overall Study||223
5028328|NCT02107703|12374942|P1|STARTED|Overall Study||446
5028329|NCT02107599|12374967|P1|NOT COMPLETED|Overall Study||0
5028330|NCT02107599|12374967|P1|COMPLETED|Overall Study||96
5028331|NCT02107599|12374967|P1|STARTED|Overall Study||96
5028332|NCT02107482|12374974|P1|NOT COMPLETED|Overall Study||4
5028333|NCT02107482|12374974|P1|COMPLETED|Overall Study||17
5028334|NCT02107482|12374974|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
5028335|NCT02107443|12374982|P2|NOT COMPLETED|Overall Study||83
5028336|NCT02107443|12374983|P1|NOT COMPLETED|Overall Study||98
5028337|NCT02107443|12374982|P2|COMPLETED|Overall Study||167
5028338|NCT02107443|12374983|P1|COMPLETED|Overall Study||198
5028339|NCT02107443|12374982|P2|STARTED|Overall Study||250
5028340|NCT02107443|12374983|P1|STARTED|Overall Study||296
5028341|NCT02107339|12374993|P2|NOT COMPLETED|Overall Study||4
5028342|NCT02107339|12374994|P1|NOT COMPLETED|Overall Study||1
5028343|NCT02107339|12374993|P2|COMPLETED|Overall Study||53
5028344|NCT02107339|12374994|P1|COMPLETED|Overall Study||62
5028345|NCT02107339|12374993|P2|STARTED|Overall Study||57
5028346|NCT02107339|12374994|P1|STARTED|Overall Study||63
5028347|NCT02107313|12375030|P2|NOT COMPLETED|Overall Study||1
5028348|NCT02107313|12375031|P1|NOT COMPLETED|Overall Study||0
5028349|NCT02107313|12375030|P2|COMPLETED|Overall Study||8
5028350|NCT02107313|12375031|P1|COMPLETED|Overall Study||9
5028351|NCT02107313|12375030|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
5028352|NCT02107313|12375031|P1|STARTED|Overall Study||9
5028353|NCT02107300|12375041|P2|NOT COMPLETED|Overall Study||0
5028354|NCT02107300|12375042|P1|NOT COMPLETED|Overall Study||0
5028355|NCT02107300|12375041|P2|COMPLETED|Overall Study||15
5028356|NCT02107300|12375042|P1|COMPLETED|Overall Study||16
5028357|NCT02107300|12375041|P2|STARTED|Overall Study||15
5028358|NCT02107300|12375042|P1|STARTED|Overall Study||16
5028359|NCT02107274|12375052|P2|NOT COMPLETED|Control Phase||2
5028360|NCT02107274|12375053|P1|NOT COMPLETED|Control Phase||3
5028361|NCT02107274|12375052|P2|COMPLETED|Control Phase||35
5028362|NCT02107274|12375053|P1|COMPLETED|Control Phase||33
5028363|NCT02107274|12375052|P2|STARTED|Control Phase||37
5028364|NCT02107274|12375053|P1|STARTED|Control Phase||36
5028365|NCT02107274|12375052|P2|NOT COMPLETED|Treatment vs. Placebo||2
5028366|NCT02107274|12375053|P1|NOT COMPLETED|Treatment vs. Placebo||3
5028367|NCT02107274|12375052|P2|COMPLETED|Treatment vs. Placebo||37
5028368|NCT02107274|12375053|P1|COMPLETED|Treatment vs. Placebo||36
5028369|NCT02107274|12375052|P2|STARTED|Treatment vs. Placebo||39
5028370|NCT02107274|12375053|P1|STARTED|Treatment vs. Placebo||39
5028371|NCT02107196|12375067|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
5028372|NCT02107196|12375068|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
5028373|NCT02107196|12375067|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
5028374|NCT02107196|12375068|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
5028375|NCT02107196|12375067|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
5028376|NCT02107196|12375068|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
5028377|NCT02107196|12375067|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
5028378|NCT02107196|12375068|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
5028379|NCT02107196|12375067|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
5028380|NCT02107196|12375068|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
5028381|NCT02107196|12375067|P2|NOT COMPLETED|12-week Treatment Period||39
5028382|NCT02107196|12375068|P1|NOT COMPLETED|12-week Treatment Period||44
5028383|NCT02107196|12375067|P2|COMPLETED|12-week Treatment Period||225
5028384|NCT02107196|12375068|P1|COMPLETED|12-week Treatment Period||227
5028385|NCT02107196|12375067|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
5028386|NCT02107196|12375068|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
5028387|NCT02107196|12375067|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
5028388|NCT02107196|12375068|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
5028389|NCT02107196|12375067|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
5028390|NCT02107196|12375068|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
5028391|NCT02107131|12375083|P2|NOT COMPLETED|Overall Study||9
5028392|NCT02107131|12375084|P1|NOT COMPLETED|Overall Study||8
5028393|NCT02107131|12375083|P2|COMPLETED|Overall Study||11
5028394|NCT02107131|12375084|P1|COMPLETED|Overall Study||12
5028395|NCT02107131|12375083|P2|STARTED|Overall Study||20
5028396|NCT02107131|12375084|P1|STARTED|Overall Study||20
5028397|NCT02107092|12375096|P1|NOT COMPLETED|Overall Study||44
5028398|NCT02107092|12375096|P1|COMPLETED|Overall Study||79
5028399|NCT02107092|12375096|P1|STARTED|Overall Study||123
5028400|NCT02107014|12375101|P1|NOT COMPLETED|Overall Study||1
5028401|NCT02107014|12375101|P1|COMPLETED|Overall Study||8
5028402|NCT02107014|12375101|P1|STARTED|Overall Study||9
5028403|NCT02106975|12375171|P2|NOT COMPLETED|Overall Study||39
5028404|NCT02106975|12375172|P1|NOT COMPLETED|Overall Study||25
5028405|NCT02106975|12375171|P2|COMPLETED|Overall Study||44
5028406|NCT02106975|12375172|P1|COMPLETED|Overall Study||59
5028407|NCT02106975|12375171|P2|STARTED|Overall Study||83
5028408|NCT02106975|12375172|P1|STARTED|Overall Study||84
5028409|NCT02106962|12375220|P2|NOT COMPLETED|Overall Study||0
5028410|NCT02106962|12375221|P1|NOT COMPLETED|Overall Study||0
5028411|NCT02106962|12375220|P2|COMPLETED|Overall Study||9
5028412|NCT02106962|12375221|P1|COMPLETED|Overall Study||8
5028413|NCT02106962|12375220|P2|STARTED|Overall Study||9
5028414|NCT02106962|12375221|P1|STARTED|Overall Study||8
5028415|NCT02106923|12375232|P6|NOT COMPLETED|Overall Study||1
5028416|NCT02106923|12375233|P5|NOT COMPLETED|Overall Study||0
5028417|NCT02106923|12375234|P4|NOT COMPLETED|Overall Study||0
5028418|NCT02106923|12375235|P3|NOT COMPLETED|Overall Study||0
5028419|NCT02106923|12375236|P2|NOT COMPLETED|Overall Study||0
5028420|NCT02106923|12375237|P1|NOT COMPLETED|Overall Study||0
5028421|NCT02106923|12375232|P6|COMPLETED|Overall Study||11
5028422|NCT02106923|12375233|P5|COMPLETED|Overall Study||12
5028423|NCT02106923|12375234|P4|COMPLETED|Overall Study||12
5028424|NCT02106923|12375235|P3|COMPLETED|Overall Study||12
5028425|NCT02106923|12375236|P2|COMPLETED|Overall Study||12
5028426|NCT02106923|12375237|P1|COMPLETED|Overall Study||12
5028427|NCT02106923|12375232|P6|STARTED|Overall Study||12
5028428|NCT02106923|12375233|P5|STARTED|Overall Study||12
5028429|NCT02106923|12375234|P4|STARTED|Overall Study||12
5028430|NCT02106923|12375235|P3|STARTED|Overall Study||12
5028431|NCT02106923|12375236|P2|STARTED|Overall Study||12
5028432|NCT02106923|12375237|P1|STARTED|Overall Study||12
5028433|NCT02106884|12375283|P2|NOT COMPLETED|Overall Study||1
5028434|NCT02106884|12375284|P1|NOT COMPLETED|Overall Study||0
5028435|NCT02106884|12375283|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
5028436|NCT02106884|12375284|P1|COMPLETED|Overall Study||72
5028437|NCT02106884|12375283|P2|STARTED|Overall Study||74
5028438|NCT02106884|12375284|P1|STARTED|Overall Study||72
5028439|NCT02106832|12375308|P4|NOT COMPLETED|Overall Study||15
5028440|NCT02106832|12375309|P3|NOT COMPLETED|Overall Study||16
5028441|NCT02106832|12375310|P2|NOT COMPLETED|Overall Study||25
5028442|NCT02106832|12375311|P1|NOT COMPLETED|Overall Study||23
5028443|NCT02106832|12375308|P4|COMPLETED|Overall Study||73
5028444|NCT02106832|12375309|P3|COMPLETED|Overall Study||70
5028445|NCT02106832|12375310|P2|COMPLETED|Overall Study||151
5028446|NCT02106832|12375311|P1|COMPLETED|Overall Study||148
5028447|NCT02106832|12375308|P4|Participants Received Treatment|Overall Study||88
5028448|NCT02106832|12375309|P3|Participants Received Treatment|Overall Study||86
5028449|NCT02106832|12375310|P2|Participants Received Treatment|Overall Study||174
5028450|NCT02106832|12375311|P1|Participants Received Treatment|Overall Study||171
5028451|NCT02106832|12375308|P4|STARTED|Overall Study||88
5028452|NCT02106832|12375309|P3|STARTED|Overall Study||86
5028453|NCT02106832|12375310|P2|STARTED|Overall Study||176
5028454|NCT02106832|12375311|P1|STARTED|Overall Study||171
5028455|NCT02106728|12375346|P2|NOT COMPLETED|Overall Study||0
5028456|NCT02106728|12375347|P1|NOT COMPLETED|Overall Study||0
5028457|NCT02106728|12375346|P2|COMPLETED|Overall Study||47
5028458|NCT02106728|12375347|P1|COMPLETED|Overall Study||70
5028459|NCT02106728|12375346|P2|STARTED|Overall Study||47
5028460|NCT02106728|12375347|P1|STARTED|Overall Study||70
5028461|NCT02106494|12375363|P2|NOT COMPLETED|Overall Study||25
5028462|NCT02106494|12375364|P1|NOT COMPLETED|Overall Study||26
5028463|NCT02106494|12375363|P2|COMPLETED|Overall Study||446
5028464|NCT02106494|12375364|P1|COMPLETED|Overall Study||445
5028465|NCT02106494|12375363|P2|Efficacy Population|Overall Study||452
5028466|NCT02106494|12375364|P1|Efficacy Population|Overall Study||450
5028467|NCT02106494|12375363|P2|Safety Population|Overall Study||459
5028468|NCT02106494|12375364|P1|Safety Population|Overall Study||456
5028469|NCT02106494|12375363|P2|STARTED|Overall Study||471
5028470|NCT02106494|12375364|P1|STARTED|Overall Study||471
5028471|NCT02106455|12375378|P1|NOT COMPLETED|Overall Study||8
5028472|NCT02106455|12375378|P1|COMPLETED|Overall Study||307
5028473|NCT02106455|12375378|P1|STARTED|Overall Study||315
5028474|NCT02106442|12375392|P1|NOT COMPLETED|Overall Study||37
5028475|NCT02106442|12375392|P1|COMPLETED|Overall Study||542
5028476|NCT02106442|12375392|P1|STARTED|Overall Study||579
5028477|NCT02106403|12375410|P6|NOT COMPLETED|Follow-Up Visit 3||1
5028478|NCT02106403|12375411|P5|NOT COMPLETED|Follow-Up Visit 3||0
5028479|NCT02106403|12375412|P4|NOT COMPLETED|Follow-Up Visit 3||0
5028480|NCT02106403|12375413|P3|NOT COMPLETED|Follow-Up Visit 3||0
5028481|NCT02106403|12375414|P2|NOT COMPLETED|Follow-Up Visit 3||0
5028482|NCT02106403|12375415|P1|NOT COMPLETED|Follow-Up Visit 3||0
5028483|NCT02106403|12375410|P6|COMPLETED|Follow-Up Visit 3||8
5028484|NCT02106403|12375411|P5|COMPLETED|Follow-Up Visit 3||8
5028485|NCT02106403|12375412|P4|COMPLETED|Follow-Up Visit 3||8
5028486|NCT02106403|12375413|P3|COMPLETED|Follow-Up Visit 3||9
5028487|NCT02106403|12375414|P2|COMPLETED|Follow-Up Visit 3||8
5028488|NCT02106403|12375415|P1|COMPLETED|Follow-Up Visit 3||8
5028489|NCT02106403|12375410|P6|STARTED|Follow-Up Visit 3||9
5028490|NCT02106403|12375411|P5|STARTED|Follow-Up Visit 3||8
5028491|NCT02106403|12375412|P4|STARTED|Follow-Up Visit 3||8
5028492|NCT02106403|12375413|P3|STARTED|Follow-Up Visit 3||9
5028493|NCT02106403|12375414|P2|STARTED|Follow-Up Visit 3||8
5028494|NCT02106403|12375415|P1|STARTED|Follow-Up Visit 3||8
5028495|NCT02106403|12375410|P6|NOT COMPLETED|Follow-Up Visit 2||0
5028496|NCT02106403|12375411|P5|NOT COMPLETED|Follow-Up Visit 2||0
5028497|NCT02106403|12375412|P4|NOT COMPLETED|Follow-Up Visit 2||0
5028498|NCT02106403|12375413|P3|NOT COMPLETED|Follow-Up Visit 2||0
5028499|NCT02106403|12375414|P2|NOT COMPLETED|Follow-Up Visit 2||0
5028500|NCT02106403|12375415|P1|NOT COMPLETED|Follow-Up Visit 2||0
5028501|NCT02106403|12375410|P6|COMPLETED|Follow-Up Visit 2||9
5028502|NCT02106403|12375411|P5|COMPLETED|Follow-Up Visit 2||8
5028503|NCT02106403|12375412|P4|COMPLETED|Follow-Up Visit 2||8
5028504|NCT02106403|12375413|P3|COMPLETED|Follow-Up Visit 2||9
5028505|NCT02106403|12375414|P2|COMPLETED|Follow-Up Visit 2||8
5028506|NCT02106403|12375415|P1|COMPLETED|Follow-Up Visit 2||8
5028507|NCT02106403|12375410|P6|STARTED|Follow-Up Visit 2||9
5028508|NCT02106403|12375411|P5|STARTED|Follow-Up Visit 2||8
5028509|NCT02106403|12375412|P4|STARTED|Follow-Up Visit 2||8
5028510|NCT02106403|12375413|P3|STARTED|Follow-Up Visit 2||9
5028511|NCT02106403|12375414|P2|STARTED|Follow-Up Visit 2||8
5028512|NCT02106403|12375415|P1|STARTED|Follow-Up Visit 2||8
5028513|NCT02106403|12375410|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028514|NCT02106403|12375411|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028515|NCT02106403|12375412|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028516|NCT02106403|12375413|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028517|NCT02106403|12375414|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028518|NCT02106403|12375415|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
5028519|NCT02106403|12375410|P6|COMPLETED|Visit 1, Treatment Period 3||9
5028520|NCT02106403|12375411|P5|COMPLETED|Visit 1, Treatment Period 3||8
5028521|NCT02106403|12375412|P4|COMPLETED|Visit 1, Treatment Period 3||8
5028522|NCT02106403|12375413|P3|COMPLETED|Visit 1, Treatment Period 3||9
5028523|NCT02106403|12375414|P2|COMPLETED|Visit 1, Treatment Period 3||8
5028524|NCT02106403|12375415|P1|COMPLETED|Visit 1, Treatment Period 3||8
5028525|NCT02106403|12375410|P6|STARTED|Visit 1, Treatment Period 3||9
5028526|NCT02106403|12375411|P5|STARTED|Visit 1, Treatment Period 3||8
5028527|NCT02106403|12375412|P4|STARTED|Visit 1, Treatment Period 3||8
5028528|NCT02106403|12375413|P3|STARTED|Visit 1, Treatment Period 3||9
5028529|NCT02106403|12375414|P2|STARTED|Visit 1, Treatment Period 3||8
5028530|NCT02106403|12375415|P1|STARTED|Visit 1, Treatment Period 3||8
5028531|NCT02106403|12375410|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028532|NCT02106403|12375411|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028533|NCT02106403|12375412|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028534|NCT02106403|12375413|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028535|NCT02106403|12375414|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028536|NCT02106403|12375415|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
5028537|NCT02106403|12375410|P6|COMPLETED|Visit 1, Treatment Period 2||9
5028538|NCT02106403|12375411|P5|COMPLETED|Visit 1, Treatment Period 2||8
5028539|NCT02106403|12375412|P4|COMPLETED|Visit 1, Treatment Period 2||8
5028540|NCT02106403|12375413|P3|COMPLETED|Visit 1, Treatment Period 2||9
5028541|NCT02106403|12375414|P2|COMPLETED|Visit 1, Treatment Period 2||8
5028542|NCT02106403|12375415|P1|COMPLETED|Visit 1, Treatment Period 2||8
5028543|NCT02106403|12375410|P6|STARTED|Visit 1, Treatment Period 2||9
5028544|NCT02106403|12375411|P5|STARTED|Visit 1, Treatment Period 2||8
5028545|NCT02106403|12375412|P4|STARTED|Visit 1, Treatment Period 2||8
5028546|NCT02106403|12375413|P3|STARTED|Visit 1, Treatment Period 2||9
5028547|NCT02106403|12375414|P2|STARTED|Visit 1, Treatment Period 2||8
5028548|NCT02106403|12375415|P1|STARTED|Visit 1, Treatment Period 2||8
5028549|NCT02106403|12375410|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028550|NCT02106403|12375411|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028551|NCT02106403|12375412|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028552|NCT02106403|12375413|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028553|NCT02106403|12375414|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028554|NCT02106403|12375415|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
5028555|NCT02106403|12375410|P6|COMPLETED|Visit 1, Treatment Period 1||9
5028556|NCT02106403|12375411|P5|COMPLETED|Visit 1, Treatment Period 1||8
5028557|NCT02106403|12375412|P4|COMPLETED|Visit 1, Treatment Period 1||8
5028558|NCT02106403|12375413|P3|COMPLETED|Visit 1, Treatment Period 1||9
5028559|NCT02106403|12375414|P2|COMPLETED|Visit 1, Treatment Period 1||8
5028560|NCT02106403|12375415|P1|COMPLETED|Visit 1, Treatment Period 1||8
5028561|NCT02106403|12375410|P6|STARTED|Visit 1, Treatment Period 1||9
5028562|NCT02106403|12375411|P5|STARTED|Visit 1, Treatment Period 1||8
5028563|NCT02106403|12375412|P4|STARTED|Visit 1, Treatment Period 1||8
5028564|NCT02106403|12375413|P3|STARTED|Visit 1, Treatment Period 1||9
5028565|NCT02106403|12375414|P2|STARTED|Visit 1, Treatment Period 1||8
5028566|NCT02106403|12375415|P1|STARTED|Visit 1, Treatment Period 1||8
5028567|NCT02106390|12375438|P3|NOT COMPLETED|Overall Study||43
5028568|NCT02106390|12375439|P2|NOT COMPLETED|Overall Study||48
5028569|NCT02106390|12375440|P1|NOT COMPLETED|Overall Study||49
5028570|NCT02106390|12375438|P3|COMPLETED|Overall Study||205
5028571|NCT02106390|12375439|P2|COMPLETED|Overall Study||202
5028572|NCT02106390|12375440|P1|COMPLETED|Overall Study||203
5028573|NCT02106390|12375438|P3|STARTED|Overall Study||248
5028574|NCT02106390|12375439|P2|STARTED|Overall Study||250
5028575|NCT02106390|12375440|P1|STARTED|Overall Study||252
5028576|NCT02106351|12375517|P3|NOT COMPLETED|Treatment Cycle 4||2
5028577|NCT02106351|12375518|P2|NOT COMPLETED|Treatment Cycle 4||1
5028578|NCT02106351|12375519|P1|NOT COMPLETED|Treatment Cycle 4||0
5028579|NCT02106351|12375517|P3|COMPLETED|Treatment Cycle 4||31
5028580|NCT02106351|12375518|P2|COMPLETED|Treatment Cycle 4||21
5028581|NCT02106351|12375519|P1|COMPLETED|Treatment Cycle 4||0
5028582|NCT02106351|12375517|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
5028583|NCT02106351|12375518|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
5028584|NCT02106351|12375519|P1|STARTED|Treatment Cycle 4||0
5028585|NCT02106351|12375517|P3|NOT COMPLETED|Treatment Cycle 3||5
5028586|NCT02106351|12375518|P2|NOT COMPLETED|Treatment Cycle 3||4
5028587|NCT02106351|12375519|P1|NOT COMPLETED|Treatment Cycle 3||0
5028588|NCT02106351|12375517|P3|COMPLETED|Treatment Cycle 3||53
5028589|NCT02106351|12375518|P2|COMPLETED|Treatment Cycle 3||45
5028590|NCT02106351|12375519|P1|COMPLETED|Treatment Cycle 3||0
5028591|NCT02106351|12375517|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
5028592|NCT02106351|12375518|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
5028593|NCT02106351|12375519|P1|STARTED|Treatment Cycle 3||0
5028594|NCT02106351|12375517|P3|NOT COMPLETED|Treatment Cycle 2||3
5028595|NCT02106351|12375518|P2|NOT COMPLETED|Treatment Cycle 2||5
5028596|NCT02106351|12375519|P1|NOT COMPLETED|Treatment Cycle 2||0
5028597|NCT02106351|12375517|P3|COMPLETED|Treatment Cycle 2||87
5028598|NCT02106351|12375518|P2|COMPLETED|Treatment Cycle 2||83
5028599|NCT02106351|12375519|P1|COMPLETED|Treatment Cycle 2||0
5028600|NCT02106351|12375517|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
5028601|NCT02106351|12375518|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
5028602|NCT02106351|12375519|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
5028603|NCT02106351|12375517|P3|NOT COMPLETED|Treatment Cycle 1||4
5028604|NCT02106351|12375518|P2|NOT COMPLETED|Treatment Cycle 1||3
5028605|NCT02106351|12375519|P1|NOT COMPLETED|Treatment Cycle 1||5
5028606|NCT02106351|12375517|P3|COMPLETED|Treatment Cycle 1||67
5028607|NCT02106351|12375518|P2|COMPLETED|Treatment Cycle 1||67
5028608|NCT02106351|12375519|P1|COMPLETED|Treatment Cycle 1||66
5028609|NCT02106351|12375517|P3|Received Treatment in TC 1|Treatment Cycle 1||70
5028610|NCT02106351|12375518|P2|Received Treatment in TC 1|Treatment Cycle 1||70
5028611|NCT02106351|12375519|P1|Received Treatment in TC 1|Treatment Cycle 1||70
5028612|NCT02106351|12375517|P3|STARTED|Treatment Cycle 1||71
5028613|NCT02106351|12375518|P2|STARTED|Treatment Cycle 1||70
5028614|NCT02106351|12375519|P1|STARTED|Treatment Cycle 1||71
5028615|NCT02106325|12375562|P2|NOT COMPLETED|Phase 3||1
5028616|NCT02106325|12375563|P1|NOT COMPLETED|Phase 3||2
5028617|NCT02106325|12375562|P2|COMPLETED|Phase 3||2
5028618|NCT02106325|12375563|P1|COMPLETED|Phase 3||0
5028619|NCT02106325|12375562|P2|STARTED|Phase 3||3
5028620|NCT02106325|12375563|P1|STARTED|Phase 3||2
5028621|NCT02106325|12375562|P2|NOT COMPLETED|Phase 2||3
5028622|NCT02106325|12375563|P1|NOT COMPLETED|Phase 2||2
5028623|NCT02106325|12375562|P2|COMPLETED|Phase 2||1
5028624|NCT02106325|12375563|P1|COMPLETED|Phase 2||2
5028625|NCT02106325|12375562|P2|STARTED|Phase 2||4
5028626|NCT02106325|12375563|P1|STARTED|Phase 2||4
5028627|NCT02106325|12375562|P2|NOT COMPLETED|Phase 1||2
5028628|NCT02106325|12375563|P1|NOT COMPLETED|Phase 1||2
5028629|NCT02106325|12375562|P2|COMPLETED|Phase 1||1
5028630|NCT02106325|12375563|P1|COMPLETED|Phase 1||3
5028631|NCT02106325|12375562|P2|STARTED|Phase 1||3
5028632|NCT02106325|12375563|P1|STARTED|Phase 1||5
5028633|NCT02106156|12375588|P3|NOT COMPLETED|Overall Study||0
5028634|NCT02106156|12375589|P2|NOT COMPLETED|Overall Study||40
5028635|NCT02106156|12375590|P1|NOT COMPLETED|Overall Study||2549
5028636|NCT02106156|12375588|P3|COMPLETED|Overall Study||518
5028637|NCT02106156|12375589|P2|COMPLETED|Overall Study||50
5028638|NCT02106156|12375590|P1|COMPLETED|Overall Study||7071
5028639|NCT02106156|12375588|P3|STARTED|Overall Study||518
5028640|NCT02106156|12375589|P2|STARTED|Overall Study||90
5028641|NCT02106156|12375590|P1|STARTED|Overall Study||9620
5028642|NCT02105987|12375614|P6|NOT COMPLETED|Continuation Phase||0
5028643|NCT02105987|12375615|P5|NOT COMPLETED|Continuation Phase||1
5028644|NCT02105987|12375616|P4|NOT COMPLETED|Continuation Phase||0
5028645|NCT02105987|12375617|P3|NOT COMPLETED|Continuation Phase||0
5028646|NCT02105987|12375618|P2|NOT COMPLETED|Continuation Phase||0
5028647|NCT02105987|12375619|P1|NOT COMPLETED|Continuation Phase||0
5028648|NCT02105987|12375614|P6|COMPLETED|Continuation Phase||23
5028649|NCT02105987|12375615|P5|COMPLETED|Continuation Phase||13
5028650|NCT02105987|12375616|P4|COMPLETED|Continuation Phase||0
5028651|NCT02105987|12375617|P3|COMPLETED|Continuation Phase||0
5028652|NCT02105987|12375618|P2|COMPLETED|Continuation Phase||0
5028653|NCT02105987|12375619|P1|COMPLETED|Continuation Phase||0
5028654|NCT02105987|12375614|P6|STARTED|Continuation Phase||23
5028655|NCT02105987|12375615|P5|STARTED|Continuation Phase||14
5028656|NCT02105987|12375616|P4|STARTED|Continuation Phase||0
5028657|NCT02105987|12375617|P3|STARTED|Continuation Phase||0
5028658|NCT02105987|12375618|P2|STARTED|Continuation Phase||0
5028659|NCT02105987|12375619|P1|STARTED|Continuation Phase||0
5028660|NCT02105987|12375614|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
5028661|NCT02105987|12375615|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
5028662|NCT02105987|12375616|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
5028663|NCT02105987|12375617|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
5028664|NCT02105987|12375618|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
5028665|NCT02105987|12375619|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
5028666|NCT02105987|12375614|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
5028667|NCT02105987|12375615|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
5028668|NCT02105987|12375616|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
5028669|NCT02105987|12375617|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
5028670|NCT02105987|12375618|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
5028671|NCT02105987|12375619|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
5028672|NCT02105987|12375614|P6|STARTED|Late Switch Phase (24 Weeks)||0
5028673|NCT02105987|12375615|P5|STARTED|Late Switch Phase (24 Weeks)||0
5028674|NCT02105987|12375616|P4|STARTED|Late Switch Phase (24 Weeks)||244
5028675|NCT02105987|12375617|P3|STARTED|Late Switch Phase (24 Weeks)||275
5028676|NCT02105987|12375618|P2|STARTED|Late Switch Phase (24 Weeks)||0
5028677|NCT02105987|12375619|P1|STARTED|Late Switch Phase (24 Weeks)||0
5028678|NCT02105987|12375614|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
5028679|NCT02105987|12375615|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
5028680|NCT02105987|12375616|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
5028681|NCT02105987|12375617|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
5028682|NCT02105987|12375618|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
5028683|NCT02105987|12375619|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
5028684|NCT02105987|12375614|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
5028685|NCT02105987|12375615|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
5028686|NCT02105987|12375616|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
5028687|NCT02105987|12375617|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
5028688|NCT02105987|12375618|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
5028689|NCT02105987|12375619|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
5028690|NCT02105987|12375614|P6|STARTED|Early Switch Phase (24 Weeks)||0
5028691|NCT02105987|12375615|P5|STARTED|Early Switch Phase (24 Weeks)||0
5028692|NCT02105987|12375616|P4|STARTED|Early Switch Phase (24 Weeks)||0
5028693|NCT02105987|12375617|P3|STARTED|Early Switch Phase (24 Weeks)||0
5028694|NCT02105987|12375618|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
5028695|NCT02105987|12375619|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
5028696|NCT02105974|12375673|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
5028697|NCT02105974|12375674|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
5028698|NCT02105974|12375675|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
5028699|NCT02105974|12375673|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
5028700|NCT02105974|12375674|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
5028701|NCT02105974|12375675|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
5028702|NCT02105974|12375673|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
5028703|NCT02105974|12375674|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
5028704|NCT02105974|12375675|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
5028705|NCT02105974|12375673|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
5028706|NCT02105974|12375674|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
5028707|NCT02105974|12375675|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
5028708|NCT02105974|12375673|P3|NOT COMPLETED|2 Week Run-in Period||0
5028709|NCT02105974|12375674|P2|NOT COMPLETED|2 Week Run-in Period||0
5028710|NCT02105974|12375675|P1|NOT COMPLETED|2 Week Run-in Period||801
5028711|NCT02105974|12375673|P3|COMPLETED|2 Week Run-in Period||0
5028712|NCT02105974|12375674|P2|COMPLETED|2 Week Run-in Period||0
5028713|NCT02105974|12375675|P1|COMPLETED|2 Week Run-in Period||1622
5028714|NCT02105974|12375673|P3|STARTED|2 Week Run-in Period||0
5028715|NCT02105974|12375674|P2|STARTED|2 Week Run-in Period||0
5028716|NCT02105974|12375675|P1|STARTED|2 Week Run-in Period||2423
5028717|NCT02105961|12375688|P3|NOT COMPLETED|Overall Study||30
5028718|NCT02105961|12375689|P2|NOT COMPLETED|Overall Study||17
5028719|NCT02105961|12375690|P1|NOT COMPLETED|Overall Study||41
5028720|NCT02105961|12375688|P3|COMPLETED|Overall Study||195
5028721|NCT02105961|12375689|P2|COMPLETED|Overall Study||206
5028722|NCT02105961|12375690|P1|COMPLETED|Overall Study||185
5028723|NCT02105961|12375688|P3|Withdrew IP Due to: Site Closed|Overall Study||1
5028724|NCT02105961|12375689|P2|Withdrew IP Due to: Site Closed|Overall Study||0
5028725|NCT02105961|12375690|P1|Withdrew IP Due to: Site Closed|Overall Study||1
5028726|NCT02105961|12375688|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
5028727|NCT02105961|12375689|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
5028728|NCT02105961|12375690|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
5028729|NCT02105961|12375688|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
5028730|NCT02105961|12375689|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
5028731|NCT02105961|12375690|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
5028732|NCT02105961|12375688|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
5028733|NCT02105961|12375689|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
5028734|NCT02105961|12375690|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
5028735|NCT02105961|12375688|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
5028736|NCT02105961|12375689|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
5028737|NCT02105961|12375690|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
5028738|NCT02105961|12375688|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
5028739|NCT02105961|12375689|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
5028740|NCT02105961|12375690|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
5028741|NCT02105961|12375688|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
5028742|NCT02105961|12375689|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
5028743|NCT02105961|12375690|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
5028744|NCT02105961|12375688|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
5028745|NCT02105961|12375689|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
5028746|NCT02105961|12375690|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
5028747|NCT02105961|12375688|P3|Not Completed IP|Overall Study||42
5028748|NCT02105961|12375689|P2|Not Completed IP|Overall Study||27
5028749|NCT02105961|12375690|P1|Not Completed IP|Overall Study||56
5028750|NCT02105961|12375688|P3|Completed Investigational Product (IP)|Overall Study||183
5028751|NCT02105961|12375689|P2|Completed Investigational Product (IP)|Overall Study||196
5028752|NCT02105961|12375690|P1|Completed Investigational Product (IP)|Overall Study||170
5028753|NCT02105961|12375688|P3|STARTED|Overall Study||225
5028754|NCT02105961|12375689|P2|STARTED|Overall Study||223
5028755|NCT02105961|12375690|P1|STARTED|Overall Study||226
5028756|NCT02105948|12375714|P4|NOT COMPLETED|Overall Study||27
5028757|NCT02105948|12375715|P3|NOT COMPLETED|Overall Study||28
5028758|NCT02105948|12375716|P2|NOT COMPLETED|Overall Study||20
5028759|NCT02105948|12375717|P1|NOT COMPLETED|Overall Study||27
5028760|NCT02105948|12375714|P4|COMPLETED|Overall Study||157
5028761|NCT02105948|12375715|P3|COMPLETED|Overall Study||162
5028762|NCT02105948|12375716|P2|COMPLETED|Overall Study||213
5028763|NCT02105948|12375717|P1|COMPLETED|Overall Study||202
5028764|NCT02105948|12375714|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
5028765|NCT02105948|12375715|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
5028766|NCT02105948|12375716|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
5028767|NCT02105948|12375717|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
5028768|NCT02105948|12375714|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
5028769|NCT02105948|12375715|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
5028770|NCT02105948|12375716|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
5028771|NCT02105948|12375717|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
5028772|NCT02105948|12375714|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
5028773|NCT02105948|12375715|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
5028774|NCT02105948|12375716|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
5028775|NCT02105948|12375717|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
5028776|NCT02105948|12375714|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
5028777|NCT02105948|12375715|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
5028778|NCT02105948|12375716|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
5028779|NCT02105948|12375717|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
5028780|NCT02105948|12375714|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
5028781|NCT02105948|12375715|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
5028782|NCT02105948|12375716|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
5028783|NCT02105948|12375717|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
5028784|NCT02105948|12375714|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
5028785|NCT02105948|12375715|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
5028786|NCT02105948|12375716|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
5028787|NCT02105948|12375717|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
5028788|NCT02105948|12375714|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
5028789|NCT02105948|12375715|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
5028790|NCT02105948|12375716|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
5028791|NCT02105948|12375717|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
5028792|NCT02105948|12375714|P4|Not Completed IP|Overall Study||35
5028793|NCT02105948|12375715|P3|Not Completed IP|Overall Study||42
5028794|NCT02105948|12375716|P2|Not Completed IP|Overall Study||30
5028795|NCT02105948|12375717|P1|Not Completed IP|Overall Study||44
5028796|NCT02105948|12375714|P4|Completed Investigational Product (IP)|Overall Study||149
5028797|NCT02105948|12375715|P3|Completed Investigational Product (IP)|Overall Study||148
5028798|NCT02105948|12375716|P2|Completed Investigational Product (IP)|Overall Study||203
5028799|NCT02105948|12375717|P1|Completed Investigational Product (IP)|Overall Study||185
5028800|NCT02105948|12375714|P4|STARTED|Overall Study||184
5028801|NCT02105948|12375715|P3|STARTED|Overall Study||190
5028802|NCT02105948|12375716|P2|STARTED|Overall Study||233
5028803|NCT02105948|12375717|P1|STARTED|Overall Study||229
5028804|NCT02105740|12375745|P2|NOT COMPLETED|Overall Study||1
5028805|NCT02105740|12375746|P1|NOT COMPLETED|Overall Study||0
5028806|NCT02105740|12375745|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
5028807|NCT02105740|12375746|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
5028808|NCT02105740|12375745|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
5028809|NCT02105740|12375746|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
5028810|NCT02105740|12375745|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
5028811|NCT02105740|12375746|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
5028812|NCT02105701|12375758|P4|NOT COMPLETED|Overall Study||2
5028813|NCT02105701|12375759|P3|NOT COMPLETED|Overall Study||3
5028814|NCT02105701|12375760|P2|NOT COMPLETED|Overall Study||1
5028815|NCT02105701|12375761|P1|NOT COMPLETED|Overall Study||4
5028816|NCT02105701|12375758|P4|COMPLETED|Overall Study||104
5028817|NCT02105701|12375759|P3|COMPLETED|Overall Study||102
5028818|NCT02105701|12375760|P2|COMPLETED|Overall Study||103
5028819|NCT02105701|12375761|P1|COMPLETED|Overall Study||101
5028820|NCT02105701|12375758|P4|STARTED|Overall Study||106
5028821|NCT02105701|12375759|P3|STARTED|Overall Study||105
5028822|NCT02105701|12375760|P2|STARTED|Overall Study||104
5028823|NCT02105701|12375761|P1|STARTED|Overall Study||105
5028824|NCT02105688|12375785|P2|NOT COMPLETED|Part B: Observational Follow-up||20
5028825|NCT02105688|12375786|P1|NOT COMPLETED|Part B: Observational Follow-up||37
5028826|NCT02105688|12375785|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
5028827|NCT02105688|12375786|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
5028828|NCT02105688|12375785|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
5028829|NCT02105688|12375786|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
5028830|NCT02105688|12375785|P2|NOT COMPLETED|Part A: Double-Blind||17
5028831|NCT02105688|12375786|P1|NOT COMPLETED|Part A: Double-Blind||20
5028832|NCT02105688|12375785|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
5028833|NCT02105688|12375786|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
5028834|NCT02105688|12375785|P2|STARTED|Part A: Double-Blind||100
5028835|NCT02105688|12375786|P1|STARTED|Part A: Double-Blind||201
5028836|NCT02105662|12375799|P1|NOT COMPLETED|Overall Study||6
5028837|NCT02105662|12375799|P1|COMPLETED|Overall Study||212
5028838|NCT02105662|12375799|P1|STARTED|Overall Study||218
5028839|NCT02105636|12375808|P2|NOT COMPLETED|Overall Study||108
5028840|NCT02105636|12375809|P1|NOT COMPLETED|Overall Study||195
5028841|NCT02105636|12375808|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
5028842|NCT02105636|12375809|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
5028843|NCT02105636|12375808|P2|STARTED|Overall Study||111
5028844|NCT02105636|12375809|P1|STARTED|Overall Study||236
5028845|NCT02105558|12375821|P2|NOT COMPLETED|Overall Study||0
5028846|NCT02105558|12375822|P1|NOT COMPLETED|Overall Study||0
5028847|NCT02105558|12375821|P2|COMPLETED|Overall Study||28
5028848|NCT02105558|12375822|P1|COMPLETED|Overall Study||15
5028849|NCT02105558|12375821|P2|STARTED|Overall Study||28
5028850|NCT02105558|12375822|P1|STARTED|Overall Study||15
5028851|NCT02105467|12375852|P2|NOT COMPLETED|Period 3||1
5028852|NCT02105467|12375853|P1|NOT COMPLETED|Period 3||0
5028853|NCT02105467|12375852|P2|COMPLETED|Period 3||102
5028854|NCT02105467|12375853|P1|COMPLETED|Period 3||0
5028855|NCT02105467|12375852|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
5028856|NCT02105467|12375853|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
5028857|NCT02105467|12375852|P2|NOT COMPLETED|Period 2||2
5028858|NCT02105467|12375853|P1|NOT COMPLETED|Period 2||2
5028859|NCT02105467|12375852|P2|COMPLETED|Period 2||102
5028860|NCT02105467|12375853|P1|COMPLETED|Period 2||312
5028861|NCT02105467|12375852|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
5028862|NCT02105467|12375853|P1|STARTED|Period 2||314
5028863|NCT02105467|12375852|P2|NOT COMPLETED|Period 1||0
5028864|NCT02105467|12375853|P1|NOT COMPLETED|Period 1||2
5028865|NCT02105467|12375852|P2|COMPLETED|Period 1||105
5028866|NCT02105467|12375853|P1|COMPLETED|Period 1||314
5028867|NCT02105467|12375852|P2|STARTED|Period 1||105
5028868|NCT02105467|12375853|P1|STARTED|Period 1||316
5028869|NCT02105454|12375865|P1|NOT COMPLETED|Overall Study||1
5028870|NCT02105454|12375865|P1|COMPLETED|Overall Study||78
5028871|NCT02105454|12375865|P1|STARTED|Overall Study||79
5028872|NCT02105415|12375874|P2|NOT COMPLETED|Overall Study||5
5028873|NCT02105415|12375875|P1|NOT COMPLETED|Overall Study||3
5028874|NCT02105415|12375874|P2|COMPLETED|Overall Study||79
5028875|NCT02105415|12375875|P1|COMPLETED|Overall Study||73
5028876|NCT02105415|12375874|P2|STARTED|Overall Study||84
5028877|NCT02105415|12375875|P1|STARTED|Overall Study||76
5028878|NCT02105324|12375897|P2|NOT COMPLETED|Period 2||0
5028879|NCT02105324|12375898|P1|NOT COMPLETED|Period 2||0
5028880|NCT02105324|12375897|P2|COMPLETED|Period 2||10
5028881|NCT02105324|12375898|P1|COMPLETED|Period 2||9
5028882|NCT02105324|12375897|P2|STARTED|Period 2||10
5028883|NCT02105324|12375898|P1|STARTED|Period 2||9
5028884|NCT02105324|12375897|P2|NOT COMPLETED|Period 1||0
5028885|NCT02105324|12375898|P1|NOT COMPLETED|Period 1||0
5028886|NCT02105324|12375897|P2|COMPLETED|Period 1||10
5028887|NCT02105324|12375898|P1|COMPLETED|Period 1||9
5028888|NCT02105324|12375897|P2|STARTED|Period 1||10
5028889|NCT02105324|12375898|P1|STARTED|Period 1||9
5028890|NCT02105285|12375977|P3|NOT COMPLETED|Overall Study||0
5028891|NCT02105285|12375978|P2|NOT COMPLETED|Overall Study||2
5028892|NCT02105285|12375979|P1|NOT COMPLETED|Overall Study||2
5028893|NCT02105285|12375977|P3|COMPLETED|Overall Study||37
5028894|NCT02105285|12375978|P2|COMPLETED|Overall Study||76
5028895|NCT02105285|12375979|P1|COMPLETED|Overall Study||76
5028896|NCT02105285|12375977|P3|STARTED|Overall Study||37
5028897|NCT02105285|12375978|P2|STARTED|Overall Study||78
5028898|NCT02105285|12375979|P1|STARTED|Overall Study||78
5028899|NCT02105272|12375998|P2|NOT COMPLETED|Overall Study||3
5028900|NCT02105272|12375999|P1|NOT COMPLETED|Overall Study||5
5028901|NCT02105272|12375998|P2|COMPLETED|Overall Study||116
5028902|NCT02105272|12375999|P1|COMPLETED|Overall Study||113
5028903|NCT02105272|12375998|P2|STARTED|Overall Study||119
5028904|NCT02105272|12375999|P1|STARTED|Overall Study||118
5028905|NCT02105246|12376017|P2|NOT COMPLETED|Overall Study||0
5028906|NCT02105246|12376018|P1|NOT COMPLETED|Overall Study||0
5028907|NCT02105246|12376017|P2|COMPLETED|Overall Study||597
5028908|NCT02105246|12376018|P1|COMPLETED|Overall Study||557
5028909|NCT02105246|12376017|P2|STARTED|Overall Study||597
5028910|NCT02105246|12376018|P1|STARTED|Overall Study||557
5028911|NCT02105116|12376028|P1|NOT COMPLETED|Overall Study||6
5028912|NCT02105116|12376028|P1|COMPLETED|Overall Study||0
5028913|NCT02105116|12376028|P1|STARTED|Overall Study||6
5028914|NCT02105012|12376035|P1|NOT COMPLETED|Overall Study||33
5028915|NCT02105012|12376035|P1|COMPLETED|Overall Study||114
5028916|NCT02105012|12376035|P1|Placebo MDI|Overall Study||127
5028917|NCT02105012|12376035|P1|BD MDI 40 µg|Overall Study||63
5028918|NCT02105012|12376035|P1|BD MDI 80 µg|Overall Study||64
5028919|NCT02105012|12376035|P1|BD MDI 160 µg|Overall Study||132
5028920|NCT02105012|12376035|P1|BD MDI 320 µg|Overall Study||124
5028921|NCT02105012|12376035|P1|STARTED|Overall Study||147
5028922|NCT02104947|12376069|P2|NOT COMPLETED|Overall Study||56
5028923|NCT02104947|12376070|P1|NOT COMPLETED|Overall Study||79
5028924|NCT02104947|12376069|P2|COMPLETED|Overall Study||146
5028925|NCT02104947|12376070|P1|COMPLETED|Overall Study||222
5028926|NCT02104947|12376069|P2|STARTED|Overall Study||202
5028927|NCT02104947|12376070|P1|STARTED|Overall Study||301
5028928|NCT02104895|12376088|P2|NOT COMPLETED|Overall Study||14
5028929|NCT02104895|12376089|P1|NOT COMPLETED|Overall Study||0
5028930|NCT02104895|12376088|P2|COMPLETED|Overall Study||246
5028931|NCT02104895|12376089|P1|COMPLETED|Overall Study||260
5028932|NCT02104895|12376088|P2|STARTED|Overall Study||260
5028933|NCT02104895|12376089|P1|STARTED|Overall Study||260
5028934|NCT02104830|12376102|P3|NOT COMPLETED|Overall Study||7
5028935|NCT02104830|12376103|P2|NOT COMPLETED|Overall Study||7
5028936|NCT02104830|12376104|P1|NOT COMPLETED|Overall Study||4
5028937|NCT02104830|12376102|P3|COMPLETED|Overall Study||36
5028938|NCT02104830|12376103|P2|COMPLETED|Overall Study||36
5028939|NCT02104830|12376104|P1|COMPLETED|Overall Study||38
5028940|NCT02104830|12376102|P3|STARTED|Overall Study||43
5028941|NCT02104830|12376103|P2|STARTED|Overall Study||43
5028942|NCT02104830|12376104|P1|STARTED|Overall Study||42
5028943|NCT02104804|12376129|P2|NOT COMPLETED|Overall Study||19
5028944|NCT02104804|12376130|P1|NOT COMPLETED|Overall Study||16
5028945|NCT02104804|12376129|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
5028946|NCT02104804|12376130|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
5028947|NCT02104804|12376129|P2|STARTED|Overall Study|Number of patients who were randomized|232
5028948|NCT02104804|12376130|P1|STARTED|Overall Study|Number of patients who were randomized|234
5028949|NCT02104765|12376153|P7|NOT COMPLETED|Overall Study||1
5028950|NCT02104765|12376154|P6|NOT COMPLETED|Overall Study||0
5028951|NCT02104765|12376155|P5|NOT COMPLETED|Overall Study||1
5028952|NCT02104765|12376156|P4|NOT COMPLETED|Overall Study||1
5028953|NCT02104765|12376157|P3|NOT COMPLETED|Overall Study||1
5028954|NCT02104765|12376158|P2|NOT COMPLETED|Overall Study||0
5028955|NCT02104765|12376159|P1|NOT COMPLETED|Overall Study||0
5028956|NCT02104765|12376153|P7|COMPLETED|Overall Study||7
5028957|NCT02104765|12376154|P6|COMPLETED|Overall Study||2
5028958|NCT02104765|12376155|P5|COMPLETED|Overall Study||7
5028959|NCT02104765|12376156|P4|COMPLETED|Overall Study||6
5028960|NCT02104765|12376157|P3|COMPLETED|Overall Study||5
5028961|NCT02104765|12376158|P2|COMPLETED|Overall Study||6
5028962|NCT02104765|12376159|P1|COMPLETED|Overall Study||8
5028963|NCT02104765|12376153|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
5028964|NCT02104765|12376154|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
5028965|NCT02104765|12376155|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
5028966|NCT02104765|12376156|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
5028967|NCT02104765|12376157|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5028968|NCT02104765|12376158|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5028969|NCT02104765|12376159|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5028970|NCT02104765|12376153|P7|STARTED|Overall Study||8
5028971|NCT02104765|12376154|P6|STARTED|Overall Study||2
5028972|NCT02104765|12376155|P5|STARTED|Overall Study||8
5028973|NCT02104765|12376156|P4|STARTED|Overall Study||7
5028974|NCT02104765|12376157|P3|STARTED|Overall Study||6
5028975|NCT02104765|12376158|P2|STARTED|Overall Study||6
5028976|NCT02104765|12376159|P1|STARTED|Overall Study||8
5028977|NCT02104752|12376187|P2|NOT COMPLETED|Overall Study||2
5028978|NCT02104752|12376188|P1|NOT COMPLETED|Overall Study||1
5028979|NCT02104752|12376187|P2|COMPLETED|Overall Study||19
5028980|NCT02104752|12376188|P1|COMPLETED|Overall Study||17
5028981|NCT02104752|12376187|P2|STARTED|Overall Study||21
5028982|NCT02104752|12376188|P1|STARTED|Overall Study||18
5028983|NCT02104739|12376202|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
5028984|NCT02104739|12376203|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028985|NCT02104739|12376204|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028986|NCT02104739|12376205|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028987|NCT02104739|12376206|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028988|NCT02104739|12376207|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028989|NCT02104739|12376208|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
5028990|NCT02104739|12376202|P7|COMPLETED|Extension Phase (6 Weeks)||7
5028991|NCT02104739|12376203|P6|COMPLETED|Extension Phase (6 Weeks)||0
5028992|NCT02104739|12376204|P5|COMPLETED|Extension Phase (6 Weeks)||0
5028993|NCT02104739|12376205|P4|COMPLETED|Extension Phase (6 Weeks)||0
5028994|NCT02104739|12376206|P3|COMPLETED|Extension Phase (6 Weeks)||0
5028995|NCT02104739|12376207|P2|COMPLETED|Extension Phase (6 Weeks)||0
5028996|NCT02104739|12376208|P1|COMPLETED|Extension Phase (6 Weeks)||0
5028997|NCT02104739|12376202|P7|STARTED|Extension Phase (6 Weeks)||8
5028998|NCT02104739|12376203|P6|STARTED|Extension Phase (6 Weeks)||0
5028999|NCT02104739|12376204|P5|STARTED|Extension Phase (6 Weeks)||0
5029000|NCT02104739|12376205|P4|STARTED|Extension Phase (6 Weeks)||0
5029001|NCT02104739|12376206|P3|STARTED|Extension Phase (6 Weeks)||0
5029002|NCT02104739|12376207|P2|STARTED|Extension Phase (6 Weeks)||0
5029003|NCT02104739|12376208|P1|STARTED|Extension Phase (6 Weeks)||0
5029004|NCT02104739|12376202|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
5029005|NCT02104739|12376203|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029006|NCT02104739|12376204|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029007|NCT02104739|12376205|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029008|NCT02104739|12376206|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029009|NCT02104739|12376207|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029010|NCT02104739|12376208|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029011|NCT02104739|12376202|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
5029012|NCT02104739|12376203|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029013|NCT02104739|12376204|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029014|NCT02104739|12376205|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029015|NCT02104739|12376206|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029016|NCT02104739|12376207|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029017|NCT02104739|12376208|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
5029018|NCT02104739|12376202|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
5029019|NCT02104739|12376203|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029020|NCT02104739|12376204|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029021|NCT02104739|12376205|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029022|NCT02104739|12376206|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029023|NCT02104739|12376207|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029024|NCT02104739|12376208|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
5029025|NCT02104739|12376202|P7|NOT COMPLETED|Third Intervention (1 Day)||0
5029026|NCT02104739|12376203|P6|NOT COMPLETED|Third Intervention (1 Day)||0
5029027|NCT02104739|12376204|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5029028|NCT02104739|12376205|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5029029|NCT02104739|12376206|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5029030|NCT02104739|12376207|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5029031|NCT02104739|12376208|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5029032|NCT02104739|12376202|P7|COMPLETED|Third Intervention (1 Day)||0
5029033|NCT02104739|12376203|P6|COMPLETED|Third Intervention (1 Day)||2
5029034|NCT02104739|12376204|P5|COMPLETED|Third Intervention (1 Day)||0
5029035|NCT02104739|12376205|P4|COMPLETED|Third Intervention (1 Day)||7
5029036|NCT02104739|12376206|P3|COMPLETED|Third Intervention (1 Day)||2
5029037|NCT02104739|12376207|P2|COMPLETED|Third Intervention (1 Day)||4
5029038|NCT02104739|12376208|P1|COMPLETED|Third Intervention (1 Day)||1
5029039|NCT02104739|12376202|P7|STARTED|Third Intervention (1 Day)||0
5029040|NCT02104739|12376203|P6|STARTED|Third Intervention (1 Day)||2
5029041|NCT02104739|12376204|P5|STARTED|Third Intervention (1 Day)||0
5029042|NCT02104739|12376205|P4|STARTED|Third Intervention (1 Day)||7
5029043|NCT02104739|12376206|P3|STARTED|Third Intervention (1 Day)||2
5029044|NCT02104739|12376207|P2|STARTED|Third Intervention (1 Day)||4
5029045|NCT02104739|12376208|P1|STARTED|Third Intervention (1 Day)||1
5029046|NCT02104739|12376202|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029047|NCT02104739|12376203|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029048|NCT02104739|12376204|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029049|NCT02104739|12376205|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029050|NCT02104739|12376206|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029051|NCT02104739|12376207|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029052|NCT02104739|12376208|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029053|NCT02104739|12376202|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029054|NCT02104739|12376203|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
5029055|NCT02104739|12376204|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029056|NCT02104739|12376205|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
5029057|NCT02104739|12376206|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
5029058|NCT02104739|12376207|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
5029059|NCT02104739|12376208|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
5029060|NCT02104739|12376202|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
5029061|NCT02104739|12376203|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
5029062|NCT02104739|12376204|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
5029063|NCT02104739|12376205|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
5029064|NCT02104739|12376206|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
5029065|NCT02104739|12376207|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
5029066|NCT02104739|12376208|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
5029067|NCT02104739|12376202|P7|NOT COMPLETED|Second Intervention (1 Day)||0
5029068|NCT02104739|12376203|P6|NOT COMPLETED|Second Intervention (1 Day)||0
5029069|NCT02104739|12376204|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5029070|NCT02104739|12376205|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5029071|NCT02104739|12376206|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5029072|NCT02104739|12376207|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5029073|NCT02104739|12376208|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5029074|NCT02104739|12376202|P7|COMPLETED|Second Intervention (1 Day)||0
5029075|NCT02104739|12376203|P6|COMPLETED|Second Intervention (1 Day)||2
5029076|NCT02104739|12376204|P5|COMPLETED|Second Intervention (1 Day)||0
5029077|NCT02104739|12376205|P4|COMPLETED|Second Intervention (1 Day)||7
5029078|NCT02104739|12376206|P3|COMPLETED|Second Intervention (1 Day)||2
5029079|NCT02104739|12376207|P2|COMPLETED|Second Intervention (1 Day)||4
5029080|NCT02104739|12376208|P1|COMPLETED|Second Intervention (1 Day)||1
5029081|NCT02104739|12376202|P7|STARTED|Second Intervention (1 Day)||0
5029082|NCT02104739|12376203|P6|STARTED|Second Intervention (1 Day)||2
5029083|NCT02104739|12376204|P5|STARTED|Second Intervention (1 Day)||0
5029084|NCT02104739|12376205|P4|STARTED|Second Intervention (1 Day)||7
5029085|NCT02104739|12376206|P3|STARTED|Second Intervention (1 Day)||2
5029086|NCT02104739|12376207|P2|STARTED|Second Intervention (1 Day)||4
5029087|NCT02104739|12376208|P1|STARTED|Second Intervention (1 Day)||1
5029088|NCT02104739|12376202|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029089|NCT02104739|12376203|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029090|NCT02104739|12376204|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029091|NCT02104739|12376205|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029092|NCT02104739|12376206|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029093|NCT02104739|12376207|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029094|NCT02104739|12376208|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029095|NCT02104739|12376202|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029096|NCT02104739|12376203|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
5029097|NCT02104739|12376204|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
5029098|NCT02104739|12376205|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
5029099|NCT02104739|12376206|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
5029100|NCT02104739|12376207|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
5029101|NCT02104739|12376208|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
5029102|NCT02104739|12376202|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
5029103|NCT02104739|12376203|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
5029104|NCT02104739|12376204|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
5029105|NCT02104739|12376205|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
5029106|NCT02104739|12376206|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
5029107|NCT02104739|12376207|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
5029108|NCT02104739|12376208|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
5029109|NCT02104739|12376202|P7|NOT COMPLETED|First Intervention (1 Day)||0
5029110|NCT02104739|12376203|P6|NOT COMPLETED|First Intervention (1 Day)||0
5029111|NCT02104739|12376204|P5|NOT COMPLETED|First Intervention (1 Day)||0
5029112|NCT02104739|12376205|P4|NOT COMPLETED|First Intervention (1 Day)||1
5029113|NCT02104739|12376206|P3|NOT COMPLETED|First Intervention (1 Day)||0
5029114|NCT02104739|12376207|P2|NOT COMPLETED|First Intervention (1 Day)||1
5029115|NCT02104739|12376208|P1|NOT COMPLETED|First Intervention (1 Day)||0
5029116|NCT02104739|12376202|P7|COMPLETED|First Intervention (1 Day)||0
5029117|NCT02104739|12376203|P6|COMPLETED|First Intervention (1 Day)||3
5029118|NCT02104739|12376204|P5|COMPLETED|First Intervention (1 Day)||0
5029119|NCT02104739|12376205|P4|COMPLETED|First Intervention (1 Day)||7
5029120|NCT02104739|12376206|P3|COMPLETED|First Intervention (1 Day)||2
5029121|NCT02104739|12376207|P2|COMPLETED|First Intervention (1 Day)||4
5029122|NCT02104739|12376208|P1|COMPLETED|First Intervention (1 Day)||2
5029123|NCT02104739|12376202|P7|STARTED|First Intervention (1 Day)||0
5029124|NCT02104739|12376203|P6|STARTED|First Intervention (1 Day)||3
5029125|NCT02104739|12376204|P5|STARTED|First Intervention (1 Day)||0
5029126|NCT02104739|12376205|P4|STARTED|First Intervention (1 Day)||8
5029127|NCT02104739|12376206|P3|STARTED|First Intervention (1 Day)||2
5029128|NCT02104739|12376207|P2|STARTED|First Intervention (1 Day)||5
5029129|NCT02104739|12376208|P1|STARTED|First Intervention (1 Day)||2
5029130|NCT02104583|12376271|P5|NOT COMPLETED|Overall Study||12
5029131|NCT02104583|12376272|P4|NOT COMPLETED|Overall Study||17
5029132|NCT02104583|12376273|P3|NOT COMPLETED|Overall Study||16
5029133|NCT02104583|12376274|P2|NOT COMPLETED|Overall Study||11
5029134|NCT02104583|12376275|P1|NOT COMPLETED|Overall Study||18
5029135|NCT02104583|12376271|P5|COMPLETED|Overall Study||63
5029136|NCT02104583|12376272|P4|COMPLETED|Overall Study||57
5029137|NCT02104583|12376273|P3|COMPLETED|Overall Study||54
5029138|NCT02104583|12376274|P2|COMPLETED|Overall Study||35
5029139|NCT02104583|12376275|P1|COMPLETED|Overall Study||30
5029140|NCT02104583|12376271|P5|STARTED|Overall Study||75
5029141|NCT02104583|12376272|P4|STARTED|Overall Study||74
5029142|NCT02104583|12376273|P3|STARTED|Overall Study||70
5029143|NCT02104583|12376274|P2|STARTED|Overall Study||46
5029144|NCT02104583|12376275|P1|STARTED|Overall Study||48
5029145|NCT02104505|12376338|P2|NOT COMPLETED|Second Intervention (14 Days)||1
5029146|NCT02104505|12376339|P1|NOT COMPLETED|Second Intervention (14 Days)||2
5029147|NCT02104505|12376338|P2|COMPLETED|Second Intervention (14 Days)||7
5029148|NCT02104505|12376339|P1|COMPLETED|Second Intervention (14 Days)||8
5029149|NCT02104505|12376338|P2|STARTED|Second Intervention (14 Days)||8
5029150|NCT02104505|12376339|P1|STARTED|Second Intervention (14 Days)||10
5029151|NCT02104505|12376338|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
5029152|NCT02104505|12376339|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
5029153|NCT02104505|12376338|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
5029154|NCT02104505|12376339|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
5029155|NCT02104505|12376338|P2|STARTED|Washout (Minimum 3 Weeks)||8
5029156|NCT02104505|12376339|P1|STARTED|Washout (Minimum 3 Weeks)||10
5029157|NCT02104505|12376338|P2|NOT COMPLETED|First Intervention (14 Days)||3
5029158|NCT02104505|12376339|P1|NOT COMPLETED|First Intervention (14 Days)||2
5029159|NCT02104505|12376338|P2|COMPLETED|First Intervention (14 Days)||8
5029160|NCT02104505|12376339|P1|COMPLETED|First Intervention (14 Days)||10
5029161|NCT02104505|12376338|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
5029162|NCT02104505|12376339|P1|STARTED|First Intervention (14 Days)||12
5029163|NCT02104427|12376351|P1|NOT COMPLETED|Overall Study||0
5029164|NCT02104427|12376351|P1|COMPLETED|Overall Study||12
5029165|NCT02104427|12376351|P1|STARTED|Overall Study||12
5029166|NCT02104414|12376377|P3|NOT COMPLETED|Overall Study||0
5029167|NCT02104414|12376378|P2|NOT COMPLETED|Overall Study||0
5029168|NCT02104414|12376379|P1|NOT COMPLETED|Overall Study||0
5029169|NCT02104414|12376377|P3|COMPLETED|Overall Study||2
5029170|NCT02104414|12376378|P2|COMPLETED|Overall Study||4
5029171|NCT02104414|12376379|P1|COMPLETED|Overall Study||5
5029172|NCT02104414|12376377|P3|STARTED|Overall Study||2
5029173|NCT02104414|12376378|P2|STARTED|Overall Study||4
5029174|NCT02104414|12376379|P1|STARTED|Overall Study||5
5029175|NCT02104219|12376402|P1|NOT COMPLETED|Overall Study||0
5029176|NCT02104219|12376402|P1|COMPLETED|Overall Study||32
5029177|NCT02104219|12376402|P1|STARTED|Overall Study||32
5029178|NCT02104180|12376411|P2|NOT COMPLETED|Overall Study||0
5029179|NCT02104180|12376412|P1|NOT COMPLETED|Overall Study||1
5029180|NCT02104180|12376411|P2|COMPLETED|Overall Study||31
5029181|NCT02104180|12376412|P1|COMPLETED|Overall Study||30
5029182|NCT02104180|12376411|P2|STARTED|Overall Study||31
5029183|NCT02104180|12376412|P1|STARTED|Overall Study||31
5029184|NCT02104167|12376418|P1|NOT COMPLETED|Overall Study||0
5029185|NCT02104167|12376418|P1|COMPLETED|Overall Study||110
5029186|NCT02104167|12376418|P1|STARTED|Overall Study||110
5029187|NCT02104141|12376423|P1|NOT COMPLETED|Overall Study||0
5029188|NCT02104141|12376423|P1|COMPLETED|Overall Study||51
5029189|NCT02104141|12376423|P1|STARTED|Overall Study||51
5029190|NCT02103855|12376428|P1|NOT COMPLETED|Overall Study||2
5029191|NCT02103855|12376428|P1|COMPLETED|Overall Study||4
5029192|NCT02103855|12376428|P1|STARTED|Overall Study||6
5029193|NCT02103608|12376436|P1|NOT COMPLETED|Overall Study||2
5029194|NCT02103608|12376436|P1|COMPLETED|Overall Study||15
5029195|NCT02103608|12376436|P1|STARTED|Overall Study||17
5029196|NCT02103439|12376442|P2|NOT COMPLETED|Overall Study||3
5029197|NCT02103439|12376443|P1|NOT COMPLETED|Overall Study||3
5029198|NCT02103439|12376442|P2|COMPLETED|Overall Study||67
5029199|NCT02103439|12376443|P1|COMPLETED|Overall Study||67
5029200|NCT02103439|12376442|P2|STARTED|Overall Study||70
5029201|NCT02103439|12376443|P1|STARTED|Overall Study||70
5029202|NCT02103309|12376463|P2|NOT COMPLETED|Overall Study||0
5029203|NCT02103309|12376464|P1|NOT COMPLETED|Overall Study||0
5029204|NCT02103309|12376463|P2|COMPLETED|Overall Study||22
5029205|NCT02103309|12376464|P1|COMPLETED|Overall Study||20
5029206|NCT02103309|12376463|P2|STARTED|Overall Study||22
5029207|NCT02103309|12376464|P1|STARTED|Overall Study||20
5029208|NCT02103270|12376479|P3|NOT COMPLETED|Overall Study||24
5029209|NCT02103270|12376480|P2|NOT COMPLETED|Overall Study||6
5029210|NCT02103270|12376481|P1|NOT COMPLETED|Overall Study||9
5029211|NCT02103270|12376479|P3|COMPLETED|Overall Study||1
5029212|NCT02103270|12376480|P2|COMPLETED|Overall Study||29
5029213|NCT02103270|12376481|P1|COMPLETED|Overall Study||51
5029214|NCT02103270|12376479|P3|STARTED|Overall Study||25
5029215|NCT02103270|12376480|P2|STARTED|Overall Study||35
5029216|NCT02103270|12376481|P1|STARTED|Overall Study||60
5029217|NCT02103218|12376496|P4|NOT COMPLETED|Overall Study||7
5029218|NCT02103218|12376497|P3|NOT COMPLETED|Overall Study||4
5029219|NCT02103218|12376498|P2|NOT COMPLETED|Overall Study||8
5029220|NCT02103218|12376499|P1|NOT COMPLETED|Overall Study||5
5029221|NCT02103218|12376496|P4|COMPLETED|Overall Study||47
5029222|NCT02103218|12376497|P3|COMPLETED|Overall Study||44
5029223|NCT02103218|12376498|P2|COMPLETED|Overall Study||51
5029224|NCT02103218|12376499|P1|COMPLETED|Overall Study||46
5029225|NCT02103218|12376496|P4|STARTED|Overall Study||54
5029226|NCT02103218|12376497|P3|STARTED|Overall Study||48
5029227|NCT02103218|12376498|P2|STARTED|Overall Study||59
5029228|NCT02103218|12376499|P1|STARTED|Overall Study||51
5029229|NCT02103114|12376545|P2|NOT COMPLETED|Overall Study||1
5029230|NCT02103114|12376546|P1|NOT COMPLETED|Overall Study||0
5029231|NCT02103114|12376545|P2|COMPLETED|Overall Study||19
5029232|NCT02103114|12376546|P1|COMPLETED|Overall Study||20
5029233|NCT02103114|12376545|P2|STARTED|Overall Study||20
5029234|NCT02103114|12376546|P1|STARTED|Overall Study||20
5029235|NCT02103062|12376602|P2|NOT COMPLETED|Overall Study||23
5029236|NCT02103062|12376603|P1|NOT COMPLETED|Overall Study||18
5029237|NCT02103062|12376602|P2|COMPLETED|Overall Study||0
5029238|NCT02103062|12376603|P1|COMPLETED|Overall Study||0
5029239|NCT02103062|12376602|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
5029240|NCT02103062|12376603|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
5029241|NCT02103062|12376602|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
5029242|NCT02103062|12376603|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
5029243|NCT02103062|12376602|P2|STARTED|Overall Study||23
5029244|NCT02103062|12376603|P1|STARTED|Overall Study||18
5029245|NCT02102932|12376629|P8|NOT COMPLETED|Overall Study||0
5029246|NCT02102932|12376630|P7|NOT COMPLETED|Overall Study||0
5029247|NCT02102932|12376631|P6|NOT COMPLETED|Overall Study||0
5029248|NCT02102932|12376632|P5|NOT COMPLETED|Overall Study||0
5029249|NCT02102932|12376633|P4|NOT COMPLETED|Overall Study||0
5029250|NCT02102932|12376634|P3|NOT COMPLETED|Overall Study||0
5029251|NCT02102932|12376635|P2|NOT COMPLETED|Overall Study||0
5029252|NCT02102932|12376636|P1|NOT COMPLETED|Overall Study||0
5029253|NCT02102932|12376629|P8|COMPLETED|Overall Study||12
5029254|NCT02102932|12376630|P7|COMPLETED|Overall Study||12
5029255|NCT02102932|12376631|P6|COMPLETED|Overall Study||12
5029256|NCT02102932|12376632|P5|COMPLETED|Overall Study||12
5029257|NCT02102932|12376633|P4|COMPLETED|Overall Study||12
5029258|NCT02102932|12376634|P3|COMPLETED|Overall Study||12
5029259|NCT02102932|12376635|P2|COMPLETED|Overall Study||12
5029260|NCT02102932|12376636|P1|COMPLETED|Overall Study||12
5029261|NCT02102932|12376629|P8|STARTED|Overall Study||12
5029262|NCT02102932|12376630|P7|STARTED|Overall Study||12
5029263|NCT02102932|12376631|P6|STARTED|Overall Study||12
5029264|NCT02102932|12376632|P5|STARTED|Overall Study||12
5029265|NCT02102932|12376633|P4|STARTED|Overall Study||12
5029266|NCT02102932|12376634|P3|STARTED|Overall Study||12
5029267|NCT02102932|12376635|P2|STARTED|Overall Study||12
5029268|NCT02102932|12376636|P1|STARTED|Overall Study||12
5029269|NCT02102724|12376696|P2|NOT COMPLETED|Overall Study||1
5029270|NCT02102724|12376697|P1|NOT COMPLETED|Overall Study||2
5029271|NCT02102724|12376696|P2|COMPLETED|Overall Study||18
5029272|NCT02102724|12376697|P1|COMPLETED|Overall Study||16
5029273|NCT02102724|12376696|P2|STARTED|Overall Study||19
5029274|NCT02102724|12376697|P1|STARTED|Overall Study||18
5029275|NCT02102490|12376703|P1|NOT COMPLETED|Overall Study||7
5029276|NCT02102490|12376703|P1|COMPLETED|Overall Study||125
5029277|NCT02102490|12376703|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
5029278|NCT02102490|12376703|P1|STARTED|Overall Study||132
5029279|NCT02102464|12376717|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
5029280|NCT02102464|12376718|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
5029281|NCT02102464|12376719|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
5029282|NCT02102464|12376717|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
5029283|NCT02102464|12376718|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
5029284|NCT02102464|12376719|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
5029285|NCT02102464|12376717|P3|STARTED|Crossover LipiFlow Treatment of Control||25
5029286|NCT02102464|12376718|P2|STARTED|Crossover LipiFlow Treatment of Control||0
5029287|NCT02102464|12376719|P1|STARTED|Crossover LipiFlow Treatment of Control||0
5029288|NCT02102464|12376717|P3|NOT COMPLETED|Randomized Study||0
5029289|NCT02102464|12376718|P2|NOT COMPLETED|Randomized Study||1
5029290|NCT02102464|12376719|P1|NOT COMPLETED|Randomized Study||0
5029291|NCT02102464|12376717|P3|COMPLETED|Randomized Study||0
5029292|NCT02102464|12376718|P2|COMPLETED|Randomized Study||25
5029293|NCT02102464|12376719|P1|COMPLETED|Randomized Study||29
5029294|NCT02102464|12376717|P3|STARTED|Randomized Study||0
5029295|NCT02102464|12376718|P2|STARTED|Randomized Study||26
5029296|NCT02102464|12376719|P1|STARTED|Randomized Study||29
5029297|NCT02102399|12376738|P2|NOT COMPLETED|Overall Study||4
5029298|NCT02102399|12376739|P1|NOT COMPLETED|Overall Study||6
5029299|NCT02102399|12376738|P2|COMPLETED|Overall Study||17
5029300|NCT02102399|12376739|P1|COMPLETED|Overall Study||14
5029301|NCT02102399|12376738|P2|STARTED|Overall Study||21
5029302|NCT02102399|12376739|P1|STARTED|Overall Study||20
5029303|NCT02102230|12376790|P3|NOT COMPLETED|Overall Study||17
5029304|NCT02102230|12376791|P2|NOT COMPLETED|Overall Study||17
5029305|NCT02102230|12376792|P1|NOT COMPLETED|Overall Study||17
5029306|NCT02102230|12376790|P3|COMPLETED|Overall Study||24
5029307|NCT02102230|12376791|P2|COMPLETED|Overall Study||11
5029308|NCT02102230|12376792|P1|COMPLETED|Overall Study||25
5029309|NCT02102230|12376790|P3|STARTED|Overall Study||41
5029310|NCT02102230|12376791|P2|STARTED|Overall Study||28
5029311|NCT02102230|12376792|P1|STARTED|Overall Study||42
5029312|NCT02102204|12376809|P1|NOT COMPLETED|Overall Study||304
5029313|NCT02102204|12376809|P1|COMPLETED|Overall Study||598
5029314|NCT02102204|12376809|P1|Received Etelcalcetide|Overall Study||884
5029315|NCT02102204|12376809|P1|STARTED|Overall Study||902
5029316|NCT02102100|12376820|P2|NOT COMPLETED|Overall Study||7
5029317|NCT02102100|12376821|P1|NOT COMPLETED|Overall Study||9
5029318|NCT02102100|12376820|P2|COMPLETED|Overall Study||18
5029319|NCT02102100|12376821|P1|COMPLETED|Overall Study||23
5029320|NCT02102100|12376820|P2|STARTED|Overall Study||25
5029321|NCT02102100|12376821|P1|STARTED|Overall Study||32
5029322|NCT02101983|12376829|P2|NOT COMPLETED|Overall Study||0
5029323|NCT02101983|12376830|P1|NOT COMPLETED|Overall Study||1
5029324|NCT02101983|12376829|P2|COMPLETED|Overall Study||6
5029325|NCT02101983|12376830|P1|COMPLETED|Overall Study||4
5029326|NCT02101983|12376829|P2|STARTED|Overall Study||6
5029327|NCT02101983|12376830|P1|STARTED|Overall Study||5
5029328|NCT02101918|12376840|P1|NOT COMPLETED|Overall Study||0
5029329|NCT02101918|12376840|P1|COMPLETED|Overall Study||22
5029330|NCT02101918|12376840|P1|STARTED|Overall Study||22
5029331|NCT02101554|12376856|P3|NOT COMPLETED|Overall Study||1
5029332|NCT02101554|12376857|P2|NOT COMPLETED|Overall Study||5
5029333|NCT02101554|12376858|P1|NOT COMPLETED|Overall Study||3
5029334|NCT02101554|12376856|P3|COMPLETED|Overall Study||2
5029335|NCT02101554|12376857|P2|COMPLETED|Overall Study||5
5029336|NCT02101554|12376858|P1|COMPLETED|Overall Study||3
5029337|NCT02101554|12376856|P3|STARTED|Overall Study||3
5029338|NCT02101554|12376857|P2|STARTED|Overall Study||10
5029339|NCT02101554|12376858|P1|STARTED|Overall Study||6
5029340|NCT02101515|12376940|P2|NOT COMPLETED|Overall Study||0
5029341|NCT02101515|12376941|P1|NOT COMPLETED|Overall Study||0
5029342|NCT02101515|12376940|P2|COMPLETED|Overall Study||41
5029343|NCT02101515|12376941|P1|COMPLETED|Overall Study||37
5029344|NCT02101515|12376940|P2|STARTED|Overall Study||41
5029345|NCT02101515|12376941|P1|STARTED|Overall Study||37
5029346|NCT02101437|12376983|P4|NOT COMPLETED|Overall Study||0
5029347|NCT02101437|12376984|P3|NOT COMPLETED|Overall Study||0
5029348|NCT02101437|12376985|P2|NOT COMPLETED|Overall Study||0
5029349|NCT02101437|12376986|P1|NOT COMPLETED|Overall Study||0
5029350|NCT02101437|12376983|P4|COMPLETED|Overall Study||49
5029351|NCT02101437|12376984|P3|COMPLETED|Overall Study||52
5029352|NCT02101437|12376985|P2|COMPLETED|Overall Study||54
5029353|NCT02101437|12376986|P1|COMPLETED|Overall Study||20
5029354|NCT02101437|12376983|P4|STARTED|Overall Study||49
5029355|NCT02101437|12376984|P3|STARTED|Overall Study||52
5029356|NCT02101437|12376985|P2|STARTED|Overall Study||54
5029357|NCT02101437|12376986|P1|STARTED|Overall Study||20
5029358|NCT02101411|12376999|P3|NOT COMPLETED|Overall Study||10
5029359|NCT02101411|12377000|P2|NOT COMPLETED|Overall Study||7
5029360|NCT02101411|12377001|P1|NOT COMPLETED|Overall Study||4
5029361|NCT02101411|12376999|P3|COMPLETED|Overall Study||104
5029362|NCT02101411|12377000|P2|COMPLETED|Overall Study||102
5029363|NCT02101411|12377001|P1|COMPLETED|Overall Study||107
5029364|NCT02101411|12376999|P3|STARTED|Overall Study||114
5029365|NCT02101411|12377000|P2|STARTED|Overall Study||109
5029366|NCT02101411|12377001|P1|STARTED|Overall Study||111
5029367|NCT02101359|12377011|P2|NOT COMPLETED|Overall Study||19
5029368|NCT02101359|12377012|P1|NOT COMPLETED|Overall Study||29
5029369|NCT02101359|12377011|P2|COMPLETED|Overall Study||277
5029370|NCT02101359|12377012|P1|COMPLETED|Overall Study||266
5029371|NCT02101359|12377011|P2|STARTED|Overall Study||296
5029372|NCT02101359|12377012|P1|STARTED|Overall Study||295
5029373|NCT02101294|12377018|P1|NOT COMPLETED|Overall Study||11
5029374|NCT02101294|12377018|P1|COMPLETED|Overall Study||20
5029375|NCT02101294|12377018|P1|STARTED|Overall Study||31
5029376|NCT02101281|12377027|P2|NOT COMPLETED|Overall Study||1
5029377|NCT02101281|12377028|P1|NOT COMPLETED|Overall Study||0
5029378|NCT02101281|12377027|P2|COMPLETED|Overall Study||19
5029379|NCT02101281|12377028|P1|COMPLETED|Overall Study||20
5029380|NCT02101281|12377027|P2|STARTED|Overall Study||20
5029381|NCT02101281|12377028|P1|STARTED|Overall Study||20
5029382|NCT02101190|12377070|P2|NOT COMPLETED|Overall Study||0
5029383|NCT02101190|12377071|P1|NOT COMPLETED|Overall Study||0
5029384|NCT02101190|12377070|P2|COMPLETED|Overall Study||8
5029385|NCT02101190|12377071|P1|COMPLETED|Overall Study||8
5029386|NCT02101190|12377070|P2|STARTED|Overall Study||8
5029387|NCT02101190|12377071|P1|STARTED|Overall Study||8
5029388|NCT02101112|12377081|P6|NOT COMPLETED|Overall Study||0
5029389|NCT02101112|12377082|P5|NOT COMPLETED|Overall Study||1
5029390|NCT02101112|12377083|P4|NOT COMPLETED|Overall Study||0
5029391|NCT02101112|12377084|P3|NOT COMPLETED|Overall Study||1
5029392|NCT02101112|12377085|P2|NOT COMPLETED|Overall Study||0
5029393|NCT02101112|12377086|P1|NOT COMPLETED|Overall Study||0
5029394|NCT02101112|12377081|P6|COMPLETED|Overall Study||5
5029395|NCT02101112|12377082|P5|COMPLETED|Overall Study||5
5029396|NCT02101112|12377083|P4|COMPLETED|Overall Study||5
5029397|NCT02101112|12377084|P3|COMPLETED|Overall Study||5
5029398|NCT02101112|12377085|P2|COMPLETED|Overall Study||5
5029399|NCT02101112|12377086|P1|COMPLETED|Overall Study||6
5029400|NCT02101112|12377081|P6|STARTED|Overall Study||5
5029401|NCT02101112|12377082|P5|STARTED|Overall Study||6
5029402|NCT02101112|12377083|P4|STARTED|Overall Study||5
5029403|NCT02101112|12377084|P3|STARTED|Overall Study||6
5029404|NCT02101112|12377085|P2|STARTED|Overall Study||5
5029405|NCT02101112|12377086|P1|STARTED|Overall Study||6
5029406|NCT02101021|12377116|P5|NOT COMPLETED|Overall Study||4
5029407|NCT02101021|12377117|P4|NOT COMPLETED|Overall Study||3
5029408|NCT02101021|12377118|P3|NOT COMPLETED|Overall Study||7
5029409|NCT02101021|12377119|P2|NOT COMPLETED|Overall Study||4
5029410|NCT02101021|12377120|P1|NOT COMPLETED|Overall Study||7
5029411|NCT02101021|12377116|P5|COMPLETED|Overall Study||0
5029412|NCT02101021|12377117|P4|COMPLETED|Overall Study||0
5029413|NCT02101021|12377118|P3|COMPLETED|Overall Study||0
5029414|NCT02101021|12377119|P2|COMPLETED|Overall Study||0
5029415|NCT02101021|12377120|P1|COMPLETED|Overall Study||0
5029416|NCT02101021|12377116|P5|STARTED|Overall Study||4
5029417|NCT02101021|12377117|P4|STARTED|Overall Study||3
5029418|NCT02101021|12377118|P3|STARTED|Overall Study||7
5029419|NCT02101021|12377119|P2|STARTED|Overall Study||4
5029420|NCT02101021|12377120|P1|STARTED|Overall Study||7
5029421|NCT02101008|12377162|P1|NOT COMPLETED|Overall Study||0
5029422|NCT02101008|12377162|P1|COMPLETED|Overall Study||12
5029423|NCT02101008|12377162|P1|STARTED|Overall Study||12
5029424|NCT02100969|12377167|P1|NOT COMPLETED|Overall Study||1
5029425|NCT02100969|12377167|P1|COMPLETED|Overall Study||22
5029426|NCT02100969|12377167|P1|STARTED|Overall Study||23
5029427|NCT02100930|12377179|P1|NOT COMPLETED|Overall Study||0
5029428|NCT02100930|12377179|P1|COMPLETED|Overall Study||69
5029429|NCT02100930|12377179|P1|STARTED|Overall Study||69
5029430|NCT02100839|12377186|P2|NOT COMPLETED|Multiple Ascending Dose||0
5029431|NCT02100839|12377187|P1|NOT COMPLETED|Multiple Ascending Dose||4
5029432|NCT02100839|12377186|P2|COMPLETED|Multiple Ascending Dose||3
5029433|NCT02100839|12377187|P1|COMPLETED|Multiple Ascending Dose||9
5029434|NCT02100839|12377186|P2|STARTED|Multiple Ascending Dose||3
5029435|NCT02100839|12377187|P1|STARTED|Multiple Ascending Dose||13
5029436|NCT02100839|12377186|P2|NOT COMPLETED|Single Ascending Dose||0
5029437|NCT02100839|12377187|P1|NOT COMPLETED|Single Ascending Dose||0
5029438|NCT02100839|12377186|P2|COMPLETED|Single Ascending Dose||12
5029439|NCT02100839|12377187|P1|COMPLETED|Single Ascending Dose||24
5029440|NCT02100839|12377186|P2|STARTED|Single Ascending Dose||12
5029441|NCT02100839|12377187|P1|STARTED|Single Ascending Dose||24
5029442|NCT02100826|12377199|P2|NOT COMPLETED|Period 2 (7 Days)||0
5029443|NCT02100826|12377200|P1|NOT COMPLETED|Period 2 (7 Days)||0
5029444|NCT02100826|12377199|P2|COMPLETED|Period 2 (7 Days)||14
5029445|NCT02100826|12377200|P1|COMPLETED|Period 2 (7 Days)||14
5029446|NCT02100826|12377199|P2|STARTED|Period 2 (7 Days)||14
5029447|NCT02100826|12377200|P1|STARTED|Period 2 (7 Days)||14
5029448|NCT02100826|12377199|P2|NOT COMPLETED|Washout Period (1 Day)||0
5029449|NCT02100826|12377200|P1|NOT COMPLETED|Washout Period (1 Day)||0
5029450|NCT02100826|12377199|P2|COMPLETED|Washout Period (1 Day)||14
5029451|NCT02100826|12377200|P1|COMPLETED|Washout Period (1 Day)||14
5029452|NCT02100826|12377199|P2|STARTED|Washout Period (1 Day)||14
5029453|NCT02100826|12377200|P1|STARTED|Washout Period (1 Day)||14
5029454|NCT02100826|12377199|P2|NOT COMPLETED|Period 1 (7 Days)||0
5029455|NCT02100826|12377200|P1|NOT COMPLETED|Period 1 (7 Days)||0
5029456|NCT02100826|12377199|P2|COMPLETED|Period 1 (7 Days)||14
5029457|NCT02100826|12377200|P1|COMPLETED|Period 1 (7 Days)||14
5029458|NCT02100826|12377199|P2|STARTED|Period 1 (7 Days)||14
5029459|NCT02100826|12377200|P1|STARTED|Period 1 (7 Days)||14
5029460|NCT02100813|12377218|P8|NOT COMPLETED|Overall Study||1
5029461|NCT02100813|12377219|P7|NOT COMPLETED|Overall Study||0
5029462|NCT02100813|12377220|P6|NOT COMPLETED|Overall Study||0
5029463|NCT02100813|12377221|P5|NOT COMPLETED|Overall Study||0
5029464|NCT02100813|12377222|P4|NOT COMPLETED|Overall Study||0
5029465|NCT02100813|12377223|P3|NOT COMPLETED|Overall Study||0
5029466|NCT02100813|12377224|P2|NOT COMPLETED|Overall Study||0
5029467|NCT02100813|12377225|P1|NOT COMPLETED|Overall Study||0
5029468|NCT02100813|12377218|P8|COMPLETED|Overall Study||66
5029469|NCT02100813|12377219|P7|COMPLETED|Overall Study||64
5029470|NCT02100813|12377220|P6|COMPLETED|Overall Study||32
5029471|NCT02100813|12377221|P5|COMPLETED|Overall Study||12
5029472|NCT02100813|12377222|P4|COMPLETED|Overall Study||12
5029473|NCT02100813|12377223|P3|COMPLETED|Overall Study||12
5029474|NCT02100813|12377224|P2|COMPLETED|Overall Study||11
5029475|NCT02100813|12377225|P1|COMPLETED|Overall Study||10
5029476|NCT02100813|12377218|P8|STARTED|Overall Study||67
5029477|NCT02100813|12377219|P7|STARTED|Overall Study||64
5029478|NCT02100813|12377220|P6|STARTED|Overall Study||32
5029479|NCT02100813|12377221|P5|STARTED|Overall Study||12
5029480|NCT02100813|12377222|P4|STARTED|Overall Study||12
5029481|NCT02100813|12377223|P3|STARTED|Overall Study||12
5029482|NCT02100813|12377224|P2|STARTED|Overall Study||11
5029483|NCT02100813|12377225|P1|STARTED|Overall Study||10
5029484|NCT02100670|12377253|P4|NOT COMPLETED|Overall Study||1
5029485|NCT02100670|12377254|P3|NOT COMPLETED|Overall Study||4
5029486|NCT02100670|12377255|P2|NOT COMPLETED|Overall Study||7
5029487|NCT02100670|12377256|P1|NOT COMPLETED|Overall Study||13
5029488|NCT02100670|12377253|P4|COMPLETED|Overall Study||75
5029489|NCT02100670|12377254|P3|COMPLETED|Overall Study||74
5029490|NCT02100670|12377255|P2|COMPLETED|Overall Study||106
5029491|NCT02100670|12377256|P1|COMPLETED|Overall Study||105
5029492|NCT02100670|12377253|P4|STARTED|Overall Study||76
5029493|NCT02100670|12377254|P3|STARTED|Overall Study||78
5029494|NCT02100670|12377255|P2|STARTED|Overall Study||113
5029495|NCT02100670|12377256|P1|STARTED|Overall Study||118
5029496|NCT02100644|12377316|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
5029497|NCT02100644|12377317|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
5029498|NCT02100644|12377318|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
5029499|NCT02100644|12377316|P3|COMPLETED|LTG and VPA Maintenance Phase||20
5029500|NCT02100644|12377317|P2|COMPLETED|LTG and VPA Maintenance Phase||0
5029501|NCT02100644|12377318|P1|COMPLETED|LTG and VPA Maintenance Phase||0
5029502|NCT02100644|12377316|P3|STARTED|LTG and VPA Maintenance Phase||20
5029503|NCT02100644|12377317|P2|STARTED|LTG and VPA Maintenance Phase||0
5029504|NCT02100644|12377318|P1|STARTED|LTG and VPA Maintenance Phase||0
5029505|NCT02100644|12377316|P3|NOT COMPLETED|VPA Reduction Phase||0
5029506|NCT02100644|12377317|P2|NOT COMPLETED|VPA Reduction Phase||0
5029507|NCT02100644|12377318|P1|NOT COMPLETED|VPA Reduction Phase||0
5029508|NCT02100644|12377316|P3|COMPLETED|VPA Reduction Phase||0
5029509|NCT02100644|12377317|P2|COMPLETED|VPA Reduction Phase||20
5029510|NCT02100644|12377318|P1|COMPLETED|VPA Reduction Phase||0
5029511|NCT02100644|12377316|P3|STARTED|VPA Reduction Phase||0
5029512|NCT02100644|12377317|P2|STARTED|VPA Reduction Phase||20
5029513|NCT02100644|12377318|P1|STARTED|VPA Reduction Phase||0
5029514|NCT02100644|12377316|P3|NOT COMPLETED|LTG Escalation Phase||0
5029515|NCT02100644|12377317|P2|NOT COMPLETED|LTG Escalation Phase||0
5029516|NCT02100644|12377318|P1|NOT COMPLETED|LTG Escalation Phase||13
5029517|NCT02100644|12377316|P3|COMPLETED|LTG Escalation Phase||0
5029518|NCT02100644|12377317|P2|COMPLETED|LTG Escalation Phase||0
5029519|NCT02100644|12377318|P1|COMPLETED|LTG Escalation Phase||20
5029520|NCT02100644|12377316|P3|STARTED|LTG Escalation Phase||0
5029521|NCT02100644|12377317|P2|STARTED|LTG Escalation Phase||0
5029522|NCT02100644|12377318|P1|STARTED|LTG Escalation Phase||33
5029523|NCT02100579|12377330|P2|NOT COMPLETED|Overall Study||0
5029524|NCT02100579|12377331|P1|NOT COMPLETED|Overall Study||0
5029525|NCT02100579|12377330|P2|COMPLETED|Overall Study||20
5029526|NCT02100579|12377331|P1|COMPLETED|Overall Study||20
5029527|NCT02100579|12377330|P2|STARTED|Overall Study||20
5029528|NCT02100579|12377331|P1|STARTED|Overall Study||20
5029529|NCT02100514|12377343|P5|NOT COMPLETED|Extension Period||0
5029530|NCT02100514|12377344|P4|NOT COMPLETED|Extension Period||0
5029531|NCT02100514|12377345|P3|NOT COMPLETED|Extension Period||2
5029532|NCT02100514|12377346|P2|NOT COMPLETED|Extension Period||0
5029533|NCT02100514|12377347|P1|NOT COMPLETED|Extension Period||0
5029534|NCT02100514|12377343|P5|COMPLETED|Extension Period||56
5029535|NCT02100514|12377344|P4|COMPLETED|Extension Period||33
5029536|NCT02100514|12377345|P3|COMPLETED|Extension Period||42
5029537|NCT02100514|12377346|P2|COMPLETED|Extension Period||0
5029538|NCT02100514|12377347|P1|COMPLETED|Extension Period||0
5029539|NCT02100514|12377343|P5|STARTED|Extension Period||56
5029540|NCT02100514|12377344|P4|STARTED|Extension Period||33
5029541|NCT02100514|12377345|P3|STARTED|Extension Period||44
5029542|NCT02100514|12377346|P2|STARTED|Extension Period||0
5029543|NCT02100514|12377347|P1|STARTED|Extension Period||0
5029544|NCT02100514|12377343|P5|NOT COMPLETED|Treatment Period||0
5029545|NCT02100514|12377344|P4|NOT COMPLETED|Treatment Period||0
5029546|NCT02100514|12377345|P3|NOT COMPLETED|Treatment Period||0
5029547|NCT02100514|12377346|P2|NOT COMPLETED|Treatment Period||74
5029548|NCT02100514|12377347|P1|NOT COMPLETED|Treatment Period||29
5029549|NCT02100514|12377343|P5|COMPLETED|Treatment Period||0
5029550|NCT02100514|12377344|P4|COMPLETED|Treatment Period||0
5029551|NCT02100514|12377345|P3|COMPLETED|Treatment Period||0
5029552|NCT02100514|12377346|P2|COMPLETED|Treatment Period||425
5029553|NCT02100514|12377347|P1|COMPLETED|Treatment Period||218
5029554|NCT02100514|12377343|P5|STARTED|Treatment Period||0
5029555|NCT02100514|12377344|P4|STARTED|Treatment Period||0
5029556|NCT02100514|12377345|P3|STARTED|Treatment Period||0
5029557|NCT02100514|12377346|P2|STARTED|Treatment Period||499
5029558|NCT02100514|12377347|P1|STARTED|Treatment Period||247
5029559|NCT02100475|12377415|P2|NOT COMPLETED|Overall Study||2
5029560|NCT02100475|12377416|P1|NOT COMPLETED|Overall Study||2
5029561|NCT02100475|12377415|P2|COMPLETED|Overall Study||13
5029562|NCT02100475|12377416|P1|COMPLETED|Overall Study||14
5029563|NCT02100475|12377415|P2|STARTED|Overall Study||15
5029564|NCT02100475|12377416|P1|STARTED|Overall Study||16
5029565|NCT02100410|12377426|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029566|NCT02100410|12377427|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029567|NCT02100410|12377428|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029568|NCT02100410|12377429|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029569|NCT02100410|12377430|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029570|NCT02100410|12377431|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
5029571|NCT02100410|12377426|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
5029572|NCT02100410|12377427|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
5029573|NCT02100410|12377428|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
5029574|NCT02100410|12377429|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
5029575|NCT02100410|12377430|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
5029576|NCT02100410|12377431|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
5029577|NCT02100410|12377426|P6|STARTED|Exposure Pair 3, 30 Minutes||9
5029578|NCT02100410|12377427|P5|STARTED|Exposure Pair 3, 30 Minutes||8
5029579|NCT02100410|12377428|P4|STARTED|Exposure Pair 3, 30 Minutes||8
5029580|NCT02100410|12377429|P3|STARTED|Exposure Pair 3, 30 Minutes||8
5029581|NCT02100410|12377430|P2|STARTED|Exposure Pair 3, 30 Minutes||8
5029582|NCT02100410|12377431|P1|STARTED|Exposure Pair 3, 30 Minutes||8
5029583|NCT02100410|12377426|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029584|NCT02100410|12377427|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029585|NCT02100410|12377428|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029586|NCT02100410|12377429|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029587|NCT02100410|12377430|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029588|NCT02100410|12377431|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
5029589|NCT02100410|12377426|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
5029590|NCT02100410|12377427|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
5029591|NCT02100410|12377428|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
5029592|NCT02100410|12377429|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
5029593|NCT02100410|12377430|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
5029594|NCT02100410|12377431|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
5029595|NCT02100410|12377426|P6|STARTED|Exposure Pair 2, 30 Minutes||9
5029596|NCT02100410|12377427|P5|STARTED|Exposure Pair 2, 30 Minutes||8
5029597|NCT02100410|12377428|P4|STARTED|Exposure Pair 2, 30 Minutes||8
5029598|NCT02100410|12377429|P3|STARTED|Exposure Pair 2, 30 Minutes||8
5029599|NCT02100410|12377430|P2|STARTED|Exposure Pair 2, 30 Minutes||8
5029600|NCT02100410|12377431|P1|STARTED|Exposure Pair 2, 30 Minutes||8
5029601|NCT02100410|12377426|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029602|NCT02100410|12377427|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029603|NCT02100410|12377428|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029604|NCT02100410|12377429|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029605|NCT02100410|12377430|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029606|NCT02100410|12377431|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
5029607|NCT02100410|12377426|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
5029608|NCT02100410|12377427|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
5029609|NCT02100410|12377428|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
5029610|NCT02100410|12377429|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
5029611|NCT02100410|12377430|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
5029612|NCT02100410|12377431|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
5029613|NCT02100410|12377426|P6|STARTED|Exposure Pair 1, 30 Minutes||9
5029614|NCT02100410|12377427|P5|STARTED|Exposure Pair 1, 30 Minutes||8
5029615|NCT02100410|12377428|P4|STARTED|Exposure Pair 1, 30 Minutes||8
5029616|NCT02100410|12377429|P3|STARTED|Exposure Pair 1, 30 Minutes||8
5029617|NCT02100410|12377430|P2|STARTED|Exposure Pair 1, 30 Minutes||8
5029618|NCT02100410|12377431|P1|STARTED|Exposure Pair 1, 30 Minutes||8
5029619|NCT02100319|12377447|P1|NOT COMPLETED|Overall Study||16
5029620|NCT02100319|12377447|P1|COMPLETED|Overall Study||371
5029621|NCT02100319|12377447|P1|STARTED|Overall Study||387
5029622|NCT02100280|12377458|P2|NOT COMPLETED|Overall Study||4
5029623|NCT02100280|12377459|P1|NOT COMPLETED|Overall Study||4
5029624|NCT02100280|12377458|P2|COMPLETED|Overall Study||44
5029625|NCT02100280|12377459|P1|COMPLETED|Overall Study||44
5029626|NCT02100280|12377458|P2|STARTED|Overall Study||48
5029627|NCT02100280|12377459|P1|STARTED|Overall Study||48
5029628|NCT02100228|12377475|P2|NOT COMPLETED|Overall Study||90
5029629|NCT02100228|12377476|P1|NOT COMPLETED|Overall Study||75
5029630|NCT02100228|12377475|P2|COMPLETED|Overall Study||657
5029631|NCT02100228|12377476|P1|COMPLETED|Overall Study||678
5029632|NCT02100228|12377475|P2|STARTED|Overall Study|721 treated with Usual Care|747
5029633|NCT02100228|12377476|P1|STARTED|Overall Study|735 treated with Apixaban|753
5029634|NCT02100189|12377502|P1|NOT COMPLETED|Overall Study||0
5029635|NCT02100189|12377502|P1|COMPLETED|Overall Study||50
5029636|NCT02100189|12377502|P1|STARTED|Overall Study||50
5029637|NCT02100124|12377512|P3|NOT COMPLETED|Overall Study||3
5029638|NCT02100124|12377513|P2|NOT COMPLETED|Overall Study||11
5029639|NCT02100124|12377514|P1|NOT COMPLETED|Overall Study||6
5029640|NCT02100124|12377512|P3|COMPLETED|Overall Study||323
5029641|NCT02100124|12377513|P2|COMPLETED|Overall Study||318
5029642|NCT02100124|12377514|P1|COMPLETED|Overall Study||323
5029643|NCT02100124|12377512|P3|STARTED|Overall Study||326
5029644|NCT02100124|12377513|P2|STARTED|Overall Study||329
5029645|NCT02100124|12377514|P1|STARTED|Overall Study||329
5029646|NCT02100007|12377531|P1|NOT COMPLETED|Overall Study||0
5029647|NCT02100007|12377531|P1|COMPLETED|Overall Study||46
5029648|NCT02100007|12377531|P1|STARTED|Overall Study||46
5029649|NCT02099838|12377544|P2|NOT COMPLETED|Overall Study||2
5029650|NCT02099838|12377545|P1|NOT COMPLETED|Overall Study||4
5029651|NCT02099838|12377544|P2|COMPLETED|Overall Study||49
5029652|NCT02099838|12377545|P1|COMPLETED|Overall Study||43
5029653|NCT02099838|12377544|P2|STARTED|Overall Study||51
5029654|NCT02099838|12377545|P1|STARTED|Overall Study||47
5029655|NCT02099786|12377577|P2|NOT COMPLETED|Overall Study||8
5029656|NCT02099786|12377578|P1|NOT COMPLETED|Overall Study||3
5029657|NCT02099786|12377577|P2|COMPLETED|Overall Study||15
5029658|NCT02099786|12377578|P1|COMPLETED|Overall Study||21
5029659|NCT02099786|12377577|P2|Program Eval 3|Overall Study|One year post randomization|15
5029660|NCT02099786|12377578|P1|Program Eval 3|Overall Study|One year post randomization|21
5029661|NCT02099786|12377577|P2|Program Eval 2|Overall Study|One month post randomization|19
5029662|NCT02099786|12377578|P1|Program Eval 2|Overall Study|One month post randomization|23
5029663|NCT02099786|12377577|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
5029664|NCT02099786|12377578|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
5029665|NCT02099786|12377577|P2|STARTED|Overall Study||23
5029666|NCT02099786|12377578|P1|STARTED|Overall Study||24
5029667|NCT02099708|12377590|P1|NOT COMPLETED|Overall Study||200
5029668|NCT02099708|12377590|P1|COMPLETED|Overall Study||3302
5029669|NCT02099708|12377590|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
5029670|NCT02099708|12377590|P1|STARTED|Overall Study|Number of cases.|3502
5029671|NCT02099682|12377601|P1|NOT COMPLETED|Overall Study||111
5029672|NCT02099682|12377601|P1|COMPLETED|Overall Study||3255
5029673|NCT02099682|12377601|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
5029674|NCT02099682|12377601|P1|STARTED|Overall Study|Number of cases.|3366
5029675|NCT02099461|12377615|P3|NOT COMPLETED|Overall Study||0
5029676|NCT02099461|12377616|P2|NOT COMPLETED|Overall Study||0
5029677|NCT02099461|12377617|P1|NOT COMPLETED|Overall Study||0
5029678|NCT02099461|12377615|P3|COMPLETED|Overall Study||28
5029679|NCT02099461|12377616|P2|COMPLETED|Overall Study||27
5029680|NCT02099461|12377617|P1|COMPLETED|Overall Study||27
5029681|NCT02099461|12377615|P3|STARTED|Overall Study||28
5029682|NCT02099461|12377616|P2|STARTED|Overall Study||27
5029683|NCT02099461|12377617|P1|STARTED|Overall Study||27
5029684|NCT02099344|12377627|P2|NOT COMPLETED|Overall Study||0
5029685|NCT02099344|12377628|P1|NOT COMPLETED|Overall Study||1
5029686|NCT02099344|12377627|P2|COMPLETED|Overall Study||0
5029687|NCT02099344|12377628|P1|COMPLETED|Overall Study||0
5029688|NCT02099344|12377627|P2|STARTED|Overall Study||0
5029689|NCT02099344|12377628|P1|STARTED|Overall Study||1
5029690|NCT02099318|12377638|P2|NOT COMPLETED|Overall Study||0
5029691|NCT02099318|12377639|P1|NOT COMPLETED|Overall Study||0
5029692|NCT02099318|12377638|P2|COMPLETED|Overall Study||20
5029693|NCT02099318|12377639|P1|COMPLETED|Overall Study||20
5029694|NCT02099318|12377638|P2|STARTED|Overall Study||20
5029695|NCT02099318|12377639|P1|STARTED|Overall Study||20
5029696|NCT02099266|12377653|P1|NOT COMPLETED|Overall Study||0
5029697|NCT02099266|12377653|P1|COMPLETED|Overall Study||15
5029698|NCT02099266|12377653|P1|STARTED|Overall Study||15
5029699|NCT02099110|12377665|P5|NOT COMPLETED|Overall Study||27
5029700|NCT02099110|12377666|P4|NOT COMPLETED|Overall Study||22
5029701|NCT02099110|12377667|P3|NOT COMPLETED|Overall Study||28
5029702|NCT02099110|12377668|P2|NOT COMPLETED|Overall Study||31
5029703|NCT02099110|12377669|P1|NOT COMPLETED|Overall Study||24
5029704|NCT02099110|12377665|P5|COMPLETED|Overall Study||218
5029705|NCT02099110|12377666|P4|COMPLETED|Overall Study||221
5029706|NCT02099110|12377667|P3|COMPLETED|Overall Study||219
5029707|NCT02099110|12377668|P2|COMPLETED|Overall Study||217
5029708|NCT02099110|12377669|P1|COMPLETED|Overall Study||226
5029709|NCT02099110|12377665|P5|Treated|Overall Study||244
5029710|NCT02099110|12377666|P4|Treated|Overall Study||243
5029711|NCT02099110|12377667|P3|Treated|Overall Study||247
5029712|NCT02099110|12377668|P2|Treated|Overall Study||248
5029713|NCT02099110|12377669|P1|Treated|Overall Study||250
5029714|NCT02099110|12377665|P5|STARTED|Overall Study||245
5029715|NCT02099110|12377666|P4|STARTED|Overall Study||243
5029716|NCT02099110|12377667|P3|STARTED|Overall Study||247
5029717|NCT02099110|12377668|P2|STARTED|Overall Study||248
5029718|NCT02099110|12377669|P1|STARTED|Overall Study||250
5029719|NCT02099084|12377716|P2|NOT COMPLETED|Second Intervention||0
5029720|NCT02099084|12377717|P1|NOT COMPLETED|Second Intervention||0
5029721|NCT02099084|12377716|P2|COMPLETED|Second Intervention||4
5029722|NCT02099084|12377717|P1|COMPLETED|Second Intervention||4
5029723|NCT02099084|12377716|P2|STARTED|Second Intervention||4
5029724|NCT02099084|12377717|P1|STARTED|Second Intervention||4
5029725|NCT02099084|12377716|P2|NOT COMPLETED|Washout Period of 14 Days||0
5029726|NCT02099084|12377717|P1|NOT COMPLETED|Washout Period of 14 Days||0
5029727|NCT02099084|12377716|P2|COMPLETED|Washout Period of 14 Days||4
5029728|NCT02099084|12377717|P1|COMPLETED|Washout Period of 14 Days||4
5029729|NCT02099084|12377716|P2|STARTED|Washout Period of 14 Days||4
5029730|NCT02099084|12377717|P1|STARTED|Washout Period of 14 Days||4
5029731|NCT02099084|12377716|P2|NOT COMPLETED|First Intervention||0
5029732|NCT02099084|12377717|P1|NOT COMPLETED|First Intervention||0
5029733|NCT02099084|12377716|P2|COMPLETED|First Intervention||4
5029734|NCT02099084|12377717|P1|COMPLETED|First Intervention||4
5029735|NCT02099084|12377716|P2|STARTED|First Intervention||4
5029736|NCT02099084|12377717|P1|STARTED|First Intervention||4
5029737|NCT02099006|12377735|P1|NOT COMPLETED|Overall Study||1
5029738|NCT02099006|12377735|P1|COMPLETED|Overall Study||8
5029739|NCT02099006|12377735|P1|Received Gabapentin|Overall Study||8
5029740|NCT02099006|12377735|P1|Received Ketamine|Overall Study||6
5029741|NCT02099006|12377735|P1|Received Loperamide|Overall Study||7
5029742|NCT02099006|12377735|P1|Received Ketoprofen|Overall Study||3
5029743|NCT02099006|12377735|P1|Received Amitriptyline/ Baclofen|Overall Study||7
5029744|NCT02099006|12377735|P1|Received Placebo|Overall Study||9
5029745|NCT02099006|12377735|P1|STARTED|Overall Study||9
5029746|NCT02098993|12377745|P2|NOT COMPLETED|Overall Study||0
5029747|NCT02098993|12377746|P1|NOT COMPLETED|Overall Study||0
5029748|NCT02098993|12377745|P2|COMPLETED|Overall Study||3
5029749|NCT02098993|12377746|P1|COMPLETED|Overall Study||4
5029750|NCT02098993|12377745|P2|STARTED|Overall Study||3
5029751|NCT02098993|12377746|P1|STARTED|Overall Study||4
5029752|NCT02098746|12377770|P1|NOT COMPLETED|Overall Study||5
5029753|NCT02098746|12377770|P1|COMPLETED|Overall Study||289
5029754|NCT02098746|12377770|P1|STARTED|Overall Study||294
5029755|NCT02098733|12377778|P1|NOT COMPLETED|Overall Study||10
5029756|NCT02098733|12377778|P1|COMPLETED|Overall Study||1158
5029757|NCT02098733|12377778|P1|STARTED|Overall Study||1168
5029758|NCT02098395|12377792|P4|NOT COMPLETED|Overall Study||27
5029759|NCT02098395|12377793|P3|NOT COMPLETED|Overall Study||42
5029760|NCT02098395|12377794|P2|NOT COMPLETED|Overall Study||32
5029761|NCT02098395|12377795|P1|NOT COMPLETED|Overall Study||26
5029762|NCT02098395|12377792|P4|COMPLETED|Overall Study||180
5029763|NCT02098395|12377793|P3|COMPLETED|Overall Study||165
5029764|NCT02098395|12377794|P2|COMPLETED|Overall Study||177
5029765|NCT02098395|12377795|P1|COMPLETED|Overall Study||186
5029766|NCT02098395|12377792|P4|Exposed|Overall Study||206
5029767|NCT02098395|12377793|P3|Exposed|Overall Study||206
5029768|NCT02098395|12377794|P2|Exposed|Overall Study||209
5029769|NCT02098395|12377795|P1|Exposed|Overall Study||211
5029770|NCT02098395|12377792|P4|STARTED|Overall Study||207
5029771|NCT02098395|12377793|P3|STARTED|Overall Study||207
5029772|NCT02098395|12377794|P2|STARTED|Overall Study||209
5029773|NCT02098395|12377795|P1|STARTED|Overall Study||212
5029774|NCT02098369|12377816|P3|NOT COMPLETED|Overall Study||5
5029775|NCT02098369|12377817|P2|NOT COMPLETED|Overall Study||9
5029776|NCT02098369|12377818|P1|NOT COMPLETED|Overall Study||7
5029777|NCT02098369|12377816|P3|COMPLETED|Overall Study||143
5029778|NCT02098369|12377817|P2|COMPLETED|Overall Study||145
5029779|NCT02098369|12377818|P1|COMPLETED|Overall Study||135
5029780|NCT02098369|12377816|P3|STARTED|Overall Study||148
5029781|NCT02098369|12377817|P2|STARTED|Overall Study||154
5029782|NCT02098369|12377818|P1|STARTED|Overall Study||142
5029783|NCT02098304|12377847|P1|NOT COMPLETED|Overall Study||0
5029784|NCT02098304|12377847|P1|COMPLETED|Overall Study||42
5029785|NCT02098304|12377847|P1|STARTED|Overall Study||42
5029786|NCT02098109|12377856|P2|NOT COMPLETED|Overall Study||0
5029787|NCT02098109|12377857|P1|NOT COMPLETED|Overall Study||3
5029788|NCT02098109|12377856|P2|COMPLETED|Overall Study||51
5029789|NCT02098109|12377857|P1|COMPLETED|Overall Study||46
5029790|NCT02098109|12377856|P2|STARTED|Overall Study||51
5029791|NCT02098109|12377857|P1|STARTED|Overall Study||49
5029792|NCT02097992|12377883|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
5029793|NCT02097992|12377884|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
5029794|NCT02097992|12377885|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
5029795|NCT02097992|12377886|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
5029796|NCT02097992|12377883|P4|COMPLETED|Treatment 3 (4 Weeks)||2
5029797|NCT02097992|12377884|P3|COMPLETED|Treatment 3 (4 Weeks)||4
5029798|NCT02097992|12377885|P2|COMPLETED|Treatment 3 (4 Weeks)||3
5029799|NCT02097992|12377886|P1|COMPLETED|Treatment 3 (4 Weeks)||2
5029800|NCT02097992|12377883|P4|STARTED|Treatment 3 (4 Weeks)||2
5029801|NCT02097992|12377884|P3|STARTED|Treatment 3 (4 Weeks)||4
5029802|NCT02097992|12377885|P2|STARTED|Treatment 3 (4 Weeks)||3
5029803|NCT02097992|12377886|P1|STARTED|Treatment 3 (4 Weeks)||2
5029804|NCT02097992|12377883|P4|NOT COMPLETED|Washout (4 Weeks)||0
5029805|NCT02097992|12377884|P3|NOT COMPLETED|Washout (4 Weeks)||0
5029806|NCT02097992|12377885|P2|NOT COMPLETED|Washout (4 Weeks)||0
5029807|NCT02097992|12377886|P1|NOT COMPLETED|Washout (4 Weeks)||0
5029808|NCT02097992|12377883|P4|COMPLETED|Washout (4 Weeks)||2
5029809|NCT02097992|12377884|P3|COMPLETED|Washout (4 Weeks)||4
5029810|NCT02097992|12377885|P2|COMPLETED|Washout (4 Weeks)||3
5029811|NCT02097992|12377886|P1|COMPLETED|Washout (4 Weeks)||2
5029812|NCT02097992|12377883|P4|STARTED|Washout (4 Weeks)||2
5029813|NCT02097992|12377884|P3|STARTED|Washout (4 Weeks)||4
5029814|NCT02097992|12377885|P2|STARTED|Washout (4 Weeks)||3
5029815|NCT02097992|12377886|P1|STARTED|Washout (4 Weeks)||2
5029816|NCT02097992|12377883|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
5029817|NCT02097992|12377884|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
5029818|NCT02097992|12377885|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
5029819|NCT02097992|12377886|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
5029820|NCT02097992|12377883|P4|COMPLETED|Treatment 2 (4 Weeks)||2
5029821|NCT02097992|12377884|P3|COMPLETED|Treatment 2 (4 Weeks)||4
5029822|NCT02097992|12377885|P2|COMPLETED|Treatment 2 (4 Weeks)||3
5029823|NCT02097992|12377886|P1|COMPLETED|Treatment 2 (4 Weeks)||2
5029824|NCT02097992|12377883|P4|STARTED|Treatment 2 (4 Weeks)||2
5029825|NCT02097992|12377884|P3|STARTED|Treatment 2 (4 Weeks)||4
5029826|NCT02097992|12377885|P2|STARTED|Treatment 2 (4 Weeks)||3
5029827|NCT02097992|12377886|P1|STARTED|Treatment 2 (4 Weeks)||2
5029828|NCT02097992|12377883|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
5029829|NCT02097992|12377884|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
5029830|NCT02097992|12377885|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
5029831|NCT02097992|12377886|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
5029832|NCT02097992|12377883|P4|COMPLETED|Treatment 1 (1 Day)||2
5029833|NCT02097992|12377884|P3|COMPLETED|Treatment 1 (1 Day)||4
5029834|NCT02097992|12377885|P2|COMPLETED|Treatment 1 (1 Day)||3
5029835|NCT02097992|12377886|P1|COMPLETED|Treatment 1 (1 Day)||2
5029836|NCT02097992|12377883|P4|STARTED|Treatment 1 (1 Day)||2
5029837|NCT02097992|12377884|P3|STARTED|Treatment 1 (1 Day)||4
5029838|NCT02097992|12377885|P2|STARTED|Treatment 1 (1 Day)||3
5029839|NCT02097992|12377886|P1|STARTED|Treatment 1 (1 Day)||2
5029840|NCT02097849|12377896|P2|NOT COMPLETED|Overall Study||0
5029841|NCT02097849|12377897|P1|NOT COMPLETED|Overall Study||0
5029842|NCT02097849|12377896|P2|COMPLETED|Overall Study||38
5029843|NCT02097849|12377897|P1|COMPLETED|Overall Study||33
5029844|NCT02097849|12377896|P2|STARTED|Overall Study||38
5029845|NCT02097849|12377897|P1|STARTED|Overall Study||33
5029846|NCT02097823|12377935|P2|NOT COMPLETED|Overall Study||1
5029847|NCT02097823|12377936|P1|NOT COMPLETED|Overall Study||1
5029848|NCT02097823|12377935|P2|COMPLETED|Overall Study||3
5029849|NCT02097823|12377936|P1|COMPLETED|Overall Study||10
5029850|NCT02097823|12377935|P2|STARTED|Overall Study||4
5029851|NCT02097823|12377936|P1|STARTED|Overall Study||11
5029852|NCT02097745|12377951|P1|NOT COMPLETED|Overall Study||178
5029853|NCT02097745|12377951|P1|COMPLETED|Overall Study||157
5029854|NCT02097745|12377951|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
5029855|NCT02097732|12377975|P2|NOT COMPLETED|Overall Study||0
5029856|NCT02097732|12377976|P1|NOT COMPLETED|Overall Study||0
5029857|NCT02097732|12377975|P2|COMPLETED|Overall Study||3
5029858|NCT02097732|12377976|P1|COMPLETED|Overall Study||1
5029859|NCT02097732|12377975|P2|STARTED|Overall Study||3
5029860|NCT02097732|12377976|P1|STARTED|Overall Study||1
5029861|NCT02097719|12377989|P2|NOT COMPLETED|Overall Study||1
5029862|NCT02097719|12377990|P1|NOT COMPLETED|Overall Study||3
5029863|NCT02097719|12377989|P2|COMPLETED|Overall Study||50
5029864|NCT02097719|12377990|P1|COMPLETED|Overall Study||46
5029865|NCT02097719|12377989|P2|STARTED|Overall Study||51
5029866|NCT02097719|12377990|P1|STARTED|Overall Study||49
5029867|NCT02097641|12377998|P2|NOT COMPLETED|Overall Study||0
5029868|NCT02097641|12377999|P1|NOT COMPLETED|Overall Study||0
5029869|NCT02097641|12377998|P2|COMPLETED|Overall Study||20
5029870|NCT02097641|12377999|P1|COMPLETED|Overall Study||40
5029871|NCT02097641|12377998|P2|STARTED|Overall Study||20
5029872|NCT02097641|12377999|P1|STARTED|Overall Study||40
5029873|NCT02097537|12378041|P1|NOT COMPLETED|Overall Study||0
5029874|NCT02097537|12378041|P1|COMPLETED|Overall Study||10
5029875|NCT02097537|12378041|P1|Follow-Up|Overall Study||10
5029876|NCT02097537|12378041|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
5029877|NCT02097537|12378041|P1|STARTED|Overall Study||10
5029878|NCT02097472|12378055|P8|NOT COMPLETED|Assessed for Immunogenicity||1
5029879|NCT02097472|12378056|P7|NOT COMPLETED|Assessed for Immunogenicity||2
5029880|NCT02097472|12378057|P6|NOT COMPLETED|Assessed for Immunogenicity||2
5029881|NCT02097472|12378058|P5|NOT COMPLETED|Assessed for Immunogenicity||0
5029882|NCT02097472|12378059|P4|NOT COMPLETED|Assessed for Immunogenicity||2
5029883|NCT02097472|12378060|P3|NOT COMPLETED|Assessed for Immunogenicity||1
5029884|NCT02097472|12378061|P2|NOT COMPLETED|Assessed for Immunogenicity||0
5029885|NCT02097472|12378062|P1|NOT COMPLETED|Assessed for Immunogenicity||0
5029886|NCT02097472|12378055|P8|COMPLETED|Assessed for Immunogenicity||49
5029887|NCT02097472|12378056|P7|COMPLETED|Assessed for Immunogenicity||47
5029888|NCT02097472|12378057|P6|COMPLETED|Assessed for Immunogenicity||48
5029889|NCT02097472|12378058|P5|COMPLETED|Assessed for Immunogenicity||50
5029890|NCT02097472|12378059|P4|COMPLETED|Assessed for Immunogenicity||48
5029891|NCT02097472|12378060|P3|COMPLETED|Assessed for Immunogenicity||17
5029892|NCT02097472|12378061|P2|COMPLETED|Assessed for Immunogenicity||18
5029893|NCT02097472|12378062|P1|COMPLETED|Assessed for Immunogenicity||18
5029894|NCT02097472|12378055|P8|STARTED|Assessed for Immunogenicity||50
5029895|NCT02097472|12378056|P7|STARTED|Assessed for Immunogenicity||49
5029896|NCT02097472|12378057|P6|STARTED|Assessed for Immunogenicity||50
5029897|NCT02097472|12378058|P5|STARTED|Assessed for Immunogenicity||50
5029898|NCT02097472|12378059|P4|STARTED|Assessed for Immunogenicity||50
5029899|NCT02097472|12378060|P3|STARTED|Assessed for Immunogenicity||18
5029900|NCT02097472|12378061|P2|STARTED|Assessed for Immunogenicity||18
5029901|NCT02097472|12378062|P1|STARTED|Assessed for Immunogenicity||18
5029902|NCT02097472|12378055|P8|NOT COMPLETED|Received Vaccination 2||0
5029903|NCT02097472|12378056|P7|NOT COMPLETED|Received Vaccination 2||1
5029904|NCT02097472|12378057|P6|NOT COMPLETED|Received Vaccination 2||0
5029905|NCT02097472|12378058|P5|NOT COMPLETED|Received Vaccination 2||0
5029906|NCT02097472|12378059|P4|NOT COMPLETED|Received Vaccination 2||0
5029907|NCT02097472|12378060|P3|NOT COMPLETED|Received Vaccination 2||0
5029908|NCT02097472|12378061|P2|NOT COMPLETED|Received Vaccination 2||0
5029909|NCT02097472|12378062|P1|NOT COMPLETED|Received Vaccination 2||0
5029910|NCT02097472|12378055|P8|COMPLETED|Received Vaccination 2||50
5029911|NCT02097472|12378056|P7|COMPLETED|Received Vaccination 2||49
5029912|NCT02097472|12378057|P6|COMPLETED|Received Vaccination 2||50
5029913|NCT02097472|12378058|P5|COMPLETED|Received Vaccination 2||50
5029914|NCT02097472|12378059|P4|COMPLETED|Received Vaccination 2||50
5029915|NCT02097472|12378060|P3|COMPLETED|Received Vaccination 2||18
5029916|NCT02097472|12378061|P2|COMPLETED|Received Vaccination 2||18
5029917|NCT02097472|12378062|P1|COMPLETED|Received Vaccination 2||18
5029918|NCT02097472|12378055|P8|STARTED|Received Vaccination 2||50
5029919|NCT02097472|12378056|P7|STARTED|Received Vaccination 2||50
5029920|NCT02097472|12378057|P6|STARTED|Received Vaccination 2||50
5029921|NCT02097472|12378058|P5|STARTED|Received Vaccination 2||50
5029922|NCT02097472|12378059|P4|STARTED|Received Vaccination 2||50
5029923|NCT02097472|12378060|P3|STARTED|Received Vaccination 2||18
5029924|NCT02097472|12378061|P2|STARTED|Received Vaccination 2||18
5029925|NCT02097472|12378062|P1|STARTED|Received Vaccination 2||18
5029926|NCT02097472|12378055|P8|NOT COMPLETED|Received Vaccination 1||0
5029927|NCT02097472|12378056|P7|NOT COMPLETED|Received Vaccination 1||0
5029928|NCT02097472|12378057|P6|NOT COMPLETED|Received Vaccination 1||0
5029929|NCT02097472|12378058|P5|NOT COMPLETED|Received Vaccination 1||0
5029930|NCT02097472|12378059|P4|NOT COMPLETED|Received Vaccination 1||0
5029931|NCT02097472|12378060|P3|NOT COMPLETED|Received Vaccination 1||0
5029932|NCT02097472|12378061|P2|NOT COMPLETED|Received Vaccination 1||0
5029933|NCT02097472|12378062|P1|NOT COMPLETED|Received Vaccination 1||0
5029934|NCT02097472|12378055|P8|COMPLETED|Received Vaccination 1||50
5029935|NCT02097472|12378056|P7|COMPLETED|Received Vaccination 1||50
5029936|NCT02097472|12378057|P6|COMPLETED|Received Vaccination 1||50
5029937|NCT02097472|12378058|P5|COMPLETED|Received Vaccination 1||50
5029938|NCT02097472|12378059|P4|COMPLETED|Received Vaccination 1||50
5029939|NCT02097472|12378060|P3|COMPLETED|Received Vaccination 1||18
5029940|NCT02097472|12378061|P2|COMPLETED|Received Vaccination 1||18
5029941|NCT02097472|12378062|P1|COMPLETED|Received Vaccination 1||18
5029942|NCT02097472|12378055|P8|STARTED|Received Vaccination 1||50
5029943|NCT02097472|12378056|P7|STARTED|Received Vaccination 1||50
5029944|NCT02097472|12378057|P6|STARTED|Received Vaccination 1||50
5029945|NCT02097472|12378058|P5|STARTED|Received Vaccination 1||50
5029946|NCT02097472|12378059|P4|STARTED|Received Vaccination 1||50
5029947|NCT02097472|12378060|P3|STARTED|Received Vaccination 1||18
5029948|NCT02097472|12378061|P2|STARTED|Received Vaccination 1||18
5029949|NCT02097472|12378062|P1|STARTED|Received Vaccination 1||18
5029950|NCT02097420|12378483|P1|NOT COMPLETED|Overall Study||14
5029951|NCT02097420|12378483|P1|COMPLETED|Overall Study||6
5029952|NCT02097420|12378483|P1|STARTED|Overall Study||20
5029953|NCT02097303|12378493|P1|NOT COMPLETED|Overall Study||5
5029954|NCT02097303|12378493|P1|COMPLETED|Overall Study||31
5029955|NCT02097303|12378493|P1|STARTED|Overall Study||36
5029956|NCT02097290|12378503|P1|NOT COMPLETED|Overall Study||17
5029957|NCT02097290|12378503|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
5029958|NCT02097290|12378503|P1|STARTED|Overall Study||210
5029959|NCT02097277|12378518|P5|NOT COMPLETED|Overall Study||1
5029960|NCT02097277|12378519|P4|NOT COMPLETED|Overall Study||4
5029961|NCT02097277|12378520|P3|NOT COMPLETED|Overall Study||2
5029962|NCT02097277|12378521|P2|NOT COMPLETED|Overall Study||3
5029963|NCT02097277|12378522|P1|NOT COMPLETED|Overall Study||2
5029964|NCT02097277|12378518|P5|COMPLETED|Overall Study||23
5029965|NCT02097277|12378519|P4|COMPLETED|Overall Study||20
5029966|NCT02097277|12378520|P3|COMPLETED|Overall Study||22
5029967|NCT02097277|12378521|P2|COMPLETED|Overall Study||21
5029968|NCT02097277|12378522|P1|COMPLETED|Overall Study||22
5029969|NCT02097277|12378518|P5|STARTED|Overall Study||24
5029970|NCT02097277|12378519|P4|STARTED|Overall Study||24
5029971|NCT02097277|12378520|P3|STARTED|Overall Study||24
5029972|NCT02097277|12378521|P2|STARTED|Overall Study||24
5029973|NCT02097277|12378522|P1|STARTED|Overall Study||24
5029974|NCT02097238|12378605|P1|NOT COMPLETED|Overall Study||19
5029975|NCT02097238|12378605|P1|COMPLETED|Overall Study||0
5029976|NCT02097238|12378605|P1|STARTED|Overall Study||19
5029977|NCT02097134|12378614|P1|NOT COMPLETED|Overall Study||9
5029978|NCT02097134|12378614|P1|COMPLETED|Overall Study||5
5029979|NCT02097134|12378614|P1|STARTED|Overall Study||14
5029980|NCT02097108|12378622|P1|NOT COMPLETED|Overall Study||2
5029981|NCT02097108|12378622|P1|COMPLETED|Overall Study||9
5029982|NCT02097108|12378622|P1|STARTED|Overall Study||11
5029983|NCT02097056|12378629|P1|NOT COMPLETED|Overall Study||58
5029984|NCT02097056|12378629|P1|COMPLETED|Overall Study||113
5029985|NCT02097056|12378629|P1|ParticipantsTreated|Overall Study||170
5029986|NCT02097056|12378629|P1|STARTED|Overall Study||171
5029987|NCT02097030|12378637|P2|NOT COMPLETED|Second Intervention (3 Days)||0
5029988|NCT02097030|12378638|P1|NOT COMPLETED|Second Intervention (3 Days)||0
5029989|NCT02097030|12378637|P2|COMPLETED|Second Intervention (3 Days)||16
5029990|NCT02097030|12378638|P1|COMPLETED|Second Intervention (3 Days)||14
5029991|NCT02097030|12378637|P2|STARTED|Second Intervention (3 Days)||16
5029992|NCT02097030|12378638|P1|STARTED|Second Intervention (3 Days)||14
5029993|NCT02097030|12378637|P2|NOT COMPLETED|First Intervention (3 Days)||1
5029994|NCT02097030|12378638|P1|NOT COMPLETED|First Intervention (3 Days)||1
5029995|NCT02097030|12378637|P2|COMPLETED|First Intervention (3 Days)||16
5029996|NCT02097030|12378638|P1|COMPLETED|First Intervention (3 Days)||14
5029997|NCT02097030|12378637|P2|STARTED|First Intervention (3 Days)||17
5029998|NCT02097030|12378638|P1|STARTED|First Intervention (3 Days)||15
5029999|NCT02096952|12378699|P1|NOT COMPLETED|Overall Study||1
5030000|NCT02096952|12378699|P1|COMPLETED|Overall Study||14
5030001|NCT02096952|12378699|P1|STARTED|Overall Study||15
5030002|NCT02096900|12378705|P2|NOT COMPLETED|Overall Study||2
5030003|NCT02096900|12378706|P1|NOT COMPLETED|Overall Study||4
5030004|NCT02096900|12378705|P2|COMPLETED|Overall Study||42
5030005|NCT02096900|12378706|P1|COMPLETED|Overall Study||38
5030006|NCT02096900|12378705|P2|STARTED|Overall Study|Allocated to Zolpidem|44
5030007|NCT02096900|12378706|P1|STARTED|Overall Study|Allocated to Midazolam|42
5030008|NCT02096861|12378724|P4|NOT COMPLETED|Overall Study||10
5030009|NCT02096861|12378725|P3|NOT COMPLETED|Overall Study||17
5030010|NCT02096861|12378726|P2|NOT COMPLETED|Overall Study||15
5030011|NCT02096861|12378727|P1|NOT COMPLETED|Overall Study||12
5030012|NCT02096861|12378724|P4|COMPLETED|Overall Study||45
5030013|NCT02096861|12378725|P3|COMPLETED|Overall Study||37
5030014|NCT02096861|12378726|P2|COMPLETED|Overall Study||40
5030015|NCT02096861|12378727|P1|COMPLETED|Overall Study||44
5030016|NCT02096861|12378724|P4|Drug Switching at Week 30|Overall Study||47
5030017|NCT02096861|12378725|P3|Drug Switching at Week 30|Overall Study||41
5030018|NCT02096861|12378726|P2|Drug Switching at Week 30|Overall Study||44
5030019|NCT02096861|12378727|P1|Drug Switching at Week 30|Overall Study||48
5030020|NCT02096861|12378724|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
5030021|NCT02096861|12378725|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
5030022|NCT02096861|12378726|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
5030023|NCT02096861|12378727|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
5030024|NCT02096835|12378758|P3|NOT COMPLETED|Overall Study||1
5030025|NCT02096835|12378759|P2|NOT COMPLETED|Overall Study||0
5030026|NCT02096835|12378760|P1|NOT COMPLETED|Overall Study||3
5030027|NCT02096835|12378758|P3|COMPLETED|Overall Study||50
5030028|NCT02096835|12378759|P2|COMPLETED|Overall Study||53
5030029|NCT02096835|12378760|P1|COMPLETED|Overall Study||50
5030030|NCT02096835|12378758|P3|STARTED|Overall Study||51
5030031|NCT02096835|12378759|P2|STARTED|Overall Study||53
5030032|NCT02096835|12378760|P1|STARTED|Overall Study||53
5030033|NCT02096744|12378777|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
5030034|NCT02096744|12378778|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5030035|NCT02096744|12378777|P2|COMPLETED|Treatment Period 3 (7 Days)||27
5030036|NCT02096744|12378778|P1|COMPLETED|Treatment Period 3 (7 Days)||28
5030037|NCT02096744|12378777|P2|STARTED|Treatment Period 3 (7 Days)||28
5030038|NCT02096744|12378778|P1|STARTED|Treatment Period 3 (7 Days)||28
5030039|NCT02096744|12378777|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
5030040|NCT02096744|12378778|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
5030041|NCT02096744|12378777|P2|COMPLETED|Washout Period 2 (3 Days)||28
5030042|NCT02096744|12378778|P1|COMPLETED|Washout Period 2 (3 Days)||28
5030043|NCT02096744|12378777|P2|STARTED|Washout Period 2 (3 Days)||28
5030044|NCT02096744|12378778|P1|STARTED|Washout Period 2 (3 Days)||28
5030045|NCT02096744|12378777|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5030046|NCT02096744|12378778|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5030047|NCT02096744|12378777|P2|COMPLETED|Treatment Period 2 (7 Days)||28
5030048|NCT02096744|12378778|P1|COMPLETED|Treatment Period 2 (7 Days)||28
5030049|NCT02096744|12378777|P2|STARTED|Treatment Period 2 (7 Days)||28
5030050|NCT02096744|12378778|P1|STARTED|Treatment Period 2 (7 Days)||28
5030051|NCT02096744|12378777|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
5030052|NCT02096744|12378778|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
5030053|NCT02096744|12378777|P2|COMPLETED|Washout Period 1(7 Days)||28
5030054|NCT02096744|12378778|P1|COMPLETED|Washout Period 1(7 Days)||28
5030055|NCT02096744|12378777|P2|STARTED|Washout Period 1(7 Days)||28
5030056|NCT02096744|12378778|P1|STARTED|Washout Period 1(7 Days)||28
5030057|NCT02096744|12378777|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
5030058|NCT02096744|12378778|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
5030059|NCT02096744|12378777|P2|COMPLETED|Treatment Period 1(7 Days)||28
5030060|NCT02096744|12378778|P1|COMPLETED|Treatment Period 1(7 Days)||28
5030061|NCT02096744|12378777|P2|STARTED|Treatment Period 1(7 Days)||29
5030062|NCT02096744|12378778|P1|STARTED|Treatment Period 1(7 Days)||29
5030063|NCT02096731|12378793|P2|NOT COMPLETED|Overall Study||0
5030064|NCT02096731|12378794|P1|NOT COMPLETED|Overall Study||0
5030065|NCT02096731|12378793|P2|COMPLETED|Overall Study||88955
5030066|NCT02096731|12378794|P1|COMPLETED|Overall Study||26442
5030067|NCT02096731|12378793|P2|STARTED|Overall Study||88955
5030068|NCT02096731|12378794|P1|STARTED|Overall Study||26442
5030069|NCT02096718|12378811|P3|NOT COMPLETED|Overall Study||0
5030070|NCT02096718|12378812|P2|NOT COMPLETED|Overall Study||0
5030071|NCT02096718|12378813|P1|NOT COMPLETED|Overall Study||0
5030072|NCT02096718|12378811|P3|COMPLETED|Overall Study||14
5030073|NCT02096718|12378812|P2|COMPLETED|Overall Study||8
5030074|NCT02096718|12378813|P1|COMPLETED|Overall Study||8
5030075|NCT02096718|12378811|P3|STARTED|Overall Study||14
5030076|NCT02096718|12378812|P2|STARTED|Overall Study||8
5030077|NCT02096718|12378813|P1|STARTED|Overall Study||8
5030078|NCT02096705|12378832|P2|NOT COMPLETED|Follow-up||4
5030079|NCT02096705|12378833|P1|NOT COMPLETED|Follow-up||4
5030080|NCT02096705|12378832|P2|COMPLETED|Follow-up||135
5030081|NCT02096705|12378833|P1|COMPLETED|Follow-up||125
5030082|NCT02096705|12378832|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
5030083|NCT02096705|12378833|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
5030084|NCT02096705|12378832|P2|NOT COMPLETED|Treatment||5
5030085|NCT02096705|12378833|P1|NOT COMPLETED|Treatment||9
5030086|NCT02096705|12378832|P2|COMPLETED|Treatment||134
5030087|NCT02096705|12378833|P1|COMPLETED|Treatment||124
5030088|NCT02096705|12378832|P2|STARTED|Treatment||139
5030089|NCT02096705|12378833|P1|STARTED|Treatment||133
5030090|NCT02096692|12378845|P1|NOT COMPLETED|Overall Study||4
5030091|NCT02096692|12378845|P1|COMPLETED|Overall Study||150
5030092|NCT02096692|12378845|P1|STARTED|Overall Study||154
5030093|NCT02096679|12378851|P1|NOT COMPLETED|Overall Study||0
5030094|NCT02096679|12378851|P1|COMPLETED|Overall Study||8
5030095|NCT02096679|12378851|P1|STARTED|Overall Study||8
5030096|NCT02096588|12378876|P2|NOT COMPLETED|Overall Study||1
5030097|NCT02096588|12378877|P1|NOT COMPLETED|Overall Study||2
5030098|NCT02096588|12378876|P2|COMPLETED|Overall Study||15
5030099|NCT02096588|12378877|P1|COMPLETED|Overall Study||13
5030100|NCT02096588|12378876|P2|STARTED|Overall Study||16
5030101|NCT02096588|12378877|P1|STARTED|Overall Study||15
5030102|NCT02096575|12378887|P3|NOT COMPLETED|Overall Study||5
5030103|NCT02096575|12378888|P2|NOT COMPLETED|Overall Study||0
5030104|NCT02096575|12378889|P1|NOT COMPLETED|Overall Study||0
5030105|NCT02096575|12378887|P3|COMPLETED|Overall Study||0
5030106|NCT02096575|12378888|P2|COMPLETED|Overall Study||67
5030107|NCT02096575|12378889|P1|COMPLETED|Overall Study||68
5030108|NCT02096575|12378887|P3|STARTED|Overall Study||5
5030109|NCT02096575|12378888|P2|STARTED|Overall Study||67
5030110|NCT02096575|12378889|P1|STARTED|Overall Study||68
5030111|NCT02096471|12378903|P1|NOT COMPLETED|Overall Study||13
5030112|NCT02096471|12378903|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
5030113|NCT02096471|12378903|P1|STARTED|Overall Study||19
5030114|NCT02096458|12378914|P1|NOT COMPLETED|Overall Study||0
5030115|NCT02096458|12378914|P1|COMPLETED|Overall Study||8
5030116|NCT02096458|12378914|P1|STARTED|Overall Study||8
5030117|NCT02096263|12378921|P3|NOT COMPLETED|Overall Study||39
5030118|NCT02096263|12378922|P2|NOT COMPLETED|Overall Study||36
5030119|NCT02096263|12378923|P1|NOT COMPLETED|Overall Study||34
5030120|NCT02096263|12378921|P3|COMPLETED|Overall Study||157
5030121|NCT02096263|12378922|P2|COMPLETED|Overall Study||158
5030122|NCT02096263|12378923|P1|COMPLETED|Overall Study||161
5030123|NCT02096263|12378921|P3|STARTED|Overall Study||196
5030124|NCT02096263|12378922|P2|STARTED|Overall Study||194
5030125|NCT02096263|12378923|P1|STARTED|Overall Study||195
5030126|NCT02096107|12379059|P2|NOT COMPLETED|Overall Study||0
5030127|NCT02096107|12379060|P1|NOT COMPLETED|Overall Study||0
5030128|NCT02096107|12379059|P2|COMPLETED|Overall Study||30
5030129|NCT02096107|12379060|P1|COMPLETED|Overall Study||30
5030130|NCT02096107|12379059|P2|STARTED|Overall Study||30
5030131|NCT02096107|12379060|P1|STARTED|Overall Study||30
5030132|NCT02096081|12379078|P2|NOT COMPLETED|Overall Study||4
5030133|NCT02096081|12379079|P1|NOT COMPLETED|Overall Study||3
5030134|NCT02096081|12379078|P2|COMPLETED|Overall Study||124
5030135|NCT02096081|12379079|P1|COMPLETED|Overall Study||119
5030136|NCT02096081|12379078|P2|STARTED|Overall Study||128
5030137|NCT02096081|12379079|P1|STARTED|Overall Study||122
5030138|NCT02096042|12379111|P3|NOT COMPLETED|Overall Study||0
5030139|NCT02096042|12379112|P2|NOT COMPLETED|Overall Study||0
5030140|NCT02096042|12379113|P1|NOT COMPLETED|Overall Study||1
5030141|NCT02096042|12379111|P3|COMPLETED|Overall Study||0
5030142|NCT02096042|12379112|P2|COMPLETED|Overall Study||0
5030143|NCT02096042|12379113|P1|COMPLETED|Overall Study||0
5030144|NCT02096042|12379111|P3|STARTED|Overall Study||0
5030145|NCT02096042|12379112|P2|STARTED|Overall Study||0
5030146|NCT02096042|12379113|P1|STARTED|Overall Study||1
5030147|NCT02096029|12379122|P2|NOT COMPLETED|Overall Study||0
5030148|NCT02096029|12379123|P1|NOT COMPLETED|Overall Study||0
5030149|NCT02096029|12379122|P2|COMPLETED|Overall Study||593
5030150|NCT02096029|12379123|P1|COMPLETED|Overall Study||652
5030151|NCT02096029|12379122|P2|STARTED|Overall Study||593
5030152|NCT02096029|12379123|P1|STARTED|Overall Study||652
5030153|NCT02096003|12379135|P2|NOT COMPLETED|Overall Study||3
5030154|NCT02096003|12379136|P1|NOT COMPLETED|Overall Study||2
5030155|NCT02096003|12379135|P2|COMPLETED|Overall Study||37
5030156|NCT02096003|12379136|P1|COMPLETED|Overall Study||38
5030157|NCT02096003|12379135|P2|STARTED|Overall Study||40
5030158|NCT02096003|12379136|P1|STARTED|Overall Study||40
5030159|NCT02095951|12379152|P2|NOT COMPLETED|Overall Study||6
5030160|NCT02095951|12379153|P1|NOT COMPLETED|Overall Study||9
5030161|NCT02095951|12379152|P2|COMPLETED|Overall Study||8
5030162|NCT02095951|12379153|P1|COMPLETED|Overall Study||4
5030163|NCT02095951|12379152|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
5030164|NCT02095951|12379153|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
5030165|NCT02095873|12379173|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
5030166|NCT02095873|12379174|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
5030167|NCT02095873|12379173|P2|COMPLETED|Second Intervention (8 Weeks)||16
5030168|NCT02095873|12379174|P1|COMPLETED|Second Intervention (8 Weeks)||13
5030169|NCT02095873|12379173|P2|STARTED|Second Intervention (8 Weeks)||16
5030170|NCT02095873|12379174|P1|STARTED|Second Intervention (8 Weeks)||15
5030171|NCT02095873|12379173|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
5030172|NCT02095873|12379174|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
5030173|NCT02095873|12379173|P2|COMPLETED|First Intervention (8 Weeks)||16
5030174|NCT02095873|12379174|P1|COMPLETED|First Intervention (8 Weeks)||15
5030175|NCT02095873|12379173|P2|STARTED|First Intervention (8 Weeks)||16
5030176|NCT02095873|12379174|P1|STARTED|First Intervention (8 Weeks)||16
5030177|NCT02095691|12379186|P1|NOT COMPLETED|Overall Study||1
5030178|NCT02095691|12379186|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
5030179|NCT02095691|12379186|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
5030180|NCT02095561|12379205|P2|NOT COMPLETED|Overall Study||0
5030181|NCT02095561|12379206|P1|NOT COMPLETED|Overall Study||0
5030182|NCT02095561|12379205|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
5030183|NCT02095561|12379206|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
5030184|NCT02095561|12379205|P2|HPV Tested at Health Centers|Overall Study||599
5030185|NCT02095561|12379206|P1|HPV Tested at Health Centers|Overall Study||99
5030186|NCT02095561|12379205|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
5030187|NCT02095561|12379206|P1|HPV Self-tested Women|Overall Study||2519
5030188|NCT02095561|12379205|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
5030189|NCT02095561|12379206|P1|Self-testing Acceptability|Overall Study||2616
5030190|NCT02095561|12379205|P2|STARTED|Overall Study||2964
5030191|NCT02095561|12379206|P1|STARTED|Overall Study||3049
5030192|NCT02095535|12379218|P1|NOT COMPLETED|Analysis||0
5030193|NCT02095535|12379218|P1|COMPLETED|Analysis||18
5030194|NCT02095535|12379218|P1|STARTED|Analysis||18
5030195|NCT02095535|12379218|P1|NOT COMPLETED|Recruitment||2
5030196|NCT02095535|12379218|P1|COMPLETED|Recruitment||18
5030197|NCT02095535|12379218|P1|STARTED|Recruitment||20
5030198|NCT02095340|12379225|P3|NOT COMPLETED|Overall Study||0
5030199|NCT02095340|12379226|P2|NOT COMPLETED|Overall Study||0
5030200|NCT02095340|12379227|P1|NOT COMPLETED|Overall Study||0
5030201|NCT02095340|12379225|P3|COMPLETED|Overall Study||105
5030202|NCT02095340|12379226|P2|COMPLETED|Overall Study||54
5030203|NCT02095340|12379227|P1|COMPLETED|Overall Study||51
5030204|NCT02095340|12379225|P3|STARTED|Overall Study||105
5030205|NCT02095340|12379226|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
5030206|NCT02095340|12379227|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
5030207|NCT02095223|12379240|P2|NOT COMPLETED|Overall Study||0
5030208|NCT02095223|12379241|P1|NOT COMPLETED|Overall Study||1
5030209|NCT02095223|12379240|P2|COMPLETED|Overall Study||2
5030210|NCT02095223|12379241|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
5030211|NCT02095223|12379240|P2|STARTED|Overall Study||2
5030212|NCT02095223|12379241|P1|STARTED|Overall Study||2
5030213|NCT02095197|12379251|P2|NOT COMPLETED|Overall Study||3
5030214|NCT02095197|12379252|P1|NOT COMPLETED|Overall Study||0
5030215|NCT02095197|12379251|P2|COMPLETED|Overall Study||36
5030216|NCT02095197|12379252|P1|COMPLETED|Overall Study||40
5030217|NCT02095197|12379251|P2|STARTED|Overall Study||39
5030218|NCT02095197|12379252|P1|STARTED|Overall Study||40
5030219|NCT02095158|12379264|P1|NOT COMPLETED|Overall Study||75
5030220|NCT02095158|12379264|P1|COMPLETED|Overall Study||365
5030221|NCT02095158|12379264|P1|STARTED|Overall Study||440
5030222|NCT02095145|12379271|P2|NOT COMPLETED|Overall Study||0
5030223|NCT02095145|12379272|P1|NOT COMPLETED|Overall Study||1
5030224|NCT02095145|12379271|P2|COMPLETED|Overall Study||15
5030225|NCT02095145|12379272|P1|COMPLETED|Overall Study||14
5030226|NCT02095145|12379271|P2|STARTED|Overall Study||15
5030227|NCT02095145|12379272|P1|STARTED|Overall Study||15
5030228|NCT02095106|12379318|P2|NOT COMPLETED|Second Intervention (14 Days)||1
5030229|NCT02095106|12379319|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5030230|NCT02095106|12379318|P2|COMPLETED|Second Intervention (14 Days)||12
5030231|NCT02095106|12379319|P1|COMPLETED|Second Intervention (14 Days)||14
5030232|NCT02095106|12379318|P2|STARTED|Second Intervention (14 Days)||13
5030233|NCT02095106|12379319|P1|STARTED|Second Intervention (14 Days)||14
5030234|NCT02095106|12379318|P2|NOT COMPLETED|First Intervention (14 Days)||0
5030235|NCT02095106|12379319|P1|NOT COMPLETED|First Intervention (14 Days)||0
5030236|NCT02095106|12379318|P2|COMPLETED|First Intervention (14 Days)||13
5030237|NCT02095106|12379319|P1|COMPLETED|First Intervention (14 Days)||14
5030238|NCT02095106|12379318|P2|STARTED|First Intervention (14 Days)||13
5030239|NCT02095106|12379319|P1|STARTED|First Intervention (14 Days)||14
5030240|NCT02094937|12379335|P4|NOT COMPLETED|12 Weeks in Period 2||12
5030241|NCT02094937|12379336|P3|NOT COMPLETED|12 Weeks in Period 2||12
5030242|NCT02094937|12379337|P2|NOT COMPLETED|12 Weeks in Period 2||11
5030243|NCT02094937|12379338|P1|NOT COMPLETED|12 Weeks in Period 2||0
5030244|NCT02094937|12379335|P4|COMPLETED|12 Weeks in Period 2||112
5030245|NCT02094937|12379336|P3|COMPLETED|12 Weeks in Period 2||112
5030246|NCT02094937|12379337|P2|COMPLETED|12 Weeks in Period 2||112
5030247|NCT02094937|12379338|P1|COMPLETED|12 Weeks in Period 2||0
5030248|NCT02094937|12379335|P4|STARTED|12 Weeks in Period 2||124
5030249|NCT02094937|12379336|P3|STARTED|12 Weeks in Period 2||124
5030250|NCT02094937|12379337|P2|STARTED|12 Weeks in Period 2||123
5030251|NCT02094937|12379338|P1|STARTED|12 Weeks in Period 2||0
5030252|NCT02094937|12379335|P4|NOT COMPLETED|8 Weeks in Period 1||0
5030253|NCT02094937|12379336|P3|NOT COMPLETED|8 Weeks in Period 1||0
5030254|NCT02094937|12379337|P2|NOT COMPLETED|8 Weeks in Period 1||0
5030255|NCT02094937|12379338|P1|NOT COMPLETED|8 Weeks in Period 1||60
5030256|NCT02094937|12379335|P4|COMPLETED|8 Weeks in Period 1||0
5030257|NCT02094937|12379336|P3|COMPLETED|8 Weeks in Period 1||0
5030258|NCT02094937|12379337|P2|COMPLETED|8 Weeks in Period 1||0
5030259|NCT02094937|12379338|P1|COMPLETED|8 Weeks in Period 1||370
5030260|NCT02094937|12379335|P4|STARTED|8 Weeks in Period 1||0
5030261|NCT02094937|12379336|P3|STARTED|8 Weeks in Period 1||0
5030262|NCT02094937|12379337|P2|STARTED|8 Weeks in Period 1||0
5030263|NCT02094937|12379338|P1|STARTED|8 Weeks in Period 1||430
5030264|NCT02094898|12379368|P1|NOT COMPLETED|Overall Study||5
5030265|NCT02094898|12379368|P1|COMPLETED|Overall Study||7
5030266|NCT02094898|12379368|P1|STARTED|Overall Study||12
5030267|NCT02094885|12379415|P2|NOT COMPLETED|Overall Study||5
5030268|NCT02094885|12379416|P1|NOT COMPLETED|Overall Study||2
5030269|NCT02094885|12379415|P2|COMPLETED|Overall Study||122
5030270|NCT02094885|12379416|P1|COMPLETED|Overall Study||123
5030271|NCT02094885|12379415|P2|STARTED|Overall Study||127
5030272|NCT02094885|12379416|P1|STARTED|Overall Study||125
5030273|NCT02094872|12379428|P1|NOT COMPLETED|Overall Study||29
5030274|NCT02094872|12379428|P1|COMPLETED|Overall Study||20
5030275|NCT02094872|12379428|P1|Patients Treated With MEK162|Overall Study||20
5030276|NCT02094872|12379428|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
5030277|NCT02094872|12379428|P1|Received Targeted Therapy|Overall Study||20
5030278|NCT02094872|12379428|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
5030279|NCT02094872|12379428|P1|Received Biopsy|Overall Study||37
5030280|NCT02094872|12379428|P1|STARTED|Overall Study||49
5030281|NCT02094755|12379433|P1|NOT COMPLETED|Overall Study||0
5030282|NCT02094755|12379433|P1|COMPLETED|Overall Study||100
5030283|NCT02094755|12379433|P1|STARTED|Overall Study||100
5030284|NCT02094677|12379439|P2|NOT COMPLETED|Overall Study||1
5030285|NCT02094677|12379440|P1|NOT COMPLETED|Overall Study||3
5030286|NCT02094677|12379439|P2|COMPLETED|Overall Study||30
5030287|NCT02094677|12379440|P1|COMPLETED|Overall Study||40
5030288|NCT02094677|12379439|P2|STARTED|Overall Study||31
5030289|NCT02094677|12379440|P1|STARTED|Overall Study||43
5030290|NCT02094664|12379504|P2|NOT COMPLETED|Overall Study||0
5030291|NCT02094664|12379505|P1|NOT COMPLETED|Overall Study||0
5030292|NCT02094664|12379504|P2|COMPLETED|Overall Study||16
5030293|NCT02094664|12379505|P1|COMPLETED|Overall Study||16
5030294|NCT02094664|12379504|P2|STARTED|Overall Study||16
5030295|NCT02094664|12379505|P1|STARTED|Overall Study||16
5030296|NCT02094612|12379519|P2|NOT COMPLETED|Overall Study||70
5030297|NCT02094612|12379520|P1|NOT COMPLETED|Overall Study||79
5030298|NCT02094612|12379519|P2|COMPLETED|Overall Study||25
5030299|NCT02094612|12379520|P1|COMPLETED|Overall Study||33
5030300|NCT02094612|12379519|P2|6 Month Follow up|Overall Study||25
5030301|NCT02094612|12379520|P1|6 Month Follow up|Overall Study||33
5030302|NCT02094612|12379519|P2|3 Month Follow up|Overall Study||43
5030303|NCT02094612|12379520|P1|3 Month Follow up|Overall Study||50
5030304|NCT02094612|12379519|P2|1 Month Follow up|Overall Study||50
5030305|NCT02094612|12379520|P1|1 Month Follow up|Overall Study||67
5030306|NCT02094612|12379519|P2|STARTED|Overall Study||95
5030307|NCT02094612|12379520|P1|STARTED|Overall Study||112
5030308|NCT02094573|12379540|P2|NOT COMPLETED|Overall Study||110
5030309|NCT02094573|12379541|P1|NOT COMPLETED|Overall Study||112
5030310|NCT02094573|12379540|P2|COMPLETED|Overall Study||0
5030311|NCT02094573|12379541|P1|COMPLETED|Overall Study||0
5030312|NCT02094573|12379540|P2|Treated|Overall Study||110
5030313|NCT02094573|12379541|P1|Treated|Overall Study||109
5030314|NCT02094573|12379540|P2|STARTED|Overall Study||110
5030315|NCT02094573|12379541|P1|STARTED|Overall Study||112
5030316|NCT02094534|12379575|P2|NOT COMPLETED|Overall Study||0
5030317|NCT02094534|12379576|P1|NOT COMPLETED|Overall Study||0
5030318|NCT02094534|12379575|P2|COMPLETED|Overall Study||10
5030319|NCT02094534|12379576|P1|COMPLETED|Overall Study||15
5030320|NCT02094534|12379575|P2|STARTED|Overall Study||10
5030321|NCT02094534|12379576|P1|STARTED|Overall Study||15
5030322|NCT02094443|12379586|P2|NOT COMPLETED|Overall Study||17
5030323|NCT02094443|12379587|P1|NOT COMPLETED|Overall Study||15
5030324|NCT02094443|12379586|P2|COMPLETED|Overall Study||9
5030325|NCT02094443|12379587|P1|COMPLETED|Overall Study||11
5030326|NCT02094443|12379586|P2|Completed at Week 24|Overall Study||8
5030327|NCT02094443|12379587|P1|Completed at Week 24|Overall Study||11
5030328|NCT02094443|12379586|P2|Completed at Week 12|Overall Study||1
5030329|NCT02094443|12379587|P1|Completed at Week 12|Overall Study||0
5030330|NCT02094443|12379586|P2|STARTED|Overall Study||26
5030331|NCT02094443|12379587|P1|STARTED|Overall Study||26
5030332|NCT02094352|12379607|P2|NOT COMPLETED|Overall Study||0
5030333|NCT02094352|12379608|P1|NOT COMPLETED|Overall Study||0
5030334|NCT02094352|12379607|P2|COMPLETED|Overall Study||1
5030335|NCT02094352|12379608|P1|COMPLETED|Overall Study||2
5030336|NCT02094352|12379607|P2|STARTED|Overall Study||1
5030337|NCT02094352|12379608|P1|STARTED|Overall Study||2
5030338|NCT02094326|12379614|P1|NOT COMPLETED|Overall Study||0
5030339|NCT02094326|12379614|P1|COMPLETED|Overall Study||301
5030340|NCT02094326|12379614|P1|STARTED|Overall Study||301
5030341|NCT02094300|12379623|P1|NOT COMPLETED|Overall Study||20
5030342|NCT02094300|12379623|P1|COMPLETED|Overall Study||6
5030343|NCT02094300|12379623|P1|30 Days|Overall Study||24
5030344|NCT02094300|12379623|P1|STARTED|Overall Study||26
5030345|NCT02094261|12379627|P1|NOT COMPLETED|Overall Study||210
5030346|NCT02094261|12379627|P1|COMPLETED|Overall Study||0
5030347|NCT02094261|12379627|P1|STARTED|Overall Study||210
5030348|NCT02093962|12379636|P2|NOT COMPLETED|Overall Study||131
5030349|NCT02093962|12379637|P1|NOT COMPLETED|Overall Study||134
5030350|NCT02093962|12379636|P2|COMPLETED|Overall Study||0
5030351|NCT02093962|12379637|P1|COMPLETED|Overall Study||0
5030352|NCT02093962|12379636|P2|Received Treatment|Overall Study||130
5030353|NCT02093962|12379637|P1|Received Treatment|Overall Study||130
5030354|NCT02093962|12379636|P2|STARTED|Overall Study||131
5030355|NCT02093962|12379637|P1|STARTED|Overall Study||134
5030356|NCT02093949|12379645|P2|NOT COMPLETED|Overall Study||0
5030357|NCT02093949|12379646|P1|NOT COMPLETED|Overall Study||0
5030358|NCT02093949|12379645|P2|COMPLETED|Overall Study||47
5030359|NCT02093949|12379646|P1|COMPLETED|Overall Study||105
5030360|NCT02093949|12379645|P2|STARTED|Overall Study||47
5030361|NCT02093949|12379646|P1|STARTED|Overall Study||105
5030362|NCT02093923|12379669|P5|NOT COMPLETED|Overall Study||0
5030363|NCT02093923|12379670|P4|NOT COMPLETED|Overall Study||2
5030364|NCT02093923|12379671|P3|NOT COMPLETED|Overall Study||0
5030365|NCT02093923|12379672|P2|NOT COMPLETED|Overall Study||0
5030366|NCT02093923|12379673|P1|NOT COMPLETED|Overall Study||0
5030367|NCT02093923|12379669|P5|COMPLETED|Overall Study||13
5030368|NCT02093923|12379670|P4|COMPLETED|Overall Study||10
5030369|NCT02093923|12379671|P3|COMPLETED|Overall Study||5
5030370|NCT02093923|12379672|P2|COMPLETED|Overall Study||4
5030371|NCT02093923|12379673|P1|COMPLETED|Overall Study||4
5030372|NCT02093923|12379669|P5|Treated - 2 Doses:|Overall Study||13
5030373|NCT02093923|12379670|P4|Treated - 2 Doses:|Overall Study||10
5030374|NCT02093923|12379671|P3|Treated - 2 Doses:|Overall Study||5
5030375|NCT02093923|12379672|P2|Treated - 2 Doses:|Overall Study||4
5030376|NCT02093923|12379673|P1|Treated - 2 Doses:|Overall Study||4
5030377|NCT02093923|12379669|P5|Treated - 1 Dose Only:|Overall Study||0
5030378|NCT02093923|12379670|P4|Treated - 1 Dose Only:|Overall Study||1
5030379|NCT02093923|12379671|P3|Treated - 1 Dose Only:|Overall Study||0
5030380|NCT02093923|12379672|P2|Treated - 1 Dose Only:|Overall Study||0
5030381|NCT02093923|12379673|P1|Treated - 1 Dose Only:|Overall Study||0
5030382|NCT02093923|12379669|P5|Total Treated|Overall Study||13
5030383|NCT02093923|12379670|P4|Total Treated|Overall Study||11
5030384|NCT02093923|12379671|P3|Total Treated|Overall Study||5
5030385|NCT02093923|12379672|P2|Total Treated|Overall Study||4
5030386|NCT02093923|12379673|P1|Total Treated|Overall Study||4
5030387|NCT02093923|12379669|P5|STARTED|Overall Study||13
5030388|NCT02093923|12379670|P4|STARTED|Overall Study||12
5030389|NCT02093923|12379671|P3|STARTED|Overall Study||5
5030390|NCT02093923|12379672|P2|STARTED|Overall Study||4
5030391|NCT02093923|12379673|P1|STARTED|Overall Study||4
5030392|NCT02093897|12379728|P1|NOT COMPLETED|Overall Study||19
5030393|NCT02093897|12379728|P1|COMPLETED|Overall Study||65
5030394|NCT02093897|12379728|P1|STARTED|Overall Study||84
5030395|NCT02093819|12379756|P8|NOT COMPLETED|Overall Study||0
5030396|NCT02093819|12379757|P7|NOT COMPLETED|Overall Study||0
5030397|NCT02093819|12379758|P6|NOT COMPLETED|Overall Study||0
5030398|NCT02093819|12379759|P5|NOT COMPLETED|Overall Study||0
5030399|NCT02093819|12379760|P4|NOT COMPLETED|Overall Study||0
5030400|NCT02093819|12379761|P3|NOT COMPLETED|Overall Study||0
5030401|NCT02093819|12379762|P2|NOT COMPLETED|Overall Study||0
5030402|NCT02093819|12379763|P1|NOT COMPLETED|Overall Study||0
5030403|NCT02093819|12379756|P8|COMPLETED|Overall Study||6
5030404|NCT02093819|12379757|P7|COMPLETED|Overall Study||5
5030405|NCT02093819|12379758|P6|COMPLETED|Overall Study||6
5030406|NCT02093819|12379759|P5|COMPLETED|Overall Study||6
5030407|NCT02093819|12379760|P4|COMPLETED|Overall Study||6
5030408|NCT02093819|12379761|P3|COMPLETED|Overall Study||10
5030409|NCT02093819|12379762|P2|COMPLETED|Overall Study||6
5030410|NCT02093819|12379763|P1|COMPLETED|Overall Study||15
5030411|NCT02093819|12379756|P8|STARTED|Overall Study||6
5030412|NCT02093819|12379757|P7|STARTED|Overall Study||5
5030413|NCT02093819|12379758|P6|STARTED|Overall Study||6
5030414|NCT02093819|12379759|P5|STARTED|Overall Study||6
5030415|NCT02093819|12379760|P4|STARTED|Overall Study||6
5030416|NCT02093819|12379761|P3|STARTED|Overall Study||10
5030417|NCT02093819|12379762|P2|STARTED|Overall Study||6
5030418|NCT02093819|12379763|P1|STARTED|Overall Study||15
5030419|NCT02093793|12379800|P3|NOT COMPLETED|Overall Study||3
5030420|NCT02093793|12379801|P2|NOT COMPLETED|Overall Study||10
5030421|NCT02093793|12379802|P1|NOT COMPLETED|Overall Study||7
5030422|NCT02093793|12379800|P3|COMPLETED|Overall Study||65
5030423|NCT02093793|12379801|P2|COMPLETED|Overall Study||80
5030424|NCT02093793|12379802|P1|COMPLETED|Overall Study||91
5030425|NCT02093793|12379800|P3|STARTED|Overall Study||68
5030426|NCT02093793|12379801|P2|STARTED|Overall Study||90
5030427|NCT02093793|12379802|P1|STARTED|Overall Study||98
5030428|NCT02093702|12379812|P2|NOT COMPLETED|Overall Study||0
5030429|NCT02093702|12379813|P1|NOT COMPLETED|Overall Study||0
5030430|NCT02093702|12379812|P2|COMPLETED|Overall Study||3
5030431|NCT02093702|12379813|P1|COMPLETED|Overall Study||2
5030432|NCT02093702|12379812|P2|STARTED|Overall Study||3
5030433|NCT02093702|12379813|P1|STARTED|Overall Study||2
5030434|NCT02093689|12379844|P3|NOT COMPLETED|Overall Study||0
5030435|NCT02093689|12379845|P2|NOT COMPLETED|Overall Study||0
5030436|NCT02093689|12379846|P1|NOT COMPLETED|Overall Study||4
5030437|NCT02093689|12379844|P3|COMPLETED|Overall Study||0
5030438|NCT02093689|12379845|P2|COMPLETED|Overall Study||0
5030439|NCT02093689|12379846|P1|COMPLETED|Overall Study||14
5030440|NCT02093689|12379844|P3|STARTED|Overall Study||0
5030441|NCT02093689|12379845|P2|STARTED|Overall Study||0
5030442|NCT02093689|12379846|P1|STARTED|Overall Study||18
5030443|NCT02093663|12379852|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
5030444|NCT02093663|12379853|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
5030445|NCT02093663|12379854|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030446|NCT02093663|12379855|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030447|NCT02093663|12379856|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030448|NCT02093663|12379852|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
5030449|NCT02093663|12379853|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
5030450|NCT02093663|12379854|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030451|NCT02093663|12379855|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030452|NCT02093663|12379856|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
5030453|NCT02093663|12379852|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
5030454|NCT02093663|12379853|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
5030455|NCT02093663|12379854|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
5030456|NCT02093663|12379855|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
5030457|NCT02093663|12379856|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
5030458|NCT02093663|12379852|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
5030459|NCT02093663|12379853|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
5030460|NCT02093663|12379854|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
5030461|NCT02093663|12379855|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
5030462|NCT02093663|12379856|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
5030463|NCT02093663|12379852|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
5030464|NCT02093663|12379853|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
5030465|NCT02093663|12379854|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
5030466|NCT02093663|12379855|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
5030467|NCT02093663|12379856|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
5030468|NCT02093663|12379852|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
5030469|NCT02093663|12379853|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
5030470|NCT02093663|12379854|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
5030471|NCT02093663|12379855|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
5030472|NCT02093663|12379856|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
5030473|NCT02093663|12379852|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030474|NCT02093663|12379853|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030475|NCT02093663|12379854|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
5030476|NCT02093663|12379855|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030477|NCT02093663|12379856|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030478|NCT02093663|12379852|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030479|NCT02093663|12379853|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030480|NCT02093663|12379854|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
5030481|NCT02093663|12379855|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030482|NCT02093663|12379856|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
5030483|NCT02093663|12379852|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
5030484|NCT02093663|12379853|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
5030485|NCT02093663|12379854|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
5030486|NCT02093663|12379855|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
5030487|NCT02093663|12379856|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
5030488|NCT02093663|12379852|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
5030489|NCT02093663|12379853|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
5030490|NCT02093663|12379854|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
5030491|NCT02093663|12379855|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
5030492|NCT02093663|12379856|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
5030493|NCT02093663|12379852|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030494|NCT02093663|12379853|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030495|NCT02093663|12379854|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030496|NCT02093663|12379855|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
5030497|NCT02093663|12379856|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
5030498|NCT02093663|12379852|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030499|NCT02093663|12379853|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030500|NCT02093663|12379854|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
5030501|NCT02093663|12379855|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
5030502|NCT02093663|12379856|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
5030503|NCT02093663|12379852|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
5030504|NCT02093663|12379853|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
5030505|NCT02093663|12379854|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
5030506|NCT02093663|12379855|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
5030507|NCT02093663|12379856|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
5030508|NCT02093520|12379885|P2|NOT COMPLETED|Overall Study||22
5030509|NCT02093520|12379886|P1|NOT COMPLETED|Overall Study||6
5030510|NCT02093520|12379885|P2|COMPLETED|Overall Study||131
5030511|NCT02093520|12379886|P1|COMPLETED|Overall Study||143
5030512|NCT02093520|12379885|P2|STARTED|Overall Study||153
5030513|NCT02093520|12379886|P1|STARTED|Overall Study||149
5030514|NCT02093390|12379898|P2|NOT COMPLETED|Overall Study||1
5030515|NCT02093390|12379899|P1|NOT COMPLETED|Overall Study||0
5030516|NCT02093390|12379898|P2|COMPLETED|Overall Study||19
5030517|NCT02093390|12379899|P1|COMPLETED|Overall Study||20
5030518|NCT02093390|12379898|P2|STARTED|Overall Study||20
5030519|NCT02093390|12379899|P1|STARTED|Overall Study||20
5030520|NCT02093351|12379938|P4|NOT COMPLETED|Part B||63
5030521|NCT02093351|12379939|P3|NOT COMPLETED|Part B||0
5030522|NCT02093351|12379940|P2|NOT COMPLETED|Part B||0
5030523|NCT02093351|12379941|P1|NOT COMPLETED|Part B||0
5030524|NCT02093351|12379938|P4|COMPLETED|Part B||6
5030525|NCT02093351|12379939|P3|COMPLETED|Part B||0
5030526|NCT02093351|12379940|P2|COMPLETED|Part B||0
5030527|NCT02093351|12379941|P1|COMPLETED|Part B||0
5030528|NCT02093351|12379938|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
5030529|NCT02093351|12379939|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
5030530|NCT02093351|12379940|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
5030531|NCT02093351|12379941|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
5030532|NCT02093351|12379938|P4|NOT COMPLETED|Part A||0
5030533|NCT02093351|12379939|P3|NOT COMPLETED|Part A||3
5030534|NCT02093351|12379940|P2|NOT COMPLETED|Part A||2
5030535|NCT02093351|12379941|P1|NOT COMPLETED|Part A||2
5030536|NCT02093351|12379938|P4|COMPLETED|Part A||0
5030537|NCT02093351|12379939|P3|COMPLETED|Part A||23
5030538|NCT02093351|12379940|P2|COMPLETED|Part A||21
5030539|NCT02093351|12379941|P1|COMPLETED|Part A||28
5030540|NCT02093351|12379938|P4|Completing Treatment Period 3|Part A||0
5030541|NCT02093351|12379939|P3|Completing Treatment Period 3|Part A||23
5030542|NCT02093351|12379940|P2|Completing Treatment Period 3|Part A||21
5030543|NCT02093351|12379941|P1|Completing Treatment Period 3|Part A||28
5030544|NCT02093351|12379938|P4|Completing Treatment Period 2|Part A||0
5030545|NCT02093351|12379939|P3|Completing Treatment Period 2|Part A||23
5030546|NCT02093351|12379940|P2|Completing Treatment Period 2|Part A||21
5030547|NCT02093351|12379941|P1|Completing Treatment Period 2|Part A||29
5030548|NCT02093351|12379938|P4|Completing Treatment Period 1|Part A||0
5030549|NCT02093351|12379939|P3|Completing Treatment Period 1|Part A||23
5030550|NCT02093351|12379940|P2|Completing Treatment Period 1|Part A||22
5030551|NCT02093351|12379941|P1|Completing Treatment Period 1|Part A||29
5030552|NCT02093351|12379938|P4|STARTED|Part A||0
5030553|NCT02093351|12379939|P3|STARTED|Part A||26
5030554|NCT02093351|12379940|P2|STARTED|Part A||23
5030555|NCT02093351|12379941|P1|STARTED|Part A||30
5030556|NCT02093234|12379974|P3|NOT COMPLETED|Overall Study||4
5030557|NCT02093234|12379975|P2|NOT COMPLETED|Overall Study||4
5030558|NCT02093234|12379976|P1|NOT COMPLETED|Overall Study||3
5030559|NCT02093234|12379974|P3|COMPLETED|Overall Study||50
5030560|NCT02093234|12379975|P2|COMPLETED|Overall Study||52
5030561|NCT02093234|12379976|P1|COMPLETED|Overall Study||53
5030562|NCT02093234|12379974|P3|STARTED|Overall Study||54
5030563|NCT02093234|12379975|P2|STARTED|Overall Study||56
5030564|NCT02093234|12379976|P1|STARTED|Overall Study||56
5030565|NCT02093221|12379998|P5|NOT COMPLETED|Overall Study||8
5030566|NCT02093221|12379999|P4|NOT COMPLETED|Overall Study||8
5030567|NCT02093221|12380000|P3|NOT COMPLETED|Overall Study||9
5030568|NCT02093221|12380001|P2|NOT COMPLETED|Overall Study||8
5030569|NCT02093221|12380002|P1|NOT COMPLETED|Overall Study||10
5030570|NCT02093221|12379998|P5|COMPLETED|Overall Study||7
5030571|NCT02093221|12379999|P4|COMPLETED|Overall Study||7
5030572|NCT02093221|12380000|P3|COMPLETED|Overall Study||6
5030573|NCT02093221|12380001|P2|COMPLETED|Overall Study||8
5030574|NCT02093221|12380002|P1|COMPLETED|Overall Study||5
5030575|NCT02093221|12379998|P5|STARTED|Overall Study||15
5030576|NCT02093221|12379999|P4|STARTED|Overall Study||15
5030577|NCT02093221|12380000|P3|STARTED|Overall Study||15
5030578|NCT02093221|12380001|P2|STARTED|Overall Study||16
5030579|NCT02093221|12380002|P1|STARTED|Overall Study||15
5030580|NCT02093026|12380039|P1|NOT COMPLETED|Overall Study||193
5030581|NCT02093026|12380039|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
5030582|NCT02093026|12380039|P1|STARTED|Overall Study||465
5030583|NCT02092961|12380061|P3|NOT COMPLETED|Overall Study||16
5030584|NCT02092961|12380062|P2|NOT COMPLETED|Overall Study||14
5030585|NCT02092961|12380063|P1|NOT COMPLETED|Overall Study||21
5030586|NCT02092961|12380061|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
5030587|NCT02092961|12380062|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
5030588|NCT02092961|12380063|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
5030589|NCT02092961|12380061|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
5030590|NCT02092961|12380062|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
5030591|NCT02092961|12380063|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
5030592|NCT02092961|12380061|P3|STARTED|Overall Study|Patients who received treatment|29
5030593|NCT02092961|12380062|P2|STARTED|Overall Study|Patients who received treatment|28
5030594|NCT02092961|12380063|P1|STARTED|Overall Study|Patients who received treatment|33
5030595|NCT02092909|12380088|P4|NOT COMPLETED|Overall Study||6
5030596|NCT02092909|12380089|P3|NOT COMPLETED|Overall Study||9
5030597|NCT02092909|12380090|P2|NOT COMPLETED|Overall Study||3
5030598|NCT02092909|12380091|P1|NOT COMPLETED|Overall Study||1
5030599|NCT02092909|12380088|P4|COMPLETED|Overall Study||0
5030600|NCT02092909|12380089|P3|COMPLETED|Overall Study||5
5030601|NCT02092909|12380090|P2|COMPLETED|Overall Study||2
5030602|NCT02092909|12380091|P1|COMPLETED|Overall Study||5
5030603|NCT02092909|12380088|P4|STARTED|Overall Study||6
5030604|NCT02092909|12380089|P3|STARTED|Overall Study||14
5030605|NCT02092909|12380090|P2|STARTED|Overall Study||5
5030606|NCT02092909|12380091|P1|STARTED|Overall Study||6
5030607|NCT02092857|12380120|P3|NOT COMPLETED|Overall Study||13
5030608|NCT02092857|12380121|P2|NOT COMPLETED|Overall Study||12
5030609|NCT02092857|12380122|P1|NOT COMPLETED|Overall Study||10
5030610|NCT02092857|12380120|P3|COMPLETED|Overall Study||16
5030611|NCT02092857|12380121|P2|COMPLETED|Overall Study||18
5030612|NCT02092857|12380122|P1|COMPLETED|Overall Study||20
5030613|NCT02092857|12380120|P3|STARTED|Overall Study||29
5030614|NCT02092857|12380121|P2|STARTED|Overall Study||30
5030615|NCT02092857|12380122|P1|STARTED|Overall Study||30
5030616|NCT02092662|12380132|P2|NOT COMPLETED|Overall Study||0
5030617|NCT02092662|12380133|P1|NOT COMPLETED|Overall Study||13
5030618|NCT02092662|12380132|P2|COMPLETED|Overall Study||19
5030619|NCT02092662|12380133|P1|COMPLETED|Overall Study||25
5030620|NCT02092662|12380132|P2|Recruited|Overall Study||19
5030621|NCT02092662|12380133|P1|Recruited|Overall Study||38
5030622|NCT02092662|12380132|P2|STARTED|Overall Study||19
5030623|NCT02092662|12380133|P1|STARTED|Overall Study||38
5030624|NCT02092649|12380142|P2|NOT COMPLETED|Overall Study||0
5030625|NCT02092649|12380143|P1|NOT COMPLETED|Overall Study||0
5030626|NCT02092649|12380142|P2|COMPLETED|Overall Study|13 participants finished study|13
5030627|NCT02092649|12380143|P1|COMPLETED|Overall Study|13 participants finished study|13
5030628|NCT02092649|12380142|P2|STARTED|Overall Study|13 participants recruited|13
5030629|NCT02092649|12380143|P1|STARTED|Overall Study|13 participants recruited|13
5030630|NCT02092610|12380161|P2|NOT COMPLETED|Overall Study||12
5030631|NCT02092610|12380162|P1|NOT COMPLETED|Overall Study||8
5030632|NCT02092610|12380161|P2|COMPLETED|Overall Study||40
5030633|NCT02092610|12380162|P1|COMPLETED|Overall Study||17
5030634|NCT02092610|12380161|P2|STARTED|Overall Study||52
5030635|NCT02092610|12380162|P1|STARTED|Overall Study||25
5030636|NCT02092441|12380176|P2|NOT COMPLETED|Overall Study||0
5030637|NCT02092441|12380177|P1|NOT COMPLETED|Overall Study||0
5030638|NCT02092441|12380176|P2|COMPLETED|Overall Study||43
5030639|NCT02092441|12380177|P1|COMPLETED|Overall Study||37
5030640|NCT02092441|12380176|P2|STARTED|Overall Study||43
5030641|NCT02092441|12380177|P1|STARTED|Overall Study||37
5030642|NCT02092415|12380187|P1|NOT COMPLETED|Overall Study||0
5030643|NCT02092415|12380187|P1|COMPLETED|Overall Study||10
5030644|NCT02092415|12380187|P1|STARTED|Overall Study||10
5030645|NCT02092389|12380192|P1|NOT COMPLETED|Overall Study||6
5030646|NCT02092389|12380192|P1|COMPLETED|Overall Study||4
5030647|NCT02092389|12380192|P1|STARTED|Overall Study||10
5030648|NCT02092350|12380204|P2|NOT COMPLETED|Overall Study||12
5030649|NCT02092350|12380205|P1|NOT COMPLETED|Overall Study||10
5030650|NCT02092350|12380204|P2|COMPLETED|Overall Study||102
5030651|NCT02092350|12380205|P1|COMPLETED|Overall Study||113
5030652|NCT02092350|12380204|P2|STARTED|Overall Study||114
5030653|NCT02092350|12380205|P1|STARTED|Overall Study||123
5030654|NCT02092311|12380222|P2|NOT COMPLETED|Overall Study||0
5030655|NCT02092311|12380223|P1|NOT COMPLETED|Overall Study||0
5030656|NCT02092311|12380222|P2|COMPLETED|Overall Study||285
5030657|NCT02092311|12380223|P1|COMPLETED|Overall Study||285
5030658|NCT02092311|12380222|P2|STARTED|Overall Study||285
5030659|NCT02092311|12380223|P1|STARTED|Overall Study||285
5030660|NCT02092285|12380233|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
5030661|NCT02092285|12380233|P1|COMPLETED|Maintenance Phase & Follow-up||60
5030662|NCT02092285|12380233|P1|STARTED|Maintenance Phase & Follow-up||170
5030663|NCT02092285|12380233|P1|NOT COMPLETED|Induction Phase||35
5030664|NCT02092285|12380233|P1|COMPLETED|Induction Phase||170
5030665|NCT02092285|12380233|P1|STARTED|Induction Phase||205
5030666|NCT02092220|12380237|P2|NOT COMPLETED|Period 2||1
5030667|NCT02092220|12380238|P1|NOT COMPLETED|Period 2||1
5030668|NCT02092220|12380237|P2|COMPLETED|Period 2||19
5030669|NCT02092220|12380238|P1|COMPLETED|Period 2||20
5030670|NCT02092220|12380237|P2|STARTED|Period 2||20
5030671|NCT02092220|12380238|P1|STARTED|Period 2||21
5030672|NCT02092220|12380237|P2|NOT COMPLETED|Period 1||2
5030673|NCT02092220|12380238|P1|NOT COMPLETED|Period 1||0
5030674|NCT02092220|12380237|P2|COMPLETED|Period 1||20
5030675|NCT02092220|12380238|P1|COMPLETED|Period 1||21
5030676|NCT02092220|12380237|P2|STARTED|Period 1||22
5030677|NCT02092220|12380238|P1|STARTED|Period 1||21
5030678|NCT02092168|12380298|P2|NOT COMPLETED|Overall Study||0
5030679|NCT02092168|12380299|P1|NOT COMPLETED|Overall Study||0
5030680|NCT02092168|12380298|P2|COMPLETED|Overall Study||12
5030681|NCT02092168|12380299|P1|COMPLETED|Overall Study||12
5030682|NCT02092168|12380298|P2|STARTED|Overall Study||12
5030683|NCT02092168|12380299|P1|STARTED|Overall Study||12
5030684|NCT02092116|12380311|P2|NOT COMPLETED|Overall Study||4
5030685|NCT02092116|12380312|P1|NOT COMPLETED|Overall Study||0
5030686|NCT02092116|12380311|P2|COMPLETED|Overall Study||16
5030687|NCT02092116|12380312|P1|COMPLETED|Overall Study||6
5030688|NCT02092116|12380311|P2|STARTED|Overall Study||20
5030689|NCT02092116|12380312|P1|STARTED|Overall Study||6
5030690|NCT02092025|12380321|P1|NOT COMPLETED|Overall Study||68
5030691|NCT02092025|12380321|P1|COMPLETED|Overall Study||3369
5030692|NCT02092025|12380321|P1|STARTED|Overall Study||3437
5030693|NCT02091986|12380330|P3|NOT COMPLETED|Overall Study||8
5030694|NCT02091986|12380331|P2|NOT COMPLETED|Overall Study||11
5030695|NCT02091986|12380332|P1|NOT COMPLETED|Overall Study||7
5030696|NCT02091986|12380330|P3|COMPLETED|Overall Study||84
5030697|NCT02091986|12380331|P2|COMPLETED|Overall Study||84
5030698|NCT02091986|12380332|P1|COMPLETED|Overall Study||85
5030699|NCT02091986|12380330|P3|STARTED|Overall Study||92
5030700|NCT02091986|12380331|P2|STARTED|Overall Study||95
5030701|NCT02091986|12380332|P1|STARTED|Overall Study||92
5030702|NCT02091960|12380379|P1|NOT COMPLETED|Overall Study||51
5030703|NCT02091960|12380379|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
5030704|NCT02091960|12380379|P1|Received Treatment|Overall Study||103
5030705|NCT02091960|12380379|P1|STARTED|Overall Study||103
5030706|NCT02091921|12380390|P1|NOT COMPLETED|Overall Study||3
5030707|NCT02091921|12380390|P1|COMPLETED|Overall Study||50
5030708|NCT02091921|12380390|P1|STARTED|Overall Study||53
5030709|NCT02091869|12380399|P2|NOT COMPLETED|Overall Study||3
5030710|NCT02091869|12380400|P1|NOT COMPLETED|Overall Study||0
5030711|NCT02091869|12380399|P2|COMPLETED|Overall Study||14
5030712|NCT02091869|12380400|P1|COMPLETED|Overall Study||17
5030713|NCT02091869|12380399|P2|STARTED|Overall Study||17
5030714|NCT02091869|12380400|P1|STARTED|Overall Study||17
5030715|NCT02091856|12380415|P3|NOT COMPLETED|Follow-up Assessment||0
5030716|NCT02091856|12380416|P2|NOT COMPLETED|Follow-up Assessment||3
5030717|NCT02091856|12380417|P1|NOT COMPLETED|Follow-up Assessment||5
5030718|NCT02091856|12380415|P3|COMPLETED|Follow-up Assessment||0
5030719|NCT02091856|12380416|P2|COMPLETED|Follow-up Assessment||9
5030720|NCT02091856|12380417|P1|COMPLETED|Follow-up Assessment||10
5030721|NCT02091856|12380415|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
5030722|NCT02091856|12380416|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
5030723|NCT02091856|12380417|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
5030724|NCT02091856|12380415|P3|NOT COMPLETED|Active Intervention Interval||7
5030725|NCT02091856|12380416|P2|NOT COMPLETED|Active Intervention Interval||7
5030726|NCT02091856|12380417|P1|NOT COMPLETED|Active Intervention Interval||19
5030727|NCT02091856|12380415|P3|COMPLETED|Active Intervention Interval||19
5030728|NCT02091856|12380416|P2|COMPLETED|Active Intervention Interval||12
5030729|NCT02091856|12380417|P1|COMPLETED|Active Intervention Interval||15
5030730|NCT02091856|12380415|P3|STARTED|Active Intervention Interval||26
5030731|NCT02091856|12380416|P2|STARTED|Active Intervention Interval||19
5030732|NCT02091856|12380417|P1|STARTED|Active Intervention Interval||34
5030733|NCT02091778|12380437|P1|NOT COMPLETED|Overall Study||1
5030734|NCT02091778|12380437|P1|COMPLETED|Overall Study||20
5030735|NCT02091778|12380437|P1|STARTED|Overall Study||21
5030736|NCT02091752|12380441|P1|NOT COMPLETED|Overall Study||3
5030737|NCT02091752|12380441|P1|COMPLETED|Overall Study||0
5030738|NCT02091752|12380441|P1|STARTED|Overall Study||3
5030739|NCT02091739|12380455|P5|NOT COMPLETED|EP: 48 Weeks||14
5030740|NCT02091739|12380456|P4|NOT COMPLETED|EP: 48 Weeks||8
5030741|NCT02091739|12380457|P3|NOT COMPLETED|EP: 48 Weeks||0
5030742|NCT02091739|12380458|P2|NOT COMPLETED|EP: 48 Weeks||0
5030743|NCT02091739|12380459|P1|NOT COMPLETED|EP: 48 Weeks||0
5030744|NCT02091739|12380455|P5|COMPLETED|EP: 48 Weeks||75
5030745|NCT02091739|12380456|P4|COMPLETED|EP: 48 Weeks||76
5030746|NCT02091739|12380457|P3|COMPLETED|EP: 48 Weeks||0
5030747|NCT02091739|12380458|P2|COMPLETED|EP: 48 Weeks||0
5030748|NCT02091739|12380459|P1|COMPLETED|EP: 48 Weeks||0
5030749|NCT02091739|12380455|P5|STARTED|EP: 48 Weeks||89
5030750|NCT02091739|12380456|P4|STARTED|EP: 48 Weeks||84
5030751|NCT02091739|12380457|P3|STARTED|EP: 48 Weeks||0
5030752|NCT02091739|12380458|P2|STARTED|EP: 48 Weeks||0
5030753|NCT02091739|12380459|P1|STARTED|EP: 48 Weeks||0
5030754|NCT02091739|12380455|P5|NOT COMPLETED|MP: 16 Weeks||0
5030755|NCT02091739|12380456|P4|NOT COMPLETED|MP: 16 Weeks||0
5030756|NCT02091739|12380457|P3|NOT COMPLETED|MP: 16 Weeks||2
5030757|NCT02091739|12380458|P2|NOT COMPLETED|MP: 16 Weeks||5
5030758|NCT02091739|12380459|P1|NOT COMPLETED|MP: 16 Weeks||4
5030759|NCT02091739|12380455|P5|COMPLETED|MP: 16 Weeks||0
5030760|NCT02091739|12380456|P4|COMPLETED|MP: 16 Weeks||0
5030761|NCT02091739|12380457|P3|COMPLETED|MP: 16 Weeks||72
5030762|NCT02091739|12380458|P2|COMPLETED|MP: 16 Weeks||69
5030763|NCT02091739|12380459|P1|COMPLETED|MP: 16 Weeks||32
5030764|NCT02091739|12380455|P5|STARTED|MP: 16 Weeks||0
5030765|NCT02091739|12380456|P4|STARTED|MP: 16 Weeks||0
5030766|NCT02091739|12380457|P3|STARTED|MP: 16 Weeks||74
5030767|NCT02091739|12380458|P2|STARTED|MP: 16 Weeks||74
5030768|NCT02091739|12380459|P1|STARTED|MP: 16 Weeks||36
5030769|NCT02091726|12380478|P1|NOT COMPLETED|Overall Study||6
5030770|NCT02091726|12380478|P1|COMPLETED|Overall Study||104
5030771|NCT02091726|12380478|P1|4 Week Followup|Overall Study||104
5030772|NCT02091726|12380478|P1|1 Week Followup|Overall Study||110
5030773|NCT02091726|12380478|P1|STARTED|Overall Study||110
5030774|NCT02091531|12380486|P1|NOT COMPLETED|Overall Study||0
5030775|NCT02091531|12380486|P1|COMPLETED|Overall Study||9
5030776|NCT02091531|12380486|P1|STARTED|Overall Study||9
5030777|NCT02091466|12380494|P2|NOT COMPLETED|Overall Study||0
5030778|NCT02091466|12380495|P1|NOT COMPLETED|Overall Study||0
5030779|NCT02091466|12380494|P2|COMPLETED|Overall Study||20
5030780|NCT02091466|12380495|P1|COMPLETED|Overall Study||20
5030781|NCT02091466|12380494|P2|STARTED|Overall Study||20
5030782|NCT02091466|12380495|P1|STARTED|Overall Study||20
5030783|NCT02091440|12380501|P1|NOT COMPLETED|Overall Study||2
5030784|NCT02091440|12380501|P1|COMPLETED|Overall Study||4
5030785|NCT02091440|12380501|P1|Overall Survival at 180 Days|Overall Study||6
5030786|NCT02091440|12380501|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
5030787|NCT02091440|12380501|P1|STARTED|Overall Study||6
5030788|NCT02091414|12380511|P1|NOT COMPLETED|Overall Study||4
5030789|NCT02091414|12380511|P1|COMPLETED|Overall Study||32
5030790|NCT02091414|12380511|P1|STARTED|Overall Study||36
5030791|NCT02091375|12380525|P2|NOT COMPLETED|Overall Study||3
5030792|NCT02091375|12380526|P1|NOT COMPLETED|Overall Study||9
5030793|NCT02091375|12380525|P2|COMPLETED|Overall Study||56
5030794|NCT02091375|12380526|P1|COMPLETED|Overall Study||52
5030795|NCT02091375|12380525|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
5030796|NCT02091375|12380526|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
5030797|NCT02091375|12380525|P2|Safety Analysis Set|Overall Study||59
5030798|NCT02091375|12380526|P1|Safety Analysis Set|Overall Study||61
5030799|NCT02091375|12380525|P2|STARTED|Overall Study||59
5030800|NCT02091375|12380526|P1|STARTED|Overall Study||61
5030801|NCT02091362|12380556|P2|NOT COMPLETED|Period 2||2
5030802|NCT02091362|12380557|P1|NOT COMPLETED|Period 2||2
5030803|NCT02091362|12380556|P2|COMPLETED|Period 2||128
5030804|NCT02091362|12380557|P1|COMPLETED|Period 2||125
5030805|NCT02091362|12380556|P2|STARTED|Period 2||130
5030806|NCT02091362|12380557|P1|STARTED|Period 2||127
5030807|NCT02091362|12380556|P2|NOT COMPLETED|Wash-out||3
5030808|NCT02091362|12380557|P1|NOT COMPLETED|Wash-out||1
5030809|NCT02091362|12380556|P2|COMPLETED|Wash-out||130
5030810|NCT02091362|12380557|P1|COMPLETED|Wash-out||127
5030811|NCT02091362|12380556|P2|STARTED|Wash-out||133
5030812|NCT02091362|12380557|P1|STARTED|Wash-out||128
5030813|NCT02091362|12380556|P2|NOT COMPLETED|Period 1||4
5030814|NCT02091362|12380557|P1|NOT COMPLETED|Period 1||5
5030815|NCT02091362|12380556|P2|COMPLETED|Period 1||133
5030816|NCT02091362|12380557|P1|COMPLETED|Period 1||128
5030817|NCT02091362|12380556|P2|STARTED|Period 1||137
5030818|NCT02091362|12380557|P1|STARTED|Period 1||133
5030819|NCT02091284|12380579|P2|NOT COMPLETED|Overall Study||1
5030820|NCT02091284|12380580|P1|NOT COMPLETED|Overall Study||3
5030821|NCT02091284|12380579|P2|COMPLETED|Overall Study||22
5030822|NCT02091284|12380580|P1|COMPLETED|Overall Study||23
5030823|NCT02091284|12380579|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
5030824|NCT02091284|12380580|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
5030825|NCT02091206|12380602|P4|NOT COMPLETED|Taper Period||2
5030826|NCT02091206|12380603|P3|NOT COMPLETED|Taper Period||0
5030827|NCT02091206|12380604|P2|NOT COMPLETED|Taper Period||0
5030828|NCT02091206|12380605|P1|NOT COMPLETED|Taper Period||1
5030829|NCT02091206|12380602|P4|COMPLETED|Taper Period||5
5030830|NCT02091206|12380603|P3|COMPLETED|Taper Period||8
5030831|NCT02091206|12380604|P2|COMPLETED|Taper Period||7
5030832|NCT02091206|12380605|P1|COMPLETED|Taper Period||9
5030833|NCT02091206|12380602|P4|STARTED|Taper Period||7
5030834|NCT02091206|12380603|P3|STARTED|Taper Period||8
5030835|NCT02091206|12380604|P2|STARTED|Taper Period||7
5030836|NCT02091206|12380605|P1|STARTED|Taper Period||10
5030837|NCT02091206|12380602|P4|NOT COMPLETED|Treatment Period||0
5030838|NCT02091206|12380603|P3|NOT COMPLETED|Treatment Period||1
5030839|NCT02091206|12380604|P2|NOT COMPLETED|Treatment Period||1
5030840|NCT02091206|12380605|P1|NOT COMPLETED|Treatment Period||0
5030841|NCT02091206|12380602|P4|COMPLETED|Treatment Period||7
5030842|NCT02091206|12380603|P3|COMPLETED|Treatment Period||8
5030843|NCT02091206|12380604|P2|COMPLETED|Treatment Period||7
5030844|NCT02091206|12380605|P1|COMPLETED|Treatment Period||10
5030845|NCT02091206|12380602|P4|Safety Analysis Set|Treatment Period||7
5030846|NCT02091206|12380603|P3|Safety Analysis Set|Treatment Period||9
5030847|NCT02091206|12380604|P2|Safety Analysis Set|Treatment Period||8
5030848|NCT02091206|12380605|P1|Safety Analysis Set|Treatment Period||10
5030849|NCT02091206|12380602|P4|STARTED|Treatment Period||7
5030850|NCT02091206|12380603|P3|STARTED|Treatment Period||9
5030851|NCT02091206|12380604|P2|STARTED|Treatment Period||8
5030852|NCT02091206|12380605|P1|STARTED|Treatment Period||10
5030853|NCT02091167|12380624|P2|NOT COMPLETED|Overall Study||2
5030854|NCT02091167|12380625|P1|NOT COMPLETED|Overall Study||0
5030855|NCT02091167|12380624|P2|COMPLETED|Overall Study||14
5030856|NCT02091167|12380625|P1|COMPLETED|Overall Study||19
5030857|NCT02091167|12380624|P2|STARTED|Overall Study||16
5030858|NCT02091167|12380625|P1|STARTED|Overall Study||19
5030859|NCT02090894|12380633|P1|NOT COMPLETED|Overall Study||0
5030860|NCT02090894|12380633|P1|COMPLETED|Overall Study||11
5030861|NCT02090894|12380633|P1|STARTED|Overall Study||11
5030862|NCT02090855|12380638|P1|NOT COMPLETED|Overall Study||2
5030863|NCT02090855|12380638|P1|COMPLETED|Overall Study||106
5030864|NCT02090855|12380638|P1|STARTED|Overall Study||108
5030865|NCT02090777|12380645|P1|NOT COMPLETED|Overall Study||0
5030866|NCT02090777|12380645|P1|COMPLETED|Overall Study||4
5030867|NCT02090777|12380645|P1|STARTED|Overall Study||4
5030868|NCT02090764|12380651|P2|NOT COMPLETED|Overall Study||20
5030869|NCT02090764|12380652|P1|NOT COMPLETED|Overall Study||6
5030870|NCT02090764|12380651|P2|COMPLETED|Overall Study||186
5030871|NCT02090764|12380652|P1|COMPLETED|Overall Study||200
5030872|NCT02090764|12380651|P2|STARTED|Overall Study||206
5030873|NCT02090764|12380652|P1|STARTED|Overall Study||206
5030874|NCT02090725|12380658|P1|NOT COMPLETED|Overall Study||4
5030875|NCT02090725|12380658|P1|COMPLETED|Overall Study||0
5030876|NCT02090725|12380658|P1|STARTED|Overall Study||4
5030877|NCT02090426|12380664|P2|NOT COMPLETED|Overall Study||6
5030878|NCT02090426|12380665|P1|NOT COMPLETED|Overall Study||12
5030879|NCT02090426|12380664|P2|COMPLETED|Overall Study||393
5030880|NCT02090426|12380665|P1|COMPLETED|Overall Study||389
5030881|NCT02090426|12380664|P2|Analysis Population|Overall Study||393
5030882|NCT02090426|12380665|P1|Analysis Population|Overall Study||389
5030883|NCT02090426|12380664|P2|STARTED|Overall Study||399
5030884|NCT02090426|12380665|P1|STARTED|Overall Study||401
5030885|NCT02090413|12380696|P3|NOT COMPLETED|Overall Study||23
5030886|NCT02090413|12380697|P2|NOT COMPLETED|Overall Study||20
5030887|NCT02090413|12380698|P1|NOT COMPLETED|Overall Study||19
5030888|NCT02090413|12380696|P3|COMPLETED|Overall Study||57
5030889|NCT02090413|12380697|P2|COMPLETED|Overall Study||60
5030890|NCT02090413|12380698|P1|COMPLETED|Overall Study||62
5030891|NCT02090413|12380696|P3|STARTED|Overall Study||80
5030892|NCT02090413|12380697|P2|STARTED|Overall Study||80
5030893|NCT02090413|12380698|P1|STARTED|Overall Study||81
5030894|NCT02090283|12380775|P3|NOT COMPLETED|Overall Study||10
5030895|NCT02090283|12380776|P2|NOT COMPLETED|Overall Study||15
5030896|NCT02090283|12380777|P1|NOT COMPLETED|Overall Study||17
5030897|NCT02090283|12380775|P3|COMPLETED|Overall Study||0
5030898|NCT02090283|12380776|P2|COMPLETED|Overall Study||0
5030899|NCT02090283|12380777|P1|COMPLETED|Overall Study||0
5030900|NCT02090283|12380775|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
5030901|NCT02090283|12380776|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
5030902|NCT02090283|12380777|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
5030903|NCT02090283|12380775|P3|STARTED|Overall Study||10
5030904|NCT02090283|12380776|P2|STARTED|Overall Study||15
5030905|NCT02090283|12380777|P1|STARTED|Overall Study||17
5030906|NCT02090088|12380788|P1|NOT COMPLETED|Overall Study||0
5030907|NCT02090088|12380788|P1|COMPLETED|Overall Study||4
5030908|NCT02090088|12380788|P1|Gave Birth|Overall Study||4
5030909|NCT02090088|12380788|P1|STARTED|Overall Study||4
5030910|NCT02090075|12380802|P2|NOT COMPLETED|Overall Study||3
5030911|NCT02090075|12380803|P1|NOT COMPLETED|Overall Study||7
5030912|NCT02090075|12380802|P2|COMPLETED|Overall Study||30
5030913|NCT02090075|12380803|P1|COMPLETED|Overall Study||26
5030914|NCT02090075|12380802|P2|STARTED|Overall Study||33
5030915|NCT02090075|12380803|P1|STARTED|Overall Study||33
5030916|NCT02089997|12380811|P1|NOT COMPLETED|Overall Study||246
5030917|NCT02089997|12380811|P1|COMPLETED|Overall Study||3058
5030918|NCT02089997|12380811|P1|STARTED|Overall Study||3304
5030919|NCT02089737|12380826|P1|NOT COMPLETED|Overall Study||6
5030920|NCT02089737|12380826|P1|COMPLETED|Overall Study||3085
5030921|NCT02089737|12380826|P1|STARTED|Overall Study||3091
5030922|NCT02089659|12380835|P3|NOT COMPLETED|Overall Study||0
5030923|NCT02089659|12380836|P2|NOT COMPLETED|Overall Study||0
5030924|NCT02089659|12380837|P1|NOT COMPLETED|Overall Study||0
5030925|NCT02089659|12380835|P3|COMPLETED|Overall Study||0
5030926|NCT02089659|12380836|P2|COMPLETED|Overall Study||8
5030927|NCT02089659|12380837|P1|COMPLETED|Overall Study||8
5030928|NCT02089659|12380835|P3|STARTED|Overall Study||0
5030929|NCT02089659|12380836|P2|STARTED|Overall Study||8
5030930|NCT02089659|12380837|P1|STARTED|Overall Study||8
5030931|NCT02089347|12380851|P2|NOT COMPLETED|Overall Study||0
5030932|NCT02089347|12380852|P1|NOT COMPLETED|Overall Study||1
5030933|NCT02089347|12380851|P2|COMPLETED|Overall Study||178
5030934|NCT02089347|12380852|P1|COMPLETED|Overall Study||355
5030935|NCT02089347|12380851|P2|STARTED|Overall Study||178
5030936|NCT02089347|12380852|P1|STARTED|Overall Study||356
5030937|NCT02089334|12380878|P4|NOT COMPLETED|Overall Study||7
5030938|NCT02089334|12380879|P3|NOT COMPLETED|Overall Study||1
5030939|NCT02089334|12380880|P2|NOT COMPLETED|Overall Study||0
5030940|NCT02089334|12380881|P1|NOT COMPLETED|Overall Study||0
5030941|NCT02089334|12380878|P4|COMPLETED|Overall Study||6
5030942|NCT02089334|12380879|P3|COMPLETED|Overall Study||3
5030943|NCT02089334|12380880|P2|COMPLETED|Overall Study||4
5030944|NCT02089334|12380881|P1|COMPLETED|Overall Study||3
5030945|NCT02089334|12380878|P4|Received Study Drug|Overall Study||11
5030946|NCT02089334|12380879|P3|Received Study Drug|Overall Study||3
5030947|NCT02089334|12380880|P2|Received Study Drug|Overall Study||4
5030948|NCT02089334|12380881|P1|Received Study Drug|Overall Study||3
5030949|NCT02089334|12380878|P4|STARTED|Overall Study||13
5030950|NCT02089334|12380879|P3|STARTED|Overall Study||4
5030951|NCT02089334|12380880|P2|STARTED|Overall Study||4
5030952|NCT02089334|12380881|P1|STARTED|Overall Study||3
5030953|NCT02089191|12380898|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
5030954|NCT02089191|12380899|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
5030955|NCT02089191|12380898|P2|COMPLETED|Period 2, Second 12 Hours||15
5030956|NCT02089191|12380899|P1|COMPLETED|Period 2, Second 12 Hours||15
5030957|NCT02089191|12380898|P2|STARTED|Period 2, Second 12 Hours||15
5030958|NCT02089191|12380899|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
5030959|NCT02089191|12380898|P2|NOT COMPLETED|Period 1, First 12 Hours||0
5030960|NCT02089191|12380899|P1|NOT COMPLETED|Period 1, First 12 Hours||0
5030961|NCT02089191|12380898|P2|COMPLETED|Period 1, First 12 Hours||15
5030962|NCT02089191|12380899|P1|COMPLETED|Period 1, First 12 Hours||16
5030963|NCT02089191|12380898|P2|STARTED|Period 1, First 12 Hours||15
5030964|NCT02089191|12380899|P1|STARTED|Period 1, First 12 Hours||16
5030965|NCT02089113|12380909|P2|NOT COMPLETED|Overall Study||0
5030966|NCT02089113|12380910|P1|NOT COMPLETED|Overall Study||1
5030967|NCT02089113|12380909|P2|COMPLETED|Overall Study||80
5030968|NCT02089113|12380910|P1|COMPLETED|Overall Study||160
5030969|NCT02089113|12380909|P2|STARTED|Overall Study||80
5030970|NCT02089113|12380910|P1|STARTED|Overall Study||161
5030971|NCT02088957|12380918|P2|NOT COMPLETED|Overall Study||0
5030972|NCT02088957|12380919|P1|NOT COMPLETED|Overall Study||1
5030973|NCT02088957|12380918|P2|COMPLETED|Overall Study||0
5030974|NCT02088957|12380919|P1|COMPLETED|Overall Study||0
5030975|NCT02088957|12380918|P2|STARTED|Overall Study||0
5030976|NCT02088957|12380919|P1|STARTED|Overall Study||1
5030977|NCT02088905|12380937|P2|NOT COMPLETED|Overall Study||1
5030978|NCT02088905|12380938|P1|NOT COMPLETED|Overall Study||5
5030979|NCT02088905|12380937|P2|COMPLETED|Overall Study||9
5030980|NCT02088905|12380938|P1|COMPLETED|Overall Study||8
5030981|NCT02088905|12380937|P2|Week 9|Overall Study||9
5030982|NCT02088905|12380938|P1|Week 9|Overall Study||10
5030983|NCT02088905|12380937|P2|STARTED|Overall Study||10
5030984|NCT02088905|12380938|P1|STARTED|Overall Study||13
5030985|NCT02088788|12380960|P2|NOT COMPLETED|Overall Study||41
5030986|NCT02088788|12380961|P1|NOT COMPLETED|Overall Study||30
5030987|NCT02088788|12380960|P2|COMPLETED|Overall Study||89
5030988|NCT02088788|12380961|P1|COMPLETED|Overall Study||105
5030989|NCT02088788|12380960|P2|STARTED|Overall Study||130
5030990|NCT02088788|12380961|P1|STARTED|Overall Study||135
5030991|NCT02088385|12380971|P2|NOT COMPLETED|Overall Study||0
5030992|NCT02088385|12380972|P1|NOT COMPLETED|Overall Study||0
5030993|NCT02088385|12380971|P2|COMPLETED|Overall Study||10
5030994|NCT02088385|12380972|P1|COMPLETED|Overall Study||10
5030995|NCT02088385|12380971|P2|STARTED|Overall Study||10
5030996|NCT02088385|12380972|P1|STARTED|Overall Study||10
5030997|NCT02088216|12380982|P2|NOT COMPLETED|Overall Study||10
5030998|NCT02088216|12380983|P1|NOT COMPLETED|Overall Study||12
5030999|NCT02088216|12380982|P2|COMPLETED|Overall Study||70
5031000|NCT02088216|12380983|P1|COMPLETED|Overall Study||69
5031001|NCT02088216|12380982|P2|STARTED|Overall Study||80
5031002|NCT02088216|12380983|P1|STARTED|Overall Study||81
5031003|NCT02088177|12381009|P1|NOT COMPLETED|Overall Study||3
5031004|NCT02088177|12381009|P1|COMPLETED|Overall Study||9
5031005|NCT02088177|12381009|P1|STARTED|Overall Study||12
5031006|NCT02088073|12381019|P5|NOT COMPLETED|Maintanance Phase||7
5031007|NCT02088073|12381020|P4|NOT COMPLETED|Maintanance Phase||7
5031008|NCT02088073|12381021|P3|NOT COMPLETED|Maintanance Phase||5
5031009|NCT02088073|12381022|P2|NOT COMPLETED|Maintanance Phase||10
5031010|NCT02088073|12381023|P1|NOT COMPLETED|Maintanance Phase||0
5031011|NCT02088073|12381019|P5|COMPLETED|Maintanance Phase||49
5031012|NCT02088073|12381020|P4|COMPLETED|Maintanance Phase||44
5031013|NCT02088073|12381021|P3|COMPLETED|Maintanance Phase||40
5031014|NCT02088073|12381022|P2|COMPLETED|Maintanance Phase||75
5031015|NCT02088073|12381023|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
5031016|NCT02088073|12381019|P5|STARTED|Maintanance Phase||56
5031017|NCT02088073|12381020|P4|STARTED|Maintanance Phase||51
5031018|NCT02088073|12381021|P3|STARTED|Maintanance Phase||45
5031019|NCT02088073|12381022|P2|STARTED|Maintanance Phase||85
5031020|NCT02088073|12381023|P1|STARTED|Maintanance Phase||0
5031021|NCT02088073|12381019|P5|NOT COMPLETED|Acute Phase||0
5031022|NCT02088073|12381020|P4|NOT COMPLETED|Acute Phase||0
5031023|NCT02088073|12381021|P3|NOT COMPLETED|Acute Phase||0
5031024|NCT02088073|12381022|P2|NOT COMPLETED|Acute Phase||0
5031025|NCT02088073|12381023|P1|NOT COMPLETED|Acute Phase||7
5031026|NCT02088073|12381019|P5|COMPLETED|Acute Phase||0
5031027|NCT02088073|12381020|P4|COMPLETED|Acute Phase||0
5031028|NCT02088073|12381021|P3|COMPLETED|Acute Phase||0
5031029|NCT02088073|12381022|P2|COMPLETED|Acute Phase||0
5031030|NCT02088073|12381023|P1|COMPLETED|Acute Phase||251
5031031|NCT02088073|12381019|P5|STARTED|Acute Phase||0
5031032|NCT02088073|12381020|P4|STARTED|Acute Phase||0
5031033|NCT02088073|12381021|P3|STARTED|Acute Phase||0
5031034|NCT02088073|12381022|P2|STARTED|Acute Phase||0
5031035|NCT02088073|12381023|P1|STARTED|Acute Phase||258
5031036|NCT02087995|12381075|P1|NOT COMPLETED|Overall Study||0
5031037|NCT02087995|12381075|P1|COMPLETED|Overall Study||51
5031038|NCT02087995|12381075|P1|STARTED|Overall Study||51
5031039|NCT02087956|12381081|P2|NOT COMPLETED|Overall Study||5
5031040|NCT02087956|12381082|P1|NOT COMPLETED|Overall Study||6
5031041|NCT02087956|12381081|P2|COMPLETED|Overall Study||107
5031042|NCT02087956|12381082|P1|COMPLETED|Overall Study||105
5031043|NCT02087956|12381081|P2|STARTED|Overall Study||112
5031044|NCT02087956|12381082|P1|STARTED|Overall Study||111
5031045|NCT02087943|12381097|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
5031046|NCT02087943|12381098|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
5031047|NCT02087943|12381099|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
5031048|NCT02087943|12381100|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
5031049|NCT02087943|12381101|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
5031050|NCT02087943|12381097|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
5031051|NCT02087943|12381098|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
5031052|NCT02087943|12381099|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
5031053|NCT02087943|12381100|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
5031054|NCT02087943|12381101|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
5031055|NCT02087943|12381097|P5|STARTED|Observational Follow-up Phase Week 24-30||23
5031056|NCT02087943|12381098|P4|STARTED|Observational Follow-up Phase Week 24-30||24
5031057|NCT02087943|12381099|P3|STARTED|Observational Follow-up Phase Week 24-30||48
5031058|NCT02087943|12381100|P2|STARTED|Observational Follow-up Phase Week 24-30||46
5031059|NCT02087943|12381101|P1|STARTED|Observational Follow-up Phase Week 24-30||0
5031060|NCT02087943|12381097|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
5031061|NCT02087943|12381098|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
5031062|NCT02087943|12381099|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
5031063|NCT02087943|12381100|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
5031064|NCT02087943|12381101|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
5031065|NCT02087943|12381097|P5|COMPLETED|Active Treatment Phase Week 12-24||21
5031066|NCT02087943|12381098|P4|COMPLETED|Active Treatment Phase Week 12-24||22
5031067|NCT02087943|12381099|P3|COMPLETED|Active Treatment Phase Week 12-24||44
5031068|NCT02087943|12381100|P2|COMPLETED|Active Treatment Phase Week 12-24||42
5031069|NCT02087943|12381101|P1|COMPLETED|Active Treatment Phase Week 12-24||0
5031070|NCT02087943|12381097|P5|STARTED|Active Treatment Phase Week 12-24||23
5031071|NCT02087943|12381098|P4|STARTED|Active Treatment Phase Week 12-24||24
5031072|NCT02087943|12381099|P3|STARTED|Active Treatment Phase Week 12-24||49
5031073|NCT02087943|12381100|P2|STARTED|Active Treatment Phase Week 12-24||46
5031074|NCT02087943|12381101|P1|STARTED|Active Treatment Phase Week 12-24||0
5031075|NCT02087943|12381097|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
5031076|NCT02087943|12381098|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
5031077|NCT02087943|12381099|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
5031078|NCT02087943|12381100|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
5031079|NCT02087943|12381101|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
5031080|NCT02087943|12381097|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
5031081|NCT02087943|12381098|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
5031082|NCT02087943|12381099|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
5031083|NCT02087943|12381100|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
5031084|NCT02087943|12381101|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
5031085|NCT02087943|12381097|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
5031086|NCT02087943|12381098|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
5031087|NCT02087943|12381099|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
5031088|NCT02087943|12381100|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
5031089|NCT02087943|12381101|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
5031090|NCT02087943|12381097|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
5031091|NCT02087943|12381098|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
5031092|NCT02087943|12381099|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
5031093|NCT02087943|12381100|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
5031094|NCT02087943|12381101|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
5031095|NCT02087904|12381129|P4|NOT COMPLETED|Overall Study||25
5031096|NCT02087904|12381130|P3|NOT COMPLETED|Overall Study||22
5031097|NCT02087904|12381131|P2|NOT COMPLETED|Overall Study||19
5031098|NCT02087904|12381132|P1|NOT COMPLETED|Overall Study||25
5031099|NCT02087904|12381129|P4|COMPLETED|Overall Study||64
5031100|NCT02087904|12381130|P3|COMPLETED|Overall Study||65
5031101|NCT02087904|12381131|P2|COMPLETED|Overall Study||70
5031102|NCT02087904|12381132|P1|COMPLETED|Overall Study||60
5031103|NCT02087904|12381129|P4|STARTED|Overall Study||89
5031104|NCT02087904|12381130|P3|STARTED|Overall Study||87
5031105|NCT02087904|12381131|P2|STARTED|Overall Study||89
5031106|NCT02087904|12381132|P1|STARTED|Overall Study||85
5031107|NCT02087774|12381248|P2|NOT COMPLETED|Overall Study||20
5031108|NCT02087774|12381249|P1|NOT COMPLETED|Overall Study||8
5031109|NCT02087774|12381248|P2|COMPLETED|Overall Study||130
5031110|NCT02087774|12381249|P1|COMPLETED|Overall Study||142
5031111|NCT02087774|12381248|P2|STARTED|Overall Study||150
5031112|NCT02087774|12381249|P1|STARTED|Overall Study||150
5031113|NCT02087748|12381257|P1|NOT COMPLETED|Overall Study||0
5031114|NCT02087748|12381257|P1|COMPLETED|Overall Study||24
5031115|NCT02087748|12381257|P1|STARTED|Overall Study||24
5031116|NCT02087670|12381269|P2|NOT COMPLETED|Overall Study||2
5031117|NCT02087670|12381270|P1|NOT COMPLETED|Overall Study||3
5031118|NCT02087670|12381269|P2|COMPLETED|Overall Study||20
5031119|NCT02087670|12381270|P1|COMPLETED|Overall Study||17
5031120|NCT02087670|12381269|P2|STARTED|Overall Study||22
5031121|NCT02087670|12381270|P1|STARTED|Overall Study||20
5031122|NCT02087514|12381284|P6|NOT COMPLETED|Overall Study||1
5031123|NCT02087514|12381285|P5|NOT COMPLETED|Overall Study||0
5031124|NCT02087514|12381286|P4|NOT COMPLETED|Overall Study||2
5031125|NCT02087514|12381287|P3|NOT COMPLETED|Overall Study||3
5031126|NCT02087514|12381288|P2|NOT COMPLETED|Overall Study||0
5031127|NCT02087514|12381289|P1|NOT COMPLETED|Overall Study||2
5031128|NCT02087514|12381284|P6|COMPLETED|Overall Study||9
5031129|NCT02087514|12381285|P5|COMPLETED|Overall Study||10
5031130|NCT02087514|12381286|P4|COMPLETED|Overall Study||8
5031131|NCT02087514|12381287|P3|COMPLETED|Overall Study||7
5031132|NCT02087514|12381288|P2|COMPLETED|Overall Study||10
5031133|NCT02087514|12381289|P1|COMPLETED|Overall Study||8
5031134|NCT02087514|12381284|P6|STARTED|Overall Study||10
5031135|NCT02087514|12381285|P5|STARTED|Overall Study||10
5031136|NCT02087514|12381286|P4|STARTED|Overall Study||10
5031137|NCT02087514|12381287|P3|STARTED|Overall Study||10
5031138|NCT02087514|12381288|P2|STARTED|Overall Study||10
5031139|NCT02087514|12381289|P1|STARTED|Overall Study||10
5031140|NCT02087423|12381306|P3|NOT COMPLETED|Overall Study||68
5031141|NCT02087423|12381307|P2|NOT COMPLETED|Overall Study||265
5031142|NCT02087423|12381308|P1|NOT COMPLETED|Overall Study||111
5031143|NCT02087423|12381306|P3|COMPLETED|Overall Study||0
5031144|NCT02087423|12381307|P2|COMPLETED|Overall Study||0
5031145|NCT02087423|12381308|P1|COMPLETED|Overall Study||0
5031146|NCT02087423|12381306|P3|Completed 12 Months of Treatment|Overall Study||26
5031147|NCT02087423|12381307|P2|Completed 12 Months of Treatment|Overall Study||60
5031148|NCT02087423|12381308|P1|Completed 12 Months of Treatment|Overall Study||18
5031149|NCT02087423|12381306|P3|STARTED|Overall Study|Treated|68
5031150|NCT02087423|12381307|P2|STARTED|Overall Study|Treated|265
5031151|NCT02087423|12381308|P1|STARTED|Overall Study|Treated|111
5031152|NCT02087241|12381337|P4|NOT COMPLETED|Overall Study||7
5031153|NCT02087241|12381338|P3|NOT COMPLETED|Overall Study||1
5031154|NCT02087241|12381339|P2|NOT COMPLETED|Overall Study||3
5031155|NCT02087241|12381340|P1|NOT COMPLETED|Overall Study||3
5031156|NCT02087241|12381337|P4|COMPLETED|Overall Study||0
5031157|NCT02087241|12381338|P3|COMPLETED|Overall Study||0
5031158|NCT02087241|12381339|P2|COMPLETED|Overall Study||0
5031159|NCT02087241|12381340|P1|COMPLETED|Overall Study||0
5031160|NCT02087241|12381337|P4|STARTED|Overall Study||7
5031161|NCT02087241|12381338|P3|STARTED|Overall Study||1
5031162|NCT02087241|12381339|P2|STARTED|Overall Study||3
5031163|NCT02087241|12381340|P1|STARTED|Overall Study||3
5031164|NCT02087176|12381366|P1|NOT COMPLETED|Overall Study||32
5031165|NCT02087176|12381366|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
5031166|NCT02087176|12381366|P1|STARTED|Overall Study||32
5031167|NCT02087163|12381371|P1|NOT COMPLETED|Overall Study||17
5031168|NCT02087163|12381371|P1|COMPLETED|Overall Study||73
5031169|NCT02087163|12381371|P1|STARTED|Overall Study||90
5031170|NCT02087150|12381379|P3|NOT COMPLETED|Overall Study||11
5031171|NCT02087150|12381380|P2|NOT COMPLETED|Overall Study||34
5031172|NCT02087150|12381381|P1|NOT COMPLETED|Overall Study||10
5031173|NCT02087150|12381379|P3|COMPLETED|Overall Study||69
5031174|NCT02087150|12381380|P2|COMPLETED|Overall Study||128
5031175|NCT02087150|12381381|P1|COMPLETED|Overall Study||71
5031176|NCT02087150|12381379|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
5031177|NCT02087150|12381380|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
5031178|NCT02087150|12381381|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
5031179|NCT02087150|12381379|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
5031180|NCT02087150|12381380|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
5031181|NCT02087150|12381381|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
5031182|NCT02087150|12381379|P3|STARTED|Overall Study||80
5031183|NCT02087150|12381380|P2|STARTED|Overall Study||162
5031184|NCT02087150|12381381|P1|STARTED|Overall Study||81
5031185|NCT02087085|12381400|P2|NOT COMPLETED|Overall Study||116
5031186|NCT02087085|12381401|P1|NOT COMPLETED|Overall Study||120
5031187|NCT02087085|12381400|P2|COMPLETED|Overall Study||40
5031188|NCT02087085|12381401|P1|COMPLETED|Overall Study||34
5031189|NCT02087085|12381400|P2|STARTED|Overall Study||156
5031190|NCT02087085|12381401|P1|STARTED|Overall Study||154
5031191|NCT02087059|12381411|P1|NOT COMPLETED|Overall Study||7
5031192|NCT02087059|12381411|P1|COMPLETED|Overall Study||44
5031193|NCT02087059|12381411|P1|STARTED|Overall Study||51
5031194|NCT02086786|12381421|P2|NOT COMPLETED|Overall Study||16
5031195|NCT02086786|12381422|P1|NOT COMPLETED|Overall Study||18
5031196|NCT02086786|12381421|P2|COMPLETED|Overall Study||19
5031197|NCT02086786|12381422|P1|COMPLETED|Overall Study||17
5031198|NCT02086786|12381421|P2|STARTED|Overall Study||35
5031199|NCT02086786|12381422|P1|STARTED|Overall Study||35
5031200|NCT02086708|12381446|P1|NOT COMPLETED|Overall Study||0
5031201|NCT02086708|12381446|P1|COMPLETED|Overall Study||24
5031202|NCT02086708|12381446|P1|STARTED|Overall Study||24
5031203|NCT02086682|12381460|P2|NOT COMPLETED|Overall Study||0
5031204|NCT02086682|12381461|P1|NOT COMPLETED|Overall Study||0
5031205|NCT02086682|12381460|P2|COMPLETED|Overall Study||182
5031206|NCT02086682|12381461|P1|COMPLETED|Overall Study||156
5031207|NCT02086682|12381460|P2|STARTED|Overall Study||182
5031208|NCT02086682|12381461|P1|STARTED|Overall Study||156
5031209|NCT02086591|12381467|P1|NOT COMPLETED|Overall Study||5
5031210|NCT02086591|12381467|P1|COMPLETED|Overall Study||2
5031211|NCT02086591|12381467|P1|STARTED|Overall Study||7
5031212|NCT02086565|12381475|P2|NOT COMPLETED|Overall Study||12
5031213|NCT02086565|12381476|P1|NOT COMPLETED|Overall Study||16
5031214|NCT02086565|12381475|P2|COMPLETED|Overall Study||138
5031215|NCT02086565|12381476|P1|COMPLETED|Overall Study||135
5031216|NCT02086565|12381475|P2|STARTED|Overall Study||150
5031217|NCT02086565|12381476|P1|STARTED|Overall Study||151
5031218|NCT02086552|12381490|P1|NOT COMPLETED|Overall Study||1
5031219|NCT02086552|12381490|P1|COMPLETED|Overall Study||27
5031220|NCT02086552|12381490|P1|STARTED|Overall Study||28
5031221|NCT02086162|12381499|P2|NOT COMPLETED|Overall Study||7
5031222|NCT02086162|12381500|P1|NOT COMPLETED|Overall Study||10
5031223|NCT02086162|12381499|P2|COMPLETED|Overall Study||77
5031224|NCT02086162|12381500|P1|COMPLETED|Overall Study||68
5031225|NCT02086162|12381499|P2|STARTED|Overall Study||84
5031226|NCT02086162|12381500|P1|STARTED|Overall Study||78
5031227|NCT02086110|12381512|P2|NOT COMPLETED|Overall Study||1
5031228|NCT02086110|12381513|P1|NOT COMPLETED|Overall Study||1
5031229|NCT02086110|12381512|P2|COMPLETED|Overall Study||5
5031230|NCT02086110|12381513|P1|COMPLETED|Overall Study||4
5031231|NCT02086110|12381512|P2|STARTED|Overall Study||6
5031232|NCT02086110|12381513|P1|STARTED|Overall Study||5
5031233|NCT02085785|12381524|P2|NOT COMPLETED|Overall Study||2
5031234|NCT02085785|12381525|P1|NOT COMPLETED|Overall Study||2
5031235|NCT02085785|12381524|P2|COMPLETED|Overall Study||6
5031236|NCT02085785|12381525|P1|COMPLETED|Overall Study||5
5031237|NCT02085785|12381524|P2|STARTED|Overall Study||8
5031238|NCT02085785|12381525|P1|STARTED|Overall Study||7
5031239|NCT02085720|12381537|P1|NOT COMPLETED|Overall Study||0
5031240|NCT02085720|12381537|P1|COMPLETED|Overall Study||819
5031241|NCT02085720|12381537|P1|STARTED|Overall Study||819
5031242|NCT02085551|12381545|P1|NOT COMPLETED|Overall Study||0
5031243|NCT02085551|12381545|P1|COMPLETED|Overall Study||85
5031244|NCT02085551|12381545|P1|STARTED|Overall Study||85
5031245|NCT02085473|12381554|P4|NOT COMPLETED|Overall Study||0
5031246|NCT02085473|12381555|P3|NOT COMPLETED|Overall Study||0
5031247|NCT02085473|12381556|P2|NOT COMPLETED|Overall Study||0
5031248|NCT02085473|12381557|P1|NOT COMPLETED|Overall Study||0
5031249|NCT02085473|12381554|P4|COMPLETED|Overall Study||15
5031250|NCT02085473|12381555|P3|COMPLETED|Overall Study||15
5031251|NCT02085473|12381556|P2|COMPLETED|Overall Study||15
5031252|NCT02085473|12381557|P1|COMPLETED|Overall Study||15
5031253|NCT02085473|12381554|P4|STARTED|Overall Study||15
5031254|NCT02085473|12381555|P3|STARTED|Overall Study||15
5031255|NCT02085473|12381556|P2|STARTED|Overall Study||15
5031256|NCT02085473|12381557|P1|STARTED|Overall Study||15
5031257|NCT02085447|12381619|P1|NOT COMPLETED|Overall Study||4
5031258|NCT02085447|12381619|P1|COMPLETED|Overall Study||26
5031259|NCT02085447|12381619|P1|STARTED|Overall Study||30
5031260|NCT02085356|12381648|P4|NOT COMPLETED|Overall Study||0
5031261|NCT02085356|12381649|P3|NOT COMPLETED|Overall Study||0
5031262|NCT02085356|12381650|P2|NOT COMPLETED|Overall Study||0
5031263|NCT02085356|12381651|P1|NOT COMPLETED|Overall Study||0
5031264|NCT02085356|12381648|P4|COMPLETED|Overall Study||361
5031265|NCT02085356|12381649|P3|COMPLETED|Overall Study||681
5031266|NCT02085356|12381650|P2|COMPLETED|Overall Study||348
5031267|NCT02085356|12381651|P1|COMPLETED|Overall Study||577
5031268|NCT02085356|12381648|P4|STARTED|Overall Study||361
5031269|NCT02085356|12381649|P3|STARTED|Overall Study||681
5031270|NCT02085356|12381650|P2|STARTED|Overall Study||348
5031271|NCT02085356|12381651|P1|STARTED|Overall Study||577
5031272|NCT02085252|12381679|P2|NOT COMPLETED|Overall Study||4
5031273|NCT02085252|12381680|P1|NOT COMPLETED|Overall Study||1
5031274|NCT02085252|12381679|P2|COMPLETED|Overall Study||53
5031275|NCT02085252|12381680|P1|COMPLETED|Overall Study||57
5031276|NCT02085252|12381679|P2|STARTED|Overall Study||57
5031277|NCT02085252|12381680|P1|STARTED|Overall Study||58
5031278|NCT02085161|12381704|P4|NOT COMPLETED|Overall Study||10
5031279|NCT02085161|12381705|P3|NOT COMPLETED|Overall Study||5
5031280|NCT02085161|12381706|P2|NOT COMPLETED|Overall Study||10
5031281|NCT02085161|12381707|P1|NOT COMPLETED|Overall Study||12
5031282|NCT02085161|12381704|P4|COMPLETED|Overall Study||66
5031283|NCT02085161|12381705|P3|COMPLETED|Overall Study||71
5031284|NCT02085161|12381706|P2|COMPLETED|Overall Study||66
5031285|NCT02085161|12381707|P1|COMPLETED|Overall Study||64
5031286|NCT02085161|12381704|P4|STARTED|Overall Study||76
5031287|NCT02085161|12381705|P3|STARTED|Overall Study||76
5031288|NCT02085161|12381706|P2|STARTED|Overall Study||76
5031289|NCT02085161|12381707|P1|STARTED|Overall Study||76
5031290|NCT02085135|12381748|P2|NOT COMPLETED|Overall Study||9
5031291|NCT02085135|12381749|P1|NOT COMPLETED|Overall Study||11
5031292|NCT02085135|12381748|P2|COMPLETED|Overall Study||23
5031293|NCT02085135|12381749|P1|COMPLETED|Overall Study||23
5031294|NCT02085135|12381748|P2|STARTED|Overall Study||32
5031295|NCT02085135|12381749|P1|STARTED|Overall Study||34
5031296|NCT02084797|12381755|P1|NOT COMPLETED|Overall Study||0
5031297|NCT02084797|12381755|P1|COMPLETED|Overall Study||10
5031298|NCT02084797|12381755|P1|STARTED|Overall Study||10
5031299|NCT02084706|12381764|P2|NOT COMPLETED|Overall Study||0
5031300|NCT02084706|12381765|P1|NOT COMPLETED|Overall Study||0
5031301|NCT02084706|12381764|P2|COMPLETED|Overall Study||31
5031302|NCT02084706|12381765|P1|COMPLETED|Overall Study||29
5031303|NCT02084706|12381764|P2|STARTED|Overall Study||31
5031304|NCT02084706|12381765|P1|STARTED|Overall Study||29
5031305|NCT02084628|12381771|P1|NOT COMPLETED|Overall Study||0
5031306|NCT02084628|12381771|P1|COMPLETED|Overall Study||1
5031307|NCT02084628|12381771|P1|STARTED|Overall Study||1
5031308|NCT02084511|12381788|P4|NOT COMPLETED|Overall Study||0
5031309|NCT02084511|12381789|P3|NOT COMPLETED|Overall Study||0
5031310|NCT02084511|12381790|P2|NOT COMPLETED|Overall Study||0
5031311|NCT02084511|12381791|P1|NOT COMPLETED|Overall Study||0
5031312|NCT02084511|12381788|P4|COMPLETED|Overall Study||20
5031313|NCT02084511|12381789|P3|COMPLETED|Overall Study||20
5031314|NCT02084511|12381790|P2|COMPLETED|Overall Study||20
5031315|NCT02084511|12381791|P1|COMPLETED|Overall Study||20
5031316|NCT02084511|12381788|P4|STARTED|Overall Study||20
5031317|NCT02084511|12381789|P3|STARTED|Overall Study||20
5031318|NCT02084511|12381790|P2|STARTED|Overall Study||20
5031319|NCT02084511|12381791|P1|STARTED|Overall Study||20
5031320|NCT02084238|12381821|P1|NOT COMPLETED|Overall Study||2
5031321|NCT02084238|12381821|P1|COMPLETED|Overall Study||38
5031322|NCT02084238|12381821|P1|STARTED|Overall Study||40
5031323|NCT02084160|12381832|P1|NOT COMPLETED|Overall Study||0
5031324|NCT02084160|12381832|P1|COMPLETED|Overall Study||579
5031325|NCT02084160|12381832|P1|STARTED|Overall Study||579
5031326|NCT02084147|12381836|P1|NOT COMPLETED|Overall Study||0
5031327|NCT02084147|12381836|P1|COMPLETED|Overall Study||72
5031328|NCT02084147|12381836|P1|STARTED|Overall Study||72
5031329|NCT02084134|12381846|P2|NOT COMPLETED|Overall Study||3
5031330|NCT02084134|12381847|P1|NOT COMPLETED|Overall Study||4
5031331|NCT02084134|12381846|P2|COMPLETED|Overall Study||17
5031332|NCT02084134|12381847|P1|COMPLETED|Overall Study||19
5031333|NCT02084134|12381846|P2|STARTED|Overall Study||20
5031334|NCT02084134|12381847|P1|STARTED|Overall Study||23
5031335|NCT02084082|12381857|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031336|NCT02084082|12381858|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031337|NCT02084082|12381859|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031338|NCT02084082|12381860|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031339|NCT02084082|12381857|P4|COMPLETED|Treatment Period 2 (4 Days)||6
5031340|NCT02084082|12381858|P3|COMPLETED|Treatment Period 2 (4 Days)||7
5031341|NCT02084082|12381859|P2|COMPLETED|Treatment Period 2 (4 Days)||26
5031342|NCT02084082|12381860|P1|COMPLETED|Treatment Period 2 (4 Days)||26
5031343|NCT02084082|12381857|P4|STARTED|Treatment Period 2 (4 Days)||6
5031344|NCT02084082|12381858|P3|STARTED|Treatment Period 2 (4 Days)||7
5031345|NCT02084082|12381859|P2|STARTED|Treatment Period 2 (4 Days)||26
5031346|NCT02084082|12381860|P1|STARTED|Treatment Period 2 (4 Days)||26
5031347|NCT02084082|12381857|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
5031348|NCT02084082|12381858|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
5031349|NCT02084082|12381859|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
5031350|NCT02084082|12381860|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
5031351|NCT02084082|12381857|P4|COMPLETED|Washout Period 1 (35 Days)||6
5031352|NCT02084082|12381858|P3|COMPLETED|Washout Period 1 (35 Days)||7
5031353|NCT02084082|12381859|P2|COMPLETED|Washout Period 1 (35 Days)||26
5031354|NCT02084082|12381860|P1|COMPLETED|Washout Period 1 (35 Days)||26
5031355|NCT02084082|12381857|P4|STARTED|Washout Period 1 (35 Days)||8
5031356|NCT02084082|12381858|P3|STARTED|Washout Period 1 (35 Days)||8
5031357|NCT02084082|12381859|P2|STARTED|Washout Period 1 (35 Days)||26
5031358|NCT02084082|12381860|P1|STARTED|Washout Period 1 (35 Days)||26
5031359|NCT02084082|12381857|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031360|NCT02084082|12381858|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031361|NCT02084082|12381859|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031362|NCT02084082|12381860|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031363|NCT02084082|12381857|P4|COMPLETED|Treatment Period 1 (4 Days)||8
5031364|NCT02084082|12381858|P3|COMPLETED|Treatment Period 1 (4 Days)||8
5031365|NCT02084082|12381859|P2|COMPLETED|Treatment Period 1 (4 Days)||26
5031366|NCT02084082|12381860|P1|COMPLETED|Treatment Period 1 (4 Days)||26
5031367|NCT02084082|12381857|P4|STARTED|Treatment Period 1 (4 Days)||8
5031368|NCT02084082|12381858|P3|STARTED|Treatment Period 1 (4 Days)||8
5031369|NCT02084082|12381859|P2|STARTED|Treatment Period 1 (4 Days)||26
5031370|NCT02084082|12381860|P1|STARTED|Treatment Period 1 (4 Days)||26
5031371|NCT02084069|12381892|P2|NOT COMPLETED|Overall Study||0
5031372|NCT02084069|12381893|P1|NOT COMPLETED|Overall Study||0
5031373|NCT02084069|12381892|P2|COMPLETED|Overall Study||29
5031374|NCT02084069|12381893|P1|COMPLETED|Overall Study||29
5031375|NCT02084069|12381892|P2|STARTED|Overall Study||29
5031376|NCT02084069|12381893|P1|STARTED|Overall Study||29
5031377|NCT02084056|12381901|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031378|NCT02084056|12381902|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031379|NCT02084056|12381903|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031380|NCT02084056|12381904|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5031381|NCT02084056|12381901|P4|COMPLETED|Treatment Period 2 (4 Days)||8
5031382|NCT02084056|12381902|P3|COMPLETED|Treatment Period 2 (4 Days)||8
5031383|NCT02084056|12381903|P2|COMPLETED|Treatment Period 2 (4 Days)||30
5031384|NCT02084056|12381904|P1|COMPLETED|Treatment Period 2 (4 Days)||26
5031385|NCT02084056|12381901|P4|STARTED|Treatment Period 2 (4 Days)||8
5031386|NCT02084056|12381902|P3|STARTED|Treatment Period 2 (4 Days)||8
5031387|NCT02084056|12381903|P2|STARTED|Treatment Period 2 (4 Days)||30
5031388|NCT02084056|12381904|P1|STARTED|Treatment Period 2 (4 Days)||26
5031389|NCT02084056|12381901|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
5031390|NCT02084056|12381902|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
5031391|NCT02084056|12381903|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
5031392|NCT02084056|12381904|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
5031393|NCT02084056|12381901|P4|COMPLETED|Washout Period 1 (35 Days)||8
5031394|NCT02084056|12381902|P3|COMPLETED|Washout Period 1 (35 Days)||8
5031395|NCT02084056|12381903|P2|COMPLETED|Washout Period 1 (35 Days)||30
5031396|NCT02084056|12381904|P1|COMPLETED|Washout Period 1 (35 Days)||26
5031397|NCT02084056|12381901|P4|STARTED|Washout Period 1 (35 Days)||8
5031398|NCT02084056|12381902|P3|STARTED|Washout Period 1 (35 Days)||8
5031399|NCT02084056|12381903|P2|STARTED|Washout Period 1 (35 Days)||30
5031400|NCT02084056|12381904|P1|STARTED|Washout Period 1 (35 Days)||27
5031401|NCT02084056|12381901|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031402|NCT02084056|12381902|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031403|NCT02084056|12381903|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5031404|NCT02084056|12381904|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
5031405|NCT02084056|12381901|P4|COMPLETED|Treatment Period 1 (4 Days)||8
5031406|NCT02084056|12381902|P3|COMPLETED|Treatment Period 1 (4 Days)||8
5031407|NCT02084056|12381903|P2|COMPLETED|Treatment Period 1 (4 Days)||30
5031408|NCT02084056|12381904|P1|COMPLETED|Treatment Period 1 (4 Days)||27
5031409|NCT02084056|12381901|P4|STARTED|Treatment Period 1 (4 Days)||8
5031410|NCT02084056|12381902|P3|STARTED|Treatment Period 1 (4 Days)||8
5031411|NCT02084056|12381903|P2|STARTED|Treatment Period 1 (4 Days)||30
5031412|NCT02084056|12381904|P1|STARTED|Treatment Period 1 (4 Days)||28
5031413|NCT02083965|12381936|P2|NOT COMPLETED|Treatment Period||0
5031414|NCT02083965|12381937|P1|NOT COMPLETED|Treatment Period||1
5031415|NCT02083965|12381936|P2|COMPLETED|Treatment Period||8
5031416|NCT02083965|12381937|P1|COMPLETED|Treatment Period||9
5031417|NCT02083965|12381936|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
5031418|NCT02083965|12381937|P1|STARTED|Treatment Period||10
5031419|NCT02083965|12381936|P2|NOT COMPLETED|PK Period 2||0
5031420|NCT02083965|12381937|P1|NOT COMPLETED|PK Period 2||0
5031421|NCT02083965|12381936|P2|COMPLETED|PK Period 2||9
5031422|NCT02083965|12381937|P1|COMPLETED|PK Period 2||10
5031423|NCT02083965|12381936|P2|STARTED|PK Period 2||9
5031424|NCT02083965|12381937|P1|STARTED|PK Period 2||10
5031425|NCT02083965|12381936|P2|NOT COMPLETED|Washout Period||0
5031426|NCT02083965|12381937|P1|NOT COMPLETED|Washout Period||0
5031427|NCT02083965|12381936|P2|COMPLETED|Washout Period||9
5031428|NCT02083965|12381937|P1|COMPLETED|Washout Period||10
5031429|NCT02083965|12381936|P2|STARTED|Washout Period||9
5031430|NCT02083965|12381937|P1|STARTED|Washout Period||10
5031431|NCT02083965|12381936|P2|NOT COMPLETED|PK Period 1||0
5031432|NCT02083965|12381937|P1|NOT COMPLETED|PK Period 1||0
5031433|NCT02083965|12381936|P2|COMPLETED|PK Period 1||9
5031434|NCT02083965|12381937|P1|COMPLETED|PK Period 1||10
5031435|NCT02083965|12381936|P2|STARTED|PK Period 1||9
5031436|NCT02083965|12381937|P1|STARTED|PK Period 1||10
5031437|NCT02083861|12381995|P2|NOT COMPLETED|Overall Study||3
5031438|NCT02083861|12381996|P1|NOT COMPLETED|Overall Study||6
5031439|NCT02083861|12381995|P2|COMPLETED|Overall Study||33
5031440|NCT02083861|12381996|P1|COMPLETED|Overall Study||51
5031441|NCT02083861|12381995|P2|Treated|Overall Study||35
5031442|NCT02083861|12381996|P1|Treated|Overall Study||55
5031443|NCT02083861|12381995|P2|STARTED|Overall Study||36
5031444|NCT02083861|12381996|P1|STARTED|Overall Study||57
5031445|NCT02083679|12382012|P4|NOT COMPLETED|Overall Study||0
5031446|NCT02083679|12382013|P3|NOT COMPLETED|Overall Study||0
5031447|NCT02083679|12382014|P2|NOT COMPLETED|Overall Study||0
5031448|NCT02083679|12382015|P1|NOT COMPLETED|Overall Study||0
5031449|NCT02083679|12382012|P4|COMPLETED|Overall Study||3
5031450|NCT02083679|12382013|P3|COMPLETED|Overall Study||3
5031451|NCT02083679|12382014|P2|COMPLETED|Overall Study||6
5031452|NCT02083679|12382015|P1|COMPLETED|Overall Study||3
5031453|NCT02083679|12382012|P4|STARTED|Overall Study||3
5031454|NCT02083679|12382013|P3|STARTED|Overall Study||3
5031455|NCT02083679|12382014|P2|STARTED|Overall Study||6
5031456|NCT02083679|12382015|P1|STARTED|Overall Study||3
5031457|NCT02083653|12382032|P3|NOT COMPLETED|Overall Study||84
5031458|NCT02083653|12382033|P2|NOT COMPLETED|Overall Study||85
5031459|NCT02083653|12382034|P1|NOT COMPLETED|Overall Study||82
5031460|NCT02083653|12382032|P3|COMPLETED|Overall Study||1
5031461|NCT02083653|12382033|P2|COMPLETED|Overall Study||1
5031462|NCT02083653|12382034|P1|COMPLETED|Overall Study||1
5031463|NCT02083653|12382032|P3|STARTED|Overall Study||85
5031464|NCT02083653|12382033|P2|STARTED|Overall Study||86
5031465|NCT02083653|12382034|P1|STARTED|Overall Study||83
5031466|NCT02083406|12382080|P3|NOT COMPLETED|Overall Study||0
5031467|NCT02083406|12382081|P2|NOT COMPLETED|Overall Study||0
5031468|NCT02083406|12382082|P1|NOT COMPLETED|Overall Study||0
5031469|NCT02083406|12382080|P3|COMPLETED|Overall Study||7
5031470|NCT02083406|12382081|P2|COMPLETED|Overall Study||8
5031471|NCT02083406|12382082|P1|COMPLETED|Overall Study||7
5031472|NCT02083406|12382080|P3|STARTED|Overall Study||7
5031473|NCT02083406|12382081|P2|STARTED|Overall Study||8
5031474|NCT02083406|12382082|P1|STARTED|Overall Study||7
5031475|NCT02083380|12382102|P3|NOT COMPLETED|Overall Study||84
5031476|NCT02083380|12382103|P2|NOT COMPLETED|Overall Study||95
5031477|NCT02083380|12382104|P1|NOT COMPLETED|Overall Study||91
5031478|NCT02083380|12382102|P3|COMPLETED|Overall Study||65
5031479|NCT02083380|12382103|P2|COMPLETED|Overall Study||56
5031480|NCT02083380|12382104|P1|COMPLETED|Overall Study||57
5031481|NCT02083380|12382102|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
5031482|NCT02083380|12382103|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
5031483|NCT02083380|12382104|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
5031484|NCT02083263|12382199|P2|NOT COMPLETED|Overall Study||0
5031485|NCT02083263|12382200|P1|NOT COMPLETED|Overall Study||0
5031486|NCT02083263|12382199|P2|COMPLETED|Overall Study||16
5031487|NCT02083263|12382200|P1|COMPLETED|Overall Study||16
5031488|NCT02083263|12382199|P2|STARTED|Overall Study||16
5031489|NCT02083263|12382200|P1|STARTED|Overall Study||16
5031490|NCT02083185|12382209|P3|NOT COMPLETED|Overall Study||7
5031491|NCT02083185|12382210|P2|NOT COMPLETED|Overall Study||29
5031492|NCT02083185|12382211|P1|NOT COMPLETED|Overall Study||20
5031493|NCT02083185|12382209|P3|COMPLETED|Overall Study||17
5031494|NCT02083185|12382210|P2|COMPLETED|Overall Study||27
5031495|NCT02083185|12382211|P1|COMPLETED|Overall Study||36
5031496|NCT02083185|12382209|P3|Safety Population|Overall Study||24
5031497|NCT02083185|12382210|P2|Safety Population|Overall Study||54
5031498|NCT02083185|12382211|P1|Safety Population|Overall Study||56
5031499|NCT02083185|12382209|P3|STARTED|Overall Study||24
5031500|NCT02083185|12382210|P2|STARTED|Overall Study||56
5031501|NCT02083185|12382211|P1|STARTED|Overall Study||56
5031502|NCT02083107|12382269|P3|NOT COMPLETED|Overall Study||0
5031503|NCT02083107|12382270|P2|NOT COMPLETED|Overall Study||0
5031504|NCT02083107|12382271|P1|NOT COMPLETED|Overall Study||0
5031505|NCT02083107|12382269|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
5031506|NCT02083107|12382270|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
5031507|NCT02083107|12382271|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
5031508|NCT02083107|12382269|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
5031509|NCT02083107|12382270|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
5031510|NCT02083107|12382271|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
5031511|NCT02082977|12382316|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031512|NCT02082977|12382317|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031513|NCT02082977|12382318|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031514|NCT02082977|12382319|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031515|NCT02082977|12382320|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031516|NCT02082977|12382321|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031517|NCT02082977|12382322|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031518|NCT02082977|12382323|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031519|NCT02082977|12382324|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031520|NCT02082977|12382325|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
5031521|NCT02082977|12382316|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031522|NCT02082977|12382317|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031523|NCT02082977|12382318|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031524|NCT02082977|12382319|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031525|NCT02082977|12382320|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031526|NCT02082977|12382321|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031527|NCT02082977|12382322|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031528|NCT02082977|12382323|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031529|NCT02082977|12382324|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031530|NCT02082977|12382325|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
5031531|NCT02082977|12382316|P10|STARTED|Part 2 (Up to 3.2 Years)||0
5031532|NCT02082977|12382317|P9|STARTED|Part 2 (Up to 3.2 Years)||0
5031533|NCT02082977|12382318|P8|STARTED|Part 2 (Up to 3.2 Years)||0
5031534|NCT02082977|12382319|P7|STARTED|Part 2 (Up to 3.2 Years)||0
5031535|NCT02082977|12382320|P6|STARTED|Part 2 (Up to 3.2 Years)||0
5031536|NCT02082977|12382321|P5|STARTED|Part 2 (Up to 3.2 Years)||0
5031537|NCT02082977|12382322|P4|STARTED|Part 2 (Up to 3.2 Years)||0
5031538|NCT02082977|12382323|P3|STARTED|Part 2 (Up to 3.2 Years)||0
5031539|NCT02082977|12382324|P2|STARTED|Part 2 (Up to 3.2 Years)||0
5031540|NCT02082977|12382325|P1|STARTED|Part 2 (Up to 3.2 Years)||0
5031541|NCT02082977|12382316|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
5031542|NCT02082977|12382317|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
5031543|NCT02082977|12382318|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
5031544|NCT02082977|12382319|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
5031545|NCT02082977|12382320|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
5031546|NCT02082977|12382321|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
5031547|NCT02082977|12382322|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
5031548|NCT02082977|12382323|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
5031549|NCT02082977|12382324|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
5031550|NCT02082977|12382325|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
5031551|NCT02082977|12382316|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
5031552|NCT02082977|12382317|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
5031553|NCT02082977|12382318|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
5031554|NCT02082977|12382319|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
5031555|NCT02082977|12382320|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
5031556|NCT02082977|12382321|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
5031557|NCT02082977|12382322|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
5031558|NCT02082977|12382323|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
5031559|NCT02082977|12382324|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
5031560|NCT02082977|12382325|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
5031561|NCT02082977|12382316|P10|STARTED|Part 1 (Up to 3.2 Years)||0
5031562|NCT02082977|12382317|P9|STARTED|Part 1 (Up to 3.2 Years)||7
5031563|NCT02082977|12382318|P8|STARTED|Part 1 (Up to 3.2 Years)||12
5031564|NCT02082977|12382319|P7|STARTED|Part 1 (Up to 3.2 Years)||10
5031565|NCT02082977|12382320|P6|STARTED|Part 1 (Up to 3.2 Years)||4
5031566|NCT02082977|12382321|P5|STARTED|Part 1 (Up to 3.2 Years)||3
5031567|NCT02082977|12382322|P4|STARTED|Part 1 (Up to 3.2 Years)||1
5031568|NCT02082977|12382323|P3|STARTED|Part 1 (Up to 3.2 Years)||1
5031569|NCT02082977|12382324|P2|STARTED|Part 1 (Up to 3.2 Years)||1
5031570|NCT02082977|12382325|P1|STARTED|Part 1 (Up to 3.2 Years)||2
5031571|NCT02082912|12382579|P2|NOT COMPLETED|Overall Study||1
5031572|NCT02082912|12382580|P1|NOT COMPLETED|Overall Study||0
5031573|NCT02082912|12382579|P2|COMPLETED|Overall Study||6
5031574|NCT02082912|12382580|P1|COMPLETED|Overall Study||7
5031575|NCT02082912|12382579|P2|STARTED|Overall Study||7
5031576|NCT02082912|12382580|P1|STARTED|Overall Study||7
5031577|NCT02082769|12382597|P3|NOT COMPLETED|Overall Study||36
5031578|NCT02082769|12382598|P2|NOT COMPLETED|Overall Study||27
5031579|NCT02082769|12382599|P1|NOT COMPLETED|Overall Study||24
5031580|NCT02082769|12382597|P3|COMPLETED|Overall Study||132
5031581|NCT02082769|12382598|P2|COMPLETED|Overall Study||141
5031582|NCT02082769|12382599|P1|COMPLETED|Overall Study||144
5031583|NCT02082769|12382597|P3|STARTED|Overall Study||168
5031584|NCT02082769|12382598|P2|STARTED|Overall Study||168
5031585|NCT02082769|12382599|P1|STARTED|Overall Study||168
5031586|NCT02082678|12382615|P2|NOT COMPLETED|Overall Study||13
5031587|NCT02082678|12382616|P1|NOT COMPLETED|Overall Study||11
5031588|NCT02082678|12382615|P2|COMPLETED|Overall Study||22
5031589|NCT02082678|12382616|P1|COMPLETED|Overall Study||24
5031590|NCT02082678|12382615|P2|STARTED|Overall Study||35
5031591|NCT02082678|12382616|P1|STARTED|Overall Study||35
5031592|NCT02082522|12382628|P2|NOT COMPLETED|Overall Study||13
5031593|NCT02082522|12382629|P1|NOT COMPLETED|Overall Study||15
5031594|NCT02082522|12382628|P2|COMPLETED|Overall Study||0
5031595|NCT02082522|12382629|P1|COMPLETED|Overall Study||0
5031596|NCT02082522|12382628|P2|STARTED|Overall Study||13
5031597|NCT02082522|12382629|P1|STARTED|Overall Study||15
5031598|NCT02082483|12382679|P2|NOT COMPLETED|Overall Study||6
5031599|NCT02082483|12382680|P1|NOT COMPLETED|Overall Study||6
5031600|NCT02082483|12382679|P2|COMPLETED|Overall Study||67
5031601|NCT02082483|12382680|P1|COMPLETED|Overall Study||65
5031602|NCT02082483|12382679|P2|STARTED|Overall Study||73
5031603|NCT02082483|12382680|P1|STARTED|Overall Study||71
5031604|NCT02082392|12382697|P2|NOT COMPLETED|Overall Study||0
5031605|NCT02082392|12382698|P1|NOT COMPLETED|Overall Study||0
5031606|NCT02082392|12382697|P2|COMPLETED|Overall Study||1
5031607|NCT02082392|12382698|P1|COMPLETED|Overall Study||2
5031608|NCT02082392|12382697|P2|STARTED|Overall Study||1
5031609|NCT02082392|12382698|P1|STARTED|Overall Study||2
5031610|NCT02082340|12382732|P2|NOT COMPLETED|Overall Study||1
5031611|NCT02082340|12382733|P1|NOT COMPLETED|Overall Study||1
5031612|NCT02082340|12382732|P2|COMPLETED|Overall Study||197
5031613|NCT02082340|12382733|P1|COMPLETED|Overall Study||193
5031614|NCT02082340|12382732|P2|STARTED|Overall Study||198
5031615|NCT02082340|12382733|P1|STARTED|Overall Study||194
5031616|NCT02082288|12382739|P1|NOT COMPLETED|Overall Study||0
5031617|NCT02082288|12382739|P1|COMPLETED|Overall Study||243
5031618|NCT02082288|12382739|P1|STARTED|Overall Study||243
5031619|NCT02082262|12382743|P1|NOT COMPLETED|Overall Study||51
5031620|NCT02082262|12382743|P1|COMPLETED|Overall Study||89
5031621|NCT02082262|12382743|P1|STARTED|Overall Study||140
5031622|NCT02082184|12382749|P2|NOT COMPLETED|Overall Study||13
5031623|NCT02082184|12382750|P1|NOT COMPLETED|Overall Study||10
5031624|NCT02082184|12382749|P2|COMPLETED|Overall Study||62
5031625|NCT02082184|12382750|P1|COMPLETED|Overall Study||139
5031626|NCT02082184|12382749|P2|STARTED|Overall Study||75
5031627|NCT02082184|12382750|P1|STARTED|Overall Study||149
5031628|NCT02082158|12382775|P6|NOT COMPLETED|Overall Study||7
5031629|NCT02082158|12382776|P5|NOT COMPLETED|Overall Study||4
5031630|NCT02082158|12382777|P4|NOT COMPLETED|Overall Study||4
5031631|NCT02082158|12382778|P3|NOT COMPLETED|Overall Study||14
5031632|NCT02082158|12382779|P2|NOT COMPLETED|Overall Study||8
5031633|NCT02082158|12382780|P1|NOT COMPLETED|Overall Study||8
5031634|NCT02082158|12382775|P6|COMPLETED|Overall Study||56
5031635|NCT02082158|12382776|P5|COMPLETED|Overall Study||64
5031636|NCT02082158|12382777|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
5031637|NCT02082158|12382778|P3|COMPLETED|Overall Study||38
5031638|NCT02082158|12382779|P2|COMPLETED|Overall Study||53
5031639|NCT02082158|12382780|P1|COMPLETED|Overall Study||58
5031640|NCT02082158|12382775|P6|STARTED|Overall Study||63
5031641|NCT02082158|12382776|P5|STARTED|Overall Study||68
5031642|NCT02082158|12382777|P4|STARTED|Overall Study||72
5031643|NCT02082158|12382778|P3|STARTED|Overall Study||52
5031644|NCT02082158|12382779|P2|STARTED|Overall Study||61
5031645|NCT02082158|12382780|P1|STARTED|Overall Study||66
5031646|NCT02082145|12382802|P2|NOT COMPLETED|Overall Study||0
5031647|NCT02082145|12382803|P1|NOT COMPLETED|Overall Study||0
5031648|NCT02082145|12382802|P2|COMPLETED|Overall Study||9
5031649|NCT02082145|12382803|P1|COMPLETED|Overall Study||5
5031650|NCT02082145|12382802|P2|STARTED|Overall Study||9
5031651|NCT02082145|12382803|P1|STARTED|Overall Study||5
5031652|NCT02081963|12382817|P2|NOT COMPLETED|Overall Study||4
5031653|NCT02081963|12382818|P1|NOT COMPLETED|Overall Study||5
5031654|NCT02081963|12382817|P2|COMPLETED|Overall Study||69
5031655|NCT02081963|12382818|P1|COMPLETED|Overall Study||74
5031656|NCT02081963|12382817|P2|STARTED|Overall Study||73
5031657|NCT02081963|12382818|P1|STARTED|Overall Study||79
5031658|NCT02081859|12382834|P2|NOT COMPLETED|Overall Study||31
5031659|NCT02081859|12382835|P1|NOT COMPLETED|Overall Study||34
5031660|NCT02081859|12382834|P2|COMPLETED|Overall Study||119
5031661|NCT02081859|12382835|P1|COMPLETED|Overall Study||116
5031662|NCT02081859|12382834|P2|STARTED|Overall Study||150
5031663|NCT02081859|12382835|P1|STARTED|Overall Study||150
5031664|NCT02081846|12382845|P2|NOT COMPLETED|Overall Study||0
5031665|NCT02081846|12382846|P1|NOT COMPLETED|Overall Study||2
5031666|NCT02081846|12382845|P2|COMPLETED|Overall Study||749
5031667|NCT02081846|12382846|P1|COMPLETED|Overall Study||749
5031668|NCT02081846|12382845|P2|STARTED|Overall Study||749
5031669|NCT02081846|12382846|P1|STARTED|Overall Study||751
5031670|NCT02081807|12382872|P8|NOT COMPLETED|Overall Study||0
5031671|NCT02081807|12382873|P7|NOT COMPLETED|Overall Study||0
5031672|NCT02081807|12382874|P6|NOT COMPLETED|Overall Study||0
5031673|NCT02081807|12382875|P5|NOT COMPLETED|Overall Study||0
5031674|NCT02081807|12382876|P4|NOT COMPLETED|Overall Study||0
5031675|NCT02081807|12382877|P3|NOT COMPLETED|Overall Study||0
5031676|NCT02081807|12382878|P2|NOT COMPLETED|Overall Study||0
5031677|NCT02081807|12382879|P1|NOT COMPLETED|Overall Study||0
5031678|NCT02081807|12382872|P8|COMPLETED|Overall Study||19729
5031679|NCT02081807|12382873|P7|COMPLETED|Overall Study||40207
5031680|NCT02081807|12382874|P6|COMPLETED|Overall Study||76055
5031681|NCT02081807|12382875|P5|COMPLETED|Overall Study||27456
5031682|NCT02081807|12382876|P4|COMPLETED|Overall Study||9112
5031683|NCT02081807|12382877|P3|COMPLETED|Overall Study||14852
5031684|NCT02081807|12382878|P2|COMPLETED|Overall Study||26149
5031685|NCT02081807|12382879|P1|COMPLETED|Overall Study||7668
5031686|NCT02081807|12382872|P8|STARTED|Overall Study||19729
5031687|NCT02081807|12382873|P7|STARTED|Overall Study||40207
5031688|NCT02081807|12382874|P6|STARTED|Overall Study||76055
5031689|NCT02081807|12382875|P5|STARTED|Overall Study||27456
5031690|NCT02081807|12382876|P4|STARTED|Overall Study||9112
5031691|NCT02081807|12382877|P3|STARTED|Overall Study||14852
5031692|NCT02081807|12382878|P2|STARTED|Overall Study||26149
5031693|NCT02081807|12382879|P1|STARTED|Overall Study||7668
5031694|NCT02081690|12383015|P1|NOT COMPLETED|Overall Study||7
5031695|NCT02081690|12383015|P1|COMPLETED|Overall Study||81
5031696|NCT02081690|12383015|P1|STARTED|Overall Study||88
5031697|NCT02081677|12383026|P4|NOT COMPLETED|Overall Study||0
5031698|NCT02081677|12383027|P3|NOT COMPLETED|Overall Study||2
5031699|NCT02081677|12383028|P2|NOT COMPLETED|Overall Study||1
5031700|NCT02081677|12383029|P1|NOT COMPLETED|Overall Study||1
5031701|NCT02081677|12383026|P4|COMPLETED|Overall Study||19
5031702|NCT02081677|12383027|P3|COMPLETED|Overall Study||17
5031703|NCT02081677|12383028|P2|COMPLETED|Overall Study||18
5031704|NCT02081677|12383029|P1|COMPLETED|Overall Study||18
5031705|NCT02081677|12383026|P4|STARTED|Overall Study||19
5031706|NCT02081677|12383027|P3|STARTED|Overall Study||19
5031707|NCT02081677|12383028|P2|STARTED|Overall Study||19
5031708|NCT02081677|12383029|P1|STARTED|Overall Study||19
5031709|NCT02081599|12383121|P2|NOT COMPLETED|Period 2：Open-label Period||4
5031710|NCT02081599|12383122|P1|NOT COMPLETED|Period 2：Open-label Period||6
5031711|NCT02081599|12383121|P2|COMPLETED|Period 2：Open-label Period||71
5031712|NCT02081599|12383122|P1|COMPLETED|Period 2：Open-label Period||57
5031713|NCT02081599|12383121|P2|STARTED|Period 2：Open-label Period||75
5031714|NCT02081599|12383122|P1|STARTED|Period 2：Open-label Period||63
5031715|NCT02081599|12383121|P2|NOT COMPLETED|Period 1：Double-blind Period||2
5031716|NCT02081599|12383122|P1|NOT COMPLETED|Period 1：Double-blind Period||8
5031717|NCT02081599|12383121|P2|COMPLETED|Period 1：Double-blind Period||75
5031718|NCT02081599|12383122|P1|COMPLETED|Period 1：Double-blind Period||63
5031719|NCT02081599|12383121|P2|STARTED|Period 1：Double-blind Period||77
5031720|NCT02081599|12383122|P1|STARTED|Period 1：Double-blind Period||71
5031721|NCT02081586|12383140|P4|NOT COMPLETED|Overall Study||1
5031722|NCT02081586|12383141|P3|NOT COMPLETED|Overall Study||1
5031723|NCT02081586|12383142|P2|NOT COMPLETED|Overall Study||1
5031724|NCT02081586|12383143|P1|NOT COMPLETED|Overall Study||0
5031725|NCT02081586|12383140|P4|COMPLETED|Overall Study||2
5031726|NCT02081586|12383141|P3|COMPLETED|Overall Study||3
5031727|NCT02081586|12383142|P2|COMPLETED|Overall Study||2
5031728|NCT02081586|12383143|P1|COMPLETED|Overall Study||3
5031729|NCT02081586|12383140|P4|STARTED|Overall Study||3
5031730|NCT02081586|12383141|P3|STARTED|Overall Study||4
5031731|NCT02081586|12383142|P2|STARTED|Overall Study||3
5031732|NCT02081586|12383143|P1|STARTED|Overall Study||3
5031733|NCT02081573|12383170|P1|NOT COMPLETED|Overall Study||0
5031734|NCT02081573|12383170|P1|COMPLETED|Overall Study||10
5031735|NCT02081573|12383170|P1|STARTED|Overall Study||10
5031736|NCT02081456|12383181|P2|NOT COMPLETED|Overall Study||0
5031737|NCT02081456|12383182|P1|NOT COMPLETED|Overall Study||0
5031738|NCT02081456|12383181|P2|COMPLETED|Overall Study||12
5031739|NCT02081456|12383182|P1|COMPLETED|Overall Study||11
5031740|NCT02081456|12383181|P2|STARTED|Overall Study||12
5031741|NCT02081456|12383182|P1|STARTED|Overall Study||11
5031742|NCT02081443|12383196|P2|NOT COMPLETED|Overall Study||0
5031743|NCT02081443|12383197|P1|NOT COMPLETED|Overall Study||0
5031744|NCT02081443|12383196|P2|COMPLETED|Overall Study||30
5031745|NCT02081443|12383197|P1|COMPLETED|Overall Study||30
5031746|NCT02081443|12383196|P2|STARTED|Overall Study||30
5031747|NCT02081443|12383197|P1|STARTED|Overall Study||30
5031748|NCT02081417|12383209|P2|NOT COMPLETED|Overall Study||51
5031749|NCT02081417|12383210|P1|NOT COMPLETED|Overall Study||56
5031750|NCT02081417|12383209|P2|COMPLETED|Overall Study||115
5031751|NCT02081417|12383210|P1|COMPLETED|Overall Study||107
5031752|NCT02081417|12383209|P2|6-Month Follow-Up|Overall Study||92
5031753|NCT02081417|12383210|P1|6-Month Follow-Up|Overall Study||82
5031754|NCT02081417|12383209|P2|3-Month Follow-Up|Overall Study||95
5031755|NCT02081417|12383210|P1|3-Month Follow-Up|Overall Study||94
5031756|NCT02081417|12383209|P2|1st Interview Completed|Overall Study||145
5031757|NCT02081417|12383210|P1|1st Interview Completed|Overall Study||146
5031758|NCT02081417|12383209|P2|STARTED|Overall Study||166
5031759|NCT02081417|12383210|P1|STARTED|Overall Study|Randomized to intervention|163
5031760|NCT02081391|12383230|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
5031761|NCT02081391|12383231|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
5031762|NCT02081391|12383232|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
5031763|NCT02081391|12383233|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
5031764|NCT02081391|12383230|P4|COMPLETED|24-hour Treatment and Trial Completion||4
5031765|NCT02081391|12383231|P3|COMPLETED|24-hour Treatment and Trial Completion||9
5031766|NCT02081391|12383232|P2|COMPLETED|24-hour Treatment and Trial Completion||28
5031767|NCT02081391|12383233|P1|COMPLETED|24-hour Treatment and Trial Completion||63
5031768|NCT02081391|12383230|P4|STARTED|24-hour Treatment and Trial Completion||4
5031769|NCT02081391|12383231|P3|STARTED|24-hour Treatment and Trial Completion||10
5031770|NCT02081391|12383232|P2|STARTED|24-hour Treatment and Trial Completion||46
5031771|NCT02081391|12383233|P1|STARTED|24-hour Treatment and Trial Completion||90
5031772|NCT02081391|12383230|P4|NOT COMPLETED|12-hour Treatment||0
5031773|NCT02081391|12383231|P3|NOT COMPLETED|12-hour Treatment||1
5031774|NCT02081391|12383232|P2|NOT COMPLETED|12-hour Treatment||6
5031775|NCT02081391|12383233|P1|NOT COMPLETED|12-hour Treatment||18
5031776|NCT02081391|12383230|P4|COMPLETED|12-hour Treatment||4
5031777|NCT02081391|12383231|P3|COMPLETED|12-hour Treatment||10
5031778|NCT02081391|12383232|P2|COMPLETED|12-hour Treatment||46
5031779|NCT02081391|12383233|P1|COMPLETED|12-hour Treatment||90
5031780|NCT02081391|12383230|P4|STARTED|12-hour Treatment||4
5031781|NCT02081391|12383231|P3|STARTED|12-hour Treatment||11
5031782|NCT02081391|12383232|P2|STARTED|12-hour Treatment||52
5031783|NCT02081391|12383233|P1|STARTED|12-hour Treatment||108
5031784|NCT02081365|12383287|P2|NOT COMPLETED|Overall Study||23
5031785|NCT02081365|12383288|P1|NOT COMPLETED|Overall Study||30
5031786|NCT02081365|12383287|P2|COMPLETED|Overall Study||54
5031787|NCT02081365|12383288|P1|COMPLETED|Overall Study||44
5031788|NCT02081365|12383287|P2|Received Allocated Intervention|Overall Study||59
5031789|NCT02081365|12383288|P1|Received Allocated Intervention|Overall Study||46
5031790|NCT02081365|12383287|P2|STARTED|Overall Study||77
5031791|NCT02081365|12383288|P1|STARTED|Overall Study||74
5031792|NCT02081248|12383302|P2|NOT COMPLETED|Overall Study||13
5031793|NCT02081248|12383303|P1|NOT COMPLETED|Overall Study||22
5031794|NCT02081248|12383302|P2|COMPLETED|Overall Study||87
5031795|NCT02081248|12383303|P1|COMPLETED|Overall Study||76
5031796|NCT02081248|12383302|P2|STARTED|Overall Study||100
5031797|NCT02081248|12383303|P1|STARTED|Overall Study||98
5031798|NCT02081183|12383327|P2|NOT COMPLETED|Overall Study||4
5031799|NCT02081183|12383328|P1|NOT COMPLETED|Overall Study||4
5031800|NCT02081183|12383327|P2|COMPLETED|Overall Study||2
5031801|NCT02081183|12383328|P1|COMPLETED|Overall Study||1
5031802|NCT02081183|12383327|P2|STARTED|Overall Study||6
5031803|NCT02081183|12383328|P1|STARTED|Overall Study||5
5031804|NCT02081079|12383344|P2|NOT COMPLETED|Overall Study||2
5031805|NCT02081079|12383345|P1|NOT COMPLETED|Overall Study||4
5031806|NCT02081079|12383344|P2|COMPLETED|Overall Study||39
5031807|NCT02081079|12383345|P1|COMPLETED|Overall Study||40
5031808|NCT02081079|12383344|P2|STARTED|Overall Study||41
5031809|NCT02081079|12383345|P1|STARTED|Overall Study||44
5031810|NCT02081014|12383367|P6|NOT COMPLETED|Overall Study||0
5031811|NCT02081014|12383368|P5|NOT COMPLETED|Overall Study||0
5031812|NCT02081014|12383369|P4|NOT COMPLETED|Overall Study||0
5031813|NCT02081014|12383370|P3|NOT COMPLETED|Overall Study||0
5031814|NCT02081014|12383371|P2|NOT COMPLETED|Overall Study||0
5031815|NCT02081014|12383372|P1|NOT COMPLETED|Overall Study||0
5031816|NCT02081014|12383367|P6|COMPLETED|Overall Study||2
5031817|NCT02081014|12383368|P5|COMPLETED|Overall Study||2
5031818|NCT02081014|12383369|P4|COMPLETED|Overall Study||2
5031819|NCT02081014|12383370|P3|COMPLETED|Overall Study||2
5031820|NCT02081014|12383371|P2|COMPLETED|Overall Study||2
5031821|NCT02081014|12383372|P1|COMPLETED|Overall Study||2
5031822|NCT02081014|12383367|P6|STARTED|Overall Study||2
5031823|NCT02081014|12383368|P5|STARTED|Overall Study||2
5031824|NCT02081014|12383369|P4|STARTED|Overall Study||2
5031825|NCT02081014|12383370|P3|STARTED|Overall Study||2
5031826|NCT02081014|12383371|P2|STARTED|Overall Study||2
5031827|NCT02081014|12383372|P1|STARTED|Overall Study||2
5031828|NCT02081001|12383418|P12|NOT COMPLETED|Overall Study||0
5031829|NCT02081001|12383419|P11|NOT COMPLETED|Overall Study||0
5031830|NCT02081001|12383420|P10|NOT COMPLETED|Overall Study||0
5031831|NCT02081001|12383421|P9|NOT COMPLETED|Overall Study||0
5031832|NCT02081001|12383422|P8|NOT COMPLETED|Overall Study||0
5031833|NCT02081001|12383423|P7|NOT COMPLETED|Overall Study||0
5031834|NCT02081001|12383424|P6|NOT COMPLETED|Overall Study||0
5031835|NCT02081001|12383425|P5|NOT COMPLETED|Overall Study||1
5031836|NCT02081001|12383426|P4|NOT COMPLETED|Overall Study||0
5031837|NCT02081001|12383427|P3|NOT COMPLETED|Overall Study||0
5031838|NCT02081001|12383428|P2|NOT COMPLETED|Overall Study||0
5031839|NCT02081001|12383429|P1|NOT COMPLETED|Overall Study||0
5031840|NCT02081001|12383418|P12|COMPLETED|Overall Study||1
5031841|NCT02081001|12383419|P11|COMPLETED|Overall Study||2
5031842|NCT02081001|12383420|P10|COMPLETED|Overall Study||1
5031843|NCT02081001|12383421|P9|COMPLETED|Overall Study||2
5031844|NCT02081001|12383422|P8|COMPLETED|Overall Study||1
5031845|NCT02081001|12383423|P7|COMPLETED|Overall Study||2
5031846|NCT02081001|12383424|P6|COMPLETED|Overall Study||1
5031847|NCT02081001|12383425|P5|COMPLETED|Overall Study||2
5031848|NCT02081001|12383426|P4|COMPLETED|Overall Study||1
5031849|NCT02081001|12383427|P3|COMPLETED|Overall Study||2
5031850|NCT02081001|12383428|P2|COMPLETED|Overall Study||1
5031851|NCT02081001|12383429|P1|COMPLETED|Overall Study||2
5031852|NCT02081001|12383418|P12|STARTED|Overall Study||1
5031853|NCT02081001|12383419|P11|STARTED|Overall Study||2
5031854|NCT02081001|12383420|P10|STARTED|Overall Study||1
5031855|NCT02081001|12383421|P9|STARTED|Overall Study||2
5031856|NCT02081001|12383422|P8|STARTED|Overall Study||1
5031857|NCT02081001|12383423|P7|STARTED|Overall Study||2
5031858|NCT02081001|12383424|P6|STARTED|Overall Study||1
5031859|NCT02081001|12383425|P5|STARTED|Overall Study||3
5031860|NCT02081001|12383426|P4|STARTED|Overall Study||1
5031861|NCT02081001|12383427|P3|STARTED|Overall Study||2
5031862|NCT02081001|12383428|P2|STARTED|Overall Study||1
5031863|NCT02081001|12383429|P1|STARTED|Overall Study||2
5031864|NCT02080871|12383493|P1|NOT COMPLETED|Overall Study||2
5031865|NCT02080871|12383493|P1|COMPLETED|Overall Study||132
5031866|NCT02080871|12383493|P1|STARTED|Overall Study||134
5031867|NCT02080832|12383577|P3|NOT COMPLETED|Overall Study||16
5031868|NCT02080832|12383578|P2|NOT COMPLETED|Overall Study||12
5031869|NCT02080832|12383579|P1|NOT COMPLETED|Overall Study||9
5031870|NCT02080832|12383577|P3|COMPLETED|Overall Study||6
5031871|NCT02080832|12383578|P2|COMPLETED|Overall Study||5
5031872|NCT02080832|12383579|P1|COMPLETED|Overall Study||6
5031873|NCT02080832|12383577|P3|STARTED|Overall Study||22
5031874|NCT02080832|12383578|P2|STARTED|Overall Study||17
5031875|NCT02080832|12383579|P1|STARTED|Overall Study||15
5031876|NCT02080819|12383596|P3|NOT COMPLETED|Overall Study||22
5031877|NCT02080819|12383597|P2|NOT COMPLETED|Overall Study||26
5031878|NCT02080819|12383598|P1|NOT COMPLETED|Overall Study||25
5031879|NCT02080819|12383596|P3|COMPLETED|Overall Study||11
5031880|NCT02080819|12383597|P2|COMPLETED|Overall Study||9
5031881|NCT02080819|12383598|P1|COMPLETED|Overall Study||38
5031882|NCT02080819|12383596|P3|STARTED|Overall Study||33
5031883|NCT02080819|12383597|P2|STARTED|Overall Study||35
5031884|NCT02080819|12383598|P1|STARTED|Overall Study||63
5031885|NCT02080780|12383606|P1|NOT COMPLETED|Overall Study||0
5031886|NCT02080780|12383606|P1|COMPLETED|Overall Study||24
5031887|NCT02080780|12383606|P1|STARTED|Overall Study||24
5031888|NCT02080637|12383615|P2|NOT COMPLETED|Overall Study||0
5031889|NCT02080637|12383616|P1|NOT COMPLETED|Overall Study||0
5031890|NCT02080637|12383615|P2|COMPLETED|Overall Study||3
5031891|NCT02080637|12383616|P1|COMPLETED|Overall Study||13
5031892|NCT02080637|12383615|P2|STARTED|Overall Study||3
5031893|NCT02080637|12383616|P1|STARTED|Overall Study||13
5031894|NCT02080546|12383629|P2|NOT COMPLETED|Overall Study||11
5031895|NCT02080546|12383630|P1|NOT COMPLETED|Overall Study||8
5031896|NCT02080546|12383629|P2|COMPLETED|Overall Study||52
5031897|NCT02080546|12383630|P1|COMPLETED|Overall Study||49
5031898|NCT02080546|12383629|P2|STARTED|Overall Study||63
5031899|NCT02080546|12383630|P1|STARTED|Overall Study||57
5031900|NCT02080507|12383640|P2|NOT COMPLETED|Overall Study||0
5031901|NCT02080507|12383641|P1|NOT COMPLETED|Overall Study||0
5031902|NCT02080507|12383640|P2|COMPLETED|Overall Study||7
5031903|NCT02080507|12383641|P1|COMPLETED|Overall Study||5
5031904|NCT02080507|12383640|P2|STARTED|Overall Study||7
5031905|NCT02080507|12383641|P1|STARTED|Overall Study||5
5031906|NCT02080481|12383651|P2|NOT COMPLETED|Overall Study||0
5031907|NCT02080481|12383652|P1|NOT COMPLETED|Overall Study||1
5031908|NCT02080481|12383651|P2|COMPLETED|Overall Study||67
5031909|NCT02080481|12383652|P1|COMPLETED|Overall Study||67
5031910|NCT02080481|12383651|P2|STARTED|Overall Study||67
5031911|NCT02080481|12383652|P1|STARTED|Overall Study||68
5031912|NCT02080468|12383666|P2|NOT COMPLETED|Overall Study||2
5031913|NCT02080468|12383667|P1|NOT COMPLETED|Overall Study||2
5031914|NCT02080468|12383666|P2|COMPLETED|Overall Study||14
5031915|NCT02080468|12383667|P1|COMPLETED|Overall Study||14
5031916|NCT02080468|12383666|P2|STARTED|Overall Study||16
5031917|NCT02080468|12383667|P1|STARTED|Overall Study||16
5031918|NCT02080455|12383733|P2|NOT COMPLETED|Overall Study||0
5031919|NCT02080455|12383734|P1|NOT COMPLETED|Overall Study||0
5031920|NCT02080455|12383733|P2|COMPLETED|Overall Study||16
5031921|NCT02080455|12383734|P1|COMPLETED|Overall Study||16
5031922|NCT02080455|12383733|P2|STARTED|Overall Study||16
5031923|NCT02080455|12383734|P1|STARTED|Overall Study||16
5031924|NCT02080312|12383798|P1|NOT COMPLETED|Overall Study||0
5031925|NCT02080312|12383798|P1|COMPLETED|Overall Study||6
5031926|NCT02080312|12383798|P1|STARTED|Overall Study||6
5031927|NCT02080273|12383807|P3|NOT COMPLETED|Overall Study||0
5031928|NCT02080273|12383808|P2|NOT COMPLETED|Overall Study||0
5031929|NCT02080273|12383809|P1|NOT COMPLETED|Overall Study||0
5031930|NCT02080273|12383807|P3|COMPLETED|Overall Study||45
5031931|NCT02080273|12383808|P2|COMPLETED|Overall Study||45
5031932|NCT02080273|12383809|P1|COMPLETED|Overall Study||45
5031933|NCT02080273|12383807|P3|STARTED|Overall Study||45
5031934|NCT02080273|12383808|P2|STARTED|Overall Study||45
5031935|NCT02080273|12383809|P1|STARTED|Overall Study||45
5031936|NCT02080260|12383838|P1|NOT COMPLETED|Overall Study||19
5031937|NCT02080260|12383838|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
5031938|NCT02080260|12383838|P1|STARTED|Overall Study||20
5031939|NCT02080195|12383846|P1|NOT COMPLETED|Overall Study||0
5031940|NCT02080195|12383846|P1|COMPLETED|Overall Study||1
5031941|NCT02080195|12383846|P1|STARTED|Overall Study||1
5031942|NCT02080091|12383855|P1|NOT COMPLETED|Overall Study||25
5031943|NCT02080091|12383855|P1|COMPLETED|Overall Study||0
5031944|NCT02080091|12383855|P1|STARTED|Overall Study||25
5031945|NCT02079987|12383863|P2|NOT COMPLETED|Overall Study||0
5031946|NCT02079987|12383864|P1|NOT COMPLETED|Overall Study||0
5031947|NCT02079987|12383863|P2|COMPLETED|Overall Study||544
5031948|NCT02079987|12383864|P1|COMPLETED|Overall Study||557
5031949|NCT02079987|12383863|P2|STARTED|Overall Study||544
5031950|NCT02079987|12383864|P1|STARTED|Overall Study||557
5031951|NCT02079909|12383883|P3|NOT COMPLETED|Overall Study||18
5031952|NCT02079909|12383884|P2|NOT COMPLETED|Overall Study||49
5031953|NCT02079909|12383885|P1|NOT COMPLETED|Overall Study||38
5031954|NCT02079909|12383883|P3|COMPLETED|Overall Study||140
5031955|NCT02079909|12383884|P2|COMPLETED|Overall Study||117
5031956|NCT02079909|12383885|P1|COMPLETED|Overall Study||120
5031957|NCT02079909|12383883|P3|STARTED|Overall Study||158
5031958|NCT02079909|12383884|P2|STARTED|Overall Study||166
5031959|NCT02079909|12383885|P1|STARTED|Overall Study||158
5031960|NCT02079844|12383902|P3|NOT COMPLETED|Treatment Period 3||0
5031961|NCT02079844|12383903|P2|NOT COMPLETED|Treatment Period 3||0
5031962|NCT02079844|12383904|P1|NOT COMPLETED|Treatment Period 3||0
5031963|NCT02079844|12383902|P3|COMPLETED|Treatment Period 3||5
5031964|NCT02079844|12383903|P2|COMPLETED|Treatment Period 3||5
5031965|NCT02079844|12383904|P1|COMPLETED|Treatment Period 3||5
5031966|NCT02079844|12383902|P3|STARTED|Treatment Period 3||5
5031967|NCT02079844|12383903|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
5031968|NCT02079844|12383904|P1|STARTED|Treatment Period 3||5
5031969|NCT02079844|12383902|P3|NOT COMPLETED|Treatment Period 2||0
5031970|NCT02079844|12383903|P2|NOT COMPLETED|Treatment Period 2||1
5031971|NCT02079844|12383904|P1|NOT COMPLETED|Treatment Period 2||0
5031972|NCT02079844|12383902|P3|COMPLETED|Treatment Period 2||5
5031973|NCT02079844|12383903|P2|COMPLETED|Treatment Period 2||6
5031974|NCT02079844|12383904|P1|COMPLETED|Treatment Period 2||5
5031975|NCT02079844|12383902|P3|STARTED|Treatment Period 2||5
5031976|NCT02079844|12383903|P2|STARTED|Treatment Period 2||7
5031977|NCT02079844|12383904|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
5031978|NCT02079844|12383902|P3|NOT COMPLETED|Treatment Period 1||2
5031979|NCT02079844|12383903|P2|NOT COMPLETED|Treatment Period 1||0
5031980|NCT02079844|12383904|P1|NOT COMPLETED|Treatment Period 1||0
5031981|NCT02079844|12383902|P3|COMPLETED|Treatment Period 1||5
5031982|NCT02079844|12383903|P2|COMPLETED|Treatment Period 1||7
5031983|NCT02079844|12383904|P1|COMPLETED|Treatment Period 1||6
5031984|NCT02079844|12383902|P3|STARTED|Treatment Period 1||7
5031985|NCT02079844|12383903|P2|STARTED|Treatment Period 1||7
5031986|NCT02079844|12383904|P1|STARTED|Treatment Period 1||6
5031987|NCT02079805|12383962|P2|NOT COMPLETED|Overall Study||2
5031988|NCT02079805|12383963|P1|NOT COMPLETED|Overall Study||0
5031989|NCT02079805|12383962|P2|COMPLETED|Overall Study||15
5031990|NCT02079805|12383963|P1|COMPLETED|Overall Study||16
5031991|NCT02079805|12383962|P2|STARTED|Overall Study||17
5031992|NCT02079805|12383963|P1|STARTED|Overall Study||16
5031993|NCT02079649|12383985|P4|NOT COMPLETED|Overall Study||2
5031994|NCT02079649|12383986|P3|NOT COMPLETED|Overall Study||1
5031995|NCT02079649|12383987|P2|NOT COMPLETED|Overall Study||0
5031996|NCT02079649|12383988|P1|NOT COMPLETED|Overall Study||1
5031997|NCT02079649|12383985|P4|COMPLETED|Overall Study||38
5031998|NCT02079649|12383986|P3|COMPLETED|Overall Study||40
5031999|NCT02079649|12383987|P2|COMPLETED|Overall Study||41
5032000|NCT02079649|12383988|P1|COMPLETED|Overall Study||41
5032001|NCT02079649|12383985|P4|Treated|Overall Study||40
5032002|NCT02079649|12383986|P3|Treated|Overall Study||40
5032003|NCT02079649|12383987|P2|Treated|Overall Study||41
5032004|NCT02079649|12383988|P1|Treated|Overall Study||41
5032005|NCT02079649|12383985|P4|STARTED|Overall Study||40
5032006|NCT02079649|12383986|P3|STARTED|Overall Study||41
5032007|NCT02079649|12383987|P2|STARTED|Overall Study||41
5032008|NCT02079649|12383988|P1|STARTED|Overall Study||42
5032009|NCT02079610|12384005|P2|NOT COMPLETED|Overall Study||1
5032010|NCT02079610|12384006|P1|NOT COMPLETED|Overall Study||1
5032011|NCT02079610|12384005|P2|COMPLETED|Overall Study||16
5032012|NCT02079610|12384006|P1|COMPLETED|Overall Study||18
5032013|NCT02079610|12384005|P2|STARTED|Overall Study||17
5032014|NCT02079610|12384006|P1|STARTED|Overall Study||19
5032015|NCT02079532|12384016|P1|NOT COMPLETED|Overall Study||29
5032016|NCT02079532|12384016|P1|COMPLETED|Overall Study||273
5032017|NCT02079532|12384016|P1|STARTED|Overall Study||302
5032018|NCT02079519|12384038|P1|NOT COMPLETED|Overall Study||10
5032019|NCT02079519|12384038|P1|COMPLETED|Overall Study||0
5032020|NCT02079519|12384038|P1|STARTED|Overall Study||10
5032021|NCT02079311|12384044|P2|NOT COMPLETED|Overall Study||1
5032022|NCT02079311|12384045|P1|NOT COMPLETED|Overall Study||0
5032023|NCT02079311|12384044|P2|COMPLETED|Overall Study||26
5032024|NCT02079311|12384045|P1|COMPLETED|Overall Study||28
5032025|NCT02079311|12384044|P2|STARTED|Overall Study||27
5032026|NCT02079311|12384045|P1|STARTED|Overall Study||28
5032027|NCT02079246|12384051|P2|NOT COMPLETED|OLEX-MEM||19
5032028|NCT02079246|12384052|P1|NOT COMPLETED|OLEX-MEM||0
5032029|NCT02079246|12384051|P2|COMPLETED|OLEX-MEM||82
5032030|NCT02079246|12384052|P1|COMPLETED|OLEX-MEM||0
5032031|NCT02079246|12384051|P2|STARTED|OLEX-MEM||101
5032032|NCT02079246|12384052|P1|STARTED|OLEX-MEM||0
5032033|NCT02079246|12384051|P2|NOT COMPLETED|OLEX||0
5032034|NCT02079246|12384052|P1|NOT COMPLETED|OLEX||228
5032035|NCT02079246|12384051|P2|COMPLETED|OLEX||0
5032036|NCT02079246|12384052|P1|COMPLETED|OLEX||1235
5032037|NCT02079246|12384051|P2|STARTED|OLEX||0
5032038|NCT02079246|12384052|P1|STARTED|OLEX||1463
5032039|NCT02079077|12384071|P2|NOT COMPLETED|Overall Study||9
5032040|NCT02079077|12384072|P1|NOT COMPLETED|Overall Study||6
5032041|NCT02079077|12384071|P2|COMPLETED|Overall Study||39
5032042|NCT02079077|12384072|P1|COMPLETED|Overall Study||37
5032043|NCT02079077|12384071|P2|STARTED|Overall Study||48
5032044|NCT02079077|12384072|P1|STARTED|Overall Study||43
5032045|NCT02079025|12384082|P2|NOT COMPLETED|Overall Study||0
5032046|NCT02079025|12384083|P1|NOT COMPLETED|Overall Study||0
5032047|NCT02079025|12384082|P2|COMPLETED|Overall Study||837
5032048|NCT02079025|12384083|P1|COMPLETED|Overall Study||839
5032049|NCT02079025|12384082|P2|STARTED|Overall Study||837
5032050|NCT02079025|12384083|P1|STARTED|Overall Study||839
5032051|NCT02078960|12384095|P3|NOT COMPLETED|Follow-up Period||0
5032052|NCT02078960|12384096|P2|NOT COMPLETED|Follow-up Period||1
5032053|NCT02078960|12384097|P1|NOT COMPLETED|Follow-up Period||2
5032054|NCT02078960|12384095|P3|COMPLETED|Follow-up Period||1
5032055|NCT02078960|12384096|P2|COMPLETED|Follow-up Period||1
5032056|NCT02078960|12384097|P1|COMPLETED|Follow-up Period||0
5032057|NCT02078960|12384095|P3|STARTED|Follow-up Period||1
5032058|NCT02078960|12384096|P2|STARTED|Follow-up Period||2
5032059|NCT02078960|12384097|P1|STARTED|Follow-up Period||2
5032060|NCT02078960|12384095|P3|NOT COMPLETED|Treatment Period||3
5032061|NCT02078960|12384096|P2|NOT COMPLETED|Treatment Period||3
5032062|NCT02078960|12384097|P1|NOT COMPLETED|Treatment Period||2
5032063|NCT02078960|12384095|P3|COMPLETED|Treatment Period||1
5032064|NCT02078960|12384096|P2|COMPLETED|Treatment Period||1
5032065|NCT02078960|12384097|P1|COMPLETED|Treatment Period||0
5032066|NCT02078960|12384095|P3|STARTED|Treatment Period||4
5032067|NCT02078960|12384096|P2|STARTED|Treatment Period||4
5032068|NCT02078960|12384097|P1|STARTED|Treatment Period||2
5032069|NCT02078882|12384119|P1|NOT COMPLETED|Overall Study||0
5032070|NCT02078882|12384119|P1|COMPLETED|Overall Study||16
5032071|NCT02078882|12384119|P1|STARTED|Overall Study||16
5032072|NCT02078817|12384131|P1|NOT COMPLETED|Overall Study||1
5032073|NCT02078817|12384131|P1|COMPLETED|Overall Study||13
5032074|NCT02078817|12384131|P1|STARTED|Overall Study||14
5032075|NCT02078752|12384153|P10|NOT COMPLETED|Overall Study||10
5032076|NCT02078752|12384154|P9|NOT COMPLETED|Overall Study||0
5032077|NCT02078752|12384155|P8|NOT COMPLETED|Overall Study||3
5032078|NCT02078752|12384156|P7|NOT COMPLETED|Overall Study||2
5032079|NCT02078752|12384157|P6|NOT COMPLETED|Overall Study||4
5032080|NCT02078752|12384158|P5|NOT COMPLETED|Overall Study||1
5032081|NCT02078752|12384159|P4|NOT COMPLETED|Overall Study||2
5032082|NCT02078752|12384160|P3|NOT COMPLETED|Overall Study||1
5032083|NCT02078752|12384161|P2|NOT COMPLETED|Overall Study||7
5032084|NCT02078752|12384162|P1|NOT COMPLETED|Overall Study||2
5032085|NCT02078752|12384153|P10|COMPLETED|Overall Study||2
5032086|NCT02078752|12384154|P9|COMPLETED|Overall Study||2
5032087|NCT02078752|12384155|P8|COMPLETED|Overall Study||3
5032088|NCT02078752|12384156|P7|COMPLETED|Overall Study||1
5032089|NCT02078752|12384157|P6|COMPLETED|Overall Study||5
5032090|NCT02078752|12384158|P5|COMPLETED|Overall Study||2
5032091|NCT02078752|12384159|P4|COMPLETED|Overall Study||5
5032092|NCT02078752|12384160|P3|COMPLETED|Overall Study||1
5032093|NCT02078752|12384161|P2|COMPLETED|Overall Study||6
5032094|NCT02078752|12384162|P1|COMPLETED|Overall Study||1
5032095|NCT02078752|12384153|P10|STARTED|Overall Study||12
5032096|NCT02078752|12384154|P9|STARTED|Overall Study||2
5032097|NCT02078752|12384155|P8|STARTED|Overall Study||6
5032098|NCT02078752|12384156|P7|STARTED|Overall Study||3
5032099|NCT02078752|12384157|P6|STARTED|Overall Study||9
5032100|NCT02078752|12384158|P5|STARTED|Overall Study||3
5032101|NCT02078752|12384159|P4|STARTED|Overall Study||7
5032102|NCT02078752|12384160|P3|STARTED|Overall Study||2
5032103|NCT02078752|12384161|P2|STARTED|Overall Study||13
5032104|NCT02078752|12384162|P1|STARTED|Overall Study||3
5032105|NCT02078713|12384438|P4|NOT COMPLETED|Overall Study||0
5032106|NCT02078713|12384439|P3|NOT COMPLETED|Overall Study||0
5032107|NCT02078713|12384440|P2|NOT COMPLETED|Overall Study||61
5032108|NCT02078713|12384441|P1|NOT COMPLETED|Overall Study||52
5032109|NCT02078713|12384438|P4|COMPLETED|Overall Study||13
5032110|NCT02078713|12384439|P3|COMPLETED|Overall Study||15
5032111|NCT02078713|12384440|P2|COMPLETED|Overall Study||290
5032112|NCT02078713|12384441|P1|COMPLETED|Overall Study||355
5032113|NCT02078713|12384438|P4|STARTED|Overall Study||13
5032114|NCT02078713|12384439|P3|STARTED|Overall Study||15
5032115|NCT02078713|12384440|P2|STARTED|Overall Study||351
5032116|NCT02078713|12384441|P1|STARTED|Overall Study||407
5032117|NCT02078557|12384493|P1|NOT COMPLETED|Overall Study||0
5032118|NCT02078557|12384493|P1|COMPLETED|Overall Study||4
5032119|NCT02078557|12384493|P1|STARTED|Overall Study||4
5032120|NCT02078492|12384502|P3|NOT COMPLETED|Overall Study||0
5032121|NCT02078492|12384503|P2|NOT COMPLETED|Overall Study||0
5032122|NCT02078492|12384504|P1|NOT COMPLETED|Overall Study||0
5032123|NCT02078492|12384502|P3|COMPLETED|Overall Study||80
5032124|NCT02078492|12384503|P2|COMPLETED|Overall Study||80
5032125|NCT02078492|12384504|P1|COMPLETED|Overall Study||80
5032126|NCT02078492|12384502|P3|STARTED|Overall Study||80
5032127|NCT02078492|12384503|P2|STARTED|Overall Study||80
5032128|NCT02078492|12384504|P1|STARTED|Overall Study||80
5032129|NCT02078219|12384526|P5|NOT COMPLETED|Overall Study||2
5032130|NCT02078219|12384527|P4|NOT COMPLETED|Overall Study||4
5032131|NCT02078219|12384528|P3|NOT COMPLETED|Overall Study||6
5032132|NCT02078219|12384529|P2|NOT COMPLETED|Overall Study||4
5032133|NCT02078219|12384530|P1|NOT COMPLETED|Overall Study||3
5032134|NCT02078219|12384526|P5|COMPLETED|Overall Study||39
5032135|NCT02078219|12384527|P4|COMPLETED|Overall Study||37
5032136|NCT02078219|12384528|P3|COMPLETED|Overall Study||35
5032137|NCT02078219|12384529|P2|COMPLETED|Overall Study||36
5032138|NCT02078219|12384530|P1|COMPLETED|Overall Study||38
5032139|NCT02078219|12384526|P5|STARTED|Overall Study||41
5032140|NCT02078219|12384527|P4|STARTED|Overall Study||41
5032141|NCT02078219|12384528|P3|STARTED|Overall Study||41
5032142|NCT02078219|12384529|P2|STARTED|Overall Study||40
5032143|NCT02078219|12384530|P1|STARTED|Overall Study||41
5032144|NCT02078193|12384557|P1|NOT COMPLETED|Overall Study||0
5032145|NCT02078193|12384557|P1|COMPLETED|Overall Study||3
5032146|NCT02078193|12384557|P1|STARTED|Overall Study||3
5032147|NCT02078180|12384563|P1|NOT COMPLETED|Overall Study||5
5032148|NCT02078180|12384563|P1|COMPLETED|Overall Study||29
5032149|NCT02078180|12384563|P1|XL 300|Overall Study||32
5032150|NCT02078180|12384563|P1|XL 150|Overall Study||31
5032151|NCT02078180|12384563|P1|SR150|Overall Study||32
5032152|NCT02078180|12384563|P1|SR100|Overall Study||31
5032153|NCT02078180|12384563|P1|IR100|Overall Study||31
5032154|NCT02078180|12384563|P1|IR75|Overall Study||30
5032155|NCT02078180|12384563|P1|STARTED|Overall Study||34
5032156|NCT02077374|12384580|P2|NOT COMPLETED|Overall Study||2
5032157|NCT02077374|12384581|P1|NOT COMPLETED|Overall Study||0
5032158|NCT02077374|12384580|P2|COMPLETED|Overall Study||17
5032159|NCT02077374|12384581|P1|COMPLETED|Overall Study||19
5032160|NCT02077374|12384580|P2|STARTED|Overall Study||19
5032161|NCT02077374|12384581|P1|STARTED|Overall Study||19
5032162|NCT02077140|12384602|P5|NOT COMPLETED|Overall Study||5
5032163|NCT02077140|12384603|P4|NOT COMPLETED|Overall Study||4
5032164|NCT02077140|12384604|P3|NOT COMPLETED|Overall Study||2
5032165|NCT02077140|12384605|P2|NOT COMPLETED|Overall Study||2
5032166|NCT02077140|12384606|P1|NOT COMPLETED|Overall Study||4
5032167|NCT02077140|12384602|P5|COMPLETED|Overall Study||43
5032168|NCT02077140|12384603|P4|COMPLETED|Overall Study||32
5032169|NCT02077140|12384604|P3|COMPLETED|Overall Study||34
5032170|NCT02077140|12384605|P2|COMPLETED|Overall Study||34
5032171|NCT02077140|12384606|P1|COMPLETED|Overall Study||32
5032172|NCT02077140|12384602|P5|STARTED|Overall Study||48
5032173|NCT02077140|12384603|P4|STARTED|Overall Study||36
5032174|NCT02077140|12384604|P3|STARTED|Overall Study||36
5032175|NCT02077140|12384605|P2|STARTED|Overall Study||36
5032176|NCT02077140|12384606|P1|STARTED|Overall Study||36
5032177|NCT02076919|12384705|P4|NOT COMPLETED|Overall Study||0
5032178|NCT02076919|12384706|P3|NOT COMPLETED|Overall Study||0
5032179|NCT02076919|12384707|P2|NOT COMPLETED|Overall Study||0
5032180|NCT02076919|12384708|P1|NOT COMPLETED|Overall Study||0
5032181|NCT02076919|12384705|P4|COMPLETED|Overall Study||12
5032182|NCT02076919|12384706|P3|COMPLETED|Overall Study||36
5032183|NCT02076919|12384707|P2|COMPLETED|Overall Study||8
5032184|NCT02076919|12384708|P1|COMPLETED|Overall Study||24
5032185|NCT02076919|12384705|P4|STARTED|Overall Study||12
5032186|NCT02076919|12384706|P3|STARTED|Overall Study||36
5032187|NCT02076919|12384707|P2|STARTED|Overall Study||8
5032188|NCT02076919|12384708|P1|STARTED|Overall Study||24
5032189|NCT02076776|12384809|P3|NOT COMPLETED|Overall Study||0
5032190|NCT02076776|12384810|P2|NOT COMPLETED|Overall Study||2
5032191|NCT02076776|12384811|P1|NOT COMPLETED|Overall Study||1
5032192|NCT02076776|12384809|P3|COMPLETED|Overall Study||6
5032193|NCT02076776|12384810|P2|COMPLETED|Overall Study||6
5032194|NCT02076776|12384811|P1|COMPLETED|Overall Study||5
5032195|NCT02076776|12384809|P3|STARTED|Overall Study||6
5032196|NCT02076776|12384810|P2|STARTED|Overall Study||8
5032197|NCT02076776|12384811|P1|STARTED|Overall Study||6
5032198|NCT02076425|12384827|P2|NOT COMPLETED|Overall Study||24
5032199|NCT02076425|12384828|P1|NOT COMPLETED|Overall Study||14
5032200|NCT02076425|12384827|P2|COMPLETED|Overall Study||91
5032201|NCT02076425|12384828|P1|COMPLETED|Overall Study||100
5032202|NCT02076425|12384827|P2|STARTED|Overall Study||115
5032203|NCT02076425|12384828|P1|STARTED|Overall Study||114
5032204|NCT02076412|12384840|P2|NOT COMPLETED|Overall Study||22
5032205|NCT02076412|12384841|P1|NOT COMPLETED|Overall Study||37
5032206|NCT02076412|12384840|P2|COMPLETED|Overall Study||2
5032207|NCT02076412|12384841|P1|COMPLETED|Overall Study||13
5032208|NCT02076412|12384840|P2|STARTED|Overall Study||24
5032209|NCT02076412|12384841|P1|STARTED|Overall Study||50
5032210|NCT02076399|12384861|P2|NOT COMPLETED|Overall Study||24
5032211|NCT02076399|12384862|P1|NOT COMPLETED|Overall Study||39
5032212|NCT02076399|12384861|P2|COMPLETED|Overall Study||1
5032213|NCT02076399|12384862|P1|COMPLETED|Overall Study||12
5032214|NCT02076399|12384861|P2|STARTED|Overall Study||25
5032215|NCT02076399|12384862|P1|STARTED|Overall Study||51
5032216|NCT02076334|12384884|P4|NOT COMPLETED|Overall Study||1
5032217|NCT02076334|12384885|P3|NOT COMPLETED|Overall Study||1
5032218|NCT02076334|12384886|P2|NOT COMPLETED|Overall Study||1
5032219|NCT02076334|12384887|P1|NOT COMPLETED|Overall Study||1
5032220|NCT02076334|12384884|P4|COMPLETED|Overall Study||20
5032221|NCT02076334|12384885|P3|COMPLETED|Overall Study||20
5032222|NCT02076334|12384886|P2|COMPLETED|Overall Study||20
5032223|NCT02076334|12384887|P1|COMPLETED|Overall Study||20
5032224|NCT02076334|12384884|P4|STARTED|Overall Study||21
5032225|NCT02076334|12384885|P3|STARTED|Overall Study||21
5032226|NCT02076334|12384886|P2|STARTED|Overall Study||21
5032227|NCT02076334|12384887|P1|STARTED|Overall Study||21
5032228|NCT02076321|12384903|P2|NOT COMPLETED|Overall Study||2
5032229|NCT02076321|12384904|P1|NOT COMPLETED|Overall Study||5
5032230|NCT02076321|12384903|P2|COMPLETED|Overall Study||49
5032231|NCT02076321|12384904|P1|COMPLETED|Overall Study||46
5032232|NCT02076321|12384903|P2|STARTED|Overall Study||51
5032233|NCT02076321|12384904|P1|STARTED|Overall Study||51
5032234|NCT02076243|12384910|P1|NOT COMPLETED|Overall Study||2
5032235|NCT02076243|12384910|P1|COMPLETED|Overall Study||0
5032236|NCT02076243|12384910|P1|STARTED|Overall Study||2
5032237|NCT02076178|12384920|P2|NOT COMPLETED|Injection Phase||7
5032238|NCT02076178|12384921|P1|NOT COMPLETED|Injection Phase||1
5032239|NCT02076178|12384920|P2|COMPLETED|Injection Phase||87
5032240|NCT02076178|12384921|P1|COMPLETED|Injection Phase||20
5032241|NCT02076178|12384920|P2|STARTED|Injection Phase||94
5032242|NCT02076178|12384921|P1|STARTED|Injection Phase||21
5032243|NCT02076178|12384920|P2|NOT COMPLETED|Oral Phase||12
5032244|NCT02076178|12384921|P1|NOT COMPLETED|Oral Phase||0
5032245|NCT02076178|12384920|P2|COMPLETED|Oral Phase||94
5032246|NCT02076178|12384921|P1|COMPLETED|Oral Phase||21
5032247|NCT02076178|12384920|P2|STARTED|Oral Phase||106
5032248|NCT02076178|12384921|P1|STARTED|Oral Phase||21
5032249|NCT02076165|12384955|P2|NOT COMPLETED|Overall Study||6
5032250|NCT02076165|12384956|P1|NOT COMPLETED|Overall Study||8
5032251|NCT02076165|12384955|P2|COMPLETED|Overall Study||69
5032252|NCT02076165|12384956|P1|COMPLETED|Overall Study||66
5032253|NCT02076165|12384955|P2|STARTED|Overall Study||75
5032254|NCT02076165|12384956|P1|STARTED|Overall Study||74
5032255|NCT02076100|12384987|P7|NOT COMPLETED|Overall Study||0
5032256|NCT02076100|12384988|P6|NOT COMPLETED|Overall Study||0
5032257|NCT02076100|12384989|P5|NOT COMPLETED|Overall Study||0
5032258|NCT02076100|12384990|P4|NOT COMPLETED|Overall Study||0
5032259|NCT02076100|12384991|P3|NOT COMPLETED|Overall Study||0
5032260|NCT02076100|12384992|P2|NOT COMPLETED|Overall Study||0
5032261|NCT02076100|12384993|P1|NOT COMPLETED|Overall Study||0
5032262|NCT02076100|12384987|P7|COMPLETED|Overall Study||4
5032263|NCT02076100|12384988|P6|COMPLETED|Overall Study||3
5032264|NCT02076100|12384989|P5|COMPLETED|Overall Study||3
5032265|NCT02076100|12384990|P4|COMPLETED|Overall Study||3
5032266|NCT02076100|12384991|P3|COMPLETED|Overall Study||3
5032267|NCT02076100|12384992|P2|COMPLETED|Overall Study||3
5032268|NCT02076100|12384993|P1|COMPLETED|Overall Study||3
5032269|NCT02076100|12384987|P7|STARTED|Overall Study||4
5032270|NCT02076100|12384988|P6|STARTED|Overall Study||3
5032271|NCT02076100|12384989|P5|STARTED|Overall Study||3
5032272|NCT02076100|12384990|P4|STARTED|Overall Study||3
5032273|NCT02076100|12384991|P3|STARTED|Overall Study||3
5032274|NCT02076100|12384992|P2|STARTED|Overall Study||3
5032275|NCT02076100|12384993|P1|STARTED|Overall Study||3
5032276|NCT02076022|12385026|P2|NOT COMPLETED|Overall Study||0
5032277|NCT02076022|12385027|P1|NOT COMPLETED|Overall Study||2
5032278|NCT02076022|12385026|P2|COMPLETED|Overall Study||3
5032279|NCT02076022|12385027|P1|COMPLETED|Overall Study||5
5032280|NCT02076022|12385026|P2|STARTED|Overall Study||3
5032281|NCT02076022|12385027|P1|STARTED|Overall Study||7
5032282|NCT02076009|12385039|P2|NOT COMPLETED|Overall Study||286
5032283|NCT02076009|12385040|P1|NOT COMPLETED|Overall Study||283
5032284|NCT02076009|12385039|P2|COMPLETED|Overall Study||0
5032285|NCT02076009|12385040|P1|COMPLETED|Overall Study||0
5032286|NCT02076009|12385039|P2|Treated|Overall Study||283
5032287|NCT02076009|12385040|P1|Treated|Overall Study||281
5032288|NCT02076009|12385039|P2|STARTED|Overall Study||286
5032289|NCT02076009|12385040|P1|STARTED|Overall Study||283
5032290|NCT02075840|12385062|P2|NOT COMPLETED|Overall Study||151
5032291|NCT02075840|12385063|P1|NOT COMPLETED|Overall Study||152
5032292|NCT02075840|12385062|P2|COMPLETED|Overall Study||0
5032293|NCT02075840|12385063|P1|COMPLETED|Overall Study||0
5032294|NCT02075840|12385062|P2|STARTED|Overall Study||151
5032295|NCT02075840|12385063|P1|STARTED|Overall Study||152
5032296|NCT02075658|12385119|P2|NOT COMPLETED|Overall Study||2
5032297|NCT02075658|12385120|P1|NOT COMPLETED|Overall Study||2
5032298|NCT02075658|12385119|P2|COMPLETED|Overall Study||28
5032299|NCT02075658|12385120|P1|COMPLETED|Overall Study||28
5032300|NCT02075658|12385119|P2|STARTED|Overall Study||30
5032301|NCT02075658|12385120|P1|STARTED|Overall Study||30
5032302|NCT02075632|12385130|P2|NOT COMPLETED|Overall Study||5
5032303|NCT02075632|12385131|P1|NOT COMPLETED|Overall Study||1
5032304|NCT02075632|12385130|P2|COMPLETED|Overall Study||143
5032305|NCT02075632|12385131|P1|COMPLETED|Overall Study||161
5032306|NCT02075632|12385130|P2|STARTED|Overall Study||148
5032307|NCT02075632|12385131|P1|STARTED|Overall Study||162
5032308|NCT02075606|12385141|P1|NOT COMPLETED|Overall Study||10
5032309|NCT02075606|12385141|P1|COMPLETED|Overall Study||40
5032310|NCT02075606|12385141|P1|STARTED|Overall Study||50
5032311|NCT02075541|12385165|P2|NOT COMPLETED|Overall Study||8
5032312|NCT02075541|12385166|P1|NOT COMPLETED|Overall Study||4
5032313|NCT02075541|12385165|P2|COMPLETED|Overall Study||64
5032314|NCT02075541|12385166|P1|COMPLETED|Overall Study||69
5032315|NCT02075541|12385165|P2|STARTED|Overall Study||72
5032316|NCT02075541|12385166|P1|STARTED|Overall Study||73
5032317|NCT02075515|12385215|P3|NOT COMPLETED|Overall Study||8
5032318|NCT02075515|12385216|P2|NOT COMPLETED|Overall Study||5
5032319|NCT02075515|12385217|P1|NOT COMPLETED|Overall Study||4
5032320|NCT02075515|12385215|P3|COMPLETED|Overall Study||208
5032321|NCT02075515|12385216|P2|COMPLETED|Overall Study||212
5032322|NCT02075515|12385217|P1|COMPLETED|Overall Study||214
5032323|NCT02075515|12385215|P3|STARTED|Overall Study||216
5032324|NCT02075515|12385216|P2|STARTED|Overall Study||217
5032325|NCT02075515|12385217|P1|STARTED|Overall Study||218
5032326|NCT02075476|12385254|P2|NOT COMPLETED|Overall Study||5
5032327|NCT02075476|12385255|P1|NOT COMPLETED|Overall Study||3
5032328|NCT02075476|12385254|P2|COMPLETED|Overall Study||15
5032329|NCT02075476|12385255|P1|COMPLETED|Overall Study||17
5032330|NCT02075476|12385254|P2|STARTED|Overall Study||20
5032331|NCT02075476|12385255|P1|STARTED|Overall Study||20
5032332|NCT02075463|12385265|P1|NOT COMPLETED|Overall Study||8
5032333|NCT02075463|12385265|P1|COMPLETED|Overall Study||7
5032334|NCT02075463|12385265|P1|STARTED|Overall Study||15
5032335|NCT02075411|12385294|P4|NOT COMPLETED|Overall Study||0
5032336|NCT02075411|12385295|P3|NOT COMPLETED|Overall Study||0
5032337|NCT02075411|12385296|P2|NOT COMPLETED|Overall Study||0
5032338|NCT02075411|12385297|P1|NOT COMPLETED|Overall Study||0
5032339|NCT02075411|12385294|P4|COMPLETED|Overall Study||1
5032340|NCT02075411|12385295|P3|COMPLETED|Overall Study||0
5032341|NCT02075411|12385296|P2|COMPLETED|Overall Study||0
5032342|NCT02075411|12385297|P1|COMPLETED|Overall Study||0
5032343|NCT02075411|12385294|P4|STARTED|Overall Study||1
5032344|NCT02075411|12385295|P3|STARTED|Overall Study||0
5032345|NCT02075411|12385296|P2|STARTED|Overall Study||0
5032346|NCT02075411|12385297|P1|STARTED|Overall Study||0
5032347|NCT02075320|12385315|P1|NOT COMPLETED|Overall Study||2
5032348|NCT02075320|12385315|P1|COMPLETED|Overall Study||48
5032349|NCT02075320|12385315|P1|STARTED|Overall Study||50
5032350|NCT02075255|12385325|P3|NOT COMPLETED|Overall Study||3
5032351|NCT02075255|12385326|P2|NOT COMPLETED|Overall Study||4
5032352|NCT02075255|12385327|P1|NOT COMPLETED|Overall Study||4
5032353|NCT02075255|12385325|P3|COMPLETED|Overall Study||72
5032354|NCT02075255|12385326|P2|COMPLETED|Overall Study||69
5032355|NCT02075255|12385327|P1|COMPLETED|Overall Study||68
5032356|NCT02075255|12385325|P3|STARTED|Overall Study||75
5032357|NCT02075255|12385326|P2|STARTED|Overall Study||73
5032358|NCT02075255|12385327|P1|STARTED|Overall Study||72
5032359|NCT02075203|12385437|P3|NOT COMPLETED|Overall Study||1
5032360|NCT02075203|12385438|P2|NOT COMPLETED|Overall Study||0
5032361|NCT02075203|12385439|P1|NOT COMPLETED|Overall Study||3
5032362|NCT02075203|12385437|P3|COMPLETED|Overall Study||328
5032363|NCT02075203|12385438|P2|COMPLETED|Overall Study||330
5032364|NCT02075203|12385439|P1|COMPLETED|Overall Study||327
5032365|NCT02075203|12385437|P3|STARTED|Overall Study||329
5032366|NCT02075203|12385438|P2|STARTED|Overall Study||330
5032367|NCT02075203|12385439|P1|STARTED|Overall Study||330
5032368|NCT02075125|12385458|P2|NOT COMPLETED|Overall Study||1
5032369|NCT02075125|12385459|P1|NOT COMPLETED|Overall Study||0
5032462|NCT02074553|12385579|P4|COMPLETED|Washout Period 3||11
5032370|NCT02075125|12385458|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
5032371|NCT02075125|12385459|P1|COMPLETED|Overall Study||19
5032372|NCT02075125|12385458|P2|STARTED|Overall Study||20
5032373|NCT02075125|12385459|P1|STARTED|Overall Study||19
5032374|NCT02075073|12385480|P3|NOT COMPLETED|Overall Study||0
5032375|NCT02075073|12385481|P2|NOT COMPLETED|Overall Study||1
5032376|NCT02075073|12385482|P1|NOT COMPLETED|Overall Study||0
5032377|NCT02075073|12385480|P3|COMPLETED|Overall Study||36
5032378|NCT02075073|12385481|P2|COMPLETED|Overall Study||36
5032379|NCT02075073|12385482|P1|COMPLETED|Overall Study||36
5032380|NCT02075073|12385480|P3|STARTED|Overall Study||36
5032381|NCT02075073|12385481|P2|STARTED|Overall Study||37
5032382|NCT02075073|12385482|P1|STARTED|Overall Study||36
5032383|NCT02075021|12385499|P1|NOT COMPLETED|Overall Study||0
5032384|NCT02075021|12385499|P1|COMPLETED|Overall Study||3
5032385|NCT02075021|12385499|P1|STARTED|Overall Study||3
5032386|NCT02075008|12385504|P1|NOT COMPLETED|Overall Study||176
5032387|NCT02075008|12385504|P1|COMPLETED|Overall Study||94
5032388|NCT02075008|12385504|P1|STARTED|Overall Study||270
5032389|NCT02074995|12385508|P3|NOT COMPLETED|Overall Study||0
5032390|NCT02074995|12385509|P2|NOT COMPLETED|Overall Study||0
5032391|NCT02074995|12385510|P1|NOT COMPLETED|Overall Study||0
5032392|NCT02074995|12385508|P3|COMPLETED|Overall Study||0
5032393|NCT02074995|12385509|P2|COMPLETED|Overall Study||0
5032394|NCT02074995|12385510|P1|COMPLETED|Overall Study||1
5032395|NCT02074995|12385508|P3|STARTED|Overall Study||0
5032396|NCT02074995|12385509|P2|STARTED|Overall Study||0
5032397|NCT02074995|12385510|P1|STARTED|Overall Study||1
5032398|NCT02074982|12385527|P2|NOT COMPLETED|Overall Study||54
5032399|NCT02074982|12385528|P1|NOT COMPLETED|Overall Study||51
5032400|NCT02074982|12385527|P2|COMPLETED|Overall Study||285
5032401|NCT02074982|12385528|P1|COMPLETED|Overall Study||286
5032402|NCT02074982|12385527|P2|Safety Set (SF)|Overall Study||336
5032403|NCT02074982|12385528|P1|Safety Set (SF)|Overall Study||335
5032404|NCT02074982|12385527|P2|Full Analysis Set (FAS)|Overall Study||339
5032405|NCT02074982|12385528|P1|Full Analysis Set (FAS)|Overall Study||336
5032406|NCT02074982|12385527|P2|STARTED|Overall Study||339
5032407|NCT02074982|12385528|P1|STARTED|Overall Study||337
5032408|NCT02074904|12385540|P2|NOT COMPLETED|Overall Study||0
5032409|NCT02074904|12385541|P1|NOT COMPLETED|Overall Study||0
5032410|NCT02074904|12385540|P2|COMPLETED|Overall Study||0
5032411|NCT02074904|12385541|P1|COMPLETED|Overall Study||1
5032412|NCT02074904|12385540|P2|STARTED|Overall Study||0
5032413|NCT02074904|12385541|P1|STARTED|Overall Study||1
5032414|NCT02074735|12385557|P2|NOT COMPLETED|Overall Study||4
5032415|NCT02074735|12385558|P1|NOT COMPLETED|Overall Study||3
5032416|NCT02074735|12385557|P2|COMPLETED|Overall Study||29
5032417|NCT02074735|12385558|P1|COMPLETED|Overall Study||26
5032418|NCT02074735|12385557|P2|STARTED|Overall Study||33
5032419|NCT02074735|12385558|P1|STARTED|Overall Study||29
5032420|NCT02074709|12385566|P2|NOT COMPLETED|Overall Study||1
5032421|NCT02074709|12385567|P1|NOT COMPLETED|Overall Study||1
5032422|NCT02074709|12385566|P2|COMPLETED|Overall Study||29
5032423|NCT02074709|12385567|P1|COMPLETED|Overall Study||29
5032424|NCT02074709|12385566|P2|STARTED|Overall Study||30
5032425|NCT02074709|12385567|P1|STARTED|Overall Study||30
5032426|NCT02074553|12385575|P8|NOT COMPLETED|Intervention Period 4||0
5032427|NCT02074553|12385576|P7|NOT COMPLETED|Intervention Period 4||0
5032428|NCT02074553|12385577|P6|NOT COMPLETED|Intervention Period 4||0
5032429|NCT02074553|12385578|P5|NOT COMPLETED|Intervention Period 4||0
5032430|NCT02074553|12385579|P4|NOT COMPLETED|Intervention Period 4||0
5032431|NCT02074553|12385580|P3|NOT COMPLETED|Intervention Period 4||0
5032432|NCT02074553|12385581|P2|NOT COMPLETED|Intervention Period 4||0
5032433|NCT02074553|12385582|P1|NOT COMPLETED|Intervention Period 4||0
5032434|NCT02074553|12385575|P8|COMPLETED|Intervention Period 4||11
5032435|NCT02074553|12385576|P7|COMPLETED|Intervention Period 4||11
5032436|NCT02074553|12385577|P6|COMPLETED|Intervention Period 4||10
5032437|NCT02074553|12385578|P5|COMPLETED|Intervention Period 4||12
5032438|NCT02074553|12385579|P4|COMPLETED|Intervention Period 4||11
5032439|NCT02074553|12385580|P3|COMPLETED|Intervention Period 4||11
5032440|NCT02074553|12385581|P2|COMPLETED|Intervention Period 4||12
5032441|NCT02074553|12385582|P1|COMPLETED|Intervention Period 4||11
5032442|NCT02074553|12385575|P8|STARTED|Intervention Period 4||11
5032443|NCT02074553|12385576|P7|STARTED|Intervention Period 4||11
5032444|NCT02074553|12385577|P6|STARTED|Intervention Period 4||10
5032445|NCT02074553|12385578|P5|STARTED|Intervention Period 4||12
5032446|NCT02074553|12385579|P4|STARTED|Intervention Period 4||11
5032447|NCT02074553|12385580|P3|STARTED|Intervention Period 4||11
5032448|NCT02074553|12385581|P2|STARTED|Intervention Period 4||12
5032449|NCT02074553|12385582|P1|STARTED|Intervention Period 4||11
5032450|NCT02074553|12385575|P8|NOT COMPLETED|Washout Period 3||1
5032451|NCT02074553|12385576|P7|NOT COMPLETED|Washout Period 3||0
5032452|NCT02074553|12385577|P6|NOT COMPLETED|Washout Period 3||0
5032453|NCT02074553|12385578|P5|NOT COMPLETED|Washout Period 3||0
5032454|NCT02074553|12385579|P4|NOT COMPLETED|Washout Period 3||0
5032455|NCT02074553|12385580|P3|NOT COMPLETED|Washout Period 3||0
5032456|NCT02074553|12385581|P2|NOT COMPLETED|Washout Period 3||0
5032457|NCT02074553|12385582|P1|NOT COMPLETED|Washout Period 3||0
5032458|NCT02074553|12385575|P8|COMPLETED|Washout Period 3||11
5032459|NCT02074553|12385576|P7|COMPLETED|Washout Period 3||11
5032460|NCT02074553|12385577|P6|COMPLETED|Washout Period 3||10
5032461|NCT02074553|12385578|P5|COMPLETED|Washout Period 3||12
5032463|NCT02074553|12385580|P3|COMPLETED|Washout Period 3||11
5032464|NCT02074553|12385581|P2|COMPLETED|Washout Period 3||12
5032465|NCT02074553|12385582|P1|COMPLETED|Washout Period 3||11
5032466|NCT02074553|12385575|P8|STARTED|Washout Period 3||12
5032467|NCT02074553|12385576|P7|STARTED|Washout Period 3||11
5032468|NCT02074553|12385577|P6|STARTED|Washout Period 3||10
5032469|NCT02074553|12385578|P5|STARTED|Washout Period 3||12
5032470|NCT02074553|12385579|P4|STARTED|Washout Period 3||11
5032471|NCT02074553|12385580|P3|STARTED|Washout Period 3||11
5032472|NCT02074553|12385581|P2|STARTED|Washout Period 3||12
5032473|NCT02074553|12385582|P1|STARTED|Washout Period 3||11
5032474|NCT02074553|12385575|P8|NOT COMPLETED|Intervention Period 3||0
5032475|NCT02074553|12385576|P7|NOT COMPLETED|Intervention Period 3||0
5032476|NCT02074553|12385577|P6|NOT COMPLETED|Intervention Period 3||0
5032477|NCT02074553|12385578|P5|NOT COMPLETED|Intervention Period 3||0
5032478|NCT02074553|12385579|P4|NOT COMPLETED|Intervention Period 3||0
5032479|NCT02074553|12385580|P3|NOT COMPLETED|Intervention Period 3||0
5032480|NCT02074553|12385581|P2|NOT COMPLETED|Intervention Period 3||0
5032481|NCT02074553|12385582|P1|NOT COMPLETED|Intervention Period 3||0
5032482|NCT02074553|12385575|P8|COMPLETED|Intervention Period 3||12
5032483|NCT02074553|12385576|P7|COMPLETED|Intervention Period 3||11
5032484|NCT02074553|12385577|P6|COMPLETED|Intervention Period 3||10
5032485|NCT02074553|12385578|P5|COMPLETED|Intervention Period 3||12
5032486|NCT02074553|12385579|P4|COMPLETED|Intervention Period 3||11
5032487|NCT02074553|12385580|P3|COMPLETED|Intervention Period 3||11
5032488|NCT02074553|12385581|P2|COMPLETED|Intervention Period 3||12
5032489|NCT02074553|12385582|P1|COMPLETED|Intervention Period 3||11
5032490|NCT02074553|12385575|P8|STARTED|Intervention Period 3||12
5032491|NCT02074553|12385576|P7|STARTED|Intervention Period 3||11
5032492|NCT02074553|12385577|P6|STARTED|Intervention Period 3||10
5032493|NCT02074553|12385578|P5|STARTED|Intervention Period 3||12
5032494|NCT02074553|12385579|P4|STARTED|Intervention Period 3||11
5032495|NCT02074553|12385580|P3|STARTED|Intervention Period 3||11
5032496|NCT02074553|12385581|P2|STARTED|Intervention Period 3||12
5032497|NCT02074553|12385582|P1|STARTED|Intervention Period 3||11
5032498|NCT02074553|12385575|P8|NOT COMPLETED|Washout Period 2||0
5032499|NCT02074553|12385576|P7|NOT COMPLETED|Washout Period 2||1
5032500|NCT02074553|12385577|P6|NOT COMPLETED|Washout Period 2||1
5032501|NCT02074553|12385578|P5|NOT COMPLETED|Washout Period 2||0
5032502|NCT02074553|12385579|P4|NOT COMPLETED|Washout Period 2||0
5032503|NCT02074553|12385580|P3|NOT COMPLETED|Washout Period 2||1
5032504|NCT02074553|12385581|P2|NOT COMPLETED|Washout Period 2||0
5032505|NCT02074553|12385582|P1|NOT COMPLETED|Washout Period 2||0
5032506|NCT02074553|12385575|P8|COMPLETED|Washout Period 2||12
5032507|NCT02074553|12385576|P7|COMPLETED|Washout Period 2||11
5032508|NCT02074553|12385577|P6|COMPLETED|Washout Period 2||10
5032509|NCT02074553|12385578|P5|COMPLETED|Washout Period 2||12
5032510|NCT02074553|12385579|P4|COMPLETED|Washout Period 2||11
5032511|NCT02074553|12385580|P3|COMPLETED|Washout Period 2||11
5032512|NCT02074553|12385581|P2|COMPLETED|Washout Period 2||12
5032513|NCT02074553|12385582|P1|COMPLETED|Washout Period 2||11
5032514|NCT02074553|12385575|P8|STARTED|Washout Period 2||12
5032515|NCT02074553|12385576|P7|STARTED|Washout Period 2||12
5032516|NCT02074553|12385577|P6|STARTED|Washout Period 2||11
5032517|NCT02074553|12385578|P5|STARTED|Washout Period 2||12
5032518|NCT02074553|12385579|P4|STARTED|Washout Period 2||11
5032519|NCT02074553|12385580|P3|STARTED|Washout Period 2||12
5032520|NCT02074553|12385581|P2|STARTED|Washout Period 2||12
5032521|NCT02074553|12385582|P1|STARTED|Washout Period 2||11
5032522|NCT02074553|12385575|P8|NOT COMPLETED|Intervention Period 2||0
5032523|NCT02074553|12385576|P7|NOT COMPLETED|Intervention Period 2||0
5032524|NCT02074553|12385577|P6|NOT COMPLETED|Intervention Period 2||0
5032525|NCT02074553|12385578|P5|NOT COMPLETED|Intervention Period 2||0
5032526|NCT02074553|12385579|P4|NOT COMPLETED|Intervention Period 2||0
5032527|NCT02074553|12385580|P3|NOT COMPLETED|Intervention Period 2||0
5032528|NCT02074553|12385581|P2|NOT COMPLETED|Intervention Period 2||0
5032529|NCT02074553|12385582|P1|NOT COMPLETED|Intervention Period 2||0
5032530|NCT02074553|12385575|P8|COMPLETED|Intervention Period 2||12
5032531|NCT02074553|12385576|P7|COMPLETED|Intervention Period 2||12
5032532|NCT02074553|12385577|P6|COMPLETED|Intervention Period 2||11
5032533|NCT02074553|12385578|P5|COMPLETED|Intervention Period 2||12
5032534|NCT02074553|12385579|P4|COMPLETED|Intervention Period 2||11
5032535|NCT02074553|12385580|P3|COMPLETED|Intervention Period 2||12
5032536|NCT02074553|12385581|P2|COMPLETED|Intervention Period 2||12
5032537|NCT02074553|12385582|P1|COMPLETED|Intervention Period 2||11
5032538|NCT02074553|12385575|P8|STARTED|Intervention Period 2||12
5032539|NCT02074553|12385576|P7|STARTED|Intervention Period 2||12
5032540|NCT02074553|12385577|P6|STARTED|Intervention Period 2||11
5032541|NCT02074553|12385578|P5|STARTED|Intervention Period 2||12
5032542|NCT02074553|12385579|P4|STARTED|Intervention Period 2||11
5032543|NCT02074553|12385580|P3|STARTED|Intervention Period 2||12
5032544|NCT02074553|12385581|P2|STARTED|Intervention Period 2||12
5032545|NCT02074553|12385582|P1|STARTED|Intervention Period 2||11
5032546|NCT02074553|12385575|P8|NOT COMPLETED|Washout Period 1||0
5032547|NCT02074553|12385576|P7|NOT COMPLETED|Washout Period 1||0
5032548|NCT02074553|12385577|P6|NOT COMPLETED|Washout Period 1||1
5032549|NCT02074553|12385578|P5|NOT COMPLETED|Washout Period 1||0
5032550|NCT02074553|12385579|P4|NOT COMPLETED|Washout Period 1||1
5032551|NCT02074553|12385580|P3|NOT COMPLETED|Washout Period 1||0
5032552|NCT02074553|12385581|P2|NOT COMPLETED|Washout Period 1||0
5032553|NCT02074553|12385582|P1|NOT COMPLETED|Washout Period 1||1
5032554|NCT02074553|12385575|P8|COMPLETED|Washout Period 1||12
5032555|NCT02074553|12385576|P7|COMPLETED|Washout Period 1||12
5032556|NCT02074553|12385577|P6|COMPLETED|Washout Period 1||11
5032557|NCT02074553|12385578|P5|COMPLETED|Washout Period 1||12
5032558|NCT02074553|12385579|P4|COMPLETED|Washout Period 1||11
5032559|NCT02074553|12385580|P3|COMPLETED|Washout Period 1||12
5032560|NCT02074553|12385581|P2|COMPLETED|Washout Period 1||12
5032561|NCT02074553|12385582|P1|COMPLETED|Washout Period 1||11
5032562|NCT02074553|12385575|P8|STARTED|Washout Period 1||12
5032563|NCT02074553|12385576|P7|STARTED|Washout Period 1||12
5032564|NCT02074553|12385577|P6|STARTED|Washout Period 1||12
5032565|NCT02074553|12385578|P5|STARTED|Washout Period 1||12
5032566|NCT02074553|12385579|P4|STARTED|Washout Period 1||12
5032567|NCT02074553|12385580|P3|STARTED|Washout Period 1||12
5032568|NCT02074553|12385581|P2|STARTED|Washout Period 1||12
5032569|NCT02074553|12385582|P1|STARTED|Washout Period 1||12
5032570|NCT02074553|12385575|P8|NOT COMPLETED|Intervention Period 1||0
5032571|NCT02074553|12385576|P7|NOT COMPLETED|Intervention Period 1||0
5032572|NCT02074553|12385577|P6|NOT COMPLETED|Intervention Period 1||0
5032573|NCT02074553|12385578|P5|NOT COMPLETED|Intervention Period 1||0
5032574|NCT02074553|12385579|P4|NOT COMPLETED|Intervention Period 1||1
5032575|NCT02074553|12385580|P3|NOT COMPLETED|Intervention Period 1||0
5032576|NCT02074553|12385581|P2|NOT COMPLETED|Intervention Period 1||0
5032577|NCT02074553|12385582|P1|NOT COMPLETED|Intervention Period 1||0
5032578|NCT02074553|12385575|P8|COMPLETED|Intervention Period 1||12
5032579|NCT02074553|12385576|P7|COMPLETED|Intervention Period 1||12
5032580|NCT02074553|12385577|P6|COMPLETED|Intervention Period 1||12
5032581|NCT02074553|12385578|P5|COMPLETED|Intervention Period 1||12
5032582|NCT02074553|12385579|P4|COMPLETED|Intervention Period 1||12
5032583|NCT02074553|12385580|P3|COMPLETED|Intervention Period 1||12
5032584|NCT02074553|12385581|P2|COMPLETED|Intervention Period 1||12
5032585|NCT02074553|12385582|P1|COMPLETED|Intervention Period 1||12
5032586|NCT02074553|12385575|P8|STARTED|Intervention Period 1||12
5032587|NCT02074553|12385576|P7|STARTED|Intervention Period 1||12
5032588|NCT02074553|12385577|P6|STARTED|Intervention Period 1||12
5032589|NCT02074553|12385578|P5|STARTED|Intervention Period 1||12
5032590|NCT02074553|12385579|P4|STARTED|Intervention Period 1||13
5032591|NCT02074553|12385580|P3|STARTED|Intervention Period 1||12
5032592|NCT02074553|12385581|P2|STARTED|Intervention Period 1||12
5032593|NCT02074553|12385582|P1|STARTED|Intervention Period 1||12
5032594|NCT02074514|12385764|P2|NOT COMPLETED|Overall Study||4
5032595|NCT02074514|12385765|P1|NOT COMPLETED|Overall Study||3
5032596|NCT02074514|12385764|P2|COMPLETED|Overall Study||54
5032597|NCT02074514|12385765|P1|COMPLETED|Overall Study||56
5032598|NCT02074514|12385764|P2|STARTED|Overall Study||58
5032599|NCT02074514|12385765|P1|STARTED|Overall Study||59
5032600|NCT02074384|12385786|P3|NOT COMPLETED|Overall Study||0
5032601|NCT02074384|12385787|P2|NOT COMPLETED|Overall Study||0
5032602|NCT02074384|12385788|P1|NOT COMPLETED|Overall Study||0
5032603|NCT02074384|12385786|P3|COMPLETED|Overall Study||17
5032604|NCT02074384|12385787|P2|COMPLETED|Overall Study||70
5032605|NCT02074384|12385788|P1|COMPLETED|Overall Study||74
5032606|NCT02074384|12385786|P3|STARTED|Overall Study||17
5032607|NCT02074384|12385787|P2|STARTED|Overall Study||70
5032608|NCT02074384|12385788|P1|STARTED|Overall Study||74
5032609|NCT02074358|12385796|P6|NOT COMPLETED|Overall Study||0
5032610|NCT02074358|12385797|P5|NOT COMPLETED|Overall Study||0
5032611|NCT02074358|12385798|P4|NOT COMPLETED|Overall Study||0
5032612|NCT02074358|12385799|P3|NOT COMPLETED|Overall Study||0
5032613|NCT02074358|12385800|P2|NOT COMPLETED|Overall Study||0
5032614|NCT02074358|12385801|P1|NOT COMPLETED|Overall Study||0
5032615|NCT02074358|12385796|P6|COMPLETED|Overall Study||2
5032616|NCT02074358|12385797|P5|COMPLETED|Overall Study||3
5032617|NCT02074358|12385798|P4|COMPLETED|Overall Study||2
5032618|NCT02074358|12385799|P3|COMPLETED|Overall Study||2
5032619|NCT02074358|12385800|P2|COMPLETED|Overall Study||3
5032620|NCT02074358|12385801|P1|COMPLETED|Overall Study||3
5032621|NCT02074358|12385796|P6|STARTED|Overall Study||2
5032622|NCT02074358|12385797|P5|STARTED|Overall Study||3
5032623|NCT02074358|12385798|P4|STARTED|Overall Study||2
5032624|NCT02074358|12385799|P3|STARTED|Overall Study||2
5032625|NCT02074358|12385800|P2|STARTED|Overall Study||3
5032626|NCT02074358|12385801|P1|STARTED|Overall Study||3
5032627|NCT02074345|12385890|P1|NOT COMPLETED|Overall Study||0
5032628|NCT02074345|12385890|P1|COMPLETED|Overall Study||31
5032629|NCT02074345|12385890|P1|STARTED|Overall Study||31
5032630|NCT02074059|12385906|P6|NOT COMPLETED|Overall Study||1
5032631|NCT02074059|12385907|P5|NOT COMPLETED|Overall Study||1
5032632|NCT02074059|12385908|P4|NOT COMPLETED|Overall Study||0
5032633|NCT02074059|12385909|P3|NOT COMPLETED|Overall Study||0
5032634|NCT02074059|12385910|P2|NOT COMPLETED|Overall Study||0
5032635|NCT02074059|12385911|P1|NOT COMPLETED|Overall Study||0
5032636|NCT02074059|12385906|P6|COMPLETED|Overall Study||39
5032637|NCT02074059|12385907|P5|COMPLETED|Overall Study||7
5032638|NCT02074059|12385908|P4|COMPLETED|Overall Study||8
5032639|NCT02074059|12385909|P3|COMPLETED|Overall Study||8
5032640|NCT02074059|12385910|P2|COMPLETED|Overall Study||8
5032641|NCT02074059|12385911|P1|COMPLETED|Overall Study||8
5032642|NCT02074059|12385906|P6|STARTED|Overall Study||40
5032643|NCT02074059|12385907|P5|STARTED|Overall Study||8
5032644|NCT02074059|12385908|P4|STARTED|Overall Study||8
5032645|NCT02074059|12385909|P3|STARTED|Overall Study||8
5032646|NCT02074059|12385910|P2|STARTED|Overall Study||8
5032647|NCT02074059|12385911|P1|STARTED|Overall Study||8
5032648|NCT02073968|12385949|P1|NOT COMPLETED|Overall Study||0
5032649|NCT02073968|12385949|P1|COMPLETED|Overall Study||35
5032650|NCT02073968|12385949|P1|STARTED|Overall Study||35
5032651|NCT02073929|12385955|P2|NOT COMPLETED|Overall Study||3
5032652|NCT02073929|12385956|P1|NOT COMPLETED|Overall Study||4
5032653|NCT02073929|12385955|P2|COMPLETED|Overall Study||21
5032654|NCT02073929|12385956|P1|COMPLETED|Overall Study||44
5032655|NCT02073929|12385955|P2|STARTED|Overall Study||24
5032656|NCT02073929|12385956|P1|STARTED|Overall Study||48
5032657|NCT02073747|12385984|P2|NOT COMPLETED|Overall Study||1
5032658|NCT02073747|12385985|P1|NOT COMPLETED|Overall Study||1
5032659|NCT02073747|12385984|P2|COMPLETED|Overall Study||14
5032660|NCT02073747|12385985|P1|COMPLETED|Overall Study||14
5032661|NCT02073747|12385984|P2|STARTED|Overall Study||15
5032662|NCT02073747|12385985|P1|STARTED|Overall Study||15
5032663|NCT02073682|12385993|P2|NOT COMPLETED|Overall Study||370
5032664|NCT02073682|12385994|P1|NOT COMPLETED|Overall Study||322
5032665|NCT02073682|12385993|P2|COMPLETED|Overall Study||154
5032666|NCT02073682|12385994|P1|COMPLETED|Overall Study||200
5032667|NCT02073682|12385993|P2|STARTED|Overall Study||524
5032668|NCT02073682|12385994|P1|STARTED|Overall Study||522
5032669|NCT02073656|12386012|P1|NOT COMPLETED|Retreatment Substudy||0
5032670|NCT02073656|12386012|P1|COMPLETED|Retreatment Substudy||9
5032671|NCT02073656|12386012|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
5032672|NCT02073656|12386012|P1|NOT COMPLETED|Primary Study||8
5032673|NCT02073656|12386012|P1|COMPLETED|Primary Study||327
5032674|NCT02073656|12386012|P1|STARTED|Primary Study||335
5032675|NCT02073643|12386028|P1|NOT COMPLETED|Overall Study||24
5032676|NCT02073643|12386028|P1|COMPLETED|Overall Study||180
5032677|NCT02073643|12386028|P1|STARTED|Overall Study||204
5032678|NCT02073565|12386039|P2|NOT COMPLETED|Cohort C||4
5032679|NCT02073565|12386040|P1|NOT COMPLETED|Cohort C||0
5032680|NCT02073565|12386039|P2|COMPLETED|Cohort C||211
5032681|NCT02073565|12386040|P1|COMPLETED|Cohort C||217
5032682|NCT02073565|12386039|P2|STARTED|Cohort C||215
5032683|NCT02073565|12386040|P1|STARTED|Cohort C||217
5032684|NCT02073565|12386039|P2|NOT COMPLETED|Cohort B||2
5032685|NCT02073565|12386040|P1|NOT COMPLETED|Cohort B||1
5032686|NCT02073565|12386039|P2|COMPLETED|Cohort B||54
5032687|NCT02073565|12386040|P1|COMPLETED|Cohort B||53
5032688|NCT02073565|12386039|P2|STARTED|Cohort B||56
5032689|NCT02073565|12386040|P1|STARTED|Cohort B||54
5032690|NCT02073565|12386039|P2|NOT COMPLETED|Cohort A||0
5032691|NCT02073565|12386040|P1|NOT COMPLETED|Cohort A||1
5032692|NCT02073565|12386039|P2|COMPLETED|Cohort A||14
5032693|NCT02073565|12386040|P1|COMPLETED|Cohort A||15
5032694|NCT02073565|12386039|P2|STARTED|Cohort A||14
5032695|NCT02073565|12386040|P1|STARTED|Cohort A||16
5032696|NCT02073565|12386039|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
5032697|NCT02073565|12386040|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
5032698|NCT02073565|12386039|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
5032699|NCT02073565|12386040|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
5032700|NCT02073565|12386039|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
5032701|NCT02073565|12386040|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
5032702|NCT02073461|12386055|P3|NOT COMPLETED|Overall Study||1
5032703|NCT02073461|12386056|P2|NOT COMPLETED|Overall Study||1
5032704|NCT02073461|12386057|P1|NOT COMPLETED|Overall Study||4
5032705|NCT02073461|12386055|P3|COMPLETED|Overall Study||78
5032706|NCT02073461|12386056|P2|COMPLETED|Overall Study||77
5032707|NCT02073461|12386057|P1|COMPLETED|Overall Study||75
5032708|NCT02073461|12386055|P3|STARTED|Overall Study||79
5032709|NCT02073461|12386056|P2|STARTED|Overall Study||78
5032710|NCT02073461|12386057|P1|STARTED|Overall Study||79
5032711|NCT02073448|12386086|P3|NOT COMPLETED|Overall Study||5
5032712|NCT02073448|12386087|P2|NOT COMPLETED|Overall Study||12
5032713|NCT02073448|12386088|P1|NOT COMPLETED|Overall Study||2
5032714|NCT02073448|12386086|P3|COMPLETED|Overall Study||99
5032715|NCT02073448|12386087|P2|COMPLETED|Overall Study||200
5032716|NCT02073448|12386088|P1|COMPLETED|Overall Study||99
5032717|NCT02073448|12386086|P3|STARTED|Overall Study||104
5032718|NCT02073448|12386087|P2|STARTED|Overall Study||212
5032719|NCT02073448|12386088|P1|STARTED|Overall Study||101
5032720|NCT02073435|12386116|P2|NOT COMPLETED|Overall Study||0
5032721|NCT02073435|12386117|P1|NOT COMPLETED|Overall Study||0
5032722|NCT02073435|12386116|P2|COMPLETED|Overall Study||96
5032723|NCT02073435|12386117|P1|COMPLETED|Overall Study||81
5032724|NCT02073435|12386116|P2|STARTED|Overall Study||96
5032725|NCT02073435|12386117|P1|STARTED|Overall Study||81
5032726|NCT02073331|12386125|P1|NOT COMPLETED|Overall Study||0
5032727|NCT02073331|12386125|P1|COMPLETED|Overall Study||1420
5032728|NCT02073331|12386125|P1|STARTED|Overall Study||1420
5032729|NCT02073162|12386131|P2|NOT COMPLETED|Overall Study||11
5032730|NCT02073162|12386132|P1|NOT COMPLETED|Overall Study||6
5032731|NCT02073162|12386131|P2|COMPLETED|Overall Study||1490
5032732|NCT02073162|12386132|P1|COMPLETED|Overall Study||1493
5032733|NCT02073162|12386131|P2|STARTED|Overall Study||1501
5032734|NCT02073162|12386132|P1|STARTED|Overall Study||1499
5032735|NCT02072980|12386160|P2|NOT COMPLETED|Period 2, Second Wear||1
5032736|NCT02072980|12386161|P1|NOT COMPLETED|Period 2, Second Wear||0
5032737|NCT02072980|12386160|P2|COMPLETED|Period 2, Second Wear||7
5032738|NCT02072980|12386161|P1|COMPLETED|Period 2, Second Wear||7
5032739|NCT02072980|12386160|P2|STARTED|Period 2, Second Wear||8
5032740|NCT02072980|12386161|P1|STARTED|Period 2, Second Wear||7
5032741|NCT02072980|12386160|P2|NOT COMPLETED|Period 1, First Wear||0
5032742|NCT02072980|12386161|P1|NOT COMPLETED|Period 1, First Wear||0
5032743|NCT02072980|12386160|P2|COMPLETED|Period 1, First Wear||8
5032744|NCT02072980|12386161|P1|COMPLETED|Period 1, First Wear||7
5032745|NCT02072980|12386160|P2|STARTED|Period 1, First Wear||8
5032746|NCT02072980|12386161|P1|STARTED|Period 1, First Wear||7
5032747|NCT02072941|12386169|P2|NOT COMPLETED|Overall Study||29
5032748|NCT02072941|12386170|P1|NOT COMPLETED|Overall Study||38
5032749|NCT02072941|12386169|P2|COMPLETED|Overall Study||197
5032750|NCT02072941|12386170|P1|COMPLETED|Overall Study||181
5032751|NCT02072941|12386169|P2|STARTED|Overall Study||226
5032752|NCT02072941|12386170|P1|STARTED|Overall Study||219
5032753|NCT02072928|12386178|P1|NOT COMPLETED|Overall Study||0
5032754|NCT02072928|12386178|P1|COMPLETED|Overall Study||55
5032755|NCT02072928|12386178|P1|STARTED|Overall Study||55
5032756|NCT02072824|12386185|P3|NOT COMPLETED|Overall Study||3
5032757|NCT02072824|12386186|P2|NOT COMPLETED|Overall Study||1
5032758|NCT02072824|12386187|P1|NOT COMPLETED|Overall Study||2
5032759|NCT02072824|12386185|P3|COMPLETED|Overall Study||67
5032760|NCT02072824|12386186|P2|COMPLETED|Overall Study||33
5032761|NCT02072824|12386187|P1|COMPLETED|Overall Study||69
5032762|NCT02072824|12386185|P3|STARTED|Overall Study||70
5032763|NCT02072824|12386186|P2|STARTED|Overall Study||34
5032764|NCT02072824|12386187|P1|STARTED|Overall Study||71
5032765|NCT02072668|12386222|P2|NOT COMPLETED|Second Intervention||0
5032766|NCT02072668|12386223|P1|NOT COMPLETED|Second Intervention||1
5032767|NCT02072668|12386222|P2|COMPLETED|Second Intervention||7
5032768|NCT02072668|12386223|P1|COMPLETED|Second Intervention||6
5032769|NCT02072668|12386222|P2|STARTED|Second Intervention||7
5032770|NCT02072668|12386223|P1|STARTED|Second Intervention||7
5032771|NCT02072668|12386222|P2|NOT COMPLETED|Washout (2 Weeks)||0
5032772|NCT02072668|12386223|P1|NOT COMPLETED|Washout (2 Weeks)||0
5032773|NCT02072668|12386222|P2|COMPLETED|Washout (2 Weeks)||7
5032774|NCT02072668|12386223|P1|COMPLETED|Washout (2 Weeks)||7
5032775|NCT02072668|12386222|P2|STARTED|Washout (2 Weeks)||7
5032776|NCT02072668|12386223|P1|STARTED|Washout (2 Weeks)||7
5032777|NCT02072668|12386222|P2|NOT COMPLETED|First Intervention||0
5032778|NCT02072668|12386223|P1|NOT COMPLETED|First Intervention||0
5032779|NCT02072668|12386222|P2|COMPLETED|First Intervention||7
5032780|NCT02072668|12386223|P1|COMPLETED|First Intervention||7
5032781|NCT02072668|12386222|P2|STARTED|First Intervention||7
5032782|NCT02072668|12386223|P1|STARTED|First Intervention||7
5032783|NCT02072434|12386263|P2|NOT COMPLETED|Overall Study||90
5032784|NCT02072434|12386264|P1|NOT COMPLETED|Overall Study||54
5032785|NCT02072434|12386263|P2|COMPLETED|Overall Study||1014
5032786|NCT02072434|12386264|P1|COMPLETED|Overall Study||1041
5032787|NCT02072434|12386263|P2|Safety Analysis Set|Overall Study||1082
5032788|NCT02072434|12386264|P1|Safety Analysis Set|Overall Study||1067
5032789|NCT02072434|12386263|P2|Received Study Drug|Overall Study||1082
5032790|NCT02072434|12386264|P1|Received Study Drug|Overall Study||1067
5032791|NCT02072434|12386263|P2|Intent to Treat Analysis Set|Overall Study||1104
5032792|NCT02072434|12386264|P1|Intent to Treat Analysis Set|Overall Study||1095
5032793|NCT02072434|12386263|P2|STARTED|Overall Study||1104
5032794|NCT02072434|12386264|P1|STARTED|Overall Study||1095
5032795|NCT02072421|12386274|P1|NOT COMPLETED|Overall Study||390
5032796|NCT02072421|12386274|P1|COMPLETED|Overall Study||2489
5032797|NCT02072421|12386274|P1|STARTED|Overall Study||2879
5032798|NCT02072226|12386284|P2|NOT COMPLETED|Overall Study||10
5032799|NCT02072226|12386285|P1|NOT COMPLETED|Overall Study||15
5032800|NCT02072226|12386284|P2|COMPLETED|Overall Study||147
5032801|NCT02072226|12386285|P1|COMPLETED|Overall Study||141
5032802|NCT02072226|12386284|P2|STARTED|Overall Study||157
5032803|NCT02072226|12386285|P1|STARTED|Overall Study||156
5032804|NCT02072200|12386307|P1|NOT COMPLETED|Overall Study||2
5032805|NCT02072200|12386307|P1|COMPLETED|Overall Study||145
5032806|NCT02072200|12386307|P1|STARTED|Overall Study||147
5032807|NCT02072174|12386315|P2|NOT COMPLETED|Overall Study||39
5032808|NCT02072174|12386316|P1|NOT COMPLETED|Overall Study||32
5032809|NCT02072174|12386315|P2|COMPLETED|Overall Study||240
5032810|NCT02072174|12386316|P1|COMPLETED|Overall Study||258
5032811|NCT02072174|12386315|P2|STARTED|Overall Study||279
5032812|NCT02072174|12386316|P1|STARTED|Overall Study||290
5032813|NCT02072096|12386340|P2|NOT COMPLETED|Overall Study||78
5032814|NCT02072096|12386341|P1|NOT COMPLETED|Overall Study||85
5032815|NCT02072096|12386340|P2|COMPLETED|Overall Study||15
5032816|NCT02072096|12386341|P1|COMPLETED|Overall Study||14
5032817|NCT02072096|12386340|P2|Received at Least One Dose of Study Drug|Overall Study||93
5032818|NCT02072096|12386341|P1|Received at Least One Dose of Study Drug|Overall Study||98
5032819|NCT02072096|12386340|P2|STARTED|Overall Study||93
5032820|NCT02072096|12386341|P1|STARTED|Overall Study||99
5032821|NCT02071914|12386366|P3|NOT COMPLETED|Overall Study||0
5032822|NCT02071914|12386367|P2|NOT COMPLETED|Overall Study||0
5032823|NCT02071914|12386368|P1|NOT COMPLETED|Overall Study||0
5032824|NCT02071914|12386366|P3|COMPLETED|Overall Study||27
5032825|NCT02071914|12386367|P2|COMPLETED|Overall Study||27
5032826|NCT02071914|12386368|P1|COMPLETED|Overall Study||27
5032827|NCT02071914|12386366|P3|STARTED|Overall Study||27
5032828|NCT02071914|12386367|P2|STARTED|Overall Study||27
5032829|NCT02071914|12386368|P1|STARTED|Overall Study||27
5032830|NCT02071849|12386376|P1|NOT COMPLETED|2-year Extended Follow-up||1
5032831|NCT02071849|12386376|P1|COMPLETED|2-year Extended Follow-up||14
5032832|NCT02071849|12386376|P1|STARTED|2-year Extended Follow-up||15
5032833|NCT02071849|12386376|P1|NOT COMPLETED|6-month Primary Endpoint||5
5032834|NCT02071849|12386376|P1|COMPLETED|6-month Primary Endpoint||15
5032835|NCT02071849|12386376|P1|STARTED|6-month Primary Endpoint||20
5032836|NCT02071823|12386410|P2|NOT COMPLETED|Overall Study||0
5032837|NCT02071823|12386411|P1|NOT COMPLETED|Overall Study||1
5032838|NCT02071823|12386410|P2|COMPLETED|Overall Study||6
5032839|NCT02071823|12386411|P1|COMPLETED|Overall Study||5
5032840|NCT02071823|12386410|P2|STARTED|Overall Study||6
5032841|NCT02071823|12386411|P1|STARTED|Overall Study||6
5032842|NCT02071810|12386426|P5|NOT COMPLETED|Overall Study||1
5032843|NCT02071810|12386427|P4|NOT COMPLETED|Overall Study||1
5032844|NCT02071810|12386428|P3|NOT COMPLETED|Overall Study||0
5032845|NCT02071810|12386429|P2|NOT COMPLETED|Overall Study||0
5032846|NCT02071810|12386430|P1|NOT COMPLETED|Overall Study||0
5032847|NCT02071810|12386426|P5|COMPLETED|Overall Study||8
5032848|NCT02071810|12386427|P4|COMPLETED|Overall Study||6
5032849|NCT02071810|12386428|P3|COMPLETED|Overall Study||6
5032850|NCT02071810|12386429|P2|COMPLETED|Overall Study||6
5032851|NCT02071810|12386430|P1|COMPLETED|Overall Study||6
5032852|NCT02071810|12386426|P5|STARTED|Overall Study||9
5032853|NCT02071810|12386427|P4|STARTED|Overall Study||7
5032854|NCT02071810|12386428|P3|STARTED|Overall Study||6
5032855|NCT02071810|12386429|P2|STARTED|Overall Study||6
5032856|NCT02071810|12386430|P1|STARTED|Overall Study||6
5032857|NCT02071771|12386442|P2|NOT COMPLETED|Period 2: Second 10 Days||0
5032858|NCT02071771|12386443|P1|NOT COMPLETED|Period 2: Second 10 Days||0
5032859|NCT02071771|12386442|P2|COMPLETED|Period 2: Second 10 Days||38
5032860|NCT02071771|12386443|P1|COMPLETED|Period 2: Second 10 Days||39
5032861|NCT02071771|12386442|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
5032862|NCT02071771|12386443|P1|STARTED|Period 2: Second 10 Days||39
5032863|NCT02071771|12386442|P2|NOT COMPLETED|Period 1: First 10 Days||0
5032864|NCT02071771|12386443|P1|NOT COMPLETED|Period 1: First 10 Days||2
5032865|NCT02071771|12386442|P2|COMPLETED|Period 1: First 10 Days||39
5032866|NCT02071771|12386443|P1|COMPLETED|Period 1: First 10 Days||39
5032867|NCT02071771|12386442|P2|Dispensed|Period 1: First 10 Days||39
5032868|NCT02071771|12386443|P1|Dispensed|Period 1: First 10 Days||39
5032869|NCT02071771|12386442|P2|STARTED|Period 1: First 10 Days||39
5032870|NCT02071771|12386443|P1|STARTED|Period 1: First 10 Days||41
5032871|NCT02071706|12386451|P1|NOT COMPLETED|Overall Study||3
5032872|NCT02071706|12386451|P1|COMPLETED|Overall Study||59
5032873|NCT02071706|12386451|P1|STARTED|Overall Study||62
5032874|NCT02071420|12386458|P2|NOT COMPLETED|Overall Study||3
5032875|NCT02071420|12386459|P1|NOT COMPLETED|Overall Study||3
5032876|NCT02071420|12386458|P2|COMPLETED|Overall Study||27
5032877|NCT02071420|12386459|P1|COMPLETED|Overall Study||27
5032878|NCT02071420|12386458|P2|STARTED|Overall Study||30
5032879|NCT02071420|12386459|P1|STARTED|Overall Study||30
5032880|NCT02071290|12386467|P2|NOT COMPLETED|Overall Study||7
5032881|NCT02071290|12386468|P1|NOT COMPLETED|Overall Study||4
5032882|NCT02071290|12386467|P2|COMPLETED|Overall Study||18
5032883|NCT02071290|12386468|P1|COMPLETED|Overall Study||21
5032884|NCT02071290|12386467|P2|STARTED|Overall Study||25
5032885|NCT02071290|12386468|P1|STARTED|Overall Study||25
5032886|NCT02071225|12386522|P1|NOT COMPLETED|Overall Study||30
5032887|NCT02071225|12386522|P1|COMPLETED|Overall Study||42
5032888|NCT02071225|12386522|P1|STARTED|Overall Study||72
5032889|NCT02071108|12386540|P1|NOT COMPLETED|Overall Study||0
5032890|NCT02071108|12386540|P1|COMPLETED|Overall Study||35
5032891|NCT02071108|12386540|P1|STARTED|Overall Study||35
5032892|NCT02071095|12386561|P2|NOT COMPLETED|Overall Study||0
5032893|NCT02071095|12386562|P1|NOT COMPLETED|Overall Study||0
5032894|NCT02071095|12386561|P2|COMPLETED|Overall Study||3
5032895|NCT02071095|12386562|P1|COMPLETED|Overall Study||12
5032896|NCT02071095|12386561|P2|STARTED|Overall Study||3
5032897|NCT02071095|12386562|P1|STARTED|Overall Study||12
5032898|NCT02071082|12386578|P2|NOT COMPLETED|Overall Study||7
5032899|NCT02071082|12386579|P1|NOT COMPLETED|Overall Study||2
5032900|NCT02071082|12386578|P2|COMPLETED|Overall Study||68
5032901|NCT02071082|12386579|P1|COMPLETED|Overall Study||2
5032902|NCT02071082|12386578|P2|STARTED|Overall Study||75
5032903|NCT02071082|12386579|P1|STARTED|Overall Study||4
5032904|NCT02070991|12386609|P2|NOT COMPLETED|Overall Study||0
5032905|NCT02070991|12386610|P1|NOT COMPLETED|Overall Study||3
5032906|NCT02070991|12386609|P2|COMPLETED|Overall Study||32
5032907|NCT02070991|12386610|P1|COMPLETED|Overall Study||28
5032908|NCT02070991|12386609|P2|STARTED|Overall Study||32
5032909|NCT02070991|12386610|P1|STARTED|Overall Study||31
5032910|NCT02070978|12386633|P3|NOT COMPLETED|Overall Study||53
5032911|NCT02070978|12386634|P2|NOT COMPLETED|Overall Study||53
5032912|NCT02070978|12386635|P1|NOT COMPLETED|Overall Study||47
5032913|NCT02070978|12386633|P3|COMPLETED|Overall Study||35
5032914|NCT02070978|12386634|P2|COMPLETED|Overall Study||29
5032915|NCT02070978|12386635|P1|COMPLETED|Overall Study||36
5032916|NCT02070978|12386633|P3|STARTED|Overall Study||88
5032917|NCT02070978|12386634|P2|STARTED|Overall Study||82
5032918|NCT02070978|12386635|P1|STARTED|Overall Study||83
5032919|NCT02070965|12386697|P3|NOT COMPLETED|Overall Study||1
5032920|NCT02070965|12386698|P2|NOT COMPLETED|Overall Study||2
5032921|NCT02070965|12386699|P1|NOT COMPLETED|Overall Study||2
5032922|NCT02070965|12386697|P3|COMPLETED|Overall Study||24
5032923|NCT02070965|12386698|P2|COMPLETED|Overall Study||21
5032924|NCT02070965|12386699|P1|COMPLETED|Overall Study||25
5032925|NCT02070965|12386697|P3|STARTED|Overall Study||25
5032926|NCT02070965|12386698|P2|STARTED|Overall Study||23
5032927|NCT02070965|12386699|P1|STARTED|Overall Study||27
5032928|NCT02070757|12386709|P2|NOT COMPLETED|Overall Study||114
5032929|NCT02070757|12386710|P1|NOT COMPLETED|Overall Study||117
5032930|NCT02070757|12386709|P2|COMPLETED|Overall Study||250
5032931|NCT02070757|12386710|P1|COMPLETED|Overall Study||245
5032932|NCT02070757|12386709|P2|Treated Participants|Overall Study||359
5032933|NCT02070757|12386710|P1|Treated Participants|Overall Study||361
5032934|NCT02070757|12386709|P2|STARTED|Overall Study||364
5032935|NCT02070757|12386710|P1|STARTED|Overall Study||362
5032936|NCT02070744|12386744|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
5032937|NCT02070744|12386745|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
5032938|NCT02070744|12386746|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
5032939|NCT02070744|12386747|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
5032940|NCT02070744|12386748|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
5032941|NCT02070744|12386744|P5|COMPLETED|OLE Phase (48 Weeks)||24
5032942|NCT02070744|12386745|P4|COMPLETED|OLE Phase (48 Weeks)||0
5032943|NCT02070744|12386746|P3|COMPLETED|OLE Phase (48 Weeks)||0
5032944|NCT02070744|12386747|P2|COMPLETED|OLE Phase (48 Weeks)||0
5032945|NCT02070744|12386748|P1|COMPLETED|OLE Phase (48 Weeks)||0
5032946|NCT02070744|12386744|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
5032947|NCT02070744|12386745|P4|STARTED|OLE Phase (48 Weeks)||0
5032948|NCT02070744|12386746|P3|STARTED|OLE Phase (48 Weeks)||0
5032949|NCT02070744|12386747|P2|STARTED|OLE Phase (48 Weeks)||0
5032950|NCT02070744|12386748|P1|STARTED|OLE Phase (48 Weeks)||0
5032951|NCT02070744|12386744|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
5032952|NCT02070744|12386745|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
5032953|NCT02070744|12386746|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
5032954|NCT02070744|12386747|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
5032955|NCT02070744|12386748|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
5032956|NCT02070744|12386744|P5|COMPLETED|PC Phase (12 Weeks)||0
5032957|NCT02070744|12386745|P4|COMPLETED|PC Phase (12 Weeks)||13
5032958|NCT02070744|12386746|P3|COMPLETED|PC Phase (12 Weeks)||15
5032959|NCT02070744|12386747|P2|COMPLETED|PC Phase (12 Weeks)||5
5032960|NCT02070744|12386748|P1|COMPLETED|PC Phase (12 Weeks)||6
5032961|NCT02070744|12386744|P5|Treated|PC Phase (12 Weeks)||0
5032962|NCT02070744|12386745|P4|Treated|PC Phase (12 Weeks)||13
5032963|NCT02070744|12386746|P3|Treated|PC Phase (12 Weeks)||15
5032964|NCT02070744|12386747|P2|Treated|PC Phase (12 Weeks)||5
5032965|NCT02070744|12386748|P1|Treated|PC Phase (12 Weeks)||6
5032966|NCT02070744|12386744|P5|STARTED|PC Phase (12 Weeks)||0
5032967|NCT02070744|12386745|P4|STARTED|PC Phase (12 Weeks)||14
5032968|NCT02070744|12386746|P3|STARTED|PC Phase (12 Weeks)||15
5032969|NCT02070744|12386747|P2|STARTED|PC Phase (12 Weeks)||5
5032970|NCT02070744|12386748|P1|STARTED|PC Phase (12 Weeks)||6
5032971|NCT02070692|12386800|P2|NOT COMPLETED|Overall Study||12
5032972|NCT02070692|12386801|P1|NOT COMPLETED|Overall Study||10
5032973|NCT02070692|12386800|P2|COMPLETED|Overall Study||16
5032974|NCT02070692|12386801|P1|COMPLETED|Overall Study||18
5032975|NCT02070692|12386800|P2|STARTED|Overall Study||28
5032976|NCT02070692|12386801|P1|STARTED|Overall Study||28
5032977|NCT02070640|12386817|P2|NOT COMPLETED|Overall Study||0
5032978|NCT02070640|12386818|P1|NOT COMPLETED|Overall Study||11
5032979|NCT02070640|12386817|P2|COMPLETED|Overall Study||6
5032980|NCT02070640|12386818|P1|COMPLETED|Overall Study||82
5032981|NCT02070640|12386817|P2|STARTED|Overall Study||6
5032982|NCT02070640|12386818|P1|STARTED|Overall Study||93
5032983|NCT02070588|12386831|P3|NOT COMPLETED|Overall Study||0
5032984|NCT02070588|12386832|P2|NOT COMPLETED|Overall Study||1
5032985|NCT02070588|12386833|P1|NOT COMPLETED|Overall Study||39
5032986|NCT02070588|12386831|P3|COMPLETED|Overall Study||0
5032987|NCT02070588|12386832|P2|COMPLETED|Overall Study||25
5032988|NCT02070588|12386833|P1|COMPLETED|Overall Study||47
5032989|NCT02070588|12386831|P3|STARTED|Overall Study||0
5032990|NCT02070588|12386832|P2|STARTED|Overall Study||26
5032991|NCT02070588|12386833|P1|STARTED|Overall Study||86
5032992|NCT02070484|12386849|P2|NOT COMPLETED|Overall Study||0
5032993|NCT02070484|12386850|P1|NOT COMPLETED|Overall Study||1
5032994|NCT02070484|12386849|P2|COMPLETED|Overall Study||3
5032995|NCT02070484|12386850|P1|COMPLETED|Overall Study||2
5032996|NCT02070484|12386849|P2|STARTED|Overall Study||3
5032997|NCT02070484|12386850|P1|STARTED|Overall Study||3
5032998|NCT02070380|12386872|P4|NOT COMPLETED|Second Injection||5
5032999|NCT02070380|12386873|P3|NOT COMPLETED|Second Injection||1
5033000|NCT02070380|12386874|P2|NOT COMPLETED|Second Injection||2
5033001|NCT02070380|12386875|P1|NOT COMPLETED|Second Injection||0
5033002|NCT02070380|12386872|P4|COMPLETED|Second Injection||46
5033003|NCT02070380|12386873|P3|COMPLETED|Second Injection||50
5033004|NCT02070380|12386874|P2|COMPLETED|Second Injection||32
5033005|NCT02070380|12386875|P1|COMPLETED|Second Injection||31
5033006|NCT02070380|12386872|P4|STARTED|Second Injection||51
5033007|NCT02070380|12386873|P3|STARTED|Second Injection||51
5033008|NCT02070380|12386874|P2|STARTED|Second Injection||34
5033009|NCT02070380|12386875|P1|STARTED|Second Injection||31
5033010|NCT02070380|12386872|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
5033011|NCT02070380|12386873|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
5033012|NCT02070380|12386874|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
5033013|NCT02070380|12386875|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
5033014|NCT02070380|12386872|P4|COMPLETED|Washout (no Second Injection/MRI)||51
5033015|NCT02070380|12386873|P3|COMPLETED|Washout (no Second Injection/MRI)||51
5033016|NCT02070380|12386874|P2|COMPLETED|Washout (no Second Injection/MRI)||34
5033017|NCT02070380|12386875|P1|COMPLETED|Washout (no Second Injection/MRI)||31
5033018|NCT02070380|12386872|P4|STARTED|Washout (no Second Injection/MRI)||54
5033019|NCT02070380|12386873|P3|STARTED|Washout (no Second Injection/MRI)||53
5033020|NCT02070380|12386874|P2|STARTED|Washout (no Second Injection/MRI)||39
5033021|NCT02070380|12386875|P1|STARTED|Washout (no Second Injection/MRI)||31
5033022|NCT02070380|12386872|P4|NOT COMPLETED|First Injection||0
5033023|NCT02070380|12386873|P3|NOT COMPLETED|First Injection||0
5033024|NCT02070380|12386874|P2|NOT COMPLETED|First Injection||0
5033025|NCT02070380|12386875|P1|NOT COMPLETED|First Injection||0
5033026|NCT02070380|12386872|P4|COMPLETED|First Injection||54
5033027|NCT02070380|12386873|P3|COMPLETED|First Injection||53
5033028|NCT02070380|12386874|P2|COMPLETED|First Injection||39
5033029|NCT02070380|12386875|P1|COMPLETED|First Injection||31
5033030|NCT02070380|12386872|P4|STARTED|First Injection||54
5033031|NCT02070380|12386873|P3|STARTED|First Injection||53
5033032|NCT02070380|12386874|P2|STARTED|First Injection||39
5033033|NCT02070380|12386875|P1|STARTED|First Injection||31
5033034|NCT02070302|12386925|P2|NOT COMPLETED|Overall Study||0
5033035|NCT02070302|12386926|P1|NOT COMPLETED|Overall Study||0
5033036|NCT02070302|12386925|P2|COMPLETED|Overall Study||5
5033037|NCT02070302|12386926|P1|COMPLETED|Overall Study||5
5033038|NCT02070302|12386925|P2|STARTED|Overall Study||5
5033039|NCT02070302|12386926|P1|STARTED|Overall Study||5
5033040|NCT02070276|12386945|P3|NOT COMPLETED|Overall Study||0
5033041|NCT02070276|12386946|P2|NOT COMPLETED|Overall Study||0
5033042|NCT02070276|12386947|P1|NOT COMPLETED|Overall Study||0
5033043|NCT02070276|12386945|P3|COMPLETED|Overall Study||148
5033044|NCT02070276|12386946|P2|COMPLETED|Overall Study||132
5033045|NCT02070276|12386947|P1|COMPLETED|Overall Study||149
5033046|NCT02070276|12386945|P3|STARTED|Overall Study||148
5033047|NCT02070276|12386946|P2|STARTED|Overall Study||132
5033048|NCT02070276|12386947|P1|STARTED|Overall Study||149
5033049|NCT02070237|12386963|P2|NOT COMPLETED|Overall Study||3
5033050|NCT02070237|12386964|P1|NOT COMPLETED|Overall Study||3
5033051|NCT02070237|12386963|P2|COMPLETED|Overall Study||42
5033052|NCT02070237|12386964|P1|COMPLETED|Overall Study||42
5033053|NCT02070237|12386963|P2|STARTED|Overall Study||45
5033054|NCT02070237|12386964|P1|STARTED|Overall Study||45
5033055|NCT02069847|12386974|P2|NOT COMPLETED|Overall Study||0
5033056|NCT02069847|12386975|P1|NOT COMPLETED|Overall Study||0
5033057|NCT02069847|12386974|P2|COMPLETED|Overall Study||68
5033058|NCT02069847|12386975|P1|COMPLETED|Overall Study||22
5033059|NCT02069847|12386974|P2|STARTED|Overall Study||68
5033060|NCT02069847|12386975|P1|STARTED|Overall Study||22
5033061|NCT02069704|12386984|P2|NOT COMPLETED|Overall Study||0
5033062|NCT02069704|12386985|P1|NOT COMPLETED|Overall Study||0
5033063|NCT02069704|12386984|P2|COMPLETED|Overall Study||71
5033064|NCT02069704|12386985|P1|COMPLETED|Overall Study||69
5033065|NCT02069704|12386984|P2|STARTED|Overall Study||71
5033066|NCT02069704|12386985|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
5033067|NCT02069392|12387017|P2|NOT COMPLETED|Overall Study||2
5033068|NCT02069392|12387018|P1|NOT COMPLETED|Overall Study||4
5033069|NCT02069392|12387017|P2|COMPLETED|Overall Study||15
5033070|NCT02069392|12387018|P1|COMPLETED|Overall Study||10
5033071|NCT02069392|12387017|P2|STARTED|Overall Study||17
5033072|NCT02069392|12387018|P1|STARTED|Overall Study||14
5033073|NCT02069379|12387042|P4|NOT COMPLETED|Second Treatment Arm||0
5033074|NCT02069379|12387043|P3|NOT COMPLETED|Second Treatment Arm||1
5033075|NCT02069379|12387044|P2|NOT COMPLETED|Second Treatment Arm||0
5033076|NCT02069379|12387045|P1|NOT COMPLETED|Second Treatment Arm||0
5033077|NCT02069379|12387042|P4|COMPLETED|Second Treatment Arm||0
5033078|NCT02069379|12387043|P3|COMPLETED|Second Treatment Arm||0
5033079|NCT02069379|12387044|P2|COMPLETED|Second Treatment Arm||1
5033080|NCT02069379|12387045|P1|COMPLETED|Second Treatment Arm||0
5033081|NCT02069379|12387042|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
5033082|NCT02069379|12387043|P3|STARTED|Second Treatment Arm||1
5033083|NCT02069379|12387044|P2|STARTED|Second Treatment Arm||1
5033084|NCT02069379|12387045|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
5033085|NCT02069379|12387042|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
5033086|NCT02069379|12387043|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
5033087|NCT02069379|12387044|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
5033088|NCT02069379|12387045|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
5033089|NCT02069379|12387042|P4|COMPLETED|Washout Period (4 Weeks)||0
5033090|NCT02069379|12387043|P3|COMPLETED|Washout Period (4 Weeks)||1
5033091|NCT02069379|12387044|P2|COMPLETED|Washout Period (4 Weeks)||1
5033092|NCT02069379|12387045|P1|COMPLETED|Washout Period (4 Weeks)||0
5033093|NCT02069379|12387042|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
5033094|NCT02069379|12387043|P3|STARTED|Washout Period (4 Weeks)||1
5033095|NCT02069379|12387044|P2|STARTED|Washout Period (4 Weeks)||3
5033096|NCT02069379|12387045|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
5033097|NCT02069379|12387042|P4|NOT COMPLETED|First Treatment Arm||0
5033098|NCT02069379|12387043|P3|NOT COMPLETED|First Treatment Arm||1
5033099|NCT02069379|12387044|P2|NOT COMPLETED|First Treatment Arm||1
5033100|NCT02069379|12387045|P1|NOT COMPLETED|First Treatment Arm||0
5033101|NCT02069379|12387042|P4|COMPLETED|First Treatment Arm||0
5033102|NCT02069379|12387043|P3|COMPLETED|First Treatment Arm||1
5033103|NCT02069379|12387044|P2|COMPLETED|First Treatment Arm||3
5033104|NCT02069379|12387045|P1|COMPLETED|First Treatment Arm||0
5033105|NCT02069379|12387042|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
5033106|NCT02069379|12387043|P3|STARTED|First Treatment Arm||2
5033107|NCT02069379|12387044|P2|STARTED|First Treatment Arm||4
5033108|NCT02069379|12387045|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
5033109|NCT02069379|12387042|P4|NOT COMPLETED|Baseline Measurements||2
5033110|NCT02069379|12387043|P3|NOT COMPLETED|Baseline Measurements||0
5033111|NCT02069379|12387044|P2|NOT COMPLETED|Baseline Measurements||0
5033112|NCT02069379|12387045|P1|NOT COMPLETED|Baseline Measurements||3
5033113|NCT02069379|12387042|P4|COMPLETED|Baseline Measurements||4
5033114|NCT02069379|12387043|P3|COMPLETED|Baseline Measurements||2
5033115|NCT02069379|12387044|P2|COMPLETED|Baseline Measurements||4
5033116|NCT02069379|12387045|P1|COMPLETED|Baseline Measurements||27
5033117|NCT02069379|12387042|P4|Baseline Measurements Taken|Baseline Measurements||6
5033118|NCT02069379|12387043|P3|Baseline Measurements Taken|Baseline Measurements||2
5033119|NCT02069379|12387044|P2|Baseline Measurements Taken|Baseline Measurements||4
5033120|NCT02069379|12387045|P1|Baseline Measurements Taken|Baseline Measurements||30
5033121|NCT02069379|12387042|P4|STARTED|Baseline Measurements||6
5033122|NCT02069379|12387043|P3|STARTED|Baseline Measurements||2
5033123|NCT02069379|12387044|P2|STARTED|Baseline Measurements||4
5033124|NCT02069379|12387045|P1|STARTED|Baseline Measurements||30
5033125|NCT02069353|12387071|P1|NOT COMPLETED|Overall Study||0
5033126|NCT02069353|12387071|P1|COMPLETED|Overall Study||4
5033127|NCT02069353|12387071|P1|STARTED|Overall Study||4
5033128|NCT02069184|12387082|P2|NOT COMPLETED|Overall Study||2
5033129|NCT02069184|12387083|P1|NOT COMPLETED|Overall Study||6
5033130|NCT02069184|12387082|P2|COMPLETED|Overall Study||31
5033131|NCT02069184|12387083|P1|COMPLETED|Overall Study||27
5033132|NCT02069184|12387082|P2|STARTED|Overall Study||33
5033133|NCT02069184|12387083|P1|STARTED|Overall Study||33
5033134|NCT02069119|12387105|P4|NOT COMPLETED|Overall Study||0
5033135|NCT02069119|12387106|P3|NOT COMPLETED|Overall Study||0
5033136|NCT02069119|12387107|P2|NOT COMPLETED|Overall Study||0
5033137|NCT02069119|12387108|P1|NOT COMPLETED|Overall Study||0
5033138|NCT02069119|12387105|P4|COMPLETED|Overall Study||4
5033139|NCT02069119|12387106|P3|COMPLETED|Overall Study||20
5033140|NCT02069119|12387107|P2|COMPLETED|Overall Study||4
5033141|NCT02069119|12387108|P1|COMPLETED|Overall Study||20
5033142|NCT02069119|12387105|P4|STARTED|Overall Study||4
5033143|NCT02069119|12387106|P3|STARTED|Overall Study||20
5033144|NCT02069119|12387107|P2|STARTED|Overall Study||4
5033145|NCT02069119|12387108|P1|STARTED|Overall Study||20
5033146|NCT02069093|12387132|P1|NOT COMPLETED|Overall Study||30
5033147|NCT02069093|12387132|P1|COMPLETED|Overall Study||56
5033148|NCT02069093|12387132|P1|Pharmacokinetic Analysis Set|Overall Study||50
5033149|NCT02069093|12387132|P1|STARTED|Overall Study||86
5033150|NCT02069041|12387141|P1|NOT COMPLETED|Overall Study||0
5033151|NCT02069041|12387141|P1|COMPLETED|Overall Study||8
5033152|NCT02069041|12387141|P1|Received at Least One Dose of Study Drug|Overall Study||8
5033153|NCT02069041|12387141|P1|STARTED|Overall Study||8
5033154|NCT02068846|12387151|P2|NOT COMPLETED|Overall Study||1
5033155|NCT02068846|12387152|P1|NOT COMPLETED|Overall Study||1
5033156|NCT02068846|12387151|P2|COMPLETED|Overall Study||7
5033157|NCT02068846|12387152|P1|COMPLETED|Overall Study||8
5033158|NCT02068846|12387151|P2|STARTED|Overall Study||8
5033159|NCT02068846|12387152|P1|STARTED|Overall Study||9
5033160|NCT02068820|12387170|P2|NOT COMPLETED|Overall Study||0
5033161|NCT02068820|12387171|P1|NOT COMPLETED|Overall Study||0
5033162|NCT02068820|12387170|P2|COMPLETED|Overall Study||180
5033163|NCT02068820|12387171|P1|COMPLETED|Overall Study||20
5033164|NCT02068820|12387170|P2|STARTED|Overall Study||180
5033165|NCT02068820|12387171|P1|STARTED|Overall Study||20
5033166|NCT02068768|12387182|P1|NOT COMPLETED|Overall Study||7
5033167|NCT02068768|12387182|P1|COMPLETED|Overall Study||6
5033168|NCT02068768|12387182|P1|STARTED|Overall Study||13
5033169|NCT02068599|12387191|P3|NOT COMPLETED|Overall Study||13
5033170|NCT02068599|12387192|P2|NOT COMPLETED|Overall Study||10
5033171|NCT02068599|12387193|P1|NOT COMPLETED|Overall Study||11
5033172|NCT02068599|12387191|P3|COMPLETED|Overall Study||117
5033173|NCT02068599|12387192|P2|COMPLETED|Overall Study||119
5033174|NCT02068599|12387193|P1|COMPLETED|Overall Study||119
5033175|NCT02068599|12387191|P3|Full Analysis Set|Overall Study||130
5033176|NCT02068599|12387192|P2|Full Analysis Set|Overall Study||128
5033177|NCT02068599|12387193|P1|Full Analysis Set|Overall Study||129
5033178|NCT02068599|12387191|P3|Safety Analysis Set|Overall Study||130
5033179|NCT02068599|12387192|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
5033180|NCT02068599|12387193|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
5033181|NCT02068599|12387191|P3|STARTED|Overall Study||130
5033182|NCT02068599|12387192|P2|STARTED|Overall Study||129
5033183|NCT02068599|12387193|P1|STARTED|Overall Study||130
5033184|NCT02068547|12387233|P2|NOT COMPLETED|Overall Study||3
5033185|NCT02068547|12387234|P1|NOT COMPLETED|Overall Study||4
5033186|NCT02068547|12387233|P2|COMPLETED|Overall Study||1
5033187|NCT02068547|12387234|P1|COMPLETED|Overall Study||0
5033188|NCT02068547|12387233|P2|STARTED|Overall Study||4
5033189|NCT02068547|12387234|P1|STARTED|Overall Study||4
5033190|NCT02068508|12387244|P1|NOT COMPLETED|Overall Study||32
5033191|NCT02068508|12387244|P1|COMPLETED|Overall Study||1035
5033192|NCT02068508|12387244|P1|STARTED|Overall Study||1067
5033193|NCT02068495|12387254|P1|NOT COMPLETED|Overall Study||109
5033194|NCT02068495|12387254|P1|COMPLETED|Overall Study||3300
5033195|NCT02068495|12387254|P1|STARTED|Overall Study||3409
5033196|NCT02068443|12387266|P3|NOT COMPLETED|Overall Study||3
5033197|NCT02068443|12387267|P2|NOT COMPLETED|Overall Study||6
5033198|NCT02068443|12387268|P1|NOT COMPLETED|Overall Study||7
5033199|NCT02068443|12387266|P3|COMPLETED|Overall Study||148
5033200|NCT02068443|12387267|P2|COMPLETED|Overall Study||146
5033201|NCT02068443|12387268|P1|COMPLETED|Overall Study||64
5033202|NCT02068443|12387266|P3|STARTED|Overall Study||151
5033203|NCT02068443|12387267|P2|STARTED|Overall Study||152
5033204|NCT02068443|12387268|P1|STARTED|Overall Study||71
5033205|NCT02068222|12387303|P1|NOT COMPLETED|Overall Study||1
5033206|NCT02068222|12387303|P1|COMPLETED|Overall Study||9
5033207|NCT02068222|12387303|P1|STARTED|Overall Study||10
5033208|NCT02068157|12387310|P1|NOT COMPLETED|Overall Study||0
5033209|NCT02068157|12387310|P1|COMPLETED|Overall Study||3
5033210|NCT02068157|12387310|P1|STARTED|Overall Study||3
5033211|NCT02068027|12387317|P2|NOT COMPLETED|Overall Study||16
5033212|NCT02068027|12387318|P1|NOT COMPLETED|Overall Study||13
5033213|NCT02068027|12387317|P2|COMPLETED|Overall Study||114
5033214|NCT02068027|12387318|P1|COMPLETED|Overall Study||117
5033215|NCT02068027|12387317|P2|STARTED|Overall Study||130
5033216|NCT02068027|12387318|P1|STARTED|Overall Study||130
5033217|NCT02067858|12387326|P1|NOT COMPLETED|Overall Study||0
5033218|NCT02067858|12387326|P1|COMPLETED|Overall Study||6
5033219|NCT02067858|12387326|P1|STARTED|Overall Study||6
5033220|NCT02067728|12387334|P2|NOT COMPLETED|6 Month Measurements||97
5033221|NCT02067728|12387335|P1|NOT COMPLETED|6 Month Measurements||114
5033222|NCT02067728|12387334|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
5033223|NCT02067728|12387335|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
5033224|NCT02067728|12387334|P2|STARTED|6 Month Measurements||210
5033225|NCT02067728|12387335|P1|STARTED|6 Month Measurements||220
5033226|NCT02067728|12387334|P2|NOT COMPLETED|6 Month Follow up Survey||60
5033227|NCT02067728|12387335|P1|NOT COMPLETED|6 Month Follow up Survey||48
5033228|NCT02067728|12387334|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
5033229|NCT02067728|12387335|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
5033230|NCT02067728|12387334|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
5033231|NCT02067728|12387335|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
5033232|NCT02067728|12387334|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
5033233|NCT02067728|12387335|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
5033234|NCT02067728|12387334|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
5033235|NCT02067728|12387335|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
5033236|NCT02067728|12387334|P2|STARTED|Baseline - 1 Month Follow up Survey||210
5033237|NCT02067728|12387335|P1|STARTED|Baseline - 1 Month Follow up Survey||220
5033238|NCT02067676|12387369|P6|NOT COMPLETED|Overall Study||0
5033239|NCT02067676|12387370|P5|NOT COMPLETED|Overall Study||0
5033240|NCT02067676|12387371|P4|NOT COMPLETED|Overall Study||0
5033241|NCT02067676|12387372|P3|NOT COMPLETED|Overall Study||0
5033242|NCT02067676|12387373|P2|NOT COMPLETED|Overall Study||0
5033243|NCT02067676|12387374|P1|NOT COMPLETED|Overall Study||1
5033244|NCT02067676|12387369|P6|COMPLETED|Overall Study||8
5033245|NCT02067676|12387370|P5|COMPLETED|Overall Study||8
5033246|NCT02067676|12387371|P4|COMPLETED|Overall Study||8
5033247|NCT02067676|12387372|P3|COMPLETED|Overall Study||8
5033248|NCT02067676|12387373|P2|COMPLETED|Overall Study||8
5033249|NCT02067676|12387374|P1|COMPLETED|Overall Study||7
5033250|NCT02067676|12387369|P6|STARTED|Overall Study||8
5033251|NCT02067676|12387370|P5|STARTED|Overall Study||8
5033252|NCT02067676|12387371|P4|STARTED|Overall Study||8
5033253|NCT02067676|12387372|P3|STARTED|Overall Study||8
5033254|NCT02067676|12387373|P2|STARTED|Overall Study||8
5033255|NCT02067676|12387374|P1|STARTED|Overall Study||8
5033256|NCT02067663|12387414|P2|NOT COMPLETED|Overall Study||14
5033257|NCT02067663|12387415|P1|NOT COMPLETED|Overall Study||13
5033258|NCT02067663|12387414|P2|COMPLETED|Overall Study||41
5033259|NCT02067663|12387415|P1|COMPLETED|Overall Study||55
5033260|NCT02067663|12387414|P2|STARTED|Overall Study||55
5033261|NCT02067663|12387415|P1|STARTED|Overall Study||68
5033262|NCT02067611|12387435|P3|NOT COMPLETED|Overall Study||4
5033263|NCT02067611|12387436|P2|NOT COMPLETED|Overall Study||6
5033264|NCT02067611|12387437|P1|NOT COMPLETED|Overall Study||6
5033265|NCT02067611|12387435|P3|COMPLETED|Overall Study||68
5033266|NCT02067611|12387436|P2|COMPLETED|Overall Study||66
5033267|NCT02067611|12387437|P1|COMPLETED|Overall Study||66
5033268|NCT02067611|12387435|P3|STARTED|Overall Study||72
5033269|NCT02067611|12387436|P2|STARTED|Overall Study||72
5033270|NCT02067611|12387437|P1|STARTED|Overall Study||72
5033271|NCT02067585|12387475|P3|NOT COMPLETED|Overall Study||0
5033272|NCT02067585|12387476|P2|NOT COMPLETED|Overall Study||0
5033273|NCT02067585|12387477|P1|NOT COMPLETED|Overall Study||0
5033274|NCT02067585|12387475|P3|COMPLETED|Overall Study||16
5033275|NCT02067585|12387476|P2|COMPLETED|Overall Study||16
5033276|NCT02067585|12387477|P1|COMPLETED|Overall Study||16
5033277|NCT02067585|12387475|P3|STARTED|Overall Study||16
5033278|NCT02067585|12387476|P2|STARTED|Overall Study||16
5033279|NCT02067585|12387477|P1|STARTED|Overall Study||16
5033280|NCT02067533|12387514|P2|NOT COMPLETED|Overall Study||2
5033281|NCT02067533|12387515|P1|NOT COMPLETED|Overall Study||4
5033282|NCT02067533|12387514|P2|COMPLETED|Overall Study||44
5033283|NCT02067533|12387515|P1|COMPLETED|Overall Study||41
5033284|NCT02067533|12387514|P2|STARTED|Overall Study||46
5033285|NCT02067533|12387515|P1|STARTED|Overall Study||45
5033286|NCT02067468|12387524|P3|NOT COMPLETED|Overall Study||0
5033287|NCT02067468|12387525|P2|NOT COMPLETED|Overall Study||0
5033288|NCT02067468|12387526|P1|NOT COMPLETED|Overall Study||0
5033289|NCT02067468|12387524|P3|COMPLETED|Overall Study||889
5033290|NCT02067468|12387525|P2|COMPLETED|Overall Study||890
5033291|NCT02067468|12387526|P1|COMPLETED|Overall Study||882
5033292|NCT02067468|12387524|P3|Had at Least One Routine Colposcopy|Overall Study||462
5033293|NCT02067468|12387525|P2|Had at Least One Routine Colposcopy|Overall Study||372
5033294|NCT02067468|12387526|P1|Had at Least One Routine Colposcopy|Overall Study||772
5033295|NCT02067468|12387524|P3|Followed-up Through Medical Records|Overall Study||889
5033296|NCT02067468|12387525|P2|Followed-up Through Medical Records|Overall Study||890
5033297|NCT02067468|12387526|P1|Followed-up Through Medical Records|Overall Study||882
5033298|NCT02067468|12387524|P3|STARTED|Overall Study||889
5033299|NCT02067468|12387525|P2|STARTED|Overall Study||890
5033300|NCT02067468|12387526|P1|STARTED|Overall Study||882
5033301|NCT02067273|12387557|P2|NOT COMPLETED|Overall Study||3
5033302|NCT02067273|12387558|P1|NOT COMPLETED|Overall Study||0
5033303|NCT02067273|12387557|P2|COMPLETED|Overall Study||12
5033304|NCT02067273|12387558|P1|COMPLETED|Overall Study||5
5033305|NCT02067273|12387557|P2|STARTED|Overall Study||15
5033306|NCT02067273|12387558|P1|STARTED|Overall Study||5
5033307|NCT02067104|12387566|P2|NOT COMPLETED|Overall Study||5
5033308|NCT02067104|12387567|P1|NOT COMPLETED|Overall Study||4
5033309|NCT02067104|12387566|P2|COMPLETED|Overall Study||0
5033310|NCT02067104|12387567|P1|COMPLETED|Overall Study||0
5033311|NCT02067104|12387566|P2|STARTED|Overall Study||5
5033312|NCT02067104|12387567|P1|STARTED|Overall Study||4
5033313|NCT02067039|12387577|P2|NOT COMPLETED|Overall Study||508
5033314|NCT02067039|12387578|P1|NOT COMPLETED|Overall Study||573
5033315|NCT02067039|12387577|P2|COMPLETED|Overall Study||832
5033316|NCT02067039|12387578|P1|COMPLETED|Overall Study||752
5033317|NCT02067039|12387577|P2|9 Month Survey|Overall Study||838
5033318|NCT02067039|12387578|P1|9 Month Survey|Overall Study||748
5033319|NCT02067039|12387577|P2|6 Month Survey|Overall Study||756
5033320|NCT02067039|12387578|P1|6 Month Survey|Overall Study||735
5033321|NCT02067039|12387577|P2|3 Month Survey|Overall Study||766
5033322|NCT02067039|12387578|P1|3 Month Survey|Overall Study||824
5033323|NCT02067039|12387577|P2|STARTED|Overall Study||1340
5033324|NCT02067039|12387578|P1|STARTED|Overall Study||1325
5033325|NCT02067000|12387590|P1|NOT COMPLETED|Overall Study||50
5033326|NCT02067000|12387590|P1|COMPLETED|Overall Study||167
5033327|NCT02067000|12387590|P1|STARTED|Overall Study||217
5033328|NCT02066922|12387596|P1|NOT COMPLETED|Overall Study||1
5033329|NCT02066922|12387596|P1|COMPLETED|Overall Study||14
5033330|NCT02066922|12387596|P1|STARTED|Overall Study||15
5033331|NCT02066896|12387606|P2|NOT COMPLETED|Overall Study||0
5033332|NCT02066896|12387607|P1|NOT COMPLETED|Overall Study||0
5033333|NCT02066896|12387606|P2|COMPLETED|Overall Study||33
5033334|NCT02066896|12387607|P1|COMPLETED|Overall Study||33
5033335|NCT02066896|12387606|P2|STARTED|Overall Study||33
5033336|NCT02066896|12387607|P1|STARTED|Overall Study||33
5033337|NCT02066857|12387619|P2|NOT COMPLETED|Overall Study||1
5033338|NCT02066857|12387620|P1|NOT COMPLETED|Overall Study||1
5033339|NCT02066857|12387619|P2|COMPLETED|Overall Study||3
5033340|NCT02066857|12387620|P1|COMPLETED|Overall Study||0
5033341|NCT02066857|12387619|P2|STARTED|Overall Study||4
5033342|NCT02066857|12387620|P1|STARTED|Overall Study||1
5033343|NCT02066792|12387638|P4|NOT COMPLETED|Overall Study||9
5033344|NCT02066792|12387639|P3|NOT COMPLETED|Overall Study||8
5033345|NCT02066792|12387640|P2|NOT COMPLETED|Overall Study||5
5033346|NCT02066792|12387641|P1|NOT COMPLETED|Overall Study||7
5033347|NCT02066792|12387638|P4|COMPLETED|Overall Study||27
5033348|NCT02066792|12387639|P3|COMPLETED|Overall Study||30
5033349|NCT02066792|12387640|P2|COMPLETED|Overall Study||33
5033350|NCT02066792|12387641|P1|COMPLETED|Overall Study||33
5033351|NCT02066792|12387638|P4|STARTED|Overall Study||36
5033352|NCT02066792|12387639|P3|STARTED|Overall Study||38
5033353|NCT02066792|12387640|P2|STARTED|Overall Study||38
5033354|NCT02066792|12387641|P1|STARTED|Overall Study||40
5033355|NCT02066740|12387651|P1|NOT COMPLETED|Overall Study||2
5033356|NCT02066740|12387651|P1|COMPLETED|Overall Study||32
5033357|NCT02066740|12387651|P1|STARTED|Overall Study||34
5033358|NCT02066727|12387658|P2|NOT COMPLETED|Overall Study||0
5033359|NCT02066727|12387659|P1|NOT COMPLETED|Overall Study||0
5033360|NCT02066727|12387658|P2|COMPLETED|Overall Study||30
5033361|NCT02066727|12387659|P1|COMPLETED|Overall Study||30
5033362|NCT02066727|12387658|P2|STARTED|Overall Study||30
5033363|NCT02066727|12387659|P1|STARTED|Overall Study||30
5033364|NCT02066467|12387665|P1|NOT COMPLETED|Overall Study||215
5033365|NCT02066467|12387665|P1|COMPLETED|Overall Study||648
5033366|NCT02066467|12387665|P1|STARTED|Overall Study||863
5033367|NCT02066415|12387674|P3|NOT COMPLETED|Overall Study||8
5033368|NCT02066415|12387675|P2|NOT COMPLETED|Overall Study||7
5033369|NCT02066415|12387676|P1|NOT COMPLETED|Overall Study||21
5033370|NCT02066415|12387674|P3|COMPLETED|Overall Study||182
5033371|NCT02066415|12387675|P2|COMPLETED|Overall Study||184
5033372|NCT02066415|12387676|P1|COMPLETED|Overall Study||265
5033373|NCT02066415|12387674|P3|Received Study Drug|Overall Study||188
5033374|NCT02066415|12387675|P2|Received Study Drug|Overall Study||190
5033375|NCT02066415|12387676|P1|Received Study Drug|Overall Study||282
5033376|NCT02066415|12387674|P3|STARTED|Overall Study||190
5033377|NCT02066415|12387675|P2|STARTED|Overall Study||191
5033378|NCT02066415|12387676|P1|STARTED|Overall Study||286
5033379|NCT02066402|12387701|P2|NOT COMPLETED|Overall Study||23
5033380|NCT02066402|12387702|P1|NOT COMPLETED|Overall Study||26
5033381|NCT02066402|12387701|P2|COMPLETED|Overall Study||275
5033382|NCT02066402|12387702|P1|COMPLETED|Overall Study||274
5033383|NCT02066402|12387701|P2|Completed Study Treatment Period|Overall Study||256
5033384|NCT02066402|12387702|P1|Completed Study Treatment Period|Overall Study||261
5033385|NCT02066402|12387701|P2|Participants Received Treatment|Overall Study||297
5033386|NCT02066402|12387702|P1|Participants Received Treatment|Overall Study||292
5033387|NCT02066402|12387701|P2|STARTED|Overall Study||298
5033388|NCT02066402|12387702|P1|STARTED|Overall Study||300
5033389|NCT02066389|12387734|P6|NOT COMPLETED|Overall Study||5
5033390|NCT02066389|12387735|P5|NOT COMPLETED|Overall Study||7
5033391|NCT02066389|12387736|P4|NOT COMPLETED|Overall Study||3
5033392|NCT02066389|12387737|P3|NOT COMPLETED|Overall Study||6
5033393|NCT02066389|12387738|P2|NOT COMPLETED|Overall Study||1
5033394|NCT02066389|12387739|P1|NOT COMPLETED|Overall Study||5
5033395|NCT02066389|12387734|P6|COMPLETED|Overall Study||45
5033396|NCT02066389|12387735|P5|COMPLETED|Overall Study||43
5033397|NCT02066389|12387736|P4|COMPLETED|Overall Study||47
5033398|NCT02066389|12387737|P3|COMPLETED|Overall Study||44
5033399|NCT02066389|12387738|P2|COMPLETED|Overall Study||49
5033400|NCT02066389|12387739|P1|COMPLETED|Overall Study||45
5033401|NCT02066389|12387734|P6|Received Study Drug|Overall Study||49
5033402|NCT02066389|12387735|P5|Received Study Drug|Overall Study||50
5033403|NCT02066389|12387736|P4|Received Study Drug|Overall Study||50
5033404|NCT02066389|12387737|P3|Received Study Drug|Overall Study||50
5033405|NCT02066389|12387738|P2|Received Study Drug|Overall Study||50
5033406|NCT02066389|12387739|P1|Received Study Drug|Overall Study||50
5033407|NCT02066389|12387734|P6|STARTED|Overall Study||50
5033408|NCT02066389|12387735|P5|STARTED|Overall Study||50
5033409|NCT02066389|12387736|P4|STARTED|Overall Study||50
5033410|NCT02066389|12387737|P3|STARTED|Overall Study||50
5033411|NCT02066389|12387738|P2|STARTED|Overall Study||50
5033412|NCT02066389|12387739|P1|STARTED|Overall Study||50
5033413|NCT02066311|12387789|P1|NOT COMPLETED|Overall Study||5
5033414|NCT02066311|12387789|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
5033415|NCT02066311|12387789|P1|STARTED|Overall Study||15
5033416|NCT02066298|12387799|P6|NOT COMPLETED|Overall Study||12
5033417|NCT02066298|12387800|P5|NOT COMPLETED|Overall Study||9
5033418|NCT02066298|12387801|P4|NOT COMPLETED|Overall Study||6
5033419|NCT02066298|12387802|P3|NOT COMPLETED|Overall Study||10
5033420|NCT02066298|12387803|P2|NOT COMPLETED|Overall Study||8
5033421|NCT02066298|12387804|P1|NOT COMPLETED|Overall Study||9
5033422|NCT02066298|12387799|P6|COMPLETED|Overall Study||38
5033423|NCT02066298|12387800|P5|COMPLETED|Overall Study||38
5033424|NCT02066298|12387801|P4|COMPLETED|Overall Study||45
5033425|NCT02066298|12387802|P3|COMPLETED|Overall Study||40
5033426|NCT02066298|12387803|P2|COMPLETED|Overall Study||40
5033427|NCT02066298|12387804|P1|COMPLETED|Overall Study||40
5033428|NCT02066298|12387799|P6|Completed 3rd Period|Overall Study||38
5033429|NCT02066298|12387800|P5|Completed 3rd Period|Overall Study||38
5033430|NCT02066298|12387801|P4|Completed 3rd Period|Overall Study||45
5033431|NCT02066298|12387802|P3|Completed 3rd Period|Overall Study||40
5033432|NCT02066298|12387803|P2|Completed 3rd Period|Overall Study||40
5033433|NCT02066298|12387804|P1|Completed 3rd Period|Overall Study||40
5033434|NCT02066298|12387799|P6|Completed 2nd Period|Overall Study||41
5033435|NCT02066298|12387800|P5|Completed 2nd Period|Overall Study||42
5033436|NCT02066298|12387801|P4|Completed 2nd Period|Overall Study||46
5033437|NCT02066298|12387802|P3|Completed 2nd Period|Overall Study||41
5033438|NCT02066298|12387803|P2|Completed 2nd Period|Overall Study||41
5033439|NCT02066298|12387804|P1|Completed 2nd Period|Overall Study||41
5033440|NCT02066298|12387799|P6|Completed 1st Period|Overall Study||45
5033441|NCT02066298|12387800|P5|Completed 1st Period|Overall Study||46
5033442|NCT02066298|12387801|P4|Completed 1st Period|Overall Study||48
5033443|NCT02066298|12387802|P3|Completed 1st Period|Overall Study||45
5033444|NCT02066298|12387803|P2|Completed 1st Period|Overall Study||47
5033445|NCT02066298|12387804|P1|Completed 1st Period|Overall Study||44
5033446|NCT02066298|12387799|P6|STARTED|Overall Study||50
5033447|NCT02066298|12387800|P5|STARTED|Overall Study||47
5033448|NCT02066298|12387801|P4|STARTED|Overall Study||51
5033449|NCT02066298|12387802|P3|STARTED|Overall Study||50
5033450|NCT02066298|12387803|P2|STARTED|Overall Study||48
5033451|NCT02066298|12387804|P1|STARTED|Overall Study||49
5033452|NCT02066233|12387828|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
5033453|NCT02066233|12387829|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
5033454|NCT02066233|12387828|P2|COMPLETED|Standard Endoscopy (Day 2)||44
5033455|NCT02066233|12387829|P1|COMPLETED|Standard Endoscopy (Day 2)||44
5033456|NCT02066233|12387828|P2|STARTED|Standard Endoscopy (Day 2)||44
5033457|NCT02066233|12387829|P1|STARTED|Standard Endoscopy (Day 2)||44
5033458|NCT02066233|12387828|P2|NOT COMPLETED|EG Scan II (Day 1)||6
5033459|NCT02066233|12387829|P1|NOT COMPLETED|EG Scan II (Day 1)||6
5033460|NCT02066233|12387828|P2|COMPLETED|EG Scan II (Day 1)||44
5033461|NCT02066233|12387829|P1|COMPLETED|EG Scan II (Day 1)||44
5033462|NCT02066233|12387828|P2|STARTED|EG Scan II (Day 1)||50
5033463|NCT02066233|12387829|P1|STARTED|EG Scan II (Day 1)||50
5033464|NCT02066181|12387839|P2|NOT COMPLETED|Overall Study||1
5033465|NCT02066181|12387840|P1|NOT COMPLETED|Overall Study||1
5033466|NCT02066181|12387839|P2|COMPLETED|Overall Study||36
5033467|NCT02066181|12387840|P1|COMPLETED|Overall Study||49
5033468|NCT02066181|12387839|P2|Crossed Over|Overall Study||28
5033469|NCT02066181|12387840|P1|Crossed Over|Overall Study||0
5033470|NCT02066181|12387839|P2|STARTED|Overall Study||37
5033471|NCT02066181|12387840|P1|STARTED|Overall Study||50
5033472|NCT02066129|12387862|P2|NOT COMPLETED|Overall Study||33
5033473|NCT02066129|12387863|P1|NOT COMPLETED|Overall Study||29
5033474|NCT02066129|12387862|P2|COMPLETED|Overall Study||94
5033475|NCT02066129|12387863|P1|COMPLETED|Overall Study||98
5033476|NCT02066129|12387862|P2|STARTED|Overall Study||127
5033477|NCT02066129|12387863|P1|STARTED|Overall Study||127
5033478|NCT02066051|12387877|P1|NOT COMPLETED|Overall Study||1
5033479|NCT02066051|12387877|P1|COMPLETED|Overall Study||7
5033480|NCT02066051|12387877|P1|STARTED|Overall Study||8
5033481|NCT02065895|12387882|P6|NOT COMPLETED|Overall Study||0
5033482|NCT02065895|12387883|P5|NOT COMPLETED|Overall Study||0
5033483|NCT02065895|12387884|P4|NOT COMPLETED|Overall Study||1
5033484|NCT02065895|12387885|P3|NOT COMPLETED|Overall Study||0
5033485|NCT02065895|12387886|P2|NOT COMPLETED|Overall Study||1
5033486|NCT02065895|12387887|P1|NOT COMPLETED|Overall Study||1
5033487|NCT02065895|12387882|P6|COMPLETED|Overall Study||1
5033488|NCT02065895|12387883|P5|COMPLETED|Overall Study||1
5033489|NCT02065895|12387884|P4|COMPLETED|Overall Study||0
5033490|NCT02065895|12387885|P3|COMPLETED|Overall Study||1
5033491|NCT02065895|12387886|P2|COMPLETED|Overall Study||2
5033492|NCT02065895|12387887|P1|COMPLETED|Overall Study||0
5033493|NCT02065895|12387882|P6|STARTED|Overall Study||1
5033494|NCT02065895|12387883|P5|STARTED|Overall Study||1
5033495|NCT02065895|12387884|P4|STARTED|Overall Study||1
5033496|NCT02065895|12387885|P3|STARTED|Overall Study||1
5033497|NCT02065895|12387886|P2|STARTED|Overall Study||3
5033498|NCT02065895|12387887|P1|STARTED|Overall Study||1
5033499|NCT02065791|12387906|P2|NOT COMPLETED|Overall Study||15
5033500|NCT02065791|12387907|P1|NOT COMPLETED|Overall Study||25
5033501|NCT02065791|12387906|P2|COMPLETED|Overall Study||2187
5033502|NCT02065791|12387907|P1|COMPLETED|Overall Study||2174
5033503|NCT02065791|12387906|P2|Treated|Overall Study||2200
5033504|NCT02065791|12387907|P1|Treated|Overall Study||2197
5033505|NCT02065791|12387906|P2|STARTED|Overall Study||2202
5033506|NCT02065791|12387907|P1|STARTED|Overall Study||2199
5033507|NCT02065518|12387931|P4|NOT COMPLETED|Overall Study||5
5033508|NCT02065518|12387932|P3|NOT COMPLETED|Overall Study||9
5033509|NCT02065518|12387933|P2|NOT COMPLETED|Overall Study||8
5033510|NCT02065518|12387934|P1|NOT COMPLETED|Overall Study||6
5033511|NCT02065518|12387931|P4|COMPLETED|Overall Study||15
5033512|NCT02065518|12387932|P3|COMPLETED|Overall Study||11
5033513|NCT02065518|12387933|P2|COMPLETED|Overall Study||11
5033514|NCT02065518|12387934|P1|COMPLETED|Overall Study||13
5033515|NCT02065518|12387931|P4|STARTED|Overall Study||20
5033516|NCT02065518|12387932|P3|STARTED|Overall Study||20
5033517|NCT02065518|12387933|P2|STARTED|Overall Study||19
5033518|NCT02065518|12387934|P1|STARTED|Overall Study||19
5033519|NCT02065453|12387986|P2|NOT COMPLETED|Overall Study||4
5033520|NCT02065453|12387987|P1|NOT COMPLETED|Overall Study||3
5033521|NCT02065453|12387986|P2|COMPLETED|Overall Study||21
5033522|NCT02065453|12387987|P1|COMPLETED|Overall Study||24
5033523|NCT02065453|12387986|P2|STARTED|Overall Study||25
5033524|NCT02065453|12387987|P1|STARTED|Overall Study||27
5033525|NCT02065336|12388000|P10|NOT COMPLETED|Extension Phase||8
5033526|NCT02065336|12388001|P9|NOT COMPLETED|Extension Phase||2
5033527|NCT02065336|12388002|P8|NOT COMPLETED|Extension Phase||0
5033528|NCT02065336|12388003|P7|NOT COMPLETED|Extension Phase||0
5033529|NCT02065336|12388004|P6|NOT COMPLETED|Extension Phase||0
5033530|NCT02065336|12388005|P5|NOT COMPLETED|Extension Phase||0
5033531|NCT02065336|12388006|P4|NOT COMPLETED|Extension Phase||0
5033532|NCT02065336|12388007|P3|NOT COMPLETED|Extension Phase||0
5033533|NCT02065336|12388008|P2|NOT COMPLETED|Extension Phase||0
5033534|NCT02065336|12388009|P1|NOT COMPLETED|Extension Phase||0
5033535|NCT02065336|12388000|P10|COMPLETED|Extension Phase||0
5033536|NCT02065336|12388001|P9|COMPLETED|Extension Phase||0
5033537|NCT02065336|12388002|P8|COMPLETED|Extension Phase||0
5033538|NCT02065336|12388003|P7|COMPLETED|Extension Phase||0
5033539|NCT02065336|12388004|P6|COMPLETED|Extension Phase||0
5033540|NCT02065336|12388005|P5|COMPLETED|Extension Phase||0
5033541|NCT02065336|12388006|P4|COMPLETED|Extension Phase||0
5033542|NCT02065336|12388007|P3|COMPLETED|Extension Phase||0
5033543|NCT02065336|12388008|P2|COMPLETED|Extension Phase||0
5033544|NCT02065336|12388009|P1|COMPLETED|Extension Phase||0
5033545|NCT02065336|12388000|P10|STARTED|Extension Phase||8
5033546|NCT02065336|12388001|P9|STARTED|Extension Phase||2
5033547|NCT02065336|12388002|P8|STARTED|Extension Phase||0
5033548|NCT02065336|12388003|P7|STARTED|Extension Phase||0
5033549|NCT02065336|12388004|P6|STARTED|Extension Phase||0
5033550|NCT02065336|12388005|P5|STARTED|Extension Phase||0
5033551|NCT02065336|12388006|P4|STARTED|Extension Phase||0
5033552|NCT02065336|12388007|P3|STARTED|Extension Phase||0
5033553|NCT02065336|12388008|P2|STARTED|Extension Phase||0
5033554|NCT02065336|12388009|P1|STARTED|Extension Phase||0
5033555|NCT02065336|12388000|P10|NOT COMPLETED|Main Study||0
5033556|NCT02065336|12388001|P9|NOT COMPLETED|Main Study||0
5033557|NCT02065336|12388002|P8|NOT COMPLETED|Main Study||0
5033558|NCT02065336|12388003|P7|NOT COMPLETED|Main Study||0
5033559|NCT02065336|12388004|P6|NOT COMPLETED|Main Study||0
5033560|NCT02065336|12388005|P5|NOT COMPLETED|Main Study||0
5033561|NCT02065336|12388006|P4|NOT COMPLETED|Main Study||0
5033562|NCT02065336|12388007|P3|NOT COMPLETED|Main Study||0
5033563|NCT02065336|12388008|P2|NOT COMPLETED|Main Study||0
5033564|NCT02065336|12388009|P1|NOT COMPLETED|Main Study||0
5033565|NCT02065336|12388000|P10|COMPLETED|Main Study||0
5033566|NCT02065336|12388001|P9|COMPLETED|Main Study||0
5033567|NCT02065336|12388002|P8|COMPLETED|Main Study||10
5033568|NCT02065336|12388003|P7|COMPLETED|Main Study||12
5033569|NCT02065336|12388004|P6|COMPLETED|Main Study||6
5033570|NCT02065336|12388005|P5|COMPLETED|Main Study||6
5033571|NCT02065336|12388006|P4|COMPLETED|Main Study||6
5033572|NCT02065336|12388007|P3|COMPLETED|Main Study||6
5033573|NCT02065336|12388008|P2|COMPLETED|Main Study||6
5033574|NCT02065336|12388009|P1|COMPLETED|Main Study||6
5033575|NCT02065336|12388000|P10|STARTED|Main Study||0
5033576|NCT02065336|12388001|P9|STARTED|Main Study||0
5033577|NCT02065336|12388002|P8|STARTED|Main Study||10
5033578|NCT02065336|12388003|P7|STARTED|Main Study||12
5033579|NCT02065336|12388004|P6|STARTED|Main Study||6
5033580|NCT02065336|12388005|P5|STARTED|Main Study||6
5033581|NCT02065336|12388006|P4|STARTED|Main Study||6
5033582|NCT02065336|12388007|P3|STARTED|Main Study||6
5033583|NCT02065336|12388008|P2|STARTED|Main Study||6
5033584|NCT02065336|12388009|P1|STARTED|Main Study||6
5033585|NCT02064985|12388104|P3|NOT COMPLETED|Overall Study||0
5033586|NCT02064985|12388105|P2|NOT COMPLETED|Overall Study||0
5033587|NCT02064985|12388106|P1|NOT COMPLETED|Overall Study||0
5033588|NCT02064985|12388104|P3|COMPLETED|Overall Study||12
5033589|NCT02064985|12388105|P2|COMPLETED|Overall Study||12
5033590|NCT02064985|12388106|P1|COMPLETED|Overall Study||12
5033591|NCT02064985|12388104|P3|STARTED|Overall Study||12
5033592|NCT02064985|12388105|P2|STARTED|Overall Study||12
5033593|NCT02064985|12388106|P1|STARTED|Overall Study||12
5033594|NCT02064920|12388269|P2|NOT COMPLETED|Overall Study||9
5033595|NCT02064920|12388270|P1|NOT COMPLETED|Overall Study||1
5033596|NCT02064920|12388269|P2|COMPLETED|Overall Study||21
5033597|NCT02064920|12388270|P1|COMPLETED|Overall Study||5
5033598|NCT02064920|12388269|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
5033599|NCT02064920|12388270|P1|Treated|Overall Study||6
5033600|NCT02064920|12388269|P2|STARTED|Overall Study||30
5033601|NCT02064920|12388270|P1|STARTED|Overall Study||6
5033602|NCT02064907|12388280|P2|NOT COMPLETED|Period 2||0
5033603|NCT02064907|12388281|P1|NOT COMPLETED|Period 2||0
5033604|NCT02064907|12388280|P2|COMPLETED|Period 2||26
5033605|NCT02064907|12388281|P1|COMPLETED|Period 2||26
5033606|NCT02064907|12388280|P2|STARTED|Period 2||26
5033607|NCT02064907|12388281|P1|STARTED|Period 2||26
5033608|NCT02064907|12388280|P2|NOT COMPLETED|Period 1||0
5033609|NCT02064907|12388281|P1|NOT COMPLETED|Period 1||0
5033610|NCT02064907|12388280|P2|COMPLETED|Period 1||26
5033611|NCT02064907|12388281|P1|COMPLETED|Period 1||26
5033612|NCT02064907|12388280|P2|STARTED|Period 1||26
5033613|NCT02064907|12388281|P1|STARTED|Period 1||26
5033614|NCT02064894|12388300|P3|NOT COMPLETED|Overall Study||115
5033615|NCT02064894|12388301|P2|NOT COMPLETED|Overall Study||102
5033616|NCT02064894|12388302|P1|NOT COMPLETED|Overall Study||43
5033617|NCT02064894|12388300|P3|COMPLETED|Overall Study||86
5033618|NCT02064894|12388301|P2|COMPLETED|Overall Study||99
5033619|NCT02064894|12388302|P1|COMPLETED|Overall Study||56
5033620|NCT02064894|12388300|P3|Avalaible at T-90|Overall Study||129
5033621|NCT02064894|12388301|P2|Avalaible at T-90|Overall Study||134
5033622|NCT02064894|12388302|P1|Avalaible at T-90|Overall Study||74
5033623|NCT02064894|12388300|P3|Available at T-60|Overall Study||177
5033624|NCT02064894|12388301|P2|Available at T-60|Overall Study||188
5033625|NCT02064894|12388302|P1|Available at T-60|Overall Study||91
5033626|NCT02064894|12388300|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
5033627|NCT02064894|12388301|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
5033628|NCT02064894|12388302|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
5033629|NCT02064868|12388315|P2|NOT COMPLETED|Overall Study||13
5033630|NCT02064868|12388316|P1|NOT COMPLETED|Overall Study||34
5033631|NCT02064868|12388315|P2|COMPLETED|Overall Study||881
5033632|NCT02064868|12388316|P1|COMPLETED|Overall Study||1722
5033633|NCT02064868|12388315|P2|Per Protocol Set|Overall Study||627
5033634|NCT02064868|12388316|P1|Per Protocol Set|Overall Study||1155
5033635|NCT02064868|12388315|P2|Safety Set|Overall Study||894
5033636|NCT02064868|12388316|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
5033637|NCT02064868|12388315|P2|Full Analysis Set|Overall Study||894
5033638|NCT02064868|12388316|P1|Full Analysis Set|Overall Study||1756
5033639|NCT02064868|12388315|P2|STARTED|Overall Study||894
5033640|NCT02064868|12388316|P1|STARTED|Overall Study||1756
5033641|NCT02064816|12388336|P2|NOT COMPLETED|Overall Study||8
5033642|NCT02064816|12388337|P1|NOT COMPLETED|Overall Study||8
5033643|NCT02064816|12388336|P2|COMPLETED|Overall Study||88
5033644|NCT02064816|12388337|P1|COMPLETED|Overall Study||96
5033645|NCT02064816|12388336|P2|STARTED|Overall Study||96
5033646|NCT02064816|12388337|P1|STARTED|Overall Study||104
5033647|NCT02064439|12388378|P3|NOT COMPLETED|Overall Study||182
5033648|NCT02064439|12388379|P2|NOT COMPLETED|Overall Study||138
5033649|NCT02064439|12388380|P1|NOT COMPLETED|Overall Study||143
5033650|NCT02064439|12388378|P3|COMPLETED|Overall Study||949
5033651|NCT02064439|12388379|P2|COMPLETED|Overall Study||969
5033652|NCT02064439|12388380|P1|COMPLETED|Overall Study||984
5033653|NCT02064439|12388378|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
5033654|NCT02064439|12388379|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
5033655|NCT02064439|12388380|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
5033656|NCT02064387|12388408|P11|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||13
5033657|NCT02064387|12388409|P10|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033658|NCT02064387|12388410|P9|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033659|NCT02064387|12388411|P8|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033660|NCT02064387|12388412|P7|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033661|NCT02064387|12388413|P6|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033662|NCT02064387|12388414|P5|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033663|NCT02064387|12388415|P4|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033664|NCT02064387|12388416|P3|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033665|NCT02064387|12388417|P2|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033666|NCT02064387|12388418|P1|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033667|NCT02064387|12388408|P11|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||22
5033668|NCT02064387|12388409|P10|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033669|NCT02064387|12388410|P9|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033670|NCT02064387|12388411|P8|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033671|NCT02064387|12388412|P7|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033672|NCT02064387|12388413|P6|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033673|NCT02064387|12388414|P5|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033674|NCT02064387|12388415|P4|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033675|NCT02064387|12388416|P3|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033676|NCT02064387|12388417|P2|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033677|NCT02064387|12388418|P1|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033678|NCT02064387|12388408|P11|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||35
5033679|NCT02064387|12388409|P10|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033680|NCT02064387|12388410|P9|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033681|NCT02064387|12388411|P8|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033682|NCT02064387|12388412|P7|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033683|NCT02064387|12388413|P6|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033684|NCT02064387|12388414|P5|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033685|NCT02064387|12388415|P4|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033686|NCT02064387|12388416|P3|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033687|NCT02064387|12388417|P2|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033688|NCT02064387|12388418|P1|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
5033689|NCT02064387|12388408|P11|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033690|NCT02064387|12388409|P10|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033691|NCT02064387|12388410|P9|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033692|NCT02064387|12388411|P8|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
5033693|NCT02064387|12388412|P7|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033694|NCT02064387|12388413|P6|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033695|NCT02064387|12388414|P5|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033696|NCT02064387|12388415|P4|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033697|NCT02064387|12388416|P3|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033698|NCT02064387|12388417|P2|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033699|NCT02064387|12388418|P1|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033700|NCT02064387|12388408|P11|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033701|NCT02064387|12388409|P10|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
5033702|NCT02064387|12388410|P9|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||2
5033703|NCT02064387|12388411|P8|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
5033704|NCT02064387|12388412|P7|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033705|NCT02064387|12388413|P6|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
5033706|NCT02064387|12388414|P5|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033707|NCT02064387|12388415|P4|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033708|NCT02064387|12388416|P3|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033709|NCT02064387|12388417|P2|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033710|NCT02064387|12388418|P1|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033711|NCT02064387|12388408|P11|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||0
5033712|NCT02064387|12388409|P10|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||6
5033713|NCT02064387|12388410|P9|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
5033714|NCT02064387|12388411|P8|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||8
5033715|NCT02064387|12388412|P7|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033716|NCT02064387|12388413|P6|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
5033717|NCT02064387|12388414|P5|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033718|NCT02064387|12388415|P4|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033719|NCT02064387|12388416|P3|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
5033720|NCT02064387|12388417|P2|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033721|NCT02064387|12388418|P1|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
5033722|NCT02064270|12388717|P2|NOT COMPLETED|Overall Study||32
5033723|NCT02064270|12388718|P1|NOT COMPLETED|Overall Study||62
5033724|NCT02064270|12388717|P2|COMPLETED|Overall Study||231
5033725|NCT02064270|12388718|P1|COMPLETED|Overall Study||201
5033726|NCT02064270|12388717|P2|STARTED|Overall Study||263
5033727|NCT02064270|12388718|P1|STARTED|Overall Study||263
5033728|NCT02064231|12388733|P4|NOT COMPLETED|Third Test Period (Own Product)||0
5033729|NCT02064231|12388734|P3|NOT COMPLETED|Third Test Period (Own Product)||0
5033730|NCT02064231|12388735|P2|NOT COMPLETED|Third Test Period (Own Product)||0
5033731|NCT02064231|12388736|P1|NOT COMPLETED|Third Test Period (Own Product)||0
5033732|NCT02064231|12388733|P4|COMPLETED|Third Test Period (Own Product)||1
5033733|NCT02064231|12388734|P3|COMPLETED|Third Test Period (Own Product)||0
5033734|NCT02064231|12388735|P2|COMPLETED|Third Test Period (Own Product)||8
5033735|NCT02064231|12388736|P1|COMPLETED|Third Test Period (Own Product)||8
5033736|NCT02064231|12388733|P4|STARTED|Third Test Period (Own Product)||1
5033737|NCT02064231|12388734|P3|STARTED|Third Test Period (Own Product)||0
5033738|NCT02064231|12388735|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
5033739|NCT02064231|12388736|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
5033740|NCT02064231|12388733|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
5033741|NCT02064231|12388734|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
5033742|NCT02064231|12388735|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
5033743|NCT02064231|12388736|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
5033744|NCT02064231|12388733|P4|COMPLETED|Second Test Period (Test B or Test D)||1
5033745|NCT02064231|12388734|P3|COMPLETED|Second Test Period (Test B or Test D)||0
5033746|NCT02064231|12388735|P2|COMPLETED|Second Test Period (Test B or Test D)||7
5033747|NCT02064231|12388736|P1|COMPLETED|Second Test Period (Test B or Test D)||6
5033748|NCT02064231|12388733|P4|STARTED|Second Test Period (Test B or Test D)||1
5033749|NCT02064231|12388734|P3|STARTED|Second Test Period (Test B or Test D)||0
5033750|NCT02064231|12388735|P2|STARTED|Second Test Period (Test B or Test D)||8
5033751|NCT02064231|12388736|P1|STARTED|Second Test Period (Test B or Test D)||7
5033752|NCT02064231|12388733|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
5033753|NCT02064231|12388734|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
5033754|NCT02064231|12388735|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
5033755|NCT02064231|12388736|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
5033756|NCT02064231|12388733|P4|COMPLETED|First Test Period (Test A or Test C)||1
5033757|NCT02064231|12388734|P3|COMPLETED|First Test Period (Test A or Test C)||0
5033758|NCT02064231|12388735|P2|COMPLETED|First Test Period (Test A or Test C)||8
5033759|NCT02064231|12388736|P1|COMPLETED|First Test Period (Test A or Test C)||7
5033760|NCT02064231|12388733|P4|STARTED|First Test Period (Test A or Test C)||1
5033761|NCT02064231|12388734|P3|STARTED|First Test Period (Test A or Test C)||1
5033762|NCT02064231|12388735|P2|STARTED|First Test Period (Test A or Test C)||12
5033763|NCT02064231|12388736|P1|STARTED|First Test Period (Test A or Test C)||14
5033764|NCT02064205|12388748|P1|NOT COMPLETED|Overall Study||1
5033765|NCT02064205|12388748|P1|COMPLETED|Overall Study||31
5033766|NCT02064205|12388748|P1|Condition D|Overall Study||32
5033767|NCT02064205|12388748|P1|Condition C|Overall Study||31
5033768|NCT02064205|12388748|P1|Condition B|Overall Study||32
5033769|NCT02064205|12388748|P1|Condition A|Overall Study||32
5033770|NCT02064205|12388748|P1|STARTED|Overall Study||32
5033771|NCT02064166|12388766|P2|NOT COMPLETED|Overall Study||0
5033772|NCT02064166|12388767|P1|NOT COMPLETED|Overall Study||1
5033773|NCT02064166|12388766|P2|COMPLETED|Overall Study||6
5033774|NCT02064166|12388767|P1|COMPLETED|Overall Study||8
5033775|NCT02064166|12388766|P2|STARTED|Overall Study||6
5033776|NCT02064166|12388767|P1|STARTED|Overall Study||9
5033777|NCT02063880|12388797|P2|NOT COMPLETED|Overall Study||27
5033778|NCT02063880|12388798|P1|NOT COMPLETED|Overall Study||28
5033779|NCT02063880|12388797|P2|COMPLETED|Overall Study||66
5033780|NCT02063880|12388798|P1|COMPLETED|Overall Study||62
5033781|NCT02063880|12388797|P2|STARTED|Overall Study||93
5033782|NCT02063880|12388798|P1|STARTED|Overall Study||90
5033783|NCT02063867|12388810|P2|NOT COMPLETED|Overall Study||2965
5033784|NCT02063867|12388811|P1|NOT COMPLETED|Overall Study||4291
5033785|NCT02063867|12388810|P2|COMPLETED|Overall Study||180048
5033786|NCT02063867|12388811|P1|COMPLETED|Overall Study||152598
5033787|NCT02063867|12388810|P2|STARTED|Overall Study||183013
5033788|NCT02063867|12388811|P1|STARTED|Overall Study||156889
5033789|NCT02063854|12388836|P7|NOT COMPLETED|Overall Study||6
5033790|NCT02063854|12388837|P6|NOT COMPLETED|Overall Study||31
5033791|NCT02063854|12388838|P5|NOT COMPLETED|Overall Study||11
5033792|NCT02063854|12388839|P4|NOT COMPLETED|Overall Study||10
5033793|NCT02063854|12388840|P3|NOT COMPLETED|Overall Study||30
5033794|NCT02063854|12388841|P2|NOT COMPLETED|Overall Study||12
5033795|NCT02063854|12388842|P1|NOT COMPLETED|Overall Study||21
5033796|NCT02063854|12388836|P7|COMPLETED|Overall Study||60
5033797|NCT02063854|12388837|P6|COMPLETED|Overall Study||170
5033798|NCT02063854|12388838|P5|COMPLETED|Overall Study||54
5033799|NCT02063854|12388839|P4|COMPLETED|Overall Study||58
5033800|NCT02063854|12388840|P3|COMPLETED|Overall Study||176
5033801|NCT02063854|12388841|P2|COMPLETED|Overall Study||54
5033802|NCT02063854|12388842|P1|COMPLETED|Overall Study||178
5033803|NCT02063854|12388836|P7|Full Analysis Set: Received Study Drug|Overall Study||66
5033804|NCT02063854|12388837|P6|Full Analysis Set: Received Study Drug|Overall Study||200
5033805|NCT02063854|12388838|P5|Full Analysis Set: Received Study Drug|Overall Study||65
5033806|NCT02063854|12388839|P4|Full Analysis Set: Received Study Drug|Overall Study||68
5033807|NCT02063854|12388840|P3|Full Analysis Set: Received Study Drug|Overall Study||206
5033808|NCT02063854|12388841|P2|Full Analysis Set: Received Study Drug|Overall Study||66
5033809|NCT02063854|12388842|P1|Full Analysis Set: Received Study Drug|Overall Study||199
5033810|NCT02063854|12388836|P7|STARTED|Overall Study||66
5033811|NCT02063854|12388837|P6|STARTED|Overall Study||201
5033812|NCT02063854|12388838|P5|STARTED|Overall Study||65
5033813|NCT02063854|12388839|P4|STARTED|Overall Study||68
5033814|NCT02063854|12388840|P3|STARTED|Overall Study||206
5033815|NCT02063854|12388841|P2|STARTED|Overall Study||66
5033816|NCT02063854|12388842|P1|STARTED|Overall Study||199
5033817|NCT02063737|12388926|P2|NOT COMPLETED|Overall Study||4
5033818|NCT02063737|12388927|P1|NOT COMPLETED|Overall Study||11
5033819|NCT02063737|12388926|P2|COMPLETED|Overall Study||44
5033820|NCT02063737|12388927|P1|COMPLETED|Overall Study||41
5033821|NCT02063737|12388926|P2|STARTED|Overall Study||48
5033822|NCT02063737|12388927|P1|STARTED|Overall Study||52
5033823|NCT02063724|12388959|P1|NOT COMPLETED|Overall Study||1
5033824|NCT02063724|12388959|P1|COMPLETED|Overall Study||14
5033825|NCT02063724|12388959|P1|STARTED|Overall Study||15
5033826|NCT02063698|12388967|P2|NOT COMPLETED|Overall Study||2
5033827|NCT02063698|12388968|P1|NOT COMPLETED|Overall Study||1
5033828|NCT02063698|12388967|P2|COMPLETED|Overall Study||13
5033829|NCT02063698|12388968|P1|COMPLETED|Overall Study||14
5033830|NCT02063698|12388967|P2|STARTED|Overall Study||15
5033831|NCT02063698|12388968|P1|STARTED|Overall Study||15
5033832|NCT02063672|12388992|P2|NOT COMPLETED|Overall Study||22
5033833|NCT02063672|12388993|P1|NOT COMPLETED|Overall Study||35
5033834|NCT02063672|12388992|P2|COMPLETED|Overall Study||7
5033835|NCT02063672|12388993|P1|COMPLETED|Overall Study||18
5033836|NCT02063672|12388992|P2|STARTED|Overall Study||29
5033837|NCT02063672|12388993|P1|STARTED|Overall Study||53
5033838|NCT02063659|12389040|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
5033839|NCT02063659|12389041|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5033840|NCT02063659|12389042|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5033841|NCT02063659|12389043|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5033842|NCT02063659|12389040|P4|COMPLETED|Open-Label Extension Period (OLE)||47
5033843|NCT02063659|12389041|P3|COMPLETED|Open-Label Extension Period (OLE)||0
5033844|NCT02063659|12389042|P2|COMPLETED|Open-Label Extension Period (OLE)||0
5033845|NCT02063659|12389043|P1|COMPLETED|Open-Label Extension Period (OLE)||0
5033846|NCT02063659|12389040|P4|STARTED|Open-Label Extension Period (OLE)||67
5033847|NCT02063659|12389041|P3|STARTED|Open-Label Extension Period (OLE)||0
5033848|NCT02063659|12389042|P2|STARTED|Open-Label Extension Period (OLE)||0
5033849|NCT02063659|12389043|P1|STARTED|Open-Label Extension Period (OLE)||0
5033850|NCT02063659|12389040|P4|NOT COMPLETED|Double-Blind Treatment Period||0
5033851|NCT02063659|12389041|P3|NOT COMPLETED|Double-Blind Treatment Period||3
5033852|NCT02063659|12389042|P2|NOT COMPLETED|Double-Blind Treatment Period||3
5033853|NCT02063659|12389043|P1|NOT COMPLETED|Double-Blind Treatment Period||2
5033854|NCT02063659|12389040|P4|COMPLETED|Double-Blind Treatment Period||0
5033855|NCT02063659|12389041|P3|COMPLETED|Double-Blind Treatment Period||22
5033856|NCT02063659|12389042|P2|COMPLETED|Double-Blind Treatment Period||22
5033857|NCT02063659|12389043|P1|COMPLETED|Double-Blind Treatment Period||24
5033858|NCT02063659|12389040|P4|STARTED|Double-Blind Treatment Period||0
5033859|NCT02063659|12389041|P3|STARTED|Double-Blind Treatment Period||25
5033860|NCT02063659|12389042|P2|STARTED|Double-Blind Treatment Period||25
5033861|NCT02063659|12389043|P1|STARTED|Double-Blind Treatment Period||26
5033862|NCT02063516|12389075|P2|NOT COMPLETED|Overall Study||0
5033863|NCT02063516|12389076|P1|NOT COMPLETED|Overall Study||0
5033864|NCT02063516|12389075|P2|COMPLETED|Overall Study||40
5033865|NCT02063516|12389076|P1|COMPLETED|Overall Study||40
5033866|NCT02063516|12389075|P2|STARTED|Overall Study||40
5033867|NCT02063516|12389076|P1|STARTED|Overall Study||40
5033868|NCT02063230|12389090|P4|NOT COMPLETED|Overall Study||0
5033869|NCT02063230|12389091|P3|NOT COMPLETED|Overall Study||0
5033870|NCT02063230|12389092|P2|NOT COMPLETED|Overall Study||0
5033871|NCT02063230|12389093|P1|NOT COMPLETED|Overall Study||0
5033872|NCT02063230|12389090|P4|COMPLETED|Overall Study||8
5033873|NCT02063230|12389091|P3|COMPLETED|Overall Study||8
5033874|NCT02063230|12389092|P2|COMPLETED|Overall Study||8
5033875|NCT02063230|12389093|P1|COMPLETED|Overall Study||8
5033876|NCT02063230|12389090|P4|Received Treatment|Overall Study||8
5033877|NCT02063230|12389091|P3|Received Treatment|Overall Study||8
5033878|NCT02063230|12389092|P2|Received Treatment|Overall Study||8
5033879|NCT02063230|12389093|P1|Received Treatment|Overall Study||8
5033880|NCT02063230|12389090|P4|STARTED|Overall Study||8
5033881|NCT02063230|12389091|P3|STARTED|Overall Study||8
5033882|NCT02063230|12389092|P2|STARTED|Overall Study||8
5033883|NCT02063230|12389093|P1|STARTED|Overall Study||8
5033884|NCT02063217|12389126|P3|NOT COMPLETED|Overall Study||0
5033885|NCT02063217|12389127|P2|NOT COMPLETED|Overall Study||0
5033886|NCT02063217|12389128|P1|NOT COMPLETED|Overall Study||1
5033887|NCT02063217|12389126|P3|COMPLETED|Overall Study||12
5033888|NCT02063217|12389127|P2|COMPLETED|Overall Study||12
5033889|NCT02063217|12389128|P1|COMPLETED|Overall Study||11
5033890|NCT02063217|12389126|P3|STARTED|Overall Study||12
5033891|NCT02063217|12389127|P2|STARTED|Overall Study||12
5033892|NCT02063217|12389128|P1|STARTED|Overall Study||12
5033893|NCT02063178|12389138|P2|NOT COMPLETED|Overall Study||47
5033894|NCT02063178|12389139|P1|NOT COMPLETED|Overall Study||29
5033895|NCT02063178|12389138|P2|COMPLETED|Overall Study||77
5033896|NCT02063178|12389139|P1|COMPLETED|Overall Study||95
5033897|NCT02063178|12389138|P2|STARTED|Overall Study||124
5033898|NCT02063178|12389139|P1|STARTED|Overall Study||124
5033899|NCT02063087|12389153|P2|NOT COMPLETED|7 Day Follow-up||0
5033900|NCT02063087|12389154|P1|NOT COMPLETED|7 Day Follow-up||0
5033901|NCT02063087|12389153|P2|COMPLETED|7 Day Follow-up||478
5033902|NCT02063087|12389154|P1|COMPLETED|7 Day Follow-up||493
5033903|NCT02063087|12389153|P2|STARTED|7 Day Follow-up||478
5033904|NCT02063087|12389154|P1|STARTED|7 Day Follow-up||493
5033905|NCT02063087|12389153|P2|NOT COMPLETED|Emergency Department Intervention||0
5033906|NCT02063087|12389154|P1|NOT COMPLETED|Emergency Department Intervention||0
5033907|NCT02063087|12389153|P2|COMPLETED|Emergency Department Intervention||478
5033908|NCT02063087|12389154|P1|COMPLETED|Emergency Department Intervention||493
5033909|NCT02063087|12389153|P2|STARTED|Emergency Department Intervention||478
5033910|NCT02063087|12389154|P1|STARTED|Emergency Department Intervention||493
5033911|NCT02063035|12389178|P2|NOT COMPLETED|Overall Study||0
5033912|NCT02063035|12389179|P1|NOT COMPLETED|Overall Study||0
5033913|NCT02063035|12389178|P2|COMPLETED|Overall Study||17
5033914|NCT02063035|12389179|P1|COMPLETED|Overall Study||12
5033915|NCT02063035|12389178|P2|STARTED|Overall Study||17
5033916|NCT02063035|12389179|P1|STARTED|Overall Study||12
5033917|NCT02062905|12389193|P2|NOT COMPLETED|Overall Study||2
5033918|NCT02062905|12389194|P1|NOT COMPLETED|Overall Study||7
5033919|NCT02062905|12389193|P2|COMPLETED|Overall Study||31
5033920|NCT02062905|12389194|P1|COMPLETED|Overall Study||28
5033921|NCT02062905|12389193|P2|STARTED|Overall Study||33
5033922|NCT02062905|12389194|P1|STARTED|Overall Study||35
5033923|NCT02062879|12389204|P2|NOT COMPLETED|Overall Study||1
5033924|NCT02062879|12389205|P1|NOT COMPLETED|Overall Study||4
5033925|NCT02062879|12389204|P2|COMPLETED|Overall Study||9
5033926|NCT02062879|12389205|P1|COMPLETED|Overall Study||6
5033927|NCT02062879|12389204|P2|STARTED|Overall Study||10
5033928|NCT02062879|12389205|P1|STARTED|Overall Study||10
5033929|NCT02062801|12389217|P2|NOT COMPLETED|Overall Study||4
5033930|NCT02062801|12389218|P1|NOT COMPLETED|Overall Study||2
5033931|NCT02062801|12389217|P2|COMPLETED|Overall Study||297
5033932|NCT02062801|12389218|P1|COMPLETED|Overall Study||299
5033933|NCT02062801|12389217|P2|STARTED|Overall Study||301
5033934|NCT02062801|12389218|P1|STARTED|Overall Study||301
5033935|NCT02062710|12389228|P6|NOT COMPLETED|Overall Study||0
5033936|NCT02062710|12389229|P5|NOT COMPLETED|Overall Study||0
5033937|NCT02062710|12389230|P4|NOT COMPLETED|Overall Study||0
5033938|NCT02062710|12389231|P3|NOT COMPLETED|Overall Study||0
5033939|NCT02062710|12389232|P2|NOT COMPLETED|Overall Study||0
5033940|NCT02062710|12389233|P1|NOT COMPLETED|Overall Study||0
5033941|NCT02062710|12389228|P6|COMPLETED|Overall Study||4
5033942|NCT02062710|12389229|P5|COMPLETED|Overall Study||3
5033943|NCT02062710|12389230|P4|COMPLETED|Overall Study||3
5033944|NCT02062710|12389231|P3|COMPLETED|Overall Study||5
5033945|NCT02062710|12389232|P2|COMPLETED|Overall Study||4
5033946|NCT02062710|12389233|P1|COMPLETED|Overall Study||3
5033947|NCT02062710|12389228|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
5033948|NCT02062710|12389229|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
5033949|NCT02062710|12389230|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
5033950|NCT02062710|12389231|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
5033951|NCT02062710|12389232|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
5033952|NCT02062710|12389233|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
5033953|NCT02062658|12389241|P1|NOT COMPLETED|Overall Study||2
5033954|NCT02062658|12389241|P1|COMPLETED|Overall Study||8
5033955|NCT02062658|12389241|P1|STARTED|Overall Study||10
5033956|NCT02062645|12389245|P1|NOT COMPLETED|Overall Study||15
5033957|NCT02062645|12389245|P1|COMPLETED|Overall Study||100
5033958|NCT02062645|12389245|P1|STARTED|Overall Study||115
5033959|NCT02062632|12389253|P1|NOT COMPLETED|Overall Study||1
5033960|NCT02062632|12389253|P1|COMPLETED|Overall Study||2
5033961|NCT02062632|12389253|P1|STARTED|Overall Study||3
5033962|NCT02062580|12389262|P2|NOT COMPLETED|Overall Study||13
5033963|NCT02062580|12389263|P1|NOT COMPLETED|Overall Study||12
5033964|NCT02062580|12389262|P2|COMPLETED|Overall Study||65
5033965|NCT02062580|12389263|P1|COMPLETED|Overall Study||59
5033966|NCT02062580|12389262|P2|STARTED|Overall Study||78
5033967|NCT02062580|12389263|P1|STARTED|Overall Study||71
5033968|NCT02062502|12389273|P2|NOT COMPLETED|Overall Study||35
5033969|NCT02062502|12389274|P1|NOT COMPLETED|Overall Study||43
5033970|NCT02062502|12389273|P2|COMPLETED|Overall Study||270
5033971|NCT02062502|12389274|P1|COMPLETED|Overall Study||263
5033972|NCT02062502|12389273|P2|Vaccinated Dose 1|Overall Study||305
5033973|NCT02062502|12389274|P1|Vaccinated Dose 1|Overall Study||306
5033974|NCT02062502|12389273|P2|STARTED|Overall Study||305
5033975|NCT02062502|12389274|P1|STARTED|Overall Study||306
5033976|NCT02062450|12389294|P1|NOT COMPLETED|Overall Study||124
5033977|NCT02062450|12389294|P1|COMPLETED|Overall Study||255
5033978|NCT02062450|12389294|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
5033979|NCT02062450|12389294|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
5033980|NCT02062437|12389308|P1|NOT COMPLETED|Overall Study||52
5033981|NCT02062437|12389308|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
5033982|NCT02062437|12389308|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
5033983|NCT02062398|12389317|P1|NOT COMPLETED|Overall Study||1
5033984|NCT02062398|12389317|P1|COMPLETED|Overall Study||12
5033985|NCT02062398|12389317|P1|STARTED|Overall Study||13
5033986|NCT02062385|12389329|P4|NOT COMPLETED|Overall Study||9
5033987|NCT02062385|12389330|P3|NOT COMPLETED|Overall Study||12
5033988|NCT02062385|12389331|P2|NOT COMPLETED|Overall Study||65
5033989|NCT02062385|12389332|P1|NOT COMPLETED|Overall Study||78
5033990|NCT02062385|12389329|P4|COMPLETED|Overall Study||391
5033991|NCT02062385|12389330|P3|COMPLETED|Overall Study||388
5033992|NCT02062385|12389331|P2|COMPLETED|Overall Study||1555
5033993|NCT02062385|12389332|P1|COMPLETED|Overall Study||1542
5033994|NCT02062385|12389329|P4|Received Vaccination 3|Overall Study||392
5033995|NCT02062385|12389330|P3|Received Vaccination 3|Overall Study||389
5033996|NCT02062385|12389331|P2|Received Vaccination 3|Overall Study||1554
5033997|NCT02062385|12389332|P1|Received Vaccination 3|Overall Study||1543
5033998|NCT02062385|12389329|P4|Received Vaccination 2|Overall Study||393
5033999|NCT02062385|12389330|P3|Received Vaccination 2|Overall Study||392
5034000|NCT02062385|12389331|P2|Received Vaccination 2|Overall Study||1566
5034001|NCT02062385|12389332|P1|Received Vaccination 2|Overall Study||1554
5034002|NCT02062385|12389329|P4|Received Vaccination 1|Overall Study||400
5034003|NCT02062385|12389330|P3|Received Vaccination 1|Overall Study||400
5034004|NCT02062385|12389331|P2|Received Vaccination 1|Overall Study||1619
5034005|NCT02062385|12389332|P1|Received Vaccination 1|Overall Study||1618
5034006|NCT02062385|12389329|P4|STARTED|Overall Study||400
5034007|NCT02062385|12389330|P3|STARTED|Overall Study||400
5034008|NCT02062385|12389331|P2|STARTED|Overall Study||1620
5034009|NCT02062385|12389332|P1|STARTED|Overall Study||1620
5034010|NCT02062359|12389352|P1|NOT COMPLETED|Overall Study||0
5034011|NCT02062359|12389352|P1|COMPLETED|Overall Study||2
5034012|NCT02062359|12389352|P1|STARTED|Overall Study||2
5034013|NCT02062294|12389358|P1|NOT COMPLETED|Overall Study||0
5034014|NCT02062294|12389358|P1|COMPLETED|Overall Study||14
5034015|NCT02062294|12389358|P1|STARTED|Overall Study||14
5034016|NCT02062177|12389365|P2|NOT COMPLETED|Overall Study||0
5034017|NCT02062177|12389366|P1|NOT COMPLETED|Overall Study||0
5034018|NCT02062177|12389365|P2|COMPLETED|Overall Study||70
5034019|NCT02062177|12389366|P1|COMPLETED|Overall Study||70
5034020|NCT02062177|12389365|P2|STARTED|Overall Study||70
5034021|NCT02062177|12389366|P1|STARTED|Overall Study||70
5034022|NCT02062151|12389376|P1|NOT COMPLETED|Overall Study||1
5034023|NCT02062151|12389376|P1|COMPLETED|Overall Study||20
5034024|NCT02062151|12389376|P1|STARTED|Overall Study||21
5034025|NCT02061969|12389383|P2|NOT COMPLETED|Overall Study||0
5034026|NCT02061969|12389384|P1|NOT COMPLETED|Overall Study||0
5034027|NCT02061969|12389383|P2|COMPLETED|Overall Study||67
5034028|NCT02061969|12389384|P1|COMPLETED|Overall Study||73
5034029|NCT02061969|12389383|P2|STARTED|Overall Study||67
5034030|NCT02061969|12389384|P1|STARTED|Overall Study||73
5034031|NCT02061774|12389414|P2|NOT COMPLETED|Overall Study||0
5034032|NCT02061774|12389415|P1|NOT COMPLETED|Overall Study||0
5034033|NCT02061774|12389414|P2|COMPLETED|Overall Study||11
5034034|NCT02061774|12389415|P1|COMPLETED|Overall Study||10
5034035|NCT02061774|12389414|P2|STARTED|Overall Study||11
5034036|NCT02061774|12389415|P1|STARTED|Overall Study||10
5034037|NCT02061748|12389429|P2|NOT COMPLETED|Overall Study||0
5034038|NCT02061748|12389430|P1|NOT COMPLETED|Overall Study||0
5034039|NCT02061748|12389429|P2|COMPLETED|Overall Study||30853
5034040|NCT02061748|12389430|P1|COMPLETED|Overall Study||7646
5034041|NCT02061748|12389429|P2|STARTED|Overall Study||30853
5034042|NCT02061748|12389430|P1|STARTED|Overall Study||7646
5034043|NCT02061696|12389504|P2|NOT COMPLETED|Overall Study||0
5034044|NCT02061696|12389505|P1|NOT COMPLETED|Overall Study||0
5034045|NCT02061696|12389504|P2|COMPLETED|Overall Study||22
5034046|NCT02061696|12389505|P1|COMPLETED|Overall Study||17
5034047|NCT02061696|12389504|P2|STARTED|Overall Study||22
5034048|NCT02061696|12389505|P1|STARTED|Overall Study||17
5034049|NCT02061683|12389529|P1|NOT COMPLETED|Overall Study||60
5034050|NCT02061683|12389529|P1|COMPLETED|Overall Study||203
5034051|NCT02061683|12389529|P1|STARTED|Overall Study||263
5034052|NCT02061592|12389536|P2|NOT COMPLETED|Period 2||1
5034053|NCT02061592|12389537|P1|NOT COMPLETED|Period 2||0
5034054|NCT02061592|12389536|P2|COMPLETED|Period 2||61
5034055|NCT02061592|12389537|P1|COMPLETED|Period 2||64
5034056|NCT02061592|12389536|P2|STARTED|Period 2||62
5034057|NCT02061592|12389537|P1|STARTED|Period 2||64
5034058|NCT02061592|12389536|P2|NOT COMPLETED|Period 1||0
5034059|NCT02061592|12389537|P1|NOT COMPLETED|Period 1||2
5034060|NCT02061592|12389536|P2|COMPLETED|Period 1||62
5034061|NCT02061592|12389537|P1|COMPLETED|Period 1||64
5034062|NCT02061592|12389536|P2|STARTED|Period 1||62
5034063|NCT02061592|12389537|P1|STARTED|Period 1||66
5034064|NCT02061540|12389549|P1|NOT COMPLETED|Overall Study||4
5034065|NCT02061540|12389549|P1|COMPLETED|Overall Study||23
5034066|NCT02061540|12389549|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
5034067|NCT02061540|12389549|P1|STARTED|Overall Study||27
5034068|NCT02061358|12389571|P9|NOT COMPLETED|Overall Study||0
5034069|NCT02061358|12389572|P8|NOT COMPLETED|Overall Study||0
5034070|NCT02061358|12389573|P7|NOT COMPLETED|Overall Study||0
5034071|NCT02061358|12389574|P6|NOT COMPLETED|Overall Study||0
5034072|NCT02061358|12389575|P5|NOT COMPLETED|Overall Study||0
5034073|NCT02061358|12389576|P4|NOT COMPLETED|Overall Study||0
5034074|NCT02061358|12389577|P3|NOT COMPLETED|Overall Study||0
5034075|NCT02061358|12389578|P2|NOT COMPLETED|Overall Study||0
5034076|NCT02061358|12389579|P1|NOT COMPLETED|Overall Study||0
5034077|NCT02061358|12389571|P9|COMPLETED|Overall Study||16
5034078|NCT02061358|12389572|P8|COMPLETED|Overall Study||6
5034079|NCT02061358|12389573|P7|COMPLETED|Overall Study||6
5034080|NCT02061358|12389574|P6|COMPLETED|Overall Study||6
5034081|NCT02061358|12389575|P5|COMPLETED|Overall Study||6
5034082|NCT02061358|12389576|P4|COMPLETED|Overall Study||6
5034083|NCT02061358|12389577|P3|COMPLETED|Overall Study||6
5034084|NCT02061358|12389578|P2|COMPLETED|Overall Study||6
5034085|NCT02061358|12389579|P1|COMPLETED|Overall Study||6
5034086|NCT02061358|12389571|P9|STARTED|Overall Study||16
5034087|NCT02061358|12389572|P8|STARTED|Overall Study||6
5034088|NCT02061358|12389573|P7|STARTED|Overall Study||6
5034089|NCT02061358|12389574|P6|STARTED|Overall Study||6
5034090|NCT02061358|12389575|P5|STARTED|Overall Study||6
5034091|NCT02061358|12389576|P4|STARTED|Overall Study||6
5034092|NCT02061358|12389577|P3|STARTED|Overall Study||6
5034093|NCT02061358|12389578|P2|STARTED|Overall Study||6
5034094|NCT02061358|12389579|P1|STARTED|Overall Study||6
5034095|NCT02061280|12389717|P2|NOT COMPLETED|Overall Study||12
5034096|NCT02061280|12389718|P1|NOT COMPLETED|Overall Study||18
5034097|NCT02061280|12389717|P2|COMPLETED|Overall Study||25
5034098|NCT02061280|12389718|P1|COMPLETED|Overall Study||53
5034099|NCT02061280|12389717|P2|Randomized to Treatment|Overall Study||25
5034100|NCT02061280|12389718|P1|Randomized to Treatment|Overall Study||54
5034101|NCT02061280|12389717|P2|STARTED|Overall Study||37
5034102|NCT02061280|12389718|P1|STARTED|Overall Study||71
5034103|NCT02061202|12389750|P2|NOT COMPLETED|Overall Study||1
5034104|NCT02061202|12389751|P1|NOT COMPLETED|Overall Study||1
5034105|NCT02061202|12389750|P2|COMPLETED|Overall Study||17
5034106|NCT02061202|12389751|P1|COMPLETED|Overall Study||35
5034107|NCT02061202|12389750|P2|STARTED|Overall Study||18
5034108|NCT02061202|12389751|P1|STARTED|Overall Study||36
5034109|NCT02060890|12389775|P1|NOT COMPLETED|Overall Study||4
5034110|NCT02060890|12389775|P1|COMPLETED|Overall Study||16
5034111|NCT02060890|12389775|P1|STARTED|Overall Study||20
5034112|NCT02060838|12389784|P2|NOT COMPLETED|Overall Study||0
5034113|NCT02060838|12389785|P1|NOT COMPLETED|Overall Study||0
5034114|NCT02060838|12389784|P2|COMPLETED|Overall Study||22
5034115|NCT02060838|12389785|P1|COMPLETED|Overall Study||28
5034116|NCT02060838|12389784|P2|STARTED|Overall Study||22
5034117|NCT02060838|12389785|P1|STARTED|Overall Study||28
5034118|NCT02060539|12389793|P1|NOT COMPLETED|Overall Study||0
5034119|NCT02060539|12389793|P1|COMPLETED|Overall Study||19
5034120|NCT02060539|12389793|P1|STARTED|Overall Study||19
5034121|NCT02060526|12389841|P3|NOT COMPLETED|Overall Study||0
5034122|NCT02060526|12389842|P2|NOT COMPLETED|Overall Study||0
5034123|NCT02060526|12389843|P1|NOT COMPLETED|Overall Study||0
5034124|NCT02060526|12389841|P3|COMPLETED|Overall Study||7
5034125|NCT02060526|12389842|P2|COMPLETED|Overall Study||7
5034126|NCT02060526|12389843|P1|COMPLETED|Overall Study||7
5034127|NCT02060526|12389841|P3|STARTED|Overall Study||7
5034128|NCT02060526|12389842|P2|STARTED|Overall Study||7
5034129|NCT02060526|12389843|P1|STARTED|Overall Study||7
5034130|NCT02060461|12389879|P1|NOT COMPLETED|Overall Study||0
5034131|NCT02060461|12389879|P1|COMPLETED|Overall Study||33
5034132|NCT02060461|12389879|P1|STARTED|Overall Study||33
5034133|NCT02060383|12389890|P5|NOT COMPLETED|Extension Phase||7
5034134|NCT02060383|12389891|P4|NOT COMPLETED|Extension Phase||2
5034135|NCT02060383|12389892|P3|NOT COMPLETED|Extension Phase||3
5034136|NCT02060383|12389893|P2|NOT COMPLETED|Extension Phase||3
5034137|NCT02060383|12389894|P1|NOT COMPLETED|Extension Phase||3
5034138|NCT02060383|12389890|P5|COMPLETED|Extension Phase||46
5034139|NCT02060383|12389891|P4|COMPLETED|Extension Phase||19
5034140|NCT02060383|12389892|P3|COMPLETED|Extension Phase||7
5034141|NCT02060383|12389893|P2|COMPLETED|Extension Phase||14
5034142|NCT02060383|12389894|P1|COMPLETED|Extension Phase||14
5034143|NCT02060383|12389890|P5|STARTED|Extension Phase||53
5034144|NCT02060383|12389891|P4|STARTED|Extension Phase||21
5034145|NCT02060383|12389892|P3|STARTED|Extension Phase||10
5034146|NCT02060383|12389893|P2|STARTED|Extension Phase||17
5034147|NCT02060383|12389894|P1|STARTED|Extension Phase||17
5034148|NCT02060383|12389890|P5|NOT COMPLETED|Core Phase||8
5034149|NCT02060383|12389891|P4|NOT COMPLETED|Core Phase||7
5034150|NCT02060383|12389892|P3|NOT COMPLETED|Core Phase||0
5034151|NCT02060383|12389893|P2|NOT COMPLETED|Core Phase||6
5034152|NCT02060383|12389894|P1|NOT COMPLETED|Core Phase||3
5034153|NCT02060383|12389890|P5|COMPLETED|Core Phase||95
5034154|NCT02060383|12389891|P4|COMPLETED|Core Phase||39
5034155|NCT02060383|12389892|P3|COMPLETED|Core Phase||19
5034156|NCT02060383|12389893|P2|COMPLETED|Core Phase||37
5034157|NCT02060383|12389894|P1|COMPLETED|Core Phase||35
5034158|NCT02060383|12389890|P5|Completed Core/Did Not Enter Extension|Core Phase||42
5034159|NCT02060383|12389891|P4|Completed Core/Did Not Enter Extension|Core Phase||18
5034160|NCT02060383|12389892|P3|Completed Core/Did Not Enter Extension|Core Phase||9
5034161|NCT02060383|12389893|P2|Completed Core/Did Not Enter Extension|Core Phase||20
5034162|NCT02060383|12389894|P1|Completed Core/Did Not Enter Extension|Core Phase||18
5034163|NCT02060383|12389890|P5|Completed Core/Entered Extension|Core Phase||53
5034164|NCT02060383|12389891|P4|Completed Core/Entered Extension|Core Phase||21
5034165|NCT02060383|12389892|P3|Completed Core/Entered Extension|Core Phase||10
5034166|NCT02060383|12389893|P2|Completed Core/Entered Extension|Core Phase||17
5034167|NCT02060383|12389894|P1|Completed Core/Entered Extension|Core Phase||17
5034168|NCT02060383|12389890|P5|STARTED|Core Phase||103
5034169|NCT02060383|12389891|P4|STARTED|Core Phase||46
5034170|NCT02060383|12389892|P3|STARTED|Core Phase||19
5034171|NCT02060383|12389893|P2|STARTED|Core Phase||43
5034172|NCT02060383|12389894|P1|STARTED|Core Phase||38
5034173|NCT02060370|12389920|P1|NOT COMPLETED|Overall Study||1
5034174|NCT02060370|12389920|P1|COMPLETED|Overall Study||59
5034175|NCT02060370|12389920|P1|STARTED|Overall Study||60
5034176|NCT02060058|12389932|P3|NOT COMPLETED|Overall Study||0
5034177|NCT02060058|12389933|P2|NOT COMPLETED|Overall Study||0
5034178|NCT02060058|12389934|P1|NOT COMPLETED|Overall Study||0
5034179|NCT02060058|12389932|P3|COMPLETED|Overall Study||8
5034180|NCT02060058|12389933|P2|COMPLETED|Overall Study||0
5034181|NCT02060058|12389934|P1|COMPLETED|Overall Study||4
5034182|NCT02060058|12389932|P3|STARTED|Overall Study||8
5034183|NCT02060058|12389933|P2|STARTED|Overall Study||0
5034184|NCT02060058|12389934|P1|STARTED|Overall Study||4
5034185|NCT02059993|12389950|P2|NOT COMPLETED|Overall Study||4
5034186|NCT02059993|12389951|P1|NOT COMPLETED|Overall Study||2
5034187|NCT02059993|12389950|P2|COMPLETED|Overall Study||37
5034188|NCT02059993|12389951|P1|COMPLETED|Overall Study||40
5034189|NCT02059993|12389950|P2|STARTED|Overall Study||41
5034190|NCT02059993|12389951|P1|STARTED|Overall Study||42
5034191|NCT02059980|12389961|P2|NOT COMPLETED|Overall Study||1
5034192|NCT02059980|12389962|P1|NOT COMPLETED|Overall Study||2
5034193|NCT02059980|12389961|P2|COMPLETED|Overall Study||14
5034194|NCT02059980|12389962|P1|COMPLETED|Overall Study||16
5034195|NCT02059980|12389961|P2|STARTED|Overall Study||15
5034196|NCT02059980|12389962|P1|STARTED|Overall Study||18
5034197|NCT02059928|12389974|P1|NOT COMPLETED|Overall Study||0
5034198|NCT02059928|12389974|P1|COMPLETED|Overall Study||20
5034199|NCT02059928|12389974|P1|STARTED|Overall Study||20
5034200|NCT02059902|12389980|P2|NOT COMPLETED|Overall Study||4
5034201|NCT02059902|12389981|P1|NOT COMPLETED|Overall Study||4
5034202|NCT02059902|12389980|P2|COMPLETED|Overall Study||14
5034203|NCT02059902|12389981|P1|COMPLETED|Overall Study||14
5034204|NCT02059902|12389980|P2|STARTED|Overall Study||18
5034205|NCT02059902|12389981|P1|STARTED|Overall Study||18
5034206|NCT02059642|12389989|P2|NOT COMPLETED|Overall Study||24
5034207|NCT02059642|12389990|P1|NOT COMPLETED|Overall Study||27
5034208|NCT02059642|12389989|P2|COMPLETED|Overall Study||128
5034209|NCT02059642|12389990|P1|COMPLETED|Overall Study||121
5034210|NCT02059642|12389989|P2|STARTED|Overall Study||152
5034211|NCT02059642|12389990|P1|STARTED|Overall Study||148
5034212|NCT02059434|12390007|P9|NOT COMPLETED|Period 8||0
5034213|NCT02059434|12390008|P8|NOT COMPLETED|Period 8||0
5034214|NCT02059434|12390009|P7|NOT COMPLETED|Period 8||0
5034215|NCT02059434|12390010|P6|NOT COMPLETED|Period 8||0
5034216|NCT02059434|12390011|P5|NOT COMPLETED|Period 8||0
5034217|NCT02059434|12390012|P4|NOT COMPLETED|Period 8||0
5034218|NCT02059434|12390013|P3|NOT COMPLETED|Period 8||0
5034219|NCT02059434|12390014|P2|NOT COMPLETED|Period 8||0
5034220|NCT02059434|12390015|P1|NOT COMPLETED|Period 8||0
5034221|NCT02059434|12390007|P9|COMPLETED|Period 8||34
5034222|NCT02059434|12390008|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034223|NCT02059434|12390009|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034224|NCT02059434|12390010|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034225|NCT02059434|12390011|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034226|NCT02059434|12390012|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034227|NCT02059434|12390013|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034228|NCT02059434|12390014|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034229|NCT02059434|12390015|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
5034230|NCT02059434|12390007|P9|STARTED|Period 8||34
5034231|NCT02059434|12390008|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034232|NCT02059434|12390009|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034233|NCT02059434|12390010|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034234|NCT02059434|12390011|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034235|NCT02059434|12390012|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034236|NCT02059434|12390013|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034237|NCT02059434|12390014|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034238|NCT02059434|12390015|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
5034239|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
5034240|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034241|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034242|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034243|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034244|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034245|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034246|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034247|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
5034248|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 7 and 8||34
5034249|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034250|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034251|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034252|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034253|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034254|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034255|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034256|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034257|NCT02059434|12390007|P9|STARTED|Washout Between Periods 7 and 8||36
5034258|NCT02059434|12390008|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034259|NCT02059434|12390009|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034260|NCT02059434|12390010|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034261|NCT02059434|12390011|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034262|NCT02059434|12390012|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034263|NCT02059434|12390013|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034264|NCT02059434|12390014|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034265|NCT02059434|12390015|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
5034266|NCT02059434|12390007|P9|NOT COMPLETED|Period 7||0
5034267|NCT02059434|12390008|P8|NOT COMPLETED|Period 7||0
5034268|NCT02059434|12390009|P7|NOT COMPLETED|Period 7||0
5034269|NCT02059434|12390010|P6|NOT COMPLETED|Period 7||0
5034270|NCT02059434|12390011|P5|NOT COMPLETED|Period 7||0
5034271|NCT02059434|12390012|P4|NOT COMPLETED|Period 7||0
5034272|NCT02059434|12390013|P3|NOT COMPLETED|Period 7||0
5034273|NCT02059434|12390014|P2|NOT COMPLETED|Period 7||0
5034274|NCT02059434|12390015|P1|NOT COMPLETED|Period 7||0
5034275|NCT02059434|12390007|P9|COMPLETED|Period 7||36
5034276|NCT02059434|12390008|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034277|NCT02059434|12390009|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034278|NCT02059434|12390010|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034279|NCT02059434|12390011|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034280|NCT02059434|12390012|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034281|NCT02059434|12390013|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034282|NCT02059434|12390014|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034283|NCT02059434|12390015|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
5034284|NCT02059434|12390007|P9|STARTED|Period 7||36
5034285|NCT02059434|12390008|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034286|NCT02059434|12390009|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034287|NCT02059434|12390010|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034288|NCT02059434|12390011|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034289|NCT02059434|12390012|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034290|NCT02059434|12390013|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034291|NCT02059434|12390014|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034292|NCT02059434|12390015|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
5034293|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
5034294|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034295|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034296|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034297|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034298|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034299|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034300|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034301|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
5034302|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 6 and 7||36
5034303|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034304|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034305|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034306|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034307|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034308|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034309|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034310|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034311|NCT02059434|12390007|P9|STARTED|Washout Between Periods 6 and 7||37
5034312|NCT02059434|12390008|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034313|NCT02059434|12390009|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034314|NCT02059434|12390010|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034315|NCT02059434|12390011|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034316|NCT02059434|12390012|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034317|NCT02059434|12390013|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034318|NCT02059434|12390014|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034319|NCT02059434|12390015|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
5034320|NCT02059434|12390007|P9|NOT COMPLETED|Period 6||0
5034321|NCT02059434|12390008|P8|NOT COMPLETED|Period 6||0
5034322|NCT02059434|12390009|P7|NOT COMPLETED|Period 6||0
5034323|NCT02059434|12390010|P6|NOT COMPLETED|Period 6||0
5034324|NCT02059434|12390011|P5|NOT COMPLETED|Period 6||0
5034325|NCT02059434|12390012|P4|NOT COMPLETED|Period 6||0
5034326|NCT02059434|12390013|P3|NOT COMPLETED|Period 6||0
5034327|NCT02059434|12390014|P2|NOT COMPLETED|Period 6||0
5034328|NCT02059434|12390015|P1|NOT COMPLETED|Period 6||0
5034329|NCT02059434|12390007|P9|COMPLETED|Period 6||37
5034330|NCT02059434|12390008|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034331|NCT02059434|12390009|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034332|NCT02059434|12390010|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034333|NCT02059434|12390011|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034334|NCT02059434|12390012|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034335|NCT02059434|12390013|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034336|NCT02059434|12390014|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034337|NCT02059434|12390015|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
5034338|NCT02059434|12390007|P9|STARTED|Period 6||37
5034339|NCT02059434|12390008|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034340|NCT02059434|12390009|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034341|NCT02059434|12390010|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034342|NCT02059434|12390011|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034343|NCT02059434|12390012|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034344|NCT02059434|12390013|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034345|NCT02059434|12390014|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034346|NCT02059434|12390015|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
5034347|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034348|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034349|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034350|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034351|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034352|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034353|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034354|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034355|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
5034356|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 5 and 6||37
5034357|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034358|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034359|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034360|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034361|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034362|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034363|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034364|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034365|NCT02059434|12390007|P9|STARTED|Washout Between Periods 5 and 6||37
5034366|NCT02059434|12390008|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034367|NCT02059434|12390009|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034368|NCT02059434|12390010|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034369|NCT02059434|12390011|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034370|NCT02059434|12390012|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034371|NCT02059434|12390013|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034372|NCT02059434|12390014|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034373|NCT02059434|12390015|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
5034374|NCT02059434|12390007|P9|NOT COMPLETED|Period 5||0
5034375|NCT02059434|12390008|P8|NOT COMPLETED|Period 5||0
5034376|NCT02059434|12390009|P7|NOT COMPLETED|Period 5||0
5034377|NCT02059434|12390010|P6|NOT COMPLETED|Period 5||0
5034378|NCT02059434|12390011|P5|NOT COMPLETED|Period 5||0
5034379|NCT02059434|12390012|P4|NOT COMPLETED|Period 5||0
5034380|NCT02059434|12390013|P3|NOT COMPLETED|Period 5||0
5034381|NCT02059434|12390014|P2|NOT COMPLETED|Period 5||0
5034382|NCT02059434|12390015|P1|NOT COMPLETED|Period 5||0
5034383|NCT02059434|12390007|P9|COMPLETED|Period 5||37
5034384|NCT02059434|12390008|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034385|NCT02059434|12390009|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034386|NCT02059434|12390010|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034387|NCT02059434|12390011|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034388|NCT02059434|12390012|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034389|NCT02059434|12390013|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034390|NCT02059434|12390014|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034391|NCT02059434|12390015|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
5034392|NCT02059434|12390007|P9|STARTED|Period 5||37
5034393|NCT02059434|12390008|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034394|NCT02059434|12390009|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034395|NCT02059434|12390010|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034396|NCT02059434|12390011|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034397|NCT02059434|12390012|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034398|NCT02059434|12390013|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034399|NCT02059434|12390014|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034400|NCT02059434|12390015|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
5034401|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
5034402|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034403|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034404|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034405|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034406|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034407|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034408|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034409|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
5034410|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 4 and 5||37
5034411|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034412|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034413|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034414|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034415|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034416|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034417|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034418|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034419|NCT02059434|12390007|P9|STARTED|Washout Between Periods 4 and 5||38
5034420|NCT02059434|12390008|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034421|NCT02059434|12390009|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034422|NCT02059434|12390010|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034423|NCT02059434|12390011|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034424|NCT02059434|12390012|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034425|NCT02059434|12390013|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034426|NCT02059434|12390014|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034427|NCT02059434|12390015|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
5034428|NCT02059434|12390007|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034429|NCT02059434|12390008|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034430|NCT02059434|12390009|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034431|NCT02059434|12390010|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034432|NCT02059434|12390011|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034433|NCT02059434|12390012|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034434|NCT02059434|12390013|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034435|NCT02059434|12390014|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034436|NCT02059434|12390015|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
5034437|NCT02059434|12390007|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
5034438|NCT02059434|12390008|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034439|NCT02059434|12390009|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034440|NCT02059434|12390010|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034441|NCT02059434|12390011|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034442|NCT02059434|12390012|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034443|NCT02059434|12390013|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034444|NCT02059434|12390014|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034445|NCT02059434|12390015|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034446|NCT02059434|12390007|P9|STARTED|Period 4 (After Screening/run-in Period)||38
5034447|NCT02059434|12390008|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034448|NCT02059434|12390009|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034449|NCT02059434|12390010|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034450|NCT02059434|12390011|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034451|NCT02059434|12390012|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034452|NCT02059434|12390013|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034453|NCT02059434|12390014|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034454|NCT02059434|12390015|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
5034455|NCT02059434|12390007|P9|NOT COMPLETED|Period 3||0
5034456|NCT02059434|12390008|P8|NOT COMPLETED|Period 3||0
5034457|NCT02059434|12390009|P7|NOT COMPLETED|Period 3||0
5034458|NCT02059434|12390010|P6|NOT COMPLETED|Period 3||0
5034459|NCT02059434|12390011|P5|NOT COMPLETED|Period 3||0
5034460|NCT02059434|12390012|P4|NOT COMPLETED|Period 3||0
5034461|NCT02059434|12390013|P3|NOT COMPLETED|Period 3||0
5034462|NCT02059434|12390014|P2|NOT COMPLETED|Period 3||0
5034463|NCT02059434|12390015|P1|NOT COMPLETED|Period 3||0
5034464|NCT02059434|12390007|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034465|NCT02059434|12390008|P8|COMPLETED|Period 3||2
5034466|NCT02059434|12390009|P7|COMPLETED|Period 3||2
5034467|NCT02059434|12390010|P6|COMPLETED|Period 3||2
5034468|NCT02059434|12390011|P5|COMPLETED|Period 3||2
5034469|NCT02059434|12390012|P4|COMPLETED|Period 3||2
5034470|NCT02059434|12390013|P3|COMPLETED|Period 3||2
5034471|NCT02059434|12390014|P2|COMPLETED|Period 3||2
5034472|NCT02059434|12390015|P1|COMPLETED|Period 3||2
5034473|NCT02059434|12390007|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034474|NCT02059434|12390008|P8|STARTED|Period 3||2
5034475|NCT02059434|12390009|P7|STARTED|Period 3||2
5034476|NCT02059434|12390010|P6|STARTED|Period 3||2
5034477|NCT02059434|12390011|P5|STARTED|Period 3||2
5034478|NCT02059434|12390012|P4|STARTED|Period 3||2
5034479|NCT02059434|12390013|P3|STARTED|Period 3||2
5034480|NCT02059434|12390014|P2|STARTED|Period 3||2
5034481|NCT02059434|12390015|P1|STARTED|Period 3||2
5034482|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034483|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034484|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034485|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034486|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034487|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034488|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034489|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034490|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
5034491|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034492|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 2 and 3||2
5034493|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 2 and 3||2
5034494|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 2 and 3||2
5034495|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 2 and 3||2
5034496|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 2 and 3||2
5034497|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 2 and 3||2
5034498|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 2 and 3||2
5034499|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 2 and 3||2
5034500|NCT02059434|12390007|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034501|NCT02059434|12390008|P8|STARTED|Washout Between Periods 2 and 3||2
5034502|NCT02059434|12390009|P7|STARTED|Washout Between Periods 2 and 3||2
5034503|NCT02059434|12390010|P6|STARTED|Washout Between Periods 2 and 3||2
5034504|NCT02059434|12390011|P5|STARTED|Washout Between Periods 2 and 3||2
5034505|NCT02059434|12390012|P4|STARTED|Washout Between Periods 2 and 3||2
5034506|NCT02059434|12390013|P3|STARTED|Washout Between Periods 2 and 3||2
5034507|NCT02059434|12390014|P2|STARTED|Washout Between Periods 2 and 3||2
5034508|NCT02059434|12390015|P1|STARTED|Washout Between Periods 2 and 3||2
5034509|NCT02059434|12390007|P9|NOT COMPLETED|Period 2||0
5034510|NCT02059434|12390008|P8|NOT COMPLETED|Period 2||0
5034511|NCT02059434|12390009|P7|NOT COMPLETED|Period 2||0
5034512|NCT02059434|12390010|P6|NOT COMPLETED|Period 2||0
5034513|NCT02059434|12390011|P5|NOT COMPLETED|Period 2||0
5034514|NCT02059434|12390012|P4|NOT COMPLETED|Period 2||0
5034515|NCT02059434|12390013|P3|NOT COMPLETED|Period 2||0
5034516|NCT02059434|12390014|P2|NOT COMPLETED|Period 2||0
5034517|NCT02059434|12390015|P1|NOT COMPLETED|Period 2||0
5034518|NCT02059434|12390007|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034519|NCT02059434|12390008|P8|COMPLETED|Period 2||2
5034520|NCT02059434|12390009|P7|COMPLETED|Period 2||2
5034521|NCT02059434|12390010|P6|COMPLETED|Period 2||2
5034522|NCT02059434|12390011|P5|COMPLETED|Period 2||2
5034523|NCT02059434|12390012|P4|COMPLETED|Period 2||2
5034524|NCT02059434|12390013|P3|COMPLETED|Period 2||2
5034525|NCT02059434|12390014|P2|COMPLETED|Period 2||2
5034526|NCT02059434|12390015|P1|COMPLETED|Period 2||2
5034527|NCT02059434|12390007|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034528|NCT02059434|12390008|P8|STARTED|Period 2||2
5034529|NCT02059434|12390009|P7|STARTED|Period 2||2
5034530|NCT02059434|12390010|P6|STARTED|Period 2||2
5034531|NCT02059434|12390011|P5|STARTED|Period 2||2
5034532|NCT02059434|12390012|P4|STARTED|Period 2||2
5034533|NCT02059434|12390013|P3|STARTED|Period 2||2
5034534|NCT02059434|12390014|P2|STARTED|Period 2||2
5034535|NCT02059434|12390015|P1|STARTED|Period 2||2
5034536|NCT02059434|12390007|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034537|NCT02059434|12390008|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
5034538|NCT02059434|12390009|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034539|NCT02059434|12390010|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034540|NCT02059434|12390011|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034541|NCT02059434|12390012|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034542|NCT02059434|12390013|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034543|NCT02059434|12390014|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034544|NCT02059434|12390015|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
5034545|NCT02059434|12390007|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034546|NCT02059434|12390008|P8|COMPLETED|Washout Between Periods 1 and 2||2
5034547|NCT02059434|12390009|P7|COMPLETED|Washout Between Periods 1 and 2||2
5034548|NCT02059434|12390010|P6|COMPLETED|Washout Between Periods 1 and 2||2
5034549|NCT02059434|12390011|P5|COMPLETED|Washout Between Periods 1 and 2||2
5034550|NCT02059434|12390012|P4|COMPLETED|Washout Between Periods 1 and 2||2
5034551|NCT02059434|12390013|P3|COMPLETED|Washout Between Periods 1 and 2||2
5034552|NCT02059434|12390014|P2|COMPLETED|Washout Between Periods 1 and 2||2
5034553|NCT02059434|12390015|P1|COMPLETED|Washout Between Periods 1 and 2||2
5034554|NCT02059434|12390007|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034555|NCT02059434|12390008|P8|STARTED|Washout Between Periods 1 and 2||3
5034556|NCT02059434|12390009|P7|STARTED|Washout Between Periods 1 and 2||2
5034557|NCT02059434|12390010|P6|STARTED|Washout Between Periods 1 and 2||2
5034558|NCT02059434|12390011|P5|STARTED|Washout Between Periods 1 and 2||2
5034559|NCT02059434|12390012|P4|STARTED|Washout Between Periods 1 and 2||2
5034560|NCT02059434|12390013|P3|STARTED|Washout Between Periods 1 and 2||2
5034561|NCT02059434|12390014|P2|STARTED|Washout Between Periods 1 and 2||2
5034562|NCT02059434|12390015|P1|STARTED|Washout Between Periods 1 and 2||2
5034563|NCT02059434|12390007|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034564|NCT02059434|12390008|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034565|NCT02059434|12390009|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034566|NCT02059434|12390010|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034567|NCT02059434|12390011|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034568|NCT02059434|12390012|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034569|NCT02059434|12390013|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034570|NCT02059434|12390014|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034571|NCT02059434|12390015|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
5034572|NCT02059434|12390007|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034573|NCT02059434|12390008|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
5034574|NCT02059434|12390009|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034575|NCT02059434|12390010|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034576|NCT02059434|12390011|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034577|NCT02059434|12390012|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034578|NCT02059434|12390013|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034579|NCT02059434|12390014|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034580|NCT02059434|12390015|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
5034581|NCT02059434|12390007|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
5034582|NCT02059434|12390008|P8|STARTED|Period 1 (After Screening/run-in Period)||3
5034583|NCT02059434|12390009|P7|STARTED|Period 1 (After Screening/run-in Period)||2
5034584|NCT02059434|12390010|P6|STARTED|Period 1 (After Screening/run-in Period)||2
5034585|NCT02059434|12390011|P5|STARTED|Period 1 (After Screening/run-in Period)||2
5034586|NCT02059434|12390012|P4|STARTED|Period 1 (After Screening/run-in Period)||2
5034587|NCT02059434|12390013|P3|STARTED|Period 1 (After Screening/run-in Period)||2
5034588|NCT02059434|12390014|P2|STARTED|Period 1 (After Screening/run-in Period)||2
5034589|NCT02059434|12390015|P1|STARTED|Period 1 (After Screening/run-in Period)||2
5034590|NCT02059408|12390080|P3|NOT COMPLETED|Overall Study||358
5034591|NCT02059408|12390081|P2|NOT COMPLETED|Overall Study||330
5034592|NCT02059408|12390082|P1|NOT COMPLETED|Overall Study||0
5034593|NCT02059408|12390080|P3|COMPLETED|Overall Study||258
5034594|NCT02059408|12390081|P2|COMPLETED|Overall Study||269
5034595|NCT02059408|12390082|P1|COMPLETED|Overall Study||604
5034596|NCT02059408|12390080|P3|STARTED|Overall Study||616
5034597|NCT02059408|12390081|P2|STARTED|Overall Study||599
5034598|NCT02059408|12390082|P1|STARTED|Overall Study||604
5034599|NCT02059395|12390101|P2|NOT COMPLETED|Overall Study||4
5034600|NCT02059395|12390102|P1|NOT COMPLETED|Overall Study||2
5034601|NCT02059395|12390101|P2|COMPLETED|Overall Study||23
5034602|NCT02059395|12390102|P1|COMPLETED|Overall Study||20
5034603|NCT02059395|12390101|P2|STARTED|Overall Study||27
5034604|NCT02059395|12390102|P1|STARTED|Overall Study||22
5034605|NCT02059291|12390117|P25|NOT COMPLETED|Epoch 4||0
5034606|NCT02059291|12390118|P24|NOT COMPLETED|Epoch 4||1
5034607|NCT02059291|12390119|P23|NOT COMPLETED|Epoch 4||1
5034608|NCT02059291|12390120|P22|NOT COMPLETED|Epoch 4||0
5034609|NCT02059291|12390121|P21|NOT COMPLETED|Epoch 4||1
5034610|NCT02059291|12390122|P20|NOT COMPLETED|Epoch 4||0
5034611|NCT02059291|12390123|P19|NOT COMPLETED|Epoch 4||0
5034612|NCT02059291|12390124|P18|NOT COMPLETED|Epoch 4||0
5034613|NCT02059291|12390125|P17|NOT COMPLETED|Epoch 4||2
5034614|NCT02059291|12390126|P16|NOT COMPLETED|Epoch 4||0
5034615|NCT02059291|12390127|P15|NOT COMPLETED|Epoch 4||0
5034616|NCT02059291|12390128|P14|NOT COMPLETED|Epoch 4||0
5034617|NCT02059291|12390129|P13|NOT COMPLETED|Epoch 4||0
5034618|NCT02059291|12390130|P12|NOT COMPLETED|Epoch 4||0
5034619|NCT02059291|12390131|P11|NOT COMPLETED|Epoch 4||0
5034620|NCT02059291|12390132|P10|NOT COMPLETED|Epoch 4||0
5034621|NCT02059291|12390133|P9|NOT COMPLETED|Epoch 4||0
5034622|NCT02059291|12390134|P8|NOT COMPLETED|Epoch 4||0
5034623|NCT02059291|12390135|P7|NOT COMPLETED|Epoch 4||0
5034624|NCT02059291|12390136|P6|NOT COMPLETED|Epoch 4||0
5034625|NCT02059291|12390137|P5|NOT COMPLETED|Epoch 4||0
5034626|NCT02059291|12390138|P4|NOT COMPLETED|Epoch 4||0
5034627|NCT02059291|12390139|P3|NOT COMPLETED|Epoch 4||0
5034628|NCT02059291|12390140|P2|NOT COMPLETED|Epoch 4||0
5034629|NCT02059291|12390141|P1|NOT COMPLETED|Epoch 4||0
5034630|NCT02059291|12390117|P25|COMPLETED|Epoch 4||0
5034631|NCT02059291|12390118|P24|COMPLETED|Epoch 4||21
5034632|NCT02059291|12390119|P23|COMPLETED|Epoch 4||30
5034633|NCT02059291|12390120|P22|COMPLETED|Epoch 4||14
5034634|NCT02059291|12390121|P21|COMPLETED|Epoch 4||33
5034635|NCT02059291|12390122|P20|COMPLETED|Epoch 4||18
5034636|NCT02059291|12390123|P19|COMPLETED|Epoch 4||2
5034637|NCT02059291|12390124|P18|COMPLETED|Epoch 4||14
5034638|NCT02059291|12390125|P17|COMPLETED|Epoch 4||41
5034639|NCT02059291|12390126|P16|COMPLETED|Epoch 4||0
5034640|NCT02059291|12390127|P15|COMPLETED|Epoch 4||0
5034641|NCT02059291|12390128|P14|COMPLETED|Epoch 4||0
5034642|NCT02059291|12390129|P13|COMPLETED|Epoch 4||0
5034643|NCT02059291|12390130|P12|COMPLETED|Epoch 4||0
5034644|NCT02059291|12390131|P11|COMPLETED|Epoch 4||0
5034645|NCT02059291|12390132|P10|COMPLETED|Epoch 4||0
5034646|NCT02059291|12390133|P9|COMPLETED|Epoch 4||0
5034647|NCT02059291|12390134|P8|COMPLETED|Epoch 4||0
5034648|NCT02059291|12390135|P7|COMPLETED|Epoch 4||0
5034649|NCT02059291|12390136|P6|COMPLETED|Epoch 4||0
5034650|NCT02059291|12390137|P5|COMPLETED|Epoch 4||0
5034651|NCT02059291|12390138|P4|COMPLETED|Epoch 4||0
5034652|NCT02059291|12390139|P3|COMPLETED|Epoch 4||0
5034653|NCT02059291|12390140|P2|COMPLETED|Epoch 4||0
5034654|NCT02059291|12390141|P1|COMPLETED|Epoch 4||0
5034655|NCT02059291|12390117|P25|STARTED|Epoch 4||0
5034656|NCT02059291|12390118|P24|STARTED|Epoch 4||22
5034657|NCT02059291|12390119|P23|STARTED|Epoch 4||31
5034658|NCT02059291|12390120|P22|STARTED|Epoch 4||14
5034659|NCT02059291|12390121|P21|STARTED|Epoch 4||34
5034660|NCT02059291|12390122|P20|STARTED|Epoch 4||18
5034661|NCT02059291|12390123|P19|STARTED|Epoch 4||2
5034662|NCT02059291|12390124|P18|STARTED|Epoch 4||14
5034663|NCT02059291|12390125|P17|STARTED|Epoch 4||43
5034664|NCT02059291|12390126|P16|STARTED|Epoch 4||0
5034665|NCT02059291|12390127|P15|STARTED|Epoch 4||0
5034666|NCT02059291|12390128|P14|STARTED|Epoch 4||0
5034667|NCT02059291|12390129|P13|STARTED|Epoch 4||0
5034668|NCT02059291|12390130|P12|STARTED|Epoch 4||0
5034669|NCT02059291|12390131|P11|STARTED|Epoch 4||0
5034670|NCT02059291|12390132|P10|STARTED|Epoch 4||0
5034671|NCT02059291|12390133|P9|STARTED|Epoch 4||0
5034672|NCT02059291|12390134|P8|STARTED|Epoch 4||0
5034673|NCT02059291|12390135|P7|STARTED|Epoch 4||0
5034674|NCT02059291|12390136|P6|STARTED|Epoch 4||0
5034675|NCT02059291|12390137|P5|STARTED|Epoch 4||0
5034676|NCT02059291|12390138|P4|STARTED|Epoch 4||0
5034677|NCT02059291|12390139|P3|STARTED|Epoch 4||0
5034678|NCT02059291|12390140|P2|STARTED|Epoch 4||0
5034679|NCT02059291|12390141|P1|STARTED|Epoch 4||0
5034680|NCT02059291|12390117|P25|NOT COMPLETED|Epoch 3||0
5034681|NCT02059291|12390118|P24|NOT COMPLETED|Epoch 3||0
5034682|NCT02059291|12390119|P23|NOT COMPLETED|Epoch 3||0
5034683|NCT02059291|12390120|P22|NOT COMPLETED|Epoch 3||0
5034684|NCT02059291|12390121|P21|NOT COMPLETED|Epoch 3||0
5034685|NCT02059291|12390122|P20|NOT COMPLETED|Epoch 3||0
5034686|NCT02059291|12390123|P19|NOT COMPLETED|Epoch 3||0
5034687|NCT02059291|12390124|P18|NOT COMPLETED|Epoch 3||0
5034688|NCT02059291|12390125|P17|NOT COMPLETED|Epoch 3||0
5034689|NCT02059291|12390126|P16|NOT COMPLETED|Epoch 3||6
5034690|NCT02059291|12390127|P15|NOT COMPLETED|Epoch 3||0
5034691|NCT02059291|12390128|P14|NOT COMPLETED|Epoch 3||1
5034692|NCT02059291|12390129|P13|NOT COMPLETED|Epoch 3||0
5034693|NCT02059291|12390130|P12|NOT COMPLETED|Epoch 3||0
5034694|NCT02059291|12390131|P11|NOT COMPLETED|Epoch 3||0
5034695|NCT02059291|12390132|P10|NOT COMPLETED|Epoch 3||0
5034696|NCT02059291|12390133|P9|NOT COMPLETED|Epoch 3||0
5034697|NCT02059291|12390134|P8|NOT COMPLETED|Epoch 3||0
5034698|NCT02059291|12390135|P7|NOT COMPLETED|Epoch 3||0
5034699|NCT02059291|12390136|P6|NOT COMPLETED|Epoch 3||0
5034700|NCT02059291|12390137|P5|NOT COMPLETED|Epoch 3||0
5034701|NCT02059291|12390138|P4|NOT COMPLETED|Epoch 3||0
5034702|NCT02059291|12390139|P3|NOT COMPLETED|Epoch 3||0
5034703|NCT02059291|12390140|P2|NOT COMPLETED|Epoch 3||0
5034704|NCT02059291|12390141|P1|NOT COMPLETED|Epoch 3||0
5034705|NCT02059291|12390117|P25|COMPLETED|Epoch 3||0
5034706|NCT02059291|12390118|P24|COMPLETED|Epoch 3||0
5034707|NCT02059291|12390119|P23|COMPLETED|Epoch 3||0
5034708|NCT02059291|12390120|P22|COMPLETED|Epoch 3||0
5034709|NCT02059291|12390121|P21|COMPLETED|Epoch 3||0
5034710|NCT02059291|12390122|P20|COMPLETED|Epoch 3||0
5034711|NCT02059291|12390123|P19|COMPLETED|Epoch 3||0
5034712|NCT02059291|12390124|P18|COMPLETED|Epoch 3||0
5034713|NCT02059291|12390125|P17|COMPLETED|Epoch 3||0
5034714|NCT02059291|12390126|P16|COMPLETED|Epoch 3||120
5034715|NCT02059291|12390127|P15|COMPLETED|Epoch 3||5
5034716|NCT02059291|12390128|P14|COMPLETED|Epoch 3||3
5034717|NCT02059291|12390129|P13|COMPLETED|Epoch 3||7
5034718|NCT02059291|12390130|P12|COMPLETED|Epoch 3||6
5034719|NCT02059291|12390131|P11|COMPLETED|Epoch 3||10
5034720|NCT02059291|12390132|P10|COMPLETED|Epoch 3||9
5034721|NCT02059291|12390133|P9|COMPLETED|Epoch 3||0
5034722|NCT02059291|12390134|P8|COMPLETED|Epoch 3||1
5034723|NCT02059291|12390135|P7|COMPLETED|Epoch 3||2
5034724|NCT02059291|12390136|P6|COMPLETED|Epoch 3||0
5034725|NCT02059291|12390137|P5|COMPLETED|Epoch 3||0
5034726|NCT02059291|12390138|P4|COMPLETED|Epoch 3||0
5034727|NCT02059291|12390139|P3|COMPLETED|Epoch 3||0
5034728|NCT02059291|12390140|P2|COMPLETED|Epoch 3||0
5034729|NCT02059291|12390141|P1|COMPLETED|Epoch 3||0
5034730|NCT02059291|12390117|P25|STARTED|Epoch 3||0
5034731|NCT02059291|12390118|P24|STARTED|Epoch 3||0
5034732|NCT02059291|12390119|P23|STARTED|Epoch 3||0
5034733|NCT02059291|12390120|P22|STARTED|Epoch 3||0
5034734|NCT02059291|12390121|P21|STARTED|Epoch 3||0
5034735|NCT02059291|12390122|P20|STARTED|Epoch 3||0
5034736|NCT02059291|12390123|P19|STARTED|Epoch 3||0
5034737|NCT02059291|12390124|P18|STARTED|Epoch 3||0
5034738|NCT02059291|12390125|P17|STARTED|Epoch 3||0
5034739|NCT02059291|12390126|P16|STARTED|Epoch 3||126
5034740|NCT02059291|12390127|P15|STARTED|Epoch 3||5
5034741|NCT02059291|12390128|P14|STARTED|Epoch 3||4
5034742|NCT02059291|12390129|P13|STARTED|Epoch 3||7
5034743|NCT02059291|12390130|P12|STARTED|Epoch 3||6
5034744|NCT02059291|12390131|P11|STARTED|Epoch 3||10
5034745|NCT02059291|12390132|P10|STARTED|Epoch 3||9
5034746|NCT02059291|12390133|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
5034747|NCT02059291|12390134|P8|STARTED|Epoch 3||1
5034748|NCT02059291|12390135|P7|STARTED|Epoch 3||2
5034749|NCT02059291|12390136|P6|STARTED|Epoch 3||0
5034750|NCT02059291|12390137|P5|STARTED|Epoch 3||0
5034751|NCT02059291|12390138|P4|STARTED|Epoch 3||0
5034752|NCT02059291|12390139|P3|STARTED|Epoch 3||0
5034753|NCT02059291|12390140|P2|STARTED|Epoch 3||0
5034754|NCT02059291|12390141|P1|STARTED|Epoch 3||0
5034755|NCT02059291|12390117|P25|NOT COMPLETED|Epoch 2||0
5034756|NCT02059291|12390118|P24|NOT COMPLETED|Epoch 2||0
5034757|NCT02059291|12390119|P23|NOT COMPLETED|Epoch 2||0
5034758|NCT02059291|12390120|P22|NOT COMPLETED|Epoch 2||0
5034759|NCT02059291|12390121|P21|NOT COMPLETED|Epoch 2||0
5034760|NCT02059291|12390122|P20|NOT COMPLETED|Epoch 2||0
5034761|NCT02059291|12390123|P19|NOT COMPLETED|Epoch 2||0
5034762|NCT02059291|12390124|P18|NOT COMPLETED|Epoch 2||0
5034763|NCT02059291|12390125|P17|NOT COMPLETED|Epoch 2||0
5034764|NCT02059291|12390126|P16|NOT COMPLETED|Epoch 2||0
5034765|NCT02059291|12390127|P15|NOT COMPLETED|Epoch 2||0
5034766|NCT02059291|12390128|P14|NOT COMPLETED|Epoch 2||0
5034767|NCT02059291|12390129|P13|NOT COMPLETED|Epoch 2||0
5034768|NCT02059291|12390130|P12|NOT COMPLETED|Epoch 2||0
5034769|NCT02059291|12390131|P11|NOT COMPLETED|Epoch 2||0
5034770|NCT02059291|12390132|P10|NOT COMPLETED|Epoch 2||0
5034771|NCT02059291|12390133|P9|NOT COMPLETED|Epoch 2||2
5034772|NCT02059291|12390134|P8|NOT COMPLETED|Epoch 2||1
5034773|NCT02059291|12390135|P7|NOT COMPLETED|Epoch 2||0
5034774|NCT02059291|12390136|P6|NOT COMPLETED|Epoch 2||2
5034775|NCT02059291|12390137|P5|NOT COMPLETED|Epoch 2||0
5034776|NCT02059291|12390138|P4|NOT COMPLETED|Epoch 2||2
5034777|NCT02059291|12390139|P3|NOT COMPLETED|Epoch 2||1
5034778|NCT02059291|12390140|P2|NOT COMPLETED|Epoch 2||1
5034779|NCT02059291|12390141|P1|NOT COMPLETED|Epoch 2||0
5034780|NCT02059291|12390117|P25|COMPLETED|Epoch 2||0
5034781|NCT02059291|12390118|P24|COMPLETED|Epoch 2||0
5034782|NCT02059291|12390119|P23|COMPLETED|Epoch 2||0
5034783|NCT02059291|12390120|P22|COMPLETED|Epoch 2||0
5034784|NCT02059291|12390121|P21|COMPLETED|Epoch 2||0
5034785|NCT02059291|12390122|P20|COMPLETED|Epoch 2||0
5034786|NCT02059291|12390123|P19|COMPLETED|Epoch 2||0
5034787|NCT02059291|12390124|P18|COMPLETED|Epoch 2||0
5034788|NCT02059291|12390125|P17|COMPLETED|Epoch 2||0
5034789|NCT02059291|12390126|P16|COMPLETED|Epoch 2||0
5034790|NCT02059291|12390127|P15|COMPLETED|Epoch 2||0
5034791|NCT02059291|12390128|P14|COMPLETED|Epoch 2||0
5034792|NCT02059291|12390129|P13|COMPLETED|Epoch 2||0
5034793|NCT02059291|12390130|P12|COMPLETED|Epoch 2||0
5034794|NCT02059291|12390131|P11|COMPLETED|Epoch 2||0
5034795|NCT02059291|12390132|P10|COMPLETED|Epoch 2||0
5034796|NCT02059291|12390133|P9|COMPLETED|Epoch 2||16
5034797|NCT02059291|12390134|P8|COMPLETED|Epoch 2||1
5034798|NCT02059291|12390135|P7|COMPLETED|Epoch 2||2
5034799|NCT02059291|12390136|P6|COMPLETED|Epoch 2||22
5034800|NCT02059291|12390137|P5|COMPLETED|Epoch 2||22
5034801|NCT02059291|12390138|P4|COMPLETED|Epoch 2||33
5034802|NCT02059291|12390139|P3|COMPLETED|Epoch 2||36
5034803|NCT02059291|12390140|P2|COMPLETED|Epoch 2||31
5034804|NCT02059291|12390141|P1|COMPLETED|Epoch 2||31
5034805|NCT02059291|12390117|P25|STARTED|Epoch 2||0
5034806|NCT02059291|12390118|P24|STARTED|Epoch 2||0
5034807|NCT02059291|12390119|P23|STARTED|Epoch 2||0
5034808|NCT02059291|12390120|P22|STARTED|Epoch 2||0
5034809|NCT02059291|12390121|P21|STARTED|Epoch 2||0
5034810|NCT02059291|12390122|P20|STARTED|Epoch 2||0
5034811|NCT02059291|12390123|P19|STARTED|Epoch 2||0
5034812|NCT02059291|12390124|P18|STARTED|Epoch 2||0
5034813|NCT02059291|12390125|P17|STARTED|Epoch 2||0
5034814|NCT02059291|12390126|P16|STARTED|Epoch 2||0
5034815|NCT02059291|12390127|P15|STARTED|Epoch 2||0
5034816|NCT02059291|12390128|P14|STARTED|Epoch 2||0
5034817|NCT02059291|12390129|P13|STARTED|Epoch 2||0
5034818|NCT02059291|12390130|P12|STARTED|Epoch 2||0
5034819|NCT02059291|12390131|P11|STARTED|Epoch 2||0
5034820|NCT02059291|12390132|P10|STARTED|Epoch 2||0
5034821|NCT02059291|12390133|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
5034822|NCT02059291|12390134|P8|STARTED|Epoch 2||2
5034823|NCT02059291|12390135|P7|STARTED|Epoch 2||2
5034824|NCT02059291|12390136|P6|STARTED|Epoch 2||24
5034825|NCT02059291|12390137|P5|STARTED|Epoch 2||22
5034826|NCT02059291|12390138|P4|STARTED|Epoch 2||35
5034827|NCT02059291|12390139|P3|STARTED|Epoch 2||37
5034828|NCT02059291|12390140|P2|STARTED|Epoch 2||32
5034829|NCT02059291|12390141|P1|STARTED|Epoch 2||31
5034830|NCT02059278|12390195|P2|NOT COMPLETED|Overall Study||4
5034831|NCT02059278|12390196|P1|NOT COMPLETED|Overall Study||3
5034832|NCT02059278|12390195|P2|COMPLETED|Overall Study||166
5034833|NCT02059278|12390196|P1|COMPLETED|Overall Study||162
5034834|NCT02059278|12390195|P2|STARTED|Overall Study||170
5034835|NCT02059278|12390196|P1|STARTED|Overall Study||165
5034836|NCT02059265|12390210|P1|NOT COMPLETED|Overall Study||4
5034837|NCT02059265|12390210|P1|COMPLETED|Overall Study||28
5034838|NCT02059265|12390210|P1|STARTED|Overall Study||32
5034839|NCT02059213|12390220|P2|NOT COMPLETED|Overall Study||2
5034840|NCT02059213|12390221|P1|NOT COMPLETED|Overall Study||0
5034841|NCT02059213|12390220|P2|COMPLETED|Overall Study||40
5034842|NCT02059213|12390221|P1|COMPLETED|Overall Study||20
5034843|NCT02059213|12390220|P2|Initiated Treatment|Overall Study||40
5034844|NCT02059213|12390221|P1|Initiated Treatment|Overall Study||20
5034845|NCT02059213|12390220|P2|STARTED|Overall Study||42
5034846|NCT02059213|12390221|P1|STARTED|Overall Study||20
5034847|NCT02059187|12390229|P2|NOT COMPLETED|Overall Study||22
5034848|NCT02059187|12390230|P1|NOT COMPLETED|Overall Study||25
5034849|NCT02059187|12390229|P2|COMPLETED|Overall Study||244
5034850|NCT02059187|12390230|P1|COMPLETED|Overall Study||240
5034851|NCT02059187|12390229|P2|STARTED|Overall Study||266
5034852|NCT02059187|12390230|P1|STARTED|Overall Study||265
5034853|NCT02059174|12390256|P2|NOT COMPLETED|Period 4||0
5034854|NCT02059174|12390257|P1|NOT COMPLETED|Period 4||0
5034855|NCT02059174|12390256|P2|COMPLETED|Period 4||35
5034856|NCT02059174|12390257|P1|COMPLETED|Period 4||35
5034857|NCT02059174|12390256|P2|STARTED|Period 4||35
5034858|NCT02059174|12390257|P1|STARTED|Period 4||35
5034859|NCT02059174|12390256|P2|NOT COMPLETED|Period 3||0
5034860|NCT02059174|12390257|P1|NOT COMPLETED|Period 3||1
5034861|NCT02059174|12390256|P2|COMPLETED|Period 3||35
5034862|NCT02059174|12390257|P1|COMPLETED|Period 3||35
5034863|NCT02059174|12390256|P2|STARTED|Period 3||35
5034864|NCT02059174|12390257|P1|STARTED|Period 3||36
5034865|NCT02059174|12390256|P2|NOT COMPLETED|Period 2||2
5034866|NCT02059174|12390257|P1|NOT COMPLETED|Period 2||1
5034867|NCT02059174|12390256|P2|COMPLETED|Period 2||35
5034868|NCT02059174|12390257|P1|COMPLETED|Period 2||36
5034869|NCT02059174|12390256|P2|STARTED|Period 2||37
5034870|NCT02059174|12390257|P1|STARTED|Period 2||37
5034871|NCT02059174|12390256|P2|NOT COMPLETED|Period 1||2
5034872|NCT02059174|12390257|P1|NOT COMPLETED|Period 1||0
5034873|NCT02059174|12390256|P2|COMPLETED|Period 1||37
5034874|NCT02059174|12390257|P1|COMPLETED|Period 1||37
5034875|NCT02059174|12390256|P2|STARTED|Period 1||39
5034876|NCT02059174|12390257|P1|STARTED|Period 1||37
5034877|NCT02059161|12390281|P2|NOT COMPLETED|Overall Study||41
5034878|NCT02059161|12390282|P1|NOT COMPLETED|Overall Study||49
5034879|NCT02059161|12390281|P2|COMPLETED|Overall Study||222
5034880|NCT02059161|12390282|P1|COMPLETED|Overall Study||196
5034881|NCT02059161|12390281|P2|Treated|Overall Study||258
5034882|NCT02059161|12390282|P1|Treated|Overall Study||241
5034883|NCT02059161|12390281|P2|STARTED|Overall Study||263
5034884|NCT02059161|12390282|P1|STARTED|Overall Study||245
5034885|NCT02059148|12390342|P6|NOT COMPLETED|Treatment 3||0
5034886|NCT02059148|12390343|P5|NOT COMPLETED|Treatment 3||0
5034887|NCT02059148|12390344|P4|NOT COMPLETED|Treatment 3||0
5034888|NCT02059148|12390345|P3|NOT COMPLETED|Treatment 3||0
5034889|NCT02059148|12390346|P2|NOT COMPLETED|Treatment 3||0
5034890|NCT02059148|12390347|P1|NOT COMPLETED|Treatment 3||0
5034891|NCT02059148|12390342|P6|COMPLETED|Treatment 3||3
5034892|NCT02059148|12390343|P5|COMPLETED|Treatment 3||4
5034893|NCT02059148|12390344|P4|COMPLETED|Treatment 3||4
5034894|NCT02059148|12390345|P3|COMPLETED|Treatment 3||4
5034895|NCT02059148|12390346|P2|COMPLETED|Treatment 3||4
5034896|NCT02059148|12390347|P1|COMPLETED|Treatment 3||4
5034897|NCT02059148|12390342|P6|STARTED|Treatment 3||3
5034898|NCT02059148|12390343|P5|STARTED|Treatment 3||4
5034899|NCT02059148|12390344|P4|STARTED|Treatment 3||4
5034900|NCT02059148|12390345|P3|STARTED|Treatment 3||4
5034901|NCT02059148|12390346|P2|STARTED|Treatment 3||4
5034902|NCT02059148|12390347|P1|STARTED|Treatment 3||4
5034903|NCT02059148|12390342|P6|NOT COMPLETED|Treatment 2||0
5034904|NCT02059148|12390343|P5|NOT COMPLETED|Treatment 2||0
5034905|NCT02059148|12390344|P4|NOT COMPLETED|Treatment 2||0
5034906|NCT02059148|12390345|P3|NOT COMPLETED|Treatment 2||0
5034907|NCT02059148|12390346|P2|NOT COMPLETED|Treatment 2||0
5034908|NCT02059148|12390347|P1|NOT COMPLETED|Treatment 2||0
5034909|NCT02059148|12390342|P6|COMPLETED|Treatment 2||3
5034910|NCT02059148|12390343|P5|COMPLETED|Treatment 2||4
5034911|NCT02059148|12390344|P4|COMPLETED|Treatment 2||4
5034912|NCT02059148|12390345|P3|COMPLETED|Treatment 2||4
5034913|NCT02059148|12390346|P2|COMPLETED|Treatment 2||4
5034914|NCT02059148|12390347|P1|COMPLETED|Treatment 2||4
5034915|NCT02059148|12390342|P6|STARTED|Treatment 2||3
5034916|NCT02059148|12390343|P5|STARTED|Treatment 2||4
5034917|NCT02059148|12390344|P4|STARTED|Treatment 2||4
5034918|NCT02059148|12390345|P3|STARTED|Treatment 2||4
5034919|NCT02059148|12390346|P2|STARTED|Treatment 2||4
5034920|NCT02059148|12390347|P1|STARTED|Treatment 2||4
5034921|NCT02059148|12390342|P6|NOT COMPLETED|Treatment 1||1
5034922|NCT02059148|12390343|P5|NOT COMPLETED|Treatment 1||0
5034923|NCT02059148|12390344|P4|NOT COMPLETED|Treatment 1||0
5034924|NCT02059148|12390345|P3|NOT COMPLETED|Treatment 1||0
5034925|NCT02059148|12390346|P2|NOT COMPLETED|Treatment 1||0
5034926|NCT02059148|12390347|P1|NOT COMPLETED|Treatment 1||0
5034927|NCT02059148|12390342|P6|COMPLETED|Treatment 1||3
5034928|NCT02059148|12390343|P5|COMPLETED|Treatment 1||4
5034929|NCT02059148|12390344|P4|COMPLETED|Treatment 1||4
5034930|NCT02059148|12390345|P3|COMPLETED|Treatment 1||4
5034931|NCT02059148|12390346|P2|COMPLETED|Treatment 1||4
5034932|NCT02059148|12390347|P1|COMPLETED|Treatment 1||4
5034933|NCT02059148|12390342|P6|STARTED|Treatment 1||4
5034934|NCT02059148|12390343|P5|STARTED|Treatment 1||4
5034935|NCT02059148|12390344|P4|STARTED|Treatment 1||4
5034936|NCT02059148|12390345|P3|STARTED|Treatment 1||4
5034937|NCT02059148|12390346|P2|STARTED|Treatment 1||4
5034938|NCT02059148|12390347|P1|STARTED|Treatment 1||4
5034939|NCT02059135|12390366|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
5034940|NCT02059135|12390367|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
5034941|NCT02059135|12390366|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
5034942|NCT02059135|12390367|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
5034943|NCT02059135|12390366|P2|STARTED|Neonatal Follow-up (Safety Population)||54
5034944|NCT02059135|12390367|P1|STARTED|Neonatal Follow-up (Safety Population)||60
5034945|NCT02059135|12390366|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
5034946|NCT02059135|12390367|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
5034947|NCT02059135|12390366|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
5034948|NCT02059135|12390367|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
5034949|NCT02059135|12390366|P2|STARTED|Maternal Follow-up (ITT Population)||58
5034950|NCT02059135|12390367|P1|STARTED|Maternal Follow-up (ITT Population)||62
5034951|NCT02059070|12390381|P2|NOT COMPLETED|Overall Study||4
5034952|NCT02059070|12390382|P1|NOT COMPLETED|Overall Study||5
5034953|NCT02059070|12390381|P2|COMPLETED|Overall Study||16
5034954|NCT02059070|12390382|P1|COMPLETED|Overall Study||14
5034955|NCT02059070|12390381|P2|STARTED|Overall Study||20
5034956|NCT02059070|12390382|P1|STARTED|Overall Study||19
5034957|NCT02059057|12390394|P1|NOT COMPLETED|Overall Study||15
5034958|NCT02059057|12390394|P1|COMPLETED|Overall Study||87
5034959|NCT02059057|12390394|P1|STARTED|Overall Study||102
5034960|NCT02059005|12390403|P2|NOT COMPLETED|Overall Study||24
5034961|NCT02059005|12390404|P1|NOT COMPLETED|Overall Study||20
5034962|NCT02059005|12390403|P2|COMPLETED|Overall Study||24
5034963|NCT02059005|12390404|P1|COMPLETED|Overall Study||29
5034964|NCT02059005|12390403|P2|6 Month Assessment|Overall Study||24
5034965|NCT02059005|12390404|P1|6 Month Assessment|Overall Study||29
5034966|NCT02059005|12390403|P2|3 Month Assessment|Overall Study||33
5034967|NCT02059005|12390404|P1|3 Month Assessment|Overall Study||37
5034968|NCT02059005|12390403|P2|STARTED|Overall Study||48
5034969|NCT02059005|12390404|P1|STARTED|Overall Study||49
5034970|NCT02058992|12390414|P1|NOT COMPLETED|Overall Study||116
5034971|NCT02058992|12390414|P1|COMPLETED|Overall Study||3223
5034972|NCT02058992|12390414|P1|STARTED|Overall Study||3339
5034973|NCT02058966|12390423|P1|NOT COMPLETED|Fourth Intervention||0
5034974|NCT02058966|12390423|P1|COMPLETED|Fourth Intervention||12
5034975|NCT02058966|12390423|P1|Received Entacapone-Meth|Fourth Intervention||2
5034976|NCT02058966|12390423|P1|Received Entacapone-Placebo|Fourth Intervention||3
5034977|NCT02058966|12390423|P1|Received Placebo-Meth|Fourth Intervention||3
5034978|NCT02058966|12390423|P1|Received Placebo-Placebo|Fourth Intervention||4
5034979|NCT02058966|12390423|P1|STARTED|Fourth Intervention||12
5034980|NCT02058966|12390423|P1|NOT COMPLETED|Third Intervention||0
5034981|NCT02058966|12390423|P1|COMPLETED|Third Intervention||12
5034982|NCT02058966|12390423|P1|Received Entacapone-Meth|Third Intervention||3
5034983|NCT02058966|12390423|P1|Received Entacapone-Placebo|Third Intervention||1
5034984|NCT02058966|12390423|P1|Received Placebo-Meth|Third Intervention||4
5034985|NCT02058966|12390423|P1|Received Placebo-Placebo|Third Intervention||4
5034986|NCT02058966|12390423|P1|STARTED|Third Intervention||12
5034987|NCT02058966|12390423|P1|NOT COMPLETED|Second Intervention||0
5034988|NCT02058966|12390423|P1|COMPLETED|Second Intervention||13
5034989|NCT02058966|12390423|P1|Received Entacapone-Meth|Second Intervention||3
5034990|NCT02058966|12390423|P1|Received Entacapone-Placebo|Second Intervention||6
5034991|NCT02058966|12390423|P1|Received Placebo-Meth|Second Intervention||2
5034992|NCT02058966|12390423|P1|Received Placebo-Placebo|Second Intervention||2
5034993|NCT02058966|12390423|P1|STARTED|Second Intervention||13
5034994|NCT02058966|12390423|P1|NOT COMPLETED|First Intervention||1
5034995|NCT02058966|12390423|P1|COMPLETED|First Intervention||14
5034996|NCT02058966|12390423|P1|Received Entacapone-Meth|First Intervention||5
5034997|NCT02058966|12390423|P1|Received Entacapone-Placebo|First Intervention||2
5034998|NCT02058966|12390423|P1|Received Placebo-Meth|First Intervention||4
5034999|NCT02058966|12390423|P1|Received Placebo-Placebo|First Intervention||3
5035000|NCT02058966|12390423|P1|STARTED|First Intervention||15
5035001|NCT02058966|12390423|P1|NOT COMPLETED|Open-Label Methamphetamine||1
5035002|NCT02058966|12390423|P1|COMPLETED|Open-Label Methamphetamine||18
5035003|NCT02058966|12390423|P1|Received Methamphetamine|Open-Label Methamphetamine||18
5035004|NCT02058966|12390423|P1|STARTED|Open-Label Methamphetamine||19
5035005|NCT02058940|12390450|P1|NOT COMPLETED|Overall Study||1
5035006|NCT02058940|12390450|P1|COMPLETED|Overall Study||7
5035007|NCT02058940|12390450|P1|STARTED|Overall Study||8
5035008|NCT02058849|12390474|P2|NOT COMPLETED|Overall Study||1
5035009|NCT02058849|12390475|P1|NOT COMPLETED|Overall Study||7
5035010|NCT02058849|12390474|P2|COMPLETED|Overall Study||1
5035011|NCT02058849|12390475|P1|COMPLETED|Overall Study||4
5035012|NCT02058849|12390474|P2|STARTED|Overall Study||2
5035013|NCT02058849|12390475|P1|STARTED|Overall Study||11
5035014|NCT02058836|12390503|P2|NOT COMPLETED|Overall Study||1
5035015|NCT02058836|12390504|P1|NOT COMPLETED|Overall Study||1
5035016|NCT02058836|12390503|P2|COMPLETED|Overall Study||3
5035017|NCT02058836|12390504|P1|COMPLETED|Overall Study||3
5035018|NCT02058836|12390503|P2|STARTED|Overall Study||4
5035019|NCT02058836|12390504|P1|STARTED|Overall Study||4
5035020|NCT02058628|12390534|P2|NOT COMPLETED|Overall Study||8
5035021|NCT02058628|12390535|P1|NOT COMPLETED|Overall Study||7
5035022|NCT02058628|12390534|P2|COMPLETED|Overall Study||102
5035023|NCT02058628|12390535|P1|COMPLETED|Overall Study||104
5035024|NCT02058628|12390534|P2|STARTED|Overall Study||110
5035025|NCT02058628|12390535|P1|STARTED|Overall Study||111
5035026|NCT02058589|12390567|P2|NOT COMPLETED|Overall Study||2
5035027|NCT02058589|12390568|P1|NOT COMPLETED|Overall Study||2
5035028|NCT02058589|12390567|P2|COMPLETED|Overall Study||130
5035029|NCT02058589|12390568|P1|COMPLETED|Overall Study||130
5035030|NCT02058589|12390567|P2|STARTED|Overall Study||132
5035031|NCT02058589|12390568|P1|STARTED|Overall Study||132
5035032|NCT02058563|12390610|P2|NOT COMPLETED|Overall Study||24
5035033|NCT02058563|12390611|P1|NOT COMPLETED|Overall Study||28
5035034|NCT02058563|12390610|P2|COMPLETED|Overall Study||433
5035035|NCT02058563|12390611|P1|COMPLETED|Overall Study||426
5035036|NCT02058563|12390610|P2|STARTED|Overall Study||457
5035037|NCT02058563|12390611|P1|STARTED|Overall Study||454
5035038|NCT02058537|12390647|P1|NOT COMPLETED|Overall Study||1
5035039|NCT02058537|12390647|P1|COMPLETED|Overall Study||2
5035040|NCT02058537|12390647|P1|STARTED|Overall Study||3
5035041|NCT02058511|12390653|P1|NOT COMPLETED|Overall Study||0
5035042|NCT02058511|12390653|P1|COMPLETED|Overall Study||24
5035043|NCT02058511|12390653|P1|STARTED|Overall Study||24
5035044|NCT02058498|12390658|P1|NOT COMPLETED|Overall Study||4
5035045|NCT02058498|12390658|P1|COMPLETED|Overall Study||8
5035046|NCT02058498|12390658|P1|6 Weeks|Overall Study||8
5035047|NCT02058498|12390658|P1|STARTED|Overall Study||12
5035048|NCT02058368|12390666|P2|NOT COMPLETED|Overall Study||54
5035049|NCT02058368|12390667|P1|NOT COMPLETED|Overall Study||41
5035050|NCT02058368|12390666|P2|COMPLETED|Overall Study||251
5035051|NCT02058368|12390667|P1|COMPLETED|Overall Study||261
5035052|NCT02058368|12390666|P2|STARTED|Overall Study||305
5035053|NCT02058368|12390667|P1|STARTED|Overall Study||302
5035054|NCT02058290|12390719|P2|NOT COMPLETED|Overall Study||9
5035055|NCT02058290|12390720|P1|NOT COMPLETED|Overall Study||11
5035056|NCT02058290|12390719|P2|COMPLETED|Overall Study||36
5035057|NCT02058290|12390720|P1|COMPLETED|Overall Study||66
5035058|NCT02058290|12390719|P2|STARTED|Overall Study||45
5035059|NCT02058290|12390720|P1|STARTED|Overall Study||77
5035060|NCT02058251|12390736|P2|NOT COMPLETED|Overall Study||0
5035061|NCT02058251|12390737|P1|NOT COMPLETED|Overall Study||0
5035062|NCT02058251|12390736|P2|COMPLETED|Overall Study||38
5035063|NCT02058251|12390737|P1|COMPLETED|Overall Study||35
5035064|NCT02058251|12390736|P2|STARTED|Overall Study||38
5035065|NCT02058251|12390737|P1|STARTED|Overall Study||35
5035066|NCT02058160|12390747|P2|NOT COMPLETED|Overall Study||14
5035067|NCT02058160|12390748|P1|NOT COMPLETED|Overall Study||31
5035068|NCT02058160|12390747|P2|COMPLETED|Overall Study||355
5035069|NCT02058160|12390748|P1|COMPLETED|Overall Study||336
5035070|NCT02058160|12390747|P2|Treated|Overall Study||365
5035071|NCT02058160|12390748|P1|Treated|Overall Study||365
5035072|NCT02058160|12390747|P2|STARTED|Overall Study||369
5035073|NCT02058160|12390748|P1|STARTED|Overall Study||367
5035074|NCT02058147|12390785|P3|NOT COMPLETED|Overall Study||29
5035075|NCT02058147|12390786|P2|NOT COMPLETED|Overall Study||27
5035076|NCT02058147|12390787|P1|NOT COMPLETED|Overall Study||29
5035077|NCT02058147|12390785|P3|COMPLETED|Overall Study||205
5035078|NCT02058147|12390786|P2|COMPLETED|Overall Study||440
5035079|NCT02058147|12390787|P1|COMPLETED|Overall Study||440
5035080|NCT02058147|12390785|P3|Treated|Overall Study||233
5035081|NCT02058147|12390786|P2|Treated|Overall Study||467
5035082|NCT02058147|12390787|P1|Treated|Overall Study||469
5035083|NCT02058147|12390785|P3|STARTED|Overall Study||234
5035084|NCT02058147|12390786|P2|STARTED|Overall Study||467
5035085|NCT02058147|12390787|P1|STARTED|Overall Study||469
5035086|NCT02058108|12390838|P2|NOT COMPLETED|Overall Study||10
5035087|NCT02058108|12390839|P1|NOT COMPLETED|Overall Study||41
5035088|NCT02058108|12390838|P2|COMPLETED|Overall Study||0
5035089|NCT02058108|12390839|P1|COMPLETED|Overall Study||2
5035090|NCT02058108|12390838|P2|Switched to Telbivudine After Week 24|Overall Study||5
5035091|NCT02058108|12390839|P1|Switched to Telbivudine After Week 24|Overall Study||0
5035092|NCT02058108|12390838|P2|STARTED|Overall Study||10
5035093|NCT02058108|12390839|P1|STARTED|Overall Study||43
5035094|NCT02058095|12390865|P2|NOT COMPLETED|Overall Study||0
5035095|NCT02058095|12390866|P1|NOT COMPLETED|Overall Study||1
5035096|NCT02058095|12390865|P2|COMPLETED|Overall Study||7
5035097|NCT02058095|12390866|P1|COMPLETED|Overall Study||14
5035098|NCT02058095|12390865|P2|STARTED|Overall Study||7
5035099|NCT02058095|12390866|P1|STARTED|Overall Study||15
5035100|NCT02058069|12390876|P1|NOT COMPLETED|Overall Study||11
5035101|NCT02058069|12390876|P1|COMPLETED|Overall Study||89
5035102|NCT02058069|12390876|P1|STARTED|Overall Study||100
5035103|NCT02057952|12390888|P3|NOT COMPLETED|Overall Study||22
5035104|NCT02057952|12390889|P2|NOT COMPLETED|Overall Study||10
5035105|NCT02057952|12390890|P1|NOT COMPLETED|Overall Study||8
5035106|NCT02057952|12390888|P3|COMPLETED|Overall Study||28
5035107|NCT02057952|12390889|P2|COMPLETED|Overall Study||39
5035108|NCT02057952|12390890|P1|COMPLETED|Overall Study||43
5035109|NCT02057952|12390888|P3|STARTED|Overall Study||50
5035110|NCT02057952|12390889|P2|STARTED|Overall Study||49
5035111|NCT02057952|12390890|P1|STARTED|Overall Study||51
5035112|NCT02057939|12390925|P1|NOT COMPLETED|Overall Study||1
5035113|NCT02057939|12390925|P1|COMPLETED|Overall Study||37
5035114|NCT02057939|12390925|P1|STARTED|Overall Study||38
5035115|NCT02057874|12390935|P1|NOT COMPLETED|Overall Study||1
5035116|NCT02057874|12390935|P1|COMPLETED|Overall Study||1
5035117|NCT02057874|12390935|P1|STARTED|Overall Study||2
5035118|NCT02057835|12390953|P10|NOT COMPLETED|Overall Study||0
5035119|NCT02057835|12390954|P9|NOT COMPLETED|Overall Study||0
5035120|NCT02057835|12390955|P8|NOT COMPLETED|Overall Study||0
5035121|NCT02057835|12390956|P7|NOT COMPLETED|Overall Study||0
5035122|NCT02057835|12390957|P6|NOT COMPLETED|Overall Study||0
5035123|NCT02057835|12390958|P5|NOT COMPLETED|Overall Study||0
5035124|NCT02057835|12390959|P4|NOT COMPLETED|Overall Study||0
5035125|NCT02057835|12390960|P3|NOT COMPLETED|Overall Study||0
5035126|NCT02057835|12390961|P2|NOT COMPLETED|Overall Study||2
5035127|NCT02057835|12390962|P1|NOT COMPLETED|Overall Study||0
5035128|NCT02057835|12390953|P10|COMPLETED|Overall Study||6
5035129|NCT02057835|12390954|P9|COMPLETED|Overall Study||6
5035130|NCT02057835|12390955|P8|COMPLETED|Overall Study||6
5035131|NCT02057835|12390956|P7|COMPLETED|Overall Study||6
5035132|NCT02057835|12390957|P6|COMPLETED|Overall Study||8
5035133|NCT02057835|12390958|P5|COMPLETED|Overall Study||6
5035134|NCT02057835|12390959|P4|COMPLETED|Overall Study||6
5035135|NCT02057835|12390960|P3|COMPLETED|Overall Study||6
5035136|NCT02057835|12390961|P2|COMPLETED|Overall Study||4
5035137|NCT02057835|12390962|P1|COMPLETED|Overall Study||8
5035138|NCT02057835|12390953|P10|STARTED|Overall Study||6
5035139|NCT02057835|12390954|P9|STARTED|Overall Study||6
5035140|NCT02057835|12390955|P8|STARTED|Overall Study||6
5035141|NCT02057835|12390956|P7|STARTED|Overall Study||6
5035142|NCT02057835|12390957|P6|STARTED|Overall Study||8
5035143|NCT02057835|12390958|P5|STARTED|Overall Study||6
5035144|NCT02057835|12390959|P4|STARTED|Overall Study||6
5035145|NCT02057835|12390960|P3|STARTED|Overall Study||6
5035146|NCT02057835|12390961|P2|STARTED|Overall Study||6
5035147|NCT02057835|12390962|P1|STARTED|Overall Study||8
5035148|NCT02057757|12391041|P2|NOT COMPLETED|Overall Study||8
5035149|NCT02057757|12391042|P1|NOT COMPLETED|Overall Study||14
5035150|NCT02057757|12391041|P2|COMPLETED|Overall Study||121
5035151|NCT02057757|12391042|P1|COMPLETED|Overall Study||117
5035152|NCT02057757|12391041|P2|Intent to Treat|Overall Study||127
5035153|NCT02057757|12391042|P1|Intent to Treat|Overall Study||130
5035154|NCT02057757|12391041|P2|STARTED|Overall Study||129
5035155|NCT02057757|12391042|P1|STARTED|Overall Study||131
5035156|NCT02057692|12391096|P4|NOT COMPLETED|Overall Study||1
5035157|NCT02057692|12391097|P3|NOT COMPLETED|Overall Study||0
5035158|NCT02057692|12391098|P2|NOT COMPLETED|Overall Study||0
5035159|NCT02057692|12391099|P1|NOT COMPLETED|Overall Study||1
5035160|NCT02057692|12391096|P4|COMPLETED|Overall Study||11
5035161|NCT02057692|12391097|P3|COMPLETED|Overall Study||6
5035162|NCT02057692|12391098|P2|COMPLETED|Overall Study||11
5035163|NCT02057692|12391099|P1|COMPLETED|Overall Study||7
5035164|NCT02057692|12391096|P4|STARTED|Overall Study||12
5035165|NCT02057692|12391097|P3|STARTED|Overall Study||6
5035166|NCT02057692|12391098|P2|STARTED|Overall Study||11
5035167|NCT02057692|12391099|P1|STARTED|Overall Study||8
5035168|NCT02057640|12391129|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
5035169|NCT02057640|12391130|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
5035170|NCT02057640|12391129|P2|COMPLETED|Phase II Portion of Study at DL2||9
5035171|NCT02057640|12391130|P1|COMPLETED|Phase II Portion of Study at DL2||0
5035172|NCT02057640|12391129|P2|STARTED|Phase II Portion of Study at DL2||9
5035173|NCT02057640|12391130|P1|STARTED|Phase II Portion of Study at DL2||0
5035174|NCT02057640|12391129|P2|NOT COMPLETED|Weeks 1-4||0
5035175|NCT02057640|12391130|P1|NOT COMPLETED|Weeks 1-4||0
5035176|NCT02057640|12391129|P2|COMPLETED|Weeks 1-4||3
5035177|NCT02057640|12391130|P1|COMPLETED|Weeks 1-4||4
5035178|NCT02057640|12391129|P2|STARTED|Weeks 1-4||3
5035179|NCT02057640|12391130|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
5035180|NCT02057575|12391145|P4|NOT COMPLETED|Overall Study||1
5035181|NCT02057575|12391146|P3|NOT COMPLETED|Overall Study||0
5035182|NCT02057575|12391147|P2|NOT COMPLETED|Overall Study||4
5035183|NCT02057575|12391148|P1|NOT COMPLETED|Overall Study||1
5035184|NCT02057575|12391145|P4|COMPLETED|Overall Study||72
5035185|NCT02057575|12391146|P3|COMPLETED|Overall Study||78
5035186|NCT02057575|12391147|P2|COMPLETED|Overall Study||69
5035187|NCT02057575|12391148|P1|COMPLETED|Overall Study||73
5035188|NCT02057575|12391145|P4|STARTED|Overall Study||73
5035189|NCT02057575|12391146|P3|STARTED|Overall Study||78
5035190|NCT02057575|12391147|P2|STARTED|Overall Study||73
5035191|NCT02057575|12391148|P1|STARTED|Overall Study||74
5035192|NCT02057549|12391160|P2|NOT COMPLETED|Overall Study||0
5035193|NCT02057549|12391161|P1|NOT COMPLETED|Overall Study||3
5035194|NCT02057549|12391160|P2|COMPLETED|Overall Study||18
5035195|NCT02057549|12391161|P1|COMPLETED|Overall Study||15
5035196|NCT02057549|12391160|P2|STARTED|Overall Study||18
5035197|NCT02057549|12391161|P1|STARTED|Overall Study||18
5035198|NCT02057458|12391181|P3|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
5035199|NCT02057458|12391182|P2|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
5035200|NCT02057458|12391183|P1|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
5035201|NCT02057458|12391181|P3|COMPLETED|Sub-Chronic Study (4 Weeks)||3
5035202|NCT02057458|12391182|P2|COMPLETED|Sub-Chronic Study (4 Weeks)||7
5035203|NCT02057458|12391183|P1|COMPLETED|Sub-Chronic Study (4 Weeks)||5
5035204|NCT02057458|12391181|P3|STARTED|Sub-Chronic Study (4 Weeks)||3
5035205|NCT02057458|12391182|P2|STARTED|Sub-Chronic Study (4 Weeks)||7
5035206|NCT02057458|12391183|P1|STARTED|Sub-Chronic Study (4 Weeks)||6
5035207|NCT02057458|12391181|P3|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
5035208|NCT02057458|12391182|P2|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
5035209|NCT02057458|12391183|P1|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
5035210|NCT02057458|12391181|P3|COMPLETED|Acute Study (1 Hour): Second Int.||0
5035211|NCT02057458|12391182|P2|COMPLETED|Acute Study (1 Hour): Second Int.||7
5035212|NCT02057458|12391183|P1|COMPLETED|Acute Study (1 Hour): Second Int.||6
5035213|NCT02057458|12391181|P3|STARTED|Acute Study (1 Hour): Second Int.||0
5035214|NCT02057458|12391182|P2|STARTED|Acute Study (1 Hour): Second Int.||7
5035215|NCT02057458|12391183|P1|STARTED|Acute Study (1 Hour): Second Int.||6
5035216|NCT02057458|12391181|P3|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
5035217|NCT02057458|12391182|P2|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
5035218|NCT02057458|12391183|P1|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
5035219|NCT02057458|12391181|P3|COMPLETED|Acute Study (1 Hour): First Intervention||0
5035220|NCT02057458|12391182|P2|COMPLETED|Acute Study (1 Hour): First Intervention||7
5035221|NCT02057458|12391183|P1|COMPLETED|Acute Study (1 Hour): First Intervention||6
5035222|NCT02057458|12391181|P3|STARTED|Acute Study (1 Hour): First Intervention||0
5035223|NCT02057458|12391182|P2|STARTED|Acute Study (1 Hour): First Intervention||7
5035224|NCT02057458|12391183|P1|STARTED|Acute Study (1 Hour): First Intervention||8
5035225|NCT02057458|12391181|P3|NOT COMPLETED|Met Inclusion Criteria||0
5035226|NCT02057458|12391182|P2|NOT COMPLETED|Met Inclusion Criteria||1
5035227|NCT02057458|12391183|P1|NOT COMPLETED|Met Inclusion Criteria||0
5035228|NCT02057458|12391181|P3|COMPLETED|Met Inclusion Criteria||3
5035229|NCT02057458|12391182|P2|COMPLETED|Met Inclusion Criteria||7
5035230|NCT02057458|12391183|P1|COMPLETED|Met Inclusion Criteria||8
5035231|NCT02057458|12391181|P3|STARTED|Met Inclusion Criteria||3
5035232|NCT02057458|12391182|P2|STARTED|Met Inclusion Criteria||8
5035233|NCT02057458|12391183|P1|STARTED|Met Inclusion Criteria||8
5035234|NCT02057458|12391181|P3|NOT COMPLETED|Recruited for Participation||0
5035235|NCT02057458|12391182|P2|NOT COMPLETED|Recruited for Participation||0
5035236|NCT02057458|12391183|P1|NOT COMPLETED|Recruited for Participation||0
5035237|NCT02057458|12391181|P3|COMPLETED|Recruited for Participation||3
5035238|NCT02057458|12391182|P2|COMPLETED|Recruited for Participation||8
5035239|NCT02057458|12391183|P1|COMPLETED|Recruited for Participation||8
5035240|NCT02057458|12391181|P3|STARTED|Recruited for Participation||3
5035241|NCT02057458|12391182|P2|STARTED|Recruited for Participation||8
5035242|NCT02057458|12391183|P1|STARTED|Recruited for Participation||8
5035243|NCT02057406|12391221|P3|NOT COMPLETED|Overall Study||4
5035244|NCT02057406|12391222|P2|NOT COMPLETED|Overall Study||3
5035245|NCT02057406|12391223|P1|NOT COMPLETED|Overall Study||1
5035246|NCT02057406|12391221|P3|COMPLETED|Overall Study||32
5035247|NCT02057406|12391222|P2|COMPLETED|Overall Study||33
5035248|NCT02057406|12391223|P1|COMPLETED|Overall Study||35
5035249|NCT02057406|12391221|P3|STARTED|Overall Study||36
5035250|NCT02057406|12391222|P2|STARTED|Overall Study||36
5035251|NCT02057406|12391223|P1|STARTED|Overall Study||36
5035252|NCT02057393|12391234|P1|NOT COMPLETED|Overall Study||2
5035253|NCT02057393|12391234|P1|COMPLETED|Overall Study||87
5035254|NCT02057393|12391234|P1|STARTED|Overall Study||89
5035255|NCT02057276|12391240|P2|NOT COMPLETED|Overall Study||0
5035256|NCT02057276|12391241|P1|NOT COMPLETED|Overall Study||0
5035257|NCT02057276|12391240|P2|COMPLETED|Overall Study||0
5035258|NCT02057276|12391241|P1|COMPLETED|Overall Study||0
5035259|NCT02057276|12391240|P2|STARTED|Overall Study||0
5035260|NCT02057276|12391241|P1|STARTED|Overall Study||0
5035261|NCT02057250|12391255|P5|NOT COMPLETED|Extension Phase||36
5035262|NCT02057250|12391256|P4|NOT COMPLETED|Extension Phase||0
5035263|NCT02057250|12391257|P3|NOT COMPLETED|Extension Phase||0
5035264|NCT02057250|12391258|P2|NOT COMPLETED|Extension Phase||0
5035265|NCT02057250|12391259|P1|NOT COMPLETED|Extension Phase||0
5035266|NCT02057250|12391255|P5|COMPLETED|Extension Phase||156
5035267|NCT02057250|12391256|P4|COMPLETED|Extension Phase||0
5035268|NCT02057250|12391257|P3|COMPLETED|Extension Phase||0
5035269|NCT02057250|12391258|P2|COMPLETED|Extension Phase||0
5035270|NCT02057250|12391259|P1|COMPLETED|Extension Phase||0
5035271|NCT02057250|12391255|P5|Treated|Extension Phase||188
5035272|NCT02057250|12391256|P4|Treated|Extension Phase||0
5035273|NCT02057250|12391257|P3|Treated|Extension Phase||0
5035274|NCT02057250|12391258|P2|Treated|Extension Phase||0
5035275|NCT02057250|12391259|P1|Treated|Extension Phase||0
5035276|NCT02057250|12391255|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
5035277|NCT02057250|12391256|P4|STARTED|Extension Phase||0
5035278|NCT02057250|12391257|P3|STARTED|Extension Phase||0
5035279|NCT02057250|12391258|P2|STARTED|Extension Phase||0
5035280|NCT02057250|12391259|P1|STARTED|Extension Phase||0
5035281|NCT02057250|12391255|P5|NOT COMPLETED|AID Assessment Phase||0
5035282|NCT02057250|12391256|P4|NOT COMPLETED|AID Assessment Phase||2
5035283|NCT02057250|12391257|P3|NOT COMPLETED|AID Assessment Phase||7
5035284|NCT02057250|12391258|P2|NOT COMPLETED|AID Assessment Phase||3
5035285|NCT02057250|12391259|P1|NOT COMPLETED|AID Assessment Phase||4
5035286|NCT02057250|12391255|P5|COMPLETED|AID Assessment Phase||0
5035287|NCT02057250|12391256|P4|COMPLETED|AID Assessment Phase||54
5035288|NCT02057250|12391257|P3|COMPLETED|AID Assessment Phase||45
5035289|NCT02057250|12391258|P2|COMPLETED|AID Assessment Phase||50
5035290|NCT02057250|12391259|P1|COMPLETED|AID Assessment Phase||52
5035291|NCT02057250|12391255|P5|STARTED|AID Assessment Phase||0
5035292|NCT02057250|12391256|P4|STARTED|AID Assessment Phase||56
5035293|NCT02057250|12391257|P3|STARTED|AID Assessment Phase||52
5035294|NCT02057250|12391258|P2|STARTED|AID Assessment Phase||53
5035295|NCT02057250|12391259|P1|STARTED|AID Assessment Phase||56
5035296|NCT02057237|12391272|P1|NOT COMPLETED|Overall Study||0
5035297|NCT02057237|12391272|P1|COMPLETED|Overall Study||1
5035298|NCT02057237|12391272|P1|STARTED|Overall Study||1
5035299|NCT02057198|12391280|P3|NOT COMPLETED|Overall Study||1
5035300|NCT02057198|12391281|P2|NOT COMPLETED|Overall Study||1
5035301|NCT02057198|12391282|P1|NOT COMPLETED|Overall Study||0
5035302|NCT02057198|12391280|P3|COMPLETED|Overall Study||10
5035303|NCT02057198|12391281|P2|COMPLETED|Overall Study||10
5035304|NCT02057198|12391282|P1|COMPLETED|Overall Study||11
5035305|NCT02057198|12391280|P3|STARTED|Overall Study||11
5035306|NCT02057198|12391281|P2|STARTED|Overall Study||11
5035307|NCT02057198|12391282|P1|STARTED|Overall Study||11
5035308|NCT02057081|12391307|P2|NOT COMPLETED|Overall Study||68
5035309|NCT02057081|12391308|P1|NOT COMPLETED|Overall Study||90
5035310|NCT02057081|12391307|P2|COMPLETED|Overall Study||44
5035311|NCT02057081|12391308|P1|COMPLETED|Overall Study||46
5035312|NCT02057081|12391307|P2|Post-Treatment Assessment|Overall Study||52
5035313|NCT02057081|12391308|P1|Post-Treatment Assessment|Overall Study||58
5035314|NCT02057081|12391307|P2|Completed Baseline|Overall Study||80
5035315|NCT02057081|12391308|P1|Completed Baseline|Overall Study||88
5035316|NCT02057081|12391307|P2|STARTED|Overall Study||112
5035317|NCT02057081|12391308|P1|STARTED|Overall Study||136
5035318|NCT02057068|12391318|P2|NOT COMPLETED|Overall Study||8
5035319|NCT02057068|12391319|P1|NOT COMPLETED|Overall Study||8
5035320|NCT02057068|12391318|P2|COMPLETED|Overall Study||28
5035321|NCT02057068|12391319|P1|COMPLETED|Overall Study||52
5035322|NCT02057068|12391318|P2|STARTED|Overall Study||36
5035323|NCT02057068|12391319|P1|STARTED|Overall Study||60
5035324|NCT02057042|12391331|P2|NOT COMPLETED|Overall Study||66
5035325|NCT02057042|12391332|P1|NOT COMPLETED|Overall Study||45
5035326|NCT02057042|12391331|P2|COMPLETED|Overall Study||101
5035327|NCT02057042|12391332|P1|COMPLETED|Overall Study||118
5035328|NCT02057042|12391331|P2|STARTED|Overall Study||167
5035329|NCT02057042|12391332|P1|STARTED|Overall Study||163
5035330|NCT02056834|12391348|P1|NOT COMPLETED|Overall Study||7
5035331|NCT02056834|12391348|P1|COMPLETED|Overall Study||29
5035332|NCT02056834|12391348|P1|6 Months|Overall Study||31
5035333|NCT02056834|12391348|P1|6 Weeks|Overall Study||34
5035334|NCT02056834|12391348|P1|STARTED|Overall Study||36
5035335|NCT02056652|12391369|P2|NOT COMPLETED|Overall Study||3
5035336|NCT02056652|12391370|P1|NOT COMPLETED|Overall Study||1
5035337|NCT02056652|12391369|P2|COMPLETED|Overall Study||58
5035338|NCT02056652|12391370|P1|COMPLETED|Overall Study||60
5035339|NCT02056652|12391369|P2|STARTED|Overall Study||61
5035340|NCT02056652|12391370|P1|STARTED|Overall Study||61
5035341|NCT02056639|12391388|P2|NOT COMPLETED|Overall Study||0
5035342|NCT02056639|12391389|P1|NOT COMPLETED|Overall Study||0
5035343|NCT02056639|12391388|P2|COMPLETED|Overall Study||23
5035344|NCT02056639|12391389|P1|COMPLETED|Overall Study||23
5035345|NCT02056639|12391388|P2|STARTED|Overall Study||23
5035346|NCT02056639|12391389|P1|STARTED|Overall Study||23
5035347|NCT02056626|12391407|P4|NOT COMPLETED|Overall Study||0
5035348|NCT02056626|12391408|P3|NOT COMPLETED|Overall Study||0
5035349|NCT02056626|12391409|P2|NOT COMPLETED|Overall Study||1
5035350|NCT02056626|12391410|P1|NOT COMPLETED|Overall Study||3
5035351|NCT02056626|12391407|P4|COMPLETED|Overall Study||14
5035352|NCT02056626|12391408|P3|COMPLETED|Overall Study||4
5035353|NCT02056626|12391409|P2|COMPLETED|Overall Study||12
5035354|NCT02056626|12391410|P1|COMPLETED|Overall Study||10
5035355|NCT02056626|12391407|P4|STARTED|Overall Study||14
5035356|NCT02056626|12391408|P3|STARTED|Overall Study||4
5035357|NCT02056626|12391409|P2|STARTED|Overall Study||13
5035358|NCT02056626|12391410|P1|STARTED|Overall Study||13
5035359|NCT02056431|12391430|P2|NOT COMPLETED|Overall Study||47
5035360|NCT02056431|12391431|P1|NOT COMPLETED|Overall Study||44
5035361|NCT02056431|12391430|P2|COMPLETED|Overall Study||619
5035362|NCT02056431|12391431|P1|COMPLETED|Overall Study||560
5035363|NCT02056431|12391430|P2|STARTED|Overall Study||666
5035364|NCT02056431|12391431|P1|STARTED|Overall Study||604
5035365|NCT02056392|12391445|P6|NOT COMPLETED|Overall Study||0
5035366|NCT02056392|12391446|P5|NOT COMPLETED|Overall Study||1
5035367|NCT02056392|12391447|P4|NOT COMPLETED|Overall Study||0
5035368|NCT02056392|12391448|P3|NOT COMPLETED|Overall Study||3
5035369|NCT02056392|12391449|P2|NOT COMPLETED|Overall Study||1
5035370|NCT02056392|12391450|P1|NOT COMPLETED|Overall Study||2
5035371|NCT02056392|12391445|P6|COMPLETED|Overall Study||9
5035372|NCT02056392|12391446|P5|COMPLETED|Overall Study||7
5035373|NCT02056392|12391447|P4|COMPLETED|Overall Study||9
5035374|NCT02056392|12391448|P3|COMPLETED|Overall Study||6
5035375|NCT02056392|12391449|P2|COMPLETED|Overall Study||8
5035376|NCT02056392|12391450|P1|COMPLETED|Overall Study||8
5035377|NCT02056392|12391445|P6|STARTED|Overall Study||9
5035378|NCT02056392|12391446|P5|STARTED|Overall Study||8
5035379|NCT02056392|12391447|P4|STARTED|Overall Study||9
5035380|NCT02056392|12391448|P3|STARTED|Overall Study||9
5035381|NCT02056392|12391449|P2|STARTED|Overall Study||9
5035382|NCT02056392|12391450|P1|STARTED|Overall Study||10
5035383|NCT02056340|12391487|P2|NOT COMPLETED|Overall Study||11
5035384|NCT02056340|12391488|P1|NOT COMPLETED|Overall Study||7
5035385|NCT02056340|12391487|P2|COMPLETED|Overall Study||46
5035386|NCT02056340|12391488|P1|COMPLETED|Overall Study||52
5035387|NCT02056340|12391487|P2|STARTED|Overall Study||57
5035388|NCT02056340|12391488|P1|STARTED|Overall Study||59
5035389|NCT02056301|12391498|P2|NOT COMPLETED|Overall Study||6
5035390|NCT02056301|12391499|P1|NOT COMPLETED|Overall Study||2
5035391|NCT02056301|12391498|P2|COMPLETED|Overall Study||23
5035392|NCT02056301|12391499|P1|COMPLETED|Overall Study||31
5035393|NCT02056301|12391498|P2|STARTED|Overall Study||29
5035394|NCT02056301|12391499|P1|STARTED|Overall Study||33
5035395|NCT02056171|12391511|P2|NOT COMPLETED|Overall Study||0
5035396|NCT02056171|12391512|P1|NOT COMPLETED|Overall Study||0
5035397|NCT02056171|12391511|P2|COMPLETED|Overall Study||3
5035398|NCT02056171|12391512|P1|COMPLETED|Overall Study||3
5035399|NCT02056171|12391511|P2|STARTED|Overall Study||3
5035400|NCT02056171|12391512|P1|STARTED|Overall Study||3
5035401|NCT02055976|12391531|P9|NOT COMPLETED|Overall Study||0
5035402|NCT02055976|12391532|P8|NOT COMPLETED|Overall Study||0
5035403|NCT02055976|12391533|P7|NOT COMPLETED|Overall Study||2
5035404|NCT02055976|12391534|P6|NOT COMPLETED|Overall Study||1
5035405|NCT02055976|12391535|P5|NOT COMPLETED|Overall Study||0
5035406|NCT02055976|12391536|P4|NOT COMPLETED|Overall Study||1
5035407|NCT02055976|12391537|P3|NOT COMPLETED|Overall Study||1
5035408|NCT02055976|12391538|P2|NOT COMPLETED|Overall Study||0
5035409|NCT02055976|12391539|P1|NOT COMPLETED|Overall Study||0
5035410|NCT02055976|12391531|P9|COMPLETED|Overall Study||23
5035411|NCT02055976|12391532|P8|COMPLETED|Overall Study||24
5035412|NCT02055976|12391533|P7|COMPLETED|Overall Study||23
5035413|NCT02055976|12391534|P6|COMPLETED|Overall Study||24
5035414|NCT02055976|12391535|P5|COMPLETED|Overall Study||22
5035415|NCT02055976|12391536|P4|COMPLETED|Overall Study||25
5035416|NCT02055976|12391537|P3|COMPLETED|Overall Study||23
5035417|NCT02055976|12391538|P2|COMPLETED|Overall Study||24
5035418|NCT02055976|12391539|P1|COMPLETED|Overall Study||25
5035419|NCT02055976|12391531|P9|STARTED|Overall Study||23
5035420|NCT02055976|12391532|P8|STARTED|Overall Study||24
5035421|NCT02055976|12391533|P7|STARTED|Overall Study||25
5035422|NCT02055976|12391534|P6|STARTED|Overall Study||25
5035423|NCT02055976|12391535|P5|STARTED|Overall Study||22
5035424|NCT02055976|12391536|P4|STARTED|Overall Study||26
5035425|NCT02055976|12391537|P3|STARTED|Overall Study||24
5035426|NCT02055976|12391538|P2|STARTED|Overall Study||24
5035427|NCT02055976|12391539|P1|STARTED|Overall Study||25
5035428|NCT02055820|12391968|P10|NOT COMPLETED|Phase II: Expansion||0
5035429|NCT02055820|12391969|P9|NOT COMPLETED|Phase II: Expansion||0
5035430|NCT02055820|12391970|P8|NOT COMPLETED|Phase II: Expansion||0
5035431|NCT02055820|12391971|P7|NOT COMPLETED|Phase II: Expansion||0
5035432|NCT02055820|12391972|P6|NOT COMPLETED|Phase II: Expansion||0
5035433|NCT02055820|12391973|P5|NOT COMPLETED|Phase II: Expansion||49
5035434|NCT02055820|12391974|P4|NOT COMPLETED|Phase II: Expansion||0
5035435|NCT02055820|12391975|P3|NOT COMPLETED|Phase II: Expansion||0
5035436|NCT02055820|12391976|P2|NOT COMPLETED|Phase II: Expansion||0
5035437|NCT02055820|12391977|P1|NOT COMPLETED|Phase II: Expansion||0
5035438|NCT02055820|12391968|P10|COMPLETED|Phase II: Expansion||0
5035439|NCT02055820|12391969|P9|COMPLETED|Phase II: Expansion||0
5035440|NCT02055820|12391970|P8|COMPLETED|Phase II: Expansion||0
5035441|NCT02055820|12391971|P7|COMPLETED|Phase II: Expansion||0
5035442|NCT02055820|12391972|P6|COMPLETED|Phase II: Expansion||0
5035443|NCT02055820|12391973|P5|COMPLETED|Phase II: Expansion||159
5035444|NCT02055820|12391974|P4|COMPLETED|Phase II: Expansion||0
5035445|NCT02055820|12391975|P3|COMPLETED|Phase II: Expansion||0
5035446|NCT02055820|12391976|P2|COMPLETED|Phase II: Expansion||0
5035447|NCT02055820|12391977|P1|COMPLETED|Phase II: Expansion||0
5035448|NCT02055820|12391968|P10|STARTED|Phase II: Expansion||0
5035449|NCT02055820|12391969|P9|STARTED|Phase II: Expansion||0
5035450|NCT02055820|12391970|P8|STARTED|Phase II: Expansion||0
5035451|NCT02055820|12391971|P7|STARTED|Phase II: Expansion||0
5035452|NCT02055820|12391972|P6|STARTED|Phase II: Expansion||0
5035453|NCT02055820|12391973|P5|STARTED|Phase II: Expansion||208
5035454|NCT02055820|12391974|P4|STARTED|Phase II: Expansion||0
5035455|NCT02055820|12391975|P3|STARTED|Phase II: Expansion||0
5035456|NCT02055820|12391976|P2|STARTED|Phase II: Expansion||0
5035457|NCT02055820|12391977|P1|STARTED|Phase II: Expansion||0
5035458|NCT02055820|12391968|P10|NOT COMPLETED|Phase I: Dose-Finding||0
5035459|NCT02055820|12391969|P9|NOT COMPLETED|Phase I: Dose-Finding||0
5035460|NCT02055820|12391970|P8|NOT COMPLETED|Phase I: Dose-Finding||0
5035461|NCT02055820|12391971|P7|NOT COMPLETED|Phase I: Dose-Finding||2
5035462|NCT02055820|12391972|P6|NOT COMPLETED|Phase I: Dose-Finding||2
5035463|NCT02055820|12391973|P5|NOT COMPLETED|Phase I: Dose-Finding||0
5035464|NCT02055820|12391974|P4|NOT COMPLETED|Phase I: Dose-Finding||3
5035465|NCT02055820|12391975|P3|NOT COMPLETED|Phase I: Dose-Finding||1
5035466|NCT02055820|12391976|P2|NOT COMPLETED|Phase I: Dose-Finding||0
5035467|NCT02055820|12391977|P1|NOT COMPLETED|Phase I: Dose-Finding||1
5035468|NCT02055820|12391968|P10|COMPLETED|Phase I: Dose-Finding||6
5035469|NCT02055820|12391969|P9|COMPLETED|Phase I: Dose-Finding||6
5035470|NCT02055820|12391970|P8|COMPLETED|Phase I: Dose-Finding||6
5035471|NCT02055820|12391971|P7|COMPLETED|Phase I: Dose-Finding||5
5035472|NCT02055820|12391972|P6|COMPLETED|Phase I: Dose-Finding||5
5035473|NCT02055820|12391973|P5|COMPLETED|Phase I: Dose-Finding||0
5035474|NCT02055820|12391974|P4|COMPLETED|Phase I: Dose-Finding||3
5035475|NCT02055820|12391975|P3|COMPLETED|Phase I: Dose-Finding||7
5035476|NCT02055820|12391976|P2|COMPLETED|Phase I: Dose-Finding||3
5035477|NCT02055820|12391977|P1|COMPLETED|Phase I: Dose-Finding||6
5035478|NCT02055820|12391968|P10|STARTED|Phase I: Dose-Finding||6
5035479|NCT02055820|12391969|P9|STARTED|Phase I: Dose-Finding||6
5035480|NCT02055820|12391970|P8|STARTED|Phase I: Dose-Finding||6
5035481|NCT02055820|12391971|P7|STARTED|Phase I: Dose-Finding||7
5035482|NCT02055820|12391972|P6|STARTED|Phase I: Dose-Finding||7
5035483|NCT02055820|12391973|P5|STARTED|Phase I: Dose-Finding||0
5035484|NCT02055820|12391974|P4|STARTED|Phase I: Dose-Finding||6
5035485|NCT02055820|12391975|P3|STARTED|Phase I: Dose-Finding||8
5035486|NCT02055820|12391976|P2|STARTED|Phase I: Dose-Finding||3
5035487|NCT02055820|12391977|P1|STARTED|Phase I: Dose-Finding||7
5035488|NCT02055638|12392081|P2|NOT COMPLETED|Overall Study||8
5035489|NCT02055638|12392082|P1|NOT COMPLETED|Overall Study||10
5035490|NCT02055638|12392081|P2|COMPLETED|Overall Study||40
5035491|NCT02055638|12392082|P1|COMPLETED|Overall Study||39
5035492|NCT02055638|12392081|P2|STARTED|Overall Study||48
5035493|NCT02055638|12392082|P1|STARTED|Overall Study||49
5035494|NCT02055547|12392088|P19|NOT COMPLETED|Overall Study||0
5035495|NCT02055547|12392089|P18|NOT COMPLETED|Overall Study||0
5035496|NCT02055547|12392090|P17|NOT COMPLETED|Overall Study||0
5035497|NCT02055547|12392091|P16|NOT COMPLETED|Overall Study||1
5035498|NCT02055547|12392092|P15|NOT COMPLETED|Overall Study||0
5035499|NCT02055547|12392093|P14|NOT COMPLETED|Overall Study||1
5035500|NCT02055547|12392094|P13|NOT COMPLETED|Overall Study||0
5035501|NCT02055547|12392095|P12|NOT COMPLETED|Overall Study||0
5035502|NCT02055547|12392096|P11|NOT COMPLETED|Overall Study||1
5035503|NCT02055547|12392097|P10|NOT COMPLETED|Overall Study||1
5035504|NCT02055547|12392098|P9|NOT COMPLETED|Overall Study||2
5035505|NCT02055547|12392099|P8|NOT COMPLETED|Overall Study||0
5035506|NCT02055547|12392100|P7|NOT COMPLETED|Overall Study||2
5035507|NCT02055547|12392101|P6|NOT COMPLETED|Overall Study||1
5035508|NCT02055547|12392102|P5|NOT COMPLETED|Overall Study||1
5035509|NCT02055547|12392103|P4|NOT COMPLETED|Overall Study||0
5035510|NCT02055547|12392104|P3|NOT COMPLETED|Overall Study||3
5035511|NCT02055547|12392105|P2|NOT COMPLETED|Overall Study||1
5035512|NCT02055547|12392106|P1|NOT COMPLETED|Overall Study||0
5035513|NCT02055547|12392088|P19|COMPLETED|Overall Study||2
5035514|NCT02055547|12392089|P18|COMPLETED|Overall Study||2
5035515|NCT02055547|12392090|P17|COMPLETED|Overall Study||2
5035516|NCT02055547|12392091|P16|COMPLETED|Overall Study||1
5035517|NCT02055547|12392092|P15|COMPLETED|Overall Study||2
5035518|NCT02055547|12392093|P14|COMPLETED|Overall Study||1
5035519|NCT02055547|12392094|P13|COMPLETED|Overall Study||2
5035520|NCT02055547|12392095|P12|COMPLETED|Overall Study||6
5035521|NCT02055547|12392096|P11|COMPLETED|Overall Study||5
5035522|NCT02055547|12392097|P10|COMPLETED|Overall Study||5
5035523|NCT02055547|12392098|P9|COMPLETED|Overall Study||4
5035524|NCT02055547|12392099|P8|COMPLETED|Overall Study||6
5035525|NCT02055547|12392100|P7|COMPLETED|Overall Study||0
5035526|NCT02055547|12392101|P6|COMPLETED|Overall Study||1
5035527|NCT02055547|12392102|P5|COMPLETED|Overall Study||1
5035528|NCT02055547|12392103|P4|COMPLETED|Overall Study||2
5035529|NCT02055547|12392104|P3|COMPLETED|Overall Study||2
5035530|NCT02055547|12392105|P2|COMPLETED|Overall Study||1
5035531|NCT02055547|12392106|P1|COMPLETED|Overall Study||2
5035532|NCT02055547|12392088|P19|STARTED|Overall Study||2
5035533|NCT02055547|12392089|P18|STARTED|Overall Study||2
5035534|NCT02055547|12392090|P17|STARTED|Overall Study||2
5035535|NCT02055547|12392091|P16|STARTED|Overall Study||2
5035536|NCT02055547|12392092|P15|STARTED|Overall Study||2
5035537|NCT02055547|12392093|P14|STARTED|Overall Study||2
5035538|NCT02055547|12392094|P13|STARTED|Overall Study||2
5035539|NCT02055547|12392095|P12|STARTED|Overall Study||6
5035540|NCT02055547|12392096|P11|STARTED|Overall Study||6
5035541|NCT02055547|12392097|P10|STARTED|Overall Study||6
5035542|NCT02055547|12392098|P9|STARTED|Overall Study||6
5035543|NCT02055547|12392099|P8|STARTED|Overall Study||6
5035544|NCT02055547|12392100|P7|STARTED|Overall Study||2
5035545|NCT02055547|12392101|P6|STARTED|Overall Study||2
5035546|NCT02055547|12392102|P5|STARTED|Overall Study||2
5035547|NCT02055547|12392103|P4|STARTED|Overall Study||2
5035548|NCT02055547|12392104|P3|STARTED|Overall Study||5
5035549|NCT02055547|12392105|P2|STARTED|Overall Study||2
5035550|NCT02055547|12392106|P1|STARTED|Overall Study||2
5035551|NCT02055430|12392255|P2|NOT COMPLETED|Overall Study||0
5035552|NCT02055430|12392256|P1|NOT COMPLETED|Overall Study||0
5035553|NCT02055430|12392255|P2|COMPLETED|Overall Study||45
5035554|NCT02055430|12392256|P1|COMPLETED|Overall Study||45
5035555|NCT02055430|12392255|P2|STARTED|Overall Study||45
5035556|NCT02055430|12392256|P1|STARTED|Overall Study||45
5035557|NCT02055404|12392262|P1|NOT COMPLETED|Overall Study||0
5035558|NCT02055404|12392262|P1|COMPLETED|Overall Study||3
5035559|NCT02055404|12392262|P1|STARTED|Overall Study||3
5035560|NCT02055365|12392275|P1|NOT COMPLETED|Overall Study||1
5035561|NCT02055365|12392275|P1|COMPLETED|Overall Study||9
5035562|NCT02055365|12392275|P1|STARTED|Overall Study||10
5035563|NCT02055352|12392288|P2|NOT COMPLETED|Overall Study||17
5035564|NCT02055352|12392289|P1|NOT COMPLETED|Overall Study||6
5035565|NCT02055352|12392288|P2|COMPLETED|Overall Study||96
5035566|NCT02055352|12392289|P1|COMPLETED|Overall Study||103
5035567|NCT02055352|12392288|P2|Per-Protocol Set (PPS)|Overall Study||111
5035568|NCT02055352|12392289|P1|Per-Protocol Set (PPS)|Overall Study||108
5035569|NCT02055352|12392288|P2|STARTED|Overall Study||113
5035570|NCT02055352|12392289|P1|STARTED|Overall Study||109
5035571|NCT02055118|12392306|P3|NOT COMPLETED|Overall Study||0
5035572|NCT02055118|12392307|P2|NOT COMPLETED|Overall Study||2
5035573|NCT02055118|12392308|P1|NOT COMPLETED|Overall Study||0
5035574|NCT02055118|12392306|P3|COMPLETED|Overall Study||9
5035575|NCT02055118|12392307|P2|COMPLETED|Overall Study||32
5035576|NCT02055118|12392308|P1|COMPLETED|Overall Study||15
5035577|NCT02055118|12392306|P3|STARTED|Overall Study||9
5035578|NCT02055118|12392307|P2|STARTED|Overall Study||34
5035579|NCT02055118|12392308|P1|STARTED|Overall Study||15
5035580|NCT02054910|12392367|P2|NOT COMPLETED|Overall Study||1
5035581|NCT02054910|12392368|P1|NOT COMPLETED|Overall Study||4
5035582|NCT02054910|12392367|P2|COMPLETED|Overall Study||0
5035583|NCT02054910|12392368|P1|COMPLETED|Overall Study||0
5035584|NCT02054910|12392367|P2|STARTED|Overall Study||1
5035585|NCT02054910|12392368|P1|STARTED|Overall Study||4
5035586|NCT02054897|12392387|P3|NOT COMPLETED|Overall Study||12
5035587|NCT02054897|12392388|P2|NOT COMPLETED|Overall Study||7
5035588|NCT02054897|12392389|P1|NOT COMPLETED|Overall Study||10
5035589|NCT02054897|12392387|P3|COMPLETED|Overall Study||117
5035590|NCT02054897|12392388|P2|COMPLETED|Overall Study||123
5035591|NCT02054897|12392389|P1|COMPLETED|Overall Study||119
5035592|NCT02054897|12392387|P3|Exposed|Overall Study||129
5035593|NCT02054897|12392388|P2|Exposed|Overall Study||130
5035594|NCT02054897|12392389|P1|Exposed|Overall Study||128
5035595|NCT02054897|12392387|P3|STARTED|Overall Study||129
5035596|NCT02054897|12392388|P2|STARTED|Overall Study||130
5035597|NCT02054897|12392389|P1|STARTED|Overall Study||129
5035598|NCT02054754|12392414|P6|NOT COMPLETED|Overall Study||0
5035599|NCT02054754|12392415|P5|NOT COMPLETED|Overall Study||0
5035600|NCT02054754|12392416|P4|NOT COMPLETED|Overall Study||0
5035601|NCT02054754|12392417|P3|NOT COMPLETED|Overall Study||0
5035602|NCT02054754|12392418|P2|NOT COMPLETED|Overall Study||0
5035603|NCT02054754|12392419|P1|NOT COMPLETED|Overall Study||0
5035604|NCT02054754|12392414|P6|COMPLETED|Overall Study||10
5035605|NCT02054754|12392415|P5|COMPLETED|Overall Study||6
5035606|NCT02054754|12392416|P4|COMPLETED|Overall Study||6
5035607|NCT02054754|12392417|P3|COMPLETED|Overall Study||6
5035608|NCT02054754|12392418|P2|COMPLETED|Overall Study||6
5035609|NCT02054754|12392419|P1|COMPLETED|Overall Study||6
5035610|NCT02054754|12392414|P6|STARTED|Overall Study||10
5035611|NCT02054754|12392415|P5|STARTED|Overall Study||6
5035612|NCT02054754|12392416|P4|STARTED|Overall Study||6
5035613|NCT02054754|12392417|P3|STARTED|Overall Study||6
5035614|NCT02054754|12392418|P2|STARTED|Overall Study||6
5035615|NCT02054754|12392419|P1|STARTED|Overall Study||6
5035616|NCT02054715|12392436|P2|NOT COMPLETED|Follow-up 2||19
5035617|NCT02054715|12392437|P1|NOT COMPLETED|Follow-up 2||19
5035618|NCT02054715|12392436|P2|COMPLETED|Follow-up 2||173
5035619|NCT02054715|12392437|P1|COMPLETED|Follow-up 2||192
5035620|NCT02054715|12392436|P2|STARTED|Follow-up 2||192
5035621|NCT02054715|12392437|P1|STARTED|Follow-up 2||211
5035622|NCT02054715|12392436|P2|NOT COMPLETED|Baseline/Follow-up 1||7
5035623|NCT02054715|12392437|P1|NOT COMPLETED|Baseline/Follow-up 1||8
5035624|NCT02054715|12392436|P2|COMPLETED|Baseline/Follow-up 1||192
5035625|NCT02054715|12392437|P1|COMPLETED|Baseline/Follow-up 1||211
5035626|NCT02054715|12392436|P2|STARTED|Baseline/Follow-up 1||199
5035627|NCT02054715|12392437|P1|STARTED|Baseline/Follow-up 1||219
5035628|NCT02054702|12392451|P2|NOT COMPLETED|Overall Study||12
5035629|NCT02054702|12392452|P1|NOT COMPLETED|Overall Study||24
5035630|NCT02054702|12392451|P2|COMPLETED|Overall Study||21
5035631|NCT02054702|12392452|P1|COMPLETED|Overall Study||40
5035632|NCT02054702|12392451|P2|STARTED|Overall Study||33
5035633|NCT02054702|12392452|P1|STARTED|Overall Study||64
5035634|NCT02054572|12392480|P1|NOT COMPLETED|Overall Study||0
5035635|NCT02054572|12392480|P1|COMPLETED|Overall Study||6
5035636|NCT02054572|12392480|P1|STARTED|Overall Study||6
5035637|NCT02054520|12392509|P6|NOT COMPLETED|Overall Study||3
5035638|NCT02054520|12392510|P5|NOT COMPLETED|Overall Study||5
5035639|NCT02054520|12392511|P4|NOT COMPLETED|Overall Study||6
5035640|NCT02054520|12392512|P3|NOT COMPLETED|Overall Study||6
5035641|NCT02054520|12392513|P2|NOT COMPLETED|Overall Study||5
5035642|NCT02054520|12392514|P1|NOT COMPLETED|Overall Study||9
5035643|NCT02054520|12392509|P6|COMPLETED|Overall Study||0
5035644|NCT02054520|12392510|P5|COMPLETED|Overall Study||0
5035645|NCT02054520|12392511|P4|COMPLETED|Overall Study||0
5035646|NCT02054520|12392512|P3|COMPLETED|Overall Study||0
5035647|NCT02054520|12392513|P2|COMPLETED|Overall Study||11
5035648|NCT02054520|12392514|P1|COMPLETED|Overall Study||2
5035649|NCT02054520|12392509|P6|STARTED|Overall Study||3
5035650|NCT02054520|12392510|P5|STARTED|Overall Study||5
5035651|NCT02054520|12392511|P4|STARTED|Overall Study||6
5035652|NCT02054520|12392512|P3|STARTED|Overall Study||6
5035653|NCT02054520|12392513|P2|STARTED|Overall Study||16
5035654|NCT02054520|12392514|P1|STARTED|Overall Study||11
5035655|NCT02054481|12392538|P4|NOT COMPLETED|Overall Study||1
5035656|NCT02054481|12392539|P3|NOT COMPLETED|Overall Study||2
5035657|NCT02054481|12392540|P2|NOT COMPLETED|Overall Study||2
5035658|NCT02054481|12392541|P1|NOT COMPLETED|Overall Study||4
5035659|NCT02054481|12392538|P4|COMPLETED|Overall Study||39
5035660|NCT02054481|12392539|P3|COMPLETED|Overall Study||40
5035661|NCT02054481|12392540|P2|COMPLETED|Overall Study||39
5035662|NCT02054481|12392541|P1|COMPLETED|Overall Study||39
5035663|NCT02054481|12392538|P4|STARTED|Overall Study||40
5035664|NCT02054481|12392539|P3|STARTED|Overall Study||42
5035665|NCT02054481|12392540|P2|STARTED|Overall Study||41
5035666|NCT02054481|12392541|P1|STARTED|Overall Study||43
5035667|NCT02054338|12392589|P2|NOT COMPLETED|Overall Study||501
5035668|NCT02054338|12392590|P1|NOT COMPLETED|Overall Study||503
5035669|NCT02054338|12392589|P2|COMPLETED|Overall Study||0
5035670|NCT02054338|12392590|P1|COMPLETED|Overall Study||0
5035671|NCT02054338|12392589|P2|STARTED|Overall Study||501
5035672|NCT02054338|12392590|P1|STARTED|Overall Study||503
5035673|NCT02054325|12392602|P2|NOT COMPLETED|Overall Study||5
5035674|NCT02054325|12392603|P1|NOT COMPLETED|Overall Study||8
5035675|NCT02054325|12392602|P2|COMPLETED|Overall Study||50
5035676|NCT02054325|12392603|P1|COMPLETED|Overall Study||43
5035677|NCT02054325|12392602|P2|STARTED|Overall Study||55
5035678|NCT02054325|12392603|P1|STARTED|Overall Study||51
5035679|NCT02054156|12392613|P2|NOT COMPLETED|Overall Study||81
5035680|NCT02054156|12392614|P1|NOT COMPLETED|Overall Study||75
5035681|NCT02054156|12392613|P2|COMPLETED|Overall Study||30
5035682|NCT02054156|12392614|P1|COMPLETED|Overall Study||35
5035683|NCT02054156|12392613|P2|STARTED|Overall Study||111
5035684|NCT02054156|12392614|P1|STARTED|Overall Study||110
5035685|NCT02054130|12392630|P4|NOT COMPLETED|Overall Study||22
5035686|NCT02054130|12392631|P3|NOT COMPLETED|Overall Study||15
5035687|NCT02054130|12392632|P2|NOT COMPLETED|Overall Study||11
5035688|NCT02054130|12392633|P1|NOT COMPLETED|Overall Study||8
5035689|NCT02054130|12392630|P4|COMPLETED|Overall Study||115
5035690|NCT02054130|12392631|P3|COMPLETED|Overall Study||122
5035691|NCT02054130|12392632|P2|COMPLETED|Overall Study||127
5035692|NCT02054130|12392633|P1|COMPLETED|Overall Study||130
5035693|NCT02054130|12392630|P4|STARTED|Overall Study||137
5035694|NCT02054130|12392631|P3|STARTED|Overall Study||137
5035695|NCT02054130|12392632|P2|STARTED|Overall Study||138
5035696|NCT02054130|12392633|P1|STARTED|Overall Study||138
5035697|NCT02053753|12392727|P2|NOT COMPLETED|Overall Study||8
5035698|NCT02053753|12392728|P1|NOT COMPLETED|Overall Study||7
5035699|NCT02053753|12392727|P2|COMPLETED|Overall Study||66
5035700|NCT02053753|12392728|P1|COMPLETED|Overall Study||65
5035701|NCT02053753|12392727|P2|Received Treatment|Overall Study||71
5035702|NCT02053753|12392728|P1|Received Treatment|Overall Study||71
5035703|NCT02053753|12392727|P2|STARTED|Overall Study||74
5035704|NCT02053753|12392728|P1|STARTED|Overall Study||72
5035705|NCT02053610|12392752|P2|NOT COMPLETED|Overall Study||67
5035706|NCT02053610|12392753|P1|NOT COMPLETED|Overall Study||42
5035707|NCT02053610|12392752|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
5035708|NCT02053610|12392753|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
5035709|NCT02053610|12392752|P2|Received Study Drug|Overall Study||331
5035710|NCT02053610|12392753|P1|Received Study Drug|Overall Study||326
5035711|NCT02053610|12392752|P2|STARTED|Overall Study||333
5035712|NCT02053610|12392753|P1|STARTED|Overall Study||330
5035713|NCT02053493|12392785|P2|NOT COMPLETED|Overall Study||1
5035714|NCT02053493|12392786|P1|NOT COMPLETED|Overall Study||1
5035715|NCT02053493|12392785|P2|COMPLETED|Overall Study||58
5035716|NCT02053493|12392786|P1|COMPLETED|Overall Study||50
5035717|NCT02053493|12392785|P2|STARTED|Overall Study||59
5035718|NCT02053493|12392786|P1|STARTED|Overall Study||51
5035719|NCT02053376|12392824|P1|NOT COMPLETED|Overall Study||0
5035720|NCT02053376|12392824|P1|COMPLETED|Overall Study||43
5035721|NCT02053376|12392824|P1|STARTED|Overall Study||43
5035722|NCT02053259|12392839|P4|NOT COMPLETED|Overall Study||0
5035723|NCT02053259|12392840|P3|NOT COMPLETED|Overall Study||0
5035724|NCT02053259|12392841|P2|NOT COMPLETED|Overall Study||0
5035725|NCT02053259|12392842|P1|NOT COMPLETED|Overall Study||0
5035726|NCT02053259|12392839|P4|COMPLETED|Overall Study||23
5035727|NCT02053259|12392840|P3|COMPLETED|Overall Study||24
5035728|NCT02053259|12392841|P2|COMPLETED|Overall Study||24
5035729|NCT02053259|12392842|P1|COMPLETED|Overall Study||25
5035730|NCT02053259|12392839|P4|STARTED|Overall Study||23
5035731|NCT02053259|12392840|P3|STARTED|Overall Study||24
5035732|NCT02053259|12392841|P2|STARTED|Overall Study||24
5035733|NCT02053259|12392842|P1|STARTED|Overall Study||25
5035734|NCT02053168|12392852|P1|NOT COMPLETED|Overall Study||3
5035735|NCT02053168|12392852|P1|COMPLETED|Overall Study||22
5035736|NCT02053168|12392852|P1|STARTED|Overall Study||25
5035737|NCT02052895|12392869|P3|NOT COMPLETED|Overall Study||0
5035738|NCT02052895|12392870|P2|NOT COMPLETED|Overall Study||0
5035739|NCT02052895|12392871|P1|NOT COMPLETED|Overall Study||0
5035740|NCT02052895|12392869|P3|COMPLETED|Overall Study||15
5035741|NCT02052895|12392870|P2|COMPLETED|Overall Study||15
5035742|NCT02052895|12392871|P1|COMPLETED|Overall Study||196
5035743|NCT02052895|12392869|P3|STARTED|Overall Study||15
5035744|NCT02052895|12392870|P2|STARTED|Overall Study||15
5035745|NCT02052895|12392871|P1|STARTED|Overall Study||196
5035746|NCT02052752|12392881|P3|NOT COMPLETED|Overall Study||0
5035747|NCT02052752|12392882|P2|NOT COMPLETED|Overall Study||0
5035748|NCT02052752|12392883|P1|NOT COMPLETED|Overall Study||0
5035749|NCT02052752|12392881|P3|COMPLETED|Overall Study||30
5035750|NCT02052752|12392882|P2|COMPLETED|Overall Study||30
5035751|NCT02052752|12392883|P1|COMPLETED|Overall Study||30
5035752|NCT02052752|12392881|P3|STARTED|Overall Study||30
5035753|NCT02052752|12392882|P2|STARTED|Overall Study||30
5035754|NCT02052752|12392883|P1|STARTED|Overall Study||30
5035755|NCT02052661|12392906|P1|NOT COMPLETED|Overall Study||0
5035756|NCT02052661|12392906|P1|COMPLETED|Overall Study||300
5035757|NCT02052661|12392906|P1|STARTED|Overall Study||300
5035758|NCT02052635|12392920|P2|NOT COMPLETED|Overall Study||0
5035759|NCT02052635|12392921|P1|NOT COMPLETED|Overall Study||0
5035760|NCT02052635|12392920|P2|COMPLETED|Overall Study||6
5035761|NCT02052635|12392921|P1|COMPLETED|Overall Study||7
5035762|NCT02052635|12392920|P2|STARTED|Overall Study||6
5035763|NCT02052635|12392921|P1|STARTED|Overall Study||7
5035764|NCT02052596|12392931|P2|NOT COMPLETED|Safety Phase||35
5035765|NCT02052596|12392932|P1|NOT COMPLETED|Safety Phase||27
5035766|NCT02052596|12392931|P2|COMPLETED|Safety Phase||383
5035767|NCT02052596|12392932|P1|COMPLETED|Safety Phase||385
5035768|NCT02052596|12392931|P2|STARTED|Safety Phase||418
5035769|NCT02052596|12392932|P1|STARTED|Safety Phase||412
5035770|NCT02052596|12392931|P2|NOT COMPLETED|Active Phase||20
5035771|NCT02052596|12392932|P1|NOT COMPLETED|Active Phase||16
5035772|NCT02052596|12392931|P2|COMPLETED|Active Phase||398
5035773|NCT02052596|12392932|P1|COMPLETED|Active Phase||396
5035774|NCT02052596|12392931|P2|STARTED|Active Phase||418
5035775|NCT02052596|12392932|P1|STARTED|Active Phase||412
5035776|NCT02052544|12392957|P1|NOT COMPLETED|Overall Study||0
5035777|NCT02052544|12392957|P1|COMPLETED|Overall Study|Last Subject Out|123
5035778|NCT02052544|12392957|P1|STARTED|Overall Study|First Subject In|123
5035779|NCT02052466|12392962|P1|NOT COMPLETED|Overall Study||2
5035780|NCT02052466|12392962|P1|COMPLETED|Overall Study||30
5035781|NCT02052466|12392962|P1|STARTED|Overall Study||32
5035782|NCT02052440|12392979|P2|NOT COMPLETED|Overall Study||1
5035783|NCT02052440|12392980|P1|NOT COMPLETED|Overall Study||0
5035784|NCT02052440|12392979|P2|COMPLETED|Overall Study||51
5035785|NCT02052440|12392980|P1|COMPLETED|Overall Study||50
5035786|NCT02052440|12392979|P2|STARTED|Overall Study||52
5035787|NCT02052440|12392980|P1|STARTED|Overall Study||50
5035788|NCT02052414|12392992|P1|NOT COMPLETED|Overall Study||17
5035789|NCT02052414|12392992|P1|COMPLETED|Overall Study||17
5035790|NCT02052414|12392992|P1|STARTED|Overall Study||34
5035791|NCT02052141|12393002|P2|NOT COMPLETED|Intervention Period 2||0
5035792|NCT02052141|12393003|P1|NOT COMPLETED|Intervention Period 2||0
5035793|NCT02052141|12393002|P2|COMPLETED|Intervention Period 2||7
5035794|NCT02052141|12393003|P1|COMPLETED|Intervention Period 2||5
5035795|NCT02052141|12393002|P2|STARTED|Intervention Period 2||7
5035796|NCT02052141|12393003|P1|STARTED|Intervention Period 2||5
5035797|NCT02052141|12393002|P2|NOT COMPLETED|Intervention Period 1||0
5035798|NCT02052141|12393003|P1|NOT COMPLETED|Intervention Period 1||0
5035799|NCT02052141|12393002|P2|COMPLETED|Intervention Period 1||7
5035800|NCT02052141|12393003|P1|COMPLETED|Intervention Period 1||5
5035801|NCT02052141|12393002|P2|STARTED|Intervention Period 1||7
5035802|NCT02052141|12393003|P1|STARTED|Intervention Period 1||5
5035803|NCT02052011|12393027|P2|NOT COMPLETED|Overall Study||2
5035804|NCT02052011|12393028|P1|NOT COMPLETED|Overall Study||4
5035805|NCT02052011|12393027|P2|COMPLETED|Overall Study||8
5035806|NCT02052011|12393028|P1|COMPLETED|Overall Study||17
5035807|NCT02052011|12393027|P2|STARTED|Overall Study||10
5035808|NCT02052011|12393028|P1|STARTED|Overall Study||21
5035809|NCT02051816|12393038|P4|NOT COMPLETED|Overall Study||0
5035810|NCT02051816|12393039|P3|NOT COMPLETED|Overall Study||0
5035811|NCT02051816|12393040|P2|NOT COMPLETED|Overall Study||0
5035812|NCT02051816|12393041|P1|NOT COMPLETED|Overall Study||0
5035813|NCT02051816|12393038|P4|COMPLETED|Overall Study||36
5035814|NCT02051816|12393039|P3|COMPLETED|Overall Study||37
5035815|NCT02051816|12393040|P2|COMPLETED|Overall Study||40
5035816|NCT02051816|12393041|P1|COMPLETED|Overall Study||37
5035817|NCT02051816|12393038|P4|STARTED|Overall Study||36
5035818|NCT02051816|12393039|P3|STARTED|Overall Study||37
5035819|NCT02051816|12393040|P2|STARTED|Overall Study||40
5035820|NCT02051816|12393041|P1|STARTED|Overall Study||37
5035821|NCT02051790|12393079|P1|NOT COMPLETED|Overall Study||0
5035822|NCT02051790|12393079|P1|COMPLETED|Overall Study||241
5035823|NCT02051790|12393079|P1|STARTED|Overall Study||241
5035824|NCT02051686|12393085|P2|NOT COMPLETED|Overall Study||0
5035825|NCT02051686|12393086|P1|NOT COMPLETED|Overall Study||0
5035826|NCT02051686|12393085|P2|COMPLETED|Overall Study||46
5035827|NCT02051686|12393086|P1|COMPLETED|Overall Study||42
5035828|NCT02051686|12393085|P2|STARTED|Overall Study||46
5035829|NCT02051686|12393086|P1|STARTED|Overall Study||42
5035830|NCT02051595|12393094|P1|NOT COMPLETED|Overall Study||0
5035831|NCT02051595|12393094|P1|COMPLETED|Overall Study||25
5035832|NCT02051595|12393094|P1|STARTED|Overall Study||25
5035833|NCT02051452|12393100|P2|NOT COMPLETED|Overall Study||0
5035834|NCT02051452|12393101|P1|NOT COMPLETED|Overall Study||0
5035835|NCT02051452|12393100|P2|COMPLETED|Overall Study||16
5035836|NCT02051452|12393101|P1|COMPLETED|Overall Study||16
5035837|NCT02051452|12393100|P2|STARTED|Overall Study||16
5035838|NCT02051452|12393101|P1|STARTED|Overall Study||16
5035839|NCT02051426|12393113|P2|NOT COMPLETED|Second Intervention||0
5035840|NCT02051426|12393114|P1|NOT COMPLETED|Second Intervention||0
5035841|NCT02051426|12393113|P2|COMPLETED|Second Intervention||19
5035842|NCT02051426|12393114|P1|COMPLETED|Second Intervention||16
5035843|NCT02051426|12393113|P2|STARTED|Second Intervention||19
5035844|NCT02051426|12393114|P1|STARTED|Second Intervention||16
5035845|NCT02051426|12393113|P2|NOT COMPLETED|Washout Period of 1 Month||0
5035846|NCT02051426|12393114|P1|NOT COMPLETED|Washout Period of 1 Month||0
5035847|NCT02051426|12393113|P2|COMPLETED|Washout Period of 1 Month||19
5035848|NCT02051426|12393114|P1|COMPLETED|Washout Period of 1 Month||16
5035849|NCT02051426|12393113|P2|STARTED|Washout Period of 1 Month||19
5035850|NCT02051426|12393114|P1|STARTED|Washout Period of 1 Month||16
5035851|NCT02051426|12393113|P2|NOT COMPLETED|First Intervention||0
5035852|NCT02051426|12393114|P1|NOT COMPLETED|First Intervention||0
5035853|NCT02051426|12393113|P2|COMPLETED|First Intervention||19
5035854|NCT02051426|12393114|P1|COMPLETED|First Intervention||16
5035855|NCT02051426|12393113|P2|STARTED|First Intervention||19
5035856|NCT02051426|12393114|P1|STARTED|First Intervention||16
5035857|NCT02051335|12393128|P4|NOT COMPLETED|Period 4||0
5035858|NCT02051335|12393129|P3|NOT COMPLETED|Period 4||0
5035859|NCT02051335|12393130|P2|NOT COMPLETED|Period 4||0
5035860|NCT02051335|12393131|P1|NOT COMPLETED|Period 4||0
5035861|NCT02051335|12393128|P4|COMPLETED|Period 4||4
5035862|NCT02051335|12393129|P3|COMPLETED|Period 4||5
5035863|NCT02051335|12393130|P2|COMPLETED|Period 4||7
5035864|NCT02051335|12393131|P1|COMPLETED|Period 4||7
5035865|NCT02051335|12393128|P4|STARTED|Period 4||4
5035866|NCT02051335|12393129|P3|STARTED|Period 4||5
5035867|NCT02051335|12393130|P2|STARTED|Period 4||7
5035868|NCT02051335|12393131|P1|STARTED|Period 4||7
5035869|NCT02051335|12393128|P4|NOT COMPLETED|Period 3||0
5035870|NCT02051335|12393129|P3|NOT COMPLETED|Period 3||0
5035871|NCT02051335|12393130|P2|NOT COMPLETED|Period 3||0
5035872|NCT02051335|12393131|P1|NOT COMPLETED|Period 3||0
5035873|NCT02051335|12393128|P4|COMPLETED|Period 3||4
5035874|NCT02051335|12393129|P3|COMPLETED|Period 3||5
5035875|NCT02051335|12393130|P2|COMPLETED|Period 3||7
5035876|NCT02051335|12393131|P1|COMPLETED|Period 3||7
5035877|NCT02051335|12393128|P4|STARTED|Period 3||4
5035974|NCT02049931|12393353|P2|STARTED|Overall Study||20
5035878|NCT02051335|12393129|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
5035879|NCT02051335|12393130|P2|STARTED|Period 3||7
5035880|NCT02051335|12393131|P1|STARTED|Period 3||7
5035881|NCT02051335|12393128|P4|NOT COMPLETED|Period 2||0
5035882|NCT02051335|12393129|P3|NOT COMPLETED|Period 2||0
5035883|NCT02051335|12393130|P2|NOT COMPLETED|Period 2||0
5035884|NCT02051335|12393131|P1|NOT COMPLETED|Period 2||0
5035885|NCT02051335|12393128|P4|COMPLETED|Period 2||4
5035886|NCT02051335|12393129|P3|COMPLETED|Period 2||7
5035887|NCT02051335|12393130|P2|COMPLETED|Period 2||7
5035888|NCT02051335|12393131|P1|COMPLETED|Period 2||7
5035889|NCT02051335|12393128|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
5035890|NCT02051335|12393129|P3|STARTED|Period 2||7
5035891|NCT02051335|12393130|P2|STARTED|Period 2||7
5035892|NCT02051335|12393131|P1|STARTED|Period 2||7
5035893|NCT02051335|12393128|P4|NOT COMPLETED|Period 1||0
5035894|NCT02051335|12393129|P3|NOT COMPLETED|Period 1||0
5035895|NCT02051335|12393130|P2|NOT COMPLETED|Period 1||0
5035896|NCT02051335|12393131|P1|NOT COMPLETED|Period 1||0
5035897|NCT02051335|12393128|P4|COMPLETED|Period 1||6
5035898|NCT02051335|12393129|P3|COMPLETED|Period 1||7
5035899|NCT02051335|12393130|P2|COMPLETED|Period 1||7
5035900|NCT02051335|12393131|P1|COMPLETED|Period 1||7
5035901|NCT02051335|12393128|P4|STARTED|Period 1||6
5035902|NCT02051335|12393129|P3|STARTED|Period 1||7
5035903|NCT02051335|12393130|P2|STARTED|Period 1||7
5035904|NCT02051335|12393131|P1|STARTED|Period 1||7
5035905|NCT02051296|12393183|P2|NOT COMPLETED|Overall Study||9
5035906|NCT02051296|12393184|P1|NOT COMPLETED|Overall Study||8
5035907|NCT02051296|12393183|P2|COMPLETED|Overall Study||56
5035908|NCT02051296|12393184|P1|COMPLETED|Overall Study||58
5035909|NCT02051296|12393183|P2|Received Allocated Intervention|Overall Study||58
5035910|NCT02051296|12393184|P1|Received Allocated Intervention|Overall Study||59
5035911|NCT02051296|12393183|P2|STARTED|Overall Study||65
5035912|NCT02051296|12393184|P1|STARTED|Overall Study||66
5035913|NCT02050919|12393190|P1|NOT COMPLETED|Overall Study||0
5035914|NCT02050919|12393190|P1|COMPLETED|Overall Study||20
5035915|NCT02050919|12393190|P1|STARTED|Overall Study||20
5035916|NCT02050841|12393194|P1|NOT COMPLETED|Overall Study||1
5035917|NCT02050841|12393194|P1|COMPLETED|Overall Study||49
5035918|NCT02050841|12393194|P1|STARTED|Overall Study||50
5035919|NCT02050334|12393235|P2|NOT COMPLETED|Overall Study||0
5035920|NCT02050334|12393236|P1|NOT COMPLETED|Overall Study||0
5035921|NCT02050334|12393235|P2|COMPLETED|Overall Study||9
5035922|NCT02050334|12393236|P1|COMPLETED|Overall Study||9
5035923|NCT02050334|12393235|P2|STARTED|Overall Study||9
5035924|NCT02050334|12393236|P1|STARTED|Overall Study||9
5035925|NCT02050321|12393244|P1|NOT COMPLETED|Overall Study||2
5035926|NCT02050321|12393244|P1|COMPLETED|Overall Study||0
5035927|NCT02050321|12393244|P1|STARTED|Overall Study||2
5035928|NCT02050308|12393251|P2|NOT COMPLETED|Overall Study||102
5035929|NCT02050308|12393252|P1|NOT COMPLETED|Overall Study||99
5035930|NCT02050308|12393251|P2|COMPLETED|Overall Study||22
5035931|NCT02050308|12393252|P1|COMPLETED|Overall Study||28
5035932|NCT02050308|12393251|P2|STARTED|Overall Study||124
5035933|NCT02050308|12393252|P1|STARTED|Overall Study||127
5035934|NCT02050048|12393260|P2|NOT COMPLETED|Overall Study||2
5035935|NCT02050048|12393261|P1|NOT COMPLETED|Overall Study||5
5035936|NCT02050048|12393260|P2|COMPLETED|Overall Study||10
5035937|NCT02050048|12393261|P1|COMPLETED|Overall Study||9
5035938|NCT02050048|12393260|P2|STARTED|Overall Study||12
5035939|NCT02050048|12393261|P1|STARTED|Overall Study||14
5035940|NCT02049957|12393276|P9|NOT COMPLETED|Overall Study||8
5035941|NCT02049957|12393277|P8|NOT COMPLETED|Overall Study||35
5035942|NCT02049957|12393278|P7|NOT COMPLETED|Overall Study||8
5035943|NCT02049957|12393279|P6|NOT COMPLETED|Overall Study||43
5035944|NCT02049957|12393280|P5|NOT COMPLETED|Overall Study||6
5035945|NCT02049957|12393281|P4|NOT COMPLETED|Overall Study||3
5035946|NCT02049957|12393282|P3|NOT COMPLETED|Overall Study||3
5035947|NCT02049957|12393283|P2|NOT COMPLETED|Overall Study||6
5035948|NCT02049957|12393284|P1|NOT COMPLETED|Overall Study||6
5035949|NCT02049957|12393276|P9|COMPLETED|Overall Study||0
5035950|NCT02049957|12393277|P8|COMPLETED|Overall Study||0
5035951|NCT02049957|12393278|P7|COMPLETED|Overall Study||0
5035952|NCT02049957|12393279|P6|COMPLETED|Overall Study||0
5035953|NCT02049957|12393280|P5|COMPLETED|Overall Study||0
5035954|NCT02049957|12393281|P4|COMPLETED|Overall Study||0
5035955|NCT02049957|12393282|P3|COMPLETED|Overall Study||0
5035956|NCT02049957|12393283|P2|COMPLETED|Overall Study||0
5035957|NCT02049957|12393284|P1|COMPLETED|Overall Study||0
5035958|NCT02049957|12393276|P9|STARTED|Overall Study||8
5035959|NCT02049957|12393277|P8|STARTED|Overall Study||35
5035960|NCT02049957|12393278|P7|STARTED|Overall Study||8
5035961|NCT02049957|12393279|P6|STARTED|Overall Study||43
5035962|NCT02049957|12393280|P5|STARTED|Overall Study||6
5035963|NCT02049957|12393281|P4|STARTED|Overall Study||3
5035964|NCT02049957|12393282|P3|STARTED|Overall Study||3
5035965|NCT02049957|12393283|P2|STARTED|Overall Study||6
5035966|NCT02049957|12393284|P1|STARTED|Overall Study||6
5035967|NCT02049931|12393352|P3|NOT COMPLETED|Overall Study||3
5035968|NCT02049931|12393353|P2|NOT COMPLETED|Overall Study||5
5035969|NCT02049931|12393354|P1|NOT COMPLETED|Overall Study||3
5035970|NCT02049931|12393352|P3|COMPLETED|Overall Study||17
5035971|NCT02049931|12393353|P2|COMPLETED|Overall Study||15
5035972|NCT02049931|12393354|P1|COMPLETED|Overall Study||17
5035973|NCT02049931|12393352|P3|STARTED|Overall Study||20
5035975|NCT02049931|12393354|P1|STARTED|Overall Study||20
5035976|NCT02049814|12393376|P2|NOT COMPLETED|Overall Study||27
5035977|NCT02049814|12393377|P1|NOT COMPLETED|Overall Study||29
5035978|NCT02049814|12393376|P2|COMPLETED|Overall Study||219
5035979|NCT02049814|12393377|P1|COMPLETED|Overall Study||219
5035980|NCT02049814|12393376|P2|Safety Set|Overall Study||245
5035981|NCT02049814|12393377|P1|Safety Set|Overall Study||248
5035982|NCT02049814|12393376|P2|STARTED|Overall Study||246
5035983|NCT02049814|12393377|P1|STARTED|Overall Study||248
5035984|NCT02049749|12393405|P2|NOT COMPLETED|Overall Study||0
5035985|NCT02049749|12393406|P1|NOT COMPLETED|Overall Study||0
5035986|NCT02049749|12393405|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
5035987|NCT02049749|12393406|P1|COMPLETED|Overall Study||80
5035988|NCT02049749|12393405|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
5035989|NCT02049749|12393406|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
5035990|NCT02049502|12393414|P1|NOT COMPLETED|Overall Study||0
5035991|NCT02049502|12393414|P1|COMPLETED|Overall Study||8
5035992|NCT02049502|12393414|P1|STARTED|Overall Study||8
5035993|NCT02049476|12393419|P1|NOT COMPLETED|Overall Study||0
5035994|NCT02049476|12393419|P1|COMPLETED|Overall Study|20th patient completed the study|20
5035995|NCT02049476|12393419|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
5035996|NCT02049450|12393426|P1|NOT COMPLETED|Overall Study||4
5035997|NCT02049450|12393426|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
5035998|NCT02049450|12393426|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
5035999|NCT02049450|12393426|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
5036000|NCT02049450|12393426|P1|STARTED|Overall Study||30
5036001|NCT02049385|12393440|P2|NOT COMPLETED|Second Intervention||2
5036002|NCT02049385|12393441|P1|NOT COMPLETED|Second Intervention||0
5036003|NCT02049385|12393440|P2|COMPLETED|Second Intervention||0
5036004|NCT02049385|12393441|P1|COMPLETED|Second Intervention||1
5036005|NCT02049385|12393440|P2|STARTED|Second Intervention||2
5036006|NCT02049385|12393441|P1|STARTED|Second Intervention||1
5036007|NCT02049385|12393440|P2|NOT COMPLETED|First Intervention||0
5036008|NCT02049385|12393441|P1|NOT COMPLETED|First Intervention||3
5036009|NCT02049385|12393440|P2|COMPLETED|First Intervention||2
5036010|NCT02049385|12393441|P1|COMPLETED|First Intervention||1
5036011|NCT02049385|12393440|P2|STARTED|First Intervention||2
5036012|NCT02049385|12393441|P1|STARTED|First Intervention||4
5036013|NCT02049307|12393449|P2|NOT COMPLETED|Overall Study||1
5036014|NCT02049307|12393450|P1|NOT COMPLETED|Overall Study||2
5036015|NCT02049307|12393449|P2|COMPLETED|Overall Study||55
5036016|NCT02049307|12393450|P1|COMPLETED|Overall Study||50
5036017|NCT02049307|12393449|P2|STARTED|Overall Study||56
5036018|NCT02049307|12393450|P1|STARTED|Overall Study||52
5036019|NCT02049151|12393460|P2|NOT COMPLETED|Overall Study||0
5036020|NCT02049151|12393461|P1|NOT COMPLETED|Overall Study||0
5036021|NCT02049151|12393460|P2|COMPLETED|Overall Study||17
5036022|NCT02049151|12393461|P1|COMPLETED|Overall Study||15
5036023|NCT02049151|12393460|P2|STARTED|Overall Study|1 subject did not receive treatment|17
5036024|NCT02049151|12393461|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
5036025|NCT02048904|12393475|P1|NOT COMPLETED|Overall Study||77
5036026|NCT02048904|12393475|P1|COMPLETED|Overall Study||65
5036027|NCT02048904|12393475|P1|STARTED|Overall Study||142
5036028|NCT02048891|12393481|P2|NOT COMPLETED|Overall Study||0
5036029|NCT02048891|12393482|P1|NOT COMPLETED|Overall Study||0
5036030|NCT02048891|12393481|P2|COMPLETED|Overall Study||1
5036031|NCT02048891|12393482|P1|COMPLETED|Overall Study||2
5036032|NCT02048891|12393481|P2|STARTED|Overall Study||1
5036033|NCT02048891|12393482|P1|STARTED|Overall Study||2
5036034|NCT02048878|12393490|P2|NOT COMPLETED|Overall Study||3
5036035|NCT02048878|12393491|P1|NOT COMPLETED|Overall Study||1
5036036|NCT02048878|12393490|P2|COMPLETED|Overall Study||12
5036037|NCT02048878|12393491|P1|COMPLETED|Overall Study||12
5036038|NCT02048878|12393490|P2|STARTED|Overall Study||15
5036039|NCT02048878|12393491|P1|STARTED|Overall Study||13
5036040|NCT02048722|12393507|P1|NOT COMPLETED|Follow up for 5 Years||29
5036041|NCT02048722|12393507|P1|COMPLETED|Follow up for 5 Years||0
5036042|NCT02048722|12393507|P1|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
5036043|NCT02048722|12393507|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
5036044|NCT02048722|12393507|P1|COMPLETED|Reached 1st Response/Continued Treatment||13
5036045|NCT02048722|12393507|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
5036046|NCT02048722|12393507|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||23
5036047|NCT02048722|12393507|P1|STARTED|Reached 1st Response/Continued Treatment||23
5036048|NCT02048722|12393507|P1|NOT COMPLETED|2 Cycles of Treatment||8
5036049|NCT02048722|12393507|P1|COMPLETED|2 Cycles of Treatment||23
5036050|NCT02048722|12393507|P1|Attempted 2nd Cycle|2 Cycles of Treatment||23
5036051|NCT02048722|12393507|P1|Attempted 1st Cycle|2 Cycles of Treatment||31
5036052|NCT02048722|12393507|P1|STARTED|2 Cycles of Treatment||31
5036053|NCT02048670|12393519|P2|NOT COMPLETED|Overall Study||0
5036054|NCT02048670|12393520|P1|NOT COMPLETED|Overall Study||0
5036055|NCT02048670|12393519|P2|COMPLETED|Overall Study||6
5036056|NCT02048670|12393520|P1|COMPLETED|Overall Study||6
5036057|NCT02048670|12393519|P2|STARTED|Overall Study||6
5036058|NCT02048670|12393520|P1|STARTED|Overall Study||6
5036059|NCT02048241|12393530|P2|NOT COMPLETED|Overall Study||1
5036060|NCT02048241|12393531|P1|NOT COMPLETED|Overall Study||0
5036061|NCT02048241|12393530|P2|COMPLETED|Overall Study||5
5036062|NCT02048241|12393531|P1|COMPLETED|Overall Study||5
5036063|NCT02048241|12393530|P2|STARTED|Overall Study||6
5036064|NCT02048241|12393531|P1|STARTED|Overall Study||5
5036065|NCT02048072|12393537|P1|NOT COMPLETED|Overall Study||4
5036066|NCT02048072|12393537|P1|COMPLETED|Overall Study||29
5036067|NCT02048072|12393537|P1|STARTED|Overall Study||33
5036068|NCT02047981|12393543|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
5036069|NCT02047981|12393544|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
5036070|NCT02047981|12393543|P2|COMPLETED|MORDOR Stage II Year 3||30931
5036071|NCT02047981|12393544|P1|COMPLETED|MORDOR Stage II Year 3||34611
5036072|NCT02047981|12393543|P2|STARTED|MORDOR Stage II Year 3||33294
5036073|NCT02047981|12393544|P1|STARTED|MORDOR Stage II Year 3||37497
5036074|NCT02047981|12393543|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
5036075|NCT02047981|12393544|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
5036076|NCT02047981|12393543|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
5036077|NCT02047981|12393544|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
5036078|NCT02047981|12393543|P2|STARTED|MORDOR Stage I Year 1-2||93191
5036079|NCT02047981|12393544|P1|STARTED|MORDOR Stage I Year 1-2||97047
5036080|NCT02047929|12393561|P3|NOT COMPLETED|Overall Study||0
5036081|NCT02047929|12393562|P2|NOT COMPLETED|Overall Study||0
5036082|NCT02047929|12393563|P1|NOT COMPLETED|Overall Study||0
5036083|NCT02047929|12393561|P3|COMPLETED|Overall Study||2248
5036084|NCT02047929|12393562|P2|COMPLETED|Overall Study||2523
5036085|NCT02047929|12393563|P1|COMPLETED|Overall Study||1503
5036086|NCT02047929|12393561|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
5036087|NCT02047929|12393562|P2|Surveys Collected|Overall Study||2523
5036088|NCT02047929|12393563|P1|Surveys Collected|Overall Study||1503
5036089|NCT02047929|12393561|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
5036090|NCT02047929|12393562|P2|Practice Refresher|Overall Study||2523
5036091|NCT02047929|12393563|P1|Practice Refresher|Overall Study||1503
5036092|NCT02047929|12393561|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
5036093|NCT02047929|12393562|P2|Practice Rollout|Overall Study||2523
5036094|NCT02047929|12393563|P1|Practice Rollout|Overall Study||1503
5036095|NCT02047929|12393561|P3|STARTED|Overall Study||2248
5036096|NCT02047929|12393562|P2|STARTED|Overall Study||2523
5036097|NCT02047929|12393563|P1|STARTED|Overall Study||1503
5036098|NCT02047903|12393576|P1|NOT COMPLETED|Overall Study||59
5036099|NCT02047903|12393576|P1|COMPLETED|Overall Study||102
5036100|NCT02047903|12393576|P1|Treated|Overall Study||152
5036101|NCT02047903|12393576|P1|STARTED|Overall Study||161
5036102|NCT02047747|12393588|P1|NOT COMPLETED|Overall Study||3
5036103|NCT02047747|12393588|P1|COMPLETED|Overall Study||1
5036104|NCT02047747|12393588|P1|STARTED|Overall Study||4
5036105|NCT02047643|12393593|P2|NOT COMPLETED|Overall Study||0
5036106|NCT02047643|12393594|P1|NOT COMPLETED|Overall Study||0
5036107|NCT02047643|12393593|P2|COMPLETED|Overall Study||9
5036108|NCT02047643|12393594|P1|COMPLETED|Overall Study||9
5036109|NCT02047643|12393593|P2|STARTED|Overall Study||9
5036110|NCT02047643|12393594|P1|STARTED|Overall Study||9
5036111|NCT02047500|12393602|P1|NOT COMPLETED|Overall Study||19
5036112|NCT02047500|12393602|P1|COMPLETED|Overall Study||0
5036113|NCT02047500|12393602|P1|STARTED|Overall Study||19
5036114|NCT02047344|12393608|P2|NOT COMPLETED|Overall Study||0
5036115|NCT02047344|12393609|P1|NOT COMPLETED|Overall Study||0
5036116|NCT02047344|12393608|P2|COMPLETED|Overall Study||15
5036117|NCT02047344|12393609|P1|COMPLETED|Overall Study||16
5036118|NCT02047344|12393608|P2|STARTED|Overall Study||15
5036119|NCT02047344|12393609|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
5036120|NCT02047305|12393627|P1|NOT COMPLETED|Overall Study||0
5036121|NCT02047305|12393627|P1|COMPLETED|Overall Study||96
5036122|NCT02047305|12393627|P1|STARTED|Overall Study||96
5036123|NCT02047253|12393631|P1|NOT COMPLETED|Overall Study||8
5036124|NCT02047253|12393631|P1|COMPLETED|Overall Study||20
5036125|NCT02047253|12393631|P1|STARTED|Overall Study||28
5036126|NCT02047227|12393641|P2|NOT COMPLETED|Overall Study||130
5036127|NCT02047227|12393642|P1|NOT COMPLETED|Overall Study||144
5036128|NCT02047227|12393641|P2|COMPLETED|Overall Study||347
5036129|NCT02047227|12393642|P1|COMPLETED|Overall Study||318
5036130|NCT02047227|12393641|P2|Completed Ovarian Stimulation Phase|Overall Study||440
5036131|NCT02047227|12393642|P1|Completed Ovarian Stimulation Phase|Overall Study||424
5036132|NCT02047227|12393641|P2|STARTED|Overall Study||477
5036133|NCT02047227|12393642|P1|STARTED|Overall Study||462
5036134|NCT02047110|12393662|P4|NOT COMPLETED|OLE Treatment Period||0
5036135|NCT02047110|12393663|P3|NOT COMPLETED|OLE Treatment Period||1
5036136|NCT02047110|12393664|P2|NOT COMPLETED|OLE Treatment Period||0
5036137|NCT02047110|12393665|P1|NOT COMPLETED|OLE Treatment Period||0
5036138|NCT02047110|12393662|P4|COMPLETED|OLE Treatment Period||9
5036139|NCT02047110|12393663|P3|COMPLETED|OLE Treatment Period||4
5036140|NCT02047110|12393664|P2|COMPLETED|OLE Treatment Period||8
5036141|NCT02047110|12393665|P1|COMPLETED|OLE Treatment Period||4
5036142|NCT02047110|12393662|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
5036143|NCT02047110|12393663|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
5036144|NCT02047110|12393664|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
5036145|NCT02047110|12393665|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
5036146|NCT02047110|12393662|P4|NOT COMPLETED|Escape Treatment Period||2
5036147|NCT02047110|12393663|P3|NOT COMPLETED|Escape Treatment Period||3
5036148|NCT02047110|12393664|P2|NOT COMPLETED|Escape Treatment Period||6
5036149|NCT02047110|12393665|P1|NOT COMPLETED|Escape Treatment Period||3
5036150|NCT02047110|12393662|P4|COMPLETED|Escape Treatment Period||24
5036151|NCT02047110|12393663|P3|COMPLETED|Escape Treatment Period||20
5036152|NCT02047110|12393664|P2|COMPLETED|Escape Treatment Period||15
5036153|NCT02047110|12393665|P1|COMPLETED|Escape Treatment Period||23
5036154|NCT02047110|12393662|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
5036155|NCT02047110|12393663|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
5036156|NCT02047110|12393664|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
5036157|NCT02047110|12393665|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
5036158|NCT02047110|12393662|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
5036159|NCT02047110|12393663|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
5036160|NCT02047110|12393664|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
5036161|NCT02047110|12393665|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
5036162|NCT02047110|12393662|P4|COMPLETED|DB (Week 12 up to Week 24)||12
5036163|NCT02047110|12393663|P3|COMPLETED|DB (Week 12 up to Week 24)||12
5036164|NCT02047110|12393664|P2|COMPLETED|DB (Week 12 up to Week 24)||15
5036165|NCT02047110|12393665|P1|COMPLETED|DB (Week 12 up to Week 24)||9
5036166|NCT02047110|12393662|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
5036167|NCT02047110|12393663|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
5036168|NCT02047110|12393664|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
5036169|NCT02047110|12393665|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
5036170|NCT02047110|12393662|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
5036171|NCT02047110|12393663|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
5036172|NCT02047110|12393664|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
5036173|NCT02047110|12393665|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
5036174|NCT02047110|12393662|P4|COMPLETED|DB Treatment Period up to Week 24||38
5036175|NCT02047110|12393663|P3|COMPLETED|DB Treatment Period up to Week 24||36
5036176|NCT02047110|12393664|P2|COMPLETED|DB Treatment Period up to Week 24||38
5036177|NCT02047110|12393665|P1|COMPLETED|DB Treatment Period up to Week 24||35
5036178|NCT02047110|12393662|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
5036179|NCT02047110|12393663|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
5036180|NCT02047110|12393664|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
5036181|NCT02047110|12393665|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
5036182|NCT02047045|12393708|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||0
5036183|NCT02047045|12393709|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||0
5036184|NCT02047045|12393708|P2|COMPLETED|Follow-up Period (24 Weeks)||262
5036185|NCT02047045|12393709|P1|COMPLETED|Follow-up Period (24 Weeks)||265
5036186|NCT02047045|12393708|P2|STARTED|Follow-up Period (24 Weeks)||262
5036187|NCT02047045|12393709|P1|STARTED|Follow-up Period (24 Weeks)||265
5036188|NCT02047045|12393708|P2|NOT COMPLETED|Treatment Period (8 Weeks )||3
5036189|NCT02047045|12393709|P1|NOT COMPLETED|Treatment Period (8 Weeks )||7
5036190|NCT02047045|12393708|P2|COMPLETED|Treatment Period (8 Weeks )||262
5036191|NCT02047045|12393709|P1|COMPLETED|Treatment Period (8 Weeks )||265
5036192|NCT02047045|12393708|P2|STARTED|Treatment Period (8 Weeks )||265
5036193|NCT02047045|12393709|P1|STARTED|Treatment Period (8 Weeks )||272
5036194|NCT02047045|12393708|P2|NOT COMPLETED|Baseline||15
5036195|NCT02047045|12393709|P1|NOT COMPLETED|Baseline||8
5036196|NCT02047045|12393708|P2|COMPLETED|Baseline||265
5036197|NCT02047045|12393709|P1|COMPLETED|Baseline||272
5036198|NCT02047045|12393708|P2|STARTED|Baseline||280
5036199|NCT02047045|12393709|P1|STARTED|Baseline||280
5036200|NCT02047032|12393743|P2|NOT COMPLETED|Overall Study||15
5036201|NCT02047032|12393744|P1|NOT COMPLETED|Overall Study||5
5036202|NCT02047032|12393743|P2|COMPLETED|Overall Study||235
5036203|NCT02047032|12393744|P1|COMPLETED|Overall Study||245
5036204|NCT02047032|12393743|P2|STARTED|Overall Study||250
5036205|NCT02047032|12393744|P1|STARTED|Overall Study||250
5036206|NCT02046993|12393773|P2|NOT COMPLETED|Overall Study||11
5036207|NCT02046993|12393774|P1|NOT COMPLETED|Overall Study||3
5036208|NCT02046993|12393773|P2|COMPLETED|Overall Study||94
5036209|NCT02046993|12393774|P1|COMPLETED|Overall Study||102
5036210|NCT02046993|12393773|P2|6th Month|Overall Study||94
5036211|NCT02046993|12393774|P1|6th Month|Overall Study||102
5036212|NCT02046993|12393773|P2|3rd Month|Overall Study||97
5036213|NCT02046993|12393774|P1|3rd Month|Overall Study||104
5036214|NCT02046993|12393773|P2|STARTED|Overall Study||105
5036215|NCT02046993|12393774|P1|STARTED|Overall Study||105
5036216|NCT02046980|12393793|P3|NOT COMPLETED|Overall Study||1
5036217|NCT02046980|12393794|P2|NOT COMPLETED|Overall Study||5
5036218|NCT02046980|12393795|P1|NOT COMPLETED|Overall Study||2
5036219|NCT02046980|12393793|P3|COMPLETED|Overall Study||72
5036220|NCT02046980|12393794|P2|COMPLETED|Overall Study||67
5036221|NCT02046980|12393795|P1|COMPLETED|Overall Study||70
5036222|NCT02046980|12393793|P3|STARTED|Overall Study||73
5036223|NCT02046980|12393794|P2|STARTED|Overall Study||72
5036224|NCT02046980|12393795|P1|STARTED|Overall Study||72
5036225|NCT02046941|12393803|P1|NOT COMPLETED|Overall Study||7
5036226|NCT02046941|12393803|P1|COMPLETED|Overall Study||10
5036227|NCT02046941|12393803|P1|STARTED|Overall Study||17
5036228|NCT02046902|12393812|P3|NOT COMPLETED|Overall Study||0
5036229|NCT02046902|12393813|P2|NOT COMPLETED|Overall Study||0
5036230|NCT02046902|12393814|P1|NOT COMPLETED|Overall Study||0
5036231|NCT02046902|12393812|P3|COMPLETED|Overall Study||137
5036232|NCT02046902|12393813|P2|COMPLETED|Overall Study||113
5036233|NCT02046902|12393814|P1|COMPLETED|Overall Study||336
5036234|NCT02046902|12393812|P3|STARTED|Overall Study||137
5036235|NCT02046902|12393813|P2|STARTED|Overall Study||113
5036236|NCT02046902|12393814|P1|STARTED|Overall Study||336
5036237|NCT02046863|12393825|P1|NOT COMPLETED|Overall Study||0
5036238|NCT02046863|12393825|P1|COMPLETED|Overall Study||7
5036239|NCT02046863|12393825|P1|STARTED|Overall Study||7
5036240|NCT02046772|12393831|P2|NOT COMPLETED|Overall Study||0
5036241|NCT02046772|12393832|P1|NOT COMPLETED|Overall Study||0
5036242|NCT02046772|12393831|P2|COMPLETED|Overall Study||33
5036243|NCT02046772|12393832|P1|COMPLETED|Overall Study||30
5036244|NCT02046772|12393831|P2|STARTED|Overall Study||33
5036245|NCT02046772|12393832|P1|STARTED|Overall Study||30
5036246|NCT02046616|12393846|P1|NOT COMPLETED|8-Week FU Period||1
5036247|NCT02046616|12393846|P1|COMPLETED|8-Week FU Period||113
5036248|NCT02046616|12393846|P1|STARTED|8-Week FU Period||114
5036249|NCT02046616|12393846|P1|NOT COMPLETED|24-Week Treatment Period||19
5036250|NCT02046616|12393846|P1|COMPLETED|24-Week Treatment Period||114
5036251|NCT02046616|12393846|P1|STARTED|24-Week Treatment Period||133
5036252|NCT02046603|12393868|P2|NOT COMPLETED|Overall Study||75
5036253|NCT02046603|12393869|P1|NOT COMPLETED|Overall Study||15
5036254|NCT02046603|12393868|P2|COMPLETED|Overall Study||65
5036255|NCT02046603|12393869|P1|COMPLETED|Overall Study||7
5036256|NCT02046603|12393868|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
5036257|NCT02046603|12393869|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
5036258|NCT02046603|12393868|P2|STARTED|Overall Study||140
5036259|NCT02046603|12393869|P1|STARTED|Overall Study||22
5036260|NCT02046564|12393948|P2|NOT COMPLETED|Overall Study||20
5036261|NCT02046564|12393949|P1|NOT COMPLETED|Overall Study||15
5036262|NCT02046564|12393948|P2|COMPLETED|Overall Study||183
5036263|NCT02046564|12393949|P1|COMPLETED|Overall Study||194
5036264|NCT02046564|12393948|P2|STARTED|Overall Study||203
5036265|NCT02046564|12393949|P1|STARTED|Overall Study||209
5036266|NCT02046525|12393973|P2|NOT COMPLETED|Overall Study||0
5036267|NCT02046525|12393974|P1|NOT COMPLETED|Overall Study||0
5036268|NCT02046525|12393973|P2|COMPLETED|Overall Study||5
5036269|NCT02046525|12393974|P1|COMPLETED|Overall Study||5
5036270|NCT02046525|12393973|P2|STARTED|Overall Study||5
5036271|NCT02046525|12393974|P1|STARTED|Overall Study||5
5036272|NCT02046382|12393982|P2|NOT COMPLETED|Overall Study||20
5036273|NCT02046382|12393983|P1|NOT COMPLETED|Overall Study||8
5036274|NCT02046382|12393982|P2|COMPLETED|Overall Study||47
5036275|NCT02046382|12393983|P1|COMPLETED|Overall Study||57
5036276|NCT02046382|12393982|P2|STARTED|Overall Study||67
5036277|NCT02046382|12393983|P1|STARTED|Overall Study||65
5036278|NCT02046369|12393997|P2|NOT COMPLETED|Overall Study||18
5036279|NCT02046369|12393998|P1|NOT COMPLETED|Overall Study||14
5036280|NCT02046369|12393997|P2|COMPLETED|Overall Study||156
5036281|NCT02046369|12393998|P1|COMPLETED|Overall Study||162
5036282|NCT02046369|12393997|P2|STARTED|Overall Study||174
5036283|NCT02046369|12393998|P1|STARTED|Overall Study||176
5036284|NCT02046317|12394016|P2|NOT COMPLETED|Overall Study||0
5036285|NCT02046317|12394017|P1|NOT COMPLETED|Overall Study||0
5036286|NCT02046317|12394016|P2|COMPLETED|Overall Study||8
5036287|NCT02046317|12394017|P1|COMPLETED|Overall Study||4
5036288|NCT02046317|12394016|P2|STARTED|Overall Study||8
5036289|NCT02046317|12394017|P1|STARTED|Overall Study||4
5036290|NCT02046265|12394029|P4|NOT COMPLETED|Overall Study||2
5036291|NCT02046265|12394030|P3|NOT COMPLETED|Overall Study||2
5036292|NCT02046265|12394031|P2|NOT COMPLETED|Overall Study||2
5036293|NCT02046265|12394032|P1|NOT COMPLETED|Overall Study||1
5036294|NCT02046265|12394029|P4|COMPLETED|Overall Study||12
5036295|NCT02046265|12394030|P3|COMPLETED|Overall Study||10
5036296|NCT02046265|12394031|P2|COMPLETED|Overall Study||15
5036297|NCT02046265|12394032|P1|COMPLETED|Overall Study||16
5036298|NCT02046265|12394029|P4|STARTED|Overall Study||14
5036299|NCT02046265|12394030|P3|STARTED|Overall Study||12
5036300|NCT02046265|12394031|P2|STARTED|Overall Study||17
5036301|NCT02046265|12394032|P1|STARTED|Overall Study||17
5036302|NCT02046226|12394042|P1|NOT COMPLETED|Overall Study||7
5036303|NCT02046226|12394042|P1|COMPLETED|Overall Study||0
5036304|NCT02046226|12394042|P1|STARTED|Overall Study||7
5036305|NCT02046200|12394049|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5036306|NCT02046200|12394050|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5036307|NCT02046200|12394049|P2|COMPLETED|Second Intervention (1 Day)||6
5036308|NCT02046200|12394050|P1|COMPLETED|Second Intervention (1 Day)||5
5036309|NCT02046200|12394049|P2|STARTED|Second Intervention (1 Day)||6
5036310|NCT02046200|12394050|P1|STARTED|Second Intervention (1 Day)||5
5036311|NCT02046200|12394049|P2|NOT COMPLETED|First Intervention (1 Day)||0
5036312|NCT02046200|12394050|P1|NOT COMPLETED|First Intervention (1 Day)||0
5036313|NCT02046200|12394049|P2|COMPLETED|First Intervention (1 Day)||6
5036314|NCT02046200|12394050|P1|COMPLETED|First Intervention (1 Day)||5
5036315|NCT02046200|12394049|P2|STARTED|First Intervention (1 Day)||6
5036316|NCT02046200|12394050|P1|STARTED|First Intervention (1 Day)||5
5036317|NCT02046148|12394090|P2|NOT COMPLETED|Overall Study||3
5036318|NCT02046148|12394091|P1|NOT COMPLETED|Overall Study||1
5036319|NCT02046148|12394090|P2|COMPLETED|Overall Study||23
5036320|NCT02046148|12394091|P1|COMPLETED|Overall Study||48
5036321|NCT02046148|12394090|P2|STARTED|Overall Study||26
5036322|NCT02046148|12394091|P1|STARTED|Overall Study||49
5036323|NCT02046122|12394151|P1|NOT COMPLETED|Overall Study||9
5036324|NCT02046122|12394151|P1|COMPLETED|Overall Study||8
5036325|NCT02046122|12394151|P1|STARTED|Overall Study||17
5036326|NCT02046070|12394161|P3|NOT COMPLETED|Overall Study||70
5036327|NCT02046070|12394162|P2|NOT COMPLETED|Overall Study||28
5036328|NCT02046070|12394163|P1|NOT COMPLETED|Overall Study||32
5036329|NCT02046070|12394161|P3|COMPLETED|Overall Study||8
5036330|NCT02046070|12394162|P2|COMPLETED|Overall Study||6
5036331|NCT02046070|12394163|P1|COMPLETED|Overall Study||4
5036332|NCT02046070|12394161|P3|STARTED|Overall Study||78
5036333|NCT02046070|12394162|P2|STARTED|Overall Study||34
5036334|NCT02046070|12394163|P1|STARTED|Overall Study||36
5036335|NCT02046005|12394210|P3|NOT COMPLETED|Overall Study||10
5036336|NCT02046005|12394211|P2|NOT COMPLETED|Overall Study||7
5036337|NCT02046005|12394212|P1|NOT COMPLETED|Overall Study||8
5036338|NCT02046005|12394210|P3|COMPLETED|Overall Study||70
5036339|NCT02046005|12394211|P2|COMPLETED|Overall Study||71
5036340|NCT02046005|12394212|P1|COMPLETED|Overall Study||72
5036341|NCT02046005|12394210|P3|STARTED|Overall Study||80
5036342|NCT02046005|12394211|P2|STARTED|Overall Study||78
5036343|NCT02046005|12394212|P1|STARTED|Overall Study||80
5036344|NCT02045979|12394223|P3|NOT COMPLETED|Overall Study||1
5036345|NCT02045979|12394224|P2|NOT COMPLETED|Overall Study||1
5036346|NCT02045979|12394225|P1|NOT COMPLETED|Overall Study||2
5036347|NCT02045979|12394223|P3|COMPLETED|Overall Study||107
5036348|NCT02045979|12394224|P2|COMPLETED|Overall Study||107
5036349|NCT02045979|12394225|P1|COMPLETED|Overall Study||106
5036350|NCT02045979|12394223|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
5036351|NCT02045979|12394224|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
5036352|NCT02045979|12394225|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
5036353|NCT02045875|12394262|P2|NOT COMPLETED|Overall Study||3
5036354|NCT02045875|12394263|P1|NOT COMPLETED|Overall Study||7
5036355|NCT02045875|12394262|P2|COMPLETED|Overall Study||20
5036356|NCT02045875|12394263|P1|COMPLETED|Overall Study||20
5036357|NCT02045875|12394262|P2|STARTED|Overall Study||23
5036358|NCT02045875|12394263|P1|STARTED|Overall Study||27
5036359|NCT02045862|12394274|P3|NOT COMPLETED|Overall Study||126
5036360|NCT02045862|12394275|P2|NOT COMPLETED|Overall Study||40
5036361|NCT02045862|12394276|P1|NOT COMPLETED|Overall Study||39
5036362|NCT02045862|12394274|P3|COMPLETED|Overall Study||1092
5036363|NCT02045862|12394275|P2|COMPLETED|Overall Study||265
5036364|NCT02045862|12394276|P1|COMPLETED|Overall Study||267
5036365|NCT02045862|12394274|P3|Treated|Overall Study||1210
5036366|NCT02045862|12394275|P2|Treated|Overall Study||303
5036367|NCT02045862|12394276|P1|Treated|Overall Study||306
5036368|NCT02045862|12394274|P3|STARTED|Overall Study||1218
5036369|NCT02045862|12394275|P2|STARTED|Overall Study||305
5036370|NCT02045862|12394276|P1|STARTED|Overall Study||306
5036371|NCT02045836|12394457|P2|NOT COMPLETED|Overall Study||14
5036372|NCT02045836|12394458|P1|NOT COMPLETED|Overall Study||9
5036373|NCT02045836|12394457|P2|COMPLETED|Overall Study||419
5036374|NCT02045836|12394458|P1|COMPLETED|Overall Study||423
5036375|NCT02045836|12394457|P2|STARTED|Overall Study||433
5036376|NCT02045836|12394458|P1|STARTED|Overall Study||432
5036377|NCT02045797|12394490|P3|NOT COMPLETED|Overall Study||1
5036378|NCT02045797|12394491|P2|NOT COMPLETED|Overall Study||7
5036379|NCT02045797|12394492|P1|NOT COMPLETED|Overall Study||7
5036380|NCT02045797|12394490|P3|COMPLETED|Overall Study||24
5036381|NCT02045797|12394491|P2|COMPLETED|Overall Study||32
5036382|NCT02045797|12394492|P1|COMPLETED|Overall Study||51
5036383|NCT02045797|12394490|P3|STARTED|Overall Study||25
5036384|NCT02045797|12394491|P2|STARTED|Overall Study||39
5036385|NCT02045797|12394492|P1|STARTED|Overall Study||58
5036386|NCT02045732|12394637|P2|NOT COMPLETED|Overall Study||1
5036387|NCT02045732|12394638|P1|NOT COMPLETED|Overall Study||1
5036388|NCT02045732|12394637|P2|COMPLETED|Overall Study||2
5036389|NCT02045732|12394638|P1|COMPLETED|Overall Study||0
5036390|NCT02045732|12394637|P2|STARTED|Overall Study||3
5036391|NCT02045732|12394638|P1|STARTED|Overall Study||1
5036392|NCT02045511|12394658|P2|NOT COMPLETED|Overall Study||0
5036393|NCT02045511|12394659|P1|NOT COMPLETED|Overall Study||0
5036394|NCT02045511|12394658|P2|COMPLETED|Overall Study||7
5036395|NCT02045511|12394659|P1|COMPLETED|Overall Study||8
5036396|NCT02045511|12394658|P2|STARTED|Overall Study||7
5036397|NCT02045511|12394659|P1|STARTED|Overall Study||8
5036398|NCT02045433|12394675|P1|NOT COMPLETED|Overall Study||1
5036399|NCT02045433|12394675|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
5036400|NCT02045433|12394675|P1|STARTED|Overall Study||16
5036401|NCT02045264|12394679|P1|NOT COMPLETED|Overall Study||0
5036402|NCT02045264|12394679|P1|COMPLETED|Overall Study||12
5036403|NCT02045264|12394679|P1|STARTED|Overall Study||12
5036404|NCT02045238|12394696|P2|NOT COMPLETED|Overall Study||1
5036405|NCT02045238|12394697|P1|NOT COMPLETED|Overall Study||7
5036406|NCT02045238|12394696|P2|COMPLETED|Overall Study||14
5036407|NCT02045238|12394697|P1|COMPLETED|Overall Study||9
5036408|NCT02045238|12394696|P2|STARTED|Overall Study||15
5036409|NCT02045238|12394697|P1|STARTED|Overall Study||16
5036410|NCT02045212|12394707|P2|NOT COMPLETED|Overall Study||1
5036411|NCT02045212|12394708|P1|NOT COMPLETED|Overall Study||2
5036412|NCT02045212|12394707|P2|COMPLETED|Overall Study||8
5036413|NCT02045212|12394708|P1|COMPLETED|Overall Study||11
5036414|NCT02045212|12394707|P2|STARTED|Overall Study||9
5036415|NCT02045212|12394708|P1|STARTED|Overall Study||13
5036416|NCT02045108|12394724|P4|NOT COMPLETED|Overall Study||1
5036417|NCT02045108|12394725|P3|NOT COMPLETED|Overall Study||2
5036418|NCT02045108|12394726|P2|NOT COMPLETED|Overall Study||3
5036419|NCT02045108|12394727|P1|NOT COMPLETED|Overall Study||1
5036420|NCT02045108|12394724|P4|COMPLETED|Overall Study||19
5036421|NCT02045108|12394725|P3|COMPLETED|Overall Study||18
5036422|NCT02045108|12394726|P2|COMPLETED|Overall Study||12
5036423|NCT02045108|12394727|P1|COMPLETED|Overall Study||21
5036424|NCT02045108|12394724|P4|STARTED|Overall Study||20
5036425|NCT02045108|12394725|P3|STARTED|Overall Study||20
5036426|NCT02045108|12394726|P2|STARTED|Overall Study||15
5036427|NCT02045108|12394727|P1|STARTED|Overall Study||22
5036428|NCT02045095|12394773|P7|NOT COMPLETED|Overall Study||1
5036429|NCT02045095|12394774|P6|NOT COMPLETED|Overall Study||8
5036430|NCT02045095|12394775|P5|NOT COMPLETED|Overall Study||5
5036431|NCT02045095|12394776|P4|NOT COMPLETED|Overall Study||4
5036432|NCT02045095|12394777|P3|NOT COMPLETED|Overall Study||4
5036433|NCT02045095|12394778|P2|NOT COMPLETED|Overall Study||4
5036434|NCT02045095|12394779|P1|NOT COMPLETED|Overall Study||3
5036435|NCT02045095|12394773|P7|COMPLETED|Overall Study||0
5036436|NCT02045095|12394774|P6|COMPLETED|Overall Study||0
5036437|NCT02045095|12394775|P5|COMPLETED|Overall Study||0
5036438|NCT02045095|12394776|P4|COMPLETED|Overall Study||0
5036439|NCT02045095|12394777|P3|COMPLETED|Overall Study||0
5036440|NCT02045095|12394778|P2|COMPLETED|Overall Study||0
5036441|NCT02045095|12394779|P1|COMPLETED|Overall Study||0
5036442|NCT02045095|12394773|P7|STARTED|Overall Study||1
5036443|NCT02045095|12394774|P6|STARTED|Overall Study||8
5036444|NCT02045095|12394775|P5|STARTED|Overall Study||5
5036445|NCT02045095|12394776|P4|STARTED|Overall Study||4
5036446|NCT02045095|12394777|P3|STARTED|Overall Study||4
5036447|NCT02045095|12394778|P2|STARTED|Overall Study||4
5036448|NCT02045095|12394779|P1|STARTED|Overall Study||3
5036449|NCT02044991|12394923|P2|NOT COMPLETED|Overall Study||0
5036450|NCT02044991|12394924|P1|NOT COMPLETED|Overall Study||0
5036451|NCT02044991|12394923|P2|COMPLETED|Overall Study||0
5036452|NCT02044991|12394924|P1|COMPLETED|Overall Study||2
5036453|NCT02044991|12394923|P2|STARTED|Overall Study||0
5036454|NCT02044991|12394924|P1|STARTED|Overall Study||2
5036455|NCT02044874|12394937|P3|NOT COMPLETED|Overall Study||60
5036456|NCT02044874|12394938|P2|NOT COMPLETED|Overall Study||55
5036457|NCT02044874|12394939|P1|NOT COMPLETED|Overall Study||30
5036458|NCT02044874|12394937|P3|COMPLETED|Overall Study||140
5036459|NCT02044874|12394938|P2|COMPLETED|Overall Study||147
5036460|NCT02044874|12394939|P1|COMPLETED|Overall Study||171
5036461|NCT02044874|12394937|P3|STARTED|Overall Study||200
5036462|NCT02044874|12394938|P2|STARTED|Overall Study||202
5036463|NCT02044874|12394939|P1|STARTED|Overall Study||201
5036464|NCT02044848|12394961|P2|NOT COMPLETED|Overall Study||3
5036465|NCT02044848|12394962|P1|NOT COMPLETED|Overall Study||2
5036466|NCT02044848|12394961|P2|COMPLETED|Overall Study||0
5036467|NCT02044848|12394962|P1|COMPLETED|Overall Study||0
5036468|NCT02044848|12394961|P2|STARTED|Overall Study||3
5036469|NCT02044848|12394962|P1|STARTED|Overall Study||2
5036470|NCT02044822|12394968|P1|NOT COMPLETED|Overall Study||93
5036471|NCT02044822|12394968|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
5036472|NCT02044822|12394968|P1|STARTED|Overall Study||102
5036473|NCT02044796|12394980|P10|NOT COMPLETED|Overall Study||0
5036474|NCT02044796|12394981|P9|NOT COMPLETED|Overall Study||0
5036475|NCT02044796|12394982|P8|NOT COMPLETED|Overall Study||0
5036476|NCT02044796|12394983|P7|NOT COMPLETED|Overall Study||0
5036477|NCT02044796|12394984|P6|NOT COMPLETED|Overall Study||0
5036478|NCT02044796|12394985|P5|NOT COMPLETED|Overall Study||0
5036479|NCT02044796|12394986|P4|NOT COMPLETED|Overall Study||0
5036480|NCT02044796|12394987|P3|NOT COMPLETED|Overall Study||0
5036481|NCT02044796|12394988|P2|NOT COMPLETED|Overall Study||0
5036482|NCT02044796|12394989|P1|NOT COMPLETED|Overall Study||0
5036483|NCT02044796|12394980|P10|COMPLETED|Overall Study||34
5036484|NCT02044796|12394981|P9|COMPLETED|Overall Study||106
5036485|NCT02044796|12394982|P8|COMPLETED|Overall Study||4
5036486|NCT02044796|12394983|P7|COMPLETED|Overall Study||6
5036487|NCT02044796|12394984|P6|COMPLETED|Overall Study||6
5036488|NCT02044796|12394985|P5|COMPLETED|Overall Study||10
5036489|NCT02044796|12394986|P4|COMPLETED|Overall Study||6
5036490|NCT02044796|12394987|P3|COMPLETED|Overall Study||9
5036491|NCT02044796|12394988|P2|COMPLETED|Overall Study||9
5036492|NCT02044796|12394989|P1|COMPLETED|Overall Study||9
5036493|NCT02044796|12394980|P10|STARTED|Overall Study||34
5036494|NCT02044796|12394981|P9|STARTED|Overall Study||106
5036495|NCT02044796|12394982|P8|STARTED|Overall Study||4
5036496|NCT02044796|12394983|P7|STARTED|Overall Study||6
5036497|NCT02044796|12394984|P6|STARTED|Overall Study||6
5036498|NCT02044796|12394985|P5|STARTED|Overall Study||10
5036499|NCT02044796|12394986|P4|STARTED|Overall Study||6
5036500|NCT02044796|12394987|P3|STARTED|Overall Study||9
5036501|NCT02044796|12394988|P2|STARTED|Overall Study||9
5036502|NCT02044796|12394989|P1|STARTED|Overall Study||9
5036503|NCT02044510|12395010|P2|NOT COMPLETED|Overall Study||2
5036504|NCT02044510|12395011|P1|NOT COMPLETED|Overall Study||1
5036505|NCT02044510|12395010|P2|COMPLETED|Overall Study||14
5036506|NCT02044510|12395011|P1|COMPLETED|Overall Study||15
5036507|NCT02044510|12395010|P2|STARTED|Overall Study||16
5036508|NCT02044510|12395011|P1|STARTED|Overall Study||16
5036509|NCT02044458|12395019|P2|NOT COMPLETED|Overall Study||8
5036510|NCT02044458|12395020|P1|NOT COMPLETED|Overall Study||3
5036511|NCT02044458|12395019|P2|COMPLETED|Overall Study||61
5036512|NCT02044458|12395020|P1|COMPLETED|Overall Study||62
5036513|NCT02044458|12395019|P2|STARTED|Overall Study||69
5036514|NCT02044458|12395020|P1|STARTED|Overall Study||65
5036515|NCT02044419|12395033|P3|NOT COMPLETED|Third Intervention||0
5036516|NCT02044419|12395034|P2|NOT COMPLETED|Third Intervention||0
5036517|NCT02044419|12395035|P1|NOT COMPLETED|Third Intervention||0
5036518|NCT02044419|12395033|P3|COMPLETED|Third Intervention||10
5036519|NCT02044419|12395034|P2|COMPLETED|Third Intervention||9
5036520|NCT02044419|12395035|P1|COMPLETED|Third Intervention||11
5036521|NCT02044419|12395033|P3|STARTED|Third Intervention||10
5036522|NCT02044419|12395034|P2|STARTED|Third Intervention||9
5036523|NCT02044419|12395035|P1|STARTED|Third Intervention||11
5036524|NCT02044419|12395033|P3|NOT COMPLETED|Second Intervention||0
5036525|NCT02044419|12395034|P2|NOT COMPLETED|Second Intervention||0
5036526|NCT02044419|12395035|P1|NOT COMPLETED|Second Intervention||0
5036527|NCT02044419|12395033|P3|COMPLETED|Second Intervention||10
5036528|NCT02044419|12395034|P2|COMPLETED|Second Intervention||9
5036529|NCT02044419|12395035|P1|COMPLETED|Second Intervention||11
5036530|NCT02044419|12395033|P3|STARTED|Second Intervention||10
5036531|NCT02044419|12395034|P2|STARTED|Second Intervention||9
5036532|NCT02044419|12395035|P1|STARTED|Second Intervention||11
5036533|NCT02044419|12395033|P3|NOT COMPLETED|First Intervention||1
5036534|NCT02044419|12395034|P2|NOT COMPLETED|First Intervention||1
5036535|NCT02044419|12395035|P1|NOT COMPLETED|First Intervention||0
5036536|NCT02044419|12395033|P3|COMPLETED|First Intervention||10
5036537|NCT02044419|12395034|P2|COMPLETED|First Intervention||9
5036538|NCT02044419|12395035|P1|COMPLETED|First Intervention||11
5036539|NCT02044419|12395033|P3|STARTED|First Intervention||11
5036540|NCT02044419|12395034|P2|STARTED|First Intervention||10
5036541|NCT02044419|12395035|P1|STARTED|First Intervention||11
5036542|NCT02044393|12395060|P2|NOT COMPLETED|Period 2||0
5036543|NCT02044393|12395061|P1|NOT COMPLETED|Period 2||0
5036544|NCT02044393|12395060|P2|COMPLETED|Period 2||10
5036545|NCT02044393|12395061|P1|COMPLETED|Period 2||10
5036546|NCT02044393|12395060|P2|STARTED|Period 2||10
5036547|NCT02044393|12395061|P1|STARTED|Period 2||10
5036548|NCT02044393|12395060|P2|NOT COMPLETED|Period 1||0
5036549|NCT02044393|12395061|P1|NOT COMPLETED|Period 1||0
5036550|NCT02044393|12395060|P2|COMPLETED|Period 1||10
5036551|NCT02044393|12395061|P1|COMPLETED|Period 1||10
5036552|NCT02044393|12395060|P2|STARTED|Period 1||10
5036553|NCT02044393|12395061|P1|STARTED|Period 1||10
5036554|NCT02044380|12395074|P1|NOT COMPLETED|Overall Study||0
5036555|NCT02044380|12395074|P1|COMPLETED|Overall Study||14
5036556|NCT02044380|12395074|P1|STARTED|Overall Study|Started are the treated patients|14
5036557|NCT02044367|12395078|P6|NOT COMPLETED|Overall Study||0
5036558|NCT02044367|12395079|P5|NOT COMPLETED|Overall Study||0
5036559|NCT02044367|12395080|P4|NOT COMPLETED|Overall Study||0
5036560|NCT02044367|12395081|P3|NOT COMPLETED|Overall Study||0
5036561|NCT02044367|12395082|P2|NOT COMPLETED|Overall Study||0
5036562|NCT02044367|12395083|P1|NOT COMPLETED|Overall Study||0
5036563|NCT02044367|12395078|P6|COMPLETED|Overall Study||9
5036564|NCT02044367|12395079|P5|COMPLETED|Overall Study||9
5036565|NCT02044367|12395080|P4|COMPLETED|Overall Study||9
5036566|NCT02044367|12395081|P3|COMPLETED|Overall Study||9
5036567|NCT02044367|12395082|P2|COMPLETED|Overall Study||9
5036568|NCT02044367|12395083|P1|COMPLETED|Overall Study||9
5036569|NCT02044367|12395078|P6|STARTED|Overall Study||9
5036570|NCT02044367|12395079|P5|STARTED|Overall Study||9
5036571|NCT02044367|12395080|P4|STARTED|Overall Study||9
5036572|NCT02044367|12395081|P3|STARTED|Overall Study||9
5036573|NCT02044367|12395082|P2|STARTED|Overall Study||9
5036574|NCT02044367|12395083|P1|STARTED|Overall Study||9
5036575|NCT02044302|12395106|P2|NOT COMPLETED|Overall Study||0
5036576|NCT02044302|12395107|P1|NOT COMPLETED|Overall Study||2
5036577|NCT02044302|12395106|P2|COMPLETED|Overall Study||0
5036578|NCT02044302|12395107|P1|COMPLETED|Overall Study||0
5036579|NCT02044302|12395106|P2|STARTED|Overall Study||0
5036580|NCT02044302|12395107|P1|STARTED|Overall Study||2
5036581|NCT02044159|12395115|P2|NOT COMPLETED|Overall Study||4
5036582|NCT02044159|12395116|P1|NOT COMPLETED|Overall Study||4
5036583|NCT02044159|12395115|P2|COMPLETED|Overall Study||26
5036584|NCT02044159|12395116|P1|COMPLETED|Overall Study||23
5036585|NCT02044159|12395115|P2|STARTED|Overall Study||30
5036586|NCT02044159|12395116|P1|STARTED|Overall Study||27
5036587|NCT02044094|12395129|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
5036588|NCT02044094|12395129|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
5036589|NCT02044094|12395129|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
5036590|NCT02044094|12395129|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
5036591|NCT02044094|12395129|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
5036592|NCT02044094|12395129|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
5036593|NCT02044094|12395129|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
5036594|NCT02044094|12395129|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
5036595|NCT02043938|12395186|P1|NOT COMPLETED|Overall Study||10
5036596|NCT02043938|12395186|P1|COMPLETED|Overall Study||36
5036597|NCT02043938|12395186|P1|STARTED|Overall Study||46
5036598|NCT02043860|12395196|P1|NOT COMPLETED|Overall Study||0
5036599|NCT02043860|12395196|P1|COMPLETED|Overall Study||2
5036600|NCT02043860|12395196|P1|STARTED|Overall Study||2
5036601|NCT02043808|12395202|P2|NOT COMPLETED|Overall Study||0
5036602|NCT02043808|12395203|P1|NOT COMPLETED|Overall Study||0
5036603|NCT02043808|12395202|P2|COMPLETED|Overall Study||12793
5036604|NCT02043808|12395203|P1|COMPLETED|Overall Study||12793
5036605|NCT02043808|12395202|P2|STARTED|Overall Study||12793
5036606|NCT02043808|12395203|P1|STARTED|Overall Study||12793
5036607|NCT02043782|12395241|P6|NOT COMPLETED|Period 3||0
5036608|NCT02043782|12395242|P5|NOT COMPLETED|Period 3||0
5036609|NCT02043782|12395243|P4|NOT COMPLETED|Period 3||0
5036610|NCT02043782|12395244|P3|NOT COMPLETED|Period 3||0
5036611|NCT02043782|12395245|P2|NOT COMPLETED|Period 3||0
5036612|NCT02043782|12395246|P1|NOT COMPLETED|Period 3||0
5036613|NCT02043782|12395241|P6|COMPLETED|Period 3||6
5036614|NCT02043782|12395242|P5|COMPLETED|Period 3||6
5036615|NCT02043782|12395243|P4|COMPLETED|Period 3||6
5036616|NCT02043782|12395244|P3|COMPLETED|Period 3||6
5036617|NCT02043782|12395245|P2|COMPLETED|Period 3||6
5036618|NCT02043782|12395246|P1|COMPLETED|Period 3||7
5036619|NCT02043782|12395241|P6|STARTED|Period 3||6
5036620|NCT02043782|12395242|P5|STARTED|Period 3||6
5036621|NCT02043782|12395243|P4|STARTED|Period 3||6
5036622|NCT02043782|12395244|P3|STARTED|Period 3||6
5036623|NCT02043782|12395245|P2|STARTED|Period 3||6
5036624|NCT02043782|12395246|P1|STARTED|Period 3||7
5036625|NCT02043782|12395241|P6|NOT COMPLETED|Period 2||0
5036626|NCT02043782|12395242|P5|NOT COMPLETED|Period 2||0
5036627|NCT02043782|12395243|P4|NOT COMPLETED|Period 2||0
5036628|NCT02043782|12395244|P3|NOT COMPLETED|Period 2||0
5036629|NCT02043782|12395245|P2|NOT COMPLETED|Period 2||0
5036630|NCT02043782|12395246|P1|NOT COMPLETED|Period 2||0
5036631|NCT02043782|12395241|P6|COMPLETED|Period 2||6
5036632|NCT02043782|12395242|P5|COMPLETED|Period 2||6
5036633|NCT02043782|12395243|P4|COMPLETED|Period 2||6
5036634|NCT02043782|12395244|P3|COMPLETED|Period 2||6
5036635|NCT02043782|12395245|P2|COMPLETED|Period 2||6
5036636|NCT02043782|12395246|P1|COMPLETED|Period 2||7
5036637|NCT02043782|12395241|P6|STARTED|Period 2||6
5036638|NCT02043782|12395242|P5|STARTED|Period 2||6
5036639|NCT02043782|12395243|P4|STARTED|Period 2||6
5036640|NCT02043782|12395244|P3|STARTED|Period 2||6
5036641|NCT02043782|12395245|P2|STARTED|Period 2||6
5036642|NCT02043782|12395246|P1|STARTED|Period 2||7
5036643|NCT02043782|12395241|P6|NOT COMPLETED|Period 1||0
5036644|NCT02043782|12395242|P5|NOT COMPLETED|Period 1||0
5036645|NCT02043782|12395243|P4|NOT COMPLETED|Period 1||0
5036646|NCT02043782|12395244|P3|NOT COMPLETED|Period 1||1
5036647|NCT02043782|12395245|P2|NOT COMPLETED|Period 1||0
5036648|NCT02043782|12395246|P1|NOT COMPLETED|Period 1||0
5036649|NCT02043782|12395241|P6|COMPLETED|Period 1||6
5036650|NCT02043782|12395242|P5|COMPLETED|Period 1||6
5036651|NCT02043782|12395243|P4|COMPLETED|Period 1||6
5036652|NCT02043782|12395244|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
5036653|NCT02043782|12395245|P2|COMPLETED|Period 1||6
5036654|NCT02043782|12395246|P1|COMPLETED|Period 1||7
5036655|NCT02043782|12395241|P6|STARTED|Period 1||6
5036656|NCT02043782|12395242|P5|STARTED|Period 1||6
5036657|NCT02043782|12395243|P4|STARTED|Period 1||6
5036658|NCT02043782|12395244|P3|STARTED|Period 1||7
5036659|NCT02043782|12395245|P2|STARTED|Period 1||6
5036660|NCT02043782|12395246|P1|STARTED|Period 1||7
5036661|NCT02043704|12395256|P2|NOT COMPLETED|Overall Study||7
5036662|NCT02043704|12395257|P1|NOT COMPLETED|Overall Study||3
5036663|NCT02043704|12395256|P2|COMPLETED|Overall Study||43
5036664|NCT02043704|12395257|P1|COMPLETED|Overall Study||47
5036665|NCT02043704|12395256|P2|STARTED|Overall Study||50
5036666|NCT02043704|12395257|P1|STARTED|Overall Study||50
5036667|NCT02043678|12395289|P2|NOT COMPLETED|Overall Study||405
5036668|NCT02043678|12395290|P1|NOT COMPLETED|Overall Study||401
5036669|NCT02043678|12395289|P2|COMPLETED|Overall Study||0
5036670|NCT02043678|12395290|P1|COMPLETED|Overall Study||0
5036671|NCT02043678|12395289|P2|Treated|Overall Study||396
5036672|NCT02043678|12395290|P1|Treated|Overall Study||390
5036673|NCT02043678|12395289|P2|STARTED|Overall Study||405
5036674|NCT02043678|12395290|P1|STARTED|Overall Study||401
5036675|NCT02043652|12395306|P1|NOT COMPLETED|Overall Study||26
5036676|NCT02043652|12395306|P1|COMPLETED|Overall Study||93
5036677|NCT02043652|12395306|P1|STARTED|Overall Study||119
5036678|NCT02043574|12395313|P2|NOT COMPLETED|Overall Study||6
5036679|NCT02043574|12395314|P1|NOT COMPLETED|Overall Study||6
5036680|NCT02043574|12395313|P2|COMPLETED|Overall Study||20
5036681|NCT02043574|12395314|P1|COMPLETED|Overall Study||19
5036682|NCT02043574|12395313|P2|STARTED|Overall Study||26
5036683|NCT02043574|12395314|P1|STARTED|Overall Study||25
5036684|NCT02043509|12395326|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
5036685|NCT02043509|12395327|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
5036686|NCT02043509|12395326|P2|COMPLETED|Baseline to 2nd Follow-up||132
5036687|NCT02043509|12395327|P1|COMPLETED|Baseline to 2nd Follow-up||129
5036688|NCT02043509|12395326|P2|STARTED|Baseline to 2nd Follow-up||204
5036689|NCT02043509|12395327|P1|STARTED|Baseline to 2nd Follow-up||203
5036690|NCT02043509|12395326|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
5036691|NCT02043509|12395327|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
5036692|NCT02043509|12395326|P2|COMPLETED|Baseline to 1st Follow-up||157
5036693|NCT02043509|12395327|P1|COMPLETED|Baseline to 1st Follow-up||138
5036694|NCT02043509|12395326|P2|STARTED|Baseline to 1st Follow-up||204
5036695|NCT02043509|12395327|P1|STARTED|Baseline to 1st Follow-up||203
5036696|NCT02043379|12395352|P2|NOT COMPLETED|Overall Study||0
5036697|NCT02043379|12395353|P1|NOT COMPLETED|Overall Study||0
5036698|NCT02043379|12395352|P2|COMPLETED|Overall Study||20
5036699|NCT02043379|12395353|P1|COMPLETED|Overall Study||30
5036700|NCT02043379|12395352|P2|STARTED|Overall Study||20
5036701|NCT02043379|12395353|P1|STARTED|Overall Study||30
5036702|NCT02043366|12395415|P6|NOT COMPLETED|Overall Study||2
5036703|NCT02043366|12395416|P5|NOT COMPLETED|Overall Study||2
5036704|NCT02043366|12395417|P4|NOT COMPLETED|Overall Study||2
5036705|NCT02043366|12395418|P3|NOT COMPLETED|Overall Study||2
5036706|NCT02043366|12395419|P2|NOT COMPLETED|Overall Study||2
5036707|NCT02043366|12395420|P1|NOT COMPLETED|Overall Study||2
5036708|NCT02043366|12395415|P6|COMPLETED|Overall Study||28
5036709|NCT02043366|12395416|P5|COMPLETED|Overall Study||28
5036710|NCT02043366|12395417|P4|COMPLETED|Overall Study||28
5036711|NCT02043366|12395418|P3|COMPLETED|Overall Study||28
5036712|NCT02043366|12395419|P2|COMPLETED|Overall Study||28
5036713|NCT02043366|12395420|P1|COMPLETED|Overall Study||28
5036714|NCT02043366|12395415|P6|STARTED|Overall Study||30
5036715|NCT02043366|12395416|P5|STARTED|Overall Study||30
5036716|NCT02043366|12395417|P4|STARTED|Overall Study||30
5036717|NCT02043366|12395418|P3|STARTED|Overall Study||30
5036718|NCT02043366|12395419|P2|STARTED|Overall Study||30
5036719|NCT02043366|12395420|P1|STARTED|Overall Study||30
5036720|NCT02043301|12395443|P3|NOT COMPLETED|Overall Study||0
5036721|NCT02043301|12395444|P2|NOT COMPLETED|Overall Study||1
5036722|NCT02043301|12395445|P1|NOT COMPLETED|Overall Study||0
5036723|NCT02043301|12395443|P3|COMPLETED|Overall Study||25
5036724|NCT02043301|12395444|P2|COMPLETED|Overall Study||24
5036725|NCT02043301|12395445|P1|COMPLETED|Overall Study||25
5036726|NCT02043301|12395443|P3|STARTED|Overall Study||25
5036727|NCT02043301|12395444|P2|STARTED|Overall Study||25
5036728|NCT02043301|12395445|P1|STARTED|Overall Study||25
5036729|NCT02043197|12395503|P1|NOT COMPLETED|Overall Study||8
5036730|NCT02043197|12395503|P1|COMPLETED|Overall Study||292
5036731|NCT02043197|12395503|P1|STARTED|Overall Study||300
5036732|NCT02043145|12395527|P3|NOT COMPLETED|Overall Study||0
5036733|NCT02043145|12395528|P2|NOT COMPLETED|Overall Study||0
5036734|NCT02043145|12395529|P1|NOT COMPLETED|Overall Study||0
5036735|NCT02043145|12395527|P3|COMPLETED|Overall Study||425
5036736|NCT02043145|12395528|P2|COMPLETED|Overall Study||247
5036737|NCT02043145|12395529|P1|COMPLETED|Overall Study||55
5036738|NCT02043145|12395527|P3|STARTED|Overall Study||425
5036739|NCT02043145|12395528|P2|STARTED|Overall Study||247
5036740|NCT02043145|12395529|P1|STARTED|Overall Study||55
5036741|NCT02043132|12395542|P2|NOT COMPLETED|Overall Study||9
5036742|NCT02043132|12395543|P1|NOT COMPLETED|Overall Study||5
5036743|NCT02043132|12395542|P2|COMPLETED|Overall Study||49
5036744|NCT02043132|12395543|P1|COMPLETED|Overall Study||53
5036745|NCT02043132|12395542|P2|STARTED|Overall Study||58
5036746|NCT02043132|12395543|P1|STARTED|Overall Study||58
5036747|NCT02043015|12395563|P1|NOT COMPLETED|Overall Study||28
5036748|NCT02043015|12395563|P1|COMPLETED|Overall Study||87
5036749|NCT02043015|12395563|P1|STARTED|Overall Study||115
5036750|NCT02042950|12395576|P1|NOT COMPLETED|Overall Study||4
5036751|NCT02042950|12395576|P1|COMPLETED|Overall Study||0
5036752|NCT02042950|12395576|P1|STARTED|Overall Study||4
5036753|NCT02042924|12395582|P1|NOT COMPLETED|Overall Study||1
5036754|NCT02042924|12395582|P1|COMPLETED|Overall Study||1
5036755|NCT02042924|12395582|P1|STARTED|Overall Study||2
5036756|NCT02042911|12395588|P1|NOT COMPLETED|Overall Study||1
5036757|NCT02042911|12395588|P1|COMPLETED|Overall Study||9
5036758|NCT02042911|12395588|P1|STARTED|Overall Study||10
5036759|NCT02042872|12395602|P2|NOT COMPLETED|Overall Study||5
5036760|NCT02042872|12395603|P1|NOT COMPLETED|Overall Study||0
5036761|NCT02042872|12395602|P2|COMPLETED|Overall Study||8
5036762|NCT02042872|12395603|P1|COMPLETED|Overall Study||8
5036763|NCT02042872|12395602|P2|STARTED|Overall Study||13
5036764|NCT02042872|12395603|P1|STARTED|Overall Study||8
5036765|NCT02042534|12395613|P2|NOT COMPLETED|Overall Study||0
5036766|NCT02042534|12395614|P1|NOT COMPLETED|Overall Study||0
5036767|NCT02042534|12395613|P2|COMPLETED|Overall Study||94
5036768|NCT02042534|12395614|P1|COMPLETED|Overall Study||101
5036769|NCT02042534|12395613|P2|STARTED|Overall Study||94
5036770|NCT02042534|12395614|P1|STARTED|Overall Study||101
5036771|NCT02042443|12395630|P2|NOT COMPLETED|Overall Study||26
5036772|NCT02042443|12395631|P1|NOT COMPLETED|Overall Study||27
5036773|NCT02042443|12395630|P2|COMPLETED|Overall Study||0
5036774|NCT02042443|12395631|P1|COMPLETED|Overall Study||0
5036775|NCT02042443|12395630|P2|Eligible and Analyzable|Overall Study||20
5036776|NCT02042443|12395631|P1|Eligible and Analyzable|Overall Study||24
5036777|NCT02042443|12395630|P2|STARTED|Overall Study||26
5036778|NCT02042443|12395631|P1|STARTED|Overall Study||27
5036779|NCT02042404|12395643|P2|NOT COMPLETED|Overall Study||0
5036780|NCT02042404|12395644|P1|NOT COMPLETED|Overall Study||5
5036781|NCT02042404|12395643|P2|COMPLETED|Overall Study||5
5036782|NCT02042404|12395644|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
5036783|NCT02042404|12395643|P2|STARTED|Overall Study||5
5036784|NCT02042404|12395644|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
5036785|NCT02042274|12395655|P1|NOT COMPLETED|Overall Study||0
5036786|NCT02042274|12395655|P1|COMPLETED|Overall Study||12
5036787|NCT02042274|12395655|P1|STARTED|Overall Study||12
5036788|NCT02042183|12395662|P2|NOT COMPLETED|Overall Study||36
5036789|NCT02042183|12395663|P1|NOT COMPLETED|Overall Study||65
5036790|NCT02042183|12395662|P2|COMPLETED|Overall Study||166
5036791|NCT02042183|12395663|P1|COMPLETED|Overall Study||339
5036792|NCT02042183|12395662|P2|Modified Intent-to-treat (mITT)|Overall Study||195
5036793|NCT02042183|12395663|P1|Modified Intent-to-treat (mITT)|Overall Study||399
5036794|NCT02042183|12395662|P2|Safety Population|Overall Study||195
5036795|NCT02042183|12395663|P1|Safety Population|Overall Study||400
5036796|NCT02042183|12395662|P2|STARTED|Overall Study||202
5036797|NCT02042183|12395663|P1|STARTED|Overall Study||404
5036798|NCT02042131|12395674|P3|NOT COMPLETED|Overall Study||0
5036799|NCT02042131|12395675|P2|NOT COMPLETED|Overall Study||0
5036800|NCT02042131|12395676|P1|NOT COMPLETED|Overall Study||0
5036801|NCT02042131|12395674|P3|COMPLETED|Overall Study||33
5036802|NCT02042131|12395675|P2|COMPLETED|Overall Study||32
5036803|NCT02042131|12395676|P1|COMPLETED|Overall Study||32
5036804|NCT02042131|12395674|P3|STARTED|Overall Study||33
5036805|NCT02042131|12395675|P2|STARTED|Overall Study||32
5036806|NCT02042131|12395676|P1|STARTED|Overall Study||32
5036807|NCT02042014|12395693|P1|NOT COMPLETED|Overall Study||8
5036808|NCT02042014|12395693|P1|COMPLETED|Overall Study||0
5036809|NCT02042014|12395693|P1|STARTED|Overall Study||8
5036810|NCT02041962|12395699|P2|NOT COMPLETED|Overall Study||84
5036811|NCT02041962|12395700|P1|NOT COMPLETED|Overall Study||81
5036812|NCT02041962|12395699|P2|COMPLETED|Overall Study||31
5036813|NCT02041962|12395700|P1|COMPLETED|Overall Study||42
5036814|NCT02041962|12395699|P2|Participants Completing 12 mo. f/up|Overall Study||31
5036815|NCT02041962|12395700|P1|Participants Completing 12 mo. f/up|Overall Study||42
5036816|NCT02041962|12395699|P2|Participants Completing 6 mo. f/up|Overall Study||44
5036817|NCT02041962|12395700|P1|Participants Completing 6 mo. f/up|Overall Study||69
5036818|NCT02041962|12395699|P2|STARTED|Overall Study||115
5036819|NCT02041962|12395700|P1|STARTED|Overall Study||123
5036820|NCT02041702|12395710|P2|NOT COMPLETED|Overall Study||9
5036821|NCT02041702|12395711|P1|NOT COMPLETED|Overall Study||11
5036822|NCT02041702|12395710|P2|COMPLETED|Overall Study||134
5036823|NCT02041702|12395711|P1|COMPLETED|Overall Study||129
5036824|NCT02041702|12395710|P2|Post MRI Scan/ Post Waiting|Overall Study||140
5036825|NCT02041702|12395711|P1|Post MRI Scan/ Post Waiting|Overall Study||129
5036826|NCT02041702|12395710|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
5036827|NCT02041702|12395711|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
5036828|NCT02041702|12395710|P2|STARTED|Overall Study||143
5036829|NCT02041702|12395711|P1|STARTED|Overall Study||140
5036830|NCT02041533|12395726|P2|NOT COMPLETED|Overall Study||258
5036831|NCT02041533|12395727|P1|NOT COMPLETED|Overall Study||228
5036832|NCT02041533|12395726|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
5036833|NCT02041533|12395727|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
5036834|NCT02041533|12395726|P2|Began Treatment|Overall Study||263
5036835|NCT02041533|12395727|P1|Began Treatment|Overall Study||267
5036836|NCT02041533|12395726|P2|STARTED|Overall Study||270
5036837|NCT02041533|12395727|P1|STARTED|Overall Study||271
5036838|NCT02041520|12395749|P2|NOT COMPLETED|Overall Study||7
5036839|NCT02041520|12395750|P1|NOT COMPLETED|Overall Study||6
5036840|NCT02041520|12395749|P2|COMPLETED|Overall Study||28
5036841|NCT02041520|12395750|P1|COMPLETED|Overall Study||29
5036842|NCT02041520|12395749|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
5036843|NCT02041520|12395750|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
5036844|NCT02041377|12395770|P1|NOT COMPLETED|Overall Study||0
5036845|NCT02041377|12395770|P1|COMPLETED|Overall Study||134
5036846|NCT02041377|12395770|P1|STARTED|Overall Study||134
5036847|NCT02041325|12395780|P2|NOT COMPLETED|Overall Study||3
5036848|NCT02041325|12395781|P1|NOT COMPLETED|Overall Study||3
5036849|NCT02041325|12395780|P2|COMPLETED|Overall Study||13
5036850|NCT02041325|12395781|P1|COMPLETED|Overall Study||19
5036851|NCT02041325|12395780|P2|STARTED|Overall Study||16
5036852|NCT02041325|12395781|P1|STARTED|Overall Study||22
5036853|NCT02041286|12395793|P1|NOT COMPLETED|Overall Study||1
5036854|NCT02041286|12395793|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
5036855|NCT02041286|12395793|P1|STARTED|Overall Study||136
5036856|NCT02041221|12395807|P6|NOT COMPLETED|Part 2||0
5036857|NCT02041221|12395808|P5|NOT COMPLETED|Part 2||0
5036858|NCT02041221|12395809|P4|NOT COMPLETED|Part 2||0
5036859|NCT02041221|12395810|P3|NOT COMPLETED|Part 2||1
5036860|NCT02041221|12395811|P2|NOT COMPLETED|Part 2||0
5036861|NCT02041221|12395812|P1|NOT COMPLETED|Part 2||0
5036862|NCT02041221|12395807|P6|COMPLETED|Part 2||6
5036863|NCT02041221|12395808|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
5036864|NCT02041221|12395809|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
5036865|NCT02041221|12395810|P3|COMPLETED|Part 2||5
5036866|NCT02041221|12395811|P2|COMPLETED|Part 2||6
5036867|NCT02041221|12395812|P1|COMPLETED|Part 2||6
5036868|NCT02041221|12395807|P6|STARTED|Part 2||6
5036869|NCT02041221|12395808|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
5036870|NCT02041221|12395809|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
5036871|NCT02041221|12395810|P3|STARTED|Part 2||6
5036872|NCT02041221|12395811|P2|STARTED|Part 2||6
5036873|NCT02041221|12395812|P1|STARTED|Part 2||6
5036874|NCT02041221|12395807|P6|NOT COMPLETED|Part 1||0
5036875|NCT02041221|12395808|P5|NOT COMPLETED|Part 1||0
5036876|NCT02041221|12395809|P4|NOT COMPLETED|Part 1||0
5036877|NCT02041221|12395810|P3|NOT COMPLETED|Part 1||0
5036878|NCT02041221|12395811|P2|NOT COMPLETED|Part 1||0
5036879|NCT02041221|12395812|P1|NOT COMPLETED|Part 1||0
5036880|NCT02041221|12395807|P6|COMPLETED|Part 1||10
5036881|NCT02041221|12395808|P5|COMPLETED|Part 1||6
5036882|NCT02041221|12395809|P4|COMPLETED|Part 1||6
5036883|NCT02041221|12395810|P3|COMPLETED|Part 1||6
5036884|NCT02041221|12395811|P2|COMPLETED|Part 1||6
5036885|NCT02041221|12395812|P1|COMPLETED|Part 1||6
5036886|NCT02041221|12395807|P6|STARTED|Part 1||10
5036887|NCT02041221|12395808|P5|STARTED|Part 1||6
5036888|NCT02041221|12395809|P4|STARTED|Part 1||6
5036889|NCT02041221|12395810|P3|STARTED|Part 1||6
5036890|NCT02041221|12395811|P2|STARTED|Part 1||6
5036891|NCT02041221|12395812|P1|STARTED|Part 1||6
5036892|NCT02041104|12395828|P2|NOT COMPLETED|Overall Study||7
5036893|NCT02041104|12395829|P1|NOT COMPLETED|Overall Study||1
5036894|NCT02041104|12395828|P2|COMPLETED|Overall Study||16
5036895|NCT02041104|12395829|P1|COMPLETED|Overall Study||27
5036896|NCT02041104|12395828|P2|STARTED|Overall Study||23
5036897|NCT02041104|12395829|P1|STARTED|Overall Study||28
5036898|NCT02041091|12395869|P2|NOT COMPLETED|Optional Safety Extension Period||82
5036899|NCT02041091|12395870|P1|NOT COMPLETED|Optional Safety Extension Period||85
5036900|NCT02041091|12395869|P2|COMPLETED|Optional Safety Extension Period||0
5036901|NCT02041091|12395870|P1|COMPLETED|Optional Safety Extension Period||0
5036902|NCT02041091|12395869|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
5036903|NCT02041091|12395870|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
5036904|NCT02041091|12395869|P2|NOT COMPLETED|Treatment||23
5036905|NCT02041091|12395870|P1|NOT COMPLETED|Treatment||22
5036906|NCT02041091|12395869|P2|COMPLETED|Treatment||91
5036907|NCT02041091|12395870|P1|COMPLETED|Treatment||90
5036908|NCT02041091|12395869|P2|Participated in Follow Up|Treatment||96
5036909|NCT02041091|12395870|P1|Participated in Follow Up|Treatment||106
5036910|NCT02041091|12395869|P2|Received At Least One Dose of Study Drug|Treatment||114
5036911|NCT02041091|12395870|P1|Received At Least One Dose of Study Drug|Treatment||112
5036912|NCT02041091|12395869|P2|STARTED|Treatment||114
5036913|NCT02041091|12395870|P1|STARTED|Treatment||112
5036914|NCT02040870|12395892|P1|NOT COMPLETED|Overall Study||103
5036915|NCT02040870|12395892|P1|COMPLETED|Overall Study||0
5036916|NCT02040870|12395892|P1|Discontinue From Study|Overall Study||26
5036917|NCT02040870|12395892|P1|Entered Survival Follow-up|Overall Study||75
5036918|NCT02040870|12395892|P1|Entered Post-treatment Follow-up|Overall Study||2
5036919|NCT02040870|12395892|P1|STARTED|Overall Study||103
5036920|NCT02040844|12395916|P3|NOT COMPLETED|Overall Study||47
5036921|NCT02040844|12395917|P2|NOT COMPLETED|Overall Study||39
5036922|NCT02040844|12395918|P1|NOT COMPLETED|Overall Study||50
5036923|NCT02040844|12395916|P3|COMPLETED|Overall Study||97
5036924|NCT02040844|12395917|P2|COMPLETED|Overall Study||109
5036925|NCT02040844|12395918|P1|COMPLETED|Overall Study||88
5036926|NCT02040844|12395916|P3|STARTED|Overall Study||144
5036927|NCT02040844|12395917|P2|STARTED|Overall Study||148
5036928|NCT02040844|12395918|P1|STARTED|Overall Study||138
5036929|NCT02040805|12395943|P2|NOT COMPLETED|Overall Study||50
5036930|NCT02040805|12395944|P1|NOT COMPLETED|Overall Study||42
5036931|NCT02040805|12395943|P2|COMPLETED|Overall Study||113
5036932|NCT02040805|12395944|P1|COMPLETED|Overall Study||118
5036933|NCT02040805|12395943|P2|STARTED|Overall Study||163
5036934|NCT02040805|12395944|P1|STARTED|Overall Study||160
5036935|NCT02040792|12395961|P5|NOT COMPLETED|Overall Study||7
5036936|NCT02040792|12395962|P4|NOT COMPLETED|Overall Study||7
5036937|NCT02040792|12395963|P3|NOT COMPLETED|Overall Study||3
5036938|NCT02040792|12395964|P2|NOT COMPLETED|Overall Study||3
5036939|NCT02040792|12395965|P1|NOT COMPLETED|Overall Study||6
5036940|NCT02040792|12395961|P5|COMPLETED|Overall Study||67
5036941|NCT02040792|12395962|P4|COMPLETED|Overall Study||64
5036942|NCT02040792|12395963|P3|COMPLETED|Overall Study||68
5036943|NCT02040792|12395964|P2|COMPLETED|Overall Study||65
5036944|NCT02040792|12395965|P1|COMPLETED|Overall Study||64
5036945|NCT02040792|12395961|P5|STARTED|Overall Study||74
5036946|NCT02040792|12395962|P4|STARTED|Overall Study||71
5036947|NCT02040792|12395963|P3|STARTED|Overall Study||71
5036948|NCT02040792|12395964|P2|STARTED|Overall Study||68
5036949|NCT02040792|12395965|P1|STARTED|Overall Study||70
5036950|NCT02040779|12395980|P3|NOT COMPLETED|Overall Study||4
5036951|NCT02040779|12395981|P2|NOT COMPLETED|Overall Study||7
5036952|NCT02040779|12395982|P1|NOT COMPLETED|Overall Study||12
5036953|NCT02040779|12395980|P3|COMPLETED|Overall Study||88
5036954|NCT02040779|12395981|P2|COMPLETED|Overall Study||83
5036955|NCT02040779|12395982|P1|COMPLETED|Overall Study||79
5036956|NCT02040779|12395980|P3|Full Analysis Set (FAS)|Overall Study||92
5036957|NCT02040779|12395981|P2|Full Analysis Set (FAS)|Overall Study||88
5036958|NCT02040779|12395982|P1|Full Analysis Set (FAS)|Overall Study||90
5036959|NCT02040779|12395980|P3|STARTED|Overall Study||92
5036960|NCT02040779|12395981|P2|STARTED|Overall Study||90
5036961|NCT02040779|12395982|P1|STARTED|Overall Study||91
5036962|NCT02040766|12396022|P5|NOT COMPLETED|Overall Study||13
5036963|NCT02040766|12396023|P4|NOT COMPLETED|Overall Study||13
5036964|NCT02040766|12396024|P3|NOT COMPLETED|Overall Study||12
5036965|NCT02040766|12396025|P2|NOT COMPLETED|Overall Study||10
5036966|NCT02040766|12396026|P1|NOT COMPLETED|Overall Study||18
5036967|NCT02040766|12396022|P5|COMPLETED|Overall Study||112
5036968|NCT02040766|12396023|P4|COMPLETED|Overall Study||112
5036969|NCT02040766|12396024|P3|COMPLETED|Overall Study||113
5036970|NCT02040766|12396025|P2|COMPLETED|Overall Study||116
5036971|NCT02040766|12396026|P1|COMPLETED|Overall Study||109
5036972|NCT02040766|12396022|P5|STARTED|Overall Study||125
5036973|NCT02040766|12396023|P4|STARTED|Overall Study||125
5036974|NCT02040766|12396024|P3|STARTED|Overall Study||125
5036975|NCT02040766|12396025|P2|STARTED|Overall Study||126
5036976|NCT02040766|12396026|P1|STARTED|Overall Study||127
5036977|NCT02040623|12396067|P3|NOT COMPLETED|Overall Study||2
5036978|NCT02040623|12396068|P2|NOT COMPLETED|Overall Study||6
5036979|NCT02040623|12396069|P1|NOT COMPLETED|Overall Study||4
5036980|NCT02040623|12396067|P3|COMPLETED|Overall Study||10
5036981|NCT02040623|12396068|P2|COMPLETED|Overall Study||6
5036982|NCT02040623|12396069|P1|COMPLETED|Overall Study||7
5036983|NCT02040623|12396067|P3|STARTED|Overall Study||12
5036984|NCT02040623|12396068|P2|STARTED|Overall Study||12
5036985|NCT02040623|12396069|P1|STARTED|Overall Study||11
5036986|NCT02040584|12396079|P2|NOT COMPLETED|Overall Study||32
5036987|NCT02040584|12396080|P1|NOT COMPLETED|Overall Study||35
5036988|NCT02040584|12396079|P2|COMPLETED|Overall Study||74
5036989|NCT02040584|12396080|P1|COMPLETED|Overall Study||70
5036990|NCT02040584|12396079|P2|STARTED|Overall Study||106
5036991|NCT02040584|12396080|P1|STARTED|Overall Study||105
5036992|NCT02040532|12396113|P1|NOT COMPLETED|Overall Study||12
5036993|NCT02040532|12396113|P1|COMPLETED|Overall Study||20
5036994|NCT02040532|12396113|P1|Received at Least One Dose of Medication|Overall Study||26
5036995|NCT02040532|12396113|P1|STARTED|Overall Study||32
5036996|NCT02040428|12396126|P2|NOT COMPLETED|Overall Study||4
5036997|NCT02040428|12396127|P1|NOT COMPLETED|Overall Study||5
5036998|NCT02040428|12396126|P2|COMPLETED|Overall Study||77
5036999|NCT02040428|12396127|P1|COMPLETED|Overall Study||70
5037000|NCT02040428|12396126|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
5037001|NCT02040428|12396127|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
5037002|NCT02040428|12396126|P2|STARTED|Overall Study||81
5037003|NCT02040428|12396127|P1|STARTED|Overall Study||75
5037004|NCT02040259|12396139|P1|NOT COMPLETED|Overall Study||363
5037005|NCT02040259|12396139|P1|COMPLETED|Overall Study||1645
5037006|NCT02040259|12396139|P1|STARTED|Overall Study||2008
5037007|NCT02040116|12396147|P1|NOT COMPLETED|Overall Study||0
5037008|NCT02040116|12396147|P1|COMPLETED|Overall Study||19
5037009|NCT02040116|12396147|P1|STARTED|Overall Study||19
5037010|NCT02040077|12396158|P3|NOT COMPLETED|Overall Study||0
5037011|NCT02040077|12396159|P2|NOT COMPLETED|Overall Study||0
5037012|NCT02040077|12396160|P1|NOT COMPLETED|Overall Study||0
5037013|NCT02040077|12396158|P3|COMPLETED|Overall Study||25
5037014|NCT02040077|12396159|P2|COMPLETED|Overall Study||24
5037015|NCT02040077|12396160|P1|COMPLETED|Overall Study||27
5037016|NCT02040077|12396158|P3|STARTED|Overall Study||25
5037017|NCT02040077|12396159|P2|STARTED|Overall Study||24
5037018|NCT02040077|12396160|P1|STARTED|Overall Study||27
5037019|NCT02039947|12396175|P4|NOT COMPLETED|Overall Study||0
5037020|NCT02039947|12396176|P3|NOT COMPLETED|Overall Study||0
5037021|NCT02039947|12396177|P2|NOT COMPLETED|Overall Study||0
5037022|NCT02039947|12396178|P1|NOT COMPLETED|Overall Study||0
5037023|NCT02039947|12396175|P4|COMPLETED|Overall Study||17
5037024|NCT02039947|12396176|P3|COMPLETED|Overall Study||16
5037025|NCT02039947|12396177|P2|COMPLETED|Overall Study||16
5037026|NCT02039947|12396178|P1|COMPLETED|Overall Study||76
5037027|NCT02039947|12396175|P4|STARTED|Overall Study||17
5037028|NCT02039947|12396176|P3|STARTED|Overall Study||16
5037029|NCT02039947|12396177|P2|STARTED|Overall Study||16
5037030|NCT02039947|12396178|P1|STARTED|Overall Study||76
5037031|NCT02039908|12396213|P4|NOT COMPLETED|Phase 2-School Year||8
5037032|NCT02039908|12396214|P3|NOT COMPLETED|Phase 2-School Year||12
5037033|NCT02039908|12396215|P2|NOT COMPLETED|Phase 2-School Year||0
5037034|NCT02039908|12396216|P1|NOT COMPLETED|Phase 2-School Year||0
5037035|NCT02039908|12396213|P4|COMPLETED|Phase 2-School Year||116
5037036|NCT02039908|12396214|P3|COMPLETED|Phase 2-School Year||109
5037037|NCT02039908|12396215|P2|COMPLETED|Phase 2-School Year||0
5037038|NCT02039908|12396216|P1|COMPLETED|Phase 2-School Year||0
5037039|NCT02039908|12396213|P4|STARTED|Phase 2-School Year||124
5037040|NCT02039908|12396214|P3|STARTED|Phase 2-School Year||121
5037041|NCT02039908|12396215|P2|STARTED|Phase 2-School Year||0
5037042|NCT02039908|12396216|P1|STARTED|Phase 2-School Year||0
5037043|NCT02039908|12396213|P4|NOT COMPLETED|Phase 1-Summer||0
5037044|NCT02039908|12396214|P3|NOT COMPLETED|Phase 1-Summer||0
5037045|NCT02039908|12396215|P2|NOT COMPLETED|Phase 1-Summer||6
5037046|NCT02039908|12396216|P1|NOT COMPLETED|Phase 1-Summer||13
5037047|NCT02039908|12396213|P4|COMPLETED|Phase 1-Summer||0
5037048|NCT02039908|12396214|P3|COMPLETED|Phase 1-Summer||0
5037049|NCT02039908|12396215|P2|COMPLETED|Phase 1-Summer||132
5037050|NCT02039908|12396216|P1|COMPLETED|Phase 1-Summer||116
5037051|NCT02039908|12396213|P4|STARTED|Phase 1-Summer||0
5037052|NCT02039908|12396214|P3|STARTED|Phase 1-Summer||0
5037053|NCT02039908|12396215|P2|STARTED|Phase 1-Summer||138
5037054|NCT02039908|12396216|P1|STARTED|Phase 1-Summer||129
5037055|NCT02039856|12396230|P2|NOT COMPLETED|Overall Study||853
5037056|NCT02039856|12396231|P1|NOT COMPLETED|Overall Study||2027
5037057|NCT02039856|12396230|P2|COMPLETED|Overall Study||327
5037058|NCT02039856|12396231|P1|COMPLETED|Overall Study||693
5037059|NCT02039856|12396230|P2|Total 24-month Completed|Overall Study||327
5037060|NCT02039856|12396231|P1|Total 24-month Completed|Overall Study||693
5037061|NCT02039856|12396230|P2|24-month Completed Providers/Staff|Overall Study||105
5037062|NCT02039856|12396231|P1|24-month Completed Providers/Staff|Overall Study||174
5037063|NCT02039856|12396230|P2|24-month Started Providers/Staff|Overall Study||304
5037064|NCT02039856|12396231|P1|24-month Started Providers/Staff|Overall Study||565
5037065|NCT02039856|12396230|P2|24-month Completed - Patients|Overall Study||222
5037066|NCT02039856|12396231|P1|24-month Completed - Patients|Overall Study||519
5037067|NCT02039856|12396230|P2|24-month Started - Patients|Overall Study||442
5037068|NCT02039856|12396231|P1|24-month Started - Patients|Overall Study||953
5037069|NCT02039856|12396230|P2|24-month Started|Overall Study||746
5037070|NCT02039856|12396231|P1|24-month Started|Overall Study||1518
5037071|NCT02039856|12396230|P2|12-month Providers/Staff|Overall Study||0
5037072|NCT02039856|12396231|P1|12-month Providers/Staff|Overall Study||0
5037073|NCT02039856|12396230|P2|12-month Completed- Patients|Overall Study||241
5037074|NCT02039856|12396231|P1|12-month Completed- Patients|Overall Study||580
5037075|NCT02039856|12396230|P2|12-month Started-patients|Overall Study||442
5037076|NCT02039856|12396231|P1|12-month Started-patients|Overall Study||953
5037077|NCT02039856|12396230|P2|Total Baseline Completed|Overall Study||536
5037078|NCT02039856|12396231|P1|Total Baseline Completed|Overall Study||1147
5037079|NCT02039856|12396230|P2|Baseline Completed -Providers/Staff|Overall Study||94
5037080|NCT02039856|12396231|P1|Baseline Completed -Providers/Staff|Overall Study||194
5037081|NCT02039856|12396230|P2|Baseline Started - Providers/Staff|Overall Study||261
5037082|NCT02039856|12396231|P1|Baseline Started - Providers/Staff|Overall Study||537
5037083|NCT02039856|12396230|P2|Baseline Completed - Patients|Overall Study||442
5037084|NCT02039856|12396231|P1|Baseline Completed - Patients|Overall Study||953
5037085|NCT02039856|12396230|P2|Baseline Started - Patients|Overall Study||919
5037086|NCT02039856|12396231|P1|Baseline Started - Patients|Overall Study||2183
5037087|NCT02039856|12396230|P2|STARTED|Overall Study||1180
5037088|NCT02039856|12396231|P1|STARTED|Overall Study||2720
5037089|NCT02039817|12396253|P2|NOT COMPLETED|Overall Study||0
5037090|NCT02039817|12396254|P1|NOT COMPLETED|Overall Study||0
5037091|NCT02039817|12396253|P2|COMPLETED|Overall Study||8
5037092|NCT02039817|12396254|P1|COMPLETED|Overall Study||8
5037093|NCT02039817|12396253|P2|STARTED|Overall Study||8
5037094|NCT02039817|12396254|P1|STARTED|Overall Study||8
5037095|NCT02039778|12396263|P1|NOT COMPLETED|Overall Study||4
5037096|NCT02039778|12396263|P1|COMPLETED|Overall Study||0
5037097|NCT02039778|12396263|P1|STARTED|Overall Study||4
5037098|NCT02039726|12396273|P2|NOT COMPLETED|Overall Study||16
5037099|NCT02039726|12396274|P1|NOT COMPLETED|Overall Study||45
5037100|NCT02039726|12396273|P2|COMPLETED|Overall Study||106
5037101|NCT02039726|12396274|P1|COMPLETED|Overall Study||200
5037102|NCT02039726|12396273|P2|Did Not Receive Treatment|Overall Study||28
5037103|NCT02039726|12396274|P1|Did Not Receive Treatment|Overall Study||4
5037104|NCT02039726|12396273|P2|Ongoing (as of Data Cutoff)|Overall Study||16
5037105|NCT02039726|12396274|P1|Ongoing (as of Data Cutoff)|Overall Study||45
5037106|NCT02039726|12396273|P2|STARTED|Overall Study||122
5037107|NCT02039726|12396274|P1|STARTED|Overall Study||245
5037108|NCT02039687|12396286|P4|NOT COMPLETED|Overall Study||0
5037109|NCT02039687|12396287|P3|NOT COMPLETED|Overall Study||3
5037110|NCT02039687|12396288|P2|NOT COMPLETED|Overall Study||1
5037111|NCT02039687|12396289|P1|NOT COMPLETED|Overall Study||0
5037112|NCT02039687|12396286|P4|COMPLETED|Overall Study||16
5037113|NCT02039687|12396287|P3|COMPLETED|Overall Study||13
5037114|NCT02039687|12396288|P2|COMPLETED|Overall Study||15
5037115|NCT02039687|12396289|P1|COMPLETED|Overall Study||16
5037116|NCT02039687|12396286|P4|STARTED|Overall Study||16
5037117|NCT02039687|12396287|P3|STARTED|Overall Study||16
5037118|NCT02039687|12396288|P2|STARTED|Overall Study||16
5037119|NCT02039687|12396289|P1|STARTED|Overall Study||16
5037120|NCT02039674|12396329|P14|NOT COMPLETED|Overall Study||33
5037121|NCT02039674|12396330|P13|NOT COMPLETED|Overall Study||63
5037122|NCT02039674|12396331|P12|NOT COMPLETED|Overall Study||60
5037123|NCT02039674|12396332|P11|NOT COMPLETED|Overall Study||7
5037124|NCT02039674|12396333|P10|NOT COMPLETED|Overall Study||12
5037125|NCT02039674|12396334|P9|NOT COMPLETED|Overall Study||12
5037126|NCT02039674|12396335|P8|NOT COMPLETED|Overall Study||3
5037127|NCT02039674|12396336|P7|NOT COMPLETED|Overall Study||3
5037128|NCT02039674|12396337|P6|NOT COMPLETED|Overall Study||12
5037129|NCT02039674|12396338|P5|NOT COMPLETED|Overall Study||12
5037130|NCT02039674|12396339|P4|NOT COMPLETED|Overall Study||13
5037131|NCT02039674|12396340|P3|NOT COMPLETED|Overall Study||12
5037132|NCT02039674|12396341|P2|NOT COMPLETED|Overall Study||12
5037133|NCT02039674|12396342|P1|NOT COMPLETED|Overall Study||12
5037134|NCT02039674|12396329|P14|COMPLETED|Overall Study||0
5037135|NCT02039674|12396330|P13|COMPLETED|Overall Study||0
5037136|NCT02039674|12396331|P12|COMPLETED|Overall Study||0
5037137|NCT02039674|12396332|P11|COMPLETED|Overall Study||0
5037138|NCT02039674|12396333|P10|COMPLETED|Overall Study||0
5037139|NCT02039674|12396334|P9|COMPLETED|Overall Study||0
5037140|NCT02039674|12396335|P8|COMPLETED|Overall Study||0
5037141|NCT02039674|12396336|P7|COMPLETED|Overall Study||0
5037142|NCT02039674|12396337|P6|COMPLETED|Overall Study||0
5037143|NCT02039674|12396338|P5|COMPLETED|Overall Study||0
5037144|NCT02039674|12396339|P4|COMPLETED|Overall Study||0
5037145|NCT02039674|12396340|P3|COMPLETED|Overall Study||0
5037146|NCT02039674|12396341|P2|COMPLETED|Overall Study||0
5037147|NCT02039674|12396342|P1|COMPLETED|Overall Study||1
5037148|NCT02039674|12396329|P14|Treated|Overall Study||33
5037149|NCT02039674|12396330|P13|Treated|Overall Study||62
5037150|NCT02039674|12396331|P12|Treated|Overall Study||59
5037151|NCT02039674|12396332|P11|Treated|Overall Study||7
5037152|NCT02039674|12396333|P10|Treated|Overall Study||12
5037153|NCT02039674|12396334|P9|Treated|Overall Study||12
5037154|NCT02039674|12396335|P8|Treated|Overall Study||3
5037155|NCT02039674|12396336|P7|Treated|Overall Study||3
5037156|NCT02039674|12396337|P6|Treated|Overall Study||12
5037157|NCT02039674|12396338|P5|Treated|Overall Study||12
5037158|NCT02039674|12396339|P4|Treated|Overall Study||13
5037159|NCT02039674|12396340|P3|Treated|Overall Study||11
5037160|NCT02039674|12396341|P2|Treated|Overall Study||12
5037161|NCT02039674|12396342|P1|Treated|Overall Study||13
5037162|NCT02039674|12396329|P14|STARTED|Overall Study||33
5037163|NCT02039674|12396330|P13|STARTED|Overall Study||63
5037164|NCT02039674|12396331|P12|STARTED|Overall Study||60
5037165|NCT02039674|12396332|P11|STARTED|Overall Study||7
5037166|NCT02039674|12396333|P10|STARTED|Overall Study||12
5037167|NCT02039674|12396334|P9|STARTED|Overall Study||12
5037168|NCT02039674|12396335|P8|STARTED|Overall Study||3
5037169|NCT02039674|12396336|P7|STARTED|Overall Study||3
5037170|NCT02039674|12396337|P6|STARTED|Overall Study||12
5037171|NCT02039674|12396338|P5|STARTED|Overall Study||12
5037172|NCT02039674|12396339|P4|STARTED|Overall Study||13
5037173|NCT02039674|12396340|P3|STARTED|Overall Study||12
5037174|NCT02039674|12396341|P2|STARTED|Overall Study||12
5037175|NCT02039674|12396342|P1|STARTED|Overall Study||13
5037176|NCT02039505|12396384|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
5037177|NCT02039505|12396385|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037178|NCT02039505|12396386|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037179|NCT02039505|12396387|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037180|NCT02039505|12396388|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037181|NCT02039505|12396389|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037182|NCT02039505|12396390|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037183|NCT02039505|12396384|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
5037184|NCT02039505|12396385|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037185|NCT02039505|12396386|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037186|NCT02039505|12396387|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037187|NCT02039505|12396388|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037188|NCT02039505|12396389|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037189|NCT02039505|12396390|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
5037190|NCT02039505|12396384|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
5037191|NCT02039505|12396385|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
5037192|NCT02039505|12396386|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
5037193|NCT02039505|12396387|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
5037194|NCT02039505|12396388|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
5037195|NCT02039505|12396389|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
5037196|NCT02039505|12396390|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
5037197|NCT02039505|12396384|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037198|NCT02039505|12396385|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
5037199|NCT02039505|12396386|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
5037200|NCT02039505|12396387|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
5037201|NCT02039505|12396388|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037202|NCT02039505|12396389|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037203|NCT02039505|12396390|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037204|NCT02039505|12396384|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037205|NCT02039505|12396385|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
5037206|NCT02039505|12396386|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
5037207|NCT02039505|12396387|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
5037208|NCT02039505|12396388|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037209|NCT02039505|12396389|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037210|NCT02039505|12396390|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
5037211|NCT02039505|12396384|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
5037212|NCT02039505|12396385|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
5037213|NCT02039505|12396386|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
5037214|NCT02039505|12396387|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
5037215|NCT02039505|12396388|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
5037216|NCT02039505|12396389|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
5037217|NCT02039505|12396390|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
5037218|NCT02039505|12396384|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037219|NCT02039505|12396385|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037220|NCT02039505|12396386|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037221|NCT02039505|12396387|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037222|NCT02039505|12396388|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
5037223|NCT02039505|12396389|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
5037224|NCT02039505|12396390|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
5037225|NCT02039505|12396384|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037226|NCT02039505|12396385|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037227|NCT02039505|12396386|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037228|NCT02039505|12396387|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
5037229|NCT02039505|12396388|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
5037230|NCT02039505|12396389|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
5037231|NCT02039505|12396390|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
5037232|NCT02039505|12396384|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
5037233|NCT02039505|12396385|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
5037234|NCT02039505|12396386|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
5037235|NCT02039505|12396387|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
5037236|NCT02039505|12396388|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
5037237|NCT02039505|12396389|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
5037238|NCT02039505|12396390|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
5037239|NCT02039427|12396466|P4|NOT COMPLETED|Overall Study||5
5037240|NCT02039427|12396467|P3|NOT COMPLETED|Overall Study||3
5037241|NCT02039427|12396468|P2|NOT COMPLETED|Overall Study||1
5037242|NCT02039427|12396469|P1|NOT COMPLETED|Overall Study||3
5037243|NCT02039427|12396466|P4|COMPLETED|Overall Study||43
5037244|NCT02039427|12396467|P3|COMPLETED|Overall Study||45
5037245|NCT02039427|12396468|P2|COMPLETED|Overall Study||47
5037246|NCT02039427|12396469|P1|COMPLETED|Overall Study||45
5037247|NCT02039427|12396466|P4|STARTED|Overall Study||48
5037248|NCT02039427|12396467|P3|STARTED|Overall Study||48
5037249|NCT02039427|12396468|P2|STARTED|Overall Study||48
5037250|NCT02039427|12396469|P1|STARTED|Overall Study||48
5037251|NCT02039414|12396489|P2|NOT COMPLETED|Overall Study||2
5037252|NCT02039414|12396490|P1|NOT COMPLETED|Overall Study||6
5037253|NCT02039414|12396489|P2|COMPLETED|Overall Study||16
5037254|NCT02039414|12396490|P1|COMPLETED|Overall Study||16
5037255|NCT02039414|12396489|P2|STARTED|Overall Study||18
5037256|NCT02039414|12396490|P1|STARTED|Overall Study||22
5037257|NCT02039375|12396502|P1|NOT COMPLETED|Overall Study||2
5037258|NCT02039375|12396502|P1|COMPLETED|Overall Study||33
5037259|NCT02039375|12396502|P1|STARTED|Overall Study||35
5037260|NCT02039219|12396513|P2|NOT COMPLETED|Follow up||1
5037261|NCT02039219|12396514|P1|NOT COMPLETED|Follow up||0
5037262|NCT02039219|12396513|P2|COMPLETED|Follow up||5
5037263|NCT02039219|12396514|P1|COMPLETED|Follow up||7
5037264|NCT02039219|12396513|P2|STARTED|Follow up||6
5037265|NCT02039219|12396514|P1|STARTED|Follow up||7
5037266|NCT02039219|12396513|P2|NOT COMPLETED|Treatment||2
5037267|NCT02039219|12396514|P1|NOT COMPLETED|Treatment||4
5037268|NCT02039219|12396513|P2|COMPLETED|Treatment||6
5037269|NCT02039219|12396514|P1|COMPLETED|Treatment||7
5037270|NCT02039219|12396513|P2|STARTED|Treatment||8
5037271|NCT02039219|12396514|P1|STARTED|Treatment||11
5037272|NCT02039115|12396554|P2|NOT COMPLETED|Overall Study||0
5037273|NCT02039115|12396555|P1|NOT COMPLETED|Overall Study||0
5037274|NCT02039115|12396554|P2|COMPLETED|Overall Study||0
5037275|NCT02039115|12396555|P1|COMPLETED|Overall Study||1
5037276|NCT02039115|12396554|P2|STARTED|Overall Study||0
5037277|NCT02039115|12396555|P1|STARTED|Overall Study||1
5037278|NCT02038959|12396563|P2|NOT COMPLETED|Overall Study||8
5037279|NCT02038959|12396564|P1|NOT COMPLETED|Overall Study||6
5037280|NCT02038959|12396563|P2|COMPLETED|Overall Study||89
5037281|NCT02038959|12396564|P1|COMPLETED|Overall Study||92
5037282|NCT02038959|12396563|P2|STARTED|Overall Study||97
5037283|NCT02038959|12396564|P1|STARTED|Overall Study||98
5037284|NCT02038946|12396590|P1|NOT COMPLETED|Overall Study||11
5037285|NCT02038946|12396590|P1|COMPLETED|Overall Study||81
5037286|NCT02038946|12396590|P1|STARTED|Overall Study||92
5037287|NCT02038933|12396601|P1|NOT COMPLETED|Follow-up||19
5037288|NCT02038933|12396601|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
5037289|NCT02038933|12396601|P1|STARTED|Follow-up||121
5037290|NCT02038933|12396601|P1|NOT COMPLETED|Treatment||114
5037291|NCT02038933|12396601|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
5037292|NCT02038933|12396601|P1|STARTED|Treatment||121
5037293|NCT02038920|12396622|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
5037294|NCT02038920|12396623|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037295|NCT02038920|12396624|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037296|NCT02038920|12396625|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037297|NCT02038920|12396626|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037298|NCT02038920|12396627|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037299|NCT02038920|12396622|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
5037300|NCT02038920|12396623|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037301|NCT02038920|12396624|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037302|NCT02038920|12396625|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037303|NCT02038920|12396626|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037304|NCT02038920|12396627|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
5037305|NCT02038920|12396622|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
5037306|NCT02038920|12396623|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
5037307|NCT02038920|12396624|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
5037308|NCT02038920|12396625|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
5037309|NCT02038920|12396626|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
5037310|NCT02038920|12396627|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
5037311|NCT02038920|12396622|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037312|NCT02038920|12396623|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
5037313|NCT02038920|12396624|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
5037314|NCT02038920|12396625|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
5037315|NCT02038920|12396626|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037316|NCT02038920|12396627|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037317|NCT02038920|12396622|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037318|NCT02038920|12396623|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
5037319|NCT02038920|12396624|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
5037320|NCT02038920|12396625|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
5037321|NCT02038920|12396626|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037322|NCT02038920|12396627|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
5037323|NCT02038920|12396622|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
5037324|NCT02038920|12396623|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
5037325|NCT02038920|12396624|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
5037326|NCT02038920|12396625|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
5037327|NCT02038920|12396626|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
5037328|NCT02038920|12396627|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
5037329|NCT02038920|12396622|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
5037330|NCT02038920|12396623|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
5037331|NCT02038920|12396624|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
5037332|NCT02038920|12396625|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
5037333|NCT02038920|12396626|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
5037334|NCT02038920|12396627|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
5037335|NCT02038920|12396622|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
5037336|NCT02038920|12396623|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
5037337|NCT02038920|12396624|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
5037338|NCT02038920|12396625|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
5037339|NCT02038920|12396626|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
5037340|NCT02038920|12396627|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
5037341|NCT02038920|12396622|P6|STARTED|Induction Phase (Week 0 to 14)||0
5037342|NCT02038920|12396623|P5|STARTED|Induction Phase (Week 0 to 14)||0
5037343|NCT02038920|12396624|P4|STARTED|Induction Phase (Week 0 to 14)||0
5037344|NCT02038920|12396625|P3|STARTED|Induction Phase (Week 0 to 14)||0
5037345|NCT02038920|12396626|P2|STARTED|Induction Phase (Week 0 to 14)||78
5037346|NCT02038920|12396627|P1|STARTED|Induction Phase (Week 0 to 14)||79
5037347|NCT02038907|12396704|P14|NOT COMPLETED|Overall Study||0
5037348|NCT02038907|12396705|P13|NOT COMPLETED|Overall Study||0
5037349|NCT02038907|12396706|P12|NOT COMPLETED|Overall Study||0
5037350|NCT02038907|12396707|P11|NOT COMPLETED|Overall Study||2
5037351|NCT02038907|12396708|P10|NOT COMPLETED|Overall Study||0
5037352|NCT02038907|12396709|P9|NOT COMPLETED|Overall Study||0
5037353|NCT02038907|12396710|P8|NOT COMPLETED|Overall Study||0
5037354|NCT02038907|12396711|P7|NOT COMPLETED|Overall Study||0
5037355|NCT02038907|12396712|P6|NOT COMPLETED|Overall Study||0
5037356|NCT02038907|12396713|P5|NOT COMPLETED|Overall Study||0
5037357|NCT02038907|12396714|P4|NOT COMPLETED|Overall Study||0
5037358|NCT02038907|12396715|P3|NOT COMPLETED|Overall Study||0
5037359|NCT02038907|12396716|P2|NOT COMPLETED|Overall Study||0
5037360|NCT02038907|12396717|P1|NOT COMPLETED|Overall Study||0
5037361|NCT02038907|12396704|P14|COMPLETED|Overall Study||31
5037362|NCT02038907|12396705|P13|COMPLETED|Overall Study||29
5037363|NCT02038907|12396706|P12|COMPLETED|Overall Study||28
5037364|NCT02038907|12396707|P11|COMPLETED|Overall Study||27
5037365|NCT02038907|12396708|P10|COMPLETED|Overall Study||30
5037366|NCT02038907|12396709|P9|COMPLETED|Overall Study||29
5037367|NCT02038907|12396710|P8|COMPLETED|Overall Study||32
5037368|NCT02038907|12396711|P7|COMPLETED|Overall Study||30
5037369|NCT02038907|12396712|P6|COMPLETED|Overall Study||31
5037370|NCT02038907|12396713|P5|COMPLETED|Overall Study||30
5037371|NCT02038907|12396714|P4|COMPLETED|Overall Study||31
5037372|NCT02038907|12396715|P3|COMPLETED|Overall Study||30
5037373|NCT02038907|12396716|P2|COMPLETED|Overall Study||30
5037374|NCT02038907|12396717|P1|COMPLETED|Overall Study||30
5037375|NCT02038907|12396704|P14|STARTED|Overall Study||31
5037376|NCT02038907|12396705|P13|STARTED|Overall Study||29
5037377|NCT02038907|12396706|P12|STARTED|Overall Study||28
5037378|NCT02038907|12396707|P11|STARTED|Overall Study||29
5037379|NCT02038907|12396708|P10|STARTED|Overall Study||30
5037380|NCT02038907|12396709|P9|STARTED|Overall Study||29
5037381|NCT02038907|12396710|P8|STARTED|Overall Study||32
5037382|NCT02038907|12396711|P7|STARTED|Overall Study||30
5037383|NCT02038907|12396712|P6|STARTED|Overall Study||31
5037384|NCT02038907|12396713|P5|STARTED|Overall Study||30
5037385|NCT02038907|12396714|P4|STARTED|Overall Study||31
5037386|NCT02038907|12396715|P3|STARTED|Overall Study||30
5037387|NCT02038907|12396716|P2|STARTED|Overall Study||30
5037388|NCT02038907|12396717|P1|STARTED|Overall Study||30
5037389|NCT02038881|12397248|P3|NOT COMPLETED|Overall Study||1
5037390|NCT02038881|12397249|P2|NOT COMPLETED|Overall Study||0
5037391|NCT02038881|12397250|P1|NOT COMPLETED|Overall Study||3
5037392|NCT02038881|12397248|P3|COMPLETED|Overall Study||30
5037393|NCT02038881|12397249|P2|COMPLETED|Overall Study||29
5037394|NCT02038881|12397250|P1|COMPLETED|Overall Study||24
5037395|NCT02038881|12397248|P3|STARTED|Overall Study||31
5037396|NCT02038881|12397249|P2|STARTED|Overall Study||29
5037397|NCT02038881|12397250|P1|STARTED|Overall Study||27
5037398|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 6||0
5037399|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 6||0
5037400|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 6||0
5037401|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 6||0
5037402|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 6||0
5037403|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 6||0
5037404|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 6||0
5037405|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 6||0
5037406|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 6||0
5037407|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 6||1
5037408|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 6||0
5037409|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 6||0
5037410|NCT02038829|12397323|P12|COMPLETED|Treatment Period 6||8
5037411|NCT02038829|12397324|P11|COMPLETED|Treatment Period 6||7
5037412|NCT02038829|12397325|P10|COMPLETED|Treatment Period 6||8
5037413|NCT02038829|12397326|P9|COMPLETED|Treatment Period 6||7
5037414|NCT02038829|12397327|P8|COMPLETED|Treatment Period 6||8
5037415|NCT02038829|12397328|P7|COMPLETED|Treatment Period 6||7
5037416|NCT02038829|12397329|P6|COMPLETED|Treatment Period 6||7
5037417|NCT02038829|12397330|P5|COMPLETED|Treatment Period 6||7
5037418|NCT02038829|12397331|P4|COMPLETED|Treatment Period 6||8
5037419|NCT02038829|12397332|P3|COMPLETED|Treatment Period 6||7
5037420|NCT02038829|12397333|P2|COMPLETED|Treatment Period 6||7
5037421|NCT02038829|12397334|P1|COMPLETED|Treatment Period 6||7
5037422|NCT02038829|12397323|P12|STARTED|Treatment Period 6||8
5037423|NCT02038829|12397324|P11|STARTED|Treatment Period 6||7
5037424|NCT02038829|12397325|P10|STARTED|Treatment Period 6||8
5037425|NCT02038829|12397326|P9|STARTED|Treatment Period 6||7
5037426|NCT02038829|12397327|P8|STARTED|Treatment Period 6||8
5037427|NCT02038829|12397328|P7|STARTED|Treatment Period 6||7
5037428|NCT02038829|12397329|P6|STARTED|Treatment Period 6||7
5037429|NCT02038829|12397330|P5|STARTED|Treatment Period 6||7
5037430|NCT02038829|12397331|P4|STARTED|Treatment Period 6||8
5037431|NCT02038829|12397332|P3|STARTED|Treatment Period 6||8
5037432|NCT02038829|12397333|P2|STARTED|Treatment Period 6||7
5037433|NCT02038829|12397334|P1|STARTED|Treatment Period 6||7
5037434|NCT02038829|12397323|P12|NOT COMPLETED|Washout Period 5||0
5037435|NCT02038829|12397324|P11|NOT COMPLETED|Washout Period 5||0
5037436|NCT02038829|12397325|P10|NOT COMPLETED|Washout Period 5||0
5037437|NCT02038829|12397326|P9|NOT COMPLETED|Washout Period 5||0
5037438|NCT02038829|12397327|P8|NOT COMPLETED|Washout Period 5||0
5037439|NCT02038829|12397328|P7|NOT COMPLETED|Washout Period 5||0
5037440|NCT02038829|12397329|P6|NOT COMPLETED|Washout Period 5||0
5037441|NCT02038829|12397330|P5|NOT COMPLETED|Washout Period 5||0
5037442|NCT02038829|12397331|P4|NOT COMPLETED|Washout Period 5||0
5037443|NCT02038829|12397332|P3|NOT COMPLETED|Washout Period 5||0
5037444|NCT02038829|12397333|P2|NOT COMPLETED|Washout Period 5||0
5037445|NCT02038829|12397334|P1|NOT COMPLETED|Washout Period 5||0
5037446|NCT02038829|12397323|P12|COMPLETED|Washout Period 5||8
5037447|NCT02038829|12397324|P11|COMPLETED|Washout Period 5||7
5037448|NCT02038829|12397325|P10|COMPLETED|Washout Period 5||8
5037449|NCT02038829|12397326|P9|COMPLETED|Washout Period 5||7
5037450|NCT02038829|12397327|P8|COMPLETED|Washout Period 5||8
5037451|NCT02038829|12397328|P7|COMPLETED|Washout Period 5||7
5037452|NCT02038829|12397329|P6|COMPLETED|Washout Period 5||7
5037453|NCT02038829|12397330|P5|COMPLETED|Washout Period 5||7
5037454|NCT02038829|12397331|P4|COMPLETED|Washout Period 5||8
5037455|NCT02038829|12397332|P3|COMPLETED|Washout Period 5||8
5037456|NCT02038829|12397333|P2|COMPLETED|Washout Period 5||7
5037457|NCT02038829|12397334|P1|COMPLETED|Washout Period 5||7
5037458|NCT02038829|12397323|P12|STARTED|Washout Period 5||8
5037459|NCT02038829|12397324|P11|STARTED|Washout Period 5||7
5037460|NCT02038829|12397325|P10|STARTED|Washout Period 5||8
5037461|NCT02038829|12397326|P9|STARTED|Washout Period 5||7
5037462|NCT02038829|12397327|P8|STARTED|Washout Period 5||8
5037463|NCT02038829|12397328|P7|STARTED|Washout Period 5||7
5037464|NCT02038829|12397329|P6|STARTED|Washout Period 5||7
5037465|NCT02038829|12397330|P5|STARTED|Washout Period 5||7
5037466|NCT02038829|12397331|P4|STARTED|Washout Period 5||8
5037467|NCT02038829|12397332|P3|STARTED|Washout Period 5||8
5037468|NCT02038829|12397333|P2|STARTED|Washout Period 5||7
5037469|NCT02038829|12397334|P1|STARTED|Washout Period 5||7
5037470|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 5||0
5037471|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 5||0
5037472|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 5||0
5037473|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 5||0
5037474|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 5||0
5037475|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 5||0
5037476|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 5||0
5037477|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 5||0
5037478|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 5||0
5037479|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 5||0
5037480|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 5||0
5037481|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 5||0
5037482|NCT02038829|12397323|P12|COMPLETED|Treatment Period 5||8
5037483|NCT02038829|12397324|P11|COMPLETED|Treatment Period 5||7
5037484|NCT02038829|12397325|P10|COMPLETED|Treatment Period 5||8
5037485|NCT02038829|12397326|P9|COMPLETED|Treatment Period 5||7
5037486|NCT02038829|12397327|P8|COMPLETED|Treatment Period 5||8
5037487|NCT02038829|12397328|P7|COMPLETED|Treatment Period 5||7
5037488|NCT02038829|12397329|P6|COMPLETED|Treatment Period 5||7
5037489|NCT02038829|12397330|P5|COMPLETED|Treatment Period 5||7
5037490|NCT02038829|12397331|P4|COMPLETED|Treatment Period 5||8
5037491|NCT02038829|12397332|P3|COMPLETED|Treatment Period 5||8
5037492|NCT02038829|12397333|P2|COMPLETED|Treatment Period 5||7
5037493|NCT02038829|12397334|P1|COMPLETED|Treatment Period 5||7
5037494|NCT02038829|12397323|P12|STARTED|Treatment Period 5||8
5037495|NCT02038829|12397324|P11|STARTED|Treatment Period 5||7
5037496|NCT02038829|12397325|P10|STARTED|Treatment Period 5||8
5037497|NCT02038829|12397326|P9|STARTED|Treatment Period 5||7
5037498|NCT02038829|12397327|P8|STARTED|Treatment Period 5||8
5037499|NCT02038829|12397328|P7|STARTED|Treatment Period 5||7
5037500|NCT02038829|12397329|P6|STARTED|Treatment Period 5||7
5037501|NCT02038829|12397330|P5|STARTED|Treatment Period 5||7
5037502|NCT02038829|12397331|P4|STARTED|Treatment Period 5||8
5037503|NCT02038829|12397332|P3|STARTED|Treatment Period 5||8
5037504|NCT02038829|12397333|P2|STARTED|Treatment Period 5||7
5037505|NCT02038829|12397334|P1|STARTED|Treatment Period 5||7
5037506|NCT02038829|12397323|P12|NOT COMPLETED|Washout Period 4||0
5037507|NCT02038829|12397324|P11|NOT COMPLETED|Washout Period 4||0
5037508|NCT02038829|12397325|P10|NOT COMPLETED|Washout Period 4||0
5037509|NCT02038829|12397326|P9|NOT COMPLETED|Washout Period 4||0
5037510|NCT02038829|12397327|P8|NOT COMPLETED|Washout Period 4||0
5037511|NCT02038829|12397328|P7|NOT COMPLETED|Washout Period 4||1
5037512|NCT02038829|12397329|P6|NOT COMPLETED|Washout Period 4||0
5037513|NCT02038829|12397330|P5|NOT COMPLETED|Washout Period 4||0
5037514|NCT02038829|12397331|P4|NOT COMPLETED|Washout Period 4||0
5037515|NCT02038829|12397332|P3|NOT COMPLETED|Washout Period 4||0
5037516|NCT02038829|12397333|P2|NOT COMPLETED|Washout Period 4||0
5037517|NCT02038829|12397334|P1|NOT COMPLETED|Washout Period 4||0
5037518|NCT02038829|12397323|P12|COMPLETED|Washout Period 4||8
5037519|NCT02038829|12397324|P11|COMPLETED|Washout Period 4||7
5037520|NCT02038829|12397325|P10|COMPLETED|Washout Period 4||8
5037521|NCT02038829|12397326|P9|COMPLETED|Washout Period 4||7
5037522|NCT02038829|12397327|P8|COMPLETED|Washout Period 4||8
5037523|NCT02038829|12397328|P7|COMPLETED|Washout Period 4||7
5037524|NCT02038829|12397329|P6|COMPLETED|Washout Period 4||7
5037525|NCT02038829|12397330|P5|COMPLETED|Washout Period 4||7
5037526|NCT02038829|12397331|P4|COMPLETED|Washout Period 4||8
5037527|NCT02038829|12397332|P3|COMPLETED|Washout Period 4||8
5037528|NCT02038829|12397333|P2|COMPLETED|Washout Period 4||7
5037529|NCT02038829|12397334|P1|COMPLETED|Washout Period 4||7
5037530|NCT02038829|12397323|P12|STARTED|Washout Period 4||8
5037531|NCT02038829|12397324|P11|STARTED|Washout Period 4||7
5037532|NCT02038829|12397325|P10|STARTED|Washout Period 4||8
5037533|NCT02038829|12397326|P9|STARTED|Washout Period 4||7
5037534|NCT02038829|12397327|P8|STARTED|Washout Period 4||8
5037535|NCT02038829|12397328|P7|STARTED|Washout Period 4||8
5037536|NCT02038829|12397329|P6|STARTED|Washout Period 4||7
5037537|NCT02038829|12397330|P5|STARTED|Washout Period 4||7
5037538|NCT02038829|12397331|P4|STARTED|Washout Period 4||8
5037539|NCT02038829|12397332|P3|STARTED|Washout Period 4||8
5037540|NCT02038829|12397333|P2|STARTED|Washout Period 4||7
5037541|NCT02038829|12397334|P1|STARTED|Washout Period 4||7
5037542|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 4||0
5037543|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 4||0
5037544|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 4||0
5037545|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 4||0
5037546|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 4||0
5037547|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 4||0
5037548|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 4||0
5037549|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 4||0
5037550|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 4||0
5037551|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 4||0
5037552|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 4||1
5037553|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 4||0
5037554|NCT02038829|12397323|P12|COMPLETED|Treatment Period 4||8
5037555|NCT02038829|12397324|P11|COMPLETED|Treatment Period 4||7
5037556|NCT02038829|12397325|P10|COMPLETED|Treatment Period 4||8
5037557|NCT02038829|12397326|P9|COMPLETED|Treatment Period 4||7
5037558|NCT02038829|12397327|P8|COMPLETED|Treatment Period 4||8
5037559|NCT02038829|12397328|P7|COMPLETED|Treatment Period 4||8
5037560|NCT02038829|12397329|P6|COMPLETED|Treatment Period 4||7
5037561|NCT02038829|12397330|P5|COMPLETED|Treatment Period 4||7
5037562|NCT02038829|12397331|P4|COMPLETED|Treatment Period 4||8
5037563|NCT02038829|12397332|P3|COMPLETED|Treatment Period 4||8
5037564|NCT02038829|12397333|P2|COMPLETED|Treatment Period 4||7
5037565|NCT02038829|12397334|P1|COMPLETED|Treatment Period 4||7
5037566|NCT02038829|12397323|P12|STARTED|Treatment Period 4||8
5037567|NCT02038829|12397324|P11|STARTED|Treatment Period 4||7
5037568|NCT02038829|12397325|P10|STARTED|Treatment Period 4||8
5037569|NCT02038829|12397326|P9|STARTED|Treatment Period 4||7
5037570|NCT02038829|12397327|P8|STARTED|Treatment Period 4||8
5037571|NCT02038829|12397328|P7|STARTED|Treatment Period 4||8
5037572|NCT02038829|12397329|P6|STARTED|Treatment Period 4||7
5037573|NCT02038829|12397330|P5|STARTED|Treatment Period 4||7
5037574|NCT02038829|12397331|P4|STARTED|Treatment Period 4||8
5037575|NCT02038829|12397332|P3|STARTED|Treatment Period 4||8
5037576|NCT02038829|12397333|P2|STARTED|Treatment Period 4||8
5037577|NCT02038829|12397334|P1|STARTED|Treatment Period 4||7
5037578|NCT02038829|12397323|P12|NOT COMPLETED|Washout Period 3||0
5037579|NCT02038829|12397324|P11|NOT COMPLETED|Washout Period 3||0
5037580|NCT02038829|12397325|P10|NOT COMPLETED|Washout Period 3||0
5037581|NCT02038829|12397326|P9|NOT COMPLETED|Washout Period 3||0
5037582|NCT02038829|12397327|P8|NOT COMPLETED|Washout Period 3||0
5037583|NCT02038829|12397328|P7|NOT COMPLETED|Washout Period 3||0
5037584|NCT02038829|12397329|P6|NOT COMPLETED|Washout Period 3||0
5037585|NCT02038829|12397330|P5|NOT COMPLETED|Washout Period 3||0
5037586|NCT02038829|12397331|P4|NOT COMPLETED|Washout Period 3||0
5037587|NCT02038829|12397332|P3|NOT COMPLETED|Washout Period 3||0
5037588|NCT02038829|12397333|P2|NOT COMPLETED|Washout Period 3||0
5037589|NCT02038829|12397334|P1|NOT COMPLETED|Washout Period 3||0
5037590|NCT02038829|12397323|P12|COMPLETED|Washout Period 3||8
5037591|NCT02038829|12397324|P11|COMPLETED|Washout Period 3||7
5037592|NCT02038829|12397325|P10|COMPLETED|Washout Period 3||8
5037593|NCT02038829|12397326|P9|COMPLETED|Washout Period 3||7
5037594|NCT02038829|12397327|P8|COMPLETED|Washout Period 3||8
5037595|NCT02038829|12397328|P7|COMPLETED|Washout Period 3||8
5037596|NCT02038829|12397329|P6|COMPLETED|Washout Period 3||7
5037597|NCT02038829|12397330|P5|COMPLETED|Washout Period 3||7
5037598|NCT02038829|12397331|P4|COMPLETED|Washout Period 3||8
5037599|NCT02038829|12397332|P3|COMPLETED|Washout Period 3||8
5037600|NCT02038829|12397333|P2|COMPLETED|Washout Period 3||8
5037601|NCT02038829|12397334|P1|COMPLETED|Washout Period 3||7
5037602|NCT02038829|12397323|P12|STARTED|Washout Period 3||8
5037603|NCT02038829|12397324|P11|STARTED|Washout Period 3||7
5037604|NCT02038829|12397325|P10|STARTED|Washout Period 3||8
5037605|NCT02038829|12397326|P9|STARTED|Washout Period 3||7
5037606|NCT02038829|12397327|P8|STARTED|Washout Period 3||8
5037607|NCT02038829|12397328|P7|STARTED|Washout Period 3||8
5037608|NCT02038829|12397329|P6|STARTED|Washout Period 3||7
5037609|NCT02038829|12397330|P5|STARTED|Washout Period 3||7
5037610|NCT02038829|12397331|P4|STARTED|Washout Period 3||8
5037611|NCT02038829|12397332|P3|STARTED|Washout Period 3||8
5037612|NCT02038829|12397333|P2|STARTED|Washout Period 3||8
5037613|NCT02038829|12397334|P1|STARTED|Washout Period 3||7
5037614|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 3||0
5037615|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 3||0
5037616|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 3||0
5037617|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 3||0
5037618|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 3||0
5037619|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 3||0
5037620|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 3||0
5037621|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 3||0
5037622|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 3||0
5037623|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 3||0
5037624|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 3||0
5037625|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 3||0
5037626|NCT02038829|12397323|P12|COMPLETED|Treatment Period 3||8
5037627|NCT02038829|12397324|P11|COMPLETED|Treatment Period 3||7
5037628|NCT02038829|12397325|P10|COMPLETED|Treatment Period 3||8
5037629|NCT02038829|12397326|P9|COMPLETED|Treatment Period 3||7
5037630|NCT02038829|12397327|P8|COMPLETED|Treatment Period 3||8
5037631|NCT02038829|12397328|P7|COMPLETED|Treatment Period 3||8
5037632|NCT02038829|12397329|P6|COMPLETED|Treatment Period 3||7
5037633|NCT02038829|12397330|P5|COMPLETED|Treatment Period 3||7
5037634|NCT02038829|12397331|P4|COMPLETED|Treatment Period 3||8
5037635|NCT02038829|12397332|P3|COMPLETED|Treatment Period 3||8
5037636|NCT02038829|12397333|P2|COMPLETED|Treatment Period 3||8
5037637|NCT02038829|12397334|P1|COMPLETED|Treatment Period 3||7
5037638|NCT02038829|12397323|P12|STARTED|Treatment Period 3||8
5037639|NCT02038829|12397324|P11|STARTED|Treatment Period 3||7
5037640|NCT02038829|12397325|P10|STARTED|Treatment Period 3||8
5037641|NCT02038829|12397326|P9|STARTED|Treatment Period 3||7
5037642|NCT02038829|12397327|P8|STARTED|Treatment Period 3||8
5037643|NCT02038829|12397328|P7|STARTED|Treatment Period 3||8
5037644|NCT02038829|12397329|P6|STARTED|Treatment Period 3||7
5037645|NCT02038829|12397330|P5|STARTED|Treatment Period 3||7
5037646|NCT02038829|12397331|P4|STARTED|Treatment Period 3||8
5037647|NCT02038829|12397332|P3|STARTED|Treatment Period 3||8
5037648|NCT02038829|12397333|P2|STARTED|Treatment Period 3||8
5037649|NCT02038829|12397334|P1|STARTED|Treatment Period 3||7
5037650|NCT02038829|12397323|P12|NOT COMPLETED|Washout Period 2||0
5037651|NCT02038829|12397324|P11|NOT COMPLETED|Washout Period 2||0
5037652|NCT02038829|12397325|P10|NOT COMPLETED|Washout Period 2||0
5037653|NCT02038829|12397326|P9|NOT COMPLETED|Washout Period 2||1
5037654|NCT02038829|12397327|P8|NOT COMPLETED|Washout Period 2||0
5037655|NCT02038829|12397328|P7|NOT COMPLETED|Washout Period 2||0
5037656|NCT02038829|12397329|P6|NOT COMPLETED|Washout Period 2||1
5037657|NCT02038829|12397330|P5|NOT COMPLETED|Washout Period 2||0
5037658|NCT02038829|12397331|P4|NOT COMPLETED|Washout Period 2||0
5037659|NCT02038829|12397332|P3|NOT COMPLETED|Washout Period 2||0
5037660|NCT02038829|12397333|P2|NOT COMPLETED|Washout Period 2||0
5037661|NCT02038829|12397334|P1|NOT COMPLETED|Washout Period 2||0
5037662|NCT02038829|12397323|P12|COMPLETED|Washout Period 2||8
5037663|NCT02038829|12397324|P11|COMPLETED|Washout Period 2||7
5037664|NCT02038829|12397325|P10|COMPLETED|Washout Period 2||8
5037665|NCT02038829|12397326|P9|COMPLETED|Washout Period 2||7
5037666|NCT02038829|12397327|P8|COMPLETED|Washout Period 2||8
5037667|NCT02038829|12397328|P7|COMPLETED|Washout Period 2||8
5037668|NCT02038829|12397329|P6|COMPLETED|Washout Period 2||7
5037669|NCT02038829|12397330|P5|COMPLETED|Washout Period 2||7
5037670|NCT02038829|12397331|P4|COMPLETED|Washout Period 2||8
5037671|NCT02038829|12397332|P3|COMPLETED|Washout Period 2||8
5037672|NCT02038829|12397333|P2|COMPLETED|Washout Period 2||8
5037673|NCT02038829|12397334|P1|COMPLETED|Washout Period 2||7
5037674|NCT02038829|12397323|P12|STARTED|Washout Period 2||8
5037675|NCT02038829|12397324|P11|STARTED|Washout Period 2||7
5037676|NCT02038829|12397325|P10|STARTED|Washout Period 2||8
5037677|NCT02038829|12397326|P9|STARTED|Washout Period 2||8
5037678|NCT02038829|12397327|P8|STARTED|Washout Period 2||8
5037679|NCT02038829|12397328|P7|STARTED|Washout Period 2||8
5037680|NCT02038829|12397329|P6|STARTED|Washout Period 2||8
5037681|NCT02038829|12397330|P5|STARTED|Washout Period 2||7
5037682|NCT02038829|12397331|P4|STARTED|Washout Period 2||8
5037683|NCT02038829|12397332|P3|STARTED|Washout Period 2||8
5037684|NCT02038829|12397333|P2|STARTED|Washout Period 2||8
5037685|NCT02038829|12397334|P1|STARTED|Washout Period 2||7
5037686|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 2||0
5037687|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 2||1
5037688|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 2||0
5037689|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 2||0
5037690|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 2||0
5037691|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 2||0
5037692|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 2||0
5037693|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 2||0
5037694|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 2||0
5037695|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 2||0
5037696|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 2||0
5037697|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 2||1
5037698|NCT02038829|12397323|P12|COMPLETED|Treatment Period 2||8
5037699|NCT02038829|12397324|P11|COMPLETED|Treatment Period 2||7
5037700|NCT02038829|12397325|P10|COMPLETED|Treatment Period 2||8
5037701|NCT02038829|12397326|P9|COMPLETED|Treatment Period 2||8
5037702|NCT02038829|12397327|P8|COMPLETED|Treatment Period 2||8
5037703|NCT02038829|12397328|P7|COMPLETED|Treatment Period 2||8
5037704|NCT02038829|12397329|P6|COMPLETED|Treatment Period 2||8
5037705|NCT02038829|12397330|P5|COMPLETED|Treatment Period 2||7
5037706|NCT02038829|12397331|P4|COMPLETED|Treatment Period 2||8
5037707|NCT02038829|12397332|P3|COMPLETED|Treatment Period 2||8
5037708|NCT02038829|12397333|P2|COMPLETED|Treatment Period 2||8
5037709|NCT02038829|12397334|P1|COMPLETED|Treatment Period 2||7
5037710|NCT02038829|12397323|P12|STARTED|Treatment Period 2||8
5037711|NCT02038829|12397324|P11|STARTED|Treatment Period 2||8
5037712|NCT02038829|12397325|P10|STARTED|Treatment Period 2||8
5037713|NCT02038829|12397326|P9|STARTED|Treatment Period 2||8
5037714|NCT02038829|12397327|P8|STARTED|Treatment Period 2||8
5037715|NCT02038829|12397328|P7|STARTED|Treatment Period 2||8
5037716|NCT02038829|12397329|P6|STARTED|Treatment Period 2||8
5037717|NCT02038829|12397330|P5|STARTED|Treatment Period 2||7
5037718|NCT02038829|12397331|P4|STARTED|Treatment Period 2||8
5037719|NCT02038829|12397332|P3|STARTED|Treatment Period 2||8
5037720|NCT02038829|12397333|P2|STARTED|Treatment Period 2||8
5037721|NCT02038829|12397334|P1|STARTED|Treatment Period 2||8
5037722|NCT02038829|12397323|P12|NOT COMPLETED|Washout Period 1||0
5037723|NCT02038829|12397324|P11|NOT COMPLETED|Washout Period 1||0
5037724|NCT02038829|12397325|P10|NOT COMPLETED|Washout Period 1||0
5037725|NCT02038829|12397326|P9|NOT COMPLETED|Washout Period 1||0
5037726|NCT02038829|12397327|P8|NOT COMPLETED|Washout Period 1||0
5037727|NCT02038829|12397328|P7|NOT COMPLETED|Washout Period 1||0
5037728|NCT02038829|12397329|P6|NOT COMPLETED|Washout Period 1||0
5037729|NCT02038829|12397330|P5|NOT COMPLETED|Washout Period 1||1
5037730|NCT02038829|12397331|P4|NOT COMPLETED|Washout Period 1||0
5037731|NCT02038829|12397332|P3|NOT COMPLETED|Washout Period 1||0
5037732|NCT02038829|12397333|P2|NOT COMPLETED|Washout Period 1||0
5037733|NCT02038829|12397334|P1|NOT COMPLETED|Washout Period 1||0
5037734|NCT02038829|12397323|P12|COMPLETED|Washout Period 1||8
5037735|NCT02038829|12397324|P11|COMPLETED|Washout Period 1||8
5037736|NCT02038829|12397325|P10|COMPLETED|Washout Period 1||8
5037737|NCT02038829|12397326|P9|COMPLETED|Washout Period 1||8
5037738|NCT02038829|12397327|P8|COMPLETED|Washout Period 1||8
5037739|NCT02038829|12397328|P7|COMPLETED|Washout Period 1||8
5037740|NCT02038829|12397329|P6|COMPLETED|Washout Period 1||8
5037741|NCT02038829|12397330|P5|COMPLETED|Washout Period 1||7
5037742|NCT02038829|12397331|P4|COMPLETED|Washout Period 1||8
5037743|NCT02038829|12397332|P3|COMPLETED|Washout Period 1||8
5037744|NCT02038829|12397333|P2|COMPLETED|Washout Period 1||8
5037745|NCT02038829|12397334|P1|COMPLETED|Washout Period 1||8
5037746|NCT02038829|12397323|P12|STARTED|Washout Period 1||8
5037747|NCT02038829|12397324|P11|STARTED|Washout Period 1||8
5037748|NCT02038829|12397325|P10|STARTED|Washout Period 1||8
5037749|NCT02038829|12397326|P9|STARTED|Washout Period 1||8
5037750|NCT02038829|12397327|P8|STARTED|Washout Period 1||8
5037751|NCT02038829|12397328|P7|STARTED|Washout Period 1||8
5037752|NCT02038829|12397329|P6|STARTED|Washout Period 1||8
5037753|NCT02038829|12397330|P5|STARTED|Washout Period 1||8
5037754|NCT02038829|12397331|P4|STARTED|Washout Period 1||8
5037755|NCT02038829|12397332|P3|STARTED|Washout Period 1||8
5037756|NCT02038829|12397333|P2|STARTED|Washout Period 1||8
5037757|NCT02038829|12397334|P1|STARTED|Washout Period 1||8
5037758|NCT02038829|12397323|P12|NOT COMPLETED|Treatment Period 1||0
5037759|NCT02038829|12397324|P11|NOT COMPLETED|Treatment Period 1||0
5037760|NCT02038829|12397325|P10|NOT COMPLETED|Treatment Period 1||0
5037761|NCT02038829|12397326|P9|NOT COMPLETED|Treatment Period 1||0
5037762|NCT02038829|12397327|P8|NOT COMPLETED|Treatment Period 1||0
5037763|NCT02038829|12397328|P7|NOT COMPLETED|Treatment Period 1||0
5037764|NCT02038829|12397329|P6|NOT COMPLETED|Treatment Period 1||0
5037765|NCT02038829|12397330|P5|NOT COMPLETED|Treatment Period 1||0
5037766|NCT02038829|12397331|P4|NOT COMPLETED|Treatment Period 1||0
5037767|NCT02038829|12397332|P3|NOT COMPLETED|Treatment Period 1||0
5037768|NCT02038829|12397333|P2|NOT COMPLETED|Treatment Period 1||0
5037769|NCT02038829|12397334|P1|NOT COMPLETED|Treatment Period 1||0
5037770|NCT02038829|12397323|P12|COMPLETED|Treatment Period 1||8
5037771|NCT02038829|12397324|P11|COMPLETED|Treatment Period 1||8
5037772|NCT02038829|12397325|P10|COMPLETED|Treatment Period 1||8
5037773|NCT02038829|12397326|P9|COMPLETED|Treatment Period 1||8
5037774|NCT02038829|12397327|P8|COMPLETED|Treatment Period 1||8
5037775|NCT02038829|12397328|P7|COMPLETED|Treatment Period 1||8
5037776|NCT02038829|12397329|P6|COMPLETED|Treatment Period 1||8
5037777|NCT02038829|12397330|P5|COMPLETED|Treatment Period 1||8
5037778|NCT02038829|12397331|P4|COMPLETED|Treatment Period 1||8
5037779|NCT02038829|12397332|P3|COMPLETED|Treatment Period 1||8
5037780|NCT02038829|12397333|P2|COMPLETED|Treatment Period 1||8
5037781|NCT02038829|12397334|P1|COMPLETED|Treatment Period 1||8
5037782|NCT02038829|12397323|P12|STARTED|Treatment Period 1||8
5037783|NCT02038829|12397324|P11|STARTED|Treatment Period 1||8
5037784|NCT02038829|12397325|P10|STARTED|Treatment Period 1||8
5037785|NCT02038829|12397326|P9|STARTED|Treatment Period 1||8
5037786|NCT02038829|12397327|P8|STARTED|Treatment Period 1||8
5037787|NCT02038829|12397328|P7|STARTED|Treatment Period 1||8
5037788|NCT02038829|12397329|P6|STARTED|Treatment Period 1||8
5037789|NCT02038829|12397330|P5|STARTED|Treatment Period 1||8
5037790|NCT02038829|12397331|P4|STARTED|Treatment Period 1||8
5037791|NCT02038829|12397332|P3|STARTED|Treatment Period 1||8
5037792|NCT02038829|12397333|P2|STARTED|Treatment Period 1||8
5037793|NCT02038829|12397334|P1|STARTED|Treatment Period 1||8
5037794|NCT02038790|12397368|P2|NOT COMPLETED|Day 1 - Second Treatment||0
5037795|NCT02038790|12397369|P1|NOT COMPLETED|Day 1 - Second Treatment||0
5037796|NCT02038790|12397368|P2|COMPLETED|Day 1 - Second Treatment||16
5037797|NCT02038790|12397369|P1|COMPLETED|Day 1 - Second Treatment||15
5037798|NCT02038790|12397368|P2|STARTED|Day 1 - Second Treatment||16
5037799|NCT02038790|12397369|P1|STARTED|Day 1 - Second Treatment||15
5037800|NCT02038790|12397368|P2|NOT COMPLETED|Day 0 - First Treatment||1
5037801|NCT02038790|12397369|P1|NOT COMPLETED|Day 0 - First Treatment||1
5037802|NCT02038790|12397368|P2|COMPLETED|Day 0 - First Treatment||16
5037803|NCT02038790|12397369|P1|COMPLETED|Day 0 - First Treatment||15
5037804|NCT02038790|12397368|P2|STARTED|Day 0 - First Treatment||17
5037805|NCT02038790|12397369|P1|STARTED|Day 0 - First Treatment||16
5037806|NCT02038764|12397405|P5|NOT COMPLETED|Overall Study||1
5037807|NCT02038764|12397406|P4|NOT COMPLETED|Overall Study||0
5037808|NCT02038764|12397407|P3|NOT COMPLETED|Overall Study||2
5037809|NCT02038764|12397408|P2|NOT COMPLETED|Overall Study||1
5037810|NCT02038764|12397409|P1|NOT COMPLETED|Overall Study||1
5037811|NCT02038764|12397405|P5|COMPLETED|Overall Study||7
5037812|NCT02038764|12397406|P4|COMPLETED|Overall Study||5
5037813|NCT02038764|12397407|P3|COMPLETED|Overall Study||7
5037814|NCT02038764|12397408|P2|COMPLETED|Overall Study||7
5037815|NCT02038764|12397409|P1|COMPLETED|Overall Study||6
5037816|NCT02038764|12397405|P5|STARTED|Overall Study||8
5037817|NCT02038764|12397406|P4|STARTED|Overall Study||5
5037818|NCT02038764|12397407|P3|STARTED|Overall Study||9
5037819|NCT02038764|12397408|P2|STARTED|Overall Study||8
5037820|NCT02038764|12397409|P1|STARTED|Overall Study||7
5037821|NCT02038647|12397511|P2|NOT COMPLETED|Overall Study||89
5037822|NCT02038647|12397512|P1|NOT COMPLETED|Overall Study||89
5037823|NCT02038647|12397511|P2|COMPLETED|Overall Study||0
5037824|NCT02038647|12397512|P1|COMPLETED|Overall Study||0
5037825|NCT02038647|12397511|P2|STARTED|Overall Study||89
5037826|NCT02038647|12397512|P1|STARTED|Overall Study||89
5037827|NCT02038569|12397544|P1|NOT COMPLETED|Overall Study||5
5037828|NCT02038569|12397544|P1|COMPLETED|Overall Study||102
5037829|NCT02038569|12397544|P1|STARTED|Overall Study||107
5037830|NCT02038543|12397575|P4|NOT COMPLETED|Overall Study||2
5037831|NCT02038543|12397576|P3|NOT COMPLETED|Overall Study||0
5037832|NCT02038543|12397577|P2|NOT COMPLETED|Overall Study||0
5037833|NCT02038543|12397578|P1|NOT COMPLETED|Overall Study||0
5037834|NCT02038543|12397575|P4|COMPLETED|Overall Study||1
5037835|NCT02038543|12397576|P3|COMPLETED|Overall Study||8
5037836|NCT02038543|12397577|P2|COMPLETED|Overall Study||4
5037837|NCT02038543|12397578|P1|COMPLETED|Overall Study||7
5037838|NCT02038543|12397575|P4|STARTED|Overall Study||3
5037839|NCT02038543|12397576|P3|STARTED|Overall Study||8
5037840|NCT02038543|12397577|P2|STARTED|Overall Study||4
5037841|NCT02038543|12397578|P1|STARTED|Overall Study||7
5037842|NCT02038179|12397592|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
5037843|NCT02038179|12397593|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
5037844|NCT02038179|12397592|P2|COMPLETED|Phase 2 (4 Weeks)||38
5037845|NCT02038179|12397593|P1|COMPLETED|Phase 2 (4 Weeks)||44
5037846|NCT02038179|12397592|P2|STARTED|Phase 2 (4 Weeks)||40
5037847|NCT02038179|12397593|P1|STARTED|Phase 2 (4 Weeks)||46
5037848|NCT02038179|12397592|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
5037849|NCT02038179|12397593|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
5037850|NCT02038179|12397592|P2|COMPLETED|Washout (2-4 Weeks)||40
5037851|NCT02038179|12397593|P1|COMPLETED|Washout (2-4 Weeks)||46
5037852|NCT02038179|12397592|P2|STARTED|Washout (2-4 Weeks)||42
5037853|NCT02038179|12397593|P1|STARTED|Washout (2-4 Weeks)||48
5037854|NCT02038179|12397592|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
5037855|NCT02038179|12397593|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
5037856|NCT02038179|12397592|P2|COMPLETED|Phase 1 (4 Weeks)||42
5037857|NCT02038179|12397593|P1|COMPLETED|Phase 1 (4 Weeks)||48
5037858|NCT02038179|12397592|P2|STARTED|Phase 1 (4 Weeks)||47
5037859|NCT02038179|12397593|P1|STARTED|Phase 1 (4 Weeks)||52
5037860|NCT02038153|12397603|P1|NOT COMPLETED|Overall Study||1
5037861|NCT02038153|12397603|P1|COMPLETED|Overall Study||2
5037862|NCT02038153|12397603|P1|STARTED|Overall Study||3
5037863|NCT02038075|12397610|P2|NOT COMPLETED|Overall Study||0
5037864|NCT02038075|12397611|P1|NOT COMPLETED|Overall Study||3
5037865|NCT02038075|12397610|P2|COMPLETED|Overall Study||76
5037866|NCT02038075|12397611|P1|COMPLETED|Overall Study||73
5037867|NCT02038075|12397610|P2|STARTED|Overall Study||76
5037868|NCT02038075|12397611|P1|STARTED|Overall Study||76
5037869|NCT02038049|12397619|P2|NOT COMPLETED|Overall Study||0
5037870|NCT02038049|12397620|P1|NOT COMPLETED|Overall Study||1
5037871|NCT02038049|12397619|P2|COMPLETED|Overall Study||4
5037872|NCT02038049|12397620|P1|COMPLETED|Overall Study||3
5037873|NCT02038049|12397619|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
5037874|NCT02038049|12397620|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
5037875|NCT02038049|12397619|P2|STARTED|Overall Study||4
5037876|NCT02038049|12397620|P1|STARTED|Overall Study||4
5037877|NCT02038023|12397642|P1|NOT COMPLETED|Overall Study||1
5037878|NCT02038023|12397642|P1|COMPLETED|Overall Study||73
5037879|NCT02038023|12397642|P1|STARTED|Overall Study||74
5037880|NCT02038010|12397649|P4|NOT COMPLETED|Follow Up||0
5037881|NCT02038010|12397650|P3|NOT COMPLETED|Follow Up||0
5037882|NCT02038010|12397651|P2|NOT COMPLETED|Follow Up||3
5037883|NCT02038010|12397652|P1|NOT COMPLETED|Follow Up||7
5037884|NCT02038010|12397649|P4|COMPLETED|Follow Up||0
5037885|NCT02038010|12397650|P3|COMPLETED|Follow Up||0
5037886|NCT02038010|12397651|P2|COMPLETED|Follow Up||3
5037887|NCT02038010|12397652|P1|COMPLETED|Follow Up||4
5037888|NCT02038010|12397649|P4|STARTED|Follow Up||0
5037889|NCT02038010|12397650|P3|STARTED|Follow Up||0
5037890|NCT02038010|12397651|P2|STARTED|Follow Up||6
5037891|NCT02038010|12397652|P1|STARTED|Follow Up||11
5037892|NCT02038010|12397649|P4|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
5037893|NCT02038010|12397650|P3|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
5037894|NCT02038010|12397651|P2|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
5037895|NCT02038010|12397652|P1|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
5037896|NCT02038010|12397649|P4|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
5037897|NCT02038010|12397650|P3|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
5037898|NCT02038010|12397651|P2|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
5037899|NCT02038010|12397652|P1|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
5037900|NCT02038010|12397649|P4|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
5037901|NCT02038010|12397650|P3|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
5037902|NCT02038010|12397651|P2|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
5037903|NCT02038010|12397652|P1|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
5037904|NCT02038010|12397649|P4|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
5037905|NCT02038010|12397650|P3|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
5037906|NCT02038010|12397651|P2|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
5037907|NCT02038010|12397652|P1|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
5037908|NCT02038010|12397649|P4|STARTED|Completed 3 Cycles/Reached 1st Response||0
5037909|NCT02038010|12397650|P3|STARTED|Completed 3 Cycles/Reached 1st Response||0
5037910|NCT02038010|12397651|P2|STARTED|Completed 3 Cycles/Reached 1st Response||4
5037911|NCT02038010|12397652|P1|STARTED|Completed 3 Cycles/Reached 1st Response||10
5037912|NCT02038010|12397649|P4|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
5037913|NCT02038010|12397650|P3|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
5037914|NCT02038010|12397651|P2|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
5037915|NCT02038010|12397652|P1|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
5037916|NCT02038010|12397649|P4|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
5037917|NCT02038010|12397650|P3|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
5037918|NCT02038010|12397651|P2|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
5037919|NCT02038010|12397652|P1|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
5037920|NCT02038010|12397649|P4|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
5037921|NCT02038010|12397650|P3|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
5037922|NCT02038010|12397651|P2|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
5037923|NCT02038010|12397652|P1|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
5037924|NCT02038010|12397649|P4|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
5037925|NCT02038010|12397650|P3|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
5037926|NCT02038010|12397651|P2|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
5037927|NCT02038010|12397652|P1|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
5037928|NCT02038010|12397649|P4|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
5037929|NCT02038010|12397650|P3|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
5037930|NCT02038010|12397651|P2|STARTED|Completed 1st Cycle and Started Cycle 2||6
5037931|NCT02038010|12397652|P1|STARTED|Completed 1st Cycle and Started Cycle 2||11
5037932|NCT02037984|12397679|P8|NOT COMPLETED|Overall Study||12
5037933|NCT02037984|12397680|P7|NOT COMPLETED|Overall Study||17
5037934|NCT02037984|12397681|P6|NOT COMPLETED|Overall Study||12
5037935|NCT02037984|12397682|P5|NOT COMPLETED|Overall Study||12
5037936|NCT02037984|12397683|P4|NOT COMPLETED|Overall Study||21
5037937|NCT02037984|12397684|P3|NOT COMPLETED|Overall Study||12
5037938|NCT02037984|12397685|P2|NOT COMPLETED|Overall Study||0
5037939|NCT02037984|12397686|P1|NOT COMPLETED|Overall Study||1
5037940|NCT02037984|12397679|P8|COMPLETED|Overall Study||39
5037941|NCT02037984|12397680|P7|COMPLETED|Overall Study||33
5037942|NCT02037984|12397681|P6|COMPLETED|Overall Study||37
5037943|NCT02037984|12397682|P5|COMPLETED|Overall Study||38
5037944|NCT02037984|12397683|P4|COMPLETED|Overall Study||30
5037945|NCT02037984|12397684|P3|COMPLETED|Overall Study||38
5037946|NCT02037984|12397685|P2|COMPLETED|Overall Study||20
5037947|NCT02037984|12397686|P1|COMPLETED|Overall Study||19
5037948|NCT02037984|12397679|P8|STARTED|Overall Study||51
5037949|NCT02037984|12397680|P7|STARTED|Overall Study||50
5037950|NCT02037984|12397681|P6|STARTED|Overall Study||49
5037951|NCT02037984|12397682|P5|STARTED|Overall Study||50
5037952|NCT02037984|12397683|P4|STARTED|Overall Study||51
5037953|NCT02037984|12397684|P3|STARTED|Overall Study||50
5037954|NCT02037984|12397685|P2|STARTED|Overall Study||20
5037955|NCT02037984|12397686|P1|STARTED|Overall Study||20
5037956|NCT02037893|12397753|P4|NOT COMPLETED|Overall Study||0
5037957|NCT02037893|12397754|P3|NOT COMPLETED|Overall Study||1
5037958|NCT02037893|12397755|P2|NOT COMPLETED|Overall Study||0
5037959|NCT02037893|12397756|P1|NOT COMPLETED|Overall Study||0
5037960|NCT02037893|12397753|P4|COMPLETED|Overall Study||28
5037961|NCT02037893|12397754|P3|COMPLETED|Overall Study||26
5037962|NCT02037893|12397755|P2|COMPLETED|Overall Study||25
5037963|NCT02037893|12397756|P1|COMPLETED|Overall Study||32
5037964|NCT02037893|12397753|P4|STARTED|Overall Study||28
5037965|NCT02037893|12397754|P3|STARTED|Overall Study||27
5037966|NCT02037893|12397755|P2|STARTED|Overall Study||25
5037967|NCT02037893|12397756|P1|STARTED|Overall Study||32
5037968|NCT02037776|12397808|P2|NOT COMPLETED|Overall Study||4
5037969|NCT02037776|12397809|P1|NOT COMPLETED|Overall Study||5
5037970|NCT02037776|12397808|P2|COMPLETED|Overall Study||60
5037971|NCT02037776|12397809|P1|COMPLETED|Overall Study||56
5037972|NCT02037776|12397808|P2|STARTED|Overall Study||64
5037973|NCT02037776|12397809|P1|STARTED|Overall Study||61
5037974|NCT02037607|12397825|P1|NOT COMPLETED|Overall Study||9
5037975|NCT02037607|12397825|P1|COMPLETED|Overall Study||91
5037976|NCT02037607|12397825|P1|STARTED|Overall Study||100
5037977|NCT02037568|12397831|P2|NOT COMPLETED|Overall Study||39
5037978|NCT02037568|12397832|P1|NOT COMPLETED|Overall Study||36
5037979|NCT02037568|12397831|P2|COMPLETED|Overall Study||37
5037980|NCT02037568|12397832|P1|COMPLETED|Overall Study||47
5037981|NCT02037568|12397831|P2|Month 6 (Post Transplantation)|Overall Study||52
5037982|NCT02037568|12397832|P1|Month 6 (Post Transplantation)|Overall Study||63
5037983|NCT02037568|12397831|P2|Month 3 (Post Transplantation)|Overall Study||62
5037984|NCT02037568|12397832|P1|Month 3 (Post Transplantation)|Overall Study||66
5037985|NCT02037568|12397831|P2|Month 1.5 (Post Transplantation)|Overall Study||76
5037986|NCT02037568|12397832|P1|Month 1.5 (Post Transplantation)|Overall Study||79
5037987|NCT02037568|12397831|P2|STARTED|Overall Study||76
5037988|NCT02037568|12397832|P1|STARTED|Overall Study||83
5037989|NCT02037555|12397856|P2|NOT COMPLETED|Overall Study||21
5037990|NCT02037555|12397857|P1|NOT COMPLETED|Overall Study||23
5037991|NCT02037555|12397856|P2|COMPLETED|Overall Study||191
5037992|NCT02037555|12397857|P1|COMPLETED|Overall Study||190
5037993|NCT02037555|12397856|P2|Dosed and Operated On|Overall Study||196
5037994|NCT02037555|12397857|P1|Dosed and Operated On|Overall Study||200
5037995|NCT02037555|12397856|P2|Dosed|Overall Study||198
5037996|NCT02037555|12397857|P1|Dosed|Overall Study||201
5037997|NCT02037555|12397856|P2|STARTED|Overall Study||212
5037998|NCT02037555|12397857|P1|STARTED|Overall Study||213
5037999|NCT02037477|12397867|P4|NOT COMPLETED|Treatment Period 2||0
5038000|NCT02037477|12397868|P3|NOT COMPLETED|Treatment Period 2||0
5038001|NCT02037477|12397869|P2|NOT COMPLETED|Treatment Period 2||0
5038002|NCT02037477|12397870|P1|NOT COMPLETED|Treatment Period 2||0
5038003|NCT02037477|12397867|P4|COMPLETED|Treatment Period 2||5
5038004|NCT02037477|12397868|P3|COMPLETED|Treatment Period 2||4
5038005|NCT02037477|12397869|P2|COMPLETED|Treatment Period 2||5
5038006|NCT02037477|12397870|P1|COMPLETED|Treatment Period 2||5
5038007|NCT02037477|12397867|P4|STARTED|Treatment Period 2||5
5038008|NCT02037477|12397868|P3|STARTED|Treatment Period 2||4
5038009|NCT02037477|12397869|P2|STARTED|Treatment Period 2||5
5038010|NCT02037477|12397870|P1|STARTED|Treatment Period 2||5
5038011|NCT02037477|12397867|P4|NOT COMPLETED|Treatment Period 1||0
5038012|NCT02037477|12397868|P3|NOT COMPLETED|Treatment Period 1||1
5038013|NCT02037477|12397869|P2|NOT COMPLETED|Treatment Period 1||0
5038014|NCT02037477|12397870|P1|NOT COMPLETED|Treatment Period 1||0
5038015|NCT02037477|12397867|P4|COMPLETED|Treatment Period 1||5
5038016|NCT02037477|12397868|P3|COMPLETED|Treatment Period 1||4
5038017|NCT02037477|12397869|P2|COMPLETED|Treatment Period 1||5
5038018|NCT02037477|12397870|P1|COMPLETED|Treatment Period 1||5
5038019|NCT02037477|12397867|P4|STARTED|Treatment Period 1||5
5038020|NCT02037477|12397868|P3|STARTED|Treatment Period 1||5
5038021|NCT02037477|12397869|P2|STARTED|Treatment Period 1||5
5038022|NCT02037477|12397870|P1|STARTED|Treatment Period 1||5
5038023|NCT02037438|12397898|P2|NOT COMPLETED|Overall Study||355
5038024|NCT02037438|12397899|P1|NOT COMPLETED|Overall Study||346
5038025|NCT02037438|12397898|P2|COMPLETED|Overall Study||561
5038026|NCT02037438|12397899|P1|COMPLETED|Overall Study||574
5038027|NCT02037438|12397898|P2|STARTED|Overall Study||916
5038028|NCT02037438|12397899|P1|STARTED|Overall Study||920
5038029|NCT02037425|12397913|P1|NOT COMPLETED|Overall Study||26
5038030|NCT02037425|12397913|P1|COMPLETED|Overall Study||18
5038031|NCT02037425|12397913|P1|Randomized to Treatment|Overall Study||32
5038032|NCT02037425|12397913|P1|STARTED|Overall Study||44
5038033|NCT02037347|12397955|P1|NOT COMPLETED|Overall Study||0
5038034|NCT02037347|12397955|P1|COMPLETED|Overall Study||1
5038035|NCT02037347|12397955|P1|STARTED|Overall Study||1
5038036|NCT02037295|12397965|P4|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
5038037|NCT02037295|12397966|P3|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
5038038|NCT02037295|12397967|P2|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
5038039|NCT02037295|12397968|P1|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
5038040|NCT02037295|12397965|P4|COMPLETED|Phase 2: Vancomycin and Placebo||6
5038041|NCT02037295|12397966|P3|COMPLETED|Phase 2: Vancomycin and Placebo||4
5038042|NCT02037295|12397967|P2|COMPLETED|Phase 2: Vancomycin and Placebo||7
5038043|NCT02037295|12397968|P1|COMPLETED|Phase 2: Vancomycin and Placebo||8
5038044|NCT02037295|12397965|P4|STARTED|Phase 2: Vancomycin and Placebo||7
5038045|NCT02037295|12397966|P3|STARTED|Phase 2: Vancomycin and Placebo||4
5038046|NCT02037295|12397967|P2|STARTED|Phase 2: Vancomycin and Placebo||7
5038047|NCT02037295|12397968|P1|STARTED|Phase 2: Vancomycin and Placebo||9
5038048|NCT02037295|12397965|P4|NOT COMPLETED|Phase 1: Crossover UF and OF||0
5038049|NCT02037295|12397966|P3|NOT COMPLETED|Phase 1: Crossover UF and OF||0
5038050|NCT02037295|12397967|P2|NOT COMPLETED|Phase 1: Crossover UF and OF||0
5038051|NCT02037295|12397968|P1|NOT COMPLETED|Phase 1: Crossover UF and OF||0
5038052|NCT02037295|12397965|P4|COMPLETED|Phase 1: Crossover UF and OF||7
5038053|NCT02037295|12397966|P3|COMPLETED|Phase 1: Crossover UF and OF||4
5038054|NCT02037295|12397967|P2|COMPLETED|Phase 1: Crossover UF and OF||7
5038055|NCT02037295|12397968|P1|COMPLETED|Phase 1: Crossover UF and OF||9
5038056|NCT02037295|12397965|P4|STARTED|Phase 1: Crossover UF and OF||7
5038057|NCT02037295|12397966|P3|STARTED|Phase 1: Crossover UF and OF||4
5038058|NCT02037295|12397967|P2|STARTED|Phase 1: Crossover UF and OF||7
5038059|NCT02037295|12397968|P1|STARTED|Phase 1: Crossover UF and OF||9
5038060|NCT02037230|12397992|P4|NOT COMPLETED|Overall Study||6
5038061|NCT02037230|12397993|P3|NOT COMPLETED|Overall Study||6
5038062|NCT02037230|12397994|P2|NOT COMPLETED|Overall Study||6
5038063|NCT02037230|12397995|P1|NOT COMPLETED|Overall Study||1
5038064|NCT02037230|12397992|P4|COMPLETED|Overall Study||5
5038065|NCT02037230|12397993|P3|COMPLETED|Overall Study||3
5038066|NCT02037230|12397994|P2|COMPLETED|Overall Study||7
5038067|NCT02037230|12397995|P1|COMPLETED|Overall Study||0
5038068|NCT02037230|12397992|P4|Completed 4 Cycles of Treatment|Overall Study||9
5038069|NCT02037230|12397993|P3|Completed 4 Cycles of Treatment|Overall Study||7
5038070|NCT02037230|12397994|P2|Completed 4 Cycles of Treatment|Overall Study||9
5038071|NCT02037230|12397995|P1|Completed 4 Cycles of Treatment|Overall Study||1
5038072|NCT02037230|12397992|P4|STARTED|Overall Study||11
5038073|NCT02037230|12397993|P3|STARTED|Overall Study||9
5038074|NCT02037230|12397994|P2|STARTED|Overall Study||13
5038075|NCT02037230|12397995|P1|STARTED|Overall Study||1
5038076|NCT02037204|12398014|P1|NOT COMPLETED|Overall Study||0
5038077|NCT02037204|12398014|P1|COMPLETED|Overall Study||35
5038078|NCT02037204|12398014|P1|STARTED|Overall Study||35
5038079|NCT02037165|12398024|P5|NOT COMPLETED|Period 5 (2 Days)||0
5038080|NCT02037165|12398025|P4|NOT COMPLETED|Period 5 (2 Days)||0
5038081|NCT02037165|12398026|P3|NOT COMPLETED|Period 5 (2 Days)||0
5038082|NCT02037165|12398027|P2|NOT COMPLETED|Period 5 (2 Days)||0
5038083|NCT02037165|12398028|P1|NOT COMPLETED|Period 5 (2 Days)||0
5038084|NCT02037165|12398024|P5|COMPLETED|Period 5 (2 Days)||4
5038085|NCT02037165|12398025|P4|COMPLETED|Period 5 (2 Days)||5
5038086|NCT02037165|12398026|P3|COMPLETED|Period 5 (2 Days)||5
5038087|NCT02037165|12398027|P2|COMPLETED|Period 5 (2 Days)||5
5038088|NCT02037165|12398028|P1|COMPLETED|Period 5 (2 Days)||5
5038089|NCT02037165|12398024|P5|STARTED|Period 5 (2 Days)||4
5038090|NCT02037165|12398025|P4|STARTED|Period 5 (2 Days)||5
5038091|NCT02037165|12398026|P3|STARTED|Period 5 (2 Days)||5
5038092|NCT02037165|12398027|P2|STARTED|Period 5 (2 Days)||5
5038093|NCT02037165|12398028|P1|STARTED|Period 5 (2 Days)||5
5038094|NCT02037165|12398024|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
5038095|NCT02037165|12398025|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
5038096|NCT02037165|12398026|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
5038097|NCT02037165|12398027|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
5038098|NCT02037165|12398028|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
5038099|NCT02037165|12398024|P5|COMPLETED|Washout Period 4 (6 Days)||4
5038100|NCT02037165|12398025|P4|COMPLETED|Washout Period 4 (6 Days)||5
5038101|NCT02037165|12398026|P3|COMPLETED|Washout Period 4 (6 Days)||5
5038102|NCT02037165|12398027|P2|COMPLETED|Washout Period 4 (6 Days)||5
5038103|NCT02037165|12398028|P1|COMPLETED|Washout Period 4 (6 Days)||5
5038104|NCT02037165|12398024|P5|STARTED|Washout Period 4 (6 Days)||5
5038105|NCT02037165|12398025|P4|STARTED|Washout Period 4 (6 Days)||5
5038106|NCT02037165|12398026|P3|STARTED|Washout Period 4 (6 Days)||5
5038107|NCT02037165|12398027|P2|STARTED|Washout Period 4 (6 Days)||5
5038108|NCT02037165|12398028|P1|STARTED|Washout Period 4 (6 Days)||5
5038109|NCT02037165|12398024|P5|NOT COMPLETED|Period 4 (2 Days)||0
5038110|NCT02037165|12398025|P4|NOT COMPLETED|Period 4 (2 Days)||0
5038111|NCT02037165|12398026|P3|NOT COMPLETED|Period 4 (2 Days)||0
5038112|NCT02037165|12398027|P2|NOT COMPLETED|Period 4 (2 Days)||0
5038113|NCT02037165|12398028|P1|NOT COMPLETED|Period 4 (2 Days)||0
5038114|NCT02037165|12398024|P5|COMPLETED|Period 4 (2 Days)||5
5038115|NCT02037165|12398025|P4|COMPLETED|Period 4 (2 Days)||5
5038116|NCT02037165|12398026|P3|COMPLETED|Period 4 (2 Days)||5
5038117|NCT02037165|12398027|P2|COMPLETED|Period 4 (2 Days)||5
5038118|NCT02037165|12398028|P1|COMPLETED|Period 4 (2 Days)||5
5038119|NCT02037165|12398024|P5|STARTED|Period 4 (2 Days)||5
5038120|NCT02037165|12398025|P4|STARTED|Period 4 (2 Days)||5
5038121|NCT02037165|12398026|P3|STARTED|Period 4 (2 Days)||5
5038122|NCT02037165|12398027|P2|STARTED|Period 4 (2 Days)||5
5038123|NCT02037165|12398028|P1|STARTED|Period 4 (2 Days)||5
5038124|NCT02037165|12398024|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
5038125|NCT02037165|12398025|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
5038126|NCT02037165|12398026|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
5038127|NCT02037165|12398027|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
5038128|NCT02037165|12398028|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
5038129|NCT02037165|12398024|P5|COMPLETED|Washout Period 3 (6 Days)||5
5038130|NCT02037165|12398025|P4|COMPLETED|Washout Period 3 (6 Days)||5
5038131|NCT02037165|12398026|P3|COMPLETED|Washout Period 3 (6 Days)||5
5038132|NCT02037165|12398027|P2|COMPLETED|Washout Period 3 (6 Days)||5
5038133|NCT02037165|12398028|P1|COMPLETED|Washout Period 3 (6 Days)||5
5038134|NCT02037165|12398024|P5|STARTED|Washout Period 3 (6 Days)||5
5038135|NCT02037165|12398025|P4|STARTED|Washout Period 3 (6 Days)||5
5038136|NCT02037165|12398026|P3|STARTED|Washout Period 3 (6 Days)||5
5038137|NCT02037165|12398027|P2|STARTED|Washout Period 3 (6 Days)||5
5038138|NCT02037165|12398028|P1|STARTED|Washout Period 3 (6 Days)||5
5038139|NCT02037165|12398024|P5|NOT COMPLETED|Period 3 (2 Days)||0
5038140|NCT02037165|12398025|P4|NOT COMPLETED|Period 3 (2 Days)||0
5038141|NCT02037165|12398026|P3|NOT COMPLETED|Period 3 (2 Days)||0
5038142|NCT02037165|12398027|P2|NOT COMPLETED|Period 3 (2 Days)||0
5038143|NCT02037165|12398028|P1|NOT COMPLETED|Period 3 (2 Days)||0
5038144|NCT02037165|12398024|P5|COMPLETED|Period 3 (2 Days)||5
5038145|NCT02037165|12398025|P4|COMPLETED|Period 3 (2 Days)||5
5038146|NCT02037165|12398026|P3|COMPLETED|Period 3 (2 Days)||5
5038147|NCT02037165|12398027|P2|COMPLETED|Period 3 (2 Days)||5
5038148|NCT02037165|12398028|P1|COMPLETED|Period 3 (2 Days)||5
5038149|NCT02037165|12398024|P5|STARTED|Period 3 (2 Days)||5
5038150|NCT02037165|12398025|P4|STARTED|Period 3 (2 Days)||5
5038151|NCT02037165|12398026|P3|STARTED|Period 3 (2 Days)||5
5038152|NCT02037165|12398027|P2|STARTED|Period 3 (2 Days)||5
5038153|NCT02037165|12398028|P1|STARTED|Period 3 (2 Days)||5
5038154|NCT02037165|12398024|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
5038155|NCT02037165|12398025|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
5038156|NCT02037165|12398026|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
5038157|NCT02037165|12398027|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
5038158|NCT02037165|12398028|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
5038159|NCT02037165|12398024|P5|COMPLETED|Washout Period 2 (6 Days)||5
5038160|NCT02037165|12398025|P4|COMPLETED|Washout Period 2 (6 Days)||5
5038161|NCT02037165|12398026|P3|COMPLETED|Washout Period 2 (6 Days)||5
5038162|NCT02037165|12398027|P2|COMPLETED|Washout Period 2 (6 Days)||5
5038163|NCT02037165|12398028|P1|COMPLETED|Washout Period 2 (6 Days)||5
5038164|NCT02037165|12398024|P5|STARTED|Washout Period 2 (6 Days)||5
5038165|NCT02037165|12398025|P4|STARTED|Washout Period 2 (6 Days)||5
5038166|NCT02037165|12398026|P3|STARTED|Washout Period 2 (6 Days)||5
5038167|NCT02037165|12398027|P2|STARTED|Washout Period 2 (6 Days)||5
5038168|NCT02037165|12398028|P1|STARTED|Washout Period 2 (6 Days)||5
5038169|NCT02037165|12398024|P5|NOT COMPLETED|Period 2 (2 Days)||0
5038170|NCT02037165|12398025|P4|NOT COMPLETED|Period 2 (2 Days)||0
5038171|NCT02037165|12398026|P3|NOT COMPLETED|Period 2 (2 Days)||0
5038172|NCT02037165|12398027|P2|NOT COMPLETED|Period 2 (2 Days)||0
5038173|NCT02037165|12398028|P1|NOT COMPLETED|Period 2 (2 Days)||0
5038174|NCT02037165|12398024|P5|COMPLETED|Period 2 (2 Days)||5
5038175|NCT02037165|12398025|P4|COMPLETED|Period 2 (2 Days)||5
5038176|NCT02037165|12398026|P3|COMPLETED|Period 2 (2 Days)||5
5038177|NCT02037165|12398027|P2|COMPLETED|Period 2 (2 Days)||5
5038178|NCT02037165|12398028|P1|COMPLETED|Period 2 (2 Days)||5
5038179|NCT02037165|12398024|P5|STARTED|Period 2 (2 Days)||5
5038180|NCT02037165|12398025|P4|STARTED|Period 2 (2 Days)||5
5038181|NCT02037165|12398026|P3|STARTED|Period 2 (2 Days)||5
5038182|NCT02037165|12398027|P2|STARTED|Period 2 (2 Days)||5
5038183|NCT02037165|12398028|P1|STARTED|Period 2 (2 Days)||5
5038184|NCT02037165|12398024|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
5038185|NCT02037165|12398025|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
5038186|NCT02037165|12398026|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
5038187|NCT02037165|12398027|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
5038188|NCT02037165|12398028|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
5038189|NCT02037165|12398024|P5|COMPLETED|Washout Period 1 (6 Days)||5
5038190|NCT02037165|12398025|P4|COMPLETED|Washout Period 1 (6 Days)||5
5038191|NCT02037165|12398026|P3|COMPLETED|Washout Period 1 (6 Days)||5
5038192|NCT02037165|12398027|P2|COMPLETED|Washout Period 1 (6 Days)||5
5038193|NCT02037165|12398028|P1|COMPLETED|Washout Period 1 (6 Days)||5
5038194|NCT02037165|12398024|P5|STARTED|Washout Period 1 (6 Days)||5
5038195|NCT02037165|12398025|P4|STARTED|Washout Period 1 (6 Days)||5
5038196|NCT02037165|12398026|P3|STARTED|Washout Period 1 (6 Days)||5
5038197|NCT02037165|12398027|P2|STARTED|Washout Period 1 (6 Days)||5
5038198|NCT02037165|12398028|P1|STARTED|Washout Period 1 (6 Days)||5
5038199|NCT02037165|12398024|P5|NOT COMPLETED|Period 1 (2 Days)||0
5038200|NCT02037165|12398025|P4|NOT COMPLETED|Period 1 (2 Days)||0
5038201|NCT02037165|12398026|P3|NOT COMPLETED|Period 1 (2 Days)||0
5038202|NCT02037165|12398027|P2|NOT COMPLETED|Period 1 (2 Days)||0
5038203|NCT02037165|12398028|P1|NOT COMPLETED|Period 1 (2 Days)||0
5038204|NCT02037165|12398024|P5|COMPLETED|Period 1 (2 Days)||5
5038205|NCT02037165|12398025|P4|COMPLETED|Period 1 (2 Days)||5
5038206|NCT02037165|12398026|P3|COMPLETED|Period 1 (2 Days)||5
5038207|NCT02037165|12398027|P2|COMPLETED|Period 1 (2 Days)||5
5038208|NCT02037165|12398028|P1|COMPLETED|Period 1 (2 Days)||5
5038209|NCT02037165|12398024|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
5038210|NCT02037165|12398025|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
5038211|NCT02037165|12398026|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
5038212|NCT02037165|12398027|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
5038213|NCT02037165|12398028|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
5038214|NCT02037061|12398073|P2|NOT COMPLETED|Overall Study||0
5038215|NCT02037061|12398074|P1|NOT COMPLETED|Overall Study||0
5038216|NCT02037061|12398073|P2|COMPLETED|Overall Study||24
5038217|NCT02037061|12398074|P1|COMPLETED|Overall Study||22
5038218|NCT02037061|12398073|P2|STARTED|Overall Study||24
5038219|NCT02037061|12398074|P1|STARTED|Overall Study||22
5038220|NCT02036840|12398084|P1|NOT COMPLETED|Overall Study||0
5038221|NCT02036840|12398084|P1|COMPLETED|Overall Study||513
5038222|NCT02036840|12398084|P1|STARTED|Overall Study||513
5038223|NCT02036775|12398088|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038224|NCT02036775|12398089|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038225|NCT02036775|12398090|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038226|NCT02036775|12398091|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038227|NCT02036775|12398092|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038228|NCT02036775|12398093|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
5038229|NCT02036775|12398088|P6|COMPLETED|Treatment Period 3 (6 Days)||3
5038230|NCT02036775|12398089|P5|COMPLETED|Treatment Period 3 (6 Days)||4
5038231|NCT02036775|12398090|P4|COMPLETED|Treatment Period 3 (6 Days)||4
5038232|NCT02036775|12398091|P3|COMPLETED|Treatment Period 3 (6 Days)||4
5038233|NCT02036775|12398092|P2|COMPLETED|Treatment Period 3 (6 Days)||4
5038234|NCT02036775|12398093|P1|COMPLETED|Treatment Period 3 (6 Days)||4
5038235|NCT02036775|12398088|P6|STARTED|Treatment Period 3 (6 Days)||3
5038236|NCT02036775|12398089|P5|STARTED|Treatment Period 3 (6 Days)||4
5038237|NCT02036775|12398090|P4|STARTED|Treatment Period 3 (6 Days)||4
5038238|NCT02036775|12398091|P3|STARTED|Treatment Period 3 (6 Days)||4
5038239|NCT02036775|12398092|P2|STARTED|Treatment Period 3 (6 Days)||4
5038240|NCT02036775|12398093|P1|STARTED|Treatment Period 3 (6 Days)||4
5038241|NCT02036775|12398088|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
5038242|NCT02036775|12398089|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
5038243|NCT02036775|12398090|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
5038244|NCT02036775|12398091|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
5038245|NCT02036775|12398092|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
5038246|NCT02036775|12398093|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
5038247|NCT02036775|12398088|P6|COMPLETED|Treatment Period 2 (6 Days)||3
5038248|NCT02036775|12398089|P5|COMPLETED|Treatment Period 2 (6 Days)||4
5038249|NCT02036775|12398090|P4|COMPLETED|Treatment Period 2 (6 Days)||4
5038250|NCT02036775|12398091|P3|COMPLETED|Treatment Period 2 (6 Days)||4
5038251|NCT02036775|12398092|P2|COMPLETED|Treatment Period 2 (6 Days)||4
5038252|NCT02036775|12398093|P1|COMPLETED|Treatment Period 2 (6 Days)||4
5038253|NCT02036775|12398088|P6|STARTED|Treatment Period 2 (6 Days)||4
5038254|NCT02036775|12398089|P5|STARTED|Treatment Period 2 (6 Days)||4
5038255|NCT02036775|12398090|P4|STARTED|Treatment Period 2 (6 Days)||4
5038256|NCT02036775|12398091|P3|STARTED|Treatment Period 2 (6 Days)||4
5038257|NCT02036775|12398092|P2|STARTED|Treatment Period 2 (6 Days)||4
5038258|NCT02036775|12398093|P1|STARTED|Treatment Period 2 (6 Days)||4
5038259|NCT02036775|12398088|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038260|NCT02036775|12398089|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038261|NCT02036775|12398090|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038262|NCT02036775|12398091|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038263|NCT02036775|12398092|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038264|NCT02036775|12398093|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
5038265|NCT02036775|12398088|P6|COMPLETED|Treatment Period 1 (6 Days)||4
5038266|NCT02036775|12398089|P5|COMPLETED|Treatment Period 1 (6 Days)||4
5038267|NCT02036775|12398090|P4|COMPLETED|Treatment Period 1 (6 Days)||4
5038268|NCT02036775|12398091|P3|COMPLETED|Treatment Period 1 (6 Days)||4
5038269|NCT02036775|12398092|P2|COMPLETED|Treatment Period 1 (6 Days)||4
5038270|NCT02036775|12398093|P1|COMPLETED|Treatment Period 1 (6 Days)||4
5038271|NCT02036775|12398088|P6|STARTED|Treatment Period 1 (6 Days)||4
5038272|NCT02036775|12398089|P5|STARTED|Treatment Period 1 (6 Days)||4
5038273|NCT02036775|12398090|P4|STARTED|Treatment Period 1 (6 Days)||4
5038274|NCT02036775|12398091|P3|STARTED|Treatment Period 1 (6 Days)||4
5038275|NCT02036775|12398092|P2|STARTED|Treatment Period 1 (6 Days)||4
5038276|NCT02036775|12398093|P1|STARTED|Treatment Period 1 (6 Days)||4
5038277|NCT02036645|12398143|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038278|NCT02036645|12398144|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038279|NCT02036645|12398145|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038280|NCT02036645|12398146|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038281|NCT02036645|12398147|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038282|NCT02036645|12398148|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038283|NCT02036645|12398149|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038284|NCT02036645|12398150|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038285|NCT02036645|12398151|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038286|NCT02036645|12398152|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038287|NCT02036645|12398153|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038288|NCT02036645|12398154|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
5038289|NCT02036645|12398143|P12|COMPLETED|MAD Cohorts: Study Part 2||6
5038290|NCT02036645|12398144|P11|COMPLETED|MAD Cohorts: Study Part 2||6
5038291|NCT02036645|12398145|P10|COMPLETED|MAD Cohorts: Study Part 2||6
5038292|NCT02036645|12398146|P9|COMPLETED|MAD Cohorts: Study Part 2||6
5038293|NCT02036645|12398147|P8|COMPLETED|MAD Cohorts: Study Part 2||8
5038294|NCT02036645|12398148|P7|COMPLETED|MAD Cohorts: Study Part 2||0
5038295|NCT02036645|12398149|P6|COMPLETED|MAD Cohorts: Study Part 2||0
5038296|NCT02036645|12398150|P5|COMPLETED|MAD Cohorts: Study Part 2||0
5038297|NCT02036645|12398151|P4|COMPLETED|MAD Cohorts: Study Part 2||0
5038298|NCT02036645|12398152|P3|COMPLETED|MAD Cohorts: Study Part 2||0
5038299|NCT02036645|12398153|P2|COMPLETED|MAD Cohorts: Study Part 2||0
5038300|NCT02036645|12398154|P1|COMPLETED|MAD Cohorts: Study Part 2||0
5038301|NCT02036645|12398143|P12|STARTED|MAD Cohorts: Study Part 2||6
5038302|NCT02036645|12398144|P11|STARTED|MAD Cohorts: Study Part 2||6
5038303|NCT02036645|12398145|P10|STARTED|MAD Cohorts: Study Part 2||6
5038304|NCT02036645|12398146|P9|STARTED|MAD Cohorts: Study Part 2||6
5038305|NCT02036645|12398147|P8|STARTED|MAD Cohorts: Study Part 2||8
5038306|NCT02036645|12398148|P7|STARTED|MAD Cohorts: Study Part 2||0
5038307|NCT02036645|12398149|P6|STARTED|MAD Cohorts: Study Part 2||0
5038308|NCT02036645|12398150|P5|STARTED|MAD Cohorts: Study Part 2||0
5038309|NCT02036645|12398151|P4|STARTED|MAD Cohorts: Study Part 2||0
5038310|NCT02036645|12398152|P3|STARTED|MAD Cohorts: Study Part 2||0
5038311|NCT02036645|12398153|P2|STARTED|MAD Cohorts: Study Part 2||0
5038312|NCT02036645|12398154|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
5038313|NCT02036645|12398143|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038314|NCT02036645|12398144|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038315|NCT02036645|12398145|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038316|NCT02036645|12398146|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038317|NCT02036645|12398147|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038318|NCT02036645|12398148|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
5038319|NCT02036645|12398149|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038320|NCT02036645|12398150|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038321|NCT02036645|12398151|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
5038322|NCT02036645|12398152|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038323|NCT02036645|12398153|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038324|NCT02036645|12398154|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
5038325|NCT02036645|12398143|P12|COMPLETED|SAD Cohorts : Study Part 1||0
5038326|NCT02036645|12398144|P11|COMPLETED|SAD Cohorts : Study Part 1||0
5038327|NCT02036645|12398145|P10|COMPLETED|SAD Cohorts : Study Part 1||0
5038328|NCT02036645|12398146|P9|COMPLETED|SAD Cohorts : Study Part 1||0
5038329|NCT02036645|12398147|P8|COMPLETED|SAD Cohorts : Study Part 1||0
5038330|NCT02036645|12398148|P7|COMPLETED|SAD Cohorts : Study Part 1||5
5038331|NCT02036645|12398149|P6|COMPLETED|SAD Cohorts : Study Part 1||6
5038332|NCT02036645|12398150|P5|COMPLETED|SAD Cohorts : Study Part 1||6
5038333|NCT02036645|12398151|P4|COMPLETED|SAD Cohorts : Study Part 1||5
5038334|NCT02036645|12398152|P3|COMPLETED|SAD Cohorts : Study Part 1||6
5038335|NCT02036645|12398153|P2|COMPLETED|SAD Cohorts : Study Part 1||3
5038336|NCT02036645|12398154|P1|COMPLETED|SAD Cohorts : Study Part 1||12
5038337|NCT02036645|12398143|P12|STARTED|SAD Cohorts : Study Part 1||0
5038338|NCT02036645|12398144|P11|STARTED|SAD Cohorts : Study Part 1||0
5038339|NCT02036645|12398145|P10|STARTED|SAD Cohorts : Study Part 1||0
5038340|NCT02036645|12398146|P9|STARTED|SAD Cohorts : Study Part 1||0
5038341|NCT02036645|12398147|P8|STARTED|SAD Cohorts : Study Part 1||0
5038342|NCT02036645|12398148|P7|STARTED|SAD Cohorts : Study Part 1||6
5038343|NCT02036645|12398149|P6|STARTED|SAD Cohorts : Study Part 1||6
5038344|NCT02036645|12398150|P5|STARTED|SAD Cohorts : Study Part 1||6
5038345|NCT02036645|12398151|P4|STARTED|SAD Cohorts : Study Part 1||6
5038346|NCT02036645|12398152|P3|STARTED|SAD Cohorts : Study Part 1||6
5038347|NCT02036645|12398153|P2|STARTED|SAD Cohorts : Study Part 1||3
5038348|NCT02036645|12398154|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
5038349|NCT02036580|12398259|P3|NOT COMPLETED|Overall Study||0
5038350|NCT02036580|12398260|P2|NOT COMPLETED|Overall Study||1
5038351|NCT02036580|12398261|P1|NOT COMPLETED|Overall Study||1
5038352|NCT02036580|12398259|P3|COMPLETED|Overall Study||4
5038353|NCT02036580|12398260|P2|COMPLETED|Overall Study||7
5038354|NCT02036580|12398261|P1|COMPLETED|Overall Study||7
5038355|NCT02036580|12398259|P3|STARTED|Overall Study||4
5038356|NCT02036580|12398260|P2|STARTED|Overall Study||8
5038357|NCT02036580|12398261|P1|STARTED|Overall Study||8
5038358|NCT02036541|12398274|P1|NOT COMPLETED|Overall Study||16
5038359|NCT02036541|12398274|P1|COMPLETED|Overall Study||49
5038360|NCT02036541|12398274|P1|Completed Endpoint Visit|Overall Study||54
5038361|NCT02036541|12398274|P1|STARTED|Overall Study||65
5038362|NCT02036515|12398282|P3|NOT COMPLETED|Overall Study||14
5038363|NCT02036515|12398283|P2|NOT COMPLETED|Overall Study||12
5038364|NCT02036515|12398284|P1|NOT COMPLETED|Overall Study||5
5038365|NCT02036515|12398282|P3|COMPLETED|Overall Study||139
5038366|NCT02036515|12398283|P2|COMPLETED|Overall Study||143
5038367|NCT02036515|12398284|P1|COMPLETED|Overall Study||151
5038368|NCT02036515|12398282|P3|Treated|Overall Study||153
5038369|NCT02036515|12398283|P2|Treated|Overall Study||153
5038370|NCT02036515|12398284|P1|Treated|Overall Study||156
5038371|NCT02036515|12398282|P3|STARTED|Overall Study||153
5038372|NCT02036515|12398283|P2|STARTED|Overall Study||155
5038373|NCT02036515|12398284|P1|STARTED|Overall Study||156
5038374|NCT02036424|12398363|P2|NOT COMPLETED|Overall Study||0
5038375|NCT02036424|12398364|P1|NOT COMPLETED|Overall Study||0
5038376|NCT02036424|12398363|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
5038377|NCT02036424|12398364|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
5038378|NCT02036424|12398363|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
5038379|NCT02036424|12398364|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
5038380|NCT02036320|12398372|P2|NOT COMPLETED|Period 2||0
5038381|NCT02036320|12398373|P1|NOT COMPLETED|Period 2||0
5038382|NCT02036320|12398372|P2|COMPLETED|Period 2||95
5038383|NCT02036320|12398373|P1|COMPLETED|Period 2||95
5038384|NCT02036320|12398372|P2|STARTED|Period 2||95
5038385|NCT02036320|12398373|P1|STARTED|Period 2||95
5038386|NCT02036320|12398372|P2|NOT COMPLETED|Period 1||0
5038387|NCT02036320|12398373|P1|NOT COMPLETED|Period 1||0
5038388|NCT02036320|12398372|P2|COMPLETED|Period 1||95
5038389|NCT02036320|12398373|P1|COMPLETED|Period 1||95
5038390|NCT02036320|12398372|P2|STARTED|Period 1||95
5038391|NCT02036320|12398373|P1|STARTED|Period 1||95
5038392|NCT02036294|12398385|P2|NOT COMPLETED|Overall Study||11
5038393|NCT02036294|12398386|P1|NOT COMPLETED|Overall Study||9
5038394|NCT02036294|12398385|P2|COMPLETED|Overall Study||109
5038395|NCT02036294|12398386|P1|COMPLETED|Overall Study||111
5038396|NCT02036294|12398385|P2|STARTED|Overall Study||120
5038397|NCT02036294|12398386|P1|STARTED|Overall Study||120
5038398|NCT02035748|12398402|P1|NOT COMPLETED|Overall Study||20
5038399|NCT02035748|12398402|P1|COMPLETED|Overall Study||448
5038400|NCT02035748|12398402|P1|STARTED|Overall Study||468
5038401|NCT02035696|12398416|P4|NOT COMPLETED|Overall Study||3
5038402|NCT02035696|12398417|P3|NOT COMPLETED|Overall Study||3
5038403|NCT02035696|12398418|P2|NOT COMPLETED|Overall Study||3
5038404|NCT02035696|12398419|P1|NOT COMPLETED|Overall Study||3
5038405|NCT02035696|12398416|P4|COMPLETED|Overall Study||161
5038406|NCT02035696|12398417|P3|COMPLETED|Overall Study||164
5038407|NCT02035696|12398418|P2|COMPLETED|Overall Study||163
5038408|NCT02035696|12398419|P1|COMPLETED|Overall Study||171
5038409|NCT02035696|12398416|P4|STARTED|Overall Study||164
5038410|NCT02035696|12398417|P3|STARTED|Overall Study||167
5038411|NCT02035696|12398418|P2|STARTED|Overall Study||166
5038412|NCT02035696|12398419|P1|STARTED|Overall Study||174
5038413|NCT02035553|12398475|P2|NOT COMPLETED|Overall Study||23
5038414|NCT02035553|12398476|P1|NOT COMPLETED|Overall Study||18
5038415|NCT02035553|12398475|P2|COMPLETED|Overall Study||67
5038416|NCT02035553|12398476|P1|COMPLETED|Overall Study||73
5038417|NCT02035553|12398475|P2|STARTED|Overall Study||90
5038418|NCT02035553|12398476|P1|STARTED|Overall Study||91
5038419|NCT02035475|12398482|P1|NOT COMPLETED|Overall Study||6
5038420|NCT02035475|12398482|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
5038421|NCT02035475|12398482|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
5038422|NCT02035345|12398488|P1|NOT COMPLETED|Overall Study||0
5038423|NCT02035345|12398488|P1|COMPLETED|Overall Study||15
5038424|NCT02035345|12398488|P1|STARTED|Overall Study||15
5038425|NCT02035332|12398493|P1|NOT COMPLETED|Overall Study||1
5038426|NCT02035332|12398493|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
5038427|NCT02035332|12398493|P1|Treated|Overall Study|Treatment Completed|20
5038428|NCT02035332|12398493|P1|STARTED|Overall Study|Treatment Attempted|21
5038429|NCT02035267|12398503|P4|NOT COMPLETED|Overall Study||1
5038430|NCT02035267|12398504|P3|NOT COMPLETED|Overall Study||2
5038431|NCT02035267|12398505|P2|NOT COMPLETED|Overall Study||1
5038432|NCT02035267|12398506|P1|NOT COMPLETED|Overall Study||0
5038433|NCT02035267|12398503|P4|COMPLETED|Overall Study||15
5038434|NCT02035267|12398504|P3|COMPLETED|Overall Study||28
5038435|NCT02035267|12398505|P2|COMPLETED|Overall Study||15
5038436|NCT02035267|12398506|P1|COMPLETED|Overall Study||31
5038437|NCT02035267|12398503|P4|STARTED|Overall Study||16
5038438|NCT02035267|12398504|P3|STARTED|Overall Study||30
5038439|NCT02035267|12398505|P2|STARTED|Overall Study||16
5038440|NCT02035267|12398506|P1|STARTED|Overall Study||31
5038441|NCT02035202|12398537|P3|NOT COMPLETED|Overall Study||2
5038442|NCT02035202|12398538|P2|NOT COMPLETED|Overall Study||16
5038443|NCT02035202|12398539|P1|NOT COMPLETED|Overall Study||8
5038444|NCT02035202|12398537|P3|COMPLETED|Overall Study||83
5038445|NCT02035202|12398538|P2|COMPLETED|Overall Study||69
5038446|NCT02035202|12398539|P1|COMPLETED|Overall Study||77
5038447|NCT02035202|12398537|P3|STARTED|Overall Study||85
5038448|NCT02035202|12398538|P2|STARTED|Overall Study||85
5038449|NCT02035202|12398539|P1|STARTED|Overall Study||85
5038450|NCT02034916|12398555|P2|NOT COMPLETED|Overall Study||35
5038451|NCT02034916|12398556|P1|NOT COMPLETED|Overall Study||49
5038452|NCT02034916|12398555|P2|COMPLETED|Overall Study||0
5038453|NCT02034916|12398556|P1|COMPLETED|Overall Study||0
5038454|NCT02034916|12398555|P2|Treated|Overall Study||35
5038455|NCT02034916|12398556|P1|Treated|Overall Study||48
5038456|NCT02034916|12398555|P2|STARTED|Overall Study||35
5038457|NCT02034916|12398556|P1|STARTED|Overall Study||49
5038458|NCT02034877|12398593|P2|NOT COMPLETED|Overall Study||6
5038459|NCT02034877|12398594|P1|NOT COMPLETED|Overall Study||0
5038460|NCT02034877|12398593|P2|COMPLETED|Overall Study||993
5038461|NCT02034877|12398594|P1|COMPLETED|Overall Study||200
5038462|NCT02034877|12398593|P2|STARTED|Overall Study||999
5038463|NCT02034877|12398594|P1|STARTED|Overall Study||200
5038464|NCT02034799|12398612|P2|NOT COMPLETED|Overall Study||4
5038465|NCT02034799|12398613|P1|NOT COMPLETED|Overall Study||2
5038466|NCT02034799|12398612|P2|COMPLETED|Overall Study||123
5038467|NCT02034799|12398613|P1|COMPLETED|Overall Study||127
5038468|NCT02034799|12398612|P2|STARTED|Overall Study||127
5038469|NCT02034799|12398613|P1|STARTED|Overall Study||129
5038470|NCT02034708|12398627|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
5038471|NCT02034708|12398628|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
5038472|NCT02034708|12398627|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
5038473|NCT02034708|12398628|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
5038474|NCT02034708|12398627|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
5038475|NCT02034708|12398628|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
5038476|NCT02034708|12398627|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
5038477|NCT02034708|12398628|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
5038478|NCT02034708|12398627|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
5038479|NCT02034708|12398628|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
5038480|NCT02034708|12398627|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
5038481|NCT02034708|12398628|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
5038482|NCT02034708|12398627|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
5038483|NCT02034708|12398628|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
5038484|NCT02034708|12398627|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
5038485|NCT02034708|12398628|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
5038486|NCT02034708|12398627|P2|STARTED|First Contrast Agent Injection (1 Day)||130
5038487|NCT02034708|12398628|P1|STARTED|First Contrast Agent Injection (1 Day)||138
5038488|NCT02034591|12398639|P6|NOT COMPLETED|Overall Study||0
5038489|NCT02034591|12398640|P5|NOT COMPLETED|Overall Study||1
5038490|NCT02034591|12398641|P4|NOT COMPLETED|Overall Study||0
5038491|NCT02034591|12398642|P3|NOT COMPLETED|Overall Study||0
5038492|NCT02034591|12398643|P2|NOT COMPLETED|Overall Study||0
5038493|NCT02034591|12398644|P1|NOT COMPLETED|Overall Study||0
5038494|NCT02034591|12398639|P6|COMPLETED|Overall Study||3
5038495|NCT02034591|12398640|P5|COMPLETED|Overall Study||3
5038496|NCT02034591|12398641|P4|COMPLETED|Overall Study||3
5038497|NCT02034591|12398642|P3|COMPLETED|Overall Study||4
5038498|NCT02034591|12398643|P2|COMPLETED|Overall Study||3
5038499|NCT02034591|12398644|P1|COMPLETED|Overall Study||4
5038500|NCT02034591|12398639|P6|STARTED|Overall Study||3
5038501|NCT02034591|12398640|P5|STARTED|Overall Study||4
5038502|NCT02034591|12398641|P4|STARTED|Overall Study||3
5038503|NCT02034591|12398642|P3|STARTED|Overall Study||4
5038504|NCT02034591|12398643|P2|STARTED|Overall Study||3
5038505|NCT02034591|12398644|P1|STARTED|Overall Study||4
5038506|NCT02034578|12398667|P6|NOT COMPLETED|Overall Study||0
5038507|NCT02034578|12398668|P5|NOT COMPLETED|Overall Study||0
5038508|NCT02034578|12398669|P4|NOT COMPLETED|Overall Study||0
5038509|NCT02034578|12398670|P3|NOT COMPLETED|Overall Study||0
5038510|NCT02034578|12398671|P2|NOT COMPLETED|Overall Study||0
5038511|NCT02034578|12398672|P1|NOT COMPLETED|Overall Study||0
5038512|NCT02034578|12398667|P6|COMPLETED|Overall Study||3
5038513|NCT02034578|12398668|P5|COMPLETED|Overall Study||4
5038514|NCT02034578|12398669|P4|COMPLETED|Overall Study||3
5038515|NCT02034578|12398670|P3|COMPLETED|Overall Study||4
5038516|NCT02034578|12398671|P2|COMPLETED|Overall Study||3
5038517|NCT02034578|12398672|P1|COMPLETED|Overall Study||4
5038518|NCT02034578|12398667|P6|STARTED|Overall Study||3
5038519|NCT02034578|12398668|P5|STARTED|Overall Study||4
5038520|NCT02034578|12398669|P4|STARTED|Overall Study||3
5038521|NCT02034578|12398670|P3|STARTED|Overall Study||4
5038522|NCT02034578|12398671|P2|STARTED|Overall Study||3
5038523|NCT02034578|12398672|P1|STARTED|Overall Study||4
5038524|NCT02034565|12398699|P2|NOT COMPLETED|Overall Study||0
5038525|NCT02034565|12398700|P1|NOT COMPLETED|Overall Study||1
5038526|NCT02034565|12398699|P2|COMPLETED|Overall Study||7
5038527|NCT02034565|12398700|P1|COMPLETED|Overall Study||6
5038528|NCT02034565|12398699|P2|STARTED|Overall Study||7
5038529|NCT02034565|12398700|P1|STARTED|Overall Study||7
5038530|NCT02034552|12398717|P3|NOT COMPLETED|Overall Study||17
5038531|NCT02034552|12398718|P2|NOT COMPLETED|Overall Study||20
5038532|NCT02034552|12398719|P1|NOT COMPLETED|Overall Study||14
5038533|NCT02034552|12398717|P3|COMPLETED|Overall Study||5
5038534|NCT02034552|12398718|P2|COMPLETED|Overall Study||4
5038535|NCT02034552|12398719|P1|COMPLETED|Overall Study||8
5038536|NCT02034552|12398717|P3|Received Treatment|Overall Study||22
5038537|NCT02034552|12398718|P2|Received Treatment|Overall Study||22
5038538|NCT02034552|12398719|P1|Received Treatment|Overall Study||19
5038539|NCT02034552|12398717|P3|STARTED|Overall Study||22
5038540|NCT02034552|12398718|P2|STARTED|Overall Study||24
5038541|NCT02034552|12398719|P1|STARTED|Overall Study||22
5038542|NCT02034513|12398750|P2|NOT COMPLETED|Overall Study||57
5038543|NCT02034513|12398751|P1|NOT COMPLETED|Overall Study||49
5038544|NCT02034513|12398750|P2|COMPLETED|Overall Study||195
5038545|NCT02034513|12398751|P1|COMPLETED|Overall Study||200
5038546|NCT02034513|12398750|P2|Exposed|Overall Study||251
5038547|NCT02034513|12398751|P1|Exposed|Overall Study||249
5038548|NCT02034513|12398750|P2|STARTED|Overall Study||252
5038549|NCT02034513|12398751|P1|STARTED|Overall Study||249
5038550|NCT02034474|12398769|P2|NOT COMPLETED|Overall Study||4
5038551|NCT02034474|12398770|P1|NOT COMPLETED|Overall Study||4
5038552|NCT02034474|12398769|P2|COMPLETED|Overall Study||13
5038553|NCT02034474|12398770|P1|COMPLETED|Overall Study||15
5038554|NCT02034474|12398769|P2|3 Doses|Overall Study||13
5038555|NCT02034474|12398770|P1|3 Doses|Overall Study||15
5038556|NCT02034474|12398769|P2|2 Doses|Overall Study||0
5038557|NCT02034474|12398770|P1|2 Doses|Overall Study||2
5038558|NCT02034474|12398769|P2|1 Dose|Overall Study||4
5038559|NCT02034474|12398770|P1|1 Dose|Overall Study||2
5038560|NCT02034474|12398769|P2|STARTED|Overall Study||17
5038561|NCT02034474|12398770|P1|STARTED|Overall Study||19
5038562|NCT02034175|12398780|P1|NOT COMPLETED|Overall Study||0
5038563|NCT02034175|12398780|P1|COMPLETED|Overall Study||190
5038564|NCT02034175|12398780|P1|STARTED|Overall Study||190
5038565|NCT02034162|12398786|P3|NOT COMPLETED|Open-label||0
5038566|NCT02034162|12398787|P2|NOT COMPLETED|Open-label||0
5038567|NCT02034162|12398788|P1|NOT COMPLETED|Open-label||0
5038568|NCT02034162|12398786|P3|COMPLETED|Open-label||278
5038569|NCT02034162|12398787|P2|COMPLETED|Open-label||0
5038570|NCT02034162|12398788|P1|COMPLETED|Open-label||0
5038571|NCT02034162|12398786|P3|STARTED|Open-label||278
5038572|NCT02034162|12398787|P2|STARTED|Open-label||0
5038573|NCT02034162|12398788|P1|STARTED|Open-label||0
5038574|NCT02034162|12398786|P3|NOT COMPLETED|Double-blind||0
5038575|NCT02034162|12398787|P2|NOT COMPLETED|Double-blind||8
5038576|NCT02034162|12398788|P1|NOT COMPLETED|Double-blind||9
5038577|NCT02034162|12398786|P3|COMPLETED|Double-blind||0
5038578|NCT02034162|12398787|P2|COMPLETED|Double-blind||141
5038579|NCT02034162|12398788|P1|COMPLETED|Double-blind||137
5038580|NCT02034162|12398786|P3|STARTED|Double-blind||0
5038581|NCT02034162|12398787|P2|STARTED|Double-blind||149
5038582|NCT02034162|12398788|P1|STARTED|Double-blind||146
5038583|NCT02034123|12398834|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
5038584|NCT02034123|12398835|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
5038585|NCT02034123|12398836|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
5038586|NCT02034123|12398837|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
5038587|NCT02034123|12398838|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
5038588|NCT02034123|12398839|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
5038589|NCT02034123|12398840|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
5038590|NCT02034123|12398841|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
5038591|NCT02034123|12398842|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
5038592|NCT02034123|12398843|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
5038593|NCT02034123|12398844|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
5038594|NCT02034123|12398845|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
5038595|NCT02034123|12398846|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
5038596|NCT02034123|12398847|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
5038597|NCT02034123|12398848|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
5038598|NCT02034123|12398849|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
5038599|NCT02034123|12398850|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
5038600|NCT02034123|12398851|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
5038601|NCT02034123|12398834|P18|COMPLETED|Part2(Up to 2 Years)||0
5038602|NCT02034123|12398835|P17|COMPLETED|Part2(Up to 2 Years)||0
5038603|NCT02034123|12398836|P16|COMPLETED|Part2(Up to 2 Years)||0
5038604|NCT02034123|12398837|P15|COMPLETED|Part2(Up to 2 Years)||0
5038605|NCT02034123|12398838|P14|COMPLETED|Part2(Up to 2 Years)||0
5038606|NCT02034123|12398839|P13|COMPLETED|Part2(Up to 2 Years)||0
5038607|NCT02034123|12398840|P12|COMPLETED|Part2(Up to 2 Years)||0
5038608|NCT02034123|12398841|P11|COMPLETED|Part2(Up to 2 Years)||0
5038609|NCT02034123|12398842|P10|COMPLETED|Part2(Up to 2 Years)||0
5038610|NCT02034123|12398843|P9|COMPLETED|Part2(Up to 2 Years)||0
5038611|NCT02034123|12398844|P8|COMPLETED|Part2(Up to 2 Years)||0
5038612|NCT02034123|12398845|P7|COMPLETED|Part2(Up to 2 Years)||0
5038613|NCT02034123|12398846|P6|COMPLETED|Part2(Up to 2 Years)||0
5038614|NCT02034123|12398847|P5|COMPLETED|Part2(Up to 2 Years)||0
5038615|NCT02034123|12398848|P4|COMPLETED|Part2(Up to 2 Years)||0
5038616|NCT02034123|12398849|P3|COMPLETED|Part2(Up to 2 Years)||0
5038617|NCT02034123|12398850|P2|COMPLETED|Part2(Up to 2 Years)||0
5038618|NCT02034123|12398851|P1|COMPLETED|Part2(Up to 2 Years)||0
5038619|NCT02034123|12398834|P18|STARTED|Part2(Up to 2 Years)||0
5038620|NCT02034123|12398835|P17|STARTED|Part2(Up to 2 Years)||0
5038621|NCT02034123|12398836|P16|STARTED|Part2(Up to 2 Years)||0
5038622|NCT02034123|12398837|P15|STARTED|Part2(Up to 2 Years)||0
5038623|NCT02034123|12398838|P14|STARTED|Part2(Up to 2 Years)||0
5038624|NCT02034123|12398839|P13|STARTED|Part2(Up to 2 Years)||0
5038625|NCT02034123|12398840|P12|STARTED|Part2(Up to 2 Years)||0
5038626|NCT02034123|12398841|P11|STARTED|Part2(Up to 2 Years)||0
5038627|NCT02034123|12398842|P10|STARTED|Part2(Up to 2 Years)||0
5038628|NCT02034123|12398843|P9|STARTED|Part2(Up to 2 Years)||0
5038629|NCT02034123|12398844|P8|STARTED|Part2(Up to 2 Years)||0
5038630|NCT02034123|12398845|P7|STARTED|Part2(Up to 2 Years)||0
5038631|NCT02034123|12398846|P6|STARTED|Part2(Up to 2 Years)||0
5038632|NCT02034123|12398847|P5|STARTED|Part2(Up to 2 Years)||0
5038633|NCT02034123|12398848|P4|STARTED|Part2(Up to 2 Years)||0
5038634|NCT02034123|12398849|P3|STARTED|Part2(Up to 2 Years)||0
5038635|NCT02034123|12398850|P2|STARTED|Part2(Up to 2 Years)||0
5038636|NCT02034123|12398851|P1|STARTED|Part2(Up to 2 Years)||0
5038637|NCT02034123|12398834|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038638|NCT02034123|12398835|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038639|NCT02034123|12398836|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038640|NCT02034123|12398837|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038641|NCT02034123|12398838|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038642|NCT02034123|12398839|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038643|NCT02034123|12398840|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038644|NCT02034123|12398841|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038645|NCT02034123|12398842|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038646|NCT02034123|12398843|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
5038647|NCT02034123|12398844|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
5038648|NCT02034123|12398845|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038649|NCT02034123|12398846|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038650|NCT02034123|12398847|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
5038651|NCT02034123|12398848|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
5038652|NCT02034123|12398849|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038653|NCT02034123|12398850|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038654|NCT02034123|12398851|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038655|NCT02034123|12398834|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038656|NCT02034123|12398835|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038657|NCT02034123|12398836|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038658|NCT02034123|12398837|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038659|NCT02034123|12398838|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038660|NCT02034123|12398839|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038661|NCT02034123|12398840|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038662|NCT02034123|12398841|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038663|NCT02034123|12398842|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038664|NCT02034123|12398843|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
5038665|NCT02034123|12398844|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
5038666|NCT02034123|12398845|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
5038667|NCT02034123|12398846|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
5038668|NCT02034123|12398847|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
5038669|NCT02034123|12398848|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
5038670|NCT02034123|12398849|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
5038671|NCT02034123|12398850|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
5038672|NCT02034123|12398851|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
5038673|NCT02034123|12398834|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038674|NCT02034123|12398835|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038675|NCT02034123|12398836|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038676|NCT02034123|12398837|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038677|NCT02034123|12398838|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038678|NCT02034123|12398839|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038679|NCT02034123|12398840|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038680|NCT02034123|12398841|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038681|NCT02034123|12398842|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
5038682|NCT02034123|12398843|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
5038683|NCT02034123|12398844|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
5038684|NCT02034123|12398845|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
5038685|NCT02034123|12398846|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
5038686|NCT02034123|12398847|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
5038687|NCT02034123|12398848|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
5038688|NCT02034123|12398849|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
5038689|NCT02034123|12398850|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
5038690|NCT02034123|12398851|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
5038691|NCT02034058|12399170|P1|NOT COMPLETED|Overall Study||3
5038692|NCT02034058|12399170|P1|COMPLETED|Overall Study||149
5038693|NCT02034058|12399170|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
5038694|NCT02034019|12399180|P2|NOT COMPLETED|Overall Study||2
5038695|NCT02034019|12399181|P1|NOT COMPLETED|Overall Study||1
5038696|NCT02034019|12399180|P2|COMPLETED|Overall Study||81
5038697|NCT02034019|12399181|P1|COMPLETED|Overall Study||163
5038698|NCT02034019|12399180|P2|STARTED|Overall Study||83
5038699|NCT02034019|12399181|P1|STARTED|Overall Study||164
5038700|NCT02034006|12399191|P1|NOT COMPLETED|Overall Study||14
5038701|NCT02034006|12399191|P1|COMPLETED|Overall Study||186
5038702|NCT02034006|12399191|P1|Re-treated Patients|Overall Study||130
5038703|NCT02034006|12399191|P1|Once Treated Patients|Overall Study||70
5038704|NCT02034006|12399191|P1|STARTED|Overall Study||200
5038705|NCT02033993|12399224|P2|NOT COMPLETED|Overall Study||9
5038706|NCT02033993|12399225|P1|NOT COMPLETED|Overall Study||3
5038707|NCT02033993|12399224|P2|COMPLETED|Overall Study||91
5038708|NCT02033993|12399225|P1|COMPLETED|Overall Study||96
5038709|NCT02033993|12399224|P2|STARTED|Overall Study||100
5038710|NCT02033993|12399225|P1|STARTED|Overall Study||99
5038711|NCT02033889|12399242|P3|NOT COMPLETED|Overall Study||25
5038712|NCT02033889|12399243|P2|NOT COMPLETED|Overall Study||20
5038713|NCT02033889|12399244|P1|NOT COMPLETED|Overall Study||34
5038714|NCT02033889|12399242|P3|COMPLETED|Overall Study||180
5038715|NCT02033889|12399243|P2|COMPLETED|Overall Study||187
5038716|NCT02033889|12399244|P1|COMPLETED|Overall Study||175
5038717|NCT02033889|12399242|P3|STARTED|Overall Study||205
5038718|NCT02033889|12399243|P2|STARTED|Overall Study||207
5038719|NCT02033889|12399244|P1|STARTED|Overall Study||209
5038720|NCT02033876|12399398|P2|NOT COMPLETED|Overall Study||0
5038721|NCT02033876|12399399|P1|NOT COMPLETED|Overall Study||0
5038722|NCT02033876|12399398|P2|COMPLETED|Overall Study||12
5038723|NCT02033876|12399399|P1|COMPLETED|Overall Study||12
5038724|NCT02033876|12399398|P2|STARTED|Overall Study||12
5038725|NCT02033876|12399399|P1|STARTED|Overall Study||12
5038726|NCT02033850|12399421|P2|NOT COMPLETED|Overall Study||1
5038727|NCT02033850|12399422|P1|NOT COMPLETED|Overall Study||2
5038728|NCT02033850|12399421|P2|COMPLETED|Overall Study||22
5038729|NCT02033850|12399422|P1|COMPLETED|Overall Study||21
5038730|NCT02033850|12399421|P2|STARTED|Overall Study||23
5038731|NCT02033850|12399422|P1|STARTED|Overall Study||23
5038732|NCT02033759|12399446|P2|NOT COMPLETED|Overall Study||2
5038733|NCT02033759|12399447|P1|NOT COMPLETED|Overall Study||3
5038734|NCT02033759|12399446|P2|COMPLETED|Overall Study||19
5038735|NCT02033759|12399447|P1|COMPLETED|Overall Study||19
5038736|NCT02033759|12399446|P2|STARTED|Overall Study||21
5038737|NCT02033759|12399447|P1|STARTED|Overall Study||22
5038738|NCT02033694|12399457|P1|NOT COMPLETED|Overall Study||0
5038739|NCT02033694|12399457|P1|COMPLETED|Overall Study||1271
5038740|NCT02033694|12399457|P1|STARTED|Overall Study||1271
5038741|NCT02033499|12399465|P3|NOT COMPLETED|Overall Study||9
5038742|NCT02033499|12399466|P2|NOT COMPLETED|Overall Study||8
5038743|NCT02033499|12399467|P1|NOT COMPLETED|Overall Study||5
5038744|NCT02033499|12399465|P3|COMPLETED|Overall Study||139
5038745|NCT02033499|12399466|P2|COMPLETED|Overall Study||142
5038746|NCT02033499|12399467|P1|COMPLETED|Overall Study||147
5038747|NCT02033499|12399465|P3|STARTED|Overall Study||148
5038748|NCT02033499|12399466|P2|STARTED|Overall Study||150
5038749|NCT02033499|12399467|P1|STARTED|Overall Study||152
5038750|NCT02033369|12399507|P2|NOT COMPLETED|Overall Study||5
5038751|NCT02033369|12399508|P1|NOT COMPLETED|Overall Study||5
5038752|NCT02033369|12399507|P2|COMPLETED|Overall Study||21
5038753|NCT02033369|12399508|P1|COMPLETED|Overall Study||21
5038754|NCT02033369|12399507|P2|STARTED|Overall Study||26
5038755|NCT02033369|12399508|P1|STARTED|Overall Study||26
5038756|NCT02033317|12399518|P1|NOT COMPLETED|Overall Study||0
5038757|NCT02033317|12399518|P1|COMPLETED|Overall Study||6
5038758|NCT02033317|12399518|P1|STARTED|Overall Study||6
5038759|NCT02033213|12399525|P2|NOT COMPLETED|Overall Study||0
5038760|NCT02033213|12399526|P1|NOT COMPLETED|Overall Study||0
5038761|NCT02033213|12399525|P2|COMPLETED|Overall Study||8
5038762|NCT02033213|12399526|P1|COMPLETED|Overall Study||8
5038763|NCT02033213|12399525|P2|STARTED|Overall Study||8
5038764|NCT02033213|12399526|P1|STARTED|Overall Study||8
5038765|NCT02033200|12399544|P2|NOT COMPLETED|Overall Study||0
5038766|NCT02033200|12399545|P1|NOT COMPLETED|Overall Study||0
5038767|NCT02033200|12399544|P2|COMPLETED|Overall Study||40
5038768|NCT02033200|12399545|P1|COMPLETED|Overall Study||40
5038769|NCT02033200|12399544|P2|STARTED|Overall Study||40
5038770|NCT02033200|12399545|P1|STARTED|Overall Study||40
5038771|NCT02033174|12399565|P2|NOT COMPLETED|Second Intervention||0
5038772|NCT02033174|12399566|P1|NOT COMPLETED|Second Intervention||0
5038773|NCT02033174|12399565|P2|COMPLETED|Second Intervention||8
5038774|NCT02033174|12399566|P1|COMPLETED|Second Intervention||8
5038775|NCT02033174|12399565|P2|STARTED|Second Intervention||8
5038776|NCT02033174|12399566|P1|STARTED|Second Intervention||8
5038777|NCT02033174|12399565|P2|NOT COMPLETED|Washout (1 Week)||0
5038778|NCT02033174|12399566|P1|NOT COMPLETED|Washout (1 Week)||0
5038779|NCT02033174|12399565|P2|COMPLETED|Washout (1 Week)||8
5038780|NCT02033174|12399566|P1|COMPLETED|Washout (1 Week)||8
5038781|NCT02033174|12399565|P2|STARTED|Washout (1 Week)||8
5038782|NCT02033174|12399566|P1|STARTED|Washout (1 Week)||8
5038783|NCT02033174|12399565|P2|NOT COMPLETED|First Intervention||0
5038784|NCT02033174|12399566|P1|NOT COMPLETED|First Intervention||0
5038785|NCT02033174|12399565|P2|COMPLETED|First Intervention||8
5038786|NCT02033174|12399566|P1|COMPLETED|First Intervention||8
5038787|NCT02033174|12399565|P2|STARTED|First Intervention||8
5038788|NCT02033174|12399566|P1|STARTED|First Intervention||8
5038789|NCT02033083|12399574|P2|NOT COMPLETED|Overall Study||1
5038790|NCT02033083|12399575|P1|NOT COMPLETED|Overall Study||1
5038791|NCT02033083|12399574|P2|COMPLETED|Overall Study||88
5038792|NCT02033083|12399575|P1|COMPLETED|Overall Study||88
5038793|NCT02033083|12399574|P2|STARTED|Overall Study||89
5038794|NCT02033083|12399575|P1|STARTED|Overall Study||89
5038795|NCT02033005|12399584|P3|NOT COMPLETED|Overall Study||10
5038796|NCT02033005|12399585|P2|NOT COMPLETED|Overall Study||0
5038797|NCT02033005|12399586|P1|NOT COMPLETED|Overall Study||44
5038798|NCT02033005|12399584|P3|COMPLETED|Overall Study||25
5038799|NCT02033005|12399585|P2|COMPLETED|Overall Study||9
5038800|NCT02033005|12399586|P1|COMPLETED|Overall Study||36
5038801|NCT02033005|12399584|P3|STARTED|Overall Study||35
5038802|NCT02033005|12399585|P2|STARTED|Overall Study||9
5038803|NCT02033005|12399586|P1|STARTED|Overall Study||80
5038804|NCT02032901|12399602|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
5038805|NCT02032901|12399603|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
5038806|NCT02032901|12399602|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
5038807|NCT02032901|12399603|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
5038808|NCT02032901|12399602|P2|STARTED|Follow-Up Period (24 Weeks)||51
5038809|NCT02032901|12399603|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
5038810|NCT02032901|12399602|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
5038811|NCT02032901|12399603|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
5038812|NCT02032901|12399602|P2|COMPLETED|Treatment Period (12 Weeks)||51
5038813|NCT02032901|12399603|P1|COMPLETED|Treatment Period (12 Weeks)||100
5038814|NCT02032901|12399602|P2|STARTED|Treatment Period (12 Weeks)||51
5038815|NCT02032901|12399603|P1|STARTED|Treatment Period (12 Weeks)||101
5038816|NCT02032888|12399627|P3|NOT COMPLETED|Follow-up Period||0
5038817|NCT02032888|12399628|P2|NOT COMPLETED|Follow-up Period||2
5038818|NCT02032888|12399629|P1|NOT COMPLETED|Follow-up Period||3
5038819|NCT02032888|12399627|P3|COMPLETED|Follow-up Period||52
5038820|NCT02032888|12399628|P2|COMPLETED|Follow-up Period||47
5038821|NCT02032888|12399629|P1|COMPLETED|Follow-up Period||97
5038822|NCT02032888|12399627|P3|STARTED|Follow-up Period||52
5038823|NCT02032888|12399628|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
5038824|NCT02032888|12399629|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
5038825|NCT02032888|12399627|P3|NOT COMPLETED|Treatment Period||0
5038826|NCT02032888|12399628|P2|NOT COMPLETED|Treatment Period||2
5038827|NCT02032888|12399629|P1|NOT COMPLETED|Treatment Period||2
5038828|NCT02032888|12399627|P3|COMPLETED|Treatment Period||52
5038829|NCT02032888|12399628|P2|COMPLETED|Treatment Period||48
5038830|NCT02032888|12399629|P1|COMPLETED|Treatment Period||99
5038831|NCT02032888|12399627|P3|STARTED|Treatment Period||52
5038832|NCT02032888|12399628|P2|STARTED|Treatment Period||50
5038833|NCT02032888|12399629|P1|STARTED|Treatment Period||101
5038834|NCT02032875|12399660|P2|NOT COMPLETED|Follow-up Period||11
5038835|NCT02032875|12399661|P1|NOT COMPLETED|Follow-up Period||3
5038836|NCT02032875|12399660|P2|COMPLETED|Follow-up Period||46
5038837|NCT02032875|12399661|P1|COMPLETED|Follow-up Period||50
5038838|NCT02032875|12399660|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
5038839|NCT02032875|12399661|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
5038840|NCT02032875|12399660|P2|NOT COMPLETED|Treatment Period||4
5038841|NCT02032875|12399661|P1|NOT COMPLETED|Treatment Period||1
5038842|NCT02032875|12399660|P2|COMPLETED|Treatment Period||56
5038843|NCT02032875|12399661|P1|COMPLETED|Treatment Period||52
5038844|NCT02032875|12399660|P2|STARTED|Treatment Period||60
5038845|NCT02032875|12399661|P1|STARTED|Treatment Period||53
5038846|NCT02032810|12399681|P2|NOT COMPLETED|Overall Study||0
5038847|NCT02032810|12399682|P1|NOT COMPLETED|Overall Study||0
5038848|NCT02032810|12399681|P2|COMPLETED|Overall Study||11
5038849|NCT02032810|12399682|P1|COMPLETED|Overall Study||6
5038850|NCT02032810|12399681|P2|STARTED|Overall Study||11
5038851|NCT02032810|12399682|P1|STARTED|Overall Study||6
5038852|NCT02032758|12399695|P2|NOT COMPLETED|Overall Study||0
5038853|NCT02032758|12399696|P1|NOT COMPLETED|Overall Study||0
5038854|NCT02032758|12399695|P2|COMPLETED|Overall Study||11
5038855|NCT02032758|12399696|P1|COMPLETED|Overall Study||27
5038856|NCT02032758|12399695|P2|STARTED|Overall Study||11
5038857|NCT02032758|12399696|P1|STARTED|Overall Study||27
5038858|NCT02032706|12399704|P1|NOT COMPLETED|Overall Study||6
5038859|NCT02032706|12399704|P1|COMPLETED|Overall Study||30
5038860|NCT02032706|12399704|P1|STARTED|Overall Study||36
5038861|NCT02032641|12399717|P1|NOT COMPLETED|Overall Study||1
5038862|NCT02032641|12399717|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
5038863|NCT02032641|12399717|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
5038864|NCT02032433|12399729|P2|NOT COMPLETED|Overall Study||62
5038865|NCT02032433|12399730|P1|NOT COMPLETED|Overall Study||78
5038866|NCT02032433|12399729|P2|COMPLETED|Overall Study||225
5038867|NCT02032433|12399730|P1|COMPLETED|Overall Study||205
5038868|NCT02032433|12399729|P2|STARTED|Overall Study||287
5038869|NCT02032433|12399730|P1|STARTED|Overall Study||283
5038870|NCT02032420|12399748|P2|NOT COMPLETED|Overall Study||0
5038871|NCT02032420|12399749|P1|NOT COMPLETED|Overall Study||0
5038872|NCT02032420|12399748|P2|COMPLETED|Overall Study||17
5038873|NCT02032420|12399749|P1|COMPLETED|Overall Study||18
5038874|NCT02032420|12399748|P2|STARTED|Overall Study||17
5038875|NCT02032420|12399749|P1|STARTED|Overall Study||18
5038876|NCT02032407|12399761|P1|NOT COMPLETED|Overall Study||5
5038877|NCT02032407|12399761|P1|COMPLETED|Overall Study||63
5038878|NCT02032407|12399761|P1|STARTED|Overall Study||68
5038879|NCT02032238|12399774|P2|NOT COMPLETED|Overall Study||0
5038880|NCT02032238|12399775|P1|NOT COMPLETED|Overall Study||2
5038881|NCT02032238|12399774|P2|COMPLETED|Overall Study||0
5038882|NCT02032238|12399775|P1|COMPLETED|Overall Study||10
5038883|NCT02032238|12399774|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
5038884|NCT02032238|12399775|P1|STARTED|Overall Study||12
5038885|NCT02032212|12399785|P4|NOT COMPLETED|Overall Study||0
5038886|NCT02032212|12399786|P3|NOT COMPLETED|Overall Study||0
5038887|NCT02032212|12399787|P2|NOT COMPLETED|Overall Study||0
5038888|NCT02032212|12399788|P1|NOT COMPLETED|Overall Study||0
5038889|NCT02032212|12399785|P4|COMPLETED|Overall Study||3
5038890|NCT02032212|12399786|P3|COMPLETED|Overall Study||3
5038891|NCT02032212|12399787|P2|COMPLETED|Overall Study||3
5038892|NCT02032212|12399788|P1|COMPLETED|Overall Study||3
5038893|NCT02032212|12399785|P4|STARTED|Overall Study||3
5038894|NCT02032212|12399786|P3|STARTED|Overall Study||3
5038895|NCT02032212|12399787|P2|STARTED|Overall Study||3
5038896|NCT02032212|12399788|P1|STARTED|Overall Study||3
5038897|NCT02031679|12399816|P2|NOT COMPLETED|Overall Study||2
5038898|NCT02031679|12399817|P1|NOT COMPLETED|Overall Study||0
5038899|NCT02031679|12399816|P2|COMPLETED|Overall Study||12
5038900|NCT02031679|12399817|P1|COMPLETED|Overall Study||14
5038901|NCT02031679|12399816|P2|STARTED|Overall Study||14
5038902|NCT02031679|12399817|P1|STARTED|Overall Study||14
5038903|NCT02031640|12399832|P6|NOT COMPLETED|Double-blind Treatment Period||3
5038904|NCT02031640|12399833|P5|NOT COMPLETED|Double-blind Treatment Period||11
5038905|NCT02031640|12399834|P4|NOT COMPLETED|Double-blind Treatment Period||7
5038906|NCT02031640|12399835|P3|NOT COMPLETED|Double-blind Treatment Period||6
5038907|NCT02031640|12399836|P2|NOT COMPLETED|Double-blind Treatment Period||22
5038908|NCT02031640|12399837|P1|NOT COMPLETED|Double-blind Treatment Period||0
5038909|NCT02031640|12399832|P6|COMPLETED|Double-blind Treatment Period||104
5038910|NCT02031640|12399833|P5|COMPLETED|Double-blind Treatment Period||96
5038911|NCT02031640|12399834|P4|COMPLETED|Double-blind Treatment Period||99
5038912|NCT02031640|12399835|P3|COMPLETED|Double-blind Treatment Period||100
5038913|NCT02031640|12399836|P2|COMPLETED|Double-blind Treatment Period||84
5038914|NCT02031640|12399837|P1|COMPLETED|Double-blind Treatment Period||0
5038915|NCT02031640|12399832|P6|Full Analysis Set|Double-blind Treatment Period||107
5038916|NCT02031640|12399833|P5|Full Analysis Set|Double-blind Treatment Period||106
5038917|NCT02031640|12399834|P4|Full Analysis Set|Double-blind Treatment Period||106
5038918|NCT02031640|12399835|P3|Full Analysis Set|Double-blind Treatment Period||104
5038919|NCT02031640|12399836|P2|Full Analysis Set|Double-blind Treatment Period||106
5038920|NCT02031640|12399837|P1|Full Analysis Set|Double-blind Treatment Period||0
5038921|NCT02031640|12399832|P6|STARTED|Double-blind Treatment Period||107
5038922|NCT02031640|12399833|P5|STARTED|Double-blind Treatment Period||107
5038923|NCT02031640|12399834|P4|STARTED|Double-blind Treatment Period||106
5038924|NCT02031640|12399835|P3|STARTED|Double-blind Treatment Period||106
5038925|NCT02031640|12399836|P2|STARTED|Double-blind Treatment Period||106
5038926|NCT02031640|12399837|P1|STARTED|Double-blind Treatment Period||0
5038927|NCT02031640|12399832|P6|NOT COMPLETED|Run-In Period||0
5038928|NCT02031640|12399833|P5|NOT COMPLETED|Run-In Period||0
5038929|NCT02031640|12399834|P4|NOT COMPLETED|Run-In Period||0
5038930|NCT02031640|12399835|P3|NOT COMPLETED|Run-In Period||0
5038931|NCT02031640|12399836|P2|NOT COMPLETED|Run-In Period||0
5038932|NCT02031640|12399837|P1|NOT COMPLETED|Run-In Period||169
5038933|NCT02031640|12399832|P6|COMPLETED|Run-In Period||0
5038934|NCT02031640|12399833|P5|COMPLETED|Run-In Period||0
5038935|NCT02031640|12399834|P4|COMPLETED|Run-In Period||0
5038936|NCT02031640|12399835|P3|COMPLETED|Run-In Period||0
5038937|NCT02031640|12399836|P2|COMPLETED|Run-In Period||0
5038938|NCT02031640|12399837|P1|COMPLETED|Run-In Period||532
5038939|NCT02031640|12399832|P6|STARTED|Run-In Period||0
5038940|NCT02031640|12399833|P5|STARTED|Run-In Period||0
5038941|NCT02031640|12399834|P4|STARTED|Run-In Period||0
5038942|NCT02031640|12399835|P3|STARTED|Run-In Period||0
5038943|NCT02031640|12399836|P2|STARTED|Run-In Period||0
5038944|NCT02031640|12399837|P1|STARTED|Run-In Period||701
5038945|NCT02031640|12399832|P6|NOT COMPLETED|Screening Period||0
5038946|NCT02031640|12399833|P5|NOT COMPLETED|Screening Period||0
5038947|NCT02031640|12399834|P4|NOT COMPLETED|Screening Period||0
5038948|NCT02031640|12399835|P3|NOT COMPLETED|Screening Period||0
5038949|NCT02031640|12399836|P2|NOT COMPLETED|Screening Period||0
5038950|NCT02031640|12399837|P1|NOT COMPLETED|Screening Period||412
5038951|NCT02031640|12399832|P6|COMPLETED|Screening Period||0
5038952|NCT02031640|12399833|P5|COMPLETED|Screening Period||0
5038953|NCT02031640|12399834|P4|COMPLETED|Screening Period||0
5038954|NCT02031640|12399835|P3|COMPLETED|Screening Period||0
5038955|NCT02031640|12399836|P2|COMPLETED|Screening Period||0
5038956|NCT02031640|12399837|P1|COMPLETED|Screening Period||701
5038957|NCT02031640|12399832|P6|STARTED|Screening Period||0
5038958|NCT02031640|12399833|P5|STARTED|Screening Period||0
5038959|NCT02031640|12399834|P4|STARTED|Screening Period||0
5038960|NCT02031640|12399835|P3|STARTED|Screening Period||0
5038961|NCT02031640|12399836|P2|STARTED|Screening Period||0
5038962|NCT02031640|12399837|P1|STARTED|Screening Period|Consented|1113
5038963|NCT02031471|12399880|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
5038964|NCT02031471|12399880|P1|COMPLETED|Long Term Extension (LTE) Period||37
5038965|NCT02031471|12399880|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
5038966|NCT02031471|12399880|P1|NOT COMPLETED|24 Week Treatment Period||11
5038967|NCT02031471|12399880|P1|COMPLETED|24 Week Treatment Period||46
5038968|NCT02031471|12399880|P1|STARTED|24 Week Treatment Period||57
5038969|NCT02031458|12399913|P3|NOT COMPLETED|Baseline to May 8, 2015||253
5038970|NCT02031458|12399914|P2|NOT COMPLETED|Baseline to May 8, 2015||267
5038971|NCT02031458|12399915|P1|NOT COMPLETED|Baseline to May 8, 2015||139
5038972|NCT02031458|12399913|P3|COMPLETED|Baseline to May 8, 2015||0
5038973|NCT02031458|12399914|P2|COMPLETED|Baseline to May 8, 2015||0
5038974|NCT02031458|12399915|P1|COMPLETED|Baseline to May 8, 2015||0
5038975|NCT02031458|12399913|P3|STARTED|Baseline to May 8, 2015||253
5038976|NCT02031458|12399914|P2|STARTED|Baseline to May 8, 2015||267
5038977|NCT02031458|12399915|P1|STARTED|Baseline to May 8, 2015||139
5038978|NCT02031458|12399913|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
5038979|NCT02031458|12399914|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
5038980|NCT02031458|12399915|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
5038981|NCT02031458|12399913|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
5038982|NCT02031458|12399914|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
5038983|NCT02031458|12399915|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
5038984|NCT02031458|12399913|P3|STARTED|May 8, 2015 to January 11, 2019||252
5038985|NCT02031458|12399914|P2|STARTED|May 8, 2015 to January 11, 2019||269
5038986|NCT02031458|12399915|P1|STARTED|May 8, 2015 to January 11, 2019||138
5038987|NCT02031432|12400009|P1|NOT COMPLETED|Overall Study||38
5038988|NCT02031432|12400009|P1|COMPLETED|Overall Study||38
5038989|NCT02031432|12400009|P1|Completing the Treatment|Overall Study||39
5038990|NCT02031432|12400009|P1|Completing the Titration Phase|Overall Study||67
5038991|NCT02031432|12400009|P1|STARTED|Overall Study||76
5038992|NCT02031302|12400036|P2|NOT COMPLETED|Overall Study||0
5038993|NCT02031302|12400037|P1|NOT COMPLETED|Overall Study||164
5038994|NCT02031302|12400036|P2|COMPLETED|Overall Study||50
5038995|NCT02031302|12400037|P1|COMPLETED|Overall Study||850
5038996|NCT02031302|12400036|P2|STARTED|Overall Study||50
5038997|NCT02031302|12400037|P1|STARTED|Overall Study||1014
5038998|NCT02031276|12400058|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
5038999|NCT02031276|12400059|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
5039000|NCT02031276|12400060|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
5039001|NCT02031276|12400058|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
5039002|NCT02031276|12400059|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
5039003|NCT02031276|12400060|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
5039004|NCT02031276|12400058|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
5039005|NCT02031276|12400059|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
5039006|NCT02031276|12400060|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
5039007|NCT02031276|12400058|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
5039008|NCT02031276|12400059|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
5039009|NCT02031276|12400060|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
5039010|NCT02031276|12400058|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
5039011|NCT02031276|12400059|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
5039012|NCT02031276|12400060|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
5039013|NCT02031276|12400058|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
5039014|NCT02031276|12400059|P2|STARTED|Period 2 Open-label Risankizumab IV||35
5039015|NCT02031276|12400060|P1|STARTED|Period 2 Open-label Risankizumab IV||33
5039016|NCT02031276|12400058|P3|NOT COMPLETED|Period 1 Double-blind IV||1
5039017|NCT02031276|12400059|P2|NOT COMPLETED|Period 1 Double-blind IV||6
5039018|NCT02031276|12400060|P1|NOT COMPLETED|Period 1 Double-blind IV||6
5039019|NCT02031276|12400058|P3|COMPLETED|Period 1 Double-blind IV||40
5039020|NCT02031276|12400059|P2|COMPLETED|Period 1 Double-blind IV||35
5039021|NCT02031276|12400060|P1|COMPLETED|Period 1 Double-blind IV||33
5039022|NCT02031276|12400058|P3|STARTED|Period 1 Double-blind IV||41
5039023|NCT02031276|12400059|P2|STARTED|Period 1 Double-blind IV||41
5039024|NCT02031276|12400060|P1|STARTED|Period 1 Double-blind IV||39
5039025|NCT02031237|12400094|P3|NOT COMPLETED|Overall Study||3
5039026|NCT02031237|12400095|P2|NOT COMPLETED|Overall Study||14
5039027|NCT02031237|12400096|P1|NOT COMPLETED|Overall Study||5
5039028|NCT02031237|12400094|P3|COMPLETED|Overall Study||0
5039029|NCT02031237|12400095|P2|COMPLETED|Overall Study||21
5039030|NCT02031237|12400096|P1|COMPLETED|Overall Study||9
5039031|NCT02031237|12400094|P3|STARTED|Overall Study||3
5039032|NCT02031237|12400095|P2|STARTED|Overall Study||35
5039033|NCT02031237|12400096|P1|STARTED|Overall Study||14
5039034|NCT02030847|12400103|P1|NOT COMPLETED|Overall Study||37
5039035|NCT02030847|12400103|P1|COMPLETED|Overall Study||5
5039036|NCT02030847|12400103|P1|STARTED|Overall Study||42
5039037|NCT02030821|12400112|P4|NOT COMPLETED|Overall Study||2
5039038|NCT02030821|12400113|P3|NOT COMPLETED|Overall Study||5
5039039|NCT02030821|12400114|P2|NOT COMPLETED|Overall Study||2
5039040|NCT02030821|12400115|P1|NOT COMPLETED|Overall Study||2
5039041|NCT02030821|12400112|P4|COMPLETED|Overall Study||72
5039042|NCT02030821|12400113|P3|COMPLETED|Overall Study||73
5039043|NCT02030821|12400114|P2|COMPLETED|Overall Study||44
5039044|NCT02030821|12400115|P1|COMPLETED|Overall Study||46
5039045|NCT02030821|12400112|P4|STARTED|Overall Study||74
5039046|NCT02030821|12400113|P3|STARTED|Overall Study||78
5039047|NCT02030821|12400114|P2|STARTED|Overall Study||46
5039048|NCT02030821|12400115|P1|STARTED|Overall Study||48
5039049|NCT02030600|12400143|P2|NOT COMPLETED|Treatment Period 2||18
5039050|NCT02030600|12400144|P1|NOT COMPLETED|Treatment Period 2||25
5039051|NCT02030600|12400143|P2|COMPLETED|Treatment Period 2||297
5039052|NCT02030600|12400144|P1|COMPLETED|Treatment Period 2||283
5039053|NCT02030600|12400143|P2|STARTED|Treatment Period 2||315
5039054|NCT02030600|12400144|P1|STARTED|Treatment Period 2||308
5039055|NCT02030600|12400143|P2|NOT COMPLETED|Treatment Period 1||45
5039056|NCT02030600|12400144|P1|NOT COMPLETED|Treatment Period 1||53
5039057|NCT02030600|12400143|P2|COMPLETED|Treatment Period 1||315
5039058|NCT02030600|12400144|P1|COMPLETED|Treatment Period 1||308
5039059|NCT02030600|12400143|P2|Exposed|Treatment Period 1||357
5039060|NCT02030600|12400144|P1|Exposed|Treatment Period 1||356
5039061|NCT02030600|12400143|P2|STARTED|Treatment Period 1||360
5039062|NCT02030600|12400144|P1|STARTED|Treatment Period 1||361
5039063|NCT02030574|12400160|P1|NOT COMPLETED|Overall Study||0
5039064|NCT02030574|12400160|P1|COMPLETED|Overall Study||2
5039065|NCT02030574|12400160|P1|STARTED|Overall Study||2
5039066|NCT02030535|12400165|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5039067|NCT02030535|12400165|P1|COMPLETED|Treatment Period 3 (1 Day)||52
5039068|NCT02030535|12400165|P1|STARTED|Treatment Period 3 (1 Day)||52
5039069|NCT02030535|12400165|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
5039070|NCT02030535|12400165|P1|COMPLETED|Washout Period 2 (21 Days)||52
5039071|NCT02030535|12400165|P1|STARTED|Washout Period 2 (21 Days)||52
5039072|NCT02030535|12400165|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5039073|NCT02030535|12400165|P1|COMPLETED|Treatment Period 2 (1 Day)||52
5039074|NCT02030535|12400165|P1|STARTED|Treatment Period 2 (1 Day)||52
5039075|NCT02030535|12400165|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
5039076|NCT02030535|12400165|P1|COMPLETED|Washout Period 1 (21 Days)||52
5039077|NCT02030535|12400165|P1|STARTED|Washout Period 1 (21 Days)||53
5039078|NCT02030535|12400165|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5039079|NCT02030535|12400165|P1|COMPLETED|Treatment Period 1 (1 Day)||53
5039080|NCT02030535|12400165|P1|STARTED|Treatment Period 1 (1 Day)||53
5039081|NCT02030405|12400233|P1|NOT COMPLETED|Overall Study||2
5039082|NCT02030405|12400233|P1|COMPLETED|Overall Study||2
5039083|NCT02030405|12400233|P1|STARTED|Overall Study||4
5039084|NCT02030119|12400244|P4|NOT COMPLETED|Overall Study||3
5039085|NCT02030119|12400245|P3|NOT COMPLETED|Overall Study||6
5039086|NCT02030119|12400246|P2|NOT COMPLETED|Overall Study||2
5039087|NCT02030119|12400247|P1|NOT COMPLETED|Overall Study||3
5039088|NCT02030119|12400244|P4|COMPLETED|Overall Study||67
5039089|NCT02030119|12400245|P3|COMPLETED|Overall Study||65
5039090|NCT02030119|12400246|P2|COMPLETED|Overall Study||68
5039091|NCT02030119|12400247|P1|COMPLETED|Overall Study||67
5039092|NCT02030119|12400244|P4|STARTED|Overall Study||70
5039093|NCT02030119|12400245|P3|STARTED|Overall Study||71
5039094|NCT02030119|12400246|P2|STARTED|Overall Study||70
5039095|NCT02030119|12400247|P1|STARTED|Overall Study||70
5039096|NCT02030080|12400265|P4|NOT COMPLETED|Overall Study||2
5039097|NCT02030080|12400266|P3|NOT COMPLETED|Overall Study||0
5039098|NCT02030080|12400267|P2|NOT COMPLETED|Overall Study||0
5039099|NCT02030080|12400268|P1|NOT COMPLETED|Overall Study||0
5039100|NCT02030080|12400265|P4|COMPLETED|Overall Study||42
5039101|NCT02030080|12400266|P3|COMPLETED|Overall Study||80
5039102|NCT02030080|12400267|P2|COMPLETED|Overall Study||64
5039103|NCT02030080|12400268|P1|COMPLETED|Overall Study||100
5039104|NCT02030080|12400265|P4|STARTED|Overall Study|11 teams|44
5039105|NCT02030080|12400266|P3|STARTED|Overall Study|20 teams|80
5039106|NCT02030080|12400267|P2|STARTED|Overall Study|16 teams|64
5039107|NCT02030080|12400268|P1|STARTED|Overall Study|25 teams|100
5039108|NCT02030041|12400285|P3|NOT COMPLETED|Overall Study||1
5039109|NCT02030041|12400286|P2|NOT COMPLETED|Overall Study||2
5039110|NCT02030041|12400287|P1|NOT COMPLETED|Overall Study||2
5039111|NCT02030041|12400285|P3|COMPLETED|Overall Study||10
5039112|NCT02030041|12400286|P2|COMPLETED|Overall Study||9
5039113|NCT02030041|12400287|P1|COMPLETED|Overall Study||9
5039114|NCT02030041|12400285|P3|STARTED|Overall Study||11
5039115|NCT02030041|12400286|P2|STARTED|Overall Study||11
5039116|NCT02030041|12400287|P1|STARTED|Overall Study||11
5039117|NCT02029989|12400300|P2|NOT COMPLETED|Overall Study||11
5039118|NCT02029989|12400301|P1|NOT COMPLETED|Overall Study||16
5039119|NCT02029989|12400300|P2|COMPLETED|Overall Study||49
5039120|NCT02029989|12400301|P1|COMPLETED|Overall Study||45
5039121|NCT02029989|12400300|P2|STARTED|Overall Study||60
5039122|NCT02029989|12400301|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
5039123|NCT02029976|12400309|P2|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
5039124|NCT02029976|12400310|P1|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
5039125|NCT02029976|12400309|P2|COMPLETED|YR-2 Follow Up vs Baseline||124
5039126|NCT02029976|12400310|P1|COMPLETED|YR-2 Follow Up vs Baseline||122
5039127|NCT02029976|12400309|P2|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
5039128|NCT02029976|12400310|P1|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
5039129|NCT02029976|12400309|P2|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
5039130|NCT02029976|12400310|P1|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
5039131|NCT02029976|12400309|P2|COMPLETED|YR-1 Post Intervention vs Baseline||124
5039132|NCT02029976|12400310|P1|COMPLETED|YR-1 Post Intervention vs Baseline||120
5039133|NCT02029976|12400309|P2|STARTED|YR-1 Post Intervention vs Baseline||132
5039134|NCT02029976|12400310|P1|STARTED|YR-1 Post Intervention vs Baseline||132
5039135|NCT02029911|12400322|P1|NOT COMPLETED|Overall Study||0
5039136|NCT02029911|12400322|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
5039137|NCT02029911|12400322|P1|Treated|Overall Study|Treatment Completed|60
5039138|NCT02029911|12400322|P1|STARTED|Overall Study|Treatment Attempted|60
5039139|NCT02029872|12400330|P2|NOT COMPLETED|Overall Study||3
5039140|NCT02029872|12400331|P1|NOT COMPLETED|Overall Study||2
5039141|NCT02029872|12400330|P2|COMPLETED|Overall Study||6
5039142|NCT02029872|12400331|P1|COMPLETED|Overall Study||7
5039143|NCT02029872|12400330|P2|STARTED|Overall Study||9
5039144|NCT02029872|12400331|P1|STARTED|Overall Study||9
5039145|NCT02029846|12400339|P2|NOT COMPLETED|Overall Study||1
5039146|NCT02029846|12400340|P1|NOT COMPLETED|Overall Study||1
5039147|NCT02029846|12400339|P2|COMPLETED|Overall Study||0
5039148|NCT02029846|12400340|P1|COMPLETED|Overall Study||0
5039149|NCT02029846|12400339|P2|STARTED|Overall Study||1
5039150|NCT02029846|12400340|P1|STARTED|Overall Study||1
5039151|NCT02029755|12400353|P3|NOT COMPLETED|Overall Study||0
5039152|NCT02029755|12400354|P2|NOT COMPLETED|Overall Study||0
5039153|NCT02029755|12400355|P1|NOT COMPLETED|Overall Study||0
5039154|NCT02029755|12400353|P3|COMPLETED|Overall Study||36
5039155|NCT02029755|12400354|P2|COMPLETED|Overall Study||36
5039156|NCT02029755|12400355|P1|COMPLETED|Overall Study||36
5039157|NCT02029755|12400353|P3|STARTED|Overall Study||36
5039158|NCT02029755|12400354|P2|STARTED|Overall Study||36
5039159|NCT02029755|12400355|P1|STARTED|Overall Study||36
5039160|NCT02029703|12400368|P2|NOT COMPLETED|Overall Study||0
5039161|NCT02029703|12400369|P1|NOT COMPLETED|Overall Study||0
5039162|NCT02029703|12400368|P2|COMPLETED|Overall Study||22
5039163|NCT02029703|12400369|P1|COMPLETED|Overall Study||20
5039164|NCT02029703|12400368|P2|STARTED|Overall Study||22
5039165|NCT02029703|12400369|P1|STARTED|Overall Study||20
5039166|NCT02029638|12400378|P3|NOT COMPLETED|Overall Study||1
5039167|NCT02029638|12400379|P2|NOT COMPLETED|Overall Study||0
5039168|NCT02029638|12400380|P1|NOT COMPLETED|Overall Study||2
5039169|NCT02029638|12400378|P3|COMPLETED|Overall Study||0
5039170|NCT02029638|12400379|P2|COMPLETED|Overall Study||1
5039171|NCT02029638|12400380|P1|COMPLETED|Overall Study||0
5039172|NCT02029638|12400378|P3|STARTED|Overall Study||1
5039173|NCT02029638|12400379|P2|STARTED|Overall Study||1
5039174|NCT02029638|12400380|P1|STARTED|Overall Study||2
5039175|NCT02029521|12400409|P2|NOT COMPLETED|Overall Study||1
5039176|NCT02029521|12400410|P1|NOT COMPLETED|Overall Study||2
5039177|NCT02029521|12400409|P2|COMPLETED|Overall Study||22
5039178|NCT02029521|12400410|P1|COMPLETED|Overall Study||22
5039179|NCT02029521|12400409|P2|STARTED|Overall Study||23
5039180|NCT02029521|12400410|P1|STARTED|Overall Study||24
5039181|NCT02029495|12400495|P3|NOT COMPLETED|Overall Study||2
5039182|NCT02029495|12400496|P2|NOT COMPLETED|Overall Study||0
5039183|NCT02029495|12400497|P1|NOT COMPLETED|Overall Study||1
5039184|NCT02029495|12400495|P3|COMPLETED|Overall Study||159
5039185|NCT02029495|12400496|P2|COMPLETED|Overall Study||158
5039186|NCT02029495|12400497|P1|COMPLETED|Overall Study||158
5039187|NCT02029495|12400495|P3|STARTED|Overall Study||161
5039188|NCT02029495|12400496|P2|STARTED|Overall Study||158
5039189|NCT02029495|12400497|P1|STARTED|Overall Study||159
5039190|NCT02029417|12400508|P1|NOT COMPLETED|Overall Study||2
5039191|NCT02029417|12400508|P1|COMPLETED|Overall Study||0
5039192|NCT02029417|12400508|P1|STARTED|Overall Study||2
5039193|NCT02029274|12400517|P4|NOT COMPLETED|Overall Study||2
5039194|NCT02029274|12400518|P3|NOT COMPLETED|Overall Study||2
5039195|NCT02029274|12400519|P2|NOT COMPLETED|Overall Study||0
5039196|NCT02029274|12400520|P1|NOT COMPLETED|Overall Study||1
5039197|NCT02029274|12400517|P4|COMPLETED|Overall Study||2
5039198|NCT02029274|12400518|P3|COMPLETED|Overall Study||2
5039199|NCT02029274|12400519|P2|COMPLETED|Overall Study||4
5039200|NCT02029274|12400520|P1|COMPLETED|Overall Study||4
5039201|NCT02029274|12400517|P4|Fixed Dose Period 2|Overall Study||4
5039202|NCT02029274|12400518|P3|Fixed Dose Period 2|Overall Study||4
5039203|NCT02029274|12400519|P2|Fixed Dose Period 2|Overall Study||4
5039204|NCT02029274|12400520|P1|Fixed Dose Period 2|Overall Study||5
5039205|NCT02029274|12400517|P4|STARTED|Overall Study||4
5039206|NCT02029274|12400518|P3|STARTED|Overall Study||4
5039207|NCT02029274|12400519|P2|STARTED|Overall Study||4
5039208|NCT02029274|12400520|P1|STARTED|Overall Study||5
5039209|NCT02029235|12400552|P2|NOT COMPLETED|Overall Study||1
5039210|NCT02029235|12400553|P1|NOT COMPLETED|Overall Study||4
5039211|NCT02029235|12400552|P2|COMPLETED|Overall Study||30
5039212|NCT02029235|12400553|P1|COMPLETED|Overall Study||30
5039213|NCT02029235|12400552|P2|STARTED|Overall Study||31
5039214|NCT02029235|12400553|P1|STARTED|Overall Study||34
5039215|NCT02029196|12400563|P2|NOT COMPLETED|Overall Study||1
5039216|NCT02029196|12400564|P1|NOT COMPLETED|Overall Study||20
5039217|NCT02029196|12400563|P2|COMPLETED|Overall Study||101
5039218|NCT02029196|12400564|P1|COMPLETED|Overall Study||286
5039219|NCT02029196|12400563|P2|STARTED|Overall Study||102
5039220|NCT02029196|12400564|P1|STARTED|Overall Study||306
5039221|NCT02029040|12400574|P2|NOT COMPLETED|Overall Study||0
5039222|NCT02029040|12400575|P1|NOT COMPLETED|Overall Study||0
5039223|NCT02029040|12400574|P2|COMPLETED|Overall Study||25
5039224|NCT02029040|12400575|P1|COMPLETED|Overall Study||27
5039225|NCT02029040|12400574|P2|STARTED|Overall Study||25
5039226|NCT02029040|12400575|P1|STARTED|Overall Study||27
5039227|NCT02028871|12400585|P2|NOT COMPLETED|Overall Study||3
5039228|NCT02028871|12400586|P1|NOT COMPLETED|Overall Study||4
5039229|NCT02028871|12400585|P2|COMPLETED|Overall Study||9
5039230|NCT02028871|12400586|P1|COMPLETED|Overall Study||10
5039231|NCT02028871|12400585|P2|STARTED|Overall Study||12
5039232|NCT02028871|12400586|P1|STARTED|Overall Study||14
5039233|NCT02028780|12400607|P12|NOT COMPLETED|Follow up Phase||0
5039234|NCT02028780|12400608|P11|NOT COMPLETED|Follow up Phase||0
5039235|NCT02028780|12400609|P10|NOT COMPLETED|Follow up Phase||0
5039236|NCT02028780|12400610|P9|NOT COMPLETED|Follow up Phase||0
5039237|NCT02028780|12400611|P8|NOT COMPLETED|Follow up Phase||0
5039238|NCT02028780|12400612|P7|NOT COMPLETED|Follow up Phase||0
5039239|NCT02028780|12400613|P6|NOT COMPLETED|Follow up Phase||0
5039240|NCT02028780|12400614|P5|NOT COMPLETED|Follow up Phase||0
5039241|NCT02028780|12400615|P4|NOT COMPLETED|Follow up Phase||0
5039242|NCT02028780|12400616|P3|NOT COMPLETED|Follow up Phase||0
5039243|NCT02028780|12400617|P2|NOT COMPLETED|Follow up Phase||0
5039244|NCT02028780|12400618|P1|NOT COMPLETED|Follow up Phase||0
5039245|NCT02028780|12400607|P12|COMPLETED|Follow up Phase||9
5039246|NCT02028780|12400608|P11|COMPLETED|Follow up Phase||9
5039247|NCT02028780|12400609|P10|COMPLETED|Follow up Phase||9
5039248|NCT02028780|12400610|P9|COMPLETED|Follow up Phase||9
5039249|NCT02028780|12400611|P8|COMPLETED|Follow up Phase||3
5039250|NCT02028780|12400612|P7|COMPLETED|Follow up Phase||9
5039251|NCT02028780|12400613|P6|COMPLETED|Follow up Phase||6
5039252|NCT02028780|12400614|P5|COMPLETED|Follow up Phase||6
5039253|NCT02028780|12400615|P4|COMPLETED|Follow up Phase||6
5039254|NCT02028780|12400616|P3|COMPLETED|Follow up Phase||6
5039255|NCT02028780|12400617|P2|COMPLETED|Follow up Phase||2
5039256|NCT02028780|12400618|P1|COMPLETED|Follow up Phase||6
5039257|NCT02028780|12400607|P12|STARTED|Follow up Phase||9
5039258|NCT02028780|12400608|P11|STARTED|Follow up Phase||9
5039259|NCT02028780|12400609|P10|STARTED|Follow up Phase||9
5039260|NCT02028780|12400610|P9|STARTED|Follow up Phase||9
5039261|NCT02028780|12400611|P8|STARTED|Follow up Phase||3
5039262|NCT02028780|12400612|P7|STARTED|Follow up Phase||9
5039263|NCT02028780|12400613|P6|STARTED|Follow up Phase||6
5039264|NCT02028780|12400614|P5|STARTED|Follow up Phase||6
5039265|NCT02028780|12400615|P4|STARTED|Follow up Phase||6
5039266|NCT02028780|12400616|P3|STARTED|Follow up Phase||6
5039267|NCT02028780|12400617|P2|STARTED|Follow up Phase||2
5039268|NCT02028780|12400618|P1|STARTED|Follow up Phase||6
5039269|NCT02028780|12400607|P12|NOT COMPLETED|Observation Phase||0
5039270|NCT02028780|12400608|P11|NOT COMPLETED|Observation Phase||0
5039271|NCT02028780|12400609|P10|NOT COMPLETED|Observation Phase||0
5039272|NCT02028780|12400610|P9|NOT COMPLETED|Observation Phase||0
5039273|NCT02028780|12400611|P8|NOT COMPLETED|Observation Phase||0
5039274|NCT02028780|12400612|P7|NOT COMPLETED|Observation Phase||0
5039275|NCT02028780|12400613|P6|NOT COMPLETED|Observation Phase||0
5039276|NCT02028780|12400614|P5|NOT COMPLETED|Observation Phase||0
5039277|NCT02028780|12400615|P4|NOT COMPLETED|Observation Phase||0
5039278|NCT02028780|12400616|P3|NOT COMPLETED|Observation Phase||0
5039279|NCT02028780|12400617|P2|NOT COMPLETED|Observation Phase||0
5039280|NCT02028780|12400618|P1|NOT COMPLETED|Observation Phase||0
5039281|NCT02028780|12400607|P12|COMPLETED|Observation Phase||9
5039282|NCT02028780|12400608|P11|COMPLETED|Observation Phase||9
5039283|NCT02028780|12400609|P10|COMPLETED|Observation Phase||9
5039284|NCT02028780|12400610|P9|COMPLETED|Observation Phase||9
5039285|NCT02028780|12400611|P8|COMPLETED|Observation Phase||3
5039286|NCT02028780|12400612|P7|COMPLETED|Observation Phase||9
5039287|NCT02028780|12400613|P6|COMPLETED|Observation Phase||6
5039288|NCT02028780|12400614|P5|COMPLETED|Observation Phase||6
5039289|NCT02028780|12400615|P4|COMPLETED|Observation Phase||6
5039290|NCT02028780|12400616|P3|COMPLETED|Observation Phase||6
5039291|NCT02028780|12400617|P2|COMPLETED|Observation Phase||2
5039292|NCT02028780|12400618|P1|COMPLETED|Observation Phase||6
5039293|NCT02028780|12400607|P12|STARTED|Observation Phase||9
5039294|NCT02028780|12400608|P11|STARTED|Observation Phase||9
5039295|NCT02028780|12400609|P10|STARTED|Observation Phase||9
5039296|NCT02028780|12400610|P9|STARTED|Observation Phase||9
5039297|NCT02028780|12400611|P8|STARTED|Observation Phase||3
5039298|NCT02028780|12400612|P7|STARTED|Observation Phase||9
5039299|NCT02028780|12400613|P6|STARTED|Observation Phase||6
5039300|NCT02028780|12400614|P5|STARTED|Observation Phase||6
5039301|NCT02028780|12400615|P4|STARTED|Observation Phase||6
5039302|NCT02028780|12400616|P3|STARTED|Observation Phase||6
5039303|NCT02028780|12400617|P2|STARTED|Observation Phase||2
5039304|NCT02028780|12400618|P1|STARTED|Observation Phase||6
5039305|NCT02028767|12400683|P2|NOT COMPLETED|Treatment Period 2||0
5039306|NCT02028767|12400684|P1|NOT COMPLETED|Treatment Period 2||2
5039307|NCT02028767|12400683|P2|COMPLETED|Treatment Period 2||16
5039308|NCT02028767|12400684|P1|COMPLETED|Treatment Period 2||14
5039309|NCT02028767|12400683|P2|STARTED|Treatment Period 2||16
5039310|NCT02028767|12400684|P1|STARTED|Treatment Period 2||16
5039311|NCT02028767|12400683|P2|NOT COMPLETED|Treatment Period 1||0
5039312|NCT02028767|12400684|P1|NOT COMPLETED|Treatment Period 1||0
5039313|NCT02028767|12400683|P2|COMPLETED|Treatment Period 1||16
5039314|NCT02028767|12400684|P1|COMPLETED|Treatment Period 1||16
5039315|NCT02028767|12400683|P2|STARTED|Treatment Period 1||16
5039316|NCT02028767|12400684|P1|STARTED|Treatment Period 1||16
5039317|NCT02028754|12400696|P2|NOT COMPLETED|Overall Study||8
5039318|NCT02028754|12400697|P1|NOT COMPLETED|Overall Study||7
5039319|NCT02028754|12400696|P2|COMPLETED|Overall Study||82
5039320|NCT02028754|12400697|P1|COMPLETED|Overall Study||83
5039321|NCT02028754|12400696|P2|STARTED|Overall Study||90
5039322|NCT02028754|12400697|P1|STARTED|Overall Study||90
5039323|NCT02028715|12400717|P2|NOT COMPLETED|Overall Study||4
5039324|NCT02028715|12400718|P1|NOT COMPLETED|Overall Study||5
5039325|NCT02028715|12400717|P2|COMPLETED|Overall Study||30
5039326|NCT02028715|12400718|P1|COMPLETED|Overall Study||29
5039327|NCT02028715|12400717|P2|STARTED|Overall Study||34
5039328|NCT02028715|12400718|P1|STARTED|Overall Study||34
5039329|NCT02028676|12400745|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039330|NCT02028676|12400746|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039331|NCT02028676|12400747|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039332|NCT02028676|12400748|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039333|NCT02028676|12400749|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039334|NCT02028676|12400750|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039335|NCT02028676|12400751|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039336|NCT02028676|12400752|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039337|NCT02028676|12400753|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039338|NCT02028676|12400745|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
5039339|NCT02028676|12400746|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
5039340|NCT02028676|12400747|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039341|NCT02028676|12400748|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039342|NCT02028676|12400749|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039343|NCT02028676|12400750|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039344|NCT02028676|12400751|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039345|NCT02028676|12400752|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039346|NCT02028676|12400753|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
5039347|NCT02028676|12400745|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
5039348|NCT02028676|12400746|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
5039349|NCT02028676|12400747|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
5039350|NCT02028676|12400748|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
5039351|NCT02028676|12400749|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
5039352|NCT02028676|12400750|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
5039353|NCT02028676|12400751|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
5039354|NCT02028676|12400752|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
5039355|NCT02028676|12400753|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
5039356|NCT02028676|12400745|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039357|NCT02028676|12400746|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039358|NCT02028676|12400747|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039359|NCT02028676|12400748|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039360|NCT02028676|12400749|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039361|NCT02028676|12400750|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039362|NCT02028676|12400751|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039363|NCT02028676|12400752|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039364|NCT02028676|12400753|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039365|NCT02028676|12400745|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039366|NCT02028676|12400746|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039367|NCT02028676|12400747|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
5039368|NCT02028676|12400748|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
5039369|NCT02028676|12400749|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039370|NCT02028676|12400750|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039371|NCT02028676|12400751|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039372|NCT02028676|12400752|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039373|NCT02028676|12400753|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
5039374|NCT02028676|12400745|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039375|NCT02028676|12400746|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039376|NCT02028676|12400747|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
5039377|NCT02028676|12400748|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
5039378|NCT02028676|12400749|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039379|NCT02028676|12400750|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039380|NCT02028676|12400751|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039381|NCT02028676|12400752|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039382|NCT02028676|12400753|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
5039383|NCT02028676|12400745|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039384|NCT02028676|12400746|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039385|NCT02028676|12400747|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039386|NCT02028676|12400748|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039387|NCT02028676|12400749|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039388|NCT02028676|12400750|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039389|NCT02028676|12400751|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039390|NCT02028676|12400752|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039391|NCT02028676|12400753|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
5039392|NCT02028676|12400745|P9|COMPLETED|Initial Enrolment: Induction ART||0
5039393|NCT02028676|12400746|P8|COMPLETED|Initial Enrolment: Induction ART||0
5039394|NCT02028676|12400747|P7|COMPLETED|Initial Enrolment: Induction ART||0
5039395|NCT02028676|12400748|P6|COMPLETED|Initial Enrolment: Induction ART||0
5039396|NCT02028676|12400749|P5|COMPLETED|Initial Enrolment: Induction ART||405
5039397|NCT02028676|12400750|P4|COMPLETED|Initial Enrolment: Induction ART||404
5039398|NCT02028676|12400751|P3|COMPLETED|Initial Enrolment: Induction ART||397
5039399|NCT02028676|12400752|P2|COMPLETED|Initial Enrolment: Induction ART||0
5039400|NCT02028676|12400753|P1|COMPLETED|Initial Enrolment: Induction ART||0
5039401|NCT02028676|12400745|P9|STARTED|Initial Enrolment: Induction ART||0
5039402|NCT02028676|12400746|P8|STARTED|Initial Enrolment: Induction ART||0
5039403|NCT02028676|12400747|P7|STARTED|Initial Enrolment: Induction ART||0
5039404|NCT02028676|12400748|P6|STARTED|Initial Enrolment: Induction ART||0
5039405|NCT02028676|12400749|P5|STARTED|Initial Enrolment: Induction ART||405
5039406|NCT02028676|12400750|P4|STARTED|Initial Enrolment: Induction ART||404
5039407|NCT02028676|12400751|P3|STARTED|Initial Enrolment: Induction ART||397
5039408|NCT02028676|12400752|P2|STARTED|Initial Enrolment: Induction ART||0
5039409|NCT02028676|12400753|P1|STARTED|Initial Enrolment: Induction ART||0
5039410|NCT02028676|12400745|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039411|NCT02028676|12400746|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039412|NCT02028676|12400747|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039413|NCT02028676|12400748|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039414|NCT02028676|12400749|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039415|NCT02028676|12400750|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039416|NCT02028676|12400751|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039417|NCT02028676|12400752|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039418|NCT02028676|12400753|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
5039419|NCT02028676|12400745|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039420|NCT02028676|12400746|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039421|NCT02028676|12400747|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039422|NCT02028676|12400748|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039423|NCT02028676|12400749|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039424|NCT02028676|12400750|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039425|NCT02028676|12400751|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
5039426|NCT02028676|12400752|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
5039427|NCT02028676|12400753|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
5039428|NCT02028676|12400745|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
5039429|NCT02028676|12400746|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
5039430|NCT02028676|12400747|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
5039431|NCT02028676|12400748|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
5039432|NCT02028676|12400749|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
5039433|NCT02028676|12400750|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
5039434|NCT02028676|12400751|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
5039435|NCT02028676|12400752|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
5039436|NCT02028676|12400753|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
5039437|NCT02028325|12400926|P1|NOT COMPLETED|Overall Study||10
5039438|NCT02028325|12400926|P1|COMPLETED|Overall Study||126
5039439|NCT02028325|12400926|P1|STARTED|Overall Study||136
5039440|NCT02028169|12400930|P1|NOT COMPLETED|Overall Study||28
5039441|NCT02028169|12400930|P1|COMPLETED|Overall Study||92
5039442|NCT02028169|12400930|P1|STARTED|Overall Study||120
5039443|NCT02028065|12400956|P3|NOT COMPLETED|Treatment Through Study Completion||14
5039444|NCT02028065|12400957|P2|NOT COMPLETED|Treatment Through Study Completion||15
5039445|NCT02028065|12400958|P1|NOT COMPLETED|Treatment Through Study Completion||12
5039446|NCT02028065|12400956|P3|COMPLETED|Treatment Through Study Completion||134
5039447|NCT02028065|12400957|P2|COMPLETED|Treatment Through Study Completion||136
5039448|NCT02028065|12400958|P1|COMPLETED|Treatment Through Study Completion||64
5039449|NCT02028065|12400956|P3|Received Third Dose|Treatment Through Study Completion||134
5039450|NCT02028065|12400957|P2|Received Third Dose|Treatment Through Study Completion||136
5039451|NCT02028065|12400958|P1|Received Third Dose|Treatment Through Study Completion||64
5039452|NCT02028065|12400956|P3|Received Second Dose|Treatment Through Study Completion||138
5039453|NCT02028065|12400957|P2|Received Second Dose|Treatment Through Study Completion||140
5039454|NCT02028065|12400958|P1|Received Second Dose|Treatment Through Study Completion||69
5039455|NCT02028065|12400956|P3|Received First Dose|Treatment Through Study Completion||148
5039456|NCT02028065|12400957|P2|Received First Dose|Treatment Through Study Completion||151
5039457|NCT02028065|12400958|P1|Received First Dose|Treatment Through Study Completion||76
5039458|NCT02028065|12400956|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
5039459|NCT02028065|12400957|P2|STARTED|Treatment Through Study Completion||151
5039460|NCT02028065|12400958|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
5039461|NCT02028065|12400956|P3|NOT COMPLETED|Randomization Through Start Treatment||3
5039462|NCT02028065|12400957|P2|NOT COMPLETED|Randomization Through Start Treatment||3
5039463|NCT02028065|12400958|P1|NOT COMPLETED|Randomization Through Start Treatment||1
5039464|NCT02028065|12400956|P3|COMPLETED|Randomization Through Start Treatment||149
5039465|NCT02028065|12400957|P2|COMPLETED|Randomization Through Start Treatment||151
5039466|NCT02028065|12400958|P1|COMPLETED|Randomization Through Start Treatment||75
5039467|NCT02028065|12400956|P3|STARTED|Randomization Through Start Treatment|Randomized|152
5039468|NCT02028065|12400957|P2|STARTED|Randomization Through Start Treatment|Randomized|154
5039469|NCT02028065|12400958|P1|STARTED|Randomization Through Start Treatment|Randomized|76
5039470|NCT02027883|12400971|P2|NOT COMPLETED|Overall Study||0
5039471|NCT02027883|12400972|P1|NOT COMPLETED|Overall Study||0
5039472|NCT02027883|12400971|P2|COMPLETED|Overall Study||50
5039473|NCT02027883|12400972|P1|COMPLETED|Overall Study||50
5039474|NCT02027883|12400971|P2|STARTED|Overall Study||50
5039475|NCT02027883|12400972|P1|STARTED|Overall Study||50
5039476|NCT02027844|12400985|P3|NOT COMPLETED|Overall Study||2
5039477|NCT02027844|12400986|P2|NOT COMPLETED|Overall Study||6
5039478|NCT02027844|12400987|P1|NOT COMPLETED|Overall Study||5
5039479|NCT02027844|12400985|P3|COMPLETED|Overall Study||37
5039480|NCT02027844|12400986|P2|COMPLETED|Overall Study||33
5039481|NCT02027844|12400987|P1|COMPLETED|Overall Study||34
5039482|NCT02027844|12400985|P3|STARTED|Overall Study||39
5039483|NCT02027844|12400986|P2|STARTED|Overall Study||39
5039484|NCT02027844|12400987|P1|STARTED|Overall Study||39
5039485|NCT02027701|12401004|P1|NOT COMPLETED|Overall Study||16
5039486|NCT02027701|12401004|P1|COMPLETED|Overall Study||66
5039487|NCT02027701|12401004|P1|STARTED|Overall Study||82
5039488|NCT02027623|12401022|P2|NOT COMPLETED|Overall Study||12
5039489|NCT02027623|12401023|P1|NOT COMPLETED|Overall Study||9
5039490|NCT02027623|12401022|P2|COMPLETED|Overall Study||65
5039491|NCT02027623|12401023|P1|COMPLETED|Overall Study||68
5039492|NCT02027623|12401022|P2|STARTED|Overall Study||77
5039493|NCT02027623|12401023|P1|STARTED|Overall Study||77
5039494|NCT02027558|12401115|P2|NOT COMPLETED|Overall Study||2
5039495|NCT02027558|12401116|P1|NOT COMPLETED|Overall Study||9
5039496|NCT02027558|12401115|P2|COMPLETED|Overall Study||61
5039497|NCT02027558|12401116|P1|COMPLETED|Overall Study||53
5039498|NCT02027558|12401115|P2|6-month Follow-up|Overall Study||61
5039499|NCT02027558|12401116|P1|6-month Follow-up|Overall Study||53
5039500|NCT02027558|12401115|P2|3-month Follow-up|Overall Study||58
5039501|NCT02027558|12401116|P1|3-month Follow-up|Overall Study||53
5039502|NCT02027558|12401115|P2|Post-treatment|Overall Study||60
5039503|NCT02027558|12401116|P1|Post-treatment|Overall Study||49
5039504|NCT02027558|12401115|P2|STARTED|Overall Study||63
5039505|NCT02027558|12401116|P1|STARTED|Overall Study||62
5039506|NCT02027545|12401134|P2|NOT COMPLETED|Overall Study||2
5039507|NCT02027545|12401135|P1|NOT COMPLETED|Overall Study||2
5039508|NCT02027545|12401134|P2|COMPLETED|Overall Study||173
5039509|NCT02027545|12401135|P1|COMPLETED|Overall Study||259
5039510|NCT02027545|12401134|P2|STARTED|Overall Study||175
5039511|NCT02027545|12401135|P1|STARTED|Overall Study||261
5039512|NCT02027428|12401147|P3|NOT COMPLETED|Survival Follow-up||30
5039513|NCT02027428|12401148|P2|NOT COMPLETED|Survival Follow-up||48
5039514|NCT02027428|12401149|P1|NOT COMPLETED|Survival Follow-up||0
5039515|NCT02027428|12401147|P3|COMPLETED|Survival Follow-up||19
5039516|NCT02027428|12401148|P2|COMPLETED|Survival Follow-up||43
5039517|NCT02027428|12401149|P1|COMPLETED|Survival Follow-up||0
5039518|NCT02027428|12401147|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|49
5039519|NCT02027428|12401148|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|91
5039520|NCT02027428|12401149|P1|STARTED|Survival Follow-up||0
5039521|NCT02027428|12401147|P3|NOT COMPLETED|Maintenance||60
5039522|NCT02027428|12401148|P2|NOT COMPLETED|Maintenance||124
5039523|NCT02027428|12401149|P1|NOT COMPLETED|Maintenance||0
5039524|NCT02027428|12401147|P3|COMPLETED|Maintenance||6
5039525|NCT02027428|12401148|P2|COMPLETED|Maintenance||12
5039526|NCT02027428|12401149|P1|COMPLETED|Maintenance||0
5039527|NCT02027428|12401147|P3|STARTED|Maintenance||66
5039528|NCT02027428|12401148|P2|STARTED|Maintenance||136
5039529|NCT02027428|12401149|P1|STARTED|Maintenance||0
5039530|NCT02027428|12401147|P3|NOT COMPLETED|Induction||0
5039531|NCT02027428|12401148|P2|NOT COMPLETED|Induction||0
5039532|NCT02027428|12401149|P1|NOT COMPLETED|Induction||225
5039533|NCT02027428|12401147|P3|COMPLETED|Induction||0
5039534|NCT02027428|12401148|P2|COMPLETED|Induction||0
5039535|NCT02027428|12401149|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
5039536|NCT02027428|12401147|P3|STARTED|Induction||0
5039537|NCT02027428|12401148|P2|STARTED|Induction||0
5039538|NCT02027428|12401149|P1|STARTED|Induction||427
5039539|NCT02027402|12401187|P2|NOT COMPLETED|Overall Study||1
5039540|NCT02027402|12401188|P1|NOT COMPLETED|Overall Study||4
5039541|NCT02027402|12401187|P2|COMPLETED|Overall Study||99
5039542|NCT02027402|12401188|P1|COMPLETED|Overall Study||94
5039543|NCT02027402|12401187|P2|STARTED|Overall Study||100
5039544|NCT02027402|12401188|P1|STARTED|Overall Study||98
5039545|NCT02027376|12401200|P3|NOT COMPLETED|Overall Study||0
5039546|NCT02027376|12401201|P2|NOT COMPLETED|Overall Study||0
5039547|NCT02027376|12401202|P1|NOT COMPLETED|Overall Study||1
5039548|NCT02027376|12401200|P3|COMPLETED|Overall Study||3
5039549|NCT02027376|12401201|P2|COMPLETED|Overall Study||4
5039550|NCT02027376|12401202|P1|COMPLETED|Overall Study||4
5039551|NCT02027376|12401200|P3|STARTED|Overall Study||3
5039552|NCT02027376|12401201|P2|STARTED|Overall Study||4
5039553|NCT02027376|12401202|P1|STARTED|Overall Study||5
5039554|NCT02027311|12401228|P2|NOT COMPLETED|Overall Study||2
5039555|NCT02027311|12401229|P1|NOT COMPLETED|Overall Study||3
5039556|NCT02027311|12401228|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
5039557|NCT02027311|12401229|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
5039558|NCT02027311|12401228|P2|STARTED|Overall Study||35
5039559|NCT02027311|12401229|P1|STARTED|Overall Study||33
5039560|NCT02027272|12401239|P2|NOT COMPLETED|Overall Study||1
5039561|NCT02027272|12401240|P1|NOT COMPLETED|Overall Study||0
5039562|NCT02027272|12401239|P2|COMPLETED|Overall Study||0
5039563|NCT02027272|12401240|P1|COMPLETED|Overall Study||0
5039564|NCT02027272|12401239|P2|STARTED|Overall Study||1
5039565|NCT02027272|12401240|P1|STARTED|Overall Study||0
5039566|NCT02027025|12401249|P3|NOT COMPLETED|Overall Study||1
5039567|NCT02027025|12401250|P2|NOT COMPLETED|Overall Study||5
5039568|NCT02027025|12401251|P1|NOT COMPLETED|Overall Study||1
5039569|NCT02027025|12401249|P3|COMPLETED|Overall Study||46
5039570|NCT02027025|12401250|P2|COMPLETED|Overall Study||42
5039571|NCT02027025|12401251|P1|COMPLETED|Overall Study||47
5039572|NCT02027025|12401249|P3|STARTED|Overall Study||47
5039573|NCT02027025|12401250|P2|STARTED|Overall Study||47
5039574|NCT02027025|12401251|P1|STARTED|Overall Study||48
5039575|NCT02026687|12401272|P2|NOT COMPLETED|Overall Study||2
5039576|NCT02026687|12401273|P1|NOT COMPLETED|Overall Study||1
5039577|NCT02026687|12401272|P2|COMPLETED|Overall Study||38
5039578|NCT02026687|12401273|P1|COMPLETED|Overall Study||39
5039579|NCT02026687|12401272|P2|STARTED|Overall Study||40
5039580|NCT02026687|12401273|P1|STARTED|Overall Study||40
5039581|NCT02026453|12401286|P3|NOT COMPLETED|Overall Study||13
5039582|NCT02026453|12401287|P2|NOT COMPLETED|Overall Study||9
5039583|NCT02026453|12401288|P1|NOT COMPLETED|Overall Study||6
5039584|NCT02026453|12401286|P3|COMPLETED|Overall Study||89
5039585|NCT02026453|12401287|P2|COMPLETED|Overall Study||94
5039586|NCT02026453|12401288|P1|COMPLETED|Overall Study||95
5039587|NCT02026453|12401286|P3|STARTED|Overall Study||102
5039588|NCT02026453|12401287|P2|STARTED|Overall Study||103
5039589|NCT02026453|12401288|P1|STARTED|Overall Study||101
5039590|NCT02026258|12401301|P2|NOT COMPLETED|Recieved Allocated Intervention||2
5039591|NCT02026258|12401302|P1|NOT COMPLETED|Recieved Allocated Intervention||1
5039592|NCT02026258|12401301|P2|COMPLETED|Recieved Allocated Intervention||17
5039593|NCT02026258|12401302|P1|COMPLETED|Recieved Allocated Intervention||15
5039594|NCT02026258|12401301|P2|STARTED|Recieved Allocated Intervention||19
5039595|NCT02026258|12401302|P1|STARTED|Recieved Allocated Intervention||16
5039596|NCT02026258|12401301|P2|NOT COMPLETED|Randomized||2
5039597|NCT02026258|12401302|P1|NOT COMPLETED|Randomized||4
5039598|NCT02026258|12401301|P2|COMPLETED|Randomized||19
5039599|NCT02026258|12401302|P1|COMPLETED|Randomized||16
5039600|NCT02026258|12401301|P2|STARTED|Randomized||21
5039601|NCT02026258|12401302|P1|STARTED|Randomized||20
5039602|NCT02026206|12401316|P2|NOT COMPLETED|Overall Study||8
5039603|NCT02026206|12401317|P1|NOT COMPLETED|Overall Study||4
5039604|NCT02026206|12401316|P2|COMPLETED|Overall Study||36
5039605|NCT02026206|12401317|P1|COMPLETED|Overall Study||40
5039606|NCT02026206|12401316|P2|STARTED|Overall Study||44
5039607|NCT02026206|12401317|P1|STARTED|Overall Study||44
5039608|NCT02026193|12401327|P2|NOT COMPLETED|Overall Study||0
5039609|NCT02026193|12401328|P1|NOT COMPLETED|Overall Study||0
5039610|NCT02026193|12401327|P2|COMPLETED|Overall Study||8
5039611|NCT02026193|12401328|P1|COMPLETED|Overall Study||3
5039612|NCT02026193|12401327|P2|STARTED|Overall Study||8
5039613|NCT02026193|12401328|P1|STARTED|Overall Study||3
5039614|NCT02026141|12401336|P2|NOT COMPLETED|Overall Study||1
5039615|NCT02026141|12401337|P1|NOT COMPLETED|Overall Study||0
5039616|NCT02026141|12401336|P2|COMPLETED|Overall Study||19
5039617|NCT02026141|12401337|P1|COMPLETED|Overall Study||20
5039618|NCT02026141|12401336|P2|STARTED|Overall Study||20
5039619|NCT02026141|12401337|P1|STARTED|Overall Study||20
5039620|NCT02026063|12401345|P2|NOT COMPLETED|Overall Study||49
5039621|NCT02026063|12401346|P1|NOT COMPLETED|Overall Study||9
5039622|NCT02026063|12401345|P2|COMPLETED|Overall Study||53
5039623|NCT02026063|12401346|P1|COMPLETED|Overall Study||13
5039624|NCT02026063|12401345|P2|STARTED|Overall Study||102
5039625|NCT02026063|12401346|P1|STARTED|Overall Study||22
5039626|NCT02026011|12401358|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
5039627|NCT02026011|12401359|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
5039628|NCT02026011|12401358|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
5039629|NCT02026011|12401359|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
5039630|NCT02026011|12401358|P2|STARTED|Allocation 2 (Second Set of Medication)||37
5039631|NCT02026011|12401359|P1|STARTED|Allocation 2 (Second Set of Medication)||38
5039632|NCT02026011|12401358|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
5039633|NCT02026011|12401359|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
5039634|NCT02026011|12401358|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
5039635|NCT02026011|12401359|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
5039636|NCT02026011|12401358|P2|STARTED|Allocation 1 (First Set of Medication)||41
5039637|NCT02026011|12401359|P1|STARTED|Allocation 1 (First Set of Medication)||46
5039638|NCT02025907|12401385|P2|NOT COMPLETED|Overall Study||12
5039639|NCT02025907|12401386|P1|NOT COMPLETED|Overall Study||27
5039640|NCT02025907|12401385|P2|COMPLETED|Overall Study||96
5039641|NCT02025907|12401386|P1|COMPLETED|Overall Study||81
5039642|NCT02025907|12401385|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
5039643|NCT02025907|12401386|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
5039644|NCT02025829|12401402|P2|NOT COMPLETED|Overall Study||0
5039645|NCT02025829|12401403|P1|NOT COMPLETED|Overall Study||0
5039646|NCT02025829|12401402|P2|COMPLETED|Overall Study||11
5039647|NCT02025829|12401403|P1|COMPLETED|Overall Study||3
5039648|NCT02025829|12401402|P2|STARTED|Overall Study||11
5039649|NCT02025829|12401403|P1|STARTED|Overall Study||3
5039650|NCT02025751|12401414|P2|NOT COMPLETED|Overall Study||3
5039651|NCT02025751|12401415|P1|NOT COMPLETED|Overall Study||1
5039652|NCT02025751|12401414|P2|COMPLETED|Overall Study||24
5039653|NCT02025751|12401415|P1|COMPLETED|Overall Study||25
5039654|NCT02025751|12401414|P2|STARTED|Overall Study||27
5039655|NCT02025751|12401415|P1|STARTED|Overall Study||26
5039656|NCT02025725|12401423|P2|NOT COMPLETED|Overall Study||4
5039657|NCT02025725|12401424|P1|NOT COMPLETED|Overall Study||11
5039658|NCT02025725|12401423|P2|COMPLETED|Overall Study||99
5039659|NCT02025725|12401424|P1|COMPLETED|Overall Study||91
5039660|NCT02025725|12401423|P2|STARTED|Overall Study||103
5039661|NCT02025725|12401424|P1|STARTED|Overall Study||102
5039662|NCT02025647|12401432|P1|NOT COMPLETED|Overall Study||0
5039663|NCT02025647|12401432|P1|COMPLETED|Overall Study||139
5039664|NCT02025647|12401432|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
5039665|NCT02025647|12401432|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
5039666|NCT02025647|12401432|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
5039667|NCT02025647|12401432|P1|Session 1 (Narrative Module)|Overall Study||139
5039668|NCT02025647|12401432|P1|STARTED|Overall Study||139
5039669|NCT02025621|12401463|P2|NOT COMPLETED|Overall Study||19
5039670|NCT02025621|12401464|P1|NOT COMPLETED|Overall Study||14
5039671|NCT02025621|12401463|P2|COMPLETED|Overall Study||421
5039672|NCT02025621|12401464|P1|COMPLETED|Overall Study||428
5039673|NCT02025621|12401463|P2|STARTED|Overall Study||440
5039674|NCT02025621|12401464|P1|STARTED|Overall Study||442
5039675|NCT02025530|12401484|P2|NOT COMPLETED|Overall Study||1
5039676|NCT02025530|12401485|P1|NOT COMPLETED|Overall Study||5
5039677|NCT02025530|12401484|P2|COMPLETED|Overall Study||733
5039678|NCT02025530|12401485|P1|COMPLETED|Overall Study||291
5039679|NCT02025530|12401484|P2|STARTED|Overall Study||734
5039680|NCT02025530|12401485|P1|STARTED|Overall Study||296
5039681|NCT02025205|12401497|P2|NOT COMPLETED|Overall Study||3
5039682|NCT02025205|12401498|P1|NOT COMPLETED|Overall Study||3
5039683|NCT02025205|12401497|P2|COMPLETED|Overall Study||47
5039684|NCT02025205|12401498|P1|COMPLETED|Overall Study||40
5039685|NCT02025205|12401497|P2|STARTED|Overall Study||50
5039686|NCT02025205|12401498|P1|STARTED|Overall Study||43
5039687|NCT02025179|12401542|P3|NOT COMPLETED|Overall Study||1
5039688|NCT02025179|12401543|P2|NOT COMPLETED|Overall Study||0
5039689|NCT02025179|12401544|P1|NOT COMPLETED|Overall Study||0
5039690|NCT02025179|12401542|P3|COMPLETED|Overall Study||7
5039691|NCT02025179|12401543|P2|COMPLETED|Overall Study||9
5039692|NCT02025179|12401544|P1|COMPLETED|Overall Study||8
5039693|NCT02025179|12401542|P3|STARTED|Overall Study||8
5039694|NCT02025179|12401543|P2|STARTED|Overall Study||9
5039695|NCT02025179|12401544|P1|STARTED|Overall Study||8
5039696|NCT02025075|12401569|P2|NOT COMPLETED|Overall Study||2
5039697|NCT02025075|12401570|P1|NOT COMPLETED|Overall Study||0
5039698|NCT02025075|12401569|P2|COMPLETED|Overall Study||19
5039699|NCT02025075|12401570|P1|COMPLETED|Overall Study||16
5039700|NCT02025075|12401569|P2|STARTED|Overall Study||21
5039701|NCT02025075|12401570|P1|STARTED|Overall Study||16
5039702|NCT02024971|12401594|P1|NOT COMPLETED|Overall Study||36
5039703|NCT02024971|12401594|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
5039704|NCT02024971|12401594|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
5039705|NCT02024971|12401594|P1|STARTED|Overall Study||1103
5039706|NCT02024932|12401607|P6|NOT COMPLETED|Overall Study||0
5039707|NCT02024932|12401608|P5|NOT COMPLETED|Overall Study||2
5039708|NCT02024932|12401609|P4|NOT COMPLETED|Overall Study||2
5039709|NCT02024932|12401610|P3|NOT COMPLETED|Overall Study||0
5039710|NCT02024932|12401611|P2|NOT COMPLETED|Overall Study||3
5039711|NCT02024932|12401612|P1|NOT COMPLETED|Overall Study||2
5039712|NCT02024932|12401607|P6|COMPLETED|Overall Study||9
5039713|NCT02024932|12401608|P5|COMPLETED|Overall Study||16
5039714|NCT02024932|12401609|P4|COMPLETED|Overall Study||0
5039715|NCT02024932|12401610|P3|COMPLETED|Overall Study||2
5039716|NCT02024932|12401611|P2|COMPLETED|Overall Study||1
5039717|NCT02024932|12401612|P1|COMPLETED|Overall Study||0
5039718|NCT02024932|12401607|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
5039719|NCT02024932|12401608|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
5039720|NCT02024932|12401609|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
5039721|NCT02024932|12401610|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
5039722|NCT02024932|12401611|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
5039723|NCT02024932|12401612|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
5039724|NCT02024932|12401607|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
5039725|NCT02024932|12401608|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
5039726|NCT02024932|12401609|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
5039727|NCT02024932|12401610|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
5039728|NCT02024932|12401611|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
5039729|NCT02024932|12401612|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
5039730|NCT02024932|12401607|P6|Safety Analysis Set|Overall Study||9
5039731|NCT02024932|12401608|P5|Safety Analysis Set|Overall Study||18
5039732|NCT02024932|12401609|P4|Safety Analysis Set|Overall Study||2
5039733|NCT02024932|12401610|P3|Safety Analysis Set|Overall Study||2
5039734|NCT02024932|12401611|P2|Safety Analysis Set|Overall Study||4
5039735|NCT02024932|12401612|P1|Safety Analysis Set|Overall Study||2
5039736|NCT02024932|12401607|P6|STARTED|Overall Study||9
5039737|NCT02024932|12401608|P5|STARTED|Overall Study||18
5039738|NCT02024932|12401609|P4|STARTED|Overall Study||2
5039739|NCT02024932|12401610|P3|STARTED|Overall Study||2
5039740|NCT02024932|12401611|P2|STARTED|Overall Study||4
5039741|NCT02024932|12401612|P1|STARTED|Overall Study||2
5039742|NCT02024867|12401671|P2|NOT COMPLETED|Overall Study||7
5039743|NCT02024867|12401672|P1|NOT COMPLETED|Overall Study||9
5039744|NCT02024867|12401671|P2|COMPLETED|Overall Study||124
5039745|NCT02024867|12401672|P1|COMPLETED|Overall Study||125
5039746|NCT02024867|12401671|P2|STARTED|Overall Study||131
5039747|NCT02024867|12401672|P1|STARTED|Overall Study||134
5039748|NCT02024750|12401690|P2|NOT COMPLETED|Overall Study||1
5039749|NCT02024750|12401691|P1|NOT COMPLETED|Overall Study||2
5039750|NCT02024750|12401690|P2|COMPLETED|Overall Study||107
5039751|NCT02024750|12401691|P1|COMPLETED|Overall Study||104
5039752|NCT02024750|12401690|P2|STARTED|Overall Study||108
5039753|NCT02024750|12401691|P1|STARTED|Overall Study||106
5039754|NCT02024724|12401705|P2|NOT COMPLETED|Overall Study||0
5039755|NCT02024724|12401706|P1|NOT COMPLETED|Overall Study||1
5039756|NCT02024724|12401705|P2|COMPLETED|Overall Study||30
5039757|NCT02024724|12401706|P1|COMPLETED|Overall Study||29
5039758|NCT02024724|12401705|P2|STARTED|Overall Study||30
5039759|NCT02024724|12401706|P1|STARTED|Overall Study||30
5039760|NCT02024698|12401712|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5039761|NCT02024698|12401713|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5039762|NCT02024698|12401712|P2|COMPLETED|Second Intervention (7 Days)||26
5039763|NCT02024698|12401713|P1|COMPLETED|Second Intervention (7 Days)||16
5039764|NCT02024698|12401712|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
5039765|NCT02024698|12401713|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
5039766|NCT02024698|12401712|P2|STARTED|Second Intervention (7 Days)||26
5039767|NCT02024698|12401713|P1|STARTED|Second Intervention (7 Days)||16
5039768|NCT02024698|12401712|P2|NOT COMPLETED|First Intervention (7 Days)||1
5039769|NCT02024698|12401713|P1|NOT COMPLETED|First Intervention (7 Days)||0
5039770|NCT02024698|12401712|P2|COMPLETED|First Intervention (7 Days)||26
5039771|NCT02024698|12401713|P1|COMPLETED|First Intervention (7 Days)||16
5039772|NCT02024698|12401712|P2|STARTED|First Intervention (7 Days)||27
5039773|NCT02024698|12401713|P1|STARTED|First Intervention (7 Days)||16
5039774|NCT02024555|12401741|P2|NOT COMPLETED|Overall Study||2
5039775|NCT02024555|12401742|P1|NOT COMPLETED|Overall Study||6
5039776|NCT02024555|12401741|P2|COMPLETED|Overall Study||46
5039777|NCT02024555|12401742|P1|COMPLETED|Overall Study||43
5039778|NCT02024555|12401741|P2|STARTED|Overall Study||48
5039779|NCT02024555|12401742|P1|STARTED|Overall Study||49
5039780|NCT02024477|12401772|P2|NOT COMPLETED|Overall Study||0
5039781|NCT02024477|12401773|P1|NOT COMPLETED|Overall Study||0
5039782|NCT02024477|12401772|P2|COMPLETED|Overall Study||21
5039783|NCT02024477|12401773|P1|COMPLETED|Overall Study||21
5039784|NCT02024477|12401772|P2|STARTED|Overall Study||21
5039785|NCT02024477|12401773|P1|STARTED|Overall Study||21
5039786|NCT02024386|12401794|P3|NOT COMPLETED|Overall Study||0
5039787|NCT02024386|12401795|P2|NOT COMPLETED|Overall Study||0
5039788|NCT02024386|12401796|P1|NOT COMPLETED|Overall Study||0
5039789|NCT02024386|12401794|P3|COMPLETED|Overall Study||5
5039790|NCT02024386|12401795|P2|COMPLETED|Overall Study||11
5039791|NCT02024386|12401796|P1|COMPLETED|Overall Study||6
5039792|NCT02024386|12401794|P3|STARTED|Overall Study||5
5039793|NCT02024386|12401795|P2|STARTED|Overall Study||11
5039794|NCT02024386|12401796|P1|STARTED|Overall Study||6
5039795|NCT02024165|12401819|P1|NOT COMPLETED|Overall Study||0
5039796|NCT02024165|12401819|P1|COMPLETED|Overall Study||71
5039797|NCT02024165|12401819|P1|STARTED|Overall Study||71
5039798|NCT02023983|12401826|P2|NOT COMPLETED|Overall Study||0
5039799|NCT02023983|12401827|P1|NOT COMPLETED|Overall Study||0
5039800|NCT02023983|12401826|P2|COMPLETED|Overall Study||75
5039801|NCT02023983|12401827|P1|COMPLETED|Overall Study||76
5039802|NCT02023983|12401826|P2|STARTED|Overall Study||75
5039803|NCT02023983|12401827|P1|STARTED|Overall Study||76
5039804|NCT02023944|12401837|P2|NOT COMPLETED|Overall Study||1
5039805|NCT02023944|12401838|P1|NOT COMPLETED|Overall Study||0
5039806|NCT02023944|12401837|P2|COMPLETED|Overall Study||24
5039807|NCT02023944|12401838|P1|COMPLETED|Overall Study||25
5039808|NCT02023944|12401837|P2|STARTED|Overall Study||25
5039809|NCT02023944|12401838|P1|STARTED|Overall Study||25
5039810|NCT02023918|12401846|P1|NOT COMPLETED|Overall Study||0
5039811|NCT02023918|12401846|P1|COMPLETED|Overall Study||6
5039812|NCT02023918|12401846|P1|STARTED|Overall Study||6
5039813|NCT02023879|12401854|P3|NOT COMPLETED|Extension Open Label Treatment||5
5039814|NCT02023879|12401855|P2|NOT COMPLETED|Extension Open Label Treatment||17
5039815|NCT02023879|12401856|P1|NOT COMPLETED|Extension Open Label Treatment||5
5039816|NCT02023879|12401854|P3|COMPLETED|Extension Open Label Treatment||43
5039817|NCT02023879|12401855|P2|COMPLETED|Extension Open Label Treatment||89
5039818|NCT02023879|12401856|P1|COMPLETED|Extension Open Label Treatment||46
5039819|NCT02023879|12401854|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
5039820|NCT02023879|12401855|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
5039821|NCT02023879|12401856|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
5039822|NCT02023879|12401854|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
5039823|NCT02023879|12401855|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
5039824|NCT02023879|12401856|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
5039825|NCT02023879|12401854|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
5039826|NCT02023879|12401855|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
5039827|NCT02023879|12401856|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
5039828|NCT02023879|12401854|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
5039829|NCT02023879|12401855|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
5039830|NCT02023879|12401856|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
5039831|NCT02023879|12401854|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
5039832|NCT02023879|12401855|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
5039833|NCT02023879|12401856|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
5039834|NCT02023866|12401945|P1|NOT COMPLETED|Overall Study||6
5039835|NCT02023866|12401945|P1|COMPLETED|Overall Study||30
5039836|NCT02023866|12401945|P1|STARTED|Overall Study||36
5039837|NCT02023801|12401958|P1|NOT COMPLETED|Overall Study||0
5039838|NCT02023801|12401958|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
5039839|NCT02023801|12401958|P1|Treated|Overall Study|Treatment Completed|24
5039840|NCT02023801|12401958|P1|STARTED|Overall Study|Treatment Attempted|24
5039841|NCT02023697|12401967|P3|NOT COMPLETED|Long-term Follow-up Period||17
5039842|NCT02023697|12401968|P2|NOT COMPLETED|Long-term Follow-up Period||21
5039843|NCT02023697|12401969|P1|NOT COMPLETED|Long-term Follow-up Period||28
5039844|NCT02023697|12401967|P3|COMPLETED|Long-term Follow-up Period||0
5039845|NCT02023697|12401968|P2|COMPLETED|Long-term Follow-up Period||0
5039846|NCT02023697|12401969|P1|COMPLETED|Long-term Follow-up Period||0
5039847|NCT02023697|12401967|P3|STARTED|Long-term Follow-up Period||17
5039848|NCT02023697|12401968|P2|STARTED|Long-term Follow-up Period||21
5039849|NCT02023697|12401969|P1|STARTED|Long-term Follow-up Period||28
5039850|NCT02023697|12401967|P3|NOT COMPLETED|Active Follow-up Period||99
5039851|NCT02023697|12401968|P2|NOT COMPLETED|Active Follow-up Period||99
5039852|NCT02023697|12401969|P1|NOT COMPLETED|Active Follow-up Period||92
5039853|NCT02023697|12401967|P3|COMPLETED|Active Follow-up Period||17
5039854|NCT02023697|12401968|P2|COMPLETED|Active Follow-up Period||21
5039855|NCT02023697|12401969|P1|COMPLETED|Active Follow-up Period||28
5039856|NCT02023697|12401967|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
5039857|NCT02023697|12401968|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
5039858|NCT02023697|12401969|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
5039859|NCT02023697|12401967|P3|NOT COMPLETED|Treatment Period||102
5039860|NCT02023697|12401968|P2|NOT COMPLETED|Treatment Period||63
5039861|NCT02023697|12401969|P1|NOT COMPLETED|Treatment Period||46
5039862|NCT02023697|12401967|P3|COMPLETED|Treatment Period||29
5039863|NCT02023697|12401968|P2|COMPLETED|Treatment Period||67
5039864|NCT02023697|12401969|P1|COMPLETED|Treatment Period||84
5039865|NCT02023697|12401967|P3|Received Treatment|Treatment Period||121
5039866|NCT02023697|12401968|P2|Received Treatment|Treatment Period||124
5039867|NCT02023697|12401969|P1|Received Treatment|Treatment Period||125
5039868|NCT02023697|12401967|P3|STARTED|Treatment Period||131
5039869|NCT02023697|12401968|P2|STARTED|Treatment Period||130
5039870|NCT02023697|12401969|P1|STARTED|Treatment Period||130
5039871|NCT02023515|12402071|P2|NOT COMPLETED|Overall Study||3
5039872|NCT02023515|12402072|P1|NOT COMPLETED|Overall Study||1
5039873|NCT02023515|12402071|P2|COMPLETED|Overall Study||22
5039874|NCT02023515|12402072|P1|COMPLETED|Overall Study||23
5039875|NCT02023515|12402071|P2|STARTED|Overall Study||25
5039876|NCT02023515|12402072|P1|STARTED|Overall Study||24
5039877|NCT02023268|12402082|P2|NOT COMPLETED|Overall Study||4
5039878|NCT02023268|12402083|P1|NOT COMPLETED|Overall Study||0
5039879|NCT02023268|12402082|P2|COMPLETED|Overall Study||49
5039880|NCT02023268|12402083|P1|COMPLETED|Overall Study||52
5039881|NCT02023268|12402082|P2|STARTED|Overall Study||53
5039882|NCT02023268|12402083|P1|STARTED|Overall Study||52
5039883|NCT02023242|12402091|P2|NOT COMPLETED|Overall Study||2
5039884|NCT02023242|12402092|P1|NOT COMPLETED|Overall Study||3
5039885|NCT02023242|12402091|P2|COMPLETED|Overall Study||75
5039886|NCT02023242|12402092|P1|COMPLETED|Overall Study||72
5039887|NCT02023242|12402091|P2|STARTED|Overall Study||77
5039888|NCT02023242|12402092|P1|STARTED|Overall Study||75
5039889|NCT02023151|12402106|P1|NOT COMPLETED|Overall Study||4
5039890|NCT02023151|12402106|P1|COMPLETED|Overall Study||13
5039891|NCT02023151|12402106|P1|STARTED|Overall Study||17
5039892|NCT02023125|12402113|P3|NOT COMPLETED|Period 2||0
5039893|NCT02023125|12402114|P2|NOT COMPLETED|Period 2||0
5039894|NCT02023125|12402115|P1|NOT COMPLETED|Period 2||0
5039895|NCT02023125|12402113|P3|COMPLETED|Period 2||24
5039896|NCT02023125|12402114|P2|COMPLETED|Period 2||9
5039897|NCT02023125|12402115|P1|COMPLETED|Period 2||9
5039898|NCT02023125|12402113|P3|STARTED|Period 2||24
5039899|NCT02023125|12402114|P2|STARTED|Period 2||9
5039900|NCT02023125|12402115|P1|STARTED|Period 2||9
5039901|NCT02023125|12402113|P3|NOT COMPLETED|Washout Period||0
5039902|NCT02023125|12402114|P2|NOT COMPLETED|Washout Period||0
5039903|NCT02023125|12402115|P1|NOT COMPLETED|Washout Period||0
5039904|NCT02023125|12402113|P3|COMPLETED|Washout Period||24
5039905|NCT02023125|12402114|P2|COMPLETED|Washout Period||9
5039906|NCT02023125|12402115|P1|COMPLETED|Washout Period||9
5039907|NCT02023125|12402113|P3|STARTED|Washout Period||24
5039908|NCT02023125|12402114|P2|STARTED|Washout Period||9
5039909|NCT02023125|12402115|P1|STARTED|Washout Period||9
5039910|NCT02023125|12402113|P3|NOT COMPLETED|Period 1||0
5039911|NCT02023125|12402114|P2|NOT COMPLETED|Period 1||0
5039912|NCT02023125|12402115|P1|NOT COMPLETED|Period 1||0
5039913|NCT02023125|12402113|P3|COMPLETED|Period 1||24
5039914|NCT02023125|12402114|P2|COMPLETED|Period 1||9
5039915|NCT02023125|12402115|P1|COMPLETED|Period 1||9
5039916|NCT02023125|12402113|P3|STARTED|Period 1||24
5039917|NCT02023125|12402114|P2|STARTED|Period 1||9
5039918|NCT02023125|12402115|P1|STARTED|Period 1||9
5039919|NCT02023112|12402176|P2|NOT COMPLETED|Overall Study||1
5039920|NCT02023112|12402177|P1|NOT COMPLETED|Overall Study||2
5039921|NCT02023112|12402176|P2|COMPLETED|Overall Study||85
5039922|NCT02023112|12402177|P1|COMPLETED|Overall Study||83
5039923|NCT02023112|12402176|P2|STARTED|Overall Study||86
5039924|NCT02023112|12402177|P1|STARTED|Overall Study||85
5039925|NCT02023099|12402198|P3|NOT COMPLETED|Overall Study||3
5039926|NCT02023099|12402199|P2|NOT COMPLETED|Overall Study||0
5039927|NCT02023099|12402200|P1|NOT COMPLETED|Overall Study||3
5039928|NCT02023099|12402198|P3|COMPLETED|Overall Study||39
5039929|NCT02023099|12402199|P2|COMPLETED|Overall Study||106
5039930|NCT02023099|12402200|P1|COMPLETED|Overall Study||212
5039931|NCT02023099|12402198|P3|STARTED|Overall Study||42
5039932|NCT02023099|12402199|P2|STARTED|Overall Study||106
5039933|NCT02023099|12402200|P1|STARTED|Overall Study||215
5039934|NCT02022826|12402216|P1|NOT COMPLETED|Overall Study||28
5039935|NCT02022826|12402216|P1|COMPLETED|Overall Study||139
5039936|NCT02022826|12402216|P1|STARTED|Overall Study||167
5039937|NCT02022748|12402223|P3|NOT COMPLETED|Overall Study||0
5039938|NCT02022748|12402224|P2|NOT COMPLETED|Overall Study||2
5039939|NCT02022748|12402225|P1|NOT COMPLETED|Overall Study||1
5039940|NCT02022748|12402223|P3|COMPLETED|Overall Study||13
5039941|NCT02022748|12402224|P2|COMPLETED|Overall Study||4
5039942|NCT02022748|12402225|P1|COMPLETED|Overall Study||7
5039943|NCT02022748|12402223|P3|Subjects Who Completed Treatment|Overall Study||13
5039944|NCT02022748|12402224|P2|Subjects Who Completed Treatment|Overall Study||4
5039945|NCT02022748|12402225|P1|Subjects Who Completed Treatment|Overall Study||7
5039946|NCT02022748|12402223|P3|Subject Who Started Treatment|Overall Study||13
5039947|NCT02022748|12402224|P2|Subject Who Started Treatment|Overall Study||6
5039948|NCT02022748|12402225|P1|Subject Who Started Treatment|Overall Study||8
5039949|NCT02022748|12402223|P3|STARTED|Overall Study||13
5039950|NCT02022748|12402224|P2|STARTED|Overall Study||6
5039951|NCT02022748|12402225|P1|STARTED|Overall Study||8
5039952|NCT02022670|12402251|P3|NOT COMPLETED|Overall Study||1
5039953|NCT02022670|12402252|P2|NOT COMPLETED|Overall Study||0
5039954|NCT02022670|12402253|P1|NOT COMPLETED|Overall Study||1
5039955|NCT02022670|12402251|P3|COMPLETED|Overall Study||11
5039956|NCT02022670|12402252|P2|COMPLETED|Overall Study||10
5039957|NCT02022670|12402253|P1|COMPLETED|Overall Study||10
5039958|NCT02022670|12402251|P3|STARTED|Overall Study||12
5039959|NCT02022670|12402252|P2|STARTED|Overall Study||10
5039960|NCT02022670|12402253|P1|STARTED|Overall Study||11
5039961|NCT02022657|12402267|P6|NOT COMPLETED|Overall Study||1
5039962|NCT02022657|12402268|P5|NOT COMPLETED|Overall Study||0
5039963|NCT02022657|12402269|P4|NOT COMPLETED|Overall Study||0
5039964|NCT02022657|12402270|P3|NOT COMPLETED|Overall Study||1
5039965|NCT02022657|12402271|P2|NOT COMPLETED|Overall Study||0
5039966|NCT02022657|12402272|P1|NOT COMPLETED|Overall Study||2
5039967|NCT02022657|12402267|P6|COMPLETED|Overall Study||8
5039968|NCT02022657|12402268|P5|COMPLETED|Overall Study||8
5039969|NCT02022657|12402269|P4|COMPLETED|Overall Study||8
5039970|NCT02022657|12402270|P3|COMPLETED|Overall Study||8
5039971|NCT02022657|12402271|P2|COMPLETED|Overall Study||8
5039972|NCT02022657|12402272|P1|COMPLETED|Overall Study||8
5039973|NCT02022657|12402267|P6|STARTED|Overall Study||9
5039974|NCT02022657|12402268|P5|STARTED|Overall Study||8
5039975|NCT02022657|12402269|P4|STARTED|Overall Study||8
5039976|NCT02022657|12402270|P3|STARTED|Overall Study||9
5039977|NCT02022657|12402271|P2|STARTED|Overall Study||8
5039978|NCT02022657|12402272|P1|STARTED|Overall Study||10
5039979|NCT02022111|12402280|P2|NOT COMPLETED|Overall Study||15
5039980|NCT02022111|12402281|P1|NOT COMPLETED|Overall Study||10
5039981|NCT02022111|12402280|P2|COMPLETED|Overall Study||193
5039982|NCT02022111|12402281|P1|COMPLETED|Overall Study||186
5039983|NCT02022111|12402280|P2|STARTED|Overall Study||208
5039984|NCT02022111|12402281|P1|STARTED|Overall Study||196
5039985|NCT02022085|12402287|P1|NOT COMPLETED|Overall Study||1
5039986|NCT02022085|12402287|P1|COMPLETED|Overall Study||53
5039987|NCT02022085|12402287|P1|STARTED|Overall Study||54
5039988|NCT02022020|12402313|P1|NOT COMPLETED|Overall Study||0
5039989|NCT02022020|12402313|P1|COMPLETED|Overall Study||220
5039990|NCT02022020|12402313|P1|STARTED|Overall Study||220
5039991|NCT02022007|12402322|P3|NOT COMPLETED|Overall Study||2
5039992|NCT02022007|12402323|P2|NOT COMPLETED|Overall Study||1
5039993|NCT02022007|12402324|P1|NOT COMPLETED|Overall Study||1
5039994|NCT02022007|12402322|P3|COMPLETED|Overall Study||11
5039995|NCT02022007|12402323|P2|COMPLETED|Overall Study||11
5039996|NCT02022007|12402324|P1|COMPLETED|Overall Study||12
5039997|NCT02022007|12402322|P3|STARTED|Overall Study||13
5039998|NCT02022007|12402323|P2|STARTED|Overall Study||12
5039999|NCT02022007|12402324|P1|STARTED|Overall Study||13
5040000|NCT02021942|12402365|P1|NOT COMPLETED|Overall Study||0
5040001|NCT02021942|12402365|P1|COMPLETED|Overall Study||16
5040002|NCT02021942|12402365|P1|STARTED|Overall Study||16
5040003|NCT02021929|12402377|P2|NOT COMPLETED|Overall Study||1
5040004|NCT02021929|12402378|P1|NOT COMPLETED|Overall Study||2
5040005|NCT02021929|12402377|P2|COMPLETED|Overall Study||11
5040006|NCT02021929|12402378|P1|COMPLETED|Overall Study||14
5040007|NCT02021929|12402377|P2|STARTED|Overall Study||12
5040008|NCT02021929|12402378|P1|STARTED|Overall Study||16
5040009|NCT02021812|12402388|P1|NOT COMPLETED|Overall Study||24
5040010|NCT02021812|12402388|P1|COMPLETED|Overall Study||7
5040011|NCT02021812|12402388|P1|STARTED|Overall Study||31
5040012|NCT02021669|12402398|P2|NOT COMPLETED|Overall Study||3
5040013|NCT02021669|12402399|P1|NOT COMPLETED|Overall Study||7
5040014|NCT02021669|12402398|P2|COMPLETED|Overall Study||70
5040015|NCT02021669|12402399|P1|COMPLETED|Overall Study||64
5040016|NCT02021669|12402398|P2|STARTED|Overall Study||73
5040017|NCT02021669|12402399|P1|STARTED|Overall Study||71
5040018|NCT02021656|12402407|P1|NOT COMPLETED|Overall Study||6
5040019|NCT02021656|12402407|P1|COMPLETED|Overall Study||378
5040020|NCT02021656|12402407|P1|STARTED|Overall Study||384
5040021|NCT02021643|12402427|P4|NOT COMPLETED|Overall Study||12
5040022|NCT02021643|12402428|P3|NOT COMPLETED|Overall Study||0
5040023|NCT02021643|12402429|P2|NOT COMPLETED|Overall Study||10
5040024|NCT02021643|12402430|P1|NOT COMPLETED|Overall Study||9
5040025|NCT02021643|12402427|P4|COMPLETED|Overall Study||218
5040026|NCT02021643|12402428|P3|COMPLETED|Overall Study||11
5040027|NCT02021643|12402429|P2|COMPLETED|Overall Study||280
5040028|NCT02021643|12402430|P1|COMPLETED|Overall Study||147
5040029|NCT02021643|12402427|P4|STARTED|Overall Study||230
5040030|NCT02021643|12402428|P3|STARTED|Overall Study||11
5040031|NCT02021643|12402429|P2|STARTED|Overall Study||290
5040032|NCT02021643|12402430|P1|STARTED|Overall Study||156
5040033|NCT02021565|12402472|P2|NOT COMPLETED|3-month Follow-up||2
5040034|NCT02021565|12402473|P1|NOT COMPLETED|3-month Follow-up||10
5040035|NCT02021565|12402472|P2|COMPLETED|3-month Follow-up||34
5040036|NCT02021565|12402473|P1|COMPLETED|3-month Follow-up||50
5040037|NCT02021565|12402472|P2|Care Recipients|3-month Follow-up||18
5040038|NCT02021565|12402473|P1|Care Recipients|3-month Follow-up||30
5040039|NCT02021565|12402472|P2|Caregivers|3-month Follow-up||18
5040040|NCT02021565|12402473|P1|Caregivers|3-month Follow-up||30
5040041|NCT02021565|12402472|P2|STARTED|3-month Follow-up||36
5040042|NCT02021565|12402473|P1|STARTED|3-month Follow-up||60
5040043|NCT02021565|12402472|P2|NOT COMPLETED|Baseline Through Intervention||18
5040044|NCT02021565|12402473|P1|NOT COMPLETED|Baseline Through Intervention||12
5040045|NCT02021565|12402472|P2|COMPLETED|Baseline Through Intervention||36
5040046|NCT02021565|12402473|P1|COMPLETED|Baseline Through Intervention||60
5040047|NCT02021565|12402472|P2|Care Recipients|Baseline Through Intervention||27
5040048|NCT02021565|12402473|P1|Care Recipients|Baseline Through Intervention||36
5040049|NCT02021565|12402472|P2|Caregivers|Baseline Through Intervention||27
5040050|NCT02021565|12402473|P1|Caregivers|Baseline Through Intervention||36
5040051|NCT02021565|12402472|P2|STARTED|Baseline Through Intervention||54
5040052|NCT02021565|12402473|P1|STARTED|Baseline Through Intervention||72
5040053|NCT02021461|12402485|P1|NOT COMPLETED|Overall Study||0
5040054|NCT02021461|12402485|P1|COMPLETED|Overall Study||38
5040055|NCT02021461|12402485|P1|STARTED|Overall Study||38
5040056|NCT02021331|12402493|P2|NOT COMPLETED|Overall Study||2
5040057|NCT02021331|12402494|P1|NOT COMPLETED|Overall Study||0
5040058|NCT02021331|12402493|P2|COMPLETED|Overall Study||1
5040059|NCT02021331|12402494|P1|COMPLETED|Overall Study||2
5040060|NCT02021331|12402493|P2|STARTED|Overall Study||3
5040061|NCT02021331|12402494|P1|STARTED|Overall Study||2
5040062|NCT02021292|12402506|P2|NOT COMPLETED|Overall Study||3
5040063|NCT02021292|12402507|P1|NOT COMPLETED|Overall Study||0
5040064|NCT02021292|12402506|P2|COMPLETED|Overall Study||37
5040065|NCT02021292|12402507|P1|COMPLETED|Overall Study||40
5040066|NCT02021292|12402506|P2|STARTED|Overall Study||40
5040067|NCT02021292|12402507|P1|STARTED|Overall Study||40
5040068|NCT02021071|12402529|P2|NOT COMPLETED|Overall Study||0
5040069|NCT02021071|12402530|P1|NOT COMPLETED|Overall Study||0
5040070|NCT02021071|12402529|P2|COMPLETED|Overall Study||12
5040071|NCT02021071|12402530|P1|COMPLETED|Overall Study||12
5040072|NCT02021071|12402529|P2|STARTED|Overall Study||12
5040073|NCT02021071|12402530|P1|STARTED|Overall Study||12
5040074|NCT02020941|12402537|P1|NOT COMPLETED|Overall Study||8
5040075|NCT02020941|12402537|P1|COMPLETED|Overall Study||2
5040076|NCT02020941|12402537|P1|STARTED|Overall Study||10
5040077|NCT02020889|12402548|P2|NOT COMPLETED|Overall Study||3
5040078|NCT02020889|12402549|P1|NOT COMPLETED|Overall Study||7
5040079|NCT02020889|12402548|P2|COMPLETED|Overall Study||65
5040080|NCT02020889|12402549|P1|COMPLETED|Overall Study||61
5040081|NCT02020889|12402548|P2|STARTED|Overall Study||68
5040082|NCT02020889|12402549|P1|STARTED|Overall Study||68
5040083|NCT02020863|12402603|P1|NOT COMPLETED|Overall Study||5
5040084|NCT02020863|12402603|P1|COMPLETED|Overall Study||35
5040085|NCT02020863|12402603|P1|STARTED|Overall Study||40
5040086|NCT02020837|12402607|P1|NOT COMPLETED|Overall Study||0
5040087|NCT02020837|12402607|P1|COMPLETED|Overall Study||2
5040088|NCT02020837|12402607|P1|STARTED|Overall Study||2
5040089|NCT02020785|12402613|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5040090|NCT02020785|12402614|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
5040091|NCT02020785|12402613|P2|COMPLETED|Second Intervention (3 Weeks)||16
5040092|NCT02020785|12402614|P1|COMPLETED|Second Intervention (3 Weeks)||15
5040093|NCT02020785|12402613|P2|STARTED|Second Intervention (3 Weeks)||16
5040094|NCT02020785|12402614|P1|STARTED|Second Intervention (3 Weeks)||15
5040095|NCT02020785|12402613|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
5040096|NCT02020785|12402614|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
5040097|NCT02020785|12402613|P2|COMPLETED|First Intervention (3 Weeks)||16
5040098|NCT02020785|12402614|P1|COMPLETED|First Intervention (3 Weeks)||15
5040099|NCT02020785|12402613|P2|STARTED|First Intervention (3 Weeks)||16
5040100|NCT02020785|12402614|P1|STARTED|First Intervention (3 Weeks)||15
5040101|NCT02020616|12402633|P7|NOT COMPLETED|Overall Study||4
5040102|NCT02020616|12402634|P6|NOT COMPLETED|Overall Study||5
5040103|NCT02020616|12402635|P5|NOT COMPLETED|Overall Study||2
5040104|NCT02020616|12402636|P4|NOT COMPLETED|Overall Study||2
5040105|NCT02020616|12402637|P3|NOT COMPLETED|Overall Study||2
5040106|NCT02020616|12402638|P2|NOT COMPLETED|Overall Study||1
5040107|NCT02020616|12402639|P1|NOT COMPLETED|Overall Study||0
5040108|NCT02020616|12402633|P7|COMPLETED|Overall Study||6
5040109|NCT02020616|12402634|P6|COMPLETED|Overall Study||3
5040110|NCT02020616|12402635|P5|COMPLETED|Overall Study||6
5040111|NCT02020616|12402636|P4|COMPLETED|Overall Study||6
5040112|NCT02020616|12402637|P3|COMPLETED|Overall Study||6
5040113|NCT02020616|12402638|P2|COMPLETED|Overall Study||7
5040114|NCT02020616|12402639|P1|COMPLETED|Overall Study||10
5040115|NCT02020616|12402633|P7|Received at Least One Dose of Study Drug|Overall Study||10
5040116|NCT02020616|12402634|P6|Received at Least One Dose of Study Drug|Overall Study||8
5040117|NCT02020616|12402635|P5|Received at Least One Dose of Study Drug|Overall Study||8
5040118|NCT02020616|12402636|P4|Received at Least One Dose of Study Drug|Overall Study||7
5040119|NCT02020616|12402637|P3|Received at Least One Dose of Study Drug|Overall Study||8
5040120|NCT02020616|12402638|P2|Received at Least One Dose of Study Drug|Overall Study||8
5040121|NCT02020616|12402639|P1|Received at Least One Dose of Study Drug|Overall Study||10
5040122|NCT02020616|12402633|P7|STARTED|Overall Study||10
5040123|NCT02020616|12402634|P6|STARTED|Overall Study||8
5040124|NCT02020616|12402635|P5|STARTED|Overall Study||8
5040125|NCT02020616|12402636|P4|STARTED|Overall Study||8
5040126|NCT02020616|12402637|P3|STARTED|Overall Study||8
5040127|NCT02020616|12402638|P2|STARTED|Overall Study||8
5040128|NCT02020616|12402639|P1|STARTED|Overall Study||10
5040129|NCT02020577|12402732|P2|NOT COMPLETED|Overall Study||55
5040130|NCT02020577|12402733|P1|NOT COMPLETED|Overall Study||3
5040131|NCT02020577|12402732|P2|COMPLETED|Overall Study||0
5040132|NCT02020577|12402733|P1|COMPLETED|Overall Study||0
5040133|NCT02020577|12402732|P2|STARTED|Overall Study||55
5040134|NCT02020577|12402733|P1|STARTED|Overall Study||3
5040135|NCT02020512|12402760|P1|NOT COMPLETED|Overall Study||8
5040136|NCT02020512|12402760|P1|COMPLETED|Overall Study||79
5040137|NCT02020512|12402760|P1|STARTED|Overall Study||87
5040138|NCT02020408|12402764|P1|NOT COMPLETED|Overall Study||3
5040139|NCT02020408|12402764|P1|COMPLETED|Overall Study||85
5040140|NCT02020408|12402764|P1|STARTED|Overall Study||88
5040141|NCT02020369|12402776|P2|NOT COMPLETED|Overall Study||2
5040142|NCT02020369|12402777|P1|NOT COMPLETED|Overall Study||3
5040143|NCT02020369|12402776|P2|COMPLETED|Overall Study||11
5040144|NCT02020369|12402777|P1|COMPLETED|Overall Study||11
5040145|NCT02020369|12402776|P2|STARTED|Overall Study||13
5040146|NCT02020369|12402777|P1|STARTED|Overall Study||14
5040147|NCT02020304|12402793|P2|NOT COMPLETED|Overall Study||2
5040148|NCT02020304|12402794|P1|NOT COMPLETED|Overall Study||3
5040149|NCT02020304|12402793|P2|COMPLETED|Overall Study||26
5040150|NCT02020304|12402794|P1|COMPLETED|Overall Study||27
5040151|NCT02020304|12402793|P2|STARTED|Overall Study||28
5040152|NCT02020304|12402794|P1|STARTED|Overall Study||30
5040153|NCT02020278|12402808|P1|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
5040154|NCT02020278|12402808|P1|COMPLETED|Optional Tolvaptan Treatment Component||0
5040155|NCT02020278|12402808|P1|STARTED|Optional Tolvaptan Treatment Component||0
5040156|NCT02020278|12402808|P1|NOT COMPLETED|Core Safety Follow-up Component||0
5040157|NCT02020278|12402808|P1|COMPLETED|Core Safety Follow-up Component||3
5040158|NCT02020278|12402808|P1|STARTED|Core Safety Follow-up Component||3
5040159|NCT02020135|12402827|P1|NOT COMPLETED|Overall Study||9
5040160|NCT02020135|12402827|P1|COMPLETED|Overall Study||0
5040161|NCT02020135|12402827|P1|STARTED|Overall Study||9
5040162|NCT02020031|12402839|P2|NOT COMPLETED|Overall Study||1
5040163|NCT02020031|12402840|P1|NOT COMPLETED|Overall Study||1
5040164|NCT02020031|12402839|P2|COMPLETED|Overall Study||10
5040165|NCT02020031|12402840|P1|COMPLETED|Overall Study||10
5040166|NCT02020031|12402839|P2|STARTED|Overall Study||11
5040167|NCT02020031|12402840|P1|STARTED|Overall Study||11
5040168|NCT02020018|12402850|P2|NOT COMPLETED|Overall Study||0
5040169|NCT02020018|12402851|P1|NOT COMPLETED|Overall Study||0
5040170|NCT02020018|12402850|P2|COMPLETED|Overall Study||1597
5040171|NCT02020018|12402851|P1|COMPLETED|Overall Study||272
5040172|NCT02020018|12402850|P2|STARTED|Overall Study||1597
5040173|NCT02020018|12402851|P1|STARTED|Overall Study||272
5040174|NCT02019979|12402861|P1|NOT COMPLETED|Overall Study||14
5040175|NCT02019979|12402861|P1|COMPLETED|Overall Study||0
5040176|NCT02019979|12402861|P1|STARTED|Overall Study||14
5040177|NCT02019940|12402867|P1|NOT COMPLETED|Overall Study||10
5040178|NCT02019940|12402867|P1|COMPLETED|Overall Study||8
5040179|NCT02019940|12402867|P1|STARTED|Overall Study||18
5040180|NCT02019927|12402877|P6|NOT COMPLETED|Overall Study||1
5040181|NCT02019927|12402878|P5|NOT COMPLETED|Overall Study||3
5040182|NCT02019927|12402879|P4|NOT COMPLETED|Overall Study||2
5040183|NCT02019927|12402880|P3|NOT COMPLETED|Overall Study||1
5040184|NCT02019927|12402881|P2|NOT COMPLETED|Overall Study||4
5040185|NCT02019927|12402882|P1|NOT COMPLETED|Overall Study||2
5040186|NCT02019927|12402877|P6|COMPLETED|Overall Study||3
5040187|NCT02019927|12402878|P5|COMPLETED|Overall Study||7
5040188|NCT02019927|12402879|P4|COMPLETED|Overall Study||3
5040189|NCT02019927|12402880|P3|COMPLETED|Overall Study||8
5040190|NCT02019927|12402881|P2|COMPLETED|Overall Study||19
5040191|NCT02019927|12402882|P1|COMPLETED|Overall Study||44
5040192|NCT02019927|12402877|P6|STARTED|Overall Study||4
5040193|NCT02019927|12402878|P5|STARTED|Overall Study||10
5040194|NCT02019927|12402879|P4|STARTED|Overall Study||5
5040195|NCT02019927|12402880|P3|STARTED|Overall Study||9
5040196|NCT02019927|12402881|P2|STARTED|Overall Study||23
5040197|NCT02019927|12402882|P1|STARTED|Overall Study||46
5040198|NCT02019758|12402952|P2|NOT COMPLETED|Overall Study||9
5040199|NCT02019758|12402953|P1|NOT COMPLETED|Overall Study||9
5040200|NCT02019758|12402952|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
5040201|NCT02019758|12402953|P1|COMPLETED|Overall Study||56
5040202|NCT02019758|12402952|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
5040203|NCT02019758|12402953|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
5040204|NCT02019758|12402952|P2|Did Not Receive Intervention|Overall Study||1
5040205|NCT02019758|12402953|P1|Did Not Receive Intervention|Overall Study||1
5040206|NCT02019758|12402952|P2|Received Intervention|Overall Study||63
5040207|NCT02019758|12402953|P1|Received Intervention|Overall Study||64
5040208|NCT02019758|12402952|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
5040209|NCT02019758|12402953|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
5040210|NCT02019719|12402982|P5|NOT COMPLETED|Overall Study||2
5040211|NCT02019719|12402983|P4|NOT COMPLETED|Overall Study||2
5040212|NCT02019719|12402984|P3|NOT COMPLETED|Overall Study||0
5040213|NCT02019719|12402985|P2|NOT COMPLETED|Overall Study||1
5040214|NCT02019719|12402986|P1|NOT COMPLETED|Overall Study||6
5040215|NCT02019719|12402982|P5|COMPLETED|Overall Study||18
5040216|NCT02019719|12402983|P4|COMPLETED|Overall Study||17
5040217|NCT02019719|12402984|P3|COMPLETED|Overall Study||20
5040218|NCT02019719|12402985|P2|COMPLETED|Overall Study||18
5040219|NCT02019719|12402986|P1|COMPLETED|Overall Study||13
5040220|NCT02019719|12402982|P5|STARTED|Overall Study||20
5040221|NCT02019719|12402983|P4|STARTED|Overall Study||19
5040222|NCT02019719|12402984|P3|STARTED|Overall Study||20
5040223|NCT02019719|12402985|P2|STARTED|Overall Study||19
5040224|NCT02019719|12402986|P1|STARTED|Overall Study||19
5040225|NCT02019667|12403083|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
5040226|NCT02019667|12403084|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
5040227|NCT02019667|12403083|P2|COMPLETED|Washout Period (9 Weeks)||6
5040228|NCT02019667|12403084|P1|COMPLETED|Washout Period (9 Weeks)||10
5040229|NCT02019667|12403083|P2|STARTED|Washout Period (9 Weeks)||6
5040230|NCT02019667|12403084|P1|STARTED|Washout Period (9 Weeks)||10
5040231|NCT02019667|12403083|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
5040232|NCT02019667|12403084|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
5040233|NCT02019667|12403083|P2|COMPLETED|2nd Intervention (6 Months)||6
5040234|NCT02019667|12403084|P1|COMPLETED|2nd Intervention (6 Months)||10
5040235|NCT02019667|12403083|P2|STARTED|2nd Intervention (6 Months)||8
5040236|NCT02019667|12403084|P1|STARTED|2nd Intervention (6 Months)||10
5040237|NCT02019667|12403083|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
5040238|NCT02019667|12403084|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
5040239|NCT02019667|12403083|P2|COMPLETED|Washout Period (9 Weeks)||8
5040240|NCT02019667|12403084|P1|COMPLETED|Washout Period (9 Weeks)||10
5040241|NCT02019667|12403083|P2|STARTED|Washout Period (9 Weeks)||8
5040242|NCT02019667|12403084|P1|STARTED|Washout Period (9 Weeks)||10
5040243|NCT02019667|12403083|P2|NOT COMPLETED|First Intervention (6 Months)||1
5040244|NCT02019667|12403084|P1|NOT COMPLETED|First Intervention (6 Months)||0
5040245|NCT02019667|12403083|P2|COMPLETED|First Intervention (6 Months)||8
5040246|NCT02019667|12403084|P1|COMPLETED|First Intervention (6 Months)||10
5040247|NCT02019667|12403083|P2|STARTED|First Intervention (6 Months)||9
5040248|NCT02019667|12403084|P1|STARTED|First Intervention (6 Months)||10
5040249|NCT02019602|12403104|P2|NOT COMPLETED|Sampling Period||0
5040250|NCT02019602|12403105|P1|NOT COMPLETED|Sampling Period||0
5040251|NCT02019602|12403104|P2|COMPLETED|Sampling Period||16
5040252|NCT02019602|12403105|P1|COMPLETED|Sampling Period||16
5040253|NCT02019602|12403104|P2|STARTED|Sampling Period||16
5040254|NCT02019602|12403105|P1|STARTED|Sampling Period||16
5040255|NCT02019602|12403104|P2|NOT COMPLETED|Screening Period||0
5040256|NCT02019602|12403105|P1|NOT COMPLETED|Screening Period||5
5040257|NCT02019602|12403104|P2|COMPLETED|Screening Period||16
5040258|NCT02019602|12403105|P1|COMPLETED|Screening Period||16
5040259|NCT02019602|12403104|P2|STARTED|Screening Period||16
5040260|NCT02019602|12403105|P1|STARTED|Screening Period||21
5040261|NCT02019563|12403117|P2|NOT COMPLETED|Overall Study||0
5040262|NCT02019563|12403118|P1|NOT COMPLETED|Overall Study||0
5040263|NCT02019563|12403117|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
5040264|NCT02019563|12403118|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
5040265|NCT02019563|12403117|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
5040266|NCT02019563|12403118|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
5040267|NCT02019550|12403134|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5040268|NCT02019550|12403135|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5040269|NCT02019550|12403134|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
5040270|NCT02019550|12403135|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
5040271|NCT02019550|12403134|P2|STARTED|Treatment Period 2 (4 Weeks)||50
5040272|NCT02019550|12403135|P1|STARTED|Treatment Period 2 (4 Weeks)||46
5040273|NCT02019550|12403134|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
5040274|NCT02019550|12403135|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
5040275|NCT02019550|12403134|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
5040276|NCT02019550|12403135|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
5040277|NCT02019550|12403134|P2|STARTED|Treatment Period 1 (4 Weeks)||51
5040278|NCT02019550|12403135|P1|STARTED|Treatment Period 1 (4 Weeks)||46
5040279|NCT02019472|12403176|P3|NOT COMPLETED|Overall Study||42
5040280|NCT02019472|12403177|P2|NOT COMPLETED|Overall Study||52
5040281|NCT02019472|12403178|P1|NOT COMPLETED|Overall Study||37
5040282|NCT02019472|12403176|P3|COMPLETED|Overall Study||145
5040283|NCT02019472|12403177|P2|COMPLETED|Overall Study||134
5040284|NCT02019472|12403178|P1|COMPLETED|Overall Study||149
5040285|NCT02019472|12403176|P3|STARTED|Overall Study||187
5040286|NCT02019472|12403177|P2|STARTED|Overall Study||186
5040287|NCT02019472|12403178|P1|STARTED|Overall Study||186
5040288|NCT02019420|12403201|P2|NOT COMPLETED|Overall Study||106
5040289|NCT02019420|12403202|P1|NOT COMPLETED|Overall Study||108
5040290|NCT02019420|12403201|P2|COMPLETED|Overall Study||254
5040291|NCT02019420|12403202|P1|COMPLETED|Overall Study||258
5040292|NCT02019420|12403201|P2|Treated|Overall Study||357
5040293|NCT02019420|12403202|P1|Treated|Overall Study||361
5040294|NCT02019420|12403201|P2|STARTED|Overall Study||360
5040295|NCT02019420|12403202|P1|STARTED|Overall Study||366
5040296|NCT02019277|12403230|P1|NOT COMPLETED|Overall Study||12
5040297|NCT02019277|12403230|P1|COMPLETED|Overall Study||38
5040298|NCT02019277|12403230|P1|STARTED|Overall Study||50
5040299|NCT02019264|12403249|P2|NOT COMPLETED|Overall Study||207
5040300|NCT02019264|12403250|P1|NOT COMPLETED|Overall Study||248
5040301|NCT02019264|12403249|P2|COMPLETED|Overall Study||5793
5040302|NCT02019264|12403250|P1|COMPLETED|Overall Study||5752
5040303|NCT02019264|12403249|P2|Safety Analysis Set|Overall Study||5995
5040304|NCT02019264|12403250|P1|Safety Analysis Set|Overall Study||5992
5040305|NCT02019264|12403249|P2|STARTED|Overall Study||6000
5040306|NCT02019264|12403250|P1|STARTED|Overall Study||6000
5040307|NCT02019108|12403286|P2|NOT COMPLETED|Overall Study||7
5040308|NCT02019108|12403287|P1|NOT COMPLETED|Overall Study||5
5040309|NCT02019108|12403286|P2|COMPLETED|Overall Study||32
5040310|NCT02019108|12403287|P1|COMPLETED|Overall Study||35
5040311|NCT02019108|12403286|P2|Retention (Week 21)|Overall Study||32
5040312|NCT02019108|12403287|P1|Retention (Week 21)|Overall Study||35
5040313|NCT02019108|12403286|P2|Follow-up (Week 17)|Overall Study||36
5040314|NCT02019108|12403287|P1|Follow-up (Week 17)|Overall Study||38
5040315|NCT02019108|12403286|P2|Baseline (Week 0)|Overall Study||39
5040316|NCT02019108|12403287|P1|Baseline (Week 0)|Overall Study||40
5040317|NCT02019108|12403286|P2|STARTED|Overall Study||39
5040318|NCT02019108|12403287|P1|STARTED|Overall Study||40
5040319|NCT02019069|12403309|P1|NOT COMPLETED|Overall Study||0
5040320|NCT02019069|12403309|P1|COMPLETED|Overall Study||11
5040321|NCT02019069|12403309|P1|STARTED|Overall Study||11
5040322|NCT02018887|12403329|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
5040323|NCT02018887|12403330|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
5040324|NCT02018887|12403331|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
5040325|NCT02018887|12403332|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040326|NCT02018887|12403333|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040327|NCT02018887|12403334|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040328|NCT02018887|12403335|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040329|NCT02018887|12403336|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040330|NCT02018887|12403337|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040331|NCT02018887|12403338|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040332|NCT02018887|12403339|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
5040333|NCT02018887|12403329|P11|COMPLETED|Part C: Cohort 8 Overall||6
5040334|NCT02018887|12403330|P10|COMPLETED|Part C: Cohort 8 Overall||1
5040335|NCT02018887|12403331|P9|COMPLETED|Part C: Cohort 8 Overall||7
5040336|NCT02018887|12403332|P8|COMPLETED|Part C: Cohort 8 Overall||0
5040337|NCT02018887|12403333|P7|COMPLETED|Part C: Cohort 8 Overall||0
5040338|NCT02018887|12403334|P6|COMPLETED|Part C: Cohort 8 Overall||0
5040339|NCT02018887|12403335|P5|COMPLETED|Part C: Cohort 8 Overall||0
5040340|NCT02018887|12403336|P4|COMPLETED|Part C: Cohort 8 Overall||0
5040341|NCT02018887|12403337|P3|COMPLETED|Part C: Cohort 8 Overall||0
5040342|NCT02018887|12403338|P2|COMPLETED|Part C: Cohort 8 Overall||0
5040343|NCT02018887|12403339|P1|COMPLETED|Part C: Cohort 8 Overall||0
5040344|NCT02018887|12403329|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
5040345|NCT02018887|12403330|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
5040346|NCT02018887|12403331|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
5040347|NCT02018887|12403332|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040348|NCT02018887|12403333|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040349|NCT02018887|12403334|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040350|NCT02018887|12403335|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040351|NCT02018887|12403336|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040352|NCT02018887|12403337|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040353|NCT02018887|12403338|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040354|NCT02018887|12403339|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
5040355|NCT02018887|12403329|P11|STARTED|Part C: Cohort 8 Overall||7
5040356|NCT02018887|12403330|P10|STARTED|Part C: Cohort 8 Overall||4
5040357|NCT02018887|12403331|P9|STARTED|Part C: Cohort 8 Overall||10
5040358|NCT02018887|12403332|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
5040359|NCT02018887|12403333|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
5040360|NCT02018887|12403334|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
5040361|NCT02018887|12403335|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
5040362|NCT02018887|12403336|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
5040363|NCT02018887|12403337|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
5040364|NCT02018887|12403338|P2|STARTED|Part C: Cohort 8 Overall||0
5040365|NCT02018887|12403339|P1|STARTED|Part C: Cohort 8 Overall||0
5040366|NCT02018887|12403329|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040367|NCT02018887|12403330|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040368|NCT02018887|12403331|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040369|NCT02018887|12403332|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
5040370|NCT02018887|12403333|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
5040371|NCT02018887|12403334|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040372|NCT02018887|12403335|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
5040373|NCT02018887|12403336|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040374|NCT02018887|12403337|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040375|NCT02018887|12403338|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040376|NCT02018887|12403339|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
5040377|NCT02018887|12403329|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
5040378|NCT02018887|12403330|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
5040379|NCT02018887|12403331|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
5040380|NCT02018887|12403332|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
5040381|NCT02018887|12403333|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
5040382|NCT02018887|12403334|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
5040383|NCT02018887|12403335|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
5040384|NCT02018887|12403336|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
5040385|NCT02018887|12403337|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
5040386|NCT02018887|12403338|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
5040387|NCT02018887|12403339|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
5040388|NCT02018887|12403329|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
5040389|NCT02018887|12403330|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
5040390|NCT02018887|12403331|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
5040391|NCT02018887|12403332|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
5040392|NCT02018887|12403333|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
5040393|NCT02018887|12403334|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
5040394|NCT02018887|12403335|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
5040395|NCT02018887|12403336|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
5040396|NCT02018887|12403337|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
5040397|NCT02018887|12403338|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
5040398|NCT02018887|12403339|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
5040399|NCT02018887|12403329|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
5040400|NCT02018887|12403330|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
5040401|NCT02018887|12403331|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
5040402|NCT02018887|12403332|P8|STARTED|Part B: Cohorts 3-7 Overall||9
5040403|NCT02018887|12403333|P7|STARTED|Part B: Cohorts 3-7 Overall||9
5040404|NCT02018887|12403334|P6|STARTED|Part B: Cohorts 3-7 Overall||9
5040405|NCT02018887|12403335|P5|STARTED|Part B: Cohorts 3-7 Overall||9
5040406|NCT02018887|12403336|P4|STARTED|Part B: Cohorts 3-7 Overall||9
5040407|NCT02018887|12403337|P3|STARTED|Part B: Cohorts 3-7 Overall||15
5040408|NCT02018887|12403338|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
5040409|NCT02018887|12403339|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
5040410|NCT02018887|12403329|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040411|NCT02018887|12403330|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040412|NCT02018887|12403331|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040413|NCT02018887|12403332|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040414|NCT02018887|12403333|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040415|NCT02018887|12403334|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040416|NCT02018887|12403335|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040417|NCT02018887|12403336|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040418|NCT02018887|12403337|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040419|NCT02018887|12403338|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040420|NCT02018887|12403339|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
5040421|NCT02018887|12403329|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040422|NCT02018887|12403330|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040423|NCT02018887|12403331|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040424|NCT02018887|12403332|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040425|NCT02018887|12403333|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040426|NCT02018887|12403334|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040427|NCT02018887|12403335|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040428|NCT02018887|12403336|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040429|NCT02018887|12403337|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
5040430|NCT02018887|12403338|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
5040431|NCT02018887|12403339|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
5040432|NCT02018887|12403329|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040433|NCT02018887|12403330|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040434|NCT02018887|12403331|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040435|NCT02018887|12403332|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040436|NCT02018887|12403333|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040437|NCT02018887|12403334|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040438|NCT02018887|12403335|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040439|NCT02018887|12403336|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040440|NCT02018887|12403337|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
5040441|NCT02018887|12403338|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
5040442|NCT02018887|12403339|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
5040443|NCT02018887|12403329|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040444|NCT02018887|12403330|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040445|NCT02018887|12403331|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
5040446|NCT02018887|12403332|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040447|NCT02018887|12403333|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040448|NCT02018887|12403334|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040449|NCT02018887|12403335|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040450|NCT02018887|12403336|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
5040451|NCT02018887|12403337|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
5040452|NCT02018887|12403338|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
5040453|NCT02018887|12403339|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
5040454|NCT02018887|12403329|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040455|NCT02018887|12403330|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040456|NCT02018887|12403331|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040457|NCT02018887|12403332|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040458|NCT02018887|12403333|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040459|NCT02018887|12403334|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040460|NCT02018887|12403335|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040461|NCT02018887|12403336|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040462|NCT02018887|12403337|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040463|NCT02018887|12403338|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040464|NCT02018887|12403339|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040465|NCT02018887|12403329|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040466|NCT02018887|12403330|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040467|NCT02018887|12403331|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040468|NCT02018887|12403332|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040469|NCT02018887|12403333|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040470|NCT02018887|12403334|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040471|NCT02018887|12403335|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040472|NCT02018887|12403336|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040473|NCT02018887|12403337|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
5040474|NCT02018887|12403338|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
5040475|NCT02018887|12403339|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
5040476|NCT02018887|12403329|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040477|NCT02018887|12403330|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040478|NCT02018887|12403331|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040479|NCT02018887|12403332|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040480|NCT02018887|12403333|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040481|NCT02018887|12403334|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040482|NCT02018887|12403335|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040483|NCT02018887|12403336|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040484|NCT02018887|12403337|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
5040485|NCT02018887|12403338|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
5040486|NCT02018887|12403339|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
5040487|NCT02018887|12403329|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040488|NCT02018887|12403330|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040489|NCT02018887|12403331|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
5040490|NCT02018887|12403332|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040491|NCT02018887|12403333|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040492|NCT02018887|12403334|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040493|NCT02018887|12403335|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040494|NCT02018887|12403336|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
5040495|NCT02018887|12403337|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
5040496|NCT02018887|12403338|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
5040497|NCT02018887|12403339|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
5040498|NCT02018887|12403329|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040499|NCT02018887|12403330|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040500|NCT02018887|12403331|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040501|NCT02018887|12403332|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040502|NCT02018887|12403333|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040503|NCT02018887|12403334|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040504|NCT02018887|12403335|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040505|NCT02018887|12403336|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040506|NCT02018887|12403337|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040507|NCT02018887|12403338|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040508|NCT02018887|12403339|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040509|NCT02018887|12403329|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040510|NCT02018887|12403330|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040511|NCT02018887|12403331|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040512|NCT02018887|12403332|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040513|NCT02018887|12403333|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040514|NCT02018887|12403334|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040515|NCT02018887|12403335|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040516|NCT02018887|12403336|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040517|NCT02018887|12403337|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
5040518|NCT02018887|12403338|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
5040519|NCT02018887|12403339|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
5040520|NCT02018887|12403329|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040521|NCT02018887|12403330|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040522|NCT02018887|12403331|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040523|NCT02018887|12403332|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040524|NCT02018887|12403333|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040525|NCT02018887|12403334|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040526|NCT02018887|12403335|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040527|NCT02018887|12403336|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040528|NCT02018887|12403337|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
5040529|NCT02018887|12403338|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
5040530|NCT02018887|12403339|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
5040531|NCT02018887|12403329|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040532|NCT02018887|12403330|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040533|NCT02018887|12403331|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
5040534|NCT02018887|12403332|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040535|NCT02018887|12403333|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040536|NCT02018887|12403334|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040537|NCT02018887|12403335|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040538|NCT02018887|12403336|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
5040539|NCT02018887|12403337|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
5040540|NCT02018887|12403338|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
5040541|NCT02018887|12403339|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
5040542|NCT02018822|12403428|P3|NOT COMPLETED|Overall Study||6
5040543|NCT02018822|12403429|P2|NOT COMPLETED|Overall Study||8
5040544|NCT02018822|12403430|P1|NOT COMPLETED|Overall Study||6
5040545|NCT02018822|12403428|P3|COMPLETED|Overall Study||29
5040546|NCT02018822|12403429|P2|COMPLETED|Overall Study||42
5040547|NCT02018822|12403430|P1|COMPLETED|Overall Study||44
5040548|NCT02018822|12403428|P3|STARTED|Overall Study||35
5040549|NCT02018822|12403429|P2|STARTED|Overall Study||50
5040550|NCT02018822|12403430|P1|STARTED|Overall Study||50
5040551|NCT02018809|12403457|P4|NOT COMPLETED|Overall Study||0
5040552|NCT02018809|12403458|P3|NOT COMPLETED|Overall Study||0
5040553|NCT02018809|12403459|P2|NOT COMPLETED|Overall Study||0
5040554|NCT02018809|12403460|P1|NOT COMPLETED|Overall Study||0
5040555|NCT02018809|12403457|P4|COMPLETED|Overall Study||50
5040556|NCT02018809|12403458|P3|COMPLETED|Overall Study||50
5040557|NCT02018809|12403459|P2|COMPLETED|Overall Study||50
5040558|NCT02018809|12403460|P1|COMPLETED|Overall Study||50
5040559|NCT02018809|12403457|P4|STARTED|Overall Study||50
5040560|NCT02018809|12403458|P3|STARTED|Overall Study||50
5040561|NCT02018809|12403459|P2|STARTED|Overall Study||50
5040562|NCT02018809|12403460|P1|STARTED|Overall Study||50
5040563|NCT02018653|12403476|P2|NOT COMPLETED|Overall Study||1
5040564|NCT02018653|12403477|P1|NOT COMPLETED|Overall Study||0
5040565|NCT02018653|12403476|P2|COMPLETED|Overall Study||0
5040566|NCT02018653|12403477|P1|COMPLETED|Overall Study||1
5040567|NCT02018653|12403476|P2|STARTED|Overall Study||1
5040568|NCT02018653|12403477|P1|STARTED|Overall Study||1
5040569|NCT02018627|12403485|P2|NOT COMPLETED|Overall Study||0
5040570|NCT02018627|12403486|P1|NOT COMPLETED|Overall Study||0
5040571|NCT02018627|12403485|P2|COMPLETED|Overall Study||6
5040572|NCT02018627|12403486|P1|COMPLETED|Overall Study||7
5040573|NCT02018627|12403485|P2|STARTED|Overall Study||6
5040574|NCT02018627|12403486|P1|STARTED|Overall Study||7
5040575|NCT02018562|12403510|P2|NOT COMPLETED|Overall Study||0
5040576|NCT02018562|12403511|P1|NOT COMPLETED|Overall Study||3
5040577|NCT02018562|12403510|P2|COMPLETED|Overall Study||25
5040578|NCT02018562|12403511|P1|COMPLETED|Overall Study||22
5040579|NCT02018562|12403510|P2|STARTED|Overall Study||25
5040580|NCT02018562|12403511|P1|STARTED|Overall Study||25
5040581|NCT02018458|12403529|P1|NOT COMPLETED|Overall Study||4
5040582|NCT02018458|12403529|P1|COMPLETED|Overall Study||6
5040583|NCT02018458|12403529|P1|STARTED|Overall Study||10
5040584|NCT02018445|12403535|P1|NOT COMPLETED|Overall Study||7
5040585|NCT02018445|12403535|P1|COMPLETED|Overall Study||29
5040586|NCT02018445|12403535|P1|STARTED|Overall Study||36
5040587|NCT02018315|12403546|P1|NOT COMPLETED|Overall Study||0
5040588|NCT02018315|12403546|P1|COMPLETED|Overall Study||14
5040589|NCT02018315|12403546|P1|STARTED|Overall Study||14
5040590|NCT02018107|12403551|P1|NOT COMPLETED|Overall Study||0
5040591|NCT02018107|12403551|P1|COMPLETED|Overall Study||27
5040592|NCT02018107|12403551|P1|STARTED|Overall Study||27
5040593|NCT02018042|12403556|P1|NOT COMPLETED|Overall Study||1
5040594|NCT02018042|12403556|P1|COMPLETED|Overall Study||14
5040595|NCT02018042|12403556|P1|STARTED|Overall Study||15
5040596|NCT02017964|12403562|P1|NOT COMPLETED|Overall Study||1
5040597|NCT02017964|12403562|P1|COMPLETED|Overall Study||25
5040598|NCT02017964|12403562|P1|STARTED|Overall Study||26
5040599|NCT02017899|12403576|P6|NOT COMPLETED|Overall Study||0
5040600|NCT02017899|12403577|P5|NOT COMPLETED|Overall Study||1
5040601|NCT02017899|12403578|P4|NOT COMPLETED|Overall Study||1
5040602|NCT02017899|12403579|P3|NOT COMPLETED|Overall Study||0
5040603|NCT02017899|12403580|P2|NOT COMPLETED|Overall Study||0
5040604|NCT02017899|12403581|P1|NOT COMPLETED|Overall Study||0
5040605|NCT02017899|12403576|P6|COMPLETED|Overall Study||8
5040606|NCT02017899|12403577|P5|COMPLETED|Overall Study||8
5040607|NCT02017899|12403578|P4|COMPLETED|Overall Study||7
5040608|NCT02017899|12403579|P3|COMPLETED|Overall Study||8
5040609|NCT02017899|12403580|P2|COMPLETED|Overall Study||9
5040610|NCT02017899|12403581|P1|COMPLETED|Overall Study||8
5040611|NCT02017899|12403576|P6|STARTED|Overall Study||8
5040612|NCT02017899|12403577|P5|STARTED|Overall Study||9
5040613|NCT02017899|12403578|P4|STARTED|Overall Study||8
5040614|NCT02017899|12403579|P3|STARTED|Overall Study||8
5040615|NCT02017899|12403580|P2|STARTED|Overall Study||9
5040616|NCT02017899|12403581|P1|STARTED|Overall Study||8
5040617|NCT02017860|12403655|P1|NOT COMPLETED|Overall Study||2
5040618|NCT02017860|12403655|P1|COMPLETED|Overall Study||2
5040619|NCT02017860|12403655|P1|STARTED|Overall Study||4
5040620|NCT02017574|12403661|P2|NOT COMPLETED|Overall Study||0
5040621|NCT02017574|12403662|P1|NOT COMPLETED|Overall Study||0
5040622|NCT02017574|12403661|P2|COMPLETED|Overall Study||12
5040623|NCT02017574|12403662|P1|COMPLETED|Overall Study||12
5040624|NCT02017574|12403661|P2|STARTED|Overall Study||12
5040625|NCT02017574|12403662|P1|STARTED|Overall Study||12
5040626|NCT02017535|12403674|P4|NOT COMPLETED|Overall Study||0
5040627|NCT02017535|12403675|P3|NOT COMPLETED|Overall Study||0
5040628|NCT02017535|12403676|P2|NOT COMPLETED|Overall Study||0
5040629|NCT02017535|12403677|P1|NOT COMPLETED|Overall Study||1
5040630|NCT02017535|12403674|P4|COMPLETED|Overall Study||1
5040631|NCT02017535|12403675|P3|COMPLETED|Overall Study||2
5040632|NCT02017535|12403676|P2|COMPLETED|Overall Study||3
5040633|NCT02017535|12403677|P1|COMPLETED|Overall Study||8
5040634|NCT02017535|12403674|P4|STARTED|Overall Study||1
5040635|NCT02017535|12403675|P3|STARTED|Overall Study||2
5040636|NCT02017535|12403676|P2|STARTED|Overall Study||3
5040637|NCT02017535|12403677|P1|STARTED|Overall Study||9
5040638|NCT02017522|12403699|P1|NOT COMPLETED|Overall Study||1
5040639|NCT02017522|12403699|P1|COMPLETED|Overall Study||2
5040640|NCT02017522|12403699|P1|Scan|Overall Study||2
5040641|NCT02017522|12403699|P1|STARTED|Overall Study||3
5040642|NCT02017327|12403707|P3|NOT COMPLETED|Overall Study||15
5040643|NCT02017327|12403708|P2|NOT COMPLETED|Overall Study||12
5040644|NCT02017327|12403709|P1|NOT COMPLETED|Overall Study||16
5040645|NCT02017327|12403707|P3|COMPLETED|Overall Study||117
5040646|NCT02017327|12403708|P2|COMPLETED|Overall Study||113
5040647|NCT02017327|12403709|P1|COMPLETED|Overall Study||106
5040648|NCT02017327|12403707|P3|STARTED|Overall Study||132
5040649|NCT02017327|12403708|P2|STARTED|Overall Study||125
5040650|NCT02017327|12403709|P1|STARTED|Overall Study||122
5040651|NCT02017223|12403717|P1|NOT COMPLETED|Overall Study||2
5040652|NCT02017223|12403717|P1|COMPLETED|Overall Study||10
5040653|NCT02017223|12403717|P1|STARTED|Overall Study||12
5040654|NCT02017210|12403724|P3|NOT COMPLETED|Overall Study||0
5040655|NCT02017210|12403725|P2|NOT COMPLETED|Overall Study||0
5040656|NCT02017210|12403726|P1|NOT COMPLETED|Overall Study||0
5040657|NCT02017210|12403724|P3|COMPLETED|Overall Study||20
5040658|NCT02017210|12403725|P2|COMPLETED|Overall Study||20
5040659|NCT02017210|12403726|P1|COMPLETED|Overall Study||17
5040660|NCT02017210|12403724|P3|STARTED|Overall Study||20
5040661|NCT02017210|12403725|P2|STARTED|Overall Study||20
5040662|NCT02017210|12403726|P1|STARTED|Overall Study||17
5040663|NCT02017093|12403763|P2|NOT COMPLETED|Overall Study||0
5040664|NCT02017093|12403764|P1|NOT COMPLETED|Overall Study||0
5040665|NCT02017093|12403763|P2|COMPLETED|Overall Study||3
5040666|NCT02017093|12403764|P1|COMPLETED|Overall Study||4
5040667|NCT02017093|12403763|P2|STARTED|Overall Study||3
5040668|NCT02017093|12403764|P1|STARTED|Overall Study||4
5040669|NCT02017015|12403772|P1|NOT COMPLETED|Overall Study||69
5040670|NCT02017015|12403772|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
5040671|NCT02017015|12403772|P1|Safety Population|Overall Study||83
5040672|NCT02017015|12403772|P1|STARTED|Overall Study||83
5040673|NCT02016963|12403779|P1|NOT COMPLETED|Overall Study||0
5040674|NCT02016963|12403779|P1|COMPLETED|Overall Study||20
5040675|NCT02016963|12403779|P1|STARTED|Overall Study||20
5040676|NCT02016898|12403797|P2|NOT COMPLETED|Overall Study||5
5040677|NCT02016898|12403798|P1|NOT COMPLETED|Overall Study||5
5040678|NCT02016898|12403797|P2|COMPLETED|Overall Study||40
5040679|NCT02016898|12403798|P1|COMPLETED|Overall Study||45
5040680|NCT02016898|12403797|P2|STARTED|Overall Study||45
5040681|NCT02016898|12403798|P1|STARTED|Overall Study||50
5040682|NCT02016885|12403811|P5|NOT COMPLETED|Overall Study||1
5040683|NCT02016885|12403812|P4|NOT COMPLETED|Overall Study||10
5040684|NCT02016885|12403813|P3|NOT COMPLETED|Overall Study||1
5040685|NCT02016885|12403814|P2|NOT COMPLETED|Overall Study||4
5040686|NCT02016885|12403815|P1|NOT COMPLETED|Overall Study||4
5040687|NCT02016885|12403811|P5|COMPLETED|Overall Study||39
5040688|NCT02016885|12403812|P4|COMPLETED|Overall Study||30
5040689|NCT02016885|12403813|P3|COMPLETED|Overall Study||39
5040690|NCT02016885|12403814|P2|COMPLETED|Overall Study||36
5040691|NCT02016885|12403815|P1|COMPLETED|Overall Study||34
5040692|NCT02016885|12403811|P5|STARTED|Overall Study||40
5040693|NCT02016885|12403812|P4|STARTED|Overall Study||40
5040694|NCT02016885|12403813|P3|STARTED|Overall Study||40
5040695|NCT02016885|12403814|P2|STARTED|Overall Study||40
5040696|NCT02016885|12403815|P1|STARTED|Overall Study||38
5040697|NCT02016716|12403855|P3|NOT COMPLETED|Overall Study||6
5040698|NCT02016716|12403856|P2|NOT COMPLETED|Overall Study||8
5040699|NCT02016716|12403857|P1|NOT COMPLETED|Overall Study||6
5040700|NCT02016716|12403855|P3|COMPLETED|Overall Study||117
5040701|NCT02016716|12403856|P2|COMPLETED|Overall Study||110
5040702|NCT02016716|12403857|P1|COMPLETED|Overall Study||47
5040703|NCT02016716|12403855|P3|Received Study Treatment|Overall Study||123
5040704|NCT02016716|12403856|P2|Received Study Treatment|Overall Study||118
5040705|NCT02016716|12403857|P1|Received Study Treatment|Overall Study||53
5040706|NCT02016716|12403855|P3|STARTED|Overall Study||123
5040707|NCT02016716|12403856|P2|STARTED|Overall Study||118
5040708|NCT02016716|12403857|P1|STARTED|Overall Study||53
5040709|NCT02016690|12403878|P1|NOT COMPLETED|Overall Study||24
5040710|NCT02016690|12403878|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
5040711|NCT02016690|12403878|P1|Safety Analysis Set (SAS)|Overall Study||304
5040712|NCT02016690|12403878|P1|Treated|Overall Study||312
5040713|NCT02016690|12403878|P1|STARTED|Overall Study||312
5040714|NCT02016625|12403891|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
5040715|NCT02016625|12403892|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
5040716|NCT02016625|12403891|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
5040717|NCT02016625|12403892|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
5040718|NCT02016625|12403891|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
5040719|NCT02016625|12403892|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
5040720|NCT02016625|12403891|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
5040721|NCT02016625|12403892|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
5040722|NCT02016625|12403891|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
5040723|NCT02016625|12403892|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
5040724|NCT02016625|12403891|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
5040725|NCT02016625|12403892|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
5040726|NCT02016612|12403928|P4|NOT COMPLETED|Overall Study||0
5040727|NCT02016612|12403929|P3|NOT COMPLETED|Overall Study||0
5040728|NCT02016612|12403930|P2|NOT COMPLETED|Overall Study||0
5040729|NCT02016612|12403931|P1|NOT COMPLETED|Overall Study||0
5040730|NCT02016612|12403928|P4|COMPLETED|Overall Study||61
5040731|NCT02016612|12403929|P3|COMPLETED|Overall Study||26
5040732|NCT02016612|12403930|P2|COMPLETED|Overall Study||25
5040733|NCT02016612|12403931|P1|COMPLETED|Overall Study||25
5040734|NCT02016612|12403928|P4|STARTED|Overall Study||61
5040735|NCT02016612|12403929|P3|STARTED|Overall Study||26
5040736|NCT02016612|12403930|P2|STARTED|Overall Study||25
5040737|NCT02016612|12403931|P1|STARTED|Overall Study||25
5040738|NCT02016482|12403947|P2|NOT COMPLETED|Period B||7
5040739|NCT02016482|12403948|P1|NOT COMPLETED|Period B||13
5040740|NCT02016482|12403947|P2|COMPLETED|Period B||87
5040741|NCT02016482|12403948|P1|COMPLETED|Period B||81
5040742|NCT02016482|12403947|P2|STARTED|Period B||94
5040743|NCT02016482|12403948|P1|STARTED|Period B||94
5040744|NCT02016482|12403947|P2|NOT COMPLETED|Period A||15
5040745|NCT02016482|12403948|P1|NOT COMPLETED|Period A||14
5040746|NCT02016482|12403947|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
5040747|NCT02016482|12403948|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
5040748|NCT02016482|12403947|P2|STARTED|Period A||109
5040749|NCT02016482|12403948|P1|STARTED|Period A||108
5040750|NCT02016300|12404038|P2|NOT COMPLETED|Overall Study||3
5040751|NCT02016300|12404039|P1|NOT COMPLETED|Overall Study||0
5040752|NCT02016300|12404038|P2|COMPLETED|Overall Study||9
5040753|NCT02016300|12404039|P1|COMPLETED|Overall Study||12
5040754|NCT02016300|12404038|P2|STARTED|Overall Study||12
5040755|NCT02016300|12404039|P1|STARTED|Overall Study||12
5040756|NCT02016235|12404060|P3|NOT COMPLETED|Overall Study||0
5040757|NCT02016235|12404061|P2|NOT COMPLETED|Overall Study||0
5040758|NCT02016235|12404062|P1|NOT COMPLETED|Overall Study||0
5040759|NCT02016235|12404060|P3|COMPLETED|Overall Study||10
5040760|NCT02016235|12404061|P2|COMPLETED|Overall Study||10
5040761|NCT02016235|12404062|P1|COMPLETED|Overall Study||10
5040762|NCT02016235|12404060|P3|STARTED|Overall Study||10
5040763|NCT02016235|12404061|P2|STARTED|Overall Study||10
5040764|NCT02016235|12404062|P1|STARTED|Overall Study||10
5040765|NCT02016183|12404070|P1|NOT COMPLETED|Overall Study||65
5040766|NCT02016183|12404070|P1|COMPLETED|Overall Study||3157
5040767|NCT02016183|12404070|P1|STARTED|Overall Study||3222
5040768|NCT02016170|12404080|P3|NOT COMPLETED|Overall Study||0
5040769|NCT02016170|12404081|P2|NOT COMPLETED|Overall Study||1
5040770|NCT02016170|12404082|P1|NOT COMPLETED|Overall Study||2
5040771|NCT02016170|12404080|P3|COMPLETED|Overall Study||27
5040772|NCT02016170|12404081|P2|COMPLETED|Overall Study||27
5040773|NCT02016170|12404082|P1|COMPLETED|Overall Study||25
5040774|NCT02016170|12404080|P3|STARTED|Overall Study||27
5040775|NCT02016170|12404081|P2|STARTED|Overall Study||28
5040776|NCT02016170|12404082|P1|STARTED|Overall Study||27
5040777|NCT02016105|12404093|P6|NOT COMPLETED|EXTENSION PERIOD||6
5040778|NCT02016105|12404094|P5|NOT COMPLETED|EXTENSION PERIOD||6
5040779|NCT02016105|12404095|P4|NOT COMPLETED|EXTENSION PERIOD||5
5040780|NCT02016105|12404096|P3|NOT COMPLETED|EXTENSION PERIOD||5
5040781|NCT02016105|12404097|P2|NOT COMPLETED|EXTENSION PERIOD||0
5040782|NCT02016105|12404098|P1|NOT COMPLETED|EXTENSION PERIOD||0
5040783|NCT02016105|12404093|P6|COMPLETED|EXTENSION PERIOD||100
5040784|NCT02016105|12404094|P5|COMPLETED|EXTENSION PERIOD||50
5040785|NCT02016105|12404095|P4|COMPLETED|EXTENSION PERIOD||104
5040786|NCT02016105|12404096|P3|COMPLETED|EXTENSION PERIOD||47
5040787|NCT02016105|12404097|P2|COMPLETED|EXTENSION PERIOD||0
5040788|NCT02016105|12404098|P1|COMPLETED|EXTENSION PERIOD||0
5040789|NCT02016105|12404093|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
5040790|NCT02016105|12404094|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
5040791|NCT02016105|12404095|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
5040792|NCT02016105|12404096|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
5040793|NCT02016105|12404097|P2|STARTED|EXTENSION PERIOD||0
5040794|NCT02016105|12404098|P1|STARTED|EXTENSION PERIOD||0
5040795|NCT02016105|12404093|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
5040796|NCT02016105|12404094|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
5040797|NCT02016105|12404095|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
5040798|NCT02016105|12404096|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
5040799|NCT02016105|12404097|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
5040800|NCT02016105|12404098|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
5040801|NCT02016105|12404093|P6|COMPLETED|TREATMENT PERIOD 2||112
5040802|NCT02016105|12404094|P5|COMPLETED|TREATMENT PERIOD 2||59
5040803|NCT02016105|12404095|P4|COMPLETED|TREATMENT PERIOD 2||116
5040804|NCT02016105|12404096|P3|COMPLETED|TREATMENT PERIOD 2||57
5040805|NCT02016105|12404097|P2|COMPLETED|TREATMENT PERIOD 2||0
5040806|NCT02016105|12404098|P1|COMPLETED|TREATMENT PERIOD 2||0
5040807|NCT02016105|12404093|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
5040808|NCT02016105|12404094|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
5040809|NCT02016105|12404095|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
5040810|NCT02016105|12404096|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
5040811|NCT02016105|12404097|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
5040812|NCT02016105|12404098|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
5040813|NCT02016105|12404093|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
5040814|NCT02016105|12404094|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
5040815|NCT02016105|12404095|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
5040816|NCT02016105|12404096|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
5040817|NCT02016105|12404097|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
5040818|NCT02016105|12404098|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
5040819|NCT02016105|12404093|P6|COMPLETED|TREATMENT PERIOD 1||0
5040820|NCT02016105|12404094|P5|COMPLETED|TREATMENT PERIOD 1||0
5040821|NCT02016105|12404095|P4|COMPLETED|TREATMENT PERIOD 1||0
5040822|NCT02016105|12404096|P3|COMPLETED|TREATMENT PERIOD 1||0
5040823|NCT02016105|12404097|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
5040824|NCT02016105|12404098|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
5040825|NCT02016105|12404093|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5040826|NCT02016105|12404094|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5040827|NCT02016105|12404095|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5040828|NCT02016105|12404096|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5040829|NCT02016105|12404097|P2|STARTED|TREATMENT PERIOD 1||234
5040830|NCT02016105|12404098|P1|STARTED|TREATMENT PERIOD 1||231
5040831|NCT02015910|12404148|P2|NOT COMPLETED|Overall Study||0
5040832|NCT02015910|12404149|P1|NOT COMPLETED|Overall Study||0
5040833|NCT02015910|12404148|P2|COMPLETED|Overall Study||1
5040834|NCT02015910|12404149|P1|COMPLETED|Overall Study||0
5040835|NCT02015910|12404148|P2|STARTED|Overall Study||1
5040836|NCT02015910|12404149|P1|STARTED|Overall Study||0
5040837|NCT02015793|12404157|P2|NOT COMPLETED|Overall Study||4
5040838|NCT02015793|12404158|P1|NOT COMPLETED|Overall Study||4
5040839|NCT02015793|12404157|P2|COMPLETED|Overall Study||11
5040840|NCT02015793|12404158|P1|COMPLETED|Overall Study||11
5040841|NCT02015793|12404157|P2|Entered Open-label Extension Period|Overall Study||14
5040842|NCT02015793|12404158|P1|Entered Open-label Extension Period|Overall Study||13
5040843|NCT02015793|12404157|P2|Completed Double-Blind Period|Overall Study||14
5040844|NCT02015793|12404158|P1|Completed Double-Blind Period|Overall Study||14
5040845|NCT02015793|12404157|P2|STARTED|Overall Study||15
5040846|NCT02015793|12404158|P1|STARTED|Overall Study||15
5040847|NCT02015754|12404188|P1|NOT COMPLETED|Overall Study||11
5040848|NCT02015754|12404188|P1|COMPLETED|Overall Study||3
5040849|NCT02015754|12404188|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
5040850|NCT02015754|12404188|P1|Completed First TACE|Overall Study||14
5040851|NCT02015754|12404188|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
5040852|NCT02015676|12404208|P3|NOT COMPLETED|Overall Study||3
5040853|NCT02015676|12404209|P2|NOT COMPLETED|Overall Study||34
5040854|NCT02015676|12404210|P1|NOT COMPLETED|Overall Study||9
5040855|NCT02015676|12404208|P3|COMPLETED|Overall Study||3
5040856|NCT02015676|12404209|P2|COMPLETED|Overall Study||14
5040857|NCT02015676|12404210|P1|COMPLETED|Overall Study||6
5040858|NCT02015676|12404208|P3|STARTED|Overall Study||6
5040859|NCT02015676|12404209|P2|STARTED|Overall Study||48
5040860|NCT02015676|12404210|P1|STARTED|Overall Study||15
5040861|NCT02015663|12404226|P2|NOT COMPLETED|Overall Study||12
5040862|NCT02015663|12404227|P1|NOT COMPLETED|Overall Study||15
5040863|NCT02015663|12404226|P2|COMPLETED|Overall Study||4
5040864|NCT02015663|12404227|P1|COMPLETED|Overall Study||1
5040865|NCT02015663|12404226|P2|STARTED|Overall Study||16
5040866|NCT02015663|12404227|P1|STARTED|Overall Study||16
5040867|NCT02015637|12404258|P2|NOT COMPLETED|Overall Study||5
5040868|NCT02015637|12404259|P1|NOT COMPLETED|Overall Study||8
5040869|NCT02015637|12404258|P2|COMPLETED|Overall Study||149
5040870|NCT02015637|12404259|P1|COMPLETED|Overall Study||298
5040871|NCT02015637|12404258|P2|STARTED|Overall Study||154
5040872|NCT02015637|12404259|P1|STARTED|Overall Study||306
5040873|NCT02015546|12404270|P3|NOT COMPLETED|Overall Study||4
5040874|NCT02015546|12404271|P2|NOT COMPLETED|Overall Study||2
5040875|NCT02015546|12404272|P1|NOT COMPLETED|Overall Study||3
5040876|NCT02015546|12404270|P3|COMPLETED|Overall Study||22
5040877|NCT02015546|12404271|P2|COMPLETED|Overall Study||19
5040878|NCT02015546|12404272|P1|COMPLETED|Overall Study||20
5040879|NCT02015546|12404270|P3|STARTED|Overall Study||26
5040880|NCT02015546|12404271|P2|STARTED|Overall Study||21
5040881|NCT02015546|12404272|P1|STARTED|Overall Study||23
5040882|NCT02015481|12404304|P1|NOT COMPLETED|Overall Study||1
5040883|NCT02015481|12404304|P1|COMPLETED|Overall Study||24
5040884|NCT02015481|12404304|P1|STARTED|Overall Study||25
5040885|NCT02015442|12404311|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5040886|NCT02015442|12404312|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5040887|NCT02015442|12404311|P2|COMPLETED|Second Intervention (7 Days)||4
5040888|NCT02015442|12404312|P1|COMPLETED|Second Intervention (7 Days)||5
5040889|NCT02015442|12404311|P2|STARTED|Second Intervention (7 Days)||4
5040890|NCT02015442|12404312|P1|STARTED|Second Intervention (7 Days)||5
5040891|NCT02015442|12404311|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
5040892|NCT02015442|12404312|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
5040893|NCT02015442|12404311|P2|COMPLETED|Wash-out (4 Weeks)||4
5040894|NCT02015442|12404312|P1|COMPLETED|Wash-out (4 Weeks)||5
5040895|NCT02015442|12404311|P2|STARTED|Wash-out (4 Weeks)||4
5040896|NCT02015442|12404312|P1|STARTED|Wash-out (4 Weeks)||5
5040897|NCT02015442|12404311|P2|NOT COMPLETED|First Intervention (7 Days)||0
5040898|NCT02015442|12404312|P1|NOT COMPLETED|First Intervention (7 Days)||0
5040899|NCT02015442|12404311|P2|COMPLETED|First Intervention (7 Days)||4
5040900|NCT02015442|12404312|P1|COMPLETED|First Intervention (7 Days)||5
5040901|NCT02015442|12404311|P2|STARTED|First Intervention (7 Days)||4
5040902|NCT02015442|12404312|P1|STARTED|First Intervention (7 Days)||5
5040903|NCT02015234|12404322|P2|NOT COMPLETED|Overall Study||25
5040904|NCT02015234|12404323|P1|NOT COMPLETED|Overall Study||36
5040905|NCT02015234|12404322|P2|COMPLETED|Overall Study||54
5040906|NCT02015234|12404323|P1|COMPLETED|Overall Study||43
5040907|NCT02015234|12404322|P2|STARTED|Overall Study||79
5040908|NCT02015234|12404323|P1|STARTED|Overall Study||79
5040909|NCT02015221|12404337|P2|NOT COMPLETED|Overall Study||6
5040910|NCT02015221|12404338|P1|NOT COMPLETED|Overall Study||9
5040911|NCT02015221|12404337|P2|COMPLETED|Overall Study||34
5040912|NCT02015221|12404338|P1|COMPLETED|Overall Study||32
5040913|NCT02015221|12404337|P2|STARTED|Overall Study||40
5040914|NCT02015221|12404338|P1|STARTED|Overall Study||41
5040915|NCT02015195|12404351|P7|NOT COMPLETED|Overall Study||0
5040916|NCT02015195|12404352|P6|NOT COMPLETED|Overall Study||0
5040917|NCT02015195|12404353|P5|NOT COMPLETED|Overall Study||0
5040918|NCT02015195|12404354|P4|NOT COMPLETED|Overall Study||1
5040919|NCT02015195|12404355|P3|NOT COMPLETED|Overall Study||0
5040920|NCT02015195|12404356|P2|NOT COMPLETED|Overall Study||0
5040921|NCT02015195|12404357|P1|NOT COMPLETED|Overall Study||0
5040922|NCT02015195|12404351|P7|COMPLETED|Overall Study||16
5040923|NCT02015195|12404352|P6|COMPLETED|Overall Study||16
5040924|NCT02015195|12404353|P5|COMPLETED|Overall Study||16
5040925|NCT02015195|12404354|P4|COMPLETED|Overall Study||0
5040926|NCT02015195|12404355|P3|COMPLETED|Overall Study||16
5040927|NCT02015195|12404356|P2|COMPLETED|Overall Study||16
5040928|NCT02015195|12404357|P1|COMPLETED|Overall Study||16
5040929|NCT02015195|12404351|P7|STARTED|Overall Study||16
5040930|NCT02015195|12404352|P6|STARTED|Overall Study||16
5040931|NCT02015195|12404353|P5|STARTED|Overall Study||16
5040932|NCT02015195|12404354|P4|STARTED|Overall Study||1
5040933|NCT02015195|12404355|P3|STARTED|Overall Study||16
5040934|NCT02015195|12404356|P2|STARTED|Overall Study||16
5040935|NCT02015195|12404357|P1|STARTED|Overall Study||16
5040936|NCT02015104|12404380|P2|NOT COMPLETED|Overall Study||1
5040937|NCT02015104|12404381|P1|NOT COMPLETED|Overall Study||1
5040938|NCT02015104|12404380|P2|COMPLETED|Overall Study||15
5040939|NCT02015104|12404381|P1|COMPLETED|Overall Study||15
5040940|NCT02015104|12404380|P2|STARTED|Overall Study||16
5040941|NCT02015104|12404381|P1|STARTED|Overall Study||16
5040942|NCT02015065|12404398|P3|NOT COMPLETED|Overall Study||1
5040943|NCT02015065|12404399|P2|NOT COMPLETED|Overall Study||2
5040944|NCT02015065|12404400|P1|NOT COMPLETED|Overall Study||1
5040945|NCT02015065|12404398|P3|COMPLETED|Overall Study||1
5040946|NCT02015065|12404399|P2|COMPLETED|Overall Study||3
5040947|NCT02015065|12404400|P1|COMPLETED|Overall Study||1
5040948|NCT02015065|12404398|P3|STARTED|Overall Study||2
5040949|NCT02015065|12404399|P2|STARTED|Overall Study||5
5040950|NCT02015065|12404400|P1|STARTED|Overall Study||2
5040951|NCT02015039|12404422|P2|NOT COMPLETED|Overall Study||1
5040952|NCT02015039|12404423|P1|NOT COMPLETED|Overall Study||0
5040953|NCT02015039|12404422|P2|COMPLETED|Overall Study||6
5040954|NCT02015039|12404423|P1|COMPLETED|Overall Study||6
5040955|NCT02015039|12404422|P2|STARTED|Overall Study||7
5040956|NCT02015039|12404423|P1|STARTED|Overall Study||6
5040957|NCT02014740|12404443|P2|NOT COMPLETED|Overall Study||5
5040958|NCT02014740|12404444|P1|NOT COMPLETED|Overall Study||6
5040959|NCT02014740|12404443|P2|COMPLETED|Overall Study||40
5040960|NCT02014740|12404444|P1|COMPLETED|Overall Study||49
5040961|NCT02014740|12404443|P2|STARTED|Overall Study||45
5040962|NCT02014740|12404444|P1|STARTED|Overall Study||55
5040963|NCT02014584|12404452|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040964|NCT02014584|12404453|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
5040965|NCT02014584|12404454|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040966|NCT02014584|12404455|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040967|NCT02014584|12404456|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040968|NCT02014584|12404457|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040969|NCT02014584|12404452|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
5040970|NCT02014584|12404453|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
5040971|NCT02014584|12404454|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040972|NCT02014584|12404455|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040973|NCT02014584|12404456|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040974|NCT02014584|12404457|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
5040975|NCT02014584|12404452|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
5040976|NCT02014584|12404453|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
5040977|NCT02014584|12404454|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
5040978|NCT02014584|12404455|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
5040979|NCT02014584|12404456|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
5040980|NCT02014584|12404457|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
5040981|NCT02014584|12404452|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
5040982|NCT02014584|12404453|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
5040983|NCT02014584|12404454|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
5040984|NCT02014584|12404455|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
5040985|NCT02014584|12404456|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
5040986|NCT02014584|12404457|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
5040987|NCT02014584|12404452|P6|COMPLETED|Open-Label Period (24 Weeks)||0
5040988|NCT02014584|12404453|P5|COMPLETED|Open-Label Period (24 Weeks)||0
5040989|NCT02014584|12404454|P4|COMPLETED|Open-Label Period (24 Weeks)||47
5040990|NCT02014584|12404455|P3|COMPLETED|Open-Label Period (24 Weeks)||44
5040991|NCT02014584|12404456|P2|COMPLETED|Open-Label Period (24 Weeks)||0
5040992|NCT02014584|12404457|P1|COMPLETED|Open-Label Period (24 Weeks)||0
5040993|NCT02014584|12404452|P6|STARTED|Open-Label Period (24 Weeks)||0
5040994|NCT02014584|12404453|P5|STARTED|Open-Label Period (24 Weeks)||0
5040995|NCT02014584|12404454|P4|STARTED|Open-Label Period (24 Weeks)||48
5040996|NCT02014584|12404455|P3|STARTED|Open-Label Period (24 Weeks)||49
5040997|NCT02014584|12404456|P2|STARTED|Open-Label Period (24 Weeks)||0
5040998|NCT02014584|12404457|P1|STARTED|Open-Label Period (24 Weeks)||0
5040999|NCT02014584|12404452|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
5041000|NCT02014584|12404453|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
5041001|NCT02014584|12404454|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
5041002|NCT02014584|12404455|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
5041003|NCT02014584|12404456|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
5041004|NCT02014584|12404457|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
5041005|NCT02014584|12404452|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
5041006|NCT02014584|12404453|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
5041007|NCT02014584|12404454|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
5041008|NCT02014584|12404455|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
5041009|NCT02014584|12404456|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
5041010|NCT02014584|12404457|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
5041011|NCT02014584|12404452|P6|STARTED|Double-Blind Period (24 Weeks)||0
5041012|NCT02014584|12404453|P5|STARTED|Double-Blind Period (24 Weeks)||0
5041013|NCT02014584|12404454|P4|STARTED|Double-Blind Period (24 Weeks)||0
5041014|NCT02014584|12404455|P3|STARTED|Double-Blind Period (24 Weeks)||0
5041015|NCT02014584|12404456|P2|STARTED|Double-Blind Period (24 Weeks)||58
5041016|NCT02014584|12404457|P1|STARTED|Double-Blind Period (24 Weeks)||59
5041017|NCT02014558|12404587|P13|NOT COMPLETED|Overall Study||17
5041018|NCT02014558|12404588|P12|NOT COMPLETED|Overall Study||102
5041019|NCT02014558|12404589|P11|NOT COMPLETED|Overall Study||69
5041020|NCT02014558|12404590|P10|NOT COMPLETED|Overall Study||21
5041021|NCT02014558|12404591|P9|NOT COMPLETED|Overall Study||15
5041022|NCT02014558|12404592|P8|NOT COMPLETED|Overall Study||11
5041023|NCT02014558|12404593|P7|NOT COMPLETED|Overall Study||4
5041024|NCT02014558|12404594|P6|NOT COMPLETED|Overall Study||3
5041025|NCT02014558|12404595|P5|NOT COMPLETED|Overall Study||4
5041026|NCT02014558|12404596|P4|NOT COMPLETED|Overall Study||3
5041027|NCT02014558|12404597|P3|NOT COMPLETED|Overall Study||3
5041028|NCT02014558|12404598|P2|NOT COMPLETED|Overall Study||3
5041029|NCT02014558|12404599|P1|NOT COMPLETED|Overall Study||5
5041030|NCT02014558|12404587|P13|COMPLETED|Overall Study||0
5041031|NCT02014558|12404588|P12|COMPLETED|Overall Study||0
5041032|NCT02014558|12404589|P11|COMPLETED|Overall Study||0
5041033|NCT02014558|12404590|P10|COMPLETED|Overall Study||0
5041034|NCT02014558|12404591|P9|COMPLETED|Overall Study||0
5041035|NCT02014558|12404592|P8|COMPLETED|Overall Study||0
5041036|NCT02014558|12404593|P7|COMPLETED|Overall Study||0
5041037|NCT02014558|12404594|P6|COMPLETED|Overall Study||0
5041038|NCT02014558|12404595|P5|COMPLETED|Overall Study||0
5041039|NCT02014558|12404596|P4|COMPLETED|Overall Study||0
5041040|NCT02014558|12404597|P3|COMPLETED|Overall Study||0
5041041|NCT02014558|12404598|P2|COMPLETED|Overall Study||0
5041042|NCT02014558|12404599|P1|COMPLETED|Overall Study||0
5041043|NCT02014558|12404587|P13|Treated|Overall Study||17
5041044|NCT02014558|12404588|P12|Treated|Overall Study||100
5041045|NCT02014558|12404589|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
5041046|NCT02014558|12404590|P10|Treated|Overall Study||21
5041047|NCT02014558|12404591|P9|Treated|Overall Study||13
5041048|NCT02014558|12404592|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
5041049|NCT02014558|12404593|P7|Treated|Overall Study||3
5041050|NCT02014558|12404594|P6|Treated|Overall Study||3
5041051|NCT02014558|12404595|P5|Treated|Overall Study||3
5041052|NCT02014558|12404596|P4|Treated|Overall Study||3
5041053|NCT02014558|12404597|P3|Treated|Overall Study||3
5041054|NCT02014558|12404598|P2|Treated|Overall Study||3
5041055|NCT02014558|12404599|P1|Treated|Overall Study||5
5041056|NCT02014558|12404587|P13|STARTED|Overall Study||17
5041057|NCT02014558|12404588|P12|STARTED|Overall Study||102
5041058|NCT02014558|12404589|P11|STARTED|Overall Study||69
5041059|NCT02014558|12404590|P10|STARTED|Overall Study||21
5041060|NCT02014558|12404591|P9|STARTED|Overall Study||15
5041061|NCT02014558|12404592|P8|STARTED|Overall Study||11
5041062|NCT02014558|12404593|P7|STARTED|Overall Study||4
5041063|NCT02014558|12404594|P6|STARTED|Overall Study||3
5041064|NCT02014558|12404595|P5|STARTED|Overall Study||4
5041065|NCT02014558|12404596|P4|STARTED|Overall Study||3
5041066|NCT02014558|12404597|P3|STARTED|Overall Study||3
5041067|NCT02014558|12404598|P2|STARTED|Overall Study||3
5041068|NCT02014558|12404599|P1|STARTED|Overall Study||5
5041069|NCT02014519|12404907|P1|NOT COMPLETED|Overall Study||0
5041070|NCT02014519|12404907|P1|COMPLETED|Overall Study||2000
5041071|NCT02014519|12404907|P1|STARTED|Overall Study||2000
5041072|NCT02014480|12404964|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
5041073|NCT02014480|12404965|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5041074|NCT02014480|12404966|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5041075|NCT02014480|12404967|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5041076|NCT02014480|12404968|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5041077|NCT02014480|12404969|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5041078|NCT02014480|12404964|P6|COMPLETED|Treatment Period 3 (14 Days)||32
5041079|NCT02014480|12404965|P5|COMPLETED|Treatment Period 3 (14 Days)||34
5041080|NCT02014480|12404966|P4|COMPLETED|Treatment Period 3 (14 Days)||31
5041081|NCT02014480|12404967|P3|COMPLETED|Treatment Period 3 (14 Days)||29
5041082|NCT02014480|12404968|P2|COMPLETED|Treatment Period 3 (14 Days)||32
5041083|NCT02014480|12404969|P1|COMPLETED|Treatment Period 3 (14 Days)||34
5041084|NCT02014480|12404964|P6|STARTED|Treatment Period 3 (14 Days)||34
5041085|NCT02014480|12404965|P5|STARTED|Treatment Period 3 (14 Days)||34
5041086|NCT02014480|12404966|P4|STARTED|Treatment Period 3 (14 Days)||31
5041087|NCT02014480|12404967|P3|STARTED|Treatment Period 3 (14 Days)||30
5041088|NCT02014480|12404968|P2|STARTED|Treatment Period 3 (14 Days)||33
5041089|NCT02014480|12404969|P1|STARTED|Treatment Period 3 (14 Days)||34
5041090|NCT02014480|12404964|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041091|NCT02014480|12404965|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041092|NCT02014480|12404966|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041093|NCT02014480|12404967|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041094|NCT02014480|12404968|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041095|NCT02014480|12404969|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5041096|NCT02014480|12404964|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
5041097|NCT02014480|12404965|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
5041098|NCT02014480|12404966|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
5041099|NCT02014480|12404967|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
5041100|NCT02014480|12404968|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
5041101|NCT02014480|12404969|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
5041102|NCT02014480|12404964|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
5041103|NCT02014480|12404965|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
5041104|NCT02014480|12404966|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
5041105|NCT02014480|12404967|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
5041106|NCT02014480|12404968|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
5041107|NCT02014480|12404969|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
5041108|NCT02014480|12404964|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5041109|NCT02014480|12404965|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5041110|NCT02014480|12404966|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5041111|NCT02014480|12404967|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
5041112|NCT02014480|12404968|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5041113|NCT02014480|12404969|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5041114|NCT02014480|12404964|P6|COMPLETED|Treatment Period 2 (14 Days)||34
5041115|NCT02014480|12404965|P5|COMPLETED|Treatment Period 2 (14 Days)||34
5041116|NCT02014480|12404966|P4|COMPLETED|Treatment Period 2 (14 Days)||31
5041117|NCT02014480|12404967|P3|COMPLETED|Treatment Period 2 (14 Days)||30
5041118|NCT02014480|12404968|P2|COMPLETED|Treatment Period 2 (14 Days)||33
5041119|NCT02014480|12404969|P1|COMPLETED|Treatment Period 2 (14 Days)||34
5041120|NCT02014480|12404964|P6|STARTED|Treatment Period 2 (14 Days)||34
5041121|NCT02014480|12404965|P5|STARTED|Treatment Period 2 (14 Days)||34
5041122|NCT02014480|12404966|P4|STARTED|Treatment Period 2 (14 Days)||32
5041123|NCT02014480|12404967|P3|STARTED|Treatment Period 2 (14 Days)||32
5041124|NCT02014480|12404968|P2|STARTED|Treatment Period 2 (14 Days)||34
5041125|NCT02014480|12404969|P1|STARTED|Treatment Period 2 (14 Days)||35
5041126|NCT02014480|12404964|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5041127|NCT02014480|12404965|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5041128|NCT02014480|12404966|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5041129|NCT02014480|12404967|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
5041130|NCT02014480|12404968|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5041131|NCT02014480|12404969|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5041132|NCT02014480|12404964|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
5041133|NCT02014480|12404965|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
5041134|NCT02014480|12404966|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
5041135|NCT02014480|12404967|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
5041136|NCT02014480|12404968|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
5041137|NCT02014480|12404969|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
5041138|NCT02014480|12404964|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
5041139|NCT02014480|12404965|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
5041140|NCT02014480|12404966|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
5041141|NCT02014480|12404967|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
5041142|NCT02014480|12404968|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
5041143|NCT02014480|12404969|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
5041144|NCT02014480|12404964|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5041145|NCT02014480|12404965|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5041146|NCT02014480|12404966|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5041147|NCT02014480|12404967|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5041148|NCT02014480|12404968|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5041149|NCT02014480|12404969|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5041150|NCT02014480|12404964|P6|COMPLETED|Treatment Period 1 (14 Days)||34
5041151|NCT02014480|12404965|P5|COMPLETED|Treatment Period 1 (14 Days)||34
5041152|NCT02014480|12404966|P4|COMPLETED|Treatment Period 1 (14 Days)||32
5041153|NCT02014480|12404967|P3|COMPLETED|Treatment Period 1 (14 Days)||33
5041154|NCT02014480|12404968|P2|COMPLETED|Treatment Period 1 (14 Days)||34
5041155|NCT02014480|12404969|P1|COMPLETED|Treatment Period 1 (14 Days)||35
5041156|NCT02014480|12404964|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
5041157|NCT02014480|12404965|P5|STARTED|Treatment Period 1 (14 Days)||35
5041158|NCT02014480|12404966|P4|STARTED|Treatment Period 1 (14 Days)||34
5041159|NCT02014480|12404967|P3|STARTED|Treatment Period 1 (14 Days)||34
5041160|NCT02014480|12404968|P2|STARTED|Treatment Period 1 (14 Days)||35
5041161|NCT02014480|12404969|P1|STARTED|Treatment Period 1 (14 Days)||35
5041162|NCT02014467|12404988|P2|NOT COMPLETED|Overall Study||7
5041163|NCT02014467|12404989|P1|NOT COMPLETED|Overall Study||25
5041164|NCT02014467|12404988|P2|COMPLETED|Overall Study||112
5041165|NCT02014467|12404989|P1|COMPLETED|Overall Study||340
5041166|NCT02014467|12404988|P2|STARTED|Overall Study||119
5041167|NCT02014467|12404989|P1|STARTED|Overall Study||365
5041168|NCT02014441|12405049|P1|NOT COMPLETED|Overall Study||12
5041169|NCT02014441|12405049|P1|COMPLETED|Overall Study||49
5041170|NCT02014441|12405049|P1|Received Treatment|Overall Study||60
5041171|NCT02014441|12405049|P1|STARTED|Overall Study||61
5041172|NCT02014402|12405145|P4|NOT COMPLETED|Overall Study||3
5041173|NCT02014402|12405146|P3|NOT COMPLETED|Overall Study||3
5041174|NCT02014402|12405147|P2|NOT COMPLETED|Overall Study||3
5041175|NCT02014402|12405148|P1|NOT COMPLETED|Overall Study||2
5041176|NCT02014402|12405145|P4|COMPLETED|Overall Study||82
5041177|NCT02014402|12405146|P3|COMPLETED|Overall Study||32
5041178|NCT02014402|12405147|P2|COMPLETED|Overall Study||27
5041179|NCT02014402|12405148|P1|COMPLETED|Overall Study||29
5041180|NCT02014402|12405145|P4|Bovine Thrombin|Overall Study||28
5041181|NCT02014402|12405146|P3|Bovine Thrombin|Overall Study||12
5041182|NCT02014402|12405147|P2|Bovine Thrombin|Overall Study||10
5041183|NCT02014402|12405148|P1|Bovine Thrombin|Overall Study||11
5041184|NCT02014402|12405145|P4|Human Thrombin|Overall Study||57
5041185|NCT02014402|12405146|P3|Human Thrombin|Overall Study||23
5041186|NCT02014402|12405147|P2|Human Thrombin|Overall Study||20
5041187|NCT02014402|12405148|P1|Human Thrombin|Overall Study||20
5041188|NCT02014402|12405145|P4|STARTED|Overall Study||85
5041189|NCT02014402|12405146|P3|STARTED|Overall Study||35
5041190|NCT02014402|12405147|P2|STARTED|Overall Study||30
5041191|NCT02014402|12405148|P1|STARTED|Overall Study||31
5041192|NCT02014376|12405178|P3|NOT COMPLETED|Overall Study||0
5041193|NCT02014376|12405179|P2|NOT COMPLETED|Overall Study||1
5041194|NCT02014376|12405180|P1|NOT COMPLETED|Overall Study||3
5041195|NCT02014376|12405178|P3|COMPLETED|Overall Study||17
5041196|NCT02014376|12405179|P2|COMPLETED|Overall Study||15
5041197|NCT02014376|12405180|P1|COMPLETED|Overall Study||12
5041198|NCT02014376|12405178|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
5041199|NCT02014376|12405179|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
5041200|NCT02014376|12405180|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
5041201|NCT02014376|12405178|P3|STARTED|Overall Study||17
5041202|NCT02014376|12405179|P2|STARTED|Overall Study||16
5041203|NCT02014376|12405180|P1|STARTED|Overall Study||15
5041204|NCT02014363|12405206|P3|NOT COMPLETED|Overall Study||24
5041205|NCT02014363|12405207|P2|NOT COMPLETED|Overall Study||19
5041206|NCT02014363|12405208|P1|NOT COMPLETED|Overall Study||17
5041207|NCT02014363|12405206|P3|COMPLETED|Overall Study||31
5041208|NCT02014363|12405207|P2|COMPLETED|Overall Study||35
5041209|NCT02014363|12405208|P1|COMPLETED|Overall Study||38
5041210|NCT02014363|12405206|P3|STARTED|Overall Study||55
5041211|NCT02014363|12405207|P2|STARTED|Overall Study||54
5041212|NCT02014363|12405208|P1|STARTED|Overall Study||55
5041213|NCT02014272|12405216|P2|NOT COMPLETED|Intervention Period 2||0
5041214|NCT02014272|12405217|P1|NOT COMPLETED|Intervention Period 2||0
5041215|NCT02014272|12405216|P2|COMPLETED|Intervention Period 2||13
5041216|NCT02014272|12405217|P1|COMPLETED|Intervention Period 2||13
5041217|NCT02014272|12405216|P2|STARTED|Intervention Period 2||13
5041218|NCT02014272|12405217|P1|STARTED|Intervention Period 2||13
5041219|NCT02014272|12405216|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5041220|NCT02014272|12405217|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5041221|NCT02014272|12405216|P2|COMPLETED|Washout Period 1 (7 Days)||13
5041222|NCT02014272|12405217|P1|COMPLETED|Washout Period 1 (7 Days)||13
5041223|NCT02014272|12405216|P2|STARTED|Washout Period 1 (7 Days)||13
5041224|NCT02014272|12405217|P1|STARTED|Washout Period 1 (7 Days)||13
5041225|NCT02014272|12405216|P2|NOT COMPLETED|Intervention Period 1||1
5041226|NCT02014272|12405217|P1|NOT COMPLETED|Intervention Period 1||1
5041227|NCT02014272|12405216|P2|COMPLETED|Intervention Period 1||13
5041228|NCT02014272|12405217|P1|COMPLETED|Intervention Period 1||13
5041229|NCT02014272|12405216|P2|STARTED|Intervention Period 1||14
5041230|NCT02014272|12405217|P1|STARTED|Intervention Period 1||14
5041231|NCT02014116|12405244|P9|NOT COMPLETED|Overall Study||10
5041232|NCT02014116|12405245|P8|NOT COMPLETED|Overall Study||5
5041233|NCT02014116|12405246|P7|NOT COMPLETED|Overall Study||1
5041234|NCT02014116|12405247|P6|NOT COMPLETED|Overall Study||16
5041235|NCT02014116|12405248|P5|NOT COMPLETED|Overall Study||2
5041236|NCT02014116|12405249|P4|NOT COMPLETED|Overall Study||7
5041237|NCT02014116|12405250|P3|NOT COMPLETED|Overall Study||3
5041238|NCT02014116|12405251|P2|NOT COMPLETED|Overall Study||4
5041239|NCT02014116|12405252|P1|NOT COMPLETED|Overall Study||3
5041240|NCT02014116|12405244|P9|COMPLETED|Overall Study||0
5041241|NCT02014116|12405245|P8|COMPLETED|Overall Study||0
5041242|NCT02014116|12405246|P7|COMPLETED|Overall Study||0
5041243|NCT02014116|12405247|P6|COMPLETED|Overall Study||0
5041244|NCT02014116|12405248|P5|COMPLETED|Overall Study||0
5041245|NCT02014116|12405249|P4|COMPLETED|Overall Study||0
5041246|NCT02014116|12405250|P3|COMPLETED|Overall Study||0
5041247|NCT02014116|12405251|P2|COMPLETED|Overall Study||0
5041248|NCT02014116|12405252|P1|COMPLETED|Overall Study||0
5041249|NCT02014116|12405244|P9|Received at Least One Dose of Study Drug|Overall Study||10
5041250|NCT02014116|12405245|P8|Received at Least One Dose of Study Drug|Overall Study||5
5041251|NCT02014116|12405246|P7|Received at Least One Dose of Study Drug|Overall Study||1
5041252|NCT02014116|12405247|P6|Received at Least One Dose of Study Drug|Overall Study||16
5041253|NCT02014116|12405248|P5|Received at Least One Dose of Study Drug|Overall Study||2
5041254|NCT02014116|12405249|P4|Received at Least One Dose of Study Drug|Overall Study||7
5041255|NCT02014116|12405250|P3|Received at Least One Dose of Study Drug|Overall Study||3
5041256|NCT02014116|12405251|P2|Received at Least One Dose of Study Drug|Overall Study||4
5041257|NCT02014116|12405252|P1|Received at Least One Dose of Study Drug|Overall Study||3
5041258|NCT02014116|12405244|P9|STARTED|Overall Study||10
5041259|NCT02014116|12405245|P8|STARTED|Overall Study||5
5041260|NCT02014116|12405246|P7|STARTED|Overall Study||1
5041261|NCT02014116|12405247|P6|STARTED|Overall Study||16
5041262|NCT02014116|12405248|P5|STARTED|Overall Study||2
5041263|NCT02014116|12405249|P4|STARTED|Overall Study||7
5041264|NCT02014116|12405250|P3|STARTED|Overall Study||3
5041265|NCT02014116|12405251|P2|STARTED|Overall Study||4
5041266|NCT02014116|12405252|P1|STARTED|Overall Study||3
5041267|NCT02014051|12405303|P2|NOT COMPLETED|Overall Study||1
5041268|NCT02014051|12405304|P1|NOT COMPLETED|Overall Study||1
5041269|NCT02014051|12405303|P2|COMPLETED|Overall Study||5
5041270|NCT02014051|12405304|P1|COMPLETED|Overall Study||2
5041271|NCT02014051|12405303|P2|STARTED|Overall Study||6
5041272|NCT02014051|12405304|P1|STARTED|Overall Study||3
5041273|NCT02013830|12405317|P1|NOT COMPLETED|Overall Study||30
5041274|NCT02013830|12405317|P1|COMPLETED|Overall Study||15
5041275|NCT02013830|12405317|P1|STARTED|Overall Study||45
5041276|NCT02013817|12405328|P1|NOT COMPLETED|Overall Study||27
5041277|NCT02013817|12405328|P1|COMPLETED|Overall Study||16
5041278|NCT02013817|12405328|P1|STARTED|Overall Study||43
5041279|NCT02013791|12405346|P9|NOT COMPLETED|Period 2||0
5041280|NCT02013791|12405347|P8|NOT COMPLETED|Period 2||0
5041281|NCT02013791|12405348|P7|NOT COMPLETED|Period 2||0
5041282|NCT02013791|12405349|P6|NOT COMPLETED|Period 2||0
5041283|NCT02013791|12405350|P5|NOT COMPLETED|Period 2||0
5041284|NCT02013791|12405351|P4|NOT COMPLETED|Period 2||0
5041285|NCT02013791|12405352|P3|NOT COMPLETED|Period 2||0
5041286|NCT02013791|12405353|P2|NOT COMPLETED|Period 2||0
5041287|NCT02013791|12405354|P1|NOT COMPLETED|Period 2||0
5041288|NCT02013791|12405346|P9|COMPLETED|Period 2||0
5041289|NCT02013791|12405347|P8|COMPLETED|Period 2||0
5041290|NCT02013791|12405348|P7|COMPLETED|Period 2||3
5041291|NCT02013791|12405349|P6|COMPLETED|Period 2||0
5041292|NCT02013791|12405350|P5|COMPLETED|Period 2||0
5041293|NCT02013791|12405351|P4|COMPLETED|Period 2||0
5041294|NCT02013791|12405352|P3|COMPLETED|Period 2||2
5041295|NCT02013791|12405353|P2|COMPLETED|Period 2||0
5041296|NCT02013791|12405354|P1|COMPLETED|Period 2||0
5041297|NCT02013791|12405346|P9|STARTED|Period 2||0
5041298|NCT02013791|12405347|P8|STARTED|Period 2||0
5041299|NCT02013791|12405348|P7|STARTED|Period 2||3
5041300|NCT02013791|12405349|P6|STARTED|Period 2||0
5041301|NCT02013791|12405350|P5|STARTED|Period 2||0
5041302|NCT02013791|12405351|P4|STARTED|Period 2||0
5041303|NCT02013791|12405352|P3|STARTED|Period 2||2
5041304|NCT02013791|12405353|P2|STARTED|Period 2||0
5041305|NCT02013791|12405354|P1|STARTED|Period 2||0
5041306|NCT02013791|12405346|P9|NOT COMPLETED|Period 1||0
5041307|NCT02013791|12405347|P8|NOT COMPLETED|Period 1||1
5041308|NCT02013791|12405348|P7|NOT COMPLETED|Period 1||1
5041309|NCT02013791|12405349|P6|NOT COMPLETED|Period 1||0
5041310|NCT02013791|12405350|P5|NOT COMPLETED|Period 1||0
5041311|NCT02013791|12405351|P4|NOT COMPLETED|Period 1||1
5041312|NCT02013791|12405352|P3|NOT COMPLETED|Period 1||0
5041313|NCT02013791|12405353|P2|NOT COMPLETED|Period 1||2
5041314|NCT02013791|12405354|P1|NOT COMPLETED|Period 1||0
5041315|NCT02013791|12405346|P9|COMPLETED|Period 1||3
5041316|NCT02013791|12405347|P8|COMPLETED|Period 1||7
5041317|NCT02013791|12405348|P7|COMPLETED|Period 1||3
5041318|NCT02013791|12405349|P6|COMPLETED|Period 1||8
5041319|NCT02013791|12405350|P5|COMPLETED|Period 1||4
5041320|NCT02013791|12405351|P4|COMPLETED|Period 1||7
5041321|NCT02013791|12405352|P3|COMPLETED|Period 1||4
5041322|NCT02013791|12405353|P2|COMPLETED|Period 1||6
5041323|NCT02013791|12405354|P1|COMPLETED|Period 1||8
5041324|NCT02013791|12405346|P9|STARTED|Period 1||3
5041325|NCT02013791|12405347|P8|STARTED|Period 1||8
5041326|NCT02013791|12405348|P7|STARTED|Period 1||4
5041327|NCT02013791|12405349|P6|STARTED|Period 1||8
5041328|NCT02013791|12405350|P5|STARTED|Period 1||4
5041329|NCT02013791|12405351|P4|STARTED|Period 1||8
5041330|NCT02013791|12405352|P3|STARTED|Period 1||4
5041331|NCT02013791|12405353|P2|STARTED|Period 1||8
5041332|NCT02013791|12405354|P1|STARTED|Period 1||8
5041333|NCT02013778|12405375|P1|NOT COMPLETED|Overall Study||7
5041334|NCT02013778|12405375|P1|COMPLETED|Overall Study||1
5041335|NCT02013778|12405375|P1|STARTED|Overall Study||8
5041336|NCT02013765|12405379|P1|NOT COMPLETED|Overall Study||1
5041337|NCT02013765|12405379|P1|COMPLETED|Overall Study||4
5041338|NCT02013765|12405379|P1|STARTED|Overall Study||5
5041339|NCT02013687|12405393|P4|NOT COMPLETED|Overall Study||2
5041340|NCT02013687|12405394|P3|NOT COMPLETED|Overall Study||2
5041341|NCT02013687|12405395|P2|NOT COMPLETED|Overall Study||0
5041342|NCT02013687|12405396|P1|NOT COMPLETED|Overall Study||0
5041343|NCT02013687|12405393|P4|COMPLETED|Overall Study||14
5041344|NCT02013687|12405394|P3|COMPLETED|Overall Study||14
5041345|NCT02013687|12405395|P2|COMPLETED|Overall Study||6
5041346|NCT02013687|12405396|P1|COMPLETED|Overall Study||6
5041347|NCT02013687|12405393|P4|STARTED|Overall Study||16
5041348|NCT02013687|12405394|P3|STARTED|Overall Study||16
5041349|NCT02013687|12405395|P2|STARTED|Overall Study||6
5041350|NCT02013687|12405396|P1|STARTED|Overall Study||6
5041351|NCT02013674|12405428|P2|NOT COMPLETED|Overall Study||1
5041352|NCT02013674|12405429|P1|NOT COMPLETED|Overall Study||1
5041353|NCT02013674|12405428|P2|COMPLETED|Overall Study||14
5041354|NCT02013674|12405429|P1|COMPLETED|Overall Study||14
5041355|NCT02013674|12405428|P2|STARTED|Overall Study||15
5041356|NCT02013674|12405429|P1|STARTED|Overall Study||15
5041357|NCT02013622|12405479|P1|NOT COMPLETED|Overall Study||24
5041358|NCT02013622|12405479|P1|COMPLETED|Overall Study||25
5041359|NCT02013622|12405479|P1|STARTED|Overall Study||49
5041360|NCT02013609|12405499|P1|NOT COMPLETED|Overall Study||18
5041361|NCT02013609|12405499|P1|COMPLETED|Overall Study||29
5041362|NCT02013609|12405499|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
5041363|NCT02013544|12405524|P2|NOT COMPLETED|Overall Study||20
5041364|NCT02013544|12405525|P1|NOT COMPLETED|Overall Study||11
5041365|NCT02013544|12405524|P2|COMPLETED|Overall Study||356
5041366|NCT02013544|12405525|P1|COMPLETED|Overall Study||171
5041367|NCT02013544|12405524|P2|ITT Population|Overall Study||325
5041368|NCT02013544|12405525|P1|ITT Population|Overall Study||157
5041369|NCT02013544|12405524|P2|Safety Population|Overall Study||374
5041370|NCT02013544|12405525|P1|Safety Population|Overall Study||180
5041371|NCT02013544|12405524|P2|STARTED|Overall Study||376
5041372|NCT02013544|12405525|P1|STARTED|Overall Study||182
5041373|NCT02013531|12405547|P1|NOT COMPLETED|Overall Study||5
5041374|NCT02013531|12405547|P1|COMPLETED|Overall Study||32
5041375|NCT02013531|12405547|P1|STARTED|Overall Study||37
5041376|NCT02013414|12405569|P1|NOT COMPLETED|Overall Study||0
5041377|NCT02013414|12405569|P1|COMPLETED|Overall Study||9
5041378|NCT02013414|12405569|P1|STARTED|Overall Study||9
5041379|NCT02013388|12405583|P8|NOT COMPLETED|Overall Study||0
5041380|NCT02013388|12405584|P7|NOT COMPLETED|Overall Study||0
5041381|NCT02013388|12405585|P6|NOT COMPLETED|Overall Study||0
5041382|NCT02013388|12405586|P5|NOT COMPLETED|Overall Study||1
5041383|NCT02013388|12405587|P4|NOT COMPLETED|Overall Study||0
5041384|NCT02013388|12405588|P3|NOT COMPLETED|Overall Study||0
5041385|NCT02013388|12405589|P2|NOT COMPLETED|Overall Study||0
5041386|NCT02013388|12405590|P1|NOT COMPLETED|Overall Study||1
5041387|NCT02013388|12405583|P8|COMPLETED|Overall Study||4
5041388|NCT02013388|12405584|P7|COMPLETED|Overall Study||6
5041389|NCT02013388|12405585|P6|COMPLETED|Overall Study||6
5041390|NCT02013388|12405586|P5|COMPLETED|Overall Study||5
5041391|NCT02013388|12405587|P4|COMPLETED|Overall Study||6
5041392|NCT02013388|12405588|P3|COMPLETED|Overall Study||6
5041393|NCT02013388|12405589|P2|COMPLETED|Overall Study||6
5041394|NCT02013388|12405590|P1|COMPLETED|Overall Study||8
5041395|NCT02013388|12405583|P8|STARTED|Overall Study||4
5041396|NCT02013388|12405584|P7|STARTED|Overall Study||6
5041397|NCT02013388|12405585|P6|STARTED|Overall Study||6
5041398|NCT02013388|12405586|P5|STARTED|Overall Study||6
5041399|NCT02013388|12405587|P4|STARTED|Overall Study||6
5041400|NCT02013388|12405588|P3|STARTED|Overall Study||6
5041401|NCT02013388|12405589|P2|STARTED|Overall Study||6
5041402|NCT02013388|12405590|P1|STARTED|Overall Study||9
5041403|NCT02013375|12405624|P1|NOT COMPLETED|Overall Study||2
5041404|NCT02013375|12405624|P1|COMPLETED|Overall Study||0
5041405|NCT02013375|12405624|P1|STARTED|Overall Study||2
5041406|NCT02013245|12405635|P4|NOT COMPLETED|Overall Study||0
5041407|NCT02013245|12405636|P3|NOT COMPLETED|Overall Study||0
5041408|NCT02013245|12405637|P2|NOT COMPLETED|Overall Study||1
5041409|NCT02013245|12405638|P1|NOT COMPLETED|Overall Study||0
5041410|NCT02013245|12405635|P4|COMPLETED|Overall Study||9
5041411|NCT02013245|12405636|P3|COMPLETED|Overall Study||9
5041412|NCT02013245|12405637|P2|COMPLETED|Overall Study||8
5041413|NCT02013245|12405638|P1|COMPLETED|Overall Study||9
5041414|NCT02013245|12405635|P4|STARTED|Overall Study||9
5041415|NCT02013245|12405636|P3|STARTED|Overall Study||9
5041416|NCT02013245|12405637|P2|STARTED|Overall Study||9
5041417|NCT02013245|12405638|P1|STARTED|Overall Study||9
5041418|NCT02013206|12405654|P2|NOT COMPLETED|Overall Study||22
5041419|NCT02013206|12405655|P1|NOT COMPLETED|Overall Study||27
5041420|NCT02013206|12405654|P2|COMPLETED|Overall Study||1
5041421|NCT02013206|12405655|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
5041422|NCT02013206|12405654|P2|Received Study Drug|Overall Study||23
5041423|NCT02013206|12405655|P1|Received Study Drug|Overall Study||26
5041424|NCT02013206|12405654|P2|STARTED|Overall Study||23
5041425|NCT02013206|12405655|P1|STARTED|Overall Study||29
5041426|NCT02013180|12405677|P2|NOT COMPLETED|Overall Study||0
5041427|NCT02013180|12405678|P1|NOT COMPLETED|Overall Study||0
5041428|NCT02013180|12405677|P2|COMPLETED|Overall Study||361
5041429|NCT02013180|12405678|P1|COMPLETED|Overall Study||119
5041430|NCT02013180|12405677|P2|STARTED|Overall Study||361
5041431|NCT02013180|12405678|P1|STARTED|Overall Study||119
5041432|NCT02013167|12405686|P2|NOT COMPLETED|Overall Study||178
5041433|NCT02013167|12405687|P1|NOT COMPLETED|Overall Study||101
5041434|NCT02013167|12405686|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
5041435|NCT02013167|12405687|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
5041436|NCT02013167|12405686|P2|Received Treatment|Overall Study||267
5041437|NCT02013167|12405687|P1|Received Treatment|Overall Study||109
5041438|NCT02013167|12405686|P2|STARTED|Overall Study||271
5041439|NCT02013167|12405687|P1|STARTED|Overall Study||134
5041440|NCT02013050|12405718|P4|NOT COMPLETED|Overall Study||4
5041441|NCT02013050|12405719|P3|NOT COMPLETED|Overall Study||0
5041442|NCT02013050|12405720|P2|NOT COMPLETED|Overall Study||5
5041443|NCT02013050|12405721|P1|NOT COMPLETED|Overall Study||4
5041444|NCT02013050|12405718|P4|COMPLETED|Overall Study||19
5041445|NCT02013050|12405719|P3|COMPLETED|Overall Study||3
5041446|NCT02013050|12405720|P2|COMPLETED|Overall Study||36
5041447|NCT02013050|12405721|P1|COMPLETED|Overall Study||38
5041448|NCT02013050|12405718|P4|STARTED|Overall Study||23
5041449|NCT02013050|12405719|P3|STARTED|Overall Study||3
5041450|NCT02013050|12405720|P2|STARTED|Overall Study||41
5041451|NCT02013050|12405721|P1|STARTED|Overall Study||42
5041452|NCT02012959|12405763|P5|NOT COMPLETED|Treatment Phase B||0
5041453|NCT02012959|12405764|P4|NOT COMPLETED|Treatment Phase B||0
5041454|NCT02012959|12405765|P3|NOT COMPLETED|Treatment Phase B||0
5041455|NCT02012959|12405766|P2|NOT COMPLETED|Treatment Phase B||0
5041456|NCT02012959|12405767|P1|NOT COMPLETED|Treatment Phase B||0
5041457|NCT02012959|12405763|P5|COMPLETED|Treatment Phase B||1
5041458|NCT02012959|12405764|P4|COMPLETED|Treatment Phase B||1
5041459|NCT02012959|12405765|P3|COMPLETED|Treatment Phase B||3
5041460|NCT02012959|12405766|P2|COMPLETED|Treatment Phase B||2
5041461|NCT02012959|12405767|P1|COMPLETED|Treatment Phase B||0
5041462|NCT02012959|12405763|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
5041463|NCT02012959|12405764|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
5041464|NCT02012959|12405765|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
5041465|NCT02012959|12405766|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
5041466|NCT02012959|12405767|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
5041467|NCT02012959|12405763|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
5041468|NCT02012959|12405764|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator’s discretion|1
5041469|NCT02012959|12405765|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
5041470|NCT02012959|12405766|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
5041471|NCT02012959|12405767|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
5041472|NCT02012959|12405763|P5|NOT COMPLETED|Treatment Phase A||0
5041473|NCT02012959|12405764|P4|NOT COMPLETED|Treatment Phase A||0
5041474|NCT02012959|12405765|P3|NOT COMPLETED|Treatment Phase A||0
5041475|NCT02012959|12405766|P2|NOT COMPLETED|Treatment Phase A||0
5041476|NCT02012959|12405767|P1|NOT COMPLETED|Treatment Phase A||2
5041477|NCT02012959|12405763|P5|COMPLETED|Treatment Phase A||0
5041478|NCT02012959|12405764|P4|COMPLETED|Treatment Phase A||0
5041479|NCT02012959|12405765|P3|COMPLETED|Treatment Phase A||0
5041480|NCT02012959|12405766|P2|COMPLETED|Treatment Phase A||0
5041481|NCT02012959|12405767|P1|COMPLETED|Treatment Phase A||7
5041482|NCT02012959|12405763|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
5041483|NCT02012959|12405764|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
5041484|NCT02012959|12405765|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
5041485|NCT02012959|12405766|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
5041486|NCT02012959|12405767|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
5041487|NCT02012959|12405763|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
5041488|NCT02012959|12405764|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
5041489|NCT02012959|12405765|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
5041490|NCT02012959|12405766|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
5041491|NCT02012959|12405767|P1|STARTED|Treatment Phase A||9
5041492|NCT02012686|12405780|P2|NOT COMPLETED|Overall Study||2
5041493|NCT02012686|12405781|P1|NOT COMPLETED|Overall Study||0
5041494|NCT02012686|12405780|P2|COMPLETED|Overall Study||48
5041495|NCT02012686|12405781|P1|COMPLETED|Overall Study||50
5041496|NCT02012686|12405780|P2|STARTED|Overall Study||50
5041497|NCT02012686|12405781|P1|STARTED|Overall Study||50
5041498|NCT02012621|12405793|P1|NOT COMPLETED|Overall Study||0
5041499|NCT02012621|12405793|P1|COMPLETED|Overall Study||807
5041500|NCT02012621|12405793|P1|Visit 3 Completed|Overall Study||444
5041501|NCT02012621|12405793|P1|Visit 2 Completed|Overall Study||688
5041502|NCT02012621|12405793|P1|Visit 1 Completed|Overall Study||807
5041503|NCT02012621|12405793|P1|STARTED|Overall Study||807
5041504|NCT02012608|12405801|P2|NOT COMPLETED|Overall Study||0
5041505|NCT02012608|12405802|P1|NOT COMPLETED|Overall Study||3
5041506|NCT02012608|12405801|P2|COMPLETED|Overall Study||7
5041507|NCT02012608|12405802|P1|COMPLETED|Overall Study||4
5041508|NCT02012608|12405801|P2|STARTED|Overall Study||7
5041509|NCT02012608|12405802|P1|STARTED|Overall Study||7
5041510|NCT02012582|12405812|P4|NOT COMPLETED|Overall Study||1
5041511|NCT02012582|12405813|P3|NOT COMPLETED|Overall Study||0
5041512|NCT02012582|12405814|P2|NOT COMPLETED|Overall Study||0
5041513|NCT02012582|12405815|P1|NOT COMPLETED|Overall Study||0
5041514|NCT02012582|12405812|P4|COMPLETED|Overall Study||7
5041515|NCT02012582|12405813|P3|COMPLETED|Overall Study||8
5041516|NCT02012582|12405814|P2|COMPLETED|Overall Study||8
5041517|NCT02012582|12405815|P1|COMPLETED|Overall Study||8
5041518|NCT02012582|12405812|P4|STARTED|Overall Study||8
5041519|NCT02012582|12405813|P3|STARTED|Overall Study||8
5041520|NCT02012582|12405814|P2|STARTED|Overall Study||8
5041521|NCT02012582|12405815|P1|STARTED|Overall Study||8
5041522|NCT02012491|12405843|P2|NOT COMPLETED|Overall Study||1
5041523|NCT02012491|12405844|P1|NOT COMPLETED|Overall Study||2
5041524|NCT02012491|12405843|P2|COMPLETED|Overall Study||148
5041525|NCT02012491|12405844|P1|COMPLETED|Overall Study||149
5041526|NCT02012491|12405843|P2|STARTED|Overall Study||149
5041527|NCT02012491|12405844|P1|STARTED|Overall Study||151
5041528|NCT02012452|12405862|P2|NOT COMPLETED|Overall Study||1
5041529|NCT02012452|12405863|P1|NOT COMPLETED|Overall Study||6
5041530|NCT02012452|12405862|P2|COMPLETED|Overall Study||1
5041531|NCT02012452|12405863|P1|COMPLETED|Overall Study||1
5041532|NCT02012452|12405862|P2|STARTED|Overall Study||2
5041533|NCT02012452|12405863|P1|STARTED|Overall Study||7
5041534|NCT02012348|12405874|P3|NOT COMPLETED|Overall Study||0
5041535|NCT02012348|12405875|P2|NOT COMPLETED|Overall Study||0
5041536|NCT02012348|12405876|P1|NOT COMPLETED|Overall Study||0
5041537|NCT02012348|12405874|P3|COMPLETED|Overall Study||10
5041538|NCT02012348|12405875|P2|COMPLETED|Overall Study||10
5041539|NCT02012348|12405876|P1|COMPLETED|Overall Study||10
5041540|NCT02012348|12405874|P3|STARTED|Overall Study||10
5041541|NCT02012348|12405875|P2|STARTED|Overall Study||10
5041542|NCT02012348|12405876|P1|STARTED|Overall Study||10
5041543|NCT02012283|12405889|P2|NOT COMPLETED|Third Intervention||0
5041544|NCT02012283|12405890|P1|NOT COMPLETED|Third Intervention||0
5041545|NCT02012283|12405889|P2|COMPLETED|Third Intervention||10
5041546|NCT02012283|12405890|P1|COMPLETED|Third Intervention||10
5041547|NCT02012283|12405889|P2|STARTED|Third Intervention||10
5041548|NCT02012283|12405890|P1|STARTED|Third Intervention||10
5041549|NCT02012283|12405889|P2|NOT COMPLETED|Second Intervention||0
5041550|NCT02012283|12405890|P1|NOT COMPLETED|Second Intervention||0
5041551|NCT02012283|12405889|P2|COMPLETED|Second Intervention||10
5041552|NCT02012283|12405890|P1|COMPLETED|Second Intervention||10
5041553|NCT02012283|12405889|P2|STARTED|Second Intervention||10
5041554|NCT02012283|12405890|P1|STARTED|Second Intervention||10
5041555|NCT02012283|12405889|P2|NOT COMPLETED|First Intervention||0
5041556|NCT02012283|12405890|P1|NOT COMPLETED|First Intervention||0
5041557|NCT02012283|12405889|P2|COMPLETED|First Intervention||10
5041558|NCT02012283|12405890|P1|COMPLETED|First Intervention||10
5041559|NCT02012283|12405889|P2|STARTED|First Intervention||10
5041560|NCT02012283|12405890|P1|STARTED|First Intervention||10
5041561|NCT02012218|12405906|P5|NOT COMPLETED|Overall Study||1
5041562|NCT02012218|12405907|P4|NOT COMPLETED|Overall Study||2
5041563|NCT02012218|12405908|P3|NOT COMPLETED|Overall Study||2
5041564|NCT02012218|12405909|P2|NOT COMPLETED|Overall Study||1
5041565|NCT02012218|12405910|P1|NOT COMPLETED|Overall Study||4
5041566|NCT02012218|12405906|P5|COMPLETED|Overall Study||5
5041567|NCT02012218|12405907|P4|COMPLETED|Overall Study||17
5041568|NCT02012218|12405908|P3|COMPLETED|Overall Study||11
5041569|NCT02012218|12405909|P2|COMPLETED|Overall Study||10
5041570|NCT02012218|12405910|P1|COMPLETED|Overall Study||8
5041571|NCT02012218|12405906|P5|STARTED|Overall Study||6
5041572|NCT02012218|12405907|P4|STARTED|Overall Study||19
5041573|NCT02012218|12405908|P3|STARTED|Overall Study||13
5041574|NCT02012218|12405909|P2|STARTED|Overall Study||11
5041575|NCT02012218|12405910|P1|STARTED|Overall Study||12
5041576|NCT02012192|12405924|P2|NOT COMPLETED|Overall Study||0
5041577|NCT02012192|12405925|P1|NOT COMPLETED|Overall Study||27
5041578|NCT02012192|12405924|P2|COMPLETED|Overall Study||43
5041579|NCT02012192|12405925|P1|COMPLETED|Overall Study||63
5041580|NCT02012192|12405924|P2|STARTED|Overall Study||43
5041581|NCT02012192|12405925|P1|STARTED|Overall Study||90
5041582|NCT02011945|12405934|P3|NOT COMPLETED|Overall Study||10
5041583|NCT02011945|12405935|P2|NOT COMPLETED|Overall Study||10
5041584|NCT02011945|12405936|P1|NOT COMPLETED|Overall Study||2
5041585|NCT02011945|12405934|P3|COMPLETED|Overall Study||6
5041586|NCT02011945|12405935|P2|COMPLETED|Overall Study||3
5041587|NCT02011945|12405936|P1|COMPLETED|Overall Study||0
5041588|NCT02011945|12405934|P3|STARTED|Overall Study||16
5041589|NCT02011945|12405935|P2|STARTED|Overall Study||13
5041590|NCT02011945|12405936|P1|STARTED|Overall Study||2
5041591|NCT02011893|12406013|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
5041592|NCT02011893|12406014|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
5041593|NCT02011893|12406015|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
5041594|NCT02011893|12406013|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
5041595|NCT02011893|12406014|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
5041596|NCT02011893|12406015|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
5041597|NCT02011893|12406013|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
5041598|NCT02011893|12406014|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
5041599|NCT02011893|12406015|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
5041600|NCT02011893|12406013|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
5041601|NCT02011893|12406014|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
5041602|NCT02011893|12406015|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
5041603|NCT02011893|12406013|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
5041604|NCT02011893|12406014|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
5041605|NCT02011893|12406015|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
5041606|NCT02011893|12406013|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
5041607|NCT02011893|12406014|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
5041608|NCT02011893|12406015|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
5041609|NCT02011893|12406013|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
5041610|NCT02011893|12406014|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
5041611|NCT02011893|12406015|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
5041612|NCT02011893|12406013|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
5041613|NCT02011893|12406014|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
5041614|NCT02011893|12406015|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
5041615|NCT02011893|12406013|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
5041616|NCT02011893|12406014|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
5041617|NCT02011893|12406015|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
5041618|NCT02011893|12406013|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
5041619|NCT02011893|12406014|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
5041620|NCT02011893|12406015|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
5041621|NCT02011893|12406013|P3|NOT COMPLETED|Enrollment to Randomization||0
5041622|NCT02011893|12406014|P2|NOT COMPLETED|Enrollment to Randomization||0
5041623|NCT02011893|12406015|P1|NOT COMPLETED|Enrollment to Randomization||73
5041624|NCT02011893|12406013|P3|COMPLETED|Enrollment to Randomization||0
5041625|NCT02011893|12406014|P2|COMPLETED|Enrollment to Randomization||0
5041626|NCT02011893|12406015|P1|COMPLETED|Enrollment to Randomization||100
5041627|NCT02011893|12406013|P3|Randomization|Enrollment to Randomization||0
5041628|NCT02011893|12406014|P2|Randomization|Enrollment to Randomization||0
5041629|NCT02011893|12406015|P1|Randomization|Enrollment to Randomization||100
5041630|NCT02011893|12406013|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
5041631|NCT02011893|12406014|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
5041632|NCT02011893|12406015|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
5041633|NCT02011893|12406013|P3|Trial Stimulation Implant|Enrollment to Randomization||0
5041634|NCT02011893|12406014|P2|Trial Stimulation Implant|Enrollment to Randomization||0
5041635|NCT02011893|12406015|P1|Trial Stimulation Implant|Enrollment to Randomization||121
5041636|NCT02011893|12406013|P3|Baseline|Enrollment to Randomization||0
5041637|NCT02011893|12406014|P2|Baseline|Enrollment to Randomization||0
5041638|NCT02011893|12406015|P1|Baseline|Enrollment to Randomization||141
5041639|NCT02011893|12406013|P3|STARTED|Enrollment to Randomization||0
5041640|NCT02011893|12406014|P2|STARTED|Enrollment to Randomization||0
5041641|NCT02011893|12406015|P1|STARTED|Enrollment to Randomization||173
5041642|NCT02011542|12406026|P1|NOT COMPLETED|Overall Study||1
5041643|NCT02011542|12406026|P1|COMPLETED|Overall Study||29
5041644|NCT02011542|12406026|P1|STARTED|Overall Study||30
5041645|NCT02011516|12406033|P2|NOT COMPLETED|Overall Study||2
5041646|NCT02011516|12406034|P1|NOT COMPLETED|Overall Study||4
5041647|NCT02011516|12406033|P2|COMPLETED|Overall Study||6
5041648|NCT02011516|12406034|P1|COMPLETED|Overall Study||4
5041649|NCT02011516|12406033|P2|STARTED|Overall Study||8
5041650|NCT02011516|12406034|P1|STARTED|Overall Study||8
5041651|NCT02011490|12406043|P6|NOT COMPLETED|Part 2||0
5041652|NCT02011490|12406044|P5|NOT COMPLETED|Part 2||0
5041653|NCT02011490|12406045|P4|NOT COMPLETED|Part 2||0
5041654|NCT02011490|12406046|P3|NOT COMPLETED|Part 2||0
5041655|NCT02011490|12406047|P2|NOT COMPLETED|Part 2||0
5041656|NCT02011490|12406048|P1|NOT COMPLETED|Part 2||0
5041657|NCT02011490|12406043|P6|COMPLETED|Part 2||6
5041658|NCT02011490|12406044|P5|COMPLETED|Part 2||6
5041659|NCT02011490|12406045|P4|COMPLETED|Part 2||6
5041660|NCT02011490|12406046|P3|COMPLETED|Part 2||0
5041661|NCT02011490|12406047|P2|COMPLETED|Part 2||0
5041662|NCT02011490|12406048|P1|COMPLETED|Part 2||0
5041663|NCT02011490|12406043|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
5041664|NCT02011490|12406044|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
5041665|NCT02011490|12406045|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
5041666|NCT02011490|12406046|P3|STARTED|Part 2||0
5041667|NCT02011490|12406047|P2|STARTED|Part 2||0
5041668|NCT02011490|12406048|P1|STARTED|Part 2||0
5041669|NCT02011490|12406043|P6|NOT COMPLETED|Part 1||0
5041670|NCT02011490|12406044|P5|NOT COMPLETED|Part 1||0
5041671|NCT02011490|12406045|P4|NOT COMPLETED|Part 1||0
5041672|NCT02011490|12406046|P3|NOT COMPLETED|Part 1||0
5041673|NCT02011490|12406047|P2|NOT COMPLETED|Part 1||0
5041674|NCT02011490|12406048|P1|NOT COMPLETED|Part 1||0
5041675|NCT02011490|12406043|P6|COMPLETED|Part 1||0
5041676|NCT02011490|12406044|P5|COMPLETED|Part 1||0
5041677|NCT02011490|12406045|P4|COMPLETED|Part 1||0
5041678|NCT02011490|12406046|P3|COMPLETED|Part 1||8
5041679|NCT02011490|12406047|P2|COMPLETED|Part 1||8
5041680|NCT02011490|12406048|P1|COMPLETED|Part 1||8
5041681|NCT02011490|12406043|P6|STARTED|Part 1||0
5041682|NCT02011490|12406044|P5|STARTED|Part 1||0
5041683|NCT02011490|12406045|P4|STARTED|Part 1||0
5041684|NCT02011490|12406046|P3|STARTED|Part 1||8
5041685|NCT02011490|12406047|P2|STARTED|Part 1||8
5041686|NCT02011490|12406048|P1|STARTED|Part 1||8
5041687|NCT02011464|12406136|P2|NOT COMPLETED|Overall Study||0
5041688|NCT02011464|12406137|P1|NOT COMPLETED|Overall Study||0
5041689|NCT02011464|12406136|P2|COMPLETED|Overall Study||10
5041690|NCT02011464|12406137|P1|COMPLETED|Overall Study||10
5041691|NCT02011464|12406136|P2|STARTED|Overall Study||10
5041692|NCT02011464|12406137|P1|STARTED|Overall Study||10
5041693|NCT02011113|12406157|P1|NOT COMPLETED|Overall Study||36
5041694|NCT02011113|12406157|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
5041695|NCT02011113|12406157|P1|STARTED|Overall Study||36
5041696|NCT02010996|12406173|P2|NOT COMPLETED|Overall Study||0
5041697|NCT02010996|12406174|P1|NOT COMPLETED|Overall Study||0
5041698|NCT02010996|12406173|P2|COMPLETED|Overall Study||36
5041699|NCT02010996|12406174|P1|COMPLETED|Overall Study||36
5041700|NCT02010996|12406173|P2|STARTED|Overall Study||36
5041701|NCT02010996|12406174|P1|STARTED|Overall Study||36
5041702|NCT02010775|12406189|P5|NOT COMPLETED|Overall Study||6
5041703|NCT02010775|12406190|P4|NOT COMPLETED|Overall Study||3
5041704|NCT02010775|12406191|P3|NOT COMPLETED|Overall Study||3
5041705|NCT02010775|12406192|P2|NOT COMPLETED|Overall Study||3
5041706|NCT02010775|12406193|P1|NOT COMPLETED|Overall Study||5
5041707|NCT02010775|12406189|P5|COMPLETED|Overall Study||31
5041708|NCT02010775|12406190|P4|COMPLETED|Overall Study||34
5041709|NCT02010775|12406191|P3|COMPLETED|Overall Study||34
5041710|NCT02010775|12406192|P2|COMPLETED|Overall Study||35
5041711|NCT02010775|12406193|P1|COMPLETED|Overall Study||33
5041712|NCT02010775|12406189|P5|STARTED|Overall Study||37
5041713|NCT02010775|12406190|P4|STARTED|Overall Study||37
5041714|NCT02010775|12406191|P3|STARTED|Overall Study||37
5041715|NCT02010775|12406192|P2|STARTED|Overall Study||38
5041716|NCT02010775|12406193|P1|STARTED|Overall Study||38
5041717|NCT02010697|12406213|P3|NOT COMPLETED|Overall Study||0
5041718|NCT02010697|12406214|P2|NOT COMPLETED|Overall Study||0
5041719|NCT02010697|12406215|P1|NOT COMPLETED|Overall Study||0
5041720|NCT02010697|12406213|P3|COMPLETED|Overall Study||1043
5041721|NCT02010697|12406214|P2|COMPLETED|Overall Study||1038
5041722|NCT02010697|12406215|P1|COMPLETED|Overall Study||1044
5041723|NCT02010697|12406213|P3|STARTED|Overall Study||1043
5041724|NCT02010697|12406214|P2|STARTED|Overall Study||1038
5041725|NCT02010697|12406215|P1|STARTED|Overall Study||1044
5041726|NCT02010684|12406234|P2|NOT COMPLETED|Overall Study||23
5041727|NCT02010684|12406235|P1|NOT COMPLETED|Overall Study||12
5041728|NCT02010684|12406234|P2|COMPLETED|Overall Study||59
5041729|NCT02010684|12406235|P1|COMPLETED|Overall Study||27
5041730|NCT02010684|12406234|P2|STARTED|Overall Study||82
5041731|NCT02010684|12406235|P1|STARTED|Overall Study||39
5041732|NCT02010645|12406253|P1|NOT COMPLETED|Overall Study||0
5041733|NCT02010645|12406253|P1|COMPLETED|Overall Study||6
5041734|NCT02010645|12406253|P1|STARTED|Overall Study||6
5041735|NCT02010632|12406257|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5041736|NCT02010632|12406258|P1|NOT COMPLETED|Second Intervention (7 Days)||1
5041737|NCT02010632|12406257|P2|COMPLETED|Second Intervention (7 Days)||16
5041738|NCT02010632|12406258|P1|COMPLETED|Second Intervention (7 Days)||15
5041739|NCT02010632|12406257|P2|STARTED|Second Intervention (7 Days)||16
5041740|NCT02010632|12406258|P1|STARTED|Second Intervention (7 Days)||16
5041741|NCT02010632|12406257|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
5041742|NCT02010632|12406258|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
5041743|NCT02010632|12406257|P2|COMPLETED|Wash Out Period (14 Days)||16
5041744|NCT02010632|12406258|P1|COMPLETED|Wash Out Period (14 Days)||16
5041745|NCT02010632|12406257|P2|STARTED|Wash Out Period (14 Days)||16
5041746|NCT02010632|12406258|P1|STARTED|Wash Out Period (14 Days)||16
5041747|NCT02010632|12406257|P2|NOT COMPLETED|First Intervention (7 Days)||0
5041748|NCT02010632|12406258|P1|NOT COMPLETED|First Intervention (7 Days)||0
5041749|NCT02010632|12406257|P2|COMPLETED|First Intervention (7 Days)||16
5041750|NCT02010632|12406258|P1|COMPLETED|First Intervention (7 Days)||16
5041751|NCT02010632|12406257|P2|STARTED|First Intervention (7 Days)||16
5041752|NCT02010632|12406258|P1|STARTED|First Intervention (7 Days)||16
5041753|NCT02010567|12406269|P5|NOT COMPLETED|Overall Study||1
5041754|NCT02010567|12406270|P4|NOT COMPLETED|Overall Study||0
5041755|NCT02010567|12406271|P3|NOT COMPLETED|Overall Study||1
5041756|NCT02010567|12406272|P2|NOT COMPLETED|Overall Study||0
5041757|NCT02010567|12406273|P1|NOT COMPLETED|Overall Study||0
5041758|NCT02010567|12406269|P5|COMPLETED|Overall Study||5
5041759|NCT02010567|12406270|P4|COMPLETED|Overall Study||3
5041760|NCT02010567|12406271|P3|COMPLETED|Overall Study||13
5041761|NCT02010567|12406272|P2|COMPLETED|Overall Study||6
5041762|NCT02010567|12406273|P1|COMPLETED|Overall Study||3
5041763|NCT02010567|12406269|P5|STARTED|Overall Study||6
5041764|NCT02010567|12406270|P4|STARTED|Overall Study||3
5041765|NCT02010567|12406271|P3|STARTED|Overall Study||14
5041766|NCT02010567|12406272|P2|STARTED|Overall Study||6
5041767|NCT02010567|12406273|P1|STARTED|Overall Study||3
5041768|NCT02010359|12406286|P2|NOT COMPLETED|Overall Study||2
5041769|NCT02010359|12406287|P1|NOT COMPLETED|Overall Study||2
5041770|NCT02010359|12406286|P2|COMPLETED|Overall Study||12
5041771|NCT02010359|12406287|P1|COMPLETED|Overall Study||13
5041772|NCT02010359|12406286|P2|STARTED|Overall Study||14
5041773|NCT02010359|12406287|P1|STARTED|Overall Study||15
5041774|NCT02010255|12406325|P14|NOT COMPLETED|Overall Study||1
5041775|NCT02010255|12406326|P13|NOT COMPLETED|Overall Study||0
5041776|NCT02010255|12406327|P12|NOT COMPLETED|Overall Study||1
5041777|NCT02010255|12406328|P11|NOT COMPLETED|Overall Study||2
5041778|NCT02010255|12406329|P10|NOT COMPLETED|Overall Study||0
5041779|NCT02010255|12406330|P9|NOT COMPLETED|Overall Study||1
5041780|NCT02010255|12406331|P8|NOT COMPLETED|Overall Study||1
5041781|NCT02010255|12406332|P7|NOT COMPLETED|Overall Study||1
5041782|NCT02010255|12406333|P6|NOT COMPLETED|Overall Study||0
5041783|NCT02010255|12406334|P5|NOT COMPLETED|Overall Study||4
5041784|NCT02010255|12406335|P4|NOT COMPLETED|Overall Study||6
5041785|NCT02010255|12406336|P3|NOT COMPLETED|Overall Study||7
5041786|NCT02010255|12406337|P2|NOT COMPLETED|Overall Study||2
5041787|NCT02010255|12406338|P1|NOT COMPLETED|Overall Study||6
5041788|NCT02010255|12406325|P14|COMPLETED|Overall Study||2
5041789|NCT02010255|12406326|P13|COMPLETED|Overall Study||3
5041790|NCT02010255|12406327|P12|COMPLETED|Overall Study||4
5041791|NCT02010255|12406328|P11|COMPLETED|Overall Study||1
5041792|NCT02010255|12406329|P10|COMPLETED|Overall Study||23
5041793|NCT02010255|12406330|P9|COMPLETED|Overall Study||21
5041794|NCT02010255|12406331|P8|COMPLETED|Overall Study||32
5041795|NCT02010255|12406332|P7|COMPLETED|Overall Study||33
5041796|NCT02010255|12406333|P6|COMPLETED|Overall Study||49
5041797|NCT02010255|12406334|P5|COMPLETED|Overall Study||48
5041798|NCT02010255|12406335|P4|COMPLETED|Overall Study||20
5041799|NCT02010255|12406336|P3|COMPLETED|Overall Study||18
5041800|NCT02010255|12406337|P2|COMPLETED|Overall Study||26
5041801|NCT02010255|12406338|P1|COMPLETED|Overall Study||22
5041802|NCT02010255|12406325|P14|STARTED|Overall Study||3
5041803|NCT02010255|12406326|P13|STARTED|Overall Study||3
5041804|NCT02010255|12406327|P12|STARTED|Overall Study||5
5041805|NCT02010255|12406328|P11|STARTED|Overall Study||3
5041806|NCT02010255|12406329|P10|STARTED|Overall Study||23
5041807|NCT02010255|12406330|P9|STARTED|Overall Study||22
5041808|NCT02010255|12406331|P8|STARTED|Overall Study||33
5041809|NCT02010255|12406332|P7|STARTED|Overall Study||34
5041810|NCT02010255|12406333|P6|STARTED|Overall Study||49
5041811|NCT02010255|12406334|P5|STARTED|Overall Study||52
5041812|NCT02010255|12406335|P4|STARTED|Overall Study||26
5041813|NCT02010255|12406336|P3|STARTED|Overall Study||25
5041814|NCT02010255|12406337|P2|STARTED|Overall Study||28
5041815|NCT02010255|12406338|P1|STARTED|Overall Study||28
5041816|NCT02010216|12406662|P1|NOT COMPLETED|Overall Study||0
5041817|NCT02010216|12406662|P1|COMPLETED|Overall Study||23
5041818|NCT02010216|12406662|P1|STARTED|Overall Study||23
5041819|NCT02010203|12406673|P5|NOT COMPLETED|Overall Study||13
5041820|NCT02010203|12406674|P4|NOT COMPLETED|Overall Study||3
5041821|NCT02010203|12406675|P3|NOT COMPLETED|Overall Study||10
5041822|NCT02010203|12406676|P2|NOT COMPLETED|Overall Study||9
5041823|NCT02010203|12406677|P1|NOT COMPLETED|Overall Study||0
5041824|NCT02010203|12406673|P5|COMPLETED|Overall Study||3
5041825|NCT02010203|12406674|P4|COMPLETED|Overall Study||23
5041826|NCT02010203|12406675|P3|COMPLETED|Overall Study||16
5041827|NCT02010203|12406676|P2|COMPLETED|Overall Study||17
5041828|NCT02010203|12406677|P1|COMPLETED|Overall Study||10
5041829|NCT02010203|12406673|P5|STARTED|Overall Study||16
5041830|NCT02010203|12406674|P4|STARTED|Overall Study||26
5041831|NCT02010203|12406675|P3|STARTED|Overall Study||26
5041832|NCT02010203|12406676|P2|STARTED|Overall Study||26
5041833|NCT02010203|12406677|P1|STARTED|Overall Study||10
5041834|NCT02010151|12406750|P2|NOT COMPLETED|Overall Study||0
5041835|NCT02010151|12406751|P1|NOT COMPLETED|Overall Study||0
5041836|NCT02010151|12406750|P2|COMPLETED|Overall Study|TM sent: 598|1696
5041837|NCT02010151|12406751|P1|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
5041838|NCT02010151|12406750|P2|STARTED|Overall Study|January 2013 to December 2017|1696
5041839|NCT02010151|12406751|P1|STARTED|Overall Study|January 2013 to December 2017|1498
5041840|NCT02010021|12406763|P2|NOT COMPLETED|Overall Study||0
5041841|NCT02010021|12406764|P1|NOT COMPLETED|Overall Study||0
5041842|NCT02010021|12406763|P2|COMPLETED|Overall Study||7
5041843|NCT02010021|12406764|P1|COMPLETED|Overall Study||10
5041844|NCT02010021|12406763|P2|STARTED|Overall Study||7
5041845|NCT02010021|12406764|P1|STARTED|Overall Study||10
5041846|NCT02009982|12406774|P2|NOT COMPLETED|Overall Study||0
5041847|NCT02009982|12406775|P1|NOT COMPLETED|Overall Study||0
5041848|NCT02009982|12406774|P2|COMPLETED|Overall Study||2
5041849|NCT02009982|12406775|P1|COMPLETED|Overall Study||1
5041850|NCT02009982|12406774|P2|STARTED|Overall Study||2
5041851|NCT02009982|12406775|P1|STARTED|Overall Study||1
5041852|NCT02009930|12406783|P1|NOT COMPLETED|Overall Study||5
5041853|NCT02009930|12406783|P1|COMPLETED|Overall Study||107
5041854|NCT02009930|12406783|P1|STARTED|Overall Study|5 withdrawn|112
5041855|NCT02009878|12406808|P3|NOT COMPLETED|Overall Study||0
5041856|NCT02009878|12406809|P2|NOT COMPLETED|Overall Study||1
5041857|NCT02009878|12406810|P1|NOT COMPLETED|Overall Study||0
5041858|NCT02009878|12406808|P3|COMPLETED|Overall Study||9
5041859|NCT02009878|12406809|P2|COMPLETED|Overall Study||10
5041860|NCT02009878|12406810|P1|COMPLETED|Overall Study||10
5041861|NCT02009878|12406808|P3|STARTED|Overall Study||9
5041862|NCT02009878|12406809|P2|STARTED|Overall Study||11
5041863|NCT02009878|12406810|P1|STARTED|Overall Study||10
5041864|NCT02009865|12406844|P2|NOT COMPLETED|Overall Study||5
5041865|NCT02009865|12406845|P1|NOT COMPLETED|Overall Study||1
5041866|NCT02009865|12406844|P2|COMPLETED|Overall Study||76
5041867|NCT02009865|12406845|P1|COMPLETED|Overall Study||80
5041868|NCT02009865|12406844|P2|STARTED|Overall Study||81
5041869|NCT02009865|12406845|P1|STARTED|Overall Study||81
5041870|NCT02009722|12406861|P2|NOT COMPLETED|Overall Study||3
5041871|NCT02009722|12406862|P1|NOT COMPLETED|Overall Study||1
5041872|NCT02009722|12406861|P2|COMPLETED|Overall Study||40
5041873|NCT02009722|12406862|P1|COMPLETED|Overall Study||40
5041874|NCT02009722|12406861|P2|Received Intervention|Overall Study||42
5041875|NCT02009722|12406862|P1|Received Intervention|Overall Study||41
5041876|NCT02009722|12406861|P2|STARTED|Overall Study||43
5041877|NCT02009722|12406862|P1|STARTED|Overall Study||41
5041878|NCT02009696|12406886|P1|NOT COMPLETED|Overall Study||2
5041879|NCT02009696|12406886|P1|COMPLETED|Overall Study||219
5041880|NCT02009696|12406886|P1|STARTED|Overall Study||221
5041881|NCT02009501|12406896|P2|NOT COMPLETED|Overall Study||0
5041882|NCT02009501|12406897|P1|NOT COMPLETED|Overall Study||0
5041883|NCT02009501|12406896|P2|COMPLETED|Overall Study||11
5041884|NCT02009501|12406897|P1|COMPLETED|Overall Study||9
5041885|NCT02009501|12406896|P2|STARTED|Overall Study||11
5041886|NCT02009501|12406897|P1|STARTED|Overall Study||9
5041887|NCT02009163|12406903|P3|NOT COMPLETED|Randomized-withdrawal Period||35
5041888|NCT02009163|12406904|P2|NOT COMPLETED|Randomized-withdrawal Period||88
5041889|NCT02009163|12406905|P1|NOT COMPLETED|Randomized-withdrawal Period||0
5041890|NCT02009163|12406903|P3|COMPLETED|Randomized-withdrawal Period||102
5041891|NCT02009163|12406904|P2|COMPLETED|Randomized-withdrawal Period||50
5041892|NCT02009163|12406905|P1|COMPLETED|Randomized-withdrawal Period||0
5041893|NCT02009163|12406903|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
5041894|NCT02009163|12406904|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
5041895|NCT02009163|12406905|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
5041896|NCT02009163|12406903|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
5041897|NCT02009163|12406904|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
5041898|NCT02009163|12406905|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
5041899|NCT02009163|12406903|P3|COMPLETED|Open-label Period (Non-randomized)||0
5041900|NCT02009163|12406904|P2|COMPLETED|Open-label Period (Non-randomized)||0
5041901|NCT02009163|12406905|P1|COMPLETED|Open-label Period (Non-randomized)||275
5041902|NCT02009163|12406903|P3|STARTED|Open-label Period (Non-randomized)||0
5041903|NCT02009163|12406904|P2|STARTED|Open-label Period (Non-randomized)||0
5041904|NCT02009163|12406905|P1|STARTED|Open-label Period (Non-randomized)||418
5041905|NCT02009046|12406940|P2|NOT COMPLETED|Overall Study||206
5041906|NCT02009046|12406941|P1|NOT COMPLETED|Overall Study||256
5041907|NCT02009046|12406940|P2|COMPLETED|Overall Study||678
5041908|NCT02009046|12406941|P1|COMPLETED|Overall Study||769
5041909|NCT02009046|12406940|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
5041910|NCT02009046|12406941|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
5041911|NCT02009046|12406940|P2|Ctrl Curriculum Only|Overall Study||456
5041912|NCT02009046|12406941|P1|Ctrl Curriculum Only|Overall Study||0
5041913|NCT02009046|12406940|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
5041914|NCT02009046|12406941|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
5041915|NCT02009046|12406940|P2|SEI Curriculum Only|Overall Study||0
5041916|NCT02009046|12406941|P1|SEI Curriculum Only|Overall Study||461
5041917|NCT02009046|12406940|P2|STARTED|Overall Study||884
5041918|NCT02009046|12406941|P1|STARTED|Overall Study||1025
5041919|NCT02008942|12406991|P2|NOT COMPLETED|Second Intervention||0
5041920|NCT02008942|12406992|P1|NOT COMPLETED|Second Intervention||1
5041921|NCT02008942|12406991|P2|COMPLETED|Second Intervention||30
5041922|NCT02008942|12406992|P1|COMPLETED|Second Intervention||25
5041923|NCT02008942|12406991|P2|STARTED|Second Intervention||30
5041924|NCT02008942|12406992|P1|STARTED|Second Intervention||26
5041925|NCT02008942|12406991|P2|NOT COMPLETED|First Intervention||0
5041926|NCT02008942|12406992|P1|NOT COMPLETED|First Intervention||0
5041927|NCT02008942|12406991|P2|COMPLETED|First Intervention||30
5041928|NCT02008942|12406992|P1|COMPLETED|First Intervention||27
5041929|NCT02008942|12406991|P2|STARTED|First Intervention||30
5041930|NCT02008942|12406992|P1|STARTED|First Intervention||27
5041931|NCT02008916|12407001|P3|NOT COMPLETED|Week 16 - 156||10
5041932|NCT02008916|12407002|P2|NOT COMPLETED|Week 16 - 156||13
5041933|NCT02008916|12407003|P1|NOT COMPLETED|Week 16 - 156||19
5041934|NCT02008916|12407001|P3|COMPLETED|Week 16 - 156||63
5041935|NCT02008916|12407002|P2|COMPLETED|Week 16 - 156||62
5041936|NCT02008916|12407003|P1|COMPLETED|Week 16 - 156||55
5041937|NCT02008916|12407001|P3|STARTED|Week 16 - 156||73
5041938|NCT02008916|12407002|P2|STARTED|Week 16 - 156||75
5041939|NCT02008916|12407003|P1|STARTED|Week 16 - 156||74
5041940|NCT02008916|12407001|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
5041941|NCT02008916|12407002|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
5041942|NCT02008916|12407003|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
5041943|NCT02008916|12407001|P3|COMPLETED|Primary Assessment (up to Week 16)||73
5041944|NCT02008916|12407002|P2|COMPLETED|Primary Assessment (up to Week 16)||75
5041945|NCT02008916|12407003|P1|COMPLETED|Primary Assessment (up to Week 16)||74
5041946|NCT02008916|12407001|P3|Safety Set|Primary Assessment (up to Week 16)||75
5041947|NCT02008916|12407002|P2|Safety Set|Primary Assessment (up to Week 16)||76
5041948|NCT02008916|12407003|P1|Safety Set|Primary Assessment (up to Week 16)||74
5041949|NCT02008916|12407001|P3|FAS|Primary Assessment (up to Week 16)||76
5041950|NCT02008916|12407002|P2|FAS|Primary Assessment (up to Week 16)||76
5041951|NCT02008916|12407003|P1|FAS|Primary Assessment (up to Week 16)||74
5041952|NCT02008916|12407001|P3|STARTED|Primary Assessment (up to Week 16)||76
5041953|NCT02008916|12407002|P2|STARTED|Primary Assessment (up to Week 16)||76
5041954|NCT02008916|12407003|P1|STARTED|Primary Assessment (up to Week 16)||74
5041955|NCT02008890|12407039|P5|NOT COMPLETED|Extension Period||4
5041956|NCT02008890|12407040|P4|NOT COMPLETED|Extension Period||4
5041957|NCT02008890|12407041|P3|NOT COMPLETED|Extension Period||0
5041958|NCT02008890|12407042|P2|NOT COMPLETED|Extension Period||5
5041959|NCT02008890|12407043|P1|NOT COMPLETED|Extension Period||5
5041960|NCT02008890|12407039|P5|COMPLETED|Extension Period||13
5041961|NCT02008890|12407040|P4|COMPLETED|Extension Period||6
5041962|NCT02008890|12407041|P3|COMPLETED|Extension Period||0
5041963|NCT02008890|12407042|P2|COMPLETED|Extension Period||31
5041964|NCT02008890|12407043|P1|COMPLETED|Extension Period||26
5041965|NCT02008890|12407039|P5|STARTED|Extension Period||17
5041966|NCT02008890|12407040|P4|STARTED|Extension Period||10
5041967|NCT02008890|12407041|P3|STARTED|Extension Period||0
5041968|NCT02008890|12407042|P2|STARTED|Extension Period||36
5041969|NCT02008890|12407043|P1|STARTED|Extension Period||31
5041970|NCT02008890|12407039|P5|NOT COMPLETED|Period 2||8
5041971|NCT02008890|12407040|P4|NOT COMPLETED|Period 2||14
5041972|NCT02008890|12407041|P3|NOT COMPLETED|Period 2||1
5041973|NCT02008890|12407042|P2|NOT COMPLETED|Period 2||15
5041974|NCT02008890|12407043|P1|NOT COMPLETED|Period 2||27
5041975|NCT02008890|12407039|P5|COMPLETED|Period 2||20
5041976|NCT02008890|12407040|P4|COMPLETED|Period 2||13
5041977|NCT02008890|12407041|P3|COMPLETED|Period 2||9
5041978|NCT02008890|12407042|P2|COMPLETED|Period 2||49
5041979|NCT02008890|12407043|P1|COMPLETED|Period 2||38
5041980|NCT02008890|12407039|P5|STARTED|Period 2||28
5041981|NCT02008890|12407040|P4|STARTED|Period 2||27
5041982|NCT02008890|12407041|P3|STARTED|Period 2||10
5041983|NCT02008890|12407042|P2|STARTED|Period 2||64
5041984|NCT02008890|12407043|P1|STARTED|Period 2||65
5041985|NCT02008890|12407039|P5|NOT COMPLETED|Period 1||0
5041986|NCT02008890|12407040|P4|NOT COMPLETED|Period 1||0
5041987|NCT02008890|12407041|P3|NOT COMPLETED|Period 1||12
5041988|NCT02008890|12407042|P2|NOT COMPLETED|Period 1||15
5041989|NCT02008890|12407043|P1|NOT COMPLETED|Period 1||15
5041990|NCT02008890|12407039|P5|COMPLETED|Period 1||0
5041991|NCT02008890|12407040|P4|COMPLETED|Period 1||0
5041992|NCT02008890|12407041|P3|COMPLETED|Period 1||66
5041993|NCT02008890|12407042|P2|COMPLETED|Period 1||64
5041994|NCT02008890|12407043|P1|COMPLETED|Period 1||65
5041995|NCT02008890|12407039|P5|STARTED|Period 1||0
5041996|NCT02008890|12407040|P4|STARTED|Period 1||0
5041997|NCT02008890|12407041|P3|STARTED|Period 1||78
5041998|NCT02008890|12407042|P2|STARTED|Period 1||79
5041999|NCT02008890|12407043|P1|STARTED|Period 1||80
5042000|NCT02008877|12407079|P3|NOT COMPLETED|Overall Study||0
5042001|NCT02008877|12407080|P2|NOT COMPLETED|Overall Study||1
5042002|NCT02008877|12407081|P1|NOT COMPLETED|Overall Study||0
5042003|NCT02008877|12407079|P3|COMPLETED|Overall Study||10
5042004|NCT02008877|12407080|P2|COMPLETED|Overall Study||6
5042005|NCT02008877|12407081|P1|COMPLETED|Overall Study||3
5042006|NCT02008877|12407079|P3|STARTED|Overall Study||10
5042007|NCT02008877|12407080|P2|STARTED|Overall Study||7
5042008|NCT02008877|12407081|P1|STARTED|Overall Study||3
5042009|NCT02008773|12407100|P4|NOT COMPLETED|Overall Study||12
5042010|NCT02008773|12407101|P3|NOT COMPLETED|Overall Study||14
5042011|NCT02008773|12407102|P2|NOT COMPLETED|Overall Study||9
5042012|NCT02008773|12407103|P1|NOT COMPLETED|Overall Study||13
5042013|NCT02008773|12407100|P4|COMPLETED|Overall Study||38
5042014|NCT02008773|12407101|P3|COMPLETED|Overall Study||32
5042015|NCT02008773|12407102|P2|COMPLETED|Overall Study||25
5042016|NCT02008773|12407103|P1|COMPLETED|Overall Study||27
5042017|NCT02008773|12407100|P4|STARTED|Overall Study||50
5042018|NCT02008773|12407101|P3|STARTED|Overall Study||46
5042019|NCT02008773|12407102|P2|STARTED|Overall Study||34
5042020|NCT02008773|12407103|P1|STARTED|Overall Study||40
5042021|NCT02008682|12407133|P2|NOT COMPLETED|Overall Study||14
5042022|NCT02008682|12407134|P1|NOT COMPLETED|Overall Study||27
5042023|NCT02008682|12407133|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
5042024|NCT02008682|12407134|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
5042025|NCT02008682|12407133|P2|Exposed|Overall Study||184
5042026|NCT02008682|12407134|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
5042027|NCT02008682|12407133|P2|STARTED|Overall Study||184
5042028|NCT02008682|12407134|P1|STARTED|Overall Study||184
5042029|NCT02008617|12407152|P2|NOT COMPLETED|Overall Study||0
5042030|NCT02008617|12407153|P1|NOT COMPLETED|Overall Study||0
5042031|NCT02008617|12407152|P2|COMPLETED|Overall Study||10
5042032|NCT02008617|12407153|P1|COMPLETED|Overall Study||8
5042033|NCT02008617|12407152|P2|STARTED|Overall Study||10
5042034|NCT02008617|12407153|P1|STARTED|Overall Study||8
5042035|NCT02008565|12407169|P4|NOT COMPLETED|Overall Study||0
5042036|NCT02008565|12407170|P3|NOT COMPLETED|Overall Study||2
5042037|NCT02008565|12407171|P2|NOT COMPLETED|Overall Study||1
5042038|NCT02008565|12407172|P1|NOT COMPLETED|Overall Study||1
5042039|NCT02008565|12407169|P4|COMPLETED|Overall Study||42
5042040|NCT02008565|12407170|P3|COMPLETED|Overall Study||86
5042041|NCT02008565|12407171|P2|COMPLETED|Overall Study||83
5042042|NCT02008565|12407172|P1|COMPLETED|Overall Study||85
5042043|NCT02008565|12407169|P4|STARTED|Overall Study||42
5042044|NCT02008565|12407170|P3|STARTED|Overall Study||88
5042045|NCT02008565|12407171|P2|STARTED|Overall Study||84
5042046|NCT02008565|12407172|P1|STARTED|Overall Study||86
5042047|NCT02008526|12407233|P3|NOT COMPLETED|Overall Study||9
5042048|NCT02008526|12407234|P2|NOT COMPLETED|Overall Study||14
5042049|NCT02008526|12407235|P1|NOT COMPLETED|Overall Study||8
5042050|NCT02008526|12407233|P3|COMPLETED|Overall Study||84
5042051|NCT02008526|12407234|P2|COMPLETED|Overall Study||85
5042052|NCT02008526|12407235|P1|COMPLETED|Overall Study||86
5042053|NCT02008526|12407233|P3|STARTED|Overall Study||93
5042054|NCT02008526|12407234|P2|STARTED|Overall Study||99
5042055|NCT02008526|12407235|P1|STARTED|Overall Study||94
5042056|NCT02008370|12407246|P1|NOT COMPLETED|Overall Study||7
5042057|NCT02008370|12407246|P1|COMPLETED|Overall Study||0
5042058|NCT02008370|12407246|P1|STARTED|Overall Study||7
5042059|NCT02008318|12407254|P2|NOT COMPLETED|Overall Study||1
5042060|NCT02008318|12407255|P1|NOT COMPLETED|Overall Study||12
5042061|NCT02008318|12407254|P2|COMPLETED|Overall Study||1
5042062|NCT02008318|12407255|P1|COMPLETED|Overall Study||29
5042063|NCT02008318|12407254|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
5042064|NCT02008318|12407255|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
5042065|NCT02008318|12407254|P2|STARTED|Overall Study||2
5042066|NCT02008318|12407255|P1|STARTED|Overall Study||41
5042067|NCT02008227|12407276|P2|NOT COMPLETED|Overall Study||613
5042068|NCT02008227|12407277|P1|NOT COMPLETED|Overall Study||612
5042069|NCT02008227|12407276|P2|COMPLETED|Overall Study||0
5042070|NCT02008227|12407277|P1|COMPLETED|Overall Study||0
5042071|NCT02008227|12407276|P2|Treated|Overall Study||608
5042072|NCT02008227|12407277|P1|Treated|Overall Study||579
5042073|NCT02008227|12407276|P2|STARTED|Overall Study||613
5042074|NCT02008227|12407277|P1|STARTED|Overall Study||612
5042075|NCT02008149|12407355|P3|NOT COMPLETED|Overall Study||0
5042076|NCT02008149|12407356|P2|NOT COMPLETED|Overall Study||1
5042077|NCT02008149|12407357|P1|NOT COMPLETED|Overall Study||3
5042078|NCT02008149|12407355|P3|COMPLETED|Overall Study||1
5042079|NCT02008149|12407356|P2|COMPLETED|Overall Study||0
5042080|NCT02008149|12407357|P1|COMPLETED|Overall Study||4
5042081|NCT02008149|12407355|P3|STARTED|Overall Study||1
5042082|NCT02008149|12407356|P2|STARTED|Overall Study||1
5042083|NCT02008149|12407357|P1|STARTED|Overall Study||7
5042084|NCT02007954|12407365|P1|NOT COMPLETED|Overall Study||7
5042085|NCT02007954|12407365|P1|COMPLETED|Overall Study||17
5042086|NCT02007954|12407365|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
5042087|NCT02007954|12407365|P1|Completed First TACE|Overall Study||24
5042088|NCT02007954|12407365|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
5042089|NCT02007863|12407378|P1|NOT COMPLETED|Overall Study||0
5042090|NCT02007863|12407378|P1|COMPLETED|Overall Study||2
5042091|NCT02007863|12407378|P1|STARTED|Overall Study||2
5042092|NCT02007720|12407384|P2|NOT COMPLETED|Overall Study||72
5042093|NCT02007720|12407385|P1|NOT COMPLETED|Overall Study||82
5042094|NCT02007720|12407384|P2|COMPLETED|Overall Study||368
5042095|NCT02007720|12407385|P1|COMPLETED|Overall Study||354
5042096|NCT02007720|12407384|P2|Safety Set|Overall Study||432
5042097|NCT02007720|12407385|P1|Safety Set|Overall Study||426
5042098|NCT02007720|12407384|P2|Full Analysis Set|Overall Study||437
5042099|NCT02007720|12407385|P1|Full Analysis Set|Overall Study||433
5042100|NCT02007720|12407384|P2|STARTED|Overall Study||440
5042101|NCT02007720|12407385|P1|STARTED|Overall Study||436
5042102|NCT02007577|12407420|P2|NOT COMPLETED|Overall Study||1
5042103|NCT02007577|12407421|P1|NOT COMPLETED|Overall Study||1
5042104|NCT02007577|12407420|P2|COMPLETED|Overall Study||13
5042105|NCT02007577|12407421|P1|COMPLETED|Overall Study||26
5042106|NCT02007577|12407420|P2|STARTED|Overall Study||14
5042107|NCT02007577|12407421|P1|STARTED|Overall Study||27
5042108|NCT02007512|12407433|P4|NOT COMPLETED|Open Label Treatment Period||12
5042109|NCT02007512|12407434|P3|NOT COMPLETED|Open Label Treatment Period||0
5042110|NCT02007512|12407435|P2|NOT COMPLETED|Open Label Treatment Period||21
5042111|NCT02007512|12407436|P1|NOT COMPLETED|Open Label Treatment Period||0
5042112|NCT02007512|12407433|P4|COMPLETED|Open Label Treatment Period||0
5042113|NCT02007512|12407434|P3|COMPLETED|Open Label Treatment Period||0
5042114|NCT02007512|12407435|P2|COMPLETED|Open Label Treatment Period||0
5042115|NCT02007512|12407436|P1|COMPLETED|Open Label Treatment Period||0
5042116|NCT02007512|12407433|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
5042117|NCT02007512|12407434|P3|STARTED|Open Label Treatment Period||0
5042118|NCT02007512|12407435|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
5042119|NCT02007512|12407436|P1|STARTED|Open Label Treatment Period||0
5042120|NCT02007512|12407433|P4|NOT COMPLETED|Double Blind Treatment Period||60
5042121|NCT02007512|12407434|P3|NOT COMPLETED|Double Blind Treatment Period||60
5042122|NCT02007512|12407435|P2|NOT COMPLETED|Double Blind Treatment Period||64
5042123|NCT02007512|12407436|P1|NOT COMPLETED|Double Blind Treatment Period||63
5042124|NCT02007512|12407433|P4|COMPLETED|Double Blind Treatment Period||0
5042125|NCT02007512|12407434|P3|COMPLETED|Double Blind Treatment Period||0
5042126|NCT02007512|12407435|P2|COMPLETED|Double Blind Treatment Period||0
5042127|NCT02007512|12407436|P1|COMPLETED|Double Blind Treatment Period||0
5042128|NCT02007512|12407433|P4|Treated|Double Blind Treatment Period||60
5042129|NCT02007512|12407434|P3|Treated|Double Blind Treatment Period||60
5042130|NCT02007512|12407435|P2|Treated|Double Blind Treatment Period||63
5042131|NCT02007512|12407436|P1|Treated|Double Blind Treatment Period||62
5042132|NCT02007512|12407433|P4|STARTED|Double Blind Treatment Period||60
5042133|NCT02007512|12407434|P3|STARTED|Double Blind Treatment Period||60
5042134|NCT02007512|12407435|P2|STARTED|Double Blind Treatment Period||64
5042135|NCT02007512|12407436|P1|STARTED|Double Blind Treatment Period||63
5042136|NCT02007434|12407514|P8|NOT COMPLETED|Overall Study||0
5042137|NCT02007434|12407515|P7|NOT COMPLETED|Overall Study||0
5042138|NCT02007434|12407516|P6|NOT COMPLETED|Overall Study||0
5042139|NCT02007434|12407517|P5|NOT COMPLETED|Overall Study||0
5042140|NCT02007434|12407518|P4|NOT COMPLETED|Overall Study||0
5042141|NCT02007434|12407519|P3|NOT COMPLETED|Overall Study||1
5042142|NCT02007434|12407520|P2|NOT COMPLETED|Overall Study||1
5042143|NCT02007434|12407521|P1|NOT COMPLETED|Overall Study||1
5042144|NCT02007434|12407514|P8|COMPLETED|Overall Study||4
5042145|NCT02007434|12407515|P7|COMPLETED|Overall Study||18
5042146|NCT02007434|12407516|P6|COMPLETED|Overall Study||4
5042147|NCT02007434|12407517|P5|COMPLETED|Overall Study||16
5042148|NCT02007434|12407518|P4|COMPLETED|Overall Study||4
5042149|NCT02007434|12407519|P3|COMPLETED|Overall Study||16
5042150|NCT02007434|12407520|P2|COMPLETED|Overall Study||3
5042151|NCT02007434|12407521|P1|COMPLETED|Overall Study||16
5042152|NCT02007434|12407514|P8|Received Treatment|Overall Study||4
5042153|NCT02007434|12407515|P7|Received Treatment|Overall Study||18
5042154|NCT02007434|12407516|P6|Received Treatment|Overall Study||4
5042155|NCT02007434|12407517|P5|Received Treatment|Overall Study||16
5042156|NCT02007434|12407518|P4|Received Treatment|Overall Study||4
5042157|NCT02007434|12407519|P3|Received Treatment|Overall Study||17
5042158|NCT02007434|12407520|P2|Received Treatment|Overall Study||3
5042159|NCT02007434|12407521|P1|Received Treatment|Overall Study||17
5042160|NCT02007434|12407514|P8|STARTED|Overall Study||4
5042161|NCT02007434|12407515|P7|STARTED|Overall Study||18
5042162|NCT02007434|12407516|P6|STARTED|Overall Study||4
5042163|NCT02007434|12407517|P5|STARTED|Overall Study||16
5042164|NCT02007434|12407518|P4|STARTED|Overall Study||4
5042165|NCT02007434|12407519|P3|STARTED|Overall Study||17
5042166|NCT02007434|12407520|P2|STARTED|Overall Study||4
5042167|NCT02007434|12407521|P1|STARTED|Overall Study||17
5042168|NCT02007369|12407622|P3|NOT COMPLETED|Overall Study||0
5042169|NCT02007369|12407623|P2|NOT COMPLETED|Overall Study||0
5042170|NCT02007369|12407624|P1|NOT COMPLETED|Overall Study||0
5042171|NCT02007369|12407622|P3|COMPLETED|Overall Study||54
5042172|NCT02007369|12407623|P2|COMPLETED|Overall Study||40
5042173|NCT02007369|12407624|P1|COMPLETED|Overall Study||42
5042174|NCT02007369|12407622|P3|STARTED|Overall Study||54
5042175|NCT02007369|12407623|P2|STARTED|Overall Study||40
5042176|NCT02007369|12407624|P1|STARTED|Overall Study||42
5042177|NCT02007291|12407641|P2|NOT COMPLETED|Overall Study||0
5042178|NCT02007291|12407642|P1|NOT COMPLETED|Overall Study||0
5042179|NCT02007291|12407641|P2|COMPLETED|Overall Study||23
5042180|NCT02007291|12407642|P1|COMPLETED|Overall Study||48
5042181|NCT02007291|12407641|P2|STARTED|Overall Study||23
5042182|NCT02007291|12407642|P1|STARTED|Overall Study||48
5042183|NCT02007278|12407652|P2|NOT COMPLETED|Overall Study||3
5042184|NCT02007278|12407653|P1|NOT COMPLETED|Overall Study||2
5042185|NCT02007278|12407652|P2|COMPLETED|Overall Study||17
5042186|NCT02007278|12407653|P1|COMPLETED|Overall Study||18
5042187|NCT02007278|12407652|P2|STARTED|Overall Study||20
5042188|NCT02007278|12407653|P1|STARTED|Overall Study||20
5042189|NCT02007252|12407675|P2|NOT COMPLETED|Overall Study||11
5042190|NCT02007252|12407676|P1|NOT COMPLETED|Overall Study||11
5042191|NCT02007252|12407675|P2|COMPLETED|Overall Study||22
5042192|NCT02007252|12407676|P1|COMPLETED|Overall Study||20
5042193|NCT02007252|12407675|P2|Pharmacodynamic Analysis Set|Overall Study||33
5042194|NCT02007252|12407676|P1|Pharmacodynamic Analysis Set|Overall Study||31
5042195|NCT02007252|12407675|P2|Safety Analysis Set|Overall Study||33
5042196|NCT02007252|12407676|P1|Safety Analysis Set|Overall Study||31
5042197|NCT02007252|12407675|P2|STARTED|Overall Study||33
5042198|NCT02007252|12407676|P1|STARTED|Overall Study||31
5042199|NCT02007200|12407682|P1|NOT COMPLETED|Overall Study||0
5042200|NCT02007200|12407682|P1|COMPLETED|Overall Study||55
5042201|NCT02007200|12407682|P1|STARTED|Overall Study||55
5042202|NCT02007109|12407689|P1|NOT COMPLETED|Overall Study||111
5042203|NCT02007109|12407689|P1|COMPLETED|Overall Study||82
5042204|NCT02007109|12407689|P1|PACU Analysis|Overall Study||184
5042205|NCT02007109|12407689|P1|STARTED|Overall Study||193
5042206|NCT02007096|12407698|P2|NOT COMPLETED|Overall Study||16
5042207|NCT02007096|12407699|P1|NOT COMPLETED|Overall Study||11
5042208|NCT02007096|12407698|P2|COMPLETED|Overall Study||48
5042209|NCT02007096|12407699|P1|COMPLETED|Overall Study||52
5042210|NCT02007096|12407698|P2|STARTED|Overall Study||64
5042211|NCT02007096|12407699|P1|STARTED|Overall Study||63
5042212|NCT02007070|12407711|P1|NOT COMPLETED|Overall Study||33
5042213|NCT02007070|12407711|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
5042214|NCT02007070|12407711|P1|STARTED|Overall Study||38
5042215|NCT02006979|12407732|P2|NOT COMPLETED|Overall Study||2
5042216|NCT02006979|12407733|P1|NOT COMPLETED|Overall Study||1
5042217|NCT02006979|12407732|P2|COMPLETED|Overall Study||11
5042218|NCT02006979|12407733|P1|COMPLETED|Overall Study||13
5042219|NCT02006979|12407732|P2|STARTED|Overall Study||13
5042220|NCT02006979|12407733|P1|STARTED|Overall Study||14
5042221|NCT02006888|12407748|P3|NOT COMPLETED|Overall Study||22
5042222|NCT02006888|12407749|P2|NOT COMPLETED|Overall Study||34
5042223|NCT02006888|12407750|P1|NOT COMPLETED|Overall Study||36
5042224|NCT02006888|12407748|P3|COMPLETED|Overall Study||58
5042225|NCT02006888|12407749|P2|COMPLETED|Overall Study||122
5042226|NCT02006888|12407750|P1|COMPLETED|Overall Study||122
5042227|NCT02006888|12407748|P3|STARTED|Overall Study||80
5042228|NCT02006888|12407749|P2|STARTED|Overall Study||156
5042229|NCT02006888|12407750|P1|STARTED|Overall Study||158
5042230|NCT02006836|12407761|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
5042231|NCT02006836|12407762|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
5042232|NCT02006836|12407763|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
5042233|NCT02006836|12407761|P3|COMPLETED|Self-control Period: Month 7-month 12||19
5042234|NCT02006836|12407762|P2|COMPLETED|Self-control Period: Month 7-month 12||0
5042235|NCT02006836|12407763|P1|COMPLETED|Self-control Period: Month 7-month 12||0
5042236|NCT02006836|12407761|P3|STARTED|Self-control Period: Month 7-month 12||19
5042237|NCT02006836|12407762|P2|STARTED|Self-control Period: Month 7-month 12||0
5042238|NCT02006836|12407763|P1|STARTED|Self-control Period: Month 7-month 12||0
5042239|NCT02006836|12407761|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
5042240|NCT02006836|12407762|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
5042241|NCT02006836|12407763|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
5042242|NCT02006836|12407761|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
5042243|NCT02006836|12407762|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
5042244|NCT02006836|12407763|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
5042245|NCT02006836|12407761|P3|STARTED|Case-control Period: Month 1- Month 6||0
5042246|NCT02006836|12407762|P2|STARTED|Case-control Period: Month 1- Month 6||20
5042247|NCT02006836|12407763|P1|STARTED|Case-control Period: Month 1- Month 6||20
5042248|NCT02006758|12407779|P1|NOT COMPLETED|Overall Study||13
5042249|NCT02006758|12407779|P1|COMPLETED|Overall Study||55
5042250|NCT02006758|12407779|P1|12-month Follow up|Overall Study|12-month follow up completed|55
5042251|NCT02006758|12407779|P1|6-month Follow up|Overall Study|6-month follow up completed|60
5042252|NCT02006758|12407779|P1|1-month Follow up|Overall Study|1-month follow up completed|66
5042253|NCT02006758|12407779|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
5042254|NCT02006758|12407779|P1|STARTED|Overall Study|Total number of enrolled participants|68
5042255|NCT02006732|12407810|P4|NOT COMPLETED|Overall Study||4
5042256|NCT02006732|12407811|P3|NOT COMPLETED|Overall Study||9
5042257|NCT02006732|12407812|P2|NOT COMPLETED|Overall Study||12
5042258|NCT02006732|12407813|P1|NOT COMPLETED|Overall Study||20
5042259|NCT02006732|12407810|P4|COMPLETED|Overall Study||198
5042260|NCT02006732|12407811|P3|COMPLETED|Overall Study||193
5042261|NCT02006732|12407812|P2|COMPLETED|Overall Study||191
5042262|NCT02006732|12407813|P1|COMPLETED|Overall Study||182
5042263|NCT02006732|12407810|P4|STARTED|Overall Study||202
5042264|NCT02006732|12407811|P3|STARTED|Overall Study||202
5042265|NCT02006732|12407812|P2|STARTED|Overall Study||203
5042266|NCT02006732|12407813|P1|STARTED|Overall Study||202
5042267|NCT02006719|12407853|P2|NOT COMPLETED|Overall Study||5
5042268|NCT02006719|12407854|P1|NOT COMPLETED|Overall Study||18
5042269|NCT02006719|12407853|P2|COMPLETED|Overall Study||80
5042270|NCT02006719|12407854|P1|COMPLETED|Overall Study||219
5042271|NCT02006719|12407853|P2|STARTED|Overall Study||85
5042272|NCT02006719|12407854|P1|STARTED|Overall Study||237
5042273|NCT02006706|12407884|P1|NOT COMPLETED|Overall Study||1
5042274|NCT02006706|12407884|P1|COMPLETED|Overall Study||14
5042275|NCT02006706|12407884|P1|STARTED|Overall Study||15
5042276|NCT02006693|12407891|P2|NOT COMPLETED|Overall Study||13
5042277|NCT02006693|12407892|P1|NOT COMPLETED|Overall Study||28
5042278|NCT02006693|12407891|P2|COMPLETED|Overall Study||74
5042279|NCT02006693|12407892|P1|COMPLETED|Overall Study||84
5042280|NCT02006693|12407891|P2|STARTED|Overall Study||87
5042281|NCT02006693|12407892|P1|STARTED|Overall Study||112
5042282|NCT02006667|12407904|P1|NOT COMPLETED|Overall Study||6
5042283|NCT02006667|12407904|P1|COMPLETED|Overall Study||7
5042284|NCT02006667|12407904|P1|STARTED|Overall Study||13
5042285|NCT02006654|12407916|P2|NOT COMPLETED|Overall Study||44
5042286|NCT02006654|12407917|P1|NOT COMPLETED|Overall Study||45
5042287|NCT02006654|12407916|P2|COMPLETED|Overall Study||321
5042288|NCT02006654|12407917|P1|COMPLETED|Overall Study||324
5042289|NCT02006654|12407916|P2|Treated|Overall Study||363
5042290|NCT02006654|12407917|P1|Treated|Overall Study||365
5042291|NCT02006654|12407916|P2|STARTED|Overall Study||365
5042292|NCT02006654|12407917|P1|STARTED|Overall Study||369
5042293|NCT02006641|12407946|P3|NOT COMPLETED|Overall Study||36
5042294|NCT02006641|12407947|P2|NOT COMPLETED|Overall Study||33
5042295|NCT02006641|12407948|P1|NOT COMPLETED|Overall Study||26
5042296|NCT02006641|12407946|P3|COMPLETED|Overall Study||248
5042297|NCT02006641|12407947|P2|COMPLETED|Overall Study||257
5042298|NCT02006641|12407948|P1|COMPLETED|Overall Study||258
5042299|NCT02006641|12407946|P3|Treated|Overall Study||281
5042300|NCT02006641|12407947|P2|Treated|Overall Study||285
5042301|NCT02006641|12407948|P1|Treated|Overall Study||282
5042302|NCT02006641|12407946|P3|STARTED|Overall Study||284
5042303|NCT02006641|12407947|P2|STARTED|Overall Study||290
5042304|NCT02006641|12407948|P1|STARTED|Overall Study||284
5042305|NCT02006628|12407988|P2|NOT COMPLETED|Overall Study||2
5042306|NCT02006628|12407989|P1|NOT COMPLETED|Overall Study||3
5042307|NCT02006628|12407988|P2|COMPLETED|Overall Study||43
5042308|NCT02006628|12407989|P1|COMPLETED|Overall Study||40
5042309|NCT02006628|12407988|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
5042310|NCT02006628|12407989|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
5042311|NCT02006628|12407988|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
5042312|NCT02006628|12407989|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
5042313|NCT02006628|12407988|P2|STARTED|Overall Study||45
5042314|NCT02006628|12407989|P1|STARTED|Overall Study||43
5042315|NCT02006576|12408014|P3|NOT COMPLETED|Overall Study||17
5042316|NCT02006576|12408015|P2|NOT COMPLETED|Overall Study||7
5042317|NCT02006576|12408016|P1|NOT COMPLETED|Overall Study||18
5042318|NCT02006576|12408014|P3|COMPLETED|Overall Study||15
5042319|NCT02006576|12408015|P2|COMPLETED|Overall Study||44
5042320|NCT02006576|12408016|P1|COMPLETED|Overall Study||17
5042321|NCT02006576|12408014|P3|STARTED|Overall Study||32
5042322|NCT02006576|12408015|P2|STARTED|Overall Study||51
5042323|NCT02006576|12408016|P1|STARTED|Overall Study||35
5042324|NCT02006420|12408029|P2|NOT COMPLETED|Overall Study||0
5042325|NCT02006420|12408030|P1|NOT COMPLETED|Overall Study||0
5042326|NCT02006420|12408029|P2|COMPLETED|Overall Study||21
5042327|NCT02006420|12408030|P1|COMPLETED|Overall Study||24
5042328|NCT02006420|12408029|P2|STARTED|Overall Study||21
5042329|NCT02006420|12408030|P1|STARTED|Overall Study||24
5042330|NCT02006407|12408044|P1|NOT COMPLETED|Overall Study||0
5042331|NCT02006407|12408044|P1|COMPLETED|Overall Study||5
5042332|NCT02006407|12408044|P1|STARTED|Overall Study||5
5042333|NCT02006342|12408052|P2|NOT COMPLETED|Overall Study||0
5042334|NCT02006342|12408053|P1|NOT COMPLETED|Overall Study||1
5042335|NCT02006342|12408052|P2|COMPLETED|Overall Study||20
5042336|NCT02006342|12408053|P1|COMPLETED|Overall Study||19
5042337|NCT02006342|12408052|P2|STARTED|Overall Study||20
5042338|NCT02006342|12408053|P1|STARTED|Overall Study||20
5042339|NCT02006264|12408069|P2|NOT COMPLETED|Overall Study||0
5042340|NCT02006264|12408070|P1|NOT COMPLETED|Overall Study||1
5042341|NCT02006264|12408069|P2|COMPLETED|Overall Study||15
5042342|NCT02006264|12408070|P1|COMPLETED|Overall Study||14
5042343|NCT02006264|12408069|P2|STARTED|Overall Study||15
5042344|NCT02006264|12408070|P1|STARTED|Overall Study||15
5042345|NCT02006160|12408090|P2|NOT COMPLETED|Overall Study||0
5042346|NCT02006160|12408091|P1|NOT COMPLETED|Overall Study||4
5042347|NCT02006160|12408090|P2|COMPLETED|Overall Study||16
5042348|NCT02006160|12408091|P1|COMPLETED|Overall Study||41
5042349|NCT02006160|12408090|P2|STARTED|Overall Study||16
5042350|NCT02006160|12408091|P1|STARTED|Overall Study||45
5042351|NCT02006121|12408099|P2|NOT COMPLETED|Open Label Phase||0
5042352|NCT02006121|12408100|P1|NOT COMPLETED|Open Label Phase||25
5042353|NCT02006121|12408099|P2|COMPLETED|Open Label Phase||0
5042354|NCT02006121|12408100|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
5042355|NCT02006121|12408099|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
5042356|NCT02006121|12408100|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
5042357|NCT02006121|12408099|P2|NOT COMPLETED|Double Blind Phase||24
5042358|NCT02006121|12408100|P1|NOT COMPLETED|Double Blind Phase||12
5042359|NCT02006121|12408099|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
5042360|NCT02006121|12408100|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
5042361|NCT02006121|12408099|P2|STARTED|Double Blind Phase||53
5042362|NCT02006121|12408100|P1|STARTED|Double Blind Phase||54
5042363|NCT02006108|12408114|P1|NOT COMPLETED|Overall Study||2
5042364|NCT02006108|12408114|P1|COMPLETED|Overall Study||19
5042365|NCT02006108|12408114|P1|MR Imaging|Overall Study||19
5042366|NCT02006108|12408114|P1|STARTED|Overall Study||21
5042367|NCT02006056|12408121|P2|NOT COMPLETED|Overall Study||0
5042368|NCT02006056|12408122|P1|NOT COMPLETED|Overall Study||0
5042369|NCT02006056|12408121|P2|COMPLETED|Overall Study||4
5042370|NCT02006056|12408122|P1|COMPLETED|Overall Study||26
5042371|NCT02006056|12408121|P2|STARTED|Overall Study||4
5042372|NCT02006056|12408122|P1|STARTED|Overall Study||26
5042373|NCT02005887|12408133|P2|NOT COMPLETED|Overall Study||2
5042374|NCT02005887|12408134|P1|NOT COMPLETED|Overall Study||0
5042375|NCT02005887|12408133|P2|COMPLETED|Overall Study||23
5042376|NCT02005887|12408134|P1|COMPLETED|Overall Study||26
5042377|NCT02005887|12408133|P2|STARTED|Overall Study||25
5042378|NCT02005887|12408134|P1|STARTED|Overall Study||26
5042379|NCT02005692|12408152|P1|NOT COMPLETED|Overall Study||7
5042380|NCT02005692|12408152|P1|COMPLETED|Overall Study||63
5042381|NCT02005692|12408152|P1|STARTED|Overall Study||70
5042382|NCT02005627|12408159|P2|NOT COMPLETED|Overall Study||4
5042383|NCT02005627|12408160|P1|NOT COMPLETED|Overall Study||2
5042384|NCT02005627|12408159|P2|COMPLETED|Overall Study||19
5042385|NCT02005627|12408160|P1|COMPLETED|Overall Study||21
5042386|NCT02005627|12408159|P2|STARTED|Overall Study||23
5042387|NCT02005627|12408160|P1|STARTED|Overall Study||23
5042388|NCT02005601|12408176|P2|NOT COMPLETED|Overall Study||0
5042389|NCT02005601|12408177|P1|NOT COMPLETED|Overall Study||0
5042390|NCT02005601|12408176|P2|COMPLETED|Overall Study||53
5042391|NCT02005601|12408177|P1|COMPLETED|Overall Study||53
5042392|NCT02005601|12408176|P2|STARTED|Overall Study||53
5042393|NCT02005601|12408177|P1|STARTED|Overall Study||53
5042394|NCT02005562|12408189|P2|NOT COMPLETED|Overall Study||15
5042395|NCT02005562|12408190|P1|NOT COMPLETED|Overall Study||12
5042396|NCT02005562|12408189|P2|COMPLETED|Overall Study||110
5042397|NCT02005562|12408190|P1|COMPLETED|Overall Study||115
5042398|NCT02005562|12408189|P2|Transplanted|Overall Study||121
5042399|NCT02005562|12408190|P1|Transplanted|Overall Study||126
5042400|NCT02005562|12408189|P2|STARTED|Overall Study||125
5042401|NCT02005562|12408190|P1|STARTED|Overall Study||127
5042402|NCT02005549|12408218|P1|NOT COMPLETED|Overall Study||0
5042403|NCT02005549|12408218|P1|COMPLETED|Overall Study||18
5042404|NCT02005549|12408218|P1|STARTED|Overall Study||18
5042405|NCT02005536|12408224|P1|NOT COMPLETED|Overall Study||0
5042406|NCT02005536|12408224|P1|COMPLETED|Overall Study||60
5042407|NCT02005536|12408224|P1|STARTED|Overall Study||60
5042408|NCT02005484|12408232|P1|NOT COMPLETED|Overall Study||4
5042409|NCT02005484|12408232|P1|COMPLETED|Overall Study||2
5042410|NCT02005484|12408232|P1|STARTED|Overall Study||6
5042411|NCT02005471|12408244|P2|NOT COMPLETED|Overall Study||194
5042412|NCT02005471|12408245|P1|NOT COMPLETED|Overall Study||195
5042413|NCT02005471|12408244|P2|COMPLETED|Overall Study||0
5042414|NCT02005471|12408245|P1|COMPLETED|Overall Study||0
5042415|NCT02005471|12408244|P2|Treated|Overall Study||194
5042416|NCT02005471|12408245|P1|Treated|Overall Study||188
5042417|NCT02005471|12408244|P2|STARTED|Overall Study||194
5042418|NCT02005471|12408245|P1|STARTED|Overall Study||195
5042419|NCT02005445|12408300|P2|NOT COMPLETED|Overall Study||1
5042420|NCT02005445|12408301|P1|NOT COMPLETED|Overall Study||0
5042421|NCT02005445|12408300|P2|COMPLETED|Overall Study||1
5042422|NCT02005445|12408301|P1|COMPLETED|Overall Study||2
5042423|NCT02005445|12408300|P2|STARTED|Overall Study||2
5042424|NCT02005445|12408301|P1|STARTED|Overall Study||2
5042425|NCT02005393|12408307|P1|NOT COMPLETED|Overall Study||0
5042426|NCT02005393|12408307|P1|COMPLETED|Overall Study||20
5042427|NCT02005393|12408307|P1|STARTED|Overall Study||20
5042428|NCT02005354|12408313|P2|NOT COMPLETED|Overall Study||0
5042429|NCT02005354|12408314|P1|NOT COMPLETED|Overall Study||0
5042430|NCT02005354|12408313|P2|COMPLETED|Overall Study||35
5042431|NCT02005354|12408314|P1|COMPLETED|Overall Study||35
5042432|NCT02005354|12408313|P2|STARTED|Overall Study||35
5042433|NCT02005354|12408314|P1|STARTED|Overall Study||35
5042434|NCT02005276|12408324|P4|NOT COMPLETED|Overall Study||3
5042435|NCT02005276|12408325|P3|NOT COMPLETED|Overall Study||3
5042436|NCT02005276|12408326|P2|NOT COMPLETED|Overall Study||2
5042437|NCT02005276|12408327|P1|NOT COMPLETED|Overall Study||5
5042438|NCT02005276|12408324|P4|COMPLETED|Overall Study||41
5042439|NCT02005276|12408325|P3|COMPLETED|Overall Study||56
5042440|NCT02005276|12408326|P2|COMPLETED|Overall Study||39
5042441|NCT02005276|12408327|P1|COMPLETED|Overall Study||60
5042442|NCT02005276|12408324|P4|Completed Intervention|Overall Study||42
5042443|NCT02005276|12408325|P3|Completed Intervention|Overall Study||56
5042444|NCT02005276|12408326|P2|Completed Intervention|Overall Study||39
5042445|NCT02005276|12408327|P1|Completed Intervention|Overall Study||61
5042446|NCT02005276|12408324|P4|STARTED|Overall Study||44
5042447|NCT02005276|12408325|P3|STARTED|Overall Study||59
5042448|NCT02005276|12408326|P2|STARTED|Overall Study||41
5042449|NCT02005276|12408327|P1|STARTED|Overall Study||65
5042450|NCT02005250|12408343|P2|NOT COMPLETED|Overall Study||5
5042451|NCT02005250|12408344|P1|NOT COMPLETED|Overall Study||15
5042452|NCT02005250|12408343|P2|COMPLETED|Overall Study||27
5042453|NCT02005250|12408344|P1|COMPLETED|Overall Study||46
5042454|NCT02005250|12408343|P2|STARTED|Overall Study||32
5042455|NCT02005250|12408344|P1|STARTED|Overall Study||61
5042456|NCT02005211|12408357|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042457|NCT02005211|12408358|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042458|NCT02005211|12408359|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
5042459|NCT02005211|12408360|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042460|NCT02005211|12408361|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042461|NCT02005211|12408362|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042462|NCT02005211|12408363|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042463|NCT02005211|12408357|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
5042464|NCT02005211|12408358|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
5042465|NCT02005211|12408359|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
5042466|NCT02005211|12408360|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042467|NCT02005211|12408361|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042468|NCT02005211|12408362|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042469|NCT02005211|12408363|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042470|NCT02005211|12408357|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
5042471|NCT02005211|12408358|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
5042472|NCT02005211|12408359|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
5042473|NCT02005211|12408360|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042474|NCT02005211|12408361|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042475|NCT02005211|12408362|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042476|NCT02005211|12408363|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
5042477|NCT02005211|12408357|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042478|NCT02005211|12408358|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042479|NCT02005211|12408359|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042480|NCT02005211|12408360|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042481|NCT02005211|12408361|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042482|NCT02005211|12408362|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042483|NCT02005211|12408363|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042484|NCT02005211|12408357|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042485|NCT02005211|12408358|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042486|NCT02005211|12408359|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042487|NCT02005211|12408360|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042488|NCT02005211|12408361|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042489|NCT02005211|12408362|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042490|NCT02005211|12408363|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042491|NCT02005211|12408357|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042492|NCT02005211|12408358|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042493|NCT02005211|12408359|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
5042494|NCT02005211|12408360|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042495|NCT02005211|12408361|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042496|NCT02005211|12408362|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042497|NCT02005211|12408363|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
5042498|NCT02005029|12408398|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5042499|NCT02005029|12408399|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5042500|NCT02005029|12408398|P2|COMPLETED|Second Intervention (1 Day)||5
5042501|NCT02005029|12408399|P1|COMPLETED|Second Intervention (1 Day)||4
5042502|NCT02005029|12408398|P2|STARTED|Second Intervention (1 Day)||5
5042503|NCT02005029|12408399|P1|STARTED|Second Intervention (1 Day)||4
5042504|NCT02005029|12408398|P2|NOT COMPLETED|Washout (2 Weeks)||0
5042505|NCT02005029|12408399|P1|NOT COMPLETED|Washout (2 Weeks)||0
5042506|NCT02005029|12408398|P2|COMPLETED|Washout (2 Weeks)||5
5042507|NCT02005029|12408399|P1|COMPLETED|Washout (2 Weeks)||4
5042508|NCT02005029|12408398|P2|STARTED|Washout (2 Weeks)||5
5042509|NCT02005029|12408399|P1|STARTED|Washout (2 Weeks)||4
5042510|NCT02005029|12408398|P2|NOT COMPLETED|First Intervention (1 Day)||0
5042511|NCT02005029|12408399|P1|NOT COMPLETED|First Intervention (1 Day)||1
5042512|NCT02005029|12408398|P2|COMPLETED|First Intervention (1 Day)||5
5042513|NCT02005029|12408399|P1|COMPLETED|First Intervention (1 Day)||4
5042514|NCT02005029|12408398|P2|STARTED|First Intervention (1 Day)||5
5042515|NCT02005029|12408399|P1|STARTED|First Intervention (1 Day)||5
5042516|NCT02005016|12408425|P1|NOT COMPLETED|Overall Study||2
5042517|NCT02005016|12408425|P1|COMPLETED|Overall Study||44
5042518|NCT02005016|12408425|P1|STARTED|Overall Study||46
5042519|NCT02004990|12408430|P1|NOT COMPLETED|Overall Study||0
5042520|NCT02004990|12408430|P1|COMPLETED|Overall Study||12
5042521|NCT02004990|12408430|P1|STARTED|Overall Study||12
5042522|NCT02004977|12408437|P2|NOT COMPLETED|Overall Study||5
5042523|NCT02004977|12408438|P1|NOT COMPLETED|Overall Study||54
5042524|NCT02004977|12408437|P2|COMPLETED|Overall Study||436
5042525|NCT02004977|12408438|P1|COMPLETED|Overall Study||409
5042526|NCT02004977|12408437|P2|STARTED|Overall Study||441
5042527|NCT02004977|12408438|P1|STARTED|Overall Study||463
5042528|NCT02004886|12408456|P4|NOT COMPLETED|Overall Study||0
5042529|NCT02004886|12408457|P3|NOT COMPLETED|Overall Study||0
5042530|NCT02004886|12408458|P2|NOT COMPLETED|Overall Study||1
5042531|NCT02004886|12408459|P1|NOT COMPLETED|Overall Study||1
5042532|NCT02004886|12408456|P4|COMPLETED|Overall Study||19
5042533|NCT02004886|12408457|P3|COMPLETED|Overall Study||18
5042534|NCT02004886|12408458|P2|COMPLETED|Overall Study||17
5042535|NCT02004886|12408459|P1|COMPLETED|Overall Study||18
5042536|NCT02004886|12408456|P4|STARTED|Overall Study||19
5042537|NCT02004886|12408457|P3|STARTED|Overall Study||18
5042538|NCT02004886|12408458|P2|STARTED|Overall Study||18
5042539|NCT02004886|12408459|P1|STARTED|Overall Study||19
5042540|NCT02004873|12408509|P1|NOT COMPLETED|Overall Study||424
5042541|NCT02004873|12408509|P1|COMPLETED|Overall Study|6-Month Follow-up|301
5042542|NCT02004873|12408509|P1|Micra Implant Success|Overall Study||719
5042543|NCT02004873|12408509|P1|STARTED|Overall Study|Micra Implant Attempt|725
5042544|NCT02004847|12408518|P2|NOT COMPLETED|Overall Study||1
5042545|NCT02004847|12408519|P1|NOT COMPLETED|Overall Study||1
5042546|NCT02004847|12408518|P2|COMPLETED|Overall Study||22
5042547|NCT02004847|12408519|P1|COMPLETED|Overall Study||23
5042548|NCT02004847|12408518|P2|STARTED|Overall Study||23
5042549|NCT02004847|12408519|P1|STARTED|Overall Study||24
5042550|NCT02004522|12408565|P2|NOT COMPLETED|Overall Study||159
5042551|NCT02004522|12408566|P1|NOT COMPLETED|Overall Study||126
5042552|NCT02004522|12408565|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
5042553|NCT02004522|12408566|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
5042554|NCT02004522|12408565|P2|Number of Subjects Treated|Overall Study||155
5042555|NCT02004522|12408566|P1|Number of Subjects Treated|Overall Study||158
5042556|NCT02004522|12408565|P2|STARTED|Overall Study||159
5042557|NCT02004522|12408566|P1|STARTED|Overall Study||160
5042558|NCT02004366|12408590|P5|NOT COMPLETED|On Discharge||0
5042559|NCT02004366|12408591|P4|NOT COMPLETED|On Discharge||0
5042560|NCT02004366|12408592|P3|NOT COMPLETED|On Discharge||0
5042561|NCT02004366|12408593|P2|NOT COMPLETED|On Discharge||0
5042562|NCT02004366|12408594|P1|NOT COMPLETED|On Discharge||0
5042563|NCT02004366|12408590|P5|COMPLETED|On Discharge||39
5042564|NCT02004366|12408591|P4|COMPLETED|On Discharge||93
5042565|NCT02004366|12408592|P3|COMPLETED|On Discharge||92
5042566|NCT02004366|12408593|P2|COMPLETED|On Discharge||0
5042567|NCT02004366|12408594|P1|COMPLETED|On Discharge||0
5042568|NCT02004366|12408590|P5|STARTED|On Discharge||39
5042569|NCT02004366|12408591|P4|STARTED|On Discharge||93
5042570|NCT02004366|12408592|P3|STARTED|On Discharge||92
5042571|NCT02004366|12408593|P2|STARTED|On Discharge||0
5042572|NCT02004366|12408594|P1|STARTED|On Discharge||0
5042573|NCT02004366|12408590|P5|NOT COMPLETED|In-hospital||0
5042574|NCT02004366|12408591|P4|NOT COMPLETED|In-hospital||0
5042575|NCT02004366|12408592|P3|NOT COMPLETED|In-hospital||0
5042576|NCT02004366|12408593|P2|NOT COMPLETED|In-hospital||0
5042577|NCT02004366|12408594|P1|NOT COMPLETED|In-hospital||0
5042578|NCT02004366|12408590|P5|COMPLETED|In-hospital||0
5042579|NCT02004366|12408591|P4|COMPLETED|In-hospital||0
5042580|NCT02004366|12408592|P3|COMPLETED|In-hospital||0
5042581|NCT02004366|12408593|P2|COMPLETED|In-hospital||122
5042582|NCT02004366|12408594|P1|COMPLETED|In-hospital||128
5042583|NCT02004366|12408590|P5|STARTED|In-hospital||0
5042584|NCT02004366|12408591|P4|STARTED|In-hospital||0
5042585|NCT02004366|12408592|P3|STARTED|In-hospital||0
5042586|NCT02004366|12408593|P2|STARTED|In-hospital||122
5042587|NCT02004366|12408594|P1|STARTED|In-hospital||128
5042588|NCT02004262|12408687|P6|NOT COMPLETED|Overall Study||30
5042589|NCT02004262|12408688|P5|NOT COMPLETED|Overall Study||31
5042590|NCT02004262|12408689|P4|NOT COMPLETED|Overall Study||29
5042591|NCT02004262|12408690|P3|NOT COMPLETED|Overall Study||72
5042592|NCT02004262|12408691|P2|NOT COMPLETED|Overall Study||68
5042593|NCT02004262|12408692|P1|NOT COMPLETED|Overall Study||73
5042594|NCT02004262|12408687|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042595|NCT02004262|12408688|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042596|NCT02004262|12408689|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042597|NCT02004262|12408690|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042598|NCT02004262|12408691|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042599|NCT02004262|12408692|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
5042600|NCT02004262|12408687|P6|Treated|Overall Study||11
5042601|NCT02004262|12408688|P5|Treated|Overall Study||29
5042602|NCT02004262|12408689|P4|Treated|Overall Study||26
5042603|NCT02004262|12408690|P3|Treated|Overall Study||43
5042604|NCT02004262|12408691|P2|Treated|Overall Study||58
5042605|NCT02004262|12408692|P1|Treated|Overall Study||68
5042606|NCT02004262|12408687|P6|STARTED|Overall Study||30
5042607|NCT02004262|12408688|P5|STARTED|Overall Study||31
5042608|NCT02004262|12408689|P4|STARTED|Overall Study||29
5042609|NCT02004262|12408690|P3|STARTED|Overall Study||72
5042610|NCT02004262|12408691|P2|STARTED|Overall Study||68
5042611|NCT02004262|12408692|P1|STARTED|Overall Study||73
5042612|NCT02004236|12408712|P3|NOT COMPLETED|Overall Study||16
5042613|NCT02004236|12408713|P2|NOT COMPLETED|Overall Study||0
5042614|NCT02004236|12408714|P1|NOT COMPLETED|Overall Study||0
5042615|NCT02004236|12408712|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
5042616|NCT02004236|12408713|P2|COMPLETED|Overall Study||75
5042617|NCT02004236|12408714|P1|COMPLETED|Overall Study||75
5042618|NCT02004236|12408712|P3|STARTED|Overall Study||75
5042619|NCT02004236|12408713|P2|STARTED|Overall Study||75
5042620|NCT02004236|12408714|P1|STARTED|Overall Study||75
5042621|NCT02004158|12408758|P1|NOT COMPLETED|Overall Study||3
5042622|NCT02004158|12408758|P1|COMPLETED|Overall Study||20
5042623|NCT02004158|12408758|P1|STARTED|Overall Study||23
5042624|NCT02004132|12408766|P1|NOT COMPLETED|Overall Study||0
5042625|NCT02004132|12408766|P1|COMPLETED|Overall Study||12
5042626|NCT02004132|12408766|P1|Received Study Drug|Overall Study||12
5042627|NCT02004132|12408766|P1|STARTED|Overall Study||12
5042628|NCT02004093|12408774|P2|NOT COMPLETED|Overall Study||73
5042629|NCT02004093|12408775|P1|NOT COMPLETED|Overall Study||74
5042630|NCT02004093|12408774|P2|COMPLETED|Overall Study||1
5042631|NCT02004093|12408775|P1|COMPLETED|Overall Study||1
5042632|NCT02004093|12408774|P2|STARTED|Overall Study||74
5042633|NCT02004093|12408775|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
5042634|NCT02003963|12408807|P2|NOT COMPLETED|Overall Study||1
5042635|NCT02003963|12408808|P1|NOT COMPLETED|Overall Study||2
5042636|NCT02003963|12408807|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
5042637|NCT02003963|12408808|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
5042638|NCT02003963|12408807|P2|STARTED|Overall Study||19
5042639|NCT02003963|12408808|P1|STARTED|Overall Study||22
5042640|NCT02003924|12408830|P2|NOT COMPLETED|Overall Study||468
5042641|NCT02003924|12408831|P1|NOT COMPLETED|Overall Study||933
5042642|NCT02003924|12408830|P2|COMPLETED|Overall Study||0
5042643|NCT02003924|12408831|P1|COMPLETED|Overall Study||0
5042644|NCT02003924|12408830|P2|Treated|Overall Study||465
5042645|NCT02003924|12408831|P1|Treated|Overall Study||930
5042646|NCT02003924|12408830|P2|STARTED|Overall Study||468
5042647|NCT02003924|12408831|P1|STARTED|Overall Study||933
5042648|NCT02003898|12408929|P1|NOT COMPLETED|Overall Study||67
5042649|NCT02003898|12408929|P1|COMPLETED|Overall Study||305
5042650|NCT02003898|12408929|P1|STARTED|Overall Study||372
5042651|NCT02003638|12408938|P2|NOT COMPLETED|Overall Study||0
5042652|NCT02003638|12408939|P1|NOT COMPLETED|Overall Study||1
5042653|NCT02003638|12408938|P2|COMPLETED|Overall Study||3
5042654|NCT02003638|12408939|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
5042655|NCT02003638|12408938|P2|STARTED|Overall Study||3
5042656|NCT02003638|12408939|P1|STARTED|Overall Study||6
5042657|NCT02003625|12408947|P2|NOT COMPLETED|Overall Study||3
5042658|NCT02003625|12408948|P1|NOT COMPLETED|Overall Study||1
5042659|NCT02003625|12408947|P2|COMPLETED|Overall Study||12
5042660|NCT02003625|12408948|P1|COMPLETED|Overall Study||14
5042661|NCT02003625|12408947|P2|Received Transplant|Overall Study||12
5042662|NCT02003625|12408948|P1|Received Transplant|Overall Study||14
5042663|NCT02003625|12408947|P2|STARTED|Overall Study||15
5042664|NCT02003625|12408948|P1|STARTED|Overall Study||15
5042665|NCT02003573|12408969|P3|NOT COMPLETED|Overall Study||6
5042666|NCT02003573|12408970|P2|NOT COMPLETED|Overall Study||4
5042667|NCT02003573|12408971|P1|NOT COMPLETED|Overall Study||3
5042668|NCT02003573|12408969|P3|COMPLETED|Overall Study||0
5042669|NCT02003573|12408970|P2|COMPLETED|Overall Study||0
5042670|NCT02003573|12408971|P1|COMPLETED|Overall Study||0
5042671|NCT02003573|12408969|P3|STARTED|Overall Study|Started are treated patients|6
5042672|NCT02003573|12408970|P2|STARTED|Overall Study|Started are treated patients|4
5042673|NCT02003573|12408971|P1|STARTED|Overall Study|Started are treated patients|3
5042674|NCT02003534|12408981|P1|NOT COMPLETED|Overall Study||47
5042675|NCT02003534|12408981|P1|COMPLETED|Overall Study||329
5042676|NCT02003534|12408981|P1|STARTED|Overall Study||376
5042677|NCT02003508|12408987|P2|NOT COMPLETED|Overall Study||0
5042678|NCT02003508|12408988|P1|NOT COMPLETED|Overall Study||0
5042679|NCT02003508|12408987|P2|COMPLETED|Overall Study||166
5042680|NCT02003508|12408988|P1|COMPLETED|Overall Study||179
5042681|NCT02003508|12408987|P2|STARTED|Overall Study||166
5042682|NCT02003508|12408988|P1|STARTED|Overall Study||179
5042683|NCT02003404|12408994|P1|NOT COMPLETED|Overall Study||0
5042684|NCT02003404|12408994|P1|COMPLETED|Overall Study||17
5042685|NCT02003404|12408994|P1|STARTED|Overall Study||17
5042686|NCT02003391|12409002|P2|NOT COMPLETED|Overall Study||2
5042687|NCT02003391|12409003|P1|NOT COMPLETED|Overall Study||3
5042688|NCT02003391|12409002|P2|COMPLETED|Overall Study||73
5042689|NCT02003391|12409003|P1|COMPLETED|Overall Study||78
5042690|NCT02003391|12409002|P2|Intent to Treat Population|Overall Study||73
5042691|NCT02003391|12409003|P1|Intent to Treat Population|Overall Study||78
5042692|NCT02003391|12409002|P2|Safety Population|Overall Study||75
5042693|NCT02003391|12409003|P1|Safety Population|Overall Study||81
5042694|NCT02003391|12409002|P2|STARTED|Overall Study||75
5042695|NCT02003391|12409003|P1|STARTED|Overall Study||81
5042696|NCT02003365|12409016|P3|NOT COMPLETED|Overall Study||1
5042697|NCT02003365|12409017|P2|NOT COMPLETED|Overall Study||0
5042698|NCT02003365|12409018|P1|NOT COMPLETED|Overall Study||0
5042699|NCT02003365|12409016|P3|COMPLETED|Overall Study||9
5042700|NCT02003365|12409017|P2|COMPLETED|Overall Study||30
5042701|NCT02003365|12409018|P1|COMPLETED|Overall Study||10
5042702|NCT02003365|12409016|P3|STARTED|Overall Study||10
5042703|NCT02003365|12409017|P2|STARTED|Overall Study||30
5042704|NCT02003365|12409018|P1|STARTED|Overall Study||10
5042705|NCT02003352|12409029|P1|NOT COMPLETED|Overall Study||0
5042706|NCT02003352|12409029|P1|COMPLETED|Overall Study||98
5042707|NCT02003352|12409029|P1|STARTED|Overall Study||98
5042708|NCT02003183|12409035|P2|NOT COMPLETED|Overall Study||2
5042709|NCT02003183|12409036|P1|NOT COMPLETED|Overall Study||0
5042710|NCT02003183|12409035|P2|COMPLETED|Overall Study||15
5042711|NCT02003183|12409036|P1|COMPLETED|Overall Study||7
5042712|NCT02003183|12409035|P2|STARTED|Overall Study||17
5042713|NCT02003183|12409036|P1|STARTED|Overall Study||7
5042714|NCT02003053|12409044|P2|NOT COMPLETED|Overall Study||0
5042715|NCT02003053|12409045|P1|NOT COMPLETED|Overall Study||0
5042716|NCT02003053|12409044|P2|COMPLETED|Overall Study||3
5042717|NCT02003053|12409045|P1|COMPLETED|Overall Study||4
5042718|NCT02003053|12409044|P2|STARTED|Overall Study||3
5042719|NCT02003053|12409045|P1|STARTED|Overall Study||4
5042720|NCT02003014|12409051|P1|NOT COMPLETED|Overall Study||19
5042721|NCT02003014|12409051|P1|COMPLETED|Overall Study||880
5042722|NCT02003014|12409051|P1|STARTED|Overall Study||899
5042723|NCT02002975|12409061|P1|NOT COMPLETED|Overall Study||572
5042724|NCT02002975|12409061|P1|COMPLETED|Overall Study||17651
5042725|NCT02002975|12409061|P1|STARTED|Overall Study||18223
5042726|NCT02002936|12409077|P1|NOT COMPLETED|Overall Study||0
5042727|NCT02002936|12409077|P1|COMPLETED|Overall Study||1
5042728|NCT02002936|12409077|P1|STARTED|Overall Study||1
5042729|NCT02002871|12409086|P1|NOT COMPLETED|Overall Study||1
5042730|NCT02002871|12409086|P1|COMPLETED|Overall Study||20
5042731|NCT02002871|12409086|P1|STARTED|Overall Study||21
5042732|NCT02002832|12409114|P2|NOT COMPLETED|Overall Study||26
5042733|NCT02002832|12409115|P1|NOT COMPLETED|Overall Study||28
5042734|NCT02002832|12409114|P2|COMPLETED|Overall Study||168
5042735|NCT02002832|12409115|P1|COMPLETED|Overall Study||166
5042736|NCT02002832|12409114|P2|STARTED|Overall Study||194
5042737|NCT02002832|12409115|P1|STARTED|Overall Study||194
5042738|NCT02002702|12409126|P3|NOT COMPLETED|Overall Study||0
5042739|NCT02002702|12409127|P2|NOT COMPLETED|Overall Study||0
5042740|NCT02002702|12409128|P1|NOT COMPLETED|Overall Study||0
5042741|NCT02002702|12409126|P3|COMPLETED|Overall Study||15
5042742|NCT02002702|12409127|P2|COMPLETED|Overall Study||15
5042743|NCT02002702|12409128|P1|COMPLETED|Overall Study||16
5042744|NCT02002702|12409126|P3|STARTED|Overall Study||15
5042745|NCT02002702|12409127|P2|STARTED|Overall Study||15
5042746|NCT02002702|12409128|P1|STARTED|Overall Study||16
5042747|NCT02002689|12409160|P1|NOT COMPLETED|Overall Study||10
5042748|NCT02002689|12409160|P1|COMPLETED|Overall Study||0
5042749|NCT02002689|12409160|P1|STARTED|Overall Study||10
5042750|NCT02002650|12409168|P2|NOT COMPLETED|Overall Study||0
5042751|NCT02002650|12409169|P1|NOT COMPLETED|Overall Study||0
5042752|NCT02002650|12409168|P2|COMPLETED|Overall Study||1303
5042753|NCT02002650|12409169|P1|COMPLETED|Overall Study||1297
5042754|NCT02002650|12409168|P2|STARTED|Overall Study||1303
5042755|NCT02002650|12409169|P1|STARTED|Overall Study||1297
5042756|NCT02002533|12409179|P2|NOT COMPLETED|Overall Study||18
5042757|NCT02002533|12409180|P1|NOT COMPLETED|Overall Study||6
5042758|NCT02002533|12409179|P2|COMPLETED|Overall Study||19
5042759|NCT02002533|12409180|P1|COMPLETED|Overall Study||28
5042760|NCT02002533|12409179|P2|STARTED|Overall Study||37
5042761|NCT02002533|12409180|P1|STARTED|Overall Study||34
5042762|NCT02002494|12409203|P1|NOT COMPLETED|Overall Study||0
5042763|NCT02002494|12409203|P1|COMPLETED|Overall Study||27
5042764|NCT02002494|12409203|P1|STARTED|Overall Study||27
5042765|NCT02002221|12409220|P2|NOT COMPLETED|Overall Study||3
5042766|NCT02002221|12409221|P1|NOT COMPLETED|Overall Study||2
5042767|NCT02002221|12409220|P2|COMPLETED|Overall Study||75
5042768|NCT02002221|12409221|P1|COMPLETED|Overall Study||76
5042769|NCT02002221|12409220|P2|STARTED|Overall Study||78
5042770|NCT02002221|12409221|P1|STARTED|Overall Study||78
5042771|NCT02002208|12409237|P2|NOT COMPLETED|Overall Study||40
5042772|NCT02002208|12409238|P1|NOT COMPLETED|Overall Study||37
5042773|NCT02002208|12409237|P2|COMPLETED|Overall Study||30
5042774|NCT02002208|12409238|P1|COMPLETED|Overall Study||32
5042775|NCT02002208|12409237|P2|STARTED|Overall Study||70
5042776|NCT02002208|12409238|P1|STARTED|Overall Study||69
5042777|NCT02002182|12409248|P2|NOT COMPLETED|Overall Study||1
5042778|NCT02002182|12409249|P1|NOT COMPLETED|Overall Study||5
5042779|NCT02002182|12409248|P2|COMPLETED|Overall Study||5
5042780|NCT02002182|12409249|P1|COMPLETED|Overall Study||4
5042781|NCT02002182|12409248|P2|STARTED|Overall Study||6
5042782|NCT02002182|12409249|P1|STARTED|Overall Study||9
5042783|NCT02002091|12409261|P2|NOT COMPLETED|One Year Follow up||0
5042784|NCT02002091|12409262|P1|NOT COMPLETED|One Year Follow up||0
5042785|NCT02002091|12409261|P2|COMPLETED|One Year Follow up||191
5042786|NCT02002091|12409262|P1|COMPLETED|One Year Follow up||109
5042787|NCT02002091|12409261|P2|STARTED|One Year Follow up||191
5042788|NCT02002091|12409262|P1|STARTED|One Year Follow up||109
5042789|NCT02002091|12409261|P2|NOT COMPLETED|Screening||14
5042790|NCT02002091|12409262|P1|NOT COMPLETED|Screening||13
5042791|NCT02002091|12409261|P2|COMPLETED|Screening||191
5042792|NCT02002091|12409262|P1|COMPLETED|Screening||109
5042793|NCT02002091|12409261|P2|STARTED|Screening||205
5042794|NCT02002091|12409262|P1|STARTED|Screening||122
5042795|NCT02001987|12409297|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
5042796|NCT02001987|12409297|P1|COMPLETED|LTE Period (52 Weeks)||107
5042797|NCT02001987|12409297|P1|STARTED|LTE Period (52 Weeks)||116
5042798|NCT02001987|12409297|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
5042799|NCT02001987|12409297|P1|COMPLETED|Core Study Period (24 Weeks)||116
5042800|NCT02001987|12409297|P1|STARTED|Core Study Period (24 Weeks)||139
5042801|NCT02001714|12409373|P2|NOT COMPLETED|Overall Study||12
5042802|NCT02001714|12409374|P1|NOT COMPLETED|Overall Study||22
5042803|NCT02001714|12409373|P2|COMPLETED|Overall Study||219
5042804|NCT02001714|12409374|P1|COMPLETED|Overall Study||210
5042805|NCT02001714|12409373|P2|STARTED|Overall Study||231
5042806|NCT02001714|12409374|P1|STARTED|Overall Study||232
5042807|NCT02001688|12409383|P3|NOT COMPLETED|Overall Study||1
5042808|NCT02001688|12409384|P2|NOT COMPLETED|Overall Study||1
5042809|NCT02001688|12409385|P1|NOT COMPLETED|Overall Study||0
5042810|NCT02001688|12409383|P3|COMPLETED|Overall Study||11
5042811|NCT02001688|12409384|P2|COMPLETED|Overall Study||11
5042812|NCT02001688|12409385|P1|COMPLETED|Overall Study||12
5042813|NCT02001688|12409383|P3|STARTED|Overall Study||12
5042814|NCT02001688|12409384|P2|STARTED|Overall Study||12
5042815|NCT02001688|12409385|P1|STARTED|Overall Study||12
5042816|NCT02001558|12409404|P2|NOT COMPLETED|Overall Study||14
5042817|NCT02001558|12409405|P1|NOT COMPLETED|Overall Study||8
5042818|NCT02001558|12409404|P2|COMPLETED|Overall Study||19
5042819|NCT02001558|12409405|P1|COMPLETED|Overall Study||24
5042820|NCT02001558|12409404|P2|STARTED|Overall Study||33
5042821|NCT02001558|12409405|P1|STARTED|Overall Study||32
5042822|NCT02001194|12409441|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
5042823|NCT02001194|12409442|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
5042824|NCT02001194|12409443|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
5042825|NCT02001194|12409444|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
5042826|NCT02001194|12409441|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
5042827|NCT02001194|12409442|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
5042828|NCT02001194|12409443|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
5042829|NCT02001194|12409444|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
5042830|NCT02001194|12409441|P4|STARTED|Follow-Up Period (13 Weeks)||78
5042831|NCT02001194|12409442|P3|STARTED|Follow-Up Period (13 Weeks)||74
5042832|NCT02001194|12409443|P2|STARTED|Follow-Up Period (13 Weeks)||80
5042833|NCT02001194|12409444|P1|STARTED|Follow-Up Period (13 Weeks)||67
5042834|NCT02001194|12409441|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
5042835|NCT02001194|12409442|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
5042836|NCT02001194|12409443|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
5042837|NCT02001194|12409444|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
5042838|NCT02001194|12409441|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
5042839|NCT02001194|12409442|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
5042840|NCT02001194|12409443|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
5042841|NCT02001194|12409444|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
5042842|NCT02001194|12409441|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
5042843|NCT02001194|12409442|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
5042844|NCT02001194|12409443|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
5042845|NCT02001194|12409444|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
5042846|NCT02001181|12409460|P2|NOT COMPLETED|Overall Study||3
5042847|NCT02001181|12409461|P1|NOT COMPLETED|Overall Study||1
5042848|NCT02001181|12409460|P2|COMPLETED|Overall Study||31
5042849|NCT02001181|12409461|P1|COMPLETED|Overall Study||34
5042850|NCT02001181|12409460|P2|STARTED|Overall Study||34
5042851|NCT02001181|12409461|P1|STARTED|Overall Study||35
5042852|NCT02001051|12409477|P2|NOT COMPLETED|Overall Study||1
5042853|NCT02001051|12409478|P1|NOT COMPLETED|Overall Study||0
5042854|NCT02001051|12409477|P2|COMPLETED|Overall Study||1
5042855|NCT02001051|12409478|P1|COMPLETED|Overall Study||2
5042856|NCT02001051|12409477|P2|STARTED|Overall Study||2
5042857|NCT02001051|12409478|P1|STARTED|Overall Study||2
5042858|NCT02000973|12409502|P4|NOT COMPLETED|Overall Study||0
5042859|NCT02000973|12409503|P3|NOT COMPLETED|Overall Study||0
5042860|NCT02000973|12409504|P2|NOT COMPLETED|Overall Study||0
5042861|NCT02000973|12409505|P1|NOT COMPLETED|Overall Study||0
5042862|NCT02000973|12409502|P4|COMPLETED|Overall Study||20
5042863|NCT02000973|12409503|P3|COMPLETED|Overall Study||20
5042864|NCT02000973|12409504|P2|COMPLETED|Overall Study||20
5042865|NCT02000973|12409505|P1|COMPLETED|Overall Study||20
5042866|NCT02000973|12409502|P4|STARTED|Overall Study||20
5042867|NCT02000973|12409503|P3|STARTED|Overall Study||20
5042868|NCT02000973|12409504|P2|STARTED|Overall Study||20
5042869|NCT02000973|12409505|P1|STARTED|Overall Study||20
5042870|NCT02000921|12409530|P3|NOT COMPLETED|Overall Study||10
5042871|NCT02000921|12409531|P2|NOT COMPLETED|Overall Study||16
5042872|NCT02000921|12409532|P1|NOT COMPLETED|Overall Study||5
5042873|NCT02000921|12409530|P3|COMPLETED|Overall Study||46
5042874|NCT02000921|12409531|P2|COMPLETED|Overall Study||37
5042875|NCT02000921|12409532|P1|COMPLETED|Overall Study||22
5042876|NCT02000921|12409530|P3|STARTED|Overall Study||56
5042877|NCT02000921|12409531|P2|STARTED|Overall Study||53
5042878|NCT02000921|12409532|P1|STARTED|Overall Study||27
5042879|NCT02000908|12409551|P2|NOT COMPLETED|Overall Study||4
5042880|NCT02000908|12409552|P1|NOT COMPLETED|Overall Study||2
5042881|NCT02000908|12409551|P2|COMPLETED|Overall Study||36
5042882|NCT02000908|12409552|P1|COMPLETED|Overall Study||28
5042883|NCT02000908|12409551|P2|STARTED|Overall Study||40
5042884|NCT02000908|12409552|P1|STARTED|Overall Study||30
5042885|NCT02000817|12409562|P4|NOT COMPLETED|Overall Study||0
5042886|NCT02000817|12409563|P3|NOT COMPLETED|Overall Study||1
5042887|NCT02000817|12409564|P2|NOT COMPLETED|Overall Study||1
5042888|NCT02000817|12409565|P1|NOT COMPLETED|Overall Study||2
5042889|NCT02000817|12409562|P4|COMPLETED|Overall Study||7
5042890|NCT02000817|12409563|P3|COMPLETED|Overall Study||7
5042891|NCT02000817|12409564|P2|COMPLETED|Overall Study||8
5042892|NCT02000817|12409565|P1|COMPLETED|Overall Study||4
5042893|NCT02000817|12409562|P4|STARTED|Overall Study||7
5042894|NCT02000817|12409563|P3|STARTED|Overall Study||8
5042895|NCT02000817|12409564|P2|STARTED|Overall Study||9
5042896|NCT02000817|12409565|P1|STARTED|Overall Study||6
5042897|NCT02000752|12409660|P2|NOT COMPLETED|Overall Study||13
5042898|NCT02000752|12409661|P1|NOT COMPLETED|Overall Study||31
5042899|NCT02000752|12409660|P2|COMPLETED|Overall Study||47
5042900|NCT02000752|12409661|P1|COMPLETED|Overall Study||29
5042901|NCT02000752|12409660|P2|STARTED|Overall Study||60
5042902|NCT02000752|12409661|P1|STARTED|Overall Study||60
5042903|NCT02000622|12409675|P2|NOT COMPLETED|Overall Study||53
5042904|NCT02000622|12409676|P1|NOT COMPLETED|Overall Study||101
5042905|NCT02000622|12409675|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
5042906|NCT02000622|12409676|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
5042907|NCT02000622|12409675|P2|STARTED|Overall Study||97
5042908|NCT02000622|12409676|P1|STARTED|Overall Study||205
5042909|NCT02000583|12409698|P2|NOT COMPLETED|Overall Study||5
5042910|NCT02000583|12409699|P1|NOT COMPLETED|Overall Study||3
5042911|NCT02000583|12409698|P2|COMPLETED|Overall Study||34
5042912|NCT02000583|12409699|P1|COMPLETED|Overall Study||75
5042913|NCT02000583|12409698|P2|STARTED|Overall Study||39
5042914|NCT02000583|12409699|P1|STARTED|Overall Study||78
5042915|NCT02000531|12409711|P2|NOT COMPLETED|Overall Study||8
5042916|NCT02000531|12409712|P1|NOT COMPLETED|Overall Study||4
5042917|NCT02000531|12409711|P2|COMPLETED|Overall Study||16
5042918|NCT02000531|12409712|P1|COMPLETED|Overall Study||17
5042919|NCT02000531|12409711|P2|Safety Population|Overall Study||24
5042920|NCT02000531|12409712|P1|Safety Population|Overall Study||21
5042921|NCT02000531|12409711|P2|STARTED|Overall Study||24
5042922|NCT02000531|12409712|P1|STARTED|Overall Study||21
5042923|NCT02000440|12409720|P1|NOT COMPLETED|Overall Study||4
5042924|NCT02000440|12409720|P1|COMPLETED|Overall Study||13
5042925|NCT02000440|12409720|P1|STARTED|Overall Study||17
5042926|NCT02000427|12409740|P1|NOT COMPLETED|Overall Study||22
5042927|NCT02000427|12409740|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
5042928|NCT02000427|12409740|P1|STARTED|Overall Study||45
5042929|NCT02000180|12409757|P2|NOT COMPLETED|Overall Study||0
5042930|NCT02000180|12409758|P1|NOT COMPLETED|Overall Study||0
5042931|NCT02000180|12409757|P2|COMPLETED|Overall Study||19
5042932|NCT02000180|12409758|P1|COMPLETED|Overall Study||18
5042933|NCT02000180|12409757|P2|STARTED|Overall Study||19
5042934|NCT02000180|12409758|P1|STARTED|Overall Study||18
5042935|NCT02000154|12409770|P1|NOT COMPLETED|Overall Study||0
5042936|NCT02000154|12409770|P1|COMPLETED|Overall Study||1
5042937|NCT02000154|12409770|P1|STARTED|Overall Study||1
5042938|NCT01999985|12409778|P3|NOT COMPLETED|Overall Study||0
5042939|NCT01999985|12409779|P2|NOT COMPLETED|Overall Study||0
5042940|NCT01999985|12409780|P1|NOT COMPLETED|Overall Study||0
5042941|NCT01999985|12409778|P3|COMPLETED|Overall Study||14
5042942|NCT01999985|12409779|P2|COMPLETED|Overall Study||3
5042943|NCT01999985|12409780|P1|COMPLETED|Overall Study||8
5042944|NCT01999985|12409778|P3|STARTED|Overall Study||14
5042945|NCT01999985|12409779|P2|STARTED|Overall Study||3
5042946|NCT01999985|12409780|P1|STARTED|Overall Study||8
5042947|NCT01999972|12409794|P6|NOT COMPLETED|Dose Expansion Part||7
5042948|NCT01999972|12409795|P5|NOT COMPLETED|Dose Expansion Part||21
5042949|NCT01999972|12409796|P4|NOT COMPLETED|Dose Expansion Part||0
5042950|NCT01999972|12409797|P3|NOT COMPLETED|Dose Expansion Part||0
5042951|NCT01999972|12409798|P2|NOT COMPLETED|Dose Expansion Part||0
5042952|NCT01999972|12409799|P1|NOT COMPLETED|Dose Expansion Part||0
5042953|NCT01999972|12409794|P6|COMPLETED|Dose Expansion Part||0
5042954|NCT01999972|12409795|P5|COMPLETED|Dose Expansion Part||0
5042955|NCT01999972|12409796|P4|COMPLETED|Dose Expansion Part||0
5042956|NCT01999972|12409797|P3|COMPLETED|Dose Expansion Part||0
5042957|NCT01999972|12409798|P2|COMPLETED|Dose Expansion Part||0
5042958|NCT01999972|12409799|P1|COMPLETED|Dose Expansion Part||0
5042959|NCT01999972|12409794|P6|Treated|Dose Expansion Part||7
5042960|NCT01999972|12409795|P5|Treated|Dose Expansion Part||21
5042961|NCT01999972|12409796|P4|Treated|Dose Expansion Part||0
5042962|NCT01999972|12409797|P3|Treated|Dose Expansion Part||0
5042963|NCT01999972|12409798|P2|Treated|Dose Expansion Part||0
5042964|NCT01999972|12409799|P1|Treated|Dose Expansion Part||0
5042965|NCT01999972|12409794|P6|STARTED|Dose Expansion Part||7
5042966|NCT01999972|12409795|P5|STARTED|Dose Expansion Part||21
5042967|NCT01999972|12409796|P4|STARTED|Dose Expansion Part||0
5042968|NCT01999972|12409797|P3|STARTED|Dose Expansion Part||0
5042969|NCT01999972|12409798|P2|STARTED|Dose Expansion Part||0
5042970|NCT01999972|12409799|P1|STARTED|Dose Expansion Part||0
5042971|NCT01999972|12409794|P6|NOT COMPLETED|Dose Escalation Part||0
5042972|NCT01999972|12409795|P5|NOT COMPLETED|Dose Escalation Part||0
5042973|NCT01999972|12409796|P4|NOT COMPLETED|Dose Escalation Part||11
5042974|NCT01999972|12409797|P3|NOT COMPLETED|Dose Escalation Part||5
5042975|NCT01999972|12409798|P2|NOT COMPLETED|Dose Escalation Part||3
5042976|NCT01999972|12409799|P1|NOT COMPLETED|Dose Escalation Part||5
5042977|NCT01999972|12409794|P6|COMPLETED|Dose Escalation Part||0
5042978|NCT01999972|12409795|P5|COMPLETED|Dose Escalation Part||0
5042979|NCT01999972|12409796|P4|COMPLETED|Dose Escalation Part||0
5042980|NCT01999972|12409797|P3|COMPLETED|Dose Escalation Part||0
5042981|NCT01999972|12409798|P2|COMPLETED|Dose Escalation Part||0
5042982|NCT01999972|12409799|P1|COMPLETED|Dose Escalation Part||0
5042983|NCT01999972|12409794|P6|Treated|Dose Escalation Part||0
5042984|NCT01999972|12409795|P5|Treated|Dose Escalation Part||0
5042985|NCT01999972|12409796|P4|Treated|Dose Escalation Part||10
5042986|NCT01999972|12409797|P3|Treated|Dose Escalation Part||4
5042987|NCT01999972|12409798|P2|Treated|Dose Escalation Part||3
5042988|NCT01999972|12409799|P1|Treated|Dose Escalation Part||5
5042989|NCT01999972|12409794|P6|STARTED|Dose Escalation Part||0
5042990|NCT01999972|12409795|P5|STARTED|Dose Escalation Part||0
5042991|NCT01999972|12409796|P4|STARTED|Dose Escalation Part||11
5042992|NCT01999972|12409797|P3|STARTED|Dose Escalation Part||5
5042993|NCT01999972|12409798|P2|STARTED|Dose Escalation Part||3
5042994|NCT01999972|12409799|P1|STARTED|Dose Escalation Part||5
5042995|NCT01999946|12409914|P3|NOT COMPLETED|Overall Study||79
5042996|NCT01999946|12409915|P2|NOT COMPLETED|Overall Study||2
5042997|NCT01999946|12409916|P1|NOT COMPLETED|Overall Study||2
5042998|NCT01999946|12409914|P3|COMPLETED|Overall Study||0
5042999|NCT01999946|12409915|P2|COMPLETED|Overall Study||56
5043000|NCT01999946|12409916|P1|COMPLETED|Overall Study||59
5043001|NCT01999946|12409914|P3|STARTED|Overall Study||79
5043002|NCT01999946|12409915|P2|STARTED|Overall Study||58
5043003|NCT01999946|12409916|P1|STARTED|Overall Study||61
5043004|NCT01999920|12409925|P2|NOT COMPLETED|Overall Study||2
5043005|NCT01999920|12409926|P1|NOT COMPLETED|Overall Study||6
5043006|NCT01999920|12409925|P2|COMPLETED|Overall Study||9
5043007|NCT01999920|12409926|P1|COMPLETED|Overall Study||7
5043008|NCT01999920|12409925|P2|STARTED|Overall Study||11
5043009|NCT01999920|12409926|P1|STARTED|Overall Study||13
5043010|NCT01999894|12409942|P1|NOT COMPLETED|Overall Study||36
5043011|NCT01999894|12409942|P1|COMPLETED|Overall Study||66
5043012|NCT01999894|12409942|P1|STARTED|Overall Study||102
5043013|NCT01999868|12409950|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
5043014|NCT01999868|12409951|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||29
5043015|NCT01999868|12409952|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||23
5043016|NCT01999868|12409950|P3|COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
5043017|NCT01999868|12409951|P2|COMPLETED|Blinded Observation Phase (Week 40 – 88)||6
5043018|NCT01999868|12409952|P1|COMPLETED|Blinded Observation Phase (Week 40 – 88)||4
5043019|NCT01999868|12409950|P3|STARTED|Blinded Observation Phase (Week 40 – 88)||0
5043020|NCT01999868|12409951|P2|STARTED|Blinded Observation Phase (Week 40 – 88)||35
5043021|NCT01999868|12409952|P1|STARTED|Blinded Observation Phase (Week 40 – 88)||27
5043022|NCT01999868|12409950|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
5043023|NCT01999868|12409951|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||11
5043024|NCT01999868|12409952|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||18
5043025|NCT01999868|12409950|P3|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
5043026|NCT01999868|12409951|P2|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||35
5043027|NCT01999868|12409952|P1|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||27
5043028|NCT01999868|12409950|P3|STARTED|Blinded Treatment Phase (Week 12 – 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
5043029|NCT01999868|12409951|P2|STARTED|Blinded Treatment Phase (Week 12 – 40)||46
5043030|NCT01999868|12409952|P1|STARTED|Blinded Treatment Phase (Week 12 – 40)||45
5043031|NCT01999868|12409950|P3|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||5
5043032|NCT01999868|12409951|P2|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
5043033|NCT01999868|12409952|P1|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
5043034|NCT01999868|12409950|P3|COMPLETED|Lead-in Phase (Week 0 – 12)||12
5043035|NCT01999868|12409951|P2|COMPLETED|Lead-in Phase (Week 0 – 12)||46
5043036|NCT01999868|12409952|P1|COMPLETED|Lead-in Phase (Week 0 – 12)||45
5043037|NCT01999868|12409950|P3|STARTED|Lead-in Phase (Week 0 – 12)||17
5043038|NCT01999868|12409951|P2|STARTED|Lead-in Phase (Week 0 – 12)||46
5043039|NCT01999868|12409952|P1|STARTED|Lead-in Phase (Week 0 – 12)||45
5043040|NCT01999777|12409979|P2|NOT COMPLETED|Overall Study||0
5043041|NCT01999777|12409980|P1|NOT COMPLETED|Overall Study||0
5043042|NCT01999777|12409979|P2|COMPLETED|Overall Study||31
5043043|NCT01999777|12409980|P1|COMPLETED|Overall Study||31
5043044|NCT01999777|12409979|P2|STARTED|Overall Study||31
5043045|NCT01999777|12409980|P1|STARTED|Overall Study||31
5043046|NCT01999530|12409988|P1|NOT COMPLETED|Overall Study||13
5043047|NCT01999530|12409988|P1|COMPLETED|Overall Study||7
5043048|NCT01999530|12409988|P1|STARTED|Overall Study||20
5043049|NCT01999517|12409994|P2|NOT COMPLETED|Overall Study||0
5043050|NCT01999517|12409995|P1|NOT COMPLETED|Overall Study||0
5043051|NCT01999517|12409994|P2|COMPLETED|Overall Study||54
5043052|NCT01999517|12409995|P1|COMPLETED|Overall Study||68
5043053|NCT01999517|12409994|P2|STARTED|Overall Study||54
5043054|NCT01999517|12409995|P1|STARTED|Overall Study||68
5043055|NCT01999465|12410003|P2|NOT COMPLETED|Overall Study||3
5043056|NCT01999465|12410004|P1|NOT COMPLETED|Overall Study||0
5043057|NCT01999465|12410003|P2|COMPLETED|Overall Study||7
5043058|NCT01999465|12410004|P1|COMPLETED|Overall Study||10
5043059|NCT01999465|12410003|P2|STARTED|Overall Study||10
5043060|NCT01999465|12410004|P1|STARTED|Overall Study||10
5043061|NCT01999400|12410012|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043062|NCT01999400|12410013|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043063|NCT01999400|12410014|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043064|NCT01999400|12410015|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043065|NCT01999400|12410016|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043066|NCT01999400|12410017|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
5043067|NCT01999400|12410012|P6|COMPLETED|Fourth Intervention (1 Day)||0
5043068|NCT01999400|12410013|P5|COMPLETED|Fourth Intervention (1 Day)||0
5043069|NCT01999400|12410014|P4|COMPLETED|Fourth Intervention (1 Day)||0
5043070|NCT01999400|12410015|P3|COMPLETED|Fourth Intervention (1 Day)||1
5043071|NCT01999400|12410016|P2|COMPLETED|Fourth Intervention (1 Day)||0
5043072|NCT01999400|12410017|P1|COMPLETED|Fourth Intervention (1 Day)||1
5043073|NCT01999400|12410012|P6|STARTED|Fourth Intervention (1 Day)||0
5043074|NCT01999400|12410013|P5|STARTED|Fourth Intervention (1 Day)||0
5043075|NCT01999400|12410014|P4|STARTED|Fourth Intervention (1 Day)||0
5043076|NCT01999400|12410015|P3|STARTED|Fourth Intervention (1 Day)||1
5043077|NCT01999400|12410016|P2|STARTED|Fourth Intervention (1 Day)||0
5043078|NCT01999400|12410017|P1|STARTED|Fourth Intervention (1 Day)||1
5043079|NCT01999400|12410012|P6|NOT COMPLETED|Washout (10 Days)||0
5043080|NCT01999400|12410013|P5|NOT COMPLETED|Washout (10 Days)||0
5043081|NCT01999400|12410014|P4|NOT COMPLETED|Washout (10 Days)||0
5043082|NCT01999400|12410015|P3|NOT COMPLETED|Washout (10 Days)||0
5043083|NCT01999400|12410016|P2|NOT COMPLETED|Washout (10 Days)||0
5043084|NCT01999400|12410017|P1|NOT COMPLETED|Washout (10 Days)||0
5043085|NCT01999400|12410012|P6|COMPLETED|Washout (10 Days)||0
5043086|NCT01999400|12410013|P5|COMPLETED|Washout (10 Days)||0
5043087|NCT01999400|12410014|P4|COMPLETED|Washout (10 Days)||0
5043088|NCT01999400|12410015|P3|COMPLETED|Washout (10 Days)||1
5043089|NCT01999400|12410016|P2|COMPLETED|Washout (10 Days)||0
5043090|NCT01999400|12410017|P1|COMPLETED|Washout (10 Days)||1
5043091|NCT01999400|12410012|P6|STARTED|Washout (10 Days)||0
5043092|NCT01999400|12410013|P5|STARTED|Washout (10 Days)||0
5043093|NCT01999400|12410014|P4|STARTED|Washout (10 Days)||0
5043094|NCT01999400|12410015|P3|STARTED|Washout (10 Days)||1
5043095|NCT01999400|12410016|P2|STARTED|Washout (10 Days)||0
5043096|NCT01999400|12410017|P1|STARTED|Washout (10 Days)||1
5043097|NCT01999400|12410012|P6|NOT COMPLETED|Third Intervention (1 Day)||1
5043098|NCT01999400|12410013|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5043099|NCT01999400|12410014|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5043100|NCT01999400|12410015|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5043101|NCT01999400|12410016|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5043102|NCT01999400|12410017|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5043103|NCT01999400|12410012|P6|COMPLETED|Third Intervention (1 Day)||0
5043104|NCT01999400|12410013|P5|COMPLETED|Third Intervention (1 Day)||1
5043105|NCT01999400|12410014|P4|COMPLETED|Third Intervention (1 Day)||1
5043106|NCT01999400|12410015|P3|COMPLETED|Third Intervention (1 Day)||1
5043107|NCT01999400|12410016|P2|COMPLETED|Third Intervention (1 Day)||0
5043108|NCT01999400|12410017|P1|COMPLETED|Third Intervention (1 Day)||2
5043109|NCT01999400|12410012|P6|STARTED|Third Intervention (1 Day)||1
5043110|NCT01999400|12410013|P5|STARTED|Third Intervention (1 Day)||1
5043111|NCT01999400|12410014|P4|STARTED|Third Intervention (1 Day)||1
5043112|NCT01999400|12410015|P3|STARTED|Third Intervention (1 Day)||1
5043113|NCT01999400|12410016|P2|STARTED|Third Intervention (1 Day)||0
5043114|NCT01999400|12410017|P1|STARTED|Third Intervention (1 Day)||2
5043115|NCT01999400|12410012|P6|NOT COMPLETED|Washout (10 Days)||0
5043116|NCT01999400|12410013|P5|NOT COMPLETED|Washout (10 Days)||0
5043117|NCT01999400|12410014|P4|NOT COMPLETED|Washout (10 Days)||0
5043118|NCT01999400|12410015|P3|NOT COMPLETED|Washout (10 Days)||0
5043119|NCT01999400|12410016|P2|NOT COMPLETED|Washout (10 Days)||0
5043120|NCT01999400|12410017|P1|NOT COMPLETED|Washout (10 Days)||0
5043121|NCT01999400|12410012|P6|COMPLETED|Washout (10 Days)||1
5043122|NCT01999400|12410013|P5|COMPLETED|Washout (10 Days)||1
5043123|NCT01999400|12410014|P4|COMPLETED|Washout (10 Days)||1
5043124|NCT01999400|12410015|P3|COMPLETED|Washout (10 Days)||1
5043125|NCT01999400|12410016|P2|COMPLETED|Washout (10 Days)||0
5043126|NCT01999400|12410017|P1|COMPLETED|Washout (10 Days)||2
5043127|NCT01999400|12410012|P6|STARTED|Washout (10 Days)||1
5043128|NCT01999400|12410013|P5|STARTED|Washout (10 Days)||1
5043129|NCT01999400|12410014|P4|STARTED|Washout (10 Days)||1
5043130|NCT01999400|12410015|P3|STARTED|Washout (10 Days)||1
5043131|NCT01999400|12410016|P2|STARTED|Washout (10 Days)||0
5043132|NCT01999400|12410017|P1|STARTED|Washout (10 Days)||2
5043133|NCT01999400|12410012|P6|NOT COMPLETED|Second Intervention (1 Day)||0
5043134|NCT01999400|12410013|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5043135|NCT01999400|12410014|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5043136|NCT01999400|12410015|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5043137|NCT01999400|12410016|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5043138|NCT01999400|12410017|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5043139|NCT01999400|12410012|P6|COMPLETED|Second Intervention (1 Day)||3
5043140|NCT01999400|12410013|P5|COMPLETED|Second Intervention (1 Day)||3
5043141|NCT01999400|12410014|P4|COMPLETED|Second Intervention (1 Day)||2
5043142|NCT01999400|12410015|P3|COMPLETED|Second Intervention (1 Day)||3
5043143|NCT01999400|12410016|P2|COMPLETED|Second Intervention (1 Day)||4
5043144|NCT01999400|12410017|P1|COMPLETED|Second Intervention (1 Day)||5
5043145|NCT01999400|12410012|P6|STARTED|Second Intervention (1 Day)||3
5043146|NCT01999400|12410013|P5|STARTED|Second Intervention (1 Day)||3
5043147|NCT01999400|12410014|P4|STARTED|Second Intervention (1 Day)||2
5043148|NCT01999400|12410015|P3|STARTED|Second Intervention (1 Day)||3
5043149|NCT01999400|12410016|P2|STARTED|Second Intervention (1 Day)||4
5043150|NCT01999400|12410017|P1|STARTED|Second Intervention (1 Day)||5
5043151|NCT01999400|12410012|P6|NOT COMPLETED|Washout (10 Days)||0
5043152|NCT01999400|12410013|P5|NOT COMPLETED|Washout (10 Days)||0
5043153|NCT01999400|12410014|P4|NOT COMPLETED|Washout (10 Days)||0
5043154|NCT01999400|12410015|P3|NOT COMPLETED|Washout (10 Days)||0
5043155|NCT01999400|12410016|P2|NOT COMPLETED|Washout (10 Days)||0
5043156|NCT01999400|12410017|P1|NOT COMPLETED|Washout (10 Days)||0
5043157|NCT01999400|12410012|P6|COMPLETED|Washout (10 Days)||3
5043158|NCT01999400|12410013|P5|COMPLETED|Washout (10 Days)||3
5043159|NCT01999400|12410014|P4|COMPLETED|Washout (10 Days)||2
5043160|NCT01999400|12410015|P3|COMPLETED|Washout (10 Days)||3
5043161|NCT01999400|12410016|P2|COMPLETED|Washout (10 Days)||4
5043162|NCT01999400|12410017|P1|COMPLETED|Washout (10 Days)||5
5043163|NCT01999400|12410012|P6|STARTED|Washout (10 Days)||3
5043164|NCT01999400|12410013|P5|STARTED|Washout (10 Days)||3
5043165|NCT01999400|12410014|P4|STARTED|Washout (10 Days)||2
5043166|NCT01999400|12410015|P3|STARTED|Washout (10 Days)||3
5043167|NCT01999400|12410016|P2|STARTED|Washout (10 Days)||4
5043168|NCT01999400|12410017|P1|STARTED|Washout (10 Days)||5
5043169|NCT01999400|12410012|P6|NOT COMPLETED|First Intervention (1 Day)||1
5043170|NCT01999400|12410013|P5|NOT COMPLETED|First Intervention (1 Day)||0
5043171|NCT01999400|12410014|P4|NOT COMPLETED|First Intervention (1 Day)||3
5043172|NCT01999400|12410015|P3|NOT COMPLETED|First Intervention (1 Day)||2
5043173|NCT01999400|12410016|P2|NOT COMPLETED|First Intervention (1 Day)||2
5043174|NCT01999400|12410017|P1|NOT COMPLETED|First Intervention (1 Day)||2
5043175|NCT01999400|12410012|P6|COMPLETED|First Intervention (1 Day)||3
5043176|NCT01999400|12410013|P5|COMPLETED|First Intervention (1 Day)||4
5043177|NCT01999400|12410014|P4|COMPLETED|First Intervention (1 Day)||2
5043178|NCT01999400|12410015|P3|COMPLETED|First Intervention (1 Day)||3
5043179|NCT01999400|12410016|P2|COMPLETED|First Intervention (1 Day)||4
5043180|NCT01999400|12410017|P1|COMPLETED|First Intervention (1 Day)||4
5043181|NCT01999400|12410012|P6|STARTED|First Intervention (1 Day)||4
5043182|NCT01999400|12410013|P5|STARTED|First Intervention (1 Day)||4
5043183|NCT01999400|12410014|P4|STARTED|First Intervention (1 Day)||5
5043184|NCT01999400|12410015|P3|STARTED|First Intervention (1 Day)||5
5043185|NCT01999400|12410016|P2|STARTED|First Intervention (1 Day)||6
5043186|NCT01999400|12410017|P1|STARTED|First Intervention (1 Day)||6
5043187|NCT01999348|12410037|P1|NOT COMPLETED|Overall Study||120
5043188|NCT01999348|12410037|P1|COMPLETED|Overall Study||1433
5043189|NCT01999348|12410037|P1|STARTED|Overall Study||1553
5043190|NCT01999322|12410049|P2|NOT COMPLETED|Overall Study||0
5043191|NCT01999322|12410050|P1|NOT COMPLETED|Overall Study||1
5043192|NCT01999322|12410049|P2|COMPLETED|Overall Study||12
5043193|NCT01999322|12410050|P1|COMPLETED|Overall Study||24
5043194|NCT01999322|12410049|P2|STARTED|Overall Study||12
5043195|NCT01999322|12410050|P1|STARTED|Overall Study||25
5043196|NCT01999231|12410066|P4|NOT COMPLETED|Overall Study||0
5043197|NCT01999231|12410067|P3|NOT COMPLETED|Overall Study||0
5043198|NCT01999231|12410068|P2|NOT COMPLETED|Overall Study||0
5043199|NCT01999231|12410069|P1|NOT COMPLETED|Overall Study||0
5043200|NCT01999231|12410066|P4|COMPLETED|Overall Study||6
5043201|NCT01999231|12410067|P3|COMPLETED|Overall Study||6
5043202|NCT01999231|12410068|P2|COMPLETED|Overall Study||6
5043203|NCT01999231|12410069|P1|COMPLETED|Overall Study||6
5043204|NCT01999231|12410066|P4|STARTED|Overall Study||6
5043205|NCT01999231|12410067|P3|STARTED|Overall Study||6
5043206|NCT01999231|12410068|P2|STARTED|Overall Study||6
5043207|NCT01999231|12410069|P1|STARTED|Overall Study||6
5043208|NCT01999218|12410102|P3|NOT COMPLETED|Overall Study||110
5043209|NCT01999218|12410103|P2|NOT COMPLETED|Overall Study||101
5043210|NCT01999218|12410104|P1|NOT COMPLETED|Overall Study||109
5043211|NCT01999218|12410102|P3|COMPLETED|Overall Study||327
5043212|NCT01999218|12410103|P2|COMPLETED|Overall Study||340
5043213|NCT01999218|12410104|P1|COMPLETED|Overall Study||339
5043214|NCT01999218|12410102|P3|Site Issue|Overall Study||435
5043215|NCT01999218|12410103|P2|Site Issue|Overall Study||435
5043216|NCT01999218|12410104|P1|Site Issue|Overall Study||445
5043217|NCT01999218|12410102|P3|Treated|Overall Study||437
5043218|NCT01999218|12410103|P2|Treated|Overall Study||440
5043219|NCT01999218|12410104|P1|Treated|Overall Study||448
5043220|NCT01999218|12410102|P3|STARTED|Overall Study||437
5043221|NCT01999218|12410103|P2|STARTED|Overall Study||441
5043222|NCT01999218|12410104|P1|STARTED|Overall Study||448
5043223|NCT01999192|12410131|P4|NOT COMPLETED|Extension Phase||0
5043224|NCT01999192|12410132|P3|NOT COMPLETED|Extension Phase||24
5043225|NCT01999192|12410133|P2|NOT COMPLETED|Extension Phase||18
5043226|NCT01999192|12410134|P1|NOT COMPLETED|Extension Phase||13
5043227|NCT01999192|12410131|P4|COMPLETED|Extension Phase||0
5043228|NCT01999192|12410132|P3|COMPLETED|Extension Phase||44
5043229|NCT01999192|12410133|P2|COMPLETED|Extension Phase||38
5043230|NCT01999192|12410134|P1|COMPLETED|Extension Phase||41
5043231|NCT01999192|12410131|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
5043232|NCT01999192|12410132|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
5043233|NCT01999192|12410133|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
5043234|NCT01999192|12410134|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
5043235|NCT01999192|12410131|P4|NOT COMPLETED|Main Phase II||1
5043236|NCT01999192|12410132|P3|NOT COMPLETED|Main Phase II||22
5043237|NCT01999192|12410133|P2|NOT COMPLETED|Main Phase II||9
5043238|NCT01999192|12410134|P1|NOT COMPLETED|Main Phase II||9
5043239|NCT01999192|12410131|P4|COMPLETED|Main Phase II||43
5043240|NCT01999192|12410132|P3|COMPLETED|Main Phase II||76
5043241|NCT01999192|12410133|P2|COMPLETED|Main Phase II||66
5043242|NCT01999192|12410134|P1|COMPLETED|Main Phase II||55
5043243|NCT01999192|12410131|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
5043244|NCT01999192|12410132|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
5043245|NCT01999192|12410133|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
5043246|NCT01999192|12410134|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
5043247|NCT01999192|12410131|P4|NOT COMPLETED|Main Phase I||8
5043248|NCT01999192|12410132|P3|NOT COMPLETED|Main Phase I||8
5043249|NCT01999192|12410133|P2|NOT COMPLETED|Main Phase I||10
5043250|NCT01999192|12410134|P1|NOT COMPLETED|Main Phase I||11
5043251|NCT01999192|12410131|P4|COMPLETED|Main Phase I||72
5043252|NCT01999192|12410132|P3|COMPLETED|Main Phase I||70
5043253|NCT01999192|12410133|P2|COMPLETED|Main Phase I||70
5043254|NCT01999192|12410134|P1|COMPLETED|Main Phase I||72
5043255|NCT01999192|12410131|P4|STARTED|Main Phase I||80
5043256|NCT01999192|12410132|P3|STARTED|Main Phase I||78
5043257|NCT01999192|12410133|P2|STARTED|Main Phase I||80
5043258|NCT01999192|12410134|P1|STARTED|Main Phase I||83
5043259|NCT01999114|12410149|P5|NOT COMPLETED|Overall Study||4
5043260|NCT01999114|12410150|P4|NOT COMPLETED|Overall Study||3
5043261|NCT01999114|12410151|P3|NOT COMPLETED|Overall Study||5
5043262|NCT01999114|12410152|P2|NOT COMPLETED|Overall Study||7
5043263|NCT01999114|12410153|P1|NOT COMPLETED|Overall Study||8
5043264|NCT01999114|12410149|P5|COMPLETED|Overall Study||61
5043265|NCT01999114|12410150|P4|COMPLETED|Overall Study||62
5043266|NCT01999114|12410151|P3|COMPLETED|Overall Study||61
5043267|NCT01999114|12410152|P2|COMPLETED|Overall Study||59
5043268|NCT01999114|12410153|P1|COMPLETED|Overall Study||58
5043269|NCT01999114|12410149|P5|STARTED|Overall Study||65
5043270|NCT01999114|12410150|P4|STARTED|Overall Study||65
5043271|NCT01999114|12410151|P3|STARTED|Overall Study||66
5043272|NCT01999114|12410152|P2|STARTED|Overall Study||66
5043273|NCT01999114|12410153|P1|STARTED|Overall Study||66
5043274|NCT01998984|12410221|P4|NOT COMPLETED|Overall Study||3
5043275|NCT01998984|12410222|P3|NOT COMPLETED|Overall Study||1
5043276|NCT01998984|12410223|P2|NOT COMPLETED|Overall Study||1
5043277|NCT01998984|12410224|P1|NOT COMPLETED|Overall Study||0
5043278|NCT01998984|12410221|P4|COMPLETED|Overall Study||58
5043279|NCT01998984|12410222|P3|COMPLETED|Overall Study||48
5043280|NCT01998984|12410223|P2|COMPLETED|Overall Study||58
5043281|NCT01998984|12410224|P1|COMPLETED|Overall Study||55
5043282|NCT01998984|12410221|P4|STARTED|Overall Study||61
5043283|NCT01998984|12410222|P3|STARTED|Overall Study||49
5043284|NCT01998984|12410223|P2|STARTED|Overall Study||59
5043285|NCT01998984|12410224|P1|STARTED|Overall Study||55
5043286|NCT01998958|12410249|P32|NOT COMPLETED|Follow-up Phase||0
5043287|NCT01998958|12410250|P31|NOT COMPLETED|Follow-up Phase||0
5043288|NCT01998958|12410251|P30|NOT COMPLETED|Follow-up Phase||0
5043289|NCT01998958|12410252|P29|NOT COMPLETED|Follow-up Phase||0
5043290|NCT01998958|12410253|P28|NOT COMPLETED|Follow-up Phase||0
5043291|NCT01998958|12410254|P27|NOT COMPLETED|Follow-up Phase||0
5043292|NCT01998958|12410255|P26|NOT COMPLETED|Follow-up Phase||0
5043293|NCT01998958|12410256|P25|NOT COMPLETED|Follow-up Phase||0
5043294|NCT01998958|12410257|P24|NOT COMPLETED|Follow-up Phase||0
5043295|NCT01998958|12410258|P23|NOT COMPLETED|Follow-up Phase||0
5043296|NCT01998958|12410259|P22|NOT COMPLETED|Follow-up Phase||0
5043297|NCT01998958|12410260|P21|NOT COMPLETED|Follow-up Phase||0
5043298|NCT01998958|12410261|P20|NOT COMPLETED|Follow-up Phase||0
5043299|NCT01998958|12410262|P19|NOT COMPLETED|Follow-up Phase||0
5043300|NCT01998958|12410263|P18|NOT COMPLETED|Follow-up Phase||0
5043301|NCT01998958|12410264|P17|NOT COMPLETED|Follow-up Phase||0
5043302|NCT01998958|12410265|P16|NOT COMPLETED|Follow-up Phase||0
5043303|NCT01998958|12410266|P15|NOT COMPLETED|Follow-up Phase||0
5043304|NCT01998958|12410267|P14|NOT COMPLETED|Follow-up Phase||0
5043305|NCT01998958|12410268|P13|NOT COMPLETED|Follow-up Phase||0
5043306|NCT01998958|12410269|P12|NOT COMPLETED|Follow-up Phase||0
5043307|NCT01998958|12410270|P11|NOT COMPLETED|Follow-up Phase||0
5043308|NCT01998958|12410271|P10|NOT COMPLETED|Follow-up Phase||0
5043309|NCT01998958|12410272|P9|NOT COMPLETED|Follow-up Phase||0
5043310|NCT01998958|12410273|P8|NOT COMPLETED|Follow-up Phase||0
5043311|NCT01998958|12410274|P7|NOT COMPLETED|Follow-up Phase||0
5043312|NCT01998958|12410275|P6|NOT COMPLETED|Follow-up Phase||0
5043313|NCT01998958|12410276|P5|NOT COMPLETED|Follow-up Phase||0
5043314|NCT01998958|12410277|P4|NOT COMPLETED|Follow-up Phase||0
5043315|NCT01998958|12410278|P3|NOT COMPLETED|Follow-up Phase||0
5043316|NCT01998958|12410279|P2|NOT COMPLETED|Follow-up Phase||0
5043317|NCT01998958|12410280|P1|NOT COMPLETED|Follow-up Phase||0
5043318|NCT01998958|12410249|P32|COMPLETED|Follow-up Phase||42
5043319|NCT01998958|12410250|P31|COMPLETED|Follow-up Phase||39
5043320|NCT01998958|12410251|P30|COMPLETED|Follow-up Phase||12
5043321|NCT01998958|12410252|P29|COMPLETED|Follow-up Phase||4
5043322|NCT01998958|12410253|P28|COMPLETED|Follow-up Phase||1
5043323|NCT01998958|12410254|P27|COMPLETED|Follow-up Phase||0
5043324|NCT01998958|12410255|P26|COMPLETED|Follow-up Phase||0
5043325|NCT01998958|12410256|P25|COMPLETED|Follow-up Phase||0
5043326|NCT01998958|12410257|P24|COMPLETED|Follow-up Phase||0
5043327|NCT01998958|12410258|P23|COMPLETED|Follow-up Phase||0
5043328|NCT01998958|12410259|P22|COMPLETED|Follow-up Phase||0
5043329|NCT01998958|12410260|P21|COMPLETED|Follow-up Phase||0
5043330|NCT01998958|12410261|P20|COMPLETED|Follow-up Phase||0
5043331|NCT01998958|12410262|P19|COMPLETED|Follow-up Phase||0
5043332|NCT01998958|12410263|P18|COMPLETED|Follow-up Phase||0
5043333|NCT01998958|12410264|P17|COMPLETED|Follow-up Phase||0
5043334|NCT01998958|12410265|P16|COMPLETED|Follow-up Phase||0
5043335|NCT01998958|12410266|P15|COMPLETED|Follow-up Phase||0
5043336|NCT01998958|12410267|P14|COMPLETED|Follow-up Phase||0
5043337|NCT01998958|12410268|P13|COMPLETED|Follow-up Phase||0
5043338|NCT01998958|12410269|P12|COMPLETED|Follow-up Phase||0
5043339|NCT01998958|12410270|P11|COMPLETED|Follow-up Phase||0
5043340|NCT01998958|12410271|P10|COMPLETED|Follow-up Phase||0
5043341|NCT01998958|12410272|P9|COMPLETED|Follow-up Phase||0
5043342|NCT01998958|12410273|P8|COMPLETED|Follow-up Phase||0
5043343|NCT01998958|12410274|P7|COMPLETED|Follow-up Phase||0
5043344|NCT01998958|12410275|P6|COMPLETED|Follow-up Phase||0
5043345|NCT01998958|12410276|P5|COMPLETED|Follow-up Phase||0
5043346|NCT01998958|12410277|P4|COMPLETED|Follow-up Phase||0
5043347|NCT01998958|12410278|P3|COMPLETED|Follow-up Phase||0
5043348|NCT01998958|12410279|P2|COMPLETED|Follow-up Phase||0
5043349|NCT01998958|12410280|P1|COMPLETED|Follow-up Phase||0
5043350|NCT01998958|12410249|P32|STARTED|Follow-up Phase||42
5043351|NCT01998958|12410250|P31|STARTED|Follow-up Phase||39
5043352|NCT01998958|12410251|P30|STARTED|Follow-up Phase||12
5043353|NCT01998958|12410252|P29|STARTED|Follow-up Phase||4
5043354|NCT01998958|12410253|P28|STARTED|Follow-up Phase||1
5043355|NCT01998958|12410254|P27|STARTED|Follow-up Phase||0
5043356|NCT01998958|12410255|P26|STARTED|Follow-up Phase||0
5043357|NCT01998958|12410256|P25|STARTED|Follow-up Phase||0
5043358|NCT01998958|12410257|P24|STARTED|Follow-up Phase||0
5043359|NCT01998958|12410258|P23|STARTED|Follow-up Phase||0
5043360|NCT01998958|12410259|P22|STARTED|Follow-up Phase||0
5043361|NCT01998958|12410260|P21|STARTED|Follow-up Phase||0
5043362|NCT01998958|12410261|P20|STARTED|Follow-up Phase||0
5043363|NCT01998958|12410262|P19|STARTED|Follow-up Phase||0
5043364|NCT01998958|12410263|P18|STARTED|Follow-up Phase||0
5043365|NCT01998958|12410264|P17|STARTED|Follow-up Phase||0
5043366|NCT01998958|12410265|P16|STARTED|Follow-up Phase||0
5043367|NCT01998958|12410266|P15|STARTED|Follow-up Phase||0
5043368|NCT01998958|12410267|P14|STARTED|Follow-up Phase||0
5043369|NCT01998958|12410268|P13|STARTED|Follow-up Phase||0
5043370|NCT01998958|12410269|P12|STARTED|Follow-up Phase||0
5043371|NCT01998958|12410270|P11|STARTED|Follow-up Phase||0
5043372|NCT01998958|12410271|P10|STARTED|Follow-up Phase||0
5043373|NCT01998958|12410272|P9|STARTED|Follow-up Phase||0
5043374|NCT01998958|12410273|P8|STARTED|Follow-up Phase||0
5043375|NCT01998958|12410274|P7|STARTED|Follow-up Phase||0
5043376|NCT01998958|12410275|P6|STARTED|Follow-up Phase||0
5043377|NCT01998958|12410276|P5|STARTED|Follow-up Phase||0
5043378|NCT01998958|12410277|P4|STARTED|Follow-up Phase||0
5043379|NCT01998958|12410278|P3|STARTED|Follow-up Phase||0
5043380|NCT01998958|12410279|P2|STARTED|Follow-up Phase||0
5043381|NCT01998958|12410280|P1|STARTED|Follow-up Phase||0
5043382|NCT01998958|12410249|P32|NOT COMPLETED|Open Label Phase (Optional)||0
5043383|NCT01998958|12410250|P31|NOT COMPLETED|Open Label Phase (Optional)||0
5043384|NCT01998958|12410251|P30|NOT COMPLETED|Open Label Phase (Optional)||0
5043385|NCT01998958|12410252|P29|NOT COMPLETED|Open Label Phase (Optional)||0
5043386|NCT01998958|12410253|P28|NOT COMPLETED|Open Label Phase (Optional)||0
5043387|NCT01998958|12410254|P27|NOT COMPLETED|Open Label Phase (Optional)||0
5043388|NCT01998958|12410255|P26|NOT COMPLETED|Open Label Phase (Optional)||0
5043389|NCT01998958|12410256|P25|NOT COMPLETED|Open Label Phase (Optional)||0
5043390|NCT01998958|12410257|P24|NOT COMPLETED|Open Label Phase (Optional)||4
5043391|NCT01998958|12410258|P23|NOT COMPLETED|Open Label Phase (Optional)||9
5043392|NCT01998958|12410259|P22|NOT COMPLETED|Open Label Phase (Optional)||3
5043393|NCT01998958|12410260|P21|NOT COMPLETED|Open Label Phase (Optional)||0
5043394|NCT01998958|12410261|P20|NOT COMPLETED|Open Label Phase (Optional)||0
5043395|NCT01998958|12410262|P19|NOT COMPLETED|Open Label Phase (Optional)||0
5043396|NCT01998958|12410263|P18|NOT COMPLETED|Open Label Phase (Optional)||0
5043397|NCT01998958|12410264|P17|NOT COMPLETED|Open Label Phase (Optional)||0
5043398|NCT01998958|12410265|P16|NOT COMPLETED|Open Label Phase (Optional)||0
5043399|NCT01998958|12410266|P15|NOT COMPLETED|Open Label Phase (Optional)||0
5043400|NCT01998958|12410267|P14|NOT COMPLETED|Open Label Phase (Optional)||0
5043401|NCT01998958|12410268|P13|NOT COMPLETED|Open Label Phase (Optional)||0
5043402|NCT01998958|12410269|P12|NOT COMPLETED|Open Label Phase (Optional)||0
5043403|NCT01998958|12410270|P11|NOT COMPLETED|Open Label Phase (Optional)||0
5043404|NCT01998958|12410271|P10|NOT COMPLETED|Open Label Phase (Optional)||0
5043405|NCT01998958|12410272|P9|NOT COMPLETED|Open Label Phase (Optional)||0
5043406|NCT01998958|12410273|P8|NOT COMPLETED|Open Label Phase (Optional)||0
5043407|NCT01998958|12410274|P7|NOT COMPLETED|Open Label Phase (Optional)||0
5043408|NCT01998958|12410275|P6|NOT COMPLETED|Open Label Phase (Optional)||0
5043409|NCT01998958|12410276|P5|NOT COMPLETED|Open Label Phase (Optional)||0
5043410|NCT01998958|12410277|P4|NOT COMPLETED|Open Label Phase (Optional)||0
5043411|NCT01998958|12410278|P3|NOT COMPLETED|Open Label Phase (Optional)||0
5043412|NCT01998958|12410279|P2|NOT COMPLETED|Open Label Phase (Optional)||0
5043413|NCT01998958|12410280|P1|NOT COMPLETED|Open Label Phase (Optional)||0
5043414|NCT01998958|12410249|P32|COMPLETED|Open Label Phase (Optional)||0
5043415|NCT01998958|12410250|P31|COMPLETED|Open Label Phase (Optional)||0
5043416|NCT01998958|12410251|P30|COMPLETED|Open Label Phase (Optional)||0
5043417|NCT01998958|12410252|P29|COMPLETED|Open Label Phase (Optional)||0
5043418|NCT01998958|12410253|P28|COMPLETED|Open Label Phase (Optional)||0
5043419|NCT01998958|12410254|P27|COMPLETED|Open Label Phase (Optional)||19
5043420|NCT01998958|12410255|P26|COMPLETED|Open Label Phase (Optional)||7
5043421|NCT01998958|12410256|P25|COMPLETED|Open Label Phase (Optional)||13
5043422|NCT01998958|12410257|P24|COMPLETED|Open Label Phase (Optional)||23
5043423|NCT01998958|12410258|P23|COMPLETED|Open Label Phase (Optional)||11
5043424|NCT01998958|12410259|P22|COMPLETED|Open Label Phase (Optional)||7
5043425|NCT01998958|12410260|P21|COMPLETED|Open Label Phase (Optional)||0
5043426|NCT01998958|12410261|P20|COMPLETED|Open Label Phase (Optional)||0
5043427|NCT01998958|12410262|P19|COMPLETED|Open Label Phase (Optional)||0
5043428|NCT01998958|12410263|P18|COMPLETED|Open Label Phase (Optional)||0
5043429|NCT01998958|12410264|P17|COMPLETED|Open Label Phase (Optional)||0
5043430|NCT01998958|12410265|P16|COMPLETED|Open Label Phase (Optional)||0
5043431|NCT01998958|12410266|P15|COMPLETED|Open Label Phase (Optional)||0
5043432|NCT01998958|12410267|P14|COMPLETED|Open Label Phase (Optional)||0
5043433|NCT01998958|12410268|P13|COMPLETED|Open Label Phase (Optional)||0
5043434|NCT01998958|12410269|P12|COMPLETED|Open Label Phase (Optional)||0
5043435|NCT01998958|12410270|P11|COMPLETED|Open Label Phase (Optional)||0
5043436|NCT01998958|12410271|P10|COMPLETED|Open Label Phase (Optional)||0
5043437|NCT01998958|12410272|P9|COMPLETED|Open Label Phase (Optional)||0
5043438|NCT01998958|12410273|P8|COMPLETED|Open Label Phase (Optional)||0
5043439|NCT01998958|12410274|P7|COMPLETED|Open Label Phase (Optional)||0
5043440|NCT01998958|12410275|P6|COMPLETED|Open Label Phase (Optional)||0
5043441|NCT01998958|12410276|P5|COMPLETED|Open Label Phase (Optional)||0
5043442|NCT01998958|12410277|P4|COMPLETED|Open Label Phase (Optional)||0
5043443|NCT01998958|12410278|P3|COMPLETED|Open Label Phase (Optional)||0
5043444|NCT01998958|12410279|P2|COMPLETED|Open Label Phase (Optional)||0
5043445|NCT01998958|12410280|P1|COMPLETED|Open Label Phase (Optional)||0
5043446|NCT01998958|12410249|P32|STARTED|Open Label Phase (Optional)||0
5043447|NCT01998958|12410250|P31|STARTED|Open Label Phase (Optional)||0
5043448|NCT01998958|12410251|P30|STARTED|Open Label Phase (Optional)||0
5043449|NCT01998958|12410252|P29|STARTED|Open Label Phase (Optional)||0
5043450|NCT01998958|12410253|P28|STARTED|Open Label Phase (Optional)||0
5043451|NCT01998958|12410254|P27|STARTED|Open Label Phase (Optional)||19
5043452|NCT01998958|12410255|P26|STARTED|Open Label Phase (Optional)||7
5043453|NCT01998958|12410256|P25|STARTED|Open Label Phase (Optional)||13
5043454|NCT01998958|12410257|P24|STARTED|Open Label Phase (Optional)||27
5043455|NCT01998958|12410258|P23|STARTED|Open Label Phase (Optional)||20
5043456|NCT01998958|12410259|P22|STARTED|Open Label Phase (Optional)||10
5043457|NCT01998958|12410260|P21|STARTED|Open Label Phase (Optional)||0
5043458|NCT01998958|12410261|P20|STARTED|Open Label Phase (Optional)||0
5043459|NCT01998958|12410262|P19|STARTED|Open Label Phase (Optional)||0
5043460|NCT01998958|12410263|P18|STARTED|Open Label Phase (Optional)||0
5043461|NCT01998958|12410264|P17|STARTED|Open Label Phase (Optional)||0
5043462|NCT01998958|12410265|P16|STARTED|Open Label Phase (Optional)||0
5043463|NCT01998958|12410266|P15|STARTED|Open Label Phase (Optional)||0
5043464|NCT01998958|12410267|P14|STARTED|Open Label Phase (Optional)||0
5043465|NCT01998958|12410268|P13|STARTED|Open Label Phase (Optional)||0
5043466|NCT01998958|12410269|P12|STARTED|Open Label Phase (Optional)||0
5043467|NCT01998958|12410270|P11|STARTED|Open Label Phase (Optional)||0
5043468|NCT01998958|12410271|P10|STARTED|Open Label Phase (Optional)||0
5043469|NCT01998958|12410272|P9|STARTED|Open Label Phase (Optional)||0
5043470|NCT01998958|12410273|P8|STARTED|Open Label Phase (Optional)||0
5043471|NCT01998958|12410274|P7|STARTED|Open Label Phase (Optional)||0
5043472|NCT01998958|12410275|P6|STARTED|Open Label Phase (Optional)||0
5043473|NCT01998958|12410276|P5|STARTED|Open Label Phase (Optional)||0
5043474|NCT01998958|12410277|P4|STARTED|Open Label Phase (Optional)||0
5043475|NCT01998958|12410278|P3|STARTED|Open Label Phase (Optional)||0
5043476|NCT01998958|12410279|P2|STARTED|Open Label Phase (Optional)||0
5043477|NCT01998958|12410280|P1|STARTED|Open Label Phase (Optional)||0
5043478|NCT01998958|12410249|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
5043479|NCT01998958|12410250|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
5043480|NCT01998958|12410251|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
5043481|NCT01998958|12410252|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
5043482|NCT01998958|12410253|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
5043483|NCT01998958|12410254|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
5043484|NCT01998958|12410255|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
5043485|NCT01998958|12410256|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
5043486|NCT01998958|12410257|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
5043487|NCT01998958|12410258|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
5043488|NCT01998958|12410259|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
5043489|NCT01998958|12410260|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
5043490|NCT01998958|12410261|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
5043491|NCT01998958|12410262|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
5043492|NCT01998958|12410263|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
5043493|NCT01998958|12410264|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
5043494|NCT01998958|12410265|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
5043495|NCT01998958|12410266|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
5043496|NCT01998958|12410267|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
5043497|NCT01998958|12410268|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
5043498|NCT01998958|12410269|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
5043499|NCT01998958|12410270|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
5043500|NCT01998958|12410271|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
5043501|NCT01998958|12410272|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
5043502|NCT01998958|12410273|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
5043503|NCT01998958|12410274|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
5043504|NCT01998958|12410275|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
5043505|NCT01998958|12410276|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
5043506|NCT01998958|12410277|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
5043507|NCT01998958|12410278|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
5043508|NCT01998958|12410279|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
5043509|NCT01998958|12410280|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
5043510|NCT01998958|12410249|P32|COMPLETED|Period 2 (Panel A and B)||0
5043511|NCT01998958|12410250|P31|COMPLETED|Period 2 (Panel A and B)||0
5043512|NCT01998958|12410251|P30|COMPLETED|Period 2 (Panel A and B)||0
5043513|NCT01998958|12410252|P29|COMPLETED|Period 2 (Panel A and B)||0
5043514|NCT01998958|12410253|P28|COMPLETED|Period 2 (Panel A and B)||0
5043515|NCT01998958|12410254|P27|COMPLETED|Period 2 (Panel A and B)||0
5043516|NCT01998958|12410255|P26|COMPLETED|Period 2 (Panel A and B)||0
5043517|NCT01998958|12410256|P25|COMPLETED|Period 2 (Panel A and B)||0
5043518|NCT01998958|12410257|P24|COMPLETED|Period 2 (Panel A and B)||0
5043519|NCT01998958|12410258|P23|COMPLETED|Period 2 (Panel A and B)||0
5043520|NCT01998958|12410259|P22|COMPLETED|Period 2 (Panel A and B)||0
5043521|NCT01998958|12410260|P21|COMPLETED|Period 2 (Panel A and B)||9
5043522|NCT01998958|12410261|P20|COMPLETED|Period 2 (Panel A and B)||11
5043523|NCT01998958|12410262|P19|COMPLETED|Period 2 (Panel A and B)||2
5043524|NCT01998958|12410263|P18|COMPLETED|Period 2 (Panel A and B)||5
5043525|NCT01998958|12410264|P17|COMPLETED|Period 2 (Panel A and B)||8
5043526|NCT01998958|12410265|P16|COMPLETED|Period 2 (Panel A and B)||5
5043527|NCT01998958|12410266|P15|COMPLETED|Period 2 (Panel A and B)||10
5043528|NCT01998958|12410267|P14|COMPLETED|Period 2 (Panel A and B)||11
5043529|NCT01998958|12410268|P13|COMPLETED|Period 2 (Panel A and B)||8
5043530|NCT01998958|12410269|P12|COMPLETED|Period 2 (Panel A and B)||5
5043531|NCT01998958|12410270|P11|COMPLETED|Period 2 (Panel A and B)||8
5043532|NCT01998958|12410271|P10|COMPLETED|Period 2 (Panel A and B)||8
5043533|NCT01998958|12410272|P9|COMPLETED|Period 2 (Panel A and B)||4
5043534|NCT01998958|12410273|P8|COMPLETED|Period 2 (Panel A and B)||6
5043535|NCT01998958|12410274|P7|COMPLETED|Period 2 (Panel A and B)||0
5043536|NCT01998958|12410275|P6|COMPLETED|Period 2 (Panel A and B)||0
5043537|NCT01998958|12410276|P5|COMPLETED|Period 2 (Panel A and B)||0
5043538|NCT01998958|12410277|P4|COMPLETED|Period 2 (Panel A and B)||0
5043539|NCT01998958|12410278|P3|COMPLETED|Period 2 (Panel A and B)||0
5043540|NCT01998958|12410279|P2|COMPLETED|Period 2 (Panel A and B)||0
5043541|NCT01998958|12410280|P1|COMPLETED|Period 2 (Panel A and B)||0
5043542|NCT01998958|12410249|P32|STARTED|Period 2 (Panel A and B)||0
5043543|NCT01998958|12410250|P31|STARTED|Period 2 (Panel A and B)||0
5043544|NCT01998958|12410251|P30|STARTED|Period 2 (Panel A and B)||0
5043545|NCT01998958|12410252|P29|STARTED|Period 2 (Panel A and B)||0
5043546|NCT01998958|12410253|P28|STARTED|Period 2 (Panel A and B)||0
5043547|NCT01998958|12410254|P27|STARTED|Period 2 (Panel A and B)||0
5043548|NCT01998958|12410255|P26|STARTED|Period 2 (Panel A and B)||0
5043549|NCT01998958|12410256|P25|STARTED|Period 2 (Panel A and B)||0
5043550|NCT01998958|12410257|P24|STARTED|Period 2 (Panel A and B)||0
5043551|NCT01998958|12410258|P23|STARTED|Period 2 (Panel A and B)||0
5043552|NCT01998958|12410259|P22|STARTED|Period 2 (Panel A and B)||0
5043553|NCT01998958|12410260|P21|STARTED|Period 2 (Panel A and B)||9
5043554|NCT01998958|12410261|P20|STARTED|Period 2 (Panel A and B)||11
5043555|NCT01998958|12410262|P19|STARTED|Period 2 (Panel A and B)||3
5043556|NCT01998958|12410263|P18|STARTED|Period 2 (Panel A and B)||5
5043557|NCT01998958|12410264|P17|STARTED|Period 2 (Panel A and B)||8
5043558|NCT01998958|12410265|P16|STARTED|Period 2 (Panel A and B)||5
5043559|NCT01998958|12410266|P15|STARTED|Period 2 (Panel A and B)||12
5043560|NCT01998958|12410267|P14|STARTED|Period 2 (Panel A and B)||11
5043561|NCT01998958|12410268|P13|STARTED|Period 2 (Panel A and B)||8
5043562|NCT01998958|12410269|P12|STARTED|Period 2 (Panel A and B)||5
5043563|NCT01998958|12410270|P11|STARTED|Period 2 (Panel A and B)||9
5043564|NCT01998958|12410271|P10|STARTED|Period 2 (Panel A and B)||8
5043565|NCT01998958|12410272|P9|STARTED|Period 2 (Panel A and B)||4
5043566|NCT01998958|12410273|P8|STARTED|Period 2 (Panel A and B)||6
5043567|NCT01998958|12410274|P7|STARTED|Period 2 (Panel A and B)||0
5043568|NCT01998958|12410275|P6|STARTED|Period 2 (Panel A and B)||0
5043569|NCT01998958|12410276|P5|STARTED|Period 2 (Panel A and B)||0
5043570|NCT01998958|12410277|P4|STARTED|Period 2 (Panel A and B)||0
5043571|NCT01998958|12410278|P3|STARTED|Period 2 (Panel A and B)||0
5043572|NCT01998958|12410279|P2|STARTED|Period 2 (Panel A and B)||0
5043573|NCT01998958|12410280|P1|STARTED|Period 2 (Panel A and B)||0
5043574|NCT01998958|12410249|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
5043575|NCT01998958|12410250|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
5043576|NCT01998958|12410251|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
5043577|NCT01998958|12410252|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
5043578|NCT01998958|12410253|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
5043579|NCT01998958|12410254|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
5043580|NCT01998958|12410255|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
5043581|NCT01998958|12410256|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
5043582|NCT01998958|12410257|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
5043583|NCT01998958|12410258|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
5043584|NCT01998958|12410259|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
5043585|NCT01998958|12410260|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
5043586|NCT01998958|12410261|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
5043587|NCT01998958|12410262|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
5043588|NCT01998958|12410263|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
5043589|NCT01998958|12410264|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
5043590|NCT01998958|12410265|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
5043591|NCT01998958|12410266|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
5043592|NCT01998958|12410267|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
5043593|NCT01998958|12410268|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
5043594|NCT01998958|12410269|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
5043595|NCT01998958|12410270|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
5043596|NCT01998958|12410271|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
5043597|NCT01998958|12410272|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
5043598|NCT01998958|12410273|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
5043599|NCT01998958|12410274|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
5043600|NCT01998958|12410275|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
5043601|NCT01998958|12410276|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
5043602|NCT01998958|12410277|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
5043603|NCT01998958|12410278|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
5043604|NCT01998958|12410279|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
5043605|NCT01998958|12410280|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
5043606|NCT01998958|12410249|P32|COMPLETED|Period 1 (Panel A and B)||0
5043607|NCT01998958|12410250|P31|COMPLETED|Period 1 (Panel A and B)||0
5043608|NCT01998958|12410251|P30|COMPLETED|Period 1 (Panel A and B)||0
5043609|NCT01998958|12410252|P29|COMPLETED|Period 1 (Panel A and B)||0
5043610|NCT01998958|12410253|P28|COMPLETED|Period 1 (Panel A and B)||0
5043611|NCT01998958|12410254|P27|COMPLETED|Period 1 (Panel A and B)||0
5043612|NCT01998958|12410255|P26|COMPLETED|Period 1 (Panel A and B)||0
5043613|NCT01998958|12410256|P25|COMPLETED|Period 1 (Panel A and B)||0
5043614|NCT01998958|12410257|P24|COMPLETED|Period 1 (Panel A and B)||0
5043615|NCT01998958|12410258|P23|COMPLETED|Period 1 (Panel A and B)||0
5043616|NCT01998958|12410259|P22|COMPLETED|Period 1 (Panel A and B)||0
5043617|NCT01998958|12410260|P21|COMPLETED|Period 1 (Panel A and B)||0
5043618|NCT01998958|12410261|P20|COMPLETED|Period 1 (Panel A and B)||0
5043619|NCT01998958|12410262|P19|COMPLETED|Period 1 (Panel A and B)||0
5043620|NCT01998958|12410263|P18|COMPLETED|Period 1 (Panel A and B)||0
5043621|NCT01998958|12410264|P17|COMPLETED|Period 1 (Panel A and B)||0
5043622|NCT01998958|12410265|P16|COMPLETED|Period 1 (Panel A and B)||0
5043623|NCT01998958|12410266|P15|COMPLETED|Period 1 (Panel A and B)||0
5043624|NCT01998958|12410267|P14|COMPLETED|Period 1 (Panel A and B)||0
5043625|NCT01998958|12410268|P13|COMPLETED|Period 1 (Panel A and B)||0
5043626|NCT01998958|12410269|P12|COMPLETED|Period 1 (Panel A and B)||0
5043627|NCT01998958|12410270|P11|COMPLETED|Period 1 (Panel A and B)||0
5043628|NCT01998958|12410271|P10|COMPLETED|Period 1 (Panel A and B)||0
5043629|NCT01998958|12410272|P9|COMPLETED|Period 1 (Panel A and B)||0
5043630|NCT01998958|12410273|P8|COMPLETED|Period 1 (Panel A and B)||0
5043631|NCT01998958|12410274|P7|COMPLETED|Period 1 (Panel A and B)||9
5043632|NCT01998958|12410275|P6|COMPLETED|Period 1 (Panel A and B)||11
5043633|NCT01998958|12410276|P5|COMPLETED|Period 1 (Panel A and B)||21
5043634|NCT01998958|12410277|P4|COMPLETED|Period 1 (Panel A and B)||12
5043635|NCT01998958|12410278|P3|COMPLETED|Period 1 (Panel A and B)||11
5043636|NCT01998958|12410279|P2|COMPLETED|Period 1 (Panel A and B)||8
5043637|NCT01998958|12410280|P1|COMPLETED|Period 1 (Panel A and B)||32
5043638|NCT01998958|12410249|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043639|NCT01998958|12410250|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043640|NCT01998958|12410251|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043641|NCT01998958|12410252|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043642|NCT01998958|12410253|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043643|NCT01998958|12410254|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043644|NCT01998958|12410255|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043645|NCT01998958|12410256|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043646|NCT01998958|12410257|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043647|NCT01998958|12410258|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043648|NCT01998958|12410259|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043649|NCT01998958|12410260|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043650|NCT01998958|12410261|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043651|NCT01998958|12410262|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043652|NCT01998958|12410263|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043653|NCT01998958|12410264|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043654|NCT01998958|12410265|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043655|NCT01998958|12410266|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043656|NCT01998958|12410267|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043657|NCT01998958|12410268|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043658|NCT01998958|12410269|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043659|NCT01998958|12410270|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043660|NCT01998958|12410271|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043661|NCT01998958|12410272|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043662|NCT01998958|12410273|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043663|NCT01998958|12410274|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043664|NCT01998958|12410275|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043665|NCT01998958|12410276|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043666|NCT01998958|12410277|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043667|NCT01998958|12410278|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043668|NCT01998958|12410279|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
5043669|NCT01998958|12410280|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
5043670|NCT01998958|12410249|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043671|NCT01998958|12410250|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043672|NCT01998958|12410251|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043673|NCT01998958|12410252|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043674|NCT01998958|12410253|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043675|NCT01998958|12410254|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043676|NCT01998958|12410255|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043677|NCT01998958|12410256|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043678|NCT01998958|12410257|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043679|NCT01998958|12410258|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043680|NCT01998958|12410259|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043681|NCT01998958|12410260|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043682|NCT01998958|12410261|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043683|NCT01998958|12410262|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043684|NCT01998958|12410263|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043685|NCT01998958|12410264|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043686|NCT01998958|12410265|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043687|NCT01998958|12410266|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043688|NCT01998958|12410267|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043689|NCT01998958|12410268|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043690|NCT01998958|12410269|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043691|NCT01998958|12410270|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043692|NCT01998958|12410271|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043693|NCT01998958|12410272|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043694|NCT01998958|12410273|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043695|NCT01998958|12410274|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043696|NCT01998958|12410275|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043697|NCT01998958|12410276|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043698|NCT01998958|12410277|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043699|NCT01998958|12410278|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043700|NCT01998958|12410279|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
5043701|NCT01998958|12410280|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
5043702|NCT01998958|12410249|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043703|NCT01998958|12410250|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043704|NCT01998958|12410251|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043705|NCT01998958|12410252|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043706|NCT01998958|12410253|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043707|NCT01998958|12410254|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043708|NCT01998958|12410255|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043709|NCT01998958|12410256|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043710|NCT01998958|12410257|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043711|NCT01998958|12410258|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043712|NCT01998958|12410259|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043713|NCT01998958|12410260|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043714|NCT01998958|12410261|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043715|NCT01998958|12410262|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043716|NCT01998958|12410263|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043717|NCT01998958|12410264|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043718|NCT01998958|12410265|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043719|NCT01998958|12410266|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043720|NCT01998958|12410267|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043721|NCT01998958|12410268|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043722|NCT01998958|12410269|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043723|NCT01998958|12410270|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043724|NCT01998958|12410271|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043725|NCT01998958|12410272|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043726|NCT01998958|12410273|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043727|NCT01998958|12410274|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043728|NCT01998958|12410275|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043729|NCT01998958|12410276|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043730|NCT01998958|12410277|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043731|NCT01998958|12410278|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043732|NCT01998958|12410279|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
5043733|NCT01998958|12410280|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
5043734|NCT01998958|12410249|P32|STARTED|Period 1 (Panel A and B)||0
5043735|NCT01998958|12410250|P31|STARTED|Period 1 (Panel A and B)||0
5043736|NCT01998958|12410251|P30|STARTED|Period 1 (Panel A and B)||0
5043737|NCT01998958|12410252|P29|STARTED|Period 1 (Panel A and B)||0
5043738|NCT01998958|12410253|P28|STARTED|Period 1 (Panel A and B)||0
5043739|NCT01998958|12410254|P27|STARTED|Period 1 (Panel A and B)||0
5043740|NCT01998958|12410255|P26|STARTED|Period 1 (Panel A and B)||0
5043741|NCT01998958|12410256|P25|STARTED|Period 1 (Panel A and B)||0
5043742|NCT01998958|12410257|P24|STARTED|Period 1 (Panel A and B)||0
5043743|NCT01998958|12410258|P23|STARTED|Period 1 (Panel A and B)||0
5043744|NCT01998958|12410259|P22|STARTED|Period 1 (Panel A and B)||0
5043745|NCT01998958|12410260|P21|STARTED|Period 1 (Panel A and B)||0
5043746|NCT01998958|12410261|P20|STARTED|Period 1 (Panel A and B)||0
5043747|NCT01998958|12410262|P19|STARTED|Period 1 (Panel A and B)||0
5043748|NCT01998958|12410263|P18|STARTED|Period 1 (Panel A and B)||0
5043749|NCT01998958|12410264|P17|STARTED|Period 1 (Panel A and B)||0
5043750|NCT01998958|12410265|P16|STARTED|Period 1 (Panel A and B)||0
5043751|NCT01998958|12410266|P15|STARTED|Period 1 (Panel A and B)||0
5043752|NCT01998958|12410267|P14|STARTED|Period 1 (Panel A and B)||0
5043753|NCT01998958|12410268|P13|STARTED|Period 1 (Panel A and B)||0
5043754|NCT01998958|12410269|P12|STARTED|Period 1 (Panel A and B)||0
5043755|NCT01998958|12410270|P11|STARTED|Period 1 (Panel A and B)||0
5043756|NCT01998958|12410271|P10|STARTED|Period 1 (Panel A and B)||0
5043757|NCT01998958|12410272|P9|STARTED|Period 1 (Panel A and B)||0
5043758|NCT01998958|12410273|P8|STARTED|Period 1 (Panel A and B)||0
5043759|NCT01998958|12410274|P7|STARTED|Period 1 (Panel A and B)||9
5043760|NCT01998958|12410275|P6|STARTED|Period 1 (Panel A and B)||11
5043761|NCT01998958|12410276|P5|STARTED|Period 1 (Panel A and B)||21
5043762|NCT01998958|12410277|P4|STARTED|Period 1 (Panel A and B)||12
5043763|NCT01998958|12410278|P3|STARTED|Period 1 (Panel A and B)||11
5043764|NCT01998958|12410279|P2|STARTED|Period 1 (Panel A and B)||11
5043765|NCT01998958|12410280|P1|STARTED|Period 1 (Panel A and B)||33
5043766|NCT01998919|12410419|P2|NOT COMPLETED|Overall Study||35
5043767|NCT01998919|12410420|P1|NOT COMPLETED|Overall Study||42
5043768|NCT01998919|12410419|P2|COMPLETED|Overall Study||39
5043769|NCT01998919|12410420|P1|COMPLETED|Overall Study||37
5043770|NCT01998919|12410419|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
5043771|NCT01998919|12410420|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
5043772|NCT01998919|12410419|P2|STARTED|Overall Study||74
5043773|NCT01998919|12410420|P1|STARTED|Overall Study||79
5043774|NCT01998906|12410441|P3|NOT COMPLETED|Overall Study||98
5043775|NCT01998906|12410442|P2|NOT COMPLETED|Overall Study||114
5043776|NCT01998906|12410443|P1|NOT COMPLETED|Overall Study||114
5043777|NCT01998906|12410441|P3|COMPLETED|Overall Study||1
5043778|NCT01998906|12410442|P2|COMPLETED|Overall Study||2
5043779|NCT01998906|12410443|P1|COMPLETED|Overall Study||1
5043780|NCT01998906|12410441|P3|STARTED|Overall Study||99
5043781|NCT01998906|12410442|P2|STARTED|Overall Study||116
5043782|NCT01998906|12410443|P1|STARTED|Overall Study||115
5043783|NCT01998893|12410487|P1|NOT COMPLETED|Overall Study||17
5043784|NCT01998893|12410487|P1|COMPLETED|Overall Study||21
5043785|NCT01998893|12410487|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
5043786|NCT01998893|12410487|P1|2nd Treatment Cycle Started|Overall Study||5
5043787|NCT01998893|12410487|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
5043788|NCT01998893|12410487|P1|STARTED|Overall Study||38
5043789|NCT01998880|12410499|P2|NOT COMPLETED|Overall Study||40
5043790|NCT01998880|12410500|P1|NOT COMPLETED|Overall Study||28
5043791|NCT01998880|12410499|P2|COMPLETED|Overall Study||78
5043792|NCT01998880|12410500|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
5043793|NCT01998880|12410499|P2|Received Study Drug|Overall Study||116
5043794|NCT01998880|12410500|P1|Received Study Drug|Overall Study||230
5043795|NCT01998880|12410499|P2|STARTED|Overall Study||118
5043796|NCT01998880|12410500|P1|STARTED|Overall Study||233
5043797|NCT01998737|12410532|P2|NOT COMPLETED|Overall Study||0
5043798|NCT01998737|12410533|P1|NOT COMPLETED|Overall Study||23
5043799|NCT01998737|12410532|P2|COMPLETED|Overall Study||100
5043800|NCT01998737|12410533|P1|COMPLETED|Overall Study||888
5043801|NCT01998737|12410532|P2|STARTED|Overall Study||100
5043802|NCT01998737|12410533|P1|STARTED|Overall Study||911
5043803|NCT01998633|12410545|P1|NOT COMPLETED|Overall Study||1
5043804|NCT01998633|12410545|P1|COMPLETED|Overall Study||46
5043805|NCT01998633|12410545|P1|STARTED|Overall Study||47
5043806|NCT01998581|12410563|P2|NOT COMPLETED|Overall Study||12
5043807|NCT01998581|12410564|P1|NOT COMPLETED|Overall Study||46
5043808|NCT01998581|12410563|P2|COMPLETED|Overall Study||44
5043809|NCT01998581|12410564|P1|COMPLETED|Overall Study||123
5043810|NCT01998581|12410563|P2|STARTED|Overall Study||56
5043811|NCT01998581|12410564|P1|STARTED|Overall Study||169
5043812|NCT01998477|12410577|P2|NOT COMPLETED|Overall Study||5
5043813|NCT01998477|12410578|P1|NOT COMPLETED|Overall Study||10
5043814|NCT01998477|12410577|P2|COMPLETED|Overall Study||143
5043815|NCT01998477|12410578|P1|COMPLETED|Overall Study||272
5043816|NCT01998477|12410577|P2|STARTED|Overall Study||148
5043817|NCT01998477|12410578|P1|STARTED|Overall Study||282
5043818|NCT01998438|12410612|P3|NOT COMPLETED|Overall Study||0
5043819|NCT01998438|12410613|P2|NOT COMPLETED|Overall Study||0
5043820|NCT01998438|12410614|P1|NOT COMPLETED|Overall Study||0
5043821|NCT01998438|12410612|P3|COMPLETED|Overall Study||318
5043822|NCT01998438|12410613|P2|COMPLETED|Overall Study||318
5043823|NCT01998438|12410614|P1|COMPLETED|Overall Study||319
5043824|NCT01998438|12410612|P3|STARTED|Overall Study||318
5043825|NCT01998438|12410613|P2|STARTED|Overall Study||318
5043826|NCT01998438|12410614|P1|STARTED|Overall Study||319
5043827|NCT01998399|12410624|P2|NOT COMPLETED|Overall Study||9
5043828|NCT01998399|12410625|P1|NOT COMPLETED|Overall Study||8
5043829|NCT01998399|12410624|P2|COMPLETED|Overall Study||4
5043830|NCT01998399|12410625|P1|COMPLETED|Overall Study||4
5043831|NCT01998399|12410624|P2|STARTED|Overall Study||13
5043832|NCT01998399|12410625|P1|STARTED|Overall Study||12
5043833|NCT01998360|12410659|P2|NOT COMPLETED|Overall Study||0
5043834|NCT01998360|12410660|P1|NOT COMPLETED|Overall Study||0
5043835|NCT01998360|12410659|P2|COMPLETED|Overall Study||50
5043836|NCT01998360|12410660|P1|COMPLETED|Overall Study||50
5043837|NCT01998360|12410659|P2|STARTED|Overall Study||50
5043838|NCT01998360|12410660|P1|STARTED|Overall Study||50
5043839|NCT01998269|12410674|P1|NOT COMPLETED|Overall Study||0
5043840|NCT01998269|12410674|P1|COMPLETED|Overall Study||193
5043841|NCT01998269|12410674|P1|STARTED|Overall Study||193
5043842|NCT01998243|12410680|P2|NOT COMPLETED|Overall Study||7
5043843|NCT01998243|12410681|P1|NOT COMPLETED|Overall Study||8
5043844|NCT01998243|12410680|P2|COMPLETED|Overall Study||32
5043845|NCT01998243|12410681|P1|COMPLETED|Overall Study||34
5043846|NCT01998243|12410680|P2|STARTED|Overall Study||39
5043847|NCT01998243|12410681|P1|STARTED|Overall Study||42
5043848|NCT01997905|12410695|P1|NOT COMPLETED|Overall Study||3
5043849|NCT01997905|12410695|P1|COMPLETED|Overall Study||10
5043850|NCT01997905|12410695|P1|Baseline Completed|Overall Study||11
5043851|NCT01997905|12410695|P1|STARTED|Overall Study||13
5043852|NCT01997892|12410704|P1|NOT COMPLETED|Overall Study||68
5043853|NCT01997892|12410704|P1|COMPLETED|Overall Study||959
5043854|NCT01997892|12410704|P1|Received Darbepoetin Alfa|Overall Study||987
5043855|NCT01997892|12410704|P1|STARTED|Overall Study||1027
5043856|NCT01997723|12410716|P1|NOT COMPLETED|Overall Study||0
5043857|NCT01997723|12410716|P1|COMPLETED|Overall Study||75
5043858|NCT01997723|12410716|P1|STARTED|Overall Study||75
5043859|NCT01997567|12410724|P2|NOT COMPLETED|Overall Study||0
5043860|NCT01997567|12410725|P1|NOT COMPLETED|Overall Study||0
5043861|NCT01997567|12410724|P2|COMPLETED|Overall Study||0
5043862|NCT01997567|12410725|P1|COMPLETED|Overall Study||0
5043863|NCT01997567|12410724|P2|STARTED|Overall Study||0
5043864|NCT01997567|12410725|P1|STARTED|Overall Study||0
5043865|NCT01997515|12410745|P2|NOT COMPLETED|Overall Study||5
5043866|NCT01997515|12410746|P1|NOT COMPLETED|Overall Study||4
5043867|NCT01997515|12410745|P2|COMPLETED|Overall Study||35
5043868|NCT01997515|12410746|P1|COMPLETED|Overall Study||36
5043869|NCT01997515|12410745|P2|STARTED|Overall Study||40
5043870|NCT01997515|12410746|P1|STARTED|Overall Study||40
5043871|NCT01997437|12410758|P1|NOT COMPLETED|Overall Study||0
5043872|NCT01997437|12410758|P1|COMPLETED|Overall Study||6
5043873|NCT01997437|12410758|P1|STARTED|Overall Study||6
5043874|NCT01997411|12410770|P8|NOT COMPLETED|Overall Study||0
5043875|NCT01997411|12410771|P7|NOT COMPLETED|Overall Study||0
5043876|NCT01997411|12410772|P6|NOT COMPLETED|Overall Study||1
5043877|NCT01997411|12410773|P5|NOT COMPLETED|Overall Study||0
5043878|NCT01997411|12410774|P4|NOT COMPLETED|Overall Study||0
5043879|NCT01997411|12410775|P3|NOT COMPLETED|Overall Study||0
5043880|NCT01997411|12410776|P2|NOT COMPLETED|Overall Study||0
5043881|NCT01997411|12410777|P1|NOT COMPLETED|Overall Study||0
5043882|NCT01997411|12410770|P8|COMPLETED|Overall Study||6
5043883|NCT01997411|12410771|P7|COMPLETED|Overall Study||6
5043884|NCT01997411|12410772|P6|COMPLETED|Overall Study||5
5043885|NCT01997411|12410773|P5|COMPLETED|Overall Study||6
5043886|NCT01997411|12410774|P4|COMPLETED|Overall Study||6
5043887|NCT01997411|12410775|P3|COMPLETED|Overall Study||6
5043888|NCT01997411|12410776|P2|COMPLETED|Overall Study||6
5043889|NCT01997411|12410777|P1|COMPLETED|Overall Study||6
5043890|NCT01997411|12410770|P8|STARTED|Overall Study||6
5043891|NCT01997411|12410771|P7|STARTED|Overall Study||6
5043892|NCT01997411|12410772|P6|STARTED|Overall Study||6
5043893|NCT01997411|12410773|P5|STARTED|Overall Study||6
5043894|NCT01997411|12410774|P4|STARTED|Overall Study||6
5043895|NCT01997411|12410775|P3|STARTED|Overall Study||6
5043896|NCT01997411|12410776|P2|STARTED|Overall Study||6
5043897|NCT01997411|12410777|P1|STARTED|Overall Study||6
5043898|NCT01997398|12410867|P1|NOT COMPLETED|Overall Study||1
5043899|NCT01997398|12410867|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
5043900|NCT01997398|12410867|P1|STARTED|Overall Study||35
5043901|NCT01997333|12410878|P2|NOT COMPLETED|Survival Follow up||14
5043902|NCT01997333|12410879|P1|NOT COMPLETED|Survival Follow up||16
5043903|NCT01997333|12410878|P2|COMPLETED|Survival Follow up||199
5043904|NCT01997333|12410879|P1|COMPLETED|Survival Follow up||76
5043905|NCT01997333|12410878|P2|STARTED|Survival Follow up||213
5043906|NCT01997333|12410879|P1|STARTED|Survival Follow up||92
5043907|NCT01997333|12410878|P2|NOT COMPLETED|Randomization and Treatment||203
5043908|NCT01997333|12410879|P1|NOT COMPLETED|Randomization and Treatment||103
5043909|NCT01997333|12410878|P2|COMPLETED|Randomization and Treatment||15
5043910|NCT01997333|12410879|P1|COMPLETED|Randomization and Treatment||6
5043911|NCT01997333|12410878|P2|STARTED|Randomization and Treatment||218
5043912|NCT01997333|12410879|P1|STARTED|Randomization and Treatment||109
5043913|NCT01997229|12410896|P2|NOT COMPLETED|Overall Study||2
5043914|NCT01997229|12410897|P1|NOT COMPLETED|Overall Study||5
5043915|NCT01997229|12410896|P2|COMPLETED|Overall Study||61
5043916|NCT01997229|12410897|P1|COMPLETED|Overall Study||57
5043917|NCT01997229|12410896|P2|STARTED|Overall Study||63
5043918|NCT01997229|12410897|P1|STARTED|Overall Study||62
5043919|NCT01997216|12410903|P2|NOT COMPLETED|Second 9 Hours||0
5043920|NCT01997216|12410904|P1|NOT COMPLETED|Second 9 Hours||0
5043921|NCT01997216|12410903|P2|COMPLETED|Second 9 Hours||21
5043922|NCT01997216|12410904|P1|COMPLETED|Second 9 Hours||19
5043923|NCT01997216|12410903|P2|STARTED|Second 9 Hours||21
5043924|NCT01997216|12410904|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
5043925|NCT01997216|12410903|P2|NOT COMPLETED|First 9 Hours||0
5043926|NCT01997216|12410904|P1|NOT COMPLETED|First 9 Hours||0
5043927|NCT01997216|12410903|P2|COMPLETED|First 9 Hours||21
5043928|NCT01997216|12410904|P1|COMPLETED|First 9 Hours||18
5043929|NCT01997216|12410903|P2|STARTED|First 9 Hours||21
5043930|NCT01997216|12410904|P1|STARTED|First 9 Hours||18
5043931|NCT01996982|12410914|P1|NOT COMPLETED|Overall Study||7
5043932|NCT01996982|12410914|P1|COMPLETED|Overall Study||0
5043933|NCT01996982|12410914|P1|STARTED|Overall Study||7
5043934|NCT01996917|12410919|P1|NOT COMPLETED|Overall Study||0
5043935|NCT01996917|12410919|P1|COMPLETED|Overall Study||21
5043936|NCT01996917|12410919|P1|STARTED|Overall Study||21
5043937|NCT01996904|12410930|P2|NOT COMPLETED|Overall Study||27
5043938|NCT01996904|12410931|P1|NOT COMPLETED|Overall Study||38
5043939|NCT01996904|12410930|P2|COMPLETED|Overall Study||90
5043940|NCT01996904|12410931|P1|COMPLETED|Overall Study||101
5043941|NCT01996904|12410930|P2|STARTED|Overall Study||117
5043942|NCT01996904|12410931|P1|STARTED|Overall Study||139
5043943|NCT01996852|12410940|P3|NOT COMPLETED|Overall Study||0
5043944|NCT01996852|12410941|P2|NOT COMPLETED|Overall Study||0
5043945|NCT01996852|12410942|P1|NOT COMPLETED|Overall Study||0
5043946|NCT01996852|12410940|P3|COMPLETED|Overall Study||0
5043947|NCT01996852|12410941|P2|COMPLETED|Overall Study||0
5043948|NCT01996852|12410942|P1|COMPLETED|Overall Study||0
5043949|NCT01996852|12410940|P3|STARTED|Overall Study||0
5043950|NCT01996852|12410941|P2|STARTED|Overall Study||0
5043951|NCT01996852|12410942|P1|STARTED|Overall Study||0
5043952|NCT01996813|12410988|P2|NOT COMPLETED|Overall Study||0
5043953|NCT01996813|12410989|P1|NOT COMPLETED|Overall Study||0
5043954|NCT01996813|12410988|P2|COMPLETED|Overall Study||24
5043955|NCT01996813|12410989|P1|COMPLETED|Overall Study||23
5043956|NCT01996813|12410988|P2|STARTED|Overall Study||24
5043957|NCT01996813|12410989|P1|STARTED|Overall Study||23
5043958|NCT01996748|12410999|P2|NOT COMPLETED|Overall Study||6
5043959|NCT01996748|12411000|P1|NOT COMPLETED|Overall Study||8
5043960|NCT01996748|12410999|P2|COMPLETED|Overall Study||63
5043961|NCT01996748|12411000|P1|COMPLETED|Overall Study||58
5043962|NCT01996748|12410999|P2|STARTED|Overall Study||69
5043963|NCT01996748|12411000|P1|STARTED|Overall Study||66
5043964|NCT01996709|12411014|P2|NOT COMPLETED|Overall Study||1
5043965|NCT01996709|12411015|P1|NOT COMPLETED|Overall Study||5
5043966|NCT01996709|12411014|P2|COMPLETED|Overall Study||67
5043967|NCT01996709|12411015|P1|COMPLETED|Overall Study||61
5043968|NCT01996709|12411014|P2|STARTED|Overall Study||68
5043969|NCT01996709|12411015|P1|STARTED|Overall Study||66
5043970|NCT01996657|12411032|P3|NOT COMPLETED|Overall Study||14
5043971|NCT01996657|12411033|P2|NOT COMPLETED|Overall Study||11
5043972|NCT01996657|12411034|P1|NOT COMPLETED|Overall Study||13
5043973|NCT01996657|12411032|P3|COMPLETED|Overall Study||234
5043974|NCT01996657|12411033|P2|COMPLETED|Overall Study||239
5043975|NCT01996657|12411034|P1|COMPLETED|Overall Study||237
5043976|NCT01996657|12411032|P3|STARTED|Overall Study||248
5043977|NCT01996657|12411033|P2|STARTED|Overall Study||250
5043978|NCT01996657|12411034|P1|STARTED|Overall Study||250
5043979|NCT01996644|12411050|P2|NOT COMPLETED|Overall Study||0
5043980|NCT01996644|12411051|P1|NOT COMPLETED|Overall Study||0
5043981|NCT01996644|12411050|P2|COMPLETED|Overall Study||16
5043982|NCT01996644|12411051|P1|COMPLETED|Overall Study||20
5043983|NCT01996644|12411050|P2|STARTED|Overall Study||16
5043984|NCT01996644|12411051|P1|STARTED|Overall Study||20
5043985|NCT01996592|12411062|P1|NOT COMPLETED|Overall Study||45
5043986|NCT01996592|12411062|P1|COMPLETED|Overall Study||530
5043987|NCT01996592|12411062|P1|STARTED|Overall Study||575
5043988|NCT01996410|12411079|P8|NOT COMPLETED|Overall Study||0
5043989|NCT01996410|12411080|P7|NOT COMPLETED|Overall Study||0
5043990|NCT01996410|12411081|P6|NOT COMPLETED|Overall Study||0
5043991|NCT01996410|12411082|P5|NOT COMPLETED|Overall Study||0
5043992|NCT01996410|12411083|P4|NOT COMPLETED|Overall Study||0
5043993|NCT01996410|12411084|P3|NOT COMPLETED|Overall Study||0
5043994|NCT01996410|12411085|P2|NOT COMPLETED|Overall Study||0
5043995|NCT01996410|12411086|P1|NOT COMPLETED|Overall Study||0
5043996|NCT01996410|12411079|P8|COMPLETED|Overall Study||0
5043997|NCT01996410|12411080|P7|COMPLETED|Overall Study||0
5043998|NCT01996410|12411081|P6|COMPLETED|Overall Study||2
5043999|NCT01996410|12411082|P5|COMPLETED|Overall Study||2
5044000|NCT01996410|12411083|P4|COMPLETED|Overall Study||0
5044001|NCT01996410|12411084|P3|COMPLETED|Overall Study||0
5044002|NCT01996410|12411085|P2|COMPLETED|Overall Study||3
5044003|NCT01996410|12411086|P1|COMPLETED|Overall Study||3
5044004|NCT01996410|12411079|P8|STARTED|Overall Study||0
5044005|NCT01996410|12411080|P7|STARTED|Overall Study||0
5044006|NCT01996410|12411081|P6|STARTED|Overall Study||2
5044007|NCT01996410|12411082|P5|STARTED|Overall Study||2
5044008|NCT01996410|12411083|P4|STARTED|Overall Study||0
5044009|NCT01996410|12411084|P3|STARTED|Overall Study||0
5044010|NCT01996410|12411085|P2|STARTED|Overall Study||3
5044011|NCT01996410|12411086|P1|STARTED|Overall Study||3
5044012|NCT01996332|12411098|P1|NOT COMPLETED|Overall Study||1805
5044013|NCT01996332|12411098|P1|COMPLETED|Overall Study||0
5044014|NCT01996332|12411098|P1|STARTED|Overall Study||1805
5044015|NCT01996319|12411106|P2|NOT COMPLETED|Overall Study||3
5044016|NCT01996319|12411107|P1|NOT COMPLETED|Overall Study||8
5044017|NCT01996319|12411106|P2|COMPLETED|Overall Study||95
5044018|NCT01996319|12411107|P1|COMPLETED|Overall Study||88
5044019|NCT01996319|12411106|P2|STARTED|Overall Study||98
5044020|NCT01996319|12411107|P1|STARTED|Overall Study||96
5044021|NCT01996254|12411129|P3|NOT COMPLETED|Overall Study||8
5044022|NCT01996254|12411130|P2|NOT COMPLETED|Overall Study||5
5044023|NCT01996254|12411131|P1|NOT COMPLETED|Overall Study||1
5044024|NCT01996254|12411129|P3|COMPLETED|Overall Study||6
5044025|NCT01996254|12411130|P2|COMPLETED|Overall Study||9
5044026|NCT01996254|12411131|P1|COMPLETED|Overall Study||4
5044027|NCT01996254|12411129|P3|Per Protocol Set|Overall Study||13
5044028|NCT01996254|12411130|P2|Per Protocol Set|Overall Study||10
5044029|NCT01996254|12411131|P1|Per Protocol Set|Overall Study||0
5044030|NCT01996254|12411129|P3|Long Term Analysis Set|Overall Study||14
5044031|NCT01996254|12411130|P2|Long Term Analysis Set|Overall Study||12
5044032|NCT01996254|12411131|P1|Long Term Analysis Set|Overall Study||0
5044033|NCT01996254|12411129|P3|Full Analysis Set|Overall Study||14
5044034|NCT01996254|12411130|P2|Full Analysis Set|Overall Study||12
5044035|NCT01996254|12411131|P1|Full Analysis Set|Overall Study||0
5044036|NCT01996254|12411129|P3|Safety Set|Overall Study||14
5044037|NCT01996254|12411130|P2|Safety Set|Overall Study||14
5044038|NCT01996254|12411131|P1|Safety Set|Overall Study||5
5044039|NCT01996254|12411129|P3|STARTED|Overall Study||14
5044040|NCT01996254|12411130|P2|STARTED|Overall Study||14
5044041|NCT01996254|12411131|P1|STARTED|Overall Study||5
5044042|NCT01996241|12411159|P2|NOT COMPLETED|Overall Study||235
5044043|NCT01996241|12411160|P1|NOT COMPLETED|Overall Study||252
5044044|NCT01996241|12411159|P2|COMPLETED|Overall Study||876
5044045|NCT01996241|12411160|P1|COMPLETED|Overall Study||912
5044046|NCT01996241|12411159|P2|STARTED|Overall Study||1111
5044047|NCT01996241|12411160|P1|STARTED|Overall Study||1164
5044048|NCT01996033|12411176|P1|NOT COMPLETED|Overall Study||9
5044049|NCT01996033|12411176|P1|COMPLETED|Overall Study||16
5044050|NCT01996033|12411176|P1|STARTED|Overall Study||25
5044051|NCT01995838|12411196|P7|NOT COMPLETED|Overall Study||5
5044052|NCT01995838|12411197|P6|NOT COMPLETED|Overall Study||2
5044053|NCT01995838|12411198|P5|NOT COMPLETED|Overall Study||2
5044054|NCT01995838|12411199|P4|NOT COMPLETED|Overall Study||2
5044055|NCT01995838|12411200|P3|NOT COMPLETED|Overall Study||0
5044056|NCT01995838|12411201|P2|NOT COMPLETED|Overall Study||2
5044057|NCT01995838|12411202|P1|NOT COMPLETED|Overall Study||5
5044058|NCT01995838|12411196|P7|COMPLETED|Overall Study||45
5044059|NCT01995838|12411197|P6|COMPLETED|Overall Study||54
5044060|NCT01995838|12411198|P5|COMPLETED|Overall Study||30
5044061|NCT01995838|12411199|P4|COMPLETED|Overall Study||36
5044062|NCT01995838|12411200|P3|COMPLETED|Overall Study||27
5044063|NCT01995838|12411201|P2|COMPLETED|Overall Study||30
5044064|NCT01995838|12411202|P1|COMPLETED|Overall Study||51
5044065|NCT01995838|12411196|P7|STARTED|Overall Study||50
5044066|NCT01995838|12411197|P6|STARTED|Overall Study||56
5044067|NCT01995838|12411198|P5|STARTED|Overall Study||32
5044068|NCT01995838|12411199|P4|STARTED|Overall Study||38
5044069|NCT01995838|12411200|P3|STARTED|Overall Study||27
5044070|NCT01995838|12411201|P2|STARTED|Overall Study||32
5044071|NCT01995838|12411202|P1|STARTED|Overall Study||56
5044072|NCT01995552|12411301|P1|NOT COMPLETED|Overall Study||17
5044073|NCT01995552|12411301|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
5044074|NCT01995552|12411301|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
5044075|NCT01995539|12411307|P1|NOT COMPLETED|Overall Study||33
5044076|NCT01995539|12411307|P1|COMPLETED|Overall Study||148
5044077|NCT01995539|12411307|P1|STARTED|Overall Study||181
5044078|NCT01995526|12411312|P1|NOT COMPLETED|Overall Study||1
5044079|NCT01995526|12411312|P1|COMPLETED|Overall Study||10
5044080|NCT01995526|12411312|P1|Received One Dose of Study Drug|Overall Study||11
5044081|NCT01995526|12411312|P1|STARTED|Overall Study||11
5044082|NCT01995513|12411320|P3|NOT COMPLETED|Double Blind Treatment Period||125
5044083|NCT01995513|12411321|P2|NOT COMPLETED|Double Blind Treatment Period||126
5044084|NCT01995513|12411322|P1|NOT COMPLETED|Double Blind Treatment Period||0
5044085|NCT01995513|12411320|P3|COMPLETED|Double Blind Treatment Period||0
5044086|NCT01995513|12411321|P2|COMPLETED|Double Blind Treatment Period||0
5044087|NCT01995513|12411322|P1|COMPLETED|Double Blind Treatment Period||0
5044088|NCT01995513|12411320|P3|Treated|Double Blind Treatment Period||124
5044089|NCT01995513|12411321|P2|Treated|Double Blind Treatment Period||125
5044090|NCT01995513|12411322|P1|Treated|Double Blind Treatment Period||0
5044091|NCT01995513|12411320|P3|STARTED|Double Blind Treatment Period||125
5044092|NCT01995513|12411321|P2|STARTED|Double Blind Treatment Period||126
5044093|NCT01995513|12411322|P1|STARTED|Double Blind Treatment Period||0
5044094|NCT01995513|12411320|P3|NOT COMPLETED|Open Label Treatment Period||0
5044095|NCT01995513|12411321|P2|NOT COMPLETED|Open Label Treatment Period||0
5044096|NCT01995513|12411322|P1|NOT COMPLETED|Open Label Treatment Period||258
5044097|NCT01995513|12411320|P3|COMPLETED|Open Label Treatment Period||0
5044098|NCT01995513|12411321|P2|COMPLETED|Open Label Treatment Period||0
5044099|NCT01995513|12411322|P1|COMPLETED|Open Label Treatment Period||251
5044100|NCT01995513|12411320|P3|STARTED|Open Label Treatment Period||0
5044101|NCT01995513|12411321|P2|STARTED|Open Label Treatment Period||0
5044102|NCT01995513|12411322|P1|STARTED|Open Label Treatment Period||509
5044103|NCT01995461|12411365|P1|NOT COMPLETED|Overall Study||5
5044104|NCT01995461|12411365|P1|COMPLETED|Overall Study||21
5044105|NCT01995461|12411365|P1|STARTED|Overall Study||26
5044106|NCT01995357|12411371|P6|NOT COMPLETED|Period 5||0
5044107|NCT01995357|12411372|P5|NOT COMPLETED|Period 5||0
5044108|NCT01995357|12411373|P4|NOT COMPLETED|Period 5||0
5044109|NCT01995357|12411374|P3|NOT COMPLETED|Period 5||1
5044110|NCT01995357|12411375|P2|NOT COMPLETED|Period 5||0
5044111|NCT01995357|12411376|P1|NOT COMPLETED|Period 5||2
5044112|NCT01995357|12411371|P6|COMPLETED|Period 5||4
5044113|NCT01995357|12411372|P5|COMPLETED|Period 5||4
5044114|NCT01995357|12411373|P4|COMPLETED|Period 5||3
5044115|NCT01995357|12411374|P3|COMPLETED|Period 5||3
5044116|NCT01995357|12411375|P2|COMPLETED|Period 5||3
5044117|NCT01995357|12411376|P1|COMPLETED|Period 5||2
5044118|NCT01995357|12411371|P6|STARTED|Period 5||4
5044119|NCT01995357|12411372|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
5044120|NCT01995357|12411373|P4|STARTED|Period 5||3
5044121|NCT01995357|12411374|P3|STARTED|Period 5||4
5044122|NCT01995357|12411375|P2|STARTED|Period 5||3
5044123|NCT01995357|12411376|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
5044124|NCT01995357|12411371|P6|NOT COMPLETED|Period 4||0
5044125|NCT01995357|12411372|P5|NOT COMPLETED|Period 4||0
5044126|NCT01995357|12411373|P4|NOT COMPLETED|Period 4||0
5044127|NCT01995357|12411374|P3|NOT COMPLETED|Period 4||0
5044128|NCT01995357|12411375|P2|NOT COMPLETED|Period 4||0
5044129|NCT01995357|12411376|P1|NOT COMPLETED|Period 4||0
5044130|NCT01995357|12411371|P6|COMPLETED|Period 4||4
5044131|NCT01995357|12411372|P5|COMPLETED|Period 4||4
5044132|NCT01995357|12411373|P4|COMPLETED|Period 4||3
5044133|NCT01995357|12411374|P3|COMPLETED|Period 4||4
5044134|NCT01995357|12411375|P2|COMPLETED|Period 4||3
5044135|NCT01995357|12411376|P1|COMPLETED|Period 4||4
5044136|NCT01995357|12411371|P6|STARTED|Period 4||4
5044137|NCT01995357|12411372|P5|STARTED|Period 4||4
5044138|NCT01995357|12411373|P4|STARTED|Period 4||3
5044139|NCT01995357|12411374|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
5044140|NCT01995357|12411375|P2|STARTED|Period 4||3
5044141|NCT01995357|12411376|P1|STARTED|Period 4||4
5044142|NCT01995357|12411371|P6|NOT COMPLETED|Period 3||0
5044143|NCT01995357|12411372|P5|NOT COMPLETED|Period 3||0
5044144|NCT01995357|12411373|P4|NOT COMPLETED|Period 3||0
5044145|NCT01995357|12411374|P3|NOT COMPLETED|Period 3||0
5044146|NCT01995357|12411375|P2|NOT COMPLETED|Period 3||0
5044147|NCT01995357|12411376|P1|NOT COMPLETED|Period 3||0
5044148|NCT01995357|12411371|P6|COMPLETED|Period 3||4
5044149|NCT01995357|12411372|P5|COMPLETED|Period 3||4
5044150|NCT01995357|12411373|P4|COMPLETED|Period 3||3
5044151|NCT01995357|12411374|P3|COMPLETED|Period 3||4
5044152|NCT01995357|12411375|P2|COMPLETED|Period 3||3
5044153|NCT01995357|12411376|P1|COMPLETED|Period 3||4
5044154|NCT01995357|12411371|P6|STARTED|Period 3||4
5044155|NCT01995357|12411372|P5|STARTED|Period 3||4
5044156|NCT01995357|12411373|P4|STARTED|Period 3||3
5044157|NCT01995357|12411374|P3|STARTED|Period 3||4
5044158|NCT01995357|12411375|P2|STARTED|Period 3||3
5044159|NCT01995357|12411376|P1|STARTED|Period 3||4
5044160|NCT01995357|12411371|P6|NOT COMPLETED|Period 2||0
5044161|NCT01995357|12411372|P5|NOT COMPLETED|Period 2||0
5044162|NCT01995357|12411373|P4|NOT COMPLETED|Period 2||0
5044163|NCT01995357|12411374|P3|NOT COMPLETED|Period 2||0
5044164|NCT01995357|12411375|P2|NOT COMPLETED|Period 2||0
5044165|NCT01995357|12411376|P1|NOT COMPLETED|Period 2||0
5044166|NCT01995357|12411371|P6|COMPLETED|Period 2||4
5044167|NCT01995357|12411372|P5|COMPLETED|Period 2||4
5044168|NCT01995357|12411373|P4|COMPLETED|Period 2||3
5044169|NCT01995357|12411374|P3|COMPLETED|Period 2||4
5044170|NCT01995357|12411375|P2|COMPLETED|Period 2||3
5044171|NCT01995357|12411376|P1|COMPLETED|Period 2||4
5044172|NCT01995357|12411371|P6|STARTED|Period 2||4
5044173|NCT01995357|12411372|P5|STARTED|Period 2||4
5044174|NCT01995357|12411373|P4|STARTED|Period 2||3
5044175|NCT01995357|12411374|P3|STARTED|Period 2||4
5044176|NCT01995357|12411375|P2|STARTED|Period 2||3
5044177|NCT01995357|12411376|P1|STARTED|Period 2||4
5044178|NCT01995357|12411371|P6|NOT COMPLETED|Period 1||0
5044179|NCT01995357|12411372|P5|NOT COMPLETED|Period 1||0
5044180|NCT01995357|12411373|P4|NOT COMPLETED|Period 1||0
5044181|NCT01995357|12411374|P3|NOT COMPLETED|Period 1||0
5044182|NCT01995357|12411375|P2|NOT COMPLETED|Period 1||0
5044183|NCT01995357|12411376|P1|NOT COMPLETED|Period 1||0
5044184|NCT01995357|12411371|P6|COMPLETED|Period 1||4
5044185|NCT01995357|12411372|P5|COMPLETED|Period 1||4
5044186|NCT01995357|12411373|P4|COMPLETED|Period 1||3
5044187|NCT01995357|12411374|P3|COMPLETED|Period 1||4
5044188|NCT01995357|12411375|P2|COMPLETED|Period 1||3
5044189|NCT01995357|12411376|P1|COMPLETED|Period 1||4
5044190|NCT01995357|12411371|P6|STARTED|Period 1||4
5044191|NCT01995357|12411372|P5|STARTED|Period 1||4
5044192|NCT01995357|12411373|P4|STARTED|Period 1||3
5044193|NCT01995357|12411374|P3|STARTED|Period 1||4
5044194|NCT01995357|12411375|P2|STARTED|Period 1||3
5044195|NCT01995357|12411376|P1|STARTED|Period 1||4
5044196|NCT01995266|12411392|P1|NOT COMPLETED|Overall Study||9
5044197|NCT01995266|12411392|P1|COMPLETED|Overall Study||150
5044198|NCT01995266|12411392|P1|STARTED|Overall Study||159
5044199|NCT01995201|12411407|P7|NOT COMPLETED|From Week 24 Until Week 48||2
5044200|NCT01995201|12411408|P6|NOT COMPLETED|From Week 24 Until Week 48||8
5044201|NCT01995201|12411409|P5|NOT COMPLETED|From Week 24 Until Week 48||6
5044202|NCT01995201|12411410|P4|NOT COMPLETED|From Week 24 Until Week 48||1
5044203|NCT01995201|12411411|P3|NOT COMPLETED|From Week 24 Until Week 48||5
5044204|NCT01995201|12411412|P2|NOT COMPLETED|From Week 24 Until Week 48||0
5044205|NCT01995201|12411413|P1|NOT COMPLETED|From Week 24 Until Week 48||0
5044206|NCT01995201|12411407|P7|COMPLETED|From Week 24 Until Week 48||0
5044207|NCT01995201|12411408|P6|COMPLETED|From Week 24 Until Week 48||59
5044208|NCT01995201|12411409|P5|COMPLETED|From Week 24 Until Week 48||89
5044209|NCT01995201|12411410|P4|COMPLETED|From Week 24 Until Week 48||89
5044210|NCT01995201|12411411|P3|COMPLETED|From Week 24 Until Week 48||84
5044211|NCT01995201|12411412|P2|COMPLETED|From Week 24 Until Week 48||0
5044212|NCT01995201|12411413|P1|COMPLETED|From Week 24 Until Week 48||0
5044213|NCT01995201|12411407|P7|STARTED|From Week 24 Until Week 48||2
5044214|NCT01995201|12411408|P6|STARTED|From Week 24 Until Week 48||67
5044215|NCT01995201|12411409|P5|STARTED|From Week 24 Until Week 48||95
5044216|NCT01995201|12411410|P4|STARTED|From Week 24 Until Week 48||90
5044217|NCT01995201|12411411|P3|STARTED|From Week 24 Until Week 48||89
5044218|NCT01995201|12411412|P2|STARTED|From Week 24 Until Week 48||0
5044219|NCT01995201|12411413|P1|STARTED|From Week 24 Until Week 48||0
5044220|NCT01995201|12411407|P7|NOT COMPLETED|From Baseline Until Week 24||0
5044221|NCT01995201|12411408|P6|NOT COMPLETED|From Baseline Until Week 24||0
5044222|NCT01995201|12411409|P5|NOT COMPLETED|From Baseline Until Week 24||0
5044223|NCT01995201|12411410|P4|NOT COMPLETED|From Baseline Until Week 24||0
5044224|NCT01995201|12411411|P3|NOT COMPLETED|From Baseline Until Week 24||0
5044225|NCT01995201|12411412|P2|NOT COMPLETED|From Baseline Until Week 24||46
5044226|NCT01995201|12411413|P1|NOT COMPLETED|From Baseline Until Week 24||10
5044227|NCT01995201|12411407|P7|COMPLETED|From Baseline Until Week 24||0
5044228|NCT01995201|12411408|P6|COMPLETED|From Baseline Until Week 24||0
5044229|NCT01995201|12411409|P5|COMPLETED|From Baseline Until Week 24||0
5044230|NCT01995201|12411410|P4|COMPLETED|From Baseline Until Week 24||0
5044231|NCT01995201|12411411|P3|COMPLETED|From Baseline Until Week 24||0
5044232|NCT01995201|12411412|P2|COMPLETED|From Baseline Until Week 24||281
5044233|NCT01995201|12411413|P1|COMPLETED|From Baseline Until Week 24||64
5044234|NCT01995201|12411407|P7|STARTED|From Baseline Until Week 24||0
5044235|NCT01995201|12411408|P6|STARTED|From Baseline Until Week 24||0
5044236|NCT01995201|12411409|P5|STARTED|From Baseline Until Week 24||0
5044237|NCT01995201|12411410|P4|STARTED|From Baseline Until Week 24||0
5044238|NCT01995201|12411411|P3|STARTED|From Baseline Until Week 24||0
5044239|NCT01995201|12411412|P2|STARTED|From Baseline Until Week 24||327
5044240|NCT01995201|12411413|P1|STARTED|From Baseline Until Week 24||74
5044241|NCT01995175|12411522|P1|NOT COMPLETED|Overall Study||253
5044242|NCT01995175|12411522|P1|COMPLETED|Overall Study||2148
5044243|NCT01995175|12411522|P1|STARTED|Overall Study||2401
5044244|NCT01995136|12411532|P1|NOT COMPLETED|Overall Study||1
5044245|NCT01995136|12411532|P1|COMPLETED|Overall Study||31
5044246|NCT01995136|12411532|P1|STARTED|Overall Study||32
5044247|NCT01995123|12411538|P2|NOT COMPLETED|Overall Study||15
5044248|NCT01995123|12411539|P1|NOT COMPLETED|Overall Study||18
5044249|NCT01995123|12411538|P2|COMPLETED|Overall Study||46
5044250|NCT01995123|12411539|P1|COMPLETED|Overall Study||45
5044251|NCT01995123|12411538|P2|STARTED|Overall Study||61
5044252|NCT01995123|12411539|P1|STARTED|Overall Study||63
5044253|NCT01995071|12411561|P12|NOT COMPLETED|Overall Study||0
5044254|NCT01995071|12411562|P11|NOT COMPLETED|Overall Study||1
5044255|NCT01995071|12411563|P10|NOT COMPLETED|Overall Study||0
5044256|NCT01995071|12411564|P9|NOT COMPLETED|Overall Study||1
5044257|NCT01995071|12411565|P8|NOT COMPLETED|Overall Study||2
5044258|NCT01995071|12411566|P7|NOT COMPLETED|Overall Study||1
5044259|NCT01995071|12411567|P6|NOT COMPLETED|Overall Study||0
5044260|NCT01995071|12411568|P5|NOT COMPLETED|Overall Study||1
5044261|NCT01995071|12411569|P4|NOT COMPLETED|Overall Study||0
5044262|NCT01995071|12411570|P3|NOT COMPLETED|Overall Study||1
5044263|NCT01995071|12411571|P2|NOT COMPLETED|Overall Study||0
5044264|NCT01995071|12411572|P1|NOT COMPLETED|Overall Study||1
5044265|NCT01995071|12411561|P12|COMPLETED|Overall Study||0
5044266|NCT01995071|12411562|P11|COMPLETED|Overall Study||7
5044267|NCT01995071|12411563|P10|COMPLETED|Overall Study||8
5044268|NCT01995071|12411564|P9|COMPLETED|Overall Study||7
5044269|NCT01995071|12411565|P8|COMPLETED|Overall Study||6
5044270|NCT01995071|12411566|P7|COMPLETED|Overall Study||7
5044271|NCT01995071|12411567|P6|COMPLETED|Overall Study||8
5044272|NCT01995071|12411568|P5|COMPLETED|Overall Study||7
5044273|NCT01995071|12411569|P4|COMPLETED|Overall Study||8
5044274|NCT01995071|12411570|P3|COMPLETED|Overall Study||8
5044275|NCT01995071|12411571|P2|COMPLETED|Overall Study||8
5044276|NCT01995071|12411572|P1|COMPLETED|Overall Study||7
5044277|NCT01995071|12411561|P12|STARTED|Overall Study||0
5044278|NCT01995071|12411562|P11|STARTED|Overall Study||8
5044279|NCT01995071|12411563|P10|STARTED|Overall Study||8
5044280|NCT01995071|12411564|P9|STARTED|Overall Study||8
5044281|NCT01995071|12411565|P8|STARTED|Overall Study||8
5044282|NCT01995071|12411566|P7|STARTED|Overall Study||8
5044283|NCT01995071|12411567|P6|STARTED|Overall Study||8
5044284|NCT01995071|12411568|P5|STARTED|Overall Study||8
5044285|NCT01995071|12411569|P4|STARTED|Overall Study||8
5044286|NCT01995071|12411570|P3|STARTED|Overall Study||9
5044287|NCT01995071|12411571|P2|STARTED|Overall Study||8
5044288|NCT01995071|12411572|P1|STARTED|Overall Study||8
5044289|NCT01995045|12411633|P2|NOT COMPLETED|Overall Study||0
5044290|NCT01995045|12411634|P1|NOT COMPLETED|Overall Study||0
5044291|NCT01995045|12411633|P2|COMPLETED|Overall Study||28
5044292|NCT01995045|12411634|P1|COMPLETED|Overall Study||29
5044293|NCT01995045|12411633|P2|STARTED|Overall Study||28
5044294|NCT01995045|12411634|P1|STARTED|Overall Study||29
5044295|NCT01994993|12411651|P5|NOT COMPLETED|Overall Study||2
5044296|NCT01994993|12411652|P4|NOT COMPLETED|Overall Study||46
5044297|NCT01994993|12411653|P3|NOT COMPLETED|Overall Study||47
5044298|NCT01994993|12411654|P2|NOT COMPLETED|Overall Study||35
5044299|NCT01994993|12411655|P1|NOT COMPLETED|Overall Study||35
5044300|NCT01994993|12411651|P5|COMPLETED|Overall Study||22
5044301|NCT01994993|12411652|P4|COMPLETED|Overall Study||9
5044302|NCT01994993|12411653|P3|COMPLETED|Overall Study||23
5044303|NCT01994993|12411654|P2|COMPLETED|Overall Study||12
5044304|NCT01994993|12411655|P1|COMPLETED|Overall Study||28
5044305|NCT01994993|12411651|P5|STARTED|Overall Study||24
5044306|NCT01994993|12411652|P4|STARTED|Overall Study||55
5044307|NCT01994993|12411653|P3|STARTED|Overall Study||70
5044308|NCT01994993|12411654|P2|STARTED|Overall Study||47
5044309|NCT01994993|12411655|P1|STARTED|Overall Study||63
5044310|NCT01994954|12411709|P2|NOT COMPLETED|Overall Study||30
5044311|NCT01994954|12411710|P1|NOT COMPLETED|Overall Study||25
5044312|NCT01994954|12411709|P2|COMPLETED|Overall Study||67
5044313|NCT01994954|12411710|P1|COMPLETED|Overall Study||74
5044314|NCT01994954|12411709|P2|STARTED|Overall Study||97
5044315|NCT01994954|12411710|P1|STARTED|Overall Study||99
5044316|NCT01994902|12411728|P2|NOT COMPLETED|Test Period 2||6
5044317|NCT01994902|12411729|P1|NOT COMPLETED|Test Period 2||0
5044318|NCT01994902|12411728|P2|COMPLETED|Test Period 2||55
5044319|NCT01994902|12411729|P1|COMPLETED|Test Period 2||57
5044320|NCT01994902|12411728|P2|STARTED|Test Period 2||61
5044321|NCT01994902|12411729|P1|STARTED|Test Period 2||57
5044322|NCT01994902|12411728|P2|NOT COMPLETED|Test Period 1||3
5044323|NCT01994902|12411729|P1|NOT COMPLETED|Test Period 1||6
5044324|NCT01994902|12411728|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
5044325|NCT01994902|12411729|P1|COMPLETED|Test Period 1||57
5044326|NCT01994902|12411728|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
5044327|NCT01994902|12411729|P1|STARTED|Test Period 1||63
5044328|NCT01994889|12411738|P3|NOT COMPLETED|Overall Study||92
5044329|NCT01994889|12411739|P2|NOT COMPLETED|Overall Study||63
5044330|NCT01994889|12411740|P1|NOT COMPLETED|Overall Study||28
5044331|NCT01994889|12411738|P3|COMPLETED|Overall Study||85
5044332|NCT01994889|12411739|P2|COMPLETED|Overall Study||113
5044333|NCT01994889|12411740|P1|COMPLETED|Overall Study||60
5044334|NCT01994889|12411738|P3|STARTED|Overall Study||177
5044335|NCT01994889|12411739|P2|STARTED|Overall Study||176
5044336|NCT01994889|12411740|P1|STARTED|Overall Study||88
5044337|NCT01994876|12411759|P2|NOT COMPLETED|Test Period 2||1
5044338|NCT01994876|12411760|P1|NOT COMPLETED|Test Period 2||1
5044339|NCT01994876|12411759|P2|COMPLETED|Test Period 2||6
5044340|NCT01994876|12411760|P1|COMPLETED|Test Period 2||8
5044341|NCT01994876|12411759|P2|STARTED|Test Period 2||7
5044342|NCT01994876|12411760|P1|STARTED|Test Period 2||9
5044343|NCT01994876|12411759|P2|NOT COMPLETED|Test Period 1||2
5044344|NCT01994876|12411760|P1|NOT COMPLETED|Test Period 1||0
5044345|NCT01994876|12411759|P2|COMPLETED|Test Period 1||7
5044346|NCT01994876|12411760|P1|COMPLETED|Test Period 1||9
5044347|NCT01994876|12411759|P2|STARTED|Test Period 1||9
5044348|NCT01994876|12411760|P1|STARTED|Test Period 1||9
5044349|NCT01994876|12411759|P2|NOT COMPLETED|Baseline - Own Product||0
5044350|NCT01994876|12411760|P1|NOT COMPLETED|Baseline - Own Product||0
5044351|NCT01994876|12411759|P2|COMPLETED|Baseline - Own Product||9
5044352|NCT01994876|12411760|P1|COMPLETED|Baseline - Own Product||9
5044353|NCT01994876|12411759|P2|STARTED|Baseline - Own Product||9
5044354|NCT01994876|12411760|P1|STARTED|Baseline - Own Product||9
5044355|NCT01994863|12411768|P2|NOT COMPLETED|Period 2||4
5044356|NCT01994863|12411769|P1|NOT COMPLETED|Period 2||1
5044357|NCT01994863|12411768|P2|COMPLETED|Period 2||5
5044358|NCT01994863|12411769|P1|COMPLETED|Period 2||7
5044359|NCT01994863|12411768|P2|STARTED|Period 2||9
5044360|NCT01994863|12411769|P1|STARTED|Period 2||8
5044361|NCT01994863|12411768|P2|NOT COMPLETED|Period 1||3
5044362|NCT01994863|12411769|P1|NOT COMPLETED|Period 1||7
5044363|NCT01994863|12411768|P2|COMPLETED|Period 1||9
5044364|NCT01994863|12411769|P1|COMPLETED|Period 1||4
5044365|NCT01994863|12411768|P2|STARTED|Period 1||12
5044366|NCT01994863|12411769|P1|STARTED|Period 1||11
5044367|NCT01994850|12411775|P1|NOT COMPLETED|Overall Study||2
5044368|NCT01994850|12411775|P1|COMPLETED|Overall Study||30
5044369|NCT01994850|12411775|P1|STARTED|Overall Study||32
5044370|NCT01994837|12411780|P1|NOT COMPLETED|Overall Study||32
5044371|NCT01994837|12411780|P1|COMPLETED|Overall Study||0
5044372|NCT01994837|12411780|P1|Treated|Overall Study||32
5044373|NCT01994837|12411780|P1|STARTED|Overall Study||32
5044374|NCT01994785|12411797|P4|NOT COMPLETED|Overall Study||3
5044375|NCT01994785|12411798|P3|NOT COMPLETED|Overall Study||0
5044376|NCT01994785|12411799|P2|NOT COMPLETED|Overall Study||1
5044377|NCT01994785|12411800|P1|NOT COMPLETED|Overall Study||8
5044378|NCT01994785|12411797|P4|COMPLETED|Overall Study||114
5044379|NCT01994785|12411798|P3|COMPLETED|Overall Study||117
5044380|NCT01994785|12411799|P2|COMPLETED|Overall Study||108
5044381|NCT01994785|12411800|P1|COMPLETED|Overall Study||101
5044382|NCT01994785|12411797|P4|STARTED|Overall Study||117
5044383|NCT01994785|12411798|P3|STARTED|Overall Study||117
5044384|NCT01994785|12411799|P2|STARTED|Overall Study||109
5044385|NCT01994785|12411800|P1|STARTED|Overall Study||109
5044386|NCT01994746|12411810|P2|NOT COMPLETED|Second Visit||0
5044387|NCT01994746|12411811|P1|NOT COMPLETED|Second Visit||0
5044388|NCT01994746|12411810|P2|COMPLETED|Second Visit||38
5044389|NCT01994746|12411811|P1|COMPLETED|Second Visit||38
5044390|NCT01994746|12411810|P2|Completed Both Dosing Visits|Second Visit||38
5044391|NCT01994746|12411811|P1|Completed Both Dosing Visits|Second Visit||38
5044392|NCT01994746|12411810|P2|STARTED|Second Visit||38
5044393|NCT01994746|12411811|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
5044394|NCT01994746|12411810|P2|NOT COMPLETED|First Visit||0
5044395|NCT01994746|12411811|P1|NOT COMPLETED|First Visit||0
5044396|NCT01994746|12411810|P2|COMPLETED|First Visit||38
5044397|NCT01994746|12411811|P1|COMPLETED|First Visit||39
5044398|NCT01994746|12411810|P2|Received At Least 1 Dose|First Visit||38
5044399|NCT01994746|12411811|P1|Received At Least 1 Dose|First Visit||39
5044400|NCT01994746|12411810|P2|STARTED|First Visit||38
5044401|NCT01994746|12411811|P1|STARTED|First Visit||39
5044402|NCT01994720|12411837|P2|NOT COMPLETED|Overall Study||56
5044403|NCT01994720|12411838|P1|NOT COMPLETED|Overall Study||46
5044404|NCT01994720|12411837|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
5044405|NCT01994720|12411838|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
5044406|NCT01994720|12411837|P2|STARTED|Overall Study||6610
5044407|NCT01994720|12411838|P1|STARTED|Overall Study||6589
5044408|NCT01994629|12411880|P2|NOT COMPLETED|Overall Study||3
5044409|NCT01994629|12411881|P1|NOT COMPLETED|Overall Study||1
5044410|NCT01994629|12411880|P2|COMPLETED|Overall Study||99
5044411|NCT01994629|12411881|P1|COMPLETED|Overall Study||99
5044412|NCT01994629|12411880|P2|STARTED|Overall Study||102
5044413|NCT01994629|12411881|P1|STARTED|Overall Study||100
5044414|NCT01994590|12411905|P1|NOT COMPLETED|Overall Study||2
5044415|NCT01994590|12411905|P1|COMPLETED|Overall Study||2
5044416|NCT01994590|12411905|P1|STARTED|Overall Study||4
5044417|NCT01994486|12411909|P1|NOT COMPLETED|Overall Study||0
5044418|NCT01994486|12411909|P1|COMPLETED|Overall Study||20
5044419|NCT01994486|12411909|P1|STARTED|Overall Study||20
5044420|NCT01994395|12411920|P2|NOT COMPLETED|Overall Study||2
5044421|NCT01994395|12411921|P1|NOT COMPLETED|Overall Study||1
5044422|NCT01994395|12411920|P2|COMPLETED|Overall Study||25
5044423|NCT01994395|12411921|P1|COMPLETED|Overall Study||25
5044424|NCT01994395|12411920|P2|STARTED|Overall Study||27
5044425|NCT01994395|12411921|P1|STARTED|Overall Study||26
5044426|NCT01994291|12411946|P3|NOT COMPLETED|Overall Study||9
5044427|NCT01994291|12411947|P2|NOT COMPLETED|Overall Study||7
5044428|NCT01994291|12411948|P1|NOT COMPLETED|Overall Study||15
5044429|NCT01994291|12411946|P3|COMPLETED|Overall Study||47
5044430|NCT01994291|12411947|P2|COMPLETED|Overall Study||36
5044431|NCT01994291|12411948|P1|COMPLETED|Overall Study||84
5044432|NCT01994291|12411946|P3|Received Treatment|Overall Study||56
5044433|NCT01994291|12411947|P2|Received Treatment|Overall Study||43
5044434|NCT01994291|12411948|P1|Received Treatment|Overall Study||99
5044435|NCT01994291|12411946|P3|STARTED|Overall Study||56
5044436|NCT01994291|12411947|P2|STARTED|Overall Study||43
5044437|NCT01994291|12411948|P1|STARTED|Overall Study||99
5044438|NCT01994226|12412004|P2|NOT COMPLETED|Overall Study||21
5044439|NCT01994226|12412005|P1|NOT COMPLETED|Overall Study||19
5044440|NCT01994226|12412004|P2|COMPLETED|Overall Study||179
5044441|NCT01994226|12412005|P1|COMPLETED|Overall Study||180
5044442|NCT01994226|12412004|P2|STARTED|Overall Study||200
5044443|NCT01994226|12412005|P1|STARTED|Overall Study||199
5044444|NCT01994109|12412014|P4|NOT COMPLETED|Open-label Phase (Part B)||42
5044445|NCT01994109|12412015|P3|NOT COMPLETED|Open-label Phase (Part B)||0
5044446|NCT01994109|12412016|P2|NOT COMPLETED|Open-label Phase (Part B)||0
5044447|NCT01994109|12412017|P1|NOT COMPLETED|Open-label Phase (Part B)||0
5044448|NCT01994109|12412014|P4|COMPLETED|Open-label Phase (Part B)||128
5044449|NCT01994109|12412015|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
5044450|NCT01994109|12412016|P2|COMPLETED|Open-label Phase (Part B)||0
5044451|NCT01994109|12412017|P1|COMPLETED|Open-label Phase (Part B)||0
5044452|NCT01994109|12412014|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
5044453|NCT01994109|12412015|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
5044454|NCT01994109|12412016|P2|STARTED|Open-label Phase (Part B)||0
5044455|NCT01994109|12412017|P1|STARTED|Open-label Phase (Part B)||0
5044456|NCT01994109|12412014|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
5044457|NCT01994109|12412015|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
5044458|NCT01994109|12412016|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
5044459|NCT01994109|12412017|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
5044460|NCT01994109|12412014|P4|COMPLETED|Double-blind Phase (Part A)||0
5044461|NCT01994109|12412015|P3|COMPLETED|Double-blind Phase (Part A)||53
5044462|NCT01994109|12412016|P2|COMPLETED|Double-blind Phase (Part A)||61
5044463|NCT01994109|12412017|P1|COMPLETED|Double-blind Phase (Part A)||62
5044464|NCT01994109|12412014|P4|STARTED|Double-blind Phase (Part A)||0
5044465|NCT01994109|12412015|P3|STARTED|Double-blind Phase (Part A)||60
5044466|NCT01994109|12412016|P2|STARTED|Double-blind Phase (Part A)||64
5044467|NCT01994109|12412017|P1|STARTED|Double-blind Phase (Part A)||63
5044468|NCT01993940|12412031|P2|NOT COMPLETED|Overall Study||44
5044469|NCT01993940|12412032|P1|NOT COMPLETED|Overall Study||40
5044470|NCT01993940|12412031|P2|COMPLETED|Overall Study||232
5044471|NCT01993940|12412032|P1|COMPLETED|Overall Study||237
5044472|NCT01993940|12412031|P2|Received Treatment|Overall Study||276
5044473|NCT01993940|12412032|P1|Received Treatment|Overall Study||272
5044474|NCT01993940|12412031|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
5044475|NCT01993940|12412032|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
5044476|NCT01993927|12412046|P1|NOT COMPLETED|Overall Study||29
5044477|NCT01993927|12412046|P1|COMPLETED|Overall Study||713
5044478|NCT01993927|12412046|P1|STARTED|Overall Study||742
5044479|NCT01993888|12412054|P2|NOT COMPLETED|Overall Study||3
5044480|NCT01993888|12412055|P1|NOT COMPLETED|Overall Study||2
5044481|NCT01993888|12412054|P2|COMPLETED|Overall Study||49
5044482|NCT01993888|12412055|P1|COMPLETED|Overall Study||48
5044483|NCT01993888|12412054|P2|STARTED|Overall Study||52
5044484|NCT01993888|12412055|P1|STARTED|Overall Study||50
5044485|NCT01993875|12412073|P2|NOT COMPLETED|Overall Study||6
5044486|NCT01993875|12412074|P1|NOT COMPLETED|Overall Study||7
5044487|NCT01993875|12412073|P2|COMPLETED|Overall Study||76
5044488|NCT01993875|12412074|P1|COMPLETED|Overall Study||75
5044489|NCT01993875|12412073|P2|STARTED|Overall Study||82
5044490|NCT01993875|12412074|P1|STARTED|Overall Study||82
5044491|NCT01993849|12412092|P2|NOT COMPLETED|Overall Study||2
5044492|NCT01993849|12412093|P1|NOT COMPLETED|Overall Study||3
5044493|NCT01993849|12412092|P2|COMPLETED|Overall Study||9
5044494|NCT01993849|12412093|P1|COMPLETED|Overall Study||9
5044495|NCT01993849|12412092|P2|STARTED|Overall Study||11
5044496|NCT01993849|12412093|P1|STARTED|Overall Study||12
5044497|NCT01993836|12412104|P3|NOT COMPLETED|Overall Study||5
5044498|NCT01993836|12412105|P2|NOT COMPLETED|Overall Study||13
5044499|NCT01993836|12412106|P1|NOT COMPLETED|Overall Study||17
5044500|NCT01993836|12412104|P3|COMPLETED|Overall Study||46
5044501|NCT01993836|12412105|P2|COMPLETED|Overall Study||55
5044502|NCT01993836|12412106|P1|COMPLETED|Overall Study||55
5044503|NCT01993836|12412104|P3|STARTED|Overall Study||51
5044504|NCT01993836|12412105|P2|STARTED|Overall Study||68
5044505|NCT01993836|12412106|P1|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
5044506|NCT01993823|12412122|P2|NOT COMPLETED|Overall Study||16
5044507|NCT01993823|12412123|P1|NOT COMPLETED|Overall Study||7
5044508|NCT01993823|12412122|P2|COMPLETED|Overall Study||79
5044509|NCT01993823|12412123|P1|COMPLETED|Overall Study||88
5044510|NCT01993823|12412122|P2|STARTED|Overall Study||95
5044511|NCT01993823|12412123|P1|STARTED|Overall Study||95
5044512|NCT01993667|12412133|P2|NOT COMPLETED|Overall Study||19
5044513|NCT01993667|12412134|P1|NOT COMPLETED|Overall Study||21
5044514|NCT01993667|12412133|P2|COMPLETED|Overall Study||47
5044515|NCT01993667|12412134|P1|COMPLETED|Overall Study||43
5044516|NCT01993667|12412133|P2|STARTED|Overall Study||66
5044517|NCT01993667|12412134|P1|STARTED|Overall Study||64
5044518|NCT01993238|12412142|P1|NOT COMPLETED|Overall Study||0
5044519|NCT01993238|12412142|P1|COMPLETED|Overall Study||11
5044520|NCT01993238|12412142|P1|STARTED|Overall Study||11
5044521|NCT01993186|12412149|P2|NOT COMPLETED|Open-Label Extension Period||6
5044522|NCT01993186|12412150|P1|NOT COMPLETED|Open-Label Extension Period||7
5044523|NCT01993186|12412149|P2|COMPLETED|Open-Label Extension Period||5
5044524|NCT01993186|12412150|P1|COMPLETED|Open-Label Extension Period||16
5044525|NCT01993186|12412149|P2|STARTED|Open-Label Extension Period||11
5044526|NCT01993186|12412150|P1|STARTED|Open-Label Extension Period||23
5044527|NCT01993186|12412149|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
5044528|NCT01993186|12412150|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
5044529|NCT01993186|12412149|P2|COMPLETED|Double-Blind Placebo-Controlled Period||11
5044530|NCT01993186|12412150|P1|COMPLETED|Double-Blind Placebo-Controlled Period||23
5044531|NCT01993186|12412149|P2|STARTED|Double-Blind Placebo-Controlled Period||11
5044532|NCT01993186|12412150|P1|STARTED|Double-Blind Placebo-Controlled Period||25
5044533|NCT01993108|12412195|P2|NOT COMPLETED|Overall Study||0
5044534|NCT01993108|12412196|P1|NOT COMPLETED|Overall Study||0
5044535|NCT01993108|12412195|P2|COMPLETED|Overall Study||12
5044536|NCT01993108|12412196|P1|COMPLETED|Overall Study||11
5044537|NCT01993108|12412195|P2|STARTED|Overall Study||12
5044538|NCT01993108|12412196|P1|STARTED|Overall Study||11
5044539|NCT01993030|12412227|P2|NOT COMPLETED|Overall Study||4
5044540|NCT01993030|12412228|P1|NOT COMPLETED|Overall Study||0
5044541|NCT01993030|12412227|P2|COMPLETED|Overall Study||31
5044542|NCT01993030|12412228|P1|COMPLETED|Overall Study||36
5044543|NCT01993030|12412227|P2|STARTED|Overall Study||35
5044544|NCT01993030|12412228|P1|STARTED|Overall Study||36
5044545|NCT01993017|12412245|P3|NOT COMPLETED|Overall Study||79
5044546|NCT01993017|12412246|P2|NOT COMPLETED|Overall Study||90
5044547|NCT01993017|12412247|P1|NOT COMPLETED|Overall Study||106
5044548|NCT01993017|12412245|P3|COMPLETED|Overall Study||421
5044549|NCT01993017|12412246|P2|COMPLETED|Overall Study||411
5044550|NCT01993017|12412247|P1|COMPLETED|Overall Study||393
5044551|NCT01993017|12412245|P3|STARTED|Overall Study||500
5044552|NCT01993017|12412246|P2|STARTED|Overall Study||501
5044553|NCT01993017|12412247|P1|STARTED|Overall Study||499
5044554|NCT01992874|12412258|P3|NOT COMPLETED|Part B||0
5044555|NCT01992874|12412259|P2|NOT COMPLETED|Part B||0
5044556|NCT01992874|12412260|P1|NOT COMPLETED|Part B||0
5044557|NCT01992874|12412258|P3|COMPLETED|Part B||38
5044558|NCT01992874|12412259|P2|COMPLETED|Part B||0
5044559|NCT01992874|12412260|P1|COMPLETED|Part B||0
5044560|NCT01992874|12412258|P3|STARTED|Part B||38
5044561|NCT01992874|12412259|P2|STARTED|Part B||0
5044562|NCT01992874|12412260|P1|STARTED|Part B||0
5044563|NCT01992874|12412258|P3|NOT COMPLETED|Part A||0
5044564|NCT01992874|12412259|P2|NOT COMPLETED|Part A||0
5044565|NCT01992874|12412260|P1|NOT COMPLETED|Part A||0
5044566|NCT01992874|12412258|P3|COMPLETED|Part A||0
5044567|NCT01992874|12412259|P2|COMPLETED|Part A||17
5044568|NCT01992874|12412260|P1|COMPLETED|Part A||21
5044569|NCT01992874|12412258|P3|STARTED|Part A||0
5044570|NCT01992874|12412259|P2|STARTED|Part A||17
5044571|NCT01992874|12412260|P1|STARTED|Part A||21
5044572|NCT01992757|12412288|P1|NOT COMPLETED|Overall Study||2
5044573|NCT01992757|12412288|P1|COMPLETED|Overall Study||49
5044574|NCT01992757|12412288|P1|STARTED|Overall Study||51
5044575|NCT01992653|12412301|P8|NOT COMPLETED|Overall Study||4
5044576|NCT01992653|12412302|P7|NOT COMPLETED|Overall Study||8
5044577|NCT01992653|12412303|P6|NOT COMPLETED|Overall Study||0
5044578|NCT01992653|12412304|P5|NOT COMPLETED|Overall Study||1
5044579|NCT01992653|12412305|P4|NOT COMPLETED|Overall Study||0
5044580|NCT01992653|12412306|P3|NOT COMPLETED|Overall Study||1
5044581|NCT01992653|12412307|P2|NOT COMPLETED|Overall Study||0
5044582|NCT01992653|12412308|P1|NOT COMPLETED|Overall Study||0
5044583|NCT01992653|12412301|P8|COMPLETED|Overall Study||13
5044584|NCT01992653|12412302|P7|COMPLETED|Overall Study||32
5044585|NCT01992653|12412303|P6|COMPLETED|Overall Study||6
5044586|NCT01992653|12412304|P5|COMPLETED|Overall Study||5
5044587|NCT01992653|12412305|P4|COMPLETED|Overall Study||1
5044588|NCT01992653|12412306|P3|COMPLETED|Overall Study||5
5044589|NCT01992653|12412307|P2|COMPLETED|Overall Study||3
5044590|NCT01992653|12412308|P1|COMPLETED|Overall Study||3
5044591|NCT01992653|12412301|P8|STARTED|Overall Study||17
5044592|NCT01992653|12412302|P7|STARTED|Overall Study||40
5044593|NCT01992653|12412303|P6|STARTED|Overall Study||6
5044594|NCT01992653|12412304|P5|STARTED|Overall Study||6
5044595|NCT01992653|12412305|P4|STARTED|Overall Study||1
5044596|NCT01992653|12412306|P3|STARTED|Overall Study||6
5044597|NCT01992653|12412307|P2|STARTED|Overall Study||3
5044598|NCT01992653|12412308|P1|STARTED|Overall Study||3
5044599|NCT01992549|12412534|P1|NOT COMPLETED|Overall Study||4
5044600|NCT01992549|12412534|P1|COMPLETED|Overall Study||44
5044601|NCT01992549|12412534|P1|SURG Population|Overall Study||3
5044602|NCT01992549|12412534|P1|BLEED Population|Overall Study||29
5044603|NCT01992549|12412534|P1|PROPH Population|Overall Study||47
5044604|NCT01992549|12412534|P1|ITT Population|Overall Study||47
5044605|NCT01992549|12412534|P1|SAF Population|Overall Study||48
5044606|NCT01992549|12412534|P1|STARTED|Overall Study||48
5044607|NCT01992536|12412554|P10|NOT COMPLETED|Overall Study||1
5044608|NCT01992536|12412555|P9|NOT COMPLETED|Overall Study||1
5044609|NCT01992536|12412556|P8|NOT COMPLETED|Overall Study||0
5044610|NCT01992536|12412557|P7|NOT COMPLETED|Overall Study||7
5044611|NCT01992536|12412558|P6|NOT COMPLETED|Overall Study||1
5044612|NCT01992536|12412559|P5|NOT COMPLETED|Overall Study||0
5044613|NCT01992536|12412560|P4|NOT COMPLETED|Overall Study||2
5044614|NCT01992536|12412561|P3|NOT COMPLETED|Overall Study||1
5044615|NCT01992536|12412562|P2|NOT COMPLETED|Overall Study||3
5044616|NCT01992536|12412563|P1|NOT COMPLETED|Overall Study||4
5044617|NCT01992536|12412554|P10|COMPLETED|Overall Study||18
5044618|NCT01992536|12412555|P9|COMPLETED|Overall Study||18
5044619|NCT01992536|12412556|P8|COMPLETED|Overall Study||21
5044620|NCT01992536|12412557|P7|COMPLETED|Overall Study||0
5044621|NCT01992536|12412558|P6|COMPLETED|Overall Study||20
5044622|NCT01992536|12412559|P5|COMPLETED|Overall Study||11
5044623|NCT01992536|12412560|P4|COMPLETED|Overall Study||22
5044624|NCT01992536|12412561|P3|COMPLETED|Overall Study||16
5044625|NCT01992536|12412562|P2|COMPLETED|Overall Study||22
5044626|NCT01992536|12412563|P1|COMPLETED|Overall Study||22
5044627|NCT01992536|12412554|P10|STARTED|Overall Study||19
5044628|NCT01992536|12412555|P9|STARTED|Overall Study||19
5044629|NCT01992536|12412556|P8|STARTED|Overall Study||21
5044630|NCT01992536|12412557|P7|STARTED|Overall Study||7
5044631|NCT01992536|12412558|P6|STARTED|Overall Study||21
5044632|NCT01992536|12412559|P5|STARTED|Overall Study||11
5044633|NCT01992536|12412560|P4|STARTED|Overall Study||24
5044634|NCT01992536|12412561|P3|STARTED|Overall Study||17
5044635|NCT01992536|12412562|P2|STARTED|Overall Study||25
5044636|NCT01992536|12412563|P1|STARTED|Overall Study||26
5044637|NCT01992523|12412780|P2|NOT COMPLETED|Overall Study||0
5044638|NCT01992523|12412781|P1|NOT COMPLETED|Overall Study||0
5044639|NCT01992523|12412780|P2|COMPLETED|Overall Study||41
5044640|NCT01992523|12412781|P1|COMPLETED|Overall Study||41
5044641|NCT01992523|12412780|P2|STARTED|Overall Study||41
5044642|NCT01992523|12412781|P1|STARTED|Overall Study||41
5044643|NCT01992354|12412793|P1|NOT COMPLETED|Overall Study||0
5044644|NCT01992354|12412793|P1|COMPLETED|Overall Study||4
5044645|NCT01992354|12412793|P1|STARTED|Overall Study||4
5044646|NCT01992185|12412800|P2|NOT COMPLETED|Overall Study||0
5044647|NCT01992185|12412801|P1|NOT COMPLETED|Overall Study||0
5044648|NCT01992185|12412800|P2|COMPLETED|Overall Study||8
5044649|NCT01992185|12412801|P1|COMPLETED|Overall Study||7
5044650|NCT01992185|12412800|P2|STARTED|Overall Study||8
5044651|NCT01992185|12412801|P1|STARTED|Overall Study||7
5044652|NCT01992172|12412809|P2|NOT COMPLETED|Overall Study||0
5044653|NCT01992172|12412810|P1|NOT COMPLETED|Overall Study||0
5044654|NCT01992172|12412809|P2|COMPLETED|Overall Study||0
5044655|NCT01992172|12412810|P1|COMPLETED|Overall Study||7
5044656|NCT01992172|12412809|P2|STARTED|Overall Study||0
5044657|NCT01992172|12412810|P1|STARTED|Overall Study||7
5044658|NCT01992159|12412820|P4|NOT COMPLETED|Overall Study||4
5044659|NCT01992159|12412821|P3|NOT COMPLETED|Overall Study||1
5044660|NCT01992159|12412822|P2|NOT COMPLETED|Overall Study||8
5044661|NCT01992159|12412823|P1|NOT COMPLETED|Overall Study||4
5044662|NCT01992159|12412820|P4|COMPLETED|Overall Study||59
5044663|NCT01992159|12412821|P3|COMPLETED|Overall Study||62
5044664|NCT01992159|12412822|P2|COMPLETED|Overall Study||55
5044665|NCT01992159|12412823|P1|COMPLETED|Overall Study||59
5044666|NCT01992159|12412820|P4|Completed First 12 Months of Study|Overall Study||59
5044667|NCT01992159|12412821|P3|Completed First 12 Months of Study|Overall Study||63
5044668|NCT01992159|12412822|P2|Completed First 12 Months of Study|Overall Study||56
5044669|NCT01992159|12412823|P1|Completed First 12 Months of Study|Overall Study||59
5044670|NCT01992159|12412820|P4|Received Treatment|Overall Study||63
5044671|NCT01992159|12412821|P3|Received Treatment|Overall Study||63
5044672|NCT01992159|12412822|P2|Received Treatment|Overall Study||63
5044673|NCT01992159|12412823|P1|Received Treatment|Overall Study||63
5044674|NCT01992159|12412820|P4|STARTED|Overall Study||63
5044675|NCT01992159|12412821|P3|STARTED|Overall Study||63
5044676|NCT01992159|12412822|P2|STARTED|Overall Study||63
5044677|NCT01992159|12412823|P1|STARTED|Overall Study||63
5044678|NCT01992107|12412876|P3|NOT COMPLETED|Overall Study||36
5044679|NCT01992107|12412877|P2|NOT COMPLETED|Overall Study||33
5044680|NCT01992107|12412878|P1|NOT COMPLETED|Overall Study||68
5044681|NCT01992107|12412876|P3|COMPLETED|Overall Study||545
5044682|NCT01992107|12412877|P2|COMPLETED|Overall Study||560
5044683|NCT01992107|12412878|P1|COMPLETED|Overall Study||1091
5044684|NCT01992107|12412876|P3|STARTED|Overall Study||581
5044685|NCT01992107|12412877|P2|STARTED|Overall Study||593
5044686|NCT01992107|12412878|P1|STARTED|Overall Study||1159
5044687|NCT01992094|12412934|P3|NOT COMPLETED|Overall Study||21
5044688|NCT01992094|12412935|P2|NOT COMPLETED|Overall Study||24
5044689|NCT01992094|12412936|P1|NOT COMPLETED|Overall Study||50
5044690|NCT01992094|12412934|P3|COMPLETED|Overall Study||648
5044691|NCT01992094|12412935|P2|COMPLETED|Overall Study||652
5044692|NCT01992094|12412936|P1|COMPLETED|Overall Study||1285
5044693|NCT01992094|12412934|P3|STARTED|Overall Study||669
5044694|NCT01992094|12412935|P2|STARTED|Overall Study||676
5044695|NCT01992094|12412936|P1|STARTED|Overall Study||1335
5044696|NCT01992016|12412994|P2|NOT COMPLETED|Overall Study||0
5044697|NCT01992016|12412995|P1|NOT COMPLETED|Overall Study||0
5044698|NCT01992016|12412994|P2|COMPLETED|Overall Study||7
5044699|NCT01992016|12412995|P1|COMPLETED|Overall Study||4
5044700|NCT01992016|12412994|P2|STARTED|Overall Study||7
5044701|NCT01992016|12412995|P1|STARTED|Overall Study||4
5044702|NCT01991990|12413003|P2|NOT COMPLETED|Overall Study||0
5044703|NCT01991990|12413004|P1|NOT COMPLETED|Overall Study||0
5044704|NCT01991990|12413003|P2|COMPLETED|Overall Study||12
5044705|NCT01991990|12413004|P1|COMPLETED|Overall Study||6
5044706|NCT01991990|12413003|P2|STARTED|Overall Study||12
5044707|NCT01991990|12413004|P1|STARTED|Overall Study||6
5044708|NCT01991977|12413044|P1|NOT COMPLETED|Overall Study||12
5044709|NCT01991977|12413044|P1|COMPLETED|Overall Study||79
5044710|NCT01991977|12413044|P1|Evaluable for the Primary Outcome|Overall Study||39
5044711|NCT01991977|12413044|P1|Received IMRT Treatment|Overall Study||79
5044712|NCT01991977|12413044|P1|Received PET Tracer|Overall Study||84
5044713|NCT01991977|12413044|P1|STARTED|Overall Study||91
5044714|NCT01991860|12413050|P2|NOT COMPLETED|Overall Study||2
5044715|NCT01991860|12413051|P1|NOT COMPLETED|Overall Study||4
5044716|NCT01991860|12413050|P2|COMPLETED|Overall Study||164
5044717|NCT01991860|12413051|P1|COMPLETED|Overall Study||172
5044718|NCT01991860|12413050|P2|STARTED|Overall Study||166
5044719|NCT01991860|12413051|P1|STARTED|Overall Study||176
5044720|NCT01991821|12413071|P2|NOT COMPLETED|Overall Study||167
5044721|NCT01991821|12413072|P1|NOT COMPLETED|Overall Study||163
5044722|NCT01991821|12413071|P2|COMPLETED|Overall Study||11
5044723|NCT01991821|12413072|P1|COMPLETED|Overall Study||6
5044724|NCT01991821|12413071|P2|STARTED|Overall Study||178
5044725|NCT01991821|12413072|P1|STARTED|Overall Study||169
5044726|NCT01991808|12413090|P1|NOT COMPLETED|Overall Study||0
5044727|NCT01991808|12413090|P1|COMPLETED|Overall Study||16
5044728|NCT01991808|12413090|P1|STARTED|Overall Study||16
5044729|NCT01991795|12413096|P2|NOT COMPLETED|Overall Study||123
5044730|NCT01991795|12413097|P1|NOT COMPLETED|Overall Study||149
5044731|NCT01991795|12413096|P2|COMPLETED|Overall Study||9503
5044732|NCT01991795|12413097|P1|COMPLETED|Overall Study||9496
5044733|NCT01991795|12413096|P2|STARTED|Overall Study||9626
5044734|NCT01991795|12413097|P1|STARTED|Overall Study||9645
5044735|NCT01991743|12413123|P4|NOT COMPLETED|Overall Study||0
5044736|NCT01991743|12413124|P3|NOT COMPLETED|Overall Study||1
5044737|NCT01991743|12413125|P2|NOT COMPLETED|Overall Study||0
5044738|NCT01991743|12413126|P1|NOT COMPLETED|Overall Study||0
5044739|NCT01991743|12413123|P4|COMPLETED|Overall Study||60
5044740|NCT01991743|12413124|P3|COMPLETED|Overall Study||59
5044741|NCT01991743|12413125|P2|COMPLETED|Overall Study||60
5044742|NCT01991743|12413126|P1|COMPLETED|Overall Study||60
5044743|NCT01991743|12413123|P4|STARTED|Overall Study||60
5044744|NCT01991743|12413124|P3|STARTED|Overall Study||60
5044745|NCT01991743|12413125|P2|STARTED|Overall Study||60
5044746|NCT01991743|12413126|P1|STARTED|Overall Study||60
5044747|NCT01991548|12413152|P1|NOT COMPLETED|Overall Study||1
5044748|NCT01991548|12413152|P1|COMPLETED|Overall Study||39
5044749|NCT01991548|12413152|P1|STARTED|Overall Study||40
5044750|NCT01991522|12413158|P2|NOT COMPLETED|Overall Study||0
5044751|NCT01991522|12413159|P1|NOT COMPLETED|Overall Study||0
5044752|NCT01991522|12413158|P2|COMPLETED|Overall Study||17
5044753|NCT01991522|12413159|P1|COMPLETED|Overall Study||16
5044754|NCT01991522|12413158|P2|STARTED|Overall Study||17
5044755|NCT01991522|12413159|P1|STARTED|Overall Study||16
5044756|NCT01991483|12413171|P4|NOT COMPLETED|Dose Level 1000 mg||1
5044757|NCT01991483|12413172|P3|NOT COMPLETED|Dose Level 1000 mg||0
5044758|NCT01991483|12413173|P2|NOT COMPLETED|Dose Level 1000 mg||0
5044759|NCT01991483|12413174|P1|NOT COMPLETED|Dose Level 1000 mg||0
5044760|NCT01991483|12413171|P4|COMPLETED|Dose Level 1000 mg||3
5044761|NCT01991483|12413172|P3|COMPLETED|Dose Level 1000 mg||0
5044762|NCT01991483|12413173|P2|COMPLETED|Dose Level 1000 mg||0
5044763|NCT01991483|12413174|P1|COMPLETED|Dose Level 1000 mg||0
5044764|NCT01991483|12413171|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
5044765|NCT01991483|12413172|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
5044766|NCT01991483|12413173|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
5044767|NCT01991483|12413174|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
5044768|NCT01991483|12413171|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
5044769|NCT01991483|12413172|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
5044770|NCT01991483|12413173|P2|STARTED|Dose Level 1000 mg||0
5044771|NCT01991483|12413174|P1|STARTED|Dose Level 1000 mg||0
5044772|NCT01991483|12413171|P4|NOT COMPLETED|Dose Level 600 mg||0
5044773|NCT01991483|12413172|P3|NOT COMPLETED|Dose Level 600 mg||2
5044774|NCT01991483|12413173|P2|NOT COMPLETED|Dose Level 600 mg||0
5044775|NCT01991483|12413174|P1|NOT COMPLETED|Dose Level 600 mg||0
5044776|NCT01991483|12413171|P4|COMPLETED|Dose Level 600 mg||0
5044777|NCT01991483|12413172|P3|COMPLETED|Dose Level 600 mg||9
5044778|NCT01991483|12413173|P2|COMPLETED|Dose Level 600 mg||0
5044779|NCT01991483|12413174|P1|COMPLETED|Dose Level 600 mg||0
5044780|NCT01991483|12413171|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
5044781|NCT01991483|12413172|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
5044782|NCT01991483|12413173|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
5044783|NCT01991483|12413174|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
5044784|NCT01991483|12413171|P4|STARTED|Dose Level 600 mg||0
5044785|NCT01991483|12413172|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
5044786|NCT01991483|12413173|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
5044787|NCT01991483|12413174|P1|STARTED|Dose Level 600 mg||0
5044788|NCT01991483|12413171|P4|NOT COMPLETED|Dose Level 300 mg||0
5044789|NCT01991483|12413172|P3|NOT COMPLETED|Dose Level 300 mg||0
5044790|NCT01991483|12413173|P2|NOT COMPLETED|Dose Level 300 mg||0
5044791|NCT01991483|12413174|P1|NOT COMPLETED|Dose Level 300 mg||0
5044792|NCT01991483|12413171|P4|COMPLETED|Dose Level 300 mg||0
5044793|NCT01991483|12413172|P3|COMPLETED|Dose Level 300 mg||0
5044794|NCT01991483|12413173|P2|COMPLETED|Dose Level 300 mg||6
5044795|NCT01991483|12413174|P1|COMPLETED|Dose Level 300 mg||0
5044796|NCT01991483|12413171|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
5044797|NCT01991483|12413172|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
5044798|NCT01991483|12413173|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
5044799|NCT01991483|12413174|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
5044800|NCT01991483|12413171|P4|STARTED|Dose Level 300 mg||0
5044801|NCT01991483|12413172|P3|STARTED|Dose Level 300 mg||0
5044802|NCT01991483|12413173|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
5044803|NCT01991483|12413174|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
5044804|NCT01991483|12413171|P4|NOT COMPLETED|Dose Level: Placebo||0
5044805|NCT01991483|12413172|P3|NOT COMPLETED|Dose Level: Placebo||0
5044806|NCT01991483|12413173|P2|NOT COMPLETED|Dose Level: Placebo||0
5044807|NCT01991483|12413174|P1|NOT COMPLETED|Dose Level: Placebo||0
5044808|NCT01991483|12413171|P4|COMPLETED|Dose Level: Placebo||0
5044809|NCT01991483|12413172|P3|COMPLETED|Dose Level: Placebo||0
5044810|NCT01991483|12413173|P2|COMPLETED|Dose Level: Placebo||0
5044811|NCT01991483|12413174|P1|COMPLETED|Dose Level: Placebo||7
5044812|NCT01991483|12413171|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
5044813|NCT01991483|12413172|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
5044814|NCT01991483|12413173|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
5044815|NCT01991483|12413174|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
5044816|NCT01991483|12413171|P4|STARTED|Dose Level: Placebo||0
5044817|NCT01991483|12413172|P3|STARTED|Dose Level: Placebo||0
5044818|NCT01991483|12413173|P2|STARTED|Dose Level: Placebo||0
5044819|NCT01991483|12413174|P1|STARTED|Dose Level: Placebo||7
5044820|NCT01991470|12413240|P1|NOT COMPLETED|Enlite 3 Period||12
5044821|NCT01991470|12413240|P1|COMPLETED|Enlite 3 Period||146
5044822|NCT01991470|12413240|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
5044823|NCT01991470|12413240|P1|NOT COMPLETED|Enlite 1 Period||20
5044824|NCT01991470|12413240|P1|COMPLETED|Enlite 1 Period||141
5044825|NCT01991470|12413240|P1|STARTED|Enlite 1 Period||161
5044826|NCT01991314|12413254|P2|NOT COMPLETED|Overall Study||11
5044827|NCT01991314|12413255|P1|NOT COMPLETED|Overall Study||11
5044828|NCT01991314|12413254|P2|COMPLETED|Overall Study||32
5044829|NCT01991314|12413255|P1|COMPLETED|Overall Study||34
5044830|NCT01991314|12413254|P2|STARTED|Overall Study||43
5044831|NCT01991314|12413255|P1|STARTED|Overall Study||45
5044832|NCT01991197|12413275|P2|NOT COMPLETED|Overall Study||3
5044833|NCT01991197|12413276|P1|NOT COMPLETED|Overall Study||3
5044834|NCT01991197|12413275|P2|COMPLETED|Overall Study||8
5044835|NCT01991197|12413276|P1|COMPLETED|Overall Study||6
5044836|NCT01991197|12413275|P2|STARTED|Overall Study||11
5044837|NCT01991197|12413276|P1|STARTED|Overall Study||9
5044838|NCT01991067|12413314|P2|NOT COMPLETED|Overall Study||5
5044839|NCT01991067|12413315|P1|NOT COMPLETED|Overall Study||6
5044840|NCT01991067|12413314|P2|COMPLETED|Overall Study||10
5044841|NCT01991067|12413315|P1|COMPLETED|Overall Study||13
5044842|NCT01991067|12413314|P2|STARTED|Overall Study||15
5044843|NCT01991067|12413315|P1|STARTED|Overall Study||19
5044844|NCT01990898|12413325|P1|NOT COMPLETED|Overall Study||4
5044845|NCT01990898|12413325|P1|COMPLETED|Overall Study||22
5044846|NCT01990898|12413325|P1|3 Months|Overall Study||22
5044847|NCT01990898|12413325|P1|STARTED|Overall Study||26
5044848|NCT01990859|12413329|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
5044849|NCT01990859|12413329|P1|COMPLETED|90 Day Follow Up for All Participants||20
5044850|NCT01990859|12413329|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
5044851|NCT01990859|12413329|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
5044852|NCT01990859|12413329|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
5044853|NCT01990859|12413329|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
5044854|NCT01990859|12413329|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
5044855|NCT01990859|12413329|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
5044856|NCT01990859|12413329|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
5044857|NCT01990820|12413342|P2|NOT COMPLETED|Overall Study||0
5044858|NCT01990820|12413343|P1|NOT COMPLETED|Overall Study||0
5044859|NCT01990820|12413342|P2|COMPLETED|Overall Study||12
5044860|NCT01990820|12413343|P1|COMPLETED|Overall Study||13
5044861|NCT01990820|12413342|P2|STARTED|Overall Study||12
5044862|NCT01990820|12413343|P1|STARTED|Overall Study||13
5044863|NCT01990794|12413349|P1|NOT COMPLETED|Overall Study||3
5044864|NCT01990794|12413349|P1|COMPLETED|Overall Study||10
5044865|NCT01990794|12413349|P1|One Month Into Study|Overall Study||10
5044866|NCT01990794|12413349|P1|STARTED|Overall Study||13
5044867|NCT01990768|12413464|P3|NOT COMPLETED|6-Month Follow-up||58
5044868|NCT01990768|12413465|P2|NOT COMPLETED|6-Month Follow-up||51
5044869|NCT01990768|12413466|P1|NOT COMPLETED|6-Month Follow-up||39
5044870|NCT01990768|12413464|P3|COMPLETED|6-Month Follow-up||288
5044871|NCT01990768|12413465|P2|COMPLETED|6-Month Follow-up||261
5044872|NCT01990768|12413466|P1|COMPLETED|6-Month Follow-up||270
5044873|NCT01990768|12413464|P3|STARTED|6-Month Follow-up||346
5044874|NCT01990768|12413465|P2|STARTED|6-Month Follow-up||312
5044875|NCT01990768|12413466|P1|STARTED|6-Month Follow-up||309
5044876|NCT01990768|12413464|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
5044877|NCT01990768|12413465|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
5044878|NCT01990768|12413466|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
5044879|NCT01990768|12413464|P3|COMPLETED|In-Hospital Study Drug Infusion||266
5044880|NCT01990768|12413465|P2|COMPLETED|In-Hospital Study Drug Infusion||229
5044881|NCT01990768|12413466|P1|COMPLETED|In-Hospital Study Drug Infusion||214
5044882|NCT01990768|12413464|P3|STARTED|In-Hospital Study Drug Infusion||346
5044883|NCT01990768|12413465|P2|STARTED|In-Hospital Study Drug Infusion||312
5044884|NCT01990768|12413466|P1|STARTED|In-Hospital Study Drug Infusion||309
5044885|NCT01990768|12413464|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
5044886|NCT01990768|12413465|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
5044887|NCT01990768|12413466|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
5044888|NCT01990768|12413464|P3|COMPLETED|Prehospital Study Drug Infusion||327
5044889|NCT01990768|12413465|P2|COMPLETED|Prehospital Study Drug Infusion||285
5044890|NCT01990768|12413466|P1|COMPLETED|Prehospital Study Drug Infusion||290
5044891|NCT01990768|12413464|P3|STARTED|Prehospital Study Drug Infusion||346
5044892|NCT01990768|12413465|P2|STARTED|Prehospital Study Drug Infusion||312
5044893|NCT01990768|12413466|P1|STARTED|Prehospital Study Drug Infusion||309
5044894|NCT01990768|12413464|P3|NOT COMPLETED|Intervention Started||27
5044895|NCT01990768|12413465|P2|NOT COMPLETED|Intervention Started||33
5044896|NCT01990768|12413466|P1|NOT COMPLETED|Intervention Started||36
5044897|NCT01990768|12413464|P3|COMPLETED|Intervention Started||346
5044898|NCT01990768|12413465|P2|COMPLETED|Intervention Started||312
5044899|NCT01990768|12413466|P1|COMPLETED|Intervention Started||309
5044900|NCT01990768|12413464|P3|STARTED|Intervention Started||373
5044901|NCT01990768|12413465|P2|STARTED|Intervention Started||345
5044902|NCT01990768|12413466|P1|STARTED|Intervention Started||345
5044903|NCT01990742|12413531|P2|NOT COMPLETED|Overall Study||1353
5044904|NCT01990742|12413532|P1|NOT COMPLETED|Overall Study||407
5044905|NCT01990742|12413531|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
5044906|NCT01990742|12413532|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
5044907|NCT01990742|12413531|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
5044908|NCT01990742|12413532|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
5044909|NCT01990703|12413544|P2|NOT COMPLETED|Overall Study||45
5044910|NCT01990703|12413545|P1|NOT COMPLETED|Overall Study||39
5044911|NCT01990703|12413544|P2|COMPLETED|Overall Study||93
5044912|NCT01990703|12413545|P1|COMPLETED|Overall Study||108
5044913|NCT01990703|12413544|P2|STARTED|Overall Study||138
5044914|NCT01990703|12413545|P1|STARTED|Overall Study||147
5044915|NCT01990677|12413555|P2|NOT COMPLETED|Overall Study||1
5044916|NCT01990677|12413556|P1|NOT COMPLETED|Overall Study||2
5044917|NCT01990677|12413555|P2|COMPLETED|Overall Study||5
5044918|NCT01990677|12413556|P1|COMPLETED|Overall Study||10
5044919|NCT01990677|12413555|P2|STARTED|Overall Study||6
5044920|NCT01990677|12413556|P1|STARTED|Overall Study||12
5044921|NCT01990664|12413568|P2|NOT COMPLETED|Overall Study||11
5044922|NCT01990664|12413569|P1|NOT COMPLETED|Overall Study||7
5044923|NCT01990664|12413568|P2|COMPLETED|Overall Study||79
5044924|NCT01990664|12413569|P1|COMPLETED|Overall Study||95
5044925|NCT01990664|12413568|P2|STARTED|Overall Study||90
5044926|NCT01990664|12413569|P1|STARTED|Overall Study||102
5044927|NCT01990612|12413577|P2|NOT COMPLETED|Overall Study||3
5044928|NCT01990612|12413578|P1|NOT COMPLETED|Overall Study||7
5044929|NCT01990612|12413577|P2|COMPLETED|Overall Study||3059
5044930|NCT01990612|12413578|P1|COMPLETED|Overall Study||3037
5044931|NCT01990612|12413577|P2|STARTED|Overall Study||3062
5044932|NCT01990612|12413578|P1|STARTED|Overall Study||3044
5044933|NCT01990573|12413659|P3|NOT COMPLETED|Overall Study||1
5044934|NCT01990573|12413660|P2|NOT COMPLETED|Overall Study||0
5044935|NCT01990573|12413661|P1|NOT COMPLETED|Overall Study||0
5044936|NCT01990573|12413659|P3|COMPLETED|Overall Study||16
5044937|NCT01990573|12413660|P2|COMPLETED|Overall Study||14
5044938|NCT01990573|12413661|P1|COMPLETED|Overall Study||20
5044939|NCT01990573|12413659|P3|STARTED|Overall Study||17
5044940|NCT01990573|12413660|P2|STARTED|Overall Study||14
5044941|NCT01990573|12413661|P1|STARTED|Overall Study||20
5044942|NCT01990560|12413674|P1|NOT COMPLETED|Overall Study||1
5044943|NCT01990560|12413674|P1|COMPLETED|Overall Study||7
5044944|NCT01990560|12413674|P1|STARTED|Overall Study||8
5044945|NCT01990534|12413688|P1|NOT COMPLETED|Overall Study||60
5044946|NCT01990534|12413688|P1|COMPLETED|Overall Study||0
5044947|NCT01990534|12413688|P1|Ongoing|Overall Study||36
5044948|NCT01990534|12413688|P1|STARTED|Overall Study||60
5044949|NCT01990339|12413704|P1|NOT COMPLETED|Overall Study||2312
5044950|NCT01990339|12413704|P1|COMPLETED|Overall Study||12653
5044951|NCT01990339|12413704|P1|STARTED|Overall Study||14965
5044952|NCT01990313|12413709|P1|NOT COMPLETED|Overall Study||1
5044953|NCT01990313|12413709|P1|COMPLETED|Overall Study||14
5044954|NCT01990313|12413709|P1|STARTED|Overall Study||15
5044955|NCT01990300|12413714|P1|NOT COMPLETED|Overall Study||142
5044956|NCT01990300|12413714|P1|COMPLETED|Overall Study||3139
5044957|NCT01990300|12413714|P1|STARTED|Overall Study||3281
5044958|NCT01990261|12413720|P1|NOT COMPLETED|Overall Study||25
5044959|NCT01990261|12413720|P1|COMPLETED|Overall Study||8
5044960|NCT01990261|12413720|P1|Treated|Overall Study||29
5044961|NCT01990261|12413720|P1|STARTED|Overall Study||33
5044962|NCT01989975|12413730|P1|NOT COMPLETED|Overall Study||0
5044963|NCT01989975|12413730|P1|COMPLETED|Overall Study||40
5044964|NCT01989975|12413730|P1|STARTED|Overall Study||40
5044965|NCT01989910|12413739|P2|NOT COMPLETED|Overall Study||0
5044966|NCT01989910|12413740|P1|NOT COMPLETED|Overall Study||2
5044967|NCT01989910|12413739|P2|COMPLETED|Overall Study||54
5044968|NCT01989910|12413740|P1|COMPLETED|Overall Study||51
5044969|NCT01989910|12413739|P2|STARTED|Overall Study||54
5044970|NCT01989910|12413740|P1|STARTED|Overall Study||53
5044971|NCT01989793|12413752|P2|NOT COMPLETED|Overall Study||4
5044972|NCT01989793|12413753|P1|NOT COMPLETED|Overall Study||8
5044973|NCT01989793|12413752|P2|COMPLETED|Overall Study||15
5044974|NCT01989793|12413753|P1|COMPLETED|Overall Study||10
5044975|NCT01989793|12413752|P2|STARTED|Overall Study||19
5044976|NCT01989793|12413753|P1|STARTED|Overall Study||18
5044977|NCT01989754|12413777|P2|NOT COMPLETED|Overall Study||35
5044978|NCT01989754|12413778|P1|NOT COMPLETED|Overall Study||39
5044979|NCT01989754|12413777|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
5044980|NCT01989754|12413778|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
5044981|NCT01989754|12413777|P2|Treated|Overall Study||2904
5044982|NCT01989754|12413778|P1|Treated|Overall Study||2903
5044983|NCT01989754|12413777|P2|STARTED|Overall Study||2907
5044984|NCT01989754|12413778|P1|STARTED|Overall Study||2905
5044985|NCT01989689|12413790|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
5044986|NCT01989689|12413791|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
5044987|NCT01989689|12413790|P2|COMPLETED|Treatment Period ( 3 Months)||10
5044988|NCT01989689|12413791|P1|COMPLETED|Treatment Period ( 3 Months)||11
5044989|NCT01989689|12413790|P2|STARTED|Treatment Period ( 3 Months)||10
5044990|NCT01989689|12413791|P1|STARTED|Treatment Period ( 3 Months)||11
5044991|NCT01989689|12413790|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
5044992|NCT01989689|12413791|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
5044993|NCT01989689|12413790|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
5044994|NCT01989689|12413791|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
5044995|NCT01989689|12413790|P2|STARTED|Treatment Period 1 ( 3 Months)||13
5044996|NCT01989689|12413791|P1|STARTED|Treatment Period 1 ( 3 Months)||11
5044997|NCT01989689|12413790|P2|NOT COMPLETED|Baseline||0
5044998|NCT01989689|12413791|P1|NOT COMPLETED|Baseline||0
5044999|NCT01989689|12413790|P2|COMPLETED|Baseline||13
5045000|NCT01989689|12413791|P1|COMPLETED|Baseline||11
5045001|NCT01989689|12413790|P2|STARTED|Baseline||13
5045002|NCT01989689|12413791|P1|STARTED|Baseline||11
5045003|NCT01989676|12413803|P2|NOT COMPLETED|Overall Study||347
5045004|NCT01989676|12413804|P1|NOT COMPLETED|Overall Study||338
5045005|NCT01989676|12413803|P2|COMPLETED|Overall Study||6
5045006|NCT01989676|12413804|P1|COMPLETED|Overall Study||11
5045007|NCT01989676|12413803|P2|STARTED|Overall Study|Treated (355 randomized)|353
5045008|NCT01989676|12413804|P1|STARTED|Overall Study|Treated (352 randomized)|349
5045009|NCT01989572|12413830|P6|NOT COMPLETED|Overall Study||110
5045010|NCT01989572|12413831|P5|NOT COMPLETED|Overall Study||98
5045011|NCT01989572|12413832|P4|NOT COMPLETED|Overall Study||51
5045012|NCT01989572|12413833|P3|NOT COMPLETED|Overall Study||62
5045013|NCT01989572|12413834|P2|NOT COMPLETED|Overall Study||58
5045014|NCT01989572|12413835|P1|NOT COMPLETED|Overall Study||55
5045015|NCT01989572|12413830|P6|COMPLETED|Overall Study||79
5045016|NCT01989572|12413831|P5|COMPLETED|Overall Study||92
5045017|NCT01989572|12413832|P4|COMPLETED|Overall Study||56
5045018|NCT01989572|12413833|P3|COMPLETED|Overall Study||47
5045019|NCT01989572|12413834|P2|COMPLETED|Overall Study||53
5045020|NCT01989572|12413835|P1|COMPLETED|Overall Study||54
5045021|NCT01989572|12413830|P6|Treated|Overall Study||171
5045022|NCT01989572|12413831|P5|Treated|Overall Study||186
5045023|NCT01989572|12413832|P4|Treated|Overall Study||104
5045024|NCT01989572|12413833|P3|Treated|Overall Study||107
5045025|NCT01989572|12413834|P2|Treated|Overall Study||110
5045026|NCT01989572|12413835|P1|Treated|Overall Study||104
5045027|NCT01989572|12413830|P6|STARTED|Overall Study||189
5045028|NCT01989572|12413831|P5|STARTED|Overall Study||190
5045029|NCT01989572|12413832|P4|STARTED|Overall Study||107
5045030|NCT01989572|12413833|P3|STARTED|Overall Study||109
5045031|NCT01989572|12413834|P2|STARTED|Overall Study||111
5045032|NCT01989572|12413835|P1|STARTED|Overall Study||109
5045033|NCT01989468|12413866|P5|NOT COMPLETED|Overall Study||8
5045034|NCT01989468|12413867|P4|NOT COMPLETED|Overall Study||16
5045035|NCT01989468|12413868|P3|NOT COMPLETED|Overall Study||19
5045036|NCT01989468|12413869|P2|NOT COMPLETED|Overall Study||37
5045037|NCT01989468|12413870|P1|NOT COMPLETED|Overall Study||47
5045038|NCT01989468|12413866|P5|COMPLETED|Overall Study||0
5045039|NCT01989468|12413867|P4|COMPLETED|Overall Study||49
5045040|NCT01989468|12413868|P3|COMPLETED|Overall Study||45
5045041|NCT01989468|12413869|P2|COMPLETED|Overall Study||102
5045042|NCT01989468|12413870|P1|COMPLETED|Overall Study||91
5045043|NCT01989468|12413866|P5|STARTED|Overall Study||8
5045044|NCT01989468|12413867|P4|STARTED|Overall Study||65
5045045|NCT01989468|12413868|P3|STARTED|Overall Study||64
5045046|NCT01989468|12413869|P2|STARTED|Overall Study||139
5045047|NCT01989468|12413870|P1|STARTED|Overall Study||138
5045048|NCT01989455|12413912|P5|NOT COMPLETED|Overall Study||1
5045049|NCT01989455|12413913|P4|NOT COMPLETED|Overall Study||0
5045050|NCT01989455|12413914|P3|NOT COMPLETED|Overall Study||1
5045051|NCT01989455|12413915|P2|NOT COMPLETED|Overall Study||2
5045052|NCT01989455|12413916|P1|NOT COMPLETED|Overall Study||0
5045053|NCT01989455|12413912|P5|COMPLETED|Overall Study||7
5045054|NCT01989455|12413913|P4|COMPLETED|Overall Study||14
5045055|NCT01989455|12413914|P3|COMPLETED|Overall Study||13
5045056|NCT01989455|12413915|P2|COMPLETED|Overall Study||12
5045057|NCT01989455|12413916|P1|COMPLETED|Overall Study||14
5045058|NCT01989455|12413912|P5|STARTED|Overall Study||8
5045059|NCT01989455|12413913|P4|STARTED|Overall Study||14
5045060|NCT01989455|12413914|P3|STARTED|Overall Study||14
5045061|NCT01989455|12413915|P2|STARTED|Overall Study||14
5045062|NCT01989455|12413916|P1|STARTED|Overall Study||14
5045063|NCT01989208|12413952|P2|NOT COMPLETED|800 mg (7 Days)||0
5045064|NCT01989208|12413953|P1|NOT COMPLETED|800 mg (7 Days)||0
5045065|NCT01989208|12413952|P2|COMPLETED|800 mg (7 Days)||11
5045066|NCT01989208|12413953|P1|COMPLETED|800 mg (7 Days)||4
5045067|NCT01989208|12413952|P2|STARTED|800 mg (7 Days)||11
5045068|NCT01989208|12413953|P1|STARTED|800 mg (7 Days)||4
5045069|NCT01989208|12413952|P2|NOT COMPLETED|400 mg (7 Days)||0
5045070|NCT01989208|12413953|P1|NOT COMPLETED|400 mg (7 Days)||0
5045071|NCT01989208|12413952|P2|COMPLETED|400 mg (7 Days)||11
5045072|NCT01989208|12413953|P1|COMPLETED|400 mg (7 Days)||4
5045073|NCT01989208|12413952|P2|STARTED|400 mg (7 Days)||11
5045074|NCT01989208|12413953|P1|STARTED|400 mg (7 Days)||4
5045075|NCT01989208|12413952|P2|NOT COMPLETED|200 mg (7 Days)||1
5045076|NCT01989208|12413953|P1|NOT COMPLETED|200 mg (7 Days)||0
5045077|NCT01989208|12413952|P2|COMPLETED|200 mg (7 Days)||11
5045078|NCT01989208|12413953|P1|COMPLETED|200 mg (7 Days)||4
5045079|NCT01989208|12413952|P2|STARTED|200 mg (7 Days)||12
5045080|NCT01989208|12413953|P1|STARTED|200 mg (7 Days)||4
5045081|NCT01989195|12413971|P1|NOT COMPLETED|Overall Study||0
5045082|NCT01989195|12413971|P1|COMPLETED|Overall Study||6
5045083|NCT01989195|12413971|P1|STARTED|Overall Study||6
5045084|NCT01989169|12413981|P2|NOT COMPLETED|Period 2||1
5045085|NCT01989169|12413982|P1|NOT COMPLETED|Period 2||0
5045086|NCT01989169|12413981|P2|COMPLETED|Period 2||14
5045087|NCT01989169|12413982|P1|COMPLETED|Period 2||15
5045088|NCT01989169|12413981|P2|STARTED|Period 2||15
5045089|NCT01989169|12413982|P1|STARTED|Period 2||15
5045090|NCT01989169|12413981|P2|NOT COMPLETED|Period 1||0
5045091|NCT01989169|12413982|P1|NOT COMPLETED|Period 1||0
5045092|NCT01989169|12413981|P2|COMPLETED|Period 1||15
5045093|NCT01989169|12413982|P1|COMPLETED|Period 1||15
5045094|NCT01989169|12413981|P2|STARTED|Period 1||15
5045095|NCT01989169|12413982|P1|STARTED|Period 1||15
5045096|NCT01989156|12413995|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
5045097|NCT01989156|12413996|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
5045098|NCT01989156|12413997|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
5045099|NCT01989156|12413995|P3|COMPLETED|End of Study (Population at Day 90)||31
5045100|NCT01989156|12413996|P2|COMPLETED|End of Study (Population at Day 90)||35
5045101|NCT01989156|12413997|P1|COMPLETED|End of Study (Population at Day 90)||73
5045102|NCT01989156|12413995|P3|STARTED|End of Study (Population at Day 90)||34
5045103|NCT01989156|12413996|P2|STARTED|End of Study (Population at Day 90)||40
5045104|NCT01989156|12413997|P1|STARTED|End of Study (Population at Day 90)||80
5045105|NCT01989156|12413995|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
5045106|NCT01989156|12413996|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
5045107|NCT01989156|12413997|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
5045108|NCT01989156|12413995|P3|COMPLETED|Confinement Period (Population at Day 5)||34
5045109|NCT01989156|12413996|P2|COMPLETED|Confinement Period (Population at Day 5)||40
5045110|NCT01989156|12413997|P1|COMPLETED|Confinement Period (Population at Day 5)||80
5045111|NCT01989156|12413995|P3|STARTED|Confinement Period (Population at Day 5)||39
5045112|NCT01989156|12413996|P2|STARTED|Confinement Period (Population at Day 5)||41
5045113|NCT01989156|12413997|P1|STARTED|Confinement Period (Population at Day 5)||80
5045114|NCT01989130|12414019|P2|NOT COMPLETED|Overall Study||0
5045115|NCT01989130|12414020|P1|NOT COMPLETED|Overall Study||0
5045116|NCT01989130|12414019|P2|COMPLETED|Overall Study||27
5045117|NCT01989130|12414020|P1|COMPLETED|Overall Study||43
5045118|NCT01989130|12414019|P2|STARTED|Overall Study||27
5045119|NCT01989130|12414020|P1|STARTED|Overall Study||43
5045120|NCT01988922|12414035|P3|NOT COMPLETED|Overall Study||0
5045121|NCT01988922|12414036|P2|NOT COMPLETED|Overall Study||0
5045122|NCT01988922|12414037|P1|NOT COMPLETED|Overall Study||0
5045123|NCT01988922|12414035|P3|COMPLETED|Overall Study||10
5045124|NCT01988922|12414036|P2|COMPLETED|Overall Study||10
5045125|NCT01988922|12414037|P1|COMPLETED|Overall Study||10
5045126|NCT01988922|12414035|P3|STARTED|Overall Study||10
5045127|NCT01988922|12414036|P2|STARTED|Overall Study||10
5045128|NCT01988922|12414037|P1|STARTED|Overall Study||10
5045129|NCT01988857|12414048|P1|NOT COMPLETED|Overall Study||0
5045130|NCT01988857|12414048|P1|COMPLETED|Overall Study||300
5045131|NCT01988857|12414048|P1|STARTED|Overall Study||300
5045132|NCT01988779|12414057|P2|NOT COMPLETED|Overall Study||2
5045133|NCT01988779|12414058|P1|NOT COMPLETED|Overall Study||3
5045134|NCT01988779|12414057|P2|COMPLETED|Overall Study||11
5045135|NCT01988779|12414058|P1|COMPLETED|Overall Study||9
5045136|NCT01988779|12414057|P2|STARTED|Overall Study||13
5045137|NCT01988779|12414058|P1|STARTED|Overall Study||12
5045138|NCT01988662|12414074|P2|NOT COMPLETED|Overall Study||2
5045139|NCT01988662|12414075|P1|NOT COMPLETED|Overall Study||4
5045140|NCT01988662|12414074|P2|COMPLETED|Overall Study||99
5045141|NCT01988662|12414075|P1|COMPLETED|Overall Study||100
5045142|NCT01988662|12414074|P2|STARTED|Overall Study||101
5045143|NCT01988662|12414075|P1|STARTED|Overall Study||104
5045144|NCT01988493|12414097|P5|NOT COMPLETED|Overall Study||1
5045145|NCT01988493|12414098|P4|NOT COMPLETED|Overall Study||2
5045146|NCT01988493|12414099|P3|NOT COMPLETED|Overall Study||0
5045147|NCT01988493|12414100|P2|NOT COMPLETED|Overall Study||0
5045148|NCT01988493|12414101|P1|NOT COMPLETED|Overall Study||0
5045149|NCT01988493|12414097|P5|COMPLETED|Overall Study||44
5045150|NCT01988493|12414098|P4|COMPLETED|Overall Study||43
5045151|NCT01988493|12414099|P3|COMPLETED|Overall Study||6
5045152|NCT01988493|12414100|P2|COMPLETED|Overall Study||14
5045153|NCT01988493|12414101|P1|COMPLETED|Overall Study||7
5045154|NCT01988493|12414097|P5|Safety Population|Overall Study||44
5045155|NCT01988493|12414098|P4|Safety Population|Overall Study||45
5045156|NCT01988493|12414099|P3|Safety Population|Overall Study||6
5045157|NCT01988493|12414100|P2|Safety Population|Overall Study||14
5045158|NCT01988493|12414101|P1|Safety Population|Overall Study||7
5045159|NCT01988493|12414097|P5|Treated|Overall Study||44
5045160|NCT01988493|12414098|P4|Treated|Overall Study||45
5045161|NCT01988493|12414099|P3|Treated|Overall Study||6
5045162|NCT01988493|12414100|P2|Treated|Overall Study||14
5045163|NCT01988493|12414101|P1|Treated|Overall Study||7
5045164|NCT01988493|12414097|P5|STARTED|Overall Study||45
5045165|NCT01988493|12414098|P4|STARTED|Overall Study||45
5045166|NCT01988493|12414099|P3|STARTED|Overall Study||6
5045167|NCT01988493|12414100|P2|STARTED|Overall Study||14
5045168|NCT01988493|12414101|P1|STARTED|Overall Study||7
5045169|NCT01988415|12414170|P1|NOT COMPLETED|Overall Study||0
5045170|NCT01988415|12414170|P1|COMPLETED|Overall Study||26
5045171|NCT01988415|12414170|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
5045172|NCT01988402|12414180|P2|NOT COMPLETED|Overall Study||2
5045173|NCT01988402|12414181|P1|NOT COMPLETED|Overall Study||2
5045174|NCT01988402|12414180|P2|COMPLETED|Overall Study||17
5045175|NCT01988402|12414181|P1|COMPLETED|Overall Study||14
5045176|NCT01988402|12414180|P2|STARTED|Overall Study||19
5045177|NCT01988402|12414181|P1|STARTED|Overall Study||16
5045178|NCT01988376|12414195|P2|NOT COMPLETED|Overall Study||0
5045179|NCT01988376|12414196|P1|NOT COMPLETED|Overall Study||0
5045180|NCT01988376|12414195|P2|COMPLETED|Overall Study||129
5045181|NCT01988376|12414196|P1|COMPLETED|Overall Study||129
5045182|NCT01988376|12414195|P2|STARTED|Overall Study||129
5045183|NCT01988376|12414196|P1|STARTED|Overall Study||129
5045184|NCT01988246|12414204|P2|NOT COMPLETED|Overall Study||0
5045185|NCT01988246|12414205|P1|NOT COMPLETED|Overall Study||1
5045186|NCT01988246|12414204|P2|COMPLETED|Overall Study||15
5045187|NCT01988246|12414205|P1|COMPLETED|Overall Study||14
5045188|NCT01988246|12414204|P2|STARTED|Overall Study||15
5045189|NCT01988246|12414205|P1|STARTED|Overall Study||15
5045190|NCT01988129|12414217|P2|NOT COMPLETED|Overall Study||0
5045191|NCT01988129|12414218|P1|NOT COMPLETED|Overall Study||0
5045192|NCT01988129|12414217|P2|COMPLETED|Overall Study||588
5045193|NCT01988129|12414218|P1|COMPLETED|Overall Study||601
5045194|NCT01988129|12414217|P2|Completed 1-year Follow-up Survey|Overall Study||4
5045195|NCT01988129|12414218|P1|Completed 1-year Follow-up Survey|Overall Study||100
5045196|NCT01988129|12414217|P2|Screened for Sleep Disorders|Overall Study||15
5045197|NCT01988129|12414218|P1|Screened for Sleep Disorders|Overall Study||416
5045198|NCT01988129|12414217|P2|Attended Education Session|Overall Study||18
5045199|NCT01988129|12414218|P1|Attended Education Session|Overall Study||542
5045200|NCT01988129|12414217|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
5045201|NCT01988129|12414218|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
5045202|NCT01988103|12414248|P5|NOT COMPLETED|Observational Follow-up Phase||0
5045203|NCT01988103|12414249|P4|NOT COMPLETED|Observational Follow-up Phase||0
5045204|NCT01988103|12414250|P3|NOT COMPLETED|Observational Follow-up Phase||1
5045205|NCT01988103|12414251|P2|NOT COMPLETED|Observational Follow-up Phase||3
5045206|NCT01988103|12414252|P1|NOT COMPLETED|Observational Follow-up Phase||0
5045207|NCT01988103|12414248|P5|COMPLETED|Observational Follow-up Phase||33
5045208|NCT01988103|12414249|P4|COMPLETED|Observational Follow-up Phase||36
5045209|NCT01988103|12414250|P3|COMPLETED|Observational Follow-up Phase||82
5045210|NCT01988103|12414251|P2|COMPLETED|Observational Follow-up Phase||79
5045211|NCT01988103|12414252|P1|COMPLETED|Observational Follow-up Phase||12
5045212|NCT01988103|12414248|P5|STARTED|Observational Follow-up Phase||33
5045213|NCT01988103|12414249|P4|STARTED|Observational Follow-up Phase||36
5045214|NCT01988103|12414250|P3|STARTED|Observational Follow-up Phase||83
5045215|NCT01988103|12414251|P2|STARTED|Observational Follow-up Phase||82
5045216|NCT01988103|12414252|P1|STARTED|Observational Follow-up Phase||12
5045217|NCT01988103|12414248|P5|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
5045218|NCT01988103|12414249|P4|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
5045219|NCT01988103|12414250|P3|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
5045220|NCT01988103|12414251|P2|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
5045221|NCT01988103|12414252|P1|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
5045222|NCT01988103|12414248|P5|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
5045223|NCT01988103|12414249|P4|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
5045224|NCT01988103|12414250|P3|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
5045225|NCT01988103|12414251|P2|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
5045226|NCT01988103|12414252|P1|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
5045227|NCT01988103|12414248|P5|STARTED|Active Treatment Phase (Weeks 16-68)||35
5045228|NCT01988103|12414249|P4|STARTED|Active Treatment Phase (Weeks 16-68)||36
5045229|NCT01988103|12414250|P3|STARTED|Active Treatment Phase (Weeks 16-68)||76
5045230|NCT01988103|12414251|P2|STARTED|Active Treatment Phase (Weeks 16-68)||69
5045231|NCT01988103|12414252|P1|STARTED|Active Treatment Phase (Weeks 16-68)||0
5045232|NCT01988103|12414248|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
5045233|NCT01988103|12414249|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
5045234|NCT01988103|12414250|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
5045235|NCT01988103|12414251|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
5045236|NCT01988103|12414252|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
5045237|NCT01988103|12414248|P5|COMPLETED|Placebo-Controlled Phase Week 0-16||0
5045238|NCT01988103|12414249|P4|COMPLETED|Placebo-Controlled Phase Week 0-16||0
5045239|NCT01988103|12414250|P3|COMPLETED|Placebo-Controlled Phase Week 0-16||76
5045240|NCT01988103|12414251|P2|COMPLETED|Placebo-Controlled Phase Week 0-16||69
5045241|NCT01988103|12414252|P1|COMPLETED|Placebo-Controlled Phase Week 0-16||72
5045242|NCT01988103|12414248|P5|STARTED|Placebo-Controlled Phase Week 0-16||0
5045243|NCT01988103|12414249|P4|STARTED|Placebo-Controlled Phase Week 0-16||0
5045244|NCT01988103|12414250|P3|STARTED|Placebo-Controlled Phase Week 0-16||85
5045245|NCT01988103|12414251|P2|STARTED|Placebo-Controlled Phase Week 0-16||85
5045246|NCT01988103|12414252|P1|STARTED|Placebo-Controlled Phase Week 0-16||84
5045247|NCT01988090|12414299|P2|NOT COMPLETED|Complete Study After Start||1
5045248|NCT01988090|12414300|P1|NOT COMPLETED|Complete Study After Start||3
5045249|NCT01988090|12414299|P2|COMPLETED|Complete Study After Start||42
5045250|NCT01988090|12414300|P1|COMPLETED|Complete Study After Start||41
5045251|NCT01988090|12414299|P2|STARTED|Complete Study After Start||43
5045252|NCT01988090|12414300|P1|STARTED|Complete Study After Start||44
5045253|NCT01988090|12414299|P2|NOT COMPLETED|Start Treament After Randomization||4
5045254|NCT01988090|12414300|P1|NOT COMPLETED|Start Treament After Randomization||2
5045255|NCT01988090|12414299|P2|COMPLETED|Start Treament After Randomization||43
5045256|NCT01988090|12414300|P1|COMPLETED|Start Treament After Randomization||44
5045257|NCT01988090|12414299|P2|STARTED|Start Treament After Randomization||47
5045258|NCT01988090|12414300|P1|STARTED|Start Treament After Randomization||46
5045259|NCT01988012|12414310|P1|NOT COMPLETED|Overall Study||15
5045260|NCT01988012|12414310|P1|COMPLETED|Overall Study||85
5045261|NCT01988012|12414310|P1|STARTED|Overall Study||100
5045262|NCT01987986|12414336|P4|NOT COMPLETED|Overall Study||0
5045263|NCT01987986|12414337|P3|NOT COMPLETED|Overall Study||2
5045264|NCT01987986|12414338|P2|NOT COMPLETED|Overall Study||0
5045265|NCT01987986|12414339|P1|NOT COMPLETED|Overall Study||2
5045266|NCT01987986|12414336|P4|COMPLETED|Overall Study||24
5045267|NCT01987986|12414337|P3|COMPLETED|Overall Study||38
5045268|NCT01987986|12414338|P2|COMPLETED|Overall Study||43
5045269|NCT01987986|12414339|P1|COMPLETED|Overall Study||41
5045270|NCT01987986|12414336|P4|STARTED|Overall Study||24
5045271|NCT01987986|12414337|P3|STARTED|Overall Study||40
5045272|NCT01987986|12414338|P2|STARTED|Overall Study||43
5045273|NCT01987986|12414339|P1|STARTED|Overall Study||43
5045274|NCT01987960|12414379|P4|NOT COMPLETED|Period 3||71
5045275|NCT01987960|12414380|P3|NOT COMPLETED|Period 3||0
5045276|NCT01987960|12414381|P2|NOT COMPLETED|Period 3||0
5045277|NCT01987960|12414382|P1|NOT COMPLETED|Period 3||0
5045278|NCT01987960|12414379|P4|COMPLETED|Period 3||119
5045279|NCT01987960|12414380|P3|COMPLETED|Period 3||0
5045280|NCT01987960|12414381|P2|COMPLETED|Period 3||0
5045281|NCT01987960|12414382|P1|COMPLETED|Period 3||0
5045282|NCT01987960|12414379|P4|STARTED|Period 3||190
5045283|NCT01987960|12414380|P3|STARTED|Period 3||0
5045284|NCT01987960|12414381|P2|STARTED|Period 3||0
5045285|NCT01987960|12414382|P1|STARTED|Period 3||0
5045286|NCT01987960|12414379|P4|NOT COMPLETED|Period 2||0
5045287|NCT01987960|12414380|P3|NOT COMPLETED|Period 2||9
5045288|NCT01987960|12414381|P2|NOT COMPLETED|Period 2||5
5045289|NCT01987960|12414382|P1|NOT COMPLETED|Period 2||0
5045290|NCT01987960|12414379|P4|COMPLETED|Period 2||0
5045291|NCT01987960|12414380|P3|COMPLETED|Period 2||14
5045292|NCT01987960|12414381|P2|COMPLETED|Period 2||12
5045293|NCT01987960|12414382|P1|COMPLETED|Period 2||0
5045294|NCT01987960|12414379|P4|STARTED|Period 2||0
5045295|NCT01987960|12414380|P3|STARTED|Period 2||23
5045296|NCT01987960|12414381|P2|STARTED|Period 2||17
5045297|NCT01987960|12414382|P1|STARTED|Period 2||0
5045298|NCT01987960|12414379|P4|NOT COMPLETED|Period 1||0
5045299|NCT01987960|12414380|P3|NOT COMPLETED|Period 1||0
5045300|NCT01987960|12414381|P2|NOT COMPLETED|Period 1||0
5045301|NCT01987960|12414382|P1|NOT COMPLETED|Period 1||186
5045302|NCT01987960|12414379|P4|COMPLETED|Period 1||0
5045303|NCT01987960|12414380|P3|COMPLETED|Period 1||0
5045304|NCT01987960|12414381|P2|COMPLETED|Period 1||0
5045305|NCT01987960|12414382|P1|COMPLETED|Period 1||231
5045306|NCT01987960|12414379|P4|STARTED|Period 1||0
5045307|NCT01987960|12414380|P3|STARTED|Period 1||0
5045308|NCT01987960|12414381|P2|STARTED|Period 1||0
5045309|NCT01987960|12414382|P1|STARTED|Period 1||417
5045310|NCT01987908|12414394|P3|NOT COMPLETED|Post-Treatment Observation Period||0
5045311|NCT01987908|12414395|P2|NOT COMPLETED|Post-Treatment Observation Period||3
5045312|NCT01987908|12414396|P1|NOT COMPLETED|Post-Treatment Observation Period||0
5045313|NCT01987908|12414394|P3|COMPLETED|Post-Treatment Observation Period||2
5045314|NCT01987908|12414395|P2|COMPLETED|Post-Treatment Observation Period||7
5045315|NCT01987908|12414396|P1|COMPLETED|Post-Treatment Observation Period||0
5045316|NCT01987908|12414394|P3|STARTED|Post-Treatment Observation Period||2
5045317|NCT01987908|12414395|P2|STARTED|Post-Treatment Observation Period||10
5045318|NCT01987908|12414396|P1|STARTED|Post-Treatment Observation Period||0
5045319|NCT01987908|12414394|P3|NOT COMPLETED|Treatment Period||1
5045320|NCT01987908|12414395|P2|NOT COMPLETED|Treatment Period||1
5045321|NCT01987908|12414396|P1|NOT COMPLETED|Treatment Period||0
5045322|NCT01987908|12414394|P3|COMPLETED|Treatment Period||2
5045323|NCT01987908|12414395|P2|COMPLETED|Treatment Period||10
5045324|NCT01987908|12414396|P1|COMPLETED|Treatment Period||0
5045325|NCT01987908|12414394|P3|STARTED|Treatment Period||3
5045326|NCT01987908|12414395|P2|STARTED|Treatment Period||11
5045327|NCT01987908|12414396|P1|STARTED|Treatment Period||0
5045328|NCT01987908|12414394|P3|NOT COMPLETED|Placebo Lead-in Period||0
5045329|NCT01987908|12414395|P2|NOT COMPLETED|Placebo Lead-in Period||0
5045330|NCT01987908|12414396|P1|NOT COMPLETED|Placebo Lead-in Period||9
5045331|NCT01987908|12414394|P3|COMPLETED|Placebo Lead-in Period||0
5045332|NCT01987908|12414395|P2|COMPLETED|Placebo Lead-in Period||0
5045333|NCT01987908|12414396|P1|COMPLETED|Placebo Lead-in Period||14
5045334|NCT01987908|12414394|P3|STARTED|Placebo Lead-in Period||0
5045335|NCT01987908|12414395|P2|STARTED|Placebo Lead-in Period||0
5045336|NCT01987908|12414396|P1|STARTED|Placebo Lead-in Period||23
5045337|NCT01987895|12414479|P2|NOT COMPLETED|Overall Study||30
5045338|NCT01987895|12414480|P1|NOT COMPLETED|Overall Study||30
5045339|NCT01987895|12414479|P2|COMPLETED|Overall Study||296
5045340|NCT01987895|12414480|P1|COMPLETED|Overall Study||276
5045341|NCT01987895|12414479|P2|STARTED|Overall Study||326
5045342|NCT01987895|12414480|P1|STARTED|Overall Study||306
5045343|NCT01987765|12414504|P1|NOT COMPLETED|Overall Study||102
5045344|NCT01987765|12414504|P1|COMPLETED|Overall Study||745
5045345|NCT01987765|12414504|P1|STARTED|Overall Study||847
5045346|NCT01987752|12414509|P1|NOT COMPLETED|Overall Study||0
5045347|NCT01987752|12414509|P1|COMPLETED|Overall Study||732
5045348|NCT01987752|12414509|P1|STARTED|Overall Study||732
5045349|NCT01987609|12414514|P1|NOT COMPLETED|Overall Study||1
5045350|NCT01987609|12414514|P1|COMPLETED|Overall Study||6
5045351|NCT01987609|12414514|P1|Normal Saline Injected in Arm|Overall Study||6
5045352|NCT01987609|12414514|P1|Hylenex Injected in Arm|Overall Study||6
5045353|NCT01987609|12414514|P1|STARTED|Overall Study|one arm on one patient|7
5045354|NCT01987583|12414547|P2|NOT COMPLETED|Overall Study||2
5045355|NCT01987583|12414548|P1|NOT COMPLETED|Overall Study||3
5045356|NCT01987583|12414547|P2|COMPLETED|Overall Study||38
5045357|NCT01987583|12414548|P1|COMPLETED|Overall Study||37
5045358|NCT01987583|12414547|P2|STARTED|Overall Study||40
5045359|NCT01987583|12414548|P1|STARTED|Overall Study||40
5045360|NCT01987557|12414559|P3|NOT COMPLETED|Overall Study||3
5045361|NCT01987557|12414560|P2|NOT COMPLETED|Overall Study||3
5045362|NCT01987557|12414561|P1|NOT COMPLETED|Overall Study||3
5045363|NCT01987557|12414559|P3|COMPLETED|Overall Study||13
5045364|NCT01987557|12414560|P2|COMPLETED|Overall Study||13
5045365|NCT01987557|12414561|P1|COMPLETED|Overall Study||13
5045366|NCT01987557|12414559|P3|STARTED|Overall Study||16
5045367|NCT01987557|12414560|P2|STARTED|Overall Study||16
5045368|NCT01987557|12414561|P1|STARTED|Overall Study||16
5045369|NCT01987505|12414571|P1|NOT COMPLETED|Overall Study||34
5045370|NCT01987505|12414571|P1|COMPLETED|Overall Study||106
5045371|NCT01987505|12414571|P1|STARTED|Overall Study||140
5045372|NCT01987479|12414601|P1|NOT COMPLETED|Overall Study||17
5045373|NCT01987479|12414601|P1|COMPLETED|Overall Study||133
5045374|NCT01987479|12414601|P1|STARTED|Overall Study||150
5045375|NCT01987453|12414629|P3|NOT COMPLETED|Overall Study||1
5045376|NCT01987453|12414630|P2|NOT COMPLETED|Overall Study||12
5045377|NCT01987453|12414631|P1|NOT COMPLETED|Overall Study||1
5045378|NCT01987453|12414629|P3|COMPLETED|Overall Study||7
5045379|NCT01987453|12414630|P2|COMPLETED|Overall Study||29
5045380|NCT01987453|12414631|P1|COMPLETED|Overall Study||50
5045381|NCT01987453|12414629|P3|STARTED|Overall Study||8
5045382|NCT01987453|12414630|P2|STARTED|Overall Study||41
5045383|NCT01987453|12414631|P1|STARTED|Overall Study||51
5045384|NCT01987427|12414657|P3|NOT COMPLETED|Overall Study||20
5045385|NCT01987427|12414658|P2|NOT COMPLETED|Overall Study||10
5045386|NCT01987427|12414659|P1|NOT COMPLETED|Overall Study||14
5045387|NCT01987427|12414657|P3|COMPLETED|Overall Study||59
5045388|NCT01987427|12414658|P2|COMPLETED|Overall Study||68
5045389|NCT01987427|12414659|P1|COMPLETED|Overall Study||64
5045390|NCT01987427|12414657|P3|STARTED|Overall Study||79
5045391|NCT01987427|12414658|P2|STARTED|Overall Study||78
5045392|NCT01987427|12414659|P1|STARTED|Overall Study||78
5045393|NCT01987414|12414690|P2|NOT COMPLETED|Overall Study||2
5045394|NCT01987414|12414691|P1|NOT COMPLETED|Overall Study||2
5045395|NCT01987414|12414690|P2|COMPLETED|Overall Study||6
5045396|NCT01987414|12414691|P1|COMPLETED|Overall Study||8
5045397|NCT01987414|12414690|P2|STARTED|Overall Study||8
5045398|NCT01987414|12414691|P1|STARTED|Overall Study||10
5045399|NCT01987401|12414740|P3|NOT COMPLETED|Overall Study||44
5045400|NCT01987401|12414741|P2|NOT COMPLETED|Overall Study||470
5045401|NCT01987401|12414742|P1|NOT COMPLETED|Overall Study||454
5045402|NCT01987401|12414740|P3|COMPLETED|Overall Study||16
5045403|NCT01987401|12414741|P2|COMPLETED|Overall Study||121
5045404|NCT01987401|12414742|P1|COMPLETED|Overall Study||137
5045405|NCT01987401|12414740|P3|STARTED|Overall Study||60
5045406|NCT01987401|12414741|P2|STARTED|Overall Study||591
5045407|NCT01987401|12414742|P1|STARTED|Overall Study||591
5045408|NCT01987349|12414758|P8|NOT COMPLETED|Overall Study||1
5045409|NCT01987349|12414759|P7|NOT COMPLETED|Overall Study||0
5045410|NCT01987349|12414760|P6|NOT COMPLETED|Overall Study||0
5045411|NCT01987349|12414761|P5|NOT COMPLETED|Overall Study||0
5045412|NCT01987349|12414762|P4|NOT COMPLETED|Overall Study||0
5045413|NCT01987349|12414763|P3|NOT COMPLETED|Overall Study||0
5045414|NCT01987349|12414764|P2|NOT COMPLETED|Overall Study||0
5045415|NCT01987349|12414765|P1|NOT COMPLETED|Overall Study||0
5045416|NCT01987349|12414758|P8|COMPLETED|Overall Study||24
5045417|NCT01987349|12414759|P7|COMPLETED|Overall Study||10
5045418|NCT01987349|12414760|P6|COMPLETED|Overall Study||6
5045419|NCT01987349|12414761|P5|COMPLETED|Overall Study||6
5045420|NCT01987349|12414762|P4|COMPLETED|Overall Study||6
5045421|NCT01987349|12414763|P3|COMPLETED|Overall Study||8
5045422|NCT01987349|12414764|P2|COMPLETED|Overall Study||6
5045423|NCT01987349|12414765|P1|COMPLETED|Overall Study||6
5045424|NCT01987349|12414758|P8|STARTED|Overall Study||25
5045425|NCT01987349|12414759|P7|STARTED|Overall Study||10
5045426|NCT01987349|12414760|P6|STARTED|Overall Study||6
5045427|NCT01987349|12414761|P5|STARTED|Overall Study||6
5045428|NCT01987349|12414762|P4|STARTED|Overall Study||6
5045429|NCT01987349|12414763|P3|STARTED|Overall Study||8
5045430|NCT01987349|12414764|P2|STARTED|Overall Study||6
5045431|NCT01987349|12414765|P1|STARTED|Overall Study||6
5045432|NCT01987232|12414796|P5|NOT COMPLETED|Overall Study||0
5045433|NCT01987232|12414797|P4|NOT COMPLETED|Overall Study||1
5045434|NCT01987232|12414798|P3|NOT COMPLETED|Overall Study||0
5045435|NCT01987232|12414799|P2|NOT COMPLETED|Overall Study||0
5045436|NCT01987232|12414800|P1|NOT COMPLETED|Overall Study||0
5045437|NCT01987232|12414796|P5|COMPLETED|Overall Study||6
5045438|NCT01987232|12414797|P4|COMPLETED|Overall Study||14
5045439|NCT01987232|12414798|P3|COMPLETED|Overall Study||3
5045440|NCT01987232|12414799|P2|COMPLETED|Overall Study||3
5045441|NCT01987232|12414800|P1|COMPLETED|Overall Study||5
5045442|NCT01987232|12414796|P5|STARTED|Overall Study||6
5045443|NCT01987232|12414797|P4|STARTED|Overall Study||15
5045444|NCT01987232|12414798|P3|STARTED|Overall Study||3
5045445|NCT01987232|12414799|P2|STARTED|Overall Study||3
5045446|NCT01987232|12414800|P1|STARTED|Overall Study||5
5045447|NCT01987219|12414865|P6|NOT COMPLETED|Overall Study||0
5045448|NCT01987219|12414866|P5|NOT COMPLETED|Overall Study||0
5045449|NCT01987219|12414867|P4|NOT COMPLETED|Overall Study||0
5045450|NCT01987219|12414868|P3|NOT COMPLETED|Overall Study||1
5045451|NCT01987219|12414869|P2|NOT COMPLETED|Overall Study||0
5045452|NCT01987219|12414870|P1|NOT COMPLETED|Overall Study||0
5045453|NCT01987219|12414865|P6|COMPLETED|Overall Study||1
5045454|NCT01987219|12414866|P5|COMPLETED|Overall Study||1
5045455|NCT01987219|12414867|P4|COMPLETED|Overall Study||2
5045456|NCT01987219|12414868|P3|COMPLETED|Overall Study||6
5045457|NCT01987219|12414869|P2|COMPLETED|Overall Study||2
5045458|NCT01987219|12414870|P1|COMPLETED|Overall Study||2
5045459|NCT01987219|12414865|P6|STARTED|Overall Study||1
5045460|NCT01987219|12414866|P5|STARTED|Overall Study||1
5045461|NCT01987219|12414867|P4|STARTED|Overall Study||2
5045462|NCT01987219|12414868|P3|STARTED|Overall Study||7
5045463|NCT01987219|12414869|P2|STARTED|Overall Study||2
5045464|NCT01987219|12414870|P1|STARTED|Overall Study||2
5045465|NCT01987102|12414889|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
5045466|NCT01987102|12414890|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
5045467|NCT01987102|12414889|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
5045468|NCT01987102|12414890|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
5045469|NCT01987102|12414889|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
5045470|NCT01987102|12414890|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
5045471|NCT01987102|12414889|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
5045472|NCT01987102|12414890|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
5045473|NCT01987102|12414889|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
5045474|NCT01987102|12414890|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
5045475|NCT01987102|12414889|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
5045476|NCT01987102|12414890|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
5045477|NCT01986985|12414922|P1|NOT COMPLETED|Overall Study||7
5045478|NCT01986985|12414922|P1|COMPLETED|Overall Study||51
5045479|NCT01986985|12414922|P1|STARTED|Overall Study||58
5045480|NCT01986946|12414928|P2|NOT COMPLETED|Overall Study||0
5045481|NCT01986946|12414929|P1|NOT COMPLETED|Overall Study||0
5045482|NCT01986946|12414928|P2|COMPLETED|Overall Study||9
5045483|NCT01986946|12414929|P1|COMPLETED|Overall Study||5
5045484|NCT01986946|12414928|P2|STARTED|Overall Study||9
5045485|NCT01986946|12414929|P1|STARTED|Overall Study||5
5045486|NCT01986920|12414959|P4|NOT COMPLETED|Placebo||1
5045487|NCT01986920|12414960|P3|NOT COMPLETED|Placebo||0
5045488|NCT01986920|12414961|P2|NOT COMPLETED|Placebo||0
5045489|NCT01986920|12414962|P1|NOT COMPLETED|Placebo||0
5045490|NCT01986920|12414959|P4|COMPLETED|Placebo||34
5045491|NCT01986920|12414960|P3|COMPLETED|Placebo||0
5045492|NCT01986920|12414961|P2|COMPLETED|Placebo||0
5045493|NCT01986920|12414962|P1|COMPLETED|Placebo||0
5045494|NCT01986920|12414959|P4|STARTED|Placebo||35
5045495|NCT01986920|12414960|P3|STARTED|Placebo||0
5045496|NCT01986920|12414961|P2|STARTED|Placebo||0
5045497|NCT01986920|12414962|P1|STARTED|Placebo||0
5045498|NCT01986920|12414959|P4|NOT COMPLETED|A-101 40%||0
5045499|NCT01986920|12414960|P3|NOT COMPLETED|A-101 40%||1
5045500|NCT01986920|12414961|P2|NOT COMPLETED|A-101 40%||0
5045501|NCT01986920|12414962|P1|NOT COMPLETED|A-101 40%||0
5045502|NCT01986920|12414959|P4|COMPLETED|A-101 40%||0
5045503|NCT01986920|12414960|P3|COMPLETED|A-101 40%||34
5045504|NCT01986920|12414961|P2|COMPLETED|A-101 40%||0
5045505|NCT01986920|12414962|P1|COMPLETED|A-101 40%||0
5045506|NCT01986920|12414959|P4|STARTED|A-101 40%||0
5045507|NCT01986920|12414960|P3|STARTED|A-101 40%||35
5045508|NCT01986920|12414961|P2|STARTED|A-101 40%||0
5045509|NCT01986920|12414962|P1|STARTED|A-101 40%||0
5045510|NCT01986920|12414959|P4|NOT COMPLETED|A-101 32.5%||0
5045511|NCT01986920|12414960|P3|NOT COMPLETED|A-101 32.5%||0
5045512|NCT01986920|12414961|P2|NOT COMPLETED|A-101 32.5%||1
5045513|NCT01986920|12414962|P1|NOT COMPLETED|A-101 32.5%||0
5045514|NCT01986920|12414959|P4|COMPLETED|A-101 32.5%||0
5045515|NCT01986920|12414960|P3|COMPLETED|A-101 32.5%||0
5045516|NCT01986920|12414961|P2|COMPLETED|A-101 32.5%||34
5045517|NCT01986920|12414962|P1|COMPLETED|A-101 32.5%||0
5045518|NCT01986920|12414959|P4|STARTED|A-101 32.5%||0
5045519|NCT01986920|12414960|P3|STARTED|A-101 32.5%||0
5045520|NCT01986920|12414961|P2|STARTED|A-101 32.5%||35
5045521|NCT01986920|12414962|P1|STARTED|A-101 32.5%||0
5045522|NCT01986920|12414959|P4|NOT COMPLETED|A- 101 25%||0
5045523|NCT01986920|12414960|P3|NOT COMPLETED|A- 101 25%||0
5045524|NCT01986920|12414961|P2|NOT COMPLETED|A- 101 25%||0
5045525|NCT01986920|12414962|P1|NOT COMPLETED|A- 101 25%||1
5045526|NCT01986920|12414959|P4|COMPLETED|A- 101 25%||0
5045527|NCT01986920|12414960|P3|COMPLETED|A- 101 25%||0
5045528|NCT01986920|12414961|P2|COMPLETED|A- 101 25%||0
5045529|NCT01986920|12414962|P1|COMPLETED|A- 101 25%||34
5045530|NCT01986920|12414959|P4|STARTED|A- 101 25%||0
5045531|NCT01986920|12414960|P3|STARTED|A- 101 25%||0
5045532|NCT01986920|12414961|P2|STARTED|A- 101 25%||0
5045533|NCT01986920|12414962|P1|STARTED|A- 101 25%||35
5045534|NCT01986907|12414976|P1|NOT COMPLETED|Overall Study||162
5045535|NCT01986907|12414976|P1|COMPLETED|Overall Study||774
5045536|NCT01986907|12414976|P1|STARTED|Overall Study||936
5045537|NCT01986855|12414989|P3|NOT COMPLETED|Overall Study||11
5045538|NCT01986855|12414990|P2|NOT COMPLETED|Overall Study||14
5045539|NCT01986855|12414991|P1|NOT COMPLETED|Overall Study||13
5045540|NCT01986855|12414989|P3|COMPLETED|Overall Study||143
5045541|NCT01986855|12414990|P2|COMPLETED|Overall Study||142
5045542|NCT01986855|12414991|P1|COMPLETED|Overall Study||145
5045543|NCT01986855|12414989|P3|Treated|Overall Study||154
5045544|NCT01986855|12414990|P2|Treated|Overall Study||155
5045545|NCT01986855|12414991|P1|Treated|Overall Study||158
5045546|NCT01986855|12414989|P3|STARTED|Overall Study||154
5045547|NCT01986855|12414990|P2|STARTED|Overall Study||156
5045548|NCT01986855|12414991|P1|STARTED|Overall Study||158
5045549|NCT01986829|12415020|P1|NOT COMPLETED|Overall Study||1
5045550|NCT01986829|12415020|P1|COMPLETED|Overall Study||8
5045551|NCT01986829|12415020|P1|STARTED|Overall Study||9
5045552|NCT01986790|12415050|P3|NOT COMPLETED|Overall Study||0
5045553|NCT01986790|12415051|P2|NOT COMPLETED|Overall Study||0
5045554|NCT01986790|12415052|P1|NOT COMPLETED|Overall Study||0
5045555|NCT01986790|12415050|P3|COMPLETED|Overall Study||98
5045556|NCT01986790|12415051|P2|COMPLETED|Overall Study||154
5045557|NCT01986790|12415052|P1|COMPLETED|Overall Study||91
5045558|NCT01986790|12415050|P3|STARTED|Overall Study||98
5045559|NCT01986790|12415051|P2|STARTED|Overall Study||154
5045560|NCT01986790|12415052|P1|STARTED|Overall Study||91
5045561|NCT01986751|12415068|P2|NOT COMPLETED|Overall Study||2
5045562|NCT01986751|12415069|P1|NOT COMPLETED|Overall Study||10
5045563|NCT01986751|12415068|P2|COMPLETED|Overall Study||2
5045564|NCT01986751|12415069|P1|COMPLETED|Overall Study||0
5045565|NCT01986751|12415068|P2|STARTED|Overall Study||4
5045566|NCT01986751|12415069|P1|STARTED|Overall Study||10
5045567|NCT01986686|12415091|P2|NOT COMPLETED|Overall Study||0
5045568|NCT01986686|12415092|P1|NOT COMPLETED|Overall Study||0
5045569|NCT01986686|12415091|P2|COMPLETED|Overall Study||26
5045570|NCT01986686|12415092|P1|COMPLETED|Overall Study||81
5045571|NCT01986686|12415091|P2|STARTED|Overall Study||26
5045572|NCT01986686|12415092|P1|STARTED|Overall Study||81
5045573|NCT01986647|12415102|P4|NOT COMPLETED|Overall Study||11
5045574|NCT01986647|12415103|P3|NOT COMPLETED|Overall Study||12
5045575|NCT01986647|12415104|P2|NOT COMPLETED|Overall Study||7
5045576|NCT01986647|12415105|P1|NOT COMPLETED|Overall Study||10
5045577|NCT01986647|12415102|P4|COMPLETED|Overall Study||66
5045578|NCT01986647|12415103|P3|COMPLETED|Overall Study||37
5045579|NCT01986647|12415104|P2|COMPLETED|Overall Study||139
5045580|NCT01986647|12415105|P1|COMPLETED|Overall Study||142
5045581|NCT01986647|12415102|P4|STARTED|Overall Study||77
5045582|NCT01986647|12415103|P3|STARTED|Overall Study||49
5045583|NCT01986647|12415104|P2|STARTED|Overall Study||146
5045584|NCT01986647|12415105|P1|STARTED|Overall Study||152
5045585|NCT01986361|12415177|P2|NOT COMPLETED|Overall Study||0
5045586|NCT01986361|12415178|P1|NOT COMPLETED|Overall Study||0
5045587|NCT01986361|12415177|P2|COMPLETED|Overall Study||21
5045588|NCT01986361|12415178|P1|COMPLETED|Overall Study||101
5045589|NCT01986361|12415177|P2|STARTED|Overall Study||21
5045590|NCT01986361|12415178|P1|STARTED|Overall Study||101
5045591|NCT01986231|12415200|P1|NOT COMPLETED|Overall Study||1
5045592|NCT01986231|12415200|P1|COMPLETED|Overall Study||11
5045593|NCT01986231|12415200|P1|STARTED|Overall Study||12
5045594|NCT01986140|12415207|P2|NOT COMPLETED|Overall Study||28
5045595|NCT01986140|12415208|P1|NOT COMPLETED|Overall Study||35
5045596|NCT01986140|12415207|P2|COMPLETED|Overall Study||51
5045597|NCT01986140|12415208|P1|COMPLETED|Overall Study||122
5045598|NCT01986140|12415207|P2|STARTED|Overall Study||79
5045599|NCT01986140|12415208|P1|STARTED|Overall Study||157
5045600|NCT01986114|12415214|P1|NOT COMPLETED|Overall Study||156
5045601|NCT01986114|12415214|P1|COMPLETED|Overall Study||339
5045602|NCT01986114|12415214|P1|STARTED|Overall Study||495
5045603|NCT01986101|12415229|P3|NOT COMPLETED|Overall Study||32
5045604|NCT01986101|12415230|P2|NOT COMPLETED|Overall Study||27
5045605|NCT01986101|12415231|P1|NOT COMPLETED|Overall Study||33
5045606|NCT01986101|12415229|P3|COMPLETED|Overall Study||137
5045607|NCT01986101|12415230|P2|COMPLETED|Overall Study||157
5045608|NCT01986101|12415231|P1|COMPLETED|Overall Study||139
5045609|NCT01986101|12415229|P3|Safety Population|Overall Study||169
5045610|NCT01986101|12415230|P2|Safety Population|Overall Study||184
5045611|NCT01986101|12415231|P1|Safety Population|Overall Study||172
5045612|NCT01986101|12415229|P3|Intent-to-Treat Population|Overall Study||169
5045613|NCT01986101|12415230|P2|Intent-to-Treat Population|Overall Study||182
5045614|NCT01986101|12415231|P1|Intent-to-Treat Population|Overall Study||171
5045615|NCT01986101|12415229|P3|STARTED|Overall Study||169
5045616|NCT01986101|12415230|P2|STARTED|Overall Study||184
5045617|NCT01986101|12415231|P1|STARTED|Overall Study||172
5045618|NCT01986062|12415253|P2|NOT COMPLETED|Overall Study||1
5045619|NCT01986062|12415254|P1|NOT COMPLETED|Overall Study||1
5045620|NCT01986062|12415253|P2|COMPLETED|Overall Study||49
5045621|NCT01986062|12415254|P1|COMPLETED|Overall Study||46
5045622|NCT01986062|12415253|P2|STARTED|Overall Study||50
5045623|NCT01986062|12415254|P1|STARTED|Overall Study||47
5045624|NCT01985971|12415270|P1|NOT COMPLETED|Overall Study||1
5045625|NCT01985971|12415270|P1|COMPLETED|Overall Study||1
5045626|NCT01985971|12415270|P1|STARTED|Overall Study||2
5045627|NCT01985958|12415274|P1|NOT COMPLETED|Overall Study||1
5045628|NCT01985958|12415274|P1|COMPLETED|Overall Study||3
5045629|NCT01985958|12415274|P1|STARTED|Overall Study||4
5045630|NCT01985932|12415278|P1|NOT COMPLETED|Overall Study||0
5045631|NCT01985932|12415278|P1|COMPLETED|Overall Study||15
5045632|NCT01985932|12415278|P1|STARTED|Overall Study||15
5045633|NCT01985763|12415282|P1|NOT COMPLETED|Overall Study||0
5045634|NCT01985763|12415282|P1|COMPLETED|Overall Study||13
5045635|NCT01985763|12415282|P1|STARTED|Overall Study||13
5045636|NCT01985685|12415297|P2|NOT COMPLETED|Overall Study||0
5045637|NCT01985685|12415298|P1|NOT COMPLETED|Overall Study||0
5045638|NCT01985685|12415297|P2|COMPLETED|Overall Study||29
5045639|NCT01985685|12415298|P1|COMPLETED|Overall Study||27
5045640|NCT01985685|12415297|P2|STARTED|Overall Study||29
5045641|NCT01985685|12415298|P1|STARTED|Overall Study||27
5045642|NCT01985581|12415310|P2|NOT COMPLETED|Second Intervention||4
5045643|NCT01985581|12415311|P1|NOT COMPLETED|Second Intervention||2
5045644|NCT01985581|12415310|P2|COMPLETED|Second Intervention||19
5045645|NCT01985581|12415311|P1|COMPLETED|Second Intervention||20
5045646|NCT01985581|12415310|P2|STARTED|Second Intervention||23
5045647|NCT01985581|12415311|P1|STARTED|Second Intervention||22
5045648|NCT01985581|12415310|P2|NOT COMPLETED|First Intervention||2
5045649|NCT01985581|12415311|P1|NOT COMPLETED|First Intervention||3
5045650|NCT01985581|12415310|P2|COMPLETED|First Intervention||23
5045651|NCT01985581|12415311|P1|COMPLETED|First Intervention||22
5045652|NCT01985581|12415310|P2|STARTED|First Intervention||25
5045653|NCT01985581|12415311|P1|STARTED|First Intervention||25
5045654|NCT01985425|12415331|P2|NOT COMPLETED|Overall Study||0
5045655|NCT01985425|12415332|P1|NOT COMPLETED|Overall Study||0
5045656|NCT01985425|12415331|P2|COMPLETED|Overall Study||51
5045657|NCT01985425|12415332|P1|COMPLETED|Overall Study||49
5045658|NCT01985425|12415331|P2|STARTED|Overall Study||51
5045659|NCT01985425|12415332|P1|STARTED|Overall Study||49
5045660|NCT01985334|12415358|P8|NOT COMPLETED|Overall Study||121
5045661|NCT01985334|12415359|P7|NOT COMPLETED|Overall Study||37
5045662|NCT01985334|12415360|P6|NOT COMPLETED|Overall Study||156
5045663|NCT01985334|12415361|P5|NOT COMPLETED|Overall Study||40
5045664|NCT01985334|12415362|P4|NOT COMPLETED|Overall Study||229
5045665|NCT01985334|12415363|P3|NOT COMPLETED|Overall Study||53
5045666|NCT01985334|12415364|P2|NOT COMPLETED|Overall Study||84
5045667|NCT01985334|12415365|P1|NOT COMPLETED|Overall Study||23
5045668|NCT01985334|12415358|P8|COMPLETED|Overall Study||699
5045669|NCT01985334|12415359|P7|COMPLETED|Overall Study||237
5045670|NCT01985334|12415360|P6|COMPLETED|Overall Study||666
5045671|NCT01985334|12415361|P5|COMPLETED|Overall Study||234
5045672|NCT01985334|12415362|P4|COMPLETED|Overall Study||1033
5045673|NCT01985334|12415363|P3|COMPLETED|Overall Study||367
5045674|NCT01985334|12415364|P2|COMPLETED|Overall Study||303
5045675|NCT01985334|12415365|P1|COMPLETED|Overall Study||107
5045676|NCT01985334|12415358|P8|The Intention-to-treat (ITT) Population|Overall Study||811
5045677|NCT01985334|12415359|P7|The Intention-to-treat (ITT) Population|Overall Study||268
5045678|NCT01985334|12415360|P6|The Intention-to-treat (ITT) Population|Overall Study||811
5045679|NCT01985334|12415361|P5|The Intention-to-treat (ITT) Population|Overall Study||269
5045680|NCT01985334|12415362|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
5045681|NCT01985334|12415363|P3|The Intention-to-treat (ITT) Population|Overall Study||420
5045682|NCT01985334|12415364|P2|The Intention-to-treat (ITT) Population|Overall Study||369
5045683|NCT01985334|12415365|P1|The Intention-to-treat (ITT) Population|Overall Study||122
5045684|NCT01985334|12415358|P8|STARTED|Overall Study||820
5045685|NCT01985334|12415359|P7|STARTED|Overall Study||274
5045686|NCT01985334|12415360|P6|STARTED|Overall Study||822
5045687|NCT01985334|12415361|P5|STARTED|Overall Study||274
5045688|NCT01985334|12415362|P4|STARTED|Overall Study||1262
5045689|NCT01985334|12415363|P3|STARTED|Overall Study||420
5045690|NCT01985334|12415364|P2|STARTED|Overall Study||387
5045691|NCT01985334|12415365|P1|STARTED|Overall Study||130
5045692|NCT01985321|12415433|P2|NOT COMPLETED|Overall Study||5
5045693|NCT01985321|12415434|P1|NOT COMPLETED|Overall Study||11
5045694|NCT01985321|12415433|P2|COMPLETED|Overall Study||78
5045695|NCT01985321|12415434|P1|COMPLETED|Overall Study||79
5045696|NCT01985321|12415433|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
5045697|NCT01985321|12415434|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
5045698|NCT01985126|12415444|P2|NOT COMPLETED|Overall Study||106
5045699|NCT01985126|12415445|P1|NOT COMPLETED|Overall Study||18
5045700|NCT01985126|12415444|P2|COMPLETED|Overall Study||0
5045701|NCT01985126|12415445|P1|COMPLETED|Overall Study||0
5045702|NCT01985126|12415444|P2|STARTED|Overall Study||106
5045703|NCT01985126|12415445|P1|STARTED|Overall Study||18
5045704|NCT01984892|12415463|P1|NOT COMPLETED|Overall Study||7
5045705|NCT01984892|12415463|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
5045706|NCT01984892|12415463|P1|STARTED|Overall Study||8
5045707|NCT01984697|12415474|P5|NOT COMPLETED|Overall Study||35
5045708|NCT01984697|12415475|P4|NOT COMPLETED|Overall Study||21
5045709|NCT01984697|12415476|P3|NOT COMPLETED|Overall Study||29
5045710|NCT01984697|12415477|P2|NOT COMPLETED|Overall Study||31
5045711|NCT01984697|12415478|P1|NOT COMPLETED|Overall Study||43
5045712|NCT01984697|12415474|P5|COMPLETED|Overall Study||279
5045713|NCT01984697|12415475|P4|COMPLETED|Overall Study||280
5045714|NCT01984697|12415476|P3|COMPLETED|Overall Study||272
5045715|NCT01984697|12415477|P2|COMPLETED|Overall Study||270
5045716|NCT01984697|12415478|P1|COMPLETED|Overall Study||258
5045717|NCT01984697|12415474|P5|Month 36 Vaccination|Overall Study||31
5045718|NCT01984697|12415475|P4|Month 36 Vaccination|Overall Study||9
5045719|NCT01984697|12415476|P3|Month 36 Vaccination|Overall Study||280
5045720|NCT01984697|12415477|P2|Month 36 Vaccination|Overall Study||281
5045721|NCT01984697|12415478|P1|Month 36 Vaccination|Overall Study||270
5045722|NCT01984697|12415474|P5|Vaccination 3|Overall Study||311
5045723|NCT01984697|12415475|P4|Vaccination 3|Overall Study||293
5045724|NCT01984697|12415476|P3|Vaccination 3|Overall Study||0
5045725|NCT01984697|12415477|P2|Vaccination 3|Overall Study||0
5045726|NCT01984697|12415478|P1|Vaccination 3|Overall Study||0
5045727|NCT01984697|12415474|P5|Vaccination 2|Overall Study||313
5045728|NCT01984697|12415475|P4|Vaccination 2|Overall Study||298
5045729|NCT01984697|12415476|P3|Vaccination 2|Overall Study||291
5045730|NCT01984697|12415477|P2|Vaccination 2|Overall Study||296
5045731|NCT01984697|12415478|P1|Vaccination 2|Overall Study||293
5045732|NCT01984697|12415474|P5|Vaccination 1|Overall Study||314
5045733|NCT01984697|12415475|P4|Vaccination 1|Overall Study||300
5045734|NCT01984697|12415476|P3|Vaccination 1|Overall Study||300
5045735|NCT01984697|12415477|P2|Vaccination 1|Overall Study||301
5045736|NCT01984697|12415478|P1|Vaccination 1|Overall Study||301
5045737|NCT01984697|12415474|P5|STARTED|Overall Study||314
5045738|NCT01984697|12415475|P4|STARTED|Overall Study||301
5045739|NCT01984697|12415476|P3|STARTED|Overall Study||301
5045740|NCT01984697|12415477|P2|STARTED|Overall Study||301
5045741|NCT01984697|12415478|P1|STARTED|Overall Study||301
5045742|NCT01984684|12415597|P2|NOT COMPLETED|Overall Study||59
5045743|NCT01984684|12415598|P1|NOT COMPLETED|Overall Study||57
5045744|NCT01984684|12415597|P2|COMPLETED|Overall Study||368
5045745|NCT01984684|12415598|P1|COMPLETED|Overall Study||366
5045746|NCT01984684|12415597|P2|STARTED|Overall Study||427
5045747|NCT01984684|12415598|P1|STARTED|Overall Study||423
5045748|NCT01984515|12415608|P1|NOT COMPLETED|Overall Study||19
5045749|NCT01984515|12415608|P1|COMPLETED|Overall Study||40
5045750|NCT01984515|12415608|P1|Received CBT Session|Overall Study||40
5045751|NCT01984515|12415608|P1|STARTED|Overall Study||59
5045752|NCT01984424|12415616|P2|NOT COMPLETED|Overall Study||7
5045753|NCT01984424|12415617|P1|NOT COMPLETED|Overall Study||3
5045754|NCT01984424|12415616|P2|COMPLETED|Overall Study||138
5045755|NCT01984424|12415617|P1|COMPLETED|Overall Study||70
5045756|NCT01984424|12415616|P2|STARTED|Overall Study||145
5045757|NCT01984424|12415617|P1|STARTED|Overall Study||73
5045758|NCT01984398|12415671|P4|NOT COMPLETED|Treatment Period 2||0
5045759|NCT01984398|12415672|P3|NOT COMPLETED|Treatment Period 2||0
5045760|NCT01984398|12415673|P2|NOT COMPLETED|Treatment Period 2||0
5045761|NCT01984398|12415674|P1|NOT COMPLETED|Treatment Period 2||0
5045762|NCT01984398|12415671|P4|COMPLETED|Treatment Period 2||4
5045763|NCT01984398|12415672|P3|COMPLETED|Treatment Period 2||4
5045764|NCT01984398|12415673|P2|COMPLETED|Treatment Period 2||4
5045765|NCT01984398|12415674|P1|COMPLETED|Treatment Period 2||4
5045766|NCT01984398|12415671|P4|STARTED|Treatment Period 2||4
5045767|NCT01984398|12415672|P3|STARTED|Treatment Period 2||4
5045768|NCT01984398|12415673|P2|STARTED|Treatment Period 2||4
5045769|NCT01984398|12415674|P1|STARTED|Treatment Period 2||4
5045770|NCT01984398|12415671|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
5045771|NCT01984398|12415672|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
5045772|NCT01984398|12415673|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
5045773|NCT01984398|12415674|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
5045774|NCT01984398|12415671|P4|COMPLETED|Washout Period of 5 to 7 Days||4
5045775|NCT01984398|12415672|P3|COMPLETED|Washout Period of 5 to 7 Days||4
5045776|NCT01984398|12415673|P2|COMPLETED|Washout Period of 5 to 7 Days||4
5045777|NCT01984398|12415674|P1|COMPLETED|Washout Period of 5 to 7 Days||4
5045778|NCT01984398|12415671|P4|STARTED|Washout Period of 5 to 7 Days||4
5045779|NCT01984398|12415672|P3|STARTED|Washout Period of 5 to 7 Days||4
5045780|NCT01984398|12415673|P2|STARTED|Washout Period of 5 to 7 Days||4
5045781|NCT01984398|12415674|P1|STARTED|Washout Period of 5 to 7 Days||4
5045782|NCT01984398|12415671|P4|NOT COMPLETED|Treatment Period 1||0
5045783|NCT01984398|12415672|P3|NOT COMPLETED|Treatment Period 1||0
5045784|NCT01984398|12415673|P2|NOT COMPLETED|Treatment Period 1||0
5045785|NCT01984398|12415674|P1|NOT COMPLETED|Treatment Period 1||0
5045786|NCT01984398|12415671|P4|COMPLETED|Treatment Period 1||4
5045787|NCT01984398|12415672|P3|COMPLETED|Treatment Period 1||4
5045788|NCT01984398|12415673|P2|COMPLETED|Treatment Period 1||4
5045789|NCT01984398|12415674|P1|COMPLETED|Treatment Period 1||4
5045790|NCT01984398|12415671|P4|STARTED|Treatment Period 1||4
5045791|NCT01984398|12415672|P3|STARTED|Treatment Period 1||4
5045792|NCT01984398|12415673|P2|STARTED|Treatment Period 1||4
5045793|NCT01984398|12415674|P1|STARTED|Treatment Period 1||4
5045794|NCT01984294|12415687|P3|NOT COMPLETED|Overall Study||7
5045795|NCT01984294|12415688|P2|NOT COMPLETED|Overall Study||3
5045796|NCT01984294|12415689|P1|NOT COMPLETED|Overall Study||4
5045797|NCT01984294|12415687|P3|COMPLETED|Overall Study||27
5045798|NCT01984294|12415688|P2|COMPLETED|Overall Study||29
5045799|NCT01984294|12415689|P1|COMPLETED|Overall Study||31
5045800|NCT01984294|12415687|P3|STARTED|Overall Study||34
5045801|NCT01984294|12415688|P2|STARTED|Overall Study||32
5045802|NCT01984294|12415689|P1|STARTED|Overall Study||35
5045803|NCT01984242|12415712|P3|NOT COMPLETED|Overall Study||101
5045804|NCT01984242|12415713|P2|NOT COMPLETED|Overall Study||103
5045805|NCT01984242|12415714|P1|NOT COMPLETED|Overall Study||101
5045806|NCT01984242|12415712|P3|COMPLETED|Overall Study||0
5045807|NCT01984242|12415713|P2|COMPLETED|Overall Study||0
5045808|NCT01984242|12415714|P1|COMPLETED|Overall Study||0
5045809|NCT01984242|12415712|P3|Treated|Overall Study||100
5045810|NCT01984242|12415713|P2|Treated|Overall Study||103
5045811|NCT01984242|12415714|P1|Treated|Overall Study||101
5045812|NCT01984242|12415712|P3|STARTED|Overall Study||101
5045813|NCT01984242|12415713|P2|STARTED|Overall Study||103
5045814|NCT01984242|12415714|P1|STARTED|Overall Study||101
5045815|NCT01984229|12415864|P2|NOT COMPLETED|Safety Follow-up Period||1
5045816|NCT01984229|12415865|P1|NOT COMPLETED|Safety Follow-up Period||2
5045817|NCT01984229|12415864|P2|COMPLETED|Safety Follow-up Period||16
5045818|NCT01984229|12415865|P1|COMPLETED|Safety Follow-up Period||4
5045819|NCT01984229|12415864|P2|STARTED|Safety Follow-up Period||17
5045820|NCT01984229|12415865|P1|STARTED|Safety Follow-up Period||6
5045821|NCT01984229|12415864|P2|NOT COMPLETED|Period 3||0
5045822|NCT01984229|12415865|P1|NOT COMPLETED|Period 3||0
5045823|NCT01984229|12415864|P2|COMPLETED|Period 3||17
5045824|NCT01984229|12415865|P1|COMPLETED|Period 3||6
5045825|NCT01984229|12415864|P2|STARTED|Period 3||17
5045826|NCT01984229|12415865|P1|STARTED|Period 3||6
5045827|NCT01984229|12415864|P2|NOT COMPLETED|Period 2||0
5045828|NCT01984229|12415865|P1|NOT COMPLETED|Period 2||0
5045829|NCT01984229|12415864|P2|COMPLETED|Period 2||17
5045830|NCT01984229|12415865|P1|COMPLETED|Period 2||6
5045831|NCT01984229|12415864|P2|STARTED|Period 2||17
5045832|NCT01984229|12415865|P1|STARTED|Period 2||6
5045833|NCT01984229|12415864|P2|NOT COMPLETED|Period 1||0
5045834|NCT01984229|12415865|P1|NOT COMPLETED|Period 1||0
5045835|NCT01984229|12415864|P2|COMPLETED|Period 1||17
5045836|NCT01984229|12415865|P1|COMPLETED|Period 1||6
5045837|NCT01984229|12415864|P2|STARTED|Period 1||17
5045838|NCT01984229|12415865|P1|STARTED|Period 1||6
5045839|NCT01983969|12415918|P3|NOT COMPLETED|Overall Study||0
5045840|NCT01983969|12415919|P2|NOT COMPLETED|Overall Study||1
5045841|NCT01983969|12415920|P1|NOT COMPLETED|Overall Study||0
5045842|NCT01983969|12415918|P3|COMPLETED|Overall Study||5
5045843|NCT01983969|12415919|P2|COMPLETED|Overall Study||18
5045844|NCT01983969|12415920|P1|COMPLETED|Overall Study||37
5045845|NCT01983969|12415918|P3|STARTED|Overall Study||5
5045846|NCT01983969|12415919|P2|STARTED|Overall Study||19
5045847|NCT01983969|12415920|P1|STARTED|Overall Study||37
5045848|NCT01983930|12415934|P2|NOT COMPLETED|Overall Study||9
5045849|NCT01983930|12415935|P1|NOT COMPLETED|Overall Study||9
5045850|NCT01983930|12415934|P2|COMPLETED|Overall Study||29
5045851|NCT01983930|12415935|P1|COMPLETED|Overall Study||32
5045852|NCT01983930|12415934|P2|STARTED|Overall Study||38
5045853|NCT01983930|12415935|P1|STARTED|Overall Study||41
5045854|NCT01983878|12415947|P1|NOT COMPLETED|Overall Study||0
5045855|NCT01983878|12415947|P1|COMPLETED|Overall Study||36
5045856|NCT01983878|12415947|P1|Received At Least One Dose of Study Drug|Overall Study||36
5045857|NCT01983878|12415947|P1|STARTED|Overall Study||36
5045858|NCT01983839|12415958|P1|NOT COMPLETED|Overall Study||0
5045859|NCT01983839|12415958|P1|COMPLETED|Overall Study||18
5045860|NCT01983839|12415958|P1|STARTED|Overall Study||18
5045861|NCT01983826|12415965|P2|NOT COMPLETED|Overall Study||0
5045862|NCT01983826|12415966|P1|NOT COMPLETED|Overall Study||0
5045863|NCT01983826|12415965|P2|COMPLETED|Overall Study||8
5045864|NCT01983826|12415966|P1|COMPLETED|Overall Study||13
5045865|NCT01983826|12415965|P2|STARTED|Overall Study||8
5045866|NCT01983826|12415966|P1|STARTED|Overall Study||13
5045867|NCT01983787|12415984|P1|NOT COMPLETED|Overall Study||0
5045868|NCT01983787|12415984|P1|COMPLETED|Overall Study||10
5045869|NCT01983787|12415984|P1|STARTED|Overall Study||10
5045870|NCT01983683|12416009|P2|NOT COMPLETED|Overall Study||51
5045871|NCT01983683|12416010|P1|NOT COMPLETED|Overall Study||38
5045872|NCT01983683|12416009|P2|COMPLETED|Overall Study||260
5045873|NCT01983683|12416010|P1|COMPLETED|Overall Study||260
5045874|NCT01983683|12416009|P2|STARTED|Overall Study||311
5045875|NCT01983683|12416010|P1|STARTED|Overall Study||298
5045876|NCT01983566|12416038|P4|NOT COMPLETED|Test Period 4||0
5045877|NCT01983566|12416039|P3|NOT COMPLETED|Test Period 4||0
5045878|NCT01983566|12416040|P2|NOT COMPLETED|Test Period 4||0
5045879|NCT01983566|12416041|P1|NOT COMPLETED|Test Period 4||0
5045880|NCT01983566|12416038|P4|COMPLETED|Test Period 4||0
5045881|NCT01983566|12416039|P3|COMPLETED|Test Period 4||0
5045882|NCT01983566|12416040|P2|COMPLETED|Test Period 4||0
5045883|NCT01983566|12416041|P1|COMPLETED|Test Period 4||0
5045884|NCT01983566|12416038|P4|STARTED|Test Period 4||0
5045885|NCT01983566|12416039|P3|STARTED|Test Period 4||0
5045886|NCT01983566|12416040|P2|STARTED|Test Period 4||0
5045887|NCT01983566|12416041|P1|STARTED|Test Period 4||0
5045888|NCT01983566|12416038|P4|NOT COMPLETED|Wash-Out 3||0
5045889|NCT01983566|12416039|P3|NOT COMPLETED|Wash-Out 3||0
5045890|NCT01983566|12416040|P2|NOT COMPLETED|Wash-Out 3||0
5045891|NCT01983566|12416041|P1|NOT COMPLETED|Wash-Out 3||0
5045892|NCT01983566|12416038|P4|COMPLETED|Wash-Out 3||0
5045893|NCT01983566|12416039|P3|COMPLETED|Wash-Out 3||0
5045894|NCT01983566|12416040|P2|COMPLETED|Wash-Out 3||0
5045895|NCT01983566|12416041|P1|COMPLETED|Wash-Out 3||0
5045896|NCT01983566|12416038|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
5045897|NCT01983566|12416039|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
5045898|NCT01983566|12416040|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
5045899|NCT01983566|12416041|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
5045900|NCT01983566|12416038|P4|NOT COMPLETED|Test Period 3||0
5045901|NCT01983566|12416039|P3|NOT COMPLETED|Test Period 3||0
5045902|NCT01983566|12416040|P2|NOT COMPLETED|Test Period 3||0
5045903|NCT01983566|12416041|P1|NOT COMPLETED|Test Period 3||0
5045904|NCT01983566|12416038|P4|COMPLETED|Test Period 3||4
5045905|NCT01983566|12416039|P3|COMPLETED|Test Period 3||2
5045906|NCT01983566|12416040|P2|COMPLETED|Test Period 3||3
5045907|NCT01983566|12416041|P1|COMPLETED|Test Period 3||2
5045908|NCT01983566|12416038|P4|STARTED|Test Period 3||4
5045909|NCT01983566|12416039|P3|STARTED|Test Period 3||2
5045910|NCT01983566|12416040|P2|STARTED|Test Period 3||3
5045911|NCT01983566|12416041|P1|STARTED|Test Period 3||2
5045912|NCT01983566|12416038|P4|NOT COMPLETED|Wash-Out 2||0
5045913|NCT01983566|12416039|P3|NOT COMPLETED|Wash-Out 2||0
5045914|NCT01983566|12416040|P2|NOT COMPLETED|Wash-Out 2||0
5045915|NCT01983566|12416041|P1|NOT COMPLETED|Wash-Out 2||0
5045916|NCT01983566|12416038|P4|COMPLETED|Wash-Out 2||4
5045917|NCT01983566|12416039|P3|COMPLETED|Wash-Out 2||2
5045918|NCT01983566|12416040|P2|COMPLETED|Wash-Out 2||3
5045919|NCT01983566|12416041|P1|COMPLETED|Wash-Out 2||2
5045920|NCT01983566|12416038|P4|STARTED|Wash-Out 2||4
5045921|NCT01983566|12416039|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
5045922|NCT01983566|12416040|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
5045923|NCT01983566|12416041|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
5045924|NCT01983566|12416038|P4|NOT COMPLETED|Test Period 2||0
5045925|NCT01983566|12416039|P3|NOT COMPLETED|Test Period 2||0
5045926|NCT01983566|12416040|P2|NOT COMPLETED|Test Period 2||0
5045927|NCT01983566|12416041|P1|NOT COMPLETED|Test Period 2||0
5045928|NCT01983566|12416038|P4|COMPLETED|Test Period 2||4
5045929|NCT01983566|12416039|P3|COMPLETED|Test Period 2||4
5045930|NCT01983566|12416040|P2|COMPLETED|Test Period 2||4
5045931|NCT01983566|12416041|P1|COMPLETED|Test Period 2||4
5045932|NCT01983566|12416038|P4|STARTED|Test Period 2||4
5045933|NCT01983566|12416039|P3|STARTED|Test Period 2||4
5045934|NCT01983566|12416040|P2|STARTED|Test Period 2||4
5045935|NCT01983566|12416041|P1|STARTED|Test Period 2||4
5045936|NCT01983566|12416038|P4|NOT COMPLETED|Wash-Out 1||0
5045937|NCT01983566|12416039|P3|NOT COMPLETED|Wash-Out 1||0
5045938|NCT01983566|12416040|P2|NOT COMPLETED|Wash-Out 1||0
5045939|NCT01983566|12416041|P1|NOT COMPLETED|Wash-Out 1||0
5045940|NCT01983566|12416038|P4|COMPLETED|Wash-Out 1||4
5045941|NCT01983566|12416039|P3|COMPLETED|Wash-Out 1||4
5045942|NCT01983566|12416040|P2|COMPLETED|Wash-Out 1||4
5045943|NCT01983566|12416041|P1|COMPLETED|Wash-Out 1||4
5045944|NCT01983566|12416038|P4|STARTED|Wash-Out 1||4
5045945|NCT01983566|12416039|P3|STARTED|Wash-Out 1||4
5045946|NCT01983566|12416040|P2|STARTED|Wash-Out 1||4
5045947|NCT01983566|12416041|P1|STARTED|Wash-Out 1||4
5045948|NCT01983566|12416038|P4|NOT COMPLETED|Test Period 1||0
5045949|NCT01983566|12416039|P3|NOT COMPLETED|Test Period 1||0
5045950|NCT01983566|12416040|P2|NOT COMPLETED|Test Period 1||0
5045951|NCT01983566|12416041|P1|NOT COMPLETED|Test Period 1||0
5045952|NCT01983566|12416038|P4|COMPLETED|Test Period 1||4
5045953|NCT01983566|12416039|P3|COMPLETED|Test Period 1||4
5045954|NCT01983566|12416040|P2|COMPLETED|Test Period 1||4
5045955|NCT01983566|12416041|P1|COMPLETED|Test Period 1||4
5045956|NCT01983566|12416038|P4|STARTED|Test Period 1||4
5045957|NCT01983566|12416039|P3|STARTED|Test Period 1||4
5045958|NCT01983566|12416040|P2|STARTED|Test Period 1||4
5045959|NCT01983566|12416041|P1|STARTED|Test Period 1||4
5045960|NCT01983553|12416062|P2|NOT COMPLETED|Overall Study||0
5045961|NCT01983553|12416063|P1|NOT COMPLETED|Overall Study||0
5045962|NCT01983553|12416062|P2|COMPLETED|Overall Study||1072
5045963|NCT01983553|12416063|P1|COMPLETED|Overall Study||2131
5045964|NCT01983553|12416062|P2|STARTED|Overall Study||1072
5045965|NCT01983553|12416063|P1|STARTED|Overall Study||2131
5045966|NCT01983293|12416097|P2|NOT COMPLETED|Overall Study||19
5045967|NCT01983293|12416098|P1|NOT COMPLETED|Overall Study||33
5045968|NCT01983293|12416097|P2|COMPLETED|Overall Study||62
5045969|NCT01983293|12416098|P1|COMPLETED|Overall Study||128
5045970|NCT01983293|12416097|P2|STARTED|Overall Study||81
5045971|NCT01983293|12416098|P1|STARTED|Overall Study||161
5045972|NCT01983254|12416106|P2|NOT COMPLETED|Overall Study||30
5045973|NCT01983254|12416107|P1|NOT COMPLETED|Overall Study||34
5045974|NCT01983254|12416106|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
5045975|NCT01983254|12416107|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
5045976|NCT01983254|12416106|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
5045977|NCT01983254|12416107|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
5045978|NCT01983254|12416106|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
5045979|NCT01983254|12416107|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
5045980|NCT01983254|12416106|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
5045981|NCT01983254|12416107|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
5045982|NCT01983254|12416106|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
5045983|NCT01983254|12416107|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
5045984|NCT01983111|12416119|P2|NOT COMPLETED|Overall Study||7
5045985|NCT01983111|12416120|P1|NOT COMPLETED|Overall Study||12
5045986|NCT01983111|12416119|P2|COMPLETED|Overall Study||59
5045987|NCT01983111|12416120|P1|COMPLETED|Overall Study||58
5045988|NCT01983111|12416119|P2|STARTED|Overall Study||66
5045989|NCT01983111|12416120|P1|STARTED|Overall Study||70
5045990|NCT01983020|12416140|P4|NOT COMPLETED|Overall Study||0
5045991|NCT01983020|12416141|P3|NOT COMPLETED|Overall Study||0
5045992|NCT01983020|12416142|P2|NOT COMPLETED|Overall Study||0
5045993|NCT01983020|12416143|P1|NOT COMPLETED|Overall Study||0
5045994|NCT01983020|12416140|P4|COMPLETED|Overall Study||11
5045995|NCT01983020|12416141|P3|COMPLETED|Overall Study||12
5045996|NCT01983020|12416142|P2|COMPLETED|Overall Study||11
5045997|NCT01983020|12416143|P1|COMPLETED|Overall Study||12
5045998|NCT01983020|12416140|P4|STARTED|Overall Study||11
5045999|NCT01983020|12416141|P3|STARTED|Overall Study||12
5046000|NCT01983020|12416142|P2|STARTED|Overall Study||11
5046001|NCT01983020|12416143|P1|STARTED|Overall Study||12
5046002|NCT01982955|12416158|P5|NOT COMPLETED|Overall Study||0
5046003|NCT01982955|12416159|P4|NOT COMPLETED|Overall Study||1
5046004|NCT01982955|12416160|P3|NOT COMPLETED|Overall Study||4
5046005|NCT01982955|12416161|P2|NOT COMPLETED|Overall Study||0
5046006|NCT01982955|12416162|P1|NOT COMPLETED|Overall Study||0
5046007|NCT01982955|12416158|P5|COMPLETED|Overall Study||15
5046008|NCT01982955|12416159|P4|COMPLETED|Overall Study||23
5046009|NCT01982955|12416160|P3|COMPLETED|Overall Study||27
5046010|NCT01982955|12416161|P2|COMPLETED|Overall Study||12
5046011|NCT01982955|12416162|P1|COMPLETED|Overall Study||6
5046012|NCT01982955|12416158|P5|Treated|Overall Study||15
5046013|NCT01982955|12416159|P4|Treated|Overall Study||23
5046014|NCT01982955|12416160|P3|Treated|Overall Study||31
5046015|NCT01982955|12416161|P2|Treated|Overall Study||12
5046016|NCT01982955|12416162|P1|Treated|Overall Study||6
5046017|NCT01982955|12416158|P5|STARTED|Overall Study||15
5046018|NCT01982955|12416159|P4|STARTED|Overall Study||24
5046019|NCT01982955|12416160|P3|STARTED|Overall Study||31
5046020|NCT01982955|12416161|P2|STARTED|Overall Study||12
5046021|NCT01982955|12416162|P1|STARTED|Overall Study||6
5046022|NCT01982942|12416264|P2|NOT COMPLETED|Overall Study||14
5046023|NCT01982942|12416265|P1|NOT COMPLETED|Overall Study||21
5046024|NCT01982942|12416264|P2|COMPLETED|Overall Study||112
5046025|NCT01982942|12416265|P1|COMPLETED|Overall Study||108
5046026|NCT01982942|12416264|P2|STARTED|Overall Study||126
5046027|NCT01982942|12416265|P1|STARTED|Overall Study||129
5046028|NCT01982812|12416283|P2|NOT COMPLETED|Overall Study||10
5046029|NCT01982812|12416284|P1|NOT COMPLETED|Overall Study||1
5046030|NCT01982812|12416283|P2|COMPLETED|Overall Study||11
5046031|NCT01982812|12416284|P1|COMPLETED|Overall Study||22
5046032|NCT01982812|12416283|P2|STARTED|Overall Study||21
5046033|NCT01982812|12416284|P1|STARTED|Overall Study||23
5046034|NCT01982773|12416298|P2|NOT COMPLETED|Overall Study||4
5046035|NCT01982773|12416299|P1|NOT COMPLETED|Overall Study||8
5046036|NCT01982773|12416298|P2|COMPLETED|Overall Study||56
5046037|NCT01982773|12416299|P1|COMPLETED|Overall Study||50
5046038|NCT01982773|12416298|P2|STARTED|Overall Study||60
5046039|NCT01982773|12416299|P1|STARTED|Overall Study||58
5046040|NCT01982695|12416313|P2|NOT COMPLETED|Overall Study||1
5046041|NCT01982695|12416314|P1|NOT COMPLETED|Overall Study||0
5046042|NCT01982695|12416313|P2|COMPLETED|Overall Study||10
5046043|NCT01982695|12416314|P1|COMPLETED|Overall Study||12
5046044|NCT01982695|12416313|P2|STARTED|Overall Study||11
5046045|NCT01982695|12416314|P1|STARTED|Overall Study||12
5046046|NCT01982682|12416320|P1|NOT COMPLETED|Overall Study||1
5046047|NCT01982682|12416320|P1|COMPLETED|Overall Study||40
5046048|NCT01982682|12416320|P1|STARTED|Overall Study||41
5046049|NCT01982643|12416328|P1|NOT COMPLETED|Overall Study||12
5046050|NCT01982643|12416328|P1|COMPLETED|Overall Study||37
5046051|NCT01982643|12416328|P1|STARTED|Overall Study||49
5046052|NCT01982539|12416332|P1|NOT COMPLETED|Overall Study||0
5046053|NCT01982539|12416332|P1|COMPLETED|Overall Study||25
5046054|NCT01982539|12416332|P1|STARTED|Overall Study||25
5046055|NCT01982435|12416340|P2|NOT COMPLETED|Overall Study||0
5046056|NCT01982435|12416341|P1|NOT COMPLETED|Overall Study||1
5046057|NCT01982435|12416340|P2|COMPLETED|Overall Study||12
5046058|NCT01982435|12416341|P1|COMPLETED|Overall Study||14
5046059|NCT01982435|12416340|P2|STARTED|Overall Study||12
5046060|NCT01982435|12416341|P1|STARTED|Overall Study||15
5046061|NCT01982383|12416371|P2|NOT COMPLETED|Overall Study||0
5046062|NCT01982383|12416372|P1|NOT COMPLETED|Overall Study||0
5046063|NCT01982383|12416371|P2|COMPLETED|Overall Study||0
5046064|NCT01982383|12416372|P1|COMPLETED|Overall Study||2
5046065|NCT01982383|12416371|P2|STARTED|Overall Study||0
5046066|NCT01982383|12416372|P1|STARTED|Overall Study||2
5046067|NCT01982331|12416380|P2|NOT COMPLETED|Completed Study (Day 112)||0
5046068|NCT01982331|12416381|P1|NOT COMPLETED|Completed Study (Day 112)||2
5046069|NCT01982331|12416380|P2|COMPLETED|Completed Study (Day 112)||7
5046070|NCT01982331|12416381|P1|COMPLETED|Completed Study (Day 112)||25
5046071|NCT01982331|12416380|P2|STARTED|Completed Study (Day 112)||7
5046072|NCT01982331|12416381|P1|STARTED|Completed Study (Day 112)||27
5046073|NCT01982331|12416380|P2|NOT COMPLETED|Received Vaccination 2||3
5046074|NCT01982331|12416381|P1|NOT COMPLETED|Received Vaccination 2||1
5046075|NCT01982331|12416380|P2|COMPLETED|Received Vaccination 2||7
5046076|NCT01982331|12416381|P1|COMPLETED|Received Vaccination 2||27
5046077|NCT01982331|12416380|P2|STARTED|Received Vaccination 2||10
5046078|NCT01982331|12416381|P1|STARTED|Received Vaccination 2||28
5046079|NCT01982331|12416380|P2|NOT COMPLETED|Received Vaccination 1||0
5046080|NCT01982331|12416381|P1|NOT COMPLETED|Received Vaccination 1||0
5046081|NCT01982331|12416380|P2|COMPLETED|Received Vaccination 1||10
5046082|NCT01982331|12416381|P1|COMPLETED|Received Vaccination 1||28
5046083|NCT01982331|12416380|P2|STARTED|Received Vaccination 1||10
5046084|NCT01982331|12416381|P1|STARTED|Received Vaccination 1||28
5046085|NCT01982292|12416417|P2|NOT COMPLETED|Overall Study||1
5046086|NCT01982292|12416418|P1|NOT COMPLETED|Overall Study||12
5046087|NCT01982292|12416417|P2|COMPLETED|Overall Study||107
5046088|NCT01982292|12416418|P1|COMPLETED|Overall Study||203
5046089|NCT01982292|12416417|P2|Safety Set|Overall Study||108
5046090|NCT01982292|12416418|P1|Safety Set|Overall Study||212
5046091|NCT01982292|12416417|P2|Full Analaysis Set (FAS)|Overall Study||108
5046092|NCT01982292|12416418|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
5046093|NCT01982292|12416417|P2|STARTED|Overall Study||108
5046094|NCT01982292|12416418|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
5046095|NCT01982253|12416439|P3|NOT COMPLETED|Overall Study||4
5046096|NCT01982253|12416440|P2|NOT COMPLETED|Overall Study||4
5046097|NCT01982253|12416441|P1|NOT COMPLETED|Overall Study||2
5046098|NCT01982253|12416439|P3|COMPLETED|Overall Study||0
5046099|NCT01982253|12416440|P2|COMPLETED|Overall Study||0
5046100|NCT01982253|12416441|P1|COMPLETED|Overall Study||0
5046101|NCT01982253|12416439|P3|STARTED|Overall Study||4
5046102|NCT01982253|12416440|P2|STARTED|Overall Study||4
5046103|NCT01982253|12416441|P1|STARTED|Overall Study||2
5046104|NCT01982240|12416455|P3|NOT COMPLETED|Overall Study||70
5046105|NCT01982240|12416456|P2|NOT COMPLETED|Overall Study||69
5046106|NCT01982240|12416457|P1|NOT COMPLETED|Overall Study||67
5046107|NCT01982240|12416455|P3|COMPLETED|Overall Study||371
5046108|NCT01982240|12416456|P2|COMPLETED|Overall Study||384
5046109|NCT01982240|12416457|P1|COMPLETED|Overall Study||385
5046110|NCT01982240|12416455|P3|STARTED|Overall Study||441
5046111|NCT01982240|12416456|P2|STARTED|Overall Study||453
5046112|NCT01982240|12416457|P1|STARTED|Overall Study||452
5046113|NCT01982123|12416477|P1|NOT COMPLETED|Overall Study||0
5046114|NCT01982123|12416477|P1|COMPLETED|Overall Study||12
5046115|NCT01982123|12416477|P1|STARTED|Overall Study||12
5046116|NCT01981967|12416484|P2|NOT COMPLETED|Overall Study||0
5046117|NCT01981967|12416485|P1|NOT COMPLETED|Overall Study||0
5046118|NCT01981967|12416484|P2|COMPLETED|Overall Study||3149
5046119|NCT01981967|12416485|P1|COMPLETED|Overall Study||6851
5046120|NCT01981967|12416484|P2|STARTED|Overall Study||3149
5046121|NCT01981967|12416485|P1|STARTED|Overall Study||6851
5046122|NCT01981954|12416495|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
5046123|NCT01981954|12416495|P1|COMPLETED|Fixed-Dose Assessment Period||21
5046124|NCT01981954|12416495|P1|Treated|Fixed-Dose Assessment Period||22
5046125|NCT01981954|12416495|P1|STARTED|Fixed-Dose Assessment Period||22
5046126|NCT01981954|12416495|P1|NOT COMPLETED|Titration Period||1
5046127|NCT01981954|12416495|P1|COMPLETED|Titration Period||22
5046128|NCT01981954|12416495|P1|Treated|Titration Period||23
5046129|NCT01981954|12416495|P1|STARTED|Titration Period||23
5046130|NCT01981863|12416542|P2|NOT COMPLETED|Overall Study||0
5046131|NCT01981863|12416543|P1|NOT COMPLETED|Overall Study||0
5046132|NCT01981863|12416542|P2|COMPLETED|Overall Study||20
5046133|NCT01981863|12416543|P1|COMPLETED|Overall Study||20
5046134|NCT01981863|12416542|P2|STARTED|Overall Study||20
5046135|NCT01981863|12416543|P1|STARTED|Overall Study||20
5046136|NCT01981759|12416555|P2|NOT COMPLETED|Overall Study||11
5046137|NCT01981759|12416556|P1|NOT COMPLETED|Overall Study||7
5046138|NCT01981759|12416555|P2|COMPLETED|Overall Study||19
5046139|NCT01981759|12416556|P1|COMPLETED|Overall Study||21
5046140|NCT01981759|12416555|P2|Completed Week 12|Overall Study||22
5046141|NCT01981759|12416556|P1|Completed Week 12|Overall Study||22
5046142|NCT01981759|12416555|P2|Randomization (Week 3)|Overall Study||30
5046143|NCT01981759|12416556|P1|Randomization (Week 3)|Overall Study||28
5046144|NCT01981759|12416555|P2|Baseline (Week 1)|Overall Study||30
5046145|NCT01981759|12416556|P1|Baseline (Week 1)|Overall Study||28
5046146|NCT01981759|12416555|P2|STARTED|Overall Study||30
5046147|NCT01981759|12416556|P1|STARTED|Overall Study||28
5046148|NCT01981616|12416568|P2|NOT COMPLETED|Overall Study||1
5046149|NCT01981616|12416569|P1|NOT COMPLETED|Overall Study||1
5046150|NCT01981616|12416568|P2|COMPLETED|Overall Study||62
5046151|NCT01981616|12416569|P1|COMPLETED|Overall Study||63
5046152|NCT01981616|12416568|P2|STARTED|Overall Study||63
5046153|NCT01981616|12416569|P1|STARTED|Overall Study||64
5046154|NCT01981590|12416581|P1|NOT COMPLETED|Overall Study||0
5046155|NCT01981590|12416581|P1|COMPLETED|Overall Study||15
5046156|NCT01981590|12416581|P1|STARTED|Overall Study||15
5046157|NCT01981564|12416590|P2|NOT COMPLETED|Overall Study||9
5046158|NCT01981564|12416591|P1|NOT COMPLETED|Overall Study||9
5046159|NCT01981564|12416590|P2|COMPLETED|Overall Study||106
5046160|NCT01981564|12416591|P1|COMPLETED|Overall Study||98
5046161|NCT01981564|12416590|P2|STARTED|Overall Study||115
5046162|NCT01981564|12416591|P1|STARTED|Overall Study||107
5046163|NCT01981551|12416599|P1|NOT COMPLETED|Overall Study||9
5046164|NCT01981551|12416599|P1|COMPLETED|Overall Study||8
5046165|NCT01981551|12416599|P1|STARTED|Overall Study||17
5046166|NCT01981473|12416609|P3|NOT COMPLETED|Overall Study||8
5046167|NCT01981473|12416610|P2|NOT COMPLETED|Overall Study||0
5046168|NCT01981473|12416611|P1|NOT COMPLETED|Overall Study||2
5046169|NCT01981473|12416609|P3|COMPLETED|Overall Study||196
5046170|NCT01981473|12416610|P2|COMPLETED|Overall Study||199
5046171|NCT01981473|12416611|P1|COMPLETED|Overall Study||200
5046172|NCT01981473|12416609|P3|STARTED|Overall Study||204
5046173|NCT01981473|12416610|P2|STARTED|Overall Study||199
5046174|NCT01981473|12416611|P1|STARTED|Overall Study||202
5046175|NCT01981356|12416652|P2|NOT COMPLETED|Overall Study||2
5046176|NCT01981356|12416653|P1|NOT COMPLETED|Overall Study||7
5046177|NCT01981356|12416652|P2|COMPLETED|Overall Study||4
5046178|NCT01981356|12416653|P1|COMPLETED|Overall Study||5
5046179|NCT01981356|12416652|P2|STARTED|Overall Study||6
5046180|NCT01981356|12416653|P1|STARTED|Overall Study||12
5046181|NCT01981122|12416680|P2|NOT COMPLETED|Overall Study||20
5046182|NCT01981122|12416681|P1|NOT COMPLETED|Overall Study||14
5046183|NCT01981122|12416680|P2|COMPLETED|Overall Study||7
5046184|NCT01981122|12416681|P1|COMPLETED|Overall Study||11
5046185|NCT01981122|12416680|P2|STARTED|Overall Study||27
5046186|NCT01981122|12416681|P1|STARTED|Overall Study||25
5046187|NCT01981109|12416687|P1|NOT COMPLETED|Overall Study||224
5046188|NCT01981109|12416687|P1|COMPLETED|Overall Study||1
5046189|NCT01981109|12416687|P1|STARTED|Overall Study||225
5046190|NCT01981096|12416694|P2|NOT COMPLETED|Overall Study||1
5046191|NCT01981096|12416695|P1|NOT COMPLETED|Overall Study||3
5046192|NCT01981096|12416694|P2|COMPLETED|Overall Study||19
5046193|NCT01981096|12416695|P1|COMPLETED|Overall Study||17
5046194|NCT01981096|12416694|P2|Post-treatment|Overall Study||19
5046195|NCT01981096|12416695|P1|Post-treatment|Overall Study||17
5046196|NCT01981096|12416694|P2|STARTED|Overall Study||20
5046197|NCT01981096|12416695|P1|STARTED|Overall Study||20
5046198|NCT01981057|12416707|P2|NOT COMPLETED|Overall Study||0
5046199|NCT01981057|12416708|P1|NOT COMPLETED|Overall Study||0
5046200|NCT01981057|12416707|P2|COMPLETED|Overall Study||50
5046201|NCT01981057|12416708|P1|COMPLETED|Overall Study||50
5046202|NCT01981057|12416707|P2|STARTED|Overall Study||50
5046203|NCT01981057|12416708|P1|STARTED|Overall Study||50
5046204|NCT01980992|12416716|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
5046205|NCT01980992|12416717|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
5046206|NCT01980992|12416716|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
5046207|NCT01980992|12416717|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
5046208|NCT01980992|12416716|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
5046209|NCT01980992|12416717|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
5046210|NCT01980992|12416716|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
5046211|NCT01980992|12416717|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
5046212|NCT01980992|12416716|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
5046213|NCT01980992|12416717|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
5046214|NCT01980992|12416716|P2|STARTED|52 Weeks Blinded Study Treatment||23
5046215|NCT01980992|12416717|P1|STARTED|52 Weeks Blinded Study Treatment||23
5046216|NCT01980940|12416742|P8|NOT COMPLETED|Overall Study||0
5046217|NCT01980940|12416743|P7|NOT COMPLETED|Overall Study||0
5046218|NCT01980940|12416744|P6|NOT COMPLETED|Overall Study||2
5046219|NCT01980940|12416745|P5|NOT COMPLETED|Overall Study||0
5046220|NCT01980940|12416746|P4|NOT COMPLETED|Overall Study||0
5046221|NCT01980940|12416747|P3|NOT COMPLETED|Overall Study||0
5046222|NCT01980940|12416748|P2|NOT COMPLETED|Overall Study||0
5046223|NCT01980940|12416749|P1|NOT COMPLETED|Overall Study||0
5046224|NCT01980940|12416742|P8|COMPLETED|Overall Study||24
5046225|NCT01980940|12416743|P7|COMPLETED|Overall Study||24
5046226|NCT01980940|12416744|P6|COMPLETED|Overall Study||0
5046227|NCT01980940|12416745|P5|COMPLETED|Overall Study||2
5046228|NCT01980940|12416746|P4|COMPLETED|Overall Study||3
5046229|NCT01980940|12416747|P3|COMPLETED|Overall Study||5
5046230|NCT01980940|12416748|P2|COMPLETED|Overall Study||5
5046231|NCT01980940|12416749|P1|COMPLETED|Overall Study||5
5046232|NCT01980940|12416742|P8|Treated|Overall Study||24
5046233|NCT01980940|12416743|P7|Treated|Overall Study||24
5046234|NCT01980940|12416744|P6|Treated|Overall Study||2
5046235|NCT01980940|12416745|P5|Treated|Overall Study||2
5046236|NCT01980940|12416746|P4|Treated|Overall Study||3
5046237|NCT01980940|12416747|P3|Treated|Overall Study||5
5046238|NCT01980940|12416748|P2|Treated|Overall Study||5
5046239|NCT01980940|12416749|P1|Treated|Overall Study||5
5046240|NCT01980940|12416742|P8|STARTED|Overall Study||24
5046241|NCT01980940|12416743|P7|STARTED|Overall Study||24
5046242|NCT01980940|12416744|P6|STARTED|Overall Study||2
5046243|NCT01980940|12416745|P5|STARTED|Overall Study||2
5046244|NCT01980940|12416746|P4|STARTED|Overall Study||3
5046245|NCT01980940|12416747|P3|STARTED|Overall Study||5
5046246|NCT01980940|12416748|P2|STARTED|Overall Study||5
5046247|NCT01980940|12416749|P1|STARTED|Overall Study||5
5046248|NCT01980914|12416801|P1|NOT COMPLETED|Overall Study||0
5046249|NCT01980914|12416801|P1|COMPLETED|Overall Study||11
5046250|NCT01980914|12416801|P1|STARTED|Overall Study||11
5046251|NCT01980888|12416808|P2|NOT COMPLETED|Overall Study||133
5046252|NCT01980888|12416809|P1|NOT COMPLETED|Overall Study||144
5046253|NCT01980888|12416808|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
5046254|NCT01980888|12416809|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
5046255|NCT01980888|12416808|P2|STARTED|Overall Study||154
5046256|NCT01980888|12416809|P1|STARTED|Overall Study||157
5046257|NCT01980875|12416828|P3|NOT COMPLETED|Overall Study||24
5046258|NCT01980875|12416829|P2|NOT COMPLETED|Overall Study||25
5046259|NCT01980875|12416830|P1|NOT COMPLETED|Overall Study||8
5046260|NCT01980875|12416828|P3|COMPLETED|Overall Study||0
5046261|NCT01980875|12416829|P2|COMPLETED|Overall Study||0
5046262|NCT01980875|12416830|P1|COMPLETED|Overall Study||0
5046263|NCT01980875|12416828|P3|STARTED|Overall Study||24
5046264|NCT01980875|12416829|P2|STARTED|Overall Study||25
5046265|NCT01980875|12416830|P1|STARTED|Overall Study||8
5046266|NCT01980771|12416855|P2|NOT COMPLETED|Overall Study||119
5046267|NCT01980771|12416856|P1|NOT COMPLETED|Overall Study||84
5046268|NCT01980771|12416855|P2|COMPLETED|Overall Study||305
5046269|NCT01980771|12416856|P1|COMPLETED|Overall Study||352
5046270|NCT01980771|12416855|P2|STARTED|Overall Study||424
5046271|NCT01980771|12416856|P1|STARTED|Overall Study||436
5046272|NCT01980706|12416865|P3|NOT COMPLETED|Overall Study||13
5046273|NCT01980706|12416866|P2|NOT COMPLETED|Overall Study||17
5046274|NCT01980706|12416867|P1|NOT COMPLETED|Overall Study||17
5046275|NCT01980706|12416865|P3|COMPLETED|Overall Study||24
5046276|NCT01980706|12416866|P2|COMPLETED|Overall Study||26
5046277|NCT01980706|12416867|P1|COMPLETED|Overall Study||23
5046278|NCT01980706|12416865|P3|STARTED|Overall Study||37
5046279|NCT01980706|12416866|P2|STARTED|Overall Study||43
5046280|NCT01980706|12416867|P1|STARTED|Overall Study||40
5046281|NCT01980654|12416892|P2|NOT COMPLETED|Overall Study||0
5046282|NCT01980654|12416893|P1|NOT COMPLETED|Overall Study||0
5046283|NCT01980654|12416892|P2|COMPLETED|Overall Study||20
5046284|NCT01980654|12416893|P1|COMPLETED|Overall Study||60
5046285|NCT01980654|12416892|P2|STARTED|Overall Study||20
5046286|NCT01980654|12416893|P1|STARTED|Overall Study||60
5046287|NCT01980628|12416907|P1|NOT COMPLETED|Overall Study||63
5046288|NCT01980628|12416907|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
5046289|NCT01980628|12416907|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
5046290|NCT01980589|12416915|P3|NOT COMPLETED|Overall Study||0
5046291|NCT01980589|12416916|P2|NOT COMPLETED|Overall Study||0
5046292|NCT01980589|12416917|P1|NOT COMPLETED|Overall Study||0
5046293|NCT01980589|12416915|P3|COMPLETED|Overall Study||16
5046294|NCT01980589|12416916|P2|COMPLETED|Overall Study||3
5046295|NCT01980589|12416917|P1|COMPLETED|Overall Study||3
5046296|NCT01980589|12416915|P3|STARTED|Overall Study||16
5046297|NCT01980589|12416916|P2|STARTED|Overall Study||3
5046298|NCT01980589|12416917|P1|STARTED|Overall Study||3
5046299|NCT01980524|12416934|P2|NOT COMPLETED|Study Day 2||0
5046300|NCT01980524|12416935|P1|NOT COMPLETED|Study Day 2||0
5046301|NCT01980524|12416934|P2|COMPLETED|Study Day 2||4
5046302|NCT01980524|12416935|P1|COMPLETED|Study Day 2||4
5046303|NCT01980524|12416934|P2|STARTED|Study Day 2||4
5046304|NCT01980524|12416935|P1|STARTED|Study Day 2||4
5046305|NCT01980524|12416934|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
5046306|NCT01980524|12416935|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
5046307|NCT01980524|12416934|P2|COMPLETED|Washout (at Least 2 Weeks)||4
5046308|NCT01980524|12416935|P1|COMPLETED|Washout (at Least 2 Weeks)||4
5046309|NCT01980524|12416934|P2|STARTED|Washout (at Least 2 Weeks)||4
5046310|NCT01980524|12416935|P1|STARTED|Washout (at Least 2 Weeks)||4
5046311|NCT01980524|12416934|P2|NOT COMPLETED|Study Day 1||0
5046312|NCT01980524|12416935|P1|NOT COMPLETED|Study Day 1||0
5046313|NCT01980524|12416934|P2|COMPLETED|Study Day 1||4
5046314|NCT01980524|12416935|P1|COMPLETED|Study Day 1||4
5046315|NCT01980524|12416934|P2|STARTED|Study Day 1||4
5046316|NCT01980524|12416935|P1|STARTED|Study Day 1||4
5046317|NCT01980485|12416947|P2|NOT COMPLETED|Overall Study||25
5046318|NCT01980485|12416948|P1|NOT COMPLETED|Overall Study||36
5046319|NCT01980485|12416947|P2|COMPLETED|Overall Study||80
5046320|NCT01980485|12416948|P1|COMPLETED|Overall Study||84
5046321|NCT01980485|12416947|P2|STARTED|Overall Study||105
5046322|NCT01980485|12416948|P1|STARTED|Overall Study||120
5046323|NCT01980342|12416956|P1|NOT COMPLETED|Overall Study||1
5046324|NCT01980342|12416956|P1|COMPLETED|Overall Study||0
5046325|NCT01980342|12416956|P1|STARTED|Overall Study||1
5046326|NCT01980095|12416966|P2|NOT COMPLETED|Overall Study||11
5046327|NCT01980095|12416967|P1|NOT COMPLETED|Overall Study||15
5046328|NCT01980095|12416966|P2|COMPLETED|Overall Study||30
5046329|NCT01980095|12416967|P1|COMPLETED|Overall Study||63
5046330|NCT01980095|12416966|P2|Treated|Overall Study||41
5046331|NCT01980095|12416967|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
5046332|NCT01980095|12416966|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
5046333|NCT01980095|12416967|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
5046334|NCT01980056|12416978|P3|NOT COMPLETED|Overall Study||0
5046335|NCT01980056|12416979|P2|NOT COMPLETED|Overall Study||1
5046336|NCT01980056|12416980|P1|NOT COMPLETED|Overall Study||1
5046337|NCT01980056|12416978|P3|COMPLETED|Overall Study||2
5046338|NCT01980056|12416979|P2|COMPLETED|Overall Study||3
5046339|NCT01980056|12416980|P1|COMPLETED|Overall Study||3
5046340|NCT01980056|12416978|P3|STARTED|Overall Study||2
5046341|NCT01980056|12416979|P2|STARTED|Overall Study||4
5046342|NCT01980056|12416980|P1|STARTED|Overall Study||4
5046343|NCT01979952|12416994|P2|NOT COMPLETED|Overall Study||6
5046344|NCT01979952|12416995|P1|NOT COMPLETED|Overall Study||8
5046345|NCT01979952|12416994|P2|COMPLETED|Overall Study||51
5046346|NCT01979952|12416995|P1|COMPLETED|Overall Study||48
5046347|NCT01979952|12416994|P2|STARTED|Overall Study||57
5046348|NCT01979952|12416995|P1|STARTED|Overall Study||56
5046349|NCT01979835|12417023|P1|NOT COMPLETED|Follow-up||32
5046350|NCT01979835|12417023|P1|COMPLETED|Follow-up||980
5046351|NCT01979835|12417023|P1|STARTED|Follow-up||1012
5046352|NCT01979835|12417023|P1|NOT COMPLETED|Primary Outcome SA Measurment||18
5046353|NCT01979835|12417023|P1|COMPLETED|Primary Outcome SA Measurment||1012
5046354|NCT01979835|12417023|P1|STARTED|Primary Outcome SA Measurment||1030
5046355|NCT01979614|12417030|P2|NOT COMPLETED|Overall Study||1
5046356|NCT01979614|12417031|P1|NOT COMPLETED|Overall Study||1
5046357|NCT01979614|12417030|P2|COMPLETED|Overall Study||27
5046358|NCT01979614|12417031|P1|COMPLETED|Overall Study||29
5046359|NCT01979614|12417030|P2|PD Analysis Set|Overall Study||26
5046360|NCT01979614|12417031|P1|PD Analysis Set|Overall Study||25
5046361|NCT01979614|12417030|P2|PK Analysis Set|Overall Study||0
5046362|NCT01979614|12417031|P1|PK Analysis Set|Overall Study||30
5046363|NCT01979614|12417030|P2|Safety Analysis Set|Overall Study||28
5046364|NCT01979614|12417031|P1|Safety Analysis Set|Overall Study||30
5046365|NCT01979614|12417030|P2|STARTED|Overall Study||28
5046366|NCT01979614|12417031|P1|STARTED|Overall Study||30
5046367|NCT01979523|12417053|P2|NOT COMPLETED|Overall Study||0
5046368|NCT01979523|12417054|P1|NOT COMPLETED|Overall Study||1
5046369|NCT01979523|12417053|P2|COMPLETED|Overall Study||21
5046370|NCT01979523|12417054|P1|COMPLETED|Overall Study||20
5046371|NCT01979523|12417053|P2|STARTED|Overall Study||21
5046372|NCT01979523|12417054|P1|STARTED|Overall Study||21
5046373|NCT01979445|12417077|P4|NOT COMPLETED|Overall Study||0
5046374|NCT01979445|12417078|P3|NOT COMPLETED|Overall Study||0
5046375|NCT01979445|12417079|P2|NOT COMPLETED|Overall Study||0
5046376|NCT01979445|12417080|P1|NOT COMPLETED|Overall Study||0
5046377|NCT01979445|12417077|P4|COMPLETED|Overall Study||3
5046378|NCT01979445|12417078|P3|COMPLETED|Overall Study||6
5046379|NCT01979445|12417079|P2|COMPLETED|Overall Study||3
5046380|NCT01979445|12417080|P1|COMPLETED|Overall Study||3
5046381|NCT01979445|12417077|P4|ITT Population|Overall Study||3
5046382|NCT01979445|12417078|P3|ITT Population|Overall Study||6
5046383|NCT01979445|12417079|P2|ITT Population|Overall Study||3
5046384|NCT01979445|12417080|P1|ITT Population|Overall Study||3
5046385|NCT01979445|12417077|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5046386|NCT01979445|12417078|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5046387|NCT01979445|12417079|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5046388|NCT01979445|12417080|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5046389|NCT01979445|12417077|P4|STARTED|Overall Study||3
5046390|NCT01979445|12417078|P3|STARTED|Overall Study||6
5046391|NCT01979445|12417079|P2|STARTED|Overall Study||3
5046392|NCT01979445|12417080|P1|STARTED|Overall Study||3
5046393|NCT01979276|12417106|P1|NOT COMPLETED|Overall Study||0
5046394|NCT01979276|12417106|P1|COMPLETED|Overall Study||2
5046395|NCT01979276|12417106|P1|STARTED|Overall Study||2
5046396|NCT01979185|12417114|P2|NOT COMPLETED|Period 2||1
5046397|NCT01979185|12417115|P1|NOT COMPLETED|Period 2||0
5046398|NCT01979185|12417114|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
5046399|NCT01979185|12417115|P1|COMPLETED|Period 2||15
5046400|NCT01979185|12417114|P2|STARTED|Period 2||15
5046401|NCT01979185|12417115|P1|STARTED|Period 2||15
5046402|NCT01979185|12417114|P2|NOT COMPLETED|Period 1||0
5046403|NCT01979185|12417115|P1|NOT COMPLETED|Period 1||0
5046404|NCT01979185|12417114|P2|COMPLETED|Period 1||15
5046405|NCT01979185|12417115|P1|COMPLETED|Period 1||15
5046406|NCT01979185|12417114|P2|STARTED|Period 1||15
5046407|NCT01979185|12417115|P1|STARTED|Period 1||15
5046408|NCT01979159|12417125|P1|NOT COMPLETED|Overall Study||0
5046409|NCT01979159|12417125|P1|COMPLETED|Overall Study||4
5046410|NCT01979159|12417125|P1|STARTED|Overall Study||4
5046411|NCT01979133|12417131|P1|NOT COMPLETED|Overall Study||3
5046412|NCT01979133|12417131|P1|COMPLETED|Overall Study||7
5046413|NCT01979133|12417131|P1|STARTED|Overall Study||10
5046414|NCT01979029|12417150|P2|NOT COMPLETED|Overall Study||0
5046415|NCT01979029|12417151|P1|NOT COMPLETED|Overall Study||0
5046416|NCT01979029|12417150|P2|COMPLETED|Overall Study||28
5046417|NCT01979029|12417151|P1|COMPLETED|Overall Study||29
5046418|NCT01979029|12417150|P2|STARTED|Overall Study||28
5046419|NCT01979029|12417151|P1|STARTED|Overall Study||29
5046420|NCT01979016|12417163|P2|NOT COMPLETED|Overall Study||1
5046421|NCT01979016|12417164|P1|NOT COMPLETED|Overall Study||2
5046422|NCT01979016|12417163|P2|COMPLETED|Overall Study||26
5046423|NCT01979016|12417164|P1|COMPLETED|Overall Study||25
5046424|NCT01979016|12417163|P2|STARTED|Overall Study||27
5046425|NCT01979016|12417164|P1|STARTED|Overall Study||27
5046426|NCT01978938|12417198|P2|NOT COMPLETED|Overall Study||14
5046427|NCT01978938|12417199|P1|NOT COMPLETED|Overall Study||23
5046428|NCT01978938|12417198|P2|COMPLETED|Overall Study||439
5046429|NCT01978938|12417199|P1|COMPLETED|Overall Study||432
5046430|NCT01978938|12417198|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
5046431|NCT01978938|12417199|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
5046432|NCT01978938|12417198|P2|STARTED|Overall Study||453
5046433|NCT01978938|12417199|P1|STARTED|Overall Study||455
5046434|NCT01978912|12417213|P4|NOT COMPLETED|Overall Study||3
5046435|NCT01978912|12417214|P3|NOT COMPLETED|Overall Study||3
5046436|NCT01978912|12417215|P2|NOT COMPLETED|Overall Study||3
5046437|NCT01978912|12417216|P1|NOT COMPLETED|Overall Study||3
5046438|NCT01978912|12417213|P4|COMPLETED|Overall Study||3
5046439|NCT01978912|12417214|P3|COMPLETED|Overall Study||3
5046440|NCT01978912|12417215|P2|COMPLETED|Overall Study||3
5046441|NCT01978912|12417216|P1|COMPLETED|Overall Study||3
5046442|NCT01978912|12417213|P4|STARTED|Overall Study||6
5046443|NCT01978912|12417214|P3|STARTED|Overall Study||6
5046444|NCT01978912|12417215|P2|STARTED|Overall Study||6
5046445|NCT01978912|12417216|P1|STARTED|Overall Study||6
5046446|NCT01978743|12417262|P1|NOT COMPLETED|Overall Study||0
5046447|NCT01978743|12417262|P1|COMPLETED|Overall Study||10
5046448|NCT01978743|12417262|P1|STARTED|Overall Study||10
5046449|NCT01978600|12417276|P2|NOT COMPLETED|Overall Study||0
5046450|NCT01978600|12417277|P1|NOT COMPLETED|Overall Study||0
5046451|NCT01978600|12417276|P2|COMPLETED|Overall Study||42
5046452|NCT01978600|12417277|P1|COMPLETED|Overall Study||44
5046453|NCT01978600|12417276|P2|STARTED|Overall Study||42
5046454|NCT01978600|12417277|P1|STARTED|Overall Study||44
5046455|NCT01978535|12417289|P2|NOT COMPLETED|Overall Study||0
5046456|NCT01978535|12417290|P1|NOT COMPLETED|Overall Study||0
5046457|NCT01978535|12417289|P2|COMPLETED|Overall Study||2
5046458|NCT01978535|12417290|P1|COMPLETED|Overall Study||1
5046459|NCT01978535|12417289|P2|STARTED|Overall Study||2
5046460|NCT01978535|12417290|P1|STARTED|Overall Study||1
5046461|NCT01978509|12417299|P3|NOT COMPLETED|Overall Study||0
5046462|NCT01978509|12417300|P2|NOT COMPLETED|Overall Study||5
5046463|NCT01978509|12417301|P1|NOT COMPLETED|Overall Study||2
5046464|NCT01978509|12417299|P3|COMPLETED|Overall Study||9
5046465|NCT01978509|12417300|P2|COMPLETED|Overall Study||8
5046466|NCT01978509|12417301|P1|COMPLETED|Overall Study||8
5046467|NCT01978509|12417299|P3|STARTED|Overall Study||9
5046468|NCT01978509|12417300|P2|STARTED|Overall Study||13
5046469|NCT01978509|12417301|P1|STARTED|Overall Study||10
5046470|NCT01978314|12417323|P5|NOT COMPLETED|Overall Study||0
5046471|NCT01978314|12417324|P4|NOT COMPLETED|Overall Study||0
5046472|NCT01978314|12417325|P3|NOT COMPLETED|Overall Study||0
5046473|NCT01978314|12417326|P2|NOT COMPLETED|Overall Study||0
5046474|NCT01978314|12417327|P1|NOT COMPLETED|Overall Study||0
5046475|NCT01978314|12417323|P5|COMPLETED|Overall Study||8
5046476|NCT01978314|12417324|P4|COMPLETED|Overall Study||1
5046477|NCT01978314|12417325|P3|COMPLETED|Overall Study||8
5046478|NCT01978314|12417326|P2|COMPLETED|Overall Study||8
5046479|NCT01978314|12417327|P1|COMPLETED|Overall Study||8
5046480|NCT01978314|12417323|P5|STARTED|Overall Study||8
5046481|NCT01978314|12417324|P4|STARTED|Overall Study||1
5046482|NCT01978314|12417325|P3|STARTED|Overall Study||8
5046483|NCT01978314|12417326|P2|STARTED|Overall Study||8
5046484|NCT01978314|12417327|P1|STARTED|Overall Study||8
5046485|NCT01978262|12417409|P1|NOT COMPLETED|Overall Study||11
5046486|NCT01978262|12417409|P1|COMPLETED|Overall Study||92
5046487|NCT01978262|12417409|P1|STARTED|Overall Study||103
5046488|NCT01978236|12417414|P1|NOT COMPLETED|Overall Study||2
5046489|NCT01978236|12417414|P1|COMPLETED|Overall Study||4
5046490|NCT01978236|12417414|P1|STARTED|Overall Study||6
5046491|NCT01978184|12417435|P2|NOT COMPLETED|Overall Study||20
5046492|NCT01978184|12417436|P1|NOT COMPLETED|Overall Study||13
5046493|NCT01978184|12417435|P2|COMPLETED|Overall Study||41
5046494|NCT01978184|12417436|P1|COMPLETED|Overall Study||30
5046495|NCT01978184|12417435|P2|STARTED|Overall Study||61
5046496|NCT01978184|12417436|P1|STARTED|Overall Study||43
5046497|NCT01978145|12417462|P2|NOT COMPLETED|Treatment Period 2||14
5046498|NCT01978145|12417463|P1|NOT COMPLETED|Treatment Period 2||19
5046499|NCT01978145|12417462|P2|COMPLETED|Treatment Period 2||179
5046500|NCT01978145|12417463|P1|COMPLETED|Treatment Period 2||185
5046501|NCT01978145|12417462|P2|STARTED|Treatment Period 2||193
5046502|NCT01978145|12417463|P1|STARTED|Treatment Period 2||204
5046503|NCT01978145|12417462|P2|NOT COMPLETED|Washout Period 1||3
5046504|NCT01978145|12417463|P1|NOT COMPLETED|Washout Period 1||1
5046505|NCT01978145|12417462|P2|COMPLETED|Washout Period 1||193
5046506|NCT01978145|12417463|P1|COMPLETED|Washout Period 1||204
5046507|NCT01978145|12417462|P2|STARTED|Washout Period 1||196
5046508|NCT01978145|12417463|P1|STARTED|Washout Period 1||205
5046509|NCT01978145|12417462|P2|NOT COMPLETED|Treatment Period 1||16
5046510|NCT01978145|12417463|P1|NOT COMPLETED|Treatment Period 1||9
5046511|NCT01978145|12417462|P2|COMPLETED|Treatment Period 1||196
5046512|NCT01978145|12417463|P1|COMPLETED|Treatment Period 1||205
5046513|NCT01978145|12417462|P2|STARTED|Treatment Period 1||212
5046514|NCT01978145|12417463|P1|STARTED|Treatment Period 1||214
5046515|NCT01978119|12417479|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
5046516|NCT01978119|12417480|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
5046517|NCT01978119|12417479|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
5046518|NCT01978119|12417480|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
5046519|NCT01978119|12417479|P2|STARTED|Treatment Period 2 (12 Weeks)||42
5046520|NCT01978119|12417480|P1|STARTED|Treatment Period 2 (12 Weeks)||38
5046521|NCT01978119|12417479|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
5046522|NCT01978119|12417480|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
5046523|NCT01978119|12417479|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
5046524|NCT01978119|12417480|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
5046525|NCT01978119|12417479|P2|STARTED|Washout Period 1 (3 Weeks)||42
5046526|NCT01978119|12417480|P1|STARTED|Washout Period 1 (3 Weeks)||38
5046527|NCT01978119|12417479|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
5046528|NCT01978119|12417480|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
5046529|NCT01978119|12417479|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
5046530|NCT01978119|12417480|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
5046531|NCT01978119|12417479|P2|STARTED|Treatment Period 1 (12 Weeks)||42
5046532|NCT01978119|12417480|P1|STARTED|Treatment Period 1 (12 Weeks)||40
5046533|NCT01978093|12417506|P2|NOT COMPLETED|Overall Study||73
5046534|NCT01978093|12417507|P1|NOT COMPLETED|Overall Study||65
5046535|NCT01978093|12417506|P2|COMPLETED|Overall Study||230
5046536|NCT01978093|12417507|P1|COMPLETED|Overall Study||232
5046537|NCT01978093|12417506|P2|STARTED|Overall Study||303
5046538|NCT01978093|12417507|P1|STARTED|Overall Study||297
5046539|NCT01977937|12417551|P2|NOT COMPLETED|Overall Study||2
5046540|NCT01977937|12417552|P1|NOT COMPLETED|Overall Study||3
5046541|NCT01977937|12417551|P2|COMPLETED|Overall Study||26
5046542|NCT01977937|12417552|P1|COMPLETED|Overall Study||24
5046543|NCT01977937|12417551|P2|STARTED|Overall Study||28
5046544|NCT01977937|12417552|P1|STARTED|Overall Study||27
5046545|NCT01977846|12417562|P2|NOT COMPLETED|Total Study - Prospective||29
5046546|NCT01977846|12417563|P1|NOT COMPLETED|Total Study - Prospective||0
5046547|NCT01977846|12417562|P2|COMPLETED|Total Study - Prospective||230
5046548|NCT01977846|12417563|P1|COMPLETED|Total Study - Prospective||0
5046549|NCT01977846|12417562|P2|STARTED|Total Study - Prospective||259
5046550|NCT01977846|12417563|P1|STARTED|Total Study - Prospective||0
5046551|NCT01977846|12417562|P2|NOT COMPLETED|Total Study - Retrospective||0
5046552|NCT01977846|12417563|P1|NOT COMPLETED|Total Study - Retrospective||0
5046553|NCT01977846|12417562|P2|COMPLETED|Total Study - Retrospective||0
5046554|NCT01977846|12417563|P1|COMPLETED|Total Study - Retrospective||251
5046555|NCT01977846|12417562|P2|STARTED|Total Study - Retrospective||0
5046556|NCT01977846|12417563|P1|STARTED|Total Study - Retrospective||251
5046557|NCT01977820|12417581|P2|NOT COMPLETED|Overall Study||1
5046558|NCT01977820|12417582|P1|NOT COMPLETED|Overall Study||1
5046559|NCT01977820|12417581|P2|COMPLETED|Overall Study||0
5046560|NCT01977820|12417582|P1|COMPLETED|Overall Study||0
5046561|NCT01977820|12417581|P2|STARTED|Overall Study||1
5046562|NCT01977820|12417582|P1|STARTED|Overall Study||1
5046563|NCT01977794|12417590|P2|NOT COMPLETED|Overall Study||6
5046564|NCT01977794|12417591|P1|NOT COMPLETED|Overall Study||8
5046565|NCT01977794|12417590|P2|COMPLETED|Overall Study||94
5046566|NCT01977794|12417591|P1|COMPLETED|Overall Study||92
5046567|NCT01977794|12417590|P2|STARTED|Overall Study||100
5046568|NCT01977794|12417591|P1|STARTED|Overall Study||100
5046569|NCT01977781|12417607|P2|NOT COMPLETED|Overall Study||1
5046570|NCT01977781|12417608|P1|NOT COMPLETED|Overall Study||6
5046571|NCT01977781|12417607|P2|COMPLETED|Overall Study||15
5046572|NCT01977781|12417608|P1|COMPLETED|Overall Study||18
5046573|NCT01977781|12417607|P2|STARTED|Overall Study||16
5046574|NCT01977781|12417608|P1|STARTED|Overall Study||24
5046575|NCT01977729|12417626|P1|NOT COMPLETED|Overall Study||1
5046576|NCT01977729|12417626|P1|COMPLETED|Overall Study||0
5046577|NCT01977729|12417626|P1|STARTED|Overall Study||1
5046578|NCT01977690|12417638|P2|NOT COMPLETED|Overall Study||4
5046579|NCT01977690|12417639|P1|NOT COMPLETED|Overall Study||0
5046580|NCT01977690|12417638|P2|COMPLETED|Overall Study||11
5046581|NCT01977690|12417639|P1|COMPLETED|Overall Study||15
5046582|NCT01977690|12417638|P2|STARTED|Overall Study||15
5046583|NCT01977690|12417639|P1|STARTED|Overall Study||15
5046584|NCT01977677|12417648|P3|NOT COMPLETED|Overall Study||1
5046585|NCT01977677|12417649|P2|NOT COMPLETED|Overall Study||0
5046586|NCT01977677|12417650|P1|NOT COMPLETED|Overall Study||0
5046587|NCT01977677|12417648|P3|COMPLETED|Overall Study||20
5046588|NCT01977677|12417649|P2|COMPLETED|Overall Study||6
5046589|NCT01977677|12417650|P1|COMPLETED|Overall Study||3
5046590|NCT01977677|12417648|P3|STARTED|Overall Study||21
5046591|NCT01977677|12417649|P2|STARTED|Overall Study||6
5046592|NCT01977677|12417650|P1|STARTED|Overall Study||3
5046593|NCT01977625|12417661|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
5046594|NCT01977625|12417662|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
5046595|NCT01977625|12417661|P2|COMPLETED|Second Intervention (4 Weeks)||7
5046596|NCT01977625|12417662|P1|COMPLETED|Second Intervention (4 Weeks)||7
5046597|NCT01977625|12417661|P2|STARTED|Second Intervention (4 Weeks)||7
5046598|NCT01977625|12417662|P1|STARTED|Second Intervention (4 Weeks)||8
5046599|NCT01977625|12417661|P2|NOT COMPLETED|Washout (2 Weeks)||0
5046600|NCT01977625|12417662|P1|NOT COMPLETED|Washout (2 Weeks)||0
5046601|NCT01977625|12417661|P2|COMPLETED|Washout (2 Weeks)||7
5046602|NCT01977625|12417662|P1|COMPLETED|Washout (2 Weeks)||8
5046603|NCT01977625|12417661|P2|STARTED|Washout (2 Weeks)||7
5046604|NCT01977625|12417662|P1|STARTED|Washout (2 Weeks)||8
5046605|NCT01977625|12417661|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
5046606|NCT01977625|12417662|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
5046607|NCT01977625|12417661|P2|COMPLETED|First Intervention (4 Weeks)||7
5046608|NCT01977625|12417662|P1|COMPLETED|First Intervention (4 Weeks)||8
5046609|NCT01977625|12417661|P2|STARTED|First Intervention (4 Weeks)||7
5046610|NCT01977625|12417662|P1|STARTED|First Intervention (4 Weeks)||11
5046611|NCT01977612|12417672|P2|NOT COMPLETED|Overall Study||1
5046612|NCT01977612|12417673|P1|NOT COMPLETED|Overall Study||1
5046613|NCT01977612|12417672|P2|COMPLETED|Overall Study||79
5046614|NCT01977612|12417673|P1|COMPLETED|Overall Study||84
5046615|NCT01977612|12417672|P2|STARTED|Overall Study||80
5046616|NCT01977612|12417673|P1|STARTED|Overall Study||85
5046617|NCT01977573|12417695|P4|NOT COMPLETED|Overall Study||3
5046618|NCT01977573|12417696|P3|NOT COMPLETED|Overall Study||4
5046619|NCT01977573|12417697|P2|NOT COMPLETED|Overall Study||3
5046620|NCT01977573|12417698|P1|NOT COMPLETED|Overall Study||20
5046621|NCT01977573|12417695|P4|COMPLETED|Overall Study||33
5046622|NCT01977573|12417696|P3|COMPLETED|Overall Study||32
5046623|NCT01977573|12417697|P2|COMPLETED|Overall Study||41
5046624|NCT01977573|12417698|P1|COMPLETED|Overall Study||116
5046625|NCT01977573|12417695|P4|STARTED|Overall Study||36
5046626|NCT01977573|12417696|P3|STARTED|Overall Study||36
5046627|NCT01977573|12417697|P2|STARTED|Overall Study||44
5046628|NCT01977573|12417698|P1|STARTED|Overall Study||136
5046629|NCT01977482|12417812|P6|NOT COMPLETED|Overall Study||5
5046630|NCT01977482|12417813|P5|NOT COMPLETED|Overall Study||3
5046631|NCT01977482|12417814|P4|NOT COMPLETED|Overall Study||4
5046632|NCT01977482|12417815|P3|NOT COMPLETED|Overall Study||5
5046633|NCT01977482|12417816|P2|NOT COMPLETED|Overall Study||9
5046634|NCT01977482|12417817|P1|NOT COMPLETED|Overall Study||3
5046635|NCT01977482|12417812|P6|COMPLETED|Overall Study||14
5046636|NCT01977482|12417813|P5|COMPLETED|Overall Study||37
5046637|NCT01977482|12417814|P4|COMPLETED|Overall Study||35
5046638|NCT01977482|12417815|P3|COMPLETED|Overall Study||35
5046639|NCT01977482|12417816|P2|COMPLETED|Overall Study||30
5046640|NCT01977482|12417817|P1|COMPLETED|Overall Study||36
5046641|NCT01977482|12417812|P6|STARTED|Overall Study||19
5046642|NCT01977482|12417813|P5|STARTED|Overall Study||40
5046643|NCT01977482|12417814|P4|STARTED|Overall Study||39
5046644|NCT01977482|12417815|P3|STARTED|Overall Study||40
5046645|NCT01977482|12417816|P2|STARTED|Overall Study||39
5046646|NCT01977482|12417817|P1|STARTED|Overall Study||39
5046647|NCT01977456|12417932|P1|NOT COMPLETED|Overall Study||5
5046648|NCT01977456|12417932|P1|COMPLETED|Overall Study||22
5046649|NCT01977456|12417932|P1|STARTED|Overall Study||27
5046650|NCT01977352|12417941|P2|NOT COMPLETED|Overall Study||2
5046651|NCT01977352|12417942|P1|NOT COMPLETED|Overall Study||1
5046652|NCT01977352|12417941|P2|COMPLETED|Overall Study||19
5046653|NCT01977352|12417942|P1|COMPLETED|Overall Study||20
5046654|NCT01977352|12417941|P2|STARTED|Overall Study||21
5046655|NCT01977352|12417942|P1|STARTED|Overall Study||21
5046656|NCT01977222|12417960|P1|NOT COMPLETED|Overall Study||1
5046657|NCT01977222|12417960|P1|COMPLETED|Overall Study||11
5046658|NCT01977222|12417960|P1|STARTED|Overall Study||12
5046659|NCT01977092|12417973|P2|NOT COMPLETED|Overall Study||30
5046660|NCT01977092|12417974|P1|NOT COMPLETED|Overall Study||31
5046661|NCT01977092|12417973|P2|COMPLETED|Overall Study||151
5046662|NCT01977092|12417974|P1|COMPLETED|Overall Study||118
5046663|NCT01977092|12417973|P2|STARTED|Overall Study||181
5046664|NCT01977092|12417974|P1|STARTED|Overall Study||149
5046665|NCT01977040|12417984|P1|NOT COMPLETED|Overall Study||2
5046666|NCT01977040|12417984|P1|COMPLETED|Overall Study||66
5046667|NCT01977040|12417984|P1|STARTED|Overall Study||68
5046668|NCT01976988|12417996|P2|NOT COMPLETED|Overall Study||18
5046669|NCT01976988|12417997|P1|NOT COMPLETED|Overall Study||16
5046670|NCT01976988|12417996|P2|COMPLETED|Overall Study||184
5046671|NCT01976988|12417997|P1|COMPLETED|Overall Study||192
5046672|NCT01976988|12417996|P2|STARTED|Overall Study||202
5046673|NCT01976988|12417997|P1|STARTED|Overall Study||208
5046674|NCT01976975|12418015|P2|NOT COMPLETED|Overall Study||12
5046675|NCT01976975|12418016|P1|NOT COMPLETED|Overall Study||147
5046676|NCT01976975|12418015|P2|COMPLETED|Overall Study||32
5046677|NCT01976975|12418016|P1|COMPLETED|Overall Study||79
5046678|NCT01976975|12418015|P2|STARTED|Overall Study||44
5046679|NCT01976975|12418016|P1|STARTED|Overall Study||226
5046680|NCT01976871|12418026|P1|NOT COMPLETED|Overall Study||1
5046681|NCT01976871|12418026|P1|COMPLETED|Overall Study||20
5046682|NCT01976871|12418026|P1|STARTED|Overall Study||21
5046683|NCT01976845|12418038|P3|NOT COMPLETED|Overall Study||3
5046684|NCT01976845|12418039|P2|NOT COMPLETED|Overall Study||8
5046685|NCT01976845|12418040|P1|NOT COMPLETED|Overall Study||8
5046686|NCT01976845|12418038|P3|COMPLETED|Overall Study||40
5046687|NCT01976845|12418039|P2|COMPLETED|Overall Study||40
5046688|NCT01976845|12418040|P1|COMPLETED|Overall Study||40
5046689|NCT01976845|12418038|P3|STARTED|Overall Study||43
5046690|NCT01976845|12418039|P2|STARTED|Overall Study||48
5046691|NCT01976845|12418040|P1|STARTED|Overall Study||48
5046692|NCT01976819|12418054|P1|NOT COMPLETED|Overall Study||5
5046693|NCT01976819|12418054|P1|COMPLETED|Overall Study||11
5046694|NCT01976819|12418054|P1|STARTED|Overall Study||16
5046695|NCT01976806|12418065|P2|NOT COMPLETED|Overall Study||6
5046696|NCT01976806|12418066|P1|NOT COMPLETED|Overall Study||3
5046697|NCT01976806|12418065|P2|COMPLETED|Overall Study||22
5046698|NCT01976806|12418066|P1|COMPLETED|Overall Study||24
5046699|NCT01976806|12418065|P2|STARTED|Overall Study||28
5046700|NCT01976806|12418066|P1|STARTED|Overall Study||27
5046701|NCT01976741|12418104|P10|NOT COMPLETED|Overall Study||4
5046702|NCT01976741|12418105|P9|NOT COMPLETED|Overall Study||1
5046703|NCT01976741|12418106|P8|NOT COMPLETED|Overall Study||12
5046704|NCT01976741|12418107|P7|NOT COMPLETED|Overall Study||4
5046705|NCT01976741|12418108|P6|NOT COMPLETED|Overall Study||0
5046706|NCT01976741|12418109|P5|NOT COMPLETED|Overall Study||0
5046707|NCT01976741|12418110|P4|NOT COMPLETED|Overall Study||1
5046708|NCT01976741|12418111|P3|NOT COMPLETED|Overall Study||3
5046709|NCT01976741|12418112|P2|NOT COMPLETED|Overall Study||0
5046710|NCT01976741|12418113|P1|NOT COMPLETED|Overall Study||1
5046711|NCT01976741|12418104|P10|COMPLETED|Overall Study||36
5046712|NCT01976741|12418105|P9|COMPLETED|Overall Study||7
5046713|NCT01976741|12418106|P8|COMPLETED|Overall Study||62
5046714|NCT01976741|12418107|P7|COMPLETED|Overall Study||19
5046715|NCT01976741|12418108|P6|COMPLETED|Overall Study||4
5046716|NCT01976741|12418109|P5|COMPLETED|Overall Study||4
5046717|NCT01976741|12418110|P4|COMPLETED|Overall Study||2
5046718|NCT01976741|12418111|P3|COMPLETED|Overall Study||1
5046719|NCT01976741|12418112|P2|COMPLETED|Overall Study||4
5046720|NCT01976741|12418113|P1|COMPLETED|Overall Study||3
5046721|NCT01976741|12418104|P10|STARTED|Overall Study||40
5046722|NCT01976741|12418105|P9|STARTED|Overall Study||8
5046723|NCT01976741|12418106|P8|STARTED|Overall Study||74
5046724|NCT01976741|12418107|P7|STARTED|Overall Study||23
5046725|NCT01976741|12418108|P6|STARTED|Overall Study||4
5046726|NCT01976741|12418109|P5|STARTED|Overall Study||4
5046727|NCT01976741|12418110|P4|STARTED|Overall Study||3
5046728|NCT01976741|12418111|P3|STARTED|Overall Study||4
5046729|NCT01976741|12418112|P2|STARTED|Overall Study||4
5046730|NCT01976741|12418113|P1|STARTED|Overall Study||4
5046731|NCT01976663|12418351|P1|NOT COMPLETED|Overall Study||42
5046732|NCT01976663|12418351|P1|COMPLETED|Overall Study||84
5046733|NCT01976663|12418351|P1|Received Repeat Treatment|Overall Study||85
5046734|NCT01976663|12418351|P1|Received Asymmetry Correction|Overall Study||45
5046735|NCT01976663|12418351|P1|Received Touch-up Treatment|Overall Study||63
5046736|NCT01976663|12418351|P1|STARTED|Overall Study||126
5046737|NCT01976650|12418365|P1|NOT COMPLETED|Overall Study||6
5046738|NCT01976650|12418365|P1|COMPLETED|Overall Study||718
5046739|NCT01976650|12418365|P1|STARTED|Overall Study||724
5046740|NCT01976624|12418370|P1|NOT COMPLETED|Overall Study||14
5046741|NCT01976624|12418370|P1|COMPLETED|Overall Study||742
5046742|NCT01976624|12418370|P1|STARTED|Overall Study||756
5046743|NCT01976572|12418375|P3|NOT COMPLETED|Overall Study||0
5046744|NCT01976572|12418376|P2|NOT COMPLETED|Overall Study||0
5046745|NCT01976572|12418377|P1|NOT COMPLETED|Overall Study||0
5046746|NCT01976572|12418375|P3|COMPLETED|Overall Study||6
5046747|NCT01976572|12418376|P2|COMPLETED|Overall Study||6
5046748|NCT01976572|12418377|P1|COMPLETED|Overall Study||6
5046749|NCT01976572|12418375|P3|STARTED|Overall Study||6
5046750|NCT01976572|12418376|P2|STARTED|Overall Study||6
5046751|NCT01976572|12418377|P1|STARTED|Overall Study||6
5046752|NCT01976507|12418398|P1|NOT COMPLETED|Overall Study||7
5046753|NCT01976507|12418398|P1|COMPLETED|Overall Study||94
5046754|NCT01976507|12418398|P1|Received Initial Dose of Dabigatran|Overall Study||100
5046755|NCT01976507|12418398|P1|STARTED|Overall Study||101
5046756|NCT01976442|12418407|P2|NOT COMPLETED|Overall Study||0
5046757|NCT01976442|12418408|P1|NOT COMPLETED|Overall Study||0
5046758|NCT01976442|12418407|P2|COMPLETED|Overall Study||31
5046759|NCT01976442|12418408|P1|COMPLETED|Overall Study||69
5046760|NCT01976442|12418407|P2|STARTED|Overall Study||31
5046761|NCT01976442|12418408|P1|STARTED|Overall Study||69
5046762|NCT01976416|12418422|P2|NOT COMPLETED|Overall Study||2
5046763|NCT01976416|12418423|P1|NOT COMPLETED|Overall Study||2
5046764|NCT01976416|12418422|P2|COMPLETED|Overall Study||102
5046765|NCT01976416|12418423|P1|COMPLETED|Overall Study||102
5046766|NCT01976416|12418422|P2|STARTED|Overall Study||104
5046767|NCT01976416|12418423|P1|STARTED|Overall Study||104
5046768|NCT01976364|12418429|P3|NOT COMPLETED|Sub-study (12 Months)||5
5046769|NCT01976364|12418430|P2|NOT COMPLETED|Sub-study (12 Months)||6
5046770|NCT01976364|12418431|P1|NOT COMPLETED|Sub-study (12 Months)||0
5046771|NCT01976364|12418429|P3|COMPLETED|Sub-study (12 Months)||85
5046772|NCT01976364|12418430|P2|COMPLETED|Sub-study (12 Months)||83
5046773|NCT01976364|12418431|P1|COMPLETED|Sub-study (12 Months)||0
5046774|NCT01976364|12418429|P3|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
5046775|NCT01976364|12418430|P2|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
5046776|NCT01976364|12418431|P1|STARTED|Sub-study (12 Months)||0
5046777|NCT01976364|12418429|P3|NOT COMPLETED|Main Study (36 Months)||0
5046778|NCT01976364|12418430|P2|NOT COMPLETED|Main Study (36 Months)||0
5046779|NCT01976364|12418431|P1|NOT COMPLETED|Main Study (36 Months)||221
5046780|NCT01976364|12418429|P3|COMPLETED|Main Study (36 Months)||0
5046781|NCT01976364|12418430|P2|COMPLETED|Main Study (36 Months)||0
5046782|NCT01976364|12418431|P1|COMPLETED|Main Study (36 Months)||465
5046783|NCT01976364|12418429|P3|STARTED|Main Study (36 Months)||0
5046784|NCT01976364|12418430|P2|STARTED|Main Study (36 Months)||0
5046785|NCT01976364|12418431|P1|STARTED|Main Study (36 Months)||686
5046786|NCT01976338|12418551|P2|NOT COMPLETED|Overall Study||4
5046787|NCT01976338|12418552|P1|NOT COMPLETED|Overall Study||13
5046788|NCT01976338|12418551|P2|COMPLETED|Overall Study|12 months|89
5046789|NCT01976338|12418552|P1|COMPLETED|Overall Study|12 months|177
5046790|NCT01976338|12418551|P2|Discontinued Study Prior to 6 Months|Overall Study||2
5046791|NCT01976338|12418552|P1|Discontinued Study Prior to 6 Months|Overall Study||5
5046792|NCT01976338|12418551|P2|Completed 6 Months|Overall Study||91
5046793|NCT01976338|12418552|P1|Completed 6 Months|Overall Study||185
5046794|NCT01976338|12418551|P2|STARTED|Overall Study||93
5046795|NCT01976338|12418552|P1|STARTED|Overall Study||190
5046796|NCT01976312|12418579|P2|NOT COMPLETED|Overall Study||9
5046797|NCT01976312|12418580|P1|NOT COMPLETED|Overall Study||17
5046798|NCT01976312|12418579|P2|COMPLETED|Overall Study|Completed study at 12 months|53
5046799|NCT01976312|12418580|P1|COMPLETED|Overall Study|Completed study at 12 months|173
5046800|NCT01976312|12418579|P2|Discontinued Study Prior to 3 Months|Overall Study||2
5046801|NCT01976312|12418580|P1|Discontinued Study Prior to 3 Months|Overall Study||4
5046802|NCT01976312|12418579|P2|Completed 3 Months|Overall Study||60
5046803|NCT01976312|12418580|P1|Completed 3 Months|Overall Study||186
5046804|NCT01976312|12418579|P2|STARTED|Overall Study||62
5046805|NCT01976312|12418580|P1|STARTED|Overall Study||190
5046806|NCT01976299|12418601|P2|NOT COMPLETED|Overall Study||6
5046807|NCT01976299|12418602|P1|NOT COMPLETED|Overall Study||23
5046808|NCT01976299|12418601|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
5046809|NCT01976299|12418602|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
5046810|NCT01976299|12418601|P2|Completed Procedure|Overall Study||284
5046811|NCT01976299|12418602|P1|Completed Procedure|Overall Study||283
5046812|NCT01976299|12418601|P2|STARTED|Overall Study||286
5046813|NCT01976299|12418602|P1|STARTED|Overall Study||292
5046814|NCT01976273|12418618|P2|NOT COMPLETED|Overall Study||1
5046815|NCT01976273|12418619|P1|NOT COMPLETED|Overall Study||1
5046816|NCT01976273|12418618|P2|COMPLETED|Overall Study||9
5046817|NCT01976273|12418619|P1|COMPLETED|Overall Study||9
5046818|NCT01976273|12418618|P2|STARTED|Overall Study||10
5046819|NCT01976273|12418619|P1|STARTED|Overall Study||10
5046820|NCT01976104|12418629|P4|NOT COMPLETED|Overall Study||3
5046821|NCT01976104|12418630|P3|NOT COMPLETED|Overall Study||2
5046822|NCT01976104|12418631|P2|NOT COMPLETED|Overall Study||2
5046823|NCT01976104|12418632|P1|NOT COMPLETED|Overall Study||6
5046824|NCT01976104|12418629|P4|COMPLETED|Overall Study||55
5046825|NCT01976104|12418630|P3|COMPLETED|Overall Study||31
5046826|NCT01976104|12418631|P2|COMPLETED|Overall Study||68
5046827|NCT01976104|12418632|P1|COMPLETED|Overall Study||37
5046828|NCT01976104|12418629|P4|STARTED|Overall Study||58
5046829|NCT01976104|12418630|P3|STARTED|Overall Study||33
5046830|NCT01976104|12418631|P2|STARTED|Overall Study||70
5046831|NCT01976104|12418632|P1|STARTED|Overall Study||43
5046832|NCT01975974|12418658|P1|NOT COMPLETED|Overall Study||0
5046833|NCT01975974|12418658|P1|COMPLETED|Overall Study||100
5046834|NCT01975974|12418658|P1|STARTED|Overall Study||100
5046835|NCT01975948|12418666|P4|NOT COMPLETED|Overall Study||6
5046836|NCT01975948|12418667|P3|NOT COMPLETED|Overall Study||7
5046837|NCT01975948|12418668|P2|NOT COMPLETED|Overall Study||21
5046838|NCT01975948|12418669|P1|NOT COMPLETED|Overall Study||17
5046839|NCT01975948|12418666|P4|COMPLETED|Overall Study||51
5046840|NCT01975948|12418667|P3|COMPLETED|Overall Study||65
5046841|NCT01975948|12418668|P2|COMPLETED|Overall Study||34
5046842|NCT01975948|12418669|P1|COMPLETED|Overall Study||39
5046843|NCT01975948|12418666|P4|STARTED|Overall Study||57
5046844|NCT01975948|12418667|P3|STARTED|Overall Study||72
5046845|NCT01975948|12418668|P2|STARTED|Overall Study||55
5046846|NCT01975948|12418669|P1|STARTED|Overall Study||56
5046847|NCT01975935|12418695|P2|NOT COMPLETED|Overall Study||1
5046848|NCT01975935|12418696|P1|NOT COMPLETED|Overall Study||3
5046849|NCT01975935|12418695|P2|COMPLETED|Overall Study||20
5046850|NCT01975935|12418696|P1|COMPLETED|Overall Study||18
5046851|NCT01975935|12418695|P2|STARTED|Overall Study||21
5046852|NCT01975935|12418696|P1|STARTED|Overall Study||21
5046853|NCT01975922|12418708|P2|NOT COMPLETED|Overall Study||9
5046854|NCT01975922|12418709|P1|NOT COMPLETED|Overall Study||0
5046855|NCT01975922|12418708|P2|COMPLETED|Overall Study||43
5046856|NCT01975922|12418709|P1|COMPLETED|Overall Study||45
5046857|NCT01975922|12418708|P2|STARTED|Overall Study||52
5046858|NCT01975922|12418709|P1|STARTED|Overall Study||45
5046859|NCT01975909|12418719|P2|NOT COMPLETED|Overall Study||0
5046860|NCT01975909|12418720|P1|NOT COMPLETED|Overall Study||0
5046861|NCT01975909|12418719|P2|COMPLETED|Overall Study||10
5046862|NCT01975909|12418720|P1|COMPLETED|Overall Study||10
5046863|NCT01975909|12418719|P2|STARTED|Overall Study||10
5046864|NCT01975909|12418720|P1|STARTED|Overall Study||10
5046865|NCT01975831|12418745|P9|NOT COMPLETED|Overall Study||12
5046866|NCT01975831|12418746|P8|NOT COMPLETED|Overall Study||15
5046867|NCT01975831|12418747|P7|NOT COMPLETED|Overall Study||16
5046868|NCT01975831|12418748|P6|NOT COMPLETED|Overall Study||14
5046869|NCT01975831|12418749|P5|NOT COMPLETED|Overall Study||18
5046870|NCT01975831|12418750|P4|NOT COMPLETED|Overall Study||4
5046871|NCT01975831|12418751|P3|NOT COMPLETED|Overall Study||4
5046872|NCT01975831|12418752|P2|NOT COMPLETED|Overall Study||9
5046873|NCT01975831|12418753|P1|NOT COMPLETED|Overall Study||3
5046874|NCT01975831|12418745|P9|COMPLETED|Overall Study||3
5046875|NCT01975831|12418746|P8|COMPLETED|Overall Study||1
5046876|NCT01975831|12418747|P7|COMPLETED|Overall Study||0
5046877|NCT01975831|12418748|P6|COMPLETED|Overall Study||2
5046878|NCT01975831|12418749|P5|COMPLETED|Overall Study||1
5046879|NCT01975831|12418750|P4|COMPLETED|Overall Study||0
5046880|NCT01975831|12418751|P3|COMPLETED|Overall Study||0
5046881|NCT01975831|12418752|P2|COMPLETED|Overall Study||2
5046882|NCT01975831|12418753|P1|COMPLETED|Overall Study||0
5046883|NCT01975831|12418745|P9|STARTED|Overall Study||15
5046884|NCT01975831|12418746|P8|STARTED|Overall Study||16
5046885|NCT01975831|12418747|P7|STARTED|Overall Study||16
5046886|NCT01975831|12418748|P6|STARTED|Overall Study||16
5046887|NCT01975831|12418749|P5|STARTED|Overall Study||19
5046888|NCT01975831|12418750|P4|STARTED|Overall Study||4
5046889|NCT01975831|12418751|P3|STARTED|Overall Study||4
5046890|NCT01975831|12418752|P2|STARTED|Overall Study||11
5046891|NCT01975831|12418753|P1|STARTED|Overall Study||3
5046892|NCT01975701|12418818|P1|NOT COMPLETED|Overall Study||25
5046893|NCT01975701|12418818|P1|COMPLETED|Overall Study||1
5046894|NCT01975701|12418818|P1|STARTED|Overall Study||26
5046895|NCT01975675|12418829|P4|NOT COMPLETED|Overall Study||0
5046896|NCT01975675|12418830|P3|NOT COMPLETED|Overall Study||0
5046897|NCT01975675|12418831|P2|NOT COMPLETED|Overall Study||1
5046898|NCT01975675|12418832|P1|NOT COMPLETED|Overall Study||0
5046899|NCT01975675|12418829|P4|COMPLETED|Overall Study||87
5046900|NCT01975675|12418830|P3|COMPLETED|Overall Study||88
5046901|NCT01975675|12418831|P2|COMPLETED|Overall Study||82
5046902|NCT01975675|12418832|P1|COMPLETED|Overall Study||83
5046903|NCT01975675|12418829|P4|STARTED|Overall Study||87
5046904|NCT01975675|12418830|P3|STARTED|Overall Study||88
5046905|NCT01975675|12418831|P2|STARTED|Overall Study||83
5046906|NCT01975675|12418832|P1|STARTED|Overall Study||83
5046907|NCT01975519|12418854|P2|NOT COMPLETED|Overall Study||0
5046908|NCT01975519|12418855|P1|NOT COMPLETED|Overall Study||0
5046909|NCT01975519|12418854|P2|COMPLETED|Overall Study||108
5046910|NCT01975519|12418855|P1|COMPLETED|Overall Study||3
5046911|NCT01975519|12418854|P2|Phase 2a Angiosarcoma Cohort|Overall Study||22
5046912|NCT01975519|12418855|P1|Phase 2a Angiosarcoma Cohort|Overall Study||0
5046913|NCT01975519|12418854|P2|Phase 2a Soft Tissue Sarcoma|Overall Study||63
5046914|NCT01975519|12418855|P1|Phase 2a Soft Tissue Sarcoma|Overall Study||0
5046915|NCT01975519|12418854|P2|Phase 1b|Overall Study||23
5046916|NCT01975519|12418855|P1|Phase 1b|Overall Study||3
5046917|NCT01975519|12418854|P2|STARTED|Overall Study||108
5046918|NCT01975519|12418855|P1|STARTED|Overall Study||3
5046919|NCT01975467|12418872|P2|NOT COMPLETED|Overall Study||0
5046920|NCT01975467|12418873|P1|NOT COMPLETED|Overall Study||0
5046921|NCT01975467|12418872|P2|COMPLETED|Overall Study||0
5046922|NCT01975467|12418873|P1|COMPLETED|Overall Study||0
5046923|NCT01975467|12418872|P2|STARTED|Overall Study|Study terminated before enrollment|0
5046924|NCT01975467|12418873|P1|STARTED|Overall Study|Study terminated before enrollment|0
5046925|NCT01975389|12418883|P2|NOT COMPLETED|Overall Study||236
5046926|NCT01975389|12418884|P1|NOT COMPLETED|Overall Study||252
5046927|NCT01975389|12418883|P2|COMPLETED|Overall Study||5045
5046928|NCT01975389|12418884|P1|COMPLETED|Overall Study||5031
5046929|NCT01975389|12418883|P2|Treated|Overall Study||5276
5046930|NCT01975389|12418884|P1|Treated|Overall Study||5279
5046931|NCT01975389|12418883|P2|STARTED|Overall Study||5281
5046932|NCT01975389|12418884|P1|STARTED|Overall Study||5283
5046933|NCT01975376|12418944|P2|NOT COMPLETED|Overall Study||217
5046934|NCT01975376|12418945|P1|NOT COMPLETED|Overall Study||226
5046935|NCT01975376|12418944|P2|COMPLETED|Overall Study||8177
5046936|NCT01975376|12418945|P1|COMPLETED|Overall Study||8164
5046937|NCT01975376|12418944|P2|Treated|Overall Study||8386
5046938|NCT01975376|12418945|P1|Treated|Overall Study||8374
5046939|NCT01975376|12418944|P2|STARTED|Overall Study||8394
5046940|NCT01975376|12418945|P1|STARTED|Overall Study||8390
5046941|NCT01975285|12419005|P2|NOT COMPLETED|Overall Study||2
5046942|NCT01975285|12419006|P1|NOT COMPLETED|Overall Study||2
5046943|NCT01975285|12419005|P2|COMPLETED|Overall Study||28
5046944|NCT01975285|12419006|P1|COMPLETED|Overall Study||28
5046945|NCT01975285|12419005|P2|STARTED|Overall Study||30
5046946|NCT01975285|12419006|P1|STARTED|Overall Study||30
5046947|NCT01975246|12419022|P2|NOT COMPLETED|Overall Study||2
5046948|NCT01975246|12419023|P1|NOT COMPLETED|Overall Study||4
5046949|NCT01975246|12419022|P2|COMPLETED|Overall Study||158
5046950|NCT01975246|12419023|P1|COMPLETED|Overall Study||145
5046951|NCT01975246|12419022|P2|STARTED|Overall Study||160
5046952|NCT01975246|12419023|P1|STARTED|Overall Study||149
5046953|NCT01975220|12419036|P6|NOT COMPLETED|Test Period 2||0
5046954|NCT01975220|12419037|P5|NOT COMPLETED|Test Period 2||0
5046955|NCT01975220|12419038|P4|NOT COMPLETED|Test Period 2||0
5046956|NCT01975220|12419039|P3|NOT COMPLETED|Test Period 2||0
5046957|NCT01975220|12419040|P2|NOT COMPLETED|Test Period 2||0
5046958|NCT01975220|12419041|P1|NOT COMPLETED|Test Period 2||0
5046959|NCT01975220|12419036|P6|COMPLETED|Test Period 2||12
5046960|NCT01975220|12419037|P5|COMPLETED|Test Period 2||12
5046961|NCT01975220|12419038|P4|COMPLETED|Test Period 2||12
5046962|NCT01975220|12419039|P3|COMPLETED|Test Period 2||12
5046963|NCT01975220|12419040|P2|COMPLETED|Test Period 2||11
5046964|NCT01975220|12419041|P1|COMPLETED|Test Period 2||12
5046965|NCT01975220|12419036|P6|STARTED|Test Period 2||12
5046966|NCT01975220|12419037|P5|STARTED|Test Period 2||12
5046967|NCT01975220|12419038|P4|STARTED|Test Period 2||12
5046968|NCT01975220|12419039|P3|STARTED|Test Period 2||12
5046969|NCT01975220|12419040|P2|STARTED|Test Period 2||11
5046970|NCT01975220|12419041|P1|STARTED|Test Period 2||12
5046971|NCT01975220|12419036|P6|NOT COMPLETED|Test Period 1||0
5046972|NCT01975220|12419037|P5|NOT COMPLETED|Test Period 1||0
5046973|NCT01975220|12419038|P4|NOT COMPLETED|Test Period 1||0
5046974|NCT01975220|12419039|P3|NOT COMPLETED|Test Period 1||0
5046975|NCT01975220|12419040|P2|NOT COMPLETED|Test Period 1||1
5046976|NCT01975220|12419041|P1|NOT COMPLETED|Test Period 1||0
5046977|NCT01975220|12419036|P6|COMPLETED|Test Period 1||12
5046978|NCT01975220|12419037|P5|COMPLETED|Test Period 1||12
5046979|NCT01975220|12419038|P4|COMPLETED|Test Period 1||12
5046980|NCT01975220|12419039|P3|COMPLETED|Test Period 1||12
5046981|NCT01975220|12419040|P2|COMPLETED|Test Period 1||11
5046982|NCT01975220|12419041|P1|COMPLETED|Test Period 1||12
5046983|NCT01975220|12419036|P6|STARTED|Test Period 1||12
5046984|NCT01975220|12419037|P5|STARTED|Test Period 1||12
5046985|NCT01975220|12419038|P4|STARTED|Test Period 1||12
5046986|NCT01975220|12419039|P3|STARTED|Test Period 1||12
5046987|NCT01975220|12419040|P2|STARTED|Test Period 1||12
5046988|NCT01975220|12419041|P1|STARTED|Test Period 1||12
5046989|NCT01975090|12419085|P1|NOT COMPLETED|Overall Study||12
5046990|NCT01975090|12419085|P1|COMPLETED|Overall Study||117
5046991|NCT01975090|12419085|P1|6-month Follow-up|Overall Study||117
5046992|NCT01975090|12419085|P1|STARTED|Overall Study||129
5046993|NCT01974895|12419097|P2|NOT COMPLETED|Overall Study||15
5046994|NCT01974895|12419098|P1|NOT COMPLETED|Overall Study||15
5046995|NCT01974895|12419097|P2|COMPLETED|Overall Study||141
5046996|NCT01974895|12419098|P1|COMPLETED|Overall Study||143
5046997|NCT01974895|12419097|P2|STARTED|Overall Study||156
5046998|NCT01974895|12419098|P1|STARTED|Overall Study||158
5046999|NCT01974817|12419128|P1|NOT COMPLETED|Overall Study||8
5047000|NCT01974817|12419128|P1|COMPLETED|Overall Study||17
5047001|NCT01974817|12419128|P1|STARTED|Overall Study||25
5047002|NCT01974752|12419134|P2|NOT COMPLETED|Overall Study||15
5047003|NCT01974752|12419135|P1|NOT COMPLETED|Overall Study||37
5047004|NCT01974752|12419134|P2|COMPLETED|Overall Study||17
5047005|NCT01974752|12419135|P1|COMPLETED|Overall Study||60
5047006|NCT01974752|12419134|P2|STARTED|Overall Study||32
5047007|NCT01974752|12419135|P1|STARTED|Overall Study||97
5047008|NCT01974700|12419149|P2|NOT COMPLETED|Overall Study||0
5047009|NCT01974700|12419150|P1|NOT COMPLETED|Overall Study||0
5047010|NCT01974700|12419149|P2|COMPLETED|Overall Study||3
5047011|NCT01974700|12419150|P1|COMPLETED|Overall Study||5
5047012|NCT01974700|12419149|P2|STARTED|Overall Study||3
5047013|NCT01974700|12419150|P1|STARTED|Overall Study||5
5047014|NCT01974687|12419185|P25|NOT COMPLETED|Overall Study||0
5047015|NCT01974687|12419186|P24|NOT COMPLETED|Overall Study||0
5047016|NCT01974687|12419187|P23|NOT COMPLETED|Overall Study||0
5047017|NCT01974687|12419188|P22|NOT COMPLETED|Overall Study||0
5047018|NCT01974687|12419189|P21|NOT COMPLETED|Overall Study||0
5047019|NCT01974687|12419190|P20|NOT COMPLETED|Overall Study||0
5047020|NCT01974687|12419191|P19|NOT COMPLETED|Overall Study||0
5047021|NCT01974687|12419192|P18|NOT COMPLETED|Overall Study||3
5047022|NCT01974687|12419193|P17|NOT COMPLETED|Overall Study||1
5047023|NCT01974687|12419194|P16|NOT COMPLETED|Overall Study||1
5047024|NCT01974687|12419195|P15|NOT COMPLETED|Overall Study||1
5047025|NCT01974687|12419196|P14|NOT COMPLETED|Overall Study||2
5047026|NCT01974687|12419197|P13|NOT COMPLETED|Overall Study||3
5047027|NCT01974687|12419198|P12|NOT COMPLETED|Overall Study||2
5047028|NCT01974687|12419199|P11|NOT COMPLETED|Overall Study||0
5047029|NCT01974687|12419200|P10|NOT COMPLETED|Overall Study||0
5047030|NCT01974687|12419201|P9|NOT COMPLETED|Overall Study||0
5047031|NCT01974687|12419202|P8|NOT COMPLETED|Overall Study||0
5047032|NCT01974687|12419203|P7|NOT COMPLETED|Overall Study||0
5047033|NCT01974687|12419204|P6|NOT COMPLETED|Overall Study||0
5047034|NCT01974687|12419205|P5|NOT COMPLETED|Overall Study||0
5047035|NCT01974687|12419206|P4|NOT COMPLETED|Overall Study||0
5047036|NCT01974687|12419207|P3|NOT COMPLETED|Overall Study||0
5047037|NCT01974687|12419208|P2|NOT COMPLETED|Overall Study||0
5047038|NCT01974687|12419209|P1|NOT COMPLETED|Overall Study||0
5047039|NCT01974687|12419185|P25|COMPLETED|Overall Study||10
5047040|NCT01974687|12419186|P24|COMPLETED|Overall Study||6
5047041|NCT01974687|12419187|P23|COMPLETED|Overall Study||8
5047042|NCT01974687|12419188|P22|COMPLETED|Overall Study||8
5047043|NCT01974687|12419189|P21|COMPLETED|Overall Study||3
5047044|NCT01974687|12419190|P20|COMPLETED|Overall Study||3
5047045|NCT01974687|12419191|P19|COMPLETED|Overall Study||9
5047046|NCT01974687|12419192|P18|COMPLETED|Overall Study||8
5047047|NCT01974687|12419193|P17|COMPLETED|Overall Study||8
5047048|NCT01974687|12419194|P16|COMPLETED|Overall Study||8
5047049|NCT01974687|12419195|P15|COMPLETED|Overall Study||18
5047050|NCT01974687|12419196|P14|COMPLETED|Overall Study||8
5047051|NCT01974687|12419197|P13|COMPLETED|Overall Study||10
5047052|NCT01974687|12419198|P12|COMPLETED|Overall Study||11
5047053|NCT01974687|12419199|P11|COMPLETED|Overall Study||3
5047054|NCT01974687|12419200|P10|COMPLETED|Overall Study||3
5047055|NCT01974687|12419201|P9|COMPLETED|Overall Study||3
5047056|NCT01974687|12419202|P8|COMPLETED|Overall Study||3
5047057|NCT01974687|12419203|P7|COMPLETED|Overall Study||3
5047058|NCT01974687|12419204|P6|COMPLETED|Overall Study||6
5047059|NCT01974687|12419205|P5|COMPLETED|Overall Study||2
5047060|NCT01974687|12419206|P4|COMPLETED|Overall Study||6
5047061|NCT01974687|12419207|P3|COMPLETED|Overall Study||6
5047062|NCT01974687|12419208|P2|COMPLETED|Overall Study||6
5047063|NCT01974687|12419209|P1|COMPLETED|Overall Study||6
5047064|NCT01974687|12419185|P25|Treated|Overall Study||10
5047065|NCT01974687|12419186|P24|Treated|Overall Study||6
5047066|NCT01974687|12419187|P23|Treated|Overall Study||8
5047067|NCT01974687|12419188|P22|Treated|Overall Study||8
5047068|NCT01974687|12419189|P21|Treated|Overall Study||3
5047069|NCT01974687|12419190|P20|Treated|Overall Study||3
5047070|NCT01974687|12419191|P19|Treated|Overall Study||9
5047071|NCT01974687|12419192|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
5047072|NCT01974687|12419193|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
5047073|NCT01974687|12419194|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
5047074|NCT01974687|12419195|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
5047075|NCT01974687|12419196|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
5047076|NCT01974687|12419197|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
5047077|NCT01974687|12419198|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
5047078|NCT01974687|12419199|P11|Treated|Overall Study||3
5047079|NCT01974687|12419200|P10|Treated|Overall Study||3
5047080|NCT01974687|12419201|P9|Treated|Overall Study||3
5047081|NCT01974687|12419202|P8|Treated|Overall Study||3
5047082|NCT01974687|12419203|P7|Treated|Overall Study||3
5047083|NCT01974687|12419204|P6|Treated|Overall Study||6
5047084|NCT01974687|12419205|P5|Treated|Overall Study||2
5047085|NCT01974687|12419206|P4|Treated|Overall Study||6
5047086|NCT01974687|12419207|P3|Treated|Overall Study||6
5047087|NCT01974687|12419208|P2|Treated|Overall Study||6
5047088|NCT01974687|12419209|P1|Treated|Overall Study||6
5047089|NCT01974687|12419185|P25|STARTED|Overall Study||10
5047090|NCT01974687|12419186|P24|STARTED|Overall Study||6
5047091|NCT01974687|12419187|P23|STARTED|Overall Study||8
5047092|NCT01974687|12419188|P22|STARTED|Overall Study||8
5047093|NCT01974687|12419189|P21|STARTED|Overall Study||3
5047094|NCT01974687|12419190|P20|STARTED|Overall Study||3
5047095|NCT01974687|12419191|P19|STARTED|Overall Study||9
5047096|NCT01974687|12419192|P18|STARTED|Overall Study||11
5047097|NCT01974687|12419193|P17|STARTED|Overall Study||9
5047098|NCT01974687|12419194|P16|STARTED|Overall Study||9
5047099|NCT01974687|12419195|P15|STARTED|Overall Study||19
5047100|NCT01974687|12419196|P14|STARTED|Overall Study||10
5047101|NCT01974687|12419197|P13|STARTED|Overall Study||13
5047102|NCT01974687|12419198|P12|STARTED|Overall Study||13
5047103|NCT01974687|12419199|P11|STARTED|Overall Study||3
5047104|NCT01974687|12419200|P10|STARTED|Overall Study||3
5047105|NCT01974687|12419201|P9|STARTED|Overall Study||3
5047106|NCT01974687|12419202|P8|STARTED|Overall Study||3
5047107|NCT01974687|12419203|P7|STARTED|Overall Study||3
5047108|NCT01974687|12419204|P6|STARTED|Overall Study||6
5047109|NCT01974687|12419205|P5|STARTED|Overall Study||2
5047110|NCT01974687|12419206|P4|STARTED|Overall Study||6
5047111|NCT01974687|12419207|P3|STARTED|Overall Study||6
5047112|NCT01974687|12419208|P2|STARTED|Overall Study||6
5047113|NCT01974687|12419209|P1|STARTED|Overall Study||6
5047114|NCT01974635|12419556|P1|NOT COMPLETED|Overall Study||0
5047115|NCT01974635|12419556|P1|COMPLETED|Overall Study||2
5047116|NCT01974635|12419556|P1|STARTED|Overall Study||2
5047117|NCT01974323|12419563|P2|NOT COMPLETED|Overall Study||93
5047118|NCT01974323|12419564|P1|NOT COMPLETED|Overall Study||92
5047119|NCT01974323|12419563|P2|COMPLETED|Overall Study||1027
5047120|NCT01974323|12419564|P1|COMPLETED|Overall Study||1026
5047121|NCT01974323|12419563|P2|STARTED|Overall Study||1120
5047122|NCT01974323|12419564|P1|STARTED|Overall Study||1118
5047123|NCT01974284|12419586|P1|NOT COMPLETED|Overall Study||7
5047124|NCT01974284|12419586|P1|COMPLETED|Overall Study||0
5047125|NCT01974284|12419586|P1|STARTED|Overall Study||7
5047126|NCT01974245|12419595|P2|NOT COMPLETED|Overall Study||8
5047127|NCT01974245|12419596|P1|NOT COMPLETED|Overall Study||9
5047128|NCT01974245|12419595|P2|COMPLETED|Overall Study||20
5047129|NCT01974245|12419596|P1|COMPLETED|Overall Study||18
5047130|NCT01974245|12419595|P2|STARTED|Overall Study||28
5047131|NCT01974245|12419596|P1|STARTED|Overall Study||27
5047132|NCT01974141|12419604|P2|NOT COMPLETED|Overall Study||82
5047133|NCT01974141|12419605|P1|NOT COMPLETED|Overall Study||96
5047134|NCT01974141|12419604|P2|COMPLETED|Overall Study||976
5047135|NCT01974141|12419605|P1|COMPLETED|Overall Study||948
5047136|NCT01974141|12419604|P2|STARTED|Overall Study||1058
5047137|NCT01974141|12419605|P1|STARTED|Overall Study||1044
5047138|NCT01974089|12419629|P2|NOT COMPLETED|Overall Study||0
5047139|NCT01974089|12419630|P1|NOT COMPLETED|Overall Study||0
5047140|NCT01974089|12419629|P2|COMPLETED|Overall Study||101
5047141|NCT01974089|12419630|P1|COMPLETED|Overall Study||53
5047142|NCT01974089|12419629|P2|STARTED|Overall Study||101
5047143|NCT01974089|12419630|P1|STARTED|Overall Study||53
5047144|NCT01974050|12419640|P1|NOT COMPLETED|Overall Study||25
5047145|NCT01974050|12419640|P1|COMPLETED|Overall Study||141
5047146|NCT01974050|12419640|P1|STARTED|Overall Study||166
5047147|NCT01973998|12419649|P2|NOT COMPLETED|Overall Study||2
5047148|NCT01973998|12419650|P1|NOT COMPLETED|Overall Study||2
5047149|NCT01973998|12419649|P2|COMPLETED|Overall Study||33
5047150|NCT01973998|12419650|P1|COMPLETED|Overall Study||31
5047151|NCT01973998|12419649|P2|STARTED|Overall Study||35
5047152|NCT01973998|12419650|P1|STARTED|Overall Study||33
5047153|NCT01973972|12419662|P2|NOT COMPLETED|Overall Study||19
5047154|NCT01973972|12419663|P1|NOT COMPLETED|Overall Study||18
5047155|NCT01973972|12419662|P2|COMPLETED|Overall Study||117
5047156|NCT01973972|12419663|P1|COMPLETED|Overall Study||109
5047157|NCT01973972|12419662|P2|STARTED|Overall Study||136
5047158|NCT01973972|12419663|P1|STARTED|Overall Study||127
5047159|NCT01973777|12419677|P1|NOT COMPLETED|Overall Study||7
5047160|NCT01973777|12419677|P1|COMPLETED|Overall Study||44
5047161|NCT01973777|12419677|P1|One Year Follow-up|Overall Study||44
5047162|NCT01973777|12419677|P1|STARTED|Overall Study|January 2014|51
5047163|NCT01973608|12419687|P4|NOT COMPLETED|Overall Study||0
5047164|NCT01973608|12419688|P3|NOT COMPLETED|Overall Study||0
5047165|NCT01973608|12419689|P2|NOT COMPLETED|Overall Study||0
5047166|NCT01973608|12419690|P1|NOT COMPLETED|Overall Study||0
5047167|NCT01973608|12419687|P4|COMPLETED|Overall Study||2
5047168|NCT01973608|12419688|P3|COMPLETED|Overall Study||6
5047169|NCT01973608|12419689|P2|COMPLETED|Overall Study||2
5047170|NCT01973608|12419690|P1|COMPLETED|Overall Study||2
5047171|NCT01973608|12419687|P4|STARTED|Overall Study||2
5047172|NCT01973608|12419688|P3|STARTED|Overall Study||6
5047173|NCT01973608|12419689|P2|STARTED|Overall Study||2
5047174|NCT01973608|12419690|P1|STARTED|Overall Study||2
5047175|NCT01973595|12419712|P4|NOT COMPLETED|Intervention Phase 2||0
5047176|NCT01973595|12419713|P3|NOT COMPLETED|Intervention Phase 2||0
5047177|NCT01973595|12419714|P2|NOT COMPLETED|Intervention Phase 2||0
5047178|NCT01973595|12419715|P1|NOT COMPLETED|Intervention Phase 2||0
5047179|NCT01973595|12419712|P4|COMPLETED|Intervention Phase 2||14
5047180|NCT01973595|12419713|P3|COMPLETED|Intervention Phase 2||14
5047181|NCT01973595|12419714|P2|COMPLETED|Intervention Phase 2||14
5047182|NCT01973595|12419715|P1|COMPLETED|Intervention Phase 2||14
5047183|NCT01973595|12419712|P4|STARTED|Intervention Phase 2||14
5047184|NCT01973595|12419713|P3|STARTED|Intervention Phase 2||14
5047185|NCT01973595|12419714|P2|STARTED|Intervention Phase 2||14
5047186|NCT01973595|12419715|P1|STARTED|Intervention Phase 2||14
5047187|NCT01973595|12419712|P4|NOT COMPLETED|Washout||0
5047188|NCT01973595|12419713|P3|NOT COMPLETED|Washout||1
5047189|NCT01973595|12419714|P2|NOT COMPLETED|Washout||0
5047190|NCT01973595|12419715|P1|NOT COMPLETED|Washout||1
5047191|NCT01973595|12419712|P4|COMPLETED|Washout||14
5047192|NCT01973595|12419713|P3|COMPLETED|Washout||14
5047193|NCT01973595|12419714|P2|COMPLETED|Washout||14
5047194|NCT01973595|12419715|P1|COMPLETED|Washout||14
5047195|NCT01973595|12419712|P4|STARTED|Washout||14
5047196|NCT01973595|12419713|P3|STARTED|Washout||15
5047197|NCT01973595|12419714|P2|STARTED|Washout||14
5047198|NCT01973595|12419715|P1|STARTED|Washout||15
5047199|NCT01973595|12419712|P4|NOT COMPLETED|Intervention Phase 1||0
5047200|NCT01973595|12419713|P3|NOT COMPLETED|Intervention Phase 1||0
5047201|NCT01973595|12419714|P2|NOT COMPLETED|Intervention Phase 1||0
5047202|NCT01973595|12419715|P1|NOT COMPLETED|Intervention Phase 1||0
5047203|NCT01973595|12419712|P4|COMPLETED|Intervention Phase 1||14
5047204|NCT01973595|12419713|P3|COMPLETED|Intervention Phase 1||15
5047205|NCT01973595|12419714|P2|COMPLETED|Intervention Phase 1||14
5047206|NCT01973595|12419715|P1|COMPLETED|Intervention Phase 1||15
5047207|NCT01973595|12419712|P4|STARTED|Intervention Phase 1||14
5047208|NCT01973595|12419713|P3|STARTED|Intervention Phase 1||15
5047209|NCT01973595|12419714|P2|STARTED|Intervention Phase 1||14
5047210|NCT01973595|12419715|P1|STARTED|Intervention Phase 1||15
5047211|NCT01973569|12419732|P3|NOT COMPLETED|Overall Study||18
5047212|NCT01973569|12419733|P2|NOT COMPLETED|Overall Study||25
5047213|NCT01973569|12419734|P1|NOT COMPLETED|Overall Study||29
5047214|NCT01973569|12419732|P3|COMPLETED|Overall Study||208
5047215|NCT01973569|12419733|P2|COMPLETED|Overall Study||200
5047216|NCT01973569|12419734|P1|COMPLETED|Overall Study||199
5047217|NCT01973569|12419732|P3|Discontinued Study|Overall Study||15
5047218|NCT01973569|12419733|P2|Discontinued Study|Overall Study||22
5047219|NCT01973569|12419734|P1|Discontinued Study|Overall Study||23
5047220|NCT01973569|12419732|P3|Discontinued Study Treatment|Overall Study||15
5047221|NCT01973569|12419733|P2|Discontinued Study Treatment|Overall Study||22
5047222|NCT01973569|12419734|P1|Discontinued Study Treatment|Overall Study||23
5047223|NCT01973569|12419732|P3|Did Not Receive Study Drug|Overall Study||3
5047224|NCT01973569|12419733|P2|Did Not Receive Study Drug|Overall Study||3
5047225|NCT01973569|12419734|P1|Did Not Receive Study Drug|Overall Study||6
5047226|NCT01973569|12419732|P3|Received Study Drug|Overall Study||223
5047227|NCT01973569|12419733|P2|Received Study Drug|Overall Study||222
5047228|NCT01973569|12419734|P1|Received Study Drug|Overall Study||222
5047229|NCT01973569|12419732|P3|STARTED|Overall Study||226
5047230|NCT01973569|12419733|P2|STARTED|Overall Study||225
5047231|NCT01973569|12419734|P1|STARTED|Overall Study||228
5047232|NCT01973491|12419760|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
5047233|NCT01973491|12419760|P1|COMPLETED|Treatment Period (16 Weeks)||18
5047234|NCT01973491|12419760|P1|STARTED|Treatment Period (16 Weeks)||19
5047235|NCT01973491|12419760|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
5047236|NCT01973491|12419760|P1|COMPLETED|Titration Period(4 Weeks)||19
5047237|NCT01973491|12419760|P1|STARTED|Titration Period(4 Weeks)||19
5047238|NCT01973491|12419760|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
5047239|NCT01973491|12419760|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
5047240|NCT01973491|12419760|P1|STARTED|Baseline Control Period (8 Weeks)||37
5047241|NCT01973439|12419776|P1|NOT COMPLETED|Overall Study||5
5047242|NCT01973439|12419776|P1|COMPLETED|Overall Study||18
5047243|NCT01973439|12419776|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
5047244|NCT01973439|12419776|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
5047245|NCT01973439|12419776|P1|STARTED|Overall Study||23
5047246|NCT01973413|12419785|P2|NOT COMPLETED|Overall Study||0
5047247|NCT01973413|12419786|P1|NOT COMPLETED|Overall Study||1
5047248|NCT01973413|12419785|P2|COMPLETED|Overall Study||20
5047249|NCT01973413|12419786|P1|COMPLETED|Overall Study||11
5047250|NCT01973413|12419785|P2|STARTED|Overall Study||20
5047251|NCT01973413|12419786|P1|STARTED|Overall Study||12
5047252|NCT01973387|12419798|P2|NOT COMPLETED|Overall Study||18
5047253|NCT01973387|12419799|P1|NOT COMPLETED|Overall Study||106
5047254|NCT01973387|12419798|P2|COMPLETED|Overall Study||36
5047255|NCT01973387|12419799|P1|COMPLETED|Overall Study||0
5047256|NCT01973387|12419798|P2|Treated|Overall Study||52
5047257|NCT01973387|12419799|P1|Treated|Overall Study||104
5047258|NCT01973387|12419798|P2|STARTED|Overall Study||54
5047259|NCT01973387|12419799|P1|STARTED|Overall Study||106
5047260|NCT01973348|12419817|P4|NOT COMPLETED|Overall Study||0
5047261|NCT01973348|12419818|P3|NOT COMPLETED|Overall Study||0
5047262|NCT01973348|12419819|P2|NOT COMPLETED|Overall Study||3
5047263|NCT01973348|12419820|P1|NOT COMPLETED|Overall Study||8
5047264|NCT01973348|12419817|P4|COMPLETED|Overall Study||0
5047265|NCT01973348|12419818|P3|COMPLETED|Overall Study||0
5047266|NCT01973348|12419819|P2|COMPLETED|Overall Study||15
5047267|NCT01973348|12419820|P1|COMPLETED|Overall Study||19
5047268|NCT01973348|12419817|P4|STARTED|Overall Study||0
5047269|NCT01973348|12419818|P3|STARTED|Overall Study||0
5047270|NCT01973348|12419819|P2|STARTED|Overall Study||18
5047271|NCT01973348|12419820|P1|STARTED|Overall Study||27
5047272|NCT01973335|12419842|P4|NOT COMPLETED|Overall Study||0
5047273|NCT01973335|12419843|P3|NOT COMPLETED|Overall Study||0
5047274|NCT01973335|12419844|P2|NOT COMPLETED|Overall Study||0
5047275|NCT01973335|12419845|P1|NOT COMPLETED|Overall Study||0
5047276|NCT01973335|12419842|P4|COMPLETED|Overall Study||9
5047277|NCT01973335|12419843|P3|COMPLETED|Overall Study||9
5047278|NCT01973335|12419844|P2|COMPLETED|Overall Study||7
5047279|NCT01973335|12419845|P1|COMPLETED|Overall Study||9
5047280|NCT01973335|12419842|P4|STARTED|Overall Study||9
5047281|NCT01973335|12419843|P3|STARTED|Overall Study||9
5047282|NCT01973335|12419844|P2|STARTED|Overall Study||7
5047283|NCT01973335|12419845|P1|STARTED|Overall Study||9
5047284|NCT01973231|12419881|P2|NOT COMPLETED|Overall Study||12
5047285|NCT01973231|12419882|P1|NOT COMPLETED|Overall Study||11
5047286|NCT01973231|12419881|P2|COMPLETED|Overall Study||190
5047287|NCT01973231|12419882|P1|COMPLETED|Overall Study||191
5047288|NCT01973231|12419881|P2|STARTED|Overall Study||202
5047289|NCT01973231|12419882|P1|STARTED|Overall Study||202
5047290|NCT01973218|12419902|P2|NOT COMPLETED|Overall Study||0
5047291|NCT01973218|12419903|P1|NOT COMPLETED|Overall Study||2
5047292|NCT01973218|12419902|P2|COMPLETED|Overall Study||88
5047293|NCT01973218|12419903|P1|COMPLETED|Overall Study||174
5047294|NCT01973218|12419902|P2|STARTED|Overall Study||88
5047295|NCT01973218|12419903|P1|STARTED|Overall Study||176
5047296|NCT01973205|12419926|P2|NOT COMPLETED|Overall Study||22
5047297|NCT01973205|12419927|P1|NOT COMPLETED|Overall Study||30
5047298|NCT01973205|12419926|P2|COMPLETED|Overall Study||425
5047299|NCT01973205|12419927|P1|COMPLETED|Overall Study||423
5047300|NCT01973205|12419926|P2|STARTED|Overall Study||447
5047301|NCT01973205|12419927|P1|STARTED|Overall Study||453
5047302|NCT01973062|12419939|P1|NOT COMPLETED|Overall Study||0
5047303|NCT01973062|12419939|P1|COMPLETED|Overall Study||1
5047304|NCT01973062|12419939|P1|STARTED|Overall Study||1
5047305|NCT01973036|12419949|P2|NOT COMPLETED|Overall Study||0
5047306|NCT01973036|12419950|P1|NOT COMPLETED|Overall Study||0
5047307|NCT01973036|12419949|P2|COMPLETED|Overall Study||93
5047308|NCT01973036|12419950|P1|COMPLETED|Overall Study||108
5047309|NCT01973036|12419949|P2|Received Assigned Intervention|Overall Study||88
5047310|NCT01973036|12419950|P1|Received Assigned Intervention|Overall Study||113
5047311|NCT01973036|12419949|P2|STARTED|Overall Study||93
5047312|NCT01973036|12419950|P1|STARTED|Overall Study||108
5047313|NCT01972841|12419996|P6|NOT COMPLETED|Overall Study||85
5047314|NCT01972841|12419997|P5|NOT COMPLETED|Overall Study||83
5047315|NCT01972841|12419998|P4|NOT COMPLETED|Overall Study||37
5047316|NCT01972841|12419999|P3|NOT COMPLETED|Overall Study||50
5047317|NCT01972841|12420000|P2|NOT COMPLETED|Overall Study||44
5047318|NCT01972841|12420001|P1|NOT COMPLETED|Overall Study||43
5047319|NCT01972841|12419996|P6|COMPLETED|Overall Study||798
5047320|NCT01972841|12419997|P5|COMPLETED|Overall Study||802
5047321|NCT01972841|12419998|P4|COMPLETED|Overall Study||397
5047322|NCT01972841|12419999|P3|COMPLETED|Overall Study||387
5047323|NCT01972841|12420000|P2|COMPLETED|Overall Study||397
5047324|NCT01972841|12420001|P1|COMPLETED|Overall Study||404
5047325|NCT01972841|12419996|P6|STARTED|Overall Study||883
5047326|NCT01972841|12419997|P5|STARTED|Overall Study||885
5047327|NCT01972841|12419998|P4|STARTED|Overall Study||434
5047328|NCT01972841|12419999|P3|STARTED|Overall Study||437
5047329|NCT01972841|12420000|P2|STARTED|Overall Study||441
5047330|NCT01972841|12420001|P1|STARTED|Overall Study||447
5047331|NCT01972789|12420431|P2|NOT COMPLETED|Overall Study||30
5047332|NCT01972789|12420432|P1|NOT COMPLETED|Overall Study||40
5047333|NCT01972789|12420431|P2|COMPLETED|Overall Study||145
5047334|NCT01972789|12420432|P1|COMPLETED|Overall Study||134
5047335|NCT01972789|12420431|P2|STARTED|Overall Study||175
5047336|NCT01972789|12420432|P1|STARTED|Overall Study||174
5047337|NCT01972776|12420466|P6|NOT COMPLETED|Part 2||7
5047338|NCT01972776|12420467|P5|NOT COMPLETED|Part 2||13
5047339|NCT01972776|12420468|P4|NOT COMPLETED|Part 2||0
5047340|NCT01972776|12420469|P3|NOT COMPLETED|Part 2||0
5047341|NCT01972776|12420470|P2|NOT COMPLETED|Part 2||0
5047342|NCT01972776|12420471|P1|NOT COMPLETED|Part 2||0
5047343|NCT01972776|12420466|P6|COMPLETED|Part 2||0
5047344|NCT01972776|12420467|P5|COMPLETED|Part 2||1
5047345|NCT01972776|12420468|P4|COMPLETED|Part 2||0
5047346|NCT01972776|12420469|P3|COMPLETED|Part 2||0
5047347|NCT01972776|12420470|P2|COMPLETED|Part 2||0
5047348|NCT01972776|12420471|P1|COMPLETED|Part 2||0
5047349|NCT01972776|12420466|P6|STARTED|Part 2||7
5047350|NCT01972776|12420467|P5|STARTED|Part 2||14
5047351|NCT01972776|12420468|P4|STARTED|Part 2||0
5047352|NCT01972776|12420469|P3|STARTED|Part 2||0
5047353|NCT01972776|12420470|P2|STARTED|Part 2||0
5047354|NCT01972776|12420471|P1|STARTED|Part 2||0
5047355|NCT01972776|12420466|P6|NOT COMPLETED|Part 1||0
5047356|NCT01972776|12420467|P5|NOT COMPLETED|Part 1||0
5047357|NCT01972776|12420468|P4|NOT COMPLETED|Part 1||1
5047358|NCT01972776|12420469|P3|NOT COMPLETED|Part 1||2
5047359|NCT01972776|12420470|P2|NOT COMPLETED|Part 1||0
5047360|NCT01972776|12420471|P1|NOT COMPLETED|Part 1||0
5047361|NCT01972776|12420466|P6|COMPLETED|Part 1||0
5047362|NCT01972776|12420467|P5|COMPLETED|Part 1||0
5047363|NCT01972776|12420468|P4|COMPLETED|Part 1||6
5047364|NCT01972776|12420469|P3|COMPLETED|Part 1||6
5047365|NCT01972776|12420470|P2|COMPLETED|Part 1||6
5047366|NCT01972776|12420471|P1|COMPLETED|Part 1||6
5047367|NCT01972776|12420466|P6|STARTED|Part 1||0
5047368|NCT01972776|12420467|P5|STARTED|Part 1||0
5047369|NCT01972776|12420468|P4|STARTED|Part 1||7
5047370|NCT01972776|12420469|P3|STARTED|Part 1||8
5047371|NCT01972776|12420470|P2|STARTED|Part 1||6
5047372|NCT01972776|12420471|P1|STARTED|Part 1||6
5047373|NCT01972724|12420542|P3|NOT COMPLETED|Open-Label||5
5047374|NCT01972724|12420543|P2|NOT COMPLETED|Open-Label||0
5047375|NCT01972724|12420544|P1|NOT COMPLETED|Open-Label||0
5047376|NCT01972724|12420542|P3|COMPLETED|Open-Label||72
5047377|NCT01972724|12420543|P2|COMPLETED|Open-Label||0
5047378|NCT01972724|12420544|P1|COMPLETED|Open-Label||0
5047379|NCT01972724|12420542|P3|STARTED|Open-Label||77
5047380|NCT01972724|12420543|P2|STARTED|Open-Label||0
5047381|NCT01972724|12420544|P1|STARTED|Open-Label||0
5047382|NCT01972724|12420542|P3|NOT COMPLETED|Double-Blind||0
5047383|NCT01972724|12420543|P2|NOT COMPLETED|Double-Blind||9
5047384|NCT01972724|12420544|P1|NOT COMPLETED|Double-Blind||9
5047385|NCT01972724|12420542|P3|COMPLETED|Double-Blind||0
5047386|NCT01972724|12420543|P2|COMPLETED|Double-Blind||9
5047387|NCT01972724|12420544|P1|COMPLETED|Double-Blind||10
5047388|NCT01972724|12420542|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
5047389|NCT01972724|12420543|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
5047390|NCT01972724|12420544|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
5047391|NCT01972724|12420542|P3|STARTED|Double-Blind||0
5047392|NCT01972724|12420543|P2|STARTED|Double-Blind||18
5047393|NCT01972724|12420544|P1|STARTED|Double-Blind||19
5047394|NCT01972659|12420557|P2|NOT COMPLETED|Overall Study||3
5047395|NCT01972659|12420558|P1|NOT COMPLETED|Overall Study||4
5047396|NCT01972659|12420557|P2|COMPLETED|Overall Study||37
5047397|NCT01972659|12420558|P1|COMPLETED|Overall Study||36
5047398|NCT01972659|12420557|P2|STARTED|Overall Study||40
5047399|NCT01972659|12420558|P1|STARTED|Overall Study||40
5047400|NCT01972568|12420567|P3|NOT COMPLETED|Overall Study||16
5047401|NCT01972568|12420568|P2|NOT COMPLETED|Overall Study||12
5047402|NCT01972568|12420569|P1|NOT COMPLETED|Overall Study||16
5047403|NCT01972568|12420567|P3|COMPLETED|Overall Study||84
5047404|NCT01972568|12420568|P2|COMPLETED|Overall Study||92
5047405|NCT01972568|12420569|P1|COMPLETED|Overall Study||86
5047406|NCT01972568|12420567|P3|STARTED|Overall Study||100
5047407|NCT01972568|12420568|P2|STARTED|Overall Study||104
5047408|NCT01972568|12420569|P1|STARTED|Overall Study||102
5047409|NCT01972529|12420608|P4|NOT COMPLETED|Overall Study||4
5047410|NCT01972529|12420609|P3|NOT COMPLETED|Overall Study||2
5047411|NCT01972529|12420610|P2|NOT COMPLETED|Overall Study||5
5047412|NCT01972529|12420611|P1|NOT COMPLETED|Overall Study||2
5047413|NCT01972529|12420608|P4|COMPLETED|Overall Study||55
5047414|NCT01972529|12420609|P3|COMPLETED|Overall Study||32
5047415|NCT01972529|12420610|P2|COMPLETED|Overall Study||85
5047416|NCT01972529|12420611|P1|COMPLETED|Overall Study||46
5047417|NCT01972529|12420608|P4|STARTED|Overall Study||59
5047418|NCT01972529|12420609|P3|STARTED|Overall Study||34
5047419|NCT01972529|12420610|P2|STARTED|Overall Study||90
5047420|NCT01972529|12420611|P1|STARTED|Overall Study||48
5047421|NCT01972516|12420639|P2|NOT COMPLETED|Overall Study||0
5047422|NCT01972516|12420640|P1|NOT COMPLETED|Overall Study||0
5047423|NCT01972516|12420639|P2|COMPLETED|Overall Study||1
5047424|NCT01972516|12420640|P1|COMPLETED|Overall Study||3
5047425|NCT01972516|12420639|P2|STARTED|Overall Study||1
5047426|NCT01972516|12420640|P1|STARTED|Overall Study||3
5047427|NCT01972464|12420656|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
5047428|NCT01972464|12420657|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
5047429|NCT01972464|12420656|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
5047430|NCT01972464|12420657|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
5047431|NCT01972464|12420656|P2|STARTED|3-Month Follow-Up (Week 20)||18
5047432|NCT01972464|12420657|P1|STARTED|3-Month Follow-Up (Week 20)||16
5047433|NCT01972464|12420656|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
5047434|NCT01972464|12420657|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
5047435|NCT01972464|12420656|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
5047436|NCT01972464|12420657|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
5047437|NCT01972464|12420656|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
5047438|NCT01972464|12420657|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
5047439|NCT01972438|12420673|P2|NOT COMPLETED|Post Month 12 Study Period||4
5047440|NCT01972438|12420674|P1|NOT COMPLETED|Post Month 12 Study Period||3
5047441|NCT01972438|12420673|P2|COMPLETED|Post Month 12 Study Period||0
5047442|NCT01972438|12420674|P1|COMPLETED|Post Month 12 Study Period||0
5047443|NCT01972438|12420673|P2|STARTED|Post Month 12 Study Period||4
5047444|NCT01972438|12420674|P1|STARTED|Post Month 12 Study Period||3
5047445|NCT01972438|12420673|P2|NOT COMPLETED|Months 6-12 Study Period||2
5047446|NCT01972438|12420674|P1|NOT COMPLETED|Months 6-12 Study Period||3
5047447|NCT01972438|12420673|P2|COMPLETED|Months 6-12 Study Period||4
5047448|NCT01972438|12420674|P1|COMPLETED|Months 6-12 Study Period||3
5047449|NCT01972438|12420673|P2|STARTED|Months 6-12 Study Period||6
5047450|NCT01972438|12420674|P1|STARTED|Months 6-12 Study Period||6
5047451|NCT01972438|12420673|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
5047452|NCT01972438|12420674|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
5047453|NCT01972438|12420673|P2|COMPLETED|Months 3-6 Crossover Period||6
5047454|NCT01972438|12420674|P1|COMPLETED|Months 3-6 Crossover Period||6
5047455|NCT01972438|12420673|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
5047456|NCT01972438|12420674|P1|STARTED|Months 3-6 Crossover Period||6
5047457|NCT01972438|12420673|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
5047458|NCT01972438|12420674|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
5047459|NCT01972438|12420673|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
5047460|NCT01972438|12420674|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
5047461|NCT01972438|12420673|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
5047462|NCT01972438|12420674|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
5047463|NCT01972308|12420728|P2|NOT COMPLETED|Overall Study||8
5047464|NCT01972308|12420729|P1|NOT COMPLETED|Overall Study||8
5047465|NCT01972308|12420728|P2|COMPLETED|Overall Study||148
5047466|NCT01972308|12420729|P1|COMPLETED|Overall Study||148
5047467|NCT01972308|12420728|P2|STARTED|Overall Study||156
5047468|NCT01972308|12420729|P1|STARTED|Overall Study||156
5047469|NCT01972282|12420745|P1|NOT COMPLETED|Overall Study||15
5047470|NCT01972282|12420745|P1|COMPLETED|Overall Study||1005
5047471|NCT01972282|12420745|P1|STARTED|Overall Study||1020
5047472|NCT01972217|12420755|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
5047473|NCT01972217|12420756|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
5047474|NCT01972217|12420757|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
5047475|NCT01972217|12420758|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
5047476|NCT01972217|12420755|P4|COMPLETED|Part B Double-blind, Randomised Period||24
5047477|NCT01972217|12420756|P3|COMPLETED|Part B Double-blind, Randomised Period||25
5047478|NCT01972217|12420757|P2|COMPLETED|Part B Double-blind, Randomised Period||0
5047479|NCT01972217|12420758|P1|COMPLETED|Part B Double-blind, Randomised Period||0
5047480|NCT01972217|12420755|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
5047481|NCT01972217|12420756|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
5047482|NCT01972217|12420757|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
5047483|NCT01972217|12420758|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
5047484|NCT01972217|12420755|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
5047485|NCT01972217|12420756|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
5047486|NCT01972217|12420757|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
5047487|NCT01972217|12420758|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
5047488|NCT01972217|12420755|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
5047489|NCT01972217|12420756|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
5047490|NCT01972217|12420757|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
5047491|NCT01972217|12420758|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
5047492|NCT01972217|12420755|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
5047493|NCT01972217|12420756|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
5047494|NCT01972217|12420757|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
5047495|NCT01972217|12420758|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
5047496|NCT01972217|12420755|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
5047497|NCT01972217|12420756|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
5047498|NCT01972217|12420757|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
5047499|NCT01972217|12420758|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
5047500|NCT01972217|12420755|P4|STARTED|Part A: Open-label Safety Run-in Period||0
5047501|NCT01972217|12420756|P3|STARTED|Part A: Open-label Safety Run-in Period||0
5047502|NCT01972217|12420757|P2|STARTED|Part A: Open-label Safety Run-in Period||13
5047503|NCT01972217|12420758|P1|STARTED|Part A: Open-label Safety Run-in Period||3
5047504|NCT01972204|12420806|P2|NOT COMPLETED|Overall Study||4
5047505|NCT01972204|12420807|P1|NOT COMPLETED|Overall Study||4
5047506|NCT01972204|12420806|P2|COMPLETED|Overall Study||59
5047507|NCT01972204|12420807|P1|COMPLETED|Overall Study||58
5047508|NCT01972204|12420806|P2|STARTED|Overall Study||63
5047509|NCT01972204|12420807|P1|STARTED|Overall Study||62
5047510|NCT01972152|12420819|P6|NOT COMPLETED|Third Treatment Visit||0
5047511|NCT01972152|12420820|P5|NOT COMPLETED|Third Treatment Visit||0
5047512|NCT01972152|12420821|P4|NOT COMPLETED|Third Treatment Visit||0
5047513|NCT01972152|12420822|P3|NOT COMPLETED|Third Treatment Visit||0
5047514|NCT01972152|12420823|P2|NOT COMPLETED|Third Treatment Visit||0
5047515|NCT01972152|12420824|P1|NOT COMPLETED|Third Treatment Visit||0
5047516|NCT01972152|12420819|P6|COMPLETED|Third Treatment Visit||5
5047517|NCT01972152|12420820|P5|COMPLETED|Third Treatment Visit||5
5047518|NCT01972152|12420821|P4|COMPLETED|Third Treatment Visit||5
5047519|NCT01972152|12420822|P3|COMPLETED|Third Treatment Visit||5
5047520|NCT01972152|12420823|P2|COMPLETED|Third Treatment Visit||3
5047521|NCT01972152|12420824|P1|COMPLETED|Third Treatment Visit||5
5047522|NCT01972152|12420819|P6|STARTED|Third Treatment Visit||5
5047523|NCT01972152|12420820|P5|STARTED|Third Treatment Visit||5
5047524|NCT01972152|12420821|P4|STARTED|Third Treatment Visit||5
5047525|NCT01972152|12420822|P3|STARTED|Third Treatment Visit||5
5047526|NCT01972152|12420823|P2|STARTED|Third Treatment Visit||3
5047527|NCT01972152|12420824|P1|STARTED|Third Treatment Visit||5
5047528|NCT01972152|12420819|P6|NOT COMPLETED|Second Treatment Visit||0
5047529|NCT01972152|12420820|P5|NOT COMPLETED|Second Treatment Visit||0
5047530|NCT01972152|12420821|P4|NOT COMPLETED|Second Treatment Visit||0
5047531|NCT01972152|12420822|P3|NOT COMPLETED|Second Treatment Visit||0
5047532|NCT01972152|12420823|P2|NOT COMPLETED|Second Treatment Visit||1
5047533|NCT01972152|12420824|P1|NOT COMPLETED|Second Treatment Visit||0
5047534|NCT01972152|12420819|P6|COMPLETED|Second Treatment Visit||5
5047535|NCT01972152|12420820|P5|COMPLETED|Second Treatment Visit||5
5047536|NCT01972152|12420821|P4|COMPLETED|Second Treatment Visit||5
5047537|NCT01972152|12420822|P3|COMPLETED|Second Treatment Visit||5
5047538|NCT01972152|12420823|P2|COMPLETED|Second Treatment Visit||3
5047539|NCT01972152|12420824|P1|COMPLETED|Second Treatment Visit||5
5047540|NCT01972152|12420819|P6|STARTED|Second Treatment Visit||5
5047541|NCT01972152|12420820|P5|STARTED|Second Treatment Visit||5
5047542|NCT01972152|12420821|P4|STARTED|Second Treatment Visit||5
5047543|NCT01972152|12420822|P3|STARTED|Second Treatment Visit||5
5047544|NCT01972152|12420823|P2|STARTED|Second Treatment Visit||4
5047545|NCT01972152|12420824|P1|STARTED|Second Treatment Visit||5
5047546|NCT01972152|12420819|P6|NOT COMPLETED|First Treatment Visit||0
5047547|NCT01972152|12420820|P5|NOT COMPLETED|First Treatment Visit||0
5047548|NCT01972152|12420821|P4|NOT COMPLETED|First Treatment Visit||0
5047549|NCT01972152|12420822|P3|NOT COMPLETED|First Treatment Visit||0
5047550|NCT01972152|12420823|P2|NOT COMPLETED|First Treatment Visit||1
5047551|NCT01972152|12420824|P1|NOT COMPLETED|First Treatment Visit||0
5047552|NCT01972152|12420819|P6|COMPLETED|First Treatment Visit||5
5047553|NCT01972152|12420820|P5|COMPLETED|First Treatment Visit||5
5047554|NCT01972152|12420821|P4|COMPLETED|First Treatment Visit||5
5047555|NCT01972152|12420822|P3|COMPLETED|First Treatment Visit||5
5047556|NCT01972152|12420823|P2|COMPLETED|First Treatment Visit||4
5047557|NCT01972152|12420824|P1|COMPLETED|First Treatment Visit||5
5047558|NCT01972152|12420819|P6|STARTED|First Treatment Visit||5
5047559|NCT01972152|12420820|P5|STARTED|First Treatment Visit||5
5047560|NCT01972152|12420821|P4|STARTED|First Treatment Visit||5
5047561|NCT01972152|12420822|P3|STARTED|First Treatment Visit||5
5047562|NCT01972152|12420823|P2|STARTED|First Treatment Visit||5
5047563|NCT01972152|12420824|P1|STARTED|First Treatment Visit||5
5047564|NCT01972074|12420862|P3|NOT COMPLETED|Overall Study||3
5047565|NCT01972074|12420863|P2|NOT COMPLETED|Overall Study||4
5047566|NCT01972074|12420864|P1|NOT COMPLETED|Overall Study||6
5047567|NCT01972074|12420862|P3|COMPLETED|Overall Study||15
5047568|NCT01972074|12420863|P2|COMPLETED|Overall Study||17
5047569|NCT01972074|12420864|P1|COMPLETED|Overall Study||16
5047570|NCT01972074|12420862|P3|STARTED|Overall Study||18
5047571|NCT01972074|12420863|P2|STARTED|Overall Study||21
5047572|NCT01972074|12420864|P1|STARTED|Overall Study||22
5047573|NCT01972061|12420874|P3|NOT COMPLETED|Overall Study||0
5047574|NCT01972061|12420875|P2|NOT COMPLETED|Overall Study||0
5047575|NCT01972061|12420876|P1|NOT COMPLETED|Overall Study||0
5047576|NCT01972061|12420874|P3|COMPLETED|Overall Study||20
5047577|NCT01972061|12420875|P2|COMPLETED|Overall Study||23
5047578|NCT01972061|12420876|P1|COMPLETED|Overall Study||1
5047579|NCT01972061|12420874|P3|STARTED|Overall Study||20
5047580|NCT01972061|12420875|P2|STARTED|Overall Study||23
5047581|NCT01972061|12420876|P1|STARTED|Overall Study||1
5047582|NCT01971723|12420890|P2|NOT COMPLETED|Overall Study||3
5047583|NCT01971723|12420891|P1|NOT COMPLETED|Overall Study||2
5047584|NCT01971723|12420890|P2|COMPLETED|Overall Study||13
5047585|NCT01971723|12420891|P1|COMPLETED|Overall Study||14
5047586|NCT01971723|12420890|P2|STARTED|Overall Study||16
5047587|NCT01971723|12420891|P1|STARTED|Overall Study||16
5047588|NCT01971645|12420924|P3|NOT COMPLETED|Overall Study||2
5047589|NCT01971645|12420925|P2|NOT COMPLETED|Overall Study||0
5047590|NCT01971645|12420926|P1|NOT COMPLETED|Overall Study||2
5047591|NCT01971645|12420924|P3|COMPLETED|Overall Study||23
5047592|NCT01971645|12420925|P2|COMPLETED|Overall Study||27
5047593|NCT01971645|12420926|P1|COMPLETED|Overall Study||23
5047594|NCT01971645|12420924|P3|STARTED|Overall Study||25
5047595|NCT01971645|12420925|P2|STARTED|Overall Study||27
5047596|NCT01971645|12420926|P1|STARTED|Overall Study||25
5047597|NCT01971593|12420937|P2|NOT COMPLETED|Overall Study||4
5047598|NCT01971593|12420938|P1|NOT COMPLETED|Overall Study||5
5047599|NCT01971593|12420937|P2|COMPLETED|Overall Study||8
5047600|NCT01971593|12420938|P1|COMPLETED|Overall Study||9
5047601|NCT01971593|12420937|P2|STARTED|Overall Study||12
5047602|NCT01971593|12420938|P1|STARTED|Overall Study||14
5047603|NCT01971580|12420949|P2|NOT COMPLETED|Overall Study||5
5047604|NCT01971580|12420950|P1|NOT COMPLETED|Overall Study||4
5047605|NCT01971580|12420949|P2|COMPLETED|Overall Study||9
5047606|NCT01971580|12420950|P1|COMPLETED|Overall Study||10
5047607|NCT01971580|12420949|P2|STARTED|Overall Study||14
5047608|NCT01971580|12420950|P1|STARTED|Overall Study||14
5047609|NCT01971567|12420960|P2|NOT COMPLETED|Overall Study||2
5047610|NCT01971567|12420961|P1|NOT COMPLETED|Overall Study||4
5047611|NCT01971567|12420960|P2|COMPLETED|Overall Study||49
5047612|NCT01971567|12420961|P1|COMPLETED|Overall Study||52
5047613|NCT01971567|12420960|P2|STARTED|Overall Study||51
5047614|NCT01971567|12420961|P1|STARTED|Overall Study||56
5047615|NCT01971554|12420987|P4|NOT COMPLETED|Overall Study||0
5047616|NCT01971554|12420988|P3|NOT COMPLETED|Overall Study||0
5047617|NCT01971554|12420989|P2|NOT COMPLETED|Overall Study||0
5047618|NCT01971554|12420990|P1|NOT COMPLETED|Overall Study||1
5047619|NCT01971554|12420987|P4|COMPLETED|Overall Study||18
5047620|NCT01971554|12420988|P3|COMPLETED|Overall Study||18
5047621|NCT01971554|12420989|P2|COMPLETED|Overall Study||18
5047622|NCT01971554|12420990|P1|COMPLETED|Overall Study||8
5047623|NCT01971554|12420987|P4|STARTED|Overall Study||18
5047624|NCT01971554|12420988|P3|STARTED|Overall Study||18
5047625|NCT01971554|12420989|P2|STARTED|Overall Study||18
5047626|NCT01971554|12420990|P1|STARTED|Overall Study||9
5047627|NCT01971476|12421027|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
5047628|NCT01971476|12421028|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
5047629|NCT01971476|12421029|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
5047630|NCT01971476|12421027|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
5047631|NCT01971476|12421028|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
5047632|NCT01971476|12421029|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
5047633|NCT01971476|12421027|P3|STARTED|Cohort 2: 12 to <18 Years||0
5047634|NCT01971476|12421028|P2|STARTED|Cohort 2: 12 to <18 Years||4
5047635|NCT01971476|12421029|P1|STARTED|Cohort 2: 12 to <18 Years||6
5047636|NCT01971476|12421027|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
5047637|NCT01971476|12421028|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
5047638|NCT01971476|12421029|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
5047639|NCT01971476|12421027|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
5047640|NCT01971476|12421028|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
5047641|NCT01971476|12421029|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
5047642|NCT01971476|12421027|P3|STARTED|Cohort 1: 2 to <12 Years||6
5047643|NCT01971476|12421028|P2|STARTED|Cohort 1: 2 to <12 Years||3
5047644|NCT01971476|12421029|P1|STARTED|Cohort 1: 2 to <12 Years||3
5047645|NCT01971463|12421106|P1|NOT COMPLETED|Overall Study||0
5047646|NCT01971463|12421106|P1|COMPLETED|Overall Study||81
5047647|NCT01971463|12421106|P1|STARTED|Overall Study||81
5047648|NCT01971385|12421114|P3|NOT COMPLETED|Overall Study||4
5047649|NCT01971385|12421115|P2|NOT COMPLETED|Overall Study||5
5047650|NCT01971385|12421116|P1|NOT COMPLETED|Overall Study||3
5047651|NCT01971385|12421114|P3|COMPLETED|Overall Study||15
5047652|NCT01971385|12421115|P2|COMPLETED|Overall Study||13
5047653|NCT01971385|12421116|P1|COMPLETED|Overall Study||14
5047654|NCT01971385|12421114|P3|STARTED|Overall Study||19
5047655|NCT01971385|12421115|P2|STARTED|Overall Study||18
5047656|NCT01971385|12421116|P1|STARTED|Overall Study||17
5047657|NCT01971346|12421123|P1|NOT COMPLETED|Overall Study||8
5047658|NCT01971346|12421123|P1|COMPLETED|Overall Study||42
5047659|NCT01971346|12421123|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
5047660|NCT01971255|12421137|P2|NOT COMPLETED|Overall Study||2
5047661|NCT01971255|12421138|P1|NOT COMPLETED|Overall Study||1
5047662|NCT01971255|12421137|P2|COMPLETED|Overall Study||40
5047663|NCT01971255|12421138|P1|COMPLETED|Overall Study||31
5047664|NCT01971255|12421137|P2|STARTED|Overall Study||42
5047665|NCT01971255|12421138|P1|STARTED|Overall Study||32
5047666|NCT01971203|12421156|P2|NOT COMPLETED|Overall Study||8
5047667|NCT01971203|12421157|P1|NOT COMPLETED|Overall Study||9
5047668|NCT01971203|12421156|P2|COMPLETED|Overall Study||21
5047669|NCT01971203|12421157|P1|COMPLETED|Overall Study||17
5047670|NCT01971203|12421156|P2|STARTED|Overall Study||29
5047671|NCT01971203|12421157|P1|STARTED|Overall Study||26
5047672|NCT01971086|12421169|P1|NOT COMPLETED|Overall Study||0
5047673|NCT01971086|12421169|P1|COMPLETED|Overall Study||300
5047674|NCT01971086|12421169|P1|STARTED|Overall Study||300
5047675|NCT01970995|12421184|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
5047676|NCT01970995|12421185|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
5047677|NCT01970995|12421186|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
5047678|NCT01970995|12421184|P3|COMPLETED|End of Study (Population at Day 90)||38
5047679|NCT01970995|12421185|P2|COMPLETED|End of Study (Population at Day 90)||41
5047680|NCT01970995|12421186|P1|COMPLETED|End of Study (Population at Day 90)||76
5047681|NCT01970995|12421184|P3|STARTED|End of Study (Population at Day 90)||39
5047682|NCT01970995|12421185|P2|STARTED|End of Study (Population at Day 90)||41
5047683|NCT01970995|12421186|P1|STARTED|End of Study (Population at Day 90)||77
5047684|NCT01970995|12421184|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
5047685|NCT01970995|12421185|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
5047686|NCT01970995|12421186|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
5047687|NCT01970995|12421184|P3|COMPLETED|Confinement Period (Population at Day 5)||39
5047688|NCT01970995|12421185|P2|COMPLETED|Confinement Period (Population at Day 5)||41
5047689|NCT01970995|12421186|P1|COMPLETED|Confinement Period (Population at Day 5)||77
5047690|NCT01970995|12421184|P3|STARTED|Confinement Period (Population at Day 5)||40
5047691|NCT01970995|12421185|P2|STARTED|Confinement Period (Population at Day 5)||42
5047692|NCT01970995|12421186|P1|STARTED|Confinement Period (Population at Day 5)||78
5047693|NCT01970982|12421209|P3|NOT COMPLETED|Overall Study||2
5047694|NCT01970982|12421210|P2|NOT COMPLETED|Overall Study||0
5047695|NCT01970982|12421211|P1|NOT COMPLETED|Overall Study||0
5047696|NCT01970982|12421209|P3|COMPLETED|Overall Study||38
5047697|NCT01970982|12421210|P2|COMPLETED|Overall Study||40
5047698|NCT01970982|12421211|P1|COMPLETED|Overall Study||80
5047699|NCT01970982|12421209|P3|STARTED|Overall Study||40
5047700|NCT01970982|12421210|P2|STARTED|Overall Study||40
5047701|NCT01970982|12421211|P1|STARTED|Overall Study||80
5047702|NCT01970943|12421229|P2|NOT COMPLETED|Overall Study||1
5047703|NCT01970943|12421230|P1|NOT COMPLETED|Overall Study||3
5047704|NCT01970943|12421229|P2|COMPLETED|Overall Study||11
5047705|NCT01970943|12421230|P1|COMPLETED|Overall Study||8
5047706|NCT01970943|12421229|P2|STARTED|Overall Study||12
5047707|NCT01970943|12421230|P1|STARTED|Overall Study||11
5047708|NCT01970878|12421246|P4|NOT COMPLETED|Overall Study||24
5047709|NCT01970878|12421247|P3|NOT COMPLETED|Overall Study||26
5047710|NCT01970878|12421248|P2|NOT COMPLETED|Overall Study||27
5047711|NCT01970878|12421249|P1|NOT COMPLETED|Overall Study||37
5047712|NCT01970878|12421246|P4|COMPLETED|Overall Study||147
5047713|NCT01970878|12421247|P3|COMPLETED|Overall Study||187
5047714|NCT01970878|12421248|P2|COMPLETED|Overall Study||191
5047715|NCT01970878|12421249|P1|COMPLETED|Overall Study||253
5047716|NCT01970878|12421246|P4|STARTED|Overall Study||171
5047717|NCT01970878|12421247|P3|STARTED|Overall Study||213
5047718|NCT01970878|12421248|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
5047719|NCT01970878|12421249|P1|STARTED|Overall Study||290
5047720|NCT01970865|12421292|P17|NOT COMPLETED|Overall Study||3
5047721|NCT01970865|12421293|P16|NOT COMPLETED|Overall Study||47
5047722|NCT01970865|12421294|P15|NOT COMPLETED|Overall Study||46
5047723|NCT01970865|12421295|P14|NOT COMPLETED|Overall Study||66
5047724|NCT01970865|12421296|P13|NOT COMPLETED|Overall Study||60
5047725|NCT01970865|12421297|P12|NOT COMPLETED|Overall Study||27
5047726|NCT01970865|12421298|P11|NOT COMPLETED|Overall Study||30
5047727|NCT01970865|12421299|P10|NOT COMPLETED|Overall Study||4
5047728|NCT01970865|12421300|P9|NOT COMPLETED|Overall Study||3
5047729|NCT01970865|12421301|P8|NOT COMPLETED|Overall Study||3
5047730|NCT01970865|12421302|P7|NOT COMPLETED|Overall Study||3
5047731|NCT01970865|12421303|P6|NOT COMPLETED|Overall Study||3
5047732|NCT01970865|12421304|P5|NOT COMPLETED|Overall Study||17
5047733|NCT01970865|12421305|P4|NOT COMPLETED|Overall Study||13
5047734|NCT01970865|12421306|P3|NOT COMPLETED|Overall Study||3
5047735|NCT01970865|12421307|P2|NOT COMPLETED|Overall Study||3
5047736|NCT01970865|12421308|P1|NOT COMPLETED|Overall Study||3
5047737|NCT01970865|12421292|P17|COMPLETED|Overall Study||0
5047738|NCT01970865|12421293|P16|COMPLETED|Overall Study||0
5047739|NCT01970865|12421294|P15|COMPLETED|Overall Study||0
5047740|NCT01970865|12421295|P14|COMPLETED|Overall Study||0
5047741|NCT01970865|12421296|P13|COMPLETED|Overall Study||0
5047742|NCT01970865|12421297|P12|COMPLETED|Overall Study||0
5047743|NCT01970865|12421298|P11|COMPLETED|Overall Study||0
5047744|NCT01970865|12421299|P10|COMPLETED|Overall Study||0
5047745|NCT01970865|12421300|P9|COMPLETED|Overall Study||0
5047746|NCT01970865|12421301|P8|COMPLETED|Overall Study||0
5047747|NCT01970865|12421302|P7|COMPLETED|Overall Study||0
5047748|NCT01970865|12421303|P6|COMPLETED|Overall Study||0
5047749|NCT01970865|12421304|P5|COMPLETED|Overall Study||0
5047750|NCT01970865|12421305|P4|COMPLETED|Overall Study||0
5047751|NCT01970865|12421306|P3|COMPLETED|Overall Study||0
5047752|NCT01970865|12421307|P2|COMPLETED|Overall Study||0
5047753|NCT01970865|12421308|P1|COMPLETED|Overall Study||0
5047754|NCT01970865|12421292|P17|Received Treatment|Overall Study||3
5047755|NCT01970865|12421293|P16|Received Treatment|Overall Study||47
5047756|NCT01970865|12421294|P15|Received Treatment|Overall Study||46
5047757|NCT01970865|12421295|P14|Received Treatment|Overall Study||65
5047758|NCT01970865|12421296|P13|Received Treatment|Overall Study||60
5047759|NCT01970865|12421297|P12|Received Treatment|Overall Study||27
5047760|NCT01970865|12421298|P11|Received Treatment|Overall Study||30
5047761|NCT01970865|12421299|P10|Received Treatment|Overall Study||4
5047762|NCT01970865|12421300|P9|Received Treatment|Overall Study||3
5047763|NCT01970865|12421301|P8|Received Treatment|Overall Study||3
5047764|NCT01970865|12421302|P7|Received Treatment|Overall Study||3
5047765|NCT01970865|12421303|P6|Received Treatment|Overall Study||3
5047766|NCT01970865|12421304|P5|Received Treatment|Overall Study||17
5047767|NCT01970865|12421305|P4|Received Treatment|Overall Study||12
5047768|NCT01970865|12421306|P3|Received Treatment|Overall Study||3
5047769|NCT01970865|12421307|P2|Received Treatment|Overall Study||3
5047770|NCT01970865|12421308|P1|Received Treatment|Overall Study||3
5047771|NCT01970865|12421292|P17|STARTED|Overall Study||3
5047772|NCT01970865|12421293|P16|STARTED|Overall Study||47
5047773|NCT01970865|12421294|P15|STARTED|Overall Study||46
5047774|NCT01970865|12421295|P14|STARTED|Overall Study||66
5047775|NCT01970865|12421296|P13|STARTED|Overall Study||60
5047776|NCT01970865|12421297|P12|STARTED|Overall Study||27
5047777|NCT01970865|12421298|P11|STARTED|Overall Study||30
5047778|NCT01970865|12421299|P10|STARTED|Overall Study||4
5047779|NCT01970865|12421300|P9|STARTED|Overall Study||3
5047780|NCT01970865|12421301|P8|STARTED|Overall Study||3
5047781|NCT01970865|12421302|P7|STARTED|Overall Study||3
5047782|NCT01970865|12421303|P6|STARTED|Overall Study||3
5047783|NCT01970865|12421304|P5|STARTED|Overall Study||17
5047784|NCT01970865|12421305|P4|STARTED|Overall Study||13
5047785|NCT01970865|12421306|P3|STARTED|Overall Study||3
5047786|NCT01970865|12421307|P2|STARTED|Overall Study||3
5047787|NCT01970865|12421308|P1|STARTED|Overall Study||3
5047788|NCT01970787|12421732|P1|NOT COMPLETED|Overall Study||1
5047789|NCT01970787|12421732|P1|COMPLETED|Overall Study||21
5047790|NCT01970787|12421732|P1|STARTED|Overall Study||22
5047791|NCT01970592|12421740|P1|NOT COMPLETED|Overall Study||6
5047792|NCT01970592|12421740|P1|COMPLETED|Overall Study||50
5047793|NCT01970592|12421740|P1|STARTED|Overall Study|Completed all training sessions|56
5047794|NCT01970540|12421748|P3|NOT COMPLETED|Overall Study||19
5047795|NCT01970540|12421749|P2|NOT COMPLETED|Overall Study||28
5047796|NCT01970540|12421750|P1|NOT COMPLETED|Overall Study||73
5047797|NCT01970540|12421748|P3|COMPLETED|Overall Study||0
5047798|NCT01970540|12421749|P2|COMPLETED|Overall Study||0
5047799|NCT01970540|12421750|P1|COMPLETED|Overall Study||0
5047800|NCT01970540|12421748|P3|STARTED|Overall Study||19
5047801|NCT01970540|12421749|P2|STARTED|Overall Study||28
5047802|NCT01970540|12421750|P1|STARTED|Overall Study||73
5047803|NCT01970527|12421781|P2|NOT COMPLETED|Follow-up Clinic Visit||3
5047804|NCT01970527|12421782|P1|NOT COMPLETED|Follow-up Clinic Visit||1
5047805|NCT01970527|12421781|P2|COMPLETED|Follow-up Clinic Visit||8
5047806|NCT01970527|12421782|P1|COMPLETED|Follow-up Clinic Visit||7
5047807|NCT01970527|12421781|P2|STARTED|Follow-up Clinic Visit||11
5047808|NCT01970527|12421782|P1|STARTED|Follow-up Clinic Visit||8
5047809|NCT01970527|12421781|P2|NOT COMPLETED|Treatment||3
5047810|NCT01970527|12421782|P1|NOT COMPLETED|Treatment||0
5047811|NCT01970527|12421781|P2|COMPLETED|Treatment||11
5047812|NCT01970527|12421782|P1|COMPLETED|Treatment||8
5047813|NCT01970527|12421781|P2|STARTED|Treatment||14
5047814|NCT01970527|12421782|P1|STARTED|Treatment||8
5047815|NCT01970527|12421781|P2|NOT COMPLETED|Pre-treatment/Baseline||0
5047816|NCT01970527|12421782|P1|NOT COMPLETED|Pre-treatment/Baseline||1
5047817|NCT01970527|12421781|P2|COMPLETED|Pre-treatment/Baseline||14
5047818|NCT01970527|12421782|P1|COMPLETED|Pre-treatment/Baseline||8
5047819|NCT01970527|12421781|P2|STARTED|Pre-treatment/Baseline||14
5047820|NCT01970527|12421782|P1|STARTED|Pre-treatment/Baseline||9
5047821|NCT01970488|12421795|P5|NOT COMPLETED|Part 2: Post Week 16||8
5047822|NCT01970488|12421796|P4|NOT COMPLETED|Part 2: Post Week 16||8
5047823|NCT01970488|12421797|P3|NOT COMPLETED|Part 2: Post Week 16||17
5047824|NCT01970488|12421798|P2|NOT COMPLETED|Part 2: Post Week 16||0
5047825|NCT01970488|12421799|P1|NOT COMPLETED|Part 2: Post Week 16||0
5047826|NCT01970488|12421795|P5|COMPLETED|Part 2: Post Week 16||69
5047827|NCT01970488|12421796|P4|COMPLETED|Part 2: Post Week 16||71
5047828|NCT01970488|12421797|P3|COMPLETED|Part 2: Post Week 16||135
5047829|NCT01970488|12421798|P2|COMPLETED|Part 2: Post Week 16||0
5047830|NCT01970488|12421799|P1|COMPLETED|Part 2: Post Week 16||0
5047831|NCT01970488|12421795|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
5047832|NCT01970488|12421796|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
5047833|NCT01970488|12421797|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
5047834|NCT01970488|12421798|P2|STARTED|Part 2: Post Week 16||0
5047835|NCT01970488|12421799|P1|STARTED|Part 2: Post Week 16||0
5047836|NCT01970488|12421795|P5|NOT COMPLETED|Part 1: Through Week 16||0
5047837|NCT01970488|12421796|P4|NOT COMPLETED|Part 1: Through Week 16||0
5047838|NCT01970488|12421797|P3|NOT COMPLETED|Part 1: Through Week 16||0
5047839|NCT01970488|12421798|P2|NOT COMPLETED|Part 1: Through Week 16||13
5047840|NCT01970488|12421799|P1|NOT COMPLETED|Part 1: Through Week 16||11
5047841|NCT01970488|12421795|P5|COMPLETED|Part 1: Through Week 16||0
5047842|NCT01970488|12421796|P4|COMPLETED|Part 1: Through Week 16||0
5047843|NCT01970488|12421797|P3|COMPLETED|Part 1: Through Week 16||0
5047844|NCT01970488|12421798|P2|COMPLETED|Part 1: Through Week 16||162
5047845|NCT01970488|12421799|P1|COMPLETED|Part 1: Through Week 16||164
5047846|NCT01970488|12421795|P5|Received Treatment|Part 1: Through Week 16||0
5047847|NCT01970488|12421796|P4|Received Treatment|Part 1: Through Week 16||0
5047848|NCT01970488|12421797|P3|Received Treatment|Part 1: Through Week 16||0
5047849|NCT01970488|12421798|P2|Received Treatment|Part 1: Through Week 16||173
5047850|NCT01970488|12421799|P1|Received Treatment|Part 1: Through Week 16||174
5047851|NCT01970488|12421795|P5|STARTED|Part 1: Through Week 16||0
5047852|NCT01970488|12421796|P4|STARTED|Part 1: Through Week 16||0
5047853|NCT01970488|12421797|P3|STARTED|Part 1: Through Week 16||0
5047854|NCT01970488|12421798|P2|STARTED|Part 1: Through Week 16||175
5047855|NCT01970488|12421799|P1|STARTED|Part 1: Through Week 16||175
5047856|NCT01970475|12421866|P2|NOT COMPLETED|Overall Study||11
5047857|NCT01970475|12421867|P1|NOT COMPLETED|Overall Study||21
5047858|NCT01970475|12421866|P2|COMPLETED|Overall Study||251
5047859|NCT01970475|12421867|P1|COMPLETED|Overall Study||243
5047860|NCT01970475|12421866|P2|STARTED|Overall Study||262
5047861|NCT01970475|12421867|P1|STARTED|Overall Study||264
5047862|NCT01970462|12421887|P2|NOT COMPLETED|Overall Study||2
5047863|NCT01970462|12421888|P1|NOT COMPLETED|Overall Study||0
5047864|NCT01970462|12421887|P2|COMPLETED|Overall Study||2
5047865|NCT01970462|12421888|P1|COMPLETED|Overall Study||1
5047866|NCT01970462|12421887|P2|STARTED|Overall Study||4
5047867|NCT01970462|12421888|P1|STARTED|Overall Study||1
5047868|NCT01970397|12421902|P2|NOT COMPLETED|Overall Study||5
5047869|NCT01970397|12421903|P1|NOT COMPLETED|Overall Study||2
5047870|NCT01970397|12421902|P2|COMPLETED|Overall Study||64
5047871|NCT01970397|12421903|P1|COMPLETED|Overall Study||67
5047872|NCT01970397|12421902|P2|STARTED|Overall Study||69
5047873|NCT01970397|12421903|P1|STARTED|Overall Study||69
5047874|NCT01970371|12421916|P3|NOT COMPLETED|Overall Study||13
5047875|NCT01970371|12421917|P2|NOT COMPLETED|Overall Study||13
5047876|NCT01970371|12421918|P1|NOT COMPLETED|Overall Study||8
5047877|NCT01970371|12421916|P3|COMPLETED|Overall Study||17
5047878|NCT01970371|12421917|P2|COMPLETED|Overall Study||8
5047879|NCT01970371|12421918|P1|COMPLETED|Overall Study||10
5047880|NCT01970371|12421916|P3|STARTED|Overall Study||30
5047881|NCT01970371|12421917|P2|STARTED|Overall Study||21
5047882|NCT01970371|12421918|P1|STARTED|Overall Study||18
5047883|NCT01970241|12421943|P2|NOT COMPLETED|Overall Study||8
5047884|NCT01970241|12421944|P1|NOT COMPLETED|Overall Study||17
5047885|NCT01970241|12421943|P2|COMPLETED|Overall Study||31
5047886|NCT01970241|12421944|P1|COMPLETED|Overall Study||29
5047887|NCT01970241|12421943|P2|STARTED|Overall Study||39
5047888|NCT01970241|12421944|P1|STARTED|Overall Study||46
5047889|NCT01970176|12421986|P2|NOT COMPLETED|Overall Study||0
5047890|NCT01970176|12421987|P1|NOT COMPLETED|Overall Study||0
5047891|NCT01970176|12421986|P2|COMPLETED|Overall Study||6
5047892|NCT01970176|12421987|P1|COMPLETED|Overall Study||14
5047893|NCT01970176|12421986|P2|STARTED|Overall Study||6
5047894|NCT01970176|12421987|P1|STARTED|Overall Study||14
5047895|NCT01969916|12421997|P1|NOT COMPLETED|Overall Study||45
5047896|NCT01969916|12421997|P1|COMPLETED|Overall Study||105
5047897|NCT01969916|12421997|P1|STARTED|Overall Study||150
5047898|NCT01969851|12422004|P3|NOT COMPLETED|Overall Study||7
5047899|NCT01969851|12422005|P2|NOT COMPLETED|Overall Study||3
5047900|NCT01969851|12422006|P1|NOT COMPLETED|Overall Study||1
5047901|NCT01969851|12422004|P3|COMPLETED|Overall Study||14
5047902|NCT01969851|12422005|P2|COMPLETED|Overall Study||21
5047903|NCT01969851|12422006|P1|COMPLETED|Overall Study||9
5047904|NCT01969851|12422004|P3|STARTED|Overall Study||21
5047905|NCT01969851|12422005|P2|STARTED|Overall Study||24
5047906|NCT01969851|12422006|P1|STARTED|Overall Study||10
5047907|NCT01969799|12422028|P2|NOT COMPLETED|Overall Study||14
5047908|NCT01969799|12422029|P1|NOT COMPLETED|Overall Study||17
5047909|NCT01969799|12422028|P2|COMPLETED|Overall Study||58
5047910|NCT01969799|12422029|P1|COMPLETED|Overall Study||54
5047911|NCT01969799|12422028|P2|STARTED|Overall Study||72
5047912|NCT01969799|12422029|P1|STARTED|Overall Study||71
5047913|NCT01969747|12422053|P4|NOT COMPLETED|Overall Study||0
5047914|NCT01969747|12422054|P3|NOT COMPLETED|Overall Study||0
5047915|NCT01969747|12422055|P2|NOT COMPLETED|Overall Study||0
5047916|NCT01969747|12422056|P1|NOT COMPLETED|Overall Study||0
5047917|NCT01969747|12422053|P4|COMPLETED|Overall Study||18
5047918|NCT01969747|12422054|P3|COMPLETED|Overall Study||19
5047919|NCT01969747|12422055|P2|COMPLETED|Overall Study||19
5047920|NCT01969747|12422056|P1|COMPLETED|Overall Study||19
5047921|NCT01969747|12422053|P4|STARTED|Overall Study||18
5047922|NCT01969747|12422054|P3|STARTED|Overall Study||19
5047923|NCT01969747|12422055|P2|STARTED|Overall Study||19
5047924|NCT01969747|12422056|P1|STARTED|Overall Study||19
5047925|NCT01969721|12422066|P4|NOT COMPLETED|Overall Study||6
5047926|NCT01969721|12422067|P3|NOT COMPLETED|Overall Study||5
5047927|NCT01969721|12422068|P2|NOT COMPLETED|Overall Study||12
5047928|NCT01969721|12422069|P1|NOT COMPLETED|Overall Study||4
5047929|NCT01969721|12422066|P4|COMPLETED|Overall Study||46
5047930|NCT01969721|12422067|P3|COMPLETED|Overall Study||45
5047931|NCT01969721|12422068|P2|COMPLETED|Overall Study||57
5047932|NCT01969721|12422069|P1|COMPLETED|Overall Study||54
5047933|NCT01969721|12422066|P4|STARTED|Overall Study||52
5047934|NCT01969721|12422067|P3|STARTED|Overall Study||50
5047935|NCT01969721|12422068|P2|STARTED|Overall Study||69
5047936|NCT01969721|12422069|P1|STARTED|Overall Study||58
5047937|NCT01969708|12422097|P2|NOT COMPLETED|Overall Study||9
5047938|NCT01969708|12422098|P1|NOT COMPLETED|Overall Study||5
5047939|NCT01969708|12422097|P2|COMPLETED|Overall Study||173
5047940|NCT01969708|12422098|P1|COMPLETED|Overall Study||175
5047941|NCT01969708|12422097|P2|STARTED|Overall Study||182
5047942|NCT01969708|12422098|P1|STARTED|Overall Study||180
5047943|NCT01969565|12422114|P1|NOT COMPLETED|Overall Study||1
5047944|NCT01969565|12422114|P1|COMPLETED|Overall Study||0
5047945|NCT01969565|12422114|P1|STARTED|Overall Study||1
5047946|NCT01969539|12422120|P1|NOT COMPLETED|Overall Study||0
5047947|NCT01969539|12422120|P1|COMPLETED|Overall Study||11
5047948|NCT01969539|12422120|P1|STARTED|Overall Study||11
5047949|NCT01969500|12422128|P2|NOT COMPLETED|Overall Study||2
5047950|NCT01969500|12422129|P1|NOT COMPLETED|Overall Study||1
5047951|NCT01969500|12422128|P2|COMPLETED|Overall Study||24
5047952|NCT01969500|12422129|P1|COMPLETED|Overall Study||24
5047953|NCT01969500|12422128|P2|STARTED|Overall Study||26
5047954|NCT01969500|12422129|P1|STARTED|Overall Study||25
5047955|NCT01969448|12422144|P3|NOT COMPLETED|Overall Study||0
5047956|NCT01969448|12422145|P2|NOT COMPLETED|Overall Study||0
5047957|NCT01969448|12422146|P1|NOT COMPLETED|Overall Study||0
5047958|NCT01969448|12422144|P3|COMPLETED|Overall Study||0
5047959|NCT01969448|12422145|P2|COMPLETED|Overall Study||24
5047960|NCT01969448|12422146|P1|COMPLETED|Overall Study||55
5047961|NCT01969448|12422144|P3|STARTED|Overall Study||0
5047962|NCT01969448|12422145|P2|STARTED|Overall Study||24
5047963|NCT01969448|12422146|P1|STARTED|Overall Study||55
5047964|NCT01969435|12422169|P1|NOT COMPLETED|Overall Study||0
5047965|NCT01969435|12422169|P1|COMPLETED|Overall Study||50
5047966|NCT01969435|12422169|P1|STARTED|Overall Study||50
5047967|NCT01969240|12422185|P2|NOT COMPLETED|Overall Study||0
5047968|NCT01969240|12422186|P1|NOT COMPLETED|Overall Study||0
5047969|NCT01969240|12422185|P2|COMPLETED|Overall Study||447
5047970|NCT01969240|12422186|P1|COMPLETED|Overall Study||451
5047971|NCT01969240|12422185|P2|STARTED|Overall Study||447
5047972|NCT01969240|12422186|P1|STARTED|Overall Study||451
5047973|NCT01969214|12422204|P1|NOT COMPLETED|Overall Study||15
5047974|NCT01969214|12422204|P1|COMPLETED|Overall Study||86
5047975|NCT01969214|12422204|P1|STARTED|Overall Study||101
5047976|NCT01969201|12422223|P2|NOT COMPLETED|Overall Study||45
5047977|NCT01969201|12422224|P1|NOT COMPLETED|Overall Study||45
5047978|NCT01969201|12422223|P2|COMPLETED|Overall Study||313
5047979|NCT01969201|12422224|P1|COMPLETED|Overall Study||307
5047980|NCT01969201|12422223|P2|STARTED|Overall Study||358
5047981|NCT01969201|12422224|P1|STARTED|Overall Study||352
5047982|NCT01969162|12422244|P1|NOT COMPLETED|Overall Study||0
5047983|NCT01969162|12422244|P1|COMPLETED|Overall Study||35
5047984|NCT01969162|12422244|P1|STARTED|Overall Study||35
5047985|NCT01969084|12422250|P2|NOT COMPLETED|Overall Study||1
5047986|NCT01969084|12422251|P1|NOT COMPLETED|Overall Study||0
5047987|NCT01969084|12422250|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
5047988|NCT01969084|12422251|P1|COMPLETED|Overall Study||19
5047989|NCT01969084|12422250|P2|STARTED|Overall Study||22
5047990|NCT01969084|12422251|P1|STARTED|Overall Study||19
5047991|NCT01969058|12422267|P2|NOT COMPLETED|Overall Study||0
5047992|NCT01969058|12422268|P1|NOT COMPLETED|Overall Study||3
5047993|NCT01969058|12422267|P2|COMPLETED|Overall Study||26
5047994|NCT01969058|12422268|P1|COMPLETED|Overall Study||47
5047995|NCT01969058|12422267|P2|STARTED|Overall Study||26
5047996|NCT01969058|12422268|P1|STARTED|Overall Study||50
5047997|NCT01968980|12422312|P2|NOT COMPLETED|Overall Study||14
5047998|NCT01968980|12422313|P1|NOT COMPLETED|Overall Study||16
5047999|NCT01968980|12422312|P2|COMPLETED|Overall Study||171
5048000|NCT01968980|12422313|P1|COMPLETED|Overall Study||169
5048001|NCT01968980|12422312|P2|STARTED|Overall Study||185
5048002|NCT01968980|12422313|P1|STARTED|Overall Study||185
5048003|NCT01968967|12422375|P5|NOT COMPLETED|Extension Period||5
5048004|NCT01968967|12422376|P4|NOT COMPLETED|Extension Period||0
5048005|NCT01968967|12422377|P3|NOT COMPLETED|Extension Period||2
5048006|NCT01968967|12422378|P2|NOT COMPLETED|Extension Period||0
5048007|NCT01968967|12422379|P1|NOT COMPLETED|Extension Period||0
5048008|NCT01968967|12422375|P5|COMPLETED|Extension Period||34
5048009|NCT01968967|12422376|P4|COMPLETED|Extension Period||19
5048010|NCT01968967|12422377|P3|COMPLETED|Extension Period||45
5048011|NCT01968967|12422378|P2|COMPLETED|Extension Period||0
5048012|NCT01968967|12422379|P1|COMPLETED|Extension Period||0
5048013|NCT01968967|12422375|P5|STARTED|Extension Period||39
5048014|NCT01968967|12422376|P4|STARTED|Extension Period||19
5048015|NCT01968967|12422377|P3|STARTED|Extension Period||47
5048016|NCT01968967|12422378|P2|STARTED|Extension Period||0
5048017|NCT01968967|12422379|P1|STARTED|Extension Period||0
5048018|NCT01968967|12422375|P5|NOT COMPLETED|Treatment Period||0
5048019|NCT01968967|12422376|P4|NOT COMPLETED|Treatment Period||0
5048020|NCT01968967|12422377|P3|NOT COMPLETED|Treatment Period||0
5048021|NCT01968967|12422378|P2|NOT COMPLETED|Treatment Period||134
5048022|NCT01968967|12422379|P1|NOT COMPLETED|Treatment Period||146
5048023|NCT01968967|12422375|P5|COMPLETED|Treatment Period||0
5048024|NCT01968967|12422376|P4|COMPLETED|Treatment Period||0
5048025|NCT01968967|12422377|P3|COMPLETED|Treatment Period||0
5048026|NCT01968967|12422378|P2|COMPLETED|Treatment Period||934
5048027|NCT01968967|12422379|P1|COMPLETED|Treatment Period||925
5048028|NCT01968967|12422375|P5|Treated|Treatment Period||0
5048029|NCT01968967|12422376|P4|Treated|Treatment Period||0
5048030|NCT01968967|12422377|P3|Treated|Treatment Period||0
5048031|NCT01968967|12422378|P2|Treated|Treatment Period||1063
5048032|NCT01968967|12422379|P1|Treated|Treatment Period||1065
5048033|NCT01968967|12422375|P5|STARTED|Treatment Period||0
5048034|NCT01968967|12422376|P4|STARTED|Treatment Period||0
5048035|NCT01968967|12422377|P3|STARTED|Treatment Period||0
5048036|NCT01968967|12422378|P2|STARTED|Treatment Period||1068
5048037|NCT01968967|12422379|P1|STARTED|Treatment Period||1071
5048038|NCT01968954|12422448|P2|NOT COMPLETED|Overall Study||43
5048039|NCT01968954|12422449|P1|NOT COMPLETED|Overall Study||40
5048040|NCT01968954|12422448|P2|COMPLETED|Overall Study||314
5048041|NCT01968954|12422449|P1|COMPLETED|Overall Study||314
5048042|NCT01968954|12422448|P2|Treated|Overall Study||356
5048043|NCT01968954|12422449|P1|Treated|Overall Study||353
5048044|NCT01968954|12422448|P2|STARTED|Overall Study||357
5048045|NCT01968954|12422449|P1|STARTED|Overall Study||354
5048046|NCT01968811|12422513|P1|NOT COMPLETED|Overall Study||5
5048047|NCT01968811|12422513|P1|COMPLETED|Overall Study||5
5048048|NCT01968811|12422513|P1|STARTED|Overall Study||10
5048049|NCT01968694|12422520|P2|NOT COMPLETED|Visit 2 (1 Day)||0
5048050|NCT01968694|12422521|P1|NOT COMPLETED|Visit 2 (1 Day)||0
5048051|NCT01968694|12422520|P2|COMPLETED|Visit 2 (1 Day)||8
5048052|NCT01968694|12422521|P1|COMPLETED|Visit 2 (1 Day)||10
5048053|NCT01968694|12422520|P2|STARTED|Visit 2 (1 Day)||8
5048054|NCT01968694|12422521|P1|STARTED|Visit 2 (1 Day)||10
5048055|NCT01968694|12422520|P2|NOT COMPLETED|Washout (1 Month)||1
5048056|NCT01968694|12422521|P1|NOT COMPLETED|Washout (1 Month)||0
5048057|NCT01968694|12422520|P2|COMPLETED|Washout (1 Month)||8
5048058|NCT01968694|12422521|P1|COMPLETED|Washout (1 Month)||10
5048059|NCT01968694|12422520|P2|STARTED|Washout (1 Month)||9
5048060|NCT01968694|12422521|P1|STARTED|Washout (1 Month)||10
5048061|NCT01968694|12422520|P2|NOT COMPLETED|Visit 1 (1 Day)||0
5048062|NCT01968694|12422521|P1|NOT COMPLETED|Visit 1 (1 Day)||0
5048063|NCT01968694|12422520|P2|COMPLETED|Visit 1 (1 Day)||9
5048064|NCT01968694|12422521|P1|COMPLETED|Visit 1 (1 Day)||10
5048065|NCT01968694|12422520|P2|STARTED|Visit 1 (1 Day)||9
5048066|NCT01968694|12422521|P1|STARTED|Visit 1 (1 Day)||10
5048067|NCT01968551|12422538|P3|NOT COMPLETED|Extension Phase||4
5048068|NCT01968551|12422539|P2|NOT COMPLETED|Extension Phase||1
5048069|NCT01968551|12422540|P1|NOT COMPLETED|Extension Phase||1
5048070|NCT01968551|12422538|P3|COMPLETED|Extension Phase||30
5048071|NCT01968551|12422539|P2|COMPLETED|Extension Phase||86
5048072|NCT01968551|12422540|P1|COMPLETED|Extension Phase||19
5048073|NCT01968551|12422538|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
5048074|NCT01968551|12422539|P2|STARTED|Extension Phase||87
5048075|NCT01968551|12422540|P1|STARTED|Extension Phase||20
5048076|NCT01968551|12422538|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
5048077|NCT01968551|12422539|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
5048078|NCT01968551|12422540|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
5048079|NCT01968551|12422538|P3|COMPLETED|Open Label Phase (48 Weeks)||41
5048080|NCT01968551|12422539|P2|COMPLETED|Open Label Phase (48 Weeks)||87
5048081|NCT01968551|12422540|P1|COMPLETED|Open Label Phase (48 Weeks)||20
5048082|NCT01968551|12422538|P3|STARTED|Open Label Phase (48 Weeks)||46
5048083|NCT01968551|12422539|P2|STARTED|Open Label Phase (48 Weeks)||90
5048084|NCT01968551|12422540|P1|STARTED|Open Label Phase (48 Weeks)||22
5048085|NCT01968447|12422556|P2|NOT COMPLETED|Overall Study||0
5048086|NCT01968447|12422557|P1|NOT COMPLETED|Overall Study||0
5048087|NCT01968447|12422556|P2|COMPLETED|Overall Study||20
5048088|NCT01968447|12422557|P1|COMPLETED|Overall Study||20
5048089|NCT01968447|12422556|P2|STARTED|Overall Study||20
5048090|NCT01968447|12422557|P1|STARTED|Overall Study||20
5048091|NCT01968434|12422577|P2|NOT COMPLETED|Overall Study||6
5048092|NCT01968434|12422578|P1|NOT COMPLETED|Overall Study||3
5048093|NCT01968434|12422577|P2|COMPLETED|Overall Study||66
5048094|NCT01968434|12422578|P1|COMPLETED|Overall Study||75
5048095|NCT01968434|12422577|P2|STARTED|Overall Study||72
5048096|NCT01968434|12422578|P1|STARTED|Overall Study||78
5048097|NCT01968421|12422590|P2|NOT COMPLETED|Overall Study||0
5048098|NCT01968421|12422591|P1|NOT COMPLETED|Overall Study||0
5048099|NCT01968421|12422590|P2|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
5048100|NCT01968421|12422591|P1|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
5048101|NCT01968421|12422590|P2|Starting Trial|Overall Study||97
5048102|NCT01968421|12422591|P1|Starting Trial|Overall Study||99
5048103|NCT01968421|12422590|P2|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
5048104|NCT01968421|12422591|P1|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
5048105|NCT01968382|12422600|P3|NOT COMPLETED|Overall Study||0
5048106|NCT01968382|12422601|P2|NOT COMPLETED|Overall Study||0
5048107|NCT01968382|12422602|P1|NOT COMPLETED|Overall Study||0
5048108|NCT01968382|12422600|P3|COMPLETED|Overall Study||20
5048109|NCT01968382|12422601|P2|COMPLETED|Overall Study||19
5048110|NCT01968382|12422602|P1|COMPLETED|Overall Study||18
5048111|NCT01968382|12422600|P3|STARTED|Overall Study||20
5048112|NCT01968382|12422601|P2|STARTED|Overall Study||19
5048113|NCT01968382|12422602|P1|STARTED|Overall Study||18
5048114|NCT01968226|12422646|P1|NOT COMPLETED|Overall Study||2
5048115|NCT01968226|12422646|P1|COMPLETED|Overall Study||1
5048116|NCT01968226|12422646|P1|STARTED|Overall Study||3
5048117|NCT01968213|12422652|P2|NOT COMPLETED|Overall Study||9
5048118|NCT01968213|12422653|P1|NOT COMPLETED|Overall Study||90
5048119|NCT01968213|12422652|P2|COMPLETED|Overall Study||180
5048120|NCT01968213|12422653|P1|COMPLETED|Overall Study||285
5048121|NCT01968213|12422652|P2|STARTED|Overall Study||189
5048122|NCT01968213|12422653|P1|STARTED|Overall Study||375
5048123|NCT01968135|12422664|P2|NOT COMPLETED|Overall Study||0
5048124|NCT01968135|12422665|P1|NOT COMPLETED|Overall Study||0
5048125|NCT01968135|12422664|P2|COMPLETED|Overall Study||16
5048126|NCT01968135|12422665|P1|COMPLETED|Overall Study||16
5048127|NCT01968135|12422664|P2|STARTED|Overall Study||16
5048128|NCT01968135|12422665|P1|STARTED|Overall Study||16
5048129|NCT01968070|12422695|P18|NOT COMPLETED|Period 3||0
5048130|NCT01968070|12422696|P17|NOT COMPLETED|Period 3||0
5048131|NCT01968070|12422697|P16|NOT COMPLETED|Period 3||0
5048132|NCT01968070|12422698|P15|NOT COMPLETED|Period 3||0
5048133|NCT01968070|12422699|P14|NOT COMPLETED|Period 3||0
5048134|NCT01968070|12422700|P13|NOT COMPLETED|Period 3||0
5048135|NCT01968070|12422701|P12|NOT COMPLETED|Period 3||0
5048136|NCT01968070|12422702|P11|NOT COMPLETED|Period 3||0
5048137|NCT01968070|12422703|P10|NOT COMPLETED|Period 3||0
5048138|NCT01968070|12422704|P9|NOT COMPLETED|Period 3||0
5048139|NCT01968070|12422705|P8|NOT COMPLETED|Period 3||0
5048140|NCT01968070|12422706|P7|NOT COMPLETED|Period 3||0
5048141|NCT01968070|12422707|P6|NOT COMPLETED|Period 3||0
5048142|NCT01968070|12422708|P5|NOT COMPLETED|Period 3||0
5048143|NCT01968070|12422709|P4|NOT COMPLETED|Period 3||0
5048144|NCT01968070|12422710|P3|NOT COMPLETED|Period 3||0
5048145|NCT01968070|12422711|P2|NOT COMPLETED|Period 3||0
5048146|NCT01968070|12422712|P1|NOT COMPLETED|Period 3||0
5048147|NCT01968070|12422695|P18|COMPLETED|Period 3||0
5048148|NCT01968070|12422696|P17|COMPLETED|Period 3||0
5048149|NCT01968070|12422697|P16|COMPLETED|Period 3||0
5048150|NCT01968070|12422698|P15|COMPLETED|Period 3||0
5048151|NCT01968070|12422699|P14|COMPLETED|Period 3||0
5048152|NCT01968070|12422700|P13|COMPLETED|Period 3||0
5048153|NCT01968070|12422701|P12|COMPLETED|Period 3||0
5048154|NCT01968070|12422702|P11|COMPLETED|Period 3||0
5048155|NCT01968070|12422703|P10|COMPLETED|Period 3||0
5048156|NCT01968070|12422704|P9|COMPLETED|Period 3||0
5048157|NCT01968070|12422705|P8|COMPLETED|Period 3||0
5048158|NCT01968070|12422706|P7|COMPLETED|Period 3||0
5048159|NCT01968070|12422707|P6|COMPLETED|Period 3||4
5048160|NCT01968070|12422708|P5|COMPLETED|Period 3||3
5048161|NCT01968070|12422709|P4|COMPLETED|Period 3||4
5048162|NCT01968070|12422710|P3|COMPLETED|Period 3||4
5048163|NCT01968070|12422711|P2|COMPLETED|Period 3||4
5048164|NCT01968070|12422712|P1|COMPLETED|Period 3||4
5048165|NCT01968070|12422695|P18|STARTED|Period 3||0
5048166|NCT01968070|12422696|P17|STARTED|Period 3||0
5048167|NCT01968070|12422697|P16|STARTED|Period 3||0
5048168|NCT01968070|12422698|P15|STARTED|Period 3||0
5048169|NCT01968070|12422699|P14|STARTED|Period 3||0
5048170|NCT01968070|12422700|P13|STARTED|Period 3||0
5048171|NCT01968070|12422701|P12|STARTED|Period 3||0
5048172|NCT01968070|12422702|P11|STARTED|Period 3||0
5048173|NCT01968070|12422703|P10|STARTED|Period 3||0
5048174|NCT01968070|12422704|P9|STARTED|Period 3||0
5048175|NCT01968070|12422705|P8|STARTED|Period 3||0
5048176|NCT01968070|12422706|P7|STARTED|Period 3||0
5048177|NCT01968070|12422707|P6|STARTED|Period 3||4
5048178|NCT01968070|12422708|P5|STARTED|Period 3||3
5048179|NCT01968070|12422709|P4|STARTED|Period 3||4
5048180|NCT01968070|12422710|P3|STARTED|Period 3||4
5048181|NCT01968070|12422711|P2|STARTED|Period 3||4
5048182|NCT01968070|12422712|P1|STARTED|Period 3||4
5048183|NCT01968070|12422695|P18|NOT COMPLETED|Period 2||0
5048184|NCT01968070|12422696|P17|NOT COMPLETED|Period 2||0
5048185|NCT01968070|12422697|P16|NOT COMPLETED|Period 2||0
5048186|NCT01968070|12422698|P15|NOT COMPLETED|Period 2||0
5048187|NCT01968070|12422699|P14|NOT COMPLETED|Period 2||0
5048188|NCT01968070|12422700|P13|NOT COMPLETED|Period 2||0
5048189|NCT01968070|12422701|P12|NOT COMPLETED|Period 2||0
5048190|NCT01968070|12422702|P11|NOT COMPLETED|Period 2||0
5048191|NCT01968070|12422703|P10|NOT COMPLETED|Period 2||0
5048192|NCT01968070|12422704|P9|NOT COMPLETED|Period 2||0
5048193|NCT01968070|12422705|P8|NOT COMPLETED|Period 2||0
5048194|NCT01968070|12422706|P7|NOT COMPLETED|Period 2||0
5048195|NCT01968070|12422707|P6|NOT COMPLETED|Period 2||0
5048196|NCT01968070|12422708|P5|NOT COMPLETED|Period 2||1
5048197|NCT01968070|12422709|P4|NOT COMPLETED|Period 2||0
5048198|NCT01968070|12422710|P3|NOT COMPLETED|Period 2||0
5048199|NCT01968070|12422711|P2|NOT COMPLETED|Period 2||0
5048200|NCT01968070|12422712|P1|NOT COMPLETED|Period 2||0
5048201|NCT01968070|12422695|P18|COMPLETED|Period 2||0
5048202|NCT01968070|12422696|P17|COMPLETED|Period 2||0
5048203|NCT01968070|12422697|P16|COMPLETED|Period 2||0
5048204|NCT01968070|12422698|P15|COMPLETED|Period 2||0
5048205|NCT01968070|12422699|P14|COMPLETED|Period 2||0
5048206|NCT01968070|12422700|P13|COMPLETED|Period 2||0
5048207|NCT01968070|12422701|P12|COMPLETED|Period 2||0
5048208|NCT01968070|12422702|P11|COMPLETED|Period 2||0
5048209|NCT01968070|12422703|P10|COMPLETED|Period 2||0
5048210|NCT01968070|12422704|P9|COMPLETED|Period 2||0
5048211|NCT01968070|12422705|P8|COMPLETED|Period 2||0
5048212|NCT01968070|12422706|P7|COMPLETED|Period 2||0
5048213|NCT01968070|12422707|P6|COMPLETED|Period 2||4
5048214|NCT01968070|12422708|P5|COMPLETED|Period 2||2
5048215|NCT01968070|12422709|P4|COMPLETED|Period 2||4
5048216|NCT01968070|12422710|P3|COMPLETED|Period 2||4
5048217|NCT01968070|12422711|P2|COMPLETED|Period 2||4
5048218|NCT01968070|12422712|P1|COMPLETED|Period 2||4
5048219|NCT01968070|12422695|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048220|NCT01968070|12422696|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048221|NCT01968070|12422697|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048222|NCT01968070|12422698|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048223|NCT01968070|12422699|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048224|NCT01968070|12422700|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048225|NCT01968070|12422701|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048226|NCT01968070|12422702|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048227|NCT01968070|12422703|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048228|NCT01968070|12422704|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048229|NCT01968070|12422705|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048230|NCT01968070|12422706|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
5048231|NCT01968070|12422707|P6|STARTED|Period 2||4
5048232|NCT01968070|12422708|P5|STARTED|Period 2||3
5048233|NCT01968070|12422709|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
5048234|NCT01968070|12422710|P3|STARTED|Period 2||4
5048235|NCT01968070|12422711|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
5048236|NCT01968070|12422712|P1|STARTED|Period 2||4
5048237|NCT01968070|12422695|P18|NOT COMPLETED|Period 1||0
5048238|NCT01968070|12422696|P17|NOT COMPLETED|Period 1||0
5048239|NCT01968070|12422697|P16|NOT COMPLETED|Period 1||1
5048240|NCT01968070|12422698|P15|NOT COMPLETED|Period 1||0
5048241|NCT01968070|12422699|P14|NOT COMPLETED|Period 1||0
5048242|NCT01968070|12422700|P13|NOT COMPLETED|Period 1||0
5048243|NCT01968070|12422701|P12|NOT COMPLETED|Period 1||1
5048244|NCT01968070|12422702|P11|NOT COMPLETED|Period 1||0
5048245|NCT01968070|12422703|P10|NOT COMPLETED|Period 1||0
5048246|NCT01968070|12422704|P9|NOT COMPLETED|Period 1||0
5048247|NCT01968070|12422705|P8|NOT COMPLETED|Period 1||0
5048248|NCT01968070|12422706|P7|NOT COMPLETED|Period 1||2
5048249|NCT01968070|12422707|P6|NOT COMPLETED|Period 1||0
5048250|NCT01968070|12422708|P5|NOT COMPLETED|Period 1||1
5048251|NCT01968070|12422709|P4|NOT COMPLETED|Period 1||2
5048252|NCT01968070|12422710|P3|NOT COMPLETED|Period 1||0
5048253|NCT01968070|12422711|P2|NOT COMPLETED|Period 1||1
5048254|NCT01968070|12422712|P1|NOT COMPLETED|Period 1||0
5048255|NCT01968070|12422695|P18|COMPLETED|Period 1||2
5048256|NCT01968070|12422696|P17|COMPLETED|Period 1||2
5048257|NCT01968070|12422697|P16|COMPLETED|Period 1||8
5048258|NCT01968070|12422698|P15|COMPLETED|Period 1||2
5048259|NCT01968070|12422699|P14|COMPLETED|Period 1||2
5048260|NCT01968070|12422700|P13|COMPLETED|Period 1||9
5048261|NCT01968070|12422701|P12|COMPLETED|Period 1||1
5048262|NCT01968070|12422702|P11|COMPLETED|Period 1||2
5048263|NCT01968070|12422703|P10|COMPLETED|Period 1||9
5048264|NCT01968070|12422704|P9|COMPLETED|Period 1||2
5048265|NCT01968070|12422705|P8|COMPLETED|Period 1||2
5048266|NCT01968070|12422706|P7|COMPLETED|Period 1||8
5048267|NCT01968070|12422707|P6|COMPLETED|Period 1||4
5048268|NCT01968070|12422708|P5|COMPLETED|Period 1||3
5048269|NCT01968070|12422709|P4|COMPLETED|Period 1||2
5048270|NCT01968070|12422710|P3|COMPLETED|Period 1||4
5048271|NCT01968070|12422711|P2|COMPLETED|Period 1||3
5048272|NCT01968070|12422712|P1|COMPLETED|Period 1||4
5048273|NCT01968070|12422695|P18|STARTED|Period 1||2
5048274|NCT01968070|12422696|P17|STARTED|Period 1||2
5048275|NCT01968070|12422697|P16|STARTED|Period 1||9
5048276|NCT01968070|12422698|P15|STARTED|Period 1||2
5048277|NCT01968070|12422699|P14|STARTED|Period 1||2
5048278|NCT01968070|12422700|P13|STARTED|Period 1||9
5048279|NCT01968070|12422701|P12|STARTED|Period 1||2
5048280|NCT01968070|12422702|P11|STARTED|Period 1||2
5048281|NCT01968070|12422703|P10|STARTED|Period 1||9
5048282|NCT01968070|12422704|P9|STARTED|Period 1||2
5048283|NCT01968070|12422705|P8|STARTED|Period 1||2
5048284|NCT01968070|12422706|P7|STARTED|Period 1||10
5048285|NCT01968070|12422707|P6|STARTED|Period 1||4
5048286|NCT01968070|12422708|P5|STARTED|Period 1||4
5048287|NCT01968070|12422709|P4|STARTED|Period 1||4
5048288|NCT01968070|12422710|P3|STARTED|Period 1||4
5048289|NCT01968070|12422711|P2|STARTED|Period 1||4
5048290|NCT01968070|12422712|P1|STARTED|Period 1||4
5048291|NCT01968057|12422770|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
5048292|NCT01968057|12422770|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
5048293|NCT01968057|12422770|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
5048294|NCT01968057|12422770|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
5048295|NCT01968057|12422770|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
5048296|NCT01968057|12422770|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
5048297|NCT01968057|12422770|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
5048298|NCT01968057|12422770|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
5048299|NCT01967940|12422783|P4|NOT COMPLETED|Part 2||3
5048300|NCT01967940|12422784|P3|NOT COMPLETED|Part 2||0
5048301|NCT01967940|12422785|P2|NOT COMPLETED|Part 2||0
5048302|NCT01967940|12422786|P1|NOT COMPLETED|Part 2||0
5048303|NCT01967940|12422783|P4|COMPLETED|Part 2||35
5048304|NCT01967940|12422784|P3|COMPLETED|Part 2||0
5048305|NCT01967940|12422785|P2|COMPLETED|Part 2||0
5048306|NCT01967940|12422786|P1|COMPLETED|Part 2||0
5048307|NCT01967940|12422783|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
5048308|NCT01967940|12422784|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
5048309|NCT01967940|12422785|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
5048310|NCT01967940|12422786|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
5048311|NCT01967940|12422783|P4|NOT COMPLETED|Part 1||0
5048312|NCT01967940|12422784|P3|NOT COMPLETED|Part 1||0
5048313|NCT01967940|12422785|P2|NOT COMPLETED|Part 1||0
5048314|NCT01967940|12422786|P1|NOT COMPLETED|Part 1||0
5048315|NCT01967940|12422783|P4|COMPLETED|Part 1||0
5048316|NCT01967940|12422784|P3|COMPLETED|Part 1||15
5048317|NCT01967940|12422785|P2|COMPLETED|Part 1||28
5048318|NCT01967940|12422786|P1|COMPLETED|Part 1||12
5048319|NCT01967940|12422783|P4|STARTED|Part 1||0
5048320|NCT01967940|12422784|P3|STARTED|Part 1||15
5048321|NCT01967940|12422785|P2|STARTED|Part 1||28
5048322|NCT01967940|12422786|P1|STARTED|Part 1||12
5048323|NCT01967888|12422814|P2|NOT COMPLETED|Overall Study||7
5048324|NCT01967888|12422815|P1|NOT COMPLETED|Overall Study||10
5048325|NCT01967888|12422814|P2|COMPLETED|Overall Study||45
5048326|NCT01967888|12422815|P1|COMPLETED|Overall Study||42
5048327|NCT01967888|12422814|P2|STARTED|Overall Study||52
5048328|NCT01967888|12422815|P1|STARTED|Overall Study||52
5048329|NCT01967836|12422883|P1|NOT COMPLETED|Overall Study||9
5048330|NCT01967836|12422883|P1|COMPLETED|Overall Study||11
5048331|NCT01967836|12422883|P1|STARTED|Overall Study||20
5048332|NCT01967784|12422889|P1|NOT COMPLETED|Overall Study||0
5048333|NCT01967784|12422889|P1|COMPLETED|Overall Study||100
5048334|NCT01967784|12422889|P1|STARTED|Overall Study||100
5048335|NCT01967732|12422899|P4|NOT COMPLETED|Second Intervention (Day 3)||0
5048336|NCT01967732|12422900|P3|NOT COMPLETED|Second Intervention (Day 3)||0
5048337|NCT01967732|12422901|P2|NOT COMPLETED|Second Intervention (Day 3)||0
5048338|NCT01967732|12422902|P1|NOT COMPLETED|Second Intervention (Day 3)||0
5048339|NCT01967732|12422899|P4|COMPLETED|Second Intervention (Day 3)||9
5048340|NCT01967732|12422900|P3|COMPLETED|Second Intervention (Day 3)||9
5048341|NCT01967732|12422901|P2|COMPLETED|Second Intervention (Day 3)||20
5048342|NCT01967732|12422902|P1|COMPLETED|Second Intervention (Day 3)||22
5048343|NCT01967732|12422899|P4|STARTED|Second Intervention (Day 3)||9
5048344|NCT01967732|12422900|P3|STARTED|Second Intervention (Day 3)||9
5048345|NCT01967732|12422901|P2|STARTED|Second Intervention (Day 3)||20
5048346|NCT01967732|12422902|P1|STARTED|Second Intervention (Day 3)||22
5048347|NCT01967732|12422899|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048348|NCT01967732|12422900|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048349|NCT01967732|12422901|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048350|NCT01967732|12422902|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048351|NCT01967732|12422899|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
5048352|NCT01967732|12422900|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
5048353|NCT01967732|12422901|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
5048354|NCT01967732|12422902|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
5048355|NCT01967732|12422899|P4|STARTED|Washout Period of 1 Day (Day 2)||9
5048356|NCT01967732|12422900|P3|STARTED|Washout Period of 1 Day (Day 2)||9
5048357|NCT01967732|12422901|P2|STARTED|Washout Period of 1 Day (Day 2)||20
5048358|NCT01967732|12422902|P1|STARTED|Washout Period of 1 Day (Day 2)||22
5048359|NCT01967732|12422899|P4|NOT COMPLETED|First Intervention (Day 1)||0
5048360|NCT01967732|12422900|P3|NOT COMPLETED|First Intervention (Day 1)||0
5048361|NCT01967732|12422901|P2|NOT COMPLETED|First Intervention (Day 1)||1
5048362|NCT01967732|12422902|P1|NOT COMPLETED|First Intervention (Day 1)||0
5048363|NCT01967732|12422899|P4|COMPLETED|First Intervention (Day 1)||9
5048364|NCT01967732|12422900|P3|COMPLETED|First Intervention (Day 1)||9
5048365|NCT01967732|12422901|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
5048366|NCT01967732|12422902|P1|COMPLETED|First Intervention (Day 1)||22
5048367|NCT01967732|12422899|P4|STARTED|First Intervention (Day 1)||9
5048368|NCT01967732|12422900|P3|STARTED|First Intervention (Day 1)||9
5048369|NCT01967732|12422901|P2|STARTED|First Intervention (Day 1)||21
5048370|NCT01967732|12422902|P1|STARTED|First Intervention (Day 1)||22
5048371|NCT01967732|12422899|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048372|NCT01967732|12422900|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048373|NCT01967732|12422901|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
5048374|NCT01967732|12422902|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048375|NCT01967732|12422899|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048376|NCT01967732|12422900|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048377|NCT01967732|12422901|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
5048378|NCT01967732|12422902|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
5048379|NCT01967732|12422899|P4|STARTED|Washout Period of 1 Day (Day 0)||9
5048380|NCT01967732|12422900|P3|STARTED|Washout Period of 1 Day (Day 0)||9
5048381|NCT01967732|12422901|P2|STARTED|Washout Period of 1 Day (Day 0)||22
5048382|NCT01967732|12422902|P1|STARTED|Washout Period of 1 Day (Day 0)||22
5048383|NCT01967719|12422916|P4|NOT COMPLETED|Second Intervention (Day 3)||0
5048384|NCT01967719|12422917|P3|NOT COMPLETED|Second Intervention (Day 3)||0
5048385|NCT01967719|12422918|P2|NOT COMPLETED|Second Intervention (Day 3)||1
5048386|NCT01967719|12422919|P1|NOT COMPLETED|Second Intervention (Day 3)||0
5048387|NCT01967719|12422916|P4|COMPLETED|Second Intervention (Day 3)||8
5048388|NCT01967719|12422917|P3|COMPLETED|Second Intervention (Day 3)||9
5048389|NCT01967719|12422918|P2|COMPLETED|Second Intervention (Day 3)||20
5048390|NCT01967719|12422919|P1|COMPLETED|Second Intervention (Day 3)||22
5048391|NCT01967719|12422916|P4|STARTED|Second Intervention (Day 3)||8
5048392|NCT01967719|12422917|P3|STARTED|Second Intervention (Day 3)||9
5048393|NCT01967719|12422918|P2|STARTED|Second Intervention (Day 3)||21
5048394|NCT01967719|12422919|P1|STARTED|Second Intervention (Day 3)||22
5048395|NCT01967719|12422916|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048396|NCT01967719|12422917|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048397|NCT01967719|12422918|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048398|NCT01967719|12422919|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048399|NCT01967719|12422916|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
5048400|NCT01967719|12422917|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
5048401|NCT01967719|12422918|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
5048402|NCT01967719|12422919|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
5048403|NCT01967719|12422916|P4|STARTED|Washout Period of 1 Day (Day 2)||8
5048404|NCT01967719|12422917|P3|STARTED|Washout Period of 1 Day (Day 2)||9
5048405|NCT01967719|12422918|P2|STARTED|Washout Period of 1 Day (Day 2)||21
5048406|NCT01967719|12422919|P1|STARTED|Washout Period of 1 Day (Day 2)||22
5048407|NCT01967719|12422916|P4|NOT COMPLETED|First Intervention (Day 1)||1
5048408|NCT01967719|12422917|P3|NOT COMPLETED|First Intervention (Day 1)||0
5048409|NCT01967719|12422918|P2|NOT COMPLETED|First Intervention (Day 1)||1
5048410|NCT01967719|12422919|P1|NOT COMPLETED|First Intervention (Day 1)||0
5048411|NCT01967719|12422916|P4|COMPLETED|First Intervention (Day 1)||8
5048412|NCT01967719|12422917|P3|COMPLETED|First Intervention (Day 1)||9
5048413|NCT01967719|12422918|P2|COMPLETED|First Intervention (Day 1)||21
5048414|NCT01967719|12422919|P1|COMPLETED|First Intervention (Day 1)||22
5048415|NCT01967719|12422916|P4|STARTED|First Intervention (Day 1)||9
5048416|NCT01967719|12422917|P3|STARTED|First Intervention (Day 1)||9
5048417|NCT01967719|12422918|P2|STARTED|First Intervention (Day 1)||22
5048418|NCT01967719|12422919|P1|STARTED|First Intervention (Day 1)||22
5048419|NCT01967719|12422916|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048420|NCT01967719|12422917|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048421|NCT01967719|12422918|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048422|NCT01967719|12422919|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048423|NCT01967719|12422916|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048424|NCT01967719|12422917|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048425|NCT01967719|12422918|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
5048426|NCT01967719|12422919|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
5048427|NCT01967719|12422916|P4|STARTED|Washout Period of 1 Day (Day 0)||9
5048428|NCT01967719|12422917|P3|STARTED|Washout Period of 1 Day (Day 0)||9
5048429|NCT01967719|12422918|P2|STARTED|Washout Period of 1 Day (Day 0)||22
5048430|NCT01967719|12422919|P1|STARTED|Washout Period of 1 Day (Day 0)||22
5048431|NCT01967706|12422934|P4|NOT COMPLETED|Second Intervention (Day 3)||0
5048432|NCT01967706|12422935|P3|NOT COMPLETED|Second Intervention (Day 3)||0
5048433|NCT01967706|12422936|P2|NOT COMPLETED|Second Intervention (Day 3)||0
5048434|NCT01967706|12422937|P1|NOT COMPLETED|Second Intervention (Day 3)||0
5048435|NCT01967706|12422934|P4|COMPLETED|Second Intervention (Day 3)||9
5048436|NCT01967706|12422935|P3|COMPLETED|Second Intervention (Day 3)||9
5048437|NCT01967706|12422936|P2|COMPLETED|Second Intervention (Day 3)||22
5048438|NCT01967706|12422937|P1|COMPLETED|Second Intervention (Day 3)||21
5048439|NCT01967706|12422934|P4|STARTED|Second Intervention (Day 3)||9
5048440|NCT01967706|12422935|P3|STARTED|Second Intervention (Day 3)||9
5048441|NCT01967706|12422936|P2|STARTED|Second Intervention (Day 3)||22
5048442|NCT01967706|12422937|P1|STARTED|Second Intervention (Day 3)||21
5048443|NCT01967706|12422934|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048444|NCT01967706|12422935|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048445|NCT01967706|12422936|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048446|NCT01967706|12422937|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5048447|NCT01967706|12422934|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
5048448|NCT01967706|12422935|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
5048449|NCT01967706|12422936|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
5048450|NCT01967706|12422937|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
5048451|NCT01967706|12422934|P4|STARTED|Washout Period of 1 Day (Day 2)||9
5048452|NCT01967706|12422935|P3|STARTED|Washout Period of 1 Day (Day 2)||9
5048453|NCT01967706|12422936|P2|STARTED|Washout Period of 1 Day (Day 2)||22
5048454|NCT01967706|12422937|P1|STARTED|Washout Period of 1 Day (Day 2)||21
5048455|NCT01967706|12422934|P4|NOT COMPLETED|First Intervention (Day 1)||0
5048456|NCT01967706|12422935|P3|NOT COMPLETED|First Intervention (Day 1)||0
5048457|NCT01967706|12422936|P2|NOT COMPLETED|First Intervention (Day 1)||0
5048458|NCT01967706|12422937|P1|NOT COMPLETED|First Intervention (Day 1)||1
5048459|NCT01967706|12422934|P4|COMPLETED|First Intervention (Day 1)||9
5048460|NCT01967706|12422935|P3|COMPLETED|First Intervention (Day 1)||9
5048461|NCT01967706|12422936|P2|COMPLETED|First Intervention (Day 1)||22
5048462|NCT01967706|12422937|P1|COMPLETED|First Intervention (Day 1)||21
5048463|NCT01967706|12422934|P4|STARTED|First Intervention (Day 1)||9
5048464|NCT01967706|12422935|P3|STARTED|First Intervention (Day 1)||9
5048465|NCT01967706|12422936|P2|STARTED|First Intervention (Day 1)||22
5048466|NCT01967706|12422937|P1|STARTED|First Intervention (Day 1)||22
5048467|NCT01967706|12422934|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048468|NCT01967706|12422935|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048469|NCT01967706|12422936|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048470|NCT01967706|12422937|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5048471|NCT01967706|12422934|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048472|NCT01967706|12422935|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
5048473|NCT01967706|12422936|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
5048474|NCT01967706|12422937|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
5048475|NCT01967706|12422934|P4|STARTED|Washout Period of 1 Day (Day 0)||9
5048476|NCT01967706|12422935|P3|STARTED|Washout Period of 1 Day (Day 0)||9
5048477|NCT01967706|12422936|P2|STARTED|Washout Period of 1 Day (Day 0)||22
5048478|NCT01967706|12422937|P1|STARTED|Washout Period of 1 Day (Day 0)||22
5048479|NCT01967641|12422950|P1|NOT COMPLETED|12-week Outpatient Phase||13
5048480|NCT01967641|12422950|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
5048481|NCT01967641|12422950|P1|STARTED|12-week Outpatient Phase||31
5048482|NCT01967641|12422950|P1|NOT COMPLETED|Admission to Inpatient Phase||12
5048483|NCT01967641|12422950|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
5048484|NCT01967641|12422950|P1|STARTED|Admission to Inpatient Phase||43
5048485|NCT01967641|12422950|P1|NOT COMPLETED|Randomized||8
5048486|NCT01967641|12422950|P1|COMPLETED|Randomized|Completed week 12|43
5048487|NCT01967641|12422950|P1|STARTED|Randomized||51
5048488|NCT01967628|12422958|P2|NOT COMPLETED|Overall Study||31
5048489|NCT01967628|12422959|P1|NOT COMPLETED|Overall Study||27
5048490|NCT01967628|12422958|P2|COMPLETED|Overall Study||19
5048491|NCT01967628|12422959|P1|COMPLETED|Overall Study||21
5048492|NCT01967628|12422958|P2|STARTED|Overall Study||50
5048493|NCT01967628|12422959|P1|STARTED|Overall Study||48
5048494|NCT01967550|12422967|P2|NOT COMPLETED|Overall Study||2
5048495|NCT01967550|12422968|P1|NOT COMPLETED|Overall Study||5
5048496|NCT01967550|12422967|P2|COMPLETED|Overall Study||149
5048497|NCT01967550|12422968|P1|COMPLETED|Overall Study||148
5048498|NCT01967550|12422967|P2|STARTED|Overall Study||151
5048499|NCT01967550|12422968|P1|STARTED|Overall Study||153
5048500|NCT01967537|12422974|P1|NOT COMPLETED|Overall Study||60
5048501|NCT01967537|12422974|P1|COMPLETED|Overall Study||281
5048502|NCT01967537|12422974|P1|STARTED|Overall Study||341
5048503|NCT01967433|12422985|P2|NOT COMPLETED|Overall Study||1
5048504|NCT01967433|12422986|P1|NOT COMPLETED|Overall Study||0
5048505|NCT01967433|12422985|P2|COMPLETED|Overall Study||58
5048506|NCT01967433|12422986|P1|COMPLETED|Overall Study||61
5048507|NCT01967433|12422985|P2|STARTED|Overall Study||59
5048508|NCT01967433|12422986|P1|STARTED|Overall Study||61
5048509|NCT01967342|12423007|P3|NOT COMPLETED|Overall Study||29
5048510|NCT01967342|12423008|P2|NOT COMPLETED|Overall Study||25
5048511|NCT01967342|12423009|P1|NOT COMPLETED|Overall Study||27
5048512|NCT01967342|12423007|P3|COMPLETED|Overall Study||68
5048513|NCT01967342|12423008|P2|COMPLETED|Overall Study||70
5048514|NCT01967342|12423009|P1|COMPLETED|Overall Study||71
5048515|NCT01967342|12423007|P3|10-week Follow-up|Overall Study||80
5048516|NCT01967342|12423008|P2|10-week Follow-up|Overall Study||83
5048517|NCT01967342|12423009|P1|10-week Follow-up|Overall Study||78
5048518|NCT01967342|12423007|P3|5-week Follow-up|Overall Study||76
5048519|NCT01967342|12423008|P2|5-week Follow-up|Overall Study||78
5048520|NCT01967342|12423009|P1|5-week Follow-up|Overall Study||83
5048521|NCT01967342|12423007|P3|STARTED|Overall Study||97
5048522|NCT01967342|12423008|P2|STARTED|Overall Study||95
5048523|NCT01967342|12423009|P1|STARTED|Overall Study||98
5048524|NCT01967277|12423028|P2|NOT COMPLETED|Overall Study||3
5048525|NCT01967277|12423029|P1|NOT COMPLETED|Overall Study||1
5048526|NCT01967277|12423028|P2|COMPLETED|Overall Study||19
5048527|NCT01967277|12423029|P1|COMPLETED|Overall Study||21
5048528|NCT01967277|12423028|P2|STARTED|Overall Study||22
5048529|NCT01967277|12423029|P1|STARTED|Overall Study||22
5048530|NCT01967225|12423041|P2|NOT COMPLETED|Overall Study||3
5048531|NCT01967225|12423042|P1|NOT COMPLETED|Overall Study||12
5048532|NCT01967225|12423041|P2|COMPLETED|Overall Study||38
5048533|NCT01967225|12423042|P1|COMPLETED|Overall Study||72
5048534|NCT01967225|12423041|P2|Participants Received Treatment|Overall Study||41
5048535|NCT01967225|12423042|P1|Participants Received Treatment|Overall Study||83
5048536|NCT01967225|12423041|P2|STARTED|Overall Study||41
5048537|NCT01967225|12423042|P1|STARTED|Overall Study||84
5048538|NCT01967173|12423074|P8|NOT COMPLETED|Overall Study||24
5048539|NCT01967173|12423075|P7|NOT COMPLETED|Overall Study||18
5048540|NCT01967173|12423076|P6|NOT COMPLETED|Overall Study||23
5048541|NCT01967173|12423077|P5|NOT COMPLETED|Overall Study||17
5048542|NCT01967173|12423078|P4|NOT COMPLETED|Overall Study||14
5048543|NCT01967173|12423079|P3|NOT COMPLETED|Overall Study||16
5048544|NCT01967173|12423080|P2|NOT COMPLETED|Overall Study||17
5048545|NCT01967173|12423081|P1|NOT COMPLETED|Overall Study||24
5048546|NCT01967173|12423074|P8|COMPLETED|Overall Study||50
5048547|NCT01967173|12423075|P7|COMPLETED|Overall Study||57
5048548|NCT01967173|12423076|P6|COMPLETED|Overall Study||49
5048549|NCT01967173|12423077|P5|COMPLETED|Overall Study||56
5048550|NCT01967173|12423078|P4|COMPLETED|Overall Study||57
5048551|NCT01967173|12423079|P3|COMPLETED|Overall Study||55
5048552|NCT01967173|12423080|P2|COMPLETED|Overall Study||52
5048553|NCT01967173|12423081|P1|COMPLETED|Overall Study||45
5048554|NCT01967173|12423074|P8|Completed 4th Period|Overall Study||50
5048555|NCT01967173|12423075|P7|Completed 4th Period|Overall Study||57
5048556|NCT01967173|12423076|P6|Completed 4th Period|Overall Study||49
5048557|NCT01967173|12423077|P5|Completed 4th Period|Overall Study||56
5048558|NCT01967173|12423078|P4|Completed 4th Period|Overall Study||57
5048559|NCT01967173|12423079|P3|Completed 4th Period|Overall Study||55
5048560|NCT01967173|12423080|P2|Completed 4th Period|Overall Study||52
5048561|NCT01967173|12423081|P1|Completed 4th Period|Overall Study||45
5048562|NCT01967173|12423074|P8|Completed 3rd Period|Overall Study||56
5048563|NCT01967173|12423075|P7|Completed 3rd Period|Overall Study||59
5048564|NCT01967173|12423076|P6|Completed 3rd Period|Overall Study||56
5048565|NCT01967173|12423077|P5|Completed 3rd Period|Overall Study||59
5048566|NCT01967173|12423078|P4|Completed 3rd Period|Overall Study||61
5048567|NCT01967173|12423079|P3|Completed 3rd Period|Overall Study||60
5048568|NCT01967173|12423080|P2|Completed 3rd Period|Overall Study||54
5048569|NCT01967173|12423081|P1|Completed 3rd Period|Overall Study||48
5048570|NCT01967173|12423074|P8|Completed 2nd Period|Overall Study||61
5048571|NCT01967173|12423075|P7|Completed 2nd Period|Overall Study||63
5048572|NCT01967173|12423076|P6|Completed 2nd Period|Overall Study||57
5048573|NCT01967173|12423077|P5|Completed 2nd Period|Overall Study||63
5048574|NCT01967173|12423078|P4|Completed 2nd Period|Overall Study||62
5048575|NCT01967173|12423079|P3|Completed 2nd Period|Overall Study||63
5048576|NCT01967173|12423080|P2|Completed 2nd Period|Overall Study||58
5048577|NCT01967173|12423081|P1|Completed 2nd Period|Overall Study||52
5048578|NCT01967173|12423074|P8|Completed 1st Period|Overall Study||69
5048579|NCT01967173|12423075|P7|Completed 1st Period|Overall Study||67
5048580|NCT01967173|12423076|P6|Completed 1st Period|Overall Study||62
5048581|NCT01967173|12423077|P5|Completed 1st Period|Overall Study||64
5048582|NCT01967173|12423078|P4|Completed 1st Period|Overall Study||65
5048583|NCT01967173|12423079|P3|Completed 1st Period|Overall Study||67
5048584|NCT01967173|12423080|P2|Completed 1st Period|Overall Study||60
5048585|NCT01967173|12423081|P1|Completed 1st Period|Overall Study||58
5048586|NCT01967173|12423074|P8|STARTED|Overall Study||74
5048587|NCT01967173|12423075|P7|STARTED|Overall Study||75
5048588|NCT01967173|12423076|P6|STARTED|Overall Study||72
5048589|NCT01967173|12423077|P5|STARTED|Overall Study||73
5048590|NCT01967173|12423078|P4|STARTED|Overall Study||71
5048591|NCT01967173|12423079|P3|STARTED|Overall Study||71
5048592|NCT01967173|12423080|P2|STARTED|Overall Study||69
5048593|NCT01967173|12423081|P1|STARTED|Overall Study||69
5048594|NCT01967147|12423095|P2|NOT COMPLETED|Overall Study||20
5048595|NCT01967147|12423096|P1|NOT COMPLETED|Overall Study||13
5048596|NCT01967147|12423095|P2|COMPLETED|Overall Study||82
5048597|NCT01967147|12423096|P1|COMPLETED|Overall Study||99
5048598|NCT01967147|12423095|P2|STARTED|Overall Study||102
5048599|NCT01967147|12423096|P1|STARTED|Overall Study||112
5048600|NCT01967134|12423114|P3|NOT COMPLETED|Overall Study||0
5048601|NCT01967134|12423115|P2|NOT COMPLETED|Overall Study||1
5048602|NCT01967134|12423116|P1|NOT COMPLETED|Overall Study||0
5048603|NCT01967134|12423114|P3|COMPLETED|Overall Study||9
5048604|NCT01967134|12423115|P2|COMPLETED|Overall Study||7
5048605|NCT01967134|12423116|P1|COMPLETED|Overall Study||8
5048606|NCT01967134|12423114|P3|STARTED|Overall Study||9
5048607|NCT01967134|12423115|P2|STARTED|Overall Study||8
5048608|NCT01967134|12423116|P1|STARTED|Overall Study||8
5048609|NCT01967121|12423139|P3|NOT COMPLETED|Overall Study||0
5048610|NCT01967121|12423140|P2|NOT COMPLETED|Overall Study||0
5048611|NCT01967121|12423141|P1|NOT COMPLETED|Overall Study||0
5048612|NCT01967121|12423139|P3|COMPLETED|Overall Study||25
5048613|NCT01967121|12423140|P2|COMPLETED|Overall Study||25
5048614|NCT01967121|12423141|P1|COMPLETED|Overall Study||25
5048615|NCT01967121|12423139|P3|STARTED|Overall Study||25
5048616|NCT01967121|12423140|P2|STARTED|Overall Study||25
5048617|NCT01967121|12423141|P1|STARTED|Overall Study||25
5048618|NCT01967069|12423151|P2|NOT COMPLETED|Overall Study||8
5048619|NCT01967069|12423152|P1|NOT COMPLETED|Overall Study||8
5048620|NCT01967069|12423151|P2|COMPLETED|Overall Study||87
5048621|NCT01967069|12423152|P1|COMPLETED|Overall Study||174
5048622|NCT01967069|12423151|P2|STARTED|Overall Study||95
5048623|NCT01967069|12423152|P1|STARTED|Overall Study||182
5048624|NCT01966978|12423160|P2|NOT COMPLETED|Overall Study||13
5048625|NCT01966978|12423161|P1|NOT COMPLETED|Overall Study||17
5048626|NCT01966978|12423160|P2|COMPLETED|Overall Study||46
5048627|NCT01966978|12423161|P1|COMPLETED|Overall Study||44
5048628|NCT01966978|12423160|P2|STARTED|Overall Study||59
5048629|NCT01966978|12423161|P1|STARTED|Overall Study||61
5048630|NCT01966926|12423183|P2|NOT COMPLETED|Overall Study||0
5048631|NCT01966926|12423184|P1|NOT COMPLETED|Overall Study||0
5048632|NCT01966926|12423183|P2|COMPLETED|Overall Study||15
5048633|NCT01966926|12423184|P1|COMPLETED|Overall Study||15
5048634|NCT01966926|12423183|P2|STARTED|Overall Study||15
5048635|NCT01966926|12423184|P1|STARTED|Overall Study||15
5048636|NCT01966900|12423202|P2|NOT COMPLETED|Overall Study||0
5048637|NCT01966900|12423203|P1|NOT COMPLETED|Overall Study||2
5048638|NCT01966900|12423202|P2|COMPLETED|Overall Study||6
5048639|NCT01966900|12423203|P1|COMPLETED|Overall Study||6
5048640|NCT01966900|12423202|P2|STARTED|Overall Study||6
5048641|NCT01966900|12423203|P1|STARTED|Overall Study||8
5048642|NCT01966809|12423213|P1|NOT COMPLETED|Overall Study||0
5048643|NCT01966809|12423213|P1|COMPLETED|Overall Study||1
5048644|NCT01966809|12423213|P1|STARTED|Overall Study||1
5048645|NCT01966770|12423220|P1|NOT COMPLETED|Overall Study||0
5048646|NCT01966770|12423220|P1|COMPLETED|Overall Study||20
5048647|NCT01966770|12423220|P1|STARTED|Overall Study||20
5048648|NCT01966718|12423329|P1|NOT COMPLETED|Overall Study||0
5048649|NCT01966718|12423329|P1|COMPLETED|Overall Study||8
5048650|NCT01966718|12423329|P1|STARTED|Overall Study||8
5048651|NCT01966458|12423339|P2|NOT COMPLETED|Overall Study||2
5048652|NCT01966458|12423340|P1|NOT COMPLETED|Overall Study||4
5048653|NCT01966458|12423339|P2|COMPLETED|Overall Study||155
5048654|NCT01966458|12423340|P1|COMPLETED|Overall Study||304
5048655|NCT01966458|12423339|P2|STARTED|Overall Study||157
5048656|NCT01966458|12423340|P1|STARTED|Overall Study||308
5048657|NCT01966445|12423355|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
5048658|NCT01966445|12423356|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048659|NCT01966445|12423357|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048660|NCT01966445|12423358|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048661|NCT01966445|12423359|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048662|NCT01966445|12423360|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048663|NCT01966445|12423361|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048664|NCT01966445|12423355|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
5048665|NCT01966445|12423356|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048666|NCT01966445|12423357|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048667|NCT01966445|12423358|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048668|NCT01966445|12423359|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048669|NCT01966445|12423360|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048670|NCT01966445|12423361|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
5048671|NCT01966445|12423355|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
5048672|NCT01966445|12423356|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048673|NCT01966445|12423357|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048674|NCT01966445|12423358|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048675|NCT01966445|12423359|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048676|NCT01966445|12423360|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048677|NCT01966445|12423361|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
5048678|NCT01966445|12423355|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
5048679|NCT01966445|12423356|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048680|NCT01966445|12423357|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
5048681|NCT01966445|12423358|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
5048682|NCT01966445|12423359|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048683|NCT01966445|12423360|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
5048684|NCT01966445|12423361|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
5048685|NCT01966445|12423355|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
5048686|NCT01966445|12423356|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
5048687|NCT01966445|12423357|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048688|NCT01966445|12423358|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
5048689|NCT01966445|12423359|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048690|NCT01966445|12423360|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048691|NCT01966445|12423361|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
5048692|NCT01966445|12423355|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
5048693|NCT01966445|12423356|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
5048694|NCT01966445|12423357|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
5048695|NCT01966445|12423358|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
5048696|NCT01966445|12423359|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
5048697|NCT01966445|12423360|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
5048698|NCT01966445|12423361|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
5048699|NCT01966432|12423471|P3|NOT COMPLETED|Overall Study||26
5048700|NCT01966432|12423472|P2|NOT COMPLETED|Overall Study||13
5048701|NCT01966432|12423473|P1|NOT COMPLETED|Overall Study||5
5048702|NCT01966432|12423471|P3|COMPLETED|Overall Study||28
5048703|NCT01966432|12423472|P2|COMPLETED|Overall Study||21
5048704|NCT01966432|12423473|P1|COMPLETED|Overall Study||5
5048705|NCT01966432|12423471|P3|STARTED|Overall Study||54
5048706|NCT01966432|12423472|P2|STARTED|Overall Study||34
5048707|NCT01966432|12423473|P1|STARTED|Overall Study||10
5048708|NCT01966380|12423493|P2|NOT COMPLETED|Overall Study||1
5048709|NCT01966380|12423494|P1|NOT COMPLETED|Overall Study||0
5048710|NCT01966380|12423493|P2|COMPLETED|Overall Study||2
5048711|NCT01966380|12423494|P1|COMPLETED|Overall Study||3
5048712|NCT01966380|12423493|P2|STARTED|Overall Study||3
5048713|NCT01966380|12423494|P1|STARTED|Overall Study||3
5048714|NCT01966354|12423503|P3|NOT COMPLETED|Overall Study||0
5048715|NCT01966354|12423504|P2|NOT COMPLETED|Overall Study||0
5048716|NCT01966354|12423505|P1|NOT COMPLETED|Overall Study||0
5048717|NCT01966354|12423503|P3|COMPLETED|Overall Study||72
5048718|NCT01966354|12423504|P2|COMPLETED|Overall Study||73
5048719|NCT01966354|12423505|P1|COMPLETED|Overall Study||75
5048720|NCT01966354|12423503|P3|STARTED|Overall Study||72
5048721|NCT01966354|12423504|P2|STARTED|Overall Study||73
5048722|NCT01966354|12423505|P1|STARTED|Overall Study||75
5048723|NCT01966159|12423530|P2|NOT COMPLETED|Overall Study||0
5048724|NCT01966159|12423531|P1|NOT COMPLETED|Overall Study||0
5048725|NCT01966159|12423530|P2|COMPLETED|Overall Study||207
5048726|NCT01966159|12423531|P1|COMPLETED|Overall Study||205
5048727|NCT01966159|12423530|P2|STARTED|Overall Study||207
5048728|NCT01966159|12423531|P1|STARTED|Overall Study||205
5048729|NCT01966120|12423543|P2|NOT COMPLETED|Overall Study||6
5048730|NCT01966120|12423544|P1|NOT COMPLETED|Overall Study||1
5048731|NCT01966120|12423543|P2|COMPLETED|Overall Study||26
5048732|NCT01966120|12423544|P1|COMPLETED|Overall Study||54
5048733|NCT01966120|12423543|P2|STARTED|Overall Study||32
5048734|NCT01966120|12423544|P1|STARTED|Overall Study||55
5048735|NCT01966107|12423568|P2|NOT COMPLETED|Overall Study||881
5048736|NCT01966107|12423569|P1|NOT COMPLETED|Overall Study||802
5048737|NCT01966107|12423568|P2|COMPLETED|Overall Study||937
5048738|NCT01966107|12423569|P1|COMPLETED|Overall Study||1010
5048739|NCT01966107|12423568|P2|Full Analysis Set|Overall Study||1798
5048740|NCT01966107|12423569|P1|Full Analysis Set|Overall Study||1791
5048741|NCT01966107|12423568|P2|STARTED|Overall Study||1818
5048742|NCT01966107|12423569|P1|STARTED|Overall Study||1812
5048743|NCT01966068|12423583|P1|NOT COMPLETED|Overall Study||138
5048744|NCT01966068|12423583|P1|COMPLETED|Overall Study||156
5048745|NCT01966068|12423583|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
5048746|NCT01966068|12423583|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
5048747|NCT01966068|12423583|P1|STARTED|Overall Study||294
5048748|NCT01966042|12423588|P1|NOT COMPLETED|Overall Study||2
5048749|NCT01966042|12423588|P1|COMPLETED|Overall Study||11
5048750|NCT01966042|12423588|P1|STARTED|Overall Study||13
5048751|NCT01966003|12423597|P2|NOT COMPLETED|Overall Study||270
5048752|NCT01966003|12423598|P1|NOT COMPLETED|Overall Study||270
5048753|NCT01966003|12423597|P2|COMPLETED|Overall Study||44
5048754|NCT01966003|12423598|P1|COMPLETED|Overall Study||58
5048755|NCT01966003|12423597|P2|Received Study Drug|Overall Study||309
5048756|NCT01966003|12423598|P1|Received Study Drug|Overall Study||324
5048757|NCT01966003|12423597|P2|STARTED|Overall Study||314
5048758|NCT01966003|12423598|P1|STARTED|Overall Study||328
5048759|NCT01965938|12423616|P2|NOT COMPLETED|Overall Study||0
5048760|NCT01965938|12423617|P1|NOT COMPLETED|Overall Study||1
5048761|NCT01965938|12423616|P2|COMPLETED|Overall Study||20
5048762|NCT01965938|12423617|P1|COMPLETED|Overall Study||20
5048763|NCT01965938|12423616|P2|STARTED|Overall Study||20
5048764|NCT01965938|12423617|P1|STARTED|Overall Study||21
5048765|NCT01965899|12423637|P1|NOT COMPLETED|Overall Study||6
5048766|NCT01965899|12423637|P1|COMPLETED|Overall Study||145
5048767|NCT01965899|12423637|P1|STARTED|Overall Study||151
5048768|NCT01965834|12423648|P1|NOT COMPLETED|Overall Study||4
5048769|NCT01965834|12423648|P1|COMPLETED|Overall Study||2
5048770|NCT01965834|12423648|P1|STARTED|Overall Study||6
5048771|NCT01965782|12423654|P1|NOT COMPLETED|Overall Study||0
5048772|NCT01965782|12423654|P1|COMPLETED|Overall Study||0
5048773|NCT01965782|12423654|P1|STARTED|Overall Study||0
5048774|NCT01965756|12423666|P2|NOT COMPLETED|Overall Study||0
5048775|NCT01965756|12423667|P1|NOT COMPLETED|Overall Study||0
5048776|NCT01965756|12423666|P2|COMPLETED|Overall Study||10
5048777|NCT01965756|12423667|P1|COMPLETED|Overall Study||10
5048778|NCT01965756|12423666|P2|STARTED|Overall Study||10
5048779|NCT01965756|12423667|P1|STARTED|Overall Study||10
5048780|NCT01965665|12423681|P1|NOT COMPLETED|Overall Study||1
5048781|NCT01965665|12423681|P1|COMPLETED|Overall Study||19
5048782|NCT01965665|12423681|P1|STARTED|Overall Study||20
5048783|NCT01965652|12423689|P2|NOT COMPLETED|Overall Study||210
5048784|NCT01965652|12423690|P1|NOT COMPLETED|Overall Study||210
5048785|NCT01965652|12423689|P2|COMPLETED|Overall Study||413
5048786|NCT01965652|12423690|P1|COMPLETED|Overall Study||413
5048787|NCT01965652|12423689|P2|Received Treatment|Overall Study||623
5048788|NCT01965652|12423690|P1|Received Treatment|Overall Study||622
5048789|NCT01965652|12423689|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
5048790|NCT01965652|12423690|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
5048791|NCT01965600|12423720|P4|NOT COMPLETED|Second Intervention||2
5048792|NCT01965600|12423721|P3|NOT COMPLETED|Second Intervention||2
5048793|NCT01965600|12423722|P2|NOT COMPLETED|Second Intervention||0
5048794|NCT01965600|12423723|P1|NOT COMPLETED|Second Intervention||0
5048795|NCT01965600|12423720|P4|COMPLETED|Second Intervention||0
5048796|NCT01965600|12423721|P3|COMPLETED|Second Intervention||1
5048797|NCT01965600|12423722|P2|COMPLETED|Second Intervention||4
5048798|NCT01965600|12423723|P1|COMPLETED|Second Intervention||4
5048799|NCT01965600|12423720|P4|STARTED|Second Intervention||2
5048800|NCT01965600|12423721|P3|STARTED|Second Intervention||3
5048801|NCT01965600|12423722|P2|STARTED|Second Intervention||4
5048802|NCT01965600|12423723|P1|STARTED|Second Intervention||4
5048803|NCT01965600|12423720|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
5048804|NCT01965600|12423721|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
5048805|NCT01965600|12423722|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
5048806|NCT01965600|12423723|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
5048807|NCT01965600|12423720|P4|COMPLETED|Washout Period of Approximately 15 Days||2
5048808|NCT01965600|12423721|P3|COMPLETED|Washout Period of Approximately 15 Days||3
5048809|NCT01965600|12423722|P2|COMPLETED|Washout Period of Approximately 15 Days||4
5048810|NCT01965600|12423723|P1|COMPLETED|Washout Period of Approximately 15 Days||4
5048811|NCT01965600|12423720|P4|STARTED|Washout Period of Approximately 15 Days||4
5048812|NCT01965600|12423721|P3|STARTED|Washout Period of Approximately 15 Days||5
5048813|NCT01965600|12423722|P2|STARTED|Washout Period of Approximately 15 Days||8
5048814|NCT01965600|12423723|P1|STARTED|Washout Period of Approximately 15 Days||6
5048815|NCT01965600|12423720|P4|NOT COMPLETED|First Intervention||0
5048816|NCT01965600|12423721|P3|NOT COMPLETED|First Intervention||0
5048817|NCT01965600|12423722|P2|NOT COMPLETED|First Intervention||0
5048818|NCT01965600|12423723|P1|NOT COMPLETED|First Intervention||0
5048819|NCT01965600|12423720|P4|COMPLETED|First Intervention||4
5048820|NCT01965600|12423721|P3|COMPLETED|First Intervention||5
5048821|NCT01965600|12423722|P2|COMPLETED|First Intervention||8
5048822|NCT01965600|12423723|P1|COMPLETED|First Intervention||6
5048823|NCT01965600|12423720|P4|Received at Least One Dose of Drug|First Intervention||4
5048824|NCT01965600|12423721|P3|Received at Least One Dose of Drug|First Intervention||5
5048825|NCT01965600|12423722|P2|Received at Least One Dose of Drug|First Intervention||8
5048826|NCT01965600|12423723|P1|Received at Least One Dose of Drug|First Intervention||6
5048827|NCT01965600|12423720|P4|STARTED|First Intervention||4
5048828|NCT01965600|12423721|P3|STARTED|First Intervention||5
5048829|NCT01965600|12423722|P2|STARTED|First Intervention||8
5048830|NCT01965600|12423723|P1|STARTED|First Intervention||6
5048831|NCT01965561|12423767|P1|NOT COMPLETED|Overall Study||0
5048832|NCT01965561|12423767|P1|COMPLETED|Overall Study||10
5048833|NCT01965561|12423767|P1|STARTED|Overall Study||10
5048834|NCT01965535|12423780|P2|NOT COMPLETED|Overall Study||1
5048835|NCT01965535|12423781|P1|NOT COMPLETED|Overall Study||2
5048836|NCT01965535|12423780|P2|COMPLETED|Overall Study||76
5048837|NCT01965535|12423781|P1|COMPLETED|Overall Study||76
5048838|NCT01965535|12423780|P2|STARTED|Overall Study||77
5048839|NCT01965535|12423781|P1|STARTED|Overall Study||78
5048840|NCT01965431|12423795|P6|NOT COMPLETED|Overall Study||6
5048841|NCT01965431|12423796|P5|NOT COMPLETED|Overall Study||6
5048842|NCT01965431|12423797|P4|NOT COMPLETED|Overall Study||6
5048843|NCT01965431|12423798|P3|NOT COMPLETED|Overall Study||6
5048844|NCT01965431|12423799|P2|NOT COMPLETED|Overall Study||6
5048845|NCT01965431|12423800|P1|NOT COMPLETED|Overall Study||6
5048846|NCT01965431|12423795|P6|COMPLETED|Overall Study||2
5048847|NCT01965431|12423796|P5|COMPLETED|Overall Study||2
5048848|NCT01965431|12423797|P4|COMPLETED|Overall Study||2
5048849|NCT01965431|12423798|P3|COMPLETED|Overall Study||2
5048850|NCT01965431|12423799|P2|COMPLETED|Overall Study||2
5048851|NCT01965431|12423800|P1|COMPLETED|Overall Study||2
5048852|NCT01965431|12423795|P6|STARTED|Overall Study||8
5048853|NCT01965431|12423796|P5|STARTED|Overall Study||8
5048854|NCT01965431|12423797|P4|STARTED|Overall Study||8
5048855|NCT01965431|12423798|P3|STARTED|Overall Study||8
5048856|NCT01965431|12423799|P2|STARTED|Overall Study||8
5048857|NCT01965431|12423800|P1|STARTED|Overall Study|Started are actually Treated subjects|8
5048858|NCT01965366|12423815|P2|NOT COMPLETED|Overall Study||5
5048859|NCT01965366|12423816|P1|NOT COMPLETED|Overall Study||10
5048860|NCT01965366|12423815|P2|COMPLETED|Overall Study||9
5048861|NCT01965366|12423816|P1|COMPLETED|Overall Study||3
5048862|NCT01965366|12423815|P2|STARTED|Overall Study||14
5048863|NCT01965366|12423816|P1|STARTED|Overall Study||13
5048864|NCT01965327|12423824|P1|NOT COMPLETED|Overall Study||2
5048865|NCT01965327|12423824|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
5048866|NCT01965327|12423824|P1|STARTED|Overall Study||12
5048867|NCT01965288|12423831|P2|NOT COMPLETED|Overall Study||0
5048868|NCT01965288|12423832|P1|NOT COMPLETED|Overall Study||0
5048869|NCT01965288|12423831|P2|COMPLETED|Overall Study||30
5048870|NCT01965288|12423832|P1|COMPLETED|Overall Study||30
5048871|NCT01965288|12423831|P2|STARTED|Overall Study||30
5048872|NCT01965288|12423832|P1|STARTED|Overall Study||30
5048873|NCT01965262|12424038|P2|NOT COMPLETED|Second Intervention (7 Days)||10
5048874|NCT01965262|12424039|P1|NOT COMPLETED|Second Intervention (7 Days)||1
5048875|NCT01965262|12424038|P2|COMPLETED|Second Intervention (7 Days)||5
5048876|NCT01965262|12424039|P1|COMPLETED|Second Intervention (7 Days)||14
5048877|NCT01965262|12424038|P2|STARTED|Second Intervention (7 Days)||15
5048878|NCT01965262|12424039|P1|STARTED|Second Intervention (7 Days)||15
5048879|NCT01965262|12424038|P2|NOT COMPLETED|First Intervention (7 Days)||0
5048880|NCT01965262|12424039|P1|NOT COMPLETED|First Intervention (7 Days)||0
5048881|NCT01965262|12424038|P2|COMPLETED|First Intervention (7 Days)||15
5048882|NCT01965262|12424039|P1|COMPLETED|First Intervention (7 Days)||15
5048883|NCT01965262|12424038|P2|STARTED|First Intervention (7 Days)||15
5048884|NCT01965262|12424039|P1|STARTED|First Intervention (7 Days)||15
5048885|NCT01965158|12424103|P2|NOT COMPLETED|Overall Study||35
5048886|NCT01965158|12424104|P1|NOT COMPLETED|Overall Study||41
5048887|NCT01965158|12424103|P2|COMPLETED|Overall Study||238
5048888|NCT01965158|12424104|P1|COMPLETED|Overall Study||233
5048889|NCT01965158|12424103|P2|Received Treatment|Overall Study||273
5048890|NCT01965158|12424104|P1|Received Treatment|Overall Study||272
5048891|NCT01965158|12424103|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
5048892|NCT01965158|12424104|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
5048893|NCT01965067|12424120|P2|NOT COMPLETED|Overall Study||0
5048894|NCT01965067|12424121|P1|NOT COMPLETED|Overall Study||0
5048895|NCT01965067|12424120|P2|COMPLETED|Overall Study||30
5048896|NCT01965067|12424121|P1|COMPLETED|Overall Study||30
5048897|NCT01965067|12424120|P2|STARTED|Overall Study||30
5048898|NCT01965067|12424121|P1|STARTED|Overall Study||30
5048899|NCT01965002|12424137|P1|NOT COMPLETED|Overall Study||0
5048900|NCT01965002|12424137|P1|COMPLETED|Overall Study||5
5048901|NCT01965002|12424137|P1|STARTED|Overall Study||5
5048902|NCT01964976|12424145|P1|NOT COMPLETED|Overall Study||31
5048903|NCT01964976|12424145|P1|COMPLETED|Overall Study||1065
5048904|NCT01964976|12424145|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
5048905|NCT01964963|12424157|P1|NOT COMPLETED|Overall Study||943
5048906|NCT01964963|12424157|P1|COMPLETED|Overall Study||18249
5048907|NCT01964963|12424157|P1|STARTED|Overall Study||19192
5048908|NCT01964950|12424165|P1|NOT COMPLETED|Overall Study||25
5048909|NCT01964950|12424165|P1|COMPLETED|Overall Study||1076
5048910|NCT01964950|12424165|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
5048911|NCT01964924|12424177|P2|NOT COMPLETED|Trametinib + GSK2141||0
5048912|NCT01964924|12424178|P1|NOT COMPLETED|Trametinib + GSK2141||0
5048913|NCT01964924|12424177|P2|COMPLETED|Trametinib + GSK2141||19
5048914|NCT01964924|12424178|P1|COMPLETED|Trametinib + GSK2141||0
5048915|NCT01964924|12424177|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
5048916|NCT01964924|12424178|P1|STARTED|Trametinib + GSK2141||0
5048917|NCT01964924|12424177|P2|NOT COMPLETED|Trametinib Monotherapy||0
5048918|NCT01964924|12424178|P1|NOT COMPLETED|Trametinib Monotherapy||19
5048919|NCT01964924|12424177|P2|COMPLETED|Trametinib Monotherapy||0
5048920|NCT01964924|12424178|P1|COMPLETED|Trametinib Monotherapy||18
5048921|NCT01964924|12424177|P2|STARTED|Trametinib Monotherapy||0
5048922|NCT01964924|12424178|P1|STARTED|Trametinib Monotherapy||37
5048923|NCT01964898|12424202|P2|NOT COMPLETED|Overall Study||7
5048924|NCT01964898|12424203|P1|NOT COMPLETED|Overall Study||7
5048925|NCT01964898|12424202|P2|COMPLETED|Overall Study||26
5048926|NCT01964898|12424203|P1|COMPLETED|Overall Study||24
5048927|NCT01964898|12424202|P2|12 Week Assessment|Overall Study||30
5048928|NCT01964898|12424203|P1|12 Week Assessment|Overall Study||25
5048929|NCT01964898|12424202|P2|STARTED|Overall Study||33
5048930|NCT01964898|12424203|P1|STARTED|Overall Study||31
5048931|NCT01964755|12424223|P1|NOT COMPLETED|Overall Study||2
5048932|NCT01964755|12424223|P1|COMPLETED|Overall Study||4
5048933|NCT01964755|12424223|P1|Cycle 5|Overall Study||4
5048934|NCT01964755|12424223|P1|Cycle 4|Overall Study||4
5048935|NCT01964755|12424223|P1|Cycle 3|Overall Study||4
5048936|NCT01964755|12424223|P1|Cycle 2|Overall Study||5
5048937|NCT01964755|12424223|P1|STARTED|Overall Study||6
5048938|NCT01964716|12424238|P2|NOT COMPLETED|Overall Study||6
5048939|NCT01964716|12424239|P1|NOT COMPLETED|Overall Study||5
5048940|NCT01964716|12424238|P2|COMPLETED|Overall Study||244
5048941|NCT01964716|12424239|P1|COMPLETED|Overall Study||245
5048942|NCT01964716|12424238|P2|Vaccinated Dose 3|Overall Study||244
5048943|NCT01964716|12424239|P1|Vaccinated Dose 3|Overall Study||247
5048944|NCT01964716|12424238|P2|Vaccinated Dose 2|Overall Study||248
5048945|NCT01964716|12424239|P1|Vaccinated Dose 2|Overall Study||249
5048946|NCT01964716|12424238|P2|Vaccinated Dose 1|Overall Study||250
5048947|NCT01964716|12424239|P1|Vaccinated Dose 1|Overall Study||250
5048948|NCT01964716|12424238|P2|STARTED|Overall Study||250
5048949|NCT01964716|12424239|P1|STARTED|Overall Study||250
5048950|NCT01964547|12424277|P2|NOT COMPLETED|Overall Study||11
5048951|NCT01964547|12424278|P1|NOT COMPLETED|Overall Study||12
5048952|NCT01964547|12424277|P2|COMPLETED|Overall Study||48
5048953|NCT01964547|12424278|P1|COMPLETED|Overall Study||50
5048954|NCT01964547|12424277|P2|STARTED|Overall Study||59
5048955|NCT01964547|12424278|P1|STARTED|Overall Study||62
5048956|NCT01964521|12424302|P1|NOT COMPLETED|Overall Study||4
5048957|NCT01964521|12424302|P1|COMPLETED|Overall Study||20
5048958|NCT01964521|12424302|P1|STARTED|Overall Study||24
5048959|NCT01964430|12424309|P2|NOT COMPLETED|Overall Study||124
5048960|NCT01964430|12424310|P1|NOT COMPLETED|Overall Study||145
5048961|NCT01964430|12424309|P2|COMPLETED|Overall Study||310
5048962|NCT01964430|12424310|P1|COMPLETED|Overall Study||287
5048963|NCT01964430|12424309|P2|Treated Population|Overall Study||423
5048964|NCT01964430|12424310|P1|Treated Population|Overall Study||429
5048965|NCT01964430|12424309|P2|STARTED|Overall Study||434
5048966|NCT01964430|12424310|P1|STARTED|Overall Study||432
5048967|NCT01964378|12424322|P2|NOT COMPLETED|Overall Study||21
5048968|NCT01964378|12424323|P1|NOT COMPLETED|Overall Study||25
5048969|NCT01964378|12424322|P2|COMPLETED|Overall Study||45
5048970|NCT01964378|12424323|P1|COMPLETED|Overall Study||41
5048971|NCT01964378|12424322|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
5048972|NCT01964378|12424323|P1|Participants Treated (Safety Set)|Overall Study||65
5048973|NCT01964378|12424322|P2|STARTED|Overall Study||66
5048974|NCT01964378|12424323|P1|STARTED|Overall Study||66
5048975|NCT01964352|12424359|P4|NOT COMPLETED|Overall Study||8
5048976|NCT01964352|12424360|P3|NOT COMPLETED|Overall Study||6
5048977|NCT01964352|12424361|P2|NOT COMPLETED|Overall Study||11
5048978|NCT01964352|12424362|P1|NOT COMPLETED|Overall Study||26
5048979|NCT01964352|12424359|P4|COMPLETED|Overall Study||195
5048980|NCT01964352|12424360|P3|COMPLETED|Overall Study||196
5048981|NCT01964352|12424361|P2|COMPLETED|Overall Study||192
5048982|NCT01964352|12424362|P1|COMPLETED|Overall Study||178
5048983|NCT01964352|12424359|P4|STARTED|Overall Study||203
5048984|NCT01964352|12424360|P3|STARTED|Overall Study||202
5048985|NCT01964352|12424361|P2|STARTED|Overall Study||203
5048986|NCT01964352|12424362|P1|STARTED|Overall Study||204
5048987|NCT01964326|12424392|P1|NOT COMPLETED|Overall Study||297
5048988|NCT01964326|12424392|P1|COMPLETED|Overall Study||1014
5048989|NCT01964326|12424392|P1|STARTED|Overall Study||1311
5048990|NCT01964300|12424401|P2|NOT COMPLETED|Overall Study||11
5048991|NCT01964300|12424402|P1|NOT COMPLETED|Overall Study||6
5048992|NCT01964300|12424401|P2|COMPLETED|Overall Study||1
5048993|NCT01964300|12424402|P1|COMPLETED|Overall Study||1
5048994|NCT01964300|12424401|P2|STARTED|Overall Study||12
5048995|NCT01964300|12424402|P1|STARTED|Overall Study||7
5048996|NCT01964222|12424416|P2|NOT COMPLETED|Overall Study||11
5048997|NCT01964222|12424417|P1|NOT COMPLETED|Overall Study||15
5048998|NCT01964222|12424416|P2|COMPLETED|Overall Study||89
5048999|NCT01964222|12424417|P1|COMPLETED|Overall Study||86
5049000|NCT01964222|12424416|P2|STARTED|Overall Study||100
5049001|NCT01964222|12424417|P1|STARTED|Overall Study||101
5049002|NCT01964105|12424434|P3|NOT COMPLETED|Overall Study||0
5049003|NCT01964105|12424435|P2|NOT COMPLETED|Overall Study||13
5049004|NCT01964105|12424436|P1|NOT COMPLETED|Overall Study||2
5049005|NCT01964105|12424434|P3|COMPLETED|Overall Study||10
5049006|NCT01964105|12424435|P2|COMPLETED|Overall Study||62
5049007|NCT01964105|12424436|P1|COMPLETED|Overall Study||13
5049008|NCT01964105|12424434|P3|STARTED|Overall Study||10
5049009|NCT01964105|12424435|P2|STARTED|Overall Study||75
5049010|NCT01964105|12424436|P1|STARTED|Overall Study||15
5049011|NCT01964092|12424446|P2|NOT COMPLETED|Overall Study||0
5049012|NCT01964092|12424447|P1|NOT COMPLETED|Overall Study||2
5049013|NCT01964092|12424446|P2|COMPLETED|Overall Study||181
5049014|NCT01964092|12424447|P1|COMPLETED|Overall Study||227
5049015|NCT01964092|12424446|P2|STARTED|Overall Study||181
5049016|NCT01964092|12424447|P1|STARTED|Overall Study||229
5049017|NCT01963923|12424455|P2|NOT COMPLETED|3 Months Post-surgery||1
5049018|NCT01963923|12424456|P1|NOT COMPLETED|3 Months Post-surgery||2
5049019|NCT01963923|12424455|P2|COMPLETED|3 Months Post-surgery||9
5049020|NCT01963923|12424456|P1|COMPLETED|3 Months Post-surgery||10
5049021|NCT01963923|12424455|P2|STARTED|3 Months Post-surgery||10
5049022|NCT01963923|12424456|P1|STARTED|3 Months Post-surgery||12
5049023|NCT01963923|12424455|P2|NOT COMPLETED|3 Weeks Post-surgery||10
5049024|NCT01963923|12424456|P1|NOT COMPLETED|3 Weeks Post-surgery||8
5049025|NCT01963923|12424455|P2|COMPLETED|3 Weeks Post-surgery||10
5049026|NCT01963923|12424456|P1|COMPLETED|3 Weeks Post-surgery||12
5049027|NCT01963923|12424455|P2|STARTED|3 Weeks Post-surgery||20
5049028|NCT01963923|12424456|P1|STARTED|3 Weeks Post-surgery||20
5049029|NCT01963845|12424478|P2|NOT COMPLETED|Overall Study||0
5049030|NCT01963845|12424479|P1|NOT COMPLETED|Overall Study||0
5049031|NCT01963845|12424478|P2|COMPLETED|Overall Study||25
5049032|NCT01963845|12424479|P1|COMPLETED|Overall Study||25
5049033|NCT01963845|12424478|P2|STARTED|Overall Study||25
5049034|NCT01963845|12424479|P1|STARTED|Overall Study||25
5049035|NCT01963767|12424495|P2|NOT COMPLETED|Overall Study||2
5049036|NCT01963767|12424496|P1|NOT COMPLETED|Overall Study||6
5049037|NCT01963767|12424495|P2|COMPLETED|Overall Study||53
5049038|NCT01963767|12424496|P1|COMPLETED|Overall Study||52
5049039|NCT01963767|12424495|P2|STARTED|Overall Study||55
5049040|NCT01963767|12424496|P1|STARTED|Overall Study||58
5049041|NCT01963676|12424506|P2|NOT COMPLETED|Overall Study||0
5049042|NCT01963676|12424507|P1|NOT COMPLETED|Overall Study||1
5049043|NCT01963676|12424506|P2|COMPLETED|Overall Study||13
5049044|NCT01963676|12424507|P1|COMPLETED|Overall Study||13
5049045|NCT01963676|12424506|P2|STARTED|Overall Study||13
5049046|NCT01963676|12424507|P1|STARTED|Overall Study||14
5049047|NCT01963611|12424520|P5|NOT COMPLETED|Overall Study||51
5049048|NCT01963611|12424521|P4|NOT COMPLETED|Overall Study||52
5049049|NCT01963611|12424522|P3|NOT COMPLETED|Overall Study||52
5049050|NCT01963611|12424523|P2|NOT COMPLETED|Overall Study||49
5049051|NCT01963611|12424524|P1|NOT COMPLETED|Overall Study||51
5049052|NCT01963611|12424520|P5|COMPLETED|Overall Study||0
5049053|NCT01963611|12424521|P4|COMPLETED|Overall Study||0
5049054|NCT01963611|12424522|P3|COMPLETED|Overall Study||0
5049055|NCT01963611|12424523|P2|COMPLETED|Overall Study||0
5049056|NCT01963611|12424524|P1|COMPLETED|Overall Study||0
5049057|NCT01963611|12424520|P5|Safety Analysis Set|Overall Study||50
5049058|NCT01963611|12424521|P4|Safety Analysis Set|Overall Study||52
5049059|NCT01963611|12424522|P3|Safety Analysis Set|Overall Study||52
5049060|NCT01963611|12424523|P2|Safety Analysis Set|Overall Study||49
5049061|NCT01963611|12424524|P1|Safety Analysis Set|Overall Study||51
5049062|NCT01963611|12424520|P5|STARTED|Overall Study||51
5049063|NCT01963611|12424521|P4|STARTED|Overall Study||52
5049064|NCT01963611|12424522|P3|STARTED|Overall Study||52
5049065|NCT01963611|12424523|P2|STARTED|Overall Study||49
5049066|NCT01963611|12424524|P1|STARTED|Overall Study||51
5049067|NCT01963481|12424581|P1|NOT COMPLETED|Overall Study||0
5049068|NCT01963481|12424581|P1|COMPLETED|Overall Study||23
5049069|NCT01963481|12424581|P1|STARTED|Overall Study||23
5049070|NCT01963403|12424589|P2|NOT COMPLETED|Overall Study||4
5049071|NCT01963403|12424590|P1|NOT COMPLETED|Overall Study||2
5049072|NCT01963403|12424589|P2|COMPLETED|Overall Study|Follow-up over three months|9
5049073|NCT01963403|12424590|P1|COMPLETED|Overall Study|Follow-up over three months|11
5049074|NCT01963403|12424589|P2|STARTED|Overall Study||13
5049075|NCT01963403|12424590|P1|STARTED|Overall Study||13
5049076|NCT01963260|12424612|P10|NOT COMPLETED|Overall Study||0
5049077|NCT01963260|12424613|P9|NOT COMPLETED|Overall Study||0
5049078|NCT01963260|12424614|P8|NOT COMPLETED|Overall Study||0
5049079|NCT01963260|12424615|P7|NOT COMPLETED|Overall Study||0
5049080|NCT01963260|12424616|P6|NOT COMPLETED|Overall Study||0
5049081|NCT01963260|12424617|P5|NOT COMPLETED|Overall Study||2
5049082|NCT01963260|12424618|P4|NOT COMPLETED|Overall Study||1
5049083|NCT01963260|12424619|P3|NOT COMPLETED|Overall Study||0
5049084|NCT01963260|12424620|P2|NOT COMPLETED|Overall Study||0
5049085|NCT01963260|12424621|P1|NOT COMPLETED|Overall Study||2
5049086|NCT01963260|12424612|P10|COMPLETED|Overall Study||4
5049087|NCT01963260|12424613|P9|COMPLETED|Overall Study||1
5049088|NCT01963260|12424614|P8|COMPLETED|Overall Study||2
5049089|NCT01963260|12424615|P7|COMPLETED|Overall Study||3
5049090|NCT01963260|12424616|P6|COMPLETED|Overall Study||10
5049091|NCT01963260|12424617|P5|COMPLETED|Overall Study||4
5049092|NCT01963260|12424618|P4|COMPLETED|Overall Study||5
5049093|NCT01963260|12424619|P3|COMPLETED|Overall Study||6
5049094|NCT01963260|12424620|P2|COMPLETED|Overall Study||6
5049095|NCT01963260|12424621|P1|COMPLETED|Overall Study||4
5049096|NCT01963260|12424612|P10|Treated|Overall Study||4
5049097|NCT01963260|12424613|P9|Treated|Overall Study||1
5049098|NCT01963260|12424614|P8|Treated|Overall Study||2
5049099|NCT01963260|12424615|P7|Treated|Overall Study||3
5049100|NCT01963260|12424616|P6|Treated|Overall Study||10
5049101|NCT01963260|12424617|P5|Treated|Overall Study||6
5049102|NCT01963260|12424618|P4|Treated|Overall Study||6
5049103|NCT01963260|12424619|P3|Treated|Overall Study||6
5049104|NCT01963260|12424620|P2|Treated|Overall Study||6
5049105|NCT01963260|12424621|P1|Treated|Overall Study||6
5049106|NCT01963260|12424612|P10|STARTED|Overall Study||4
5049107|NCT01963260|12424613|P9|STARTED|Overall Study||1
5049108|NCT01963260|12424614|P8|STARTED|Overall Study||2
5049109|NCT01963260|12424615|P7|STARTED|Overall Study||3
5049110|NCT01963260|12424616|P6|STARTED|Overall Study||10
5049111|NCT01963260|12424617|P5|STARTED|Overall Study||6
5049112|NCT01963260|12424618|P4|STARTED|Overall Study||6
5049113|NCT01963260|12424619|P3|STARTED|Overall Study||6
5049114|NCT01963260|12424620|P2|STARTED|Overall Study||6
5049115|NCT01963260|12424621|P1|STARTED|Overall Study||6
5049116|NCT01963234|12424676|P2|NOT COMPLETED|Overall Study||0
5049117|NCT01963234|12424677|P1|NOT COMPLETED|Overall Study||61
5049118|NCT01963234|12424676|P2|COMPLETED|Overall Study||171
5049119|NCT01963234|12424677|P1|COMPLETED|Overall Study||207
5049120|NCT01963234|12424676|P2|STARTED|Overall Study||171
5049121|NCT01963234|12424677|P1|STARTED|Overall Study||268
5049122|NCT01963169|12424704|P3|NOT COMPLETED|Overall Study||26
5049123|NCT01963169|12424705|P2|NOT COMPLETED|Overall Study||82
5049124|NCT01963169|12424706|P1|NOT COMPLETED|Overall Study||59
5049125|NCT01963169|12424704|P3|COMPLETED|Overall Study||237
5049126|NCT01963169|12424705|P2|COMPLETED|Overall Study||220
5049127|NCT01963169|12424706|P1|COMPLETED|Overall Study||242
5049128|NCT01963169|12424704|P3|STARTED|Overall Study||263
5049129|NCT01963169|12424705|P2|STARTED|Overall Study||302
5049130|NCT01963169|12424706|P1|STARTED|Overall Study||301
5049131|NCT01963143|12424723|P3|NOT COMPLETED|Overall Study||1
5049132|NCT01963143|12424724|P2|NOT COMPLETED|Overall Study||1
5049133|NCT01963143|12424725|P1|NOT COMPLETED|Overall Study||0
5049134|NCT01963143|12424723|P3|COMPLETED|Overall Study||14
5049135|NCT01963143|12424724|P2|COMPLETED|Overall Study||18
5049136|NCT01963143|12424725|P1|COMPLETED|Overall Study||14
5049137|NCT01963143|12424723|P3|STARTED|Overall Study||15
5049138|NCT01963143|12424724|P2|STARTED|Overall Study||19
5049139|NCT01963143|12424725|P1|STARTED|Overall Study||14
5049140|NCT01963117|12424735|P1|NOT COMPLETED|Overall Study||1
5049141|NCT01963117|12424735|P1|COMPLETED|Overall Study||10
5049142|NCT01963117|12424735|P1|STARTED|Overall Study||11
5049143|NCT01963091|12424746|P2|NOT COMPLETED|Overall Study||0
5049144|NCT01963091|12424747|P1|NOT COMPLETED|Overall Study||0
5049145|NCT01963091|12424746|P2|COMPLETED|Overall Study||16
5049146|NCT01963091|12424747|P1|COMPLETED|Overall Study||17
5049147|NCT01963091|12424746|P2|STARTED|Overall Study||16
5049148|NCT01963091|12424747|P1|STARTED|Overall Study||17
5049149|NCT01963078|12424761|P4|NOT COMPLETED|Overall Study||2
5049150|NCT01963078|12424762|P3|NOT COMPLETED|Overall Study||1
5049151|NCT01963078|12424763|P2|NOT COMPLETED|Overall Study||1
5049152|NCT01963078|12424764|P1|NOT COMPLETED|Overall Study||1
5049153|NCT01963078|12424761|P4|COMPLETED|Overall Study||7
5049154|NCT01963078|12424762|P3|COMPLETED|Overall Study||9
5049155|NCT01963078|12424763|P2|COMPLETED|Overall Study||9
5049156|NCT01963078|12424764|P1|COMPLETED|Overall Study||8
5049157|NCT01963078|12424761|P4|STARTED|Overall Study||9
5049158|NCT01963078|12424762|P3|STARTED|Overall Study||10
5049159|NCT01963078|12424763|P2|STARTED|Overall Study||10
5049160|NCT01963078|12424764|P1|STARTED|Overall Study||9
5049161|NCT01962987|12424777|P3|NOT COMPLETED|Overall Study||12
5049162|NCT01962987|12424778|P2|NOT COMPLETED|Overall Study||28
5049163|NCT01962987|12424779|P1|NOT COMPLETED|Overall Study||30
5049164|NCT01962987|12424777|P3|COMPLETED|Overall Study||83
5049165|NCT01962987|12424778|P2|COMPLETED|Overall Study||163
5049166|NCT01962987|12424779|P1|COMPLETED|Overall Study||160
5049167|NCT01962987|12424777|P3|STARTED|Overall Study||95
5049168|NCT01962987|12424778|P2|STARTED|Overall Study||191
5049169|NCT01962987|12424779|P1|STARTED|Overall Study||190
5049170|NCT01962974|12424787|P1|NOT COMPLETED|Overall Study||7
5049171|NCT01962974|12424787|P1|COMPLETED|Overall Study||0
5049172|NCT01962974|12424787|P1|STARTED|Overall Study||7
5049173|NCT01962961|12424796|P3|NOT COMPLETED|Overall Study||1
5049174|NCT01962961|12424797|P2|NOT COMPLETED|Overall Study||1
5049175|NCT01962961|12424798|P1|NOT COMPLETED|Overall Study||0
5049176|NCT01962961|12424796|P3|COMPLETED|Overall Study||6
5049177|NCT01962961|12424797|P2|COMPLETED|Overall Study||7
5049178|NCT01962961|12424798|P1|COMPLETED|Overall Study||9
5049179|NCT01962961|12424796|P3|STARTED|Overall Study||7
5049180|NCT01962961|12424797|P2|STARTED|Overall Study||8
5049181|NCT01962961|12424798|P1|STARTED|Overall Study||9
5049182|NCT01962922|12424814|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
5049183|NCT01962922|12424815|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
5049184|NCT01962922|12424814|P2|COMPLETED|Extendion Portion (up to Month 6)||20
5049185|NCT01962922|12424815|P1|COMPLETED|Extendion Portion (up to Month 6)||18
5049186|NCT01962922|12424814|P2|STARTED|Extendion Portion (up to Month 6)||23
5049187|NCT01962922|12424815|P1|STARTED|Extendion Portion (up to Month 6)||23
5049188|NCT01962922|12424814|P2|NOT COMPLETED|PK Portion Day 21||0
5049189|NCT01962922|12424815|P1|NOT COMPLETED|PK Portion Day 21||0
5049190|NCT01962922|12424814|P2|COMPLETED|PK Portion Day 21||23
5049191|NCT01962922|12424815|P1|COMPLETED|PK Portion Day 21||23
5049192|NCT01962922|12424814|P2|STARTED|PK Portion Day 21||23
5049193|NCT01962922|12424815|P1|STARTED|PK Portion Day 21||23
5049194|NCT01962922|12424814|P2|NOT COMPLETED|PK Portion Day 14||0
5049195|NCT01962922|12424815|P1|NOT COMPLETED|PK Portion Day 14||0
5049196|NCT01962922|12424814|P2|COMPLETED|PK Portion Day 14||23
5049197|NCT01962922|12424815|P1|COMPLETED|PK Portion Day 14||23
5049198|NCT01962922|12424814|P2|STARTED|PK Portion Day 14||23
5049199|NCT01962922|12424815|P1|STARTED|PK Portion Day 14||23
5049200|NCT01962922|12424814|P2|NOT COMPLETED|PK Portion Day 7||0
5049201|NCT01962922|12424815|P1|NOT COMPLETED|PK Portion Day 7||4
5049202|NCT01962922|12424814|P2|COMPLETED|PK Portion Day 7||23
5049203|NCT01962922|12424815|P1|COMPLETED|PK Portion Day 7||23
5049204|NCT01962922|12424814|P2|STARTED|PK Portion Day 7||23
5049205|NCT01962922|12424815|P1|STARTED|PK Portion Day 7||27
5049206|NCT01962896|12424837|P1|NOT COMPLETED|Overall Study||4
5049207|NCT01962896|12424837|P1|COMPLETED|Overall Study||0
5049208|NCT01962896|12424837|P1|STARTED|Overall Study||4
5049209|NCT01962870|12424846|P2|NOT COMPLETED|Overall Study||0
5049210|NCT01962870|12424847|P1|NOT COMPLETED|Overall Study||0
5049211|NCT01962870|12424846|P2|COMPLETED|Overall Study||17
5049212|NCT01962870|12424847|P1|COMPLETED|Overall Study||13
5049213|NCT01962870|12424846|P2|STARTED|Overall Study||17
5049214|NCT01962870|12424847|P1|STARTED|Overall Study||13
5049215|NCT01962714|12424895|P2|NOT COMPLETED|Overall Study||33
5049216|NCT01962714|12424896|P1|NOT COMPLETED|Overall Study||30
5049217|NCT01962714|12424895|P2|COMPLETED|Overall Study||60
5049218|NCT01962714|12424896|P1|COMPLETED|Overall Study||61
5049219|NCT01962714|12424895|P2|3-month Follow-up|Overall Study||56
5049220|NCT01962714|12424896|P1|3-month Follow-up|Overall Study||58
5049221|NCT01962714|12424895|P2|Immediate Post-treatment Assessment|Overall Study||57
5049222|NCT01962714|12424896|P1|Immediate Post-treatment Assessment|Overall Study||63
5049223|NCT01962714|12424895|P2|STARTED|Overall Study||93
5049224|NCT01962714|12424896|P1|STARTED|Overall Study||91
5049225|NCT01962688|12424906|P2|NOT COMPLETED|Overall Study||0
5049226|NCT01962688|12424907|P1|NOT COMPLETED|Overall Study||0
5049227|NCT01962688|12424906|P2|COMPLETED|Overall Study||18
5049228|NCT01962688|12424907|P1|COMPLETED|Overall Study||19
5049229|NCT01962688|12424906|P2|STARTED|Overall Study||18
5049230|NCT01962688|12424907|P1|STARTED|Overall Study||19
5049231|NCT01962675|12424925|P2|NOT COMPLETED|Overall Study||0
5049232|NCT01962675|12424926|P1|NOT COMPLETED|Overall Study||0
5049233|NCT01962675|12424925|P2|COMPLETED|Overall Study||7
5049234|NCT01962675|12424926|P1|COMPLETED|Overall Study||7
5049235|NCT01962675|12424925|P2|STARTED|Overall Study||7
5049236|NCT01962675|12424926|P1|STARTED|Overall Study||7
5049237|NCT01962558|12424940|P2|NOT COMPLETED|Overall Study||0
5049238|NCT01962558|12424941|P1|NOT COMPLETED|Overall Study||0
5049239|NCT01962558|12424940|P2|COMPLETED|Overall Study||14
5049240|NCT01962558|12424941|P1|COMPLETED|Overall Study||16
5049241|NCT01962558|12424940|P2|12-Weeks|Overall Study||14
5049242|NCT01962558|12424941|P1|12-Weeks|Overall Study||16
5049243|NCT01962558|12424940|P2|Acute Study|Overall Study||14
5049244|NCT01962558|12424941|P1|Acute Study|Overall Study||16
5049245|NCT01962558|12424940|P2|STARTED|Overall Study||14
5049246|NCT01962558|12424941|P1|STARTED|Overall Study||16
5049247|NCT01962493|12424959|P2|NOT COMPLETED|Overall Study||5
5049248|NCT01962493|12424960|P1|NOT COMPLETED|Overall Study||5
5049249|NCT01962493|12424959|P2|COMPLETED|Overall Study||77
5049250|NCT01962493|12424960|P1|COMPLETED|Overall Study||73
5049251|NCT01962493|12424959|P2|STARTED|Overall Study||82
5049252|NCT01962493|12424960|P1|STARTED|Overall Study||78
5049253|NCT01962441|12424983|P3|NOT COMPLETED|Retreatment Substudy||0
5049254|NCT01962441|12424984|P2|NOT COMPLETED|Retreatment Substudy||0
5049255|NCT01962441|12424985|P1|NOT COMPLETED|Retreatment Substudy||2
5049256|NCT01962441|12424983|P3|COMPLETED|Retreatment Substudy||0
5049257|NCT01962441|12424984|P2|COMPLETED|Retreatment Substudy||10
5049258|NCT01962441|12424985|P1|COMPLETED|Retreatment Substudy||18
5049259|NCT01962441|12424983|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
5049260|NCT01962441|12424984|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
5049261|NCT01962441|12424985|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
5049262|NCT01962441|12424983|P3|NOT COMPLETED|Randomized Period||11
5049263|NCT01962441|12424984|P2|NOT COMPLETED|Randomized Period||11
5049264|NCT01962441|12424985|P1|NOT COMPLETED|Randomized Period||10
5049265|NCT01962441|12424983|P3|COMPLETED|Randomized Period||189
5049266|NCT01962441|12424984|P2|COMPLETED|Randomized Period||190
5049267|NCT01962441|12424985|P1|COMPLETED|Randomized Period||190
5049268|NCT01962441|12424983|P3|STARTED|Randomized Period||200
5049269|NCT01962441|12424984|P2|STARTED|Randomized Period||201
5049270|NCT01962441|12424985|P1|STARTED|Randomized Period||200
5049271|NCT01962428|12425017|P2|NOT COMPLETED|Overall Study||6
5049272|NCT01962428|12425018|P1|NOT COMPLETED|Overall Study||10
5049273|NCT01962428|12425017|P2|COMPLETED|Overall Study||133
5049274|NCT01962428|12425018|P1|COMPLETED|Overall Study||129
5049275|NCT01962428|12425017|P2|STARTED|Overall Study||139
5049276|NCT01962428|12425018|P1|STARTED|Overall Study||139
5049277|NCT01962298|12425029|P5|NOT COMPLETED|Overall Study||6
5049278|NCT01962298|12425030|P4|NOT COMPLETED|Overall Study||2
5049279|NCT01962298|12425031|P3|NOT COMPLETED|Overall Study||5
5049280|NCT01962298|12425032|P2|NOT COMPLETED|Overall Study||4
5049281|NCT01962298|12425033|P1|NOT COMPLETED|Overall Study||3
5049282|NCT01962298|12425029|P5|COMPLETED|Overall Study||9
5049283|NCT01962298|12425030|P4|COMPLETED|Overall Study||13
5049284|NCT01962298|12425031|P3|COMPLETED|Overall Study||10
5049285|NCT01962298|12425032|P2|COMPLETED|Overall Study||11
5049286|NCT01962298|12425033|P1|COMPLETED|Overall Study||12
5049287|NCT01962298|12425029|P5|Received Intervention|Overall Study||15
5049288|NCT01962298|12425030|P4|Received Intervention|Overall Study||15
5049289|NCT01962298|12425031|P3|Received Intervention|Overall Study||15
5049290|NCT01962298|12425032|P2|Received Intervention|Overall Study||15
5049291|NCT01962298|12425033|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
5049292|NCT01962298|12425029|P5|STARTED|Overall Study||15
5049293|NCT01962298|12425030|P4|STARTED|Overall Study||15
5049294|NCT01962298|12425031|P3|STARTED|Overall Study||15
5049295|NCT01962298|12425032|P2|STARTED|Overall Study||15
5049296|NCT01962298|12425033|P1|STARTED|Overall Study||15
5049297|NCT01962207|12425054|P4|NOT COMPLETED|Booster Phase (6 Months)||0
5049298|NCT01962207|12425055|P3|NOT COMPLETED|Booster Phase (6 Months)||0
5049299|NCT01962207|12425056|P2|NOT COMPLETED|Booster Phase (6 Months)||0
5049300|NCT01962207|12425057|P1|NOT COMPLETED|Booster Phase (6 Months)||0
5049301|NCT01962207|12425054|P4|COMPLETED|Booster Phase (6 Months)||21
5049302|NCT01962207|12425055|P3|COMPLETED|Booster Phase (6 Months)||77
5049303|NCT01962207|12425056|P2|COMPLETED|Booster Phase (6 Months)||16
5049304|NCT01962207|12425057|P1|COMPLETED|Booster Phase (6 Months)||67
5049305|NCT01962207|12425054|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
5049306|NCT01962207|12425055|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
5049307|NCT01962207|12425056|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
5049308|NCT01962207|12425057|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
5049309|NCT01962207|12425054|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
5049310|NCT01962207|12425055|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
5049311|NCT01962207|12425056|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
5049312|NCT01962207|12425057|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
5049313|NCT01962207|12425054|P4|COMPLETED|Persistence Phase (5 Years)||17
5049314|NCT01962207|12425055|P3|COMPLETED|Persistence Phase (5 Years)||71
5049315|NCT01962207|12425056|P2|COMPLETED|Persistence Phase (5 Years)||10
5049316|NCT01962207|12425057|P1|COMPLETED|Persistence Phase (5 Years)||47
5049317|NCT01962207|12425054|P4|STARTED|Persistence Phase (5 Years)||29
5049318|NCT01962207|12425055|P3|STARTED|Persistence Phase (5 Years)||115
5049319|NCT01962207|12425056|P2|STARTED|Persistence Phase (5 Years)||23
5049320|NCT01962207|12425057|P1|STARTED|Persistence Phase (5 Years)||76
5049321|NCT01962103|12425168|P9|NOT COMPLETED|Phase 2||14
5049322|NCT01962103|12425169|P8|NOT COMPLETED|Phase 2||14
5049323|NCT01962103|12425170|P7|NOT COMPLETED|Phase 2||14
5049324|NCT01962103|12425171|P6|NOT COMPLETED|Phase 2||0
5049325|NCT01962103|12425172|P5|NOT COMPLETED|Phase 2||0
5049326|NCT01962103|12425173|P4|NOT COMPLETED|Phase 2||0
5049327|NCT01962103|12425174|P3|NOT COMPLETED|Phase 2||0
5049328|NCT01962103|12425175|P2|NOT COMPLETED|Phase 2||0
5049329|NCT01962103|12425176|P1|NOT COMPLETED|Phase 2||0
5049330|NCT01962103|12425168|P9|COMPLETED|Phase 2|completed treatment|0
5049331|NCT01962103|12425169|P8|COMPLETED|Phase 2|completed treatment|0
5049332|NCT01962103|12425170|P7|COMPLETED|Phase 2|completed treatment|0
5049333|NCT01962103|12425171|P6|COMPLETED|Phase 2||0
5049334|NCT01962103|12425172|P5|COMPLETED|Phase 2||0
5049335|NCT01962103|12425173|P4|COMPLETED|Phase 2||0
5049336|NCT01962103|12425174|P3|COMPLETED|Phase 2||0
5049337|NCT01962103|12425175|P2|COMPLETED|Phase 2||0
5049338|NCT01962103|12425176|P1|COMPLETED|Phase 2||0
5049339|NCT01962103|12425168|P9|STARTED|Phase 2||14
5049340|NCT01962103|12425169|P8|STARTED|Phase 2||14
5049341|NCT01962103|12425170|P7|STARTED|Phase 2||14
5049342|NCT01962103|12425171|P6|STARTED|Phase 2||0
5049343|NCT01962103|12425172|P5|STARTED|Phase 2||0
5049344|NCT01962103|12425173|P4|STARTED|Phase 2||0
5049345|NCT01962103|12425174|P3|STARTED|Phase 2||0
5049346|NCT01962103|12425175|P2|STARTED|Phase 2||0
5049347|NCT01962103|12425176|P1|STARTED|Phase 2||0
5049348|NCT01962103|12425168|P9|NOT COMPLETED|Phase 1||0
5049349|NCT01962103|12425169|P8|NOT COMPLETED|Phase 1||0
5049350|NCT01962103|12425170|P7|NOT COMPLETED|Phase 1||0
5049351|NCT01962103|12425171|P6|NOT COMPLETED|Phase 1||7
5049352|NCT01962103|12425172|P5|NOT COMPLETED|Phase 1||8
5049353|NCT01962103|12425173|P4|NOT COMPLETED|Phase 1||11
5049354|NCT01962103|12425174|P3|NOT COMPLETED|Phase 1||14
5049355|NCT01962103|12425175|P2|NOT COMPLETED|Phase 1||8
5049356|NCT01962103|12425176|P1|NOT COMPLETED|Phase 1||16
5049357|NCT01962103|12425168|P9|COMPLETED|Phase 1||0
5049358|NCT01962103|12425169|P8|COMPLETED|Phase 1||0
5049359|NCT01962103|12425170|P7|COMPLETED|Phase 1||0
5049360|NCT01962103|12425171|P6|COMPLETED|Phase 1||0
5049361|NCT01962103|12425172|P5|COMPLETED|Phase 1||0
5049362|NCT01962103|12425173|P4|COMPLETED|Phase 1||0
5049363|NCT01962103|12425174|P3|COMPLETED|Phase 1||0
5049364|NCT01962103|12425175|P2|COMPLETED|Phase 1||0
5049365|NCT01962103|12425176|P1|COMPLETED|Phase 1||0
5049366|NCT01962103|12425168|P9|STARTED|Phase 1||0
5049367|NCT01962103|12425169|P8|STARTED|Phase 1||0
5049368|NCT01962103|12425170|P7|STARTED|Phase 1||0
5049369|NCT01962103|12425171|P6|STARTED|Phase 1||7
5049370|NCT01962103|12425172|P5|STARTED|Phase 1||8
5049371|NCT01962103|12425173|P4|STARTED|Phase 1||11
5049372|NCT01962103|12425174|P3|STARTED|Phase 1||14
5049373|NCT01962103|12425175|P2|STARTED|Phase 1||8
5049374|NCT01962103|12425176|P1|STARTED|Phase 1||16
5049375|NCT01961921|12425276|P1|NOT COMPLETED|Overall Study||2
5049376|NCT01961921|12425276|P1|COMPLETED|Overall Study||25
5049377|NCT01961921|12425276|P1|STARTED|Overall Study||27
5049378|NCT01961609|12425288|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
5049379|NCT01961609|12425289|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
5049380|NCT01961609|12425290|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
5049381|NCT01961609|12425291|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
5049382|NCT01961609|12425288|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
5049383|NCT01961609|12425289|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
5049384|NCT01961609|12425290|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
5049385|NCT01961609|12425291|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
5049386|NCT01961609|12425288|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
5049387|NCT01961609|12425289|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
5049388|NCT01961609|12425290|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
5049389|NCT01961609|12425291|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
5049390|NCT01961609|12425288|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
5049391|NCT01961609|12425289|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
5049392|NCT01961609|12425290|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
5049393|NCT01961609|12425291|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
5049394|NCT01961609|12425288|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
5049395|NCT01961609|12425289|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
5049396|NCT01961609|12425290|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
5049397|NCT01961609|12425291|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
5049398|NCT01961609|12425288|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
5049399|NCT01961609|12425289|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
5049400|NCT01961609|12425290|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
5049401|NCT01961609|12425291|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
5049402|NCT01961609|12425288|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
5049403|NCT01961609|12425289|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
5049404|NCT01961609|12425290|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
5049405|NCT01961609|12425291|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
5049406|NCT01961609|12425288|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
5049407|NCT01961609|12425289|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
5049408|NCT01961609|12425290|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
5049409|NCT01961609|12425291|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
5049410|NCT01961609|12425288|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
5049411|NCT01961609|12425289|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
5049412|NCT01961609|12425290|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
5049413|NCT01961609|12425291|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
5049414|NCT01961609|12425288|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
5049415|NCT01961609|12425289|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
5049416|NCT01961609|12425290|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
5049417|NCT01961609|12425291|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
5049418|NCT01961609|12425288|P4|NOT COMPLETED|Initiation||0
5049419|NCT01961609|12425289|P3|NOT COMPLETED|Initiation||0
5049420|NCT01961609|12425290|P2|NOT COMPLETED|Initiation||13
5049421|NCT01961609|12425291|P1|NOT COMPLETED|Initiation||12
5049422|NCT01961609|12425288|P4|COMPLETED|Initiation||0
5049423|NCT01961609|12425289|P3|COMPLETED|Initiation||0
5049424|NCT01961609|12425290|P2|COMPLETED|Initiation||103
5049425|NCT01961609|12425291|P1|COMPLETED|Initiation||107
5049426|NCT01961609|12425288|P4|Full Analysis Set|Initiation||0
5049427|NCT01961609|12425289|P3|Full Analysis Set|Initiation||0
5049428|NCT01961609|12425290|P2|Full Analysis Set|Initiation||115
5049429|NCT01961609|12425291|P1|Full Analysis Set|Initiation||118
5049430|NCT01961609|12425288|P4|Safety Set|Initiation||0
5049431|NCT01961609|12425289|P3|Safety Set|Initiation||0
5049432|NCT01961609|12425290|P2|Safety Set|Initiation||115
5049433|NCT01961609|12425291|P1|Safety Set|Initiation||118
5049434|NCT01961609|12425288|P4|STARTED|Initiation||0
5049435|NCT01961609|12425289|P3|STARTED|Initiation||0
5049436|NCT01961609|12425290|P2|STARTED|Initiation||116
5049437|NCT01961609|12425291|P1|STARTED|Initiation||119
5049438|NCT01961544|12425343|P1|NOT COMPLETED|Overall Study||13
5049439|NCT01961544|12425343|P1|COMPLETED|Overall Study||88
5049440|NCT01961544|12425343|P1|STARTED|Overall Study||101
5049441|NCT01961362|12425348|P1|NOT COMPLETED|Overall Study||0
5049442|NCT01961362|12425348|P1|COMPLETED|Overall Study||19
5049443|NCT01961362|12425348|P1|STARTED|Overall Study||19
5049444|NCT01961349|12425357|P3|NOT COMPLETED|Overall Study||2
5049445|NCT01961349|12425358|P2|NOT COMPLETED|Overall Study||6
5049446|NCT01961349|12425359|P1|NOT COMPLETED|Overall Study||3
5049447|NCT01961349|12425357|P3|COMPLETED|Overall Study||109
5049448|NCT01961349|12425358|P2|COMPLETED|Overall Study||101
5049449|NCT01961349|12425359|P1|COMPLETED|Overall Study||51
5049450|NCT01961349|12425357|P3|STARTED|Overall Study||111
5049451|NCT01961349|12425358|P2|STARTED|Overall Study||107
5049452|NCT01961349|12425359|P1|STARTED|Overall Study||54
5049453|NCT01961323|12425370|P1|NOT COMPLETED|Overall Study||49
5049454|NCT01961323|12425370|P1|COMPLETED|Overall Study||21
5049455|NCT01961323|12425370|P1|STARTED|Overall Study||70
5049456|NCT01961297|12425378|P2|NOT COMPLETED|Overall Study||1
5049457|NCT01961297|12425379|P1|NOT COMPLETED|Overall Study||2
5049458|NCT01961297|12425378|P2|COMPLETED|Overall Study||22
5049459|NCT01961297|12425379|P1|COMPLETED|Overall Study||28
5049460|NCT01961297|12425378|P2|STARTED|Overall Study||23
5049461|NCT01961297|12425379|P1|STARTED|Overall Study||30
5049462|NCT01961271|12425393|P1|NOT COMPLETED|Overall Study||50
5049463|NCT01961271|12425393|P1|COMPLETED|Overall Study||64
5049464|NCT01961271|12425393|P1|STARTED|Overall Study||114
5049465|NCT01961167|12425402|P1|NOT COMPLETED|Overall Study||0
5049466|NCT01961167|12425402|P1|COMPLETED|Overall Study||27
5049467|NCT01961167|12425402|P1|STARTED|Overall Study||27
5049468|NCT01961115|12425443|P3|NOT COMPLETED|Overall Study||4
5049469|NCT01961115|12425444|P2|NOT COMPLETED|Overall Study||0
5049470|NCT01961115|12425445|P1|NOT COMPLETED|Overall Study||2
5049471|NCT01961115|12425443|P3|COMPLETED|Overall Study||5
5049472|NCT01961115|12425444|P2|COMPLETED|Overall Study||0
5049473|NCT01961115|12425445|P1|COMPLETED|Overall Study||0
5049474|NCT01961115|12425443|P3|STARTED|Overall Study||9
5049475|NCT01961115|12425444|P2|STARTED|Overall Study||0
5049476|NCT01961115|12425445|P1|STARTED|Overall Study||2
5049477|NCT01961089|12425480|P1|NOT COMPLETED|Overall Study||0
5049478|NCT01961089|12425480|P1|COMPLETED|Overall Study||40
5049479|NCT01961089|12425480|P1|STARTED|Overall Study||40
5049480|NCT01960907|12425488|P2|NOT COMPLETED|Overall Study||45
5049481|NCT01960907|12425489|P1|NOT COMPLETED|Overall Study||36
5049482|NCT01960907|12425488|P2|COMPLETED|Overall Study||109
5049483|NCT01960907|12425489|P1|COMPLETED|Overall Study||122
5049484|NCT01960907|12425488|P2|STARTED|Overall Study||154
5049485|NCT01960907|12425489|P1|STARTED|Overall Study||158
5049486|NCT01960855|12425504|P5|NOT COMPLETED|Overall Study||5
5049487|NCT01960855|12425505|P4|NOT COMPLETED|Overall Study||4
5049488|NCT01960855|12425506|P3|NOT COMPLETED|Overall Study||9
5049489|NCT01960855|12425507|P2|NOT COMPLETED|Overall Study||4
5049490|NCT01960855|12425508|P1|NOT COMPLETED|Overall Study||11
5049491|NCT01960855|12425504|P5|COMPLETED|Overall Study||50
5049492|NCT01960855|12425505|P4|COMPLETED|Overall Study||51
5049493|NCT01960855|12425506|P3|COMPLETED|Overall Study||46
5049494|NCT01960855|12425507|P2|COMPLETED|Overall Study||51
5049495|NCT01960855|12425508|P1|COMPLETED|Overall Study||45
5049496|NCT01960855|12425504|P5|STARTED|Overall Study||55
5049497|NCT01960855|12425505|P4|STARTED|Overall Study||55
5049498|NCT01960855|12425506|P3|STARTED|Overall Study||55
5049499|NCT01960855|12425507|P2|STARTED|Overall Study||55
5049500|NCT01960855|12425508|P1|STARTED|Overall Study||56
5049501|NCT01960842|12425540|P1|NOT COMPLETED|Overall Study||3
5049502|NCT01960842|12425540|P1|COMPLETED|Overall Study||28
5049503|NCT01960842|12425540|P1|STARTED|Overall Study||31
5049504|NCT01960816|12425563|P1|NOT COMPLETED|Overall Study||1
5049505|NCT01960816|12425563|P1|COMPLETED|Overall Study||32
5049506|NCT01960816|12425563|P1|STARTED|Overall Study||33
5049507|NCT01960790|12425569|P1|NOT COMPLETED|Overall Study||11
5049508|NCT01960790|12425569|P1|COMPLETED|Overall Study||462
5049509|NCT01960790|12425569|P1|STARTED|Overall Study||473
5049510|NCT01960725|12425581|P2|NOT COMPLETED|Overall Study||5
5049511|NCT01960725|12425582|P1|NOT COMPLETED|Overall Study||6
5049512|NCT01960725|12425581|P2|COMPLETED|Overall Study||28
5049513|NCT01960725|12425582|P1|COMPLETED|Overall Study||27
5049514|NCT01960725|12425581|P2|Received Third Vaccine|Overall Study||32
5049515|NCT01960725|12425582|P1|Received Third Vaccine|Overall Study||32
5049516|NCT01960725|12425581|P2|Recieved Second Vaccine|Overall Study||33
5049517|NCT01960725|12425582|P1|Recieved Second Vaccine|Overall Study||33
5049518|NCT01960725|12425581|P2|Received First Vaccine|Overall Study||33
5049519|NCT01960725|12425582|P1|Received First Vaccine|Overall Study||33
5049520|NCT01960725|12425581|P2|STARTED|Overall Study||33
5049521|NCT01960725|12425582|P1|STARTED|Overall Study||33
5049522|NCT01960530|12425604|P1|NOT COMPLETED|Overall Study||0
5049523|NCT01960530|12425604|P1|COMPLETED|Overall Study||14
5049524|NCT01960530|12425604|P1|STARTED|Overall Study||14
5049525|NCT01960413|12425639|P2|NOT COMPLETED|Overall Study||1
5049526|NCT01960413|12425640|P1|NOT COMPLETED|Overall Study||4
5049527|NCT01960413|12425639|P2|COMPLETED|Overall Study||21
5049528|NCT01960413|12425640|P1|COMPLETED|Overall Study||20
5049529|NCT01960413|12425639|P2|STARTED|Overall Study||22
5049530|NCT01960413|12425640|P1|STARTED|Overall Study||24
5049531|NCT01960400|12425648|P2|NOT COMPLETED|Overall Study||0
5049532|NCT01960400|12425649|P1|NOT COMPLETED|Overall Study||0
5049533|NCT01960400|12425648|P2|COMPLETED|Overall Study||11
5049534|NCT01960400|12425649|P1|COMPLETED|Overall Study||11
5049535|NCT01960400|12425648|P2|STARTED|Overall Study||11
5049536|NCT01960400|12425649|P1|STARTED|Overall Study||11
5049537|NCT01960387|12425661|P1|NOT COMPLETED|Overall Study||0
5049538|NCT01960387|12425661|P1|COMPLETED|Overall Study||2
5049539|NCT01960387|12425661|P1|STARTED|Overall Study||2
5049540|NCT01960348|12425670|P2|NOT COMPLETED|Overall Study||22
5049541|NCT01960348|12425671|P1|NOT COMPLETED|Overall Study||10
5049542|NCT01960348|12425670|P2|COMPLETED|Overall Study||55
5049543|NCT01960348|12425671|P1|COMPLETED|Overall Study||138
5049544|NCT01960348|12425670|P2|STARTED|Overall Study||77
5049545|NCT01960348|12425671|P1|STARTED|Overall Study||148
5049546|NCT01960296|12425691|P2|NOT COMPLETED|Overall Study||3
5049547|NCT01960296|12425692|P1|NOT COMPLETED|Overall Study||2
5049548|NCT01960296|12425691|P2|COMPLETED|Overall Study||22
5049549|NCT01960296|12425692|P1|COMPLETED|Overall Study||21
5049550|NCT01960296|12425691|P2|STARTED|Overall Study||25
5049551|NCT01960296|12425692|P1|STARTED|Overall Study||23
5049552|NCT01960140|12425712|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
5049553|NCT01960140|12425712|P1|COMPLETED|Period 2 (Days 3-18)||38
5049554|NCT01960140|12425712|P1|Received Simvastatin|Period 2 (Days 3-18)||38
5049555|NCT01960140|12425712|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
5049556|NCT01960140|12425712|P1|STARTED|Period 2 (Days 3-18)||40
5049557|NCT01960140|12425712|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
5049558|NCT01960140|12425712|P1|COMPLETED|Period 1 (Days 1-2)||40
5049559|NCT01960140|12425712|P1|Received Simvastatin|Period 1 (Days 1-2)||40
5049560|NCT01960140|12425712|P1|STARTED|Period 1 (Days 1-2)||40
5049561|NCT01960114|12425723|P2|NOT COMPLETED|Overall Study||1
5049562|NCT01960114|12425724|P1|NOT COMPLETED|Overall Study||1
5049563|NCT01960114|12425723|P2|COMPLETED|Overall Study||268
5049564|NCT01960114|12425724|P1|COMPLETED|Overall Study||133
5049565|NCT01960114|12425723|P2|STARTED|Overall Study||269
5049566|NCT01960114|12425724|P1|STARTED|Overall Study||134
5049567|NCT01960075|12425741|P3|NOT COMPLETED|Overall Study||7
5049568|NCT01960075|12425742|P2|NOT COMPLETED|Overall Study||3
5049569|NCT01960075|12425743|P1|NOT COMPLETED|Overall Study||8
5049570|NCT01960075|12425741|P3|COMPLETED|Overall Study||173
5049571|NCT01960075|12425742|P2|COMPLETED|Overall Study||146
5049572|NCT01960075|12425743|P1|COMPLETED|Overall Study||141
5049573|NCT01960075|12425741|P3|STARTED|Overall Study||180
5049574|NCT01960075|12425742|P2|STARTED|Overall Study||149
5049575|NCT01960075|12425743|P1|STARTED|Overall Study||149
5049576|NCT01959945|12425803|P4|NOT COMPLETED|Overall Study||16
5049577|NCT01959945|12425804|P3|NOT COMPLETED|Overall Study||19
5049578|NCT01959945|12425805|P2|NOT COMPLETED|Overall Study||3
5049579|NCT01959945|12425806|P1|NOT COMPLETED|Overall Study||4
5049580|NCT01959945|12425803|P4|COMPLETED|Overall Study||15
5049581|NCT01959945|12425804|P3|COMPLETED|Overall Study||9
5049582|NCT01959945|12425805|P2|COMPLETED|Overall Study||75
5049583|NCT01959945|12425806|P1|COMPLETED|Overall Study||76
5049584|NCT01959945|12425803|P4|STARTED|Overall Study||31
5049585|NCT01959945|12425804|P3|STARTED|Overall Study||28
5049586|NCT01959945|12425805|P2|STARTED|Overall Study||78
5049587|NCT01959945|12425806|P1|STARTED|Overall Study||80
5049588|NCT01959932|12425831|P3|NOT COMPLETED|Overall Study||0
5049589|NCT01959932|12425832|P2|NOT COMPLETED|Overall Study||0
5049590|NCT01959932|12425833|P1|NOT COMPLETED|Overall Study||1
5049591|NCT01959932|12425831|P3|COMPLETED|Overall Study||39
5049592|NCT01959932|12425832|P2|COMPLETED|Overall Study||41
5049593|NCT01959932|12425833|P1|COMPLETED|Overall Study||79
5049594|NCT01959932|12425831|P3|STARTED|Overall Study||39
5049595|NCT01959932|12425832|P2|STARTED|Overall Study||41
5049596|NCT01959932|12425833|P1|STARTED|Overall Study||80
5049597|NCT01959919|12425851|P1|NOT COMPLETED|Overall Study||2
5049598|NCT01959919|12425851|P1|COMPLETED|Overall Study||84
5049599|NCT01959919|12425851|P1|STARTED|Overall Study||86
5049600|NCT01959880|12425865|P4|NOT COMPLETED|Overall Study||181
5049601|NCT01959880|12425866|P3|NOT COMPLETED|Overall Study||208
5049602|NCT01959880|12425867|P2|NOT COMPLETED|Overall Study||369
5049603|NCT01959880|12425868|P1|NOT COMPLETED|Overall Study||1132
5049604|NCT01959880|12425865|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
5049605|NCT01959880|12425866|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
5049606|NCT01959880|12425867|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
5049607|NCT01959880|12425868|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
5049608|NCT01959880|12425865|P4|STARTED|Overall Study||181
5049609|NCT01959880|12425866|P3|STARTED|Overall Study||209
5049610|NCT01959880|12425867|P2|STARTED|Overall Study||369
5049611|NCT01959880|12425868|P1|STARTED|Overall Study||1132
5049612|NCT01959841|12425893|P3|NOT COMPLETED|Overall Study||43
5049613|NCT01959841|12425894|P2|NOT COMPLETED|Overall Study||57
5049614|NCT01959841|12425895|P1|NOT COMPLETED|Overall Study||43
5049615|NCT01959841|12425893|P3|COMPLETED|Overall Study||206
5049616|NCT01959841|12425894|P2|COMPLETED|Overall Study||193
5049617|NCT01959841|12425895|P1|COMPLETED|Overall Study||209
5049618|NCT01959841|12425893|P3|Reason FAS Excluding 3|Overall Study||0
5049619|NCT01959841|12425894|P2|Reason FAS Excluding 3|Overall Study||1
5049620|NCT01959841|12425895|P1|Reason FAS Excluding 3|Overall Study||0
5049621|NCT01959841|12425893|P3|Reason FAS Excluding 2|Overall Study||0
5049622|NCT01959841|12425894|P2|Reason FAS Excluding 2|Overall Study||1
5049623|NCT01959841|12425895|P1|Reason FAS Excluding 2|Overall Study||0
5049624|NCT01959841|12425893|P3|Reason FAS Excluding 1|Overall Study||4
5049625|NCT01959841|12425894|P2|Reason FAS Excluding 1|Overall Study||5
5049626|NCT01959841|12425895|P1|Reason FAS Excluding 1|Overall Study||5
5049627|NCT01959841|12425893|P3|Full Analysis Set Excluded|Overall Study||4
5049628|NCT01959841|12425894|P2|Full Analysis Set Excluded|Overall Study||7
5049629|NCT01959841|12425895|P1|Full Analysis Set Excluded|Overall Study||5
5049630|NCT01959841|12425893|P3|Full Analysis Set Included|Overall Study||245
5049631|NCT01959841|12425894|P2|Full Analysis Set Included|Overall Study||243
5049632|NCT01959841|12425895|P1|Full Analysis Set Included|Overall Study||247
5049633|NCT01959841|12425893|P3|STARTED|Overall Study||249
5049634|NCT01959841|12425894|P2|STARTED|Overall Study||250
5049635|NCT01959841|12425895|P1|STARTED|Overall Study||252
5049636|NCT01959685|12425918|P1|NOT COMPLETED|Overall Study||0
5049637|NCT01959685|12425918|P1|COMPLETED|Overall Study||9
5049638|NCT01959685|12425918|P1|STARTED|Overall Study||9
5049639|NCT01959672|12425923|P1|NOT COMPLETED|Overall Study||1
5049640|NCT01959672|12425923|P1|COMPLETED|Overall Study||10
5049641|NCT01959672|12425923|P1|STARTED|Overall Study||11
5049642|NCT01959607|12425934|P4|NOT COMPLETED|Second Intervention (Day 3)||0
5049643|NCT01959607|12425935|P3|NOT COMPLETED|Second Intervention (Day 3)||0
5049644|NCT01959607|12425936|P2|NOT COMPLETED|Second Intervention (Day 3)||0
5049645|NCT01959607|12425937|P1|NOT COMPLETED|Second Intervention (Day 3)||0
5049646|NCT01959607|12425934|P4|COMPLETED|Second Intervention (Day 3)||9
5049647|NCT01959607|12425935|P3|COMPLETED|Second Intervention (Day 3)||9
5049648|NCT01959607|12425936|P2|COMPLETED|Second Intervention (Day 3)||21
5049649|NCT01959607|12425937|P1|COMPLETED|Second Intervention (Day 3)||21
5049650|NCT01959607|12425934|P4|STARTED|Second Intervention (Day 3)||9
5049651|NCT01959607|12425935|P3|STARTED|Second Intervention (Day 3)||9
5049652|NCT01959607|12425936|P2|STARTED|Second Intervention (Day 3)||21
5049653|NCT01959607|12425937|P1|STARTED|Second Intervention (Day 3)||21
5049654|NCT01959607|12425934|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5049655|NCT01959607|12425935|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5049656|NCT01959607|12425936|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5049657|NCT01959607|12425937|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5049658|NCT01959607|12425934|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
5049659|NCT01959607|12425935|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
5049660|NCT01959607|12425936|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
5049661|NCT01959607|12425937|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
5049662|NCT01959607|12425934|P4|STARTED|Washout Period of 1 Day (Day 2)||9
5049663|NCT01959607|12425935|P3|STARTED|Washout Period of 1 Day (Day 2)||9
5049664|NCT01959607|12425936|P2|STARTED|Washout Period of 1 Day (Day 2)||21
5049665|NCT01959607|12425937|P1|STARTED|Washout Period of 1 Day (Day 2)||21
5049666|NCT01959607|12425934|P4|NOT COMPLETED|First Intervention (Day 1)||0
5049667|NCT01959607|12425935|P3|NOT COMPLETED|First Intervention (Day 1)||0
5049668|NCT01959607|12425936|P2|NOT COMPLETED|First Intervention (Day 1)||1
5049669|NCT01959607|12425937|P1|NOT COMPLETED|First Intervention (Day 1)||1
5049670|NCT01959607|12425934|P4|COMPLETED|First Intervention (Day 1)||9
5049671|NCT01959607|12425935|P3|COMPLETED|First Intervention (Day 1)||9
5049672|NCT01959607|12425936|P2|COMPLETED|First Intervention (Day 1)||21
5049673|NCT01959607|12425937|P1|COMPLETED|First Intervention (Day 1)||21
5049674|NCT01959607|12425934|P4|STARTED|First Intervention (Day 1)||9
5049675|NCT01959607|12425935|P3|STARTED|First Intervention (Day 1)||9
5049676|NCT01959607|12425936|P2|STARTED|First Intervention (Day 1)||22
5049677|NCT01959607|12425937|P1|STARTED|First Intervention (Day 1)||22
5049678|NCT01959607|12425934|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5049679|NCT01959607|12425935|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5049680|NCT01959607|12425936|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5049681|NCT01959607|12425937|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
5049682|NCT01959607|12425934|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
5049683|NCT01959607|12425935|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
5049684|NCT01959607|12425936|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
5049685|NCT01959607|12425937|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
5049686|NCT01959607|12425934|P4|STARTED|Washout Period of 1 Day (Day 0)||9
5049687|NCT01959607|12425935|P3|STARTED|Washout Period of 1 Day (Day 0)||9
5049688|NCT01959607|12425936|P2|STARTED|Washout Period of 1 Day (Day 0)||22
5049689|NCT01959607|12425937|P1|STARTED|Washout Period of 1 Day (Day 0)||22
5049690|NCT01959581|12425950|P1|NOT COMPLETED|Overall Study||5
5049691|NCT01959581|12425950|P1|COMPLETED|Overall Study||25
5049692|NCT01959581|12425950|P1|STARTED|Overall Study||30
5049693|NCT01959542|12425954|P1|NOT COMPLETED|Overall Study||3
5049694|NCT01959542|12425954|P1|COMPLETED|Overall Study||12
5049695|NCT01959542|12425954|P1|Evaluable at Visit 2|Overall Study||12
5049696|NCT01959542|12425954|P1|Evaluable at Visit 1|Overall Study||12
5049697|NCT01959542|12425954|P1|STARTED|Overall Study||15
5049698|NCT01959529|12425961|P2|NOT COMPLETED|Overall Study||72
5049699|NCT01959529|12425962|P1|NOT COMPLETED|Overall Study||76
5049700|NCT01959529|12425961|P2|COMPLETED|Overall Study||3747
5049701|NCT01959529|12425962|P1|COMPLETED|Overall Study||3742
5049702|NCT01959529|12425961|P2|Exposed|Overall Study||3806
5049703|NCT01959529|12425962|P1|Exposed|Overall Study||3809
5049704|NCT01959529|12425961|P2|STARTED|Overall Study||3819
5049705|NCT01959529|12425962|P1|STARTED|Overall Study||3818
5049706|NCT01959516|12425974|P2|NOT COMPLETED|Epoch 2||1
5049707|NCT01959516|12425975|P1|NOT COMPLETED|Epoch 2||2
5049708|NCT01959516|12425974|P2|COMPLETED|Epoch 2||62
5049709|NCT01959516|12425975|P1|COMPLETED|Epoch 2||61
5049710|NCT01959516|12425974|P2|STARTED|Epoch 2||63
5049711|NCT01959516|12425975|P1|STARTED|Epoch 2||63
5049712|NCT01959516|12425974|P2|NOT COMPLETED|Epoch 1||5
5049713|NCT01959516|12425975|P1|NOT COMPLETED|Epoch 1||10
5049714|NCT01959516|12425974|P2|COMPLETED|Epoch 1||58
5049715|NCT01959516|12425975|P1|COMPLETED|Epoch 1||53
5049716|NCT01959516|12425974|P2|ITT Population|Epoch 1||62
5049717|NCT01959516|12425975|P1|ITT Population|Epoch 1||62
5049718|NCT01959516|12425974|P2|Safety Population|Epoch 1||62
5049719|NCT01959516|12425975|P1|Safety Population|Epoch 1||62
5049720|NCT01959516|12425974|P2|STARTED|Epoch 1||63
5049721|NCT01959516|12425975|P1|STARTED|Epoch 1||63
5049722|NCT01959503|12425985|P2|NOT COMPLETED|Overall Study||2
5049723|NCT01959503|12425986|P1|NOT COMPLETED|Overall Study||3
5049724|NCT01959503|12425985|P2|COMPLETED|Overall Study||49
5049725|NCT01959503|12425986|P1|COMPLETED|Overall Study||104
5049726|NCT01959503|12425985|P2|STARTED|Overall Study||51
5049727|NCT01959503|12425986|P1|STARTED|Overall Study||107
5049728|NCT01959490|12426009|P3|NOT COMPLETED|Overall Study||0
5049729|NCT01959490|12426010|P2|NOT COMPLETED|Overall Study||0
5049730|NCT01959490|12426011|P1|NOT COMPLETED|Overall Study||0
5049731|NCT01959490|12426009|P3|COMPLETED|Overall Study||5
5049732|NCT01959490|12426010|P2|COMPLETED|Overall Study||6
5049733|NCT01959490|12426011|P1|COMPLETED|Overall Study||5
5049734|NCT01959490|12426009|P3|STARTED|Overall Study||5
5049735|NCT01959490|12426010|P2|STARTED|Overall Study||6
5049736|NCT01959490|12426011|P1|STARTED|Overall Study||5
5049737|NCT01959412|12426037|P6|NOT COMPLETED|Overall Study||0
5049738|NCT01959412|12426038|P5|NOT COMPLETED|Overall Study||3
5049739|NCT01959412|12426039|P4|NOT COMPLETED|Overall Study||2
5049740|NCT01959412|12426040|P3|NOT COMPLETED|Overall Study||0
5049741|NCT01959412|12426041|P2|NOT COMPLETED|Overall Study||1
5049742|NCT01959412|12426042|P1|NOT COMPLETED|Overall Study||1
5049743|NCT01959412|12426037|P6|COMPLETED|Overall Study||15
5049744|NCT01959412|12426038|P5|COMPLETED|Overall Study||13
5049745|NCT01959412|12426039|P4|COMPLETED|Overall Study||13
5049746|NCT01959412|12426040|P3|COMPLETED|Overall Study||15
5049747|NCT01959412|12426041|P2|COMPLETED|Overall Study||14
5049748|NCT01959412|12426042|P1|COMPLETED|Overall Study||14
5049749|NCT01959412|12426037|P6|STARTED|Overall Study||15
5049750|NCT01959412|12426038|P5|STARTED|Overall Study||16
5049751|NCT01959412|12426039|P4|STARTED|Overall Study||15
5049752|NCT01959412|12426040|P3|STARTED|Overall Study||15
5049753|NCT01959412|12426041|P2|STARTED|Overall Study||15
5049754|NCT01959412|12426042|P1|STARTED|Overall Study||15
5049755|NCT01959347|12426082|P2|NOT COMPLETED|Overall Study||7
5049756|NCT01959347|12426083|P1|NOT COMPLETED|Overall Study||9
5049757|NCT01959347|12426082|P2|COMPLETED|Overall Study||235
5049758|NCT01959347|12426083|P1|COMPLETED|Overall Study||229
5049759|NCT01959347|12426082|P2|STARTED|Overall Study||242
5049760|NCT01959347|12426083|P1|STARTED|Overall Study||238
5049761|NCT01959334|12426189|P2|NOT COMPLETED|Third Dose||1
5049762|NCT01959334|12426190|P1|NOT COMPLETED|Third Dose||0
5049763|NCT01959334|12426189|P2|COMPLETED|Third Dose||48
5049764|NCT01959334|12426190|P1|COMPLETED|Third Dose||25
5049765|NCT01959334|12426189|P2|STARTED|Third Dose||49
5049766|NCT01959334|12426190|P1|STARTED|Third Dose||25
5049767|NCT01959334|12426189|P2|NOT COMPLETED|Second Dose||0
5049768|NCT01959334|12426190|P1|NOT COMPLETED|Second Dose||1
5049769|NCT01959334|12426189|P2|COMPLETED|Second Dose||49
5049770|NCT01959334|12426190|P1|COMPLETED|Second Dose||25
5049771|NCT01959334|12426189|P2|STARTED|Second Dose||49
5049772|NCT01959334|12426190|P1|STARTED|Second Dose||26
5049773|NCT01959334|12426189|P2|NOT COMPLETED|First Dose||0
5049774|NCT01959334|12426190|P1|NOT COMPLETED|First Dose||0
5049775|NCT01959334|12426189|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
5049776|NCT01959334|12426190|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
5049777|NCT01959334|12426189|P2|STARTED|First Dose||49
5049778|NCT01959334|12426190|P1|STARTED|First Dose||26
5049779|NCT01959243|12426202|P2|NOT COMPLETED|Overall Study||4
5049780|NCT01959243|12426203|P1|NOT COMPLETED|Overall Study||13
5049781|NCT01959243|12426202|P2|COMPLETED|Overall Study||166
5049782|NCT01959243|12426203|P1|COMPLETED|Overall Study||324
5049783|NCT01959243|12426202|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
5049784|NCT01959243|12426203|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
5049785|NCT01959243|12426202|P2|STARTED|Overall Study||170
5049786|NCT01959243|12426203|P1|STARTED|Overall Study||337
5049787|NCT01959230|12426215|P2|NOT COMPLETED|Overall Study||1
5049788|NCT01959230|12426216|P1|NOT COMPLETED|Overall Study||4
5049789|NCT01959230|12426215|P2|COMPLETED|Overall Study||19
5049790|NCT01959230|12426216|P1|COMPLETED|Overall Study||36
5049791|NCT01959230|12426215|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
5049792|NCT01959230|12426216|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
5049793|NCT01959230|12426215|P2|STARTED|Overall Study||20
5049794|NCT01959230|12426216|P1|STARTED|Overall Study||40
5049795|NCT01959165|12426230|P4|NOT COMPLETED|Overall Study||2
5049796|NCT01959165|12426231|P3|NOT COMPLETED|Overall Study||0
5049797|NCT01959165|12426232|P2|NOT COMPLETED|Overall Study||1
5049798|NCT01959165|12426233|P1|NOT COMPLETED|Overall Study||1
5049799|NCT01959165|12426230|P4|COMPLETED|Overall Study||7
5049800|NCT01959165|12426231|P3|COMPLETED|Overall Study||12
5049801|NCT01959165|12426232|P2|COMPLETED|Overall Study||10
5049802|NCT01959165|12426233|P1|COMPLETED|Overall Study||12
5049803|NCT01959165|12426230|P4|STARTED|Overall Study||9
5049804|NCT01959165|12426231|P3|STARTED|Overall Study||12
5049805|NCT01959165|12426232|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
5049806|NCT01959165|12426233|P1|STARTED|Overall Study||13
5049807|NCT01959139|12426259|P4|NOT COMPLETED|Phase II||55
5049808|NCT01959139|12426260|P3|NOT COMPLETED|Phase II||56
5049809|NCT01959139|12426261|P2|NOT COMPLETED|Phase II||0
5049810|NCT01959139|12426262|P1|NOT COMPLETED|Phase II||0
5049811|NCT01959139|12426259|P4|COMPLETED|Phase II||0
5049812|NCT01959139|12426260|P3|COMPLETED|Phase II||0
5049813|NCT01959139|12426261|P2|COMPLETED|Phase II||0
5049814|NCT01959139|12426262|P1|COMPLETED|Phase II||0
5049815|NCT01959139|12426259|P4|Assessed for AEs|Phase II||51
5049816|NCT01959139|12426260|P3|Assessed for AEs|Phase II||54
5049817|NCT01959139|12426261|P2|Assessed for AEs|Phase II||0
5049818|NCT01959139|12426262|P1|Assessed for AEs|Phase II||0
5049819|NCT01959139|12426259|P4|STARTED|Phase II||55
5049820|NCT01959139|12426260|P3|STARTED|Phase II||56
5049821|NCT01959139|12426261|P2|STARTED|Phase II||0
5049822|NCT01959139|12426262|P1|STARTED|Phase II||0
5049823|NCT01959139|12426259|P4|NOT COMPLETED|Phase I: Cohort 2||0
5049824|NCT01959139|12426260|P3|NOT COMPLETED|Phase I: Cohort 2||0
5049825|NCT01959139|12426261|P2|NOT COMPLETED|Phase I: Cohort 2||0
5049826|NCT01959139|12426262|P1|NOT COMPLETED|Phase I: Cohort 2||0
5049827|NCT01959139|12426259|P4|COMPLETED|Phase I: Cohort 2||0
5049828|NCT01959139|12426260|P3|COMPLETED|Phase I: Cohort 2||0
5049829|NCT01959139|12426261|P2|COMPLETED|Phase I: Cohort 2||6
5049830|NCT01959139|12426262|P1|COMPLETED|Phase I: Cohort 2||0
5049831|NCT01959139|12426259|P4|STARTED|Phase I: Cohort 2||0
5049832|NCT01959139|12426260|P3|STARTED|Phase I: Cohort 2||0
5049833|NCT01959139|12426261|P2|STARTED|Phase I: Cohort 2||6
5049834|NCT01959139|12426262|P1|STARTED|Phase I: Cohort 2||0
5049835|NCT01959139|12426259|P4|NOT COMPLETED|Phase I: Cohort 1||0
5049836|NCT01959139|12426260|P3|NOT COMPLETED|Phase I: Cohort 1||0
5049837|NCT01959139|12426261|P2|NOT COMPLETED|Phase I: Cohort 1||0
5049838|NCT01959139|12426262|P1|NOT COMPLETED|Phase I: Cohort 1||0
5049839|NCT01959139|12426259|P4|COMPLETED|Phase I: Cohort 1||0
5049840|NCT01959139|12426260|P3|COMPLETED|Phase I: Cohort 1||0
5049841|NCT01959139|12426261|P2|COMPLETED|Phase I: Cohort 1||0
5049842|NCT01959139|12426262|P1|COMPLETED|Phase I: Cohort 1||5
5049843|NCT01959139|12426259|P4|STARTED|Phase I: Cohort 1||0
5049844|NCT01959139|12426260|P3|STARTED|Phase I: Cohort 1||0
5049845|NCT01959139|12426261|P2|STARTED|Phase I: Cohort 1||0
5049846|NCT01959139|12426262|P1|STARTED|Phase I: Cohort 1||5
5049847|NCT01959113|12426281|P1|NOT COMPLETED|Overall Study||0
5049848|NCT01959113|12426281|P1|COMPLETED|Overall Study||5
5049849|NCT01959113|12426281|P1|STARTED|Overall Study||5
5049850|NCT01959048|12426287|P1|NOT COMPLETED|Overall Study||0
5049851|NCT01959048|12426287|P1|COMPLETED|Overall Study||3
5049852|NCT01959048|12426287|P1|STARTED|Overall Study||3
5049853|NCT01959035|12426295|P1|NOT COMPLETED|Overall Study||11
5049854|NCT01959035|12426295|P1|COMPLETED|Overall Study||77
5049855|NCT01959035|12426295|P1|STARTED|Overall Study||88
5049856|NCT01958918|12426323|P2|NOT COMPLETED|Overall Study||42
5049857|NCT01958918|12426324|P1|NOT COMPLETED|Overall Study||43
5049858|NCT01958918|12426323|P2|COMPLETED|Overall Study||314
5049859|NCT01958918|12426324|P1|COMPLETED|Overall Study||313
5049860|NCT01958918|12426323|P2|Full Analysis Set|Overall Study||354
5049861|NCT01958918|12426324|P1|Full Analysis Set|Overall Study||353
5049862|NCT01958918|12426323|P2|STARTED|Overall Study||356
5049863|NCT01958918|12426324|P1|STARTED|Overall Study||356
5049864|NCT01958827|12426338|P1|NOT COMPLETED|Overall Study||10
5049865|NCT01958827|12426338|P1|COMPLETED|Overall Study||18
5049866|NCT01958827|12426338|P1|STARTED|Overall Study||28
5049867|NCT01958788|12426356|P1|NOT COMPLETED|Overall Study||0
5049868|NCT01958788|12426356|P1|COMPLETED|Overall Study||7
5049869|NCT01958788|12426356|P1|STARTED|Overall Study||7
5049870|NCT01958671|12426369|P3|NOT COMPLETED|Overall Study||32
5049871|NCT01958671|12426370|P2|NOT COMPLETED|Overall Study||24
5049872|NCT01958671|12426371|P1|NOT COMPLETED|Overall Study||19
5049873|NCT01958671|12426369|P3|COMPLETED|Overall Study||121
5049874|NCT01958671|12426370|P2|COMPLETED|Overall Study||128
5049875|NCT01958671|12426371|P1|COMPLETED|Overall Study||137
5049876|NCT01958671|12426369|P3|STARTED|Overall Study||153
5049877|NCT01958671|12426370|P2|STARTED|Overall Study||152
5049878|NCT01958671|12426371|P1|STARTED|Overall Study||156
5049879|NCT01958645|12426415|P3|NOT COMPLETED|Overall Study||0
5049880|NCT01958645|12426416|P2|NOT COMPLETED|Overall Study||0
5049881|NCT01958645|12426417|P1|NOT COMPLETED|Overall Study||0
5049882|NCT01958645|12426415|P3|COMPLETED|Overall Study||4
5049883|NCT01958645|12426416|P2|COMPLETED|Overall Study||4
5049884|NCT01958645|12426417|P1|COMPLETED|Overall Study||4
5049885|NCT01958645|12426415|P3|STARTED|Overall Study||4
5049886|NCT01958645|12426416|P2|STARTED|Overall Study||4
5049887|NCT01958645|12426417|P1|STARTED|Overall Study||4
5049888|NCT01958619|12426445|P4|NOT COMPLETED|Overall Study||0
5049889|NCT01958619|12426446|P3|NOT COMPLETED|Overall Study||1
5049890|NCT01958619|12426447|P2|NOT COMPLETED|Overall Study||0
5049891|NCT01958619|12426448|P1|NOT COMPLETED|Overall Study||2
5049892|NCT01958619|12426445|P4|COMPLETED|Overall Study||12
5049893|NCT01958619|12426446|P3|COMPLETED|Overall Study||13
5049894|NCT01958619|12426447|P2|COMPLETED|Overall Study||14
5049895|NCT01958619|12426448|P1|COMPLETED|Overall Study||13
5049896|NCT01958619|12426445|P4|STARTED|Overall Study||12
5049897|NCT01958619|12426446|P3|STARTED|Overall Study||14
5049898|NCT01958619|12426447|P2|STARTED|Overall Study||14
5049899|NCT01958619|12426448|P1|STARTED|Overall Study||15
5049900|NCT01958606|12426470|P2|NOT COMPLETED|Overall Study||0
5049901|NCT01958606|12426471|P1|NOT COMPLETED|Overall Study||2
5049902|NCT01958606|12426470|P2|COMPLETED|Overall Study||5
5049903|NCT01958606|12426471|P1|COMPLETED|Overall Study||11
5049904|NCT01958606|12426470|P2|STARTED|Overall Study||5
5049905|NCT01958606|12426471|P1|STARTED|Overall Study||13
5049906|NCT01958489|12426509|P2|NOT COMPLETED|Period 2||1
5049907|NCT01958489|12426510|P1|NOT COMPLETED|Period 2||0
5049908|NCT01958489|12426509|P2|COMPLETED|Period 2||23
5049909|NCT01958489|12426510|P1|COMPLETED|Period 2||0
5049910|NCT01958489|12426509|P2|Received at Least 1 Dose of Study Drug|Period 2||24
5049911|NCT01958489|12426510|P1|Received at Least 1 Dose of Study Drug|Period 2||0
5049912|NCT01958489|12426509|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
5049913|NCT01958489|12426510|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
5049914|NCT01958489|12426509|P2|NOT COMPLETED|Period 1||0
5049915|NCT01958489|12426510|P1|NOT COMPLETED|Period 1||0
5049916|NCT01958489|12426509|P2|COMPLETED|Period 1||0
5049917|NCT01958489|12426510|P1|COMPLETED|Period 1||24
5049918|NCT01958489|12426509|P2|Received at Least 1 Dose of Study Drug|Period 1||0
5049919|NCT01958489|12426510|P1|Received at Least 1 Dose of Study Drug|Period 1||24
5049920|NCT01958489|12426509|P2|STARTED|Period 1||0
5049921|NCT01958489|12426510|P1|STARTED|Period 1||24
5049922|NCT01958476|12426526|P2|NOT COMPLETED|Overall Study||0
5049923|NCT01958476|12426527|P1|NOT COMPLETED|Overall Study||1
5049924|NCT01958476|12426526|P2|COMPLETED|Overall Study||58
5049925|NCT01958476|12426527|P1|COMPLETED|Overall Study||58
5049926|NCT01958476|12426526|P2|STARTED|Overall Study||58
5049927|NCT01958476|12426527|P1|STARTED|Overall Study||59
5049928|NCT01958437|12426557|P4|NOT COMPLETED|Overall Study||1
5049929|NCT01958437|12426558|P3|NOT COMPLETED|Overall Study||1
5049930|NCT01958437|12426559|P2|NOT COMPLETED|Overall Study||0
5049931|NCT01958437|12426560|P1|NOT COMPLETED|Overall Study||0
5049932|NCT01958437|12426557|P4|COMPLETED|Overall Study||10
5049933|NCT01958437|12426558|P3|COMPLETED|Overall Study||10
5049934|NCT01958437|12426559|P2|COMPLETED|Overall Study||11
5049935|NCT01958437|12426560|P1|COMPLETED|Overall Study||11
5049936|NCT01958437|12426557|P4|STARTED|Overall Study||11
5049937|NCT01958437|12426558|P3|STARTED|Overall Study||11
5049938|NCT01958437|12426559|P2|STARTED|Overall Study||11
5049939|NCT01958437|12426560|P1|STARTED|Overall Study||11
5049940|NCT01958346|12426584|P2|NOT COMPLETED|Overall Study||0
5049941|NCT01958346|12426585|P1|NOT COMPLETED|Overall Study||0
5049942|NCT01958346|12426584|P2|COMPLETED|Overall Study||39
5049943|NCT01958346|12426585|P1|COMPLETED|Overall Study||39
5049944|NCT01958346|12426584|P2|STARTED|Overall Study||39
5049945|NCT01958346|12426585|P1|STARTED|Overall Study||39
5049946|NCT01958320|12426595|P2|NOT COMPLETED|Overall Study||0
5049947|NCT01958320|12426596|P1|NOT COMPLETED|Overall Study||0
5049948|NCT01958320|12426595|P2|COMPLETED|Overall Study||98
5049949|NCT01958320|12426596|P1|COMPLETED|Overall Study||104
5049950|NCT01958320|12426595|P2|STARTED|Overall Study||98
5049951|NCT01958320|12426596|P1|STARTED|Overall Study||104
5049952|NCT01958294|12426624|P1|NOT COMPLETED|Overall Study||2
5049953|NCT01958294|12426624|P1|COMPLETED|Overall Study||10
5049954|NCT01958294|12426624|P1|STARTED|Overall Study||12
5049955|NCT01958281|12426633|P3|NOT COMPLETED|Overall Study||0
5049956|NCT01958281|12426634|P2|NOT COMPLETED|Overall Study||4
5049957|NCT01958281|12426635|P1|NOT COMPLETED|Overall Study||6
5049958|NCT01958281|12426633|P3|COMPLETED|Overall Study||18
5049959|NCT01958281|12426634|P2|COMPLETED|Overall Study||6
5049960|NCT01958281|12426635|P1|COMPLETED|Overall Study||4
5049961|NCT01958281|12426633|P3|STARTED|Overall Study||18
5049962|NCT01958281|12426634|P2|STARTED|Overall Study||10
5049963|NCT01958281|12426635|P1|STARTED|Overall Study||10
5049964|NCT01958164|12426711|P2|NOT COMPLETED|Overall Study||5
5049965|NCT01958164|12426712|P1|NOT COMPLETED|Overall Study||2
5049966|NCT01958164|12426711|P2|COMPLETED|Overall Study||5
5049967|NCT01958164|12426712|P1|COMPLETED|Overall Study||4
5049968|NCT01958164|12426711|P2|STARTED|Overall Study|Randomised and treated|10
5049969|NCT01958164|12426712|P1|STARTED|Overall Study|Randomised and treated|6
5049970|NCT01958125|12426727|P2|NOT COMPLETED|Overall Study||8
5049971|NCT01958125|12426728|P1|NOT COMPLETED|Overall Study||2
5049972|NCT01958125|12426727|P2|COMPLETED|Overall Study||44
5049973|NCT01958125|12426728|P1|COMPLETED|Overall Study||48
5049974|NCT01958125|12426727|P2|STARTED|Overall Study||52
5049975|NCT01958125|12426728|P1|STARTED|Overall Study||50
5049976|NCT01958112|12426742|P1|NOT COMPLETED|Overall Study||0
5049977|NCT01958112|12426742|P1|COMPLETED|Overall Study||14
5049978|NCT01958112|12426742|P1|STARTED|Overall Study||14
5049979|NCT01958060|12426756|P6|NOT COMPLETED|Overall Study||0
5049980|NCT01958060|12426757|P5|NOT COMPLETED|Overall Study||1
5049981|NCT01958060|12426758|P4|NOT COMPLETED|Overall Study||0
5049982|NCT01958060|12426759|P3|NOT COMPLETED|Overall Study||0
5049983|NCT01958060|12426760|P2|NOT COMPLETED|Overall Study||0
5049984|NCT01958060|12426761|P1|NOT COMPLETED|Overall Study||2
5049985|NCT01958060|12426756|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
5049986|NCT01958060|12426757|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
5049987|NCT01958060|12426758|P4|COMPLETED|Overall Study||5
5049988|NCT01958060|12426759|P3|COMPLETED|Overall Study||6
5049989|NCT01958060|12426760|P2|COMPLETED|Overall Study||6
5049990|NCT01958060|12426761|P1|COMPLETED|Overall Study||8
5049991|NCT01958060|12426756|P6|STARTED|Overall Study||1
5049992|NCT01958060|12426757|P5|STARTED|Overall Study||7
5049993|NCT01958060|12426758|P4|STARTED|Overall Study||5
5049994|NCT01958060|12426759|P3|STARTED|Overall Study||6
5049995|NCT01958060|12426760|P2|STARTED|Overall Study||6
5049996|NCT01958060|12426761|P1|STARTED|Overall Study||10
5049997|NCT01958021|12426786|P2|NOT COMPLETED|Overall Study||180
5049998|NCT01958021|12426787|P1|NOT COMPLETED|Overall Study||139
5049999|NCT01958021|12426786|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
5050000|NCT01958021|12426787|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
5050001|NCT01958021|12426786|P2|Patients Treated|Overall Study||330
5050002|NCT01958021|12426787|P1|Patients Treated|Overall Study||334
5050003|NCT01958021|12426786|P2|Patients Untreated|Overall Study||4
5050004|NCT01958021|12426787|P1|Patients Untreated|Overall Study||0
5050005|NCT01958021|12426786|P2|STARTED|Overall Study||334
5050006|NCT01958021|12426787|P1|STARTED|Overall Study||334
5050007|NCT01958008|12426799|P4|NOT COMPLETED|Overall Study||0
5050008|NCT01958008|12426800|P3|NOT COMPLETED|Overall Study||1
5050009|NCT01958008|12426801|P2|NOT COMPLETED|Overall Study||0
5050010|NCT01958008|12426802|P1|NOT COMPLETED|Overall Study||1
5050011|NCT01958008|12426799|P4|COMPLETED|Overall Study||21
5050012|NCT01958008|12426800|P3|COMPLETED|Overall Study||20
5050013|NCT01958008|12426801|P2|COMPLETED|Overall Study||21
5050014|NCT01958008|12426802|P1|COMPLETED|Overall Study||20
5050015|NCT01958008|12426799|P4|STARTED|Overall Study||21
5050016|NCT01958008|12426800|P3|STARTED|Overall Study||21
5050017|NCT01958008|12426801|P2|STARTED|Overall Study||21
5050018|NCT01958008|12426802|P1|STARTED|Overall Study||21
5050019|NCT01957930|12426833|P3|NOT COMPLETED|Overall Study||0
5050020|NCT01957930|12426834|P2|NOT COMPLETED|Overall Study||0
5050021|NCT01957930|12426835|P1|NOT COMPLETED|Overall Study||0
5050022|NCT01957930|12426833|P3|COMPLETED|Overall Study||19
5050023|NCT01957930|12426834|P2|COMPLETED|Overall Study||37
5050024|NCT01957930|12426835|P1|COMPLETED|Overall Study||35
5050025|NCT01957930|12426833|P3|STARTED|Overall Study||19
5050026|NCT01957930|12426834|P2|STARTED|Overall Study||37
5050027|NCT01957930|12426835|P1|STARTED|Overall Study||35
5050028|NCT01957865|12426845|P3|NOT COMPLETED|Overall Study||3
5050029|NCT01957865|12426846|P2|NOT COMPLETED|Overall Study||2
5050030|NCT01957865|12426847|P1|NOT COMPLETED|Overall Study||0
5050031|NCT01957865|12426845|P3|COMPLETED|Overall Study||19
5050032|NCT01957865|12426846|P2|COMPLETED|Overall Study||18
5050033|NCT01957865|12426847|P1|COMPLETED|Overall Study||21
5050034|NCT01957865|12426845|P3|STARTED|Overall Study||22
5050035|NCT01957865|12426846|P2|STARTED|Overall Study||20
5050036|NCT01957865|12426847|P1|STARTED|Overall Study||21
5050037|NCT01957787|12426858|P1|NOT COMPLETED|Overall Study||36
5050038|NCT01957787|12426858|P1|COMPLETED|Overall Study||95
5050039|NCT01957787|12426858|P1|Modified ITT (mITT) Population|Overall Study||128
5050040|NCT01957787|12426858|P1|Intent-to-Treat (ITT) Population|Overall Study||130
5050041|NCT01957787|12426858|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
5050042|NCT01957761|12426873|P1|NOT COMPLETED|Overall Study||0
5050043|NCT01957761|12426873|P1|COMPLETED|Overall Study||189
5050044|NCT01957761|12426873|P1|STARTED|Overall Study||189
5050045|NCT01957709|12426877|P1|NOT COMPLETED|Overall Study||1
5050046|NCT01957709|12426877|P1|COMPLETED|Overall Study||7
5050047|NCT01957709|12426877|P1|STARTED|Overall Study||8
5050048|NCT01957657|12426883|P1|NOT COMPLETED|Overall Study||0
5050049|NCT01957657|12426883|P1|COMPLETED|Overall Study||4
5050050|NCT01957657|12426883|P1|STARTED|Overall Study||4
5050051|NCT01957644|12426902|P5|NOT COMPLETED|Overall Study||1
5050052|NCT01957644|12426903|P4|NOT COMPLETED|Overall Study||2
5050053|NCT01957644|12426904|P3|NOT COMPLETED|Overall Study||1
5050054|NCT01957644|12426905|P2|NOT COMPLETED|Overall Study||6
5050055|NCT01957644|12426906|P1|NOT COMPLETED|Overall Study||6
5050056|NCT01957644|12426902|P5|COMPLETED|Overall Study||0
5050057|NCT01957644|12426903|P4|COMPLETED|Overall Study||0
5050058|NCT01957644|12426904|P3|COMPLETED|Overall Study||0
5050059|NCT01957644|12426905|P2|COMPLETED|Overall Study||0
5050060|NCT01957644|12426906|P1|COMPLETED|Overall Study||0
5050061|NCT01957644|12426902|P5|STARTED|Overall Study||1
5050062|NCT01957644|12426903|P4|STARTED|Overall Study||2
5050063|NCT01957644|12426904|P3|STARTED|Overall Study||1
5050064|NCT01957644|12426905|P2|STARTED|Overall Study||6
5050065|NCT01957644|12426906|P1|STARTED|Overall Study||6
5050066|NCT01957579|12426930|P4|NOT COMPLETED|Overall Study||0
5050067|NCT01957579|12426931|P3|NOT COMPLETED|Overall Study||2
5050068|NCT01957579|12426932|P2|NOT COMPLETED|Overall Study||1
5050069|NCT01957579|12426933|P1|NOT COMPLETED|Overall Study||0
5050070|NCT01957579|12426930|P4|COMPLETED|Overall Study||6
5050071|NCT01957579|12426931|P3|COMPLETED|Overall Study||2
5050072|NCT01957579|12426932|P2|COMPLETED|Overall Study||6
5050073|NCT01957579|12426933|P1|COMPLETED|Overall Study||3
5050074|NCT01957579|12426930|P4|STARTED|Overall Study||6
5050075|NCT01957579|12426931|P3|STARTED|Overall Study||4
5050076|NCT01957579|12426932|P2|STARTED|Overall Study||7
5050077|NCT01957579|12426933|P1|STARTED|Overall Study||3
5050078|NCT01957553|12427000|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
5050079|NCT01957553|12427001|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
5050080|NCT01957553|12427000|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
5050081|NCT01957553|12427001|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
5050082|NCT01957553|12427000|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
5050083|NCT01957553|12427001|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
5050084|NCT01957553|12427000|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
5050085|NCT01957553|12427001|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
5050086|NCT01957553|12427000|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
5050087|NCT01957553|12427001|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
5050088|NCT01957553|12427000|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
5050089|NCT01957553|12427001|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
5050090|NCT01957488|12427007|P6|NOT COMPLETED|Test Period 3||0
5050091|NCT01957488|12427008|P5|NOT COMPLETED|Test Period 3||0
5050092|NCT01957488|12427009|P4|NOT COMPLETED|Test Period 3||0
5050093|NCT01957488|12427010|P3|NOT COMPLETED|Test Period 3||0
5050094|NCT01957488|12427011|P2|NOT COMPLETED|Test Period 3||1
5050095|NCT01957488|12427012|P1|NOT COMPLETED|Test Period 3||1
5050096|NCT01957488|12427007|P6|COMPLETED|Test Period 3||23
5050097|NCT01957488|12427008|P5|COMPLETED|Test Period 3||25
5050098|NCT01957488|12427009|P4|COMPLETED|Test Period 3||28
5050099|NCT01957488|12427010|P3|COMPLETED|Test Period 3||25
5050100|NCT01957488|12427011|P2|COMPLETED|Test Period 3||26
5050101|NCT01957488|12427012|P1|COMPLETED|Test Period 3||23
5050102|NCT01957488|12427007|P6|STARTED|Test Period 3||23
5050103|NCT01957488|12427008|P5|STARTED|Test Period 3||25
5050104|NCT01957488|12427009|P4|STARTED|Test Period 3||28
5050105|NCT01957488|12427010|P3|STARTED|Test Period 3||25
5050106|NCT01957488|12427011|P2|STARTED|Test Period 3||27
5050107|NCT01957488|12427012|P1|STARTED|Test Period 3||24
5050108|NCT01957488|12427007|P6|NOT COMPLETED|Test Period 2||1
5050109|NCT01957488|12427008|P5|NOT COMPLETED|Test Period 2||2
5050110|NCT01957488|12427009|P4|NOT COMPLETED|Test Period 2||1
5050111|NCT01957488|12427010|P3|NOT COMPLETED|Test Period 2||1
5050112|NCT01957488|12427011|P2|NOT COMPLETED|Test Period 2||1
5050113|NCT01957488|12427012|P1|NOT COMPLETED|Test Period 2||3
5050114|NCT01957488|12427007|P6|COMPLETED|Test Period 2||23
5050115|NCT01957488|12427008|P5|COMPLETED|Test Period 2||25
5050116|NCT01957488|12427009|P4|COMPLETED|Test Period 2||28
5050117|NCT01957488|12427010|P3|COMPLETED|Test Period 2||25
5050118|NCT01957488|12427011|P2|COMPLETED|Test Period 2||27
5050119|NCT01957488|12427012|P1|COMPLETED|Test Period 2||24
5050120|NCT01957488|12427007|P6|STARTED|Test Period 2||24
5050121|NCT01957488|12427008|P5|STARTED|Test Period 2||27
5050122|NCT01957488|12427009|P4|STARTED|Test Period 2||29
5050123|NCT01957488|12427010|P3|STARTED|Test Period 2||26
5050124|NCT01957488|12427011|P2|STARTED|Test Period 2||28
5050125|NCT01957488|12427012|P1|STARTED|Test Period 2||27
5050126|NCT01957488|12427007|P6|NOT COMPLETED|Test Period 1||6
5050127|NCT01957488|12427008|P5|NOT COMPLETED|Test Period 1||3
5050128|NCT01957488|12427009|P4|NOT COMPLETED|Test Period 1||3
5050129|NCT01957488|12427010|P3|NOT COMPLETED|Test Period 1||4
5050130|NCT01957488|12427011|P2|NOT COMPLETED|Test Period 1||3
5050131|NCT01957488|12427012|P1|NOT COMPLETED|Test Period 1||3
5050132|NCT01957488|12427007|P6|COMPLETED|Test Period 1||24
5050133|NCT01957488|12427008|P5|COMPLETED|Test Period 1||27
5050134|NCT01957488|12427009|P4|COMPLETED|Test Period 1||29
5050135|NCT01957488|12427010|P3|COMPLETED|Test Period 1||26
5050136|NCT01957488|12427011|P2|COMPLETED|Test Period 1||28
5050137|NCT01957488|12427012|P1|COMPLETED|Test Period 1||27
5050138|NCT01957488|12427007|P6|STARTED|Test Period 1||30
5050139|NCT01957488|12427008|P5|STARTED|Test Period 1||30
5050140|NCT01957488|12427009|P4|STARTED|Test Period 1||32
5050141|NCT01957488|12427010|P3|STARTED|Test Period 1||30
5050142|NCT01957488|12427011|P2|STARTED|Test Period 1||31
5050143|NCT01957488|12427012|P1|STARTED|Test Period 1||30
5050144|NCT01957475|12427020|P2|NOT COMPLETED|Test Period 2||0
5050145|NCT01957475|12427021|P1|NOT COMPLETED|Test Period 2||1
5050146|NCT01957475|12427020|P2|COMPLETED|Test Period 2||8
5050147|NCT01957475|12427021|P1|COMPLETED|Test Period 2||8
5050148|NCT01957475|12427020|P2|STARTED|Test Period 2||8
5050149|NCT01957475|12427021|P1|STARTED|Test Period 2||9
5050150|NCT01957475|12427020|P2|NOT COMPLETED|Test Period 1||1
5050151|NCT01957475|12427021|P1|NOT COMPLETED|Test Period 1||2
5050152|NCT01957475|12427020|P2|COMPLETED|Test Period 1||9
5050153|NCT01957475|12427021|P1|COMPLETED|Test Period 1||8
5050154|NCT01957475|12427020|P2|STARTED|Test Period 1||10
5050155|NCT01957475|12427021|P1|STARTED|Test Period 1||10
5050156|NCT01957462|12427027|P2|NOT COMPLETED|Test Period 2||0
5050157|NCT01957462|12427028|P1|NOT COMPLETED|Test Period 2||0
5050158|NCT01957462|12427027|P2|COMPLETED|Test Period 2||15
5050159|NCT01957462|12427028|P1|COMPLETED|Test Period 2||14
5050160|NCT01957462|12427027|P2|STARTED|Test Period 2||15
5050161|NCT01957462|12427028|P1|STARTED|Test Period 2||14
5050162|NCT01957462|12427027|P2|NOT COMPLETED|Test Period 1||0
5050163|NCT01957462|12427028|P1|NOT COMPLETED|Test Period 1||2
5050164|NCT01957462|12427027|P2|COMPLETED|Test Period 1||15
5050165|NCT01957462|12427028|P1|COMPLETED|Test Period 1||14
5050166|NCT01957462|12427027|P2|STARTED|Test Period 1||15
5050167|NCT01957462|12427028|P1|STARTED|Test Period 1||16
5050168|NCT01957410|12427034|P1|NOT COMPLETED|Optional Open Label||0
5050169|NCT01957410|12427034|P1|COMPLETED|Optional Open Label||13
5050170|NCT01957410|12427034|P1|STARTED|Optional Open Label||13
5050171|NCT01957410|12427034|P1|NOT COMPLETED|Open Label||0
5050172|NCT01957410|12427034|P1|COMPLETED|Open Label||13
5050173|NCT01957410|12427034|P1|STARTED|Open Label||13
5050174|NCT01957397|12427039|P2|NOT COMPLETED|Test Period 3||2
5050175|NCT01957397|12427040|P1|NOT COMPLETED|Test Period 3||2
5050176|NCT01957397|12427039|P2|COMPLETED|Test Period 3||9
5050177|NCT01957397|12427040|P1|COMPLETED|Test Period 3||9
5050178|NCT01957397|12427039|P2|STARTED|Test Period 3||11
5050179|NCT01957397|12427040|P1|STARTED|Test Period 3||11
5050180|NCT01957397|12427039|P2|NOT COMPLETED|Test Period 2||1
5050181|NCT01957397|12427040|P1|NOT COMPLETED|Test Period 2||0
5050182|NCT01957397|12427039|P2|COMPLETED|Test Period 2||11
5050183|NCT01957397|12427040|P1|COMPLETED|Test Period 2||11
5050184|NCT01957397|12427039|P2|STARTED|Test Period 2||12
5050185|NCT01957397|12427040|P1|STARTED|Test Period 2||11
5050186|NCT01957397|12427039|P2|NOT COMPLETED|Test Period 1||1
5050187|NCT01957397|12427040|P1|NOT COMPLETED|Test Period 1||2
5050188|NCT01957397|12427039|P2|COMPLETED|Test Period 1||12
5050189|NCT01957397|12427040|P1|COMPLETED|Test Period 1||11
5050190|NCT01957397|12427039|P2|STARTED|Test Period 1||13
5050191|NCT01957397|12427040|P1|STARTED|Test Period 1||13
5050192|NCT01957397|12427039|P2|NOT COMPLETED|Baseline Own Product||0
5050193|NCT01957397|12427040|P1|NOT COMPLETED|Baseline Own Product||0
5050194|NCT01957397|12427039|P2|COMPLETED|Baseline Own Product||13
5050195|NCT01957397|12427040|P1|COMPLETED|Baseline Own Product||13
5050196|NCT01957397|12427039|P2|STARTED|Baseline Own Product||13
5050197|NCT01957397|12427040|P1|STARTED|Baseline Own Product||13
5050198|NCT01957384|12427050|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
5050199|NCT01957384|12427051|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
5050200|NCT01957384|12427052|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
5050201|NCT01957384|12427053|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
5050202|NCT01957384|12427054|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
5050203|NCT01957384|12427055|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
5050204|NCT01957384|12427050|P6|COMPLETED|Test Period 3 (14 Days)||3
5050205|NCT01957384|12427051|P5|COMPLETED|Test Period 3 (14 Days)||3
5050206|NCT01957384|12427052|P4|COMPLETED|Test Period 3 (14 Days)||4
5050207|NCT01957384|12427053|P3|COMPLETED|Test Period 3 (14 Days)||4
5050208|NCT01957384|12427054|P2|COMPLETED|Test Period 3 (14 Days)||4
5050209|NCT01957384|12427055|P1|COMPLETED|Test Period 3 (14 Days)||4
5050210|NCT01957384|12427050|P6|STARTED|Test Period 3 (14 Days)||3
5050211|NCT01957384|12427051|P5|STARTED|Test Period 3 (14 Days)||3
5050212|NCT01957384|12427052|P4|STARTED|Test Period 3 (14 Days)||4
5050213|NCT01957384|12427053|P3|STARTED|Test Period 3 (14 Days)||4
5050214|NCT01957384|12427054|P2|STARTED|Test Period 3 (14 Days)||4
5050215|NCT01957384|12427055|P1|STARTED|Test Period 3 (14 Days)||4
5050216|NCT01957384|12427050|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
5050217|NCT01957384|12427051|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
5050218|NCT01957384|12427052|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
5050219|NCT01957384|12427053|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
5050220|NCT01957384|12427054|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
5050221|NCT01957384|12427055|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
5050222|NCT01957384|12427050|P6|COMPLETED|Test Period 2 (14 Days)||3
5050223|NCT01957384|12427051|P5|COMPLETED|Test Period 2 (14 Days)||3
5050224|NCT01957384|12427052|P4|COMPLETED|Test Period 2 (14 Days)||4
5050225|NCT01957384|12427053|P3|COMPLETED|Test Period 2 (14 Days)||4
5050226|NCT01957384|12427054|P2|COMPLETED|Test Period 2 (14 Days)||4
5050227|NCT01957384|12427055|P1|COMPLETED|Test Period 2 (14 Days)||4
5050228|NCT01957384|12427050|P6|STARTED|Test Period 2 (14 Days)||3
5050229|NCT01957384|12427051|P5|STARTED|Test Period 2 (14 Days)||3
5050230|NCT01957384|12427052|P4|STARTED|Test Period 2 (14 Days)||4
5050231|NCT01957384|12427053|P3|STARTED|Test Period 2 (14 Days)||4
5050232|NCT01957384|12427054|P2|STARTED|Test Period 2 (14 Days)||4
5050233|NCT01957384|12427055|P1|STARTED|Test Period 2 (14 Days)||4
5050234|NCT01957384|12427050|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
5050235|NCT01957384|12427051|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
5050236|NCT01957384|12427052|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
5050237|NCT01957384|12427053|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
5050238|NCT01957384|12427054|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
5050239|NCT01957384|12427055|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
5050240|NCT01957384|12427050|P6|COMPLETED|Test Period 1 (14 Days)||3
5050241|NCT01957384|12427051|P5|COMPLETED|Test Period 1 (14 Days)||3
5050242|NCT01957384|12427052|P4|COMPLETED|Test Period 1 (14 Days)||4
5050243|NCT01957384|12427053|P3|COMPLETED|Test Period 1 (14 Days)||4
5050244|NCT01957384|12427054|P2|COMPLETED|Test Period 1 (14 Days)||4
5050245|NCT01957384|12427055|P1|COMPLETED|Test Period 1 (14 Days)||4
5050246|NCT01957384|12427050|P6|STARTED|Test Period 1 (14 Days)||3
5050247|NCT01957384|12427051|P5|STARTED|Test Period 1 (14 Days)||3
5050248|NCT01957384|12427052|P4|STARTED|Test Period 1 (14 Days)||4
5050249|NCT01957384|12427053|P3|STARTED|Test Period 1 (14 Days)||4
5050250|NCT01957384|12427054|P2|STARTED|Test Period 1 (14 Days)||4
5050251|NCT01957384|12427055|P1|STARTED|Test Period 1 (14 Days)||4
5050252|NCT01957215|12427065|P2|NOT COMPLETED|Overall Study||12
5050253|NCT01957215|12427066|P1|NOT COMPLETED|Overall Study||13
5050254|NCT01957215|12427065|P2|COMPLETED|Overall Study||123
5050255|NCT01957215|12427066|P1|COMPLETED|Overall Study||122
5050256|NCT01957215|12427065|P2|STARTED|Overall Study||135
5050257|NCT01957215|12427066|P1|STARTED|Overall Study||135
5050258|NCT01957202|12427094|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050259|NCT01957202|12427095|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
5050260|NCT01957202|12427096|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050261|NCT01957202|12427097|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050262|NCT01957202|12427098|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050263|NCT01957202|12427099|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050264|NCT01957202|12427100|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050265|NCT01957202|12427101|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050266|NCT01957202|12427102|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050267|NCT01957202|12427103|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050268|NCT01957202|12427104|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050269|NCT01957202|12427105|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050270|NCT01957202|12427106|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050271|NCT01957202|12427107|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050272|NCT01957202|12427108|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050273|NCT01957202|12427109|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050274|NCT01957202|12427110|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050275|NCT01957202|12427111|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
5050276|NCT01957202|12427094|P18|COMPLETED|Treatment Period 3 (8 Days)||3
5050277|NCT01957202|12427095|P17|COMPLETED|Treatment Period 3 (8 Days)||4
5050278|NCT01957202|12427096|P16|COMPLETED|Treatment Period 3 (8 Days)||3
5050279|NCT01957202|12427097|P15|COMPLETED|Treatment Period 3 (8 Days)||6
5050280|NCT01957202|12427098|P14|COMPLETED|Treatment Period 3 (8 Days)||3
5050281|NCT01957202|12427099|P13|COMPLETED|Treatment Period 3 (8 Days)||3
5050282|NCT01957202|12427100|P12|COMPLETED|Treatment Period 3 (8 Days)||6
5050283|NCT01957202|12427101|P11|COMPLETED|Treatment Period 3 (8 Days)||3
5050284|NCT01957202|12427102|P10|COMPLETED|Treatment Period 3 (8 Days)||6
5050285|NCT01957202|12427103|P9|COMPLETED|Treatment Period 3 (8 Days)||3
5050286|NCT01957202|12427104|P8|COMPLETED|Treatment Period 3 (8 Days)||3
5050287|NCT01957202|12427105|P7|COMPLETED|Treatment Period 3 (8 Days)||3
5050288|NCT01957202|12427106|P6|COMPLETED|Treatment Period 3 (8 Days)||2
5050289|NCT01957202|12427107|P5|COMPLETED|Treatment Period 3 (8 Days)||3
5050290|NCT01957202|12427108|P4|COMPLETED|Treatment Period 3 (8 Days)||3
5050291|NCT01957202|12427109|P3|COMPLETED|Treatment Period 3 (8 Days)||6
5050292|NCT01957202|12427110|P2|COMPLETED|Treatment Period 3 (8 Days)||5
5050293|NCT01957202|12427111|P1|COMPLETED|Treatment Period 3 (8 Days)||3
5050294|NCT01957202|12427094|P18|STARTED|Treatment Period 3 (8 Days)||3
5050295|NCT01957202|12427095|P17|STARTED|Treatment Period 3 (8 Days)||5
5050296|NCT01957202|12427096|P16|STARTED|Treatment Period 3 (8 Days)||3
5050297|NCT01957202|12427097|P15|STARTED|Treatment Period 3 (8 Days)||6
5050298|NCT01957202|12427098|P14|STARTED|Treatment Period 3 (8 Days)||3
5050299|NCT01957202|12427099|P13|STARTED|Treatment Period 3 (8 Days)||3
5050300|NCT01957202|12427100|P12|STARTED|Treatment Period 3 (8 Days)||6
5050301|NCT01957202|12427101|P11|STARTED|Treatment Period 3 (8 Days)||3
5050302|NCT01957202|12427102|P10|STARTED|Treatment Period 3 (8 Days)||6
5050303|NCT01957202|12427103|P9|STARTED|Treatment Period 3 (8 Days)||3
5050304|NCT01957202|12427104|P8|STARTED|Treatment Period 3 (8 Days)||3
5050305|NCT01957202|12427105|P7|STARTED|Treatment Period 3 (8 Days)||3
5050306|NCT01957202|12427106|P6|STARTED|Treatment Period 3 (8 Days)||2
5050307|NCT01957202|12427107|P5|STARTED|Treatment Period 3 (8 Days)||3
5050308|NCT01957202|12427108|P4|STARTED|Treatment Period 3 (8 Days)||3
5050309|NCT01957202|12427109|P3|STARTED|Treatment Period 3 (8 Days)||6
5050310|NCT01957202|12427110|P2|STARTED|Treatment Period 3 (8 Days)||5
5050311|NCT01957202|12427111|P1|STARTED|Treatment Period 3 (8 Days)||3
5050312|NCT01957202|12427094|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050313|NCT01957202|12427095|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050314|NCT01957202|12427096|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050315|NCT01957202|12427097|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050316|NCT01957202|12427098|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050317|NCT01957202|12427099|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050318|NCT01957202|12427100|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050319|NCT01957202|12427101|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050320|NCT01957202|12427102|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050321|NCT01957202|12427103|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050322|NCT01957202|12427104|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050323|NCT01957202|12427105|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050324|NCT01957202|12427106|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050325|NCT01957202|12427107|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050326|NCT01957202|12427108|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050327|NCT01957202|12427109|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050328|NCT01957202|12427110|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050329|NCT01957202|12427111|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
5050330|NCT01957202|12427094|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050331|NCT01957202|12427095|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
5050332|NCT01957202|12427096|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050333|NCT01957202|12427097|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
5050334|NCT01957202|12427098|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050335|NCT01957202|12427099|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050336|NCT01957202|12427100|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
5050337|NCT01957202|12427101|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050338|NCT01957202|12427102|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
5050339|NCT01957202|12427103|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050340|NCT01957202|12427104|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050341|NCT01957202|12427105|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050342|NCT01957202|12427106|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
5050343|NCT01957202|12427107|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050344|NCT01957202|12427108|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050345|NCT01957202|12427109|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
5050346|NCT01957202|12427110|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
5050347|NCT01957202|12427111|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
5050348|NCT01957202|12427094|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
5050349|NCT01957202|12427095|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
5050350|NCT01957202|12427096|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
5050351|NCT01957202|12427097|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
5050352|NCT01957202|12427098|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
5050353|NCT01957202|12427099|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
5050354|NCT01957202|12427100|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
5050355|NCT01957202|12427101|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
5050356|NCT01957202|12427102|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
5050357|NCT01957202|12427103|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
5050358|NCT01957202|12427104|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
5050359|NCT01957202|12427105|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
5050360|NCT01957202|12427106|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
5050361|NCT01957202|12427107|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
5050362|NCT01957202|12427108|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
5050363|NCT01957202|12427109|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
5050364|NCT01957202|12427110|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
5050365|NCT01957202|12427111|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
5050366|NCT01957202|12427094|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050367|NCT01957202|12427095|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
5050368|NCT01957202|12427096|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050369|NCT01957202|12427097|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050370|NCT01957202|12427098|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050371|NCT01957202|12427099|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050372|NCT01957202|12427100|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050373|NCT01957202|12427101|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050374|NCT01957202|12427102|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050375|NCT01957202|12427103|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050376|NCT01957202|12427104|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050377|NCT01957202|12427105|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050378|NCT01957202|12427106|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050379|NCT01957202|12427107|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050380|NCT01957202|12427108|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050381|NCT01957202|12427109|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050382|NCT01957202|12427110|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
5050383|NCT01957202|12427111|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
5050384|NCT01957202|12427094|P18|COMPLETED|Treatment Period 2 (8 Days)||3
5050385|NCT01957202|12427095|P17|COMPLETED|Treatment Period 2 (8 Days)||5
5050386|NCT01957202|12427096|P16|COMPLETED|Treatment Period 2 (8 Days)||3
5050387|NCT01957202|12427097|P15|COMPLETED|Treatment Period 2 (8 Days)||6
5050388|NCT01957202|12427098|P14|COMPLETED|Treatment Period 2 (8 Days)||3
5050389|NCT01957202|12427099|P13|COMPLETED|Treatment Period 2 (8 Days)||3
5050390|NCT01957202|12427100|P12|COMPLETED|Treatment Period 2 (8 Days)||6
5050391|NCT01957202|12427101|P11|COMPLETED|Treatment Period 2 (8 Days)||3
5050392|NCT01957202|12427102|P10|COMPLETED|Treatment Period 2 (8 Days)||6
5050393|NCT01957202|12427103|P9|COMPLETED|Treatment Period 2 (8 Days)||3
5050394|NCT01957202|12427104|P8|COMPLETED|Treatment Period 2 (8 Days)||3
5050395|NCT01957202|12427105|P7|COMPLETED|Treatment Period 2 (8 Days)||3
5050396|NCT01957202|12427106|P6|COMPLETED|Treatment Period 2 (8 Days)||2
5050397|NCT01957202|12427107|P5|COMPLETED|Treatment Period 2 (8 Days)||3
5050398|NCT01957202|12427108|P4|COMPLETED|Treatment Period 2 (8 Days)||3
5050399|NCT01957202|12427109|P3|COMPLETED|Treatment Period 2 (8 Days)||6
5050400|NCT01957202|12427110|P2|COMPLETED|Treatment Period 2 (8 Days)||5
5050401|NCT01957202|12427111|P1|COMPLETED|Treatment Period 2 (8 Days)||3
5050402|NCT01957202|12427094|P18|STARTED|Treatment Period 2 (8 Days)||3
5050403|NCT01957202|12427095|P17|STARTED|Treatment Period 2 (8 Days)||6
5050404|NCT01957202|12427096|P16|STARTED|Treatment Period 2 (8 Days)||3
5050405|NCT01957202|12427097|P15|STARTED|Treatment Period 2 (8 Days)||6
5050406|NCT01957202|12427098|P14|STARTED|Treatment Period 2 (8 Days)||3
5050407|NCT01957202|12427099|P13|STARTED|Treatment Period 2 (8 Days)||3
5050408|NCT01957202|12427100|P12|STARTED|Treatment Period 2 (8 Days)||6
5050409|NCT01957202|12427101|P11|STARTED|Treatment Period 2 (8 Days)||3
5050410|NCT01957202|12427102|P10|STARTED|Treatment Period 2 (8 Days)||6
5050411|NCT01957202|12427103|P9|STARTED|Treatment Period 2 (8 Days)||3
5050412|NCT01957202|12427104|P8|STARTED|Treatment Period 2 (8 Days)||3
5050413|NCT01957202|12427105|P7|STARTED|Treatment Period 2 (8 Days)||3
5050414|NCT01957202|12427106|P6|STARTED|Treatment Period 2 (8 Days)||2
5050415|NCT01957202|12427107|P5|STARTED|Treatment Period 2 (8 Days)||3
5050416|NCT01957202|12427108|P4|STARTED|Treatment Period 2 (8 Days)||3
5050417|NCT01957202|12427109|P3|STARTED|Treatment Period 2 (8 Days)||6
5050418|NCT01957202|12427110|P2|STARTED|Treatment Period 2 (8 Days)||6
5050419|NCT01957202|12427111|P1|STARTED|Treatment Period 2 (8 Days)||3
5050420|NCT01957202|12427094|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050421|NCT01957202|12427095|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050422|NCT01957202|12427096|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050423|NCT01957202|12427097|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050424|NCT01957202|12427098|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050425|NCT01957202|12427099|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050426|NCT01957202|12427100|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050427|NCT01957202|12427101|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050428|NCT01957202|12427102|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050429|NCT01957202|12427103|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050430|NCT01957202|12427104|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050431|NCT01957202|12427105|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050432|NCT01957202|12427106|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050433|NCT01957202|12427107|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050434|NCT01957202|12427108|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050435|NCT01957202|12427109|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050436|NCT01957202|12427110|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050437|NCT01957202|12427111|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
5050438|NCT01957202|12427094|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050439|NCT01957202|12427095|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050440|NCT01957202|12427096|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050441|NCT01957202|12427097|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050442|NCT01957202|12427098|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050443|NCT01957202|12427099|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050444|NCT01957202|12427100|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050445|NCT01957202|12427101|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050446|NCT01957202|12427102|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050447|NCT01957202|12427103|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050448|NCT01957202|12427104|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050449|NCT01957202|12427105|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050450|NCT01957202|12427106|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
5050451|NCT01957202|12427107|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050452|NCT01957202|12427108|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050453|NCT01957202|12427109|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050454|NCT01957202|12427110|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
5050455|NCT01957202|12427111|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
5050456|NCT01957202|12427094|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
5050457|NCT01957202|12427095|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
5050458|NCT01957202|12427096|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
5050459|NCT01957202|12427097|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
5050460|NCT01957202|12427098|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
5050461|NCT01957202|12427099|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
5050462|NCT01957202|12427100|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
5050463|NCT01957202|12427101|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
5050464|NCT01957202|12427102|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
5050465|NCT01957202|12427103|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
5050466|NCT01957202|12427104|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
5050467|NCT01957202|12427105|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
5050468|NCT01957202|12427106|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
5050469|NCT01957202|12427107|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
5050470|NCT01957202|12427108|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
5050471|NCT01957202|12427109|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
5050472|NCT01957202|12427110|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
5050473|NCT01957202|12427111|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
5050474|NCT01957202|12427094|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050475|NCT01957202|12427095|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050476|NCT01957202|12427096|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050477|NCT01957202|12427097|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050478|NCT01957202|12427098|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050479|NCT01957202|12427099|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050480|NCT01957202|12427100|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050481|NCT01957202|12427101|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050482|NCT01957202|12427102|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050483|NCT01957202|12427103|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050484|NCT01957202|12427104|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050485|NCT01957202|12427105|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050486|NCT01957202|12427106|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050487|NCT01957202|12427107|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050488|NCT01957202|12427108|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050489|NCT01957202|12427109|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050490|NCT01957202|12427110|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050491|NCT01957202|12427111|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5050492|NCT01957202|12427094|P18|COMPLETED|Treatment Period 1 (8 Days)||3
5050493|NCT01957202|12427095|P17|COMPLETED|Treatment Period 1 (8 Days)||6
5050494|NCT01957202|12427096|P16|COMPLETED|Treatment Period 1 (8 Days)||3
5050495|NCT01957202|12427097|P15|COMPLETED|Treatment Period 1 (8 Days)||6
5050496|NCT01957202|12427098|P14|COMPLETED|Treatment Period 1 (8 Days)||3
5050497|NCT01957202|12427099|P13|COMPLETED|Treatment Period 1 (8 Days)||3
5050498|NCT01957202|12427100|P12|COMPLETED|Treatment Period 1 (8 Days)||6
5050499|NCT01957202|12427101|P11|COMPLETED|Treatment Period 1 (8 Days)||3
5050500|NCT01957202|12427102|P10|COMPLETED|Treatment Period 1 (8 Days)||6
5050501|NCT01957202|12427103|P9|COMPLETED|Treatment Period 1 (8 Days)||3
5050502|NCT01957202|12427104|P8|COMPLETED|Treatment Period 1 (8 Days)||3
5050503|NCT01957202|12427105|P7|COMPLETED|Treatment Period 1 (8 Days)||3
5050504|NCT01957202|12427106|P6|COMPLETED|Treatment Period 1 (8 Days)||2
5050505|NCT01957202|12427107|P5|COMPLETED|Treatment Period 1 (8 Days)||3
5050506|NCT01957202|12427108|P4|COMPLETED|Treatment Period 1 (8 Days)||3
5050507|NCT01957202|12427109|P3|COMPLETED|Treatment Period 1 (8 Days)||6
5050508|NCT01957202|12427110|P2|COMPLETED|Treatment Period 1 (8 Days)||6
5050509|NCT01957202|12427111|P1|COMPLETED|Treatment Period 1 (8 Days)||3
5050510|NCT01957202|12427094|P18|STARTED|Treatment Period 1 (8 Days)||3
5050511|NCT01957202|12427095|P17|STARTED|Treatment Period 1 (8 Days)||6
5050512|NCT01957202|12427096|P16|STARTED|Treatment Period 1 (8 Days)||3
5050513|NCT01957202|12427097|P15|STARTED|Treatment Period 1 (8 Days)||6
5050514|NCT01957202|12427098|P14|STARTED|Treatment Period 1 (8 Days)||3
5050515|NCT01957202|12427099|P13|STARTED|Treatment Period 1 (8 Days)||3
5050516|NCT01957202|12427100|P12|STARTED|Treatment Period 1 (8 Days)||6
5050517|NCT01957202|12427101|P11|STARTED|Treatment Period 1 (8 Days)||3
5050518|NCT01957202|12427102|P10|STARTED|Treatment Period 1 (8 Days)||6
5050519|NCT01957202|12427103|P9|STARTED|Treatment Period 1 (8 Days)||3
5050520|NCT01957202|12427104|P8|STARTED|Treatment Period 1 (8 Days)||3
5050521|NCT01957202|12427105|P7|STARTED|Treatment Period 1 (8 Days)||3
5050522|NCT01957202|12427106|P6|STARTED|Treatment Period 1 (8 Days)||2
5050523|NCT01957202|12427107|P5|STARTED|Treatment Period 1 (8 Days)||3
5050524|NCT01957202|12427108|P4|STARTED|Treatment Period 1 (8 Days)||3
5050525|NCT01957202|12427109|P3|STARTED|Treatment Period 1 (8 Days)||6
5050526|NCT01957202|12427110|P2|STARTED|Treatment Period 1 (8 Days)||6
5050527|NCT01957202|12427111|P1|STARTED|Treatment Period 1 (8 Days)||3
5050528|NCT01957163|12427136|P3|NOT COMPLETED|Overall Study||18
5050529|NCT01957163|12427137|P2|NOT COMPLETED|Overall Study||11
5050530|NCT01957163|12427138|P1|NOT COMPLETED|Overall Study||15
5050531|NCT01957163|12427136|P3|COMPLETED|Overall Study||189
5050532|NCT01957163|12427137|P2|COMPLETED|Overall Study||195
5050533|NCT01957163|12427138|P1|COMPLETED|Overall Study||191
5050534|NCT01957163|12427136|P3|STARTED|Overall Study||207
5050535|NCT01957163|12427137|P2|STARTED|Overall Study||206
5050536|NCT01957163|12427138|P1|STARTED|Overall Study||206
5050537|NCT01957150|12427151|P2|NOT COMPLETED|Overall Study||58
5050538|NCT01957150|12427152|P1|NOT COMPLETED|Overall Study||55
5050539|NCT01957150|12427151|P2|COMPLETED|Overall Study||83
5050540|NCT01957150|12427152|P1|COMPLETED|Overall Study||87
5050541|NCT01957150|12427151|P2|STARTED|Overall Study||141
5050542|NCT01957150|12427152|P1|STARTED|Overall Study||142
5050543|NCT01957137|12427168|P1|NOT COMPLETED|No Stimulation||0
5050544|NCT01957137|12427168|P1|COMPLETED|No Stimulation||28
5050545|NCT01957137|12427168|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
5050546|NCT01957137|12427168|P1|NOT COMPLETED|Randomized Portion||2
5050547|NCT01957137|12427168|P1|COMPLETED|Randomized Portion||28
5050548|NCT01957137|12427168|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
5050549|NCT01957137|12427168|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
5050550|NCT01957137|12427168|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
5050551|NCT01957137|12427168|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
5050552|NCT01957137|12427168|P1|STARTED|Randomized Portion||30
5050553|NCT01957111|12427198|P2|NOT COMPLETED|Overall Study||1
5050554|NCT01957111|12427199|P1|NOT COMPLETED|Overall Study||1
5050555|NCT01957111|12427198|P2|COMPLETED|Overall Study||15
5050556|NCT01957111|12427199|P1|COMPLETED|Overall Study||15
5050557|NCT01957111|12427198|P2|STARTED|Overall Study||16
5050558|NCT01957111|12427199|P1|STARTED|Overall Study||16
5050559|NCT01957085|12427207|P1|NOT COMPLETED|Overall Study||0
5050560|NCT01957085|12427207|P1|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
5050561|NCT01957085|12427207|P1|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
5050562|NCT01956773|12427218|P2|NOT COMPLETED|Overall Study||1
5050563|NCT01956773|12427219|P1|NOT COMPLETED|Overall Study||628
5050564|NCT01956773|12427218|P2|COMPLETED|Overall Study||99
5050565|NCT01956773|12427219|P1|COMPLETED|Overall Study||1892
5050566|NCT01956773|12427218|P2|STARTED|Overall Study||100
5050567|NCT01956773|12427219|P1|STARTED|Overall Study||2520
5050568|NCT01956435|12427230|P2|NOT COMPLETED|Overall Study||0
5050569|NCT01956435|12427231|P1|NOT COMPLETED|Overall Study||0
5050570|NCT01956435|12427230|P2|COMPLETED|Overall Study||3
5050571|NCT01956435|12427231|P1|COMPLETED|Overall Study||3
5050572|NCT01956435|12427230|P2|STARTED|Overall Study||3
5050573|NCT01956435|12427231|P1|STARTED|Overall Study||3
5050574|NCT01956279|12427240|P2|NOT COMPLETED|Overall Study||14
5050575|NCT01956279|12427241|P1|NOT COMPLETED|Overall Study||14
5050576|NCT01956279|12427240|P2|COMPLETED|Overall Study||74
5050577|NCT01956279|12427241|P1|COMPLETED|Overall Study||68
5050578|NCT01956279|12427240|P2|STARTED|Overall Study||88
5050579|NCT01956279|12427241|P1|STARTED|Overall Study||82
5050580|NCT01956240|12427257|P2|NOT COMPLETED|Overall Study||24
5050581|NCT01956240|12427258|P1|NOT COMPLETED|Overall Study||23
5050582|NCT01956240|12427257|P2|COMPLETED|Overall Study||25
5050583|NCT01956240|12427258|P1|COMPLETED|Overall Study||25
5050584|NCT01956240|12427257|P2|STARTED|Overall Study||49
5050585|NCT01956240|12427258|P1|STARTED|Overall Study||48
5050586|NCT01956123|12427268|P4|NOT COMPLETED|COS Cycle 3||2
5050587|NCT01956123|12427269|P3|NOT COMPLETED|COS Cycle 3||6
5050588|NCT01956123|12427270|P2|NOT COMPLETED|COS Cycle 3||0
5050589|NCT01956123|12427271|P1|NOT COMPLETED|COS Cycle 3||0
5050590|NCT01956123|12427268|P4|COMPLETED|COS Cycle 3||91
5050591|NCT01956123|12427269|P3|COMPLETED|COS Cycle 3||89
5050592|NCT01956123|12427270|P2|COMPLETED|COS Cycle 3||0
5050593|NCT01956123|12427271|P1|COMPLETED|COS Cycle 3||0
5050594|NCT01956123|12427268|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
5050595|NCT01956123|12427269|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
5050596|NCT01956123|12427270|P2|STARTED|COS Cycle 3||0
5050597|NCT01956123|12427271|P1|STARTED|COS Cycle 3||0
5050598|NCT01956123|12427268|P4|NOT COMPLETED|COS Cycle 2||0
5050599|NCT01956123|12427269|P3|NOT COMPLETED|COS Cycle 2||0
5050600|NCT01956123|12427270|P2|NOT COMPLETED|COS Cycle 2||7
5050601|NCT01956123|12427271|P1|NOT COMPLETED|COS Cycle 2||14
5050602|NCT01956123|12427268|P4|COMPLETED|COS Cycle 2||0
5050603|NCT01956123|12427269|P3|COMPLETED|COS Cycle 2||0
5050604|NCT01956123|12427270|P2|COMPLETED|COS Cycle 2||254
5050605|NCT01956123|12427271|P1|COMPLETED|COS Cycle 2||238
5050606|NCT01956123|12427268|P4|STARTED|COS Cycle 2||0
5050607|NCT01956123|12427269|P3|STARTED|COS Cycle 2||0
5050608|NCT01956123|12427270|P2|STARTED|COS Cycle 2||261
5050609|NCT01956123|12427271|P1|STARTED|COS Cycle 2||252
5050610|NCT01956110|12427323|P2|NOT COMPLETED|Overall Study||22
5050611|NCT01956110|12427324|P1|NOT COMPLETED|Overall Study||35
5050612|NCT01956110|12427323|P2|COMPLETED|Overall Study||639
5050613|NCT01956110|12427324|P1|COMPLETED|Overall Study||630
5050614|NCT01956110|12427323|P2|STARTED|Overall Study||661
5050615|NCT01956110|12427324|P1|STARTED|Overall Study||665
5050616|NCT01956097|12427377|P3|NOT COMPLETED|Overall Study||0
5050617|NCT01956097|12427378|P2|NOT COMPLETED|Overall Study||2
5050618|NCT01956097|12427379|P1|NOT COMPLETED|Overall Study||6
5050619|NCT01956097|12427377|P3|COMPLETED|Overall Study||15
5050620|NCT01956097|12427378|P2|COMPLETED|Overall Study||28
5050621|NCT01956097|12427379|P1|COMPLETED|Overall Study||24
5050622|NCT01956097|12427377|P3|STARTED|Overall Study||15
5050623|NCT01956097|12427378|P2|STARTED|Overall Study||30
5050624|NCT01956097|12427379|P1|STARTED|Overall Study||30
5050625|NCT01956071|12427396|P1|NOT COMPLETED|Overall Study||0
5050626|NCT01956071|12427396|P1|COMPLETED|Overall Study||44
5050627|NCT01956071|12427396|P1|STARTED|Overall Study||44
5050628|NCT01956032|12427400|P1|NOT COMPLETED|Overall Study||0
5050629|NCT01956032|12427400|P1|COMPLETED|Overall Study||15
5050630|NCT01956032|12427400|P1|STARTED|Overall Study||15
5050631|NCT01955954|12427447|P1|NOT COMPLETED|Overall Study||36
5050632|NCT01955954|12427447|P1|COMPLETED|Overall Study|12-months|33
5050633|NCT01955954|12427447|P1|Completed 6-month Assessement|Overall Study||42
5050634|NCT01955954|12427447|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
5050635|NCT01955954|12427447|P1|Completed Post-treatment Assessement|Overall Study||48
5050636|NCT01955954|12427447|P1|Completed Treatment|Overall Study||53
5050637|NCT01955954|12427447|P1|Received Treatment|Overall Study||66
5050638|NCT01955954|12427447|P1|STARTED|Overall Study||69
5050639|NCT01955733|12427459|P3|NOT COMPLETED|Period 2||21
5050640|NCT01955733|12427460|P2|NOT COMPLETED|Period 2||19
5050641|NCT01955733|12427461|P1|NOT COMPLETED|Period 2||12
5050642|NCT01955733|12427459|P3|COMPLETED|Period 2||8
5050643|NCT01955733|12427460|P2|COMPLETED|Period 2||10
5050644|NCT01955733|12427461|P1|COMPLETED|Period 2||20
5050645|NCT01955733|12427459|P3|STARTED|Period 2||29
5050646|NCT01955733|12427460|P2|STARTED|Period 2||29
5050647|NCT01955733|12427461|P1|STARTED|Period 2||32
5050648|NCT01955733|12427459|P3|NOT COMPLETED|Period 1||0
5050649|NCT01955733|12427460|P2|NOT COMPLETED|Period 1||0
5050650|NCT01955733|12427461|P1|NOT COMPLETED|Period 1||1
5050651|NCT01955733|12427459|P3|COMPLETED|Period 1||29
5050652|NCT01955733|12427460|P2|COMPLETED|Period 1||29
5050653|NCT01955733|12427461|P1|COMPLETED|Period 1||32
5050654|NCT01955733|12427459|P3|STARTED|Period 1||29
5050655|NCT01955733|12427460|P2|STARTED|Period 1||29
5050656|NCT01955733|12427461|P1|STARTED|Period 1||33
5050657|NCT01955720|12427481|P6|NOT COMPLETED|Overall Study||0
5050658|NCT01955720|12427482|P5|NOT COMPLETED|Overall Study||0
5050659|NCT01955720|12427483|P4|NOT COMPLETED|Overall Study||0
5050660|NCT01955720|12427484|P3|NOT COMPLETED|Overall Study||0
5050661|NCT01955720|12427485|P2|NOT COMPLETED|Overall Study||0
5050662|NCT01955720|12427486|P1|NOT COMPLETED|Overall Study||0
5050663|NCT01955720|12427481|P6|COMPLETED|Overall Study||7
5050664|NCT01955720|12427482|P5|COMPLETED|Overall Study||7
5050665|NCT01955720|12427483|P4|COMPLETED|Overall Study||3
5050666|NCT01955720|12427484|P3|COMPLETED|Overall Study||3
5050667|NCT01955720|12427485|P2|COMPLETED|Overall Study||13
5050668|NCT01955720|12427486|P1|COMPLETED|Overall Study||13
5050669|NCT01955720|12427481|P6|Subjects With Moderate Renal Impairment|Overall Study||0
5050670|NCT01955720|12427482|P5|Subjects With Moderate Renal Impairment|Overall Study||0
5050671|NCT01955720|12427483|P4|Subjects With Moderate Renal Impairment|Overall Study||0
5050672|NCT01955720|12427484|P3|Subjects With Moderate Renal Impairment|Overall Study||0
5050673|NCT01955720|12427485|P2|Subjects With Moderate Renal Impairment|Overall Study||3
5050674|NCT01955720|12427486|P1|Subjects With Moderate Renal Impairment|Overall Study||3
5050675|NCT01955720|12427481|P6|Subjects With Mild Renal Impairment|Overall Study||3
5050676|NCT01955720|12427482|P5|Subjects With Mild Renal Impairment|Overall Study||3
5050677|NCT01955720|12427483|P4|Subjects With Mild Renal Impairment|Overall Study||0
5050678|NCT01955720|12427484|P3|Subjects With Mild Renal Impairment|Overall Study||0
5050679|NCT01955720|12427485|P2|Subjects With Mild Renal Impairment|Overall Study||3
5050680|NCT01955720|12427486|P1|Subjects With Mild Renal Impairment|Overall Study||3
5050681|NCT01955720|12427481|P6|Healthy Subjects Aged 65-80|Overall Study||4
5050682|NCT01955720|12427482|P5|Healthy Subjects Aged 65-80|Overall Study||4
5050683|NCT01955720|12427483|P4|Healthy Subjects Aged 65-80|Overall Study||0
5050684|NCT01955720|12427484|P3|Healthy Subjects Aged 65-80|Overall Study||0
5050685|NCT01955720|12427485|P2|Healthy Subjects Aged 65-80|Overall Study||4
5050686|NCT01955720|12427486|P1|Healthy Subjects Aged 65-80|Overall Study||4
5050687|NCT01955720|12427481|P6|Healthy Subjects Aged 45-64|Overall Study||0
5050688|NCT01955720|12427482|P5|Healthy Subjects Aged 45-64|Overall Study||0
5050689|NCT01955720|12427483|P4|Healthy Subjects Aged 45-64|Overall Study||3
5050690|NCT01955720|12427484|P3|Healthy Subjects Aged 45-64|Overall Study||3
5050691|NCT01955720|12427485|P2|Healthy Subjects Aged 45-64|Overall Study||3
5050692|NCT01955720|12427486|P1|Healthy Subjects Aged 45-64|Overall Study||3
5050693|NCT01955720|12427481|P6|STARTED|Overall Study||7
5050694|NCT01955720|12427482|P5|STARTED|Overall Study||7
5050695|NCT01955720|12427483|P4|STARTED|Overall Study||3
5050696|NCT01955720|12427484|P3|STARTED|Overall Study||3
5050697|NCT01955720|12427485|P2|STARTED|Overall Study||13
5050698|NCT01955720|12427486|P1|STARTED|Overall Study||13
5050699|NCT01955707|12427554|P2|NOT COMPLETED|Overall Study||22
5050700|NCT01955707|12427555|P1|NOT COMPLETED|Overall Study||20
5050701|NCT01955707|12427554|P2|COMPLETED|Overall Study||57
5050702|NCT01955707|12427555|P1|COMPLETED|Overall Study||62
5050703|NCT01955707|12427554|P2|Received Total Volume of Study Drug|Overall Study||77
5050704|NCT01955707|12427555|P1|Received Total Volume of Study Drug|Overall Study||82
5050705|NCT01955707|12427554|P2|Dosed|Overall Study||78
5050706|NCT01955707|12427555|P1|Dosed|Overall Study||82
5050707|NCT01955707|12427554|P2|Withdrew Prior to Dosing|Overall Study||1
5050708|NCT01955707|12427555|P1|Withdrew Prior to Dosing|Overall Study||0
5050709|NCT01955707|12427554|P2|STARTED|Overall Study||79
5050710|NCT01955707|12427555|P1|STARTED|Overall Study||82
5050711|NCT01955629|12427579|P1|NOT COMPLETED|Overall Study||0
5050712|NCT01955629|12427579|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
5050713|NCT01955629|12427579|P1|STARTED|Overall Study||4
5050714|NCT01955564|12427598|P7|NOT COMPLETED|Overall Study||0
5050715|NCT01955564|12427599|P6|NOT COMPLETED|Overall Study||0
5050716|NCT01955564|12427600|P5|NOT COMPLETED|Overall Study||0
5050717|NCT01955564|12427601|P4|NOT COMPLETED|Overall Study||0
5050718|NCT01955564|12427602|P3|NOT COMPLETED|Overall Study||0
5050719|NCT01955564|12427603|P2|NOT COMPLETED|Overall Study||0
5050720|NCT01955564|12427604|P1|NOT COMPLETED|Overall Study||0
5050721|NCT01955564|12427598|P7|COMPLETED|Overall Study||6
5050722|NCT01955564|12427599|P6|COMPLETED|Overall Study||6
5050723|NCT01955564|12427600|P5|COMPLETED|Overall Study||6
5050724|NCT01955564|12427601|P4|COMPLETED|Overall Study||6
5050725|NCT01955564|12427602|P3|COMPLETED|Overall Study||6
5050726|NCT01955564|12427603|P2|COMPLETED|Overall Study||6
5050727|NCT01955564|12427604|P1|COMPLETED|Overall Study||18
5050728|NCT01955564|12427598|P7|STARTED|Overall Study||6
5050729|NCT01955564|12427599|P6|STARTED|Overall Study||6
5050730|NCT01955564|12427600|P5|STARTED|Overall Study||6
5050731|NCT01955564|12427601|P4|STARTED|Overall Study||6
5050732|NCT01955564|12427602|P3|STARTED|Overall Study||6
5050733|NCT01955564|12427603|P2|STARTED|Overall Study||6
5050734|NCT01955564|12427604|P1|STARTED|Overall Study||18
5050735|NCT01955473|12427637|P5|NOT COMPLETED|Overall Study||0
5050736|NCT01955473|12427638|P4|NOT COMPLETED|Overall Study||0
5050737|NCT01955473|12427639|P3|NOT COMPLETED|Overall Study||0
5050738|NCT01955473|12427640|P2|NOT COMPLETED|Overall Study||0
5050739|NCT01955473|12427641|P1|NOT COMPLETED|Overall Study||0
5050740|NCT01955473|12427637|P5|COMPLETED|Overall Study||30
5050741|NCT01955473|12427638|P4|COMPLETED|Overall Study||6
5050742|NCT01955473|12427639|P3|COMPLETED|Overall Study||6
5050743|NCT01955473|12427640|P2|COMPLETED|Overall Study||6
5050744|NCT01955473|12427641|P1|COMPLETED|Overall Study||3
5050745|NCT01955473|12427637|P5|STARTED|Overall Study||30
5050746|NCT01955473|12427638|P4|STARTED|Overall Study||6
5050747|NCT01955473|12427639|P3|STARTED|Overall Study||6
5050748|NCT01955473|12427640|P2|STARTED|Overall Study||6
5050749|NCT01955473|12427641|P1|STARTED|Overall Study||3
5050750|NCT01955434|12427795|P1|NOT COMPLETED|Overall Study||0
5050751|NCT01955434|12427795|P1|COMPLETED|Overall Study||25
5050752|NCT01955434|12427795|P1|STARTED|Overall Study||25
5050753|NCT01955382|12427805|P2|NOT COMPLETED|Overall Study||0
5050754|NCT01955382|12427806|P1|NOT COMPLETED|Overall Study||0
5050755|NCT01955382|12427805|P2|COMPLETED|Overall Study||35
5050756|NCT01955382|12427806|P1|COMPLETED|Overall Study||35
5050757|NCT01955382|12427805|P2|STARTED|Overall Study||35
5050758|NCT01955382|12427806|P1|STARTED|Overall Study||35
5050759|NCT01955369|12427814|P1|NOT COMPLETED|Overall Study||0
5050760|NCT01955369|12427814|P1|COMPLETED|Overall Study||200
5050761|NCT01955369|12427814|P1|STARTED|Overall Study||200
5050762|NCT01955161|12427823|P3|NOT COMPLETED|Overall Study||35
5050763|NCT01955161|12427824|P2|NOT COMPLETED|Overall Study||25
5050764|NCT01955161|12427825|P1|NOT COMPLETED|Overall Study||27
5050765|NCT01955161|12427823|P3|COMPLETED|Overall Study||275
5050766|NCT01955161|12427824|P2|COMPLETED|Overall Study||288
5050767|NCT01955161|12427825|P1|COMPLETED|Overall Study||283
5050768|NCT01955161|12427823|P3|Treated|Overall Study||309
5050769|NCT01955161|12427824|P2|Treated|Overall Study||313
5050770|NCT01955161|12427825|P1|Treated|Overall Study||308
5050771|NCT01955161|12427823|P3|STARTED|Overall Study||310
5050772|NCT01955161|12427824|P2|STARTED|Overall Study||313
5050773|NCT01955161|12427825|P1|STARTED|Overall Study||310
5050774|NCT01955122|12427865|P2|NOT COMPLETED|Overall Study||5
5050775|NCT01955122|12427866|P1|NOT COMPLETED|Overall Study||5
5050776|NCT01955122|12427865|P2|COMPLETED|Overall Study||57
5050777|NCT01955122|12427866|P1|COMPLETED|Overall Study||59
5050778|NCT01955122|12427865|P2|No. Patients Completed Double Procedure|Overall Study||57
5050779|NCT01955122|12427866|P1|No. Patients Completed Double Procedure|Overall Study||59
5050780|NCT01955122|12427865|P2|No.Patients Enrolled|Overall Study||62
5050781|NCT01955122|12427866|P1|No.Patients Enrolled|Overall Study||64
5050782|NCT01955122|12427865|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
5050783|NCT01955122|12427866|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
5050784|NCT01955083|12427886|P2|NOT COMPLETED|Overall Study||1
5050785|NCT01955083|12427887|P1|NOT COMPLETED|Overall Study||1
5050786|NCT01955083|12427886|P2|COMPLETED|Overall Study||14
5050787|NCT01955083|12427887|P1|COMPLETED|Overall Study||14
5050788|NCT01955083|12427886|P2|STARTED|Overall Study||15
5050789|NCT01955083|12427887|P1|STARTED|Overall Study||15
5050790|NCT01955044|12427920|P3|NOT COMPLETED|Overall Study||0
5050791|NCT01955044|12427921|P2|NOT COMPLETED|Overall Study||1
5050792|NCT01955044|12427922|P1|NOT COMPLETED|Overall Study||1
5050793|NCT01955044|12427920|P3|COMPLETED|Overall Study||10
5050794|NCT01955044|12427921|P2|COMPLETED|Overall Study||9
5050795|NCT01955044|12427922|P1|COMPLETED|Overall Study||9
5050796|NCT01955044|12427920|P3|STARTED|Overall Study||10
5050797|NCT01955044|12427921|P2|STARTED|Overall Study||10
5050798|NCT01955044|12427922|P1|STARTED|Overall Study||10
5050799|NCT01955005|12427935|P2|NOT COMPLETED|Overall Study||5
5050800|NCT01955005|12427936|P1|NOT COMPLETED|Overall Study||3
5050801|NCT01955005|12427935|P2|COMPLETED|Overall Study||25
5050802|NCT01955005|12427936|P1|COMPLETED|Overall Study||27
5050803|NCT01955005|12427935|P2|STARTED|Overall Study||30
5050804|NCT01955005|12427936|P1|STARTED|Overall Study||30
5050805|NCT01954927|12427948|P2|NOT COMPLETED|Overall Study||1
5050806|NCT01954927|12427949|P1|NOT COMPLETED|Overall Study||3
5050807|NCT01954927|12427948|P2|COMPLETED|Overall Study||44
5050808|NCT01954927|12427949|P1|COMPLETED|Overall Study||42
5050809|NCT01954927|12427948|P2|STARTED|Overall Study||45
5050810|NCT01954927|12427949|P1|STARTED|Overall Study||45
5050811|NCT01954771|12427970|P3|NOT COMPLETED|Overall Study||3
5050812|NCT01954771|12427971|P2|NOT COMPLETED|Overall Study||3
5050813|NCT01954771|12427972|P1|NOT COMPLETED|Overall Study||7
5050814|NCT01954771|12427970|P3|COMPLETED|Overall Study||25
5050815|NCT01954771|12427971|P2|COMPLETED|Overall Study||29
5050816|NCT01954771|12427972|P1|COMPLETED|Overall Study||22
5050817|NCT01954771|12427970|P3|STARTED|Overall Study||28
5050818|NCT01954771|12427971|P2|STARTED|Overall Study||32
5050819|NCT01954771|12427972|P1|STARTED|Overall Study||29
5050820|NCT01954745|12427989|P1|NOT COMPLETED|Overall Study||19
5050821|NCT01954745|12427989|P1|COMPLETED|Overall Study||0
5050822|NCT01954745|12427989|P1|STARTED|Overall Study||19
5050823|NCT01954628|12427998|P2|NOT COMPLETED|Overall Study||27
5050824|NCT01954628|12427999|P1|NOT COMPLETED|Overall Study||31
5050825|NCT01954628|12427998|P2|COMPLETED|Overall Study||173
5050826|NCT01954628|12427999|P1|COMPLETED|Overall Study||169
5050827|NCT01954628|12427998|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
5050828|NCT01954628|12427999|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
5050829|NCT01954628|12427998|P2|Pharmacokinetic Population|Overall Study||0
5050830|NCT01954628|12427999|P1|Pharmacokinetic Population|Overall Study||181
5050831|NCT01954628|12427998|P2|Safety Set|Overall Study||200
5050832|NCT01954628|12427999|P1|Safety Set|Overall Study||200
5050833|NCT01954628|12427998|P2|Full Analysis Set (FAS)|Overall Study||198
5050834|NCT01954628|12427999|P1|Full Analysis Set (FAS)|Overall Study||200
5050835|NCT01954628|12427998|P2|STARTED|Overall Study||200
5050836|NCT01954628|12427999|P1|STARTED|Overall Study||200
5050837|NCT01954394|12428020|P2|NOT COMPLETED|Overall Study||57
5050838|NCT01954394|12428021|P1|NOT COMPLETED|Overall Study||30
5050839|NCT01954394|12428020|P2|COMPLETED|Overall Study||598
5050840|NCT01954394|12428021|P1|COMPLETED|Overall Study||301
5050841|NCT01954394|12428020|P2|Treated|Overall Study|Safety population|655
5050842|NCT01954394|12428021|P1|Treated|Overall Study|Safety population|330
5050843|NCT01954394|12428020|P2|STARTED|Overall Study|Enrolled|655
5050844|NCT01954394|12428021|P1|STARTED|Overall Study|Enrolled|331
5050845|NCT01954342|12428075|P4|NOT COMPLETED|Overall Study||18
5050846|NCT01954342|12428076|P3|NOT COMPLETED|Overall Study||0
5050847|NCT01954342|12428077|P2|NOT COMPLETED|Overall Study||0
5050848|NCT01954342|12428078|P1|NOT COMPLETED|Overall Study||0
5050849|NCT01954342|12428075|P4|COMPLETED|Overall Study||0
5050850|NCT01954342|12428076|P3|COMPLETED|Overall Study||10
5050851|NCT01954342|12428077|P2|COMPLETED|Overall Study||8
5050852|NCT01954342|12428078|P1|COMPLETED|Overall Study||36
5050853|NCT01954342|12428075|P4|STARTED|Overall Study||18
5050854|NCT01954342|12428076|P3|STARTED|Overall Study||10
5050855|NCT01954342|12428077|P2|STARTED|Overall Study||8
5050856|NCT01954342|12428078|P1|STARTED|Overall Study||36
5050857|NCT01954264|12428128|P1|NOT COMPLETED|Overall Study||0
5050858|NCT01954264|12428128|P1|COMPLETED|Overall Study||2421
5050859|NCT01954264|12428128|P1|STARTED|Overall Study||2421
5050860|NCT01954251|12428180|P2|NOT COMPLETED|Overall Study||19
5050861|NCT01954251|12428181|P1|NOT COMPLETED|Overall Study||13
5050862|NCT01954251|12428180|P2|COMPLETED|Overall Study||396
5050863|NCT01954251|12428181|P1|COMPLETED|Overall Study||400
5050864|NCT01954251|12428180|P2|STARTED|Overall Study||415
5050865|NCT01954251|12428181|P1|STARTED|Overall Study||413
5050866|NCT01954160|12428217|P2|NOT COMPLETED|Overall Study||0
5050867|NCT01954160|12428218|P1|NOT COMPLETED|Overall Study||5
5050868|NCT01954160|12428217|P2|COMPLETED|Overall Study||0
5050869|NCT01954160|12428218|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
5050870|NCT01954160|12428217|P2|STARTED|Overall Study|Not started|0
5050871|NCT01954160|12428218|P1|STARTED|Overall Study||5
5050872|NCT01954121|12428278|P2|NOT COMPLETED|Overall Study||91
5050873|NCT01954121|12428279|P1|NOT COMPLETED|Overall Study||127
5050874|NCT01954121|12428278|P2|COMPLETED|Overall Study||125
5050875|NCT01954121|12428279|P1|COMPLETED|Overall Study||93
5050876|NCT01954121|12428278|P2|STARTED|Overall Study||216
5050877|NCT01954121|12428279|P1|STARTED|Overall Study||220
5050878|NCT01954082|12428295|P2|NOT COMPLETED|Overall Study||57
5050879|NCT01954082|12428296|P1|NOT COMPLETED|Overall Study||68
5050880|NCT01954082|12428295|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
5050881|NCT01954082|12428296|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
5050882|NCT01954082|12428295|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
5050883|NCT01954082|12428296|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
5050884|NCT01954082|12428295|P2|STARTED|Overall Study||321
5050885|NCT01954082|12428296|P1|STARTED|Overall Study||317
5050886|NCT01954056|12428316|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
5050887|NCT01954056|12428317|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
5050888|NCT01954056|12428316|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
5050889|NCT01954056|12428317|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
5050890|NCT01954056|12428316|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
5050891|NCT01954056|12428317|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
5050892|NCT01954056|12428316|P2|NOT COMPLETED|Birth to 60 Days of Life||0
5050893|NCT01954056|12428317|P1|NOT COMPLETED|Birth to 60 Days of Life||0
5050894|NCT01954056|12428316|P2|COMPLETED|Birth to 60 Days of Life||6
5050895|NCT01954056|12428317|P1|COMPLETED|Birth to 60 Days of Life||6
5050896|NCT01954056|12428316|P2|STARTED|Birth to 60 Days of Life||6
5050897|NCT01954056|12428317|P1|STARTED|Birth to 60 Days of Life||6
5050898|NCT01954017|12428362|P3|NOT COMPLETED|Overall Study||13
5050899|NCT01954017|12428363|P2|NOT COMPLETED|Overall Study||8
5050900|NCT01954017|12428364|P1|NOT COMPLETED|Overall Study||5
5050901|NCT01954017|12428362|P3|COMPLETED|Overall Study||21
5050902|NCT01954017|12428363|P2|COMPLETED|Overall Study||25
5050903|NCT01954017|12428364|P1|COMPLETED|Overall Study||31
5050904|NCT01954017|12428362|P3|STARTED|Overall Study||34
5050905|NCT01954017|12428363|P2|STARTED|Overall Study||33
5050906|NCT01954017|12428364|P1|STARTED|Overall Study||36
5050907|NCT01953913|12428590|P1|NOT COMPLETED|Overall Study||542
5050908|NCT01953913|12428590|P1|COMPLETED|Overall Study||0
5050909|NCT01953913|12428590|P1|Treated|Overall Study||541
5050910|NCT01953913|12428590|P1|STARTED|Overall Study||542
5050911|NCT01953874|12428598|P2|NOT COMPLETED|Overall Study||0
5050912|NCT01953874|12428599|P1|NOT COMPLETED|Overall Study||0
5050913|NCT01953874|12428598|P2|COMPLETED|Overall Study||61
5050914|NCT01953874|12428599|P1|COMPLETED|Overall Study||65
5050915|NCT01953874|12428598|P2|STARTED|Overall Study||61
5050916|NCT01953874|12428599|P1|STARTED|Overall Study||65
5050917|NCT01953601|12428645|P3|NOT COMPLETED|Part 2 (Extension Study)||204
5050918|NCT01953601|12428646|P2|NOT COMPLETED|Part 2 (Extension Study)||191
5050919|NCT01953601|12428647|P1|NOT COMPLETED|Part 2 (Extension Study)||198
5050920|NCT01953601|12428645|P3|COMPLETED|Part 2 (Extension Study)||0
5050921|NCT01953601|12428646|P2|COMPLETED|Part 2 (Extension Study)||0
5050922|NCT01953601|12428647|P1|COMPLETED|Part 2 (Extension Study)||0
5050923|NCT01953601|12428645|P3|Treated|Part 2 (Extension Study)||204
5050924|NCT01953601|12428646|P2|Treated|Part 2 (Extension Study)||191
5050925|NCT01953601|12428647|P1|Treated|Part 2 (Extension Study)||197
5050926|NCT01953601|12428645|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
5050927|NCT01953601|12428646|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
5050928|NCT01953601|12428647|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
5050929|NCT01953601|12428645|P3|NOT COMPLETED|Part 1 (Base Study)||246
5050930|NCT01953601|12428646|P2|NOT COMPLETED|Part 1 (Base Study)||253
5050931|NCT01953601|12428647|P1|NOT COMPLETED|Part 1 (Base Study)||251
5050932|NCT01953601|12428645|P3|COMPLETED|Part 1 (Base Study)||239
5050933|NCT01953601|12428646|P2|COMPLETED|Part 1 (Base Study)||231
5050934|NCT01953601|12428647|P1|COMPLETED|Part 1 (Base Study)||234
5050935|NCT01953601|12428645|P3|Treated|Part 1 (Base Study)||484
5050936|NCT01953601|12428646|P2|Treated|Part 1 (Base Study)||484
5050937|NCT01953601|12428647|P1|Treated|Part 1 (Base Study)||483
5050938|NCT01953601|12428645|P3|STARTED|Part 1 (Base Study)||485
5050939|NCT01953601|12428646|P2|STARTED|Part 1 (Base Study)||484
5050940|NCT01953601|12428647|P1|STARTED|Part 1 (Base Study)||485
5050941|NCT01953575|12428697|P3|NOT COMPLETED|Overall Study||0
5050942|NCT01953575|12428698|P2|NOT COMPLETED|Overall Study||0
5050943|NCT01953575|12428699|P1|NOT COMPLETED|Overall Study||0
5050944|NCT01953575|12428697|P3|COMPLETED|Overall Study||10
5050945|NCT01953575|12428698|P2|COMPLETED|Overall Study||10
5050946|NCT01953575|12428699|P1|COMPLETED|Overall Study||10
5050947|NCT01953575|12428697|P3|STARTED|Overall Study||10
5050948|NCT01953575|12428698|P2|STARTED|Overall Study||10
5050949|NCT01953575|12428699|P1|STARTED|Overall Study||10
5050950|NCT01953432|12428709|P2|NOT COMPLETED|Overall Study||15
5050951|NCT01953432|12428710|P1|NOT COMPLETED|Overall Study||14
5050952|NCT01953432|12428709|P2|COMPLETED|Overall Study||6
5050953|NCT01953432|12428710|P1|COMPLETED|Overall Study||8
5050954|NCT01953432|12428709|P2|STARTED|Overall Study||21
5050955|NCT01953432|12428710|P1|STARTED|Overall Study||22
5050956|NCT01953354|12428718|P2|NOT COMPLETED|Overall Study||2
5050957|NCT01953354|12428719|P1|NOT COMPLETED|Overall Study||1
5050958|NCT01953354|12428718|P2|COMPLETED|Overall Study||5
5050959|NCT01953354|12428719|P1|COMPLETED|Overall Study||8
5050960|NCT01953354|12428718|P2|STARTED|Overall Study||7
5050961|NCT01953354|12428719|P1|STARTED|Overall Study||9
5050962|NCT01953328|12428747|P8|NOT COMPLETED|Overall Study||0
5050963|NCT01953328|12428748|P7|NOT COMPLETED|Overall Study||0
5050964|NCT01953328|12428749|P6|NOT COMPLETED|Overall Study||0
5050965|NCT01953328|12428750|P5|NOT COMPLETED|Overall Study||2
5050966|NCT01953328|12428751|P4|NOT COMPLETED|Overall Study||0
5050967|NCT01953328|12428752|P3|NOT COMPLETED|Overall Study||0
5050968|NCT01953328|12428753|P2|NOT COMPLETED|Overall Study||0
5050969|NCT01953328|12428754|P1|NOT COMPLETED|Overall Study||0
5050970|NCT01953328|12428747|P8|COMPLETED|Overall Study||51
5050971|NCT01953328|12428748|P7|COMPLETED|Overall Study||51
5050972|NCT01953328|12428749|P6|COMPLETED|Overall Study||51
5050973|NCT01953328|12428750|P5|COMPLETED|Overall Study||50
5050974|NCT01953328|12428751|P4|COMPLETED|Overall Study||50
5050975|NCT01953328|12428752|P3|COMPLETED|Overall Study||50
5050976|NCT01953328|12428753|P2|COMPLETED|Overall Study||50
5050977|NCT01953328|12428754|P1|COMPLETED|Overall Study||49
5050978|NCT01953328|12428747|P8|Received Treatment|Overall Study||51
5050979|NCT01953328|12428748|P7|Received Treatment|Overall Study||51
5050980|NCT01953328|12428749|P6|Received Treatment|Overall Study||51
5050981|NCT01953328|12428750|P5|Received Treatment|Overall Study||52
5050982|NCT01953328|12428751|P4|Received Treatment|Overall Study||50
5050983|NCT01953328|12428752|P3|Received Treatment|Overall Study||50
5050984|NCT01953328|12428753|P2|Received Treatment|Overall Study||50
5050985|NCT01953328|12428754|P1|Received Treatment|Overall Study||49
5050986|NCT01953328|12428747|P8|STARTED|Overall Study||51
5050987|NCT01953328|12428748|P7|STARTED|Overall Study||51
5050988|NCT01953328|12428749|P6|STARTED|Overall Study||51
5050989|NCT01953328|12428750|P5|STARTED|Overall Study||52
5050990|NCT01953328|12428751|P4|STARTED|Overall Study||50
5050991|NCT01953328|12428752|P3|STARTED|Overall Study||50
5050992|NCT01953328|12428753|P2|STARTED|Overall Study||50
5050993|NCT01953328|12428754|P1|STARTED|Overall Study||49
5050994|NCT01953237|12428958|P2|NOT COMPLETED|Overall Study||0
5050995|NCT01953237|12428959|P1|NOT COMPLETED|Overall Study||0
5050996|NCT01953237|12428958|P2|COMPLETED|Overall Study||21
5050997|NCT01953237|12428959|P1|COMPLETED|Overall Study||10
5050998|NCT01953237|12428958|P2|STARTED|Overall Study||21
5050999|NCT01953237|12428959|P1|STARTED|Overall Study||10
5051000|NCT01953224|12428967|P2|NOT COMPLETED|Overall Study||3
5051001|NCT01953224|12428968|P1|NOT COMPLETED|Overall Study||2
5051002|NCT01953224|12428967|P2|COMPLETED|Overall Study||17
5051003|NCT01953224|12428968|P1|COMPLETED|Overall Study||18
5051004|NCT01953224|12428967|P2|STARTED|Overall Study||20
5051005|NCT01953224|12428968|P1|STARTED|Overall Study||20
5051006|NCT01953211|12428984|P1|NOT COMPLETED|Overall Study||0
5051007|NCT01953211|12428984|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
5051008|NCT01953211|12428984|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
5051009|NCT01953081|12428992|P2|NOT COMPLETED|Overall Study||3
5051010|NCT01953081|12428993|P1|NOT COMPLETED|Overall Study||2
5051011|NCT01953081|12428992|P2|COMPLETED|Overall Study||3
5051012|NCT01953081|12428993|P1|COMPLETED|Overall Study||5
5051013|NCT01953081|12428992|P2|STARTED|Overall Study||6
5051014|NCT01953081|12428993|P1|STARTED|Overall Study||7
5051015|NCT01953003|12429017|P2|NOT COMPLETED|Overall Study||55
5051016|NCT01953003|12429018|P1|NOT COMPLETED|Overall Study||56
5051017|NCT01953003|12429017|P2|COMPLETED|Overall Study||1
5051018|NCT01953003|12429018|P1|COMPLETED|Overall Study||0
5051019|NCT01953003|12429017|P2|STARTED|Overall Study||56
5051020|NCT01953003|12429018|P1|STARTED|Overall Study||56
5051021|NCT01952834|12429024|P1|NOT COMPLETED|Overall Study||1
5051022|NCT01952834|12429024|P1|COMPLETED|Overall Study||20
5051023|NCT01952834|12429024|P1|STARTED|Overall Study||21
5051024|NCT01952691|12429031|P1|NOT COMPLETED|Overall Study||2
5051025|NCT01952691|12429031|P1|COMPLETED|Overall Study||20
5051026|NCT01952691|12429031|P1|STARTED|Overall Study||22
5051027|NCT01952678|12429039|P2|NOT COMPLETED|Overall Study||0
5051028|NCT01952678|12429040|P1|NOT COMPLETED|Overall Study||0
5051029|NCT01952678|12429039|P2|COMPLETED|Overall Study||102
5051030|NCT01952678|12429040|P1|COMPLETED|Overall Study||102
5051031|NCT01952678|12429039|P2|STARTED|Overall Study||102
5051032|NCT01952678|12429040|P1|STARTED|Overall Study||102
5051033|NCT01952665|12429058|P2|NOT COMPLETED|Overall Study||6
5051034|NCT01952665|12429059|P1|NOT COMPLETED|Overall Study||6
5051035|NCT01952665|12429058|P2|COMPLETED|Overall Study||20
5051036|NCT01952665|12429059|P1|COMPLETED|Overall Study||31
5051037|NCT01952665|12429058|P2|STARTED|Overall Study||26
5051038|NCT01952665|12429059|P1|STARTED|Overall Study||37
5051039|NCT01952600|12429200|P3|NOT COMPLETED|Overall Study||7
5051040|NCT01952600|12429201|P2|NOT COMPLETED|Overall Study||13
5051041|NCT01952600|12429202|P1|NOT COMPLETED|Overall Study||15
5051042|NCT01952600|12429200|P3|COMPLETED|Overall Study||38
5051043|NCT01952600|12429201|P2|COMPLETED|Overall Study||77
5051044|NCT01952600|12429202|P1|COMPLETED|Overall Study||65
5051045|NCT01952600|12429200|P3|STARTED|Overall Study||45
5051046|NCT01952600|12429201|P2|STARTED|Overall Study||90
5051047|NCT01952600|12429202|P1|STARTED|Overall Study||80
5051048|NCT01952574|12429214|P4|NOT COMPLETED|Overall Study||6
5051049|NCT01952574|12429215|P3|NOT COMPLETED|Overall Study||9
5051050|NCT01952574|12429216|P2|NOT COMPLETED|Overall Study||3
5051051|NCT01952574|12429217|P1|NOT COMPLETED|Overall Study||17
5051052|NCT01952574|12429214|P4|COMPLETED|Overall Study||101
5051053|NCT01952574|12429215|P3|COMPLETED|Overall Study||99
5051054|NCT01952574|12429216|P2|COMPLETED|Overall Study||105
5051055|NCT01952574|12429217|P1|COMPLETED|Overall Study||143
5051056|NCT01952574|12429214|P4|Received Study Drug|Overall Study||106
5051057|NCT01952574|12429215|P3|Received Study Drug|Overall Study||105
5051058|NCT01952574|12429216|P2|Received Study Drug|Overall Study||108
5051059|NCT01952574|12429217|P1|Received Study Drug|Overall Study||153
5051060|NCT01952574|12429214|P4|STARTED|Overall Study||107
5051061|NCT01952574|12429215|P3|STARTED|Overall Study||108
5051062|NCT01952574|12429216|P2|STARTED|Overall Study||108
5051063|NCT01952574|12429217|P1|STARTED|Overall Study||160
5051064|NCT01952470|12429237|P2|NOT COMPLETED|Overall Study||3
5051065|NCT01952470|12429238|P1|NOT COMPLETED|Overall Study||3
5051066|NCT01952470|12429237|P2|COMPLETED|Overall Study||13
5051067|NCT01952470|12429238|P1|COMPLETED|Overall Study||13
5051068|NCT01952470|12429237|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
5051069|NCT01952470|12429238|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
5051070|NCT01952470|12429237|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
5051071|NCT01952470|12429238|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
5051072|NCT01952470|12429237|P2|Missing Baseline LCI 2% Data.|Overall Study||2
5051073|NCT01952470|12429238|P1|Missing Baseline LCI 2% Data.|Overall Study||0
5051074|NCT01952470|12429237|P2|Death|Overall Study||1
5051075|NCT01952470|12429238|P1|Death|Overall Study||1
5051076|NCT01952470|12429237|P2|Discontinued Intervention|Overall Study||1
5051077|NCT01952470|12429238|P1|Discontinued Intervention|Overall Study||2
5051078|NCT01952470|12429237|P2|ITT Analysis|Overall Study||16
5051079|NCT01952470|12429238|P1|ITT Analysis|Overall Study||16
5051080|NCT01952470|12429237|P2|STARTED|Overall Study||16
5051081|NCT01952470|12429238|P1|STARTED|Overall Study||16
5051082|NCT01952444|12429276|P2|NOT COMPLETED|Overall Study||1
5051083|NCT01952444|12429277|P1|NOT COMPLETED|Overall Study||0
5051084|NCT01952444|12429276|P2|COMPLETED|Overall Study||19
5051085|NCT01952444|12429277|P1|COMPLETED|Overall Study||20
5051086|NCT01952444|12429276|P2|STARTED|Overall Study||20
5051087|NCT01952444|12429277|P1|STARTED|Overall Study||20
5051088|NCT01952418|12429303|P2|NOT COMPLETED|Overall Study||0
5051089|NCT01952418|12429304|P1|NOT COMPLETED|Overall Study||0
5051090|NCT01952418|12429303|P2|COMPLETED|Overall Study||895
5051091|NCT01952418|12429304|P1|COMPLETED|Overall Study||910
5051092|NCT01952418|12429303|P2|STARTED|Overall Study||895
5051093|NCT01952418|12429304|P1|STARTED|Overall Study||910
5051094|NCT01952366|12429316|P1|NOT COMPLETED|Overall Study||31
5051095|NCT01952366|12429316|P1|COMPLETED|Overall Study||138
5051096|NCT01952366|12429316|P1|STARTED|Overall Study||169
5051097|NCT01952301|12429323|P1|NOT COMPLETED|Overall Study||0
5051098|NCT01952301|12429323|P1|COMPLETED|Overall Study||30
5051099|NCT01952301|12429323|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
5051100|NCT01952145|12429331|P2|NOT COMPLETED|Overall Study||14
5051101|NCT01952145|12429332|P1|NOT COMPLETED|Overall Study||28
5051102|NCT01952145|12429331|P2|COMPLETED|Overall Study||265
5051103|NCT01952145|12429332|P1|COMPLETED|Overall Study||250
5051104|NCT01952145|12429331|P2|STARTED|Overall Study||279
5051105|NCT01952145|12429332|P1|STARTED|Overall Study||278
5051106|NCT01952080|12429346|P4|NOT COMPLETED|Overall Study||1
5051107|NCT01952080|12429347|P3|NOT COMPLETED|Overall Study||0
5051108|NCT01952080|12429348|P2|NOT COMPLETED|Overall Study||1
5051109|NCT01952080|12429349|P1|NOT COMPLETED|Overall Study||0
5051110|NCT01952080|12429346|P4|COMPLETED|Overall Study||14
5051111|NCT01952080|12429347|P3|COMPLETED|Overall Study||14
5051112|NCT01952080|12429348|P2|COMPLETED|Overall Study||7
5051113|NCT01952080|12429349|P1|COMPLETED|Overall Study||5
5051114|NCT01952080|12429346|P4|Treated|Overall Study||15
5051115|NCT01952080|12429347|P3|Treated|Overall Study||14
5051116|NCT01952080|12429348|P2|Treated|Overall Study||8
5051117|NCT01952080|12429349|P1|Treated|Overall Study||5
5051118|NCT01952080|12429346|P4|STARTED|Overall Study||15
5051119|NCT01952080|12429347|P3|STARTED|Overall Study||14
5051120|NCT01952080|12429348|P2|STARTED|Overall Study||8
5051121|NCT01952080|12429349|P1|STARTED|Overall Study||5
5051122|NCT01952054|12429395|P1|NOT COMPLETED|Overall Study||1
5051123|NCT01952054|12429395|P1|COMPLETED|Overall Study||5
5051124|NCT01952054|12429395|P1|STARTED|Overall Study||6
5051125|NCT01952041|12429403|P2|NOT COMPLETED|Overall Study||21
5051126|NCT01952041|12429404|P1|NOT COMPLETED|Overall Study||17
5051127|NCT01952041|12429403|P2|COMPLETED|Overall Study||43
5051128|NCT01952041|12429404|P1|COMPLETED|Overall Study||45
5051129|NCT01952041|12429403|P2|STARTED|Overall Study||64
5051130|NCT01952041|12429404|P1|STARTED|Overall Study||62
5051131|NCT01952015|12429418|P1|NOT COMPLETED|Treatment Period 3||9
5051132|NCT01952015|12429418|P1|COMPLETED|Treatment Period 3||0
5051133|NCT01952015|12429418|P1|STARTED|Treatment Period 3||9
5051134|NCT01952015|12429418|P1|NOT COMPLETED|Maintenance||2
5051135|NCT01952015|12429418|P1|COMPLETED|Maintenance||9
5051136|NCT01952015|12429418|P1|STARTED|Maintenance||11
5051137|NCT01952015|12429418|P1|NOT COMPLETED|Induction||1
5051138|NCT01952015|12429418|P1|COMPLETED|Induction||11
5051139|NCT01952015|12429418|P1|STARTED|Induction||12
5051140|NCT01951963|12429441|P2|NOT COMPLETED|Overall Study||0
5051141|NCT01951963|12429442|P1|NOT COMPLETED|Overall Study||0
5051142|NCT01951963|12429441|P2|COMPLETED|Overall Study||32
5051143|NCT01951963|12429442|P1|COMPLETED|Overall Study||31
5051144|NCT01951963|12429441|P2|STARTED|Overall Study||32
5051145|NCT01951963|12429442|P1|STARTED|Overall Study||31
5051146|NCT01951950|12429454|P2|NOT COMPLETED|Overall Study||6
5051147|NCT01951950|12429455|P1|NOT COMPLETED|Overall Study||6
5051148|NCT01951950|12429454|P2|COMPLETED|Overall Study||20
5051149|NCT01951950|12429455|P1|COMPLETED|Overall Study||20
5051150|NCT01951950|12429454|P2|STARTED|Overall Study||26
5051151|NCT01951950|12429455|P1|STARTED|Overall Study||26
5051152|NCT01951820|12429463|P2|NOT COMPLETED|Overall Study||0
5051153|NCT01951820|12429464|P1|NOT COMPLETED|Overall Study||0
5051154|NCT01951820|12429463|P2|COMPLETED|Overall Study||30
5051155|NCT01951820|12429464|P1|COMPLETED|Overall Study||34
5051156|NCT01951820|12429463|P2|STARTED|Overall Study||30
5051157|NCT01951820|12429464|P1|STARTED|Overall Study||34
5051158|NCT01951768|12429472|P2|NOT COMPLETED|Overall Study||0
5051159|NCT01951768|12429473|P1|NOT COMPLETED|Overall Study||0
5051160|NCT01951768|12429472|P2|COMPLETED|Overall Study|45 patients|45
5051161|NCT01951768|12429473|P1|COMPLETED|Overall Study|43 patients|43
5051162|NCT01951768|12429472|P2|STARTED|Overall Study||45
5051163|NCT01951768|12429473|P1|STARTED|Overall Study||43
5051164|NCT01951703|12429485|P2|NOT COMPLETED|Second Intervention||2
5051165|NCT01951703|12429486|P1|NOT COMPLETED|Second Intervention||0
5051166|NCT01951703|12429485|P2|COMPLETED|Second Intervention||60
5051167|NCT01951703|12429486|P1|COMPLETED|Second Intervention||61
5051168|NCT01951703|12429485|P2|STARTED|Second Intervention||62
5051169|NCT01951703|12429486|P1|STARTED|Second Intervention||61
5051170|NCT01951703|12429485|P2|NOT COMPLETED|First Intervention||1
5051171|NCT01951703|12429486|P1|NOT COMPLETED|First Intervention||3
5051172|NCT01951703|12429485|P2|COMPLETED|First Intervention||62
5051173|NCT01951703|12429486|P1|COMPLETED|First Intervention||61
5051174|NCT01951703|12429485|P2|STARTED|First Intervention||63
5051175|NCT01951703|12429486|P1|STARTED|First Intervention||64
5051176|NCT01951651|12429496|P2|NOT COMPLETED|Overall Study||2
5051177|NCT01951651|12429497|P1|NOT COMPLETED|Overall Study||4
5051178|NCT01951651|12429496|P2|COMPLETED|Overall Study||10
5051179|NCT01951651|12429497|P1|COMPLETED|Overall Study||8
5051180|NCT01951651|12429496|P2|STARTED|Overall Study||12
5051181|NCT01951651|12429497|P1|STARTED|Overall Study||12
5051182|NCT01951586|12429511|P2|NOT COMPLETED|Overall Study||148
5051183|NCT01951586|12429512|P1|NOT COMPLETED|Overall Study||78
5051184|NCT01951586|12429511|P2|COMPLETED|Overall Study||0
5051185|NCT01951586|12429512|P1|COMPLETED|Overall Study||0
5051186|NCT01951586|12429511|P2|Received Study Drug|Overall Study||145
5051187|NCT01951586|12429512|P1|Received Study Drug|Overall Study||76
5051188|NCT01951586|12429511|P2|STARTED|Overall Study||148
5051189|NCT01951586|12429512|P1|STARTED|Overall Study||78
5051190|NCT01951573|12429536|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
5051191|NCT01951573|12429537|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
5051192|NCT01951573|12429536|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
5051193|NCT01951573|12429537|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
5051194|NCT01951573|12429536|P2|STARTED|Period 2, Second 9 Hours of Wear||16
5051195|NCT01951573|12429537|P1|STARTED|Period 2, Second 9 Hours of Wear||17
5051196|NCT01951573|12429536|P2|NOT COMPLETED|Washout Period||1
5051197|NCT01951573|12429537|P1|NOT COMPLETED|Washout Period||0
5051198|NCT01951573|12429536|P2|COMPLETED|Washout Period||16
5051199|NCT01951573|12429537|P1|COMPLETED|Washout Period||17
5051200|NCT01951573|12429536|P2|STARTED|Washout Period||17
5051201|NCT01951573|12429537|P1|STARTED|Washout Period||17
5051202|NCT01951573|12429536|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
5051203|NCT01951573|12429537|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
5051204|NCT01951573|12429536|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
5051205|NCT01951573|12429537|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
5051206|NCT01951573|12429536|P2|STARTED|Period 1, First 9 Hours of Wear||17
5051207|NCT01951573|12429537|P1|STARTED|Period 1, First 9 Hours of Wear||17
5051208|NCT01951417|12429547|P1|NOT COMPLETED|Overall Study||9
5051209|NCT01951417|12429547|P1|COMPLETED|Overall Study||72
5051210|NCT01951417|12429547|P1|STARTED|Overall Study||81
5051211|NCT01951391|12429572|P2|NOT COMPLETED|Overall Study||0
5051212|NCT01951391|12429573|P1|NOT COMPLETED|Overall Study||0
5051213|NCT01951391|12429572|P2|COMPLETED|Overall Study||5
5051214|NCT01951391|12429573|P1|COMPLETED|Overall Study||5
5051215|NCT01951391|12429572|P2|STARTED|Overall Study||5
5051216|NCT01951391|12429573|P1|STARTED|Overall Study||5
5051217|NCT01951352|12429581|P1|NOT COMPLETED|Overall Study||0
5051218|NCT01951352|12429581|P1|COMPLETED|Overall Study||10
5051219|NCT01951352|12429581|P1|STARTED|Overall Study||10
5051220|NCT01951339|12429590|P2|NOT COMPLETED|Overall Study||1
5051221|NCT01951339|12429591|P1|NOT COMPLETED|Overall Study||2
5051222|NCT01951339|12429590|P2|COMPLETED|Overall Study||14
5051223|NCT01951339|12429591|P1|COMPLETED|Overall Study||13
5051224|NCT01951339|12429590|P2|STARTED|Overall Study||15
5051225|NCT01951339|12429591|P1|STARTED|Overall Study||15
5051226|NCT01951326|12429615|P2|NOT COMPLETED|Overall Study||78
5051227|NCT01951326|12429616|P1|NOT COMPLETED|Overall Study||79
5051228|NCT01951326|12429615|P2|COMPLETED|Overall Study||87
5051229|NCT01951326|12429616|P1|COMPLETED|Overall Study||87
5051230|NCT01951326|12429615|P2|STARTED|Overall Study||165
5051231|NCT01951326|12429616|P1|STARTED|Overall Study||166
5051232|NCT01951170|12429648|P1|NOT COMPLETED|Overall Study||1
5051233|NCT01951170|12429648|P1|COMPLETED|Overall Study||51
5051234|NCT01951170|12429648|P1|STARTED|Overall Study||52
5051235|NCT01951157|12429674|P3|NOT COMPLETED|Overall Study||25
5051236|NCT01951157|12429675|P2|NOT COMPLETED|Overall Study||22
5051237|NCT01951157|12429676|P1|NOT COMPLETED|Overall Study||22
5051238|NCT01951157|12429674|P3|COMPLETED|Overall Study||0
5051239|NCT01951157|12429675|P2|COMPLETED|Overall Study||0
5051240|NCT01951157|12429676|P1|COMPLETED|Overall Study||0
5051241|NCT01951157|12429674|P3|STARTED|Overall Study||25
5051242|NCT01951157|12429675|P2|STARTED|Overall Study||22
5051243|NCT01951157|12429676|P1|STARTED|Overall Study||22
5051244|NCT01951118|12429705|P1|NOT COMPLETED|Overall Study||27
5051245|NCT01951118|12429705|P1|COMPLETED|Overall Study||94
5051246|NCT01951118|12429705|P1|STARTED|Overall Study||121
5051247|NCT01951105|12429727|P3|NOT COMPLETED|Overall Study||2
5051248|NCT01951105|12429728|P2|NOT COMPLETED|Overall Study||10
5051249|NCT01951105|12429729|P1|NOT COMPLETED|Overall Study||1
5051250|NCT01951105|12429727|P3|COMPLETED|Overall Study||28
5051251|NCT01951105|12429728|P2|COMPLETED|Overall Study||21
5051252|NCT01951105|12429729|P1|COMPLETED|Overall Study||10
5051253|NCT01951105|12429727|P3|Completed 12 Weeks Treatment|Overall Study||28
5051254|NCT01951105|12429728|P2|Completed 12 Weeks Treatment|Overall Study||24
5051255|NCT01951105|12429729|P1|Completed 12 Weeks Treatment|Overall Study||10
5051256|NCT01951105|12429727|P3|STARTED|Overall Study||30
5051257|NCT01951105|12429728|P2|STARTED|Overall Study||31
5051258|NCT01951105|12429729|P1|STARTED|Overall Study||11
5051259|NCT01951092|12429743|P1|NOT COMPLETED|Overall Study||12
5051260|NCT01951092|12429743|P1|COMPLETED|Overall Study||20
5051261|NCT01951092|12429743|P1|STARTED|Overall Study||32
5051262|NCT01951066|12429748|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
5051263|NCT01951066|12429749|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
5051264|NCT01951066|12429748|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
5051265|NCT01951066|12429749|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
5051266|NCT01951066|12429748|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
5051267|NCT01951066|12429749|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
5051268|NCT01951066|12429748|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
5051269|NCT01951066|12429749|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
5051270|NCT01951066|12429748|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
5051271|NCT01951066|12429749|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
5051272|NCT01951066|12429748|P2|STARTED|First Intervention (Baseline to Week 16)||10
5051273|NCT01951066|12429749|P1|STARTED|First Intervention (Baseline to Week 16)||10
5051274|NCT01950819|12429756|P2|NOT COMPLETED|Overall Study||134
5051275|NCT01950819|12429757|P1|NOT COMPLETED|Overall Study||129
5051276|NCT01950819|12429756|P2|COMPLETED|Overall Study||881
5051277|NCT01950819|12429757|P1|COMPLETED|Overall Study||893
5051278|NCT01950819|12429756|P2|STARTED|Overall Study||1015
5051279|NCT01950819|12429757|P1|STARTED|Overall Study||1022
5051280|NCT01950780|12429805|P1|NOT COMPLETED|Overall Study||0
5051281|NCT01950780|12429805|P1|COMPLETED|Overall Study||12
5051282|NCT01950780|12429805|P1|STARTED|Overall Study||12
5051283|NCT01950741|12429810|P1|NOT COMPLETED|Overall Study||3
5051284|NCT01950741|12429810|P1|COMPLETED|Overall Study||45
5051285|NCT01950741|12429810|P1|STARTED|Overall Study||48
5051286|NCT01950663|12429819|P1|NOT COMPLETED|Overall Study||1
5051287|NCT01950663|12429819|P1|COMPLETED|Overall Study||467
5051288|NCT01950663|12429819|P1|STARTED|Overall Study||468
5051289|NCT01950364|12429825|P2|NOT COMPLETED|Overall Study||10
5051290|NCT01950364|12429826|P1|NOT COMPLETED|Overall Study||10
5051291|NCT01950364|12429825|P2|COMPLETED|Overall Study||0
5051292|NCT01950364|12429826|P1|COMPLETED|Overall Study||0
5051293|NCT01950364|12429825|P2|STARTED|Overall Study||10
5051294|NCT01950364|12429826|P1|STARTED|Overall Study||10
5051295|NCT01950299|12429927|P3|NOT COMPLETED|Overall Study||7
5051296|NCT01950299|12429928|P2|NOT COMPLETED|Overall Study||4
5051297|NCT01950299|12429929|P1|NOT COMPLETED|Overall Study||11
5051298|NCT01950299|12429927|P3|COMPLETED|Overall Study||28
5051299|NCT01950299|12429928|P2|COMPLETED|Overall Study||27
5051300|NCT01950299|12429929|P1|COMPLETED|Overall Study||22
5051301|NCT01950299|12429927|P3|STARTED|Overall Study||35
5051302|NCT01950299|12429928|P2|STARTED|Overall Study||31
5051303|NCT01950299|12429929|P1|STARTED|Overall Study||33
5051304|NCT01950273|12429948|P2|NOT COMPLETED|Overall Study||0
5051305|NCT01950273|12429949|P1|NOT COMPLETED|Overall Study||4
5051306|NCT01950273|12429948|P2|COMPLETED|Overall Study||46
5051307|NCT01950273|12429949|P1|COMPLETED|Overall Study||45
5051308|NCT01950273|12429948|P2|STARTED|Overall Study||46
5051309|NCT01950273|12429949|P1|STARTED|Overall Study||49
5051310|NCT01950260|12429971|P2|NOT COMPLETED|Overall Study||0
5051311|NCT01950260|12429972|P1|NOT COMPLETED|Overall Study||0
5051312|NCT01950260|12429971|P2|COMPLETED|Overall Study||31
5051313|NCT01950260|12429972|P1|COMPLETED|Overall Study||30
5051314|NCT01950260|12429971|P2|STARTED|Overall Study||31
5051315|NCT01950260|12429972|P1|STARTED|Overall Study||30
5051316|NCT01950078|12429984|P2|NOT COMPLETED|Overall Study||12
5051317|NCT01950078|12429985|P1|NOT COMPLETED|Overall Study||20
5051318|NCT01950078|12429984|P2|COMPLETED|Overall Study||496
5051319|NCT01950078|12429985|P1|COMPLETED|Overall Study||1005
5051320|NCT01950078|12429984|P2|STARTED|Overall Study||508
5051321|NCT01950078|12429985|P1|STARTED|Overall Study||1025
5051322|NCT01950013|12429996|P3|NOT COMPLETED|Overall Study||0
5051323|NCT01950013|12429997|P2|NOT COMPLETED|Overall Study||2
5051324|NCT01950013|12429998|P1|NOT COMPLETED|Overall Study||0
5051325|NCT01950013|12429996|P3|COMPLETED|Overall Study||15
5051326|NCT01950013|12429997|P2|COMPLETED|Overall Study||13
5051327|NCT01950013|12429998|P1|COMPLETED|Overall Study||15
5051328|NCT01950013|12429996|P3|STARTED|Overall Study||15
5051329|NCT01950013|12429997|P2|STARTED|Overall Study||15
5051330|NCT01950013|12429998|P1|STARTED|Overall Study||15
5051331|NCT01949870|12430009|P1|NOT COMPLETED|Overall Study||6
5051332|NCT01949870|12430009|P1|COMPLETED|Overall Study||0
5051333|NCT01949870|12430009|P1|Received Treatment|Overall Study||4
5051334|NCT01949870|12430009|P1|STARTED|Overall Study||6
5051335|NCT01949844|12430013|P1|NOT COMPLETED|Overall Study||0
5051336|NCT01949844|12430013|P1|COMPLETED|Overall Study||44
5051337|NCT01949844|12430013|P1|STARTED|Overall Study||44
5051338|NCT01949779|12430017|P1|NOT COMPLETED|Overall Study||2
5051339|NCT01949779|12430017|P1|COMPLETED|Overall Study||79
5051340|NCT01949779|12430017|P1|STARTED|Overall Study||81
5051341|NCT01949545|12430027|P4|NOT COMPLETED|Overall Study||0
5051342|NCT01949545|12430028|P3|NOT COMPLETED|Overall Study||0
5051343|NCT01949545|12430029|P2|NOT COMPLETED|Overall Study||0
5051344|NCT01949545|12430030|P1|NOT COMPLETED|Overall Study||0
5051345|NCT01949545|12430027|P4|COMPLETED|Overall Study||4
5051346|NCT01949545|12430028|P3|COMPLETED|Overall Study||14
5051347|NCT01949545|12430029|P2|COMPLETED|Overall Study||17
5051348|NCT01949545|12430030|P1|COMPLETED|Overall Study||11
5051349|NCT01949545|12430027|P4|STARTED|Overall Study||4
5051350|NCT01949545|12430028|P3|STARTED|Overall Study||14
5051351|NCT01949545|12430029|P2|STARTED|Overall Study||17
5051352|NCT01949545|12430030|P1|STARTED|Overall Study||11
5051353|NCT01949532|12430178|P2|NOT COMPLETED|Overall Study||3
5051354|NCT01949532|12430179|P1|NOT COMPLETED|Overall Study||3
5051355|NCT01949532|12430178|P2|COMPLETED|Overall Study||8
5051356|NCT01949532|12430179|P1|COMPLETED|Overall Study||12
5051357|NCT01949532|12430178|P2|STARTED|Overall Study||11
5051358|NCT01949532|12430179|P1|STARTED|Overall Study||15
5051359|NCT01949480|12430249|P2|NOT COMPLETED|Overall Study||8
5051360|NCT01949480|12430250|P1|NOT COMPLETED|Overall Study||5
5051361|NCT01949480|12430249|P2|COMPLETED|Overall Study||14
5051362|NCT01949480|12430250|P1|COMPLETED|Overall Study||15
5051363|NCT01949480|12430249|P2|STARTED|Overall Study||22
5051364|NCT01949480|12430250|P1|STARTED|Overall Study||20
5051365|NCT01949389|12430278|P1|NOT COMPLETED|Overall Study||0
5051366|NCT01949389|12430278|P1|COMPLETED|Overall Study||51
5051367|NCT01949389|12430278|P1|STARTED|Overall Study||51
5051368|NCT01949337|12430285|P2|NOT COMPLETED|Overall Study||0
5051369|NCT01949337|12430286|P1|NOT COMPLETED|Overall Study||0
5051370|NCT01949337|12430285|P2|COMPLETED|Overall Study||654
5051371|NCT01949337|12430286|P1|COMPLETED|Overall Study||657
5051372|NCT01949337|12430285|P2|STARTED|Overall Study||654
5051373|NCT01949337|12430286|P1|STARTED|Overall Study||657
5051374|NCT01949155|12430296|P2|NOT COMPLETED|Overall Study||0
5051375|NCT01949155|12430297|P1|NOT COMPLETED|Overall Study||2
5051376|NCT01949155|12430296|P2|COMPLETED|Overall Study||88
5051377|NCT01949155|12430297|P1|COMPLETED|Overall Study||176
5051378|NCT01949155|12430296|P2|STARTED|Overall Study||88
5051379|NCT01949155|12430297|P1|STARTED|Overall Study||178
5051380|NCT01949142|12430309|P2|NOT COMPLETED|Overall Study||1
5051381|NCT01949142|12430310|P1|NOT COMPLETED|Overall Study||3
5051382|NCT01949142|12430309|P2|COMPLETED|Overall Study||86
5051383|NCT01949142|12430310|P1|COMPLETED|Overall Study||176
5051384|NCT01949142|12430309|P2|STARTED|Overall Study||87
5051385|NCT01949142|12430310|P1|STARTED|Overall Study||179
5051386|NCT01949116|12430322|P2|NOT COMPLETED|Overall Study||6
5051387|NCT01949116|12430323|P1|NOT COMPLETED|Overall Study||8
5051388|NCT01949116|12430322|P2|COMPLETED|Overall Study||84
5051389|NCT01949116|12430323|P1|COMPLETED|Overall Study||78
5051390|NCT01949116|12430322|P2|STARTED|Overall Study||90
5051391|NCT01949116|12430323|P1|STARTED|Overall Study||86
5051392|NCT01949090|12430360|P5|NOT COMPLETED|Overall Study||4
5051393|NCT01949090|12430361|P4|NOT COMPLETED|Overall Study||1
5051394|NCT01949090|12430362|P3|NOT COMPLETED|Overall Study||2
5051395|NCT01949090|12430363|P2|NOT COMPLETED|Overall Study||2
5051396|NCT01949090|12430364|P1|NOT COMPLETED|Overall Study||4
5051397|NCT01949090|12430360|P5|COMPLETED|Overall Study||116
5051398|NCT01949090|12430361|P4|COMPLETED|Overall Study||59
5051399|NCT01949090|12430362|P3|COMPLETED|Overall Study||58
5051400|NCT01949090|12430363|P2|COMPLETED|Overall Study||58
5051401|NCT01949090|12430364|P1|COMPLETED|Overall Study||56
5051402|NCT01949090|12430360|P5|STARTED|Overall Study||120
5051403|NCT01949090|12430361|P4|STARTED|Overall Study||60
5051404|NCT01949090|12430362|P3|STARTED|Overall Study||60
5051405|NCT01949090|12430363|P2|STARTED|Overall Study||60
5051406|NCT01949090|12430364|P1|STARTED|Overall Study||60
5051407|NCT01949051|12430541|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051408|NCT01949051|12430542|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051409|NCT01949051|12430543|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051410|NCT01949051|12430544|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051411|NCT01949051|12430545|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051412|NCT01949051|12430546|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5051413|NCT01949051|12430541|P6|COMPLETED|Treatment Period 3 (7 Days)||12
5051414|NCT01949051|12430542|P5|COMPLETED|Treatment Period 3 (7 Days)||13
5051415|NCT01949051|12430543|P4|COMPLETED|Treatment Period 3 (7 Days)||12
5051416|NCT01949051|12430544|P3|COMPLETED|Treatment Period 3 (7 Days)||12
5051417|NCT01949051|12430545|P2|COMPLETED|Treatment Period 3 (7 Days)||12
5051418|NCT01949051|12430546|P1|COMPLETED|Treatment Period 3 (7 Days)||11
5051419|NCT01949051|12430541|P6|STARTED|Treatment Period 3 (7 Days)||12
5051420|NCT01949051|12430542|P5|STARTED|Treatment Period 3 (7 Days)||13
5051421|NCT01949051|12430543|P4|STARTED|Treatment Period 3 (7 Days)||12
5051422|NCT01949051|12430544|P3|STARTED|Treatment Period 3 (7 Days)||12
5051423|NCT01949051|12430545|P2|STARTED|Treatment Period 3 (7 Days)||12
5051424|NCT01949051|12430546|P1|STARTED|Treatment Period 3 (7 Days)||11
5051425|NCT01949051|12430541|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051426|NCT01949051|12430542|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051427|NCT01949051|12430543|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051428|NCT01949051|12430544|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051429|NCT01949051|12430545|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051430|NCT01949051|12430546|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
5051431|NCT01949051|12430541|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
5051432|NCT01949051|12430542|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
5051433|NCT01949051|12430543|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
5051434|NCT01949051|12430544|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
5051435|NCT01949051|12430545|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
5051436|NCT01949051|12430546|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
5051437|NCT01949051|12430541|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
5051438|NCT01949051|12430542|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
5051439|NCT01949051|12430543|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
5051440|NCT01949051|12430544|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
5051441|NCT01949051|12430545|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
5051442|NCT01949051|12430546|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
5051443|NCT01949051|12430541|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
5051444|NCT01949051|12430542|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5051445|NCT01949051|12430543|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5051446|NCT01949051|12430544|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
5051447|NCT01949051|12430545|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
5051448|NCT01949051|12430546|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5051449|NCT01949051|12430541|P6|COMPLETED|Treatment Period 2 (7 Days)||12
5051450|NCT01949051|12430542|P5|COMPLETED|Treatment Period 2 (7 Days)||13
5051451|NCT01949051|12430543|P4|COMPLETED|Treatment Period 2 (7 Days)||12
5051452|NCT01949051|12430544|P3|COMPLETED|Treatment Period 2 (7 Days)||12
5051453|NCT01949051|12430545|P2|COMPLETED|Treatment Period 2 (7 Days)||12
5051454|NCT01949051|12430546|P1|COMPLETED|Treatment Period 2 (7 Days)||11
5051455|NCT01949051|12430541|P6|STARTED|Treatment Period 2 (7 Days)||13
5051456|NCT01949051|12430542|P5|STARTED|Treatment Period 2 (7 Days)||13
5051457|NCT01949051|12430543|P4|STARTED|Treatment Period 2 (7 Days)||12
5051458|NCT01949051|12430544|P3|STARTED|Treatment Period 2 (7 Days)||13
5051459|NCT01949051|12430545|P2|STARTED|Treatment Period 2 (7 Days)||13
5051460|NCT01949051|12430546|P1|STARTED|Treatment Period 2 (7 Days)||11
5051461|NCT01949051|12430541|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051462|NCT01949051|12430542|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051463|NCT01949051|12430543|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051464|NCT01949051|12430544|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051465|NCT01949051|12430545|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051466|NCT01949051|12430546|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
5051467|NCT01949051|12430541|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
5051468|NCT01949051|12430542|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
5051469|NCT01949051|12430543|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
5051470|NCT01949051|12430544|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
5051471|NCT01949051|12430545|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
5051472|NCT01949051|12430546|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
5051473|NCT01949051|12430541|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
5051474|NCT01949051|12430542|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
5051475|NCT01949051|12430543|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
5051476|NCT01949051|12430544|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
5051477|NCT01949051|12430545|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
5051478|NCT01949051|12430546|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
5051479|NCT01949051|12430541|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5051480|NCT01949051|12430542|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5051481|NCT01949051|12430543|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
5051482|NCT01949051|12430544|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5051483|NCT01949051|12430545|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5051484|NCT01949051|12430546|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
5051485|NCT01949051|12430541|P6|COMPLETED|Treatment Period 1 (7 Days)||13
5051486|NCT01949051|12430542|P5|COMPLETED|Treatment Period 1 (7 Days)||13
5051487|NCT01949051|12430543|P4|COMPLETED|Treatment Period 1 (7 Days)||12
5051488|NCT01949051|12430544|P3|COMPLETED|Treatment Period 1 (7 Days)||13
5051489|NCT01949051|12430545|P2|COMPLETED|Treatment Period 1 (7 Days)||13
5051490|NCT01949051|12430546|P1|COMPLETED|Treatment Period 1 (7 Days)||11
5051491|NCT01949051|12430541|P6|STARTED|Treatment Period 1 (7 Days)||13
5051492|NCT01949051|12430542|P5|STARTED|Treatment Period 1 (7 Days)||13
5051493|NCT01949051|12430543|P4|STARTED|Treatment Period 1 (7 Days)||13
5051494|NCT01949051|12430544|P3|STARTED|Treatment Period 1 (7 Days)||13
5051495|NCT01949051|12430545|P2|STARTED|Treatment Period 1 (7 Days)||13
5051496|NCT01949051|12430546|P1|STARTED|Treatment Period 1 (7 Days)||13
5051497|NCT01948986|12430562|P5|NOT COMPLETED|Overall Study||0
5051498|NCT01948986|12430563|P4|NOT COMPLETED|Overall Study||0
5051499|NCT01948986|12430564|P3|NOT COMPLETED|Overall Study||0
5051500|NCT01948986|12430565|P2|NOT COMPLETED|Overall Study||0
5051501|NCT01948986|12430566|P1|NOT COMPLETED|Overall Study||0
5051502|NCT01948986|12430562|P5|COMPLETED|Overall Study||8
5051503|NCT01948986|12430563|P4|COMPLETED|Overall Study||6
5051504|NCT01948986|12430564|P3|COMPLETED|Overall Study||8
5051505|NCT01948986|12430565|P2|COMPLETED|Overall Study||8
5051506|NCT01948986|12430566|P1|COMPLETED|Overall Study||6
5051507|NCT01948986|12430562|P5|STARTED|Overall Study||8
5051508|NCT01948986|12430563|P4|STARTED|Overall Study||6
5051509|NCT01948986|12430564|P3|STARTED|Overall Study||8
5051510|NCT01948986|12430565|P2|STARTED|Overall Study||8
5051511|NCT01948986|12430566|P1|STARTED|Overall Study||6
5051512|NCT01948947|12430725|P2|NOT COMPLETED|Overall Study||0
5051513|NCT01948947|12430726|P1|NOT COMPLETED|Overall Study||0
5051514|NCT01948947|12430725|P2|COMPLETED|Overall Study||15
5051515|NCT01948947|12430726|P1|COMPLETED|Overall Study||14
5051516|NCT01948947|12430725|P2|STARTED|Overall Study||15
5051517|NCT01948947|12430726|P1|STARTED|Overall Study||14
5051518|NCT01948908|12430741|P3|NOT COMPLETED|Overall Study||2
5051519|NCT01948908|12430742|P2|NOT COMPLETED|Overall Study||0
5051520|NCT01948908|12430743|P1|NOT COMPLETED|Overall Study||1
5051521|NCT01948908|12430741|P3|COMPLETED|Overall Study||31
5051522|NCT01948908|12430742|P2|COMPLETED|Overall Study||33
5051523|NCT01948908|12430743|P1|COMPLETED|Overall Study||32
5051524|NCT01948908|12430741|P3|STARTED|Overall Study||33
5051525|NCT01948908|12430742|P2|STARTED|Overall Study||33
5051526|NCT01948908|12430743|P1|STARTED|Overall Study||33
5051527|NCT01948830|12430759|P2|NOT COMPLETED|Overall Study||32
5051528|NCT01948830|12430760|P1|NOT COMPLETED|Overall Study||33
5051529|NCT01948830|12430759|P2|COMPLETED|Overall Study||295
5051530|NCT01948830|12430760|P1|COMPLETED|Overall Study||290
5051531|NCT01948830|12430759|P2|Safety Set|Overall Study||326
5051532|NCT01948830|12430760|P1|Safety Set|Overall Study||323
5051533|NCT01948830|12430759|P2|STARTED|Overall Study||327
5051534|NCT01948830|12430760|P1|STARTED|Overall Study||323
5051535|NCT01948791|12430792|P1|NOT COMPLETED|Overall Study||71
5051536|NCT01948791|12430792|P1|COMPLETED|Overall Study||151
5051537|NCT01948791|12430792|P1|STARTED|Overall Study||222
5051538|NCT01948518|12430800|P1|NOT COMPLETED|Overall Study||0
5051539|NCT01948518|12430800|P1|COMPLETED|Overall Study||15
5051540|NCT01948518|12430800|P1|STARTED|Overall Study||15
5051541|NCT01948388|12430807|P2|NOT COMPLETED|Overall Study||1
5051542|NCT01948388|12430808|P1|NOT COMPLETED|Overall Study||2
5051543|NCT01948388|12430807|P2|COMPLETED|Overall Study||9
5051544|NCT01948388|12430808|P1|COMPLETED|Overall Study||8
5051545|NCT01948388|12430807|P2|STARTED|Overall Study||10
5051546|NCT01948388|12430808|P1|STARTED|Overall Study||10
5051547|NCT01948375|12430824|P2|NOT COMPLETED|Overall Study||0
5051548|NCT01948375|12430825|P1|NOT COMPLETED|Overall Study||0
5051549|NCT01948375|12430824|P2|COMPLETED|Overall Study||30
5051550|NCT01948375|12430825|P1|COMPLETED|Overall Study||30
5051551|NCT01948375|12430824|P2|STARTED|Overall Study||30
5051552|NCT01948375|12430825|P1|STARTED|Overall Study||30
5051553|NCT01948310|12430841|P2|NOT COMPLETED|Overall Study||5
5051554|NCT01948310|12430842|P1|NOT COMPLETED|Overall Study||3
5051555|NCT01948310|12430841|P2|COMPLETED|Overall Study||13
5051556|NCT01948310|12430842|P1|COMPLETED|Overall Study||16
5051557|NCT01948310|12430841|P2|STARTED|Overall Study||18
5051558|NCT01948310|12430842|P1|STARTED|Overall Study||19
5051559|NCT01948258|12430852|P1|NOT COMPLETED|Overall Study||162
5051560|NCT01948258|12430852|P1|COMPLETED|Overall Study||233
5051561|NCT01948258|12430852|P1|STARTED|Overall Study||395
5051562|NCT01948193|12430858|P1|NOT COMPLETED|Overall Study||9
5051563|NCT01948193|12430858|P1|COMPLETED|Overall Study||168
5051564|NCT01948193|12430858|P1|STARTED|Overall Study||177
5051565|NCT01948141|12430867|P1|NOT COMPLETED|Overall Study||0
5051566|NCT01948141|12430867|P1|COMPLETED|Overall Study||6
5051567|NCT01948141|12430867|P1|STARTED|Overall Study||6
5051568|NCT01948076|12430880|P2|NOT COMPLETED|Overall Study||1
5051569|NCT01948076|12430881|P1|NOT COMPLETED|Overall Study||0
5051570|NCT01948076|12430880|P2|COMPLETED|Overall Study||19
5051571|NCT01948076|12430881|P1|COMPLETED|Overall Study||20
5051572|NCT01948076|12430880|P2|STARTED|Overall Study||20
5051573|NCT01948076|12430881|P1|STARTED|Overall Study||20
5051574|NCT01948063|12430891|P2|NOT COMPLETED|Overall Study||2
5051575|NCT01948063|12430892|P1|NOT COMPLETED|Overall Study||1
5051576|NCT01948063|12430891|P2|COMPLETED|Overall Study||19
5051577|NCT01948063|12430892|P1|COMPLETED|Overall Study||19
5051578|NCT01948063|12430891|P2|STARTED|Overall Study||21
5051579|NCT01948063|12430892|P1|STARTED|Overall Study||20
5051580|NCT01948050|12430900|P2|NOT COMPLETED|Overall Study||1
5051581|NCT01948050|12430901|P1|NOT COMPLETED|Overall Study||0
5051582|NCT01948050|12430900|P2|COMPLETED|Overall Study||7
5051583|NCT01948050|12430901|P1|COMPLETED|Overall Study||16
5051584|NCT01948050|12430900|P2|STARTED|Overall Study||8
5051585|NCT01948050|12430901|P1|STARTED|Overall Study||16
5051586|NCT01947946|12430910|P3|NOT COMPLETED|Overall Study||5
5051587|NCT01947946|12430911|P2|NOT COMPLETED|Overall Study||5
5051588|NCT01947946|12430912|P1|NOT COMPLETED|Overall Study||3
5051589|NCT01947946|12430910|P3|COMPLETED|Overall Study||0
5051590|NCT01947946|12430911|P2|COMPLETED|Overall Study||0
5051591|NCT01947946|12430912|P1|COMPLETED|Overall Study|Study Stopped|0
5051592|NCT01947946|12430910|P3|STARTED|Overall Study||5
5051593|NCT01947946|12430911|P2|STARTED|Overall Study||5
5051594|NCT01947946|12430912|P1|STARTED|Overall Study||3
5051595|NCT01947907|12430924|P4|NOT COMPLETED|Overall Study||0
5051596|NCT01947907|12430925|P3|NOT COMPLETED|Overall Study||0
5051597|NCT01947907|12430926|P2|NOT COMPLETED|Overall Study||0
5051598|NCT01947907|12430927|P1|NOT COMPLETED|Overall Study||0
5051599|NCT01947907|12430924|P4|COMPLETED|Overall Study||13
5051600|NCT01947907|12430925|P3|COMPLETED|Overall Study||14
5051601|NCT01947907|12430926|P2|COMPLETED|Overall Study||14
5051602|NCT01947907|12430927|P1|COMPLETED|Overall Study||12
5051603|NCT01947907|12430924|P4|STARTED|Overall Study||13
5051604|NCT01947907|12430925|P3|STARTED|Overall Study||14
5051605|NCT01947907|12430926|P2|STARTED|Overall Study||14
5051606|NCT01947907|12430927|P1|STARTED|Overall Study||12
5051607|NCT01947894|12430969|P3|NOT COMPLETED|Overall Study||27
5051608|NCT01947894|12430970|P2|NOT COMPLETED|Overall Study||18
5051609|NCT01947894|12430971|P1|NOT COMPLETED|Overall Study||87
5051610|NCT01947894|12430969|P3|COMPLETED|Overall Study||61
5051611|NCT01947894|12430970|P2|COMPLETED|Overall Study||24
5051612|NCT01947894|12430971|P1|COMPLETED|Overall Study||160
5051613|NCT01947894|12430969|P3|Treated|Overall Study||87
5051614|NCT01947894|12430970|P2|Treated|Overall Study||41
5051615|NCT01947894|12430971|P1|Treated|Overall Study||246
5051616|NCT01947894|12430969|P3|STARTED|Overall Study||88
5051617|NCT01947894|12430970|P2|STARTED|Overall Study||42
5051618|NCT01947894|12430971|P1|STARTED|Overall Study||247
5051619|NCT01947855|12431036|P3|NOT COMPLETED|Overall Study||0
5051620|NCT01947855|12431037|P2|NOT COMPLETED|Overall Study||0
5051621|NCT01947855|12431038|P1|NOT COMPLETED|Overall Study||1
5051622|NCT01947855|12431036|P3|COMPLETED|Overall Study||19
5051623|NCT01947855|12431037|P2|COMPLETED|Overall Study||20
5051624|NCT01947855|12431038|P1|COMPLETED|Overall Study||20
5051625|NCT01947855|12431036|P3|STARTED|Overall Study||19
5051626|NCT01947855|12431037|P2|STARTED|Overall Study||20
5051627|NCT01947855|12431038|P1|STARTED|Overall Study||21
5051628|NCT01947816|12431046|P1|NOT COMPLETED|Overall Study||70
5051629|NCT01947816|12431046|P1|COMPLETED|Overall Study||1523
5051630|NCT01947816|12431046|P1|STARTED|Overall Study||1593
5051631|NCT01947647|12431056|P2|NOT COMPLETED|6-month Followup Phase||8
5051632|NCT01947647|12431057|P1|NOT COMPLETED|6-month Followup Phase||9
5051633|NCT01947647|12431056|P2|COMPLETED|6-month Followup Phase||13
5051634|NCT01947647|12431057|P1|COMPLETED|6-month Followup Phase||20
5051635|NCT01947647|12431056|P2|STARTED|6-month Followup Phase||21
5051636|NCT01947647|12431057|P1|STARTED|6-month Followup Phase||29
5051637|NCT01947647|12431056|P2|NOT COMPLETED|Treatment Phase||26
5051638|NCT01947647|12431057|P1|NOT COMPLETED|Treatment Phase||17
5051639|NCT01947647|12431056|P2|COMPLETED|Treatment Phase||21
5051640|NCT01947647|12431057|P1|COMPLETED|Treatment Phase||29
5051641|NCT01947647|12431056|P2|STARTED|Treatment Phase||47
5051642|NCT01947647|12431057|P1|STARTED|Treatment Phase||46
5051643|NCT01947582|12431073|P1|NOT COMPLETED|Overall Study||1
5051644|NCT01947582|12431073|P1|COMPLETED|Overall Study||1
5051645|NCT01947582|12431073|P1|STARTED|Overall Study||2
5051646|NCT01947517|12431082|P2|NOT COMPLETED|Overall Study||1
5051647|NCT01947517|12431083|P1|NOT COMPLETED|Overall Study||1
5051648|NCT01947517|12431082|P2|COMPLETED|Overall Study||25
5051649|NCT01947517|12431083|P1|COMPLETED|Overall Study||25
5051650|NCT01947517|12431082|P2|STARTED|Overall Study||26
5051651|NCT01947517|12431083|P1|STARTED|Overall Study||26
5051652|NCT01947491|12431101|P4|NOT COMPLETED|Overall Study||5
5051653|NCT01947491|12431102|P3|NOT COMPLETED|Overall Study||2
5051654|NCT01947491|12431103|P2|NOT COMPLETED|Overall Study||6
5051655|NCT01947491|12431104|P1|NOT COMPLETED|Overall Study||8
5051656|NCT01947491|12431101|P4|COMPLETED|Overall Study||38
5051657|NCT01947491|12431102|P3|COMPLETED|Overall Study||88
5051658|NCT01947491|12431103|P2|COMPLETED|Overall Study||81
5051659|NCT01947491|12431104|P1|COMPLETED|Overall Study||166
5051660|NCT01947491|12431101|P4|STARTED|Overall Study||43
5051661|NCT01947491|12431102|P3|STARTED|Overall Study||90
5051662|NCT01947491|12431103|P2|STARTED|Overall Study||87
5051663|NCT01947491|12431104|P1|STARTED|Overall Study||174
5051664|NCT01947335|12431116|P2|NOT COMPLETED|Overall Study||0
5051665|NCT01947335|12431117|P1|NOT COMPLETED|Overall Study||0
5051666|NCT01947335|12431116|P2|COMPLETED|Overall Study||41
5051667|NCT01947335|12431117|P1|COMPLETED|Overall Study||42
5051668|NCT01947335|12431116|P2|STARTED|Overall Study||41
5051669|NCT01947335|12431117|P1|STARTED|Overall Study||42
5051670|NCT01947283|12431134|P7|NOT COMPLETED|Overall Study||8
5051671|NCT01947283|12431135|P6|NOT COMPLETED|Overall Study||7
5051672|NCT01947283|12431136|P5|NOT COMPLETED|Overall Study||0
5051673|NCT01947283|12431137|P4|NOT COMPLETED|Overall Study||17
5051674|NCT01947283|12431138|P3|NOT COMPLETED|Overall Study||21
5051675|NCT01947283|12431139|P2|NOT COMPLETED|Overall Study||23
5051676|NCT01947283|12431140|P1|NOT COMPLETED|Overall Study||29
5051677|NCT01947283|12431134|P7|COMPLETED|Overall Study||32
5051678|NCT01947283|12431135|P6|COMPLETED|Overall Study||27
5051679|NCT01947283|12431136|P5|COMPLETED|Overall Study||95
5051680|NCT01947283|12431137|P4|COMPLETED|Overall Study||55
5051681|NCT01947283|12431138|P3|COMPLETED|Overall Study||62
5051682|NCT01947283|12431139|P2|COMPLETED|Overall Study||45
5051683|NCT01947283|12431140|P1|COMPLETED|Overall Study||60
5051684|NCT01947283|12431134|P7|Completed NRCT Baseline Assessment|Overall Study||0
5051685|NCT01947283|12431135|P6|Completed NRCT Baseline Assessment|Overall Study||0
5051686|NCT01947283|12431136|P5|Completed NRCT Baseline Assessment|Overall Study||95
5051687|NCT01947283|12431137|P4|Completed NRCT Baseline Assessment|Overall Study||0
5051688|NCT01947283|12431138|P3|Completed NRCT Baseline Assessment|Overall Study||0
5051689|NCT01947283|12431139|P2|Completed NRCT Baseline Assessment|Overall Study||0
5051690|NCT01947283|12431140|P1|Completed NRCT Baseline Assessment|Overall Study||0
5051691|NCT01947283|12431134|P7|In Analysis|Overall Study||38
5051692|NCT01947283|12431135|P6|In Analysis|Overall Study||30
5051693|NCT01947283|12431136|P5|In Analysis|Overall Study||95
5051694|NCT01947283|12431137|P4|In Analysis|Overall Study||72
5051695|NCT01947283|12431138|P3|In Analysis|Overall Study||83
5051696|NCT01947283|12431139|P2|In Analysis|Overall Study||68
5051697|NCT01947283|12431140|P1|In Analysis|Overall Study||89
5051698|NCT01947283|12431134|P7|End-of-Intervention Assessment|Overall Study||33
5051699|NCT01947283|12431135|P6|End-of-Intervention Assessment|Overall Study||32
5051700|NCT01947283|12431136|P5|End-of-Intervention Assessment|Overall Study||0
5051701|NCT01947283|12431137|P4|End-of-Intervention Assessment|Overall Study||66
5051702|NCT01947283|12431138|P3|End-of-Intervention Assessment|Overall Study||73
5051703|NCT01947283|12431139|P2|End-of-Intervention Assessment|Overall Study||53
5051704|NCT01947283|12431140|P1|End-of-Intervention Assessment|Overall Study||74
5051705|NCT01947283|12431134|P7|Clinical Recording|Overall Study||0
5051706|NCT01947283|12431135|P6|Clinical Recording|Overall Study||0
5051707|NCT01947283|12431136|P5|Clinical Recording|Overall Study||0
5051708|NCT01947283|12431137|P4|Clinical Recording|Overall Study||57
5051709|NCT01947283|12431138|P3|Clinical Recording|Overall Study||68
5051710|NCT01947283|12431139|P2|Clinical Recording|Overall Study||54
5051711|NCT01947283|12431140|P1|Clinical Recording|Overall Study||65
5051712|NCT01947283|12431134|P7|Follow-up Assessment|Overall Study||36
5051713|NCT01947283|12431135|P6|Follow-up Assessment|Overall Study||27
5051714|NCT01947283|12431136|P5|Follow-up Assessment|Overall Study||0
5051715|NCT01947283|12431137|P4|Follow-up Assessment|Overall Study||59
5051716|NCT01947283|12431138|P3|Follow-up Assessment|Overall Study||65
5051717|NCT01947283|12431139|P2|Follow-up Assessment|Overall Study||51
5051718|NCT01947283|12431140|P1|Follow-up Assessment|Overall Study||64
5051719|NCT01947283|12431134|P7|Baseline Assessment|Overall Study||40
5051720|NCT01947283|12431135|P6|Baseline Assessment|Overall Study||34
5051721|NCT01947283|12431136|P5|Baseline Assessment|Overall Study||0
5051722|NCT01947283|12431137|P4|Baseline Assessment|Overall Study||72
5051723|NCT01947283|12431138|P3|Baseline Assessment|Overall Study||83
5051724|NCT01947283|12431139|P2|Baseline Assessment|Overall Study||68
5051725|NCT01947283|12431140|P1|Baseline Assessment|Overall Study||89
5051726|NCT01947283|12431134|P7|STARTED|Overall Study||40
5051727|NCT01947283|12431135|P6|STARTED|Overall Study||34
5051728|NCT01947283|12431136|P5|STARTED|Overall Study||95
5051729|NCT01947283|12431137|P4|STARTED|Overall Study||72
5051730|NCT01947283|12431138|P3|STARTED|Overall Study||83
5051731|NCT01947283|12431139|P2|STARTED|Overall Study||68
5051732|NCT01947283|12431140|P1|STARTED|Overall Study||89
5051733|NCT01947153|12431191|P2|NOT COMPLETED|Test Period 2||0
5051734|NCT01947153|12431192|P1|NOT COMPLETED|Test Period 2||0
5051735|NCT01947153|12431191|P2|COMPLETED|Test Period 2||18
5051736|NCT01947153|12431192|P1|COMPLETED|Test Period 2||18
5051737|NCT01947153|12431191|P2|STARTED|Test Period 2||18
5051738|NCT01947153|12431192|P1|STARTED|Test Period 2||18
5051739|NCT01947153|12431191|P2|NOT COMPLETED|Test Period 1||0
5051740|NCT01947153|12431192|P1|NOT COMPLETED|Test Period 1||0
5051741|NCT01947153|12431191|P2|COMPLETED|Test Period 1||18
5051742|NCT01947153|12431192|P1|COMPLETED|Test Period 1||18
5051743|NCT01947153|12431191|P2|STARTED|Test Period 1||18
5051744|NCT01947153|12431192|P1|STARTED|Test Period 1||18
5051745|NCT01947127|12431212|P2|NOT COMPLETED|Overall Study||43
5051746|NCT01947127|12431213|P1|NOT COMPLETED|Overall Study||23
5051747|NCT01947127|12431212|P2|COMPLETED|Overall Study||249
5051748|NCT01947127|12431213|P1|COMPLETED|Overall Study||143
5051749|NCT01947127|12431212|P2|STARTED|Overall Study||292
5051750|NCT01947127|12431213|P1|STARTED|Overall Study||166
5051751|NCT01946542|12431225|P2|NOT COMPLETED|Testing Visit 2||0
5051752|NCT01946542|12431226|P1|NOT COMPLETED|Testing Visit 2||0
5051753|NCT01946542|12431225|P2|COMPLETED|Testing Visit 2||1
5051754|NCT01946542|12431226|P1|COMPLETED|Testing Visit 2||1
5051755|NCT01946542|12431225|P2|STARTED|Testing Visit 2||1
5051756|NCT01946542|12431226|P1|STARTED|Testing Visit 2||1
5051757|NCT01946542|12431225|P2|NOT COMPLETED|Testing Visit 1||0
5051758|NCT01946542|12431226|P1|NOT COMPLETED|Testing Visit 1||0
5051759|NCT01946542|12431225|P2|COMPLETED|Testing Visit 1||1
5051760|NCT01946542|12431226|P1|COMPLETED|Testing Visit 1||1
5051761|NCT01946542|12431225|P2|STARTED|Testing Visit 1||1
5051762|NCT01946542|12431226|P1|STARTED|Testing Visit 1||1
5051763|NCT01946529|12431237|P3|NOT COMPLETED|Completion of All Therapy||6
5051764|NCT01946529|12431238|P2|NOT COMPLETED|Completion of All Therapy||16
5051765|NCT01946529|12431239|P1|NOT COMPLETED|Completion of All Therapy||1
5051766|NCT01946529|12431237|P3|COMPLETED|Completion of All Therapy||0
5051767|NCT01946529|12431238|P2|COMPLETED|Completion of All Therapy||0
5051768|NCT01946529|12431239|P1|COMPLETED|Completion of All Therapy||0
5051769|NCT01946529|12431237|P3|STARTED|Completion of All Therapy||6
5051770|NCT01946529|12431238|P2|STARTED|Completion of All Therapy||16
5051771|NCT01946529|12431239|P1|STARTED|Completion of All Therapy||1
5051772|NCT01946529|12431237|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
5051773|NCT01946529|12431238|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
5051774|NCT01946529|12431239|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
5051775|NCT01946529|12431237|P3|COMPLETED|End of Window Therapy (2 Courses)||6
5051776|NCT01946529|12431238|P2|COMPLETED|End of Window Therapy (2 Courses)||16
5051777|NCT01946529|12431239|P1|COMPLETED|End of Window Therapy (2 Courses)||1
5051778|NCT01946529|12431237|P3|STARTED|End of Window Therapy (2 Courses)||6
5051779|NCT01946529|12431238|P2|STARTED|End of Window Therapy (2 Courses)||17
5051780|NCT01946529|12431239|P1|STARTED|End of Window Therapy (2 Courses)||1
5051781|NCT01946438|12431250|P4|NOT COMPLETED|Overall Study||1
5051782|NCT01946438|12431251|P3|NOT COMPLETED|Overall Study||1
5051783|NCT01946438|12431252|P2|NOT COMPLETED|Overall Study||0
5051784|NCT01946438|12431253|P1|NOT COMPLETED|Overall Study||2
5051785|NCT01946438|12431250|P4|COMPLETED|Overall Study||51
5051786|NCT01946438|12431251|P3|COMPLETED|Overall Study||51
5051787|NCT01946438|12431252|P2|COMPLETED|Overall Study||52
5051788|NCT01946438|12431253|P1|COMPLETED|Overall Study||50
5051789|NCT01946438|12431250|P4|STARTED|Overall Study||52
5051790|NCT01946438|12431251|P3|STARTED|Overall Study||52
5051791|NCT01946438|12431252|P2|STARTED|Overall Study||52
5051792|NCT01946438|12431253|P1|STARTED|Overall Study||52
5051793|NCT01946425|12431281|P2|NOT COMPLETED|Overall Study||0
5051794|NCT01946425|12431282|P1|NOT COMPLETED|Overall Study||2
5051795|NCT01946425|12431281|P2|COMPLETED|Overall Study||30
5051796|NCT01946425|12431282|P1|COMPLETED|Overall Study||28
5051797|NCT01946425|12431281|P2|STARTED|Overall Study||30
5051798|NCT01946425|12431282|P1|STARTED|Overall Study||30
5051799|NCT01946412|12431296|P1|NOT COMPLETED|Overall Study||5
5051800|NCT01946412|12431296|P1|COMPLETED|Overall Study||28
5051801|NCT01946412|12431296|P1|STARTED|Overall Study||33
5051802|NCT01946282|12431321|P3|NOT COMPLETED|Year 3||30
5051803|NCT01946282|12431322|P2|NOT COMPLETED|Year 3||43
5051804|NCT01946282|12431323|P1|NOT COMPLETED|Year 3||288
5051805|NCT01946282|12431321|P3|COMPLETED|Year 3||140
5051806|NCT01946282|12431322|P2|COMPLETED|Year 3||141
5051807|NCT01946282|12431323|P1|COMPLETED|Year 3||856
5051808|NCT01946282|12431321|P3|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
5051809|NCT01946282|12431322|P2|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
5051810|NCT01946282|12431323|P1|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
5051811|NCT01946282|12431321|P3|NOT COMPLETED|Year 2||115
5051812|NCT01946282|12431322|P2|NOT COMPLETED|Year 2||131
5051813|NCT01946282|12431323|P1|NOT COMPLETED|Year 2||803
5051814|NCT01946282|12431321|P3|COMPLETED|Year 2||184
5051815|NCT01946282|12431322|P2|COMPLETED|Year 2||210
5051816|NCT01946282|12431323|P1|COMPLETED|Year 2||1248
5051817|NCT01946282|12431321|P3|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
5051818|NCT01946282|12431322|P2|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
5051819|NCT01946282|12431323|P1|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
5051820|NCT01946282|12431321|P3|NOT COMPLETED|Year 1||654
5051821|NCT01946282|12431322|P2|NOT COMPLETED|Year 1||608
5051822|NCT01946282|12431323|P1|NOT COMPLETED|Year 1||4186
5051823|NCT01946282|12431321|P3|COMPLETED|Year 1||346
5051824|NCT01946282|12431322|P2|COMPLETED|Year 1||392
5051825|NCT01946282|12431323|P1|COMPLETED|Year 1||2379
5051826|NCT01946282|12431321|P3|STARTED|Year 1||1000
5051827|NCT01946282|12431322|P2|STARTED|Year 1||1000
5051828|NCT01946282|12431323|P1|STARTED|Year 1||6565
5051829|NCT01946243|12431333|P1|NOT COMPLETED|Overall Study||0
5051830|NCT01946243|12431333|P1|COMPLETED|Overall Study||96
5051831|NCT01946243|12431333|P1|STARTED|Overall Study||96
5051832|NCT01946204|12431356|P2|NOT COMPLETED|Overall Study||806
5051833|NCT01946204|12431357|P1|NOT COMPLETED|Overall Study||401
5051834|NCT01946204|12431356|P2|COMPLETED|Overall Study||0
5051835|NCT01946204|12431357|P1|COMPLETED|Overall Study||0
5051836|NCT01946204|12431356|P2|Treated|Overall Study||803
5051837|NCT01946204|12431357|P1|Treated|Overall Study||398
5051838|NCT01946204|12431356|P2|STARTED|Overall Study||806
5051839|NCT01946204|12431357|P1|STARTED|Overall Study||401
5051840|NCT01946178|12431373|P1|NOT COMPLETED|Overall Study||2
5051841|NCT01946178|12431373|P1|COMPLETED|Overall Study||71
5051842|NCT01946178|12431373|P1|STARTED|Overall Study||73
5051843|NCT01946165|12431383|P2|NOT COMPLETED|Overall Study||2
5051844|NCT01946165|12431384|P1|NOT COMPLETED|Overall Study||2
5051845|NCT01946165|12431383|P2|COMPLETED|Overall Study||21
5051846|NCT01946165|12431384|P1|COMPLETED|Overall Study||43
5051847|NCT01946165|12431383|P2|STARTED|Overall Study||23
5051848|NCT01946165|12431384|P1|STARTED|Overall Study||45
5051849|NCT01946126|12431394|P2|NOT COMPLETED|Overall Study||0
5051850|NCT01946126|12431395|P1|NOT COMPLETED|Overall Study||0
5051851|NCT01946126|12431394|P2|COMPLETED|Overall Study||275
5051852|NCT01946126|12431395|P1|COMPLETED|Overall Study||184
5051853|NCT01946126|12431394|P2|STARTED|Overall Study||275
5051854|NCT01946126|12431395|P1|STARTED|Overall Study||184
5051855|NCT01945996|12431411|P2|NOT COMPLETED|Overall Study||5
5051856|NCT01945996|12431412|P1|NOT COMPLETED|Overall Study||3
5051857|NCT01945996|12431411|P2|COMPLETED|Overall Study||17
5051858|NCT01945996|12431412|P1|COMPLETED|Overall Study||19
5051859|NCT01945996|12431411|P2|STARTED|Overall Study||22
5051860|NCT01945996|12431412|P1|STARTED|Overall Study||22
5051861|NCT01945970|12431444|P6|NOT COMPLETED|Overall Study||0
5051862|NCT01945970|12431445|P5|NOT COMPLETED|Overall Study||0
5051863|NCT01945970|12431446|P4|NOT COMPLETED|Overall Study||0
5051864|NCT01945970|12431447|P3|NOT COMPLETED|Overall Study||0
5051865|NCT01945970|12431448|P2|NOT COMPLETED|Overall Study||0
5051866|NCT01945970|12431449|P1|NOT COMPLETED|Overall Study||0
5051867|NCT01945970|12431444|P6|COMPLETED|Overall Study||5
5051868|NCT01945970|12431445|P5|COMPLETED|Overall Study||5
5051869|NCT01945970|12431446|P4|COMPLETED|Overall Study||5
5051870|NCT01945970|12431447|P3|COMPLETED|Overall Study||5
5051871|NCT01945970|12431448|P2|COMPLETED|Overall Study||5
5051872|NCT01945970|12431449|P1|COMPLETED|Overall Study||5
5051873|NCT01945970|12431444|P6|STARTED|Overall Study||5
5051874|NCT01945970|12431445|P5|STARTED|Overall Study||5
5051875|NCT01945970|12431446|P4|STARTED|Overall Study||5
5051876|NCT01945970|12431447|P3|STARTED|Overall Study||5
5051877|NCT01945970|12431448|P2|STARTED|Overall Study||5
5051878|NCT01945970|12431449|P1|STARTED|Overall Study||5
5051879|NCT01945944|12431488|P2|NOT COMPLETED|Overall Study||3
5051880|NCT01945944|12431489|P1|NOT COMPLETED|Overall Study||1
5051881|NCT01945944|12431488|P2|COMPLETED|Overall Study||6
5051882|NCT01945944|12431489|P1|COMPLETED|Overall Study||8
5051883|NCT01945944|12431488|P2|STARTED|Overall Study||9
5051884|NCT01945944|12431489|P1|STARTED|Overall Study||9
5051885|NCT01945866|12431513|P2|NOT COMPLETED|Overall Study||0
5051886|NCT01945866|12431514|P1|NOT COMPLETED|Overall Study||2
5051887|NCT01945866|12431513|P2|COMPLETED|Overall Study||64
5051888|NCT01945866|12431514|P1|COMPLETED|Overall Study||63
5051889|NCT01945866|12431513|P2|STARTED|Overall Study||64
5051890|NCT01945866|12431514|P1|STARTED|Overall Study||65
5051891|NCT01945775|12431535|P2|NOT COMPLETED|Overall Study||144
5051892|NCT01945775|12431536|P1|NOT COMPLETED|Overall Study||287
5051893|NCT01945775|12431535|P2|COMPLETED|Overall Study||0
5051894|NCT01945775|12431536|P1|COMPLETED|Overall Study||0
5051895|NCT01945775|12431535|P2|Treated|Overall Study||126
5051896|NCT01945775|12431536|P1|Treated|Overall Study||286
5051897|NCT01945775|12431535|P2|STARTED|Overall Study||144
5051898|NCT01945775|12431536|P1|STARTED|Overall Study||287
5051899|NCT01945710|12431572|P7|NOT COMPLETED|Overall Study||23
5051900|NCT01945710|12431573|P6|NOT COMPLETED|Overall Study||3
5051901|NCT01945710|12431574|P5|NOT COMPLETED|Overall Study||9
5051902|NCT01945710|12431575|P4|NOT COMPLETED|Overall Study||3
5051903|NCT01945710|12431576|P3|NOT COMPLETED|Overall Study||7
5051904|NCT01945710|12431577|P2|NOT COMPLETED|Overall Study||6
5051905|NCT01945710|12431578|P1|NOT COMPLETED|Overall Study||7
5051906|NCT01945710|12431572|P7|COMPLETED|Overall Study||0
5051907|NCT01945710|12431573|P6|COMPLETED|Overall Study||0
5051908|NCT01945710|12431574|P5|COMPLETED|Overall Study||0
5051909|NCT01945710|12431575|P4|COMPLETED|Overall Study||0
5051910|NCT01945710|12431576|P3|COMPLETED|Overall Study||0
5051911|NCT01945710|12431577|P2|COMPLETED|Overall Study||0
5051912|NCT01945710|12431578|P1|COMPLETED|Overall Study||0
5051913|NCT01945710|12431572|P7|STARTED|Overall Study||23
5051914|NCT01945710|12431573|P6|STARTED|Overall Study||3
5051915|NCT01945710|12431574|P5|STARTED|Overall Study||9
5051916|NCT01945710|12431575|P4|STARTED|Overall Study||3
5051917|NCT01945710|12431576|P3|STARTED|Overall Study||7
5051918|NCT01945710|12431577|P2|STARTED|Overall Study||6
5051919|NCT01945710|12431578|P1|STARTED|Overall Study||7
5051920|NCT01945593|12431697|P4|NOT COMPLETED|Overall Study||20
5051921|NCT01945593|12431698|P3|NOT COMPLETED|Overall Study||3
5051922|NCT01945593|12431699|P2|NOT COMPLETED|Overall Study||8
5051923|NCT01945593|12431700|P1|NOT COMPLETED|Overall Study||0
5051924|NCT01945593|12431697|P4|COMPLETED|Overall Study||105
5051925|NCT01945593|12431698|P3|COMPLETED|Overall Study||23
5051926|NCT01945593|12431699|P2|COMPLETED|Overall Study||56
5051927|NCT01945593|12431700|P1|COMPLETED|Overall Study||3
5051928|NCT01945593|12431697|P4|STARTED|Overall Study||125
5051929|NCT01945593|12431698|P3|STARTED|Overall Study||26
5051930|NCT01945593|12431699|P2|STARTED|Overall Study||64
5051931|NCT01945593|12431700|P1|STARTED|Overall Study||3
5051932|NCT01945489|12431782|P2|NOT COMPLETED|Cycle 2||1
5051933|NCT01945489|12431783|P1|NOT COMPLETED|Cycle 2||1
5051934|NCT01945489|12431782|P2|COMPLETED|Cycle 2||106
5051935|NCT01945489|12431783|P1|COMPLETED|Cycle 2||87
5051936|NCT01945489|12431782|P2|STARTED|Cycle 2||107
5051937|NCT01945489|12431783|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
5051938|NCT01945489|12431782|P2|NOT COMPLETED|Cycle 1||4
5051939|NCT01945489|12431783|P1|NOT COMPLETED|Cycle 1||13
5051940|NCT01945489|12431782|P2|COMPLETED|Cycle 1||121
5051941|NCT01945489|12431783|P1|COMPLETED|Cycle 1||116
5051942|NCT01945489|12431782|P2|STARTED|Cycle 1||125
5051943|NCT01945489|12431783|P1|STARTED|Cycle 1||129
5051944|NCT01945294|12431803|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
5051945|NCT01945294|12431804|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
5051946|NCT01945294|12431805|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
5051947|NCT01945294|12431806|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
5051948|NCT01945294|12431803|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
5051949|NCT01945294|12431804|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
5051950|NCT01945294|12431805|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
5051951|NCT01945294|12431806|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
5051952|NCT01945294|12431803|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
5051953|NCT01945294|12431804|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
5051954|NCT01945294|12431805|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
5051955|NCT01945294|12431806|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
5051956|NCT01945294|12431803|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051957|NCT01945294|12431804|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051958|NCT01945294|12431805|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051959|NCT01945294|12431806|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
5051960|NCT01945294|12431803|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051961|NCT01945294|12431804|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051962|NCT01945294|12431805|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
5051963|NCT01945294|12431806|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
5051964|NCT01945294|12431803|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
5051965|NCT01945294|12431804|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
5051966|NCT01945294|12431805|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
5051967|NCT01945294|12431806|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
5051968|NCT01945281|12431837|P2|NOT COMPLETED|Overall Study||4
5051969|NCT01945281|12431838|P1|NOT COMPLETED|Overall Study||6
5051970|NCT01945281|12431837|P2|COMPLETED|Overall Study||13
5051971|NCT01945281|12431838|P1|COMPLETED|Overall Study||28
5051972|NCT01945281|12431837|P2|Treated|Overall Study||16
5051973|NCT01945281|12431838|P1|Treated|Overall Study||33
5051974|NCT01945281|12431837|P2|STARTED|Overall Study||17
5051975|NCT01945281|12431838|P1|STARTED|Overall Study||34
5051976|NCT01945242|12431850|P2|NOT COMPLETED|Overall Study||3
5051977|NCT01945242|12431851|P1|NOT COMPLETED|Overall Study||3
5051978|NCT01945242|12431850|P2|COMPLETED|Overall Study||120
5051979|NCT01945242|12431851|P1|COMPLETED|Overall Study||1248
5051980|NCT01945242|12431850|P2|STARTED|Overall Study||123
5051981|NCT01945242|12431851|P1|STARTED|Overall Study||1251
5051982|NCT01945216|12431866|P1|NOT COMPLETED|Overall Study||99
5051983|NCT01945216|12431866|P1|COMPLETED|Overall Study||3218
5051984|NCT01945216|12431866|P1|STARTED|Overall Study||3317
5051985|NCT01945138|12431880|P2|NOT COMPLETED|Overall Study||0
5051986|NCT01945138|12431881|P1|NOT COMPLETED|Overall Study||0
5051987|NCT01945138|12431880|P2|COMPLETED|Overall Study||7
5051988|NCT01945138|12431881|P1|COMPLETED|Overall Study||7
5051989|NCT01945138|12431880|P2|STARTED|Overall Study||7
5051990|NCT01945138|12431881|P1|STARTED|Overall Study||7
5051991|NCT01945112|12431915|P2|NOT COMPLETED|Overall Study||0
5051992|NCT01945112|12431916|P1|NOT COMPLETED|Overall Study||0
5051993|NCT01945112|12431915|P2|COMPLETED|Overall Study||51
5051994|NCT01945112|12431916|P1|COMPLETED|Overall Study||77
5051995|NCT01945112|12431915|P2|STARTED|Overall Study|total number of sites where tape was applied|51
5051996|NCT01945112|12431916|P1|STARTED|Overall Study|total number of sites where tape was applied|77
5051997|NCT01945086|12431924|P3|NOT COMPLETED|Overall Study||2
5051998|NCT01945086|12431925|P2|NOT COMPLETED|Overall Study||0
5051999|NCT01945086|12431926|P1|NOT COMPLETED|Overall Study||1
5052000|NCT01945086|12431924|P3|COMPLETED|Overall Study||26
5052001|NCT01945086|12431925|P2|COMPLETED|Overall Study||24
5052002|NCT01945086|12431926|P1|COMPLETED|Overall Study||26
5052003|NCT01945086|12431924|P3|STARTED|Overall Study||28
5052004|NCT01945086|12431925|P2|STARTED|Overall Study||24
5052005|NCT01945086|12431926|P1|STARTED|Overall Study||27
5052006|NCT01945034|12431970|P3|NOT COMPLETED|Overall Study||7
5052007|NCT01945034|12431971|P2|NOT COMPLETED|Overall Study||5
5052008|NCT01945034|12431972|P1|NOT COMPLETED|Overall Study||1
5052009|NCT01945034|12431970|P3|COMPLETED|Overall Study||145
5052010|NCT01945034|12431971|P2|COMPLETED|Overall Study||80
5052011|NCT01945034|12431972|P1|COMPLETED|Overall Study||66
5052012|NCT01945034|12431970|P3|STARTED|Overall Study||152
5052013|NCT01945034|12431971|P2|STARTED|Overall Study||85
5052014|NCT01945034|12431972|P1|STARTED|Overall Study||67
5052015|NCT01945021|12432022|P1|NOT COMPLETED|Overall Study||47
5052016|NCT01945021|12432022|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
5052017|NCT01945021|12432022|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
5052018|NCT01945021|12432022|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
5052019|NCT01945021|12432022|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
5052020|NCT01945021|12432022|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
5052021|NCT01944969|12432036|P1|NOT COMPLETED|Overall Study||26
5052022|NCT01944969|12432036|P1|COMPLETED|Overall Study||0
5052023|NCT01944969|12432036|P1|STARTED|Overall Study||26
5052024|NCT01944878|12432049|P2|NOT COMPLETED|Overall Study||0
5052025|NCT01944878|12432050|P1|NOT COMPLETED|Overall Study||0
5052026|NCT01944878|12432049|P2|COMPLETED|Overall Study||328
5052027|NCT01944878|12432050|P1|COMPLETED|Overall Study||127
5052028|NCT01944878|12432049|P2|STARTED|Overall Study||328
5052029|NCT01944878|12432050|P1|STARTED|Overall Study||127
5052030|NCT01944839|12432060|P2|NOT COMPLETED|Overall Study||28
5052031|NCT01944839|12432061|P1|NOT COMPLETED|Overall Study||22
5052032|NCT01944839|12432060|P2|COMPLETED|Overall Study||282
5052033|NCT01944839|12432061|P1|COMPLETED|Overall Study||287
5052034|NCT01944839|12432060|P2|STARTED|Overall Study||310
5052035|NCT01944839|12432061|P1|STARTED|Overall Study||309
5052036|NCT01944774|12432070|P3|NOT COMPLETED|Overall Study||8
5052037|NCT01944774|12432071|P2|NOT COMPLETED|Overall Study||8
5052038|NCT01944774|12432072|P1|NOT COMPLETED|Overall Study||6
5052039|NCT01944774|12432070|P3|COMPLETED|Overall Study||62
5052040|NCT01944774|12432071|P2|COMPLETED|Overall Study||60
5052041|NCT01944774|12432072|P1|COMPLETED|Overall Study||63
5052042|NCT01944774|12432070|P3|Received Treatment|Overall Study||70
5052043|NCT01944774|12432071|P2|Received Treatment|Overall Study||67
5052044|NCT01944774|12432072|P1|Received Treatment|Overall Study||68
5052045|NCT01944774|12432070|P3|STARTED|Overall Study||70
5052046|NCT01944774|12432071|P2|STARTED|Overall Study||68
5052047|NCT01944774|12432072|P1|STARTED|Overall Study||69
5052048|NCT01944722|12432115|P1|NOT COMPLETED|Overall Study||9515
5052049|NCT01944722|12432115|P1|COMPLETED|Overall Study||24343
5052050|NCT01944722|12432115|P1|STARTED|Overall Study||33858
5052051|NCT01944670|12432149|P1|NOT COMPLETED|Overall Study||2
5052052|NCT01944670|12432149|P1|COMPLETED|Overall Study||24
5052053|NCT01944670|12432149|P1|STARTED|Overall Study||26
5052054|NCT01944644|12432156|P2|NOT COMPLETED|Overall Study||0
5052055|NCT01944644|12432157|P1|NOT COMPLETED|Overall Study||0
5052056|NCT01944644|12432156|P2|COMPLETED|Overall Study||32
5052057|NCT01944644|12432157|P1|COMPLETED|Overall Study||34
5052058|NCT01944644|12432156|P2|STARTED|Overall Study||32
5052059|NCT01944644|12432157|P1|STARTED|Overall Study||34
5052060|NCT01944631|12432171|P2|NOT COMPLETED|Overall Study||2
5052061|NCT01944631|12432172|P1|NOT COMPLETED|Overall Study||4
5052062|NCT01944631|12432171|P2|COMPLETED|Overall Study||98
5052063|NCT01944631|12432172|P1|COMPLETED|Overall Study||96
5052064|NCT01944631|12432171|P2|STARTED|Overall Study||100
5052065|NCT01944631|12432172|P1|STARTED|Overall Study||100
5052066|NCT01944462|12432188|P1|NOT COMPLETED|Optional Vaccination||0
5052067|NCT01944462|12432188|P1|COMPLETED|Optional Vaccination||20
5052068|NCT01944462|12432188|P1|STARTED|Optional Vaccination||20
5052069|NCT01944462|12432188|P1|NOT COMPLETED|PPPP Educational Program||60
5052070|NCT01944462|12432188|P1|COMPLETED|PPPP Educational Program||143
5052071|NCT01944462|12432188|P1|3 Month Follow-Up|PPPP Educational Program||143
5052072|NCT01944462|12432188|P1|Post-Test|PPPP Educational Program||187
5052073|NCT01944462|12432188|P1|Baseline|PPPP Educational Program||203
5052074|NCT01944462|12432188|P1|STARTED|PPPP Educational Program||203
5052075|NCT01944371|12432200|P3|NOT COMPLETED|Overall Study||0
5052076|NCT01944371|12432201|P2|NOT COMPLETED|Overall Study||0
5052077|NCT01944371|12432202|P1|NOT COMPLETED|Overall Study||0
5052078|NCT01944371|12432200|P3|COMPLETED|Overall Study||10
5052079|NCT01944371|12432201|P2|COMPLETED|Overall Study||10
5052080|NCT01944371|12432202|P1|COMPLETED|Overall Study||10
5052081|NCT01944371|12432200|P3|STARTED|Overall Study||10
5052082|NCT01944371|12432201|P2|STARTED|Overall Study||10
5052083|NCT01944371|12432202|P1|STARTED|Overall Study||10
5052084|NCT01944345|12432219|P1|NOT COMPLETED|Overall Study||0
5052085|NCT01944345|12432219|P1|COMPLETED|Overall Study||69
5052086|NCT01944345|12432219|P1|STARTED|Overall Study||69
5052087|NCT01944319|12432227|P2|NOT COMPLETED|Overall Study||0
5052088|NCT01944319|12432228|P1|NOT COMPLETED|Overall Study||0
5052089|NCT01944319|12432227|P2|COMPLETED|Overall Study||39
5052090|NCT01944319|12432228|P1|COMPLETED|Overall Study||40
5052091|NCT01944319|12432227|P2|STARTED|Overall Study||39
5052092|NCT01944319|12432228|P1|STARTED|Overall Study||40
5052093|NCT01944293|12432240|P2|NOT COMPLETED|Overall Study||0
5052094|NCT01944293|12432241|P1|NOT COMPLETED|Overall Study||0
5052095|NCT01944293|12432240|P2|COMPLETED|Overall Study||9
5052096|NCT01944293|12432241|P1|COMPLETED|Overall Study||7
5052097|NCT01944293|12432240|P2|STARTED|Overall Study||9
5052098|NCT01944293|12432241|P1|STARTED|Overall Study||7
5052099|NCT01944098|12432251|P2|NOT COMPLETED|Overall Study||0
5052100|NCT01944098|12432252|P1|NOT COMPLETED|Overall Study||1
5052101|NCT01944098|12432251|P2|COMPLETED|Overall Study||10
5052102|NCT01944098|12432252|P1|COMPLETED|Overall Study||9
5052103|NCT01944098|12432251|P2|STARTED|Overall Study||10
5052104|NCT01944098|12432252|P1|STARTED|Overall Study||10
5052105|NCT01944059|12432264|P1|NOT COMPLETED|Overall Study||7
5052106|NCT01944059|12432264|P1|COMPLETED|Overall Study||24
5052107|NCT01944059|12432264|P1|STARTED|Overall Study||31
5052108|NCT01943864|12432273|P1|NOT COMPLETED|Overall Study||0
5052109|NCT01943864|12432273|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
5052110|NCT01943864|12432273|P1|STARTED|Overall Study||20
5052111|NCT01943825|12432305|P4|NOT COMPLETED|Overall Study||11
5052112|NCT01943825|12432306|P3|NOT COMPLETED|Overall Study||15
5052113|NCT01943825|12432307|P2|NOT COMPLETED|Overall Study||4
5052114|NCT01943825|12432308|P1|NOT COMPLETED|Overall Study||10
5052115|NCT01943825|12432305|P4|COMPLETED|Overall Study||14
5052116|NCT01943825|12432306|P3|COMPLETED|Overall Study||10
5052117|NCT01943825|12432307|P2|COMPLETED|Overall Study||11
5052118|NCT01943825|12432308|P1|COMPLETED|Overall Study||15
5052119|NCT01943825|12432305|P4|STARTED|Overall Study||25
5052120|NCT01943825|12432306|P3|STARTED|Overall Study||25
5052121|NCT01943825|12432307|P2|STARTED|Overall Study||15
5052122|NCT01943825|12432308|P1|STARTED|Overall Study||25
5052123|NCT01943799|12432350|P4|NOT COMPLETED|Overall Study||0
5052124|NCT01943799|12432351|P3|NOT COMPLETED|Overall Study||2
5052125|NCT01943799|12432352|P2|NOT COMPLETED|Overall Study||3
5052126|NCT01943799|12432353|P1|NOT COMPLETED|Overall Study||5
5052127|NCT01943799|12432350|P4|COMPLETED|Overall Study||50
5052128|NCT01943799|12432351|P3|COMPLETED|Overall Study||49
5052129|NCT01943799|12432352|P2|COMPLETED|Overall Study||47
5052130|NCT01943799|12432353|P1|COMPLETED|Overall Study||22
5052131|NCT01943799|12432350|P4|STARTED|Overall Study||50
5052132|NCT01943799|12432351|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
5052133|NCT01943799|12432352|P2|STARTED|Overall Study||50
5052134|NCT01943799|12432353|P1|STARTED|Overall Study||27
5052135|NCT01943591|12432393|P2|NOT COMPLETED|Overall Study||11
5052136|NCT01943591|12432394|P1|NOT COMPLETED|Overall Study||5
5052137|NCT01943591|12432393|P2|COMPLETED|Overall Study||95
5052138|NCT01943591|12432394|P1|COMPLETED|Overall Study||99
5052139|NCT01943591|12432393|P2|STARTED|Overall Study||106
5052140|NCT01943591|12432394|P1|STARTED|Overall Study||104
5052141|NCT01943565|12432419|P3|NOT COMPLETED|Overall Study||0
5052142|NCT01943565|12432420|P2|NOT COMPLETED|Overall Study||0
5052143|NCT01943565|12432421|P1|NOT COMPLETED|Overall Study||0
5052144|NCT01943565|12432419|P3|COMPLETED|Overall Study||9
5052145|NCT01943565|12432420|P2|COMPLETED|Overall Study||9
5052146|NCT01943565|12432421|P1|COMPLETED|Overall Study||11
5052147|NCT01943565|12432419|P3|STARTED|Overall Study||9
5052148|NCT01943565|12432420|P2|STARTED|Overall Study||9
5052149|NCT01943565|12432421|P1|STARTED|Overall Study||11
5052150|NCT01943552|12432452|P2|NOT COMPLETED|Overall Study||25
5052151|NCT01943552|12432453|P1|NOT COMPLETED|Overall Study||25
5052152|NCT01943552|12432452|P2|COMPLETED|Overall Study||69
5052153|NCT01943552|12432453|P1|COMPLETED|Overall Study||71
5052154|NCT01943552|12432452|P2|STARTED|Overall Study||94
5052155|NCT01943552|12432453|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
5052156|NCT01943539|12432469|P2|NOT COMPLETED|Overall Study||0
5052157|NCT01943539|12432470|P1|NOT COMPLETED|Overall Study||4
5052158|NCT01943539|12432469|P2|COMPLETED|Overall Study||40
5052159|NCT01943539|12432470|P1|COMPLETED|Overall Study||40
5052160|NCT01943539|12432469|P2|STARTED|Overall Study||40
5052161|NCT01943539|12432470|P1|STARTED|Overall Study||44
5052162|NCT01943474|12432481|P2|NOT COMPLETED|Overall Study||0
5052163|NCT01943474|12432482|P1|NOT COMPLETED|Overall Study||0
5052164|NCT01943474|12432481|P2|COMPLETED|Overall Study||125
5052165|NCT01943474|12432482|P1|COMPLETED|Overall Study||123
5052166|NCT01943474|12432481|P2|STARTED|Overall Study||125
5052167|NCT01943474|12432482|P1|STARTED|Overall Study||123
5052168|NCT01943435|12432506|P3|NOT COMPLETED|6 Month Follow up||15
5052169|NCT01943435|12432507|P2|NOT COMPLETED|6 Month Follow up||7
5052170|NCT01943435|12432508|P1|NOT COMPLETED|6 Month Follow up||12
5052171|NCT01943435|12432506|P3|COMPLETED|6 Month Follow up||65
5052172|NCT01943435|12432507|P2|COMPLETED|6 Month Follow up||59
5052173|NCT01943435|12432508|P1|COMPLETED|6 Month Follow up||67
5052174|NCT01943435|12432506|P3|STARTED|6 Month Follow up||80
5052175|NCT01943435|12432507|P2|STARTED|6 Month Follow up||66
5052176|NCT01943435|12432508|P1|STARTED|6 Month Follow up||79
5052177|NCT01943435|12432506|P3|NOT COMPLETED|2 Month Follow up||0
5052178|NCT01943435|12432507|P2|NOT COMPLETED|2 Month Follow up||3
5052179|NCT01943435|12432508|P1|NOT COMPLETED|2 Month Follow up||2
5052180|NCT01943435|12432506|P3|COMPLETED|2 Month Follow up||80
5052181|NCT01943435|12432507|P2|COMPLETED|2 Month Follow up||66
5052182|NCT01943435|12432508|P1|COMPLETED|2 Month Follow up||79
5052183|NCT01943435|12432506|P3|STARTED|2 Month Follow up||80
5052184|NCT01943435|12432507|P2|STARTED|2 Month Follow up||69
5052185|NCT01943435|12432508|P1|STARTED|2 Month Follow up||81
5052186|NCT01943435|12432506|P3|NOT COMPLETED|Intervention Period||4
5052187|NCT01943435|12432507|P2|NOT COMPLETED|Intervention Period||3
5052188|NCT01943435|12432508|P1|NOT COMPLETED|Intervention Period||3
5052189|NCT01943435|12432506|P3|COMPLETED|Intervention Period||80
5052190|NCT01943435|12432507|P2|COMPLETED|Intervention Period||69
5052191|NCT01943435|12432508|P1|COMPLETED|Intervention Period||81
5052192|NCT01943435|12432506|P3|STARTED|Intervention Period||84
5052193|NCT01943435|12432507|P2|STARTED|Intervention Period||72
5052194|NCT01943435|12432508|P1|STARTED|Intervention Period||84
5052195|NCT01943435|12432506|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
5052196|NCT01943435|12432507|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
5052197|NCT01943435|12432508|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
5052198|NCT01943435|12432506|P3|COMPLETED|Baseline Eligibility and Randomization||84
5052199|NCT01943435|12432507|P2|COMPLETED|Baseline Eligibility and Randomization||72
5052200|NCT01943435|12432508|P1|COMPLETED|Baseline Eligibility and Randomization||84
5052201|NCT01943435|12432506|P3|STARTED|Baseline Eligibility and Randomization||87
5052202|NCT01943435|12432507|P2|STARTED|Baseline Eligibility and Randomization||84
5052203|NCT01943435|12432508|P1|STARTED|Baseline Eligibility and Randomization||88
5052204|NCT01943344|12432522|P1|NOT COMPLETED|Overall Study||3
5052205|NCT01943344|12432522|P1|COMPLETED|Overall Study||9
5052206|NCT01943344|12432522|P1|STARTED|Overall Study||12
5052207|NCT01943292|12432531|P3|NOT COMPLETED|Overall Study||0
5052208|NCT01943292|12432532|P2|NOT COMPLETED|Overall Study||0
5052209|NCT01943292|12432533|P1|NOT COMPLETED|Overall Study||1
5052210|NCT01943292|12432531|P3|COMPLETED|Overall Study||3
5052211|NCT01943292|12432532|P2|COMPLETED|Overall Study||3
5052212|NCT01943292|12432533|P1|COMPLETED|Overall Study||2
5052213|NCT01943292|12432531|P3|Completed Follow-Up|Overall Study||3
5052214|NCT01943292|12432532|P2|Completed Follow-Up|Overall Study||3
5052215|NCT01943292|12432533|P1|Completed Follow-Up|Overall Study||2
5052216|NCT01943292|12432531|P3|Completed Treatment|Overall Study||3
5052217|NCT01943292|12432532|P2|Completed Treatment|Overall Study||3
5052218|NCT01943292|12432533|P1|Completed Treatment|Overall Study||3
5052219|NCT01943292|12432531|P3|Completed Cycle 1|Overall Study||3
5052220|NCT01943292|12432532|P2|Completed Cycle 1|Overall Study||3
5052221|NCT01943292|12432533|P1|Completed Cycle 1|Overall Study||3
5052222|NCT01943292|12432531|P3|STARTED|Overall Study||3
5052223|NCT01943292|12432532|P2|STARTED|Overall Study||3
5052224|NCT01943292|12432533|P1|STARTED|Overall Study||3
5052225|NCT01943227|12432546|P2|NOT COMPLETED|Overall Study||0
5052226|NCT01943227|12432547|P1|NOT COMPLETED|Overall Study||0
5052227|NCT01943227|12432546|P2|COMPLETED|Overall Study||10
5052228|NCT01943227|12432547|P1|COMPLETED|Overall Study||10
5052229|NCT01943227|12432546|P2|STARTED|Overall Study||10
5052230|NCT01943227|12432547|P1|STARTED|Overall Study||10
5052231|NCT01943110|12432553|P1|NOT COMPLETED|Overall Study||0
5052232|NCT01943110|12432553|P1|COMPLETED|Overall Study||30
5052233|NCT01943110|12432553|P1|STARTED|Overall Study||30
5052234|NCT01942785|12432569|P1|NOT COMPLETED|Overall Study||4
5052235|NCT01942785|12432569|P1|COMPLETED|Overall Study||50
5052236|NCT01942785|12432569|P1|STARTED|Overall Study||54
5052237|NCT01942733|12432598|P1|NOT COMPLETED|Overall Study||3
5052238|NCT01942733|12432598|P1|COMPLETED|Overall Study||41
5052239|NCT01942733|12432598|P1|STARTED|Overall Study||44
5052240|NCT01942720|12432627|P1|NOT COMPLETED|Overall Study||21
5052241|NCT01942720|12432627|P1|COMPLETED|Overall Study||53
5052242|NCT01942720|12432627|P1|STARTED|Overall Study||74
5052243|NCT01942707|12432637|P2|NOT COMPLETED|Overall Study||0
5052244|NCT01942707|12432638|P1|NOT COMPLETED|Overall Study||0
5052245|NCT01942707|12432637|P2|COMPLETED|Overall Study||23
5052246|NCT01942707|12432638|P1|COMPLETED|Overall Study||23
5052247|NCT01942707|12432637|P2|STARTED|Overall Study||23
5052248|NCT01942707|12432638|P1|STARTED|Overall Study||23
5052249|NCT01942668|12432653|P5|NOT COMPLETED|Overall Study||59
5052250|NCT01942668|12432654|P4|NOT COMPLETED|Overall Study||146
5052251|NCT01942668|12432655|P3|NOT COMPLETED|Overall Study||110
5052252|NCT01942668|12432656|P2|NOT COMPLETED|Overall Study||121
5052253|NCT01942668|12432657|P1|NOT COMPLETED|Overall Study||134
5052254|NCT01942668|12432653|P5|COMPLETED|Overall Study||93
5052255|NCT01942668|12432654|P4|COMPLETED|Overall Study||281
5052256|NCT01942668|12432655|P3|COMPLETED|Overall Study||312
5052257|NCT01942668|12432656|P2|COMPLETED|Overall Study||305
5052258|NCT01942668|12432657|P1|COMPLETED|Overall Study||284
5052259|NCT01942668|12432653|P5|STARTED|Overall Study||152
5052260|NCT01942668|12432654|P4|STARTED|Overall Study||427
5052261|NCT01942668|12432655|P3|STARTED|Overall Study||422
5052262|NCT01942668|12432656|P2|STARTED|Overall Study||426
5052263|NCT01942668|12432657|P1|STARTED|Overall Study||418
5052264|NCT01942590|12433716|P2|NOT COMPLETED|Overall Study||1
5052265|NCT01942590|12433717|P1|NOT COMPLETED|Overall Study||1
5052266|NCT01942590|12433716|P2|COMPLETED|Overall Study||4
5052267|NCT01942590|12433717|P1|COMPLETED|Overall Study||7
5052268|NCT01942590|12433716|P2|STARTED|Overall Study||5
5052269|NCT01942590|12433717|P1|STARTED|Overall Study||8
5052270|NCT01942486|12433747|P1|NOT COMPLETED|Overall Study||27
5052271|NCT01942486|12433747|P1|COMPLETED|Overall Study||8
5052272|NCT01942486|12433747|P1|STARTED|Overall Study||35
5052273|NCT01942161|12433754|P3|NOT COMPLETED|Overall Study||6
5052274|NCT01942161|12433755|P2|NOT COMPLETED|Overall Study||6
5052275|NCT01942161|12433756|P1|NOT COMPLETED|Overall Study||8
5052276|NCT01942161|12433754|P3|COMPLETED|Overall Study||35
5052277|NCT01942161|12433755|P2|COMPLETED|Overall Study||24
5052278|NCT01942161|12433756|P1|COMPLETED|Overall Study||27
5052279|NCT01942161|12433754|P3|STARTED|Overall Study||41
5052280|NCT01942161|12433755|P2|STARTED|Overall Study||30
5052281|NCT01942161|12433756|P1|STARTED|Overall Study||35
5052282|NCT01942148|12433776|P1|NOT COMPLETED|Overall Study||27
5052283|NCT01942148|12433776|P1|COMPLETED|Overall Study||41
5052284|NCT01942148|12433776|P1|STARTED|Overall Study||68
5052285|NCT01942135|12433784|P2|NOT COMPLETED|Overall Study||174
5052286|NCT01942135|12433785|P1|NOT COMPLETED|Overall Study||347
5052287|NCT01942135|12433784|P2|COMPLETED|Overall Study||0
5052288|NCT01942135|12433785|P1|COMPLETED|Overall Study||0
5052289|NCT01942135|12433784|P2|STARTED|Overall Study||174
5052290|NCT01942135|12433785|P1|STARTED|Overall Study||347
5052291|NCT01941940|12433822|P1|NOT COMPLETED|Overall Study||33
5052292|NCT01941940|12433822|P1|COMPLETED|Overall Study||194
5052293|NCT01941940|12433822|P1|STARTED|Overall Study||227
5052294|NCT01941927|12433864|P2|NOT COMPLETED|Overall Study||0
5052295|NCT01941927|12433865|P1|NOT COMPLETED|Overall Study||0
5052296|NCT01941927|12433864|P2|COMPLETED|Overall Study||10
5052297|NCT01941927|12433865|P1|COMPLETED|Overall Study||10
5052298|NCT01941927|12433864|P2|STARTED|Overall Study||10
5052299|NCT01941927|12433865|P1|STARTED|Overall Study||10
5052300|NCT01941745|12433881|P4|NOT COMPLETED|Overall Study||0
5052301|NCT01941745|12433882|P3|NOT COMPLETED|Overall Study||0
5052302|NCT01941745|12433883|P2|NOT COMPLETED|Overall Study||0
5052303|NCT01941745|12433884|P1|NOT COMPLETED|Overall Study||0
5052304|NCT01941745|12433881|P4|COMPLETED|Overall Study||23
5052305|NCT01941745|12433882|P3|COMPLETED|Overall Study||21
5052306|NCT01941745|12433883|P2|COMPLETED|Overall Study||22
5052307|NCT01941745|12433884|P1|COMPLETED|Overall Study||22
5052308|NCT01941745|12433881|P4|STARTED|Overall Study||23
5052309|NCT01941745|12433882|P3|STARTED|Overall Study||21
5052310|NCT01941745|12433883|P2|STARTED|Overall Study||22
5052311|NCT01941745|12433884|P1|STARTED|Overall Study||22
5052312|NCT01941628|12433908|P2|NOT COMPLETED|Overall Study||0
5052313|NCT01941628|12433909|P1|NOT COMPLETED|Overall Study||1
5052314|NCT01941628|12433908|P2|COMPLETED|Overall Study||45
5052315|NCT01941628|12433909|P1|COMPLETED|Overall Study||45
5052316|NCT01941628|12433908|P2|STARTED|Overall Study||45
5052317|NCT01941628|12433909|P1|STARTED|Overall Study||46
5052318|NCT01941615|12433919|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
5052319|NCT01941615|12433919|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
5052320|NCT01941615|12433919|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
5052321|NCT01941615|12433919|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
5052322|NCT01941615|12433919|P1|COMPLETED|Reference Treatment: Microgynon®||0
5052323|NCT01941615|12433919|P1|STARTED|Reference Treatment: Microgynon®||0
5052324|NCT01941615|12433919|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
5052325|NCT01941615|12433919|P1|COMPLETED|Run in Treatment: Microgynon®||16
5052326|NCT01941615|12433919|P1|STARTED|Run in Treatment: Microgynon®||16
5052327|NCT01941537|12433930|P2|NOT COMPLETED|Overall Study||3
5052328|NCT01941537|12433931|P1|NOT COMPLETED|Overall Study||4
5052329|NCT01941537|12433930|P2|COMPLETED|Overall Study||17
5052330|NCT01941537|12433931|P1|COMPLETED|Overall Study||36
5052331|NCT01941537|12433930|P2|STARTED|Overall Study||20
5052332|NCT01941537|12433931|P1|STARTED|Overall Study||40
5052333|NCT01941498|12433943|P1|NOT COMPLETED|Overall Study||1
5052334|NCT01941498|12433943|P1|COMPLETED|Overall Study||96
5052335|NCT01941498|12433943|P1|STARTED|Overall Study||97
5052336|NCT01941485|12433989|P1|NOT COMPLETED|Overall Study||0
5052337|NCT01941485|12433989|P1|COMPLETED|Overall Study||59
5052338|NCT01941485|12433989|P1|STARTED|Overall Study||59
5052339|NCT01941472|12434055|P1|NOT COMPLETED|Overall Study||0
5052340|NCT01941472|12434055|P1|COMPLETED|Overall Study||40
5052341|NCT01941472|12434055|P1|STARTED|Overall Study||40
5052342|NCT01941186|12434061|P2|NOT COMPLETED|Follow-up||0
5052343|NCT01941186|12434062|P1|NOT COMPLETED|Follow-up||1
5052344|NCT01941186|12434061|P2|COMPLETED|Follow-up||33
5052345|NCT01941186|12434062|P1|COMPLETED|Follow-up||30
5052346|NCT01941186|12434061|P2|STARTED|Follow-up||33
5052347|NCT01941186|12434062|P1|STARTED|Follow-up||31
5052348|NCT01941186|12434061|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
5052349|NCT01941186|12434062|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
5052350|NCT01941186|12434061|P2|COMPLETED|Randomization/Allocation to Study Group||33
5052351|NCT01941186|12434062|P1|COMPLETED|Randomization/Allocation to Study Group||31
5052352|NCT01941186|12434061|P2|STARTED|Randomization/Allocation to Study Group||33
5052353|NCT01941186|12434062|P1|STARTED|Randomization/Allocation to Study Group||31
5052354|NCT01941095|12434088|P1|NOT COMPLETED|Overall Study||56
5052355|NCT01941095|12434088|P1|COMPLETED|Overall Study||41
5052356|NCT01941095|12434088|P1|STARTED|Overall Study||97
5052357|NCT01941030|12434113|P2|NOT COMPLETED|Overall Study||13
5052358|NCT01941030|12434114|P1|NOT COMPLETED|Overall Study||13
5052359|NCT01941030|12434113|P2|COMPLETED|Overall Study||13
5052360|NCT01941030|12434114|P1|COMPLETED|Overall Study||12
5052361|NCT01941030|12434113|P2|STARTED|Overall Study||26
5052362|NCT01941030|12434114|P1|STARTED|Overall Study||25
5052363|NCT01940939|12434136|P2|NOT COMPLETED|Overall Study||8
5052364|NCT01940939|12434137|P1|NOT COMPLETED|Overall Study||2
5052365|NCT01940939|12434136|P2|COMPLETED|Overall Study||27
5052366|NCT01940939|12434137|P1|COMPLETED|Overall Study||33
5052367|NCT01940939|12434136|P2|STARTED|Overall Study||35
5052368|NCT01940939|12434137|P1|STARTED|Overall Study||35
5052369|NCT01940900|12434149|P2|NOT COMPLETED|Overall Study||31
5052370|NCT01940900|12434150|P1|NOT COMPLETED|Overall Study||29
5052371|NCT01940900|12434149|P2|COMPLETED|Overall Study||284
5052372|NCT01940900|12434150|P1|COMPLETED|Overall Study||282
5052373|NCT01940900|12434149|P2|STARTED|Overall Study||315
5052374|NCT01940900|12434150|P1|STARTED|Overall Study||311
5052375|NCT01940705|12434160|P4|NOT COMPLETED|Overall Study||4
5052376|NCT01940705|12434161|P3|NOT COMPLETED|Overall Study||8
5052377|NCT01940705|12434162|P2|NOT COMPLETED|Overall Study||8
5052378|NCT01940705|12434163|P1|NOT COMPLETED|Overall Study||4
5052379|NCT01940705|12434160|P4|COMPLETED|Overall Study||63
5052380|NCT01940705|12434161|P3|COMPLETED|Overall Study||61
5052381|NCT01940705|12434162|P2|COMPLETED|Overall Study||59
5052382|NCT01940705|12434163|P1|COMPLETED|Overall Study||62
5052383|NCT01940705|12434160|P4|STARTED|Overall Study||67
5052384|NCT01940705|12434161|P3|STARTED|Overall Study||69
5052385|NCT01940705|12434162|P2|STARTED|Overall Study||67
5052386|NCT01940705|12434163|P1|STARTED|Overall Study||66
5052387|NCT01940523|12434183|P2|NOT COMPLETED|Overall Study||0
5052388|NCT01940523|12434184|P1|NOT COMPLETED|Overall Study||0
5052389|NCT01940523|12434183|P2|COMPLETED|Overall Study||320
5052390|NCT01940523|12434184|P1|COMPLETED|Overall Study||320
5052391|NCT01940523|12434183|P2|STARTED|Overall Study||320
5052392|NCT01940523|12434184|P1|STARTED|Overall Study||320
5052393|NCT01940510|12434194|P1|NOT COMPLETED|Overall Study||0
5052394|NCT01940510|12434194|P1|COMPLETED|Overall Study||24
5052395|NCT01940510|12434194|P1|STARTED|Overall Study||24
5052396|NCT01940497|12434227|P2|NOT COMPLETED|Overall Study||18
5052397|NCT01940497|12434228|P1|NOT COMPLETED|Overall Study||21
5052398|NCT01940497|12434227|P2|COMPLETED|Overall Study||101
5052399|NCT01940497|12434228|P1|COMPLETED|Overall Study||100
5052400|NCT01940497|12434227|P2|Treated: Neoadjuvant|Overall Study||21
5052401|NCT01940497|12434228|P1|Treated: Neoadjuvant|Overall Study||20
5052402|NCT01940497|12434227|P2|Treated: Adjuvant|Overall Study||92
5052403|NCT01940497|12434228|P1|Treated: Adjuvant|Overall Study||95
5052404|NCT01940497|12434227|P2|Treated|Overall Study||113
5052405|NCT01940497|12434228|P1|Treated|Overall Study||115
5052406|NCT01940497|12434227|P2|STARTED|Overall Study||119
5052407|NCT01940497|12434228|P1|STARTED|Overall Study||121
5052408|NCT01940484|12434269|P1|NOT COMPLETED|Overall Study||10
5052409|NCT01940484|12434269|P1|COMPLETED|Overall Study||88
5052410|NCT01940484|12434269|P1|STARTED|Overall Study||98
5052411|NCT01940471|12434289|P2|NOT COMPLETED|Open-Label Extension||8
5052412|NCT01940471|12434290|P1|NOT COMPLETED|Open-Label Extension||14
5052413|NCT01940471|12434289|P2|COMPLETED|Open-Label Extension||0
5052414|NCT01940471|12434290|P1|COMPLETED|Open-Label Extension||0
5052415|NCT01940471|12434289|P2|STARTED|Open-Label Extension||8
5052416|NCT01940471|12434290|P1|STARTED|Open-Label Extension||14
5052417|NCT01940471|12434289|P2|NOT COMPLETED|Double-Blind Phase||285
5052418|NCT01940471|12434290|P1|NOT COMPLETED|Double-Blind Phase||568
5052419|NCT01940471|12434289|P2|COMPLETED|Double-Blind Phase||8
5052420|NCT01940471|12434290|P1|COMPLETED|Double-Blind Phase||14
5052421|NCT01940471|12434289|P2|STARTED|Double-Blind Phase||293
5052422|NCT01940471|12434290|P1|STARTED|Double-Blind Phase||582
5052423|NCT01940354|12434308|P2|NOT COMPLETED|Overall Study||2
5052424|NCT01940354|12434309|P1|NOT COMPLETED|Overall Study||4
5052425|NCT01940354|12434308|P2|COMPLETED|Overall Study||108
5052426|NCT01940354|12434309|P1|COMPLETED|Overall Study||106
5052427|NCT01940354|12434308|P2|STARTED|Overall Study||110
5052428|NCT01940354|12434309|P1|STARTED|Overall Study||110
5052429|NCT01940341|12434321|P2|NOT COMPLETED|Open-label Extension Phase||1
5052430|NCT01940341|12434322|P1|NOT COMPLETED|Open-label Extension Phase||4
5052431|NCT01940341|12434321|P2|COMPLETED|Open-label Extension Phase||0
5052432|NCT01940341|12434322|P1|COMPLETED|Open-label Extension Phase||0
5052433|NCT01940341|12434321|P2|STARTED|Open-label Extension Phase||1
5052434|NCT01940341|12434322|P1|STARTED|Open-label Extension Phase||4
5052435|NCT01940341|12434321|P2|NOT COMPLETED|Double-Blind Phase||140
5052436|NCT01940341|12434322|P1|NOT COMPLETED|Double-Blind Phase||281
5052437|NCT01940341|12434321|P2|COMPLETED|Double-Blind Phase||1
5052438|NCT01940341|12434322|P1|COMPLETED|Double-Blind Phase||4
5052439|NCT01940341|12434321|P2|STARTED|Double-Blind Phase||141
5052440|NCT01940341|12434322|P1|STARTED|Double-Blind Phase||285
5052441|NCT01940146|12434340|P4|NOT COMPLETED|Overall Study||2
5052442|NCT01940146|12434341|P3|NOT COMPLETED|Overall Study||1
5052443|NCT01940146|12434342|P2|NOT COMPLETED|Overall Study||0
5052444|NCT01940146|12434343|P1|NOT COMPLETED|Overall Study||1
5052445|NCT01940146|12434340|P4|COMPLETED|Overall Study||53
5052446|NCT01940146|12434341|P3|COMPLETED|Overall Study||55
5052447|NCT01940146|12434342|P2|COMPLETED|Overall Study||55
5052448|NCT01940146|12434343|P1|COMPLETED|Overall Study||55
5052449|NCT01940146|12434340|P4|STARTED|Overall Study||55
5052450|NCT01940146|12434341|P3|STARTED|Overall Study||56
5052451|NCT01940146|12434342|P2|STARTED|Overall Study||55
5052452|NCT01940146|12434343|P1|STARTED|Overall Study||56
5052453|NCT01940120|12434353|P1|NOT COMPLETED|Overall Study||48
5052454|NCT01940120|12434353|P1|COMPLETED|Overall Study||30
5052455|NCT01940120|12434353|P1|STARTED|Overall Study||78
5052456|NCT01939977|12434509|P2|NOT COMPLETED|Overall Study||7
5052457|NCT01939977|12434510|P1|NOT COMPLETED|Overall Study||9
5052458|NCT01939977|12434509|P2|COMPLETED|Overall Study||41
5052459|NCT01939977|12434510|P1|COMPLETED|Overall Study||37
5052460|NCT01939977|12434509|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
5052461|NCT01939977|12434510|P1|STARTED|Overall Study||46
5052462|NCT01939938|12434546|P1|NOT COMPLETED|Overall Study||0
5052463|NCT01939938|12434546|P1|COMPLETED|Overall Study||10
5052464|NCT01939938|12434546|P1|STARTED|Overall Study||10
5052465|NCT01939899|12434557|P5|NOT COMPLETED|Phase 2||1
5052466|NCT01939899|12434558|P4|NOT COMPLETED|Phase 2||11
5052467|NCT01939899|12434559|P3|NOT COMPLETED|Phase 2||0
5052468|NCT01939899|12434560|P2|NOT COMPLETED|Phase 2||0
5052469|NCT01939899|12434561|P1|NOT COMPLETED|Phase 2||0
5052470|NCT01939899|12434557|P5|COMPLETED|Phase 2||0
5052471|NCT01939899|12434558|P4|COMPLETED|Phase 2||1
5052472|NCT01939899|12434559|P3|COMPLETED|Phase 2||0
5052473|NCT01939899|12434560|P2|COMPLETED|Phase 2||0
5052474|NCT01939899|12434561|P1|COMPLETED|Phase 2||0
5052475|NCT01939899|12434557|P5|STARTED|Phase 2||1
5052476|NCT01939899|12434558|P4|STARTED|Phase 2||12
5052477|NCT01939899|12434559|P3|STARTED|Phase 2||0
5052478|NCT01939899|12434560|P2|STARTED|Phase 2||0
5052479|NCT01939899|12434561|P1|STARTED|Phase 2||0
5052480|NCT01939899|12434557|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
5052481|NCT01939899|12434558|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
5052482|NCT01939899|12434559|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
5052483|NCT01939899|12434560|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
5052484|NCT01939899|12434561|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
5052485|NCT01939899|12434557|P5|COMPLETED|Lead-in Dose Finding Phase||0
5052486|NCT01939899|12434558|P4|COMPLETED|Lead-in Dose Finding Phase||0
5052487|NCT01939899|12434559|P3|COMPLETED|Lead-in Dose Finding Phase||1
5052488|NCT01939899|12434560|P2|COMPLETED|Lead-in Dose Finding Phase||0
5052489|NCT01939899|12434561|P1|COMPLETED|Lead-in Dose Finding Phase||1
5052490|NCT01939899|12434557|P5|STARTED|Lead-in Dose Finding Phase||0
5052491|NCT01939899|12434558|P4|STARTED|Lead-in Dose Finding Phase||0
5052492|NCT01939899|12434559|P3|STARTED|Lead-in Dose Finding Phase||6
5052493|NCT01939899|12434560|P2|STARTED|Lead-in Dose Finding Phase||7
5052494|NCT01939899|12434561|P1|STARTED|Lead-in Dose Finding Phase||3
5052495|NCT01939548|12434608|P3|NOT COMPLETED|Overall Study||30
5052496|NCT01939548|12434609|P2|NOT COMPLETED|Overall Study||49
5052497|NCT01939548|12434610|P1|NOT COMPLETED|Overall Study||37
5052498|NCT01939548|12434608|P3|COMPLETED|Overall Study||50
5052499|NCT01939548|12434609|P2|COMPLETED|Overall Study||33
5052500|NCT01939548|12434610|P1|COMPLETED|Overall Study||41
5052501|NCT01939548|12434608|P3|STARTED|Overall Study||80
5052502|NCT01939548|12434609|P2|STARTED|Overall Study||82
5052503|NCT01939548|12434610|P1|STARTED|Overall Study||78
5052504|NCT01939496|12434684|P3|NOT COMPLETED|Overall Study||2
5052505|NCT01939496|12434685|P2|NOT COMPLETED|Overall Study||3
5052506|NCT01939496|12434686|P1|NOT COMPLETED|Overall Study||9
5052507|NCT01939496|12434684|P3|COMPLETED|Overall Study||54
5052508|NCT01939496|12434685|P2|COMPLETED|Overall Study||54
5052509|NCT01939496|12434686|P1|COMPLETED|Overall Study||47
5052510|NCT01939496|12434684|P3|STARTED|Overall Study||56
5052511|NCT01939496|12434685|P2|STARTED|Overall Study||57
5052512|NCT01939496|12434686|P1|STARTED|Overall Study||56
5052513|NCT01939405|12434738|P2|NOT COMPLETED|Overall Study||2
5052514|NCT01939405|12434739|P1|NOT COMPLETED|Overall Study||3
5052515|NCT01939405|12434738|P2|COMPLETED|Overall Study||28
5052516|NCT01939405|12434739|P1|COMPLETED|Overall Study||27
5052517|NCT01939405|12434738|P2|STARTED|Overall Study||30
5052518|NCT01939405|12434739|P1|STARTED|Overall Study||30
5052519|NCT01939366|12434756|P5|NOT COMPLETED|Overall Study||18
5052520|NCT01939366|12434757|P4|NOT COMPLETED|Overall Study||17
5052521|NCT01939366|12434758|P3|NOT COMPLETED|Overall Study||38
5052522|NCT01939366|12434759|P2|NOT COMPLETED|Overall Study||23
5052523|NCT01939366|12434760|P1|NOT COMPLETED|Overall Study||14
5052524|NCT01939366|12434756|P5|COMPLETED|Overall Study||48
5052525|NCT01939366|12434757|P4|COMPLETED|Overall Study||51
5052526|NCT01939366|12434758|P3|COMPLETED|Overall Study||27
5052527|NCT01939366|12434759|P2|COMPLETED|Overall Study||41
5052528|NCT01939366|12434760|P1|COMPLETED|Overall Study||52
5052529|NCT01939366|12434756|P5|Per Protocol Set|Overall Study||49
5052530|NCT01939366|12434757|P4|Per Protocol Set|Overall Study||51
5052531|NCT01939366|12434758|P3|Per Protocol Set|Overall Study||50
5052532|NCT01939366|12434759|P2|Per Protocol Set|Overall Study||55
5052533|NCT01939366|12434760|P1|Per Protocol Set|Overall Study||58
5052534|NCT01939366|12434756|P5|Full Analysis Set|Overall Study||62
5052535|NCT01939366|12434757|P4|Full Analysis Set|Overall Study||65
5052536|NCT01939366|12434758|P3|Full Analysis Set|Overall Study||61
5052537|NCT01939366|12434759|P2|Full Analysis Set|Overall Study||60
5052538|NCT01939366|12434760|P1|Full Analysis Set|Overall Study||64
5052539|NCT01939366|12434756|P5|Safety Set|Overall Study||62
5052540|NCT01939366|12434757|P4|Safety Set|Overall Study||65
5052541|NCT01939366|12434758|P3|Safety Set|Overall Study||62
5052542|NCT01939366|12434759|P2|Safety Set|Overall Study||61
5052543|NCT01939366|12434760|P1|Safety Set|Overall Study||64
5052544|NCT01939366|12434756|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
5052545|NCT01939366|12434757|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
5052546|NCT01939366|12434758|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
5052547|NCT01939366|12434759|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
5052548|NCT01939366|12434760|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
5052549|NCT01939366|12434756|P5|STARTED|Overall Study||66
5052550|NCT01939366|12434757|P4|STARTED|Overall Study||68
5052551|NCT01939366|12434758|P3|STARTED|Overall Study||65
5052552|NCT01939366|12434759|P2|STARTED|Overall Study||64
5052553|NCT01939366|12434760|P1|STARTED|Overall Study||66
5052554|NCT01939314|12434774|P2|NOT COMPLETED|Overall Study||8
5052555|NCT01939314|12434775|P1|NOT COMPLETED|Overall Study||9
5052556|NCT01939314|12434774|P2|COMPLETED|Overall Study||40
5052557|NCT01939314|12434775|P1|COMPLETED|Overall Study||36
5052558|NCT01939314|12434774|P2|24 Hour Endpoint|Overall Study||40
5052559|NCT01939314|12434775|P1|24 Hour Endpoint|Overall Study||36
5052560|NCT01939314|12434774|P2|15 Minute Endpoint|Overall Study||46
5052561|NCT01939314|12434775|P1|15 Minute Endpoint|Overall Study||41
5052562|NCT01939314|12434774|P2|STARTED|Overall Study||48
5052563|NCT01939314|12434775|P1|STARTED|Overall Study||45
5052564|NCT01939301|12434787|P2|NOT COMPLETED|Overall Study||1
5052565|NCT01939301|12434788|P1|NOT COMPLETED|Overall Study||1
5052566|NCT01939301|12434787|P2|COMPLETED|Overall Study||38
5052567|NCT01939301|12434788|P1|COMPLETED|Overall Study||38
5052568|NCT01939301|12434787|P2|STARTED|Overall Study||39
5052569|NCT01939301|12434788|P1|STARTED|Overall Study||39
5052570|NCT01939288|12434796|P2|NOT COMPLETED|Overall Study||0
5052571|NCT01939288|12434797|P1|NOT COMPLETED|Overall Study||0
5052572|NCT01939288|12434796|P2|COMPLETED|Overall Study||5
5052573|NCT01939288|12434797|P1|COMPLETED|Overall Study||5
5052574|NCT01939288|12434796|P2|STARTED|Overall Study||5
5052575|NCT01939288|12434797|P1|STARTED|Overall Study||5
5052576|NCT01939275|12434803|P1|NOT COMPLETED|Overall Study||0
5052577|NCT01939275|12434803|P1|COMPLETED|Overall Study||8
5052578|NCT01939275|12434803|P1|STARTED|Overall Study||8
5052579|NCT01939223|12434809|P2|NOT COMPLETED|Overall Study||11
5052580|NCT01939223|12434810|P1|NOT COMPLETED|Overall Study||13
5052581|NCT01939223|12434809|P2|COMPLETED|Overall Study||0
5052582|NCT01939223|12434810|P1|COMPLETED|Overall Study||1
5052583|NCT01939223|12434809|P2|Participants Received Treatment|Overall Study||11
5052584|NCT01939223|12434810|P1|Participants Received Treatment|Overall Study||14
5052585|NCT01939223|12434809|P2|STARTED|Overall Study||11
5052586|NCT01939223|12434810|P1|STARTED|Overall Study||14
5052587|NCT01939197|12434825|P7|NOT COMPLETED|Overall Study||2
5052588|NCT01939197|12434826|P6|NOT COMPLETED|Overall Study||1
5052589|NCT01939197|12434827|P5|NOT COMPLETED|Overall Study||4
5052590|NCT01939197|12434828|P4|NOT COMPLETED|Overall Study||1
5052591|NCT01939197|12434829|P3|NOT COMPLETED|Overall Study||0
5052592|NCT01939197|12434830|P2|NOT COMPLETED|Overall Study||1
5052593|NCT01939197|12434831|P1|NOT COMPLETED|Overall Study||1
5052594|NCT01939197|12434825|P7|COMPLETED|Overall Study||26
5052595|NCT01939197|12434826|P6|COMPLETED|Overall Study||4
5052596|NCT01939197|12434827|P5|COMPLETED|Overall Study||196
5052597|NCT01939197|12434828|P4|COMPLETED|Overall Study||11
5052598|NCT01939197|12434829|P3|COMPLETED|Overall Study||10
5052599|NCT01939197|12434830|P2|COMPLETED|Overall Study||31
5052600|NCT01939197|12434831|P1|COMPLETED|Overall Study||30
5052601|NCT01939197|12434825|P7|STARTED|Overall Study||28
5052602|NCT01939197|12434826|P6|STARTED|Overall Study||5
5052603|NCT01939197|12434827|P5|STARTED|Overall Study||200
5052604|NCT01939197|12434828|P4|STARTED|Overall Study||12
5052605|NCT01939197|12434829|P3|STARTED|Overall Study||10
5052606|NCT01939197|12434830|P2|STARTED|Overall Study||32
5052607|NCT01939197|12434831|P1|STARTED|Overall Study||31
5052608|NCT01939145|12434891|P2|NOT COMPLETED|Overall Study||7
5052609|NCT01939145|12434892|P1|NOT COMPLETED|Overall Study||2
5052610|NCT01939145|12434891|P2|COMPLETED|Overall Study||44
5052611|NCT01939145|12434892|P1|COMPLETED|Overall Study||47
5052612|NCT01939145|12434891|P2|STARTED|Overall Study||51
5052613|NCT01939145|12434892|P1|STARTED|Overall Study||49
5052614|NCT01939002|12434902|P2|NOT COMPLETED|Overall Study||18
5052615|NCT01939002|12434903|P1|NOT COMPLETED|Overall Study||19
5052616|NCT01939002|12434902|P2|COMPLETED|Overall Study||80
5052617|NCT01939002|12434903|P1|COMPLETED|Overall Study||84
5052618|NCT01939002|12434902|P2|STARTED|Overall Study||98
5052619|NCT01939002|12434903|P1|STARTED|Overall Study||103
5052620|NCT01938989|12434969|P2|NOT COMPLETED|Overall Study||0
5052621|NCT01938989|12434970|P1|NOT COMPLETED|Overall Study||0
5052622|NCT01938989|12434969|P2|COMPLETED|Overall Study||77
5052623|NCT01938989|12434970|P1|COMPLETED|Overall Study||77
5052624|NCT01938989|12434969|P2|STARTED|Overall Study||77
5052625|NCT01938989|12434970|P1|STARTED|Overall Study||77
5052626|NCT01938846|12434979|P3|NOT COMPLETED|Overall Study||24
5052627|NCT01938846|12434980|P2|NOT COMPLETED|Overall Study||25
5052628|NCT01938846|12434981|P1|NOT COMPLETED|Overall Study||41
5052629|NCT01938846|12434979|P3|COMPLETED|Overall Study||0
5052630|NCT01938846|12434980|P2|COMPLETED|Overall Study||0
5052631|NCT01938846|12434981|P1|COMPLETED|Overall Study||0
5052632|NCT01938846|12434979|P3|STARTED|Overall Study||24
5052633|NCT01938846|12434980|P2|STARTED|Overall Study||25
5052634|NCT01938846|12434981|P1|STARTED|Overall Study||41
5052635|NCT01938833|12435173|P1|NOT COMPLETED|Overall Study||0
5052636|NCT01938833|12435173|P1|COMPLETED|Overall Study||9
5052637|NCT01938833|12435173|P1|STARTED|Overall Study||9
5052638|NCT01938664|12435183|P2|NOT COMPLETED|Overall Study||10
5052639|NCT01938664|12435184|P1|NOT COMPLETED|Overall Study||15
5052640|NCT01938664|12435183|P2|COMPLETED|Overall Study||0
5052641|NCT01938664|12435184|P1|COMPLETED|Overall Study||5
5052642|NCT01938664|12435183|P2|STARTED|Overall Study||10
5052643|NCT01938664|12435184|P1|STARTED|Overall Study||20
5052644|NCT01938625|12435196|P2|NOT COMPLETED|Overall Study||2
5052645|NCT01938625|12435197|P1|NOT COMPLETED|Overall Study||0
5052646|NCT01938625|12435196|P2|COMPLETED|Overall Study||23
5052647|NCT01938625|12435197|P1|COMPLETED|Overall Study||10
5052648|NCT01938625|12435196|P2|STARTED|Overall Study||25
5052649|NCT01938625|12435197|P1|STARTED|Overall Study||10
5052650|NCT01938573|12435217|P2|NOT COMPLETED|Overall Study||0
5052651|NCT01938573|12435218|P1|NOT COMPLETED|Overall Study||2
5052652|NCT01938573|12435217|P2|COMPLETED|Overall Study||6
5052653|NCT01938573|12435218|P1|COMPLETED|Overall Study||13
5052654|NCT01938573|12435217|P2|STARTED|Overall Study||6
5052655|NCT01938573|12435218|P1|STARTED|Overall Study||15
5052656|NCT01938430|12435238|P14|NOT COMPLETED|Overall Study||1
5052657|NCT01938430|12435239|P13|NOT COMPLETED|Overall Study||0
5052658|NCT01938430|12435240|P12|NOT COMPLETED|Overall Study||1
5052659|NCT01938430|12435241|P11|NOT COMPLETED|Overall Study||3
5052660|NCT01938430|12435242|P10|NOT COMPLETED|Overall Study||3
5052661|NCT01938430|12435243|P9|NOT COMPLETED|Overall Study||4
5052662|NCT01938430|12435244|P8|NOT COMPLETED|Overall Study||1
5052663|NCT01938430|12435245|P7|NOT COMPLETED|Overall Study||2
5052664|NCT01938430|12435246|P6|NOT COMPLETED|Overall Study||1
5052665|NCT01938430|12435247|P5|NOT COMPLETED|Overall Study||0
5052666|NCT01938430|12435248|P4|NOT COMPLETED|Overall Study||2
5052667|NCT01938430|12435249|P3|NOT COMPLETED|Overall Study||5
5052668|NCT01938430|12435250|P2|NOT COMPLETED|Overall Study||3
5052669|NCT01938430|12435251|P1|NOT COMPLETED|Overall Study||4
5052670|NCT01938430|12435238|P14|COMPLETED|Overall Study||2
5052671|NCT01938430|12435239|P13|COMPLETED|Overall Study||4
5052672|NCT01938430|12435240|P12|COMPLETED|Overall Study||3
5052673|NCT01938430|12435241|P11|COMPLETED|Overall Study||3
5052674|NCT01938430|12435242|P10|COMPLETED|Overall Study||23
5052675|NCT01938430|12435243|P9|COMPLETED|Overall Study||22
5052676|NCT01938430|12435244|P8|COMPLETED|Overall Study||24
5052677|NCT01938430|12435245|P7|COMPLETED|Overall Study||24
5052678|NCT01938430|12435246|P6|COMPLETED|Overall Study||55
5052679|NCT01938430|12435247|P5|COMPLETED|Overall Study||55
5052680|NCT01938430|12435248|P4|COMPLETED|Overall Study||24
5052681|NCT01938430|12435249|P3|COMPLETED|Overall Study||18
5052682|NCT01938430|12435250|P2|COMPLETED|Overall Study||26
5052683|NCT01938430|12435251|P1|COMPLETED|Overall Study||26
5052684|NCT01938430|12435238|P14|STARTED|Overall Study||3
5052685|NCT01938430|12435239|P13|STARTED|Overall Study||4
5052686|NCT01938430|12435240|P12|STARTED|Overall Study||4
5052687|NCT01938430|12435241|P11|STARTED|Overall Study||6
5052688|NCT01938430|12435242|P10|STARTED|Overall Study||26
5052689|NCT01938430|12435243|P9|STARTED|Overall Study||26
5052690|NCT01938430|12435244|P8|STARTED|Overall Study||25
5052691|NCT01938430|12435245|P7|STARTED|Overall Study||26
5052692|NCT01938430|12435246|P6|STARTED|Overall Study||56
5052693|NCT01938430|12435247|P5|STARTED|Overall Study||55
5052694|NCT01938430|12435248|P4|STARTED|Overall Study||26
5052695|NCT01938430|12435249|P3|STARTED|Overall Study||23
5052696|NCT01938430|12435250|P2|STARTED|Overall Study||29
5052697|NCT01938430|12435251|P1|STARTED|Overall Study||30
5052698|NCT01938391|12435576|P1|NOT COMPLETED|12 Month Follow up||2
5052699|NCT01938391|12435576|P1|COMPLETED|12 Month Follow up||22
5052700|NCT01938391|12435576|P1|STARTED|12 Month Follow up||24
5052701|NCT01938391|12435576|P1|NOT COMPLETED|6 Month Follow up||1
5052702|NCT01938391|12435576|P1|COMPLETED|6 Month Follow up||24
5052703|NCT01938391|12435576|P1|STARTED|6 Month Follow up||25
5052704|NCT01938391|12435576|P1|NOT COMPLETED|2 Week Follow up||0
5052705|NCT01938391|12435576|P1|COMPLETED|2 Week Follow up||25
5052706|NCT01938391|12435576|P1|STARTED|2 Week Follow up||25
5052707|NCT01938391|12435576|P1|NOT COMPLETED|Baseline||0
5052708|NCT01938391|12435576|P1|COMPLETED|Baseline||25
5052709|NCT01938391|12435576|P1|STARTED|Baseline||25
5052710|NCT01938378|12435589|P1|NOT COMPLETED|Overall Study||0
5052711|NCT01938378|12435589|P1|COMPLETED|Overall Study||41
5052712|NCT01938378|12435589|P1|STARTED|Overall Study||41
5052713|NCT01938170|12435654|P1|NOT COMPLETED|Overall Study||0
5052714|NCT01938170|12435654|P1|COMPLETED|Overall Study||41
5052715|NCT01938170|12435654|P1|STARTED|Overall Study||41
5052716|NCT01938079|12435661|P2|NOT COMPLETED|Overall Study||0
5052717|NCT01938079|12435662|P1|NOT COMPLETED|Overall Study||0
5052718|NCT01938079|12435661|P2|COMPLETED|Overall Study||10
5052719|NCT01938079|12435662|P1|COMPLETED|Overall Study||10
5052720|NCT01938079|12435661|P2|STARTED|Overall Study||10
5052721|NCT01938079|12435662|P1|STARTED|Overall Study||10
5052722|NCT01938066|12435670|P2|NOT COMPLETED|Overall Study||2
5052723|NCT01938066|12435671|P1|NOT COMPLETED|Overall Study||1
5052724|NCT01938066|12435670|P2|COMPLETED|Overall Study||13
5052725|NCT01938066|12435671|P1|COMPLETED|Overall Study||14
5052726|NCT01938066|12435670|P2|STARTED|Overall Study||15
5052727|NCT01938066|12435671|P1|STARTED|Overall Study||15
5052728|NCT01938040|12435681|P2|NOT COMPLETED|Overall Study||0
5052729|NCT01938040|12435682|P1|NOT COMPLETED|Overall Study||0
5052730|NCT01938040|12435681|P2|COMPLETED|Overall Study||27
5052731|NCT01938040|12435682|P1|COMPLETED|Overall Study||28
5052732|NCT01938040|12435681|P2|Behavior Metrics|Overall Study||27
5052733|NCT01938040|12435682|P1|Behavior Metrics|Overall Study||28
5052734|NCT01938040|12435681|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
5052735|NCT01938040|12435682|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
5052736|NCT01938040|12435681|P2|STARTED|Overall Study||27
5052737|NCT01938040|12435682|P1|STARTED|Overall Study||28
5052738|NCT01938001|12435710|P2|NOT COMPLETED|Overall Study||47
5052739|NCT01938001|12435711|P1|NOT COMPLETED|Overall Study||43
5052740|NCT01938001|12435710|P2|COMPLETED|Overall Study||133
5052741|NCT01938001|12435711|P1|COMPLETED|Overall Study||135
5052742|NCT01938001|12435710|P2|Completed Treatment|Overall Study||110
5052743|NCT01938001|12435711|P1|Completed Treatment|Overall Study||124
5052744|NCT01938001|12435710|P2|Participants Received Treatment|Overall Study||180
5052745|NCT01938001|12435711|P1|Participants Received Treatment|Overall Study||176
5052746|NCT01938001|12435710|P2|STARTED|Overall Study||180
5052747|NCT01938001|12435711|P1|STARTED|Overall Study||178
5052748|NCT01937975|12435738|P3|NOT COMPLETED|Overall Study||0
5052749|NCT01937975|12435739|P2|NOT COMPLETED|Overall Study||0
5052750|NCT01937975|12435740|P1|NOT COMPLETED|Overall Study||0
5052751|NCT01937975|12435738|P3|COMPLETED|Overall Study||8
5052752|NCT01937975|12435739|P2|COMPLETED|Overall Study||8
5052753|NCT01937975|12435740|P1|COMPLETED|Overall Study||8
5052754|NCT01937975|12435738|P3|STARTED|Overall Study||8
5052755|NCT01937975|12435739|P2|STARTED|Overall Study||8
5052756|NCT01937975|12435740|P1|STARTED|Overall Study||8
5052757|NCT01937871|12435790|P3|NOT COMPLETED|Overall Study||11
5052758|NCT01937871|12435791|P2|NOT COMPLETED|Overall Study||17
5052759|NCT01937871|12435792|P1|NOT COMPLETED|Overall Study||24
5052760|NCT01937871|12435790|P3|COMPLETED|Overall Study||174
5052761|NCT01937871|12435791|P2|COMPLETED|Overall Study||346
5052762|NCT01937871|12435792|P1|COMPLETED|Overall Study||337
5052763|NCT01937871|12435790|P3|Received at Least One Dose of Study Drug|Overall Study||185
5052764|NCT01937871|12435791|P2|Received at Least One Dose of Study Drug|Overall Study||362
5052765|NCT01937871|12435792|P1|Received at Least One Dose of Study Drug|Overall Study||361
5052766|NCT01937871|12435790|P3|STARTED|Overall Study||185
5052767|NCT01937871|12435791|P2|STARTED|Overall Study||363
5052768|NCT01937871|12435792|P1|STARTED|Overall Study||361
5052769|NCT01937715|12435868|P5|NOT COMPLETED|Overall Study||2
5052770|NCT01937715|12435869|P4|NOT COMPLETED|Overall Study||4
5052771|NCT01937715|12435870|P3|NOT COMPLETED|Overall Study||0
5052772|NCT01937715|12435871|P2|NOT COMPLETED|Overall Study||1
5052773|NCT01937715|12435872|P1|NOT COMPLETED|Overall Study||0
5052774|NCT01937715|12435868|P5|COMPLETED|Overall Study||1
5052775|NCT01937715|12435869|P4|COMPLETED|Overall Study||1
5052776|NCT01937715|12435870|P3|COMPLETED|Overall Study||3
5052777|NCT01937715|12435871|P2|COMPLETED|Overall Study||3
5052778|NCT01937715|12435872|P1|COMPLETED|Overall Study||3
5052779|NCT01937715|12435868|P5|STARTED|Overall Study||3
5052780|NCT01937715|12435869|P4|STARTED|Overall Study||5
5052781|NCT01937715|12435870|P3|STARTED|Overall Study||3
5052782|NCT01937715|12435871|P2|STARTED|Overall Study||4
5052783|NCT01937715|12435872|P1|STARTED|Overall Study||3
5052784|NCT01937624|12435994|P1|NOT COMPLETED|Overall Study||0
5052785|NCT01937624|12435994|P1|COMPLETED|Overall Study||51
5052786|NCT01937624|12435994|P1|STARTED|Overall Study||51
5052787|NCT01937598|12435998|P2|NOT COMPLETED|Overall Study||0
5052788|NCT01937598|12435999|P1|NOT COMPLETED|Overall Study||0
5052789|NCT01937598|12435998|P2|COMPLETED|Overall Study||8
5052790|NCT01937598|12435999|P1|COMPLETED|Overall Study||8
5052791|NCT01937598|12435998|P2|STARTED|Overall Study||8
5052792|NCT01937598|12435999|P1|STARTED|Overall Study||8
5052793|NCT01937559|12436024|P3|NOT COMPLETED|Overall Study||0
5052794|NCT01937559|12436025|P2|NOT COMPLETED|Overall Study||11
5052795|NCT01937559|12436026|P1|NOT COMPLETED|Overall Study||11
5052796|NCT01937559|12436024|P3|COMPLETED|Overall Study||66
5052797|NCT01937559|12436025|P2|COMPLETED|Overall Study||50
5052798|NCT01937559|12436026|P1|COMPLETED|Overall Study||50
5052799|NCT01937559|12436024|P3|STARTED|Overall Study||66
5052800|NCT01937559|12436025|P2|STARTED|Overall Study||61
5052801|NCT01937559|12436026|P1|STARTED|Overall Study||61
5052802|NCT01937520|12436052|P2|NOT COMPLETED|Overall Study||0
5052803|NCT01937520|12436053|P1|NOT COMPLETED|Overall Study||0
5052804|NCT01937520|12436052|P2|COMPLETED|Overall Study||9
5052805|NCT01937520|12436053|P1|COMPLETED|Overall Study||11
5052806|NCT01937520|12436052|P2|STARTED|Overall Study||9
5052807|NCT01937520|12436053|P1|STARTED|Overall Study||11
5052808|NCT01937507|12436089|P1|NOT COMPLETED|Overall Study||2
5052809|NCT01937507|12436089|P1|COMPLETED|Overall Study||0
5052810|NCT01937507|12436089|P1|STARTED|Overall Study||2
5052811|NCT01937390|12436096|P1|NOT COMPLETED|Overall Study||35
5052812|NCT01937390|12436096|P1|COMPLETED|Overall Study||550
5052813|NCT01937390|12436096|P1|STARTED|Overall Study||585
5052814|NCT01937364|12436106|P2|NOT COMPLETED|Overall Study||1
5052815|NCT01937364|12436107|P1|NOT COMPLETED|Overall Study||2
5052816|NCT01937364|12436106|P2|COMPLETED|Overall Study||7
5052817|NCT01937364|12436107|P1|COMPLETED|Overall Study||7
5052818|NCT01937364|12436106|P2|STARTED|Overall Study||8
5052819|NCT01937364|12436107|P1|STARTED|Overall Study||9
5052820|NCT01937351|12436119|P2|NOT COMPLETED|Overall Study||2
5052821|NCT01937351|12436120|P1|NOT COMPLETED|Overall Study||9
5052822|NCT01937351|12436119|P2|COMPLETED|Overall Study||26
5052823|NCT01937351|12436120|P1|COMPLETED|Overall Study||125
5052824|NCT01937351|12436119|P2|6-Month Follow-up|Overall Study||26
5052825|NCT01937351|12436120|P1|6-Month Follow-up|Overall Study||125
5052826|NCT01937351|12436119|P2|30-Day Follow-up|Overall Study||27
5052827|NCT01937351|12436120|P1|30-Day Follow-up|Overall Study||128
5052828|NCT01937351|12436119|P2|Treated w Study Device|Overall Study||28
5052829|NCT01937351|12436120|P1|Treated w Study Device|Overall Study||130
5052830|NCT01937351|12436119|P2|STARTED|Overall Study||28
5052831|NCT01937351|12436120|P1|STARTED|Overall Study||134
5052832|NCT01937312|12436128|P2|NOT COMPLETED|Overall Study||3
5052833|NCT01937312|12436129|P1|NOT COMPLETED|Overall Study||11
5052834|NCT01937312|12436128|P2|COMPLETED|Overall Study||92
5052835|NCT01937312|12436129|P1|COMPLETED|Overall Study||83
5052836|NCT01937312|12436128|P2|Treated|Overall Study||95
5052837|NCT01937312|12436129|P1|Treated|Overall Study||93
5052838|NCT01937312|12436128|P2|STARTED|Overall Study||95
5052839|NCT01937312|12436129|P1|STARTED|Overall Study||94
5052840|NCT01937299|12436144|P2|NOT COMPLETED|Overall Study||4
5052841|NCT01937299|12436145|P1|NOT COMPLETED|Overall Study||14
5052842|NCT01937299|12436144|P2|COMPLETED|Overall Study||112
5052843|NCT01937299|12436145|P1|COMPLETED|Overall Study||103
5052844|NCT01937299|12436144|P2|STARTED|Overall Study||116
5052845|NCT01937299|12436145|P1|STARTED|Overall Study||117
5052846|NCT01937260|12436158|P2|NOT COMPLETED|Overall Study||0
5052847|NCT01937260|12436159|P1|NOT COMPLETED|Overall Study||1
5052848|NCT01937260|12436158|P2|COMPLETED|Overall Study||10
5052849|NCT01937260|12436159|P1|COMPLETED|Overall Study||20
5052850|NCT01937260|12436158|P2|STARTED|Overall Study||10
5052851|NCT01937260|12436159|P1|STARTED|Overall Study||21
5052852|NCT01937195|12436166|P1|NOT COMPLETED|Overall Study||0
5052853|NCT01937195|12436166|P1|COMPLETED|Overall Study||95
5052854|NCT01937195|12436166|P1|STARTED|Overall Study||95
5052855|NCT01937130|12436180|P4|NOT COMPLETED|Overall Study||2
5052856|NCT01937130|12436181|P3|NOT COMPLETED|Overall Study||3
5052857|NCT01937130|12436182|P2|NOT COMPLETED|Overall Study||4
5052858|NCT01937130|12436183|P1|NOT COMPLETED|Overall Study||5
5052859|NCT01937130|12436180|P4|COMPLETED|Overall Study||2
5052860|NCT01937130|12436181|P3|COMPLETED|Overall Study||2
5052861|NCT01937130|12436182|P2|COMPLETED|Overall Study||3
5052862|NCT01937130|12436183|P1|COMPLETED|Overall Study||0
5052863|NCT01937130|12436180|P4|STARTED|Overall Study||4
5052864|NCT01937130|12436181|P3|STARTED|Overall Study||5
5052865|NCT01937130|12436182|P2|STARTED|Overall Study||7
5052866|NCT01937130|12436183|P1|STARTED|Overall Study||5
5052867|NCT01937117|12436210|P1|NOT COMPLETED|Overall Study||13
5052868|NCT01937117|12436210|P1|COMPLETED|Overall Study||75
5052869|NCT01937117|12436210|P1|STARTED|Overall Study||88
5052870|NCT01937026|12436214|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
5052871|NCT01937026|12436214|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
5052872|NCT01937026|12436214|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
5052873|NCT01937026|12436214|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
5052874|NCT01937026|12436214|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
5052875|NCT01937026|12436214|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
5052876|NCT01937026|12436214|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
5052877|NCT01937026|12436214|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
5052878|NCT01937026|12436214|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
5052879|NCT01936974|12436225|P2|NOT COMPLETED|Overall Study||5
5052880|NCT01936974|12436226|P1|NOT COMPLETED|Overall Study||2
5052881|NCT01936974|12436225|P2|COMPLETED|Overall Study||0
5052882|NCT01936974|12436226|P1|COMPLETED|Overall Study||0
5052883|NCT01936974|12436225|P2|STARTED|Overall Study||5
5052884|NCT01936974|12436226|P1|STARTED|Overall Study||2
5052885|NCT01936909|12436235|P3|NOT COMPLETED|Overall Study||6
5052886|NCT01936909|12436236|P2|NOT COMPLETED|Overall Study||8
5052887|NCT01936909|12436237|P1|NOT COMPLETED|Overall Study||10
5052888|NCT01936909|12436235|P3|COMPLETED|Overall Study||14
5052889|NCT01936909|12436236|P2|COMPLETED|Overall Study||12
5052890|NCT01936909|12436237|P1|COMPLETED|Overall Study||10
5052891|NCT01936909|12436235|P3|STARTED|Overall Study||20
5052892|NCT01936909|12436236|P2|STARTED|Overall Study||20
5052893|NCT01936909|12436237|P1|STARTED|Overall Study||20
5052894|NCT01936896|12436251|P1|NOT COMPLETED|Overall Study||0
5052895|NCT01936896|12436251|P1|COMPLETED|Overall Study||10
5052896|NCT01936896|12436251|P1|STARTED|Overall Study||10
5052897|NCT01936870|12436256|P1|NOT COMPLETED|Overall Study||189
5052898|NCT01936870|12436256|P1|COMPLETED|Overall Study||2303
5052899|NCT01936870|12436256|P1|STARTED|Overall Study||2492
5052900|NCT01936857|12436271|P2|NOT COMPLETED|Overall Study||25
5052901|NCT01936857|12436272|P1|NOT COMPLETED|Overall Study||34
5052902|NCT01936857|12436271|P2|COMPLETED|Overall Study||115
5052903|NCT01936857|12436272|P1|COMPLETED|Overall Study||107
5052904|NCT01936857|12436271|P2|STARTED|Overall Study||140
5052905|NCT01936857|12436272|P1|STARTED|Overall Study||141
5052906|NCT01936844|12436280|P2|NOT COMPLETED|Overall Study||7
5052907|NCT01936844|12436281|P1|NOT COMPLETED|Overall Study||6
5052908|NCT01936844|12436280|P2|COMPLETED|Overall Study||8
5052909|NCT01936844|12436281|P1|COMPLETED|Overall Study||9
5052910|NCT01936844|12436280|P2|STARTED|Overall Study||15
5052911|NCT01936844|12436281|P1|STARTED|Overall Study||15
5052912|NCT01936662|12436293|P2|NOT COMPLETED|Overall Study||0
5052913|NCT01936662|12436294|P1|NOT COMPLETED|Overall Study||0
5052914|NCT01936662|12436293|P2|COMPLETED|Overall Study||42
5052915|NCT01936662|12436294|P1|COMPLETED|Overall Study||42
5052916|NCT01936662|12436293|P2|STARTED|Overall Study||42
5052917|NCT01936662|12436294|P1|STARTED|Overall Study||42
5052918|NCT01936649|12436302|P1|NOT COMPLETED|Overall Study||13
5052919|NCT01936649|12436302|P1|COMPLETED|Overall Study||50
5052920|NCT01936649|12436302|P1|Treated|Overall Study||51
5052921|NCT01936649|12436302|P1|STARTED|Overall Study||63
5052922|NCT01936623|12436309|P2|NOT COMPLETED|Overall Study||5
5052923|NCT01936623|12436310|P1|NOT COMPLETED|Overall Study||0
5052924|NCT01936623|12436309|P2|COMPLETED|Overall Study||35
5052925|NCT01936623|12436310|P1|COMPLETED|Overall Study||40
5052926|NCT01936623|12436309|P2|STARTED|Overall Study||40
5052927|NCT01936623|12436310|P1|STARTED|Overall Study||40
5052928|NCT01936467|12436324|P2|NOT COMPLETED|Overall Study||0
5052929|NCT01936467|12436325|P1|NOT COMPLETED|Overall Study||0
5052930|NCT01936467|12436324|P2|COMPLETED|Overall Study||61
5052931|NCT01936467|12436325|P1|COMPLETED|Overall Study||60
5052932|NCT01936467|12436324|P2|STARTED|Overall Study||61
5052933|NCT01936467|12436325|P1|STARTED|Overall Study||60
5052934|NCT01936389|12436345|P2|NOT COMPLETED|Overall Study||0
5052935|NCT01936389|12436346|P1|NOT COMPLETED|Overall Study||1
5052936|NCT01936389|12436345|P2|COMPLETED|Overall Study||5
5052937|NCT01936389|12436346|P1|COMPLETED|Overall Study||4
5052938|NCT01936389|12436345|P2|STARTED|Overall Study||5
5052939|NCT01936389|12436346|P1|STARTED|Overall Study||5
5052940|NCT01936363|12436354|P2|NOT COMPLETED|Overall Study||0
5052941|NCT01936363|12436355|P1|NOT COMPLETED|Overall Study||0
5052942|NCT01936363|12436354|P2|COMPLETED|Overall Study||33
5052943|NCT01936363|12436355|P1|COMPLETED|Overall Study||32
5052944|NCT01936363|12436354|P2|STARTED|Overall Study||33
5052945|NCT01936363|12436355|P1|STARTED|Overall Study||32
5052946|NCT01936324|12436382|P3|NOT COMPLETED|Overall Study||5
5052947|NCT01936324|12436383|P2|NOT COMPLETED|Overall Study||6
5052948|NCT01936324|12436384|P1|NOT COMPLETED|Overall Study||0
5052949|NCT01936324|12436382|P3|COMPLETED|Overall Study||50
5052950|NCT01936324|12436383|P2|COMPLETED|Overall Study||47
5052951|NCT01936324|12436384|P1|COMPLETED|Overall Study||6
5052952|NCT01936324|12436382|P3|STARTED|Overall Study||55
5052953|NCT01936324|12436383|P2|STARTED|Overall Study||53
5052954|NCT01936324|12436384|P1|STARTED|Overall Study||6
5052955|NCT01936259|12436397|P2|NOT COMPLETED|Overall Study||20
5052956|NCT01936259|12436398|P1|NOT COMPLETED|Overall Study||12
5052957|NCT01936259|12436397|P2|COMPLETED|Overall Study||111
5052958|NCT01936259|12436398|P1|COMPLETED|Overall Study||118
5052959|NCT01936259|12436397|P2|STARTED|Overall Study||131
5052960|NCT01936259|12436398|P1|STARTED|Overall Study||130
5052961|NCT01936181|12436418|P4|NOT COMPLETED|Transition-extension||5
5052962|NCT01936181|12436419|P3|NOT COMPLETED|Transition-extension||6
5052963|NCT01936181|12436420|P2|NOT COMPLETED|Transition-extension||0
5052964|NCT01936181|12436421|P1|NOT COMPLETED|Transition-extension||15
5052965|NCT01936181|12436418|P4|COMPLETED|Transition-extension||96
5052966|NCT01936181|12436419|P3|COMPLETED|Transition-extension||88
5052967|NCT01936181|12436420|P2|COMPLETED|Transition-extension||0
5052968|NCT01936181|12436421|P1|COMPLETED|Transition-extension||186
5052969|NCT01936181|12436418|P4|STARTED|Transition-extension||101
5052970|NCT01936181|12436419|P3|STARTED|Transition-extension||94
5052971|NCT01936181|12436420|P2|STARTED|Transition-extension||0
5052972|NCT01936181|12436421|P1|STARTED|Transition-extension||201
5052973|NCT01936181|12436418|P4|NOT COMPLETED|Randomised, Double-blind||0
5052974|NCT01936181|12436419|P3|NOT COMPLETED|Randomised, Double-blind||0
5052975|NCT01936181|12436420|P2|NOT COMPLETED|Randomised, Double-blind||68
5052976|NCT01936181|12436421|P1|NOT COMPLETED|Randomised, Double-blind||64
5052977|NCT01936181|12436418|P4|COMPLETED|Randomised, Double-blind||0
5052978|NCT01936181|12436419|P3|COMPLETED|Randomised, Double-blind||0
5052979|NCT01936181|12436420|P2|COMPLETED|Randomised, Double-blind||225
5052980|NCT01936181|12436421|P1|COMPLETED|Randomised, Double-blind||227
5052981|NCT01936181|12436418|P4|STARTED|Randomised, Double-blind||0
5052982|NCT01936181|12436419|P3|STARTED|Randomised, Double-blind||0
5052983|NCT01936181|12436420|P2|STARTED|Randomised, Double-blind||293
5052984|NCT01936181|12436421|P1|STARTED|Randomised, Double-blind||291
5052985|NCT01935947|12436435|P3|NOT COMPLETED|Overall Study||2
5052986|NCT01935947|12436436|P2|NOT COMPLETED|Overall Study||4
5052987|NCT01935947|12436437|P1|NOT COMPLETED|Overall Study||3
5052988|NCT01935947|12436435|P3|COMPLETED|Overall Study||0
5052989|NCT01935947|12436436|P2|COMPLETED|Overall Study||0
5052990|NCT01935947|12436437|P1|COMPLETED|Overall Study||1
5052991|NCT01935947|12436435|P3|Cytotoxic Therapy|Overall Study||2
5052992|NCT01935947|12436436|P2|Cytotoxic Therapy|Overall Study||3
5052993|NCT01935947|12436437|P1|Cytotoxic Therapy|Overall Study||3
5052994|NCT01935947|12436435|P3|Epigenetic Therapy|Overall Study||0
5052995|NCT01935947|12436436|P2|Epigenetic Therapy|Overall Study||4
5052996|NCT01935947|12436437|P1|Epigenetic Therapy|Overall Study||4
5052997|NCT01935947|12436435|P3|STARTED|Overall Study||2
5052998|NCT01935947|12436436|P2|STARTED|Overall Study||4
5052999|NCT01935947|12436437|P1|STARTED|Overall Study||4
5053000|NCT01935934|12436462|P2|NOT COMPLETED|Overall Study||0
5053001|NCT01935934|12436463|P1|NOT COMPLETED|Overall Study||0
5053002|NCT01935934|12436462|P2|COMPLETED|Overall Study||32
5053003|NCT01935934|12436463|P1|COMPLETED|Overall Study||70
5053004|NCT01935934|12436462|P2|STARTED|Overall Study||32
5053005|NCT01935934|12436463|P1|STARTED|Overall Study||70
5053006|NCT01935622|12436473|P3|NOT COMPLETED|Overall Study||0
5053007|NCT01935622|12436474|P2|NOT COMPLETED|Overall Study||2
5053008|NCT01935622|12436475|P1|NOT COMPLETED|Overall Study||2
5053009|NCT01935622|12436473|P3|COMPLETED|Overall Study||4
5053010|NCT01935622|12436474|P2|COMPLETED|Overall Study||1
5053011|NCT01935622|12436475|P1|COMPLETED|Overall Study||1
5053012|NCT01935622|12436473|P3|STARTED|Overall Study||4
5053013|NCT01935622|12436474|P2|STARTED|Overall Study||3
5053014|NCT01935622|12436475|P1|STARTED|Overall Study||3
5053015|NCT01935180|12436485|P2|NOT COMPLETED|Overall Study||14
5053016|NCT01935180|12436486|P1|NOT COMPLETED|Overall Study||21
5053017|NCT01935180|12436485|P2|COMPLETED|Overall Study||561
5053018|NCT01935180|12436486|P1|COMPLETED|Overall Study||552
5053019|NCT01935180|12436485|P2|STARTED|Overall Study||575
5053020|NCT01935180|12436486|P1|STARTED|Overall Study||573
5053021|NCT01934972|12436506|P2|NOT COMPLETED|Overall Study||6
5053022|NCT01934972|12436507|P1|NOT COMPLETED|Overall Study||9
5053023|NCT01934972|12436506|P2|COMPLETED|Overall Study||5
5053024|NCT01934972|12436507|P1|COMPLETED|Overall Study||4
5053025|NCT01934972|12436506|P2|STARTED|Overall Study||11
5053026|NCT01934972|12436507|P1|STARTED|Overall Study||13
5053027|NCT01934894|12436537|P2|NOT COMPLETED|Overall Study||5
5053028|NCT01934894|12436538|P1|NOT COMPLETED|Overall Study||6
5053029|NCT01934894|12436537|P2|COMPLETED|Overall Study||0
5053030|NCT01934894|12436538|P1|COMPLETED|Overall Study||0
5053031|NCT01934894|12436537|P2|STARTED|Overall Study||5
5053032|NCT01934894|12436538|P1|STARTED|Overall Study||6
5053033|NCT01934790|12436553|P1|NOT COMPLETED|Long Term Follow up||0
5053034|NCT01934790|12436553|P1|COMPLETED|Long Term Follow up||12
5053035|NCT01934790|12436553|P1|STARTED|Long Term Follow up||12
5053036|NCT01934790|12436553|P1|NOT COMPLETED|Active Follow up||24
5053037|NCT01934790|12436553|P1|COMPLETED|Active Follow up||10
5053038|NCT01934790|12436553|P1|STARTED|Active Follow up||34
5053039|NCT01934790|12436553|P1|NOT COMPLETED|Treatment||16
5053040|NCT01934790|12436553|P1|COMPLETED|Treatment||29
5053041|NCT01934790|12436553|P1|Participants Received Study Treatment|Treatment||44
5053042|NCT01934790|12436553|P1|STARTED|Treatment|Eligible for treatment|45
5053043|NCT01934647|12436584|P3|NOT COMPLETED|Overall Study||0
5053044|NCT01934647|12436585|P2|NOT COMPLETED|Overall Study||0
5053045|NCT01934647|12436586|P1|NOT COMPLETED|Overall Study||0
5053046|NCT01934647|12436584|P3|COMPLETED|Overall Study||3
5053047|NCT01934647|12436585|P2|COMPLETED|Overall Study||2
5053048|NCT01934647|12436586|P1|COMPLETED|Overall Study||2
5053049|NCT01934647|12436584|P3|STARTED|Overall Study||3
5053050|NCT01934647|12436585|P2|STARTED|Overall Study||2
5053051|NCT01934647|12436586|P1|STARTED|Overall Study||2
5053052|NCT01934582|12436594|P1|NOT COMPLETED|Overall Study||0
5053053|NCT01934582|12436594|P1|COMPLETED|Overall Study||13
5053054|NCT01934582|12436594|P1|STARTED|Overall Study||13
5053055|NCT01934517|12436608|P1|NOT COMPLETED|Overall Study||0
5053056|NCT01934517|12436608|P1|COMPLETED|Overall Study||25
5053057|NCT01934517|12436608|P1|STARTED|Overall Study||25
5053058|NCT01934504|12436620|P4|NOT COMPLETED|Overall Study||7
5053059|NCT01934504|12436621|P3|NOT COMPLETED|Overall Study||5
5053060|NCT01934504|12436622|P2|NOT COMPLETED|Overall Study||0
5053061|NCT01934504|12436623|P1|NOT COMPLETED|Overall Study||1
5053062|NCT01934504|12436620|P4|COMPLETED|Overall Study||1
5053063|NCT01934504|12436621|P3|COMPLETED|Overall Study||11
5053064|NCT01934504|12436622|P2|COMPLETED|Overall Study||3
5053065|NCT01934504|12436623|P1|COMPLETED|Overall Study||5
5053066|NCT01934504|12436620|P4|STARTED|Overall Study||8
5053067|NCT01934504|12436621|P3|STARTED|Overall Study||16
5053068|NCT01934504|12436622|P2|STARTED|Overall Study||3
5053069|NCT01934504|12436623|P1|STARTED|Overall Study||6
5053070|NCT01934231|12436645|P1|NOT COMPLETED|Overall Study||0
5053071|NCT01934231|12436645|P1|COMPLETED|Overall Study||27
5053072|NCT01934231|12436645|P1|STARTED|Overall Study||27
5053073|NCT01934218|12436656|P2|NOT COMPLETED|Open-Label Phase||24
5053074|NCT01934218|12436657|P1|NOT COMPLETED|Open-Label Phase||26
5053075|NCT01934218|12436656|P2|COMPLETED|Open-Label Phase||304
5053076|NCT01934218|12436657|P1|COMPLETED|Open-Label Phase||290
5053077|NCT01934218|12436656|P2|STARTED|Open-Label Phase||328
5053078|NCT01934218|12436657|P1|STARTED|Open-Label Phase||316
5053079|NCT01934218|12436656|P2|NOT COMPLETED|Double-blind Phase||54
5053080|NCT01934218|12436657|P1|NOT COMPLETED|Double-blind Phase||48
5053081|NCT01934218|12436656|P2|COMPLETED|Double-blind Phase||356
5053082|NCT01934218|12436657|P1|COMPLETED|Double-blind Phase||356
5053083|NCT01934218|12436656|P2|Analyzed Participants|Double-blind Phase||407
5053084|NCT01934218|12436657|P1|Analyzed Participants|Double-blind Phase||402
5053085|NCT01934218|12436656|P2|STARTED|Double-blind Phase||410
5053086|NCT01934218|12436657|P1|STARTED|Double-blind Phase||404
5053087|NCT01934192|12436668|P4|NOT COMPLETED|Overall Study||1
5053088|NCT01934192|12436669|P3|NOT COMPLETED|Overall Study||1
5053089|NCT01934192|12436670|P2|NOT COMPLETED|Overall Study||7
5053090|NCT01934192|12436671|P1|NOT COMPLETED|Overall Study||9
5053091|NCT01934192|12436668|P4|COMPLETED|Overall Study||3
5053092|NCT01934192|12436669|P3|COMPLETED|Overall Study||3
5053093|NCT01934192|12436670|P2|COMPLETED|Overall Study||37
5053094|NCT01934192|12436671|P1|COMPLETED|Overall Study||31
5053095|NCT01934192|12436668|P4|STARTED|Overall Study||4
5053096|NCT01934192|12436669|P3|STARTED|Overall Study||4
5053097|NCT01934192|12436670|P2|STARTED|Overall Study||44
5053098|NCT01934192|12436671|P1|STARTED|Overall Study||40
5053099|NCT01934140|12436807|P2|NOT COMPLETED|Booster Phase (6 Months)||3
5053100|NCT01934140|12436808|P1|NOT COMPLETED|Booster Phase (6 Months)||5
5053101|NCT01934140|12436807|P2|COMPLETED|Booster Phase (6 Months)||53
5053102|NCT01934140|12436808|P1|COMPLETED|Booster Phase (6 Months)||159
5053103|NCT01934140|12436807|P2|Vaccinated|Booster Phase (6 Months)||56
5053104|NCT01934140|12436808|P1|Vaccinated|Booster Phase (6 Months)||164
5053105|NCT01934140|12436807|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
5053106|NCT01934140|12436808|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
5053107|NCT01934140|12436807|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
5053108|NCT01934140|12436808|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
5053109|NCT01934140|12436807|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
5053110|NCT01934140|12436808|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
5053111|NCT01934140|12436807|P2|STARTED|Persistence Phase (Year 6-10)||76
5053112|NCT01934140|12436808|P1|STARTED|Persistence Phase (Year 6-10)||235
5053113|NCT01934010|12436859|P3|NOT COMPLETED|Overall Study||2
5053114|NCT01934010|12436860|P2|NOT COMPLETED|Overall Study||11
5053115|NCT01934010|12436861|P1|NOT COMPLETED|Overall Study||23
5053116|NCT01934010|12436859|P3|COMPLETED|Overall Study||74
5053117|NCT01934010|12436860|P2|COMPLETED|Overall Study||56
5053118|NCT01934010|12436861|P1|COMPLETED|Overall Study||91
5053119|NCT01934010|12436859|P3|STARTED|Overall Study||76
5053120|NCT01934010|12436860|P2|STARTED|Overall Study||67
5053121|NCT01934010|12436861|P1|STARTED|Overall Study||114
5053122|NCT01933984|12436880|P2|NOT COMPLETED|Overall Study||0
5053123|NCT01933984|12436881|P1|NOT COMPLETED|Overall Study||0
5053124|NCT01933984|12436880|P2|COMPLETED|Overall Study||25
5053125|NCT01933984|12436881|P1|COMPLETED|Overall Study||26
5053126|NCT01933984|12436880|P2|STARTED|Overall Study||25
5053127|NCT01933984|12436881|P1|STARTED|Overall Study||26
5053128|NCT01933932|12436903|P2|NOT COMPLETED|Overall Study||178
5053129|NCT01933932|12436904|P1|NOT COMPLETED|Overall Study||184
5053130|NCT01933932|12436903|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
5053131|NCT01933932|12436904|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
5053132|NCT01933932|12436903|P2|STARTED|Overall Study||256
5053133|NCT01933932|12436904|P1|STARTED|Overall Study||254
5053134|NCT01933919|12436922|P2|NOT COMPLETED|Open-label Long-term Phase||6
5053135|NCT01933919|12436923|P1|NOT COMPLETED|Open-label Long-term Phase||7
5053136|NCT01933919|12436922|P2|COMPLETED|Open-label Long-term Phase||9
5053137|NCT01933919|12436923|P1|COMPLETED|Open-label Long-term Phase||12
5053138|NCT01933919|12436922|P2|STARTED|Open-label Long-term Phase||15
5053139|NCT01933919|12436923|P1|STARTED|Open-label Long-term Phase||19
5053140|NCT01933919|12436922|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
5053141|NCT01933919|12436923|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
5053142|NCT01933919|12436922|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
5053143|NCT01933919|12436923|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
5053144|NCT01933919|12436922|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
5053145|NCT01933919|12436923|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
5053146|NCT01933919|12436922|P2|STARTED|Double-blind Placebo-controlled Phase||19
5053147|NCT01933919|12436923|P1|STARTED|Double-blind Placebo-controlled Phase||19
5053148|NCT01933880|12436959|P2|NOT COMPLETED|Overall Study||1
5053149|NCT01933880|12436960|P1|NOT COMPLETED|Overall Study||30
5053150|NCT01933880|12436959|P2|COMPLETED|Overall Study||40
5053151|NCT01933880|12436960|P1|COMPLETED|Overall Study||123
5053152|NCT01933880|12436959|P2|STARTED|Overall Study||41
5053153|NCT01933880|12436960|P1|STARTED|Overall Study||153
5053154|NCT01933789|12437034|P9|NOT COMPLETED|Overall Study||0
5053155|NCT01933789|12437035|P8|NOT COMPLETED|Overall Study||14
5053156|NCT01933789|12437036|P7|NOT COMPLETED|Overall Study||15
5053157|NCT01933789|12437037|P6|NOT COMPLETED|Overall Study||67
5053158|NCT01933789|12437038|P5|NOT COMPLETED|Overall Study||59
5053159|NCT01933789|12437039|P4|NOT COMPLETED|Overall Study||1
5053160|NCT01933789|12437040|P3|NOT COMPLETED|Overall Study||0
5053161|NCT01933789|12437041|P2|NOT COMPLETED|Overall Study||1
5053162|NCT01933789|12437042|P1|NOT COMPLETED|Overall Study||6
5053163|NCT01933789|12437034|P9|COMPLETED|Overall Study||25
5053164|NCT01933789|12437035|P8|COMPLETED|Overall Study||47
5053165|NCT01933789|12437036|P7|COMPLETED|Overall Study||43
5053166|NCT01933789|12437037|P6|COMPLETED|Overall Study||221
5053167|NCT01933789|12437038|P5|COMPLETED|Overall Study||190
5053168|NCT01933789|12437039|P4|COMPLETED|Overall Study||1
5053169|NCT01933789|12437040|P3|COMPLETED|Overall Study||2
5053170|NCT01933789|12437041|P2|COMPLETED|Overall Study||66
5053171|NCT01933789|12437042|P1|COMPLETED|Overall Study||59
5053172|NCT01933789|12437034|P9|Qualitative Interviews|Overall Study||25
5053173|NCT01933789|12437035|P8|Qualitative Interviews|Overall Study||0
5053174|NCT01933789|12437036|P7|Qualitative Interviews|Overall Study||0
5053175|NCT01933789|12437037|P6|Qualitative Interviews|Overall Study||0
5053176|NCT01933789|12437038|P5|Qualitative Interviews|Overall Study||0
5053177|NCT01933789|12437039|P4|Qualitative Interviews|Overall Study||0
5053178|NCT01933789|12437040|P3|Qualitative Interviews|Overall Study||0
5053179|NCT01933789|12437041|P2|Qualitative Interviews|Overall Study||0
5053180|NCT01933789|12437042|P1|Qualitative Interviews|Overall Study||0
5053181|NCT01933789|12437034|P9|Completed 6-Month Survey|Overall Study||0
5053182|NCT01933789|12437035|P8|Completed 6-Month Survey|Overall Study||40
5053183|NCT01933789|12437036|P7|Completed 6-Month Survey|Overall Study||35
5053184|NCT01933789|12437037|P6|Completed 6-Month Survey|Overall Study||188
5053185|NCT01933789|12437038|P5|Completed 6-Month Survey|Overall Study||160
5053186|NCT01933789|12437039|P4|Completed 6-Month Survey|Overall Study||0
5053187|NCT01933789|12437040|P3|Completed 6-Month Survey|Overall Study||0
5053188|NCT01933789|12437041|P2|Completed 6-Month Survey|Overall Study||0
5053189|NCT01933789|12437042|P1|Completed 6-Month Survey|Overall Study||0
5053190|NCT01933789|12437034|P9|Completed 3-Month Survey|Overall Study||0
5053191|NCT01933789|12437035|P8|Completed 3-Month Survey|Overall Study||43
5053192|NCT01933789|12437036|P7|Completed 3-Month Survey|Overall Study||37
5053193|NCT01933789|12437037|P6|Completed 3-Month Survey|Overall Study||211
5053194|NCT01933789|12437038|P5|Completed 3-Month Survey|Overall Study||176
5053195|NCT01933789|12437039|P4|Completed 3-Month Survey|Overall Study||0
5053196|NCT01933789|12437040|P3|Completed 3-Month Survey|Overall Study||0
5053197|NCT01933789|12437041|P2|Completed 3-Month Survey|Overall Study||0
5053198|NCT01933789|12437042|P1|Completed 3-Month Survey|Overall Study||0
5053199|NCT01933789|12437034|P9|Completed 2-Week Survey|Overall Study||0
5053200|NCT01933789|12437035|P8|Completed 2-Week Survey|Overall Study||0
5053201|NCT01933789|12437036|P7|Completed 2-Week Survey|Overall Study||0
5053202|NCT01933789|12437037|P6|Completed 2-Week Survey|Overall Study||215
5053203|NCT01933789|12437038|P5|Completed 2-Week Survey|Overall Study||184
5053204|NCT01933789|12437039|P4|Completed 2-Week Survey|Overall Study||0
5053205|NCT01933789|12437040|P3|Completed 2-Week Survey|Overall Study||0
5053206|NCT01933789|12437041|P2|Completed 2-Week Survey|Overall Study||0
5053207|NCT01933789|12437042|P1|Completed 2-Week Survey|Overall Study||0
5053208|NCT01933789|12437034|P9|Completed After-visit Survey|Overall Study||0
5053209|NCT01933789|12437035|P8|Completed After-visit Survey|Overall Study||0
5053210|NCT01933789|12437036|P7|Completed After-visit Survey|Overall Study||0
5053211|NCT01933789|12437037|P6|Completed After-visit Survey|Overall Study||0
5053212|NCT01933789|12437038|P5|Completed After-visit Survey|Overall Study||0
5053213|NCT01933789|12437039|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
5053214|NCT01933789|12437040|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
5053215|NCT01933789|12437041|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
5053216|NCT01933789|12437042|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
5053217|NCT01933789|12437034|P9|Had Target Visit|Overall Study||0
5053218|NCT01933789|12437035|P8|Had Target Visit|Overall Study||0
5053219|NCT01933789|12437036|P7|Had Target Visit|Overall Study||0
5053220|NCT01933789|12437037|P6|Had Target Visit|Overall Study||266
5053221|NCT01933789|12437038|P5|Had Target Visit|Overall Study||228
5053222|NCT01933789|12437039|P4|Had Target Visit|Overall Study||2
5053223|NCT01933789|12437040|P3|Had Target Visit|Overall Study||2
5053224|NCT01933789|12437041|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
5053225|NCT01933789|12437042|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
5053226|NCT01933789|12437034|P9|STARTED|Overall Study||25
5053227|NCT01933789|12437035|P8|STARTED|Overall Study||61
5053228|NCT01933789|12437036|P7|STARTED|Overall Study||58
5053229|NCT01933789|12437037|P6|STARTED|Overall Study||288
5053230|NCT01933789|12437038|P5|STARTED|Overall Study||249
5053231|NCT01933789|12437039|P4|STARTED|Overall Study||2
5053232|NCT01933789|12437040|P3|STARTED|Overall Study||2
5053233|NCT01933789|12437041|P2|STARTED|Overall Study||67
5053234|NCT01933789|12437042|P1|STARTED|Overall Study||65
5053235|NCT01933776|12437343|P2|NOT COMPLETED|Overall Study||0
5053236|NCT01933776|12437344|P1|NOT COMPLETED|Overall Study||0
5053237|NCT01933776|12437343|P2|COMPLETED|Overall Study||20
5053238|NCT01933776|12437344|P1|COMPLETED|Overall Study||20
5053239|NCT01933776|12437343|P2|STARTED|Overall Study||20
5053240|NCT01933776|12437344|P1|STARTED|Overall Study||20
5053241|NCT01933672|12437352|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
5053242|NCT01933672|12437353|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
5053243|NCT01933672|12437354|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
5053244|NCT01933672|12437355|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
5053245|NCT01933672|12437356|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
5053246|NCT01933672|12437357|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
5053247|NCT01933672|12437358|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
5053248|NCT01933672|12437352|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
5053249|NCT01933672|12437353|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
5053250|NCT01933672|12437354|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
5053251|NCT01933672|12437355|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
5053252|NCT01933672|12437356|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
5053253|NCT01933672|12437357|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
5053254|NCT01933672|12437358|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
5053255|NCT01933672|12437352|P7|STARTED|Third Intervention Period (12-16 Days)||6
5053256|NCT01933672|12437353|P6|STARTED|Third Intervention Period (12-16 Days)||4
5053257|NCT01933672|12437354|P5|STARTED|Third Intervention Period (12-16 Days)||6
5053258|NCT01933672|12437355|P4|STARTED|Third Intervention Period (12-16 Days)||5
5053259|NCT01933672|12437356|P3|STARTED|Third Intervention Period (12-16 Days)||1
5053260|NCT01933672|12437357|P2|STARTED|Third Intervention Period (12-16 Days)||6
5053261|NCT01933672|12437358|P1|STARTED|Third Intervention Period (12-16 Days)||0
5053262|NCT01933672|12437352|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053263|NCT01933672|12437353|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053264|NCT01933672|12437354|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053265|NCT01933672|12437355|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053266|NCT01933672|12437356|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053267|NCT01933672|12437357|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053268|NCT01933672|12437358|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
5053269|NCT01933672|12437352|P7|COMPLETED|Second Washout Period (7-14 Days)||6
5053270|NCT01933672|12437353|P6|COMPLETED|Second Washout Period (7-14 Days)||4
5053271|NCT01933672|12437354|P5|COMPLETED|Second Washout Period (7-14 Days)||6
5053272|NCT01933672|12437355|P4|COMPLETED|Second Washout Period (7-14 Days)||5
5053273|NCT01933672|12437356|P3|COMPLETED|Second Washout Period (7-14 Days)||1
5053274|NCT01933672|12437357|P2|COMPLETED|Second Washout Period (7-14 Days)||6
5053275|NCT01933672|12437358|P1|COMPLETED|Second Washout Period (7-14 Days)||0
5053276|NCT01933672|12437352|P7|STARTED|Second Washout Period (7-14 Days)||6
5053277|NCT01933672|12437353|P6|STARTED|Second Washout Period (7-14 Days)||4
5053278|NCT01933672|12437354|P5|STARTED|Second Washout Period (7-14 Days)||6
5053279|NCT01933672|12437355|P4|STARTED|Second Washout Period (7-14 Days)||5
5053280|NCT01933672|12437356|P3|STARTED|Second Washout Period (7-14 Days)||1
5053281|NCT01933672|12437357|P2|STARTED|Second Washout Period (7-14 Days)||6
5053282|NCT01933672|12437358|P1|STARTED|Second Washout Period (7-14 Days)||0
5053283|NCT01933672|12437352|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
5053284|NCT01933672|12437353|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
5053285|NCT01933672|12437354|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
5053286|NCT01933672|12437355|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
5053287|NCT01933672|12437356|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
5053288|NCT01933672|12437357|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
5053289|NCT01933672|12437358|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
5053290|NCT01933672|12437352|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
5053291|NCT01933672|12437353|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
5053292|NCT01933672|12437354|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
5053293|NCT01933672|12437355|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
5053294|NCT01933672|12437356|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
5053295|NCT01933672|12437357|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
5053296|NCT01933672|12437358|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
5053297|NCT01933672|12437352|P7|STARTED|Second Intervention Period (12-16 Days)||6
5053298|NCT01933672|12437353|P6|STARTED|Second Intervention Period (12-16 Days)||4
5053299|NCT01933672|12437354|P5|STARTED|Second Intervention Period (12-16 Days)||6
5053300|NCT01933672|12437355|P4|STARTED|Second Intervention Period (12-16 Days)||5
5053301|NCT01933672|12437356|P3|STARTED|Second Intervention Period (12-16 Days)||2
5053302|NCT01933672|12437357|P2|STARTED|Second Intervention Period (12-16 Days)||7
5053303|NCT01933672|12437358|P1|STARTED|Second Intervention Period (12-16 Days)||0
5053304|NCT01933672|12437352|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053305|NCT01933672|12437353|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053306|NCT01933672|12437354|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053307|NCT01933672|12437355|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053308|NCT01933672|12437356|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053309|NCT01933672|12437357|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053310|NCT01933672|12437358|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
5053311|NCT01933672|12437352|P7|COMPLETED|First Washout Period (7-14 Days)||6
5053312|NCT01933672|12437353|P6|COMPLETED|First Washout Period (7-14 Days)||4
5053313|NCT01933672|12437354|P5|COMPLETED|First Washout Period (7-14 Days)||6
5053314|NCT01933672|12437355|P4|COMPLETED|First Washout Period (7-14 Days)||5
5053315|NCT01933672|12437356|P3|COMPLETED|First Washout Period (7-14 Days)||2
5053316|NCT01933672|12437357|P2|COMPLETED|First Washout Period (7-14 Days)||7
5053317|NCT01933672|12437358|P1|COMPLETED|First Washout Period (7-14 Days)||0
5053318|NCT01933672|12437352|P7|STARTED|First Washout Period (7-14 Days)||6
5053319|NCT01933672|12437353|P6|STARTED|First Washout Period (7-14 Days)||4
5053320|NCT01933672|12437354|P5|STARTED|First Washout Period (7-14 Days)||6
5053321|NCT01933672|12437355|P4|STARTED|First Washout Period (7-14 Days)||5
5053322|NCT01933672|12437356|P3|STARTED|First Washout Period (7-14 Days)||2
5053323|NCT01933672|12437357|P2|STARTED|First Washout Period (7-14 Days)||7
5053324|NCT01933672|12437358|P1|STARTED|First Washout Period (7-14 Days)||0
5053325|NCT01933672|12437352|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
5053326|NCT01933672|12437353|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
5053327|NCT01933672|12437354|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
5053328|NCT01933672|12437355|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
5053329|NCT01933672|12437356|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
5053330|NCT01933672|12437357|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
5053331|NCT01933672|12437358|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
5053332|NCT01933672|12437352|P7|COMPLETED|First Intervention Period (12-16 Days)||6
5053333|NCT01933672|12437353|P6|COMPLETED|First Intervention Period (12-16 Days)||4
5053334|NCT01933672|12437354|P5|COMPLETED|First Intervention Period (12-16 Days)||6
5053335|NCT01933672|12437355|P4|COMPLETED|First Intervention Period (12-16 Days)||5
5053336|NCT01933672|12437356|P3|COMPLETED|First Intervention Period (12-16 Days)||2
5053337|NCT01933672|12437357|P2|COMPLETED|First Intervention Period (12-16 Days)||7
5053338|NCT01933672|12437358|P1|COMPLETED|First Intervention Period (12-16 Days)||0
5053339|NCT01933672|12437352|P7|STARTED|First Intervention Period (12-16 Days)||6
5053340|NCT01933672|12437353|P6|STARTED|First Intervention Period (12-16 Days)||5
5053341|NCT01933672|12437354|P5|STARTED|First Intervention Period (12-16 Days)||7
5053342|NCT01933672|12437355|P4|STARTED|First Intervention Period (12-16 Days)||5
5053343|NCT01933672|12437356|P3|STARTED|First Intervention Period (12-16 Days)||3
5053344|NCT01933672|12437357|P2|STARTED|First Intervention Period (12-16 Days)||7
5053345|NCT01933672|12437358|P1|STARTED|First Intervention Period (12-16 Days)||0
5053346|NCT01933672|12437352|P7|NOT COMPLETED|Metformin Run-in Period||0
5053347|NCT01933672|12437353|P6|NOT COMPLETED|Metformin Run-in Period||0
5053348|NCT01933672|12437354|P5|NOT COMPLETED|Metformin Run-in Period||0
5053349|NCT01933672|12437355|P4|NOT COMPLETED|Metformin Run-in Period||0
5053350|NCT01933672|12437356|P3|NOT COMPLETED|Metformin Run-in Period||0
5053351|NCT01933672|12437357|P2|NOT COMPLETED|Metformin Run-in Period||0
5053352|NCT01933672|12437358|P1|NOT COMPLETED|Metformin Run-in Period||10
5053353|NCT01933672|12437352|P7|COMPLETED|Metformin Run-in Period||0
5053354|NCT01933672|12437353|P6|COMPLETED|Metformin Run-in Period||0
5053355|NCT01933672|12437354|P5|COMPLETED|Metformin Run-in Period||0
5053356|NCT01933672|12437355|P4|COMPLETED|Metformin Run-in Period||0
5053357|NCT01933672|12437356|P3|COMPLETED|Metformin Run-in Period||0
5053358|NCT01933672|12437357|P2|COMPLETED|Metformin Run-in Period||0
5053359|NCT01933672|12437358|P1|COMPLETED|Metformin Run-in Period||33
5053360|NCT01933672|12437352|P7|Received Treatment|Metformin Run-in Period||0
5053361|NCT01933672|12437353|P6|Received Treatment|Metformin Run-in Period||0
5053362|NCT01933672|12437354|P5|Received Treatment|Metformin Run-in Period||0
5053363|NCT01933672|12437355|P4|Received Treatment|Metformin Run-in Period||0
5053364|NCT01933672|12437356|P3|Received Treatment|Metformin Run-in Period||0
5053365|NCT01933672|12437357|P2|Received Treatment|Metformin Run-in Period||0
5053366|NCT01933672|12437358|P1|Received Treatment|Metformin Run-in Period||43
5053367|NCT01933672|12437352|P7|STARTED|Metformin Run-in Period||0
5053368|NCT01933672|12437353|P6|STARTED|Metformin Run-in Period||0
5053369|NCT01933672|12437354|P5|STARTED|Metformin Run-in Period||0
5053370|NCT01933672|12437355|P4|STARTED|Metformin Run-in Period||0
5053371|NCT01933672|12437356|P3|STARTED|Metformin Run-in Period||0
5053372|NCT01933672|12437357|P2|STARTED|Metformin Run-in Period||0
5053373|NCT01933672|12437358|P1|STARTED|Metformin Run-in Period||43
5053374|NCT01933594|12437410|P6|NOT COMPLETED|Overall Study||0
5053375|NCT01933594|12437411|P5|NOT COMPLETED|Overall Study||2
5053376|NCT01933594|12437412|P4|NOT COMPLETED|Overall Study||0
5053377|NCT01933594|12437413|P3|NOT COMPLETED|Overall Study||0
5053378|NCT01933594|12437414|P2|NOT COMPLETED|Overall Study||0
5053379|NCT01933594|12437415|P1|NOT COMPLETED|Overall Study||1
5053380|NCT01933594|12437410|P6|COMPLETED|Overall Study||3
5053381|NCT01933594|12437411|P5|COMPLETED|Overall Study||11
5053382|NCT01933594|12437412|P4|COMPLETED|Overall Study||7
5053383|NCT01933594|12437413|P3|COMPLETED|Overall Study||12
5053384|NCT01933594|12437414|P2|COMPLETED|Overall Study||12
5053385|NCT01933594|12437415|P1|COMPLETED|Overall Study||11
5053386|NCT01933594|12437410|P6|STARTED|Overall Study||3
5053387|NCT01933594|12437411|P5|STARTED|Overall Study||13
5053388|NCT01933594|12437412|P4|STARTED|Overall Study||7
5053389|NCT01933594|12437413|P3|STARTED|Overall Study||12
5053390|NCT01933594|12437414|P2|STARTED|Overall Study||12
5053391|NCT01933594|12437415|P1|STARTED|Overall Study||12
5053392|NCT01933464|12437507|P2|NOT COMPLETED|Overall Study||0
5053393|NCT01933464|12437508|P1|NOT COMPLETED|Overall Study||0
5053394|NCT01933464|12437507|P2|COMPLETED|Overall Study||5
5053395|NCT01933464|12437508|P1|COMPLETED|Overall Study||5
5053396|NCT01933464|12437507|P2|STARTED|Overall Study||5
5053397|NCT01933464|12437508|P1|STARTED|Overall Study||5
5053398|NCT01933425|12437520|P2|NOT COMPLETED|Overall Study||0
5053399|NCT01933425|12437521|P1|NOT COMPLETED|Overall Study||0
5053400|NCT01933425|12437520|P2|COMPLETED|Overall Study||7
5053401|NCT01933425|12437521|P1|COMPLETED|Overall Study||7
5053402|NCT01933425|12437520|P2|STARTED|Overall Study||7
5053403|NCT01933425|12437521|P1|STARTED|Overall Study||7
5053404|NCT01933399|12437534|P3|NOT COMPLETED|Overall Study||0
5053405|NCT01933399|12437535|P2|NOT COMPLETED|Overall Study||0
5053406|NCT01933399|12437536|P1|NOT COMPLETED|Overall Study||0
5053407|NCT01933399|12437534|P3|COMPLETED|Overall Study||37
5053408|NCT01933399|12437535|P2|COMPLETED|Overall Study||32
5053409|NCT01933399|12437536|P1|COMPLETED|Overall Study||29
5053410|NCT01933399|12437534|P3|STARTED|Overall Study||37
5053411|NCT01933399|12437535|P2|STARTED|Overall Study||32
5053412|NCT01933399|12437536|P1|STARTED|Overall Study||29
5053413|NCT01933334|12437549|P2|NOT COMPLETED|Overall Study||2
5053414|NCT01933334|12437550|P1|NOT COMPLETED|Overall Study||5
5053415|NCT01933334|12437549|P2|COMPLETED|Overall Study||29
5053416|NCT01933334|12437550|P1|COMPLETED|Overall Study||27
5053417|NCT01933334|12437549|P2|STARTED|Overall Study||31
5053418|NCT01933334|12437550|P1|STARTED|Overall Study||32
5053419|NCT01933243|12437562|P2|NOT COMPLETED|Overall Study||4
5053420|NCT01933243|12437563|P1|NOT COMPLETED|Overall Study||2
5053421|NCT01933243|12437562|P2|COMPLETED|Overall Study||8
5053422|NCT01933243|12437563|P1|COMPLETED|Overall Study||10
5053423|NCT01933243|12437562|P2|STARTED|Overall Study||12
5053424|NCT01933243|12437563|P1|STARTED|Overall Study||12
5053425|NCT01933230|12437573|P1|NOT COMPLETED|Overall Study||0
5053426|NCT01933230|12437573|P1|COMPLETED|Overall Study||2
5053427|NCT01933230|12437573|P1|STARTED|Overall Study||2
5053428|NCT01933217|12437579|P2|NOT COMPLETED|Crossover (4 Weeks)||0
5053429|NCT01933217|12437580|P1|NOT COMPLETED|Crossover (4 Weeks)||0
5053430|NCT01933217|12437579|P2|COMPLETED|Crossover (4 Weeks)||10
5053431|NCT01933217|12437580|P1|COMPLETED|Crossover (4 Weeks)||10
5053432|NCT01933217|12437579|P2|STARTED|Crossover (4 Weeks)||10
5053433|NCT01933217|12437580|P1|STARTED|Crossover (4 Weeks)||10
5053434|NCT01933217|12437579|P2|NOT COMPLETED|Randomization (4 Weeks)||4
5053435|NCT01933217|12437580|P1|NOT COMPLETED|Randomization (4 Weeks)||2
5053436|NCT01933217|12437579|P2|COMPLETED|Randomization (4 Weeks)||10
5053437|NCT01933217|12437580|P1|COMPLETED|Randomization (4 Weeks)||10
5053438|NCT01933217|12437579|P2|STARTED|Randomization (4 Weeks)||14
5053439|NCT01933217|12437580|P1|STARTED|Randomization (4 Weeks)||12
5053440|NCT01933113|12437592|P1|NOT COMPLETED|Overall Study||1
5053441|NCT01933113|12437592|P1|COMPLETED|Overall Study||2
5053442|NCT01933113|12437592|P1|STARTED|Overall Study||3
5053443|NCT01933048|12437598|P2|NOT COMPLETED|Overall Study||28
5053444|NCT01933048|12437599|P1|NOT COMPLETED|Overall Study||25
5053445|NCT01933048|12437598|P2|COMPLETED|Overall Study||501
5053446|NCT01933048|12437599|P1|COMPLETED|Overall Study||523
5053447|NCT01933048|12437598|P2|STARTED|Overall Study||529
5053448|NCT01933048|12437599|P1|STARTED|Overall Study||548
5053449|NCT01932970|12437612|P1|NOT COMPLETED|Overall Study||18
5053450|NCT01932970|12437612|P1|COMPLETED|Overall Study||140
5053451|NCT01932970|12437612|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
5053452|NCT01932970|12437612|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
5053453|NCT01932788|12437622|P2|NOT COMPLETED|Overall Study||51
5053454|NCT01932788|12437623|P1|NOT COMPLETED|Overall Study||38
5053455|NCT01932788|12437622|P2|COMPLETED|Overall Study||118
5053456|NCT01932788|12437623|P1|COMPLETED|Overall Study||135
5053457|NCT01932788|12437622|P2|STARTED|Overall Study||169
5053458|NCT01932788|12437623|P1|STARTED|Overall Study||173
5053459|NCT01932762|12437633|P4|NOT COMPLETED|Overall Study||1
5053460|NCT01932762|12437634|P3|NOT COMPLETED|Overall Study||0
5053461|NCT01932762|12437635|P2|NOT COMPLETED|Overall Study||2
5053462|NCT01932762|12437636|P1|NOT COMPLETED|Overall Study||6
5053463|NCT01932762|12437633|P4|COMPLETED|Overall Study||18
5053464|NCT01932762|12437634|P3|COMPLETED|Overall Study||19
5053465|NCT01932762|12437635|P2|COMPLETED|Overall Study||28
5053466|NCT01932762|12437636|P1|COMPLETED|Overall Study||24
5053467|NCT01932762|12437633|P4|STARTED|Overall Study||19
5053468|NCT01932762|12437634|P3|STARTED|Overall Study||19
5053469|NCT01932762|12437635|P2|STARTED|Overall Study||30
5053470|NCT01932762|12437636|P1|STARTED|Overall Study||30
5053471|NCT01932697|12437672|P2|NOT COMPLETED|Overall Study||0
5053472|NCT01932697|12437673|P1|NOT COMPLETED|Overall Study||2
5053473|NCT01932697|12437672|P2|COMPLETED|Overall Study||43
5053474|NCT01932697|12437673|P1|COMPLETED|Overall Study||36
5053475|NCT01932697|12437672|P2|STARTED|Overall Study||43
5053476|NCT01932697|12437673|P1|STARTED|Overall Study||38
5053477|NCT01932606|12437687|P2|NOT COMPLETED|Overall Study||0
5053478|NCT01932606|12437688|P1|NOT COMPLETED|Overall Study||0
5053479|NCT01932606|12437687|P2|COMPLETED|Overall Study||14
5053480|NCT01932606|12437688|P1|COMPLETED|Overall Study||14
5053481|NCT01932606|12437687|P2|STARTED|Overall Study||14
5053482|NCT01932606|12437688|P1|STARTED|Overall Study||14
5053483|NCT01932437|12437740|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
5053484|NCT01932437|12437741|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053485|NCT01932437|12437742|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053486|NCT01932437|12437743|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053487|NCT01932437|12437744|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053488|NCT01932437|12437745|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053489|NCT01932437|12437740|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
5053490|NCT01932437|12437741|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053491|NCT01932437|12437742|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053492|NCT01932437|12437743|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053493|NCT01932437|12437744|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053494|NCT01932437|12437745|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
5053495|NCT01932437|12437740|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
5053496|NCT01932437|12437741|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053497|NCT01932437|12437742|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053498|NCT01932437|12437743|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053499|NCT01932437|12437744|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
5053500|NCT01932437|12437745|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
5053501|NCT01932437|12437740|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053502|NCT01932437|12437741|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053503|NCT01932437|12437742|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053504|NCT01932437|12437743|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053505|NCT01932437|12437744|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053506|NCT01932437|12437745|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053507|NCT01932437|12437740|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053508|NCT01932437|12437741|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
5053509|NCT01932437|12437742|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053510|NCT01932437|12437743|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053511|NCT01932437|12437744|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053512|NCT01932437|12437745|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
5053513|NCT01932437|12437740|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053514|NCT01932437|12437741|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
5053515|NCT01932437|12437742|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053516|NCT01932437|12437743|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053517|NCT01932437|12437744|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
5053518|NCT01932437|12437745|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
5053519|NCT01932437|12437740|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053520|NCT01932437|12437741|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053521|NCT01932437|12437742|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053522|NCT01932437|12437743|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053523|NCT01932437|12437744|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053524|NCT01932437|12437745|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053525|NCT01932437|12437740|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053526|NCT01932437|12437741|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053527|NCT01932437|12437742|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
5053528|NCT01932437|12437743|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053529|NCT01932437|12437744|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053530|NCT01932437|12437745|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
5053531|NCT01932437|12437740|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053532|NCT01932437|12437741|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053533|NCT01932437|12437742|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
5053534|NCT01932437|12437743|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053535|NCT01932437|12437744|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
5053536|NCT01932437|12437745|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
5053537|NCT01932437|12437740|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053538|NCT01932437|12437741|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053539|NCT01932437|12437742|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053540|NCT01932437|12437743|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053541|NCT01932437|12437744|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053542|NCT01932437|12437745|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053543|NCT01932437|12437740|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053544|NCT01932437|12437741|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053545|NCT01932437|12437742|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053546|NCT01932437|12437743|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
5053547|NCT01932437|12437744|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053548|NCT01932437|12437745|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
5053549|NCT01932437|12437740|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053550|NCT01932437|12437741|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053551|NCT01932437|12437742|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053552|NCT01932437|12437743|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
5053553|NCT01932437|12437744|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
5053554|NCT01932437|12437745|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
5053555|NCT01932437|12437740|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053556|NCT01932437|12437741|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053557|NCT01932437|12437742|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053558|NCT01932437|12437743|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053559|NCT01932437|12437744|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053560|NCT01932437|12437745|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053561|NCT01932437|12437740|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053562|NCT01932437|12437741|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053563|NCT01932437|12437742|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053564|NCT01932437|12437743|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053565|NCT01932437|12437744|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
5053566|NCT01932437|12437745|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
5053567|NCT01932437|12437740|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053568|NCT01932437|12437741|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053569|NCT01932437|12437742|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053570|NCT01932437|12437743|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
5053571|NCT01932437|12437744|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
5053572|NCT01932437|12437745|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
5053573|NCT01932294|12437795|P1|NOT COMPLETED|Overall Study||99
5053574|NCT01932294|12437795|P1|COMPLETED|Overall Study||72
5053575|NCT01932294|12437795|P1|STARTED|Overall Study||171
5053576|NCT01932242|12437803|P2|NOT COMPLETED|Overall Study||5
5053577|NCT01932242|12437804|P1|NOT COMPLETED|Overall Study||5
5053578|NCT01932242|12437803|P2|COMPLETED|Overall Study||30
5053579|NCT01932242|12437804|P1|COMPLETED|Overall Study||30
5053580|NCT01932242|12437803|P2|STARTED|Overall Study||35
5053581|NCT01932242|12437804|P1|STARTED|Overall Study||35
5053582|NCT01932164|12437848|P1|NOT COMPLETED|Overall Study||0
5053583|NCT01932164|12437848|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
5053584|NCT01932164|12437848|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
5053585|NCT01932164|12437848|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
5053586|NCT01932164|12437848|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
5053587|NCT01932164|12437848|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
5053588|NCT01932164|12437848|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
5053589|NCT01932164|12437848|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
5053590|NCT01932112|12437853|P1|NOT COMPLETED|Overall Study||0
5053591|NCT01932112|12437853|P1|COMPLETED|Overall Study||378
5053592|NCT01932112|12437853|P1|STARTED|Overall Study||378
5053593|NCT01932060|12437859|P2|NOT COMPLETED|Overall Study||0
5053594|NCT01932060|12437860|P1|NOT COMPLETED|Overall Study||0
5053595|NCT01932060|12437859|P2|COMPLETED|Overall Study||24
5053596|NCT01932060|12437860|P1|COMPLETED|Overall Study||27
5053597|NCT01932060|12437859|P2|STARTED|Overall Study||24
5053598|NCT01932060|12437860|P1|STARTED|Overall Study||27
5053599|NCT01931956|12437872|P4|NOT COMPLETED|Overall Study||133
5053600|NCT01931956|12437873|P3|NOT COMPLETED|Overall Study||487
5053601|NCT01931956|12437874|P2|NOT COMPLETED|Overall Study||7
5053602|NCT01931956|12437875|P1|NOT COMPLETED|Overall Study||51
5053603|NCT01931956|12437872|P4|COMPLETED|Overall Study||138
5053604|NCT01931956|12437873|P3|COMPLETED|Overall Study||141
5053605|NCT01931956|12437874|P2|COMPLETED|Overall Study||0
5053606|NCT01931956|12437875|P1|COMPLETED|Overall Study||8
5053607|NCT01931956|12437872|P4|STARTED|Overall Study||271
5053608|NCT01931956|12437873|P3|STARTED|Overall Study||628
5053609|NCT01931956|12437874|P2|STARTED|Overall Study||7
5053610|NCT01931956|12437875|P1|STARTED|Overall Study||59
5053611|NCT01931878|12438231|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
5053612|NCT01931878|12438232|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
5053613|NCT01931878|12438231|P2|COMPLETED|Second Intervention (After 3 Months)||12
5053614|NCT01931878|12438232|P1|COMPLETED|Second Intervention (After 3 Months)||9
5053615|NCT01931878|12438231|P2|STARTED|Second Intervention (After 3 Months)||14
5053616|NCT01931878|12438232|P1|STARTED|Second Intervention (After 3 Months)||9
5053617|NCT01931878|12438231|P2|NOT COMPLETED|First Intervention||0
5053618|NCT01931878|12438232|P1|NOT COMPLETED|First Intervention||1
5053619|NCT01931878|12438231|P2|COMPLETED|First Intervention||14
5053620|NCT01931878|12438232|P1|COMPLETED|First Intervention||9
5053621|NCT01931878|12438231|P2|STARTED|First Intervention||14
5053622|NCT01931878|12438232|P1|STARTED|First Intervention||10
5053623|NCT01931865|12438242|P1|NOT COMPLETED|Overall Study||4
5053624|NCT01931865|12438242|P1|COMPLETED|Overall Study||8
5053625|NCT01931865|12438242|P1|STARTED|Overall Study||12
5053626|NCT01931839|12438255|P7|NOT COMPLETED|Overall Study||4
5053627|NCT01931839|12438256|P6|NOT COMPLETED|Overall Study||5
5053628|NCT01931839|12438257|P5|NOT COMPLETED|Overall Study||1
5053629|NCT01931839|12438258|P4|NOT COMPLETED|Overall Study||14
5053630|NCT01931839|12438259|P3|NOT COMPLETED|Overall Study||39
5053631|NCT01931839|12438260|P2|NOT COMPLETED|Overall Study||26
5053632|NCT01931839|12438261|P1|NOT COMPLETED|Overall Study||41
5053633|NCT01931839|12438255|P7|COMPLETED|Overall Study||56
5053634|NCT01931839|12438256|P6|COMPLETED|Overall Study||50
5053635|NCT01931839|12438257|P5|COMPLETED|Overall Study||18
5053636|NCT01931839|12438258|P4|COMPLETED|Overall Study||162
5053637|NCT01931839|12438259|P3|COMPLETED|Overall Study||301
5053638|NCT01931839|12438260|P2|COMPLETED|Overall Study||152
5053639|NCT01931839|12438261|P1|COMPLETED|Overall Study||294
5053640|NCT01931839|12438255|P7|Safety Analysis Set (As Dosed)|Overall Study||60
5053641|NCT01931839|12438256|P6|Safety Analysis Set (As Dosed)|Overall Study||55
5053724|NCT01931527|12438503|P2|NOT COMPLETED|Overall Study||0
5053642|NCT01931839|12438257|P5|Safety Analysis Set (As Dosed)|Overall Study||19
5053643|NCT01931839|12438258|P4|Safety Analysis Set (As Dosed)|Overall Study||176
5053644|NCT01931839|12438259|P3|Safety Analysis Set (As Dosed)|Overall Study||340
5053645|NCT01931839|12438260|P2|Safety Analysis Set (As Dosed)|Overall Study||178
5053646|NCT01931839|12438261|P1|Safety Analysis Set (As Dosed)|Overall Study||335
5053647|NCT01931839|12438255|P7|Full Analysis Set (As Randomized)|Overall Study||60
5053648|NCT01931839|12438256|P6|Full Analysis Set (As Randomized)|Overall Study||55
5053649|NCT01931839|12438257|P5|Full Analysis Set (As Randomized)|Overall Study||19
5053650|NCT01931839|12438258|P4|Full Analysis Set (As Randomized)|Overall Study||176
5053651|NCT01931839|12438259|P3|Full Analysis Set (As Randomized)|Overall Study||340
5053652|NCT01931839|12438260|P2|Full Analysis Set (As Randomized)|Overall Study||179
5053653|NCT01931839|12438261|P1|Full Analysis Set (As Randomized)|Overall Study||334
5053654|NCT01931839|12438255|P7|STARTED|Overall Study||60
5053655|NCT01931839|12438256|P6|STARTED|Overall Study||55
5053656|NCT01931839|12438257|P5|STARTED|Overall Study||19
5053657|NCT01931839|12438258|P4|STARTED|Overall Study||176
5053658|NCT01931839|12438259|P3|STARTED|Overall Study||340
5053659|NCT01931839|12438260|P2|STARTED|Overall Study||178
5053660|NCT01931839|12438261|P1|STARTED|Overall Study||335
5053661|NCT01931735|12438333|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
5053662|NCT01931735|12438334|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
5053663|NCT01931735|12438335|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
5053664|NCT01931735|12438336|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
5053665|NCT01931735|12438333|P4|COMPLETED|Observational Non-Randomized Phase||9
5053666|NCT01931735|12438334|P3|COMPLETED|Observational Non-Randomized Phase||0
5053667|NCT01931735|12438335|P2|COMPLETED|Observational Non-Randomized Phase||1
5053668|NCT01931735|12438336|P1|COMPLETED|Observational Non-Randomized Phase||2
5053669|NCT01931735|12438333|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
5053670|NCT01931735|12438334|P3|STARTED|Observational Non-Randomized Phase||0
5053671|NCT01931735|12438335|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
5053672|NCT01931735|12438336|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
5053673|NCT01931735|12438333|P4|NOT COMPLETED|Randomized Phase||0
5053674|NCT01931735|12438334|P3|NOT COMPLETED|Randomized Phase||5
5053675|NCT01931735|12438335|P2|NOT COMPLETED|Randomized Phase||2
5053676|NCT01931735|12438336|P1|NOT COMPLETED|Randomized Phase||2
5053677|NCT01931735|12438333|P4|COMPLETED|Randomized Phase||0
5053678|NCT01931735|12438334|P3|COMPLETED|Randomized Phase||4
5053679|NCT01931735|12438335|P2|COMPLETED|Randomized Phase||1
5053680|NCT01931735|12438336|P1|COMPLETED|Randomized Phase||2
5053681|NCT01931735|12438333|P4|STARTED|Randomized Phase||0
5053682|NCT01931735|12438334|P3|STARTED|Randomized Phase||9
5053683|NCT01931735|12438335|P2|STARTED|Randomized Phase||3
5053684|NCT01931735|12438336|P1|STARTED|Randomized Phase||4
5053685|NCT01931709|12438370|P1|NOT COMPLETED|Overall Study||0
5053686|NCT01931709|12438370|P1|COMPLETED|Overall Study||35
5053687|NCT01931709|12438370|P1|STARTED|Overall Study||35
5053688|NCT01931670|12438383|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
5053689|NCT01931670|12438384|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
5053690|NCT01931670|12438385|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
5053691|NCT01931670|12438383|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
5053692|NCT01931670|12438384|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
5053693|NCT01931670|12438385|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
5053694|NCT01931670|12438383|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
5053695|NCT01931670|12438384|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
5053696|NCT01931670|12438385|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
5053697|NCT01931670|12438383|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
5053698|NCT01931670|12438384|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
5053699|NCT01931670|12438385|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
5053700|NCT01931670|12438383|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
5053701|NCT01931670|12438384|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
5053702|NCT01931670|12438385|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
5053703|NCT01931670|12438383|P3|NOT COMPLETED|Treatment Period||45
5053704|NCT01931670|12438384|P2|NOT COMPLETED|Treatment Period||48
5053705|NCT01931670|12438385|P1|NOT COMPLETED|Treatment Period||90
5053706|NCT01931670|12438383|P3|COMPLETED|Treatment Period||184
5053707|NCT01931670|12438384|P2|COMPLETED|Treatment Period||178
5053708|NCT01931670|12438385|P1|COMPLETED|Treatment Period||270
5053709|NCT01931670|12438383|P3|STARTED|Treatment Period||229
5053710|NCT01931670|12438384|P2|STARTED|Treatment Period||226
5053711|NCT01931670|12438385|P1|STARTED|Treatment Period||360
5053712|NCT01931566|12438486|P3|NOT COMPLETED|Overall Study||1506
5053713|NCT01931566|12438487|P2|NOT COMPLETED|Overall Study||1476
5053714|NCT01931566|12438488|P1|NOT COMPLETED|Overall Study||429
5053715|NCT01931566|12438486|P3|COMPLETED|Overall Study||39
5053716|NCT01931566|12438487|P2|COMPLETED|Overall Study||40
5053717|NCT01931566|12438488|P1|COMPLETED|Overall Study||4
5053718|NCT01931566|12438486|P3|Treated|Overall Study||1531
5053719|NCT01931566|12438487|P2|Treated|Overall Study||1507
5053720|NCT01931566|12438488|P1|Treated|Overall Study||427
5053721|NCT01931566|12438486|P3|STARTED|Overall Study||1545
5053722|NCT01931566|12438487|P2|STARTED|Overall Study||1516
5053723|NCT01931566|12438488|P1|STARTED|Overall Study||433
5053725|NCT01931527|12438504|P1|NOT COMPLETED|Overall Study||0
5053726|NCT01931527|12438503|P2|COMPLETED|Overall Study||15
5053727|NCT01931527|12438504|P1|COMPLETED|Overall Study||16
5053728|NCT01931527|12438503|P2|STARTED|Overall Study||15
5053729|NCT01931527|12438504|P1|STARTED|Overall Study||16
5053730|NCT01931475|12438526|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
5053731|NCT01931475|12438527|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
5053732|NCT01931475|12438526|P2|COMPLETED|Period 2: Extension Treatment Phase||157
5053733|NCT01931475|12438527|P1|COMPLETED|Period 2: Extension Treatment Phase||162
5053734|NCT01931475|12438526|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
5053735|NCT01931475|12438527|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
5053736|NCT01931475|12438526|P2|STARTED|Period 2: Extension Treatment Phase||176
5053737|NCT01931475|12438527|P1|STARTED|Period 2: Extension Treatment Phase||166
5053738|NCT01931475|12438526|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
5053739|NCT01931475|12438527|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
5053740|NCT01931475|12438526|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
5053741|NCT01931475|12438527|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
5053742|NCT01931475|12438526|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
5053743|NCT01931475|12438527|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
5053744|NCT01931475|12438526|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
5053745|NCT01931475|12438527|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
5053746|NCT01931462|12438554|P1|NOT COMPLETED|Overall Study||1
5053747|NCT01931462|12438554|P1|COMPLETED|Overall Study||1
5053748|NCT01931462|12438554|P1|STARTED|Overall Study||2
5053749|NCT01931397|12438565|P1|NOT COMPLETED|Overall Study||11
5053750|NCT01931397|12438565|P1|COMPLETED|Overall Study||19
5053751|NCT01931397|12438565|P1|STARTED|Overall Study||30
5053752|NCT01931202|12438577|P3|NOT COMPLETED|Overall Study||4
5053753|NCT01931202|12438578|P2|NOT COMPLETED|Overall Study||5
5053754|NCT01931202|12438579|P1|NOT COMPLETED|Overall Study||0
5053755|NCT01931202|12438577|P3|COMPLETED|Overall Study||45
5053756|NCT01931202|12438578|P2|COMPLETED|Overall Study||46
5053757|NCT01931202|12438579|P1|COMPLETED|Overall Study||8
5053758|NCT01931202|12438577|P3|STARTED|Overall Study||49
5053759|NCT01931202|12438578|P2|STARTED|Overall Study||51
5053760|NCT01931202|12438579|P1|STARTED|Overall Study||8
5053761|NCT01931150|12438625|P2|NOT COMPLETED|Overall Study||2
5053762|NCT01931150|12438626|P1|NOT COMPLETED|Overall Study||1
5053763|NCT01931150|12438625|P2|COMPLETED|Overall Study||4
5053764|NCT01931150|12438626|P1|COMPLETED|Overall Study||4
5053765|NCT01931150|12438625|P2|STARTED|Overall Study||6
5053766|NCT01931150|12438626|P1|STARTED|Overall Study||5
5053767|NCT01931059|12438634|P2|NOT COMPLETED|Day3||0
5053768|NCT01931059|12438635|P1|NOT COMPLETED|Day3||1
5053769|NCT01931059|12438634|P2|COMPLETED|Day3||4
5053770|NCT01931059|12438635|P1|COMPLETED|Day3||5
5053771|NCT01931059|12438634|P2|STARTED|Day3||4
5053772|NCT01931059|12438635|P1|STARTED|Day3||6
5053773|NCT01931059|12438634|P2|NOT COMPLETED|Day2||0
5053774|NCT01931059|12438635|P1|NOT COMPLETED|Day2||0
5053775|NCT01931059|12438634|P2|COMPLETED|Day2||4
5053776|NCT01931059|12438635|P1|COMPLETED|Day2||6
5053777|NCT01931059|12438634|P2|STARTED|Day2||4
5053778|NCT01931059|12438635|P1|STARTED|Day2||6
5053779|NCT01931059|12438634|P2|NOT COMPLETED|Day 1||1
5053780|NCT01931059|12438635|P1|NOT COMPLETED|Day 1||0
5053781|NCT01931059|12438634|P2|COMPLETED|Day 1||4
5053782|NCT01931059|12438635|P1|COMPLETED|Day 1||6
5053783|NCT01931059|12438634|P2|STARTED|Day 1||5
5053784|NCT01931059|12438635|P1|STARTED|Day 1||6
5053785|NCT01930890|12438651|P4|NOT COMPLETED|Overall Study||27
5053786|NCT01930890|12438652|P3|NOT COMPLETED|Overall Study||13
5053787|NCT01930890|12438653|P2|NOT COMPLETED|Overall Study||33
5053788|NCT01930890|12438654|P1|NOT COMPLETED|Overall Study||14
5053789|NCT01930890|12438651|P4|COMPLETED|Overall Study||0
5053790|NCT01930890|12438652|P3|COMPLETED|Overall Study||0
5053791|NCT01930890|12438653|P2|COMPLETED|Overall Study||0
5053792|NCT01930890|12438654|P1|COMPLETED|Overall Study||0
5053793|NCT01930890|12438651|P4|STARTED|Overall Study||27
5053794|NCT01930890|12438652|P3|STARTED|Overall Study||13
5053795|NCT01930890|12438653|P2|STARTED|Overall Study||33
5053796|NCT01930890|12438654|P1|STARTED|Overall Study||14
5053797|NCT01930799|12438668|P1|NOT COMPLETED|Overall Study||8
5053798|NCT01930799|12438668|P1|COMPLETED|Overall Study||112
5053799|NCT01930799|12438668|P1|STARTED|Overall Study||120
5053800|NCT01930747|12438676|P3|NOT COMPLETED|Overall Study||0
5053801|NCT01930747|12438677|P2|NOT COMPLETED|Overall Study||0
5053802|NCT01930747|12438678|P1|NOT COMPLETED|Overall Study||0
5053803|NCT01930747|12438676|P3|COMPLETED|Overall Study||12
5053804|NCT01930747|12438677|P2|COMPLETED|Overall Study||14
5053805|NCT01930747|12438678|P1|COMPLETED|Overall Study||16
5053806|NCT01930747|12438676|P3|STARTED|Overall Study||12
5053807|NCT01930747|12438677|P2|STARTED|Overall Study||14
5053808|NCT01930747|12438678|P1|STARTED|Overall Study||16
5053809|NCT01930643|12438694|P2|NOT COMPLETED|Overall Study||0
5053810|NCT01930643|12438695|P1|NOT COMPLETED|Overall Study||0
5053811|NCT01930643|12438694|P2|COMPLETED|Overall Study||6
5053812|NCT01930643|12438695|P1|COMPLETED|Overall Study||7
5053813|NCT01930643|12438694|P2|STARTED|Overall Study||6
5053814|NCT01930643|12438695|P1|STARTED|Overall Study||7
5053815|NCT01930487|12438701|P2|NOT COMPLETED|Second Intervention (30 Days)||0
5053816|NCT01930487|12438702|P1|NOT COMPLETED|Second Intervention (30 Days)||0
5053817|NCT01930487|12438701|P2|COMPLETED|Second Intervention (30 Days)||23
5053818|NCT01930487|12438702|P1|COMPLETED|Second Intervention (30 Days)||19
5053819|NCT01930487|12438701|P2|STARTED|Second Intervention (30 Days)||23
5053820|NCT01930487|12438702|P1|STARTED|Second Intervention (30 Days)||19
5053821|NCT01930487|12438701|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
5053822|NCT01930487|12438702|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
5053823|NCT01930487|12438701|P2|COMPLETED|Washout Period (3 Weeks)||23
5053824|NCT01930487|12438702|P1|COMPLETED|Washout Period (3 Weeks)||19
5053825|NCT01930487|12438701|P2|STARTED|Washout Period (3 Weeks)||23
5053826|NCT01930487|12438702|P1|STARTED|Washout Period (3 Weeks)||19
5053827|NCT01930487|12438701|P2|NOT COMPLETED|First Intervention (30 Days)||2
5053828|NCT01930487|12438702|P1|NOT COMPLETED|First Intervention (30 Days)||2
5053829|NCT01930487|12438701|P2|COMPLETED|First Intervention (30 Days)||23
5053830|NCT01930487|12438702|P1|COMPLETED|First Intervention (30 Days)||19
5053831|NCT01930487|12438701|P2|STARTED|First Intervention (30 Days)||25
5053832|NCT01930487|12438702|P1|STARTED|First Intervention (30 Days)||21
5053833|NCT01930435|12438796|P1|NOT COMPLETED|Overall Study||0
5053834|NCT01930435|12438796|P1|COMPLETED|Overall Study||20
5053835|NCT01930435|12438796|P1|STARTED|Overall Study||20
5053836|NCT01930214|12438807|P3|NOT COMPLETED|Overall Study||25
5053837|NCT01930214|12438808|P2|NOT COMPLETED|Overall Study||21
5053838|NCT01930214|12438809|P1|NOT COMPLETED|Overall Study||20
5053839|NCT01930214|12438807|P3|COMPLETED|Overall Study||108
5053840|NCT01930214|12438808|P2|COMPLETED|Overall Study||96
5053841|NCT01930214|12438809|P1|COMPLETED|Overall Study||80
5053842|NCT01930214|12438807|P3|STARTED|Overall Study||133
5053843|NCT01930214|12438808|P2|STARTED|Overall Study||117
5053844|NCT01930214|12438809|P1|STARTED|Overall Study||100
5053845|NCT01930188|12438829|P3|NOT COMPLETED|Overall Study||19
5053846|NCT01930188|12438830|P2|NOT COMPLETED|Overall Study||21
5053847|NCT01930188|12438831|P1|NOT COMPLETED|Overall Study||22
5053848|NCT01930188|12438829|P3|COMPLETED|Overall Study||388
5053849|NCT01930188|12438830|P2|COMPLETED|Overall Study||388
5053850|NCT01930188|12438831|P1|COMPLETED|Overall Study||387
5053851|NCT01930188|12438829|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
5053852|NCT01930188|12438830|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
5053853|NCT01930188|12438831|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
5053854|NCT01930188|12438829|P3|STARTED|Overall Study||407
5053855|NCT01930188|12438830|P2|STARTED|Overall Study||409
5053856|NCT01930188|12438831|P1|STARTED|Overall Study||409
5053857|NCT01930162|12438855|P1|NOT COMPLETED|Overall Study||5
5053858|NCT01930162|12438855|P1|COMPLETED|Overall Study||4
5053859|NCT01930162|12438855|P1|STARTED|Overall Study||9
5053860|NCT01930058|12438867|P3|NOT COMPLETED|Overall Study||0
5053861|NCT01930058|12438868|P2|NOT COMPLETED|Overall Study||0
5053862|NCT01930058|12438869|P1|NOT COMPLETED|Overall Study||0
5053863|NCT01930058|12438867|P3|COMPLETED|Overall Study||3
5053864|NCT01930058|12438868|P2|COMPLETED|Overall Study||3
5053865|NCT01930058|12438869|P1|COMPLETED|Overall Study||3
5053866|NCT01930058|12438867|P3|STARTED|Overall Study||3
5053867|NCT01930058|12438868|P2|STARTED|Overall Study||3
5053868|NCT01930058|12438869|P1|STARTED|Overall Study||3
5053869|NCT01930045|12438891|P6|NOT COMPLETED|Part 2 - Period 5||0
5053870|NCT01930045|12438892|P5|NOT COMPLETED|Part 2 - Period 5||0
5053871|NCT01930045|12438893|P4|NOT COMPLETED|Part 2 - Period 5||0
5053872|NCT01930045|12438894|P3|NOT COMPLETED|Part 2 - Period 5||0
5053873|NCT01930045|12438895|P2|NOT COMPLETED|Part 2 - Period 5||0
5053874|NCT01930045|12438896|P1|NOT COMPLETED|Part 2 - Period 5||0
5053875|NCT01930045|12438891|P6|COMPLETED|Part 2 - Period 5||1
5053876|NCT01930045|12438892|P5|COMPLETED|Part 2 - Period 5||3
5053877|NCT01930045|12438893|P4|COMPLETED|Part 2 - Period 5||3
5053878|NCT01930045|12438894|P3|COMPLETED|Part 2 - Period 5||3
5053879|NCT01930045|12438895|P2|COMPLETED|Part 2 - Period 5||3
5053880|NCT01930045|12438896|P1|COMPLETED|Part 2 - Period 5||3
5053881|NCT01930045|12438891|P6|STARTED|Part 2 - Period 5||1
5053882|NCT01930045|12438892|P5|STARTED|Part 2 - Period 5||3
5053883|NCT01930045|12438893|P4|STARTED|Part 2 - Period 5||3
5053884|NCT01930045|12438894|P3|STARTED|Part 2 - Period 5||3
5053885|NCT01930045|12438895|P2|STARTED|Part 2 - Period 5||3
5053886|NCT01930045|12438896|P1|STARTED|Part 2 - Period 5||3
5053887|NCT01930045|12438891|P6|NOT COMPLETED|Part 2 - Period 4||0
5053888|NCT01930045|12438892|P5|NOT COMPLETED|Part 2 - Period 4||0
5053889|NCT01930045|12438893|P4|NOT COMPLETED|Part 2 - Period 4||0
5053890|NCT01930045|12438894|P3|NOT COMPLETED|Part 2 - Period 4||0
5053891|NCT01930045|12438895|P2|NOT COMPLETED|Part 2 - Period 4||0
5053892|NCT01930045|12438896|P1|NOT COMPLETED|Part 2 - Period 4||0
5053893|NCT01930045|12438891|P6|COMPLETED|Part 2 - Period 4||1
5053894|NCT01930045|12438892|P5|COMPLETED|Part 2 - Period 4||3
5053895|NCT01930045|12438893|P4|COMPLETED|Part 2 - Period 4||3
5053896|NCT01930045|12438894|P3|COMPLETED|Part 2 - Period 4||3
5053897|NCT01930045|12438895|P2|COMPLETED|Part 2 - Period 4||3
5053898|NCT01930045|12438896|P1|COMPLETED|Part 2 - Period 4||3
5053899|NCT01930045|12438891|P6|STARTED|Part 2 - Period 4||1
5053900|NCT01930045|12438892|P5|STARTED|Part 2 - Period 4||3
5053901|NCT01930045|12438893|P4|STARTED|Part 2 - Period 4||3
5053902|NCT01930045|12438894|P3|STARTED|Part 2 - Period 4||3
5053903|NCT01930045|12438895|P2|STARTED|Part 2 - Period 4||3
5053904|NCT01930045|12438896|P1|STARTED|Part 2 - Period 4||3
5053905|NCT01930045|12438891|P6|NOT COMPLETED|Pause (up to 37 Days)||2
5053906|NCT01930045|12438892|P5|NOT COMPLETED|Pause (up to 37 Days)||0
5053907|NCT01930045|12438893|P4|NOT COMPLETED|Pause (up to 37 Days)||0
5053908|NCT01930045|12438894|P3|NOT COMPLETED|Pause (up to 37 Days)||0
5053909|NCT01930045|12438895|P2|NOT COMPLETED|Pause (up to 37 Days)||0
5053910|NCT01930045|12438896|P1|NOT COMPLETED|Pause (up to 37 Days)||0
5053911|NCT01930045|12438891|P6|COMPLETED|Pause (up to 37 Days)||1
5053912|NCT01930045|12438892|P5|COMPLETED|Pause (up to 37 Days)||3
5053913|NCT01930045|12438893|P4|COMPLETED|Pause (up to 37 Days)||3
5053914|NCT01930045|12438894|P3|COMPLETED|Pause (up to 37 Days)||3
5053915|NCT01930045|12438895|P2|COMPLETED|Pause (up to 37 Days)||3
5053916|NCT01930045|12438896|P1|COMPLETED|Pause (up to 37 Days)||3
5053917|NCT01930045|12438891|P6|STARTED|Pause (up to 37 Days)||3
5053918|NCT01930045|12438892|P5|STARTED|Pause (up to 37 Days)||3
5053919|NCT01930045|12438893|P4|STARTED|Pause (up to 37 Days)||3
5053920|NCT01930045|12438894|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
5053921|NCT01930045|12438895|P2|STARTED|Pause (up to 37 Days)||3
5053922|NCT01930045|12438896|P1|STARTED|Pause (up to 37 Days)||3
5053923|NCT01930045|12438891|P6|NOT COMPLETED|Part 1 - Period 3||0
5053924|NCT01930045|12438892|P5|NOT COMPLETED|Part 1 - Period 3||0
5053925|NCT01930045|12438893|P4|NOT COMPLETED|Part 1 - Period 3||0
5053926|NCT01930045|12438894|P3|NOT COMPLETED|Part 1 - Period 3||0
5053927|NCT01930045|12438895|P2|NOT COMPLETED|Part 1 - Period 3||0
5053928|NCT01930045|12438896|P1|NOT COMPLETED|Part 1 - Period 3||0
5053929|NCT01930045|12438891|P6|COMPLETED|Part 1 - Period 3||3
5053930|NCT01930045|12438892|P5|COMPLETED|Part 1 - Period 3||3
5053931|NCT01930045|12438893|P4|COMPLETED|Part 1 - Period 3||3
5053932|NCT01930045|12438894|P3|COMPLETED|Part 1 - Period 3||2
5053933|NCT01930045|12438895|P2|COMPLETED|Part 1 - Period 3||3
5053934|NCT01930045|12438896|P1|COMPLETED|Part 1 - Period 3||3
5053935|NCT01930045|12438891|P6|STARTED|Part 1 - Period 3||3
5053936|NCT01930045|12438892|P5|STARTED|Part 1 - Period 3||3
5053937|NCT01930045|12438893|P4|STARTED|Part 1 - Period 3||3
5053938|NCT01930045|12438894|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
5053939|NCT01930045|12438895|P2|STARTED|Part 1 - Period 3||3
5053940|NCT01930045|12438896|P1|STARTED|Part 1 - Period 3||3
5053941|NCT01930045|12438891|P6|NOT COMPLETED|Part 1 - Period 2||0
5053942|NCT01930045|12438892|P5|NOT COMPLETED|Part 1 - Period 2||0
5053943|NCT01930045|12438893|P4|NOT COMPLETED|Part 1 - Period 2||0
5053944|NCT01930045|12438894|P3|NOT COMPLETED|Part 1 - Period 2||0
5053945|NCT01930045|12438895|P2|NOT COMPLETED|Part 1 - Period 2||0
5053946|NCT01930045|12438896|P1|NOT COMPLETED|Part 1 - Period 2||0
5053947|NCT01930045|12438891|P6|COMPLETED|Part 1 - Period 2||3
5053948|NCT01930045|12438892|P5|COMPLETED|Part 1 - Period 2||3
5053949|NCT01930045|12438893|P4|COMPLETED|Part 1 - Period 2||3
5053950|NCT01930045|12438894|P3|COMPLETED|Part 1 - Period 2||3
5053951|NCT01930045|12438895|P2|COMPLETED|Part 1 - Period 2||3
5053952|NCT01930045|12438896|P1|COMPLETED|Part 1 - Period 2||3
5053953|NCT01930045|12438891|P6|STARTED|Part 1 - Period 2||3
5053954|NCT01930045|12438892|P5|STARTED|Part 1 - Period 2||3
5053955|NCT01930045|12438893|P4|STARTED|Part 1 - Period 2||3
5053956|NCT01930045|12438894|P3|STARTED|Part 1 - Period 2||3
5053957|NCT01930045|12438895|P2|STARTED|Part 1 - Period 2||3
5053958|NCT01930045|12438896|P1|STARTED|Part 1 - Period 2||3
5053959|NCT01930045|12438891|P6|NOT COMPLETED|Part 1 - Period 1||0
5053960|NCT01930045|12438892|P5|NOT COMPLETED|Part 1 - Period 1||0
5053961|NCT01930045|12438893|P4|NOT COMPLETED|Part 1 - Period 1||0
5053962|NCT01930045|12438894|P3|NOT COMPLETED|Part 1 - Period 1||0
5053963|NCT01930045|12438895|P2|NOT COMPLETED|Part 1 - Period 1||0
5053964|NCT01930045|12438896|P1|NOT COMPLETED|Part 1 - Period 1||0
5053965|NCT01930045|12438891|P6|COMPLETED|Part 1 - Period 1||3
5053966|NCT01930045|12438892|P5|COMPLETED|Part 1 - Period 1||3
5053967|NCT01930045|12438893|P4|COMPLETED|Part 1 - Period 1||3
5053968|NCT01930045|12438894|P3|COMPLETED|Part 1 - Period 1||3
5053969|NCT01930045|12438895|P2|COMPLETED|Part 1 - Period 1||3
5053970|NCT01930045|12438896|P1|COMPLETED|Part 1 - Period 1||3
5053971|NCT01930045|12438891|P6|STARTED|Part 1 - Period 1||3
5053972|NCT01930045|12438892|P5|STARTED|Part 1 - Period 1||3
5053973|NCT01930045|12438893|P4|STARTED|Part 1 - Period 1||3
5053974|NCT01930045|12438894|P3|STARTED|Part 1 - Period 1||3
5053975|NCT01930045|12438895|P2|STARTED|Part 1 - Period 1||3
5053976|NCT01930045|12438896|P1|STARTED|Part 1 - Period 1||3
5053977|NCT01929993|12438923|P2|NOT COMPLETED|Overall Study||28
5053978|NCT01929993|12438924|P1|NOT COMPLETED|Overall Study||30
5053979|NCT01929993|12438923|P2|COMPLETED|Overall Study||54
5053980|NCT01929993|12438924|P1|COMPLETED|Overall Study||52
5053981|NCT01929993|12438923|P2|STARTED|Overall Study||82
5053982|NCT01929993|12438924|P1|STARTED|Overall Study||82
5053983|NCT01929980|12438930|P1|NOT COMPLETED|Overall Study||1
5053984|NCT01929980|12438930|P1|COMPLETED|Overall Study||3
5053985|NCT01929980|12438930|P1|STARTED|Overall Study||4
5053986|NCT01929889|12438934|P1|NOT COMPLETED|Overall Study||5
5053987|NCT01929889|12438934|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
5053988|NCT01929889|12438934|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
5053989|NCT01929876|12438938|P1|NOT COMPLETED|Period 2||1
5053990|NCT01929876|12438938|P1|COMPLETED|Period 2||15
5053991|NCT01929876|12438938|P1|STARTED|Period 2||16
5053992|NCT01929876|12438938|P1|NOT COMPLETED|Period 1||0
5053993|NCT01929876|12438938|P1|COMPLETED|Period 1||16
5053994|NCT01929876|12438938|P1|STARTED|Period 1||16
5053995|NCT01929863|12438951|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
5053996|NCT01929863|12438952|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
5053997|NCT01929863|12438951|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
5053998|NCT01929863|12438952|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
5053999|NCT01929863|12438951|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
5054000|NCT01929863|12438952|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
5054001|NCT01929863|12438951|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
5054002|NCT01929863|12438952|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
5054003|NCT01929863|12438951|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
5054004|NCT01929863|12438952|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
5054005|NCT01929863|12438951|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
5054006|NCT01929863|12438952|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
5054007|NCT01929863|12438951|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
5054008|NCT01929863|12438952|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
5054009|NCT01929863|12438951|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
5054010|NCT01929863|12438952|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
5054011|NCT01929863|12438951|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
5054012|NCT01929863|12438952|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
5054013|NCT01929863|12438951|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
5054014|NCT01929863|12438952|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
5054015|NCT01929863|12438951|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
5054016|NCT01929863|12438952|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
5054017|NCT01929863|12438951|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
5054018|NCT01929863|12438952|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
5054019|NCT01929759|12438995|P1|NOT COMPLETED|Overall Study||0
5054020|NCT01929759|12438995|P1|COMPLETED|Overall Study||10
5054021|NCT01929759|12438995|P1|STARTED|Overall Study||10
5054022|NCT01929707|12439007|P8|NOT COMPLETED|Intervention Period 2||0
5054023|NCT01929707|12439008|P7|NOT COMPLETED|Intervention Period 2||0
5054024|NCT01929707|12439009|P6|NOT COMPLETED|Intervention Period 2||2
5054025|NCT01929707|12439010|P5|NOT COMPLETED|Intervention Period 2||0
5054026|NCT01929707|12439011|P4|NOT COMPLETED|Intervention Period 2||0
5054027|NCT01929707|12439012|P3|NOT COMPLETED|Intervention Period 2||0
5054028|NCT01929707|12439013|P2|NOT COMPLETED|Intervention Period 2||0
5054029|NCT01929707|12439014|P1|NOT COMPLETED|Intervention Period 2||0
5054030|NCT01929707|12439007|P8|COMPLETED|Intervention Period 2||4
5054031|NCT01929707|12439008|P7|COMPLETED|Intervention Period 2||12
5054032|NCT01929707|12439009|P6|COMPLETED|Intervention Period 2||6
5054033|NCT01929707|12439010|P5|COMPLETED|Intervention Period 2||6
5054034|NCT01929707|12439011|P4|COMPLETED|Intervention Period 2||5
5054035|NCT01929707|12439012|P3|COMPLETED|Intervention Period 2||0
5054036|NCT01929707|12439013|P2|COMPLETED|Intervention Period 2||0
5054037|NCT01929707|12439014|P1|COMPLETED|Intervention Period 2||0
5054038|NCT01929707|12439007|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
5054039|NCT01929707|12439008|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
5054040|NCT01929707|12439009|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
5054041|NCT01929707|12439010|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
5054042|NCT01929707|12439011|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
5054043|NCT01929707|12439012|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
5054044|NCT01929707|12439013|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
5054045|NCT01929707|12439014|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
5054046|NCT01929707|12439007|P8|NOT COMPLETED|Washout Period ≥7 Days||0
5054047|NCT01929707|12439008|P7|NOT COMPLETED|Washout Period ≥7 Days||0
5054048|NCT01929707|12439009|P6|NOT COMPLETED|Washout Period ≥7 Days||0
5054049|NCT01929707|12439010|P5|NOT COMPLETED|Washout Period ≥7 Days||0
5054050|NCT01929707|12439011|P4|NOT COMPLETED|Washout Period ≥7 Days||0
5054051|NCT01929707|12439012|P3|NOT COMPLETED|Washout Period ≥7 Days||0
5054052|NCT01929707|12439013|P2|NOT COMPLETED|Washout Period ≥7 Days||0
5054053|NCT01929707|12439014|P1|NOT COMPLETED|Washout Period ≥7 Days||0
5054054|NCT01929707|12439007|P8|COMPLETED|Washout Period ≥7 Days||0
5054055|NCT01929707|12439008|P7|COMPLETED|Washout Period ≥7 Days||0
5054056|NCT01929707|12439009|P6|COMPLETED|Washout Period ≥7 Days||0
5054057|NCT01929707|12439010|P5|COMPLETED|Washout Period ≥7 Days||0
5054058|NCT01929707|12439011|P4|COMPLETED|Washout Period ≥7 Days||7
5054059|NCT01929707|12439012|P3|COMPLETED|Washout Period ≥7 Days||12
5054060|NCT01929707|12439013|P2|COMPLETED|Washout Period ≥7 Days||8
5054061|NCT01929707|12439014|P1|COMPLETED|Washout Period ≥7 Days||6
5054062|NCT01929707|12439007|P8|STARTED|Washout Period ≥7 Days||0
5054063|NCT01929707|12439008|P7|STARTED|Washout Period ≥7 Days||0
5054064|NCT01929707|12439009|P6|STARTED|Washout Period ≥7 Days||0
5054065|NCT01929707|12439010|P5|STARTED|Washout Period ≥7 Days||0
5054066|NCT01929707|12439011|P4|STARTED|Washout Period ≥7 Days||7
5054067|NCT01929707|12439012|P3|STARTED|Washout Period ≥7 Days||12
5054068|NCT01929707|12439013|P2|STARTED|Washout Period ≥7 Days||8
5054069|NCT01929707|12439014|P1|STARTED|Washout Period ≥7 Days||6
5054070|NCT01929707|12439007|P8|NOT COMPLETED|Intervention Period 1||0
5054071|NCT01929707|12439008|P7|NOT COMPLETED|Intervention Period 1||0
5054072|NCT01929707|12439009|P6|NOT COMPLETED|Intervention Period 1||0
5054073|NCT01929707|12439010|P5|NOT COMPLETED|Intervention Period 1||0
5054074|NCT01929707|12439011|P4|NOT COMPLETED|Intervention Period 1||3
5054075|NCT01929707|12439012|P3|NOT COMPLETED|Intervention Period 1||0
5054076|NCT01929707|12439013|P2|NOT COMPLETED|Intervention Period 1||0
5054077|NCT01929707|12439014|P1|NOT COMPLETED|Intervention Period 1||0
5054078|NCT01929707|12439007|P8|COMPLETED|Intervention Period 1||0
5054079|NCT01929707|12439008|P7|COMPLETED|Intervention Period 1||0
5054080|NCT01929707|12439009|P6|COMPLETED|Intervention Period 1||0
5054081|NCT01929707|12439010|P5|COMPLETED|Intervention Period 1||0
5054082|NCT01929707|12439011|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
5054083|NCT01929707|12439012|P3|COMPLETED|Intervention Period 1||12
5054084|NCT01929707|12439013|P2|COMPLETED|Intervention Period 1||8
5054085|NCT01929707|12439014|P1|COMPLETED|Intervention Period 1||6
5054086|NCT01929707|12439007|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
5054087|NCT01929707|12439008|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
5054088|NCT01929707|12439009|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
5054089|NCT01929707|12439010|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
5054090|NCT01929707|12439011|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
5054091|NCT01929707|12439012|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
5054092|NCT01929707|12439013|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
5054093|NCT01929707|12439014|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
5054094|NCT01929707|12439007|P8|STARTED|Intervention Period 1||0
5054095|NCT01929707|12439008|P7|STARTED|Intervention Period 1||0
5054096|NCT01929707|12439009|P6|STARTED|Intervention Period 1||0
5054097|NCT01929707|12439010|P5|STARTED|Intervention Period 1||0
5054098|NCT01929707|12439011|P4|STARTED|Intervention Period 1||10
5054099|NCT01929707|12439012|P3|STARTED|Intervention Period 1||12
5054100|NCT01929707|12439013|P2|STARTED|Intervention Period 1||8
5054101|NCT01929707|12439014|P1|STARTED|Intervention Period 1||6
5054102|NCT01929681|12439046|P2|NOT COMPLETED|Overall Study||1
5054103|NCT01929681|12439047|P1|NOT COMPLETED|Overall Study||2
5054104|NCT01929681|12439046|P2|COMPLETED|Overall Study||24
5054105|NCT01929681|12439047|P1|COMPLETED|Overall Study||26
5054106|NCT01929681|12439046|P2|STARTED|Overall Study||25
5054107|NCT01929681|12439047|P1|STARTED|Overall Study||28
5054108|NCT01929473|12439061|P1|NOT COMPLETED|Overall Study||587
5054109|NCT01929473|12439061|P1|COMPLETED|Overall Study||3243
5054110|NCT01929473|12439061|P1|365 Day|Overall Study||3589
5054111|NCT01929473|12439061|P1|STARTED|Overall Study|0 day|3830
5054112|NCT01929460|12439067|P2|NOT COMPLETED|Overall Study||0
5054113|NCT01929460|12439068|P1|NOT COMPLETED|Overall Study||0
5054114|NCT01929460|12439067|P2|COMPLETED|Overall Study||13
5054115|NCT01929460|12439068|P1|COMPLETED|Overall Study||13
5054116|NCT01929460|12439067|P2|STARTED|Overall Study||13
5054117|NCT01929460|12439068|P1|STARTED|Overall Study||13
5054118|NCT01929408|12439090|P1|NOT COMPLETED|Overall Study||8
5054119|NCT01929408|12439090|P1|COMPLETED|Overall Study||695
5054120|NCT01929408|12439090|P1|STARTED|Overall Study||703
5054121|NCT01929395|12439098|P3|NOT COMPLETED|Overall Study||1
5054122|NCT01929395|12439099|P2|NOT COMPLETED|Overall Study||1
5054123|NCT01929395|12439100|P1|NOT COMPLETED|Overall Study||1
5054124|NCT01929395|12439098|P3|COMPLETED|Overall Study||69
5054125|NCT01929395|12439099|P2|COMPLETED|Overall Study||69
5054126|NCT01929395|12439100|P1|COMPLETED|Overall Study||18
5054127|NCT01929395|12439098|P3|STARTED|Overall Study||70
5054128|NCT01929395|12439099|P2|STARTED|Overall Study||70
5054129|NCT01929395|12439100|P1|STARTED|Overall Study||19
5054130|NCT01929317|12439112|P2|NOT COMPLETED|Long-term Phase||4
5054131|NCT01929317|12439113|P1|NOT COMPLETED|Long-term Phase||19
5054132|NCT01929317|12439112|P2|COMPLETED|Long-term Phase||14
5054133|NCT01929317|12439113|P1|COMPLETED|Long-term Phase||25
5054134|NCT01929317|12439112|P2|STARTED|Long-term Phase||18
5054135|NCT01929317|12439113|P1|STARTED|Long-term Phase||44
5054136|NCT01929317|12439112|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
5054137|NCT01929317|12439113|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
5054138|NCT01929317|12439112|P2|COMPLETED|Dose Increase Effect Verification Phase||19
5054139|NCT01929317|12439113|P1|COMPLETED|Dose Increase Effect Verification Phase||52
5054140|NCT01929317|12439112|P2|STARTED|Dose Increase Effect Verification Phase||20
5054141|NCT01929317|12439113|P1|STARTED|Dose Increase Effect Verification Phase||61
5054142|NCT01929291|12439180|P1|NOT COMPLETED|Overall Study||0
5054143|NCT01929291|12439180|P1|COMPLETED|Overall Study||672
5054144|NCT01929291|12439180|P1|STARTED|Overall Study||672
5054145|NCT01929226|12439188|P2|NOT COMPLETED|Overall Study||1
5054146|NCT01929226|12439189|P1|NOT COMPLETED|Overall Study||5
5054147|NCT01929226|12439188|P2|COMPLETED|Overall Study||69
5054148|NCT01929226|12439189|P1|COMPLETED|Overall Study||205
5054149|NCT01929226|12439188|P2|STARTED|Overall Study||70
5054150|NCT01929226|12439189|P1|STARTED|Overall Study||210
5054151|NCT01929135|12439215|P2|NOT COMPLETED|Overall Study||1
5054152|NCT01929135|12439216|P1|NOT COMPLETED|Overall Study||1
5054153|NCT01929135|12439215|P2|COMPLETED|Overall Study||18
5054154|NCT01929135|12439216|P1|COMPLETED|Overall Study||18
5054155|NCT01929135|12439215|P2|STARTED|Overall Study||19
5054156|NCT01929135|12439216|P1|STARTED|Overall Study||19
5054157|NCT01929109|12439235|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054158|NCT01929109|12439236|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054159|NCT01929109|12439237|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054160|NCT01929109|12439238|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054161|NCT01929109|12439239|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054162|NCT01929109|12439235|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
5054163|NCT01929109|12439236|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054164|NCT01929109|12439237|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054165|NCT01929109|12439238|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054166|NCT01929109|12439239|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
5054167|NCT01929109|12439235|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
5054168|NCT01929109|12439236|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
5054169|NCT01929109|12439237|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
5054170|NCT01929109|12439238|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
5054171|NCT01929109|12439239|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
5054172|NCT01929109|12439235|P5|NOT COMPLETED|Period 1 (All Groups)||0
5054173|NCT01929109|12439236|P4|NOT COMPLETED|Period 1 (All Groups)||0
5054174|NCT01929109|12439237|P3|NOT COMPLETED|Period 1 (All Groups)||1
5054175|NCT01929109|12439238|P2|NOT COMPLETED|Period 1 (All Groups)||0
5054176|NCT01929109|12439239|P1|NOT COMPLETED|Period 1 (All Groups)||0
5054177|NCT01929109|12439235|P5|COMPLETED|Period 1 (All Groups)||8
5054178|NCT01929109|12439236|P4|COMPLETED|Period 1 (All Groups)||8
5054179|NCT01929109|12439237|P3|COMPLETED|Period 1 (All Groups)||8
5054180|NCT01929109|12439238|P2|COMPLETED|Period 1 (All Groups)||8
5054181|NCT01929109|12439239|P1|COMPLETED|Period 1 (All Groups)||14
5054182|NCT01929109|12439235|P5|STARTED|Period 1 (All Groups)||8
5054183|NCT01929109|12439236|P4|STARTED|Period 1 (All Groups)||8
5054184|NCT01929109|12439237|P3|STARTED|Period 1 (All Groups)||9
5054185|NCT01929109|12439238|P2|STARTED|Period 1 (All Groups)||8
5054186|NCT01929109|12439239|P1|STARTED|Period 1 (All Groups)||14
5054187|NCT01929083|12439258|P2|NOT COMPLETED|Intervention 2||1
5054188|NCT01929083|12439259|P1|NOT COMPLETED|Intervention 2||0
5054189|NCT01929083|12439258|P2|COMPLETED|Intervention 2||8
5054190|NCT01929083|12439259|P1|COMPLETED|Intervention 2||7
5054191|NCT01929083|12439258|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
5054192|NCT01929083|12439259|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
5054193|NCT01929083|12439258|P2|STARTED|Intervention 2||9
5054194|NCT01929083|12439259|P1|STARTED|Intervention 2||7
5054195|NCT01929083|12439258|P2|NOT COMPLETED|Intervention 1||0
5054196|NCT01929083|12439259|P1|NOT COMPLETED|Intervention 1||3
5054197|NCT01929083|12439258|P2|COMPLETED|Intervention 1||9
5054198|NCT01929083|12439259|P1|COMPLETED|Intervention 1||7
5054199|NCT01929083|12439258|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
5054200|NCT01929083|12439259|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
5054201|NCT01929083|12439258|P2|STARTED|Intervention 1||9
5054202|NCT01929083|12439259|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
5054203|NCT01929057|12439285|P2|NOT COMPLETED|Overall Study||0
5054204|NCT01929057|12439286|P1|NOT COMPLETED|Overall Study||0
5054205|NCT01929057|12439285|P2|COMPLETED|Overall Study||3
5054206|NCT01929057|12439286|P1|COMPLETED|Overall Study||31
5054207|NCT01929057|12439285|P2|STARTED|Overall Study||3
5054208|NCT01929057|12439286|P1|STARTED|Overall Study||31
5054209|NCT01929044|12439296|P2|NOT COMPLETED|Overall Study||17
5054210|NCT01929044|12439297|P1|NOT COMPLETED|Overall Study||11
5054211|NCT01929044|12439296|P2|COMPLETED|Overall Study||129
5054212|NCT01929044|12439297|P1|COMPLETED|Overall Study||142
5054213|NCT01929044|12439296|P2|STARTED|Overall Study||146
5054214|NCT01929044|12439297|P1|STARTED|Overall Study||153
5054215|NCT01929031|12439319|P6|NOT COMPLETED|Overall Study||1
5054216|NCT01929031|12439320|P5|NOT COMPLETED|Overall Study||1
5054217|NCT01929031|12439321|P4|NOT COMPLETED|Overall Study||0
5054218|NCT01929031|12439322|P3|NOT COMPLETED|Overall Study||1
5054219|NCT01929031|12439323|P2|NOT COMPLETED|Overall Study||2
5054220|NCT01929031|12439324|P1|NOT COMPLETED|Overall Study||4
5054221|NCT01929031|12439319|P6|COMPLETED|Overall Study||35
5054222|NCT01929031|12439320|P5|COMPLETED|Overall Study||33
5054223|NCT01929031|12439321|P4|COMPLETED|Overall Study||35
5054224|NCT01929031|12439322|P3|COMPLETED|Overall Study||34
5054225|NCT01929031|12439323|P2|COMPLETED|Overall Study||207
5054226|NCT01929031|12439324|P1|COMPLETED|Overall Study||209
5054227|NCT01929031|12439319|P6|STARTED|Overall Study||36
5054228|NCT01929031|12439320|P5|STARTED|Overall Study||34
5054229|NCT01929031|12439321|P4|STARTED|Overall Study||35
5054230|NCT01929031|12439322|P3|STARTED|Overall Study||35
5054231|NCT01929031|12439323|P2|STARTED|Overall Study||209
5054232|NCT01929031|12439324|P1|STARTED|Overall Study||213
5054233|NCT01929018|12439348|P2|NOT COMPLETED|Overall Study||1
5054234|NCT01929018|12439349|P1|NOT COMPLETED|Overall Study||1
5054235|NCT01929018|12439348|P2|COMPLETED|Overall Study||18
5054236|NCT01929018|12439349|P1|COMPLETED|Overall Study||18
5054237|NCT01929018|12439348|P2|STARTED|Overall Study||19
5054238|NCT01929018|12439349|P1|STARTED|Overall Study||19
5054239|NCT01928940|12439373|P2|NOT COMPLETED|Overall Study||1
5054240|NCT01928940|12439374|P1|NOT COMPLETED|Overall Study||0
5054241|NCT01928940|12439373|P2|COMPLETED|Overall Study||5
5054242|NCT01928940|12439374|P1|COMPLETED|Overall Study||6
5054243|NCT01928940|12439373|P2|STARTED|Overall Study||6
5054244|NCT01928940|12439374|P1|STARTED|Overall Study||6
5054245|NCT01928927|12439417|P2|NOT COMPLETED|Overall Study||1
5054246|NCT01928927|12439418|P1|NOT COMPLETED|Overall Study||2
5054247|NCT01928927|12439417|P2|COMPLETED|Overall Study||14
5054248|NCT01928927|12439418|P1|COMPLETED|Overall Study||27
5054249|NCT01928927|12439417|P2|STARTED|Overall Study||15
5054250|NCT01928927|12439418|P1|STARTED|Overall Study||29
5054251|NCT01928862|12439559|P5|NOT COMPLETED|Overall Study||1
5054252|NCT01928862|12439560|P4|NOT COMPLETED|Overall Study||0
5054253|NCT01928862|12439561|P3|NOT COMPLETED|Overall Study||0
5054254|NCT01928862|12439562|P2|NOT COMPLETED|Overall Study||0
5054255|NCT01928862|12439563|P1|NOT COMPLETED|Overall Study||1
5054256|NCT01928862|12439559|P5|COMPLETED|Overall Study||13
5054257|NCT01928862|12439560|P4|COMPLETED|Overall Study||16
5054258|NCT01928862|12439561|P3|COMPLETED|Overall Study||16
5054259|NCT01928862|12439562|P2|COMPLETED|Overall Study||16
5054260|NCT01928862|12439563|P1|COMPLETED|Overall Study||15
5054261|NCT01928862|12439559|P5|STARTED|Overall Study||14
5054262|NCT01928862|12439560|P4|STARTED|Overall Study||16
5054263|NCT01928862|12439561|P3|STARTED|Overall Study||16
5054264|NCT01928862|12439562|P2|STARTED|Overall Study||16
5054265|NCT01928862|12439563|P1|STARTED|Overall Study||16
5054266|NCT01928849|12439602|P2|NOT COMPLETED|Overall Study||7
5054267|NCT01928849|12439603|P1|NOT COMPLETED|Overall Study||14
5054268|NCT01928849|12439602|P2|COMPLETED|Overall Study||55
5054269|NCT01928849|12439603|P1|COMPLETED|Overall Study||52
5054270|NCT01928849|12439602|P2|STARTED|Overall Study||62
5054271|NCT01928849|12439603|P1|STARTED|Overall Study||66
5054272|NCT01928797|12439623|P2|NOT COMPLETED|Overall Study||0
5054273|NCT01928797|12439624|P1|NOT COMPLETED|Overall Study||0
5054274|NCT01928797|12439623|P2|COMPLETED|Overall Study||30
5054275|NCT01928797|12439624|P1|COMPLETED|Overall Study||30
5054276|NCT01928797|12439623|P2|STARTED|Overall Study||30
5054277|NCT01928797|12439624|P1|STARTED|Overall Study||30
5054278|NCT01928771|12439637|P3|NOT COMPLETED|Overall Study||40
5054279|NCT01928771|12439638|P2|NOT COMPLETED|Overall Study||40
5054280|NCT01928771|12439639|P1|NOT COMPLETED|Overall Study||46
5054281|NCT01928771|12439637|P3|COMPLETED|Overall Study||367
5054282|NCT01928771|12439638|P2|COMPLETED|Overall Study||358
5054283|NCT01928771|12439639|P1|COMPLETED|Overall Study||354
5054284|NCT01928771|12439637|P3|Received Treatment|Overall Study||407
5054285|NCT01928771|12439638|P2|Received Treatment|Overall Study||398
5054286|NCT01928771|12439639|P1|Received Treatment|Overall Study||399
5054287|NCT01928771|12439637|P3|STARTED|Overall Study||407
5054288|NCT01928771|12439638|P2|STARTED|Overall Study||398
5054289|NCT01928771|12439639|P1|STARTED|Overall Study||400
5054290|NCT01928758|12439718|P2|NOT COMPLETED|Overall Study||20
5054291|NCT01928758|12439719|P1|NOT COMPLETED|Overall Study||25
5054292|NCT01928758|12439718|P2|COMPLETED|Overall Study||74
5054293|NCT01928758|12439719|P1|COMPLETED|Overall Study||69
5054294|NCT01928758|12439718|P2|STARTED|Overall Study||94
5054295|NCT01928758|12439719|P1|STARTED|Overall Study||94
5054296|NCT01928719|12439737|P2|NOT COMPLETED|Overall Study||19
5054297|NCT01928719|12439738|P1|NOT COMPLETED|Overall Study||52
5054298|NCT01928719|12439737|P2|COMPLETED|Overall Study||104
5054299|NCT01928719|12439738|P1|COMPLETED|Overall Study||70
5054300|NCT01928719|12439737|P2|STARTED|Overall Study||123
5054301|NCT01928719|12439738|P1|STARTED|Overall Study||122
5054302|NCT01928693|12439758|P3|NOT COMPLETED|Overall Study||0
5054303|NCT01928693|12439759|P2|NOT COMPLETED|Overall Study||0
5054304|NCT01928693|12439760|P1|NOT COMPLETED|Overall Study||0
5054305|NCT01928693|12439758|P3|COMPLETED|Overall Study||1
5054306|NCT01928693|12439759|P2|COMPLETED|Overall Study||1
5054307|NCT01928693|12439760|P1|COMPLETED|Overall Study||0
5054308|NCT01928693|12439758|P3|STARTED|Overall Study||1
5054309|NCT01928693|12439759|P2|STARTED|Overall Study||1
5054310|NCT01928693|12439760|P1|STARTED|Overall Study||0
5054311|NCT01928680|12439786|P1|NOT COMPLETED|Overall Study||0
5054312|NCT01928680|12439786|P1|COMPLETED|Overall Study||33
5054313|NCT01928680|12439786|P1|STARTED|Overall Study||33
5054314|NCT01928615|12439790|P1|NOT COMPLETED|Overall Study||2
5054315|NCT01928615|12439790|P1|COMPLETED|Overall Study||0
5054316|NCT01928615|12439790|P1|STARTED|Overall Study||2
5054317|NCT01928485|12439807|P2|NOT COMPLETED|Overall Study||1
5054318|NCT01928485|12439808|P1|NOT COMPLETED|Overall Study||0
5054319|NCT01928485|12439807|P2|COMPLETED|Overall Study||1
5054320|NCT01928485|12439808|P1|COMPLETED|Overall Study||4
5054321|NCT01928485|12439807|P2|STARTED|Overall Study||2
5054322|NCT01928485|12439808|P1|STARTED|Overall Study||4
5054323|NCT01928472|12439838|P4|NOT COMPLETED|Overall Study||2
5054324|NCT01928472|12439839|P3|NOT COMPLETED|Overall Study||7
5054325|NCT01928472|12439840|P2|NOT COMPLETED|Overall Study||8
5054326|NCT01928472|12439841|P1|NOT COMPLETED|Overall Study||8
5054327|NCT01928472|12439838|P4|COMPLETED|Overall Study||100
5054328|NCT01928472|12439839|P3|COMPLETED|Overall Study||91
5054329|NCT01928472|12439840|P2|COMPLETED|Overall Study||96
5054330|NCT01928472|12439841|P1|COMPLETED|Overall Study||90
5054331|NCT01928472|12439838|P4|STARTED|Overall Study||102
5054332|NCT01928472|12439839|P3|STARTED|Overall Study||98
5054333|NCT01928472|12439840|P2|STARTED|Overall Study||104
5054334|NCT01928472|12439841|P1|STARTED|Overall Study||98
5054335|NCT01928433|12439911|P3|NOT COMPLETED|Overall Study||28
5054336|NCT01928433|12439912|P2|NOT COMPLETED|Overall Study||21
5054337|NCT01928433|12439913|P1|NOT COMPLETED|Overall Study||20
5054338|NCT01928433|12439911|P3|COMPLETED|Overall Study||46
5054339|NCT01928433|12439912|P2|COMPLETED|Overall Study||54
5054340|NCT01928433|12439913|P1|COMPLETED|Overall Study||56
5054341|NCT01928433|12439911|P3|STARTED|Overall Study||74
5054342|NCT01928433|12439912|P2|STARTED|Overall Study||75
5054343|NCT01928433|12439913|P1|STARTED|Overall Study||76
5054344|NCT01928394|12439959|P23|NOT COMPLETED|Follow-up Period||6
5054345|NCT01928394|12439960|P22|NOT COMPLETED|Follow-up Period||9
5054346|NCT01928394|12439961|P21|NOT COMPLETED|Follow-up Period||9
5054347|NCT01928394|12439962|P20|NOT COMPLETED|Follow-up Period||21
5054348|NCT01928394|12439963|P19|NOT COMPLETED|Follow-up Period||16
5054349|NCT01928394|12439964|P18|NOT COMPLETED|Follow-up Period||8
5054350|NCT01928394|12439965|P17|NOT COMPLETED|Follow-up Period||14
5054351|NCT01928394|12439966|P16|NOT COMPLETED|Follow-up Period||0
5054352|NCT01928394|12439967|P15|NOT COMPLETED|Follow-up Period||30
5054353|NCT01928394|12439968|P14|NOT COMPLETED|Follow-up Period||38
5054354|NCT01928394|12439969|P13|NOT COMPLETED|Follow-up Period||14
5054355|NCT01928394|12439970|P12|NOT COMPLETED|Follow-up Period||22
5054356|NCT01928394|12439971|P11|NOT COMPLETED|Follow-up Period||11
5054357|NCT01928394|12439972|P10|NOT COMPLETED|Follow-up Period||2
5054358|NCT01928394|12439973|P9|NOT COMPLETED|Follow-up Period||1
5054359|NCT01928394|12439974|P8|NOT COMPLETED|Follow-up Period||6
5054360|NCT01928394|12439975|P7|NOT COMPLETED|Follow-up Period||12
5054361|NCT01928394|12439976|P6|NOT COMPLETED|Follow-up Period||8
5054362|NCT01928394|12439977|P5|NOT COMPLETED|Follow-up Period||0
5054363|NCT01928394|12439978|P4|NOT COMPLETED|Follow-up Period||10
5054364|NCT01928394|12439979|P3|NOT COMPLETED|Follow-up Period||3
5054365|NCT01928394|12439980|P2|NOT COMPLETED|Follow-up Period||0
5054366|NCT01928394|12439981|P1|NOT COMPLETED|Follow-up Period||3
5054367|NCT01928394|12439959|P23|COMPLETED|Follow-up Period||36
5054368|NCT01928394|12439960|P22|COMPLETED|Follow-up Period||34
5054369|NCT01928394|12439961|P21|COMPLETED|Follow-up Period||32
5054370|NCT01928394|12439962|P20|COMPLETED|Follow-up Period||83
5054371|NCT01928394|12439963|P19|COMPLETED|Follow-up Period||76
5054372|NCT01928394|12439964|P18|COMPLETED|Follow-up Period||50
5054373|NCT01928394|12439965|P17|COMPLETED|Follow-up Period||41
5054374|NCT01928394|12439966|P16|COMPLETED|Follow-up Period||3
5054375|NCT01928394|12439967|P15|COMPLETED|Follow-up Period||66
5054376|NCT01928394|12439968|P14|COMPLETED|Follow-up Period||107
5054377|NCT01928394|12439969|P13|COMPLETED|Follow-up Period||47
5054378|NCT01928394|12439970|P12|COMPLETED|Follow-up Period||59
5054379|NCT01928394|12439971|P11|COMPLETED|Follow-up Period||19
5054380|NCT01928394|12439972|P10|COMPLETED|Follow-up Period||16
5054381|NCT01928394|12439973|P9|COMPLETED|Follow-up Period||2
5054382|NCT01928394|12439974|P8|COMPLETED|Follow-up Period||10
5054383|NCT01928394|12439975|P7|COMPLETED|Follow-up Period||40
5054384|NCT01928394|12439976|P6|COMPLETED|Follow-up Period||41
5054385|NCT01928394|12439977|P5|COMPLETED|Follow-up Period||3
5054386|NCT01928394|12439978|P4|COMPLETED|Follow-up Period||40
5054387|NCT01928394|12439979|P3|COMPLETED|Follow-up Period||15
5054388|NCT01928394|12439980|P2|COMPLETED|Follow-up Period||3
5054389|NCT01928394|12439981|P1|COMPLETED|Follow-up Period||12
5054390|NCT01928394|12439959|P23|STARTED|Follow-up Period||42
5054391|NCT01928394|12439960|P22|STARTED|Follow-up Period||43
5054392|NCT01928394|12439961|P21|STARTED|Follow-up Period||41
5054393|NCT01928394|12439962|P20|STARTED|Follow-up Period||104
5054394|NCT01928394|12439963|P19|STARTED|Follow-up Period||92
5054395|NCT01928394|12439964|P18|STARTED|Follow-up Period||58
5054396|NCT01928394|12439965|P17|STARTED|Follow-up Period||55
5054397|NCT01928394|12439966|P16|STARTED|Follow-up Period||3
5054398|NCT01928394|12439967|P15|STARTED|Follow-up Period||96
5054399|NCT01928394|12439968|P14|STARTED|Follow-up Period||145
5054400|NCT01928394|12439969|P13|STARTED|Follow-up Period||61
5054401|NCT01928394|12439970|P12|STARTED|Follow-up Period||81
5054402|NCT01928394|12439971|P11|STARTED|Follow-up Period||30
5054403|NCT01928394|12439972|P10|STARTED|Follow-up Period||18
5054404|NCT01928394|12439973|P9|STARTED|Follow-up Period||3
5054405|NCT01928394|12439974|P8|STARTED|Follow-up Period||16
5054406|NCT01928394|12439975|P7|STARTED|Follow-up Period||52
5054407|NCT01928394|12439976|P6|STARTED|Follow-up Period||49
5054408|NCT01928394|12439977|P5|STARTED|Follow-up Period||3
5054409|NCT01928394|12439978|P4|STARTED|Follow-up Period||50
5054410|NCT01928394|12439979|P3|STARTED|Follow-up Period||18
5054411|NCT01928394|12439980|P2|STARTED|Follow-up Period||3
5054412|NCT01928394|12439981|P1|STARTED|Follow-up Period||15
5054413|NCT01928394|12439959|P23|NOT COMPLETED|Treatment Period||39
5054414|NCT01928394|12439960|P22|NOT COMPLETED|Treatment Period||42
5054415|NCT01928394|12439961|P21|NOT COMPLETED|Treatment Period||40
5054416|NCT01928394|12439962|P20|NOT COMPLETED|Treatment Period||96
5054417|NCT01928394|12439963|P19|NOT COMPLETED|Treatment Period||70
5054418|NCT01928394|12439964|P18|NOT COMPLETED|Treatment Period||71
5054419|NCT01928394|12439965|P17|NOT COMPLETED|Treatment Period||50
5054420|NCT01928394|12439966|P16|NOT COMPLETED|Treatment Period||2
5054421|NCT01928394|12439967|P15|NOT COMPLETED|Treatment Period||88
5054422|NCT01928394|12439968|P14|NOT COMPLETED|Treatment Period||139
5054423|NCT01928394|12439969|P13|NOT COMPLETED|Treatment Period||55
5054424|NCT01928394|12439970|P12|NOT COMPLETED|Treatment Period||93
5054425|NCT01928394|12439971|P11|NOT COMPLETED|Treatment Period||30
5054426|NCT01928394|12439972|P10|NOT COMPLETED|Treatment Period||18
5054427|NCT01928394|12439973|P9|NOT COMPLETED|Treatment Period||3
5054428|NCT01928394|12439974|P8|NOT COMPLETED|Treatment Period||18
5054429|NCT01928394|12439975|P7|NOT COMPLETED|Treatment Period||49
5054430|NCT01928394|12439976|P6|NOT COMPLETED|Treatment Period||43
5054431|NCT01928394|12439977|P5|NOT COMPLETED|Treatment Period||3
5054432|NCT01928394|12439978|P4|NOT COMPLETED|Treatment Period||56
5054433|NCT01928394|12439979|P3|NOT COMPLETED|Treatment Period||18
5054434|NCT01928394|12439980|P2|NOT COMPLETED|Treatment Period||3
5054435|NCT01928394|12439981|P1|NOT COMPLETED|Treatment Period||18
5054436|NCT01928394|12439959|P23|COMPLETED|Treatment Period||3
5054437|NCT01928394|12439960|P22|COMPLETED|Treatment Period||1
5054438|NCT01928394|12439961|P21|COMPLETED|Treatment Period||1
5054439|NCT01928394|12439962|P20|COMPLETED|Treatment Period||8
5054440|NCT01928394|12439963|P19|COMPLETED|Treatment Period||22
5054441|NCT01928394|12439964|P18|COMPLETED|Treatment Period||7
5054442|NCT01928394|12439965|P17|COMPLETED|Treatment Period||5
5054443|NCT01928394|12439966|P16|COMPLETED|Treatment Period||1
5054444|NCT01928394|12439967|P15|COMPLETED|Treatment Period||8
5054445|NCT01928394|12439968|P14|COMPLETED|Treatment Period||8
5054446|NCT01928394|12439969|P13|COMPLETED|Treatment Period||6
5054447|NCT01928394|12439970|P12|COMPLETED|Treatment Period||5
5054448|NCT01928394|12439971|P11|COMPLETED|Treatment Period||0
5054449|NCT01928394|12439972|P10|COMPLETED|Treatment Period||0
5054450|NCT01928394|12439973|P9|COMPLETED|Treatment Period||0
5054451|NCT01928394|12439974|P8|COMPLETED|Treatment Period||0
5054452|NCT01928394|12439975|P7|COMPLETED|Treatment Period||3
5054453|NCT01928394|12439976|P6|COMPLETED|Treatment Period||6
5054454|NCT01928394|12439977|P5|COMPLETED|Treatment Period||0
5054455|NCT01928394|12439978|P4|COMPLETED|Treatment Period||3
5054456|NCT01928394|12439979|P3|COMPLETED|Treatment Period||0
5054457|NCT01928394|12439980|P2|COMPLETED|Treatment Period||0
5054458|NCT01928394|12439981|P1|COMPLETED|Treatment Period||0
5054459|NCT01928394|12439959|P23|Transition- Continued|Treatment Period||0
5054460|NCT01928394|12439960|P22|Transition- Continued|Treatment Period||0
5054461|NCT01928394|12439961|P21|Transition- Continued|Treatment Period||0
5054462|NCT01928394|12439962|P20|Transition- Continued|Treatment Period||19
5054463|NCT01928394|12439963|P19|Transition- Continued|Treatment Period||1
5054464|NCT01928394|12439964|P18|Transition- Continued|Treatment Period||0
5054465|NCT01928394|12439965|P17|Transition- Continued|Treatment Period||0
5054466|NCT01928394|12439966|P16|Transition- Continued|Treatment Period||0
5054467|NCT01928394|12439967|P15|Transition- Continued|Treatment Period||2
5054468|NCT01928394|12439968|P14|Transition- Continued|Treatment Period||0
5054469|NCT01928394|12439969|P13|Transition- Continued|Treatment Period||17
5054470|NCT01928394|12439970|P12|Transition- Continued|Treatment Period||0
5054471|NCT01928394|12439971|P11|Transition- Continued|Treatment Period||0
5054472|NCT01928394|12439972|P10|Transition- Continued|Treatment Period||1
5054473|NCT01928394|12439973|P9|Transition- Continued|Treatment Period||1
5054474|NCT01928394|12439974|P8|Transition- Continued|Treatment Period||0
5054475|NCT01928394|12439975|P7|Transition- Continued|Treatment Period||6
5054476|NCT01928394|12439976|P6|Transition- Continued|Treatment Period||3
5054477|NCT01928394|12439977|P5|Transition- Continued|Treatment Period||0
5054478|NCT01928394|12439978|P4|Transition- Continued|Treatment Period||0
5054479|NCT01928394|12439979|P3|Transition- Continued|Treatment Period||3
5054480|NCT01928394|12439980|P2|Transition- Continued|Treatment Period||0
5054481|NCT01928394|12439981|P1|Transition- Continued|Treatment Period||0
5054482|NCT01928394|12439959|P23|Transition|Treatment Period||0
5054483|NCT01928394|12439960|P22|Transition|Treatment Period||0
5054484|NCT01928394|12439961|P21|Transition|Treatment Period||0
5054485|NCT01928394|12439962|P20|Transition|Treatment Period||0
5054486|NCT01928394|12439963|P19|Transition|Treatment Period||0
5054487|NCT01928394|12439964|P18|Transition|Treatment Period||20
5054488|NCT01928394|12439965|P17|Transition|Treatment Period||0
5054489|NCT01928394|12439966|P16|Transition|Treatment Period||0
5054490|NCT01928394|12439967|P15|Transition|Treatment Period||0
5054491|NCT01928394|12439968|P14|Transition|Treatment Period||2
5054492|NCT01928394|12439969|P13|Transition|Treatment Period||0
5054493|NCT01928394|12439970|P12|Transition|Treatment Period||17
5054494|NCT01928394|12439971|P11|Transition|Treatment Period||0
5054495|NCT01928394|12439972|P10|Transition|Treatment Period||0
5054496|NCT01928394|12439973|P9|Transition|Treatment Period||0
5054497|NCT01928394|12439974|P8|Transition|Treatment Period||2
5054498|NCT01928394|12439975|P7|Transition|Treatment Period||0
5054499|NCT01928394|12439976|P6|Transition|Treatment Period||0
5054500|NCT01928394|12439977|P5|Transition|Treatment Period||0
5054501|NCT01928394|12439978|P4|Transition|Treatment Period||9
5054502|NCT01928394|12439979|P3|Transition|Treatment Period||0
5054503|NCT01928394|12439980|P2|Transition|Treatment Period||0
5054504|NCT01928394|12439981|P1|Transition|Treatment Period||3
5054505|NCT01928394|12439959|P23|STARTED|Treatment Period||42
5054506|NCT01928394|12439960|P22|STARTED|Treatment Period||43
5054507|NCT01928394|12439961|P21|STARTED|Treatment Period||41
5054508|NCT01928394|12439962|P20|STARTED|Treatment Period||104
5054509|NCT01928394|12439963|P19|STARTED|Treatment Period||92
5054510|NCT01928394|12439964|P18|STARTED|Treatment Period||78
5054511|NCT01928394|12439965|P17|STARTED|Treatment Period||55
5054512|NCT01928394|12439966|P16|STARTED|Treatment Period||3
5054513|NCT01928394|12439967|P15|STARTED|Treatment Period||96
5054514|NCT01928394|12439968|P14|STARTED|Treatment Period||147
5054515|NCT01928394|12439969|P13|STARTED|Treatment Period||61
5054516|NCT01928394|12439970|P12|STARTED|Treatment Period||98
5054517|NCT01928394|12439971|P11|STARTED|Treatment Period||30
5054518|NCT01928394|12439972|P10|STARTED|Treatment Period||18
5054519|NCT01928394|12439973|P9|STARTED|Treatment Period||3
5054520|NCT01928394|12439974|P8|STARTED|Treatment Period||18
5054521|NCT01928394|12439975|P7|STARTED|Treatment Period||52
5054522|NCT01928394|12439976|P6|STARTED|Treatment Period||49
5054523|NCT01928394|12439977|P5|STARTED|Treatment Period||3
5054524|NCT01928394|12439978|P4|STARTED|Treatment Period||59
5054525|NCT01928394|12439979|P3|STARTED|Treatment Period||18
5054526|NCT01928394|12439980|P2|STARTED|Treatment Period||3
5054527|NCT01928394|12439981|P1|STARTED|Treatment Period||18
5054528|NCT01928381|12440029|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054529|NCT01928381|12440030|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054530|NCT01928381|12440031|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054531|NCT01928381|12440032|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054532|NCT01928381|12440033|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
5054533|NCT01928381|12440034|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054534|NCT01928381|12440035|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
5054535|NCT01928381|12440029|P7|COMPLETED|Part 2 - Post Third Intervention||5
5054536|NCT01928381|12440030|P6|COMPLETED|Part 2 - Post Third Intervention||5
5054537|NCT01928381|12440031|P5|COMPLETED|Part 2 - Post Third Intervention||3
5054538|NCT01928381|12440032|P4|COMPLETED|Part 2 - Post Third Intervention||4
5054539|NCT01928381|12440033|P3|COMPLETED|Part 2 - Post Third Intervention||3
5054540|NCT01928381|12440034|P2|COMPLETED|Part 2 - Post Third Intervention||5
5054541|NCT01928381|12440035|P1|COMPLETED|Part 2 - Post Third Intervention||0
5054542|NCT01928381|12440029|P7|STARTED|Part 2 - Post Third Intervention||5
5054543|NCT01928381|12440030|P6|STARTED|Part 2 - Post Third Intervention||5
5054544|NCT01928381|12440031|P5|STARTED|Part 2 - Post Third Intervention||3
5054545|NCT01928381|12440032|P4|STARTED|Part 2 - Post Third Intervention||4
5054546|NCT01928381|12440033|P3|STARTED|Part 2 - Post Third Intervention||4
5054547|NCT01928381|12440034|P2|STARTED|Part 2 - Post Third Intervention||5
5054548|NCT01928381|12440035|P1|STARTED|Part 2 - Post Third Intervention||0
5054549|NCT01928381|12440029|P7|NOT COMPLETED|Part 2 - Third Intervention||0
5054550|NCT01928381|12440030|P6|NOT COMPLETED|Part 2 - Third Intervention||0
5054551|NCT01928381|12440031|P5|NOT COMPLETED|Part 2 - Third Intervention||0
5054552|NCT01928381|12440032|P4|NOT COMPLETED|Part 2 - Third Intervention||0
5054553|NCT01928381|12440033|P3|NOT COMPLETED|Part 2 - Third Intervention||0
5054554|NCT01928381|12440034|P2|NOT COMPLETED|Part 2 - Third Intervention||0
5054555|NCT01928381|12440035|P1|NOT COMPLETED|Part 2 - Third Intervention||0
5054556|NCT01928381|12440029|P7|COMPLETED|Part 2 - Third Intervention||5
5054557|NCT01928381|12440030|P6|COMPLETED|Part 2 - Third Intervention||5
5054558|NCT01928381|12440031|P5|COMPLETED|Part 2 - Third Intervention||3
5054559|NCT01928381|12440032|P4|COMPLETED|Part 2 - Third Intervention||4
5054560|NCT01928381|12440033|P3|COMPLETED|Part 2 - Third Intervention||4
5054561|NCT01928381|12440034|P2|COMPLETED|Part 2 - Third Intervention||5
5054562|NCT01928381|12440035|P1|COMPLETED|Part 2 - Third Intervention||0
5054563|NCT01928381|12440029|P7|STARTED|Part 2 - Third Intervention||5
5054564|NCT01928381|12440030|P6|STARTED|Part 2 - Third Intervention||5
5054565|NCT01928381|12440031|P5|STARTED|Part 2 - Third Intervention||3
5054566|NCT01928381|12440032|P4|STARTED|Part 2 - Third Intervention||4
5054567|NCT01928381|12440033|P3|STARTED|Part 2 - Third Intervention||4
5054568|NCT01928381|12440034|P2|STARTED|Part 2 - Third Intervention||5
5054569|NCT01928381|12440035|P1|STARTED|Part 2 - Third Intervention||0
5054570|NCT01928381|12440029|P7|NOT COMPLETED|Washout Second Intervention||0
5054571|NCT01928381|12440030|P6|NOT COMPLETED|Washout Second Intervention||0
5054572|NCT01928381|12440031|P5|NOT COMPLETED|Washout Second Intervention||0
5054573|NCT01928381|12440032|P4|NOT COMPLETED|Washout Second Intervention||0
5054574|NCT01928381|12440033|P3|NOT COMPLETED|Washout Second Intervention||0
5054575|NCT01928381|12440034|P2|NOT COMPLETED|Washout Second Intervention||0
5054576|NCT01928381|12440035|P1|NOT COMPLETED|Washout Second Intervention||0
5054577|NCT01928381|12440029|P7|COMPLETED|Washout Second Intervention||5
5054578|NCT01928381|12440030|P6|COMPLETED|Washout Second Intervention||5
5054579|NCT01928381|12440031|P5|COMPLETED|Washout Second Intervention||3
5054580|NCT01928381|12440032|P4|COMPLETED|Washout Second Intervention||4
5054581|NCT01928381|12440033|P3|COMPLETED|Washout Second Intervention||4
5054582|NCT01928381|12440034|P2|COMPLETED|Washout Second Intervention||5
5054583|NCT01928381|12440035|P1|COMPLETED|Washout Second Intervention||0
5054584|NCT01928381|12440029|P7|STARTED|Washout Second Intervention||5
5054585|NCT01928381|12440030|P6|STARTED|Washout Second Intervention||5
5054586|NCT01928381|12440031|P5|STARTED|Washout Second Intervention||3
5054587|NCT01928381|12440032|P4|STARTED|Washout Second Intervention||4
5054588|NCT01928381|12440033|P3|STARTED|Washout Second Intervention||4
5054589|NCT01928381|12440034|P2|STARTED|Washout Second Intervention||5
5054590|NCT01928381|12440035|P1|STARTED|Washout Second Intervention||0
5054591|NCT01928381|12440029|P7|NOT COMPLETED|Part 2 - Second Intervention||0
5054592|NCT01928381|12440030|P6|NOT COMPLETED|Part 2 - Second Intervention||0
5054593|NCT01928381|12440031|P5|NOT COMPLETED|Part 2 - Second Intervention||0
5054594|NCT01928381|12440032|P4|NOT COMPLETED|Part 2 - Second Intervention||1
5054595|NCT01928381|12440033|P3|NOT COMPLETED|Part 2 - Second Intervention||0
5054596|NCT01928381|12440034|P2|NOT COMPLETED|Part 2 - Second Intervention||1
5054597|NCT01928381|12440035|P1|NOT COMPLETED|Part 2 - Second Intervention||0
5054598|NCT01928381|12440029|P7|COMPLETED|Part 2 - Second Intervention||5
5054599|NCT01928381|12440030|P6|COMPLETED|Part 2 - Second Intervention||5
5054600|NCT01928381|12440031|P5|COMPLETED|Part 2 - Second Intervention||3
5054601|NCT01928381|12440032|P4|COMPLETED|Part 2 - Second Intervention||4
5054602|NCT01928381|12440033|P3|COMPLETED|Part 2 - Second Intervention||4
5054603|NCT01928381|12440034|P2|COMPLETED|Part 2 - Second Intervention||5
5054604|NCT01928381|12440035|P1|COMPLETED|Part 2 - Second Intervention||0
5054605|NCT01928381|12440029|P7|STARTED|Part 2 - Second Intervention||5
5054606|NCT01928381|12440030|P6|STARTED|Part 2 - Second Intervention||5
5054607|NCT01928381|12440031|P5|STARTED|Part 2 - Second Intervention||3
5054608|NCT01928381|12440032|P4|STARTED|Part 2 - Second Intervention||5
5054609|NCT01928381|12440033|P3|STARTED|Part 2 - Second Intervention||4
5054610|NCT01928381|12440034|P2|STARTED|Part 2 - Second Intervention||6
5054611|NCT01928381|12440035|P1|STARTED|Part 2 - Second Intervention||0
5054612|NCT01928381|12440029|P7|NOT COMPLETED|Washout First Intervention||0
5054613|NCT01928381|12440030|P6|NOT COMPLETED|Washout First Intervention||0
5054614|NCT01928381|12440031|P5|NOT COMPLETED|Washout First Intervention||1
5054615|NCT01928381|12440032|P4|NOT COMPLETED|Washout First Intervention||0
5054616|NCT01928381|12440033|P3|NOT COMPLETED|Washout First Intervention||0
5054617|NCT01928381|12440034|P2|NOT COMPLETED|Washout First Intervention||0
5054618|NCT01928381|12440035|P1|NOT COMPLETED|Washout First Intervention||0
5054619|NCT01928381|12440029|P7|COMPLETED|Washout First Intervention||5
5054620|NCT01928381|12440030|P6|COMPLETED|Washout First Intervention||5
5054621|NCT01928381|12440031|P5|COMPLETED|Washout First Intervention||3
5054622|NCT01928381|12440032|P4|COMPLETED|Washout First Intervention||5
5054623|NCT01928381|12440033|P3|COMPLETED|Washout First Intervention||4
5054624|NCT01928381|12440034|P2|COMPLETED|Washout First Intervention||6
5054625|NCT01928381|12440035|P1|COMPLETED|Washout First Intervention||0
5054626|NCT01928381|12440029|P7|STARTED|Washout First Intervention||5
5054627|NCT01928381|12440030|P6|STARTED|Washout First Intervention||5
5054628|NCT01928381|12440031|P5|STARTED|Washout First Intervention||4
5054629|NCT01928381|12440032|P4|STARTED|Washout First Intervention||5
5054630|NCT01928381|12440033|P3|STARTED|Washout First Intervention||4
5054631|NCT01928381|12440034|P2|STARTED|Washout First Intervention||6
5054632|NCT01928381|12440035|P1|STARTED|Washout First Intervention||0
5054633|NCT01928381|12440029|P7|NOT COMPLETED|Part 2 - First Intervention||1
5054634|NCT01928381|12440030|P6|NOT COMPLETED|Part 2 - First Intervention||1
5054635|NCT01928381|12440031|P5|NOT COMPLETED|Part 2 - First Intervention||0
5054636|NCT01928381|12440032|P4|NOT COMPLETED|Part 2 - First Intervention||1
5054637|NCT01928381|12440033|P3|NOT COMPLETED|Part 2 - First Intervention||2
5054638|NCT01928381|12440034|P2|NOT COMPLETED|Part 2 - First Intervention||0
5054639|NCT01928381|12440035|P1|NOT COMPLETED|Part 2 - First Intervention||0
5054640|NCT01928381|12440029|P7|COMPLETED|Part 2 - First Intervention||5
5054641|NCT01928381|12440030|P6|COMPLETED|Part 2 - First Intervention||5
5054642|NCT01928381|12440031|P5|COMPLETED|Part 2 - First Intervention||4
5054643|NCT01928381|12440032|P4|COMPLETED|Part 2 - First Intervention||5
5054644|NCT01928381|12440033|P3|COMPLETED|Part 2 - First Intervention||4
5054645|NCT01928381|12440034|P2|COMPLETED|Part 2 - First Intervention||6
5054646|NCT01928381|12440035|P1|COMPLETED|Part 2 - First Intervention||0
5054647|NCT01928381|12440029|P7|STARTED|Part 2 - First Intervention||6
5054648|NCT01928381|12440030|P6|STARTED|Part 2 - First Intervention||6
5054649|NCT01928381|12440031|P5|STARTED|Part 2 - First Intervention||4
5054650|NCT01928381|12440032|P4|STARTED|Part 2 - First Intervention||6
5054651|NCT01928381|12440033|P3|STARTED|Part 2 - First Intervention||6
5054652|NCT01928381|12440034|P2|STARTED|Part 2 - First Intervention||6
5054653|NCT01928381|12440035|P1|STARTED|Part 2 - First Intervention||0
5054654|NCT01928381|12440029|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054655|NCT01928381|12440030|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054656|NCT01928381|12440031|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054657|NCT01928381|12440032|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054658|NCT01928381|12440033|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054659|NCT01928381|12440034|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054660|NCT01928381|12440035|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
5054661|NCT01928381|12440029|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054662|NCT01928381|12440030|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054663|NCT01928381|12440031|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054664|NCT01928381|12440032|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054665|NCT01928381|12440033|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054666|NCT01928381|12440034|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
5054667|NCT01928381|12440035|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
5054668|NCT01928381|12440029|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
5054669|NCT01928381|12440030|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
5054670|NCT01928381|12440031|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
5054671|NCT01928381|12440032|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
5054672|NCT01928381|12440033|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
5054673|NCT01928381|12440034|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
5054674|NCT01928381|12440035|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
5054675|NCT01928381|12440029|P7|NOT COMPLETED|Part 1 - Pain Training||0
5054676|NCT01928381|12440030|P6|NOT COMPLETED|Part 1 - Pain Training||0
5054677|NCT01928381|12440031|P5|NOT COMPLETED|Part 1 - Pain Training||0
5054678|NCT01928381|12440032|P4|NOT COMPLETED|Part 1 - Pain Training||0
5054679|NCT01928381|12440033|P3|NOT COMPLETED|Part 1 - Pain Training||0
5054680|NCT01928381|12440034|P2|NOT COMPLETED|Part 1 - Pain Training||0
5054681|NCT01928381|12440035|P1|NOT COMPLETED|Part 1 - Pain Training||35
5054682|NCT01928381|12440029|P7|COMPLETED|Part 1 - Pain Training||0
5054683|NCT01928381|12440030|P6|COMPLETED|Part 1 - Pain Training||0
5054684|NCT01928381|12440031|P5|COMPLETED|Part 1 - Pain Training||0
5054685|NCT01928381|12440032|P4|COMPLETED|Part 1 - Pain Training||0
5054686|NCT01928381|12440033|P3|COMPLETED|Part 1 - Pain Training||0
5054687|NCT01928381|12440034|P2|COMPLETED|Part 1 - Pain Training||0
5054688|NCT01928381|12440035|P1|COMPLETED|Part 1 - Pain Training||48
5054689|NCT01928381|12440029|P7|STARTED|Part 1 - Pain Training||0
5054690|NCT01928381|12440030|P6|STARTED|Part 1 - Pain Training||0
5054691|NCT01928381|12440031|P5|STARTED|Part 1 - Pain Training||0
5054692|NCT01928381|12440032|P4|STARTED|Part 1 - Pain Training||0
5054693|NCT01928381|12440033|P3|STARTED|Part 1 - Pain Training||0
5054694|NCT01928381|12440034|P2|STARTED|Part 1 - Pain Training||0
5054695|NCT01928381|12440035|P1|STARTED|Part 1 - Pain Training||83
5054696|NCT01928381|12440029|P7|NOT COMPLETED|Screening for Pain Training||0
5054697|NCT01928381|12440030|P6|NOT COMPLETED|Screening for Pain Training||0
5054698|NCT01928381|12440031|P5|NOT COMPLETED|Screening for Pain Training||0
5054699|NCT01928381|12440032|P4|NOT COMPLETED|Screening for Pain Training||0
5054700|NCT01928381|12440033|P3|NOT COMPLETED|Screening for Pain Training||0
5054701|NCT01928381|12440034|P2|NOT COMPLETED|Screening for Pain Training||0
5054702|NCT01928381|12440035|P1|NOT COMPLETED|Screening for Pain Training||60
5054703|NCT01928381|12440029|P7|COMPLETED|Screening for Pain Training||0
5054704|NCT01928381|12440030|P6|COMPLETED|Screening for Pain Training||0
5054705|NCT01928381|12440031|P5|COMPLETED|Screening for Pain Training||0
5054706|NCT01928381|12440032|P4|COMPLETED|Screening for Pain Training||0
5054707|NCT01928381|12440033|P3|COMPLETED|Screening for Pain Training||0
5054708|NCT01928381|12440034|P2|COMPLETED|Screening for Pain Training||0
5054709|NCT01928381|12440035|P1|COMPLETED|Screening for Pain Training||83
5054710|NCT01928381|12440029|P7|STARTED|Screening for Pain Training||0
5054711|NCT01928381|12440030|P6|STARTED|Screening for Pain Training||0
5054712|NCT01928381|12440031|P5|STARTED|Screening for Pain Training||0
5054713|NCT01928381|12440032|P4|STARTED|Screening for Pain Training||0
5054714|NCT01928381|12440033|P3|STARTED|Screening for Pain Training||0
5054715|NCT01928381|12440034|P2|STARTED|Screening for Pain Training||0
5054716|NCT01928381|12440035|P1|STARTED|Screening for Pain Training||143
5054717|NCT01928329|12440050|P2|NOT COMPLETED|Overall Study||14
5054718|NCT01928329|12440051|P1|NOT COMPLETED|Overall Study||12
5054719|NCT01928329|12440050|P2|COMPLETED|Overall Study||25
5054720|NCT01928329|12440051|P1|COMPLETED|Overall Study||28
5054721|NCT01928329|12440050|P2|STARTED|Overall Study||39
5054722|NCT01928329|12440051|P1|STARTED|Overall Study||40
5054723|NCT01928290|12440065|P2|NOT COMPLETED|Overall Study||0
5054724|NCT01928290|12440066|P1|NOT COMPLETED|Overall Study||0
5054725|NCT01928290|12440065|P2|COMPLETED|Overall Study||26
5054726|NCT01928290|12440066|P1|COMPLETED|Overall Study||41
5054727|NCT01928290|12440065|P2|STARTED|Overall Study||26
5054728|NCT01928290|12440066|P1|STARTED|Overall Study||41
5054729|NCT01928225|12440078|P2|NOT COMPLETED|Overall Study||3
5054730|NCT01928225|12440079|P1|NOT COMPLETED|Overall Study||3
5054731|NCT01928225|12440078|P2|COMPLETED|Overall Study||87
5054732|NCT01928225|12440079|P1|COMPLETED|Overall Study||87
5054733|NCT01928225|12440078|P2|STARTED|Overall Study||90
5054734|NCT01928225|12440079|P1|STARTED|Overall Study||90
5054735|NCT01928186|12440087|P1|NOT COMPLETED|Overall Study||0
5054736|NCT01928186|12440087|P1|COMPLETED|Overall Study||28
5054737|NCT01928186|12440087|P1|STARTED|Overall Study||28
5054738|NCT01928082|12440101|P1|NOT COMPLETED|Overall Study||1
5054739|NCT01928082|12440101|P1|COMPLETED|Overall Study||0
5054740|NCT01928082|12440101|P1|STARTED|Overall Study||1
5054741|NCT01928030|12440119|P3|NOT COMPLETED|Overall Study||0
5054742|NCT01928030|12440120|P2|NOT COMPLETED|Overall Study||0
5054743|NCT01928030|12440121|P1|NOT COMPLETED|Overall Study||0
5054744|NCT01928030|12440119|P3|COMPLETED|Overall Study||0
5054745|NCT01928030|12440120|P2|COMPLETED|Overall Study||0
5054746|NCT01928030|12440121|P1|COMPLETED|Overall Study||3
5054747|NCT01928030|12440119|P3|STARTED|Overall Study||0
5054748|NCT01928030|12440120|P2|STARTED|Overall Study||0
5054749|NCT01928030|12440121|P1|STARTED|Overall Study||3
5054750|NCT01927887|12440128|P1|NOT COMPLETED|Overall Study||0
5054751|NCT01927887|12440128|P1|COMPLETED|Overall Study||12
5054752|NCT01927887|12440128|P1|STARTED|Overall Study||12
5054753|NCT01927861|12440135|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
5054754|NCT01927861|12440136|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
5054755|NCT01927861|12440135|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
5054756|NCT01927861|12440136|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
5054757|NCT01927861|12440135|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
5054758|NCT01927861|12440136|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
5054759|NCT01927861|12440135|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
5054760|NCT01927861|12440136|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
5054761|NCT01927861|12440135|P2|COMPLETED|Extension Phase (104 Weeks)||23
5054762|NCT01927861|12440136|P1|COMPLETED|Extension Phase (104 Weeks)||25
5054763|NCT01927861|12440135|P2|STARTED|Extension Phase (104 Weeks)||26
5054764|NCT01927861|12440136|P1|STARTED|Extension Phase (104 Weeks)||25
5054765|NCT01927861|12440135|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
5054766|NCT01927861|12440136|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
5054767|NCT01927861|12440135|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
5054768|NCT01927861|12440136|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
5054769|NCT01927861|12440135|P2|STARTED|Pivotal Phase (104 Weeks)||26
5054770|NCT01927861|12440136|P1|STARTED|Pivotal Phase (104 Weeks)||25
5054771|NCT01927757|12440274|P1|NOT COMPLETED|Overall Study||23
5054772|NCT01927757|12440274|P1|COMPLETED|Overall Study||67
5054773|NCT01927757|12440274|P1|Received Etanercept|Overall Study||88
5054774|NCT01927757|12440274|P1|STARTED|Overall Study||90
5054775|NCT01927718|12440292|P1|NOT COMPLETED|Overall Study||0
5054776|NCT01927718|12440292|P1|COMPLETED|Overall Study||10
5054777|NCT01927718|12440292|P1|STARTED|Overall Study||10
5054778|NCT01927627|12440296|P1|NOT COMPLETED|Overall Study||5
5054779|NCT01927627|12440296|P1|COMPLETED|Overall Study||37
5054780|NCT01927627|12440296|P1|STARTED|Overall Study||42
5054781|NCT01927575|12440301|P1|NOT COMPLETED|Overall Study||0
5054782|NCT01927575|12440301|P1|COMPLETED|Overall Study||1
5054783|NCT01927575|12440301|P1|STARTED|Overall Study||1
5054784|NCT01927562|12440309|P1|NOT COMPLETED|Overall Study||38
5054785|NCT01927562|12440309|P1|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
5054786|NCT01927562|12440309|P1|STARTED|Overall Study||57
5054787|NCT01927419|12440315|P2|NOT COMPLETED|Overall Study||28
5054788|NCT01927419|12440316|P1|NOT COMPLETED|Overall Study||70
5054789|NCT01927419|12440315|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
5054790|NCT01927419|12440316|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
5054791|NCT01927419|12440315|P2|Received Treatment|Overall Study||46
5054792|NCT01927419|12440316|P1|Received Treatment|Overall Study||94
5054793|NCT01927419|12440315|P2|STARTED|Overall Study||47
5054794|NCT01927419|12440316|P1|STARTED|Overall Study||95
5054795|NCT01927120|12440332|P1|NOT COMPLETED|Overall Study||10
5054796|NCT01927120|12440332|P1|COMPLETED|Overall Study||10
5054797|NCT01927120|12440332|P1|STARTED|Overall Study||20
5054798|NCT01927055|12440350|P3|NOT COMPLETED|Double-Blind||13
5054799|NCT01927055|12440351|P2|NOT COMPLETED|Double-Blind||11
5054800|NCT01927055|12440352|P1|NOT COMPLETED|Double-Blind||0
5054801|NCT01927055|12440350|P3|COMPLETED|Double-Blind||10
5054802|NCT01927055|12440351|P2|COMPLETED|Double-Blind||11
5054803|NCT01927055|12440352|P1|COMPLETED|Double-Blind||0
5054804|NCT01927055|12440350|P3|STARTED|Double-Blind||23
5054805|NCT01927055|12440351|P2|STARTED|Double-Blind||22
5054806|NCT01927055|12440352|P1|STARTED|Double-Blind||0
5054807|NCT01927055|12440350|P3|NOT COMPLETED|Open-label||0
5054808|NCT01927055|12440351|P2|NOT COMPLETED|Open-label||0
5054809|NCT01927055|12440352|P1|NOT COMPLETED|Open-label||16
5054810|NCT01927055|12440350|P3|COMPLETED|Open-label||0
5054811|NCT01927055|12440351|P2|COMPLETED|Open-label||0
5054812|NCT01927055|12440352|P1|COMPLETED|Open-label||45
5054813|NCT01927055|12440350|P3|STARTED|Open-label||0
5054814|NCT01927055|12440351|P2|STARTED|Open-label||0
5054815|NCT01927055|12440352|P1|STARTED|Open-label||61
5054816|NCT01926977|12440361|P2|NOT COMPLETED|Overall Study||0
5054817|NCT01926977|12440362|P1|NOT COMPLETED|Overall Study||0
5054818|NCT01926977|12440361|P2|COMPLETED|Overall Study||53
5054819|NCT01926977|12440362|P1|COMPLETED|Overall Study||47
5054820|NCT01926977|12440361|P2|STARTED|Overall Study||53
5054821|NCT01926977|12440362|P1|STARTED|Overall Study||47
5054822|NCT01926886|12440370|P2|NOT COMPLETED|Overall Study||0
5054823|NCT01926886|12440371|P1|NOT COMPLETED|Overall Study||32
5054824|NCT01926886|12440370|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
5054825|NCT01926886|12440371|P1|COMPLETED|Overall Study||70
5054826|NCT01926886|12440370|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
5054827|NCT01926886|12440371|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
5054828|NCT01926886|12440370|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
5054829|NCT01926886|12440371|P1|STARTED|Overall Study||102
5054830|NCT01926782|12440390|P6|NOT COMPLETED|Overall Study||41
5054831|NCT01926782|12440391|P5|NOT COMPLETED|Overall Study||8
5054832|NCT01926782|12440392|P4|NOT COMPLETED|Overall Study||20
5054833|NCT01926782|12440393|P3|NOT COMPLETED|Overall Study||40
5054834|NCT01926782|12440394|P2|NOT COMPLETED|Overall Study||13
5054835|NCT01926782|12440395|P1|NOT COMPLETED|Overall Study||28
5054836|NCT01926782|12440390|P6|COMPLETED|Overall Study||105
5054837|NCT01926782|12440391|P5|COMPLETED|Overall Study||29
5054838|NCT01926782|12440392|P4|COMPLETED|Overall Study||53
5054839|NCT01926782|12440393|P3|COMPLETED|Overall Study||272
5054840|NCT01926782|12440394|P2|COMPLETED|Overall Study||65
5054841|NCT01926782|12440395|P1|COMPLETED|Overall Study||129
5054842|NCT01926782|12440390|P6|Completed 24 Weeks Treatment Period|Overall Study||120
5054843|NCT01926782|12440391|P5|Completed 24 Weeks Treatment Period|Overall Study||31
5054844|NCT01926782|12440392|P4|Completed 24 Weeks Treatment Period|Overall Study||58
5054845|NCT01926782|12440393|P3|Completed 24 Weeks Treatment Period|Overall Study||285
5054846|NCT01926782|12440394|P2|Completed 24 Weeks Treatment Period|Overall Study||68
5054847|NCT01926782|12440395|P1|Completed 24 Weeks Treatment Period|Overall Study||137
5054848|NCT01926782|12440390|P6|Treated|Overall Study||146
5054849|NCT01926782|12440391|P5|Treated|Overall Study||37
5054850|NCT01926782|12440392|P4|Treated|Overall Study||72
5054851|NCT01926782|12440393|P3|Treated|Overall Study||312
5054852|NCT01926782|12440394|P2|Treated|Overall Study||78
5054853|NCT01926782|12440395|P1|Treated|Overall Study||157
5054854|NCT01926782|12440390|P6|STARTED|Overall Study||146
5054855|NCT01926782|12440391|P5|STARTED|Overall Study||37
5054856|NCT01926782|12440392|P4|STARTED|Overall Study||73
5054857|NCT01926782|12440393|P3|STARTED|Overall Study||312
5054858|NCT01926782|12440394|P2|STARTED|Overall Study||78
5054859|NCT01926782|12440395|P1|STARTED|Overall Study||157
5054860|NCT01926626|12440544|P1|NOT COMPLETED|Overall Study||22
5054861|NCT01926626|12440544|P1|COMPLETED|Overall Study||16
5054862|NCT01926626|12440544|P1|Received Moclobemide|Overall Study||37
5054863|NCT01926626|12440544|P1|STARTED|Overall Study||38
5054864|NCT01926509|12440558|P4|NOT COMPLETED|Overall Study||0
5054865|NCT01926509|12440559|P3|NOT COMPLETED|Overall Study||0
5054866|NCT01926509|12440560|P2|NOT COMPLETED|Overall Study||0
5054867|NCT01926509|12440561|P1|NOT COMPLETED|Overall Study||1
5054868|NCT01926509|12440558|P4|COMPLETED|Overall Study||6
5054869|NCT01926509|12440559|P3|COMPLETED|Overall Study||5
5054870|NCT01926509|12440560|P2|COMPLETED|Overall Study||6
5054871|NCT01926509|12440561|P1|COMPLETED|Overall Study||5
5054872|NCT01926509|12440558|P4|STARTED|Overall Study||6
5054873|NCT01926509|12440559|P3|STARTED|Overall Study||5
5054874|NCT01926509|12440560|P2|STARTED|Overall Study||6
5054875|NCT01926509|12440561|P1|STARTED|Overall Study||6
5054876|NCT01926496|12440580|P2|NOT COMPLETED|Overall Study||48
5054877|NCT01926496|12440581|P1|NOT COMPLETED|Overall Study||37
5054878|NCT01926496|12440580|P2|COMPLETED|Overall Study||197
5054879|NCT01926496|12440581|P1|COMPLETED|Overall Study||203
5054880|NCT01926496|12440580|P2|STARTED|Overall Study||245
5054881|NCT01926496|12440581|P1|STARTED|Overall Study||240
5054882|NCT01926444|12440601|P4|NOT COMPLETED|Overall Study||2
5054883|NCT01926444|12440602|P3|NOT COMPLETED|Overall Study||4
5054884|NCT01926444|12440603|P2|NOT COMPLETED|Overall Study||0
5054885|NCT01926444|12440604|P1|NOT COMPLETED|Overall Study||0
5054886|NCT01926444|12440601|P4|COMPLETED|Overall Study||101
5054887|NCT01926444|12440602|P3|COMPLETED|Overall Study||53
5054888|NCT01926444|12440603|P2|COMPLETED|Overall Study||52
5054889|NCT01926444|12440604|P1|COMPLETED|Overall Study||56
5054890|NCT01926444|12440601|P4|STARTED|Overall Study||103
5054891|NCT01926444|12440602|P3|STARTED|Overall Study||57
5054892|NCT01926444|12440603|P2|STARTED|Overall Study||52
5054893|NCT01926444|12440604|P1|STARTED|Overall Study||56
5054894|NCT01926119|12440646|P1|NOT COMPLETED|Overall Study||1
5054895|NCT01926119|12440646|P1|COMPLETED|Overall Study||3
5054896|NCT01926119|12440646|P1|STARTED|Overall Study||4
5054897|NCT01926028|12440659|P3|NOT COMPLETED|Overall Study||2
5054898|NCT01926028|12440660|P2|NOT COMPLETED|Overall Study||22
5054899|NCT01926028|12440661|P1|NOT COMPLETED|Overall Study||21
5054900|NCT01926028|12440659|P3|COMPLETED|Overall Study||12
5054901|NCT01926028|12440660|P2|COMPLETED|Overall Study||67
5054902|NCT01926028|12440661|P1|COMPLETED|Overall Study||64
5054903|NCT01926028|12440659|P3|STARTED|Overall Study||14
5054904|NCT01926028|12440660|P2|STARTED|Overall Study||89
5054905|NCT01926028|12440661|P1|STARTED|Overall Study||85
5054906|NCT01926015|12440697|P2|NOT COMPLETED|Overall Study||1
5054907|NCT01926015|12440698|P1|NOT COMPLETED|Overall Study||2
5054908|NCT01926015|12440697|P2|COMPLETED|Overall Study||95
5054909|NCT01926015|12440698|P1|COMPLETED|Overall Study||94
5054910|NCT01926015|12440697|P2|Received >=1 Vaccination|Overall Study||96
5054911|NCT01926015|12440698|P1|Received >=1 Vaccination|Overall Study||94
5054912|NCT01926015|12440697|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
5054913|NCT01926015|12440698|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
5054914|NCT01925989|12440730|P3|NOT COMPLETED|Period 2||0
5054915|NCT01925989|12440731|P2|NOT COMPLETED|Period 2||0
5054916|NCT01925989|12440732|P1|NOT COMPLETED|Period 2||0
5054917|NCT01925989|12440730|P3|COMPLETED|Period 2||12
5054918|NCT01925989|12440731|P2|COMPLETED|Period 2||6
5054919|NCT01925989|12440732|P1|COMPLETED|Period 2||6
5054920|NCT01925989|12440730|P3|STARTED|Period 2||12
5054921|NCT01925989|12440731|P2|STARTED|Period 2||6
5054922|NCT01925989|12440732|P1|STARTED|Period 2||6
5054923|NCT01925989|12440730|P3|NOT COMPLETED|Period 1||0
5054924|NCT01925989|12440731|P2|NOT COMPLETED|Period 1||2
5054925|NCT01925989|12440732|P1|NOT COMPLETED|Period 1||1
5054926|NCT01925989|12440730|P3|COMPLETED|Period 1||12
5054927|NCT01925989|12440731|P2|COMPLETED|Period 1||6
5054928|NCT01925989|12440732|P1|COMPLETED|Period 1||6
5054929|NCT01925989|12440730|P3|Received at Least 1 Dose of Study Drug|Period 1||0
5054930|NCT01925989|12440731|P2|Received at Least 1 Dose of Study Drug|Period 1||8
5054931|NCT01925989|12440732|P1|Received at Least 1 Dose of Study Drug|Period 1||7
5054932|NCT01925989|12440730|P3|STARTED|Period 1||12
5054933|NCT01925989|12440731|P2|STARTED|Period 1||8
5054934|NCT01925989|12440732|P1|STARTED|Period 1||7
5054935|NCT01925950|12440752|P2|NOT COMPLETED|Part 2||0
5054936|NCT01925950|12440753|P1|NOT COMPLETED|Part 2||1
5054937|NCT01925950|12440752|P2|COMPLETED|Part 2||0
5054938|NCT01925950|12440753|P1|COMPLETED|Part 2||0
5054939|NCT01925950|12440752|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
5054940|NCT01925950|12440753|P1|STARTED|Part 2||1
5054941|NCT01925950|12440752|P2|NOT COMPLETED|Part 1||0
5054942|NCT01925950|12440753|P1|NOT COMPLETED|Part 1||0
5054943|NCT01925950|12440752|P2|COMPLETED|Part 1||1
5054944|NCT01925950|12440753|P1|COMPLETED|Part 1||1
5054945|NCT01925950|12440752|P2|STARTED|Part 1||1
5054946|NCT01925950|12440753|P1|STARTED|Part 1||1
5054947|NCT01925781|12440761|P2|NOT COMPLETED|Overall Study||4
5054948|NCT01925781|12440762|P1|NOT COMPLETED|Overall Study||2
5054949|NCT01925781|12440761|P2|COMPLETED|Overall Study||1
5054950|NCT01925781|12440762|P1|COMPLETED|Overall Study||3
5054951|NCT01925781|12440761|P2|STARTED|Overall Study||5
5054952|NCT01925781|12440762|P1|STARTED|Overall Study||5
5054953|NCT01925768|12440772|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
5054954|NCT01925768|12440773|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
5054955|NCT01925768|12440772|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
5054956|NCT01925768|12440773|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
5054957|NCT01925768|12440772|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
5054958|NCT01925768|12440773|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
5054959|NCT01925768|12440772|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
5054960|NCT01925768|12440773|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
5054961|NCT01925768|12440772|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
5054962|NCT01925768|12440773|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
5054963|NCT01925768|12440772|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
5054964|NCT01925768|12440773|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
5054965|NCT01925768|12440772|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
5054966|NCT01925768|12440773|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
5054967|NCT01925768|12440772|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
5054968|NCT01925768|12440773|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
5054969|NCT01925768|12440772|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
5054970|NCT01925768|12440773|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
5054971|NCT01925703|12440821|P1|NOT COMPLETED|Overall Study||4
5054972|NCT01925703|12440821|P1|COMPLETED|Overall Study||9
5054973|NCT01925703|12440821|P1|Follow-up Completed|Overall Study||9
5054974|NCT01925703|12440821|P1|Full Iron Repletion Achieved|Overall Study||11
5054975|NCT01925703|12440821|P1|Dosing Regimen Completed|Overall Study||12
5054976|NCT01925703|12440821|P1|STARTED|Overall Study||13
5054977|NCT01925677|12440827|P1|NOT COMPLETED|Overall Study||0
5054978|NCT01925677|12440827|P1|COMPLETED|Overall Study||3
5054979|NCT01925677|12440827|P1|STARTED|Overall Study||3
5054980|NCT01925612|12440839|P5|NOT COMPLETED|Overall Study||2
5054981|NCT01925612|12440840|P4|NOT COMPLETED|Overall Study||1
5054982|NCT01925612|12440841|P3|NOT COMPLETED|Overall Study||1
5054983|NCT01925612|12440842|P2|NOT COMPLETED|Overall Study||4
5054984|NCT01925612|12440843|P1|NOT COMPLETED|Overall Study||4
5054985|NCT01925612|12440839|P5|COMPLETED|Overall Study||10
5054986|NCT01925612|12440840|P4|COMPLETED|Overall Study||10
5054987|NCT01925612|12440841|P3|COMPLETED|Overall Study||10
5054988|NCT01925612|12440842|P2|COMPLETED|Overall Study||18
5054989|NCT01925612|12440843|P1|COMPLETED|Overall Study||25
5054990|NCT01925612|12440839|P5|STARTED|Overall Study||12
5054991|NCT01925612|12440840|P4|STARTED|Overall Study||11
5054992|NCT01925612|12440841|P3|STARTED|Overall Study||11
5054993|NCT01925612|12440842|P2|STARTED|Overall Study||22
5054994|NCT01925612|12440843|P1|STARTED|Overall Study||29
5054995|NCT01925469|12440882|P2|NOT COMPLETED|Overall Study||0
5054996|NCT01925469|12440883|P1|NOT COMPLETED|Overall Study||1
5054997|NCT01925469|12440882|P2|COMPLETED|Overall Study||15
5054998|NCT01925469|12440883|P1|COMPLETED|Overall Study||14
5054999|NCT01925469|12440882|P2|STARTED|Overall Study||15
5055000|NCT01925469|12440883|P1|STARTED|Overall Study||15
5055001|NCT01925417|12440893|P1|NOT COMPLETED|Overall Study||3
5055002|NCT01925417|12440893|P1|COMPLETED|Overall Study||31
5055003|NCT01925417|12440893|P1|STARTED|Overall Study||34
5055004|NCT01925404|12440905|P4|NOT COMPLETED|Overall Study||0
5055005|NCT01925404|12440906|P3|NOT COMPLETED|Overall Study||0
5055006|NCT01925404|12440907|P2|NOT COMPLETED|Overall Study||0
5055007|NCT01925404|12440908|P1|NOT COMPLETED|Overall Study||0
5055008|NCT01925404|12440905|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
5055009|NCT01925404|12440906|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
5055010|NCT01925404|12440907|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
5055011|NCT01925404|12440908|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
5055012|NCT01925404|12440905|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
5055013|NCT01925404|12440906|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
5055014|NCT01925404|12440907|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
5055015|NCT01925404|12440908|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
5055016|NCT01925339|12440924|P2|NOT COMPLETED|Overall Study||0
5055017|NCT01925339|12440925|P1|NOT COMPLETED|Overall Study||2
5055018|NCT01925339|12440924|P2|COMPLETED|Overall Study||20
5055019|NCT01925339|12440925|P1|COMPLETED|Overall Study||18
5055020|NCT01925339|12440924|P2|STARTED|Overall Study||20
5055021|NCT01925339|12440925|P1|STARTED|Overall Study||20
5055022|NCT01925274|12440936|P3|NOT COMPLETED|Overall Study||6
5055023|NCT01925274|12440937|P2|NOT COMPLETED|Overall Study||6
5055024|NCT01925274|12440938|P1|NOT COMPLETED|Overall Study||7
5055025|NCT01925274|12440936|P3|COMPLETED|Overall Study||0
5055026|NCT01925274|12440937|P2|COMPLETED|Overall Study||0
5055027|NCT01925274|12440938|P1|COMPLETED|Overall Study||0
5055028|NCT01925274|12440936|P3|STARTED|Overall Study||6
5055029|NCT01925274|12440937|P2|STARTED|Overall Study||6
5055030|NCT01925274|12440938|P1|STARTED|Overall Study||7
5055031|NCT01925209|12441019|P4|NOT COMPLETED|Follow-up||4
5055032|NCT01925209|12441020|P3|NOT COMPLETED|Follow-up||1
5055033|NCT01925209|12441021|P2|NOT COMPLETED|Follow-up||6
5055034|NCT01925209|12441022|P1|NOT COMPLETED|Follow-up||1
5055035|NCT01925209|12441019|P4|COMPLETED|Follow-up||54
5055036|NCT01925209|12441020|P3|COMPLETED|Follow-up||55
5055037|NCT01925209|12441021|P2|COMPLETED|Follow-up||55
5055038|NCT01925209|12441022|P1|COMPLETED|Follow-up||56
5055039|NCT01925209|12441019|P4|STARTED|Follow-up||58
5055040|NCT01925209|12441020|P3|STARTED|Follow-up||56
5055041|NCT01925209|12441021|P2|STARTED|Follow-up||61
5055042|NCT01925209|12441022|P1|STARTED|Follow-up||57
5055043|NCT01925209|12441019|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
5055044|NCT01925209|12441020|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
5055045|NCT01925209|12441021|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
5055046|NCT01925209|12441022|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
5055047|NCT01925209|12441019|P4|COMPLETED|Maintenance Treatment Epoch||48
5055048|NCT01925209|12441020|P3|COMPLETED|Maintenance Treatment Epoch||50
5055049|NCT01925209|12441021|P2|COMPLETED|Maintenance Treatment Epoch||45
5055050|NCT01925209|12441022|P1|COMPLETED|Maintenance Treatment Epoch||49
5055051|NCT01925209|12441019|P4|STARTED|Maintenance Treatment Epoch||50
5055052|NCT01925209|12441020|P3|STARTED|Maintenance Treatment Epoch||52
5055053|NCT01925209|12441021|P2|STARTED|Maintenance Treatment Epoch||46
5055054|NCT01925209|12441022|P1|STARTED|Maintenance Treatment Epoch||49
5055055|NCT01925209|12441019|P4|NOT COMPLETED|Treatment Epoch||5
5055056|NCT01925209|12441020|P3|NOT COMPLETED|Treatment Epoch||7
5055057|NCT01925209|12441021|P2|NOT COMPLETED|Treatment Epoch||8
5055058|NCT01925209|12441022|P1|NOT COMPLETED|Treatment Epoch||9
5055059|NCT01925209|12441019|P4|COMPLETED|Treatment Epoch||57
5055060|NCT01925209|12441020|P3|COMPLETED|Treatment Epoch||56
5055061|NCT01925209|12441021|P2|COMPLETED|Treatment Epoch||55
5055062|NCT01925209|12441022|P1|COMPLETED|Treatment Epoch||54
5055063|NCT01925209|12441019|P4|Full Analysis Set|Treatment Epoch||62
5055064|NCT01925209|12441020|P3|Full Analysis Set|Treatment Epoch||63
5055065|NCT01925209|12441021|P2|Full Analysis Set|Treatment Epoch||63
5055066|NCT01925209|12441022|P1|Full Analysis Set|Treatment Epoch||63
5055067|NCT01925209|12441019|P4|STARTED|Treatment Epoch||62
5055068|NCT01925209|12441020|P3|STARTED|Treatment Epoch||63
5055069|NCT01925209|12441021|P2|STARTED|Treatment Epoch||63
5055070|NCT01925209|12441022|P1|STARTED|Treatment Epoch||63
5055071|NCT01925183|12441054|P2|NOT COMPLETED|Overall Study||0
5055072|NCT01925183|12441055|P1|NOT COMPLETED|Overall Study||1
5055073|NCT01925183|12441054|P2|COMPLETED|Overall Study||3
5055074|NCT01925183|12441055|P1|COMPLETED|Overall Study||2
5055075|NCT01925183|12441054|P2|STARTED|Overall Study||3
5055076|NCT01925183|12441055|P1|STARTED|Overall Study||3
5055077|NCT01925170|12441063|P1|NOT COMPLETED|Overall Study||53
5055078|NCT01925170|12441063|P1|COMPLETED|Overall Study||1585
5055079|NCT01925170|12441063|P1|STARTED|Overall Study||1638
5055080|NCT01925144|12441081|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
5055081|NCT01925144|12441081|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
5055082|NCT01925144|12441081|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
5055083|NCT01925144|12441081|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
5055084|NCT01925144|12441081|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
5055085|NCT01925144|12441081|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
5055086|NCT01925144|12441081|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
5055087|NCT01925144|12441081|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
5055088|NCT01925144|12441081|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
5055089|NCT01925014|12441094|P2|NOT COMPLETED|Overall Study||19
5055090|NCT01925014|12441095|P1|NOT COMPLETED|Overall Study||9
5055091|NCT01925014|12441094|P2|COMPLETED|Overall Study||1520
5055092|NCT01925014|12441095|P1|COMPLETED|Overall Study||1526
5055093|NCT01925014|12441094|P2|STARTED|Overall Study||1539
5055094|NCT01925014|12441095|P1|STARTED|Overall Study||1535
5055095|NCT01924988|12441129|P1|NOT COMPLETED|Overall Study||0
5055096|NCT01924988|12441129|P1|COMPLETED|Overall Study||15
5055097|NCT01924988|12441129|P1|STARTED|Overall Study||15
5055098|NCT01924975|12441141|P2|NOT COMPLETED|Overall Study||0
5055099|NCT01924975|12441142|P1|NOT COMPLETED|Overall Study||0
5055100|NCT01924975|12441141|P2|COMPLETED|Overall Study||51
5055101|NCT01924975|12441142|P1|COMPLETED|Overall Study||51
5055102|NCT01924975|12441141|P2|STARTED|Overall Study||51
5055103|NCT01924975|12441142|P1|STARTED|Overall Study||51
5055104|NCT01924949|12441152|P1|NOT COMPLETED|Overall Study||0
5055105|NCT01924949|12441152|P1|COMPLETED|Overall Study||5
5055106|NCT01924949|12441152|P1|STARTED|Overall Study||5
5055107|NCT01924871|12441163|P2|NOT COMPLETED|Overall Study||2
5055108|NCT01924871|12441164|P1|NOT COMPLETED|Overall Study||6
5055109|NCT01924871|12441163|P2|COMPLETED|Overall Study||29
5055110|NCT01924871|12441164|P1|COMPLETED|Overall Study||25
5055111|NCT01924871|12441163|P2|STARTED|Overall Study||31
5055112|NCT01924871|12441164|P1|STARTED|Overall Study||31
5055113|NCT01924845|12441170|P1|NOT COMPLETED|Overall Study||6
5055114|NCT01924845|12441170|P1|COMPLETED|Overall Study||18
5055115|NCT01924845|12441170|P1|STARTED|Overall Study||24
5055116|NCT01924806|12441180|P2|NOT COMPLETED|Overall Study||1
5055117|NCT01924806|12441181|P1|NOT COMPLETED|Overall Study||2
5055118|NCT01924806|12441180|P2|COMPLETED|Overall Study||3
5055119|NCT01924806|12441181|P1|COMPLETED|Overall Study||3
5055120|NCT01924806|12441180|P2|STARTED|Overall Study||4
5055121|NCT01924806|12441181|P1|STARTED|Overall Study||5
5055122|NCT01924767|12441198|P5|NOT COMPLETED|Overall Study||0
5055123|NCT01924767|12441199|P4|NOT COMPLETED|Overall Study||0
5055124|NCT01924767|12441200|P3|NOT COMPLETED|Overall Study||1
5055125|NCT01924767|12441201|P2|NOT COMPLETED|Overall Study||0
5055126|NCT01924767|12441202|P1|NOT COMPLETED|Overall Study||1
5055127|NCT01924767|12441198|P5|COMPLETED|Overall Study||9
5055128|NCT01924767|12441199|P4|COMPLETED|Overall Study||9
5055129|NCT01924767|12441200|P3|COMPLETED|Overall Study||8
5055130|NCT01924767|12441201|P2|COMPLETED|Overall Study||9
5055131|NCT01924767|12441202|P1|COMPLETED|Overall Study||11
5055132|NCT01924767|12441198|P5|STARTED|Overall Study||9
5055133|NCT01924767|12441199|P4|STARTED|Overall Study||9
5055134|NCT01924767|12441200|P3|STARTED|Overall Study||9
5055135|NCT01924767|12441201|P2|STARTED|Overall Study||9
5055136|NCT01924767|12441202|P1|STARTED|Overall Study||12
5055137|NCT01924689|12441308|P6|NOT COMPLETED|Overall Study||2
5055138|NCT01924689|12441309|P5|NOT COMPLETED|Overall Study||6
5055139|NCT01924689|12441310|P4|NOT COMPLETED|Overall Study||6
5055140|NCT01924689|12441311|P3|NOT COMPLETED|Overall Study||4
5055141|NCT01924689|12441312|P2|NOT COMPLETED|Overall Study||3
5055142|NCT01924689|12441313|P1|NOT COMPLETED|Overall Study||3
5055143|NCT01924689|12441308|P6|COMPLETED|Overall Study||0
5055144|NCT01924689|12441309|P5|COMPLETED|Overall Study||0
5055145|NCT01924689|12441310|P4|COMPLETED|Overall Study||0
5055146|NCT01924689|12441311|P3|COMPLETED|Overall Study||0
5055147|NCT01924689|12441312|P2|COMPLETED|Overall Study||0
5055148|NCT01924689|12441313|P1|COMPLETED|Overall Study||0
5055149|NCT01924689|12441308|P6|STARTED|Overall Study||2
5055150|NCT01924689|12441309|P5|STARTED|Overall Study||6
5055151|NCT01924689|12441310|P4|STARTED|Overall Study||6
5055152|NCT01924689|12441311|P3|STARTED|Overall Study||4
5055153|NCT01924689|12441312|P2|STARTED|Overall Study||3
5055154|NCT01924689|12441313|P1|STARTED|Overall Study||3
5055155|NCT01924559|12441371|P1|NOT COMPLETED|Overall Study||0
5055156|NCT01924559|12441371|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
5055157|NCT01924559|12441371|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
5055158|NCT01924533|12441387|P2|NOT COMPLETED|Overall Study||205
5055159|NCT01924533|12441388|P1|NOT COMPLETED|Overall Study||189
5055160|NCT01924533|12441387|P2|COMPLETED|Overall Study||57
5055161|NCT01924533|12441388|P1|COMPLETED|Overall Study||74
5055162|NCT01924533|12441387|P2|STARTED|Overall Study||262
5055163|NCT01924533|12441388|P1|STARTED|Overall Study||263
5055164|NCT01924442|12441418|P2|NOT COMPLETED|Overall Study||137
5055165|NCT01924442|12441419|P1|NOT COMPLETED|Overall Study||40
5055166|NCT01924442|12441418|P2|COMPLETED|Overall Study||967
5055167|NCT01924442|12441419|P1|COMPLETED|Overall Study||1059
5055168|NCT01924442|12441418|P2|STARTED|Overall Study||1104
5055169|NCT01924442|12441419|P1|STARTED|Overall Study||1099
5055170|NCT01924429|12441429|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
5055171|NCT01924429|12441430|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
5055172|NCT01924429|12441429|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
5055173|NCT01924429|12441430|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
5055174|NCT01924429|12441429|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
5055175|NCT01924429|12441430|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
5055176|NCT01924429|12441429|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
5055177|NCT01924429|12441430|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
5055178|NCT01924429|12441429|P2|COMPLETED|Washout Period (2 Weeks)||11
5055179|NCT01924429|12441430|P1|COMPLETED|Washout Period (2 Weeks)||14
5055180|NCT01924429|12441429|P2|STARTED|Washout Period (2 Weeks)||13
5055181|NCT01924429|12441430|P1|STARTED|Washout Period (2 Weeks)||17
5055182|NCT01924429|12441429|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
5055183|NCT01924429|12441430|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
5055184|NCT01924429|12441429|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
5055185|NCT01924429|12441430|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
5055186|NCT01924429|12441429|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
5055187|NCT01924429|12441430|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
5055188|NCT01924390|12441462|P2|NOT COMPLETED|Overall Study||1
5055189|NCT01924390|12441463|P1|NOT COMPLETED|Overall Study||1
5055190|NCT01924390|12441462|P2|COMPLETED|Overall Study||21
5055191|NCT01924390|12441463|P1|COMPLETED|Overall Study||21
5055192|NCT01924390|12441462|P2|STARTED|Overall Study||22
5055193|NCT01924390|12441463|P1|STARTED|Overall Study||22
5055194|NCT01924364|12441473|P1|NOT COMPLETED|Overall Study||3
5055195|NCT01924364|12441473|P1|COMPLETED|Overall Study||4
5055196|NCT01924364|12441473|P1|STARTED|Overall Study||7
5055197|NCT01924299|12441490|P2|NOT COMPLETED|Period 2||1
5055198|NCT01924299|12441491|P1|NOT COMPLETED|Period 2||1
5055199|NCT01924299|12441490|P2|COMPLETED|Period 2||17
5055200|NCT01924299|12441491|P1|COMPLETED|Period 2||17
5055201|NCT01924299|12441490|P2|Received Baricitinib|Period 2||17
5055202|NCT01924299|12441491|P1|Received Baricitinib|Period 2||17
5055203|NCT01924299|12441490|P2|Received at Least 1 Dose of Study Drug|Period 2||18
5055204|NCT01924299|12441491|P1|Received at Least 1 Dose of Study Drug|Period 2||18
5055205|NCT01924299|12441490|P2|STARTED|Period 2||18
5055206|NCT01924299|12441491|P1|STARTED|Period 2||18
5055207|NCT01924299|12441490|P2|NOT COMPLETED|Period 1||0
5055208|NCT01924299|12441491|P1|NOT COMPLETED|Period 1||0
5055209|NCT01924299|12441490|P2|COMPLETED|Period 1||18
5055210|NCT01924299|12441491|P1|COMPLETED|Period 1||18
5055211|NCT01924299|12441490|P2|Received Baricitinib|Period 1||18
5055212|NCT01924299|12441491|P1|Received Baricitinib|Period 1||18
5055213|NCT01924299|12441490|P2|STARTED|Period 1||18
5055214|NCT01924299|12441491|P1|STARTED|Period 1||18
5055215|NCT01924182|12441513|P2|NOT COMPLETED|Overall Study||0
5055216|NCT01924182|12441514|P1|NOT COMPLETED|Overall Study||1
5055217|NCT01924182|12441513|P2|COMPLETED|Overall Study||0
5055218|NCT01924182|12441514|P1|COMPLETED|Overall Study||2
5055219|NCT01924182|12441513|P2|STARTED|Overall Study||0
5055220|NCT01924182|12441514|P1|STARTED|Overall Study||3
5055221|NCT01924169|12441526|P1|NOT COMPLETED|Overall Study||0
5055222|NCT01924169|12441526|P1|COMPLETED|Overall Study||3
5055223|NCT01924169|12441526|P1|STARTED|Overall Study||3
5055224|NCT01923961|12441534|P3|NOT COMPLETED|Third Intervention||0
5055225|NCT01923961|12441535|P2|NOT COMPLETED|Third Intervention||0
5055226|NCT01923961|12441536|P1|NOT COMPLETED|Third Intervention||0
5055227|NCT01923961|12441534|P3|COMPLETED|Third Intervention||2
5055228|NCT01923961|12441535|P2|COMPLETED|Third Intervention||3
5055229|NCT01923961|12441536|P1|COMPLETED|Third Intervention||3
5055230|NCT01923961|12441534|P3|STARTED|Third Intervention||2
5055231|NCT01923961|12441535|P2|STARTED|Third Intervention||3
5055232|NCT01923961|12441536|P1|STARTED|Third Intervention||3
5055233|NCT01923961|12441534|P3|NOT COMPLETED|Washout (1 Week)||0
5055234|NCT01923961|12441535|P2|NOT COMPLETED|Washout (1 Week)||0
5055235|NCT01923961|12441536|P1|NOT COMPLETED|Washout (1 Week)||0
5055236|NCT01923961|12441534|P3|COMPLETED|Washout (1 Week)||2
5055237|NCT01923961|12441535|P2|COMPLETED|Washout (1 Week)||3
5055238|NCT01923961|12441536|P1|COMPLETED|Washout (1 Week)||3
5055239|NCT01923961|12441534|P3|STARTED|Washout (1 Week)||2
5055240|NCT01923961|12441535|P2|STARTED|Washout (1 Week)||3
5055241|NCT01923961|12441536|P1|STARTED|Washout (1 Week)||3
5055242|NCT01923961|12441534|P3|NOT COMPLETED|Second Intervention||0
5055243|NCT01923961|12441535|P2|NOT COMPLETED|Second Intervention||0
5055244|NCT01923961|12441536|P1|NOT COMPLETED|Second Intervention||0
5055245|NCT01923961|12441534|P3|COMPLETED|Second Intervention||2
5055246|NCT01923961|12441535|P2|COMPLETED|Second Intervention||3
5055247|NCT01923961|12441536|P1|COMPLETED|Second Intervention||3
5055248|NCT01923961|12441534|P3|STARTED|Second Intervention||2
5055249|NCT01923961|12441535|P2|STARTED|Second Intervention||3
5055250|NCT01923961|12441536|P1|STARTED|Second Intervention||3
5055251|NCT01923961|12441534|P3|NOT COMPLETED|Washout (1 Week)||0
5055252|NCT01923961|12441535|P2|NOT COMPLETED|Washout (1 Week)||0
5055253|NCT01923961|12441536|P1|NOT COMPLETED|Washout (1 Week)||0
5055254|NCT01923961|12441534|P3|COMPLETED|Washout (1 Week)||2
5055255|NCT01923961|12441535|P2|COMPLETED|Washout (1 Week)||3
5055256|NCT01923961|12441536|P1|COMPLETED|Washout (1 Week)||3
5055257|NCT01923961|12441534|P3|STARTED|Washout (1 Week)||2
5055258|NCT01923961|12441535|P2|STARTED|Washout (1 Week)||3
5055259|NCT01923961|12441536|P1|STARTED|Washout (1 Week)||3
5055260|NCT01923961|12441534|P3|NOT COMPLETED|First Intervention||0
5055261|NCT01923961|12441535|P2|NOT COMPLETED|First Intervention||0
5055262|NCT01923961|12441536|P1|NOT COMPLETED|First Intervention||0
5055263|NCT01923961|12441534|P3|COMPLETED|First Intervention||2
5055264|NCT01923961|12441535|P2|COMPLETED|First Intervention||3
5055265|NCT01923961|12441536|P1|COMPLETED|First Intervention||3
5055266|NCT01923961|12441534|P3|STARTED|First Intervention||2
5055267|NCT01923961|12441535|P2|STARTED|First Intervention||3
5055268|NCT01923961|12441536|P1|STARTED|First Intervention||3
5055269|NCT01923896|12441555|P2|NOT COMPLETED|Overall Study||0
5055270|NCT01923896|12441556|P1|NOT COMPLETED|Overall Study||1
5055271|NCT01923896|12441555|P2|COMPLETED|Overall Study||8
5055272|NCT01923896|12441556|P1|COMPLETED|Overall Study||7
5055273|NCT01923896|12441555|P2|STARTED|Overall Study||8
5055274|NCT01923896|12441556|P1|STARTED|Overall Study||8
5055275|NCT01923805|12441570|P2|NOT COMPLETED|Overall Study||5
5055276|NCT01923805|12441571|P1|NOT COMPLETED|Overall Study||3
5055277|NCT01923805|12441570|P2|COMPLETED|Overall Study||0
5055278|NCT01923805|12441571|P1|COMPLETED|Overall Study||0
5055279|NCT01923805|12441570|P2|STARTED|Overall Study|early termination|5
5055280|NCT01923805|12441571|P1|STARTED|Overall Study|early termination|3
5055281|NCT01923740|12441579|P2|NOT COMPLETED|Overall Study||9
5055282|NCT01923740|12441580|P1|NOT COMPLETED|Overall Study||6
5055283|NCT01923740|12441579|P2|COMPLETED|Overall Study||223
5055284|NCT01923740|12441580|P1|COMPLETED|Overall Study||221
5055285|NCT01923740|12441579|P2|STARTED|Overall Study||232
5055286|NCT01923740|12441580|P1|STARTED|Overall Study||227
5055287|NCT01923480|12441845|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055288|NCT01923480|12441846|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055289|NCT01923480|12441847|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055290|NCT01923480|12441848|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055291|NCT01923480|12441849|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055292|NCT01923480|12441850|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
5055293|NCT01923480|12441845|P6|COMPLETED|Period 2 (Hours 1-7)||2
5055294|NCT01923480|12441846|P5|COMPLETED|Period 2 (Hours 1-7)||2
5055295|NCT01923480|12441847|P4|COMPLETED|Period 2 (Hours 1-7)||2
5055296|NCT01923480|12441848|P3|COMPLETED|Period 2 (Hours 1-7)||2
5055297|NCT01923480|12441849|P2|COMPLETED|Period 2 (Hours 1-7)||1
5055298|NCT01923480|12441850|P1|COMPLETED|Period 2 (Hours 1-7)||1
5055299|NCT01923480|12441845|P6|STARTED|Period 2 (Hours 1-7)||2
5055300|NCT01923480|12441846|P5|STARTED|Period 2 (Hours 1-7)||2
5055301|NCT01923480|12441847|P4|STARTED|Period 2 (Hours 1-7)||2
5055302|NCT01923480|12441848|P3|STARTED|Period 2 (Hours 1-7)||2
5055303|NCT01923480|12441849|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
5055304|NCT01923480|12441850|P1|STARTED|Period 2 (Hours 1-7)||1
5055305|NCT01923480|12441845|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055306|NCT01923480|12441846|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055307|NCT01923480|12441847|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055308|NCT01923480|12441848|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055309|NCT01923480|12441849|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055310|NCT01923480|12441850|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
5055311|NCT01923480|12441845|P6|COMPLETED|Period 1 (Hours 1-7)||2
5055312|NCT01923480|12441846|P5|COMPLETED|Period 1 (Hours 1-7)||2
5055313|NCT01923480|12441847|P4|COMPLETED|Period 1 (Hours 1-7)||2
5055314|NCT01923480|12441848|P3|COMPLETED|Period 1 (Hours 1-7)||2
5055315|NCT01923480|12441849|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
5055316|NCT01923480|12441850|P1|COMPLETED|Period 1 (Hours 1-7)||1
5055317|NCT01923480|12441845|P6|STARTED|Period 1 (Hours 1-7)||2
5055318|NCT01923480|12441846|P5|STARTED|Period 1 (Hours 1-7)||2
5055319|NCT01923480|12441847|P4|STARTED|Period 1 (Hours 1-7)||2
5055320|NCT01923480|12441848|P3|STARTED|Period 1 (Hours 1-7)||2
5055321|NCT01923480|12441849|P2|STARTED|Period 1 (Hours 1-7)||2
5055322|NCT01923480|12441850|P1|STARTED|Period 1 (Hours 1-7)||1
5055323|NCT01923467|12442005|P1|NOT COMPLETED|Overall Study||541
5055324|NCT01923467|12442005|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
5055325|NCT01923467|12442005|P1|Baseline Completed, Enrolled|Overall Study||288
5055326|NCT01923467|12442005|P1|STARTED|Overall Study|Offered stop smoking program|767
5055327|NCT01923428|12442013|P4|NOT COMPLETED|Overall Study||10
5055328|NCT01923428|12442014|P3|NOT COMPLETED|Overall Study||11
5055329|NCT01923428|12442015|P2|NOT COMPLETED|Overall Study||12
5055330|NCT01923428|12442016|P1|NOT COMPLETED|Overall Study||19
5055331|NCT01923428|12442013|P4|COMPLETED|Overall Study||80
5055332|NCT01923428|12442014|P3|COMPLETED|Overall Study||78
5055333|NCT01923428|12442015|P2|COMPLETED|Overall Study||77
5055334|NCT01923428|12442016|P1|COMPLETED|Overall Study||69
5055335|NCT01923428|12442013|P4|STARTED|Overall Study||90
5055336|NCT01923428|12442014|P3|STARTED|Overall Study||89
5055337|NCT01923428|12442015|P2|STARTED|Overall Study||89
5055338|NCT01923428|12442016|P1|STARTED|Overall Study||88
5055339|NCT01923389|12442028|P2|NOT COMPLETED|Overall Study||0
5055340|NCT01923389|12442029|P1|NOT COMPLETED|Overall Study||1
5055341|NCT01923389|12442028|P2|COMPLETED|Overall Study||2
5055342|NCT01923389|12442029|P1|COMPLETED|Overall Study||1
5055343|NCT01923389|12442028|P2|STARTED|Overall Study||2
5055344|NCT01923389|12442029|P1|STARTED|Overall Study||2
5055345|NCT01923363|12442051|P1|NOT COMPLETED|Overall Study||1
5055346|NCT01923363|12442051|P1|COMPLETED|Overall Study||28
5055347|NCT01923363|12442051|P1|STARTED|Overall Study||29
5055348|NCT01923311|12442060|P2|NOT COMPLETED|Overall Study||1
5055349|NCT01923311|12442061|P1|NOT COMPLETED|Overall Study||17
5055350|NCT01923311|12442060|P2|COMPLETED|Overall Study||13
5055351|NCT01923311|12442061|P1|COMPLETED|Overall Study||0
5055352|NCT01923311|12442060|P2|STARTED|Overall Study||14
5055353|NCT01923311|12442061|P1|STARTED|Overall Study||17
5055354|NCT01923181|12442113|P9|NOT COMPLETED|Overall Study||3
5055355|NCT01923181|12442114|P8|NOT COMPLETED|Overall Study||8
5055356|NCT01923181|12442115|P7|NOT COMPLETED|Overall Study||8
5055357|NCT01923181|12442116|P6|NOT COMPLETED|Overall Study||4
5055358|NCT01923181|12442117|P5|NOT COMPLETED|Overall Study||8
5055359|NCT01923181|12442118|P4|NOT COMPLETED|Overall Study||5
5055360|NCT01923181|12442119|P3|NOT COMPLETED|Overall Study||2
5055361|NCT01923181|12442120|P2|NOT COMPLETED|Overall Study||6
5055362|NCT01923181|12442121|P1|NOT COMPLETED|Overall Study||3
5055363|NCT01923181|12442113|P9|COMPLETED|Overall Study||68
5055364|NCT01923181|12442114|P8|COMPLETED|Overall Study||61
5055365|NCT01923181|12442115|P7|COMPLETED|Overall Study||62
5055366|NCT01923181|12442116|P6|COMPLETED|Overall Study||66
5055367|NCT01923181|12442117|P5|COMPLETED|Overall Study||63
5055368|NCT01923181|12442118|P4|COMPLETED|Overall Study||65
5055369|NCT01923181|12442119|P3|COMPLETED|Overall Study||67
5055370|NCT01923181|12442120|P2|COMPLETED|Overall Study||64
5055371|NCT01923181|12442121|P1|COMPLETED|Overall Study||67
5055372|NCT01923181|12442113|P9|Safety Analysis Set (SAS)|Overall Study||71
5055373|NCT01923181|12442114|P8|Safety Analysis Set (SAS)|Overall Study||69
5055374|NCT01923181|12442115|P7|Safety Analysis Set (SAS)|Overall Study||70
5055375|NCT01923181|12442116|P6|Safety Analysis Set (SAS)|Overall Study||70
5055376|NCT01923181|12442117|P5|Safety Analysis Set (SAS)|Overall Study||71
5055377|NCT01923181|12442118|P4|Safety Analysis Set (SAS)|Overall Study||70
5055378|NCT01923181|12442119|P3|Safety Analysis Set (SAS)|Overall Study||69
5055379|NCT01923181|12442120|P2|Safety Analysis Set (SAS)|Overall Study||70
5055380|NCT01923181|12442121|P1|Safety Analysis Set (SAS)|Overall Study||70
5055381|NCT01923181|12442113|P9|Full Analysis Set (FAS)|Overall Study||71
5055382|NCT01923181|12442114|P8|Full Analysis Set (FAS)|Overall Study||69
5055383|NCT01923181|12442115|P7|Full Analysis Set (FAS)|Overall Study||70
5055384|NCT01923181|12442116|P6|Full Analysis Set (FAS)|Overall Study||70
5055385|NCT01923181|12442117|P5|Full Analysis Set (FAS)|Overall Study||71
5055386|NCT01923181|12442118|P4|Full Analysis Set (FAS)|Overall Study||70
5055387|NCT01923181|12442119|P3|Full Analysis Set (FAS)|Overall Study||69
5055388|NCT01923181|12442120|P2|Full Analysis Set (FAS)|Overall Study||70
5055389|NCT01923181|12442121|P1|Full Analysis Set (FAS)|Overall Study||70
5055390|NCT01923181|12442113|P9|STARTED|Overall Study||71
5055391|NCT01923181|12442114|P8|STARTED|Overall Study||69
5055392|NCT01923181|12442115|P7|STARTED|Overall Study||70
5055393|NCT01923181|12442116|P6|STARTED|Overall Study||70
5055394|NCT01923181|12442117|P5|STARTED|Overall Study||71
5055395|NCT01923181|12442118|P4|STARTED|Overall Study||70
5055396|NCT01923181|12442119|P3|STARTED|Overall Study||69
5055397|NCT01923181|12442120|P2|STARTED|Overall Study||70
5055398|NCT01923181|12442121|P1|STARTED|Overall Study||70
5055399|NCT01923168|12442199|P3|NOT COMPLETED|Overall Study||17
5055400|NCT01923168|12442200|P2|NOT COMPLETED|Overall Study||39
5055401|NCT01923168|12442201|P1|NOT COMPLETED|Overall Study||37
5055402|NCT01923168|12442199|P3|COMPLETED|Overall Study||109
5055403|NCT01923168|12442200|P2|COMPLETED|Overall Study||44
5055404|NCT01923168|12442201|P1|COMPLETED|Overall Study||94
5055405|NCT01923168|12442199|P3|STARTED|Overall Study||126
5055406|NCT01923168|12442200|P2|STARTED|Overall Study||83
5055407|NCT01923168|12442201|P1|STARTED|Overall Study||131
5055408|NCT01923129|12442260|P2|NOT COMPLETED|Overall Study||0
5055409|NCT01923129|12442261|P1|NOT COMPLETED|Overall Study||0
5055410|NCT01923129|12442260|P2|COMPLETED|Overall Study||71
5055411|NCT01923129|12442261|P1|COMPLETED|Overall Study||71
5055412|NCT01923129|12442260|P2|STARTED|Overall Study||71
5055413|NCT01923129|12442261|P1|STARTED|Overall Study||71
5055414|NCT01922986|12442271|P2|NOT COMPLETED|Overall Study||0
5055415|NCT01922986|12442272|P1|NOT COMPLETED|Overall Study||0
5055416|NCT01922986|12442271|P2|COMPLETED|Overall Study||2
5055417|NCT01922986|12442272|P1|COMPLETED|Overall Study||2
5055418|NCT01922986|12442271|P2|STARTED|Overall Study||2
5055419|NCT01922986|12442272|P1|STARTED|Overall Study||2
5055420|NCT01922934|12442284|P2|NOT COMPLETED|Visit 12 / Final Visits||290
5055421|NCT01922934|12442285|P1|NOT COMPLETED|Visit 12 / Final Visits||6
5055422|NCT01922934|12442284|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
5055423|NCT01922934|12442285|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
5055424|NCT01922934|12442284|P2|STARTED|Visit 12 / Final Visits||2930
5055425|NCT01922934|12442285|P1|STARTED|Visit 12 / Final Visits||119
5055426|NCT01922934|12442284|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
5055427|NCT01922934|12442285|P1|NOT COMPLETED|Visit 1- Weight Measured||21
5055428|NCT01922934|12442284|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
5055429|NCT01922934|12442285|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
5055430|NCT01922934|12442284|P2|STARTED|Visit 1- Weight Measured||4214
5055431|NCT01922934|12442285|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
5055432|NCT01922934|12442284|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
5055433|NCT01922934|12442285|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
5055434|NCT01922934|12442284|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
5055435|NCT01922934|12442285|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
5055436|NCT01922934|12442284|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
5055437|NCT01922934|12442285|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
5055438|NCT01922934|12442284|P2|NOT COMPLETED|Eligible Patients||88
5055439|NCT01922934|12442285|P1|NOT COMPLETED|Eligible Patients||53
5055440|NCT01922934|12442284|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
5055441|NCT01922934|12442285|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
5055442|NCT01922934|12442284|P2|STARTED|Eligible Patients||4302
5055443|NCT01922934|12442285|P1|STARTED|Eligible Patients||428
5055444|NCT01922739|12442297|P1|NOT COMPLETED|Open-label Treatment Period||34
5055445|NCT01922739|12442297|P1|COMPLETED|Open-label Treatment Period||136
5055446|NCT01922739|12442297|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
5055447|NCT01922739|12442297|P1|STARTED|Open-label Treatment Period||170
5055448|NCT01922739|12442297|P1|NOT COMPLETED|Titration/Adjustment Period||12
5055449|NCT01922739|12442297|P1|COMPLETED|Titration/Adjustment Period||170
5055450|NCT01922739|12442297|P1|Safety Analysis Set|Titration/Adjustment Period||182
5055451|NCT01922739|12442297|P1|STARTED|Titration/Adjustment Period||182
5055452|NCT01922349|12442326|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
5055453|NCT01922349|12442327|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
5055454|NCT01922349|12442328|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
5055455|NCT01922349|12442329|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
5055456|NCT01922349|12442326|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
5055457|NCT01922349|12442327|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
5055458|NCT01922349|12442328|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
5055459|NCT01922349|12442329|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
5055460|NCT01922349|12442326|P4|STARTED|Multiple Rising Dose (MRD) Period||27
5055461|NCT01922349|12442327|P3|STARTED|Multiple Rising Dose (MRD) Period||18
5055462|NCT01922349|12442328|P2|STARTED|Multiple Rising Dose (MRD) Period||27
5055463|NCT01922349|12442329|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
5055464|NCT01922349|12442326|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
5055465|NCT01922349|12442327|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
5055466|NCT01922349|12442328|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
5055467|NCT01922349|12442329|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
5055468|NCT01922349|12442326|P4|COMPLETED|Single Rising Dose (SRD) Period||27
5055469|NCT01922349|12442327|P3|COMPLETED|Single Rising Dose (SRD) Period||18
5055470|NCT01922349|12442328|P2|COMPLETED|Single Rising Dose (SRD) Period||27
5055471|NCT01922349|12442329|P1|COMPLETED|Single Rising Dose (SRD) Period||25
5055472|NCT01922349|12442326|P4|STARTED|Single Rising Dose (SRD) Period||27
5055473|NCT01922349|12442327|P3|STARTED|Single Rising Dose (SRD) Period||18
5055474|NCT01922349|12442328|P2|STARTED|Single Rising Dose (SRD) Period||27
5055475|NCT01922349|12442329|P1|STARTED|Single Rising Dose (SRD) Period||25
5055476|NCT01922336|12442437|P3|NOT COMPLETED|Overall Study||0
5055477|NCT01922336|12442438|P2|NOT COMPLETED|Overall Study||0
5055478|NCT01922336|12442439|P1|NOT COMPLETED|Overall Study||0
5055479|NCT01922336|12442437|P3|COMPLETED|Overall Study||53
5055480|NCT01922336|12442438|P2|COMPLETED|Overall Study||53
5055481|NCT01922336|12442439|P1|COMPLETED|Overall Study||53
5055482|NCT01922336|12442437|P3|STARTED|Overall Study||53
5055483|NCT01922336|12442438|P2|STARTED|Overall Study||53
5055484|NCT01922336|12442439|P1|STARTED|Overall Study||53
5055485|NCT01922271|12442458|P2|NOT COMPLETED|PERIOD 2||0
5055486|NCT01922271|12442459|P1|NOT COMPLETED|PERIOD 2||0
5055487|NCT01922271|12442458|P2|COMPLETED|PERIOD 2||76
5055488|NCT01922271|12442459|P1|COMPLETED|PERIOD 2||75
5055489|NCT01922271|12442458|P2|STARTED|PERIOD 2||76
5055490|NCT01922271|12442459|P1|STARTED|PERIOD 2||75
5055491|NCT01922271|12442458|P2|NOT COMPLETED|WASHOUT Period||0
5055492|NCT01922271|12442459|P1|NOT COMPLETED|WASHOUT Period||1
5055493|NCT01922271|12442458|P2|COMPLETED|WASHOUT Period||76
5055494|NCT01922271|12442459|P1|COMPLETED|WASHOUT Period||75
5055495|NCT01922271|12442458|P2|STARTED|WASHOUT Period||76
5055496|NCT01922271|12442459|P1|STARTED|WASHOUT Period||76
5055497|NCT01922271|12442458|P2|NOT COMPLETED|PERIOD 1||0
5055498|NCT01922271|12442459|P1|NOT COMPLETED|PERIOD 1||0
5055499|NCT01922271|12442458|P2|COMPLETED|PERIOD 1||76
5055500|NCT01922271|12442459|P1|COMPLETED|PERIOD 1||76
5055501|NCT01922271|12442458|P2|STARTED|PERIOD 1||76
5055502|NCT01922271|12442459|P1|STARTED|PERIOD 1||76
5055503|NCT01922258|12442479|P2|NOT COMPLETED|Overall Study||16
5055504|NCT01922258|12442480|P1|NOT COMPLETED|Overall Study||16
5055505|NCT01922258|12442479|P2|COMPLETED|Overall Study||121
5055506|NCT01922258|12442480|P1|COMPLETED|Overall Study||117
5055507|NCT01922258|12442479|P2|STARTED|Overall Study||137
5055508|NCT01922258|12442480|P1|STARTED|Overall Study||133
5055509|NCT01922219|12442488|P1|NOT COMPLETED|Overall Study||9
5055510|NCT01922219|12442488|P1|COMPLETED|Overall Study||28
5055511|NCT01922219|12442488|P1|STARTED|Overall Study||37
5055512|NCT01922115|12442496|P2|NOT COMPLETED|Overall Study||7
5055513|NCT01922115|12442497|P1|NOT COMPLETED|Overall Study||7
5055514|NCT01922115|12442496|P2|COMPLETED|Overall Study||24
5055515|NCT01922115|12442497|P1|COMPLETED|Overall Study||21
5055516|NCT01922115|12442496|P2|STARTED|Overall Study||31
5055517|NCT01922115|12442497|P1|STARTED|Overall Study||28
5055518|NCT01922102|12442512|P3|NOT COMPLETED|Overall Study||8
5055519|NCT01922102|12442513|P2|NOT COMPLETED|Overall Study||9
5055520|NCT01922102|12442514|P1|NOT COMPLETED|Overall Study||9
5055521|NCT01922102|12442512|P3|COMPLETED|Overall Study||83
5055522|NCT01922102|12442513|P2|COMPLETED|Overall Study||175
5055523|NCT01922102|12442514|P1|COMPLETED|Overall Study||173
5055524|NCT01922102|12442512|P3|STARTED|Overall Study||91
5055525|NCT01922102|12442513|P2|STARTED|Overall Study||184
5055526|NCT01922102|12442514|P1|STARTED|Overall Study||182
5055527|NCT01922089|12442550|P2|NOT COMPLETED|Overall Study||30
5055528|NCT01922089|12442551|P1|NOT COMPLETED|Overall Study||39
5055529|NCT01922089|12442550|P2|COMPLETED|Overall Study||221
5055530|NCT01922089|12442551|P1|COMPLETED|Overall Study||208
5055531|NCT01922089|12442550|P2|Safety Set|Overall Study||251
5055532|NCT01922089|12442551|P1|Safety Set|Overall Study||246
5055533|NCT01922089|12442550|P2|STARTED|Overall Study||251
5055534|NCT01922089|12442551|P1|STARTED|Overall Study||247
5055535|NCT01922050|12442575|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
5055536|NCT01922050|12442576|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
5055537|NCT01922050|12442577|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
5055538|NCT01922050|12442578|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
5055539|NCT01922050|12442579|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
5055540|NCT01922050|12442580|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
5055541|NCT01922050|12442581|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
5055542|NCT01922050|12442582|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
5055543|NCT01922050|12442583|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
5055544|NCT01922050|12442584|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
5055545|NCT01922050|12442585|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
5055546|NCT01922050|12442586|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
5055547|NCT01922050|12442587|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
5055548|NCT01922050|12442588|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
5055549|NCT01922050|12442575|P14|COMPLETED|Part 2 Double-blind Phase||56
5055550|NCT01922050|12442576|P13|COMPLETED|Part 2 Double-blind Phase||62
5055551|NCT01922050|12442577|P12|COMPLETED|Part 2 Double-blind Phase||58
5055552|NCT01922050|12442578|P11|COMPLETED|Part 2 Double-blind Phase||61
5055553|NCT01922050|12442579|P10|COMPLETED|Part 2 Double-blind Phase||0
5055554|NCT01922050|12442580|P9|COMPLETED|Part 2 Double-blind Phase||0
5055555|NCT01922050|12442581|P8|COMPLETED|Part 2 Double-blind Phase||0
5055556|NCT01922050|12442582|P7|COMPLETED|Part 2 Double-blind Phase||0
5055557|NCT01922050|12442583|P6|COMPLETED|Part 2 Double-blind Phase||0
5055558|NCT01922050|12442584|P5|COMPLETED|Part 2 Double-blind Phase||0
5055559|NCT01922050|12442585|P4|COMPLETED|Part 2 Double-blind Phase||0
5055560|NCT01922050|12442586|P3|COMPLETED|Part 2 Double-blind Phase||0
5055561|NCT01922050|12442587|P2|COMPLETED|Part 2 Double-blind Phase||0
5055562|NCT01922050|12442588|P1|COMPLETED|Part 2 Double-blind Phase||0
5055563|NCT01922050|12442575|P14|STARTED|Part 2 Double-blind Phase||59
5055564|NCT01922050|12442576|P13|STARTED|Part 2 Double-blind Phase||62
5055565|NCT01922050|12442577|P12|STARTED|Part 2 Double-blind Phase||60
5055566|NCT01922050|12442578|P11|STARTED|Part 2 Double-blind Phase||62
5055567|NCT01922050|12442579|P10|STARTED|Part 2 Double-blind Phase||0
5055568|NCT01922050|12442580|P9|STARTED|Part 2 Double-blind Phase||0
5055569|NCT01922050|12442581|P8|STARTED|Part 2 Double-blind Phase||0
5055570|NCT01922050|12442582|P7|STARTED|Part 2 Double-blind Phase||0
5055571|NCT01922050|12442583|P6|STARTED|Part 2 Double-blind Phase||0
5055572|NCT01922050|12442584|P5|STARTED|Part 2 Double-blind Phase||0
5055573|NCT01922050|12442585|P4|STARTED|Part 2 Double-blind Phase||0
5055574|NCT01922050|12442586|P3|STARTED|Part 2 Double-blind Phase||0
5055575|NCT01922050|12442587|P2|STARTED|Part 2 Double-blind Phase||0
5055576|NCT01922050|12442588|P1|STARTED|Part 2 Double-blind Phase||0
5055577|NCT01922050|12442575|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055578|NCT01922050|12442576|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055579|NCT01922050|12442577|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055580|NCT01922050|12442578|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055581|NCT01922050|12442579|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055582|NCT01922050|12442580|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055583|NCT01922050|12442581|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055584|NCT01922050|12442582|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055585|NCT01922050|12442583|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055586|NCT01922050|12442584|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055587|NCT01922050|12442585|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055588|NCT01922050|12442586|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055589|NCT01922050|12442587|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055590|NCT01922050|12442588|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055591|NCT01922050|12442575|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055592|NCT01922050|12442576|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055593|NCT01922050|12442577|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055594|NCT01922050|12442578|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
5055595|NCT01922050|12442579|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
5055596|NCT01922050|12442580|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
5055597|NCT01922050|12442581|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
5055598|NCT01922050|12442582|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
5055599|NCT01922050|12442583|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
5055600|NCT01922050|12442584|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
5055601|NCT01922050|12442585|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
5055602|NCT01922050|12442586|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
5055603|NCT01922050|12442587|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
5055604|NCT01922050|12442588|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
5055605|NCT01922050|12442575|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5055606|NCT01922050|12442576|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5055607|NCT01922050|12442577|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5055608|NCT01922050|12442578|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
5055609|NCT01922050|12442579|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
5055610|NCT01922050|12442580|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
5055611|NCT01922050|12442581|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
5055612|NCT01922050|12442582|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
5055613|NCT01922050|12442583|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
5055614|NCT01922050|12442584|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
5055615|NCT01922050|12442585|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
5055616|NCT01922050|12442586|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
5055617|NCT01922050|12442587|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
5055618|NCT01922050|12442588|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
5055619|NCT01922037|12442628|P2|NOT COMPLETED|Overall Study||174
5055620|NCT01922037|12442629|P1|NOT COMPLETED|Overall Study||10
5055621|NCT01922037|12442628|P2|COMPLETED|Overall Study||563
5055622|NCT01922037|12442629|P1|COMPLETED|Overall Study||59
5055623|NCT01922037|12442628|P2|Treated|Overall Study||732
5055624|NCT01922037|12442629|P1|Treated|Overall Study||69
5055625|NCT01922037|12442628|P2|STARTED|Overall Study||737
5055626|NCT01922037|12442629|P1|STARTED|Overall Study||69
5055627|NCT01922024|12442723|P2|NOT COMPLETED|Overall Study||0
5055628|NCT01922024|12442724|P1|NOT COMPLETED|Overall Study||0
5055629|NCT01922024|12442723|P2|COMPLETED|Overall Study||471
5055630|NCT01922024|12442724|P1|COMPLETED|Overall Study||1653
5055631|NCT01922024|12442723|P2|STARTED|Overall Study||471
5055632|NCT01922024|12442724|P1|STARTED|Overall Study||1653
5055633|NCT01922011|12442732|P2|NOT COMPLETED|Overall Study||5
5055634|NCT01922011|12442733|P1|NOT COMPLETED|Overall Study||6
5055635|NCT01922011|12442732|P2|COMPLETED|Overall Study||69
5055636|NCT01922011|12442733|P1|COMPLETED|Overall Study||69
5055637|NCT01922011|12442732|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
5055638|NCT01922011|12442733|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
5055639|NCT01922011|12442732|P2|Treated|Overall Study|Treated Participants|73
5055640|NCT01922011|12442733|P1|Treated|Overall Study|Treated Participants|73
5055641|NCT01922011|12442732|P2|STARTED|Overall Study|Randomized participants|74
5055642|NCT01922011|12442733|P1|STARTED|Overall Study|Randomized participants|75
5055643|NCT01921894|12442776|P3|NOT COMPLETED|Overall Study||0
5055644|NCT01921894|12442777|P2|NOT COMPLETED|Overall Study||0
5055645|NCT01921894|12442778|P1|NOT COMPLETED|Overall Study||0
5055646|NCT01921894|12442776|P3|COMPLETED|Overall Study||8
5055647|NCT01921894|12442777|P2|COMPLETED|Overall Study||8
5055648|NCT01921894|12442778|P1|COMPLETED|Overall Study||8
5055649|NCT01921894|12442776|P3|STARTED|Overall Study||8
5055650|NCT01921894|12442777|P2|STARTED|Overall Study||8
5055651|NCT01921894|12442778|P1|STARTED|Overall Study||8
5055652|NCT01921829|12442800|P2|NOT COMPLETED|Overall Study||1
5055653|NCT01921829|12442801|P1|NOT COMPLETED|Overall Study||0
5055654|NCT01921829|12442800|P2|COMPLETED|Overall Study||8
5055655|NCT01921829|12442801|P1|COMPLETED|Overall Study||10
5055656|NCT01921829|12442800|P2|STARTED|Overall Study||9
5055657|NCT01921829|12442801|P1|STARTED|Overall Study||10
5055658|NCT01921751|12442850|P3|NOT COMPLETED|Overall Study||0
5055659|NCT01921751|12442851|P2|NOT COMPLETED|Overall Study||0
5055660|NCT01921751|12442852|P1|NOT COMPLETED|Overall Study||0
5055661|NCT01921751|12442850|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
5055662|NCT01921751|12442851|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
5055663|NCT01921751|12442852|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
5055664|NCT01921751|12442850|P3|STARTED|Overall Study||5
5055665|NCT01921751|12442851|P2|STARTED|Overall Study||4
5055666|NCT01921751|12442852|P1|STARTED|Overall Study||4
5055667|NCT01921517|12442872|P2|NOT COMPLETED|Overall Study||9
5055668|NCT01921517|12442873|P1|NOT COMPLETED|Overall Study||15
5055669|NCT01921517|12442872|P2|COMPLETED|Overall Study||29
5055670|NCT01921517|12442873|P1|COMPLETED|Overall Study||27
5055671|NCT01921517|12442872|P2|STARTED|Overall Study||38
5055672|NCT01921517|12442873|P1|STARTED|Overall Study||42
5055673|NCT01921452|12442879|P1|NOT COMPLETED|Overall Study||0
5055674|NCT01921452|12442879|P1|COMPLETED|Overall Study||283
5055675|NCT01921452|12442879|P1|STARTED|Overall Study||283
5055676|NCT01921387|12442884|P1|NOT COMPLETED|Overall Study||1
5055677|NCT01921387|12442884|P1|COMPLETED|Overall Study||19
5055678|NCT01921387|12442884|P1|STARTED|Overall Study||20
5055679|NCT01921348|12442893|P2|NOT COMPLETED|Overall Study||2
5055680|NCT01921348|12442894|P1|NOT COMPLETED|Overall Study||1
5055681|NCT01921348|12442893|P2|COMPLETED|Overall Study||7
5055682|NCT01921348|12442894|P1|COMPLETED|Overall Study||8
5055683|NCT01921348|12442893|P2|STARTED|Overall Study||9
5055684|NCT01921348|12442894|P1|STARTED|Overall Study||9
5055685|NCT01921322|12442906|P2|NOT COMPLETED|Overall Study||17
5055686|NCT01921322|12442907|P1|NOT COMPLETED|Overall Study||15
5055687|NCT01921322|12442906|P2|COMPLETED|Overall Study||44
5055688|NCT01921322|12442907|P1|COMPLETED|Overall Study||42
5055689|NCT01921322|12442906|P2|STARTED|Overall Study||61
5055690|NCT01921322|12442907|P1|STARTED|Overall Study||57
5055691|NCT01921296|12442915|P1|NOT COMPLETED|Overall Study||0
5055692|NCT01921296|12442915|P1|COMPLETED|Overall Study||2
5055693|NCT01921296|12442915|P1|STARTED|Overall Study||2
5055694|NCT01921270|12442923|P1|NOT COMPLETED|Overall Study||1
5055695|NCT01921270|12442923|P1|COMPLETED|Overall Study||17
5055696|NCT01921270|12442923|P1|STARTED|Overall Study||18
5055697|NCT01921257|12442939|P1|NOT COMPLETED|Overall Study||3
5055698|NCT01921257|12442939|P1|COMPLETED|Overall Study||13
5055699|NCT01921257|12442939|P1|Active Treatment|Overall Study||13
5055700|NCT01921257|12442939|P1|Placebo run-in|Overall Study||16
5055701|NCT01921257|12442939|P1|STARTED|Overall Study||16
5055702|NCT01921205|12442946|P2|NOT COMPLETED|Overall Study||20
5055703|NCT01921205|12442947|P1|NOT COMPLETED|Overall Study||21
5055704|NCT01921205|12442946|P2|COMPLETED|Overall Study||151
5055705|NCT01921205|12442947|P1|COMPLETED|Overall Study||151
5055706|NCT01921205|12442946|P2|STARTED|Overall Study||171
5055707|NCT01921205|12442947|P1|STARTED|Overall Study||172
5055708|NCT01921179|12442977|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
5055709|NCT01921179|12442978|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
5055710|NCT01921179|12442977|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
5055711|NCT01921179|12442978|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
5055712|NCT01921179|12442977|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
5055713|NCT01921179|12442978|P1|STARTED|Long Term Follow-up After GOALS Training||34
5055714|NCT01921179|12442977|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
5055715|NCT01921179|12442978|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
5055716|NCT01921179|12442977|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
5055717|NCT01921179|12442978|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
5055718|NCT01921179|12442977|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
5055719|NCT01921179|12442978|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
5055720|NCT01921166|12442993|P2|NOT COMPLETED|Overall Study||0
5055721|NCT01921166|12442994|P1|NOT COMPLETED|Overall Study||0
5055722|NCT01921166|12442993|P2|COMPLETED|Overall Study||15
5055723|NCT01921166|12442994|P1|COMPLETED|Overall Study||8
5055724|NCT01921166|12442993|P2|STARTED|Overall Study||15
5055725|NCT01921166|12442994|P1|STARTED|Overall Study||8
5055726|NCT01921114|12443004|P2|NOT COMPLETED|Overall Study||0
5055727|NCT01921114|12443005|P1|NOT COMPLETED|Overall Study||0
5055728|NCT01921114|12443004|P2|COMPLETED|Overall Study||0
5055729|NCT01921114|12443005|P1|COMPLETED|Overall Study||0
5055730|NCT01921114|12443004|P2|STARTED|Overall Study||0
5055731|NCT01921114|12443005|P1|STARTED|Overall Study||0
5055732|NCT01921101|12443015|P2|NOT COMPLETED|Overall Study||6
5055733|NCT01921101|12443016|P1|NOT COMPLETED|Overall Study||16
5055734|NCT01921101|12443015|P2|COMPLETED|Overall Study||32
5055735|NCT01921101|12443016|P1|COMPLETED|Overall Study||24
5055736|NCT01921101|12443015|P2|STARTED|Overall Study||38
5055737|NCT01921101|12443016|P1|STARTED|Overall Study||40
5055738|NCT01920958|12443024|P1|NOT COMPLETED|Overall Study||5
5055739|NCT01920958|12443024|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
5055740|NCT01920958|12443024|P1|STARTED|Overall Study||233
5055741|NCT01920893|12443042|P2|NOT COMPLETED|Overall Study||2
5055742|NCT01920893|12443043|P1|NOT COMPLETED|Overall Study||7
5055743|NCT01920893|12443042|P2|COMPLETED|Overall Study||28
5055744|NCT01920893|12443043|P1|COMPLETED|Overall Study||23
5055745|NCT01920893|12443042|P2|Treated (Safety Population)|Overall Study||30
5055746|NCT01920893|12443043|P1|Treated (Safety Population)|Overall Study||30
5055747|NCT01920893|12443042|P2|STARTED|Overall Study||30
5055748|NCT01920893|12443043|P1|STARTED|Overall Study||30
5055749|NCT01920854|12443076|P7|NOT COMPLETED|Overall Study||1
5055750|NCT01920854|12443077|P6|NOT COMPLETED|Overall Study||0
5055751|NCT01920854|12443078|P5|NOT COMPLETED|Overall Study||1
5055752|NCT01920854|12443079|P4|NOT COMPLETED|Overall Study||0
5055753|NCT01920854|12443080|P3|NOT COMPLETED|Overall Study||0
5055754|NCT01920854|12443081|P2|NOT COMPLETED|Overall Study||0
5055755|NCT01920854|12443082|P1|NOT COMPLETED|Overall Study||1
5055756|NCT01920854|12443076|P7|COMPLETED|Overall Study||5
5055757|NCT01920854|12443077|P6|COMPLETED|Overall Study||6
5055758|NCT01920854|12443078|P5|COMPLETED|Overall Study||5
5055759|NCT01920854|12443079|P4|COMPLETED|Overall Study||6
5055760|NCT01920854|12443080|P3|COMPLETED|Overall Study||6
5055761|NCT01920854|12443081|P2|COMPLETED|Overall Study||6
5055762|NCT01920854|12443082|P1|COMPLETED|Overall Study||11
5055763|NCT01920854|12443076|P7|STARTED|Overall Study||6
5055764|NCT01920854|12443077|P6|STARTED|Overall Study||6
5055765|NCT01920854|12443078|P5|STARTED|Overall Study||6
5055766|NCT01920854|12443079|P4|STARTED|Overall Study||6
5055767|NCT01920854|12443080|P3|STARTED|Overall Study||6
5055768|NCT01920854|12443081|P2|STARTED|Overall Study||6
5055769|NCT01920854|12443082|P1|STARTED|Overall Study||12
5055770|NCT01920802|12443209|P3|NOT COMPLETED|Overall Study||1
5055771|NCT01920802|12443210|P2|NOT COMPLETED|Overall Study||2
5055772|NCT01920802|12443211|P1|NOT COMPLETED|Overall Study||4
5055773|NCT01920802|12443209|P3|COMPLETED|Overall Study||10
5055774|NCT01920802|12443210|P2|COMPLETED|Overall Study||7
5055775|NCT01920802|12443211|P1|COMPLETED|Overall Study||7
5055776|NCT01920802|12443209|P3|STARTED|Overall Study||11
5055777|NCT01920802|12443210|P2|STARTED|Overall Study||9
5055778|NCT01920802|12443211|P1|STARTED|Overall Study||11
5055779|NCT01920594|12443242|P2|NOT COMPLETED|Overall Study||3
5055780|NCT01920594|12443243|P1|NOT COMPLETED|Overall Study||7
5055781|NCT01920594|12443242|P2|COMPLETED|Overall Study||25
5055782|NCT01920594|12443243|P1|COMPLETED|Overall Study||20
5055783|NCT01920594|12443242|P2|STARTED|Overall Study||28
5055784|NCT01920594|12443243|P1|STARTED|Overall Study||27
5055785|NCT01920568|12443293|P2|NOT COMPLETED|Overall Study||84
5055786|NCT01920568|12443294|P1|NOT COMPLETED|Overall Study||151
5055787|NCT01920568|12443293|P2|COMPLETED|Overall Study||75
5055788|NCT01920568|12443294|P1|COMPLETED|Overall Study||175
5055789|NCT01920568|12443293|P2|STARTED|Overall Study||159
5055790|NCT01920568|12443294|P1|STARTED|Overall Study||326
5055791|NCT01920555|12443320|P5|NOT COMPLETED|Overall Study||1
5055792|NCT01920555|12443321|P4|NOT COMPLETED|Overall Study||3
5055793|NCT01920555|12443322|P3|NOT COMPLETED|Overall Study||1
5055794|NCT01920555|12443323|P2|NOT COMPLETED|Overall Study||4
5055795|NCT01920555|12443324|P1|NOT COMPLETED|Overall Study||4
5055796|NCT01920555|12443320|P5|COMPLETED|Overall Study||18
5055797|NCT01920555|12443321|P4|COMPLETED|Overall Study||17
5055798|NCT01920555|12443322|P3|COMPLETED|Overall Study||21
5055799|NCT01920555|12443323|P2|COMPLETED|Overall Study||16
5055800|NCT01920555|12443324|P1|COMPLETED|Overall Study||14
5055801|NCT01920555|12443320|P5|STARTED|Overall Study||19
5055802|NCT01920555|12443321|P4|STARTED|Overall Study||20
5055803|NCT01920555|12443322|P3|STARTED|Overall Study||22
5055804|NCT01920555|12443323|P2|STARTED|Overall Study||20
5055805|NCT01920555|12443324|P1|STARTED|Overall Study||18
5055806|NCT01920477|12443383|P2|NOT COMPLETED|Overall Study||17
5055807|NCT01920477|12443384|P1|NOT COMPLETED|Overall Study||15
5055808|NCT01920477|12443383|P2|COMPLETED|Overall Study||1
5055809|NCT01920477|12443384|P1|COMPLETED|Overall Study||2
5055810|NCT01920477|12443383|P2|Requiried Individualized Follow-up|Overall Study||0
5055811|NCT01920477|12443384|P1|Requiried Individualized Follow-up|Overall Study||1
5055812|NCT01920477|12443383|P2|STARTED|Overall Study||18
5055813|NCT01920477|12443384|P1|STARTED|Overall Study||17
5055814|NCT01920282|12443418|P3|NOT COMPLETED|Overall Study||0
5055815|NCT01920282|12443419|P2|NOT COMPLETED|Overall Study||0
5055816|NCT01920282|12443420|P1|NOT COMPLETED|Overall Study||0
5055817|NCT01920282|12443418|P3|COMPLETED|Overall Study||15
5055818|NCT01920282|12443419|P2|COMPLETED|Overall Study||15
5055819|NCT01920282|12443420|P1|COMPLETED|Overall Study||15
5055820|NCT01920282|12443418|P3|STARTED|Overall Study||15
5055821|NCT01920282|12443419|P2|STARTED|Overall Study||15
5055822|NCT01920282|12443420|P1|STARTED|Overall Study||15
5055823|NCT01920178|12443433|P2|NOT COMPLETED|Overall Study||1
5055824|NCT01920178|12443434|P1|NOT COMPLETED|Overall Study||2
5055825|NCT01920178|12443433|P2|COMPLETED|Overall Study||1
5055826|NCT01920178|12443434|P1|COMPLETED|Overall Study||3
5055827|NCT01920178|12443433|P2|STARTED|Overall Study||2
5055828|NCT01920178|12443434|P1|STARTED|Overall Study||5
5055829|NCT01919996|12443444|P1|NOT COMPLETED|Overall Study||0
5055830|NCT01919996|12443444|P1|COMPLETED|Overall Study||8
5055831|NCT01919996|12443444|P1|STARTED|Overall Study||8
5055832|NCT01919970|12443452|P2|NOT COMPLETED|Overall Study||0
5055833|NCT01919970|12443453|P1|NOT COMPLETED|Overall Study||3
5055834|NCT01919970|12443452|P2|COMPLETED|Overall Study||18
5055835|NCT01919970|12443453|P1|COMPLETED|Overall Study||11
5055836|NCT01919970|12443452|P2|STARTED|Overall Study||18
5055837|NCT01919970|12443453|P1|STARTED|Overall Study||14
5055838|NCT01919814|12443461|P2|NOT COMPLETED|Overall Study||0
5055839|NCT01919814|12443462|P1|NOT COMPLETED|Overall Study||3
5055840|NCT01919814|12443461|P2|COMPLETED|Overall Study||30
5055841|NCT01919814|12443462|P1|COMPLETED|Overall Study||27
5055842|NCT01919814|12443461|P2|STARTED|Overall Study||30
5055843|NCT01919814|12443462|P1|STARTED|Overall Study||30
5055844|NCT01919801|12443474|P2|NOT COMPLETED|Overall Study||3
5055845|NCT01919801|12443475|P1|NOT COMPLETED|Overall Study||1
5055846|NCT01919801|12443474|P2|COMPLETED|Overall Study||57
5055847|NCT01919801|12443475|P1|COMPLETED|Overall Study||60
5055848|NCT01919801|12443474|P2|STARTED|Overall Study||60
5055849|NCT01919801|12443475|P1|STARTED|Overall Study||61
5055850|NCT01919723|12443500|P2|NOT COMPLETED|Overall Study||2
5055851|NCT01919723|12443501|P1|NOT COMPLETED|Overall Study||2
5055852|NCT01919723|12443500|P2|COMPLETED|Overall Study||33
5055853|NCT01919723|12443501|P1|COMPLETED|Overall Study||33
5055854|NCT01919723|12443500|P2|STARTED|Overall Study||35
5055855|NCT01919723|12443501|P1|STARTED|Overall Study||35
5055856|NCT01919697|12443515|P2|NOT COMPLETED|Overall Study||385
5055857|NCT01919697|12443516|P1|NOT COMPLETED|Overall Study||53
5055858|NCT01919697|12443515|P2|COMPLETED|Overall Study||1761
5055859|NCT01919697|12443516|P1|COMPLETED|Overall Study||171
5055860|NCT01919697|12443515|P2|STARTED|Overall Study||2146
5055861|NCT01919697|12443516|P1|STARTED|Overall Study||224
5055862|NCT01919606|12443546|P2|NOT COMPLETED|Overall Study||0
5055863|NCT01919606|12443547|P1|NOT COMPLETED|Overall Study||0
5055864|NCT01919606|12443546|P2|COMPLETED|Overall Study||0
5055865|NCT01919606|12443547|P1|COMPLETED|Overall Study||1
5055866|NCT01919606|12443546|P2|STARTED|Overall Study||0
5055867|NCT01919606|12443547|P1|STARTED|Overall Study||1
5055868|NCT01919450|12443559|P4|NOT COMPLETED|Overall Study||1
5055869|NCT01919450|12443560|P3|NOT COMPLETED|Overall Study||0
5055870|NCT01919450|12443561|P2|NOT COMPLETED|Overall Study||0
5055871|NCT01919450|12443562|P1|NOT COMPLETED|Overall Study||0
5055872|NCT01919450|12443559|P4|COMPLETED|Overall Study||19
5055873|NCT01919450|12443560|P3|COMPLETED|Overall Study||20
5055874|NCT01919450|12443561|P2|COMPLETED|Overall Study||20
5055875|NCT01919450|12443562|P1|COMPLETED|Overall Study||20
5055876|NCT01919450|12443559|P4|STARTED|Overall Study||20
5055877|NCT01919450|12443560|P3|STARTED|Overall Study||20
5055878|NCT01919450|12443561|P2|STARTED|Overall Study||20
5055879|NCT01919450|12443562|P1|STARTED|Overall Study||20
5055880|NCT01919411|12443574|P2|NOT COMPLETED|Overall Study||5
5055881|NCT01919411|12443575|P1|NOT COMPLETED|Overall Study||5
5055882|NCT01919411|12443574|P2|COMPLETED|Overall Study||41
5055883|NCT01919411|12443575|P1|COMPLETED|Overall Study||38
5055884|NCT01919411|12443574|P2|STARTED|Overall Study||46
5055885|NCT01919411|12443575|P1|STARTED|Overall Study||43
5055886|NCT01919398|12443594|P3|NOT COMPLETED|Overall Study||4
5055887|NCT01919398|12443595|P2|NOT COMPLETED|Overall Study||0
5055888|NCT01919398|12443596|P1|NOT COMPLETED|Overall Study||0
5055889|NCT01919398|12443594|P3|COMPLETED|Overall Study||9
5055890|NCT01919398|12443595|P2|COMPLETED|Overall Study||3
5055891|NCT01919398|12443596|P1|COMPLETED|Overall Study||3
5055892|NCT01919398|12443594|P3|Received at Least One Dose of Study Drug|Overall Study||13
5055893|NCT01919398|12443595|P2|Received at Least One Dose of Study Drug|Overall Study||3
5055894|NCT01919398|12443596|P1|Received at Least One Dose of Study Drug|Overall Study||3
5055895|NCT01919398|12443594|P3|STARTED|Overall Study||13
5055896|NCT01919398|12443595|P2|STARTED|Overall Study||3
5055897|NCT01919398|12443596|P1|STARTED|Overall Study||3
5055898|NCT01919307|12443616|P1|NOT COMPLETED|Overall Study||9
5055899|NCT01919307|12443616|P1|COMPLETED|Overall Study||20
5055900|NCT01919307|12443616|P1|STARTED|Overall Study||29
5055901|NCT01919229|12443626|P3|NOT COMPLETED|Overall Study||1
5055902|NCT01919229|12443627|P2|NOT COMPLETED|Overall Study||0
5055903|NCT01919229|12443628|P1|NOT COMPLETED|Overall Study||0
5055904|NCT01919229|12443626|P3|COMPLETED|Overall Study||3
5055905|NCT01919229|12443627|P2|COMPLETED|Overall Study||6
5055906|NCT01919229|12443628|P1|COMPLETED|Overall Study||4
5055907|NCT01919229|12443626|P3|STARTED|Overall Study||4
5055908|NCT01919229|12443627|P2|STARTED|Overall Study||6
5055909|NCT01919229|12443628|P1|STARTED|Overall Study||4
5055910|NCT01919216|12443660|P3|NOT COMPLETED|Overall Study||1
5055911|NCT01919216|12443661|P2|NOT COMPLETED|Overall Study||1
5055912|NCT01919216|12443662|P1|NOT COMPLETED|Overall Study||2
5055913|NCT01919216|12443660|P3|COMPLETED|Overall Study||4
5055914|NCT01919216|12443661|P2|COMPLETED|Overall Study||20
5055915|NCT01919216|12443662|P1|COMPLETED|Overall Study||26
5055916|NCT01919216|12443660|P3|STARTED|Overall Study||5
5055917|NCT01919216|12443661|P2|STARTED|Overall Study||21
5055918|NCT01919216|12443662|P1|STARTED|Overall Study||28
5055919|NCT01919164|12443675|P5|NOT COMPLETED|Overall Study||33
5055920|NCT01919164|12443676|P4|NOT COMPLETED|Overall Study||28
5055921|NCT01919164|12443677|P3|NOT COMPLETED|Overall Study||37
5055922|NCT01919164|12443678|P2|NOT COMPLETED|Overall Study||30
5055923|NCT01919164|12443679|P1|NOT COMPLETED|Overall Study||43
5055924|NCT01919164|12443675|P5|COMPLETED|Overall Study||77
5055925|NCT01919164|12443676|P4|COMPLETED|Overall Study||82
5055926|NCT01919164|12443677|P3|COMPLETED|Overall Study||74
5055927|NCT01919164|12443678|P2|COMPLETED|Overall Study||80
5055928|NCT01919164|12443679|P1|COMPLETED|Overall Study||65
5055929|NCT01919164|12443675|P5|Safety Analysis Set|Overall Study||109
5055930|NCT01919164|12443676|P4|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
5055931|NCT01919164|12443677|P3|Safety Analysis Set|Overall Study||111
5055932|NCT01919164|12443678|P2|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
5055933|NCT01919164|12443679|P1|Safety Analysis Set|Overall Study||107
5055934|NCT01919164|12443675|P5|STARTED|Overall Study||110
5055935|NCT01919164|12443676|P4|STARTED|Overall Study||110
5055936|NCT01919164|12443677|P3|STARTED|Overall Study||111
5055937|NCT01919164|12443678|P2|STARTED|Overall Study||110
5055938|NCT01919164|12443679|P1|STARTED|Overall Study||108
5055939|NCT01919112|12443734|P3|NOT COMPLETED|Secondary Analysis-day 30||1
5055940|NCT01919112|12443735|P2|NOT COMPLETED|Secondary Analysis-day 30||1
5055941|NCT01919112|12443736|P1|NOT COMPLETED|Secondary Analysis-day 30||2
5055942|NCT01919112|12443734|P3|COMPLETED|Secondary Analysis-day 30||14
5055943|NCT01919112|12443735|P2|COMPLETED|Secondary Analysis-day 30||12
5055944|NCT01919112|12443736|P1|COMPLETED|Secondary Analysis-day 30||12
5055945|NCT01919112|12443734|P3|STARTED|Secondary Analysis-day 30||15
5055946|NCT01919112|12443735|P2|STARTED|Secondary Analysis-day 30||13
5055947|NCT01919112|12443736|P1|STARTED|Secondary Analysis-day 30||14
5055948|NCT01919112|12443734|P3|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
5055949|NCT01919112|12443735|P2|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
5055950|NCT01919112|12443736|P1|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
5055951|NCT01919112|12443734|P3|COMPLETED|Primary Analysis-day 5 of Intervention||15
5055952|NCT01919112|12443735|P2|COMPLETED|Primary Analysis-day 5 of Intervention||13
5055953|NCT01919112|12443736|P1|COMPLETED|Primary Analysis-day 5 of Intervention||14
5055954|NCT01919112|12443734|P3|STARTED|Primary Analysis-day 5 of Intervention||15
5055955|NCT01919112|12443735|P2|STARTED|Primary Analysis-day 5 of Intervention||13
5055956|NCT01919112|12443736|P1|STARTED|Primary Analysis-day 5 of Intervention||14
5055957|NCT01918800|12443776|P2|NOT COMPLETED|Overall Study||5
5055958|NCT01918800|12443777|P1|NOT COMPLETED|Overall Study||9
5055959|NCT01918800|12443776|P2|COMPLETED|Overall Study||104
5055960|NCT01918800|12443777|P1|COMPLETED|Overall Study||100
5055961|NCT01918800|12443776|P2|STARTED|Overall Study||109
5055962|NCT01918800|12443777|P1|STARTED|Overall Study||109
5055963|NCT01918774|12443795|P1|NOT COMPLETED|Overall Study||5
5055964|NCT01918774|12443795|P1|COMPLETED|Overall Study||52
5055965|NCT01918774|12443795|P1|STARTED|Overall Study||57
5055966|NCT01918761|12443810|P1|NOT COMPLETED|Overall Study||0
5055967|NCT01918761|12443810|P1|COMPLETED|Overall Study||5
5055968|NCT01918761|12443810|P1|STARTED|Overall Study||5
5055969|NCT01918371|12443819|P2|NOT COMPLETED|Overall Study||1
5055970|NCT01918371|12443820|P1|NOT COMPLETED|Overall Study||1
5055971|NCT01918371|12443819|P2|COMPLETED|Overall Study||156
5055972|NCT01918371|12443820|P1|COMPLETED|Overall Study||165
5055973|NCT01918371|12443819|P2|Participants With Complete Data|Overall Study||156
5055974|NCT01918371|12443820|P1|Participants With Complete Data|Overall Study||165
5055975|NCT01918371|12443819|P2|STARTED|Overall Study||157
5055976|NCT01918371|12443820|P1|STARTED|Overall Study||166
5055977|NCT01918332|12443898|P4|NOT COMPLETED|Overall Study||7
5055978|NCT01918332|12443899|P3|NOT COMPLETED|Overall Study||9
5055979|NCT01918332|12443900|P2|NOT COMPLETED|Overall Study||5
5055980|NCT01918332|12443901|P1|NOT COMPLETED|Overall Study||8
5055981|NCT01918332|12443898|P4|COMPLETED|Overall Study||38
5055982|NCT01918332|12443899|P3|COMPLETED|Overall Study||30
5055983|NCT01918332|12443900|P2|COMPLETED|Overall Study||36
5055984|NCT01918332|12443901|P1|COMPLETED|Overall Study||35
5055985|NCT01918332|12443898|P4|STARTED|Overall Study||45
5055986|NCT01918332|12443899|P3|STARTED|Overall Study||39
5055987|NCT01918332|12443900|P2|STARTED|Overall Study||41
5055988|NCT01918332|12443901|P1|STARTED|Overall Study||43
5055989|NCT01918306|12443913|P4|NOT COMPLETED|Overall Study||3
5055990|NCT01918306|12443914|P3|NOT COMPLETED|Overall Study||2
5055991|NCT01918306|12443915|P2|NOT COMPLETED|Overall Study||0
5055992|NCT01918306|12443916|P1|NOT COMPLETED|Overall Study||6
5055993|NCT01918306|12443913|P4|COMPLETED|Overall Study||0
5055994|NCT01918306|12443914|P3|COMPLETED|Overall Study||0
5055995|NCT01918306|12443915|P2|COMPLETED|Overall Study||0
5055996|NCT01918306|12443916|P1|COMPLETED|Overall Study||0
5055997|NCT01918306|12443913|P4|STARTED|Overall Study||3
5055998|NCT01918306|12443914|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
5055999|NCT01918306|12443915|P2|STARTED|Overall Study|No patients enrolled|0
5056000|NCT01918306|12443916|P1|STARTED|Overall Study||6
5056001|NCT01918189|12443936|P1|NOT COMPLETED|Overall Study||18
5056002|NCT01918189|12443936|P1|COMPLETED|Overall Study||41
5056003|NCT01918189|12443936|P1|Completed Follow-up Assessment|Overall Study||41
5056004|NCT01918189|12443936|P1|Completed Baseline Assessment|Overall Study||58
5056005|NCT01918189|12443936|P1|STARTED|Overall Study||59
5056006|NCT01918085|12443947|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
5056007|NCT01918085|12443948|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
5056008|NCT01918085|12443947|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
5056009|NCT01918085|12443948|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
5056010|NCT01918085|12443947|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
5056011|NCT01918085|12443948|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
5056012|NCT01918085|12443947|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
5056013|NCT01918085|12443948|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
5056014|NCT01918085|12443947|P2|COMPLETED|Test Period 2: Strata Strip||11
5056015|NCT01918085|12443948|P1|COMPLETED|Test Period 2: Strata Strip||10
5056016|NCT01918085|12443947|P2|STARTED|Test Period 2: Strata Strip||11
5056017|NCT01918085|12443948|P1|STARTED|Test Period 2: Strata Strip||10
5056018|NCT01918085|12443947|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
5056019|NCT01918085|12443948|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
5056020|NCT01918085|12443947|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
5056021|NCT01918085|12443948|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
5056022|NCT01918085|12443947|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
5056023|NCT01918085|12443948|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
5056024|NCT01918085|12443947|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
5056025|NCT01918085|12443948|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
5056026|NCT01918085|12443947|P2|COMPLETED|Test Period 1: Strata Strip||11
5056027|NCT01918085|12443948|P1|COMPLETED|Test Period 1: Strata Strip||10
5056028|NCT01918085|12443947|P2|STARTED|Test Period 1: Strata Strip||12
5056029|NCT01918085|12443948|P1|STARTED|Test Period 1: Strata Strip||10
5056030|NCT01918072|12443956|P3|NOT COMPLETED|Quality Assessment Period||0
5056031|NCT01918072|12443957|P2|NOT COMPLETED|Quality Assessment Period||0
5056032|NCT01918072|12443958|P1|NOT COMPLETED|Quality Assessment Period||0
5056033|NCT01918072|12443956|P3|COMPLETED|Quality Assessment Period||202
5056034|NCT01918072|12443957|P2|COMPLETED|Quality Assessment Period||0
5056035|NCT01918072|12443958|P1|COMPLETED|Quality Assessment Period||0
5056036|NCT01918072|12443956|P3|STARTED|Quality Assessment Period||202
5056037|NCT01918072|12443957|P2|STARTED|Quality Assessment Period||0
5056038|NCT01918072|12443958|P1|STARTED|Quality Assessment Period||0
5056039|NCT01918072|12443956|P3|NOT COMPLETED|E-consult Assessment Period||0
5056040|NCT01918072|12443957|P2|NOT COMPLETED|E-consult Assessment Period||0
5056041|NCT01918072|12443958|P1|NOT COMPLETED|E-consult Assessment Period||0
5056042|NCT01918072|12443956|P3|COMPLETED|E-consult Assessment Period||0
5056043|NCT01918072|12443957|P2|COMPLETED|E-consult Assessment Period||42
5056044|NCT01918072|12443958|P1|COMPLETED|E-consult Assessment Period||0
5056045|NCT01918072|12443956|P3|STARTED|E-consult Assessment Period||0
5056046|NCT01918072|12443957|P2|STARTED|E-consult Assessment Period||42
5056047|NCT01918072|12443958|P1|STARTED|E-consult Assessment Period||0
5056048|NCT01918072|12443956|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
5056049|NCT01918072|12443957|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
5056050|NCT01918072|12443958|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
5056051|NCT01918072|12443956|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
5056052|NCT01918072|12443957|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
5056053|NCT01918072|12443958|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
5056054|NCT01918072|12443956|P3|Control|Controlled Trial Step Five - Four Months||0
5056055|NCT01918072|12443957|P2|Control|Controlled Trial Step Five - Four Months||0
5056056|NCT01918072|12443958|P1|Control|Controlled Trial Step Five - Four Months||0
5056057|NCT01918072|12443956|P3|Intervention|Controlled Trial Step Five - Four Months||0
5056058|NCT01918072|12443957|P2|Intervention|Controlled Trial Step Five - Four Months||0
5056059|NCT01918072|12443958|P1|Intervention|Controlled Trial Step Five - Four Months||11
5056060|NCT01918072|12443956|P3|STARTED|Controlled Trial Step Five - Four Months||0
5056061|NCT01918072|12443957|P2|STARTED|Controlled Trial Step Five - Four Months||0
5056062|NCT01918072|12443958|P1|STARTED|Controlled Trial Step Five - Four Months||11
5056063|NCT01918072|12443956|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
5056064|NCT01918072|12443957|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
5056065|NCT01918072|12443958|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
5056066|NCT01918072|12443956|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
5056067|NCT01918072|12443957|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
5056068|NCT01918072|12443958|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
5056069|NCT01918072|12443956|P3|Control|Controlled Trial Step Four - Six Months||0
5056070|NCT01918072|12443957|P2|Control|Controlled Trial Step Four - Six Months||0
5056071|NCT01918072|12443958|P1|Control|Controlled Trial Step Four - Six Months||0
5056072|NCT01918072|12443956|P3|Intervention|Controlled Trial Step Four - Six Months||0
5056073|NCT01918072|12443957|P2|Intervention|Controlled Trial Step Four - Six Months||0
5056074|NCT01918072|12443958|P1|Intervention|Controlled Trial Step Four - Six Months||11
5056075|NCT01918072|12443956|P3|STARTED|Controlled Trial Step Four - Six Months||0
5056076|NCT01918072|12443957|P2|STARTED|Controlled Trial Step Four - Six Months||0
5056077|NCT01918072|12443958|P1|STARTED|Controlled Trial Step Four - Six Months||11
5056078|NCT01918072|12443956|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
5056079|NCT01918072|12443957|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
5056080|NCT01918072|12443958|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
5056081|NCT01918072|12443956|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
5056082|NCT01918072|12443957|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
5056083|NCT01918072|12443958|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
5056084|NCT01918072|12443956|P3|Control|Controlled Trial Step Three - Six Months||0
5056085|NCT01918072|12443957|P2|Control|Controlled Trial Step Three - Six Months||0
5056086|NCT01918072|12443958|P1|Control|Controlled Trial Step Three - Six Months||2
5056087|NCT01918072|12443956|P3|Intervention|Controlled Trial Step Three - Six Months||0
5056088|NCT01918072|12443957|P2|Intervention|Controlled Trial Step Three - Six Months||0
5056089|NCT01918072|12443958|P1|Intervention|Controlled Trial Step Three - Six Months||9
5056090|NCT01918072|12443956|P3|STARTED|Controlled Trial Step Three - Six Months||0
5056091|NCT01918072|12443957|P2|STARTED|Controlled Trial Step Three - Six Months||0
5056092|NCT01918072|12443958|P1|STARTED|Controlled Trial Step Three - Six Months||11
5056093|NCT01918072|12443956|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
5056094|NCT01918072|12443957|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
5056095|NCT01918072|12443958|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
5056096|NCT01918072|12443956|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
5056097|NCT01918072|12443957|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
5056098|NCT01918072|12443958|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
5056099|NCT01918072|12443956|P3|Control|Controlled Trial Step Two - Six Months||0
5056100|NCT01918072|12443957|P2|Control|Controlled Trial Step Two - Six Months||0
5056101|NCT01918072|12443958|P1|Control|Controlled Trial Step Two - Six Months||4
5056102|NCT01918072|12443956|P3|Intervention|Controlled Trial Step Two - Six Months||0
5056103|NCT01918072|12443957|P2|Intervention|Controlled Trial Step Two - Six Months||0
5056104|NCT01918072|12443958|P1|Intervention|Controlled Trial Step Two - Six Months||7
5056105|NCT01918072|12443956|P3|STARTED|Controlled Trial Step Two - Six Months||0
5056106|NCT01918072|12443957|P2|STARTED|Controlled Trial Step Two - Six Months||0
5056107|NCT01918072|12443958|P1|STARTED|Controlled Trial Step Two - Six Months||11
5056108|NCT01918072|12443956|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
5056109|NCT01918072|12443957|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
5056110|NCT01918072|12443958|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
5056111|NCT01918072|12443956|P3|COMPLETED|Controlled Trial Step One - Six Months||0
5056112|NCT01918072|12443957|P2|COMPLETED|Controlled Trial Step One - Six Months||0
5056113|NCT01918072|12443958|P1|COMPLETED|Controlled Trial Step One - Six Months||11
5056114|NCT01918072|12443956|P3|Control|Controlled Trial Step One - Six Months||0
5056115|NCT01918072|12443957|P2|Control|Controlled Trial Step One - Six Months||0
5056116|NCT01918072|12443958|P1|Control|Controlled Trial Step One - Six Months||10
5056117|NCT01918072|12443956|P3|Intervention|Controlled Trial Step One - Six Months||0
5056118|NCT01918072|12443957|P2|Intervention|Controlled Trial Step One - Six Months||0
5056119|NCT01918072|12443958|P1|Intervention|Controlled Trial Step One - Six Months||1
5056120|NCT01918072|12443956|P3|STARTED|Controlled Trial Step One - Six Months||0
5056121|NCT01918072|12443957|P2|STARTED|Controlled Trial Step One - Six Months||0
5056122|NCT01918072|12443958|P1|STARTED|Controlled Trial Step One - Six Months||11
5056123|NCT01918033|12443972|P3|NOT COMPLETED|Overall Study||3
5056124|NCT01918033|12443973|P2|NOT COMPLETED|Overall Study||2
5056125|NCT01918033|12443974|P1|NOT COMPLETED|Overall Study||5
5056126|NCT01918033|12443972|P3|COMPLETED|Overall Study||199
5056127|NCT01918033|12443973|P2|COMPLETED|Overall Study||201
5056128|NCT01918033|12443974|P1|COMPLETED|Overall Study||198
5056129|NCT01918033|12443972|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
5056130|NCT01918033|12443973|P2|Treated|Overall Study||203
5056131|NCT01918033|12443974|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
5056132|NCT01918033|12443972|P3|STARTED|Overall Study||202
5056133|NCT01918033|12443973|P2|STARTED|Overall Study||203
5056134|NCT01918033|12443974|P1|STARTED|Overall Study||203
5056135|NCT01917812|12444015|P3|NOT COMPLETED|Overall Study||0
5056136|NCT01917812|12444016|P2|NOT COMPLETED|Overall Study||0
5056137|NCT01917812|12444017|P1|NOT COMPLETED|Overall Study||1
5056138|NCT01917812|12444015|P3|COMPLETED|Overall Study||16
5056139|NCT01917812|12444016|P2|COMPLETED|Overall Study||16
5056140|NCT01917812|12444017|P1|COMPLETED|Overall Study||15
5056141|NCT01917812|12444015|P3|STARTED|Overall Study||16
5056142|NCT01917812|12444016|P2|STARTED|Overall Study||16
5056143|NCT01917812|12444017|P1|STARTED|Overall Study||16
5056144|NCT01917773|12444037|P1|NOT COMPLETED|Overall Study||0
5056145|NCT01917773|12444037|P1|COMPLETED|Overall Study||13
5056146|NCT01917773|12444037|P1|STARTED|Overall Study||13
5056147|NCT01917747|12444045|P2|NOT COMPLETED|Overall Study||11
5056148|NCT01917747|12444046|P1|NOT COMPLETED|Overall Study||19
5056149|NCT01917747|12444045|P2|COMPLETED|Overall Study||35
5056150|NCT01917747|12444046|P1|COMPLETED|Overall Study||41
5056151|NCT01917747|12444045|P2|STARTED|Overall Study||46
5056152|NCT01917747|12444046|P1|STARTED|Overall Study||60
5056153|NCT01917656|12444060|P2|NOT COMPLETED|Overall Study||24
5056154|NCT01917656|12444061|P1|NOT COMPLETED|Overall Study||26
5056155|NCT01917656|12444060|P2|COMPLETED|Overall Study||147
5056156|NCT01917656|12444061|P1|COMPLETED|Overall Study||146
5056157|NCT01917656|12444060|P2|Exposed During Ramadan (Fasting)|Overall Study||163
5056158|NCT01917656|12444061|P1|Exposed During Ramadan (Fasting)|Overall Study||152
5056159|NCT01917656|12444060|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
5056160|NCT01917656|12444061|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
5056161|NCT01917656|12444060|P2|STARTED|Overall Study||171
5056162|NCT01917656|12444061|P1|STARTED|Overall Study||172
5056163|NCT01917526|12444087|P2|NOT COMPLETED|Overall Study||1
5056164|NCT01917526|12444088|P1|NOT COMPLETED|Overall Study||1
5056165|NCT01917526|12444087|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
5056166|NCT01917526|12444088|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
5056167|NCT01917526|12444087|P2|STARTED|Overall Study||250
5056168|NCT01917526|12444088|P1|STARTED|Overall Study||250
5056169|NCT01917513|12444098|P2|NOT COMPLETED|Overall Study||102
5056170|NCT01917513|12444099|P1|NOT COMPLETED|Overall Study||95
5056171|NCT01917513|12444098|P2|COMPLETED|Overall Study||396
5056172|NCT01917513|12444099|P1|COMPLETED|Overall Study||407
5056173|NCT01917513|12444098|P2|STARTED|Overall Study||498
5056174|NCT01917513|12444099|P1|STARTED|Overall Study||502
5056175|NCT01917344|12444105|P1|NOT COMPLETED|Overall Study||1
5056176|NCT01917344|12444105|P1|COMPLETED|Overall Study||9
5056177|NCT01917344|12444105|P1|STARTED|Overall Study||10
5056178|NCT01917318|12444111|P2|NOT COMPLETED|Second Treatment||0
5056179|NCT01917318|12444112|P1|NOT COMPLETED|Second Treatment||0
5056180|NCT01917318|12444111|P2|COMPLETED|Second Treatment||0
5056181|NCT01917318|12444112|P1|COMPLETED|Second Treatment||0
5056182|NCT01917318|12444111|P2|STARTED|Second Treatment||0
5056183|NCT01917318|12444112|P1|STARTED|Second Treatment||0
5056184|NCT01917318|12444111|P2|NOT COMPLETED|First Treatment||1
5056185|NCT01917318|12444112|P1|NOT COMPLETED|First Treatment||0
5056186|NCT01917318|12444111|P2|COMPLETED|First Treatment||0
5056187|NCT01917318|12444112|P1|COMPLETED|First Treatment||0
5056188|NCT01917318|12444111|P2|STARTED|First Treatment||1
5056189|NCT01917318|12444112|P1|STARTED|First Treatment||0
5056190|NCT01917214|12444132|P1|NOT COMPLETED|Overall Study||0
5056191|NCT01917214|12444132|P1|COMPLETED|Overall Study||212
5056192|NCT01917214|12444132|P1|STARTED|Overall Study||212
5056193|NCT01917188|12444144|P3|NOT COMPLETED|Overall Study||9
5056194|NCT01917188|12444145|P2|NOT COMPLETED|Overall Study||6
5056195|NCT01917188|12444146|P1|NOT COMPLETED|Overall Study||12
5056196|NCT01917188|12444144|P3|COMPLETED|Overall Study||11
5056197|NCT01917188|12444145|P2|COMPLETED|Overall Study||17
5056198|NCT01917188|12444146|P1|COMPLETED|Overall Study||17
5056199|NCT01917188|12444144|P3|STARTED|Overall Study||20
5056200|NCT01917188|12444145|P2|STARTED|Overall Study||23
5056201|NCT01917188|12444146|P1|STARTED|Overall Study||29
5056202|NCT01917136|12444154|P1|NOT COMPLETED|Overall Study||0
5056203|NCT01917136|12444154|P1|COMPLETED|Overall Study||21
5056204|NCT01917136|12444154|P1|STARTED|Overall Study||21
5056205|NCT01917006|12444165|P8|NOT COMPLETED|Open-label Period||2
5056206|NCT01917006|12444166|P7|NOT COMPLETED|Open-label Period||0
5056207|NCT01917006|12444167|P6|NOT COMPLETED|Open-label Period||0
5056208|NCT01917006|12444168|P5|NOT COMPLETED|Open-label Period||0
5056209|NCT01917006|12444169|P4|NOT COMPLETED|Open-label Period||0
5056210|NCT01917006|12444170|P3|NOT COMPLETED|Open-label Period||0
5056211|NCT01917006|12444171|P2|NOT COMPLETED|Open-label Period||0
5056212|NCT01917006|12444172|P1|NOT COMPLETED|Open-label Period||0
5056213|NCT01917006|12444165|P8|COMPLETED|Open-label Period||6
5056214|NCT01917006|12444166|P7|COMPLETED|Open-label Period||0
5056215|NCT01917006|12444167|P6|COMPLETED|Open-label Period||0
5056216|NCT01917006|12444168|P5|COMPLETED|Open-label Period||0
5056217|NCT01917006|12444169|P4|COMPLETED|Open-label Period||0
5056218|NCT01917006|12444170|P3|COMPLETED|Open-label Period||0
5056219|NCT01917006|12444171|P2|COMPLETED|Open-label Period||0
5056220|NCT01917006|12444172|P1|COMPLETED|Open-label Period||0
5056221|NCT01917006|12444165|P8|STARTED|Open-label Period||8
5056222|NCT01917006|12444166|P7|STARTED|Open-label Period||0
5056223|NCT01917006|12444167|P6|STARTED|Open-label Period||0
5056224|NCT01917006|12444168|P5|STARTED|Open-label Period||0
5056225|NCT01917006|12444169|P4|STARTED|Open-label Period||0
5056226|NCT01917006|12444170|P3|STARTED|Open-label Period||0
5056227|NCT01917006|12444171|P2|STARTED|Open-label Period||0
5056228|NCT01917006|12444172|P1|STARTED|Open-label Period||0
5056229|NCT01917006|12444165|P8|NOT COMPLETED|Randomized-treatment Period||0
5056230|NCT01917006|12444166|P7|NOT COMPLETED|Randomized-treatment Period||1
5056231|NCT01917006|12444167|P6|NOT COMPLETED|Randomized-treatment Period||1
5056232|NCT01917006|12444168|P5|NOT COMPLETED|Randomized-treatment Period||0
5056233|NCT01917006|12444169|P4|NOT COMPLETED|Randomized-treatment Period||1
5056234|NCT01917006|12444170|P3|NOT COMPLETED|Randomized-treatment Period||0
5056235|NCT01917006|12444171|P2|NOT COMPLETED|Randomized-treatment Period||0
5056236|NCT01917006|12444172|P1|NOT COMPLETED|Randomized-treatment Period||2
5056237|NCT01917006|12444165|P8|COMPLETED|Randomized-treatment Period||0
5056238|NCT01917006|12444166|P7|COMPLETED|Randomized-treatment Period||14
5056239|NCT01917006|12444167|P6|COMPLETED|Randomized-treatment Period||7
5056240|NCT01917006|12444168|P5|COMPLETED|Randomized-treatment Period||8
5056241|NCT01917006|12444169|P4|COMPLETED|Randomized-treatment Period||7
5056242|NCT01917006|12444170|P3|COMPLETED|Randomized-treatment Period||8
5056243|NCT01917006|12444171|P2|COMPLETED|Randomized-treatment Period||7
5056244|NCT01917006|12444172|P1|COMPLETED|Randomized-treatment Period||3
5056245|NCT01917006|12444165|P8|STARTED|Randomized-treatment Period||0
5056246|NCT01917006|12444166|P7|STARTED|Randomized-treatment Period||15
5056247|NCT01917006|12444167|P6|STARTED|Randomized-treatment Period||8
5056248|NCT01917006|12444168|P5|STARTED|Randomized-treatment Period||8
5056249|NCT01917006|12444169|P4|STARTED|Randomized-treatment Period||8
5056250|NCT01917006|12444170|P3|STARTED|Randomized-treatment Period||8
5056251|NCT01917006|12444171|P2|STARTED|Randomized-treatment Period||7
5056252|NCT01917006|12444172|P1|STARTED|Randomized-treatment Period||5
5056253|NCT01916980|12444205|P2|NOT COMPLETED|Overall Study||4
5056254|NCT01916980|12444206|P1|NOT COMPLETED|Overall Study||7
5056255|NCT01916980|12444205|P2|COMPLETED|Overall Study||25
5056256|NCT01916980|12444206|P1|COMPLETED|Overall Study||58
5056257|NCT01916980|12444205|P2|STARTED|Overall Study||29
5056258|NCT01916980|12444206|P1|STARTED|Overall Study||65
5056259|NCT01916967|12444225|P3|NOT COMPLETED|Overall Study||9
5056260|NCT01916967|12444226|P2|NOT COMPLETED|Overall Study||1
5056261|NCT01916967|12444227|P1|NOT COMPLETED|Overall Study||0
5056262|NCT01916967|12444225|P3|COMPLETED|Overall Study||71
5056263|NCT01916967|12444226|P2|COMPLETED|Overall Study||78
5056264|NCT01916967|12444227|P1|COMPLETED|Overall Study||80
5056265|NCT01916967|12444225|P3|STARTED|Overall Study||80
5056266|NCT01916967|12444226|P2|STARTED|Overall Study||79
5056267|NCT01916967|12444227|P1|STARTED|Overall Study||80
5056268|NCT01916941|12444270|P2|NOT COMPLETED|Overall Study||4
5056269|NCT01916941|12444271|P1|NOT COMPLETED|Overall Study||5
5056270|NCT01916941|12444270|P2|COMPLETED|Overall Study||14
5056271|NCT01916941|12444271|P1|COMPLETED|Overall Study||13
5056272|NCT01916941|12444270|P2|STARTED|Overall Study||18
5056273|NCT01916941|12444271|P1|STARTED|Overall Study||18
5056274|NCT01916928|12444277|P1|NOT COMPLETED|Overall Study||0
5056275|NCT01916928|12444277|P1|COMPLETED|Overall Study||50
5056276|NCT01916928|12444277|P1|STARTED|Overall Study||50
5056277|NCT01916824|12444283|P2|NOT COMPLETED|Overall Study||9
5056278|NCT01916824|12444284|P1|NOT COMPLETED|Overall Study||7
5056279|NCT01916824|12444283|P2|COMPLETED|Overall Study||20
5056280|NCT01916824|12444284|P1|COMPLETED|Overall Study||17
5056281|NCT01916824|12444283|P2|STARTED|Overall Study||29
5056282|NCT01916824|12444284|P1|STARTED|Overall Study||24
5056283|NCT01916681|12444294|P4|NOT COMPLETED|Overall Study||0
5056284|NCT01916681|12444295|P3|NOT COMPLETED|Overall Study||0
5056285|NCT01916681|12444296|P2|NOT COMPLETED|Overall Study||0
5056286|NCT01916681|12444297|P1|NOT COMPLETED|Overall Study||0
5056287|NCT01916681|12444294|P4|COMPLETED|Overall Study||125
5056288|NCT01916681|12444295|P3|COMPLETED|Overall Study||123
5056289|NCT01916681|12444296|P2|COMPLETED|Overall Study||120
5056290|NCT01916681|12444297|P1|COMPLETED|Overall Study||123
5056291|NCT01916681|12444294|P4|STARTED|Overall Study||125
5056292|NCT01916681|12444295|P3|STARTED|Overall Study||123
5056293|NCT01916681|12444296|P2|STARTED|Overall Study||120
5056294|NCT01916681|12444297|P1|STARTED|Overall Study||123
5056295|NCT01916655|12444338|P3|NOT COMPLETED|Overall Study||29
5056296|NCT01916655|12444339|P2|NOT COMPLETED|Overall Study||20
5056297|NCT01916655|12444340|P1|NOT COMPLETED|Overall Study||15
5056298|NCT01916655|12444338|P3|COMPLETED|Overall Study||91
5056299|NCT01916655|12444339|P2|COMPLETED|Overall Study||89
5056300|NCT01916655|12444340|P1|COMPLETED|Overall Study||116
5056301|NCT01916655|12444338|P3|STARTED|Overall Study||120
5056302|NCT01916655|12444339|P2|STARTED|Overall Study||109
5056303|NCT01916655|12444340|P1|STARTED|Overall Study||131
5056304|NCT01916629|12444350|P2|NOT COMPLETED|Overall Study||0
5056305|NCT01916629|12444351|P1|NOT COMPLETED|Overall Study||0
5056306|NCT01916629|12444350|P2|COMPLETED|Overall Study||5
5056307|NCT01916629|12444351|P1|COMPLETED|Overall Study||7
5056308|NCT01916629|12444350|P2|STARTED|Overall Study||5
5056309|NCT01916629|12444351|P1|STARTED|Overall Study||7
5056310|NCT01916590|12444359|P2|NOT COMPLETED|Overall Study||0
5056311|NCT01916590|12444360|P1|NOT COMPLETED|Overall Study||0
5056312|NCT01916590|12444359|P2|COMPLETED|Overall Study||3
5056313|NCT01916590|12444360|P1|COMPLETED|Overall Study||4
5056314|NCT01916590|12444359|P2|STARTED|Overall Study||3
5056315|NCT01916590|12444360|P1|STARTED|Overall Study||4
5056316|NCT01916304|12444366|P1|NOT COMPLETED|Overall Study||17
5056317|NCT01916304|12444366|P1|COMPLETED|Overall Study||84
5056318|NCT01916304|12444366|P1|Intent-to-Treat Set|Overall Study||84
5056319|NCT01916304|12444366|P1|Safety Set|Overall Study||101
5056320|NCT01916304|12444366|P1|STARTED|Overall Study||101
5056321|NCT01916226|12444378|P4|NOT COMPLETED|Overall Study||4
5056322|NCT01916226|12444379|P3|NOT COMPLETED|Overall Study||3
5056323|NCT01916226|12444380|P2|NOT COMPLETED|Overall Study||1
5056324|NCT01916226|12444381|P1|NOT COMPLETED|Overall Study||1
5056325|NCT01916226|12444378|P4|COMPLETED|Overall Study||167
5056326|NCT01916226|12444379|P3|COMPLETED|Overall Study||168
5056327|NCT01916226|12444380|P2|COMPLETED|Overall Study||169
5056328|NCT01916226|12444381|P1|COMPLETED|Overall Study||169
5056329|NCT01916226|12444378|P4|STARTED|Overall Study||171
5056330|NCT01916226|12444379|P3|STARTED|Overall Study||171
5056331|NCT01916226|12444380|P2|STARTED|Overall Study||170
5056332|NCT01916226|12444381|P1|STARTED|Overall Study||170
5056333|NCT01916109|12444415|P1|NOT COMPLETED|Overall Study||1
5056334|NCT01916109|12444415|P1|COMPLETED|Overall Study||3
5056335|NCT01916109|12444415|P1|STARTED|Overall Study||4
5056336|NCT01915940|12444421|P3|NOT COMPLETED|Treatment Period||4
5056337|NCT01915940|12444422|P2|NOT COMPLETED|Treatment Period||11
5056338|NCT01915940|12444423|P1|NOT COMPLETED|Treatment Period||0
5056339|NCT01915940|12444421|P3|COMPLETED|Treatment Period||62
5056340|NCT01915940|12444422|P2|COMPLETED|Treatment Period||53
5056341|NCT01915940|12444423|P1|COMPLETED|Treatment Period||0
5056342|NCT01915940|12444421|P3|STARTED|Treatment Period||66
5056343|NCT01915940|12444422|P2|STARTED|Treatment Period||64
5056344|NCT01915940|12444423|P1|STARTED|Treatment Period||0
5056345|NCT01915940|12444421|P3|NOT COMPLETED|Pre-randomization Washout Period||0
5056346|NCT01915940|12444422|P2|NOT COMPLETED|Pre-randomization Washout Period||0
5056347|NCT01915940|12444423|P1|NOT COMPLETED|Pre-randomization Washout Period||39
5056348|NCT01915940|12444421|P3|COMPLETED|Pre-randomization Washout Period||0
5056349|NCT01915940|12444422|P2|COMPLETED|Pre-randomization Washout Period||0
5056350|NCT01915940|12444423|P1|COMPLETED|Pre-randomization Washout Period||130
5056351|NCT01915940|12444421|P3|STARTED|Pre-randomization Washout Period||0
5056352|NCT01915940|12444422|P2|STARTED|Pre-randomization Washout Period||0
5056353|NCT01915940|12444423|P1|STARTED|Pre-randomization Washout Period||169
5056354|NCT01915914|12444439|P4|NOT COMPLETED|Follow-up Phase||2
5056355|NCT01915914|12444440|P3|NOT COMPLETED|Follow-up Phase||0
5056356|NCT01915914|12444441|P2|NOT COMPLETED|Follow-up Phase||0
5056357|NCT01915914|12444442|P1|NOT COMPLETED|Follow-up Phase||0
5056358|NCT01915914|12444439|P4|COMPLETED|Follow-up Phase||64
5056359|NCT01915914|12444440|P3|COMPLETED|Follow-up Phase||0
5056360|NCT01915914|12444441|P2|COMPLETED|Follow-up Phase||0
5056361|NCT01915914|12444442|P1|COMPLETED|Follow-up Phase||0
5056362|NCT01915914|12444439|P4|STARTED|Follow-up Phase||66
5056363|NCT01915914|12444440|P3|STARTED|Follow-up Phase||0
5056364|NCT01915914|12444441|P2|STARTED|Follow-up Phase||0
5056365|NCT01915914|12444442|P1|STARTED|Follow-up Phase||0
5056366|NCT01915914|12444439|P4|NOT COMPLETED|Maintenance Phase||0
5056367|NCT01915914|12444440|P3|NOT COMPLETED|Maintenance Phase||2
5056368|NCT01915914|12444441|P2|NOT COMPLETED|Maintenance Phase||6
5056369|NCT01915914|12444442|P1|NOT COMPLETED|Maintenance Phase||0
5056370|NCT01915914|12444439|P4|COMPLETED|Maintenance Phase||0
5056371|NCT01915914|12444440|P3|COMPLETED|Maintenance Phase||51
5056372|NCT01915914|12444441|P2|COMPLETED|Maintenance Phase||48
5056373|NCT01915914|12444442|P1|COMPLETED|Maintenance Phase||0
5056374|NCT01915914|12444439|P4|STARTED|Maintenance Phase||0
5056375|NCT01915914|12444440|P3|STARTED|Maintenance Phase||53
5056376|NCT01915914|12444441|P2|STARTED|Maintenance Phase||54
5056377|NCT01915914|12444442|P1|STARTED|Maintenance Phase||0
5056378|NCT01915914|12444439|P4|NOT COMPLETED|Acute Phase||0
5056379|NCT01915914|12444440|P3|NOT COMPLETED|Acute Phase||0
5056380|NCT01915914|12444441|P2|NOT COMPLETED|Acute Phase||0
5056381|NCT01915914|12444442|P1|NOT COMPLETED|Acute Phase||12
5056382|NCT01915914|12444439|P4|COMPLETED|Acute Phase||0
5056383|NCT01915914|12444440|P3|COMPLETED|Acute Phase||0
5056384|NCT01915914|12444441|P2|COMPLETED|Acute Phase||0
5056385|NCT01915914|12444442|P1|COMPLETED|Acute Phase||111
5056386|NCT01915914|12444439|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
5056387|NCT01915914|12444440|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
5056388|NCT01915914|12444441|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
5056389|NCT01915914|12444442|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
5056390|NCT01915914|12444439|P4|STARTED|Acute Phase||0
5056391|NCT01915914|12444440|P3|STARTED|Acute Phase||0
5056392|NCT01915914|12444441|P2|STARTED|Acute Phase||0
5056393|NCT01915914|12444442|P1|STARTED|Acute Phase||123
5056394|NCT01915849|12444474|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
5056395|NCT01915849|12444475|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
5056396|NCT01915849|12444476|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
5056397|NCT01915849|12444477|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
5056398|NCT01915849|12444474|P4|COMPLETED|Treatment Period 4 (4 Days)||3
5056399|NCT01915849|12444475|P3|COMPLETED|Treatment Period 4 (4 Days)||3
5056400|NCT01915849|12444476|P2|COMPLETED|Treatment Period 4 (4 Days)||3
5056401|NCT01915849|12444477|P1|COMPLETED|Treatment Period 4 (4 Days)||3
5056402|NCT01915849|12444474|P4|STARTED|Treatment Period 4 (4 Days)||3
5056403|NCT01915849|12444475|P3|STARTED|Treatment Period 4 (4 Days)||3
5056404|NCT01915849|12444476|P2|STARTED|Treatment Period 4 (4 Days)||3
5056405|NCT01915849|12444477|P1|STARTED|Treatment Period 4 (4 Days)||3
5056406|NCT01915849|12444474|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
5056407|NCT01915849|12444475|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
5056408|NCT01915849|12444476|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
5056409|NCT01915849|12444477|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
5056410|NCT01915849|12444474|P4|COMPLETED|Treatment Period 3 (4 Days)||3
5056411|NCT01915849|12444475|P3|COMPLETED|Treatment Period 3 (4 Days)||3
5056412|NCT01915849|12444476|P2|COMPLETED|Treatment Period 3 (4 Days)||3
5056413|NCT01915849|12444477|P1|COMPLETED|Treatment Period 3 (4 Days)||3
5056414|NCT01915849|12444474|P4|STARTED|Treatment Period 3 (4 Days)||3
5056415|NCT01915849|12444475|P3|STARTED|Treatment Period 3 (4 Days)||3
5056416|NCT01915849|12444476|P2|STARTED|Treatment Period 3 (4 Days)||3
5056417|NCT01915849|12444477|P1|STARTED|Treatment Period 3 (4 Days)||3
5056418|NCT01915849|12444474|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5056419|NCT01915849|12444475|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5056420|NCT01915849|12444476|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5056421|NCT01915849|12444477|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
5056422|NCT01915849|12444474|P4|COMPLETED|Treatment Period 2 (4 Days)||3
5056423|NCT01915849|12444475|P3|COMPLETED|Treatment Period 2 (4 Days)||3
5056424|NCT01915849|12444476|P2|COMPLETED|Treatment Period 2 (4 Days)||3
5056425|NCT01915849|12444477|P1|COMPLETED|Treatment Period 2 (4 Days)||3
5056426|NCT01915849|12444474|P4|STARTED|Treatment Period 2 (4 Days)||3
5056427|NCT01915849|12444475|P3|STARTED|Treatment Period 2 (4 Days)||3
5056428|NCT01915849|12444476|P2|STARTED|Treatment Period 2 (4 Days)||3
5056429|NCT01915849|12444477|P1|STARTED|Treatment Period 2 (4 Days)||3
5056430|NCT01915849|12444474|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5056431|NCT01915849|12444475|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5056432|NCT01915849|12444476|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
5056433|NCT01915849|12444477|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
5056434|NCT01915849|12444474|P4|COMPLETED|Treatment Period 1 (4 Days)||3
5056435|NCT01915849|12444475|P3|COMPLETED|Treatment Period 1 (4 Days)||3
5056436|NCT01915849|12444476|P2|COMPLETED|Treatment Period 1 (4 Days)||3
5056437|NCT01915849|12444477|P1|COMPLETED|Treatment Period 1 (4 Days)||3
5056438|NCT01915849|12444474|P4|STARTED|Treatment Period 1 (4 Days)||3
5056439|NCT01915849|12444475|P3|STARTED|Treatment Period 1 (4 Days)||3
5056440|NCT01915849|12444476|P2|STARTED|Treatment Period 1 (4 Days)||3
5056441|NCT01915849|12444477|P1|STARTED|Treatment Period 1 (4 Days)||5
5056442|NCT01915823|12444489|P2|NOT COMPLETED|Overall Study||2
5056443|NCT01915823|12444490|P1|NOT COMPLETED|Overall Study||2
5056444|NCT01915823|12444489|P2|COMPLETED|Overall Study||173
5056445|NCT01915823|12444490|P1|COMPLETED|Overall Study||171
5056446|NCT01915823|12444489|P2|STARTED|Overall Study||175
5056447|NCT01915823|12444490|P1|STARTED|Overall Study||173
5056448|NCT01915771|12444500|P1|NOT COMPLETED|Day 15||1
5056449|NCT01915771|12444500|P1|COMPLETED|Day 15||13
5056450|NCT01915771|12444500|P1|STARTED|Day 15||14
5056451|NCT01915771|12444500|P1|NOT COMPLETED|Day 1||1
5056452|NCT01915771|12444500|P1|COMPLETED|Day 1||14
5056453|NCT01915771|12444500|P1|STARTED|Day 1||15
5056454|NCT01915732|12444524|P2|NOT COMPLETED|Overall Study||71
5056455|NCT01915732|12444525|P1|NOT COMPLETED|Overall Study||70
5056456|NCT01915732|12444524|P2|COMPLETED|Overall Study||445
5056457|NCT01915732|12444525|P1|COMPLETED|Overall Study||430
5056458|NCT01915732|12444524|P2|STARTED|Overall Study||516
5056459|NCT01915732|12444525|P1|STARTED|Overall Study||500
5056460|NCT01915563|12444551|P2|NOT COMPLETED|Overall Study||0
5056461|NCT01915563|12444552|P1|NOT COMPLETED|Overall Study||0
5056462|NCT01915563|12444551|P2|COMPLETED|Overall Study||227
5056463|NCT01915563|12444552|P1|COMPLETED|Overall Study||243
5056464|NCT01915563|12444551|P2|STARTED|Overall Study||227
5056465|NCT01915563|12444552|P1|STARTED|Overall Study||243
5056466|NCT01915173|12444564|P4|NOT COMPLETED|Overall Study||0
5056467|NCT01915173|12444565|P3|NOT COMPLETED|Overall Study||0
5056468|NCT01915173|12444566|P2|NOT COMPLETED|Overall Study||0
5056469|NCT01915173|12444567|P1|NOT COMPLETED|Overall Study||0
5056470|NCT01915173|12444564|P4|COMPLETED|Overall Study||6
5056471|NCT01915173|12444565|P3|COMPLETED|Overall Study||6
5056472|NCT01915173|12444566|P2|COMPLETED|Overall Study||6
5056473|NCT01915173|12444567|P1|COMPLETED|Overall Study||6
5056474|NCT01915173|12444564|P4|STARTED|Overall Study||6
5056475|NCT01915173|12444565|P3|STARTED|Overall Study||6
5056476|NCT01915173|12444566|P2|STARTED|Overall Study||6
5056477|NCT01915173|12444567|P1|STARTED|Overall Study||6
5056478|NCT01915108|12444589|P4|NOT COMPLETED|Overall Study||2
5056479|NCT01915108|12444590|P3|NOT COMPLETED|Overall Study||1
5056480|NCT01915108|12444591|P2|NOT COMPLETED|Overall Study||3
5056481|NCT01915108|12444592|P1|NOT COMPLETED|Overall Study||2
5056482|NCT01915108|12444589|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
5056483|NCT01915108|12444590|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
5056484|NCT01915108|12444591|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
5056485|NCT01915108|12444592|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
5056486|NCT01915108|12444589|P4|STARTED|Overall Study||32
5056487|NCT01915108|12444590|P3|STARTED|Overall Study||32
5056488|NCT01915108|12444591|P2|STARTED|Overall Study||32
5056489|NCT01915108|12444592|P1|STARTED|Overall Study||32
5056490|NCT01914926|12444604|P2|NOT COMPLETED|Overall Study||1
5056491|NCT01914926|12444605|P1|NOT COMPLETED|Overall Study||1
5056492|NCT01914926|12444604|P2|COMPLETED|Overall Study||24
5056493|NCT01914926|12444605|P1|COMPLETED|Overall Study||28
5056494|NCT01914926|12444604|P2|STARTED|Overall Study||25
5056495|NCT01914926|12444605|P1|STARTED|Overall Study||29
5056496|NCT01914757|12444614|P3|NOT COMPLETED|Overall Study||38
5056497|NCT01914757|12444615|P2|NOT COMPLETED|Overall Study||51
5056498|NCT01914757|12444616|P1|NOT COMPLETED|Overall Study||36
5056499|NCT01914757|12444614|P3|COMPLETED|Overall Study||402
5056500|NCT01914757|12444615|P2|COMPLETED|Overall Study||390
5056501|NCT01914757|12444616|P1|COMPLETED|Overall Study||389
5056502|NCT01914757|12444614|P3|STARTED|Overall Study||440
5056503|NCT01914757|12444615|P2|STARTED|Overall Study||441
5056504|NCT01914757|12444616|P1|STARTED|Overall Study||425
5056505|NCT01914679|12444690|P1|NOT COMPLETED|Overall Study||5
5056506|NCT01914679|12444690|P1|COMPLETED|Overall Study||12
5056507|NCT01914679|12444690|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
5056508|NCT01914679|12444690|P1|STARTED|Overall Study||17
5056509|NCT01914666|12444697|P3|NOT COMPLETED|Tapering Period||0
5056510|NCT01914666|12444698|P2|NOT COMPLETED|Tapering Period||0
5056511|NCT01914666|12444699|P1|NOT COMPLETED|Tapering Period||0
5056512|NCT01914666|12444697|P3|COMPLETED|Tapering Period||40
5056513|NCT01914666|12444698|P2|COMPLETED|Tapering Period||39
5056514|NCT01914666|12444699|P1|COMPLETED|Tapering Period||59
5056515|NCT01914666|12444697|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
5056516|NCT01914666|12444698|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
5056517|NCT01914666|12444699|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
5056518|NCT01914666|12444697|P3|NOT COMPLETED|Treatment Period||8
5056519|NCT01914666|12444698|P2|NOT COMPLETED|Treatment Period||6
5056520|NCT01914666|12444699|P1|NOT COMPLETED|Treatment Period||13
5056521|NCT01914666|12444697|P3|COMPLETED|Treatment Period||33
5056522|NCT01914666|12444698|P2|COMPLETED|Treatment Period||36
5056523|NCT01914666|12444699|P1|COMPLETED|Treatment Period||55
5056524|NCT01914666|12444697|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
5056525|NCT01914666|12444698|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
5056526|NCT01914666|12444699|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
5056527|NCT01914666|12444697|P3|STARTED|Treatment Period||41
5056528|NCT01914666|12444698|P2|STARTED|Treatment Period||42
5056529|NCT01914666|12444699|P1|STARTED|Treatment Period||68
5056530|NCT01914510|12444732|P1|NOT COMPLETED|Overall Study||2
5056531|NCT01914510|12444732|P1|COMPLETED|Overall Study||38
5056532|NCT01914510|12444732|P1|STARTED|Overall Study||40
5056533|NCT01914393|12444742|P3|NOT COMPLETED|Overall Study||138
5056534|NCT01914393|12444743|P2|NOT COMPLETED|Overall Study||71
5056535|NCT01914393|12444744|P1|NOT COMPLETED|Overall Study||115
5056536|NCT01914393|12444742|P3|COMPLETED|Overall Study||168
5056537|NCT01914393|12444743|P2|COMPLETED|Overall Study||54
5056538|NCT01914393|12444744|P1|COMPLETED|Overall Study||156
5056539|NCT01914393|12444742|P3|STARTED|Overall Study||306
5056540|NCT01914393|12444743|P2|STARTED|Overall Study||125
5056541|NCT01914393|12444744|P1|STARTED|Overall Study||271
5056542|NCT01914159|12444776|P1|NOT COMPLETED|Overall Study||3
5056543|NCT01914159|12444776|P1|COMPLETED|Overall Study||21
5056544|NCT01914159|12444776|P1|STARTED|Overall Study||24
5056545|NCT01914003|12444784|P2|NOT COMPLETED|Overall Study||12
5056546|NCT01914003|12444785|P1|NOT COMPLETED|Overall Study||8
5056547|NCT01914003|12444784|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
5056548|NCT01914003|12444785|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
5056549|NCT01914003|12444784|P2|STARTED|Overall Study||26
5056550|NCT01914003|12444785|P1|STARTED|Overall Study||27
5056551|NCT01913795|12444795|P4|NOT COMPLETED|Overall Study||1
5056552|NCT01913795|12444796|P3|NOT COMPLETED|Overall Study||0
5056553|NCT01913795|12444797|P2|NOT COMPLETED|Overall Study||3
5056554|NCT01913795|12444798|P1|NOT COMPLETED|Overall Study||0
5056555|NCT01913795|12444795|P4|COMPLETED|Overall Study||5
5056556|NCT01913795|12444796|P3|COMPLETED|Overall Study||9
5056557|NCT01913795|12444797|P2|COMPLETED|Overall Study||7
5056558|NCT01913795|12444798|P1|COMPLETED|Overall Study||4
5056559|NCT01913795|12444795|P4|STARTED|Overall Study||6
5056560|NCT01913795|12444796|P3|STARTED|Overall Study||9
5056561|NCT01913795|12444797|P2|STARTED|Overall Study||10
5056562|NCT01913795|12444798|P1|STARTED|Overall Study||4
5056563|NCT01913639|12444812|P1|NOT COMPLETED|Overall Study||3
5056564|NCT01913639|12444812|P1|COMPLETED|Overall Study||36
5056565|NCT01913639|12444812|P1|STARTED|Overall Study||39
5056566|NCT01913600|12444819|P1|NOT COMPLETED|Overall Study||1
5056567|NCT01913600|12444819|P1|COMPLETED|Overall Study||55
5056568|NCT01913600|12444819|P1|STARTED|Overall Study||56
5056569|NCT01913535|12444841|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
5056570|NCT01913535|12444842|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
5056571|NCT01913535|12444843|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
5056572|NCT01913535|12444844|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
5056573|NCT01913535|12444845|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
5056574|NCT01913535|12444841|P5|COMPLETED|Phase 2 (Days 3-5)||1
5056575|NCT01913535|12444842|P4|COMPLETED|Phase 2 (Days 3-5)||2
5056576|NCT01913535|12444843|P3|COMPLETED|Phase 2 (Days 3-5)||1
5056577|NCT01913535|12444844|P2|COMPLETED|Phase 2 (Days 3-5)||2
5056578|NCT01913535|12444845|P1|COMPLETED|Phase 2 (Days 3-5)||2
5056579|NCT01913535|12444841|P5|STARTED|Phase 2 (Days 3-5)||1
5056580|NCT01913535|12444842|P4|STARTED|Phase 2 (Days 3-5)||2
5056581|NCT01913535|12444843|P3|STARTED|Phase 2 (Days 3-5)||1
5056582|NCT01913535|12444844|P2|STARTED|Phase 2 (Days 3-5)||2
5056583|NCT01913535|12444845|P1|STARTED|Phase 2 (Days 3-5)||2
5056584|NCT01913535|12444841|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
5056585|NCT01913535|12444842|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
5056586|NCT01913535|12444843|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
5056587|NCT01913535|12444844|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
5056588|NCT01913535|12444845|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
5056589|NCT01913535|12444841|P5|COMPLETED|Phase 1 (Days 0-2)||1
5056590|NCT01913535|12444842|P4|COMPLETED|Phase 1 (Days 0-2)||2
5056591|NCT01913535|12444843|P3|COMPLETED|Phase 1 (Days 0-2)||1
5056592|NCT01913535|12444844|P2|COMPLETED|Phase 1 (Days 0-2)||2
5056593|NCT01913535|12444845|P1|COMPLETED|Phase 1 (Days 0-2)||2
5056594|NCT01913535|12444841|P5|STARTED|Phase 1 (Days 0-2)||1
5056595|NCT01913535|12444842|P4|STARTED|Phase 1 (Days 0-2)||2
5056596|NCT01913535|12444843|P3|STARTED|Phase 1 (Days 0-2)||1
5056597|NCT01913535|12444844|P2|STARTED|Phase 1 (Days 0-2)||2
5056598|NCT01913535|12444845|P1|STARTED|Phase 1 (Days 0-2)||2
5056599|NCT01913483|12444878|P2|NOT COMPLETED|Overall Study||22
5056600|NCT01913483|12444879|P1|NOT COMPLETED|Overall Study||21
5056601|NCT01913483|12444878|P2|COMPLETED|Overall Study||343
5056602|NCT01913483|12444879|P1|COMPLETED|Overall Study||346
5056603|NCT01913483|12444878|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
5056604|NCT01913483|12444879|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
5056605|NCT01913483|12444878|P2|STARTED|Overall Study||365
5056606|NCT01913483|12444879|P1|STARTED|Overall Study||367
5056607|NCT01913470|12444891|P2|NOT COMPLETED|Overall Study||3
5056608|NCT01913470|12444892|P1|NOT COMPLETED|Overall Study||0
5056609|NCT01913470|12444891|P2|COMPLETED|Overall Study||4
5056610|NCT01913470|12444892|P1|COMPLETED|Overall Study||5
5056611|NCT01913470|12444891|P2|STARTED|Overall Study||7
5056612|NCT01913470|12444892|P1|STARTED|Overall Study||5
5056613|NCT01913405|12444910|P1|NOT COMPLETED|Overall Study||2
5056614|NCT01913405|12444910|P1|COMPLETED|Overall Study||20
5056615|NCT01913405|12444910|P1|STARTED|Overall Study||22
5056616|NCT01913353|12444966|P2|NOT COMPLETED|Overall Study||15
5056617|NCT01913353|12444967|P1|NOT COMPLETED|Overall Study||32
5056618|NCT01913353|12444966|P2|COMPLETED|Overall Study||204
5056619|NCT01913353|12444967|P1|COMPLETED|Overall Study||189
5056620|NCT01913353|12444966|P2|STARTED|Overall Study||219
5056621|NCT01913353|12444967|P1|STARTED|Overall Study||221
5056622|NCT01913340|12445037|P2|NOT COMPLETED|Overall Study||6
5056623|NCT01913340|12445038|P1|NOT COMPLETED|Overall Study||3
5056624|NCT01913340|12445037|P2|COMPLETED|Overall Study||20
5056625|NCT01913340|12445038|P1|COMPLETED|Overall Study||21
5056626|NCT01913340|12445037|P2|STARTED|Overall Study||26
5056627|NCT01913340|12445038|P1|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
5056628|NCT01913327|12445062|P2|NOT COMPLETED|Overall Study||1
5056629|NCT01913327|12445063|P1|NOT COMPLETED|Overall Study||0
5056630|NCT01913327|12445062|P2|COMPLETED|Overall Study||1
5056631|NCT01913327|12445063|P1|COMPLETED|Overall Study||1
5056632|NCT01913327|12445062|P2|STARTED|Overall Study||2
5056633|NCT01913327|12445063|P1|STARTED|Overall Study||1
5056634|NCT01913314|12445075|P1|NOT COMPLETED|Overall Study||0
5056635|NCT01913314|12445075|P1|COMPLETED|Overall Study||6
5056636|NCT01913314|12445075|P1|Received Study Drug|Overall Study||6
5056637|NCT01913314|12445075|P1|STARTED|Overall Study||6
5056638|NCT01913041|12445088|P1|NOT COMPLETED|Overall Study||39
5056639|NCT01913041|12445088|P1|COMPLETED|Overall Study||830
5056640|NCT01913041|12445088|P1|STARTED|Overall Study||869
5056641|NCT01912963|12445095|P3|NOT COMPLETED|Overall Study||7
5056642|NCT01912963|12445096|P2|NOT COMPLETED|Overall Study||19
5056643|NCT01912963|12445097|P1|NOT COMPLETED|Overall Study||6
5056644|NCT01912963|12445095|P3|COMPLETED|Overall Study||0
5056645|NCT01912963|12445096|P2|COMPLETED|Overall Study||0
5056646|NCT01912963|12445097|P1|COMPLETED|Overall Study||0
5056647|NCT01912963|12445095|P3|STARTED|Overall Study||7
5056648|NCT01912963|12445096|P2|STARTED|Overall Study||19
5056649|NCT01912963|12445097|P1|STARTED|Overall Study||6
5056650|NCT01912872|12445120|P4|NOT COMPLETED|Overall Study||12
5056651|NCT01912872|12445121|P3|NOT COMPLETED|Overall Study||10
5056652|NCT01912872|12445122|P2|NOT COMPLETED|Overall Study||4
5056653|NCT01912872|12445123|P1|NOT COMPLETED|Overall Study||5
5056654|NCT01912872|12445120|P4|COMPLETED|Overall Study||27
5056655|NCT01912872|12445121|P3|COMPLETED|Overall Study||30
5056656|NCT01912872|12445122|P2|COMPLETED|Overall Study||13
5056657|NCT01912872|12445123|P1|COMPLETED|Overall Study||11
5056658|NCT01912872|12445120|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
5056659|NCT01912872|12445121|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
5056660|NCT01912872|12445122|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
5056661|NCT01912872|12445123|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
5056662|NCT01912872|12445120|P4|Completed Study Treatment at Month 12|Overall Study||27
5056663|NCT01912872|12445121|P3|Completed Study Treatment at Month 12|Overall Study||30
5056664|NCT01912872|12445122|P2|Completed Study Treatment at Month 12|Overall Study||13
5056665|NCT01912872|12445123|P1|Completed Study Treatment at Month 12|Overall Study||11
5056666|NCT01912872|12445120|P4|STARTED|Overall Study||39
5056667|NCT01912872|12445121|P3|STARTED|Overall Study||40
5056668|NCT01912872|12445122|P2|STARTED|Overall Study||17
5056669|NCT01912872|12445123|P1|STARTED|Overall Study||16
5056670|NCT01912781|12445167|P2|NOT COMPLETED|Overall Study||0
5056671|NCT01912781|12445168|P1|NOT COMPLETED|Overall Study||2
5056672|NCT01912781|12445167|P2|COMPLETED|Overall Study||35
5056673|NCT01912781|12445168|P1|COMPLETED|Overall Study||69
5056674|NCT01912781|12445167|P2|STARTED|Overall Study||35
5056675|NCT01912781|12445168|P1|STARTED|Overall Study||71
5056676|NCT01912768|12445199|P2|NOT COMPLETED|Overall Study||4
5056677|NCT01912768|12445200|P1|NOT COMPLETED|Overall Study||10
5056678|NCT01912768|12445199|P2|COMPLETED|Overall Study||109
5056679|NCT01912768|12445200|P1|COMPLETED|Overall Study||229
5056680|NCT01912768|12445199|P2|STARTED|Overall Study||113
5056681|NCT01912768|12445200|P1|STARTED|Overall Study||239
5056682|NCT01912729|12445231|P2|NOT COMPLETED|Overall Study||1
5056683|NCT01912729|12445232|P1|NOT COMPLETED|Overall Study||0
5056684|NCT01912729|12445231|P2|COMPLETED|Overall Study||19
5056685|NCT01912729|12445232|P1|COMPLETED|Overall Study||20
5056686|NCT01912729|12445231|P2|STARTED|Overall Study||20
5056687|NCT01912729|12445232|P1|STARTED|Overall Study||20
5056688|NCT01912716|12445244|P2|NOT COMPLETED|Overall Study||0
5056689|NCT01912716|12445245|P1|NOT COMPLETED|Overall Study||0
5056690|NCT01912716|12445244|P2|COMPLETED|Overall Study||515
5056691|NCT01912716|12445245|P1|COMPLETED|Overall Study||522
5056692|NCT01912716|12445244|P2|3-day Follow-up|Overall Study||513
5056693|NCT01912716|12445245|P1|3-day Follow-up|Overall Study||521
5056694|NCT01912716|12445244|P2|5-day Follow-up|Overall Study||515
5056695|NCT01912716|12445245|P1|5-day Follow-up|Overall Study||522
5056696|NCT01912716|12445244|P2|Receipt of 2nd Dose|Overall Study||503
5056697|NCT01912716|12445245|P1|Receipt of 2nd Dose|Overall Study||511
5056698|NCT01912716|12445244|P2|STARTED|Overall Study||515
5056699|NCT01912716|12445245|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
5056700|NCT01912599|12445255|P2|NOT COMPLETED|Overall Study||1
5056701|NCT01912599|12445256|P1|NOT COMPLETED|Overall Study||0
5056702|NCT01912599|12445255|P2|COMPLETED|Overall Study||15
5056703|NCT01912599|12445256|P1|COMPLETED|Overall Study||20
5056704|NCT01912599|12445255|P2|STARTED|Overall Study||16
5056705|NCT01912599|12445256|P1|STARTED|Overall Study||20
5056706|NCT01912495|12445270|P1|NOT COMPLETED|Overall Study||0
5056707|NCT01912495|12445270|P1|COMPLETED|Overall Study||57
5056708|NCT01912495|12445270|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
5056709|NCT01912404|12445281|P2|NOT COMPLETED|Overall Study||0
5056710|NCT01912404|12445282|P1|NOT COMPLETED|Overall Study||1
5056711|NCT01912404|12445281|P2|COMPLETED|Overall Study||2
5056712|NCT01912404|12445282|P1|COMPLETED|Overall Study||2
5056713|NCT01912404|12445281|P2|STARTED|Overall Study||2
5056714|NCT01912404|12445282|P1|STARTED|Overall Study||3
5056715|NCT01912352|12445288|P1|NOT COMPLETED|Overall Study||5
5056716|NCT01912352|12445288|P1|COMPLETED|Overall Study||78
5056717|NCT01912352|12445288|P1|STARTED|Overall Study||83
5056718|NCT01912339|12445295|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
5056719|NCT01912339|12445296|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
5056720|NCT01912339|12445297|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
5056721|NCT01912339|12445295|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
5056722|NCT01912339|12445296|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
5056723|NCT01912339|12445297|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
5056724|NCT01912339|12445295|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
5056725|NCT01912339|12445296|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
5056726|NCT01912339|12445297|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
5056727|NCT01912339|12445295|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
5056728|NCT01912339|12445296|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
5056729|NCT01912339|12445297|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
5056730|NCT01912339|12445295|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
5056731|NCT01912339|12445296|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
5056732|NCT01912339|12445297|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
5056733|NCT01912339|12445295|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
5056734|NCT01912339|12445296|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
5056735|NCT01912339|12445297|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
5056736|NCT01912339|12445295|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
5056737|NCT01912339|12445296|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
5056738|NCT01912339|12445297|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
5056739|NCT01912339|12445295|P3|COMPLETED|Blinded (0 to 3 Months)||0
5056740|NCT01912339|12445296|P2|COMPLETED|Blinded (0 to 3 Months)||61
5056741|NCT01912339|12445297|P1|COMPLETED|Blinded (0 to 3 Months)||134
5056742|NCT01912339|12445295|P3|STARTED|Blinded (0 to 3 Months)||0
5056743|NCT01912339|12445296|P2|STARTED|Blinded (0 to 3 Months)||61
5056744|NCT01912339|12445297|P1|STARTED|Blinded (0 to 3 Months)||136
5056745|NCT01912287|12445314|P3|NOT COMPLETED|Overall Study||15
5056746|NCT01912287|12445315|P2|NOT COMPLETED|Overall Study||23
5056747|NCT01912287|12445316|P1|NOT COMPLETED|Overall Study||33
5056748|NCT01912287|12445314|P3|COMPLETED|Overall Study||28
5056749|NCT01912287|12445315|P2|COMPLETED|Overall Study||67
5056750|NCT01912287|12445316|P1|COMPLETED|Overall Study||60
5056751|NCT01912287|12445314|P3|STARTED|Overall Study||43
5056752|NCT01912287|12445315|P2|STARTED|Overall Study||90
5056753|NCT01912287|12445316|P1|STARTED|Overall Study||93
5056754|NCT01912222|12445327|P3|NOT COMPLETED|Part B: Treatment Period||20
5056755|NCT01912222|12445328|P2|NOT COMPLETED|Part B: Treatment Period||15
5056756|NCT01912222|12445329|P1|NOT COMPLETED|Part B: Treatment Period||13
5056757|NCT01912222|12445327|P3|COMPLETED|Part B: Treatment Period||0
5056758|NCT01912222|12445328|P2|COMPLETED|Part B: Treatment Period||0
5056759|NCT01912222|12445329|P1|COMPLETED|Part B: Treatment Period||0
5056760|NCT01912222|12445327|P3|STARTED|Part B: Treatment Period||20
5056761|NCT01912222|12445328|P2|STARTED|Part B: Treatment Period||15
5056762|NCT01912222|12445329|P1|STARTED|Part B: Treatment Period||13
5056763|NCT01912222|12445327|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
5056764|NCT01912222|12445328|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
5056765|NCT01912222|12445329|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
5056766|NCT01912222|12445327|P3|COMPLETED|Part A: Pharmacokinetic Period||18
5056767|NCT01912222|12445328|P2|COMPLETED|Part A: Pharmacokinetic Period||13
5056768|NCT01912222|12445329|P1|COMPLETED|Part A: Pharmacokinetic Period||12
5056769|NCT01912222|12445327|P3|STARTED|Part A: Pharmacokinetic Period||20
5056770|NCT01912222|12445328|P2|STARTED|Part A: Pharmacokinetic Period||15
5056771|NCT01912222|12445329|P1|STARTED|Part A: Pharmacokinetic Period||13
5056772|NCT01911845|12445352|P1|NOT COMPLETED|Overall Study||6
5056773|NCT01911845|12445352|P1|COMPLETED|Overall Study||32
5056774|NCT01911845|12445352|P1|Completed Study Drug|Overall Study||37
5056775|NCT01911845|12445352|P1|STARTED|Overall Study||38
5056776|NCT01911819|12445369|P3|NOT COMPLETED|Overall Study||0
5056777|NCT01911819|12445370|P2|NOT COMPLETED|Overall Study||2
5056778|NCT01911819|12445371|P1|NOT COMPLETED|Overall Study||1
5056779|NCT01911819|12445369|P3|COMPLETED|Overall Study||10
5056780|NCT01911819|12445370|P2|COMPLETED|Overall Study||9
5056781|NCT01911819|12445371|P1|COMPLETED|Overall Study||9
5056782|NCT01911819|12445369|P3|STARTED|Overall Study||10
5056783|NCT01911819|12445370|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
5056784|NCT01911819|12445371|P1|STARTED|Overall Study||10
5056785|NCT01911793|12445384|P2|NOT COMPLETED|Overall Study||5
5056786|NCT01911793|12445385|P1|NOT COMPLETED|Overall Study||1
5056787|NCT01911793|12445384|P2|COMPLETED|Overall Study||0
5056788|NCT01911793|12445385|P1|COMPLETED|Overall Study||0
5056789|NCT01911793|12445384|P2|STARTED|Overall Study||5
5056790|NCT01911793|12445385|P1|STARTED|Overall Study||1
5056791|NCT01911780|12445409|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
5056792|NCT01911780|12445410|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
5056793|NCT01911780|12445409|P2|COMPLETED|Extension Period (52 Weeks)||58
5056794|NCT01911780|12445410|P1|COMPLETED|Extension Period (52 Weeks)||61
5056795|NCT01911780|12445409|P2|STARTED|Extension Period (52 Weeks)||61
5056796|NCT01911780|12445410|P1|STARTED|Extension Period (52 Weeks)||65
5056797|NCT01911780|12445409|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
5056798|NCT01911780|12445410|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
5056799|NCT01911780|12445409|P2|COMPLETED|Double-blind Period (8 Weeks)||61
5056800|NCT01911780|12445410|P1|COMPLETED|Double-blind Period (8 Weeks)||65
5056801|NCT01911780|12445409|P2|STARTED|Double-blind Period (8 Weeks)||64
5056802|NCT01911780|12445410|P1|STARTED|Double-blind Period (8 Weeks)||68
5056803|NCT01911689|12445430|P2|NOT COMPLETED|Overall Study||0
5056804|NCT01911689|12445431|P1|NOT COMPLETED|Overall Study||0
5056805|NCT01911689|12445430|P2|COMPLETED|Overall Study||51
5056806|NCT01911689|12445431|P1|COMPLETED|Overall Study||117
5056807|NCT01911689|12445430|P2|STARTED|Overall Study||51
5056808|NCT01911689|12445431|P1|STARTED|Overall Study||117
5056809|NCT01911546|12445444|P1|NOT COMPLETED|Overall Study||6
5056810|NCT01911546|12445444|P1|COMPLETED|Overall Study||14
5056811|NCT01911546|12445444|P1|STARTED|Overall Study||20
5056812|NCT01911442|12445454|P3|NOT COMPLETED|Overall Study||12
5056813|NCT01911442|12445455|P2|NOT COMPLETED|Overall Study||4
5056814|NCT01911442|12445456|P1|NOT COMPLETED|Overall Study||6
5056815|NCT01911442|12445454|P3|COMPLETED|Overall Study||38
5056816|NCT01911442|12445455|P2|COMPLETED|Overall Study||47
5056817|NCT01911442|12445456|P1|COMPLETED|Overall Study||43
5056818|NCT01911442|12445454|P3|STARTED|Overall Study||50
5056819|NCT01911442|12445455|P2|STARTED|Overall Study||51
5056820|NCT01911442|12445456|P1|STARTED|Overall Study||49
5056821|NCT01911429|12445485|P3|NOT COMPLETED|Overall Study||20
5056822|NCT01911429|12445486|P2|NOT COMPLETED|Overall Study||10
5056823|NCT01911429|12445487|P1|NOT COMPLETED|Overall Study||12
5056824|NCT01911429|12445485|P3|COMPLETED|Overall Study||93
5056825|NCT01911429|12445486|P2|COMPLETED|Overall Study||96
5056826|NCT01911429|12445487|P1|COMPLETED|Overall Study||96
5056827|NCT01911429|12445485|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
5056828|NCT01911429|12445486|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
5056829|NCT01911429|12445487|P1|STARTED|Overall Study||108
5056830|NCT01911403|12445521|P2|NOT COMPLETED|Overall Study||3
5056831|NCT01911403|12445522|P1|NOT COMPLETED|Overall Study||9
5056832|NCT01911403|12445521|P2|COMPLETED|Overall Study||59
5056833|NCT01911403|12445522|P1|COMPLETED|Overall Study||52
5056834|NCT01911403|12445521|P2|STARTED|Overall Study||62
5056835|NCT01911403|12445522|P1|STARTED|Overall Study||61
5056836|NCT01911390|12445543|P4|NOT COMPLETED|Overall Study||1
5056837|NCT01911390|12445544|P3|NOT COMPLETED|Overall Study||1
5056838|NCT01911390|12445545|P2|NOT COMPLETED|Overall Study||0
5056839|NCT01911390|12445546|P1|NOT COMPLETED|Overall Study||1
5056840|NCT01911390|12445543|P4|COMPLETED|Overall Study||10
5056841|NCT01911390|12445544|P3|COMPLETED|Overall Study||9
5056842|NCT01911390|12445545|P2|COMPLETED|Overall Study||10
5056843|NCT01911390|12445546|P1|COMPLETED|Overall Study||9
5056844|NCT01911390|12445543|P4|STARTED|Overall Study||11
5056845|NCT01911390|12445544|P3|STARTED|Overall Study||10
5056846|NCT01911390|12445545|P2|STARTED|Overall Study||10
5056847|NCT01911390|12445546|P1|STARTED|Overall Study||10
5056848|NCT01911351|12445562|P2|NOT COMPLETED|Overall Study||0
5056849|NCT01911351|12445563|P1|NOT COMPLETED|Overall Study||0
5056850|NCT01911351|12445562|P2|COMPLETED|Overall Study||43
5056851|NCT01911351|12445563|P1|COMPLETED|Overall Study||39
5056852|NCT01911351|12445562|P2|STARTED|Overall Study||43
5056853|NCT01911351|12445563|P1|STARTED|Overall Study||39
5056854|NCT01911273|12445579|P2|NOT COMPLETED|Overall Study||2
5056855|NCT01911273|12445580|P1|NOT COMPLETED|Overall Study||1
5056856|NCT01911273|12445579|P2|COMPLETED|Overall Study||0
5056857|NCT01911273|12445580|P1|COMPLETED|Overall Study||0
5056858|NCT01911273|12445579|P2|STARTED|Overall Study||2
5056859|NCT01911273|12445580|P1|STARTED|Overall Study||1
5056860|NCT01911260|12445614|P4|NOT COMPLETED|Follow-up Period||12
5056861|NCT01911260|12445615|P3|NOT COMPLETED|Follow-up Period||15
5056862|NCT01911260|12445616|P2|NOT COMPLETED|Follow-up Period||20
5056863|NCT01911260|12445617|P1|NOT COMPLETED|Follow-up Period||13
5056864|NCT01911260|12445614|P4|COMPLETED|Follow-up Period||30
5056865|NCT01911260|12445615|P3|COMPLETED|Follow-up Period||24
5056866|NCT01911260|12445616|P2|COMPLETED|Follow-up Period||18
5056867|NCT01911260|12445617|P1|COMPLETED|Follow-up Period||27
5056868|NCT01911260|12445614|P4|STARTED|Follow-up Period||42
5056869|NCT01911260|12445615|P3|STARTED|Follow-up Period||39
5056870|NCT01911260|12445616|P2|STARTED|Follow-up Period||38
5056871|NCT01911260|12445617|P1|STARTED|Follow-up Period||40
5056872|NCT01911260|12445614|P4|NOT COMPLETED|Supplementation Period||8
5056873|NCT01911260|12445615|P3|NOT COMPLETED|Supplementation Period||10
5056874|NCT01911260|12445616|P2|NOT COMPLETED|Supplementation Period||12
5056875|NCT01911260|12445617|P1|NOT COMPLETED|Supplementation Period||10
5056876|NCT01911260|12445614|P4|COMPLETED|Supplementation Period||42
5056877|NCT01911260|12445615|P3|COMPLETED|Supplementation Period||39
5056878|NCT01911260|12445616|P2|COMPLETED|Supplementation Period||38
5056879|NCT01911260|12445617|P1|COMPLETED|Supplementation Period||40
5056880|NCT01911260|12445614|P4|STARTED|Supplementation Period||50
5056881|NCT01911260|12445615|P3|STARTED|Supplementation Period||49
5056882|NCT01911260|12445616|P2|STARTED|Supplementation Period||50
5056883|NCT01911260|12445617|P1|STARTED|Supplementation Period||50
5056884|NCT01911221|12445627|P1|NOT COMPLETED|Overall Study||0
5056885|NCT01911221|12445627|P1|COMPLETED|Overall Study||13
5056886|NCT01911221|12445627|P1|STARTED|Overall Study||13
5056887|NCT01911169|12445643|P2|NOT COMPLETED|Overall Study||0
5056888|NCT01911169|12445644|P1|NOT COMPLETED|Overall Study||0
5056889|NCT01911169|12445643|P2|COMPLETED|Overall Study||3
5056890|NCT01911169|12445644|P1|COMPLETED|Overall Study||6
5056891|NCT01911169|12445643|P2|STARTED|Overall Study||3
5056892|NCT01911169|12445644|P1|STARTED|Overall Study||6
5056893|NCT01911065|12445654|P2|NOT COMPLETED|Overall Study||0
5056894|NCT01911065|12445655|P1|NOT COMPLETED|Overall Study||0
5056895|NCT01911065|12445654|P2|COMPLETED|Overall Study||9
5056896|NCT01911065|12445655|P1|COMPLETED|Overall Study||45
5056897|NCT01911065|12445654|P2|STARTED|Overall Study||9
5056898|NCT01911065|12445655|P1|STARTED|Overall Study||45
5056899|NCT01910831|12445663|P1|NOT COMPLETED|Overall Study||1
5056900|NCT01910831|12445663|P1|COMPLETED|Overall Study||19
5056901|NCT01910831|12445663|P1|STARTED|Overall Study||20
5056902|NCT01910792|12445672|P2|NOT COMPLETED|Overall Study||0
5056903|NCT01910792|12445673|P1|NOT COMPLETED|Overall Study||0
5056904|NCT01910792|12445672|P2|COMPLETED|Overall Study||10
5056905|NCT01910792|12445673|P1|COMPLETED|Overall Study||9
5056906|NCT01910792|12445672|P2|STARTED|Overall Study||10
5056907|NCT01910792|12445673|P1|STARTED|Overall Study||9
5056908|NCT01910688|12445679|P1|NOT COMPLETED|Overall Study||5
5056909|NCT01910688|12445679|P1|COMPLETED|Overall Study||20
5056910|NCT01910688|12445679|P1|12months|Overall Study||22
5056911|NCT01910688|12445679|P1|3rd RFA Treatment|Overall Study||18
5056912|NCT01910688|12445679|P1|7.5months|Overall Study||24
5056913|NCT01910688|12445679|P1|2nd RFA Treatment|Overall Study||22
5056914|NCT01910688|12445679|P1|3.5month|Overall Study||25
5056915|NCT01910688|12445679|P1|STARTED|Overall Study||25
5056916|NCT01910636|12445688|P2|NOT COMPLETED|Overall Study||0
5056917|NCT01910636|12445689|P1|NOT COMPLETED|Overall Study||0
5056918|NCT01910636|12445688|P2|COMPLETED|Overall Study||63
5056919|NCT01910636|12445689|P1|COMPLETED|Overall Study||90
5056920|NCT01910636|12445688|P2|STARTED|Overall Study||63
5056921|NCT01910636|12445689|P1|STARTED|Overall Study||90
5056922|NCT01910519|12445703|P2|NOT COMPLETED|Overall Study||0
5056923|NCT01910519|12445704|P1|NOT COMPLETED|Overall Study||4
5056924|NCT01910519|12445703|P2|COMPLETED|Overall Study||15
5056925|NCT01910519|12445704|P1|COMPLETED|Overall Study||31
5056926|NCT01910519|12445703|P2|STARTED|Overall Study||15
5056927|NCT01910519|12445704|P1|STARTED|Overall Study||35
5056928|NCT01910441|12445730|P2|NOT COMPLETED|Overall Study||10
5056929|NCT01910441|12445731|P1|NOT COMPLETED|Overall Study||7
5056930|NCT01910441|12445730|P2|COMPLETED|Overall Study||37
5056931|NCT01910441|12445731|P1|COMPLETED|Overall Study||41
5056932|NCT01910441|12445730|P2|STARTED|Overall Study||47
5056933|NCT01910441|12445731|P1|STARTED|Overall Study||48
5056934|NCT01910402|12445739|P2|NOT COMPLETED|Continuation Phase||0
5056935|NCT01910402|12445740|P1|NOT COMPLETED|Continuation Phase||90
5056936|NCT01910402|12445739|P2|COMPLETED|Continuation Phase||0
5056937|NCT01910402|12445740|P1|COMPLETED|Continuation Phase||30
5056938|NCT01910402|12445739|P2|STARTED|Continuation Phase||0
5056939|NCT01910402|12445740|P1|STARTED|Continuation Phase||120
5056940|NCT01910402|12445739|P2|NOT COMPLETED|Randomized Phase||55
5056941|NCT01910402|12445740|P1|NOT COMPLETED|Randomized Phase||42
5056942|NCT01910402|12445739|P2|COMPLETED|Randomized Phase||192
5056943|NCT01910402|12445740|P1|COMPLETED|Randomized Phase||206
5056944|NCT01910402|12445739|P2|STARTED|Randomized Phase||247
5056945|NCT01910402|12445740|P1|STARTED|Randomized Phase||248
5056946|NCT01910389|12445810|P2|NOT COMPLETED|Overall Study||8
5056947|NCT01910389|12445811|P1|NOT COMPLETED|Overall Study||15
5056948|NCT01910389|12445810|P2|COMPLETED|Overall Study||0
5056949|NCT01910389|12445811|P1|COMPLETED|Overall Study||0
5056950|NCT01910389|12445810|P2|STARTED|Overall Study||8
5056951|NCT01910389|12445811|P1|STARTED|Overall Study||15
5056952|NCT01910311|12445841|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
5056953|NCT01910311|12445841|P1|COMPLETED|Period 2 (Days 3-32)||18
5056954|NCT01910311|12445841|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
5056955|NCT01910311|12445841|P1|Received Baricitinib|Period 2 (Days 3-32)||18
5056956|NCT01910311|12445841|P1|STARTED|Period 2 (Days 3-32)||18
5056957|NCT01910311|12445841|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
5056958|NCT01910311|12445841|P1|COMPLETED|Period 1 (Days 1-2)||18
5056959|NCT01910311|12445841|P1|Received Baricitinib|Period 1 (Days 1-2)||18
5056960|NCT01910311|12445841|P1|STARTED|Period 1 (Days 1-2)||18
5056961|NCT01910298|12445854|P2|NOT COMPLETED|Overall Study||32
5056962|NCT01910298|12445855|P1|NOT COMPLETED|Overall Study||5
5056963|NCT01910298|12445854|P2|COMPLETED|Overall Study||23
5056964|NCT01910298|12445855|P1|COMPLETED|Overall Study||71
5056965|NCT01910298|12445854|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
5056966|NCT01910298|12445855|P1|Safety Set|Overall Study||76
5056967|NCT01910298|12445854|P2|STARTED|Overall Study||55
5056968|NCT01910298|12445855|P1|STARTED|Overall Study||76
5056969|NCT01910181|12445873|P1|NOT COMPLETED|Overall Study||46
5056970|NCT01910181|12445873|P1|COMPLETED|Overall Study||0
5056971|NCT01910181|12445873|P1|Expansion Cohort|Overall Study||26
5056972|NCT01910181|12445873|P1|PK Cohort|Overall Study||20
5056973|NCT01910181|12445873|P1|STARTED|Overall Study||46
5056974|NCT01910129|12445900|P3|NOT COMPLETED|Randomized Phase 3||0
5056975|NCT01910129|12445901|P2|NOT COMPLETED|Randomized Phase 3||1
5056976|NCT01910129|12445902|P1|NOT COMPLETED|Randomized Phase 3||0
5056977|NCT01910129|12445900|P3|COMPLETED|Randomized Phase 3||0
5056978|NCT01910129|12445901|P2|COMPLETED|Randomized Phase 3||4
5056979|NCT01910129|12445902|P1|COMPLETED|Randomized Phase 3||5
5056980|NCT01910129|12445900|P3|STARTED|Randomized Phase 3||0
5056981|NCT01910129|12445901|P2|STARTED|Randomized Phase 3||5
5056982|NCT01910129|12445902|P1|STARTED|Randomized Phase 3||5
5056983|NCT01910129|12445900|P3|NOT COMPLETED|Randomized Phase 2||0
5056984|NCT01910129|12445901|P2|NOT COMPLETED|Randomized Phase 2||1
5056985|NCT01910129|12445902|P1|NOT COMPLETED|Randomized Phase 2||2
5056986|NCT01910129|12445900|P3|COMPLETED|Randomized Phase 2||0
5056987|NCT01910129|12445901|P2|COMPLETED|Randomized Phase 2||5
5056988|NCT01910129|12445902|P1|COMPLETED|Randomized Phase 2||5
5056989|NCT01910129|12445900|P3|STARTED|Randomized Phase 2||0
5056990|NCT01910129|12445901|P2|STARTED|Randomized Phase 2||6
5056991|NCT01910129|12445902|P1|STARTED|Randomized Phase 2||7
5056992|NCT01910129|12445900|P3|NOT COMPLETED|Run-in Period Phase 1||0
5056993|NCT01910129|12445901|P2|NOT COMPLETED|Run-in Period Phase 1||0
5056994|NCT01910129|12445902|P1|NOT COMPLETED|Run-in Period Phase 1||0
5056995|NCT01910129|12445900|P3|COMPLETED|Run-in Period Phase 1||13
5056996|NCT01910129|12445901|P2|COMPLETED|Run-in Period Phase 1||0
5056997|NCT01910129|12445902|P1|COMPLETED|Run-in Period Phase 1||0
5056998|NCT01910129|12445900|P3|STARTED|Run-in Period Phase 1||13
5056999|NCT01910129|12445901|P2|STARTED|Run-in Period Phase 1||0
5057000|NCT01910129|12445902|P1|STARTED|Run-in Period Phase 1||0
5057001|NCT01910116|12445926|P2|NOT COMPLETED|Overall Study||16
5057002|NCT01910116|12445927|P1|NOT COMPLETED|Overall Study||14
5057003|NCT01910116|12445926|P2|COMPLETED|Overall Study||94
5057004|NCT01910116|12445927|P1|COMPLETED|Overall Study||96
5057005|NCT01910116|12445926|P2|Week 16|Overall Study||94
5057006|NCT01910116|12445927|P1|Week 16|Overall Study||96
5057007|NCT01910116|12445926|P2|Week 12|Overall Study||96
5057008|NCT01910116|12445927|P1|Week 12|Overall Study||97
5057009|NCT01910116|12445926|P2|Week 8|Overall Study||99
5057010|NCT01910116|12445927|P1|Week 8|Overall Study||98
5057011|NCT01910116|12445926|P2|Week 4|Overall Study||102
5057012|NCT01910116|12445927|P1|Week 4|Overall Study||106
5057013|NCT01910116|12445926|P2|STARTED|Overall Study||110
5057014|NCT01910116|12445927|P1|STARTED|Overall Study||110
5057015|NCT01910064|12446003|P1|NOT COMPLETED|Overall Study||45
5057016|NCT01910064|12446003|P1|COMPLETED|Overall Study||391
5057017|NCT01910064|12446003|P1|STARTED|Overall Study||436
5057018|NCT01909973|12446014|P2|NOT COMPLETED|Overall Study||0
5057019|NCT01909973|12446015|P1|NOT COMPLETED|Overall Study||1
5057020|NCT01909973|12446014|P2|COMPLETED|Overall Study||7
5057021|NCT01909973|12446015|P1|COMPLETED|Overall Study||7
5057022|NCT01909973|12446014|P2|STARTED|Overall Study||7
5057023|NCT01909973|12446015|P1|STARTED|Overall Study||8
5057024|NCT01909804|12446035|P12|NOT COMPLETED|Overall Study||3
5057025|NCT01909804|12446036|P11|NOT COMPLETED|Overall Study||1
5057026|NCT01909804|12446037|P10|NOT COMPLETED|Overall Study||1
5057027|NCT01909804|12446038|P9|NOT COMPLETED|Overall Study||0
5057028|NCT01909804|12446039|P8|NOT COMPLETED|Overall Study||1
5057029|NCT01909804|12446040|P7|NOT COMPLETED|Overall Study||2
5057030|NCT01909804|12446041|P6|NOT COMPLETED|Overall Study||4
5057031|NCT01909804|12446042|P5|NOT COMPLETED|Overall Study||8
5057032|NCT01909804|12446043|P4|NOT COMPLETED|Overall Study||0
5057033|NCT01909804|12446044|P3|NOT COMPLETED|Overall Study||0
5057034|NCT01909804|12446045|P2|NOT COMPLETED|Overall Study||1
5057035|NCT01909804|12446046|P1|NOT COMPLETED|Overall Study||4
5057036|NCT01909804|12446035|P12|COMPLETED|Overall Study||26
5057037|NCT01909804|12446036|P11|COMPLETED|Overall Study||26
5057038|NCT01909804|12446037|P10|COMPLETED|Overall Study||28
5057039|NCT01909804|12446038|P9|COMPLETED|Overall Study||27
5057040|NCT01909804|12446039|P8|COMPLETED|Overall Study||25
5057041|NCT01909804|12446040|P7|COMPLETED|Overall Study||25
5057042|NCT01909804|12446041|P6|COMPLETED|Overall Study||21
5057043|NCT01909804|12446042|P5|COMPLETED|Overall Study||18
5057044|NCT01909804|12446043|P4|COMPLETED|Overall Study||26
5057045|NCT01909804|12446044|P3|COMPLETED|Overall Study||27
5057046|NCT01909804|12446045|P2|COMPLETED|Overall Study||27
5057047|NCT01909804|12446046|P1|COMPLETED|Overall Study||22
5057048|NCT01909804|12446035|P12|STARTED|Overall Study||29
5057049|NCT01909804|12446036|P11|STARTED|Overall Study||27
5057050|NCT01909804|12446037|P10|STARTED|Overall Study||29
5057051|NCT01909804|12446038|P9|STARTED|Overall Study||27
5057052|NCT01909804|12446039|P8|STARTED|Overall Study||26
5057053|NCT01909804|12446040|P7|STARTED|Overall Study||27
5057054|NCT01909804|12446041|P6|STARTED|Overall Study||25
5057055|NCT01909804|12446042|P5|STARTED|Overall Study||26
5057056|NCT01909804|12446043|P4|STARTED|Overall Study||26
5057057|NCT01909804|12446044|P3|STARTED|Overall Study||27
5057058|NCT01909804|12446045|P2|STARTED|Overall Study||28
5057059|NCT01909804|12446046|P1|STARTED|Overall Study||26
5057060|NCT01909791|12446095|P3|NOT COMPLETED|Overall Study||28
5057061|NCT01909791|12446096|P2|NOT COMPLETED|Overall Study||28
5057062|NCT01909791|12446097|P1|NOT COMPLETED|Overall Study||21
5057063|NCT01909791|12446095|P3|COMPLETED|Overall Study||208
5057064|NCT01909791|12446096|P2|COMPLETED|Overall Study||212
5057065|NCT01909791|12446097|P1|COMPLETED|Overall Study||205
5057066|NCT01909791|12446095|P3|STARTED|Overall Study||236
5057067|NCT01909791|12446096|P2|STARTED|Overall Study||240
5057068|NCT01909791|12446097|P1|STARTED|Overall Study||226
5057069|NCT01909778|12446155|P1|NOT COMPLETED|Overall Study||1
5057070|NCT01909778|12446155|P1|COMPLETED|Overall Study||1
5057071|NCT01909778|12446155|P1|STARTED|Overall Study||2
5057072|NCT01909713|12446179|P1|NOT COMPLETED|Overall Study||0
5057073|NCT01909713|12446179|P1|COMPLETED|Overall Study||35
5057074|NCT01909713|12446179|P1|STARTED|Overall Study||35
5057075|NCT01909674|12446234|P2|NOT COMPLETED|Overall Study||2
5057076|NCT01909674|12446235|P1|NOT COMPLETED|Overall Study||5
5057077|NCT01909674|12446234|P2|COMPLETED|Overall Study||7
5057078|NCT01909674|12446235|P1|COMPLETED|Overall Study||7
5057079|NCT01909674|12446234|P2|STARTED|Overall Study||9
5057080|NCT01909674|12446235|P1|STARTED|Overall Study||12
5057081|NCT01909570|12446243|P2|NOT COMPLETED|Overall Study||27
5057082|NCT01909570|12446244|P1|NOT COMPLETED|Overall Study||27
5057083|NCT01909570|12446243|P2|COMPLETED|Overall Study||64
5057084|NCT01909570|12446244|P1|COMPLETED|Overall Study||57
5057085|NCT01909570|12446243|P2|STARTED|Overall Study||91
5057086|NCT01909570|12446244|P1|STARTED|Overall Study||84
5057087|NCT01909466|12446254|P2|NOT COMPLETED|Overall Study||23
5057088|NCT01909466|12446255|P1|NOT COMPLETED|Overall Study||22
5057089|NCT01909466|12446254|P2|COMPLETED|Overall Study||50
5057090|NCT01909466|12446255|P1|COMPLETED|Overall Study||46
5057091|NCT01909466|12446254|P2|STARTED|Overall Study||73
5057092|NCT01909466|12446255|P1|STARTED|Overall Study||68
5057093|NCT01909336|12446278|P3|NOT COMPLETED|Overall Study||3
5057094|NCT01909336|12446279|P2|NOT COMPLETED|Overall Study||3
5057095|NCT01909336|12446280|P1|NOT COMPLETED|Overall Study||4
5057096|NCT01909336|12446278|P3|COMPLETED|Overall Study||52
5057097|NCT01909336|12446279|P2|COMPLETED|Overall Study||50
5057098|NCT01909336|12446280|P1|COMPLETED|Overall Study||49
5057099|NCT01909336|12446278|P3|STARTED|Overall Study||55
5057100|NCT01909336|12446279|P2|STARTED|Overall Study||53
5057101|NCT01909336|12446280|P1|STARTED|Overall Study||53
5057102|NCT01909180|12446294|P1|NOT COMPLETED|Overall Study||0
5057103|NCT01909180|12446294|P1|COMPLETED|Overall Study||49
5057104|NCT01909180|12446294|P1|STARTED|Overall Study||49
5057105|NCT01909154|12446300|P1|NOT COMPLETED|Overall Study||0
5057106|NCT01909154|12446300|P1|COMPLETED|Overall Study||12
5057107|NCT01909154|12446300|P1|STARTED|Overall Study||12
5057108|NCT01909141|12446311|P2|NOT COMPLETED|Overall Study||0
5057109|NCT01909141|12446312|P1|NOT COMPLETED|Overall Study||0
5057110|NCT01909141|12446311|P2|COMPLETED|Overall Study||50
5057111|NCT01909141|12446312|P1|COMPLETED|Overall Study||50
5057112|NCT01909141|12446311|P2|STARTED|Overall Study||50
5057113|NCT01909141|12446312|P1|STARTED|Overall Study||50
5057114|NCT01909011|12446328|P2|NOT COMPLETED|Overall Study||0
5057115|NCT01909011|12446329|P1|NOT COMPLETED|Overall Study||0
5057116|NCT01909011|12446328|P2|COMPLETED|Overall Study||9
5057117|NCT01909011|12446329|P1|COMPLETED|Overall Study||7
5057118|NCT01909011|12446328|P2|STARTED|Overall Study||9
5057119|NCT01909011|12446329|P1|STARTED|Overall Study||7
5057120|NCT01908972|12446341|P2|NOT COMPLETED|Overall Study||0
5057121|NCT01908972|12446342|P1|NOT COMPLETED|Overall Study||2
5057122|NCT01908972|12446341|P2|COMPLETED|Overall Study||17
5057123|NCT01908972|12446342|P1|COMPLETED|Overall Study||15
5057124|NCT01908972|12446341|P2|STARTED|Overall Study||17
5057125|NCT01908972|12446342|P1|STARTED|Overall Study||17
5057126|NCT01908907|12446378|P2|NOT COMPLETED|Overall Study||0
5057127|NCT01908907|12446379|P1|NOT COMPLETED|Overall Study||2
5057128|NCT01908907|12446378|P2|COMPLETED|Overall Study||29
5057129|NCT01908907|12446379|P1|COMPLETED|Overall Study||29
5057130|NCT01908907|12446378|P2|STARTED|Overall Study||29
5057131|NCT01908907|12446379|P1|STARTED|Overall Study||31
5057132|NCT01908842|12446401|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
5057133|NCT01908842|12446402|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
5057134|NCT01908842|12446401|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
5057135|NCT01908842|12446402|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
5057136|NCT01908842|12446401|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
5057137|NCT01908842|12446402|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
5057138|NCT01908842|12446401|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
5057139|NCT01908842|12446402|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
5057140|NCT01908842|12446401|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
5057141|NCT01908842|12446402|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
5057142|NCT01908842|12446401|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
5057143|NCT01908842|12446402|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
5057144|NCT01908842|12446401|P2|NOT COMPLETED|Induction||31
5057145|NCT01908842|12446402|P1|NOT COMPLETED|Induction||26
5057146|NCT01908842|12446401|P2|COMPLETED|Induction||344
5057147|NCT01908842|12446402|P1|COMPLETED|Induction||357
5057148|NCT01908842|12446401|P2|STARTED|Induction||375
5057149|NCT01908842|12446402|P1|STARTED|Induction||383
5057150|NCT01908829|12446423|P3|NOT COMPLETED|Overall Study||39
5057151|NCT01908829|12446424|P2|NOT COMPLETED|Overall Study||49
5057152|NCT01908829|12446425|P1|NOT COMPLETED|Overall Study||49
5057153|NCT01908829|12446423|P3|COMPLETED|Overall Study||680
5057154|NCT01908829|12446424|P2|COMPLETED|Overall Study||679
5057155|NCT01908829|12446425|P1|COMPLETED|Overall Study||678
5057156|NCT01908829|12446423|P3|Treated With Double-blind Drug|Overall Study||719
5057157|NCT01908829|12446424|P2|Treated With Double-blind Drug|Overall Study||728
5057158|NCT01908829|12446425|P1|Treated With Double-blind Drug|Overall Study||725
5057159|NCT01908829|12446423|P3|STARTED|Overall Study||719
5057160|NCT01908829|12446424|P2|STARTED|Overall Study||728
5057161|NCT01908829|12446425|P1|STARTED|Overall Study||727
5057162|NCT01908816|12446542|P4|NOT COMPLETED|Overall Study||35
5057163|NCT01908816|12446543|P3|NOT COMPLETED|Overall Study||58
5057164|NCT01908816|12446544|P2|NOT COMPLETED|Overall Study||84
5057165|NCT01908816|12446545|P1|NOT COMPLETED|Overall Study||93
5057166|NCT01908816|12446542|P4|COMPLETED|Overall Study||0
5057167|NCT01908816|12446543|P3|COMPLETED|Overall Study||0
5057168|NCT01908816|12446544|P2|COMPLETED|Overall Study||0
5057169|NCT01908816|12446545|P1|COMPLETED|Overall Study||0
5057170|NCT01908816|12446542|P4|STARTED|Overall Study||35
5057171|NCT01908816|12446543|P3|STARTED|Overall Study||58
5057172|NCT01908816|12446544|P2|STARTED|Overall Study||84
5057173|NCT01908816|12446545|P1|STARTED|Overall Study||93
5057174|NCT01908803|12446570|P2|NOT COMPLETED|Overall Study||1
5057175|NCT01908803|12446571|P1|NOT COMPLETED|Overall Study||4
5057176|NCT01908803|12446570|P2|COMPLETED|Overall Study||23
5057177|NCT01908803|12446571|P1|COMPLETED|Overall Study||42
5057178|NCT01908803|12446570|P2|Treated|Overall Study||24
5057179|NCT01908803|12446571|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
5057180|NCT01908803|12446570|P2|STARTED|Overall Study||24
5057181|NCT01908803|12446571|P1|STARTED|Overall Study||46
5057182|NCT01908699|12446584|P2|NOT COMPLETED|Overall Study||78
5057183|NCT01908699|12446585|P1|NOT COMPLETED|Overall Study||75
5057184|NCT01908699|12446584|P2|COMPLETED|Overall Study||58
5057185|NCT01908699|12446585|P1|COMPLETED|Overall Study||62
5057186|NCT01908699|12446584|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
5057187|NCT01908699|12446585|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
5057188|NCT01908699|12446584|P2|STARTED|Overall Study||136
5057189|NCT01908699|12446585|P1|STARTED|Overall Study||137
5057190|NCT01908582|12446601|P1|NOT COMPLETED|Period 2||2
5057191|NCT01908582|12446601|P1|COMPLETED|Period 2||24
5057192|NCT01908582|12446601|P1|STARTED|Period 2||26
5057193|NCT01908582|12446601|P1|NOT COMPLETED|Period 1||0
5057194|NCT01908582|12446601|P1|COMPLETED|Period 1||26
5057195|NCT01908582|12446601|P1|Received at Least One Dose of Study Drug|Period 1||26
5057196|NCT01908582|12446601|P1|STARTED|Period 1||26
5057197|NCT01908530|12446615|P3|NOT COMPLETED|Overall Study||0
5057198|NCT01908530|12446616|P2|NOT COMPLETED|Overall Study||0
5057199|NCT01908530|12446617|P1|NOT COMPLETED|Overall Study||0
5057200|NCT01908530|12446615|P3|COMPLETED|Overall Study||10
5057201|NCT01908530|12446616|P2|COMPLETED|Overall Study||8
5057202|NCT01908530|12446617|P1|COMPLETED|Overall Study||8
5057203|NCT01908530|12446615|P3|STARTED|Overall Study||10
5057204|NCT01908530|12446616|P2|STARTED|Overall Study||8
5057205|NCT01908530|12446617|P1|STARTED|Overall Study||8
5057206|NCT01908426|12446645|P2|NOT COMPLETED|Overall Study||211
5057207|NCT01908426|12446646|P1|NOT COMPLETED|Overall Study||397
5057208|NCT01908426|12446645|P2|COMPLETED|Overall Study||26
5057209|NCT01908426|12446646|P1|COMPLETED|Overall Study||73
5057210|NCT01908426|12446645|P2|STARTED|Overall Study||237
5057211|NCT01908426|12446646|P1|STARTED|Overall Study||470
5057212|NCT01908140|12446658|P2|NOT COMPLETED|Overall Study||79
5057213|NCT01908140|12446659|P1|NOT COMPLETED|Overall Study||66
5057214|NCT01908140|12446658|P2|COMPLETED|Overall Study||386
5057215|NCT01908140|12446659|P1|COMPLETED|Overall Study||402
5057216|NCT01908140|12446658|P2|STARTED|Overall Study||465
5057217|NCT01908140|12446659|P1|STARTED|Overall Study||468
5057218|NCT01908127|12446669|P2|NOT COMPLETED|Overall Study||0
5057219|NCT01908127|12446670|P1|NOT COMPLETED|Overall Study||1
5057220|NCT01908127|12446669|P2|COMPLETED|Overall Study||23
5057221|NCT01908127|12446670|P1|COMPLETED|Overall Study||22
5057222|NCT01908127|12446669|P2|STARTED|Overall Study||23
5057223|NCT01908127|12446670|P1|STARTED|Overall Study||23
5057224|NCT01908101|12446678|P1|NOT COMPLETED|Overall Study||9
5057225|NCT01908101|12446678|P1|COMPLETED|Overall Study||59
5057226|NCT01908101|12446678|P1|STARTED|Overall Study||68
5057227|NCT01908062|12446684|P2|NOT COMPLETED|Overall Study||3
5057228|NCT01908062|12446685|P1|NOT COMPLETED|Overall Study||2
5057229|NCT01908062|12446684|P2|COMPLETED|Overall Study||22
5057230|NCT01908062|12446685|P1|COMPLETED|Overall Study||24
5057231|NCT01908062|12446684|P2|STARTED|Overall Study||25
5057232|NCT01908062|12446685|P1|STARTED|Overall Study||26
5057233|NCT01907906|12446712|P2|NOT COMPLETED|Overall Study||1
5057234|NCT01907906|12446713|P1|NOT COMPLETED|Overall Study||4
5057235|NCT01907906|12446712|P2|COMPLETED|Overall Study||12
5057236|NCT01907906|12446713|P1|COMPLETED|Overall Study||12
5057237|NCT01907906|12446712|P2|STARTED|Overall Study||13
5057238|NCT01907906|12446713|P1|STARTED|Overall Study||16
5057239|NCT01907854|12446793|P2|NOT COMPLETED|Overall Study||13
5057240|NCT01907854|12446794|P1|NOT COMPLETED|Overall Study||16
5057241|NCT01907854|12446793|P2|COMPLETED|Overall Study||191
5057242|NCT01907854|12446794|P1|COMPLETED|Overall Study||187
5057243|NCT01907854|12446793|P2|Exposed|Overall Study||204
5057244|NCT01907854|12446794|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
5057245|NCT01907854|12446793|P2|STARTED|Overall Study||204
5057246|NCT01907854|12446794|P1|STARTED|Overall Study||203
5057247|NCT01907828|12446814|P2|NOT COMPLETED|Overall Study||6
5057248|NCT01907828|12446815|P1|NOT COMPLETED|Overall Study||7
5057249|NCT01907828|12446814|P2|COMPLETED|Overall Study||16
5057250|NCT01907828|12446815|P1|COMPLETED|Overall Study||32
5057251|NCT01907828|12446814|P2|24-month Follow-up|Overall Study||16
5057252|NCT01907828|12446815|P1|24-month Follow-up|Overall Study|2 participants terminated early|32
5057253|NCT01907828|12446814|P2|12-month Follow-up|Overall Study||16
5057254|NCT01907828|12446815|P1|12-month Follow-up|Overall Study|1 participant terminated early|34
5057255|NCT01907828|12446814|P2|6-month Follow-up|Overall Study||16
5057256|NCT01907828|12446815|P1|6-month Follow-up|Overall Study|1 participant terminated early|35
5057257|NCT01907828|12446814|P2|3-month Follow-up|Overall Study|1 participant terminated early|16
5057258|NCT01907828|12446815|P1|3-month Follow-up|Overall Study|1 participant terminated early|36
5057259|NCT01907828|12446814|P2|1-month Follow-up|Overall Study|3 participants terminated early|17
5057260|NCT01907828|12446815|P1|1-month Follow-up|Overall Study|2 participants terminated early|37
5057261|NCT01907828|12446814|P2|Underwent Procedure|Overall Study|2 participants terminated early|20
5057262|NCT01907828|12446815|P1|Underwent Procedure|Overall Study||39
5057263|NCT01907828|12446814|P2|STARTED|Overall Study||22
5057264|NCT01907828|12446815|P1|STARTED|Overall Study||39
5057265|NCT01907815|12446843|P2|NOT COMPLETED|Overall Study||0
5057266|NCT01907815|12446844|P1|NOT COMPLETED|Overall Study||1
5057267|NCT01907815|12446843|P2|COMPLETED|Overall Study||7
5057268|NCT01907815|12446844|P1|COMPLETED|Overall Study||16
5057269|NCT01907815|12446843|P2|STARTED|Overall Study||7
5057270|NCT01907815|12446844|P1|STARTED|Overall Study||17
5057271|NCT01907737|12446858|P1|NOT COMPLETED|Overall Study||1
5057272|NCT01907737|12446858|P1|COMPLETED|Overall Study||21
5057273|NCT01907737|12446858|P1|STARTED|Overall Study||22
5057274|NCT01907516|12446870|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5057275|NCT01907516|12446871|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
5057276|NCT01907516|12446870|P2|COMPLETED|Second Intervention (3 Weeks)||34
5057277|NCT01907516|12446871|P1|COMPLETED|Second Intervention (3 Weeks)||40
5057278|NCT01907516|12446870|P2|STARTED|Second Intervention (3 Weeks)||34
5057279|NCT01907516|12446871|P1|STARTED|Second Intervention (3 Weeks)||40
5057280|NCT01907516|12446870|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
5057281|NCT01907516|12446871|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
5057282|NCT01907516|12446870|P2|COMPLETED|First Intervention (3 Weeks)||34
5057283|NCT01907516|12446871|P1|COMPLETED|First Intervention (3 Weeks)||40
5057284|NCT01907516|12446870|P2|STARTED|First Intervention (3 Weeks)||50
5057285|NCT01907516|12446871|P1|STARTED|First Intervention (3 Weeks)||50
5057286|NCT01907490|12446878|P1|NOT COMPLETED|Overall Study||0
5057287|NCT01907490|12446878|P1|COMPLETED|Overall Study||38
5057288|NCT01907490|12446878|P1|STARTED|Overall Study||38
5057289|NCT01907334|12446885|P2|NOT COMPLETED|Overall Study||0
5057290|NCT01907334|12446886|P1|NOT COMPLETED|Overall Study||0
5057291|NCT01907334|12446885|P2|COMPLETED|Overall Study||4
5057292|NCT01907334|12446886|P1|COMPLETED|Overall Study||6
5057293|NCT01907334|12446885|P2|STARTED|Overall Study||4
5057294|NCT01907334|12446886|P1|STARTED|Overall Study||6
5057295|NCT01907321|12446891|P1|NOT COMPLETED|Overall Study||2
5057296|NCT01907321|12446891|P1|COMPLETED|Overall Study||12
5057297|NCT01907321|12446891|P1|STARTED|Overall Study||14
5057298|NCT01907269|12446898|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
5057299|NCT01907269|12446899|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
5057300|NCT01907269|12446898|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
5057301|NCT01907269|12446899|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
5057302|NCT01907269|12446898|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
5057303|NCT01907269|12446899|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
5057304|NCT01907269|12446898|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
5057305|NCT01907269|12446899|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
5057306|NCT01907269|12446898|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
5057307|NCT01907269|12446899|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
5057308|NCT01907269|12446898|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
5057309|NCT01907269|12446899|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
5057310|NCT01907217|12446915|P2|NOT COMPLETED|Overall Study||2
5057311|NCT01907217|12446916|P1|NOT COMPLETED|Overall Study||0
5057312|NCT01907217|12446915|P2|COMPLETED|Overall Study||67
5057313|NCT01907217|12446916|P1|COMPLETED|Overall Study||69
5057314|NCT01907217|12446915|P2|STARTED|Overall Study||69
5057315|NCT01907217|12446916|P1|STARTED|Overall Study||69
5057316|NCT01907113|12446933|P5|NOT COMPLETED|Overall Study||0
5057317|NCT01907113|12446934|P4|NOT COMPLETED|Overall Study||0
5057318|NCT01907113|12446935|P3|NOT COMPLETED|Overall Study||0
5057319|NCT01907113|12446936|P2|NOT COMPLETED|Overall Study||0
5057320|NCT01907113|12446937|P1|NOT COMPLETED|Overall Study||0
5057321|NCT01907113|12446933|P5|COMPLETED|Overall Study||8
5057322|NCT01907113|12446934|P4|COMPLETED|Overall Study||8
5057323|NCT01907113|12446935|P3|COMPLETED|Overall Study||7
5057324|NCT01907113|12446936|P2|COMPLETED|Overall Study||9
5057325|NCT01907113|12446937|P1|COMPLETED|Overall Study||8
5057326|NCT01907113|12446933|P5|STARTED|Overall Study||8
5057327|NCT01907113|12446934|P4|STARTED|Overall Study||8
5057328|NCT01907113|12446935|P3|STARTED|Overall Study||7
5057329|NCT01907113|12446936|P2|STARTED|Overall Study||9
5057330|NCT01907113|12446937|P1|STARTED|Overall Study||8
5057331|NCT01907100|12447028|P4|NOT COMPLETED|Overall Study||146
5057332|NCT01907100|12447029|P3|NOT COMPLETED|Overall Study||147
5057333|NCT01907100|12447030|P2|NOT COMPLETED|Overall Study||40
5057334|NCT01907100|12447031|P1|NOT COMPLETED|Overall Study||42
5057335|NCT01907100|12447028|P4|COMPLETED|Overall Study||83
5057336|NCT01907100|12447029|P3|COMPLETED|Overall Study||82
5057337|NCT01907100|12447030|P2|COMPLETED|Overall Study||4
5057338|NCT01907100|12447031|P1|COMPLETED|Overall Study||1
5057339|NCT01907100|12447028|P4|Treated Patients|Overall Study||227
5057340|NCT01907100|12447029|P3|Treated Patients|Overall Study||228
5057341|NCT01907100|12447030|P2|Treated Patients|Overall Study||44
5057342|NCT01907100|12447031|P1|Treated Patients|Overall Study||41
5057343|NCT01907100|12447028|P4|STARTED|Overall Study||229
5057344|NCT01907100|12447029|P3|STARTED|Overall Study||229
5057345|NCT01907100|12447030|P2|STARTED|Overall Study||44
5057346|NCT01907100|12447031|P1|STARTED|Overall Study||43
5057347|NCT01907087|12447045|P1|NOT COMPLETED|Overall Study||1
5057348|NCT01907087|12447045|P1|COMPLETED|Overall Study||23
5057349|NCT01907087|12447045|P1|STARTED|Overall Study||24
5057350|NCT01906866|12447056|P2|NOT COMPLETED|Overall Study||21
5057351|NCT01906866|12447057|P1|NOT COMPLETED|Overall Study||9
5057352|NCT01906866|12447056|P2|COMPLETED|Overall Study||44
5057353|NCT01906866|12447057|P1|COMPLETED|Overall Study||51
5057354|NCT01906866|12447056|P2|STARTED|Overall Study||65
5057355|NCT01906866|12447057|P1|STARTED|Overall Study||60
5057356|NCT01906658|12447070|P4|NOT COMPLETED|Overall Study||0
5057357|NCT01906658|12447071|P3|NOT COMPLETED|Overall Study||3
5057358|NCT01906658|12447072|P2|NOT COMPLETED|Overall Study||1
5057359|NCT01906658|12447073|P1|NOT COMPLETED|Overall Study||2
5057360|NCT01906658|12447070|P4|COMPLETED|Overall Study||11
5057361|NCT01906658|12447071|P3|COMPLETED|Overall Study||7
5057362|NCT01906658|12447072|P2|COMPLETED|Overall Study||10
5057363|NCT01906658|12447073|P1|COMPLETED|Overall Study||9
5057364|NCT01906658|12447070|P4|STARTED|Overall Study||11
5057365|NCT01906658|12447071|P3|STARTED|Overall Study||10
5057366|NCT01906658|12447072|P2|STARTED|Overall Study||11
5057367|NCT01906658|12447073|P1|STARTED|Overall Study||11
5057368|NCT01906515|12447097|P2|NOT COMPLETED|Overall Study||0
5057369|NCT01906515|12447098|P1|NOT COMPLETED|Overall Study||0
5057370|NCT01906515|12447097|P2|COMPLETED|Overall Study||61
5057371|NCT01906515|12447098|P1|COMPLETED|Overall Study||45
5057372|NCT01906515|12447097|P2|STARTED|Overall Study||61
5057373|NCT01906515|12447098|P1|STARTED|Overall Study||45
5057374|NCT01906476|12447108|P2|NOT COMPLETED|Overall Study||16
5057375|NCT01906476|12447109|P1|NOT COMPLETED|Overall Study||17
5057376|NCT01906476|12447108|P2|COMPLETED|Overall Study||139
5057377|NCT01906476|12447109|P1|COMPLETED|Overall Study||140
5057378|NCT01906476|12447108|P2|STARTED|Overall Study||155
5057379|NCT01906476|12447109|P1|STARTED|Overall Study||157
5057380|NCT01906372|12447117|P1|NOT COMPLETED|Overall Study||2
5057381|NCT01906372|12447117|P1|COMPLETED|Overall Study||10
5057382|NCT01906372|12447117|P1|Visit 10: Follow up Phase Completed|Overall Study||8
5057383|NCT01906372|12447117|P1|Visit 7: Treatment Phase Completed|Overall Study||10
5057384|NCT01906372|12447117|P1|STARTED|Overall Study||12
5057385|NCT01906346|12447122|P1|NOT COMPLETED|Overall Study||1
5057386|NCT01906346|12447122|P1|COMPLETED|Overall Study||8
5057387|NCT01906346|12447122|P1|STARTED|Overall Study||9
5057388|NCT01906008|12447130|P2|NOT COMPLETED|Overall Study||27
5057389|NCT01906008|12447131|P1|NOT COMPLETED|Overall Study||27
5057390|NCT01906008|12447130|P2|COMPLETED|Overall Study||34
5057391|NCT01906008|12447131|P1|COMPLETED|Overall Study||32
5057392|NCT01906008|12447130|P2|STARTED|Overall Study||61
5057393|NCT01906008|12447131|P1|STARTED|Overall Study||59
5057394|NCT01905956|12447141|P2|NOT COMPLETED|Overall Study||11
5057395|NCT01905956|12447142|P1|NOT COMPLETED|Overall Study||6
5057396|NCT01905956|12447141|P2|COMPLETED|Overall Study|Per-protocol population|48
5057397|NCT01905956|12447142|P1|COMPLETED|Overall Study|Per-protocol population|54
5057398|NCT01905956|12447141|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
5057399|NCT01905956|12447142|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
5057400|NCT01905956|12447141|P2|STARTED|Overall Study|Randomized|59
5057401|NCT01905956|12447142|P1|STARTED|Overall Study|Randomized|60
5057402|NCT01905943|12447164|P1|NOT COMPLETED|Overall Study||314
5057403|NCT01905943|12447164|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
5057404|NCT01905943|12447164|P1|STARTED|Overall Study||972
5057405|NCT01905683|12447281|P1|NOT COMPLETED|Overall Study||51
5057406|NCT01905683|12447281|P1|COMPLETED|Overall Study||319
5057407|NCT01905683|12447281|P1|STARTED|Overall Study||370
5057408|NCT01905657|12447297|P3|NOT COMPLETED|Overall Study||328
5057409|NCT01905657|12447298|P2|NOT COMPLETED|Overall Study||346
5057410|NCT01905657|12447299|P1|NOT COMPLETED|Overall Study||345
5057411|NCT01905657|12447297|P3|COMPLETED|Overall Study||15
5057412|NCT01905657|12447298|P2|COMPLETED|Overall Study||0
5057413|NCT01905657|12447299|P1|COMPLETED|Overall Study||0
5057414|NCT01905657|12447297|P3|Treated|Overall Study||309
5057415|NCT01905657|12447298|P2|Treated|Overall Study||343
5057416|NCT01905657|12447299|P1|Treated|Overall Study||339
5057417|NCT01905657|12447297|P3|STARTED|Overall Study||343
5057418|NCT01905657|12447298|P2|STARTED|Overall Study||346
5057419|NCT01905657|12447299|P1|STARTED|Overall Study||345
5057420|NCT01905553|12447324|P2|NOT COMPLETED|Period 2||0
5057421|NCT01905553|12447325|P1|NOT COMPLETED|Period 2||1
5057422|NCT01905553|12447324|P2|COMPLETED|Period 2||4
5057423|NCT01905553|12447325|P1|COMPLETED|Period 2||4
5057424|NCT01905553|12447324|P2|STARTED|Period 2||4
5057425|NCT01905553|12447325|P1|STARTED|Period 2||5
5057426|NCT01905553|12447324|P2|NOT COMPLETED|Period 1||0
5057427|NCT01905553|12447325|P1|NOT COMPLETED|Period 1||0
5057428|NCT01905553|12447324|P2|COMPLETED|Period 1||4
5057429|NCT01905553|12447325|P1|COMPLETED|Period 1||5
5057430|NCT01905553|12447324|P2|STARTED|Period 1||4
5057431|NCT01905553|12447325|P1|STARTED|Period 1||5
5057432|NCT01905540|12447339|P4|NOT COMPLETED|Period 3||1
5057433|NCT01905540|12447340|P3|NOT COMPLETED|Period 3||1
5057434|NCT01905540|12447341|P2|NOT COMPLETED|Period 3||0
5057435|NCT01905540|12447342|P1|NOT COMPLETED|Period 3||1
5057436|NCT01905540|12447339|P4|COMPLETED|Period 3||6
5057437|NCT01905540|12447340|P3|COMPLETED|Period 3||6
5057438|NCT01905540|12447341|P2|COMPLETED|Period 3||7
5057439|NCT01905540|12447342|P1|COMPLETED|Period 3||6
5057440|NCT01905540|12447339|P4|STARTED|Period 3||7
5057441|NCT01905540|12447340|P3|STARTED|Period 3||7
5057442|NCT01905540|12447341|P2|STARTED|Period 3||7
5057443|NCT01905540|12447342|P1|STARTED|Period 3||7
5057444|NCT01905540|12447339|P4|NOT COMPLETED|Period 2||0
5057445|NCT01905540|12447340|P3|NOT COMPLETED|Period 2||0
5057446|NCT01905540|12447341|P2|NOT COMPLETED|Period 2||0
5057447|NCT01905540|12447342|P1|NOT COMPLETED|Period 2||0
5057448|NCT01905540|12447339|P4|COMPLETED|Period 2||7
5057449|NCT01905540|12447340|P3|COMPLETED|Period 2||7
5057450|NCT01905540|12447341|P2|COMPLETED|Period 2||7
5057451|NCT01905540|12447342|P1|COMPLETED|Period 2||7
5057452|NCT01905540|12447339|P4|STARTED|Period 2||7
5057453|NCT01905540|12447340|P3|STARTED|Period 2||7
5057454|NCT01905540|12447341|P2|STARTED|Period 2||7
5057455|NCT01905540|12447342|P1|STARTED|Period 2||7
5057456|NCT01905540|12447339|P4|NOT COMPLETED|Period 1||0
5057457|NCT01905540|12447340|P3|NOT COMPLETED|Period 1||0
5057458|NCT01905540|12447341|P2|NOT COMPLETED|Period 1||0
5057459|NCT01905540|12447342|P1|NOT COMPLETED|Period 1||0
5057460|NCT01905540|12447339|P4|COMPLETED|Period 1||7
5057461|NCT01905540|12447340|P3|COMPLETED|Period 1||7
5057462|NCT01905540|12447341|P2|COMPLETED|Period 1||7
5057463|NCT01905540|12447342|P1|COMPLETED|Period 1||7
5057464|NCT01905540|12447339|P4|STARTED|Period 1||7
5057465|NCT01905540|12447340|P3|STARTED|Period 1||7
5057466|NCT01905540|12447341|P2|STARTED|Period 1||7
5057467|NCT01905540|12447342|P1|STARTED|Period 1||7
5057468|NCT01905423|12447364|P4|NOT COMPLETED|Overall Study||0
5057469|NCT01905423|12447365|P3|NOT COMPLETED|Overall Study||0
5057470|NCT01905423|12447366|P2|NOT COMPLETED|Overall Study||0
5057471|NCT01905423|12447367|P1|NOT COMPLETED|Overall Study||0
5057472|NCT01905423|12447364|P4|COMPLETED|Overall Study||3324
5057473|NCT01905423|12447365|P3|COMPLETED|Overall Study||4119
5057474|NCT01905423|12447366|P2|COMPLETED|Overall Study||4111
5057475|NCT01905423|12447367|P1|COMPLETED|Overall Study||7753
5057476|NCT01905423|12447364|P4|Year 3 Follow-up|Overall Study||0
5057477|NCT01905423|12447365|P3|Year 3 Follow-up|Overall Study||0
5057478|NCT01905423|12447366|P2|Year 3 Follow-up|Overall Study||1028
5057479|NCT01905423|12447367|P1|Year 3 Follow-up|Overall Study||1776
5057480|NCT01905423|12447364|P4|Year 2 Follow-up|Overall Study||0
5057481|NCT01905423|12447365|P3|Year 2 Follow-up|Overall Study||0
5057482|NCT01905423|12447366|P2|Year 2 Follow-up|Overall Study||1043
5057483|NCT01905423|12447367|P1|Year 2 Follow-up|Overall Study||1972
5057484|NCT01905423|12447364|P4|Year 1 Follow-up|Overall Study||1690
5057485|NCT01905423|12447365|P3|Year 1 Follow-up|Overall Study||2037
5057486|NCT01905423|12447366|P2|Year 1 Follow-up|Overall Study||1007
5057487|NCT01905423|12447367|P1|Year 1 Follow-up|Overall Study||1840
5057488|NCT01905423|12447364|P4|Baseline|Overall Study||1634
5057489|NCT01905423|12447365|P3|Baseline|Overall Study||2082
5057490|NCT01905423|12447366|P2|Baseline|Overall Study||1033
5057491|NCT01905423|12447367|P1|Baseline|Overall Study||2165
5057492|NCT01905423|12447364|P4|STARTED|Overall Study||3324
5057493|NCT01905423|12447365|P3|STARTED|Overall Study||4119
5057494|NCT01905423|12447366|P2|STARTED|Overall Study||4111
5057495|NCT01905423|12447367|P1|STARTED|Overall Study||7753
5057496|NCT01905267|12447377|P2|NOT COMPLETED|Overall Study||2
5057497|NCT01905267|12447378|P1|NOT COMPLETED|Overall Study||2
5057498|NCT01905267|12447377|P2|COMPLETED|Overall Study||14
5057499|NCT01905267|12447378|P1|COMPLETED|Overall Study||15
5057500|NCT01905267|12447377|P2|STARTED|Overall Study||16
5057501|NCT01905267|12447378|P1|STARTED|Overall Study||17
5057502|NCT01905254|12447386|P1|NOT COMPLETED|Overall Study||0
5057503|NCT01905254|12447386|P1|COMPLETED|Overall Study||34
5057504|NCT01905254|12447386|P1|STARTED|Overall Study||34
5057505|NCT01904864|12447392|P2|NOT COMPLETED|Overall Study||12
5057506|NCT01904864|12447393|P1|NOT COMPLETED|Overall Study||9
5057507|NCT01904864|12447392|P2|COMPLETED|Overall Study||28
5057508|NCT01904864|12447393|P1|COMPLETED|Overall Study||31
5057509|NCT01904864|12447392|P2|STARTED|Overall Study||40
5057510|NCT01904864|12447393|P1|STARTED|Overall Study||40
5057511|NCT01904773|12447399|P9|NOT COMPLETED|Sixth Intervention||0
5057512|NCT01904773|12447400|P8|NOT COMPLETED|Sixth Intervention||0
5057513|NCT01904773|12447401|P7|NOT COMPLETED|Sixth Intervention||0
5057514|NCT01904773|12447402|P6|NOT COMPLETED|Sixth Intervention||0
5057515|NCT01904773|12447403|P5|NOT COMPLETED|Sixth Intervention||0
5057516|NCT01904773|12447404|P4|NOT COMPLETED|Sixth Intervention||0
5057517|NCT01904773|12447405|P3|NOT COMPLETED|Sixth Intervention||0
5057518|NCT01904773|12447406|P2|NOT COMPLETED|Sixth Intervention||0
5057519|NCT01904773|12447407|P1|NOT COMPLETED|Sixth Intervention||0
5057520|NCT01904773|12447399|P9|COMPLETED|Sixth Intervention||4
5057521|NCT01904773|12447400|P8|COMPLETED|Sixth Intervention||2
5057522|NCT01904773|12447401|P7|COMPLETED|Sixth Intervention||3
5057523|NCT01904773|12447402|P6|COMPLETED|Sixth Intervention||4
5057524|NCT01904773|12447403|P5|COMPLETED|Sixth Intervention||3
5057525|NCT01904773|12447404|P4|COMPLETED|Sixth Intervention||2
5057526|NCT01904773|12447405|P3|COMPLETED|Sixth Intervention||1
5057527|NCT01904773|12447406|P2|COMPLETED|Sixth Intervention||0
5057528|NCT01904773|12447407|P1|COMPLETED|Sixth Intervention||0
5057529|NCT01904773|12447399|P9|STARTED|Sixth Intervention||4
5057530|NCT01904773|12447400|P8|STARTED|Sixth Intervention||2
5057531|NCT01904773|12447401|P7|STARTED|Sixth Intervention||3
5057532|NCT01904773|12447402|P6|STARTED|Sixth Intervention||4
5057533|NCT01904773|12447403|P5|STARTED|Sixth Intervention||3
5057534|NCT01904773|12447404|P4|STARTED|Sixth Intervention||2
5057535|NCT01904773|12447405|P3|STARTED|Sixth Intervention||1
5057536|NCT01904773|12447406|P2|STARTED|Sixth Intervention||0
5057537|NCT01904773|12447407|P1|STARTED|Sixth Intervention||0
5057538|NCT01904773|12447399|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057539|NCT01904773|12447400|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057540|NCT01904773|12447401|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057541|NCT01904773|12447402|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057542|NCT01904773|12447403|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057543|NCT01904773|12447404|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057544|NCT01904773|12447405|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057545|NCT01904773|12447406|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
5057546|NCT01904773|12447407|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
5057547|NCT01904773|12447399|P9|COMPLETED|Placebo Washout Fifth Intervention||4
5057548|NCT01904773|12447400|P8|COMPLETED|Placebo Washout Fifth Intervention||2
5057549|NCT01904773|12447401|P7|COMPLETED|Placebo Washout Fifth Intervention||3
5057550|NCT01904773|12447402|P6|COMPLETED|Placebo Washout Fifth Intervention||4
5057551|NCT01904773|12447403|P5|COMPLETED|Placebo Washout Fifth Intervention||3
5057552|NCT01904773|12447404|P4|COMPLETED|Placebo Washout Fifth Intervention||2
5057553|NCT01904773|12447405|P3|COMPLETED|Placebo Washout Fifth Intervention||1
5057554|NCT01904773|12447406|P2|COMPLETED|Placebo Washout Fifth Intervention||0
5057555|NCT01904773|12447407|P1|COMPLETED|Placebo Washout Fifth Intervention||0
5057556|NCT01904773|12447399|P9|STARTED|Placebo Washout Fifth Intervention||4
5057557|NCT01904773|12447400|P8|STARTED|Placebo Washout Fifth Intervention||2
5057558|NCT01904773|12447401|P7|STARTED|Placebo Washout Fifth Intervention||3
5057559|NCT01904773|12447402|P6|STARTED|Placebo Washout Fifth Intervention||4
5057560|NCT01904773|12447403|P5|STARTED|Placebo Washout Fifth Intervention||3
5057561|NCT01904773|12447404|P4|STARTED|Placebo Washout Fifth Intervention||2
5057562|NCT01904773|12447405|P3|STARTED|Placebo Washout Fifth Intervention||1
5057563|NCT01904773|12447406|P2|STARTED|Placebo Washout Fifth Intervention||1
5057564|NCT01904773|12447407|P1|STARTED|Placebo Washout Fifth Intervention||0
5057565|NCT01904773|12447399|P9|NOT COMPLETED|Fifth Intervention||0
5057566|NCT01904773|12447400|P8|NOT COMPLETED|Fifth Intervention||1
5057567|NCT01904773|12447401|P7|NOT COMPLETED|Fifth Intervention||0
5057568|NCT01904773|12447402|P6|NOT COMPLETED|Fifth Intervention||0
5057569|NCT01904773|12447403|P5|NOT COMPLETED|Fifth Intervention||0
5057570|NCT01904773|12447404|P4|NOT COMPLETED|Fifth Intervention||0
5057571|NCT01904773|12447405|P3|NOT COMPLETED|Fifth Intervention||0
5057572|NCT01904773|12447406|P2|NOT COMPLETED|Fifth Intervention||0
5057573|NCT01904773|12447407|P1|NOT COMPLETED|Fifth Intervention||0
5057574|NCT01904773|12447399|P9|COMPLETED|Fifth Intervention||4
5057575|NCT01904773|12447400|P8|COMPLETED|Fifth Intervention||2
5057576|NCT01904773|12447401|P7|COMPLETED|Fifth Intervention||3
5057577|NCT01904773|12447402|P6|COMPLETED|Fifth Intervention||4
5057578|NCT01904773|12447403|P5|COMPLETED|Fifth Intervention||3
5057579|NCT01904773|12447404|P4|COMPLETED|Fifth Intervention||2
5057580|NCT01904773|12447405|P3|COMPLETED|Fifth Intervention||1
5057581|NCT01904773|12447406|P2|COMPLETED|Fifth Intervention||1
5057582|NCT01904773|12447407|P1|COMPLETED|Fifth Intervention||0
5057583|NCT01904773|12447399|P9|STARTED|Fifth Intervention||4
5057584|NCT01904773|12447400|P8|STARTED|Fifth Intervention||3
5057585|NCT01904773|12447401|P7|STARTED|Fifth Intervention||3
5057586|NCT01904773|12447402|P6|STARTED|Fifth Intervention||4
5057587|NCT01904773|12447403|P5|STARTED|Fifth Intervention||3
5057588|NCT01904773|12447404|P4|STARTED|Fifth Intervention||2
5057589|NCT01904773|12447405|P3|STARTED|Fifth Intervention||1
5057590|NCT01904773|12447406|P2|STARTED|Fifth Intervention||1
5057591|NCT01904773|12447407|P1|STARTED|Fifth Intervention||0
5057592|NCT01904773|12447399|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057593|NCT01904773|12447400|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057594|NCT01904773|12447401|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057595|NCT01904773|12447402|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057596|NCT01904773|12447403|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057597|NCT01904773|12447404|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057598|NCT01904773|12447405|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057599|NCT01904773|12447406|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057600|NCT01904773|12447407|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
5057601|NCT01904773|12447399|P9|COMPLETED|Placebo Washout Fourth Intervention||4
5057602|NCT01904773|12447400|P8|COMPLETED|Placebo Washout Fourth Intervention||3
5057603|NCT01904773|12447401|P7|COMPLETED|Placebo Washout Fourth Intervention||3
5057604|NCT01904773|12447402|P6|COMPLETED|Placebo Washout Fourth Intervention||4
5057605|NCT01904773|12447403|P5|COMPLETED|Placebo Washout Fourth Intervention||3
5057606|NCT01904773|12447404|P4|COMPLETED|Placebo Washout Fourth Intervention||2
5057607|NCT01904773|12447405|P3|COMPLETED|Placebo Washout Fourth Intervention||1
5057608|NCT01904773|12447406|P2|COMPLETED|Placebo Washout Fourth Intervention||1
5057609|NCT01904773|12447407|P1|COMPLETED|Placebo Washout Fourth Intervention||0
5057610|NCT01904773|12447399|P9|STARTED|Placebo Washout Fourth Intervention||4
5057611|NCT01904773|12447400|P8|STARTED|Placebo Washout Fourth Intervention||3
5057612|NCT01904773|12447401|P7|STARTED|Placebo Washout Fourth Intervention||3
5057613|NCT01904773|12447402|P6|STARTED|Placebo Washout Fourth Intervention||4
5057614|NCT01904773|12447403|P5|STARTED|Placebo Washout Fourth Intervention||3
5057615|NCT01904773|12447404|P4|STARTED|Placebo Washout Fourth Intervention||2
5057616|NCT01904773|12447405|P3|STARTED|Placebo Washout Fourth Intervention||1
5057617|NCT01904773|12447406|P2|STARTED|Placebo Washout Fourth Intervention||1
5057618|NCT01904773|12447407|P1|STARTED|Placebo Washout Fourth Intervention||0
5057619|NCT01904773|12447399|P9|NOT COMPLETED|Fourth Intervention||0
5057620|NCT01904773|12447400|P8|NOT COMPLETED|Fourth Intervention||0
5057621|NCT01904773|12447401|P7|NOT COMPLETED|Fourth Intervention||0
5057622|NCT01904773|12447402|P6|NOT COMPLETED|Fourth Intervention||0
5057623|NCT01904773|12447403|P5|NOT COMPLETED|Fourth Intervention||0
5057624|NCT01904773|12447404|P4|NOT COMPLETED|Fourth Intervention||0
5057625|NCT01904773|12447405|P3|NOT COMPLETED|Fourth Intervention||0
5057626|NCT01904773|12447406|P2|NOT COMPLETED|Fourth Intervention||0
5057627|NCT01904773|12447407|P1|NOT COMPLETED|Fourth Intervention||0
5057628|NCT01904773|12447399|P9|COMPLETED|Fourth Intervention||4
5057629|NCT01904773|12447400|P8|COMPLETED|Fourth Intervention||3
5057630|NCT01904773|12447401|P7|COMPLETED|Fourth Intervention||3
5057631|NCT01904773|12447402|P6|COMPLETED|Fourth Intervention||4
5057632|NCT01904773|12447403|P5|COMPLETED|Fourth Intervention||3
5057633|NCT01904773|12447404|P4|COMPLETED|Fourth Intervention||2
5057634|NCT01904773|12447405|P3|COMPLETED|Fourth Intervention||1
5057635|NCT01904773|12447406|P2|COMPLETED|Fourth Intervention||1
5057636|NCT01904773|12447407|P1|COMPLETED|Fourth Intervention||0
5057637|NCT01904773|12447399|P9|STARTED|Fourth Intervention||4
5057638|NCT01904773|12447400|P8|STARTED|Fourth Intervention||3
5057639|NCT01904773|12447401|P7|STARTED|Fourth Intervention||3
5057640|NCT01904773|12447402|P6|STARTED|Fourth Intervention||4
5057641|NCT01904773|12447403|P5|STARTED|Fourth Intervention||3
5057642|NCT01904773|12447404|P4|STARTED|Fourth Intervention||2
5057643|NCT01904773|12447405|P3|STARTED|Fourth Intervention||1
5057644|NCT01904773|12447406|P2|STARTED|Fourth Intervention||1
5057645|NCT01904773|12447407|P1|STARTED|Fourth Intervention||0
5057646|NCT01904773|12447399|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
5057647|NCT01904773|12447400|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
5057648|NCT01904773|12447401|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
5057649|NCT01904773|12447402|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
5057650|NCT01904773|12447403|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
5057651|NCT01904773|12447404|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
5057652|NCT01904773|12447405|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
5057653|NCT01904773|12447406|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
5057654|NCT01904773|12447407|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
5057655|NCT01904773|12447399|P9|COMPLETED|Placebo Washout Third Intervention||4
5057656|NCT01904773|12447400|P8|COMPLETED|Placebo Washout Third Intervention||3
5057657|NCT01904773|12447401|P7|COMPLETED|Placebo Washout Third Intervention||3
5057658|NCT01904773|12447402|P6|COMPLETED|Placebo Washout Third Intervention||4
5057659|NCT01904773|12447403|P5|COMPLETED|Placebo Washout Third Intervention||3
5057660|NCT01904773|12447404|P4|COMPLETED|Placebo Washout Third Intervention||2
5057661|NCT01904773|12447405|P3|COMPLETED|Placebo Washout Third Intervention||1
5057662|NCT01904773|12447406|P2|COMPLETED|Placebo Washout Third Intervention||1
5057663|NCT01904773|12447407|P1|COMPLETED|Placebo Washout Third Intervention||0
5057664|NCT01904773|12447399|P9|STARTED|Placebo Washout Third Intervention||4
5057665|NCT01904773|12447400|P8|STARTED|Placebo Washout Third Intervention||3
5057666|NCT01904773|12447401|P7|STARTED|Placebo Washout Third Intervention||3
5057667|NCT01904773|12447402|P6|STARTED|Placebo Washout Third Intervention||4
5057668|NCT01904773|12447403|P5|STARTED|Placebo Washout Third Intervention||3
5057669|NCT01904773|12447404|P4|STARTED|Placebo Washout Third Intervention||2
5057670|NCT01904773|12447405|P3|STARTED|Placebo Washout Third Intervention||1
5057671|NCT01904773|12447406|P2|STARTED|Placebo Washout Third Intervention||1
5057672|NCT01904773|12447407|P1|STARTED|Placebo Washout Third Intervention||0
5057673|NCT01904773|12447399|P9|NOT COMPLETED|Third Intervention||0
5057674|NCT01904773|12447400|P8|NOT COMPLETED|Third Intervention||0
5057675|NCT01904773|12447401|P7|NOT COMPLETED|Third Intervention||0
5057676|NCT01904773|12447402|P6|NOT COMPLETED|Third Intervention||0
5057677|NCT01904773|12447403|P5|NOT COMPLETED|Third Intervention||0
5057678|NCT01904773|12447404|P4|NOT COMPLETED|Third Intervention||0
5057679|NCT01904773|12447405|P3|NOT COMPLETED|Third Intervention||0
5057680|NCT01904773|12447406|P2|NOT COMPLETED|Third Intervention||0
5057681|NCT01904773|12447407|P1|NOT COMPLETED|Third Intervention||0
5057682|NCT01904773|12447399|P9|COMPLETED|Third Intervention||4
5057683|NCT01904773|12447400|P8|COMPLETED|Third Intervention||3
5057684|NCT01904773|12447401|P7|COMPLETED|Third Intervention||3
5057685|NCT01904773|12447402|P6|COMPLETED|Third Intervention||4
5057686|NCT01904773|12447403|P5|COMPLETED|Third Intervention||3
5057687|NCT01904773|12447404|P4|COMPLETED|Third Intervention||2
5057688|NCT01904773|12447405|P3|COMPLETED|Third Intervention||1
5057689|NCT01904773|12447406|P2|COMPLETED|Third Intervention||1
5057690|NCT01904773|12447407|P1|COMPLETED|Third Intervention||0
5057691|NCT01904773|12447399|P9|STARTED|Third Intervention||4
5057692|NCT01904773|12447400|P8|STARTED|Third Intervention||3
5057693|NCT01904773|12447401|P7|STARTED|Third Intervention||3
5057694|NCT01904773|12447402|P6|STARTED|Third Intervention||4
5057695|NCT01904773|12447403|P5|STARTED|Third Intervention||3
5057696|NCT01904773|12447404|P4|STARTED|Third Intervention||2
5057697|NCT01904773|12447405|P3|STARTED|Third Intervention||1
5057698|NCT01904773|12447406|P2|STARTED|Third Intervention||1
5057699|NCT01904773|12447407|P1|STARTED|Third Intervention||0
5057700|NCT01904773|12447399|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
5057701|NCT01904773|12447400|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
5057702|NCT01904773|12447401|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
5057703|NCT01904773|12447402|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
5057704|NCT01904773|12447403|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
5057705|NCT01904773|12447404|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
5057706|NCT01904773|12447405|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
5057707|NCT01904773|12447406|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
5057708|NCT01904773|12447407|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
5057709|NCT01904773|12447399|P9|COMPLETED|Placebo Washout Second Intervention||4
5057710|NCT01904773|12447400|P8|COMPLETED|Placebo Washout Second Intervention||3
5057711|NCT01904773|12447401|P7|COMPLETED|Placebo Washout Second Intervention||3
5057712|NCT01904773|12447402|P6|COMPLETED|Placebo Washout Second Intervention||4
5057713|NCT01904773|12447403|P5|COMPLETED|Placebo Washout Second Intervention||3
5057714|NCT01904773|12447404|P4|COMPLETED|Placebo Washout Second Intervention||2
5057715|NCT01904773|12447405|P3|COMPLETED|Placebo Washout Second Intervention||1
5057716|NCT01904773|12447406|P2|COMPLETED|Placebo Washout Second Intervention||1
5057717|NCT01904773|12447407|P1|COMPLETED|Placebo Washout Second Intervention||0
5057718|NCT01904773|12447399|P9|STARTED|Placebo Washout Second Intervention||4
5057719|NCT01904773|12447400|P8|STARTED|Placebo Washout Second Intervention||3
5057720|NCT01904773|12447401|P7|STARTED|Placebo Washout Second Intervention||3
5057721|NCT01904773|12447402|P6|STARTED|Placebo Washout Second Intervention||4
5057722|NCT01904773|12447403|P5|STARTED|Placebo Washout Second Intervention||3
5057723|NCT01904773|12447404|P4|STARTED|Placebo Washout Second Intervention||2
5057724|NCT01904773|12447405|P3|STARTED|Placebo Washout Second Intervention||1
5057725|NCT01904773|12447406|P2|STARTED|Placebo Washout Second Intervention||1
5057726|NCT01904773|12447407|P1|STARTED|Placebo Washout Second Intervention||0
5057727|NCT01904773|12447399|P9|NOT COMPLETED|Second Intervention||0
5057728|NCT01904773|12447400|P8|NOT COMPLETED|Second Intervention||0
5057729|NCT01904773|12447401|P7|NOT COMPLETED|Second Intervention||0
5057730|NCT01904773|12447402|P6|NOT COMPLETED|Second Intervention||0
5057731|NCT01904773|12447403|P5|NOT COMPLETED|Second Intervention||0
5057732|NCT01904773|12447404|P4|NOT COMPLETED|Second Intervention||0
5057733|NCT01904773|12447405|P3|NOT COMPLETED|Second Intervention||0
5057734|NCT01904773|12447406|P2|NOT COMPLETED|Second Intervention||0
5057735|NCT01904773|12447407|P1|NOT COMPLETED|Second Intervention||0
5057736|NCT01904773|12447399|P9|COMPLETED|Second Intervention||4
5057737|NCT01904773|12447400|P8|COMPLETED|Second Intervention||3
5057738|NCT01904773|12447401|P7|COMPLETED|Second Intervention||3
5057739|NCT01904773|12447402|P6|COMPLETED|Second Intervention||4
5057740|NCT01904773|12447403|P5|COMPLETED|Second Intervention||3
5057741|NCT01904773|12447404|P4|COMPLETED|Second Intervention||2
5057742|NCT01904773|12447405|P3|COMPLETED|Second Intervention||1
5057743|NCT01904773|12447406|P2|COMPLETED|Second Intervention||1
5057744|NCT01904773|12447407|P1|COMPLETED|Second Intervention||0
5057745|NCT01904773|12447399|P9|STARTED|Second Intervention||4
5057746|NCT01904773|12447400|P8|STARTED|Second Intervention||3
5057747|NCT01904773|12447401|P7|STARTED|Second Intervention||3
5057748|NCT01904773|12447402|P6|STARTED|Second Intervention||4
5057749|NCT01904773|12447403|P5|STARTED|Second Intervention||3
5057750|NCT01904773|12447404|P4|STARTED|Second Intervention||2
5057751|NCT01904773|12447405|P3|STARTED|Second Intervention||1
5057752|NCT01904773|12447406|P2|STARTED|Second Intervention||1
5057753|NCT01904773|12447407|P1|STARTED|Second Intervention||0
5057754|NCT01904773|12447399|P9|NOT COMPLETED|Placebo Washout First Intervention||0
5057755|NCT01904773|12447400|P8|NOT COMPLETED|Placebo Washout First Intervention||0
5057756|NCT01904773|12447401|P7|NOT COMPLETED|Placebo Washout First Intervention||0
5057757|NCT01904773|12447402|P6|NOT COMPLETED|Placebo Washout First Intervention||0
5057758|NCT01904773|12447403|P5|NOT COMPLETED|Placebo Washout First Intervention||0
5057759|NCT01904773|12447404|P4|NOT COMPLETED|Placebo Washout First Intervention||0
5057760|NCT01904773|12447405|P3|NOT COMPLETED|Placebo Washout First Intervention||0
5057761|NCT01904773|12447406|P2|NOT COMPLETED|Placebo Washout First Intervention||1
5057762|NCT01904773|12447407|P1|NOT COMPLETED|Placebo Washout First Intervention||0
5057763|NCT01904773|12447399|P9|COMPLETED|Placebo Washout First Intervention||4
5057764|NCT01904773|12447400|P8|COMPLETED|Placebo Washout First Intervention||3
5057765|NCT01904773|12447401|P7|COMPLETED|Placebo Washout First Intervention||3
5057766|NCT01904773|12447402|P6|COMPLETED|Placebo Washout First Intervention||4
5057767|NCT01904773|12447403|P5|COMPLETED|Placebo Washout First Intervention||3
5057768|NCT01904773|12447404|P4|COMPLETED|Placebo Washout First Intervention||2
5057769|NCT01904773|12447405|P3|COMPLETED|Placebo Washout First Intervention||1
5057770|NCT01904773|12447406|P2|COMPLETED|Placebo Washout First Intervention||1
5057771|NCT01904773|12447407|P1|COMPLETED|Placebo Washout First Intervention||0
5057772|NCT01904773|12447399|P9|STARTED|Placebo Washout First Intervention||4
5057773|NCT01904773|12447400|P8|STARTED|Placebo Washout First Intervention||3
5057774|NCT01904773|12447401|P7|STARTED|Placebo Washout First Intervention||3
5057775|NCT01904773|12447402|P6|STARTED|Placebo Washout First Intervention||4
5057776|NCT01904773|12447403|P5|STARTED|Placebo Washout First Intervention||3
5057777|NCT01904773|12447404|P4|STARTED|Placebo Washout First Intervention||2
5057778|NCT01904773|12447405|P3|STARTED|Placebo Washout First Intervention||1
5057779|NCT01904773|12447406|P2|STARTED|Placebo Washout First Intervention||2
5057780|NCT01904773|12447407|P1|STARTED|Placebo Washout First Intervention||0
5057781|NCT01904773|12447399|P9|NOT COMPLETED|First Intervention||0
5057782|NCT01904773|12447400|P8|NOT COMPLETED|First Intervention||0
5057783|NCT01904773|12447401|P7|NOT COMPLETED|First Intervention||1
5057784|NCT01904773|12447402|P6|NOT COMPLETED|First Intervention||0
5057785|NCT01904773|12447403|P5|NOT COMPLETED|First Intervention||0
5057786|NCT01904773|12447404|P4|NOT COMPLETED|First Intervention||0
5057787|NCT01904773|12447405|P3|NOT COMPLETED|First Intervention||0
5057788|NCT01904773|12447406|P2|NOT COMPLETED|First Intervention||0
5057789|NCT01904773|12447407|P1|NOT COMPLETED|First Intervention||0
5057790|NCT01904773|12447399|P9|COMPLETED|First Intervention||4
5057791|NCT01904773|12447400|P8|COMPLETED|First Intervention||3
5057792|NCT01904773|12447401|P7|COMPLETED|First Intervention||3
5057793|NCT01904773|12447402|P6|COMPLETED|First Intervention||4
5057794|NCT01904773|12447403|P5|COMPLETED|First Intervention||3
5057795|NCT01904773|12447404|P4|COMPLETED|First Intervention||2
5057796|NCT01904773|12447405|P3|COMPLETED|First Intervention||1
5057797|NCT01904773|12447406|P2|COMPLETED|First Intervention||2
5057798|NCT01904773|12447407|P1|COMPLETED|First Intervention||0
5057799|NCT01904773|12447399|P9|STARTED|First Intervention||4
5057800|NCT01904773|12447400|P8|STARTED|First Intervention||3
5057801|NCT01904773|12447401|P7|STARTED|First Intervention||4
5057802|NCT01904773|12447402|P6|STARTED|First Intervention||4
5057803|NCT01904773|12447403|P5|STARTED|First Intervention||3
5057804|NCT01904773|12447404|P4|STARTED|First Intervention||2
5057805|NCT01904773|12447405|P3|STARTED|First Intervention||1
5057806|NCT01904773|12447406|P2|STARTED|First Intervention||2
5057807|NCT01904773|12447407|P1|STARTED|First Intervention||0
5057808|NCT01904773|12447399|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057809|NCT01904773|12447400|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057810|NCT01904773|12447401|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057811|NCT01904773|12447402|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057812|NCT01904773|12447403|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057813|NCT01904773|12447404|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057814|NCT01904773|12447405|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057815|NCT01904773|12447406|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057816|NCT01904773|12447407|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
5057817|NCT01904773|12447399|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057818|NCT01904773|12447400|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057819|NCT01904773|12447401|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057820|NCT01904773|12447402|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057821|NCT01904773|12447403|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057822|NCT01904773|12447404|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057823|NCT01904773|12447405|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057824|NCT01904773|12447406|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057825|NCT01904773|12447407|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
5057826|NCT01904773|12447399|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057827|NCT01904773|12447400|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057828|NCT01904773|12447401|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057829|NCT01904773|12447402|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057830|NCT01904773|12447403|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057831|NCT01904773|12447404|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057832|NCT01904773|12447405|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057833|NCT01904773|12447406|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057834|NCT01904773|12447407|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
5057835|NCT01904773|12447399|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057836|NCT01904773|12447400|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057837|NCT01904773|12447401|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057838|NCT01904773|12447402|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057839|NCT01904773|12447403|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057840|NCT01904773|12447404|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057841|NCT01904773|12447405|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057842|NCT01904773|12447406|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057843|NCT01904773|12447407|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
5057844|NCT01904773|12447399|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057845|NCT01904773|12447400|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057846|NCT01904773|12447401|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057847|NCT01904773|12447402|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057848|NCT01904773|12447403|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057849|NCT01904773|12447404|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057850|NCT01904773|12447405|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057851|NCT01904773|12447406|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
5057852|NCT01904773|12447407|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
5057853|NCT01904773|12447399|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057854|NCT01904773|12447400|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057855|NCT01904773|12447401|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057856|NCT01904773|12447402|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057857|NCT01904773|12447403|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057858|NCT01904773|12447404|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057859|NCT01904773|12447405|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057860|NCT01904773|12447406|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057861|NCT01904773|12447407|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057862|NCT01904773|12447399|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057863|NCT01904773|12447400|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057864|NCT01904773|12447401|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057865|NCT01904773|12447402|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057866|NCT01904773|12447403|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057867|NCT01904773|12447404|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057868|NCT01904773|12447405|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057869|NCT01904773|12447406|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057870|NCT01904773|12447407|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
5057871|NCT01904773|12447399|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057872|NCT01904773|12447400|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057873|NCT01904773|12447401|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057874|NCT01904773|12447402|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057875|NCT01904773|12447403|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057876|NCT01904773|12447404|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057877|NCT01904773|12447405|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057878|NCT01904773|12447406|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
5057879|NCT01904773|12447407|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
5057880|NCT01904773|12447399|P9|NOT COMPLETED|Screen||0
5057881|NCT01904773|12447400|P8|NOT COMPLETED|Screen||0
5057882|NCT01904773|12447401|P7|NOT COMPLETED|Screen||0
5057883|NCT01904773|12447402|P6|NOT COMPLETED|Screen||0
5057884|NCT01904773|12447403|P5|NOT COMPLETED|Screen||0
5057885|NCT01904773|12447404|P4|NOT COMPLETED|Screen||0
5057886|NCT01904773|12447405|P3|NOT COMPLETED|Screen||0
5057887|NCT01904773|12447406|P2|NOT COMPLETED|Screen||0
5057888|NCT01904773|12447407|P1|NOT COMPLETED|Screen||4
5057889|NCT01904773|12447399|P9|COMPLETED|Screen||0
5057890|NCT01904773|12447400|P8|COMPLETED|Screen||0
5057891|NCT01904773|12447401|P7|COMPLETED|Screen||0
5057892|NCT01904773|12447402|P6|COMPLETED|Screen||0
5057893|NCT01904773|12447403|P5|COMPLETED|Screen||0
5057894|NCT01904773|12447404|P4|COMPLETED|Screen||0
5057895|NCT01904773|12447405|P3|COMPLETED|Screen||0
5057896|NCT01904773|12447406|P2|COMPLETED|Screen||0
5057897|NCT01904773|12447407|P1|COMPLETED|Screen||24
5057898|NCT01904773|12447399|P9|STARTED|Screen||0
5057899|NCT01904773|12447400|P8|STARTED|Screen||0
5057900|NCT01904773|12447401|P7|STARTED|Screen||0
5057901|NCT01904773|12447402|P6|STARTED|Screen||0
5057902|NCT01904773|12447403|P5|STARTED|Screen||0
5057903|NCT01904773|12447404|P4|STARTED|Screen||0
5057904|NCT01904773|12447405|P3|STARTED|Screen||0
5057905|NCT01904773|12447406|P2|STARTED|Screen||0
5057906|NCT01904773|12447407|P1|STARTED|Screen||28
5057907|NCT01904760|12447424|P2|NOT COMPLETED|Overall Study||0
5057908|NCT01904760|12447425|P1|NOT COMPLETED|Overall Study||1
5057909|NCT01904760|12447424|P2|COMPLETED|Overall Study||40
5057910|NCT01904760|12447425|P1|COMPLETED|Overall Study||39
5057911|NCT01904760|12447424|P2|STARTED|Overall Study||40
5057912|NCT01904760|12447425|P1|STARTED|Overall Study||40
5057913|NCT01904721|12447440|P7|NOT COMPLETED|Overall Study||7
5057914|NCT01904721|12447441|P6|NOT COMPLETED|Overall Study||9
5057915|NCT01904721|12447442|P5|NOT COMPLETED|Overall Study||8
5057916|NCT01904721|12447443|P4|NOT COMPLETED|Overall Study||1
5057917|NCT01904721|12447444|P3|NOT COMPLETED|Overall Study||1
5057918|NCT01904721|12447445|P2|NOT COMPLETED|Overall Study||0
5057919|NCT01904721|12447446|P1|NOT COMPLETED|Overall Study||0
5057920|NCT01904721|12447440|P7|COMPLETED|Overall Study||57
5057921|NCT01904721|12447441|P6|COMPLETED|Overall Study||56
5057922|NCT01904721|12447442|P5|COMPLETED|Overall Study||57
5057923|NCT01904721|12447443|P4|COMPLETED|Overall Study||11
5057924|NCT01904721|12447444|P3|COMPLETED|Overall Study||11
5057925|NCT01904721|12447445|P2|COMPLETED|Overall Study||13
5057926|NCT01904721|12447446|P1|COMPLETED|Overall Study||13
5057927|NCT01904721|12447440|P7|STARTED|Overall Study||64
5057928|NCT01904721|12447441|P6|STARTED|Overall Study||65
5057929|NCT01904721|12447442|P5|STARTED|Overall Study||65
5057930|NCT01904721|12447443|P4|STARTED|Overall Study||12
5057931|NCT01904721|12447444|P3|STARTED|Overall Study||12
5057932|NCT01904721|12447445|P2|STARTED|Overall Study||13
5057933|NCT01904721|12447446|P1|STARTED|Overall Study||13
5057934|NCT01904604|12447476|P3|NOT COMPLETED|Overall Study||2
5057935|NCT01904604|12447477|P2|NOT COMPLETED|Overall Study||7
5057936|NCT01904604|12447478|P1|NOT COMPLETED|Overall Study||7
5057937|NCT01904604|12447476|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
5057938|NCT01904604|12447477|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
5057939|NCT01904604|12447478|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
5057940|NCT01904604|12447476|P3|Completed Week 130 OFC|Overall Study||23
5057941|NCT01904604|12447477|P2|Completed Week 130 OFC|Overall Study||18
5057942|NCT01904604|12447478|P1|Completed Week 130 OFC|Overall Study||18
5057943|NCT01904604|12447476|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
5057944|NCT01904604|12447477|P2|Began Crossover Treatment|Overall Study||21
5057945|NCT01904604|12447478|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
5057946|NCT01904604|12447476|P3|Completed Week 52 OFC|Overall Study||25
5057947|NCT01904604|12447477|P2|Completed Week 52 OFC|Overall Study||21
5057948|NCT01904604|12447478|P1|Completed Week 52 OFC|Overall Study||22
5057949|NCT01904604|12447476|P3|STARTED|Overall Study||25
5057950|NCT01904604|12447477|P2|STARTED|Overall Study||25
5057951|NCT01904604|12447478|P1|STARTED|Overall Study||25
5057952|NCT01904526|12447507|P1|NOT COMPLETED|Overall Study||0
5057953|NCT01904526|12447507|P1|COMPLETED|Overall Study||5
5057954|NCT01904526|12447507|P1|STARTED|Overall Study||5
5057955|NCT01904448|12447521|P1|NOT COMPLETED|Overall Study||0
5057956|NCT01904448|12447521|P1|COMPLETED|Overall Study||5
5057957|NCT01904448|12447521|P1|STARTED|Overall Study||5
5057958|NCT01904383|12447543|P1|NOT COMPLETED|Overall Study||1774
5057959|NCT01904383|12447543|P1|COMPLETED|Overall Study||2283
5057960|NCT01904383|12447543|P1|Treated|Overall Study||3940
5057961|NCT01904383|12447543|P1|STARTED|Overall Study||4057
5057962|NCT01904279|12447550|P2|NOT COMPLETED|Overall Study||3
5057963|NCT01904279|12447551|P1|NOT COMPLETED|Overall Study||3
5057964|NCT01904279|12447550|P2|COMPLETED|Overall Study||22
5057965|NCT01904279|12447551|P1|COMPLETED|Overall Study||24
5057966|NCT01904279|12447550|P2|STARTED|Overall Study||25
5057967|NCT01904279|12447551|P1|STARTED|Overall Study||27
5057968|NCT01904149|12447577|P6|NOT COMPLETED|Overall Study||3
5057969|NCT01904149|12447578|P5|NOT COMPLETED|Overall Study||5
5057970|NCT01904149|12447579|P4|NOT COMPLETED|Overall Study||4
5057971|NCT01904149|12447580|P3|NOT COMPLETED|Overall Study||2
5057972|NCT01904149|12447581|P2|NOT COMPLETED|Overall Study||11
5057973|NCT01904149|12447582|P1|NOT COMPLETED|Overall Study||5
5057974|NCT01904149|12447577|P6|COMPLETED|Overall Study||48
5057975|NCT01904149|12447578|P5|COMPLETED|Overall Study||46
5057976|NCT01904149|12447579|P4|COMPLETED|Overall Study||47
5057977|NCT01904149|12447580|P3|COMPLETED|Overall Study||148
5057978|NCT01904149|12447581|P2|COMPLETED|Overall Study||140
5057979|NCT01904149|12447582|P1|COMPLETED|Overall Study||147
5057980|NCT01904149|12447577|P6|Multiple-dose Phase|Overall Study||49
5057981|NCT01904149|12447578|P5|Multiple-dose Phase|Overall Study||48
5057982|NCT01904149|12447579|P4|Multiple-dose Phase|Overall Study||48
5057983|NCT01904149|12447580|P3|Multiple-dose Phase|Overall Study||149
5057984|NCT01904149|12447581|P2|Multiple-dose Phase|Overall Study||146
5057985|NCT01904149|12447582|P1|Multiple-dose Phase|Overall Study||150
5057986|NCT01904149|12447577|P6|Single-dose Phase|Overall Study||51
5057987|NCT01904149|12447578|P5|Single-dose Phase|Overall Study||51
5057988|NCT01904149|12447579|P4|Single-dose Phase|Overall Study||51
5057989|NCT01904149|12447580|P3|Single-dose Phase|Overall Study||150
5057990|NCT01904149|12447581|P2|Single-dose Phase|Overall Study||151
5057991|NCT01904149|12447582|P1|Single-dose Phase|Overall Study||152
5057992|NCT01904149|12447577|P6|STARTED|Overall Study||51
5057993|NCT01904149|12447578|P5|STARTED|Overall Study||51
5057994|NCT01904149|12447579|P4|STARTED|Overall Study||51
5057995|NCT01904149|12447580|P3|STARTED|Overall Study||150
5057996|NCT01904149|12447581|P2|STARTED|Overall Study||151
5057997|NCT01904149|12447582|P1|STARTED|Overall Study||152
5057998|NCT01904071|12447607|P3|NOT COMPLETED|Overall Study||0
5057999|NCT01904071|12447608|P2|NOT COMPLETED|Overall Study||0
5058000|NCT01904071|12447609|P1|NOT COMPLETED|Overall Study||0
5058001|NCT01904071|12447607|P3|COMPLETED|Overall Study||20
5058002|NCT01904071|12447608|P2|COMPLETED|Overall Study||20
5058003|NCT01904071|12447609|P1|COMPLETED|Overall Study||24
5058004|NCT01904071|12447607|P3|STARTED|Overall Study||20
5058005|NCT01904071|12447608|P2|STARTED|Overall Study||20
5058006|NCT01904071|12447609|P1|STARTED|Overall Study||24
5058007|NCT01904058|12447633|P4|NOT COMPLETED|Overall Study||1
5058008|NCT01904058|12447634|P3|NOT COMPLETED|Overall Study||1
5058009|NCT01904058|12447635|P2|NOT COMPLETED|Overall Study||0
5058010|NCT01904058|12447636|P1|NOT COMPLETED|Overall Study||3
5058011|NCT01904058|12447633|P4|COMPLETED|Overall Study||12
5058012|NCT01904058|12447634|P3|COMPLETED|Overall Study||10
5058013|NCT01904058|12447635|P2|COMPLETED|Overall Study||21
5058014|NCT01904058|12447636|P1|COMPLETED|Overall Study||18
5058015|NCT01904058|12447633|P4|STARTED|Overall Study||13
5058016|NCT01904058|12447634|P3|STARTED|Overall Study||11
5058017|NCT01904058|12447635|P2|STARTED|Overall Study||21
5058018|NCT01904058|12447636|P1|STARTED|Overall Study||21
5058019|NCT01903993|12447676|P2|NOT COMPLETED|Overall Study||144
5058020|NCT01903993|12447677|P1|NOT COMPLETED|Overall Study||143
5058021|NCT01903993|12447676|P2|COMPLETED|Overall Study||0
5058022|NCT01903993|12447677|P1|COMPLETED|Overall Study||0
5058023|NCT01903993|12447676|P2|Received Treatment|Overall Study||142
5058024|NCT01903993|12447677|P1|Received Treatment|Overall Study||135
5058025|NCT01903993|12447676|P2|STARTED|Overall Study||144
5058026|NCT01903993|12447677|P1|STARTED|Overall Study||143
5058027|NCT01903876|12447694|P2|NOT COMPLETED|Six-Month Follow-up Period||145
5058028|NCT01903876|12447695|P1|NOT COMPLETED|Six-Month Follow-up Period||91
5058029|NCT01903876|12447694|P2|COMPLETED|Six-Month Follow-up Period||123
5058030|NCT01903876|12447695|P1|COMPLETED|Six-Month Follow-up Period||92
5058031|NCT01903876|12447694|P2|STARTED|Six-Month Follow-up Period||268
5058032|NCT01903876|12447695|P1|STARTED|Six-Month Follow-up Period||183
5058033|NCT01903876|12447694|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
5058034|NCT01903876|12447695|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
5058035|NCT01903876|12447694|P2|COMPLETED|Baseline to Post-Intervention Period||268
5058036|NCT01903876|12447695|P1|COMPLETED|Baseline to Post-Intervention Period||183
5058037|NCT01903876|12447694|P2|STARTED|Baseline to Post-Intervention Period||376
5058038|NCT01903876|12447695|P1|STARTED|Baseline to Post-Intervention Period||367
5058039|NCT01903863|12447705|P2|NOT COMPLETED|Overall Study||0
5058040|NCT01903863|12447706|P1|NOT COMPLETED|Overall Study||2
5058041|NCT01903863|12447705|P2|COMPLETED|Overall Study||16
5058042|NCT01903863|12447706|P1|COMPLETED|Overall Study||13
5058043|NCT01903863|12447705|P2|STARTED|Overall Study||16
5058044|NCT01903863|12447706|P1|STARTED|Overall Study||15
5058045|NCT01903811|12447728|P2|NOT COMPLETED|Overall Study||14
5058046|NCT01903811|12447729|P1|NOT COMPLETED|Overall Study||8
5058047|NCT01903811|12447728|P2|COMPLETED|Overall Study||57
5058048|NCT01903811|12447729|P1|COMPLETED|Overall Study||64
5058049|NCT01903811|12447728|P2|Crossover to Arm II|Overall Study||0
5058050|NCT01903811|12447729|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
5058051|NCT01903811|12447728|P2|STARTED|Overall Study||71
5058052|NCT01903811|12447729|P1|STARTED|Overall Study||72
5058053|NCT01903798|12447746|P4|NOT COMPLETED|Overall Study||0
5058054|NCT01903798|12447747|P3|NOT COMPLETED|Overall Study||0
5058055|NCT01903798|12447748|P2|NOT COMPLETED|Overall Study||0
5058056|NCT01903798|12447749|P1|NOT COMPLETED|Overall Study||0
5058057|NCT01903798|12447746|P4|COMPLETED|Overall Study||1
5058058|NCT01903798|12447747|P3|COMPLETED|Overall Study||1
5058059|NCT01903798|12447748|P2|COMPLETED|Overall Study||0
5058060|NCT01903798|12447749|P1|COMPLETED|Overall Study||2
5058061|NCT01903798|12447746|P4|STARTED|Overall Study||1
5058062|NCT01903798|12447747|P3|STARTED|Overall Study||1
5058063|NCT01903798|12447748|P2|STARTED|Overall Study||0
5058064|NCT01903798|12447749|P1|STARTED|Overall Study||2
5058065|NCT01903720|12447763|P1|NOT COMPLETED|Overall Study||12
5058066|NCT01903720|12447763|P1|COMPLETED|Overall Study||59
5058067|NCT01903720|12447763|P1|STARTED|Overall Study||71
5058068|NCT01903564|12447780|P2|NOT COMPLETED|Overall Study||0
5058069|NCT01903564|12447781|P1|NOT COMPLETED|Overall Study||0
5058070|NCT01903564|12447780|P2|COMPLETED|Overall Study||29
5058071|NCT01903564|12447781|P1|COMPLETED|Overall Study||10
5058072|NCT01903564|12447780|P2|STARTED|Overall Study||29
5058073|NCT01903564|12447781|P1|STARTED|Overall Study||10
5058074|NCT01903460|12447801|P4|NOT COMPLETED|Overall Study||1
5058075|NCT01903460|12447802|P3|NOT COMPLETED|Overall Study||0
5058076|NCT01903460|12447803|P2|NOT COMPLETED|Overall Study||0
5058077|NCT01903460|12447804|P1|NOT COMPLETED|Overall Study||0
5058078|NCT01903460|12447801|P4|COMPLETED|Overall Study||2
5058079|NCT01903460|12447802|P3|COMPLETED|Overall Study||3
5058080|NCT01903460|12447803|P2|COMPLETED|Overall Study||8
5058081|NCT01903460|12447804|P1|COMPLETED|Overall Study||6
5058082|NCT01903460|12447801|P4|STARTED|Overall Study||3
5058083|NCT01903460|12447802|P3|STARTED|Overall Study||3
5058084|NCT01903460|12447803|P2|STARTED|Overall Study||8
5058085|NCT01903460|12447804|P1|STARTED|Overall Study||6
5058086|NCT01903434|12447821|P2|NOT COMPLETED|Treatment Period 3||0
5058087|NCT01903434|12447822|P1|NOT COMPLETED|Treatment Period 3||0
5058088|NCT01903434|12447821|P2|COMPLETED|Treatment Period 3||28
5058089|NCT01903434|12447822|P1|COMPLETED|Treatment Period 3||29
5058090|NCT01903434|12447821|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
5058091|NCT01903434|12447822|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
5058092|NCT01903434|12447821|P2|STARTED|Treatment Period 3||28
5058093|NCT01903434|12447822|P1|STARTED|Treatment Period 3||29
5058094|NCT01903434|12447821|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5058095|NCT01903434|12447822|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5058096|NCT01903434|12447821|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
5058097|NCT01903434|12447822|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
5058098|NCT01903434|12447821|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
5058099|NCT01903434|12447822|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
5058100|NCT01903434|12447821|P2|NOT COMPLETED|Treatment Period 2||0
5058101|NCT01903434|12447822|P1|NOT COMPLETED|Treatment Period 2||0
5058102|NCT01903434|12447821|P2|COMPLETED|Treatment Period 2||28
5058103|NCT01903434|12447822|P1|COMPLETED|Treatment Period 2||29
5058104|NCT01903434|12447821|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
5058105|NCT01903434|12447822|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
5058106|NCT01903434|12447821|P2|STARTED|Treatment Period 2||28
5058107|NCT01903434|12447822|P1|STARTED|Treatment Period 2||29
5058108|NCT01903434|12447821|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
5058109|NCT01903434|12447822|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
5058110|NCT01903434|12447821|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
5058111|NCT01903434|12447822|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
5058112|NCT01903434|12447821|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
5058113|NCT01903434|12447822|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
5058114|NCT01903434|12447821|P2|NOT COMPLETED|Treatment Period 1||0
5058115|NCT01903434|12447822|P1|NOT COMPLETED|Treatment Period 1||0
5058116|NCT01903434|12447821|P2|COMPLETED|Treatment Period 1||30
5058117|NCT01903434|12447822|P1|COMPLETED|Treatment Period 1||30
5058118|NCT01903434|12447821|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
5058119|NCT01903434|12447822|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
5058120|NCT01903434|12447821|P2|STARTED|Treatment Period 1||30
5058121|NCT01903434|12447822|P1|STARTED|Treatment Period 1||30
5058122|NCT01903356|12447830|P1|NOT COMPLETED|Overall Study||15
5058123|NCT01903356|12447830|P1|COMPLETED|Overall Study||709
5058124|NCT01903356|12447830|P1|STARTED|Overall Study||724
5058125|NCT01903265|12447840|P2|NOT COMPLETED|Overall Study||17
5058126|NCT01903265|12447841|P1|NOT COMPLETED|Overall Study||14
5058127|NCT01903265|12447840|P2|COMPLETED|Overall Study||85
5058128|NCT01903265|12447841|P1|COMPLETED|Overall Study||89
5058129|NCT01903265|12447840|P2|STARTED|Overall Study||102
5058130|NCT01903265|12447841|P1|STARTED|Overall Study||103
5058131|NCT01903252|12447857|P6|NOT COMPLETED|Maintenance, Open-Label||18
5058132|NCT01903252|12447858|P5|NOT COMPLETED|Maintenance, Open-Label||21
5058133|NCT01903252|12447859|P4|NOT COMPLETED|Maintenance, Open-Label||6
5058134|NCT01903252|12447860|P3|NOT COMPLETED|Maintenance, Open-Label||0
5058135|NCT01903252|12447861|P2|NOT COMPLETED|Maintenance, Open-Label||0
5058136|NCT01903252|12447862|P1|NOT COMPLETED|Maintenance, Open-Label||0
5058137|NCT01903252|12447857|P6|COMPLETED|Maintenance, Open-Label||181
5058138|NCT01903252|12447858|P5|COMPLETED|Maintenance, Open-Label||253
5058139|NCT01903252|12447859|P4|COMPLETED|Maintenance, Open-Label||196
5058140|NCT01903252|12447860|P3|COMPLETED|Maintenance, Open-Label||0
5058141|NCT01903252|12447861|P2|COMPLETED|Maintenance, Open-Label||0
5058142|NCT01903252|12447862|P1|COMPLETED|Maintenance, Open-Label||0
5058143|NCT01903252|12447857|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
5058144|NCT01903252|12447858|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
5058145|NCT01903252|12447859|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
5058146|NCT01903252|12447860|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
5058147|NCT01903252|12447861|P2|STARTED|Maintenance, Open-Label||0
5058148|NCT01903252|12447862|P1|STARTED|Maintenance, Open-Label||0
5058149|NCT01903252|12447857|P6|NOT COMPLETED|Extended Induction, Open-Label||0
5058150|NCT01903252|12447858|P5|NOT COMPLETED|Extended Induction, Open-Label||0
5058151|NCT01903252|12447859|P4|NOT COMPLETED|Extended Induction, Open-Label||0
5058152|NCT01903252|12447860|P3|NOT COMPLETED|Extended Induction, Open-Label||23
5058153|NCT01903252|12447861|P2|NOT COMPLETED|Extended Induction, Open-Label||0
5058154|NCT01903252|12447862|P1|NOT COMPLETED|Extended Induction, Open-Label||0
5058155|NCT01903252|12447857|P6|COMPLETED|Extended Induction, Open-Label||0
5058156|NCT01903252|12447858|P5|COMPLETED|Extended Induction, Open-Label||0
5058157|NCT01903252|12447859|P4|COMPLETED|Extended Induction, Open-Label||0
5058158|NCT01903252|12447860|P3|COMPLETED|Extended Induction, Open-Label||220
5058159|NCT01903252|12447861|P2|COMPLETED|Extended Induction, Open-Label||0
5058160|NCT01903252|12447862|P1|COMPLETED|Extended Induction, Open-Label||0
5058161|NCT01903252|12447857|P6|STARTED|Extended Induction, Open-Label||0
5058162|NCT01903252|12447858|P5|STARTED|Extended Induction, Open-Label||0
5058163|NCT01903252|12447859|P4|STARTED|Extended Induction, Open-Label||0
5058164|NCT01903252|12447860|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
5058165|NCT01903252|12447861|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
5058166|NCT01903252|12447862|P1|STARTED|Extended Induction, Open-Label||0
5058167|NCT01903252|12447857|P6|NOT COMPLETED|Double-Blind Induction||0
5058168|NCT01903252|12447858|P5|NOT COMPLETED|Double-Blind Induction||0
5058169|NCT01903252|12447859|P4|NOT COMPLETED|Double-Blind Induction||0
5058170|NCT01903252|12447860|P3|NOT COMPLETED|Double-Blind Induction||0
5058171|NCT01903252|12447861|P2|NOT COMPLETED|Double-Blind Induction||41
5058172|NCT01903252|12447862|P1|NOT COMPLETED|Double-Blind Induction||39
5058173|NCT01903252|12447857|P6|COMPLETED|Double-Blind Induction||0
5058174|NCT01903252|12447858|P5|COMPLETED|Double-Blind Induction||0
5058175|NCT01903252|12447859|P4|COMPLETED|Double-Blind Induction||0
5058176|NCT01903252|12447860|P3|COMPLETED|Double-Blind Induction||0
5058177|NCT01903252|12447861|P2|COMPLETED|Double-Blind Induction||367
5058178|NCT01903252|12447862|P1|COMPLETED|Double-Blind Induction||370
5058179|NCT01903252|12447857|P6|STARTED|Double-Blind Induction||0
5058180|NCT01903252|12447858|P5|STARTED|Double-Blind Induction||0
5058181|NCT01903252|12447859|P4|STARTED|Double-Blind Induction||0
5058182|NCT01903252|12447860|P3|STARTED|Double-Blind Induction||0
5058183|NCT01903252|12447861|P2|STARTED|Double-Blind Induction||408
5058184|NCT01903252|12447862|P1|STARTED|Double-Blind Induction||409
5058185|NCT01903187|12447941|P2|NOT COMPLETED|12 Month||0
5058186|NCT01903187|12447942|P1|NOT COMPLETED|12 Month||0
5058187|NCT01903187|12447941|P2|COMPLETED|12 Month||0
5058188|NCT01903187|12447942|P1|COMPLETED|12 Month||2
5058189|NCT01903187|12447941|P2|STARTED|12 Month||0
5058190|NCT01903187|12447942|P1|STARTED|12 Month||2
5058191|NCT01903187|12447941|P2|NOT COMPLETED|6 Month||0
5058192|NCT01903187|12447942|P1|NOT COMPLETED|6 Month||0
5058193|NCT01903187|12447941|P2|COMPLETED|6 Month||0
5058194|NCT01903187|12447942|P1|COMPLETED|6 Month||2
5058195|NCT01903187|12447941|P2|STARTED|6 Month||0
5058196|NCT01903187|12447942|P1|STARTED|6 Month||2
5058197|NCT01903187|12447941|P2|NOT COMPLETED|3 Month||0
5058198|NCT01903187|12447942|P1|NOT COMPLETED|3 Month||0
5058199|NCT01903187|12447941|P2|COMPLETED|3 Month||0
5058200|NCT01903187|12447942|P1|COMPLETED|3 Month||2
5058201|NCT01903187|12447941|P2|STARTED|3 Month||0
5058202|NCT01903187|12447942|P1|STARTED|3 Month||2
5058203|NCT01903187|12447941|P2|NOT COMPLETED|1 Month||0
5058204|NCT01903187|12447942|P1|NOT COMPLETED|1 Month||0
5058205|NCT01903187|12447941|P2|COMPLETED|1 Month||2
5058206|NCT01903187|12447942|P1|COMPLETED|1 Month||2
5058207|NCT01903187|12447941|P2|STARTED|1 Month||2
5058208|NCT01903187|12447942|P1|STARTED|1 Month||2
5058209|NCT01903187|12447941|P2|NOT COMPLETED|Procedure||0
5058210|NCT01903187|12447942|P1|NOT COMPLETED|Procedure||0
5058211|NCT01903187|12447941|P2|COMPLETED|Procedure||2
5058212|NCT01903187|12447942|P1|COMPLETED|Procedure||2
5058213|NCT01903187|12447941|P2|STARTED|Procedure||2
5058214|NCT01903187|12447942|P1|STARTED|Procedure||2
5058215|NCT01903148|12447956|P1|NOT COMPLETED|Overall Study||0
5058216|NCT01903148|12447956|P1|COMPLETED|Overall Study||441
5058217|NCT01903148|12447956|P1|STARTED|Overall Study||441
5058218|NCT01903031|12447975|P3|NOT COMPLETED|Overall Study||5
5058219|NCT01903031|12447976|P2|NOT COMPLETED|Overall Study||3
5058220|NCT01903031|12447977|P1|NOT COMPLETED|Overall Study||2
5058221|NCT01903031|12447975|P3|COMPLETED|Overall Study||24
5058222|NCT01903031|12447976|P2|COMPLETED|Overall Study||25
5058223|NCT01903031|12447977|P1|COMPLETED|Overall Study||25
5058224|NCT01903031|12447975|P3|STARTED|Overall Study||29
5058225|NCT01903031|12447976|P2|STARTED|Overall Study||28
5058226|NCT01903031|12447977|P1|STARTED|Overall Study||27
5058227|NCT01903005|12448019|P1|NOT COMPLETED|Overall Study||373
5058228|NCT01903005|12448019|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
5058229|NCT01903005|12448019|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
5058230|NCT01902953|12448033|P1|NOT COMPLETED|Overall Study||0
5058231|NCT01902953|12448033|P1|COMPLETED|Overall Study||16
5058232|NCT01902953|12448033|P1|STARTED|Overall Study||16
5058233|NCT01902901|12448040|P2|NOT COMPLETED|Overall Study||2
5058234|NCT01902901|12448041|P1|NOT COMPLETED|Overall Study||0
5058235|NCT01902901|12448040|P2|COMPLETED|Overall Study||201
5058236|NCT01902901|12448041|P1|COMPLETED|Overall Study||180
5058237|NCT01902901|12448040|P2|STARTED|Overall Study||203
5058238|NCT01902901|12448041|P1|STARTED|Overall Study||180
5058239|NCT01902888|12448051|P1|NOT COMPLETED|Overall Study||3
5058240|NCT01902888|12448051|P1|COMPLETED|Overall Study||0
5058241|NCT01902888|12448051|P1|STARTED|Overall Study||3
5058242|NCT01902758|12448058|P2|NOT COMPLETED|Overall Study||0
5058243|NCT01902758|12448059|P1|NOT COMPLETED|Overall Study||0
5058244|NCT01902758|12448058|P2|COMPLETED|Overall Study||14
5058245|NCT01902758|12448059|P1|COMPLETED|Overall Study||14
5058246|NCT01902758|12448058|P2|STARTED|Overall Study||14
5058247|NCT01902758|12448059|P1|STARTED|Overall Study||14
5058248|NCT01902628|12448065|P1|NOT COMPLETED|Overall Study||83
5058249|NCT01902628|12448065|P1|COMPLETED|Overall Study||354
5058250|NCT01902628|12448065|P1|STARTED|Overall Study||437
5058251|NCT01902459|12448074|P2|NOT COMPLETED|Overall Study||0
5058252|NCT01902459|12448075|P1|NOT COMPLETED|Overall Study||0
5058253|NCT01902459|12448074|P2|COMPLETED|Overall Study||75
5058254|NCT01902459|12448075|P1|COMPLETED|Overall Study||75
5058255|NCT01902459|12448074|P2|STARTED|Overall Study||75
5058256|NCT01902459|12448075|P1|STARTED|Overall Study||75
5058257|NCT01902303|12448093|P2|NOT COMPLETED|Overall Study||24
5058258|NCT01902303|12448094|P1|NOT COMPLETED|Overall Study||23
5058259|NCT01902303|12448093|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
5058260|NCT01902303|12448094|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
5058261|NCT01902303|12448093|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
5058262|NCT01902303|12448094|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
5058263|NCT01902303|12448093|P2|STARTED|Overall Study|Allocated to active treatment|81
5058264|NCT01902303|12448094|P1|STARTED|Overall Study|Allocated to placebo|77
5058265|NCT01902134|12448108|P6|NOT COMPLETED|Overall Study||9
5058266|NCT01902134|12448109|P5|NOT COMPLETED|Overall Study||7
5058267|NCT01902134|12448110|P4|NOT COMPLETED|Overall Study||2
5058268|NCT01902134|12448111|P3|NOT COMPLETED|Overall Study||15
5058269|NCT01902134|12448112|P2|NOT COMPLETED|Overall Study||11
5058270|NCT01902134|12448113|P1|NOT COMPLETED|Overall Study||8
5058271|NCT01902134|12448108|P6|COMPLETED|Overall Study||45
5058272|NCT01902134|12448109|P5|COMPLETED|Overall Study||46
5058273|NCT01902134|12448110|P4|COMPLETED|Overall Study||52
5058274|NCT01902134|12448111|P3|COMPLETED|Overall Study||145
5058275|NCT01902134|12448112|P2|COMPLETED|Overall Study||150
5058276|NCT01902134|12448113|P1|COMPLETED|Overall Study||151
5058277|NCT01902134|12448108|P6|Multiple-dose Phase|Overall Study||52
5058278|NCT01902134|12448109|P5|Multiple-dose Phase|Overall Study||53
5058279|NCT01902134|12448110|P4|Multiple-dose Phase|Overall Study||54
5058280|NCT01902134|12448111|P3|Multiple-dose Phase|Overall Study||160
5058281|NCT01902134|12448112|P2|Multiple-dose Phase|Overall Study||160
5058282|NCT01902134|12448113|P1|Multiple-dose Phase|Overall Study||159
5058283|NCT01902134|12448108|P6|Single-dose Phase|Overall Study||54
5058284|NCT01902134|12448109|P5|Single-dose Phase|Overall Study||53
5058285|NCT01902134|12448110|P4|Single-dose Phase|Overall Study||54
5058286|NCT01902134|12448111|P3|Single-dose Phase|Overall Study||160
5058287|NCT01902134|12448112|P2|Single-dose Phase|Overall Study||161
5058288|NCT01902134|12448113|P1|Single-dose Phase|Overall Study||159
5058289|NCT01902134|12448108|P6|STARTED|Overall Study||54
5058290|NCT01902134|12448109|P5|STARTED|Overall Study||53
5058291|NCT01902134|12448110|P4|STARTED|Overall Study||54
5058292|NCT01902134|12448111|P3|STARTED|Overall Study||160
5058293|NCT01902134|12448112|P2|STARTED|Overall Study||161
5058294|NCT01902134|12448113|P1|STARTED|Overall Study||159
5058295|NCT01902004|12448137|P2|NOT COMPLETED|Overall Study||18
5058296|NCT01902004|12448138|P1|NOT COMPLETED|Overall Study||15
5058297|NCT01902004|12448137|P2|COMPLETED|Overall Study||29
5058298|NCT01902004|12448138|P1|COMPLETED|Overall Study||33
5058299|NCT01902004|12448137|P2|STARTED|Overall Study||47
5058300|NCT01902004|12448138|P1|STARTED|Overall Study||48
5058301|NCT01901874|12448150|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
5058302|NCT01901874|12448150|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
5058303|NCT01901874|12448150|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
5058304|NCT01901874|12448150|P1|NOT COMPLETED|30-Day MAE Evaluation||1
5058305|NCT01901874|12448150|P1|COMPLETED|30-Day MAE Evaluation||264
5058306|NCT01901874|12448150|P1|STARTED|30-Day MAE Evaluation||265
5058307|NCT01901874|12448150|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
5058308|NCT01901874|12448150|P1|COMPLETED|Screening Committee Retrospective Review||265
5058309|NCT01901874|12448150|P1|STARTED|Screening Committee Retrospective Review||312
5058310|NCT01901874|12448150|P1|NOT COMPLETED|Procedure||0
5058311|NCT01901874|12448150|P1|COMPLETED|Procedure||312
5058312|NCT01901874|12448150|P1|STARTED|Procedure||312
5058313|NCT01901848|12448165|P2|NOT COMPLETED|Removed From Analyses||0
5058314|NCT01901848|12448166|P1|NOT COMPLETED|Removed From Analyses||10
5058315|NCT01901848|12448165|P2|COMPLETED|Removed From Analyses||19
5058316|NCT01901848|12448166|P1|COMPLETED|Removed From Analyses||12
5058317|NCT01901848|12448165|P2|STARTED|Removed From Analyses||19
5058318|NCT01901848|12448166|P1|STARTED|Removed From Analyses||22
5058319|NCT01901848|12448165|P2|NOT COMPLETED|Randomized and Treated||6
5058320|NCT01901848|12448166|P1|NOT COMPLETED|Randomized and Treated||3
5058321|NCT01901848|12448165|P2|COMPLETED|Randomized and Treated||19
5058322|NCT01901848|12448166|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
5058323|NCT01901848|12448165|P2|STARTED|Randomized and Treated||25
5058324|NCT01901848|12448166|P1|STARTED|Randomized and Treated||25
5058325|NCT01901809|12448178|P4|NOT COMPLETED|Overall Study||2
5058326|NCT01901809|12448179|P3|NOT COMPLETED|Overall Study||3
5058327|NCT01901809|12448180|P2|NOT COMPLETED|Overall Study||0
5058328|NCT01901809|12448181|P1|NOT COMPLETED|Overall Study||0
5058329|NCT01901809|12448178|P4|COMPLETED|Overall Study||22
5058330|NCT01901809|12448179|P3|COMPLETED|Overall Study||21
5058331|NCT01901809|12448180|P2|COMPLETED|Overall Study||23
5058332|NCT01901809|12448181|P1|COMPLETED|Overall Study||19
5058333|NCT01901809|12448178|P4|STARTED|Overall Study||24
5058334|NCT01901809|12448179|P3|STARTED|Overall Study||24
5058335|NCT01901809|12448180|P2|STARTED|Overall Study||23
5058336|NCT01901809|12448181|P1|STARTED|Overall Study||19
5058337|NCT01901653|12448208|P13|NOT COMPLETED|Overall Study||5
5058338|NCT01901653|12448209|P12|NOT COMPLETED|Overall Study||16
5058339|NCT01901653|12448210|P11|NOT COMPLETED|Overall Study||2
5058340|NCT01901653|12448211|P10|NOT COMPLETED|Overall Study||18
5058341|NCT01901653|12448212|P9|NOT COMPLETED|Overall Study||1
5058342|NCT01901653|12448213|P8|NOT COMPLETED|Overall Study||10
5058343|NCT01901653|12448214|P7|NOT COMPLETED|Overall Study||7
5058344|NCT01901653|12448215|P6|NOT COMPLETED|Overall Study||3
5058345|NCT01901653|12448216|P5|NOT COMPLETED|Overall Study||2
5058346|NCT01901653|12448217|P4|NOT COMPLETED|Overall Study||3
5058347|NCT01901653|12448218|P3|NOT COMPLETED|Overall Study||11
5058348|NCT01901653|12448219|P2|NOT COMPLETED|Overall Study||1
5058349|NCT01901653|12448220|P1|NOT COMPLETED|Overall Study||3
5058350|NCT01901653|12448208|P13|COMPLETED|Overall Study||0
5058351|NCT01901653|12448209|P12|COMPLETED|Overall Study||0
5058352|NCT01901653|12448210|P11|COMPLETED|Overall Study||0
5058353|NCT01901653|12448211|P10|COMPLETED|Overall Study||0
5058354|NCT01901653|12448212|P9|COMPLETED|Overall Study||0
5058355|NCT01901653|12448213|P8|COMPLETED|Overall Study||0
5058356|NCT01901653|12448214|P7|COMPLETED|Overall Study||0
5058357|NCT01901653|12448215|P6|COMPLETED|Overall Study||0
5058358|NCT01901653|12448216|P5|COMPLETED|Overall Study||0
5058359|NCT01901653|12448217|P4|COMPLETED|Overall Study||0
5058360|NCT01901653|12448218|P3|COMPLETED|Overall Study||0
5058361|NCT01901653|12448219|P2|COMPLETED|Overall Study||0
5058362|NCT01901653|12448220|P1|COMPLETED|Overall Study||0
5058363|NCT01901653|12448208|P13|STARTED|Overall Study||5
5058364|NCT01901653|12448209|P12|STARTED|Overall Study||16
5058365|NCT01901653|12448210|P11|STARTED|Overall Study||2
5058366|NCT01901653|12448211|P10|STARTED|Overall Study||18
5058367|NCT01901653|12448212|P9|STARTED|Overall Study||1
5058368|NCT01901653|12448213|P8|STARTED|Overall Study||10
5058369|NCT01901653|12448214|P7|STARTED|Overall Study||7
5058370|NCT01901653|12448215|P6|STARTED|Overall Study||3
5058371|NCT01901653|12448216|P5|STARTED|Overall Study||2
5058372|NCT01901653|12448217|P4|STARTED|Overall Study||3
5058373|NCT01901653|12448218|P3|STARTED|Overall Study||11
5058374|NCT01901653|12448219|P2|STARTED|Overall Study||1
5058375|NCT01901653|12448220|P1|STARTED|Overall Study||3
5058376|NCT01901614|12448264|P2|NOT COMPLETED|Overall Study||1
5058377|NCT01901614|12448265|P1|NOT COMPLETED|Overall Study||2
5058378|NCT01901614|12448264|P2|COMPLETED|Overall Study||1
5058379|NCT01901614|12448265|P1|COMPLETED|Overall Study||1
5058380|NCT01901614|12448264|P2|STARTED|Overall Study||2
5058381|NCT01901614|12448265|P1|STARTED|Overall Study||3
5058382|NCT01901588|12448273|P2|NOT COMPLETED|Overall Study||0
5058383|NCT01901588|12448274|P1|NOT COMPLETED|Overall Study||0
5058384|NCT01901588|12448273|P2|COMPLETED|Overall Study||31
5058385|NCT01901588|12448274|P1|COMPLETED|Overall Study||32
5058386|NCT01901588|12448273|P2|STARTED|Overall Study||31
5058387|NCT01901588|12448274|P1|STARTED|Overall Study||32
5058388|NCT01901575|12448290|P1|NOT COMPLETED|Overall Study||0
5058389|NCT01901575|12448290|P1|COMPLETED|Overall Study||16
5058390|NCT01901575|12448290|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
5058391|NCT01901432|12448300|P5|NOT COMPLETED|Overall Study||9
5058392|NCT01901432|12448301|P4|NOT COMPLETED|Overall Study||0
5058393|NCT01901432|12448302|P3|NOT COMPLETED|Overall Study||2
5058394|NCT01901432|12448303|P2|NOT COMPLETED|Overall Study||1
5058395|NCT01901432|12448304|P1|NOT COMPLETED|Overall Study||0
5058396|NCT01901432|12448300|P5|COMPLETED|Overall Study||27
5058397|NCT01901432|12448301|P4|COMPLETED|Overall Study||3
5058398|NCT01901432|12448302|P3|COMPLETED|Overall Study||1
5058399|NCT01901432|12448303|P2|COMPLETED|Overall Study||2
5058400|NCT01901432|12448304|P1|COMPLETED|Overall Study||3
5058401|NCT01901432|12448300|P5|Received Study Drug|Overall Study||35
5058402|NCT01901432|12448301|P4|Received Study Drug|Overall Study||3
5058403|NCT01901432|12448302|P3|Received Study Drug|Overall Study||3
5058404|NCT01901432|12448303|P2|Received Study Drug|Overall Study||3
5058405|NCT01901432|12448304|P1|Received Study Drug|Overall Study||3
5058406|NCT01901432|12448300|P5|STARTED|Overall Study||36
5058407|NCT01901432|12448301|P4|STARTED|Overall Study||3
5058408|NCT01901432|12448302|P3|STARTED|Overall Study||3
5058409|NCT01901432|12448303|P2|STARTED|Overall Study||3
5058410|NCT01901432|12448304|P1|STARTED|Overall Study||3
5058411|NCT01901393|12448356|P2|NOT COMPLETED|Overall Study||0
5058412|NCT01901393|12448357|P1|NOT COMPLETED|Overall Study||1
5058413|NCT01901393|12448356|P2|COMPLETED|Overall Study||49
5058414|NCT01901393|12448357|P1|COMPLETED|Overall Study||50
5058415|NCT01901393|12448356|P2|STARTED|Overall Study||49
5058416|NCT01901393|12448357|P1|STARTED|Overall Study||51
5058417|NCT01901341|12448375|P2|NOT COMPLETED|Overall Study||21
5058418|NCT01901341|12448376|P1|NOT COMPLETED|Overall Study||20
5058419|NCT01901341|12448375|P2|COMPLETED|Overall Study||1
5058420|NCT01901341|12448376|P1|COMPLETED|Overall Study||2
5058421|NCT01901341|12448375|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
5058422|NCT01901341|12448376|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
5058423|NCT01901341|12448375|P2|STARTED|Overall Study||22
5058424|NCT01901341|12448376|P1|STARTED|Overall Study||22
5058425|NCT01901328|12448390|P2|NOT COMPLETED|Overall Study||21
5058426|NCT01901328|12448391|P1|NOT COMPLETED|Overall Study||22
5058427|NCT01901328|12448390|P2|COMPLETED|Overall Study||2
5058428|NCT01901328|12448391|P1|COMPLETED|Overall Study||4
5058429|NCT01901328|12448390|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
5058430|NCT01901328|12448391|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
5058431|NCT01901328|12448390|P2|STARTED|Overall Study||23
5058432|NCT01901328|12448391|P1|STARTED|Overall Study||26
5058433|NCT01901302|12448405|P2|NOT COMPLETED|Overall Study||23
5058434|NCT01901302|12448406|P1|NOT COMPLETED|Overall Study||27
5058435|NCT01901302|12448405|P2|COMPLETED|Overall Study||7
5058436|NCT01901302|12448406|P1|COMPLETED|Overall Study||4
5058437|NCT01901302|12448405|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
5058438|NCT01901302|12448406|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
5058439|NCT01901302|12448405|P2|STARTED|Overall Study||30
5058440|NCT01901302|12448406|P1|STARTED|Overall Study||31
5058441|NCT01901289|12448418|P1|NOT COMPLETED|Overall Study||200
5058442|NCT01901289|12448418|P1|COMPLETED|Overall Study||0
5058443|NCT01901289|12448418|P1|12-Month Follow-up|Overall Study||175
5058444|NCT01901289|12448418|P1|STARTED|Overall Study||200
5058445|NCT01901250|12448424|P2|NOT COMPLETED|Overall Study||126
5058446|NCT01901250|12448425|P1|NOT COMPLETED|Overall Study||138
5058447|NCT01901250|12448424|P2|COMPLETED|Overall Study||139
5058448|NCT01901250|12448425|P1|COMPLETED|Overall Study||122
5058449|NCT01901250|12448424|P2|End of 1st Grade|Overall Study||151
5058450|NCT01901250|12448425|P1|End of 1st Grade|Overall Study||143
5058451|NCT01901250|12448424|P2|Start of 1st Grade|Overall Study||176
5058452|NCT01901250|12448425|P1|Start of 1st Grade|Overall Study||173
5058453|NCT01901250|12448424|P2|End of Kidergarten|Overall Study||212
5058454|NCT01901250|12448425|P1|End of Kidergarten|Overall Study||215
5058455|NCT01901250|12448424|P2|STARTED|Overall Study||265
5058456|NCT01901250|12448425|P1|STARTED|Overall Study||260
5058457|NCT01901224|12448431|P1|NOT COMPLETED|Overall Study||2
5058458|NCT01901224|12448431|P1|COMPLETED|Overall Study||0
5058459|NCT01901224|12448431|P1|STARTED|Overall Study||2
5058460|NCT01901211|12448442|P2|NOT COMPLETED|Second Ten-week Period||0
5058461|NCT01901211|12448443|P1|NOT COMPLETED|Second Ten-week Period||0
5058462|NCT01901211|12448442|P2|COMPLETED|Second Ten-week Period||5
5058463|NCT01901211|12448443|P1|COMPLETED|Second Ten-week Period||6
5058464|NCT01901211|12448442|P2|STARTED|Second Ten-week Period||5
5058465|NCT01901211|12448443|P1|STARTED|Second Ten-week Period||6
5058466|NCT01901211|12448442|P2|NOT COMPLETED|Washout (6 Weeks)||0
5058467|NCT01901211|12448443|P1|NOT COMPLETED|Washout (6 Weeks)||0
5058468|NCT01901211|12448442|P2|COMPLETED|Washout (6 Weeks)||5
5058469|NCT01901211|12448443|P1|COMPLETED|Washout (6 Weeks)||6
5058470|NCT01901211|12448442|P2|STARTED|Washout (6 Weeks)||5
5058471|NCT01901211|12448443|P1|STARTED|Washout (6 Weeks)||6
5058472|NCT01901211|12448442|P2|NOT COMPLETED|First Ten-week Period||0
5058473|NCT01901211|12448443|P1|NOT COMPLETED|First Ten-week Period||0
5058474|NCT01901211|12448442|P2|COMPLETED|First Ten-week Period||5
5058475|NCT01901211|12448443|P1|COMPLETED|First Ten-week Period||6
5058476|NCT01901211|12448442|P2|STARTED|First Ten-week Period||5
5058477|NCT01901211|12448443|P1|STARTED|First Ten-week Period||6
5058478|NCT01901185|12448466|P1|NOT COMPLETED|Overall Study||2
5058479|NCT01901185|12448466|P1|COMPLETED|Overall Study||75
5058480|NCT01901185|12448466|P1|Received Etanercept With Autoinjector A|Overall Study||75
5058481|NCT01901185|12448466|P1|STARTED|Overall Study||77
5058482|NCT01901146|12448475|P5|NOT COMPLETED|Adjuvant Phase||14
5058483|NCT01901146|12448476|P4|NOT COMPLETED|Adjuvant Phase||7
5058484|NCT01901146|12448477|P3|NOT COMPLETED|Adjuvant Phase||26
5058485|NCT01901146|12448478|P2|NOT COMPLETED|Adjuvant Phase||0
5058486|NCT01901146|12448479|P1|NOT COMPLETED|Adjuvant Phase||0
5058487|NCT01901146|12448475|P5|COMPLETED|Adjuvant Phase||157
5058488|NCT01901146|12448476|P4|COMPLETED|Adjuvant Phase||164
5058489|NCT01901146|12448477|P3|COMPLETED|Adjuvant Phase||323
5058490|NCT01901146|12448478|P2|COMPLETED|Adjuvant Phase||0
5058491|NCT01901146|12448479|P1|COMPLETED|Adjuvant Phase||0
5058492|NCT01901146|12448475|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
5058493|NCT01901146|12448476|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
5058494|NCT01901146|12448477|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
5058495|NCT01901146|12448478|P2|STARTED|Adjuvant Phase||0
5058496|NCT01901146|12448479|P1|STARTED|Adjuvant Phase||0
5058497|NCT01901146|12448475|P5|NOT COMPLETED|Neoadjuvant Phase||0
5058498|NCT01901146|12448476|P4|NOT COMPLETED|Neoadjuvant Phase||0
5058499|NCT01901146|12448477|P3|NOT COMPLETED|Neoadjuvant Phase||0
5058500|NCT01901146|12448478|P2|NOT COMPLETED|Neoadjuvant Phase||14
5058501|NCT01901146|12448479|P1|NOT COMPLETED|Neoadjuvant Phase||6
5058502|NCT01901146|12448475|P5|COMPLETED|Neoadjuvant Phase||0
5058503|NCT01901146|12448476|P4|COMPLETED|Neoadjuvant Phase||0
5058504|NCT01901146|12448477|P3|COMPLETED|Neoadjuvant Phase||0
5058505|NCT01901146|12448478|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
5058506|NCT01901146|12448479|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
5058507|NCT01901146|12448475|P5|STARTED|Neoadjuvant Phase||0
5058508|NCT01901146|12448476|P4|STARTED|Neoadjuvant Phase||0
5058509|NCT01901146|12448477|P3|STARTED|Neoadjuvant Phase||0
5058510|NCT01901146|12448478|P2|STARTED|Neoadjuvant Phase||361
5058511|NCT01901146|12448479|P1|STARTED|Neoadjuvant Phase||364
5058512|NCT01900899|12448494|P2|NOT COMPLETED|Overall Study||1
5058513|NCT01900899|12448495|P1|NOT COMPLETED|Overall Study||9
5058514|NCT01900899|12448494|P2|COMPLETED|Overall Study||24
5058515|NCT01900899|12448495|P1|COMPLETED|Overall Study||150
5058516|NCT01900899|12448494|P2|STARTED|Overall Study||25
5058517|NCT01900899|12448495|P1|STARTED|Overall Study||159
5058518|NCT01900730|12448521|P2|NOT COMPLETED|Overall Study||0
5058519|NCT01900730|12448522|P1|NOT COMPLETED|Overall Study||2
5058520|NCT01900730|12448521|P2|COMPLETED|Overall Study||0
5058521|NCT01900730|12448522|P1|COMPLETED|Overall Study||1
5058522|NCT01900730|12448521|P2|STARTED|Overall Study||0
5058523|NCT01900730|12448522|P1|STARTED|Overall Study||3
5058524|NCT01900665|12448530|P2|NOT COMPLETED|Open Label Period||859
5058525|NCT01900665|12448531|P1|NOT COMPLETED|Open Label Period||881
5058526|NCT01900665|12448530|P2|COMPLETED|Open Label Period||0
5058527|NCT01900665|12448531|P1|COMPLETED|Open Label Period||0
5058528|NCT01900665|12448530|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
5058529|NCT01900665|12448531|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
5058530|NCT01900665|12448530|P2|NOT COMPLETED|Placebo Controlled Period||164
5058531|NCT01900665|12448531|P1|NOT COMPLETED|Placebo Controlled Period||143
5058532|NCT01900665|12448530|P2|COMPLETED|Placebo Controlled Period||908
5058533|NCT01900665|12448531|P1|COMPLETED|Placebo Controlled Period||914
5058534|NCT01900665|12448530|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
5058535|NCT01900665|12448531|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
5058536|NCT01900665|12448530|P2|STARTED|Placebo Controlled Period||1072
5058537|NCT01900665|12448531|P1|STARTED|Placebo Controlled Period||1057
5058538|NCT01900652|12448574|P2|NOT COMPLETED|Overall Study||3
5058539|NCT01900652|12448575|P1|NOT COMPLETED|Overall Study||8
5058540|NCT01900652|12448574|P2|COMPLETED|Overall Study||25
5058541|NCT01900652|12448575|P1|COMPLETED|Overall Study||75
5058542|NCT01900652|12448574|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
5058543|NCT01900652|12448575|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
5058544|NCT01900652|12448574|P2|STARTED|Overall Study||28
5058545|NCT01900652|12448575|P1|STARTED|Overall Study||83
5058546|NCT01900626|12448611|P2|NOT COMPLETED|Overall Study||1
5058547|NCT01900626|12448612|P1|NOT COMPLETED|Overall Study||1
5058548|NCT01900626|12448611|P2|COMPLETED|Overall Study||0
5058549|NCT01900626|12448612|P1|COMPLETED|Overall Study||0
5058550|NCT01900626|12448611|P2|STARTED|Overall Study||1
5058551|NCT01900626|12448612|P1|STARTED|Overall Study||1
5058552|NCT01900561|12448630|P2|NOT COMPLETED|Overall Study||9
5058553|NCT01900561|12448631|P1|NOT COMPLETED|Overall Study||17
5058554|NCT01900561|12448630|P2|COMPLETED|Overall Study||269
5058555|NCT01900561|12448631|P1|COMPLETED|Overall Study||261
5058556|NCT01900561|12448630|P2|STARTED|Overall Study||278
5058557|NCT01900561|12448631|P1|STARTED|Overall Study||278
5058558|NCT01900444|12448691|P1|NOT COMPLETED|Overall Study||3
5058559|NCT01900444|12448691|P1|COMPLETED|Overall Study||116
5058560|NCT01900444|12448691|P1|STARTED|Overall Study||119
5058561|NCT01900431|12448704|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
5058562|NCT01900431|12448705|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
5058563|NCT01900431|12448706|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
5058564|NCT01900431|12448704|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
5058565|NCT01900431|12448705|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
5058566|NCT01900431|12448706|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
5058567|NCT01900431|12448704|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
5058568|NCT01900431|12448705|P2|STARTED|Open-Label Treatment Period (Part C)||0
5058569|NCT01900431|12448706|P1|STARTED|Open-Label Treatment Period (Part C)||0
5058570|NCT01900431|12448704|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
5058571|NCT01900431|12448705|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
5058572|NCT01900431|12448706|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
5058573|NCT01900431|12448704|P3|COMPLETED|Extended Treatment Period (Part B)||0
5058574|NCT01900431|12448705|P2|COMPLETED|Extended Treatment Period (Part B)||12
5058575|NCT01900431|12448706|P1|COMPLETED|Extended Treatment Period (Part B)||7
5058576|NCT01900431|12448704|P3|STARTED|Extended Treatment Period (Part B)||0
5058577|NCT01900431|12448705|P2|STARTED|Extended Treatment Period (Part B)||22
5058578|NCT01900431|12448706|P1|STARTED|Extended Treatment Period (Part B)||8
5058579|NCT01900431|12448704|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
5058580|NCT01900431|12448705|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
5058581|NCT01900431|12448706|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
5058582|NCT01900431|12448704|P3|COMPLETED|Principal Treatment Period (Part A)||0
5058583|NCT01900431|12448705|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
5058584|NCT01900431|12448706|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
5058585|NCT01900431|12448704|P3|STARTED|Principal Treatment Period (Part A)||0
5058586|NCT01900431|12448705|P2|STARTED|Principal Treatment Period (Part A)||38
5058587|NCT01900431|12448706|P1|STARTED|Principal Treatment Period (Part A)||20
5058588|NCT01900392|12448733|P3|NOT COMPLETED|Overall Study||0
5058589|NCT01900392|12448734|P2|NOT COMPLETED|Overall Study||1
5058590|NCT01900392|12448735|P1|NOT COMPLETED|Overall Study||1
5058591|NCT01900392|12448733|P3|COMPLETED|Overall Study||77
5058592|NCT01900392|12448734|P2|COMPLETED|Overall Study||74
5058593|NCT01900392|12448735|P1|COMPLETED|Overall Study||38
5058594|NCT01900392|12448733|P3|STARTED|Overall Study||77
5058595|NCT01900392|12448734|P2|STARTED|Overall Study||75
5058596|NCT01900392|12448735|P1|STARTED|Overall Study||39
5058597|NCT01900314|12448748|P2|NOT COMPLETED|Overall Study||4
5058598|NCT01900314|12448749|P1|NOT COMPLETED|Overall Study||4
5058599|NCT01900314|12448748|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
5058600|NCT01900314|12448749|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
5058601|NCT01900314|12448748|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
5058602|NCT01900314|12448749|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
5058603|NCT01900314|12448748|P2|STARTED|Overall Study||20
5058604|NCT01900314|12448749|P1|STARTED|Overall Study||20
5058605|NCT01900249|12448760|P3|NOT COMPLETED|Overall Study||4
5058606|NCT01900249|12448761|P2|NOT COMPLETED|Overall Study||5
5058607|NCT01900249|12448762|P1|NOT COMPLETED|Overall Study||3
5058608|NCT01900249|12448760|P3|COMPLETED|Overall Study||65
5058609|NCT01900249|12448761|P2|COMPLETED|Overall Study||63
5058610|NCT01900249|12448762|P1|COMPLETED|Overall Study||64
5058611|NCT01900249|12448760|P3|STARTED|Overall Study||69
5058612|NCT01900249|12448761|P2|STARTED|Overall Study||68
5058613|NCT01900249|12448762|P1|STARTED|Overall Study||67
5058614|NCT01900067|12448772|P2|NOT COMPLETED|Overall Study||13
5058615|NCT01900067|12448773|P1|NOT COMPLETED|Overall Study||12
5058616|NCT01900067|12448772|P2|COMPLETED|Overall Study||124
5058617|NCT01900067|12448773|P1|COMPLETED|Overall Study||122
5058618|NCT01900067|12448772|P2|STARTED|Overall Study||137
5058619|NCT01900067|12448773|P1|STARTED|Overall Study||134
5058620|NCT01900054|12448779|P1|NOT COMPLETED|Overall Study||2
5058621|NCT01900054|12448779|P1|COMPLETED|Overall Study||56
5058622|NCT01900054|12448779|P1|STARTED|Overall Study||58
5058623|NCT01899911|12448784|P1|NOT COMPLETED|Overall Study||0
5058624|NCT01899911|12448784|P1|COMPLETED|Overall Study||12
5058625|NCT01899911|12448784|P1|STARTED|Overall Study||12
5058626|NCT01899768|12448788|P1|NOT COMPLETED|Part C||0
5058627|NCT01899768|12448788|P1|COMPLETED|Part C||11
5058628|NCT01899768|12448788|P1|STARTED|Part C||11
5058629|NCT01899768|12448788|P1|NOT COMPLETED|Part B||2
5058630|NCT01899768|12448788|P1|COMPLETED|Part B||11
5058631|NCT01899768|12448788|P1|STARTED|Part B||13
5058632|NCT01899768|12448788|P1|NOT COMPLETED|Part A||3
5058633|NCT01899768|12448788|P1|COMPLETED|Part A||13
5058634|NCT01899768|12448788|P1|STARTED|Part A||16
5058635|NCT01899742|12448862|P2|NOT COMPLETED|Overall Study||16
5058636|NCT01899742|12448863|P1|NOT COMPLETED|Overall Study||17
5058637|NCT01899742|12448862|P2|COMPLETED|Overall Study||231
5058638|NCT01899742|12448863|P1|COMPLETED|Overall Study||230
5058639|NCT01899742|12448862|P2|STARTED|Overall Study||247
5058640|NCT01899742|12448863|P1|STARTED|Overall Study||247
5058641|NCT01899729|12448876|P5|NOT COMPLETED|Overall Study||2
5058642|NCT01899729|12448877|P4|NOT COMPLETED|Overall Study||0
5058643|NCT01899729|12448878|P3|NOT COMPLETED|Overall Study||2
5058644|NCT01899729|12448879|P2|NOT COMPLETED|Overall Study||2
5058645|NCT01899729|12448880|P1|NOT COMPLETED|Overall Study||2
5058646|NCT01899729|12448876|P5|COMPLETED|Overall Study||9
5058647|NCT01899729|12448877|P4|COMPLETED|Overall Study||9
5058648|NCT01899729|12448878|P3|COMPLETED|Overall Study||6
5058649|NCT01899729|12448879|P2|COMPLETED|Overall Study||7
5058650|NCT01899729|12448880|P1|COMPLETED|Overall Study||7
5058651|NCT01899729|12448876|P5|STARTED|Overall Study||11
5058652|NCT01899729|12448877|P4|STARTED|Overall Study||9
5058653|NCT01899729|12448878|P3|STARTED|Overall Study||8
5058654|NCT01899729|12448879|P2|STARTED|Overall Study||9
5058655|NCT01899729|12448880|P1|STARTED|Overall Study||9
5058656|NCT01899677|12448894|P2|NOT COMPLETED|Overall Study||7
5058657|NCT01899677|12448895|P1|NOT COMPLETED|Overall Study||10
5058658|NCT01899677|12448894|P2|COMPLETED|Overall Study||28
5058659|NCT01899677|12448895|P1|COMPLETED|Overall Study||25
5058660|NCT01899677|12448894|P2|STARTED|Overall Study||35
5058661|NCT01899677|12448895|P1|STARTED|Overall Study||35
5058662|NCT01899261|12448923|P1|NOT COMPLETED|Overall Study||0
5058663|NCT01899261|12448923|P1|COMPLETED|Overall Study||20
5058664|NCT01899261|12448923|P1|STARTED|Overall Study||20
5058665|NCT01899144|12448927|P1|NOT COMPLETED|Treatment Period 5||1
5058666|NCT01899144|12448927|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
5058667|NCT01899144|12448927|P1|STARTED|Treatment Period 5||58
5058668|NCT01899144|12448927|P1|NOT COMPLETED|Treatment Period 4||0
5058669|NCT01899144|12448927|P1|COMPLETED|Treatment Period 4||58
5058670|NCT01899144|12448927|P1|STARTED|Treatment Period 4||58
5058671|NCT01899144|12448927|P1|NOT COMPLETED|Treatment Period 3||2
5058672|NCT01899144|12448927|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
5058673|NCT01899144|12448927|P1|STARTED|Treatment Period 3||60
5058674|NCT01899144|12448927|P1|NOT COMPLETED|Treatment Period 2||1
5058675|NCT01899144|12448927|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
5058676|NCT01899144|12448927|P1|STARTED|Treatment Period 2||61
5058677|NCT01899144|12448927|P1|NOT COMPLETED|Treatment Period 1||0
5058678|NCT01899144|12448927|P1|COMPLETED|Treatment Period 1||61
5058679|NCT01899144|12448927|P1|STARTED|Treatment Period 1||61
5058680|NCT01899053|12448963|P14|NOT COMPLETED|Overall Study||20
5058681|NCT01899053|12448964|P13|NOT COMPLETED|Overall Study||14
5058682|NCT01899053|12448965|P12|NOT COMPLETED|Overall Study||7
5058683|NCT01899053|12448966|P11|NOT COMPLETED|Overall Study||16
5058684|NCT01899053|12448967|P10|NOT COMPLETED|Overall Study||3
5058685|NCT01899053|12448968|P9|NOT COMPLETED|Overall Study||6
5058686|NCT01899053|12448969|P8|NOT COMPLETED|Overall Study||3
5058687|NCT01899053|12448970|P7|NOT COMPLETED|Overall Study||3
5058688|NCT01899053|12448971|P6|NOT COMPLETED|Overall Study||3
5058689|NCT01899053|12448972|P5|NOT COMPLETED|Overall Study||6
5058690|NCT01899053|12448973|P4|NOT COMPLETED|Overall Study||3
5058691|NCT01899053|12448974|P3|NOT COMPLETED|Overall Study||7
5058692|NCT01899053|12448975|P2|NOT COMPLETED|Overall Study||3
5058693|NCT01899053|12448976|P1|NOT COMPLETED|Overall Study||7
5058694|NCT01899053|12448963|P14|COMPLETED|Overall Study||0
5058695|NCT01899053|12448964|P13|COMPLETED|Overall Study||0
5058696|NCT01899053|12448965|P12|COMPLETED|Overall Study||0
5058697|NCT01899053|12448966|P11|COMPLETED|Overall Study||0
5058698|NCT01899053|12448967|P10|COMPLETED|Overall Study||0
5058699|NCT01899053|12448968|P9|COMPLETED|Overall Study||0
5058700|NCT01899053|12448969|P8|COMPLETED|Overall Study||0
5058701|NCT01899053|12448970|P7|COMPLETED|Overall Study||0
5058702|NCT01899053|12448971|P6|COMPLETED|Overall Study||0
5058703|NCT01899053|12448972|P5|COMPLETED|Overall Study||0
5058704|NCT01899053|12448973|P4|COMPLETED|Overall Study||0
5058705|NCT01899053|12448974|P3|COMPLETED|Overall Study||0
5058706|NCT01899053|12448975|P2|COMPLETED|Overall Study||0
5058707|NCT01899053|12448976|P1|COMPLETED|Overall Study||0
5058708|NCT01899053|12448963|P14|STARTED|Overall Study||20
5058709|NCT01899053|12448964|P13|STARTED|Overall Study||14
5058710|NCT01899053|12448965|P12|STARTED|Overall Study||7
5058711|NCT01899053|12448966|P11|STARTED|Overall Study||16
5058712|NCT01899053|12448967|P10|STARTED|Overall Study||3
5058713|NCT01899053|12448968|P9|STARTED|Overall Study||6
5058714|NCT01899053|12448969|P8|STARTED|Overall Study||3
5058715|NCT01899053|12448970|P7|STARTED|Overall Study||3
5058716|NCT01899053|12448971|P6|STARTED|Overall Study||3
5058717|NCT01899053|12448972|P5|STARTED|Overall Study||6
5058718|NCT01899053|12448973|P4|STARTED|Overall Study||3
5058719|NCT01899053|12448974|P3|STARTED|Overall Study||7
5058720|NCT01899053|12448975|P2|STARTED|Overall Study||3
5058721|NCT01899053|12448976|P1|STARTED|Overall Study||7
5058722|NCT01898884|12449233|P9|NOT COMPLETED|Multiple Dose Period||1
5058723|NCT01898884|12449234|P8|NOT COMPLETED|Multiple Dose Period||0
5058724|NCT01898884|12449235|P7|NOT COMPLETED|Multiple Dose Period||1
5058725|NCT01898884|12449236|P6|NOT COMPLETED|Multiple Dose Period||0
5058726|NCT01898884|12449237|P5|NOT COMPLETED|Multiple Dose Period||0
5058727|NCT01898884|12449238|P4|NOT COMPLETED|Multiple Dose Period||0
5058728|NCT01898884|12449239|P3|NOT COMPLETED|Multiple Dose Period||0
5058729|NCT01898884|12449240|P2|NOT COMPLETED|Multiple Dose Period||0
5058730|NCT01898884|12449241|P1|NOT COMPLETED|Multiple Dose Period||0
5058731|NCT01898884|12449233|P9|COMPLETED|Multiple Dose Period||5
5058732|NCT01898884|12449234|P8|COMPLETED|Multiple Dose Period||6
5058733|NCT01898884|12449235|P7|COMPLETED|Multiple Dose Period||5
5058734|NCT01898884|12449236|P6|COMPLETED|Multiple Dose Period||6
5058735|NCT01898884|12449237|P5|COMPLETED|Multiple Dose Period||0
5058736|NCT01898884|12449238|P4|COMPLETED|Multiple Dose Period||0
5058737|NCT01898884|12449239|P3|COMPLETED|Multiple Dose Period||0
5058738|NCT01898884|12449240|P2|COMPLETED|Multiple Dose Period||0
5058739|NCT01898884|12449241|P1|COMPLETED|Multiple Dose Period||0
5058740|NCT01898884|12449233|P9|Treated|Multiple Dose Period||5
5058741|NCT01898884|12449234|P8|Treated|Multiple Dose Period||6
5058742|NCT01898884|12449235|P7|Treated|Multiple Dose Period||6
5058743|NCT01898884|12449236|P6|Treated|Multiple Dose Period||6
5058744|NCT01898884|12449237|P5|Treated|Multiple Dose Period||0
5058745|NCT01898884|12449238|P4|Treated|Multiple Dose Period||0
5058746|NCT01898884|12449239|P3|Treated|Multiple Dose Period||0
5058747|NCT01898884|12449240|P2|Treated|Multiple Dose Period||0
5058748|NCT01898884|12449241|P1|Treated|Multiple Dose Period||0
5058749|NCT01898884|12449233|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
5058750|NCT01898884|12449234|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
5058751|NCT01898884|12449235|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
5058752|NCT01898884|12449236|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
5058753|NCT01898884|12449237|P5|STARTED|Multiple Dose Period||0
5058754|NCT01898884|12449238|P4|STARTED|Multiple Dose Period||0
5058755|NCT01898884|12449239|P3|STARTED|Multiple Dose Period||0
5058756|NCT01898884|12449240|P2|STARTED|Multiple Dose Period||0
5058757|NCT01898884|12449241|P1|STARTED|Multiple Dose Period||0
5058758|NCT01898884|12449233|P9|NOT COMPLETED|Single Dose Period||0
5058759|NCT01898884|12449234|P8|NOT COMPLETED|Single Dose Period||0
5058760|NCT01898884|12449235|P7|NOT COMPLETED|Single Dose Period||0
5058761|NCT01898884|12449236|P6|NOT COMPLETED|Single Dose Period||0
5058762|NCT01898884|12449237|P5|NOT COMPLETED|Single Dose Period||0
5058763|NCT01898884|12449238|P4|NOT COMPLETED|Single Dose Period||0
5058764|NCT01898884|12449239|P3|NOT COMPLETED|Single Dose Period||0
5058765|NCT01898884|12449240|P2|NOT COMPLETED|Single Dose Period||0
5058766|NCT01898884|12449241|P1|NOT COMPLETED|Single Dose Period||0
5058767|NCT01898884|12449233|P9|COMPLETED|Single Dose Period||0
5058768|NCT01898884|12449234|P8|COMPLETED|Single Dose Period||0
5058769|NCT01898884|12449235|P7|COMPLETED|Single Dose Period||0
5058770|NCT01898884|12449236|P6|COMPLETED|Single Dose Period||0
5058771|NCT01898884|12449237|P5|COMPLETED|Single Dose Period||6
5058772|NCT01898884|12449238|P4|COMPLETED|Single Dose Period||6
5058773|NCT01898884|12449239|P3|COMPLETED|Single Dose Period||6
5058774|NCT01898884|12449240|P2|COMPLETED|Single Dose Period||6
5058775|NCT01898884|12449241|P1|COMPLETED|Single Dose Period||8
5058776|NCT01898884|12449233|P9|STARTED|Single Dose Period||0
5058777|NCT01898884|12449234|P8|STARTED|Single Dose Period||0
5058778|NCT01898884|12449235|P7|STARTED|Single Dose Period||0
5058779|NCT01898884|12449236|P6|STARTED|Single Dose Period||0
5058780|NCT01898884|12449237|P5|STARTED|Single Dose Period||6
5058781|NCT01898884|12449238|P4|STARTED|Single Dose Period||6
5058782|NCT01898884|12449239|P3|STARTED|Single Dose Period||6
5058783|NCT01898884|12449240|P2|STARTED|Single Dose Period||6
5058784|NCT01898884|12449241|P1|STARTED|Single Dose Period||8
5058785|NCT01898806|12449391|P1|NOT COMPLETED|Overall Study||3
5058786|NCT01898806|12449391|P1|COMPLETED|Overall Study||8
5058787|NCT01898806|12449391|P1|STARTED|Overall Study||11
5058788|NCT01898611|12449398|P2|NOT COMPLETED|Overall Study||1
5058789|NCT01898611|12449399|P1|NOT COMPLETED|Overall Study||0
5058790|NCT01898611|12449398|P2|COMPLETED|Overall Study||10
5058791|NCT01898611|12449399|P1|COMPLETED|Overall Study||5
5058792|NCT01898611|12449398|P2|STARTED|Overall Study||11
5058793|NCT01898611|12449399|P1|STARTED|Overall Study||5
5058794|NCT01898598|12449421|P2|NOT COMPLETED|Overall Study||2
5058795|NCT01898598|12449422|P1|NOT COMPLETED|Overall Study||4
5058796|NCT01898598|12449421|P2|COMPLETED|Overall Study||4
5058797|NCT01898598|12449422|P1|COMPLETED|Overall Study||8
5058798|NCT01898598|12449421|P2|Treated|Overall Study||5
5058799|NCT01898598|12449422|P1|Treated|Overall Study||11
5058800|NCT01898598|12449421|P2|STARTED|Overall Study||6
5058801|NCT01898598|12449422|P1|STARTED|Overall Study||12
5058802|NCT01898442|12449441|P3|NOT COMPLETED|Overall Study||3
5058803|NCT01898442|12449442|P2|NOT COMPLETED|Overall Study||2
5058804|NCT01898442|12449443|P1|NOT COMPLETED|Overall Study||1
5058805|NCT01898442|12449441|P3|COMPLETED|Overall Study||15
5058806|NCT01898442|12449442|P2|COMPLETED|Overall Study||15
5058807|NCT01898442|12449443|P1|COMPLETED|Overall Study||16
5058808|NCT01898442|12449441|P3|STARTED|Overall Study||18
5058809|NCT01898442|12449442|P2|STARTED|Overall Study||17
5058810|NCT01898442|12449443|P1|STARTED|Overall Study||17
5058811|NCT01898429|12449466|P3|NOT COMPLETED|Phase 3||0
5058812|NCT01898429|12449467|P2|NOT COMPLETED|Phase 3||0
5058813|NCT01898429|12449468|P1|NOT COMPLETED|Phase 3||0
5058814|NCT01898429|12449466|P3|COMPLETED|Phase 3||5
5058815|NCT01898429|12449467|P2|COMPLETED|Phase 3||0
5058816|NCT01898429|12449468|P1|COMPLETED|Phase 3||0
5058817|NCT01898429|12449466|P3|STARTED|Phase 3||5
5058818|NCT01898429|12449467|P2|STARTED|Phase 3||0
5058819|NCT01898429|12449468|P1|STARTED|Phase 3||0
5058820|NCT01898429|12449466|P3|NOT COMPLETED|Phase 2||0
5058821|NCT01898429|12449467|P2|NOT COMPLETED|Phase 2||0
5058822|NCT01898429|12449468|P1|NOT COMPLETED|Phase 2||0
5058823|NCT01898429|12449466|P3|COMPLETED|Phase 2||0
5058824|NCT01898429|12449467|P2|COMPLETED|Phase 2||5
5058825|NCT01898429|12449468|P1|COMPLETED|Phase 2||0
5058826|NCT01898429|12449466|P3|STARTED|Phase 2||0
5058827|NCT01898429|12449467|P2|STARTED|Phase 2||5
5058828|NCT01898429|12449468|P1|STARTED|Phase 2||0
5058829|NCT01898429|12449466|P3|NOT COMPLETED|Phase 1||0
5058830|NCT01898429|12449467|P2|NOT COMPLETED|Phase 1||0
5058831|NCT01898429|12449468|P1|NOT COMPLETED|Phase 1||0
5058832|NCT01898429|12449466|P3|COMPLETED|Phase 1||0
5058833|NCT01898429|12449467|P2|COMPLETED|Phase 1||0
5058834|NCT01898429|12449468|P1|COMPLETED|Phase 1||5
5058835|NCT01898429|12449466|P3|STARTED|Phase 1||0
5058836|NCT01898429|12449467|P2|STARTED|Phase 1||0
5058837|NCT01898429|12449468|P1|STARTED|Phase 1||5
5058838|NCT01898403|12449472|P1|NOT COMPLETED|Overall Study||0
5058839|NCT01898403|12449472|P1|COMPLETED|Overall Study||50
5058840|NCT01898403|12449472|P1|STARTED|Overall Study||50
5058841|NCT01898299|12449480|P2|NOT COMPLETED|Post Treatment (One Month)||4
5058842|NCT01898299|12449481|P1|NOT COMPLETED|Post Treatment (One Month)||3
5058843|NCT01898299|12449480|P2|COMPLETED|Post Treatment (One Month)||38
5058844|NCT01898299|12449481|P1|COMPLETED|Post Treatment (One Month)||44
5058845|NCT01898299|12449480|P2|STARTED|Post Treatment (One Month)||42
5058846|NCT01898299|12449481|P1|STARTED|Post Treatment (One Month)||47
5058847|NCT01898299|12449480|P2|NOT COMPLETED|Post Treatment (One Week)||0
5058848|NCT01898299|12449481|P1|NOT COMPLETED|Post Treatment (One Week)||0
5058849|NCT01898299|12449480|P2|COMPLETED|Post Treatment (One Week)||42
5058850|NCT01898299|12449481|P1|COMPLETED|Post Treatment (One Week)||47
5058851|NCT01898299|12449480|P2|STARTED|Post Treatment (One Week)||42
5058852|NCT01898299|12449481|P1|STARTED|Post Treatment (One Week)||47
5058853|NCT01898286|12449487|P1|NOT COMPLETED|Overall Study||3
5058854|NCT01898286|12449487|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
5058855|NCT01898286|12449487|P1|STARTED|Overall Study||38
5058856|NCT01898208|12449497|P3|NOT COMPLETED|Overall Study||37
5058857|NCT01898208|12449498|P2|NOT COMPLETED|Overall Study||49
5058858|NCT01898208|12449499|P1|NOT COMPLETED|Overall Study||40
5058859|NCT01898208|12449497|P3|COMPLETED|Overall Study||212
5058860|NCT01898208|12449498|P2|COMPLETED|Overall Study||198
5058861|NCT01898208|12449499|P1|COMPLETED|Overall Study||207
5058862|NCT01898208|12449497|P3|STARTED|Overall Study||249
5058863|NCT01898208|12449498|P2|STARTED|Overall Study||247
5058864|NCT01898208|12449499|P1|STARTED|Overall Study||247
5058865|NCT01898195|12449546|P3|NOT COMPLETED|Smoking Abstinence||36
5058866|NCT01898195|12449547|P2|NOT COMPLETED|Smoking Abstinence||38
5058867|NCT01898195|12449548|P1|NOT COMPLETED|Smoking Abstinence||35
5058868|NCT01898195|12449546|P3|COMPLETED|Smoking Abstinence||15
5058869|NCT01898195|12449547|P2|COMPLETED|Smoking Abstinence||16
5058870|NCT01898195|12449548|P1|COMPLETED|Smoking Abstinence||18
5058871|NCT01898195|12449546|P3|STARTED|Smoking Abstinence||51
5058872|NCT01898195|12449547|P2|STARTED|Smoking Abstinence||54
5058873|NCT01898195|12449548|P1|STARTED|Smoking Abstinence||53
5058874|NCT01898195|12449546|P3|NOT COMPLETED|Varenicline Adherence||36
5058875|NCT01898195|12449547|P2|NOT COMPLETED|Varenicline Adherence||38
5058876|NCT01898195|12449548|P1|NOT COMPLETED|Varenicline Adherence||35
5058877|NCT01898195|12449546|P3|COMPLETED|Varenicline Adherence||15
5058878|NCT01898195|12449547|P2|COMPLETED|Varenicline Adherence||16
5058879|NCT01898195|12449548|P1|COMPLETED|Varenicline Adherence||18
5058880|NCT01898195|12449546|P3|STARTED|Varenicline Adherence||51
5058881|NCT01898195|12449547|P2|STARTED|Varenicline Adherence||54
5058882|NCT01898195|12449548|P1|STARTED|Varenicline Adherence||53
5058883|NCT01898130|12449559|P1|NOT COMPLETED|Follow up Until PD or Death||1
5058884|NCT01898130|12449559|P1|COMPLETED|Follow up Until PD or Death||26
5058885|NCT01898130|12449559|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
5058886|NCT01898130|12449559|P1|NOT COMPLETED|Treatment||6
5058887|NCT01898130|12449559|P1|COMPLETED|Treatment||21
5058888|NCT01898130|12449559|P1|Went on to Start Cycle 3|Treatment||21
5058889|NCT01898130|12449559|P1|Reached 1st Response/2 Cycles|Treatment||24
5058890|NCT01898130|12449559|P1|STARTED|Treatment||27
5058891|NCT01898091|12449574|P2|NOT COMPLETED|Overall Study||6
5058892|NCT01898091|12449575|P1|NOT COMPLETED|Overall Study||2
5058893|NCT01898091|12449574|P2|COMPLETED|Overall Study||19
5058894|NCT01898091|12449575|P1|COMPLETED|Overall Study||23
5058895|NCT01898091|12449574|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
5058896|NCT01898091|12449575|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
5058897|NCT01898078|12449583|P2|NOT COMPLETED|Overall Study||8
5058898|NCT01898078|12449584|P1|NOT COMPLETED|Overall Study||6
5058899|NCT01898078|12449583|P2|COMPLETED|Overall Study|Completed treatment|5
5058900|NCT01898078|12449584|P1|COMPLETED|Overall Study|Completed treatment|7
5058901|NCT01898078|12449583|P2|STARTED|Overall Study||13
5058902|NCT01898078|12449584|P1|STARTED|Overall Study||13
5058903|NCT01898013|12449602|P2|NOT COMPLETED|Visit 6||5
5058904|NCT01898013|12449603|P1|NOT COMPLETED|Visit 6||3
5058905|NCT01898013|12449602|P2|COMPLETED|Visit 6||42
5058906|NCT01898013|12449603|P1|COMPLETED|Visit 6||41
5058907|NCT01898013|12449602|P2|STARTED|Visit 6||47
5058908|NCT01898013|12449603|P1|STARTED|Visit 6||44
5058909|NCT01898013|12449602|P2|NOT COMPLETED|Visit 5||1
5058910|NCT01898013|12449603|P1|NOT COMPLETED|Visit 5||1
5058911|NCT01898013|12449602|P2|COMPLETED|Visit 5||47
5058912|NCT01898013|12449603|P1|COMPLETED|Visit 5||44
5058913|NCT01898013|12449602|P2|STARTED|Visit 5||48
5058914|NCT01898013|12449603|P1|STARTED|Visit 5||45
5058915|NCT01898013|12449602|P2|NOT COMPLETED|Visit 4||1
5058916|NCT01898013|12449603|P1|NOT COMPLETED|Visit 4||0
5058917|NCT01898013|12449602|P2|COMPLETED|Visit 4||48
5058918|NCT01898013|12449603|P1|COMPLETED|Visit 4||45
5058919|NCT01898013|12449602|P2|STARTED|Visit 4||49
5058920|NCT01898013|12449603|P1|STARTED|Visit 4||45
5058921|NCT01898013|12449602|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
5058922|NCT01898013|12449603|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
5058923|NCT01898013|12449602|P2|COMPLETED|Visit 3 (Randomization Visit)||49
5058924|NCT01898013|12449603|P1|COMPLETED|Visit 3 (Randomization Visit)||45
5058925|NCT01898013|12449602|P2|STARTED|Visit 3 (Randomization Visit)||49
5058926|NCT01898013|12449603|P1|STARTED|Visit 3 (Randomization Visit)||45
5058927|NCT01897896|12449621|P2|NOT COMPLETED|Overall Study||12
5058928|NCT01897896|12449622|P1|NOT COMPLETED|Overall Study||26
5058929|NCT01897896|12449621|P2|COMPLETED|Overall Study||25
5058930|NCT01897896|12449622|P1|COMPLETED|Overall Study||56
5058931|NCT01897896|12449621|P2|STARTED|Overall Study||37
5058932|NCT01897896|12449622|P1|STARTED|Overall Study||82
5058933|NCT01897792|12449704|P2|NOT COMPLETED|Overall Study||0
5058934|NCT01897792|12449705|P1|NOT COMPLETED|Overall Study||0
5058935|NCT01897792|12449704|P2|COMPLETED|Overall Study||5
5058936|NCT01897792|12449705|P1|COMPLETED|Overall Study||6
5058937|NCT01897792|12449704|P2|STARTED|Overall Study||5
5058938|NCT01897792|12449705|P1|STARTED|Overall Study||6
5058939|NCT01897766|12449729|P1|NOT COMPLETED|Overall Study||0
5058940|NCT01897766|12449729|P1|COMPLETED|Overall Study||482
5058941|NCT01897766|12449729|P1|STARTED|Overall Study||482
5058942|NCT01897727|12449754|P2|NOT COMPLETED|Overall Study||1
5058943|NCT01897727|12449755|P1|NOT COMPLETED|Overall Study||0
5058944|NCT01897727|12449754|P2|COMPLETED|Overall Study||8
5058945|NCT01897727|12449755|P1|COMPLETED|Overall Study||8
5058946|NCT01897727|12449754|P2|STARTED|Overall Study||9
5058947|NCT01897727|12449755|P1|STARTED|Overall Study||8
5058948|NCT01897532|12449763|P2|NOT COMPLETED|Discontinuation From Trial||41
5058949|NCT01897532|12449764|P1|NOT COMPLETED|Discontinuation From Trial||62
5058950|NCT01897532|12449763|P2|COMPLETED|Discontinuation From Trial||3458
5058951|NCT01897532|12449764|P1|COMPLETED|Discontinuation From Trial||3430
5058952|NCT01897532|12449763|P2|Treated|Discontinuation From Trial||3494
5058953|NCT01897532|12449764|P1|Treated|Discontinuation From Trial||3485
5058954|NCT01897532|12449763|P2|STARTED|Discontinuation From Trial||3499
5058955|NCT01897532|12449764|P1|STARTED|Discontinuation From Trial||3492
5058956|NCT01897532|12449763|P2|NOT COMPLETED|Discontinuation From Treatment||839
5058957|NCT01897532|12449764|P1|NOT COMPLETED|Discontinuation From Treatment||962
5058958|NCT01897532|12449763|P2|COMPLETED|Discontinuation From Treatment||2660
5058959|NCT01897532|12449764|P1|COMPLETED|Discontinuation From Treatment||2530
5058960|NCT01897532|12449763|P2|Treated|Discontinuation From Treatment||3494
5058961|NCT01897532|12449764|P1|Treated|Discontinuation From Treatment||3485
5058962|NCT01897532|12449763|P2|STARTED|Discontinuation From Treatment||3499
5058963|NCT01897532|12449764|P1|STARTED|Discontinuation From Treatment||3492
5058964|NCT01897493|12449772|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
5058965|NCT01897493|12449772|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
5058966|NCT01897493|12449772|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
5058967|NCT01897493|12449772|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
5058968|NCT01897493|12449772|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
5058969|NCT01897493|12449772|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
5058970|NCT01897493|12449772|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
5058971|NCT01897493|12449772|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
5058972|NCT01897402|12449787|P2|NOT COMPLETED|Overall Study||16
5058973|NCT01897402|12449788|P1|NOT COMPLETED|Overall Study||19
5058974|NCT01897402|12449787|P2|COMPLETED|Overall Study||244
5058975|NCT01897402|12449788|P1|COMPLETED|Overall Study||246
5058976|NCT01897402|12449787|P2|STARTED|Overall Study||260
5058977|NCT01897402|12449788|P1|STARTED|Overall Study||265
5058978|NCT01897285|12449800|P1|NOT COMPLETED|Overall Study||0
5058979|NCT01897285|12449800|P1|COMPLETED|Overall Study||20
5058980|NCT01897285|12449800|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
5058981|NCT01897233|12449808|P1|NOT COMPLETED|Part B (24 Weeks)||4
5058982|NCT01897233|12449808|P1|COMPLETED|Part B (24 Weeks)||54
5058983|NCT01897233|12449808|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
5058984|NCT01897233|12449808|P1|NOT COMPLETED|Part A (14 Days)||0
5058985|NCT01897233|12449808|P1|COMPLETED|Part A (14 Days)||10
5058986|NCT01897233|12449808|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
5058987|NCT01897233|12449808|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
5058988|NCT01897233|12449808|P1|STARTED|Part A (14 Days)||10
5058989|NCT01897077|12449832|P2|NOT COMPLETED|Overall Study||0
5058990|NCT01897077|12449833|P1|NOT COMPLETED|Overall Study||0
5058991|NCT01897077|12449832|P2|COMPLETED|Overall Study||5
5058992|NCT01897077|12449833|P1|COMPLETED|Overall Study||0
5058993|NCT01897077|12449832|P2|STARTED|Overall Study||5
5058994|NCT01897077|12449833|P1|STARTED|Overall Study||0
5058995|NCT01897025|12449851|P2|NOT COMPLETED|Overall Study||0
5058996|NCT01897025|12449852|P1|NOT COMPLETED|Overall Study||0
5058997|NCT01897025|12449851|P2|COMPLETED|Overall Study||9
5058998|NCT01897025|12449852|P1|COMPLETED|Overall Study||10
5058999|NCT01897025|12449851|P2|STARTED|Overall Study||9
5059000|NCT01897025|12449852|P1|STARTED|Overall Study||10
5059001|NCT01896986|12449860|P2|NOT COMPLETED|Overall Study||23
5059002|NCT01896986|12449861|P1|NOT COMPLETED|Overall Study||14
5059003|NCT01896986|12449860|P2|COMPLETED|Overall Study||0
5059004|NCT01896986|12449861|P1|COMPLETED|Overall Study||0
5059005|NCT01896986|12449860|P2|STARTED|Overall Study||23
5059006|NCT01896986|12449861|P1|STARTED|Overall Study||14
5059007|NCT01896934|12449867|P1|NOT COMPLETED|Overall Study||2
5059008|NCT01896934|12449867|P1|COMPLETED|Overall Study||19
5059009|NCT01896934|12449867|P1|STARTED|Overall Study||21
5059010|NCT01896921|12449873|P1|NOT COMPLETED|Overall Study||2
5059011|NCT01896921|12449873|P1|COMPLETED|Overall Study||5
5059012|NCT01896921|12449873|P1|STARTED|Overall Study||7
5059013|NCT01896895|12449880|P4|NOT COMPLETED|OLEX Period||0
5059014|NCT01896895|12449881|P3|NOT COMPLETED|OLEX Period||0
5059015|NCT01896895|12449882|P2|NOT COMPLETED|OLEX Period||0
5059016|NCT01896895|12449883|P1|NOT COMPLETED|OLEX Period||0
5059017|NCT01896895|12449880|P4|COMPLETED|OLEX Period||39
5059018|NCT01896895|12449881|P3|COMPLETED|OLEX Period||0
5059019|NCT01896895|12449882|P2|COMPLETED|OLEX Period||0
5059020|NCT01896895|12449883|P1|COMPLETED|OLEX Period||0
5059021|NCT01896895|12449880|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
5059022|NCT01896895|12449881|P3|STARTED|OLEX Period||0
5059023|NCT01896895|12449882|P2|STARTED|OLEX Period||0
5059024|NCT01896895|12449883|P1|STARTED|OLEX Period||0
5059025|NCT01896895|12449880|P4|NOT COMPLETED|Double-blind MP||0
5059026|NCT01896895|12449881|P3|NOT COMPLETED|Double-blind MP||3
5059027|NCT01896895|12449882|P2|NOT COMPLETED|Double-blind MP||2
5059028|NCT01896895|12449883|P1|NOT COMPLETED|Double-blind MP||1
5059029|NCT01896895|12449880|P4|COMPLETED|Double-blind MP||0
5059030|NCT01896895|12449881|P3|COMPLETED|Double-blind MP||16
5059031|NCT01896895|12449882|P2|COMPLETED|Double-blind MP||20
5059032|NCT01896895|12449883|P1|COMPLETED|Double-blind MP||19
5059033|NCT01896895|12449880|P4|STARTED|Double-blind MP||0
5059034|NCT01896895|12449881|P3|STARTED|Double-blind MP||19
5059035|NCT01896895|12449882|P2|STARTED|Double-blind MP||22
5059036|NCT01896895|12449883|P1|STARTED|Double-blind MP||20
5059037|NCT01896869|12449900|P2|NOT COMPLETED|Overall Study||6
5059038|NCT01896869|12449901|P1|NOT COMPLETED|Overall Study||1
5059039|NCT01896869|12449900|P2|COMPLETED|Overall Study||36
5059040|NCT01896869|12449901|P1|COMPLETED|Overall Study||40
5059041|NCT01896869|12449900|P2|STARTED|Overall Study||42
5059042|NCT01896869|12449901|P1|STARTED|Overall Study||41
5059043|NCT01896726|12449920|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
5059044|NCT01896726|12449920|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
5059045|NCT01896726|12449920|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
5059046|NCT01896726|12449920|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
5059047|NCT01896726|12449920|P1|STARTED|Treatment Period 2 (Days 23-31)||20
5059048|NCT01896726|12449920|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
5059049|NCT01896726|12449920|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
5059050|NCT01896726|12449920|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
5059051|NCT01896726|12449920|P1|STARTED|Treatment Period 1 (Days 1-22)||20
5059052|NCT01896700|12449935|P2|NOT COMPLETED|Overall Study||6
5059053|NCT01896700|12449936|P1|NOT COMPLETED|Overall Study||4
5059054|NCT01896700|12449935|P2|COMPLETED|Overall Study||6
5059055|NCT01896700|12449936|P1|COMPLETED|Overall Study||8
5059056|NCT01896700|12449935|P2|STARTED|Overall Study||12
5059057|NCT01896700|12449936|P1|STARTED|Overall Study||12
5059058|NCT01896687|12449958|P2|NOT COMPLETED|Overall Study||0
5059059|NCT01896687|12449959|P1|NOT COMPLETED|Overall Study||0
5059060|NCT01896687|12449958|P2|COMPLETED|Overall Study||15
5059061|NCT01896687|12449959|P1|COMPLETED|Overall Study||15
5059062|NCT01896687|12449958|P2|STARTED|Overall Study||15
5059063|NCT01896687|12449959|P1|STARTED|Overall Study||15
5059064|NCT01896557|12449967|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
5059065|NCT01896557|12449968|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
5059066|NCT01896557|12449967|P2|COMPLETED|Clopidogrel + GI Protector||44
5059067|NCT01896557|12449968|P1|COMPLETED|Clopidogrel + GI Protector||41
5059068|NCT01896557|12449967|P2|STARTED|Clopidogrel + GI Protector||48
5059069|NCT01896557|12449968|P1|STARTED|Clopidogrel + GI Protector||43
5059070|NCT01896557|12449967|P2|NOT COMPLETED|Clopidogrel Alone||0
5059071|NCT01896557|12449968|P1|NOT COMPLETED|Clopidogrel Alone||1
5059072|NCT01896557|12449967|P2|COMPLETED|Clopidogrel Alone||48
5059073|NCT01896557|12449968|P1|COMPLETED|Clopidogrel Alone||43
5059074|NCT01896557|12449967|P2|STARTED|Clopidogrel Alone||48
5059075|NCT01896557|12449968|P1|STARTED|Clopidogrel Alone||44
5059076|NCT01896544|12449983|P3|NOT COMPLETED|Overall Study||0
5059077|NCT01896544|12449984|P2|NOT COMPLETED|Overall Study||0
5059078|NCT01896544|12449985|P1|NOT COMPLETED|Overall Study||0
5059079|NCT01896544|12449983|P3|COMPLETED|Overall Study||10
5059080|NCT01896544|12449984|P2|COMPLETED|Overall Study||10
5059081|NCT01896544|12449985|P1|COMPLETED|Overall Study||10
5059082|NCT01896544|12449983|P3|STARTED|Overall Study||10
5059083|NCT01896544|12449984|P2|STARTED|Overall Study||10
5059084|NCT01896544|12449985|P1|STARTED|Overall Study||10
5059085|NCT01896297|12450005|P1|NOT COMPLETED|Overall Study||1
5059086|NCT01896297|12450005|P1|COMPLETED|Overall Study||59
5059087|NCT01896297|12450005|P1|STARTED|Overall Study||60
5059088|NCT01896232|12450012|P2|NOT COMPLETED|Overall Study||53
5059089|NCT01896232|12450013|P1|NOT COMPLETED|Overall Study||49
5059090|NCT01896232|12450012|P2|COMPLETED|Overall Study||287
5059091|NCT01896232|12450013|P1|COMPLETED|Overall Study||294
5059092|NCT01896232|12450012|P2|Received Treatment|Overall Study||338
5059093|NCT01896232|12450013|P1|Received Treatment|Overall Study||341
5059094|NCT01896232|12450012|P2|STARTED|Overall Study||340
5059095|NCT01896232|12450013|P1|STARTED|Overall Study||343
5059096|NCT01896206|12450033|P1|NOT COMPLETED|Overall Study||0
5059097|NCT01896206|12450033|P1|COMPLETED|Overall Study||21
5059098|NCT01896206|12450033|P1|STARTED|Overall Study||21
5059099|NCT01896193|12450041|P2|NOT COMPLETED|Overall Study||12
5059100|NCT01896193|12450042|P1|NOT COMPLETED|Overall Study||21
5059101|NCT01896193|12450041|P2|COMPLETED|Overall Study||53
5059102|NCT01896193|12450042|P1|COMPLETED|Overall Study||41
5059103|NCT01896193|12450041|P2|STARTED|Overall Study||65
5059104|NCT01896193|12450042|P1|STARTED|Overall Study||62
5059105|NCT01896128|12450068|P2|NOT COMPLETED|Overall Study||3
5059106|NCT01896128|12450069|P1|NOT COMPLETED|Overall Study||3
5059107|NCT01896128|12450068|P2|COMPLETED|Overall Study||8
5059108|NCT01896128|12450069|P1|COMPLETED|Overall Study||5
5059109|NCT01896128|12450068|P2|STARTED|Overall Study||11
5059110|NCT01896128|12450069|P1|STARTED|Overall Study||8
5059111|NCT01896115|12450085|P2|NOT COMPLETED|Overall Study||0
5059112|NCT01896115|12450086|P1|NOT COMPLETED|Overall Study||1
5059113|NCT01896115|12450085|P2|COMPLETED|Overall Study||24
5059114|NCT01896115|12450086|P1|COMPLETED|Overall Study||15
5059115|NCT01896115|12450085|P2|Phase 2 Steering|Overall Study||24
5059116|NCT01896115|12450086|P1|Phase 2 Steering|Overall Study||0
5059117|NCT01896115|12450085|P2|Phase 2 Single Contact|Overall Study||24
5059118|NCT01896115|12450086|P1|Phase 2 Single Contact|Overall Study||0
5059119|NCT01896115|12450085|P2|Phase 1 Ventral Steering|Overall Study||0
5059120|NCT01896115|12450086|P1|Phase 1 Ventral Steering|Overall Study||15
5059121|NCT01896115|12450085|P2|Phase 1 Dorsal Steering|Overall Study||0
5059122|NCT01896115|12450086|P1|Phase 1 Dorsal Steering|Overall Study||15
5059123|NCT01896115|12450085|P2|Phase 1 Conventional PW|Overall Study||0
5059124|NCT01896115|12450086|P1|Phase 1 Conventional PW|Overall Study||15
5059125|NCT01896115|12450085|P2|Phase 1 Short PW|Overall Study||0
5059126|NCT01896115|12450086|P1|Phase 1 Short PW|Overall Study||15
5059127|NCT01896115|12450085|P2|STARTED|Overall Study||24
5059128|NCT01896115|12450086|P1|STARTED|Overall Study||16
5059129|NCT01896050|12450111|P2|NOT COMPLETED|Overall Study||2
5059130|NCT01896050|12450112|P1|NOT COMPLETED|Overall Study||38
5059131|NCT01896050|12450111|P2|COMPLETED|Overall Study||20
5059132|NCT01896050|12450112|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
5059133|NCT01896050|12450111|P2|STARTED|Overall Study||22
5059134|NCT01896050|12450112|P1|STARTED|Overall Study||93
5059135|NCT01895972|12450122|P1|NOT COMPLETED|Overall Study||9
5059136|NCT01895972|12450122|P1|COMPLETED|Overall Study||121
5059137|NCT01895972|12450122|P1|STARTED|Overall Study||130
5059138|NCT01895946|12450129|P2|NOT COMPLETED|Overall Study||0
5059139|NCT01895946|12450130|P1|NOT COMPLETED|Overall Study||0
5059140|NCT01895946|12450129|P2|COMPLETED|Overall Study||12
5059141|NCT01895946|12450130|P1|COMPLETED|Overall Study||18
5059142|NCT01895946|12450129|P2|STARTED|Overall Study||12
5059143|NCT01895946|12450130|P1|STARTED|Overall Study||18
5059144|NCT01895777|12450150|P2|NOT COMPLETED|Overall Study||5
5059145|NCT01895777|12450151|P1|NOT COMPLETED|Overall Study||9
5059146|NCT01895777|12450150|P2|COMPLETED|Overall Study||85
5059147|NCT01895777|12450151|P1|COMPLETED|Overall Study||168
5059148|NCT01895777|12450150|P2|Treated|Overall Study||90
5059149|NCT01895777|12450151|P1|Treated|Overall Study||176
5059150|NCT01895777|12450150|P2|STARTED|Overall Study||90
5059151|NCT01895777|12450151|P1|STARTED|Overall Study||177
5059152|NCT01895647|12450179|P3|NOT COMPLETED|Overall Study||0
5059153|NCT01895647|12450180|P2|NOT COMPLETED|Overall Study||0
5059154|NCT01895647|12450181|P1|NOT COMPLETED|Overall Study||0
5059155|NCT01895647|12450179|P3|COMPLETED|Overall Study||7
5059156|NCT01895647|12450180|P2|COMPLETED|Overall Study||10
5059157|NCT01895647|12450181|P1|COMPLETED|Overall Study||8
5059158|NCT01895647|12450179|P3|STARTED|Overall Study||7
5059159|NCT01895647|12450180|P2|STARTED|Overall Study||10
5059160|NCT01895647|12450181|P1|STARTED|Overall Study||8
5059161|NCT01895634|12450195|P1|NOT COMPLETED|Overall Study||3
5059162|NCT01895634|12450195|P1|COMPLETED|Overall Study||46
5059163|NCT01895634|12450195|P1|STARTED|Overall Study||49
5059164|NCT01895608|12450207|P4|NOT COMPLETED|Overall Study||0
5059165|NCT01895608|12450208|P3|NOT COMPLETED|Overall Study||3
5059166|NCT01895608|12450209|P2|NOT COMPLETED|Overall Study||1
5059167|NCT01895608|12450210|P1|NOT COMPLETED|Overall Study||0
5059168|NCT01895608|12450207|P4|COMPLETED|Overall Study||6
5059169|NCT01895608|12450208|P3|COMPLETED|Overall Study||8
5059170|NCT01895608|12450209|P2|COMPLETED|Overall Study||6
5059171|NCT01895608|12450210|P1|COMPLETED|Overall Study||10
5059172|NCT01895608|12450207|P4|STARTED|Overall Study||6
5059173|NCT01895608|12450208|P3|STARTED|Overall Study||11
5059174|NCT01895608|12450209|P2|STARTED|Overall Study||7
5059175|NCT01895608|12450210|P1|STARTED|Overall Study||10
5059176|NCT01895543|12450240|P1|NOT COMPLETED|Overall Study||129
5059177|NCT01895543|12450240|P1|COMPLETED|Overall Study||282
5059178|NCT01895543|12450240|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
5059179|NCT01895543|12450240|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
5059180|NCT01895543|12450240|P1|STARTED|Overall Study||411
5059181|NCT01895452|12450256|P2|NOT COMPLETED|Overall Study||28
5059182|NCT01895452|12450257|P1|NOT COMPLETED|Overall Study||4
5059183|NCT01895452|12450256|P2|COMPLETED|Overall Study||198
5059184|NCT01895452|12450257|P1|COMPLETED|Overall Study||61
5059185|NCT01895452|12450256|P2|STARTED|Overall Study||226
5059186|NCT01895452|12450257|P1|STARTED|Overall Study||65
5059187|NCT01895361|12450270|P3|NOT COMPLETED|Overall Study||24
5059188|NCT01895361|12450271|P2|NOT COMPLETED|Overall Study||21
5059189|NCT01895361|12450272|P1|NOT COMPLETED|Overall Study||24
5059190|NCT01895361|12450270|P3|COMPLETED|Overall Study||41
5059191|NCT01895361|12450271|P2|COMPLETED|Overall Study||45
5059192|NCT01895361|12450272|P1|COMPLETED|Overall Study||43
5059193|NCT01895361|12450270|P3|STARTED|Overall Study||65
5059194|NCT01895361|12450271|P2|STARTED|Overall Study||66
5059195|NCT01895361|12450272|P1|STARTED|Overall Study||67
5059196|NCT01895335|12450301|P1|NOT COMPLETED|Overall Study||215
5059197|NCT01895335|12450301|P1|COMPLETED|Overall Study||786
5059198|NCT01895335|12450301|P1|Treated|Overall Study||1000
5059199|NCT01895335|12450301|P1|STARTED|Overall Study||1001
5059200|NCT01895322|12450318|P1|NOT COMPLETED|Overall Study||13
5059201|NCT01895322|12450318|P1|COMPLETED|Overall Study||7
5059202|NCT01895322|12450318|P1|STARTED|Overall Study||20
5059203|NCT01895309|12450327|P2|NOT COMPLETED|Overall Study||51
5059204|NCT01895309|12450328|P1|NOT COMPLETED|Overall Study||40
5059205|NCT01895309|12450327|P2|COMPLETED|Overall Study||246
5059206|NCT01895309|12450328|P1|COMPLETED|Overall Study||259
5059207|NCT01895309|12450327|P2|STARTED|Overall Study||297
5059208|NCT01895309|12450328|P1|STARTED|Overall Study||299
5059209|NCT01895270|12450342|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
5059210|NCT01895270|12450343|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
5059211|NCT01895270|12450342|P2|COMPLETED|Isradipine Taper (W7-8)||0
5059212|NCT01895270|12450343|P1|COMPLETED|Isradipine Taper (W7-8)||2
5059213|NCT01895270|12450342|P2|STARTED|Isradipine Taper (W7-8)||2
5059214|NCT01895270|12450343|P1|STARTED|Isradipine Taper (W7-8)||2
5059215|NCT01895270|12450342|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
5059216|NCT01895270|12450343|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
5059217|NCT01895270|12450342|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
5059218|NCT01895270|12450343|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
5059219|NCT01895270|12450342|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
5059220|NCT01895270|12450343|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
5059221|NCT01895270|12450342|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
5059222|NCT01895270|12450343|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
5059223|NCT01895270|12450342|P2|COMPLETED|Study Medications Induction (W1-4)||8
5059224|NCT01895270|12450343|P1|COMPLETED|Study Medications Induction (W1-4)||5
5059225|NCT01895270|12450342|P2|STARTED|Study Medications Induction (W1-4)||14
5059226|NCT01895270|12450343|P1|STARTED|Study Medications Induction (W1-4)||11
5059227|NCT01895127|12450351|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
5059228|NCT01895127|12450352|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
5059229|NCT01895127|12450351|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
5059230|NCT01895127|12450352|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
5059231|NCT01895127|12450351|P2|STARTED|Long Term Follow-up (Month 3-12)||7
5059232|NCT01895127|12450352|P1|STARTED|Long Term Follow-up (Month 3-12)||3
5059233|NCT01895127|12450351|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
5059234|NCT01895127|12450352|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
5059235|NCT01895127|12450351|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
5059236|NCT01895127|12450352|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
5059237|NCT01895127|12450351|P2|STARTED|Month 3 Follow-up & Biopsy||7
5059238|NCT01895127|12450352|P1|STARTED|Month 3 Follow-up & Biopsy||3
5059239|NCT01895127|12450351|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
5059240|NCT01895127|12450352|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
5059241|NCT01895127|12450351|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
5059242|NCT01895127|12450352|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
5059243|NCT01895127|12450351|P2|STARTED|Treatment Period (Week 0-Month 3)||7
5059244|NCT01895127|12450352|P1|STARTED|Treatment Period (Week 0-Month 3)||3
5059245|NCT01895127|12450351|P2|NOT COMPLETED|Screening||0
5059246|NCT01895127|12450352|P1|NOT COMPLETED|Screening||0
5059247|NCT01895127|12450351|P2|COMPLETED|Screening||7
5059248|NCT01895127|12450352|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
5059249|NCT01895127|12450351|P2|STARTED|Screening||7
5059250|NCT01895127|12450352|P1|STARTED|Screening||4
5059251|NCT01895101|12450362|P3|NOT COMPLETED|Overall Study||5
5059252|NCT01895101|12450363|P2|NOT COMPLETED|Overall Study||5
5059253|NCT01895101|12450364|P1|NOT COMPLETED|Overall Study||1
5059254|NCT01895101|12450362|P3|COMPLETED|Overall Study||245
5059255|NCT01895101|12450363|P2|COMPLETED|Overall Study||245
5059256|NCT01895101|12450364|P1|COMPLETED|Overall Study||249
5059257|NCT01895101|12450362|P3|STARTED|Overall Study||250
5059258|NCT01895101|12450363|P2|STARTED|Overall Study||250
5059259|NCT01895101|12450364|P1|STARTED|Overall Study||250
5059260|NCT01895088|12450378|P1|NOT COMPLETED|Overall Study||18
5059261|NCT01895088|12450378|P1|COMPLETED|Overall Study||253
5059262|NCT01895088|12450378|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
5059263|NCT01895062|12450384|P2|NOT COMPLETED|Overall Study||0
5059264|NCT01895062|12450385|P1|NOT COMPLETED|Overall Study||0
5059265|NCT01895062|12450384|P2|COMPLETED|Overall Study||24
5059266|NCT01895062|12450385|P1|COMPLETED|Overall Study||30
5059267|NCT01895062|12450384|P2|STARTED|Overall Study||24
5059268|NCT01895062|12450385|P1|STARTED|Overall Study||30
5059269|NCT01895036|12450393|P1|NOT COMPLETED|Overall Study||0
5059270|NCT01895036|12450393|P1|COMPLETED|Overall Study||6
5059271|NCT01895036|12450393|P1|STARTED|Overall Study||6
5059272|NCT01894984|12450399|P2|NOT COMPLETED|Overall Study||175
5059273|NCT01894984|12450400|P1|NOT COMPLETED|Overall Study||314
5059274|NCT01894984|12450399|P2|COMPLETED|Overall Study||69
5059275|NCT01894984|12450400|P1|COMPLETED|Overall Study||82
5059276|NCT01894984|12450399|P2|STARTED|Overall Study||244
5059277|NCT01894984|12450400|P1|STARTED|Overall Study||396
5059278|NCT01894919|12450429|P13|NOT COMPLETED|Overall Study||0
5059279|NCT01894919|12450430|P12|NOT COMPLETED|Overall Study||0
5059280|NCT01894919|12450431|P11|NOT COMPLETED|Overall Study||2
5059281|NCT01894919|12450432|P10|NOT COMPLETED|Overall Study||1
5059282|NCT01894919|12450433|P9|NOT COMPLETED|Overall Study||0
5059283|NCT01894919|12450434|P8|NOT COMPLETED|Overall Study||0
5059284|NCT01894919|12450435|P7|NOT COMPLETED|Overall Study||0
5059285|NCT01894919|12450436|P6|NOT COMPLETED|Overall Study||0
5059286|NCT01894919|12450437|P5|NOT COMPLETED|Overall Study||3
5059287|NCT01894919|12450438|P4|NOT COMPLETED|Overall Study||0
5059288|NCT01894919|12450439|P3|NOT COMPLETED|Overall Study||0
5059289|NCT01894919|12450440|P2|NOT COMPLETED|Overall Study||0
5059290|NCT01894919|12450441|P1|NOT COMPLETED|Overall Study||2
5059291|NCT01894919|12450429|P13|COMPLETED|Overall Study||50
5059292|NCT01894919|12450430|P12|COMPLETED|Overall Study||55
5059293|NCT01894919|12450431|P11|COMPLETED|Overall Study||98
5059294|NCT01894919|12450432|P10|COMPLETED|Overall Study||89
5059295|NCT01894919|12450433|P9|COMPLETED|Overall Study||91
5059296|NCT01894919|12450434|P8|COMPLETED|Overall Study||36
5059297|NCT01894919|12450435|P7|COMPLETED|Overall Study||32
5059298|NCT01894919|12450436|P6|COMPLETED|Overall Study||39
5059299|NCT01894919|12450437|P5|COMPLETED|Overall Study||78
5059300|NCT01894919|12450438|P4|COMPLETED|Overall Study||43
5059301|NCT01894919|12450439|P3|COMPLETED|Overall Study||89
5059302|NCT01894919|12450440|P2|COMPLETED|Overall Study||47
5059303|NCT01894919|12450441|P1|COMPLETED|Overall Study||96
5059304|NCT01894919|12450429|P13|STARTED|Overall Study||50
5059305|NCT01894919|12450430|P12|STARTED|Overall Study||55
5059306|NCT01894919|12450431|P11|STARTED|Overall Study||100
5059307|NCT01894919|12450432|P10|STARTED|Overall Study||90
5059308|NCT01894919|12450433|P9|STARTED|Overall Study||91
5059309|NCT01894919|12450434|P8|STARTED|Overall Study||36
5059310|NCT01894919|12450435|P7|STARTED|Overall Study||32
5059311|NCT01894919|12450436|P6|STARTED|Overall Study||39
5059312|NCT01894919|12450437|P5|STARTED|Overall Study||81
5059313|NCT01894919|12450438|P4|STARTED|Overall Study||43
5059314|NCT01894919|12450439|P3|STARTED|Overall Study||89
5059315|NCT01894919|12450440|P2|STARTED|Overall Study||47
5059316|NCT01894919|12450441|P1|STARTED|Overall Study||98
5059317|NCT01894906|12450563|P2|NOT COMPLETED|Overall Study||0
5059318|NCT01894906|12450564|P1|NOT COMPLETED|Overall Study||0
5059319|NCT01894906|12450563|P2|COMPLETED|Overall Study||6
5059320|NCT01894906|12450564|P1|COMPLETED|Overall Study||6
5059321|NCT01894906|12450563|P2|Treatment F|Overall Study||6
5059322|NCT01894906|12450564|P1|Treatment F|Overall Study||6
5059323|NCT01894906|12450563|P2|Treatment E|Overall Study||6
5059324|NCT01894906|12450564|P1|Treatment E|Overall Study||6
5059325|NCT01894906|12450563|P2|Treatment D|Overall Study||6
5059326|NCT01894906|12450564|P1|Treatment D|Overall Study||6
5059327|NCT01894906|12450563|P2|Treatment C|Overall Study||6
5059328|NCT01894906|12450564|P1|Treatment C|Overall Study||6
5059329|NCT01894906|12450563|P2|Treatment B|Overall Study||6
5059330|NCT01894906|12450564|P1|Treatment B|Overall Study||6
5059331|NCT01894906|12450563|P2|Treatment A|Overall Study||6
5059332|NCT01894906|12450564|P1|Treatment A|Overall Study||6
5059333|NCT01894906|12450563|P2|STARTED|Overall Study||6
5059334|NCT01894906|12450564|P1|STARTED|Overall Study||6
5059335|NCT01894841|12450596|P2|NOT COMPLETED|Overall Study||9
5059336|NCT01894841|12450597|P1|NOT COMPLETED|Overall Study||18
5059337|NCT01894841|12450596|P2|COMPLETED|Overall Study||44
5059338|NCT01894841|12450597|P1|COMPLETED|Overall Study||34
5059339|NCT01894841|12450596|P2|STARTED|Overall Study||53
5059340|NCT01894841|12450597|P1|STARTED|Overall Study||52
5059341|NCT01894776|12450613|P1|NOT COMPLETED|Overall Study||1
5059342|NCT01894776|12450613|P1|COMPLETED|Overall Study||14
5059343|NCT01894776|12450613|P1|STARTED|Overall Study||15
5059344|NCT01894672|12450619|P1|NOT COMPLETED|Overall Study||0
5059345|NCT01894672|12450619|P1|COMPLETED|Overall Study||7
5059346|NCT01894672|12450619|P1|STARTED|Overall Study||7
5059347|NCT01894620|12450627|P2|NOT COMPLETED|Overall Study||1
5059348|NCT01894620|12450628|P1|NOT COMPLETED|Overall Study||0
5059349|NCT01894620|12450627|P2|COMPLETED|Overall Study||4
5059350|NCT01894620|12450628|P1|COMPLETED|Overall Study||6
5059351|NCT01894620|12450627|P2|STARTED|Overall Study||5
5059352|NCT01894620|12450628|P1|STARTED|Overall Study||6
5059353|NCT01894607|12450636|P1|NOT COMPLETED|Overall Study||1
5059354|NCT01894607|12450636|P1|COMPLETED|Overall Study||10
5059355|NCT01894607|12450636|P1|STARTED|Overall Study||11
5059356|NCT01894581|12450643|P2|NOT COMPLETED|Overall Study||7
5059357|NCT01894581|12450644|P1|NOT COMPLETED|Overall Study||5
5059358|NCT01894581|12450643|P2|COMPLETED|Overall Study||12
5059359|NCT01894581|12450644|P1|COMPLETED|Overall Study||15
5059360|NCT01894581|12450643|P2|STARTED|Overall Study||19
5059361|NCT01894581|12450644|P1|STARTED|Overall Study||20
5059362|NCT01894568|12450652|P2|NOT COMPLETED|Overall Study||10
5059363|NCT01894568|12450653|P1|NOT COMPLETED|Overall Study||10
5059364|NCT01894568|12450652|P2|COMPLETED|Overall Study||186
5059365|NCT01894568|12450653|P1|COMPLETED|Overall Study||182
5059366|NCT01894568|12450652|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
5059367|NCT01894568|12450653|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
5059368|NCT01894568|12450652|P2|STARTED|Overall Study||196
5059369|NCT01894568|12450653|P1|STARTED|Overall Study||192
5059370|NCT01894555|12450693|P1|NOT COMPLETED|Overall Study||0
5059371|NCT01894555|12450693|P1|COMPLETED|Overall Study||33
5059372|NCT01894555|12450693|P1|STARTED|Overall Study||33
5059373|NCT01894503|12450697|P1|NOT COMPLETED|Overall Study||0
5059374|NCT01894503|12450697|P1|COMPLETED|Overall Study||5
5059375|NCT01894503|12450697|P1|STARTED|Overall Study||5
5059376|NCT01894477|12450704|P2|NOT COMPLETED|Overall Study||2
5059377|NCT01894477|12450705|P1|NOT COMPLETED|Overall Study||0
5059378|NCT01894477|12450704|P2|COMPLETED|Overall Study||65
5059379|NCT01894477|12450705|P1|COMPLETED|Overall Study||35
5059380|NCT01894477|12450704|P2|STARTED|Overall Study||67
5059381|NCT01894477|12450705|P1|STARTED|Overall Study||35
5059382|NCT01894256|12450716|P3|NOT COMPLETED|Part B||14
5059383|NCT01894256|12450717|P2|NOT COMPLETED|Part B||14
5059384|NCT01894256|12450718|P1|NOT COMPLETED|Part B||15
5059385|NCT01894256|12450716|P3|COMPLETED|Part B||0
5059386|NCT01894256|12450717|P2|COMPLETED|Part B||0
5059387|NCT01894256|12450718|P1|COMPLETED|Part B||0
5059388|NCT01894256|12450716|P3|STARTED|Part B||14
5059389|NCT01894256|12450717|P2|STARTED|Part B||14
5059390|NCT01894256|12450718|P1|STARTED|Part B||15
5059391|NCT01894256|12450716|P3|NOT COMPLETED|Part A||0
5059392|NCT01894256|12450717|P2|NOT COMPLETED|Part A||1
5059393|NCT01894256|12450718|P1|NOT COMPLETED|Part A||0
5059394|NCT01894256|12450716|P3|COMPLETED|Part A||14
5059395|NCT01894256|12450717|P2|COMPLETED|Part A||14
5059396|NCT01894256|12450718|P1|COMPLETED|Part A||15
5059397|NCT01894256|12450716|P3|STARTED|Part A||14
5059398|NCT01894256|12450717|P2|STARTED|Part A||15
5059399|NCT01894256|12450718|P1|STARTED|Part A||15
5059400|NCT01894243|12450765|P3|NOT COMPLETED|Overall Study||8
5059401|NCT01894243|12450766|P2|NOT COMPLETED|Overall Study||10
5059402|NCT01894243|12450767|P1|NOT COMPLETED|Overall Study||13
5059403|NCT01894243|12450765|P3|COMPLETED|Overall Study||0
5059404|NCT01894243|12450766|P2|COMPLETED|Overall Study||0
5059405|NCT01894243|12450767|P1|COMPLETED|Overall Study||0
5059406|NCT01894243|12450765|P3|Ongoing Into Part B|Overall Study||8
5059407|NCT01894243|12450766|P2|Ongoing Into Part B|Overall Study||10
5059408|NCT01894243|12450767|P1|Ongoing Into Part B|Overall Study||13
5059409|NCT01894243|12450765|P3|Completed Treatment in Part A|Overall Study||8
5059410|NCT01894243|12450766|P2|Completed Treatment in Part A|Overall Study||10
5059411|NCT01894243|12450767|P1|Completed Treatment in Part A|Overall Study||13
5059412|NCT01894243|12450765|P3|STARTED|Overall Study||8
5059413|NCT01894243|12450766|P2|STARTED|Overall Study||10
5059414|NCT01894243|12450767|P1|STARTED|Overall Study||13
5059415|NCT01894230|12450806|P2|NOT COMPLETED|Overall Study||7
5059416|NCT01894230|12450807|P1|NOT COMPLETED|Overall Study||7
5059417|NCT01894230|12450806|P2|COMPLETED|Overall Study||69
5059418|NCT01894230|12450807|P1|COMPLETED|Overall Study||76
5059419|NCT01894230|12450806|P2|STARTED|Overall Study||76
5059420|NCT01894230|12450807|P1|STARTED|Overall Study||83
5059421|NCT01894178|12450833|P2|NOT COMPLETED|Overall Study||0
5059422|NCT01894178|12450834|P1|NOT COMPLETED|Overall Study||0
5059423|NCT01894178|12450833|P2|COMPLETED|Overall Study||30
5059424|NCT01894178|12450834|P1|COMPLETED|Overall Study||30
5059425|NCT01894178|12450833|P2|STARTED|Overall Study||30
5059426|NCT01894178|12450834|P1|STARTED|Overall Study||30
5059427|NCT01894152|12450842|P1|NOT COMPLETED|Overall Study||151
5059428|NCT01894152|12450842|P1|COMPLETED|Overall Study||1851
5059429|NCT01894152|12450842|P1|STARTED|Overall Study||2002
5059430|NCT01894100|12450885|P2|NOT COMPLETED|Overall Study||1
5059431|NCT01894100|12450886|P1|NOT COMPLETED|Overall Study||3
5059432|NCT01894100|12450885|P2|COMPLETED|Overall Study||14
5059433|NCT01894100|12450886|P1|COMPLETED|Overall Study||12
5059434|NCT01894100|12450885|P2|STARTED|Overall Study||15
5059435|NCT01894100|12450886|P1|STARTED|Overall Study||15
5059436|NCT01894087|12450896|P2|NOT COMPLETED|Overall Study||0
5059437|NCT01894087|12450897|P1|NOT COMPLETED|Overall Study||6
5059438|NCT01894087|12450896|P2|COMPLETED|Overall Study||102
5059439|NCT01894087|12450897|P1|COMPLETED|Overall Study||96
5059440|NCT01894087|12450896|P2|STARTED|Overall Study||102
5059441|NCT01894087|12450897|P1|STARTED|Overall Study||102
5059442|NCT01894022|12450911|P2|NOT COMPLETED|Overall Study||10
5059443|NCT01894022|12450912|P1|NOT COMPLETED|Overall Study||9
5059444|NCT01894022|12450911|P2|COMPLETED|Overall Study||0
5059445|NCT01894022|12450912|P1|COMPLETED|Overall Study||0
5059446|NCT01894022|12450911|P2|STARTED|Overall Study||10
5059447|NCT01894022|12450912|P1|STARTED|Overall Study||9
5059448|NCT01893983|12450966|P2|NOT COMPLETED|Overall Study||6
5059449|NCT01893983|12450967|P1|NOT COMPLETED|Overall Study||10
5059450|NCT01893983|12450966|P2|COMPLETED|Overall Study||134
5059451|NCT01893983|12450967|P1|COMPLETED|Overall Study||130
5059452|NCT01893983|12450966|P2|STARTED|Overall Study||140
5059453|NCT01893983|12450967|P1|STARTED|Overall Study||140
5059454|NCT01893905|12450981|P2|NOT COMPLETED|Overall Study||14
5059455|NCT01893905|12450982|P1|NOT COMPLETED|Overall Study||25
5059456|NCT01893905|12450981|P2|COMPLETED|Overall Study||64
5059457|NCT01893905|12450982|P1|COMPLETED|Overall Study||55
5059458|NCT01893905|12450981|P2|STARTED|Overall Study||78
5059459|NCT01893905|12450982|P1|STARTED|Overall Study||80
5059460|NCT01893879|12450990|P2|NOT COMPLETED|Overall Study||3
5059461|NCT01893879|12450991|P1|NOT COMPLETED|Overall Study||2
5059462|NCT01893879|12450990|P2|COMPLETED|Overall Study||4
5059463|NCT01893879|12450991|P1|COMPLETED|Overall Study||5
5059464|NCT01893879|12450990|P2|STARTED|Overall Study||7
5059465|NCT01893879|12450991|P1|STARTED|Overall Study||7
5059466|NCT01893827|12450999|P2|NOT COMPLETED|Overall Study||26
5059467|NCT01893827|12451000|P1|NOT COMPLETED|Overall Study||19
5059468|NCT01893827|12450999|P2|COMPLETED|Overall Study||94
5059469|NCT01893827|12451000|P1|COMPLETED|Overall Study||98
5059470|NCT01893827|12450999|P2|STARTED|Overall Study||120
5059471|NCT01893827|12451000|P1|STARTED|Overall Study||117
5059472|NCT01893801|12451006|P1|NOT COMPLETED|Overall Study||0
5059473|NCT01893801|12451006|P1|COMPLETED|Overall Study||25
5059474|NCT01893801|12451006|P1|STARTED|Overall Study||25
5059475|NCT01893632|12451016|P2|NOT COMPLETED|Overall Study||0
5059476|NCT01893632|12451017|P1|NOT COMPLETED|Overall Study||0
5059477|NCT01893632|12451016|P2|COMPLETED|Overall Study||1
5059478|NCT01893632|12451017|P1|COMPLETED|Overall Study||1
5059479|NCT01893632|12451016|P2|STARTED|Overall Study||1
5059480|NCT01893632|12451017|P1|STARTED|Overall Study||1
5059481|NCT01893567|12451023|P1|NOT COMPLETED|Overall Study||0
5059482|NCT01893567|12451023|P1|COMPLETED|Overall Study||28
5059483|NCT01893567|12451023|P1|STARTED|Overall Study||28
5059484|NCT01893411|12451030|P3|NOT COMPLETED|Overall Study||9
5059485|NCT01893411|12451031|P2|NOT COMPLETED|Overall Study||7
5059486|NCT01893411|12451032|P1|NOT COMPLETED|Overall Study||17
5059487|NCT01893411|12451030|P3|COMPLETED|Overall Study||69
5059488|NCT01893411|12451031|P2|COMPLETED|Overall Study||70
5059489|NCT01893411|12451032|P1|COMPLETED|Overall Study||139
5059490|NCT01893411|12451030|P3|STARTED|Overall Study||78
5059491|NCT01893411|12451031|P2|STARTED|Overall Study||77
5059492|NCT01893411|12451032|P1|STARTED|Overall Study||156
5059493|NCT01893372|12451096|P2|NOT COMPLETED|Overall Study||0
5059494|NCT01893372|12451097|P1|NOT COMPLETED|Overall Study||0
5059495|NCT01893372|12451096|P2|COMPLETED|Overall Study||22
5059496|NCT01893372|12451097|P1|COMPLETED|Overall Study||7
5059497|NCT01893372|12451096|P2|STARTED|Overall Study||22
5059498|NCT01893372|12451097|P1|STARTED|Overall Study||7
5059499|NCT01893359|12451112|P3|NOT COMPLETED|Overall Study||0
5059500|NCT01893359|12451113|P2|NOT COMPLETED|Overall Study||0
5059501|NCT01893359|12451114|P1|NOT COMPLETED|Overall Study||0
5059502|NCT01893359|12451112|P3|COMPLETED|Overall Study||0
5059503|NCT01893359|12451113|P2|COMPLETED|Overall Study||2
5059504|NCT01893359|12451114|P1|COMPLETED|Overall Study||0
5059505|NCT01893359|12451112|P3|STARTED|Overall Study||0
5059506|NCT01893359|12451113|P2|STARTED|Overall Study||2
5059507|NCT01893359|12451114|P1|STARTED|Overall Study||0
5059508|NCT01893346|12451129|P4|NOT COMPLETED|Overall Study||0
5059509|NCT01893346|12451130|P3|NOT COMPLETED|Overall Study||0
5059510|NCT01893346|12451131|P2|NOT COMPLETED|Overall Study||1
5059511|NCT01893346|12451132|P1|NOT COMPLETED|Overall Study||3
5059512|NCT01893346|12451129|P4|COMPLETED|Overall Study||8
5059513|NCT01893346|12451130|P3|COMPLETED|Overall Study||8
5059514|NCT01893346|12451131|P2|COMPLETED|Overall Study||7
5059515|NCT01893346|12451132|P1|COMPLETED|Overall Study||8
5059516|NCT01893346|12451129|P4|Patients Who Received Full Infusion|Overall Study||8
5059517|NCT01893346|12451130|P3|Patients Who Received Full Infusion|Overall Study||8
5059518|NCT01893346|12451131|P2|Patients Who Received Full Infusion|Overall Study||8
5059519|NCT01893346|12451132|P1|Patients Who Received Full Infusion|Overall Study||8
5059520|NCT01893346|12451129|P4|STARTED|Overall Study||8
5059521|NCT01893346|12451130|P3|STARTED|Overall Study||8
5059522|NCT01893346|12451131|P2|STARTED|Overall Study||8
5059523|NCT01893346|12451132|P1|STARTED|Overall Study||11
5059524|NCT01893281|12451146|P1|NOT COMPLETED|Overall Study||3
5059525|NCT01893281|12451146|P1|COMPLETED|Overall Study||75
5059526|NCT01893281|12451146|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
5059527|NCT01893281|12451146|P1|STARTED|Overall Study||78
5059528|NCT01893203|12451153|P1|NOT COMPLETED|Overall Study||1
5059529|NCT01893203|12451153|P1|COMPLETED|Overall Study||13
5059530|NCT01893203|12451153|P1|STARTED|Overall Study||14
5059531|NCT01892865|12451162|P2|NOT COMPLETED|Overall Study||0
5059532|NCT01892865|12451163|P1|NOT COMPLETED|Overall Study||0
5059533|NCT01892865|12451162|P2|COMPLETED|Overall Study||379
5059534|NCT01892865|12451163|P1|COMPLETED|Overall Study||356
5059535|NCT01892865|12451162|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
5059536|NCT01892865|12451163|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
5059537|NCT01892722|12451177|P2|NOT COMPLETED|Overall Study||20
5059538|NCT01892722|12451178|P1|NOT COMPLETED|Overall Study||7
5059539|NCT01892722|12451177|P2|COMPLETED|Overall Study||88
5059540|NCT01892722|12451178|P1|COMPLETED|Overall Study||100
5059541|NCT01892722|12451177|P2|Full Analysis Set|Overall Study||107
5059542|NCT01892722|12451178|P1|Full Analysis Set|Overall Study||107
5059543|NCT01892722|12451177|P2|STARTED|Overall Study||108
5059544|NCT01892722|12451178|P1|STARTED|Overall Study||107
5059545|NCT01892709|12451184|P1|NOT COMPLETED|Overall Study||0
5059546|NCT01892709|12451184|P1|COMPLETED|Overall Study||215
5059547|NCT01892709|12451184|P1|STARTED|Overall Study||215
5059548|NCT01892657|12451194|P1|NOT COMPLETED|Overall Study||18
5059549|NCT01892657|12451194|P1|COMPLETED|Overall Study||110
5059550|NCT01892657|12451194|P1|STARTED|Overall Study||128
5059551|NCT01892540|12451213|P3|NOT COMPLETED|Overall Study||3
5059552|NCT01892540|12451214|P2|NOT COMPLETED|Overall Study||0
5059553|NCT01892540|12451215|P1|NOT COMPLETED|Overall Study||0
5059554|NCT01892540|12451213|P3|COMPLETED|Overall Study||25
5059555|NCT01892540|12451214|P2|COMPLETED|Overall Study||0
5059556|NCT01892540|12451215|P1|COMPLETED|Overall Study||15
5059557|NCT01892540|12451213|P3|STARTED|Overall Study||28
5059558|NCT01892540|12451214|P2|STARTED|Overall Study||0
5059559|NCT01892540|12451215|P1|STARTED|Overall Study||15
5059560|NCT01892436|12451236|P4|NOT COMPLETED|Overall Study||14
5059561|NCT01892436|12451237|P3|NOT COMPLETED|Overall Study||11
5059562|NCT01892436|12451238|P2|NOT COMPLETED|Overall Study||29
5059563|NCT01892436|12451239|P1|NOT COMPLETED|Overall Study||23
5059564|NCT01892436|12451236|P4|COMPLETED|Overall Study||61
5059565|NCT01892436|12451237|P3|COMPLETED|Overall Study||63
5059566|NCT01892436|12451238|P2|COMPLETED|Overall Study||132
5059567|NCT01892436|12451239|P1|COMPLETED|Overall Study||124
5059568|NCT01892436|12451236|P4|STARTED|Overall Study||75
5059569|NCT01892436|12451237|P3|STARTED|Overall Study||74
5059570|NCT01892436|12451238|P2|STARTED|Overall Study||161
5059571|NCT01892436|12451239|P1|STARTED|Overall Study||147
5059572|NCT01892345|12451279|P2|NOT COMPLETED|Overall Study||3
5059573|NCT01892345|12451280|P1|NOT COMPLETED|Overall Study||16
5059574|NCT01892345|12451279|P2|COMPLETED|Overall Study||44
5059575|NCT01892345|12451280|P1|COMPLETED|Overall Study||80
5059576|NCT01892345|12451279|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
5059577|NCT01892345|12451280|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
5059578|NCT01892345|12451279|P2|STARTED|Overall Study||47
5059579|NCT01892345|12451280|P1|STARTED|Overall Study||96
5059580|NCT01892306|12451300|P2|NOT COMPLETED|Overall Study||6
5059581|NCT01892306|12451301|P1|NOT COMPLETED|Overall Study||5
5059582|NCT01892306|12451300|P2|COMPLETED|Overall Study||10
5059583|NCT01892306|12451301|P1|COMPLETED|Overall Study||8
5059584|NCT01892306|12451300|P2|STARTED|Overall Study||16
5059585|NCT01892306|12451301|P1|STARTED|Overall Study||13
5059586|NCT01892293|12451321|P1|NOT COMPLETED|Overall Study||4
5059587|NCT01892293|12451321|P1|COMPLETED|Overall Study||2
5059588|NCT01892293|12451321|P1|Received T-cell|Overall Study||2
5059589|NCT01892293|12451321|P1|STARTED|Overall Study||6
5059590|NCT01892267|12451329|P2|NOT COMPLETED|Overall Study||0
5059591|NCT01892267|12451330|P1|NOT COMPLETED|Overall Study||0
5059592|NCT01892267|12451329|P2|COMPLETED|Overall Study||10
5059593|NCT01892267|12451330|P1|COMPLETED|Overall Study||9
5059594|NCT01892267|12451329|P2|STARTED|Overall Study||10
5059595|NCT01892267|12451330|P1|STARTED|Overall Study||9
5059596|NCT01892189|12451365|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059597|NCT01892189|12451366|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059598|NCT01892189|12451367|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059599|NCT01892189|12451368|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059600|NCT01892189|12451369|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059601|NCT01892189|12451370|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059602|NCT01892189|12451371|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059603|NCT01892189|12451372|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059604|NCT01892189|12451373|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
5059605|NCT01892189|12451365|P9|COMPLETED|Third Intervention Period (1 Day)||1
5059606|NCT01892189|12451366|P8|COMPLETED|Third Intervention Period (1 Day)||3
5059607|NCT01892189|12451367|P7|COMPLETED|Third Intervention Period (1 Day)||2
5059608|NCT01892189|12451368|P6|COMPLETED|Third Intervention Period (1 Day)||2
5059609|NCT01892189|12451369|P5|COMPLETED|Third Intervention Period (1 Day)||3
5059610|NCT01892189|12451370|P4|COMPLETED|Third Intervention Period (1 Day)||2
5059611|NCT01892189|12451371|P3|COMPLETED|Third Intervention Period (1 Day)||1
5059612|NCT01892189|12451372|P2|COMPLETED|Third Intervention Period (1 Day)||3
5059613|NCT01892189|12451373|P1|COMPLETED|Third Intervention Period (1 Day)||3
5059614|NCT01892189|12451365|P9|STARTED|Third Intervention Period (1 Day)||1
5059615|NCT01892189|12451366|P8|STARTED|Third Intervention Period (1 Day)||3
5059616|NCT01892189|12451367|P7|STARTED|Third Intervention Period (1 Day)||2
5059617|NCT01892189|12451368|P6|STARTED|Third Intervention Period (1 Day)||2
5059618|NCT01892189|12451369|P5|STARTED|Third Intervention Period (1 Day)||3
5059619|NCT01892189|12451370|P4|STARTED|Third Intervention Period (1 Day)||2
5059620|NCT01892189|12451371|P3|STARTED|Third Intervention Period (1 Day)||1
5059621|NCT01892189|12451372|P2|STARTED|Third Intervention Period (1 Day)||3
5059622|NCT01892189|12451373|P1|STARTED|Third Intervention Period (1 Day)||3
5059623|NCT01892189|12451365|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059624|NCT01892189|12451366|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059625|NCT01892189|12451367|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059626|NCT01892189|12451368|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059627|NCT01892189|12451369|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059628|NCT01892189|12451370|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059629|NCT01892189|12451371|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059630|NCT01892189|12451372|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059631|NCT01892189|12451373|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5059632|NCT01892189|12451365|P9|COMPLETED|Washout Period 2 (7 Days)||1
5059633|NCT01892189|12451366|P8|COMPLETED|Washout Period 2 (7 Days)||3
5059634|NCT01892189|12451367|P7|COMPLETED|Washout Period 2 (7 Days)||2
5059635|NCT01892189|12451368|P6|COMPLETED|Washout Period 2 (7 Days)||2
5059636|NCT01892189|12451369|P5|COMPLETED|Washout Period 2 (7 Days)||3
5059637|NCT01892189|12451370|P4|COMPLETED|Washout Period 2 (7 Days)||2
5059638|NCT01892189|12451371|P3|COMPLETED|Washout Period 2 (7 Days)||1
5059639|NCT01892189|12451372|P2|COMPLETED|Washout Period 2 (7 Days)||3
5059640|NCT01892189|12451373|P1|COMPLETED|Washout Period 2 (7 Days)||3
5059641|NCT01892189|12451365|P9|STARTED|Washout Period 2 (7 Days)||1
5059642|NCT01892189|12451366|P8|STARTED|Washout Period 2 (7 Days)||3
5059643|NCT01892189|12451367|P7|STARTED|Washout Period 2 (7 Days)||2
5059644|NCT01892189|12451368|P6|STARTED|Washout Period 2 (7 Days)||2
5059645|NCT01892189|12451369|P5|STARTED|Washout Period 2 (7 Days)||3
5059646|NCT01892189|12451370|P4|STARTED|Washout Period 2 (7 Days)||2
5059647|NCT01892189|12451371|P3|STARTED|Washout Period 2 (7 Days)||1
5059648|NCT01892189|12451372|P2|STARTED|Washout Period 2 (7 Days)||3
5059649|NCT01892189|12451373|P1|STARTED|Washout Period 2 (7 Days)||3
5059650|NCT01892189|12451365|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059651|NCT01892189|12451366|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059652|NCT01892189|12451367|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059653|NCT01892189|12451368|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059654|NCT01892189|12451369|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059655|NCT01892189|12451370|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059656|NCT01892189|12451371|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059657|NCT01892189|12451372|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059658|NCT01892189|12451373|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
5059659|NCT01892189|12451365|P9|COMPLETED|Second Intervention Period (1 Day)||1
5059660|NCT01892189|12451366|P8|COMPLETED|Second Intervention Period (1 Day)||3
5059661|NCT01892189|12451367|P7|COMPLETED|Second Intervention Period (1 Day)||2
5059662|NCT01892189|12451368|P6|COMPLETED|Second Intervention Period (1 Day)||2
5059663|NCT01892189|12451369|P5|COMPLETED|Second Intervention Period (1 Day)||3
5059664|NCT01892189|12451370|P4|COMPLETED|Second Intervention Period (1 Day)||2
5059665|NCT01892189|12451371|P3|COMPLETED|Second Intervention Period (1 Day)||1
5059666|NCT01892189|12451372|P2|COMPLETED|Second Intervention Period (1 Day)||3
5059667|NCT01892189|12451373|P1|COMPLETED|Second Intervention Period (1 Day)||3
5059668|NCT01892189|12451365|P9|STARTED|Second Intervention Period (1 Day)||1
5059669|NCT01892189|12451366|P8|STARTED|Second Intervention Period (1 Day)||3
5059670|NCT01892189|12451367|P7|STARTED|Second Intervention Period (1 Day)||2
5059671|NCT01892189|12451368|P6|STARTED|Second Intervention Period (1 Day)||2
5059672|NCT01892189|12451369|P5|STARTED|Second Intervention Period (1 Day)||3
5059673|NCT01892189|12451370|P4|STARTED|Second Intervention Period (1 Day)||2
5059674|NCT01892189|12451371|P3|STARTED|Second Intervention Period (1 Day)||1
5059675|NCT01892189|12451372|P2|STARTED|Second Intervention Period (1 Day)||3
5059676|NCT01892189|12451373|P1|STARTED|Second Intervention Period (1 Day)||3
5059677|NCT01892189|12451365|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
5059678|NCT01892189|12451366|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
5059679|NCT01892189|12451367|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
5059680|NCT01892189|12451368|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
5059681|NCT01892189|12451369|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5059682|NCT01892189|12451370|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
5059683|NCT01892189|12451371|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
5059684|NCT01892189|12451372|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5059685|NCT01892189|12451373|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5059686|NCT01892189|12451365|P9|COMPLETED|Washout Period 1 (7 Days)||1
5059687|NCT01892189|12451366|P8|COMPLETED|Washout Period 1 (7 Days)||3
5059688|NCT01892189|12451367|P7|COMPLETED|Washout Period 1 (7 Days)||2
5059689|NCT01892189|12451368|P6|COMPLETED|Washout Period 1 (7 Days)||2
5059690|NCT01892189|12451369|P5|COMPLETED|Washout Period 1 (7 Days)||3
5059691|NCT01892189|12451370|P4|COMPLETED|Washout Period 1 (7 Days)||2
5059692|NCT01892189|12451371|P3|COMPLETED|Washout Period 1 (7 Days)||1
5059693|NCT01892189|12451372|P2|COMPLETED|Washout Period 1 (7 Days)||3
5059694|NCT01892189|12451373|P1|COMPLETED|Washout Period 1 (7 Days)||3
5059695|NCT01892189|12451365|P9|STARTED|Washout Period 1 (7 Days)||3
5059696|NCT01892189|12451366|P8|STARTED|Washout Period 1 (7 Days)||3
5059697|NCT01892189|12451367|P7|STARTED|Washout Period 1 (7 Days)||3
5059698|NCT01892189|12451368|P6|STARTED|Washout Period 1 (7 Days)||3
5059699|NCT01892189|12451369|P5|STARTED|Washout Period 1 (7 Days)||3
5059700|NCT01892189|12451370|P4|STARTED|Washout Period 1 (7 Days)||3
5059701|NCT01892189|12451371|P3|STARTED|Washout Period 1 (7 Days)||3
5059702|NCT01892189|12451372|P2|STARTED|Washout Period 1 (7 Days)||3
5059703|NCT01892189|12451373|P1|STARTED|Washout Period 1 (7 Days)||3
5059704|NCT01892189|12451365|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
5059705|NCT01892189|12451366|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
5059706|NCT01892189|12451367|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
5059707|NCT01892189|12451368|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
5059708|NCT01892189|12451369|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
5059709|NCT01892189|12451370|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
5059710|NCT01892189|12451371|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
5059711|NCT01892189|12451372|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
5059712|NCT01892189|12451373|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
5059713|NCT01892189|12451365|P9|COMPLETED|First Intervention Period (1 Day)||3
5059714|NCT01892189|12451366|P8|COMPLETED|First Intervention Period (1 Day)||3
5059715|NCT01892189|12451367|P7|COMPLETED|First Intervention Period (1 Day)||3
5059716|NCT01892189|12451368|P6|COMPLETED|First Intervention Period (1 Day)||3
5059717|NCT01892189|12451369|P5|COMPLETED|First Intervention Period (1 Day)||3
5059718|NCT01892189|12451370|P4|COMPLETED|First Intervention Period (1 Day)||3
5059719|NCT01892189|12451371|P3|COMPLETED|First Intervention Period (1 Day)||3
5059720|NCT01892189|12451372|P2|COMPLETED|First Intervention Period (1 Day)||3
5059721|NCT01892189|12451373|P1|COMPLETED|First Intervention Period (1 Day)||3
5059722|NCT01892189|12451365|P9|STARTED|First Intervention Period (1 Day)||3
5059723|NCT01892189|12451366|P8|STARTED|First Intervention Period (1 Day)||3
5059724|NCT01892189|12451367|P7|STARTED|First Intervention Period (1 Day)||3
5059725|NCT01892189|12451368|P6|STARTED|First Intervention Period (1 Day)||3
5059726|NCT01892189|12451369|P5|STARTED|First Intervention Period (1 Day)||3
5059727|NCT01892189|12451370|P4|STARTED|First Intervention Period (1 Day)||3
5059728|NCT01892189|12451371|P3|STARTED|First Intervention Period (1 Day)||3
5059729|NCT01892189|12451372|P2|STARTED|First Intervention Period (1 Day)||3
5059730|NCT01892189|12451373|P1|STARTED|First Intervention Period (1 Day)||3
5059731|NCT01892163|12451415|P2|NOT COMPLETED|Overall Study||1
5059732|NCT01892163|12451416|P1|NOT COMPLETED|Overall Study||2
5059733|NCT01892163|12451415|P2|COMPLETED|Overall Study||49
5059734|NCT01892163|12451416|P1|COMPLETED|Overall Study||48
5059735|NCT01892163|12451415|P2|STARTED|Overall Study||50
5059736|NCT01892163|12451416|P1|STARTED|Overall Study||50
5059737|NCT01892020|12451428|P2|NOT COMPLETED|Period 2||0
5059738|NCT01892020|12451429|P1|NOT COMPLETED|Period 2||1
5059739|NCT01892020|12451428|P2|COMPLETED|Period 2||74
5059740|NCT01892020|12451429|P1|COMPLETED|Period 2||77
5059741|NCT01892020|12451428|P2|STARTED|Period 2||74
5059742|NCT01892020|12451429|P1|STARTED|Period 2||78
5059743|NCT01892020|12451428|P2|NOT COMPLETED|Period 1||6
5059744|NCT01892020|12451429|P1|NOT COMPLETED|Period 1||3
5059745|NCT01892020|12451428|P2|COMPLETED|Period 1||74
5059746|NCT01892020|12451429|P1|COMPLETED|Period 1||78
5059747|NCT01892020|12451428|P2|STARTED|Period 1||80
5059748|NCT01892020|12451429|P1|STARTED|Period 1||81
5059749|NCT01891994|12451447|P1|NOT COMPLETED|Overall Study||0
5059750|NCT01891994|12451447|P1|COMPLETED|Overall Study||40
5059751|NCT01891994|12451447|P1|STARTED|Overall Study||40
5059752|NCT01891968|12451451|P1|NOT COMPLETED|Overall Study||0
5059753|NCT01891968|12451451|P1|COMPLETED|Overall Study||15
5059754|NCT01891968|12451451|P1|STARTED|Overall Study||15
5059755|NCT01891890|12451458|P3|NOT COMPLETED|Overall Study||7
5059756|NCT01891890|12451459|P2|NOT COMPLETED|Overall Study||3
5059757|NCT01891890|12451460|P1|NOT COMPLETED|Overall Study||7
5059758|NCT01891890|12451458|P3|COMPLETED|Overall Study||14
5059759|NCT01891890|12451459|P2|COMPLETED|Overall Study||24
5059760|NCT01891890|12451460|P1|COMPLETED|Overall Study||17
5059761|NCT01891890|12451458|P3|STARTED|Overall Study||21
5059762|NCT01891890|12451459|P2|STARTED|Overall Study||27
5059763|NCT01891890|12451460|P1|STARTED|Overall Study||24
5059764|NCT01891864|12451503|P6|NOT COMPLETED|Extension Period||0
5059765|NCT01891864|12451504|P5|NOT COMPLETED|Extension Period||7
5059766|NCT01891864|12451505|P4|NOT COMPLETED|Extension Period||5
5059767|NCT01891864|12451506|P3|NOT COMPLETED|Extension Period||8
5059768|NCT01891864|12451507|P2|NOT COMPLETED|Extension Period||0
5059769|NCT01891864|12451508|P1|NOT COMPLETED|Extension Period||0
5059770|NCT01891864|12451503|P6|COMPLETED|Extension Period||90
5059771|NCT01891864|12451504|P5|COMPLETED|Extension Period||88
5059772|NCT01891864|12451505|P4|COMPLETED|Extension Period||137
5059773|NCT01891864|12451506|P3|COMPLETED|Extension Period||132
5059774|NCT01891864|12451507|P2|COMPLETED|Extension Period||0
5059775|NCT01891864|12451508|P1|COMPLETED|Extension Period||0
5059776|NCT01891864|12451503|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
5059777|NCT01891864|12451504|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
5059778|NCT01891864|12451505|P4|STARTED|Extension Period||142
5059779|NCT01891864|12451506|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
5059780|NCT01891864|12451507|P2|STARTED|Extension Period||0
5059781|NCT01891864|12451508|P1|STARTED|Extension Period||0
5059782|NCT01891864|12451503|P6|NOT COMPLETED|Treatment Period 2||5
5059783|NCT01891864|12451504|P5|NOT COMPLETED|Treatment Period 2||4
5059784|NCT01891864|12451505|P4|NOT COMPLETED|Treatment Period 2||9
5059785|NCT01891864|12451506|P3|NOT COMPLETED|Treatment Period 2||7
5059786|NCT01891864|12451507|P2|NOT COMPLETED|Treatment Period 2||0
5059787|NCT01891864|12451508|P1|NOT COMPLETED|Treatment Period 2||0
5059788|NCT01891864|12451503|P6|COMPLETED|Treatment Period 2||91
5059789|NCT01891864|12451504|P5|COMPLETED|Treatment Period 2||96
5059790|NCT01891864|12451505|P4|COMPLETED|Treatment Period 2||142
5059791|NCT01891864|12451506|P3|COMPLETED|Treatment Period 2||143
5059792|NCT01891864|12451507|P2|COMPLETED|Treatment Period 2||0
5059793|NCT01891864|12451508|P1|COMPLETED|Treatment Period 2||0
5059794|NCT01891864|12451503|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
5059795|NCT01891864|12451504|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
5059796|NCT01891864|12451505|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
5059797|NCT01891864|12451506|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
5059798|NCT01891864|12451507|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
5059799|NCT01891864|12451508|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
5059800|NCT01891864|12451503|P6|NOT COMPLETED|Treatment Period 1||0
5059801|NCT01891864|12451504|P5|NOT COMPLETED|Treatment Period 1||0
5059802|NCT01891864|12451505|P4|NOT COMPLETED|Treatment Period 1||0
5059803|NCT01891864|12451506|P3|NOT COMPLETED|Treatment Period 1||0
5059804|NCT01891864|12451507|P2|NOT COMPLETED|Treatment Period 1||12
5059805|NCT01891864|12451508|P1|NOT COMPLETED|Treatment Period 1||8
5059806|NCT01891864|12451503|P6|COMPLETED|Treatment Period 1||0
5059807|NCT01891864|12451504|P5|COMPLETED|Treatment Period 1||0
5059808|NCT01891864|12451505|P4|COMPLETED|Treatment Period 1||0
5059809|NCT01891864|12451506|P3|COMPLETED|Treatment Period 1||0
5059810|NCT01891864|12451507|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
5059811|NCT01891864|12451508|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
5059812|NCT01891864|12451503|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5059813|NCT01891864|12451504|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5059814|NCT01891864|12451505|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5059815|NCT01891864|12451506|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
5059816|NCT01891864|12451507|P2|STARTED|Treatment Period 1||267
5059817|NCT01891864|12451508|P1|STARTED|Treatment Period 1||264
5059818|NCT01891734|12451530|P2|NOT COMPLETED|Overall Study||3
5059819|NCT01891734|12451531|P1|NOT COMPLETED|Overall Study||3
5059820|NCT01891734|12451530|P2|COMPLETED|Overall Study||13
5059821|NCT01891734|12451531|P1|COMPLETED|Overall Study||14
5059822|NCT01891734|12451530|P2|STARTED|Overall Study||16
5059823|NCT01891734|12451531|P1|STARTED|Overall Study||17
5059824|NCT01891721|12451544|P3|NOT COMPLETED|Overall Study||1
5059825|NCT01891721|12451545|P2|NOT COMPLETED|Overall Study||5
5059826|NCT01891721|12451546|P1|NOT COMPLETED|Overall Study||10
5059827|NCT01891721|12451544|P3|COMPLETED|Overall Study||19
5059828|NCT01891721|12451545|P2|COMPLETED|Overall Study||35
5059829|NCT01891721|12451546|P1|COMPLETED|Overall Study||29
5059830|NCT01891721|12451544|P3|STARTED|Overall Study||20
5059831|NCT01891721|12451545|P2|STARTED|Overall Study||40
5059832|NCT01891721|12451546|P1|STARTED|Overall Study||39
5059833|NCT01891669|12451570|P10|NOT COMPLETED|Overall Study||2
5059834|NCT01891669|12451571|P9|NOT COMPLETED|Overall Study||1
5059835|NCT01891669|12451572|P8|NOT COMPLETED|Overall Study||4
5059836|NCT01891669|12451573|P7|NOT COMPLETED|Overall Study||1
5059837|NCT01891669|12451574|P6|NOT COMPLETED|Overall Study||0
5059838|NCT01891669|12451575|P5|NOT COMPLETED|Overall Study||0
5059839|NCT01891669|12451576|P4|NOT COMPLETED|Overall Study||0
5059840|NCT01891669|12451577|P3|NOT COMPLETED|Overall Study||0
5059841|NCT01891669|12451578|P2|NOT COMPLETED|Overall Study||1
5059842|NCT01891669|12451579|P1|NOT COMPLETED|Overall Study||2
5059843|NCT01891669|12451570|P10|COMPLETED|Overall Study||1
5059844|NCT01891669|12451571|P9|COMPLETED|Overall Study||2
5059845|NCT01891669|12451572|P8|COMPLETED|Overall Study||2
5059846|NCT01891669|12451573|P7|COMPLETED|Overall Study||1
5059847|NCT01891669|12451574|P6|COMPLETED|Overall Study||2
5059848|NCT01891669|12451575|P5|COMPLETED|Overall Study||2
5059849|NCT01891669|12451576|P4|COMPLETED|Overall Study||2
5059850|NCT01891669|12451577|P3|COMPLETED|Overall Study||2
5059851|NCT01891669|12451578|P2|COMPLETED|Overall Study||1
5059852|NCT01891669|12451579|P1|COMPLETED|Overall Study||0
5059853|NCT01891669|12451570|P10|STARTED|Overall Study||3
5059854|NCT01891669|12451571|P9|STARTED|Overall Study||3
5059855|NCT01891669|12451572|P8|STARTED|Overall Study||6
5059856|NCT01891669|12451573|P7|STARTED|Overall Study||2
5059857|NCT01891669|12451574|P6|STARTED|Overall Study||2
5059858|NCT01891669|12451575|P5|STARTED|Overall Study||2
5059859|NCT01891669|12451576|P4|STARTED|Overall Study||2
5059860|NCT01891669|12451577|P3|STARTED|Overall Study||2
5059861|NCT01891669|12451578|P2|STARTED|Overall Study||2
5059862|NCT01891669|12451579|P1|STARTED|Overall Study||2
5059863|NCT01891357|12451730|P1|NOT COMPLETED|Overall Study||3
5059864|NCT01891357|12451730|P1|COMPLETED|Overall Study||61
5059865|NCT01891357|12451730|P1|STARTED|Overall Study||64
5059866|NCT01891331|12451741|P4|NOT COMPLETED|Overall Study||2
5059867|NCT01891331|12451742|P3|NOT COMPLETED|Overall Study||1
5059868|NCT01891331|12451743|P2|NOT COMPLETED|Overall Study||2
5059869|NCT01891331|12451744|P1|NOT COMPLETED|Overall Study||2
5059870|NCT01891331|12451741|P4|COMPLETED|Overall Study||13
5059871|NCT01891331|12451742|P3|COMPLETED|Overall Study||13
5059872|NCT01891331|12451743|P2|COMPLETED|Overall Study||10
5059873|NCT01891331|12451744|P1|COMPLETED|Overall Study||12
5059874|NCT01891331|12451741|P4|STARTED|Overall Study||15
5059875|NCT01891331|12451742|P3|STARTED|Overall Study||14
5059876|NCT01891331|12451743|P2|STARTED|Overall Study||12
5059877|NCT01891331|12451744|P1|STARTED|Overall Study||14
5059878|NCT01891305|12451758|P4|NOT COMPLETED|Overall Study||0
5059879|NCT01891305|12451759|P3|NOT COMPLETED|Overall Study||3
5059880|NCT01891305|12451760|P2|NOT COMPLETED|Overall Study||1
5059881|NCT01891305|12451761|P1|NOT COMPLETED|Overall Study||3
5059882|NCT01891305|12451758|P4|COMPLETED|Overall Study||12
5059883|NCT01891305|12451759|P3|COMPLETED|Overall Study||11
5059884|NCT01891305|12451760|P2|COMPLETED|Overall Study||11
5059885|NCT01891305|12451761|P1|COMPLETED|Overall Study||9
5059886|NCT01891305|12451758|P4|STARTED|Overall Study||12
5059887|NCT01891305|12451759|P3|STARTED|Overall Study||14
5059888|NCT01891305|12451760|P2|STARTED|Overall Study||12
5059889|NCT01891305|12451761|P1|STARTED|Overall Study||12
5059890|NCT01890967|12451777|P6|NOT COMPLETED|Overall Study||13
5059891|NCT01890967|12451778|P5|NOT COMPLETED|Overall Study||10
5059892|NCT01890967|12451779|P4|NOT COMPLETED|Overall Study||11
5059893|NCT01890967|12451780|P3|NOT COMPLETED|Overall Study||10
5059894|NCT01890967|12451781|P2|NOT COMPLETED|Overall Study||11
5059895|NCT01890967|12451782|P1|NOT COMPLETED|Overall Study||10
5059896|NCT01890967|12451777|P6|COMPLETED|Overall Study||75
5059897|NCT01890967|12451778|P5|COMPLETED|Overall Study||77
5059898|NCT01890967|12451779|P4|COMPLETED|Overall Study||77
5059899|NCT01890967|12451780|P3|COMPLETED|Overall Study||78
5059900|NCT01890967|12451781|P2|COMPLETED|Overall Study||77
5059901|NCT01890967|12451782|P1|COMPLETED|Overall Study||78
5059902|NCT01890967|12451777|P6|Received at Least One Dose of Study Drug|Overall Study||87
5059903|NCT01890967|12451778|P5|Received at Least One Dose of Study Drug|Overall Study||86
5059904|NCT01890967|12451779|P4|Received at Least One Dose of Study Drug|Overall Study||86
5059905|NCT01890967|12451780|P3|Received at Least One Dose of Study Drug|Overall Study||86
5059906|NCT01890967|12451781|P2|Received at Least One Dose of Study Drug|Overall Study||87
5059907|NCT01890967|12451782|P1|Received at Least One Dose of Study Drug|Overall Study||87
5059908|NCT01890967|12451777|P6|STARTED|Overall Study||88
5059909|NCT01890967|12451778|P5|STARTED|Overall Study||87
5059910|NCT01890967|12451779|P4|STARTED|Overall Study||88
5059911|NCT01890967|12451780|P3|STARTED|Overall Study||88
5059912|NCT01890967|12451781|P2|STARTED|Overall Study||88
5059913|NCT01890967|12451782|P1|STARTED|Overall Study||88
5059914|NCT01890954|12451851|P2|NOT COMPLETED|Overall Study||0
5059915|NCT01890954|12451852|P1|NOT COMPLETED|Overall Study||1
5059916|NCT01890954|12451851|P2|COMPLETED|Overall Study||8
5059917|NCT01890954|12451852|P1|COMPLETED|Overall Study||8
5059918|NCT01890954|12451851|P2|STARTED|Overall Study||8
5059919|NCT01890954|12451852|P1|STARTED|Overall Study||9
5059920|NCT01890915|12451860|P2|NOT COMPLETED|Overall Study||1
5059921|NCT01890915|12451861|P1|NOT COMPLETED|Overall Study||3
5059922|NCT01890915|12451860|P2|COMPLETED|Overall Study||9
5059923|NCT01890915|12451861|P1|COMPLETED|Overall Study||8
5059924|NCT01890915|12451860|P2|STARTED|Overall Study||10
5059925|NCT01890915|12451861|P1|STARTED|Overall Study||11
5059926|NCT01890785|12451877|P6|NOT COMPLETED|Third Intervention||0
5059927|NCT01890785|12451878|P5|NOT COMPLETED|Third Intervention||0
5059928|NCT01890785|12451879|P4|NOT COMPLETED|Third Intervention||0
5059929|NCT01890785|12451880|P3|NOT COMPLETED|Third Intervention||0
5059930|NCT01890785|12451881|P2|NOT COMPLETED|Third Intervention||1
5059931|NCT01890785|12451882|P1|NOT COMPLETED|Third Intervention||0
5059932|NCT01890785|12451877|P6|COMPLETED|Third Intervention||5
5059933|NCT01890785|12451878|P5|COMPLETED|Third Intervention||5
5059934|NCT01890785|12451879|P4|COMPLETED|Third Intervention||5
5059935|NCT01890785|12451880|P3|COMPLETED|Third Intervention||5
5059936|NCT01890785|12451881|P2|COMPLETED|Third Intervention||4
5059937|NCT01890785|12451882|P1|COMPLETED|Third Intervention||5
5059938|NCT01890785|12451877|P6|STARTED|Third Intervention||5
5059939|NCT01890785|12451878|P5|STARTED|Third Intervention||5
5059940|NCT01890785|12451879|P4|STARTED|Third Intervention||5
5059941|NCT01890785|12451880|P3|STARTED|Third Intervention||5
5059942|NCT01890785|12451881|P2|STARTED|Third Intervention||5
5059943|NCT01890785|12451882|P1|STARTED|Third Intervention||5
5059944|NCT01890785|12451877|P6|NOT COMPLETED|Second Intervention||0
5059945|NCT01890785|12451878|P5|NOT COMPLETED|Second Intervention||0
5059946|NCT01890785|12451879|P4|NOT COMPLETED|Second Intervention||0
5059947|NCT01890785|12451880|P3|NOT COMPLETED|Second Intervention||0
5059948|NCT01890785|12451881|P2|NOT COMPLETED|Second Intervention||0
5059949|NCT01890785|12451882|P1|NOT COMPLETED|Second Intervention||0
5059950|NCT01890785|12451877|P6|COMPLETED|Second Intervention||5
5059951|NCT01890785|12451878|P5|COMPLETED|Second Intervention||5
5059952|NCT01890785|12451879|P4|COMPLETED|Second Intervention||5
5059953|NCT01890785|12451880|P3|COMPLETED|Second Intervention||5
5059954|NCT01890785|12451881|P2|COMPLETED|Second Intervention||5
5059955|NCT01890785|12451882|P1|COMPLETED|Second Intervention||5
5059956|NCT01890785|12451877|P6|STARTED|Second Intervention||5
5059957|NCT01890785|12451878|P5|STARTED|Second Intervention||5
5059958|NCT01890785|12451879|P4|STARTED|Second Intervention||5
5059959|NCT01890785|12451880|P3|STARTED|Second Intervention||5
5059960|NCT01890785|12451881|P2|STARTED|Second Intervention||5
5059961|NCT01890785|12451882|P1|STARTED|Second Intervention||5
5059962|NCT01890785|12451877|P6|NOT COMPLETED|First Intervention||0
5059963|NCT01890785|12451878|P5|NOT COMPLETED|First Intervention||0
5059964|NCT01890785|12451879|P4|NOT COMPLETED|First Intervention||0
5059965|NCT01890785|12451880|P3|NOT COMPLETED|First Intervention||0
5059966|NCT01890785|12451881|P2|NOT COMPLETED|First Intervention||0
5059967|NCT01890785|12451882|P1|NOT COMPLETED|First Intervention||0
5059968|NCT01890785|12451877|P6|COMPLETED|First Intervention||5
5059969|NCT01890785|12451878|P5|COMPLETED|First Intervention||5
5059970|NCT01890785|12451879|P4|COMPLETED|First Intervention||5
5059971|NCT01890785|12451880|P3|COMPLETED|First Intervention||5
5059972|NCT01890785|12451881|P2|COMPLETED|First Intervention||5
5059973|NCT01890785|12451882|P1|COMPLETED|First Intervention||5
5059974|NCT01890785|12451877|P6|STARTED|First Intervention||5
5059975|NCT01890785|12451878|P5|STARTED|First Intervention||5
5059976|NCT01890785|12451879|P4|STARTED|First Intervention||5
5059977|NCT01890785|12451880|P3|STARTED|First Intervention||5
5059978|NCT01890785|12451881|P2|STARTED|First Intervention||5
5059979|NCT01890785|12451882|P1|STARTED|First Intervention||5
5059980|NCT01890759|12451901|P2|NOT COMPLETED|Overall Study||12
5059981|NCT01890759|12451902|P1|NOT COMPLETED|Overall Study||2
5059982|NCT01890759|12451901|P2|COMPLETED|Overall Study||188
5059983|NCT01890759|12451902|P1|COMPLETED|Overall Study||98
5059984|NCT01890759|12451901|P2|STARTED|Overall Study||200
5059985|NCT01890759|12451902|P1|STARTED|Overall Study||100
5059986|NCT01890746|12451936|P2|NOT COMPLETED|Overall Study||41
5059987|NCT01890746|12451937|P1|NOT COMPLETED|Overall Study||52
5059988|NCT01890746|12451936|P2|COMPLETED|Overall Study||33
5059989|NCT01890746|12451937|P1|COMPLETED|Overall Study||22
5059990|NCT01890746|12451936|P2|STARTED|Overall Study||74
5059991|NCT01890746|12451937|P1|STARTED|Overall Study||74
5059992|NCT01890707|12452023|P2|NOT COMPLETED|Overall Study||1
5059993|NCT01890707|12452024|P1|NOT COMPLETED|Overall Study||1
5059994|NCT01890707|12452023|P2|COMPLETED|Overall Study||7
5059995|NCT01890707|12452024|P1|COMPLETED|Overall Study||10
5059996|NCT01890707|12452023|P2|STARTED|Overall Study||8
5059997|NCT01890707|12452024|P1|STARTED|Overall Study||11
5059998|NCT01890694|12452032|P2|NOT COMPLETED|Overall Study||1
5059999|NCT01890694|12452033|P1|NOT COMPLETED|Overall Study||1
5060000|NCT01890694|12452032|P2|COMPLETED|Overall Study||0
5060001|NCT01890694|12452033|P1|COMPLETED|Overall Study||0
5060002|NCT01890694|12452032|P2|STARTED|Overall Study||1
5060003|NCT01890694|12452033|P1|STARTED|Overall Study||1
5060004|NCT01890642|12452068|P3|NOT COMPLETED|Overall Study||0
5060005|NCT01890642|12452069|P2|NOT COMPLETED|Overall Study||0
5060006|NCT01890642|12452070|P1|NOT COMPLETED|Overall Study||0
5060007|NCT01890642|12452068|P3|COMPLETED|Overall Study||96
5060008|NCT01890642|12452069|P2|COMPLETED|Overall Study||53
5060009|NCT01890642|12452070|P1|COMPLETED|Overall Study||56
5060010|NCT01890642|12452068|P3|STARTED|Overall Study||96
5060011|NCT01890642|12452069|P2|STARTED|Overall Study||53
5060012|NCT01890642|12452070|P1|STARTED|Overall Study||56
5060013|NCT01890577|12452090|P1|NOT COMPLETED|Overall Study||28
5060014|NCT01890577|12452090|P1|COMPLETED|Overall Study||0
5060015|NCT01890577|12452090|P1|STARTED|Overall Study||28
5060016|NCT01890512|12452103|P1|NOT COMPLETED|Overall Study||3
5060017|NCT01890512|12452103|P1|COMPLETED|Overall Study||17
5060018|NCT01890512|12452103|P1|STARTED|Overall Study||20
5060019|NCT01890473|12452109|P2|NOT COMPLETED|Overall Study||0
5060020|NCT01890473|12452110|P1|NOT COMPLETED|Overall Study||2
5060021|NCT01890473|12452109|P2|COMPLETED|Overall Study||113
5060022|NCT01890473|12452110|P1|COMPLETED|Overall Study||109
5060023|NCT01890473|12452109|P2|STARTED|Overall Study||113
5060024|NCT01890473|12452110|P1|STARTED|Overall Study||111
5060025|NCT01890434|12452136|P1|NOT COMPLETED|Overall Study||20
5060026|NCT01890434|12452136|P1|COMPLETED|Overall Study||458
5060027|NCT01890434|12452136|P1|Evaluated for Efficacy|Overall Study||389
5060028|NCT01890434|12452136|P1|STARTED|Overall Study||478
5060029|NCT01890421|12452166|P1|NOT COMPLETED|Overall Study||11
5060030|NCT01890421|12452166|P1|COMPLETED|Overall Study||415
5060031|NCT01890421|12452166|P1|STARTED|Overall Study||426
5060032|NCT01890343|12452192|P3|NOT COMPLETED|Overall Study||0
5060033|NCT01890343|12452193|P2|NOT COMPLETED|Overall Study||0
5060034|NCT01890343|12452194|P1|NOT COMPLETED|Overall Study||0
5060035|NCT01890343|12452192|P3|COMPLETED|Overall Study||10
5060036|NCT01890343|12452193|P2|COMPLETED|Overall Study||10
5060037|NCT01890343|12452194|P1|COMPLETED|Overall Study||8
5060038|NCT01890343|12452192|P3|STARTED|Overall Study||10
5060039|NCT01890343|12452193|P2|STARTED|Overall Study||10
5060040|NCT01890343|12452194|P1|STARTED|Overall Study||8
5060041|NCT01890226|12452207|P2|NOT COMPLETED|Overall Study||0
5060042|NCT01890226|12452208|P1|NOT COMPLETED|Overall Study||0
5060043|NCT01890226|12452207|P2|COMPLETED|Overall Study||156
5060044|NCT01890226|12452208|P1|COMPLETED|Overall Study||155
5060045|NCT01890226|12452207|P2|STARTED|Overall Study||156
5060046|NCT01890226|12452208|P1|STARTED|Overall Study||155
5060047|NCT01890148|12452220|P1|NOT COMPLETED|Overall Study||1
5060048|NCT01890148|12452220|P1|COMPLETED|Overall Study||4
5060049|NCT01890148|12452220|P1|STARTED|Overall Study||5
5060050|NCT01890122|12452240|P4|NOT COMPLETED|Overall Study||59
5060051|NCT01890122|12452241|P3|NOT COMPLETED|Overall Study||13
5060052|NCT01890122|12452242|P2|NOT COMPLETED|Overall Study||37
5060053|NCT01890122|12452243|P1|NOT COMPLETED|Overall Study||27
5060054|NCT01890122|12452240|P4|COMPLETED|Overall Study||104
5060055|NCT01890122|12452241|P3|COMPLETED|Overall Study||146
5060056|NCT01890122|12452242|P2|COMPLETED|Overall Study||126
5060057|NCT01890122|12452243|P1|COMPLETED|Overall Study||135
5060058|NCT01890122|12452240|P4|Treated|Overall Study||163
5060059|NCT01890122|12452241|P3|Treated|Overall Study||159
5060060|NCT01890122|12452242|P2|Treated|Overall Study||162
5060061|NCT01890122|12452243|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
5060062|NCT01890122|12452240|P4|STARTED|Overall Study||163
5060063|NCT01890122|12452241|P3|STARTED|Overall Study||159
5060064|NCT01890122|12452242|P2|STARTED|Overall Study||163
5060065|NCT01890122|12452243|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
5060066|NCT01890109|12452307|P2|NOT COMPLETED|Overall Study||5
5060067|NCT01890109|12452308|P1|NOT COMPLETED|Overall Study||1
5060068|NCT01890109|12452307|P2|COMPLETED|Overall Study||46
5060069|NCT01890109|12452308|P1|COMPLETED|Overall Study||51
5060070|NCT01890109|12452307|P2|Received Study Treatment|Overall Study||50
5060071|NCT01890109|12452308|P1|Received Study Treatment|Overall Study||52
5060072|NCT01890109|12452307|P2|STARTED|Overall Study||51
5060073|NCT01890109|12452308|P1|STARTED|Overall Study||52
5060074|NCT01890031|12452332|P5|NOT COMPLETED|Overall Study||0
5060075|NCT01890031|12452333|P4|NOT COMPLETED|Overall Study||0
5060076|NCT01890031|12452334|P3|NOT COMPLETED|Overall Study||0
5060077|NCT01890031|12452335|P2|NOT COMPLETED|Overall Study||0
5060078|NCT01890031|12452336|P1|NOT COMPLETED|Overall Study||0
5060079|NCT01890031|12452332|P5|COMPLETED|Overall Study||8
5060080|NCT01890031|12452333|P4|COMPLETED|Overall Study||11
5060081|NCT01890031|12452334|P3|COMPLETED|Overall Study||12
5060082|NCT01890031|12452335|P2|COMPLETED|Overall Study||50
5060083|NCT01890031|12452336|P1|COMPLETED|Overall Study||50
5060084|NCT01890031|12452332|P5|STARTED|Overall Study||8
5060085|NCT01890031|12452333|P4|STARTED|Overall Study||11
5060086|NCT01890031|12452334|P3|STARTED|Overall Study||12
5060087|NCT01890031|12452335|P2|STARTED|Overall Study||50
5060088|NCT01890031|12452336|P1|STARTED|Overall Study||50
5060089|NCT01889862|12452357|P4|NOT COMPLETED|Overall Study||0
5060090|NCT01889862|12452358|P3|NOT COMPLETED|Overall Study||1
5060091|NCT01889862|12452359|P2|NOT COMPLETED|Overall Study||0
5060092|NCT01889862|12452360|P1|NOT COMPLETED|Overall Study||0
5060093|NCT01889862|12452357|P4|COMPLETED|Overall Study||14
5060094|NCT01889862|12452358|P3|COMPLETED|Overall Study||31
5060095|NCT01889862|12452359|P2|COMPLETED|Overall Study||15
5060096|NCT01889862|12452360|P1|COMPLETED|Overall Study||34
5060097|NCT01889862|12452357|P4|STARTED|Overall Study||14
5060098|NCT01889862|12452358|P3|STARTED|Overall Study||32
5060099|NCT01889862|12452359|P2|STARTED|Overall Study||15
5060100|NCT01889862|12452360|P1|STARTED|Overall Study||34
5060101|NCT01889797|12452372|P2|NOT COMPLETED|Overall Study||0
5060102|NCT01889797|12452373|P1|NOT COMPLETED|Overall Study||0
5060103|NCT01889797|12452372|P2|COMPLETED|Overall Study||16
5060104|NCT01889797|12452373|P1|COMPLETED|Overall Study||16
5060105|NCT01889797|12452372|P2|STARTED|Overall Study||16
5060106|NCT01889797|12452373|P1|STARTED|Overall Study||16
5060107|NCT01889667|12452388|P3|NOT COMPLETED|Overall Study||0
5060108|NCT01889667|12452389|P2|NOT COMPLETED|Overall Study||0
5060109|NCT01889667|12452390|P1|NOT COMPLETED|Overall Study||0
5060110|NCT01889667|12452388|P3|COMPLETED|Overall Study||10
5060111|NCT01889667|12452389|P2|COMPLETED|Overall Study||10
5060112|NCT01889667|12452390|P1|COMPLETED|Overall Study||10
5060113|NCT01889667|12452388|P3|STARTED|Overall Study||10
5060114|NCT01889667|12452389|P2|STARTED|Overall Study||10
5060115|NCT01889667|12452390|P1|STARTED|Overall Study||10
5060116|NCT01889602|12452413|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
5060117|NCT01889602|12452414|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
5060118|NCT01889602|12452415|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
5060119|NCT01889602|12452413|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
5060120|NCT01889602|12452414|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
5060121|NCT01889602|12452415|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
5060122|NCT01889602|12452413|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
5060123|NCT01889602|12452414|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
5060124|NCT01889602|12452415|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
5060125|NCT01889602|12452413|P3|NOT COMPLETED|Third Intervention||0
5060126|NCT01889602|12452414|P2|NOT COMPLETED|Third Intervention||2
5060127|NCT01889602|12452415|P1|NOT COMPLETED|Third Intervention||3
5060128|NCT01889602|12452413|P3|COMPLETED|Third Intervention||16
5060129|NCT01889602|12452414|P2|COMPLETED|Third Intervention||15
5060130|NCT01889602|12452415|P1|COMPLETED|Third Intervention||15
5060131|NCT01889602|12452413|P3|STARTED|Third Intervention||16
5060132|NCT01889602|12452414|P2|STARTED|Third Intervention||17
5060133|NCT01889602|12452415|P1|STARTED|Third Intervention||18
5060134|NCT01889602|12452413|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
5060135|NCT01889602|12452414|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
5060136|NCT01889602|12452415|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
5060137|NCT01889602|12452413|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
5060138|NCT01889602|12452414|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
5060139|NCT01889602|12452415|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
5060140|NCT01889602|12452413|P3|STARTED|Second Washout Period of at Least 2 Week||16
5060141|NCT01889602|12452414|P2|STARTED|Second Washout Period of at Least 2 Week||17
5060142|NCT01889602|12452415|P1|STARTED|Second Washout Period of at Least 2 Week||18
5060143|NCT01889602|12452413|P3|NOT COMPLETED|Second Intervention||2
5060144|NCT01889602|12452414|P2|NOT COMPLETED|Second Intervention||0
5060145|NCT01889602|12452415|P1|NOT COMPLETED|Second Intervention||1
5060146|NCT01889602|12452413|P3|COMPLETED|Second Intervention||16
5060147|NCT01889602|12452414|P2|COMPLETED|Second Intervention||17
5060148|NCT01889602|12452415|P1|COMPLETED|Second Intervention||18
5060149|NCT01889602|12452413|P3|STARTED|Second Intervention||18
5060150|NCT01889602|12452414|P2|STARTED|Second Intervention||17
5060151|NCT01889602|12452415|P1|STARTED|Second Intervention||19
5060152|NCT01889602|12452413|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
5060153|NCT01889602|12452414|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
5060154|NCT01889602|12452415|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
5060155|NCT01889602|12452413|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
5060156|NCT01889602|12452414|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
5060157|NCT01889602|12452415|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
5060158|NCT01889602|12452413|P3|STARTED|First Washout Period of at Least 2 Weeks||18
5060159|NCT01889602|12452414|P2|STARTED|First Washout Period of at Least 2 Weeks||17
5060160|NCT01889602|12452415|P1|STARTED|First Washout Period of at Least 2 Weeks||19
5060161|NCT01889602|12452413|P3|NOT COMPLETED|First Intervention||2
5060162|NCT01889602|12452414|P2|NOT COMPLETED|First Intervention||3
5060163|NCT01889602|12452415|P1|NOT COMPLETED|First Intervention||1
5060164|NCT01889602|12452413|P3|COMPLETED|First Intervention||18
5060165|NCT01889602|12452414|P2|COMPLETED|First Intervention||17
5060166|NCT01889602|12452415|P1|COMPLETED|First Intervention||19
5060167|NCT01889602|12452413|P3|STARTED|First Intervention||20
5060168|NCT01889602|12452414|P2|STARTED|First Intervention||20
5060169|NCT01889602|12452415|P1|STARTED|First Intervention||20
5060170|NCT01889563|12452442|P2|NOT COMPLETED|Overall Study||5
5060171|NCT01889563|12452443|P1|NOT COMPLETED|Overall Study||7
5060172|NCT01889563|12452442|P2|COMPLETED|Overall Study||10
5060173|NCT01889563|12452443|P1|COMPLETED|Overall Study||10
5060174|NCT01889563|12452442|P2|STARTED|Overall Study||15
5060175|NCT01889563|12452443|P1|STARTED|Overall Study||17
5060176|NCT01889420|12452451|P1|NOT COMPLETED|Overall Study||0
5060177|NCT01889420|12452451|P1|COMPLETED|Overall Study||1
5060178|NCT01889420|12452451|P1|STARTED|Overall Study||1
5060179|NCT01889355|12452457|P1|NOT COMPLETED|Overall Study||2
5060180|NCT01889355|12452457|P1|COMPLETED|Overall Study||113
5060181|NCT01889355|12452457|P1|STARTED|Overall Study||115
5060182|NCT01889251|12452463|P2|NOT COMPLETED|Overall Study||0
5060183|NCT01889251|12452464|P1|NOT COMPLETED|Overall Study||1
5060184|NCT01889251|12452463|P2|COMPLETED|Overall Study||57
5060185|NCT01889251|12452464|P1|COMPLETED|Overall Study||114
5060186|NCT01889251|12452463|P2|STARTED|Overall Study||57
5060187|NCT01889251|12452464|P1|STARTED|Overall Study||115
5060188|NCT01889238|12452470|P1|NOT COMPLETED|Overall Study||9
5060189|NCT01889238|12452470|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
5060190|NCT01889238|12452470|P1|STARTED|Overall Study||118
5060191|NCT01888965|12452487|P1|NOT COMPLETED|Overall Study||9
5060192|NCT01888965|12452487|P1|COMPLETED|Overall Study||0
5060193|NCT01888965|12452487|P1|STARTED|Overall Study||9
5060194|NCT01888952|12452493|P1|NOT COMPLETED|Overall Study||0
5060195|NCT01888952|12452493|P1|COMPLETED|Overall Study||10
5060196|NCT01888952|12452493|P1|STARTED|Overall Study||10
5060197|NCT01888900|12452499|P2|NOT COMPLETED|Overall Study||2
5060198|NCT01888900|12452500|P1|NOT COMPLETED|Overall Study||0
5060199|NCT01888900|12452499|P2|COMPLETED|Overall Study||11
5060200|NCT01888900|12452500|P1|COMPLETED|Overall Study||22
5060201|NCT01888900|12452499|P2|STARTED|Overall Study||13
5060202|NCT01888900|12452500|P1|STARTED|Overall Study||22
5060203|NCT01888640|12452523|P3|NOT COMPLETED|Overall Study||5
5060204|NCT01888640|12452524|P2|NOT COMPLETED|Overall Study||31
5060205|NCT01888640|12452525|P1|NOT COMPLETED|Overall Study||27
5060206|NCT01888640|12452523|P3|COMPLETED|Overall Study||94
5060207|NCT01888640|12452524|P2|COMPLETED|Overall Study||68
5060208|NCT01888640|12452525|P1|COMPLETED|Overall Study||76
5060209|NCT01888640|12452523|P3|STARTED|Overall Study||99
5060210|NCT01888640|12452524|P2|STARTED|Overall Study||99
5060211|NCT01888640|12452525|P1|STARTED|Overall Study||103
5060212|NCT01888432|12452581|P2|NOT COMPLETED|36-month Analysis (Extension)||0
5060213|NCT01888432|12452582|P1|NOT COMPLETED|36-month Analysis (Extension)||1
5060214|NCT01888432|12452581|P2|COMPLETED|36-month Analysis (Extension)||5
5060215|NCT01888432|12452582|P1|COMPLETED|36-month Analysis (Extension)||12
5060216|NCT01888432|12452581|P2|STARTED|36-month Analysis (Extension)||5
5060217|NCT01888432|12452582|P1|STARTED|36-month Analysis (Extension)||13
5060218|NCT01888432|12452581|P2|NOT COMPLETED|24-month Analysis (FAS)||17
5060219|NCT01888432|12452582|P1|NOT COMPLETED|24-month Analysis (FAS)||17
5060220|NCT01888432|12452581|P2|COMPLETED|24-month Analysis (FAS)||125
5060221|NCT01888432|12452582|P1|COMPLETED|24-month Analysis (FAS)||125
5060222|NCT01888432|12452581|P2|STARTED|24-month Analysis (FAS)||142
5060223|NCT01888432|12452582|P1|STARTED|24-month Analysis (FAS)||142
5060224|NCT01888432|12452581|P2|NOT COMPLETED|12-month Analysis (FAS)||9
5060225|NCT01888432|12452582|P1|NOT COMPLETED|12-month Analysis (FAS)||11
5060226|NCT01888432|12452581|P2|COMPLETED|12-month Analysis (FAS)||133
5060227|NCT01888432|12452582|P1|COMPLETED|12-month Analysis (FAS)||131
5060228|NCT01888432|12452581|P2|STARTED|12-month Analysis (FAS)||142
5060229|NCT01888432|12452582|P1|STARTED|12-month Analysis (FAS)||142
5060230|NCT01888367|12452623|P3|NOT COMPLETED|Overall Study||5
5060231|NCT01888367|12452624|P2|NOT COMPLETED|Overall Study||5
5060232|NCT01888367|12452625|P1|NOT COMPLETED|Overall Study||8
5060233|NCT01888367|12452623|P3|COMPLETED|Overall Study||73
5060234|NCT01888367|12452624|P2|COMPLETED|Overall Study||66
5060235|NCT01888367|12452625|P1|COMPLETED|Overall Study||288
5060236|NCT01888367|12452623|P3|STARTED|Overall Study||78
5060237|NCT01888367|12452624|P2|STARTED|Overall Study||71
5060238|NCT01888367|12452625|P1|STARTED|Overall Study||296
5060239|NCT01888003|12452645|P3|NOT COMPLETED|Overall Study||40
5060240|NCT01888003|12452646|P2|NOT COMPLETED|Overall Study||6
5060241|NCT01888003|12452647|P1|NOT COMPLETED|Overall Study||5
5060242|NCT01888003|12452645|P3|COMPLETED|Overall Study||0
5060243|NCT01888003|12452646|P2|COMPLETED|Overall Study||0
5060244|NCT01888003|12452647|P1|COMPLETED|Overall Study||0
5060245|NCT01888003|12452645|P3|STARTED|Overall Study||40
5060246|NCT01888003|12452646|P2|STARTED|Overall Study||6
5060247|NCT01888003|12452647|P1|STARTED|Overall Study||5
5060248|NCT01887990|12452668|P4|NOT COMPLETED|Overall Study||0
5060249|NCT01887990|12452669|P3|NOT COMPLETED|Overall Study||0
5060250|NCT01887990|12452670|P2|NOT COMPLETED|Overall Study||0
5060251|NCT01887990|12452671|P1|NOT COMPLETED|Overall Study||0
5060252|NCT01887990|12452668|P4|COMPLETED|Overall Study||2
5060253|NCT01887990|12452669|P3|COMPLETED|Overall Study||2
5060254|NCT01887990|12452670|P2|COMPLETED|Overall Study||7
5060255|NCT01887990|12452671|P1|COMPLETED|Overall Study||7
5060256|NCT01887990|12452668|P4|STARTED|Overall Study||2
5060257|NCT01887990|12452669|P3|STARTED|Overall Study||2
5060258|NCT01887990|12452670|P2|STARTED|Overall Study||7
5060259|NCT01887990|12452671|P1|STARTED|Overall Study||7
5060260|NCT01887912|12452687|P2|NOT COMPLETED|Overall Study||731
5060261|NCT01887912|12452688|P1|NOT COMPLETED|Overall Study||1392
5060262|NCT01887912|12452687|P2|COMPLETED|Overall Study||2370
5060263|NCT01887912|12452688|P1|COMPLETED|Overall Study||4809
5060264|NCT01887912|12452687|P2|Safety Population|Overall Study||3057
5060265|NCT01887912|12452688|P1|Safety Population|Overall Study||6113
5060266|NCT01887912|12452687|P2|STARTED|Overall Study||3101
5060267|NCT01887912|12452688|P1|STARTED|Overall Study||6201
5060268|NCT01887717|12452716|P2|NOT COMPLETED|Overall Study||11
5060269|NCT01887717|12452717|P1|NOT COMPLETED|Overall Study||6
5060270|NCT01887717|12452716|P2|COMPLETED|Overall Study||8
5060271|NCT01887717|12452717|P1|COMPLETED|Overall Study||11
5060272|NCT01887717|12452716|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
5060273|NCT01887717|12452717|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
5060274|NCT01887717|12452716|P2|STARTED|Overall Study||19
5060275|NCT01887717|12452717|P1|STARTED|Overall Study||17
5060276|NCT01887678|12452739|P2|NOT COMPLETED|Overall Study||28
5060277|NCT01887678|12452740|P1|NOT COMPLETED|Overall Study||17
5060278|NCT01887678|12452739|P2|COMPLETED|Overall Study||85
5060279|NCT01887678|12452740|P1|COMPLETED|Overall Study||102
5060280|NCT01887678|12452739|P2|STARTED|Overall Study||113
5060281|NCT01887678|12452740|P1|STARTED|Overall Study||119
5060282|NCT01887587|12452782|P1|NOT COMPLETED|Overall Study||0
5060283|NCT01887587|12452782|P1|COMPLETED|Overall Study||5
5060284|NCT01887587|12452782|P1|STARTED|Overall Study||5
5060285|NCT01887470|12452791|P4|NOT COMPLETED|Overall Study||0
5060286|NCT01887470|12452792|P3|NOT COMPLETED|Overall Study||0
5060287|NCT01887470|12452793|P2|NOT COMPLETED|Overall Study||0
5060288|NCT01887470|12452794|P1|NOT COMPLETED|Overall Study||0
5060289|NCT01887470|12452791|P4|COMPLETED|Overall Study||10
5060290|NCT01887470|12452792|P3|COMPLETED|Overall Study||10
5060291|NCT01887470|12452793|P2|COMPLETED|Overall Study||10
5060292|NCT01887470|12452794|P1|COMPLETED|Overall Study||10
5060293|NCT01887470|12452791|P4|STARTED|Overall Study||10
5060294|NCT01887470|12452792|P3|STARTED|Overall Study||10
5060295|NCT01887470|12452793|P2|STARTED|Overall Study||10
5060296|NCT01887470|12452794|P1|STARTED|Overall Study||10
5060297|NCT01887418|12452813|P3|NOT COMPLETED|Overall Study||1
5060298|NCT01887418|12452814|P2|NOT COMPLETED|Overall Study||0
5060299|NCT01887418|12452815|P1|NOT COMPLETED|Overall Study||0
5060300|NCT01887418|12452813|P3|COMPLETED|Overall Study||9
5060301|NCT01887418|12452814|P2|COMPLETED|Overall Study||14
5060302|NCT01887418|12452815|P1|COMPLETED|Overall Study||15
5060303|NCT01887418|12452813|P3|STARTED|Overall Study||10
5060304|NCT01887418|12452814|P2|STARTED|Overall Study||14
5060305|NCT01887418|12452815|P1|STARTED|Overall Study||15
5060306|NCT01887353|12452834|P2|NOT COMPLETED|Overall Study||3
5060307|NCT01887353|12452835|P1|NOT COMPLETED|Overall Study||4
5060308|NCT01887353|12452834|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
5060309|NCT01887353|12452835|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
5060310|NCT01887353|12452834|P2|STARTED|Overall Study||4
5060311|NCT01887353|12452835|P1|STARTED|Overall Study||4
5060312|NCT01887327|12452844|P3|NOT COMPLETED|Overall Study||3
5060313|NCT01887327|12452845|P2|NOT COMPLETED|Overall Study||4
5060314|NCT01887327|12452846|P1|NOT COMPLETED|Overall Study||1
5060315|NCT01887327|12452844|P3|COMPLETED|Overall Study||27
5060316|NCT01887327|12452845|P2|COMPLETED|Overall Study||27
5060317|NCT01887327|12452846|P1|COMPLETED|Overall Study||29
5060318|NCT01887327|12452844|P3|STARTED|Overall Study||30
5060319|NCT01887327|12452845|P2|STARTED|Overall Study||31
5060320|NCT01887327|12452846|P1|STARTED|Overall Study||30
5060321|NCT01887288|12452863|P1|NOT COMPLETED|Overall Study||16
5060322|NCT01887288|12452863|P1|COMPLETED|Overall Study||0
5060323|NCT01887288|12452863|P1|STARTED|Overall Study||16
5060324|NCT01887210|12452870|P2|NOT COMPLETED|Overall Study||4
5060325|NCT01887210|12452871|P1|NOT COMPLETED|Overall Study||1
5060326|NCT01887210|12452870|P2|COMPLETED|Overall Study||29
5060327|NCT01887210|12452871|P1|COMPLETED|Overall Study||32
5060328|NCT01887210|12452870|P2|STARTED|Overall Study||33
5060329|NCT01887210|12452871|P1|STARTED|Overall Study||33
5060330|NCT01887171|12452885|P2|NOT COMPLETED|Overall Study||0
5060331|NCT01887171|12452886|P1|NOT COMPLETED|Overall Study||0
5060332|NCT01887171|12452885|P2|COMPLETED|Overall Study||43
5060333|NCT01887171|12452886|P1|COMPLETED|Overall Study||43
5060334|NCT01887171|12452885|P2|STARTED|Overall Study||43
5060335|NCT01887171|12452886|P1|STARTED|Overall Study||43
5060336|NCT01887132|12452892|P1|NOT COMPLETED|Overall Study||0
5060337|NCT01887132|12452892|P1|COMPLETED|Overall Study||4
5060338|NCT01887132|12452892|P1|STARTED|Overall Study||4
5060339|NCT01886963|12452899|P2|NOT COMPLETED|Overall Study||4
5060340|NCT01886963|12452900|P1|NOT COMPLETED|Overall Study||5
5060341|NCT01886963|12452899|P2|COMPLETED|Overall Study||49
5060342|NCT01886963|12452900|P1|COMPLETED|Overall Study||46
5060343|NCT01886963|12452899|P2|12 Week Follow Up|Overall Study||22
5060344|NCT01886963|12452900|P1|12 Week Follow Up|Overall Study||24
5060345|NCT01886963|12452899|P2|4 Week Follow Up|Overall Study||26
5060346|NCT01886963|12452900|P1|4 Week Follow Up|Overall Study||24
5060347|NCT01886963|12452899|P2|2 Week Follow Up|Overall Study||35
5060348|NCT01886963|12452900|P1|2 Week Follow Up|Overall Study||38
5060349|NCT01886963|12452899|P2|STARTED|Overall Study||53
5060350|NCT01886963|12452900|P1|STARTED|Overall Study||51
5060351|NCT01886937|12452908|P2|NOT COMPLETED|Overall Study||0
5060352|NCT01886937|12452909|P1|NOT COMPLETED|Overall Study||0
5060353|NCT01886937|12452908|P2|COMPLETED|Overall Study||6
5060354|NCT01886937|12452909|P1|COMPLETED|Overall Study||7
5060355|NCT01886937|12452908|P2|STARTED|Overall Study||6
5060356|NCT01886937|12452909|P1|STARTED|Overall Study||7
5060357|NCT01886872|12452918|P3|NOT COMPLETED|Overall Study||12
5060358|NCT01886872|12452919|P2|NOT COMPLETED|Overall Study||4
5060359|NCT01886872|12452920|P1|NOT COMPLETED|Overall Study||7
5060360|NCT01886872|12452918|P3|COMPLETED|Overall Study||170
5060361|NCT01886872|12452919|P2|COMPLETED|Overall Study||178
5060362|NCT01886872|12452920|P1|COMPLETED|Overall Study||176
5060363|NCT01886872|12452918|P3|Crossover Cohort|Overall Study||0
5060364|NCT01886872|12452919|P2|Crossover Cohort|Overall Study||0
5060365|NCT01886872|12452920|P1|Crossover Cohort|Overall Study||30
5060366|NCT01886872|12452918|P3|Evaluable for Adverse Events|Overall Study||181
5060367|NCT01886872|12452919|P2|Evaluable for Adverse Events|Overall Study||180
5060368|NCT01886872|12452920|P1|Evaluable for Adverse Events|Overall Study||176
5060369|NCT01886872|12452918|P3|Evaluable for Secondary Endpoints|Overall Study||182
5060370|NCT01886872|12452919|P2|Evaluable for Secondary Endpoints|Overall Study||182
5060371|NCT01886872|12452920|P1|Evaluable for Secondary Endpoints|Overall Study||183
5060372|NCT01886872|12452918|P3|STARTED|Overall Study||182
5060373|NCT01886872|12452919|P2|STARTED|Overall Study||182
5060374|NCT01886872|12452920|P1|STARTED|Overall Study||183
5060375|NCT01886833|12452953|P1|NOT COMPLETED|Overall Study||204
5060376|NCT01886833|12452953|P1|COMPLETED|Overall Study||216
5060377|NCT01886833|12452953|P1|STARTED|Overall Study||420
5060378|NCT01886807|12452964|P3|NOT COMPLETED|Overall Study||10
5060379|NCT01886807|12452965|P2|NOT COMPLETED|Overall Study||10
5060380|NCT01886807|12452966|P1|NOT COMPLETED|Overall Study||5
5060381|NCT01886807|12452964|P3|COMPLETED|Overall Study||153
5060382|NCT01886807|12452965|P2|COMPLETED|Overall Study||145
5060383|NCT01886807|12452966|P1|COMPLETED|Overall Study||159
5060384|NCT01886807|12452964|P3|STARTED|Overall Study||163
5060385|NCT01886807|12452965|P2|STARTED|Overall Study||155
5060386|NCT01886807|12452966|P1|STARTED|Overall Study||164
5060387|NCT01886781|12452985|P2|NOT COMPLETED|Overall Study||2
5060388|NCT01886781|12452986|P1|NOT COMPLETED|Overall Study||14
5060389|NCT01886781|12452985|P2|COMPLETED|Overall Study||25
5060390|NCT01886781|12452986|P1|COMPLETED|Overall Study||40
5060391|NCT01886781|12452985|P2|STARTED|Overall Study||27
5060392|NCT01886781|12452986|P1|STARTED|Overall Study||54
5060393|NCT01886716|12452996|P4|NOT COMPLETED|1-Month Post Follow-Up||0
5060394|NCT01886716|12452997|P3|NOT COMPLETED|1-Month Post Follow-Up||0
5060395|NCT01886716|12452998|P2|NOT COMPLETED|1-Month Post Follow-Up||0
5060396|NCT01886716|12452999|P1|NOT COMPLETED|1-Month Post Follow-Up||0
5060397|NCT01886716|12452996|P4|COMPLETED|1-Month Post Follow-Up||14
5060398|NCT01886716|12452997|P3|COMPLETED|1-Month Post Follow-Up||19
5060399|NCT01886716|12452998|P2|COMPLETED|1-Month Post Follow-Up||17
5060400|NCT01886716|12452999|P1|COMPLETED|1-Month Post Follow-Up||20
5060401|NCT01886716|12452996|P4|STARTED|1-Month Post Follow-Up||14
5060402|NCT01886716|12452997|P3|STARTED|1-Month Post Follow-Up||19
5060403|NCT01886716|12452998|P2|STARTED|1-Month Post Follow-Up||17
5060404|NCT01886716|12452999|P1|STARTED|1-Month Post Follow-Up||20
5060405|NCT01886716|12452996|P4|NOT COMPLETED|1-Week Post Follow-Up||0
5060406|NCT01886716|12452997|P3|NOT COMPLETED|1-Week Post Follow-Up||0
5060407|NCT01886716|12452998|P2|NOT COMPLETED|1-Week Post Follow-Up||0
5060408|NCT01886716|12452999|P1|NOT COMPLETED|1-Week Post Follow-Up||0
5060409|NCT01886716|12452996|P4|COMPLETED|1-Week Post Follow-Up||14
5060410|NCT01886716|12452997|P3|COMPLETED|1-Week Post Follow-Up||19
5060411|NCT01886716|12452998|P2|COMPLETED|1-Week Post Follow-Up||17
5060412|NCT01886716|12452999|P1|COMPLETED|1-Week Post Follow-Up||20
5060413|NCT01886716|12452996|P4|STARTED|1-Week Post Follow-Up||14
5060414|NCT01886716|12452997|P3|STARTED|1-Week Post Follow-Up||19
5060415|NCT01886716|12452998|P2|STARTED|1-Week Post Follow-Up||17
5060416|NCT01886716|12452999|P1|STARTED|1-Week Post Follow-Up||20
5060417|NCT01886716|12452996|P4|NOT COMPLETED|Week 4||0
5060418|NCT01886716|12452997|P3|NOT COMPLETED|Week 4||0
5060419|NCT01886716|12452998|P2|NOT COMPLETED|Week 4||0
5060420|NCT01886716|12452999|P1|NOT COMPLETED|Week 4||0
5060421|NCT01886716|12452996|P4|COMPLETED|Week 4||14
5060422|NCT01886716|12452997|P3|COMPLETED|Week 4||19
5060423|NCT01886716|12452998|P2|COMPLETED|Week 4||17
5060424|NCT01886716|12452999|P1|COMPLETED|Week 4||20
5060425|NCT01886716|12452996|P4|STARTED|Week 4||14
5060426|NCT01886716|12452997|P3|STARTED|Week 4||19
5060427|NCT01886716|12452998|P2|STARTED|Week 4||17
5060428|NCT01886716|12452999|P1|STARTED|Week 4||20
5060429|NCT01886716|12452996|P4|NOT COMPLETED|Week 3||1
5060430|NCT01886716|12452997|P3|NOT COMPLETED|Week 3||0
5060431|NCT01886716|12452998|P2|NOT COMPLETED|Week 3||1
5060432|NCT01886716|12452999|P1|NOT COMPLETED|Week 3||1
5060433|NCT01886716|12452996|P4|COMPLETED|Week 3||14
5060434|NCT01886716|12452997|P3|COMPLETED|Week 3||19
5060435|NCT01886716|12452998|P2|COMPLETED|Week 3||17
5060436|NCT01886716|12452999|P1|COMPLETED|Week 3||20
5060437|NCT01886716|12452996|P4|STARTED|Week 3||15
5060438|NCT01886716|12452997|P3|STARTED|Week 3||19
5060439|NCT01886716|12452998|P2|STARTED|Week 3||18
5060440|NCT01886716|12452999|P1|STARTED|Week 3||21
5060441|NCT01886716|12452996|P4|NOT COMPLETED|Week 2||3
5060442|NCT01886716|12452997|P3|NOT COMPLETED|Week 2||1
5060443|NCT01886716|12452998|P2|NOT COMPLETED|Week 2||2
5060444|NCT01886716|12452999|P1|NOT COMPLETED|Week 2||3
5060445|NCT01886716|12452996|P4|COMPLETED|Week 2||15
5060446|NCT01886716|12452997|P3|COMPLETED|Week 2||19
5060447|NCT01886716|12452998|P2|COMPLETED|Week 2||18
5060448|NCT01886716|12452999|P1|COMPLETED|Week 2||21
5060449|NCT01886716|12452996|P4|STARTED|Week 2||18
5060450|NCT01886716|12452997|P3|STARTED|Week 2||20
5060451|NCT01886716|12452998|P2|STARTED|Week 2||20
5060452|NCT01886716|12452999|P1|STARTED|Week 2||24
5060453|NCT01886716|12452996|P4|NOT COMPLETED|Week 1||2
5060454|NCT01886716|12452997|P3|NOT COMPLETED|Week 1||2
5060455|NCT01886716|12452998|P2|NOT COMPLETED|Week 1||0
5060456|NCT01886716|12452999|P1|NOT COMPLETED|Week 1||0
5060457|NCT01886716|12452996|P4|COMPLETED|Week 1||18
5060458|NCT01886716|12452997|P3|COMPLETED|Week 1||20
5060459|NCT01886716|12452998|P2|COMPLETED|Week 1||20
5060460|NCT01886716|12452999|P1|COMPLETED|Week 1||24
5060461|NCT01886716|12452996|P4|STARTED|Week 1||20
5060462|NCT01886716|12452997|P3|STARTED|Week 1||22
5060463|NCT01886716|12452998|P2|STARTED|Week 1||20
5060464|NCT01886716|12452999|P1|STARTED|Week 1||24
5060465|NCT01886690|12453015|P2|NOT COMPLETED|Overall Study||2
5060466|NCT01886690|12453016|P1|NOT COMPLETED|Overall Study||0
5060467|NCT01886690|12453015|P2|COMPLETED|Overall Study||71
5060468|NCT01886690|12453016|P1|COMPLETED|Overall Study||75
5060469|NCT01886690|12453015|P2|STARTED|Overall Study||73
5060470|NCT01886690|12453016|P1|STARTED|Overall Study||75
5060471|NCT01886313|12453032|P2|NOT COMPLETED|Overall Study||1
5060472|NCT01886313|12453033|P1|NOT COMPLETED|Overall Study||1
5060473|NCT01886313|12453032|P2|COMPLETED|Overall Study||4
5060474|NCT01886313|12453033|P1|COMPLETED|Overall Study||5
5060475|NCT01886313|12453032|P2|STARTED|Overall Study||5
5060476|NCT01886313|12453033|P1|STARTED|Overall Study||6
5060477|NCT01886300|12453039|P1|NOT COMPLETED|Overall Study||16
5060478|NCT01886300|12453039|P1|COMPLETED|Overall Study||0
5060479|NCT01886300|12453039|P1|STARTED|Overall Study||16
5060480|NCT01886287|12453050|P1|NOT COMPLETED|Overall Study||2
5060481|NCT01886287|12453050|P1|COMPLETED|Overall Study||0
5060482|NCT01886287|12453050|P1|STARTED|Overall Study||2
5060483|NCT01886235|12453055|P1|NOT COMPLETED|Overall Study||0
5060484|NCT01886235|12453055|P1|COMPLETED|Overall Study||10
5060485|NCT01886235|12453055|P1|STARTED|Overall Study||10
5060486|NCT01886105|12453066|P1|NOT COMPLETED|Overall Study||3
5060487|NCT01886105|12453066|P1|COMPLETED|Overall Study||1
5060488|NCT01886105|12453066|P1|STARTED|Overall Study||4
5060489|NCT01885936|12453073|P2|NOT COMPLETED|Overall Study||0
5060490|NCT01885936|12453074|P1|NOT COMPLETED|Overall Study||1
5060491|NCT01885936|12453073|P2|COMPLETED|Overall Study||5
5060492|NCT01885936|12453074|P1|COMPLETED|Overall Study||7
5060493|NCT01885936|12453073|P2|STARTED|Overall Study||5
5060494|NCT01885936|12453074|P1|STARTED|Overall Study||8
5060495|NCT01885910|12453084|P1|NOT COMPLETED|Overall Study||8
5060496|NCT01885910|12453084|P1|COMPLETED|Overall Study||24
5060497|NCT01885910|12453084|P1|STARTED|Overall Study||32
5060498|NCT01885871|12453098|P1|NOT COMPLETED|Overall Study||0
5060499|NCT01885871|12453098|P1|COMPLETED|Overall Study||20
5060500|NCT01885871|12453098|P1|STARTED|Overall Study||20
5060501|NCT01885559|12453108|P2|NOT COMPLETED|Overall Study||36
5060502|NCT01885559|12453109|P1|NOT COMPLETED|Overall Study||24
5060503|NCT01885559|12453108|P2|COMPLETED|Overall Study||208
5060504|NCT01885559|12453109|P1|COMPLETED|Overall Study||218
5060505|NCT01885559|12453108|P2|STARTED|Overall Study||244
5060506|NCT01885559|12453109|P1|STARTED|Overall Study||242
5060507|NCT01885208|12453131|P2|NOT COMPLETED|Overall Study||38
5060508|NCT01885208|12453132|P1|NOT COMPLETED|Overall Study||32
5060509|NCT01885208|12453131|P2|COMPLETED|Overall Study||369
5060510|NCT01885208|12453132|P1|COMPLETED|Overall Study||374
5060511|NCT01885208|12453131|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
5060512|NCT01885208|12453132|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
5060513|NCT01885208|12453131|P2|Exposed|Overall Study||405
5060514|NCT01885208|12453132|P1|Exposed|Overall Study||404
5060515|NCT01885208|12453131|P2|STARTED|Overall Study||407
5060516|NCT01885208|12453132|P1|STARTED|Overall Study||406
5060517|NCT01885182|12453150|P2|NOT COMPLETED|Overall Study||22
5060518|NCT01885182|12453151|P1|NOT COMPLETED|Overall Study||34
5060519|NCT01885182|12453150|P2|COMPLETED|Overall Study||93
5060520|NCT01885182|12453151|P1|COMPLETED|Overall Study||83
5060521|NCT01885182|12453150|P2|FAP Population|Overall Study||106
5060522|NCT01885182|12453151|P1|FAP Population|Overall Study||107
5060523|NCT01885182|12453150|P2|Safety Population|Overall Study||111
5060524|NCT01885182|12453151|P1|Safety Population|Overall Study||114
5060525|NCT01885182|12453150|P2|STARTED|Overall Study||115
5060526|NCT01885182|12453151|P1|STARTED|Overall Study||117
5060527|NCT01885117|12453175|P2|NOT COMPLETED|Overall Study||0
5060528|NCT01885117|12453176|P1|NOT COMPLETED|Overall Study||0
5060529|NCT01885117|12453175|P2|COMPLETED|Overall Study||64
5060530|NCT01885117|12453176|P1|COMPLETED|Overall Study||61
5060531|NCT01885117|12453175|P2|STARTED|Overall Study||64
5060532|NCT01885117|12453176|P1|STARTED|Overall Study||61
5060533|NCT01885104|12453198|P2|NOT COMPLETED|Overall Study||1
5060534|NCT01885104|12453199|P1|NOT COMPLETED|Overall Study||2
5060535|NCT01885104|12453198|P2|COMPLETED|Overall Study||33
5060536|NCT01885104|12453199|P1|COMPLETED|Overall Study||29
5060537|NCT01885104|12453198|P2|STARTED|Overall Study||34
5060538|NCT01885104|12453199|P1|STARTED|Overall Study||31
5060539|NCT01885000|12453209|P2|NOT COMPLETED|Overall Study||2
5060540|NCT01885000|12453210|P1|NOT COMPLETED|Overall Study||2
5060541|NCT01885000|12453209|P2|COMPLETED|Overall Study||42
5060542|NCT01885000|12453210|P1|COMPLETED|Overall Study||46
5060543|NCT01885000|12453209|P2|STARTED|Overall Study||44
5060544|NCT01885000|12453210|P1|STARTED|Overall Study||48
5060545|NCT01884844|12453224|P2|NOT COMPLETED|Overall Study||5
5060546|NCT01884844|12453225|P1|NOT COMPLETED|Overall Study||3
5060547|NCT01884844|12453224|P2|COMPLETED|Overall Study||12
5060548|NCT01884844|12453225|P1|COMPLETED|Overall Study||13
5060549|NCT01884844|12453224|P2|STARTED|Overall Study||17
5060550|NCT01884844|12453225|P1|STARTED|Overall Study||16
5060551|NCT01884688|12453231|P1|NOT COMPLETED|Overall Study||2
5060552|NCT01884688|12453231|P1|COMPLETED|Overall Study||1
5060553|NCT01884688|12453231|P1|STARTED|Overall Study||3
5060554|NCT01884675|12453237|P2|NOT COMPLETED|Overall Study||2
5060555|NCT01884675|12453238|P1|NOT COMPLETED|Overall Study||3
5060556|NCT01884675|12453237|P2|COMPLETED|Overall Study||15
5060557|NCT01884675|12453238|P1|COMPLETED|Overall Study||13
5060558|NCT01884675|12453237|P2|STARTED|Overall Study||17
5060559|NCT01884675|12453238|P1|STARTED|Overall Study||16
5060560|NCT01884597|12453281|P3|NOT COMPLETED|Overall Study||1
5060561|NCT01884597|12453282|P2|NOT COMPLETED|Overall Study||1
5060562|NCT01884597|12453283|P1|NOT COMPLETED|Overall Study||1
5060563|NCT01884597|12453281|P3|COMPLETED|Overall Study||15
5060564|NCT01884597|12453282|P2|COMPLETED|Overall Study||2
5060565|NCT01884597|12453283|P1|COMPLETED|Overall Study||4
5060566|NCT01884597|12453281|P3|STARTED|Overall Study||16
5060567|NCT01884597|12453282|P2|STARTED|Overall Study||3
5060568|NCT01884597|12453283|P1|STARTED|Overall Study||5
5060569|NCT01884571|12453312|P1|NOT COMPLETED|Overall Study||8
5060570|NCT01884571|12453312|P1|COMPLETED|Overall Study||23
5060571|NCT01884571|12453312|P1|STARTED|Overall Study||31
5060572|NCT01884545|12453327|P4|NOT COMPLETED|Overall Study||9
5060573|NCT01884545|12453328|P3|NOT COMPLETED|Overall Study||14
5060574|NCT01884545|12453329|P2|NOT COMPLETED|Overall Study||18
5060575|NCT01884545|12453330|P1|NOT COMPLETED|Overall Study||13
5060576|NCT01884545|12453327|P4|COMPLETED|Overall Study||43
5060577|NCT01884545|12453328|P3|COMPLETED|Overall Study||35
5060578|NCT01884545|12453329|P2|COMPLETED|Overall Study||31
5060579|NCT01884545|12453330|P1|COMPLETED|Overall Study||37
5060580|NCT01884545|12453327|P4|STARTED|Overall Study||52
5060581|NCT01884545|12453328|P3|STARTED|Overall Study||49
5060582|NCT01884545|12453329|P2|STARTED|Overall Study||49
5060583|NCT01884545|12453330|P1|STARTED|Overall Study||50
5060584|NCT01884519|12453438|P2|NOT COMPLETED|Overall Study||0
5060585|NCT01884519|12453439|P1|NOT COMPLETED|Overall Study||0
5060586|NCT01884519|12453438|P2|COMPLETED|Overall Study||60
5060587|NCT01884519|12453439|P1|COMPLETED|Overall Study||60
5060588|NCT01884519|12453438|P2|STARTED|Overall Study||60
5060589|NCT01884519|12453439|P1|STARTED|Overall Study||60
5060590|NCT01884350|12453483|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
5060591|NCT01884350|12453484|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
5060592|NCT01884350|12453485|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
5060593|NCT01884350|12453483|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
5060594|NCT01884350|12453484|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
5060595|NCT01884350|12453485|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
5060596|NCT01884350|12453483|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
5060597|NCT01884350|12453484|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
5060598|NCT01884350|12453485|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
5060599|NCT01884350|12453483|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
5060600|NCT01884350|12453484|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
5060601|NCT01884350|12453485|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
5060602|NCT01884350|12453483|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
5060603|NCT01884350|12453484|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
5060604|NCT01884350|12453485|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
5060605|NCT01884350|12453483|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
5060606|NCT01884350|12453484|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
5060607|NCT01884350|12453485|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
5060608|NCT01884350|12453483|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
5060609|NCT01884350|12453484|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
5060610|NCT01884350|12453485|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
5060611|NCT01884350|12453483|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
5060612|NCT01884350|12453484|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
5060613|NCT01884350|12453485|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
5060614|NCT01884337|12453508|P2|NOT COMPLETED|Follow-up Period||1
5060615|NCT01884337|12453509|P1|NOT COMPLETED|Follow-up Period||1
5060616|NCT01884337|12453508|P2|COMPLETED|Follow-up Period||170
5060617|NCT01884337|12453509|P1|COMPLETED|Follow-up Period||323
5060618|NCT01884337|12453508|P2|STARTED|Follow-up Period||171
5060619|NCT01884337|12453509|P1|STARTED|Follow-up Period||324
5060620|NCT01884337|12453508|P2|NOT COMPLETED|Treatment||2
5060621|NCT01884337|12453509|P1|NOT COMPLETED|Treatment||4
5060622|NCT01884337|12453508|P2|COMPLETED|Treatment||170
5060623|NCT01884337|12453509|P1|COMPLETED|Treatment||322
5060624|NCT01884337|12453508|P2|Continuing Into Follow-up Period|Treatment||171
5060625|NCT01884337|12453509|P1|Continuing Into Follow-up Period|Treatment||324
5060626|NCT01884337|12453508|P2|STARTED|Treatment||172
5060627|NCT01884337|12453509|P1|STARTED|Treatment||326
5060628|NCT01884311|12453517|P1|NOT COMPLETED|Overall Study||5
5060629|NCT01884311|12453517|P1|COMPLETED|Overall Study||33
5060630|NCT01884311|12453517|P1|STARTED|Overall Study||38
5060631|NCT01884077|12453527|P2|NOT COMPLETED|Overall Study||10
5060632|NCT01884077|12453528|P1|NOT COMPLETED|Overall Study||8
5060633|NCT01884077|12453527|P2|COMPLETED|Overall Study||1
5060634|NCT01884077|12453528|P1|COMPLETED|Overall Study||0
5060635|NCT01884077|12453527|P2|STARTED|Overall Study||11
5060636|NCT01884077|12453528|P1|STARTED|Overall Study||8
5060637|NCT01884064|12453540|P2|NOT COMPLETED|Overall Study||0
5060638|NCT01884064|12453541|P1|NOT COMPLETED|Overall Study||0
5060639|NCT01884064|12453540|P2|COMPLETED|Overall Study||5
5060640|NCT01884064|12453541|P1|COMPLETED|Overall Study||12
5060641|NCT01884064|12453540|P2|STARTED|Overall Study||5
5060642|NCT01884064|12453541|P1|STARTED|Overall Study||12
5060643|NCT01884025|12453549|P2|NOT COMPLETED|Overall Study||4
5060644|NCT01884025|12453550|P1|NOT COMPLETED|Overall Study||3
5060645|NCT01884025|12453549|P2|COMPLETED|Overall Study||10
5060646|NCT01884025|12453550|P1|COMPLETED|Overall Study||10
5060647|NCT01884025|12453549|P2|STARTED|Overall Study||14
5060648|NCT01884025|12453550|P1|STARTED|Overall Study||13
5060649|NCT01883999|12453578|P1|NOT COMPLETED|Overall Study||3
5060650|NCT01883999|12453578|P1|COMPLETED|Overall Study||61
5060651|NCT01883999|12453578|P1|STARTED|Overall Study||64
5060652|NCT01883986|12453586|P2|NOT COMPLETED|Overall Study||1
5060653|NCT01883986|12453587|P1|NOT COMPLETED|Overall Study||3
5060654|NCT01883986|12453586|P2|COMPLETED|Overall Study|Completed study|19
5060655|NCT01883986|12453587|P1|COMPLETED|Overall Study|Received allocated intervention|17
5060656|NCT01883986|12453586|P2|Did Not Complete Study|Overall Study|Did not completed study|1
5060657|NCT01883986|12453587|P1|Did Not Complete Study|Overall Study||3
5060658|NCT01883986|12453586|P2|STARTED|Overall Study|Allocated to usual care arm|20
5060659|NCT01883986|12453587|P1|STARTED|Overall Study|Allocated to intervention arm|20
5060660|NCT01883908|12453601|P2|NOT COMPLETED|Overall Study||0
5060661|NCT01883908|12453602|P1|NOT COMPLETED|Overall Study||0
5060662|NCT01883908|12453601|P2|COMPLETED|Overall Study||1
5060663|NCT01883908|12453602|P1|COMPLETED|Overall Study||3
5060664|NCT01883908|12453601|P2|STARTED|Overall Study||1
5060665|NCT01883908|12453602|P1|STARTED|Overall Study||3
5060666|NCT01883895|12453610|P1|NOT COMPLETED|Overall Study||2
5060667|NCT01883895|12453610|P1|COMPLETED|Overall Study||32
5060668|NCT01883895|12453610|P1|STARTED|Overall Study||34
5060669|NCT01883804|12453615|P1|NOT COMPLETED|Overall Study||5
5060670|NCT01883804|12453615|P1|COMPLETED|Overall Study||20
5060671|NCT01883804|12453615|P1|STARTED|Overall Study||25
5060672|NCT01883635|12453624|P2|NOT COMPLETED|Overall Study||0
5060673|NCT01883635|12453625|P1|NOT COMPLETED|Overall Study||4
5060674|NCT01883635|12453624|P2|COMPLETED|Overall Study||20
5060675|NCT01883635|12453625|P1|COMPLETED|Overall Study||20
5060676|NCT01883635|12453624|P2|STARTED|Overall Study||20
5060677|NCT01883635|12453625|P1|STARTED|Overall Study||24
5060678|NCT01883492|12453639|P2|NOT COMPLETED|Overall Study||11
5060679|NCT01883492|12453640|P1|NOT COMPLETED|Overall Study||13
5060680|NCT01883492|12453639|P2|COMPLETED|Overall Study||67
5060681|NCT01883492|12453640|P1|COMPLETED|Overall Study||62
5060682|NCT01883492|12453639|P2|STARTED|Overall Study||78
5060683|NCT01883492|12453640|P1|STARTED|Overall Study||75
5060684|NCT01883453|12453672|P2|NOT COMPLETED|Overall Study||23
5060685|NCT01883453|12453673|P1|NOT COMPLETED|Overall Study||25
5060686|NCT01883453|12453672|P2|COMPLETED|Overall Study||50
5060687|NCT01883453|12453673|P1|COMPLETED|Overall Study||48
5060688|NCT01883453|12453672|P2|STARTED|Overall Study||73
5060689|NCT01883453|12453673|P1|STARTED|Overall Study||73
5060690|NCT01883440|12453681|P2|NOT COMPLETED|Overall Study||0
5060691|NCT01883440|12453682|P1|NOT COMPLETED|Overall Study||3
5060692|NCT01883440|12453681|P2|COMPLETED|Overall Study||45
5060693|NCT01883440|12453682|P1|COMPLETED|Overall Study||42
5060694|NCT01883440|12453681|P2|STARTED|Overall Study||45
5060695|NCT01883440|12453682|P1|STARTED|Overall Study||45
5060696|NCT01883427|12453692|P2|NOT COMPLETED|Overall Study||0
5060697|NCT01883427|12453693|P1|NOT COMPLETED|Overall Study||0
5060698|NCT01883427|12453692|P2|COMPLETED|Overall Study||20
5060699|NCT01883427|12453693|P1|COMPLETED|Overall Study||20
5060700|NCT01883427|12453692|P2|STARTED|Overall Study||20
5060701|NCT01883427|12453693|P1|STARTED|Overall Study||20
5060702|NCT01883141|12453699|P1|NOT COMPLETED|Overall Study||0
5060703|NCT01883141|12453699|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
5060704|NCT01883141|12453699|P1|Multivein|Overall Study||23
5060705|NCT01883141|12453699|P1|Biv Pacing-Posterior|Overall Study||22
5060706|NCT01883141|12453699|P1|BiV Pacing-Anterior|Overall Study||23
5060707|NCT01883141|12453699|P1|Multispot-pacing|Overall Study||24
5060708|NCT01883141|12453699|P1|BiV Pacing-Standard Therapy|Overall Study||26
5060709|NCT01883141|12453699|P1|BiV Pacing-Mid|Overall Study||25
5060710|NCT01883141|12453699|P1|BiV Pacing-Distal|Overall Study||24
5060711|NCT01883141|12453699|P1|Usable EP Data|Overall Study||26
5060712|NCT01883141|12453699|P1|EP Study Performed|Overall Study||30
5060713|NCT01883141|12453699|P1|Passing Eligibility|Overall Study||30
5060714|NCT01883141|12453699|P1|STARTED|Overall Study||31
5060715|NCT01882985|12453708|P1|NOT COMPLETED|Overall Study||2
5060716|NCT01882985|12453708|P1|COMPLETED|Overall Study||12
5060717|NCT01882985|12453708|P1|STARTED|Overall Study||14
5060718|NCT01882907|12453717|P2|NOT COMPLETED|Overall Study||28
5060719|NCT01882907|12453718|P1|NOT COMPLETED|Overall Study||14
5060720|NCT01882907|12453717|P2|COMPLETED|Overall Study||83
5060721|NCT01882907|12453718|P1|COMPLETED|Overall Study||103
5060722|NCT01882907|12453717|P2|STARTED|Overall Study||111
5060723|NCT01882907|12453718|P1|STARTED|Overall Study||117
5060724|NCT01882868|12453734|P1|NOT COMPLETED|Overall Study||0
5060725|NCT01882868|12453734|P1|COMPLETED|Overall Study||62
5060726|NCT01882868|12453734|P1|STARTED|Overall Study||62
5060727|NCT01882829|12453764|P1|NOT COMPLETED|Overall Study||6
5060728|NCT01882829|12453764|P1|COMPLETED|Overall Study||14
5060729|NCT01882829|12453764|P1|STARTED|Overall Study||20
5060730|NCT01882803|12453778|P1|NOT COMPLETED|Overall Study||94
5060731|NCT01882803|12453778|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
5060732|NCT01882803|12453778|P1|STARTED|Overall Study||129
5060733|NCT01882764|12453791|P2|NOT COMPLETED|Overall Study||18
5060734|NCT01882764|12453792|P1|NOT COMPLETED|Overall Study||47
5060735|NCT01882764|12453791|P2|COMPLETED|Overall Study||1
5060736|NCT01882764|12453792|P1|COMPLETED|Overall Study||0
5060737|NCT01882764|12453791|P2|STARTED|Overall Study||19
5060738|NCT01882764|12453792|P1|STARTED|Overall Study||47
5060739|NCT01882725|12453798|P1|NOT COMPLETED|Overall Study||0
5060740|NCT01882725|12453798|P1|COMPLETED|Overall Study||14
5060741|NCT01882725|12453798|P1|STARTED|Overall Study||14
5060742|NCT01882647|12453805|P2|NOT COMPLETED|Overall Study||6
5060743|NCT01882647|12453806|P1|NOT COMPLETED|Overall Study||2
5060744|NCT01882647|12453805|P2|COMPLETED|Overall Study||106
5060745|NCT01882647|12453806|P1|COMPLETED|Overall Study||108
5060746|NCT01882647|12453805|P2|STARTED|Overall Study||112
5060747|NCT01882647|12453806|P1|STARTED|Overall Study||110
5060748|NCT01882543|12453824|P2|NOT COMPLETED|Overall Study||3
5060749|NCT01882543|12453825|P1|NOT COMPLETED|Overall Study||4
5060750|NCT01882543|12453824|P2|COMPLETED|Overall Study||29
5060751|NCT01882543|12453825|P1|COMPLETED|Overall Study||33
5060752|NCT01882543|12453824|P2|STARTED|Overall Study||32
5060753|NCT01882543|12453825|P1|STARTED|Overall Study||37
5060754|NCT01882465|12453846|P7|NOT COMPLETED|Period 3||0
5060755|NCT01882465|12453847|P6|NOT COMPLETED|Period 3||0
5060756|NCT01882465|12453848|P5|NOT COMPLETED|Period 3||0
5060757|NCT01882465|12453849|P4|NOT COMPLETED|Period 3||0
5060758|NCT01882465|12453850|P3|NOT COMPLETED|Period 3||0
5060759|NCT01882465|12453851|P2|NOT COMPLETED|Period 3||0
5060760|NCT01882465|12453852|P1|NOT COMPLETED|Period 3||0
5060761|NCT01882465|12453846|P7|COMPLETED|Period 3||0
5060762|NCT01882465|12453847|P6|COMPLETED|Period 3||5
5060763|NCT01882465|12453848|P5|COMPLETED|Period 3||4
5060764|NCT01882465|12453849|P4|COMPLETED|Period 3||5
5060765|NCT01882465|12453850|P3|COMPLETED|Period 3||5
5060766|NCT01882465|12453851|P2|COMPLETED|Period 3||6
5060767|NCT01882465|12453852|P1|COMPLETED|Period 3||6
5060768|NCT01882465|12453846|P7|STARTED|Period 3||0
5060769|NCT01882465|12453847|P6|STARTED|Period 3||5
5060770|NCT01882465|12453848|P5|STARTED|Period 3||4
5060771|NCT01882465|12453849|P4|STARTED|Period 3||5
5060772|NCT01882465|12453850|P3|STARTED|Period 3||5
5060773|NCT01882465|12453851|P2|STARTED|Period 3||6
5060774|NCT01882465|12453852|P1|STARTED|Period 3||6
5060775|NCT01882465|12453846|P7|NOT COMPLETED|Period 2||0
5060776|NCT01882465|12453847|P6|NOT COMPLETED|Period 2||0
5060777|NCT01882465|12453848|P5|NOT COMPLETED|Period 2||1
5060778|NCT01882465|12453849|P4|NOT COMPLETED|Period 2||0
5060779|NCT01882465|12453850|P3|NOT COMPLETED|Period 2||0
5060780|NCT01882465|12453851|P2|NOT COMPLETED|Period 2||0
5060781|NCT01882465|12453852|P1|NOT COMPLETED|Period 2||0
5060782|NCT01882465|12453846|P7|COMPLETED|Period 2||0
5060783|NCT01882465|12453847|P6|COMPLETED|Period 2||5
5060784|NCT01882465|12453848|P5|COMPLETED|Period 2||4
5060785|NCT01882465|12453849|P4|COMPLETED|Period 2||5
5060786|NCT01882465|12453850|P3|COMPLETED|Period 2||5
5060787|NCT01882465|12453851|P2|COMPLETED|Period 2||6
5060788|NCT01882465|12453852|P1|COMPLETED|Period 2||6
5060789|NCT01882465|12453846|P7|STARTED|Period 2||0
5060790|NCT01882465|12453847|P6|STARTED|Period 2||5
5060791|NCT01882465|12453848|P5|STARTED|Period 2||5
5060792|NCT01882465|12453849|P4|STARTED|Period 2||5
5060793|NCT01882465|12453850|P3|STARTED|Period 2||5
5060794|NCT01882465|12453851|P2|STARTED|Period 2||6
5060795|NCT01882465|12453852|P1|STARTED|Period 2||6
5060796|NCT01882465|12453846|P7|NOT COMPLETED|Period 1||1
5060797|NCT01882465|12453847|P6|NOT COMPLETED|Period 1||0
5060798|NCT01882465|12453848|P5|NOT COMPLETED|Period 1||0
5060799|NCT01882465|12453849|P4|NOT COMPLETED|Period 1||1
5060800|NCT01882465|12453850|P3|NOT COMPLETED|Period 1||0
5060801|NCT01882465|12453851|P2|NOT COMPLETED|Period 1||0
5060802|NCT01882465|12453852|P1|NOT COMPLETED|Period 1||0
5060803|NCT01882465|12453846|P7|COMPLETED|Period 1||0
5060804|NCT01882465|12453847|P6|COMPLETED|Period 1||5
5060805|NCT01882465|12453848|P5|COMPLETED|Period 1||5
5060806|NCT01882465|12453849|P4|COMPLETED|Period 1||5
5060807|NCT01882465|12453850|P3|COMPLETED|Period 1||5
5060808|NCT01882465|12453851|P2|COMPLETED|Period 1||6
5060809|NCT01882465|12453852|P1|COMPLETED|Period 1||6
5060810|NCT01882465|12453846|P7|STARTED|Period 1||1
5060811|NCT01882465|12453847|P6|STARTED|Period 1||5
5060812|NCT01882465|12453848|P5|STARTED|Period 1||5
5060813|NCT01882465|12453849|P4|STARTED|Period 1||6
5060814|NCT01882465|12453850|P3|STARTED|Period 1||5
5060815|NCT01882465|12453851|P2|STARTED|Period 1||6
5060816|NCT01882465|12453852|P1|STARTED|Period 1||6
5060817|NCT01882439|12453864|P4|NOT COMPLETED|Overall Study||9
5060818|NCT01882439|12453865|P3|NOT COMPLETED|Overall Study||10
5060819|NCT01882439|12453866|P2|NOT COMPLETED|Overall Study||21
5060820|NCT01882439|12453867|P1|NOT COMPLETED|Overall Study||9
5060821|NCT01882439|12453864|P4|COMPLETED|Overall Study||56
5060822|NCT01882439|12453865|P3|COMPLETED|Overall Study||56
5060823|NCT01882439|12453866|P2|COMPLETED|Overall Study||111
5060824|NCT01882439|12453867|P1|COMPLETED|Overall Study||122
5060825|NCT01882439|12453864|P4|STARTED|Overall Study|Received treatment|65
5060826|NCT01882439|12453865|P3|STARTED|Overall Study|Received treatment|66
5060827|NCT01882439|12453866|P2|STARTED|Overall Study|Received treatment|132
5060828|NCT01882439|12453867|P1|STARTED|Overall Study|Received treatment|131
5060829|NCT01882413|12454047|P1|NOT COMPLETED|Overall Study||0
5060830|NCT01882413|12454047|P1|COMPLETED|Overall Study||204
5060831|NCT01882413|12454047|P1|STARTED|Overall Study||204
5060832|NCT01882257|12454064|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
5060833|NCT01882257|12454065|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
5060834|NCT01882257|12454066|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
5060835|NCT01882257|12454064|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
5060836|NCT01882257|12454065|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
5060837|NCT01882257|12454066|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
5060838|NCT01882257|12454064|P3|STARTED|Therapy Portion of Study (12 Months)||22
5060839|NCT01882257|12454065|P2|STARTED|Therapy Portion of Study (12 Months)||38
5060840|NCT01882257|12454066|P1|STARTED|Therapy Portion of Study (12 Months)||11
5060841|NCT01882257|12454064|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
5060842|NCT01882257|12454065|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
5060843|NCT01882257|12454066|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
5060844|NCT01882257|12454064|P3|COMPLETED|Study Origination to Beginning Therapy||22
5060845|NCT01882257|12454065|P2|COMPLETED|Study Origination to Beginning Therapy||38
5060846|NCT01882257|12454066|P1|COMPLETED|Study Origination to Beginning Therapy||11
5060847|NCT01882257|12454064|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
5060848|NCT01882257|12454065|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
5060849|NCT01882257|12454066|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
5060850|NCT01882257|12454064|P3|STARTED|Study Origination to Beginning Therapy||23
5060851|NCT01882257|12454065|P2|STARTED|Study Origination to Beginning Therapy||40
5060852|NCT01882257|12454066|P1|STARTED|Study Origination to Beginning Therapy||11
5060853|NCT01882088|12454073|P1|NOT COMPLETED|Overall Study||5
5060854|NCT01882088|12454073|P1|COMPLETED|Overall Study||30
5060855|NCT01882088|12454073|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
5060856|NCT01882062|12454086|P1|NOT COMPLETED|Overall Study||0
5060857|NCT01882062|12454086|P1|COMPLETED|Overall Study|18th of july 2013|10
5060858|NCT01882062|12454086|P1|STARTED|Overall Study|16th of may 2013|10
5060859|NCT01881984|12454090|P1|NOT COMPLETED|Overall Study||0
5060860|NCT01881984|12454090|P1|COMPLETED|Overall Study||4
5060861|NCT01881984|12454090|P1|STARTED|Overall Study||4
5060862|NCT01881932|12454098|P3|NOT COMPLETED|Overall Study||0
5060863|NCT01881932|12454099|P2|NOT COMPLETED|Overall Study||0
5060864|NCT01881932|12454100|P1|NOT COMPLETED|Overall Study||0
5060865|NCT01881932|12454098|P3|COMPLETED|Overall Study||13
5060866|NCT01881932|12454099|P2|COMPLETED|Overall Study||4
5060867|NCT01881932|12454100|P1|COMPLETED|Overall Study||2
5060868|NCT01881932|12454098|P3|STARTED|Overall Study||13
5060869|NCT01881932|12454099|P2|STARTED|Overall Study||4
5060870|NCT01881932|12454100|P1|STARTED|Overall Study||2
5060871|NCT01881867|12454110|P2|NOT COMPLETED|Overall Study||13
5060872|NCT01881867|12454111|P1|NOT COMPLETED|Overall Study||12
5060873|NCT01881867|12454110|P2|COMPLETED|Overall Study||15
5060874|NCT01881867|12454111|P1|COMPLETED|Overall Study||14
5060875|NCT01881867|12454110|P2|STARTED|Overall Study||28
5060876|NCT01881867|12454111|P1|STARTED|Overall Study||26
5060877|NCT01881828|12454131|P2|NOT COMPLETED|Overall Study||0
5060878|NCT01881828|12454132|P1|NOT COMPLETED|Overall Study||0
5060879|NCT01881828|12454131|P2|COMPLETED|Overall Study||69
5060880|NCT01881828|12454132|P1|COMPLETED|Overall Study||71
5060881|NCT01881828|12454131|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
5060882|NCT01881828|12454132|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
5060883|NCT01881776|12454155|P3|NOT COMPLETED|Overall Study||2
5060884|NCT01881776|12454156|P2|NOT COMPLETED|Overall Study||4
5060885|NCT01881776|12454157|P1|NOT COMPLETED|Overall Study||1
5060886|NCT01881776|12454155|P3|COMPLETED|Overall Study||20
5060887|NCT01881776|12454156|P2|COMPLETED|Overall Study||20
5060888|NCT01881776|12454157|P1|COMPLETED|Overall Study||23
5060889|NCT01881776|12454155|P3|STARTED|Overall Study||22
5060890|NCT01881776|12454156|P2|STARTED|Overall Study||24
5060891|NCT01881776|12454157|P1|STARTED|Overall Study||24
5060892|NCT01881750|12454185|P2|NOT COMPLETED|Overall Study||4
5060893|NCT01881750|12454186|P1|NOT COMPLETED|Overall Study||2
5060894|NCT01881750|12454185|P2|COMPLETED|Overall Study||22
5060895|NCT01881750|12454186|P1|COMPLETED|Overall Study||25
5060896|NCT01881750|12454185|P2|STARTED|Overall Study||26
5060897|NCT01881750|12454186|P1|STARTED|Overall Study||27
5060898|NCT01881737|12454204|P1|NOT COMPLETED|Overall Study||5
5060899|NCT01881737|12454204|P1|COMPLETED|Overall Study||10
5060900|NCT01881737|12454204|P1|Number Screened|Overall Study||15
5060901|NCT01881737|12454204|P1|STARTED|Overall Study|This is a pilot study|15
5060902|NCT01881620|12454213|P1|NOT COMPLETED|Overall Study||4
5060903|NCT01881620|12454213|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
5060904|NCT01881620|12454213|P1|STARTED|Overall Study||109
5060905|NCT01881412|12454224|P2|NOT COMPLETED|Overall Study||2
5060906|NCT01881412|12454225|P1|NOT COMPLETED|Overall Study||10
5060907|NCT01881412|12454224|P2|COMPLETED|Overall Study||57
5060908|NCT01881412|12454225|P1|COMPLETED|Overall Study||49
5060909|NCT01881412|12454224|P2|STARTED|Overall Study||59
5060910|NCT01881412|12454225|P1|STARTED|Overall Study||59
5060911|NCT01881373|12454244|P3|NOT COMPLETED|24 Months||0
5060912|NCT01881373|12454245|P2|NOT COMPLETED|24 Months||0
5060913|NCT01881373|12454246|P1|NOT COMPLETED|24 Months||0
5060914|NCT01881373|12454244|P3|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
5060915|NCT01881373|12454245|P2|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
5060916|NCT01881373|12454246|P1|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
5060917|NCT01881373|12454244|P3|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
5060918|NCT01881373|12454245|P2|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
5060919|NCT01881373|12454246|P1|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
5060920|NCT01881373|12454244|P3|NOT COMPLETED|Baseline||0
5060921|NCT01881373|12454245|P2|NOT COMPLETED|Baseline||0
5060922|NCT01881373|12454246|P1|NOT COMPLETED|Baseline||0
5060923|NCT01881373|12454244|P3|COMPLETED|Baseline|Cross-sectional sample|1321
5060924|NCT01881373|12454245|P2|COMPLETED|Baseline|Cross-sectional sample|1491
5060925|NCT01881373|12454246|P1|COMPLETED|Baseline|Cross-sectional sample|1517
5060926|NCT01881373|12454244|P3|STARTED|Baseline|Cross-sectional sample|1321
5060927|NCT01881373|12454245|P2|STARTED|Baseline|Cross-sectional sample|1491
5060928|NCT01881373|12454246|P1|STARTED|Baseline|Cross-sectional sample|1517
5060929|NCT01881230|12454293|P3|NOT COMPLETED|Overall Study||66
5060930|NCT01881230|12454294|P2|NOT COMPLETED|Overall Study||64
5060931|NCT01881230|12454295|P1|NOT COMPLETED|Overall Study||61
5060932|NCT01881230|12454293|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
5060933|NCT01881230|12454294|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
5060934|NCT01881230|12454295|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
5060935|NCT01881230|12454293|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
5060936|NCT01881230|12454294|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
5060937|NCT01881230|12454295|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
5060938|NCT01881230|12454293|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
5060939|NCT01881230|12454294|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
5060940|NCT01881230|12454295|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
5060941|NCT01881230|12454293|P3|STARTED|Overall Study||66
5060942|NCT01881230|12454294|P2|STARTED|Overall Study||64
5060943|NCT01881230|12454295|P1|STARTED|Overall Study||61
5060944|NCT01881126|12454323|P2|NOT COMPLETED|Overall Study||2
5060945|NCT01881126|12454324|P1|NOT COMPLETED|Overall Study||1
5060946|NCT01881126|12454323|P2|COMPLETED|Overall Study||44
5060947|NCT01881126|12454324|P1|COMPLETED|Overall Study||46
5060948|NCT01881126|12454323|P2|STARTED|Overall Study||46
5060949|NCT01881126|12454324|P1|STARTED|Overall Study||47
5060950|NCT01881113|12454332|P2|NOT COMPLETED|Overall Study||6
5060951|NCT01881113|12454333|P1|NOT COMPLETED|Overall Study||8
5060952|NCT01881113|12454332|P2|COMPLETED|Overall Study||44
5060953|NCT01881113|12454333|P1|COMPLETED|Overall Study||43
5060954|NCT01881113|12454332|P2|STARTED|Overall Study||50
5060955|NCT01881113|12454333|P1|STARTED|Overall Study||51
5060956|NCT01881087|12454390|P3|NOT COMPLETED|Overall Study||2
5060957|NCT01881087|12454391|P2|NOT COMPLETED|Overall Study||0
5060958|NCT01881087|12454392|P1|NOT COMPLETED|Overall Study||1
5060959|NCT01881087|12454390|P3|COMPLETED|Overall Study||60
5060960|NCT01881087|12454391|P2|COMPLETED|Overall Study||61
5060961|NCT01881087|12454392|P1|COMPLETED|Overall Study||59
5060962|NCT01881087|12454390|P3|STARTED|Overall Study||62
5060963|NCT01881087|12454391|P2|STARTED|Overall Study||61
5060964|NCT01881087|12454392|P1|STARTED|Overall Study||60
5060965|NCT01881009|12454405|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
5060966|NCT01881009|12454406|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
5060967|NCT01881009|12454405|P2|COMPLETED|Summer Camp Session (6 Days)||21
5060968|NCT01881009|12454406|P1|COMPLETED|Summer Camp Session (6 Days)||0
5060969|NCT01881009|12454405|P2|STARTED|Summer Camp Session (6 Days)||22
5060970|NCT01881009|12454406|P1|STARTED|Summer Camp Session (6 Days)||0
5060971|NCT01881009|12454405|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
5060972|NCT01881009|12454406|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
5060973|NCT01881009|12454405|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
5060974|NCT01881009|12454406|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
5060975|NCT01881009|12454405|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
5060976|NCT01881009|12454406|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
5060977|NCT01880840|12454417|P2|NOT COMPLETED|Overall Study||5
5060978|NCT01880840|12454418|P1|NOT COMPLETED|Overall Study||8
5060979|NCT01880840|12454417|P2|COMPLETED|Overall Study||91
5060980|NCT01880840|12454418|P1|COMPLETED|Overall Study||87
5060981|NCT01880840|12454417|P2|STARTED|Overall Study||96
5060982|NCT01880840|12454418|P1|STARTED|Overall Study||95
5060983|NCT01880736|12454428|P4|NOT COMPLETED|Overall Study||6
5060984|NCT01880736|12454429|P3|NOT COMPLETED|Overall Study||1
5060985|NCT01880736|12454430|P2|NOT COMPLETED|Overall Study||2
5060986|NCT01880736|12454431|P1|NOT COMPLETED|Overall Study||1
5060987|NCT01880736|12454428|P4|COMPLETED|Overall Study||108
5060988|NCT01880736|12454429|P3|COMPLETED|Overall Study||114
5060989|NCT01880736|12454430|P2|COMPLETED|Overall Study||113
5060990|NCT01880736|12454431|P1|COMPLETED|Overall Study||113
5060991|NCT01880736|12454428|P4|STARTED|Overall Study||114
5060992|NCT01880736|12454429|P3|STARTED|Overall Study||115
5060993|NCT01880736|12454430|P2|STARTED|Overall Study||115
5060994|NCT01880736|12454431|P1|STARTED|Overall Study||114
5060995|NCT01880723|12454475|P2|NOT COMPLETED|Overall Study||0
5060996|NCT01880723|12454476|P1|NOT COMPLETED|Overall Study||0
5060997|NCT01880723|12454475|P2|COMPLETED|Overall Study||16
5060998|NCT01880723|12454476|P1|COMPLETED|Overall Study||16
5060999|NCT01880723|12454475|P2|STARTED|Overall Study||16
5061000|NCT01880723|12454476|P1|STARTED|Overall Study||16
5061001|NCT01880697|12454492|P2|NOT COMPLETED|Overall Study||1
5061002|NCT01880697|12454493|P1|NOT COMPLETED|Overall Study||0
5061003|NCT01880697|12454492|P2|COMPLETED|Overall Study||62
5061004|NCT01880697|12454493|P1|COMPLETED|Overall Study||63
5061005|NCT01880697|12454492|P2|STARTED|Overall Study||63
5061006|NCT01880697|12454493|P1|STARTED|Overall Study||63
5061007|NCT01880593|12454515|P2|NOT COMPLETED|Overall Study||6
5061008|NCT01880593|12454516|P1|NOT COMPLETED|Overall Study||8
5061009|NCT01880593|12454515|P2|COMPLETED|Overall Study||10
5061010|NCT01880593|12454516|P1|COMPLETED|Overall Study||10
5061011|NCT01880593|12454515|P2|STARTED|Overall Study||16
5061012|NCT01880593|12454516|P1|STARTED|Overall Study||18
5061013|NCT01880528|12454536|P2|NOT COMPLETED|Overall Study||1
5061014|NCT01880528|12454537|P1|NOT COMPLETED|Overall Study||1
5061015|NCT01880528|12454536|P2|COMPLETED|Overall Study||10
5061016|NCT01880528|12454537|P1|COMPLETED|Overall Study||11
5061017|NCT01880528|12454536|P2|STARTED|Overall Study||11
5061018|NCT01880528|12454537|P1|STARTED|Overall Study||12
5061019|NCT01880515|12454553|P2|NOT COMPLETED|Overall Study||9
5061020|NCT01880515|12454554|P1|NOT COMPLETED|Overall Study||8
5061021|NCT01880515|12454553|P2|COMPLETED|Overall Study||45
5061022|NCT01880515|12454554|P1|COMPLETED|Overall Study||45
5061023|NCT01880515|12454553|P2|STARTED|Overall Study||54
5061024|NCT01880515|12454554|P1|STARTED|Overall Study||53
5061025|NCT01880437|12454565|P3|NOT COMPLETED|Overall Study||19
5061026|NCT01880437|12454566|P2|NOT COMPLETED|Overall Study||4
5061027|NCT01880437|12454567|P1|NOT COMPLETED|Overall Study||15
5061028|NCT01880437|12454565|P3|COMPLETED|Overall Study||0
5061029|NCT01880437|12454566|P2|COMPLETED|Overall Study||0
5061030|NCT01880437|12454567|P1|COMPLETED|Overall Study||0
5061031|NCT01880437|12454565|P3|STARTED|Overall Study||19
5061032|NCT01880437|12454566|P2|STARTED|Overall Study||4
5061033|NCT01880437|12454567|P1|STARTED|Overall Study||15
5061034|NCT01880424|12454593|P2|NOT COMPLETED|Overall Study||55
5061035|NCT01880424|12454594|P1|NOT COMPLETED|Overall Study||33
5061036|NCT01880424|12454593|P2|COMPLETED|Overall Study||367
5061037|NCT01880424|12454594|P1|COMPLETED|Overall Study||384
5061038|NCT01880424|12454593|P2|STARTED|Overall Study||422
5061039|NCT01880424|12454594|P1|STARTED|Overall Study||417
5061040|NCT01880320|12454619|P3|NOT COMPLETED|Overall Study||8
5061041|NCT01880320|12454620|P2|NOT COMPLETED|Overall Study||25
5061042|NCT01880320|12454621|P1|NOT COMPLETED|Overall Study||20
5061043|NCT01880320|12454619|P3|COMPLETED|Overall Study||61
5061044|NCT01880320|12454620|P2|COMPLETED|Overall Study||192
5061045|NCT01880320|12454621|P1|COMPLETED|Overall Study||197
5061046|NCT01880320|12454619|P3|STARTED|Overall Study||69
5061047|NCT01880320|12454620|P2|STARTED|Overall Study||217
5061048|NCT01880320|12454621|P1|STARTED|Overall Study||217
5061049|NCT01880099|12454638|P3|NOT COMPLETED|Overall Study||7
5061050|NCT01880099|12454639|P2|NOT COMPLETED|Overall Study||10
5061051|NCT01880099|12454640|P1|NOT COMPLETED|Overall Study||8
5061052|NCT01880099|12454638|P3|COMPLETED|Overall Study||15
5061053|NCT01880099|12454639|P2|COMPLETED|Overall Study||11
5061054|NCT01880099|12454640|P1|COMPLETED|Overall Study||9
5061055|NCT01880099|12454638|P3|STARTED|Overall Study||22
5061056|NCT01880099|12454639|P2|STARTED|Overall Study||21
5061057|NCT01880099|12454640|P1|STARTED|Overall Study||17
5061058|NCT01880086|12454650|P2|NOT COMPLETED|Overall Study||1
5061059|NCT01880086|12454651|P1|NOT COMPLETED|Overall Study||1
5061060|NCT01880086|12454650|P2|COMPLETED|Overall Study||6
5061061|NCT01880086|12454651|P1|COMPLETED|Overall Study||5
5061062|NCT01880086|12454650|P2|STARTED|Overall Study||7
5061063|NCT01880086|12454651|P1|STARTED|Overall Study||6
5061064|NCT01880073|12454669|P1|NOT COMPLETED|Overall Study||0
5061065|NCT01880073|12454669|P1|COMPLETED|Overall Study||24
5061066|NCT01880073|12454669|P1|STARTED|Overall Study||24
5061067|NCT01880047|12454680|P4|NOT COMPLETED|Extension Phase - 18 Months||2
5061068|NCT01880047|12454681|P3|NOT COMPLETED|Extension Phase - 18 Months||1
5061069|NCT01880047|12454682|P2|NOT COMPLETED|Extension Phase - 18 Months||3
5061070|NCT01880047|12454683|P1|NOT COMPLETED|Extension Phase - 18 Months||9
5061071|NCT01880047|12454680|P4|COMPLETED|Extension Phase - 18 Months||0
5061072|NCT01880047|12454681|P3|COMPLETED|Extension Phase - 18 Months||3
5061073|NCT01880047|12454682|P2|COMPLETED|Extension Phase - 18 Months||3
5061074|NCT01880047|12454683|P1|COMPLETED|Extension Phase - 18 Months||6
5061075|NCT01880047|12454680|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
5061076|NCT01880047|12454681|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
5061077|NCT01880047|12454682|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
5061078|NCT01880047|12454683|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
5061079|NCT01880047|12454680|P4|NOT COMPLETED|Weeks 5-8||0
5061080|NCT01880047|12454681|P3|NOT COMPLETED|Weeks 5-8||0
5061081|NCT01880047|12454682|P2|NOT COMPLETED|Weeks 5-8||1
5061082|NCT01880047|12454683|P1|NOT COMPLETED|Weeks 5-8||2
5061083|NCT01880047|12454680|P4|COMPLETED|Weeks 5-8||2
5061084|NCT01880047|12454681|P3|COMPLETED|Weeks 5-8||4
5061085|NCT01880047|12454682|P2|COMPLETED|Weeks 5-8||6
5061086|NCT01880047|12454683|P1|COMPLETED|Weeks 5-8||15
5061087|NCT01880047|12454680|P4|STARTED|Weeks 5-8||2
5061088|NCT01880047|12454681|P3|STARTED|Weeks 5-8||4
5061089|NCT01880047|12454682|P2|STARTED|Weeks 5-8||7
5061090|NCT01880047|12454683|P1|STARTED|Weeks 5-8||17
5061091|NCT01880047|12454680|P4|NOT COMPLETED|Weeks 3-4||0
5061092|NCT01880047|12454681|P3|NOT COMPLETED|Weeks 3-4||0
5061093|NCT01880047|12454682|P2|NOT COMPLETED|Weeks 3-4||1
5061094|NCT01880047|12454683|P1|NOT COMPLETED|Weeks 3-4||0
5061095|NCT01880047|12454680|P4|COMPLETED|Weeks 3-4||2
5061096|NCT01880047|12454681|P3|COMPLETED|Weeks 3-4||4
5061097|NCT01880047|12454682|P2|COMPLETED|Weeks 3-4||7
5061098|NCT01880047|12454683|P1|COMPLETED|Weeks 3-4||17
5061099|NCT01880047|12454680|P4|STARTED|Weeks 3-4||2
5061100|NCT01880047|12454681|P3|STARTED|Weeks 3-4||4
5061101|NCT01880047|12454682|P2|STARTED|Weeks 3-4||8
5061102|NCT01880047|12454683|P1|STARTED|Weeks 3-4||17
5061103|NCT01880047|12454680|P4|NOT COMPLETED|Weeks 0-2||1
5061104|NCT01880047|12454681|P3|NOT COMPLETED|Weeks 0-2||1
5061105|NCT01880047|12454682|P2|NOT COMPLETED|Weeks 0-2||1
5061106|NCT01880047|12454683|P1|NOT COMPLETED|Weeks 0-2||0
5061107|NCT01880047|12454680|P4|COMPLETED|Weeks 0-2||2
5061108|NCT01880047|12454681|P3|COMPLETED|Weeks 0-2||4
5061109|NCT01880047|12454682|P2|COMPLETED|Weeks 0-2||8
5061110|NCT01880047|12454683|P1|COMPLETED|Weeks 0-2||17
5061111|NCT01880047|12454680|P4|STARTED|Weeks 0-2||3
5061112|NCT01880047|12454681|P3|STARTED|Weeks 0-2||5
5061113|NCT01880047|12454682|P2|STARTED|Weeks 0-2||9
5061114|NCT01880047|12454683|P1|STARTED|Weeks 0-2||17
5061115|NCT01879852|12454706|P2|NOT COMPLETED|Overall Study||0
5061116|NCT01879852|12454707|P1|NOT COMPLETED|Overall Study||2
5061117|NCT01879852|12454706|P2|COMPLETED|Overall Study||13
5061118|NCT01879852|12454707|P1|COMPLETED|Overall Study||12
5061119|NCT01879852|12454706|P2|STARTED|Overall Study||13
5061120|NCT01879852|12454707|P1|STARTED|Overall Study||14
5061121|NCT01879826|12454721|P2|NOT COMPLETED|Overall Study||0
5061122|NCT01879826|12454722|P1|NOT COMPLETED|Overall Study||0
5061123|NCT01879826|12454721|P2|COMPLETED|Overall Study||40
5061124|NCT01879826|12454722|P1|COMPLETED|Overall Study||41
5061125|NCT01879826|12454721|P2|STARTED|Overall Study||40
5061126|NCT01879826|12454722|P1|STARTED|Overall Study||41
5061127|NCT01879800|12454732|P2|NOT COMPLETED|Overall Study||4
5061128|NCT01879800|12454733|P1|NOT COMPLETED|Overall Study||0
5061129|NCT01879800|12454732|P2|COMPLETED|Overall Study||26
5061130|NCT01879800|12454733|P1|COMPLETED|Overall Study||14
5061131|NCT01879800|12454732|P2|STARTED|Overall Study||30
5061132|NCT01879800|12454733|P1|STARTED|Overall Study||14
5061133|NCT01879735|12454745|P2|NOT COMPLETED|Overall Study||0
5061134|NCT01879735|12454746|P1|NOT COMPLETED|Overall Study||0
5061135|NCT01879735|12454745|P2|COMPLETED|Overall Study||16
5061136|NCT01879735|12454746|P1|COMPLETED|Overall Study||6
5061137|NCT01879735|12454745|P2|STARTED|Overall Study||16
5061138|NCT01879735|12454746|P1|STARTED|Overall Study||6
5061139|NCT01879722|12454762|P10|NOT COMPLETED|Overall Study||0
5061140|NCT01879722|12454763|P9|NOT COMPLETED|Overall Study||2
5061141|NCT01879722|12454764|P8|NOT COMPLETED|Overall Study||1
5061142|NCT01879722|12454765|P7|NOT COMPLETED|Overall Study||0
5061143|NCT01879722|12454766|P6|NOT COMPLETED|Overall Study||0
5061144|NCT01879722|12454767|P5|NOT COMPLETED|Overall Study||1
5061145|NCT01879722|12454768|P4|NOT COMPLETED|Overall Study||1
5061146|NCT01879722|12454769|P3|NOT COMPLETED|Overall Study||0
5061147|NCT01879722|12454770|P2|NOT COMPLETED|Overall Study||1
5061148|NCT01879722|12454771|P1|NOT COMPLETED|Overall Study||0
5061149|NCT01879722|12454762|P10|COMPLETED|Overall Study||6
5061150|NCT01879722|12454763|P9|COMPLETED|Overall Study||6
5061151|NCT01879722|12454764|P8|COMPLETED|Overall Study||7
5061152|NCT01879722|12454765|P7|COMPLETED|Overall Study||8
5061153|NCT01879722|12454766|P6|COMPLETED|Overall Study||9
5061154|NCT01879722|12454767|P5|COMPLETED|Overall Study||7
5061155|NCT01879722|12454768|P4|COMPLETED|Overall Study||7
5061156|NCT01879722|12454769|P3|COMPLETED|Overall Study||7
5061157|NCT01879722|12454770|P2|COMPLETED|Overall Study||7
5061158|NCT01879722|12454771|P1|COMPLETED|Overall Study||7
5061159|NCT01879722|12454762|P10|STARTED|Overall Study||6
5061160|NCT01879722|12454763|P9|STARTED|Overall Study||8
5061161|NCT01879722|12454764|P8|STARTED|Overall Study||8
5061162|NCT01879722|12454765|P7|STARTED|Overall Study||8
5061163|NCT01879722|12454766|P6|STARTED|Overall Study||9
5061164|NCT01879722|12454767|P5|STARTED|Overall Study||8
5061165|NCT01879722|12454768|P4|STARTED|Overall Study||8
5061166|NCT01879722|12454769|P3|STARTED|Overall Study||7
5061167|NCT01879722|12454770|P2|STARTED|Overall Study||8
5061168|NCT01879722|12454771|P1|STARTED|Overall Study||7
5061169|NCT01879683|12454919|P1|NOT COMPLETED|Overall Study||1
5061170|NCT01879683|12454919|P1|COMPLETED|Overall Study||9
5061171|NCT01879683|12454919|P1|STARTED|Overall Study||10
5061172|NCT01879618|12454926|P1|NOT COMPLETED|Overall Study||21
5061173|NCT01879618|12454926|P1|COMPLETED|Overall Study||131
5061174|NCT01879618|12454926|P1|STARTED|Overall Study||152
5061175|NCT01879579|12454933|P2|NOT COMPLETED|Overall Study||2
5061176|NCT01879579|12454934|P1|NOT COMPLETED|Overall Study||5
5061177|NCT01879579|12454933|P2|COMPLETED|Overall Study||26
5061178|NCT01879579|12454934|P1|COMPLETED|Overall Study||28
5061179|NCT01879579|12454933|P2|STARTED|Overall Study||28
5061180|NCT01879579|12454934|P1|STARTED|Overall Study||33
5061181|NCT01879553|12454964|P2|NOT COMPLETED|Overall Study||0
5061182|NCT01879553|12454965|P1|NOT COMPLETED|Overall Study||1
5061183|NCT01879553|12454964|P2|COMPLETED|Overall Study||63
5061184|NCT01879553|12454965|P1|COMPLETED|Overall Study||62
5061185|NCT01879553|12454964|P2|STARTED|Overall Study||63
5061186|NCT01879553|12454965|P1|STARTED|Overall Study||63
5061187|NCT01879540|12454986|P1|NOT COMPLETED|Overall Study||0
5061188|NCT01879540|12454986|P1|COMPLETED|Overall Study||63
5061189|NCT01879540|12454986|P1|STARTED|Overall Study||63
5061190|NCT01879410|12454999|P2|NOT COMPLETED|Overall Study||38
5061191|NCT01879410|12455000|P1|NOT COMPLETED|Overall Study||24
5061192|NCT01879410|12454999|P2|COMPLETED|Overall Study||312
5061193|NCT01879410|12455000|P1|COMPLETED|Overall Study||326
5061194|NCT01879410|12454999|P2|Intent-to-Treat Population|Overall Study||348
5061195|NCT01879410|12455000|P1|Intent-to-Treat Population|Overall Study||349
5061196|NCT01879410|12454999|P2|STARTED|Overall Study||350
5061197|NCT01879410|12455000|P1|STARTED|Overall Study||350
5061198|NCT01879371|12455014|P6|NOT COMPLETED|Overall Study||0
5061199|NCT01879371|12455015|P5|NOT COMPLETED|Overall Study||0
5061200|NCT01879371|12455016|P4|NOT COMPLETED|Overall Study||0
5061201|NCT01879371|12455017|P3|NOT COMPLETED|Overall Study||0
5061202|NCT01879371|12455018|P2|NOT COMPLETED|Overall Study||0
5061203|NCT01879371|12455019|P1|NOT COMPLETED|Overall Study||0
5061204|NCT01879371|12455014|P6|COMPLETED|Overall Study||6
5061205|NCT01879371|12455015|P5|COMPLETED|Overall Study||6
5061206|NCT01879371|12455016|P4|COMPLETED|Overall Study||6
5061207|NCT01879371|12455017|P3|COMPLETED|Overall Study||6
5061208|NCT01879371|12455018|P2|COMPLETED|Overall Study||6
5061209|NCT01879371|12455019|P1|COMPLETED|Overall Study||6
5061210|NCT01879371|12455014|P6|STARTED|Overall Study||6
5061211|NCT01879371|12455015|P5|STARTED|Overall Study||6
5061212|NCT01879371|12455016|P4|STARTED|Overall Study||6
5061213|NCT01879371|12455017|P3|STARTED|Overall Study||6
5061214|NCT01879371|12455018|P2|STARTED|Overall Study||6
5061215|NCT01879371|12455019|P1|STARTED|Overall Study||6
5061216|NCT01879345|12455036|P3|NOT COMPLETED|7-day Multiple-dose Period||0
5061217|NCT01879345|12455037|P2|NOT COMPLETED|7-day Multiple-dose Period||0
5061218|NCT01879345|12455038|P1|NOT COMPLETED|7-day Multiple-dose Period||0
5061219|NCT01879345|12455036|P3|COMPLETED|7-day Multiple-dose Period||6
5061220|NCT01879345|12455037|P2|COMPLETED|7-day Multiple-dose Period||6
5061221|NCT01879345|12455038|P1|COMPLETED|7-day Multiple-dose Period||6
5061222|NCT01879345|12455036|P3|STARTED|7-day Multiple-dose Period||6
5061223|NCT01879345|12455037|P2|STARTED|7-day Multiple-dose Period||6
5061224|NCT01879345|12455038|P1|STARTED|7-day Multiple-dose Period||6
5061225|NCT01879345|12455036|P3|NOT COMPLETED|Single-dose Period||0
5061226|NCT01879345|12455037|P2|NOT COMPLETED|Single-dose Period||0
5061227|NCT01879345|12455038|P1|NOT COMPLETED|Single-dose Period||0
5061228|NCT01879345|12455036|P3|COMPLETED|Single-dose Period||6
5061229|NCT01879345|12455037|P2|COMPLETED|Single-dose Period||6
5061230|NCT01879345|12455038|P1|COMPLETED|Single-dose Period||6
5061231|NCT01879345|12455036|P3|STARTED|Single-dose Period||6
5061232|NCT01879345|12455037|P2|STARTED|Single-dose Period||6
5061233|NCT01879345|12455038|P1|STARTED|Single-dose Period||6
5061234|NCT01879332|12455055|P3|NOT COMPLETED|Overall Study||4
5061235|NCT01879332|12455056|P2|NOT COMPLETED|Overall Study||6
5061236|NCT01879332|12455057|P1|NOT COMPLETED|Overall Study||6
5061237|NCT01879332|12455055|P3|COMPLETED|Overall Study||0
5061238|NCT01879332|12455056|P2|COMPLETED|Overall Study||0
5061239|NCT01879332|12455057|P1|COMPLETED|Overall Study||0
5061240|NCT01879332|12455055|P3|STARTED|Overall Study||4
5061241|NCT01879332|12455056|P2|STARTED|Overall Study||6
5061242|NCT01879332|12455057|P1|STARTED|Overall Study||6
5061243|NCT01879319|12455067|P2|NOT COMPLETED|Overall Study||5
5061244|NCT01879319|12455068|P1|NOT COMPLETED|Overall Study||2
5061245|NCT01879319|12455067|P2|COMPLETED|Overall Study||77
5061246|NCT01879319|12455068|P1|COMPLETED|Overall Study||80
5061247|NCT01879319|12455067|P2|Received Treatment|Overall Study||82
5061248|NCT01879319|12455068|P1|Received Treatment|Overall Study||82
5061249|NCT01879319|12455067|P2|STARTED|Overall Study||82
5061250|NCT01879319|12455068|P1|STARTED|Overall Study||82
5061251|NCT01879176|12455078|P2|NOT COMPLETED|Overall Study||6
5061252|NCT01879176|12455079|P1|NOT COMPLETED|Overall Study||8
5061253|NCT01879176|12455078|P2|COMPLETED|Overall Study||16
5061254|NCT01879176|12455079|P1|COMPLETED|Overall Study||16
5061255|NCT01879176|12455078|P2|STARTED|Overall Study||22
5061256|NCT01879176|12455079|P1|STARTED|Overall Study||24
5061257|NCT01879072|12455085|P1|NOT COMPLETED|Overall Study||151
5061258|NCT01879072|12455085|P1|COMPLETED|Overall Study||1709
5061259|NCT01879072|12455085|P1|STARTED|Overall Study||1860
5061260|NCT01879059|12455089|P1|NOT COMPLETED|Overall Study||0
5061261|NCT01879059|12455089|P1|COMPLETED|Overall Study||13
5061262|NCT01879059|12455089|P1|STARTED|Overall Study||13
5061263|NCT01878825|12455095|P2|NOT COMPLETED|Overall Study||0
5061264|NCT01878825|12455096|P1|NOT COMPLETED|Overall Study||0
5061265|NCT01878825|12455095|P2|COMPLETED|Overall Study||60
5061266|NCT01878825|12455096|P1|COMPLETED|Overall Study||60
5061267|NCT01878825|12455095|P2|STARTED|Overall Study||60
5061268|NCT01878825|12455096|P1|STARTED|Overall Study||60
5061269|NCT01878812|12455134|P2|NOT COMPLETED|Overall Study||0
5061270|NCT01878812|12455135|P1|NOT COMPLETED|Overall Study||0
5061271|NCT01878812|12455134|P2|COMPLETED|Overall Study||57
5061272|NCT01878812|12455135|P1|COMPLETED|Overall Study||60
5061273|NCT01878812|12455134|P2|STARTED|Overall Study||57
5061274|NCT01878812|12455135|P1|STARTED|Overall Study||60
5061275|NCT01878799|12455171|P2|NOT COMPLETED|Overall Study||0
5061276|NCT01878799|12455172|P1|NOT COMPLETED|Overall Study||1
5061277|NCT01878799|12455171|P2|COMPLETED|Overall Study||13
5061278|NCT01878799|12455172|P1|COMPLETED|Overall Study||36
5061279|NCT01878799|12455171|P2|STARTED|Overall Study||13
5061280|NCT01878799|12455172|P1|STARTED|Overall Study||37
5061281|NCT01878786|12455181|P3|NOT COMPLETED|Overall Study||7
5061282|NCT01878786|12455182|P2|NOT COMPLETED|Overall Study||9
5061283|NCT01878786|12455183|P1|NOT COMPLETED|Overall Study||9
5061284|NCT01878786|12455181|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
5061285|NCT01878786|12455182|P2|COMPLETED|Overall Study|Study closed prematurely|0
5061286|NCT01878786|12455183|P1|COMPLETED|Overall Study|Study closed prematurely|0
5061287|NCT01878786|12455181|P3|STARTED|Overall Study||7
5061288|NCT01878786|12455182|P2|STARTED|Overall Study||9
5061289|NCT01878786|12455183|P1|STARTED|Overall Study||9
5061290|NCT01878656|12455199|P2|NOT COMPLETED|Overall Study||0
5061291|NCT01878656|12455200|P1|NOT COMPLETED|Overall Study||0
5061292|NCT01878656|12455199|P2|COMPLETED|Overall Study||72
5061293|NCT01878656|12455200|P1|COMPLETED|Overall Study||72
5061294|NCT01878656|12455199|P2|STARTED|Overall Study||72
5061295|NCT01878656|12455200|P1|STARTED|Overall Study||72
5061296|NCT01878604|12455206|P1|NOT COMPLETED|Overall Study||0
5061297|NCT01878604|12455206|P1|COMPLETED|Overall Study||5
5061298|NCT01878604|12455206|P1|STARTED|Overall Study||5
5061299|NCT01878526|12455213|P2|NOT COMPLETED|Overall Study||2
5061300|NCT01878526|12455214|P1|NOT COMPLETED|Overall Study||3
5061301|NCT01878526|12455213|P2|COMPLETED|Overall Study||38
5061302|NCT01878526|12455214|P1|COMPLETED|Overall Study||37
5061303|NCT01878526|12455213|P2|STARTED|Overall Study||40
5061304|NCT01878526|12455214|P1|STARTED|Overall Study||40
5061305|NCT01878292|12455230|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
5061306|NCT01878292|12455231|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
5061307|NCT01878292|12455232|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
5061308|NCT01878292|12455230|P3|COMPLETED|Double-blind Down-Taper Period||142
5061309|NCT01878292|12455231|P2|COMPLETED|Double-blind Down-Taper Period||132
5061310|NCT01878292|12455232|P1|COMPLETED|Double-blind Down-Taper Period||122
5061311|NCT01878292|12455230|P3|STARTED|Double-blind Down-Taper Period||146
5061312|NCT01878292|12455231|P2|STARTED|Double-blind Down-Taper Period||140
5061313|NCT01878292|12455232|P1|STARTED|Double-blind Down-Taper Period||127
5061314|NCT01878292|12455230|P3|NOT COMPLETED|Double-blind Treatment Period||19
5061315|NCT01878292|12455231|P2|NOT COMPLETED|Double-blind Treatment Period||26
5061316|NCT01878292|12455232|P1|NOT COMPLETED|Double-blind Treatment Period||29
5061317|NCT01878292|12455230|P3|COMPLETED|Double-blind Treatment Period||161
5061318|NCT01878292|12455231|P2|COMPLETED|Double-blind Treatment Period||149
5061319|NCT01878292|12455232|P1|COMPLETED|Double-blind Treatment Period||142
5061320|NCT01878292|12455230|P3|STARTED|Double-blind Treatment Period||180
5061321|NCT01878292|12455231|P2|STARTED|Double-blind Treatment Period||175
5061322|NCT01878292|12455232|P1|STARTED|Double-blind Treatment Period||171
5061323|NCT01878292|12455230|P3|NOT COMPLETED|Randomized||0
5061324|NCT01878292|12455231|P2|NOT COMPLETED|Randomized||0
5061325|NCT01878292|12455232|P1|NOT COMPLETED|Randomized||3
5061326|NCT01878292|12455230|P3|COMPLETED|Randomized||180
5061327|NCT01878292|12455231|P2|COMPLETED|Randomized||175
5061328|NCT01878292|12455232|P1|COMPLETED|Randomized||171
5061329|NCT01878292|12455230|P3|STARTED|Randomized||180
5061330|NCT01878292|12455231|P2|STARTED|Randomized||175
5061331|NCT01878292|12455232|P1|STARTED|Randomized||174
5061332|NCT01878253|12455243|P1|NOT COMPLETED|Overall Study||9
5061333|NCT01878253|12455243|P1|COMPLETED|Overall Study||86
5061334|NCT01878253|12455243|P1|2 Year|Overall Study||86
5061335|NCT01878253|12455243|P1|1 Year|Overall Study||88
5061336|NCT01878253|12455243|P1|6 Months|Overall Study||90
5061337|NCT01878253|12455243|P1|6 Weeks|Overall Study||95
5061338|NCT01878253|12455243|P1|Pre-Operative|Overall Study||95
5061339|NCT01878253|12455243|P1|STARTED|Overall Study||95
5061340|NCT01878214|12455254|P2|NOT COMPLETED|Overall Study||44
5061341|NCT01878214|12455255|P1|NOT COMPLETED|Overall Study||53
5061342|NCT01878214|12455254|P2|COMPLETED|Overall Study||175
5061343|NCT01878214|12455255|P1|COMPLETED|Overall Study||170
5061344|NCT01878214|12455254|P2|STARTED|Overall Study||219
5061345|NCT01878214|12455255|P1|STARTED|Overall Study||223
5061346|NCT01878175|12455269|P1|NOT COMPLETED|Overall Study||2
5061347|NCT01878175|12455269|P1|COMPLETED|Overall Study||13
5061348|NCT01878175|12455269|P1|STARTED|Overall Study||15
5061349|NCT01878149|12455288|P2|NOT COMPLETED|Overall Study||2
5061350|NCT01878149|12455289|P1|NOT COMPLETED|Overall Study||2
5061351|NCT01878149|12455288|P2|COMPLETED|Overall Study||15
5061352|NCT01878149|12455289|P1|COMPLETED|Overall Study||19
5061353|NCT01878149|12455288|P2|STARTED|Overall Study||17
5061354|NCT01878149|12455289|P1|STARTED|Overall Study||21
5061355|NCT01878097|12455297|P2|NOT COMPLETED|Implementation Year 4||3007
5061356|NCT01878097|12455298|P1|NOT COMPLETED|Implementation Year 4||3604
5061357|NCT01878097|12455297|P2|COMPLETED|Implementation Year 4||6607
5061358|NCT01878097|12455298|P1|COMPLETED|Implementation Year 4||6981
5061359|NCT01878097|12455297|P2|STARTED|Implementation Year 4||9614
5061360|NCT01878097|12455298|P1|STARTED|Implementation Year 4||10585
5061361|NCT01878097|12455297|P2|NOT COMPLETED|Implementation Year 3||2980
5061362|NCT01878097|12455298|P1|NOT COMPLETED|Implementation Year 3||3494
5061363|NCT01878097|12455297|P2|COMPLETED|Implementation Year 3||6770
5061364|NCT01878097|12455298|P1|COMPLETED|Implementation Year 3||7046
5061365|NCT01878097|12455297|P2|STARTED|Implementation Year 3||9750
5061366|NCT01878097|12455298|P1|STARTED|Implementation Year 3||10540
5061367|NCT01878097|12455297|P2|NOT COMPLETED|Implementation Year 2||2841
5061368|NCT01878097|12455298|P1|NOT COMPLETED|Implementation Year 2||3281
5061369|NCT01878097|12455297|P2|COMPLETED|Implementation Year 2||6770
5061370|NCT01878097|12455298|P1|COMPLETED|Implementation Year 2||8286
5061371|NCT01878097|12455297|P2|STARTED|Implementation Year 2||9611
5061372|NCT01878097|12455298|P1|STARTED|Implementation Year 2||11567
5061373|NCT01878097|12455297|P2|NOT COMPLETED|Implementation Year 1||2549
5061374|NCT01878097|12455298|P1|NOT COMPLETED|Implementation Year 1||3202
5061375|NCT01878097|12455297|P2|COMPLETED|Implementation Year 1||7317
5061376|NCT01878097|12455298|P1|COMPLETED|Implementation Year 1||8540
5061377|NCT01878097|12455297|P2|STARTED|Implementation Year 1||9866
5061378|NCT01878097|12455298|P1|STARTED|Implementation Year 1||11742
5061379|NCT01878097|12455297|P2|NOT COMPLETED|Baseline||1800
5061380|NCT01878097|12455298|P1|NOT COMPLETED|Baseline||2497
5061381|NCT01878097|12455297|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
5061382|NCT01878097|12455298|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
5061383|NCT01878097|12455297|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
5061477|NCT01877538|12455698|P1|NOT COMPLETED|Overall Study||0
5061384|NCT01878097|12455298|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
5061385|NCT01878084|12455306|P1|NOT COMPLETED|Overall Study||2
5061386|NCT01878084|12455306|P1|COMPLETED|Overall Study||7
5061387|NCT01878084|12455306|P1|Control (Sockets Were Left Empty)|Overall Study||7
5061388|NCT01878084|12455306|P1|Test(Received TAMP Bioglass) s|Overall Study||7
5061389|NCT01878084|12455306|P1|STARTED|Overall Study||9
5061390|NCT01878006|12455311|P2|NOT COMPLETED|Study Session 2||0
5061391|NCT01878006|12455312|P1|NOT COMPLETED|Study Session 2||0
5061392|NCT01878006|12455311|P2|COMPLETED|Study Session 2||5
5061393|NCT01878006|12455312|P1|COMPLETED|Study Session 2||5
5061394|NCT01878006|12455311|P2|STARTED|Study Session 2||5
5061395|NCT01878006|12455312|P1|STARTED|Study Session 2||5
5061396|NCT01878006|12455311|P2|NOT COMPLETED|Study Session 1||0
5061397|NCT01878006|12455312|P1|NOT COMPLETED|Study Session 1||0
5061398|NCT01878006|12455311|P2|COMPLETED|Study Session 1||5
5061399|NCT01878006|12455312|P1|COMPLETED|Study Session 1||5
5061400|NCT01878006|12455311|P2|STARTED|Study Session 1||5
5061401|NCT01878006|12455312|P1|STARTED|Study Session 1||5
5061402|NCT01877941|12455332|P1|NOT COMPLETED|Overall Study||0
5061403|NCT01877941|12455332|P1|COMPLETED|Overall Study||39
5061404|NCT01877941|12455332|P1|STARTED|Overall Study||39
5061405|NCT01877915|12455340|P2|NOT COMPLETED|Overall Study||68
5061406|NCT01877915|12455341|P1|NOT COMPLETED|Overall Study||54
5061407|NCT01877915|12455340|P2|COMPLETED|Overall Study||2447
5061408|NCT01877915|12455341|P1|COMPLETED|Overall Study||2453
5061409|NCT01877915|12455340|P2|STARTED|Overall Study||2515
5061410|NCT01877915|12455341|P1|STARTED|Overall Study||2507
5061411|NCT01877720|12455363|P2|NOT COMPLETED|Overall Study||0
5061412|NCT01877720|12455364|P1|NOT COMPLETED|Overall Study||1
5061413|NCT01877720|12455363|P2|COMPLETED|Overall Study||8
5061414|NCT01877720|12455364|P1|COMPLETED|Overall Study||7
5061415|NCT01877720|12455363|P2|2nd Intervention|Overall Study||8
5061416|NCT01877720|12455364|P1|2nd Intervention|Overall Study||7
5061417|NCT01877720|12455363|P2|1st Intervention|Overall Study||8
5061418|NCT01877720|12455364|P1|1st Intervention|Overall Study||7
5061419|NCT01877720|12455363|P2|STARTED|Overall Study||8
5061420|NCT01877720|12455364|P1|STARTED|Overall Study||8
5061421|NCT01877668|12455393|P5|NOT COMPLETED|Overall Study||10
5061422|NCT01877668|12455394|P4|NOT COMPLETED|Overall Study||8
5061423|NCT01877668|12455395|P3|NOT COMPLETED|Overall Study||12
5061424|NCT01877668|12455396|P2|NOT COMPLETED|Overall Study||8
5061425|NCT01877668|12455397|P1|NOT COMPLETED|Overall Study||11
5061426|NCT01877668|12455393|P5|COMPLETED|Overall Study||43
5061427|NCT01877668|12455394|P4|COMPLETED|Overall Study||44
5061428|NCT01877668|12455395|P3|COMPLETED|Overall Study||94
5061429|NCT01877668|12455396|P2|COMPLETED|Overall Study||96
5061430|NCT01877668|12455397|P1|COMPLETED|Overall Study||96
5061431|NCT01877668|12455393|P5|STARTED|Overall Study|Received treatment|53
5061432|NCT01877668|12455394|P4|STARTED|Overall Study|Received treatment|52
5061433|NCT01877668|12455395|P3|STARTED|Overall Study|Received treatment|106
5061434|NCT01877668|12455396|P2|STARTED|Overall Study|Received treatment|104
5061435|NCT01877668|12455397|P1|STARTED|Overall Study|Received treatment|107
5061436|NCT01877655|12455628|P2|NOT COMPLETED|Overall Study||97
5061437|NCT01877655|12455629|P1|NOT COMPLETED|Overall Study||98
5061438|NCT01877655|12455628|P2|COMPLETED|Overall Study||154
5061439|NCT01877655|12455629|P1|COMPLETED|Overall Study||165
5061440|NCT01877655|12455628|P2|Received Treatment|Overall Study||246
5061441|NCT01877655|12455629|P1|Received Treatment|Overall Study||255
5061442|NCT01877655|12455628|P2|STARTED|Overall Study||251
5061443|NCT01877655|12455629|P1|STARTED|Overall Study||263
5061444|NCT01877642|12455647|P7|NOT COMPLETED|Overall Study||0
5061445|NCT01877642|12455648|P6|NOT COMPLETED|Overall Study||0
5061446|NCT01877642|12455649|P5|NOT COMPLETED|Overall Study||0
5061447|NCT01877642|12455650|P4|NOT COMPLETED|Overall Study||0
5061448|NCT01877642|12455651|P3|NOT COMPLETED|Overall Study||0
5061449|NCT01877642|12455652|P2|NOT COMPLETED|Overall Study||0
5061450|NCT01877642|12455653|P1|NOT COMPLETED|Overall Study||0
5061451|NCT01877642|12455647|P7|COMPLETED|Overall Study||3
5061452|NCT01877642|12455648|P6|COMPLETED|Overall Study||3
5061453|NCT01877642|12455649|P5|COMPLETED|Overall Study||3
5061454|NCT01877642|12455650|P4|COMPLETED|Overall Study||3
5061455|NCT01877642|12455651|P3|COMPLETED|Overall Study||3
5061456|NCT01877642|12455652|P2|COMPLETED|Overall Study||3
5061457|NCT01877642|12455653|P1|COMPLETED|Overall Study||4
5061458|NCT01877642|12455647|P7|STARTED|Overall Study||3
5061459|NCT01877642|12455648|P6|STARTED|Overall Study||3
5061460|NCT01877642|12455649|P5|STARTED|Overall Study||3
5061461|NCT01877642|12455650|P4|STARTED|Overall Study||3
5061462|NCT01877642|12455651|P3|STARTED|Overall Study||3
5061463|NCT01877642|12455652|P2|STARTED|Overall Study||3
5061464|NCT01877642|12455653|P1|STARTED|Overall Study||4
5061465|NCT01877564|12455676|P2|NOT COMPLETED|Overall Study||0
5061466|NCT01877564|12455677|P1|NOT COMPLETED|Overall Study||0
5061467|NCT01877564|12455676|P2|COMPLETED|Overall Study||4
5061468|NCT01877564|12455677|P1|COMPLETED|Overall Study||6
5061469|NCT01877564|12455676|P2|STARTED|Overall Study||4
5061470|NCT01877564|12455677|P1|STARTED|Overall Study||6
5061471|NCT01877551|12455685|P2|NOT COMPLETED|Overall Study||1
5061472|NCT01877551|12455686|P1|NOT COMPLETED|Overall Study||0
5061473|NCT01877551|12455685|P2|COMPLETED|Overall Study||13
5061474|NCT01877551|12455686|P1|COMPLETED|Overall Study||13
5061475|NCT01877551|12455685|P2|STARTED|Overall Study||14
5061476|NCT01877551|12455686|P1|STARTED|Overall Study||13
5061478|NCT01877538|12455698|P1|COMPLETED|Overall Study||7
5061479|NCT01877538|12455698|P1|STARTED|Overall Study||7
5061480|NCT01877421|12455735|P18|NOT COMPLETED|Phase 2||0
5061481|NCT01877421|12455736|P17|NOT COMPLETED|Phase 2||0
5061482|NCT01877421|12455737|P16|NOT COMPLETED|Phase 2||1
5061483|NCT01877421|12455738|P15|NOT COMPLETED|Phase 2||0
5061484|NCT01877421|12455739|P14|NOT COMPLETED|Phase 2||0
5061485|NCT01877421|12455740|P13|NOT COMPLETED|Phase 2||1
5061486|NCT01877421|12455741|P12|NOT COMPLETED|Phase 2||0
5061487|NCT01877421|12455742|P11|NOT COMPLETED|Phase 2||2
5061488|NCT01877421|12455743|P10|NOT COMPLETED|Phase 2||0
5061489|NCT01877421|12455744|P9|NOT COMPLETED|Phase 2||1
5061490|NCT01877421|12455745|P8|NOT COMPLETED|Phase 2||0
5061491|NCT01877421|12455746|P7|NOT COMPLETED|Phase 2||1
5061492|NCT01877421|12455747|P6|NOT COMPLETED|Phase 2||0
5061493|NCT01877421|12455748|P5|NOT COMPLETED|Phase 2||0
5061494|NCT01877421|12455749|P4|NOT COMPLETED|Phase 2||0
5061495|NCT01877421|12455750|P3|NOT COMPLETED|Phase 2||0
5061496|NCT01877421|12455751|P2|NOT COMPLETED|Phase 2||0
5061497|NCT01877421|12455752|P1|NOT COMPLETED|Phase 2||0
5061498|NCT01877421|12455735|P18|COMPLETED|Phase 2||0
5061499|NCT01877421|12455736|P17|COMPLETED|Phase 2||0
5061500|NCT01877421|12455737|P16|COMPLETED|Phase 2||2
5061501|NCT01877421|12455738|P15|COMPLETED|Phase 2||7
5061502|NCT01877421|12455739|P14|COMPLETED|Phase 2||3
5061503|NCT01877421|12455740|P13|COMPLETED|Phase 2||6
5061504|NCT01877421|12455741|P12|COMPLETED|Phase 2||3
5061505|NCT01877421|12455742|P11|COMPLETED|Phase 2||5
5061506|NCT01877421|12455743|P10|COMPLETED|Phase 2||3
5061507|NCT01877421|12455744|P9|COMPLETED|Phase 2||5
5061508|NCT01877421|12455745|P8|COMPLETED|Phase 2||2
5061509|NCT01877421|12455746|P7|COMPLETED|Phase 2||6
5061510|NCT01877421|12455747|P6|COMPLETED|Phase 2||3
5061511|NCT01877421|12455748|P5|COMPLETED|Phase 2||7
5061512|NCT01877421|12455749|P4|COMPLETED|Phase 2||2
5061513|NCT01877421|12455750|P3|COMPLETED|Phase 2||4
5061514|NCT01877421|12455751|P2|COMPLETED|Phase 2||0
5061515|NCT01877421|12455752|P1|COMPLETED|Phase 2||0
5061516|NCT01877421|12455735|P18|STARTED|Phase 2||0
5061517|NCT01877421|12455736|P17|STARTED|Phase 2||0
5061518|NCT01877421|12455737|P16|STARTED|Phase 2||3
5061519|NCT01877421|12455738|P15|STARTED|Phase 2||7
5061520|NCT01877421|12455739|P14|STARTED|Phase 2||3
5061521|NCT01877421|12455740|P13|STARTED|Phase 2||7
5061522|NCT01877421|12455741|P12|STARTED|Phase 2||3
5061523|NCT01877421|12455742|P11|STARTED|Phase 2||7
5061524|NCT01877421|12455743|P10|STARTED|Phase 2||3
5061525|NCT01877421|12455744|P9|STARTED|Phase 2||6
5061526|NCT01877421|12455745|P8|STARTED|Phase 2||2
5061527|NCT01877421|12455746|P7|STARTED|Phase 2||7
5061528|NCT01877421|12455747|P6|STARTED|Phase 2||3
5061529|NCT01877421|12455748|P5|STARTED|Phase 2||7
5061530|NCT01877421|12455749|P4|STARTED|Phase 2||2
5061531|NCT01877421|12455750|P3|STARTED|Phase 2||4
5061532|NCT01877421|12455751|P2|STARTED|Phase 2||0
5061533|NCT01877421|12455752|P1|STARTED|Phase 2||0
5061534|NCT01877421|12455735|P18|NOT COMPLETED|Phase 1||0
5061535|NCT01877421|12455736|P17|NOT COMPLETED|Phase 1||0
5061536|NCT01877421|12455737|P16|NOT COMPLETED|Phase 1||0
5061537|NCT01877421|12455738|P15|NOT COMPLETED|Phase 1||0
5061538|NCT01877421|12455739|P14|NOT COMPLETED|Phase 1||0
5061539|NCT01877421|12455740|P13|NOT COMPLETED|Phase 1||0
5061540|NCT01877421|12455741|P12|NOT COMPLETED|Phase 1||0
5061541|NCT01877421|12455742|P11|NOT COMPLETED|Phase 1||0
5061542|NCT01877421|12455743|P10|NOT COMPLETED|Phase 1||0
5061543|NCT01877421|12455744|P9|NOT COMPLETED|Phase 1||0
5061544|NCT01877421|12455745|P8|NOT COMPLETED|Phase 1||0
5061545|NCT01877421|12455746|P7|NOT COMPLETED|Phase 1||0
5061546|NCT01877421|12455747|P6|NOT COMPLETED|Phase 1||0
5061547|NCT01877421|12455748|P5|NOT COMPLETED|Phase 1||0
5061548|NCT01877421|12455749|P4|NOT COMPLETED|Phase 1||0
5061549|NCT01877421|12455750|P3|NOT COMPLETED|Phase 1||0
5061550|NCT01877421|12455751|P2|NOT COMPLETED|Phase 1||0
5061551|NCT01877421|12455752|P1|NOT COMPLETED|Phase 1||0
5061552|NCT01877421|12455735|P18|COMPLETED|Phase 1||3
5061553|NCT01877421|12455736|P17|COMPLETED|Phase 1||7
5061554|NCT01877421|12455737|P16|COMPLETED|Phase 1||3
5061555|NCT01877421|12455738|P15|COMPLETED|Phase 1||7
5061556|NCT01877421|12455739|P14|COMPLETED|Phase 1||3
5061557|NCT01877421|12455740|P13|COMPLETED|Phase 1||7
5061558|NCT01877421|12455741|P12|COMPLETED|Phase 1||3
5061559|NCT01877421|12455742|P11|COMPLETED|Phase 1||7
5061560|NCT01877421|12455743|P10|COMPLETED|Phase 1||3
5061561|NCT01877421|12455744|P9|COMPLETED|Phase 1||7
5061562|NCT01877421|12455745|P8|COMPLETED|Phase 1||2
5061563|NCT01877421|12455746|P7|COMPLETED|Phase 1||4
5061564|NCT01877421|12455747|P6|COMPLETED|Phase 1||2
5061565|NCT01877421|12455748|P5|COMPLETED|Phase 1||4
5061566|NCT01877421|12455749|P4|COMPLETED|Phase 1||2
5061567|NCT01877421|12455750|P3|COMPLETED|Phase 1||4
5061568|NCT01877421|12455751|P2|COMPLETED|Phase 1||1
5061569|NCT01877421|12455752|P1|COMPLETED|Phase 1||2
5061570|NCT01877421|12455735|P18|STARTED|Phase 1||3
5061571|NCT01877421|12455736|P17|STARTED|Phase 1||7
5061572|NCT01877421|12455737|P16|STARTED|Phase 1||3
5061573|NCT01877421|12455738|P15|STARTED|Phase 1||7
5061574|NCT01877421|12455739|P14|STARTED|Phase 1||3
5061575|NCT01877421|12455740|P13|STARTED|Phase 1||7
5061576|NCT01877421|12455741|P12|STARTED|Phase 1||3
5061577|NCT01877421|12455742|P11|STARTED|Phase 1||7
5061578|NCT01877421|12455743|P10|STARTED|Phase 1||3
5061579|NCT01877421|12455744|P9|STARTED|Phase 1||7
5061580|NCT01877421|12455745|P8|STARTED|Phase 1||2
5061581|NCT01877421|12455746|P7|STARTED|Phase 1||4
5061582|NCT01877421|12455747|P6|STARTED|Phase 1||2
5061583|NCT01877421|12455748|P5|STARTED|Phase 1||4
5061584|NCT01877421|12455749|P4|STARTED|Phase 1||2
5061585|NCT01877421|12455750|P3|STARTED|Phase 1||4
5061586|NCT01877421|12455751|P2|STARTED|Phase 1||1
5061587|NCT01877421|12455752|P1|STARTED|Phase 1||2
5061588|NCT01877408|12455862|P2|NOT COMPLETED|Overall Study||2
5061589|NCT01877408|12455863|P1|NOT COMPLETED|Overall Study||0
5061590|NCT01877408|12455862|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
5061591|NCT01877408|12455863|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
5061592|NCT01877408|12455862|P2|STARTED|Overall Study||100
5061593|NCT01877408|12455863|P1|STARTED|Overall Study||50
5061594|NCT01877343|12455883|P7|NOT COMPLETED|Overall Study||0
5061595|NCT01877343|12455884|P6|NOT COMPLETED|Overall Study||0
5061596|NCT01877343|12455885|P5|NOT COMPLETED|Overall Study||0
5061597|NCT01877343|12455886|P4|NOT COMPLETED|Overall Study||0
5061598|NCT01877343|12455887|P3|NOT COMPLETED|Overall Study||0
5061599|NCT01877343|12455888|P2|NOT COMPLETED|Overall Study||0
5061600|NCT01877343|12455889|P1|NOT COMPLETED|Overall Study||0
5061601|NCT01877343|12455883|P7|COMPLETED|Overall Study||0
5061602|NCT01877343|12455884|P6|COMPLETED|Overall Study||5
5061603|NCT01877343|12455885|P5|COMPLETED|Overall Study||0
5061604|NCT01877343|12455886|P4|COMPLETED|Overall Study||0
5061605|NCT01877343|12455887|P3|COMPLETED|Overall Study||0
5061606|NCT01877343|12455888|P2|COMPLETED|Overall Study||3
5061607|NCT01877343|12455889|P1|COMPLETED|Overall Study||2
5061608|NCT01877343|12455883|P7|STARTED|Overall Study||0
5061609|NCT01877343|12455884|P6|STARTED|Overall Study||5
5061610|NCT01877343|12455885|P5|STARTED|Overall Study||0
5061611|NCT01877343|12455886|P4|STARTED|Overall Study||0
5061612|NCT01877343|12455887|P3|STARTED|Overall Study||0
5061613|NCT01877343|12455888|P2|STARTED|Overall Study||3
5061614|NCT01877343|12455889|P1|STARTED|Overall Study||2
5061615|NCT01877278|12455896|P2|NOT COMPLETED|Overall Study||3
5061616|NCT01877278|12455897|P1|NOT COMPLETED|Overall Study||3
5061617|NCT01877278|12455896|P2|COMPLETED|Overall Study||30
5061618|NCT01877278|12455897|P1|COMPLETED|Overall Study||30
5061619|NCT01877278|12455896|P2|STARTED|Overall Study||33
5061620|NCT01877278|12455897|P1|STARTED|Overall Study||33
5061621|NCT01877265|12455905|P6|NOT COMPLETED|Treatment Period 3||0
5061622|NCT01877265|12455906|P5|NOT COMPLETED|Treatment Period 3||0
5061623|NCT01877265|12455907|P4|NOT COMPLETED|Treatment Period 3||0
5061624|NCT01877265|12455908|P3|NOT COMPLETED|Treatment Period 3||0
5061625|NCT01877265|12455909|P2|NOT COMPLETED|Treatment Period 3||0
5061626|NCT01877265|12455910|P1|NOT COMPLETED|Treatment Period 3||1
5061627|NCT01877265|12455905|P6|COMPLETED|Treatment Period 3||2
5061628|NCT01877265|12455906|P5|COMPLETED|Treatment Period 3||3
5061629|NCT01877265|12455907|P4|COMPLETED|Treatment Period 3||3
5061630|NCT01877265|12455908|P3|COMPLETED|Treatment Period 3||2
5061631|NCT01877265|12455909|P2|COMPLETED|Treatment Period 3||3
5061632|NCT01877265|12455910|P1|COMPLETED|Treatment Period 3||2
5061633|NCT01877265|12455905|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
5061634|NCT01877265|12455906|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
5061635|NCT01877265|12455907|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
5061636|NCT01877265|12455908|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
5061637|NCT01877265|12455909|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
5061638|NCT01877265|12455910|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
5061639|NCT01877265|12455905|P6|STARTED|Treatment Period 3||2
5061640|NCT01877265|12455906|P5|STARTED|Treatment Period 3||3
5061641|NCT01877265|12455907|P4|STARTED|Treatment Period 3||3
5061642|NCT01877265|12455908|P3|STARTED|Treatment Period 3||2
5061643|NCT01877265|12455909|P2|STARTED|Treatment Period 3||3
5061644|NCT01877265|12455910|P1|STARTED|Treatment Period 3||3
5061645|NCT01877265|12455905|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
5061646|NCT01877265|12455906|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
5061647|NCT01877265|12455907|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
5061648|NCT01877265|12455908|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
5061649|NCT01877265|12455909|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
5061650|NCT01877265|12455910|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
5061651|NCT01877265|12455905|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
5061652|NCT01877265|12455906|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
5061653|NCT01877265|12455907|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
5061654|NCT01877265|12455908|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
5061655|NCT01877265|12455909|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
5061656|NCT01877265|12455910|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
5061657|NCT01877265|12455905|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
5061658|NCT01877265|12455906|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
5061659|NCT01877265|12455907|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
5061660|NCT01877265|12455908|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
5061661|NCT01877265|12455909|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
5061662|NCT01877265|12455910|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
5061663|NCT01877265|12455905|P6|NOT COMPLETED|Treatment Period 2||0
5061664|NCT01877265|12455906|P5|NOT COMPLETED|Treatment Period 2||0
5061665|NCT01877265|12455907|P4|NOT COMPLETED|Treatment Period 2||0
5061666|NCT01877265|12455908|P3|NOT COMPLETED|Treatment Period 2||0
5061667|NCT01877265|12455909|P2|NOT COMPLETED|Treatment Period 2||0
5061668|NCT01877265|12455910|P1|NOT COMPLETED|Treatment Period 2||0
5061669|NCT01877265|12455905|P6|COMPLETED|Treatment Period 2||3
5061670|NCT01877265|12455906|P5|COMPLETED|Treatment Period 2||3
5061671|NCT01877265|12455907|P4|COMPLETED|Treatment Period 2||3
5061672|NCT01877265|12455908|P3|COMPLETED|Treatment Period 2||2
5061673|NCT01877265|12455909|P2|COMPLETED|Treatment Period 2||3
5061674|NCT01877265|12455910|P1|COMPLETED|Treatment Period 2||3
5061675|NCT01877265|12455905|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
5061676|NCT01877265|12455906|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
5061677|NCT01877265|12455907|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
5061678|NCT01877265|12455908|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
5061679|NCT01877265|12455909|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
5061680|NCT01877265|12455910|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
5061681|NCT01877265|12455905|P6|STARTED|Treatment Period 2||3
5061682|NCT01877265|12455906|P5|STARTED|Treatment Period 2||3
5061683|NCT01877265|12455907|P4|STARTED|Treatment Period 2||3
5061684|NCT01877265|12455908|P3|STARTED|Treatment Period 2||2
5061685|NCT01877265|12455909|P2|STARTED|Treatment Period 2||3
5061686|NCT01877265|12455910|P1|STARTED|Treatment Period 2||3
5061687|NCT01877265|12455905|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061688|NCT01877265|12455906|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061689|NCT01877265|12455907|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061690|NCT01877265|12455908|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061691|NCT01877265|12455909|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061692|NCT01877265|12455910|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
5061693|NCT01877265|12455905|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
5061694|NCT01877265|12455906|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
5061695|NCT01877265|12455907|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
5061696|NCT01877265|12455908|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
5061697|NCT01877265|12455909|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
5061698|NCT01877265|12455910|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
5061699|NCT01877265|12455905|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
5061700|NCT01877265|12455906|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
5061701|NCT01877265|12455907|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
5061702|NCT01877265|12455908|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
5061703|NCT01877265|12455909|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
5061704|NCT01877265|12455910|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
5061705|NCT01877265|12455905|P6|NOT COMPLETED|Treatment Period 1||0
5061706|NCT01877265|12455906|P5|NOT COMPLETED|Treatment Period 1||0
5061707|NCT01877265|12455907|P4|NOT COMPLETED|Treatment Period 1||0
5061708|NCT01877265|12455908|P3|NOT COMPLETED|Treatment Period 1||1
5061709|NCT01877265|12455909|P2|NOT COMPLETED|Treatment Period 1||0
5061710|NCT01877265|12455910|P1|NOT COMPLETED|Treatment Period 1||0
5061711|NCT01877265|12455905|P6|COMPLETED|Treatment Period 1||3
5061712|NCT01877265|12455906|P5|COMPLETED|Treatment Period 1||3
5061713|NCT01877265|12455907|P4|COMPLETED|Treatment Period 1||3
5061714|NCT01877265|12455908|P3|COMPLETED|Treatment Period 1||2
5061715|NCT01877265|12455909|P2|COMPLETED|Treatment Period 1||3
5061716|NCT01877265|12455910|P1|COMPLETED|Treatment Period 1||3
5061717|NCT01877265|12455905|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061718|NCT01877265|12455906|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061719|NCT01877265|12455907|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061720|NCT01877265|12455908|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061721|NCT01877265|12455909|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061722|NCT01877265|12455910|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
5061723|NCT01877265|12455905|P6|STARTED|Treatment Period 1||3
5061724|NCT01877265|12455906|P5|STARTED|Treatment Period 1||3
5061725|NCT01877265|12455907|P4|STARTED|Treatment Period 1||3
5061726|NCT01877265|12455908|P3|STARTED|Treatment Period 1||3
5061727|NCT01877265|12455909|P2|STARTED|Treatment Period 1||3
5061728|NCT01877265|12455910|P1|STARTED|Treatment Period 1||3
5061729|NCT01877239|12455927|P1|NOT COMPLETED|Overall Study||50
5061730|NCT01877239|12455927|P1|COMPLETED|Overall Study||61
5061731|NCT01877239|12455927|P1|Treated|Overall Study||76
5061732|NCT01877239|12455927|P1|STARTED|Overall Study||111
5061733|NCT01877187|12455933|P1|NOT COMPLETED|Overall Study||22
5061734|NCT01877187|12455933|P1|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
5061735|NCT01877187|12455933|P1|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
5061736|NCT01877187|12455933|P1|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
5061737|NCT01877187|12455933|P1|STARTED|Overall Study|21 HCC, 18 non-HCC|39
5061738|NCT01877161|12455962|P1|NOT COMPLETED|Third Session of Stimulation||0
5061739|NCT01877161|12455962|P1|COMPLETED|Third Session of Stimulation||12
5061740|NCT01877161|12455962|P1|STARTED|Third Session of Stimulation||12
5061741|NCT01877161|12455962|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
5061742|NCT01877161|12455962|P1|COMPLETED|Washout (at Least 3 Days)||12
5061743|NCT01877161|12455962|P1|STARTED|Washout (at Least 3 Days)||12
5061744|NCT01877161|12455962|P1|NOT COMPLETED|Second Session of Stimulation||0
5061745|NCT01877161|12455962|P1|COMPLETED|Second Session of Stimulation||12
5061746|NCT01877161|12455962|P1|STARTED|Second Session of Stimulation||12
5061747|NCT01877161|12455962|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
5061748|NCT01877161|12455962|P1|COMPLETED|Washout (at Least 3 Days)||12
5061749|NCT01877161|12455962|P1|STARTED|Washout (at Least 3 Days)||12
5061750|NCT01877161|12455962|P1|NOT COMPLETED|First Session of Stimulation||0
5061751|NCT01877161|12455962|P1|COMPLETED|First Session of Stimulation||12
5061752|NCT01877161|12455962|P1|STARTED|First Session of Stimulation||12
5061753|NCT01877148|12455972|P2|NOT COMPLETED|Overall Study||1
5061754|NCT01877148|12455973|P1|NOT COMPLETED|Overall Study||1
5061755|NCT01877148|12455972|P2|COMPLETED|Overall Study||5
5061756|NCT01877148|12455973|P1|COMPLETED|Overall Study||5
5061757|NCT01877148|12455972|P2|STARTED|Overall Study||6
5061758|NCT01877148|12455973|P1|STARTED|Overall Study||6
5061759|NCT01877083|12455985|P1|NOT COMPLETED|Extension Phase||5
5061760|NCT01877083|12455985|P1|COMPLETED|Extension Phase||0
5061761|NCT01877083|12455985|P1|STARTED|Extension Phase||5
5061762|NCT01877083|12455985|P1|NOT COMPLETED|Treatment Phase||20
5061763|NCT01877083|12455985|P1|COMPLETED|Treatment Phase||5
5061764|NCT01877083|12455985|P1|STARTED|Treatment Phase||25
5061765|NCT01876992|12455994|P2|NOT COMPLETED|Overall Study||0
5061766|NCT01876992|12455995|P1|NOT COMPLETED|Overall Study||0
5061767|NCT01876992|12455994|P2|COMPLETED|Overall Study||5
5061768|NCT01876992|12455995|P1|COMPLETED|Overall Study||5
5061769|NCT01876992|12455994|P2|STARTED|Overall Study||5
5061770|NCT01876992|12455995|P1|STARTED|Overall Study||5
5061771|NCT01876979|12456009|P2|NOT COMPLETED|Overall Study||3
5061772|NCT01876979|12456010|P1|NOT COMPLETED|Overall Study||2
5061773|NCT01876979|12456009|P2|COMPLETED|Overall Study||0
5061774|NCT01876979|12456010|P1|COMPLETED|Overall Study||0
5061775|NCT01876979|12456009|P2|STARTED|Overall Study||3
5061776|NCT01876979|12456010|P1|STARTED|Overall Study||2
5061777|NCT01876823|12456016|P1|NOT COMPLETED|Overall Study||9
5061778|NCT01876823|12456016|P1|COMPLETED|Overall Study||26
5061779|NCT01876823|12456016|P1|STARTED|Overall Study||35
5061780|NCT01876810|12456029|P2|NOT COMPLETED|Overall Study||1
5061781|NCT01876810|12456030|P1|NOT COMPLETED|Overall Study||0
5061782|NCT01876810|12456029|P2|COMPLETED|Overall Study||13
5061783|NCT01876810|12456030|P1|COMPLETED|Overall Study||14
5061784|NCT01876810|12456029|P2|STARTED|Overall Study||14
5061785|NCT01876810|12456030|P1|STARTED|Overall Study||14
5061786|NCT01876784|12456042|P2|NOT COMPLETED|Overall Study||119
5061787|NCT01876784|12456043|P1|NOT COMPLETED|Overall Study||119
5061788|NCT01876784|12456042|P2|COMPLETED|Overall Study||0
5061789|NCT01876784|12456043|P1|COMPLETED|Overall Study||0
5061790|NCT01876784|12456042|P2|Treated|Overall Study||118
5061791|NCT01876784|12456043|P1|Treated|Overall Study||117
5061792|NCT01876784|12456042|P2|STARTED|Overall Study||119
5061793|NCT01876784|12456043|P1|STARTED|Overall Study||119
5061794|NCT01876732|12456049|P1|NOT COMPLETED|Overall Study||75
5061795|NCT01876732|12456049|P1|COMPLETED|Overall Study||57
5061796|NCT01876732|12456049|P1|STARTED|Overall Study||132
5061797|NCT01876706|12456054|P1|NOT COMPLETED|Overall Study||25
5061798|NCT01876706|12456054|P1|COMPLETED|Overall Study||26
5061799|NCT01876706|12456054|P1|60 Months|Overall Study||26
5061800|NCT01876706|12456054|P1|48 Months|Overall Study||31
5061801|NCT01876706|12456054|P1|36 Months|Overall Study||32
5061802|NCT01876706|12456054|P1|24 Months|Overall Study||35
5061803|NCT01876706|12456054|P1|12 Months|Overall Study||42
5061804|NCT01876706|12456054|P1|6 Months|Overall Study||46
5061805|NCT01876706|12456054|P1|3 Months|Overall Study||51
5061806|NCT01876706|12456054|P1|1 Month|Overall Study||51
5061807|NCT01876706|12456054|P1|STARTED|Overall Study||51
5061808|NCT01876511|12456074|P3|NOT COMPLETED|Overall Study||31
5061809|NCT01876511|12456075|P2|NOT COMPLETED|Overall Study||25
5061810|NCT01876511|12456076|P1|NOT COMPLETED|Overall Study||23
5061811|NCT01876511|12456074|P3|COMPLETED|Overall Study||16
5061812|NCT01876511|12456075|P2|COMPLETED|Overall Study||0
5061813|NCT01876511|12456076|P1|COMPLETED|Overall Study||18
5061814|NCT01876511|12456074|P3|Stages 1 and 2|Overall Study||21
5061815|NCT01876511|12456075|P2|Stages 1 and 2|Overall Study||25
5061816|NCT01876511|12456076|P1|Stages 1 and 2|Overall Study||24
5061817|NCT01876511|12456074|P3|STARTED|Overall Study||47
5061818|NCT01876511|12456075|P2|STARTED|Overall Study||25
5061819|NCT01876511|12456076|P1|STARTED|Overall Study||41
5061820|NCT01876485|12456113|P2|NOT COMPLETED|Overall Study||26
5061821|NCT01876485|12456114|P1|NOT COMPLETED|Overall Study||24
5061822|NCT01876485|12456113|P2|COMPLETED|Overall Study||114
5061823|NCT01876485|12456114|P1|COMPLETED|Overall Study||116
5061824|NCT01876485|12456113|P2|Maintenance|Overall Study||114
5061825|NCT01876485|12456114|P1|Maintenance|Overall Study||116
5061826|NCT01876485|12456113|P2|Post-Intervention|Overall Study||129
5061827|NCT01876485|12456114|P1|Post-Intervention|Overall Study||125
5061828|NCT01876485|12456113|P2|STARTED|Overall Study||140
5061829|NCT01876485|12456114|P1|STARTED|Overall Study||140
5061830|NCT01876446|12456124|P2|NOT COMPLETED|Overall Study||6
5061831|NCT01876446|12456125|P1|NOT COMPLETED|Overall Study||2
5061832|NCT01876446|12456124|P2|COMPLETED|Overall Study||12
5061833|NCT01876446|12456125|P1|COMPLETED|Overall Study||18
5061834|NCT01876446|12456124|P2|STARTED|Overall Study||18
5061835|NCT01876446|12456125|P1|STARTED|Overall Study||20
5061836|NCT01876420|12456141|P1|NOT COMPLETED|Overall Study||1
5061837|NCT01876420|12456141|P1|COMPLETED|Overall Study||59
5061838|NCT01876420|12456141|P1|STARTED|Overall Study||60
5061839|NCT01876381|12456153|P1|NOT COMPLETED|Overall Study||7
5061840|NCT01876381|12456153|P1|COMPLETED|Overall Study||16
5061841|NCT01876381|12456153|P1|STARTED|Overall Study||23
5061842|NCT01876368|12456160|P2|NOT COMPLETED|Overall Study||13
5061843|NCT01876368|12456161|P1|NOT COMPLETED|Overall Study||9
5061844|NCT01876368|12456160|P2|COMPLETED|Overall Study||175
5061845|NCT01876368|12456161|P1|COMPLETED|Overall Study||179
5061846|NCT01876368|12456160|P2|Safety Set (SAF)|Overall Study||187
5061847|NCT01876368|12456161|P1|Safety Set (SAF)|Overall Study||188
5061848|NCT01876368|12456160|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
5061849|NCT01876368|12456161|P1|Full Analysis Set (FAS)|Overall Study||188
5061850|NCT01876368|12456160|P2|STARTED|Overall Study||188
5061851|NCT01876368|12456161|P1|STARTED|Overall Study||188
5061852|NCT01876329|12456190|P3|NOT COMPLETED|Overall Study||0
5061853|NCT01876329|12456191|P2|NOT COMPLETED|Overall Study||0
5061854|NCT01876329|12456192|P1|NOT COMPLETED|Overall Study||0
5061855|NCT01876329|12456190|P3|COMPLETED|Overall Study||44
5061856|NCT01876329|12456191|P2|COMPLETED|Overall Study||36
5061857|NCT01876329|12456192|P1|COMPLETED|Overall Study||45
5061858|NCT01876329|12456190|P3|STARTED|Overall Study||44
5061859|NCT01876329|12456191|P2|STARTED|Overall Study||36
5061860|NCT01876329|12456192|P1|STARTED|Overall Study||45
5061861|NCT01876251|12456206|P3|NOT COMPLETED|Overall Study||11
5061862|NCT01876251|12456207|P2|NOT COMPLETED|Overall Study||3
5061863|NCT01876251|12456208|P1|NOT COMPLETED|Overall Study||15
5061864|NCT01876251|12456206|P3|COMPLETED|Overall Study||0
5061865|NCT01876251|12456207|P2|COMPLETED|Overall Study||0
5061866|NCT01876251|12456208|P1|COMPLETED|Overall Study||0
5061867|NCT01876251|12456206|P3|STARTED|Overall Study||11
5061868|NCT01876251|12456207|P2|STARTED|Overall Study||3
5061869|NCT01876251|12456208|P1|STARTED|Overall Study||15
5061870|NCT01876212|12456267|P2|NOT COMPLETED|Overall Study||0
5061871|NCT01876212|12456268|P1|NOT COMPLETED|Overall Study||0
5061872|NCT01876212|12456267|P2|COMPLETED|Overall Study||6
5061873|NCT01876212|12456268|P1|COMPLETED|Overall Study||9
5061874|NCT01876212|12456267|P2|STARTED|Overall Study||6
5061875|NCT01876212|12456268|P1|STARTED|Overall Study||9
5061876|NCT01876043|12456312|P1|NOT COMPLETED|Overall Study||2
5061877|NCT01876043|12456312|P1|COMPLETED|Overall Study||22
5061878|NCT01876043|12456312|P1|Interim Analysis Population|Overall Study||17
5061879|NCT01876043|12456312|P1|STARTED|Overall Study||24
5061880|NCT01875991|12456324|P2|NOT COMPLETED|Overall Study||6
5061881|NCT01875991|12456325|P1|NOT COMPLETED|Overall Study||7
5061882|NCT01875991|12456324|P2|COMPLETED|Overall Study||103
5061883|NCT01875991|12456325|P1|COMPLETED|Overall Study||101
5061884|NCT01875991|12456324|P2|Received Etanercept in Period 2|Overall Study||103
5061885|NCT01875991|12456325|P1|Received Etanercept in Period 2|Overall Study||102
5061886|NCT01875991|12456324|P2|Received Etanercept in Period 1|Overall Study||108
5061887|NCT01875991|12456325|P1|Received Etanercept in Period 1|Overall Study||108
5061888|NCT01875991|12456324|P2|STARTED|Overall Study||109
5061889|NCT01875991|12456325|P1|STARTED|Overall Study||108
5061890|NCT01875978|12456348|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
5061891|NCT01875978|12456349|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
5061892|NCT01875978|12456348|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
5061893|NCT01875978|12456349|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
5061894|NCT01875978|12456348|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
5061895|NCT01875978|12456349|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
5061896|NCT01875978|12456348|P2|NOT COMPLETED|Study 4weeks||0
5061897|NCT01875978|12456349|P1|NOT COMPLETED|Study 4weeks||0
5061898|NCT01875978|12456348|P2|COMPLETED|Study 4weeks||20
5061899|NCT01875978|12456349|P1|COMPLETED|Study 4weeks||20
5061900|NCT01875978|12456348|P2|STARTED|Study 4weeks||20
5061901|NCT01875978|12456349|P1|STARTED|Study 4weeks||20
5061902|NCT01875874|12456361|P1|NOT COMPLETED|Overall Study||3
5061903|NCT01875874|12456361|P1|COMPLETED|Overall Study||5
5061904|NCT01875874|12456361|P1|STARTED|Overall Study||8
5061905|NCT01875861|12456368|P2|NOT COMPLETED|Sustainability||0
5061906|NCT01875861|12456369|P1|NOT COMPLETED|Sustainability||0
5061907|NCT01875861|12456368|P2|COMPLETED|Sustainability||3444
5061908|NCT01875861|12456369|P1|COMPLETED|Sustainability||4306
5061909|NCT01875861|12456368|P2|STARTED|Sustainability||3444
5061910|NCT01875861|12456369|P1|STARTED|Sustainability||4306
5061911|NCT01875861|12456368|P2|NOT COMPLETED|Implementation||0
5061912|NCT01875861|12456369|P1|NOT COMPLETED|Implementation||0
5061913|NCT01875861|12456368|P2|COMPLETED|Implementation||3444
5061914|NCT01875861|12456369|P1|COMPLETED|Implementation||4546
5061915|NCT01875861|12456368|P2|STARTED|Implementation||3444
5061916|NCT01875861|12456369|P1|STARTED|Implementation||4546
5061917|NCT01875861|12456368|P2|NOT COMPLETED|Pre-implementation||0
5061918|NCT01875861|12456369|P1|NOT COMPLETED|Pre-implementation||0
5061919|NCT01875861|12456368|P2|COMPLETED|Pre-implementation||3714
5061920|NCT01875861|12456369|P1|COMPLETED|Pre-implementation||4779
5061921|NCT01875861|12456368|P2|STARTED|Pre-implementation||3714
5061922|NCT01875861|12456369|P1|STARTED|Pre-implementation||4779
5061923|NCT01875848|12456381|P2|NOT COMPLETED|Overall Study||0
5061924|NCT01875848|12456382|P1|NOT COMPLETED|Overall Study||2
5061925|NCT01875848|12456381|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
5061926|NCT01875848|12456382|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
5061927|NCT01875848|12456381|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
5061928|NCT01875848|12456382|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
5061929|NCT01875783|12456390|P1|NOT COMPLETED|Overall Study||0
5061930|NCT01875783|12456390|P1|COMPLETED|Overall Study||385
5061931|NCT01875783|12456390|P1|STARTED|Overall Study||385
5061932|NCT01875731|12456399|P2|NOT COMPLETED|Overall Study||0
5061933|NCT01875731|12456400|P1|NOT COMPLETED|Overall Study||1
5061934|NCT01875731|12456399|P2|COMPLETED|Overall Study||32
5061935|NCT01875731|12456400|P1|COMPLETED|Overall Study||33
5061936|NCT01875731|12456399|P2|STARTED|Overall Study||32
5061937|NCT01875731|12456400|P1|STARTED|Overall Study||34
5061938|NCT01875510|12456410|P2|NOT COMPLETED|Overall Study||0
5061939|NCT01875510|12456411|P1|NOT COMPLETED|Overall Study||0
5061940|NCT01875510|12456410|P2|COMPLETED|Overall Study||40
5061941|NCT01875510|12456411|P1|COMPLETED|Overall Study||40
5061942|NCT01875510|12456410|P2|STARTED|Overall Study||40
5061943|NCT01875510|12456411|P1|STARTED|Overall Study||40
5061944|NCT01875471|12456419|P2|NOT COMPLETED|Overall Study||1
5061945|NCT01875471|12456420|P1|NOT COMPLETED|Overall Study||1
5061946|NCT01875471|12456419|P2|COMPLETED|Overall Study||137
5061947|NCT01875471|12456420|P1|COMPLETED|Overall Study||136
5061948|NCT01875471|12456419|P2|Completed Per Protocol|Overall Study||123
5061949|NCT01875471|12456420|P1|Completed Per Protocol|Overall Study||127
5061950|NCT01875471|12456419|P2|STARTED|Overall Study||138
5061951|NCT01875471|12456420|P1|STARTED|Overall Study||137
5061952|NCT01875445|12456428|P2|NOT COMPLETED|Overall Study||0
5061953|NCT01875445|12456429|P1|NOT COMPLETED|Overall Study||7
5061954|NCT01875445|12456428|P2|COMPLETED|Overall Study||19
5061955|NCT01875445|12456429|P1|COMPLETED|Overall Study||12
5061956|NCT01875445|12456428|P2|STARTED|Overall Study||19
5061957|NCT01875445|12456429|P1|STARTED|Overall Study||19
5061958|NCT01875237|12456439|P2|NOT COMPLETED|Overall Study||0
5061959|NCT01875237|12456440|P1|NOT COMPLETED|Overall Study||2
5061960|NCT01875237|12456439|P2|COMPLETED|Overall Study||1
5061961|NCT01875237|12456440|P1|COMPLETED|Overall Study||0
5061962|NCT01875237|12456439|P2|STARTED|Overall Study||1
5061963|NCT01875237|12456440|P1|STARTED|Overall Study||2
5061964|NCT01875185|12456466|P2|NOT COMPLETED|Overall Study||48
5061965|NCT01875185|12456467|P1|NOT COMPLETED|Overall Study||52
5061966|NCT01875185|12456466|P2|COMPLETED|Overall Study||0
5061967|NCT01875185|12456467|P1|COMPLETED|Overall Study||0
5061968|NCT01875185|12456466|P2|STARTED|Overall Study||48
5061969|NCT01875185|12456467|P1|STARTED|Overall Study||52
5061970|NCT01875159|12456481|P2|NOT COMPLETED|Overall Study||0
5061971|NCT01875159|12456482|P1|NOT COMPLETED|Overall Study||3
5061972|NCT01875159|12456481|P2|COMPLETED|Overall Study||53
5061973|NCT01875159|12456482|P1|COMPLETED|Overall Study||42
5061974|NCT01875159|12456481|P2|STARTED|Overall Study||53
5061975|NCT01875159|12456482|P1|STARTED|Overall Study||45
5061976|NCT01874951|12456492|P2|NOT COMPLETED|Overall Study||0
5061977|NCT01874951|12456493|P1|NOT COMPLETED|Overall Study||0
5061978|NCT01874951|12456492|P2|COMPLETED|Overall Study||6
5061979|NCT01874951|12456493|P1|COMPLETED|Overall Study||6
5061980|NCT01874951|12456492|P2|STARTED|Overall Study||6
5061981|NCT01874951|12456493|P1|STARTED|Overall Study||6
5061982|NCT01874756|12456517|P4|NOT COMPLETED|Overall Study||6
5061983|NCT01874756|12456518|P3|NOT COMPLETED|Overall Study||2
5061984|NCT01874756|12456519|P2|NOT COMPLETED|Overall Study||0
5061985|NCT01874756|12456520|P1|NOT COMPLETED|Overall Study||1
5061986|NCT01874756|12456517|P4|COMPLETED|Overall Study||21
5061987|NCT01874756|12456518|P3|COMPLETED|Overall Study||27
5061988|NCT01874756|12456519|P2|COMPLETED|Overall Study||10
5061989|NCT01874756|12456520|P1|COMPLETED|Overall Study||28
5061990|NCT01874756|12456517|P4|STARTED|Overall Study||27
5061991|NCT01874756|12456518|P3|STARTED|Overall Study||29
5061992|NCT01874756|12456519|P2|STARTED|Overall Study||10
5061993|NCT01874756|12456520|P1|STARTED|Overall Study||29
5061994|NCT01874665|12456552|P2|NOT COMPLETED|Overall Study||15
5061995|NCT01874665|12456553|P1|NOT COMPLETED|Overall Study||30
5061996|NCT01874665|12456552|P2|COMPLETED|Overall Study||0
5061997|NCT01874665|12456553|P1|COMPLETED|Overall Study||0
5061998|NCT01874665|12456552|P2|STARTED|Overall Study||15
5061999|NCT01874665|12456553|P1|STARTED|Overall Study||30
5062000|NCT01874535|12456581|P2|NOT COMPLETED|Overall Study||44
5062001|NCT01874535|12456582|P1|NOT COMPLETED|Overall Study||55
5062002|NCT01874535|12456581|P2|COMPLETED|Overall Study||157
5062003|NCT01874535|12456582|P1|COMPLETED|Overall Study||152
5062004|NCT01874535|12456581|P2|STARTED|Overall Study||201
5062005|NCT01874535|12456582|P1|STARTED|Overall Study||207
5062006|NCT01874353|12456590|P2|NOT COMPLETED|Overall Study||37
5062007|NCT01874353|12456591|P1|NOT COMPLETED|Overall Study||55
5062008|NCT01874353|12456590|P2|COMPLETED|Overall Study||62
5062009|NCT01874353|12456591|P1|COMPLETED|Overall Study||141
5062010|NCT01874353|12456590|P2|STARTED|Overall Study||99
5062011|NCT01874353|12456591|P1|STARTED|Overall Study||196
5062012|NCT01874340|12456618|P4|NOT COMPLETED|Overall Study||5
5062013|NCT01874340|12456619|P3|NOT COMPLETED|Overall Study||8
5062014|NCT01874340|12456620|P2|NOT COMPLETED|Overall Study||8
5062015|NCT01874340|12456621|P1|NOT COMPLETED|Overall Study||6
5062016|NCT01874340|12456618|P4|COMPLETED|Overall Study||1
5062017|NCT01874340|12456619|P3|COMPLETED|Overall Study||0
5062018|NCT01874340|12456620|P2|COMPLETED|Overall Study||0
5062019|NCT01874340|12456621|P1|COMPLETED|Overall Study||0
5062020|NCT01874340|12456618|P4|STARTED|Overall Study||6
5062021|NCT01874340|12456619|P3|STARTED|Overall Study||8
5062022|NCT01874340|12456620|P2|STARTED|Overall Study||8
5062023|NCT01874340|12456621|P1|STARTED|Overall Study||6
5062024|NCT01874275|12456649|P2|NOT COMPLETED|Overall Study||0
5062025|NCT01874275|12456650|P1|NOT COMPLETED|Overall Study||1
5062026|NCT01874275|12456649|P2|COMPLETED|Overall Study||2
5062027|NCT01874275|12456650|P1|COMPLETED|Overall Study||3
5062028|NCT01874275|12456649|P2|STARTED|Overall Study||2
5062029|NCT01874275|12456650|P1|STARTED|Overall Study||4
5062030|NCT01874262|12456664|P2|NOT COMPLETED|Overall Study||3
5062031|NCT01874262|12456665|P1|NOT COMPLETED|Overall Study||5
5062032|NCT01874262|12456664|P2|COMPLETED|Overall Study||80
5062033|NCT01874262|12456665|P1|COMPLETED|Overall Study||86
5062034|NCT01874262|12456664|P2|Not Included Due to Tehnical Issues|Overall Study||3
5062035|NCT01874262|12456665|P1|Not Included Due to Tehnical Issues|Overall Study||3
5062036|NCT01874262|12456664|P2|Not Correctly Randomised|Overall Study||0
5062037|NCT01874262|12456665|P1|Not Correctly Randomised|Overall Study||2
5062038|NCT01874262|12456664|P2|STARTED|Overall Study||83
5062039|NCT01874262|12456665|P1|STARTED|Overall Study||91
5062040|NCT01874145|12456673|P2|NOT COMPLETED|Extension Period||4
5062041|NCT01874145|12456674|P1|NOT COMPLETED|Extension Period||6
5062042|NCT01874145|12456673|P2|COMPLETED|Extension Period||97
5062043|NCT01874145|12456674|P1|COMPLETED|Extension Period||91
5062044|NCT01874145|12456673|P2|Full Analysis Set|Extension Period||101
5062045|NCT01874145|12456674|P1|Full Analysis Set|Extension Period||95
5062046|NCT01874145|12456673|P2|STARTED|Extension Period|Non-Switchers|101
5062047|NCT01874145|12456674|P1|STARTED|Extension Period|Switchers|97
5062048|NCT01874145|12456673|P2|NOT COMPLETED|Core Period||7
5062049|NCT01874145|12456674|P1|NOT COMPLETED|Core Period||3
5062050|NCT01874145|12456673|P2|COMPLETED|Core Period||101
5062051|NCT01874145|12456674|P1|COMPLETED|Core Period||98
5062052|NCT01874145|12456673|P2|Full Analysis Set|Core Period||108
5062053|NCT01874145|12456674|P1|Full Analysis Set|Core Period||100
5062054|NCT01874145|12456673|P2|STARTED|Core Period||108
5062055|NCT01874145|12456674|P1|STARTED|Core Period||101
5062056|NCT01874132|12456713|P3|NOT COMPLETED|Overall Study||3
5062057|NCT01874132|12456714|P2|NOT COMPLETED|Overall Study||4
5062058|NCT01874132|12456715|P1|NOT COMPLETED|Overall Study||4
5062059|NCT01874132|12456713|P3|COMPLETED|Overall Study||19
5062060|NCT01874132|12456714|P2|COMPLETED|Overall Study||18
5062061|NCT01874132|12456715|P1|COMPLETED|Overall Study||18
5062062|NCT01874132|12456713|P3|STARTED|Overall Study||22
5062063|NCT01874132|12456714|P2|STARTED|Overall Study||22
5062064|NCT01874132|12456715|P1|STARTED|Overall Study||22
5062065|NCT01874119|12456726|P2|NOT COMPLETED|Second Intervention (6 Days)||0
5062066|NCT01874119|12456727|P1|NOT COMPLETED|Second Intervention (6 Days)||0
5062067|NCT01874119|12456726|P2|COMPLETED|Second Intervention (6 Days)||3
5062068|NCT01874119|12456727|P1|COMPLETED|Second Intervention (6 Days)||4
5062069|NCT01874119|12456726|P2|STARTED|Second Intervention (6 Days)||3
5062070|NCT01874119|12456727|P1|STARTED|Second Intervention (6 Days)||4
5062071|NCT01874119|12456726|P2|NOT COMPLETED|Washout (7 Days)||2
5062072|NCT01874119|12456727|P1|NOT COMPLETED|Washout (7 Days)||3
5062073|NCT01874119|12456726|P2|COMPLETED|Washout (7 Days)||3
5062074|NCT01874119|12456727|P1|COMPLETED|Washout (7 Days)||4
5062075|NCT01874119|12456726|P2|STARTED|Washout (7 Days)||5
5062076|NCT01874119|12456727|P1|STARTED|Washout (7 Days)||7
5062077|NCT01874119|12456726|P2|NOT COMPLETED|First Intervention (6 Days)||0
5062078|NCT01874119|12456727|P1|NOT COMPLETED|First Intervention (6 Days)||1
5062079|NCT01874119|12456726|P2|COMPLETED|First Intervention (6 Days)||5
5062080|NCT01874119|12456727|P1|COMPLETED|First Intervention (6 Days)||7
5062081|NCT01874119|12456726|P2|STARTED|First Intervention (6 Days)||5
5062082|NCT01874119|12456727|P1|STARTED|First Intervention (6 Days)||8
5062083|NCT01874054|12456733|P1|NOT COMPLETED|Overall Study||55
5062084|NCT01874054|12456733|P1|COMPLETED|Overall Study||0
5062085|NCT01874054|12456733|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
5062086|NCT01874054|12456733|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
5062087|NCT01874054|12456733|P1|STARTED|Overall Study||55
5062088|NCT01873989|12456744|P2|NOT COMPLETED|Overall Study||1
5062089|NCT01873989|12456745|P1|NOT COMPLETED|Overall Study||1
5062090|NCT01873989|12456744|P2|COMPLETED|Overall Study||6
5062091|NCT01873989|12456745|P1|COMPLETED|Overall Study||7
5062092|NCT01873989|12456744|P2|STARTED|Overall Study||7
5062093|NCT01873989|12456745|P1|STARTED|Overall Study||8
5062094|NCT01873950|12456755|P5|NOT COMPLETED|Period 5||0
5062095|NCT01873950|12456756|P4|NOT COMPLETED|Period 5||1
5062096|NCT01873950|12456757|P3|NOT COMPLETED|Period 5||0
5062097|NCT01873950|12456758|P2|NOT COMPLETED|Period 5||0
5062098|NCT01873950|12456759|P1|NOT COMPLETED|Period 5||0
5062099|NCT01873950|12456755|P5|COMPLETED|Period 5||4
5062100|NCT01873950|12456756|P4|COMPLETED|Period 5||3
5062101|NCT01873950|12456757|P3|COMPLETED|Period 5||4
5062102|NCT01873950|12456758|P2|COMPLETED|Period 5||5
5062103|NCT01873950|12456759|P1|COMPLETED|Period 5||4
5062104|NCT01873950|12456755|P5|STARTED|Period 5||4
5062105|NCT01873950|12456756|P4|STARTED|Period 5||4
5062106|NCT01873950|12456757|P3|STARTED|Period 5||4
5062107|NCT01873950|12456758|P2|STARTED|Period 5||5
5062108|NCT01873950|12456759|P1|STARTED|Period 5||4
5062109|NCT01873950|12456755|P5|NOT COMPLETED|Period 4||0
5062110|NCT01873950|12456756|P4|NOT COMPLETED|Period 4||0
5062111|NCT01873950|12456757|P3|NOT COMPLETED|Period 4||0
5062112|NCT01873950|12456758|P2|NOT COMPLETED|Period 4||0
5062113|NCT01873950|12456759|P1|NOT COMPLETED|Period 4||0
5062114|NCT01873950|12456755|P5|COMPLETED|Period 4||5
5062115|NCT01873950|12456756|P4|COMPLETED|Period 4||4
5062116|NCT01873950|12456757|P3|COMPLETED|Period 4||4
5062117|NCT01873950|12456758|P2|COMPLETED|Period 4||5
5062118|NCT01873950|12456759|P1|COMPLETED|Period 4||4
5062119|NCT01873950|12456755|P5|STARTED|Period 4||5
5062120|NCT01873950|12456756|P4|STARTED|Period 4||4
5062121|NCT01873950|12456757|P3|STARTED|Period 4||4
5062122|NCT01873950|12456758|P2|STARTED|Period 4||5
5062123|NCT01873950|12456759|P1|STARTED|Period 4||4
5062124|NCT01873950|12456755|P5|NOT COMPLETED|Period 3||0
5062125|NCT01873950|12456756|P4|NOT COMPLETED|Period 3||0
5062126|NCT01873950|12456757|P3|NOT COMPLETED|Period 3||0
5062127|NCT01873950|12456758|P2|NOT COMPLETED|Period 3||0
5062128|NCT01873950|12456759|P1|NOT COMPLETED|Period 3||0
5062129|NCT01873950|12456755|P5|COMPLETED|Period 3||4
5062130|NCT01873950|12456756|P4|COMPLETED|Period 3||5
5062131|NCT01873950|12456757|P3|COMPLETED|Period 3||5
5062132|NCT01873950|12456758|P2|COMPLETED|Period 3||4
5062133|NCT01873950|12456759|P1|COMPLETED|Period 3||4
5062134|NCT01873950|12456755|P5|STARTED|Period 3||4
5062135|NCT01873950|12456756|P4|STARTED|Period 3||5
5062136|NCT01873950|12456757|P3|STARTED|Period 3||5
5062137|NCT01873950|12456758|P2|STARTED|Period 3||4
5062138|NCT01873950|12456759|P1|STARTED|Period 3||4
5062139|NCT01873950|12456755|P5|NOT COMPLETED|Period 2||0
5062140|NCT01873950|12456756|P4|NOT COMPLETED|Period 2||0
5062141|NCT01873950|12456757|P3|NOT COMPLETED|Period 2||0
5062142|NCT01873950|12456758|P2|NOT COMPLETED|Period 2||0
5062143|NCT01873950|12456759|P1|NOT COMPLETED|Period 2||0
5062144|NCT01873950|12456755|P5|COMPLETED|Period 2||5
5062145|NCT01873950|12456756|P4|COMPLETED|Period 2||4
5062146|NCT01873950|12456757|P3|COMPLETED|Period 2||4
5062147|NCT01873950|12456758|P2|COMPLETED|Period 2||4
5062148|NCT01873950|12456759|P1|COMPLETED|Period 2||5
5062149|NCT01873950|12456755|P5|STARTED|Period 2||5
5062150|NCT01873950|12456756|P4|STARTED|Period 2||4
5062151|NCT01873950|12456757|P3|STARTED|Period 2||4
5062152|NCT01873950|12456758|P2|STARTED|Period 2||4
5062153|NCT01873950|12456759|P1|STARTED|Period 2||5
5062154|NCT01873950|12456755|P5|NOT COMPLETED|Period 1||0
5062155|NCT01873950|12456756|P4|NOT COMPLETED|Period 1||0
5062156|NCT01873950|12456757|P3|NOT COMPLETED|Period 1||0
5062157|NCT01873950|12456758|P2|NOT COMPLETED|Period 1||0
5062158|NCT01873950|12456759|P1|NOT COMPLETED|Period 1||0
5062159|NCT01873950|12456755|P5|COMPLETED|Period 1||4
5062160|NCT01873950|12456756|P4|COMPLETED|Period 1||4
5062161|NCT01873950|12456757|P3|COMPLETED|Period 1||5
5062162|NCT01873950|12456758|P2|COMPLETED|Period 1||4
5062163|NCT01873950|12456759|P1|COMPLETED|Period 1||5
5062164|NCT01873950|12456755|P5|STARTED|Period 1||4
5062165|NCT01873950|12456756|P4|STARTED|Period 1||4
5062166|NCT01873950|12456757|P3|STARTED|Period 1||5
5062167|NCT01873950|12456758|P2|STARTED|Period 1||4
5062168|NCT01873950|12456759|P1|STARTED|Period 1||5
5062169|NCT01873859|12456796|P2|NOT COMPLETED|Overall Study||4
5062170|NCT01873859|12456797|P1|NOT COMPLETED|Overall Study||0
5062171|NCT01873859|12456796|P2|COMPLETED|Overall Study||79
5062172|NCT01873859|12456797|P1|COMPLETED|Overall Study||83
5062173|NCT01873859|12456796|P2|STARTED|Overall Study||83
5062174|NCT01873859|12456797|P1|STARTED|Overall Study||83
5062175|NCT01873846|12456805|P1|NOT COMPLETED|Overall Study||12
5062176|NCT01873846|12456805|P1|COMPLETED|Overall Study||388
5062177|NCT01873846|12456805|P1|Eligble Participants Dispensed Lenses|Overall Study||396
5062178|NCT01873846|12456805|P1|STARTED|Overall Study||400
5062179|NCT01873742|12456815|P2|NOT COMPLETED|Overall Study||76
5062180|NCT01873742|12456816|P1|NOT COMPLETED|Overall Study||68
5062181|NCT01873742|12456815|P2|COMPLETED|Overall Study||87
5062182|NCT01873742|12456816|P1|COMPLETED|Overall Study||97
5062183|NCT01873742|12456815|P2|STARTED|Overall Study||163
5062184|NCT01873742|12456816|P1|STARTED|Overall Study||165
5062185|NCT01873729|12456822|P1|NOT COMPLETED|Overall Study||1
5062186|NCT01873729|12456822|P1|COMPLETED|Overall Study||2
5062187|NCT01873729|12456822|P1|STARTED|Overall Study||3
5062188|NCT01873586|12456827|P1|NOT COMPLETED|Overall Study||3
5062189|NCT01873586|12456827|P1|COMPLETED|Overall Study||26
5062190|NCT01873586|12456827|P1|STARTED|Overall Study||29
5062191|NCT01873495|12456840|P1|NOT COMPLETED|Overall Study||7
5062192|NCT01873495|12456840|P1|COMPLETED|Overall Study||0
5062193|NCT01873495|12456840|P1|STARTED|Overall Study||7
5062194|NCT01873417|12456848|P1|NOT COMPLETED|Overall Study||35
5062195|NCT01873417|12456848|P1|COMPLETED|Overall Study||202
5062196|NCT01873417|12456848|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
5062197|NCT01873417|12456848|P1|STARTED|Overall Study||237
5062198|NCT01873287|12456861|P2|NOT COMPLETED|Overall Study||174
5062199|NCT01873287|12456862|P1|NOT COMPLETED|Overall Study||305
5062200|NCT01873287|12456861|P2|COMPLETED|Overall Study||883
5062201|NCT01873287|12456862|P1|COMPLETED|Overall Study||1701
5062202|NCT01873287|12456861|P2|STARTED|Overall Study||1057
5062203|NCT01873287|12456862|P1|STARTED|Overall Study||2006
5062204|NCT01872910|12456876|P6|NOT COMPLETED|Overall Study||0
5062205|NCT01872910|12456877|P5|NOT COMPLETED|Overall Study||0
5062206|NCT01872910|12456878|P4|NOT COMPLETED|Overall Study||0
5062207|NCT01872910|12456879|P3|NOT COMPLETED|Overall Study||2
5062208|NCT01872910|12456880|P2|NOT COMPLETED|Overall Study||0
5062209|NCT01872910|12456881|P1|NOT COMPLETED|Overall Study||2
5062210|NCT01872910|12456876|P6|COMPLETED|Overall Study||3
5062211|NCT01872910|12456877|P5|COMPLETED|Overall Study||15
5062212|NCT01872910|12456878|P4|COMPLETED|Overall Study||15
5062213|NCT01872910|12456879|P3|COMPLETED|Overall Study||28
5062214|NCT01872910|12456880|P2|COMPLETED|Overall Study||31
5062215|NCT01872910|12456881|P1|COMPLETED|Overall Study||28
5062216|NCT01872910|12456876|P6|Received Any Study Drug|Overall Study||3
5062217|NCT01872910|12456877|P5|Received Any Study Drug|Overall Study||15
5062218|NCT01872910|12456878|P4|Received Any Study Drug|Overall Study||15
5062219|NCT01872910|12456879|P3|Received Any Study Drug|Overall Study||30
5062220|NCT01872910|12456880|P2|Received Any Study Drug|Overall Study||31
5062221|NCT01872910|12456881|P1|Received Any Study Drug|Overall Study||30
5062222|NCT01872910|12456876|P6|STARTED|Overall Study||3
5062223|NCT01872910|12456877|P5|STARTED|Overall Study||15
5062224|NCT01872910|12456878|P4|STARTED|Overall Study||15
5062225|NCT01872910|12456879|P3|STARTED|Overall Study||30
5062226|NCT01872910|12456880|P2|STARTED|Overall Study||31
5062227|NCT01872910|12456881|P1|STARTED|Overall Study||30
5062228|NCT01872819|12456921|P1|NOT COMPLETED|Overall Study||0
5062229|NCT01872819|12456921|P1|COMPLETED|Overall Study||14
5062230|NCT01872819|12456921|P1|STARTED|Overall Study||14
5062231|NCT01872715|12456926|P1|NOT COMPLETED|Overall Study||4
5062232|NCT01872715|12456926|P1|COMPLETED|Overall Study||20
5062233|NCT01872715|12456926|P1|STARTED|Overall Study||24
5062234|NCT01872689|12456945|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
5062235|NCT01872689|12456946|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
5062236|NCT01872689|12456947|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
5062237|NCT01872689|12456948|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
5062238|NCT01872689|12456945|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
5062239|NCT01872689|12456946|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
5062240|NCT01872689|12456947|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
5062241|NCT01872689|12456948|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
5062242|NCT01872689|12456945|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
5062243|NCT01872689|12456946|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
5062244|NCT01872689|12456947|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
5062245|NCT01872689|12456948|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
5062246|NCT01872689|12456945|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
5062247|NCT01872689|12456946|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
5062248|NCT01872689|12456947|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
5062249|NCT01872689|12456948|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
5062250|NCT01872689|12456945|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
5062251|NCT01872689|12456946|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
5062252|NCT01872689|12456947|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
5062253|NCT01872689|12456948|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
5062254|NCT01872689|12456945|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
5062255|NCT01872689|12456946|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
5062256|NCT01872689|12456947|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
5062257|NCT01872689|12456948|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
5062258|NCT01872611|12457024|P2|NOT COMPLETED|Overall Study||12
5062259|NCT01872611|12457025|P1|NOT COMPLETED|Overall Study||24
5062260|NCT01872611|12457024|P2|COMPLETED|Overall Study||292
5062261|NCT01872611|12457025|P1|COMPLETED|Overall Study||277
5062262|NCT01872611|12457024|P2|Full Analysis Set|Overall Study||293
5062263|NCT01872611|12457025|P1|Full Analysis Set|Overall Study||289
5062264|NCT01872611|12457024|P2|Treated (Safety Analysis Set)|Overall Study||295
5062265|NCT01872611|12457025|P1|Treated (Safety Analysis Set)|Overall Study||293
5062266|NCT01872611|12457024|P2|Randomized|Overall Study||304
5062267|NCT01872611|12457025|P1|Randomized|Overall Study||301
5062268|NCT01872611|12457024|P2|STARTED|Overall Study||304
5062269|NCT01872611|12457025|P1|STARTED|Overall Study||301
5062270|NCT01872338|12457045|P2|NOT COMPLETED|Overall Study||0
5062271|NCT01872338|12457046|P1|NOT COMPLETED|Overall Study||20
5062272|NCT01872338|12457045|P2|COMPLETED|Overall Study||69
5062273|NCT01872338|12457046|P1|COMPLETED|Overall Study||46
5062274|NCT01872338|12457045|P2|STARTED|Overall Study||69
5062275|NCT01872338|12457046|P1|STARTED|Overall Study||66
5062276|NCT01872078|12457062|P4|NOT COMPLETED|Overall Study||2
5062277|NCT01872078|12457063|P3|NOT COMPLETED|Overall Study||3
5062278|NCT01872078|12457064|P2|NOT COMPLETED|Overall Study||0
5062279|NCT01872078|12457065|P1|NOT COMPLETED|Overall Study||0
5062280|NCT01872078|12457062|P4|COMPLETED|Overall Study||15
5062281|NCT01872078|12457063|P3|COMPLETED|Overall Study||14
5062282|NCT01872078|12457064|P2|COMPLETED|Overall Study||15
5062283|NCT01872078|12457065|P1|COMPLETED|Overall Study||16
5062284|NCT01872078|12457062|P4|STARTED|Overall Study||17
5062285|NCT01872078|12457063|P3|STARTED|Overall Study||17
5062286|NCT01872078|12457064|P2|STARTED|Overall Study||15
5062287|NCT01872078|12457065|P1|STARTED|Overall Study||16
5062288|NCT01871870|12457075|P1|NOT COMPLETED|Overall Study||9
5062289|NCT01871870|12457075|P1|COMPLETED|Overall Study||11
5062290|NCT01871870|12457075|P1|STARTED|Overall Study||20
5062291|NCT01871805|12457086|P6|NOT COMPLETED|Phase II||87
5062292|NCT01871805|12457087|P5|NOT COMPLETED|Phase II||0
5062293|NCT01871805|12457088|P4|NOT COMPLETED|Phase II||0
5062294|NCT01871805|12457089|P3|NOT COMPLETED|Phase II||0
5062295|NCT01871805|12457090|P2|NOT COMPLETED|Phase II||0
5062296|NCT01871805|12457091|P1|NOT COMPLETED|Phase II||0
5062297|NCT01871805|12457086|P6|COMPLETED|Phase II||0
5062298|NCT01871805|12457087|P5|COMPLETED|Phase II||0
5062299|NCT01871805|12457088|P4|COMPLETED|Phase II||0
5062300|NCT01871805|12457089|P3|COMPLETED|Phase II||0
5062301|NCT01871805|12457090|P2|COMPLETED|Phase II||0
5062302|NCT01871805|12457091|P1|COMPLETED|Phase II||0
5062303|NCT01871805|12457086|P6|STARTED|Phase II||87
5062304|NCT01871805|12457087|P5|STARTED|Phase II||0
5062305|NCT01871805|12457088|P4|STARTED|Phase II||0
5062306|NCT01871805|12457089|P3|STARTED|Phase II||0
5062307|NCT01871805|12457090|P2|STARTED|Phase II||0
5062308|NCT01871805|12457091|P1|STARTED|Phase II||0
5062309|NCT01871805|12457086|P6|NOT COMPLETED|Phase I||0
5062310|NCT01871805|12457087|P5|NOT COMPLETED|Phase I||13
5062311|NCT01871805|12457088|P4|NOT COMPLETED|Phase I||7
5062312|NCT01871805|12457089|P3|NOT COMPLETED|Phase I||13
5062313|NCT01871805|12457090|P2|NOT COMPLETED|Phase I||7
5062314|NCT01871805|12457091|P1|NOT COMPLETED|Phase I||7
5062315|NCT01871805|12457086|P6|COMPLETED|Phase I||0
5062316|NCT01871805|12457087|P5|COMPLETED|Phase I||0
5062317|NCT01871805|12457088|P4|COMPLETED|Phase I||0
5062318|NCT01871805|12457089|P3|COMPLETED|Phase I||0
5062319|NCT01871805|12457090|P2|COMPLETED|Phase I||0
5062320|NCT01871805|12457091|P1|COMPLETED|Phase I||0
5062321|NCT01871805|12457086|P6|STARTED|Phase I||0
5062322|NCT01871805|12457087|P5|STARTED|Phase I||13
5062323|NCT01871805|12457088|P4|STARTED|Phase I||7
5062324|NCT01871805|12457089|P3|STARTED|Phase I||13
5062325|NCT01871805|12457090|P2|STARTED|Phase I||7
5062326|NCT01871805|12457091|P1|STARTED|Phase I||7
5062327|NCT01871558|12457163|P2|NOT COMPLETED|Overall Study||2
5062328|NCT01871558|12457164|P1|NOT COMPLETED|Overall Study||3
5062329|NCT01871558|12457163|P2|COMPLETED|Overall Study||19
5062330|NCT01871558|12457164|P1|COMPLETED|Overall Study||18
5062331|NCT01871558|12457163|P2|STARTED|Overall Study||21
5062332|NCT01871558|12457164|P1|STARTED|Overall Study||21
5062333|NCT01871545|12457184|P2|NOT COMPLETED|Overall Study||3
5062334|NCT01871545|12457185|P1|NOT COMPLETED|Overall Study||17
5062335|NCT01871545|12457184|P2|COMPLETED|Overall Study||8
5062336|NCT01871545|12457185|P1|COMPLETED|Overall Study||56
5062337|NCT01871545|12457184|P2|STARTED|Overall Study||11
5062338|NCT01871545|12457185|P1|STARTED|Overall Study||73
5062339|NCT01871532|12457226|P2|NOT COMPLETED|Overall Study||2
5062340|NCT01871532|12457227|P1|NOT COMPLETED|Overall Study||1
5062341|NCT01871532|12457226|P2|COMPLETED|Overall Study||10
5062342|NCT01871532|12457227|P1|COMPLETED|Overall Study||11
5062343|NCT01871532|12457226|P2|Subjects Received hCG Treatment|Overall Study||9
5062344|NCT01871532|12457227|P1|Subjects Received hCG Treatment|Overall Study||11
5062345|NCT01871532|12457226|P2|STARTED|Overall Study||12
5062346|NCT01871532|12457227|P1|STARTED|Overall Study||12
5062347|NCT01871519|12457261|P1|NOT COMPLETED|Overall Study||90
5062348|NCT01871519|12457261|P1|COMPLETED|Overall Study||260
5062349|NCT01871519|12457261|P1|STARTED|Overall Study||350
5062350|NCT01871506|12457284|P2|NOT COMPLETED|Overall Study||0
5062351|NCT01871506|12457285|P1|NOT COMPLETED|Overall Study||0
5062352|NCT01871506|12457284|P2|COMPLETED|Overall Study||153
5062353|NCT01871506|12457285|P1|COMPLETED|Overall Study||150
5062354|NCT01871506|12457284|P2|STARTED|Overall Study||153
5062355|NCT01871506|12457285|P1|STARTED|Overall Study||150
5062356|NCT01871441|12457309|P1|NOT COMPLETED|Overall Study||0
5062357|NCT01871441|12457309|P1|COMPLETED|Overall Study||4
5062358|NCT01871441|12457309|P1|STARTED|Overall Study||4
5062359|NCT01871402|12457318|P2|NOT COMPLETED|Overall Study||3
5062360|NCT01871402|12457319|P1|NOT COMPLETED|Overall Study||1
5062361|NCT01871402|12457318|P2|COMPLETED|Overall Study||108
5062362|NCT01871402|12457319|P1|COMPLETED|Overall Study||109
5062363|NCT01871402|12457318|P2|STARTED|Overall Study||111
5062364|NCT01871402|12457319|P1|STARTED|Overall Study||110
5062365|NCT01871285|12457337|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5062366|NCT01871285|12457338|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5062367|NCT01871285|12457339|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5062368|NCT01871285|12457340|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5062369|NCT01871285|12457337|P4|COMPLETED|Second Intervention (1 Day)||2
5062370|NCT01871285|12457338|P3|COMPLETED|Second Intervention (1 Day)||3
5062371|NCT01871285|12457339|P2|COMPLETED|Second Intervention (1 Day)||14
5062372|NCT01871285|12457340|P1|COMPLETED|Second Intervention (1 Day)||17
5062373|NCT01871285|12457337|P4|STARTED|Second Intervention (1 Day)||2
5062374|NCT01871285|12457338|P3|STARTED|Second Intervention (1 Day)||3
5062375|NCT01871285|12457339|P2|STARTED|Second Intervention (1 Day)||14
5062376|NCT01871285|12457340|P1|STARTED|Second Intervention (1 Day)||17
5062377|NCT01871285|12457337|P4|NOT COMPLETED|First Intervention (1 Day)||0
5062378|NCT01871285|12457338|P3|NOT COMPLETED|First Intervention (1 Day)||1
5062379|NCT01871285|12457339|P2|NOT COMPLETED|First Intervention (1 Day)||1
5062380|NCT01871285|12457340|P1|NOT COMPLETED|First Intervention (1 Day)||1
5062381|NCT01871285|12457337|P4|COMPLETED|First Intervention (1 Day)||2
5062382|NCT01871285|12457338|P3|COMPLETED|First Intervention (1 Day)||3
5062383|NCT01871285|12457339|P2|COMPLETED|First Intervention (1 Day)||14
5062384|NCT01871285|12457340|P1|COMPLETED|First Intervention (1 Day)||17
5062385|NCT01871285|12457337|P4|STARTED|First Intervention (1 Day)||2
5062386|NCT01871285|12457338|P3|STARTED|First Intervention (1 Day)||4
5062387|NCT01871285|12457339|P2|STARTED|First Intervention (1 Day)||15
5062388|NCT01871285|12457340|P1|STARTED|First Intervention (1 Day)||18
5062389|NCT01871142|12457366|P1|NOT COMPLETED|Overall Study||1
5062390|NCT01871142|12457366|P1|COMPLETED|Overall Study||11
5062391|NCT01871142|12457366|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
5062392|NCT01871142|12457366|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
5062393|NCT01871142|12457366|P1|Received Placebo + Hypoxia|Overall Study||12
5062394|NCT01871142|12457366|P1|Received Placebo + Normoixa|Overall Study||11
5062395|NCT01871142|12457366|P1|STARTED|Overall Study||12
5062396|NCT01871090|12457382|P2|NOT COMPLETED|Overall Study||23
5062397|NCT01871090|12457383|P1|NOT COMPLETED|Overall Study||2
5062398|NCT01871090|12457382|P2|COMPLETED|Overall Study||25
5062399|NCT01871090|12457383|P1|COMPLETED|Overall Study||33
5062400|NCT01871090|12457382|P2|STARTED|Overall Study||48
5062401|NCT01871090|12457383|P1|STARTED|Overall Study||35
5062402|NCT01871077|12457393|P1|NOT COMPLETED|Overall Study||0
5062403|NCT01871077|12457393|P1|COMPLETED|Overall Study||30
5062404|NCT01871077|12457393|P1|STARTED|Overall Study||30
5062405|NCT01870999|12457403|P3|NOT COMPLETED|Overall Study||7
5062406|NCT01870999|12457404|P2|NOT COMPLETED|Overall Study||8
5062407|NCT01870999|12457405|P1|NOT COMPLETED|Overall Study||4
5062408|NCT01870999|12457403|P3|COMPLETED|Overall Study||4
5062409|NCT01870999|12457404|P2|COMPLETED|Overall Study||8
5062410|NCT01870999|12457405|P1|COMPLETED|Overall Study||10
5062411|NCT01870999|12457403|P3|Safety Population; Received Study Drug|Overall Study||10
5062412|NCT01870999|12457404|P2|Safety Population; Received Study Drug|Overall Study||15
5062413|NCT01870999|12457405|P1|Safety Population; Received Study Drug|Overall Study||14
5062414|NCT01870999|12457403|P3|STARTED|Overall Study||11
5062415|NCT01870999|12457404|P2|STARTED|Overall Study||16
5062416|NCT01870999|12457405|P1|STARTED|Overall Study||14
5062417|NCT01870973|12457463|P2|NOT COMPLETED|Overall Study||3
5062418|NCT01870973|12457464|P1|NOT COMPLETED|Overall Study||10
5062419|NCT01870973|12457463|P2|COMPLETED|Overall Study||49
5062420|NCT01870973|12457464|P1|COMPLETED|Overall Study||46
5062421|NCT01870973|12457463|P2|STARTED|Overall Study||52
5062422|NCT01870973|12457464|P1|STARTED|Overall Study||56
5062423|NCT01870921|12457470|P1|NOT COMPLETED|Overall Study||90
5062424|NCT01870921|12457470|P1|COMPLETED|Overall Study||1914
5062425|NCT01870921|12457470|P1|STARTED|Overall Study||2004
5062426|NCT01870869|12457480|P4|NOT COMPLETED|Overall Study||30
5062427|NCT01870869|12457481|P3|NOT COMPLETED|Overall Study||130
5062428|NCT01870869|12457482|P2|NOT COMPLETED|Overall Study||14
5062429|NCT01870869|12457483|P1|NOT COMPLETED|Overall Study||28
5062430|NCT01870869|12457480|P4|COMPLETED|Overall Study||205
5062431|NCT01870869|12457481|P3|COMPLETED|Overall Study||1092
5062432|NCT01870869|12457482|P2|COMPLETED|Overall Study||192
5062433|NCT01870869|12457483|P1|COMPLETED|Overall Study||260
5062434|NCT01870869|12457480|P4|STARTED|Overall Study||235
5062435|NCT01870869|12457481|P3|STARTED|Overall Study||1222
5062436|NCT01870869|12457482|P2|STARTED|Overall Study||206
5062437|NCT01870869|12457483|P1|STARTED|Overall Study||288
5062438|NCT01870856|12457511|P2|NOT COMPLETED|Overall Study||0
5062439|NCT01870856|12457512|P1|NOT COMPLETED|Overall Study||0
5062440|NCT01870856|12457511|P2|COMPLETED|Overall Study||27
5062441|NCT01870856|12457512|P1|COMPLETED|Overall Study||25
5062442|NCT01870856|12457511|P2|STARTED|Overall Study||27
5062443|NCT01870856|12457512|P1|STARTED|Overall Study||25
5062444|NCT01870843|12457522|P1|NOT COMPLETED|Overall Study||53
5062445|NCT01870843|12457522|P1|COMPLETED|Overall Study||208
5062446|NCT01870843|12457522|P1|STARTED|Overall Study||261
5062447|NCT01870778|12457537|P2|NOT COMPLETED|Overall Study||9
5062448|NCT01870778|12457538|P1|NOT COMPLETED|Overall Study||8
5062449|NCT01870778|12457537|P2|COMPLETED|Overall Study||3262
5062450|NCT01870778|12457538|P1|COMPLETED|Overall Study||3266
5062451|NCT01870778|12457537|P2|Biomarker Analysis Set|Overall Study||510
5062452|NCT01870778|12457538|P1|Biomarker Analysis Set|Overall Study||521
5062453|NCT01870778|12457537|P2|Full Analysis Set|Overall Study||3271
5062454|NCT01870778|12457538|P1|Full Analysis Set|Overall Study||3274
5062455|NCT01870778|12457537|P2|Safety Set|Overall Study||3248
5062456|NCT01870778|12457538|P1|Safety Set|Overall Study||3257
5062457|NCT01870778|12457537|P2|STARTED|Overall Study||3271
5062458|NCT01870778|12457538|P1|STARTED|Overall Study||3274
5062459|NCT01870739|12457564|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
5062460|NCT01870739|12457565|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
5062461|NCT01870739|12457564|P2|COMPLETED|Add-on Period (40 Weeks)||51
5062462|NCT01870739|12457565|P1|COMPLETED|Add-on Period (40 Weeks)||51
5062463|NCT01870739|12457564|P2|STARTED|Add-on Period (40 Weeks)||53
5062464|NCT01870739|12457565|P1|STARTED|Add-on Period (40 Weeks)||54
5062465|NCT01870739|12457564|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
5062466|NCT01870739|12457565|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
5062467|NCT01870739|12457564|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
5062468|NCT01870739|12457565|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
5062469|NCT01870739|12457564|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
5062470|NCT01870739|12457565|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
5062471|NCT01870739|12457564|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
5062472|NCT01870739|12457565|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
5062473|NCT01870739|12457564|P2|STARTED|Single Drug Treatment (12 Weeks)||57
5062474|NCT01870739|12457565|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
5062475|NCT01870726|12457604|P7|NOT COMPLETED|Overall Study||10
5062476|NCT01870726|12457605|P6|NOT COMPLETED|Overall Study||5
5062477|NCT01870726|12457606|P5|NOT COMPLETED|Overall Study||7
5062478|NCT01870726|12457607|P4|NOT COMPLETED|Overall Study||6
5062479|NCT01870726|12457608|P3|NOT COMPLETED|Overall Study||4
5062480|NCT01870726|12457609|P2|NOT COMPLETED|Overall Study||6
5062481|NCT01870726|12457610|P1|NOT COMPLETED|Overall Study||5
5062482|NCT01870726|12457604|P7|COMPLETED|Overall Study||0
5062483|NCT01870726|12457605|P6|COMPLETED|Overall Study||0
5062484|NCT01870726|12457606|P5|COMPLETED|Overall Study||0
5062485|NCT01870726|12457607|P4|COMPLETED|Overall Study||0
5062486|NCT01870726|12457608|P3|COMPLETED|Overall Study||0
5062487|NCT01870726|12457609|P2|COMPLETED|Overall Study||0
5062488|NCT01870726|12457610|P1|COMPLETED|Overall Study||0
5062489|NCT01870726|12457604|P7|STARTED|Overall Study||10
5062490|NCT01870726|12457605|P6|STARTED|Overall Study||5
5062491|NCT01870726|12457606|P5|STARTED|Overall Study||7
5062492|NCT01870726|12457607|P4|STARTED|Overall Study||6
5062493|NCT01870726|12457608|P3|STARTED|Overall Study||4
5062494|NCT01870726|12457609|P2|STARTED|Overall Study||6
5062495|NCT01870726|12457610|P1|STARTED|Overall Study||5
5062496|NCT01870596|12457695|P2|NOT COMPLETED|Overall Study||0
5062497|NCT01870596|12457696|P1|NOT COMPLETED|Overall Study||0
5062498|NCT01870596|12457695|P2|COMPLETED|Overall Study||18
5062499|NCT01870596|12457696|P1|COMPLETED|Overall Study||14
5062500|NCT01870596|12457695|P2|STARTED|Overall Study||18
5062501|NCT01870596|12457696|P1|STARTED|Overall Study||14
5062502|NCT01870583|12457705|P3|NOT COMPLETED|Overall Study||8
5062503|NCT01870583|12457706|P2|NOT COMPLETED|Overall Study||18
5062504|NCT01870583|12457707|P1|NOT COMPLETED|Overall Study||11
5062505|NCT01870583|12457705|P3|COMPLETED|Overall Study||455
5062506|NCT01870583|12457706|P2|COMPLETED|Overall Study||456
5062507|NCT01870583|12457707|P1|COMPLETED|Overall Study||456
5062508|NCT01870583|12457705|P3|STARTED|Overall Study||463
5062509|NCT01870583|12457706|P2|STARTED|Overall Study||474
5062510|NCT01870583|12457707|P1|STARTED|Overall Study||467
5062511|NCT01870388|12457717|P2|NOT COMPLETED|Overall Study||0
5062512|NCT01870388|12457718|P1|NOT COMPLETED|Overall Study||0
5062513|NCT01870388|12457717|P2|COMPLETED|Overall Study||8
5062514|NCT01870388|12457718|P1|COMPLETED|Overall Study||8
5062515|NCT01870388|12457717|P2|Received 1 Dose of Study Drug|Overall Study||8
5062516|NCT01870388|12457718|P1|Received 1 Dose of Study Drug|Overall Study||8
5062517|NCT01870388|12457717|P2|STARTED|Overall Study||8
5062518|NCT01870388|12457718|P1|STARTED|Overall Study||8
5062519|NCT01870297|12457733|P7|NOT COMPLETED|Overall Study||2
5062520|NCT01870297|12457734|P6|NOT COMPLETED|Overall Study||1
5062521|NCT01870297|12457735|P5|NOT COMPLETED|Overall Study||3
5062522|NCT01870297|12457736|P4|NOT COMPLETED|Overall Study||0
5062523|NCT01870297|12457737|P3|NOT COMPLETED|Overall Study||1
5062524|NCT01870297|12457738|P2|NOT COMPLETED|Overall Study||7
5062525|NCT01870297|12457739|P1|NOT COMPLETED|Overall Study||0
5062526|NCT01870297|12457733|P7|COMPLETED|Overall Study||8
5062527|NCT01870297|12457734|P6|COMPLETED|Overall Study||8
5062528|NCT01870297|12457735|P5|COMPLETED|Overall Study||7
5062529|NCT01870297|12457736|P4|COMPLETED|Overall Study||9
5062530|NCT01870297|12457737|P3|COMPLETED|Overall Study||7
5062531|NCT01870297|12457738|P2|COMPLETED|Overall Study||8
5062532|NCT01870297|12457739|P1|COMPLETED|Overall Study||11
5062533|NCT01870297|12457733|P7|STARTED|Overall Study||10
5062534|NCT01870297|12457734|P6|STARTED|Overall Study||9
5062535|NCT01870297|12457735|P5|STARTED|Overall Study||10
5062536|NCT01870297|12457736|P4|STARTED|Overall Study||9
5062537|NCT01870297|12457737|P3|STARTED|Overall Study||8
5062538|NCT01870297|12457738|P2|STARTED|Overall Study||15
5062539|NCT01870297|12457739|P1|STARTED|Overall Study||11
5062540|NCT01870076|12457783|P4|NOT COMPLETED|Overall Study||0
5062541|NCT01870076|12457784|P3|NOT COMPLETED|Overall Study||1
5062542|NCT01870076|12457785|P2|NOT COMPLETED|Overall Study||0
5062543|NCT01870076|12457786|P1|NOT COMPLETED|Overall Study||1
5062544|NCT01870076|12457783|P4|COMPLETED|Overall Study||11
5062545|NCT01870076|12457784|P3|COMPLETED|Overall Study||7
5062546|NCT01870076|12457785|P2|COMPLETED|Overall Study||12
5062547|NCT01870076|12457786|P1|COMPLETED|Overall Study||9
5062548|NCT01870076|12457783|P4|STARTED|Overall Study||11
5062549|NCT01870076|12457784|P3|STARTED|Overall Study||8
5062550|NCT01870076|12457785|P2|STARTED|Overall Study||12
5062551|NCT01870076|12457786|P1|STARTED|Overall Study||10
5062552|NCT01869959|12457804|P5|NOT COMPLETED|Treatment Period||0
5062553|NCT01869959|12457805|P4|NOT COMPLETED|Treatment Period||2
5062554|NCT01869959|12457806|P3|NOT COMPLETED|Treatment Period||3
5062555|NCT01869959|12457807|P2|NOT COMPLETED|Treatment Period||2
5062556|NCT01869959|12457808|P1|NOT COMPLETED|Treatment Period||1
5062557|NCT01869959|12457804|P5|COMPLETED|Treatment Period||0
5062558|NCT01869959|12457805|P4|COMPLETED|Treatment Period||8
5062559|NCT01869959|12457806|P3|COMPLETED|Treatment Period||12
5062560|NCT01869959|12457807|P2|COMPLETED|Treatment Period||8
5062561|NCT01869959|12457808|P1|COMPLETED|Treatment Period||10
5062562|NCT01869959|12457804|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
5062563|NCT01869959|12457805|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
5062564|NCT01869959|12457806|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
5062565|NCT01869959|12457807|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
5062566|NCT01869959|12457808|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
5062567|NCT01869959|12457804|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
5062568|NCT01869959|12457805|P4|STARTED|Treatment Period||10
5062569|NCT01869959|12457806|P3|STARTED|Treatment Period||15
5062570|NCT01869959|12457807|P2|STARTED|Treatment Period||10
5062571|NCT01869959|12457808|P1|STARTED|Treatment Period||11
5062572|NCT01869959|12457804|P5|NOT COMPLETED|Randomization Period||1
5062573|NCT01869959|12457805|P4|NOT COMPLETED|Randomization Period||0
5062574|NCT01869959|12457806|P3|NOT COMPLETED|Randomization Period||0
5062575|NCT01869959|12457807|P2|NOT COMPLETED|Randomization Period||0
5062576|NCT01869959|12457808|P1|NOT COMPLETED|Randomization Period||0
5062577|NCT01869959|12457804|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
5062578|NCT01869959|12457805|P4|COMPLETED|Randomization Period||0
5062579|NCT01869959|12457806|P3|COMPLETED|Randomization Period||0
5062580|NCT01869959|12457807|P2|COMPLETED|Randomization Period||0
5062581|NCT01869959|12457808|P1|COMPLETED|Randomization Period||0
5062582|NCT01869959|12457804|P5|STARTED|Randomization Period||47
5062583|NCT01869959|12457805|P4|STARTED|Randomization Period||0
5062584|NCT01869959|12457806|P3|STARTED|Randomization Period||0
5062585|NCT01869959|12457807|P2|STARTED|Randomization Period||0
5062586|NCT01869959|12457808|P1|STARTED|Randomization Period||0
5062587|NCT01869777|12457876|P1|NOT COMPLETED|Overall Study||1
5062588|NCT01869777|12457876|P1|COMPLETED|Overall Study||101
5062589|NCT01869777|12457876|P1|STARTED|Overall Study||102
5062590|NCT01869764|12457889|P2|NOT COMPLETED|Overall Study||2
5062591|NCT01869764|12457890|P1|NOT COMPLETED|Overall Study||0
5062592|NCT01869764|12457889|P2|COMPLETED|Overall Study||27
5062593|NCT01869764|12457890|P1|COMPLETED|Overall Study||28
5062594|NCT01869764|12457889|P2|STARTED|Overall Study||29
5062595|NCT01869764|12457890|P1|STARTED|Overall Study||28
5062596|NCT01869699|12457908|P2|NOT COMPLETED|Overall Study||0
5062597|NCT01869699|12457909|P1|NOT COMPLETED|Overall Study||1
5062598|NCT01869699|12457908|P2|COMPLETED|Overall Study||20
5062599|NCT01869699|12457909|P1|COMPLETED|Overall Study||20
5062600|NCT01869699|12457908|P2|STARTED|Overall Study||20
5062601|NCT01869699|12457909|P1|STARTED|Overall Study||21
5062602|NCT01869686|12457927|P1|NOT COMPLETED|Overall Study||0
5062603|NCT01869686|12457927|P1|COMPLETED|Overall Study||12
5062604|NCT01869686|12457927|P1|STARTED|Overall Study||12
5062605|NCT01869647|12457942|P3|NOT COMPLETED|Overall Study||0
5062606|NCT01869647|12457943|P2|NOT COMPLETED|Overall Study||6
5062607|NCT01869647|12457944|P1|NOT COMPLETED|Overall Study||1
5062608|NCT01869647|12457942|P3|COMPLETED|Overall Study||62
5062609|NCT01869647|12457943|P2|COMPLETED|Overall Study||130
5062610|NCT01869647|12457944|P1|COMPLETED|Overall Study||65
5062611|NCT01869647|12457942|P3|STARTED|Overall Study||62
5062612|NCT01869647|12457943|P2|STARTED|Overall Study||136
5062613|NCT01869647|12457944|P1|STARTED|Overall Study||66
5062614|NCT01869634|12457957|P2|NOT COMPLETED|Overall Study||0
5062615|NCT01869634|12457958|P1|NOT COMPLETED|Overall Study||2
5062616|NCT01869634|12457957|P2|COMPLETED|Overall Study||17
5062617|NCT01869634|12457958|P1|COMPLETED|Overall Study||18
5062618|NCT01869634|12457957|P2|STARTED|Overall Study||17
5062619|NCT01869634|12457958|P1|STARTED|Overall Study||20
5062620|NCT01869478|12457970|P2|NOT COMPLETED|Overall Study||0
5062621|NCT01869478|12457971|P1|NOT COMPLETED|Overall Study||0
5062622|NCT01869478|12457970|P2|COMPLETED|Overall Study||1
5062623|NCT01869478|12457971|P1|COMPLETED|Overall Study||0
5062624|NCT01869478|12457970|P2|STARTED|Overall Study||1
5062625|NCT01869478|12457971|P1|STARTED|Overall Study||0
5062626|NCT01869439|12457979|P1|NOT COMPLETED|Overall Study||0
5062627|NCT01869439|12457979|P1|COMPLETED|Overall Study||40
5062628|NCT01869439|12457979|P1|STARTED|Overall Study||40
5062629|NCT01869374|12457985|P2|NOT COMPLETED|Overall Study||1
5062630|NCT01869374|12457986|P1|NOT COMPLETED|Overall Study||0
5062631|NCT01869374|12457985|P2|COMPLETED|Overall Study||8
5062632|NCT01869374|12457986|P1|COMPLETED|Overall Study||9
5062633|NCT01869374|12457985|P2|STARTED|Overall Study||9
5062634|NCT01869374|12457986|P1|STARTED|Overall Study||9
5062635|NCT01869348|12457994|P2|NOT COMPLETED|Overall Study||1
5062636|NCT01869348|12457995|P1|NOT COMPLETED|Overall Study||1
5062637|NCT01869348|12457994|P2|COMPLETED|Overall Study||19
5062638|NCT01869348|12457995|P1|COMPLETED|Overall Study||19
5062639|NCT01869348|12457994|P2|STARTED|Overall Study||20
5062640|NCT01869348|12457995|P1|STARTED|Overall Study||20
5062641|NCT01869192|12458003|P2|NOT COMPLETED|Postoperative Chemotherapy||2
5062642|NCT01869192|12458004|P1|NOT COMPLETED|Postoperative Chemotherapy||0
5062643|NCT01869192|12458003|P2|COMPLETED|Postoperative Chemotherapy||31
5062644|NCT01869192|12458004|P1|COMPLETED|Postoperative Chemotherapy||32
5062645|NCT01869192|12458003|P2|STARTED|Postoperative Chemotherapy||33
5062646|NCT01869192|12458004|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
5062647|NCT01869192|12458003|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
5062648|NCT01869192|12458004|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
5062649|NCT01869192|12458003|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
5062650|NCT01869192|12458004|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
5062651|NCT01869192|12458003|P2|STARTED|Preoperative Chemotherapy to Surgery||35
5062652|NCT01869192|12458004|P1|STARTED|Preoperative Chemotherapy to Surgery||37
5062653|NCT01869075|12458018|P6|NOT COMPLETED|Phase 2||0
5062654|NCT01869075|12458019|P5|NOT COMPLETED|Phase 2||0
5062655|NCT01869075|12458020|P4|NOT COMPLETED|Phase 2||0
5062656|NCT01869075|12458021|P3|NOT COMPLETED|Phase 2||0
5062657|NCT01869075|12458022|P2|NOT COMPLETED|Phase 2||0
5062658|NCT01869075|12458023|P1|NOT COMPLETED|Phase 2||0
5062659|NCT01869075|12458018|P6|COMPLETED|Phase 2||45
5062660|NCT01869075|12458019|P5|COMPLETED|Phase 2||75
5062661|NCT01869075|12458020|P4|COMPLETED|Phase 2||45
5062662|NCT01869075|12458021|P3|COMPLETED|Phase 2||75
5062663|NCT01869075|12458022|P2|COMPLETED|Phase 2||30
5062664|NCT01869075|12458023|P1|COMPLETED|Phase 2||90
5062665|NCT01869075|12458018|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
5062666|NCT01869075|12458019|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
5062667|NCT01869075|12458020|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
5062668|NCT01869075|12458021|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
5062669|NCT01869075|12458022|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
5062758|NCT01868477|12458182|P1|COMPLETED|Overall Study||8
5062670|NCT01869075|12458023|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
5062671|NCT01869075|12458018|P6|NOT COMPLETED|Phase 1||0
5062672|NCT01869075|12458019|P5|NOT COMPLETED|Phase 1||0
5062673|NCT01869075|12458020|P4|NOT COMPLETED|Phase 1||0
5062674|NCT01869075|12458021|P3|NOT COMPLETED|Phase 1||0
5062675|NCT01869075|12458022|P2|NOT COMPLETED|Phase 1||0
5062676|NCT01869075|12458023|P1|NOT COMPLETED|Phase 1||0
5062677|NCT01869075|12458018|P6|COMPLETED|Phase 1||90
5062678|NCT01869075|12458019|P5|COMPLETED|Phase 1||30
5062679|NCT01869075|12458020|P4|COMPLETED|Phase 1||75
5062680|NCT01869075|12458021|P3|COMPLETED|Phase 1||45
5062681|NCT01869075|12458022|P2|COMPLETED|Phase 1||75
5062682|NCT01869075|12458023|P1|COMPLETED|Phase 1||45
5062683|NCT01869075|12458018|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
5062684|NCT01869075|12458019|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
5062685|NCT01869075|12458020|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
5062686|NCT01869075|12458021|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
5062687|NCT01869075|12458022|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
5062688|NCT01869075|12458023|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
5062689|NCT01869075|12458018|P6|NOT COMPLETED|Phase 0 (Baseline)||0
5062690|NCT01869075|12458019|P5|NOT COMPLETED|Phase 0 (Baseline)||0
5062691|NCT01869075|12458020|P4|NOT COMPLETED|Phase 0 (Baseline)||0
5062692|NCT01869075|12458021|P3|NOT COMPLETED|Phase 0 (Baseline)||0
5062693|NCT01869075|12458022|P2|NOT COMPLETED|Phase 0 (Baseline)||0
5062694|NCT01869075|12458023|P1|NOT COMPLETED|Phase 0 (Baseline)||0
5062695|NCT01869075|12458018|P6|COMPLETED|Phase 0 (Baseline)||341
5062696|NCT01869075|12458019|P5|COMPLETED|Phase 0 (Baseline)||0
5062697|NCT01869075|12458020|P4|COMPLETED|Phase 0 (Baseline)||416
5062698|NCT01869075|12458021|P3|COMPLETED|Phase 0 (Baseline)||0
5062699|NCT01869075|12458022|P2|COMPLETED|Phase 0 (Baseline)||418
5062700|NCT01869075|12458023|P1|COMPLETED|Phase 0 (Baseline)||0
5062701|NCT01869075|12458018|P6|STARTED|Phase 0 (Baseline)||341
5062702|NCT01869075|12458019|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
5062703|NCT01869075|12458020|P4|STARTED|Phase 0 (Baseline)||416
5062704|NCT01869075|12458021|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
5062705|NCT01869075|12458022|P2|STARTED|Phase 0 (Baseline)||418
5062706|NCT01869075|12458023|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
5062707|NCT01868997|12458039|P2|NOT COMPLETED|Overall Study||6
5062708|NCT01868997|12458040|P1|NOT COMPLETED|Overall Study||7
5062709|NCT01868997|12458039|P2|COMPLETED|Overall Study||36
5062710|NCT01868997|12458040|P1|COMPLETED|Overall Study||38
5062711|NCT01868997|12458039|P2|STARTED|Overall Study|randomized and treated|42
5062712|NCT01868997|12458040|P1|STARTED|Overall Study|randomized and treated|45
5062713|NCT01868893|12458056|P1|NOT COMPLETED|Overall Study||20
5062714|NCT01868893|12458056|P1|COMPLETED|Overall Study||0
5062715|NCT01868893|12458056|P1|STARTED|Overall Study||20
5062716|NCT01868789|12458065|P2|NOT COMPLETED|Overall Study||2
5062717|NCT01868789|12458066|P1|NOT COMPLETED|Overall Study||2
5062718|NCT01868789|12458065|P2|COMPLETED|Overall Study||12
5062719|NCT01868789|12458066|P1|COMPLETED|Overall Study||7
5062720|NCT01868789|12458065|P2|STARTED|Overall Study||14
5062721|NCT01868789|12458066|P1|STARTED|Overall Study||9
5062722|NCT01868776|12458076|P2|NOT COMPLETED|Overall Study||0
5062723|NCT01868776|12458077|P1|NOT COMPLETED|Overall Study||0
5062724|NCT01868776|12458076|P2|COMPLETED|Overall Study||50
5062725|NCT01868776|12458077|P1|COMPLETED|Overall Study||50
5062726|NCT01868776|12458076|P2|STARTED|Overall Study||50
5062727|NCT01868776|12458077|P1|STARTED|Overall Study||50
5062728|NCT01868646|12458085|P2|NOT COMPLETED|Overall Study||5
5062729|NCT01868646|12458086|P1|NOT COMPLETED|Overall Study||3
5062730|NCT01868646|12458085|P2|COMPLETED|Overall Study||67
5062731|NCT01868646|12458086|P1|COMPLETED|Overall Study||73
5062732|NCT01868646|12458085|P2|STARTED|Overall Study||72
5062733|NCT01868646|12458086|P1|STARTED|Overall Study||76
5062734|NCT01868633|12458114|P2|NOT COMPLETED|Overall Study||0
5062735|NCT01868633|12458115|P1|NOT COMPLETED|Overall Study||0
5062736|NCT01868633|12458114|P2|COMPLETED|Overall Study||26
5062737|NCT01868633|12458115|P1|COMPLETED|Overall Study||26
5062738|NCT01868633|12458114|P2|STARTED|Overall Study||26
5062739|NCT01868633|12458115|P1|STARTED|Overall Study||26
5062740|NCT01868594|12458131|P2|NOT COMPLETED|Overall Study||3
5062741|NCT01868594|12458132|P1|NOT COMPLETED|Overall Study||4
5062742|NCT01868594|12458131|P2|COMPLETED|Overall Study||72
5062743|NCT01868594|12458132|P1|COMPLETED|Overall Study||72
5062744|NCT01868594|12458131|P2|STARTED|Overall Study||75
5062745|NCT01868594|12458132|P1|STARTED|Overall Study||76
5062746|NCT01868542|12458152|P2|NOT COMPLETED|Overall Study||2
5062747|NCT01868542|12458153|P1|NOT COMPLETED|Overall Study||0
5062748|NCT01868542|12458152|P2|COMPLETED|Overall Study||21
5062749|NCT01868542|12458153|P1|COMPLETED|Overall Study||23
5062750|NCT01868542|12458152|P2|STARTED|Overall Study||23
5062751|NCT01868542|12458153|P1|STARTED|Overall Study||23
5062752|NCT01868503|12458171|P1|NOT COMPLETED|Overall Study||2
5062753|NCT01868503|12458171|P1|COMPLETED|Overall Study||5
5062754|NCT01868503|12458171|P1|STARTED|Overall Study||7
5062755|NCT01868477|12458181|P2|NOT COMPLETED|Overall Study||5
5062756|NCT01868477|12458182|P1|NOT COMPLETED|Overall Study||4
5062757|NCT01868477|12458181|P2|COMPLETED|Overall Study||6
5062759|NCT01868477|12458181|P2|Not Switched to EPO+DFX|Overall Study||0
5062760|NCT01868477|12458182|P1|Not Switched to EPO+DFX|Overall Study||7
5062761|NCT01868477|12458181|P2|Switched to EPO+DFX|Overall Study||0
5062762|NCT01868477|12458182|P1|Switched to EPO+DFX|Overall Study||5
5062763|NCT01868477|12458181|P2|STARTED|Overall Study||11
5062764|NCT01868477|12458182|P1|STARTED|Overall Study||12
5062765|NCT01868425|12458208|P2|NOT COMPLETED|Overall Study||0
5062766|NCT01868425|12458209|P1|NOT COMPLETED|Overall Study||0
5062767|NCT01868425|12458208|P2|COMPLETED|Overall Study||57
5062768|NCT01868425|12458209|P1|COMPLETED|Overall Study||55
5062769|NCT01868425|12458208|P2|STARTED|Overall Study||57
5062770|NCT01868425|12458209|P1|STARTED|Overall Study||55
5062771|NCT01868334|12458243|P4|NOT COMPLETED|Year 2 Pre-post Study||0
5062772|NCT01868334|12458244|P3|NOT COMPLETED|Year 2 Pre-post Study||0
5062773|NCT01868334|12458245|P2|NOT COMPLETED|Year 2 Pre-post Study||0
5062774|NCT01868334|12458246|P1|NOT COMPLETED|Year 2 Pre-post Study||0
5062775|NCT01868334|12458243|P4|COMPLETED|Year 2 Pre-post Study||19274
5062776|NCT01868334|12458244|P3|COMPLETED|Year 2 Pre-post Study||20904
5062777|NCT01868334|12458245|P2|COMPLETED|Year 2 Pre-post Study||8047
5062778|NCT01868334|12458246|P1|COMPLETED|Year 2 Pre-post Study||22324
5062779|NCT01868334|12458243|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
5062780|NCT01868334|12458244|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
5062781|NCT01868334|12458245|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
5062782|NCT01868334|12458246|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
5062783|NCT01868334|12458243|P4|NOT COMPLETED|Year 1 RCCT Study||0
5062784|NCT01868334|12458244|P3|NOT COMPLETED|Year 1 RCCT Study||0
5062785|NCT01868334|12458245|P2|NOT COMPLETED|Year 1 RCCT Study||0
5062786|NCT01868334|12458246|P1|NOT COMPLETED|Year 1 RCCT Study||0
5062787|NCT01868334|12458243|P4|COMPLETED|Year 1 RCCT Study||20904
5062788|NCT01868334|12458244|P3|COMPLETED|Year 1 RCCT Study||19274
5062789|NCT01868334|12458245|P2|COMPLETED|Year 1 RCCT Study||17185
5062790|NCT01868334|12458246|P1|COMPLETED|Year 1 RCCT Study||13186
5062791|NCT01868334|12458243|P4|STARTED|Year 1 RCCT Study||20904
5062792|NCT01868334|12458244|P3|STARTED|Year 1 RCCT Study||19274
5062793|NCT01868334|12458245|P2|STARTED|Year 1 RCCT Study||17185
5062794|NCT01868334|12458246|P1|STARTED|Year 1 RCCT Study||13186
5062795|NCT01868243|12458286|P2|NOT COMPLETED|Overall Study||1
5062796|NCT01868243|12458287|P1|NOT COMPLETED|Overall Study||0
5062797|NCT01868243|12458286|P2|COMPLETED|Overall Study||11
5062798|NCT01868243|12458287|P1|COMPLETED|Overall Study||15
5062799|NCT01868243|12458286|P2|STARTED|Overall Study||12
5062800|NCT01868243|12458287|P1|STARTED|Overall Study||15
5062801|NCT01868165|12458295|P1|NOT COMPLETED|Overall Study||45
5062802|NCT01868165|12458295|P1|COMPLETED|Overall Study||292
5062803|NCT01868165|12458295|P1|STARTED|Overall Study||337
5062804|NCT01868139|12458299|P1|NOT COMPLETED|Overall Study||1
5062805|NCT01868139|12458299|P1|COMPLETED|Overall Study||0
5062806|NCT01868139|12458299|P1|STARTED|Overall Study||1
5062807|NCT01868074|12458311|P2|NOT COMPLETED|Overall Study||4
5062808|NCT01868074|12458312|P1|NOT COMPLETED|Overall Study||7
5062809|NCT01868074|12458311|P2|COMPLETED|Overall Study||32
5062810|NCT01868074|12458312|P1|COMPLETED|Overall Study||29
5062811|NCT01868074|12458311|P2|STARTED|Overall Study||36
5062812|NCT01868074|12458312|P1|STARTED|Overall Study||36
5062813|NCT01868035|12458322|P1|NOT COMPLETED|Overall Study||7
5062814|NCT01868035|12458322|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
5062815|NCT01868035|12458322|P1|STARTED|Overall Study||15
5062816|NCT01868022|12458347|P9|NOT COMPLETED|Overall Study||2
5062817|NCT01868022|12458348|P8|NOT COMPLETED|Overall Study||9
5062818|NCT01868022|12458349|P7|NOT COMPLETED|Overall Study||0
5062819|NCT01868022|12458350|P6|NOT COMPLETED|Overall Study||1
5062820|NCT01868022|12458351|P5|NOT COMPLETED|Overall Study||2
5062821|NCT01868022|12458352|P4|NOT COMPLETED|Overall Study||1
5062822|NCT01868022|12458353|P3|NOT COMPLETED|Overall Study||1
5062823|NCT01868022|12458354|P2|NOT COMPLETED|Overall Study||0
5062824|NCT01868022|12458355|P1|NOT COMPLETED|Overall Study||0
5062825|NCT01868022|12458347|P9|COMPLETED|Overall Study||6
5062826|NCT01868022|12458348|P8|COMPLETED|Overall Study||16
5062827|NCT01868022|12458349|P7|COMPLETED|Overall Study||3
5062828|NCT01868022|12458350|P6|COMPLETED|Overall Study||2
5062829|NCT01868022|12458351|P5|COMPLETED|Overall Study||1
5062830|NCT01868022|12458352|P4|COMPLETED|Overall Study||2
5062831|NCT01868022|12458353|P3|COMPLETED|Overall Study||13
5062832|NCT01868022|12458354|P2|COMPLETED|Overall Study||3
5062833|NCT01868022|12458355|P1|COMPLETED|Overall Study||3
5062834|NCT01868022|12458347|P9|STARTED|Overall Study||8
5062835|NCT01868022|12458348|P8|STARTED|Overall Study||25
5062836|NCT01868022|12458349|P7|STARTED|Overall Study||3
5062837|NCT01868022|12458350|P6|STARTED|Overall Study||3
5062838|NCT01868022|12458351|P5|STARTED|Overall Study||3
5062839|NCT01868022|12458352|P4|STARTED|Overall Study||3
5062840|NCT01868022|12458353|P3|STARTED|Overall Study||14
5062841|NCT01868022|12458354|P2|STARTED|Overall Study||3
5062842|NCT01868022|12458355|P1|STARTED|Overall Study||3
5062843|NCT01868009|12458561|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
5062844|NCT01868009|12458562|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
5062845|NCT01868009|12458561|P2|COMPLETED|Period 2 (5-9 Days)||142
5062846|NCT01868009|12458562|P1|COMPLETED|Period 2 (5-9 Days)||141
5062847|NCT01868009|12458561|P2|STARTED|Period 2 (5-9 Days)||142
5062848|NCT01868009|12458562|P1|STARTED|Period 2 (5-9 Days)||143
5062849|NCT01868009|12458561|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
5062850|NCT01868009|12458562|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
5062851|NCT01868009|12458561|P2|COMPLETED|Period 1 (5-9 Days)||142
5062852|NCT01868009|12458562|P1|COMPLETED|Period 1 (5-9 Days)||143
5062853|NCT01868009|12458561|P2|STARTED|Period 1 (5-9 Days)||144
5062854|NCT01868009|12458562|P1|STARTED|Period 1 (5-9 Days)||143
5062855|NCT01867710|12458576|P4|NOT COMPLETED|Overall Study||42
5062856|NCT01867710|12458577|P3|NOT COMPLETED|Overall Study||40
5062857|NCT01867710|12458578|P2|NOT COMPLETED|Overall Study||41
5062858|NCT01867710|12458579|P1|NOT COMPLETED|Overall Study||41
5062859|NCT01867710|12458576|P4|COMPLETED|Overall Study||0
5062860|NCT01867710|12458577|P3|COMPLETED|Overall Study||0
5062861|NCT01867710|12458578|P2|COMPLETED|Overall Study||0
5062862|NCT01867710|12458579|P1|COMPLETED|Overall Study||0
5062863|NCT01867710|12458576|P4|Treated|Overall Study||42
5062864|NCT01867710|12458577|P3|Treated|Overall Study||39
5062865|NCT01867710|12458578|P2|Treated|Overall Study||41
5062866|NCT01867710|12458579|P1|Treated|Overall Study||41
5062867|NCT01867710|12458576|P4|STARTED|Overall Study||42
5062868|NCT01867710|12458577|P3|STARTED|Overall Study||40
5062869|NCT01867710|12458578|P2|STARTED|Overall Study||41
5062870|NCT01867710|12458579|P1|STARTED|Overall Study||41
5062871|NCT01867671|12458647|P2|NOT COMPLETED|Overall Study||28
5062872|NCT01867671|12458648|P1|NOT COMPLETED|Overall Study||29
5062873|NCT01867671|12458647|P2|COMPLETED|Overall Study||22
5062874|NCT01867671|12458648|P1|COMPLETED|Overall Study||67
5062875|NCT01867671|12458647|P2|STARTED|Overall Study||50
5062876|NCT01867671|12458648|P1|STARTED|Overall Study||96
5062877|NCT01867658|12458661|P1|NOT COMPLETED|Overall Study||9
5062878|NCT01867658|12458661|P1|COMPLETED|Overall Study||103
5062879|NCT01867658|12458661|P1|STARTED|Overall Study||112
5062880|NCT01867632|12458674|P2|NOT COMPLETED|Overall Study||0
5062881|NCT01867632|12458675|P1|NOT COMPLETED|Overall Study||0
5062882|NCT01867632|12458674|P2|COMPLETED|Overall Study||66
5062883|NCT01867632|12458675|P1|COMPLETED|Overall Study||65
5062884|NCT01867632|12458674|P2|STARTED|Overall Study||66
5062885|NCT01867632|12458675|P1|STARTED|Overall Study||65
5062886|NCT01867606|12458685|P2|NOT COMPLETED|Overall Study||15
5062887|NCT01867606|12458686|P1|NOT COMPLETED|Overall Study||10
5062888|NCT01867606|12458685|P2|COMPLETED|Overall Study||17
5062889|NCT01867606|12458686|P1|COMPLETED|Overall Study||16
5062890|NCT01867606|12458685|P2|STARTED|Overall Study||32
5062891|NCT01867606|12458686|P1|STARTED|Overall Study||26
5062892|NCT01867580|12458704|P2|NOT COMPLETED|Overall Study||24
5062893|NCT01867580|12458705|P1|NOT COMPLETED|Overall Study||28
5062894|NCT01867580|12458704|P2|COMPLETED|Overall Study||64
5062895|NCT01867580|12458705|P1|COMPLETED|Overall Study||65
5062896|NCT01867580|12458704|P2|STARTED|Overall Study||88
5062897|NCT01867580|12458705|P1|STARTED|Overall Study||93
5062898|NCT01867515|12458718|P3|NOT COMPLETED|Overall Study||11
5062899|NCT01867515|12458719|P2|NOT COMPLETED|Overall Study||1
5062900|NCT01867515|12458720|P1|NOT COMPLETED|Overall Study||0
5062901|NCT01867515|12458718|P3|COMPLETED|Overall Study||14
5062902|NCT01867515|12458719|P2|COMPLETED|Overall Study||11
5062903|NCT01867515|12458720|P1|COMPLETED|Overall Study||13
5062904|NCT01867515|12458718|P3|STARTED|Overall Study||25
5062905|NCT01867515|12458719|P2|STARTED|Overall Study||12
5062906|NCT01867515|12458720|P1|STARTED|Overall Study||13
5062907|NCT01867424|12458730|P2|NOT COMPLETED|Overall Study||1
5062908|NCT01867424|12458731|P1|NOT COMPLETED|Overall Study||2
5062909|NCT01867424|12458730|P2|COMPLETED|Overall Study||11
5062910|NCT01867424|12458731|P1|COMPLETED|Overall Study||10
5062911|NCT01867424|12458730|P2|STARTED|Overall Study||12
5062912|NCT01867424|12458731|P1|STARTED|Overall Study||12
5062913|NCT01867307|12458745|P2|NOT COMPLETED|Overall Study||3
5062914|NCT01867307|12458746|P1|NOT COMPLETED|Overall Study||3
5062915|NCT01867307|12458745|P2|COMPLETED|Overall Study||16
5062916|NCT01867307|12458746|P1|COMPLETED|Overall Study||15
5062917|NCT01867307|12458745|P2|STARTED|Overall Study|Started are the treated patients|19
5062918|NCT01867307|12458746|P1|STARTED|Overall Study|Started are the treated patients|18
5062919|NCT01867294|12458756|P4|NOT COMPLETED|Overall Study||0
5062920|NCT01867294|12458757|P3|NOT COMPLETED|Overall Study||0
5062921|NCT01867294|12458758|P2|NOT COMPLETED|Overall Study||1
5062922|NCT01867294|12458759|P1|NOT COMPLETED|Overall Study||1
5062923|NCT01867294|12458756|P4|COMPLETED|Overall Study||0
5062924|NCT01867294|12458757|P3|COMPLETED|Overall Study||0
5062925|NCT01867294|12458758|P2|COMPLETED|Overall Study||9
5062926|NCT01867294|12458759|P1|COMPLETED|Overall Study||8
5062927|NCT01867294|12458756|P4|STARTED|Overall Study||0
5062928|NCT01867294|12458757|P3|STARTED|Overall Study||0
5062929|NCT01867294|12458758|P2|STARTED|Overall Study||10
5062930|NCT01867294|12458759|P1|STARTED|Overall Study||9
5062931|NCT01867216|12458806|P7|NOT COMPLETED|Overall Study||1
5062932|NCT01867216|12458807|P6|NOT COMPLETED|Overall Study||0
5062933|NCT01867216|12458808|P5|NOT COMPLETED|Overall Study||1
5062934|NCT01867216|12458809|P4|NOT COMPLETED|Overall Study||0
5062935|NCT01867216|12458810|P3|NOT COMPLETED|Overall Study||0
5062936|NCT01867216|12458811|P2|NOT COMPLETED|Overall Study||0
5062937|NCT01867216|12458812|P1|NOT COMPLETED|Overall Study||4
5062938|NCT01867216|12458806|P7|COMPLETED|Overall Study||8
5062939|NCT01867216|12458807|P6|COMPLETED|Overall Study||8
5062940|NCT01867216|12458808|P5|COMPLETED|Overall Study||8
5062941|NCT01867216|12458809|P4|COMPLETED|Overall Study||8
5062942|NCT01867216|12458810|P3|COMPLETED|Overall Study||8
5062943|NCT01867216|12458811|P2|COMPLETED|Overall Study||8
5062944|NCT01867216|12458812|P1|COMPLETED|Overall Study||12
5062945|NCT01867216|12458806|P7|Received Study Drug|Overall Study||9
5062946|NCT01867216|12458807|P6|Received Study Drug|Overall Study||8
5062947|NCT01867216|12458808|P5|Received Study Drug|Overall Study||9
5062948|NCT01867216|12458809|P4|Received Study Drug|Overall Study||8
5062949|NCT01867216|12458810|P3|Received Study Drug|Overall Study||8
5062950|NCT01867216|12458811|P2|Received Study Drug|Overall Study||8
5062951|NCT01867216|12458812|P1|Received Study Drug|Overall Study||14
5062952|NCT01867216|12458806|P7|STARTED|Overall Study||9
5062953|NCT01867216|12458807|P6|STARTED|Overall Study||8
5062954|NCT01867216|12458808|P5|STARTED|Overall Study||9
5062955|NCT01867216|12458809|P4|STARTED|Overall Study||8
5062956|NCT01867216|12458810|P3|STARTED|Overall Study||8
5062957|NCT01867216|12458811|P2|STARTED|Overall Study||8
5062958|NCT01867216|12458812|P1|STARTED|Overall Study||16
5062959|NCT01867164|12458869|P2|NOT COMPLETED|Overall Study||0
5062960|NCT01867164|12458870|P1|NOT COMPLETED|Overall Study||0
5062961|NCT01867164|12458869|P2|COMPLETED|Overall Study||79
5062962|NCT01867164|12458870|P1|COMPLETED|Overall Study||81
5062963|NCT01867164|12458869|P2|STARTED|Overall Study||79
5062964|NCT01867164|12458870|P1|STARTED|Overall Study||81
5062965|NCT01867086|12458884|P1|NOT COMPLETED|Overall Study||1
5062966|NCT01867086|12458884|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
5062967|NCT01867086|12458884|P1|STARTED|Overall Study||1
5062968|NCT01867047|12458893|P2|NOT COMPLETED|Overall Study||5
5062969|NCT01867047|12458894|P1|NOT COMPLETED|Overall Study||8
5062970|NCT01867047|12458893|P2|COMPLETED|Overall Study||23
5062971|NCT01867047|12458894|P1|COMPLETED|Overall Study||23
5062972|NCT01867047|12458893|P2|STARTED|Overall Study||28
5062973|NCT01867047|12458894|P1|STARTED|Overall Study||31
5062974|NCT01867021|12458914|P2|NOT COMPLETED|Overall Study||10
5062975|NCT01867021|12458915|P1|NOT COMPLETED|Overall Study||2
5062976|NCT01867021|12458914|P2|COMPLETED|Overall Study||1440
5062977|NCT01867021|12458915|P1|COMPLETED|Overall Study||1450
5062978|NCT01867021|12458914|P2|STARTED|Overall Study||1450
5062979|NCT01867021|12458915|P1|STARTED|Overall Study||1452
5062980|NCT01866943|12458934|P2|NOT COMPLETED|Overall Study||22
5062981|NCT01866943|12458935|P1|NOT COMPLETED|Overall Study||19
5062982|NCT01866943|12458934|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
5062983|NCT01866943|12458935|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
5062984|NCT01866943|12458934|P2|STARTED|Overall Study||22
5062985|NCT01866943|12458935|P1|STARTED|Overall Study||19
5062986|NCT01866839|12458944|P1|NOT COMPLETED|Overall Study||10
5062987|NCT01866839|12458944|P1|COMPLETED|Overall Study||30
5062988|NCT01866839|12458944|P1|STARTED|Overall Study||40
5062989|NCT01866826|12458960|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
5062990|NCT01866826|12458961|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
5062991|NCT01866826|12458960|P2|COMPLETED|Second Intervention - 4 Weeks||20
5062992|NCT01866826|12458961|P1|COMPLETED|Second Intervention - 4 Weeks||22
5062993|NCT01866826|12458960|P2|STARTED|Second Intervention - 4 Weeks||20
5062994|NCT01866826|12458961|P1|STARTED|Second Intervention - 4 Weeks||22
5062995|NCT01866826|12458960|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
5062996|NCT01866826|12458961|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
5062997|NCT01866826|12458960|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
5062998|NCT01866826|12458961|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
5062999|NCT01866826|12458960|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
5063000|NCT01866826|12458961|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
5063001|NCT01866826|12458960|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
5063002|NCT01866826|12458961|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
5063003|NCT01866826|12458960|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
5063004|NCT01866826|12458961|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
5063005|NCT01866826|12458960|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
5063006|NCT01866826|12458961|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
5063007|NCT01866709|12458977|P2|NOT COMPLETED|Overall Study||0
5063008|NCT01866709|12458978|P1|NOT COMPLETED|Overall Study||1
5063009|NCT01866709|12458977|P2|COMPLETED|Overall Study||17
5063010|NCT01866709|12458978|P1|COMPLETED|Overall Study||14
5063011|NCT01866709|12458977|P2|STARTED|Overall Study||17
5063012|NCT01866709|12458978|P1|STARTED|Overall Study||15
5063013|NCT01866592|12458986|P1|NOT COMPLETED|Overall Study||23
5063014|NCT01866592|12458986|P1|COMPLETED|Overall Study||58
5063015|NCT01866592|12458986|P1|STARTED|Overall Study||81
5063016|NCT01866423|12459019|P1|NOT COMPLETED|Overall Study||4
5063017|NCT01866423|12459019|P1|COMPLETED|Overall Study||0
5063018|NCT01866423|12459019|P1|STARTED|Overall Study||4
5063019|NCT01866410|12459029|P1|NOT COMPLETED|Overall Study||0
5063020|NCT01866410|12459029|P1|COMPLETED|Overall Study||37
5063021|NCT01866410|12459029|P1|STARTED|Overall Study||37
5063022|NCT01866319|12459047|P3|NOT COMPLETED|Overall Study||180
5063023|NCT01866319|12459048|P2|NOT COMPLETED|Overall Study||178
5063024|NCT01866319|12459049|P1|NOT COMPLETED|Overall Study||207
5063025|NCT01866319|12459047|P3|COMPLETED|Overall Study||97
5063026|NCT01866319|12459048|P2|COMPLETED|Overall Study||101
5063027|NCT01866319|12459049|P1|COMPLETED|Overall Study||71
5063028|NCT01866319|12459047|P3|Treated|Overall Study||277
5063029|NCT01866319|12459048|P2|Treated|Overall Study||278
5063030|NCT01866319|12459049|P1|Treated|Overall Study||256
5063031|NCT01866319|12459047|P3|STARTED|Overall Study||277
5063032|NCT01866319|12459048|P2|STARTED|Overall Study||279
5063033|NCT01866319|12459049|P1|STARTED|Overall Study||278
5063034|NCT01866306|12459070|P7|NOT COMPLETED|Overall Study||0
5063035|NCT01866306|12459071|P6|NOT COMPLETED|Overall Study||0
5063036|NCT01866306|12459072|P5|NOT COMPLETED|Overall Study||0
5063037|NCT01866306|12459073|P4|NOT COMPLETED|Overall Study||0
5063038|NCT01866306|12459074|P3|NOT COMPLETED|Overall Study||0
5063039|NCT01866306|12459075|P2|NOT COMPLETED|Overall Study||0
5063040|NCT01866306|12459076|P1|NOT COMPLETED|Overall Study||0
5063041|NCT01866306|12459070|P7|COMPLETED|Overall Study||23
5063042|NCT01866306|12459071|P6|COMPLETED|Overall Study||6
5063043|NCT01866306|12459072|P5|COMPLETED|Overall Study||6
5063044|NCT01866306|12459073|P4|COMPLETED|Overall Study||6
5063045|NCT01866306|12459074|P3|COMPLETED|Overall Study||6
5063046|NCT01866306|12459075|P2|COMPLETED|Overall Study||6
5063047|NCT01866306|12459076|P1|COMPLETED|Overall Study||6
5063048|NCT01866306|12459070|P7|STARTED|Overall Study||23
5063049|NCT01866306|12459071|P6|STARTED|Overall Study||6
5063050|NCT01866306|12459072|P5|STARTED|Overall Study||6
5063051|NCT01866306|12459073|P4|STARTED|Overall Study||6
5063052|NCT01866306|12459074|P3|STARTED|Overall Study||6
5063053|NCT01866306|12459075|P2|STARTED|Overall Study||6
5063054|NCT01866306|12459076|P1|STARTED|Overall Study||6
5063055|NCT01866293|12459148|P1|NOT COMPLETED|Overall Study||2
5063056|NCT01866293|12459148|P1|COMPLETED|Overall Study||9
5063057|NCT01866293|12459148|P1|STARTED|Overall Study||11
5063058|NCT01866163|12459158|P2|NOT COMPLETED|Overall Study||4
5063059|NCT01866163|12459159|P1|NOT COMPLETED|Overall Study||10
5063060|NCT01866163|12459158|P2|COMPLETED|Overall Study||99
5063061|NCT01866163|12459159|P1|COMPLETED|Overall Study||313
5063062|NCT01866163|12459158|P2|STARTED|Overall Study||103
5063063|NCT01866163|12459159|P1|STARTED|Overall Study||323
5063064|NCT01866150|12459169|P1|NOT COMPLETED|Overall Study||0
5063065|NCT01866150|12459169|P1|COMPLETED|Overall Study||450
5063066|NCT01866150|12459169|P1|STARTED|Overall Study||450
5063067|NCT01866098|12459193|P3|NOT COMPLETED|Overall Study||21
5063068|NCT01866098|12459194|P2|NOT COMPLETED|Overall Study||27
5063069|NCT01866098|12459195|P1|NOT COMPLETED|Overall Study||19
5063070|NCT01866098|12459193|P3|COMPLETED|Overall Study||25
5063071|NCT01866098|12459194|P2|COMPLETED|Overall Study||20
5063072|NCT01866098|12459195|P1|COMPLETED|Overall Study||32
5063073|NCT01866098|12459193|P3|STARTED|Overall Study||46
5063074|NCT01866098|12459194|P2|STARTED|Overall Study||47
5063075|NCT01866098|12459195|P1|STARTED|Overall Study||51
5063076|NCT01865812|12459224|P1|NOT COMPLETED|Overall Study||2
5063077|NCT01865812|12459224|P1|COMPLETED|Overall Study||24
5063078|NCT01865812|12459224|P1|STARTED|Overall Study||26
5063079|NCT01865747|12459232|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
5063080|NCT01865747|12459233|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
5063081|NCT01865747|12459232|P2|COMPLETED|Primary Intent to Treat (PITT)||36
5063082|NCT01865747|12459233|P1|COMPLETED|Primary Intent to Treat (PITT)||56
5063083|NCT01865747|12459232|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
5063084|NCT01865747|12459233|P1|STARTED|Primary Intent to Treat (PITT)||187
5063085|NCT01865747|12459232|P2|NOT COMPLETED|Overall Study (ITT)||255
5063086|NCT01865747|12459233|P1|NOT COMPLETED|Overall Study (ITT)||198
5063087|NCT01865747|12459232|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
5063088|NCT01865747|12459233|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
5063089|NCT01865747|12459232|P2|STARTED|Overall Study (ITT)||328
5063090|NCT01865747|12459233|P1|STARTED|Overall Study (ITT)||330
5063091|NCT01865708|12459243|P1|NOT COMPLETED|Overall Study||0
5063092|NCT01865708|12459243|P1|COMPLETED|Overall Study||10
5063093|NCT01865708|12459243|P1|STARTED|Overall Study||10
5063094|NCT01865552|12459254|P6|NOT COMPLETED|Period 2||0
5063095|NCT01865552|12459255|P5|NOT COMPLETED|Period 2||0
5063096|NCT01865552|12459256|P4|NOT COMPLETED|Period 2||0
5063097|NCT01865552|12459257|P3|NOT COMPLETED|Period 2||0
5063098|NCT01865552|12459258|P2|NOT COMPLETED|Period 2||0
5063099|NCT01865552|12459259|P1|NOT COMPLETED|Period 2||0
5063100|NCT01865552|12459254|P6|COMPLETED|Period 2||22
5063101|NCT01865552|12459255|P5|COMPLETED|Period 2||20
5063102|NCT01865552|12459256|P4|COMPLETED|Period 2||22
5063103|NCT01865552|12459257|P3|COMPLETED|Period 2||23
5063104|NCT01865552|12459258|P2|COMPLETED|Period 2||23
5063105|NCT01865552|12459259|P1|COMPLETED|Period 2||22
5063106|NCT01865552|12459254|P6|STARTED|Period 2||22
5063107|NCT01865552|12459255|P5|STARTED|Period 2||20
5063108|NCT01865552|12459256|P4|STARTED|Period 2||22
5063109|NCT01865552|12459257|P3|STARTED|Period 2||23
5063110|NCT01865552|12459258|P2|STARTED|Period 2||23
5063111|NCT01865552|12459259|P1|STARTED|Period 2||22
5063112|NCT01865552|12459254|P6|NOT COMPLETED|Period 1||1
5063113|NCT01865552|12459255|P5|NOT COMPLETED|Period 1||3
5063114|NCT01865552|12459256|P4|NOT COMPLETED|Period 1||1
5063115|NCT01865552|12459257|P3|NOT COMPLETED|Period 1||0
5063116|NCT01865552|12459258|P2|NOT COMPLETED|Period 1||0
5063117|NCT01865552|12459259|P1|NOT COMPLETED|Period 1||1
5063118|NCT01865552|12459254|P6|COMPLETED|Period 1||22
5063119|NCT01865552|12459255|P5|COMPLETED|Period 1||20
5063120|NCT01865552|12459256|P4|COMPLETED|Period 1||22
5063121|NCT01865552|12459257|P3|COMPLETED|Period 1||23
5063122|NCT01865552|12459258|P2|COMPLETED|Period 1||23
5063123|NCT01865552|12459259|P1|COMPLETED|Period 1||22
5063124|NCT01865552|12459254|P6|Discontinued From Period 1|Period 1||1
5063125|NCT01865552|12459255|P5|Discontinued From Period 1|Period 1||3
5063126|NCT01865552|12459256|P4|Discontinued From Period 1|Period 1||1
5063127|NCT01865552|12459257|P3|Discontinued From Period 1|Period 1||0
5063128|NCT01865552|12459258|P2|Discontinued From Period 1|Period 1||0
5063129|NCT01865552|12459259|P1|Discontinued From Period 1|Period 1||1
5063130|NCT01865552|12459254|P6|STARTED|Period 1||23
5063131|NCT01865552|12459255|P5|STARTED|Period 1||23
5063132|NCT01865552|12459256|P4|STARTED|Period 1||23
5063133|NCT01865552|12459257|P3|STARTED|Period 1||23
5063134|NCT01865552|12459258|P2|STARTED|Period 1||23
5063135|NCT01865552|12459259|P1|STARTED|Period 1||23
5063136|NCT01865487|12459297|P10|NOT COMPLETED|Overall Study||0
5063137|NCT01865487|12459298|P9|NOT COMPLETED|Overall Study||0
5063138|NCT01865487|12459299|P8|NOT COMPLETED|Overall Study||0
5063139|NCT01865487|12459300|P7|NOT COMPLETED|Overall Study||1
5063140|NCT01865487|12459301|P6|NOT COMPLETED|Overall Study||0
5063141|NCT01865487|12459302|P5|NOT COMPLETED|Overall Study||1
5063142|NCT01865487|12459303|P4|NOT COMPLETED|Overall Study||1
5063143|NCT01865487|12459304|P3|NOT COMPLETED|Overall Study||0
5063144|NCT01865487|12459305|P2|NOT COMPLETED|Overall Study||0
5063145|NCT01865487|12459306|P1|NOT COMPLETED|Overall Study||0
5063146|NCT01865487|12459297|P10|COMPLETED|Overall Study||4
5063147|NCT01865487|12459298|P9|COMPLETED|Overall Study||12
5063148|NCT01865487|12459299|P8|COMPLETED|Overall Study||4
5063149|NCT01865487|12459300|P7|COMPLETED|Overall Study||11
5063150|NCT01865487|12459301|P6|COMPLETED|Overall Study||4
5063151|NCT01865487|12459302|P5|COMPLETED|Overall Study||11
5063152|NCT01865487|12459303|P4|COMPLETED|Overall Study||4
5063153|NCT01865487|12459304|P3|COMPLETED|Overall Study||15
5063154|NCT01865487|12459305|P2|COMPLETED|Overall Study||15
5063155|NCT01865487|12459306|P1|COMPLETED|Overall Study||15
5063156|NCT01865487|12459297|P10|STARTED|Overall Study||4
5063157|NCT01865487|12459298|P9|STARTED|Overall Study||12
5063158|NCT01865487|12459299|P8|STARTED|Overall Study||4
5063159|NCT01865487|12459300|P7|STARTED|Overall Study||12
5063160|NCT01865487|12459301|P6|STARTED|Overall Study||4
5063161|NCT01865487|12459302|P5|STARTED|Overall Study||12
5063162|NCT01865487|12459303|P4|STARTED|Overall Study||5
5063163|NCT01865487|12459304|P3|STARTED|Overall Study||15
5063164|NCT01865487|12459305|P2|STARTED|Overall Study||15
5063165|NCT01865487|12459306|P1|STARTED|Overall Study||15
5063166|NCT01865448|12459345|P2|NOT COMPLETED|Overall Study||3
5063167|NCT01865448|12459346|P1|NOT COMPLETED|Overall Study||2
5063168|NCT01865448|12459345|P2|COMPLETED|Overall Study||14
5063169|NCT01865448|12459346|P1|COMPLETED|Overall Study||15
5063170|NCT01865448|12459345|P2|STARTED|Overall Study||17
5063171|NCT01865448|12459346|P1|STARTED|Overall Study||17
5063172|NCT01865084|12459457|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
5063173|NCT01865084|12459458|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
5063174|NCT01865084|12459459|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
5063175|NCT01865084|12459457|P3|COMPLETED|Open Label Extension (OLE) Period||158
5063176|NCT01865084|12459458|P2|COMPLETED|Open Label Extension (OLE) Period||139
5063177|NCT01865084|12459459|P1|COMPLETED|Open Label Extension (OLE) Period||0
5063178|NCT01865084|12459457|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
5063179|NCT01865084|12459458|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
5063180|NCT01865084|12459459|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
5063181|NCT01865084|12459457|P3|NOT COMPLETED|Double Blind Period (DB)||6
5063182|NCT01865084|12459458|P2|NOT COMPLETED|Double Blind Period (DB)||4
5063183|NCT01865084|12459459|P1|NOT COMPLETED|Double Blind Period (DB)||5
5063184|NCT01865084|12459457|P3|COMPLETED|Double Blind Period (DB)||107
5063185|NCT01865084|12459458|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
5063186|NCT01865084|12459459|P1|COMPLETED|Double Blind Period (DB)||111
5063187|NCT01865084|12459457|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
5063188|NCT01865084|12459458|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
5063189|NCT01865084|12459459|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
5063190|NCT01865084|12459457|P3|STARTED|Double Blind Period (DB)||113
5063191|NCT01865084|12459458|P2|STARTED|Double Blind Period (DB)||102
5063192|NCT01865084|12459459|P1|STARTED|Double Blind Period (DB)||116
5063193|NCT01864564|12459487|P2|NOT COMPLETED|Overall Study||95
5063194|NCT01864564|12459488|P1|NOT COMPLETED|Overall Study||37
5063195|NCT01864564|12459487|P2|COMPLETED|Overall Study||387
5063196|NCT01864564|12459488|P1|COMPLETED|Overall Study||443
5063197|NCT01864564|12459487|P2|STARTED|Overall Study||482
5063198|NCT01864564|12459488|P1|STARTED|Overall Study||480
5063199|NCT01864538|12459514|P1|NOT COMPLETED|Overall Study||11
5063200|NCT01864538|12459514|P1|COMPLETED|Overall Study||0
5063201|NCT01864538|12459514|P1|STARTED|Overall Study||11
5063202|NCT01864525|12459520|P2|NOT COMPLETED|Overall Study||0
5063203|NCT01864525|12459521|P1|NOT COMPLETED|Overall Study||1
5063204|NCT01864525|12459520|P2|COMPLETED|Overall Study||7
5063205|NCT01864525|12459521|P1|COMPLETED|Overall Study||9
5063206|NCT01864525|12459520|P2|STARTED|Overall Study||7
5063207|NCT01864525|12459521|P1|STARTED|Overall Study||10
5063208|NCT01864434|12459531|P2|NOT COMPLETED|Overall Study||0
5063209|NCT01864434|12459532|P1|NOT COMPLETED|Overall Study||0
5063210|NCT01864434|12459531|P2|COMPLETED|Overall Study||25
5063211|NCT01864434|12459532|P1|COMPLETED|Overall Study||25
5063212|NCT01864434|12459531|P2|STARTED|Overall Study||25
5063213|NCT01864434|12459532|P1|STARTED|Overall Study||25
5063214|NCT01864291|12459542|P1|NOT COMPLETED|Overall Study||2
5063215|NCT01864291|12459542|P1|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
5063216|NCT01864291|12459542|P1|STARTED|Overall Study||9
5063217|NCT01864200|12459550|P2|NOT COMPLETED|Overall Study||3
5063218|NCT01864200|12459551|P1|NOT COMPLETED|Overall Study||2
5063219|NCT01864200|12459550|P2|COMPLETED|Overall Study||26
5063220|NCT01864200|12459551|P1|COMPLETED|Overall Study||43
5063221|NCT01864200|12459550|P2|STARTED|Overall Study||29
5063222|NCT01864200|12459551|P1|STARTED|Overall Study||45
5063223|NCT01864174|12459559|P2|NOT COMPLETED|Off Treatment Follow-Up||0
5063224|NCT01864174|12459560|P1|NOT COMPLETED|Off Treatment Follow-Up||3
5063225|NCT01864174|12459559|P2|COMPLETED|Off Treatment Follow-Up||1
5063226|NCT01864174|12459560|P1|COMPLETED|Off Treatment Follow-Up||6
5063227|NCT01864174|12459559|P2|STARTED|Off Treatment Follow-Up||1
5063228|NCT01864174|12459560|P1|STARTED|Off Treatment Follow-Up||9
5063229|NCT01864174|12459559|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
5063230|NCT01864174|12459560|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
5063231|NCT01864174|12459559|P2|COMPLETED|Double Blind - Compliant Randomized||245
5063232|NCT01864174|12459560|P1|COMPLETED|Double Blind - Compliant Randomized||245
5063233|NCT01864174|12459559|P2|STARTED|Double Blind - Compliant Randomized||271
5063234|NCT01864174|12459560|P1|STARTED|Double Blind - Compliant Randomized||268
5063235|NCT01864174|12459559|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
5063236|NCT01864174|12459560|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
5063237|NCT01864174|12459559|P2|COMPLETED|Double Blind Treatment - All Treated||271
5063238|NCT01864174|12459560|P1|COMPLETED|Double Blind Treatment - All Treated||268
5063239|NCT01864174|12459559|P2|STARTED|Double Blind Treatment - All Treated||285
5063240|NCT01864174|12459560|P1|STARTED|Double Blind Treatment - All Treated||283
5063241|NCT01864148|12459579|P5|NOT COMPLETED|Overall Study||23
5063242|NCT01864148|12459580|P4|NOT COMPLETED|Overall Study||26
5063243|NCT01864148|12459581|P3|NOT COMPLETED|Overall Study||11
5063244|NCT01864148|12459582|P2|NOT COMPLETED|Overall Study||5
5063245|NCT01864148|12459583|P1|NOT COMPLETED|Overall Study||20
5063246|NCT01864148|12459579|P5|COMPLETED|Overall Study||69
5063247|NCT01864148|12459580|P4|COMPLETED|Overall Study||68
5063248|NCT01864148|12459581|P3|COMPLETED|Overall Study||84
5063249|NCT01864148|12459582|P2|COMPLETED|Overall Study||40
5063250|NCT01864148|12459583|P1|COMPLETED|Overall Study||73
5063251|NCT01864148|12459579|P5|Randomized and Dosed|Overall Study||92
5063252|NCT01864148|12459580|P4|Randomized and Dosed|Overall Study||93
5063253|NCT01864148|12459581|P3|Randomized and Dosed|Overall Study||95
5063254|NCT01864148|12459582|P2|Randomized and Dosed|Overall Study||45
5063255|NCT01864148|12459583|P1|Randomized and Dosed|Overall Study||93
5063256|NCT01864148|12459579|P5|STARTED|Overall Study||92
5063257|NCT01864148|12459580|P4|STARTED|Overall Study||94
5063258|NCT01864148|12459581|P3|STARTED|Overall Study||95
5063259|NCT01864148|12459582|P2|STARTED|Overall Study||45
5063260|NCT01864148|12459583|P1|STARTED|Overall Study||93
5063261|NCT01864005|12459612|P2|NOT COMPLETED|Overall Study||6
5063262|NCT01864005|12459613|P1|NOT COMPLETED|Overall Study||3
5063263|NCT01864005|12459612|P2|COMPLETED|Overall Study||25
5063264|NCT01864005|12459613|P1|COMPLETED|Overall Study||26
5063265|NCT01864005|12459612|P2|STARTED|Overall Study||31
5063266|NCT01864005|12459613|P1|STARTED|Overall Study||29
5063267|NCT01863953|12459630|P3|NOT COMPLETED|Overall Study||1
5063268|NCT01863953|12459631|P2|NOT COMPLETED|Overall Study||0
5063269|NCT01863953|12459632|P1|NOT COMPLETED|Overall Study||0
5063270|NCT01863953|12459630|P3|COMPLETED|Overall Study||37
5063271|NCT01863953|12459631|P2|COMPLETED|Overall Study||36
5063272|NCT01863953|12459632|P1|COMPLETED|Overall Study||38
5063273|NCT01863953|12459630|P3|STARTED|Overall Study||38
5063274|NCT01863953|12459631|P2|STARTED|Overall Study||36
5063275|NCT01863953|12459632|P1|STARTED|Overall Study||38
5063276|NCT01863771|12459646|P4|NOT COMPLETED|Maintenance Phase||43
5063277|NCT01863771|12459647|P3|NOT COMPLETED|Maintenance Phase||12
5063278|NCT01863771|12459648|P2|NOT COMPLETED|Maintenance Phase||5
5063279|NCT01863771|12459649|P1|NOT COMPLETED|Maintenance Phase||0
5063280|NCT01863771|12459646|P4|COMPLETED|Maintenance Phase||17
5063281|NCT01863771|12459647|P3|COMPLETED|Maintenance Phase||19
5063282|NCT01863771|12459648|P2|COMPLETED|Maintenance Phase||27
5063283|NCT01863771|12459649|P1|COMPLETED|Maintenance Phase||0
5063284|NCT01863771|12459646|P4|STARTED|Maintenance Phase||60
5063285|NCT01863771|12459647|P3|STARTED|Maintenance Phase||31
5063286|NCT01863771|12459648|P2|STARTED|Maintenance Phase||32
5063287|NCT01863771|12459649|P1|STARTED|Maintenance Phase||0
5063288|NCT01863771|12459646|P4|NOT COMPLETED|Induction Phase||0
5063289|NCT01863771|12459647|P3|NOT COMPLETED|Induction Phase||0
5063290|NCT01863771|12459648|P2|NOT COMPLETED|Induction Phase||0
5063291|NCT01863771|12459649|P1|NOT COMPLETED|Induction Phase||21
5063292|NCT01863771|12459646|P4|COMPLETED|Induction Phase||0
5063293|NCT01863771|12459647|P3|COMPLETED|Induction Phase||0
5063294|NCT01863771|12459648|P2|COMPLETED|Induction Phase||0
5063295|NCT01863771|12459649|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
5063296|NCT01863771|12459646|P4|STARTED|Induction Phase||0
5063297|NCT01863771|12459647|P3|STARTED|Induction Phase||0
5063298|NCT01863771|12459648|P2|STARTED|Induction Phase||0
5063299|NCT01863771|12459649|P1|STARTED|Induction Phase||144
5063300|NCT01863758|12459661|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
5063301|NCT01863758|12459661|P1|COMPLETED|Prophylactic Treatment-Phase II||64
5063302|NCT01863758|12459661|P1|STARTED|Prophylactic Treatment-Phase II||66
5063303|NCT01863758|12459661|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
5063304|NCT01863758|12459661|P1|COMPLETED|Prophylactic Treatment-Phase I||66
5063305|NCT01863758|12459661|P1|STARTED|Prophylactic Treatment-Phase I||66
5063306|NCT01863758|12459661|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
5063307|NCT01863758|12459661|P1|COMPLETED|Pharmacokinetic Assessment||66
5063308|NCT01863758|12459661|P1|STARTED|Pharmacokinetic Assessment||66
5063309|NCT01863732|12459673|P4|NOT COMPLETED|Overall Study||8
5063310|NCT01863732|12459674|P3|NOT COMPLETED|Overall Study||11
5063311|NCT01863732|12459675|P2|NOT COMPLETED|Overall Study||12
5063312|NCT01863732|12459676|P1|NOT COMPLETED|Overall Study||13
5063313|NCT01863732|12459673|P4|COMPLETED|Overall Study||33
5063314|NCT01863732|12459674|P3|COMPLETED|Overall Study||35
5063315|NCT01863732|12459675|P2|COMPLETED|Overall Study||75
5063316|NCT01863732|12459676|P1|COMPLETED|Overall Study||87
5063317|NCT01863732|12459673|P4|STARTED|Overall Study||41
5063318|NCT01863732|12459674|P3|STARTED|Overall Study||46
5063319|NCT01863732|12459675|P2|STARTED|Overall Study||87
5063320|NCT01863732|12459676|P1|STARTED|Overall Study||100
5063321|NCT01863680|12459689|P1|NOT COMPLETED|Overall Study||57
5063322|NCT01863680|12459689|P1|COMPLETED|Overall Study||121
5063323|NCT01863680|12459689|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
5063324|NCT01863680|12459689|P1|Subjects Received Study Drug|Overall Study||149
5063325|NCT01863680|12459689|P1|Subjects Received hCG Injection|Overall Study||162
5063326|NCT01863680|12459689|P1|Subjects Started COS Treatment|Overall Study||169
5063327|NCT01863680|12459689|P1|STARTED|Overall Study||178
5063328|NCT01863667|12459697|P2|NOT COMPLETED|Overall Study||32
5063329|NCT01863667|12459698|P1|NOT COMPLETED|Overall Study||33
5063330|NCT01863667|12459697|P2|COMPLETED|Overall Study||0
5063331|NCT01863667|12459698|P1|COMPLETED|Overall Study||0
5063332|NCT01863667|12459697|P2|STARTED|Overall Study||32
5063333|NCT01863667|12459698|P1|STARTED|Overall Study||33
5063334|NCT01863563|12459718|P1|NOT COMPLETED|Overall Study||0
5063335|NCT01863563|12459718|P1|COMPLETED|Overall Study||100
5063336|NCT01863563|12459718|P1|STARTED|Overall Study||100
5063337|NCT01863433|12459722|P1|NOT COMPLETED|Overall Study||1
5063338|NCT01863433|12459722|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
5063339|NCT01863433|12459722|P1|STARTED|Overall Study||120
5063340|NCT01863368|12459732|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
5063341|NCT01863368|12459733|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
5063342|NCT01863368|12459732|P2|COMPLETED|Phase II, Day 35 to Day 90||41
5063343|NCT01863368|12459733|P1|COMPLETED|Phase II, Day 35 to Day 90||41
5063344|NCT01863368|12459732|P2|STARTED|Phase II, Day 35 to Day 90||41
5063345|NCT01863368|12459733|P1|STARTED|Phase II, Day 35 to Day 90||43
5063346|NCT01863368|12459732|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
5063347|NCT01863368|12459733|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
5063348|NCT01863368|12459732|P2|COMPLETED|Phase I, Day 0 to Day 35||41
5063349|NCT01863368|12459733|P1|COMPLETED|Phase I, Day 0 to Day 35||43
5063350|NCT01863368|12459732|P2|Treated|Phase I, Day 0 to Day 35||47
5063351|NCT01863368|12459733|P1|Treated|Phase I, Day 0 to Day 35||46
5063352|NCT01863368|12459732|P2|STARTED|Phase I, Day 0 to Day 35||48
5063353|NCT01863368|12459733|P1|STARTED|Phase I, Day 0 to Day 35||46
5063354|NCT01863134|12459748|P2|NOT COMPLETED|Overall Study||0
5063355|NCT01863134|12459749|P1|NOT COMPLETED|Overall Study||0
5063356|NCT01863134|12459748|P2|COMPLETED|Overall Study||68
5063357|NCT01863134|12459749|P1|COMPLETED|Overall Study||72
5063358|NCT01863134|12459748|P2|STARTED|Overall Study||68
5063359|NCT01863134|12459749|P1|STARTED|Overall Study||72
5063360|NCT01863030|12459755|P1|NOT COMPLETED|Follow up||18
5063361|NCT01863030|12459755|P1|COMPLETED|Follow up||13
5063362|NCT01863030|12459755|P1|24 Months|Follow up||13
5063363|NCT01863030|12459755|P1|12 Months|Follow up||26
5063364|NCT01863030|12459755|P1|6 Months|Follow up||29
5063365|NCT01863030|12459755|P1|3 Months|Follow up||28
5063366|NCT01863030|12459755|P1|2 Weeks|Follow up||31
5063367|NCT01863030|12459755|P1|STARTED|Follow up||31
5063368|NCT01863030|12459755|P1|NOT COMPLETED|Baseline||0
5063369|NCT01863030|12459755|P1|COMPLETED|Baseline||31
5063370|NCT01863030|12459755|P1|STARTED|Baseline||31
5063371|NCT01863017|12459773|P2|NOT COMPLETED|Overall Study||0
5063372|NCT01863017|12459774|P1|NOT COMPLETED|Overall Study||0
5063373|NCT01863017|12459773|P2|COMPLETED|Overall Study||19
5063374|NCT01863017|12459774|P1|COMPLETED|Overall Study||12
5063375|NCT01863017|12459773|P2|Participants With PWS|Overall Study||7
5063376|NCT01863017|12459774|P1|Participants With PWS|Overall Study||3
5063377|NCT01863017|12459773|P2|Obese Participants|Overall Study||7
5063378|NCT01863017|12459774|P1|Obese Participants|Overall Study||4
5063379|NCT01863017|12459773|P2|Normal Weight Participants|Overall Study||5
5063380|NCT01863017|12459774|P1|Normal Weight Participants|Overall Study||5
5063381|NCT01863017|12459773|P2|STARTED|Overall Study||19
5063382|NCT01863017|12459774|P1|STARTED|Overall Study||12
5063383|NCT01862991|12459787|P3|NOT COMPLETED|Overall Study||1
5063384|NCT01862991|12459788|P2|NOT COMPLETED|Overall Study||1
5063385|NCT01862991|12459789|P1|NOT COMPLETED|Overall Study||3
5063386|NCT01862991|12459787|P3|COMPLETED|Overall Study||27
5063387|NCT01862991|12459788|P2|COMPLETED|Overall Study||27
5063388|NCT01862991|12459789|P1|COMPLETED|Overall Study||21
5063389|NCT01862991|12459787|P3|STARTED|Overall Study||28
5063390|NCT01862991|12459788|P2|STARTED|Overall Study||28
5063391|NCT01862991|12459789|P1|STARTED|Overall Study||24
5063392|NCT01862874|12459802|P2|NOT COMPLETED|Overall Study||77
5063393|NCT01862874|12459803|P1|NOT COMPLETED|Overall Study||79
5063394|NCT01862874|12459802|P2|COMPLETED|Overall Study||485
5063395|NCT01862874|12459803|P1|COMPLETED|Overall Study||483
5063396|NCT01862874|12459802|P2|Vaccination 3|Overall Study||532
5063397|NCT01862874|12459803|P1|Vaccination 3|Overall Study||530
5063398|NCT01862874|12459802|P2|Vaccination 2|Overall Study||542
5063399|NCT01862874|12459803|P1|Vaccination 2|Overall Study||539
5063400|NCT01862874|12459802|P2|Vaccination 1|Overall Study||562
5063401|NCT01862874|12459803|P1|Vaccination 1|Overall Study||561
5063402|NCT01862874|12459802|P2|STARTED|Overall Study|Randomized participants|562
5063403|NCT01862874|12459803|P1|STARTED|Overall Study|Randomized participants|562
5063404|NCT01862796|12459822|P3|NOT COMPLETED|Overall Study||1
5063405|NCT01862796|12459823|P2|NOT COMPLETED|Overall Study||0
5063406|NCT01862796|12459824|P1|NOT COMPLETED|Overall Study||0
5063407|NCT01862796|12459822|P3|COMPLETED|Overall Study||23
5063408|NCT01862796|12459823|P2|COMPLETED|Overall Study||18
5063409|NCT01862796|12459824|P1|COMPLETED|Overall Study||19
5063410|NCT01862796|12459822|P3|STARTED|Overall Study||24
5063411|NCT01862796|12459823|P2|STARTED|Overall Study||18
5063412|NCT01862796|12459824|P1|STARTED|Overall Study||19
5063413|NCT01862640|12459839|P4|NOT COMPLETED|Overall Study||15
5063414|NCT01862640|12459840|P3|NOT COMPLETED|Overall Study||18
5063415|NCT01862640|12459841|P2|NOT COMPLETED|Overall Study||16
5063416|NCT01862640|12459842|P1|NOT COMPLETED|Overall Study||7
5063417|NCT01862640|12459839|P4|COMPLETED|Overall Study||121
5063418|NCT01862640|12459840|P3|COMPLETED|Overall Study||122
5063419|NCT01862640|12459841|P2|COMPLETED|Overall Study||121
5063420|NCT01862640|12459842|P1|COMPLETED|Overall Study||13
5063421|NCT01862640|12459839|P4|STARTED|Overall Study||136
5063422|NCT01862640|12459840|P3|STARTED|Overall Study||140
5063423|NCT01862640|12459841|P2|STARTED|Overall Study||137
5063424|NCT01862640|12459842|P1|STARTED|Overall Study||20
5063425|NCT01862484|12459856|P2|NOT COMPLETED|Overall Study||8
5063426|NCT01862484|12459857|P1|NOT COMPLETED|Overall Study||2
5063427|NCT01862484|12459856|P2|COMPLETED|Overall Study||6
5063428|NCT01862484|12459857|P1|COMPLETED|Overall Study||13
5063429|NCT01862484|12459856|P2|STARTED|Overall Study||14
5063430|NCT01862484|12459857|P1|STARTED|Overall Study||15
5063431|NCT01862419|12459865|P2|NOT COMPLETED|Overall Study||0
5063432|NCT01862419|12459866|P1|NOT COMPLETED|Overall Study||0
5063433|NCT01862419|12459865|P2|COMPLETED|Overall Study||1192
5063434|NCT01862419|12459866|P1|COMPLETED|Overall Study||1201
5063435|NCT01862419|12459865|P2|STARTED|Overall Study||1192
5063436|NCT01862419|12459866|P1|STARTED|Overall Study||1201
5063437|NCT01862328|12459883|P7|NOT COMPLETED|Overall Study||10
5063438|NCT01862328|12459884|P6|NOT COMPLETED|Overall Study||7
5063439|NCT01862328|12459885|P5|NOT COMPLETED|Overall Study||12
5063440|NCT01862328|12459886|P4|NOT COMPLETED|Overall Study||7
5063441|NCT01862328|12459887|P3|NOT COMPLETED|Overall Study||6
5063442|NCT01862328|12459888|P2|NOT COMPLETED|Overall Study||18
5063443|NCT01862328|12459889|P1|NOT COMPLETED|Overall Study||4
5063444|NCT01862328|12459883|P7|COMPLETED|Overall Study||0
5063445|NCT01862328|12459884|P6|COMPLETED|Overall Study||0
5063446|NCT01862328|12459885|P5|COMPLETED|Overall Study||0
5063447|NCT01862328|12459886|P4|COMPLETED|Overall Study||0
5063448|NCT01862328|12459887|P3|COMPLETED|Overall Study||0
5063449|NCT01862328|12459888|P2|COMPLETED|Overall Study||0
5063450|NCT01862328|12459889|P1|COMPLETED|Overall Study||0
5063451|NCT01862328|12459883|P7|STARTED|Overall Study||10
5063452|NCT01862328|12459884|P6|STARTED|Overall Study||7
5063453|NCT01862328|12459885|P5|STARTED|Overall Study||12
5063454|NCT01862328|12459886|P4|STARTED|Overall Study||7
5063455|NCT01862328|12459887|P3|STARTED|Overall Study||6
5063456|NCT01862328|12459888|P2|STARTED|Overall Study||18
5063457|NCT01862328|12459889|P1|STARTED|Overall Study||4
5063458|NCT01862250|12459941|P1|NOT COMPLETED|Overall Study||4
5063459|NCT01862250|12459941|P1|COMPLETED|Overall Study||8
5063460|NCT01862250|12459941|P1|STARTED|Overall Study||12
5063461|NCT01862159|12459948|P1|NOT COMPLETED|Overall Study||0
5063462|NCT01862159|12459948|P1|COMPLETED|Overall Study||25038
5063463|NCT01862159|12459948|P1|STARTED|Overall Study||25038
5063464|NCT01862133|12459955|P2|NOT COMPLETED|Overall Study||0
5063465|NCT01862133|12459956|P1|NOT COMPLETED|Overall Study||0
5063466|NCT01862133|12459955|P2|COMPLETED|Overall Study||31
5063467|NCT01862133|12459956|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
5063468|NCT01862133|12459955|P2|Returned During 6 mo Study|Overall Study||31
5063469|NCT01862133|12459956|P1|Returned During 6 mo Study|Overall Study||92
5063470|NCT01862133|12459955|P2|STARTED|Overall Study||31
5063471|NCT01862133|12459956|P1|STARTED|Overall Study||105
5063472|NCT01862029|12459962|P1|NOT COMPLETED|Overall Study||1
5063473|NCT01862029|12459962|P1|COMPLETED|Overall Study||8
5063474|NCT01862029|12459962|P1|STARTED|Overall Study||9
5063475|NCT01861925|12459970|P3|NOT COMPLETED|Overall Study||0
5063476|NCT01861925|12459971|P2|NOT COMPLETED|Overall Study||0
5063477|NCT01861925|12459972|P1|NOT COMPLETED|Overall Study||0
5063478|NCT01861925|12459970|P3|COMPLETED|Overall Study||8
5063479|NCT01861925|12459971|P2|COMPLETED|Overall Study||8
5063480|NCT01861925|12459972|P1|COMPLETED|Overall Study||34
5063481|NCT01861925|12459970|P3|STARTED|Overall Study||8
5063482|NCT01861925|12459971|P2|STARTED|Overall Study||8
5063483|NCT01861925|12459972|P1|STARTED|Overall Study||34
5063484|NCT01861756|12459995|P2|NOT COMPLETED|Overall Study||18
5063485|NCT01861756|12459996|P1|NOT COMPLETED|Overall Study||13
5063486|NCT01861756|12459995|P2|COMPLETED|Overall Study||85
5063487|NCT01861756|12459996|P1|COMPLETED|Overall Study||88
5063488|NCT01861756|12459995|P2|STARTED|Overall Study||103
5063489|NCT01861756|12459996|P1|STARTED|Overall Study||101
5063490|NCT01861704|12460004|P2|NOT COMPLETED|Overall Study||3
5063491|NCT01861704|12460005|P1|NOT COMPLETED|Overall Study||3
5063492|NCT01861704|12460004|P2|COMPLETED|Overall Study||104
5063493|NCT01861704|12460005|P1|COMPLETED|Overall Study||67
5063494|NCT01861704|12460004|P2|STARTED|Overall Study||107
5063495|NCT01861704|12460005|P1|STARTED|Overall Study||70
5063496|NCT01861665|12460013|P2|NOT COMPLETED|Overall Study||0
5063497|NCT01861665|12460014|P1|NOT COMPLETED|Overall Study||0
5063498|NCT01861665|12460013|P2|COMPLETED|Overall Study||17
5063499|NCT01861665|12460014|P1|COMPLETED|Overall Study||10
5063500|NCT01861665|12460013|P2|STARTED|Overall Study||17
5063501|NCT01861665|12460014|P1|STARTED|Overall Study||10
5063502|NCT01861587|12460022|P2|NOT COMPLETED|Overall Study||0
5063503|NCT01861587|12460023|P1|NOT COMPLETED|Overall Study||0
5063504|NCT01861587|12460022|P2|COMPLETED|Overall Study||13
5063505|NCT01861587|12460023|P1|COMPLETED|Overall Study||14
5063506|NCT01861587|12460022|P2|STARTED|Overall Study||13
5063507|NCT01861587|12460023|P1|STARTED|Overall Study||14
5063508|NCT01861574|12460039|P4|NOT COMPLETED|Overall Study||0
5063509|NCT01861574|12460040|P3|NOT COMPLETED|Overall Study||0
5063510|NCT01861574|12460041|P2|NOT COMPLETED|Overall Study||0
5063511|NCT01861574|12460042|P1|NOT COMPLETED|Overall Study||0
5063512|NCT01861574|12460039|P4|COMPLETED|Overall Study||28
5063513|NCT01861574|12460040|P3|COMPLETED|Overall Study||27
5063514|NCT01861574|12460041|P2|COMPLETED|Overall Study||25
5063515|NCT01861574|12460042|P1|COMPLETED|Overall Study||28
5063516|NCT01861574|12460039|P4|STARTED|Overall Study||28
5063517|NCT01861574|12460040|P3|STARTED|Overall Study||27
5063518|NCT01861574|12460041|P2|STARTED|Overall Study||25
5063519|NCT01861574|12460042|P1|STARTED|Overall Study||28
5063520|NCT01861522|12460065|P2|NOT COMPLETED|Overall Study||0
5063521|NCT01861522|12460066|P1|NOT COMPLETED|Overall Study||3
5063522|NCT01861522|12460065|P2|COMPLETED|Overall Study||232
5063523|NCT01861522|12460066|P1|COMPLETED|Overall Study||237
5063524|NCT01861522|12460065|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
5063525|NCT01861522|12460066|P1|STARTED|Overall Study||240
5063526|NCT01861457|12460074|P2|NOT COMPLETED|Overall Study||0
5063527|NCT01861457|12460075|P1|NOT COMPLETED|Overall Study||0
5063528|NCT01861457|12460074|P2|COMPLETED|Overall Study||19
5063529|NCT01861457|12460075|P1|COMPLETED|Overall Study||20
5063530|NCT01861457|12460074|P2|STARTED|Overall Study||19
5063531|NCT01861457|12460075|P1|STARTED|Overall Study||20
5063532|NCT01861301|12460083|P1|NOT COMPLETED|Overall Study||0
5063533|NCT01861301|12460083|P1|COMPLETED|Overall Study||18
5063534|NCT01861301|12460083|P1|STARTED|Overall Study||18
5063535|NCT01860989|12460090|P1|NOT COMPLETED|Overall Study||5
5063536|NCT01860989|12460090|P1|COMPLETED|Overall Study||6
5063537|NCT01860989|12460090|P1|STARTED|Overall Study||11
5063538|NCT01860976|12460096|P2|NOT COMPLETED|Long Term Extension||107
5063539|NCT01860976|12460097|P1|NOT COMPLETED|Long Term Extension||113
5063540|NCT01860976|12460096|P2|COMPLETED|Long Term Extension||8
5063541|NCT01860976|12460097|P1|COMPLETED|Long Term Extension||0
5063542|NCT01860976|12460096|P2|STARTED|Long Term Extension||115
5063543|NCT01860976|12460097|P1|STARTED|Long Term Extension||113
5063544|NCT01860976|12460096|P2|NOT COMPLETED|Open-Label||64
5063545|NCT01860976|12460097|P1|NOT COMPLETED|Open-Label||74
5063546|NCT01860976|12460096|P2|COMPLETED|Open-Label||121
5063547|NCT01860976|12460097|P1|COMPLETED|Open-Label||123
5063548|NCT01860976|12460096|P2|STARTED|Open-Label||185
5063549|NCT01860976|12460097|P1|STARTED|Open-Label||197
5063550|NCT01860976|12460096|P2|NOT COMPLETED|Blinded Treatment||113
5063551|NCT01860976|12460097|P1|NOT COMPLETED|Blinded Treatment||88
5063552|NCT01860976|12460096|P2|COMPLETED|Blinded Treatment||98
5063553|NCT01860976|12460097|P1|COMPLETED|Blinded Treatment||125
5063554|NCT01860976|12460096|P2|STARTED|Blinded Treatment||211
5063555|NCT01860976|12460097|P1|STARTED|Blinded Treatment||213
5063556|NCT01860950|12460125|P6|NOT COMPLETED|Overall Study||0
5063557|NCT01860950|12460126|P5|NOT COMPLETED|Overall Study||0
5063558|NCT01860950|12460127|P4|NOT COMPLETED|Overall Study||0
5063559|NCT01860950|12460128|P3|NOT COMPLETED|Overall Study||0
5063560|NCT01860950|12460129|P2|NOT COMPLETED|Overall Study||0
5063561|NCT01860950|12460130|P1|NOT COMPLETED|Overall Study||0
5063562|NCT01860950|12460125|P6|COMPLETED|Overall Study||13
5063563|NCT01860950|12460126|P5|COMPLETED|Overall Study||14
5063564|NCT01860950|12460127|P4|COMPLETED|Overall Study||13
5063565|NCT01860950|12460128|P3|COMPLETED|Overall Study||10
5063566|NCT01860950|12460129|P2|COMPLETED|Overall Study||15
5063567|NCT01860950|12460130|P1|COMPLETED|Overall Study||14
5063568|NCT01860950|12460125|P6|STARTED|Overall Study||13
5063569|NCT01860950|12460126|P5|STARTED|Overall Study||14
5063570|NCT01860950|12460127|P4|STARTED|Overall Study||13
5063571|NCT01860950|12460128|P3|STARTED|Overall Study||10
5063572|NCT01860950|12460129|P2|STARTED|Overall Study||15
5063573|NCT01860950|12460130|P1|STARTED|Overall Study||14
5063574|NCT01860846|12460151|P1|NOT COMPLETED|Overall Study||33
5063575|NCT01860846|12460151|P1|COMPLETED|Overall Study||73
5063576|NCT01860846|12460151|P1|Month 12|Overall Study||73
5063577|NCT01860846|12460151|P1|Month 6|Overall Study||85
5063578|NCT01860846|12460151|P1|Month 4|Overall Study||82
5063579|NCT01860846|12460151|P1|Month 2|Overall Study||83
5063580|NCT01860846|12460151|P1|Month 1|Overall Study||97
5063581|NCT01860846|12460151|P1|STARTED|Overall Study||106
5063582|NCT01860807|12460164|P2|NOT COMPLETED|Overall Study||29
5063583|NCT01860807|12460165|P1|NOT COMPLETED|Overall Study||30
5063584|NCT01860807|12460164|P2|COMPLETED|Overall Study||32
5063585|NCT01860807|12460165|P1|COMPLETED|Overall Study||34
5063586|NCT01860807|12460164|P2|STARTED|Overall Study||61
5063587|NCT01860807|12460165|P1|STARTED|Overall Study||64
5063588|NCT01860703|12460171|P4|NOT COMPLETED|Overall Study||2
5063589|NCT01860703|12460172|P3|NOT COMPLETED|Overall Study||1
5063590|NCT01860703|12460173|P2|NOT COMPLETED|Overall Study||5
5063591|NCT01860703|12460174|P1|NOT COMPLETED|Overall Study||2
5063592|NCT01860703|12460171|P4|COMPLETED|Overall Study||10
5063593|NCT01860703|12460172|P3|COMPLETED|Overall Study||11
5063594|NCT01860703|12460173|P2|COMPLETED|Overall Study||8
5063595|NCT01860703|12460174|P1|COMPLETED|Overall Study||11
5063596|NCT01860703|12460171|P4|STARTED|Overall Study||12
5063597|NCT01860703|12460172|P3|STARTED|Overall Study||12
5063598|NCT01860703|12460173|P2|STARTED|Overall Study||13
5063599|NCT01860703|12460174|P1|STARTED|Overall Study||13
5063600|NCT01860677|12460206|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5063601|NCT01860677|12460207|P1|NOT COMPLETED|Second Intervention (1 Day)||7
5063602|NCT01860677|12460206|P2|COMPLETED|Second Intervention (1 Day)||0
5063603|NCT01860677|12460207|P1|COMPLETED|Second Intervention (1 Day)||1
5063604|NCT01860677|12460206|P2|STARTED|Second Intervention (1 Day)||0
5063605|NCT01860677|12460207|P1|STARTED|Second Intervention (1 Day)||8
5063606|NCT01860677|12460206|P2|NOT COMPLETED|First Intervention (1 Day)||0
5063607|NCT01860677|12460207|P1|NOT COMPLETED|First Intervention (1 Day)||0
5063608|NCT01860677|12460206|P2|COMPLETED|First Intervention (1 Day)||0
5063609|NCT01860677|12460207|P1|COMPLETED|First Intervention (1 Day)||8
5063610|NCT01860677|12460206|P2|STARTED|First Intervention (1 Day)||0
5063611|NCT01860677|12460207|P1|STARTED|First Intervention (1 Day)||8
5063612|NCT01860651|12460218|P2|NOT COMPLETED|Overall Study||8
5063613|NCT01860651|12460219|P1|NOT COMPLETED|Overall Study||25
5063614|NCT01860651|12460218|P2|COMPLETED|Overall Study||39
5063615|NCT01860651|12460219|P1|COMPLETED|Overall Study||31
5063616|NCT01860651|12460218|P2|STARTED|Overall Study||47
5063617|NCT01860651|12460219|P1|STARTED|Overall Study||56
5063618|NCT01860586|12460235|P1|NOT COMPLETED|Overall Study||0
5063619|NCT01860586|12460235|P1|COMPLETED|Overall Study||20
5063620|NCT01860586|12460235|P1|STARTED|Overall Study||20
5063621|NCT01860573|12460243|P2|NOT COMPLETED|Overall Study||0
5063622|NCT01860573|12460244|P1|NOT COMPLETED|Overall Study||0
5063623|NCT01860573|12460243|P2|COMPLETED|Overall Study||85
5063624|NCT01860573|12460244|P1|COMPLETED|Overall Study||83
5063625|NCT01860573|12460243|P2|STARTED|Overall Study||85
5063626|NCT01860573|12460244|P1|STARTED|Overall Study||83
5063627|NCT01860534|12460264|P2|NOT COMPLETED|ROP #2||0
5063628|NCT01860534|12460265|P1|NOT COMPLETED|ROP #2||1
5063629|NCT01860534|12460264|P2|COMPLETED|ROP #2||13
5063630|NCT01860534|12460265|P1|COMPLETED|ROP #2||13
5063631|NCT01860534|12460264|P2|STARTED|ROP #2||13
5063632|NCT01860534|12460265|P1|STARTED|ROP #2||14
5063633|NCT01860534|12460264|P2|NOT COMPLETED|ROP #1||1
5063634|NCT01860534|12460265|P1|NOT COMPLETED|ROP #1||0
5063635|NCT01860534|12460264|P2|COMPLETED|ROP #1||13
5063636|NCT01860534|12460265|P1|COMPLETED|ROP #1||14
5063637|NCT01860534|12460264|P2|STARTED|ROP #1||14
5063638|NCT01860534|12460265|P1|STARTED|ROP #1||14
5063639|NCT01860521|12460279|P2|NOT COMPLETED|Overall Study||0
5063640|NCT01860521|12460280|P1|NOT COMPLETED|Overall Study||0
5063641|NCT01860521|12460279|P2|COMPLETED|Overall Study|June 2013|52
5063642|NCT01860521|12460280|P1|COMPLETED|Overall Study|June 2013|52
5063643|NCT01860521|12460279|P2|STARTED|Overall Study|September 2011|52
5063644|NCT01860521|12460280|P1|STARTED|Overall Study|September 2011|52
5063645|NCT01860287|12460295|P3|NOT COMPLETED|Overall Study||0
5063646|NCT01860287|12460296|P2|NOT COMPLETED|Overall Study||0
5063647|NCT01860287|12460297|P1|NOT COMPLETED|Overall Study||0
5063648|NCT01860287|12460295|P3|COMPLETED|Overall Study||15
5063649|NCT01860287|12460296|P2|COMPLETED|Overall Study||15
5063650|NCT01860287|12460297|P1|COMPLETED|Overall Study||18
5063651|NCT01860287|12460295|P3|STARTED|Overall Study||15
5063652|NCT01860287|12460296|P2|STARTED|Overall Study||15
5063653|NCT01860287|12460297|P1|STARTED|Overall Study||18
5063654|NCT01860170|12460308|P3|NOT COMPLETED|Overall Study||0
5063655|NCT01860170|12460309|P2|NOT COMPLETED|Overall Study||0
5063656|NCT01860170|12460310|P1|NOT COMPLETED|Overall Study||0
5063657|NCT01860170|12460308|P3|COMPLETED|Overall Study||22
5063658|NCT01860170|12460309|P2|COMPLETED|Overall Study||3
5063659|NCT01860170|12460310|P1|COMPLETED|Overall Study||3
5063660|NCT01860170|12460308|P3|STARTED|Overall Study||22
5063661|NCT01860170|12460309|P2|STARTED|Overall Study||3
5063662|NCT01860170|12460310|P1|STARTED|Overall Study||3
5063663|NCT01860079|12460326|P2|NOT COMPLETED|Overall Study||22
5063664|NCT01860079|12460327|P1|NOT COMPLETED|Overall Study||14
5063665|NCT01860079|12460326|P2|COMPLETED|Overall Study||363
5063666|NCT01860079|12460327|P1|COMPLETED|Overall Study||370
5063667|NCT01860079|12460326|P2|STARTED|Overall Study||385
5063668|NCT01860079|12460327|P1|STARTED|Overall Study||384
5063669|NCT01860040|12460335|P2|NOT COMPLETED|Overall Study||0
5063670|NCT01860040|12460336|P1|NOT COMPLETED|Overall Study||1
5063671|NCT01860040|12460335|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
5063672|NCT01860040|12460336|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
5063673|NCT01860040|12460335|P2|STARTED|Overall Study|did not meet recruitment goal|0
5063674|NCT01860040|12460336|P1|STARTED|Overall Study|did not meet recruitment goal|1
5063675|NCT01859988|12460347|P6|NOT COMPLETED|Overall Study||19
5063676|NCT01859988|12460348|P5|NOT COMPLETED|Overall Study||23
5063677|NCT01859988|12460349|P4|NOT COMPLETED|Overall Study||10
5063678|NCT01859988|12460350|P3|NOT COMPLETED|Overall Study||28
5063679|NCT01859988|12460351|P2|NOT COMPLETED|Overall Study||12
5063680|NCT01859988|12460352|P1|NOT COMPLETED|Overall Study||11
5063681|NCT01859988|12460347|P6|COMPLETED|Overall Study||42
5063682|NCT01859988|12460348|P5|COMPLETED|Overall Study||42
5063683|NCT01859988|12460349|P4|COMPLETED|Overall Study||55
5063684|NCT01859988|12460350|P3|COMPLETED|Overall Study||34
5063685|NCT01859988|12460351|P2|COMPLETED|Overall Study||52
5063686|NCT01859988|12460352|P1|COMPLETED|Overall Study||52
5063687|NCT01859988|12460347|P6|Treated|Overall Study||61
5063688|NCT01859988|12460348|P5|Treated|Overall Study||65
5063689|NCT01859988|12460349|P4|Treated|Overall Study||65
5063690|NCT01859988|12460350|P3|Treated|Overall Study||61
5063691|NCT01859988|12460351|P2|Treated|Overall Study||64
5063692|NCT01859988|12460352|P1|Treated|Overall Study||63
5063693|NCT01859988|12460347|P6|STARTED|Overall Study||61
5063694|NCT01859988|12460348|P5|STARTED|Overall Study||65
5063695|NCT01859988|12460349|P4|STARTED|Overall Study||65
5063696|NCT01859988|12460350|P3|STARTED|Overall Study||62
5063697|NCT01859988|12460351|P2|STARTED|Overall Study||64
5063698|NCT01859988|12460352|P1|STARTED|Overall Study||63
5063699|NCT01859949|12460446|P2|NOT COMPLETED|Overall Study||17
5063700|NCT01859949|12460447|P1|NOT COMPLETED|Overall Study||14
5063701|NCT01859949|12460446|P2|COMPLETED|Overall Study||15
5063702|NCT01859949|12460447|P1|COMPLETED|Overall Study||15
5063703|NCT01859949|12460446|P2|STARTED|Overall Study|Treated participants|32
5063704|NCT01859949|12460447|P1|STARTED|Overall Study|Treated participants|29
5063705|NCT01859793|12460465|P2|NOT COMPLETED|2nd Intervention Period||0
5063706|NCT01859793|12460466|P1|NOT COMPLETED|2nd Intervention Period||0
5063707|NCT01859793|12460465|P2|COMPLETED|2nd Intervention Period||16
5063708|NCT01859793|12460466|P1|COMPLETED|2nd Intervention Period||14
5063709|NCT01859793|12460465|P2|STARTED|2nd Intervention Period||16
5063710|NCT01859793|12460466|P1|STARTED|2nd Intervention Period||14
5063711|NCT01859793|12460465|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
5063712|NCT01859793|12460466|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
5063713|NCT01859793|12460465|P2|COMPLETED|Washout Period (4 Weeks)||16
5063714|NCT01859793|12460466|P1|COMPLETED|Washout Period (4 Weeks)||14
5063715|NCT01859793|12460465|P2|STARTED|Washout Period (4 Weeks)||17
5063716|NCT01859793|12460466|P1|STARTED|Washout Period (4 Weeks)||15
5063717|NCT01859793|12460465|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
5063718|NCT01859793|12460466|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
5063719|NCT01859793|12460465|P2|COMPLETED|First Intervention (8 Weeks)||17
5063720|NCT01859793|12460466|P1|COMPLETED|First Intervention (8 Weeks)||15
5063721|NCT01859793|12460465|P2|STARTED|First Intervention (8 Weeks)||18
5063722|NCT01859793|12460466|P1|STARTED|First Intervention (8 Weeks)||20
5063723|NCT01859741|12460484|P8|NOT COMPLETED|Overall Study||70
5063724|NCT01859741|12460485|P7|NOT COMPLETED|Overall Study||70
5063725|NCT01859741|12460486|P6|NOT COMPLETED|Overall Study||6
5063726|NCT01859741|12460487|P5|NOT COMPLETED|Overall Study||6
5063727|NCT01859741|12460488|P4|NOT COMPLETED|Overall Study||3
5063728|NCT01859741|12460489|P3|NOT COMPLETED|Overall Study||6
5063729|NCT01859741|12460490|P2|NOT COMPLETED|Overall Study||3
5063730|NCT01859741|12460491|P1|NOT COMPLETED|Overall Study||3
5063731|NCT01859741|12460484|P8|COMPLETED|Overall Study||3
5063732|NCT01859741|12460485|P7|COMPLETED|Overall Study||2
5063733|NCT01859741|12460486|P6|COMPLETED|Overall Study||0
5063734|NCT01859741|12460487|P5|COMPLETED|Overall Study||0
5063735|NCT01859741|12460488|P4|COMPLETED|Overall Study||0
5063736|NCT01859741|12460489|P3|COMPLETED|Overall Study||0
5063737|NCT01859741|12460490|P2|COMPLETED|Overall Study||0
5063738|NCT01859741|12460491|P1|COMPLETED|Overall Study||0
5063739|NCT01859741|12460484|P8|STARTED|Overall Study||73
5063740|NCT01859741|12460485|P7|STARTED|Overall Study||72
5063741|NCT01859741|12460486|P6|STARTED|Overall Study||6
5063742|NCT01859741|12460487|P5|STARTED|Overall Study||6
5063743|NCT01859741|12460488|P4|STARTED|Overall Study||3
5063744|NCT01859741|12460489|P3|STARTED|Overall Study||6
5063745|NCT01859741|12460490|P2|STARTED|Overall Study||3
5063746|NCT01859741|12460491|P1|STARTED|Overall Study||3
5063747|NCT01859715|12460520|P3|NOT COMPLETED|Overall Study||23
5063748|NCT01859715|12460521|P2|NOT COMPLETED|Overall Study||8
5063749|NCT01859715|12460522|P1|NOT COMPLETED|Overall Study||16
5063750|NCT01859715|12460520|P3|COMPLETED|Overall Study||93
5063751|NCT01859715|12460521|P2|COMPLETED|Overall Study||83
5063752|NCT01859715|12460522|P1|COMPLETED|Overall Study||125
5063753|NCT01859715|12460520|P3|STARTED|Overall Study||116
5063754|NCT01859715|12460521|P2|STARTED|Overall Study||91
5063755|NCT01859715|12460522|P1|STARTED|Overall Study||141
5063756|NCT01859702|12460533|P1|NOT COMPLETED|Overall Study||5
5063757|NCT01859702|12460533|P1|COMPLETED|Overall Study||31
5063758|NCT01859702|12460533|P1|STARTED|Overall Study||36
5063759|NCT01859637|12460537|P1|NOT COMPLETED|Overall Study||0
5063760|NCT01859637|12460537|P1|COMPLETED|Overall Study||6
5063761|NCT01859637|12460537|P1|STARTED|Overall Study||6
5063762|NCT01859611|12460543|P1|NOT COMPLETED|Overall Study||8
5063763|NCT01859611|12460543|P1|COMPLETED|Overall Study||43
5063764|NCT01859611|12460543|P1|STARTED|Overall Study||51
5063765|NCT01859598|12460547|P1|NOT COMPLETED|Visit 3 at 6 Months||912
5063766|NCT01859598|12460547|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
5063767|NCT01859598|12460547|P1|STARTED|Visit 3 at 6 Months||17253
5063768|NCT01859598|12460547|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
5063769|NCT01859598|12460547|P1|COMPLETED|Visit 2 at 3 Months||17253
5063770|NCT01859598|12460547|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
5063771|NCT01859507|12460555|P1|NOT COMPLETED|Overall Study||4
5063772|NCT01859507|12460555|P1|COMPLETED|Overall Study||28
5063773|NCT01859507|12460555|P1|STARTED|Overall Study||32
5063774|NCT01859494|12460560|P1|NOT COMPLETED|Overall Study||1
5063775|NCT01859494|12460560|P1|COMPLETED|Overall Study||218
5063776|NCT01859494|12460560|P1|STARTED|Overall Study||219
5063777|NCT01859390|12460571|P2|NOT COMPLETED|Overall Study||7
5063778|NCT01859390|12460572|P1|NOT COMPLETED|Overall Study||1
5063779|NCT01859390|12460571|P2|COMPLETED|Overall Study||30
5063780|NCT01859390|12460572|P1|COMPLETED|Overall Study||35
5063781|NCT01859390|12460571|P2|Withdrawals|Overall Study||2
5063782|NCT01859390|12460572|P1|Withdrawals|Overall Study||2
5063783|NCT01859390|12460571|P2|STARTED|Overall Study||37
5063784|NCT01859390|12460572|P1|STARTED|Overall Study||36
5063785|NCT01859325|12460596|P3|NOT COMPLETED|Overall Study||0
5063786|NCT01859325|12460597|P2|NOT COMPLETED|Overall Study||4
5063787|NCT01859325|12460598|P1|NOT COMPLETED|Overall Study||3
5063788|NCT01859325|12460596|P3|COMPLETED|Overall Study||2
5063789|NCT01859325|12460597|P2|COMPLETED|Overall Study||12
5063790|NCT01859325|12460598|P1|COMPLETED|Overall Study||12
5063791|NCT01859325|12460596|P3|STARTED|Overall Study||2
5063792|NCT01859325|12460597|P2|STARTED|Overall Study||16
5063793|NCT01859325|12460598|P1|STARTED|Overall Study||15
5063794|NCT01859312|12460606|P1|NOT COMPLETED|Overall Study||0
5063795|NCT01859312|12460606|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
5063796|NCT01859312|12460606|P1|STARTED|Overall Study||8
5063797|NCT01859247|12460661|P8|NOT COMPLETED|Overall Study||0
5063798|NCT01859247|12460662|P7|NOT COMPLETED|Overall Study||0
5063799|NCT01859247|12460663|P6|NOT COMPLETED|Overall Study||0
5063800|NCT01859247|12460664|P5|NOT COMPLETED|Overall Study||0
5063801|NCT01859247|12460665|P4|NOT COMPLETED|Overall Study||0
5063802|NCT01859247|12460666|P3|NOT COMPLETED|Overall Study||0
5063803|NCT01859247|12460667|P2|NOT COMPLETED|Overall Study||0
5063804|NCT01859247|12460668|P1|NOT COMPLETED|Overall Study||0
5063805|NCT01859247|12460661|P8|COMPLETED|Overall Study||1
5063806|NCT01859247|12460662|P7|COMPLETED|Overall Study||1
5063807|NCT01859247|12460663|P6|COMPLETED|Overall Study||1
5063808|NCT01859247|12460664|P5|COMPLETED|Overall Study||1
5063809|NCT01859247|12460665|P4|COMPLETED|Overall Study||1
5063810|NCT01859247|12460666|P3|COMPLETED|Overall Study||1
5063811|NCT01859247|12460667|P2|COMPLETED|Overall Study||1
5063812|NCT01859247|12460668|P1|COMPLETED|Overall Study||1
5063813|NCT01859247|12460661|P8|STARTED|Overall Study||1
5063814|NCT01859247|12460662|P7|STARTED|Overall Study||1
5063815|NCT01859247|12460663|P6|STARTED|Overall Study||1
5063816|NCT01859247|12460664|P5|STARTED|Overall Study||1
5063817|NCT01859247|12460665|P4|STARTED|Overall Study||1
5063818|NCT01859247|12460666|P3|STARTED|Overall Study||1
5063819|NCT01859247|12460667|P2|STARTED|Overall Study||1
5063820|NCT01859247|12460668|P1|STARTED|Overall Study||1
5063821|NCT01859195|12460695|P2|NOT COMPLETED|Overall Study||0
5063822|NCT01859195|12460696|P1|NOT COMPLETED|Overall Study||0
5063823|NCT01859195|12460695|P2|COMPLETED|Overall Study||12
5063824|NCT01859195|12460696|P1|COMPLETED|Overall Study||24
5063825|NCT01859195|12460695|P2|STARTED|Overall Study||12
5063826|NCT01859195|12460696|P1|STARTED|Overall Study||24
5063827|NCT01859143|12460706|P2|NOT COMPLETED|Overall Study||0
5063828|NCT01859143|12460707|P1|NOT COMPLETED|Overall Study||2
5063829|NCT01859143|12460706|P2|COMPLETED|Overall Study||60
5063830|NCT01859143|12460707|P1|COMPLETED|Overall Study||238
5063831|NCT01859143|12460706|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
5063832|NCT01859143|12460707|P1|STARTED|Overall Study||240
5063833|NCT01859078|12460721|P1|NOT COMPLETED|Overall Study||0
5063834|NCT01859078|12460721|P1|COMPLETED|Overall Study||28
5063835|NCT01859078|12460721|P1|STARTED|Overall Study||28
5063836|NCT01859013|12460737|P2|NOT COMPLETED|Overall Study||5
5063837|NCT01859013|12460738|P1|NOT COMPLETED|Overall Study||4
5063838|NCT01859013|12460737|P2|COMPLETED|Overall Study||9
5063839|NCT01859013|12460738|P1|COMPLETED|Overall Study||12
5063840|NCT01859013|12460737|P2|STARTED|Overall Study||14
5063841|NCT01859013|12460738|P1|STARTED|Overall Study||16
5063842|NCT01858766|12460763|P19|NOT COMPLETED|Overall Study||4
5063843|NCT01858766|12460764|P18|NOT COMPLETED|Overall Study||4
5063844|NCT01858766|12460765|P17|NOT COMPLETED|Overall Study||3
5063845|NCT01858766|12460766|P16|NOT COMPLETED|Overall Study||6
5063846|NCT01858766|12460767|P15|NOT COMPLETED|Overall Study||8
5063847|NCT01858766|12460768|P14|NOT COMPLETED|Overall Study||3
5063848|NCT01858766|12460769|P13|NOT COMPLETED|Overall Study||5
5063849|NCT01858766|12460770|P12|NOT COMPLETED|Overall Study||5
5063850|NCT01858766|12460771|P11|NOT COMPLETED|Overall Study||0
5063851|NCT01858766|12460772|P10|NOT COMPLETED|Overall Study||0
5063852|NCT01858766|12460773|P9|NOT COMPLETED|Overall Study||0
5063853|NCT01858766|12460774|P8|NOT COMPLETED|Overall Study||2
5063854|NCT01858766|12460775|P7|NOT COMPLETED|Overall Study||0
5063855|NCT01858766|12460776|P6|NOT COMPLETED|Overall Study||4
5063856|NCT01858766|12460777|P5|NOT COMPLETED|Overall Study||1
5063857|NCT01858766|12460778|P4|NOT COMPLETED|Overall Study||0
5063858|NCT01858766|12460779|P3|NOT COMPLETED|Overall Study||1
5063859|NCT01858766|12460780|P2|NOT COMPLETED|Overall Study||0
5063860|NCT01858766|12460781|P1|NOT COMPLETED|Overall Study||1
5063861|NCT01858766|12460763|P19|COMPLETED|Overall Study||22
5063862|NCT01858766|12460764|P18|COMPLETED|Overall Study||23
5063863|NCT01858766|12460765|P17|COMPLETED|Overall Study||22
5063864|NCT01858766|12460766|P16|COMPLETED|Overall Study||20
5063865|NCT01858766|12460767|P15|COMPLETED|Overall Study||23
5063866|NCT01858766|12460768|P14|COMPLETED|Overall Study||26
5063867|NCT01858766|12460769|P13|COMPLETED|Overall Study||25
5063868|NCT01858766|12460770|P12|COMPLETED|Overall Study||25
5063869|NCT01858766|12460771|P11|COMPLETED|Overall Study||5
5063870|NCT01858766|12460772|P10|COMPLETED|Overall Study||4
5063871|NCT01858766|12460773|P9|COMPLETED|Overall Study||1
5063872|NCT01858766|12460774|P8|COMPLETED|Overall Study||5
5063873|NCT01858766|12460775|P7|COMPLETED|Overall Study||7
5063874|NCT01858766|12460776|P6|COMPLETED|Overall Study||24
5063875|NCT01858766|12460777|P5|COMPLETED|Overall Study||26
5063876|NCT01858766|12460778|P4|COMPLETED|Overall Study||10
5063877|NCT01858766|12460779|P3|COMPLETED|Overall Study||10
5063878|NCT01858766|12460780|P2|COMPLETED|Overall Study||28
5063879|NCT01858766|12460781|P1|COMPLETED|Overall Study||26
5063880|NCT01858766|12460763|P19|STARTED|Overall Study||26
5063881|NCT01858766|12460764|P18|STARTED|Overall Study||27
5063882|NCT01858766|12460765|P17|STARTED|Overall Study||25
5063883|NCT01858766|12460766|P16|STARTED|Overall Study||26
5063884|NCT01858766|12460767|P15|STARTED|Overall Study||31
5063885|NCT01858766|12460768|P14|STARTED|Overall Study||29
5063886|NCT01858766|12460769|P13|STARTED|Overall Study||30
5063887|NCT01858766|12460770|P12|STARTED|Overall Study||30
5063888|NCT01858766|12460771|P11|STARTED|Overall Study||5
5063889|NCT01858766|12460772|P10|STARTED|Overall Study||4
5063890|NCT01858766|12460773|P9|STARTED|Overall Study||1
5063891|NCT01858766|12460774|P8|STARTED|Overall Study||7
5063892|NCT01858766|12460775|P7|STARTED|Overall Study||7
5063893|NCT01858766|12460776|P6|STARTED|Overall Study||28
5063894|NCT01858766|12460777|P5|STARTED|Overall Study||27
5063895|NCT01858766|12460778|P4|STARTED|Overall Study||10
5063896|NCT01858766|12460779|P3|STARTED|Overall Study||11
5063897|NCT01858766|12460780|P2|STARTED|Overall Study||28
5063898|NCT01858766|12460781|P1|STARTED|Overall Study||27
5063899|NCT01858701|12460852|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
5063900|NCT01858701|12460853|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
5063901|NCT01858701|12460852|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
5063902|NCT01858701|12460853|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
5063903|NCT01858701|12460852|P2|STARTED|Period 2, Second 30 Days of Wear||17
5063904|NCT01858701|12460853|P1|STARTED|Period 2, Second 30 Days of Wear||18
5063905|NCT01858701|12460852|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
5063906|NCT01858701|12460853|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
5063907|NCT01858701|12460852|P2|COMPLETED|Washout Period, 1-13 Days||17
5063908|NCT01858701|12460853|P1|COMPLETED|Washout Period, 1-13 Days||18
5063909|NCT01858701|12460852|P2|STARTED|Washout Period, 1-13 Days||19
5063910|NCT01858701|12460853|P1|STARTED|Washout Period, 1-13 Days||20
5063911|NCT01858701|12460852|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
5063912|NCT01858701|12460853|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
5063913|NCT01858701|12460852|P2|COMPLETED|Period 1, First 30 Days of Wear||19
5063914|NCT01858701|12460853|P1|COMPLETED|Period 1, First 30 Days of Wear||20
5063915|NCT01858701|12460852|P2|STARTED|Period 1, First 30 Days of Wear||20
5063916|NCT01858701|12460853|P1|STARTED|Period 1, First 30 Days of Wear||20
5063917|NCT01858636|12460859|P1|NOT COMPLETED|Overall Study||28
5063918|NCT01858636|12460859|P1|COMPLETED|Overall Study||207
5063919|NCT01858636|12460859|P1|Device Deployment|Overall Study||211
5063920|NCT01858636|12460859|P1|STARTED|Overall Study|Subjects consented|235
5063921|NCT01858558|12460866|P2|NOT COMPLETED|Overall Study||2
5063922|NCT01858558|12460867|P1|NOT COMPLETED|Overall Study||9
5063923|NCT01858558|12460866|P2|COMPLETED|Overall Study||29
5063924|NCT01858558|12460867|P1|COMPLETED|Overall Study||61
5063925|NCT01858558|12460866|P2|STARTED|Overall Study||31
5063926|NCT01858558|12460867|P1|STARTED|Overall Study||70
5063927|NCT01858545|12460878|P2|NOT COMPLETED|Overall Study||6
5063928|NCT01858545|12460879|P1|NOT COMPLETED|Overall Study||4
5063929|NCT01858545|12460878|P2|COMPLETED|Overall Study||23
5063930|NCT01858545|12460879|P1|COMPLETED|Overall Study||23
5063931|NCT01858545|12460878|P2|STARTED|Overall Study||29
5063932|NCT01858545|12460879|P1|STARTED|Overall Study||27
5063933|NCT01858532|12460889|P4|NOT COMPLETED|Overall Study||93
5063934|NCT01858532|12460890|P3|NOT COMPLETED|Overall Study||98
5063935|NCT01858532|12460891|P2|NOT COMPLETED|Overall Study||192
5063936|NCT01858532|12460892|P1|NOT COMPLETED|Overall Study||181
5063937|NCT01858532|12460889|P4|COMPLETED|Overall Study||418
5063938|NCT01858532|12460890|P3|COMPLETED|Overall Study||411
5063939|NCT01858532|12460891|P2|COMPLETED|Overall Study||1131
5063940|NCT01858532|12460892|P1|COMPLETED|Overall Study||1144
5063941|NCT01858532|12460889|P4|STARTED|Overall Study||511
5063942|NCT01858532|12460890|P3|STARTED|Overall Study||509
5063943|NCT01858532|12460891|P2|STARTED|Overall Study||1323
5063944|NCT01858532|12460892|P1|STARTED|Overall Study||1325
5063945|NCT01858428|12460909|P2|NOT COMPLETED|Overall Study||10
5063946|NCT01858428|12460910|P1|NOT COMPLETED|Overall Study||1
5063947|NCT01858428|12460909|P2|COMPLETED|Overall Study||190
5063948|NCT01858428|12460910|P1|COMPLETED|Overall Study||99
5063949|NCT01858428|12460909|P2|STARTED|Overall Study||200
5063950|NCT01858428|12460910|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
5063951|NCT01858389|12460946|P2|NOT COMPLETED|Overall Study||25
5063952|NCT01858389|12460947|P1|NOT COMPLETED|Overall Study||16
5063953|NCT01858389|12460946|P2|COMPLETED|Overall Study||0
5063954|NCT01858389|12460947|P1|COMPLETED|Overall Study||0
5063955|NCT01858389|12460946|P2|Received Treatment|Overall Study||22
5063956|NCT01858389|12460947|P1|Received Treatment|Overall Study||16
5063957|NCT01858389|12460946|P2|STARTED|Overall Study|Enrolled|25
5063958|NCT01858389|12460947|P1|STARTED|Overall Study|Enrolled|16
5063959|NCT01858376|12460962|P1|NOT COMPLETED|Overall Study||4
5063960|NCT01858376|12460962|P1|COMPLETED|Overall Study||20
5063961|NCT01858376|12460962|P1|STARTED|Overall Study||24
5063962|NCT01858194|12460971|P2|NOT COMPLETED|Overall Study||2
5063963|NCT01858194|12460972|P1|NOT COMPLETED|Overall Study||0
5063964|NCT01858194|12460971|P2|COMPLETED|Overall Study||7
5063965|NCT01858194|12460972|P1|COMPLETED|Overall Study|All patients in Control arm completed.|8
5063966|NCT01858194|12460971|P2|STARTED|Overall Study||9
5063967|NCT01858194|12460972|P1|STARTED|Overall Study||8
5063968|NCT01857986|12461014|P2|NOT COMPLETED|Overall Study||7
5063969|NCT01857986|12461015|P1|NOT COMPLETED|Overall Study||5
5063970|NCT01857986|12461014|P2|COMPLETED|Overall Study||30
5063971|NCT01857986|12461015|P1|COMPLETED|Overall Study||34
5063972|NCT01857986|12461014|P2|STARTED|Overall Study||37
5063973|NCT01857986|12461015|P1|STARTED|Overall Study||39
5063974|NCT01857973|12461025|P1|NOT COMPLETED|Overall Study||5
5063975|NCT01857973|12461025|P1|COMPLETED|Overall Study||73
5063976|NCT01857973|12461025|P1|Phase 7|Overall Study||4
5063977|NCT01857973|12461025|P1|Phase 6|Overall Study||4
5063978|NCT01857973|12461025|P1|Phase 4|Overall Study||10
5063979|NCT01857973|12461025|P1|Phase 3|Overall Study||10
5063980|NCT01857973|12461025|P1|Phase 2|Overall Study||14
5063981|NCT01857973|12461025|P1|Phase 1|Overall Study||17
5063982|NCT01857973|12461025|P1|Xploratory B Phase|Overall Study||9
5063983|NCT01857973|12461025|P1|Exploratory A Phase|Overall Study||9
5063984|NCT01857973|12461025|P1|STARTED|Overall Study||78
5063985|NCT01857882|12461038|P2|NOT COMPLETED|Overall Study||0
5063986|NCT01857882|12461039|P1|NOT COMPLETED|Overall Study||0
5063987|NCT01857882|12461038|P2|COMPLETED|Overall Study||20
5063988|NCT01857882|12461039|P1|COMPLETED|Overall Study||21
5063989|NCT01857882|12461038|P2|STARTED|Overall Study||20
5063990|NCT01857882|12461039|P1|STARTED|Overall Study||21
5063991|NCT01857869|12461055|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
5063992|NCT01857869|12461056|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
5063993|NCT01857869|12461057|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
5063994|NCT01857869|12461058|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
5063995|NCT01857869|12461059|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
5063996|NCT01857869|12461060|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
5063997|NCT01857869|12461061|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
5063998|NCT01857869|12461062|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
5063999|NCT01857869|12461063|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
5064000|NCT01857869|12461064|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
5064001|NCT01857869|12461055|P10|COMPLETED|Booster/Rechallenge Phase||6
5064002|NCT01857869|12461056|P9|COMPLETED|Booster/Rechallenge Phase||3
5064003|NCT01857869|12461057|P8|COMPLETED|Booster/Rechallenge Phase||4
5064004|NCT01857869|12461058|P7|COMPLETED|Booster/Rechallenge Phase||5
5064005|NCT01857869|12461059|P6|COMPLETED|Booster/Rechallenge Phase||2
5064006|NCT01857869|12461060|P5|COMPLETED|Booster/Rechallenge Phase||10
5064007|NCT01857869|12461061|P4|COMPLETED|Booster/Rechallenge Phase||7
5064008|NCT01857869|12461062|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064009|NCT01857869|12461063|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064010|NCT01857869|12461064|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064011|NCT01857869|12461055|P10|STARTED|Booster/Rechallenge Phase||6
5064012|NCT01857869|12461056|P9|STARTED|Booster/Rechallenge Phase||3
5064013|NCT01857869|12461057|P8|STARTED|Booster/Rechallenge Phase||4
5064014|NCT01857869|12461058|P7|STARTED|Booster/Rechallenge Phase||5
5064015|NCT01857869|12461059|P6|STARTED|Booster/Rechallenge Phase||2
5064016|NCT01857869|12461060|P5|STARTED|Booster/Rechallenge Phase||10
5064017|NCT01857869|12461061|P4|STARTED|Booster/Rechallenge Phase||9
5064018|NCT01857869|12461062|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064019|NCT01857869|12461063|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064020|NCT01857869|12461064|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
5064021|NCT01857869|12461055|P10|NOT COMPLETED|Primary/Challenge Phase||0
5064022|NCT01857869|12461056|P9|NOT COMPLETED|Primary/Challenge Phase||0
5064023|NCT01857869|12461057|P8|NOT COMPLETED|Primary/Challenge Phase||0
5064024|NCT01857869|12461058|P7|NOT COMPLETED|Primary/Challenge Phase||0
5064025|NCT01857869|12461059|P6|NOT COMPLETED|Primary/Challenge Phase||0
5064026|NCT01857869|12461060|P5|NOT COMPLETED|Primary/Challenge Phase||0
5064027|NCT01857869|12461061|P4|NOT COMPLETED|Primary/Challenge Phase||0
5064028|NCT01857869|12461062|P3|NOT COMPLETED|Primary/Challenge Phase||0
5064029|NCT01857869|12461063|P2|NOT COMPLETED|Primary/Challenge Phase||1
5064030|NCT01857869|12461064|P1|NOT COMPLETED|Primary/Challenge Phase||5
5064031|NCT01857869|12461055|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064032|NCT01857869|12461056|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064033|NCT01857869|12461057|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064034|NCT01857869|12461058|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064035|NCT01857869|12461059|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064036|NCT01857869|12461060|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064037|NCT01857869|12461061|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064038|NCT01857869|12461062|P3|COMPLETED|Primary/Challenge Phase||12
5064039|NCT01857869|12461063|P2|COMPLETED|Primary/Challenge Phase||16
5064040|NCT01857869|12461064|P1|COMPLETED|Primary/Challenge Phase||29
5064041|NCT01857869|12461055|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064042|NCT01857869|12461056|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064043|NCT01857869|12461057|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064044|NCT01857869|12461058|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064045|NCT01857869|12461059|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064046|NCT01857869|12461060|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064047|NCT01857869|12461061|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
5064048|NCT01857869|12461062|P3|STARTED|Primary/Challenge Phase||12
5064049|NCT01857869|12461063|P2|STARTED|Primary/Challenge Phase||17
5064050|NCT01857869|12461064|P1|STARTED|Primary/Challenge Phase||34
5064051|NCT01857713|12461144|P1|NOT COMPLETED|Overall Study||6
5064052|NCT01857713|12461144|P1|COMPLETED|Overall Study||89
5064053|NCT01857713|12461144|P1|STARTED|Overall Study||95
5064054|NCT01857622|12461154|P3|NOT COMPLETED|Overall Study||2
5064055|NCT01857622|12461155|P2|NOT COMPLETED|Overall Study||1
5064056|NCT01857622|12461156|P1|NOT COMPLETED|Overall Study||11
5064057|NCT01857622|12461154|P3|COMPLETED|Overall Study||19
5064058|NCT01857622|12461155|P2|COMPLETED|Overall Study||21
5064059|NCT01857622|12461156|P1|COMPLETED|Overall Study||39
5064060|NCT01857622|12461154|P3|STARTED|Overall Study||21
5064061|NCT01857622|12461155|P2|STARTED|Overall Study||22
5064062|NCT01857622|12461156|P1|STARTED|Overall Study||50
5064063|NCT01857583|12461168|P4|NOT COMPLETED|Overall Study||4
5064064|NCT01857583|12461169|P3|NOT COMPLETED|Overall Study||3
5064065|NCT01857583|12461170|P2|NOT COMPLETED|Overall Study||1
5064066|NCT01857583|12461171|P1|NOT COMPLETED|Overall Study||1
5064067|NCT01857583|12461168|P4|COMPLETED|Overall Study||17
5064068|NCT01857583|12461169|P3|COMPLETED|Overall Study||19
5064069|NCT01857583|12461170|P2|COMPLETED|Overall Study||6
5064070|NCT01857583|12461171|P1|COMPLETED|Overall Study||29
5064071|NCT01857583|12461168|P4|Safety Analysis Population|Overall Study||20
5064072|NCT01857583|12461169|P3|Safety Analysis Population|Overall Study||22
5064073|NCT01857583|12461170|P2|Safety Analysis Population|Overall Study||7
5064074|NCT01857583|12461171|P1|Safety Analysis Population|Overall Study||30
5064075|NCT01857583|12461168|P4|STARTED|Overall Study||21
5064076|NCT01857583|12461169|P3|STARTED|Overall Study||22
5064077|NCT01857583|12461170|P2|STARTED|Overall Study||7
5064078|NCT01857583|12461171|P1|STARTED|Overall Study||30
5064079|NCT01857531|12461181|P1|NOT COMPLETED|Overall Study||4
5064080|NCT01857531|12461181|P1|COMPLETED|Overall Study||12
5064081|NCT01857531|12461181|P1|STARTED|Overall Study||16
5064082|NCT01857362|12461190|P2|NOT COMPLETED|Overall Study||0
5064083|NCT01857362|12461191|P1|NOT COMPLETED|Overall Study||0
5064084|NCT01857362|12461190|P2|COMPLETED|Overall Study||6
5064085|NCT01857362|12461191|P1|COMPLETED|Overall Study||6
5064086|NCT01857362|12461190|P2|STARTED|Overall Study||6
5064087|NCT01857362|12461191|P1|STARTED|Overall Study||6
5064088|NCT01857323|12461199|P1|NOT COMPLETED|Overall Study||64
5064089|NCT01857323|12461199|P1|COMPLETED|Overall Study||253
5064090|NCT01857323|12461199|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
5064091|NCT01857323|12461199|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
5064092|NCT01857297|12461210|P2|NOT COMPLETED|Overall Study||0
5064093|NCT01857297|12461211|P1|NOT COMPLETED|Overall Study||0
5064094|NCT01857297|12461210|P2|COMPLETED|Overall Study||60
5064095|NCT01857297|12461211|P1|COMPLETED|Overall Study||60
5064096|NCT01857297|12461210|P2|STARTED|Overall Study||60
5064097|NCT01857297|12461211|P1|STARTED|Overall Study||60
5064098|NCT01857271|12461225|P1|NOT COMPLETED|Overall Study||1
5064099|NCT01857271|12461225|P1|COMPLETED|Overall Study||2
5064100|NCT01857271|12461225|P1|STARTED|Overall Study||3
5064101|NCT01857258|12461229|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
5064102|NCT01857258|12461230|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
5064103|NCT01857258|12461229|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
5064104|NCT01857258|12461230|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
5064105|NCT01857258|12461229|P2|STARTED|Second Intervention (3 h Postprandially)||7
5064106|NCT01857258|12461230|P1|STARTED|Second Intervention (3 h Postprandially)||8
5064107|NCT01857258|12461229|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
5064108|NCT01857258|12461230|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
5064109|NCT01857258|12461229|P2|COMPLETED|Wash-out Period (7 Days)||7
5064110|NCT01857258|12461230|P1|COMPLETED|Wash-out Period (7 Days)||8
5064111|NCT01857258|12461229|P2|STARTED|Wash-out Period (7 Days)||7
5064112|NCT01857258|12461230|P1|STARTED|Wash-out Period (7 Days)||8
5064113|NCT01857258|12461229|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
5064114|NCT01857258|12461230|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
5064115|NCT01857258|12461229|P2|COMPLETED|First Intervention (3 h Postprandially)||7
5064116|NCT01857258|12461230|P1|COMPLETED|First Intervention (3 h Postprandially)||8
5064117|NCT01857258|12461229|P2|STARTED|First Intervention (3 h Postprandially)||7
5064118|NCT01857258|12461230|P1|STARTED|First Intervention (3 h Postprandially)||8
5064119|NCT01857232|12461255|P5|NOT COMPLETED|Overall Study||6
5064120|NCT01857232|12461256|P4|NOT COMPLETED|Overall Study||2
5064121|NCT01857232|12461257|P3|NOT COMPLETED|Overall Study||4
5064122|NCT01857232|12461258|P2|NOT COMPLETED|Overall Study||2
5064123|NCT01857232|12461259|P1|NOT COMPLETED|Overall Study||8
5064124|NCT01857232|12461255|P5|COMPLETED|Overall Study||63
5064125|NCT01857232|12461256|P4|COMPLETED|Overall Study||68
5064126|NCT01857232|12461257|P3|COMPLETED|Overall Study||63
5064127|NCT01857232|12461258|P2|COMPLETED|Overall Study||65
5064128|NCT01857232|12461259|P1|COMPLETED|Overall Study||61
5064129|NCT01857232|12461255|P5|Evaluable ITT|Overall Study||65
5064130|NCT01857232|12461256|P4|Evaluable ITT|Overall Study||68
5064131|NCT01857232|12461257|P3|Evaluable ITT|Overall Study||63
5064132|NCT01857232|12461258|P2|Evaluable ITT|Overall Study||66
5064133|NCT01857232|12461259|P1|Evaluable ITT|Overall Study||66
5064134|NCT01857232|12461255|P5|STARTED|Overall Study||69
5064135|NCT01857232|12461256|P4|STARTED|Overall Study||70
5064136|NCT01857232|12461257|P3|STARTED|Overall Study||67
5064137|NCT01857232|12461258|P2|STARTED|Overall Study||67
5064138|NCT01857232|12461259|P1|STARTED|Overall Study||69
5064139|NCT01857206|12461278|P2|NOT COMPLETED|Overall Study||10
5064140|NCT01857206|12461279|P1|NOT COMPLETED|Overall Study||13
5064141|NCT01857206|12461278|P2|COMPLETED|Overall Study||673
5064142|NCT01857206|12461279|P1|COMPLETED|Overall Study||1359
5064143|NCT01857206|12461278|P2|STARTED|Overall Study||683
5064144|NCT01857206|12461279|P1|STARTED|Overall Study||1372
5064145|NCT01857102|12461297|P2|NOT COMPLETED|Period 2||0
5064146|NCT01857102|12461298|P1|NOT COMPLETED|Period 2||2
5064147|NCT01857102|12461297|P2|COMPLETED|Period 2||51
5064148|NCT01857102|12461298|P1|COMPLETED|Period 2||53
5064149|NCT01857102|12461297|P2|Neophytes|Period 2||4
5064150|NCT01857102|12461298|P1|Neophytes|Period 2||7
5064151|NCT01857102|12461297|P2|Habitual Users|Period 2||47
5064152|NCT01857102|12461298|P1|Habitual Users|Period 2||48
5064153|NCT01857102|12461297|P2|STARTED|Period 2||51
5064154|NCT01857102|12461298|P1|STARTED|Period 2||55
5064155|NCT01857102|12461297|P2|NOT COMPLETED|Period 1||5
5064156|NCT01857102|12461298|P1|NOT COMPLETED|Period 1||3
5064157|NCT01857102|12461297|P2|COMPLETED|Period 1||51
5064158|NCT01857102|12461298|P1|COMPLETED|Period 1||55
5064159|NCT01857102|12461297|P2|Neophtyes|Period 1||4
5064160|NCT01857102|12461298|P1|Neophtyes|Period 1||7
5064161|NCT01857102|12461297|P2|Habitual Users|Period 1||52
5064162|NCT01857102|12461298|P1|Habitual Users|Period 1||51
5064163|NCT01857102|12461297|P2|STARTED|Period 1||56
5064164|NCT01857102|12461298|P1|STARTED|Period 1||58
5064165|NCT01857063|12461308|P2|NOT COMPLETED|Period 2 (7 Days)||2
5064166|NCT01857063|12461309|P1|NOT COMPLETED|Period 2 (7 Days)||4
5064167|NCT01857063|12461308|P2|COMPLETED|Period 2 (7 Days)||104
5064168|NCT01857063|12461309|P1|COMPLETED|Period 2 (7 Days)||104
5064169|NCT01857063|12461308|P2|STARTED|Period 2 (7 Days)||106
5064170|NCT01857063|12461309|P1|STARTED|Period 2 (7 Days)||108
5064171|NCT01857063|12461308|P2|NOT COMPLETED|Period 1 (7 Days)||4
5064172|NCT01857063|12461309|P1|NOT COMPLETED|Period 1 (7 Days)||2
5064173|NCT01857063|12461308|P2|COMPLETED|Period 1 (7 Days)||106
5064174|NCT01857063|12461309|P1|COMPLETED|Period 1 (7 Days)||108
5064175|NCT01857063|12461308|P2|STARTED|Period 1 (7 Days)||110
5064176|NCT01857063|12461309|P1|STARTED|Period 1 (7 Days)||110
5064177|NCT01856933|12461335|P1|NOT COMPLETED|Overall Study||0
5064178|NCT01856933|12461335|P1|COMPLETED|Overall Study||6
5064179|NCT01856933|12461335|P1|STARTED|Overall Study||6
5064180|NCT01856907|12461343|P3|NOT COMPLETED|Overall Study||0
5064181|NCT01856907|12461344|P2|NOT COMPLETED|Overall Study||3
5064182|NCT01856907|12461345|P1|NOT COMPLETED|Overall Study||0
5064183|NCT01856907|12461343|P3|COMPLETED|Overall Study||12
5064184|NCT01856907|12461344|P2|COMPLETED|Overall Study||9
5064185|NCT01856907|12461345|P1|COMPLETED|Overall Study||12
5064186|NCT01856907|12461343|P3|STARTED|Overall Study||12
5064187|NCT01856907|12461344|P2|STARTED|Overall Study||12
5064188|NCT01856907|12461345|P1|STARTED|Overall Study||12
5064189|NCT01856790|12461383|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
5064190|NCT01856790|12461383|P1|COMPLETED|Closed Loop Control + Liraglutide||11
5064191|NCT01856790|12461383|P1|STARTED|Closed Loop Control + Liraglutide||13
5064192|NCT01856790|12461383|P1|NOT COMPLETED|Closed Loop Control||2
5064193|NCT01856790|12461383|P1|COMPLETED|Closed Loop Control||13
5064194|NCT01856790|12461383|P1|STARTED|Closed Loop Control||15
5064195|NCT01856764|12461409|P2|NOT COMPLETED|Overall Study||0
5064196|NCT01856764|12461410|P1|NOT COMPLETED|Overall Study||0
5064197|NCT01856764|12461409|P2|COMPLETED|Overall Study||20
5064198|NCT01856764|12461410|P1|COMPLETED|Overall Study||20
5064199|NCT01856764|12461409|P2|STARTED|Overall Study||20
5064200|NCT01856764|12461410|P1|STARTED|Overall Study||20
5064201|NCT01856712|12461422|P2|NOT COMPLETED|Overall Study||3
5064202|NCT01856712|12461423|P1|NOT COMPLETED|Overall Study||7
5064203|NCT01856712|12461422|P2|COMPLETED|Overall Study||19
5064204|NCT01856712|12461423|P1|COMPLETED|Overall Study||16
5064205|NCT01856712|12461422|P2|Lost to 45 Day Follow up|Overall Study||1
5064206|NCT01856712|12461423|P1|Lost to 45 Day Follow up|Overall Study||1
5064207|NCT01856712|12461422|P2|Lost to 14 Day Follow up|Overall Study||2
5064208|NCT01856712|12461423|P1|Lost to 14 Day Follow up|Overall Study||6
5064209|NCT01856712|12461422|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
5064210|NCT01856712|12461423|P1|STARTED|Overall Study||23
5064211|NCT01856686|12461437|P2|NOT COMPLETED|Overall Study||11
5064212|NCT01856686|12461438|P1|NOT COMPLETED|Overall Study||5
5064213|NCT01856686|12461437|P2|COMPLETED|Overall Study||22
5064214|NCT01856686|12461438|P1|COMPLETED|Overall Study||26
5064215|NCT01856686|12461437|P2|STARTED|Overall Study||33
5064216|NCT01856686|12461438|P1|STARTED|Overall Study||31
5064217|NCT01856673|12461481|P3|NOT COMPLETED|Overall Study||34
5064218|NCT01856673|12461482|P2|NOT COMPLETED|Overall Study||85
5064219|NCT01856673|12461483|P1|NOT COMPLETED|Overall Study||98
5064220|NCT01856673|12461481|P3|COMPLETED|Overall Study||137
5064221|NCT01856673|12461482|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
5064222|NCT01856673|12461483|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
5064223|NCT01856673|12461481|P3|Quibdó Participants|Overall Study||83
5064224|NCT01856673|12461482|P2|Quibdó Participants|Overall Study||86
5064225|NCT01856673|12461483|P1|Quibdó Participants|Overall Study||83
5064226|NCT01856673|12461481|P3|Buenaventura Participants|Overall Study||88
5064227|NCT01856673|12461482|P2|Buenaventura Participants|Overall Study||89
5064228|NCT01856673|12461483|P1|Buenaventura Participants|Overall Study||92
5064229|NCT01856673|12461481|P3|STARTED|Overall Study||171
5064230|NCT01856673|12461482|P2|STARTED|Overall Study||175
5064231|NCT01856673|12461483|P1|STARTED|Overall Study||175
5064232|NCT01856595|12461503|P9|NOT COMPLETED|Overall Study||0
5064233|NCT01856595|12461504|P8|NOT COMPLETED|Overall Study||0
5064234|NCT01856595|12461505|P7|NOT COMPLETED|Overall Study||1
5064235|NCT01856595|12461506|P6|NOT COMPLETED|Overall Study||0
5064236|NCT01856595|12461507|P5|NOT COMPLETED|Overall Study||0
5064237|NCT01856595|12461508|P4|NOT COMPLETED|Overall Study||0
5064238|NCT01856595|12461509|P3|NOT COMPLETED|Overall Study||0
5064239|NCT01856595|12461510|P2|NOT COMPLETED|Overall Study||1
5064240|NCT01856595|12461511|P1|NOT COMPLETED|Overall Study||0
5064241|NCT01856595|12461503|P9|COMPLETED|Overall Study||14
5064242|NCT01856595|12461504|P8|COMPLETED|Overall Study||10
5064243|NCT01856595|12461505|P7|COMPLETED|Overall Study||12
5064244|NCT01856595|12461506|P6|COMPLETED|Overall Study||12
5064245|NCT01856595|12461507|P5|COMPLETED|Overall Study||14
5064246|NCT01856595|12461508|P4|COMPLETED|Overall Study||12
5064247|NCT01856595|12461509|P3|COMPLETED|Overall Study||12
5064248|NCT01856595|12461510|P2|COMPLETED|Overall Study||11
5064249|NCT01856595|12461511|P1|COMPLETED|Overall Study||18
5064250|NCT01856595|12461503|P9|STARTED|Overall Study||14
5064251|NCT01856595|12461504|P8|STARTED|Overall Study||10
5064252|NCT01856595|12461505|P7|STARTED|Overall Study||13
5064253|NCT01856595|12461506|P6|STARTED|Overall Study||12
5064254|NCT01856595|12461507|P5|STARTED|Overall Study||14
5064255|NCT01856595|12461508|P4|STARTED|Overall Study||12
5064256|NCT01856595|12461509|P3|STARTED|Overall Study||12
5064257|NCT01856595|12461510|P2|STARTED|Overall Study||12
5064258|NCT01856595|12461511|P1|STARTED|Overall Study||18
5064259|NCT01856582|12461744|P1|NOT COMPLETED|Overall Study||1
5064260|NCT01856582|12461744|P1|COMPLETED|Overall Study||22
5064261|NCT01856582|12461744|P1|STARTED|Overall Study||23
5064262|NCT01856569|12461748|P1|NOT COMPLETED|Overall Study||13
5064263|NCT01856569|12461748|P1|COMPLETED|Overall Study||139
5064264|NCT01856569|12461748|P1|Full Analysis Set|Overall Study||144
5064265|NCT01856569|12461748|P1|STARTED|Overall Study||152
5064266|NCT01856543|12461759|P2|NOT COMPLETED|Overall Study||6
5064267|NCT01856543|12461760|P1|NOT COMPLETED|Overall Study||13
5064268|NCT01856543|12461759|P2|COMPLETED|Overall Study||64
5064269|NCT01856543|12461760|P1|COMPLETED|Overall Study||60
5064270|NCT01856543|12461759|P2|STARTED|Overall Study||70
5064271|NCT01856543|12461760|P1|STARTED|Overall Study||73
5064272|NCT01856530|12461772|P2|NOT COMPLETED|Overall Study||0
5064273|NCT01856530|12461773|P1|NOT COMPLETED|Overall Study||0
5064274|NCT01856530|12461772|P2|COMPLETED|Overall Study||27
5064275|NCT01856530|12461773|P1|COMPLETED|Overall Study||27
5064276|NCT01856530|12461772|P2|STARTED|Overall Study||27
5064277|NCT01856530|12461773|P1|STARTED|Overall Study||27
5064278|NCT01856491|12461789|P1|NOT COMPLETED|Overall Study||15
5064279|NCT01856491|12461789|P1|COMPLETED|Overall Study||152
5064280|NCT01856491|12461789|P1|STARTED|Overall Study||167
5064281|NCT01856361|12461800|P2|NOT COMPLETED|Overall Study||0
5064282|NCT01856361|12461801|P1|NOT COMPLETED|Overall Study||0
5064283|NCT01856361|12461800|P2|COMPLETED|Overall Study||1
5064284|NCT01856361|12461801|P1|COMPLETED|Overall Study||1
5064285|NCT01856361|12461800|P2|STARTED|Overall Study||1
5064286|NCT01856361|12461801|P1|STARTED|Overall Study||1
5064287|NCT01856322|12461818|P3|NOT COMPLETED|Overall Study||3
5064288|NCT01856322|12461819|P2|NOT COMPLETED|Overall Study||0
5064289|NCT01856322|12461820|P1|NOT COMPLETED|Overall Study||0
5064290|NCT01856322|12461818|P3|COMPLETED|Overall Study||0
5064291|NCT01856322|12461819|P2|COMPLETED|Overall Study||0
5064292|NCT01856322|12461820|P1|COMPLETED|Overall Study||0
5064293|NCT01856322|12461818|P3|STARTED|Overall Study||3
5064294|NCT01856322|12461819|P2|STARTED|Overall Study||0
5064295|NCT01856322|12461820|P1|STARTED|Overall Study||0
5064296|NCT01856309|12461831|P4|NOT COMPLETED|Overall Study||609
5064297|NCT01856309|12461832|P3|NOT COMPLETED|Overall Study||595
5064298|NCT01856309|12461833|P2|NOT COMPLETED|Overall Study||288
5064299|NCT01856309|12461834|P1|NOT COMPLETED|Overall Study||299
5064300|NCT01856309|12461831|P4|COMPLETED|Overall Study||9
5064301|NCT01856309|12461832|P3|COMPLETED|Overall Study||11
5064302|NCT01856309|12461833|P2|COMPLETED|Overall Study||3
5064303|NCT01856309|12461834|P1|COMPLETED|Overall Study||6
5064304|NCT01856309|12461831|P4|Treated Partcipants|Overall Study||618
5064305|NCT01856309|12461832|P3|Treated Partcipants|Overall Study||605
5064306|NCT01856309|12461833|P2|Treated Partcipants|Overall Study||290
5064307|NCT01856309|12461834|P1|Treated Partcipants|Overall Study||305
5064308|NCT01856309|12461831|P4|Participants From Study CNTO136ARA3003|Overall Study||206
5064309|NCT01856309|12461832|P3|Participants From Study CNTO136ARA3003|Overall Study||201
5064310|NCT01856309|12461833|P2|Participants From Study CNTO136ARA3003|Overall Study||104
5064311|NCT01856309|12461834|P1|Participants From Study CNTO136ARA3003|Overall Study||108
5064312|NCT01856309|12461831|P4|Participants From Study CNTO136ARA3002|Overall Study||412
5064313|NCT01856309|12461832|P3|Participants From Study CNTO136ARA3002|Overall Study||405
5064314|NCT01856309|12461833|P2|Participants From Study CNTO136ARA3002|Overall Study||187
5064315|NCT01856309|12461834|P1|Participants From Study CNTO136ARA3002|Overall Study||197
5064316|NCT01856309|12461831|P4|STARTED|Overall Study||618
5064317|NCT01856309|12461832|P3|STARTED|Overall Study||606
5064318|NCT01856309|12461833|P2|STARTED|Overall Study||291
5064319|NCT01856309|12461834|P1|STARTED|Overall Study||305
5064320|NCT01856270|12461934|P2|NOT COMPLETED|Overall Study||12
5064321|NCT01856270|12461935|P1|NOT COMPLETED|Overall Study||11
5064322|NCT01856270|12461934|P2|COMPLETED|Overall Study||14
5064323|NCT01856270|12461935|P1|COMPLETED|Overall Study||13
5064324|NCT01856270|12461934|P2|STARTED|Overall Study||26
5064325|NCT01856270|12461935|P1|STARTED|Overall Study||24
5064326|NCT01856257|12461958|P4|NOT COMPLETED|Overall Study||2
5064327|NCT01856257|12461959|P3|NOT COMPLETED|Overall Study||0
5064328|NCT01856257|12461960|P2|NOT COMPLETED|Overall Study||1
5064329|NCT01856257|12461961|P1|NOT COMPLETED|Overall Study||3
5064330|NCT01856257|12461958|P4|COMPLETED|Overall Study||0
5064331|NCT01856257|12461959|P3|COMPLETED|Overall Study||11
5064332|NCT01856257|12461960|P2|COMPLETED|Overall Study||28
5064333|NCT01856257|12461961|P1|COMPLETED|Overall Study||26
5064334|NCT01856257|12461958|P4|STARTED|Overall Study||2
5064335|NCT01856257|12461959|P3|STARTED|Overall Study||11
5064336|NCT01856257|12461960|P2|STARTED|Overall Study||29
5064337|NCT01856257|12461961|P1|STARTED|Overall Study||29
5064338|NCT01856218|12462060|P1|NOT COMPLETED|Long-Term Extension Phase||0
5064339|NCT01856218|12462060|P1|COMPLETED|Long-Term Extension Phase||3
5064340|NCT01856218|12462060|P1|STARTED|Long-Term Extension Phase||3
5064341|NCT01856218|12462060|P1|NOT COMPLETED|First Phase||0
5064342|NCT01856218|12462060|P1|COMPLETED|First Phase||3
5064343|NCT01856218|12462060|P1|STARTED|First Phase||3
5064344|NCT01855997|12462074|P1|NOT COMPLETED|Overall Study||0
5064345|NCT01855997|12462074|P1|COMPLETED|Overall Study||1669
5064346|NCT01855997|12462074|P1|STARTED|Overall Study||1669
5064347|NCT01855958|12462129|P2|NOT COMPLETED|Overall Study||0
5064348|NCT01855958|12462130|P1|NOT COMPLETED|Overall Study||1
5064349|NCT01855958|12462129|P2|COMPLETED|Overall Study||13
5064350|NCT01855958|12462130|P1|COMPLETED|Overall Study||12
5064351|NCT01855958|12462129|P2|STARTED|Overall Study||13
5064352|NCT01855958|12462130|P1|STARTED|Overall Study||13
5064353|NCT01855945|12462160|P12|NOT COMPLETED|Overall Study||3
5064354|NCT01855945|12462161|P11|NOT COMPLETED|Overall Study||5
5064355|NCT01855945|12462162|P10|NOT COMPLETED|Overall Study||2
5064356|NCT01855945|12462163|P9|NOT COMPLETED|Overall Study||2
5064357|NCT01855945|12462164|P8|NOT COMPLETED|Overall Study||8
5064358|NCT01855945|12462165|P7|NOT COMPLETED|Overall Study||10
5064359|NCT01855945|12462166|P6|NOT COMPLETED|Overall Study||3
5064360|NCT01855945|12462167|P5|NOT COMPLETED|Overall Study||1
5064361|NCT01855945|12462168|P4|NOT COMPLETED|Overall Study||4
5064362|NCT01855945|12462169|P3|NOT COMPLETED|Overall Study||12
5064363|NCT01855945|12462170|P2|NOT COMPLETED|Overall Study||11
5064364|NCT01855945|12462171|P1|NOT COMPLETED|Overall Study||16
5064365|NCT01855945|12462160|P12|COMPLETED|Overall Study||49
5064366|NCT01855945|12462161|P11|COMPLETED|Overall Study||46
5064367|NCT01855945|12462162|P10|COMPLETED|Overall Study||49
5064368|NCT01855945|12462163|P9|COMPLETED|Overall Study||46
5064369|NCT01855945|12462164|P8|COMPLETED|Overall Study||47
5064370|NCT01855945|12462165|P7|COMPLETED|Overall Study||43
5064371|NCT01855945|12462166|P6|COMPLETED|Overall Study||50
5064372|NCT01855945|12462167|P5|COMPLETED|Overall Study||50
5064373|NCT01855945|12462168|P4|COMPLETED|Overall Study||49
5064374|NCT01855945|12462169|P3|COMPLETED|Overall Study||39
5064375|NCT01855945|12462170|P2|COMPLETED|Overall Study||44
5064376|NCT01855945|12462171|P1|COMPLETED|Overall Study||38
5064377|NCT01855945|12462160|P12|STARTED|Overall Study||52
5064378|NCT01855945|12462161|P11|STARTED|Overall Study||51
5064379|NCT01855945|12462162|P10|STARTED|Overall Study||51
5064380|NCT01855945|12462163|P9|STARTED|Overall Study||48
5064381|NCT01855945|12462164|P8|STARTED|Overall Study||55
5064382|NCT01855945|12462165|P7|STARTED|Overall Study||53
5064383|NCT01855945|12462166|P6|STARTED|Overall Study||53
5064384|NCT01855945|12462167|P5|STARTED|Overall Study||51
5064385|NCT01855945|12462168|P4|STARTED|Overall Study||53
5064386|NCT01855945|12462169|P3|STARTED|Overall Study||51
5064387|NCT01855945|12462170|P2|STARTED|Overall Study||55
5064388|NCT01855945|12462171|P1|STARTED|Overall Study||54
5064389|NCT01855919|12462307|P2|NOT COMPLETED|Overall Study||26
5064390|NCT01855919|12462308|P1|NOT COMPLETED|Overall Study||23
5064391|NCT01855919|12462307|P2|COMPLETED|Overall Study||200
5064392|NCT01855919|12462308|P1|COMPLETED|Overall Study||209
5064481|NCT01854944|12462459|P3|COMPLETED|Overall Study||3
5064393|NCT01855919|12462307|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
5064394|NCT01855919|12462308|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
5064395|NCT01855919|12462307|P2|STARTED|Overall Study||226
5064396|NCT01855919|12462308|P1|STARTED|Overall Study||232
5064397|NCT01855828|12462340|P1|NOT COMPLETED|Overall Study||2
5064398|NCT01855828|12462340|P1|COMPLETED|Overall Study||48
5064399|NCT01855828|12462340|P1|STARTED|Overall Study||50
5064400|NCT01855789|12462350|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
5064401|NCT01855789|12462351|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
5064402|NCT01855789|12462352|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
5064403|NCT01855789|12462353|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
5064404|NCT01855789|12462350|P4|COMPLETED|2) Week 24 up to End of Study||250
5064405|NCT01855789|12462351|P3|COMPLETED|2) Week 24 up to End of Study||129
5064406|NCT01855789|12462352|P2|COMPLETED|2) Week 24 up to End of Study||132
5064407|NCT01855789|12462353|P1|COMPLETED|2) Week 24 up to End of Study||0
5064408|NCT01855789|12462350|P4|STARTED|2) Week 24 up to End of Study||308
5064409|NCT01855789|12462351|P3|STARTED|2) Week 24 up to End of Study||147
5064410|NCT01855789|12462352|P2|STARTED|2) Week 24 up to End of Study||147
5064411|NCT01855789|12462353|P1|STARTED|2) Week 24 up to End of Study||0
5064412|NCT01855789|12462350|P4|NOT COMPLETED|1) Baseline up to Week 24||0
5064413|NCT01855789|12462351|P3|NOT COMPLETED|1) Baseline up to Week 24||0
5064414|NCT01855789|12462352|P2|NOT COMPLETED|1) Baseline up to Week 24||0
5064415|NCT01855789|12462353|P1|NOT COMPLETED|1) Baseline up to Week 24||116
5064416|NCT01855789|12462350|P4|COMPLETED|1) Baseline up to Week 24||0
5064417|NCT01855789|12462351|P3|COMPLETED|1) Baseline up to Week 24||0
5064418|NCT01855789|12462352|P2|COMPLETED|1) Baseline up to Week 24||0
5064419|NCT01855789|12462353|P1|COMPLETED|1) Baseline up to Week 24||602
5064420|NCT01855789|12462350|P4|STARTED|1) Baseline up to Week 24||0
5064421|NCT01855789|12462351|P3|STARTED|1) Baseline up to Week 24||0
5064422|NCT01855789|12462352|P2|STARTED|1) Baseline up to Week 24||0
5064423|NCT01855789|12462353|P1|STARTED|1) Baseline up to Week 24||718
5064424|NCT01855750|12462377|P2|NOT COMPLETED|Overall Study||419
5064425|NCT01855750|12462378|P1|NOT COMPLETED|Overall Study||419
5064426|NCT01855750|12462377|P2|COMPLETED|Overall Study||0
5064427|NCT01855750|12462378|P1|COMPLETED|Overall Study||0
5064428|NCT01855750|12462377|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
5064429|NCT01855750|12462378|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
5064430|NCT01855750|12462377|P2|STARTED|Overall Study||419
5064431|NCT01855750|12462378|P1|STARTED|Overall Study||419
5064432|NCT01855425|12462394|P1|NOT COMPLETED|Overall Study||20
5064433|NCT01855425|12462394|P1|COMPLETED|Overall Study||76
5064434|NCT01855425|12462394|P1|STARTED|Overall Study||96
5064435|NCT01855399|12462400|P2|NOT COMPLETED|12 Month||11
5064436|NCT01855399|12462401|P1|NOT COMPLETED|12 Month||7
5064437|NCT01855399|12462400|P2|COMPLETED|12 Month||118
5064438|NCT01855399|12462401|P1|COMPLETED|12 Month||119
5064439|NCT01855399|12462400|P2|STARTED|12 Month||129
5064440|NCT01855399|12462401|P1|STARTED|12 Month||126
5064441|NCT01855399|12462400|P2|NOT COMPLETED|6 Month||15
5064442|NCT01855399|12462401|P1|NOT COMPLETED|6 Month||20
5064443|NCT01855399|12462400|P2|COMPLETED|6 Month||129
5064444|NCT01855399|12462401|P1|COMPLETED|6 Month||126
5064445|NCT01855399|12462400|P2|STARTED|6 Month||144
5064446|NCT01855399|12462401|P1|STARTED|6 Month||146
5064447|NCT01855243|12462410|P3|NOT COMPLETED|Overall Study||0
5064448|NCT01855243|12462411|P2|NOT COMPLETED|Overall Study||0
5064449|NCT01855243|12462412|P1|NOT COMPLETED|Overall Study||1
5064450|NCT01855243|12462410|P3|COMPLETED|Overall Study||22
5064451|NCT01855243|12462411|P2|COMPLETED|Overall Study||21
5064452|NCT01855243|12462412|P1|COMPLETED|Overall Study||19
5064453|NCT01855243|12462410|P3|STARTED|Overall Study||22
5064454|NCT01855243|12462411|P2|STARTED|Overall Study||21
5064455|NCT01855243|12462412|P1|STARTED|Overall Study||20
5064456|NCT01855126|12462434|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
5064457|NCT01855126|12462435|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
5064458|NCT01855126|12462434|P2|COMPLETED|Second Intervention (8 Weeks)||14
5064459|NCT01855126|12462435|P1|COMPLETED|Second Intervention (8 Weeks)||18
5064460|NCT01855126|12462434|P2|STARTED|Second Intervention (8 Weeks)||16
5064461|NCT01855126|12462435|P1|STARTED|Second Intervention (8 Weeks)||20
5064462|NCT01855126|12462434|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
5064463|NCT01855126|12462435|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
5064464|NCT01855126|12462434|P2|COMPLETED|Washout Period (2 Weeks)||16
5064465|NCT01855126|12462435|P1|COMPLETED|Washout Period (2 Weeks)||20
5064466|NCT01855126|12462434|P2|STARTED|Washout Period (2 Weeks)||16
5064467|NCT01855126|12462435|P1|STARTED|Washout Period (2 Weeks)||20
5064468|NCT01855126|12462434|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
5064469|NCT01855126|12462435|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
5064470|NCT01855126|12462434|P2|COMPLETED|First Intervention (8 Weeks)||16
5064471|NCT01855126|12462435|P1|COMPLETED|First Intervention (8 Weeks)||20
5064472|NCT01855126|12462434|P2|STARTED|First Intervention (8 Weeks)||22
5064473|NCT01855126|12462435|P1|STARTED|First Intervention (8 Weeks)||24
5064474|NCT01855074|12462447|P1|NOT COMPLETED|Overall Study||14
5064475|NCT01855074|12462447|P1|COMPLETED|Overall Study||66
5064476|NCT01855074|12462447|P1|Treated|Overall Study||79
5064477|NCT01855074|12462447|P1|STARTED|Overall Study||80
5064478|NCT01854944|12462459|P3|NOT COMPLETED|Overall Study||1
5064479|NCT01854944|12462460|P2|NOT COMPLETED|Overall Study||0
5064480|NCT01854944|12462461|P1|NOT COMPLETED|Overall Study||0
5064482|NCT01854944|12462460|P2|COMPLETED|Overall Study||4
5064483|NCT01854944|12462461|P1|COMPLETED|Overall Study||4
5064484|NCT01854944|12462459|P3|STARTED|Overall Study||4
5064485|NCT01854944|12462460|P2|STARTED|Overall Study||4
5064486|NCT01854944|12462461|P1|STARTED|Overall Study||4
5064487|NCT01854918|12462513|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
5064488|NCT01854918|12462514|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
5064489|NCT01854918|12462513|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
5064490|NCT01854918|12462514|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
5064491|NCT01854918|12462513|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
5064492|NCT01854918|12462514|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
5064493|NCT01854918|12462513|P2|STARTED|All-IP Period (Years 2 and 3)||2391
5064494|NCT01854918|12462514|P1|STARTED|All-IP Period (Years 2 and 3)||1197
5064495|NCT01854918|12462513|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
5064496|NCT01854918|12462514|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
5064497|NCT01854918|12462513|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
5064498|NCT01854918|12462514|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
5064499|NCT01854918|12462513|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
5064500|NCT01854918|12462514|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
5064501|NCT01854918|12462513|P2|STARTED|SOC-controlled Period (Year 1)||2454
5064502|NCT01854918|12462514|P1|STARTED|SOC-controlled Period (Year 1)||1227
5064503|NCT01854905|12462529|P1|NOT COMPLETED|Overall Study||0
5064504|NCT01854905|12462529|P1|COMPLETED|Overall Study||400
5064505|NCT01854905|12462529|P1|STARTED|Overall Study||400
5064506|NCT01854827|12462533|P1|NOT COMPLETED|Overall Study||1
5064507|NCT01854827|12462533|P1|COMPLETED|Overall Study||29
5064508|NCT01854827|12462533|P1|STARTED|Overall Study||30
5064509|NCT01854710|12462545|P6|NOT COMPLETED|Overall Study||2
5064510|NCT01854710|12462546|P5|NOT COMPLETED|Overall Study||2
5064511|NCT01854710|12462547|P4|NOT COMPLETED|Overall Study||2
5064512|NCT01854710|12462548|P3|NOT COMPLETED|Overall Study||2
5064513|NCT01854710|12462549|P2|NOT COMPLETED|Overall Study||3
5064514|NCT01854710|12462550|P1|NOT COMPLETED|Overall Study||4
5064515|NCT01854710|12462545|P6|COMPLETED|Overall Study||8
5064516|NCT01854710|12462546|P5|COMPLETED|Overall Study||8
5064517|NCT01854710|12462547|P4|COMPLETED|Overall Study||8
5064518|NCT01854710|12462548|P3|COMPLETED|Overall Study||8
5064519|NCT01854710|12462549|P2|COMPLETED|Overall Study||7
5064520|NCT01854710|12462550|P1|COMPLETED|Overall Study||6
5064521|NCT01854710|12462545|P6|STARTED|Overall Study||10
5064522|NCT01854710|12462546|P5|STARTED|Overall Study||10
5064523|NCT01854710|12462547|P4|STARTED|Overall Study||10
5064524|NCT01854710|12462548|P3|STARTED|Overall Study||10
5064525|NCT01854710|12462549|P2|STARTED|Overall Study||10
5064526|NCT01854710|12462550|P1|STARTED|Overall Study||10
5064527|NCT01854697|12462571|P5|NOT COMPLETED|Overall Study||2
5064528|NCT01854697|12462572|P4|NOT COMPLETED|Overall Study||3
5064529|NCT01854697|12462573|P3|NOT COMPLETED|Overall Study||2
5064530|NCT01854697|12462574|P2|NOT COMPLETED|Overall Study||3
5064531|NCT01854697|12462575|P1|NOT COMPLETED|Overall Study||6
5064532|NCT01854697|12462571|P5|COMPLETED|Overall Study||39
5064533|NCT01854697|12462572|P4|COMPLETED|Overall Study||80
5064534|NCT01854697|12462573|P3|COMPLETED|Overall Study||82
5064535|NCT01854697|12462574|P2|COMPLETED|Overall Study||31
5064536|NCT01854697|12462575|P1|COMPLETED|Overall Study||63
5064537|NCT01854697|12462571|P5|STARTED|Overall Study||41
5064538|NCT01854697|12462572|P4|STARTED|Overall Study||83
5064539|NCT01854697|12462573|P3|STARTED|Overall Study||84
5064540|NCT01854697|12462574|P2|STARTED|Overall Study||34
5064541|NCT01854697|12462575|P1|STARTED|Overall Study||69
5064542|NCT01854658|12462619|P4|NOT COMPLETED|Overall Study||59
5064543|NCT01854658|12462620|P3|NOT COMPLETED|Overall Study||80
5064544|NCT01854658|12462621|P2|NOT COMPLETED|Overall Study||75
5064545|NCT01854658|12462622|P1|NOT COMPLETED|Overall Study||93
5064546|NCT01854658|12462619|P4|COMPLETED|Overall Study||165
5064547|NCT01854658|12462620|P3|COMPLETED|Overall Study||432
5064548|NCT01854658|12462621|P2|COMPLETED|Overall Study||365
5064549|NCT01854658|12462622|P1|COMPLETED|Overall Study||346
5064550|NCT01854658|12462619|P4|STARTED|Overall Study||224
5064551|NCT01854658|12462620|P3|STARTED|Overall Study||512
5064552|NCT01854658|12462621|P2|STARTED|Overall Study||440
5064553|NCT01854658|12462622|P1|STARTED|Overall Study||439
5064554|NCT01854645|12462657|P5|NOT COMPLETED|Overall Study||60
5064555|NCT01854645|12462658|P4|NOT COMPLETED|Overall Study||62
5064556|NCT01854645|12462659|P3|NOT COMPLETED|Overall Study||82
5064557|NCT01854645|12462660|P2|NOT COMPLETED|Overall Study||106
5064558|NCT01854645|12462661|P1|NOT COMPLETED|Overall Study||98
5064559|NCT01854645|12462657|P5|COMPLETED|Overall Study||160
5064560|NCT01854645|12462658|P4|COMPLETED|Overall Study||391
5064561|NCT01854645|12462659|P3|COMPLETED|Overall Study||370
5064562|NCT01854645|12462660|P2|COMPLETED|Overall Study||345
5064563|NCT01854645|12462661|P1|COMPLETED|Overall Study||429
5064564|NCT01854645|12462657|P5|STARTED|Overall Study||220
5064565|NCT01854645|12462658|P4|STARTED|Overall Study||453
5064566|NCT01854645|12462659|P3|STARTED|Overall Study||452
5064567|NCT01854645|12462660|P2|STARTED|Overall Study||451
5064568|NCT01854645|12462661|P1|STARTED|Overall Study||527
5064569|NCT01854632|12462700|P2|NOT COMPLETED|Overall Study||13
5064570|NCT01854632|12462701|P1|NOT COMPLETED|Overall Study||26
5064571|NCT01854632|12462700|P2|COMPLETED|Overall Study||574
5064572|NCT01854632|12462701|P1|COMPLETED|Overall Study||1148
5064573|NCT01854632|12462700|P2|STARTED|Overall Study||587
5064574|NCT01854632|12462701|P1|STARTED|Overall Study||1174
5064575|NCT01854593|12462709|P2|NOT COMPLETED|Overall Study||1
5064576|NCT01854593|12462710|P1|NOT COMPLETED|Overall Study||2
5064577|NCT01854593|12462709|P2|COMPLETED|Overall Study||34
5064578|NCT01854593|12462710|P1|COMPLETED|Overall Study||32
5064579|NCT01854593|12462709|P2|STARTED|Overall Study||35
5064580|NCT01854593|12462710|P1|STARTED|Overall Study||34
5064581|NCT01854528|12462742|P2|NOT COMPLETED|Overall Study||15
5064582|NCT01854528|12462743|P1|NOT COMPLETED|Overall Study||0
5064583|NCT01854528|12462742|P2|COMPLETED|Overall Study||32
5064584|NCT01854528|12462743|P1|COMPLETED|Overall Study||101
5064585|NCT01854528|12462742|P2|STARTED|Overall Study||47
5064586|NCT01854528|12462743|P1|STARTED|Overall Study||101
5064587|NCT01854281|12462763|P4|NOT COMPLETED|Overall Study||0
5064588|NCT01854281|12462764|P3|NOT COMPLETED|Overall Study||0
5064589|NCT01854281|12462765|P2|NOT COMPLETED|Overall Study||0
5064590|NCT01854281|12462766|P1|NOT COMPLETED|Overall Study||0
5064591|NCT01854281|12462763|P4|COMPLETED|Overall Study||8
5064592|NCT01854281|12462764|P3|COMPLETED|Overall Study||5
5064593|NCT01854281|12462765|P2|COMPLETED|Overall Study||19
5064594|NCT01854281|12462766|P1|COMPLETED|Overall Study||15
5064595|NCT01854281|12462763|P4|STARTED|Overall Study||8
5064596|NCT01854281|12462764|P3|STARTED|Overall Study||5
5064597|NCT01854281|12462765|P2|STARTED|Overall Study||19
5064598|NCT01854281|12462766|P1|STARTED|Overall Study||15
5064599|NCT01854268|12462776|P1|NOT COMPLETED|Overall Study||0
5064600|NCT01854268|12462776|P1|COMPLETED|Overall Study||25
5064601|NCT01854268|12462776|P1|STARTED|Overall Study||25
5064602|NCT01854242|12462782|P1|NOT COMPLETED|Overall Study||0
5064603|NCT01854242|12462782|P1|COMPLETED|Overall Study||50
5064604|NCT01854242|12462782|P1|STARTED|Overall Study||50
5064605|NCT01854177|12462786|P1|NOT COMPLETED|Overall Study||0
5064606|NCT01854177|12462786|P1|COMPLETED|Overall Study||10
5064607|NCT01854177|12462786|P1|STARTED|Overall Study||10
5064608|NCT01854138|12462796|P2|NOT COMPLETED|Overall Study||52
5064609|NCT01854138|12462797|P1|NOT COMPLETED|Overall Study||0
5064610|NCT01854138|12462796|P2|COMPLETED|Overall Study||196
5064611|NCT01854138|12462797|P1|COMPLETED|Overall Study||400
5064612|NCT01854138|12462796|P2|STARTED|Overall Study||248
5064613|NCT01854138|12462797|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
5064614|NCT01854047|12462814|P5|NOT COMPLETED|Overall Study||19
5064615|NCT01854047|12462815|P4|NOT COMPLETED|Overall Study||15
5064616|NCT01854047|12462816|P3|NOT COMPLETED|Overall Study||13
5064617|NCT01854047|12462817|P2|NOT COMPLETED|Overall Study||8
5064618|NCT01854047|12462818|P1|NOT COMPLETED|Overall Study||12
5064619|NCT01854047|12462814|P5|COMPLETED|Overall Study||135
5064620|NCT01854047|12462815|P4|COMPLETED|Overall Study||142
5064621|NCT01854047|12462816|P3|COMPLETED|Overall Study||137
5064622|NCT01854047|12462817|P2|COMPLETED|Overall Study||149
5064623|NCT01854047|12462818|P1|COMPLETED|Overall Study||146
5064624|NCT01854047|12462814|P5|Completed 12-week Study Treatment|Overall Study||143
5064625|NCT01854047|12462815|P4|Completed 12-week Study Treatment|Overall Study||146
5064626|NCT01854047|12462816|P3|Completed 12-week Study Treatment|Overall Study||141
5064627|NCT01854047|12462817|P2|Completed 12-week Study Treatment|Overall Study||149
5064628|NCT01854047|12462818|P1|Completed 12-week Study Treatment|Overall Study||153
5064629|NCT01854047|12462814|P5|Treated|Overall Study||150
5064630|NCT01854047|12462815|P4|Treated|Overall Study||157
5064631|NCT01854047|12462816|P3|Treated|Overall Study||148
5064632|NCT01854047|12462817|P2|Treated|Overall Study||156
5064633|NCT01854047|12462818|P1|Treated|Overall Study||158
5064634|NCT01854047|12462814|P5|STARTED|Overall Study||154
5064635|NCT01854047|12462815|P4|STARTED|Overall Study||157
5064636|NCT01854047|12462816|P3|STARTED|Overall Study||150
5064637|NCT01854047|12462817|P2|STARTED|Overall Study||157
5064638|NCT01854047|12462818|P1|STARTED|Overall Study||158
5064639|NCT01854034|12462940|P1|NOT COMPLETED|Overall Study||0
5064640|NCT01854034|12462940|P1|COMPLETED|Overall Study||29
5064641|NCT01854034|12462940|P1|STARTED|Overall Study||29
5064642|NCT01853982|12462949|P2|NOT COMPLETED|Overall Study||1
5064643|NCT01853982|12462950|P1|NOT COMPLETED|Overall Study||2
5064644|NCT01853982|12462949|P2|COMPLETED|Overall Study||1
5064645|NCT01853982|12462950|P1|COMPLETED|Overall Study||0
5064646|NCT01853982|12462949|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
5064647|NCT01853982|12462950|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
5064648|NCT01853982|12462949|P2|STARTED|Overall Study||2
5064649|NCT01853982|12462950|P1|STARTED|Overall Study||2
5064650|NCT01853930|12462958|P2|NOT COMPLETED|Overall Study||0
5064651|NCT01853930|12462959|P1|NOT COMPLETED|Overall Study||0
5064652|NCT01853930|12462958|P2|COMPLETED|Overall Study||8
5064653|NCT01853930|12462959|P1|COMPLETED|Overall Study||25
5064654|NCT01853930|12462958|P2|STARTED|Overall Study||8
5064655|NCT01853930|12462959|P1|STARTED|Overall Study||25
5064656|NCT01853878|12462967|P2|NOT COMPLETED|Overall Study||44
5064657|NCT01853878|12462968|P1|NOT COMPLETED|Overall Study||63
5064658|NCT01853878|12462967|P2|COMPLETED|Overall Study||3
5064659|NCT01853878|12462968|P1|COMPLETED|Overall Study||23
5064660|NCT01853878|12462967|P2|STARTED|Overall Study||47
5064661|NCT01853878|12462968|P1|STARTED|Overall Study||86
5064662|NCT01853839|12462992|P1|NOT COMPLETED|Overall Study||429
5064663|NCT01853839|12462992|P1|COMPLETED|Overall Study||1663
5064664|NCT01853839|12462992|P1|STARTED|Overall Study||2092
5064665|NCT01853774|12463014|P2|NOT COMPLETED|Overall Study||28
5064666|NCT01853774|12463015|P1|NOT COMPLETED|Overall Study||46
5064667|NCT01853774|12463014|P2|COMPLETED|Overall Study||134
5064668|NCT01853774|12463015|P1|COMPLETED|Overall Study||211
5064669|NCT01853774|12463014|P2|STARTED|Overall Study||162
5064670|NCT01853774|12463015|P1|STARTED|Overall Study||257
5064671|NCT01853696|12463025|P2|NOT COMPLETED|Overall Study||5
5064672|NCT01853696|12463026|P1|NOT COMPLETED|Overall Study||6
5064673|NCT01853696|12463025|P2|COMPLETED|Overall Study||78
5064674|NCT01853696|12463026|P1|COMPLETED|Overall Study||78
5064675|NCT01853696|12463025|P2|STARTED|Overall Study||83
5064676|NCT01853696|12463026|P1|STARTED|Overall Study||84
5064677|NCT01853644|12463034|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
5064678|NCT01853644|12463034|P1|COMPLETED|Follow up for 3 Years or Until Death||26
5064679|NCT01853644|12463034|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
5064680|NCT01853644|12463034|P1|NOT COMPLETED|Continued Treatment After First Response||12
5064681|NCT01853644|12463034|P1|COMPLETED|Continued Treatment After First Response||12
5064682|NCT01853644|12463034|P1|STARTED|Continued Treatment After First Response||24
5064683|NCT01853644|12463034|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
5064684|NCT01853644|12463034|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
5064685|NCT01853644|12463034|P1|STARTED|Reached First Response/Complete 2 Cycles||30
5064686|NCT01853644|12463034|P1|NOT COMPLETED|Registration and Treatment Start||1
5064687|NCT01853644|12463034|P1|COMPLETED|Registration and Treatment Start||30
5064688|NCT01853644|12463034|P1|Started Treatment|Registration and Treatment Start||30
5064689|NCT01853644|12463034|P1|Registered|Registration and Treatment Start||31
5064690|NCT01853644|12463034|P1|STARTED|Registration and Treatment Start||31
5064691|NCT01853618|12463048|P5|NOT COMPLETED|Overall Study||3
5064692|NCT01853618|12463049|P4|NOT COMPLETED|Overall Study||1
5064693|NCT01853618|12463050|P3|NOT COMPLETED|Overall Study||2
5064694|NCT01853618|12463051|P2|NOT COMPLETED|Overall Study||2
5064695|NCT01853618|12463052|P1|NOT COMPLETED|Overall Study||2
5064696|NCT01853618|12463048|P5|COMPLETED|Overall Study||17
5064697|NCT01853618|12463049|P4|COMPLETED|Overall Study||8
5064698|NCT01853618|12463050|P3|COMPLETED|Overall Study||10
5064699|NCT01853618|12463051|P2|COMPLETED|Overall Study||10
5064700|NCT01853618|12463052|P1|COMPLETED|Overall Study||6
5064701|NCT01853618|12463048|P5|STARTED|Overall Study||20
5064702|NCT01853618|12463049|P4|STARTED|Overall Study||9
5064703|NCT01853618|12463050|P3|STARTED|Overall Study||12
5064704|NCT01853618|12463051|P2|STARTED|Overall Study||12
5064705|NCT01853618|12463052|P1|STARTED|Overall Study||8
5064706|NCT01853605|12463083|P4|NOT COMPLETED|Overall Study||0
5064707|NCT01853605|12463084|P3|NOT COMPLETED|Overall Study||0
5064708|NCT01853605|12463085|P2|NOT COMPLETED|Overall Study||0
5064709|NCT01853605|12463086|P1|NOT COMPLETED|Overall Study||0
5064710|NCT01853605|12463083|P4|COMPLETED|Overall Study||428
5064711|NCT01853605|12463084|P3|COMPLETED|Overall Study||751
5064712|NCT01853605|12463085|P2|COMPLETED|Overall Study||693
5064713|NCT01853605|12463086|P1|COMPLETED|Overall Study||1939
5064714|NCT01853605|12463083|P4|STARTED|Overall Study||428
5064715|NCT01853605|12463084|P3|STARTED|Overall Study||751
5064716|NCT01853605|12463085|P2|STARTED|Overall Study||693
5064717|NCT01853605|12463086|P1|STARTED|Overall Study||1939
5064718|NCT01853553|12463106|P2|NOT COMPLETED|Overall Study||0
5064719|NCT01853553|12463107|P1|NOT COMPLETED|Overall Study||1
5064720|NCT01853553|12463106|P2|COMPLETED|Overall Study||32
5064721|NCT01853553|12463107|P1|COMPLETED|Overall Study||28
5064722|NCT01853553|12463106|P2|STARTED|Overall Study||32
5064723|NCT01853553|12463107|P1|STARTED|Overall Study||29
5064724|NCT01853475|12463118|P3|NOT COMPLETED|Overall Study||0
5064725|NCT01853475|12463119|P2|NOT COMPLETED|Overall Study||1
5064726|NCT01853475|12463120|P1|NOT COMPLETED|Overall Study||0
5064727|NCT01853475|12463118|P3|COMPLETED|Overall Study||8
5064728|NCT01853475|12463119|P2|COMPLETED|Overall Study||7
5064729|NCT01853475|12463120|P1|COMPLETED|Overall Study||8
5064730|NCT01853475|12463118|P3|STARTED|Overall Study||8
5064731|NCT01853475|12463119|P2|STARTED|Overall Study||8
5064732|NCT01853475|12463120|P1|STARTED|Overall Study||8
5064733|NCT01853462|12463139|P2|NOT COMPLETED|Overall Study||1
5064734|NCT01853462|12463140|P1|NOT COMPLETED|Overall Study||1
5064735|NCT01853462|12463139|P2|COMPLETED|Overall Study||10
5064736|NCT01853462|12463140|P1|COMPLETED|Overall Study||10
5064737|NCT01853462|12463139|P2|STARTED|Overall Study||11
5064738|NCT01853462|12463140|P1|STARTED|Overall Study||11
5064739|NCT01853397|12463210|P4|NOT COMPLETED|Overall Study||2
5064740|NCT01853397|12463211|P3|NOT COMPLETED|Overall Study||0
5064741|NCT01853397|12463212|P2|NOT COMPLETED|Overall Study||0
5064742|NCT01853397|12463213|P1|NOT COMPLETED|Overall Study||0
5064743|NCT01853397|12463210|P4|COMPLETED|Overall Study||15
5064744|NCT01853397|12463211|P3|COMPLETED|Overall Study||17
5064745|NCT01853397|12463212|P2|COMPLETED|Overall Study||20
5064746|NCT01853397|12463213|P1|COMPLETED|Overall Study||18
5064747|NCT01853397|12463210|P4|STARTED|Overall Study||17
5064748|NCT01853397|12463211|P3|STARTED|Overall Study||17
5064749|NCT01853397|12463212|P2|STARTED|Overall Study||20
5064750|NCT01853397|12463213|P1|STARTED|Overall Study||18
5064751|NCT01853384|12463241|P2|NOT COMPLETED|Completed Follow up Visit 2||3
5064752|NCT01853384|12463242|P1|NOT COMPLETED|Completed Follow up Visit 2||3
5064753|NCT01853384|12463241|P2|COMPLETED|Completed Follow up Visit 2||91
5064754|NCT01853384|12463242|P1|COMPLETED|Completed Follow up Visit 2||93
5064755|NCT01853384|12463241|P2|STARTED|Completed Follow up Visit 2||94
5064756|NCT01853384|12463242|P1|STARTED|Completed Follow up Visit 2||96
5064757|NCT01853384|12463241|P2|NOT COMPLETED|Completed Follow up Visit 1||9
5064758|NCT01853384|12463242|P1|NOT COMPLETED|Completed Follow up Visit 1||14
5064759|NCT01853384|12463241|P2|COMPLETED|Completed Follow up Visit 1||85
5064760|NCT01853384|12463242|P1|COMPLETED|Completed Follow up Visit 1||82
5064761|NCT01853384|12463241|P2|STARTED|Completed Follow up Visit 1||94
5064762|NCT01853384|12463242|P1|STARTED|Completed Follow up Visit 1||96
5064763|NCT01853384|12463241|P2|NOT COMPLETED|Enrolled in Follow up Period||0
5064764|NCT01853384|12463242|P1|NOT COMPLETED|Enrolled in Follow up Period||0
5064765|NCT01853384|12463241|P2|COMPLETED|Enrolled in Follow up Period||94
5064766|NCT01853384|12463242|P1|COMPLETED|Enrolled in Follow up Period||96
5064767|NCT01853384|12463241|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
5064768|NCT01853384|12463242|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
5064769|NCT01853384|12463241|P2|STARTED|Enrolled in Follow up Period||94
5064770|NCT01853384|12463242|P1|STARTED|Enrolled in Follow up Period||96
5064771|NCT01853384|12463241|P2|NOT COMPLETED|Randomized||46
5064772|NCT01853384|12463242|P1|NOT COMPLETED|Randomized||62
5064773|NCT01853384|12463241|P2|COMPLETED|Randomized||75
5064774|NCT01853384|12463242|P1|COMPLETED|Randomized||69
5064775|NCT01853384|12463241|P2|STARTED|Randomized||121
5064776|NCT01853384|12463242|P1|STARTED|Randomized||131
5064777|NCT01853371|12463262|P2|NOT COMPLETED|Overall Study||2
5064778|NCT01853371|12463263|P1|NOT COMPLETED|Overall Study||0
5064779|NCT01853371|12463262|P2|COMPLETED|Overall Study||8
5064780|NCT01853371|12463263|P1|COMPLETED|Overall Study||10
5064781|NCT01853371|12463262|P2|STARTED|Overall Study||10
5064782|NCT01853371|12463263|P1|STARTED|Overall Study||10
5064783|NCT01853332|12463271|P1|NOT COMPLETED|Overall Study||59
5064784|NCT01853332|12463271|P1|COMPLETED|Overall Study||151
5064785|NCT01853332|12463271|P1|STARTED|Overall Study||210
5064786|NCT01853280|12463282|P2|NOT COMPLETED|Overall Study||6
5064787|NCT01853280|12463283|P1|NOT COMPLETED|Overall Study||2
5064788|NCT01853280|12463282|P2|COMPLETED|Overall Study||16
5064789|NCT01853280|12463283|P1|COMPLETED|Overall Study||20
5064790|NCT01853280|12463282|P2|STARTED|Overall Study||22
5064791|NCT01853280|12463283|P1|STARTED|Overall Study||22
5064792|NCT01853254|12463289|P1|NOT COMPLETED|Overall Study||104
5064793|NCT01853254|12463289|P1|COMPLETED|Overall Study||168
5064794|NCT01853254|12463289|P1|STARTED|Overall Study||272
5064795|NCT01853228|12463293|P2|NOT COMPLETED|Phase 2||8
5064796|NCT01853228|12463294|P1|NOT COMPLETED|Phase 2||0
5064797|NCT01853228|12463293|P2|COMPLETED|Phase 2||0
5064798|NCT01853228|12463294|P1|COMPLETED|Phase 2||0
5064799|NCT01853228|12463293|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
5064800|NCT01853228|12463294|P1|STARTED|Phase 2||0
5064801|NCT01853228|12463293|P2|NOT COMPLETED|Phase 1||0
5064802|NCT01853228|12463294|P1|NOT COMPLETED|Phase 1||9
5064803|NCT01853228|12463293|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
5064804|NCT01853228|12463294|P1|COMPLETED|Phase 1||0
5064805|NCT01853228|12463293|P2|STARTED|Phase 1||7
5064806|NCT01853228|12463294|P1|STARTED|Phase 1||9
5064807|NCT01853215|12463311|P1|NOT COMPLETED|Overall Study||0
5064808|NCT01853215|12463311|P1|COMPLETED|Overall Study||24
5064809|NCT01853215|12463311|P1|STARTED|Overall Study||24
5064810|NCT01853176|12463324|P2|NOT COMPLETED|Overall Study||0
5064811|NCT01853176|12463325|P1|NOT COMPLETED|Overall Study||4
5064812|NCT01853176|12463324|P2|COMPLETED|Overall Study||0
5064813|NCT01853176|12463325|P1|COMPLETED|Overall Study||0
5064814|NCT01853176|12463324|P2|STARTED|Overall Study||0
5064815|NCT01853176|12463325|P1|STARTED|Overall Study||4
5064816|NCT01853085|12463331|P1|NOT COMPLETED|Overall Study||235
5064817|NCT01853085|12463331|P1|COMPLETED|Overall Study||1595
5064818|NCT01853085|12463331|P1|STARTED|Overall Study||1830
5064819|NCT01853072|12463344|P2|NOT COMPLETED|Overall Study||21
5064820|NCT01853072|12463345|P1|NOT COMPLETED|Overall Study||12
5064821|NCT01853072|12463344|P2|COMPLETED|Overall Study||286
5064822|NCT01853072|12463345|P1|COMPLETED|Overall Study||296
5064823|NCT01853072|12463344|P2|Full Analysis Set|Overall Study||300
5064824|NCT01853072|12463345|P1|Full Analysis Set|Overall Study||298
5064825|NCT01853072|12463344|P2|Treated (Safety Analysis Set)|Overall Study||302
5064826|NCT01853072|12463345|P1|Treated (Safety Analysis Set)|Overall Study||301
5064827|NCT01853072|12463344|P2|Randomized|Overall Study||307
5064828|NCT01853072|12463345|P1|Randomized|Overall Study||308
5064829|NCT01853072|12463344|P2|STARTED|Overall Study||307
5064830|NCT01853072|12463345|P1|STARTED|Overall Study||308
5064831|NCT01853046|12463365|P2|NOT COMPLETED|Overall Study||6
5064832|NCT01853046|12463366|P1|NOT COMPLETED|Overall Study||18
5064833|NCT01853046|12463365|P2|COMPLETED|Overall Study||0
5064834|NCT01853046|12463366|P1|COMPLETED|Overall Study||0
5064835|NCT01853046|12463365|P2|Received Treatment|Overall Study||6
5064836|NCT01853046|12463366|P1|Received Treatment|Overall Study||18
5064837|NCT01853046|12463365|P2|STARTED|Overall Study||6
5064838|NCT01853046|12463366|P1|STARTED|Overall Study||18
5064839|NCT01852955|12463420|P2|NOT COMPLETED|Overall Study||3
5064840|NCT01852955|12463421|P1|NOT COMPLETED|Overall Study||2
5064841|NCT01852955|12463420|P2|COMPLETED|Overall Study||32
5064842|NCT01852955|12463421|P1|COMPLETED|Overall Study||33
5064843|NCT01852955|12463420|P2|STARTED|Overall Study||35
5064844|NCT01852955|12463421|P1|STARTED|Overall Study||35
5064845|NCT01852825|12463434|P3|NOT COMPLETED|Overall Study||0
5064846|NCT01852825|12463435|P2|NOT COMPLETED|Overall Study||0
5064847|NCT01852825|12463436|P1|NOT COMPLETED|Overall Study||2
5064848|NCT01852825|12463434|P3|COMPLETED|Overall Study||3
5064849|NCT01852825|12463435|P2|COMPLETED|Overall Study||7
5064850|NCT01852825|12463436|P1|COMPLETED|Overall Study||14
5064851|NCT01852825|12463434|P3|STARTED|Overall Study||3
5064852|NCT01852825|12463435|P2|STARTED|Overall Study||7
5064853|NCT01852825|12463436|P1|STARTED|Overall Study||16
5064854|NCT01852812|12463462|P3|NOT COMPLETED|Overall Study||1
5064855|NCT01852812|12463463|P2|NOT COMPLETED|Overall Study||1
5064856|NCT01852812|12463464|P1|NOT COMPLETED|Overall Study||0
5064857|NCT01852812|12463462|P3|COMPLETED|Overall Study||17
5064858|NCT01852812|12463463|P2|COMPLETED|Overall Study||17
5064859|NCT01852812|12463464|P1|COMPLETED|Overall Study||51
5064860|NCT01852812|12463462|P3|STARTED|Overall Study||18
5064861|NCT01852812|12463463|P2|STARTED|Overall Study||18
5064862|NCT01852812|12463464|P1|STARTED|Overall Study||51
5064863|NCT01852799|12463484|P1|NOT COMPLETED|Overall Study||18
5064864|NCT01852799|12463484|P1|COMPLETED|Overall Study||0
5064865|NCT01852799|12463484|P1|STARTED|Overall Study||18
5064866|NCT01852669|12463495|P2|NOT COMPLETED|Overall Study||1
5064867|NCT01852669|12463496|P1|NOT COMPLETED|Overall Study||0
5064868|NCT01852669|12463495|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
5064869|NCT01852669|12463496|P1|COMPLETED|Overall Study||71
5064870|NCT01852669|12463495|P2|STARTED|Overall Study||69
5064871|NCT01852669|12463496|P1|STARTED|Overall Study||71
5064872|NCT01852591|12463502|P1|NOT COMPLETED|Overall Study||3
5064873|NCT01852591|12463502|P1|COMPLETED|Overall Study||5
5064874|NCT01852591|12463502|P1|STARTED|Overall Study||8
5064875|NCT01852383|12463509|P1|NOT COMPLETED|Overall Study||11
5064876|NCT01852383|12463509|P1|COMPLETED|Overall Study||19
5064877|NCT01852383|12463509|P1|STARTED|Overall Study||30
5064878|NCT01852344|12463520|P4|NOT COMPLETED|Overall Study||0
5064879|NCT01852344|12463521|P3|NOT COMPLETED|Overall Study||0
5064880|NCT01852344|12463522|P2|NOT COMPLETED|Overall Study||0
5064881|NCT01852344|12463523|P1|NOT COMPLETED|Overall Study||0
5064882|NCT01852344|12463520|P4|COMPLETED|Overall Study||27
5064883|NCT01852344|12463521|P3|COMPLETED|Overall Study||27
5064884|NCT01852344|12463522|P2|COMPLETED|Overall Study||27
5064885|NCT01852344|12463523|P1|COMPLETED|Overall Study||27
5064886|NCT01852344|12463520|P4|Actual Participation in First Assignment|Overall Study||27
5064887|NCT01852344|12463521|P3|Actual Participation in First Assignment|Overall Study||27
5064888|NCT01852344|12463522|P2|Actual Participation in First Assignment|Overall Study||27
5064889|NCT01852344|12463523|P1|Actual Participation in First Assignment|Overall Study||27
5064890|NCT01852344|12463520|P4|STARTED|Overall Study||27
5064891|NCT01852344|12463521|P3|STARTED|Overall Study||27
5064892|NCT01852344|12463522|P2|STARTED|Overall Study||27
5064893|NCT01852344|12463523|P1|STARTED|Overall Study||27
5064894|NCT01852292|12463543|P2|NOT COMPLETED|Overall Study||79
5064895|NCT01852292|12463544|P1|NOT COMPLETED|Overall Study||79
5064896|NCT01852292|12463543|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
5064897|NCT01852292|12463544|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
5064898|NCT01852292|12463543|P2|STARTED|Overall Study||79
5064899|NCT01852292|12463544|P1|STARTED|Overall Study||79
5064900|NCT01852214|12463568|P2|NOT COMPLETED|Period 2||0
5064901|NCT01852214|12463569|P1|NOT COMPLETED|Period 2||0
5064902|NCT01852214|12463568|P2|COMPLETED|Period 2||20
5064903|NCT01852214|12463569|P1|COMPLETED|Period 2||25
5064904|NCT01852214|12463568|P2|STARTED|Period 2||20
5064905|NCT01852214|12463569|P1|STARTED|Period 2||25
5064906|NCT01852214|12463568|P2|NOT COMPLETED|Washout Period||1
5064907|NCT01852214|12463569|P1|NOT COMPLETED|Washout Period||0
5064908|NCT01852214|12463568|P2|COMPLETED|Washout Period||20
5064909|NCT01852214|12463569|P1|COMPLETED|Washout Period||25
5064910|NCT01852214|12463568|P2|STARTED|Washout Period||21
5064911|NCT01852214|12463569|P1|STARTED|Washout Period||25
5064912|NCT01852214|12463568|P2|NOT COMPLETED|Period 1||3
5064913|NCT01852214|12463569|P1|NOT COMPLETED|Period 1||1
5064914|NCT01852214|12463568|P2|COMPLETED|Period 1||21
5064915|NCT01852214|12463569|P1|COMPLETED|Period 1||25
5064916|NCT01852214|12463568|P2|STARTED|Period 1||24
5064917|NCT01852214|12463569|P1|STARTED|Period 1||26
5064918|NCT01852201|12463583|P2|NOT COMPLETED|Overall Study||0
5064919|NCT01852201|12463584|P1|NOT COMPLETED|Overall Study||0
5064920|NCT01852201|12463583|P2|COMPLETED|Overall Study||12
5064921|NCT01852201|12463584|P1|COMPLETED|Overall Study||21
5064922|NCT01852201|12463583|P2|STARTED|Overall Study||12
5064923|NCT01852201|12463584|P1|STARTED|Overall Study||21
5064924|NCT01852175|12463608|P2|NOT COMPLETED|Overall Study||0
5064925|NCT01852175|12463609|P1|NOT COMPLETED|Overall Study||0
5064926|NCT01852175|12463608|P2|COMPLETED|Overall Study||55
5064927|NCT01852175|12463609|P1|COMPLETED|Overall Study||55
5064928|NCT01852175|12463608|P2|STARTED|Overall Study||55
5064929|NCT01852175|12463609|P1|STARTED|Overall Study||55
5064930|NCT01852162|12463621|P2|NOT COMPLETED|Overall Study||1
5064931|NCT01852162|12463622|P1|NOT COMPLETED|Overall Study||4
5064932|NCT01852162|12463621|P2|COMPLETED|Overall Study||16
5064933|NCT01852162|12463622|P1|COMPLETED|Overall Study||14
5064934|NCT01852162|12463621|P2|STARTED|Overall Study||17
5064935|NCT01852162|12463622|P1|STARTED|Overall Study||18
5064936|NCT01852110|12463638|P6|NOT COMPLETED|Overall Study||0
5064937|NCT01852110|12463639|P5|NOT COMPLETED|Overall Study||0
5064938|NCT01852110|12463640|P4|NOT COMPLETED|Overall Study||0
5064939|NCT01852110|12463641|P3|NOT COMPLETED|Overall Study||0
5064940|NCT01852110|12463642|P2|NOT COMPLETED|Overall Study||46
5064941|NCT01852110|12463643|P1|NOT COMPLETED|Overall Study||50
5064942|NCT01852110|12463638|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064943|NCT01852110|12463639|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064944|NCT01852110|12463640|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064945|NCT01852110|12463641|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064946|NCT01852110|12463642|P2|COMPLETED|Overall Study||74
5064947|NCT01852110|12463643|P1|COMPLETED|Overall Study||70
5064948|NCT01852110|12463638|P6|Treated|Overall Study||0
5064949|NCT01852110|12463639|P5|Treated|Overall Study||0
5064950|NCT01852110|12463640|P4|Treated|Overall Study||0
5064951|NCT01852110|12463641|P3|Treated|Overall Study||0
5064952|NCT01852110|12463642|P2|Treated|Overall Study||120
5064953|NCT01852110|12463643|P1|Treated|Overall Study||119
5064954|NCT01852110|12463638|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064955|NCT01852110|12463639|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064956|NCT01852110|12463640|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064957|NCT01852110|12463641|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
5064958|NCT01852110|12463642|P2|STARTED|Overall Study||120
5064959|NCT01852110|12463643|P1|STARTED|Overall Study||120
5064960|NCT01852058|12463674|P12|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064961|NCT01852058|12463675|P11|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064962|NCT01852058|12463676|P10|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064963|NCT01852058|12463677|P9|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064964|NCT01852058|12463678|P8|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064965|NCT01852058|12463679|P7|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064966|NCT01852058|12463680|P6|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064967|NCT01852058|12463681|P5|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064968|NCT01852058|12463682|P4|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064969|NCT01852058|12463683|P3|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064970|NCT01852058|12463684|P2|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064971|NCT01852058|12463685|P1|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064972|NCT01852058|12463674|P12|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
5064973|NCT01852058|12463675|P11|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
5064974|NCT01852058|12463676|P10|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
5064975|NCT01852058|12463677|P9|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064976|NCT01852058|12463678|P8|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064977|NCT01852058|12463679|P7|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064978|NCT01852058|12463680|P6|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064979|NCT01852058|12463681|P5|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064980|NCT01852058|12463682|P4|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064981|NCT01852058|12463683|P3|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064982|NCT01852058|12463684|P2|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064983|NCT01852058|12463685|P1|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
5064984|NCT01852058|12463674|P12|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
5064985|NCT01852058|12463675|P11|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
5064986|NCT01852058|12463676|P10|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
5064987|NCT01852058|12463677|P9|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064988|NCT01852058|12463678|P8|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064989|NCT01852058|12463679|P7|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064990|NCT01852058|12463680|P6|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064991|NCT01852058|12463681|P5|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064992|NCT01852058|12463682|P4|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064993|NCT01852058|12463683|P3|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064994|NCT01852058|12463684|P2|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064995|NCT01852058|12463685|P1|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
5064996|NCT01852058|12463674|P12|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5064997|NCT01852058|12463675|P11|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5064998|NCT01852058|12463676|P10|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5064999|NCT01852058|12463677|P9|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
5065000|NCT01852058|12463678|P8|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
5065001|NCT01852058|12463679|P7|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065002|NCT01852058|12463680|P6|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065003|NCT01852058|12463681|P5|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065004|NCT01852058|12463682|P4|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065005|NCT01852058|12463683|P3|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065006|NCT01852058|12463684|P2|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065007|NCT01852058|12463685|P1|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065008|NCT01852058|12463674|P12|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065009|NCT01852058|12463675|P11|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065010|NCT01852058|12463676|P10|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065011|NCT01852058|12463677|P9|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
5065012|NCT01852058|12463678|P8|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
5065013|NCT01852058|12463679|P7|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
5065014|NCT01852058|12463680|P6|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065015|NCT01852058|12463681|P5|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065016|NCT01852058|12463682|P4|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065017|NCT01852058|12463683|P3|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065018|NCT01852058|12463684|P2|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065019|NCT01852058|12463685|P1|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
5065020|NCT01852058|12463674|P12|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065021|NCT01852058|12463675|P11|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065022|NCT01852058|12463676|P10|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065023|NCT01852058|12463677|P9|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
5065024|NCT01852058|12463678|P8|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
5065025|NCT01852058|12463679|P7|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
5065026|NCT01852058|12463680|P6|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065027|NCT01852058|12463681|P5|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065028|NCT01852058|12463682|P4|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065029|NCT01852058|12463683|P3|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065030|NCT01852058|12463684|P2|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065031|NCT01852058|12463685|P1|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
5065032|NCT01852058|12463674|P12|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065033|NCT01852058|12463675|P11|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065034|NCT01852058|12463676|P10|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065035|NCT01852058|12463677|P9|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065036|NCT01852058|12463678|P8|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065037|NCT01852058|12463679|P7|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065038|NCT01852058|12463680|P6|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
5065039|NCT01852058|12463681|P5|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
5065040|NCT01852058|12463682|P4|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
5065041|NCT01852058|12463683|P3|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065042|NCT01852058|12463684|P2|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065043|NCT01852058|12463685|P1|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065044|NCT01852058|12463674|P12|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065045|NCT01852058|12463675|P11|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065046|NCT01852058|12463676|P10|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065047|NCT01852058|12463677|P9|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065048|NCT01852058|12463678|P8|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065049|NCT01852058|12463679|P7|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065050|NCT01852058|12463680|P6|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
5065051|NCT01852058|12463681|P5|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
5065052|NCT01852058|12463682|P4|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
5065053|NCT01852058|12463683|P3|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065054|NCT01852058|12463684|P2|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065055|NCT01852058|12463685|P1|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
5065056|NCT01852058|12463674|P12|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065057|NCT01852058|12463675|P11|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065058|NCT01852058|12463676|P10|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065059|NCT01852058|12463677|P9|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065060|NCT01852058|12463678|P8|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065061|NCT01852058|12463679|P7|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065062|NCT01852058|12463680|P6|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
5065063|NCT01852058|12463681|P5|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
5065064|NCT01852058|12463682|P4|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
5065065|NCT01852058|12463683|P3|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065066|NCT01852058|12463684|P2|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065067|NCT01852058|12463685|P1|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
5065068|NCT01852058|12463674|P12|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065069|NCT01852058|12463675|P11|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065070|NCT01852058|12463676|P10|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065071|NCT01852058|12463677|P9|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065072|NCT01852058|12463678|P8|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065073|NCT01852058|12463679|P7|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065074|NCT01852058|12463680|P6|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065075|NCT01852058|12463681|P5|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065076|NCT01852058|12463682|P4|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065077|NCT01852058|12463683|P3|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065078|NCT01852058|12463684|P2|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065079|NCT01852058|12463685|P1|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
5065080|NCT01852058|12463674|P12|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065081|NCT01852058|12463675|P11|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065082|NCT01852058|12463676|P10|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065083|NCT01852058|12463677|P9|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065084|NCT01852058|12463678|P8|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065085|NCT01852058|12463679|P7|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065086|NCT01852058|12463680|P6|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065087|NCT01852058|12463681|P5|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065088|NCT01852058|12463682|P4|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
5065089|NCT01852058|12463683|P3|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
5065090|NCT01852058|12463684|P2|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
5065091|NCT01852058|12463685|P1|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
5065092|NCT01852058|12463674|P12|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065093|NCT01852058|12463675|P11|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065094|NCT01852058|12463676|P10|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065095|NCT01852058|12463677|P9|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065096|NCT01852058|12463678|P8|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065097|NCT01852058|12463679|P7|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065098|NCT01852058|12463680|P6|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065099|NCT01852058|12463681|P5|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065100|NCT01852058|12463682|P4|STARTED|Treatment Cycle 1, Occurred in Study 120||0
5065101|NCT01852058|12463683|P3|STARTED|Treatment Cycle 1, Occurred in Study 120||25
5065102|NCT01852058|12463684|P2|STARTED|Treatment Cycle 1, Occurred in Study 120||39
5065103|NCT01852058|12463685|P1|STARTED|Treatment Cycle 1, Occurred in Study 120||31
5065104|NCT01852045|12463765|P3|NOT COMPLETED|Overall Study||4
5065105|NCT01852045|12463766|P2|NOT COMPLETED|Overall Study||4
5065106|NCT01852045|12463767|P1|NOT COMPLETED|Overall Study||6
5065107|NCT01852045|12463765|P3|COMPLETED|Overall Study||26
5065108|NCT01852045|12463766|P2|COMPLETED|Overall Study||41
5065109|NCT01852045|12463767|P1|COMPLETED|Overall Study||33
5065110|NCT01852045|12463765|P3|Safety Population|Overall Study||30
5065111|NCT01852045|12463766|P2|Safety Population|Overall Study||45
5065112|NCT01852045|12463767|P1|Safety Population|Overall Study||38
5065113|NCT01852045|12463765|P3|mITT Population|Overall Study||30
5065114|NCT01852045|12463766|P2|mITT Population|Overall Study||45
5065115|NCT01852045|12463767|P1|mITT Population|Overall Study||38
5065116|NCT01852045|12463765|P3|STARTED|Overall Study||30
5065117|NCT01852045|12463766|P2|STARTED|Overall Study||45
5065118|NCT01852045|12463767|P1|STARTED|Overall Study||39
5065119|NCT01852032|12463805|P1|NOT COMPLETED|Overall Study||0
5065120|NCT01852032|12463805|P1|COMPLETED|Overall Study||23
5065121|NCT01852032|12463805|P1|STARTED|Overall Study||23
5065122|NCT01852019|12463815|P5|NOT COMPLETED|Day 8||0
5065123|NCT01852019|12463816|P4|NOT COMPLETED|Day 8||0
5065124|NCT01852019|12463817|P3|NOT COMPLETED|Day 8||0
5065125|NCT01852019|12463818|P2|NOT COMPLETED|Day 8||0
5065126|NCT01852019|12463819|P1|NOT COMPLETED|Day 8||0
5065127|NCT01852019|12463815|P5|COMPLETED|Day 8||6
5065128|NCT01852019|12463816|P4|COMPLETED|Day 8||6
5065129|NCT01852019|12463817|P3|COMPLETED|Day 8||0
5065130|NCT01852019|12463818|P2|COMPLETED|Day 8||0
5065131|NCT01852019|12463819|P1|COMPLETED|Day 8||0
5065132|NCT01852019|12463815|P5|STARTED|Day 8||6
5065133|NCT01852019|12463816|P4|STARTED|Day 8||6
5065134|NCT01852019|12463817|P3|STARTED|Day 8||0
5065135|NCT01852019|12463818|P2|STARTED|Day 8||0
5065136|NCT01852019|12463819|P1|STARTED|Day 8||0
5065137|NCT01852019|12463815|P5|NOT COMPLETED|Day 1||0
5065138|NCT01852019|12463816|P4|NOT COMPLETED|Day 1||0
5065139|NCT01852019|12463817|P3|NOT COMPLETED|Day 1||0
5065140|NCT01852019|12463818|P2|NOT COMPLETED|Day 1||0
5065141|NCT01852019|12463819|P1|NOT COMPLETED|Day 1||0
5065142|NCT01852019|12463815|P5|COMPLETED|Day 1||0
5065143|NCT01852019|12463816|P4|COMPLETED|Day 1||0
5065144|NCT01852019|12463817|P3|COMPLETED|Day 1||6
5065145|NCT01852019|12463818|P2|COMPLETED|Day 1||3
5065146|NCT01852019|12463819|P1|COMPLETED|Day 1||3
5065147|NCT01852019|12463815|P5|STARTED|Day 1||0
5065148|NCT01852019|12463816|P4|STARTED|Day 1||0
5065149|NCT01852019|12463817|P3|STARTED|Day 1||6
5065150|NCT01852019|12463818|P2|STARTED|Day 1||3
5065151|NCT01852019|12463819|P1|STARTED|Day 1||3
5065152|NCT01851876|12463840|P2|NOT COMPLETED|Overall Study||0
5065153|NCT01851876|12463841|P1|NOT COMPLETED|Overall Study||0
5065154|NCT01851876|12463840|P2|COMPLETED|Overall Study||62
5065155|NCT01851876|12463841|P1|COMPLETED|Overall Study||56
5065156|NCT01851876|12463840|P2|STARTED|Overall Study||62
5065157|NCT01851876|12463841|P1|STARTED|Overall Study||56
5065158|NCT01851863|12463851|P4|NOT COMPLETED|Overall Study||3
5065159|NCT01851863|12463852|P3|NOT COMPLETED|Overall Study||5
5065160|NCT01851863|12463853|P2|NOT COMPLETED|Overall Study||9
5065161|NCT01851863|12463854|P1|NOT COMPLETED|Overall Study||5
5065162|NCT01851863|12463851|P4|COMPLETED|Overall Study||63
5065163|NCT01851863|12463852|P3|COMPLETED|Overall Study||60
5065164|NCT01851863|12463853|P2|COMPLETED|Overall Study||57
5065165|NCT01851863|12463854|P1|COMPLETED|Overall Study||60
5065166|NCT01851863|12463851|P4|STARTED|Overall Study||66
5065167|NCT01851863|12463852|P3|STARTED|Overall Study||65
5065168|NCT01851863|12463853|P2|STARTED|Overall Study||66
5065169|NCT01851863|12463854|P1|STARTED|Overall Study||65
5065170|NCT01851772|12463875|P1|NOT COMPLETED|Overall Study||0
5065171|NCT01851772|12463875|P1|COMPLETED|Overall Study||3
5065172|NCT01851772|12463875|P1|STARTED|Overall Study||3
5065173|NCT01851720|12463883|P2|NOT COMPLETED|Overall Study||1
5065174|NCT01851720|12463884|P1|NOT COMPLETED|Overall Study||0
5065175|NCT01851720|12463883|P2|COMPLETED|Overall Study||0
5065176|NCT01851720|12463884|P1|COMPLETED|Overall Study||0
5065177|NCT01851720|12463883|P2|STARTED|Overall Study||1
5065178|NCT01851720|12463884|P1|STARTED|Overall Study||0
5065179|NCT01851655|12463892|P2|NOT COMPLETED|Overall Study||0
5065180|NCT01851655|12463893|P1|NOT COMPLETED|Overall Study||0
5065181|NCT01851655|12463892|P2|COMPLETED|Overall Study||12
5065182|NCT01851655|12463893|P1|COMPLETED|Overall Study||12
5065183|NCT01851655|12463892|P2|STARTED|Overall Study||12
5065184|NCT01851655|12463893|P1|STARTED|Overall Study||12
5065185|NCT01851590|12463914|P3|NOT COMPLETED|Overall Study||3
5065186|NCT01851590|12463915|P2|NOT COMPLETED|Overall Study||1
5065187|NCT01851590|12463916|P1|NOT COMPLETED|Overall Study||0
5065188|NCT01851590|12463914|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
5065189|NCT01851590|12463915|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
5065190|NCT01851590|12463916|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
5065191|NCT01851590|12463914|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
5065192|NCT01851590|12463915|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
5065193|NCT01851590|12463916|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
5065194|NCT01851590|12463914|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
5065195|NCT01851590|12463915|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
5065196|NCT01851590|12463916|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
5065197|NCT01851590|12463914|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
5065198|NCT01851590|12463915|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
5065199|NCT01851590|12463916|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
5065200|NCT01851590|12463914|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
5065201|NCT01851590|12463915|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
5065202|NCT01851590|12463916|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
5065203|NCT01851590|12463914|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
5065204|NCT01851590|12463915|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
5065205|NCT01851590|12463916|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
5065206|NCT01851330|12463939|P3|NOT COMPLETED|Overall Study||12
5065207|NCT01851330|12463940|P2|NOT COMPLETED|Overall Study||16
5065208|NCT01851330|12463941|P1|NOT COMPLETED|Overall Study||13
5065209|NCT01851330|12463939|P3|COMPLETED|Overall Study||204
5065210|NCT01851330|12463940|P2|COMPLETED|Overall Study||200
5065211|NCT01851330|12463941|P1|COMPLETED|Overall Study||202
5065212|NCT01851330|12463939|P3|STARTED|Overall Study||216
5065213|NCT01851330|12463940|P2|STARTED|Overall Study||216
5065214|NCT01851330|12463941|P1|STARTED|Overall Study||215
5065215|NCT01851174|12463976|P1|NOT COMPLETED|Overall Study||0
5065216|NCT01851174|12463976|P1|COMPLETED|Overall Study||15
5065217|NCT01851174|12463976|P1|STARTED|Overall Study||15
5065218|NCT01850745|12463984|P3|NOT COMPLETED|Overall Study||0
5065219|NCT01850745|12463985|P2|NOT COMPLETED|Overall Study||0
5065220|NCT01850745|12463986|P1|NOT COMPLETED|Overall Study||0
5065221|NCT01850745|12463984|P3|COMPLETED|Overall Study||131
5065222|NCT01850745|12463985|P2|COMPLETED|Overall Study||169
5065223|NCT01850745|12463986|P1|COMPLETED|Overall Study||147
5065224|NCT01850745|12463984|P3|STARTED|Overall Study||131
5065225|NCT01850745|12463985|P2|STARTED|Overall Study||169
5065226|NCT01850745|12463986|P1|STARTED|Overall Study||147
5065227|NCT01850641|12463994|P1|NOT COMPLETED|Overall Study||5
5065228|NCT01850641|12463994|P1|COMPLETED|Overall Study||30
5065229|NCT01850641|12463994|P1|STARTED|Overall Study||35
5065230|NCT01850615|12464008|P2|NOT COMPLETED|Overall Study||5
5065231|NCT01850615|12464009|P1|NOT COMPLETED|Overall Study||9
5065232|NCT01850615|12464008|P2|COMPLETED|Overall Study||115
5065233|NCT01850615|12464009|P1|COMPLETED|Overall Study||107
5065234|NCT01850615|12464008|P2|Exposed|Overall Study||120
5065235|NCT01850615|12464009|P1|Exposed|Overall Study||115
5065236|NCT01850615|12464008|P2|STARTED|Overall Study||120
5065237|NCT01850615|12464009|P1|STARTED|Overall Study||116
5065238|NCT01850602|12464027|P2|NOT COMPLETED|Overall Study||18
5065239|NCT01850602|12464028|P1|NOT COMPLETED|Overall Study||14
5065240|NCT01850602|12464027|P2|COMPLETED|Overall Study||87
5065241|NCT01850602|12464028|P1|COMPLETED|Overall Study||94
5065242|NCT01850602|12464027|P2|STARTED|Overall Study||105
5065243|NCT01850602|12464028|P1|STARTED|Overall Study||108
5065244|NCT01850589|12464042|P2|NOT COMPLETED|Overall Study||0
5065245|NCT01850589|12464043|P1|NOT COMPLETED|Overall Study||8
5065246|NCT01850589|12464042|P2|COMPLETED|Overall Study||22
5065247|NCT01850589|12464043|P1|COMPLETED|Overall Study||14
5065248|NCT01850589|12464042|P2|STARTED|Overall Study||22
5065249|NCT01850589|12464043|P1|STARTED|Overall Study||22
5065250|NCT01850550|12464051|P2|NOT COMPLETED|Overall Study||3
5065251|NCT01850550|12464052|P1|NOT COMPLETED|Overall Study||0
5065252|NCT01850550|12464051|P2|COMPLETED|Overall Study||37
5065253|NCT01850550|12464052|P1|COMPLETED|Overall Study||40
5065254|NCT01850550|12464051|P2|STARTED|Overall Study||40
5065255|NCT01850550|12464052|P1|STARTED|Overall Study||40
5065256|NCT01850485|12464062|P2|NOT COMPLETED|Overall Study||0
5065257|NCT01850485|12464063|P1|NOT COMPLETED|Overall Study||0
5065258|NCT01850485|12464062|P2|COMPLETED|Overall Study||13
5065259|NCT01850485|12464063|P1|COMPLETED|Overall Study||9
5065260|NCT01850485|12464062|P2|STARTED|Overall Study||13
5065261|NCT01850485|12464063|P1|STARTED|Overall Study||9
5065262|NCT01850446|12464083|P2|NOT COMPLETED|Overall Study||2
5065263|NCT01850446|12464084|P1|NOT COMPLETED|Overall Study||5
5065264|NCT01850446|12464083|P2|COMPLETED|Overall Study||90
5065265|NCT01850446|12464084|P1|COMPLETED|Overall Study||87
5065266|NCT01850446|12464083|P2|STARTED|Overall Study||92
5065267|NCT01850446|12464084|P1|STARTED|Overall Study||92
5065268|NCT01850394|12464119|P3|NOT COMPLETED|Overall Study||0
5065269|NCT01850394|12464120|P2|NOT COMPLETED|Overall Study||0
5065270|NCT01850394|12464121|P1|NOT COMPLETED|Overall Study||0
5065271|NCT01850394|12464119|P3|COMPLETED|Overall Study||45
5065272|NCT01850394|12464120|P2|COMPLETED|Overall Study||45
5065273|NCT01850394|12464121|P1|COMPLETED|Overall Study||45
5065274|NCT01850394|12464119|P3|STARTED|Overall Study||45
5065275|NCT01850394|12464120|P2|STARTED|Overall Study||45
5065276|NCT01850394|12464121|P1|STARTED|Overall Study||45
5065277|NCT01850030|12464143|P2|NOT COMPLETED|Overall Study||369
5065278|NCT01850030|12464144|P1|NOT COMPLETED|Overall Study||347
5065279|NCT01850030|12464143|P2|COMPLETED|Overall Study||142
5065280|NCT01850030|12464144|P1|COMPLETED|Overall Study||173
5065281|NCT01850030|12464143|P2|STARTED|Overall Study||511
5065282|NCT01850030|12464144|P1|STARTED|Overall Study||520
5065283|NCT01850004|12464156|P1|NOT COMPLETED|Overall Study||8
5065284|NCT01850004|12464156|P1|COMPLETED|Overall Study||76
5065285|NCT01850004|12464156|P1|STARTED|Overall Study||84
5065286|NCT01849848|12464163|P1|NOT COMPLETED|Overall Study||4
5065287|NCT01849848|12464163|P1|COMPLETED|Overall Study||13
5065288|NCT01849848|12464163|P1|STARTED|Overall Study||17
5065289|NCT01849770|12464180|P3|NOT COMPLETED|Overall Study||1
5065290|NCT01849770|12464181|P2|NOT COMPLETED|Overall Study||4
5065291|NCT01849770|12464182|P1|NOT COMPLETED|Overall Study||0
5065292|NCT01849770|12464180|P3|COMPLETED|Overall Study||19
5065293|NCT01849770|12464181|P2|COMPLETED|Overall Study||15
5065294|NCT01849770|12464182|P1|COMPLETED|Overall Study||20
5065295|NCT01849770|12464180|P3|STARTED|Overall Study||20
5065296|NCT01849770|12464181|P2|STARTED|Overall Study||19
5065297|NCT01849770|12464182|P1|STARTED|Overall Study||20
5065298|NCT01849692|12464225|P8|NOT COMPLETED|Overall Study||0
5065299|NCT01849692|12464226|P7|NOT COMPLETED|Overall Study||0
5065300|NCT01849692|12464227|P6|NOT COMPLETED|Overall Study||0
5065301|NCT01849692|12464228|P5|NOT COMPLETED|Overall Study||0
5065302|NCT01849692|12464229|P4|NOT COMPLETED|Overall Study||0
5065303|NCT01849692|12464230|P3|NOT COMPLETED|Overall Study||0
5065304|NCT01849692|12464231|P2|NOT COMPLETED|Overall Study||0
5065305|NCT01849692|12464232|P1|NOT COMPLETED|Overall Study||0
5065306|NCT01849692|12464225|P8|COMPLETED|Overall Study||3
5065307|NCT01849692|12464226|P7|COMPLETED|Overall Study||10
5065308|NCT01849692|12464227|P6|COMPLETED|Overall Study||3
5065309|NCT01849692|12464228|P5|COMPLETED|Overall Study||10
5065310|NCT01849692|12464229|P4|COMPLETED|Overall Study||3
5065311|NCT01849692|12464230|P3|COMPLETED|Overall Study||10
5065312|NCT01849692|12464231|P2|COMPLETED|Overall Study||3
5065313|NCT01849692|12464232|P1|COMPLETED|Overall Study||10
5065314|NCT01849692|12464225|P8|STARTED|Overall Study||3
5065315|NCT01849692|12464226|P7|STARTED|Overall Study||10
5065316|NCT01849692|12464227|P6|STARTED|Overall Study||3
5065317|NCT01849692|12464228|P5|STARTED|Overall Study||10
5065318|NCT01849692|12464229|P4|STARTED|Overall Study||3
5065319|NCT01849692|12464230|P3|STARTED|Overall Study||10
5065320|NCT01849692|12464231|P2|STARTED|Overall Study||3
5065321|NCT01849692|12464232|P1|STARTED|Overall Study||10
5065322|NCT01849588|12464261|P1|NOT COMPLETED|Overall Study||3
5065323|NCT01849588|12464261|P1|COMPLETED|Overall Study||0
5065324|NCT01849588|12464261|P1|STARTED|Overall Study||3
5065325|NCT01849575|12464270|P2|NOT COMPLETED|Overall Study||207
5065326|NCT01849575|12464271|P1|NOT COMPLETED|Overall Study||150
5065327|NCT01849575|12464270|P2|COMPLETED|Overall Study||1576
5065328|NCT01849575|12464271|P1|COMPLETED|Overall Study||1599
5065329|NCT01849575|12464270|P2|STARTED|Overall Study||1783
5065330|NCT01849575|12464271|P1|STARTED|Overall Study||1749
5065331|NCT01849562|12464280|P3|NOT COMPLETED|Overall Study||0
5065332|NCT01849562|12464281|P2|NOT COMPLETED|Overall Study||0
5065333|NCT01849562|12464282|P1|NOT COMPLETED|Overall Study||2
5065334|NCT01849562|12464280|P3|COMPLETED|Overall Study||10
5065335|NCT01849562|12464281|P2|COMPLETED|Overall Study||10
5065336|NCT01849562|12464282|P1|COMPLETED|Overall Study||8
5065337|NCT01849562|12464280|P3|STARTED|Overall Study||10
5065338|NCT01849562|12464281|P2|STARTED|Overall Study||10
5065339|NCT01849562|12464282|P1|STARTED|Overall Study||10
5065340|NCT01849497|12464295|P2|NOT COMPLETED|Overall Study||4
5065341|NCT01849497|12464296|P1|NOT COMPLETED|Overall Study||1
5065342|NCT01849497|12464295|P2|COMPLETED|Overall Study||70
5065343|NCT01849497|12464296|P1|COMPLETED|Overall Study||74
5065344|NCT01849497|12464295|P2|Received Treatment|Overall Study||74
5065345|NCT01849497|12464296|P1|Received Treatment|Overall Study||75
5065346|NCT01849497|12464295|P2|STARTED|Overall Study||74
5065347|NCT01849497|12464296|P1|STARTED|Overall Study||75
5065348|NCT01849458|12464304|P1|NOT COMPLETED|Overall Study||4
5065349|NCT01849458|12464304|P1|COMPLETED|Overall Study||46
5065350|NCT01849458|12464304|P1|6 Months Follow-up|Overall Study||50
5065351|NCT01849458|12464304|P1|STARTED|Overall Study||50
5065352|NCT01849419|12464314|P1|NOT COMPLETED|Overall Study||0
5065353|NCT01849419|12464314|P1|COMPLETED|Overall Study||65
5065354|NCT01849419|12464314|P1|STARTED|Overall Study||65
5065355|NCT01849289|12464343|P2|NOT COMPLETED|Overall Study||24
5065356|NCT01849289|12464344|P1|NOT COMPLETED|Overall Study||32
5065357|NCT01849289|12464343|P2|COMPLETED|Overall Study||254
5065358|NCT01849289|12464344|P1|COMPLETED|Overall Study||523
5065359|NCT01849289|12464343|P2|Exposed|Overall Study||278
5065360|NCT01849289|12464344|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
5065361|NCT01849289|12464343|P2|STARTED|Overall Study||278
5065362|NCT01849289|12464344|P1|STARTED|Overall Study||555
5065363|NCT01849276|12464360|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
5065364|NCT01849276|12464360|P1|COMPLETED|Followed for Survival for 5 Years||0
5065365|NCT01849276|12464360|P1|STARTED|Followed for Survival for 5 Years||2
5065366|NCT01849276|12464360|P1|NOT COMPLETED|Completed Treatment||0
5065367|NCT01849276|12464360|P1|COMPLETED|Completed Treatment||2
5065368|NCT01849276|12464360|P1|STARTED|Completed Treatment||2
5065369|NCT01849276|12464360|P1|NOT COMPLETED|Registered to the Study||0
5065370|NCT01849276|12464360|P1|COMPLETED|Registered to the Study||2
5065371|NCT01849276|12464360|P1|STARTED|Registered to the Study||2
5065372|NCT01849263|12464372|P1|NOT COMPLETED|Overall Study||0
5065373|NCT01849263|12464372|P1|COMPLETED|Overall Study||40
5065374|NCT01849263|12464372|P1|STARTED|Overall Study||40
5065375|NCT01849172|12464384|P2|NOT COMPLETED|Overall Study||6
5065376|NCT01849172|12464385|P1|NOT COMPLETED|Overall Study||7
5065377|NCT01849172|12464384|P2|COMPLETED|Overall Study||174
5065378|NCT01849172|12464385|P1|COMPLETED|Overall Study||173
5065379|NCT01849172|12464384|P2|STARTED|Overall Study||180
5065380|NCT01849172|12464385|P1|STARTED|Overall Study||180
5065381|NCT01849068|12464423|P2|NOT COMPLETED|Overall Study||0
5065382|NCT01849068|12464424|P1|NOT COMPLETED|Overall Study||0
5065383|NCT01849068|12464423|P2|COMPLETED|Overall Study||10
5065384|NCT01849068|12464424|P1|COMPLETED|Overall Study||10
5065385|NCT01849068|12464423|P2|STARTED|Overall Study||10
5065386|NCT01849068|12464424|P1|STARTED|Overall Study||10
5065387|NCT01849055|12464442|P6|NOT COMPLETED|Overall Study||0
5065388|NCT01849055|12464443|P5|NOT COMPLETED|Overall Study||0
5065389|NCT01849055|12464444|P4|NOT COMPLETED|Overall Study||0
5065390|NCT01849055|12464445|P3|NOT COMPLETED|Overall Study||1
5065391|NCT01849055|12464446|P2|NOT COMPLETED|Overall Study||0
5065392|NCT01849055|12464447|P1|NOT COMPLETED|Overall Study||0
5065393|NCT01849055|12464442|P6|COMPLETED|Overall Study||8
5065394|NCT01849055|12464443|P5|COMPLETED|Overall Study||8
5065395|NCT01849055|12464444|P4|COMPLETED|Overall Study||8
5065396|NCT01849055|12464445|P3|COMPLETED|Overall Study||7
5065397|NCT01849055|12464446|P2|COMPLETED|Overall Study||8
5065398|NCT01849055|12464447|P1|COMPLETED|Overall Study||8
5065399|NCT01849055|12464442|P6|STARTED|Overall Study||8
5065400|NCT01849055|12464443|P5|STARTED|Overall Study||8
5065401|NCT01849055|12464444|P4|STARTED|Overall Study||8
5065402|NCT01849055|12464445|P3|STARTED|Overall Study||8
5065403|NCT01849055|12464446|P2|STARTED|Overall Study||8
5065404|NCT01849055|12464447|P1|STARTED|Overall Study||8
5065405|NCT01848990|12464482|P3|NOT COMPLETED|Overall Study||16
5065406|NCT01848990|12464483|P2|NOT COMPLETED|Overall Study||20
5065407|NCT01848990|12464484|P1|NOT COMPLETED|Overall Study||46
5065408|NCT01848990|12464482|P3|COMPLETED|Overall Study||98
5065409|NCT01848990|12464483|P2|COMPLETED|Overall Study||95
5065410|NCT01848990|12464484|P1|COMPLETED|Overall Study||181
5065411|NCT01848990|12464482|P3|Completed Month 6|Overall Study||103
5065412|NCT01848990|12464483|P2|Completed Month 6|Overall Study||106
5065413|NCT01848990|12464484|P1|Completed Month 6|Overall Study||194
5065414|NCT01848990|12464482|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
5065415|NCT01848990|12464483|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
5065416|NCT01848990|12464484|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
5065417|NCT01848990|12464482|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
5065418|NCT01848990|12464483|P2|STARTED|Overall Study||115
5065419|NCT01848990|12464484|P1|STARTED|Overall Study||227
5065420|NCT01848977|12464543|P1|NOT COMPLETED|Overall Study||0
5065421|NCT01848977|12464543|P1|COMPLETED|Overall Study||20
5065422|NCT01848977|12464543|P1|STARTED|Overall Study||20
5065423|NCT01848938|12464554|P2|NOT COMPLETED|Overall Study||1
5065424|NCT01848938|12464555|P1|NOT COMPLETED|Overall Study||1
5065425|NCT01848938|12464554|P2|COMPLETED|Overall Study||60
5065426|NCT01848938|12464555|P1|COMPLETED|Overall Study||61
5065427|NCT01848938|12464554|P2|STARTED|Overall Study||61
5065428|NCT01848938|12464555|P1|STARTED|Overall Study||62
5065429|NCT01848899|12464573|P2|NOT COMPLETED|Overall Study||0
5065430|NCT01848899|12464574|P1|NOT COMPLETED|Overall Study||0
5065431|NCT01848899|12464573|P2|COMPLETED|Overall Study||50
5065432|NCT01848899|12464574|P1|COMPLETED|Overall Study||50
5065433|NCT01848899|12464573|P2|STARTED|Overall Study||50
5065434|NCT01848899|12464574|P1|STARTED|Overall Study||50
5065435|NCT01848847|12464590|P2|NOT COMPLETED|Overall Study||3
5065436|NCT01848847|12464591|P1|NOT COMPLETED|Overall Study||2
5065437|NCT01848847|12464590|P2|COMPLETED|Overall Study||48
5065438|NCT01848847|12464591|P1|COMPLETED|Overall Study||49
5065439|NCT01848847|12464590|P2|STARTED|Overall Study||51
5065440|NCT01848847|12464591|P1|STARTED|Overall Study||51
5065441|NCT01848834|12464604|P5|NOT COMPLETED|Overall Study||132
5065442|NCT01848834|12464605|P4|NOT COMPLETED|Overall Study||37
5065443|NCT01848834|12464606|P3|NOT COMPLETED|Overall Study||32
5065444|NCT01848834|12464607|P2|NOT COMPLETED|Overall Study||60
5065445|NCT01848834|12464608|P1|NOT COMPLETED|Overall Study||30
5065446|NCT01848834|12464604|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
5065447|NCT01848834|12464605|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
5065448|NCT01848834|12464606|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
5065449|NCT01848834|12464607|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
5065450|NCT01848834|12464608|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
5065451|NCT01848834|12464604|P5|Treated|Overall Study||132
5065452|NCT01848834|12464605|P4|Treated|Overall Study||39
5065453|NCT01848834|12464606|P3|Treated|Overall Study||33
5065454|NCT01848834|12464607|P2|Treated|Overall Study||60
5065455|NCT01848834|12464608|P1|Treated|Overall Study||32
5065456|NCT01848834|12464604|P5|STARTED|Overall Study||132
5065457|NCT01848834|12464605|P4|STARTED|Overall Study||39
5065458|NCT01848834|12464606|P3|STARTED|Overall Study||33
5065459|NCT01848834|12464607|P2|STARTED|Overall Study||61
5065460|NCT01848834|12464608|P1|STARTED|Overall Study||32
5065461|NCT01848821|12464645|P2|NOT COMPLETED|Overall Study||0
5065462|NCT01848821|12464646|P1|NOT COMPLETED|Overall Study||0
5065463|NCT01848821|12464645|P2|COMPLETED|Overall Study||7
5065464|NCT01848821|12464646|P1|COMPLETED|Overall Study||7
5065465|NCT01848821|12464645|P2|STARTED|Overall Study||7
5065466|NCT01848821|12464646|P1|STARTED|Overall Study||7
5065467|NCT01848756|12464656|P1|NOT COMPLETED|Overall Study||3
5065468|NCT01848756|12464656|P1|COMPLETED|Overall Study|Cycle 1|12
5065469|NCT01848756|12464656|P1|STARTED|Overall Study||15
5065470|NCT01848483|12464668|P2|NOT COMPLETED|Overall Study||11
5065471|NCT01848483|12464669|P1|NOT COMPLETED|Overall Study||11
5065472|NCT01848483|12464668|P2|COMPLETED|Overall Study||49
5065473|NCT01848483|12464669|P1|COMPLETED|Overall Study||50
5065474|NCT01848483|12464668|P2|STARTED|Overall Study||60
5065475|NCT01848483|12464669|P1|STARTED|Overall Study||61
5065476|NCT01848457|12464687|P4|NOT COMPLETED|Overall Study||0
5065477|NCT01848457|12464688|P3|NOT COMPLETED|Overall Study||0
5065478|NCT01848457|12464689|P2|NOT COMPLETED|Overall Study||0
5065479|NCT01848457|12464690|P1|NOT COMPLETED|Overall Study||1
5065480|NCT01848457|12464687|P4|COMPLETED|Overall Study||3
5065481|NCT01848457|12464688|P3|COMPLETED|Overall Study||3
5065482|NCT01848457|12464689|P2|COMPLETED|Overall Study||3
5065483|NCT01848457|12464690|P1|COMPLETED|Overall Study||3
5065484|NCT01848457|12464687|P4|Cycle 4|Overall Study||3
5065485|NCT01848457|12464688|P3|Cycle 4|Overall Study||3
5065486|NCT01848457|12464689|P2|Cycle 4|Overall Study||3
5065487|NCT01848457|12464690|P1|Cycle 4|Overall Study||3
5065488|NCT01848457|12464687|P4|Cycle 3|Overall Study||3
5065489|NCT01848457|12464688|P3|Cycle 3|Overall Study||3
5065490|NCT01848457|12464689|P2|Cycle 3|Overall Study||3
5065491|NCT01848457|12464690|P1|Cycle 3|Overall Study||3
5065492|NCT01848457|12464687|P4|Cycle 2|Overall Study||3
5065493|NCT01848457|12464688|P3|Cycle 2|Overall Study||3
5065494|NCT01848457|12464689|P2|Cycle 2|Overall Study||3
5065495|NCT01848457|12464690|P1|Cycle 2|Overall Study||3
5065496|NCT01848457|12464687|P4|Cycle 1|Overall Study||3
5065497|NCT01848457|12464688|P3|Cycle 1|Overall Study||3
5065498|NCT01848457|12464689|P2|Cycle 1|Overall Study||3
5065499|NCT01848457|12464690|P1|Cycle 1|Overall Study||4
5065500|NCT01848457|12464687|P4|Baseline|Overall Study||3
5065501|NCT01848457|12464688|P3|Baseline|Overall Study||3
5065502|NCT01848457|12464689|P2|Baseline|Overall Study||3
5065503|NCT01848457|12464690|P1|Baseline|Overall Study||4
5065504|NCT01848457|12464687|P4|STARTED|Overall Study||3
5065505|NCT01848457|12464688|P3|STARTED|Overall Study||3
5065506|NCT01848457|12464689|P2|STARTED|Overall Study||3
5065507|NCT01848457|12464690|P1|STARTED|Overall Study||4
5065508|NCT01848366|12464714|P1|NOT COMPLETED|Overall Study||0
5065509|NCT01848366|12464714|P1|COMPLETED|Overall Study||8
5065510|NCT01848366|12464714|P1|STARTED|Overall Study||8
5065511|NCT01848353|12464722|P4|NOT COMPLETED|Phase 3||0
5065512|NCT01848353|12464723|P3|NOT COMPLETED|Phase 3||0
5065513|NCT01848353|12464724|P2|NOT COMPLETED|Phase 3||1
5065514|NCT01848353|12464725|P1|NOT COMPLETED|Phase 3||1
5065515|NCT01848353|12464722|P4|COMPLETED|Phase 3||0
5065516|NCT01848353|12464723|P3|COMPLETED|Phase 3||0
5065517|NCT01848353|12464724|P2|COMPLETED|Phase 3||9
5065518|NCT01848353|12464725|P1|COMPLETED|Phase 3||4
5065519|NCT01848353|12464722|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
5065520|NCT01848353|12464723|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
5065521|NCT01848353|12464724|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
5065522|NCT01848353|12464725|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
5065523|NCT01848353|12464722|P4|NOT COMPLETED|Phase 2||0
5065524|NCT01848353|12464723|P3|NOT COMPLETED|Phase 2||0
5065525|NCT01848353|12464724|P2|NOT COMPLETED|Phase 2||2
5065526|NCT01848353|12464725|P1|NOT COMPLETED|Phase 2||3
5065527|NCT01848353|12464722|P4|COMPLETED|Phase 2||0
5065528|NCT01848353|12464723|P3|COMPLETED|Phase 2||0
5065529|NCT01848353|12464724|P2|COMPLETED|Phase 2||26
5065530|NCT01848353|12464725|P1|COMPLETED|Phase 2||20
5065531|NCT01848353|12464722|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
5065532|NCT01848353|12464723|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
5065533|NCT01848353|12464724|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
5065534|NCT01848353|12464725|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
5065535|NCT01848353|12464722|P4|NOT COMPLETED|Phase 1||0
5065536|NCT01848353|12464723|P3|NOT COMPLETED|Phase 1||0
5065537|NCT01848353|12464724|P2|NOT COMPLETED|Phase 1||1
5065538|NCT01848353|12464725|P1|NOT COMPLETED|Phase 1||3
5065539|NCT01848353|12464722|P4|COMPLETED|Phase 1||19
5065540|NCT01848353|12464723|P3|COMPLETED|Phase 1||20
5065541|NCT01848353|12464724|P2|COMPLETED|Phase 1||42
5065542|NCT01848353|12464725|P1|COMPLETED|Phase 1||35
5065543|NCT01848353|12464722|P4|STARTED|Phase 1||19
5065544|NCT01848353|12464723|P3|STARTED|Phase 1||20
5065545|NCT01848353|12464724|P2|STARTED|Phase 1||43
5065546|NCT01848353|12464725|P1|STARTED|Phase 1||38
5065547|NCT01848288|12464781|P1|NOT COMPLETED|Overall Study||3
5065548|NCT01848288|12464781|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
5065549|NCT01848288|12464781|P1|STARTED|Overall Study||100
5065550|NCT01848210|12464792|P2|NOT COMPLETED|Overall Study||78
5065551|NCT01848210|12464793|P1|NOT COMPLETED|Overall Study||88
5065552|NCT01848210|12464792|P2|COMPLETED|Overall Study||340
5065553|NCT01848210|12464793|P1|COMPLETED|Overall Study||323
5065554|NCT01848210|12464792|P2|Per Protocol Population|Overall Study||245
5065555|NCT01848210|12464793|P1|Per Protocol Population|Overall Study||222
5065556|NCT01848210|12464792|P2|Intent-to-Treat (ITT) Population|Overall Study||388
5065557|NCT01848210|12464793|P1|Intent-to-Treat (ITT) Population|Overall Study||383
5065558|NCT01848210|12464792|P2|Safety Population-Received Study Drug|Overall Study||398
5065559|NCT01848210|12464793|P1|Safety Population-Received Study Drug|Overall Study||394
5065560|NCT01848210|12464792|P2|STARTED|Overall Study||418
5065561|NCT01848210|12464793|P1|STARTED|Overall Study||411
5065562|NCT01848184|12464805|P1|NOT COMPLETED|Overall Study||26
5065563|NCT01848184|12464805|P1|COMPLETED|Overall Study||100
5065564|NCT01848184|12464805|P1|STARTED|Overall Study||126
5065565|NCT01848145|12464815|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
5065566|NCT01848145|12464815|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
5065567|NCT01848145|12464815|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
5065568|NCT01848145|12464815|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
5065569|NCT01848145|12464815|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
5065570|NCT01848145|12464815|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
5065571|NCT01848145|12464815|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
5065572|NCT01848145|12464815|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
5065573|NCT01848145|12464815|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
5065574|NCT01848145|12464815|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
5065575|NCT01848145|12464815|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
5065576|NCT01848145|12464815|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
5065577|NCT01848145|12464815|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
5065578|NCT01848145|12464815|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
5065579|NCT01848145|12464815|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
5065580|NCT01848067|12464824|P1|NOT COMPLETED|Overall Study||0
5065581|NCT01848067|12464824|P1|COMPLETED|Overall Study||9
5065582|NCT01848067|12464824|P1|STARTED|Overall Study||9
5065583|NCT01848054|12464832|P2|NOT COMPLETED|Stabilization/Maintenance||40
5065584|NCT01848054|12464833|P1|NOT COMPLETED|Stabilization/Maintenance||40
5065585|NCT01848054|12464832|P2|COMPLETED|Stabilization/Maintenance||107
5065586|NCT01848054|12464833|P1|COMPLETED|Stabilization/Maintenance||92
5065587|NCT01848054|12464832|P2|STARTED|Stabilization/Maintenance||147
5065588|NCT01848054|12464833|P1|STARTED|Stabilization/Maintenance||132
5065589|NCT01848054|12464832|P2|NOT COMPLETED|Induction Phase||8
5065590|NCT01848054|12464833|P1|NOT COMPLETED|Induction Phase||23
5065591|NCT01848054|12464832|P2|COMPLETED|Induction Phase||147
5065592|NCT01848054|12464833|P1|COMPLETED|Induction Phase||132
5065593|NCT01848054|12464832|P2|STARTED|Induction Phase||155
5065594|NCT01848054|12464833|P1|STARTED|Induction Phase||155
5065595|NCT01847885|12464855|P3|NOT COMPLETED|Randomization||2
5065596|NCT01847885|12464856|P2|NOT COMPLETED|Randomization||4
5065597|NCT01847885|12464857|P1|NOT COMPLETED|Randomization||0
5065598|NCT01847885|12464855|P3|COMPLETED|Randomization||13
5065599|NCT01847885|12464856|P2|COMPLETED|Randomization||27
5065600|NCT01847885|12464857|P1|COMPLETED|Randomization||0
5065601|NCT01847885|12464855|P3|Per Protocol Set|Randomization||13
5065602|NCT01847885|12464856|P2|Per Protocol Set|Randomization||27
5065603|NCT01847885|12464857|P1|Per Protocol Set|Randomization||0
5065604|NCT01847885|12464855|P3|Safety Set|Randomization||13
5065605|NCT01847885|12464856|P2|Safety Set|Randomization||28
5065606|NCT01847885|12464857|P1|Safety Set|Randomization||0
5065607|NCT01847885|12464855|P3|Full Analysis Set|Randomization||15
5065608|NCT01847885|12464856|P2|Full Analysis Set|Randomization||28
5065609|NCT01847885|12464857|P1|Full Analysis Set|Randomization||0
5065610|NCT01847885|12464855|P3|STARTED|Randomization||15
5065611|NCT01847885|12464856|P2|STARTED|Randomization||31
5065612|NCT01847885|12464857|P1|STARTED|Randomization||0
5065613|NCT01847885|12464855|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
5065614|NCT01847885|12464856|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
5065615|NCT01847885|12464857|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
5065616|NCT01847885|12464855|P3|COMPLETED|Initial Enrollment (Consented)||0
5065617|NCT01847885|12464856|P2|COMPLETED|Initial Enrollment (Consented)||0
5065618|NCT01847885|12464857|P1|COMPLETED|Initial Enrollment (Consented)||40
5065619|NCT01847885|12464855|P3|Per Protocol Set|Initial Enrollment (Consented)||0
5065620|NCT01847885|12464856|P2|Per Protocol Set|Initial Enrollment (Consented)||0
5065621|NCT01847885|12464857|P1|Per Protocol Set|Initial Enrollment (Consented)||40
5065622|NCT01847885|12464855|P3|Safety Set|Initial Enrollment (Consented)||0
5065623|NCT01847885|12464856|P2|Safety Set|Initial Enrollment (Consented)||0
5065624|NCT01847885|12464857|P1|Safety Set|Initial Enrollment (Consented)||41
5065625|NCT01847885|12464855|P3|Full Analysis Set|Initial Enrollment (Consented)||0
5065626|NCT01847885|12464856|P2|Full Analysis Set|Initial Enrollment (Consented)||0
5065627|NCT01847885|12464857|P1|Full Analysis Set|Initial Enrollment (Consented)||43
5065628|NCT01847885|12464855|P3|Randomized|Initial Enrollment (Consented)||0
5065629|NCT01847885|12464856|P2|Randomized|Initial Enrollment (Consented)||0
5065630|NCT01847885|12464857|P1|Randomized|Initial Enrollment (Consented)||46
5065631|NCT01847885|12464855|P3|STARTED|Initial Enrollment (Consented)||0
5065632|NCT01847885|12464856|P2|STARTED|Initial Enrollment (Consented)||0
5065633|NCT01847885|12464857|P1|STARTED|Initial Enrollment (Consented)||88
5065634|NCT01847638|12464891|P2|NOT COMPLETED|Overall Study||0
5065635|NCT01847638|12464892|P1|NOT COMPLETED|Overall Study||0
5065636|NCT01847638|12464891|P2|COMPLETED|Overall Study||25
5065637|NCT01847638|12464892|P1|COMPLETED|Overall Study||25
5065638|NCT01847638|12464891|P2|STARTED|Overall Study||25
5065639|NCT01847638|12464892|P1|STARTED|Overall Study||25
5065640|NCT01847560|12464912|P10|NOT COMPLETED|Overall Study||0
5065641|NCT01847560|12464913|P9|NOT COMPLETED|Overall Study||0
5065642|NCT01847560|12464914|P8|NOT COMPLETED|Overall Study||0
5065643|NCT01847560|12464915|P7|NOT COMPLETED|Overall Study||0
5065644|NCT01847560|12464916|P6|NOT COMPLETED|Overall Study||0
5065645|NCT01847560|12464917|P5|NOT COMPLETED|Overall Study||0
5065646|NCT01847560|12464918|P4|NOT COMPLETED|Overall Study||0
5065647|NCT01847560|12464919|P3|NOT COMPLETED|Overall Study||0
5065648|NCT01847560|12464920|P2|NOT COMPLETED|Overall Study||0
5065649|NCT01847560|12464921|P1|NOT COMPLETED|Overall Study||0
5065650|NCT01847560|12464912|P10|COMPLETED|Overall Study||39438
5065651|NCT01847560|12464913|P9|COMPLETED|Overall Study||77547
5065652|NCT01847560|12464914|P8|COMPLETED|Overall Study||19829
5065653|NCT01847560|12464915|P7|COMPLETED|Overall Study||40971
5065654|NCT01847560|12464916|P6|COMPLETED|Overall Study||28343
5065655|NCT01847560|12464917|P5|COMPLETED|Overall Study||27731
5065656|NCT01847560|12464918|P4|COMPLETED|Overall Study||56655
5065657|NCT01847560|12464919|P3|COMPLETED|Overall Study||9731
5065658|NCT01847560|12464920|P2|COMPLETED|Overall Study||19955
5065659|NCT01847560|12464921|P1|COMPLETED|Overall Study||13464
5065660|NCT01847560|12464912|P10|STARTED|Overall Study||39438
5065661|NCT01847560|12464913|P9|STARTED|Overall Study||77547
5065662|NCT01847560|12464914|P8|STARTED|Overall Study||19829
5065663|NCT01847560|12464915|P7|STARTED|Overall Study||40971
5065664|NCT01847560|12464916|P6|STARTED|Overall Study||28343
5065665|NCT01847560|12464917|P5|STARTED|Overall Study||27731
5065666|NCT01847560|12464918|P4|STARTED|Overall Study||56655
5065667|NCT01847560|12464919|P3|STARTED|Overall Study||9731
5065668|NCT01847560|12464920|P2|STARTED|Overall Study||19955
5065669|NCT01847560|12464921|P1|STARTED|Overall Study||13464
5065670|NCT01847547|12464965|P2|NOT COMPLETED|Overall Study||0
5065671|NCT01847547|12464966|P1|NOT COMPLETED|Overall Study||0
5065672|NCT01847547|12464965|P2|COMPLETED|Overall Study||2991
5065673|NCT01847547|12464966|P1|COMPLETED|Overall Study||2991
5065674|NCT01847547|12464965|P2|STARTED|Overall Study||2991
5065675|NCT01847547|12464966|P1|STARTED|Overall Study||2991
5065676|NCT01847469|12465010|P2|NOT COMPLETED|Overall Study||3
5065677|NCT01847469|12465011|P1|NOT COMPLETED|Overall Study||9
5065678|NCT01847469|12465010|P2|COMPLETED|Overall Study||3
5065679|NCT01847469|12465011|P1|COMPLETED|Overall Study||9
5065680|NCT01847469|12465010|P2|STARTED|Overall Study||6
5065681|NCT01847469|12465011|P1|STARTED|Overall Study||18
5065682|NCT01847443|12465021|P4|NOT COMPLETED|Study Period 4||0
5065683|NCT01847443|12465022|P3|NOT COMPLETED|Study Period 4||0
5065684|NCT01847443|12465023|P2|NOT COMPLETED|Study Period 4||0
5065685|NCT01847443|12465024|P1|NOT COMPLETED|Study Period 4||0
5065686|NCT01847443|12465021|P4|COMPLETED|Study Period 4||21
5065687|NCT01847443|12465022|P3|COMPLETED|Study Period 4||21
5065688|NCT01847443|12465023|P2|COMPLETED|Study Period 4||19
5065689|NCT01847443|12465024|P1|COMPLETED|Study Period 4||16
5065690|NCT01847443|12465021|P4|STARTED|Study Period 4||21
5065691|NCT01847443|12465022|P3|STARTED|Study Period 4||21
5065692|NCT01847443|12465023|P2|STARTED|Study Period 4||19
5065693|NCT01847443|12465024|P1|STARTED|Study Period 4||16
5065694|NCT01847443|12465021|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
5065695|NCT01847443|12465022|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
5065696|NCT01847443|12465023|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
5065697|NCT01847443|12465024|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
5065698|NCT01847443|12465021|P4|COMPLETED|Washout Period Before Study Period 4||21
5065699|NCT01847443|12465022|P3|COMPLETED|Washout Period Before Study Period 4||21
5065700|NCT01847443|12465023|P2|COMPLETED|Washout Period Before Study Period 4||19
5065701|NCT01847443|12465024|P1|COMPLETED|Washout Period Before Study Period 4||16
5065702|NCT01847443|12465021|P4|STARTED|Washout Period Before Study Period 4||21
5065703|NCT01847443|12465022|P3|STARTED|Washout Period Before Study Period 4||21
5065704|NCT01847443|12465023|P2|STARTED|Washout Period Before Study Period 4||19
5065705|NCT01847443|12465024|P1|STARTED|Washout Period Before Study Period 4||18
5065706|NCT01847443|12465021|P4|NOT COMPLETED|Study Period 3||0
5065707|NCT01847443|12465022|P3|NOT COMPLETED|Study Period 3||0
5065708|NCT01847443|12465023|P2|NOT COMPLETED|Study Period 3||0
5065709|NCT01847443|12465024|P1|NOT COMPLETED|Study Period 3||0
5065710|NCT01847443|12465021|P4|COMPLETED|Study Period 3||21
5065711|NCT01847443|12465022|P3|COMPLETED|Study Period 3||21
5065712|NCT01847443|12465023|P2|COMPLETED|Study Period 3||19
5065713|NCT01847443|12465024|P1|COMPLETED|Study Period 3||18
5065714|NCT01847443|12465021|P4|STARTED|Study Period 3||21
5065715|NCT01847443|12465022|P3|STARTED|Study Period 3||21
5065716|NCT01847443|12465023|P2|STARTED|Study Period 3||19
5065717|NCT01847443|12465024|P1|STARTED|Study Period 3||18
5065718|NCT01847443|12465021|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
5065719|NCT01847443|12465022|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
5065720|NCT01847443|12465023|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
5065721|NCT01847443|12465024|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
5065722|NCT01847443|12465021|P4|COMPLETED|Washout Period Before Study Period 3||21
5065723|NCT01847443|12465022|P3|COMPLETED|Washout Period Before Study Period 3||21
5065724|NCT01847443|12465023|P2|COMPLETED|Washout Period Before Study Period 3||19
5065725|NCT01847443|12465024|P1|COMPLETED|Washout Period Before Study Period 3||18
5065726|NCT01847443|12465021|P4|STARTED|Washout Period Before Study Period 3||21
5065727|NCT01847443|12465022|P3|STARTED|Washout Period Before Study Period 3||21
5065728|NCT01847443|12465023|P2|STARTED|Washout Period Before Study Period 3||19
5065729|NCT01847443|12465024|P1|STARTED|Washout Period Before Study Period 3||19
5065730|NCT01847443|12465021|P4|NOT COMPLETED|Study Period 2||0
5065731|NCT01847443|12465022|P3|NOT COMPLETED|Study Period 2||0
5065732|NCT01847443|12465023|P2|NOT COMPLETED|Study Period 2||0
5065733|NCT01847443|12465024|P1|NOT COMPLETED|Study Period 2||0
5065734|NCT01847443|12465021|P4|COMPLETED|Study Period 2||21
5065735|NCT01847443|12465022|P3|COMPLETED|Study Period 2||21
5065736|NCT01847443|12465023|P2|COMPLETED|Study Period 2||19
5065737|NCT01847443|12465024|P1|COMPLETED|Study Period 2||19
5065738|NCT01847443|12465021|P4|STARTED|Study Period 2||21
5065739|NCT01847443|12465022|P3|STARTED|Study Period 2||21
5065740|NCT01847443|12465023|P2|STARTED|Study Period 2||19
5065741|NCT01847443|12465024|P1|STARTED|Study Period 2||19
5065742|NCT01847443|12465021|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
5065743|NCT01847443|12465022|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
5065744|NCT01847443|12465023|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
5065745|NCT01847443|12465024|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
5065746|NCT01847443|12465021|P4|COMPLETED|Washout Period Before Study Period 2||21
5065747|NCT01847443|12465022|P3|COMPLETED|Washout Period Before Study Period 2||21
5065748|NCT01847443|12465023|P2|COMPLETED|Washout Period Before Study Period 2||19
5065749|NCT01847443|12465024|P1|COMPLETED|Washout Period Before Study Period 2||19
5065750|NCT01847443|12465021|P4|STARTED|Washout Period Before Study Period 2||21
5065751|NCT01847443|12465022|P3|STARTED|Washout Period Before Study Period 2||21
5065752|NCT01847443|12465023|P2|STARTED|Washout Period Before Study Period 2||20
5065753|NCT01847443|12465024|P1|STARTED|Washout Period Before Study Period 2||21
5065754|NCT01847443|12465021|P4|NOT COMPLETED|Study Period 1||0
5065755|NCT01847443|12465022|P3|NOT COMPLETED|Study Period 1||0
5065756|NCT01847443|12465023|P2|NOT COMPLETED|Study Period 1||1
5065757|NCT01847443|12465024|P1|NOT COMPLETED|Study Period 1||0
5065758|NCT01847443|12465021|P4|COMPLETED|Study Period 1||21
5065759|NCT01847443|12465022|P3|COMPLETED|Study Period 1||21
5065760|NCT01847443|12465023|P2|COMPLETED|Study Period 1||20
5065761|NCT01847443|12465024|P1|COMPLETED|Study Period 1||21
5065762|NCT01847443|12465021|P4|STARTED|Study Period 1||21
5065763|NCT01847443|12465022|P3|STARTED|Study Period 1||21
5065764|NCT01847443|12465023|P2|STARTED|Study Period 1||21
5065765|NCT01847443|12465024|P1|STARTED|Study Period 1||21
5065766|NCT01847430|12465054|P1|NOT COMPLETED|Overall Study||0
5065767|NCT01847430|12465054|P1|COMPLETED|Overall Study||302
5065768|NCT01847430|12465054|P1|STARTED|Overall Study||302
5065769|NCT01847313|12465067|P2|NOT COMPLETED|Overall Study||2
5065770|NCT01847313|12465068|P1|NOT COMPLETED|Overall Study||0
5065771|NCT01847313|12465067|P2|COMPLETED|Overall Study||8
5065772|NCT01847313|12465068|P1|COMPLETED|Overall Study||10
5065773|NCT01847313|12465067|P2|STARTED|Overall Study||10
5065774|NCT01847313|12465068|P1|STARTED|Overall Study||10
5065775|NCT01847274|12465084|P4|NOT COMPLETED|Overall Study||104
5065776|NCT01847274|12465085|P3|NOT COMPLETED|Overall Study||188
5065777|NCT01847274|12465086|P2|NOT COMPLETED|Overall Study||61
5065778|NCT01847274|12465087|P1|NOT COMPLETED|Overall Study||91
5065779|NCT01847274|12465084|P4|COMPLETED|Overall Study||12
5065780|NCT01847274|12465085|P3|COMPLETED|Overall Study||46
5065781|NCT01847274|12465086|P2|COMPLETED|Overall Study||4
5065782|NCT01847274|12465087|P1|COMPLETED|Overall Study||47
5065783|NCT01847274|12465084|P4|STARTED|Overall Study||116
5065784|NCT01847274|12465085|P3|STARTED|Overall Study||234
5065785|NCT01847274|12465086|P2|STARTED|Overall Study||65
5065786|NCT01847274|12465087|P1|STARTED|Overall Study||138
5065787|NCT01847209|12465141|P1|NOT COMPLETED|Overall Study||2
5065788|NCT01847209|12465141|P1|COMPLETED|Overall Study||23
5065789|NCT01847209|12465141|P1|STARTED|Overall Study||25
5065790|NCT01847196|12465146|P1|NOT COMPLETED|Overall Study||0
5065791|NCT01847196|12465146|P1|COMPLETED|Overall Study||5
5065792|NCT01847196|12465146|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
5065793|NCT01847131|12465153|P2|NOT COMPLETED|Overall Study||0
5065794|NCT01847131|12465154|P1|NOT COMPLETED|Overall Study||0
5065795|NCT01847131|12465153|P2|COMPLETED|Overall Study||25
5065796|NCT01847131|12465154|P1|COMPLETED|Overall Study||25
5065797|NCT01847131|12465153|P2|STARTED|Overall Study||25
5065798|NCT01847131|12465154|P1|STARTED|Overall Study||25
5065799|NCT01847092|12465164|P2|NOT COMPLETED|Overall Study||11
5065800|NCT01847092|12465165|P1|NOT COMPLETED|Overall Study||26
5065801|NCT01847092|12465164|P2|COMPLETED|Overall Study||66
5065802|NCT01847092|12465165|P1|COMPLETED|Overall Study||51
5065803|NCT01847092|12465164|P2|STARTED|Overall Study||77
5065804|NCT01847092|12465165|P1|STARTED|Overall Study||77
5065805|NCT01847027|12465175|P2|NOT COMPLETED|Overall Study||2
5065806|NCT01847027|12465176|P1|NOT COMPLETED|Overall Study||1
5065807|NCT01847027|12465175|P2|COMPLETED|Overall Study||10
5065808|NCT01847027|12465176|P1|COMPLETED|Overall Study||10
5065809|NCT01847027|12465175|P2|STARTED|Overall Study||12
5065810|NCT01847027|12465176|P1|STARTED|Overall Study||11
5065811|NCT01847014|12465186|P1|NOT COMPLETED|Completion of Extension Study||4
5065812|NCT01847014|12465186|P1|COMPLETED|Completion of Extension Study||0
5065813|NCT01847014|12465186|P1|STARTED|Completion of Extension Study||4
5065814|NCT01847014|12465186|P1|NOT COMPLETED|Baseline Extension Visit||0
5065815|NCT01847014|12465186|P1|COMPLETED|Baseline Extension Visit||4
5065816|NCT01847014|12465186|P1|STARTED|Baseline Extension Visit||4
5065817|NCT01847001|12465190|P1|NOT COMPLETED|Overall Study||0
5065818|NCT01847001|12465190|P1|COMPLETED|Overall Study||10
5065819|NCT01847001|12465190|P1|STARTED|Overall Study||10
5065820|NCT01846871|12465194|P1|NOT COMPLETED|Overall Study||0
5065821|NCT01846871|12465194|P1|COMPLETED|Overall Study||10
5065822|NCT01846871|12465194|P1|STARTED|Overall Study||10
5065823|NCT01846741|12465219|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
5065824|NCT01846741|12465219|P1|COMPLETED|Implantation to 18-Month/End of Study||20
5065825|NCT01846741|12465219|P1|STARTED|Implantation to 18-Month/End of Study||20
5065826|NCT01846741|12465219|P1|NOT COMPLETED|Baseline Visit||2
5065827|NCT01846741|12465219|P1|COMPLETED|Baseline Visit||20
5065828|NCT01846741|12465219|P1|STARTED|Baseline Visit||22
5065829|NCT01846728|12465275|P1|NOT COMPLETED|Overall Study||0
5065830|NCT01846728|12465275|P1|COMPLETED|Overall Study||6
5065831|NCT01846728|12465275|P1|STARTED|Overall Study||6
5065832|NCT01846702|12465290|P7|NOT COMPLETED|Overall Study||0
5065833|NCT01846702|12465291|P6|NOT COMPLETED|Overall Study||0
5065834|NCT01846702|12465292|P5|NOT COMPLETED|Overall Study||0
5065835|NCT01846702|12465293|P4|NOT COMPLETED|Overall Study||0
5065836|NCT01846702|12465294|P3|NOT COMPLETED|Overall Study||1
5065837|NCT01846702|12465295|P2|NOT COMPLETED|Overall Study||0
5065838|NCT01846702|12465296|P1|NOT COMPLETED|Overall Study||0
5065839|NCT01846702|12465290|P7|COMPLETED|Overall Study||6
5065840|NCT01846702|12465291|P6|COMPLETED|Overall Study||6
5065841|NCT01846702|12465292|P5|COMPLETED|Overall Study||6
5065842|NCT01846702|12465293|P4|COMPLETED|Overall Study||6
5065843|NCT01846702|12465294|P3|COMPLETED|Overall Study||6
5065844|NCT01846702|12465295|P2|COMPLETED|Overall Study||6
5065845|NCT01846702|12465296|P1|COMPLETED|Overall Study||6
5065846|NCT01846702|12465290|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5065847|NCT01846702|12465291|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
5065848|NCT01846702|12465292|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5065849|NCT01846702|12465293|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5065850|NCT01846702|12465294|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5065851|NCT01846702|12465295|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5065852|NCT01846702|12465296|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5065853|NCT01846702|12465290|P7|STARTED|Overall Study||6
5065854|NCT01846702|12465291|P6|STARTED|Overall Study||6
5065855|NCT01846702|12465292|P5|STARTED|Overall Study||6
5065856|NCT01846702|12465293|P4|STARTED|Overall Study||6
5065857|NCT01846702|12465294|P3|STARTED|Overall Study||7
5065858|NCT01846702|12465295|P2|STARTED|Overall Study||6
5065859|NCT01846702|12465296|P1|STARTED|Overall Study||6
5065860|NCT01846624|12465375|P1|NOT COMPLETED|Overall Study||1
5065861|NCT01846624|12465375|P1|COMPLETED|Overall Study||12
5065862|NCT01846624|12465375|P1|STARTED|Overall Study||13
5065863|NCT01846611|12465385|P2|NOT COMPLETED|Overall Study||43
5065864|NCT01846611|12465386|P1|NOT COMPLETED|Overall Study||38
5065865|NCT01846611|12465385|P2|COMPLETED|Overall Study||244
5065866|NCT01846611|12465386|P1|COMPLETED|Overall Study||251
5065867|NCT01846611|12465385|P2|Treated|Overall Study||282
5065868|NCT01846611|12465386|P1|Treated|Overall Study||286
5065869|NCT01846611|12465385|P2|STARTED|Overall Study||287
5065870|NCT01846611|12465386|P1|STARTED|Overall Study||289
5065871|NCT01846507|12465396|P1|NOT COMPLETED|Overall Study||7
5065872|NCT01846507|12465396|P1|COMPLETED|Overall Study||25
5065873|NCT01846507|12465396|P1|STARTED|Overall Study||32
5065874|NCT01846494|12465415|P2|NOT COMPLETED|Overall Study||38
5065875|NCT01846494|12465416|P1|NOT COMPLETED|Overall Study||30
5065876|NCT01846494|12465415|P2|COMPLETED|Overall Study||25
5065877|NCT01846494|12465416|P1|COMPLETED|Overall Study||20
5065878|NCT01846494|12465415|P2|STARTED|Overall Study||63
5065879|NCT01846494|12465416|P1|STARTED|Overall Study||50
5065880|NCT01846455|12465429|P5|NOT COMPLETED|Overall Study||0
5065881|NCT01846455|12465430|P4|NOT COMPLETED|Overall Study||0
5065882|NCT01846455|12465431|P3|NOT COMPLETED|Overall Study||0
5065883|NCT01846455|12465432|P2|NOT COMPLETED|Overall Study||0
5065884|NCT01846455|12465433|P1|NOT COMPLETED|Overall Study||0
5065885|NCT01846455|12465429|P5|COMPLETED|Overall Study||8
5065886|NCT01846455|12465430|P4|COMPLETED|Overall Study||10
5065887|NCT01846455|12465431|P3|COMPLETED|Overall Study||8
5065888|NCT01846455|12465432|P2|COMPLETED|Overall Study||8
5065889|NCT01846455|12465433|P1|COMPLETED|Overall Study||9
5065890|NCT01846455|12465429|P5|PK Population|Overall Study||8
5065891|NCT01846455|12465430|P4|PK Population|Overall Study||6
5065892|NCT01846455|12465431|P3|PK Population|Overall Study||6
5065893|NCT01846455|12465432|P2|PK Population|Overall Study||7
5065894|NCT01846455|12465433|P1|PK Population|Overall Study||6
5065895|NCT01846455|12465429|P5|STARTED|Overall Study||8
5065896|NCT01846455|12465430|P4|STARTED|Overall Study||10
5065897|NCT01846455|12465431|P3|STARTED|Overall Study||8
5065898|NCT01846455|12465432|P2|STARTED|Overall Study||8
5065899|NCT01846455|12465433|P1|STARTED|Overall Study||9
5065900|NCT01846442|12465494|P4|NOT COMPLETED|Overall Study||3
5065901|NCT01846442|12465495|P3|NOT COMPLETED|Overall Study||4
5065902|NCT01846442|12465496|P2|NOT COMPLETED|Overall Study||6
5065903|NCT01846442|12465497|P1|NOT COMPLETED|Overall Study||6
5065904|NCT01846442|12465494|P4|COMPLETED|Overall Study||51
5065905|NCT01846442|12465495|P3|COMPLETED|Overall Study||52
5065906|NCT01846442|12465496|P2|COMPLETED|Overall Study||48
5065907|NCT01846442|12465497|P1|COMPLETED|Overall Study||48
5065908|NCT01846442|12465494|P4|ITT Population|Overall Study||54
5065909|NCT01846442|12465495|P3|ITT Population|Overall Study||56
5065910|NCT01846442|12465496|P2|ITT Population|Overall Study||53
5065911|NCT01846442|12465497|P1|ITT Population|Overall Study||53
5065912|NCT01846442|12465494|P4|Safety Population|Overall Study||54
5065913|NCT01846442|12465495|P3|Safety Population|Overall Study||56
5065914|NCT01846442|12465496|P2|Safety Population|Overall Study||53
5065915|NCT01846442|12465497|P1|Safety Population|Overall Study||54
5065916|NCT01846442|12465494|P4|STARTED|Overall Study||54
5065917|NCT01846442|12465495|P3|STARTED|Overall Study||56
5065918|NCT01846442|12465496|P2|STARTED|Overall Study||54
5065919|NCT01846442|12465497|P1|STARTED|Overall Study||54
5065920|NCT01846416|12465538|P3|NOT COMPLETED|Survival Follow-up||12
5065921|NCT01846416|12465539|P2|NOT COMPLETED|Survival Follow-up||80
5065922|NCT01846416|12465540|P1|NOT COMPLETED|Survival Follow-up||28
5065923|NCT01846416|12465538|P3|COMPLETED|Survival Follow-up||0
5065924|NCT01846416|12465539|P2|COMPLETED|Survival Follow-up||0
5065925|NCT01846416|12465540|P1|COMPLETED|Survival Follow-up||0
5065926|NCT01846416|12465538|P3|STARTED|Survival Follow-up||12
5065927|NCT01846416|12465539|P2|STARTED|Survival Follow-up||80
5065928|NCT01846416|12465540|P1|STARTED|Survival Follow-up||28
5065929|NCT01846416|12465538|P3|NOT COMPLETED|Treatment Phase||13
5065930|NCT01846416|12465539|P2|NOT COMPLETED|Treatment Phase||93
5065931|NCT01846416|12465540|P1|NOT COMPLETED|Treatment Phase||31
5065932|NCT01846416|12465538|P3|COMPLETED|Treatment Phase||0
5065933|NCT01846416|12465539|P2|COMPLETED|Treatment Phase||0
5065934|NCT01846416|12465540|P1|COMPLETED|Treatment Phase||0
5065935|NCT01846416|12465538|P3|STARTED|Treatment Phase||13
5065936|NCT01846416|12465539|P2|STARTED|Treatment Phase||93
5065937|NCT01846416|12465540|P1|STARTED|Treatment Phase||31
5065938|NCT01846299|12465585|P2|NOT COMPLETED|Overall Study||10
5065939|NCT01846299|12465586|P1|NOT COMPLETED|Overall Study||12
5065940|NCT01846299|12465585|P2|COMPLETED|Overall Study||50
5065941|NCT01846299|12465586|P1|COMPLETED|Overall Study||106
5065942|NCT01846299|12465585|P2|Safety Set|Overall Study||58
5065943|NCT01846299|12465586|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
5065944|NCT01846299|12465585|P2|Full Analysis Set|Overall Study||60
5065945|NCT01846299|12465586|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
5065946|NCT01846299|12465585|P2|STARTED|Overall Study||60
5065947|NCT01846299|12465586|P1|STARTED|Overall Study||118
5065948|NCT01846273|12465625|P3|NOT COMPLETED|Overall Study||0
5065949|NCT01846273|12465626|P2|NOT COMPLETED|Overall Study||26
5065950|NCT01846273|12465627|P1|NOT COMPLETED|Overall Study||22
5065951|NCT01846273|12465625|P3|COMPLETED|Overall Study||41
5065952|NCT01846273|12465626|P2|COMPLETED|Overall Study||87
5065953|NCT01846273|12465627|P1|COMPLETED|Overall Study||146
5065954|NCT01846273|12465625|P3|Safety Analysis Set|Overall Study||14
5065955|NCT01846273|12465626|P2|Safety Analysis Set|Overall Study||135
5065956|NCT01846273|12465627|P1|Safety Analysis Set|Overall Study||172
5065957|NCT01846273|12465625|P3|STARTED|Overall Study||41
5065958|NCT01846273|12465626|P2|STARTED|Overall Study||113
5065959|NCT01846273|12465627|P1|STARTED|Overall Study||168
5065960|NCT01846221|12465683|P2|NOT COMPLETED|Overall Study||0
5065961|NCT01846221|12465684|P1|NOT COMPLETED|Overall Study||3
5065962|NCT01846221|12465683|P2|COMPLETED|Overall Study||51
5065963|NCT01846221|12465684|P1|COMPLETED|Overall Study||47
5065964|NCT01846221|12465683|P2|STARTED|Overall Study||51
5065965|NCT01846221|12465684|P1|STARTED|Overall Study||50
5065966|NCT01846208|12465701|P3|NOT COMPLETED|Overall Study||8
5065967|NCT01846208|12465702|P2|NOT COMPLETED|Overall Study||4
5065968|NCT01846208|12465703|P1|NOT COMPLETED|Overall Study||9
5065969|NCT01846208|12465701|P3|COMPLETED|Overall Study||32
5065970|NCT01846208|12465702|P2|COMPLETED|Overall Study||20
5065971|NCT01846208|12465703|P1|COMPLETED|Overall Study||19
5065972|NCT01846208|12465701|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
5065973|NCT01846208|12465702|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
5065974|NCT01846208|12465703|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
5065975|NCT01846208|12465701|P3|Year 2 Desensitization OFC|Overall Study||33
5065976|NCT01846208|12465702|P2|Year 2 Desensitization OFC|Overall Study||20
5065977|NCT01846208|12465703|P1|Year 2 Desensitization OFC|Overall Study||19
5065978|NCT01846208|12465701|P3|Year 1 Desensitization OFC|Overall Study||34
5065979|NCT01846208|12465702|P2|Year 1 Desensitization OFC|Overall Study||20
5065980|NCT01846208|12465703|P1|Year 1 Desensitization OFC|Overall Study||23
5065981|NCT01846208|12465701|P3|Initiatiated Treatment|Overall Study||39
5065982|NCT01846208|12465702|P2|Initiatiated Treatment|Overall Study||23
5065983|NCT01846208|12465703|P1|Initiatiated Treatment|Overall Study||27
5065984|NCT01846208|12465701|P3|STARTED|Overall Study||40
5065985|NCT01846208|12465702|P2|STARTED|Overall Study||24
5065986|NCT01846208|12465703|P1|STARTED|Overall Study||28
5065987|NCT01846104|12465723|P1|NOT COMPLETED|Overall Study||1
5065988|NCT01846104|12465723|P1|COMPLETED|Overall Study||3
5065989|NCT01846104|12465723|P1|STARTED|Overall Study||4
5065990|NCT01846039|12465729|P1|NOT COMPLETED|Overall Study||2
5065991|NCT01846039|12465729|P1|COMPLETED|Overall Study||27
5065992|NCT01846039|12465729|P1|STARTED|Overall Study||29
5065993|NCT01845974|12465741|P2|NOT COMPLETED|Overall Study||0
5065994|NCT01845974|12465742|P1|NOT COMPLETED|Overall Study||1
5065995|NCT01845974|12465741|P2|COMPLETED|Overall Study||9
5065996|NCT01845974|12465742|P1|COMPLETED|Overall Study||3
5065997|NCT01845974|12465741|P2|STARTED|Overall Study||9
5065998|NCT01845974|12465742|P1|STARTED|Overall Study||4
5065999|NCT01845831|12465750|P5|NOT COMPLETED|Outpatient Phase||0
5066000|NCT01845831|12465751|P4|NOT COMPLETED|Outpatient Phase||0
5066001|NCT01845831|12465752|P3|NOT COMPLETED|Outpatient Phase||0
5066002|NCT01845831|12465753|P2|NOT COMPLETED|Outpatient Phase||0
5066003|NCT01845831|12465754|P1|NOT COMPLETED|Outpatient Phase||0
5066004|NCT01845831|12465750|P5|COMPLETED|Outpatient Phase||87
5066005|NCT01845831|12465751|P4|COMPLETED|Outpatient Phase||98
5066006|NCT01845831|12465752|P3|COMPLETED|Outpatient Phase||68
5066007|NCT01845831|12465753|P2|COMPLETED|Outpatient Phase||0
5066008|NCT01845831|12465754|P1|COMPLETED|Outpatient Phase||0
5066009|NCT01845831|12465750|P5|STARTED|Outpatient Phase||87
5066010|NCT01845831|12465751|P4|STARTED|Outpatient Phase||98
5066011|NCT01845831|12465752|P3|STARTED|Outpatient Phase||68
5066012|NCT01845831|12465753|P2|STARTED|Outpatient Phase||0
5066013|NCT01845831|12465754|P1|STARTED|Outpatient Phase||0
5066014|NCT01845831|12465750|P5|NOT COMPLETED|Inpatient Phase||0
5066015|NCT01845831|12465751|P4|NOT COMPLETED|Inpatient Phase||0
5066016|NCT01845831|12465752|P3|NOT COMPLETED|Inpatient Phase||0
5066017|NCT01845831|12465753|P2|NOT COMPLETED|Inpatient Phase||1
5066018|NCT01845831|12465754|P1|NOT COMPLETED|Inpatient Phase||1
5066019|NCT01845831|12465750|P5|COMPLETED|Inpatient Phase||0
5066020|NCT01845831|12465751|P4|COMPLETED|Inpatient Phase||0
5066021|NCT01845831|12465752|P3|COMPLETED|Inpatient Phase||0
5066022|NCT01845831|12465753|P2|COMPLETED|Inpatient Phase||138
5066023|NCT01845831|12465754|P1|COMPLETED|Inpatient Phase||139
5066024|NCT01845831|12465750|P5|STARTED|Inpatient Phase||0
5066025|NCT01845831|12465751|P4|STARTED|Inpatient Phase||0
5066026|NCT01845831|12465752|P3|STARTED|Inpatient Phase||0
5066027|NCT01845831|12465753|P2|STARTED|Inpatient Phase||139
5066028|NCT01845831|12465754|P1|STARTED|Inpatient Phase||140
5066029|NCT01845818|12465783|P2|NOT COMPLETED|Overall Study||17
5066030|NCT01845818|12465784|P1|NOT COMPLETED|Overall Study||45
5066031|NCT01845818|12465783|P2|COMPLETED|Overall Study||40
5066032|NCT01845818|12465784|P1|COMPLETED|Overall Study||81
5066033|NCT01845818|12465783|P2|STARTED|Overall Study||57
5066034|NCT01845818|12465784|P1|STARTED|Overall Study||126
5066035|NCT01845792|12465825|P2|NOT COMPLETED|Overall Study||0
5066036|NCT01845792|12465826|P1|NOT COMPLETED|Overall Study||0
5066037|NCT01845792|12465825|P2|COMPLETED|Overall Study||2
5066038|NCT01845792|12465826|P1|COMPLETED|Overall Study||5
5066039|NCT01845792|12465825|P2|STARTED|Overall Study||2
5066040|NCT01845792|12465826|P1|STARTED|Overall Study||5
5066041|NCT01845636|12465834|P1|NOT COMPLETED|Overall Study||4
5066042|NCT01845636|12465834|P1|COMPLETED|Overall Study||37
5066043|NCT01845636|12465834|P1|STARTED|Overall Study||41
5066044|NCT01845220|12465842|P2|NOT COMPLETED|Overall Study||0
5066045|NCT01845220|12465843|P1|NOT COMPLETED|Overall Study||0
5066046|NCT01845220|12465842|P2|COMPLETED|Overall Study||30
5066047|NCT01845220|12465843|P1|COMPLETED|Overall Study||30
5066048|NCT01845220|12465842|P2|STARTED|Overall Study||30
5066049|NCT01845220|12465843|P1|STARTED|Overall Study||30
5066050|NCT01845155|12465851|P2|NOT COMPLETED|Overall Study||0
5066051|NCT01845155|12465852|P1|NOT COMPLETED|Overall Study||1
5066052|NCT01845155|12465851|P2|COMPLETED|Overall Study||144
5066053|NCT01845155|12465852|P1|COMPLETED|Overall Study||145
5066054|NCT01845155|12465851|P2|STARTED|Overall Study||144
5066055|NCT01845155|12465852|P1|STARTED|Overall Study||146
5066056|NCT01845103|12465860|P1|NOT COMPLETED|Overall Study||0
5066057|NCT01845103|12465860|P1|COMPLETED|Overall Study||1
5066058|NCT01845103|12465860|P1|STARTED|Overall Study||1
5066059|NCT01845077|12465868|P6|NOT COMPLETED|Treatment Period 2||0
5066060|NCT01845077|12465869|P5|NOT COMPLETED|Treatment Period 2||0
5066061|NCT01845077|12465870|P4|NOT COMPLETED|Treatment Period 2||0
5066062|NCT01845077|12465871|P3|NOT COMPLETED|Treatment Period 2||0
5066063|NCT01845077|12465872|P2|NOT COMPLETED|Treatment Period 2||0
5066064|NCT01845077|12465873|P1|NOT COMPLETED|Treatment Period 2||0
5066065|NCT01845077|12465868|P6|COMPLETED|Treatment Period 2||11
5066066|NCT01845077|12465869|P5|COMPLETED|Treatment Period 2||11
5066067|NCT01845077|12465870|P4|COMPLETED|Treatment Period 2||10
5066068|NCT01845077|12465871|P3|COMPLETED|Treatment Period 2||11
5066069|NCT01845077|12465872|P2|COMPLETED|Treatment Period 2||11
5066070|NCT01845077|12465873|P1|COMPLETED|Treatment Period 2||11
5066071|NCT01845077|12465868|P6|STARTED|Treatment Period 2||11
5066072|NCT01845077|12465869|P5|STARTED|Treatment Period 2||11
5066073|NCT01845077|12465870|P4|STARTED|Treatment Period 2||10
5066074|NCT01845077|12465871|P3|STARTED|Treatment Period 2||11
5066075|NCT01845077|12465872|P2|STARTED|Treatment Period 2||11
5066076|NCT01845077|12465873|P1|STARTED|Treatment Period 2||11
5066077|NCT01845077|12465868|P6|NOT COMPLETED|Washout Period||1
5066078|NCT01845077|12465869|P5|NOT COMPLETED|Washout Period||1
5066079|NCT01845077|12465870|P4|NOT COMPLETED|Washout Period||2
5066080|NCT01845077|12465871|P3|NOT COMPLETED|Washout Period||1
5066081|NCT01845077|12465872|P2|NOT COMPLETED|Washout Period||1
5066082|NCT01845077|12465873|P1|NOT COMPLETED|Washout Period||1
5066083|NCT01845077|12465868|P6|COMPLETED|Washout Period||11
5066084|NCT01845077|12465869|P5|COMPLETED|Washout Period||11
5066085|NCT01845077|12465870|P4|COMPLETED|Washout Period||10
5066086|NCT01845077|12465871|P3|COMPLETED|Washout Period||11
5066087|NCT01845077|12465872|P2|COMPLETED|Washout Period||11
5066088|NCT01845077|12465873|P1|COMPLETED|Washout Period||11
5066089|NCT01845077|12465868|P6|STARTED|Washout Period||12
5066090|NCT01845077|12465869|P5|STARTED|Washout Period||12
5066091|NCT01845077|12465870|P4|STARTED|Washout Period||12
5066092|NCT01845077|12465871|P3|STARTED|Washout Period||12
5066093|NCT01845077|12465872|P2|STARTED|Washout Period||12
5066094|NCT01845077|12465873|P1|STARTED|Washout Period||12
5066095|NCT01845077|12465868|P6|NOT COMPLETED|Treatment Period 1||0
5066096|NCT01845077|12465869|P5|NOT COMPLETED|Treatment Period 1||0
5066097|NCT01845077|12465870|P4|NOT COMPLETED|Treatment Period 1||0
5066098|NCT01845077|12465871|P3|NOT COMPLETED|Treatment Period 1||0
5066099|NCT01845077|12465872|P2|NOT COMPLETED|Treatment Period 1||0
5066100|NCT01845077|12465873|P1|NOT COMPLETED|Treatment Period 1||0
5066101|NCT01845077|12465868|P6|COMPLETED|Treatment Period 1||12
5066102|NCT01845077|12465869|P5|COMPLETED|Treatment Period 1||12
5066103|NCT01845077|12465870|P4|COMPLETED|Treatment Period 1||12
5066104|NCT01845077|12465871|P3|COMPLETED|Treatment Period 1||12
5066105|NCT01845077|12465872|P2|COMPLETED|Treatment Period 1||12
5066106|NCT01845077|12465873|P1|COMPLETED|Treatment Period 1||12
5066107|NCT01845077|12465868|P6|STARTED|Treatment Period 1||12
5066108|NCT01845077|12465869|P5|STARTED|Treatment Period 1||12
5066109|NCT01845077|12465870|P4|STARTED|Treatment Period 1||12
5066110|NCT01845077|12465871|P3|STARTED|Treatment Period 1||12
5066111|NCT01845077|12465872|P2|STARTED|Treatment Period 1||12
5066112|NCT01845077|12465873|P1|STARTED|Treatment Period 1||12
5066113|NCT01845025|12465919|P2|NOT COMPLETED|Overall Study||77
5066114|NCT01845025|12465920|P1|NOT COMPLETED|Overall Study||85
5066115|NCT01845025|12465919|P2|COMPLETED|Overall Study||332
5066116|NCT01845025|12465920|P1|COMPLETED|Overall Study||326
5066117|NCT01845025|12465919|P2|STARTED|Overall Study||409
5066118|NCT01845025|12465920|P1|STARTED|Overall Study||411
5066119|NCT01844986|12465944|P2|NOT COMPLETED|Overall Study||40
5066120|NCT01844986|12465945|P1|NOT COMPLETED|Overall Study||77
5066121|NCT01844986|12465944|P2|COMPLETED|Overall Study||91
5066122|NCT01844986|12465945|P1|COMPLETED|Overall Study||183
5066123|NCT01844986|12465944|P2|STARTED|Overall Study||131
5066124|NCT01844986|12465945|P1|STARTED|Overall Study||260
5066125|NCT01844895|12465967|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
5066126|NCT01844895|12465967|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
5066127|NCT01844895|12465967|P1|STARTED|Day 29 - Day113 - Autoinjector||117
5066128|NCT01844895|12465967|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
5066129|NCT01844895|12465967|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
5066130|NCT01844895|12465967|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
5066131|NCT01844856|12465985|P2|NOT COMPLETED|Overall Study||16
5066132|NCT01844856|12465986|P1|NOT COMPLETED|Overall Study||24
5066133|NCT01844856|12465985|P2|COMPLETED|Overall Study||255
5066134|NCT01844856|12465986|P1|COMPLETED|Overall Study||246
5066135|NCT01844856|12465985|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
5066136|NCT01844856|12465986|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
5066137|NCT01844856|12465985|P2|STARTED|Overall Study||271
5066138|NCT01844856|12465986|P1|STARTED|Overall Study||270
5066139|NCT01844830|12465998|P2|NOT COMPLETED|Overall Study||0
5066140|NCT01844830|12465999|P1|NOT COMPLETED|Overall Study||1
5066141|NCT01844830|12465998|P2|COMPLETED|Overall Study||30
5066142|NCT01844830|12465999|P1|COMPLETED|Overall Study||59
5066143|NCT01844830|12465998|P2|400 µL Dose|Overall Study||10
5066144|NCT01844830|12465999|P1|400 µL Dose|Overall Study||20
5066145|NCT01844830|12465998|P2|200 µL Dose|Overall Study||12
5066146|NCT01844830|12465999|P1|200 µL Dose|Overall Study||24
5066147|NCT01844830|12465998|P2|100 µL Dose|Overall Study||8
5066148|NCT01844830|12465999|P1|100 µL Dose|Overall Study||16
5066149|NCT01844830|12465998|P2|STARTED|Overall Study||30
5066150|NCT01844830|12465999|P1|STARTED|Overall Study||60
5066151|NCT01844817|12466029|P2|NOT COMPLETED|Treatment||63
5066152|NCT01844817|12466030|P1|NOT COMPLETED|Treatment||64
5066153|NCT01844817|12466029|P2|COMPLETED|Treatment||0
5066154|NCT01844817|12466030|P1|COMPLETED|Treatment||0
5066155|NCT01844817|12466029|P2|STARTED|Treatment||63
5066156|NCT01844817|12466030|P1|STARTED|Treatment||64
5066157|NCT01844817|12466029|P2|NOT COMPLETED|Enrolled and Randomized||3
5066158|NCT01844817|12466030|P1|NOT COMPLETED|Enrolled and Randomized||2
5066159|NCT01844817|12466029|P2|COMPLETED|Enrolled and Randomized||63
5066160|NCT01844817|12466030|P1|COMPLETED|Enrolled and Randomized||64
5066161|NCT01844817|12466029|P2|STARTED|Enrolled and Randomized||66
5066162|NCT01844817|12466030|P1|STARTED|Enrolled and Randomized||66
5066163|NCT01844778|12466043|P3|NOT COMPLETED|Overall Study||4
5066164|NCT01844778|12466044|P2|NOT COMPLETED|Overall Study||3
5066165|NCT01844778|12466045|P1|NOT COMPLETED|Overall Study||2
5066166|NCT01844778|12466043|P3|COMPLETED|Overall Study||14
5066167|NCT01844778|12466044|P2|COMPLETED|Overall Study||25
5066168|NCT01844778|12466045|P1|COMPLETED|Overall Study||12
5066169|NCT01844778|12466043|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
5066170|NCT01844778|12466044|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
5066171|NCT01844778|12466045|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
5066172|NCT01844778|12466043|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
5066173|NCT01844778|12466044|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
5066174|NCT01844778|12466045|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
5066175|NCT01844778|12466043|P3|STARTED|Overall Study||18
5066176|NCT01844778|12466044|P2|STARTED|Overall Study||28
5066177|NCT01844778|12466045|P1|STARTED|Overall Study||14
5066178|NCT01844765|12466071|P2|NOT COMPLETED|Overall Study||6
5066179|NCT01844765|12466072|P1|NOT COMPLETED|Overall Study||9
5066180|NCT01844765|12466071|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
5066181|NCT01844765|12466072|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
5066182|NCT01844765|12466071|P2|Untreated|Overall Study||0
5066183|NCT01844765|12466072|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
5066184|NCT01844765|12466071|P2|Treated|Overall Study||25
5066185|NCT01844765|12466072|P1|Treated|Overall Study||33
5066186|NCT01844765|12466071|P2|STARTED|Overall Study||25
5066187|NCT01844765|12466072|P1|STARTED|Overall Study||34
5066188|NCT01844700|12466092|P2|NOT COMPLETED|Overall Study||1
5066189|NCT01844700|12466093|P1|NOT COMPLETED|Overall Study||3
5066190|NCT01844700|12466092|P2|COMPLETED|Overall Study||2
5066191|NCT01844700|12466093|P1|COMPLETED|Overall Study||1
5066192|NCT01844700|12466092|P2|STARTED|Overall Study||3
5066193|NCT01844700|12466093|P1|STARTED|Overall Study||4
5066194|NCT01844687|12466105|P1|NOT COMPLETED|Visit 8||0
5066195|NCT01844687|12466105|P1|COMPLETED|Visit 8||31
5066196|NCT01844687|12466105|P1|STARTED|Visit 8||31
5066197|NCT01844687|12466105|P1|NOT COMPLETED|Visit 7||0
5066198|NCT01844687|12466105|P1|COMPLETED|Visit 7||31
5066199|NCT01844687|12466105|P1|STARTED|Visit 7||31
5066200|NCT01844687|12466105|P1|NOT COMPLETED|Visit 6||0
5066201|NCT01844687|12466105|P1|COMPLETED|Visit 6||31
5066202|NCT01844687|12466105|P1|STARTED|Visit 6||31
5066203|NCT01844687|12466105|P1|NOT COMPLETED|Visit 5||0
5066204|NCT01844687|12466105|P1|COMPLETED|Visit 5||31
5066205|NCT01844687|12466105|P1|STARTED|Visit 5||31
5066206|NCT01844687|12466105|P1|NOT COMPLETED|Visit 4||4
5066207|NCT01844687|12466105|P1|COMPLETED|Visit 4||31
5066208|NCT01844687|12466105|P1|STARTED|Visit 4||35
5066209|NCT01844687|12466105|P1|NOT COMPLETED|Visit 3||5
5066210|NCT01844687|12466105|P1|COMPLETED|Visit 3||35
5066211|NCT01844687|12466105|P1|STARTED|Visit 3||40
5066212|NCT01844687|12466105|P1|NOT COMPLETED|Visit 2||2
5066213|NCT01844687|12466105|P1|COMPLETED|Visit 2||40
5066214|NCT01844687|12466105|P1|STARTED|Visit 2||42
5066215|NCT01844687|12466105|P1|NOT COMPLETED|Visit 1||8
5066216|NCT01844687|12466105|P1|COMPLETED|Visit 1||42
5066217|NCT01844687|12466105|P1|STARTED|Visit 1||50
5066218|NCT01844583|12466166|P2|NOT COMPLETED|Overall Study||10
5066219|NCT01844583|12466167|P1|NOT COMPLETED|Overall Study||8
5066220|NCT01844583|12466166|P2|COMPLETED|Overall Study||19
5066221|NCT01844583|12466167|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
5066222|NCT01844583|12466166|P2|STARTED|Overall Study||29
5066223|NCT01844583|12466167|P1|STARTED|Overall Study||26
5066224|NCT01844531|12466199|P4|NOT COMPLETED|Overall Study||0
5066225|NCT01844531|12466200|P3|NOT COMPLETED|Overall Study||0
5066226|NCT01844531|12466201|P2|NOT COMPLETED|Overall Study||1
5066227|NCT01844531|12466202|P1|NOT COMPLETED|Overall Study||0
5066228|NCT01844531|12466199|P4|COMPLETED|Overall Study||6
5066229|NCT01844531|12466200|P3|COMPLETED|Overall Study||6
5066230|NCT01844531|12466201|P2|COMPLETED|Overall Study||5
5066231|NCT01844531|12466202|P1|COMPLETED|Overall Study||6
5066232|NCT01844531|12466199|P4|STARTED|Overall Study||6
5066233|NCT01844531|12466200|P3|STARTED|Overall Study||6
5066234|NCT01844531|12466201|P2|STARTED|Overall Study||6
5066235|NCT01844531|12466202|P1|STARTED|Overall Study||6
5066236|NCT01844518|12466232|P1|NOT COMPLETED|Long-Term Extension||157
5066237|NCT01844518|12466232|P1|COMPLETED|Long-Term Extension|Study is on-going|0
5066238|NCT01844518|12466232|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
5066239|NCT01844518|12466232|P1|NOT COMPLETED|Short-Term (ST) Period||9
5066240|NCT01844518|12466232|P1|COMPLETED|Short-Term (ST) Period||164
5066241|NCT01844518|12466232|P1|STARTED|Short-Term (ST) Period||173
5066242|NCT01844505|12466249|P3|NOT COMPLETED|Overall Study||295
5066243|NCT01844505|12466250|P2|NOT COMPLETED|Overall Study||269
5066244|NCT01844505|12466251|P1|NOT COMPLETED|Overall Study||249
5066245|NCT01844505|12466249|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
5066246|NCT01844505|12466250|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
5066247|NCT01844505|12466251|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
5066248|NCT01844505|12466249|P3|STARTED|Overall Study||311
5066249|NCT01844505|12466250|P2|STARTED|Overall Study||313
5066250|NCT01844505|12466251|P1|STARTED|Overall Study||313
5066251|NCT01844479|12466301|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
5066252|NCT01844479|12466302|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
5066253|NCT01844479|12466301|P2|COMPLETED|Second Intervention up to 30 Minutes||13
5066254|NCT01844479|12466302|P1|COMPLETED|Second Intervention up to 30 Minutes||14
5066255|NCT01844479|12466301|P2|STARTED|Second Intervention up to 30 Minutes||13
5066256|NCT01844479|12466302|P1|STARTED|Second Intervention up to 30 Minutes||14
5066257|NCT01844479|12466301|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
5066258|NCT01844479|12466302|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
5066259|NCT01844479|12466301|P2|COMPLETED|First Intervention up to 30 Minutes||13
5066260|NCT01844479|12466302|P1|COMPLETED|First Intervention up to 30 Minutes||14
5066261|NCT01844479|12466301|P2|STARTED|First Intervention up to 30 Minutes||13
5066262|NCT01844479|12466302|P1|STARTED|First Intervention up to 30 Minutes||14
5066263|NCT01844388|12466332|P2|NOT COMPLETED|Overall Study||7
5066264|NCT01844388|12466333|P1|NOT COMPLETED|Overall Study||8
5066265|NCT01844388|12466332|P2|COMPLETED|Overall Study||114
5066266|NCT01844388|12466333|P1|COMPLETED|Overall Study||236
5066267|NCT01844388|12466332|P2|STARTED|Overall Study||121
5066268|NCT01844388|12466333|P1|STARTED|Overall Study||244
5066269|NCT01844375|12466345|P2|NOT COMPLETED|Overall Study||1
5066270|NCT01844375|12466346|P1|NOT COMPLETED|Overall Study||1
5066271|NCT01844375|12466345|P2|COMPLETED|Overall Study||34
5066272|NCT01844375|12466346|P1|COMPLETED|Overall Study||34
5066273|NCT01844375|12466345|P2|STARTED|Overall Study||35
5066274|NCT01844375|12466346|P1|STARTED|Overall Study||35
5066275|NCT01844284|12466358|P2|NOT COMPLETED|Overall Study||7
5066276|NCT01844284|12466359|P1|NOT COMPLETED|Overall Study||12
5066277|NCT01844284|12466358|P2|COMPLETED|Overall Study||127
5066278|NCT01844284|12466359|P1|COMPLETED|Overall Study||254
5066279|NCT01844284|12466358|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
5066280|NCT01844284|12466359|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
5066281|NCT01844206|12466569|P2|NOT COMPLETED|Overall Study||1
5066282|NCT01844206|12466570|P1|NOT COMPLETED|Overall Study||0
5066283|NCT01844206|12466569|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
5066284|NCT01844206|12466570|P1|COMPLETED|Overall Study||2
5066285|NCT01844206|12466569|P2|STARTED|Overall Study||3
5066286|NCT01844206|12466570|P1|STARTED|Overall Study||2
5066287|NCT01844115|12466578|P2|NOT COMPLETED|Overall Study||58
5066288|NCT01844115|12466579|P1|NOT COMPLETED|Overall Study||39
5066289|NCT01844115|12466578|P2|COMPLETED|Overall Study||144
5066290|NCT01844115|12466579|P1|COMPLETED|Overall Study||163
5066291|NCT01844115|12466578|P2|STARTED|Overall Study||202
5066292|NCT01844115|12466579|P1|STARTED|Overall Study||202
5066293|NCT01843972|12466597|P10|NOT COMPLETED|Overall Study||0
5066294|NCT01843972|12466598|P9|NOT COMPLETED|Overall Study||0
5066295|NCT01843972|12466599|P8|NOT COMPLETED|Overall Study||0
5066296|NCT01843972|12466600|P7|NOT COMPLETED|Overall Study||0
5066297|NCT01843972|12466601|P6|NOT COMPLETED|Overall Study||0
5066298|NCT01843972|12466602|P5|NOT COMPLETED|Overall Study||1
5066299|NCT01843972|12466603|P4|NOT COMPLETED|Overall Study||0
5066300|NCT01843972|12466604|P3|NOT COMPLETED|Overall Study||0
5066301|NCT01843972|12466605|P2|NOT COMPLETED|Overall Study||0
5066302|NCT01843972|12466606|P1|NOT COMPLETED|Overall Study||0
5066303|NCT01843972|12466597|P10|COMPLETED|Overall Study||12
5066304|NCT01843972|12466598|P9|COMPLETED|Overall Study||17
5066305|NCT01843972|12466599|P8|COMPLETED|Overall Study||5
5066306|NCT01843972|12466600|P7|COMPLETED|Overall Study||5
5066307|NCT01843972|12466601|P6|COMPLETED|Overall Study||6
5066308|NCT01843972|12466602|P5|COMPLETED|Overall Study||5
5066309|NCT01843972|12466603|P4|COMPLETED|Overall Study||6
5066310|NCT01843972|12466604|P3|COMPLETED|Overall Study||5
5066311|NCT01843972|12466605|P2|COMPLETED|Overall Study||6
5066312|NCT01843972|12466606|P1|COMPLETED|Overall Study||13
5066313|NCT01843972|12466597|P10|STARTED|Overall Study||12
5066314|NCT01843972|12466598|P9|STARTED|Overall Study||17
5066315|NCT01843972|12466599|P8|STARTED|Overall Study||5
5066316|NCT01843972|12466600|P7|STARTED|Overall Study||5
5066317|NCT01843972|12466601|P6|STARTED|Overall Study||6
5066318|NCT01843972|12466602|P5|STARTED|Overall Study||6
5066319|NCT01843972|12466603|P4|STARTED|Overall Study||6
5066320|NCT01843972|12466604|P3|STARTED|Overall Study||5
5066321|NCT01843972|12466605|P2|STARTED|Overall Study||6
5066322|NCT01843972|12466606|P1|STARTED|Overall Study||13
5066323|NCT01843933|12466676|P2|NOT COMPLETED|Overall Study||4
5066324|NCT01843933|12466677|P1|NOT COMPLETED|Overall Study||6
5066325|NCT01843933|12466676|P2|COMPLETED|Overall Study||103
5066326|NCT01843933|12466677|P1|COMPLETED|Overall Study||98
5066327|NCT01843933|12466676|P2|STARTED|Overall Study||107
5066328|NCT01843933|12466677|P1|STARTED|Overall Study||104
5066329|NCT01843920|12466685|P2|NOT COMPLETED|Overall Study||0
5066330|NCT01843920|12466686|P1|NOT COMPLETED|Overall Study||0
5066331|NCT01843920|12466685|P2|COMPLETED|Overall Study||9
5066332|NCT01843920|12466686|P1|COMPLETED|Overall Study||12
5066333|NCT01843920|12466685|P2|STARTED|Overall Study||9
5066334|NCT01843920|12466686|P1|STARTED|Overall Study||12
5066335|NCT01843842|12466696|P2|NOT COMPLETED|Overall Study||1
5066336|NCT01843842|12466697|P1|NOT COMPLETED|Overall Study||1
5066337|NCT01843842|12466696|P2|COMPLETED|Overall Study||151
5066338|NCT01843842|12466697|P1|COMPLETED|Overall Study||153
5066339|NCT01843842|12466696|P2|STARTED|Overall Study||152
5066340|NCT01843842|12466697|P1|STARTED|Overall Study||154
5066341|NCT01843803|12466719|P2|NOT COMPLETED|Overall Study||3
5066342|NCT01843803|12466720|P1|NOT COMPLETED|Overall Study||1
5066343|NCT01843803|12466719|P2|COMPLETED|Overall Study||136
5066344|NCT01843803|12466720|P1|COMPLETED|Overall Study||136
5066345|NCT01843803|12466719|P2|STARTED|Overall Study||139
5066346|NCT01843803|12466720|P1|STARTED|Overall Study||137
5066347|NCT01843777|12466734|P2|NOT COMPLETED|Overall Study||0
5066348|NCT01843777|12466735|P1|NOT COMPLETED|Overall Study||1
5066349|NCT01843777|12466734|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
5066350|NCT01843777|12466735|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
5066351|NCT01843777|12466734|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
5066352|NCT01843777|12466735|P1|Per Protocol Population|Overall Study||11
5066353|NCT01843777|12466734|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
5066354|NCT01843777|12466735|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
5066355|NCT01843751|12466745|P2|NOT COMPLETED|Overall Study||7
5066356|NCT01843751|12466746|P1|NOT COMPLETED|Overall Study||11
5066357|NCT01843751|12466745|P2|COMPLETED|Overall Study||3
5066358|NCT01843751|12466746|P1|COMPLETED|Overall Study||0
5066359|NCT01843751|12466745|P2|STARTED|Overall Study||10
5066360|NCT01843751|12466746|P1|STARTED|Overall Study||11
5066361|NCT01843673|12466760|P1|NOT COMPLETED|Overall Study||6
5066362|NCT01843673|12466760|P1|COMPLETED|Overall Study||10
5066363|NCT01843673|12466760|P1|STARTED|Overall Study||16
5066364|NCT01843660|12466772|P1|NOT COMPLETED|Overall Study||30
5066365|NCT01843660|12466772|P1|COMPLETED|Overall Study||1029
5066366|NCT01843660|12466772|P1|STARTED|Overall Study||1059
5066367|NCT01843621|12466790|P1|NOT COMPLETED|Overall Study||0
5066368|NCT01843621|12466790|P1|COMPLETED|Overall Study||7
5066369|NCT01843621|12466790|P1|STARTED|Overall Study||7
5066370|NCT01843465|12466807|P1|NOT COMPLETED|Overall Study||0
5066371|NCT01843465|12466807|P1|COMPLETED|Overall Study||34
5066372|NCT01843465|12466807|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
5066373|NCT01843374|12466813|P2|NOT COMPLETED|Overall Study||379
5066374|NCT01843374|12466814|P1|NOT COMPLETED|Overall Study||189
5066375|NCT01843374|12466813|P2|COMPLETED|Overall Study||3
5066376|NCT01843374|12466814|P1|COMPLETED|Overall Study||0
5066377|NCT01843374|12466813|P2|RANDOMIZED|Overall Study||382
5066378|NCT01843374|12466814|P1|RANDOMIZED|Overall Study||189
5066379|NCT01843374|12466813|P2|STARTED|Overall Study||382
5066380|NCT01843374|12466814|P1|STARTED|Overall Study||189
5066381|NCT01843348|12466841|P3|NOT COMPLETED|Overall Study||41
5066382|NCT01843348|12466842|P2|NOT COMPLETED|Overall Study||40
5066383|NCT01843348|12466843|P1|NOT COMPLETED|Overall Study||23
5066384|NCT01843348|12466841|P3|COMPLETED|Overall Study||158
5066385|NCT01843348|12466842|P2|COMPLETED|Overall Study||168
5066386|NCT01843348|12466843|P1|COMPLETED|Overall Study||182
5066387|NCT01843348|12466841|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
5066388|NCT01843348|12466842|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
5066389|NCT01843348|12466843|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
5066390|NCT01843348|12466841|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
5066391|NCT01843348|12466842|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
5066392|NCT01843348|12466843|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
5066393|NCT01843348|12466841|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
5066394|NCT01843348|12466842|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
5066395|NCT01843348|12466843|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
5066396|NCT01843348|12466841|P3|STARTED|Overall Study||199
5066397|NCT01843348|12466842|P2|STARTED|Overall Study||208
5066398|NCT01843348|12466843|P1|STARTED|Overall Study||205
5066399|NCT01843205|12466883|P2|NOT COMPLETED|Second Treatment (11 Days)||0
5066400|NCT01843205|12466884|P1|NOT COMPLETED|Second Treatment (11 Days)||0
5066401|NCT01843205|12466883|P2|COMPLETED|Second Treatment (11 Days)||4
5066402|NCT01843205|12466884|P1|COMPLETED|Second Treatment (11 Days)||4
5066403|NCT01843205|12466883|P2|STARTED|Second Treatment (11 Days)||4
5066404|NCT01843205|12466884|P1|STARTED|Second Treatment (11 Days)||4
5066405|NCT01843205|12466883|P2|NOT COMPLETED|First Treatment (11 Days)||0
5066406|NCT01843205|12466884|P1|NOT COMPLETED|First Treatment (11 Days)||1
5066407|NCT01843205|12466883|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
5066408|NCT01843205|12466884|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
5066409|NCT01843205|12466883|P2|STARTED|First Treatment (11 Days)||4
5066410|NCT01843205|12466884|P1|STARTED|First Treatment (11 Days)||5
5066411|NCT01843192|12466945|P3|NOT COMPLETED|Overall Study||2
5066412|NCT01843192|12466946|P2|NOT COMPLETED|Overall Study||6
5066413|NCT01843192|12466947|P1|NOT COMPLETED|Overall Study||2
5066414|NCT01843192|12466945|P3|COMPLETED|Overall Study||9
5066415|NCT01843192|12466946|P2|COMPLETED|Overall Study||28
5066416|NCT01843192|12466947|P1|COMPLETED|Overall Study||24
5066417|NCT01843192|12466945|P3|STARTED|Overall Study||11
5066418|NCT01843192|12466946|P2|STARTED|Overall Study||34
5066419|NCT01843192|12466947|P1|STARTED|Overall Study||26
5066420|NCT01843062|12466978|P2|NOT COMPLETED|Overall Study||9
5066421|NCT01843062|12466979|P1|NOT COMPLETED|Overall Study||22
5066422|NCT01843062|12466978|P2|COMPLETED|Overall Study||69
5066423|NCT01843062|12466979|P1|COMPLETED|Overall Study||133
5066424|NCT01843062|12466978|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
5066425|NCT01843062|12466979|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
5066426|NCT01843062|12466978|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
5066427|NCT01843062|12466979|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
5066428|NCT01843062|12466978|P2|Safety Analysis Set|Overall Study||77
5066429|NCT01843062|12466979|P1|Safety Analysis Set|Overall Study||154
5066430|NCT01843062|12466978|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
5066431|NCT01843062|12466979|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
5066432|NCT01843062|12466978|P2|STARTED|Overall Study||78
5066433|NCT01843062|12466979|P1|STARTED|Overall Study||155
5066434|NCT01842958|12466993|P2|NOT COMPLETED|Overall Study||1
5066435|NCT01842958|12466994|P1|NOT COMPLETED|Overall Study||1
5066436|NCT01842958|12466993|P2|COMPLETED|Overall Study||24
5066437|NCT01842958|12466994|P1|COMPLETED|Overall Study||24
5066438|NCT01842958|12466993|P2|Randomized|Overall Study||25
5066439|NCT01842958|12466994|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
5066440|NCT01842958|12466993|P2|STARTED|Overall Study||25
5066441|NCT01842958|12466994|P1|STARTED|Overall Study||25
5066442|NCT01842906|12467014|P2|NOT COMPLETED|Overall Study||0
5066443|NCT01842906|12467015|P1|NOT COMPLETED|Overall Study||0
5066444|NCT01842906|12467014|P2|COMPLETED|Overall Study||104
5066445|NCT01842906|12467015|P1|COMPLETED|Overall Study||115
5066446|NCT01842906|12467014|P2|STARTED|Overall Study||104
5066447|NCT01842906|12467015|P1|STARTED|Overall Study||115
5066448|NCT01842841|12467027|P1|NOT COMPLETED|Overall Study||0
5066449|NCT01842841|12467027|P1|COMPLETED|Overall Study||5
5066450|NCT01842841|12467027|P1|STARTED|Overall Study||5
5066451|NCT01842789|12467048|P2|NOT COMPLETED|Overall Study||0
5066452|NCT01842789|12467049|P1|NOT COMPLETED|Overall Study||0
5066453|NCT01842789|12467048|P2|COMPLETED|Overall Study||8
5066454|NCT01842789|12467049|P1|COMPLETED|Overall Study||10
5066455|NCT01842789|12467048|P2|STARTED|Overall Study||8
5066456|NCT01842789|12467049|P1|STARTED|Overall Study||10
5066457|NCT01842646|12467058|P1|NOT COMPLETED|Overall Study||0
5066458|NCT01842646|12467058|P1|COMPLETED|Overall Study||35
5066459|NCT01842646|12467058|P1|STARTED|Overall Study||35
5066460|NCT01842633|12467069|P3|NOT COMPLETED|Overall Study||0
5066461|NCT01842633|12467070|P2|NOT COMPLETED|Overall Study||2
5066462|NCT01842633|12467071|P1|NOT COMPLETED|Overall Study||3
5066463|NCT01842633|12467069|P3|COMPLETED|Overall Study||34
5066464|NCT01842633|12467070|P2|COMPLETED|Overall Study||64
5066465|NCT01842633|12467071|P1|COMPLETED|Overall Study||62
5066466|NCT01842633|12467069|P3|STARTED|Overall Study||34
5066467|NCT01842633|12467070|P2|STARTED|Overall Study||66
5066468|NCT01842633|12467071|P1|STARTED|Overall Study||65
5066469|NCT01842620|12467118|P2|NOT COMPLETED|Period 2||0
5066470|NCT01842620|12467119|P1|NOT COMPLETED|Period 2||0
5066471|NCT01842620|12467118|P2|COMPLETED|Period 2||12
5066472|NCT01842620|12467119|P1|COMPLETED|Period 2||12
5066473|NCT01842620|12467118|P2|STARTED|Period 2||12
5066474|NCT01842620|12467119|P1|STARTED|Period 2||12
5066475|NCT01842620|12467118|P2|NOT COMPLETED|Washout Period||0
5066476|NCT01842620|12467119|P1|NOT COMPLETED|Washout Period||0
5066477|NCT01842620|12467118|P2|COMPLETED|Washout Period||12
5066478|NCT01842620|12467119|P1|COMPLETED|Washout Period||12
5066479|NCT01842620|12467118|P2|STARTED|Washout Period||12
5066480|NCT01842620|12467119|P1|STARTED|Washout Period||12
5066481|NCT01842620|12467118|P2|NOT COMPLETED|Period 1||0
5066482|NCT01842620|12467119|P1|NOT COMPLETED|Period 1||1
5066483|NCT01842620|12467118|P2|COMPLETED|Period 1||12
5066484|NCT01842620|12467119|P1|COMPLETED|Period 1||12
5066485|NCT01842620|12467118|P2|STARTED|Period 1||12
5066486|NCT01842620|12467119|P1|STARTED|Period 1||13
5066487|NCT01842607|12467135|P1|NOT COMPLETED|Overall Study||66
5066488|NCT01842607|12467135|P1|COMPLETED|Overall Study||585
5066489|NCT01842607|12467135|P1|STARTED|Overall Study||651
5066490|NCT01842594|12467154|P1|NOT COMPLETED|Overall Study||3
5066491|NCT01842594|12467154|P1|COMPLETED|Overall Study||10
5066492|NCT01842594|12467154|P1|STARTED|Overall Study||13
5066493|NCT01842581|12467161|P2|NOT COMPLETED|Overall Study||30
5066494|NCT01842581|12467162|P1|NOT COMPLETED|Overall Study||44
5066495|NCT01842581|12467161|P2|COMPLETED|Overall Study||79
5066496|NCT01842581|12467162|P1|COMPLETED|Overall Study||69
5066497|NCT01842581|12467161|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
5066498|NCT01842581|12467162|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
5066499|NCT01842581|12467161|P2|STARTED|Overall Study||109
5066500|NCT01842581|12467162|P1|STARTED|Overall Study||113
5066501|NCT01842464|12467178|P1|NOT COMPLETED|Overall Study||0
5066502|NCT01842464|12467178|P1|COMPLETED|Overall Study||44
5066503|NCT01842464|12467178|P1|STARTED|Overall Study||44
5066504|NCT01842438|12467186|P2|NOT COMPLETED|T2: 6month Follow-up||4
5066505|NCT01842438|12467187|P1|NOT COMPLETED|T2: 6month Follow-up||4
5066506|NCT01842438|12467186|P2|COMPLETED|T2: 6month Follow-up||32
5066507|NCT01842438|12467187|P1|COMPLETED|T2: 6month Follow-up||32
5066508|NCT01842438|12467186|P2|STARTED|T2: 6month Follow-up||36
5066509|NCT01842438|12467187|P1|STARTED|T2: 6month Follow-up||36
5066510|NCT01842438|12467186|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
5066511|NCT01842438|12467187|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
5066512|NCT01842438|12467186|P2|COMPLETED|T1: Immediately After the Intervention||36
5066513|NCT01842438|12467187|P1|COMPLETED|T1: Immediately After the Intervention||36
5066514|NCT01842438|12467186|P2|STARTED|T1: Immediately After the Intervention||44
5066515|NCT01842438|12467187|P1|STARTED|T1: Immediately After the Intervention||42
5066516|NCT01842334|12467201|P2|NOT COMPLETED|Overall Study||4
5066517|NCT01842334|12467202|P1|NOT COMPLETED|Overall Study||3
5066518|NCT01842334|12467201|P2|COMPLETED|Overall Study||3
5066519|NCT01842334|12467202|P1|COMPLETED|Overall Study||2
5066520|NCT01842334|12467201|P2|STARTED|Overall Study||7
5066521|NCT01842334|12467202|P1|STARTED|Overall Study||5
5066522|NCT01841970|12467208|P1|NOT COMPLETED|Overall Study||11
5066523|NCT01841970|12467208|P1|COMPLETED|Overall Study||9
5066524|NCT01841970|12467208|P1|STARTED|Overall Study||20
5066525|NCT01841931|12467224|P1|NOT COMPLETED|Overall Study||4
5066526|NCT01841931|12467224|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
5066527|NCT01841931|12467224|P1|STARTED|Overall Study||4
5066528|NCT01841762|12467232|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
5066529|NCT01841762|12467232|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
5066530|NCT01841762|12467232|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
5066531|NCT01841762|12467232|P1|NOT COMPLETED|Treatment Period||32
5066532|NCT01841762|12467232|P1|COMPLETED|Treatment Period||252
5066533|NCT01841762|12467232|P1|STARTED|Treatment Period||284
5066534|NCT01841762|12467232|P1|NOT COMPLETED|Screening Period||51
5066535|NCT01841762|12467232|P1|COMPLETED|Screening Period||284
5066536|NCT01841762|12467232|P1|STARTED|Screening Period||335
5066537|NCT01841736|12467242|P2|NOT COMPLETED|Overall Study||0
5066538|NCT01841736|12467243|P1|NOT COMPLETED|Overall Study||0
5066539|NCT01841736|12467242|P2|COMPLETED|Overall Study||74
5066540|NCT01841736|12467243|P1|COMPLETED|Overall Study||97
5066541|NCT01841736|12467242|P2|Crossover|Overall Study||49
5066542|NCT01841736|12467243|P1|Crossover|Overall Study||0
5066543|NCT01841736|12467242|P2|STARTED|Overall Study||74
5066544|NCT01841736|12467243|P1|STARTED|Overall Study||97
5066545|NCT01841697|12467256|P2|NOT COMPLETED|Overall Study||18
5066546|NCT01841697|12467257|P1|NOT COMPLETED|Overall Study||20
5066547|NCT01841697|12467256|P2|COMPLETED|Overall Study||302
5066548|NCT01841697|12467257|P1|COMPLETED|Overall Study||302
5066549|NCT01841697|12467256|P2|STARTED|Overall Study||320
5066550|NCT01841697|12467257|P1|STARTED|Overall Study||322
5066551|NCT01841632|12467273|P1|NOT COMPLETED|Overall Study||0
5066552|NCT01841632|12467273|P1|COMPLETED|Overall Study||3
5066553|NCT01841632|12467273|P1|STARTED|Overall Study||3
5066554|NCT01841619|12467278|P1|NOT COMPLETED|Overall Study||0
5066555|NCT01841619|12467278|P1|COMPLETED|Overall Study||16
5066556|NCT01841619|12467278|P1|STARTED|Overall Study||16
5066557|NCT01841606|12467288|P2|NOT COMPLETED|Overall Study||0
5066558|NCT01841606|12467289|P1|NOT COMPLETED|Overall Study||0
5066559|NCT01841606|12467288|P2|COMPLETED|Overall Study||27
5066560|NCT01841606|12467289|P1|COMPLETED|Overall Study||25
5066561|NCT01841606|12467288|P2|STARTED|Overall Study||27
5066562|NCT01841606|12467289|P1|STARTED|Overall Study||25
5066563|NCT01841593|12467297|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
5066564|NCT01841593|12467298|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
5066565|NCT01841593|12467297|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
5066566|NCT01841593|12467298|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
5066567|NCT01841593|12467297|P2|STARTED|Third Intervention (Days 15 to 21)||6
5066568|NCT01841593|12467298|P1|STARTED|Third Intervention (Days 15 to 21)||11
5066569|NCT01841593|12467297|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
5066570|NCT01841593|12467298|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
5066571|NCT01841593|12467297|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
5066572|NCT01841593|12467298|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
5066573|NCT01841593|12467297|P2|STARTED|Second Intervention (Days 8 to 14)||6
5066574|NCT01841593|12467298|P1|STARTED|Second Intervention (Days 8 to 14)||12
5066575|NCT01841593|12467297|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
5066576|NCT01841593|12467298|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
5066577|NCT01841593|12467297|P2|COMPLETED|First Intervention (Days 1 to 7)||6
5066578|NCT01841593|12467298|P1|COMPLETED|First Intervention (Days 1 to 7)||12
5066579|NCT01841593|12467297|P2|STARTED|First Intervention (Days 1 to 7)||7
5066580|NCT01841593|12467298|P1|STARTED|First Intervention (Days 1 to 7)||12
5066581|NCT01841567|12467314|P1|NOT COMPLETED|Overall Study||3
5066582|NCT01841567|12467314|P1|COMPLETED|Overall Study||57
5066583|NCT01841567|12467314|P1|STARTED|Overall Study||60
5066584|NCT01841554|12467319|P1|NOT COMPLETED|Overall Study||19
5066585|NCT01841554|12467319|P1|COMPLETED|Overall Study||42
5066586|NCT01841554|12467319|P1|1 Year Follow Up|Overall Study||42
5066587|NCT01841554|12467319|P1|Implanted|Overall Study||60
5066588|NCT01841554|12467319|P1|STARTED|Overall Study||61
5066589|NCT01841281|12467332|P4|NOT COMPLETED|Second Intervention (12 Weeks)||0
5066590|NCT01841281|12467333|P3|NOT COMPLETED|Second Intervention (12 Weeks)||0
5066591|NCT01841281|12467334|P2|NOT COMPLETED|Second Intervention (12 Weeks)||3
5066592|NCT01841281|12467335|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
5066593|NCT01841281|12467332|P4|COMPLETED|Second Intervention (12 Weeks)||13
5066594|NCT01841281|12467333|P3|COMPLETED|Second Intervention (12 Weeks)||10
5066595|NCT01841281|12467334|P2|COMPLETED|Second Intervention (12 Weeks)||6
5066596|NCT01841281|12467335|P1|COMPLETED|Second Intervention (12 Weeks)||9
5066597|NCT01841281|12467332|P4|STARTED|Second Intervention (12 Weeks)||13
5066598|NCT01841281|12467333|P3|STARTED|Second Intervention (12 Weeks)||10
5066599|NCT01841281|12467334|P2|STARTED|Second Intervention (12 Weeks)||9
5066600|NCT01841281|12467335|P1|STARTED|Second Intervention (12 Weeks)||9
5066601|NCT01841281|12467332|P4|NOT COMPLETED|Washout (6 Weeks)||1
5066602|NCT01841281|12467333|P3|NOT COMPLETED|Washout (6 Weeks)||3
5066603|NCT01841281|12467334|P2|NOT COMPLETED|Washout (6 Weeks)||3
5066604|NCT01841281|12467335|P1|NOT COMPLETED|Washout (6 Weeks)||2
5066605|NCT01841281|12467332|P4|COMPLETED|Washout (6 Weeks)||13
5066606|NCT01841281|12467333|P3|COMPLETED|Washout (6 Weeks)||10
5066607|NCT01841281|12467334|P2|COMPLETED|Washout (6 Weeks)||9
5066608|NCT01841281|12467335|P1|COMPLETED|Washout (6 Weeks)||9
5066609|NCT01841281|12467332|P4|STARTED|Washout (6 Weeks)||14
5066610|NCT01841281|12467333|P3|STARTED|Washout (6 Weeks)||13
5066611|NCT01841281|12467334|P2|STARTED|Washout (6 Weeks)||12
5066612|NCT01841281|12467335|P1|STARTED|Washout (6 Weeks)||11
5066613|NCT01841281|12467332|P4|NOT COMPLETED|First Intervention (12 Weeks)||0
5066614|NCT01841281|12467333|P3|NOT COMPLETED|First Intervention (12 Weeks)||0
5066615|NCT01841281|12467334|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
5066616|NCT01841281|12467335|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
5066617|NCT01841281|12467332|P4|COMPLETED|First Intervention (12 Weeks)||14
5066618|NCT01841281|12467333|P3|COMPLETED|First Intervention (12 Weeks)||13
5066619|NCT01841281|12467334|P2|COMPLETED|First Intervention (12 Weeks)||12
5066620|NCT01841281|12467335|P1|COMPLETED|First Intervention (12 Weeks)||11
5066621|NCT01841281|12467332|P4|STARTED|First Intervention (12 Weeks)||14
5066622|NCT01841281|12467333|P3|STARTED|First Intervention (12 Weeks)||13
5066623|NCT01841281|12467334|P2|STARTED|First Intervention (12 Weeks)||12
5066624|NCT01841281|12467335|P1|STARTED|First Intervention (12 Weeks)||11
5066625|NCT01841216|12467357|P2|NOT COMPLETED|Overall Study||0
5066626|NCT01841216|12467358|P1|NOT COMPLETED|Overall Study||0
5066627|NCT01841216|12467357|P2|COMPLETED|Overall Study||15
5066628|NCT01841216|12467358|P1|COMPLETED|Overall Study||15
5066629|NCT01841216|12467357|P2|STARTED|Overall Study||15
5066630|NCT01841216|12467358|P1|STARTED|Overall Study||15
5066631|NCT01841073|12467368|P2|NOT COMPLETED|Overall Study||3
5066632|NCT01841073|12467369|P1|NOT COMPLETED|Overall Study||2
5066633|NCT01841073|12467368|P2|COMPLETED|Overall Study||19
5066634|NCT01841073|12467369|P1|COMPLETED|Overall Study||20
5066635|NCT01841073|12467368|P2|STARTED|Overall Study||22
5066636|NCT01841073|12467369|P1|STARTED|Overall Study||22
5066637|NCT01841021|12467379|P1|NOT COMPLETED|Overall Study||0
5066638|NCT01841021|12467379|P1|COMPLETED|Overall Study||1
5066639|NCT01841021|12467379|P1|STARTED|Overall Study||1
5066640|NCT01840943|12467391|P2|NOT COMPLETED|Overall Study||12
5066641|NCT01840943|12467392|P1|NOT COMPLETED|Overall Study||13
5066642|NCT01840943|12467391|P2|COMPLETED|Overall Study||0
5066643|NCT01840943|12467392|P1|COMPLETED|Overall Study||1
5066644|NCT01840943|12467391|P2|STARTED|Overall Study||12
5066645|NCT01840943|12467392|P1|STARTED|Overall Study||14
5066646|NCT01840722|12467428|P2|NOT COMPLETED|Overall Study||69
5066647|NCT01840722|12467429|P1|NOT COMPLETED|Overall Study||0
5066648|NCT01840722|12467428|P2|COMPLETED|Overall Study||130
5066649|NCT01840722|12467429|P1|COMPLETED|Overall Study||201
5066650|NCT01840722|12467428|P2|STARTED|Overall Study||199
5066651|NCT01840722|12467429|P1|STARTED|Overall Study||201
5066652|NCT01840605|12467441|P2|NOT COMPLETED|Overall Study||2
5066653|NCT01840605|12467442|P1|NOT COMPLETED|Overall Study||2
5066654|NCT01840605|12467441|P2|COMPLETED|Overall Study||150
5066655|NCT01840605|12467442|P1|COMPLETED|Overall Study||149
5066656|NCT01840605|12467441|P2|STARTED|Overall Study||152
5066657|NCT01840605|12467442|P1|STARTED|Overall Study||151
5066658|NCT01840410|12467456|P2|NOT COMPLETED|Overall Study||4
5066659|NCT01840410|12467457|P1|NOT COMPLETED|Overall Study||7
5066660|NCT01840410|12467456|P2|COMPLETED|Overall Study||55
5066661|NCT01840410|12467457|P1|COMPLETED|Overall Study||112
5066662|NCT01840410|12467456|P2|Full Analysis Set|Overall Study||59
5066663|NCT01840410|12467457|P1|Full Analysis Set|Overall Study||119
5066664|NCT01840410|12467456|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
5066665|NCT01840410|12467457|P1|Safety Set|Overall Study||119
5066666|NCT01840410|12467456|P2|STARTED|Overall Study||59
5066667|NCT01840410|12467457|P1|STARTED|Overall Study||119
5066668|NCT01840345|12467493|P1|NOT COMPLETED|Overall Study||1
5066669|NCT01840345|12467493|P1|COMPLETED|Overall Study||10
5066670|NCT01840345|12467493|P1|STARTED|Overall Study||11
5066671|NCT01840319|12467500|P1|NOT COMPLETED|Overall Study||0
5066672|NCT01840319|12467500|P1|COMPLETED|Overall Study||156
5066673|NCT01840319|12467500|P1|STARTED|Overall Study||156
5066674|NCT01840228|12467506|P2|NOT COMPLETED|Overall Study||1
5066675|NCT01840228|12467507|P1|NOT COMPLETED|Overall Study||1
5066676|NCT01840228|12467506|P2|COMPLETED|Overall Study||18
5066677|NCT01840228|12467507|P1|COMPLETED|Overall Study||18
5066678|NCT01840228|12467506|P2|STARTED|Overall Study||19
5066679|NCT01840228|12467507|P1|STARTED|Overall Study||19
5066680|NCT01840163|12467535|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
5066681|NCT01840163|12467536|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
5066682|NCT01840163|12467535|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
5066683|NCT01840163|12467536|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
5066684|NCT01840163|12467535|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
5066685|NCT01840163|12467536|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
5066686|NCT01840163|12467535|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
5066687|NCT01840163|12467536|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
5066688|NCT01840163|12467535|P2|COMPLETED|First Follow up -Primary Outcome||254
5066689|NCT01840163|12467536|P1|COMPLETED|First Follow up -Primary Outcome||248
5066690|NCT01840163|12467535|P2|STARTED|First Follow up -Primary Outcome||270
5066691|NCT01840163|12467536|P1|STARTED|First Follow up -Primary Outcome||267
5066692|NCT01840072|12467558|P2|NOT COMPLETED|Overall Study||47
5066693|NCT01840072|12467559|P1|NOT COMPLETED|Overall Study||7
5066694|NCT01840072|12467558|P2|COMPLETED|Overall Study||1986
5066695|NCT01840072|12467559|P1|COMPLETED|Overall Study||2031
5066696|NCT01840072|12467558|P2|STARTED|Overall Study||2033
5066697|NCT01840072|12467559|P1|STARTED|Overall Study||2038
5066698|NCT01839916|12467581|P1|NOT COMPLETED|Overall Study||41
5066699|NCT01839916|12467581|P1|COMPLETED|Overall Study||36
5066700|NCT01839916|12467581|P1|STARTED|Overall Study||77
5066701|NCT01839708|12467592|P2|NOT COMPLETED|Overall Study||67
5066702|NCT01839708|12467593|P1|NOT COMPLETED|Overall Study||76
5066703|NCT01839708|12467592|P2|COMPLETED|Overall Study||115
5066704|NCT01839708|12467593|P1|COMPLETED|Overall Study||311
5066705|NCT01839708|12467592|P2|STARTED|Overall Study||182
5066706|NCT01839708|12467593|P1|STARTED|Overall Study||387
5066707|NCT01839695|12467625|P1|NOT COMPLETED|Overall Study||0
5066708|NCT01839695|12467625|P1|COMPLETED|Overall Study||9
5066709|NCT01839695|12467625|P1|STARTED|Overall Study||9
5066710|NCT01839656|12467632|P2|NOT COMPLETED|Overall Study||16
5066711|NCT01839656|12467633|P1|NOT COMPLETED|Overall Study||3
5066712|NCT01839656|12467632|P2|COMPLETED|Overall Study||0
5066713|NCT01839656|12467633|P1|COMPLETED|Overall Study||2
5066714|NCT01839656|12467632|P2|Completed Loading Dose Period|Overall Study||15
5066715|NCT01839656|12467633|P1|Completed Loading Dose Period|Overall Study||4
5066716|NCT01839656|12467632|P2|STARTED|Overall Study||16
5066717|NCT01839656|12467633|P1|STARTED|Overall Study||5
5066718|NCT01839604|12467660|P5|NOT COMPLETED|Overall Study||0
5066719|NCT01839604|12467661|P4|NOT COMPLETED|Overall Study||0
5066720|NCT01839604|12467662|P3|NOT COMPLETED|Overall Study||0
5066721|NCT01839604|12467663|P2|NOT COMPLETED|Overall Study||0
5066722|NCT01839604|12467664|P1|NOT COMPLETED|Overall Study||0
5066723|NCT01839604|12467660|P5|COMPLETED|Overall Study||15
5066724|NCT01839604|12467661|P4|COMPLETED|Overall Study||5
5066725|NCT01839604|12467662|P3|COMPLETED|Overall Study||7
5066726|NCT01839604|12467663|P2|COMPLETED|Overall Study||6
5066727|NCT01839604|12467664|P1|COMPLETED|Overall Study||6
5066728|NCT01839604|12467660|P5|STARTED|Overall Study||15
5066729|NCT01839604|12467661|P4|STARTED|Overall Study||5
5066730|NCT01839604|12467662|P3|STARTED|Overall Study||7
5066731|NCT01839604|12467663|P2|STARTED|Overall Study||6
5066732|NCT01839604|12467664|P1|STARTED|Overall Study||6
5066733|NCT01839487|12467693|P6|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
5066734|NCT01839487|12467694|P5|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
5066735|NCT01839487|12467695|P4|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
5066736|NCT01839487|12467696|P3|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
5066737|NCT01839487|12467697|P2|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066738|NCT01839487|12467698|P1|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066739|NCT01839487|12467693|P6|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066740|NCT01839487|12467694|P5|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
5066741|NCT01839487|12467695|P4|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066742|NCT01839487|12467696|P3|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066743|NCT01839487|12467697|P2|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066744|NCT01839487|12467698|P1|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
5066745|NCT01839487|12467693|P6|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
5066746|NCT01839487|12467694|P5|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
5066747|NCT01839487|12467695|P4|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
5066748|NCT01839487|12467696|P3|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
5066749|NCT01839487|12467697|P2|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
5066750|NCT01839487|12467698|P1|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
5066751|NCT01839487|12467693|P6|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066752|NCT01839487|12467694|P5|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066753|NCT01839487|12467695|P4|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066754|NCT01839487|12467696|P3|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066755|NCT01839487|12467697|P2|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
5066756|NCT01839487|12467698|P1|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
5066757|NCT01839487|12467693|P6|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066758|NCT01839487|12467694|P5|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066759|NCT01839487|12467695|P4|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066760|NCT01839487|12467696|P3|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066761|NCT01839487|12467697|P2|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066762|NCT01839487|12467698|P1|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
5066763|NCT01839487|12467693|P6|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
5066764|NCT01839487|12467694|P5|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
5066765|NCT01839487|12467695|P4|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
5066766|NCT01839487|12467696|P3|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
5066767|NCT01839487|12467697|P2|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
5066768|NCT01839487|12467698|P1|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
5066769|NCT01839396|12467721|P2|NOT COMPLETED|Overall Study||0
5066770|NCT01839396|12467722|P1|NOT COMPLETED|Overall Study||0
5066771|NCT01839396|12467721|P2|COMPLETED|Overall Study||39
5066772|NCT01839396|12467722|P1|COMPLETED|Overall Study||121
5066773|NCT01839396|12467721|P2|STARTED|Overall Study||39
5066774|NCT01839396|12467722|P1|STARTED|Overall Study||121
5066775|NCT01839318|12467730|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
5066776|NCT01839318|12467731|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
5066777|NCT01839318|12467732|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
5066778|NCT01839318|12467733|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
5066779|NCT01839318|12467734|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
5066780|NCT01839318|12467735|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
5066781|NCT01839318|12467730|P6|COMPLETED|Period 3, Third Day of Wear||2
5066782|NCT01839318|12467731|P5|COMPLETED|Period 3, Third Day of Wear||7
5066783|NCT01839318|12467732|P4|COMPLETED|Period 3, Third Day of Wear||6
5066784|NCT01839318|12467733|P3|COMPLETED|Period 3, Third Day of Wear||5
5066785|NCT01839318|12467734|P2|COMPLETED|Period 3, Third Day of Wear||4
5066786|NCT01839318|12467735|P1|COMPLETED|Period 3, Third Day of Wear||4
5066787|NCT01839318|12467730|P6|STARTED|Period 3, Third Day of Wear||2
5066788|NCT01839318|12467731|P5|STARTED|Period 3, Third Day of Wear||7
5066789|NCT01839318|12467732|P4|STARTED|Period 3, Third Day of Wear||6
5066790|NCT01839318|12467733|P3|STARTED|Period 3, Third Day of Wear||5
5066791|NCT01839318|12467734|P2|STARTED|Period 3, Third Day of Wear||4
5066792|NCT01839318|12467735|P1|STARTED|Period 3, Third Day of Wear||4
5066793|NCT01839318|12467730|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
5066794|NCT01839318|12467731|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
5066795|NCT01839318|12467732|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
5066796|NCT01839318|12467733|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
5066797|NCT01839318|12467734|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
5066798|NCT01839318|12467735|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
5066799|NCT01839318|12467730|P6|COMPLETED|Period 2, Second Day of Wear||2
5066800|NCT01839318|12467731|P5|COMPLETED|Period 2, Second Day of Wear||7
5066801|NCT01839318|12467732|P4|COMPLETED|Period 2, Second Day of Wear||6
5066802|NCT01839318|12467733|P3|COMPLETED|Period 2, Second Day of Wear||5
5066803|NCT01839318|12467734|P2|COMPLETED|Period 2, Second Day of Wear||4
5066804|NCT01839318|12467735|P1|COMPLETED|Period 2, Second Day of Wear||4
5066805|NCT01839318|12467730|P6|STARTED|Period 2, Second Day of Wear||2
5066806|NCT01839318|12467731|P5|STARTED|Period 2, Second Day of Wear||7
5066807|NCT01839318|12467732|P4|STARTED|Period 2, Second Day of Wear||6
5066808|NCT01839318|12467733|P3|STARTED|Period 2, Second Day of Wear||5
5066809|NCT01839318|12467734|P2|STARTED|Period 2, Second Day of Wear||4
5066810|NCT01839318|12467735|P1|STARTED|Period 2, Second Day of Wear||4
5066811|NCT01839318|12467730|P6|NOT COMPLETED|Period 1, First Day of Wear||0
5066812|NCT01839318|12467731|P5|NOT COMPLETED|Period 1, First Day of Wear||0
5066813|NCT01839318|12467732|P4|NOT COMPLETED|Period 1, First Day of Wear||0
5066814|NCT01839318|12467733|P3|NOT COMPLETED|Period 1, First Day of Wear||0
5066815|NCT01839318|12467734|P2|NOT COMPLETED|Period 1, First Day of Wear||0
5066816|NCT01839318|12467735|P1|NOT COMPLETED|Period 1, First Day of Wear||0
5066817|NCT01839318|12467730|P6|COMPLETED|Period 1, First Day of Wear||2
5066818|NCT01839318|12467731|P5|COMPLETED|Period 1, First Day of Wear||7
5066819|NCT01839318|12467732|P4|COMPLETED|Period 1, First Day of Wear||6
5066820|NCT01839318|12467733|P3|COMPLETED|Period 1, First Day of Wear||5
5066821|NCT01839318|12467734|P2|COMPLETED|Period 1, First Day of Wear||4
5066822|NCT01839318|12467735|P1|COMPLETED|Period 1, First Day of Wear||4
5066823|NCT01839318|12467730|P6|STARTED|Period 1, First Day of Wear||2
5066824|NCT01839318|12467731|P5|STARTED|Period 1, First Day of Wear||7
5066825|NCT01839318|12467732|P4|STARTED|Period 1, First Day of Wear||6
5066826|NCT01839318|12467733|P3|STARTED|Period 1, First Day of Wear||5
5066827|NCT01839318|12467734|P2|STARTED|Period 1, First Day of Wear||4
5066828|NCT01839318|12467735|P1|STARTED|Period 1, First Day of Wear||4
5066829|NCT01839279|12467749|P3|NOT COMPLETED|Overall Study||2
5066830|NCT01839279|12467750|P2|NOT COMPLETED|Overall Study||2
5066831|NCT01839279|12467751|P1|NOT COMPLETED|Overall Study||13
5066832|NCT01839279|12467749|P3|COMPLETED|Overall Study||30
5066833|NCT01839279|12467750|P2|COMPLETED|Overall Study||30
5066834|NCT01839279|12467751|P1|COMPLETED|Overall Study||59
5066835|NCT01839279|12467749|P3|PK/QTc Analysis Set|Overall Study||0
5066836|NCT01839279|12467750|P2|PK/QTc Analysis Set|Overall Study||0
5066837|NCT01839279|12467751|P1|PK/QTc Analysis Set|Overall Study||70
5066838|NCT01839279|12467749|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
5066839|NCT01839279|12467750|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
5066840|NCT01839279|12467751|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
5066841|NCT01839279|12467749|P3|PK Analysis Set|Overall Study||0
5066842|NCT01839279|12467750|P2|PK Analysis Set|Overall Study||0
5066843|NCT01839279|12467751|P1|PK Analysis Set|Overall Study||70
5066844|NCT01839279|12467749|P3|QT/QTc Analysis Set|Overall Study||32
5066845|NCT01839279|12467750|P2|QT/QTc Analysis Set|Overall Study||32
5066846|NCT01839279|12467751|P1|QT/QTc Analysis Set|Overall Study||72
5066847|NCT01839279|12467749|P3|STARTED|Overall Study||32
5066848|NCT01839279|12467750|P2|STARTED|Overall Study||32
5066849|NCT01839279|12467751|P1|STARTED|Overall Study||72
5066850|NCT01839188|12467770|P1|NOT COMPLETED|Overall Study||1
5066851|NCT01839188|12467770|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
5066852|NCT01839188|12467770|P1|Treated|Overall Study||385
5066853|NCT01839188|12467770|P1|STARTED|Overall Study||385
5066854|NCT01839110|12467813|P3|NOT COMPLETED|Overall Study||3
5066855|NCT01839110|12467814|P2|NOT COMPLETED|Overall Study||2
5066856|NCT01839110|12467815|P1|NOT COMPLETED|Overall Study||3
5066857|NCT01839110|12467813|P3|COMPLETED|Overall Study||6
5066858|NCT01839110|12467814|P2|COMPLETED|Overall Study||4
5066859|NCT01839110|12467815|P1|COMPLETED|Overall Study||4
5066860|NCT01839110|12467813|P3|STARTED|Overall Study||9
5066861|NCT01839110|12467814|P2|STARTED|Overall Study||6
5066862|NCT01839110|12467815|P1|STARTED|Overall Study||7
5066863|NCT01839058|12467825|P2|NOT COMPLETED|Overall Study||3
5066864|NCT01839058|12467826|P1|NOT COMPLETED|Overall Study||4
5066865|NCT01839058|12467825|P2|COMPLETED|Overall Study||16
5066866|NCT01839058|12467826|P1|COMPLETED|Overall Study||17
5066867|NCT01839058|12467825|P2|STARTED|Overall Study||19
5066868|NCT01839058|12467826|P1|STARTED|Overall Study||21
5066869|NCT01838980|12467838|P1|NOT COMPLETED|Overall Study||0
5066870|NCT01838980|12467838|P1|COMPLETED|Overall Study||15
5066871|NCT01838980|12467838|P1|STARTED|Overall Study||15
5066872|NCT01838941|12467842|P1|NOT COMPLETED|Overall Study||2
5066873|NCT01838941|12467842|P1|COMPLETED|Overall Study||10
5066874|NCT01838941|12467842|P1|STARTED|Overall Study||12
5066875|NCT01838876|12467847|P1|NOT COMPLETED|Overall Study||233
5066876|NCT01838876|12467847|P1|COMPLETED|Overall Study||209
5066877|NCT01838876|12467847|P1|Entered Safety Follow-up Period|Overall Study||287
5066878|NCT01838876|12467847|P1|Safety Population; Received Study Drug|Overall Study||345
5066879|NCT01838876|12467847|P1|STARTED|Overall Study||442
5066880|NCT01838863|12467862|P2|NOT COMPLETED|Overall Study||9
5066881|NCT01838863|12467863|P1|NOT COMPLETED|Overall Study||10
5066882|NCT01838863|12467862|P2|COMPLETED|Overall Study||60
5066883|NCT01838863|12467863|P1|COMPLETED|Overall Study||65
5066884|NCT01838863|12467862|P2|STARTED|Overall Study||69
5066885|NCT01838863|12467863|P1|STARTED|Overall Study||75
5066886|NCT01838785|12467949|P1|NOT COMPLETED|Overall Study||0
5066887|NCT01838785|12467949|P1|COMPLETED|Overall Study||25
5066888|NCT01838785|12467949|P1|STARTED|Overall Study||25
5066889|NCT01838694|12467956|P2|NOT COMPLETED|Overall Study||1
5066890|NCT01838694|12467957|P1|NOT COMPLETED|Overall Study||0
5066891|NCT01838694|12467956|P2|COMPLETED|Overall Study||21
5066892|NCT01838694|12467957|P1|COMPLETED|Overall Study||8
5066893|NCT01838694|12467956|P2|STARTED|Overall Study||22
5066894|NCT01838694|12467957|P1|STARTED|Overall Study||8
5066895|NCT01838681|12467966|P4|NOT COMPLETED|Period B/A+||117
5066896|NCT01838681|12467967|P3|NOT COMPLETED|Period B/A+||95
5066897|NCT01838681|12467968|P2|NOT COMPLETED|Period B/A+||62
5066898|NCT01838681|12467969|P1|NOT COMPLETED|Period B/A+||0
5066899|NCT01838681|12467966|P4|COMPLETED|Period B/A+||653
5066900|NCT01838681|12467967|P3|COMPLETED|Period B/A+||349
5066901|NCT01838681|12467968|P2|COMPLETED|Period B/A+||380
5066902|NCT01838681|12467969|P1|COMPLETED|Period B/A+||0
5066903|NCT01838681|12467966|P4|STARTED|Period B/A+||770
5066904|NCT01838681|12467967|P3|STARTED|Period B/A+||444
5066905|NCT01838681|12467968|P2|STARTED|Period B/A+||442
5066906|NCT01838681|12467969|P1|STARTED|Period B/A+||0
5066907|NCT01838681|12467966|P4|NOT COMPLETED|Period A||0
5066908|NCT01838681|12467967|P3|NOT COMPLETED|Period A||0
5066909|NCT01838681|12467968|P2|NOT COMPLETED|Period A||0
5066910|NCT01838681|12467969|P1|NOT COMPLETED|Period A||325
5066911|NCT01838681|12467966|P4|COMPLETED|Period A||0
5066912|NCT01838681|12467967|P3|COMPLETED|Period A||0
5066913|NCT01838681|12467968|P2|COMPLETED|Period A||0
5066914|NCT01838681|12467969|P1|COMPLETED|Period A||1661
5066915|NCT01838681|12467966|P4|STARTED|Period A||0
5066916|NCT01838681|12467967|P3|STARTED|Period A||0
5066917|NCT01838681|12467968|P2|STARTED|Period A||0
5066918|NCT01838681|12467969|P1|STARTED|Period A||1986
5066919|NCT01838655|12468009|P1|NOT COMPLETED|Overall Study||0
5066920|NCT01838655|12468009|P1|COMPLETED|Overall Study||5
5066921|NCT01838655|12468009|P1|STARTED|Overall Study||5
5066922|NCT01838642|12468077|P1|NOT COMPLETED|Overall Study||1
5066923|NCT01838642|12468077|P1|COMPLETED|Overall Study||2
5066924|NCT01838642|12468077|P1|STARTED|Overall Study||3
5066925|NCT01838616|12468090|P2|NOT COMPLETED|Pick-up Arm||0
5066926|NCT01838616|12468091|P1|NOT COMPLETED|Pick-up Arm||15
5066927|NCT01838616|12468090|P2|COMPLETED|Pick-up Arm||0
5066928|NCT01838616|12468091|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
5066929|NCT01838616|12468090|P2|Full Analysis Set|Pick-up Arm||0
5066930|NCT01838616|12468091|P1|Full Analysis Set|Pick-up Arm||49
5066931|NCT01838616|12468090|P2|STARTED|Pick-up Arm||0
5066932|NCT01838616|12468091|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
5066933|NCT01838616|12468090|P2|NOT COMPLETED|Continuation Period||14
5066934|NCT01838616|12468091|P1|NOT COMPLETED|Continuation Period||14
5066935|NCT01838616|12468090|P2|COMPLETED|Continuation Period||48
5066936|NCT01838616|12468091|P1|COMPLETED|Continuation Period||86
5066937|NCT01838616|12468090|P2|Switched to Pick-up Arm|Continuation Period||7
5066938|NCT01838616|12468091|P1|Switched to Pick-up Arm|Continuation Period||0
5066939|NCT01838616|12468090|P2|STARTED|Continuation Period||62
5066940|NCT01838616|12468091|P1|STARTED|Continuation Period||100
5066941|NCT01838616|12468090|P2|NOT COMPLETED|Titration Period||66
5066942|NCT01838616|12468091|P1|NOT COMPLETED|Titration Period||30
5066943|NCT01838616|12468090|P2|COMPLETED|Titration Period||62
5066944|NCT01838616|12468091|P1|COMPLETED|Titration Period||100
5066945|NCT01838616|12468090|P2|Per Protocol Set|Titration Period||112
5066946|NCT01838616|12468091|P1|Per Protocol Set|Titration Period||117
5066947|NCT01838616|12468090|P2|Full Analysis Set|Titration Period||128
5066948|NCT01838616|12468091|P1|Full Analysis Set|Titration Period||130
5066949|NCT01838616|12468090|P2|Switched to Pick-up Arm|Titration Period||43
5066950|NCT01838616|12468091|P1|Switched to Pick-up Arm|Titration Period||0
5066951|NCT01838616|12468090|P2|Major Protocol Deviations|Titration Period||16
5066952|NCT01838616|12468091|P1|Major Protocol Deviations|Titration Period||13
5066953|NCT01838616|12468090|P2|No Post Baseline Pain Intensity Values|Titration Period||2
5066954|NCT01838616|12468091|P1|No Post Baseline Pain Intensity Values|Titration Period||0
5066955|NCT01838616|12468090|P2|STARTED|Titration Period||128
5066956|NCT01838616|12468091|P1|STARTED|Titration Period||130
5066957|NCT01838590|12468162|P2|NOT COMPLETED|Overall Study||5
5066958|NCT01838590|12468163|P1|NOT COMPLETED|Overall Study||12
5066959|NCT01838590|12468162|P2|COMPLETED|Overall Study||46
5066960|NCT01838590|12468163|P1|COMPLETED|Overall Study||40
5066961|NCT01838590|12468162|P2|STARTED|Overall Study||51
5066962|NCT01838590|12468163|P1|STARTED|Overall Study||52
5066963|NCT01838499|12468187|P2|NOT COMPLETED|Overall Study||17
5066964|NCT01838499|12468188|P1|NOT COMPLETED|Overall Study||24
5066965|NCT01838499|12468187|P2|COMPLETED|Overall Study||37
5066966|NCT01838499|12468188|P1|COMPLETED|Overall Study||31
5066967|NCT01838499|12468187|P2|STARTED|Overall Study||54
5066968|NCT01838499|12468188|P1|STARTED|Overall Study||55
5066969|NCT01838447|12468200|P2|NOT COMPLETED|Overall Study||3
5066970|NCT01838447|12468201|P1|NOT COMPLETED|Overall Study||2
5066971|NCT01838447|12468200|P2|COMPLETED|Overall Study||21
5066972|NCT01838447|12468201|P1|COMPLETED|Overall Study||20
5066973|NCT01838447|12468200|P2|STARTED|Overall Study||24
5066974|NCT01838447|12468201|P1|STARTED|Overall Study||22
5066975|NCT01838304|12468221|P2|NOT COMPLETED|Overall Study||0
5066976|NCT01838304|12468222|P1|NOT COMPLETED|Overall Study||1
5066977|NCT01838304|12468221|P2|COMPLETED|Overall Study||20
5066978|NCT01838304|12468222|P1|COMPLETED|Overall Study||19
5066979|NCT01838304|12468221|P2|STARTED|Overall Study||20
5066980|NCT01838304|12468222|P1|STARTED|Overall Study||20
5066981|NCT01838226|12468236|P2|NOT COMPLETED|Overall Study||71
5066982|NCT01838226|12468237|P1|NOT COMPLETED|Overall Study||76
5066983|NCT01838226|12468236|P2|COMPLETED|Overall Study||128
5066984|NCT01838226|12468237|P1|COMPLETED|Overall Study||126
5066985|NCT01838226|12468236|P2|STARTED|Overall Study||199
5066986|NCT01838226|12468237|P1|STARTED|Overall Study||202
5066987|NCT01838213|12468249|P2|NOT COMPLETED|Overall Study||191
5066988|NCT01838213|12468250|P1|NOT COMPLETED|Overall Study||166
5066989|NCT01838213|12468249|P2|COMPLETED|Overall Study||262
5066990|NCT01838213|12468250|P1|COMPLETED|Overall Study||81
5066991|NCT01838213|12468249|P2|STARTED|Overall Study||453
5066992|NCT01838213|12468250|P1|STARTED|Overall Study||247
5066993|NCT01838200|12468258|P2|NOT COMPLETED|Overall Study||2
5066994|NCT01838200|12468259|P1|NOT COMPLETED|Overall Study||3
5066995|NCT01838200|12468258|P2|COMPLETED|Overall Study||0
5066996|NCT01838200|12468259|P1|COMPLETED|Overall Study||0
5066997|NCT01838200|12468258|P2|STARTED|Overall Study||2
5066998|NCT01838200|12468259|P1|STARTED|Overall Study||3
5066999|NCT01838044|12468271|P2|NOT COMPLETED|Overall Study||16
5067000|NCT01838044|12468272|P1|NOT COMPLETED|Overall Study||8
5067001|NCT01838044|12468271|P2|COMPLETED|Overall Study||75
5067002|NCT01838044|12468272|P1|COMPLETED|Overall Study||81
5067003|NCT01838044|12468271|P2|STARTED|Overall Study||91
5067004|NCT01838044|12468272|P1|STARTED|Overall Study||89
5067005|NCT01837966|12468305|P2|NOT COMPLETED|Overall Study||1
5067006|NCT01837966|12468306|P1|NOT COMPLETED|Overall Study||2
5067007|NCT01837966|12468305|P2|COMPLETED|Overall Study||45
5067008|NCT01837966|12468306|P1|COMPLETED|Overall Study||45
5067009|NCT01837966|12468305|P2|STARTED|Overall Study||46
5067010|NCT01837966|12468306|P1|STARTED|Overall Study||47
5067011|NCT01837823|12468312|P1|NOT COMPLETED|Overall Study||6
5067012|NCT01837823|12468312|P1|COMPLETED|Overall Study||85
5067013|NCT01837823|12468312|P1|STARTED|Overall Study||91
5067014|NCT01837797|12468343|P5|NOT COMPLETED|Period 3||23
5067015|NCT01837797|12468344|P4|NOT COMPLETED|Period 3||0
5067016|NCT01837797|12468345|P3|NOT COMPLETED|Period 3||0
5067017|NCT01837797|12468346|P2|NOT COMPLETED|Period 3||0
5067018|NCT01837797|12468347|P1|NOT COMPLETED|Period 3||0
5067019|NCT01837797|12468343|P5|COMPLETED|Period 3||24
5067020|NCT01837797|12468344|P4|COMPLETED|Period 3||0
5067021|NCT01837797|12468345|P3|COMPLETED|Period 3||0
5067022|NCT01837797|12468346|P2|COMPLETED|Period 3||0
5067023|NCT01837797|12468347|P1|COMPLETED|Period 3||0
5067024|NCT01837797|12468343|P5|STARTED|Period 3||47
5067025|NCT01837797|12468344|P4|STARTED|Period 3||0
5067026|NCT01837797|12468345|P3|STARTED|Period 3||0
5067027|NCT01837797|12468346|P2|STARTED|Period 3||0
5067028|NCT01837797|12468347|P1|STARTED|Period 3||0
5067029|NCT01837797|12468343|P5|NOT COMPLETED|Period 2||0
5067030|NCT01837797|12468344|P4|NOT COMPLETED|Period 2||5
5067031|NCT01837797|12468345|P3|NOT COMPLETED|Period 2||2
5067032|NCT01837797|12468346|P2|NOT COMPLETED|Period 2||5
5067033|NCT01837797|12468347|P1|NOT COMPLETED|Period 2||0
5067034|NCT01837797|12468343|P5|COMPLETED|Period 2||0
5067035|NCT01837797|12468344|P4|COMPLETED|Period 2||1
5067036|NCT01837797|12468345|P3|COMPLETED|Period 2||1
5067037|NCT01837797|12468346|P2|COMPLETED|Period 2||1
5067038|NCT01837797|12468347|P1|COMPLETED|Period 2||0
5067039|NCT01837797|12468343|P5|STARTED|Period 2||0
5067040|NCT01837797|12468344|P4|STARTED|Period 2||6
5067041|NCT01837797|12468345|P3|STARTED|Period 2||3
5067042|NCT01837797|12468346|P2|STARTED|Period 2||6
5067043|NCT01837797|12468347|P1|STARTED|Period 2||0
5067044|NCT01837797|12468343|P5|NOT COMPLETED|Period 1||0
5067045|NCT01837797|12468344|P4|NOT COMPLETED|Period 1||0
5067046|NCT01837797|12468345|P3|NOT COMPLETED|Period 1||0
5067047|NCT01837797|12468346|P2|NOT COMPLETED|Period 1||0
5067048|NCT01837797|12468347|P1|NOT COMPLETED|Period 1||102
5067049|NCT01837797|12468343|P5|COMPLETED|Period 1||0
5067050|NCT01837797|12468344|P4|COMPLETED|Period 1||0
5067051|NCT01837797|12468345|P3|COMPLETED|Period 1||0
5067052|NCT01837797|12468346|P2|COMPLETED|Period 1||0
5067053|NCT01837797|12468347|P1|COMPLETED|Period 1||27
5067054|NCT01837797|12468343|P5|STARTED|Period 1||0
5067055|NCT01837797|12468344|P4|STARTED|Period 1||0
5067056|NCT01837797|12468345|P3|STARTED|Period 1||0
5067057|NCT01837797|12468346|P2|STARTED|Period 1||0
5067058|NCT01837797|12468347|P1|STARTED|Period 1||129
5067059|NCT01837719|12468382|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
5067060|NCT01837719|12468382|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
5067061|NCT01837719|12468382|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
5067062|NCT01837719|12468382|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
5067063|NCT01837719|12468382|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
5067064|NCT01837719|12468382|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
5067065|NCT01837719|12468382|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
5067066|NCT01837719|12468382|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
5067067|NCT01837719|12468382|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
5067068|NCT01837719|12468382|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
5067069|NCT01837719|12468382|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
5067070|NCT01837719|12468382|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
5067071|NCT01837719|12468382|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
5067072|NCT01837719|12468382|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
5067073|NCT01837719|12468382|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
5067074|NCT01837680|12468451|P2|NOT COMPLETED|Overall Study||8
5067075|NCT01837680|12468452|P1|NOT COMPLETED|Overall Study||10
5067076|NCT01837680|12468451|P2|COMPLETED|Overall Study||45
5067077|NCT01837680|12468452|P1|COMPLETED|Overall Study||42
5067078|NCT01837680|12468451|P2|STARTED|Overall Study||53
5067079|NCT01837680|12468452|P1|STARTED|Overall Study||52
5067080|NCT01837654|12468490|P2|NOT COMPLETED|Overall Study||0
5067081|NCT01837654|12468491|P1|NOT COMPLETED|Overall Study||0
5067082|NCT01837654|12468490|P2|COMPLETED|Overall Study||11
5067083|NCT01837654|12468491|P1|COMPLETED|Overall Study||11
5067084|NCT01837654|12468490|P2|STARTED|Overall Study||11
5067085|NCT01837654|12468491|P1|STARTED|Overall Study||11
5067086|NCT01837550|12468501|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
5067087|NCT01837550|12468502|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
5067088|NCT01837550|12468501|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
5067089|NCT01837550|12468502|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
5067090|NCT01837550|12468501|P2|STARTED|T0-T2, 6 Months Follow-up||37
5067091|NCT01837550|12468502|P1|STARTED|T0-T2, 6 Months Follow-up||37
5067092|NCT01837550|12468501|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
5067093|NCT01837550|12468502|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
5067094|NCT01837550|12468501|P2|COMPLETED|T0-T1, 5 Weeks||37
5067095|NCT01837550|12468502|P1|COMPLETED|T0-T1, 5 Weeks||37
5067096|NCT01837550|12468501|P2|STARTED|T0-T1, 5 Weeks||37
5067097|NCT01837550|12468502|P1|STARTED|T0-T1, 5 Weeks||37
5067098|NCT01837537|12468514|P1|NOT COMPLETED|Overall Study||0
5067099|NCT01837537|12468514|P1|COMPLETED|Overall Study||90
5067100|NCT01837537|12468514|P1|STARTED|Overall Study||90
5067101|NCT01837524|12468521|P2|NOT COMPLETED|Overall Study||2
5067102|NCT01837524|12468522|P1|NOT COMPLETED|Overall Study||3
5067103|NCT01837524|12468521|P2|COMPLETED|Overall Study||25
5067104|NCT01837524|12468522|P1|COMPLETED|Overall Study||25
5067105|NCT01837524|12468521|P2|STARTED|Overall Study||27
5067106|NCT01837524|12468522|P1|STARTED|Overall Study||28
5067107|NCT01837069|12468530|P2|NOT COMPLETED|Overall Study||0
5067108|NCT01837069|12468531|P1|NOT COMPLETED|Overall Study||0
5067109|NCT01837069|12468530|P2|COMPLETED|Overall Study||95
5067110|NCT01837069|12468531|P1|COMPLETED|Overall Study||103
5067111|NCT01837069|12468530|P2|STARTED|Overall Study||95
5067112|NCT01837069|12468531|P1|STARTED|Overall Study||103
5067113|NCT01836809|12468547|P4|NOT COMPLETED|Overall Study||2
5067114|NCT01836809|12468548|P3|NOT COMPLETED|Overall Study||0
5067115|NCT01836809|12468549|P2|NOT COMPLETED|Overall Study||0
5067116|NCT01836809|12468550|P1|NOT COMPLETED|Overall Study||0
5067117|NCT01836809|12468547|P4|COMPLETED|Overall Study||0
5067118|NCT01836809|12468548|P3|COMPLETED|Overall Study||0
5067119|NCT01836809|12468549|P2|COMPLETED|Overall Study||0
5067120|NCT01836809|12468550|P1|COMPLETED|Overall Study||0
5067121|NCT01836809|12468547|P4|STARTED|Overall Study||2
5067122|NCT01836809|12468548|P3|STARTED|Overall Study||0
5067123|NCT01836809|12468549|P2|STARTED|Overall Study||0
5067124|NCT01836809|12468550|P1|STARTED|Overall Study||0
5067125|NCT01836549|12468586|P7|NOT COMPLETED|Overall Study||1
5067126|NCT01836549|12468587|P6|NOT COMPLETED|Overall Study||0
5067127|NCT01836549|12468588|P5|NOT COMPLETED|Overall Study||0
5067128|NCT01836549|12468589|P4|NOT COMPLETED|Overall Study||1
5067129|NCT01836549|12468590|P3|NOT COMPLETED|Overall Study||1
5067130|NCT01836549|12468591|P2|NOT COMPLETED|Overall Study||0
5067131|NCT01836549|12468592|P1|NOT COMPLETED|Overall Study||0
5067132|NCT01836549|12468586|P7|COMPLETED|Overall Study||8
5067133|NCT01836549|12468587|P6|COMPLETED|Overall Study||4
5067134|NCT01836549|12468588|P5|COMPLETED|Overall Study||18
5067135|NCT01836549|12468589|P4|COMPLETED|Overall Study||8
5067136|NCT01836549|12468590|P3|COMPLETED|Overall Study||0
5067137|NCT01836549|12468591|P2|COMPLETED|Overall Study||1
5067138|NCT01836549|12468592|P1|COMPLETED|Overall Study||1
5067139|NCT01836549|12468586|P7|STARTED|Overall Study||9
5067140|NCT01836549|12468587|P6|STARTED|Overall Study||4
5067141|NCT01836549|12468588|P5|STARTED|Overall Study||18
5067142|NCT01836549|12468589|P4|STARTED|Overall Study||9
5067143|NCT01836549|12468590|P3|STARTED|Overall Study||1
5067144|NCT01836549|12468591|P2|STARTED|Overall Study||1
5067145|NCT01836549|12468592|P1|STARTED|Overall Study||1
5067146|NCT01836523|12468616|P4|NOT COMPLETED|Overall Study||74
5067147|NCT01836523|12468617|P3|NOT COMPLETED|Overall Study||91
5067148|NCT01836523|12468618|P2|NOT COMPLETED|Overall Study||85
5067149|NCT01836523|12468619|P1|NOT COMPLETED|Overall Study||51
5067150|NCT01836523|12468616|P4|COMPLETED|Overall Study||274
5067151|NCT01836523|12468617|P3|COMPLETED|Overall Study||258
5067152|NCT01836523|12468618|P2|COMPLETED|Overall Study||265
5067153|NCT01836523|12468619|P1|COMPLETED|Overall Study||300
5067154|NCT01836523|12468616|P4|Exposed|Overall Study||348
5067155|NCT01836523|12468617|P3|Exposed|Overall Study||347
5067156|NCT01836523|12468618|P2|Exposed|Overall Study||348
5067157|NCT01836523|12468619|P1|Exposed|Overall Study||350
5067158|NCT01836523|12468616|P4|STARTED|Overall Study||348
5067159|NCT01836523|12468617|P3|STARTED|Overall Study||349
5067160|NCT01836523|12468618|P2|STARTED|Overall Study||350
5067161|NCT01836523|12468619|P1|STARTED|Overall Study||351
5067162|NCT01836471|12468646|P5|NOT COMPLETED|Overall Study||5
5067163|NCT01836471|12468647|P4|NOT COMPLETED|Overall Study||2
5067164|NCT01836471|12468648|P3|NOT COMPLETED|Overall Study||2
5067165|NCT01836471|12468649|P2|NOT COMPLETED|Overall Study||9
5067166|NCT01836471|12468650|P1|NOT COMPLETED|Overall Study||11
5067167|NCT01836471|12468646|P5|COMPLETED|Overall Study||49
5067168|NCT01836471|12468647|P4|COMPLETED|Overall Study||40
5067169|NCT01836471|12468648|P3|COMPLETED|Overall Study||49
5067170|NCT01836471|12468649|P2|COMPLETED|Overall Study||85
5067171|NCT01836471|12468650|P1|COMPLETED|Overall Study||82
5067172|NCT01836471|12468646|P5|STARTED|Overall Study||54
5067173|NCT01836471|12468647|P4|STARTED|Overall Study||42
5067174|NCT01836471|12468648|P3|STARTED|Overall Study||51
5067175|NCT01836471|12468649|P2|STARTED|Overall Study||94
5067176|NCT01836471|12468650|P1|STARTED|Overall Study||93
5067177|NCT01836458|12468679|P4|NOT COMPLETED|Overall Study||6
5067178|NCT01836458|12468680|P3|NOT COMPLETED|Overall Study||5
5067179|NCT01836458|12468681|P2|NOT COMPLETED|Overall Study||2
5067180|NCT01836458|12468682|P1|NOT COMPLETED|Overall Study||3
5067181|NCT01836458|12468679|P4|COMPLETED|Overall Study||1
5067182|NCT01836458|12468680|P3|COMPLETED|Overall Study||2
5067183|NCT01836458|12468681|P2|COMPLETED|Overall Study||2
5067184|NCT01836458|12468682|P1|COMPLETED|Overall Study||4
5067185|NCT01836458|12468679|P4|STARTED|Overall Study||7
5067186|NCT01836458|12468680|P3|STARTED|Overall Study||7
5067187|NCT01836458|12468681|P2|STARTED|Overall Study||4
5067188|NCT01836458|12468682|P1|STARTED|Overall Study||7
5067189|NCT01836445|12468706|P2|NOT COMPLETED|12 Month STI Testing||77
5067190|NCT01836445|12468707|P1|NOT COMPLETED|12 Month STI Testing||80
5067191|NCT01836445|12468706|P2|COMPLETED|12 Month STI Testing||378
5067192|NCT01836445|12468707|P1|COMPLETED|12 Month STI Testing||365
5067193|NCT01836445|12468706|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
5067194|NCT01836445|12468707|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
5067195|NCT01836445|12468706|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
5067196|NCT01836445|12468707|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
5067197|NCT01836445|12468706|P2|COMPLETED|12 Month Follow-up Assessment||391
5067198|NCT01836445|12468707|P1|COMPLETED|12 Month Follow-up Assessment||370
5067199|NCT01836445|12468706|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
5067200|NCT01836445|12468707|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
5067201|NCT01836445|12468706|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
5067202|NCT01836445|12468707|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
5067203|NCT01836445|12468706|P2|COMPLETED|6 Month Follow-up Assessment||380
5067204|NCT01836445|12468707|P1|COMPLETED|6 Month Follow-up Assessment||342
5067205|NCT01836445|12468706|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
5067206|NCT01836445|12468707|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
5067207|NCT01836445|12468706|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
5067208|NCT01836445|12468707|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
5067209|NCT01836445|12468706|P2|COMPLETED|3 Month Follow-up Assessment||409
5067210|NCT01836445|12468707|P1|COMPLETED|3 Month Follow-up Assessment||348
5067211|NCT01836445|12468706|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
5067212|NCT01836445|12468707|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
5067213|NCT01836445|12468706|P2|NOT COMPLETED|Intervention Modules||22
5067214|NCT01836445|12468707|P1|NOT COMPLETED|Intervention Modules||70
5067215|NCT01836445|12468706|P2|COMPLETED|Intervention Modules||434
5067216|NCT01836445|12468707|P1|COMPLETED|Intervention Modules||375
5067217|NCT01836445|12468706|P2|STARTED|Intervention Modules||456
5067218|NCT01836445|12468707|P1|STARTED|Intervention Modules||445
5067219|NCT01836276|12468767|P2|NOT COMPLETED|Overall Study||51
5067220|NCT01836276|12468768|P1|NOT COMPLETED|Overall Study||28
5067221|NCT01836276|12468767|P2|COMPLETED|Overall Study||174
5067222|NCT01836276|12468768|P1|COMPLETED|Overall Study||196
5067223|NCT01836276|12468767|P2|Week 12|Overall Study||165
5067224|NCT01836276|12468768|P1|Week 12|Overall Study||183
5067225|NCT01836276|12468767|P2|Week 4|Overall Study||186
5067226|NCT01836276|12468768|P1|Week 4|Overall Study||198
5067227|NCT01836276|12468767|P2|STARTED|Overall Study||225
5067228|NCT01836276|12468768|P1|STARTED|Overall Study||224
5067229|NCT01836198|12468776|P3|NOT COMPLETED|Part B||0
5067230|NCT01836198|12468777|P2|NOT COMPLETED|Part B||0
5067231|NCT01836198|12468778|P1|NOT COMPLETED|Part B||0
5067232|NCT01836198|12468776|P3|COMPLETED|Part B||12
5067233|NCT01836198|12468777|P2|COMPLETED|Part B||0
5067234|NCT01836198|12468778|P1|COMPLETED|Part B||0
5067235|NCT01836198|12468776|P3|Received at Least 1 Dose of Study Drug|Part B||12
5067236|NCT01836198|12468777|P2|Received at Least 1 Dose of Study Drug|Part B||0
5067237|NCT01836198|12468778|P1|Received at Least 1 Dose of Study Drug|Part B||0
5067238|NCT01836198|12468776|P3|STARTED|Part B||12
5067239|NCT01836198|12468777|P2|STARTED|Part B||0
5067240|NCT01836198|12468778|P1|STARTED|Part B||0
5067241|NCT01836198|12468776|P3|NOT COMPLETED|Part A, Period 2||0
5067242|NCT01836198|12468777|P2|NOT COMPLETED|Part A, Period 2||1
5067243|NCT01836198|12468778|P1|NOT COMPLETED|Part A, Period 2||0
5067244|NCT01836198|12468776|P3|COMPLETED|Part A, Period 2||0
5067245|NCT01836198|12468777|P2|COMPLETED|Part A, Period 2||14
5067246|NCT01836198|12468778|P1|COMPLETED|Part A, Period 2||15
5067247|NCT01836198|12468776|P3|Completed Part A, Entered Part B|Part A, Period 2||0
5067248|NCT01836198|12468777|P2|Completed Part A, Entered Part B|Part A, Period 2||6
5067249|NCT01836198|12468778|P1|Completed Part A, Entered Part B|Part A, Period 2||6
5067250|NCT01836198|12468776|P3|STARTED|Part A, Period 2||0
5067251|NCT01836198|12468777|P2|STARTED|Part A, Period 2||15
5067252|NCT01836198|12468778|P1|STARTED|Part A, Period 2||15
5067253|NCT01836198|12468776|P3|NOT COMPLETED|Part A, Period 1||0
5067254|NCT01836198|12468777|P2|NOT COMPLETED|Part A, Period 1||0
5067255|NCT01836198|12468778|P1|NOT COMPLETED|Part A, Period 1||0
5067256|NCT01836198|12468776|P3|COMPLETED|Part A, Period 1||0
5067257|NCT01836198|12468777|P2|COMPLETED|Part A, Period 1||15
5067258|NCT01836198|12468778|P1|COMPLETED|Part A, Period 1||15
5067259|NCT01836198|12468776|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
5067260|NCT01836198|12468777|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
5067261|NCT01836198|12468778|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
5067262|NCT01836198|12468776|P3|STARTED|Part A, Period 1||0
5067263|NCT01836198|12468777|P2|STARTED|Part A, Period 1||15
5067264|NCT01836198|12468778|P1|STARTED|Part A, Period 1||15
5067265|NCT01836185|12468804|P4|NOT COMPLETED|Overall Study||0
5067266|NCT01836185|12468805|P3|NOT COMPLETED|Overall Study||0
5067267|NCT01836185|12468806|P2|NOT COMPLETED|Overall Study||0
5067268|NCT01836185|12468807|P1|NOT COMPLETED|Overall Study||0
5067269|NCT01836185|12468804|P4|COMPLETED|Overall Study||6
5067270|NCT01836185|12468805|P3|COMPLETED|Overall Study||8
5067271|NCT01836185|12468806|P2|COMPLETED|Overall Study||8
5067272|NCT01836185|12468807|P1|COMPLETED|Overall Study||10
5067273|NCT01836185|12468804|P4|Received Single Dose of Study Treatment|Overall Study||6
5067274|NCT01836185|12468805|P3|Received Single Dose of Study Treatment|Overall Study||8
5067275|NCT01836185|12468806|P2|Received Single Dose of Study Treatment|Overall Study||8
5067276|NCT01836185|12468807|P1|Received Single Dose of Study Treatment|Overall Study||10
5067277|NCT01836185|12468804|P4|STARTED|Overall Study||6
5067278|NCT01836185|12468805|P3|STARTED|Overall Study||8
5067279|NCT01836185|12468806|P2|STARTED|Overall Study||8
5067280|NCT01836185|12468807|P1|STARTED|Overall Study||10
5067281|NCT01836133|12468825|P1|NOT COMPLETED|Overall Study||0
5067282|NCT01836133|12468825|P1|COMPLETED|Overall Study||70
5067283|NCT01836133|12468825|P1|STARTED|Overall Study||70
5067284|NCT01836042|12468834|P3|NOT COMPLETED|Overall Study||0
5067285|NCT01836042|12468835|P2|NOT COMPLETED|Overall Study||0
5067286|NCT01836042|12468836|P1|NOT COMPLETED|Overall Study||0
5067287|NCT01836042|12468834|P3|COMPLETED|Overall Study||22
5067288|NCT01836042|12468835|P2|COMPLETED|Overall Study||35
5067289|NCT01836042|12468836|P1|COMPLETED|Overall Study||51
5067290|NCT01836042|12468834|P3|STARTED|Overall Study||22
5067291|NCT01836042|12468835|P2|STARTED|Overall Study||35
5067292|NCT01836042|12468836|P1|STARTED|Overall Study||51
5067293|NCT01836029|12468846|P2|NOT COMPLETED|Overall Study||0
5067294|NCT01836029|12468847|P1|NOT COMPLETED|Overall Study||0
5067295|NCT01836029|12468846|P2|COMPLETED|Overall Study||95
5067296|NCT01836029|12468847|P1|COMPLETED|Overall Study||100
5067297|NCT01836029|12468846|P2|STARTED|Overall Study||95
5067298|NCT01836029|12468847|P1|STARTED|Overall Study||100
5067299|NCT01835912|12468859|P1|NOT COMPLETED|Overall Study||0
5067300|NCT01835912|12468859|P1|COMPLETED|Overall Study||10
5067301|NCT01835912|12468859|P1|Chronic Placebo|Overall Study||10
5067302|NCT01835912|12468859|P1|Chronic|Overall Study||10
5067303|NCT01835912|12468859|P1|Acute Placebo|Overall Study||10
5067304|NCT01835912|12468859|P1|Acute|Overall Study||10
5067305|NCT01835912|12468859|P1|STARTED|Overall Study||10
5067306|NCT01835899|12468880|P3|NOT COMPLETED|Overall Study||1
5067307|NCT01835899|12468881|P2|NOT COMPLETED|Overall Study||1
5067308|NCT01835899|12468882|P1|NOT COMPLETED|Overall Study||0
5067309|NCT01835899|12468880|P3|COMPLETED|Overall Study||8
5067310|NCT01835899|12468881|P2|COMPLETED|Overall Study||8
5067311|NCT01835899|12468882|P1|COMPLETED|Overall Study||6
5067312|NCT01835899|12468880|P3|STARTED|Overall Study||9
5067313|NCT01835899|12468881|P2|STARTED|Overall Study||9
5067314|NCT01835899|12468882|P1|STARTED|Overall Study||6
5067315|NCT01835756|12468902|P2|NOT COMPLETED|Overall Study||0
5067316|NCT01835756|12468903|P1|NOT COMPLETED|Overall Study||0
5067317|NCT01835756|12468902|P2|COMPLETED|Overall Study||31
5067318|NCT01835756|12468903|P1|COMPLETED|Overall Study||31
5067319|NCT01835756|12468902|P2|STARTED|Overall Study||31
5067320|NCT01835756|12468903|P1|STARTED|Overall Study||31
5067321|NCT01835743|12468915|P2|NOT COMPLETED|Overall Study||0
5067322|NCT01835743|12468916|P1|NOT COMPLETED|Overall Study||0
5067323|NCT01835743|12468915|P2|COMPLETED|Overall Study||32
5067324|NCT01835743|12468916|P1|COMPLETED|Overall Study||37
5067325|NCT01835743|12468915|P2|STARTED|Overall Study||32
5067326|NCT01835743|12468916|P1|STARTED|Overall Study||37
5067327|NCT01835587|12468928|P4|NOT COMPLETED|Overall Study||9
5067328|NCT01835587|12468929|P3|NOT COMPLETED|Overall Study||2
5067329|NCT01835587|12468930|P2|NOT COMPLETED|Overall Study||4
5067330|NCT01835587|12468931|P1|NOT COMPLETED|Overall Study||2
5067331|NCT01835587|12468928|P4|COMPLETED|Overall Study||10
5067332|NCT01835587|12468929|P3|COMPLETED|Overall Study||2
5067333|NCT01835587|12468930|P2|COMPLETED|Overall Study||0
5067334|NCT01835587|12468931|P1|COMPLETED|Overall Study||1
5067335|NCT01835587|12468928|P4|STARTED|Overall Study||19
5067336|NCT01835587|12468929|P3|STARTED|Overall Study||4
5067337|NCT01835587|12468930|P2|STARTED|Overall Study||4
5067338|NCT01835587|12468931|P1|STARTED|Overall Study||3
5067339|NCT01835548|12468992|P3|NOT COMPLETED|Double-Blind Treatment Period||0
5067340|NCT01835548|12468993|P2|NOT COMPLETED|Double-Blind Treatment Period||2
5067341|NCT01835548|12468994|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5067342|NCT01835548|12468992|P3|COMPLETED|Double-Blind Treatment Period||0
5067343|NCT01835548|12468993|P2|COMPLETED|Double-Blind Treatment Period||39
5067344|NCT01835548|12468994|P1|COMPLETED|Double-Blind Treatment Period||44
5067345|NCT01835548|12468992|P3|STARTED|Double-Blind Treatment Period||0
5067346|NCT01835548|12468993|P2|STARTED|Double-Blind Treatment Period||41
5067347|NCT01835548|12468994|P1|STARTED|Double-Blind Treatment Period||44
5067348|NCT01835548|12468992|P3|NOT COMPLETED|Dose Stabilization Period||0
5067349|NCT01835548|12468993|P2|NOT COMPLETED|Dose Stabilization Period||0
5067350|NCT01835548|12468994|P1|NOT COMPLETED|Dose Stabilization Period||0
5067351|NCT01835548|12468992|P3|COMPLETED|Dose Stabilization Period||85
5067352|NCT01835548|12468993|P2|COMPLETED|Dose Stabilization Period||0
5067353|NCT01835548|12468994|P1|COMPLETED|Dose Stabilization Period||0
5067354|NCT01835548|12468992|P3|STARTED|Dose Stabilization Period||85
5067355|NCT01835548|12468993|P2|STARTED|Dose Stabilization Period||0
5067356|NCT01835548|12468994|P1|STARTED|Dose Stabilization Period||0
5067357|NCT01835548|12468992|P3|NOT COMPLETED|Dose Optimization Period||2
5067358|NCT01835548|12468993|P2|NOT COMPLETED|Dose Optimization Period||0
5067359|NCT01835548|12468994|P1|NOT COMPLETED|Dose Optimization Period||0
5067360|NCT01835548|12468992|P3|COMPLETED|Dose Optimization Period||85
5067361|NCT01835548|12468993|P2|COMPLETED|Dose Optimization Period||0
5067362|NCT01835548|12468994|P1|COMPLETED|Dose Optimization Period||0
5067363|NCT01835548|12468992|P3|STARTED|Dose Optimization Period||87
5067364|NCT01835548|12468993|P2|STARTED|Dose Optimization Period||0
5067365|NCT01835548|12468994|P1|STARTED|Dose Optimization Period||0
5067366|NCT01835548|12468992|P3|NOT COMPLETED|Screening/Washout Period||0
5067367|NCT01835548|12468993|P2|NOT COMPLETED|Screening/Washout Period||0
5067368|NCT01835548|12468994|P1|NOT COMPLETED|Screening/Washout Period||0
5067369|NCT01835548|12468992|P3|COMPLETED|Screening/Washout Period||87
5067370|NCT01835548|12468993|P2|COMPLETED|Screening/Washout Period||0
5067371|NCT01835548|12468994|P1|COMPLETED|Screening/Washout Period||0
5067372|NCT01835548|12468992|P3|STARTED|Screening/Washout Period||87
5067373|NCT01835548|12468993|P2|STARTED|Screening/Washout Period||0
5067374|NCT01835548|12468994|P1|STARTED|Screening/Washout Period||0
5067375|NCT01835496|12469014|P1|NOT COMPLETED|Overall Study||0
5067376|NCT01835496|12469014|P1|COMPLETED|Overall Study||8
5067377|NCT01835496|12469014|P1|STARTED|Overall Study||8
5067378|NCT01835470|12469023|P1|NOT COMPLETED|Long Term Treatment Period||4
5067379|NCT01835470|12469023|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
5067380|NCT01835470|12469023|P1|STARTED|Long Term Treatment Period||20
5067381|NCT01835470|12469023|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
5067382|NCT01835470|12469023|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
5067383|NCT01835470|12469023|P1|STARTED|Short Term Treatment Period (to Week 16)||20
5067384|NCT01835431|12469035|P2|NOT COMPLETED|Overall Study||12
5067385|NCT01835431|12469036|P1|NOT COMPLETED|Overall Study||8
5067386|NCT01835431|12469035|P2|COMPLETED|Overall Study||168
5067387|NCT01835431|12469036|P1|COMPLETED|Overall Study||174
5067388|NCT01835431|12469035|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
5067389|NCT01835431|12469036|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
5067390|NCT01835431|12469035|P2|STARTED|Overall Study||180
5067391|NCT01835431|12469036|P1|STARTED|Overall Study||182
5067392|NCT01835379|12469056|P2|NOT COMPLETED|Overall Study||0
5067393|NCT01835379|12469057|P1|NOT COMPLETED|Overall Study||0
5067394|NCT01835379|12469056|P2|COMPLETED|Overall Study||41
5067395|NCT01835379|12469057|P1|COMPLETED|Overall Study||41
5067396|NCT01835379|12469056|P2|STARTED|Overall Study||41
5067397|NCT01835379|12469057|P1|STARTED|Overall Study||41
5067398|NCT01835262|12469067|P2|NOT COMPLETED|Overall Study||0
5067399|NCT01835262|12469068|P1|NOT COMPLETED|Overall Study||0
5067400|NCT01835262|12469067|P2|COMPLETED|Overall Study||45
5067401|NCT01835262|12469068|P1|COMPLETED|Overall Study||45
5067402|NCT01835262|12469067|P2|STARTED|Overall Study||45
5067403|NCT01835262|12469068|P1|STARTED|Overall Study||45
5067404|NCT01835158|12469076|P2|NOT COMPLETED|Overall Study||6
5067405|NCT01835158|12469077|P1|NOT COMPLETED|Overall Study||1
5067406|NCT01835158|12469076|P2|COMPLETED|Overall Study||72
5067407|NCT01835158|12469077|P1|COMPLETED|Overall Study||78
5067408|NCT01835158|12469076|P2|STARTED|Overall Study||78
5067409|NCT01835158|12469077|P1|STARTED|Overall Study||79
5067410|NCT01835145|12469089|P2|NOT COMPLETED|Overall Study||0
5067411|NCT01835145|12469090|P1|NOT COMPLETED|Overall Study||1
5067412|NCT01835145|12469089|P2|COMPLETED|Overall Study||15
5067413|NCT01835145|12469090|P1|COMPLETED|Overall Study||31
5067414|NCT01835145|12469089|P2|STARTED|Overall Study||15
5067415|NCT01835145|12469090|P1|STARTED|Overall Study||32
5067416|NCT01835132|12469105|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
5067417|NCT01835132|12469105|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
5067418|NCT01835132|12469105|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
5067419|NCT01835132|12469105|P1|NOT COMPLETED|1st Extension Phase||0
5067420|NCT01835132|12469105|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
5067421|NCT01835132|12469105|P1|STARTED|1st Extension Phase||6
5067422|NCT01835132|12469105|P1|NOT COMPLETED|Initial Phase||2
5067423|NCT01835132|12469105|P1|COMPLETED|Initial Phase||6
5067424|NCT01835132|12469105|P1|STARTED|Initial Phase||8
5067425|NCT01835015|12469150|P5|NOT COMPLETED|Overall Study||0
5067426|NCT01835015|12469151|P4|NOT COMPLETED|Overall Study||0
5067427|NCT01835015|12469152|P3|NOT COMPLETED|Overall Study||1
5067428|NCT01835015|12469153|P2|NOT COMPLETED|Overall Study||0
5067429|NCT01835015|12469154|P1|NOT COMPLETED|Overall Study||0
5067430|NCT01835015|12469150|P5|COMPLETED|Overall Study||6
5067431|NCT01835015|12469151|P4|COMPLETED|Overall Study||6
5067432|NCT01835015|12469152|P3|COMPLETED|Overall Study||6
5067433|NCT01835015|12469153|P2|COMPLETED|Overall Study||6
5067434|NCT01835015|12469154|P1|COMPLETED|Overall Study||6
5067435|NCT01835015|12469150|P5|STARTED|Overall Study||6
5067436|NCT01835015|12469151|P4|STARTED|Overall Study||6
5067437|NCT01835015|12469152|P3|STARTED|Overall Study||7
5067438|NCT01835015|12469153|P2|STARTED|Overall Study||6
5067439|NCT01835015|12469154|P1|STARTED|Overall Study||6
5067440|NCT01834729|12469231|P4|NOT COMPLETED|Overall Study||2
5067441|NCT01834729|12469232|P3|NOT COMPLETED|Overall Study||3
5067442|NCT01834729|12469233|P2|NOT COMPLETED|Overall Study||1
5067443|NCT01834729|12469234|P1|NOT COMPLETED|Overall Study||1
5067444|NCT01834729|12469231|P4|COMPLETED|Overall Study||16
5067445|NCT01834729|12469232|P3|COMPLETED|Overall Study||15
5067446|NCT01834729|12469233|P2|COMPLETED|Overall Study||19
5067447|NCT01834729|12469234|P1|COMPLETED|Overall Study||17
5067448|NCT01834729|12469231|P4|STARTED|Overall Study||18
5067449|NCT01834729|12469232|P3|STARTED|Overall Study||18
5067450|NCT01834729|12469233|P2|STARTED|Overall Study||20
5067451|NCT01834729|12469234|P1|STARTED|Overall Study||18
5067452|NCT01834716|12469250|P2|NOT COMPLETED|Overall Study||1
5067453|NCT01834716|12469251|P1|NOT COMPLETED|Overall Study||0
5067454|NCT01834716|12469250|P2|COMPLETED|Overall Study||11
5067455|NCT01834716|12469251|P1|COMPLETED|Overall Study||4
5067456|NCT01834716|12469250|P2|STARTED|Overall Study||12
5067457|NCT01834716|12469251|P1|STARTED|Overall Study||4
5067458|NCT01834651|12469257|P1|NOT COMPLETED|Overall Study||1
5067459|NCT01834651|12469257|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
5067460|NCT01834651|12469257|P1|STARTED|Overall Study||17
5067461|NCT01834586|12469267|P1|NOT COMPLETED|Overall Study||1
5067462|NCT01834586|12469267|P1|COMPLETED|Overall Study||29
5067463|NCT01834586|12469267|P1|STARTED|Overall Study||30
5067464|NCT01834404|12469274|P2|NOT COMPLETED|Overall Study||0
5067465|NCT01834404|12469275|P1|NOT COMPLETED|Overall Study||0
5067466|NCT01834404|12469274|P2|COMPLETED|Overall Study||12
5067467|NCT01834404|12469275|P1|COMPLETED|Overall Study||12
5067468|NCT01834404|12469274|P2|STARTED|Overall Study||12
5067469|NCT01834404|12469275|P1|STARTED|Overall Study||12
5067470|NCT01834274|12469307|P2|NOT COMPLETED|Overall Study||41
5067471|NCT01834274|12469308|P1|NOT COMPLETED|Overall Study||47
5067472|NCT01834274|12469307|P2|COMPLETED|Overall Study||5
5067473|NCT01834274|12469308|P1|COMPLETED|Overall Study||3
5067474|NCT01834274|12469307|P2|STARTED|Overall Study||46
5067475|NCT01834274|12469308|P1|STARTED|Overall Study||50
5067476|NCT01834261|12469320|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
5067477|NCT01834261|12469321|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
5067478|NCT01834261|12469320|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
5067479|NCT01834261|12469321|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
5067480|NCT01834261|12469320|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
5067481|NCT01834261|12469321|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
5067482|NCT01834261|12469320|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
5067483|NCT01834261|12469321|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
5067484|NCT01834261|12469320|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
5067485|NCT01834261|12469321|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
5067486|NCT01834261|12469320|P2|STARTED|MIT fMRI and MEG Resting State Study||10
5067487|NCT01834261|12469321|P1|STARTED|MIT fMRI and MEG Resting State Study||11
5067488|NCT01834222|12469331|P1|NOT COMPLETED|Overall Study||1
5067489|NCT01834222|12469331|P1|COMPLETED|Overall Study||658
5067490|NCT01834222|12469331|P1|Treated|Overall Study||658
5067491|NCT01834222|12469331|P1|STARTED|Overall Study||659
5067492|NCT01834144|12469342|P2|NOT COMPLETED|Overall Study||1
5067493|NCT01834144|12469343|P1|NOT COMPLETED|Overall Study||0
5067494|NCT01834144|12469342|P2|COMPLETED|Overall Study||2
5067495|NCT01834144|12469343|P1|COMPLETED|Overall Study||1
5067496|NCT01834144|12469342|P2|STARTED|Overall Study||3
5067497|NCT01834144|12469343|P1|STARTED|Overall Study||1
5067498|NCT01834027|12469351|P2|NOT COMPLETED|Overall Study||0
5067499|NCT01834027|12469352|P1|NOT COMPLETED|Overall Study||0
5067500|NCT01834027|12469351|P2|COMPLETED|Overall Study||28
5067501|NCT01834027|12469352|P1|COMPLETED|Overall Study||28
5067502|NCT01834027|12469351|P2|STARTED|Overall Study||28
5067503|NCT01834027|12469352|P1|STARTED|Overall Study||28
5067504|NCT01833988|12469362|P2|NOT COMPLETED|Overall Study||0
5067505|NCT01833988|12469363|P1|NOT COMPLETED|Overall Study||0
5067506|NCT01833988|12469362|P2|COMPLETED|Overall Study||16
5067507|NCT01833988|12469363|P1|COMPLETED|Overall Study||16
5067508|NCT01833988|12469362|P2|STARTED|Overall Study||16
5067509|NCT01833988|12469363|P1|STARTED|Overall Study||16
5067510|NCT01833936|12469419|P2|NOT COMPLETED|Overall Study||2
5067511|NCT01833936|12469420|P1|NOT COMPLETED|Overall Study||4
5067512|NCT01833936|12469419|P2|COMPLETED|Overall Study||18
5067513|NCT01833936|12469420|P1|COMPLETED|Overall Study||16
5067514|NCT01833936|12469419|P2|STARTED|Overall Study||20
5067515|NCT01833936|12469420|P1|STARTED|Overall Study||20
5067516|NCT01833897|12469426|P1|NOT COMPLETED|Overall Study||1
5067517|NCT01833897|12469426|P1|COMPLETED|Overall Study||7
5067518|NCT01833897|12469426|P1|STARTED|Overall Study||8
5067519|NCT01833845|12469434|P1|NOT COMPLETED|Overall Study||0
5067520|NCT01833845|12469434|P1|COMPLETED|Overall Study||4
5067521|NCT01833845|12469434|P1|STARTED|Overall Study||4
5067522|NCT01833832|12469438|P1|NOT COMPLETED|Overall Study||1
5067523|NCT01833832|12469438|P1|COMPLETED|Overall Study||10
5067524|NCT01833832|12469438|P1|STARTED|Overall Study||11
5067525|NCT01833754|12469449|P3|NOT COMPLETED|Overall Study||0
5067526|NCT01833754|12469450|P2|NOT COMPLETED|Overall Study||0
5067527|NCT01833754|12469451|P1|NOT COMPLETED|Overall Study||0
5067528|NCT01833754|12469449|P3|COMPLETED|Overall Study||8
5067529|NCT01833754|12469450|P2|COMPLETED|Overall Study||8
5067530|NCT01833754|12469451|P1|COMPLETED|Overall Study||8
5067531|NCT01833754|12469449|P3|STARTED|Overall Study||8
5067532|NCT01833754|12469450|P2|STARTED|Overall Study||8
5067533|NCT01833754|12469451|P1|STARTED|Overall Study||8
5067534|NCT01833741|12469480|P1|NOT COMPLETED|Overall Study||140
5067535|NCT01833741|12469480|P1|COMPLETED|Overall Study||997
5067536|NCT01833741|12469480|P1|STARTED|Overall Study||1137
5067537|NCT01833546|12469497|P4|NOT COMPLETED|Overall Study||0
5067538|NCT01833546|12469498|P3|NOT COMPLETED|Overall Study||0
5067539|NCT01833546|12469499|P2|NOT COMPLETED|Overall Study||0
5067540|NCT01833546|12469500|P1|NOT COMPLETED|Overall Study||0
5067541|NCT01833546|12469497|P4|COMPLETED|Overall Study||6
5067542|NCT01833546|12469498|P3|COMPLETED|Overall Study||8
5067543|NCT01833546|12469499|P2|COMPLETED|Overall Study||3
5067544|NCT01833546|12469500|P1|COMPLETED|Overall Study||3
5067545|NCT01833546|12469497|P4|STARTED|Overall Study||6
5067546|NCT01833546|12469498|P3|STARTED|Overall Study||8
5067547|NCT01833546|12469499|P2|STARTED|Overall Study||3
5067548|NCT01833546|12469500|P1|STARTED|Overall Study||3
5067549|NCT01833533|12469593|P2|NOT COMPLETED|Overall Study||21
5067550|NCT01833533|12469594|P1|NOT COMPLETED|Overall Study||6
5067551|NCT01833533|12469593|P2|COMPLETED|Overall Study||184
5067552|NCT01833533|12469594|P1|COMPLETED|Overall Study||94
5067553|NCT01833533|12469593|P2|STARTED|Overall Study||205
5067554|NCT01833533|12469594|P1|STARTED|Overall Study||100
5067555|NCT01833494|12469608|P1|NOT COMPLETED|Overall Study||45
5067556|NCT01833494|12469608|P1|COMPLETED|Overall Study||116
5067557|NCT01833494|12469608|P1|STARTED|Overall Study||161
5067558|NCT01833481|12469618|P3|NOT COMPLETED|Overall Study||0
5067559|NCT01833481|12469619|P2|NOT COMPLETED|Overall Study||0
5067560|NCT01833481|12469620|P1|NOT COMPLETED|Overall Study||0
5067561|NCT01833481|12469618|P3|COMPLETED|Overall Study||10
5067562|NCT01833481|12469619|P2|COMPLETED|Overall Study||10
5067563|NCT01833481|12469620|P1|COMPLETED|Overall Study||10
5067564|NCT01833481|12469618|P3|STARTED|Overall Study||10
5067565|NCT01833481|12469619|P2|STARTED|Overall Study||10
5067566|NCT01833481|12469620|P1|STARTED|Overall Study||10
5067567|NCT01833455|12469636|P2|NOT COMPLETED|Overall Study||0
5067568|NCT01833455|12469637|P1|NOT COMPLETED|Overall Study||1
5067569|NCT01833455|12469636|P2|COMPLETED|Overall Study||4
5067570|NCT01833455|12469637|P1|COMPLETED|Overall Study||3
5067571|NCT01833455|12469636|P2|Completed 2nd Baseline (Washout)|Overall Study||4
5067572|NCT01833455|12469637|P1|Completed 2nd Baseline (Washout)|Overall Study||3
5067573|NCT01833455|12469636|P2|Completed 1st Intervention|Overall Study||4
5067574|NCT01833455|12469637|P1|Completed 1st Intervention|Overall Study||3
5067575|NCT01833455|12469636|P2|Completed 1st Baseline|Overall Study||4
5067576|NCT01833455|12469637|P1|Completed 1st Baseline|Overall Study||4
5067577|NCT01833455|12469636|P2|STARTED|Overall Study||4
5067578|NCT01833455|12469637|P1|STARTED|Overall Study||4
5067579|NCT01833403|12469655|P1|NOT COMPLETED|Overall Study||0
5067580|NCT01833403|12469655|P1|COMPLETED|Overall Study||4
5067581|NCT01833403|12469655|P1|STARTED|Overall Study||4
5067582|NCT01833247|12469660|P1|NOT COMPLETED|Overall Study||0
5067583|NCT01833247|12469660|P1|COMPLETED|Overall Study||12
5067584|NCT01833247|12469660|P1|STARTED|Overall Study||12
5067585|NCT01833169|12469666|P1|NOT COMPLETED|Overall Study||146
5067586|NCT01833169|12469666|P1|COMPLETED|Overall Study||0
5067587|NCT01833169|12469666|P1|Consented to be Followed for Survival|Overall Study||128
5067588|NCT01833169|12469666|P1|STARTED|Overall Study||146
5067589|NCT01833143|12469677|P1|NOT COMPLETED|Overall Study||1
5067590|NCT01833143|12469677|P1|COMPLETED|Overall Study||16
5067591|NCT01833143|12469677|P1|STARTED|Overall Study||17
5067592|NCT01833130|12469686|P2|NOT COMPLETED|Overall Study||19
5067593|NCT01833130|12469687|P1|NOT COMPLETED|Overall Study||10
5067594|NCT01833130|12469686|P2|COMPLETED|Overall Study||8
5067595|NCT01833130|12469687|P1|COMPLETED|Overall Study||15
5067596|NCT01833130|12469686|P2|STARTED|Overall Study||27
5067597|NCT01833130|12469687|P1|STARTED|Overall Study||25
5067598|NCT01833117|12469725|P2|NOT COMPLETED|Overall Study||0
5067599|NCT01833117|12469726|P1|NOT COMPLETED|Overall Study||0
5067600|NCT01833117|12469725|P2|COMPLETED|Overall Study||19
5067601|NCT01833117|12469726|P1|COMPLETED|Overall Study||43
5067602|NCT01833117|12469725|P2|STARTED|Overall Study||19
5067603|NCT01833117|12469726|P1|STARTED|Overall Study||43
5067604|NCT01833078|12469734|P1|NOT COMPLETED|Overall Study||0
5067605|NCT01833078|12469734|P1|COMPLETED|Overall Study||5
5067606|NCT01833078|12469734|P1|STARTED|Overall Study||5
5067607|NCT01833065|12469742|P5|NOT COMPLETED|Overall Study||36
5067608|NCT01833065|12469743|P4|NOT COMPLETED|Overall Study||9
5067609|NCT01833065|12469744|P3|NOT COMPLETED|Overall Study||12
5067610|NCT01833065|12469745|P2|NOT COMPLETED|Overall Study||13
5067611|NCT01833065|12469746|P1|NOT COMPLETED|Overall Study||24
5067612|NCT01833065|12469742|P5|COMPLETED|Overall Study||74
5067613|NCT01833065|12469743|P4|COMPLETED|Overall Study||41
5067614|NCT01833065|12469744|P3|COMPLETED|Overall Study||23
5067615|NCT01833065|12469745|P2|COMPLETED|Overall Study||40
5067616|NCT01833065|12469746|P1|COMPLETED|Overall Study||41
5067617|NCT01833065|12469742|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
5067618|NCT01833065|12469743|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
5067619|NCT01833065|12469744|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
5067620|NCT01833065|12469745|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
5067621|NCT01833065|12469746|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
5067622|NCT01833065|12469742|P5|STARTED|Overall Study|Randomized patients - As treated|110
5067623|NCT01833065|12469743|P4|STARTED|Overall Study|Randomized patients - As treated|50
5067624|NCT01833065|12469744|P3|STARTED|Overall Study|Randomized patients - As treated|35
5067625|NCT01833065|12469745|P2|STARTED|Overall Study|Randomized patients - As treated|53
5067626|NCT01833065|12469746|P1|STARTED|Overall Study|Randomized patients - As treated|65
5067627|NCT01833026|12469779|P2|NOT COMPLETED|Overall Study||0
5067628|NCT01833026|12469780|P1|NOT COMPLETED|Overall Study||0
5067629|NCT01833026|12469779|P2|COMPLETED|Overall Study||34
5067630|NCT01833026|12469780|P1|COMPLETED|Overall Study||22
5067631|NCT01833026|12469779|P2|STARTED|Overall Study||34
5067632|NCT01833026|12469780|P1|STARTED|Overall Study||22
5067633|NCT01832961|12469786|P2|NOT COMPLETED|Third Intervention||0
5067634|NCT01832961|12469787|P1|NOT COMPLETED|Third Intervention||0
5067635|NCT01832961|12469786|P2|COMPLETED|Third Intervention||7
5067636|NCT01832961|12469787|P1|COMPLETED|Third Intervention||8
5067637|NCT01832961|12469786|P2|STARTED|Third Intervention||7
5067638|NCT01832961|12469787|P1|STARTED|Third Intervention||8
5067639|NCT01832961|12469786|P2|NOT COMPLETED|Second Intervention||0
5067640|NCT01832961|12469787|P1|NOT COMPLETED|Second Intervention||0
5067641|NCT01832961|12469786|P2|COMPLETED|Second Intervention||7
5067642|NCT01832961|12469787|P1|COMPLETED|Second Intervention||8
5067643|NCT01832961|12469786|P2|STARTED|Second Intervention||7
5067644|NCT01832961|12469787|P1|STARTED|Second Intervention||8
5067645|NCT01832961|12469786|P2|NOT COMPLETED|Washout||0
5067646|NCT01832961|12469787|P1|NOT COMPLETED|Washout||0
5067647|NCT01832961|12469786|P2|COMPLETED|Washout||7
5067648|NCT01832961|12469787|P1|COMPLETED|Washout||8
5067649|NCT01832961|12469786|P2|STARTED|Washout||7
5067650|NCT01832961|12469787|P1|STARTED|Washout||8
5067651|NCT01832961|12469786|P2|NOT COMPLETED|First Intervention||0
5067652|NCT01832961|12469787|P1|NOT COMPLETED|First Intervention||0
5067653|NCT01832961|12469786|P2|COMPLETED|First Intervention||7
5067654|NCT01832961|12469787|P1|COMPLETED|First Intervention||8
5067655|NCT01832961|12469786|P2|STARTED|First Intervention||7
5067656|NCT01832961|12469787|P1|STARTED|First Intervention||8
5067657|NCT01832818|12469815|P1|NOT COMPLETED|Overall Study||6
5067658|NCT01832818|12469815|P1|COMPLETED|Overall Study||8
5067659|NCT01832818|12469815|P1|STARTED|Overall Study||14
5067660|NCT01832766|12469824|P2|NOT COMPLETED|Second Intervention||0
5067661|NCT01832766|12469825|P1|NOT COMPLETED|Second Intervention||0
5067662|NCT01832766|12469824|P2|COMPLETED|Second Intervention||5
5067663|NCT01832766|12469825|P1|COMPLETED|Second Intervention||7
5067664|NCT01832766|12469824|P2|STARTED|Second Intervention||5
5067665|NCT01832766|12469825|P1|STARTED|Second Intervention||7
5067666|NCT01832766|12469824|P2|NOT COMPLETED|Washout||1
5067667|NCT01832766|12469825|P1|NOT COMPLETED|Washout||0
5067668|NCT01832766|12469824|P2|COMPLETED|Washout||5
5067669|NCT01832766|12469825|P1|COMPLETED|Washout||7
5067670|NCT01832766|12469824|P2|STARTED|Washout||6
5067671|NCT01832766|12469825|P1|STARTED|Washout||7
5067672|NCT01832766|12469824|P2|NOT COMPLETED|First Intervention||0
5067673|NCT01832766|12469825|P1|NOT COMPLETED|First Intervention||0
5067674|NCT01832766|12469824|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
5067675|NCT01832766|12469825|P1|COMPLETED|First Intervention||7
5067676|NCT01832766|12469824|P2|STARTED|First Intervention||6
5067677|NCT01832766|12469825|P1|STARTED|First Intervention||7
5067678|NCT01832753|12469838|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
5067679|NCT01832753|12469839|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
5067680|NCT01832753|12469840|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
5067681|NCT01832753|12469838|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
5067682|NCT01832753|12469839|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
5067683|NCT01832753|12469840|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
5067684|NCT01832753|12469838|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
5067685|NCT01832753|12469839|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
5067686|NCT01832753|12469840|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
5067687|NCT01832753|12469838|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
5067688|NCT01832753|12469839|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
5067689|NCT01832753|12469840|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
5067690|NCT01832753|12469838|P3|COMPLETED|Randomization Phase (Months 6-12)||0
5067691|NCT01832753|12469839|P2|COMPLETED|Randomization Phase (Months 6-12)||3
5067692|NCT01832753|12469840|P1|COMPLETED|Randomization Phase (Months 6-12)||4
5067693|NCT01832753|12469838|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
5067694|NCT01832753|12469839|P2|STARTED|Randomization Phase (Months 6-12)||4
5067695|NCT01832753|12469840|P1|STARTED|Randomization Phase (Months 6-12)||5
5067696|NCT01832753|12469838|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
5067697|NCT01832753|12469839|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
5067698|NCT01832753|12469840|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
5067699|NCT01832753|12469838|P3|COMPLETED|Observation Phase (Months 0-6)||1
5067700|NCT01832753|12469839|P2|COMPLETED|Observation Phase (Months 0-6)||4
5067701|NCT01832753|12469840|P1|COMPLETED|Observation Phase (Months 0-6)||5
5067702|NCT01832753|12469838|P3|STARTED|Observation Phase (Months 0-6)||3
5067703|NCT01832753|12469839|P2|STARTED|Observation Phase (Months 0-6)||4
5067704|NCT01832753|12469840|P1|STARTED|Observation Phase (Months 0-6)||5
5067705|NCT01832727|12469861|P9|NOT COMPLETED|Overall Study||18
5067706|NCT01832727|12469862|P8|NOT COMPLETED|Overall Study||6
5067707|NCT01832727|12469863|P7|NOT COMPLETED|Overall Study||8
5067708|NCT01832727|12469864|P6|NOT COMPLETED|Overall Study||6
5067709|NCT01832727|12469865|P5|NOT COMPLETED|Overall Study||4
5067710|NCT01832727|12469866|P4|NOT COMPLETED|Overall Study||4
5067711|NCT01832727|12469867|P3|NOT COMPLETED|Overall Study||3
5067712|NCT01832727|12469868|P2|NOT COMPLETED|Overall Study||7
5067713|NCT01832727|12469869|P1|NOT COMPLETED|Overall Study||9
5067714|NCT01832727|12469861|P9|COMPLETED|Overall Study||0
5067715|NCT01832727|12469862|P8|COMPLETED|Overall Study||0
5067716|NCT01832727|12469863|P7|COMPLETED|Overall Study||0
5067717|NCT01832727|12469864|P6|COMPLETED|Overall Study||0
5067718|NCT01832727|12469865|P5|COMPLETED|Overall Study||0
5067719|NCT01832727|12469866|P4|COMPLETED|Overall Study||0
5067720|NCT01832727|12469867|P3|COMPLETED|Overall Study||0
5067721|NCT01832727|12469868|P2|COMPLETED|Overall Study||0
5067722|NCT01832727|12469869|P1|COMPLETED|Overall Study||0
5067723|NCT01832727|12469861|P9|STARTED|Overall Study||18
5067724|NCT01832727|12469862|P8|STARTED|Overall Study||6
5067725|NCT01832727|12469863|P7|STARTED|Overall Study||8
5067726|NCT01832727|12469864|P6|STARTED|Overall Study||6
5067727|NCT01832727|12469865|P5|STARTED|Overall Study||4
5067728|NCT01832727|12469866|P4|STARTED|Overall Study||4
5067729|NCT01832727|12469867|P3|STARTED|Overall Study||3
5067730|NCT01832727|12469868|P2|STARTED|Overall Study||7
5067731|NCT01832727|12469869|P1|STARTED|Overall Study||9
5067732|NCT01832610|12469969|P1|NOT COMPLETED|Overall Study||4
5067733|NCT01832610|12469969|P1|COMPLETED|Overall Study||97
5067734|NCT01832610|12469969|P1|STARTED|Overall Study||101
5067735|NCT01832506|12469983|P3|NOT COMPLETED|Overall Study||0
5067736|NCT01832506|12469984|P2|NOT COMPLETED|Overall Study||0
5067737|NCT01832506|12469985|P1|NOT COMPLETED|Overall Study||0
5067738|NCT01832506|12469983|P3|COMPLETED|Overall Study||6
5067739|NCT01832506|12469984|P2|COMPLETED|Overall Study||3
5067740|NCT01832506|12469985|P1|COMPLETED|Overall Study||3
5067741|NCT01832506|12469983|P3|STARTED|Overall Study||6
5067742|NCT01832506|12469984|P2|STARTED|Overall Study||3
5067743|NCT01832506|12469985|P1|STARTED|Overall Study||3
5067744|NCT01832493|12470036|P1|NOT COMPLETED|Overall Study||8
5067745|NCT01832493|12470036|P1|COMPLETED|Overall Study||42
5067746|NCT01832493|12470036|P1|STARTED|Overall Study||50
5067747|NCT01832480|12470045|P2|NOT COMPLETED|Overall Study||42
5067748|NCT01832480|12470046|P1|NOT COMPLETED|Overall Study||41
5067749|NCT01832480|12470045|P2|COMPLETED|Overall Study||270
5067750|NCT01832480|12470046|P1|COMPLETED|Overall Study||270
5067751|NCT01832480|12470045|P2|STARTED|Overall Study||312
5067752|NCT01832480|12470046|P1|STARTED|Overall Study||311
5067753|NCT01832259|12470054|P2|NOT COMPLETED|Overall Study||0
5067754|NCT01832259|12470055|P1|NOT COMPLETED|Overall Study||0
5067755|NCT01832259|12470054|P2|COMPLETED|Overall Study||15
5067756|NCT01832259|12470055|P1|COMPLETED|Overall Study||15
5067757|NCT01832259|12470054|P2|STARTED|Overall Study||15
5067758|NCT01832259|12470055|P1|STARTED|Overall Study||15
5067759|NCT01832155|12470067|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
5067760|NCT01832155|12470068|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
5067761|NCT01832155|12470067|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
5067762|NCT01832155|12470068|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
5067763|NCT01832155|12470067|P2|STARTED|End of Study: 4 - 8 Weeks||18
5067764|NCT01832155|12470068|P1|STARTED|End of Study: 4 - 8 Weeks||16
5067765|NCT01832155|12470067|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
5067766|NCT01832155|12470068|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
5067767|NCT01832155|12470067|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
5067768|NCT01832155|12470068|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
5067769|NCT01832155|12470067|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
5067770|NCT01832155|12470068|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
5067771|NCT01832155|12470067|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
5067772|NCT01832155|12470068|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
5067773|NCT01832155|12470067|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
5067774|NCT01832155|12470068|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
5067775|NCT01832155|12470067|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
5067776|NCT01832155|12470068|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
5067777|NCT01832090|12470091|P2|NOT COMPLETED|Overall Study||1
5067778|NCT01832090|12470092|P1|NOT COMPLETED|Overall Study||6
5067779|NCT01832090|12470091|P2|COMPLETED|Overall Study||28
5067780|NCT01832090|12470092|P1|COMPLETED|Overall Study||83
5067781|NCT01832090|12470091|P2|STARTED|Overall Study||29
5067782|NCT01832090|12470092|P1|STARTED|Overall Study||89
5067783|NCT01831934|12470137|P2|NOT COMPLETED|Overall Study||0
5067784|NCT01831934|12470138|P1|NOT COMPLETED|Overall Study||1
5067785|NCT01831934|12470137|P2|COMPLETED|Overall Study||10
5067786|NCT01831934|12470138|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
5067787|NCT01831934|12470137|P2|STARTED|Overall Study||10
5067788|NCT01831934|12470138|P1|STARTED|Overall Study||12
5067789|NCT01831921|12470146|P2|NOT COMPLETED|Overall Study||39
5067790|NCT01831921|12470147|P1|NOT COMPLETED|Overall Study||84
5067791|NCT01831921|12470146|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
5067792|NCT01831921|12470147|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
5067793|NCT01831921|12470146|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
5067794|NCT01831921|12470147|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
5067795|NCT01831921|12470146|P2|12 Months|Overall Study||62
5067796|NCT01831921|12470147|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
5067797|NCT01831921|12470146|P2|6 Months|Overall Study||63
5067798|NCT01831921|12470147|P1|6 Months|Overall Study||122
5067799|NCT01831921|12470146|P2|STARTED|Overall Study||75
5067800|NCT01831921|12470147|P1|STARTED|Overall Study||150
5067801|NCT01831856|12470171|P2|NOT COMPLETED|Overall Study||37
5067802|NCT01831856|12470172|P1|NOT COMPLETED|Overall Study||34
5067803|NCT01831856|12470171|P2|COMPLETED|Overall Study||30
5067804|NCT01831856|12470172|P1|COMPLETED|Overall Study||33
5067805|NCT01831856|12470171|P2|STARTED|Overall Study||67
5067806|NCT01831856|12470172|P1|STARTED|Overall Study||67
5067807|NCT01831817|12470182|P4|NOT COMPLETED|Overall Study||0
5067808|NCT01831817|12470183|P3|NOT COMPLETED|Overall Study||0
5067809|NCT01831817|12470184|P2|NOT COMPLETED|Overall Study||0
5067810|NCT01831817|12470185|P1|NOT COMPLETED|Overall Study||4
5067811|NCT01831817|12470182|P4|COMPLETED|Overall Study||36
5067812|NCT01831817|12470183|P3|COMPLETED|Overall Study||35
5067813|NCT01831817|12470184|P2|COMPLETED|Overall Study||34
5067814|NCT01831817|12470185|P1|COMPLETED|Overall Study||31
5067815|NCT01831817|12470182|P4|STARTED|Overall Study||36
5067816|NCT01831817|12470183|P3|STARTED|Overall Study||35
5067817|NCT01831817|12470184|P2|STARTED|Overall Study||34
5067818|NCT01831817|12470185|P1|STARTED|Overall Study||35
5067819|NCT01831804|12470232|P9|NOT COMPLETED|Overall Study||2
5067820|NCT01831804|12470233|P8|NOT COMPLETED|Overall Study||3
5067821|NCT01831804|12470234|P7|NOT COMPLETED|Overall Study||1
5067822|NCT01831804|12470235|P6|NOT COMPLETED|Overall Study||0
5067823|NCT01831804|12470236|P5|NOT COMPLETED|Overall Study||2
5067824|NCT01831804|12470237|P4|NOT COMPLETED|Overall Study||0
5067825|NCT01831804|12470238|P3|NOT COMPLETED|Overall Study||6
5067826|NCT01831804|12470239|P2|NOT COMPLETED|Overall Study||2
5067827|NCT01831804|12470240|P1|NOT COMPLETED|Overall Study||1
5067828|NCT01831804|12470232|P9|COMPLETED|Overall Study||2
5067829|NCT01831804|12470233|P8|COMPLETED|Overall Study||23
5067830|NCT01831804|12470234|P7|COMPLETED|Overall Study||3
5067831|NCT01831804|12470235|P6|COMPLETED|Overall Study||3
5067832|NCT01831804|12470236|P5|COMPLETED|Overall Study||3
5067833|NCT01831804|12470237|P4|COMPLETED|Overall Study||5
5067834|NCT01831804|12470238|P3|COMPLETED|Overall Study||3
5067835|NCT01831804|12470239|P2|COMPLETED|Overall Study||1
5067836|NCT01831804|12470240|P1|COMPLETED|Overall Study||3
5067837|NCT01831804|12470232|P9|STARTED|Overall Study||4
5067838|NCT01831804|12470233|P8|STARTED|Overall Study||26
5067839|NCT01831804|12470234|P7|STARTED|Overall Study||4
5067840|NCT01831804|12470235|P6|STARTED|Overall Study||3
5067841|NCT01831804|12470236|P5|STARTED|Overall Study||5
5067842|NCT01831804|12470237|P4|STARTED|Overall Study||5
5067843|NCT01831804|12470238|P3|STARTED|Overall Study||9
5067844|NCT01831804|12470239|P2|STARTED|Overall Study||3
5067845|NCT01831804|12470240|P1|STARTED|Overall Study||4
5067846|NCT01831791|12470335|P1|NOT COMPLETED|Overall Study||10
5067847|NCT01831791|12470335|P1|COMPLETED|Overall Study||110
5067848|NCT01831791|12470335|P1|STARTED|Overall Study||120
5067849|NCT01831765|12470364|P3|NOT COMPLETED|Overall Study||42
5067850|NCT01831765|12470365|P2|NOT COMPLETED|Overall Study||27
5067851|NCT01831765|12470366|P1|NOT COMPLETED|Overall Study||44
5067852|NCT01831765|12470364|P3|COMPLETED|Overall Study||338
5067853|NCT01831765|12470365|P2|COMPLETED|Overall Study||355
5067854|NCT01831765|12470366|P1|COMPLETED|Overall Study||337
5067855|NCT01831765|12470364|P3|Completed 52 Weeks|Overall Study||338
5067856|NCT01831765|12470365|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
5067857|NCT01831765|12470366|P1|Completed 52 Weeks|Overall Study||337
5067858|NCT01831765|12470364|P3|Completed 26 Weeks|Overall Study||356
5067859|NCT01831765|12470365|P2|Completed 26 Weeks|Overall Study||355
5067860|NCT01831765|12470366|P1|Completed 26 Weeks|Overall Study||351
5067861|NCT01831765|12470364|P3|STARTED|Overall Study||380
5067862|NCT01831765|12470365|P2|STARTED|Overall Study||382
5067863|NCT01831765|12470366|P1|STARTED|Overall Study||381
5067864|NCT01831726|12470392|P1|NOT COMPLETED|Overall Study||80
5067865|NCT01831726|12470392|P1|COMPLETED|Overall Study||0
5067866|NCT01831726|12470392|P1|STARTED|Overall Study||80
5067867|NCT01831544|12470399|P1|NOT COMPLETED|Overall Study||3
5067868|NCT01831544|12470399|P1|COMPLETED|Overall Study||8
5067869|NCT01831544|12470399|P1|STARTED|Overall Study||11
5067870|NCT01831466|12470428|P12|NOT COMPLETED|Overall Study||4
5067871|NCT01831466|12470429|P11|NOT COMPLETED|Overall Study||2
5067872|NCT01831466|12470430|P10|NOT COMPLETED|Overall Study||5
5067873|NCT01831466|12470431|P9|NOT COMPLETED|Overall Study||3
5067874|NCT01831466|12470432|P8|NOT COMPLETED|Overall Study||2
5067875|NCT01831466|12470433|P7|NOT COMPLETED|Overall Study||1
5067876|NCT01831466|12470434|P6|NOT COMPLETED|Overall Study||26
5067877|NCT01831466|12470435|P5|NOT COMPLETED|Overall Study||17
5067878|NCT01831466|12470436|P4|NOT COMPLETED|Overall Study||19
5067879|NCT01831466|12470437|P3|NOT COMPLETED|Overall Study||23
5067880|NCT01831466|12470438|P2|NOT COMPLETED|Overall Study||18
5067881|NCT01831466|12470439|P1|NOT COMPLETED|Overall Study||16
5067882|NCT01831466|12470428|P12|COMPLETED|Overall Study||3
5067883|NCT01831466|12470429|P11|COMPLETED|Overall Study||4
5067884|NCT01831466|12470430|P10|COMPLETED|Overall Study||2
5067885|NCT01831466|12470431|P9|COMPLETED|Overall Study||4
5067886|NCT01831466|12470432|P8|COMPLETED|Overall Study||5
5067887|NCT01831466|12470433|P7|COMPLETED|Overall Study||6
5067888|NCT01831466|12470434|P6|COMPLETED|Overall Study||48
5067889|NCT01831466|12470435|P5|COMPLETED|Overall Study||57
5067890|NCT01831466|12470436|P4|COMPLETED|Overall Study||51
5067891|NCT01831466|12470437|P3|COMPLETED|Overall Study||48
5067892|NCT01831466|12470438|P2|COMPLETED|Overall Study||52
5067893|NCT01831466|12470439|P1|COMPLETED|Overall Study||55
5067894|NCT01831466|12470428|P12|STARTED|Overall Study|Treated|7
5067895|NCT01831466|12470429|P11|STARTED|Overall Study|Treated|6
5067896|NCT01831466|12470430|P10|STARTED|Overall Study|Treated|7
5067897|NCT01831466|12470431|P9|STARTED|Overall Study|Treated|7
5067898|NCT01831466|12470432|P8|STARTED|Overall Study|Treated|7
5067899|NCT01831466|12470433|P7|STARTED|Overall Study|Treated|7
5067900|NCT01831466|12470434|P6|STARTED|Overall Study|Treated|74
5067901|NCT01831466|12470435|P5|STARTED|Overall Study|Treated|74
5067902|NCT01831466|12470436|P4|STARTED|Overall Study|Treated|70
5067903|NCT01831466|12470437|P3|STARTED|Overall Study|Treated|71
5067904|NCT01831466|12470438|P2|STARTED|Overall Study|Treated|70
5067905|NCT01831466|12470439|P1|STARTED|Overall Study|Treated|71
5067906|NCT01831258|12470561|P2|NOT COMPLETED|Overall Study||3
5067907|NCT01831258|12470562|P1|NOT COMPLETED|Overall Study||5
5067908|NCT01831258|12470561|P2|COMPLETED|Overall Study||32
5067909|NCT01831258|12470562|P1|COMPLETED|Overall Study||30
5067910|NCT01831258|12470561|P2|STARTED|Overall Study||35
5067911|NCT01831258|12470562|P1|STARTED|Overall Study||35
5067912|NCT01831232|12470588|P1|NOT COMPLETED|Overall Study||0
5067913|NCT01831232|12470588|P1|COMPLETED|Overall Study||24
5067914|NCT01831232|12470588|P1|STARTED|Overall Study||24
5067915|NCT01831219|12470599|P2|NOT COMPLETED|Overall Study||24
5067916|NCT01831219|12470600|P1|NOT COMPLETED|Overall Study||33
5067917|NCT01831219|12470599|P2|COMPLETED|Overall Study||21
5067918|NCT01831219|12470600|P1|COMPLETED|Overall Study||40
5067919|NCT01831219|12470599|P2|STARTED|Overall Study||45
5067920|NCT01831219|12470600|P1|STARTED|Overall Study||73
5067921|NCT01831154|12470621|P3|NOT COMPLETED|Overall Study||0
5067922|NCT01831154|12470622|P2|NOT COMPLETED|Overall Study||0
5067923|NCT01831154|12470623|P1|NOT COMPLETED|Overall Study||0
5067924|NCT01831154|12470621|P3|COMPLETED|Overall Study||11
5067925|NCT01831154|12470622|P2|COMPLETED|Overall Study||11
5067926|NCT01831154|12470623|P1|COMPLETED|Overall Study||15
5067927|NCT01831154|12470621|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
5067928|NCT01831154|12470622|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
5067929|NCT01831154|12470623|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
5067930|NCT01831089|12470652|P6|NOT COMPLETED|Cohort B: Arm B||14
5067931|NCT01831089|12470653|P5|NOT COMPLETED|Cohort B: Arm B||0
5067932|NCT01831089|12470654|P4|NOT COMPLETED|Cohort B: Arm B||0
5067933|NCT01831089|12470655|P3|NOT COMPLETED|Cohort B: Arm B||0
5067934|NCT01831089|12470656|P2|NOT COMPLETED|Cohort B: Arm B||0
5067935|NCT01831089|12470657|P1|NOT COMPLETED|Cohort B: Arm B||0
5067936|NCT01831089|12470652|P6|COMPLETED|Cohort B: Arm B||0
5067937|NCT01831089|12470653|P5|COMPLETED|Cohort B: Arm B||0
5067938|NCT01831089|12470654|P4|COMPLETED|Cohort B: Arm B||0
5067939|NCT01831089|12470655|P3|COMPLETED|Cohort B: Arm B||0
5067940|NCT01831089|12470656|P2|COMPLETED|Cohort B: Arm B||0
5067941|NCT01831089|12470657|P1|COMPLETED|Cohort B: Arm B||0
5067942|NCT01831089|12470652|P6|STARTED|Cohort B: Arm B||14
5067943|NCT01831089|12470653|P5|STARTED|Cohort B: Arm B||0
5067944|NCT01831089|12470654|P4|STARTED|Cohort B: Arm B||0
5067945|NCT01831089|12470655|P3|STARTED|Cohort B: Arm B||0
5067946|NCT01831089|12470656|P2|STARTED|Cohort B: Arm B||0
5067947|NCT01831089|12470657|P1|STARTED|Cohort B: Arm B||0
5067948|NCT01831089|12470652|P6|NOT COMPLETED|Cohort V: Dose Level 5||0
5067949|NCT01831089|12470653|P5|NOT COMPLETED|Cohort V: Dose Level 5||37
5067950|NCT01831089|12470654|P4|NOT COMPLETED|Cohort V: Dose Level 5||0
5067951|NCT01831089|12470655|P3|NOT COMPLETED|Cohort V: Dose Level 5||0
5067952|NCT01831089|12470656|P2|NOT COMPLETED|Cohort V: Dose Level 5||0
5067953|NCT01831089|12470657|P1|NOT COMPLETED|Cohort V: Dose Level 5||0
5067954|NCT01831089|12470652|P6|COMPLETED|Cohort V: Dose Level 5||0
5067955|NCT01831089|12470653|P5|COMPLETED|Cohort V: Dose Level 5||0
5067956|NCT01831089|12470654|P4|COMPLETED|Cohort V: Dose Level 5||0
5067957|NCT01831089|12470655|P3|COMPLETED|Cohort V: Dose Level 5||0
5067958|NCT01831089|12470656|P2|COMPLETED|Cohort V: Dose Level 5||0
5067959|NCT01831089|12470657|P1|COMPLETED|Cohort V: Dose Level 5||0
5067960|NCT01831089|12470652|P6|STARTED|Cohort V: Dose Level 5||0
5067961|NCT01831089|12470653|P5|STARTED|Cohort V: Dose Level 5||37
5067962|NCT01831089|12470654|P4|STARTED|Cohort V: Dose Level 5||0
5067963|NCT01831089|12470655|P3|STARTED|Cohort V: Dose Level 5||0
5067964|NCT01831089|12470656|P2|STARTED|Cohort V: Dose Level 5||0
5067965|NCT01831089|12470657|P1|STARTED|Cohort V: Dose Level 5||0
5067966|NCT01831089|12470652|P6|NOT COMPLETED|Cohort IV: Dose Level 4||0
5067967|NCT01831089|12470653|P5|NOT COMPLETED|Cohort IV: Dose Level 4||0
5067968|NCT01831089|12470654|P4|NOT COMPLETED|Cohort IV: Dose Level 4||6
5067969|NCT01831089|12470655|P3|NOT COMPLETED|Cohort IV: Dose Level 4||0
5067970|NCT01831089|12470656|P2|NOT COMPLETED|Cohort IV: Dose Level 4||0
5067971|NCT01831089|12470657|P1|NOT COMPLETED|Cohort IV: Dose Level 4||0
5067972|NCT01831089|12470652|P6|COMPLETED|Cohort IV: Dose Level 4||0
5067973|NCT01831089|12470653|P5|COMPLETED|Cohort IV: Dose Level 4||0
5067974|NCT01831089|12470654|P4|COMPLETED|Cohort IV: Dose Level 4||0
5067975|NCT01831089|12470655|P3|COMPLETED|Cohort IV: Dose Level 4||0
5067976|NCT01831089|12470656|P2|COMPLETED|Cohort IV: Dose Level 4||0
5067977|NCT01831089|12470657|P1|COMPLETED|Cohort IV: Dose Level 4||0
5067978|NCT01831089|12470652|P6|STARTED|Cohort IV: Dose Level 4||0
5067979|NCT01831089|12470653|P5|STARTED|Cohort IV: Dose Level 4||0
5067980|NCT01831089|12470654|P4|STARTED|Cohort IV: Dose Level 4||6
5067981|NCT01831089|12470655|P3|STARTED|Cohort IV: Dose Level 4||0
5067982|NCT01831089|12470656|P2|STARTED|Cohort IV: Dose Level 4||0
5067983|NCT01831089|12470657|P1|STARTED|Cohort IV: Dose Level 4||0
5067984|NCT01831089|12470652|P6|NOT COMPLETED|Cohort III: Dose Level 3||0
5067985|NCT01831089|12470653|P5|NOT COMPLETED|Cohort III: Dose Level 3||0
5067986|NCT01831089|12470654|P4|NOT COMPLETED|Cohort III: Dose Level 3||0
5067987|NCT01831089|12470655|P3|NOT COMPLETED|Cohort III: Dose Level 3||6
5067988|NCT01831089|12470656|P2|NOT COMPLETED|Cohort III: Dose Level 3||0
5067989|NCT01831089|12470657|P1|NOT COMPLETED|Cohort III: Dose Level 3||0
5067990|NCT01831089|12470652|P6|COMPLETED|Cohort III: Dose Level 3||0
5067991|NCT01831089|12470653|P5|COMPLETED|Cohort III: Dose Level 3||0
5067992|NCT01831089|12470654|P4|COMPLETED|Cohort III: Dose Level 3||0
5067993|NCT01831089|12470655|P3|COMPLETED|Cohort III: Dose Level 3||0
5067994|NCT01831089|12470656|P2|COMPLETED|Cohort III: Dose Level 3||0
5067995|NCT01831089|12470657|P1|COMPLETED|Cohort III: Dose Level 3||0
5067996|NCT01831089|12470652|P6|STARTED|Cohort III: Dose Level 3||0
5067997|NCT01831089|12470653|P5|STARTED|Cohort III: Dose Level 3||0
5067998|NCT01831089|12470654|P4|STARTED|Cohort III: Dose Level 3||0
5067999|NCT01831089|12470655|P3|STARTED|Cohort III: Dose Level 3||6
5068000|NCT01831089|12470656|P2|STARTED|Cohort III: Dose Level 3||0
5068001|NCT01831089|12470657|P1|STARTED|Cohort III: Dose Level 3||0
5068002|NCT01831089|12470652|P6|NOT COMPLETED|Cohort II: Dose Level 2||0
5068003|NCT01831089|12470653|P5|NOT COMPLETED|Cohort II: Dose Level 2||0
5068004|NCT01831089|12470654|P4|NOT COMPLETED|Cohort II: Dose Level 2||0
5068005|NCT01831089|12470655|P3|NOT COMPLETED|Cohort II: Dose Level 2||0
5068006|NCT01831089|12470656|P2|NOT COMPLETED|Cohort II: Dose Level 2||3
5068007|NCT01831089|12470657|P1|NOT COMPLETED|Cohort II: Dose Level 2||0
5068008|NCT01831089|12470652|P6|COMPLETED|Cohort II: Dose Level 2||0
5068009|NCT01831089|12470653|P5|COMPLETED|Cohort II: Dose Level 2||0
5068010|NCT01831089|12470654|P4|COMPLETED|Cohort II: Dose Level 2||0
5068011|NCT01831089|12470655|P3|COMPLETED|Cohort II: Dose Level 2||0
5068012|NCT01831089|12470656|P2|COMPLETED|Cohort II: Dose Level 2||0
5068013|NCT01831089|12470657|P1|COMPLETED|Cohort II: Dose Level 2||0
5068014|NCT01831089|12470652|P6|STARTED|Cohort II: Dose Level 2||0
5068015|NCT01831089|12470653|P5|STARTED|Cohort II: Dose Level 2||0
5068016|NCT01831089|12470654|P4|STARTED|Cohort II: Dose Level 2||0
5068017|NCT01831089|12470655|P3|STARTED|Cohort II: Dose Level 2||0
5068018|NCT01831089|12470656|P2|STARTED|Cohort II: Dose Level 2||3
5068019|NCT01831089|12470657|P1|STARTED|Cohort II: Dose Level 2||0
5068020|NCT01831089|12470652|P6|NOT COMPLETED|Cohort I: Dose Level 1||0
5068021|NCT01831089|12470653|P5|NOT COMPLETED|Cohort I: Dose Level 1||0
5068022|NCT01831089|12470654|P4|NOT COMPLETED|Cohort I: Dose Level 1||0
5068023|NCT01831089|12470655|P3|NOT COMPLETED|Cohort I: Dose Level 1||0
5068024|NCT01831089|12470656|P2|NOT COMPLETED|Cohort I: Dose Level 1||0
5068025|NCT01831089|12470657|P1|NOT COMPLETED|Cohort I: Dose Level 1||3
5068026|NCT01831089|12470652|P6|COMPLETED|Cohort I: Dose Level 1||0
5068027|NCT01831089|12470653|P5|COMPLETED|Cohort I: Dose Level 1||0
5068028|NCT01831089|12470654|P4|COMPLETED|Cohort I: Dose Level 1||0
5068029|NCT01831089|12470655|P3|COMPLETED|Cohort I: Dose Level 1||0
5068030|NCT01831089|12470656|P2|COMPLETED|Cohort I: Dose Level 1||0
5068031|NCT01831089|12470657|P1|COMPLETED|Cohort I: Dose Level 1||0
5068032|NCT01831089|12470652|P6|STARTED|Cohort I: Dose Level 1||0
5068033|NCT01831089|12470653|P5|STARTED|Cohort I: Dose Level 1||0
5068034|NCT01831089|12470654|P4|STARTED|Cohort I: Dose Level 1||0
5068035|NCT01831089|12470655|P3|STARTED|Cohort I: Dose Level 1||0
5068036|NCT01831089|12470656|P2|STARTED|Cohort I: Dose Level 1||0
5068037|NCT01831089|12470657|P1|STARTED|Cohort I: Dose Level 1||3
5068038|NCT01831076|12470699|P2|NOT COMPLETED|Overall Study||1
5068039|NCT01831076|12470700|P1|NOT COMPLETED|Overall Study||1
5068040|NCT01831076|12470699|P2|COMPLETED|Overall Study||4
5068041|NCT01831076|12470700|P1|COMPLETED|Overall Study||30
5068042|NCT01831076|12470699|P2|STARTED|Overall Study||5
5068043|NCT01831076|12470700|P1|STARTED|Overall Study||31
5068044|NCT01830972|12470708|P2|NOT COMPLETED|Part IV||1
5068045|NCT01830972|12470709|P1|NOT COMPLETED|Part IV||3
5068046|NCT01830972|12470708|P2|COMPLETED|Part IV||10
5068047|NCT01830972|12470709|P1|COMPLETED|Part IV||39
5068048|NCT01830972|12470708|P2|STARTED|Part IV||11
5068049|NCT01830972|12470709|P1|STARTED|Part IV||42
5068050|NCT01830972|12470708|P2|NOT COMPLETED|Part III||0
5068051|NCT01830972|12470709|P1|NOT COMPLETED|Part III||2
5068052|NCT01830972|12470708|P2|COMPLETED|Part III||11
5068053|NCT01830972|12470709|P1|COMPLETED|Part III||42
5068054|NCT01830972|12470708|P2|STARTED|Part III||11
5068055|NCT01830972|12470709|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
5068056|NCT01830972|12470708|P2|NOT COMPLETED|Part II||2
5068057|NCT01830972|12470709|P1|NOT COMPLETED|Part II||2
5068058|NCT01830972|12470708|P2|COMPLETED|Part II||11
5068059|NCT01830972|12470709|P1|COMPLETED|Part II||44
5068060|NCT01830972|12470708|P2|STARTED|Part II|Entered study at Part 2|13
5068061|NCT01830972|12470709|P1|STARTED|Part II||46
5068062|NCT01830972|12470708|P2|NOT COMPLETED|Part I||0
5068063|NCT01830972|12470709|P1|NOT COMPLETED|Part I||0
5068064|NCT01830972|12470708|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
5068065|NCT01830972|12470709|P1|COMPLETED|Part I||46
5068066|NCT01830972|12470708|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
5068067|NCT01830972|12470709|P1|STARTED|Part I||46
5068068|NCT01830933|12470735|P2|NOT COMPLETED|Overall Study||232
5068069|NCT01830933|12470736|P1|NOT COMPLETED|Overall Study||168
5068070|NCT01830933|12470735|P2|COMPLETED|Overall Study||580
5068071|NCT01830933|12470736|P1|COMPLETED|Overall Study||655
5068072|NCT01830933|12470735|P2|Completed Meet-up|Overall Study||603
5068073|NCT01830933|12470736|P1|Completed Meet-up|Overall Study||675
5068074|NCT01830933|12470735|P2|STARTED|Overall Study||812
5068075|NCT01830933|12470736|P1|STARTED|Overall Study||823
5068076|NCT01830920|12470753|P5|NOT COMPLETED|Overall Study||8
5068077|NCT01830920|12470754|P4|NOT COMPLETED|Overall Study||16
5068078|NCT01830920|12470755|P3|NOT COMPLETED|Overall Study||8
5068079|NCT01830920|12470756|P2|NOT COMPLETED|Overall Study||6
5068080|NCT01830920|12470757|P1|NOT COMPLETED|Overall Study||21
5068081|NCT01830920|12470753|P5|COMPLETED|Overall Study||99
5068082|NCT01830920|12470754|P4|COMPLETED|Overall Study||109
5068083|NCT01830920|12470755|P3|COMPLETED|Overall Study||40
5068084|NCT01830920|12470756|P2|COMPLETED|Overall Study||40
5068085|NCT01830920|12470757|P1|COMPLETED|Overall Study||105
5068086|NCT01830920|12470753|P5|Received Allocated Drug|Overall Study||105
5068087|NCT01830920|12470754|P4|Received Allocated Drug|Overall Study||119
5068088|NCT01830920|12470755|P3|Received Allocated Drug|Overall Study||47
5068089|NCT01830920|12470756|P2|Received Allocated Drug|Overall Study||45
5068090|NCT01830920|12470757|P1|Received Allocated Drug|Overall Study||115
5068091|NCT01830920|12470753|P5|STARTED|Overall Study||107
5068092|NCT01830920|12470754|P4|STARTED|Overall Study||125
5068093|NCT01830920|12470755|P3|STARTED|Overall Study||48
5068094|NCT01830920|12470756|P2|STARTED|Overall Study||46
5068095|NCT01830920|12470757|P1|STARTED|Overall Study||126
5068096|NCT01830881|12470796|P2|NOT COMPLETED|Overall Study||1
5068097|NCT01830881|12470797|P1|NOT COMPLETED|Overall Study||0
5068098|NCT01830881|12470796|P2|COMPLETED|Overall Study||61
5068099|NCT01830881|12470797|P1|COMPLETED|Overall Study||62
5068100|NCT01830881|12470796|P2|STARTED|Overall Study||62
5068101|NCT01830881|12470797|P1|STARTED|Overall Study||62
5068102|NCT01830855|12470845|P4|NOT COMPLETED|Overall Study||82
5068103|NCT01830855|12470846|P3|NOT COMPLETED|Overall Study||66
5068104|NCT01830855|12470847|P2|NOT COMPLETED|Overall Study||61
5068105|NCT01830855|12470848|P1|NOT COMPLETED|Overall Study||155
5068106|NCT01830855|12470845|P4|COMPLETED|Overall Study||815
5068107|NCT01830855|12470846|P3|COMPLETED|Overall Study||521
5068108|NCT01830855|12470847|P2|COMPLETED|Overall Study||537
5068109|NCT01830855|12470848|P1|COMPLETED|Overall Study||1353
5068110|NCT01830855|12470845|P4|STARTED|Overall Study||897
5068111|NCT01830855|12470846|P3|STARTED|Overall Study||587
5068112|NCT01830855|12470847|P2|STARTED|Overall Study||598
5068113|NCT01830855|12470848|P1|STARTED|Overall Study||1508
5068114|NCT01830842|12470954|P2|NOT COMPLETED|Overall Study||2
5068115|NCT01830842|12470955|P1|NOT COMPLETED|Overall Study||5
5068116|NCT01830842|12470954|P2|COMPLETED|Overall Study||22
5068117|NCT01830842|12470955|P1|COMPLETED|Overall Study||25
5068118|NCT01830842|12470954|P2|STARTED|Overall Study||24
5068119|NCT01830842|12470955|P1|STARTED|Overall Study||30
5068120|NCT01830816|12470964|P3|NOT COMPLETED|Overall Study||7
5068121|NCT01830816|12470965|P2|NOT COMPLETED|Overall Study||14
5068122|NCT01830816|12470966|P1|NOT COMPLETED|Overall Study||20
5068123|NCT01830816|12470964|P3|COMPLETED|Overall Study||0
5068124|NCT01830816|12470965|P2|COMPLETED|Overall Study||0
5068125|NCT01830816|12470966|P1|COMPLETED|Overall Study||0
5068126|NCT01830816|12470964|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
5068127|NCT01830816|12470965|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
5068128|NCT01830816|12470966|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
5068129|NCT01830816|12470964|P3|STARTED|Overall Study||7
5068130|NCT01830816|12470965|P2|STARTED|Overall Study||14
5068131|NCT01830816|12470966|P1|STARTED|Overall Study||20
5068132|NCT01830790|12470991|P2|NOT COMPLETED|Overall Study||0
5068133|NCT01830790|12470992|P1|NOT COMPLETED|Overall Study||0
5068134|NCT01830790|12470991|P2|COMPLETED|Overall Study||10
5068135|NCT01830790|12470992|P1|COMPLETED|Overall Study||0
5068136|NCT01830790|12470991|P2|STARTED|Overall Study||10
5068137|NCT01830790|12470992|P1|STARTED|Overall Study||0
5068138|NCT01830699|12471002|P2|NOT COMPLETED|Overall Study||0
5068139|NCT01830699|12471003|P1|NOT COMPLETED|Overall Study||0
5068140|NCT01830699|12471002|P2|COMPLETED|Overall Study||20
5068141|NCT01830699|12471003|P1|COMPLETED|Overall Study||13
5068142|NCT01830699|12471002|P2|STARTED|Overall Study||20
5068143|NCT01830699|12471003|P1|STARTED|Overall Study||13
5068144|NCT01830621|12471015|P2|NOT COMPLETED|Overall Study||0
5068145|NCT01830621|12471016|P1|NOT COMPLETED|Overall Study||0
5068146|NCT01830621|12471015|P2|COMPLETED|Overall Study||144
5068147|NCT01830621|12471016|P1|COMPLETED|Overall Study||138
5068148|NCT01830621|12471015|P2|STARTED|Overall Study||144
5068149|NCT01830621|12471016|P1|STARTED|Overall Study||138
5068150|NCT01830595|12471030|P2|NOT COMPLETED|Second Period||0
5068151|NCT01830595|12471031|P1|NOT COMPLETED|Second Period||0
5068152|NCT01830595|12471030|P2|COMPLETED|Second Period||23
5068153|NCT01830595|12471031|P1|COMPLETED|Second Period||23
5068154|NCT01830595|12471030|P2|STARTED|Second Period||23
5068155|NCT01830595|12471031|P1|STARTED|Second Period||23
5068156|NCT01830595|12471030|P2|NOT COMPLETED|Washout||2
5068157|NCT01830595|12471031|P1|NOT COMPLETED|Washout||2
5068158|NCT01830595|12471030|P2|COMPLETED|Washout||23
5068159|NCT01830595|12471031|P1|COMPLETED|Washout||23
5068160|NCT01830595|12471030|P2|STARTED|Washout||25
5068161|NCT01830595|12471031|P1|STARTED|Washout||25
5068162|NCT01830595|12471030|P2|NOT COMPLETED|First Period||3
5068163|NCT01830595|12471031|P1|NOT COMPLETED|First Period||1
5068164|NCT01830595|12471030|P2|COMPLETED|First Period||25
5068165|NCT01830595|12471031|P1|COMPLETED|First Period||25
5068166|NCT01830595|12471030|P2|Received at Least One Dose|First Period||28
5068167|NCT01830595|12471031|P1|Received at Least One Dose|First Period||26
5068168|NCT01830595|12471030|P2|STARTED|First Period||28
5068169|NCT01830595|12471031|P1|STARTED|First Period||26
5068170|NCT01830543|12471048|P3|NOT COMPLETED|Overall Study||214
5068171|NCT01830543|12471049|P2|NOT COMPLETED|Overall Study||152
5068172|NCT01830543|12471050|P1|NOT COMPLETED|Overall Study||159
5068173|NCT01830543|12471048|P3|COMPLETED|Overall Study||492
5068174|NCT01830543|12471049|P2|COMPLETED|Overall Study||557
5068175|NCT01830543|12471050|P1|COMPLETED|Overall Study||550
5068176|NCT01830543|12471048|P3|Treated|Overall Study||697
5068177|NCT01830543|12471049|P2|Treated|Overall Study||706
5068178|NCT01830543|12471050|P1|Treated|Overall Study||696
5068179|NCT01830543|12471048|P3|STARTED|Overall Study||706
5068180|NCT01830543|12471049|P2|STARTED|Overall Study||709
5068181|NCT01830543|12471050|P1|STARTED|Overall Study||709
5068182|NCT01830205|12471086|P4|NOT COMPLETED|Overall Study||0
5068183|NCT01830205|12471087|P3|NOT COMPLETED|Overall Study||0
5068184|NCT01830205|12471088|P2|NOT COMPLETED|Overall Study||0
5068185|NCT01830205|12471089|P1|NOT COMPLETED|Overall Study||0
5068186|NCT01830205|12471086|P4|COMPLETED|Overall Study||12
5068187|NCT01830205|12471087|P3|COMPLETED|Overall Study||6
5068188|NCT01830205|12471088|P2|COMPLETED|Overall Study||6
5068189|NCT01830205|12471089|P1|COMPLETED|Overall Study||12
5068190|NCT01830205|12471086|P4|STARTED|Overall Study||12
5068191|NCT01830205|12471087|P3|STARTED|Overall Study||6
5068192|NCT01830205|12471088|P2|STARTED|Overall Study||6
5068193|NCT01830205|12471089|P1|STARTED|Overall Study||12
5068194|NCT01830140|12471173|P2|NOT COMPLETED|Overall Study||4
5068195|NCT01830140|12471174|P1|NOT COMPLETED|Overall Study||7
5068196|NCT01830140|12471173|P2|COMPLETED|Overall Study||229
5068197|NCT01830140|12471174|P1|COMPLETED|Overall Study||226
5068198|NCT01830140|12471173|P2|STARTED|Overall Study||233
5068199|NCT01830140|12471174|P1|STARTED|Overall Study||233
5068200|NCT01830127|12471182|P2|NOT COMPLETED|Overall Study||9
5068201|NCT01830127|12471183|P1|NOT COMPLETED|Overall Study||5
5068202|NCT01830127|12471182|P2|COMPLETED|Overall Study||8
5068203|NCT01830127|12471183|P1|COMPLETED|Overall Study||13
5068204|NCT01830127|12471182|P2|STARTED|Overall Study||17
5068205|NCT01830127|12471183|P1|STARTED|Overall Study||18
5068206|NCT01829997|12471191|P1|NOT COMPLETED|Overall Study||6
5068207|NCT01829997|12471191|P1|COMPLETED|Overall Study||16
5068208|NCT01829997|12471191|P1|STARTED|Overall Study||22
5068209|NCT01829919|12471200|P1|NOT COMPLETED|Overall Study||0
5068210|NCT01829919|12471200|P1|COMPLETED|Overall Study||24
5068211|NCT01829919|12471200|P1|STARTED|Overall Study||24
5068212|NCT01829711|12471216|P1|NOT COMPLETED|Overall Study||43
5068213|NCT01829711|12471216|P1|COMPLETED|Overall Study||37
5068214|NCT01829711|12471216|P1|STARTED|Overall Study||80
5068215|NCT01829516|12471247|P2|NOT COMPLETED|2nd Intervention||0
5068216|NCT01829516|12471248|P1|NOT COMPLETED|2nd Intervention||0
5068217|NCT01829516|12471247|P2|COMPLETED|2nd Intervention||14
5068218|NCT01829516|12471248|P1|COMPLETED|2nd Intervention||18
5068219|NCT01829516|12471247|P2|STARTED|2nd Intervention||14
5068220|NCT01829516|12471248|P1|STARTED|2nd Intervention||18
5068221|NCT01829516|12471247|P2|NOT COMPLETED|Washout Period - 1 Week||0
5068222|NCT01829516|12471248|P1|NOT COMPLETED|Washout Period - 1 Week||0
5068223|NCT01829516|12471247|P2|COMPLETED|Washout Period - 1 Week||14
5068224|NCT01829516|12471248|P1|COMPLETED|Washout Period - 1 Week||18
5068225|NCT01829516|12471247|P2|STARTED|Washout Period - 1 Week||14
5068226|NCT01829516|12471248|P1|STARTED|Washout Period - 1 Week||18
5068227|NCT01829516|12471247|P2|NOT COMPLETED|First Intervention||0
5068228|NCT01829516|12471248|P1|NOT COMPLETED|First Intervention||0
5068229|NCT01829516|12471247|P2|COMPLETED|First Intervention||14
5068230|NCT01829516|12471248|P1|COMPLETED|First Intervention||18
5068231|NCT01829516|12471247|P2|STARTED|First Intervention||14
5068232|NCT01829516|12471248|P1|STARTED|First Intervention||18
5068233|NCT01829503|12471256|P1|NOT COMPLETED|Overall Study||0
5068234|NCT01829503|12471256|P1|COMPLETED|Overall Study||44
5068235|NCT01829503|12471256|P1|STARTED|Overall Study||44
5068236|NCT01829477|12471273|P2|NOT COMPLETED|Overall Study||15
5068237|NCT01829477|12471274|P1|NOT COMPLETED|Overall Study||16
5068238|NCT01829477|12471273|P2|COMPLETED|Overall Study||1
5068239|NCT01829477|12471274|P1|COMPLETED|Overall Study||1
5068240|NCT01829477|12471273|P2|STARTED|Overall Study||16
5068241|NCT01829477|12471274|P1|STARTED|Overall Study||17
5068242|NCT01829464|12471287|P3|NOT COMPLETED|Overall Study||26
5068243|NCT01829464|12471288|P2|NOT COMPLETED|Overall Study||29
5068244|NCT01829464|12471289|P1|NOT COMPLETED|Overall Study||28
5068245|NCT01829464|12471287|P3|COMPLETED|Overall Study||3
5068246|NCT01829464|12471288|P2|COMPLETED|Overall Study||2
5068247|NCT01829464|12471289|P1|COMPLETED|Overall Study||2
5068248|NCT01829464|12471287|P3|STARTED|Overall Study||29
5068249|NCT01829464|12471288|P2|STARTED|Overall Study||31
5068250|NCT01829464|12471289|P1|STARTED|Overall Study||30
5068251|NCT01829425|12471305|P2|NOT COMPLETED|Overall Study||4
5068252|NCT01829425|12471306|P1|NOT COMPLETED|Overall Study||6
5068253|NCT01829425|12471305|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
5068254|NCT01829425|12471306|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
5068255|NCT01829425|12471305|P2|STARTED|Overall Study||74
5068256|NCT01829425|12471306|P1|STARTED|Overall Study||78
5068257|NCT01829399|12471336|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
5068258|NCT01829399|12471337|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
5068259|NCT01829399|12471336|P2|COMPLETED|Visit 2 (One Month Later)||12
5068260|NCT01829399|12471337|P1|COMPLETED|Visit 2 (One Month Later)||12
5068261|NCT01829399|12471336|P2|STARTED|Visit 2 (One Month Later)||12
5068262|NCT01829399|12471337|P1|STARTED|Visit 2 (One Month Later)||12
5068263|NCT01829399|12471336|P2|NOT COMPLETED|Visit 1||0
5068264|NCT01829399|12471337|P1|NOT COMPLETED|Visit 1||0
5068265|NCT01829399|12471336|P2|COMPLETED|Visit 1||12
5068266|NCT01829399|12471337|P1|COMPLETED|Visit 1||12
5068267|NCT01829399|12471336|P2|STARTED|Visit 1||12
5068268|NCT01829399|12471337|P1|STARTED|Visit 1||12
5068269|NCT01829360|12471349|P4|NOT COMPLETED|Overall Study||0
5068270|NCT01829360|12471350|P3|NOT COMPLETED|Overall Study||1
5068271|NCT01829360|12471351|P2|NOT COMPLETED|Overall Study||0
5068272|NCT01829360|12471352|P1|NOT COMPLETED|Overall Study||0
5068273|NCT01829360|12471349|P4|COMPLETED|Overall Study||8
5068274|NCT01829360|12471350|P3|COMPLETED|Overall Study||9
5068275|NCT01829360|12471351|P2|COMPLETED|Overall Study||9
5068276|NCT01829360|12471352|P1|COMPLETED|Overall Study||8
5068277|NCT01829360|12471349|P4|STARTED|Overall Study||8
5068278|NCT01829360|12471350|P3|STARTED|Overall Study||10
5068279|NCT01829360|12471351|P2|STARTED|Overall Study||9
5068280|NCT01829360|12471352|P1|STARTED|Overall Study||8
5068281|NCT01829347|12471372|P2|NOT COMPLETED|VTI-210E||6
5068282|NCT01829347|12471373|P1|NOT COMPLETED|VTI-210E||3
5068283|NCT01829347|12471372|P2|COMPLETED|VTI-210E||0
5068284|NCT01829347|12471373|P1|COMPLETED|VTI-210E||0
5068285|NCT01829347|12471372|P2|STARTED|VTI-210E||6
5068286|NCT01829347|12471373|P1|STARTED|VTI-210E||3
5068287|NCT01829347|12471372|P2|NOT COMPLETED|VTI-210||3
5068288|NCT01829347|12471373|P1|NOT COMPLETED|VTI-210||6
5068289|NCT01829347|12471372|P2|COMPLETED|VTI-210||6
5068290|NCT01829347|12471373|P1|COMPLETED|VTI-210||3
5068291|NCT01829347|12471372|P2|STARTED|VTI-210||9
5068292|NCT01829347|12471373|P1|STARTED|VTI-210||9
5068293|NCT01829295|12471383|P4|NOT COMPLETED|6-12 Months||13
5068294|NCT01829295|12471384|P3|NOT COMPLETED|6-12 Months||12
5068295|NCT01829295|12471385|P2|NOT COMPLETED|6-12 Months||2
5068296|NCT01829295|12471386|P1|NOT COMPLETED|6-12 Months||4
5068297|NCT01829295|12471383|P4|COMPLETED|6-12 Months||29
5068298|NCT01829295|12471384|P3|COMPLETED|6-12 Months||20
5068299|NCT01829295|12471385|P2|COMPLETED|6-12 Months||54
5068300|NCT01829295|12471386|P1|COMPLETED|6-12 Months||60
5068301|NCT01829295|12471383|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
5068302|NCT01829295|12471384|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
5068303|NCT01829295|12471385|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
5068304|NCT01829295|12471386|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
5068305|NCT01829295|12471383|P4|NOT COMPLETED|0-6 Months||0
5068306|NCT01829295|12471384|P3|NOT COMPLETED|0-6 Months||0
5068307|NCT01829295|12471385|P2|NOT COMPLETED|0-6 Months||11
5068308|NCT01829295|12471386|P1|NOT COMPLETED|0-6 Months||11
5068309|NCT01829295|12471383|P4|COMPLETED|0-6 Months||0
5068310|NCT01829295|12471384|P3|COMPLETED|0-6 Months||0
5068311|NCT01829295|12471385|P2|COMPLETED|0-6 Months||98
5068312|NCT01829295|12471386|P1|COMPLETED|0-6 Months||96
5068313|NCT01829295|12471383|P4|STARTED|0-6 Months||0
5068314|NCT01829295|12471384|P3|STARTED|0-6 Months||0
5068315|NCT01829295|12471385|P2|STARTED|0-6 Months||109
5068316|NCT01829295|12471386|P1|STARTED|0-6 Months||107
5068317|NCT01829243|12471396|P2|NOT COMPLETED|Second Intervention||0
5068318|NCT01829243|12471397|P1|NOT COMPLETED|Second Intervention||0
5068319|NCT01829243|12471396|P2|COMPLETED|Second Intervention||13
5068320|NCT01829243|12471397|P1|COMPLETED|Second Intervention||7
5068321|NCT01829243|12471396|P2|STARTED|Second Intervention||13
5068322|NCT01829243|12471397|P1|STARTED|Second Intervention||7
5068323|NCT01829243|12471396|P2|NOT COMPLETED|Washout Period of 1 Week||0
5068324|NCT01829243|12471397|P1|NOT COMPLETED|Washout Period of 1 Week||0
5068325|NCT01829243|12471396|P2|COMPLETED|Washout Period of 1 Week||13
5068326|NCT01829243|12471397|P1|COMPLETED|Washout Period of 1 Week||7
5068327|NCT01829243|12471396|P2|STARTED|Washout Period of 1 Week||13
5068328|NCT01829243|12471397|P1|STARTED|Washout Period of 1 Week||7
5068329|NCT01829243|12471396|P2|NOT COMPLETED|First Intervention||2
5068330|NCT01829243|12471397|P1|NOT COMPLETED|First Intervention||4
5068331|NCT01829243|12471396|P2|COMPLETED|First Intervention||13
5068332|NCT01829243|12471397|P1|COMPLETED|First Intervention||7
5068333|NCT01829243|12471396|P2|STARTED|First Intervention||15
5068334|NCT01829243|12471397|P1|STARTED|First Intervention||11
5068335|NCT01829230|12471411|P2|NOT COMPLETED|Overall Study||4
5068336|NCT01829230|12471412|P1|NOT COMPLETED|Overall Study||1
5068337|NCT01829230|12471411|P2|COMPLETED|Overall Study||38
5068338|NCT01829230|12471412|P1|COMPLETED|Overall Study||39
5068339|NCT01829230|12471411|P2|STARTED|Overall Study||42
5068340|NCT01829230|12471412|P1|STARTED|Overall Study||40
5068341|NCT01829217|12471420|P1|NOT COMPLETED|Overall Study||0
5068342|NCT01829217|12471420|P1|COMPLETED|Overall Study||13
5068343|NCT01829217|12471420|P1|STARTED|Overall Study||13
5068344|NCT01829191|12471426|P2|NOT COMPLETED|Overall Study||14
5068345|NCT01829191|12471427|P1|NOT COMPLETED|Overall Study||7
5068346|NCT01829191|12471426|P2|COMPLETED|Overall Study||50
5068347|NCT01829191|12471427|P1|COMPLETED|Overall Study||56
5068348|NCT01829191|12471426|P2|STARTED|Overall Study||64
5068349|NCT01829191|12471427|P1|STARTED|Overall Study||63
5068350|NCT01829165|12471436|P2|NOT COMPLETED|Overall Study||0
5068351|NCT01829165|12471437|P1|NOT COMPLETED|Overall Study||2
5068352|NCT01829165|12471436|P2|COMPLETED|Overall Study||13
5068353|NCT01829165|12471437|P1|COMPLETED|Overall Study||18
5068354|NCT01829165|12471436|P2|STARTED|Overall Study||13
5068355|NCT01829165|12471437|P1|STARTED|Overall Study||20
5068356|NCT01829113|12471445|P2|NOT COMPLETED|Overall Study||78
5068357|NCT01829113|12471446|P1|NOT COMPLETED|Overall Study||77
5068358|NCT01829113|12471445|P2|COMPLETED|Overall Study||0
5068359|NCT01829113|12471446|P1|COMPLETED|Overall Study||0
5068360|NCT01829113|12471445|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
5068361|NCT01829113|12471446|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
5068362|NCT01829048|12471463|P5|NOT COMPLETED|Overall Study||0
5068363|NCT01829048|12471464|P4|NOT COMPLETED|Overall Study||2
5068364|NCT01829048|12471465|P3|NOT COMPLETED|Overall Study||0
5068365|NCT01829048|12471466|P2|NOT COMPLETED|Overall Study||0
5068366|NCT01829048|12471467|P1|NOT COMPLETED|Overall Study||0
5068367|NCT01829048|12471463|P5|COMPLETED|Overall Study||2
5068368|NCT01829048|12471464|P4|COMPLETED|Overall Study||12
5068369|NCT01829048|12471465|P3|COMPLETED|Overall Study||7
5068370|NCT01829048|12471466|P2|COMPLETED|Overall Study||8
5068371|NCT01829048|12471467|P1|COMPLETED|Overall Study||6
5068372|NCT01829048|12471463|P5|STARTED|Overall Study||2
5068373|NCT01829048|12471464|P4|STARTED|Overall Study||14
5068374|NCT01829048|12471465|P3|STARTED|Overall Study||7
5068375|NCT01829048|12471466|P2|STARTED|Overall Study||8
5068376|NCT01829048|12471467|P1|STARTED|Overall Study||6
5068377|NCT01828983|12471541|P2|NOT COMPLETED|Overall Study||0
5068378|NCT01828983|12471542|P1|NOT COMPLETED|Overall Study||0
5068379|NCT01828983|12471541|P2|COMPLETED|Overall Study||81
5068380|NCT01828983|12471542|P1|COMPLETED|Overall Study||80
5068381|NCT01828983|12471541|P2|STARTED|Overall Study||81
5068382|NCT01828983|12471542|P1|STARTED|Overall Study||80
5068383|NCT01828593|12471555|P3|NOT COMPLETED|Placebo-Free Phase||6
5068384|NCT01828593|12471556|P2|NOT COMPLETED|Placebo-Free Phase||6
5068385|NCT01828593|12471557|P1|NOT COMPLETED|Placebo-Free Phase||0
5068386|NCT01828593|12471555|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
5068387|NCT01828593|12471556|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
5068388|NCT01828593|12471557|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
5068389|NCT01828593|12471555|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
5068390|NCT01828593|12471556|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
5068391|NCT01828593|12471557|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
5068392|NCT01828593|12471555|P3|NOT COMPLETED|Placebo-Controlled Phase||1
5068393|NCT01828593|12471556|P2|NOT COMPLETED|Placebo-Controlled Phase||0
5068394|NCT01828593|12471557|P1|NOT COMPLETED|Placebo-Controlled Phase||0
5068395|NCT01828593|12471555|P3|COMPLETED|Placebo-Controlled Phase||32
5068396|NCT01828593|12471556|P2|COMPLETED|Placebo-Controlled Phase||34
5068397|NCT01828593|12471557|P1|COMPLETED|Placebo-Controlled Phase||36
5068398|NCT01828593|12471555|P3|STARTED|Placebo-Controlled Phase||33
5068399|NCT01828593|12471556|P2|STARTED|Placebo-Controlled Phase||34
5068400|NCT01828593|12471557|P1|STARTED|Placebo-Controlled Phase||36
5068401|NCT01828567|12471580|P2|NOT COMPLETED|Overall Study||10
5068402|NCT01828567|12471581|P1|NOT COMPLETED|Overall Study||31
5068403|NCT01828567|12471580|P2|COMPLETED|Overall Study||199
5068404|NCT01828567|12471581|P1|COMPLETED|Overall Study||177
5068405|NCT01828567|12471580|P2|1 Month|Overall Study||192
5068406|NCT01828567|12471581|P1|1 Month|Overall Study||172
5068407|NCT01828567|12471580|P2|STARTED|Overall Study||209
5068408|NCT01828567|12471581|P1|STARTED|Overall Study||208
5068409|NCT01828554|12471597|P1|NOT COMPLETED|Overall Study||0
5068410|NCT01828554|12471597|P1|COMPLETED|Overall Study||8
5068411|NCT01828554|12471597|P1|STARTED|Overall Study||8
5068412|NCT01828515|12471604|P2|NOT COMPLETED|Second Intervention (19 Days)||3
5068413|NCT01828515|12471605|P1|NOT COMPLETED|Second Intervention (19 Days)||0
5068414|NCT01828515|12471604|P2|COMPLETED|Second Intervention (19 Days)||5
5068415|NCT01828515|12471605|P1|COMPLETED|Second Intervention (19 Days)||6
5068416|NCT01828515|12471604|P2|STARTED|Second Intervention (19 Days)||8
5068417|NCT01828515|12471605|P1|STARTED|Second Intervention (19 Days)||6
5068418|NCT01828515|12471604|P2|NOT COMPLETED|Washout (23 Days)||1
5068419|NCT01828515|12471605|P1|NOT COMPLETED|Washout (23 Days)||5
5068420|NCT01828515|12471604|P2|COMPLETED|Washout (23 Days)||8
5068421|NCT01828515|12471605|P1|COMPLETED|Washout (23 Days)||6
5068422|NCT01828515|12471604|P2|STARTED|Washout (23 Days)||9
5068423|NCT01828515|12471605|P1|STARTED|Washout (23 Days)||11
5068424|NCT01828515|12471604|P2|NOT COMPLETED|First Intervention (19 Days)||2
5068425|NCT01828515|12471605|P1|NOT COMPLETED|First Intervention (19 Days)||2
5068426|NCT01828515|12471604|P2|COMPLETED|First Intervention (19 Days)||9
5068427|NCT01828515|12471605|P1|COMPLETED|First Intervention (19 Days)||11
5068428|NCT01828515|12471604|P2|STARTED|First Intervention (19 Days)||11
5068429|NCT01828515|12471605|P1|STARTED|First Intervention (19 Days)||13
5068430|NCT01828476|12471613|P2|NOT COMPLETED|Overall Study||0
5068431|NCT01828476|12471614|P1|NOT COMPLETED|Overall Study||0
5068432|NCT01828476|12471613|P2|COMPLETED|Overall Study||0
5068433|NCT01828476|12471614|P1|COMPLETED|Overall Study||13
5068434|NCT01828476|12471613|P2|STARTED|Overall Study||0
5068435|NCT01828476|12471614|P1|STARTED|Overall Study||13
5068436|NCT01828281|12471636|P2|NOT COMPLETED|Overall Study||0
5068437|NCT01828281|12471637|P1|NOT COMPLETED|Overall Study||1
5068438|NCT01828281|12471636|P2|COMPLETED|Overall Study||45
5068439|NCT01828281|12471637|P1|COMPLETED|Overall Study||44
5068440|NCT01828281|12471636|P2|STARTED|Overall Study||45
5068441|NCT01828281|12471637|P1|STARTED|Overall Study||45
5068442|NCT01828216|12471649|P2|NOT COMPLETED|Overall Study||0
5068443|NCT01828216|12471650|P1|NOT COMPLETED|Overall Study||0
5068444|NCT01828216|12471649|P2|COMPLETED|Overall Study||157
5068445|NCT01828216|12471650|P1|COMPLETED|Overall Study||159
5068446|NCT01828216|12471649|P2|STARTED|Overall Study||157
5068447|NCT01828216|12471650|P1|STARTED|Overall Study||159
5068448|NCT01828164|12471658|P1|NOT COMPLETED|Overall Study||17
5068449|NCT01828164|12471658|P1|COMPLETED|Overall Study||32
5068450|NCT01828164|12471658|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
5068451|NCT01828112|12471670|P2|NOT COMPLETED|Overall Study||108
5068452|NCT01828112|12471671|P1|NOT COMPLETED|Overall Study||82
5068453|NCT01828112|12471670|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
5068454|NCT01828112|12471671|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
5068455|NCT01828112|12471670|P2|Treated|Overall Study||113
5068456|NCT01828112|12471671|P1|Treated|Overall Study||115
5068457|NCT01828112|12471670|P2|Untreated|Overall Study||3
5068458|NCT01828112|12471671|P1|Untreated|Overall Study||0
5068459|NCT01828112|12471670|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
5068460|NCT01828112|12471671|P1|Untreated Patients|Overall Study||0
5068461|NCT01828112|12471670|P2|Discontinued From Study|Overall Study||10
5068462|NCT01828112|12471671|P1|Discontinued From Study|Overall Study||14
5068463|NCT01828112|12471670|P2|Entered Survival Follow-up Phase|Overall Study||19
5068464|NCT01828112|12471671|P1|Entered Survival Follow-up Phase|Overall Study||61
5068465|NCT01828112|12471670|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
5068466|NCT01828112|12471671|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
5068467|NCT01828112|12471670|P2|Entered Extension Treatment Phase|Overall Study||74
5068468|NCT01828112|12471671|P1|Entered Extension Treatment Phase|Overall Study||0
5068469|NCT01828112|12471670|P2|STARTED|Overall Study||116
5068470|NCT01828112|12471671|P1|STARTED|Overall Study||115
5068471|NCT01828099|12471679|P2|NOT COMPLETED|Overall Study||157
5068472|NCT01828099|12471680|P1|NOT COMPLETED|Overall Study||94
5068473|NCT01828099|12471679|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
5068474|NCT01828099|12471680|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
5068475|NCT01828099|12471679|P2|Discontinued From Study|Overall Study||29
5068476|NCT01828099|12471680|P1|Discontinued From Study|Overall Study||20
5068477|NCT01828099|12471679|P2|Entered Survival Follow-up Phase|Overall Study||31
5068478|NCT01828099|12471680|P1|Entered Survival Follow-up Phase|Overall Study||64
5068479|NCT01828099|12471679|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
5068480|NCT01828099|12471680|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
5068481|NCT01828099|12471679|P2|Entered Extension-treatment Phase|Overall Study||81
5068482|NCT01828099|12471680|P1|Entered Extension-treatment Phase|Overall Study||0
5068483|NCT01828099|12471679|P2|Discontinued From Treatment Phase|Overall Study||157
5068484|NCT01828099|12471680|P1|Discontinued From Treatment Phase|Overall Study||94
5068485|NCT01828099|12471679|P2|Treated|Overall Study||175
5068486|NCT01828099|12471680|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
5068487|NCT01828099|12471679|P2|Untreated Patients|Overall Study||12
5068488|NCT01828099|12471680|P1|Untreated Patients|Overall Study||0
5068489|NCT01828099|12471679|P2|STARTED|Overall Study||187
5068490|NCT01828099|12471680|P1|STARTED|Overall Study||189
5068491|NCT01828073|12471688|P2|NOT COMPLETED|Overall Study||2
5068492|NCT01828073|12471689|P1|NOT COMPLETED|Overall Study||1
5068493|NCT01828073|12471688|P2|COMPLETED|Overall Study||16
5068494|NCT01828073|12471689|P1|COMPLETED|Overall Study||21
5068495|NCT01828073|12471688|P2|STARTED|Overall Study||18
5068496|NCT01828073|12471689|P1|STARTED|Overall Study||22
5068497|NCT01827839|12471709|P1|NOT COMPLETED|Overall Study||3
5068498|NCT01827839|12471709|P1|COMPLETED|Overall Study||93
5068499|NCT01827839|12471709|P1|STARTED|Overall Study||96
5068500|NCT01827787|12471733|P2|NOT COMPLETED|Overall Study||0
5068501|NCT01827787|12471734|P1|NOT COMPLETED|Overall Study||0
5068502|NCT01827787|12471733|P2|COMPLETED|Overall Study||38
5068503|NCT01827787|12471734|P1|COMPLETED|Overall Study||45
5068504|NCT01827787|12471733|P2|STARTED|Overall Study||38
5068505|NCT01827787|12471734|P1|STARTED|Overall Study||45
5068506|NCT01827670|12471754|P2|NOT COMPLETED|Overall Study||3
5068507|NCT01827670|12471755|P1|NOT COMPLETED|Overall Study||3
5068508|NCT01827670|12471754|P2|COMPLETED|Overall Study||56
5068509|NCT01827670|12471755|P1|COMPLETED|Overall Study||57
5068510|NCT01827670|12471754|P2|STARTED|Overall Study||59
5068511|NCT01827670|12471755|P1|STARTED|Overall Study||60
5068512|NCT01827592|12471774|P3|NOT COMPLETED|Overall Study||76
5068513|NCT01827592|12471775|P2|NOT COMPLETED|Overall Study||80
5068514|NCT01827592|12471776|P1|NOT COMPLETED|Overall Study||74
5068515|NCT01827592|12471774|P3|COMPLETED|Overall Study||48
5068516|NCT01827592|12471775|P2|COMPLETED|Overall Study||46
5068517|NCT01827592|12471776|P1|COMPLETED|Overall Study||52
5068518|NCT01827592|12471774|P3|Safety Analysis Set|Overall Study||124
5068519|NCT01827592|12471775|P2|Safety Analysis Set|Overall Study||126
5068520|NCT01827592|12471776|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
5068521|NCT01827592|12471774|P3|STARTED|Overall Study|Randomized patients.|124
5068522|NCT01827592|12471775|P2|STARTED|Overall Study|Randomized patients.|126
5068523|NCT01827592|12471776|P1|STARTED|Overall Study|Randomized patients.|126
5068524|NCT01827475|12471808|P3|NOT COMPLETED|Overall Study||0
5068525|NCT01827475|12471809|P2|NOT COMPLETED|Overall Study||0
5068526|NCT01827475|12471810|P1|NOT COMPLETED|Overall Study||0
5068527|NCT01827475|12471808|P3|COMPLETED|Overall Study||30
5068528|NCT01827475|12471809|P2|COMPLETED|Overall Study||30
5068529|NCT01827475|12471810|P1|COMPLETED|Overall Study||30
5068530|NCT01827475|12471808|P3|STARTED|Overall Study||30
5068531|NCT01827475|12471809|P2|STARTED|Overall Study||30
5068532|NCT01827475|12471810|P1|STARTED|Overall Study||30
5068533|NCT01827462|12471824|P3|NOT COMPLETED|Overall Study||28
5068534|NCT01827462|12471825|P2|NOT COMPLETED|Overall Study||18
5068535|NCT01827462|12471826|P1|NOT COMPLETED|Overall Study||41
5068536|NCT01827462|12471824|P3|COMPLETED|Overall Study||12
5068537|NCT01827462|12471825|P2|COMPLETED|Overall Study||19
5068538|NCT01827462|12471826|P1|COMPLETED|Overall Study||18
5068539|NCT01827462|12471824|P3|STARTED|Overall Study||40
5068540|NCT01827462|12471825|P2|STARTED|Overall Study||37
5068541|NCT01827462|12471826|P1|STARTED|Overall Study||59
5068542|NCT01827371|12471841|P4|NOT COMPLETED|Overall Study||23
5068543|NCT01827371|12471842|P3|NOT COMPLETED|Overall Study||11
5068544|NCT01827371|12471843|P2|NOT COMPLETED|Overall Study||7
5068545|NCT01827371|12471844|P1|NOT COMPLETED|Overall Study||13
5068546|NCT01827371|12471841|P4|COMPLETED|Overall Study||97
5068547|NCT01827371|12471842|P3|COMPLETED|Overall Study||93
5068548|NCT01827371|12471843|P2|COMPLETED|Overall Study||89
5068549|NCT01827371|12471844|P1|COMPLETED|Overall Study||102
5068550|NCT01827371|12471841|P4|STARTED|Overall Study||120
5068551|NCT01827371|12471842|P3|STARTED|Overall Study||104
5068552|NCT01827371|12471843|P2|STARTED|Overall Study||96
5068553|NCT01827371|12471844|P1|STARTED|Overall Study||115
5068554|NCT01827358|12471868|P2|NOT COMPLETED|Overall Study||31
5068555|NCT01827358|12471869|P1|NOT COMPLETED|Overall Study||35
5068556|NCT01827358|12471868|P2|COMPLETED|Overall Study||44
5068557|NCT01827358|12471869|P1|COMPLETED|Overall Study||45
5068558|NCT01827358|12471868|P2|STARTED|Overall Study||75
5068559|NCT01827358|12471869|P1|STARTED|Overall Study||80
5068560|NCT01827332|12471903|P2|NOT COMPLETED|Overall Study||1
5068561|NCT01827332|12471904|P1|NOT COMPLETED|Overall Study||2
5068562|NCT01827332|12471903|P2|COMPLETED|Overall Study||7
5068563|NCT01827332|12471904|P1|COMPLETED|Overall Study||6
5068564|NCT01827332|12471903|P2|STARTED|Overall Study||8
5068565|NCT01827332|12471904|P1|STARTED|Overall Study||8
5068566|NCT01827319|12471912|P1|NOT COMPLETED|Overall Study||3
5068567|NCT01827319|12471912|P1|COMPLETED|Overall Study||200
5068568|NCT01827319|12471912|P1|STARTED|Overall Study||203
5068569|NCT01827306|12471920|P2|NOT COMPLETED|Overall Study||5
5068570|NCT01827306|12471921|P1|NOT COMPLETED|Overall Study||11
5068571|NCT01827306|12471920|P2|COMPLETED|Overall Study||8
5068572|NCT01827306|12471921|P1|COMPLETED|Overall Study||10
5068573|NCT01827306|12471920|P2|STARTED|Overall Study||13
5068574|NCT01827306|12471921|P1|STARTED|Overall Study||21
5068575|NCT01827267|12471935|P2|NOT COMPLETED|Overall Study||12
5068576|NCT01827267|12471936|P1|NOT COMPLETED|Overall Study||5
5068577|NCT01827267|12471935|P2|COMPLETED|Overall Study||32
5068578|NCT01827267|12471936|P1|COMPLETED|Overall Study||13
5068579|NCT01827267|12471935|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
5068580|NCT01827267|12471936|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
5068581|NCT01827267|12471935|P2|Received Study Drug|Overall Study||43
5068582|NCT01827267|12471936|P1|Received Study Drug|Overall Study||17
5068583|NCT01827267|12471935|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
5068584|NCT01827267|12471936|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
5068585|NCT01827254|12471951|P1|NOT COMPLETED|Overall Study||59
5068586|NCT01827254|12471951|P1|COMPLETED|Overall Study||2
5068587|NCT01827254|12471951|P1|Evaluable Population|Overall Study||52
5068588|NCT01827254|12471951|P1|STARTED|Overall Study||61
5068589|NCT01827163|12471961|P1|NOT COMPLETED|Overall Study||11
5068590|NCT01827163|12471961|P1|COMPLETED|Overall Study||9
5068591|NCT01827163|12471961|P1|STARTED|Overall Study||20
5068592|NCT01827046|12471968|P2|NOT COMPLETED|Overall Study||9
5068593|NCT01827046|12471969|P1|NOT COMPLETED|Overall Study||1
5068594|NCT01827046|12471968|P2|COMPLETED|Overall Study||240
5068595|NCT01827046|12471969|P1|COMPLETED|Overall Study||249
5068596|NCT01827046|12471968|P2|STARTED|Overall Study||249
5068597|NCT01827046|12471969|P1|STARTED|Overall Study||250
5068598|NCT01826981|12472024|P15|NOT COMPLETED|Overall Study||0
5068599|NCT01826981|12472025|P14|NOT COMPLETED|Overall Study||5
5068600|NCT01826981|12472026|P13|NOT COMPLETED|Overall Study||1
5068601|NCT01826981|12472027|P12|NOT COMPLETED|Overall Study||2
5068602|NCT01826981|12472028|P11|NOT COMPLETED|Overall Study||2
5068603|NCT01826981|12472029|P10|NOT COMPLETED|Overall Study||1
5068604|NCT01826981|12472030|P9|NOT COMPLETED|Overall Study||7
5068605|NCT01826981|12472031|P8|NOT COMPLETED|Overall Study||11
5068606|NCT01826981|12472032|P7|NOT COMPLETED|Overall Study||1
5068607|NCT01826981|12472033|P6|NOT COMPLETED|Overall Study||1
5068608|NCT01826981|12472034|P5|NOT COMPLETED|Overall Study||7
5068609|NCT01826981|12472035|P4|NOT COMPLETED|Overall Study||0
5068610|NCT01826981|12472036|P3|NOT COMPLETED|Overall Study||0
5068611|NCT01826981|12472037|P2|NOT COMPLETED|Overall Study||1
5068612|NCT01826981|12472038|P1|NOT COMPLETED|Overall Study||0
5068613|NCT01826981|12472024|P15|COMPLETED|Overall Study||8
5068614|NCT01826981|12472025|P14|COMPLETED|Overall Study||15
5068615|NCT01826981|12472026|P13|COMPLETED|Overall Study||25
5068616|NCT01826981|12472027|P12|COMPLETED|Overall Study||25
5068617|NCT01826981|12472028|P11|COMPLETED|Overall Study||22
5068618|NCT01826981|12472029|P10|COMPLETED|Overall Study||26
5068619|NCT01826981|12472030|P9|COMPLETED|Overall Study||13
5068620|NCT01826981|12472031|P8|COMPLETED|Overall Study||40
5068621|NCT01826981|12472032|P7|COMPLETED|Overall Study||24
5068622|NCT01826981|12472033|P6|COMPLETED|Overall Study||25
5068623|NCT01826981|12472034|P5|COMPLETED|Overall Study||18
5068624|NCT01826981|12472035|P4|COMPLETED|Overall Study||26
5068625|NCT01826981|12472036|P3|COMPLETED|Overall Study||25
5068626|NCT01826981|12472037|P2|COMPLETED|Overall Study||9
5068627|NCT01826981|12472038|P1|COMPLETED|Overall Study||19
5068628|NCT01826981|12472024|P15|STARTED|Overall Study||8
5068629|NCT01826981|12472025|P14|STARTED|Overall Study||20
5068630|NCT01826981|12472026|P13|STARTED|Overall Study||26
5068631|NCT01826981|12472027|P12|STARTED|Overall Study||27
5068632|NCT01826981|12472028|P11|STARTED|Overall Study||24
5068633|NCT01826981|12472029|P10|STARTED|Overall Study||27
5068634|NCT01826981|12472030|P9|STARTED|Overall Study||20
5068635|NCT01826981|12472031|P8|STARTED|Overall Study||51
5068636|NCT01826981|12472032|P7|STARTED|Overall Study||25
5068637|NCT01826981|12472033|P6|STARTED|Overall Study||26
5068638|NCT01826981|12472034|P5|STARTED|Overall Study||25
5068639|NCT01826981|12472035|P4|STARTED|Overall Study||26
5068640|NCT01826981|12472036|P3|STARTED|Overall Study||25
5068641|NCT01826981|12472037|P2|STARTED|Overall Study||10
5068642|NCT01826981|12472038|P1|STARTED|Overall Study||19
5068643|NCT01826851|12472186|P2|NOT COMPLETED|Overall Study||0
5068644|NCT01826851|12472187|P1|NOT COMPLETED|Overall Study||0
5068645|NCT01826851|12472186|P2|COMPLETED|Overall Study||41
5068646|NCT01826851|12472187|P1|COMPLETED|Overall Study||38
5068647|NCT01826851|12472186|P2|STARTED|Overall Study||41
5068648|NCT01826851|12472187|P1|STARTED|Overall Study||38
5068649|NCT01826812|12472207|P2|NOT COMPLETED|Overall Study||1
5068650|NCT01826812|12472208|P1|NOT COMPLETED|Overall Study||0
5068651|NCT01826812|12472207|P2|COMPLETED|Overall Study||32
5068652|NCT01826812|12472208|P1|COMPLETED|Overall Study||167
5068653|NCT01826812|12472207|P2|STARTED|Overall Study||33
5068654|NCT01826812|12472208|P1|STARTED|Overall Study||167
5068655|NCT01826604|12472224|P2|NOT COMPLETED|Overall Study||9
5068656|NCT01826604|12472225|P1|NOT COMPLETED|Overall Study||8
5068657|NCT01826604|12472224|P2|COMPLETED|Overall Study||148
5068658|NCT01826604|12472225|P1|COMPLETED|Overall Study||136
5068659|NCT01826604|12472224|P2|STARTED|Overall Study||157
5068660|NCT01826604|12472225|P1|STARTED|Overall Study||144
5068661|NCT01826513|12472236|P3|NOT COMPLETED|Overall Study||0
5068662|NCT01826513|12472237|P2|NOT COMPLETED|Overall Study||0
5068663|NCT01826513|12472238|P1|NOT COMPLETED|Overall Study||0
5068664|NCT01826513|12472236|P3|COMPLETED|Overall Study||10
5068665|NCT01826513|12472237|P2|COMPLETED|Overall Study||10
5068666|NCT01826513|12472238|P1|COMPLETED|Overall Study||5
5068667|NCT01826513|12472236|P3|STARTED|Overall Study||10
5068668|NCT01826513|12472237|P2|STARTED|Overall Study||10
5068669|NCT01826513|12472238|P1|STARTED|Overall Study||5
5068670|NCT01826448|12472269|P2|NOT COMPLETED|Overall Study||9
5068671|NCT01826448|12472270|P1|NOT COMPLETED|Overall Study||4
5068672|NCT01826448|12472269|P2|COMPLETED|Overall Study||0
5068673|NCT01826448|12472270|P1|COMPLETED|Overall Study||0
5068674|NCT01826448|12472269|P2|STARTED|Overall Study||9
5068675|NCT01826448|12472270|P1|STARTED|Overall Study||4
5068676|NCT01826422|12472278|P2|NOT COMPLETED|Overall Study||3
5068677|NCT01826422|12472279|P1|NOT COMPLETED|Overall Study||1
5068678|NCT01826422|12472278|P2|COMPLETED|Overall Study||19
5068679|NCT01826422|12472279|P1|COMPLETED|Overall Study||17
5068680|NCT01826422|12472278|P2|STARTED|Overall Study||22
5068681|NCT01826422|12472279|P1|STARTED|Overall Study||18
5068682|NCT01826370|12472323|P1|NOT COMPLETED|Overall Study||20
5068683|NCT01826370|12472323|P1|COMPLETED|Overall Study||658
5068684|NCT01826370|12472323|P1|STARTED|Overall Study||678
5068685|NCT01826227|12472329|P1|NOT COMPLETED|Overall Study||0
5068686|NCT01826227|12472329|P1|COMPLETED|Overall Study||5
5068687|NCT01826227|12472329|P1|STARTED|Overall Study||5
5068688|NCT01826214|12472335|P2|NOT COMPLETED|Overall Study||34
5068689|NCT01826214|12472336|P1|NOT COMPLETED|Overall Study||35
5068690|NCT01826214|12472335|P2|COMPLETED|Overall Study||0
5068691|NCT01826214|12472336|P1|COMPLETED|Overall Study||0
5068692|NCT01826214|12472335|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
5068693|NCT01826214|12472336|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
5068694|NCT01826214|12472335|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
5068695|NCT01826214|12472336|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
5068696|NCT01826214|12472335|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
5068697|NCT01826214|12472336|P1|STARTED|Overall Study||35
5068698|NCT01826201|12472354|P1|NOT COMPLETED|Overall Study||4
5068699|NCT01826201|12472354|P1|COMPLETED|Overall Study||17
5068700|NCT01826201|12472354|P1|STARTED|Overall Study|Subjects in each arm are same|21
5068701|NCT01825941|12472362|P2|NOT COMPLETED|Overall Study||1
5068702|NCT01825941|12472363|P1|NOT COMPLETED|Overall Study||4
5068703|NCT01825941|12472362|P2|COMPLETED|Overall Study||103
5068704|NCT01825941|12472363|P1|COMPLETED|Overall Study||100
5068705|NCT01825941|12472362|P2|STARTED|Overall Study||104
5068706|NCT01825941|12472363|P1|STARTED|Overall Study||104
5068707|NCT01825889|12472371|P2|NOT COMPLETED|Overall Study||0
5068708|NCT01825889|12472372|P1|NOT COMPLETED|Overall Study||0
5068709|NCT01825889|12472371|P2|COMPLETED|Overall Study||10
5068710|NCT01825889|12472372|P1|COMPLETED|Overall Study||10
5068711|NCT01825889|12472371|P2|Received One Dose of Study Drug|Overall Study||10
5068712|NCT01825889|12472372|P1|Received One Dose of Study Drug|Overall Study||10
5068713|NCT01825889|12472371|P2|STARTED|Overall Study||10
5068714|NCT01825889|12472372|P1|STARTED|Overall Study||10
5068715|NCT01825876|12472382|P2|NOT COMPLETED|Period 2||1
5068716|NCT01825876|12472383|P1|NOT COMPLETED|Period 2||0
5068717|NCT01825876|12472382|P2|COMPLETED|Period 2||16
5068718|NCT01825876|12472383|P1|COMPLETED|Period 2||0
5068719|NCT01825876|12472382|P2|Received 1 Dose of Study Drug|Period 2||17
5068720|NCT01825876|12472383|P1|Received 1 Dose of Study Drug|Period 2||0
5068721|NCT01825876|12472382|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
5068722|NCT01825876|12472383|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
5068723|NCT01825876|12472382|P2|NOT COMPLETED|Period 1||0
5068724|NCT01825876|12472383|P1|NOT COMPLETED|Period 1||0
5068725|NCT01825876|12472382|P2|COMPLETED|Period 1||0
5068726|NCT01825876|12472383|P1|COMPLETED|Period 1||17
5068727|NCT01825876|12472382|P2|Received 1 Dose of Study Drug|Period 1||0
5068728|NCT01825876|12472383|P1|Received 1 Dose of Study Drug|Period 1||17
5068729|NCT01825876|12472382|P2|STARTED|Period 1||0
5068730|NCT01825876|12472383|P1|STARTED|Period 1||17
5068731|NCT01825837|12472404|P4|NOT COMPLETED|PART II||0
5068732|NCT01825837|12472405|P3|NOT COMPLETED|PART II||19
5068733|NCT01825837|12472406|P2|NOT COMPLETED|PART II||14
5068734|NCT01825837|12472407|P1|NOT COMPLETED|PART II||19
5068735|NCT01825837|12472404|P4|COMPLETED|PART II||0
5068736|NCT01825837|12472405|P3|COMPLETED|PART II||7
5068737|NCT01825837|12472406|P2|COMPLETED|PART II||12
5068738|NCT01825837|12472407|P1|COMPLETED|PART II||16
5068739|NCT01825837|12472404|P4|Per-Protocol Population|PART II||0
5068740|NCT01825837|12472405|P3|Per-Protocol Population|PART II||24
5068741|NCT01825837|12472406|P2|Per-Protocol Population|PART II||23
5068742|NCT01825837|12472407|P1|Per-Protocol Population|PART II||32
5068743|NCT01825837|12472404|P4|Intent-to-Treat Population|PART II||0
5068744|NCT01825837|12472405|P3|Intent-to-Treat Population|PART II||26
5068745|NCT01825837|12472406|P2|Intent-to-Treat Population|PART II||25
5068746|NCT01825837|12472407|P1|Intent-to-Treat Population|PART II||34
5068747|NCT01825837|12472404|P4|Safety Population (Double-Blind)|PART II||0
5068748|NCT01825837|12472405|P3|Safety Population (Double-Blind)|PART II||26
5068749|NCT01825837|12472406|P2|Safety Population (Double-Blind)|PART II||26
5068750|NCT01825837|12472407|P1|Safety Population (Double-Blind)|PART II||35
5068751|NCT01825837|12472404|P4|Randomized Patients|PART II||0
5068752|NCT01825837|12472405|P3|Randomized Patients|PART II||26
5068753|NCT01825837|12472406|P2|Randomized Patients|PART II||26
5068754|NCT01825837|12472407|P1|Randomized Patients|PART II||35
5068755|NCT01825837|12472404|P4|STARTED|PART II||0
5068756|NCT01825837|12472405|P3|STARTED|PART II||26
5068757|NCT01825837|12472406|P2|STARTED|PART II||26
5068758|NCT01825837|12472407|P1|STARTED|PART II||35
5068759|NCT01825837|12472404|P4|NOT COMPLETED|PART I||17
5068760|NCT01825837|12472405|P3|NOT COMPLETED|PART I||0
5068761|NCT01825837|12472406|P2|NOT COMPLETED|PART I||0
5068762|NCT01825837|12472407|P1|NOT COMPLETED|PART I||0
5068763|NCT01825837|12472404|P4|COMPLETED|PART I||87
5068764|NCT01825837|12472405|P3|COMPLETED|PART I||0
5068765|NCT01825837|12472406|P2|COMPLETED|PART I||0
5068766|NCT01825837|12472407|P1|COMPLETED|PART I||0
5068767|NCT01825837|12472404|P4|Safety Population (Open-Label)|PART I||104
5068768|NCT01825837|12472405|P3|Safety Population (Open-Label)|PART I||0
5068769|NCT01825837|12472406|P2|Safety Population (Open-Label)|PART I||0
5068770|NCT01825837|12472407|P1|Safety Population (Open-Label)|PART I||0
5068771|NCT01825837|12472404|P4|Enrolled|PART I||104
5068772|NCT01825837|12472405|P3|Enrolled|PART I||0
5068773|NCT01825837|12472406|P2|Enrolled|PART I||0
5068774|NCT01825837|12472407|P1|Enrolled|PART I||0
5068775|NCT01825837|12472404|P4|STARTED|PART I||104
5068776|NCT01825837|12472405|P3|STARTED|PART I||0
5068777|NCT01825837|12472406|P2|STARTED|PART I||0
5068778|NCT01825837|12472407|P1|STARTED|PART I||0
5068779|NCT01825798|12472417|P2|NOT COMPLETED|Overall Study||5
5068780|NCT01825798|12472418|P1|NOT COMPLETED|Overall Study||2
5068781|NCT01825798|12472417|P2|COMPLETED|Overall Study||23
5068782|NCT01825798|12472418|P1|COMPLETED|Overall Study||30
5068783|NCT01825798|12472417|P2|STARTED|Overall Study||28
5068784|NCT01825798|12472418|P1|STARTED|Overall Study||32
5068785|NCT01825785|12472453|P7|NOT COMPLETED|Overall Study||0
5068786|NCT01825785|12472454|P6|NOT COMPLETED|Overall Study||1
5068787|NCT01825785|12472455|P5|NOT COMPLETED|Overall Study||2
5068788|NCT01825785|12472456|P4|NOT COMPLETED|Overall Study||0
5068789|NCT01825785|12472457|P3|NOT COMPLETED|Overall Study||0
5068790|NCT01825785|12472458|P2|NOT COMPLETED|Overall Study||0
5068791|NCT01825785|12472459|P1|NOT COMPLETED|Overall Study||0
5068792|NCT01825785|12472453|P7|COMPLETED|Overall Study||6
5068793|NCT01825785|12472454|P6|COMPLETED|Overall Study||5
5068794|NCT01825785|12472455|P5|COMPLETED|Overall Study||4
5068795|NCT01825785|12472456|P4|COMPLETED|Overall Study||6
5068796|NCT01825785|12472457|P3|COMPLETED|Overall Study||6
5068797|NCT01825785|12472458|P2|COMPLETED|Overall Study||6
5068798|NCT01825785|12472459|P1|COMPLETED|Overall Study||12
5068799|NCT01825785|12472453|P7|STARTED|Overall Study||6
5068800|NCT01825785|12472454|P6|STARTED|Overall Study||6
5068801|NCT01825785|12472455|P5|STARTED|Overall Study||6
5068802|NCT01825785|12472456|P4|STARTED|Overall Study||6
5068803|NCT01825785|12472457|P3|STARTED|Overall Study||6
5068804|NCT01825785|12472458|P2|STARTED|Overall Study||6
5068805|NCT01825785|12472459|P1|STARTED|Overall Study||12
5068806|NCT01825655|12472605|P2|NOT COMPLETED|Overall Study||0
5068807|NCT01825655|12472606|P1|NOT COMPLETED|Overall Study||0
5068808|NCT01825655|12472605|P2|COMPLETED|Overall Study||2
5068809|NCT01825655|12472606|P1|COMPLETED|Overall Study||0
5068810|NCT01825655|12472605|P2|STARTED|Overall Study||2
5068811|NCT01825655|12472606|P1|STARTED|Overall Study||0
5068812|NCT01825577|12472612|P1|NOT COMPLETED|Overall Study||8
5068813|NCT01825577|12472612|P1|COMPLETED|Overall Study||6
5068814|NCT01825577|12472612|P1|STARTED|Overall Study||14
5068815|NCT01825408|12472621|P4|NOT COMPLETED|Overall Study||0
5068816|NCT01825408|12472622|P3|NOT COMPLETED|Overall Study||0
5068817|NCT01825408|12472623|P2|NOT COMPLETED|Overall Study||0
5068818|NCT01825408|12472624|P1|NOT COMPLETED|Overall Study||0
5068819|NCT01825408|12472621|P4|COMPLETED|Overall Study||12
5068820|NCT01825408|12472622|P3|COMPLETED|Overall Study||14
5068821|NCT01825408|12472623|P2|COMPLETED|Overall Study||7
5068822|NCT01825408|12472624|P1|COMPLETED|Overall Study||7
5068823|NCT01825408|12472621|P4|STARTED|Overall Study||12
5068824|NCT01825408|12472622|P3|STARTED|Overall Study||14
5068825|NCT01825408|12472623|P2|STARTED|Overall Study||7
5068826|NCT01825408|12472624|P1|STARTED|Overall Study||7
5068827|NCT01825200|12472636|P2|NOT COMPLETED|Overall Study||7
5068828|NCT01825200|12472637|P1|NOT COMPLETED|Overall Study||5
5068829|NCT01825200|12472636|P2|COMPLETED|Overall Study||1314
5068830|NCT01825200|12472637|P1|COMPLETED|Overall Study||1314
5068831|NCT01825200|12472636|P2|STARTED|Overall Study||1321
5068832|NCT01825200|12472637|P1|STARTED|Overall Study||1319
5068833|NCT01825122|12472651|P2|NOT COMPLETED|Overall Study||19
5068834|NCT01825122|12472652|P1|NOT COMPLETED|Overall Study||10
5068835|NCT01825122|12472651|P2|COMPLETED|Overall Study||59
5068836|NCT01825122|12472652|P1|COMPLETED|Overall Study||67
5068837|NCT01825122|12472651|P2|STARTED|Overall Study||78
5068838|NCT01825122|12472652|P1|STARTED|Overall Study||77
5068839|NCT01824979|12472660|P2|NOT COMPLETED|Overall Study||13
5068840|NCT01824979|12472661|P1|NOT COMPLETED|Overall Study||13
5068841|NCT01824979|12472660|P2|COMPLETED|Overall Study||37
5068842|NCT01824979|12472661|P1|COMPLETED|Overall Study||37
5068843|NCT01824979|12472660|P2|STARTED|Overall Study||50
5068844|NCT01824979|12472661|P1|STARTED|Overall Study||50
5068845|NCT01824901|12472669|P4|NOT COMPLETED|Overall Study||0
5068846|NCT01824901|12472670|P3|NOT COMPLETED|Overall Study||0
5068847|NCT01824901|12472671|P2|NOT COMPLETED|Overall Study||0
5068848|NCT01824901|12472672|P1|NOT COMPLETED|Overall Study||0
5068849|NCT01824901|12472669|P4|COMPLETED|Overall Study||0
5068850|NCT01824901|12472670|P3|COMPLETED|Overall Study||0
5068851|NCT01824901|12472671|P2|COMPLETED|Overall Study||0
5068852|NCT01824901|12472672|P1|COMPLETED|Overall Study||2
5068853|NCT01824901|12472669|P4|STARTED|Overall Study||0
5068854|NCT01824901|12472670|P3|STARTED|Overall Study||0
5068855|NCT01824901|12472671|P2|STARTED|Overall Study||0
5068856|NCT01824901|12472672|P1|STARTED|Overall Study||2
5068857|NCT01824823|12472678|P2|NOT COMPLETED|Overall Study||1
5068858|NCT01824823|12472679|P1|NOT COMPLETED|Overall Study||2
5068859|NCT01824823|12472678|P2|COMPLETED|Overall Study||0
5068860|NCT01824823|12472679|P1|COMPLETED|Overall Study||0
5068861|NCT01824823|12472678|P2|STARTED|Overall Study||1
5068862|NCT01824823|12472679|P1|STARTED|Overall Study||2
5068863|NCT01824693|12472688|P3|NOT COMPLETED|Overall Study||15
5068864|NCT01824693|12472689|P2|NOT COMPLETED|Overall Study||7
5068865|NCT01824693|12472690|P1|NOT COMPLETED|Overall Study||1
5068866|NCT01824693|12472688|P3|COMPLETED|Overall Study||0
5068867|NCT01824693|12472689|P2|COMPLETED|Overall Study||2
5068868|NCT01824693|12472690|P1|COMPLETED|Overall Study||5
5068869|NCT01824693|12472688|P3|STARTED|Overall Study||15
5068870|NCT01824693|12472689|P2|STARTED|Overall Study||9
5068871|NCT01824693|12472690|P1|STARTED|Overall Study||6
5068872|NCT01824602|12472707|P4|NOT COMPLETED|Overall Study||5
5068873|NCT01824602|12472708|P3|NOT COMPLETED|Overall Study||4
5068874|NCT01824602|12472709|P2|NOT COMPLETED|Overall Study||0
5068875|NCT01824602|12472710|P1|NOT COMPLETED|Overall Study||1
5068876|NCT01824602|12472707|P4|COMPLETED|Overall Study||5
5068877|NCT01824602|12472708|P3|COMPLETED|Overall Study||5
5068878|NCT01824602|12472709|P2|COMPLETED|Overall Study||8
5068879|NCT01824602|12472710|P1|COMPLETED|Overall Study||10
5068880|NCT01824602|12472707|P4|Intent-to-treat Population|Overall Study||9
5068881|NCT01824602|12472708|P3|Intent-to-treat Population|Overall Study||9
5068882|NCT01824602|12472709|P2|Intent-to-treat Population|Overall Study||8
5068883|NCT01824602|12472710|P1|Intent-to-treat Population|Overall Study||11
5068884|NCT01824602|12472707|P4|Safety Population|Overall Study||10
5068885|NCT01824602|12472708|P3|Safety Population|Overall Study||9
5068886|NCT01824602|12472709|P2|Safety Population|Overall Study||8
5068887|NCT01824602|12472710|P1|Safety Population|Overall Study||11
5068888|NCT01824602|12472707|P4|STARTED|Overall Study||10
5068889|NCT01824602|12472708|P3|STARTED|Overall Study||9
5068890|NCT01824602|12472709|P2|STARTED|Overall Study||8
5068891|NCT01824602|12472710|P1|STARTED|Overall Study||11
5068892|NCT01824589|12472724|P4|NOT COMPLETED|Overall Study||0
5068893|NCT01824589|12472725|P3|NOT COMPLETED|Overall Study||0
5068894|NCT01824589|12472726|P2|NOT COMPLETED|Overall Study||0
5068895|NCT01824589|12472727|P1|NOT COMPLETED|Overall Study||0
5068896|NCT01824589|12472724|P4|COMPLETED|Overall Study||0
5068897|NCT01824589|12472725|P3|COMPLETED|Overall Study||0
5068898|NCT01824589|12472726|P2|COMPLETED|Overall Study||0
5068899|NCT01824589|12472727|P1|COMPLETED|Overall Study||1
5068900|NCT01824589|12472724|P4|STARTED|Overall Study||0
5068901|NCT01824589|12472725|P3|STARTED|Overall Study||0
5068902|NCT01824589|12472726|P2|STARTED|Overall Study||0
5068903|NCT01824589|12472727|P1|STARTED|Overall Study||1
5068904|NCT01824576|12472749|P1|NOT COMPLETED|Overall Study||2
5068905|NCT01824576|12472749|P1|COMPLETED|Overall Study||7
5068906|NCT01824576|12472749|P1|STARTED|Overall Study||9
5068907|NCT01824498|12472767|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068908|NCT01824498|12472768|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068909|NCT01824498|12472769|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068910|NCT01824498|12472770|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068911|NCT01824498|12472771|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068912|NCT01824498|12472772|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
5068913|NCT01824498|12472767|P6|COMPLETED|3rd Intervention (8 Weeks)||4
5068914|NCT01824498|12472768|P5|COMPLETED|3rd Intervention (8 Weeks)||3
5068915|NCT01824498|12472769|P4|COMPLETED|3rd Intervention (8 Weeks)||2
5068916|NCT01824498|12472770|P3|COMPLETED|3rd Intervention (8 Weeks)||4
5068917|NCT01824498|12472771|P2|COMPLETED|3rd Intervention (8 Weeks)||2
5068918|NCT01824498|12472772|P1|COMPLETED|3rd Intervention (8 Weeks)||3
5068919|NCT01824498|12472767|P6|STARTED|3rd Intervention (8 Weeks)||4
5068920|NCT01824498|12472768|P5|STARTED|3rd Intervention (8 Weeks)||3
5068921|NCT01824498|12472769|P4|STARTED|3rd Intervention (8 Weeks)||2
5068922|NCT01824498|12472770|P3|STARTED|3rd Intervention (8 Weeks)||4
5068923|NCT01824498|12472771|P2|STARTED|3rd Intervention (8 Weeks)||2
5068924|NCT01824498|12472772|P1|STARTED|3rd Intervention (8 Weeks)||3
5068925|NCT01824498|12472767|P6|NOT COMPLETED|Washout (8 Weeks)||0
5068926|NCT01824498|12472768|P5|NOT COMPLETED|Washout (8 Weeks)||0
5068927|NCT01824498|12472769|P4|NOT COMPLETED|Washout (8 Weeks)||0
5068928|NCT01824498|12472770|P3|NOT COMPLETED|Washout (8 Weeks)||0
5068929|NCT01824498|12472771|P2|NOT COMPLETED|Washout (8 Weeks)||0
5068930|NCT01824498|12472772|P1|NOT COMPLETED|Washout (8 Weeks)||0
5068931|NCT01824498|12472767|P6|COMPLETED|Washout (8 Weeks)||4
5068932|NCT01824498|12472768|P5|COMPLETED|Washout (8 Weeks)||3
5068933|NCT01824498|12472769|P4|COMPLETED|Washout (8 Weeks)||2
5068934|NCT01824498|12472770|P3|COMPLETED|Washout (8 Weeks)||4
5068935|NCT01824498|12472771|P2|COMPLETED|Washout (8 Weeks)||2
5068936|NCT01824498|12472772|P1|COMPLETED|Washout (8 Weeks)||3
5068937|NCT01824498|12472767|P6|STARTED|Washout (8 Weeks)||4
5068938|NCT01824498|12472768|P5|STARTED|Washout (8 Weeks)||3
5068939|NCT01824498|12472769|P4|STARTED|Washout (8 Weeks)||2
5068940|NCT01824498|12472770|P3|STARTED|Washout (8 Weeks)||4
5068941|NCT01824498|12472771|P2|STARTED|Washout (8 Weeks)||2
5068942|NCT01824498|12472772|P1|STARTED|Washout (8 Weeks)||3
5068943|NCT01824498|12472767|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068944|NCT01824498|12472768|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068945|NCT01824498|12472769|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068946|NCT01824498|12472770|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068947|NCT01824498|12472771|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068948|NCT01824498|12472772|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
5068949|NCT01824498|12472767|P6|COMPLETED|2nd Intervention (8 Weeks)||4
5068950|NCT01824498|12472768|P5|COMPLETED|2nd Intervention (8 Weeks)||3
5068951|NCT01824498|12472769|P4|COMPLETED|2nd Intervention (8 Weeks)||2
5068952|NCT01824498|12472770|P3|COMPLETED|2nd Intervention (8 Weeks)||4
5068953|NCT01824498|12472771|P2|COMPLETED|2nd Intervention (8 Weeks)||2
5068954|NCT01824498|12472772|P1|COMPLETED|2nd Intervention (8 Weeks)||3
5068955|NCT01824498|12472767|P6|STARTED|2nd Intervention (8 Weeks)||4
5068956|NCT01824498|12472768|P5|STARTED|2nd Intervention (8 Weeks)||3
5068957|NCT01824498|12472769|P4|STARTED|2nd Intervention (8 Weeks)||2
5068958|NCT01824498|12472770|P3|STARTED|2nd Intervention (8 Weeks)||4
5068959|NCT01824498|12472771|P2|STARTED|2nd Intervention (8 Weeks)||2
5068960|NCT01824498|12472772|P1|STARTED|2nd Intervention (8 Weeks)||3
5068961|NCT01824498|12472767|P6|NOT COMPLETED|Washout (8 Weeks)||0
5068962|NCT01824498|12472768|P5|NOT COMPLETED|Washout (8 Weeks)||1
5068963|NCT01824498|12472769|P4|NOT COMPLETED|Washout (8 Weeks)||1
5068964|NCT01824498|12472770|P3|NOT COMPLETED|Washout (8 Weeks)||2
5068965|NCT01824498|12472771|P2|NOT COMPLETED|Washout (8 Weeks)||0
5068966|NCT01824498|12472772|P1|NOT COMPLETED|Washout (8 Weeks)||2
5068967|NCT01824498|12472767|P6|COMPLETED|Washout (8 Weeks)||4
5068968|NCT01824498|12472768|P5|COMPLETED|Washout (8 Weeks)||3
5068969|NCT01824498|12472769|P4|COMPLETED|Washout (8 Weeks)||2
5068970|NCT01824498|12472770|P3|COMPLETED|Washout (8 Weeks)||4
5068971|NCT01824498|12472771|P2|COMPLETED|Washout (8 Weeks)||2
5068972|NCT01824498|12472772|P1|COMPLETED|Washout (8 Weeks)||3
5068973|NCT01824498|12472767|P6|STARTED|Washout (8 Weeks)||4
5068974|NCT01824498|12472768|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
5068975|NCT01824498|12472769|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
5068976|NCT01824498|12472770|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
5068977|NCT01824498|12472771|P2|STARTED|Washout (8 Weeks)||2
5068978|NCT01824498|12472772|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
5068979|NCT01824498|12472767|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068980|NCT01824498|12472768|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068981|NCT01824498|12472769|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068982|NCT01824498|12472770|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068983|NCT01824498|12472771|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068984|NCT01824498|12472772|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
5068985|NCT01824498|12472767|P6|COMPLETED|1st Intervention (8 Weeks)||4
5068986|NCT01824498|12472768|P5|COMPLETED|1st Intervention (8 Weeks)||4
5068987|NCT01824498|12472769|P4|COMPLETED|1st Intervention (8 Weeks)||3
5068988|NCT01824498|12472770|P3|COMPLETED|1st Intervention (8 Weeks)||6
5068989|NCT01824498|12472771|P2|COMPLETED|1st Intervention (8 Weeks)||2
5068990|NCT01824498|12472772|P1|COMPLETED|1st Intervention (8 Weeks)||5
5068991|NCT01824498|12472767|P6|STARTED|1st Intervention (8 Weeks)||4
5068992|NCT01824498|12472768|P5|STARTED|1st Intervention (8 Weeks)||4
5068993|NCT01824498|12472769|P4|STARTED|1st Intervention (8 Weeks)||3
5068994|NCT01824498|12472770|P3|STARTED|1st Intervention (8 Weeks)||6
5068995|NCT01824498|12472771|P2|STARTED|1st Intervention (8 Weeks)||2
5068996|NCT01824498|12472772|P1|STARTED|1st Intervention (8 Weeks)||5
5068997|NCT01824446|12472780|P1|NOT COMPLETED|Overall Study||0
5068998|NCT01824446|12472780|P1|COMPLETED|Overall Study||6
5068999|NCT01824446|12472780|P1|STARTED|Overall Study||6
5069000|NCT01824394|12472806|P3|NOT COMPLETED|Overall Study||74
5069001|NCT01824394|12472807|P2|NOT COMPLETED|Overall Study||116
5069002|NCT01824394|12472808|P1|NOT COMPLETED|Overall Study||119
5069003|NCT01824394|12472806|P3|COMPLETED|Overall Study||51
5069004|NCT01824394|12472807|P2|COMPLETED|Overall Study||53
5069005|NCT01824394|12472808|P1|COMPLETED|Overall Study||55
5069006|NCT01824394|12472806|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
5069007|NCT01824394|12472807|P2|Per-Protocol Population|Overall Study||148
5069008|NCT01824394|12472808|P1|Per-Protocol Population|Overall Study||150
5069009|NCT01824394|12472806|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
5069010|NCT01824394|12472807|P2|Safety Population|Overall Study||149
5069011|NCT01824394|12472808|P1|Safety Population|Overall Study||151
5069012|NCT01824394|12472806|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
5069013|NCT01824394|12472807|P2|Intent to Treat Population|Overall Study||149
5069014|NCT01824394|12472808|P1|Intent to Treat Population|Overall Study||151
5069015|NCT01824394|12472806|P3|STARTED|Overall Study||125
5069016|NCT01824394|12472807|P2|STARTED|Overall Study||169
5069017|NCT01824394|12472808|P1|STARTED|Overall Study||174
5069018|NCT01824355|12472818|P1|NOT COMPLETED|Overall Study||3
5069019|NCT01824355|12472818|P1|COMPLETED|Overall Study||110
5069020|NCT01824355|12472818|P1|STARTED|Overall Study||113
5069021|NCT01824342|12472829|P2|NOT COMPLETED|Overall Study||5
5069022|NCT01824342|12472830|P1|NOT COMPLETED|Overall Study||9
5069023|NCT01824342|12472829|P2|COMPLETED|Overall Study||2
5069024|NCT01824342|12472830|P1|COMPLETED|Overall Study||2
5069025|NCT01824342|12472829|P2|STARTED|Overall Study||7
5069026|NCT01824342|12472830|P1|STARTED|Overall Study||11
5069027|NCT01824303|12472844|P2|NOT COMPLETED|Open Label Extension||0
5069028|NCT01824303|12472845|P1|NOT COMPLETED|Open Label Extension||0
5069029|NCT01824303|12472844|P2|COMPLETED|Open Label Extension||11
5069030|NCT01824303|12472845|P1|COMPLETED|Open Label Extension||12
5069031|NCT01824303|12472844|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
5069032|NCT01824303|12472845|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
5069033|NCT01824303|12472844|P2|NOT COMPLETED|Randomized Study||1
5069034|NCT01824303|12472845|P1|NOT COMPLETED|Randomized Study||2
5069035|NCT01824303|12472844|P2|COMPLETED|Randomized Study||13
5069036|NCT01824303|12472845|P1|COMPLETED|Randomized Study||14
5069037|NCT01824303|12472844|P2|STARTED|Randomized Study||14
5069038|NCT01824303|12472845|P1|STARTED|Randomized Study||16
5069039|NCT01824290|12472871|P2|NOT COMPLETED|Overall Study||2
5069040|NCT01824290|12472872|P1|NOT COMPLETED|Overall Study||3
5069041|NCT01824290|12472871|P2|COMPLETED|Overall Study||15
5069042|NCT01824290|12472872|P1|COMPLETED|Overall Study||15
5069043|NCT01824290|12472871|P2|Received 40 mg|Overall Study||13
5069044|NCT01824290|12472872|P1|Received 40 mg|Overall Study||0
5069045|NCT01824290|12472871|P2|Received 20 mg|Overall Study||4
5069046|NCT01824290|12472872|P1|Received 20 mg|Overall Study||0
5069047|NCT01824290|12472871|P2|Received at Least One Dose of Study Drug|Overall Study||17
5069048|NCT01824290|12472872|P1|Received at Least One Dose of Study Drug|Overall Study||18
5069049|NCT01824290|12472871|P2|STARTED|Overall Study||17
5069050|NCT01824290|12472872|P1|STARTED|Overall Study||18
5069051|NCT01824160|12472884|P1|NOT COMPLETED|Overall Study||0
5069052|NCT01824160|12472884|P1|COMPLETED|Overall Study||50
5069053|NCT01824160|12472884|P1|STARTED|Overall Study||50
5069054|NCT01823991|12472890|P2|NOT COMPLETED|Overall Study||5
5069055|NCT01823991|12472891|P1|NOT COMPLETED|Overall Study||8
5069056|NCT01823991|12472890|P2|COMPLETED|Overall Study||13
5069057|NCT01823991|12472891|P1|COMPLETED|Overall Study||10
5069058|NCT01823991|12472890|P2|STARTED|Overall Study||18
5069059|NCT01823991|12472891|P1|STARTED|Overall Study||18
5069060|NCT01823861|12472925|P2|NOT COMPLETED|12 Month Follow up||61
5069061|NCT01823861|12472926|P1|NOT COMPLETED|12 Month Follow up||42
5069062|NCT01823861|12472925|P2|COMPLETED|12 Month Follow up||159
5069063|NCT01823861|12472926|P1|COMPLETED|12 Month Follow up||169
5069064|NCT01823861|12472925|P2|STARTED|12 Month Follow up||220
5069065|NCT01823861|12472926|P1|STARTED|12 Month Follow up||211
5069066|NCT01823861|12472925|P2|NOT COMPLETED|4 Month Follow up||31
5069067|NCT01823861|12472926|P1|NOT COMPLETED|4 Month Follow up||38
5069068|NCT01823861|12472925|P2|COMPLETED|4 Month Follow up||220
5069069|NCT01823861|12472926|P1|COMPLETED|4 Month Follow up||211
5069070|NCT01823861|12472925|P2|STARTED|4 Month Follow up||251
5069071|NCT01823861|12472926|P1|STARTED|4 Month Follow up||249
5069072|NCT01823679|12472932|P1|NOT COMPLETED|Overall Study||1
5069073|NCT01823679|12472932|P1|COMPLETED|Overall Study||1
5069074|NCT01823679|12472932|P1|STARTED|Overall Study||2
5069075|NCT01823653|12472940|P1|NOT COMPLETED|Overall Study||0
5069076|NCT01823653|12472940|P1|COMPLETED|Overall Study||60
5069077|NCT01823653|12472940|P1|STARTED|Overall Study||60
5069078|NCT01823614|12472954|P6|NOT COMPLETED|Overall Study||0
5069079|NCT01823614|12472955|P5|NOT COMPLETED|Overall Study||0
5069080|NCT01823614|12472956|P4|NOT COMPLETED|Overall Study||0
5069081|NCT01823614|12472957|P3|NOT COMPLETED|Overall Study||0
5069082|NCT01823614|12472958|P2|NOT COMPLETED|Overall Study||0
5069083|NCT01823614|12472959|P1|NOT COMPLETED|Overall Study||0
5069084|NCT01823614|12472954|P6|COMPLETED|Overall Study||154
5069085|NCT01823614|12472955|P5|COMPLETED|Overall Study||172
5069086|NCT01823614|12472956|P4|COMPLETED|Overall Study||122
5069087|NCT01823614|12472957|P3|COMPLETED|Overall Study||176
5069088|NCT01823614|12472958|P2|COMPLETED|Overall Study||140
5069089|NCT01823614|12472959|P1|COMPLETED|Overall Study||179
5069090|NCT01823614|12472954|P6|STARTED|Overall Study||154
5069091|NCT01823614|12472955|P5|STARTED|Overall Study||172
5069092|NCT01823614|12472956|P4|STARTED|Overall Study||122
5069093|NCT01823614|12472957|P3|STARTED|Overall Study||176
5069094|NCT01823614|12472958|P2|STARTED|Overall Study||140
5069095|NCT01823614|12472959|P1|STARTED|Overall Study||179
5069096|NCT01823536|12472985|P6|NOT COMPLETED|Overall Study||0
5069097|NCT01823536|12472986|P5|NOT COMPLETED|Overall Study||2
5069098|NCT01823536|12472987|P4|NOT COMPLETED|Overall Study||2
5069099|NCT01823536|12472988|P3|NOT COMPLETED|Overall Study||1
5069100|NCT01823536|12472989|P2|NOT COMPLETED|Overall Study||2
5069101|NCT01823536|12472990|P1|NOT COMPLETED|Overall Study||2
5069102|NCT01823536|12472985|P6|COMPLETED|Overall Study||2
5069103|NCT01823536|12472986|P5|COMPLETED|Overall Study||99
5069104|NCT01823536|12472987|P4|COMPLETED|Overall Study||64
5069105|NCT01823536|12472988|P3|COMPLETED|Overall Study||119
5069106|NCT01823536|12472989|P2|COMPLETED|Overall Study||101
5069107|NCT01823536|12472990|P1|COMPLETED|Overall Study||71
5069108|NCT01823536|12472985|P6|STARTED|Overall Study||2
5069109|NCT01823536|12472986|P5|STARTED|Overall Study||101
5069110|NCT01823536|12472987|P4|STARTED|Overall Study||66
5069111|NCT01823536|12472988|P3|STARTED|Overall Study||120
5069112|NCT01823536|12472989|P2|STARTED|Overall Study||103
5069113|NCT01823536|12472990|P1|STARTED|Overall Study||73
5069114|NCT01823510|12473028|P2|NOT COMPLETED|Days 22-28||0
5069115|NCT01823510|12473029|P1|NOT COMPLETED|Days 22-28||0
5069116|NCT01823510|12473028|P2|COMPLETED|Days 22-28||10
5069117|NCT01823510|12473029|P1|COMPLETED|Days 22-28||10
5069118|NCT01823510|12473028|P2|STARTED|Days 22-28||10
5069119|NCT01823510|12473029|P1|STARTED|Days 22-28||10
5069120|NCT01823510|12473028|P2|NOT COMPLETED|Days 8-21||0
5069121|NCT01823510|12473029|P1|NOT COMPLETED|Days 8-21||0
5069122|NCT01823510|12473028|P2|COMPLETED|Days 8-21||10
5069123|NCT01823510|12473029|P1|COMPLETED|Days 8-21||10
5069124|NCT01823510|12473028|P2|STARTED|Days 8-21||10
5069125|NCT01823510|12473029|P1|STARTED|Days 8-21||10
5069126|NCT01823510|12473028|P2|NOT COMPLETED|Days 1-7||0
5069127|NCT01823510|12473029|P1|NOT COMPLETED|Days 1-7||0
5069128|NCT01823510|12473028|P2|COMPLETED|Days 1-7||10
5069129|NCT01823510|12473029|P1|COMPLETED|Days 1-7||10
5069130|NCT01823510|12473028|P2|STARTED|Days 1-7||10
5069131|NCT01823510|12473029|P1|STARTED|Days 1-7||10
5069132|NCT01823341|12473041|P1|NOT COMPLETED|Overall Study||15
5069133|NCT01823341|12473041|P1|COMPLETED|Overall Study||82
5069134|NCT01823341|12473041|P1|STARTED|Overall Study||97
5069135|NCT01823328|12473086|P2|NOT COMPLETED|Overall Study||6
5069136|NCT01823328|12473087|P1|NOT COMPLETED|Overall Study||8
5069137|NCT01823328|12473086|P2|COMPLETED|Overall Study||67
5069138|NCT01823328|12473087|P1|COMPLETED|Overall Study||62
5069139|NCT01823328|12473086|P2|STARTED|Overall Study||73
5069140|NCT01823328|12473087|P1|STARTED|Overall Study||70
5069141|NCT01823289|12473107|P1|NOT COMPLETED|Overall Study||24
5069142|NCT01823289|12473107|P1|COMPLETED|Overall Study||47
5069143|NCT01823289|12473107|P1|STARTED|Overall Study||71
5069144|NCT01823224|12473115|P2|NOT COMPLETED|Overall Study||11
5069145|NCT01823224|12473116|P1|NOT COMPLETED|Overall Study||6
5069146|NCT01823224|12473115|P2|COMPLETED|Overall Study||22
5069147|NCT01823224|12473116|P1|COMPLETED|Overall Study||28
5069148|NCT01823224|12473115|P2|STARTED|Overall Study||33
5069149|NCT01823224|12473116|P1|STARTED|Overall Study||34
5069150|NCT01823146|12473126|P2|NOT COMPLETED|Overall Study||2
5069151|NCT01823146|12473127|P1|NOT COMPLETED|Overall Study||2
5069152|NCT01823146|12473126|P2|COMPLETED|Overall Study||49
5069153|NCT01823146|12473127|P1|COMPLETED|Overall Study||53
5069154|NCT01823146|12473126|P2|STARTED|Overall Study||51
5069155|NCT01823146|12473127|P1|STARTED|Overall Study||55
5069156|NCT01823107|12473137|P1|NOT COMPLETED|Overall Study||1
5069157|NCT01823107|12473137|P1|COMPLETED|Overall Study||24
5069158|NCT01823107|12473137|P1|STARTED|Overall Study||25
5069159|NCT01822925|12473147|P4|NOT COMPLETED|Overall Study||5
5069160|NCT01822925|12473148|P3|NOT COMPLETED|Overall Study||3
5069161|NCT01822925|12473149|P2|NOT COMPLETED|Overall Study||2
5069162|NCT01822925|12473150|P1|NOT COMPLETED|Overall Study||6
5069163|NCT01822925|12473147|P4|COMPLETED|Overall Study||27
5069164|NCT01822925|12473148|P3|COMPLETED|Overall Study||29
5069165|NCT01822925|12473149|P2|COMPLETED|Overall Study||30
5069166|NCT01822925|12473150|P1|COMPLETED|Overall Study||26
5069167|NCT01822925|12473147|P4|STARTED|Overall Study||32
5069168|NCT01822925|12473148|P3|STARTED|Overall Study||32
5069169|NCT01822925|12473149|P2|STARTED|Overall Study||32
5069170|NCT01822925|12473150|P1|STARTED|Overall Study||32
5069171|NCT01822899|12473202|P2|NOT COMPLETED|Overall Study||18
5069172|NCT01822899|12473203|P1|NOT COMPLETED|Overall Study||24
5069173|NCT01822899|12473202|P2|COMPLETED|Overall Study||340
5069174|NCT01822899|12473203|P1|COMPLETED|Overall Study||334
5069175|NCT01822899|12473202|P2|STARTED|Overall Study||358
5069176|NCT01822899|12473203|P1|STARTED|Overall Study||358
5069177|NCT01822886|12473211|P1|NOT COMPLETED|Overall Study||15
5069178|NCT01822886|12473211|P1|COMPLETED|Overall Study||5
5069179|NCT01822886|12473211|P1|STARTED|Overall Study||20
5069180|NCT01822821|12473221|P2|NOT COMPLETED|Overall Study||1
5069181|NCT01822821|12473222|P1|NOT COMPLETED|Overall Study||2
5069182|NCT01822821|12473221|P2|COMPLETED|Overall Study||74
5069183|NCT01822821|12473222|P1|COMPLETED|Overall Study||73
5069184|NCT01822821|12473221|P2|STARTED|Overall Study||75
5069185|NCT01822821|12473222|P1|STARTED|Overall Study||75
5069186|NCT01822756|12473251|P5|NOT COMPLETED|Overall Study||7
5069187|NCT01822756|12473252|P4|NOT COMPLETED|Overall Study||4
5069188|NCT01822756|12473253|P3|NOT COMPLETED|Overall Study||10
5069189|NCT01822756|12473254|P2|NOT COMPLETED|Overall Study||4
5069190|NCT01822756|12473255|P1|NOT COMPLETED|Overall Study||16
5069191|NCT01822756|12473251|P5|COMPLETED|Overall Study||1
5069192|NCT01822756|12473252|P4|COMPLETED|Overall Study||0
5069193|NCT01822756|12473253|P3|COMPLETED|Overall Study||0
5069194|NCT01822756|12473254|P2|COMPLETED|Overall Study||0
5069195|NCT01822756|12473255|P1|COMPLETED|Overall Study||0
5069196|NCT01822756|12473251|P5|Discontinued From the Study|Overall Study||7
5069197|NCT01822756|12473252|P4|Discontinued From the Study|Overall Study||4
5069198|NCT01822756|12473253|P3|Discontinued From the Study|Overall Study||10
5069199|NCT01822756|12473254|P2|Discontinued From the Study|Overall Study||4
5069200|NCT01822756|12473255|P1|Discontinued From the Study|Overall Study||16
5069201|NCT01822756|12473251|P5|STARTED|Overall Study||8
5069202|NCT01822756|12473252|P4|STARTED|Overall Study||4
5069203|NCT01822756|12473253|P3|STARTED|Overall Study||10
5069204|NCT01822756|12473254|P2|STARTED|Overall Study||4
5069205|NCT01822756|12473255|P1|STARTED|Overall Study||16
5069206|NCT01822691|12473297|P1|NOT COMPLETED|Overall Study||2
5069207|NCT01822691|12473297|P1|COMPLETED|Overall Study||13
5069208|NCT01822691|12473297|P1|STARTED|Overall Study||15
5069209|NCT01822678|12473308|P3|NOT COMPLETED|Overall Study||11
5069210|NCT01822678|12473309|P2|NOT COMPLETED|Overall Study||15
5069211|NCT01822678|12473310|P1|NOT COMPLETED|Overall Study||12
5069212|NCT01822678|12473308|P3|COMPLETED|Overall Study||29
5069213|NCT01822678|12473309|P2|COMPLETED|Overall Study||49
5069214|NCT01822678|12473310|P1|COMPLETED|Overall Study||45
5069215|NCT01822678|12473308|P3|Per Protocol Population|Overall Study||34
5069216|NCT01822678|12473309|P2|Per Protocol Population|Overall Study||52
5069217|NCT01822678|12473310|P1|Per Protocol Population|Overall Study||45
5069218|NCT01822678|12473308|P3|Intention-to-Treat Population (ITT)|Overall Study||40
5069219|NCT01822678|12473309|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
5069220|NCT01822678|12473310|P1|Intention-to-Treat Population (ITT)|Overall Study||57
5069221|NCT01822678|12473308|P3|Safety Population|Overall Study||40
5069222|NCT01822678|12473309|P2|Safety Population|Overall Study||64
5069223|NCT01822678|12473310|P1|Safety Population|Overall Study||57
5069224|NCT01822678|12473308|P3|Treated|Overall Study||40
5069225|NCT01822678|12473309|P2|Treated|Overall Study||64
5069226|NCT01822678|12473310|P1|Treated|Overall Study||57
5069227|NCT01822678|12473308|P3|STARTED|Overall Study||40
5069228|NCT01822678|12473309|P2|STARTED|Overall Study||64
5069229|NCT01822678|12473310|P1|STARTED|Overall Study||57
5069230|NCT01822665|12473318|P1|NOT COMPLETED|Overall Study||8
5069231|NCT01822665|12473318|P1|COMPLETED|Overall Study||20
5069232|NCT01822665|12473318|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
5069233|NCT01822665|12473318|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
5069234|NCT01822665|12473318|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
5069235|NCT01822665|12473318|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
5069236|NCT01822665|12473318|P1|STARTED|Overall Study||28
5069237|NCT01822587|12473345|P3|NOT COMPLETED|Overall Study||18
5069238|NCT01822587|12473346|P2|NOT COMPLETED|Overall Study||15
5069239|NCT01822587|12473347|P1|NOT COMPLETED|Overall Study||16
5069240|NCT01822587|12473345|P3|COMPLETED|Overall Study||44
5069241|NCT01822587|12473346|P2|COMPLETED|Overall Study||45
5069242|NCT01822587|12473347|P1|COMPLETED|Overall Study||43
5069243|NCT01822587|12473345|P3|STARTED|Overall Study||62
5069244|NCT01822587|12473346|P2|STARTED|Overall Study||60
5069245|NCT01822587|12473347|P1|STARTED|Overall Study||59
5069246|NCT01822574|12473370|P3|NOT COMPLETED|Overall Study||0
5069247|NCT01822574|12473371|P2|NOT COMPLETED|Overall Study||0
5069248|NCT01822574|12473372|P1|NOT COMPLETED|Overall Study||0
5069249|NCT01822574|12473370|P3|COMPLETED|Overall Study||30
5069250|NCT01822574|12473371|P2|COMPLETED|Overall Study||30
5069251|NCT01822574|12473372|P1|COMPLETED|Overall Study||30
5069252|NCT01822574|12473370|P3|STARTED|Overall Study||30
5069253|NCT01822574|12473371|P2|STARTED|Overall Study||30
5069254|NCT01822574|12473372|P1|STARTED|Overall Study||30
5069255|NCT01822561|12473386|P1|NOT COMPLETED|Overall Study||2
5069256|NCT01822561|12473386|P1|COMPLETED|Overall Study||13
5069257|NCT01822561|12473386|P1|STARTED|Overall Study||15
5069258|NCT01822548|12473396|P2|NOT COMPLETED|Overall Study||0
5069259|NCT01822548|12473397|P1|NOT COMPLETED|Overall Study||0
5069260|NCT01822548|12473396|P2|COMPLETED|Overall Study||24
5069261|NCT01822548|12473397|P1|COMPLETED|Overall Study||40
5069262|NCT01822548|12473396|P2|Discontinued Intervention|Overall Study||5
5069263|NCT01822548|12473397|P1|Discontinued Intervention|Overall Study||0
5069264|NCT01822548|12473396|P2|STARTED|Overall Study||24
5069265|NCT01822548|12473397|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
5069266|NCT01822535|12473407|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
5069267|NCT01822535|12473408|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
5069268|NCT01822535|12473407|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
5069269|NCT01822535|12473408|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
5069270|NCT01822535|12473407|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
5069271|NCT01822535|12473408|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
5069272|NCT01822535|12473407|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
5069273|NCT01822535|12473408|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
5069274|NCT01822535|12473407|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
5069275|NCT01822535|12473408|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
5069276|NCT01822535|12473407|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
5069277|NCT01822535|12473408|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
5069278|NCT01822496|12473424|P4|NOT COMPLETED|Overall Study||4
5069279|NCT01822496|12473425|P3|NOT COMPLETED|Overall Study||0
5069280|NCT01822496|12473426|P2|NOT COMPLETED|Overall Study||2
5069281|NCT01822496|12473427|P1|NOT COMPLETED|Overall Study||2
5069282|NCT01822496|12473424|P4|COMPLETED|Overall Study||7
5069283|NCT01822496|12473425|P3|COMPLETED|Overall Study||9
5069284|NCT01822496|12473426|P2|COMPLETED|Overall Study||21
5069285|NCT01822496|12473427|P1|COMPLETED|Overall Study||14
5069286|NCT01822496|12473424|P4|Eligible and Started Study Treatment|Overall Study||7
5069287|NCT01822496|12473425|P3|Eligible and Started Study Treatment|Overall Study||9
5069288|NCT01822496|12473426|P2|Eligible and Started Study Treatment|Overall Study||20
5069289|NCT01822496|12473427|P1|Eligible and Started Study Treatment|Overall Study||14
5069290|NCT01822496|12473424|P4|Eligible With Disease Assessment|Overall Study||4
5069291|NCT01822496|12473425|P3|Eligible With Disease Assessment|Overall Study||6
5069292|NCT01822496|12473426|P2|Eligible With Disease Assessment|Overall Study||15
5069293|NCT01822496|12473427|P1|Eligible With Disease Assessment|Overall Study||10
5069294|NCT01822496|12473424|P4|Eligible|Overall Study||7
5069295|NCT01822496|12473425|P3|Eligible|Overall Study||9
5069296|NCT01822496|12473426|P2|Eligible|Overall Study||21
5069297|NCT01822496|12473427|P1|Eligible|Overall Study||14
5069298|NCT01822496|12473424|P4|STARTED|Overall Study||11
5069299|NCT01822496|12473425|P3|STARTED|Overall Study||9
5069300|NCT01822496|12473426|P2|STARTED|Overall Study||23
5069301|NCT01822496|12473427|P1|STARTED|Overall Study||16
5069302|NCT01822457|12473463|P2|NOT COMPLETED|Overall Study||5
5069303|NCT01822457|12473464|P1|NOT COMPLETED|Overall Study||4
5069304|NCT01822457|12473463|P2|COMPLETED|Overall Study||12
5069305|NCT01822457|12473464|P1|COMPLETED|Overall Study||16
5069306|NCT01822457|12473463|P2|STARTED|Overall Study||17
5069307|NCT01822457|12473464|P1|STARTED|Overall Study||20
5069308|NCT01822366|12473480|P4|NOT COMPLETED|Overall Study||22
5069309|NCT01822366|12473481|P3|NOT COMPLETED|Overall Study||5
5069310|NCT01822366|12473482|P2|NOT COMPLETED|Overall Study||22
5069311|NCT01822366|12473483|P1|NOT COMPLETED|Overall Study||5
5069312|NCT01822366|12473480|P4|COMPLETED|Overall Study||298
5069313|NCT01822366|12473481|P3|COMPLETED|Overall Study||315
5069314|NCT01822366|12473482|P2|COMPLETED|Overall Study||298
5069315|NCT01822366|12473483|P1|COMPLETED|Overall Study||315
5069316|NCT01822366|12473480|P4|STARTED|Overall Study||320
5069317|NCT01822366|12473481|P3|STARTED|Overall Study||320
5069318|NCT01822366|12473482|P2|STARTED|Overall Study||320
5069319|NCT01822366|12473483|P1|STARTED|Overall Study||320
5069320|NCT01822353|12473514|P3|NOT COMPLETED|Overall Study||1
5069321|NCT01822353|12473515|P2|NOT COMPLETED|Overall Study||5
5069322|NCT01822353|12473516|P1|NOT COMPLETED|Overall Study||4
5069323|NCT01822353|12473514|P3|COMPLETED|Overall Study||3
5069324|NCT01822353|12473515|P2|COMPLETED|Overall Study||4
5069325|NCT01822353|12473516|P1|COMPLETED|Overall Study||6
5069326|NCT01822353|12473514|P3|STARTED|Overall Study||4
5069327|NCT01822353|12473515|P2|STARTED|Overall Study||9
5069328|NCT01822353|12473516|P1|STARTED|Overall Study||10
5069329|NCT01822301|12473524|P1|NOT COMPLETED|Overall Study||0
5069330|NCT01822301|12473524|P1|COMPLETED|Overall Study||5
5069331|NCT01822301|12473524|P1|STARTED|Overall Study||5
5069332|NCT01822223|12473536|P2|NOT COMPLETED|Overall Study||1
5069333|NCT01822223|12473537|P1|NOT COMPLETED|Overall Study||0
5069334|NCT01822223|12473536|P2|COMPLETED|Overall Study||9
5069335|NCT01822223|12473537|P1|COMPLETED|Overall Study||10
5069336|NCT01822223|12473536|P2|STARTED|Overall Study||10
5069337|NCT01822223|12473537|P1|STARTED|Overall Study||10
5069338|NCT01822197|12473553|P1|NOT COMPLETED|Overall Study||0
5069339|NCT01822197|12473553|P1|COMPLETED|Overall Study||30
5069340|NCT01822197|12473553|P1|STARTED|Overall Study||30
5069341|NCT01822132|12473561|P2|NOT COMPLETED|Overall Study||2
5069342|NCT01822132|12473562|P1|NOT COMPLETED|Overall Study||4
5069343|NCT01822132|12473561|P2|COMPLETED|Overall Study||25
5069344|NCT01822132|12473562|P1|COMPLETED|Overall Study||21
5069345|NCT01822132|12473561|P2|STARTED|Overall Study||27
5069346|NCT01822132|12473562|P1|STARTED|Overall Study||25
5069347|NCT01822119|12473576|P1|NOT COMPLETED|Overall Study||0
5069348|NCT01822119|12473576|P1|COMPLETED|Overall Study||27
5069349|NCT01822119|12473576|P1|STARTED|Overall Study||27
5069350|NCT01821963|12473599|P1|NOT COMPLETED|Overall Study||1
5069351|NCT01821963|12473599|P1|COMPLETED|Overall Study||0
5069352|NCT01821963|12473599|P1|STARTED|Overall Study||1
5069353|NCT01821937|12473605|P2|NOT COMPLETED|Overall Study||3
5069354|NCT01821937|12473606|P1|NOT COMPLETED|Overall Study||0
5069355|NCT01821937|12473605|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
5069356|NCT01821937|12473606|P1|COMPLETED|Overall Study||10
5069357|NCT01821937|12473605|P2|STARTED|Overall Study||15
5069358|NCT01821937|12473606|P1|STARTED|Overall Study||10
5069359|NCT01821859|12473624|P1|NOT COMPLETED|Overall Study||5
5069360|NCT01821859|12473624|P1|COMPLETED|Overall Study||0
5069361|NCT01821859|12473624|P1|STARTED|Overall Study||5
5069362|NCT01821807|12473630|P2|NOT COMPLETED|Overall Study||1
5069363|NCT01821807|12473631|P1|NOT COMPLETED|Overall Study||3
5069364|NCT01821807|12473630|P2|COMPLETED|Overall Study||109
5069365|NCT01821807|12473631|P1|COMPLETED|Overall Study||147
5069366|NCT01821807|12473630|P2|STARTED|Overall Study||110
5069367|NCT01821807|12473631|P1|STARTED|Overall Study||150
5069368|NCT01821729|12473639|P1|NOT COMPLETED|Overall Study||1
5069369|NCT01821729|12473639|P1|COMPLETED|Overall Study||49
5069370|NCT01821729|12473639|P1|Underwent Attempted Surgery|Overall Study||42
5069371|NCT01821729|12473639|P1|Received Chemoradiotherapy|Overall Study||45
5069372|NCT01821729|12473639|P1|STARTED|Overall Study||50
5069373|NCT01821625|12473644|P1|NOT COMPLETED|Overall Study||6
5069374|NCT01821625|12473644|P1|COMPLETED|Overall Study||1
5069375|NCT01821625|12473644|P1|STARTED|Overall Study||7
5069376|NCT01821560|12473650|P2|NOT COMPLETED|Overall Study||7
5069377|NCT01821560|12473651|P1|NOT COMPLETED|Overall Study||6
5069378|NCT01821560|12473650|P2|COMPLETED|Overall Study||15
5069379|NCT01821560|12473651|P1|COMPLETED|Overall Study||16
5069380|NCT01821560|12473650|P2|STARTED|Overall Study||22
5069381|NCT01821560|12473651|P1|STARTED|Overall Study||22
5069382|NCT01821534|12473657|P1|NOT COMPLETED|Overall Study||0
5069383|NCT01821534|12473657|P1|COMPLETED|Overall Study||201
5069384|NCT01821534|12473657|P1|STARTED|Overall Study||201
5069385|NCT01821417|12473666|P2|NOT COMPLETED|Overall Study||0
5069386|NCT01821417|12473667|P1|NOT COMPLETED|Overall Study||0
5069387|NCT01821417|12473666|P2|COMPLETED|Overall Study||31
5069388|NCT01821417|12473667|P1|COMPLETED|Overall Study||37
5069389|NCT01821417|12473666|P2|STARTED|Overall Study||31
5069390|NCT01821417|12473667|P1|STARTED|Overall Study||37
5069391|NCT01821378|12473680|P3|NOT COMPLETED|Overall Study||42
5069392|NCT01821378|12473681|P2|NOT COMPLETED|Overall Study||54
5069393|NCT01821378|12473682|P1|NOT COMPLETED|Overall Study||27
5069394|NCT01821378|12473680|P3|COMPLETED|Overall Study||70
5069395|NCT01821378|12473681|P2|COMPLETED|Overall Study||145
5069396|NCT01821378|12473682|P1|COMPLETED|Overall Study||74
5069397|NCT01821378|12473680|P3|STARTED|Overall Study||112
5069398|NCT01821378|12473681|P2|STARTED|Overall Study||199
5069399|NCT01821378|12473682|P1|STARTED|Overall Study||101
5069400|NCT01821352|12473720|P2|NOT COMPLETED|Overall Study||0
5069401|NCT01821352|12473721|P1|NOT COMPLETED|Overall Study||0
5069402|NCT01821352|12473720|P2|COMPLETED|Overall Study||25
5069403|NCT01821352|12473721|P1|COMPLETED|Overall Study||28
5069404|NCT01821352|12473720|P2|STARTED|Overall Study||25
5069405|NCT01821352|12473721|P1|STARTED|Overall Study||28
5069406|NCT01821326|12473731|P1|NOT COMPLETED|Overall Study||0
5069407|NCT01821326|12473731|P1|COMPLETED|Overall Study||339
5069408|NCT01821326|12473731|P1|STARTED|Overall Study||339
5069409|NCT01821300|12473737|P2|NOT COMPLETED|Overall Study||0
5069410|NCT01821300|12473738|P1|NOT COMPLETED|Overall Study||0
5069411|NCT01821300|12473737|P2|COMPLETED|Overall Study||103
5069412|NCT01821300|12473738|P1|COMPLETED|Overall Study||154
5069413|NCT01821300|12473737|P2|STARTED|Overall Study||103
5069414|NCT01821300|12473738|P1|STARTED|Overall Study||154
5069415|NCT01821118|12473772|P2|NOT COMPLETED|Overall Study||1
5069416|NCT01821118|12473773|P1|NOT COMPLETED|Overall Study||0
5069417|NCT01821118|12473772|P2|COMPLETED|Overall Study||11
5069418|NCT01821118|12473773|P1|COMPLETED|Overall Study||24
5069419|NCT01821118|12473772|P2|STARTED|Overall Study||12
5069420|NCT01821118|12473773|P1|STARTED|Overall Study||24
5069421|NCT01821105|12473806|P1|NOT COMPLETED|Overall Study||0
5069422|NCT01821105|12473806|P1|COMPLETED|Overall Study||21
5069423|NCT01821105|12473806|P1|STARTED|Overall Study||21
5069424|NCT01820754|12473812|P1|NOT COMPLETED|Overall Study||0
5069425|NCT01820754|12473812|P1|COMPLETED|Overall Study||24
5069426|NCT01820754|12473812|P1|STARTED|Overall Study||24
5069427|NCT01820637|12473820|P1|NOT COMPLETED|Overall Study||3
5069428|NCT01820637|12473820|P1|COMPLETED|Overall Study||54
5069429|NCT01820637|12473820|P1|STARTED|Overall Study||57
5069430|NCT01820585|12473829|P4|NOT COMPLETED|Overall Study||49
5069431|NCT01820585|12473830|P3|NOT COMPLETED|Overall Study||34
5069432|NCT01820585|12473831|P2|NOT COMPLETED|Overall Study||32
5069433|NCT01820585|12473832|P1|NOT COMPLETED|Overall Study||27
5069434|NCT01820585|12473829|P4|COMPLETED|Overall Study||83
5069435|NCT01820585|12473830|P3|COMPLETED|Overall Study||101
5069436|NCT01820585|12473831|P2|COMPLETED|Overall Study||98
5069437|NCT01820585|12473832|P1|COMPLETED|Overall Study||104
5069438|NCT01820585|12473829|P4|Completed Maintenance Period|Overall Study||84
5069439|NCT01820585|12473830|P3|Completed Maintenance Period|Overall Study||101
5069440|NCT01820585|12473831|P2|Completed Maintenance Period|Overall Study||98
5069441|NCT01820585|12473832|P1|Completed Maintenance Period|Overall Study||105
5069442|NCT01820585|12473829|P4|Entered Maintenance Period|Overall Study||123
5069443|NCT01820585|12473830|P3|Entered Maintenance Period|Overall Study||131
5069444|NCT01820585|12473831|P2|Entered Maintenance Period|Overall Study||124
5069445|NCT01820585|12473832|P1|Entered Maintenance Period|Overall Study||128
5069446|NCT01820585|12473829|P4|Completed Titration Period|Overall Study||126
5069447|NCT01820585|12473830|P3|Completed Titration Period|Overall Study||131
5069448|NCT01820585|12473831|P2|Completed Titration Period|Overall Study||125
5069449|NCT01820585|12473832|P1|Completed Titration Period|Overall Study||128
5069450|NCT01820585|12473829|P4|Full Analysis Set|Overall Study||129
5069451|NCT01820585|12473830|P3|Full Analysis Set|Overall Study||135
5069452|NCT01820585|12473831|P2|Full Analysis Set|Overall Study||130
5069453|NCT01820585|12473832|P1|Full Analysis Set|Overall Study||131
5069454|NCT01820585|12473829|P4|Randomized and Treated|Overall Study||132
5069455|NCT01820585|12473830|P3|Randomized and Treated|Overall Study||135
5069456|NCT01820585|12473831|P2|Randomized and Treated|Overall Study||130
5069457|NCT01820585|12473832|P1|Randomized and Treated|Overall Study||131
5069458|NCT01820585|12473829|P4|STARTED|Overall Study||132
5069459|NCT01820585|12473830|P3|STARTED|Overall Study||135
5069460|NCT01820585|12473831|P2|STARTED|Overall Study||130
5069461|NCT01820585|12473832|P1|STARTED|Overall Study||131
5069462|NCT01820559|12473845|P3|NOT COMPLETED|Overall Study||29
5069463|NCT01820559|12473846|P2|NOT COMPLETED|Overall Study||13
5069464|NCT01820559|12473847|P1|NOT COMPLETED|Overall Study||14
5069465|NCT01820559|12473845|P3|COMPLETED|Overall Study||110
5069466|NCT01820559|12473846|P2|COMPLETED|Overall Study||122
5069467|NCT01820559|12473847|P1|COMPLETED|Overall Study||122
5069468|NCT01820559|12473845|P3|Completed Maintenance Period|Overall Study||110
5069469|NCT01820559|12473846|P2|Completed Maintenance Period|Overall Study||123
5069470|NCT01820559|12473847|P1|Completed Maintenance Period|Overall Study||122
5069471|NCT01820559|12473845|P3|Entered Maintenance Period|Overall Study||129
5069472|NCT01820559|12473846|P2|Entered Maintenance Period|Overall Study||133
5069473|NCT01820559|12473847|P1|Entered Maintenance Period|Overall Study||129
5069474|NCT01820559|12473845|P3|Completed Tutration Period|Overall Study||131
5069475|NCT01820559|12473846|P2|Completed Tutration Period|Overall Study||134
5069476|NCT01820559|12473847|P1|Completed Tutration Period|Overall Study||130
5069477|NCT01820559|12473845|P3|Randomized and Treated|Overall Study||139
5069478|NCT01820559|12473846|P2|Randomized and Treated|Overall Study||135
5069479|NCT01820559|12473847|P1|Randomized and Treated|Overall Study||136
5069480|NCT01820559|12473845|P3|STARTED|Overall Study||139
5069481|NCT01820559|12473846|P2|STARTED|Overall Study||135
5069482|NCT01820559|12473847|P1|STARTED|Overall Study||136
5069483|NCT01820416|12473858|P3|NOT COMPLETED|Overall Study||0
5069484|NCT01820416|12473859|P2|NOT COMPLETED|Overall Study||2
5069485|NCT01820416|12473860|P1|NOT COMPLETED|Overall Study||3
5069486|NCT01820416|12473858|P3|COMPLETED|Overall Study||11
5069487|NCT01820416|12473859|P2|COMPLETED|Overall Study||10
5069488|NCT01820416|12473860|P1|COMPLETED|Overall Study||9
5069489|NCT01820416|12473858|P3|STARTED|Overall Study||11
5069490|NCT01820416|12473859|P2|STARTED|Overall Study||12
5069491|NCT01820416|12473860|P1|STARTED|Overall Study||12
5069492|NCT01820364|12473868|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
5069493|NCT01820364|12473869|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
5069494|NCT01820364|12473868|P2|COMPLETED|Part II: LGX818 + MEK162||0
5069495|NCT01820364|12473869|P1|COMPLETED|Part II: LGX818 + MEK162||0
5069496|NCT01820364|12473868|P2|STARTED|Part II: LGX818 + MEK162||1
5069497|NCT01820364|12473869|P1|STARTED|Part II: LGX818 + MEK162||0
5069498|NCT01820364|12473868|P2|NOT COMPLETED|Part I: LGX818||0
5069499|NCT01820364|12473869|P1|NOT COMPLETED|Part I: LGX818||14
5069500|NCT01820364|12473868|P2|COMPLETED|Part I: LGX818||0
5069501|NCT01820364|12473869|P1|COMPLETED|Part I: LGX818||1
5069502|NCT01820364|12473868|P2|STARTED|Part I: LGX818||0
5069503|NCT01820364|12473869|P1|STARTED|Part I: LGX818||15
5069504|NCT01819935|12473883|P2|NOT COMPLETED|Overall Study||0
5069505|NCT01819935|12473884|P1|NOT COMPLETED|Overall Study||0
5069506|NCT01819935|12473883|P2|COMPLETED|Overall Study||4943
5069507|NCT01819935|12473884|P1|COMPLETED|Overall Study||328
5069508|NCT01819935|12473883|P2|STARTED|Overall Study||4943
5069509|NCT01819935|12473884|P1|STARTED|Overall Study||328
5069510|NCT01819922|12473904|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
5069511|NCT01819922|12473905|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
5069512|NCT01819922|12473904|P2|COMPLETED|Second Intervention Period (1 Day)||6
5069513|NCT01819922|12473905|P1|COMPLETED|Second Intervention Period (1 Day)||6
5069514|NCT01819922|12473904|P2|STARTED|Second Intervention Period (1 Day)||6
5069515|NCT01819922|12473905|P1|STARTED|Second Intervention Period (1 Day)||6
5069516|NCT01819922|12473904|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
5069517|NCT01819922|12473905|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
5069518|NCT01819922|12473904|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
5069519|NCT01819922|12473905|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
5069520|NCT01819922|12473904|P2|STARTED|Washout Period (at Least 7-10 Days)||6
5069521|NCT01819922|12473905|P1|STARTED|Washout Period (at Least 7-10 Days)||6
5069522|NCT01819922|12473904|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
5069523|NCT01819922|12473905|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
5069524|NCT01819922|12473904|P2|COMPLETED|First Intervention Period (1 Day)||6
5069525|NCT01819922|12473905|P1|COMPLETED|First Intervention Period (1 Day)||6
5069526|NCT01819922|12473904|P2|STARTED|First Intervention Period (1 Day)||6
5069527|NCT01819922|12473905|P1|STARTED|First Intervention Period (1 Day)||6
5069528|NCT01819883|12473991|P2|NOT COMPLETED|Overall Study||0
5069529|NCT01819883|12473992|P1|NOT COMPLETED|Overall Study||4
5069530|NCT01819883|12473991|P2|COMPLETED|Overall Study||20
5069531|NCT01819883|12473992|P1|COMPLETED|Overall Study||16
5069532|NCT01819883|12473991|P2|STARTED|Overall Study||20
5069533|NCT01819883|12473992|P1|STARTED|Overall Study||20
5069534|NCT01819844|12473998|P1|NOT COMPLETED|Overall Study||0
5069535|NCT01819844|12473998|P1|COMPLETED|Overall Study||12
5069536|NCT01819844|12473998|P1|STARTED|Overall Study||12
5069537|NCT01819727|12474013|P2|NOT COMPLETED|Overall Study||28
5069538|NCT01819727|12474014|P1|NOT COMPLETED|Overall Study||20
5069539|NCT01819727|12474013|P2|COMPLETED|Overall Study||102
5069540|NCT01819727|12474014|P1|COMPLETED|Overall Study||111
5069541|NCT01819727|12474013|P2|STARTED|Overall Study||130
5069542|NCT01819727|12474014|P1|STARTED|Overall Study||131
5069543|NCT01819597|12474024|P1|NOT COMPLETED|Overall Study||0
5069544|NCT01819597|12474024|P1|COMPLETED|Overall Study||52
5069545|NCT01819597|12474024|P1|STARTED|Overall Study||52
5069546|NCT01819506|12474036|P2|NOT COMPLETED|Overall Study||5
5069547|NCT01819506|12474037|P1|NOT COMPLETED|Overall Study||8
5069548|NCT01819506|12474036|P2|COMPLETED|Overall Study||47
5069549|NCT01819506|12474037|P1|COMPLETED|Overall Study||43
5069550|NCT01819506|12474036|P2|STARTED|Overall Study||52
5069551|NCT01819506|12474037|P1|STARTED|Overall Study||51
5069552|NCT01819415|12474051|P4|NOT COMPLETED|Overall Study||2
5069553|NCT01819415|12474052|P3|NOT COMPLETED|Overall Study||1
5069554|NCT01819415|12474053|P2|NOT COMPLETED|Overall Study||4
5069555|NCT01819415|12474054|P1|NOT COMPLETED|Overall Study||3
5069556|NCT01819415|12474051|P4|COMPLETED|Overall Study||8
5069557|NCT01819415|12474052|P3|COMPLETED|Overall Study||9
5069558|NCT01819415|12474053|P2|COMPLETED|Overall Study||6
5069559|NCT01819415|12474054|P1|COMPLETED|Overall Study||7
5069560|NCT01819415|12474051|P4|STARTED|Overall Study||10
5069561|NCT01819415|12474052|P3|STARTED|Overall Study||10
5069562|NCT01819415|12474053|P2|STARTED|Overall Study||10
5069563|NCT01819415|12474054|P1|STARTED|Overall Study||10
5069564|NCT01819311|12474066|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
5069565|NCT01819311|12474067|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
5069566|NCT01819311|12474066|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
5069567|NCT01819311|12474067|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
5069568|NCT01819311|12474066|P2|STARTED|Follow-up Phase (8 Weeks)||30
5069569|NCT01819311|12474067|P1|STARTED|Follow-up Phase (8 Weeks)||31
5069570|NCT01819311|12474066|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
5069571|NCT01819311|12474067|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
5069572|NCT01819311|12474066|P2|COMPLETED|Treatment Phase (4 Weeks)||30
5069573|NCT01819311|12474067|P1|COMPLETED|Treatment Phase (4 Weeks)||31
5069574|NCT01819311|12474066|P2|STARTED|Treatment Phase (4 Weeks)||31
5069575|NCT01819311|12474067|P1|STARTED|Treatment Phase (4 Weeks)||33
5069576|NCT01819272|12474089|P6|NOT COMPLETED|Overall Study||7
5069577|NCT01819272|12474090|P5|NOT COMPLETED|Overall Study||4
5069578|NCT01819272|12474091|P4|NOT COMPLETED|Overall Study||5
5069579|NCT01819272|12474092|P3|NOT COMPLETED|Overall Study||3
5069580|NCT01819272|12474093|P2|NOT COMPLETED|Overall Study||3
5069581|NCT01819272|12474094|P1|NOT COMPLETED|Overall Study||6
5069582|NCT01819272|12474089|P6|COMPLETED|Overall Study||33
5069583|NCT01819272|12474090|P5|COMPLETED|Overall Study||36
5069584|NCT01819272|12474091|P4|COMPLETED|Overall Study||35
5069585|NCT01819272|12474092|P3|COMPLETED|Overall Study||37
5069586|NCT01819272|12474093|P2|COMPLETED|Overall Study||36
5069587|NCT01819272|12474094|P1|COMPLETED|Overall Study||35
5069588|NCT01819272|12474089|P6|STARTED|Overall Study||40
5069589|NCT01819272|12474090|P5|STARTED|Overall Study||40
5069590|NCT01819272|12474091|P4|STARTED|Overall Study||40
5069591|NCT01819272|12474092|P3|STARTED|Overall Study||40
5069592|NCT01819272|12474093|P2|STARTED|Overall Study||39
5069593|NCT01819272|12474094|P1|STARTED|Overall Study||41
5069594|NCT01819233|12474120|P1|NOT COMPLETED|Overall Study||6
5069595|NCT01819233|12474120|P1|COMPLETED|Overall Study||32
5069596|NCT01819233|12474120|P1|STARTED|Overall Study||38
5069597|NCT01819194|12474132|P1|NOT COMPLETED|Overall Study||2
5069598|NCT01819194|12474132|P1|COMPLETED|Overall Study||60
5069599|NCT01819194|12474132|P1|STARTED|Overall Study||62
5069600|NCT01819129|12474139|P2|NOT COMPLETED|Overall Study||39
5069601|NCT01819129|12474140|P1|NOT COMPLETED|Overall Study||44
5069602|NCT01819129|12474139|P2|COMPLETED|Overall Study||305
5069603|NCT01819129|12474140|P1|COMPLETED|Overall Study||301
5069604|NCT01819129|12474139|P2|Exposed|Overall Study||341
5069605|NCT01819129|12474140|P1|Exposed|Overall Study||341
5069606|NCT01819129|12474139|P2|STARTED|Overall Study||344
5069607|NCT01819129|12474140|P1|STARTED|Overall Study||345
5069608|NCT01818804|12474154|P2|NOT COMPLETED|Overall Study||7
5069609|NCT01818804|12474155|P1|NOT COMPLETED|Overall Study||5
5069610|NCT01818804|12474154|P2|COMPLETED|Overall Study||65
5069611|NCT01818804|12474155|P1|COMPLETED|Overall Study||68
5069612|NCT01818804|12474154|P2|STARTED|Overall Study||72
5069613|NCT01818804|12474155|P1|STARTED|Overall Study||73
5069614|NCT01818765|12474165|P1|NOT COMPLETED|Overall Study||2
5069615|NCT01818765|12474165|P1|COMPLETED|Overall Study||18
5069616|NCT01818765|12474165|P1|STARTED|Overall Study||20
5069617|NCT01818752|12474178|P2|NOT COMPLETED|Overall Study||198
5069618|NCT01818752|12474179|P1|NOT COMPLETED|Overall Study||187
5069619|NCT01818752|12474178|P2|COMPLETED|Overall Study|Completed treatment|280
5069620|NCT01818752|12474179|P1|COMPLETED|Overall Study|Completed treatment|290
5069621|NCT01818752|12474178|P2|Received Treatment|Overall Study||474
5069622|NCT01818752|12474179|P1|Received Treatment|Overall Study||470
5069623|NCT01818752|12474178|P2|STARTED|Overall Study||478
5069624|NCT01818752|12474179|P1|STARTED|Overall Study||477
5069625|NCT01818726|12474199|P2|NOT COMPLETED|Overall Study||2
5069626|NCT01818726|12474200|P1|NOT COMPLETED|Overall Study||6
5069627|NCT01818726|12474199|P2|COMPLETED|Overall Study||3
5069628|NCT01818726|12474200|P1|COMPLETED|Overall Study||4
5069629|NCT01818726|12474199|P2|STARTED|Overall Study||5
5069630|NCT01818726|12474200|P1|STARTED|Overall Study||10
5069631|NCT01818700|12474210|P1|NOT COMPLETED|Overall Study||104
5069632|NCT01818700|12474210|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
5069633|NCT01818700|12474210|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
5069634|NCT01818700|12474210|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
5069635|NCT01818700|12474210|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
5069636|NCT01818700|12474210|P1|STARTED|Overall Study|The No. of enrolled patients|245
5069637|NCT01818596|12474221|P2|NOT COMPLETED|Overall Study||0
5069638|NCT01818596|12474222|P1|NOT COMPLETED|Overall Study||31
5069639|NCT01818596|12474221|P2|COMPLETED|Overall Study||6
5069640|NCT01818596|12474222|P1|COMPLETED|Overall Study||215
5069641|NCT01818596|12474221|P2|STARTED|Overall Study||6
5069642|NCT01818596|12474222|P1|STARTED|Overall Study||246
5069643|NCT01818531|12474261|P2|NOT COMPLETED|Overall Study||2
5069644|NCT01818531|12474262|P1|NOT COMPLETED|Overall Study||1
5069645|NCT01818531|12474261|P2|COMPLETED|Overall Study||73
5069646|NCT01818531|12474262|P1|COMPLETED|Overall Study||74
5069647|NCT01818531|12474261|P2|STARTED|Overall Study||75
5069648|NCT01818531|12474262|P1|STARTED|Overall Study||75
5069649|NCT01818518|12474282|P6|NOT COMPLETED|Overall Study||0
5069650|NCT01818518|12474283|P5|NOT COMPLETED|Overall Study||0
5069651|NCT01818518|12474284|P4|NOT COMPLETED|Overall Study||0
5069652|NCT01818518|12474285|P3|NOT COMPLETED|Overall Study||0
5069653|NCT01818518|12474286|P2|NOT COMPLETED|Overall Study||0
5069654|NCT01818518|12474287|P1|NOT COMPLETED|Overall Study||0
5069655|NCT01818518|12474282|P6|COMPLETED|Overall Study||37
5069656|NCT01818518|12474283|P5|COMPLETED|Overall Study||38
5069657|NCT01818518|12474284|P4|COMPLETED|Overall Study||59
5069658|NCT01818518|12474285|P3|COMPLETED|Overall Study||288
5069659|NCT01818518|12474286|P2|COMPLETED|Overall Study||263
5069660|NCT01818518|12474287|P1|COMPLETED|Overall Study||310
5069661|NCT01818518|12474282|P6|STARTED|Overall Study||37
5069662|NCT01818518|12474283|P5|STARTED|Overall Study||38
5069663|NCT01818518|12474284|P4|STARTED|Overall Study||59
5069664|NCT01818518|12474285|P3|STARTED|Overall Study||288
5069665|NCT01818518|12474286|P2|STARTED|Overall Study||263
5069666|NCT01818518|12474287|P1|STARTED|Overall Study||310
5069667|NCT01818427|12474303|P2|NOT COMPLETED|Overall Study||13
5069668|NCT01818427|12474304|P1|NOT COMPLETED|Overall Study||9
5069669|NCT01818427|12474303|P2|COMPLETED|Overall Study||271
5069670|NCT01818427|12474304|P1|COMPLETED|Overall Study||230
5069671|NCT01818427|12474303|P2|STARTED|Overall Study||284
5069672|NCT01818427|12474304|P1|STARTED|Overall Study||239
5069673|NCT01818414|12474320|P2|NOT COMPLETED|Overall Study||0
5069674|NCT01818414|12474321|P1|NOT COMPLETED|Overall Study||0
5069675|NCT01818414|12474320|P2|COMPLETED|Overall Study||15
5069676|NCT01818414|12474321|P1|COMPLETED|Overall Study||14
5069677|NCT01818414|12474320|P2|STARTED|Overall Study||15
5069678|NCT01818414|12474321|P1|STARTED|Overall Study||14
5069679|NCT01818336|12474335|P2|NOT COMPLETED|Overall Study||12
5069680|NCT01818336|12474336|P1|NOT COMPLETED|Overall Study||0
5069681|NCT01818336|12474335|P2|COMPLETED|Overall Study||47
5069682|NCT01818336|12474336|P1|COMPLETED|Overall Study||391
5069683|NCT01818336|12474335|P2|STARTED|Overall Study||59
5069684|NCT01818336|12474336|P1|STARTED|Overall Study||391
5069685|NCT01818297|12474344|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
5069686|NCT01818297|12474345|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
5069687|NCT01818297|12474344|P2|COMPLETED|Open Label Phase (3-12 Months)||19
5069688|NCT01818297|12474345|P1|COMPLETED|Open Label Phase (3-12 Months)||14
5069689|NCT01818297|12474344|P2|STARTED|Open Label Phase (3-12 Months)||29
5069690|NCT01818297|12474345|P1|STARTED|Open Label Phase (3-12 Months)||32
5069691|NCT01818297|12474344|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
5069692|NCT01818297|12474345|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
5069693|NCT01818297|12474344|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
5069694|NCT01818297|12474345|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
5069695|NCT01818297|12474344|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
5069696|NCT01818297|12474345|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
5069697|NCT01818297|12474344|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
5069698|NCT01818297|12474345|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
5069699|NCT01818297|12474344|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
5069700|NCT01818297|12474345|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
5069701|NCT01818284|12474363|P2|NOT COMPLETED|Overall Study||6
5069702|NCT01818284|12474364|P1|NOT COMPLETED|Overall Study||4
5069703|NCT01818284|12474363|P2|COMPLETED|Overall Study||5
5069704|NCT01818284|12474364|P1|COMPLETED|Overall Study||7
5069705|NCT01818284|12474363|P2|STARTED|Overall Study||11
5069706|NCT01818284|12474364|P1|STARTED|Overall Study||11
5069707|NCT01818245|12474372|P2|NOT COMPLETED|Intervention C||0
5069708|NCT01818245|12474373|P1|NOT COMPLETED|Intervention C||0
5069709|NCT01818245|12474372|P2|COMPLETED|Intervention C||0
5069710|NCT01818245|12474373|P1|COMPLETED|Intervention C||30
5069711|NCT01818245|12474372|P2|STARTED|Intervention C||0
5069712|NCT01818245|12474373|P1|STARTED|Intervention C||30
5069713|NCT01818245|12474372|P2|NOT COMPLETED|Washout (16-28 Days)||0
5069714|NCT01818245|12474373|P1|NOT COMPLETED|Washout (16-28 Days)||0
5069715|NCT01818245|12474372|P2|COMPLETED|Washout (16-28 Days)||0
5069716|NCT01818245|12474373|P1|COMPLETED|Washout (16-28 Days)||30
5069717|NCT01818245|12474372|P2|STARTED|Washout (16-28 Days)||0
5069718|NCT01818245|12474373|P1|STARTED|Washout (16-28 Days)||30
5069719|NCT01818245|12474372|P2|NOT COMPLETED|Intervention B||0
5069720|NCT01818245|12474373|P1|NOT COMPLETED|Intervention B||0
5069721|NCT01818245|12474372|P2|COMPLETED|Intervention B||0
5069722|NCT01818245|12474373|P1|COMPLETED|Intervention B||30
5069723|NCT01818245|12474372|P2|STARTED|Intervention B||0
5069724|NCT01818245|12474373|P1|STARTED|Intervention B||30
5069725|NCT01818245|12474372|P2|NOT COMPLETED|Washout (16-28 Days)||0
5069726|NCT01818245|12474373|P1|NOT COMPLETED|Washout (16-28 Days)||0
5069727|NCT01818245|12474372|P2|COMPLETED|Washout (16-28 Days)||0
5069728|NCT01818245|12474373|P1|COMPLETED|Washout (16-28 Days)||30
5069729|NCT01818245|12474372|P2|STARTED|Washout (16-28 Days)||0
5069730|NCT01818245|12474373|P1|STARTED|Washout (16-28 Days)||30
5069731|NCT01818245|12474372|P2|NOT COMPLETED|Intervention A||0
5069732|NCT01818245|12474373|P1|NOT COMPLETED|Intervention A||0
5069733|NCT01818245|12474372|P2|COMPLETED|Intervention A||22
5069734|NCT01818245|12474373|P1|COMPLETED|Intervention A||30
5069735|NCT01818245|12474372|P2|Received One Dose of Study Drug|Intervention A||22
5069736|NCT01818245|12474373|P1|Received One Dose of Study Drug|Intervention A||30
5069737|NCT01818245|12474372|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
5069738|NCT01818245|12474373|P1|STARTED|Intervention A||30
5069739|NCT01818141|12474397|P2|NOT COMPLETED|Overall Study||3
5069740|NCT01818141|12474398|P1|NOT COMPLETED|Overall Study||3
5069741|NCT01818141|12474397|P2|COMPLETED|Overall Study||13
5069742|NCT01818141|12474398|P1|COMPLETED|Overall Study||15
5069743|NCT01818141|12474397|P2|STARTED|Overall Study||16
5069744|NCT01818141|12474398|P1|STARTED|Overall Study||18
5069745|NCT01818063|12474408|P2|NOT COMPLETED|Overall Study||0
5069746|NCT01818063|12474409|P1|NOT COMPLETED|Overall Study||0
5069747|NCT01818063|12474408|P2|COMPLETED|Overall Study||4
5069748|NCT01818063|12474409|P1|COMPLETED|Overall Study||5
5069749|NCT01818063|12474408|P2|STARTED|Overall Study||4
5069750|NCT01818063|12474409|P1|STARTED|Overall Study||5
5069751|NCT01817959|12474421|P2|NOT COMPLETED|Overall Study||3
5069752|NCT01817959|12474422|P1|NOT COMPLETED|Overall Study||4
5069753|NCT01817959|12474421|P2|COMPLETED|Overall Study||16
5069754|NCT01817959|12474422|P1|COMPLETED|Overall Study||25
5069755|NCT01817959|12474421|P2|STARTED|Overall Study||19
5069756|NCT01817959|12474422|P1|STARTED|Overall Study||29
5069757|NCT01817907|12474468|P2|NOT COMPLETED|Second Intervention||0
5069758|NCT01817907|12474469|P1|NOT COMPLETED|Second Intervention||0
5069759|NCT01817907|12474468|P2|COMPLETED|Second Intervention||7
5069760|NCT01817907|12474469|P1|COMPLETED|Second Intervention||8
5069761|NCT01817907|12474468|P2|STARTED|Second Intervention||7
5069762|NCT01817907|12474469|P1|STARTED|Second Intervention||8
5069763|NCT01817907|12474468|P2|NOT COMPLETED|Washout Period||0
5069764|NCT01817907|12474469|P1|NOT COMPLETED|Washout Period||0
5069765|NCT01817907|12474468|P2|COMPLETED|Washout Period||7
5069766|NCT01817907|12474469|P1|COMPLETED|Washout Period||8
5069767|NCT01817907|12474468|P2|STARTED|Washout Period||7
5069768|NCT01817907|12474469|P1|STARTED|Washout Period||8
5069769|NCT01817907|12474468|P2|NOT COMPLETED|First Intervention||0
5069770|NCT01817907|12474469|P1|NOT COMPLETED|First Intervention||0
5069771|NCT01817907|12474468|P2|COMPLETED|First Intervention||7
5069772|NCT01817907|12474469|P1|COMPLETED|First Intervention||8
5069773|NCT01817907|12474468|P2|STARTED|First Intervention||7
5069774|NCT01817907|12474469|P1|STARTED|First Intervention||8
5069775|NCT01817855|12474481|P4|NOT COMPLETED|Overall Study||0
5069776|NCT01817855|12474482|P3|NOT COMPLETED|Overall Study||2
5069777|NCT01817855|12474483|P2|NOT COMPLETED|Overall Study||2
5069778|NCT01817855|12474484|P1|NOT COMPLETED|Overall Study||0
5069779|NCT01817855|12474481|P4|COMPLETED|Overall Study||5
5069780|NCT01817855|12474482|P3|COMPLETED|Overall Study||9
5069781|NCT01817855|12474483|P2|COMPLETED|Overall Study||6
5069782|NCT01817855|12474484|P1|COMPLETED|Overall Study||23
5069783|NCT01817855|12474481|P4|STARTED|Overall Study||5
5069784|NCT01817855|12474482|P3|STARTED|Overall Study||11
5069785|NCT01817855|12474483|P2|STARTED|Overall Study||8
5069786|NCT01817855|12474484|P1|STARTED|Overall Study||23
5069787|NCT01817790|12474514|P2|NOT COMPLETED|Overall Study||8
5069788|NCT01817790|12474515|P1|NOT COMPLETED|Overall Study||4
5069789|NCT01817790|12474514|P2|COMPLETED|Overall Study||304
5069790|NCT01817790|12474515|P1|COMPLETED|Overall Study||310
5069791|NCT01817790|12474514|P2|STARTED|Overall Study||312
5069792|NCT01817790|12474515|P1|STARTED|Overall Study||314
5069793|NCT01817777|12474559|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
5069794|NCT01817777|12474560|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
5069795|NCT01817777|12474561|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
5069796|NCT01817777|12474559|P3|COMPLETED|Interventional Phase (20 Weeks)||10
5069797|NCT01817777|12474560|P2|COMPLETED|Interventional Phase (20 Weeks)||11
5069798|NCT01817777|12474561|P1|COMPLETED|Interventional Phase (20 Weeks)||0
5069799|NCT01817777|12474559|P3|STARTED|Interventional Phase (20 Weeks)||15
5069800|NCT01817777|12474560|P2|STARTED|Interventional Phase (20 Weeks)||16
5069801|NCT01817777|12474561|P1|STARTED|Interventional Phase (20 Weeks)||0
5069802|NCT01817777|12474559|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
5069803|NCT01817777|12474560|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
5069804|NCT01817777|12474561|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
5069805|NCT01817777|12474559|P3|COMPLETED|Observational Phase (8 Weeks)||0
5069806|NCT01817777|12474560|P2|COMPLETED|Observational Phase (8 Weeks)||0
5069807|NCT01817777|12474561|P1|COMPLETED|Observational Phase (8 Weeks)||31
5069808|NCT01817777|12474559|P3|STARTED|Observational Phase (8 Weeks)||0
5069809|NCT01817777|12474560|P2|STARTED|Observational Phase (8 Weeks)||0
5069810|NCT01817777|12474561|P1|STARTED|Observational Phase (8 Weeks)||36
5069811|NCT01817764|12474585|P2|NOT COMPLETED|Overall Study||38
5069812|NCT01817764|12474586|P1|NOT COMPLETED|Overall Study||34
5069813|NCT01817764|12474585|P2|COMPLETED|Overall Study||315
5069814|NCT01817764|12474586|P1|COMPLETED|Overall Study||319
5069815|NCT01817764|12474585|P2|STARTED|Overall Study||353
5069816|NCT01817764|12474586|P1|STARTED|Overall Study||353
5069817|NCT01817725|12474594|P1|NOT COMPLETED|Overall Study||1
5069818|NCT01817725|12474594|P1|COMPLETED|Overall Study||19
5069819|NCT01817725|12474594|P1|STARTED|Overall Study||20
5069820|NCT01817712|12474601|P2|NOT COMPLETED|Overall Study||30
5069821|NCT01817712|12474602|P1|NOT COMPLETED|Overall Study||21
5069822|NCT01817712|12474601|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
5069823|NCT01817712|12474602|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
5069824|NCT01817712|12474601|P2|STARTED|Overall Study||270
5069825|NCT01817712|12474602|P1|STARTED|Overall Study||271
5069826|NCT01817582|12474615|P3|NOT COMPLETED|Overall Study||0
5069827|NCT01817582|12474616|P2|NOT COMPLETED|Overall Study||1
5069828|NCT01817582|12474617|P1|NOT COMPLETED|Overall Study||2
5069829|NCT01817582|12474615|P3|COMPLETED|Overall Study||33
5069830|NCT01817582|12474616|P2|COMPLETED|Overall Study||35
5069831|NCT01817582|12474617|P1|COMPLETED|Overall Study||31
5069832|NCT01817582|12474615|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
5069833|NCT01817582|12474616|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
5069834|NCT01817582|12474617|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
5069835|NCT01817582|12474615|P3|STARTED|Overall Study||33
5069836|NCT01817582|12474616|P2|STARTED|Overall Study||36
5069837|NCT01817582|12474617|P1|STARTED|Overall Study||33
5069838|NCT01817530|12474687|P8|NOT COMPLETED|Overall Study||24
5069839|NCT01817530|12474688|P7|NOT COMPLETED|Overall Study||23
5069840|NCT01817530|12474689|P6|NOT COMPLETED|Overall Study||19
5069841|NCT01817530|12474690|P5|NOT COMPLETED|Overall Study||11
5069842|NCT01817530|12474691|P4|NOT COMPLETED|Overall Study||13
5069843|NCT01817530|12474692|P3|NOT COMPLETED|Overall Study||11
5069844|NCT01817530|12474693|P2|NOT COMPLETED|Overall Study||13
5069845|NCT01817530|12474694|P1|NOT COMPLETED|Overall Study||15
5069846|NCT01817530|12474687|P8|COMPLETED|Overall Study||53
5069847|NCT01817530|12474688|P7|COMPLETED|Overall Study||53
5069848|NCT01817530|12474689|P6|COMPLETED|Overall Study||58
5069849|NCT01817530|12474690|P5|COMPLETED|Overall Study||67
5069850|NCT01817530|12474691|P4|COMPLETED|Overall Study||52
5069851|NCT01817530|12474692|P3|COMPLETED|Overall Study||53
5069852|NCT01817530|12474693|P2|COMPLETED|Overall Study||52
5069853|NCT01817530|12474694|P1|COMPLETED|Overall Study||50
5069854|NCT01817530|12474687|P8|STARTED|Overall Study||77
5069855|NCT01817530|12474688|P7|STARTED|Overall Study||76
5069856|NCT01817530|12474689|P6|STARTED|Overall Study||77
5069857|NCT01817530|12474690|P5|STARTED|Overall Study||78
5069858|NCT01817530|12474691|P4|STARTED|Overall Study||65
5069859|NCT01817530|12474692|P3|STARTED|Overall Study||64
5069860|NCT01817530|12474693|P2|STARTED|Overall Study||65
5069861|NCT01817530|12474694|P1|STARTED|Overall Study||65
5069862|NCT01817491|12474858|P2|NOT COMPLETED|Overall Study||0
5069863|NCT01817491|12474859|P1|NOT COMPLETED|Overall Study||4
5069864|NCT01817491|12474858|P2|COMPLETED|Overall Study||28
5069865|NCT01817491|12474859|P1|COMPLETED|Overall Study||28
5069866|NCT01817491|12474858|P2|STARTED|Overall Study||28
5069867|NCT01817491|12474859|P1|STARTED|Overall Study||32
5069868|NCT01817374|12474905|P1|NOT COMPLETED|Overall Study||0
5069869|NCT01817374|12474905|P1|COMPLETED|Overall Study||6
5069870|NCT01817374|12474905|P1|STARTED|Overall Study||6
5069871|NCT01817075|12474919|P2|NOT COMPLETED|Overall Study||35
5069872|NCT01817075|12474920|P1|NOT COMPLETED|Overall Study||47
5069873|NCT01817075|12474919|P2|COMPLETED|Overall Study||54
5069874|NCT01817075|12474920|P1|COMPLETED|Overall Study||41
5069875|NCT01817075|12474919|P2|STARTED|Overall Study||89
5069876|NCT01817075|12474920|P1|STARTED|Overall Study||88
5069877|NCT01816906|12474934|P2|NOT COMPLETED|12 Months||5
5069878|NCT01816906|12474935|P1|NOT COMPLETED|12 Months||4
5069879|NCT01816906|12474934|P2|COMPLETED|12 Months||14
5069880|NCT01816906|12474935|P1|COMPLETED|12 Months||16
5069881|NCT01816906|12474934|P2|STARTED|12 Months||19
5069882|NCT01816906|12474935|P1|STARTED|12 Months||20
5069883|NCT01816906|12474934|P2|NOT COMPLETED|Six Months||22
5069884|NCT01816906|12474935|P1|NOT COMPLETED|Six Months||21
5069885|NCT01816906|12474934|P2|COMPLETED|Six Months||19
5069886|NCT01816906|12474935|P1|COMPLETED|Six Months||20
5069887|NCT01816906|12474934|P2|STARTED|Six Months||41
5069888|NCT01816906|12474935|P1|STARTED|Six Months||41
5069889|NCT01816893|12474953|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
5069890|NCT01816893|12474954|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
5069891|NCT01816893|12474953|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
5069892|NCT01816893|12474954|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
5069893|NCT01816893|12474953|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
5069894|NCT01816893|12474954|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
5069895|NCT01816893|12474953|P2|NOT COMPLETED|Washout Period||0
5069896|NCT01816893|12474954|P1|NOT COMPLETED|Washout Period||2
5069897|NCT01816893|12474953|P2|COMPLETED|Washout Period||11
5069898|NCT01816893|12474954|P1|COMPLETED|Washout Period||9
5069899|NCT01816893|12474953|P2|STARTED|Washout Period||11
5069900|NCT01816893|12474954|P1|STARTED|Washout Period||11
5069901|NCT01816893|12474953|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
5069902|NCT01816893|12474954|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
5069903|NCT01816893|12474953|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
5069904|NCT01816893|12474954|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
5069905|NCT01816893|12474953|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
5069906|NCT01816893|12474954|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
5069907|NCT01816776|12474966|P2|NOT COMPLETED|Overall Study||8
5069908|NCT01816776|12474967|P1|NOT COMPLETED|Overall Study||13
5069909|NCT01816776|12474966|P2|COMPLETED|Overall Study||70
5069910|NCT01816776|12474967|P1|COMPLETED|Overall Study||60
5069911|NCT01816776|12474966|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
5069912|NCT01816776|12474967|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
5069913|NCT01816776|12474966|P2|STARTED|Overall Study||78
5069914|NCT01816776|12474967|P1|STARTED|Overall Study||73
5069915|NCT01816763|12474990|P3|NOT COMPLETED|Overall Study||11
5069916|NCT01816763|12474991|P2|NOT COMPLETED|Overall Study||15
5069917|NCT01816763|12474992|P1|NOT COMPLETED|Overall Study||4
5069918|NCT01816763|12474990|P3|COMPLETED|Overall Study||169
5069919|NCT01816763|12474991|P2|COMPLETED|Overall Study||179
5069920|NCT01816763|12474992|P1|COMPLETED|Overall Study||191
5069921|NCT01816763|12474990|P3|STARTED|Overall Study||180
5069922|NCT01816763|12474991|P2|STARTED|Overall Study||194
5069923|NCT01816763|12474992|P1|STARTED|Overall Study||195
5069924|NCT01816685|12475008|P2|NOT COMPLETED|Overall Study||11
5069925|NCT01816685|12475009|P1|NOT COMPLETED|Overall Study||10
5069926|NCT01816685|12475008|P2|COMPLETED|Overall Study||56
5069927|NCT01816685|12475009|P1|COMPLETED|Overall Study||58
5069928|NCT01816685|12475008|P2|STARTED|Overall Study||67
5069929|NCT01816685|12475009|P1|STARTED|Overall Study||68
5069930|NCT01816594|12475019|P2|NOT COMPLETED|Overall Study||2
5069931|NCT01816594|12475020|P1|NOT COMPLETED|Overall Study||11
5069932|NCT01816594|12475019|P2|COMPLETED|Overall Study||23
5069933|NCT01816594|12475020|P1|COMPLETED|Overall Study||14
5069934|NCT01816594|12475019|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
5069935|NCT01816594|12475020|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
5069936|NCT01816594|12475019|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
5069937|NCT01816594|12475020|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
5069938|NCT01816594|12475019|P2|STARTED|Overall Study||25
5069939|NCT01816594|12475020|P1|STARTED|Overall Study||25
5069940|NCT01816477|12475058|P2|NOT COMPLETED|Overall Study||1
5069941|NCT01816477|12475059|P1|NOT COMPLETED|Overall Study||16
5069942|NCT01816477|12475058|P2|COMPLETED|Overall Study||41
5069943|NCT01816477|12475059|P1|COMPLETED|Overall Study||27
5069944|NCT01816477|12475058|P2|STARTED|Overall Study||42
5069945|NCT01816477|12475059|P1|STARTED|Overall Study||43
5069946|NCT01816451|12475072|P3|NOT COMPLETED|Overall Study||0
5069947|NCT01816451|12475073|P2|NOT COMPLETED|Overall Study||0
5069948|NCT01816451|12475074|P1|NOT COMPLETED|Overall Study||0
5069949|NCT01816451|12475072|P3|COMPLETED|Overall Study||8
5069950|NCT01816451|12475073|P2|COMPLETED|Overall Study||11
5069951|NCT01816451|12475074|P1|COMPLETED|Overall Study||13
5069952|NCT01816451|12475072|P3|STARTED|Overall Study||8
5069953|NCT01816451|12475073|P2|STARTED|Overall Study||11
5069954|NCT01816451|12475074|P1|STARTED|Overall Study||13
5069955|NCT01816295|12475113|P2|NOT COMPLETED|OLE Phase||56
5069956|NCT01816295|12475114|P1|NOT COMPLETED|OLE Phase||53
5069957|NCT01816295|12475113|P2|COMPLETED|OLE Phase||227
5069958|NCT01816295|12475114|P1|COMPLETED|OLE Phase||222
5069959|NCT01816295|12475113|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
5069960|NCT01816295|12475114|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
5069961|NCT01816295|12475113|P2|NOT COMPLETED|Double Blind Phase||56
5069962|NCT01816295|12475114|P1|NOT COMPLETED|Double Blind Phase||63
5069963|NCT01816295|12475113|P2|COMPLETED|Double Blind Phase||302
5069964|NCT01816295|12475114|P1|COMPLETED|Double Blind Phase||294
5069965|NCT01816295|12475113|P2|Received Study Drug|Double Blind Phase||354
5069966|NCT01816295|12475114|P1|Received Study Drug|Double Blind Phase||356
5069967|NCT01816295|12475113|P2|STARTED|Double Blind Phase||358
5069968|NCT01816295|12475114|P1|STARTED|Double Blind Phase||357
5069969|NCT01816243|12475129|P1|NOT COMPLETED|Overall Study||12
5069970|NCT01816243|12475129|P1|COMPLETED|Overall Study||27
5069971|NCT01816243|12475129|P1|STARTED|Overall Study||39
5069972|NCT01816074|12475140|P4|NOT COMPLETED|Phase 2||1
5069973|NCT01816074|12475141|P3|NOT COMPLETED|Phase 2||0
5069974|NCT01816074|12475142|P2|NOT COMPLETED|Phase 2||2
5069975|NCT01816074|12475143|P1|NOT COMPLETED|Phase 2||2
5069976|NCT01816074|12475140|P4|COMPLETED|Phase 2||9
5069977|NCT01816074|12475141|P3|COMPLETED|Phase 2||10
5069978|NCT01816074|12475142|P2|COMPLETED|Phase 2||7
5069979|NCT01816074|12475143|P1|COMPLETED|Phase 2||9
5069980|NCT01816074|12475140|P4|STARTED|Phase 2||10
5069981|NCT01816074|12475141|P3|STARTED|Phase 2||10
5069982|NCT01816074|12475142|P2|STARTED|Phase 2||9
5069983|NCT01816074|12475143|P1|STARTED|Phase 2||11
5069984|NCT01816074|12475140|P4|NOT COMPLETED|Phase 1||0
5069985|NCT01816074|12475141|P3|NOT COMPLETED|Phase 1||1
5069986|NCT01816074|12475142|P2|NOT COMPLETED|Phase 1||0
5069987|NCT01816074|12475143|P1|NOT COMPLETED|Phase 1||0
5069988|NCT01816074|12475140|P4|COMPLETED|Phase 1||10
5069989|NCT01816074|12475141|P3|COMPLETED|Phase 1||10
5069990|NCT01816074|12475142|P2|COMPLETED|Phase 1||9
5069991|NCT01816074|12475143|P1|COMPLETED|Phase 1||11
5069992|NCT01816074|12475140|P4|STARTED|Phase 1||10
5069993|NCT01816074|12475141|P3|STARTED|Phase 1||11
5069994|NCT01816074|12475142|P2|STARTED|Phase 1||9
5069995|NCT01816074|12475143|P1|STARTED|Phase 1||11
5069996|NCT01816061|12475173|P2|NOT COMPLETED|Overall Study||24
5069997|NCT01816061|12475174|P1|NOT COMPLETED|Overall Study||13
5069998|NCT01816061|12475173|P2|COMPLETED|Overall Study||27
5069999|NCT01816061|12475174|P1|COMPLETED|Overall Study||27
5070000|NCT01816061|12475173|P2|STARTED|Overall Study||51
5070001|NCT01816061|12475174|P1|STARTED|Overall Study||40
5070002|NCT01816048|12475182|P1|NOT COMPLETED|Overall Study||6
5070003|NCT01816048|12475182|P1|COMPLETED|Overall Study||2
5070004|NCT01816048|12475182|P1|STARTED|Overall Study||8
5070005|NCT01815918|12475197|P2|NOT COMPLETED|Overall Study||19
5070006|NCT01815918|12475198|P1|NOT COMPLETED|Overall Study||18
5070007|NCT01815918|12475197|P2|COMPLETED|Overall Study||11
5070008|NCT01815918|12475198|P1|COMPLETED|Overall Study||12
5070009|NCT01815918|12475197|P2|STARTED|Overall Study||30
5070010|NCT01815918|12475198|P1|STARTED|Overall Study||30
5070011|NCT01815840|12475214|P2|NOT COMPLETED|Overall Study||63
5070012|NCT01815840|12475215|P1|NOT COMPLETED|Overall Study||59
5070013|NCT01815840|12475214|P2|COMPLETED|Overall Study||50
5070014|NCT01815840|12475215|P1|COMPLETED|Overall Study||57
5070015|NCT01815840|12475214|P2|STARTED|Overall Study||113
5070016|NCT01815840|12475215|P1|STARTED|Overall Study||116
5070017|NCT01815736|12475245|P2|NOT COMPLETED|Overall Study||478
5070018|NCT01815736|12475246|P1|NOT COMPLETED|Overall Study||961
5070019|NCT01815736|12475245|P2|COMPLETED|Overall Study||2
5070020|NCT01815736|12475246|P1|COMPLETED|Overall Study||2
5070021|NCT01815736|12475245|P2|STARTED|Overall Study||480
5070022|NCT01815736|12475246|P1|STARTED|Overall Study||963
5070023|NCT01815671|12475262|P2|NOT COMPLETED|Overall Study||0
5070024|NCT01815671|12475263|P1|NOT COMPLETED|Overall Study||0
5070025|NCT01815671|12475262|P2|COMPLETED|Overall Study||85
5070026|NCT01815671|12475263|P1|COMPLETED|Overall Study||88
5070027|NCT01815671|12475262|P2|STARTED|Overall Study||85
5070028|NCT01815671|12475263|P1|STARTED|Overall Study||88
5070029|NCT01815645|12475275|P2|NOT COMPLETED|Overall Study||0
5070030|NCT01815645|12475276|P1|NOT COMPLETED|Overall Study||0
5070031|NCT01815645|12475275|P2|COMPLETED|Overall Study||33
5070032|NCT01815645|12475276|P1|COMPLETED|Overall Study||32
5070033|NCT01815645|12475275|P2|STARTED|Overall Study||33
5070034|NCT01815645|12475276|P1|STARTED|Overall Study||32
5070035|NCT01815515|12475292|P1|NOT COMPLETED|Overall Study||0
5070036|NCT01815515|12475292|P1|COMPLETED|Overall Study||17
5070037|NCT01815515|12475292|P1|STARTED|Overall Study||17
5070038|NCT01815502|12475299|P2|NOT COMPLETED|Overall Study||0
5070039|NCT01815502|12475300|P1|NOT COMPLETED|Overall Study||0
5070040|NCT01815502|12475299|P2|COMPLETED|Overall Study||10
5070041|NCT01815502|12475300|P1|COMPLETED|Overall Study||10
5070042|NCT01815502|12475299|P2|STARTED|Overall Study||10
5070043|NCT01815502|12475300|P1|STARTED|Overall Study||10
5070044|NCT01815424|12475315|P5|NOT COMPLETED|Week 16 to 52||3
5070045|NCT01815424|12475316|P4|NOT COMPLETED|Week 16 to 52||3
5070046|NCT01815424|12475317|P3|NOT COMPLETED|Week 16 to 52||0
5070047|NCT01815424|12475318|P2|NOT COMPLETED|Week 16 to 52||5
5070048|NCT01815424|12475319|P1|NOT COMPLETED|Week 16 to 52||2
5070049|NCT01815424|12475315|P5|COMPLETED|Week 16 to 52||36
5070050|NCT01815424|12475316|P4|COMPLETED|Week 16 to 52||35
5070051|NCT01815424|12475317|P3|COMPLETED|Week 16 to 52||0
5070052|NCT01815424|12475318|P2|COMPLETED|Week 16 to 52||79
5070053|NCT01815424|12475319|P1|COMPLETED|Week 16 to 52||81
5070054|NCT01815424|12475315|P5|STARTED|Week 16 to 52||39
5070055|NCT01815424|12475316|P4|STARTED|Week 16 to 52||38
5070056|NCT01815424|12475317|P3|STARTED|Week 16 to 52||0
5070057|NCT01815424|12475318|P2|STARTED|Week 16 to 52||84
5070058|NCT01815424|12475319|P1|STARTED|Week 16 to 52||83
5070059|NCT01815424|12475315|P5|NOT COMPLETED|Week 0 to 16||0
5070060|NCT01815424|12475316|P4|NOT COMPLETED|Week 0 to 16||0
5070061|NCT01815424|12475317|P3|NOT COMPLETED|Week 0 to 16||11
5070062|NCT01815424|12475318|P2|NOT COMPLETED|Week 0 to 16||4
5070063|NCT01815424|12475319|P1|NOT COMPLETED|Week 0 to 16||7
5070064|NCT01815424|12475315|P5|COMPLETED|Week 0 to 16||0
5070065|NCT01815424|12475316|P4|COMPLETED|Week 0 to 16||0
5070066|NCT01815424|12475317|P3|COMPLETED|Week 0 to 16||77
5070067|NCT01815424|12475318|P2|COMPLETED|Week 0 to 16||84
5070068|NCT01815424|12475319|P1|COMPLETED|Week 0 to 16||83
5070069|NCT01815424|12475315|P5|STARTED|Week 0 to 16||0
5070070|NCT01815424|12475316|P4|STARTED|Week 0 to 16||0
5070071|NCT01815424|12475317|P3|STARTED|Week 0 to 16||88
5070072|NCT01815424|12475318|P2|STARTED|Week 0 to 16||88
5070073|NCT01815424|12475319|P1|STARTED|Week 0 to 16||90
5070074|NCT01815229|12475518|P3|NOT COMPLETED|Overall Study||51
5070075|NCT01815229|12475519|P2|NOT COMPLETED|Overall Study||0
5070076|NCT01815229|12475520|P1|NOT COMPLETED|Overall Study||0
5070077|NCT01815229|12475518|P3|COMPLETED|Overall Study||0
5070078|NCT01815229|12475519|P2|COMPLETED|Overall Study||18
5070079|NCT01815229|12475520|P1|COMPLETED|Overall Study||13
5070080|NCT01815229|12475518|P3|STARTED|Overall Study||51
5070081|NCT01815229|12475519|P2|STARTED|Overall Study||18
5070082|NCT01815229|12475520|P1|STARTED|Overall Study||13
5070083|NCT01815138|12475531|P2|NOT COMPLETED|Overall Study||6
5070084|NCT01815138|12475532|P1|NOT COMPLETED|Overall Study||8
5070085|NCT01815138|12475531|P2|COMPLETED|Overall Study||31
5070086|NCT01815138|12475532|P1|COMPLETED|Overall Study||26
5070087|NCT01815138|12475531|P2|STARTED|Overall Study||37
5070088|NCT01815138|12475532|P1|STARTED|Overall Study||34
5070089|NCT01815099|12475544|P1|NOT COMPLETED|Overall Study||2
5070090|NCT01815099|12475544|P1|COMPLETED|Overall Study||2
5070091|NCT01815099|12475544|P1|Began rTMS Treatment|Overall Study||3
5070092|NCT01815099|12475544|P1|STARTED|Overall Study||4
5070093|NCT01815008|12475549|P1|NOT COMPLETED|Overall Study||4
5070094|NCT01815008|12475549|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
5070095|NCT01815008|12475549|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
5070096|NCT01814878|12475558|P2|NOT COMPLETED|Overall Study||30
5070097|NCT01814878|12475559|P1|NOT COMPLETED|Overall Study||46
5070098|NCT01814878|12475558|P2|COMPLETED|Overall Study||128
5070099|NCT01814878|12475559|P1|COMPLETED|Overall Study||116
5070100|NCT01814878|12475558|P2|STARTED|Overall Study||158
5070101|NCT01814878|12475559|P1|STARTED|Overall Study||162
5070102|NCT01814826|12475582|P3|NOT COMPLETED|Overall Study||3
5070103|NCT01814826|12475583|P2|NOT COMPLETED|Overall Study||29
5070104|NCT01814826|12475584|P1|NOT COMPLETED|Overall Study||32
5070105|NCT01814826|12475582|P3|COMPLETED|Overall Study||0
5070106|NCT01814826|12475583|P2|COMPLETED|Overall Study||0
5070107|NCT01814826|12475584|P1|COMPLETED|Overall Study||0
5070108|NCT01814826|12475582|P3|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
5070109|NCT01814826|12475583|P2|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
5070110|NCT01814826|12475584|P1|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
5070111|NCT01814813|12475660|P3|NOT COMPLETED|Overall Study||0
5070112|NCT01814813|12475661|P2|NOT COMPLETED|Overall Study||0
5070113|NCT01814813|12475662|P1|NOT COMPLETED|Overall Study||0
5070114|NCT01814813|12475660|P3|COMPLETED|Overall Study||31
5070115|NCT01814813|12475661|P2|COMPLETED|Overall Study||30
5070116|NCT01814813|12475662|P1|COMPLETED|Overall Study||29
5070117|NCT01814813|12475660|P3|STARTED|Overall Study||31
5070118|NCT01814813|12475661|P2|STARTED|Overall Study||30
5070119|NCT01814813|12475662|P1|STARTED|Overall Study||29
5070120|NCT01814800|12475676|P1|NOT COMPLETED|Overall Study||5
5070121|NCT01814800|12475676|P1|COMPLETED|Overall Study||54
5070122|NCT01814800|12475676|P1|STARTED|Overall Study||59
5070123|NCT01814787|12475715|P2|NOT COMPLETED|Overall Study||0
5070124|NCT01814787|12475716|P1|NOT COMPLETED|Overall Study||0
5070125|NCT01814787|12475715|P2|COMPLETED|Overall Study||684
5070126|NCT01814787|12475716|P1|COMPLETED|Overall Study||685
5070127|NCT01814787|12475715|P2|STARTED|Overall Study||684
5070128|NCT01814787|12475716|P1|STARTED|Overall Study||685
5070129|NCT01814774|12475722|P1|NOT COMPLETED|Overall Study||0
5070130|NCT01814774|12475722|P1|COMPLETED|Overall Study||48
5070131|NCT01814774|12475722|P1|STARTED|Overall Study||48
5070132|NCT01814761|12475736|P2|NOT COMPLETED|Overall Study||30
5070133|NCT01814761|12475737|P1|NOT COMPLETED|Overall Study||8
5070134|NCT01814761|12475736|P2|COMPLETED|Overall Study||240
5070135|NCT01814761|12475737|P1|COMPLETED|Overall Study||34
5070136|NCT01814761|12475736|P2|STARTED|Overall Study||270
5070137|NCT01814761|12475737|P1|STARTED|Overall Study||42
5070138|NCT01814748|12475751|P2|NOT COMPLETED|Overall Study||7
5070139|NCT01814748|12475752|P1|NOT COMPLETED|Overall Study||8
5070140|NCT01814748|12475751|P2|COMPLETED|Overall Study||94
5070141|NCT01814748|12475752|P1|COMPLETED|Overall Study||94
5070142|NCT01814748|12475751|P2|STARTED|Overall Study||101
5070143|NCT01814748|12475752|P1|STARTED|Overall Study||102
5070144|NCT01814722|12475775|P3|NOT COMPLETED|Overall Study||0
5070145|NCT01814722|12475776|P2|NOT COMPLETED|Overall Study||0
5070146|NCT01814722|12475777|P1|NOT COMPLETED|Overall Study||0
5070147|NCT01814722|12475775|P3|COMPLETED|Overall Study||6
5070148|NCT01814722|12475776|P2|COMPLETED|Overall Study||21
5070149|NCT01814722|12475777|P1|COMPLETED|Overall Study||36
5070150|NCT01814722|12475775|P3|STARTED|Overall Study||6
5070151|NCT01814722|12475776|P2|STARTED|Overall Study||21
5070152|NCT01814722|12475777|P1|STARTED|Overall Study||36
5070153|NCT01814696|12475796|P2|NOT COMPLETED|Overall Study||0
5070154|NCT01814696|12475797|P1|NOT COMPLETED|Overall Study||2
5070155|NCT01814696|12475796|P2|COMPLETED|Overall Study||11
5070156|NCT01814696|12475797|P1|COMPLETED|Overall Study||13
5070157|NCT01814696|12475796|P2|STARTED|Overall Study||11
5070158|NCT01814696|12475797|P1|STARTED|Overall Study||15
5070159|NCT01814670|12475815|P1|NOT COMPLETED|Overall Study||12
5070160|NCT01814670|12475815|P1|COMPLETED|Overall Study||173
5070161|NCT01814670|12475815|P1|STARTED|Overall Study||185
5070162|NCT01814553|12475825|P2|NOT COMPLETED|Overall Study||22
5070163|NCT01814553|12475826|P1|NOT COMPLETED|Overall Study||18
5070164|NCT01814553|12475825|P2|COMPLETED|Overall Study||0
5070165|NCT01814553|12475826|P1|COMPLETED|Overall Study||0
5070166|NCT01814553|12475825|P2|STARTED|Overall Study||22
5070167|NCT01814553|12475826|P1|STARTED|Overall Study||18
5070168|NCT01814397|12475840|P1|NOT COMPLETED|Overall Study||14
5070169|NCT01814397|12475840|P1|COMPLETED|Overall Study||36
5070170|NCT01814397|12475840|P1|3 Month Evaluation|Overall Study||43
5070171|NCT01814397|12475840|P1|STARTED|Overall Study||50
5070172|NCT01814371|12475849|P2|NOT COMPLETED|Overall Study||27
5070173|NCT01814371|12475850|P1|NOT COMPLETED|Overall Study||30
5070174|NCT01814371|12475849|P2|COMPLETED|Overall Study||199
5070175|NCT01814371|12475850|P1|COMPLETED|Overall Study||218
5070176|NCT01814371|12475849|P2|STARTED|Overall Study||226
5070177|NCT01814371|12475850|P1|STARTED|Overall Study||248
5070178|NCT01814332|12475885|P2|NOT COMPLETED|Overall Study||16
5070179|NCT01814332|12475886|P1|NOT COMPLETED|Overall Study||16
5070180|NCT01814332|12475885|P2|COMPLETED|Overall Study||49
5070181|NCT01814332|12475886|P1|COMPLETED|Overall Study||47
5070182|NCT01814332|12475885|P2|STARTED|Overall Study||65
5070183|NCT01814332|12475886|P1|STARTED|Overall Study||63
5070184|NCT01814241|12475898|P1|NOT COMPLETED|Overall Study||4
5070185|NCT01814241|12475898|P1|COMPLETED|Overall Study||16
5070186|NCT01814241|12475898|P1|STARTED|Overall Study||20
5070187|NCT01814137|12475908|P2|NOT COMPLETED|Overall Study||5
5070188|NCT01814137|12475909|P1|NOT COMPLETED|Overall Study||5
5070189|NCT01814137|12475908|P2|COMPLETED|Overall Study||15
5070190|NCT01814137|12475909|P1|COMPLETED|Overall Study||15
5070191|NCT01814137|12475908|P2|STARTED|Overall Study||20
5070192|NCT01814137|12475909|P1|STARTED|Overall Study||20
5070193|NCT01814046|12475925|P3|NOT COMPLETED|Retreatment||0
5070194|NCT01814046|12475926|P2|NOT COMPLETED|Retreatment||0
5070195|NCT01814046|12475927|P1|NOT COMPLETED|Retreatment||0
5070196|NCT01814046|12475925|P3|COMPLETED|Retreatment||3
5070197|NCT01814046|12475926|P2|COMPLETED|Retreatment||0
5070198|NCT01814046|12475927|P1|COMPLETED|Retreatment||0
5070199|NCT01814046|12475925|P3|STARTED|Retreatment||3
5070200|NCT01814046|12475926|P2|STARTED|Retreatment||0
5070201|NCT01814046|12475927|P1|STARTED|Retreatment||0
5070202|NCT01814046|12475925|P3|NOT COMPLETED|Drug Administration||0
5070203|NCT01814046|12475926|P2|NOT COMPLETED|Drug Administration||0
5070204|NCT01814046|12475927|P1|NOT COMPLETED|Drug Administration||1
5070205|NCT01814046|12475925|P3|COMPLETED|Drug Administration||0
5070206|NCT01814046|12475926|P2|COMPLETED|Drug Administration||2
5070207|NCT01814046|12475927|P1|COMPLETED|Drug Administration||21
5070208|NCT01814046|12475925|P3|STARTED|Drug Administration||0
5070209|NCT01814046|12475926|P2|STARTED|Drug Administration||2
5070210|NCT01814046|12475927|P1|STARTED|Drug Administration||22
5070211|NCT01813890|12475941|P3|NOT COMPLETED|Overall Study||6
5070212|NCT01813890|12475942|P2|NOT COMPLETED|Overall Study||4
5070213|NCT01813890|12475943|P1|NOT COMPLETED|Overall Study||9
5070214|NCT01813890|12475941|P3|COMPLETED|Overall Study||13
5070215|NCT01813890|12475942|P2|COMPLETED|Overall Study||17
5070216|NCT01813890|12475943|P1|COMPLETED|Overall Study||11
5070217|NCT01813890|12475941|P3|STARTED|Overall Study||19
5070218|NCT01813890|12475942|P2|STARTED|Overall Study||21
5070219|NCT01813890|12475943|P1|STARTED|Overall Study||20
5070220|NCT01813734|12475972|P1|NOT COMPLETED|Overall Study||0
5070221|NCT01813734|12475972|P1|COMPLETED|Overall Study||9
5070222|NCT01813734|12475972|P1|STARTED|Overall Study||9
5070223|NCT01813721|12475980|P1|NOT COMPLETED|Overall Study||64
5070224|NCT01813721|12475980|P1|COMPLETED|Overall Study||943
5070225|NCT01813721|12475980|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
5070226|NCT01813474|12476035|P3|NOT COMPLETED|Overall Study||11
5070227|NCT01813474|12476036|P2|NOT COMPLETED|Overall Study||7
5070228|NCT01813474|12476037|P1|NOT COMPLETED|Overall Study||3
5070229|NCT01813474|12476035|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
5070230|NCT01813474|12476036|P2|COMPLETED|Overall Study||0
5070231|NCT01813474|12476037|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
5070232|NCT01813474|12476035|P3|STARTED|Overall Study||12
5070233|NCT01813474|12476036|P2|STARTED|Overall Study||7
5070234|NCT01813474|12476037|P1|STARTED|Overall Study||4
5070235|NCT01813435|12476061|P2|NOT COMPLETED|Overall Study||1007
5070236|NCT01813435|12476062|P1|NOT COMPLETED|Overall Study||2170
5070237|NCT01813435|12476061|P2|COMPLETED|Overall Study||6981
5070238|NCT01813435|12476062|P1|COMPLETED|Overall Study||5810
5070239|NCT01813435|12476061|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
5070240|NCT01813435|12476062|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
5070241|NCT01813422|12476086|P2|NOT COMPLETED|Overall Study||16
5070242|NCT01813422|12476087|P1|NOT COMPLETED|Overall Study||20
5070243|NCT01813422|12476086|P2|COMPLETED|Overall Study||468
5070244|NCT01813422|12476087|P1|COMPLETED|Overall Study||466
5070245|NCT01813422|12476086|P2|Received Treatment|Overall Study||484
5070246|NCT01813422|12476087|P1|Received Treatment|Overall Study||484
5070247|NCT01813422|12476086|P2|STARTED|Overall Study||484
5070248|NCT01813422|12476087|P1|STARTED|Overall Study||486
5070249|NCT01813214|12476101|P2|NOT COMPLETED|Overall Study||0
5070250|NCT01813214|12476102|P1|NOT COMPLETED|Overall Study||0
5070251|NCT01813214|12476101|P2|COMPLETED|Overall Study||2
5070252|NCT01813214|12476102|P1|COMPLETED|Overall Study||3
5070253|NCT01813214|12476101|P2|STARTED|Overall Study||2
5070254|NCT01813214|12476102|P1|STARTED|Overall Study||3
5070255|NCT01813110|12476112|P2|NOT COMPLETED|Overall Study||1
5070256|NCT01813110|12476113|P1|NOT COMPLETED|Overall Study||0
5070257|NCT01813110|12476112|P2|COMPLETED|Overall Study||10
5070258|NCT01813110|12476113|P1|COMPLETED|Overall Study||10
5070259|NCT01813110|12476112|P2|STARTED|Overall Study||11
5070260|NCT01813110|12476113|P1|STARTED|Overall Study||10
5070261|NCT01813071|12476132|P9|NOT COMPLETED|Overall Study||3
5070262|NCT01813071|12476133|P8|NOT COMPLETED|Overall Study||5
5070263|NCT01813071|12476134|P7|NOT COMPLETED|Overall Study||3
5070264|NCT01813071|12476135|P6|NOT COMPLETED|Overall Study||7
5070265|NCT01813071|12476136|P5|NOT COMPLETED|Overall Study||1
5070266|NCT01813071|12476137|P4|NOT COMPLETED|Overall Study||0
5070267|NCT01813071|12476138|P3|NOT COMPLETED|Overall Study||0
5070268|NCT01813071|12476139|P2|NOT COMPLETED|Overall Study||0
5070269|NCT01813071|12476140|P1|NOT COMPLETED|Overall Study||0
5070270|NCT01813071|12476132|P9|COMPLETED|Overall Study||13
5070271|NCT01813071|12476133|P8|COMPLETED|Overall Study||7
5070272|NCT01813071|12476134|P7|COMPLETED|Overall Study||9
5070273|NCT01813071|12476135|P6|COMPLETED|Overall Study||5
5070274|NCT01813071|12476136|P5|COMPLETED|Overall Study||11
5070275|NCT01813071|12476137|P4|COMPLETED|Overall Study||9
5070276|NCT01813071|12476138|P3|COMPLETED|Overall Study||10
5070277|NCT01813071|12476139|P2|COMPLETED|Overall Study||10
5070278|NCT01813071|12476140|P1|COMPLETED|Overall Study||10
5070279|NCT01813071|12476132|P9|STARTED|Overall Study||16
5070280|NCT01813071|12476133|P8|STARTED|Overall Study||12
5070281|NCT01813071|12476134|P7|STARTED|Overall Study||12
5070282|NCT01813071|12476135|P6|STARTED|Overall Study||12
5070283|NCT01813071|12476136|P5|STARTED|Overall Study||12
5070284|NCT01813071|12476137|P4|STARTED|Overall Study||9
5070285|NCT01813071|12476138|P3|STARTED|Overall Study||10
5070286|NCT01813071|12476139|P2|STARTED|Overall Study||10
5070287|NCT01813071|12476140|P1|STARTED|Overall Study||10
5070288|NCT01813058|12476607|P2|NOT COMPLETED|Overall Study||4
5070289|NCT01813058|12476608|P1|NOT COMPLETED|Overall Study||5
5070290|NCT01813058|12476607|P2|COMPLETED|Overall Study||56
5070291|NCT01813058|12476608|P1|COMPLETED|Overall Study||55
5070292|NCT01813058|12476607|P2|STARTED|Overall Study||60
5070293|NCT01813058|12476608|P1|STARTED|Overall Study||60
5070294|NCT01813019|12476616|P2|NOT COMPLETED|Overall Study||6
5070295|NCT01813019|12476617|P1|NOT COMPLETED|Overall Study||7
5070296|NCT01813019|12476616|P2|COMPLETED|Overall Study||20
5070297|NCT01813019|12476617|P1|COMPLETED|Overall Study||17
5070298|NCT01813019|12476616|P2|STARTED|Overall Study||26
5070299|NCT01813019|12476617|P1|STARTED|Overall Study||24
5070300|NCT01812837|12476628|P3|NOT COMPLETED|Overall Study||0
5070301|NCT01812837|12476629|P2|NOT COMPLETED|Overall Study||1
5070302|NCT01812837|12476630|P1|NOT COMPLETED|Overall Study||2
5070303|NCT01812837|12476628|P3|COMPLETED|Overall Study||17
5070304|NCT01812837|12476629|P2|COMPLETED|Overall Study||16
5070305|NCT01812837|12476630|P1|COMPLETED|Overall Study||15
5070306|NCT01812837|12476628|P3|STARTED|Overall Study||17
5070307|NCT01812837|12476629|P2|STARTED|Overall Study||17
5070308|NCT01812837|12476630|P1|STARTED|Overall Study||17
5070309|NCT01812707|12476642|P4|NOT COMPLETED|Overall Study||2
5070310|NCT01812707|12476643|P3|NOT COMPLETED|Overall Study||0
5070311|NCT01812707|12476644|P2|NOT COMPLETED|Overall Study||0
5070312|NCT01812707|12476645|P1|NOT COMPLETED|Overall Study||2
5070313|NCT01812707|12476642|P4|COMPLETED|Overall Study||23
5070314|NCT01812707|12476643|P3|COMPLETED|Overall Study||25
5070315|NCT01812707|12476644|P2|COMPLETED|Overall Study||25
5070316|NCT01812707|12476645|P1|COMPLETED|Overall Study||23
5070317|NCT01812707|12476642|P4|Treated|Overall Study||25
5070318|NCT01812707|12476643|P3|Treated|Overall Study||25
5070319|NCT01812707|12476644|P2|Treated|Overall Study||25
5070320|NCT01812707|12476645|P1|Treated|Overall Study||25
5070321|NCT01812707|12476642|P4|STARTED|Overall Study||25
5070322|NCT01812707|12476643|P3|STARTED|Overall Study||25
5070323|NCT01812707|12476644|P2|STARTED|Overall Study||25
5070324|NCT01812707|12476645|P1|STARTED|Overall Study||25
5070325|NCT01812681|12476681|P2|NOT COMPLETED|Overall Study||0
5070326|NCT01812681|12476682|P1|NOT COMPLETED|Overall Study||3
5070327|NCT01812681|12476681|P2|COMPLETED|Overall Study||24
5070328|NCT01812681|12476682|P1|COMPLETED|Overall Study||57
5070329|NCT01812681|12476681|P2|STARTED|Overall Study||24
5070330|NCT01812681|12476682|P1|STARTED|Overall Study||60
5070331|NCT01812655|12476693|P3|NOT COMPLETED|Overall Study||0
5070332|NCT01812655|12476694|P2|NOT COMPLETED|Overall Study||1
5070333|NCT01812655|12476695|P1|NOT COMPLETED|Overall Study||1
5070334|NCT01812655|12476693|P3|COMPLETED|Overall Study||10
5070335|NCT01812655|12476694|P2|COMPLETED|Overall Study||10
5070336|NCT01812655|12476695|P1|COMPLETED|Overall Study||8
5070337|NCT01812655|12476693|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
5070338|NCT01812655|12476694|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
5070339|NCT01812655|12476695|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
5070340|NCT01812473|12476711|P2|NOT COMPLETED|Overall Study||0
5070341|NCT01812473|12476712|P1|NOT COMPLETED|Overall Study||0
5070342|NCT01812473|12476711|P2|COMPLETED|Overall Study||13
5070343|NCT01812473|12476712|P1|COMPLETED|Overall Study||22
5070344|NCT01812473|12476711|P2|STARTED|Overall Study||13
5070345|NCT01812473|12476712|P1|STARTED|Overall Study||22
5070346|NCT01812057|12476720|P2|NOT COMPLETED|Overall Study||0
5070347|NCT01812057|12476721|P1|NOT COMPLETED|Overall Study||2
5070348|NCT01812057|12476720|P2|COMPLETED|Overall Study||24
5070349|NCT01812057|12476721|P1|COMPLETED|Overall Study||23
5070350|NCT01812057|12476720|P2|STARTED|Overall Study||24
5070351|NCT01812057|12476721|P1|STARTED|Overall Study||25
5070352|NCT01812044|12476762|P3|NOT COMPLETED|Overall Study||0
5070353|NCT01812044|12476763|P2|NOT COMPLETED|Overall Study||0
5070354|NCT01812044|12476764|P1|NOT COMPLETED|Overall Study||0
5070355|NCT01812044|12476762|P3|COMPLETED|Overall Study||16
5070356|NCT01812044|12476763|P2|COMPLETED|Overall Study||17
5070357|NCT01812044|12476764|P1|COMPLETED|Overall Study||17
5070358|NCT01812044|12476762|P3|STARTED|Overall Study||16
5070359|NCT01812044|12476763|P2|STARTED|Overall Study||17
5070360|NCT01812044|12476764|P1|STARTED|Overall Study||17
5070361|NCT01812005|12476795|P2|NOT COMPLETED|Overall Study||0
5070362|NCT01812005|12476796|P1|NOT COMPLETED|Overall Study||0
5070363|NCT01812005|12476795|P2|COMPLETED|Overall Study||13
5070364|NCT01812005|12476796|P1|COMPLETED|Overall Study||1
5070365|NCT01812005|12476795|P2|STARTED|Overall Study||13
5070366|NCT01812005|12476796|P1|STARTED|Overall Study||1
5070367|NCT01811953|12476824|P6|NOT COMPLETED|Overall Study||1
5070368|NCT01811953|12476825|P5|NOT COMPLETED|Overall Study||1
5070369|NCT01811953|12476826|P4|NOT COMPLETED|Overall Study||1
5070370|NCT01811953|12476827|P3|NOT COMPLETED|Overall Study||0
5070371|NCT01811953|12476828|P2|NOT COMPLETED|Overall Study||0
5070372|NCT01811953|12476829|P1|NOT COMPLETED|Overall Study||0
5070373|NCT01811953|12476824|P6|COMPLETED|Overall Study||11
5070374|NCT01811953|12476825|P5|COMPLETED|Overall Study||11
5070375|NCT01811953|12476826|P4|COMPLETED|Overall Study||5
5070376|NCT01811953|12476827|P3|COMPLETED|Overall Study||6
5070377|NCT01811953|12476828|P2|COMPLETED|Overall Study||6
5070378|NCT01811953|12476829|P1|COMPLETED|Overall Study||6
5070379|NCT01811953|12476824|P6|STARTED|Overall Study||12
5070380|NCT01811953|12476825|P5|STARTED|Overall Study||12
5070381|NCT01811953|12476826|P4|STARTED|Overall Study||6
5070382|NCT01811953|12476827|P3|STARTED|Overall Study||6
5070383|NCT01811953|12476828|P2|STARTED|Overall Study||6
5070384|NCT01811953|12476829|P1|STARTED|Overall Study||6
5070385|NCT01811940|12476875|P2|NOT COMPLETED|Overall Study||26
5070386|NCT01811940|12476876|P1|NOT COMPLETED|Overall Study||22
5070387|NCT01811940|12476875|P2|COMPLETED|Overall Study||37
5070388|NCT01811940|12476876|P1|COMPLETED|Overall Study||42
5070389|NCT01811940|12476875|P2|STARTED|Overall Study||63
5070390|NCT01811940|12476876|P1|STARTED|Overall Study||64
5070391|NCT01811732|12476886|P2|NOT COMPLETED|Overall Study||58
5070392|NCT01811732|12476887|P1|NOT COMPLETED|Overall Study||55
5070393|NCT01811732|12476886|P2|COMPLETED|Overall Study||271
5070394|NCT01811732|12476887|P1|COMPLETED|Overall Study||276
5070395|NCT01811732|12476886|P2|STARTED|Overall Study||329
5070396|NCT01811732|12476887|P1|STARTED|Overall Study||331
5070397|NCT01811706|12476897|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
5070398|NCT01811706|12476898|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5070399|NCT01811706|12476897|P2|COMPLETED|Second Intervention (4 Weeks)||10
5070400|NCT01811706|12476898|P1|COMPLETED|Second Intervention (4 Weeks)||9
5070401|NCT01811706|12476897|P2|STARTED|Second Intervention (4 Weeks)||10
5070402|NCT01811706|12476898|P1|STARTED|Second Intervention (4 Weeks)||9
5070403|NCT01811706|12476897|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
5070404|NCT01811706|12476898|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
5070405|NCT01811706|12476897|P2|COMPLETED|Washout ( 2 Weeks)||10
5070406|NCT01811706|12476898|P1|COMPLETED|Washout ( 2 Weeks)||9
5070407|NCT01811706|12476897|P2|STARTED|Washout ( 2 Weeks)||10
5070408|NCT01811706|12476898|P1|STARTED|Washout ( 2 Weeks)||9
5070409|NCT01811706|12476897|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
5070410|NCT01811706|12476898|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
5070411|NCT01811706|12476897|P2|COMPLETED|First Intervention ( 4 Weeks)||10
5070412|NCT01811706|12476898|P1|COMPLETED|First Intervention ( 4 Weeks)||9
5070413|NCT01811706|12476897|P2|STARTED|First Intervention ( 4 Weeks)||10
5070414|NCT01811706|12476898|P1|STARTED|First Intervention ( 4 Weeks)||10
5070415|NCT01811680|12476908|P1|NOT COMPLETED|Overall Study||0
5070416|NCT01811680|12476908|P1|COMPLETED|Overall Study||10
5070417|NCT01811680|12476908|P1|STARTED|Overall Study||10
5070418|NCT01811654|12476915|P2|NOT COMPLETED|Overall Study||0
5070419|NCT01811654|12476916|P1|NOT COMPLETED|Overall Study||0
5070420|NCT01811654|12476915|P2|COMPLETED|Overall Study||16
5070421|NCT01811654|12476916|P1|COMPLETED|Overall Study||14
5070422|NCT01811654|12476915|P2|STARTED|Overall Study||16
5070423|NCT01811654|12476916|P1|STARTED|Overall Study||14
5070424|NCT01811563|12476926|P2|NOT COMPLETED|Overall Study||3
5070425|NCT01811563|12476927|P1|NOT COMPLETED|Overall Study||5
5070426|NCT01811563|12476926|P2|COMPLETED|Overall Study||20
5070427|NCT01811563|12476927|P1|COMPLETED|Overall Study||20
5070428|NCT01811563|12476926|P2|STARTED|Overall Study||23
5070429|NCT01811563|12476927|P1|STARTED|Overall Study||25
5070430|NCT01811485|12476956|P3|NOT COMPLETED|Overall Study||5
5070431|NCT01811485|12476957|P2|NOT COMPLETED|Overall Study||4
5070432|NCT01811485|12476958|P1|NOT COMPLETED|Overall Study||2
5070433|NCT01811485|12476956|P3|COMPLETED|Overall Study||51
5070434|NCT01811485|12476957|P2|COMPLETED|Overall Study||55
5070435|NCT01811485|12476958|P1|COMPLETED|Overall Study||54
5070436|NCT01811485|12476956|P3|STARTED|Overall Study||56
5070437|NCT01811485|12476957|P2|STARTED|Overall Study||59
5070438|NCT01811485|12476958|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
5070439|NCT01811472|12476978|P3|NOT COMPLETED|Overall Study||5
5070440|NCT01811472|12476979|P2|NOT COMPLETED|Overall Study||0
5070441|NCT01811472|12476980|P1|NOT COMPLETED|Overall Study||2
5070442|NCT01811472|12476978|P3|COMPLETED|Overall Study||16
5070443|NCT01811472|12476979|P2|COMPLETED|Overall Study||11
5070444|NCT01811472|12476980|P1|COMPLETED|Overall Study||18
5070445|NCT01811472|12476978|P3|STARTED|Overall Study||21
5070446|NCT01811472|12476979|P2|STARTED|Overall Study||11
5070447|NCT01811472|12476980|P1|STARTED|Overall Study||20
5070448|NCT01811355|12477025|P2|NOT COMPLETED|Second Dose||0
5070449|NCT01811355|12477026|P1|NOT COMPLETED|Second Dose||0
5070450|NCT01811355|12477025|P2|COMPLETED|Second Dose||12
5070451|NCT01811355|12477026|P1|COMPLETED|Second Dose||9
5070452|NCT01811355|12477025|P2|STARTED|Second Dose||12
5070453|NCT01811355|12477026|P1|STARTED|Second Dose||9
5070454|NCT01811355|12477025|P2|NOT COMPLETED|Washout||0
5070455|NCT01811355|12477026|P1|NOT COMPLETED|Washout||0
5070456|NCT01811355|12477025|P2|COMPLETED|Washout||12
5070457|NCT01811355|12477026|P1|COMPLETED|Washout||9
5070458|NCT01811355|12477025|P2|STARTED|Washout||12
5070459|NCT01811355|12477026|P1|STARTED|Washout||9
5070460|NCT01811355|12477025|P2|NOT COMPLETED|First Dose||0
5070461|NCT01811355|12477026|P1|NOT COMPLETED|First Dose||2
5070462|NCT01811355|12477025|P2|COMPLETED|First Dose||12
5070463|NCT01811355|12477026|P1|COMPLETED|First Dose||9
5070464|NCT01811355|12477025|P2|STARTED|First Dose||12
5070465|NCT01811355|12477026|P1|STARTED|First Dose||11
5070466|NCT01811316|12477037|P3|NOT COMPLETED|Overall Study||0
5070467|NCT01811316|12477038|P2|NOT COMPLETED|Overall Study||0
5070468|NCT01811316|12477039|P1|NOT COMPLETED|Overall Study||3
5070469|NCT01811316|12477037|P3|COMPLETED|Overall Study||19
5070470|NCT01811316|12477038|P2|COMPLETED|Overall Study||22
5070471|NCT01811316|12477039|P1|COMPLETED|Overall Study||18
5070472|NCT01811316|12477037|P3|Visit 12 Weeks|Overall Study||19
5070473|NCT01811316|12477038|P2|Visit 12 Weeks|Overall Study||22
5070474|NCT01811316|12477039|P1|Visit 12 Weeks|Overall Study||18
5070475|NCT01811316|12477037|P3|Visit 4 Weeks|Overall Study||19
5070476|NCT01811316|12477038|P2|Visit 4 Weeks|Overall Study||22
5070477|NCT01811316|12477039|P1|Visit 4 Weeks|Overall Study||19
5070478|NCT01811316|12477037|P3|STARTED|Overall Study||19
5070479|NCT01811316|12477038|P2|STARTED|Overall Study||22
5070480|NCT01811316|12477039|P1|STARTED|Overall Study||21
5070481|NCT01811303|12477056|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
5070482|NCT01811303|12477057|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
5070483|NCT01811303|12477058|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
5070484|NCT01811303|12477059|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
5070485|NCT01811303|12477056|P4|COMPLETED|Fourth Intervention (1 Day)||2
5070486|NCT01811303|12477057|P3|COMPLETED|Fourth Intervention (1 Day)||4
5070487|NCT01811303|12477058|P2|COMPLETED|Fourth Intervention (1 Day)||4
5070488|NCT01811303|12477059|P1|COMPLETED|Fourth Intervention (1 Day)||4
5070489|NCT01811303|12477056|P4|STARTED|Fourth Intervention (1 Day)||2
5070490|NCT01811303|12477057|P3|STARTED|Fourth Intervention (1 Day)||4
5070491|NCT01811303|12477058|P2|STARTED|Fourth Intervention (1 Day)||4
5070492|NCT01811303|12477059|P1|STARTED|Fourth Intervention (1 Day)||4
5070493|NCT01811303|12477056|P4|NOT COMPLETED|Washout (2 Days or More)||0
5070494|NCT01811303|12477057|P3|NOT COMPLETED|Washout (2 Days or More)||0
5070495|NCT01811303|12477058|P2|NOT COMPLETED|Washout (2 Days or More)||0
5070496|NCT01811303|12477059|P1|NOT COMPLETED|Washout (2 Days or More)||0
5070497|NCT01811303|12477056|P4|COMPLETED|Washout (2 Days or More)||2
5070498|NCT01811303|12477057|P3|COMPLETED|Washout (2 Days or More)||4
5070499|NCT01811303|12477058|P2|COMPLETED|Washout (2 Days or More)||4
5070500|NCT01811303|12477059|P1|COMPLETED|Washout (2 Days or More)||4
5070501|NCT01811303|12477056|P4|STARTED|Washout (2 Days or More)||2
5070502|NCT01811303|12477057|P3|STARTED|Washout (2 Days or More)||4
5070503|NCT01811303|12477058|P2|STARTED|Washout (2 Days or More)||4
5070504|NCT01811303|12477059|P1|STARTED|Washout (2 Days or More)||4
5070505|NCT01811303|12477056|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5070506|NCT01811303|12477057|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5070507|NCT01811303|12477058|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5070508|NCT01811303|12477059|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5070509|NCT01811303|12477056|P4|COMPLETED|Third Intervention (1 Day)||2
5070510|NCT01811303|12477057|P3|COMPLETED|Third Intervention (1 Day)||4
5070511|NCT01811303|12477058|P2|COMPLETED|Third Intervention (1 Day)||4
5070512|NCT01811303|12477059|P1|COMPLETED|Third Intervention (1 Day)||4
5070513|NCT01811303|12477056|P4|STARTED|Third Intervention (1 Day)||2
5070514|NCT01811303|12477057|P3|STARTED|Third Intervention (1 Day)||4
5070515|NCT01811303|12477058|P2|STARTED|Third Intervention (1 Day)||4
5070516|NCT01811303|12477059|P1|STARTED|Third Intervention (1 Day)||4
5070517|NCT01811303|12477056|P4|NOT COMPLETED|Washout (2 Days or More)||0
5070518|NCT01811303|12477057|P3|NOT COMPLETED|Washout (2 Days or More)||0
5070519|NCT01811303|12477058|P2|NOT COMPLETED|Washout (2 Days or More)||0
5070520|NCT01811303|12477059|P1|NOT COMPLETED|Washout (2 Days or More)||0
5070521|NCT01811303|12477056|P4|COMPLETED|Washout (2 Days or More)||2
5070522|NCT01811303|12477057|P3|COMPLETED|Washout (2 Days or More)||4
5070523|NCT01811303|12477058|P2|COMPLETED|Washout (2 Days or More)||4
5070524|NCT01811303|12477059|P1|COMPLETED|Washout (2 Days or More)||4
5070525|NCT01811303|12477056|P4|STARTED|Washout (2 Days or More)||2
5070526|NCT01811303|12477057|P3|STARTED|Washout (2 Days or More)||4
5070527|NCT01811303|12477058|P2|STARTED|Washout (2 Days or More)||4
5070528|NCT01811303|12477059|P1|STARTED|Washout (2 Days or More)||4
5070529|NCT01811303|12477056|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5070530|NCT01811303|12477057|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5070531|NCT01811303|12477058|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5070532|NCT01811303|12477059|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5070533|NCT01811303|12477056|P4|COMPLETED|Second Intervention (1 Day)||2
5070534|NCT01811303|12477057|P3|COMPLETED|Second Intervention (1 Day)||4
5070535|NCT01811303|12477058|P2|COMPLETED|Second Intervention (1 Day)||4
5070536|NCT01811303|12477059|P1|COMPLETED|Second Intervention (1 Day)||4
5070537|NCT01811303|12477056|P4|STARTED|Second Intervention (1 Day)||2
5070538|NCT01811303|12477057|P3|STARTED|Second Intervention (1 Day)||4
5070539|NCT01811303|12477058|P2|STARTED|Second Intervention (1 Day)||4
5070540|NCT01811303|12477059|P1|STARTED|Second Intervention (1 Day)||4
5070541|NCT01811303|12477056|P4|NOT COMPLETED|Washout (2 Days or More)||0
5070542|NCT01811303|12477057|P3|NOT COMPLETED|Washout (2 Days or More)||0
5070543|NCT01811303|12477058|P2|NOT COMPLETED|Washout (2 Days or More)||0
5070544|NCT01811303|12477059|P1|NOT COMPLETED|Washout (2 Days or More)||0
5070545|NCT01811303|12477056|P4|COMPLETED|Washout (2 Days or More)||2
5070546|NCT01811303|12477057|P3|COMPLETED|Washout (2 Days or More)||4
5070547|NCT01811303|12477058|P2|COMPLETED|Washout (2 Days or More)||4
5070548|NCT01811303|12477059|P1|COMPLETED|Washout (2 Days or More)||4
5070549|NCT01811303|12477056|P4|STARTED|Washout (2 Days or More)||2
5070550|NCT01811303|12477057|P3|STARTED|Washout (2 Days or More)||4
5070551|NCT01811303|12477058|P2|STARTED|Washout (2 Days or More)||4
5070552|NCT01811303|12477059|P1|STARTED|Washout (2 Days or More)||4
5070553|NCT01811303|12477056|P4|NOT COMPLETED|First Intervention (1 Day)||0
5070554|NCT01811303|12477057|P3|NOT COMPLETED|First Intervention (1 Day)||0
5070555|NCT01811303|12477058|P2|NOT COMPLETED|First Intervention (1 Day)||0
5070556|NCT01811303|12477059|P1|NOT COMPLETED|First Intervention (1 Day)||0
5070557|NCT01811303|12477056|P4|COMPLETED|First Intervention (1 Day)||2
5070558|NCT01811303|12477057|P3|COMPLETED|First Intervention (1 Day)||4
5070559|NCT01811303|12477058|P2|COMPLETED|First Intervention (1 Day)||4
5070560|NCT01811303|12477059|P1|COMPLETED|First Intervention (1 Day)||4
5070561|NCT01811303|12477056|P4|STARTED|First Intervention (1 Day)||2
5070562|NCT01811303|12477057|P3|STARTED|First Intervention (1 Day)||4
5070563|NCT01811303|12477058|P2|STARTED|First Intervention (1 Day)||4
5070564|NCT01811303|12477059|P1|STARTED|First Intervention (1 Day)||4
5070565|NCT01811238|12477067|P1|NOT COMPLETED|Overall Study||81
5070566|NCT01811238|12477067|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
5070567|NCT01811238|12477067|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
5070568|NCT01811238|12477067|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
5070569|NCT01811238|12477067|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
5070570|NCT01811238|12477067|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
5070571|NCT01811212|12477076|P1|NOT COMPLETED|Overall Study||0
5070572|NCT01811212|12477076|P1|COMPLETED|Overall Study||25
5070573|NCT01811212|12477076|P1|STARTED|Overall Study||25
5070574|NCT01811186|12477091|P2|NOT COMPLETED|Overall Study||62
5070575|NCT01811186|12477092|P1|NOT COMPLETED|Overall Study||71
5070576|NCT01811186|12477091|P2|COMPLETED|Overall Study||64
5070577|NCT01811186|12477092|P1|COMPLETED|Overall Study||61
5070578|NCT01811186|12477091|P2|STARTED|Overall Study||126
5070579|NCT01811186|12477092|P1|STARTED|Overall Study||132
5070580|NCT01811147|12477112|P4|NOT COMPLETED|Overall Study||29
5070581|NCT01811147|12477113|P3|NOT COMPLETED|Overall Study||43
5070582|NCT01811147|12477114|P2|NOT COMPLETED|Overall Study||45
5070583|NCT01811147|12477115|P1|NOT COMPLETED|Overall Study||36
5070584|NCT01811147|12477112|P4|COMPLETED|Overall Study||4
5070585|NCT01811147|12477113|P3|COMPLETED|Overall Study||6
5070586|NCT01811147|12477114|P2|COMPLETED|Overall Study||11
5070587|NCT01811147|12477115|P1|COMPLETED|Overall Study||15
5070588|NCT01811147|12477112|P4|STARTED|Overall Study||33
5070589|NCT01811147|12477113|P3|STARTED|Overall Study||49
5070590|NCT01811147|12477114|P2|STARTED|Overall Study||56
5070591|NCT01811147|12477115|P1|STARTED|Overall Study||51
5070592|NCT01810952|12477131|P2|NOT COMPLETED|Overall Study||0
5070593|NCT01810952|12477132|P1|NOT COMPLETED|Overall Study||0
5070594|NCT01810952|12477131|P2|COMPLETED|Overall Study||17
5070595|NCT01810952|12477132|P1|COMPLETED|Overall Study||20
5070596|NCT01810952|12477131|P2|STARTED|Overall Study||17
5070597|NCT01810952|12477132|P1|STARTED|Overall Study||20
5070598|NCT01810939|12477146|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
5070599|NCT01810939|12477147|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
5070600|NCT01810939|12477148|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
5070601|NCT01810939|12477146|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
5070602|NCT01810939|12477147|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
5070603|NCT01810939|12477148|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
5070604|NCT01810939|12477146|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
5070605|NCT01810939|12477147|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
5070606|NCT01810939|12477148|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
5070607|NCT01810939|12477146|P3|NOT COMPLETED|Part A Treatment Period||0
5070608|NCT01810939|12477147|P2|NOT COMPLETED|Part A Treatment Period||0
5070609|NCT01810939|12477148|P1|NOT COMPLETED|Part A Treatment Period||24
5070610|NCT01810939|12477146|P3|COMPLETED|Part A Treatment Period||0
5070611|NCT01810939|12477147|P2|COMPLETED|Part A Treatment Period||0
5070612|NCT01810939|12477148|P1|COMPLETED|Part A Treatment Period||219
5070613|NCT01810939|12477146|P3|STARTED|Part A Treatment Period||0
5070614|NCT01810939|12477147|P2|STARTED|Part A Treatment Period||0
5070615|NCT01810939|12477148|P1|STARTED|Part A Treatment Period||243
5070616|NCT01810783|12477161|P1|NOT COMPLETED|Overall Study||109
5070617|NCT01810783|12477161|P1|COMPLETED|Overall Study||101
5070618|NCT01810783|12477161|P1|STARTED|Overall Study||210
5070619|NCT01810692|12477167|P2|NOT COMPLETED|Overall Study||0
5070620|NCT01810692|12477168|P1|NOT COMPLETED|Overall Study||0
5070621|NCT01810692|12477167|P2|COMPLETED|Overall Study||77
5070622|NCT01810692|12477168|P1|COMPLETED|Overall Study||77
5070623|NCT01810692|12477167|P2|STARTED|Overall Study||77
5070624|NCT01810692|12477168|P1|STARTED|Overall Study||77
5070625|NCT01810666|12477180|P1|NOT COMPLETED|Overall Study||0
5070626|NCT01810666|12477180|P1|COMPLETED|Overall Study||30
5070627|NCT01810666|12477180|P1|STARTED|Overall Study||30
5070628|NCT01810432|12477186|P2|NOT COMPLETED|Period 2||2
5070629|NCT01810432|12477187|P1|NOT COMPLETED|Period 2||4
5070630|NCT01810432|12477186|P2|COMPLETED|Period 2||17
5070631|NCT01810432|12477187|P1|COMPLETED|Period 2||15
5070632|NCT01810432|12477186|P2|Received at Least 1 Dose of Study Drug|Period 2||19
5070633|NCT01810432|12477187|P1|Received at Least 1 Dose of Study Drug|Period 2||19
5070634|NCT01810432|12477186|P2|STARTED|Period 2||19
5070635|NCT01810432|12477187|P1|STARTED|Period 2||19
5070636|NCT01810432|12477186|P2|NOT COMPLETED|Washout||1
5070637|NCT01810432|12477187|P1|NOT COMPLETED|Washout||1
5070638|NCT01810432|12477186|P2|COMPLETED|Washout||19
5070639|NCT01810432|12477187|P1|COMPLETED|Washout||19
5070640|NCT01810432|12477186|P2|STARTED|Washout||20
5070641|NCT01810432|12477187|P1|STARTED|Washout||20
5070642|NCT01810432|12477186|P2|NOT COMPLETED|Period 1||0
5070643|NCT01810432|12477187|P1|NOT COMPLETED|Period 1||0
5070644|NCT01810432|12477186|P2|COMPLETED|Period 1||20
5070645|NCT01810432|12477187|P1|COMPLETED|Period 1||20
5070646|NCT01810432|12477186|P2|Received at Least 1 Dose of Study Drug|Period 1||20
5070647|NCT01810432|12477187|P1|Received at Least 1 Dose of Study Drug|Period 1||20
5070648|NCT01810432|12477186|P2|STARTED|Period 1||20
5070649|NCT01810432|12477187|P1|STARTED|Period 1||20
5070650|NCT01810380|12477200|P3|NOT COMPLETED|Overall Study||32
5070651|NCT01810380|12477201|P2|NOT COMPLETED|Overall Study||38
5070652|NCT01810380|12477202|P1|NOT COMPLETED|Overall Study||55
5070653|NCT01810380|12477200|P3|COMPLETED|Overall Study||122
5070654|NCT01810380|12477201|P2|COMPLETED|Overall Study||113
5070655|NCT01810380|12477202|P1|COMPLETED|Overall Study||108
5070656|NCT01810380|12477200|P3|Treated|Overall Study||153
5070657|NCT01810380|12477201|P2|Treated|Overall Study||150
5070658|NCT01810380|12477202|P1|Treated|Overall Study||161
5070659|NCT01810380|12477200|P3|STARTED|Overall Study||154
5070660|NCT01810380|12477201|P2|STARTED|Overall Study||151
5070661|NCT01810380|12477202|P1|STARTED|Overall Study||163
5070662|NCT01810302|12477263|P2|NOT COMPLETED|Overall Study||1
5070663|NCT01810302|12477264|P1|NOT COMPLETED|Overall Study||1
5070664|NCT01810302|12477263|P2|COMPLETED|Overall Study||0
5070665|NCT01810302|12477264|P1|COMPLETED|Overall Study||0
5070666|NCT01810302|12477263|P2|STARTED|Overall Study||1
5070667|NCT01810302|12477264|P1|STARTED|Overall Study||1
5070668|NCT01810289|12477274|P2|NOT COMPLETED|Overall Study||0
5070669|NCT01810289|12477275|P1|NOT COMPLETED|Overall Study||0
5070670|NCT01810289|12477274|P2|COMPLETED|Overall Study||4747
5070671|NCT01810289|12477275|P1|COMPLETED|Overall Study||7277
5070672|NCT01810289|12477274|P2|STARTED|Overall Study||4747
5070673|NCT01810289|12477275|P1|STARTED|Overall Study||7277
5070674|NCT01810263|12477291|P2|NOT COMPLETED|Overall Study||7
5070675|NCT01810263|12477292|P1|NOT COMPLETED|Overall Study||8
5070676|NCT01810263|12477291|P2|COMPLETED|Overall Study||11
5070677|NCT01810263|12477292|P1|COMPLETED|Overall Study|2014 July|8
5070678|NCT01810263|12477291|P2|STARTED|Overall Study||18
5070679|NCT01810263|12477292|P1|STARTED|Overall Study||16
5070680|NCT01810042|12477298|P1|NOT COMPLETED|Overall Study||10
5070681|NCT01810042|12477298|P1|COMPLETED|Overall Study||39
5070682|NCT01810042|12477298|P1|STARTED|Overall Study||49
5070683|NCT01810016|12477308|P3|NOT COMPLETED|Overall Study||1
5070684|NCT01810016|12477309|P2|NOT COMPLETED|Overall Study||1
5070685|NCT01810016|12477310|P1|NOT COMPLETED|Overall Study||1
5070686|NCT01810016|12477308|P3|COMPLETED|Overall Study||0
5070687|NCT01810016|12477309|P2|COMPLETED|Overall Study||1
5070688|NCT01810016|12477310|P1|COMPLETED|Overall Study||4
5070689|NCT01810016|12477308|P3|STARTED|Overall Study||1
5070690|NCT01810016|12477309|P2|STARTED|Overall Study||2
5070691|NCT01810016|12477310|P1|STARTED|Overall Study||5
5070692|NCT01809938|12477321|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
5070693|NCT01809938|12477322|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
5070694|NCT01809938|12477321|P2|COMPLETED|Second Intervention (170 Minutes)||5
5070695|NCT01809938|12477322|P1|COMPLETED|Second Intervention (170 Minutes)||5
5070696|NCT01809938|12477321|P2|STARTED|Second Intervention (170 Minutes)||5
5070697|NCT01809938|12477322|P1|STARTED|Second Intervention (170 Minutes)||5
5070698|NCT01809938|12477321|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
5070699|NCT01809938|12477322|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
5070700|NCT01809938|12477321|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
5070701|NCT01809938|12477322|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
5070702|NCT01809938|12477321|P2|STARTED|Washout (Not Less Than 24 Hours)||5
5070703|NCT01809938|12477322|P1|STARTED|Washout (Not Less Than 24 Hours)||5
5070704|NCT01809938|12477321|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
5070705|NCT01809938|12477322|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
5070706|NCT01809938|12477321|P2|COMPLETED|First Intervention (170 Minutes)||5
5070707|NCT01809938|12477322|P1|COMPLETED|First Intervention (170 Minutes)||5
5070708|NCT01809938|12477321|P2|STARTED|First Intervention (170 Minutes)||5
5070709|NCT01809938|12477322|P1|STARTED|First Intervention (170 Minutes)||5
5070710|NCT01809899|12477331|P2|NOT COMPLETED|Overall Study||0
5070711|NCT01809899|12477332|P1|NOT COMPLETED|Overall Study||0
5070712|NCT01809899|12477331|P2|COMPLETED|Overall Study||4
5070713|NCT01809899|12477332|P1|COMPLETED|Overall Study||8
5070714|NCT01809899|12477331|P2|STARTED|Overall Study||4
5070715|NCT01809899|12477332|P1|STARTED|Overall Study||8
5070716|NCT01809834|12477340|P1|NOT COMPLETED|Overall Study||0
5070717|NCT01809834|12477340|P1|COMPLETED|Overall Study||44
5070718|NCT01809834|12477340|P1|STARTED|Overall Study||44
5070719|NCT01809639|12477368|P2|NOT COMPLETED|Overall Study||0
5070720|NCT01809639|12477369|P1|NOT COMPLETED|Overall Study||0
5070721|NCT01809639|12477368|P2|COMPLETED|Overall Study||7
5070722|NCT01809639|12477369|P1|COMPLETED|Overall Study||18
5070723|NCT01809639|12477368|P2|STARTED|Overall Study||7
5070724|NCT01809639|12477369|P1|STARTED|Overall Study||18
5070725|NCT01809327|12477380|P5|NOT COMPLETED|Overall Study||25
5070726|NCT01809327|12477381|P4|NOT COMPLETED|Overall Study||12
5070727|NCT01809327|12477382|P3|NOT COMPLETED|Overall Study||22
5070728|NCT01809327|12477383|P2|NOT COMPLETED|Overall Study||26
5070729|NCT01809327|12477384|P1|NOT COMPLETED|Overall Study||32
5070730|NCT01809327|12477380|P5|COMPLETED|Overall Study||212
5070731|NCT01809327|12477381|P4|COMPLETED|Overall Study||225
5070732|NCT01809327|12477382|P3|COMPLETED|Overall Study||216
5070733|NCT01809327|12477383|P2|COMPLETED|Overall Study||211
5070734|NCT01809327|12477384|P1|COMPLETED|Overall Study||205
5070735|NCT01809327|12477380|P5|STARTED|Overall Study||237
5070736|NCT01809327|12477381|P4|STARTED|Overall Study||237
5070737|NCT01809327|12477382|P3|STARTED|Overall Study||238
5070738|NCT01809327|12477383|P2|STARTED|Overall Study||237
5070739|NCT01809327|12477384|P1|STARTED|Overall Study||237
5070740|NCT01809314|12477426|P1|NOT COMPLETED|Overall Study||745
5070741|NCT01809314|12477426|P1|COMPLETED|Overall Study||422
5070742|NCT01809314|12477426|P1|STARTED|Overall Study||1167
5070743|NCT01809262|12477432|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070744|NCT01809262|12477433|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070745|NCT01809262|12477434|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070746|NCT01809262|12477435|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070747|NCT01809262|12477436|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070748|NCT01809262|12477437|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070749|NCT01809262|12477438|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070750|NCT01809262|12477439|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070751|NCT01809262|12477440|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070752|NCT01809262|12477441|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
5070753|NCT01809262|12477432|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
5070754|NCT01809262|12477433|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070755|NCT01809262|12477434|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
5070756|NCT01809262|12477435|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070757|NCT01809262|12477436|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070758|NCT01809262|12477437|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070759|NCT01809262|12477438|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070760|NCT01809262|12477439|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
5070761|NCT01809262|12477440|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
5070762|NCT01809262|12477441|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
5070763|NCT01809262|12477432|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
5070764|NCT01809262|12477433|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
5070765|NCT01809262|12477434|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
5070766|NCT01809262|12477435|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
5070767|NCT01809262|12477436|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
5070768|NCT01809262|12477437|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
5070769|NCT01809262|12477438|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
5070770|NCT01809262|12477439|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
5070771|NCT01809262|12477440|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
5070772|NCT01809262|12477441|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
5070773|NCT01809262|12477432|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070774|NCT01809262|12477433|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070775|NCT01809262|12477434|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070776|NCT01809262|12477435|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070777|NCT01809262|12477436|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070778|NCT01809262|12477437|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070779|NCT01809262|12477438|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070780|NCT01809262|12477439|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070781|NCT01809262|12477440|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070782|NCT01809262|12477441|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
5070783|NCT01809262|12477432|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
5070784|NCT01809262|12477433|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070785|NCT01809262|12477434|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
5070786|NCT01809262|12477435|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070787|NCT01809262|12477436|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070788|NCT01809262|12477437|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070789|NCT01809262|12477438|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070790|NCT01809262|12477439|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
5070791|NCT01809262|12477440|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
5070792|NCT01809262|12477441|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
5070793|NCT01809262|12477432|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
5070794|NCT01809262|12477433|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
5070795|NCT01809262|12477434|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
5070796|NCT01809262|12477435|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
5070797|NCT01809262|12477436|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
5070798|NCT01809262|12477437|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
5070799|NCT01809262|12477438|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
5070800|NCT01809262|12477439|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
5070801|NCT01809262|12477440|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
5070802|NCT01809262|12477441|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
5070803|NCT01809262|12477432|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070804|NCT01809262|12477433|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070805|NCT01809262|12477434|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070806|NCT01809262|12477435|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070807|NCT01809262|12477436|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070808|NCT01809262|12477437|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070809|NCT01809262|12477438|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070810|NCT01809262|12477439|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070811|NCT01809262|12477440|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
5070812|NCT01809262|12477441|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
5070813|NCT01809262|12477432|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
5070814|NCT01809262|12477433|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
5070815|NCT01809262|12477434|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
5070816|NCT01809262|12477435|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
5070817|NCT01809262|12477436|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
5070818|NCT01809262|12477437|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
5070819|NCT01809262|12477438|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
5070820|NCT01809262|12477439|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
5070821|NCT01809262|12477440|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
5070822|NCT01809262|12477441|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
5070823|NCT01809262|12477432|P10|STARTED|Period 3 (Third Dose + Washout)||4
5070824|NCT01809262|12477433|P9|STARTED|Period 3 (Third Dose + Washout)||3
5070825|NCT01809262|12477434|P8|STARTED|Period 3 (Third Dose + Washout)||4
5070826|NCT01809262|12477435|P7|STARTED|Period 3 (Third Dose + Washout)||3
5070827|NCT01809262|12477436|P6|STARTED|Period 3 (Third Dose + Washout)||3
5070828|NCT01809262|12477437|P5|STARTED|Period 3 (Third Dose + Washout)||3
5070829|NCT01809262|12477438|P4|STARTED|Period 3 (Third Dose + Washout)||3
5070830|NCT01809262|12477439|P3|STARTED|Period 3 (Third Dose + Washout)||4
5070831|NCT01809262|12477440|P2|STARTED|Period 3 (Third Dose + Washout)||4
5070832|NCT01809262|12477441|P1|STARTED|Period 3 (Third Dose + Washout)||4
5070833|NCT01809262|12477432|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070834|NCT01809262|12477433|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070835|NCT01809262|12477434|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070836|NCT01809262|12477435|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070837|NCT01809262|12477436|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070838|NCT01809262|12477437|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070839|NCT01809262|12477438|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070840|NCT01809262|12477439|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070841|NCT01809262|12477440|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070842|NCT01809262|12477441|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
5070843|NCT01809262|12477432|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
5070844|NCT01809262|12477433|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
5070845|NCT01809262|12477434|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
5070846|NCT01809262|12477435|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
5070847|NCT01809262|12477436|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
5070848|NCT01809262|12477437|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
5070849|NCT01809262|12477438|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
5070850|NCT01809262|12477439|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
5070851|NCT01809262|12477440|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
5070852|NCT01809262|12477441|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
5070853|NCT01809262|12477432|P10|STARTED|Period 2 (Second Dose + Washout)||4
5070854|NCT01809262|12477433|P9|STARTED|Period 2 (Second Dose + Washout)||3
5070855|NCT01809262|12477434|P8|STARTED|Period 2 (Second Dose + Washout)||4
5070856|NCT01809262|12477435|P7|STARTED|Period 2 (Second Dose + Washout)||3
5070857|NCT01809262|12477436|P6|STARTED|Period 2 (Second Dose + Washout)||3
5070858|NCT01809262|12477437|P5|STARTED|Period 2 (Second Dose + Washout)||3
5070859|NCT01809262|12477438|P4|STARTED|Period 2 (Second Dose + Washout)||3
5070860|NCT01809262|12477439|P3|STARTED|Period 2 (Second Dose + Washout)||4
5070861|NCT01809262|12477440|P2|STARTED|Period 2 (Second Dose + Washout)||4
5070862|NCT01809262|12477441|P1|STARTED|Period 2 (Second Dose + Washout)||4
5070863|NCT01809262|12477432|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070864|NCT01809262|12477433|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070865|NCT01809262|12477434|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070866|NCT01809262|12477435|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070867|NCT01809262|12477436|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070868|NCT01809262|12477437|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
5070869|NCT01809262|12477438|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070870|NCT01809262|12477439|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070871|NCT01809262|12477440|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070872|NCT01809262|12477441|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
5070873|NCT01809262|12477432|P10|COMPLETED|Period 1 (First Dose + Washout)||4
5070874|NCT01809262|12477433|P9|COMPLETED|Period 1 (First Dose + Washout)||3
5070875|NCT01809262|12477434|P8|COMPLETED|Period 1 (First Dose + Washout)||4
5070876|NCT01809262|12477435|P7|COMPLETED|Period 1 (First Dose + Washout)||3
5070877|NCT01809262|12477436|P6|COMPLETED|Period 1 (First Dose + Washout)||3
5070878|NCT01809262|12477437|P5|COMPLETED|Period 1 (First Dose + Washout)||3
5070879|NCT01809262|12477438|P4|COMPLETED|Period 1 (First Dose + Washout)||3
5070880|NCT01809262|12477439|P3|COMPLETED|Period 1 (First Dose + Washout)||4
5070881|NCT01809262|12477440|P2|COMPLETED|Period 1 (First Dose + Washout)||4
5070882|NCT01809262|12477441|P1|COMPLETED|Period 1 (First Dose + Washout)||4
5070883|NCT01809262|12477432|P10|STARTED|Period 1 (First Dose + Washout)||4
5070884|NCT01809262|12477433|P9|STARTED|Period 1 (First Dose + Washout)||3
5070885|NCT01809262|12477434|P8|STARTED|Period 1 (First Dose + Washout)||4
5070886|NCT01809262|12477435|P7|STARTED|Period 1 (First Dose + Washout)||3
5070887|NCT01809262|12477436|P6|STARTED|Period 1 (First Dose + Washout)||3
5070888|NCT01809262|12477437|P5|STARTED|Period 1 (First Dose + Washout)||4
5070889|NCT01809262|12477438|P4|STARTED|Period 1 (First Dose + Washout)||3
5070890|NCT01809262|12477439|P3|STARTED|Period 1 (First Dose + Washout)||4
5070891|NCT01809262|12477440|P2|STARTED|Period 1 (First Dose + Washout)||4
5070892|NCT01809262|12477441|P1|STARTED|Period 1 (First Dose + Washout)||4
5070893|NCT01809210|12477515|P7|NOT COMPLETED|Overall Study||5
5070894|NCT01809210|12477516|P6|NOT COMPLETED|Overall Study||3
5070895|NCT01809210|12477517|P5|NOT COMPLETED|Overall Study||2
5070896|NCT01809210|12477518|P4|NOT COMPLETED|Overall Study||1
5070897|NCT01809210|12477519|P3|NOT COMPLETED|Overall Study||3
5070898|NCT01809210|12477520|P2|NOT COMPLETED|Overall Study||1
5070899|NCT01809210|12477521|P1|NOT COMPLETED|Overall Study||1
5070900|NCT01809210|12477515|P7|COMPLETED|Overall Study||7
5070901|NCT01809210|12477516|P6|COMPLETED|Overall Study||12
5070902|NCT01809210|12477517|P5|COMPLETED|Overall Study||4
5070903|NCT01809210|12477518|P4|COMPLETED|Overall Study||2
5070904|NCT01809210|12477519|P3|COMPLETED|Overall Study||4
5070905|NCT01809210|12477520|P2|COMPLETED|Overall Study||8
5070906|NCT01809210|12477521|P1|COMPLETED|Overall Study||2
5070907|NCT01809210|12477515|P7|STARTED|Overall Study||12
5070908|NCT01809210|12477516|P6|STARTED|Overall Study||15
5070909|NCT01809210|12477517|P5|STARTED|Overall Study||6
5070910|NCT01809210|12477518|P4|STARTED|Overall Study||3
5070911|NCT01809210|12477519|P3|STARTED|Overall Study||7
5070912|NCT01809210|12477520|P2|STARTED|Overall Study||9
5070913|NCT01809210|12477521|P1|STARTED|Overall Study||3
5070914|NCT01809197|12477595|P2|NOT COMPLETED|Overall Study||8
5070915|NCT01809197|12477596|P1|NOT COMPLETED|Overall Study||10
5070916|NCT01809197|12477595|P2|COMPLETED|Overall Study||177
5070917|NCT01809197|12477596|P1|COMPLETED|Overall Study||177
5070918|NCT01809197|12477595|P2|STARTED|Overall Study||185
5070919|NCT01809197|12477596|P1|STARTED|Overall Study||187
5070920|NCT01809106|12477606|P4|NOT COMPLETED|Overall Study||4
5070921|NCT01809106|12477607|P3|NOT COMPLETED|Overall Study||3
5070922|NCT01809106|12477608|P2|NOT COMPLETED|Overall Study||5
5070923|NCT01809106|12477609|P1|NOT COMPLETED|Overall Study||8
5070924|NCT01809106|12477606|P4|COMPLETED|Overall Study||124
5070925|NCT01809106|12477607|P3|COMPLETED|Overall Study||127
5070926|NCT01809106|12477608|P2|COMPLETED|Overall Study||125
5070927|NCT01809106|12477609|P1|COMPLETED|Overall Study||122
5070928|NCT01809106|12477606|P4|STARTED|Overall Study||128
5070929|NCT01809106|12477607|P3|STARTED|Overall Study||130
5070930|NCT01809106|12477608|P2|STARTED|Overall Study||130
5070931|NCT01809106|12477609|P1|STARTED|Overall Study||130
5070932|NCT01809054|12477629|P2|NOT COMPLETED|Overall Study||0
5070933|NCT01809054|12477630|P1|NOT COMPLETED|Overall Study||0
5070934|NCT01809054|12477629|P2|COMPLETED|Overall Study||22
5070935|NCT01809054|12477630|P1|COMPLETED|Overall Study||27
5070936|NCT01809054|12477629|P2|STARTED|Overall Study||22
5070937|NCT01809054|12477630|P1|STARTED|Overall Study||27
5070938|NCT01808963|12477638|P1|NOT COMPLETED|Overall Study||0
5070939|NCT01808963|12477638|P1|COMPLETED|Overall Study||13
5070940|NCT01808963|12477638|P1|STARTED|Overall Study||13
5070941|NCT01808950|12477645|P3|NOT COMPLETED|Overall Study||0
5070942|NCT01808950|12477646|P2|NOT COMPLETED|Overall Study||0
5070943|NCT01808950|12477647|P1|NOT COMPLETED|Overall Study||0
5070944|NCT01808950|12477645|P3|COMPLETED|Overall Study||0
5070945|NCT01808950|12477646|P2|COMPLETED|Overall Study||3
5070946|NCT01808950|12477647|P1|COMPLETED|Overall Study||1
5070947|NCT01808950|12477645|P3|STARTED|Overall Study||0
5070948|NCT01808950|12477646|P2|STARTED|Overall Study||3
5070949|NCT01808950|12477647|P1|STARTED|Overall Study||1
5070950|NCT01808794|12477660|P2|NOT COMPLETED|Overall Study||0
5070951|NCT01808794|12477661|P1|NOT COMPLETED|Overall Study||0
5070952|NCT01808794|12477660|P2|COMPLETED|Overall Study||0
5070953|NCT01808794|12477661|P1|COMPLETED|Overall Study||0
5070954|NCT01808794|12477660|P2|STARTED|Overall Study||0
5070955|NCT01808794|12477661|P1|STARTED|Overall Study||0
5070956|NCT01808755|12477669|P2|NOT COMPLETED|Overall Study||0
5070957|NCT01808755|12477670|P1|NOT COMPLETED|Overall Study||0
5070958|NCT01808755|12477669|P2|COMPLETED|Overall Study||30
5070959|NCT01808755|12477670|P1|COMPLETED|Overall Study||30
5070960|NCT01808755|12477669|P2|STARTED|Overall Study||30
5070961|NCT01808755|12477670|P1|STARTED|Overall Study||30
5070962|NCT01808690|12477677|P2|NOT COMPLETED|Overall Study||2
5070963|NCT01808690|12477678|P1|NOT COMPLETED|Overall Study||1
5070964|NCT01808690|12477677|P2|COMPLETED|Overall Study||21
5070965|NCT01808690|12477678|P1|COMPLETED|Overall Study||24
5070966|NCT01808690|12477677|P2|STARTED|Overall Study||23
5070967|NCT01808690|12477678|P1|STARTED|Overall Study||25
5070968|NCT01808651|12477697|P3|NOT COMPLETED|Study Period 2||0
5070969|NCT01808651|12477698|P2|NOT COMPLETED|Study Period 2||0
5070970|NCT01808651|12477699|P1|NOT COMPLETED|Study Period 2||0
5070971|NCT01808651|12477697|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
5070972|NCT01808651|12477698|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
5070973|NCT01808651|12477699|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
5070974|NCT01808651|12477697|P3|STARTED|Study Period 2||33
5070975|NCT01808651|12477698|P2|STARTED|Study Period 2||52
5070976|NCT01808651|12477699|P1|STARTED|Study Period 2||77
5070977|NCT01808651|12477697|P3|NOT COMPLETED|Study Period 1||5
5070978|NCT01808651|12477698|P2|NOT COMPLETED|Study Period 1||17
5070979|NCT01808651|12477699|P1|NOT COMPLETED|Study Period 1||26
5070980|NCT01808651|12477697|P3|COMPLETED|Study Period 1||31
5070981|NCT01808651|12477698|P2|COMPLETED|Study Period 1||48
5070982|NCT01808651|12477699|P1|COMPLETED|Study Period 1||73
5070983|NCT01808651|12477697|P3|Received at Least One Dose of Study Drug|Study Period 1||36
5070984|NCT01808651|12477698|P2|Received at Least One Dose of Study Drug|Study Period 1||65
5070985|NCT01808651|12477699|P1|Received at Least One Dose of Study Drug|Study Period 1||98
5070986|NCT01808651|12477697|P3|STARTED|Study Period 1||36
5070987|NCT01808651|12477698|P2|STARTED|Study Period 1||65
5070988|NCT01808651|12477699|P1|STARTED|Study Period 1||99
5070989|NCT01808612|12477734|P3|NOT COMPLETED|Discontinuation Period||0
5070990|NCT01808612|12477735|P2|NOT COMPLETED|Discontinuation Period||1
5070991|NCT01808612|12477736|P1|NOT COMPLETED|Discontinuation Period||2
5070992|NCT01808612|12477734|P3|COMPLETED|Discontinuation Period||145
5070993|NCT01808612|12477735|P2|COMPLETED|Discontinuation Period||37
5070994|NCT01808612|12477736|P1|COMPLETED|Discontinuation Period||85
5070995|NCT01808612|12477734|P3|STARTED|Discontinuation Period||145
5070996|NCT01808612|12477735|P2|STARTED|Discontinuation Period||38
5070997|NCT01808612|12477736|P1|STARTED|Discontinuation Period||87
5070998|NCT01808612|12477734|P3|NOT COMPLETED|Treatment Period||14
5070999|NCT01808612|12477735|P2|NOT COMPLETED|Treatment Period||7
5071000|NCT01808612|12477736|P1|NOT COMPLETED|Treatment Period||15
5071001|NCT01808612|12477734|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
5071002|NCT01808612|12477735|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
5071003|NCT01808612|12477736|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
5071004|NCT01808612|12477734|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
5071005|NCT01808612|12477735|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
5071006|NCT01808612|12477736|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
5071007|NCT01808612|12477734|P3|STARTED|Treatment Period||260
5071008|NCT01808612|12477735|P2|STARTED|Treatment Period||84
5071009|NCT01808612|12477736|P1|STARTED|Treatment Period||169
5071010|NCT01808573|12477767|P2|NOT COMPLETED|Overall Study||314
5071011|NCT01808573|12477768|P1|NOT COMPLETED|Overall Study||307
5071012|NCT01808573|12477767|P2|COMPLETED|Overall Study||0
5071013|NCT01808573|12477768|P1|COMPLETED|Overall Study||0
5071014|NCT01808573|12477767|P2|Received Treatment|Overall Study||311
5071015|NCT01808573|12477768|P1|Received Treatment|Overall Study||303
5071016|NCT01808573|12477767|P2|STARTED|Overall Study||314
5071017|NCT01808573|12477768|P1|STARTED|Overall Study||307
5071018|NCT01808560|12477789|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
5071019|NCT01808560|12477790|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
5071020|NCT01808560|12477791|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
5071021|NCT01808560|12477789|P3|COMPLETED|4-Month After Cataract Surgery||13
5071022|NCT01808560|12477790|P2|COMPLETED|4-Month After Cataract Surgery||0
5071023|NCT01808560|12477791|P1|COMPLETED|4-Month After Cataract Surgery||0
5071024|NCT01808560|12477789|P3|STARTED|4-Month After Cataract Surgery||13
5071025|NCT01808560|12477790|P2|STARTED|4-Month After Cataract Surgery||0
5071026|NCT01808560|12477791|P1|STARTED|4-Month After Cataract Surgery||0
5071027|NCT01808560|12477789|P3|NOT COMPLETED|Crossover Treatment||0
5071028|NCT01808560|12477790|P2|NOT COMPLETED|Crossover Treatment||0
5071029|NCT01808560|12477791|P1|NOT COMPLETED|Crossover Treatment||0
5071030|NCT01808560|12477789|P3|COMPLETED|Crossover Treatment||13
5071031|NCT01808560|12477790|P2|COMPLETED|Crossover Treatment||0
5071032|NCT01808560|12477791|P1|COMPLETED|Crossover Treatment||0
5071033|NCT01808560|12477789|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
5071034|NCT01808560|12477790|P2|STARTED|Crossover Treatment||0
5071035|NCT01808560|12477791|P1|STARTED|Crossover Treatment||0
5071036|NCT01808560|12477789|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
5071037|NCT01808560|12477790|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
5071038|NCT01808560|12477791|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
5071039|NCT01808560|12477789|P3|COMPLETED|3-Month After Cataract Surgery||0
5071040|NCT01808560|12477790|P2|COMPLETED|3-Month After Cataract Surgery||13
5071041|NCT01808560|12477791|P1|COMPLETED|3-Month After Cataract Surgery||17
5071042|NCT01808560|12477789|P3|STARTED|3-Month After Cataract Surgery||0
5071043|NCT01808560|12477790|P2|STARTED|3-Month After Cataract Surgery||13
5071044|NCT01808560|12477791|P1|STARTED|3-Month After Cataract Surgery||17
5071045|NCT01808560|12477789|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
5071046|NCT01808560|12477790|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
5071047|NCT01808560|12477791|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
5071048|NCT01808560|12477789|P3|COMPLETED|1-Month After Cataract Surgery||0
5071049|NCT01808560|12477790|P2|COMPLETED|1-Month After Cataract Surgery||13
5071050|NCT01808560|12477791|P1|COMPLETED|1-Month After Cataract Surgery||16
5071051|NCT01808560|12477789|P3|STARTED|1-Month After Cataract Surgery||0
5071052|NCT01808560|12477790|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
5071053|NCT01808560|12477791|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
5071054|NCT01808560|12477789|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
5071055|NCT01808560|12477790|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
5071056|NCT01808560|12477791|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
5071057|NCT01808560|12477789|P3|COMPLETED|Randomization and Treatment Allocation||0
5071058|NCT01808560|12477790|P2|COMPLETED|Randomization and Treatment Allocation||16
5071059|NCT01808560|12477791|P1|COMPLETED|Randomization and Treatment Allocation||18
5071060|NCT01808560|12477789|P3|STARTED|Randomization and Treatment Allocation||0
5071061|NCT01808560|12477790|P2|STARTED|Randomization and Treatment Allocation||16
5071062|NCT01808560|12477791|P1|STARTED|Randomization and Treatment Allocation||18
5071063|NCT01808547|12477816|P2|NOT COMPLETED|Overall Study||46
5071064|NCT01808547|12477817|P1|NOT COMPLETED|Overall Study||37
5071065|NCT01808547|12477816|P2|COMPLETED|Overall Study||48
5071066|NCT01808547|12477817|P1|COMPLETED|Overall Study||137
5071067|NCT01808547|12477816|P2|mITT Population|Overall Study||85
5071068|NCT01808547|12477817|P1|mITT Population|Overall Study||168
5071069|NCT01808547|12477816|P2|Safety Population|Overall Study||85
5071070|NCT01808547|12477817|P1|Safety Population|Overall Study||170
5071071|NCT01808547|12477816|P2|STARTED|Overall Study||94
5071072|NCT01808547|12477817|P1|STARTED|Overall Study||174
5071073|NCT01808534|12477823|P1|NOT COMPLETED|Overall Study||4
5071074|NCT01808534|12477823|P1|COMPLETED|Overall Study||1
5071075|NCT01808534|12477823|P1|STARTED|Overall Study||5
5071076|NCT01808508|12477834|P3|NOT COMPLETED|Overall Study||0
5071077|NCT01808508|12477835|P2|NOT COMPLETED|Overall Study||0
5071078|NCT01808508|12477836|P1|NOT COMPLETED|Overall Study||1
5071079|NCT01808508|12477834|P3|COMPLETED|Overall Study||3
5071080|NCT01808508|12477835|P2|COMPLETED|Overall Study||9
5071081|NCT01808508|12477836|P1|COMPLETED|Overall Study||10
5071082|NCT01808508|12477834|P3|STARTED|Overall Study||3
5071083|NCT01808508|12477835|P2|STARTED|Overall Study||9
5071084|NCT01808508|12477836|P1|STARTED|Overall Study||11
5071085|NCT01808339|12477853|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5071086|NCT01808339|12477854|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5071087|NCT01808339|12477855|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5071088|NCT01808339|12477856|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5071089|NCT01808339|12477857|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5071090|NCT01808339|12477858|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5071091|NCT01808339|12477853|P6|COMPLETED|Treatment Period 3 (14 Days)||5
5071092|NCT01808339|12477854|P5|COMPLETED|Treatment Period 3 (14 Days)||4
5071093|NCT01808339|12477855|P4|COMPLETED|Treatment Period 3 (14 Days)||2
5071094|NCT01808339|12477856|P3|COMPLETED|Treatment Period 3 (14 Days)||3
5071095|NCT01808339|12477857|P2|COMPLETED|Treatment Period 3 (14 Days)||3
5071096|NCT01808339|12477858|P1|COMPLETED|Treatment Period 3 (14 Days)||4
5071097|NCT01808339|12477853|P6|STARTED|Treatment Period 3 (14 Days)||5
5071098|NCT01808339|12477854|P5|STARTED|Treatment Period 3 (14 Days)||4
5071099|NCT01808339|12477855|P4|STARTED|Treatment Period 3 (14 Days)||2
5071100|NCT01808339|12477856|P3|STARTED|Treatment Period 3 (14 Days)||4
5071101|NCT01808339|12477857|P2|STARTED|Treatment Period 3 (14 Days)||3
5071102|NCT01808339|12477858|P1|STARTED|Treatment Period 3 (14 Days)||4
5071103|NCT01808339|12477853|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071104|NCT01808339|12477854|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071105|NCT01808339|12477855|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071106|NCT01808339|12477856|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071107|NCT01808339|12477857|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071108|NCT01808339|12477858|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
5071109|NCT01808339|12477853|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
5071110|NCT01808339|12477854|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
5071111|NCT01808339|12477855|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
5071112|NCT01808339|12477856|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
5071113|NCT01808339|12477857|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
5071114|NCT01808339|12477858|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
5071115|NCT01808339|12477853|P6|STARTED|Washout Period 2 (14-21 Days)||5
5071116|NCT01808339|12477854|P5|STARTED|Washout Period 2 (14-21 Days)||4
5071117|NCT01808339|12477855|P4|STARTED|Washout Period 2 (14-21 Days)||2
5071118|NCT01808339|12477856|P3|STARTED|Washout Period 2 (14-21 Days)||4
5071119|NCT01808339|12477857|P2|STARTED|Washout Period 2 (14-21 Days)||3
5071120|NCT01808339|12477858|P1|STARTED|Washout Period 2 (14-21 Days)||4
5071121|NCT01808339|12477853|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071122|NCT01808339|12477854|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071123|NCT01808339|12477855|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071124|NCT01808339|12477856|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071125|NCT01808339|12477857|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071126|NCT01808339|12477858|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5071127|NCT01808339|12477853|P6|COMPLETED|Treatment Period 2 (14 Days)||5
5071128|NCT01808339|12477854|P5|COMPLETED|Treatment Period 2 (14 Days)||4
5071129|NCT01808339|12477855|P4|COMPLETED|Treatment Period 2 (14 Days)||2
5071130|NCT01808339|12477856|P3|COMPLETED|Treatment Period 2 (14 Days)||4
5071131|NCT01808339|12477857|P2|COMPLETED|Treatment Period 2 (14 Days)||3
5071132|NCT01808339|12477858|P1|COMPLETED|Treatment Period 2 (14 Days)||4
5071133|NCT01808339|12477853|P6|STARTED|Treatment Period 2 (14 Days)||5
5071134|NCT01808339|12477854|P5|STARTED|Treatment Period 2 (14 Days)||4
5071135|NCT01808339|12477855|P4|STARTED|Treatment Period 2 (14 Days)||2
5071136|NCT01808339|12477856|P3|STARTED|Treatment Period 2 (14 Days)||4
5071137|NCT01808339|12477857|P2|STARTED|Treatment Period 2 (14 Days)||3
5071138|NCT01808339|12477858|P1|STARTED|Treatment Period 2 (14 Days)||4
5071139|NCT01808339|12477853|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071140|NCT01808339|12477854|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071141|NCT01808339|12477855|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071142|NCT01808339|12477856|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071143|NCT01808339|12477857|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071144|NCT01808339|12477858|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
5071145|NCT01808339|12477853|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
5071146|NCT01808339|12477854|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
5071147|NCT01808339|12477855|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
5071148|NCT01808339|12477856|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
5071149|NCT01808339|12477857|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
5071150|NCT01808339|12477858|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
5071151|NCT01808339|12477853|P6|STARTED|Washout Period 1 (14-21 Days)||5
5071152|NCT01808339|12477854|P5|STARTED|Washout Period 1 (14-21 Days)||4
5071153|NCT01808339|12477855|P4|STARTED|Washout Period 1 (14-21 Days)||2
5071154|NCT01808339|12477856|P3|STARTED|Washout Period 1 (14-21 Days)||4
5071155|NCT01808339|12477857|P2|STARTED|Washout Period 1 (14-21 Days)||3
5071156|NCT01808339|12477858|P1|STARTED|Washout Period 1 (14-21 Days)||4
5071157|NCT01808339|12477853|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5071158|NCT01808339|12477854|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5071159|NCT01808339|12477855|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5071160|NCT01808339|12477856|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5071161|NCT01808339|12477857|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5071162|NCT01808339|12477858|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5071163|NCT01808339|12477853|P6|COMPLETED|Treatment Period 1 (14 Days)||5
5071164|NCT01808339|12477854|P5|COMPLETED|Treatment Period 1 (14 Days)||4
5071165|NCT01808339|12477855|P4|COMPLETED|Treatment Period 1 (14 Days)||2
5071166|NCT01808339|12477856|P3|COMPLETED|Treatment Period 1 (14 Days)||4
5071167|NCT01808339|12477857|P2|COMPLETED|Treatment Period 1 (14 Days)||3
5071168|NCT01808339|12477858|P1|COMPLETED|Treatment Period 1 (14 Days)||4
5071169|NCT01808339|12477853|P6|STARTED|Treatment Period 1 (14 Days)||6
5071170|NCT01808339|12477854|P5|STARTED|Treatment Period 1 (14 Days)||6
5071171|NCT01808339|12477855|P4|STARTED|Treatment Period 1 (14 Days)||4
5071172|NCT01808339|12477856|P3|STARTED|Treatment Period 1 (14 Days)||4
5071173|NCT01808339|12477857|P2|STARTED|Treatment Period 1 (14 Days)||4
5071174|NCT01808339|12477858|P1|STARTED|Treatment Period 1 (14 Days)||4
5071175|NCT01808326|12477875|P1|NOT COMPLETED|Overall Study||0
5071176|NCT01808326|12477875|P1|COMPLETED|Overall Study||5
5071177|NCT01808326|12477875|P1|STARTED|Overall Study||5
5071178|NCT01808313|12477902|P1|NOT COMPLETED|Overall Study||10
5071179|NCT01808313|12477902|P1|COMPLETED|Overall Study||123
5071180|NCT01808313|12477902|P1|STARTED|Overall Study||133
5071181|NCT01808261|12477932|P2|NOT COMPLETED|Overall Study||33
5071182|NCT01808261|12477933|P1|NOT COMPLETED|Overall Study||36
5071183|NCT01808261|12477932|P2|COMPLETED|Overall Study||32
5071184|NCT01808261|12477933|P1|COMPLETED|Overall Study||32
5071185|NCT01808261|12477932|P2|STARTED|Overall Study||65
5071186|NCT01808261|12477933|P1|STARTED|Overall Study||68
5071187|NCT01808248|12477989|P1|NOT COMPLETED|Overall Study||5
5071188|NCT01808248|12477989|P1|COMPLETED|Overall Study||42
5071189|NCT01808248|12477989|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
5071190|NCT01808248|12477989|P1|STARTED|Overall Study||47
5071191|NCT01808222|12478001|P1|NOT COMPLETED|Overall Study||1
5071192|NCT01808222|12478001|P1|COMPLETED|Overall Study||24
5071193|NCT01808222|12478001|P1|Completed mpMR Scan|Overall Study||24
5071194|NCT01808222|12478001|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
5071195|NCT01808222|12478001|P1|STARTED|Overall Study||25
5071196|NCT01808209|12478008|P2|NOT COMPLETED|Overall Study||1
5071197|NCT01808209|12478009|P1|NOT COMPLETED|Overall Study||0
5071198|NCT01808209|12478008|P2|COMPLETED|Overall Study||26
5071199|NCT01808209|12478009|P1|COMPLETED|Overall Study||33
5071200|NCT01808209|12478008|P2|STARTED|Overall Study||27
5071201|NCT01808209|12478009|P1|STARTED|Overall Study||33
5071202|NCT01808144|12478053|P2|NOT COMPLETED|Overall Study||48
5071203|NCT01808144|12478054|P1|NOT COMPLETED|Overall Study||40
5071204|NCT01808144|12478053|P2|COMPLETED|Overall Study||51
5071205|NCT01808144|12478054|P1|COMPLETED|Overall Study||57
5071206|NCT01808144|12478053|P2|STARTED|Overall Study||99
5071207|NCT01808144|12478054|P1|STARTED|Overall Study||97
5071208|NCT01808118|12478062|P3|NOT COMPLETED|Period 2||8
5071209|NCT01808118|12478063|P2|NOT COMPLETED|Period 2||13
5071210|NCT01808118|12478064|P1|NOT COMPLETED|Period 2||0
5071211|NCT01808118|12478062|P3|COMPLETED|Period 2||144
5071212|NCT01808118|12478063|P2|COMPLETED|Period 2||140
5071213|NCT01808118|12478064|P1|COMPLETED|Period 2||0
5071214|NCT01808118|12478062|P3|STARTED|Period 2||152
5071215|NCT01808118|12478063|P2|STARTED|Period 2||153
5071216|NCT01808118|12478064|P1|STARTED|Period 2||0
5071217|NCT01808118|12478062|P3|NOT COMPLETED|Period 1||0
5071218|NCT01808118|12478063|P2|NOT COMPLETED|Period 1||0
5071219|NCT01808118|12478064|P1|NOT COMPLETED|Period 1||368
5071220|NCT01808118|12478062|P3|COMPLETED|Period 1||0
5071221|NCT01808118|12478063|P2|COMPLETED|Period 1||0
5071222|NCT01808118|12478064|P1|COMPLETED|Period 1||305
5071223|NCT01808118|12478062|P3|STARTED|Period 1||0
5071224|NCT01808118|12478063|P2|STARTED|Period 1||0
5071225|NCT01808118|12478064|P1|STARTED|Period 1||673
5071226|NCT01808092|12478127|P2|NOT COMPLETED|Overall Study||45
5071227|NCT01808092|12478128|P1|NOT COMPLETED|Overall Study||54
5071228|NCT01808092|12478127|P2|COMPLETED|Overall Study||363
5071229|NCT01808092|12478128|P1|COMPLETED|Overall Study||355
5071230|NCT01808092|12478127|P2|STARTED|Overall Study||408
5071231|NCT01808092|12478128|P1|STARTED|Overall Study||409
5071232|NCT01808066|12478230|P1|NOT COMPLETED|Overall Study||15
5071233|NCT01808066|12478230|P1|COMPLETED|Overall Study||6
5071234|NCT01808066|12478230|P1|STARTED|Overall Study||21
5071235|NCT01807949|12478241|P3|NOT COMPLETED|Overall Study||9
5071236|NCT01807949|12478242|P2|NOT COMPLETED|Overall Study||7
5071237|NCT01807949|12478243|P1|NOT COMPLETED|Overall Study||2
5071238|NCT01807949|12478241|P3|COMPLETED|Overall Study||180
5071239|NCT01807949|12478242|P2|COMPLETED|Overall Study||180
5071240|NCT01807949|12478243|P1|COMPLETED|Overall Study||185
5071241|NCT01807949|12478241|P3|STARTED|Overall Study||189
5071242|NCT01807949|12478242|P2|STARTED|Overall Study||187
5071243|NCT01807949|12478243|P1|STARTED|Overall Study||187
5071244|NCT01807923|12478295|P3|NOT COMPLETED|Overall Study||11
5071245|NCT01807923|12478296|P2|NOT COMPLETED|Overall Study||6
5071246|NCT01807923|12478297|P1|NOT COMPLETED|Overall Study||5
5071247|NCT01807923|12478295|P3|COMPLETED|Overall Study||176
5071248|NCT01807923|12478296|P2|COMPLETED|Overall Study||179
5071249|NCT01807923|12478297|P1|COMPLETED|Overall Study||182
5071250|NCT01807923|12478295|P3|STARTED|Overall Study||187
5071251|NCT01807923|12478296|P2|STARTED|Overall Study||185
5071252|NCT01807923|12478297|P1|STARTED|Overall Study||187
5071253|NCT01807871|12478348|P2|NOT COMPLETED|Overall Study||218
5071254|NCT01807871|12478349|P1|NOT COMPLETED|Overall Study||178
5071255|NCT01807871|12478348|P2|COMPLETED|Overall Study||127
5071256|NCT01807871|12478349|P1|COMPLETED|Overall Study||178
5071257|NCT01807871|12478348|P2|STARTED|Overall Study||345
5071258|NCT01807871|12478349|P1|STARTED|Overall Study||356
5071259|NCT01807650|12478359|P1|NOT COMPLETED|Overall Study||20
5071260|NCT01807650|12478359|P1|COMPLETED|Overall Study||92
5071261|NCT01807650|12478359|P1|STARTED|Overall Study||112
5071262|NCT01807637|12478412|P2|NOT COMPLETED|One Month||0
5071263|NCT01807637|12478413|P1|NOT COMPLETED|One Month||0
5071264|NCT01807637|12478412|P2|COMPLETED|One Month||2
5071265|NCT01807637|12478413|P1|COMPLETED|One Month||4
5071266|NCT01807637|12478412|P2|STARTED|One Month||2
5071267|NCT01807637|12478413|P1|STARTED|One Month||4
5071268|NCT01807637|12478412|P2|NOT COMPLETED|One Week||0
5071269|NCT01807637|12478413|P1|NOT COMPLETED|One Week||0
5071270|NCT01807637|12478412|P2|COMPLETED|One Week||2
5071271|NCT01807637|12478413|P1|COMPLETED|One Week||4
5071272|NCT01807637|12478412|P2|STARTED|One Week||2
5071273|NCT01807637|12478413|P1|STARTED|One Week||4
5071274|NCT01807637|12478412|P2|NOT COMPLETED|Baseline||0
5071275|NCT01807637|12478413|P1|NOT COMPLETED|Baseline||0
5071276|NCT01807637|12478412|P2|COMPLETED|Baseline||2
5071277|NCT01807637|12478413|P1|COMPLETED|Baseline||4
5071278|NCT01807637|12478412|P2|STARTED|Baseline||2
5071279|NCT01807637|12478413|P1|STARTED|Baseline||4
5071280|NCT01807624|12478429|P1|NOT COMPLETED|Overall Study||0
5071281|NCT01807624|12478429|P1|COMPLETED|Overall Study||24
5071282|NCT01807624|12478429|P1|STARTED|Overall Study||24
5071283|NCT01807598|12478445|P1|NOT COMPLETED|Overall Study||6
5071284|NCT01807598|12478445|P1|COMPLETED|Overall Study||4
5071285|NCT01807598|12478445|P1|STARTED|Overall Study||10
5071286|NCT01807585|12478459|P3|NOT COMPLETED|Overall Study||6
5071287|NCT01807585|12478460|P2|NOT COMPLETED|Overall Study||4
5071288|NCT01807585|12478461|P1|NOT COMPLETED|Overall Study||1
5071289|NCT01807585|12478459|P3|COMPLETED|Overall Study||108
5071290|NCT01807585|12478460|P2|COMPLETED|Overall Study||104
5071291|NCT01807585|12478461|P1|COMPLETED|Overall Study||19
5071292|NCT01807585|12478459|P3|3 Mos|Overall Study||113
5071293|NCT01807585|12478460|P2|3 Mos|Overall Study||108
5071294|NCT01807585|12478461|P1|3 Mos|Overall Study||20
5071295|NCT01807585|12478459|P3|STARTED|Overall Study||114
5071296|NCT01807585|12478460|P2|STARTED|Overall Study||108
5071297|NCT01807585|12478461|P1|STARTED|Overall Study||20
5071298|NCT01807520|12478477|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
5071299|NCT01807520|12478478|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
5071300|NCT01807520|12478479|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
5071301|NCT01807520|12478480|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
5071302|NCT01807520|12478481|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
5071303|NCT01807520|12478482|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
5071304|NCT01807520|12478483|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
5071305|NCT01807520|12478477|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
5071306|NCT01807520|12478478|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
5071307|NCT01807520|12478479|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
5071308|NCT01807520|12478480|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
5071309|NCT01807520|12478481|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
5071310|NCT01807520|12478482|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
5071311|NCT01807520|12478483|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
5071312|NCT01807520|12478477|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
5071313|NCT01807520|12478478|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
5071314|NCT01807520|12478479|P5|STARTED|Follow-up Period (132-140 Weeks)||0
5071315|NCT01807520|12478480|P4|STARTED|Follow-up Period (132-140 Weeks)||0
5071316|NCT01807520|12478481|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
5071317|NCT01807520|12478482|P2|STARTED|Follow-up Period (132-140 Weeks)||0
5071318|NCT01807520|12478483|P1|STARTED|Follow-up Period (132-140 Weeks)||0
5071319|NCT01807520|12478477|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071320|NCT01807520|12478478|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071321|NCT01807520|12478479|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
5071322|NCT01807520|12478480|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
5071323|NCT01807520|12478481|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071324|NCT01807520|12478482|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
5071325|NCT01807520|12478483|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
5071326|NCT01807520|12478477|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071327|NCT01807520|12478478|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071328|NCT01807520|12478479|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
5071329|NCT01807520|12478480|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
5071330|NCT01807520|12478481|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
5071331|NCT01807520|12478482|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
5071332|NCT01807520|12478483|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
5071333|NCT01807520|12478477|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
5071334|NCT01807520|12478478|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
5071335|NCT01807520|12478479|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
5071336|NCT01807520|12478480|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
5071337|NCT01807520|12478481|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
5071338|NCT01807520|12478482|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
5071339|NCT01807520|12478483|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
5071340|NCT01807520|12478477|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
5071341|NCT01807520|12478478|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
5071342|NCT01807520|12478479|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
5071343|NCT01807520|12478480|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
5071344|NCT01807520|12478481|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
5071345|NCT01807520|12478482|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
5071346|NCT01807520|12478483|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
5071347|NCT01807520|12478477|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
5071348|NCT01807520|12478478|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
5071349|NCT01807520|12478479|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
5071350|NCT01807520|12478480|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
5071351|NCT01807520|12478481|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
5071352|NCT01807520|12478482|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
5071353|NCT01807520|12478483|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
5071354|NCT01807520|12478477|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071355|NCT01807520|12478478|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071356|NCT01807520|12478479|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071357|NCT01807520|12478480|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071358|NCT01807520|12478481|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
5071359|NCT01807520|12478482|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
5071360|NCT01807520|12478483|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
5071361|NCT01807520|12478477|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071362|NCT01807520|12478478|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071363|NCT01807520|12478479|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071364|NCT01807520|12478480|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
5071365|NCT01807520|12478481|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
5071366|NCT01807520|12478482|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
5071367|NCT01807520|12478483|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
5071368|NCT01807520|12478477|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
5071369|NCT01807520|12478478|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
5071370|NCT01807520|12478479|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
5071371|NCT01807520|12478480|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
5071372|NCT01807520|12478481|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
5071373|NCT01807520|12478482|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
5071374|NCT01807520|12478483|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
5071375|NCT01807520|12478477|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
5071376|NCT01807520|12478478|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
5071377|NCT01807520|12478479|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
5071378|NCT01807520|12478480|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
5071379|NCT01807520|12478481|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
5071380|NCT01807520|12478482|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
5071381|NCT01807520|12478483|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
5071382|NCT01807520|12478477|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
5071383|NCT01807520|12478478|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
5071384|NCT01807520|12478479|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
5071385|NCT01807520|12478480|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
5071386|NCT01807520|12478481|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
5071387|NCT01807520|12478482|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
5071388|NCT01807520|12478483|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
5071389|NCT01807455|12478502|P1|NOT COMPLETED|Overall Study||0
5071390|NCT01807455|12478502|P1|COMPLETED|Overall Study||12
5071391|NCT01807455|12478502|P1|STARTED|Overall Study||12
5071392|NCT01807299|12478514|P4|NOT COMPLETED|Overall Study||2
5071393|NCT01807299|12478515|P3|NOT COMPLETED|Overall Study||0
5071394|NCT01807299|12478516|P2|NOT COMPLETED|Overall Study||1
5071395|NCT01807299|12478517|P1|NOT COMPLETED|Overall Study||3
5071396|NCT01807299|12478514|P4|COMPLETED|Overall Study||11
5071397|NCT01807299|12478515|P3|COMPLETED|Overall Study||12
5071398|NCT01807299|12478516|P2|COMPLETED|Overall Study||13
5071399|NCT01807299|12478517|P1|COMPLETED|Overall Study||11
5071400|NCT01807299|12478514|P4|STARTED|Overall Study||13
5071401|NCT01807299|12478515|P3|STARTED|Overall Study||12
5071402|NCT01807299|12478516|P2|STARTED|Overall Study||14
5071403|NCT01807299|12478517|P1|STARTED|Overall Study||14
5071404|NCT01807234|12478533|P6|NOT COMPLETED|Overall Study||4
5071405|NCT01807234|12478534|P5|NOT COMPLETED|Overall Study||4
5071406|NCT01807234|12478535|P4|NOT COMPLETED|Overall Study||2
5071407|NCT01807234|12478536|P3|NOT COMPLETED|Overall Study||2
5071408|NCT01807234|12478537|P2|NOT COMPLETED|Overall Study||6
5071409|NCT01807234|12478538|P1|NOT COMPLETED|Overall Study||5
5071410|NCT01807234|12478533|P6|COMPLETED|Overall Study||8
5071411|NCT01807234|12478534|P5|COMPLETED|Overall Study||8
5071412|NCT01807234|12478535|P4|COMPLETED|Overall Study||10
5071413|NCT01807234|12478536|P3|COMPLETED|Overall Study||10
5071414|NCT01807234|12478537|P2|COMPLETED|Overall Study||6
5071415|NCT01807234|12478538|P1|COMPLETED|Overall Study||7
5071416|NCT01807234|12478533|P6|Completed Only 1 Attack|Overall Study||1
5071417|NCT01807234|12478534|P5|Completed Only 1 Attack|Overall Study||0
5071418|NCT01807234|12478535|P4|Completed Only 1 Attack|Overall Study||1
5071419|NCT01807234|12478536|P3|Completed Only 1 Attack|Overall Study||0
5071420|NCT01807234|12478537|P2|Completed Only 1 Attack|Overall Study||1
5071421|NCT01807234|12478538|P1|Completed Only 1 Attack|Overall Study||2
5071422|NCT01807234|12478533|P6|Randomized, But Did Not Take Drug|Overall Study||3
5071423|NCT01807234|12478534|P5|Randomized, But Did Not Take Drug|Overall Study||4
5071424|NCT01807234|12478535|P4|Randomized, But Did Not Take Drug|Overall Study||1
5071425|NCT01807234|12478536|P3|Randomized, But Did Not Take Drug|Overall Study||2
5071426|NCT01807234|12478537|P2|Randomized, But Did Not Take Drug|Overall Study||5
5071427|NCT01807234|12478538|P1|Randomized, But Did Not Take Drug|Overall Study||3
5071428|NCT01807234|12478533|P6|STARTED|Overall Study||12
5071429|NCT01807234|12478534|P5|STARTED|Overall Study||12
5071430|NCT01807234|12478535|P4|STARTED|Overall Study||12
5071431|NCT01807234|12478536|P3|STARTED|Overall Study||12
5071432|NCT01807234|12478537|P2|STARTED|Overall Study||12
5071433|NCT01807234|12478538|P1|STARTED|Overall Study||12
5071434|NCT01807156|12478573|P1|NOT COMPLETED|Overall Study||1
5071435|NCT01807156|12478573|P1|COMPLETED|Overall Study||6
5071436|NCT01807156|12478573|P1|STARTED|Overall Study||7
5071437|NCT01807104|12478580|P2|NOT COMPLETED|Overall Study||4
5071438|NCT01807104|12478581|P1|NOT COMPLETED|Overall Study||4
5071439|NCT01807104|12478580|P2|COMPLETED|Overall Study||40
5071440|NCT01807104|12478581|P1|COMPLETED|Overall Study||39
5071441|NCT01807104|12478580|P2|STARTED|Overall Study||44
5071442|NCT01807104|12478581|P1|STARTED|Overall Study||43
5071443|NCT01807026|12478593|P6|NOT COMPLETED|Overall Study||0
5071444|NCT01807026|12478594|P5|NOT COMPLETED|Overall Study||0
5071445|NCT01807026|12478595|P4|NOT COMPLETED|Overall Study||0
5071446|NCT01807026|12478596|P3|NOT COMPLETED|Overall Study||0
5071447|NCT01807026|12478597|P2|NOT COMPLETED|Overall Study||0
5071448|NCT01807026|12478598|P1|NOT COMPLETED|Overall Study||0
5071449|NCT01807026|12478593|P6|COMPLETED|Overall Study||3
5071450|NCT01807026|12478594|P5|COMPLETED|Overall Study||9
5071451|NCT01807026|12478595|P4|COMPLETED|Overall Study||2
5071452|NCT01807026|12478596|P3|COMPLETED|Overall Study||10
5071453|NCT01807026|12478597|P2|COMPLETED|Overall Study||2
5071454|NCT01807026|12478598|P1|COMPLETED|Overall Study||10
5071455|NCT01807026|12478593|P6|Received at Least One Dose of Study Drug|Overall Study||3
5071456|NCT01807026|12478594|P5|Received at Least One Dose of Study Drug|Overall Study||9
5071457|NCT01807026|12478595|P4|Received at Least One Dose of Study Drug|Overall Study||2
5071458|NCT01807026|12478596|P3|Received at Least One Dose of Study Drug|Overall Study||10
5071459|NCT01807026|12478597|P2|Received at Least One Dose of Study Drug|Overall Study||2
5071460|NCT01807026|12478598|P1|Received at Least One Dose of Study Drug|Overall Study||10
5071461|NCT01807026|12478593|P6|STARTED|Overall Study||3
5071462|NCT01807026|12478594|P5|STARTED|Overall Study||9
5071463|NCT01807026|12478595|P4|STARTED|Overall Study||2
5071464|NCT01807026|12478596|P3|STARTED|Overall Study||10
5071465|NCT01807026|12478597|P2|STARTED|Overall Study||2
5071466|NCT01807026|12478598|P1|STARTED|Overall Study||10
5071467|NCT01807000|12478626|P1|NOT COMPLETED|Overall Study||0
5071468|NCT01807000|12478626|P1|COMPLETED|Overall Study||6
5071469|NCT01807000|12478626|P1|STARTED|Overall Study||6
5071470|NCT01806961|12478645|P1|NOT COMPLETED|Overall Study||16
5071471|NCT01806961|12478645|P1|COMPLETED|Overall Study||0
5071472|NCT01806961|12478645|P1|STARTED|Overall Study||16
5071473|NCT01806896|12478651|P2|NOT COMPLETED|Overall Study||0
5071474|NCT01806896|12478652|P1|NOT COMPLETED|Overall Study||3
5071475|NCT01806896|12478651|P2|COMPLETED|Overall Study||17
5071476|NCT01806896|12478652|P1|COMPLETED|Overall Study||17
5071477|NCT01806896|12478651|P2|Received Treatment|Overall Study||17
5071478|NCT01806896|12478652|P1|Received Treatment|Overall Study||19
5071479|NCT01806896|12478651|P2|STARTED|Overall Study||17
5071480|NCT01806896|12478652|P1|STARTED|Overall Study||20
5071481|NCT01806857|12478680|P2|NOT COMPLETED|Overall Study||0
5071482|NCT01806857|12478681|P1|NOT COMPLETED|Overall Study||1
5071483|NCT01806857|12478680|P2|COMPLETED|Overall Study||29
5071484|NCT01806857|12478681|P1|COMPLETED|Overall Study||30
5071485|NCT01806857|12478680|P2|STARTED|Overall Study||29
5071486|NCT01806857|12478681|P1|STARTED|Overall Study||31
5071487|NCT01806779|12478719|P3|NOT COMPLETED|Overall Study||23
5071488|NCT01806779|12478720|P2|NOT COMPLETED|Overall Study||44
5071489|NCT01806779|12478721|P1|NOT COMPLETED|Overall Study||42
5071490|NCT01806779|12478719|P3|COMPLETED|Overall Study||0
5071491|NCT01806779|12478720|P2|COMPLETED|Overall Study||40
5071492|NCT01806779|12478721|P1|COMPLETED|Overall Study||48
5071493|NCT01806779|12478719|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
5071494|NCT01806779|12478720|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
5071495|NCT01806779|12478721|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
5071496|NCT01806779|12478719|P3|Randomized at Visit 2|Overall Study||0
5071497|NCT01806779|12478720|P2|Randomized at Visit 2|Overall Study||84
5071498|NCT01806779|12478721|P1|Randomized at Visit 2|Overall Study||90
5071499|NCT01806779|12478719|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
5071500|NCT01806779|12478720|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
5071501|NCT01806779|12478721|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
5071502|NCT01806779|12478719|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
5071503|NCT01806779|12478720|P2|STARTED|Overall Study||84
5071504|NCT01806779|12478721|P1|STARTED|Overall Study||90
5071505|NCT01806740|12478734|P1|NOT COMPLETED|Overall Study||6
5071506|NCT01806740|12478734|P1|COMPLETED|Overall Study||31
5071507|NCT01806740|12478734|P1|STARTED|Overall Study||37
5071508|NCT01806714|12478745|P2|NOT COMPLETED|Overall Study||170
5071509|NCT01806714|12478746|P1|NOT COMPLETED|Overall Study||200
5071510|NCT01806714|12478745|P2|COMPLETED|Overall Study||1919
5071511|NCT01806714|12478746|P1|COMPLETED|Overall Study||1893
5071512|NCT01806714|12478745|P2|STARTED|Overall Study||2089
5071513|NCT01806714|12478746|P1|STARTED|Overall Study||2093
5071514|NCT01806675|12478759|P3|NOT COMPLETED|Overall Study||0
5071515|NCT01806675|12478760|P2|NOT COMPLETED|Overall Study||0
5071516|NCT01806675|12478761|P1|NOT COMPLETED|Overall Study||0
5071517|NCT01806675|12478759|P3|COMPLETED|Overall Study||8
5071518|NCT01806675|12478760|P2|COMPLETED|Overall Study||6
5071519|NCT01806675|12478761|P1|COMPLETED|Overall Study||11
5071520|NCT01806675|12478759|P3|STARTED|Overall Study||8
5071521|NCT01806675|12478760|P2|STARTED|Overall Study||6
5071522|NCT01806675|12478761|P1|STARTED|Overall Study||11
5071523|NCT01806662|12478781|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
5071524|NCT01806662|12478782|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
5071525|NCT01806662|12478781|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
5071526|NCT01806662|12478782|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
5071527|NCT01806662|12478781|P2|STARTED|Second Intervention (Weeks 16-32)||15
5071528|NCT01806662|12478782|P1|STARTED|Second Intervention (Weeks 16-32)||12
5071529|NCT01806662|12478781|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
5071530|NCT01806662|12478782|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
5071531|NCT01806662|12478781|P2|COMPLETED|First Intervention (Weeks 0-16)||15
5071532|NCT01806662|12478782|P1|COMPLETED|First Intervention (Weeks 0-16)||12
5071533|NCT01806662|12478781|P2|Received Intervention|First Intervention (Weeks 0-16)||15
5071534|NCT01806662|12478782|P1|Received Intervention|First Intervention (Weeks 0-16)||12
5071535|NCT01806662|12478781|P2|STARTED|First Intervention (Weeks 0-16)||16
5071536|NCT01806662|12478782|P1|STARTED|First Intervention (Weeks 0-16)||16
5071537|NCT01806623|12478788|P1|NOT COMPLETED|Overall Study||58
5071538|NCT01806623|12478788|P1|COMPLETED|Overall Study||99
5071539|NCT01806623|12478788|P1|STARTED|Overall Study||157
5071540|NCT01806597|12478808|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
5071541|NCT01806597|12478809|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071542|NCT01806597|12478810|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071543|NCT01806597|12478811|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071544|NCT01806597|12478812|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071545|NCT01806597|12478813|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071546|NCT01806597|12478808|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
5071547|NCT01806597|12478809|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
5071548|NCT01806597|12478810|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071549|NCT01806597|12478811|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071550|NCT01806597|12478812|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071551|NCT01806597|12478813|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
5071552|NCT01806597|12478808|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
5071553|NCT01806597|12478809|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
5071554|NCT01806597|12478810|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
5071555|NCT01806597|12478811|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
5071556|NCT01806597|12478812|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
5071557|NCT01806597|12478813|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
5071558|NCT01806597|12478808|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
5071559|NCT01806597|12478809|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
5071560|NCT01806597|12478810|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
5071561|NCT01806597|12478811|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
5071562|NCT01806597|12478812|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
5071563|NCT01806597|12478813|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
5071564|NCT01806597|12478808|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
5071565|NCT01806597|12478809|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
5071566|NCT01806597|12478810|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
5071567|NCT01806597|12478811|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
5071568|NCT01806597|12478812|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
5071569|NCT01806597|12478813|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
5071570|NCT01806597|12478808|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
5071571|NCT01806597|12478809|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
5071572|NCT01806597|12478810|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
5071573|NCT01806597|12478811|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
5071574|NCT01806597|12478812|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
5071575|NCT01806597|12478813|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
5071576|NCT01806597|12478808|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
5071577|NCT01806597|12478809|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
5071578|NCT01806597|12478810|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
5071579|NCT01806597|12478811|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
5071580|NCT01806597|12478812|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
5071581|NCT01806597|12478813|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
5071582|NCT01806597|12478808|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
5071583|NCT01806597|12478809|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
5071584|NCT01806597|12478810|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
5071585|NCT01806597|12478811|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
5071586|NCT01806597|12478812|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
5071587|NCT01806597|12478813|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
5071588|NCT01806597|12478808|P6|STARTED|Period 1 (Baseline to Week 16)||0
5071589|NCT01806597|12478809|P5|STARTED|Period 1 (Baseline to Week 16)||68
5071590|NCT01806597|12478810|P4|STARTED|Period 1 (Baseline to Week 16)||0
5071591|NCT01806597|12478811|P3|STARTED|Period 1 (Baseline to Week 16)||0
5071592|NCT01806597|12478812|P2|STARTED|Period 1 (Baseline to Week 16)||69
5071593|NCT01806597|12478813|P1|STARTED|Period 1 (Baseline to Week 16)||68
5071594|NCT01806584|12478849|P2|NOT COMPLETED|Overall Study||18
5071595|NCT01806584|12478850|P1|NOT COMPLETED|Overall Study||14
5071596|NCT01806584|12478849|P2|COMPLETED|Overall Study||0
5071597|NCT01806584|12478850|P1|COMPLETED|Overall Study||0
5071598|NCT01806584|12478849|P2|STARTED|Overall Study||18
5071599|NCT01806584|12478850|P1|STARTED|Overall Study||14
5071600|NCT01806571|12478862|P1|NOT COMPLETED|Overall Study||0
5071601|NCT01806571|12478862|P1|COMPLETED|Overall Study||34
5071602|NCT01806571|12478862|P1|STARTED|Overall Study||34
5071603|NCT01806545|12478872|P2|NOT COMPLETED|Overall Study||5
5071604|NCT01806545|12478873|P1|NOT COMPLETED|Overall Study||6
5071605|NCT01806545|12478872|P2|COMPLETED|Overall Study||30
5071606|NCT01806545|12478873|P1|COMPLETED|Overall Study||23
5071607|NCT01806545|12478872|P2|STARTED|Overall Study||35
5071608|NCT01806545|12478873|P1|STARTED|Overall Study||29
5071609|NCT01806506|12478897|P2|NOT COMPLETED|Overall Study||1
5071610|NCT01806506|12478898|P1|NOT COMPLETED|Overall Study||2
5071611|NCT01806506|12478897|P2|COMPLETED|Overall Study||35
5071612|NCT01806506|12478898|P1|COMPLETED|Overall Study||34
5071613|NCT01806506|12478897|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
5071614|NCT01806506|12478898|P1|9 Months|Overall Study||34
5071615|NCT01806506|12478897|P2|6 Months|Overall Study||36
5071616|NCT01806506|12478898|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
5071617|NCT01806506|12478897|P2|3 Months|Overall Study||36
5071618|NCT01806506|12478898|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
5071619|NCT01806506|12478897|P2|1 Month|Overall Study||36
5071620|NCT01806506|12478898|P1|1 Month|Overall Study||36
5071621|NCT01806506|12478897|P2|STARTED|Overall Study||36
5071622|NCT01806506|12478898|P1|STARTED|Overall Study||36
5071623|NCT01806389|12478904|P1|NOT COMPLETED|Overall Study||4
5071624|NCT01806389|12478904|P1|COMPLETED|Overall Study||10
5071625|NCT01806389|12478904|P1|STARTED|Overall Study||14
5071626|NCT01806298|12478918|P1|NOT COMPLETED|Overall Study||10
5071627|NCT01806298|12478918|P1|COMPLETED|Overall Study||68
5071628|NCT01806298|12478918|P1|STARTED|Overall Study||78
5071629|NCT01806259|12478930|P2|NOT COMPLETED|Overall Study||0
5071630|NCT01806259|12478931|P1|NOT COMPLETED|Overall Study||0
5071631|NCT01806259|12478930|P2|COMPLETED|Overall Study||107
5071632|NCT01806259|12478931|P1|COMPLETED|Overall Study||96
5071633|NCT01806259|12478930|P2|STARTED|Overall Study||107
5071634|NCT01806259|12478931|P1|STARTED|Overall Study||96
5071635|NCT01806051|12478939|P1|NOT COMPLETED|Overall Study||6
5071636|NCT01806051|12478939|P1|COMPLETED|Overall Study||0
5071637|NCT01806051|12478939|P1|STARTED|Overall Study||6
5071638|NCT01805895|12478947|P2|NOT COMPLETED|Overall Study||0
5071639|NCT01805895|12478948|P1|NOT COMPLETED|Overall Study||0
5071640|NCT01805895|12478947|P2|COMPLETED|Overall Study||8
5071641|NCT01805895|12478948|P1|COMPLETED|Overall Study||8
5071642|NCT01805895|12478947|P2|STARTED|Overall Study||8
5071643|NCT01805895|12478948|P1|STARTED|Overall Study||8
5071644|NCT01805882|12478965|P9|NOT COMPLETED|Overall Study||1
5071645|NCT01805882|12478966|P8|NOT COMPLETED|Overall Study||0
5071646|NCT01805882|12478967|P7|NOT COMPLETED|Overall Study||2
5071647|NCT01805882|12478968|P6|NOT COMPLETED|Overall Study||1
5071648|NCT01805882|12478969|P5|NOT COMPLETED|Overall Study||0
5071649|NCT01805882|12478970|P4|NOT COMPLETED|Overall Study||2
5071650|NCT01805882|12478971|P3|NOT COMPLETED|Overall Study||1
5071651|NCT01805882|12478972|P2|NOT COMPLETED|Overall Study||0
5071652|NCT01805882|12478973|P1|NOT COMPLETED|Overall Study||0
5071653|NCT01805882|12478965|P9|COMPLETED|Overall Study||24
5071654|NCT01805882|12478966|P8|COMPLETED|Overall Study||25
5071655|NCT01805882|12478967|P7|COMPLETED|Overall Study||48
5071656|NCT01805882|12478968|P6|COMPLETED|Overall Study||20
5071657|NCT01805882|12478969|P5|COMPLETED|Overall Study||14
5071658|NCT01805882|12478970|P4|COMPLETED|Overall Study||32
5071659|NCT01805882|12478971|P3|COMPLETED|Overall Study||19
5071660|NCT01805882|12478972|P2|COMPLETED|Overall Study||20
5071661|NCT01805882|12478973|P1|COMPLETED|Overall Study||20
5071662|NCT01805882|12478965|P9|STARTED|Overall Study||25
5071663|NCT01805882|12478966|P8|STARTED|Overall Study||25
5071664|NCT01805882|12478967|P7|STARTED|Overall Study||50
5071665|NCT01805882|12478968|P6|STARTED|Overall Study||21
5071666|NCT01805882|12478969|P5|STARTED|Overall Study||14
5071667|NCT01805882|12478970|P4|STARTED|Overall Study||34
5071668|NCT01805882|12478971|P3|STARTED|Overall Study||20
5071669|NCT01805882|12478972|P2|STARTED|Overall Study||20
5071670|NCT01805882|12478973|P1|STARTED|Overall Study||20
5071671|NCT01805791|12478996|P3|NOT COMPLETED|Overall Study||20
5071672|NCT01805791|12478997|P2|NOT COMPLETED|Overall Study||17
5071673|NCT01805791|12478998|P1|NOT COMPLETED|Overall Study||22
5071674|NCT01805791|12478996|P3|COMPLETED|Overall Study||48
5071675|NCT01805791|12478997|P2|COMPLETED|Overall Study||50
5071676|NCT01805791|12478998|P1|COMPLETED|Overall Study||44
5071677|NCT01805791|12478996|P3|STARTED|Overall Study||68
5071678|NCT01805791|12478997|P2|STARTED|Overall Study||67
5071679|NCT01805791|12478998|P1|STARTED|Overall Study||66
5071680|NCT01805687|12479012|P1|NOT COMPLETED|Overall Study||0
5071681|NCT01805687|12479012|P1|COMPLETED|Overall Study||25
5071682|NCT01805687|12479012|P1|STARTED|Overall Study||25
5071683|NCT01805440|12479019|P3|NOT COMPLETED|Overall Study||0
5071684|NCT01805440|12479020|P2|NOT COMPLETED|Overall Study||0
5071685|NCT01805440|12479021|P1|NOT COMPLETED|Overall Study||1
5071686|NCT01805440|12479019|P3|COMPLETED|Overall Study||26
5071687|NCT01805440|12479020|P2|COMPLETED|Overall Study||17
5071688|NCT01805440|12479021|P1|COMPLETED|Overall Study||18
5071689|NCT01805440|12479019|P3|STARTED|Overall Study||26
5071690|NCT01805440|12479020|P2|STARTED|Overall Study||17
5071691|NCT01805440|12479021|P1|STARTED|Overall Study||19
5071692|NCT01805323|12479034|P1|NOT COMPLETED|Overall Study||0
5071693|NCT01805323|12479034|P1|COMPLETED|Overall Study||101
5071694|NCT01805323|12479034|P1|STARTED|Overall Study||101
5071695|NCT01805297|12479041|P2|NOT COMPLETED|Overall Study||3
5071696|NCT01805297|12479042|P1|NOT COMPLETED|Overall Study||2
5071697|NCT01805297|12479041|P2|COMPLETED|Overall Study||3
5071698|NCT01805297|12479042|P1|COMPLETED|Overall Study||4
5071699|NCT01805297|12479041|P2|STARTED|Overall Study||6
5071700|NCT01805297|12479042|P1|STARTED|Overall Study||6
5071701|NCT01805180|12479056|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
5071702|NCT01805180|12479057|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
5071703|NCT01805180|12479058|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
5071704|NCT01805180|12479056|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
5071705|NCT01805180|12479057|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
5071706|NCT01805180|12479058|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
5071707|NCT01805180|12479056|P3|STARTED|Pivotal Randomization Through Study Exit||20
5071708|NCT01805180|12479057|P2|STARTED|Pivotal Randomization Through Study Exit||22
5071709|NCT01805180|12479058|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
5071710|NCT01805180|12479056|P3|NOT COMPLETED|Lead-in Donor Phase||0
5071711|NCT01805180|12479057|P2|NOT COMPLETED|Lead-in Donor Phase||0
5071712|NCT01805180|12479058|P1|NOT COMPLETED|Lead-in Donor Phase||1
5071713|NCT01805180|12479056|P3|COMPLETED|Lead-in Donor Phase||0
5071714|NCT01805180|12479057|P2|COMPLETED|Lead-in Donor Phase||0
5071715|NCT01805180|12479058|P1|COMPLETED|Lead-in Donor Phase||6
5071716|NCT01805180|12479056|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
5071717|NCT01805180|12479057|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
5071718|NCT01805180|12479058|P1|STARTED|Lead-in Donor Phase||7
5071719|NCT01805154|12479081|P1|NOT COMPLETED|Overall Study||354
5071720|NCT01805154|12479081|P1|COMPLETED|Overall Study||1175
5071721|NCT01805154|12479081|P1|STARTED|Overall Study||1529
5071722|NCT01805089|12479091|P2|NOT COMPLETED|Overall Study||4
5071723|NCT01805089|12479092|P1|NOT COMPLETED|Overall Study||5
5071724|NCT01805089|12479091|P2|COMPLETED|Overall Study||43
5071725|NCT01805089|12479092|P1|COMPLETED|Overall Study||43
5071726|NCT01805089|12479091|P2|STARTED|Overall Study||47
5071727|NCT01805089|12479092|P1|STARTED|Overall Study||48
5071728|NCT01805024|12479106|P4|NOT COMPLETED|Overall Study||0
5071729|NCT01805024|12479107|P3|NOT COMPLETED|Overall Study||0
5071730|NCT01805024|12479108|P2|NOT COMPLETED|Overall Study||0
5071731|NCT01805024|12479109|P1|NOT COMPLETED|Overall Study||0
5071732|NCT01805024|12479106|P4|COMPLETED|Overall Study||8
5071733|NCT01805024|12479107|P3|COMPLETED|Overall Study||4
5071734|NCT01805024|12479108|P2|COMPLETED|Overall Study||4
5071735|NCT01805024|12479109|P1|COMPLETED|Overall Study||4
5071736|NCT01805024|12479106|P4|STARTED|Overall Study||8
5071737|NCT01805024|12479107|P3|STARTED|Overall Study||4
5071738|NCT01805024|12479108|P2|STARTED|Overall Study||4
5071739|NCT01805024|12479109|P1|STARTED|Overall Study||4
5071740|NCT01804946|12479133|P2|NOT COMPLETED|Overall Study||4
5071741|NCT01804946|12479134|P1|NOT COMPLETED|Overall Study||2
5071742|NCT01804946|12479133|P2|COMPLETED|Overall Study||76
5071743|NCT01804946|12479134|P1|COMPLETED|Overall Study||79
5071744|NCT01804946|12479133|P2|STARTED|Overall Study||80
5071745|NCT01804946|12479134|P1|STARTED|Overall Study||81
5071746|NCT01804881|12479158|P2|NOT COMPLETED|Overall Study||4
5071747|NCT01804881|12479159|P1|NOT COMPLETED|Overall Study||5
5071748|NCT01804881|12479158|P2|COMPLETED|Overall Study||10
5071749|NCT01804881|12479159|P1|COMPLETED|Overall Study||11
5071750|NCT01804881|12479158|P2|STARTED|Overall Study||14
5071751|NCT01804881|12479159|P1|STARTED|Overall Study||16
5071752|NCT01804842|12479172|P3|NOT COMPLETED|Overall Study||1
5071753|NCT01804842|12479173|P2|NOT COMPLETED|Overall Study||2
5071754|NCT01804842|12479174|P1|NOT COMPLETED|Overall Study||3
5071755|NCT01804842|12479172|P3|COMPLETED|Overall Study||8
5071756|NCT01804842|12479173|P2|COMPLETED|Overall Study||6
5071757|NCT01804842|12479174|P1|COMPLETED|Overall Study||6
5071758|NCT01804842|12479172|P3|Completed Treatment C|Overall Study||9
5071759|NCT01804842|12479173|P2|Completed Treatment C|Overall Study||7
5071760|NCT01804842|12479174|P1|Completed Treatment C|Overall Study||7
5071761|NCT01804842|12479172|P3|Completed Treatment B|Overall Study||8
5071762|NCT01804842|12479173|P2|Completed Treatment B|Overall Study||8
5071763|NCT01804842|12479174|P1|Completed Treatment B|Overall Study||8
5071764|NCT01804842|12479172|P3|Completed Treatment A|Overall Study||8
5071765|NCT01804842|12479173|P2|Completed Treatment A|Overall Study||6
5071766|NCT01804842|12479174|P1|Completed Treatment A|Overall Study||9
5071767|NCT01804842|12479172|P3|STARTED|Overall Study||9
5071768|NCT01804842|12479173|P2|STARTED|Overall Study||8
5071769|NCT01804842|12479174|P1|STARTED|Overall Study||9
5071770|NCT01804816|12479191|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
5071771|NCT01804816|12479191|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
5071772|NCT01804816|12479191|P1|STARTED|Acupuncture (Second 5 Weeks)||11
5071773|NCT01804816|12479191|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
5071774|NCT01804816|12479191|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
5071775|NCT01804816|12479191|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
5071776|NCT01804673|12479203|P1|NOT COMPLETED|Overall Study||140
5071777|NCT01804673|12479203|P1|COMPLETED|Overall Study||34
5071778|NCT01804673|12479203|P1|Completed Hour 72|Overall Study||36
5071779|NCT01804673|12479203|P1|Completed Hour 48|Overall Study||79
5071780|NCT01804673|12479203|P1|Completed Hour 24|Overall Study||170
5071781|NCT01804673|12479203|P1|STARTED|Overall Study||174
5071782|NCT01804582|12479221|P2|NOT COMPLETED|Overall Study||56
5071783|NCT01804582|12479222|P1|NOT COMPLETED|Overall Study||49
5071784|NCT01804582|12479221|P2|COMPLETED|Overall Study||117
5071785|NCT01804582|12479222|P1|COMPLETED|Overall Study||128
5071786|NCT01804582|12479221|P2|STARTED|Overall Study||173
5071787|NCT01804582|12479222|P1|STARTED|Overall Study||177
5071788|NCT01804257|12479238|P1|NOT COMPLETED|Overall Study||1
5071789|NCT01804257|12479238|P1|COMPLETED|Overall Study||27
5071790|NCT01804257|12479238|P1|STARTED|Overall Study||28
5071791|NCT01804140|12479242|P1|NOT COMPLETED|Overall Study||114
5071792|NCT01804140|12479242|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
5071793|NCT01804140|12479242|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
5071794|NCT01804101|12479249|P2|NOT COMPLETED|Overall Study||0
5071795|NCT01804101|12479250|P1|NOT COMPLETED|Overall Study||0
5071796|NCT01804101|12479249|P2|COMPLETED|Overall Study||10
5071797|NCT01804101|12479250|P1|COMPLETED|Overall Study||38
5071798|NCT01804101|12479249|P2|STARTED|Overall Study||10
5071799|NCT01804101|12479250|P1|STARTED|Overall Study||38
5071800|NCT01804075|12479260|P2|NOT COMPLETED|Overall Study||0
5071801|NCT01804075|12479261|P1|NOT COMPLETED|Overall Study||0
5071802|NCT01804075|12479260|P2|COMPLETED|Overall Study||16
5071803|NCT01804075|12479261|P1|COMPLETED|Overall Study||15
5071804|NCT01804075|12479260|P2|STARTED|Overall Study||16
5071805|NCT01804075|12479261|P1|STARTED|Overall Study||15
5071806|NCT01804062|12479269|P1|NOT COMPLETED|Overall Study||0
5071807|NCT01804062|12479269|P1|COMPLETED|Overall Study||30
5071808|NCT01804062|12479269|P1|STARTED|Overall Study||30
5071809|NCT01804049|12479276|P2|NOT COMPLETED|Overall Study||32
5071810|NCT01804049|12479277|P1|NOT COMPLETED|Overall Study||11
5071811|NCT01804049|12479276|P2|COMPLETED|Overall Study||45
5071812|NCT01804049|12479277|P1|COMPLETED|Overall Study||32
5071813|NCT01804049|12479276|P2|STARTED|Overall Study||77
5071814|NCT01804049|12479277|P1|STARTED|Overall Study||43
5071815|NCT01804036|12479289|P2|NOT COMPLETED|Overall Study||20
5071816|NCT01804036|12479290|P1|NOT COMPLETED|Overall Study||13
5071817|NCT01804036|12479289|P2|COMPLETED|Overall Study||21
5071818|NCT01804036|12479290|P1|COMPLETED|Overall Study||18
5071819|NCT01804036|12479289|P2|STARTED|Overall Study||41
5071820|NCT01804036|12479290|P1|STARTED|Overall Study||31
5071821|NCT01803880|12479325|P3|NOT COMPLETED|Overall Study||15
5071822|NCT01803880|12479326|P2|NOT COMPLETED|Overall Study||10
5071823|NCT01803880|12479327|P1|NOT COMPLETED|Overall Study||6
5071824|NCT01803880|12479325|P3|COMPLETED|Overall Study||14
5071825|NCT01803880|12479326|P2|COMPLETED|Overall Study||18
5071826|NCT01803880|12479327|P1|COMPLETED|Overall Study||13
5071827|NCT01803880|12479325|P3|STARTED|Overall Study||29
5071828|NCT01803880|12479326|P2|STARTED|Overall Study||28
5071829|NCT01803880|12479327|P1|STARTED|Overall Study||19
5071830|NCT01803737|12479363|P2|NOT COMPLETED|Overall Study||3
5071831|NCT01803737|12479364|P1|NOT COMPLETED|Overall Study||1
5071832|NCT01803737|12479363|P2|COMPLETED|Overall Study||10
5071833|NCT01803737|12479364|P1|COMPLETED|Overall Study||12
5071834|NCT01803737|12479363|P2|STARTED|Overall Study||13
5071835|NCT01803737|12479364|P1|STARTED|Overall Study||13
5071836|NCT01803711|12479388|P2|NOT COMPLETED|Overall Study||1
5071837|NCT01803711|12479389|P1|NOT COMPLETED|Overall Study||1
5071838|NCT01803711|12479388|P2|COMPLETED|Overall Study||2
5071839|NCT01803711|12479389|P1|COMPLETED|Overall Study||1
5071840|NCT01803711|12479388|P2|STARTED|Overall Study||3
5071841|NCT01803711|12479389|P1|STARTED|Overall Study||2
5071842|NCT01803646|12479407|P2|NOT COMPLETED|Overall Study||10
5071843|NCT01803646|12479408|P1|NOT COMPLETED|Overall Study||17
5071844|NCT01803646|12479407|P2|COMPLETED|Overall Study||129
5071845|NCT01803646|12479408|P1|COMPLETED|Overall Study||187
5071846|NCT01803646|12479407|P2|STARTED|Overall Study||139
5071847|NCT01803646|12479408|P1|STARTED|Overall Study||204
5071848|NCT01803607|12479420|P2|NOT COMPLETED|Overall Study||67
5071849|NCT01803607|12479421|P1|NOT COMPLETED|Overall Study||68
5071850|NCT01803607|12479420|P2|COMPLETED|Overall Study||0
5071851|NCT01803607|12479421|P1|COMPLETED|Overall Study||0
5071852|NCT01803607|12479420|P2|STARTED|Overall Study||67
5071853|NCT01803607|12479421|P1|STARTED|Overall Study||68
5071854|NCT01803464|12479445|P4|NOT COMPLETED|Overall Study||0
5071855|NCT01803464|12479446|P3|NOT COMPLETED|Overall Study||4
5071856|NCT01803464|12479447|P2|NOT COMPLETED|Overall Study||0
5071857|NCT01803464|12479448|P1|NOT COMPLETED|Overall Study||1
5071858|NCT01803464|12479445|P4|COMPLETED|Overall Study||10
5071859|NCT01803464|12479446|P3|COMPLETED|Overall Study||6
5071860|NCT01803464|12479447|P2|COMPLETED|Overall Study||4
5071861|NCT01803464|12479448|P1|COMPLETED|Overall Study||4
5071862|NCT01803464|12479445|P4|STARTED|Overall Study||10
5071863|NCT01803464|12479446|P3|STARTED|Overall Study||10
5071864|NCT01803464|12479447|P2|STARTED|Overall Study||4
5071865|NCT01803464|12479448|P1|STARTED|Overall Study||5
5071866|NCT01803282|12479478|P12|NOT COMPLETED|Overall Study||15
5071867|NCT01803282|12479479|P11|NOT COMPLETED|Overall Study||8
5071868|NCT01803282|12479480|P10|NOT COMPLETED|Overall Study||45
5071869|NCT01803282|12479481|P9|NOT COMPLETED|Overall Study||11
5071870|NCT01803282|12479482|P8|NOT COMPLETED|Overall Study||46
5071871|NCT01803282|12479483|P7|NOT COMPLETED|Overall Study||41
5071872|NCT01803282|12479484|P6|NOT COMPLETED|Overall Study||10
5071873|NCT01803282|12479485|P5|NOT COMPLETED|Overall Study||11
5071874|NCT01803282|12479486|P4|NOT COMPLETED|Overall Study||36
5071875|NCT01803282|12479487|P3|NOT COMPLETED|Overall Study||6
5071876|NCT01803282|12479488|P2|NOT COMPLETED|Overall Study||3
5071877|NCT01803282|12479489|P1|NOT COMPLETED|Overall Study||4
5071878|NCT01803282|12479478|P12|COMPLETED|Overall Study||0
5071879|NCT01803282|12479479|P11|COMPLETED|Overall Study||0
5071880|NCT01803282|12479480|P10|COMPLETED|Overall Study||0
5071881|NCT01803282|12479481|P9|COMPLETED|Overall Study||0
5071882|NCT01803282|12479482|P8|COMPLETED|Overall Study||0
5071883|NCT01803282|12479483|P7|COMPLETED|Overall Study||0
5071884|NCT01803282|12479484|P6|COMPLETED|Overall Study||0
5071885|NCT01803282|12479485|P5|COMPLETED|Overall Study||0
5071886|NCT01803282|12479486|P4|COMPLETED|Overall Study||0
5071887|NCT01803282|12479487|P3|COMPLETED|Overall Study||0
5071888|NCT01803282|12479488|P2|COMPLETED|Overall Study||0
5071889|NCT01803282|12479489|P1|COMPLETED|Overall Study||0
5071890|NCT01803282|12479478|P12|STARTED|Overall Study||15
5071891|NCT01803282|12479479|P11|STARTED|Overall Study||8
5071892|NCT01803282|12479480|P10|STARTED|Overall Study||45
5071893|NCT01803282|12479481|P9|STARTED|Overall Study||11
5071894|NCT01803282|12479482|P8|STARTED|Overall Study||46
5071895|NCT01803282|12479483|P7|STARTED|Overall Study||41
5071896|NCT01803282|12479484|P6|STARTED|Overall Study||10
5071897|NCT01803282|12479485|P5|STARTED|Overall Study||11
5071898|NCT01803282|12479486|P4|STARTED|Overall Study||36
5071899|NCT01803282|12479487|P3|STARTED|Overall Study||6
5071900|NCT01803282|12479488|P2|STARTED|Overall Study||3
5071901|NCT01803282|12479489|P1|STARTED|Overall Study||4
5071902|NCT01803269|12479530|P3|NOT COMPLETED|Overall Study||0
5071903|NCT01803269|12479531|P2|NOT COMPLETED|Overall Study||0
5071904|NCT01803269|12479532|P1|NOT COMPLETED|Overall Study||3
5071905|NCT01803269|12479530|P3|COMPLETED|Overall Study||14
5071906|NCT01803269|12479531|P2|COMPLETED|Overall Study||8
5071907|NCT01803269|12479532|P1|COMPLETED|Overall Study||4
5071908|NCT01803269|12479530|P3|STARTED|Overall Study||14
5071909|NCT01803269|12479531|P2|STARTED|Overall Study||8
5071910|NCT01803269|12479532|P1|STARTED|Overall Study||7
5071911|NCT01803204|12479554|P2|NOT COMPLETED|Overall Study||0
5071912|NCT01803204|12479555|P1|NOT COMPLETED|Overall Study||0
5071913|NCT01803204|12479554|P2|COMPLETED|Overall Study||20
5071914|NCT01803204|12479555|P1|COMPLETED|Overall Study||20
5071915|NCT01803204|12479554|P2|STARTED|Overall Study||20
5071916|NCT01803204|12479555|P1|STARTED|Overall Study||20
5071917|NCT01803074|12479579|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071918|NCT01803074|12479580|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071919|NCT01803074|12479581|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071920|NCT01803074|12479582|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071921|NCT01803074|12479583|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071922|NCT01803074|12479584|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071923|NCT01803074|12479585|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071924|NCT01803074|12479586|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071925|NCT01803074|12479587|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071926|NCT01803074|12479588|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071927|NCT01803074|12479589|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071928|NCT01803074|12479590|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071929|NCT01803074|12479591|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071930|NCT01803074|12479592|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071931|NCT01803074|12479579|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
5071932|NCT01803074|12479580|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
5071933|NCT01803074|12479581|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
5071934|NCT01803074|12479582|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071935|NCT01803074|12479583|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071936|NCT01803074|12479584|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071937|NCT01803074|12479585|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071938|NCT01803074|12479586|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071939|NCT01803074|12479587|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071940|NCT01803074|12479588|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071941|NCT01803074|12479589|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071942|NCT01803074|12479590|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071943|NCT01803074|12479591|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071944|NCT01803074|12479592|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
5071945|NCT01803074|12479579|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
5071946|NCT01803074|12479580|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
5071947|NCT01803074|12479581|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
5071948|NCT01803074|12479582|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071949|NCT01803074|12479583|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071950|NCT01803074|12479584|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071951|NCT01803074|12479585|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071952|NCT01803074|12479586|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071953|NCT01803074|12479587|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071954|NCT01803074|12479588|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071955|NCT01803074|12479589|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071956|NCT01803074|12479590|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071957|NCT01803074|12479591|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071958|NCT01803074|12479592|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
5071959|NCT01803074|12479579|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071960|NCT01803074|12479580|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071961|NCT01803074|12479581|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071962|NCT01803074|12479582|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071963|NCT01803074|12479583|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071964|NCT01803074|12479584|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071965|NCT01803074|12479585|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071966|NCT01803074|12479586|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071967|NCT01803074|12479587|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071968|NCT01803074|12479588|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071969|NCT01803074|12479589|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071970|NCT01803074|12479590|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071971|NCT01803074|12479591|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071972|NCT01803074|12479592|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071973|NCT01803074|12479579|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071974|NCT01803074|12479580|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071975|NCT01803074|12479581|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071976|NCT01803074|12479582|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
5071977|NCT01803074|12479583|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
5071978|NCT01803074|12479584|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
5071979|NCT01803074|12479585|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
5071980|NCT01803074|12479586|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071981|NCT01803074|12479587|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071982|NCT01803074|12479588|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071983|NCT01803074|12479589|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071984|NCT01803074|12479590|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071985|NCT01803074|12479591|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071986|NCT01803074|12479592|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
5071987|NCT01803074|12479579|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071988|NCT01803074|12479580|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071989|NCT01803074|12479581|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071990|NCT01803074|12479582|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
5071991|NCT01803074|12479583|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
5071992|NCT01803074|12479584|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
5071993|NCT01803074|12479585|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
5071994|NCT01803074|12479586|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071995|NCT01803074|12479587|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071996|NCT01803074|12479588|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071997|NCT01803074|12479589|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071998|NCT01803074|12479590|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5071999|NCT01803074|12479591|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5072000|NCT01803074|12479592|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
5072001|NCT01803074|12479579|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072002|NCT01803074|12479580|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072003|NCT01803074|12479581|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072004|NCT01803074|12479582|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072005|NCT01803074|12479583|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072006|NCT01803074|12479584|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072007|NCT01803074|12479585|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072008|NCT01803074|12479586|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072009|NCT01803074|12479587|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072010|NCT01803074|12479588|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072011|NCT01803074|12479589|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072012|NCT01803074|12479590|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072013|NCT01803074|12479591|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072014|NCT01803074|12479592|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072015|NCT01803074|12479579|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072016|NCT01803074|12479580|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072017|NCT01803074|12479581|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072018|NCT01803074|12479582|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072019|NCT01803074|12479583|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072020|NCT01803074|12479584|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072021|NCT01803074|12479585|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
5072022|NCT01803074|12479586|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
5072023|NCT01803074|12479587|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072024|NCT01803074|12479588|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072025|NCT01803074|12479589|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072026|NCT01803074|12479590|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072027|NCT01803074|12479591|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072028|NCT01803074|12479592|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
5072029|NCT01803074|12479579|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072030|NCT01803074|12479580|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072031|NCT01803074|12479581|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072032|NCT01803074|12479582|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072033|NCT01803074|12479583|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072034|NCT01803074|12479584|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072035|NCT01803074|12479585|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
5072036|NCT01803074|12479586|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
5072037|NCT01803074|12479587|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072038|NCT01803074|12479588|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072039|NCT01803074|12479589|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072040|NCT01803074|12479590|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072041|NCT01803074|12479591|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072042|NCT01803074|12479592|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
5072043|NCT01802879|12479846|P1|NOT COMPLETED|Overall Study||8
5072044|NCT01802879|12479846|P1|COMPLETED|Overall Study||0
5072045|NCT01802879|12479846|P1|STARTED|Overall Study||8
5072046|NCT01802775|12479853|P2|NOT COMPLETED|Overall Study||12
5072047|NCT01802775|12479854|P1|NOT COMPLETED|Overall Study||6
5072048|NCT01802775|12479853|P2|COMPLETED|Overall Study||89
5072049|NCT01802775|12479854|P1|COMPLETED|Overall Study||96
5072050|NCT01802775|12479853|P2|Received Drug (Safety Analysis Set)|Overall Study||100
5072051|NCT01802775|12479854|P1|Received Drug (Safety Analysis Set)|Overall Study||101
5072052|NCT01802775|12479853|P2|STARTED|Overall Study||101
5072053|NCT01802775|12479854|P1|STARTED|Overall Study||102
5072054|NCT01802710|12479872|P2|NOT COMPLETED|From T1 to T2||2
5072055|NCT01802710|12479873|P1|NOT COMPLETED|From T1 to T2||2
5072056|NCT01802710|12479872|P2|COMPLETED|From T1 to T2||70
5072057|NCT01802710|12479873|P1|COMPLETED|From T1 to T2||58
5072058|NCT01802710|12479872|P2|STARTED|From T1 to T2||72
5072059|NCT01802710|12479873|P1|STARTED|From T1 to T2||60
5072060|NCT01802710|12479872|P2|NOT COMPLETED|From T0 to T1||10
5072061|NCT01802710|12479873|P1|NOT COMPLETED|From T0 to T1||16
5072062|NCT01802710|12479872|P2|COMPLETED|From T0 to T1||72
5072063|NCT01802710|12479873|P1|COMPLETED|From T0 to T1||60
5072064|NCT01802710|12479872|P2|STARTED|From T0 to T1||82
5072065|NCT01802710|12479873|P1|STARTED|From T0 to T1||76
5072066|NCT01802632|12479889|P6|NOT COMPLETED|Overall Study||28
5072067|NCT01802632|12479890|P5|NOT COMPLETED|Overall Study||12
5072068|NCT01802632|12479891|P4|NOT COMPLETED|Overall Study||60
5072069|NCT01802632|12479892|P3|NOT COMPLETED|Overall Study||271
5072070|NCT01802632|12479893|P2|NOT COMPLETED|Overall Study||31
5072071|NCT01802632|12479894|P1|NOT COMPLETED|Overall Study||201
5072072|NCT01802632|12479889|P6|COMPLETED|Overall Study||0
5072073|NCT01802632|12479890|P5|COMPLETED|Overall Study||0
5072074|NCT01802632|12479891|P4|COMPLETED|Overall Study||0
5072075|NCT01802632|12479892|P3|COMPLETED|Overall Study||0
5072076|NCT01802632|12479893|P2|COMPLETED|Overall Study||0
5072077|NCT01802632|12479894|P1|COMPLETED|Overall Study||0
5072078|NCT01802632|12479889|P6|STARTED|Overall Study||28
5072079|NCT01802632|12479890|P5|STARTED|Overall Study||12
5072080|NCT01802632|12479891|P4|STARTED|Overall Study||60
5072081|NCT01802632|12479892|P3|STARTED|Overall Study||271
5072082|NCT01802632|12479893|P2|STARTED|Overall Study||31
5072083|NCT01802632|12479894|P1|STARTED|Overall Study||201
5072084|NCT01802580|12479910|P2|NOT COMPLETED|Overall Study||11
5072085|NCT01802580|12479911|P1|NOT COMPLETED|Overall Study||9
5072086|NCT01802580|12479910|P2|COMPLETED|Overall Study||9
5072087|NCT01802580|12479911|P1|COMPLETED|Overall Study||11
5072088|NCT01802580|12479910|P2|STARTED|Overall Study||20
5072089|NCT01802580|12479911|P1|STARTED|Overall Study||20
5072090|NCT01802554|12479924|P2|NOT COMPLETED|Overall Study||6
5072091|NCT01802554|12479925|P1|NOT COMPLETED|Overall Study||8
5072092|NCT01802554|12479924|P2|COMPLETED|Overall Study||43
5072093|NCT01802554|12479925|P1|COMPLETED|Overall Study||43
5072094|NCT01802554|12479924|P2|STARTED|Overall Study||49
5072095|NCT01802554|12479925|P1|STARTED|Overall Study||51
5072096|NCT01802515|12479942|P3|NOT COMPLETED|Overall Study||0
5072097|NCT01802515|12479943|P2|NOT COMPLETED|Overall Study||0
5072098|NCT01802515|12479944|P1|NOT COMPLETED|Overall Study||3
5072099|NCT01802515|12479942|P3|COMPLETED|Overall Study||4
5072100|NCT01802515|12479943|P2|COMPLETED|Overall Study||5
5072101|NCT01802515|12479944|P1|COMPLETED|Overall Study||2
5072102|NCT01802515|12479942|P3|STARTED|Overall Study||4
5072103|NCT01802515|12479943|P2|STARTED|Overall Study||5
5072104|NCT01802515|12479944|P1|STARTED|Overall Study||5
5072105|NCT01802437|12479957|P2|NOT COMPLETED|Overall Study||4
5072106|NCT01802437|12479958|P1|NOT COMPLETED|Overall Study||4
5072107|NCT01802437|12479957|P2|COMPLETED|Overall Study||16
5072108|NCT01802437|12479958|P1|COMPLETED|Overall Study||16
5072109|NCT01802437|12479957|P2|STARTED|Overall Study||20
5072110|NCT01802437|12479958|P1|STARTED|Overall Study||20
5072111|NCT01802385|12479970|P2|NOT COMPLETED|Overall Study||120
5072112|NCT01802385|12479971|P1|NOT COMPLETED|Overall Study||106
5072113|NCT01802385|12479970|P2|COMPLETED|Overall Study||109
5072114|NCT01802385|12479971|P1|COMPLETED|Overall Study||125
5072115|NCT01802385|12479970|P2|STARTED|Overall Study||229
5072116|NCT01802385|12479971|P1|STARTED|Overall Study||231
5072117|NCT01802333|12479994|P3|NOT COMPLETED|Overall Study||63
5072118|NCT01802333|12479995|P2|NOT COMPLETED|Overall Study||61
5072119|NCT01802333|12479996|P1|NOT COMPLETED|Overall Study||49
5072120|NCT01802333|12479994|P3|COMPLETED|Overall Study||161
5072121|NCT01802333|12479995|P2|COMPLETED|Overall Study||206
5072122|NCT01802333|12479996|P1|COMPLETED|Overall Study||214
5072123|NCT01802333|12479994|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
5072124|NCT01802333|12479995|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
5072125|NCT01802333|12479996|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
5072126|NCT01802333|12479994|P3|Known NPM1 Status at Baseline|Overall Study||142
5072127|NCT01802333|12479995|P2|Known NPM1 Status at Baseline|Overall Study||156
5072128|NCT01802333|12479996|P1|Known NPM1 Status at Baseline|Overall Study||169
5072129|NCT01802333|12479994|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
5072130|NCT01802333|12479995|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
5072131|NCT01802333|12479996|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
5072132|NCT01802333|12479994|P3|High Risk Patients|Overall Study||38
5072133|NCT01802333|12479995|P2|High Risk Patients|Overall Study||61
5072134|NCT01802333|12479996|P1|High Risk Patients|Overall Study||60
5072135|NCT01802333|12479994|P3|STARTED|Overall Study||224
5072136|NCT01802333|12479995|P2|STARTED|Overall Study||267
5072137|NCT01802333|12479996|P1|STARTED|Overall Study||263
5072138|NCT01802320|12480023|P1|NOT COMPLETED|Overall Study||2
5072139|NCT01802320|12480023|P1|COMPLETED|Overall Study||16
5072140|NCT01802320|12480023|P1|STARTED|Overall Study||18
5072141|NCT01802216|12480033|P2|NOT COMPLETED|12 Month Visit||4
5072142|NCT01802216|12480034|P1|NOT COMPLETED|12 Month Visit||3
5072143|NCT01802216|12480033|P2|COMPLETED|12 Month Visit||30
5072144|NCT01802216|12480034|P1|COMPLETED|12 Month Visit||14
5072145|NCT01802216|12480033|P2|STARTED|12 Month Visit||34
5072146|NCT01802216|12480034|P1|STARTED|12 Month Visit||17
5072147|NCT01802216|12480033|P2|NOT COMPLETED|8 Month Visit||5
5072148|NCT01802216|12480034|P1|NOT COMPLETED|8 Month Visit||3
5072149|NCT01802216|12480033|P2|COMPLETED|8 Month Visit||29
5072150|NCT01802216|12480034|P1|COMPLETED|8 Month Visit||14
5072151|NCT01802216|12480033|P2|STARTED|8 Month Visit||34
5072152|NCT01802216|12480034|P1|STARTED|8 Month Visit||17
5072153|NCT01802216|12480033|P2|NOT COMPLETED|4 Month Visit||4
5072154|NCT01802216|12480034|P1|NOT COMPLETED|4 Month Visit||3
5072155|NCT01802216|12480033|P2|COMPLETED|4 Month Visit||30
5072156|NCT01802216|12480034|P1|COMPLETED|4 Month Visit||14
5072157|NCT01802216|12480033|P2|STARTED|4 Month Visit||34
5072158|NCT01802216|12480034|P1|STARTED|4 Month Visit||17
5072159|NCT01802216|12480033|P2|NOT COMPLETED|Baseline||0
5072160|NCT01802216|12480034|P1|NOT COMPLETED|Baseline||0
5072161|NCT01802216|12480033|P2|COMPLETED|Baseline||34
5072162|NCT01802216|12480034|P1|COMPLETED|Baseline||17
5072163|NCT01802216|12480033|P2|STARTED|Baseline||34
5072164|NCT01802216|12480034|P1|STARTED|Baseline||17
5072165|NCT01802151|12480046|P4|NOT COMPLETED|Overall Study||0
5072166|NCT01802151|12480047|P3|NOT COMPLETED|Overall Study||2
5072167|NCT01802151|12480048|P2|NOT COMPLETED|Overall Study||0
5072168|NCT01802151|12480049|P1|NOT COMPLETED|Overall Study||0
5072169|NCT01802151|12480046|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
5072170|NCT01802151|12480047|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
5072171|NCT01802151|12480048|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
5072172|NCT01802151|12480049|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
5072173|NCT01802151|12480046|P4|STARTED|Overall Study||20
5072174|NCT01802151|12480047|P3|STARTED|Overall Study||22
5072175|NCT01802151|12480048|P2|STARTED|Overall Study||21
5072176|NCT01802151|12480049|P1|STARTED|Overall Study||20
5072177|NCT01802073|12480113|P2|NOT COMPLETED|Overall Study||11
5072178|NCT01802073|12480114|P1|NOT COMPLETED|Overall Study||5
5072179|NCT01802073|12480113|P2|COMPLETED|Overall Study||9
5072180|NCT01802073|12480114|P1|COMPLETED|Overall Study||9
5072181|NCT01802073|12480113|P2|STARTED|Overall Study||20
5072182|NCT01802073|12480114|P1|STARTED|Overall Study||14
5072183|NCT01801982|12480130|P1|NOT COMPLETED|Overall Study||1
5072184|NCT01801982|12480130|P1|COMPLETED|Overall Study||0
5072185|NCT01801982|12480130|P1|STARTED|Overall Study||1
5072186|NCT01801917|12480144|P4|NOT COMPLETED|Extension - All Active||0
5072187|NCT01801917|12480145|P3|NOT COMPLETED|Extension - All Active||0
5072188|NCT01801917|12480146|P2|NOT COMPLETED|Extension - All Active||0
5072189|NCT01801917|12480147|P1|NOT COMPLETED|Extension - All Active||0
5072190|NCT01801917|12480144|P4|COMPLETED|Extension - All Active||0
5072191|NCT01801917|12480145|P3|COMPLETED|Extension - All Active||3
5072192|NCT01801917|12480146|P2|COMPLETED|Extension - All Active||0
5072193|NCT01801917|12480147|P1|COMPLETED|Extension - All Active||6
5072194|NCT01801917|12480144|P4|STARTED|Extension - All Active||0
5072195|NCT01801917|12480145|P3|STARTED|Extension - All Active||3
5072196|NCT01801917|12480146|P2|STARTED|Extension - All Active||0
5072197|NCT01801917|12480147|P1|STARTED|Extension - All Active||6
5072198|NCT01801917|12480144|P4|NOT COMPLETED|Period 1 - Randomized||0
5072199|NCT01801917|12480145|P3|NOT COMPLETED|Period 1 - Randomized||1
5072200|NCT01801917|12480146|P2|NOT COMPLETED|Period 1 - Randomized||0
5072201|NCT01801917|12480147|P1|NOT COMPLETED|Period 1 - Randomized||1
5072202|NCT01801917|12480144|P4|COMPLETED|Period 1 - Randomized||1
5072203|NCT01801917|12480145|P3|COMPLETED|Period 1 - Randomized||3
5072204|NCT01801917|12480146|P2|COMPLETED|Period 1 - Randomized||2
5072205|NCT01801917|12480147|P1|COMPLETED|Period 1 - Randomized||6
5072206|NCT01801917|12480144|P4|STARTED|Period 1 - Randomized||1
5072207|NCT01801917|12480145|P3|STARTED|Period 1 - Randomized||4
5072208|NCT01801917|12480146|P2|STARTED|Period 1 - Randomized||2
5072209|NCT01801917|12480147|P1|STARTED|Period 1 - Randomized||7
5072210|NCT01801735|12480167|P1|NOT COMPLETED|Overall Study||210
5072211|NCT01801735|12480167|P1|COMPLETED|Overall Study||390
5072212|NCT01801735|12480167|P1|STARTED|Overall Study||600
5072213|NCT01801475|12480174|P5|NOT COMPLETED|Overall Study||1
5072214|NCT01801475|12480175|P4|NOT COMPLETED|Overall Study||0
5072215|NCT01801475|12480176|P3|NOT COMPLETED|Overall Study||0
5072216|NCT01801475|12480177|P2|NOT COMPLETED|Overall Study||0
5072217|NCT01801475|12480178|P1|NOT COMPLETED|Overall Study||0
5072218|NCT01801475|12480174|P5|COMPLETED|Overall Study||39
5072219|NCT01801475|12480175|P4|COMPLETED|Overall Study||10
5072220|NCT01801475|12480176|P3|COMPLETED|Overall Study||10
5072221|NCT01801475|12480177|P2|COMPLETED|Overall Study||30
5072222|NCT01801475|12480178|P1|COMPLETED|Overall Study||10
5072223|NCT01801475|12480174|P5|STARTED|Overall Study||40
5072224|NCT01801475|12480175|P4|STARTED|Overall Study||10
5072225|NCT01801475|12480176|P3|STARTED|Overall Study||10
5072226|NCT01801475|12480177|P2|STARTED|Overall Study||30
5072227|NCT01801475|12480178|P1|STARTED|Overall Study||10
5072228|NCT01801449|12480189|P1|NOT COMPLETED|Overall Study||0
5072229|NCT01801449|12480189|P1|COMPLETED|Overall Study||6
5072230|NCT01801449|12480189|P1|STARTED|Overall Study||6
5072231|NCT01801436|12480203|P1|NOT COMPLETED|Overall Study||9
5072232|NCT01801436|12480203|P1|COMPLETED|Overall Study||5
5072233|NCT01801436|12480203|P1|STARTED|Overall Study||14
5072234|NCT01801358|12480241|P6|NOT COMPLETED|Overall Study||8
5072235|NCT01801358|12480242|P5|NOT COMPLETED|Overall Study||6
5072236|NCT01801358|12480243|P4|NOT COMPLETED|Overall Study||6
5072237|NCT01801358|12480244|P3|NOT COMPLETED|Overall Study||6
5072238|NCT01801358|12480245|P2|NOT COMPLETED|Overall Study||6
5072239|NCT01801358|12480246|P1|NOT COMPLETED|Overall Study||6
5072240|NCT01801358|12480241|P6|COMPLETED|Overall Study||0
5072241|NCT01801358|12480242|P5|COMPLETED|Overall Study||0
5072242|NCT01801358|12480243|P4|COMPLETED|Overall Study||0
5072243|NCT01801358|12480244|P3|COMPLETED|Overall Study||0
5072244|NCT01801358|12480245|P2|COMPLETED|Overall Study||0
5072245|NCT01801358|12480246|P1|COMPLETED|Overall Study||0
5072246|NCT01801358|12480241|P6|STARTED|Overall Study||8
5072247|NCT01801358|12480242|P5|STARTED|Overall Study||6
5072248|NCT01801358|12480243|P4|STARTED|Overall Study||6
5072249|NCT01801358|12480244|P3|STARTED|Overall Study||6
5072250|NCT01801358|12480245|P2|STARTED|Overall Study||6
5072251|NCT01801358|12480246|P1|STARTED|Overall Study||6
5072252|NCT01801280|12480368|P4|NOT COMPLETED|Period 4||0
5072253|NCT01801280|12480369|P3|NOT COMPLETED|Period 4||1
5072254|NCT01801280|12480370|P2|NOT COMPLETED|Period 4||0
5072255|NCT01801280|12480371|P1|NOT COMPLETED|Period 4||0
5072256|NCT01801280|12480368|P4|COMPLETED|Period 4||5
5072257|NCT01801280|12480369|P3|COMPLETED|Period 4||4
5072258|NCT01801280|12480370|P2|COMPLETED|Period 4||4
5072259|NCT01801280|12480371|P1|COMPLETED|Period 4||4
5072260|NCT01801280|12480368|P4|STARTED|Period 4||5
5072261|NCT01801280|12480369|P3|STARTED|Period 4||5
5072262|NCT01801280|12480370|P2|STARTED|Period 4||4
5072263|NCT01801280|12480371|P1|STARTED|Period 4||4
5072264|NCT01801280|12480368|P4|NOT COMPLETED|Period 3||0
5072265|NCT01801280|12480369|P3|NOT COMPLETED|Period 3||0
5072266|NCT01801280|12480370|P2|NOT COMPLETED|Period 3||0
5072267|NCT01801280|12480371|P1|NOT COMPLETED|Period 3||0
5072268|NCT01801280|12480368|P4|COMPLETED|Period 3||5
5072269|NCT01801280|12480369|P3|COMPLETED|Period 3||5
5072270|NCT01801280|12480370|P2|COMPLETED|Period 3||4
5072271|NCT01801280|12480371|P1|COMPLETED|Period 3||4
5072272|NCT01801280|12480368|P4|STARTED|Period 3||5
5072273|NCT01801280|12480369|P3|STARTED|Period 3||5
5072274|NCT01801280|12480370|P2|STARTED|Period 3||4
5072275|NCT01801280|12480371|P1|STARTED|Period 3||4
5072276|NCT01801280|12480368|P4|NOT COMPLETED|Period 2||0
5072277|NCT01801280|12480369|P3|NOT COMPLETED|Period 2||0
5072278|NCT01801280|12480370|P2|NOT COMPLETED|Period 2||0
5072279|NCT01801280|12480371|P1|NOT COMPLETED|Period 2||1
5072280|NCT01801280|12480368|P4|COMPLETED|Period 2||5
5072281|NCT01801280|12480369|P3|COMPLETED|Period 2||5
5072282|NCT01801280|12480370|P2|COMPLETED|Period 2||4
5072283|NCT01801280|12480371|P1|COMPLETED|Period 2||4
5072284|NCT01801280|12480368|P4|STARTED|Period 2||5
5072285|NCT01801280|12480369|P3|STARTED|Period 2||5
5072286|NCT01801280|12480370|P2|STARTED|Period 2||4
5072287|NCT01801280|12480371|P1|STARTED|Period 2||5
5072288|NCT01801280|12480368|P4|NOT COMPLETED|Period 1||0
5072289|NCT01801280|12480369|P3|NOT COMPLETED|Period 1||0
5072290|NCT01801280|12480370|P2|NOT COMPLETED|Period 1||1
5072291|NCT01801280|12480371|P1|NOT COMPLETED|Period 1||0
5072292|NCT01801280|12480368|P4|COMPLETED|Period 1||5
5072293|NCT01801280|12480369|P3|COMPLETED|Period 1||5
5072294|NCT01801280|12480370|P2|COMPLETED|Period 1||4
5072295|NCT01801280|12480371|P1|COMPLETED|Period 1||5
5072296|NCT01801280|12480368|P4|STARTED|Period 1||5
5072297|NCT01801280|12480369|P3|STARTED|Period 1||5
5072298|NCT01801280|12480370|P2|STARTED|Period 1||5
5072299|NCT01801280|12480371|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
5072300|NCT01801124|12480381|P1|NOT COMPLETED|Overall Study||0
5072301|NCT01801124|12480381|P1|COMPLETED|Overall Study||13
5072302|NCT01801124|12480381|P1|STARTED|Overall Study||13
5072303|NCT01801111|12480386|P1|NOT COMPLETED|Overall Study||138
5072304|NCT01801111|12480386|P1|COMPLETED|Overall Study||0
5072305|NCT01801111|12480386|P1|STARTED|Overall Study||138
5072306|NCT01800968|12480427|P2|NOT COMPLETED|Overall Study||32
5072307|NCT01800968|12480428|P1|NOT COMPLETED|Overall Study||36
5072308|NCT01800968|12480427|P2|COMPLETED|Overall Study||114
5072309|NCT01800968|12480428|P1|COMPLETED|Overall Study||118
5072310|NCT01800968|12480427|P2|STARTED|Overall Study||146
5072311|NCT01800968|12480428|P1|STARTED|Overall Study||154
5072312|NCT01800916|12480470|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
5072313|NCT01800916|12480471|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
5072314|NCT01800916|12480472|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
5072315|NCT01800916|12480473|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
5072316|NCT01800916|12480474|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
5072317|NCT01800916|12480475|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
5072318|NCT01800916|12480476|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
5072319|NCT01800916|12480477|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
5072320|NCT01800916|12480478|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
5072321|NCT01800916|12480470|P9|COMPLETED|Test Period 3 (1 Week)||7
5072322|NCT01800916|12480471|P8|COMPLETED|Test Period 3 (1 Week)||7
5072323|NCT01800916|12480472|P7|COMPLETED|Test Period 3 (1 Week)||7
5072324|NCT01800916|12480473|P6|COMPLETED|Test Period 3 (1 Week)||7
5072325|NCT01800916|12480474|P5|COMPLETED|Test Period 3 (1 Week)||7
5072326|NCT01800916|12480475|P4|COMPLETED|Test Period 3 (1 Week)||6
5072327|NCT01800916|12480476|P3|COMPLETED|Test Period 3 (1 Week)||7
5072328|NCT01800916|12480477|P2|COMPLETED|Test Period 3 (1 Week)||7
5072329|NCT01800916|12480478|P1|COMPLETED|Test Period 3 (1 Week)||7
5072330|NCT01800916|12480470|P9|STARTED|Test Period 3 (1 Week)||7
5072331|NCT01800916|12480471|P8|STARTED|Test Period 3 (1 Week)||7
5072332|NCT01800916|12480472|P7|STARTED|Test Period 3 (1 Week)||7
5072333|NCT01800916|12480473|P6|STARTED|Test Period 3 (1 Week)||7
5072334|NCT01800916|12480474|P5|STARTED|Test Period 3 (1 Week)||7
5072335|NCT01800916|12480475|P4|STARTED|Test Period 3 (1 Week)||6
5072336|NCT01800916|12480476|P3|STARTED|Test Period 3 (1 Week)||7
5072337|NCT01800916|12480477|P2|STARTED|Test Period 3 (1 Week)||7
5072338|NCT01800916|12480478|P1|STARTED|Test Period 3 (1 Week)||7
5072339|NCT01800916|12480470|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
5072340|NCT01800916|12480471|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
5072341|NCT01800916|12480472|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
5072342|NCT01800916|12480473|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
5072343|NCT01800916|12480474|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
5072344|NCT01800916|12480475|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
5072345|NCT01800916|12480476|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
5072346|NCT01800916|12480477|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
5072347|NCT01800916|12480478|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
5072348|NCT01800916|12480470|P9|COMPLETED|Test Period 2 (1 Week)||7
5072349|NCT01800916|12480471|P8|COMPLETED|Test Period 2 (1 Week)||7
5072350|NCT01800916|12480472|P7|COMPLETED|Test Period 2 (1 Week)||7
5072351|NCT01800916|12480473|P6|COMPLETED|Test Period 2 (1 Week)||7
5072352|NCT01800916|12480474|P5|COMPLETED|Test Period 2 (1 Week)||7
5072353|NCT01800916|12480475|P4|COMPLETED|Test Period 2 (1 Week)||6
5072354|NCT01800916|12480476|P3|COMPLETED|Test Period 2 (1 Week)||7
5072355|NCT01800916|12480477|P2|COMPLETED|Test Period 2 (1 Week)||7
5072356|NCT01800916|12480478|P1|COMPLETED|Test Period 2 (1 Week)||7
5072357|NCT01800916|12480470|P9|STARTED|Test Period 2 (1 Week)||7
5072358|NCT01800916|12480471|P8|STARTED|Test Period 2 (1 Week)||7
5072359|NCT01800916|12480472|P7|STARTED|Test Period 2 (1 Week)||7
5072360|NCT01800916|12480473|P6|STARTED|Test Period 2 (1 Week)||7
5072361|NCT01800916|12480474|P5|STARTED|Test Period 2 (1 Week)||7
5072362|NCT01800916|12480475|P4|STARTED|Test Period 2 (1 Week)||6
5072363|NCT01800916|12480476|P3|STARTED|Test Period 2 (1 Week)||7
5072364|NCT01800916|12480477|P2|STARTED|Test Period 2 (1 Week)||7
5072365|NCT01800916|12480478|P1|STARTED|Test Period 2 (1 Week)||7
5072366|NCT01800916|12480470|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
5072367|NCT01800916|12480471|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
5072368|NCT01800916|12480472|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
5072369|NCT01800916|12480473|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
5072370|NCT01800916|12480474|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
5072371|NCT01800916|12480475|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
5072372|NCT01800916|12480476|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
5072373|NCT01800916|12480477|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
5072374|NCT01800916|12480478|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
5072375|NCT01800916|12480470|P9|COMPLETED|Test Period 1 (1 Week)||7
5072376|NCT01800916|12480471|P8|COMPLETED|Test Period 1 (1 Week)||7
5072377|NCT01800916|12480472|P7|COMPLETED|Test Period 1 (1 Week)||7
5072378|NCT01800916|12480473|P6|COMPLETED|Test Period 1 (1 Week)||7
5072379|NCT01800916|12480474|P5|COMPLETED|Test Period 1 (1 Week)||7
5072380|NCT01800916|12480475|P4|COMPLETED|Test Period 1 (1 Week)||6
5072381|NCT01800916|12480476|P3|COMPLETED|Test Period 1 (1 Week)||7
5072382|NCT01800916|12480477|P2|COMPLETED|Test Period 1 (1 Week)||7
5072383|NCT01800916|12480478|P1|COMPLETED|Test Period 1 (1 Week)||7
5072384|NCT01800916|12480470|P9|STARTED|Test Period 1 (1 Week)||7
5072385|NCT01800916|12480471|P8|STARTED|Test Period 1 (1 Week)||7
5072386|NCT01800916|12480472|P7|STARTED|Test Period 1 (1 Week)||7
5072387|NCT01800916|12480473|P6|STARTED|Test Period 1 (1 Week)||7
5072388|NCT01800916|12480474|P5|STARTED|Test Period 1 (1 Week)||8
5072389|NCT01800916|12480475|P4|STARTED|Test Period 1 (1 Week)||7
5072390|NCT01800916|12480476|P3|STARTED|Test Period 1 (1 Week)||7
5072391|NCT01800916|12480477|P2|STARTED|Test Period 1 (1 Week)||7
5072392|NCT01800916|12480478|P1|STARTED|Test Period 1 (1 Week)||7
5072393|NCT01800903|12480488|P6|NOT COMPLETED|Third Test Period||0
5072394|NCT01800903|12480489|P5|NOT COMPLETED|Third Test Period||0
5072395|NCT01800903|12480490|P4|NOT COMPLETED|Third Test Period||0
5072396|NCT01800903|12480491|P3|NOT COMPLETED|Third Test Period||0
5072397|NCT01800903|12480492|P2|NOT COMPLETED|Third Test Period||0
5072398|NCT01800903|12480493|P1|NOT COMPLETED|Third Test Period||0
5072399|NCT01800903|12480488|P6|COMPLETED|Third Test Period||6
5072400|NCT01800903|12480489|P5|COMPLETED|Third Test Period||6
5072401|NCT01800903|12480490|P4|COMPLETED|Third Test Period||7
5072402|NCT01800903|12480491|P3|COMPLETED|Third Test Period||4
5072403|NCT01800903|12480492|P2|COMPLETED|Third Test Period||6
5072404|NCT01800903|12480493|P1|COMPLETED|Third Test Period||6
5072405|NCT01800903|12480488|P6|STARTED|Third Test Period||6
5072406|NCT01800903|12480489|P5|STARTED|Third Test Period||6
5072407|NCT01800903|12480490|P4|STARTED|Third Test Period||7
5072408|NCT01800903|12480491|P3|STARTED|Third Test Period||4
5072409|NCT01800903|12480492|P2|STARTED|Third Test Period||6
5072410|NCT01800903|12480493|P1|STARTED|Third Test Period||6
5072411|NCT01800903|12480488|P6|NOT COMPLETED|Second Test Period||0
5072412|NCT01800903|12480489|P5|NOT COMPLETED|Second Test Period||0
5072413|NCT01800903|12480490|P4|NOT COMPLETED|Second Test Period||0
5072414|NCT01800903|12480491|P3|NOT COMPLETED|Second Test Period||0
5072415|NCT01800903|12480492|P2|NOT COMPLETED|Second Test Period||0
5072416|NCT01800903|12480493|P1|NOT COMPLETED|Second Test Period||1
5072417|NCT01800903|12480488|P6|COMPLETED|Second Test Period||6
5072418|NCT01800903|12480489|P5|COMPLETED|Second Test Period||6
5072419|NCT01800903|12480490|P4|COMPLETED|Second Test Period||7
5072420|NCT01800903|12480491|P3|COMPLETED|Second Test Period||4
5072421|NCT01800903|12480492|P2|COMPLETED|Second Test Period||6
5072422|NCT01800903|12480493|P1|COMPLETED|Second Test Period||6
5072423|NCT01800903|12480488|P6|STARTED|Second Test Period||6
5072424|NCT01800903|12480489|P5|STARTED|Second Test Period||6
5072425|NCT01800903|12480490|P4|STARTED|Second Test Period||7
5072426|NCT01800903|12480491|P3|STARTED|Second Test Period||4
5072427|NCT01800903|12480492|P2|STARTED|Second Test Period||6
5072428|NCT01800903|12480493|P1|STARTED|Second Test Period||7
5072429|NCT01800903|12480488|P6|NOT COMPLETED|First Test Period||0
5072430|NCT01800903|12480489|P5|NOT COMPLETED|First Test Period||0
5072431|NCT01800903|12480490|P4|NOT COMPLETED|First Test Period||0
5072432|NCT01800903|12480491|P3|NOT COMPLETED|First Test Period||0
5072433|NCT01800903|12480492|P2|NOT COMPLETED|First Test Period||0
5072434|NCT01800903|12480493|P1|NOT COMPLETED|First Test Period||0
5072435|NCT01800903|12480488|P6|COMPLETED|First Test Period||6
5072436|NCT01800903|12480489|P5|COMPLETED|First Test Period||6
5072437|NCT01800903|12480490|P4|COMPLETED|First Test Period||7
5072438|NCT01800903|12480491|P3|COMPLETED|First Test Period||4
5072439|NCT01800903|12480492|P2|COMPLETED|First Test Period||6
5072440|NCT01800903|12480493|P1|COMPLETED|First Test Period||7
5072441|NCT01800903|12480488|P6|STARTED|First Test Period||6
5072442|NCT01800903|12480489|P5|STARTED|First Test Period||6
5072443|NCT01800903|12480490|P4|STARTED|First Test Period||7
5072444|NCT01800903|12480491|P3|STARTED|First Test Period||4
5072445|NCT01800903|12480492|P2|STARTED|First Test Period||6
5072446|NCT01800903|12480493|P1|STARTED|First Test Period||7
5072447|NCT01800890|12480499|P9|NOT COMPLETED|Test Period 3||0
5072448|NCT01800890|12480500|P8|NOT COMPLETED|Test Period 3||0
5072449|NCT01800890|12480501|P7|NOT COMPLETED|Test Period 3||0
5072450|NCT01800890|12480502|P6|NOT COMPLETED|Test Period 3||0
5072451|NCT01800890|12480503|P5|NOT COMPLETED|Test Period 3||0
5072452|NCT01800890|12480504|P4|NOT COMPLETED|Test Period 3||0
5072453|NCT01800890|12480505|P3|NOT COMPLETED|Test Period 3||0
5072454|NCT01800890|12480506|P2|NOT COMPLETED|Test Period 3||0
5072455|NCT01800890|12480507|P1|NOT COMPLETED|Test Period 3||0
5072456|NCT01800890|12480499|P9|COMPLETED|Test Period 3||3
5072457|NCT01800890|12480500|P8|COMPLETED|Test Period 3||3
5072458|NCT01800890|12480501|P7|COMPLETED|Test Period 3||3
5072459|NCT01800890|12480502|P6|COMPLETED|Test Period 3||4
5072460|NCT01800890|12480503|P5|COMPLETED|Test Period 3||4
5072461|NCT01800890|12480504|P4|COMPLETED|Test Period 3||2
5072462|NCT01800890|12480505|P3|COMPLETED|Test Period 3||3
5072463|NCT01800890|12480506|P2|COMPLETED|Test Period 3||3
5072464|NCT01800890|12480507|P1|COMPLETED|Test Period 3||3
5072465|NCT01800890|12480499|P9|STARTED|Test Period 3||3
5072466|NCT01800890|12480500|P8|STARTED|Test Period 3||3
5072467|NCT01800890|12480501|P7|STARTED|Test Period 3||3
5072468|NCT01800890|12480502|P6|STARTED|Test Period 3||4
5072469|NCT01800890|12480503|P5|STARTED|Test Period 3||4
5072470|NCT01800890|12480504|P4|STARTED|Test Period 3||2
5072471|NCT01800890|12480505|P3|STARTED|Test Period 3||3
5072472|NCT01800890|12480506|P2|STARTED|Test Period 3||3
5072473|NCT01800890|12480507|P1|STARTED|Test Period 3||3
5072474|NCT01800890|12480499|P9|NOT COMPLETED|Test Period 2||0
5072475|NCT01800890|12480500|P8|NOT COMPLETED|Test Period 2||0
5072476|NCT01800890|12480501|P7|NOT COMPLETED|Test Period 2||0
5072477|NCT01800890|12480502|P6|NOT COMPLETED|Test Period 2||0
5072478|NCT01800890|12480503|P5|NOT COMPLETED|Test Period 2||0
5072479|NCT01800890|12480504|P4|NOT COMPLETED|Test Period 2||0
5072480|NCT01800890|12480505|P3|NOT COMPLETED|Test Period 2||0
5072481|NCT01800890|12480506|P2|NOT COMPLETED|Test Period 2||0
5072482|NCT01800890|12480507|P1|NOT COMPLETED|Test Period 2||0
5072483|NCT01800890|12480499|P9|COMPLETED|Test Period 2||3
5072484|NCT01800890|12480500|P8|COMPLETED|Test Period 2||3
5072485|NCT01800890|12480501|P7|COMPLETED|Test Period 2||3
5072486|NCT01800890|12480502|P6|COMPLETED|Test Period 2||4
5072487|NCT01800890|12480503|P5|COMPLETED|Test Period 2||4
5072488|NCT01800890|12480504|P4|COMPLETED|Test Period 2||2
5072489|NCT01800890|12480505|P3|COMPLETED|Test Period 2||3
5072490|NCT01800890|12480506|P2|COMPLETED|Test Period 2||3
5072491|NCT01800890|12480507|P1|COMPLETED|Test Period 2||3
5072492|NCT01800890|12480499|P9|STARTED|Test Period 2||3
5072493|NCT01800890|12480500|P8|STARTED|Test Period 2||3
5072494|NCT01800890|12480501|P7|STARTED|Test Period 2||3
5072495|NCT01800890|12480502|P6|STARTED|Test Period 2||4
5072496|NCT01800890|12480503|P5|STARTED|Test Period 2||4
5072497|NCT01800890|12480504|P4|STARTED|Test Period 2||2
5072498|NCT01800890|12480505|P3|STARTED|Test Period 2||3
5072499|NCT01800890|12480506|P2|STARTED|Test Period 2||3
5072500|NCT01800890|12480507|P1|STARTED|Test Period 2||3
5072501|NCT01800890|12480499|P9|NOT COMPLETED|Test Period 1||0
5072502|NCT01800890|12480500|P8|NOT COMPLETED|Test Period 1||0
5072503|NCT01800890|12480501|P7|NOT COMPLETED|Test Period 1||0
5072504|NCT01800890|12480502|P6|NOT COMPLETED|Test Period 1||0
5072505|NCT01800890|12480503|P5|NOT COMPLETED|Test Period 1||0
5072506|NCT01800890|12480504|P4|NOT COMPLETED|Test Period 1||1
5072507|NCT01800890|12480505|P3|NOT COMPLETED|Test Period 1||0
5072508|NCT01800890|12480506|P2|NOT COMPLETED|Test Period 1||0
5072509|NCT01800890|12480507|P1|NOT COMPLETED|Test Period 1||0
5072510|NCT01800890|12480499|P9|COMPLETED|Test Period 1||3
5072511|NCT01800890|12480500|P8|COMPLETED|Test Period 1||3
5072512|NCT01800890|12480501|P7|COMPLETED|Test Period 1||3
5072513|NCT01800890|12480502|P6|COMPLETED|Test Period 1||4
5072514|NCT01800890|12480503|P5|COMPLETED|Test Period 1||4
5072515|NCT01800890|12480504|P4|COMPLETED|Test Period 1||2
5072516|NCT01800890|12480505|P3|COMPLETED|Test Period 1||3
5072517|NCT01800890|12480506|P2|COMPLETED|Test Period 1||3
5072518|NCT01800890|12480507|P1|COMPLETED|Test Period 1||3
5072519|NCT01800890|12480499|P9|STARTED|Test Period 1||3
5072520|NCT01800890|12480500|P8|STARTED|Test Period 1||3
5072521|NCT01800890|12480501|P7|STARTED|Test Period 1||3
5072522|NCT01800890|12480502|P6|STARTED|Test Period 1||4
5072523|NCT01800890|12480503|P5|STARTED|Test Period 1||4
5072524|NCT01800890|12480504|P4|STARTED|Test Period 1||3
5072525|NCT01800890|12480505|P3|STARTED|Test Period 1||3
5072526|NCT01800890|12480506|P2|STARTED|Test Period 1||3
5072527|NCT01800890|12480507|P1|STARTED|Test Period 1||3
5072528|NCT01800877|12480519|P2|NOT COMPLETED|Overall Study||0
5072529|NCT01800877|12480520|P1|NOT COMPLETED|Overall Study||2
5072530|NCT01800877|12480519|P2|COMPLETED|Overall Study||60
5072531|NCT01800877|12480520|P1|COMPLETED|Overall Study||58
5072532|NCT01800877|12480519|P2|STARTED|Overall Study||60
5072533|NCT01800877|12480520|P1|STARTED|Overall Study||60
5072534|NCT01800838|12480530|P4|NOT COMPLETED|Overall Study||0
5072535|NCT01800838|12480531|P3|NOT COMPLETED|Overall Study||0
5072536|NCT01800838|12480532|P2|NOT COMPLETED|Overall Study||0
5072537|NCT01800838|12480533|P1|NOT COMPLETED|Overall Study||0
5072538|NCT01800838|12480530|P4|COMPLETED|Overall Study||2
5072539|NCT01800838|12480531|P3|COMPLETED|Overall Study||7
5072540|NCT01800838|12480532|P2|COMPLETED|Overall Study||1
5072541|NCT01800838|12480533|P1|COMPLETED|Overall Study||1
5072542|NCT01800838|12480530|P4|STARTED|Overall Study||2
5072543|NCT01800838|12480531|P3|STARTED|Overall Study||7
5072544|NCT01800838|12480532|P2|STARTED|Overall Study||1
5072545|NCT01800838|12480533|P1|STARTED|Overall Study||1
5072546|NCT01800786|12480540|P2|NOT COMPLETED|Overall Study||1
5072547|NCT01800786|12480541|P1|NOT COMPLETED|Overall Study||2
5072548|NCT01800786|12480540|P2|COMPLETED|Overall Study||15
5072549|NCT01800786|12480541|P1|COMPLETED|Overall Study||15
5072550|NCT01800786|12480540|P2|STARTED|Overall Study||16
5072551|NCT01800786|12480541|P1|STARTED|Overall Study||17
5072552|NCT01800318|12480551|P4|NOT COMPLETED|Overall Study||1
5072553|NCT01800318|12480552|P3|NOT COMPLETED|Overall Study||1
5072554|NCT01800318|12480553|P2|NOT COMPLETED|Overall Study||5
5072555|NCT01800318|12480554|P1|NOT COMPLETED|Overall Study||2
5072556|NCT01800318|12480551|P4|COMPLETED|Overall Study||39
5072557|NCT01800318|12480552|P3|COMPLETED|Overall Study||40
5072558|NCT01800318|12480553|P2|COMPLETED|Overall Study||37
5072559|NCT01800318|12480554|P1|COMPLETED|Overall Study||37
5072560|NCT01800318|12480551|P4|STARTED|Overall Study||40
5072561|NCT01800318|12480552|P3|STARTED|Overall Study||41
5072562|NCT01800318|12480553|P2|STARTED|Overall Study||42
5072563|NCT01800318|12480554|P1|STARTED|Overall Study||39
5072564|NCT01800201|12480582|P2|NOT COMPLETED|Overall Study||3
5072565|NCT01800201|12480583|P1|NOT COMPLETED|Overall Study||3
5072566|NCT01800201|12480582|P2|COMPLETED|Overall Study||1000
5072567|NCT01800201|12480583|P1|COMPLETED|Overall Study||503
5072568|NCT01800201|12480582|P2|STARTED|Overall Study||1003
5072569|NCT01800201|12480583|P1|STARTED|Overall Study||506
5072570|NCT01800162|12480598|P3|NOT COMPLETED|Overall Study||0
5072571|NCT01800162|12480599|P2|NOT COMPLETED|Overall Study||0
5072572|NCT01800162|12480600|P1|NOT COMPLETED|Overall Study||0
5072573|NCT01800162|12480598|P3|COMPLETED|Overall Study||1
5072574|NCT01800162|12480599|P2|COMPLETED|Overall Study||0
5072575|NCT01800162|12480600|P1|COMPLETED|Overall Study||1
5072576|NCT01800162|12480598|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
5072577|NCT01800162|12480599|P2|STARTED|Overall Study||0
5072578|NCT01800162|12480600|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
5072579|NCT01800058|12480624|P1|NOT COMPLETED|Overall Study||1
5072580|NCT01800058|12480624|P1|COMPLETED|Overall Study||65
5072581|NCT01800058|12480624|P1|STARTED|Overall Study||66
5072582|NCT01799993|12480637|P2|NOT COMPLETED|Overall Study||128
5072583|NCT01799993|12480638|P1|NOT COMPLETED|Overall Study||133
5072584|NCT01799993|12480637|P2|COMPLETED|Overall Study||235
5072585|NCT01799993|12480638|P1|COMPLETED|Overall Study||229
5072586|NCT01799993|12480637|P2|mITT Population|Overall Study||253
5072587|NCT01799993|12480638|P1|mITT Population|Overall Study||255
5072588|NCT01799993|12480637|P2|ITT Population|Overall Study||358
5072589|NCT01799993|12480638|P1|ITT Population|Overall Study||354
5072590|NCT01799993|12480637|P2|STARTED|Overall Study||363
5072591|NCT01799993|12480638|P1|STARTED|Overall Study||362
5072592|NCT01799941|12480670|P1|NOT COMPLETED|Overall Study||96
5072593|NCT01799941|12480670|P1|COMPLETED|Overall Study||271
5072594|NCT01799941|12480670|P1|STARTED|Overall Study||367
5072595|NCT01799720|12480727|P3|NOT COMPLETED|Overall Study||1
5072596|NCT01799720|12480728|P2|NOT COMPLETED|Overall Study||1
5072597|NCT01799720|12480729|P1|NOT COMPLETED|Overall Study||3
5072598|NCT01799720|12480727|P3|COMPLETED|Overall Study||18
5072599|NCT01799720|12480728|P2|COMPLETED|Overall Study||17
5072600|NCT01799720|12480729|P1|COMPLETED|Overall Study||17
5072601|NCT01799720|12480727|P3|Began the Treatment and Finished it|Overall Study||18
5072602|NCT01799720|12480728|P2|Began the Treatment and Finished it|Overall Study||17
5072603|NCT01799720|12480729|P1|Began the Treatment and Finished it|Overall Study||17
5072604|NCT01799720|12480727|P3|Began the Treatment|Overall Study||19
5072605|NCT01799720|12480728|P2|Began the Treatment|Overall Study||18
5072606|NCT01799720|12480729|P1|Began the Treatment|Overall Study||20
5072607|NCT01799720|12480727|P3|STARTED|Overall Study||19
5072608|NCT01799720|12480728|P2|STARTED|Overall Study||18
5072609|NCT01799720|12480729|P1|STARTED|Overall Study||20
5072610|NCT01799590|12480767|P3|NOT COMPLETED|Overall Study||14
5072611|NCT01799590|12480768|P2|NOT COMPLETED|Overall Study||16
5072612|NCT01799590|12480769|P1|NOT COMPLETED|Overall Study||26
5072613|NCT01799590|12480767|P3|COMPLETED|Overall Study||77
5072614|NCT01799590|12480768|P2|COMPLETED|Overall Study||78
5072615|NCT01799590|12480769|P1|COMPLETED|Overall Study||85
5072616|NCT01799590|12480767|P3|STARTED|Overall Study||91
5072617|NCT01799590|12480768|P2|STARTED|Overall Study||94
5072618|NCT01799590|12480769|P1|STARTED|Overall Study||111
5072619|NCT01799278|12480804|P1|NOT COMPLETED|Overall Study||0
5072620|NCT01799278|12480804|P1|COMPLETED|Overall Study||60
5072621|NCT01799278|12480804|P1|STARTED|Overall Study||60
5072622|NCT01799239|12480812|P2|NOT COMPLETED|Period 2 (7 Days)||1
5072623|NCT01799239|12480813|P1|NOT COMPLETED|Period 2 (7 Days)||2
5072624|NCT01799239|12480812|P2|COMPLETED|Period 2 (7 Days)||14
5072625|NCT01799239|12480813|P1|COMPLETED|Period 2 (7 Days)||11
5072626|NCT01799239|12480812|P2|STARTED|Period 2 (7 Days)||15
5072627|NCT01799239|12480813|P1|STARTED|Period 2 (7 Days)||13
5072628|NCT01799239|12480812|P2|NOT COMPLETED|Period 1 (7 Days)||1
5072629|NCT01799239|12480813|P1|NOT COMPLETED|Period 1 (7 Days)||3
5072630|NCT01799239|12480812|P2|COMPLETED|Period 1 (7 Days)||15
5072631|NCT01799239|12480813|P1|COMPLETED|Period 1 (7 Days)||12
5072632|NCT01799239|12480812|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
5072633|NCT01799239|12480813|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
5072634|NCT01799226|12480821|P2|NOT COMPLETED|Overall Study||0
5072635|NCT01799226|12480822|P1|NOT COMPLETED|Overall Study||2
5072636|NCT01799226|12480821|P2|COMPLETED|Overall Study||16
5072637|NCT01799226|12480822|P1|COMPLETED|Overall Study||14
5072638|NCT01799226|12480821|P2|Left Stent Side|Overall Study||8
5072639|NCT01799226|12480822|P1|Left Stent Side|Overall Study||8
5072640|NCT01799226|12480821|P2|Right Stent Side|Overall Study||8
5072641|NCT01799226|12480822|P1|Right Stent Side|Overall Study||8
5072642|NCT01799226|12480821|P2|STARTED|Overall Study||16
5072643|NCT01799226|12480822|P1|STARTED|Overall Study||16
5072644|NCT01799213|12480832|P2|NOT COMPLETED|Overall Study||6
5072645|NCT01799213|12480833|P1|NOT COMPLETED|Overall Study||7
5072646|NCT01799213|12480832|P2|COMPLETED|Overall Study||178
5072647|NCT01799213|12480833|P1|COMPLETED|Overall Study||173
5072648|NCT01799213|12480832|P2|STARTED|Overall Study||184
5072649|NCT01799213|12480833|P1|STARTED|Overall Study||180
5072650|NCT01798992|12480853|P4|NOT COMPLETED|Overall Study||1
5072651|NCT01798992|12480854|P3|NOT COMPLETED|Overall Study||2
5072652|NCT01798992|12480855|P2|NOT COMPLETED|Overall Study||2
5072653|NCT01798992|12480856|P1|NOT COMPLETED|Overall Study||0
5072654|NCT01798992|12480853|P4|COMPLETED|Overall Study||16
5072655|NCT01798992|12480854|P3|COMPLETED|Overall Study||14
5072656|NCT01798992|12480855|P2|COMPLETED|Overall Study||17
5072657|NCT01798992|12480856|P1|COMPLETED|Overall Study||4
5072658|NCT01798992|12480853|P4|STARTED|Overall Study||17
5072659|NCT01798992|12480854|P3|STARTED|Overall Study||16
5072660|NCT01798992|12480855|P2|STARTED|Overall Study||19
5072661|NCT01798992|12480856|P1|STARTED|Overall Study||4
5072662|NCT01798966|12480870|P1|NOT COMPLETED|Overall Study||0
5072663|NCT01798966|12480870|P1|COMPLETED|Overall Study||10
5072664|NCT01798966|12480870|P1|STARTED|Overall Study||10
5072665|NCT01798927|12480876|P1|NOT COMPLETED|Overall Study||1
5072666|NCT01798927|12480876|P1|COMPLETED|Overall Study||3
5072667|NCT01798927|12480876|P1|STARTED|Overall Study||4
5072668|NCT01798849|12480885|P3|NOT COMPLETED|Overall Study||1
5072669|NCT01798849|12480886|P2|NOT COMPLETED|Overall Study||0
5072670|NCT01798849|12480887|P1|NOT COMPLETED|Overall Study||0
5072671|NCT01798849|12480885|P3|COMPLETED|Overall Study||8
5072672|NCT01798849|12480886|P2|COMPLETED|Overall Study||8
5072673|NCT01798849|12480887|P1|COMPLETED|Overall Study||8
5072674|NCT01798849|12480885|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
5072675|NCT01798849|12480886|P2|STARTED|Overall Study||8
5072676|NCT01798849|12480887|P1|STARTED|Overall Study||8
5072677|NCT01798706|12481077|P2|NOT COMPLETED|Overall Study||21
5072678|NCT01798706|12481078|P1|NOT COMPLETED|Overall Study||21
5072679|NCT01798706|12481077|P2|COMPLETED|Overall Study||153
5072680|NCT01798706|12481078|P1|COMPLETED|Overall Study||155
5072681|NCT01798706|12481077|P2|STARTED|Overall Study||174
5072682|NCT01798706|12481078|P1|STARTED|Overall Study||176
5072683|NCT01798641|12481106|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5072684|NCT01798641|12481107|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5072685|NCT01798641|12481106|P2|COMPLETED|Second Intervention (6 Weeks)||19
5072686|NCT01798641|12481107|P1|COMPLETED|Second Intervention (6 Weeks)||19
5072687|NCT01798641|12481106|P2|STARTED|Second Intervention (6 Weeks)||19
5072688|NCT01798641|12481107|P1|STARTED|Second Intervention (6 Weeks)||19
5072689|NCT01798641|12481106|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
5072690|NCT01798641|12481107|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5072691|NCT01798641|12481106|P2|COMPLETED|First Intervention (6 Weeks)||19
5072692|NCT01798641|12481107|P1|COMPLETED|First Intervention (6 Weeks)||19
5072693|NCT01798641|12481106|P2|STARTED|First Intervention (6 Weeks)||19
5072694|NCT01798641|12481107|P1|STARTED|First Intervention (6 Weeks)||19
5072695|NCT01798589|12481121|P1|NOT COMPLETED|Overall Study||0
5072696|NCT01798589|12481121|P1|COMPLETED|Overall Study||16
5072697|NCT01798589|12481121|P1|STARTED|Overall Study||16
5072698|NCT01798550|12481132|P2|NOT COMPLETED|Overall Study||6
5072699|NCT01798550|12481133|P1|NOT COMPLETED|Overall Study||2
5072700|NCT01798550|12481132|P2|COMPLETED|Overall Study||26
5072701|NCT01798550|12481133|P1|COMPLETED|Overall Study||28
5072702|NCT01798550|12481132|P2|STARTED|Overall Study||32
5072703|NCT01798550|12481133|P1|STARTED|Overall Study||30
5072704|NCT01798485|12481149|P2|NOT COMPLETED|Overall Study||290
5072705|NCT01798485|12481150|P1|NOT COMPLETED|Overall Study||346
5072706|NCT01798485|12481149|P2|COMPLETED|Overall Study||59
5072707|NCT01798485|12481150|P1|COMPLETED|Overall Study||1
5072708|NCT01798485|12481149|P2|Randomized as of 19 October 2015|Overall Study||337
5072709|NCT01798485|12481150|P1|Randomized as of 19 October 2015|Overall Study||335
5072710|NCT01798485|12481149|P2|Safety Population as of 23 Dec 2015|Overall Study||342
5072711|NCT01798485|12481150|P1|Safety Population as of 23 Dec 2015|Overall Study||338
5072712|NCT01798485|12481149|P2|STARTED|Overall Study||349
5072713|NCT01798485|12481150|P1|STARTED|Overall Study||347
5072714|NCT01798394|12481186|P2|NOT COMPLETED|Overall Study||3
5072715|NCT01798394|12481187|P1|NOT COMPLETED|Overall Study||3
5072716|NCT01798394|12481186|P2|COMPLETED|Overall Study||19
5072717|NCT01798394|12481187|P1|COMPLETED|Overall Study||21
5072718|NCT01798394|12481186|P2|STARTED|Overall Study||22
5072719|NCT01798394|12481187|P1|STARTED|Overall Study||24
5072720|NCT01798316|12481207|P2|NOT COMPLETED|Overall Study||0
5072721|NCT01798316|12481208|P1|NOT COMPLETED|Overall Study||0
5072722|NCT01798316|12481207|P2|COMPLETED|Overall Study||53
5072723|NCT01798316|12481208|P1|COMPLETED|Overall Study||52
5072724|NCT01798316|12481207|P2|STARTED|Overall Study||53
5072725|NCT01798316|12481208|P1|STARTED|Overall Study||52
5072726|NCT01798264|12481230|P4|NOT COMPLETED|Overall Study||4
5072727|NCT01798264|12481231|P3|NOT COMPLETED|Overall Study||0
5072728|NCT01798264|12481232|P2|NOT COMPLETED|Overall Study||0
5072729|NCT01798264|12481233|P1|NOT COMPLETED|Overall Study||1
5072730|NCT01798264|12481230|P4|COMPLETED|Overall Study||7
5072731|NCT01798264|12481231|P3|COMPLETED|Overall Study||10
5072732|NCT01798264|12481232|P2|COMPLETED|Overall Study||11
5072733|NCT01798264|12481233|P1|COMPLETED|Overall Study||11
5072734|NCT01798264|12481230|P4|STARTED|Overall Study||11
5072735|NCT01798264|12481231|P3|STARTED|Overall Study||10
5072736|NCT01798264|12481232|P2|STARTED|Overall Study||11
5072737|NCT01798264|12481233|P1|STARTED|Overall Study||12
5072738|NCT01798225|12481257|P2|NOT COMPLETED|Overall Study||3
5072739|NCT01798225|12481258|P1|NOT COMPLETED|Overall Study||0
5072740|NCT01798225|12481257|P2|COMPLETED|Overall Study||53
5072741|NCT01798225|12481258|P1|COMPLETED|Overall Study||57
5072742|NCT01798225|12481257|P2|STARTED|Overall Study||56
5072743|NCT01798225|12481258|P1|STARTED|Overall Study||57
5072744|NCT01798186|12481270|P4|NOT COMPLETED|Overall Study||0
5072745|NCT01798186|12481271|P3|NOT COMPLETED|Overall Study||0
5072746|NCT01798186|12481272|P2|NOT COMPLETED|Overall Study||0
5072747|NCT01798186|12481273|P1|NOT COMPLETED|Overall Study||0
5072748|NCT01798186|12481270|P4|COMPLETED|Overall Study||8
5072749|NCT01798186|12481271|P3|COMPLETED|Overall Study||6
5072750|NCT01798186|12481272|P2|COMPLETED|Overall Study||6
5072751|NCT01798186|12481273|P1|COMPLETED|Overall Study||6
5072752|NCT01798186|12481270|P4|STARTED|Overall Study||8
5072753|NCT01798186|12481271|P3|STARTED|Overall Study||6
5072754|NCT01798186|12481272|P2|STARTED|Overall Study||6
5072755|NCT01798186|12481273|P1|STARTED|Overall Study||6
5072756|NCT01798134|12481287|P1|NOT COMPLETED|Overall Study||16
5072757|NCT01798134|12481287|P1|COMPLETED|Overall Study||9
5072758|NCT01798134|12481287|P1|STARTED|Overall Study||25
5072759|NCT01798056|12481296|P2|NOT COMPLETED|Overall Study||25
5072760|NCT01798056|12481297|P1|NOT COMPLETED|Overall Study||27
5072761|NCT01798056|12481296|P2|COMPLETED|Overall Study||90
5072762|NCT01798056|12481297|P1|COMPLETED|Overall Study||90
5072763|NCT01798056|12481296|P2|STARTED|Overall Study||115
5072764|NCT01798056|12481297|P1|STARTED|Overall Study||117
5072765|NCT01798004|12481331|P1|NOT COMPLETED|Overall Study||87
5072766|NCT01798004|12481331|P1|COMPLETED|Overall Study||63
5072767|NCT01798004|12481331|P1|STARTED|Overall Study||150
5072768|NCT01797965|12481339|P4|NOT COMPLETED|Overall Study||73
5072769|NCT01797965|12481340|P3|NOT COMPLETED|Overall Study||8
5072770|NCT01797965|12481341|P2|NOT COMPLETED|Overall Study||569
5072771|NCT01797965|12481342|P1|NOT COMPLETED|Overall Study||549
5072772|NCT01797965|12481339|P4|COMPLETED|Overall Study||154
5072773|NCT01797965|12481340|P3|COMPLETED|Overall Study||62
5072774|NCT01797965|12481341|P2|COMPLETED|Overall Study||38
5072775|NCT01797965|12481342|P1|COMPLETED|Overall Study||48
5072776|NCT01797965|12481339|P4|STARTED|Overall Study||227
5072777|NCT01797965|12481340|P3|STARTED|Overall Study||70
5072778|NCT01797965|12481341|P2|STARTED|Overall Study||607
5072779|NCT01797965|12481342|P1|STARTED|Overall Study||597
5072780|NCT01797835|12481476|P2|NOT COMPLETED|Overall Study||27
5072781|NCT01797835|12481477|P1|NOT COMPLETED|Overall Study||31
5072782|NCT01797835|12481476|P2|COMPLETED|Overall Study||114
5072783|NCT01797835|12481477|P1|COMPLETED|Overall Study||122
5072784|NCT01797835|12481476|P2|STARTED|Overall Study||141
5072785|NCT01797835|12481477|P1|STARTED|Overall Study||153
5072786|NCT01797822|12481485|P1|NOT COMPLETED|Overall Study||0
5072787|NCT01797822|12481485|P1|COMPLETED|Overall Study|The protocol is now closed.|20
5072788|NCT01797822|12481485|P1|STARTED|Overall Study||20
5072789|NCT01797783|12481493|P2|NOT COMPLETED|Overall Study||1
5072790|NCT01797783|12481494|P1|NOT COMPLETED|Overall Study||2
5072791|NCT01797783|12481493|P2|COMPLETED|Overall Study||26
5072792|NCT01797783|12481494|P1|COMPLETED|Overall Study||50
5072793|NCT01797783|12481493|P2|STARTED|Overall Study||27
5072794|NCT01797783|12481494|P1|STARTED|Overall Study||52
5072795|NCT01797731|12481518|P2|NOT COMPLETED|Overall Study||3
5072796|NCT01797731|12481519|P1|NOT COMPLETED|Overall Study||3
5072797|NCT01797731|12481518|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
5072798|NCT01797731|12481519|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
5072799|NCT01797731|12481518|P2|STARTED|Overall Study||50
5072800|NCT01797731|12481519|P1|STARTED|Overall Study||50
5072801|NCT01797705|12481527|P1|NOT COMPLETED|Overall Study||5
5072802|NCT01797705|12481527|P1|COMPLETED|Overall Study||28
5072803|NCT01797705|12481527|P1|STARTED|Overall Study||33
5072804|NCT01797575|12481535|P4|NOT COMPLETED|Week 8 Re-Randomization||3
5072805|NCT01797575|12481536|P3|NOT COMPLETED|Week 8 Re-Randomization||1
5072806|NCT01797575|12481537|P2|NOT COMPLETED|Week 8 Re-Randomization||0
5072807|NCT01797575|12481538|P1|NOT COMPLETED|Week 8 Re-Randomization||0
5072808|NCT01797575|12481535|P4|COMPLETED|Week 8 Re-Randomization||7
5072809|NCT01797575|12481536|P3|COMPLETED|Week 8 Re-Randomization||4
5072810|NCT01797575|12481537|P2|COMPLETED|Week 8 Re-Randomization||5
5072811|NCT01797575|12481538|P1|COMPLETED|Week 8 Re-Randomization||4
5072812|NCT01797575|12481535|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
5072813|NCT01797575|12481536|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
5072814|NCT01797575|12481537|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
5072815|NCT01797575|12481538|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
5072816|NCT01797575|12481535|P4|NOT COMPLETED|Baseline Allocation||7
5072817|NCT01797575|12481536|P3|NOT COMPLETED|Baseline Allocation||5
5072818|NCT01797575|12481537|P2|NOT COMPLETED|Baseline Allocation||1
5072819|NCT01797575|12481538|P1|NOT COMPLETED|Baseline Allocation||1
5072820|NCT01797575|12481535|P4|COMPLETED|Baseline Allocation||8
5072821|NCT01797575|12481536|P3|COMPLETED|Baseline Allocation||4
5072822|NCT01797575|12481537|P2|COMPLETED|Baseline Allocation||8
5072823|NCT01797575|12481538|P1|COMPLETED|Baseline Allocation||4
5072824|NCT01797575|12481535|P4|STARTED|Baseline Allocation||15
5072825|NCT01797575|12481536|P3|STARTED|Baseline Allocation||9
5072826|NCT01797575|12481537|P2|STARTED|Baseline Allocation||9
5072827|NCT01797575|12481538|P1|STARTED|Baseline Allocation||5
5072828|NCT01797536|12481592|P4|NOT COMPLETED|Overall Study||0
5072829|NCT01797536|12481593|P3|NOT COMPLETED|Overall Study||0
5072830|NCT01797536|12481594|P2|NOT COMPLETED|Overall Study||1
5072831|NCT01797536|12481595|P1|NOT COMPLETED|Overall Study||0
5072832|NCT01797536|12481592|P4|COMPLETED|Overall Study||8
5072833|NCT01797536|12481593|P3|COMPLETED|Overall Study||7
5072834|NCT01797536|12481594|P2|COMPLETED|Overall Study||10
5072835|NCT01797536|12481595|P1|COMPLETED|Overall Study||8
5072836|NCT01797536|12481592|P4|STARTED|Overall Study||8
5072837|NCT01797536|12481593|P3|STARTED|Overall Study||7
5072838|NCT01797536|12481594|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
5072839|NCT01797536|12481595|P1|STARTED|Overall Study||8
5072840|NCT01797484|12481627|P2|NOT COMPLETED|Overall Study||0
5072841|NCT01797484|12481628|P1|NOT COMPLETED|Overall Study||0
5072842|NCT01797484|12481627|P2|COMPLETED|Overall Study||10
5072843|NCT01797484|12481628|P1|COMPLETED|Overall Study||10
5072844|NCT01797484|12481627|P2|STARTED|Overall Study||10
5072845|NCT01797484|12481628|P1|STARTED|Overall Study||10
5072846|NCT01797471|12481634|P1|NOT COMPLETED|Overall Study||0
5072847|NCT01797471|12481634|P1|COMPLETED|Overall Study||1
5072848|NCT01797471|12481634|P1|STARTED|Overall Study||1
5072849|NCT01797458|12481646|P3|NOT COMPLETED|Overall Study||7
5072850|NCT01797458|12481647|P2|NOT COMPLETED|Overall Study||9
5072851|NCT01797458|12481648|P1|NOT COMPLETED|Overall Study||12
5072852|NCT01797458|12481646|P3|COMPLETED|Overall Study||58
5072853|NCT01797458|12481647|P2|COMPLETED|Overall Study||43
5072854|NCT01797458|12481648|P1|COMPLETED|Overall Study||40
5072855|NCT01797458|12481646|P3|STARTED|Overall Study||65
5072856|NCT01797458|12481647|P2|STARTED|Overall Study||52
5072857|NCT01797458|12481648|P1|STARTED|Overall Study||52
5072858|NCT01797445|12481667|P2|NOT COMPLETED|Open-Label Extension Phase||0
5072859|NCT01797445|12481668|P1|NOT COMPLETED|Open-Label Extension Phase||1
5072860|NCT01797445|12481667|P2|COMPLETED|Open-Label Extension Phase||119
5072861|NCT01797445|12481668|P1|COMPLETED|Open-Label Extension Phase||140
5072862|NCT01797445|12481667|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
5072863|NCT01797445|12481668|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
5072864|NCT01797445|12481667|P2|NOT COMPLETED|Double-Blind Phase||89
5072865|NCT01797445|12481668|P1|NOT COMPLETED|Double-Blind Phase||87
5072866|NCT01797445|12481667|P2|COMPLETED|Double-Blind Phase||348
5072867|NCT01797445|12481668|P1|COMPLETED|Double-Blind Phase||348
5072868|NCT01797445|12481667|P2|STARTED|Double-Blind Phase||437
5072869|NCT01797445|12481668|P1|STARTED|Double-Blind Phase||435
5072870|NCT01797380|12481710|P2|NOT COMPLETED|Overall Study||2
5072871|NCT01797380|12481711|P1|NOT COMPLETED|Overall Study||3
5072872|NCT01797380|12481710|P2|COMPLETED|Overall Study||0
5072873|NCT01797380|12481711|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
5072874|NCT01797380|12481710|P2|STARTED|Overall Study||2
5072875|NCT01797380|12481711|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
5072876|NCT01797328|12481719|P2|NOT COMPLETED|Overall Study||0
5072877|NCT01797328|12481720|P1|NOT COMPLETED|Overall Study||2
5072878|NCT01797328|12481719|P2|COMPLETED|Overall Study||12
5072879|NCT01797328|12481720|P1|COMPLETED|Overall Study||14
5072880|NCT01797328|12481719|P2|STARTED|Overall Study||12
5072881|NCT01797328|12481720|P1|STARTED|Overall Study||16
5072882|NCT01797302|12481729|P3|NOT COMPLETED|Overall Study||26
5072883|NCT01797302|12481730|P2|NOT COMPLETED|Overall Study||26
5072884|NCT01797302|12481731|P1|NOT COMPLETED|Overall Study||17
5072885|NCT01797302|12481729|P3|COMPLETED|Overall Study||50
5072886|NCT01797302|12481730|P2|COMPLETED|Overall Study||48
5072887|NCT01797302|12481731|P1|COMPLETED|Overall Study||58
5072888|NCT01797302|12481729|P3|3 Month Visit|Overall Study||57
5072889|NCT01797302|12481730|P2|3 Month Visit|Overall Study||57
5072890|NCT01797302|12481731|P1|3 Month Visit|Overall Study||60
5072891|NCT01797302|12481729|P3|STARTED|Overall Study||76
5072892|NCT01797302|12481730|P2|STARTED|Overall Study||74
5072893|NCT01797302|12481731|P1|STARTED|Overall Study||75
5072894|NCT01797263|12481768|P2|NOT COMPLETED|Overall Study||40
5072895|NCT01797263|12481769|P1|NOT COMPLETED|Overall Study||37
5072896|NCT01797263|12481768|P2|COMPLETED|Overall Study||87
5072897|NCT01797263|12481769|P1|COMPLETED|Overall Study||92
5072898|NCT01797263|12481768|P2|9 Month|Overall Study||87
5072899|NCT01797263|12481769|P1|9 Month|Overall Study||92
5072900|NCT01797263|12481768|P2|6 Month|Overall Study||85
5072901|NCT01797263|12481769|P1|6 Month|Overall Study||90
5072902|NCT01797263|12481768|P2|3 Month|Overall Study||84
5072903|NCT01797263|12481769|P1|3 Month|Overall Study||87
5072904|NCT01797263|12481768|P2|1 Month|Overall Study||87
5072905|NCT01797263|12481769|P1|1 Month|Overall Study||96
5072906|NCT01797263|12481768|P2|STARTED|Overall Study||127
5072907|NCT01797263|12481769|P1|STARTED|Overall Study||129
5072908|NCT01797185|12481804|P3|NOT COMPLETED|Overall Study||12
5072909|NCT01797185|12481805|P2|NOT COMPLETED|Overall Study||38
5072910|NCT01797185|12481806|P1|NOT COMPLETED|Overall Study||28
5072911|NCT01797185|12481804|P3|COMPLETED|Overall Study||38
5072912|NCT01797185|12481805|P2|COMPLETED|Overall Study||125
5072913|NCT01797185|12481806|P1|COMPLETED|Overall Study||134
5072914|NCT01797185|12481804|P3|STARTED|Overall Study||50
5072915|NCT01797185|12481805|P2|STARTED|Overall Study||163
5072916|NCT01797185|12481806|P1|STARTED|Overall Study||162
5072917|NCT01797120|12481816|P2|NOT COMPLETED|Overall Study||65
5072918|NCT01797120|12481817|P1|NOT COMPLETED|Overall Study||66
5072919|NCT01797120|12481816|P2|COMPLETED|Overall Study||0
5072920|NCT01797120|12481817|P1|COMPLETED|Overall Study||0
5072921|NCT01797120|12481816|P2|STARTED|Overall Study||65
5072922|NCT01797120|12481817|P1|STARTED|Overall Study||66
5072923|NCT01797094|12481831|P2|NOT COMPLETED|Overall Study||2
5072924|NCT01797094|12481832|P1|NOT COMPLETED|Overall Study||6
5072925|NCT01797094|12481831|P2|COMPLETED|Overall Study||51
5072926|NCT01797094|12481832|P1|COMPLETED|Overall Study||42
5072927|NCT01797094|12481831|P2|STARTED|Overall Study||53
5072928|NCT01797094|12481832|P1|STARTED|Overall Study||48
5072929|NCT01797081|12481854|P4|NOT COMPLETED|Overall Study||9
5072930|NCT01797081|12481855|P3|NOT COMPLETED|Overall Study||5
5072931|NCT01797081|12481856|P2|NOT COMPLETED|Overall Study||4
5072932|NCT01797081|12481857|P1|NOT COMPLETED|Overall Study||14
5072933|NCT01797081|12481854|P4|COMPLETED|Overall Study||40
5072934|NCT01797081|12481855|P3|COMPLETED|Overall Study||43
5072935|NCT01797081|12481856|P2|COMPLETED|Overall Study||95
5072936|NCT01797081|12481857|P1|COMPLETED|Overall Study||90
5072937|NCT01797081|12481854|P4|STARTED|Overall Study||49
5072938|NCT01797081|12481855|P3|STARTED|Overall Study||48
5072939|NCT01797081|12481856|P2|STARTED|Overall Study||99
5072940|NCT01797081|12481857|P1|STARTED|Overall Study||104
5072941|NCT01797029|12481876|P2|NOT COMPLETED|Overall Study||61
5072942|NCT01797029|12481877|P1|NOT COMPLETED|Overall Study||159
5072943|NCT01797029|12481876|P2|COMPLETED|Overall Study||526
5072944|NCT01797029|12481877|P1|COMPLETED|Overall Study||1015
5072945|NCT01797029|12481876|P2|STARTED|Overall Study||587
5072946|NCT01797029|12481877|P1|STARTED|Overall Study||1174
5072947|NCT01796977|12481885|P1|NOT COMPLETED|Overall Study||0
5072948|NCT01796977|12481885|P1|COMPLETED|Overall Study||27
5072949|NCT01796977|12481885|P1|STARTED|Overall Study||27
5072950|NCT01796964|12481898|P2|NOT COMPLETED|Overall Study||3
5072951|NCT01796964|12481899|P1|NOT COMPLETED|Overall Study||3
5072952|NCT01796964|12481898|P2|COMPLETED|Overall Study||42
5072953|NCT01796964|12481899|P1|COMPLETED|Overall Study||41
5072954|NCT01796964|12481898|P2|STARTED|Overall Study||45
5072955|NCT01796964|12481899|P1|STARTED|Overall Study||44
5072956|NCT01796912|12481921|P2|NOT COMPLETED|Second Intervention||0
5072957|NCT01796912|12481922|P1|NOT COMPLETED|Second Intervention||0
5072958|NCT01796912|12481921|P2|COMPLETED|Second Intervention||10
5072959|NCT01796912|12481922|P1|COMPLETED|Second Intervention||10
5072960|NCT01796912|12481921|P2|STARTED|Second Intervention||10
5072961|NCT01796912|12481922|P1|STARTED|Second Intervention||10
5072962|NCT01796912|12481921|P2|NOT COMPLETED|Washout||0
5072963|NCT01796912|12481922|P1|NOT COMPLETED|Washout||0
5072964|NCT01796912|12481921|P2|COMPLETED|Washout||10
5072965|NCT01796912|12481922|P1|COMPLETED|Washout||10
5072966|NCT01796912|12481921|P2|STARTED|Washout||10
5072967|NCT01796912|12481922|P1|STARTED|Washout||10
5072968|NCT01796912|12481921|P2|NOT COMPLETED|First Intervention||0
5072969|NCT01796912|12481922|P1|NOT COMPLETED|First Intervention||0
5072970|NCT01796912|12481921|P2|COMPLETED|First Intervention||10
5072971|NCT01796912|12481922|P1|COMPLETED|First Intervention||10
5072972|NCT01796912|12481921|P2|STARTED|First Intervention||10
5072973|NCT01796912|12481922|P1|STARTED|First Intervention||10
5072974|NCT01796860|12481940|P1|NOT COMPLETED|Overall Study||3
5072975|NCT01796860|12481940|P1|COMPLETED|Overall Study||7
5072976|NCT01796860|12481940|P1|STARTED|Overall Study||10
5072977|NCT01796548|12481946|P1|NOT COMPLETED|Overall Study||3
5072978|NCT01796548|12481946|P1|COMPLETED|Overall Study||14
5072979|NCT01796548|12481946|P1|Treated|Overall Study||15
5072980|NCT01796548|12481946|P1|STARTED|Overall Study||17
5072981|NCT01796470|12481963|P5|NOT COMPLETED|Overall Study||8
5072982|NCT01796470|12481964|P4|NOT COMPLETED|Overall Study||3
5072983|NCT01796470|12481965|P3|NOT COMPLETED|Overall Study||6
5072984|NCT01796470|12481966|P2|NOT COMPLETED|Overall Study||14
5072985|NCT01796470|12481967|P1|NOT COMPLETED|Overall Study||35
5072986|NCT01796470|12481963|P5|COMPLETED|Overall Study||0
5072987|NCT01796470|12481964|P4|COMPLETED|Overall Study||0
5072988|NCT01796470|12481965|P3|COMPLETED|Overall Study||0
5072989|NCT01796470|12481966|P2|COMPLETED|Overall Study||0
5072990|NCT01796470|12481967|P1|COMPLETED|Overall Study||0
5072991|NCT01796470|12481963|P5|Entospletinib Monotherapy|Overall Study||0
5072992|NCT01796470|12481964|P4|Entospletinib Monotherapy|Overall Study||0
5072993|NCT01796470|12481965|P3|Entospletinib Monotherapy|Overall Study||0
5072994|NCT01796470|12481966|P2|Entospletinib Monotherapy|Overall Study||4
5072995|NCT01796470|12481967|P1|Entospletinib Monotherapy|Overall Study||4
5072996|NCT01796470|12481963|P5|STARTED|Overall Study||8
5072997|NCT01796470|12481964|P4|STARTED|Overall Study||3
5072998|NCT01796470|12481965|P3|STARTED|Overall Study||6
5072999|NCT01796470|12481966|P2|STARTED|Overall Study||14
5073000|NCT01796470|12481967|P1|STARTED|Overall Study||35
5073001|NCT01796392|12482011|P2|NOT COMPLETED|Overall Study||3
5073002|NCT01796392|12482012|P1|NOT COMPLETED|Overall Study||9
5073003|NCT01796392|12482011|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
5073004|NCT01796392|12482012|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
5073005|NCT01796392|12482011|P2|STARTED|Overall Study||62
5073006|NCT01796392|12482012|P1|STARTED|Overall Study||128
5073007|NCT01796301|12482026|P2|NOT COMPLETED|Overall Study||20
5073008|NCT01796301|12482027|P1|NOT COMPLETED|Overall Study||18
5073009|NCT01796301|12482026|P2|COMPLETED|Overall Study||198
5073010|NCT01796301|12482027|P1|COMPLETED|Overall Study||200
5073011|NCT01796301|12482026|P2|Received Treatment|Overall Study||218
5073012|NCT01796301|12482027|P1|Received Treatment|Overall Study||214
5073013|NCT01796301|12482026|P2|STARTED|Overall Study||218
5073014|NCT01796301|12482027|P1|STARTED|Overall Study||218
5073015|NCT01796236|12482063|P2|NOT COMPLETED|Overall Study||2
5073016|NCT01796236|12482064|P1|NOT COMPLETED|Overall Study||2
5073017|NCT01796236|12482063|P2|COMPLETED|Overall Study||50
5073018|NCT01796236|12482064|P1|COMPLETED|Overall Study||49
5073019|NCT01796236|12482063|P2|STARTED|Overall Study||52
5073020|NCT01796236|12482064|P1|STARTED|Overall Study||51
5073021|NCT01795937|12482113|P3|NOT COMPLETED|Overall Study||0
5073022|NCT01795937|12482114|P2|NOT COMPLETED|Overall Study||1
5073023|NCT01795937|12482115|P1|NOT COMPLETED|Overall Study||1
5073024|NCT01795937|12482113|P3|COMPLETED|Overall Study||17
5073025|NCT01795937|12482114|P2|COMPLETED|Overall Study||15
5073026|NCT01795937|12482115|P1|COMPLETED|Overall Study||17
5073027|NCT01795937|12482113|P3|STARTED|Overall Study||17
5073028|NCT01795937|12482114|P2|STARTED|Overall Study||16
5073029|NCT01795937|12482115|P1|STARTED|Overall Study||18
5073030|NCT01795898|12482144|P1|NOT COMPLETED|Overall Study||60
5073031|NCT01795898|12482144|P1|COMPLETED|Overall Study||177
5073032|NCT01795898|12482144|P1|STARTED|Overall Study||237
5073033|NCT01795859|12482154|P2|NOT COMPLETED|Overall Study||2
5073034|NCT01795859|12482155|P1|NOT COMPLETED|Overall Study||1
5073035|NCT01795859|12482154|P2|COMPLETED|Overall Study||43
5073036|NCT01795859|12482155|P1|COMPLETED|Overall Study||44
5073037|NCT01795859|12482154|P2|STARTED|Overall Study||45
5073038|NCT01795859|12482155|P1|STARTED|Overall Study||45
5073039|NCT01795833|12482173|P2|NOT COMPLETED|Overall Study||149
5073040|NCT01795833|12482174|P1|NOT COMPLETED|Overall Study||150
5073041|NCT01795833|12482173|P2|COMPLETED|Overall Study||882
5073042|NCT01795833|12482174|P1|COMPLETED|Overall Study||881
5073043|NCT01795833|12482173|P2|STARTED|Overall Study||1031
5073044|NCT01795833|12482174|P1|STARTED|Overall Study||1031
5073045|NCT01795716|12482194|P2|NOT COMPLETED|Second Intervention (13 Days)||0
5073046|NCT01795716|12482195|P1|NOT COMPLETED|Second Intervention (13 Days)||0
5073047|NCT01795716|12482194|P2|COMPLETED|Second Intervention (13 Days)||11
5073048|NCT01795716|12482195|P1|COMPLETED|Second Intervention (13 Days)||10
5073049|NCT01795716|12482194|P2|STARTED|Second Intervention (13 Days)||11
5073050|NCT01795716|12482195|P1|STARTED|Second Intervention (13 Days)||10
5073051|NCT01795716|12482194|P2|NOT COMPLETED|Washout (10 Days)||0
5073052|NCT01795716|12482195|P1|NOT COMPLETED|Washout (10 Days)||0
5073053|NCT01795716|12482194|P2|COMPLETED|Washout (10 Days)||11
5073054|NCT01795716|12482195|P1|COMPLETED|Washout (10 Days)||10
5073055|NCT01795716|12482194|P2|STARTED|Washout (10 Days)||11
5073056|NCT01795716|12482195|P1|STARTED|Washout (10 Days)||10
5073057|NCT01795716|12482194|P2|NOT COMPLETED|First Intervention (13 Days)||0
5073058|NCT01795716|12482195|P1|NOT COMPLETED|First Intervention (13 Days)||0
5073059|NCT01795716|12482194|P2|COMPLETED|First Intervention (13 Days)||11
5073060|NCT01795716|12482195|P1|COMPLETED|First Intervention (13 Days)||10
5073061|NCT01795716|12482194|P2|STARTED|First Intervention (13 Days)||11
5073062|NCT01795716|12482195|P1|STARTED|First Intervention (13 Days)||10
5073063|NCT01795547|12482203|P2|NOT COMPLETED|Overall Study||64
5073064|NCT01795547|12482204|P1|NOT COMPLETED|Overall Study||48
5073065|NCT01795547|12482203|P2|COMPLETED|Overall Study||83
5073066|NCT01795547|12482204|P1|COMPLETED|Overall Study||100
5073067|NCT01795547|12482203|P2|STARTED|Overall Study||147
5073068|NCT01795547|12482204|P1|STARTED|Overall Study||148
5073069|NCT01795534|12482226|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
5073070|NCT01795534|12482227|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
5073071|NCT01795534|12482226|P2|COMPLETED|Second Intervention (Second Shot)||5
5073072|NCT01795534|12482227|P1|COMPLETED|Second Intervention (Second Shot)||5
5073073|NCT01795534|12482226|P2|STARTED|Second Intervention (Second Shot)||5
5073074|NCT01795534|12482227|P1|STARTED|Second Intervention (Second Shot)||5
5073075|NCT01795534|12482226|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
5073076|NCT01795534|12482227|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
5073077|NCT01795534|12482226|P2|COMPLETED|Wash Out Period (4 Days)||5
5073078|NCT01795534|12482227|P1|COMPLETED|Wash Out Period (4 Days)||5
5073079|NCT01795534|12482226|P2|STARTED|Wash Out Period (4 Days)||5
5073080|NCT01795534|12482227|P1|STARTED|Wash Out Period (4 Days)||5
5073081|NCT01795534|12482226|P2|NOT COMPLETED|First Intervention (First Shot)||0
5073082|NCT01795534|12482227|P1|NOT COMPLETED|First Intervention (First Shot)||0
5073083|NCT01795534|12482226|P2|COMPLETED|First Intervention (First Shot)||5
5073084|NCT01795534|12482227|P1|COMPLETED|First Intervention (First Shot)||5
5073085|NCT01795534|12482226|P2|STARTED|First Intervention (First Shot)||5
5073086|NCT01795534|12482227|P1|STARTED|First Intervention (First Shot)||5
5073087|NCT01795495|12482236|P3|NOT COMPLETED|Overall Study||2
5073088|NCT01795495|12482237|P2|NOT COMPLETED|Overall Study||0
5073089|NCT01795495|12482238|P1|NOT COMPLETED|Overall Study||1
5073090|NCT01795495|12482236|P3|COMPLETED|Overall Study||19
5073091|NCT01795495|12482237|P2|COMPLETED|Overall Study||22
5073092|NCT01795495|12482238|P1|COMPLETED|Overall Study||19
5073093|NCT01795495|12482236|P3|STARTED|Overall Study||21
5073094|NCT01795495|12482237|P2|STARTED|Overall Study||22
5073095|NCT01795495|12482238|P1|STARTED|Overall Study||20
5073096|NCT01795105|12482249|P1|NOT COMPLETED|Overall Study||44
5073097|NCT01795105|12482249|P1|COMPLETED|Overall Study||648
5073098|NCT01795105|12482249|P1|STARTED|Overall Study||692
5073099|NCT01794949|12482258|P2|NOT COMPLETED|Overall Study||0
5073100|NCT01794949|12482259|P1|NOT COMPLETED|Overall Study||1
5073101|NCT01794949|12482258|P2|COMPLETED|Overall Study||1
5073102|NCT01794949|12482259|P1|COMPLETED|Overall Study||6
5073103|NCT01794949|12482258|P2|6 Month Follow-up|Overall Study||1
5073104|NCT01794949|12482259|P1|6 Month Follow-up|Overall Study||6
5073105|NCT01794949|12482258|P2|STARTED|Overall Study||1
5073106|NCT01794949|12482259|P1|STARTED|Overall Study||7
5073107|NCT01794936|12482265|P1|NOT COMPLETED|Overall Study||0
5073108|NCT01794936|12482265|P1|COMPLETED|Overall Study||9
5073109|NCT01794936|12482265|P1|STARTED|Overall Study||9
5073110|NCT01794845|12482270|P1|NOT COMPLETED|Overall Study||1
5073111|NCT01794845|12482270|P1|COMPLETED|Overall Study||4
5073112|NCT01794845|12482270|P1|STARTED|Overall Study||5
5073113|NCT01794806|12482279|P2|NOT COMPLETED|Overall Study||1
5073114|NCT01794806|12482280|P1|NOT COMPLETED|Overall Study||5
5073115|NCT01794806|12482279|P2|COMPLETED|Overall Study||27
5073116|NCT01794806|12482280|P1|COMPLETED|Overall Study||26
5073117|NCT01794806|12482279|P2|4 Weeks|Overall Study||27
5073118|NCT01794806|12482280|P1|4 Weeks|Overall Study||26
5073119|NCT01794806|12482279|P2|1 Week|Overall Study||28
5073120|NCT01794806|12482280|P1|1 Week|Overall Study||28
5073121|NCT01794806|12482279|P2|STARTED|Overall Study||28
5073122|NCT01794806|12482280|P1|STARTED|Overall Study||31
5073123|NCT01794780|12482298|P8|NOT COMPLETED|Overall Study||9
5073124|NCT01794780|12482299|P7|NOT COMPLETED|Overall Study||42
5073125|NCT01794780|12482300|P6|NOT COMPLETED|Overall Study||180
5073126|NCT01794780|12482301|P5|NOT COMPLETED|Overall Study||3
5073127|NCT01794780|12482302|P4|NOT COMPLETED|Overall Study||83
5073128|NCT01794780|12482303|P3|NOT COMPLETED|Overall Study||242
5073129|NCT01794780|12482304|P2|NOT COMPLETED|Overall Study||96
5073130|NCT01794780|12482305|P1|NOT COMPLETED|Overall Study||17
5073131|NCT01794780|12482298|P8|COMPLETED|Overall Study||21
5073132|NCT01794780|12482299|P7|COMPLETED|Overall Study||112
5073133|NCT01794780|12482300|P6|COMPLETED|Overall Study||452
5073134|NCT01794780|12482301|P5|COMPLETED|Overall Study||6
5073135|NCT01794780|12482302|P4|COMPLETED|Overall Study||200
5073136|NCT01794780|12482303|P3|COMPLETED|Overall Study||571
5073137|NCT01794780|12482304|P2|COMPLETED|Overall Study||180
5073138|NCT01794780|12482305|P1|COMPLETED|Overall Study||15
5073139|NCT01794780|12482298|P8|STARTED|Overall Study||30
5073140|NCT01794780|12482299|P7|STARTED|Overall Study||154
5073141|NCT01794780|12482300|P6|STARTED|Overall Study||632
5073142|NCT01794780|12482301|P5|STARTED|Overall Study||9
5073143|NCT01794780|12482302|P4|STARTED|Overall Study||283
5073144|NCT01794780|12482303|P3|STARTED|Overall Study||813
5073145|NCT01794780|12482304|P2|STARTED|Overall Study||276
5073146|NCT01794780|12482305|P1|STARTED|Overall Study||32
5073147|NCT01794741|12482355|P2|NOT COMPLETED|Overall Study||9
5073148|NCT01794741|12482356|P1|NOT COMPLETED|Overall Study||19
5073149|NCT01794741|12482355|P2|COMPLETED|Overall Study||92
5073150|NCT01794741|12482356|P1|COMPLETED|Overall Study||285
5073151|NCT01794741|12482355|P2|STARTED|Overall Study||101
5073152|NCT01794741|12482356|P1|STARTED|Overall Study||304
5073153|NCT01794702|12482365|P3|NOT COMPLETED|Overall Study||0
5073154|NCT01794702|12482366|P2|NOT COMPLETED|Overall Study||0
5073155|NCT01794702|12482367|P1|NOT COMPLETED|Overall Study||0
5073156|NCT01794702|12482365|P3|COMPLETED|Overall Study||47
5073157|NCT01794702|12482366|P2|COMPLETED|Overall Study||0
5073158|NCT01794702|12482367|P1|COMPLETED|Overall Study||18
5073159|NCT01794702|12482365|P3|STARTED|Overall Study||47
5073160|NCT01794702|12482366|P2|STARTED|Overall Study||0
5073161|NCT01794702|12482367|P1|STARTED|Overall Study||18
5073162|NCT01794689|12482381|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
5073163|NCT01794689|12482382|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
5073164|NCT01794689|12482383|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
5073165|NCT01794689|12482384|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
5073166|NCT01794689|12482381|P4|COMPLETED|Intervention 2 (2 Nights)||18
5073167|NCT01794689|12482382|P3|COMPLETED|Intervention 2 (2 Nights)||21
5073168|NCT01794689|12482383|P2|COMPLETED|Intervention 2 (2 Nights)||27
5073169|NCT01794689|12482384|P1|COMPLETED|Intervention 2 (2 Nights)||20
5073170|NCT01794689|12482381|P4|STARTED|Intervention 2 (2 Nights)||18
5073171|NCT01794689|12482382|P3|STARTED|Intervention 2 (2 Nights)||21
5073172|NCT01794689|12482383|P2|STARTED|Intervention 2 (2 Nights)||27
5073173|NCT01794689|12482384|P1|STARTED|Intervention 2 (2 Nights)||20
5073174|NCT01794689|12482381|P4|NOT COMPLETED|Washout (2 Weeks)||0
5073175|NCT01794689|12482382|P3|NOT COMPLETED|Washout (2 Weeks)||0
5073176|NCT01794689|12482383|P2|NOT COMPLETED|Washout (2 Weeks)||0
5073177|NCT01794689|12482384|P1|NOT COMPLETED|Washout (2 Weeks)||0
5073178|NCT01794689|12482381|P4|COMPLETED|Washout (2 Weeks)||18
5073179|NCT01794689|12482382|P3|COMPLETED|Washout (2 Weeks)||21
5073180|NCT01794689|12482383|P2|COMPLETED|Washout (2 Weeks)||27
5073181|NCT01794689|12482384|P1|COMPLETED|Washout (2 Weeks)||20
5073182|NCT01794689|12482381|P4|STARTED|Washout (2 Weeks)||18
5073183|NCT01794689|12482382|P3|STARTED|Washout (2 Weeks)||21
5073184|NCT01794689|12482383|P2|STARTED|Washout (2 Weeks)||27
5073185|NCT01794689|12482384|P1|STARTED|Washout (2 Weeks)||20
5073186|NCT01794689|12482381|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
5073187|NCT01794689|12482382|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
5073188|NCT01794689|12482383|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
5073189|NCT01794689|12482384|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
5073190|NCT01794689|12482381|P4|COMPLETED|Intervention 1 (2 Nights)||18
5073191|NCT01794689|12482382|P3|COMPLETED|Intervention 1 (2 Nights)||21
5073192|NCT01794689|12482383|P2|COMPLETED|Intervention 1 (2 Nights)||27
5073193|NCT01794689|12482384|P1|COMPLETED|Intervention 1 (2 Nights)||20
5073194|NCT01794689|12482381|P4|STARTED|Intervention 1 (2 Nights)||22
5073195|NCT01794689|12482382|P3|STARTED|Intervention 1 (2 Nights)||24
5073196|NCT01794689|12482383|P2|STARTED|Intervention 1 (2 Nights)||29
5073197|NCT01794689|12482384|P1|STARTED|Intervention 1 (2 Nights)||25
5073198|NCT01794455|12482408|P2|NOT COMPLETED|Overall Study||0
5073199|NCT01794455|12482409|P1|NOT COMPLETED|Overall Study||0
5073200|NCT01794455|12482408|P2|COMPLETED|Overall Study||1
5073201|NCT01794455|12482409|P1|COMPLETED|Overall Study||0
5073202|NCT01794455|12482408|P2|STARTED|Overall Study||1
5073203|NCT01794455|12482409|P1|STARTED|Overall Study||0
5073204|NCT01794312|12482427|P2|NOT COMPLETED|Overall Study||11
5073205|NCT01794312|12482428|P1|NOT COMPLETED|Overall Study||6
5073206|NCT01794312|12482427|P2|COMPLETED|Overall Study||67
5073207|NCT01794312|12482428|P1|COMPLETED|Overall Study||68
5073208|NCT01794312|12482427|P2|STARTED|Overall Study||78
5073209|NCT01794312|12482428|P1|STARTED|Overall Study||74
5073210|NCT01794039|12482440|P2|NOT COMPLETED|Overall Study||0
5073211|NCT01794039|12482441|P1|NOT COMPLETED|Overall Study||0
5073212|NCT01794039|12482440|P2|COMPLETED|Overall Study||4
5073213|NCT01794039|12482441|P1|COMPLETED|Overall Study||5
5073214|NCT01794039|12482440|P2|STARTED|Overall Study||4
5073215|NCT01794039|12482441|P1|STARTED|Overall Study||5
5073216|NCT01794000|12482453|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
5073217|NCT01794000|12482454|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
5073218|NCT01794000|12482453|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
5073219|NCT01794000|12482454|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
5073220|NCT01794000|12482453|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
5073221|NCT01794000|12482454|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
5073222|NCT01794000|12482453|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
5073223|NCT01794000|12482454|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
5073224|NCT01794000|12482453|P2|COMPLETED|Double-Blind Phase (DBP)||4
5073225|NCT01794000|12482454|P1|COMPLETED|Double-Blind Phase (DBP)||2
5073226|NCT01794000|12482453|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
5073227|NCT01794000|12482454|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
5073228|NCT01794000|12482453|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
5073229|NCT01794000|12482454|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
5073230|NCT01794000|12482453|P2|STARTED|Double-Blind Phase (DBP)||170
5073231|NCT01794000|12482454|P1|STARTED|Double-Blind Phase (DBP)||171
5073232|NCT01793935|12482487|P2|NOT COMPLETED|Overall Study||3
5073233|NCT01793935|12482488|P1|NOT COMPLETED|Overall Study||6
5073234|NCT01793935|12482487|P2|COMPLETED|Overall Study||31
5073235|NCT01793935|12482488|P1|COMPLETED|Overall Study||28
5073236|NCT01793935|12482487|P2|STARTED|Overall Study||34
5073237|NCT01793935|12482488|P1|STARTED|Overall Study||34
5073238|NCT01793909|12482524|P2|NOT COMPLETED|Overall Study||5
5073239|NCT01793909|12482525|P1|NOT COMPLETED|Overall Study||10
5073240|NCT01793909|12482524|P2|COMPLETED|Overall Study||20
5073241|NCT01793909|12482525|P1|COMPLETED|Overall Study||20
5073242|NCT01793909|12482524|P2|STARTED|Overall Study||25
5073243|NCT01793909|12482525|P1|STARTED|Overall Study||30
5073244|NCT01793883|12482534|P3|NOT COMPLETED|Overall Study||8
5073245|NCT01793883|12482535|P2|NOT COMPLETED|Overall Study||10
5073246|NCT01793883|12482536|P1|NOT COMPLETED|Overall Study||12
5073247|NCT01793883|12482534|P3|COMPLETED|Overall Study||204
5073248|NCT01793883|12482535|P2|COMPLETED|Overall Study||204
5073249|NCT01793883|12482536|P1|COMPLETED|Overall Study||201
5073250|NCT01793883|12482534|P3|STARTED|Overall Study||212
5073251|NCT01793883|12482535|P2|STARTED|Overall Study||214
5073252|NCT01793883|12482536|P1|STARTED|Overall Study||213
5073253|NCT01793792|12482544|P1|NOT COMPLETED|Overall Study||12
5073254|NCT01793792|12482544|P1|COMPLETED|Overall Study||141
5073255|NCT01793792|12482544|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
5073256|NCT01793792|12482544|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
5073257|NCT01793688|12482549|P1|NOT COMPLETED|Overall Study||2
5073258|NCT01793688|12482549|P1|COMPLETED|Overall Study||980
5073259|NCT01793688|12482549|P1|STARTED|Overall Study||982
5073260|NCT01793285|12482556|P1|NOT COMPLETED|Overall Study||0
5073261|NCT01793285|12482556|P1|COMPLETED|Overall Study||85
5073262|NCT01793285|12482556|P1|STARTED|Overall Study||85
5073263|NCT01793142|12482576|P1|NOT COMPLETED|Overall Study||7
5073264|NCT01793142|12482576|P1|COMPLETED|Overall Study||3423
5073265|NCT01793142|12482576|P1|Treated|Overall Study||3423
5073266|NCT01793142|12482576|P1|STARTED|Overall Study||3430
5073267|NCT01792986|12482587|P1|NOT COMPLETED|Overall Study||0
5073268|NCT01792986|12482587|P1|COMPLETED|Overall Study||12
5073269|NCT01792986|12482587|P1|STARTED|Overall Study||12
5073270|NCT01792830|12482606|P11|NOT COMPLETED|Overall Study||3
5073271|NCT01792830|12482607|P10|NOT COMPLETED|Overall Study||0
5073272|NCT01792830|12482608|P9|NOT COMPLETED|Overall Study||9
5073273|NCT01792830|12482609|P8|NOT COMPLETED|Overall Study||1
5073274|NCT01792830|12482610|P7|NOT COMPLETED|Overall Study||2
5073275|NCT01792830|12482611|P6|NOT COMPLETED|Overall Study||1
5073276|NCT01792830|12482612|P5|NOT COMPLETED|Overall Study||1
5073277|NCT01792830|12482613|P4|NOT COMPLETED|Overall Study||3
5073278|NCT01792830|12482614|P3|NOT COMPLETED|Overall Study||0
5073279|NCT01792830|12482615|P2|NOT COMPLETED|Overall Study||0
5073280|NCT01792830|12482616|P1|NOT COMPLETED|Overall Study||25
5073281|NCT01792830|12482606|P11|COMPLETED|Overall Study||9
5073282|NCT01792830|12482607|P10|COMPLETED|Overall Study||4
5073283|NCT01792830|12482608|P9|COMPLETED|Overall Study||11
5073284|NCT01792830|12482609|P8|COMPLETED|Overall Study||6
5073285|NCT01792830|12482610|P7|COMPLETED|Overall Study||12
5073286|NCT01792830|12482611|P6|COMPLETED|Overall Study||3
5073287|NCT01792830|12482612|P5|COMPLETED|Overall Study||1
5073288|NCT01792830|12482613|P4|COMPLETED|Overall Study||18
5073289|NCT01792830|12482614|P3|COMPLETED|Overall Study||4
5073290|NCT01792830|12482615|P2|COMPLETED|Overall Study||3
5073291|NCT01792830|12482616|P1|COMPLETED|Overall Study||59
5073292|NCT01792830|12482606|P11|STARTED|Overall Study||12
5073293|NCT01792830|12482607|P10|STARTED|Overall Study||4
5073294|NCT01792830|12482608|P9|STARTED|Overall Study||20
5073295|NCT01792830|12482609|P8|STARTED|Overall Study||7
5073296|NCT01792830|12482610|P7|STARTED|Overall Study||14
5073297|NCT01792830|12482611|P6|STARTED|Overall Study||4
5073298|NCT01792830|12482612|P5|STARTED|Overall Study||2
5073299|NCT01792830|12482613|P4|STARTED|Overall Study||21
5073300|NCT01792830|12482614|P3|STARTED|Overall Study||4
5073301|NCT01792830|12482615|P2|STARTED|Overall Study||3
5073302|NCT01792830|12482616|P1|STARTED|Overall Study||84
5073303|NCT01792817|12482685|P3|NOT COMPLETED|Phase 2 Open Label||26
5073304|NCT01792817|12482686|P2|NOT COMPLETED|Phase 2 Open Label||0
5073305|NCT01792817|12482687|P1|NOT COMPLETED|Phase 2 Open Label||0
5073306|NCT01792817|12482685|P3|COMPLETED|Phase 2 Open Label||74
5073307|NCT01792817|12482686|P2|COMPLETED|Phase 2 Open Label||0
5073308|NCT01792817|12482687|P1|COMPLETED|Phase 2 Open Label||0
5073309|NCT01792817|12482685|P3|STARTED|Phase 2 Open Label||100
5073310|NCT01792817|12482686|P2|STARTED|Phase 2 Open Label||0
5073311|NCT01792817|12482687|P1|STARTED|Phase 2 Open Label||0
5073312|NCT01792817|12482685|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
5073313|NCT01792817|12482686|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
5073314|NCT01792817|12482687|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
5073315|NCT01792817|12482685|P3|COMPLETED|Phase 1 Double Blind Period||0
5073316|NCT01792817|12482686|P2|COMPLETED|Phase 1 Double Blind Period||42
5073317|NCT01792817|12482687|P1|COMPLETED|Phase 1 Double Blind Period||58
5073318|NCT01792817|12482685|P3|STARTED|Phase 1 Double Blind Period||0
5073319|NCT01792817|12482686|P2|STARTED|Phase 1 Double Blind Period||73
5073320|NCT01792817|12482687|P1|STARTED|Phase 1 Double Blind Period||77
5073321|NCT01792635|12482703|P3|NOT COMPLETED|Part B||4
5073322|NCT01792635|12482704|P2|NOT COMPLETED|Part B||4
5073323|NCT01792635|12482705|P1|NOT COMPLETED|Part B||0
5073324|NCT01792635|12482703|P3|COMPLETED|Part B||3
5073325|NCT01792635|12482704|P2|COMPLETED|Part B||2
5073326|NCT01792635|12482705|P1|COMPLETED|Part B||0
5073327|NCT01792635|12482703|P3|STARTED|Part B||7
5073328|NCT01792635|12482704|P2|STARTED|Part B||6
5073329|NCT01792635|12482705|P1|STARTED|Part B||0
5073330|NCT01792635|12482703|P3|NOT COMPLETED|Part A||0
5073331|NCT01792635|12482704|P2|NOT COMPLETED|Part A||0
5073332|NCT01792635|12482705|P1|NOT COMPLETED|Part A||0
5073333|NCT01792635|12482703|P3|COMPLETED|Part A||0
5073334|NCT01792635|12482704|P2|COMPLETED|Part A||0
5073335|NCT01792635|12482705|P1|COMPLETED|Part A||6
5073336|NCT01792635|12482703|P3|STARTED|Part A||0
5073337|NCT01792635|12482704|P2|STARTED|Part A||0
5073338|NCT01792635|12482705|P1|STARTED|Part A||6
5073339|NCT01792518|12482733|P2|NOT COMPLETED|Overall Study||7
5073340|NCT01792518|12482734|P1|NOT COMPLETED|Overall Study||8
5073341|NCT01792518|12482733|P2|COMPLETED|Overall Study||175
5073342|NCT01792518|12482734|P1|COMPLETED|Overall Study||170
5073343|NCT01792518|12482733|P2|STARTED|Overall Study||182
5073344|NCT01792518|12482734|P1|STARTED|Overall Study||178
5073345|NCT01792284|12482744|P3|NOT COMPLETED|Randomization Period 2||0
5073346|NCT01792284|12482745|P2|NOT COMPLETED|Randomization Period 2||3
5073347|NCT01792284|12482746|P1|NOT COMPLETED|Randomization Period 2||0
5073348|NCT01792284|12482744|P3|COMPLETED|Randomization Period 2||85
5073349|NCT01792284|12482745|P2|COMPLETED|Randomization Period 2||87
5073350|NCT01792284|12482746|P1|COMPLETED|Randomization Period 2||0
5073351|NCT01792284|12482744|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
5073352|NCT01792284|12482745|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
5073353|NCT01792284|12482746|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
5073354|NCT01792284|12482744|P3|STARTED|Randomization Period 2||85
5073355|NCT01792284|12482745|P2|STARTED|Randomization Period 2||90
5073356|NCT01792284|12482746|P1|STARTED|Randomization Period 2||0
5073357|NCT01792284|12482744|P3|NOT COMPLETED|Randomization Period 1||5
5073358|NCT01792284|12482745|P2|NOT COMPLETED|Randomization Period 1||2
5073359|NCT01792284|12482746|P1|NOT COMPLETED|Randomization Period 1||0
5073360|NCT01792284|12482744|P3|COMPLETED|Randomization Period 1||85
5073361|NCT01792284|12482745|P2|COMPLETED|Randomization Period 1||90
5073362|NCT01792284|12482746|P1|COMPLETED|Randomization Period 1||0
5073363|NCT01792284|12482744|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
5073364|NCT01792284|12482745|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
5073365|NCT01792284|12482746|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
5073366|NCT01792284|12482744|P3|STARTED|Randomization Period 1||90
5073367|NCT01792284|12482745|P2|STARTED|Randomization Period 1||92
5073368|NCT01792284|12482746|P1|STARTED|Randomization Period 1||0
5073369|NCT01792284|12482744|P3|NOT COMPLETED|Lead-in Period||0
5073370|NCT01792284|12482745|P2|NOT COMPLETED|Lead-in Period||0
5073371|NCT01792284|12482746|P1|NOT COMPLETED|Lead-in Period||30
5073372|NCT01792284|12482744|P3|COMPLETED|Lead-in Period||0
5073373|NCT01792284|12482745|P2|COMPLETED|Lead-in Period||0
5073374|NCT01792284|12482746|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
5073375|NCT01792284|12482744|P3|STARTED|Lead-in Period||0
5073376|NCT01792284|12482745|P2|STARTED|Lead-in Period||0
5073377|NCT01792284|12482746|P1|STARTED|Lead-in Period||212
5073378|NCT01792024|12482784|P1|NOT COMPLETED|Overall Study||0
5073379|NCT01792024|12482784|P1|COMPLETED|Overall Study||27
5073380|NCT01792024|12482784|P1|STARTED|Overall Study||27
5073381|NCT01791972|12482794|P2|NOT COMPLETED|Overall Study||0
5073382|NCT01791972|12482795|P1|NOT COMPLETED|Overall Study||0
5073383|NCT01791972|12482794|P2|COMPLETED|Overall Study||19
5073384|NCT01791972|12482795|P1|COMPLETED|Overall Study||19
5073385|NCT01791972|12482794|P2|STARTED|Overall Study||19
5073386|NCT01791972|12482795|P1|STARTED|Overall Study||19
5073387|NCT01791894|12482805|P1|NOT COMPLETED|Overall Study||1
5073388|NCT01791894|12482805|P1|COMPLETED|Overall Study||4
5073389|NCT01791894|12482805|P1|STARTED|Overall Study||5
5073390|NCT01791803|12482816|P4|NOT COMPLETED|Overall Study||5
5073391|NCT01791803|12482817|P3|NOT COMPLETED|Overall Study||2
5073392|NCT01791803|12482818|P2|NOT COMPLETED|Overall Study||2
5073393|NCT01791803|12482819|P1|NOT COMPLETED|Overall Study||0
5073394|NCT01791803|12482816|P4|COMPLETED|Overall Study||37
5073395|NCT01791803|12482817|P3|COMPLETED|Overall Study||38
5073396|NCT01791803|12482818|P2|COMPLETED|Overall Study||39
5073397|NCT01791803|12482819|P1|COMPLETED|Overall Study||41
5073398|NCT01791803|12482816|P4|STARTED|Overall Study||42
5073399|NCT01791803|12482817|P3|STARTED|Overall Study||40
5073400|NCT01791803|12482818|P2|STARTED|Overall Study||41
5073401|NCT01791803|12482819|P1|STARTED|Overall Study||41
5073402|NCT01791725|12482837|P3|NOT COMPLETED|Overall Study||0
5073403|NCT01791725|12482838|P2|NOT COMPLETED|Overall Study||1
5073404|NCT01791725|12482839|P1|NOT COMPLETED|Overall Study||0
5073405|NCT01791725|12482837|P3|COMPLETED|Overall Study||6
5073406|NCT01791725|12482838|P2|COMPLETED|Overall Study||4
5073407|NCT01791725|12482839|P1|COMPLETED|Overall Study||12
5073408|NCT01791725|12482837|P3|STARTED|Overall Study||6
5073409|NCT01791725|12482838|P2|STARTED|Overall Study||5
5073410|NCT01791725|12482839|P1|STARTED|Overall Study||12
5073411|NCT01791517|12482862|P12|NOT COMPLETED|Phase II||1
5073412|NCT01791517|12482863|P11|NOT COMPLETED|Phase II||1
5073413|NCT01791517|12482864|P10|NOT COMPLETED|Phase II||3
5073414|NCT01791517|12482865|P9|NOT COMPLETED|Phase II||2
5073415|NCT01791517|12482866|P8|NOT COMPLETED|Phase II||3
5073416|NCT01791517|12482867|P7|NOT COMPLETED|Phase II||2
5073417|NCT01791517|12482868|P6|NOT COMPLETED|Phase II||4
5073418|NCT01791517|12482869|P5|NOT COMPLETED|Phase II||2
5073419|NCT01791517|12482870|P4|NOT COMPLETED|Phase II||0
5073420|NCT01791517|12482871|P3|NOT COMPLETED|Phase II||1
5073421|NCT01791517|12482872|P2|NOT COMPLETED|Phase II||0
5073422|NCT01791517|12482873|P1|NOT COMPLETED|Phase II||2
5073423|NCT01791517|12482862|P12|COMPLETED|Phase II||17
5073424|NCT01791517|12482863|P11|COMPLETED|Phase II||15
5073425|NCT01791517|12482864|P10|COMPLETED|Phase II||15
5073426|NCT01791517|12482865|P9|COMPLETED|Phase II||17
5073427|NCT01791517|12482866|P8|COMPLETED|Phase II||17
5073428|NCT01791517|12482867|P7|COMPLETED|Phase II||17
5073429|NCT01791517|12482868|P6|COMPLETED|Phase II||14
5073430|NCT01791517|12482869|P5|COMPLETED|Phase II||16
5073431|NCT01791517|12482870|P4|COMPLETED|Phase II||15
5073432|NCT01791517|12482871|P3|COMPLETED|Phase II||15
5073433|NCT01791517|12482872|P2|COMPLETED|Phase II||14
5073434|NCT01791517|12482873|P1|COMPLETED|Phase II||15
5073435|NCT01791517|12482862|P12|STARTED|Phase II||18
5073436|NCT01791517|12482863|P11|STARTED|Phase II||16
5073437|NCT01791517|12482864|P10|STARTED|Phase II||18
5073438|NCT01791517|12482865|P9|STARTED|Phase II||19
5073439|NCT01791517|12482866|P8|STARTED|Phase II||20
5073440|NCT01791517|12482867|P7|STARTED|Phase II||19
5073441|NCT01791517|12482868|P6|STARTED|Phase II||18
5073442|NCT01791517|12482869|P5|STARTED|Phase II||18
5073443|NCT01791517|12482870|P4|STARTED|Phase II||15
5073444|NCT01791517|12482871|P3|STARTED|Phase II||16
5073445|NCT01791517|12482872|P2|STARTED|Phase II||14
5073446|NCT01791517|12482873|P1|STARTED|Phase II||17
5073447|NCT01791517|12482862|P12|NOT COMPLETED|Phase I: Period 4||0
5073448|NCT01791517|12482863|P11|NOT COMPLETED|Phase I: Period 4||0
5073449|NCT01791517|12482864|P10|NOT COMPLETED|Phase I: Period 4||0
5073450|NCT01791517|12482865|P9|NOT COMPLETED|Phase I: Period 4||0
5073451|NCT01791517|12482866|P8|NOT COMPLETED|Phase I: Period 4||0
5073452|NCT01791517|12482867|P7|NOT COMPLETED|Phase I: Period 4||0
5073453|NCT01791517|12482868|P6|NOT COMPLETED|Phase I: Period 4||0
5073454|NCT01791517|12482869|P5|NOT COMPLETED|Phase I: Period 4||0
5073455|NCT01791517|12482870|P4|NOT COMPLETED|Phase I: Period 4||0
5073456|NCT01791517|12482871|P3|NOT COMPLETED|Phase I: Period 4||0
5073457|NCT01791517|12482872|P2|NOT COMPLETED|Phase I: Period 4||0
5073458|NCT01791517|12482873|P1|NOT COMPLETED|Phase I: Period 4||0
5073459|NCT01791517|12482862|P12|COMPLETED|Phase I: Period 4||18
5073460|NCT01791517|12482863|P11|COMPLETED|Phase I: Period 4||16
5073461|NCT01791517|12482864|P10|COMPLETED|Phase I: Period 4||18
5073462|NCT01791517|12482865|P9|COMPLETED|Phase I: Period 4||19
5073463|NCT01791517|12482866|P8|COMPLETED|Phase I: Period 4||20
5073464|NCT01791517|12482867|P7|COMPLETED|Phase I: Period 4||19
5073465|NCT01791517|12482868|P6|COMPLETED|Phase I: Period 4||18
5073466|NCT01791517|12482869|P5|COMPLETED|Phase I: Period 4||18
5073467|NCT01791517|12482870|P4|COMPLETED|Phase I: Period 4||15
5073468|NCT01791517|12482871|P3|COMPLETED|Phase I: Period 4||16
5073469|NCT01791517|12482872|P2|COMPLETED|Phase I: Period 4||14
5073470|NCT01791517|12482873|P1|COMPLETED|Phase I: Period 4||17
5073471|NCT01791517|12482862|P12|STARTED|Phase I: Period 4||18
5073472|NCT01791517|12482863|P11|STARTED|Phase I: Period 4||16
5073473|NCT01791517|12482864|P10|STARTED|Phase I: Period 4||18
5073474|NCT01791517|12482865|P9|STARTED|Phase I: Period 4||19
5073475|NCT01791517|12482866|P8|STARTED|Phase I: Period 4||20
5073476|NCT01791517|12482867|P7|STARTED|Phase I: Period 4||19
5073477|NCT01791517|12482868|P6|STARTED|Phase I: Period 4||18
5073478|NCT01791517|12482869|P5|STARTED|Phase I: Period 4||18
5073479|NCT01791517|12482870|P4|STARTED|Phase I: Period 4||15
5073480|NCT01791517|12482871|P3|STARTED|Phase I: Period 4||16
5073481|NCT01791517|12482872|P2|STARTED|Phase I: Period 4||14
5073482|NCT01791517|12482873|P1|STARTED|Phase I: Period 4||17
5073483|NCT01791517|12482862|P12|NOT COMPLETED|Phase I: Period 3||1
5073484|NCT01791517|12482863|P11|NOT COMPLETED|Phase I: Period 3||0
5073485|NCT01791517|12482864|P10|NOT COMPLETED|Phase I: Period 3||0
5073486|NCT01791517|12482865|P9|NOT COMPLETED|Phase I: Period 3||0
5073487|NCT01791517|12482866|P8|NOT COMPLETED|Phase I: Period 3||0
5073488|NCT01791517|12482867|P7|NOT COMPLETED|Phase I: Period 3||0
5073489|NCT01791517|12482868|P6|NOT COMPLETED|Phase I: Period 3||0
5073490|NCT01791517|12482869|P5|NOT COMPLETED|Phase I: Period 3||1
5073491|NCT01791517|12482870|P4|NOT COMPLETED|Phase I: Period 3||1
5073492|NCT01791517|12482871|P3|NOT COMPLETED|Phase I: Period 3||0
5073493|NCT01791517|12482872|P2|NOT COMPLETED|Phase I: Period 3||1
5073494|NCT01791517|12482873|P1|NOT COMPLETED|Phase I: Period 3||0
5073495|NCT01791517|12482862|P12|COMPLETED|Phase I: Period 3||18
5073496|NCT01791517|12482863|P11|COMPLETED|Phase I: Period 3||16
5073497|NCT01791517|12482864|P10|COMPLETED|Phase I: Period 3||18
5073498|NCT01791517|12482865|P9|COMPLETED|Phase I: Period 3||19
5073499|NCT01791517|12482866|P8|COMPLETED|Phase I: Period 3||20
5073500|NCT01791517|12482867|P7|COMPLETED|Phase I: Period 3||19
5073501|NCT01791517|12482868|P6|COMPLETED|Phase I: Period 3||18
5073502|NCT01791517|12482869|P5|COMPLETED|Phase I: Period 3||18
5073503|NCT01791517|12482870|P4|COMPLETED|Phase I: Period 3||15
5073504|NCT01791517|12482871|P3|COMPLETED|Phase I: Period 3||16
5073505|NCT01791517|12482872|P2|COMPLETED|Phase I: Period 3||14
5073506|NCT01791517|12482873|P1|COMPLETED|Phase I: Period 3||17
5073507|NCT01791517|12482862|P12|STARTED|Phase I: Period 3||19
5073508|NCT01791517|12482863|P11|STARTED|Phase I: Period 3||16
5073509|NCT01791517|12482864|P10|STARTED|Phase I: Period 3||18
5073510|NCT01791517|12482865|P9|STARTED|Phase I: Period 3||19
5073511|NCT01791517|12482866|P8|STARTED|Phase I: Period 3||20
5073512|NCT01791517|12482867|P7|STARTED|Phase I: Period 3||19
5073513|NCT01791517|12482868|P6|STARTED|Phase I: Period 3||18
5073514|NCT01791517|12482869|P5|STARTED|Phase I: Period 3||19
5073515|NCT01791517|12482870|P4|STARTED|Phase I: Period 3||16
5073516|NCT01791517|12482871|P3|STARTED|Phase I: Period 3||16
5073517|NCT01791517|12482872|P2|STARTED|Phase I: Period 3||15
5073518|NCT01791517|12482873|P1|STARTED|Phase I: Period 3||17
5073519|NCT01791517|12482862|P12|NOT COMPLETED|Phase I: Period 2||0
5073520|NCT01791517|12482863|P11|NOT COMPLETED|Phase I: Period 2||2
5073521|NCT01791517|12482864|P10|NOT COMPLETED|Phase I: Period 2||1
5073522|NCT01791517|12482865|P9|NOT COMPLETED|Phase I: Period 2||0
5073523|NCT01791517|12482866|P8|NOT COMPLETED|Phase I: Period 2||0
5073524|NCT01791517|12482867|P7|NOT COMPLETED|Phase I: Period 2||0
5073525|NCT01791517|12482868|P6|NOT COMPLETED|Phase I: Period 2||1
5073526|NCT01791517|12482869|P5|NOT COMPLETED|Phase I: Period 2||0
5073527|NCT01791517|12482870|P4|NOT COMPLETED|Phase I: Period 2||1
5073528|NCT01791517|12482871|P3|NOT COMPLETED|Phase I: Period 2||2
5073529|NCT01791517|12482872|P2|NOT COMPLETED|Phase I: Period 2||3
5073530|NCT01791517|12482873|P1|NOT COMPLETED|Phase I: Period 2||1
5073531|NCT01791517|12482862|P12|COMPLETED|Phase I: Period 2||19
5073532|NCT01791517|12482863|P11|COMPLETED|Phase I: Period 2||16
5073533|NCT01791517|12482864|P10|COMPLETED|Phase I: Period 2||18
5073534|NCT01791517|12482865|P9|COMPLETED|Phase I: Period 2||19
5073535|NCT01791517|12482866|P8|COMPLETED|Phase I: Period 2||20
5073536|NCT01791517|12482867|P7|COMPLETED|Phase I: Period 2||19
5073537|NCT01791517|12482868|P6|COMPLETED|Phase I: Period 2||18
5073538|NCT01791517|12482869|P5|COMPLETED|Phase I: Period 2||19
5073539|NCT01791517|12482870|P4|COMPLETED|Phase I: Period 2||16
5073540|NCT01791517|12482871|P3|COMPLETED|Phase I: Period 2||16
5073541|NCT01791517|12482872|P2|COMPLETED|Phase I: Period 2||15
5073542|NCT01791517|12482873|P1|COMPLETED|Phase I: Period 2||17
5073543|NCT01791517|12482862|P12|STARTED|Phase I: Period 2||19
5073544|NCT01791517|12482863|P11|STARTED|Phase I: Period 2||18
5073545|NCT01791517|12482864|P10|STARTED|Phase I: Period 2||19
5073546|NCT01791517|12482865|P9|STARTED|Phase I: Period 2||19
5073547|NCT01791517|12482866|P8|STARTED|Phase I: Period 2||20
5073548|NCT01791517|12482867|P7|STARTED|Phase I: Period 2||19
5073549|NCT01791517|12482868|P6|STARTED|Phase I: Period 2||19
5073550|NCT01791517|12482869|P5|STARTED|Phase I: Period 2||19
5073551|NCT01791517|12482870|P4|STARTED|Phase I: Period 2||17
5073552|NCT01791517|12482871|P3|STARTED|Phase I: Period 2||18
5073553|NCT01791517|12482872|P2|STARTED|Phase I: Period 2||18
5073554|NCT01791517|12482873|P1|STARTED|Phase I: Period 2||18
5073555|NCT01791517|12482862|P12|NOT COMPLETED|Phase I: Period 1||1
5073556|NCT01791517|12482863|P11|NOT COMPLETED|Phase I: Period 1||0
5073557|NCT01791517|12482864|P10|NOT COMPLETED|Phase I: Period 1||1
5073558|NCT01791517|12482865|P9|NOT COMPLETED|Phase I: Period 1||1
5073559|NCT01791517|12482866|P8|NOT COMPLETED|Phase I: Period 1||0
5073560|NCT01791517|12482867|P7|NOT COMPLETED|Phase I: Period 1||1
5073561|NCT01791517|12482868|P6|NOT COMPLETED|Phase I: Period 1||1
5073562|NCT01791517|12482869|P5|NOT COMPLETED|Phase I: Period 1||1
5073563|NCT01791517|12482870|P4|NOT COMPLETED|Phase I: Period 1||2
5073564|NCT01791517|12482871|P3|NOT COMPLETED|Phase I: Period 1||2
5073565|NCT01791517|12482872|P2|NOT COMPLETED|Phase I: Period 1||2
5073566|NCT01791517|12482873|P1|NOT COMPLETED|Phase I: Period 1||1
5073567|NCT01791517|12482862|P12|COMPLETED|Phase I: Period 1||19
5073568|NCT01791517|12482863|P11|COMPLETED|Phase I: Period 1||18
5073569|NCT01791517|12482864|P10|COMPLETED|Phase I: Period 1||19
5073570|NCT01791517|12482865|P9|COMPLETED|Phase I: Period 1||19
5073571|NCT01791517|12482866|P8|COMPLETED|Phase I: Period 1||20
5073572|NCT01791517|12482867|P7|COMPLETED|Phase I: Period 1||19
5073573|NCT01791517|12482868|P6|COMPLETED|Phase I: Period 1||19
5073574|NCT01791517|12482869|P5|COMPLETED|Phase I: Period 1||19
5073575|NCT01791517|12482870|P4|COMPLETED|Phase I: Period 1||17
5073576|NCT01791517|12482871|P3|COMPLETED|Phase I: Period 1||18
5073577|NCT01791517|12482872|P2|COMPLETED|Phase I: Period 1||18
5073578|NCT01791517|12482873|P1|COMPLETED|Phase I: Period 1||18
5073579|NCT01791517|12482862|P12|STARTED|Phase I: Period 1||20
5073580|NCT01791517|12482863|P11|STARTED|Phase I: Period 1||18
5073581|NCT01791517|12482864|P10|STARTED|Phase I: Period 1||20
5073582|NCT01791517|12482865|P9|STARTED|Phase I: Period 1||20
5073583|NCT01791517|12482866|P8|STARTED|Phase I: Period 1||20
5073584|NCT01791517|12482867|P7|STARTED|Phase I: Period 1||20
5073585|NCT01791517|12482868|P6|STARTED|Phase I: Period 1||20
5073586|NCT01791517|12482869|P5|STARTED|Phase I: Period 1||20
5073587|NCT01791517|12482870|P4|STARTED|Phase I: Period 1||19
5073588|NCT01791517|12482871|P3|STARTED|Phase I: Period 1||20
5073589|NCT01791517|12482872|P2|STARTED|Phase I: Period 1||20
5073590|NCT01791517|12482873|P1|STARTED|Phase I: Period 1||19
5073591|NCT01791491|12482899|P1|NOT COMPLETED|Overall Study||0
5073592|NCT01791491|12482899|P1|COMPLETED|Overall Study||9
5073593|NCT01791491|12482899|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
5073594|NCT01791465|12482911|P1|NOT COMPLETED|Overall Study||0
5073595|NCT01791465|12482911|P1|COMPLETED|Overall Study||6
5073596|NCT01791465|12482911|P1|STARTED|Overall Study||6
5073597|NCT01791413|12482937|P2|NOT COMPLETED|Overall Study||1
5073598|NCT01791413|12482938|P1|NOT COMPLETED|Overall Study||5
5073599|NCT01791413|12482937|P2|COMPLETED|Overall Study||19
5073600|NCT01791413|12482938|P1|COMPLETED|Overall Study||15
5073601|NCT01791413|12482937|P2|STARTED|Overall Study||20
5073602|NCT01791413|12482938|P1|STARTED|Overall Study||20
5073603|NCT01791244|12482947|P2|NOT COMPLETED|Overall Study||18
5073604|NCT01791244|12482948|P1|NOT COMPLETED|Overall Study||15
5073605|NCT01791244|12482947|P2|COMPLETED|Overall Study||29
5073606|NCT01791244|12482948|P1|COMPLETED|Overall Study||31
5073607|NCT01791244|12482947|P2|Intent to Treat (ITT)|Overall Study||39
5073608|NCT01791244|12482948|P1|Intent to Treat (ITT)|Overall Study||38
5073609|NCT01791244|12482947|P2|STARTED|Overall Study||47
5073610|NCT01791244|12482948|P1|STARTED|Overall Study||46
5073611|NCT01791205|12482984|P2|NOT COMPLETED|Phase II||0
5073612|NCT01791205|12482985|P1|NOT COMPLETED|Phase II||12
5073613|NCT01791205|12482984|P2|COMPLETED|Phase II||0
5073614|NCT01791205|12482985|P1|COMPLETED|Phase II||92
5073615|NCT01791205|12482984|P2|STARTED|Phase II||0
5073616|NCT01791205|12482985|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
5073617|NCT01791205|12482984|P2|NOT COMPLETED|Phase I||0
5073618|NCT01791205|12482985|P1|NOT COMPLETED|Phase I||0
5073619|NCT01791205|12482984|P2|COMPLETED|Phase I||152
5073620|NCT01791205|12482985|P1|COMPLETED|Phase I||152
5073621|NCT01791205|12482984|P2|STARTED|Phase I||152
5073622|NCT01791205|12482985|P1|STARTED|Phase I||152
5073623|NCT01791153|12483069|P8|NOT COMPLETED|Part 2: Open-label Period||6
5073624|NCT01791153|12483070|P7|NOT COMPLETED|Part 2: Open-label Period||6
5073625|NCT01791153|12483071|P6|NOT COMPLETED|Part 2: Open-label Period||4
5073626|NCT01791153|12483072|P5|NOT COMPLETED|Part 2: Open-label Period||2
5073627|NCT01791153|12483073|P4|NOT COMPLETED|Part 2: Open-label Period||0
5073628|NCT01791153|12483074|P3|NOT COMPLETED|Part 2: Open-label Period||0
5073629|NCT01791153|12483075|P2|NOT COMPLETED|Part 2: Open-label Period||0
5073630|NCT01791153|12483076|P1|NOT COMPLETED|Part 2: Open-label Period||0
5073631|NCT01791153|12483069|P8|COMPLETED|Part 2: Open-label Period||61
5073632|NCT01791153|12483070|P7|COMPLETED|Part 2: Open-label Period||44
5073633|NCT01791153|12483071|P6|COMPLETED|Part 2: Open-label Period||54
5073634|NCT01791153|12483072|P5|COMPLETED|Part 2: Open-label Period||38
5073635|NCT01791153|12483073|P4|COMPLETED|Part 2: Open-label Period||0
5073636|NCT01791153|12483074|P3|COMPLETED|Part 2: Open-label Period||0
5073637|NCT01791153|12483075|P2|COMPLETED|Part 2: Open-label Period||0
5073638|NCT01791153|12483076|P1|COMPLETED|Part 2: Open-label Period||0
5073639|NCT01791153|12483069|P8|STARTED|Part 2: Open-label Period||67
5073640|NCT01791153|12483070|P7|STARTED|Part 2: Open-label Period||50
5073641|NCT01791153|12483071|P6|STARTED|Part 2: Open-label Period||58
5073642|NCT01791153|12483072|P5|STARTED|Part 2: Open-label Period||40
5073643|NCT01791153|12483073|P4|STARTED|Part 2: Open-label Period||0
5073644|NCT01791153|12483074|P3|STARTED|Part 2: Open-label Period||0
5073645|NCT01791153|12483075|P2|STARTED|Part 2: Open-label Period||0
5073646|NCT01791153|12483076|P1|STARTED|Part 2: Open-label Period||0
5073647|NCT01791153|12483069|P8|NOT COMPLETED|Part 1: Blinded Period||0
5073648|NCT01791153|12483070|P7|NOT COMPLETED|Part 1: Blinded Period||0
5073649|NCT01791153|12483071|P6|NOT COMPLETED|Part 1: Blinded Period||0
5073650|NCT01791153|12483072|P5|NOT COMPLETED|Part 1: Blinded Period||0
5073651|NCT01791153|12483073|P4|NOT COMPLETED|Part 1: Blinded Period||5
5073652|NCT01791153|12483074|P3|NOT COMPLETED|Part 1: Blinded Period||6
5073653|NCT01791153|12483075|P2|NOT COMPLETED|Part 1: Blinded Period||8
5073654|NCT01791153|12483076|P1|NOT COMPLETED|Part 1: Blinded Period||15
5073655|NCT01791153|12483069|P8|COMPLETED|Part 1: Blinded Period||0
5073656|NCT01791153|12483070|P7|COMPLETED|Part 1: Blinded Period||0
5073657|NCT01791153|12483071|P6|COMPLETED|Part 1: Blinded Period||0
5073658|NCT01791153|12483072|P5|COMPLETED|Part 1: Blinded Period||0
5073659|NCT01791153|12483073|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
5073660|NCT01791153|12483074|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
5073661|NCT01791153|12483075|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
5073662|NCT01791153|12483076|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
5073663|NCT01791153|12483069|P8|STARTED|Part 1: Blinded Period||0
5073664|NCT01791153|12483070|P7|STARTED|Part 1: Blinded Period||0
5073665|NCT01791153|12483071|P6|STARTED|Part 1: Blinded Period||0
5073666|NCT01791153|12483072|P5|STARTED|Part 1: Blinded Period||0
5073667|NCT01791153|12483073|P4|STARTED|Part 1: Blinded Period||51
5073668|NCT01791153|12483074|P3|STARTED|Part 1: Blinded Period||50
5073669|NCT01791153|12483075|P2|STARTED|Part 1: Blinded Period||49
5073670|NCT01791153|12483076|P1|STARTED|Part 1: Blinded Period||100
5073671|NCT01791127|12483136|P1|NOT COMPLETED|Overall Study||1472
5073672|NCT01791127|12483136|P1|COMPLETED|Overall Study||286
5073673|NCT01791127|12483136|P1|STARTED|Overall Study||1758
5073674|NCT01790932|12483160|P1|NOT COMPLETED|Overall Study||50
5073675|NCT01790932|12483160|P1|COMPLETED|Overall Study||0
5073676|NCT01790932|12483160|P1|STARTED|Overall Study||50
5073677|NCT01790828|12483166|P1|NOT COMPLETED|Overall Study||34
5073678|NCT01790828|12483166|P1|COMPLETED|Overall Study||8
5073679|NCT01790828|12483166|P1|STARTED|Overall Study||42
5073680|NCT01790750|12483189|P1|NOT COMPLETED|Overall Study||0
5073681|NCT01790750|12483189|P1|COMPLETED|Overall Study||50
5073682|NCT01790750|12483189|P1|STARTED|Overall Study||50
5073683|NCT01790685|12483196|P2|NOT COMPLETED|Overall Study||0
5073684|NCT01790685|12483197|P1|NOT COMPLETED|Overall Study||0
5073685|NCT01790685|12483196|P2|COMPLETED|Overall Study||17
5073686|NCT01790685|12483197|P1|COMPLETED|Overall Study||23
5073687|NCT01790685|12483196|P2|STARTED|Overall Study||17
5073688|NCT01790685|12483197|P1|STARTED|Overall Study||23
5073689|NCT01790659|12483205|P2|NOT COMPLETED|Overall Study||6
5073690|NCT01790659|12483206|P1|NOT COMPLETED|Overall Study||6
5073691|NCT01790659|12483205|P2|COMPLETED|Overall Study||192
5073692|NCT01790659|12483206|P1|COMPLETED|Overall Study||195
5073693|NCT01790659|12483205|P2|STARTED|Overall Study||198
5073694|NCT01790659|12483206|P1|STARTED|Overall Study||201
5073695|NCT01790633|12483224|P2|NOT COMPLETED|Overall Study||5
5073696|NCT01790633|12483225|P1|NOT COMPLETED|Overall Study||48
5073697|NCT01790633|12483224|P2|COMPLETED|Overall Study||159
5073698|NCT01790633|12483225|P1|COMPLETED|Overall Study||115
5073699|NCT01790633|12483224|P2|STARTED|Overall Study||164
5073700|NCT01790633|12483225|P1|STARTED|Overall Study||163
5073701|NCT01790594|12483238|P3|NOT COMPLETED|Overall Study||3
5073702|NCT01790594|12483239|P2|NOT COMPLETED|Overall Study||3
5073703|NCT01790594|12483240|P1|NOT COMPLETED|Overall Study||5
5073704|NCT01790594|12483238|P3|COMPLETED|Overall Study||0
5073705|NCT01790594|12483239|P2|COMPLETED|Overall Study||18
5073706|NCT01790594|12483240|P1|COMPLETED|Overall Study||17
5073707|NCT01790594|12483238|P3|STARTED|Overall Study||3
5073708|NCT01790594|12483239|P2|STARTED|Overall Study||21
5073709|NCT01790594|12483240|P1|STARTED|Overall Study||22
5073710|NCT01790581|12483308|P2|NOT COMPLETED|Overall Study||0
5073711|NCT01790581|12483309|P1|NOT COMPLETED|Overall Study||0
5073712|NCT01790581|12483308|P2|COMPLETED|Overall Study||12
5073713|NCT01790581|12483309|P1|COMPLETED|Overall Study||12
5073714|NCT01790581|12483308|P2|STARTED|Overall Study||12
5073715|NCT01790581|12483309|P1|STARTED|Overall Study||12
5073716|NCT01790568|12483317|P2|NOT COMPLETED|Overall Study||1
5073717|NCT01790568|12483318|P1|NOT COMPLETED|Overall Study||0
5073718|NCT01790568|12483317|P2|COMPLETED|Overall Study||25
5073719|NCT01790568|12483318|P1|COMPLETED|Overall Study||12
5073720|NCT01790568|12483317|P2|STARTED|Overall Study||26
5073721|NCT01790568|12483318|P1|STARTED|Overall Study||12
5073722|NCT01790516|12483326|P2|NOT COMPLETED|Overall Study||0
5073723|NCT01790516|12483327|P1|NOT COMPLETED|Overall Study||1
5073724|NCT01790516|12483326|P2|COMPLETED|Overall Study||1
5073725|NCT01790516|12483327|P1|COMPLETED|Overall Study||0
5073726|NCT01790516|12483326|P2|STARTED|Overall Study||1
5073727|NCT01790516|12483327|P1|STARTED|Overall Study||1
5073728|NCT01790503|12483344|P11|NOT COMPLETED|Overall Study||16
5073729|NCT01790503|12483345|P10|NOT COMPLETED|Overall Study||26
5073730|NCT01790503|12483346|P9|NOT COMPLETED|Overall Study||3
5073731|NCT01790503|12483347|P8|NOT COMPLETED|Overall Study||1
5073732|NCT01790503|12483348|P7|NOT COMPLETED|Overall Study||1
5073733|NCT01790503|12483349|P6|NOT COMPLETED|Overall Study||5
5073734|NCT01790503|12483350|P5|NOT COMPLETED|Overall Study||5
5073735|NCT01790503|12483351|P4|NOT COMPLETED|Overall Study||2
5073736|NCT01790503|12483352|P3|NOT COMPLETED|Overall Study||1
5073737|NCT01790503|12483353|P2|NOT COMPLETED|Overall Study||1
5073738|NCT01790503|12483354|P1|NOT COMPLETED|Overall Study||3
5073739|NCT01790503|12483344|P11|COMPLETED|Overall Study||0
5073740|NCT01790503|12483345|P10|COMPLETED|Overall Study||1
5073741|NCT01790503|12483346|P9|COMPLETED|Overall Study||0
5073742|NCT01790503|12483347|P8|COMPLETED|Overall Study||0
5073743|NCT01790503|12483348|P7|COMPLETED|Overall Study||0
5073744|NCT01790503|12483349|P6|COMPLETED|Overall Study||0
5073745|NCT01790503|12483350|P5|COMPLETED|Overall Study||0
5073746|NCT01790503|12483351|P4|COMPLETED|Overall Study||0
5073747|NCT01790503|12483352|P3|COMPLETED|Overall Study||0
5073748|NCT01790503|12483353|P2|COMPLETED|Overall Study||0
5073749|NCT01790503|12483354|P1|COMPLETED|Overall Study||0
5073750|NCT01790503|12483344|P11|STARTED|Overall Study||16
5073751|NCT01790503|12483345|P10|STARTED|Overall Study||27
5073752|NCT01790503|12483346|P9|STARTED|Overall Study||3
5073753|NCT01790503|12483347|P8|STARTED|Overall Study||1
5073754|NCT01790503|12483348|P7|STARTED|Overall Study||1
5073755|NCT01790503|12483349|P6|STARTED|Overall Study||5
5073756|NCT01790503|12483350|P5|STARTED|Overall Study||5
5073757|NCT01790503|12483351|P4|STARTED|Overall Study||2
5073758|NCT01790503|12483352|P3|STARTED|Overall Study||1
5073759|NCT01790503|12483353|P2|STARTED|Overall Study||1
5073760|NCT01790503|12483354|P1|STARTED|Overall Study||3
5073761|NCT01790490|12483409|P3|NOT COMPLETED|Overall Study||0
5073762|NCT01790490|12483410|P2|NOT COMPLETED|Overall Study||0
5073763|NCT01790490|12483411|P1|NOT COMPLETED|Overall Study||0
5073764|NCT01790490|12483409|P3|COMPLETED|Overall Study||2
5073765|NCT01790490|12483410|P2|COMPLETED|Overall Study||3
5073766|NCT01790490|12483411|P1|COMPLETED|Overall Study||3
5073767|NCT01790490|12483409|P3|STARTED|Overall Study||2
5073768|NCT01790490|12483410|P2|STARTED|Overall Study||3
5073769|NCT01790490|12483411|P1|STARTED|Overall Study||3
5073770|NCT01790438|12483424|P2|NOT COMPLETED|Overall Study||11
5073771|NCT01790438|12483425|P1|NOT COMPLETED|Overall Study||35
5073772|NCT01790438|12483424|P2|COMPLETED|Overall Study||202
5073773|NCT01790438|12483425|P1|COMPLETED|Overall Study||393
5073774|NCT01790438|12483424|P2|Received at Least One Dose of Study Drug|Overall Study||212
5073775|NCT01790438|12483425|P1|Received at Least One Dose of Study Drug|Overall Study||427
5073776|NCT01790438|12483424|P2|STARTED|Overall Study||213
5073777|NCT01790438|12483425|P1|STARTED|Overall Study||428
5073778|NCT01790295|12483475|P1|NOT COMPLETED|Overall Study||11
5073779|NCT01790295|12483475|P1|COMPLETED|Overall Study||10
5073780|NCT01790295|12483475|P1|STARTED|Overall Study||21
5073781|NCT01790243|12483500|P2|NOT COMPLETED|Overall Study||43
5073782|NCT01790243|12483501|P1|NOT COMPLETED|Overall Study||290
5073783|NCT01790243|12483500|P2|COMPLETED|Overall Study||117
5073784|NCT01790243|12483501|P1|COMPLETED|Overall Study||739
5073785|NCT01790243|12483500|P2|STARTED|Overall Study||160
5073786|NCT01790243|12483501|P1|STARTED|Overall Study||1029
5073787|NCT01790178|12483527|P2|NOT COMPLETED|Overall Study||0
5073788|NCT01790178|12483528|P1|NOT COMPLETED|Overall Study||0
5073789|NCT01790178|12483527|P2|COMPLETED|Overall Study||24
5073790|NCT01790178|12483528|P1|COMPLETED|Overall Study||16
5073791|NCT01790178|12483527|P2|STARTED|Overall Study||24
5073792|NCT01790178|12483528|P1|STARTED|Overall Study||16
5073793|NCT01790126|12483545|P3|NOT COMPLETED|Overall Study||31
5073794|NCT01790126|12483546|P2|NOT COMPLETED|Overall Study||29
5073795|NCT01790126|12483547|P1|NOT COMPLETED|Overall Study||30
5073796|NCT01790126|12483545|P3|COMPLETED|Overall Study||0
5073797|NCT01790126|12483546|P2|COMPLETED|Overall Study||0
5073798|NCT01790126|12483547|P1|COMPLETED|Overall Study||0
5073799|NCT01790126|12483545|P3|Treated|Overall Study||31
5073800|NCT01790126|12483546|P2|Treated|Overall Study||29
5073801|NCT01790126|12483547|P1|Treated|Overall Study||29
5073802|NCT01790126|12483545|P3|STARTED|Overall Study||31
5073803|NCT01790126|12483546|P2|STARTED|Overall Study||29
5073804|NCT01790126|12483547|P1|STARTED|Overall Study||30
5073805|NCT01790048|12483604|P2|NOT COMPLETED|Overall Study||17
5073806|NCT01790048|12483605|P1|NOT COMPLETED|Overall Study||12
5073807|NCT01790048|12483604|P2|COMPLETED|Overall Study||1086
5073808|NCT01790048|12483605|P1|COMPLETED|Overall Study||1144
5073809|NCT01790048|12483604|P2|STARTED|Overall Study||1103
5073810|NCT01790048|12483605|P1|STARTED|Overall Study||1156
5073811|NCT01789970|12483623|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
5073812|NCT01789970|12483624|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
5073813|NCT01789970|12483625|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
5073814|NCT01789970|12483623|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
5073815|NCT01789970|12483624|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
5073816|NCT01789970|12483625|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
5073817|NCT01789970|12483623|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
5073818|NCT01789970|12483624|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
5073819|NCT01789970|12483625|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
5073820|NCT01789970|12483623|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
5073821|NCT01789970|12483624|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
5073822|NCT01789970|12483625|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
5073823|NCT01789970|12483623|P3|NOT COMPLETED|Open-label Titration Period||0
5073824|NCT01789970|12483624|P2|NOT COMPLETED|Open-label Titration Period||0
5073825|NCT01789970|12483625|P1|NOT COMPLETED|Open-label Titration Period||254
5073826|NCT01789970|12483623|P3|COMPLETED|Open-label Titration Period||0
5073827|NCT01789970|12483624|P2|COMPLETED|Open-label Titration Period||0
5073828|NCT01789970|12483625|P1|COMPLETED|Open-label Titration Period||371
5073829|NCT01789970|12483623|P3|Safety Analysis Set|Open-label Titration Period||0
5073830|NCT01789970|12483624|P2|Safety Analysis Set|Open-label Titration Period||0
5073831|NCT01789970|12483625|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
5073832|NCT01789970|12483623|P3|STARTED|Open-label Titration Period||0
5073833|NCT01789970|12483624|P2|STARTED|Open-label Titration Period||0
5073834|NCT01789970|12483625|P1|STARTED|Open-label Titration Period||625
5073835|NCT01789905|12483657|P1|NOT COMPLETED|Overall Study||0
5073836|NCT01789905|12483657|P1|COMPLETED|Overall Study||116
5073837|NCT01789905|12483657|P1|STARTED|Overall Study||116
5073838|NCT01789814|12483665|P2|NOT COMPLETED|Overall Study||0
5073839|NCT01789814|12483666|P1|NOT COMPLETED|Overall Study||0
5073840|NCT01789814|12483665|P2|COMPLETED|Overall Study||12
5073841|NCT01789814|12483666|P1|COMPLETED|Overall Study||12
5073842|NCT01789814|12483665|P2|STARTED|Overall Study||12
5073843|NCT01789814|12483666|P1|STARTED|Overall Study||12
5073844|NCT01789775|12483674|P2|NOT COMPLETED|Overall Study||7
5073845|NCT01789775|12483675|P1|NOT COMPLETED|Overall Study||2
5073846|NCT01789775|12483674|P2|COMPLETED|Overall Study||50
5073847|NCT01789775|12483675|P1|COMPLETED|Overall Study||53
5073848|NCT01789775|12483674|P2|STARTED|Overall Study||57
5073849|NCT01789775|12483675|P1|STARTED|Overall Study||55
5073850|NCT01789606|12483683|P2|NOT COMPLETED|Overall Study||450
5073851|NCT01789606|12483684|P1|NOT COMPLETED|Overall Study||23
5073852|NCT01789606|12483683|P2|COMPLETED|Overall Study||382
5073853|NCT01789606|12483684|P1|COMPLETED|Overall Study||228
5073854|NCT01789606|12483683|P2|STARTED|Overall Study||832
5073855|NCT01789606|12483684|P1|STARTED|Overall Study||251
5073856|NCT01789567|12483702|P1|NOT COMPLETED|Overall Study||6
5073857|NCT01789567|12483702|P1|COMPLETED|Overall Study||14
5073858|NCT01789567|12483702|P1|STARTED|Overall Study||20
5073859|NCT01789476|12483711|P2|NOT COMPLETED|Overall Study||2
5073860|NCT01789476|12483712|P1|NOT COMPLETED|Overall Study||8
5073861|NCT01789476|12483711|P2|COMPLETED|Overall Study||15
5073862|NCT01789476|12483712|P1|COMPLETED|Overall Study||26
5073863|NCT01789476|12483711|P2|STARTED|Overall Study||17
5073864|NCT01789476|12483712|P1|STARTED|Overall Study||34
5073865|NCT01789255|12483722|P1|NOT COMPLETED|Overall Study||0
5073866|NCT01789255|12483722|P1|COMPLETED|Overall Study||12
5073867|NCT01789255|12483722|P1|STARTED|Overall Study||12
5073868|NCT01789203|12483734|P2|NOT COMPLETED|Overall Study||4
5073869|NCT01789203|12483735|P1|NOT COMPLETED|Overall Study||9
5073870|NCT01789203|12483734|P2|COMPLETED|Overall Study||63
5073871|NCT01789203|12483735|P1|COMPLETED|Overall Study||124
5073872|NCT01789203|12483734|P2|STARTED|Overall Study||67
5073873|NCT01789203|12483735|P1|STARTED|Overall Study||133
5073874|NCT01789138|12483765|P2|NOT COMPLETED|Overall Study||52
5073875|NCT01789138|12483766|P1|NOT COMPLETED|Overall Study||41
5073876|NCT01789138|12483765|P2|COMPLETED|Overall Study||206
5073877|NCT01789138|12483766|P1|COMPLETED|Overall Study||213
5073878|NCT01789138|12483765|P2|STARTED|Overall Study||258
5073879|NCT01789138|12483766|P1|STARTED|Overall Study||254
5073880|NCT01789047|12483776|P2|NOT COMPLETED|Overall Study||4
5073881|NCT01789047|12483777|P1|NOT COMPLETED|Overall Study||4
5073882|NCT01789047|12483776|P2|COMPLETED|Overall Study||17
5073883|NCT01789047|12483777|P1|COMPLETED|Overall Study||17
5073884|NCT01789047|12483776|P2|STARTED|Overall Study||21
5073885|NCT01789047|12483777|P1|STARTED|Overall Study||21
5073886|NCT01788943|12483785|P2|NOT COMPLETED|Overall Study||0
5073887|NCT01788943|12483786|P1|NOT COMPLETED|Overall Study||1
5073888|NCT01788943|12483785|P2|COMPLETED|Overall Study||12
5073889|NCT01788943|12483786|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
5073890|NCT01788943|12483785|P2|STARTED|Overall Study||12
5073891|NCT01788943|12483786|P1|STARTED|Overall Study|Recruitment for study began.|13
5073892|NCT01788631|12483796|P2|NOT COMPLETED|Overall Study||1
5073893|NCT01788631|12483797|P1|NOT COMPLETED|Overall Study||3
5073894|NCT01788631|12483796|P2|COMPLETED|Overall Study||43
5073895|NCT01788631|12483797|P1|COMPLETED|Overall Study||49
5073896|NCT01788631|12483796|P2|Randomized|Overall Study||47
5073897|NCT01788631|12483797|P1|Randomized|Overall Study||53
5073898|NCT01788631|12483796|P2|STARTED|Overall Study||44
5073899|NCT01788631|12483797|P1|STARTED|Overall Study||52
5073900|NCT01788566|12483815|P1|NOT COMPLETED|Overall Study||8
5073901|NCT01788566|12483815|P1|COMPLETED|Overall Study||53
5073902|NCT01788566|12483815|P1|STARTED|Overall Study||61
5073903|NCT01788475|12483828|P3|NOT COMPLETED|Overall Study||0
5073904|NCT01788475|12483829|P2|NOT COMPLETED|Overall Study||0
5073905|NCT01788475|12483830|P1|NOT COMPLETED|Overall Study||3
5073906|NCT01788475|12483828|P3|COMPLETED|Overall Study||0
5073907|NCT01788475|12483829|P2|COMPLETED|Overall Study||0
5073908|NCT01788475|12483830|P1|COMPLETED|Overall Study||0
5073909|NCT01788475|12483828|P3|STARTED|Overall Study||0
5073910|NCT01788475|12483829|P2|STARTED|Overall Study||0
5073911|NCT01788475|12483830|P1|STARTED|Overall Study||3
5073912|NCT01788423|12483853|P3|NOT COMPLETED|Overall Study||5
5073913|NCT01788423|12483854|P2|NOT COMPLETED|Overall Study||4
5073914|NCT01788423|12483855|P1|NOT COMPLETED|Overall Study||0
5073915|NCT01788423|12483853|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
5073916|NCT01788423|12483854|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
5073917|NCT01788423|12483855|P1|COMPLETED|Overall Study||53
5073918|NCT01788423|12483853|P3|STARTED|Overall Study||55
5073919|NCT01788423|12483854|P2|STARTED|Overall Study||55
5073920|NCT01788423|12483855|P1|STARTED|Overall Study||53
5073921|NCT01788358|12483866|P1|NOT COMPLETED|Overall Study||98
5073922|NCT01788358|12483866|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
5073923|NCT01788358|12483866|P1|Completed Week 52|Overall Study||193
5073924|NCT01788358|12483866|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
5073925|NCT01788358|12483866|P1|Completed Week 28|Overall Study||417
5073926|NCT01788358|12483866|P1|Treated|Overall Study||508
5073927|NCT01788358|12483866|P1|STARTED|Overall Study||508
5073928|NCT01788228|12483880|P2|NOT COMPLETED|Overall Study||0
5073929|NCT01788228|12483881|P1|NOT COMPLETED|Overall Study||1
5073930|NCT01788228|12483880|P2|COMPLETED|Overall Study||1
5073931|NCT01788228|12483881|P1|COMPLETED|Overall Study||48
5073932|NCT01788228|12483880|P2|STARTED|Overall Study||1
5073933|NCT01788228|12483881|P1|STARTED|Overall Study||49
5073934|NCT01788215|12483914|P2|NOT COMPLETED|Overall Study||1
5073935|NCT01788215|12483915|P1|NOT COMPLETED|Overall Study||2
5073936|NCT01788215|12483914|P2|COMPLETED|Overall Study||4
5073937|NCT01788215|12483915|P1|COMPLETED|Overall Study||3
5073938|NCT01788215|12483914|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
5073939|NCT01788215|12483915|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
5073940|NCT01788215|12483914|P2|STARTED|Overall Study||5
5073941|NCT01788215|12483915|P1|STARTED|Overall Study||5
5073942|NCT01788163|12483944|P9|NOT COMPLETED|Overall Study||16
5073943|NCT01788163|12483945|P8|NOT COMPLETED|Overall Study||48
5073944|NCT01788163|12483946|P7|NOT COMPLETED|Overall Study||1
5073945|NCT01788163|12483947|P6|NOT COMPLETED|Overall Study||7
5073946|NCT01788163|12483948|P5|NOT COMPLETED|Overall Study||0
5073947|NCT01788163|12483949|P4|NOT COMPLETED|Overall Study||0
5073948|NCT01788163|12483950|P3|NOT COMPLETED|Overall Study||0
5073949|NCT01788163|12483951|P2|NOT COMPLETED|Overall Study||0
5073950|NCT01788163|12483952|P1|NOT COMPLETED|Overall Study||55
5073951|NCT01788163|12483944|P9|COMPLETED|Overall Study||956
5073952|NCT01788163|12483945|P8|COMPLETED|Overall Study||254
5073953|NCT01788163|12483946|P7|COMPLETED|Overall Study||49
5073954|NCT01788163|12483947|P6|COMPLETED|Overall Study||95
5073955|NCT01788163|12483948|P5|COMPLETED|Overall Study||94
5073956|NCT01788163|12483949|P4|COMPLETED|Overall Study||71
5073957|NCT01788163|12483950|P3|COMPLETED|Overall Study||62
5073958|NCT01788163|12483951|P2|COMPLETED|Overall Study||271
5073959|NCT01788163|12483952|P1|COMPLETED|Overall Study||1403
5073960|NCT01788163|12483944|P9|STARTED|Overall Study||972
5073961|NCT01788163|12483945|P8|STARTED|Overall Study||302
5073962|NCT01788163|12483946|P7|STARTED|Overall Study||50
5073963|NCT01788163|12483947|P6|STARTED|Overall Study||102
5073964|NCT01788163|12483948|P5|STARTED|Overall Study||94
5073965|NCT01788163|12483949|P4|STARTED|Overall Study||71
5073966|NCT01788163|12483950|P3|STARTED|Overall Study||62
5073967|NCT01788163|12483951|P2|STARTED|Overall Study||271
5073968|NCT01788163|12483952|P1|STARTED|Overall Study||1458
5073969|NCT01788046|12484115|P2|NOT COMPLETED|Overall Study||37
5073970|NCT01788046|12484116|P1|NOT COMPLETED|Overall Study||56
5073971|NCT01788046|12484115|P2|COMPLETED|Overall Study||218
5073972|NCT01788046|12484116|P1|COMPLETED|Overall Study||204
5073973|NCT01788046|12484115|P2|Received Treatment|Overall Study||252
5073974|NCT01788046|12484116|P1|Received Treatment|Overall Study||259
5073975|NCT01788046|12484115|P2|STARTED|Overall Study||255
5073976|NCT01788046|12484116|P1|STARTED|Overall Study||260
5073977|NCT01787916|12484132|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
5073978|NCT01787916|12484133|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
5073979|NCT01787916|12484132|P2|COMPLETED|Second Intervention (24 Weeks)||7
5073980|NCT01787916|12484133|P1|COMPLETED|Second Intervention (24 Weeks)||8
5073981|NCT01787916|12484132|P2|STARTED|Second Intervention (24 Weeks)||7
5073982|NCT01787916|12484133|P1|STARTED|Second Intervention (24 Weeks)||8
5073983|NCT01787916|12484132|P2|NOT COMPLETED|Washout (4 Weeks)||0
5073984|NCT01787916|12484133|P1|NOT COMPLETED|Washout (4 Weeks)||0
5073985|NCT01787916|12484132|P2|COMPLETED|Washout (4 Weeks)||7
5073986|NCT01787916|12484133|P1|COMPLETED|Washout (4 Weeks)||8
5073987|NCT01787916|12484132|P2|STARTED|Washout (4 Weeks)||7
5073988|NCT01787916|12484133|P1|STARTED|Washout (4 Weeks)||8
5073989|NCT01787916|12484132|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
5073990|NCT01787916|12484133|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
5073991|NCT01787916|12484132|P2|COMPLETED|First Intervention (24 Weeks)||7
5073992|NCT01787916|12484133|P1|COMPLETED|First Intervention (24 Weeks)||8
5073993|NCT01787916|12484132|P2|STARTED|First Intervention (24 Weeks)||7
5073994|NCT01787916|12484133|P1|STARTED|First Intervention (24 Weeks)||8
5073995|NCT01787838|12484139|P1|NOT COMPLETED|Overall Study||1413
5073996|NCT01787838|12484139|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
5073997|NCT01787838|12484139|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
5073998|NCT01787825|12484143|P2|NOT COMPLETED|Overall Study||1
5073999|NCT01787825|12484144|P1|NOT COMPLETED|Overall Study||6
5074000|NCT01787825|12484143|P2|COMPLETED|Overall Study||60
5074001|NCT01787825|12484144|P1|COMPLETED|Overall Study||54
5074002|NCT01787825|12484143|P2|STARTED|Overall Study||61
5074003|NCT01787825|12484144|P1|STARTED|Overall Study||60
5074004|NCT01787799|12484155|P1|NOT COMPLETED|Overall Study||0
5074005|NCT01787799|12484155|P1|COMPLETED|Overall Study||100
5074006|NCT01787799|12484155|P1|STARTED|Overall Study||100
5074007|NCT01787760|12484162|P3|NOT COMPLETED|Overall Study||5
5074008|NCT01787760|12484163|P2|NOT COMPLETED|Overall Study||16
5074009|NCT01787760|12484164|P1|NOT COMPLETED|Overall Study||26
5074010|NCT01787760|12484162|P3|COMPLETED|Overall Study||46
5074011|NCT01787760|12484163|P2|COMPLETED|Overall Study||34
5074012|NCT01787760|12484164|P1|COMPLETED|Overall Study||25
5074013|NCT01787760|12484162|P3|STARTED|Overall Study||51
5074014|NCT01787760|12484163|P2|STARTED|Overall Study||50
5074015|NCT01787760|12484164|P1|STARTED|Overall Study||51
5074016|NCT01787604|12484178|P2|NOT COMPLETED|Overall Study||4
5074017|NCT01787604|12484179|P1|NOT COMPLETED|Overall Study||4
5074018|NCT01787604|12484178|P2|COMPLETED|Overall Study||28
5074019|NCT01787604|12484179|P1|COMPLETED|Overall Study||28
5074020|NCT01787604|12484178|P2|STARTED|Overall Study||32
5074021|NCT01787604|12484179|P1|STARTED|Overall Study||32
5074022|NCT01787591|12484189|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
5074023|NCT01787591|12484190|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
5074024|NCT01787591|12484191|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
5074025|NCT01787591|12484192|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
5074026|NCT01787591|12484189|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
5074027|NCT01787591|12484190|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
5074028|NCT01787591|12484191|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
5074029|NCT01787591|12484192|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
5074030|NCT01787591|12484189|P4|STARTED|Period 4 (Cross-over Arm 4)||5
5074031|NCT01787591|12484190|P3|STARTED|Period 4 (Cross-over Arm 4)||5
5074032|NCT01787591|12484191|P2|STARTED|Period 4 (Cross-over Arm 4)||5
5074033|NCT01787591|12484192|P1|STARTED|Period 4 (Cross-over Arm 4)||5
5074034|NCT01787591|12484189|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
5074035|NCT01787591|12484190|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
5074036|NCT01787591|12484191|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
5074037|NCT01787591|12484192|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
5074038|NCT01787591|12484189|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
5074039|NCT01787591|12484190|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
5074040|NCT01787591|12484191|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
5074041|NCT01787591|12484192|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
5074042|NCT01787591|12484189|P4|STARTED|Period 3 (Cross-over Arm 3)||5
5074043|NCT01787591|12484190|P3|STARTED|Period 3 (Cross-over Arm 3)||5
5074044|NCT01787591|12484191|P2|STARTED|Period 3 (Cross-over Arm 3)||5
5074045|NCT01787591|12484192|P1|STARTED|Period 3 (Cross-over Arm 3)||5
5074046|NCT01787591|12484189|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
5074047|NCT01787591|12484190|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
5074048|NCT01787591|12484191|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
5074049|NCT01787591|12484192|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
5074050|NCT01787591|12484189|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
5074051|NCT01787591|12484190|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
5074052|NCT01787591|12484191|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
5074053|NCT01787591|12484192|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
5074054|NCT01787591|12484189|P4|STARTED|Period 2 (Cross-over Arm 2)||5
5074055|NCT01787591|12484190|P3|STARTED|Period 2 (Cross-over Arm 2)||5
5074056|NCT01787591|12484191|P2|STARTED|Period 2 (Cross-over Arm 2)||5
5074057|NCT01787591|12484192|P1|STARTED|Period 2 (Cross-over Arm 2)||5
5074058|NCT01787591|12484189|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
5074059|NCT01787591|12484190|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
5074060|NCT01787591|12484191|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
5074061|NCT01787591|12484192|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
5074062|NCT01787591|12484189|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
5074063|NCT01787591|12484190|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
5074064|NCT01787591|12484191|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
5074065|NCT01787591|12484192|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
5074066|NCT01787591|12484189|P4|STARTED|Period 1 (Cross-over Arm 1)||6
5074067|NCT01787591|12484190|P3|STARTED|Period 1 (Cross-over Arm 1)||5
5074068|NCT01787591|12484191|P2|STARTED|Period 1 (Cross-over Arm 1)||5
5074069|NCT01787591|12484192|P1|STARTED|Period 1 (Cross-over Arm 1)||5
5074070|NCT01787552|12484222|P4|NOT COMPLETED|Overall Study||27
5074071|NCT01787552|12484223|P3|NOT COMPLETED|Overall Study||5
5074072|NCT01787552|12484224|P2|NOT COMPLETED|Overall Study||9
5074073|NCT01787552|12484225|P1|NOT COMPLETED|Overall Study||8
5074074|NCT01787552|12484222|P4|COMPLETED|Overall Study||0
5074075|NCT01787552|12484223|P3|COMPLETED|Overall Study||0
5074076|NCT01787552|12484224|P2|COMPLETED|Overall Study||1
5074077|NCT01787552|12484225|P1|COMPLETED|Overall Study||0
5074078|NCT01787552|12484222|P4|STARTED|Overall Study||27
5074079|NCT01787552|12484223|P3|STARTED|Overall Study||5
5074080|NCT01787552|12484224|P2|STARTED|Overall Study||10
5074081|NCT01787552|12484225|P1|STARTED|Overall Study||8
5074082|NCT01787461|12484295|P2|NOT COMPLETED|Overall Study||9
5074083|NCT01787461|12484296|P1|NOT COMPLETED|Overall Study||14
5074084|NCT01787461|12484295|P2|COMPLETED|Overall Study||89
5074085|NCT01787461|12484296|P1|COMPLETED|Overall Study||82
5074086|NCT01787461|12484295|P2|STARTED|Overall Study||98
5074087|NCT01787461|12484296|P1|STARTED|Overall Study||96
5074088|NCT01787383|12484324|P2|NOT COMPLETED|Overall Study||22
5074089|NCT01787383|12484325|P1|NOT COMPLETED|Overall Study||9
5074090|NCT01787383|12484324|P2|COMPLETED|Overall Study||76
5074091|NCT01787383|12484325|P1|COMPLETED|Overall Study||92
5074092|NCT01787383|12484324|P2|STARTED|Overall Study||98
5074093|NCT01787383|12484325|P1|STARTED|Overall Study||101
5074094|NCT01787331|12484345|P1|NOT COMPLETED|Overall Study||2
5074095|NCT01787331|12484345|P1|COMPLETED|Overall Study||19
5074096|NCT01787331|12484345|P1|STARTED|Overall Study||21
5074097|NCT01787292|12484357|P2|NOT COMPLETED|Home Based Exercise Program||1
5074098|NCT01787292|12484358|P1|NOT COMPLETED|Home Based Exercise Program||3
5074099|NCT01787292|12484357|P2|COMPLETED|Home Based Exercise Program||13
5074100|NCT01787292|12484358|P1|COMPLETED|Home Based Exercise Program||12
5074101|NCT01787292|12484357|P2|STARTED|Home Based Exercise Program||14
5074102|NCT01787292|12484358|P1|STARTED|Home Based Exercise Program||15
5074103|NCT01787292|12484357|P2|NOT COMPLETED|Crossover Exercise Interventions||2
5074104|NCT01787292|12484358|P1|NOT COMPLETED|Crossover Exercise Interventions||2
5074105|NCT01787292|12484357|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
5074106|NCT01787292|12484358|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
5074107|NCT01787292|12484357|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
5074108|NCT01787292|12484358|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
5074109|NCT01787279|12484375|P1|NOT COMPLETED|Overall Study||3
5074110|NCT01787279|12484375|P1|COMPLETED|Overall Study||56
5074111|NCT01787279|12484375|P1|STARTED|Overall Study||59
5074112|NCT01787240|12484386|P2|NOT COMPLETED|Overall Study||1
5074113|NCT01787240|12484387|P1|NOT COMPLETED|Overall Study||5
5074114|NCT01787240|12484386|P2|COMPLETED|Overall Study||4
5074115|NCT01787240|12484387|P1|COMPLETED|Overall Study||10
5074116|NCT01787240|12484386|P2|STARTED|Overall Study||5
5074117|NCT01787240|12484387|P1|STARTED|Overall Study||15
5074118|NCT01787188|12484401|P3|NOT COMPLETED|Overall Study||18
5074119|NCT01787188|12484402|P2|NOT COMPLETED|Overall Study||18
5074120|NCT01787188|12484403|P1|NOT COMPLETED|Overall Study||17
5074121|NCT01787188|12484401|P3|COMPLETED|Overall Study||116
5074122|NCT01787188|12484402|P2|COMPLETED|Overall Study||112
5074123|NCT01787188|12484403|P1|COMPLETED|Overall Study||122
5074124|NCT01787188|12484401|P3|STARTED|Overall Study||134
5074125|NCT01787188|12484402|P2|STARTED|Overall Study||130
5074126|NCT01787188|12484403|P1|STARTED|Overall Study||139
5074127|NCT01787175|12484458|P2|NOT COMPLETED|Overall Study||0
5074128|NCT01787175|12484459|P1|NOT COMPLETED|Overall Study||0
5074129|NCT01787175|12484458|P2|COMPLETED|Overall Study||28
5074130|NCT01787175|12484459|P1|COMPLETED|Overall Study||30
5074131|NCT01787175|12484458|P2|STARTED|Overall Study||28
5074132|NCT01787175|12484459|P1|STARTED|Overall Study||30
5074133|NCT01787032|12484475|P6|NOT COMPLETED|Overall Study||1
5074134|NCT01787032|12484476|P5|NOT COMPLETED|Overall Study||1
5074135|NCT01787032|12484477|P4|NOT COMPLETED|Overall Study||0
5074136|NCT01787032|12484478|P3|NOT COMPLETED|Overall Study||0
5074137|NCT01787032|12484479|P2|NOT COMPLETED|Overall Study||0
5074138|NCT01787032|12484480|P1|NOT COMPLETED|Overall Study||0
5074139|NCT01787032|12484475|P6|COMPLETED|Overall Study||3
5074140|NCT01787032|12484476|P5|COMPLETED|Overall Study||3
5074141|NCT01787032|12484477|P4|COMPLETED|Overall Study||3
5074142|NCT01787032|12484478|P3|COMPLETED|Overall Study||3
5074143|NCT01787032|12484479|P2|COMPLETED|Overall Study||3
5074144|NCT01787032|12484480|P1|COMPLETED|Overall Study||3
5074145|NCT01787032|12484475|P6|Received T2|Overall Study||4
5074146|NCT01787032|12484476|P5|Received T2|Overall Study||4
5074147|NCT01787032|12484477|P4|Received T2|Overall Study||3
5074148|NCT01787032|12484478|P3|Received T2|Overall Study||3
5074149|NCT01787032|12484479|P2|Received T2|Overall Study||3
5074150|NCT01787032|12484480|P1|Received T2|Overall Study||3
5074151|NCT01787032|12484475|P6|Received T1|Overall Study||4
5074152|NCT01787032|12484476|P5|Received T1|Overall Study||3
5074153|NCT01787032|12484477|P4|Received T1|Overall Study||3
5074154|NCT01787032|12484478|P3|Received T1|Overall Study||3
5074155|NCT01787032|12484479|P2|Received T1|Overall Study||3
5074156|NCT01787032|12484480|P1|Received T1|Overall Study||3
5074157|NCT01787032|12484475|P6|Received R|Overall Study||3
5074158|NCT01787032|12484476|P5|Received R|Overall Study||4
5074159|NCT01787032|12484477|P4|Received R|Overall Study||3
5074160|NCT01787032|12484478|P3|Received R|Overall Study||3
5074161|NCT01787032|12484479|P2|Received R|Overall Study||3
5074162|NCT01787032|12484480|P1|Received R|Overall Study||3
5074163|NCT01787032|12484475|P6|STARTED|Overall Study||4
5074164|NCT01787032|12484476|P5|STARTED|Overall Study||4
5074165|NCT01787032|12484477|P4|STARTED|Overall Study||3
5074166|NCT01787032|12484478|P3|STARTED|Overall Study||3
5074167|NCT01787032|12484479|P2|STARTED|Overall Study||3
5074168|NCT01787032|12484480|P1|STARTED|Overall Study||3
5074169|NCT01787006|12484504|P2|NOT COMPLETED|Overall Study||3
5074170|NCT01787006|12484505|P1|NOT COMPLETED|Overall Study||3
5074171|NCT01787006|12484504|P2|COMPLETED|Overall Study||36
5074172|NCT01787006|12484505|P1|COMPLETED|Overall Study||32
5074173|NCT01787006|12484504|P2|STARTED|Overall Study||39
5074174|NCT01787006|12484505|P1|STARTED|Overall Study||35
5074175|NCT01786993|12484533|P2|NOT COMPLETED|Overall Study||10
5074176|NCT01786993|12484534|P1|NOT COMPLETED|Overall Study||12
5074177|NCT01786993|12484533|P2|COMPLETED|Overall Study||170
5074178|NCT01786993|12484534|P1|COMPLETED|Overall Study||189
5074179|NCT01786993|12484533|P2|Per Protocol Population at 9 Months|Overall Study||170
5074180|NCT01786993|12484534|P1|Per Protocol Population at 9 Months|Overall Study||189
5074181|NCT01786993|12484533|P2|STARTED|Overall Study||180
5074182|NCT01786993|12484534|P1|STARTED|Overall Study||201
5074183|NCT01786967|12484541|P1|NOT COMPLETED|Overall Study||0
5074184|NCT01786967|12484541|P1|COMPLETED|Overall Study||61
5074185|NCT01786967|12484541|P1|Metabolizer Status Undetermined|Overall Study||3
5074186|NCT01786967|12484541|P1|Poor Metabolizers|Overall Study||4
5074187|NCT01786967|12484541|P1|Extensive Metabolizers|Overall Study||54
5074188|NCT01786967|12484541|P1|STARTED|Overall Study||61
5074189|NCT01786954|12484550|P2|NOT COMPLETED|Overall Study||0
5074190|NCT01786954|12484551|P1|NOT COMPLETED|Overall Study||0
5074191|NCT01786954|12484550|P2|COMPLETED|Overall Study||34
5074192|NCT01786954|12484551|P1|COMPLETED|Overall Study||34
5074193|NCT01786954|12484550|P2|STARTED|Overall Study||34
5074194|NCT01786954|12484551|P1|STARTED|Overall Study||34
5074195|NCT01786902|12484563|P2|NOT COMPLETED|Overall Study||3
5074196|NCT01786902|12484564|P1|NOT COMPLETED|Overall Study||4
5074197|NCT01786902|12484563|P2|COMPLETED|Overall Study||31
5074198|NCT01786902|12484564|P1|COMPLETED|Overall Study||32
5074199|NCT01786902|12484563|P2|STARTED|Overall Study||34
5074200|NCT01786902|12484564|P1|STARTED|Overall Study||36
5074201|NCT01786876|12484574|P1|NOT COMPLETED|Overall Study||0
5074202|NCT01786876|12484574|P1|COMPLETED|Overall Study||6
5074203|NCT01786876|12484574|P1|STARTED|Overall Study||6
5074204|NCT01786707|12484593|P2|NOT COMPLETED|Overall Study||1
5074205|NCT01786707|12484594|P1|NOT COMPLETED|Overall Study||1
5074206|NCT01786707|12484593|P2|COMPLETED|Overall Study||0
5074207|NCT01786707|12484594|P1|COMPLETED|Overall Study||0
5074208|NCT01786707|12484593|P2|STARTED|Overall Study||1
5074209|NCT01786707|12484594|P1|STARTED|Overall Study||1
5074210|NCT01786668|12484606|P4|NOT COMPLETED|Overall Study||4
5074211|NCT01786668|12484607|P3|NOT COMPLETED|Overall Study||5
5074212|NCT01786668|12484608|P2|NOT COMPLETED|Overall Study||1
5074213|NCT01786668|12484609|P1|NOT COMPLETED|Overall Study||1
5074214|NCT01786668|12484606|P4|COMPLETED|Overall Study||47
5074215|NCT01786668|12484607|P3|COMPLETED|Overall Study||47
5074216|NCT01786668|12484608|P2|COMPLETED|Overall Study||51
5074217|NCT01786668|12484609|P1|COMPLETED|Overall Study||51
5074218|NCT01786668|12484606|P4|STARTED|Overall Study||51
5074219|NCT01786668|12484607|P3|STARTED|Overall Study||52
5074220|NCT01786668|12484608|P2|STARTED|Overall Study||52
5074221|NCT01786668|12484609|P1|STARTED|Overall Study||52
5074222|NCT01786629|12484709|P2|NOT COMPLETED|Overall Study||5
5074223|NCT01786629|12484710|P1|NOT COMPLETED|Overall Study||0
5074224|NCT01786629|12484709|P2|COMPLETED|Overall Study||164
5074225|NCT01786629|12484710|P1|COMPLETED|Overall Study||169
5074226|NCT01786629|12484709|P2|STARTED|Overall Study||169
5074227|NCT01786629|12484710|P1|STARTED|Overall Study||169
5074228|NCT01786603|12484718|P2|NOT COMPLETED|Overall Study||12
5074229|NCT01786603|12484719|P1|NOT COMPLETED|Overall Study||18
5074230|NCT01786603|12484718|P2|COMPLETED|Overall Study||8
5074231|NCT01786603|12484719|P1|COMPLETED|Overall Study||42
5074232|NCT01786603|12484718|P2|STARTED|Overall Study||20
5074233|NCT01786603|12484719|P1|STARTED|Overall Study||60
5074234|NCT01786551|12484737|P1|NOT COMPLETED|Overall Study||2
5074235|NCT01786551|12484737|P1|COMPLETED|Overall Study||14
5074236|NCT01786551|12484737|P1|STARTED|Overall Study||16
5074237|NCT01786343|12484745|P2|NOT COMPLETED|Overall Study||0
5074238|NCT01786343|12484746|P1|NOT COMPLETED|Overall Study||0
5074239|NCT01786343|12484745|P2|COMPLETED|Overall Study||46
5074240|NCT01786343|12484746|P1|COMPLETED|Overall Study||28
5074241|NCT01786343|12484745|P2|STARTED|Overall Study||46
5074242|NCT01786343|12484746|P1|STARTED|Overall Study||28
5074243|NCT01786330|12484758|P2|NOT COMPLETED|Overall Study||3
5074244|NCT01786330|12484759|P1|NOT COMPLETED|Overall Study||1
5074245|NCT01786330|12484758|P2|COMPLETED|Overall Study||27
5074246|NCT01786330|12484759|P1|COMPLETED|Overall Study||29
5074247|NCT01786330|12484758|P2|STARTED|Overall Study||30
5074248|NCT01786330|12484759|P1|STARTED|Overall Study||30
5074249|NCT01786252|12484773|P2|NOT COMPLETED|Overall Study||0
5074250|NCT01786252|12484774|P1|NOT COMPLETED|Overall Study||0
5074251|NCT01786252|12484773|P2|COMPLETED|Overall Study||8
5074252|NCT01786252|12484774|P1|COMPLETED|Overall Study||7
5074253|NCT01786252|12484773|P2|STARTED|Overall Study||8
5074254|NCT01786252|12484774|P1|STARTED|Overall Study||7
5074255|NCT01786239|12484788|P2|NOT COMPLETED|Overall Study||11
5074256|NCT01786239|12484789|P1|NOT COMPLETED|Overall Study||11
5074257|NCT01786239|12484788|P2|COMPLETED|Overall Study||14
5074258|NCT01786239|12484789|P1|COMPLETED|Overall Study||14
5074259|NCT01786239|12484788|P2|STARTED|Overall Study||25
5074260|NCT01786239|12484789|P1|STARTED|Overall Study||25
5074261|NCT01786187|12484797|P2|NOT COMPLETED|Overall Study||10
5074262|NCT01786187|12484798|P1|NOT COMPLETED|Overall Study||5
5074263|NCT01786187|12484797|P2|COMPLETED|Overall Study||37
5074264|NCT01786187|12484798|P1|COMPLETED|Overall Study||35
5074265|NCT01786187|12484797|P2|STARTED|Overall Study||47
5074266|NCT01786187|12484798|P1|STARTED|Overall Study||40
5074267|NCT01786174|12484811|P2|NOT COMPLETED|Overall Study||0
5074268|NCT01786174|12484812|P1|NOT COMPLETED|Overall Study||2
5074269|NCT01786174|12484811|P2|COMPLETED|Overall Study||10
5074270|NCT01786174|12484812|P1|COMPLETED|Overall Study||16
5074271|NCT01786174|12484811|P2|Randomized|Overall Study||11
5074272|NCT01786174|12484812|P1|Randomized|Overall Study||19
5074273|NCT01786174|12484811|P2|STARTED|Overall Study||10
5074274|NCT01786174|12484812|P1|STARTED|Overall Study||18
5074275|NCT01786161|12484828|P2|NOT COMPLETED|Overall Study||0
5074276|NCT01786161|12484829|P1|NOT COMPLETED|Overall Study||0
5074277|NCT01786161|12484828|P2|COMPLETED|Overall Study||22
5074278|NCT01786161|12484829|P1|COMPLETED|Overall Study||22
5074279|NCT01786161|12484828|P2|STARTED|Overall Study||22
5074280|NCT01786161|12484829|P1|STARTED|Overall Study||22
5074281|NCT01786148|12484841|P2|NOT COMPLETED|Overall Study||22
5074282|NCT01786148|12484842|P1|NOT COMPLETED|Overall Study||22
5074283|NCT01786148|12484841|P2|COMPLETED|Overall Study||50
5074284|NCT01786148|12484842|P1|COMPLETED|Overall Study||55
5074285|NCT01786148|12484841|P2|STARTED|Overall Study||72
5074286|NCT01786148|12484842|P1|STARTED|Overall Study||77
5074287|NCT01786109|12484857|P3|NOT COMPLETED|Overall Study||2
5074288|NCT01786109|12484858|P2|NOT COMPLETED|Overall Study||0
5074289|NCT01786109|12484859|P1|NOT COMPLETED|Overall Study||1
5074290|NCT01786109|12484857|P3|COMPLETED|Overall Study||25
5074291|NCT01786109|12484858|P2|COMPLETED|Overall Study||24
5074292|NCT01786109|12484859|P1|COMPLETED|Overall Study||23
5074293|NCT01786109|12484857|P3|STARTED|Overall Study||27
5074294|NCT01786109|12484858|P2|STARTED|Overall Study||24
5074295|NCT01786109|12484859|P1|STARTED|Overall Study||24
5074296|NCT01785875|12484888|P3|NOT COMPLETED|Overall Study||107
5074297|NCT01785875|12484889|P2|NOT COMPLETED|Overall Study||289
5074298|NCT01785875|12484890|P1|NOT COMPLETED|Overall Study||294
5074299|NCT01785875|12484888|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
5074300|NCT01785875|12484889|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
5074301|NCT01785875|12484890|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
5074302|NCT01785875|12484888|P3|Received Etelcalcetide|Overall Study||123
5074303|NCT01785875|12484889|P2|Received Etelcalcetide|Overall Study||384
5074304|NCT01785875|12484890|P1|Received Etelcalcetide|Overall Study||383
5074305|NCT01785875|12484888|P3|STARTED|Overall Study||123
5074306|NCT01785875|12484889|P2|STARTED|Overall Study||384
5074307|NCT01785875|12484890|P1|STARTED|Overall Study||384
5074308|NCT01785849|12484959|P2|NOT COMPLETED|Overall Study||34
5074309|NCT01785849|12484960|P1|NOT COMPLETED|Overall Study||61
5074310|NCT01785849|12484959|P2|COMPLETED|Overall Study||220
5074311|NCT01785849|12484960|P1|COMPLETED|Overall Study||193
5074312|NCT01785849|12484959|P2|Received Treatment|Overall Study||251
5074313|NCT01785849|12484960|P1|Received Treatment|Overall Study||254
5074314|NCT01785849|12484959|P2|STARTED|Overall Study||254
5074315|NCT01785849|12484960|P1|STARTED|Overall Study||254
5074316|NCT01785680|12484978|P2|NOT COMPLETED|Overall Study||0
5074317|NCT01785680|12484979|P1|NOT COMPLETED|Overall Study||0
5074318|NCT01785680|12484978|P2|COMPLETED|Overall Study||857
5074319|NCT01785680|12484979|P1|COMPLETED|Overall Study||1100
5074320|NCT01785680|12484978|P2|STARTED|Overall Study||857
5074321|NCT01785680|12484979|P1|STARTED|Overall Study||1100
5074322|NCT01785628|12484993|P2|NOT COMPLETED|Overall Study||3
5074323|NCT01785628|12484994|P1|NOT COMPLETED|Overall Study||2
5074324|NCT01785628|12484993|P2|COMPLETED|Overall Study||12
5074325|NCT01785628|12484994|P1|COMPLETED|Overall Study||13
5074326|NCT01785628|12484993|P2|STARTED|Overall Study||15
5074327|NCT01785628|12484994|P1|STARTED|Overall Study||15
5074328|NCT01785615|12485017|P4|NOT COMPLETED|Atorvastatin Phase||0
5074329|NCT01785615|12485018|P3|NOT COMPLETED|Atorvastatin Phase||0
5074330|NCT01785615|12485019|P2|NOT COMPLETED|Atorvastatin Phase||0
5074331|NCT01785615|12485020|P1|NOT COMPLETED|Atorvastatin Phase||0
5074332|NCT01785615|12485017|P4|COMPLETED|Atorvastatin Phase||0
5074333|NCT01785615|12485018|P3|COMPLETED|Atorvastatin Phase||0
5074334|NCT01785615|12485019|P2|COMPLETED|Atorvastatin Phase||44
5074335|NCT01785615|12485020|P1|COMPLETED|Atorvastatin Phase||44
5074336|NCT01785615|12485017|P4|STARTED|Atorvastatin Phase||0
5074337|NCT01785615|12485018|P3|STARTED|Atorvastatin Phase||0
5074338|NCT01785615|12485019|P2|STARTED|Atorvastatin Phase||44
5074339|NCT01785615|12485020|P1|STARTED|Atorvastatin Phase||44
5074340|NCT01785615|12485017|P4|NOT COMPLETED|Dietary Phase||24
5074341|NCT01785615|12485018|P3|NOT COMPLETED|Dietary Phase||0
5074342|NCT01785615|12485019|P2|NOT COMPLETED|Dietary Phase||0
5074343|NCT01785615|12485020|P1|NOT COMPLETED|Dietary Phase||0
5074344|NCT01785615|12485017|P4|COMPLETED|Dietary Phase||116
5074345|NCT01785615|12485018|P3|COMPLETED|Dietary Phase||35
5074346|NCT01785615|12485019|P2|COMPLETED|Dietary Phase||0
5074347|NCT01785615|12485020|P1|COMPLETED|Dietary Phase||0
5074348|NCT01785615|12485017|P4|STARTED|Dietary Phase||140
5074349|NCT01785615|12485018|P3|STARTED|Dietary Phase||35
5074350|NCT01785615|12485019|P2|STARTED|Dietary Phase||0
5074351|NCT01785615|12485020|P1|STARTED|Dietary Phase||0
5074352|NCT01785602|12485092|P2|NOT COMPLETED|Overall Study||9
5074353|NCT01785602|12485093|P1|NOT COMPLETED|Overall Study||13
5074354|NCT01785602|12485092|P2|COMPLETED|Overall Study||18
5074355|NCT01785602|12485093|P1|COMPLETED|Overall Study||63
5074356|NCT01785602|12485092|P2|STARTED|Overall Study||27
5074357|NCT01785602|12485093|P1|STARTED|Overall Study||76
5074358|NCT01785524|12485103|P2|NOT COMPLETED|Overall Study||2
5074359|NCT01785524|12485104|P1|NOT COMPLETED|Overall Study||2
5074360|NCT01785524|12485103|P2|COMPLETED|Overall Study||2
5074361|NCT01785524|12485104|P1|COMPLETED|Overall Study||5
5074362|NCT01785524|12485103|P2|STARTED|Overall Study||4
5074363|NCT01785524|12485104|P1|STARTED|Overall Study||7
5074364|NCT01785472|12485123|P3|NOT COMPLETED|Overall Study||22
5074365|NCT01785472|12485124|P2|NOT COMPLETED|Overall Study||19
5074366|NCT01785472|12485125|P1|NOT COMPLETED|Overall Study||24
5074367|NCT01785472|12485123|P3|COMPLETED|Overall Study||464
5074368|NCT01785472|12485124|P2|COMPLETED|Overall Study||454
5074369|NCT01785472|12485125|P1|COMPLETED|Overall Study||455
5074370|NCT01785472|12485123|P3|Safety Set (SAF)|Overall Study||484
5074371|NCT01785472|12485124|P2|Safety Set (SAF)|Overall Study||472
5074372|NCT01785472|12485125|P1|Safety Set (SAF)|Overall Study||478
5074373|NCT01785472|12485123|P3|Full Analysis Set (FAS)|Overall Study||484
5074374|NCT01785472|12485124|P2|Full Analysis Set (FAS)|Overall Study||472
5074375|NCT01785472|12485125|P1|Full Analysis Set (FAS)|Overall Study||479
5074376|NCT01785472|12485123|P3|STARTED|Overall Study||486
5074377|NCT01785472|12485124|P2|STARTED|Overall Study||473
5074378|NCT01785472|12485125|P1|STARTED|Overall Study||479
5074379|NCT01785459|12485169|P2|NOT COMPLETED|Overall Study||0
5074380|NCT01785459|12485170|P1|NOT COMPLETED|Overall Study||0
5074381|NCT01785459|12485169|P2|COMPLETED|Overall Study||12
5074382|NCT01785459|12485170|P1|COMPLETED|Overall Study||11
5074383|NCT01785459|12485169|P2|STARTED|Overall Study||12
5074384|NCT01785459|12485170|P1|STARTED|Overall Study||11
5074385|NCT01785186|12485185|P5|NOT COMPLETED|Overall Study||6
5074386|NCT01785186|12485186|P4|NOT COMPLETED|Overall Study||5
5074387|NCT01785186|12485187|P3|NOT COMPLETED|Overall Study||5
5074388|NCT01785186|12485188|P2|NOT COMPLETED|Overall Study||6
5074389|NCT01785186|12485189|P1|NOT COMPLETED|Overall Study||6
5074390|NCT01785186|12485185|P5|COMPLETED|Overall Study||117
5074391|NCT01785186|12485186|P4|COMPLETED|Overall Study||58
5074392|NCT01785186|12485187|P3|COMPLETED|Overall Study||52
5074393|NCT01785186|12485188|P2|COMPLETED|Overall Study||57
5074394|NCT01785186|12485189|P1|COMPLETED|Overall Study||53
5074395|NCT01785186|12485185|P5|STARTED|Overall Study||123
5074396|NCT01785186|12485186|P4|STARTED|Overall Study||63
5074397|NCT01785186|12485187|P3|STARTED|Overall Study||57
5074398|NCT01785186|12485188|P2|STARTED|Overall Study||63
5074399|NCT01785186|12485189|P1|STARTED|Overall Study||59
5074400|NCT01785160|12485211|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
5074401|NCT01785160|12485211|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
5074402|NCT01785160|12485211|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
5074403|NCT01785160|12485211|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
5074404|NCT01785160|12485211|P1|COMPLETED|Washout Period of at Least 7 Days||23
5074405|NCT01785160|12485211|P1|STARTED|Washout Period of at Least 7 Days||24
5074406|NCT01785160|12485211|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
5074407|NCT01785160|12485211|P1|COMPLETED|Treatment Period 1: Raltegravir||24
5074408|NCT01785160|12485211|P1|STARTED|Treatment Period 1: Raltegravir||25
5074409|NCT01785134|12485221|P2|NOT COMPLETED|Overall Study||7
5074410|NCT01785134|12485222|P1|NOT COMPLETED|Overall Study||12
5074411|NCT01785134|12485221|P2|COMPLETED|Overall Study||33
5074412|NCT01785134|12485222|P1|COMPLETED|Overall Study||29
5074413|NCT01785134|12485221|P2|STARTED|Overall Study||40
5074414|NCT01785134|12485222|P1|STARTED|Overall Study||41
5074415|NCT01785095|12485236|P1|NOT COMPLETED|Overall Study||3
5074416|NCT01785095|12485236|P1|COMPLETED|Overall Study||24
5074417|NCT01785095|12485236|P1|STARTED|Overall Study||27
5074418|NCT01785069|12485248|P4|NOT COMPLETED|Overall Study||14
5074419|NCT01785069|12485249|P3|NOT COMPLETED|Overall Study||13
5074420|NCT01785069|12485250|P2|NOT COMPLETED|Overall Study||12
5074421|NCT01785069|12485251|P1|NOT COMPLETED|Overall Study||12
5074422|NCT01785069|12485248|P4|COMPLETED|Overall Study||54
5074423|NCT01785069|12485249|P3|COMPLETED|Overall Study||91
5074424|NCT01785069|12485250|P2|COMPLETED|Overall Study||64
5074425|NCT01785069|12485251|P1|COMPLETED|Overall Study||95
5074426|NCT01785069|12485248|P4|STARTED|Overall Study||68
5074427|NCT01785069|12485249|P3|STARTED|Overall Study||104
5074428|NCT01785069|12485250|P2|STARTED|Overall Study||76
5074429|NCT01785069|12485251|P1|STARTED|Overall Study||107
5074430|NCT01784991|12485279|P2|NOT COMPLETED|Overall Study||0
5074431|NCT01784991|12485280|P1|NOT COMPLETED|Overall Study||0
5074432|NCT01784991|12485279|P2|COMPLETED|Overall Study||0
5074433|NCT01784991|12485280|P1|COMPLETED|Overall Study||0
5074434|NCT01784991|12485279|P2|STARTED|Overall Study||0
5074435|NCT01784991|12485280|P1|STARTED|Overall Study||0
5074436|NCT01784965|12485300|P2|NOT COMPLETED|Overall Study||11
5074437|NCT01784965|12485301|P1|NOT COMPLETED|Overall Study||6
5074438|NCT01784965|12485300|P2|COMPLETED|Overall Study||24
5074439|NCT01784965|12485301|P1|COMPLETED|Overall Study||27
5074440|NCT01784965|12485300|P2|STARTED|Overall Study||35
5074441|NCT01784965|12485301|P1|STARTED|Overall Study||33
5074442|NCT01784926|12485313|P2|NOT COMPLETED|Overall Study||8
5074443|NCT01784926|12485314|P1|NOT COMPLETED|Overall Study||11
5074444|NCT01784926|12485313|P2|COMPLETED|Overall Study||42
5074445|NCT01784926|12485314|P1|COMPLETED|Overall Study||43
5074446|NCT01784926|12485313|P2|STARTED|Overall Study||50
5074447|NCT01784926|12485314|P1|STARTED|Overall Study||54
5074448|NCT01784848|12485332|P2|NOT COMPLETED|Overall Study||3
5074449|NCT01784848|12485333|P1|NOT COMPLETED|Overall Study||1
5074450|NCT01784848|12485332|P2|COMPLETED|Overall Study||47
5074451|NCT01784848|12485333|P1|COMPLETED|Overall Study||49
5074452|NCT01784848|12485332|P2|STARTED|Overall Study||50
5074453|NCT01784848|12485333|P1|STARTED|Overall Study||50
5074454|NCT01784796|12485341|P2|NOT COMPLETED|Overall Study||23
5074455|NCT01784796|12485342|P1|NOT COMPLETED|Overall Study||35
5074456|NCT01784796|12485341|P2|COMPLETED|Overall Study||35
5074457|NCT01784796|12485342|P1|COMPLETED|Overall Study||39
5074458|NCT01784796|12485341|P2|8 wk Data Collection|Overall Study||39
5074459|NCT01784796|12485342|P1|8 wk Data Collection|Overall Study||56
5074460|NCT01784796|12485341|P2|4 Week Data Collection|Overall Study||43
5074461|NCT01784796|12485342|P1|4 Week Data Collection|Overall Study||47
5074462|NCT01784796|12485341|P2|Baseline Data Collected|Overall Study||58
5074463|NCT01784796|12485342|P1|Baseline Data Collected|Overall Study||68
5074464|NCT01784796|12485341|P2|STARTED|Overall Study|These are participants who provided informed consent|58
5074465|NCT01784796|12485342|P1|STARTED|Overall Study|These are participants who provided informed consent|74
5074466|NCT01784770|12485354|P1|NOT COMPLETED|Overall Study||0
5074467|NCT01784770|12485354|P1|COMPLETED|Overall Study||21
5074468|NCT01784770|12485354|P1|STARTED|Overall Study||21
5074469|NCT01784666|12485362|P3|NOT COMPLETED|Overall Study||0
5074470|NCT01784666|12485363|P2|NOT COMPLETED|Overall Study||0
5074471|NCT01784666|12485364|P1|NOT COMPLETED|Overall Study||0
5074472|NCT01784666|12485362|P3|COMPLETED|Overall Study||1
5074473|NCT01784666|12485363|P2|COMPLETED|Overall Study||0
5074474|NCT01784666|12485364|P1|COMPLETED|Overall Study||1
5074475|NCT01784666|12485362|P3|STARTED|Overall Study||1
5074476|NCT01784666|12485363|P2|STARTED|Overall Study||0
5074477|NCT01784666|12485364|P1|STARTED|Overall Study||1
5074478|NCT01784614|12485372|P8|NOT COMPLETED|Period 4||0
5074479|NCT01784614|12485373|P7|NOT COMPLETED|Period 4||0
5074480|NCT01784614|12485374|P6|NOT COMPLETED|Period 4||0
5074481|NCT01784614|12485375|P5|NOT COMPLETED|Period 4||0
5074482|NCT01784614|12485376|P4|NOT COMPLETED|Period 4||0
5074483|NCT01784614|12485377|P3|NOT COMPLETED|Period 4||0
5074484|NCT01784614|12485378|P2|NOT COMPLETED|Period 4||0
5074485|NCT01784614|12485379|P1|NOT COMPLETED|Period 4||0
5074486|NCT01784614|12485372|P8|COMPLETED|Period 4||2
5074487|NCT01784614|12485373|P7|COMPLETED|Period 4||3
5074488|NCT01784614|12485374|P6|COMPLETED|Period 4||3
5074489|NCT01784614|12485375|P5|COMPLETED|Period 4||3
5074490|NCT01784614|12485376|P4|COMPLETED|Period 4||3
5074491|NCT01784614|12485377|P3|COMPLETED|Period 4||3
5074492|NCT01784614|12485378|P2|COMPLETED|Period 4||2
5074493|NCT01784614|12485379|P1|COMPLETED|Period 4||3
5074494|NCT01784614|12485372|P8|STARTED|Period 4||2
5074495|NCT01784614|12485373|P7|STARTED|Period 4||3
5074496|NCT01784614|12485374|P6|STARTED|Period 4||3
5074497|NCT01784614|12485375|P5|STARTED|Period 4||3
5074498|NCT01784614|12485376|P4|STARTED|Period 4||3
5074499|NCT01784614|12485377|P3|STARTED|Period 4||3
5074500|NCT01784614|12485378|P2|STARTED|Period 4||2
5074501|NCT01784614|12485379|P1|STARTED|Period 4||3
5074502|NCT01784614|12485372|P8|NOT COMPLETED|Period 3||0
5074503|NCT01784614|12485373|P7|NOT COMPLETED|Period 3||0
5074504|NCT01784614|12485374|P6|NOT COMPLETED|Period 3||0
5074505|NCT01784614|12485375|P5|NOT COMPLETED|Period 3||0
5074506|NCT01784614|12485376|P4|NOT COMPLETED|Period 3||0
5074507|NCT01784614|12485377|P3|NOT COMPLETED|Period 3||0
5074508|NCT01784614|12485378|P2|NOT COMPLETED|Period 3||0
5074509|NCT01784614|12485379|P1|NOT COMPLETED|Period 3||0
5074510|NCT01784614|12485372|P8|COMPLETED|Period 3||2
5074511|NCT01784614|12485373|P7|COMPLETED|Period 3||3
5074512|NCT01784614|12485374|P6|COMPLETED|Period 3||3
5074513|NCT01784614|12485375|P5|COMPLETED|Period 3||3
5074514|NCT01784614|12485376|P4|COMPLETED|Period 3||3
5074515|NCT01784614|12485377|P3|COMPLETED|Period 3||3
5074516|NCT01784614|12485378|P2|COMPLETED|Period 3||2
5074517|NCT01784614|12485379|P1|COMPLETED|Period 3||3
5074518|NCT01784614|12485372|P8|STARTED|Period 3||2
5074519|NCT01784614|12485373|P7|STARTED|Period 3||3
5074520|NCT01784614|12485374|P6|STARTED|Period 3||3
5074521|NCT01784614|12485375|P5|STARTED|Period 3||3
5074522|NCT01784614|12485376|P4|STARTED|Period 3||3
5074523|NCT01784614|12485377|P3|STARTED|Period 3||3
5074524|NCT01784614|12485378|P2|STARTED|Period 3||2
5074525|NCT01784614|12485379|P1|STARTED|Period 3||3
5074526|NCT01784614|12485372|P8|NOT COMPLETED|Period 2||0
5074527|NCT01784614|12485373|P7|NOT COMPLETED|Period 2||0
5074528|NCT01784614|12485374|P6|NOT COMPLETED|Period 2||0
5074529|NCT01784614|12485375|P5|NOT COMPLETED|Period 2||0
5074530|NCT01784614|12485376|P4|NOT COMPLETED|Period 2||0
5074531|NCT01784614|12485377|P3|NOT COMPLETED|Period 2||0
5074532|NCT01784614|12485378|P2|NOT COMPLETED|Period 2||0
5074533|NCT01784614|12485379|P1|NOT COMPLETED|Period 2||0
5074534|NCT01784614|12485372|P8|COMPLETED|Period 2||2
5074535|NCT01784614|12485373|P7|COMPLETED|Period 2||3
5074536|NCT01784614|12485374|P6|COMPLETED|Period 2||3
5074537|NCT01784614|12485375|P5|COMPLETED|Period 2||3
5074538|NCT01784614|12485376|P4|COMPLETED|Period 2||3
5074539|NCT01784614|12485377|P3|COMPLETED|Period 2||3
5074540|NCT01784614|12485378|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
5074541|NCT01784614|12485379|P1|COMPLETED|Period 2||3
5074542|NCT01784614|12485372|P8|STARTED|Period 2||2
5074543|NCT01784614|12485373|P7|STARTED|Period 2||3
5074544|NCT01784614|12485374|P6|STARTED|Period 2||3
5074545|NCT01784614|12485375|P5|STARTED|Period 2||3
5074546|NCT01784614|12485376|P4|STARTED|Period 2||3
5074547|NCT01784614|12485377|P3|STARTED|Period 2||3
5074548|NCT01784614|12485378|P2|STARTED|Period 2||3
5074549|NCT01784614|12485379|P1|STARTED|Period 2||3
5074550|NCT01784614|12485372|P8|NOT COMPLETED|Period 1||0
5074551|NCT01784614|12485373|P7|NOT COMPLETED|Period 1||0
5074552|NCT01784614|12485374|P6|NOT COMPLETED|Period 1||0
5074553|NCT01784614|12485375|P5|NOT COMPLETED|Period 1||0
5074554|NCT01784614|12485376|P4|NOT COMPLETED|Period 1||0
5074555|NCT01784614|12485377|P3|NOT COMPLETED|Period 1||0
5074556|NCT01784614|12485378|P2|NOT COMPLETED|Period 1||0
5074557|NCT01784614|12485379|P1|NOT COMPLETED|Period 1||0
5074558|NCT01784614|12485372|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
5074559|NCT01784614|12485373|P7|COMPLETED|Period 1||3
5074560|NCT01784614|12485374|P6|COMPLETED|Period 1||3
5074561|NCT01784614|12485375|P5|COMPLETED|Period 1||3
5074562|NCT01784614|12485376|P4|COMPLETED|Period 1||3
5074563|NCT01784614|12485377|P3|COMPLETED|Period 1||3
5074564|NCT01784614|12485378|P2|COMPLETED|Period 1||3
5074565|NCT01784614|12485379|P1|COMPLETED|Period 1||3
5074566|NCT01784614|12485372|P8|Received at Least 1 Dose of Study Drug|Period 1||3
5074567|NCT01784614|12485373|P7|Received at Least 1 Dose of Study Drug|Period 1||3
5074568|NCT01784614|12485374|P6|Received at Least 1 Dose of Study Drug|Period 1||3
5074569|NCT01784614|12485375|P5|Received at Least 1 Dose of Study Drug|Period 1||3
5074570|NCT01784614|12485376|P4|Received at Least 1 Dose of Study Drug|Period 1||3
5074571|NCT01784614|12485377|P3|Received at Least 1 Dose of Study Drug|Period 1||3
5074572|NCT01784614|12485378|P2|Received at Least 1 Dose of Study Drug|Period 1||3
5074573|NCT01784614|12485379|P1|Received at Least 1 Dose of Study Drug|Period 1||3
5074574|NCT01784614|12485372|P8|STARTED|Period 1||3
5074575|NCT01784614|12485373|P7|STARTED|Period 1||3
5074576|NCT01784614|12485374|P6|STARTED|Period 1||3
5074577|NCT01784614|12485375|P5|STARTED|Period 1||3
5074578|NCT01784614|12485376|P4|STARTED|Period 1||3
5074579|NCT01784614|12485377|P3|STARTED|Period 1||3
5074580|NCT01784614|12485378|P2|STARTED|Period 1||3
5074581|NCT01784614|12485379|P1|STARTED|Period 1||3
5074582|NCT01784588|12485415|P2|NOT COMPLETED|Overall Study||32
5074583|NCT01784588|12485416|P1|NOT COMPLETED|Overall Study||37
5074584|NCT01784588|12485415|P2|COMPLETED|Overall Study||108
5074585|NCT01784588|12485416|P1|COMPLETED|Overall Study||104
5074586|NCT01784588|12485415|P2|STARTED|Overall Study||140
5074587|NCT01784588|12485416|P1|STARTED|Overall Study||141
5074588|NCT01784211|12485424|P6|NOT COMPLETED|Part B (Days 16-21)||0
5074589|NCT01784211|12485425|P5|NOT COMPLETED|Part B (Days 16-21)||0
5074590|NCT01784211|12485426|P4|NOT COMPLETED|Part B (Days 16-21)||0
5074591|NCT01784211|12485427|P3|NOT COMPLETED|Part B (Days 16-21)||0
5074592|NCT01784211|12485428|P2|NOT COMPLETED|Part B (Days 16-21)||0
5074593|NCT01784211|12485429|P1|NOT COMPLETED|Part B (Days 16-21)||0
5074594|NCT01784211|12485424|P6|COMPLETED|Part B (Days 16-21)||10
5074595|NCT01784211|12485425|P5|COMPLETED|Part B (Days 16-21)||11
5074596|NCT01784211|12485426|P4|COMPLETED|Part B (Days 16-21)||9
5074597|NCT01784211|12485427|P3|COMPLETED|Part B (Days 16-21)||10
5074598|NCT01784211|12485428|P2|COMPLETED|Part B (Days 16-21)||0
5074599|NCT01784211|12485429|P1|COMPLETED|Part B (Days 16-21)||0
5074600|NCT01784211|12485424|P6|STARTED|Part B (Days 16-21)||10
5074601|NCT01784211|12485425|P5|STARTED|Part B (Days 16-21)||11
5074602|NCT01784211|12485426|P4|STARTED|Part B (Days 16-21)||9
5074603|NCT01784211|12485427|P3|STARTED|Part B (Days 16-21)||10
5074604|NCT01784211|12485428|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
5074605|NCT01784211|12485429|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
5074606|NCT01784211|12485424|P6|NOT COMPLETED|Part A (Days 1-15)||0
5074607|NCT01784211|12485425|P5|NOT COMPLETED|Part A (Days 1-15)||0
5074608|NCT01784211|12485426|P4|NOT COMPLETED|Part A (Days 1-15)||0
5074609|NCT01784211|12485427|P3|NOT COMPLETED|Part A (Days 1-15)||0
5074610|NCT01784211|12485428|P2|NOT COMPLETED|Part A (Days 1-15)||2
5074611|NCT01784211|12485429|P1|NOT COMPLETED|Part A (Days 1-15)||3
5074612|NCT01784211|12485424|P6|COMPLETED|Part A (Days 1-15)||0
5074613|NCT01784211|12485425|P5|COMPLETED|Part A (Days 1-15)||0
5074614|NCT01784211|12485426|P4|COMPLETED|Part A (Days 1-15)||0
5074615|NCT01784211|12485427|P3|COMPLETED|Part A (Days 1-15)||0
5074616|NCT01784211|12485428|P2|COMPLETED|Part A (Days 1-15)||36
5074617|NCT01784211|12485429|P1|COMPLETED|Part A (Days 1-15)||35
5074618|NCT01784211|12485424|P6|Entered Part B|Part A (Days 1-15)||0
5074619|NCT01784211|12485425|P5|Entered Part B|Part A (Days 1-15)||0
5074620|NCT01784211|12485426|P4|Entered Part B|Part A (Days 1-15)||0
5074621|NCT01784211|12485427|P3|Entered Part B|Part A (Days 1-15)||0
5074622|NCT01784211|12485428|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
5074623|NCT01784211|12485429|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
5074624|NCT01784211|12485424|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
5074625|NCT01784211|12485425|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
5074626|NCT01784211|12485426|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
5074627|NCT01784211|12485427|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
5074628|NCT01784211|12485428|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
5074629|NCT01784211|12485429|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
5074630|NCT01784211|12485424|P6|STARTED|Part A (Days 1-15)||0
5074631|NCT01784211|12485425|P5|STARTED|Part A (Days 1-15)||0
5074632|NCT01784211|12485426|P4|STARTED|Part A (Days 1-15)||0
5074633|NCT01784211|12485427|P3|STARTED|Part A (Days 1-15)||0
5074634|NCT01784211|12485428|P2|STARTED|Part A (Days 1-15)||38
5074635|NCT01784211|12485429|P1|STARTED|Part A (Days 1-15)||38
5074636|NCT01784055|12485447|P1|NOT COMPLETED|Overall Study||26
5074637|NCT01784055|12485447|P1|COMPLETED|Overall Study||100
5074638|NCT01784055|12485447|P1|STARTED|Overall Study||126
5074639|NCT01784029|12485454|P3|NOT COMPLETED|Overall Study||22
5074640|NCT01784029|12485455|P2|NOT COMPLETED|Overall Study||20
5074641|NCT01784029|12485456|P1|NOT COMPLETED|Overall Study||19
5074642|NCT01784029|12485454|P3|COMPLETED|Overall Study||41
5074643|NCT01784029|12485455|P2|COMPLETED|Overall Study||39
5074644|NCT01784029|12485456|P1|COMPLETED|Overall Study||42
5074645|NCT01784029|12485454|P3|STARTED|Overall Study||63
5074646|NCT01784029|12485455|P2|STARTED|Overall Study||59
5074647|NCT01784029|12485456|P1|STARTED|Overall Study||61
5074648|NCT01783938|12485466|P2|NOT COMPLETED|Overall Study||53
5074649|NCT01783938|12485467|P1|NOT COMPLETED|Overall Study||47
5074650|NCT01783938|12485466|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
5074651|NCT01783938|12485467|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
5074652|NCT01783938|12485466|P2|STARTED|Overall Study||70
5074653|NCT01783938|12485467|P1|STARTED|Overall Study||68
5074654|NCT01783912|12485482|P3|NOT COMPLETED|Overall Study||23
5074655|NCT01783912|12485483|P2|NOT COMPLETED|Overall Study||46
5074656|NCT01783912|12485484|P1|NOT COMPLETED|Overall Study||30
5074657|NCT01783912|12485482|P3|COMPLETED|Overall Study||25
5074658|NCT01783912|12485483|P2|COMPLETED|Overall Study||58
5074659|NCT01783912|12485484|P1|COMPLETED|Overall Study||88
5074660|NCT01783912|12485482|P3|STARTED|Overall Study||48
5074661|NCT01783912|12485483|P2|STARTED|Overall Study||104
5074662|NCT01783912|12485484|P1|STARTED|Overall Study||118
5074663|NCT01783886|12485495|P3|NOT COMPLETED|Overall Study||10
5074664|NCT01783886|12485496|P2|NOT COMPLETED|Overall Study||11
5074665|NCT01783886|12485497|P1|NOT COMPLETED|Overall Study||5
5074666|NCT01783886|12485495|P3|COMPLETED|Overall Study||117
5074667|NCT01783886|12485496|P2|COMPLETED|Overall Study||116
5074668|NCT01783886|12485497|P1|COMPLETED|Overall Study||122
5074669|NCT01783886|12485495|P3|Participants Received Treatment|Overall Study||124
5074670|NCT01783886|12485496|P2|Participants Received Treatment|Overall Study||127
5074671|NCT01783886|12485497|P1|Participants Received Treatment|Overall Study||127
5074672|NCT01783886|12485495|P3|STARTED|Overall Study||127
5074673|NCT01783886|12485496|P2|STARTED|Overall Study||127
5074674|NCT01783886|12485497|P1|STARTED|Overall Study||127
5074675|NCT01783860|12485525|P2|NOT COMPLETED|Overall Study||0
5074676|NCT01783860|12485526|P1|NOT COMPLETED|Overall Study||0
5074677|NCT01783860|12485525|P2|COMPLETED|Overall Study||50
5074678|NCT01783860|12485526|P1|COMPLETED|Overall Study||50
5074679|NCT01783860|12485525|P2|STARTED|Overall Study||50
5074680|NCT01783860|12485526|P1|STARTED|Overall Study||50
5074681|NCT01783847|12485545|P3|NOT COMPLETED|Overall Study||0
5074682|NCT01783847|12485546|P2|NOT COMPLETED|Overall Study||1
5074683|NCT01783847|12485547|P1|NOT COMPLETED|Overall Study||16
5074684|NCT01783847|12485545|P3|COMPLETED|Overall Study||16
5074685|NCT01783847|12485546|P2|COMPLETED|Overall Study||15
5074686|NCT01783847|12485547|P1|COMPLETED|Overall Study||69
5074687|NCT01783847|12485545|P3|STARTED|Overall Study||16
5074688|NCT01783847|12485546|P2|STARTED|Overall Study||16
5074689|NCT01783847|12485547|P1|STARTED|Overall Study||85
5074690|NCT01783821|12485560|P2|NOT COMPLETED|Overall Study||1
5074691|NCT01783821|12485561|P1|NOT COMPLETED|Overall Study||1
5074692|NCT01783821|12485560|P2|COMPLETED|Overall Study||30
5074693|NCT01783821|12485561|P1|COMPLETED|Overall Study||29
5074694|NCT01783821|12485560|P2|STARTED|Overall Study||31
5074695|NCT01783821|12485561|P1|STARTED|Overall Study||30
5074696|NCT01783743|12485579|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
5074697|NCT01783743|12485580|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
5074698|NCT01783743|12485579|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
5074699|NCT01783743|12485580|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
5074700|NCT01783743|12485579|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
5074701|NCT01783743|12485580|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
5074702|NCT01783743|12485579|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
5074703|NCT01783743|12485580|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
5074704|NCT01783743|12485579|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
5074705|NCT01783743|12485580|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
5074706|NCT01783743|12485579|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
5074707|NCT01783743|12485580|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
5074708|NCT01783743|12485579|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
5074709|NCT01783743|12485580|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
5074710|NCT01783743|12485579|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
5074711|NCT01783743|12485580|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
5074712|NCT01783743|12485579|P2|STARTED|Screening of Subjects by CTA During MDA||13964
5074713|NCT01783743|12485580|P1|STARTED|Screening of Subjects by CTA During MDA||13509
5074714|NCT01783730|12485594|P1|NOT COMPLETED|Overall Study||6
5074715|NCT01783730|12485594|P1|COMPLETED|Overall Study||157
5074716|NCT01783730|12485594|P1|STARTED|Overall Study||163
5074717|NCT01783678|12485619|P6|NOT COMPLETED|Overall Study||5
5074718|NCT01783678|12485620|P5|NOT COMPLETED|Overall Study||7
5074719|NCT01783678|12485621|P4|NOT COMPLETED|Overall Study||8
5074720|NCT01783678|12485622|P3|NOT COMPLETED|Overall Study||1
5074721|NCT01783678|12485623|P2|NOT COMPLETED|Overall Study||18
5074722|NCT01783678|12485624|P1|NOT COMPLETED|Overall Study||2
5074723|NCT01783678|12485619|P6|COMPLETED|Overall Study||26
5074724|NCT01783678|12485620|P5|COMPLETED|Overall Study||42
5074725|NCT01783678|12485621|P4|COMPLETED|Overall Study||50
5074726|NCT01783678|12485622|P3|COMPLETED|Overall Study||5
5074727|NCT01783678|12485623|P2|COMPLETED|Overall Study||94
5074728|NCT01783678|12485624|P1|COMPLETED|Overall Study||17
5074729|NCT01783678|12485619|P6|STARTED|Overall Study||31
5074730|NCT01783678|12485620|P5|STARTED|Overall Study||49
5074731|NCT01783678|12485621|P4|STARTED|Overall Study||58
5074732|NCT01783678|12485622|P3|STARTED|Overall Study||6
5074733|NCT01783678|12485623|P2|STARTED|Overall Study||112
5074734|NCT01783678|12485624|P1|STARTED|Overall Study||19
5074735|NCT01783639|12485696|P1|NOT COMPLETED|Overall Study||0
5074736|NCT01783639|12485696|P1|COMPLETED|Overall Study||120
5074737|NCT01783639|12485696|P1|STARTED|Overall Study||120
5074738|NCT01783574|12485702|P2|NOT COMPLETED|Overall Study||9
5074739|NCT01783574|12485703|P1|NOT COMPLETED|Overall Study||5
5074740|NCT01783574|12485702|P2|COMPLETED|Overall Study||41
5074741|NCT01783574|12485703|P1|COMPLETED|Overall Study||46
5074742|NCT01783574|12485702|P2|STARTED|Overall Study||50
5074743|NCT01783574|12485703|P1|STARTED|Overall Study||51
5074744|NCT01783561|12485715|P2|NOT COMPLETED|Overall Study||0
5074745|NCT01783561|12485716|P1|NOT COMPLETED|Overall Study||0
5074746|NCT01783561|12485715|P2|COMPLETED|Overall Study||10
5074747|NCT01783561|12485716|P1|COMPLETED|Overall Study||11
5074748|NCT01783561|12485715|P2|STARTED|Overall Study||10
5074749|NCT01783561|12485716|P1|STARTED|Overall Study||11
5074750|NCT01783548|12485728|P2|NOT COMPLETED|Overall Study||18
5074751|NCT01783548|12485729|P1|NOT COMPLETED|Overall Study||34
5074752|NCT01783548|12485728|P2|COMPLETED|Overall Study||167
5074753|NCT01783548|12485729|P1|COMPLETED|Overall Study||328
5074754|NCT01783548|12485728|P2|Full Analysis Set (FAS)|Overall Study||184
5074755|NCT01783548|12485729|P1|Full Analysis Set (FAS)|Overall Study||358
5074756|NCT01783548|12485728|P2|STARTED|Overall Study|Randomized|185
5074757|NCT01783548|12485729|P1|STARTED|Overall Study|Randomized|362
5074758|NCT01783522|12485743|P2|NOT COMPLETED|Overall Study||0
5074759|NCT01783522|12485744|P1|NOT COMPLETED|Overall Study||0
5074760|NCT01783522|12485743|P2|COMPLETED|Overall Study||5
5074761|NCT01783522|12485744|P1|COMPLETED|Overall Study||4
5074762|NCT01783522|12485743|P2|STARTED|Overall Study||5
5074763|NCT01783522|12485744|P1|STARTED|Overall Study||4
5074764|NCT01783496|12485762|P6|NOT COMPLETED|Overall Study||1
5074765|NCT01783496|12485763|P5|NOT COMPLETED|Overall Study||0
5074766|NCT01783496|12485764|P4|NOT COMPLETED|Overall Study||2
5074767|NCT01783496|12485765|P3|NOT COMPLETED|Overall Study||0
5074768|NCT01783496|12485766|P2|NOT COMPLETED|Overall Study||0
5074769|NCT01783496|12485767|P1|NOT COMPLETED|Overall Study||1
5074770|NCT01783496|12485762|P6|COMPLETED|Overall Study||4
5074771|NCT01783496|12485763|P5|COMPLETED|Overall Study||5
5074772|NCT01783496|12485764|P4|COMPLETED|Overall Study||8
5074773|NCT01783496|12485765|P3|COMPLETED|Overall Study||10
5074774|NCT01783496|12485766|P2|COMPLETED|Overall Study||10
5074775|NCT01783496|12485767|P1|COMPLETED|Overall Study||9
5074776|NCT01783496|12485762|P6|STARTED|Overall Study||5
5074777|NCT01783496|12485763|P5|STARTED|Overall Study||5
5074778|NCT01783496|12485764|P4|STARTED|Overall Study||10
5074779|NCT01783496|12485765|P3|STARTED|Overall Study||10
5074780|NCT01783496|12485766|P2|STARTED|Overall Study||10
5074781|NCT01783496|12485767|P1|STARTED|Overall Study||10
5074782|NCT01783483|12485795|P2|NOT COMPLETED|Overall Study||15
5074783|NCT01783483|12485796|P1|NOT COMPLETED|Overall Study||20
5074784|NCT01783483|12485795|P2|COMPLETED|Overall Study||101
5074785|NCT01783483|12485796|P1|COMPLETED|Overall Study||100
5074786|NCT01783483|12485795|P2|STARTED|Overall Study||116
5074787|NCT01783483|12485796|P1|STARTED|Overall Study||120
5074788|NCT01783470|12485824|P2|NOT COMPLETED|Overall Study||0
5074789|NCT01783470|12485825|P1|NOT COMPLETED|Overall Study||0
5074790|NCT01783470|12485824|P2|COMPLETED|Overall Study||6
5074791|NCT01783470|12485825|P1|COMPLETED|Overall Study||6
5074792|NCT01783470|12485824|P2|STARTED|Overall Study|Single-dose|6
5074793|NCT01783470|12485825|P1|STARTED|Overall Study||6
5074794|NCT01783418|12485834|P2|NOT COMPLETED|Overall Study||0
5074795|NCT01783418|12485835|P1|NOT COMPLETED|Overall Study||1
5074796|NCT01783418|12485834|P2|COMPLETED|Overall Study||6
5074797|NCT01783418|12485835|P1|COMPLETED|Overall Study||7
5074798|NCT01783418|12485834|P2|STARTED|Overall Study||6
5074799|NCT01783418|12485835|P1|STARTED|Overall Study||8
5074800|NCT01783236|12485855|P2|NOT COMPLETED|Overall Study||0
5074801|NCT01783236|12485856|P1|NOT COMPLETED|Overall Study||2
5074802|NCT01783236|12485855|P2|COMPLETED|Overall Study||8
5074803|NCT01783236|12485856|P1|COMPLETED|Overall Study||6
5074804|NCT01783236|12485855|P2|STARTED|Overall Study||8
5074805|NCT01783236|12485856|P1|STARTED|Overall Study||8
5074806|NCT01783080|12485870|P1|NOT COMPLETED|Overall Study||0
5074807|NCT01783080|12485870|P1|COMPLETED|Overall Study||16
5074808|NCT01783080|12485870|P1|STARTED|Overall Study||16
5074809|NCT01783054|12485877|P1|NOT COMPLETED|Overall Study||0
5074810|NCT01783054|12485877|P1|COMPLETED|Overall Study||2
5074811|NCT01783054|12485877|P1|STARTED|Overall Study||2
5074812|NCT01783015|12485888|P3|NOT COMPLETED|Open Label Treatment||6
5074813|NCT01783015|12485889|P2|NOT COMPLETED|Open Label Treatment||0
5074814|NCT01783015|12485890|P1|NOT COMPLETED|Open Label Treatment||0
5074815|NCT01783015|12485888|P3|COMPLETED|Open Label Treatment||5
5074816|NCT01783015|12485889|P2|COMPLETED|Open Label Treatment||0
5074817|NCT01783015|12485890|P1|COMPLETED|Open Label Treatment||0
5074818|NCT01783015|12485888|P3|STARTED|Open Label Treatment||11
5074819|NCT01783015|12485889|P2|STARTED|Open Label Treatment||0
5074820|NCT01783015|12485890|P1|STARTED|Open Label Treatment||0
5074821|NCT01783015|12485888|P3|NOT COMPLETED|Blinded Treatment||0
5074822|NCT01783015|12485889|P2|NOT COMPLETED|Blinded Treatment||3
5074823|NCT01783015|12485890|P1|NOT COMPLETED|Blinded Treatment||2
5074824|NCT01783015|12485888|P3|COMPLETED|Blinded Treatment||0
5074825|NCT01783015|12485889|P2|COMPLETED|Blinded Treatment||2
5074826|NCT01783015|12485890|P1|COMPLETED|Blinded Treatment||9
5074827|NCT01783015|12485888|P3|Treated|Blinded Treatment||0
5074828|NCT01783015|12485889|P2|Treated|Blinded Treatment||5
5074829|NCT01783015|12485890|P1|Treated|Blinded Treatment||11
5074830|NCT01783015|12485888|P3|STARTED|Blinded Treatment||0
5074831|NCT01783015|12485889|P2|STARTED|Blinded Treatment||5
5074832|NCT01783015|12485890|P1|STARTED|Blinded Treatment||11
5074833|NCT01782963|12485975|P1|NOT COMPLETED|Overall Study||0
5074834|NCT01782963|12485975|P1|COMPLETED|Overall Study||50
5074835|NCT01782963|12485975|P1|STARTED|Overall Study||50
5074836|NCT01782898|12485990|P2|NOT COMPLETED|Overall Study||6
5074837|NCT01782898|12485991|P1|NOT COMPLETED|Overall Study||6
5074838|NCT01782898|12485990|P2|COMPLETED|Overall Study||29
5074839|NCT01782898|12485991|P1|COMPLETED|Overall Study||29
5074840|NCT01782898|12485990|P2|STARTED|Overall Study||35
5074841|NCT01782898|12485991|P1|STARTED|Overall Study||35
5074842|NCT01782885|12486003|P2|NOT COMPLETED|Overall Study||6
5074843|NCT01782885|12486004|P1|NOT COMPLETED|Overall Study||4
5074844|NCT01782885|12486003|P2|COMPLETED|Overall Study||33
5074845|NCT01782885|12486004|P1|COMPLETED|Overall Study||32
5074846|NCT01782885|12486003|P2|STARTED|Overall Study||39
5074847|NCT01782885|12486004|P1|STARTED|Overall Study||36
5074848|NCT01782872|12486030|P4|NOT COMPLETED|Overall Study||1
5074849|NCT01782872|12486031|P3|NOT COMPLETED|Overall Study||0
5074850|NCT01782872|12486032|P2|NOT COMPLETED|Overall Study||1
5074851|NCT01782872|12486033|P1|NOT COMPLETED|Overall Study||0
5074852|NCT01782872|12486030|P4|COMPLETED|Overall Study||19
5074853|NCT01782872|12486031|P3|COMPLETED|Overall Study||20
5074854|NCT01782872|12486032|P2|COMPLETED|Overall Study||19
5074855|NCT01782872|12486033|P1|COMPLETED|Overall Study||20
5074856|NCT01782872|12486030|P4|STARTED|Overall Study||20
5074857|NCT01782872|12486031|P3|STARTED|Overall Study||20
5074858|NCT01782872|12486032|P2|STARTED|Overall Study||20
5074859|NCT01782872|12486033|P1|STARTED|Overall Study||20
5074860|NCT01782859|12486057|P2|NOT COMPLETED|Overall Study||7
5074861|NCT01782859|12486058|P1|NOT COMPLETED|Overall Study||6
5074862|NCT01782859|12486057|P2|COMPLETED|Overall Study||13
5074863|NCT01782859|12486058|P1|COMPLETED|Overall Study||14
5074864|NCT01782859|12486057|P2|STARTED|Overall Study||20
5074865|NCT01782859|12486058|P1|STARTED|Overall Study||20
5074866|NCT01782833|12486072|P1|NOT COMPLETED|Overall Study||270
5074867|NCT01782833|12486072|P1|COMPLETED|Overall Study||3365
5074868|NCT01782833|12486072|P1|STARTED|Overall Study||3635
5074869|NCT01782742|12486080|P2|NOT COMPLETED|Open Label Phase||0
5074870|NCT01782742|12486081|P1|NOT COMPLETED|Open Label Phase||0
5074871|NCT01782742|12486080|P2|COMPLETED|Open Label Phase||0
5074872|NCT01782742|12486081|P1|COMPLETED|Open Label Phase||19
5074873|NCT01782742|12486080|P2|STARTED|Open Label Phase||0
5074874|NCT01782742|12486081|P1|STARTED|Open Label Phase||19
5074875|NCT01782742|12486080|P2|NOT COMPLETED|Double-blind Treatment Phase||0
5074876|NCT01782742|12486081|P1|NOT COMPLETED|Double-blind Treatment Phase||1
5074877|NCT01782742|12486080|P2|COMPLETED|Double-blind Treatment Phase||4
5074878|NCT01782742|12486081|P1|COMPLETED|Double-blind Treatment Phase||15
5074879|NCT01782742|12486080|P2|STARTED|Double-blind Treatment Phase||4
5074880|NCT01782742|12486081|P1|STARTED|Double-blind Treatment Phase||16
5074881|NCT01782690|12486114|P1|NOT COMPLETED|Overall Study||299
5074882|NCT01782690|12486114|P1|COMPLETED|Overall Study||39
5074883|NCT01782690|12486114|P1|STARTED|Overall Study||338
5074884|NCT01782664|12486136|P6|NOT COMPLETED|Overall Study||0
5074885|NCT01782664|12486137|P5|NOT COMPLETED|Overall Study||0
5074886|NCT01782664|12486138|P4|NOT COMPLETED|Overall Study||5
5074887|NCT01782664|12486139|P3|NOT COMPLETED|Overall Study||4
5074888|NCT01782664|12486140|P2|NOT COMPLETED|Overall Study||5
5074889|NCT01782664|12486141|P1|NOT COMPLETED|Overall Study||6
5074890|NCT01782664|12486136|P6|COMPLETED|Overall Study||2
5074891|NCT01782664|12486137|P5|COMPLETED|Overall Study||6
5074892|NCT01782664|12486138|P4|COMPLETED|Overall Study||9
5074893|NCT01782664|12486139|P3|COMPLETED|Overall Study||12
5074894|NCT01782664|12486140|P2|COMPLETED|Overall Study||10
5074895|NCT01782664|12486141|P1|COMPLETED|Overall Study||8
5074896|NCT01782664|12486136|P6|STARTED|Overall Study||2
5074897|NCT01782664|12486137|P5|STARTED|Overall Study||6
5074898|NCT01782664|12486138|P4|STARTED|Overall Study||14
5074899|NCT01782664|12486139|P3|STARTED|Overall Study||16
5074900|NCT01782664|12486140|P2|STARTED|Overall Study||15
5074901|NCT01782664|12486141|P1|STARTED|Overall Study||14
5074902|NCT01782495|12486298|P11|NOT COMPLETED|Overall Study||0
5074903|NCT01782495|12486299|P10|NOT COMPLETED|Overall Study||0
5074904|NCT01782495|12486300|P9|NOT COMPLETED|Overall Study||0
5074905|NCT01782495|12486301|P8|NOT COMPLETED|Overall Study||3
5074906|NCT01782495|12486302|P7|NOT COMPLETED|Overall Study||0
5074907|NCT01782495|12486303|P6|NOT COMPLETED|Overall Study||0
5074908|NCT01782495|12486304|P5|NOT COMPLETED|Overall Study||0
5074909|NCT01782495|12486305|P4|NOT COMPLETED|Overall Study||0
5074910|NCT01782495|12486306|P3|NOT COMPLETED|Overall Study||0
5074911|NCT01782495|12486307|P2|NOT COMPLETED|Overall Study||1
5074912|NCT01782495|12486308|P1|NOT COMPLETED|Overall Study||0
5074913|NCT01782495|12486298|P11|COMPLETED|Overall Study||1
5074914|NCT01782495|12486299|P10|COMPLETED|Overall Study||2
5074915|NCT01782495|12486300|P9|COMPLETED|Overall Study||3
5074916|NCT01782495|12486301|P8|COMPLETED|Overall Study||6
5074917|NCT01782495|12486302|P7|COMPLETED|Overall Study||12
5074918|NCT01782495|12486303|P6|COMPLETED|Overall Study||22
5074919|NCT01782495|12486304|P5|COMPLETED|Overall Study||2
5074920|NCT01782495|12486305|P4|COMPLETED|Overall Study||4
5074921|NCT01782495|12486306|P3|COMPLETED|Overall Study||13
5074922|NCT01782495|12486307|P2|COMPLETED|Overall Study||26
5074923|NCT01782495|12486308|P1|COMPLETED|Overall Study||34
5074924|NCT01782495|12486298|P11|STARTED|Overall Study||1
5074925|NCT01782495|12486299|P10|STARTED|Overall Study||2
5074926|NCT01782495|12486300|P9|STARTED|Overall Study||3
5074927|NCT01782495|12486301|P8|STARTED|Overall Study||9
5074928|NCT01782495|12486302|P7|STARTED|Overall Study||12
5074929|NCT01782495|12486303|P6|STARTED|Overall Study||22
5074930|NCT01782495|12486304|P5|STARTED|Overall Study||2
5074931|NCT01782495|12486305|P4|STARTED|Overall Study||4
5074932|NCT01782495|12486306|P3|STARTED|Overall Study||13
5074933|NCT01782495|12486307|P2|STARTED|Overall Study||27
5074934|NCT01782495|12486308|P1|STARTED|Overall Study||34
5074935|NCT01782482|12486367|P2|NOT COMPLETED|Overall Study||10
5074936|NCT01782482|12486368|P1|NOT COMPLETED|Overall Study||10
5074937|NCT01782482|12486367|P2|COMPLETED|Overall Study||270
5074938|NCT01782482|12486368|P1|COMPLETED|Overall Study||271
5074939|NCT01782482|12486367|P2|STARTED|Overall Study||280
5074940|NCT01782482|12486368|P1|STARTED|Overall Study||281
5074941|NCT01782469|12486376|P1|NOT COMPLETED|Overall Study||1
5074942|NCT01782469|12486376|P1|COMPLETED|Overall Study||15
5074943|NCT01782469|12486376|P1|STARTED|Overall Study||16
5074944|NCT01782378|12486386|P2|NOT COMPLETED|Second Series||32
5074945|NCT01782378|12486387|P1|NOT COMPLETED|Second Series||26
5074946|NCT01782378|12486386|P2|COMPLETED|Second Series||0
5074947|NCT01782378|12486387|P1|COMPLETED|Second Series||5
5074948|NCT01782378|12486386|P2|STARTED|Second Series||32
5074949|NCT01782378|12486387|P1|STARTED|Second Series||31
5074950|NCT01782378|12486386|P2|NOT COMPLETED|First Series||8
5074951|NCT01782378|12486387|P1|NOT COMPLETED|First Series||7
5074952|NCT01782378|12486386|P2|COMPLETED|First Series||23
5074953|NCT01782378|12486387|P1|COMPLETED|First Series||25
5074954|NCT01782378|12486386|P2|STARTED|First Series||31
5074955|NCT01782378|12486387|P1|STARTED|First Series||32
5074956|NCT01782326|12486453|P2|NOT COMPLETED|Double-blind Treatment||320
5074957|NCT01782326|12486454|P1|NOT COMPLETED|Double-blind Treatment||278
5074958|NCT01782326|12486453|P2|COMPLETED|Double-blind Treatment||1360
5074959|NCT01782326|12486454|P1|COMPLETED|Double-blind Treatment||1400
5074960|NCT01782326|12486453|P2|STARTED|Double-blind Treatment||1680
5074961|NCT01782326|12486454|P1|STARTED|Double-blind Treatment||1678
5074962|NCT01782326|12486453|P2|NOT COMPLETED|Planned Treatment Epoch||208
5074963|NCT01782326|12486454|P1|NOT COMPLETED|Planned Treatment Epoch||202
5074964|NCT01782326|12486453|P2|COMPLETED|Planned Treatment Epoch||1474
5074965|NCT01782326|12486454|P1|COMPLETED|Planned Treatment Epoch||1478
5074966|NCT01782326|12486453|P2|Urine Cortisol Set|Planned Treatment Epoch||269
5074967|NCT01782326|12486454|P1|Urine Cortisol Set|Planned Treatment Epoch||266
5074968|NCT01782326|12486453|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
5074969|NCT01782326|12486454|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
5074970|NCT01782326|12486453|P2|Serial Spirometry Set|Planned Treatment Epoch||279
5074971|NCT01782326|12486454|P1|Serial Spirometry Set|Planned Treatment Epoch||280
5074972|NCT01782326|12486453|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
5074973|NCT01782326|12486454|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
5074974|NCT01782326|12486453|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
5074975|NCT01782326|12486454|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
5074976|NCT01782326|12486453|P2|STARTED|Planned Treatment Epoch||1682
5074977|NCT01782326|12486454|P1|STARTED|Planned Treatment Epoch||1680
5074978|NCT01782313|12486514|P1|NOT COMPLETED|Survival Follow up||1
5074979|NCT01782313|12486514|P1|COMPLETED|Survival Follow up||57
5074980|NCT01782313|12486514|P1|STARTED|Survival Follow up||58
5074981|NCT01782313|12486514|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
5074982|NCT01782313|12486514|P1|COMPLETED|Continued Treatment After 16 Weeks||18
5074983|NCT01782313|12486514|P1|STARTED|Continued Treatment After 16 Weeks||25
5074984|NCT01782313|12486514|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
5074985|NCT01782313|12486514|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
5074986|NCT01782313|12486514|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
5074987|NCT01782313|12486514|P1|NOT COMPLETED|Treated Cycle 3||21
5074988|NCT01782313|12486514|P1|COMPLETED|Treated Cycle 3||31
5074989|NCT01782313|12486514|P1|STARTED|Treated Cycle 3||52
5074990|NCT01782313|12486514|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
5074991|NCT01782313|12486514|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
5074992|NCT01782313|12486514|P1|STARTED|Reached First Response/Completed 2 Cycle||58
5074993|NCT01782222|12486528|P3|NOT COMPLETED|Overall Study||4
5074994|NCT01782222|12486529|P2|NOT COMPLETED|Overall Study||11
5074995|NCT01782222|12486530|P1|NOT COMPLETED|Overall Study||8
5074996|NCT01782222|12486528|P3|COMPLETED|Overall Study||37
5074997|NCT01782222|12486529|P2|COMPLETED|Overall Study||30
5074998|NCT01782222|12486530|P1|COMPLETED|Overall Study||32
5074999|NCT01782222|12486528|P3|STARTED|Overall Study||41
5075000|NCT01782222|12486529|P2|STARTED|Overall Study||41
5075001|NCT01782222|12486530|P1|STARTED|Overall Study||40
5075002|NCT01782209|12486562|P1|NOT COMPLETED|Overall Study||110
5075003|NCT01782209|12486562|P1|COMPLETED|Overall Study||225
5075004|NCT01782209|12486562|P1|STARTED|Overall Study||335
5075005|NCT01781975|12486568|P2|NOT COMPLETED|Overall Study||1
5075006|NCT01781975|12486569|P1|NOT COMPLETED|Overall Study||2
5075007|NCT01781975|12486568|P2|COMPLETED|Overall Study||21
5075008|NCT01781975|12486569|P1|COMPLETED|Overall Study||43
5075009|NCT01781975|12486568|P2|Follow-Up Period|Overall Study||21
5075010|NCT01781975|12486569|P1|Follow-Up Period|Overall Study||43
5075011|NCT01781975|12486568|P2|Treatment Period|Overall Study||22
5075012|NCT01781975|12486569|P1|Treatment Period|Overall Study||44
5075013|NCT01781975|12486568|P2|STARTED|Overall Study||22
5075014|NCT01781975|12486569|P1|STARTED|Overall Study||45
5075015|NCT01781962|12486585|P1|NOT COMPLETED|Overall Study||5
5075016|NCT01781962|12486585|P1|COMPLETED|Overall Study||201
5075017|NCT01781962|12486585|P1|STARTED|Overall Study||206
5075018|NCT01781832|12486591|P1|NOT COMPLETED|Overall Study||1
5075019|NCT01781832|12486591|P1|COMPLETED|Overall Study||25
5075020|NCT01781832|12486591|P1|STARTED|Overall Study||26
5075021|NCT01781806|12486598|P2|NOT COMPLETED|Overall Study||3
5075022|NCT01781806|12486599|P1|NOT COMPLETED|Overall Study||79
5075023|NCT01781806|12486598|P2|COMPLETED|Overall Study||1
5075024|NCT01781806|12486599|P1|COMPLETED|Overall Study||218
5075025|NCT01781806|12486598|P2|Week 48|Overall Study||1
5075026|NCT01781806|12486599|P1|Week 48|Overall Study||222
5075027|NCT01781806|12486598|P2|Week 36|Overall Study||1
5075028|NCT01781806|12486599|P1|Week 36|Overall Study||247
5075029|NCT01781806|12486598|P2|Week 24|Overall Study||1
5075030|NCT01781806|12486599|P1|Week 24|Overall Study||260
5075031|NCT01781806|12486598|P2|Week 12|Overall Study||2
5075032|NCT01781806|12486599|P1|Week 12|Overall Study||272
5075033|NCT01781806|12486598|P2|Week 8|Overall Study||4
5075034|NCT01781806|12486599|P1|Week 8|Overall Study||278
5075035|NCT01781806|12486598|P2|Week 4|Overall Study||4
5075036|NCT01781806|12486599|P1|Week 4|Overall Study||284
5075037|NCT01781806|12486598|P2|Week 0|Overall Study||4
5075038|NCT01781806|12486599|P1|Week 0|Overall Study||297
5075039|NCT01781806|12486598|P2|STARTED|Overall Study||4
5075040|NCT01781806|12486599|P1|STARTED|Overall Study||297
5075041|NCT01781637|12486611|P2|NOT COMPLETED|Overall Study||6
5075042|NCT01781637|12486612|P1|NOT COMPLETED|Overall Study||4
5075043|NCT01781637|12486611|P2|COMPLETED|Overall Study||2
5075044|NCT01781637|12486612|P1|COMPLETED|Overall Study||24
5075045|NCT01781637|12486611|P2|STARTED|Overall Study||8
5075046|NCT01781637|12486612|P1|STARTED|Overall Study||28
5075047|NCT01781481|12486620|P1|NOT COMPLETED|Overall Study||0
5075048|NCT01781481|12486620|P1|COMPLETED|Overall Study||148
5075049|NCT01781481|12486620|P1|STARTED|Overall Study||148
5075050|NCT01781468|12486682|P3|NOT COMPLETED|Overall Study||12
5075051|NCT01781468|12486683|P2|NOT COMPLETED|Overall Study||13
5075052|NCT01781468|12486684|P1|NOT COMPLETED|Overall Study||6
5075053|NCT01781468|12486682|P3|COMPLETED|Overall Study||97
5075054|NCT01781468|12486683|P2|COMPLETED|Overall Study||97
5075055|NCT01781468|12486684|P1|COMPLETED|Overall Study||103
5075056|NCT01781468|12486682|P3|STARTED|Overall Study||109
5075057|NCT01781468|12486683|P2|STARTED|Overall Study||110
5075058|NCT01781468|12486684|P1|STARTED|Overall Study||109
5075059|NCT01781429|12486719|P16|NOT COMPLETED|Overall Study||0
5075060|NCT01781429|12486720|P15|NOT COMPLETED|Overall Study||16
5075061|NCT01781429|12486721|P14|NOT COMPLETED|Overall Study||8
5075062|NCT01781429|12486722|P13|NOT COMPLETED|Overall Study||22
5075063|NCT01781429|12486723|P12|NOT COMPLETED|Overall Study||21
5075064|NCT01781429|12486724|P11|NOT COMPLETED|Overall Study||18
5075065|NCT01781429|12486725|P10|NOT COMPLETED|Overall Study||24
5075066|NCT01781429|12486726|P9|NOT COMPLETED|Overall Study||7
5075067|NCT01781429|12486727|P8|NOT COMPLETED|Overall Study||4
5075068|NCT01781429|12486728|P7|NOT COMPLETED|Overall Study||7
5075069|NCT01781429|12486729|P6|NOT COMPLETED|Overall Study||4
5075070|NCT01781429|12486730|P5|NOT COMPLETED|Overall Study||1
5075071|NCT01781429|12486731|P4|NOT COMPLETED|Overall Study||1
5075072|NCT01781429|12486732|P3|NOT COMPLETED|Overall Study||1
5075073|NCT01781429|12486733|P2|NOT COMPLETED|Overall Study||1
5075074|NCT01781429|12486734|P1|NOT COMPLETED|Overall Study||1
5075075|NCT01781429|12486719|P16|COMPLETED|Overall Study||0
5075076|NCT01781429|12486720|P15|COMPLETED|Overall Study||0
5075077|NCT01781429|12486721|P14|COMPLETED|Overall Study||0
5075078|NCT01781429|12486722|P13|COMPLETED|Overall Study||0
5075079|NCT01781429|12486723|P12|COMPLETED|Overall Study||0
5075080|NCT01781429|12486724|P11|COMPLETED|Overall Study||0
5075081|NCT01781429|12486725|P10|COMPLETED|Overall Study||0
5075082|NCT01781429|12486726|P9|COMPLETED|Overall Study||0
5075083|NCT01781429|12486727|P8|COMPLETED|Overall Study||0
5075084|NCT01781429|12486728|P7|COMPLETED|Overall Study||0
5075085|NCT01781429|12486729|P6|COMPLETED|Overall Study||0
5075086|NCT01781429|12486730|P5|COMPLETED|Overall Study||0
5075087|NCT01781429|12486731|P4|COMPLETED|Overall Study||0
5075088|NCT01781429|12486732|P3|COMPLETED|Overall Study||0
5075089|NCT01781429|12486733|P2|COMPLETED|Overall Study||0
5075090|NCT01781429|12486734|P1|COMPLETED|Overall Study||0
5075091|NCT01781429|12486719|P16|STARTED|Overall Study||0
5075092|NCT01781429|12486720|P15|STARTED|Overall Study||16
5075093|NCT01781429|12486721|P14|STARTED|Overall Study||8
5075094|NCT01781429|12486722|P13|STARTED|Overall Study||22
5075095|NCT01781429|12486723|P12|STARTED|Overall Study||21
5075096|NCT01781429|12486724|P11|STARTED|Overall Study||18
5075097|NCT01781429|12486725|P10|STARTED|Overall Study||24
5075098|NCT01781429|12486726|P9|STARTED|Overall Study||7
5075099|NCT01781429|12486727|P8|STARTED|Overall Study||4
5075100|NCT01781429|12486728|P7|STARTED|Overall Study||7
5075101|NCT01781429|12486729|P6|STARTED|Overall Study||4
5075102|NCT01781429|12486730|P5|STARTED|Overall Study||1
5075103|NCT01781429|12486731|P4|STARTED|Overall Study||1
5075104|NCT01781429|12486732|P3|STARTED|Overall Study||1
5075105|NCT01781429|12486733|P2|STARTED|Overall Study||1
5075106|NCT01781429|12486734|P1|STARTED|Overall Study||1
5075107|NCT01781403|12486791|P3|NOT COMPLETED|Overall Study||0
5075108|NCT01781403|12486792|P2|NOT COMPLETED|Overall Study||0
5075109|NCT01781403|12486793|P1|NOT COMPLETED|Overall Study||0
5075110|NCT01781403|12486791|P3|COMPLETED|Overall Study||18
5075111|NCT01781403|12486792|P2|COMPLETED|Overall Study||2
5075112|NCT01781403|12486793|P1|COMPLETED|Overall Study||2
5075113|NCT01781403|12486791|P3|STARTED|Overall Study||18
5075114|NCT01781403|12486792|P2|STARTED|Overall Study||2
5075115|NCT01781403|12486793|P1|STARTED|Overall Study||2
5075116|NCT01781299|12486811|P2|NOT COMPLETED|Overall Study||1
5075117|NCT01781299|12486812|P1|NOT COMPLETED|Overall Study||0
5075118|NCT01781299|12486811|P2|COMPLETED|Overall Study||4
5075119|NCT01781299|12486812|P1|COMPLETED|Overall Study||4
5075120|NCT01781299|12486811|P2|STARTED|Overall Study||5
5075121|NCT01781299|12486812|P1|STARTED|Overall Study||4
5075122|NCT01781286|12486820|P6|NOT COMPLETED|Overall Study||1
5075123|NCT01781286|12486821|P5|NOT COMPLETED|Overall Study||0
5075124|NCT01781286|12486822|P4|NOT COMPLETED|Overall Study||1
5075125|NCT01781286|12486823|P3|NOT COMPLETED|Overall Study||2
5075126|NCT01781286|12486824|P2|NOT COMPLETED|Overall Study||0
5075127|NCT01781286|12486825|P1|NOT COMPLETED|Overall Study||2
5075128|NCT01781286|12486820|P6|COMPLETED|Overall Study||2
5075129|NCT01781286|12486821|P5|COMPLETED|Overall Study||6
5075130|NCT01781286|12486822|P4|COMPLETED|Overall Study||7
5075131|NCT01781286|12486823|P3|COMPLETED|Overall Study||7
5075132|NCT01781286|12486824|P2|COMPLETED|Overall Study||4
5075133|NCT01781286|12486825|P1|COMPLETED|Overall Study||5
5075134|NCT01781286|12486820|P6|Started 3rd Intervention|Overall Study||2
5075135|NCT01781286|12486821|P5|Started 3rd Intervention|Overall Study||6
5075136|NCT01781286|12486822|P4|Started 3rd Intervention|Overall Study||7
5075137|NCT01781286|12486823|P3|Started 3rd Intervention|Overall Study||7
5075138|NCT01781286|12486824|P2|Started 3rd Intervention|Overall Study||4
5075139|NCT01781286|12486825|P1|Started 3rd Intervention|Overall Study||5
5075140|NCT01781286|12486820|P6|Started 2nd Intervention|Overall Study||2
5075141|NCT01781286|12486821|P5|Started 2nd Intervention|Overall Study||6
5075142|NCT01781286|12486822|P4|Started 2nd Intervention|Overall Study||8
5075143|NCT01781286|12486823|P3|Started 2nd Intervention|Overall Study||9
5075144|NCT01781286|12486824|P2|Started 2nd Intervention|Overall Study||4
5075145|NCT01781286|12486825|P1|Started 2nd Intervention|Overall Study||5
5075146|NCT01781286|12486820|P6|Started 1st Intervention|Overall Study||2
5075147|NCT01781286|12486821|P5|Started 1st Intervention|Overall Study||6
5075148|NCT01781286|12486822|P4|Started 1st Intervention|Overall Study||8
5075149|NCT01781286|12486823|P3|Started 1st Intervention|Overall Study||9
5075150|NCT01781286|12486824|P2|Started 1st Intervention|Overall Study||4
5075151|NCT01781286|12486825|P1|Started 1st Intervention|Overall Study||6
5075152|NCT01781286|12486820|P6|STARTED|Overall Study||3
5075153|NCT01781286|12486821|P5|STARTED|Overall Study||6
5075154|NCT01781286|12486822|P4|STARTED|Overall Study||8
5075155|NCT01781286|12486823|P3|STARTED|Overall Study||9
5075156|NCT01781286|12486824|P2|STARTED|Overall Study||4
5075157|NCT01781286|12486825|P1|STARTED|Overall Study||7
5075158|NCT01781234|12486850|P2|NOT COMPLETED|Overall Study||3
5075159|NCT01781234|12486851|P1|NOT COMPLETED|Overall Study||9
5075160|NCT01781234|12486850|P2|COMPLETED|Overall Study||21
5075161|NCT01781234|12486851|P1|COMPLETED|Overall Study||18
5075162|NCT01781234|12486850|P2|STARTED|Overall Study||24
5075163|NCT01781234|12486851|P1|STARTED|Overall Study||27
5075164|NCT01781208|12486861|P1|NOT COMPLETED|Overall Study||0
5075165|NCT01781208|12486861|P1|COMPLETED|Overall Study||62
5075166|NCT01781208|12486861|P1|Overall Study|Overall Study||62
5075167|NCT01781208|12486861|P1|STARTED|Overall Study||62
5075168|NCT01781169|12486868|P2|NOT COMPLETED|Overall Study||0
5075169|NCT01781169|12486869|P1|NOT COMPLETED|Overall Study||1
5075170|NCT01781169|12486868|P2|COMPLETED|Overall Study||21
5075171|NCT01781169|12486869|P1|COMPLETED|Overall Study||21
5075172|NCT01781169|12486868|P2|STARTED|Overall Study||21
5075173|NCT01781169|12486869|P1|STARTED|Overall Study||22
5075174|NCT01781078|12486877|P3|NOT COMPLETED|Overall Study||16
5075175|NCT01781078|12486878|P2|NOT COMPLETED|Overall Study||5
5075176|NCT01781078|12486879|P1|NOT COMPLETED|Overall Study||12
5075177|NCT01781078|12486877|P3|COMPLETED|Overall Study||0
5075178|NCT01781078|12486878|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
5075179|NCT01781078|12486879|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
5075180|NCT01781078|12486877|P3|STARTED|Overall Study||16
5075181|NCT01781078|12486878|P2|STARTED|Overall Study|Randomized post implantation|118
5075182|NCT01781078|12486879|P1|STARTED|Overall Study|Randomized post implantation|229
5075183|NCT01781026|12486889|P1|NOT COMPLETED|Overall Study||2
5075184|NCT01781026|12486889|P1|COMPLETED|Overall Study||0
5075185|NCT01781026|12486889|P1|STARTED|Overall Study||2
5075186|NCT01780987|12486895|P2|NOT COMPLETED|Overall Study||6
5075187|NCT01780987|12486896|P1|NOT COMPLETED|Overall Study||3
5075188|NCT01780987|12486895|P2|COMPLETED|Overall Study||34
5075189|NCT01780987|12486896|P1|COMPLETED|Overall Study||37
5075279|NCT01780922|12486957|P5|NOT COMPLETED|First Intervention (1 Day)||0
5075190|NCT01780987|12486895|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
5075191|NCT01780987|12486896|P1|STARTED|Overall Study||40
5075192|NCT01780974|12486914|P2|NOT COMPLETED|Overall Study||3
5075193|NCT01780974|12486915|P1|NOT COMPLETED|Overall Study||2
5075194|NCT01780974|12486914|P2|COMPLETED|Overall Study||18
5075195|NCT01780974|12486915|P1|COMPLETED|Overall Study||19
5075196|NCT01780974|12486914|P2|STARTED|Overall Study||21
5075197|NCT01780974|12486915|P1|STARTED|Overall Study||21
5075198|NCT01780935|12486925|P2|NOT COMPLETED|Overall Study||336
5075199|NCT01780935|12486926|P1|NOT COMPLETED|Overall Study||335
5075200|NCT01780935|12486925|P2|COMPLETED|Overall Study||0
5075201|NCT01780935|12486926|P1|COMPLETED|Overall Study||0
5075202|NCT01780935|12486925|P2|Safety Set|Overall Study||336
5075203|NCT01780935|12486926|P1|Safety Set|Overall Study||334
5075204|NCT01780935|12486925|P2|STARTED|Overall Study||336
5075205|NCT01780935|12486926|P1|STARTED|Overall Study||335
5075206|NCT01780922|12486956|P6|NOT COMPLETED|Third Intervention (1 Day)||0
5075207|NCT01780922|12486957|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5075208|NCT01780922|12486958|P4|NOT COMPLETED|Third Intervention (1 Day)||0
5075209|NCT01780922|12486959|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5075210|NCT01780922|12486960|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5075211|NCT01780922|12486961|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5075212|NCT01780922|12486956|P6|COMPLETED|Third Intervention (1 Day)||2
5075213|NCT01780922|12486957|P5|COMPLETED|Third Intervention (1 Day)||2
5075214|NCT01780922|12486958|P4|COMPLETED|Third Intervention (1 Day)||2
5075215|NCT01780922|12486959|P3|COMPLETED|Third Intervention (1 Day)||2
5075216|NCT01780922|12486960|P2|COMPLETED|Third Intervention (1 Day)||2
5075217|NCT01780922|12486961|P1|COMPLETED|Third Intervention (1 Day)||2
5075218|NCT01780922|12486956|P6|STARTED|Third Intervention (1 Day)||2
5075219|NCT01780922|12486957|P5|STARTED|Third Intervention (1 Day)||2
5075220|NCT01780922|12486958|P4|STARTED|Third Intervention (1 Day)||2
5075221|NCT01780922|12486959|P3|STARTED|Third Intervention (1 Day)||2
5075222|NCT01780922|12486960|P2|STARTED|Third Intervention (1 Day)||2
5075223|NCT01780922|12486961|P1|STARTED|Third Intervention (1 Day)||2
5075224|NCT01780922|12486956|P6|NOT COMPLETED|Washout (7 Days)||0
5075225|NCT01780922|12486957|P5|NOT COMPLETED|Washout (7 Days)||0
5075226|NCT01780922|12486958|P4|NOT COMPLETED|Washout (7 Days)||0
5075227|NCT01780922|12486959|P3|NOT COMPLETED|Washout (7 Days)||0
5075228|NCT01780922|12486960|P2|NOT COMPLETED|Washout (7 Days)||0
5075229|NCT01780922|12486961|P1|NOT COMPLETED|Washout (7 Days)||0
5075230|NCT01780922|12486956|P6|COMPLETED|Washout (7 Days)||2
5075231|NCT01780922|12486957|P5|COMPLETED|Washout (7 Days)||2
5075232|NCT01780922|12486958|P4|COMPLETED|Washout (7 Days)||2
5075233|NCT01780922|12486959|P3|COMPLETED|Washout (7 Days)||2
5075234|NCT01780922|12486960|P2|COMPLETED|Washout (7 Days)||2
5075235|NCT01780922|12486961|P1|COMPLETED|Washout (7 Days)||2
5075236|NCT01780922|12486956|P6|STARTED|Washout (7 Days)||2
5075237|NCT01780922|12486957|P5|STARTED|Washout (7 Days)||2
5075238|NCT01780922|12486958|P4|STARTED|Washout (7 Days)||2
5075239|NCT01780922|12486959|P3|STARTED|Washout (7 Days)||2
5075240|NCT01780922|12486960|P2|STARTED|Washout (7 Days)||2
5075241|NCT01780922|12486961|P1|STARTED|Washout (7 Days)||2
5075242|NCT01780922|12486956|P6|NOT COMPLETED|Second Intervention (1 Day)||0
5075243|NCT01780922|12486957|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5075244|NCT01780922|12486958|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5075245|NCT01780922|12486959|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5075246|NCT01780922|12486960|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5075247|NCT01780922|12486961|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5075248|NCT01780922|12486956|P6|COMPLETED|Second Intervention (1 Day)||2
5075249|NCT01780922|12486957|P5|COMPLETED|Second Intervention (1 Day)||2
5075250|NCT01780922|12486958|P4|COMPLETED|Second Intervention (1 Day)||2
5075251|NCT01780922|12486959|P3|COMPLETED|Second Intervention (1 Day)||2
5075252|NCT01780922|12486960|P2|COMPLETED|Second Intervention (1 Day)||2
5075253|NCT01780922|12486961|P1|COMPLETED|Second Intervention (1 Day)||2
5075254|NCT01780922|12486956|P6|STARTED|Second Intervention (1 Day)||2
5075255|NCT01780922|12486957|P5|STARTED|Second Intervention (1 Day)||2
5075256|NCT01780922|12486958|P4|STARTED|Second Intervention (1 Day)||2
5075257|NCT01780922|12486959|P3|STARTED|Second Intervention (1 Day)||2
5075258|NCT01780922|12486960|P2|STARTED|Second Intervention (1 Day)||2
5075259|NCT01780922|12486961|P1|STARTED|Second Intervention (1 Day)||2
5075260|NCT01780922|12486956|P6|NOT COMPLETED|Washout (7 Days)||0
5075261|NCT01780922|12486957|P5|NOT COMPLETED|Washout (7 Days)||0
5075262|NCT01780922|12486958|P4|NOT COMPLETED|Washout (7 Days)||0
5075263|NCT01780922|12486959|P3|NOT COMPLETED|Washout (7 Days)||0
5075264|NCT01780922|12486960|P2|NOT COMPLETED|Washout (7 Days)||0
5075265|NCT01780922|12486961|P1|NOT COMPLETED|Washout (7 Days)||0
5075266|NCT01780922|12486956|P6|COMPLETED|Washout (7 Days)||2
5075267|NCT01780922|12486957|P5|COMPLETED|Washout (7 Days)||2
5075268|NCT01780922|12486958|P4|COMPLETED|Washout (7 Days)||2
5075269|NCT01780922|12486959|P3|COMPLETED|Washout (7 Days)||2
5075270|NCT01780922|12486960|P2|COMPLETED|Washout (7 Days)||2
5075271|NCT01780922|12486961|P1|COMPLETED|Washout (7 Days)||2
5075272|NCT01780922|12486956|P6|STARTED|Washout (7 Days)||2
5075273|NCT01780922|12486957|P5|STARTED|Washout (7 Days)||2
5075274|NCT01780922|12486958|P4|STARTED|Washout (7 Days)||2
5075275|NCT01780922|12486959|P3|STARTED|Washout (7 Days)||2
5075276|NCT01780922|12486960|P2|STARTED|Washout (7 Days)||2
5075277|NCT01780922|12486961|P1|STARTED|Washout (7 Days)||2
5075278|NCT01780922|12486956|P6|NOT COMPLETED|First Intervention (1 Day)||0
5075280|NCT01780922|12486958|P4|NOT COMPLETED|First Intervention (1 Day)||0
5075281|NCT01780922|12486959|P3|NOT COMPLETED|First Intervention (1 Day)||0
5075282|NCT01780922|12486960|P2|NOT COMPLETED|First Intervention (1 Day)||0
5075283|NCT01780922|12486961|P1|NOT COMPLETED|First Intervention (1 Day)||0
5075284|NCT01780922|12486956|P6|COMPLETED|First Intervention (1 Day)||2
5075285|NCT01780922|12486957|P5|COMPLETED|First Intervention (1 Day)||2
5075286|NCT01780922|12486958|P4|COMPLETED|First Intervention (1 Day)||2
5075287|NCT01780922|12486959|P3|COMPLETED|First Intervention (1 Day)||2
5075288|NCT01780922|12486960|P2|COMPLETED|First Intervention (1 Day)||2
5075289|NCT01780922|12486961|P1|COMPLETED|First Intervention (1 Day)||2
5075290|NCT01780922|12486956|P6|STARTED|First Intervention (1 Day)||2
5075291|NCT01780922|12486957|P5|STARTED|First Intervention (1 Day)||2
5075292|NCT01780922|12486958|P4|STARTED|First Intervention (1 Day)||2
5075293|NCT01780922|12486959|P3|STARTED|First Intervention (1 Day)||2
5075294|NCT01780922|12486960|P2|STARTED|First Intervention (1 Day)||2
5075295|NCT01780922|12486961|P1|STARTED|First Intervention (1 Day)||2
5075296|NCT01780870|12487016|P2|NOT COMPLETED|Overall Study||0
5075297|NCT01780870|12487017|P1|NOT COMPLETED|Overall Study||0
5075298|NCT01780870|12487016|P2|COMPLETED|Overall Study||5
5075299|NCT01780870|12487017|P1|COMPLETED|Overall Study||0
5075300|NCT01780870|12487016|P2|STARTED|Overall Study||5
5075301|NCT01780870|12487017|P1|STARTED|Overall Study||0
5075302|NCT01780831|12487031|P4|NOT COMPLETED|Overall Study||1
5075303|NCT01780831|12487032|P3|NOT COMPLETED|Overall Study||4
5075304|NCT01780831|12487033|P2|NOT COMPLETED|Overall Study||0
5075305|NCT01780831|12487034|P1|NOT COMPLETED|Overall Study||0
5075306|NCT01780831|12487031|P4|COMPLETED|Overall Study||9
5075307|NCT01780831|12487032|P3|COMPLETED|Overall Study||22
5075308|NCT01780831|12487033|P2|COMPLETED|Overall Study||6
5075309|NCT01780831|12487034|P1|COMPLETED|Overall Study||10
5075310|NCT01780831|12487031|P4|STARTED|Overall Study||10
5075311|NCT01780831|12487032|P3|STARTED|Overall Study||26
5075312|NCT01780831|12487033|P2|STARTED|Overall Study||6
5075313|NCT01780831|12487034|P1|STARTED|Overall Study||10
5075314|NCT01780662|12487102|P3|NOT COMPLETED|Overall Study||10
5075315|NCT01780662|12487103|P2|NOT COMPLETED|Overall Study||6
5075316|NCT01780662|12487104|P1|NOT COMPLETED|Overall Study||1
5075317|NCT01780662|12487102|P3|COMPLETED|Overall Study||20
5075318|NCT01780662|12487103|P2|COMPLETED|Overall Study||7
5075319|NCT01780662|12487104|P1|COMPLETED|Overall Study||2
5075320|NCT01780662|12487102|P3|STARTED|Overall Study||30
5075321|NCT01780662|12487103|P2|STARTED|Overall Study||13
5075322|NCT01780662|12487104|P1|STARTED|Overall Study||3
5075323|NCT01780584|12487121|P3|NOT COMPLETED|Overall Study||2
5075324|NCT01780584|12487122|P2|NOT COMPLETED|Overall Study||1
5075325|NCT01780584|12487123|P1|NOT COMPLETED|Overall Study||1
5075326|NCT01780584|12487121|P3|COMPLETED|Overall Study||13
5075327|NCT01780584|12487122|P2|COMPLETED|Overall Study||14
5075328|NCT01780584|12487123|P1|COMPLETED|Overall Study||14
5075329|NCT01780584|12487121|P3|STARTED|Overall Study||15
5075330|NCT01780584|12487122|P2|STARTED|Overall Study||15
5075331|NCT01780584|12487123|P1|STARTED|Overall Study||15
5075332|NCT01780545|12487145|P2|NOT COMPLETED|Overall Study||2
5075333|NCT01780545|12487146|P1|NOT COMPLETED|Overall Study||4
5075334|NCT01780545|12487145|P2|COMPLETED|Overall Study||99
5075335|NCT01780545|12487146|P1|COMPLETED|Overall Study||95
5075336|NCT01780545|12487145|P2|STARTED|Overall Study||101
5075337|NCT01780545|12487146|P1|STARTED|Overall Study||99
5075338|NCT01780506|12487164|P2|NOT COMPLETED|Open-Label Extension Phase||1
5075339|NCT01780506|12487165|P1|NOT COMPLETED|Open-Label Extension Phase||0
5075340|NCT01780506|12487164|P2|COMPLETED|Open-Label Extension Phase||94
5075341|NCT01780506|12487165|P1|COMPLETED|Open-Label Extension Phase||90
5075342|NCT01780506|12487164|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
5075343|NCT01780506|12487165|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
5075344|NCT01780506|12487164|P2|NOT COMPLETED|Double-Blind Phase||78
5075345|NCT01780506|12487165|P1|NOT COMPLETED|Double-Blind Phase||70
5075346|NCT01780506|12487164|P2|COMPLETED|Double-Blind Phase||356
5075347|NCT01780506|12487165|P1|COMPLETED|Double-Blind Phase||368
5075348|NCT01780506|12487164|P2|STARTED|Double-Blind Phase||434
5075349|NCT01780506|12487165|P1|STARTED|Double-Blind Phase||438
5075350|NCT01780389|12487219|P1|NOT COMPLETED|Overall Study||1
5075351|NCT01780389|12487219|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
5075352|NCT01780389|12487219|P1|STARTED|Overall Study||5
5075353|NCT01780350|12487230|P1|NOT COMPLETED|Overall Study||0
5075354|NCT01780350|12487230|P1|COMPLETED|Overall Study||200
5075355|NCT01780350|12487230|P1|STARTED|Overall Study||200
5075356|NCT01780337|12487237|P2|NOT COMPLETED|Overall Study||0
5075357|NCT01780337|12487238|P1|NOT COMPLETED|Overall Study||0
5075358|NCT01780337|12487237|P2|COMPLETED|Overall Study||6
5075359|NCT01780337|12487238|P1|COMPLETED|Overall Study||6
5075360|NCT01780337|12487237|P2|STARTED|Overall Study||6
5075361|NCT01780337|12487238|P1|STARTED|Overall Study||6
5075362|NCT01780324|12487250|P2|NOT COMPLETED|Overall Study||6
5075363|NCT01780324|12487251|P1|NOT COMPLETED|Overall Study||1
5075364|NCT01780324|12487250|P2|COMPLETED|Overall Study||33
5075365|NCT01780324|12487251|P1|COMPLETED|Overall Study||40
5075366|NCT01780324|12487250|P2|STARTED|Overall Study||39
5075367|NCT01780324|12487251|P1|STARTED|Overall Study||41
5075368|NCT01779869|12487257|P1|NOT COMPLETED|Overall Study||2
5075369|NCT01779869|12487257|P1|COMPLETED|Overall Study||14
5075370|NCT01779869|12487257|P1|STARTED|Overall Study||16
5075371|NCT01779700|12487263|P2|NOT COMPLETED|Overall Study||5
5075372|NCT01779700|12487264|P1|NOT COMPLETED|Overall Study||4
5075373|NCT01779700|12487263|P2|COMPLETED|Overall Study||17
5075374|NCT01779700|12487264|P1|COMPLETED|Overall Study||14
5075375|NCT01779700|12487263|P2|STARTED|Overall Study||22
5075376|NCT01779700|12487264|P1|STARTED|Overall Study||18
5075377|NCT01779648|12487304|P2|NOT COMPLETED|Overall Study||0
5075378|NCT01779648|12487305|P1|NOT COMPLETED|Overall Study||1
5075379|NCT01779648|12487304|P2|COMPLETED|Overall Study||27
5075380|NCT01779648|12487305|P1|COMPLETED|Overall Study||27
5075381|NCT01779648|12487304|P2|STARTED|Overall Study||27
5075382|NCT01779648|12487305|P1|STARTED|Overall Study||28
5075383|NCT01779440|12487335|P2|NOT COMPLETED|Overall Study||5
5075384|NCT01779440|12487336|P1|NOT COMPLETED|Overall Study||3
5075385|NCT01779440|12487335|P2|COMPLETED|Overall Study||23
5075386|NCT01779440|12487336|P1|COMPLETED|Overall Study||27
5075387|NCT01779440|12487335|P2|STARTED|Overall Study||28
5075388|NCT01779440|12487336|P1|STARTED|Overall Study||30
5075389|NCT01779375|12487346|P2|NOT COMPLETED|Overall Study||3
5075390|NCT01779375|12487347|P1|NOT COMPLETED|Overall Study||2
5075391|NCT01779375|12487346|P2|COMPLETED|Overall Study||41
5075392|NCT01779375|12487347|P1|COMPLETED|Overall Study||45
5075393|NCT01779375|12487346|P2|STARTED|Overall Study||44
5075394|NCT01779375|12487347|P1|STARTED|Overall Study||47
5075395|NCT01779219|12487363|P2|NOT COMPLETED|Overall Study||0
5075396|NCT01779219|12487364|P1|NOT COMPLETED|Overall Study||0
5075397|NCT01779219|12487363|P2|COMPLETED|Overall Study|First interim analysis|21
5075398|NCT01779219|12487364|P1|COMPLETED|Overall Study|First interim analysis|21
5075399|NCT01779219|12487363|P2|STARTED|Overall Study|First interim analysis|21
5075400|NCT01779219|12487364|P1|STARTED|Overall Study|First interim analysis|21
5075401|NCT01779167|12487376|P1|NOT COMPLETED|Overall Study||1
5075402|NCT01779167|12487376|P1|COMPLETED|Overall Study||3
5075403|NCT01779167|12487376|P1|STARTED|Overall Study||4
5075404|NCT01779141|12487385|P1|NOT COMPLETED|Overall Study||181
5075405|NCT01779141|12487385|P1|COMPLETED|Overall Study||300
5075406|NCT01779141|12487385|P1|STARTED|Overall Study||481
5075407|NCT01779024|12487392|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
5075408|NCT01779024|12487393|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
5075409|NCT01779024|12487392|P2|COMPLETED|2nd Visit - Functional MRI||6
5075410|NCT01779024|12487393|P1|COMPLETED|2nd Visit - Functional MRI||5
5075411|NCT01779024|12487392|P2|STARTED|2nd Visit - Functional MRI||6
5075412|NCT01779024|12487393|P1|STARTED|2nd Visit - Functional MRI||5
5075413|NCT01779024|12487392|P2|NOT COMPLETED|1st Visit - Functional MRI||2
5075414|NCT01779024|12487393|P1|NOT COMPLETED|1st Visit - Functional MRI||2
5075415|NCT01779024|12487392|P2|COMPLETED|1st Visit - Functional MRI||5
5075416|NCT01779024|12487393|P1|COMPLETED|1st Visit - Functional MRI||4
5075417|NCT01779024|12487392|P2|STARTED|1st Visit - Functional MRI||7
5075418|NCT01779024|12487393|P1|STARTED|1st Visit - Functional MRI||6
5075419|NCT01779024|12487392|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
5075420|NCT01779024|12487393|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
5075421|NCT01779024|12487392|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
5075422|NCT01779024|12487393|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
5075423|NCT01779024|12487392|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
5075424|NCT01779024|12487393|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
5075425|NCT01779024|12487392|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
5075426|NCT01779024|12487393|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
5075427|NCT01779024|12487392|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
5075428|NCT01779024|12487393|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
5075429|NCT01779024|12487392|P2|STARTED|1st Visit - Alcohol Self-Administration||9
5075430|NCT01779024|12487393|P1|STARTED|1st Visit - Alcohol Self-Administration||8
5075431|NCT01778985|12487401|P2|NOT COMPLETED|Overall Study||3
5075432|NCT01778985|12487402|P1|NOT COMPLETED|Overall Study||7
5075433|NCT01778985|12487401|P2|COMPLETED|Overall Study||12
5075434|NCT01778985|12487402|P1|COMPLETED|Overall Study||8
5075435|NCT01778985|12487401|P2|STARTED|Overall Study||15
5075436|NCT01778985|12487402|P1|STARTED|Overall Study||15
5075437|NCT01778855|12487448|P2|NOT COMPLETED|Overall Study||1
5075438|NCT01778855|12487449|P1|NOT COMPLETED|Overall Study||0
5075439|NCT01778855|12487448|P2|COMPLETED|Overall Study||3
5075440|NCT01778855|12487449|P1|COMPLETED|Overall Study||2
5075441|NCT01778855|12487448|P2|STARTED|Overall Study||4
5075442|NCT01778855|12487449|P1|STARTED|Overall Study||2
5075443|NCT01778751|12487457|P2|NOT COMPLETED|Overall Study||2
5075444|NCT01778751|12487458|P1|NOT COMPLETED|Overall Study||2
5075445|NCT01778751|12487457|P2|COMPLETED|Overall Study||23
5075446|NCT01778751|12487458|P1|COMPLETED|Overall Study||23
5075447|NCT01778751|12487457|P2|STARTED|Overall Study||25
5075448|NCT01778751|12487458|P1|STARTED|Overall Study||25
5075449|NCT01778634|12487472|P2|NOT COMPLETED|Overall Study||0
5075450|NCT01778634|12487473|P1|NOT COMPLETED|Overall Study||0
5075451|NCT01778634|12487472|P2|COMPLETED|Overall Study||60
5075452|NCT01778634|12487473|P1|COMPLETED|Overall Study||61
5075453|NCT01778634|12487472|P2|STARTED|Overall Study||60
5075454|NCT01778634|12487473|P1|STARTED|Overall Study||61
5075455|NCT01778556|12487511|P2|NOT COMPLETED|Long-term Follow-up||0
5075456|NCT01778556|12487512|P1|NOT COMPLETED|Long-term Follow-up||1
5075457|NCT01778556|12487511|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
5075458|NCT01778556|12487512|P1|COMPLETED|Long-term Follow-up||14
5075459|NCT01778556|12487511|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
5075460|NCT01778556|12487512|P1|STARTED|Long-term Follow-up||15
5075461|NCT01778556|12487511|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
5075462|NCT01778556|12487512|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
5075463|NCT01778556|12487511|P2|COMPLETED|Intervention 2 (14 Days)||8
5075464|NCT01778556|12487512|P1|COMPLETED|Intervention 2 (14 Days)||14
5075465|NCT01778556|12487511|P2|STARTED|Intervention 2 (14 Days)||8
5075466|NCT01778556|12487512|P1|STARTED|Intervention 2 (14 Days)||15
5075467|NCT01778556|12487511|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
5075468|NCT01778556|12487512|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
5075469|NCT01778556|12487511|P2|COMPLETED|Intervention 1 (5 Days)||8
5075470|NCT01778556|12487512|P1|COMPLETED|Intervention 1 (5 Days)||15
5075471|NCT01778556|12487511|P2|STARTED|Intervention 1 (5 Days)||10
5075472|NCT01778556|12487512|P1|STARTED|Intervention 1 (5 Days)||15
5075473|NCT01778530|12487525|P1|NOT COMPLETED|Overall Study||2
5075474|NCT01778530|12487525|P1|COMPLETED|Overall Study||0
5075475|NCT01778530|12487525|P1|STARTED|Overall Study||2
5075476|NCT01778426|12487532|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
5075477|NCT01778426|12487533|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
5075478|NCT01778426|12487532|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
5075479|NCT01778426|12487533|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
5075480|NCT01778426|12487532|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
5075481|NCT01778426|12487533|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
5075482|NCT01778426|12487532|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
5075483|NCT01778426|12487533|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
5075484|NCT01778426|12487532|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
5075485|NCT01778426|12487533|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
5075486|NCT01778426|12487532|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
5075487|NCT01778426|12487533|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
5075488|NCT01778296|12487549|P1|NOT COMPLETED|Overall Study||0
5075489|NCT01778296|12487549|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
5075490|NCT01778296|12487549|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
5075491|NCT01778127|12487556|P3|NOT COMPLETED|Overall Study||6
5075492|NCT01778127|12487557|P2|NOT COMPLETED|Overall Study||2
5075493|NCT01778127|12487558|P1|NOT COMPLETED|Overall Study||8
5075494|NCT01778127|12487556|P3|COMPLETED|Overall Study||26
5075495|NCT01778127|12487557|P2|COMPLETED|Overall Study||31
5075496|NCT01778127|12487558|P1|COMPLETED|Overall Study||25
5075497|NCT01778127|12487556|P3|STARTED|Overall Study||32
5075498|NCT01778127|12487557|P2|STARTED|Overall Study||33
5075499|NCT01778127|12487558|P1|STARTED|Overall Study||33
5075500|NCT01778062|12487601|P2|NOT COMPLETED|Overall Study||11
5075501|NCT01778062|12487602|P1|NOT COMPLETED|Overall Study||6
5075502|NCT01778062|12487601|P2|COMPLETED|Overall Study||57
5075503|NCT01778062|12487602|P1|COMPLETED|Overall Study||62
5075504|NCT01778062|12487601|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
5075505|NCT01778062|12487602|P1|Intent to Treat (ITT)|Overall Study||68
5075506|NCT01778062|12487601|P2|Safety Set|Overall Study||68
5075507|NCT01778062|12487602|P1|Safety Set|Overall Study||68
5075508|NCT01778062|12487601|P2|STARTED|Overall Study||68
5075509|NCT01778062|12487602|P1|STARTED|Overall Study||68
5075510|NCT01778049|12487616|P6|NOT COMPLETED|Double Blind Treatment Period||7
5075511|NCT01778049|12487617|P5|NOT COMPLETED|Double Blind Treatment Period||12
5075512|NCT01778049|12487618|P4|NOT COMPLETED|Double Blind Treatment Period||12
5075513|NCT01778049|12487619|P3|NOT COMPLETED|Double Blind Treatment Period||15
5075514|NCT01778049|12487620|P2|NOT COMPLETED|Double Blind Treatment Period||0
5075515|NCT01778049|12487621|P1|NOT COMPLETED|Double Blind Treatment Period||0
5075516|NCT01778049|12487616|P6|COMPLETED|Double Blind Treatment Period||105
5075517|NCT01778049|12487617|P5|COMPLETED|Double Blind Treatment Period||102
5075518|NCT01778049|12487618|P4|COMPLETED|Double Blind Treatment Period||118
5075519|NCT01778049|12487619|P3|COMPLETED|Double Blind Treatment Period||111
5075520|NCT01778049|12487620|P2|COMPLETED|Double Blind Treatment Period||0
5075521|NCT01778049|12487621|P1|COMPLETED|Double Blind Treatment Period||0
5075522|NCT01778049|12487616|P6|STARTED|Double Blind Treatment Period||112
5075523|NCT01778049|12487617|P5|STARTED|Double Blind Treatment Period||114
5075524|NCT01778049|12487618|P4|STARTED|Double Blind Treatment Period||130
5075525|NCT01778049|12487619|P3|STARTED|Double Blind Treatment Period||126
5075526|NCT01778049|12487620|P2|STARTED|Double Blind Treatment Period||0
5075527|NCT01778049|12487621|P1|STARTED|Double Blind Treatment Period||0
5075528|NCT01778049|12487616|P6|NOT COMPLETED|Open Label Treatment Period||0
5075529|NCT01778049|12487617|P5|NOT COMPLETED|Open Label Treatment Period||0
5075530|NCT01778049|12487618|P4|NOT COMPLETED|Open Label Treatment Period||0
5075531|NCT01778049|12487619|P3|NOT COMPLETED|Open Label Treatment Period||0
5075532|NCT01778049|12487620|P2|NOT COMPLETED|Open Label Treatment Period||129
5075533|NCT01778049|12487621|P1|NOT COMPLETED|Open Label Treatment Period||98
5075534|NCT01778049|12487616|P6|COMPLETED|Open Label Treatment Period||0
5075535|NCT01778049|12487617|P5|COMPLETED|Open Label Treatment Period||0
5075536|NCT01778049|12487618|P4|COMPLETED|Open Label Treatment Period||0
5075537|NCT01778049|12487619|P3|COMPLETED|Open Label Treatment Period||0
5075538|NCT01778049|12487620|P2|COMPLETED|Open Label Treatment Period||226
5075539|NCT01778049|12487621|P1|COMPLETED|Open Label Treatment Period||256
5075540|NCT01778049|12487616|P6|STARTED|Open Label Treatment Period||0
5075541|NCT01778049|12487617|P5|STARTED|Open Label Treatment Period||0
5075542|NCT01778049|12487618|P4|STARTED|Open Label Treatment Period||0
5075543|NCT01778049|12487619|P3|STARTED|Open Label Treatment Period||0
5075544|NCT01778049|12487620|P2|STARTED|Open Label Treatment Period||355
5075545|NCT01778049|12487621|P1|STARTED|Open Label Treatment Period||354
5075546|NCT01778023|12487639|P2|NOT COMPLETED|Overall Study||3
5075547|NCT01778023|12487640|P1|NOT COMPLETED|Overall Study||0
5075548|NCT01778023|12487639|P2|COMPLETED|Overall Study||15
5075549|NCT01778023|12487640|P1|COMPLETED|Overall Study||36
5075550|NCT01778023|12487639|P2|Exposed|Overall Study||15
5075551|NCT01778023|12487640|P1|Exposed|Overall Study||36
5075552|NCT01778023|12487639|P2|STARTED|Overall Study||18
5075553|NCT01778023|12487640|P1|STARTED|Overall Study||36
5075554|NCT01778010|12487657|P1|NOT COMPLETED|Overall Study||5
5075555|NCT01778010|12487657|P1|COMPLETED|Overall Study||8
5075556|NCT01778010|12487657|P1|STARTED|Overall Study||13
5075557|NCT01777997|12487698|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
5075558|NCT01777997|12487698|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
5075559|NCT01777997|12487698|P1|STARTED|Weeks 48 to 72/96 on ART||28
5075560|NCT01777997|12487698|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
5075561|NCT01777997|12487698|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
5075562|NCT01777997|12487698|P1|STARTED|Weeks 0 to 24/48 on ART||36
5075563|NCT01777997|12487698|P1|NOT COMPLETED|12 Week lead-in of no ART||2
5075564|NCT01777997|12487698|P1|COMPLETED|12 Week lead-in of no ART||36
5075565|NCT01777997|12487698|P1|STARTED|12 Week lead-in of no ART||38
5075566|NCT01777945|12487710|P1|NOT COMPLETED|Overall Study||0
5075567|NCT01777945|12487710|P1|COMPLETED|Overall Study||46
5075568|NCT01777945|12487710|P1|Evaluable Participants|Overall Study||45
5075569|NCT01777945|12487710|P1|STARTED|Overall Study||46
5075570|NCT01777932|12487720|P1|NOT COMPLETED|Overall Study||205
5075571|NCT01777932|12487720|P1|COMPLETED|Overall Study||15
5075572|NCT01777932|12487720|P1|STARTED|Overall Study||220
5075573|NCT01777854|12487734|P2|NOT COMPLETED|Overall Study||3
5075574|NCT01777854|12487735|P1|NOT COMPLETED|Overall Study||3
5075575|NCT01777854|12487734|P2|COMPLETED|Overall Study||0
5075576|NCT01777854|12487735|P1|COMPLETED|Overall Study||0
5075577|NCT01777854|12487734|P2|STARTED|Overall Study||3
5075578|NCT01777854|12487735|P1|STARTED|Overall Study||3
5075579|NCT01777776|12487743|P4|NOT COMPLETED|Overall Study||4
5075580|NCT01777776|12487744|P3|NOT COMPLETED|Overall Study||6
5075581|NCT01777776|12487745|P2|NOT COMPLETED|Overall Study||12
5075582|NCT01777776|12487746|P1|NOT COMPLETED|Overall Study||6
5075583|NCT01777776|12487743|P4|COMPLETED|Overall Study||0
5075584|NCT01777776|12487744|P3|COMPLETED|Overall Study||0
5075585|NCT01777776|12487745|P2|COMPLETED|Overall Study||0
5075586|NCT01777776|12487746|P1|COMPLETED|Overall Study||0
5075587|NCT01777776|12487743|P4|STARTED|Overall Study||4
5075588|NCT01777776|12487744|P3|STARTED|Overall Study||6
5075589|NCT01777776|12487745|P2|STARTED|Overall Study||12
5075590|NCT01777776|12487746|P1|STARTED|Overall Study||6
5075591|NCT01777763|12487805|P2|NOT COMPLETED|Overall Study||47
5075592|NCT01777763|12487806|P1|NOT COMPLETED|Overall Study||4
5075593|NCT01777763|12487805|P2|COMPLETED|Overall Study||163
5075594|NCT01777763|12487806|P1|COMPLETED|Overall Study||16
5075595|NCT01777763|12487805|P2|STARTED|Overall Study||210
5075596|NCT01777763|12487806|P1|STARTED|Overall Study||20
5075597|NCT01777620|12487830|P2|NOT COMPLETED|Overall Study||0
5075598|NCT01777620|12487831|P1|NOT COMPLETED|Overall Study||1
5075599|NCT01777620|12487830|P2|COMPLETED|Overall Study||62
5075600|NCT01777620|12487831|P1|COMPLETED|Overall Study||62
5075601|NCT01777620|12487830|P2|STARTED|Overall Study||62
5075602|NCT01777620|12487831|P1|STARTED|Overall Study||63
5075603|NCT01777581|12487857|P2|NOT COMPLETED|Overall Study||2
5075604|NCT01777581|12487858|P1|NOT COMPLETED|Overall Study||3
5075605|NCT01777581|12487857|P2|COMPLETED|Overall Study||3
5075606|NCT01777581|12487858|P1|COMPLETED|Overall Study||5
5075607|NCT01777581|12487857|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
5075608|NCT01777581|12487858|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
5075609|NCT01777568|12487878|P2|NOT COMPLETED|Overall Study||0
5075610|NCT01777568|12487879|P1|NOT COMPLETED|Overall Study||0
5075611|NCT01777568|12487878|P2|COMPLETED|Overall Study||2896
5075612|NCT01777568|12487879|P1|COMPLETED|Overall Study||2853
5075613|NCT01777568|12487878|P2|STARTED|Overall Study||2896
5075614|NCT01777568|12487879|P1|STARTED|Overall Study||2853
5075615|NCT01777542|12487887|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
5075616|NCT01777542|12487888|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
5075617|NCT01777542|12487887|P2|COMPLETED|Second Intervention (20 Weeks)||14
5075618|NCT01777542|12487888|P1|COMPLETED|Second Intervention (20 Weeks)||15
5075619|NCT01777542|12487887|P2|STARTED|Second Intervention (20 Weeks)||15
5075620|NCT01777542|12487888|P1|STARTED|Second Intervention (20 Weeks)||15
5075621|NCT01777542|12487887|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
5075622|NCT01777542|12487888|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
5075623|NCT01777542|12487887|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
5075624|NCT01777542|12487888|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
5075625|NCT01777542|12487887|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
5075626|NCT01777542|12487888|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
5075627|NCT01777542|12487887|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
5075628|NCT01777542|12487888|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
5075629|NCT01777542|12487887|P2|COMPLETED|First Intervention (20 Weeks)||15
5075630|NCT01777542|12487888|P1|COMPLETED|First Intervention (20 Weeks)||15
5075631|NCT01777542|12487887|P2|STARTED|First Intervention (20 Weeks)||15
5075632|NCT01777542|12487888|P1|STARTED|First Intervention (20 Weeks)||15
5075633|NCT01777490|12487931|P4|NOT COMPLETED|Overall Study||1
5075634|NCT01777490|12487932|P3|NOT COMPLETED|Overall Study||1
5075635|NCT01777490|12487933|P2|NOT COMPLETED|Overall Study||0
5075636|NCT01777490|12487934|P1|NOT COMPLETED|Overall Study||0
5075637|NCT01777490|12487931|P4|COMPLETED|Overall Study||118
5075638|NCT01777490|12487932|P3|COMPLETED|Overall Study||118
5075639|NCT01777490|12487933|P2|COMPLETED|Overall Study||123
5075640|NCT01777490|12487934|P1|COMPLETED|Overall Study||123
5075641|NCT01777490|12487931|P4|STARTED|Overall Study||119
5075642|NCT01777490|12487932|P3|STARTED|Overall Study||119
5075643|NCT01777490|12487933|P2|STARTED|Overall Study||123
5075644|NCT01777490|12487934|P1|STARTED|Overall Study||123
5075645|NCT01777438|12487952|P2|NOT COMPLETED|Overall Study||0
5075646|NCT01777438|12487953|P1|NOT COMPLETED|Overall Study||0
5075647|NCT01777438|12487952|P2|COMPLETED|Overall Study||82
5075648|NCT01777438|12487953|P1|COMPLETED|Overall Study||352
5075649|NCT01777438|12487952|P2|STARTED|Overall Study||82
5075650|NCT01777438|12487953|P1|STARTED|Overall Study||352
5075651|NCT01777425|12487965|P1|NOT COMPLETED|Overall Study||0
5075652|NCT01777425|12487965|P1|COMPLETED|Overall Study||389
5075653|NCT01777425|12487965|P1|STARTED|Overall Study||389
5075654|NCT01777412|12487971|P1|NOT COMPLETED|Overall Study||0
5075655|NCT01777412|12487971|P1|COMPLETED|Overall Study||10
5075656|NCT01777412|12487971|P1|STARTED|Overall Study||10
5075657|NCT01777334|12487979|P2|NOT COMPLETED|Overall Study||63
5075658|NCT01777334|12487980|P1|NOT COMPLETED|Overall Study||53
5075659|NCT01777334|12487979|P2|COMPLETED|Overall Study||388
5075660|NCT01777334|12487980|P1|COMPLETED|Overall Study||401
5075661|NCT01777334|12487979|P2|STARTED|Overall Study||451
5075662|NCT01777334|12487980|P1|STARTED|Overall Study||454
5075663|NCT01777321|12487990|P2|NOT COMPLETED|Overall Study||1
5075664|NCT01777321|12487991|P1|NOT COMPLETED|Overall Study||0
5075665|NCT01777321|12487990|P2|COMPLETED|Overall Study||29
5075666|NCT01777321|12487991|P1|COMPLETED|Overall Study||30
5075667|NCT01777321|12487990|P2|STARTED|Overall Study||30
5075668|NCT01777321|12487991|P1|STARTED|Overall Study||30
5075669|NCT01777308|12488029|P2|NOT COMPLETED|Overall Study||3
5075670|NCT01777308|12488030|P1|NOT COMPLETED|Overall Study||14
5075671|NCT01777308|12488029|P2|COMPLETED|Overall Study||34
5075672|NCT01777308|12488030|P1|COMPLETED|Overall Study||105
5075673|NCT01777308|12488029|P2|Completed up to Month 73|Overall Study||37
5075674|NCT01777308|12488030|P1|Completed up to Month 73|Overall Study||118
5075675|NCT01777308|12488029|P2|STARTED|Overall Study||37
5075676|NCT01777308|12488030|P1|STARTED|Overall Study||119
5075677|NCT01777295|12488062|P2|NOT COMPLETED|Overall Study||3
5075678|NCT01777295|12488063|P1|NOT COMPLETED|Overall Study||4
5075679|NCT01777295|12488062|P2|COMPLETED|Overall Study||38
5075680|NCT01777295|12488063|P1|COMPLETED|Overall Study||36
5075681|NCT01777295|12488062|P2|STARTED|Overall Study||41
5075682|NCT01777295|12488063|P1|STARTED|Overall Study||40
5075683|NCT01777282|12488270|P5|NOT COMPLETED|Overall Study||7
5075684|NCT01777282|12488271|P4|NOT COMPLETED|Overall Study||2
5075685|NCT01777282|12488272|P3|NOT COMPLETED|Overall Study||6
5075686|NCT01777282|12488273|P2|NOT COMPLETED|Overall Study||4
5075687|NCT01777282|12488274|P1|NOT COMPLETED|Overall Study||11
5075688|NCT01777282|12488270|P5|COMPLETED|Overall Study||54
5075689|NCT01777282|12488271|P4|COMPLETED|Overall Study||59
5075690|NCT01777282|12488272|P3|COMPLETED|Overall Study||59
5075691|NCT01777282|12488273|P2|COMPLETED|Overall Study||63
5075692|NCT01777282|12488274|P1|COMPLETED|Overall Study||109
5075693|NCT01777282|12488270|P5|Completing Follow-up Period|Overall Study||54
5075694|NCT01777282|12488271|P4|Completing Follow-up Period|Overall Study||59
5075695|NCT01777282|12488272|P3|Completing Follow-up Period|Overall Study||59
5075696|NCT01777282|12488273|P2|Completing Follow-up Period|Overall Study||63
5075697|NCT01777282|12488274|P1|Completing Follow-up Period|Overall Study||109
5075698|NCT01777282|12488270|P5|Completing Treatment Period|Overall Study||54
5075699|NCT01777282|12488271|P4|Completing Treatment Period|Overall Study||59
5075700|NCT01777282|12488272|P3|Completing Treatment Period|Overall Study||59
5075701|NCT01777282|12488273|P2|Completing Treatment Period|Overall Study||63
5075702|NCT01777282|12488274|P1|Completing Treatment Period|Overall Study||109
5075703|NCT01777282|12488270|P5|STARTED|Overall Study||61
5075704|NCT01777282|12488271|P4|STARTED|Overall Study||61
5075705|NCT01777282|12488272|P3|STARTED|Overall Study||65
5075706|NCT01777282|12488273|P2|STARTED|Overall Study||67
5075707|NCT01777282|12488274|P1|STARTED|Overall Study||120
5075708|NCT01777269|12488318|P2|NOT COMPLETED|Overall Study||59
5075709|NCT01777269|12488319|P1|NOT COMPLETED|Overall Study||55
5075710|NCT01777269|12488318|P2|COMPLETED|Overall Study||184
5075711|NCT01777269|12488319|P1|COMPLETED|Overall Study||191
5075712|NCT01777269|12488318|P2|STARTED|Overall Study||243
5075713|NCT01777269|12488319|P1|STARTED|Overall Study||246
5075714|NCT01777217|12488347|P2|NOT COMPLETED|Overall Study||0
5075715|NCT01777217|12488348|P1|NOT COMPLETED|Overall Study||0
5075716|NCT01777217|12488347|P2|COMPLETED|Overall Study||4
5075717|NCT01777217|12488348|P1|COMPLETED|Overall Study||4
5075718|NCT01777217|12488347|P2|STARTED|Overall Study||4
5075719|NCT01777217|12488348|P1|STARTED|Overall Study||4
5075720|NCT01777191|12488356|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
5075721|NCT01777191|12488357|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
5075722|NCT01777191|12488356|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
5075723|NCT01777191|12488357|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
5075724|NCT01777191|12488356|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
5075725|NCT01777191|12488357|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
5075726|NCT01777191|12488356|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
5075727|NCT01777191|12488357|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
5075728|NCT01777191|12488356|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
5075729|NCT01777191|12488357|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
5075730|NCT01777191|12488356|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
5075731|NCT01777191|12488357|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
5075732|NCT01777152|12488387|P2|NOT COMPLETED|Overall Study||226
5075733|NCT01777152|12488388|P1|NOT COMPLETED|Overall Study||226
5075734|NCT01777152|12488387|P2|COMPLETED|Overall Study||0
5075735|NCT01777152|12488388|P1|COMPLETED|Overall Study||0
5075736|NCT01777152|12488387|P2|STARTED|Overall Study||226
5075737|NCT01777152|12488388|P1|STARTED|Overall Study||226
5075738|NCT01777139|12488404|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
5075739|NCT01777139|12488405|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
5075740|NCT01777139|12488404|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
5075741|NCT01777139|12488405|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
5075742|NCT01777139|12488404|P2|STARTED|SFUCP (Up to 1.4 Years)||4
5075743|NCT01777139|12488405|P1|STARTED|SFUCP (Up to 1.4 Years)||0
5075744|NCT01777139|12488404|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
5075745|NCT01777139|12488405|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
5075746|NCT01777139|12488404|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
5075747|NCT01777139|12488405|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
5075748|NCT01777139|12488404|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
5075749|NCT01777139|12488405|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
5075750|NCT01777126|12488446|P2|NOT COMPLETED|Overall Study||0
5075751|NCT01777126|12488447|P1|NOT COMPLETED|Overall Study||0
5075752|NCT01777126|12488446|P2|COMPLETED|Overall Study||46
5075753|NCT01777126|12488447|P1|COMPLETED|Overall Study||48
5075754|NCT01777126|12488446|P2|STARTED|Overall Study||46
5075755|NCT01777126|12488447|P1|STARTED|Overall Study||48
5075756|NCT01776723|12488473|P5|NOT COMPLETED|Overall Study||0
5075757|NCT01776723|12488474|P4|NOT COMPLETED|Overall Study||0
5075758|NCT01776723|12488475|P3|NOT COMPLETED|Overall Study||0
5075759|NCT01776723|12488476|P2|NOT COMPLETED|Overall Study||0
5075760|NCT01776723|12488477|P1|NOT COMPLETED|Overall Study||0
5075761|NCT01776723|12488473|P5|COMPLETED|Overall Study||30
5075762|NCT01776723|12488474|P4|COMPLETED|Overall Study||5
5075763|NCT01776723|12488475|P3|COMPLETED|Overall Study||5
5075764|NCT01776723|12488476|P2|COMPLETED|Overall Study||4
5075765|NCT01776723|12488477|P1|COMPLETED|Overall Study||6
5075766|NCT01776723|12488473|P5|STARTED|Overall Study||30
5075767|NCT01776723|12488474|P4|STARTED|Overall Study||5
5075768|NCT01776723|12488475|P3|STARTED|Overall Study||5
5075769|NCT01776723|12488476|P2|STARTED|Overall Study||4
5075770|NCT01776723|12488477|P1|STARTED|Overall Study||6
5075771|NCT01776645|12488495|P2|NOT COMPLETED|Overall Study||14
5075772|NCT01776645|12488496|P1|NOT COMPLETED|Overall Study||14
5075773|NCT01776645|12488495|P2|COMPLETED|Overall Study||14
5075774|NCT01776645|12488496|P1|COMPLETED|Overall Study||14
5075775|NCT01776645|12488495|P2|STARTED|Overall Study||28
5075776|NCT01776645|12488496|P1|STARTED|Overall Study||28
5075777|NCT01776632|12488504|P2|NOT COMPLETED|Overall Study||29
5075778|NCT01776632|12488505|P1|NOT COMPLETED|Overall Study||27
5075779|NCT01776632|12488504|P2|COMPLETED|Overall Study||190
5075780|NCT01776632|12488505|P1|COMPLETED|Overall Study||190
5075781|NCT01776632|12488504|P2|STARTED|Overall Study||219
5075782|NCT01776632|12488505|P1|STARTED|Overall Study||217
5075783|NCT01776554|12488519|P2|NOT COMPLETED|Overall Study||23
5075784|NCT01776554|12488520|P1|NOT COMPLETED|Overall Study||17
5075785|NCT01776554|12488519|P2|COMPLETED|Overall Study||307
5075786|NCT01776554|12488520|P1|COMPLETED|Overall Study||315
5075787|NCT01776554|12488519|P2|STARTED|Overall Study||330
5075788|NCT01776554|12488520|P1|STARTED|Overall Study||332
5075789|NCT01776541|12488563|P2|NOT COMPLETED|Overall Study||75
5075790|NCT01776541|12488564|P1|NOT COMPLETED|Overall Study||56
5075791|NCT01776541|12488563|P2|COMPLETED|Overall Study||416
5075792|NCT01776541|12488564|P1|COMPLETED|Overall Study||432
5075793|NCT01776541|12488563|P2|STARTED|Overall Study||491
5075794|NCT01776541|12488564|P1|STARTED|Overall Study||488
5075795|NCT01776424|12488586|P3|NOT COMPLETED|Overall Study||24
5075796|NCT01776424|12488587|P2|NOT COMPLETED|Overall Study||19
5075797|NCT01776424|12488588|P1|NOT COMPLETED|Overall Study||20
5075798|NCT01776424|12488586|P3|COMPLETED|Overall Study||9102
5075799|NCT01776424|12488587|P2|COMPLETED|Overall Study||9098
5075800|NCT01776424|12488588|P1|COMPLETED|Overall Study||9132
5075801|NCT01776424|12488586|P3|Treated|Overall Study||9107
5075802|NCT01776424|12488587|P2|Treated|Overall Study||9110
5075803|NCT01776424|12488588|P1|Treated|Overall Study||9134
5075804|NCT01776424|12488586|P3|STARTED|Overall Study||9126
5075805|NCT01776424|12488587|P2|STARTED|Overall Study||9117
5075806|NCT01776424|12488588|P1|STARTED|Overall Study||9152
5075807|NCT01776268|12488610|P2|NOT COMPLETED|Overall Study||0
5075808|NCT01776268|12488611|P1|NOT COMPLETED|Overall Study||0
5075809|NCT01776268|12488610|P2|COMPLETED|Overall Study||51
5075810|NCT01776268|12488611|P1|COMPLETED|Overall Study||48
5075811|NCT01776268|12488610|P2|STARTED|Overall Study||51
5075812|NCT01776268|12488611|P1|STARTED|Overall Study||48
5075813|NCT01776008|12488619|P1|NOT COMPLETED|Overall Study||2
5075814|NCT01776008|12488619|P1|COMPLETED|Overall Study||14
5075815|NCT01776008|12488619|P1|STARTED|Overall Study||16
5075816|NCT01775995|12488633|P2|NOT COMPLETED|Overall Study||1
5075817|NCT01775995|12488634|P1|NOT COMPLETED|Overall Study||1
5075818|NCT01775995|12488633|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
5075819|NCT01775995|12488634|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
5075820|NCT01775995|12488633|P2|STARTED|Overall Study||14
5075821|NCT01775995|12488634|P1|STARTED|Overall Study||21
5075822|NCT01775930|12488694|P1|NOT COMPLETED|Overall Study||1
5075823|NCT01775930|12488694|P1|COMPLETED|Overall Study||9
5075824|NCT01775930|12488694|P1|STARTED|Overall Study||10
5075825|NCT01775904|12488702|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
5075826|NCT01775904|12488702|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
5075827|NCT01775904|12488702|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
5075828|NCT01775904|12488702|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
5075829|NCT01775904|12488702|P1|NOT COMPLETED|Third Washout (7 Days)||0
5075830|NCT01775904|12488702|P1|COMPLETED|Third Washout (7 Days)||25
5075831|NCT01775904|12488702|P1|STARTED|Third Washout (7 Days)||25
5075832|NCT01775904|12488702|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
5075833|NCT01775904|12488702|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
5075834|NCT01775904|12488702|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
5075835|NCT01775904|12488702|P1|STARTED|LY2886721 ODT (Water, Fed)||25
5075836|NCT01775904|12488702|P1|NOT COMPLETED|Second Washout (7 Days)||0
5075837|NCT01775904|12488702|P1|COMPLETED|Second Washout (7 Days)||25
5075838|NCT01775904|12488702|P1|STARTED|Second Washout (7 Days)||25
5075839|NCT01775904|12488702|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
5075840|NCT01775904|12488702|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
5075841|NCT01775904|12488702|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
5075842|NCT01775904|12488702|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
5075843|NCT01775904|12488702|P1|NOT COMPLETED|First Washout (7 Days)||0
5075844|NCT01775904|12488702|P1|COMPLETED|First Washout (7 Days)||26
5075845|NCT01775904|12488702|P1|STARTED|First Washout (7 Days)||26
5075846|NCT01775904|12488702|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
5075847|NCT01775904|12488702|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
5075848|NCT01775904|12488702|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
5075849|NCT01775904|12488702|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
5075850|NCT01775865|12488727|P3|NOT COMPLETED|Overall Study||0
5075851|NCT01775865|12488728|P2|NOT COMPLETED|Overall Study||1
5075852|NCT01775865|12488729|P1|NOT COMPLETED|Overall Study||3
5075853|NCT01775865|12488727|P3|COMPLETED|Overall Study||17
5075854|NCT01775865|12488728|P2|COMPLETED|Overall Study||13
5075855|NCT01775865|12488729|P1|COMPLETED|Overall Study||11
5075856|NCT01775865|12488727|P3|STARTED|Overall Study||17
5075857|NCT01775865|12488728|P2|STARTED|Overall Study||14
5075858|NCT01775865|12488729|P1|STARTED|Overall Study||14
5075859|NCT01775852|12488745|P2|NOT COMPLETED|Overall Study||1
5075860|NCT01775852|12488746|P1|NOT COMPLETED|Overall Study||0
5075861|NCT01775852|12488745|P2|COMPLETED|Overall Study||13
5075862|NCT01775852|12488746|P1|COMPLETED|Overall Study||31
5075863|NCT01775852|12488745|P2|STARTED|Overall Study||14
5075864|NCT01775852|12488746|P1|STARTED|Overall Study||31
5075865|NCT01775800|12488760|P2|NOT COMPLETED|Overall Study||0
5075866|NCT01775800|12488761|P1|NOT COMPLETED|Overall Study||0
5075867|NCT01775800|12488760|P2|COMPLETED|Overall Study||8
5075868|NCT01775800|12488761|P1|COMPLETED|Overall Study||8
5075869|NCT01775800|12488760|P2|STARTED|Overall Study||8
5075870|NCT01775800|12488761|P1|STARTED|Overall Study||8
5075871|NCT01775787|12488768|P2|NOT COMPLETED|Second 7-10 Days||2
5075872|NCT01775787|12488769|P1|NOT COMPLETED|Second 7-10 Days||0
5075873|NCT01775787|12488768|P2|COMPLETED|Second 7-10 Days||6
5075874|NCT01775787|12488769|P1|COMPLETED|Second 7-10 Days||12
5075875|NCT01775787|12488768|P2|STARTED|Second 7-10 Days||8
5075876|NCT01775787|12488769|P1|STARTED|Second 7-10 Days||12
5075877|NCT01775787|12488768|P2|NOT COMPLETED|First 7-10 Days||6
5075878|NCT01775787|12488769|P1|NOT COMPLETED|First 7-10 Days||1
5075879|NCT01775787|12488768|P2|COMPLETED|First 7-10 Days||8
5075880|NCT01775787|12488769|P1|COMPLETED|First 7-10 Days||12
5075881|NCT01775787|12488768|P2|STARTED|First 7-10 Days||14
5075882|NCT01775787|12488769|P1|STARTED|First 7-10 Days||13
5075883|NCT01775774|12488780|P3|NOT COMPLETED|Overall Study||0
5075884|NCT01775774|12488781|P2|NOT COMPLETED|Overall Study||0
5075885|NCT01775774|12488782|P1|NOT COMPLETED|Overall Study||0
5075886|NCT01775774|12488780|P3|COMPLETED|Overall Study||3
5075887|NCT01775774|12488781|P2|COMPLETED|Overall Study||3
5075888|NCT01775774|12488782|P1|COMPLETED|Overall Study||3
5075889|NCT01775774|12488780|P3|STARTED|Overall Study||3
5075890|NCT01775774|12488781|P2|STARTED|Overall Study||3
5075891|NCT01775774|12488782|P1|STARTED|Overall Study||3
5075892|NCT01775735|12488810|P2|NOT COMPLETED|Open Label (24 Months)||4
5075893|NCT01775735|12488811|P1|NOT COMPLETED|Open Label (24 Months)||1
5075894|NCT01775735|12488810|P2|COMPLETED|Open Label (24 Months)||3
5075895|NCT01775735|12488811|P1|COMPLETED|Open Label (24 Months)||7
5075896|NCT01775735|12488810|P2|STARTED|Open Label (24 Months)||7
5075897|NCT01775735|12488811|P1|STARTED|Open Label (24 Months)||8
5075898|NCT01775735|12488810|P2|NOT COMPLETED|Intervention (6 Months)||0
5075899|NCT01775735|12488811|P1|NOT COMPLETED|Intervention (6 Months)||0
5075900|NCT01775735|12488810|P2|COMPLETED|Intervention (6 Months)||7
5075901|NCT01775735|12488811|P1|COMPLETED|Intervention (6 Months)||8
5075902|NCT01775735|12488810|P2|STARTED|Intervention (6 Months)||7
5075903|NCT01775735|12488811|P1|STARTED|Intervention (6 Months)||8
5075904|NCT01775722|12488817|P1|NOT COMPLETED|Overall Study||2
5075905|NCT01775722|12488817|P1|COMPLETED|Overall Study||20
5075906|NCT01775722|12488817|P1|STARTED|Overall Study||22
5075907|NCT01775670|12488825|P2|NOT COMPLETED|Overall Study||1
5075908|NCT01775670|12488826|P1|NOT COMPLETED|Overall Study||1
5075909|NCT01775670|12488825|P2|COMPLETED|Overall Study||2
5075910|NCT01775670|12488826|P1|COMPLETED|Overall Study||0
5075911|NCT01775670|12488825|P2|STARTED|Overall Study||3
5075912|NCT01775670|12488826|P1|STARTED|Overall Study||1
5075913|NCT01775553|12488852|P1|NOT COMPLETED|Overall Study||13
5075914|NCT01775553|12488852|P1|COMPLETED|Overall Study||0
5075915|NCT01775553|12488852|P1|STARTED|Overall Study||13
5075916|NCT01775501|12488860|P1|NOT COMPLETED|Overall Study||1
5075917|NCT01775501|12488860|P1|COMPLETED|Overall Study||39
5075918|NCT01775501|12488860|P1|STARTED|Overall Study||40
5075919|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075920|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075921|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075922|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075923|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075924|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075925|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5075926|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
5075927|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
5075928|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
5075929|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
5075930|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
5075931|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
5075932|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
5075933|NCT01775189|12488869|P7|STARTED|Treatment Phase: Fourth Intervention||7
5075934|NCT01775189|12488870|P6|STARTED|Treatment Phase: Fourth Intervention||7
5075935|NCT01775189|12488871|P5|STARTED|Treatment Phase: Fourth Intervention||8
5075936|NCT01775189|12488872|P4|STARTED|Treatment Phase: Fourth Intervention||6
5075937|NCT01775189|12488873|P3|STARTED|Treatment Phase: Fourth Intervention||0
5075938|NCT01775189|12488874|P2|STARTED|Treatment Phase: Fourth Intervention||0
5075939|NCT01775189|12488875|P1|STARTED|Treatment Phase: Fourth Intervention||0
5075940|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
5075941|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5075942|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5075943|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
5075944|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5075945|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5075946|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5075947|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Washout Period 3||7
5075948|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Washout Period 3||7
5075949|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Washout Period 3||8
5075950|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Washout Period 3||6
5075951|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Washout Period 3||0
5075952|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Washout Period 3||0
5075953|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Washout Period 3||0
5075954|NCT01775189|12488869|P7|STARTED|Treatment Phase: Washout Period 3||8
5075955|NCT01775189|12488870|P6|STARTED|Treatment Phase: Washout Period 3||7
5075956|NCT01775189|12488871|P5|STARTED|Treatment Phase: Washout Period 3||8
5075957|NCT01775189|12488872|P4|STARTED|Treatment Phase: Washout Period 3||7
5075958|NCT01775189|12488873|P3|STARTED|Treatment Phase: Washout Period 3||0
5075959|NCT01775189|12488874|P2|STARTED|Treatment Phase: Washout Period 3||0
5075960|NCT01775189|12488875|P1|STARTED|Treatment Phase: Washout Period 3||0
5075961|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075962|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075963|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075964|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075965|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075966|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075967|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
5075968|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Third Intervention||8
5075969|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Third Intervention||7
5075970|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Third Intervention||8
5075971|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Third Intervention||7
5075972|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Third Intervention||0
5075973|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Third Intervention||0
5075974|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Third Intervention||0
5075975|NCT01775189|12488869|P7|STARTED|Treatment Phase: Third Intervention||8
5075976|NCT01775189|12488870|P6|STARTED|Treatment Phase: Third Intervention||7
5075977|NCT01775189|12488871|P5|STARTED|Treatment Phase: Third Intervention||8
5075978|NCT01775189|12488872|P4|STARTED|Treatment Phase: Third Intervention||7
5075979|NCT01775189|12488873|P3|STARTED|Treatment Phase: Third Intervention||0
5075980|NCT01775189|12488874|P2|STARTED|Treatment Phase: Third Intervention||0
5075981|NCT01775189|12488875|P1|STARTED|Treatment Phase: Third Intervention||0
5075982|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075983|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075984|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075985|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
5075986|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075987|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075988|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5075989|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Washout Period 2||8
5075990|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Washout Period 2||7
5075991|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Washout Period 2||8
5075992|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Washout Period 2||7
5075993|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Washout Period 2||0
5075994|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Washout Period 2||0
5075995|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Washout Period 2||0
5075996|NCT01775189|12488869|P7|STARTED|Treatment Phase: Washout Period 2||8
5075997|NCT01775189|12488870|P6|STARTED|Treatment Phase: Washout Period 2||7
5075998|NCT01775189|12488871|P5|STARTED|Treatment Phase: Washout Period 2||8
5075999|NCT01775189|12488872|P4|STARTED|Treatment Phase: Washout Period 2||8
5076000|NCT01775189|12488873|P3|STARTED|Treatment Phase: Washout Period 2||0
5076001|NCT01775189|12488874|P2|STARTED|Treatment Phase: Washout Period 2||0
5076002|NCT01775189|12488875|P1|STARTED|Treatment Phase: Washout Period 2||0
5076003|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076004|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076005|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076006|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076007|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076008|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076009|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
5076010|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Second Intervention||8
5076011|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Second Intervention||7
5076012|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Second Intervention||8
5076013|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Second Intervention||8
5076014|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Second Intervention||0
5076015|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Second Intervention||0
5076016|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Second Intervention||0
5076017|NCT01775189|12488869|P7|STARTED|Treatment Phase: Second Intervention||8
5076018|NCT01775189|12488870|P6|STARTED|Treatment Phase: Second Intervention||7
5076019|NCT01775189|12488871|P5|STARTED|Treatment Phase: Second Intervention||8
5076020|NCT01775189|12488872|P4|STARTED|Treatment Phase: Second Intervention||8
5076021|NCT01775189|12488873|P3|STARTED|Treatment Phase: Second Intervention||0
5076022|NCT01775189|12488874|P2|STARTED|Treatment Phase: Second Intervention||0
5076023|NCT01775189|12488875|P1|STARTED|Treatment Phase: Second Intervention||0
5076024|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076025|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
5076026|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076027|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076028|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076029|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076030|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5076031|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: Washout Period 1||8
5076032|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: Washout Period 1||7
5076033|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: Washout Period 1||8
5076034|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: Washout Period 1||8
5076035|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: Washout Period 1||0
5076036|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: Washout Period 1||0
5076037|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: Washout Period 1||0
5076038|NCT01775189|12488869|P7|STARTED|Treatment Phase: Washout Period 1||8
5076039|NCT01775189|12488870|P6|STARTED|Treatment Phase: Washout Period 1||8
5076040|NCT01775189|12488871|P5|STARTED|Treatment Phase: Washout Period 1||8
5076041|NCT01775189|12488872|P4|STARTED|Treatment Phase: Washout Period 1||8
5076042|NCT01775189|12488873|P3|STARTED|Treatment Phase: Washout Period 1||0
5076043|NCT01775189|12488874|P2|STARTED|Treatment Phase: Washout Period 1||0
5076044|NCT01775189|12488875|P1|STARTED|Treatment Phase: Washout Period 1||0
5076045|NCT01775189|12488869|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
5076046|NCT01775189|12488870|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
5076047|NCT01775189|12488871|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
5076048|NCT01775189|12488872|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
5076049|NCT01775189|12488873|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
5076050|NCT01775189|12488874|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
5076051|NCT01775189|12488875|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
5076052|NCT01775189|12488869|P7|COMPLETED|Treatment Phase: First Intervention||8
5076053|NCT01775189|12488870|P6|COMPLETED|Treatment Phase: First Intervention||8
5076054|NCT01775189|12488871|P5|COMPLETED|Treatment Phase: First Intervention||8
5076055|NCT01775189|12488872|P4|COMPLETED|Treatment Phase: First Intervention||8
5076056|NCT01775189|12488873|P3|COMPLETED|Treatment Phase: First Intervention||0
5076057|NCT01775189|12488874|P2|COMPLETED|Treatment Phase: First Intervention||0
5076058|NCT01775189|12488875|P1|COMPLETED|Treatment Phase: First Intervention||0
5076059|NCT01775189|12488869|P7|STARTED|Treatment Phase: First Intervention||8
5076060|NCT01775189|12488870|P6|STARTED|Treatment Phase: First Intervention||8
5076061|NCT01775189|12488871|P5|STARTED|Treatment Phase: First Intervention||8
5076062|NCT01775189|12488872|P4|STARTED|Treatment Phase: First Intervention||8
5076063|NCT01775189|12488873|P3|STARTED|Treatment Phase: First Intervention||0
5076064|NCT01775189|12488874|P2|STARTED|Treatment Phase: First Intervention||0
5076065|NCT01775189|12488875|P1|STARTED|Treatment Phase: First Intervention||0
5076066|NCT01775189|12488869|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5076067|NCT01775189|12488870|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5076068|NCT01775189|12488871|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5076069|NCT01775189|12488872|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5076070|NCT01775189|12488873|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
5076071|NCT01775189|12488874|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
5076072|NCT01775189|12488875|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5076073|NCT01775189|12488869|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
5076074|NCT01775189|12488870|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
5076075|NCT01775189|12488871|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
5076076|NCT01775189|12488872|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
5076077|NCT01775189|12488873|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
5076078|NCT01775189|12488874|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
5076079|NCT01775189|12488875|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
5076080|NCT01775189|12488869|P7|STARTED|Drug Discrimination Phase: Day 2||0
5076081|NCT01775189|12488870|P6|STARTED|Drug Discrimination Phase: Day 2||0
5076082|NCT01775189|12488871|P5|STARTED|Drug Discrimination Phase: Day 2||0
5076083|NCT01775189|12488872|P4|STARTED|Drug Discrimination Phase: Day 2||0
5076084|NCT01775189|12488873|P3|STARTED|Drug Discrimination Phase: Day 2||23
5076085|NCT01775189|12488874|P2|STARTED|Drug Discrimination Phase: Day 2||19
5076086|NCT01775189|12488875|P1|STARTED|Drug Discrimination Phase: Day 2||0
5076087|NCT01775189|12488869|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076088|NCT01775189|12488870|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076089|NCT01775189|12488871|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076090|NCT01775189|12488872|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076091|NCT01775189|12488873|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076092|NCT01775189|12488874|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
5076093|NCT01775189|12488875|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5076094|NCT01775189|12488869|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
5076095|NCT01775189|12488870|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
5076096|NCT01775189|12488871|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
5076097|NCT01775189|12488872|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
5076098|NCT01775189|12488873|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
5076099|NCT01775189|12488874|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
5076100|NCT01775189|12488875|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
5076101|NCT01775189|12488869|P7|STARTED|Drug Discrimination Phase: Day 1||0
5076102|NCT01775189|12488870|P6|STARTED|Drug Discrimination Phase: Day 1||0
5076103|NCT01775189|12488871|P5|STARTED|Drug Discrimination Phase: Day 1||0
5076104|NCT01775189|12488872|P4|STARTED|Drug Discrimination Phase: Day 1||0
5076105|NCT01775189|12488873|P3|STARTED|Drug Discrimination Phase: Day 1||23
5076106|NCT01775189|12488874|P2|STARTED|Drug Discrimination Phase: Day 1||22
5076107|NCT01775189|12488875|P1|STARTED|Drug Discrimination Phase: Day 1||0
5076108|NCT01775189|12488869|P7|NOT COMPLETED|Naloxone Challenge Phase||0
5076109|NCT01775189|12488870|P6|NOT COMPLETED|Naloxone Challenge Phase||0
5076110|NCT01775189|12488871|P5|NOT COMPLETED|Naloxone Challenge Phase||0
5076111|NCT01775189|12488872|P4|NOT COMPLETED|Naloxone Challenge Phase||0
5076112|NCT01775189|12488873|P3|NOT COMPLETED|Naloxone Challenge Phase||0
5076113|NCT01775189|12488874|P2|NOT COMPLETED|Naloxone Challenge Phase||0
5076114|NCT01775189|12488875|P1|NOT COMPLETED|Naloxone Challenge Phase||0
5076115|NCT01775189|12488869|P7|COMPLETED|Naloxone Challenge Phase||0
5076116|NCT01775189|12488870|P6|COMPLETED|Naloxone Challenge Phase||0
5076117|NCT01775189|12488871|P5|COMPLETED|Naloxone Challenge Phase||0
5076118|NCT01775189|12488872|P4|COMPLETED|Naloxone Challenge Phase||0
5076119|NCT01775189|12488873|P3|COMPLETED|Naloxone Challenge Phase||0
5076120|NCT01775189|12488874|P2|COMPLETED|Naloxone Challenge Phase||0
5076121|NCT01775189|12488875|P1|COMPLETED|Naloxone Challenge Phase||45
5076122|NCT01775189|12488869|P7|STARTED|Naloxone Challenge Phase||0
5076123|NCT01775189|12488870|P6|STARTED|Naloxone Challenge Phase||0
5076124|NCT01775189|12488871|P5|STARTED|Naloxone Challenge Phase||0
5076125|NCT01775189|12488872|P4|STARTED|Naloxone Challenge Phase||0
5076126|NCT01775189|12488873|P3|STARTED|Naloxone Challenge Phase||0
5076127|NCT01775189|12488874|P2|STARTED|Naloxone Challenge Phase||0
5076128|NCT01775189|12488875|P1|STARTED|Naloxone Challenge Phase||45
5076129|NCT01775137|12489094|P1|NOT COMPLETED|Overall Study||11
5076130|NCT01775137|12489094|P1|COMPLETED|Overall Study||34
5076131|NCT01775137|12489094|P1|STARTED|Overall Study||45
5076132|NCT01775124|12489121|P2|NOT COMPLETED|Extension Period||18
5076133|NCT01775124|12489122|P1|NOT COMPLETED|Extension Period||12
5076134|NCT01775124|12489121|P2|COMPLETED|Extension Period||138
5076135|NCT01775124|12489122|P1|COMPLETED|Extension Period||145
5076136|NCT01775124|12489121|P2|STARTED|Extension Period||156
5076137|NCT01775124|12489122|P1|STARTED|Extension Period||157
5076138|NCT01775124|12489121|P2|NOT COMPLETED|Core Period||10
5076139|NCT01775124|12489122|P1|NOT COMPLETED|Core Period||11
5076140|NCT01775124|12489121|P2|COMPLETED|Core Period||156
5076141|NCT01775124|12489122|P1|COMPLETED|Core Period||157
5076142|NCT01775124|12489121|P2|Safety Set|Core Period||166
5076143|NCT01775124|12489122|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
5076144|NCT01775124|12489121|P2|Per Protocol Set|Core Period||155
5076145|NCT01775124|12489122|P1|Per Protocol Set|Core Period||157
5076146|NCT01775124|12489121|P2|Full Analysis Set|Core Period||166
5076147|NCT01775124|12489122|P1|Full Analysis Set|Core Period||167
5076148|NCT01775124|12489121|P2|STARTED|Core Period||166
5076149|NCT01775124|12489122|P1|STARTED|Core Period||168
5076150|NCT01774981|12489157|P8|NOT COMPLETED|Overall Study||1
5076151|NCT01774981|12489158|P7|NOT COMPLETED|Overall Study||0
5076152|NCT01774981|12489159|P6|NOT COMPLETED|Overall Study||1
5076153|NCT01774981|12489160|P5|NOT COMPLETED|Overall Study||1
5076154|NCT01774981|12489161|P4|NOT COMPLETED|Overall Study||0
5076155|NCT01774981|12489162|P3|NOT COMPLETED|Overall Study||0
5076156|NCT01774981|12489163|P2|NOT COMPLETED|Overall Study||0
5076157|NCT01774981|12489164|P1|NOT COMPLETED|Overall Study||0
5076158|NCT01774981|12489157|P8|COMPLETED|Overall Study||11
5076159|NCT01774981|12489158|P7|COMPLETED|Overall Study||13
5076160|NCT01774981|12489159|P6|COMPLETED|Overall Study||13
5076161|NCT01774981|12489160|P5|COMPLETED|Overall Study||5
5076162|NCT01774981|12489161|P4|COMPLETED|Overall Study||4
5076163|NCT01774981|12489162|P3|COMPLETED|Overall Study||4
5076164|NCT01774981|12489163|P2|COMPLETED|Overall Study||4
5076165|NCT01774981|12489164|P1|COMPLETED|Overall Study||3
5076166|NCT01774981|12489157|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
5076167|NCT01774981|12489158|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
5076168|NCT01774981|12489159|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
5076169|NCT01774981|12489160|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5076170|NCT01774981|12489161|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
5076171|NCT01774981|12489162|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
5076172|NCT01774981|12489163|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
5076173|NCT01774981|12489164|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5076174|NCT01774981|12489157|P8|STARTED|Overall Study||12
5076175|NCT01774981|12489158|P7|STARTED|Overall Study||13
5076176|NCT01774981|12489159|P6|STARTED|Overall Study||14
5076177|NCT01774981|12489160|P5|STARTED|Overall Study||6
5076178|NCT01774981|12489161|P4|STARTED|Overall Study||4
5076179|NCT01774981|12489162|P3|STARTED|Overall Study||4
5076180|NCT01774981|12489163|P2|STARTED|Overall Study||4
5076181|NCT01774981|12489164|P1|STARTED|Overall Study||3
5076182|NCT01774968|12489196|P2|NOT COMPLETED|Overall Study||35
5076183|NCT01774968|12489197|P1|NOT COMPLETED|Overall Study||30
5076184|NCT01774968|12489196|P2|COMPLETED|Overall Study||128
5076185|NCT01774968|12489197|P1|COMPLETED|Overall Study||132
5076186|NCT01774968|12489196|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
5076187|NCT01774968|12489197|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
5076188|NCT01774968|12489196|P2|STARTED|Overall Study||163
5076189|NCT01774968|12489197|P1|STARTED|Overall Study||162
5076190|NCT01774929|12489231|P1|NOT COMPLETED|Overall Study||3
5076191|NCT01774929|12489231|P1|COMPLETED|Overall Study||32
5076192|NCT01774929|12489231|P1|STARTED|Overall Study||35
5076193|NCT01774903|12489237|P1|NOT COMPLETED|Overall Study||11
5076194|NCT01774903|12489237|P1|COMPLETED|Overall Study||34
5076195|NCT01774903|12489237|P1|STARTED|Overall Study||45
5076196|NCT01774851|12489246|P2|NOT COMPLETED|Overall Study||0
5076197|NCT01774851|12489247|P1|NOT COMPLETED|Overall Study||0
5076198|NCT01774851|12489246|P2|COMPLETED|Overall Study||42
5076199|NCT01774851|12489247|P1|COMPLETED|Overall Study||42
5076200|NCT01774851|12489246|P2|STARTED|Overall Study||42
5076201|NCT01774851|12489247|P1|STARTED|Overall Study||42
5076202|NCT01774799|12489257|P4|NOT COMPLETED|Overall Study||0
5076203|NCT01774799|12489258|P3|NOT COMPLETED|Overall Study||0
5076204|NCT01774799|12489259|P2|NOT COMPLETED|Overall Study||1
5076205|NCT01774799|12489260|P1|NOT COMPLETED|Overall Study||1
5076206|NCT01774799|12489257|P4|COMPLETED|Overall Study||190
5076207|NCT01774799|12489258|P3|COMPLETED|Overall Study||212
5076208|NCT01774799|12489259|P2|COMPLETED|Overall Study||189
5076209|NCT01774799|12489260|P1|COMPLETED|Overall Study||211
5076210|NCT01774799|12489257|P4|STARTED|Overall Study||190
5076211|NCT01774799|12489258|P3|STARTED|Overall Study||212
5076212|NCT01774799|12489259|P2|STARTED|Overall Study||190
5076213|NCT01774799|12489260|P1|STARTED|Overall Study||212
5076214|NCT01774786|12489276|P2|NOT COMPLETED|Overall Study||392
5076215|NCT01774786|12489277|P1|NOT COMPLETED|Overall Study||388
5076216|NCT01774786|12489276|P2|COMPLETED|Overall Study||0
5076217|NCT01774786|12489277|P1|COMPLETED|Overall Study||0
5076218|NCT01774786|12489276|P2|Received at Least One Dose of Placebo|Overall Study||388
5076219|NCT01774786|12489277|P1|Received at Least One Dose of Placebo|Overall Study||0
5076220|NCT01774786|12489276|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
5076221|NCT01774786|12489277|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
5076222|NCT01774786|12489276|P2|Did Not Receive Study Drug|Overall Study||3
5076223|NCT01774786|12489277|P1|Did Not Receive Study Drug|Overall Study||4
5076224|NCT01774786|12489276|P2|STARTED|Overall Study||392
5076225|NCT01774786|12489277|P1|STARTED|Overall Study||388
5076226|NCT01774760|12489305|P1|NOT COMPLETED|Overall Study||0
5076227|NCT01774760|12489305|P1|COMPLETED|Overall Study||10
5076228|NCT01774760|12489305|P1|STARTED|Overall Study||10
5076229|NCT01774721|12489311|P2|NOT COMPLETED|Overall Study||225
5076230|NCT01774721|12489312|P1|NOT COMPLETED|Overall Study||227
5076231|NCT01774721|12489311|P2|COMPLETED|Overall Study||0
5076232|NCT01774721|12489312|P1|COMPLETED|Overall Study||0
5076233|NCT01774721|12489311|P2|Treated|Overall Study||224
5076234|NCT01774721|12489312|P1|Treated|Overall Study||227
5076235|NCT01774721|12489311|P2|STARTED|Overall Study||225
5076236|NCT01774721|12489312|P1|STARTED|Overall Study||227
5076237|NCT01774604|12489356|P2|NOT COMPLETED|Overall Study||0
5076238|NCT01774604|12489357|P1|NOT COMPLETED|Overall Study||0
5076239|NCT01774604|12489356|P2|COMPLETED|Overall Study||226
5076240|NCT01774604|12489357|P1|COMPLETED|Overall Study||223
5076241|NCT01774604|12489356|P2|STARTED|Overall Study||226
5076242|NCT01774604|12489357|P1|STARTED|Overall Study||223
5076243|NCT01774591|12489377|P2|NOT COMPLETED|Overall Study||4
5076244|NCT01774591|12489378|P1|NOT COMPLETED|Overall Study||1
5076245|NCT01774591|12489377|P2|COMPLETED|Overall Study||7
5076246|NCT01774591|12489378|P1|COMPLETED|Overall Study||9
5076247|NCT01774591|12489377|P2|STARTED|Overall Study||11
5076248|NCT01774591|12489378|P1|STARTED|Overall Study||10
5076249|NCT01774370|12489388|P1|NOT COMPLETED|Overall Study||129
5076250|NCT01774370|12489388|P1|COMPLETED|Overall Study||3053
5076251|NCT01774370|12489388|P1|STARTED|Overall Study||3182
5076252|NCT01774344|12489396|P2|NOT COMPLETED|Overall Study||148
5076253|NCT01774344|12489397|P1|NOT COMPLETED|Overall Study||32
5076254|NCT01774344|12489396|P2|COMPLETED|Overall Study||231
5076255|NCT01774344|12489397|P1|COMPLETED|Overall Study||162
5076256|NCT01774344|12489396|P2|Treated|Overall Study||374
5076257|NCT01774344|12489397|P1|Treated|Overall Study||193
5076258|NCT01774344|12489396|P2|STARTED|Overall Study||379
5076259|NCT01774344|12489397|P1|STARTED|Overall Study||194
5076260|NCT01774305|12489413|P2|NOT COMPLETED|Overall Study||0
5076261|NCT01774305|12489414|P1|NOT COMPLETED|Overall Study||1
5076262|NCT01774305|12489413|P2|COMPLETED|Overall Study||71
5076263|NCT01774305|12489414|P1|COMPLETED|Overall Study||70
5076264|NCT01774305|12489413|P2|STARTED|Overall Study||71
5076265|NCT01774305|12489414|P1|STARTED|Overall Study||71
5076266|NCT01774253|12489422|P1|NOT COMPLETED|Overall Study||9
5076267|NCT01774253|12489422|P1|COMPLETED|Overall Study||0
5076268|NCT01774253|12489422|P1|STARTED|Overall Study||9
5076269|NCT01774149|12489432|P2|NOT COMPLETED|Overall Study||3
5076270|NCT01774149|12489433|P1|NOT COMPLETED|Overall Study||1
5076271|NCT01774149|12489432|P2|COMPLETED|Overall Study||12
5076272|NCT01774149|12489433|P1|COMPLETED|Overall Study||14
5076273|NCT01774149|12489432|P2|STARTED|Overall Study||15
5076274|NCT01774149|12489433|P1|STARTED|Overall Study||15
5076275|NCT01774110|12489441|P1|NOT COMPLETED|Overall Study||7
5076276|NCT01774110|12489441|P1|COMPLETED|Overall Study||5
5076277|NCT01774110|12489441|P1|STARTED|Overall Study||12
5076278|NCT01774097|12489449|P2|NOT COMPLETED|Overall Study||2
5076279|NCT01774097|12489450|P1|NOT COMPLETED|Overall Study||2
5076280|NCT01774097|12489449|P2|COMPLETED|Overall Study||40
5076281|NCT01774097|12489450|P1|COMPLETED|Overall Study||38
5076282|NCT01774097|12489449|P2|STARTED|Overall Study||42
5076283|NCT01774097|12489450|P1|STARTED|Overall Study||40
5076284|NCT01774084|12489480|P2|NOT COMPLETED|Overall Study||0
5076285|NCT01774084|12489481|P1|NOT COMPLETED|Overall Study||1
5076286|NCT01774084|12489480|P2|COMPLETED|Overall Study||12
5076287|NCT01774084|12489481|P1|COMPLETED|Overall Study||10
5076288|NCT01774084|12489480|P2|STARTED|Overall Study||12
5076289|NCT01774084|12489481|P1|STARTED|Overall Study||11
5076290|NCT01774045|12489491|P2|NOT COMPLETED|Overall Study||0
5076291|NCT01774045|12489492|P1|NOT COMPLETED|Overall Study||0
5076292|NCT01774045|12489491|P2|COMPLETED|Overall Study||7
5076293|NCT01774045|12489492|P1|COMPLETED|Overall Study||23
5076294|NCT01774045|12489491|P2|STARTED|Overall Study||7
5076295|NCT01774045|12489492|P1|STARTED|Overall Study||23
5076296|NCT01773993|12489506|P1|NOT COMPLETED|Overall Study||35
5076297|NCT01773993|12489506|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
5076298|NCT01773993|12489506|P1|STARTED|Overall Study||534
5076299|NCT01773967|12489525|P2|NOT COMPLETED|Overall Study||13
5076300|NCT01773967|12489526|P1|NOT COMPLETED|Overall Study||15
5076301|NCT01773967|12489525|P2|COMPLETED|Overall Study||475
5076302|NCT01773967|12489526|P1|COMPLETED|Overall Study||468
5076303|NCT01773967|12489525|P2|STARTED|Overall Study||488
5076304|NCT01773967|12489526|P1|STARTED|Overall Study||483
5076305|NCT01773954|12489536|P1|NOT COMPLETED|Overall Study||9
5076306|NCT01773954|12489536|P1|COMPLETED|Overall Study||31
5076307|NCT01773954|12489536|P1|STARTED|Overall Study||40
5076308|NCT01773889|12489541|P1|NOT COMPLETED|Overall Study||2
5076309|NCT01773889|12489541|P1|COMPLETED|Overall Study||0
5076310|NCT01773889|12489541|P1|STARTED|Overall Study||2
5076311|NCT01773473|12489547|P2|NOT COMPLETED|Overall Study||19
5076312|NCT01773473|12489548|P1|NOT COMPLETED|Overall Study||16
5076313|NCT01773473|12489547|P2|COMPLETED|Overall Study||177
5076314|NCT01773473|12489548|P1|COMPLETED|Overall Study||191
5076315|NCT01773473|12489547|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
5076316|NCT01773473|12489548|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
5076317|NCT01773473|12489547|P2|STARTED|Overall Study||196
5076318|NCT01773473|12489548|P1|STARTED|Overall Study||207
5076319|NCT01773421|12489570|P7|NOT COMPLETED|Extension Phase||0
5076320|NCT01773421|12489571|P6|NOT COMPLETED|Extension Phase||2
5076321|NCT01773421|12489572|P5|NOT COMPLETED|Extension Phase||3
5076322|NCT01773421|12489573|P4|NOT COMPLETED|Extension Phase||0
5076323|NCT01773421|12489574|P3|NOT COMPLETED|Extension Phase||0
5076324|NCT01773421|12489575|P2|NOT COMPLETED|Extension Phase||0
5076325|NCT01773421|12489576|P1|NOT COMPLETED|Extension Phase||0
5076326|NCT01773421|12489570|P7|COMPLETED|Extension Phase||0
5076327|NCT01773421|12489571|P6|COMPLETED|Extension Phase||1
5076328|NCT01773421|12489572|P5|COMPLETED|Extension Phase||12
5076329|NCT01773421|12489573|P4|COMPLETED|Extension Phase||0
5076330|NCT01773421|12489574|P3|COMPLETED|Extension Phase||0
5076331|NCT01773421|12489575|P2|COMPLETED|Extension Phase||0
5076332|NCT01773421|12489576|P1|COMPLETED|Extension Phase||0
5076333|NCT01773421|12489570|P7|STARTED|Extension Phase||0
5076334|NCT01773421|12489571|P6|STARTED|Extension Phase||3
5076335|NCT01773421|12489572|P5|STARTED|Extension Phase||15
5076336|NCT01773421|12489573|P4|STARTED|Extension Phase||0
5076337|NCT01773421|12489574|P3|STARTED|Extension Phase||0
5076338|NCT01773421|12489575|P2|STARTED|Extension Phase||0
5076339|NCT01773421|12489576|P1|STARTED|Extension Phase||0
5076340|NCT01773421|12489570|P7|NOT COMPLETED|Treatment Phase||0
5076341|NCT01773421|12489571|P6|NOT COMPLETED|Treatment Phase||0
5076342|NCT01773421|12489572|P5|NOT COMPLETED|Treatment Phase||0
5076343|NCT01773421|12489573|P4|NOT COMPLETED|Treatment Phase||2
5076344|NCT01773421|12489574|P3|NOT COMPLETED|Treatment Phase||6
5076345|NCT01773421|12489575|P2|NOT COMPLETED|Treatment Phase||0
5076346|NCT01773421|12489576|P1|NOT COMPLETED|Treatment Phase||0
5076347|NCT01773421|12489570|P7|COMPLETED|Treatment Phase||0
5076348|NCT01773421|12489571|P6|COMPLETED|Treatment Phase||0
5076349|NCT01773421|12489572|P5|COMPLETED|Treatment Phase||0
5076350|NCT01773421|12489573|P4|COMPLETED|Treatment Phase||5
5076351|NCT01773421|12489574|P3|COMPLETED|Treatment Phase||13
5076352|NCT01773421|12489575|P2|COMPLETED|Treatment Phase||8
5076353|NCT01773421|12489576|P1|COMPLETED|Treatment Phase||7
5076354|NCT01773421|12489570|P7|STARTED|Treatment Phase||0
5076355|NCT01773421|12489571|P6|STARTED|Treatment Phase||0
5076356|NCT01773421|12489572|P5|STARTED|Treatment Phase||0
5076357|NCT01773421|12489573|P4|STARTED|Treatment Phase||7
5076358|NCT01773421|12489574|P3|STARTED|Treatment Phase||19
5076359|NCT01773421|12489575|P2|STARTED|Treatment Phase||8
5076360|NCT01773421|12489576|P1|STARTED|Treatment Phase||7
5076361|NCT01773291|12489607|P3|NOT COMPLETED|Overall Study||1
5076362|NCT01773291|12489608|P2|NOT COMPLETED|Overall Study||0
5076363|NCT01773291|12489609|P1|NOT COMPLETED|Overall Study||1
5076364|NCT01773291|12489607|P3|COMPLETED|Overall Study||6
5076365|NCT01773291|12489608|P2|COMPLETED|Overall Study||9
5076366|NCT01773291|12489609|P1|COMPLETED|Overall Study||7
5076367|NCT01773291|12489607|P3|STARTED|Overall Study||7
5076368|NCT01773291|12489608|P2|STARTED|Overall Study||9
5076369|NCT01773291|12489609|P1|STARTED|Overall Study||8
5076370|NCT01773226|12489620|P1|NOT COMPLETED|Overall Study||1
5076371|NCT01773226|12489620|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
5076372|NCT01773226|12489620|P1|STARTED|Overall Study||11
5076373|NCT01773135|12489630|P1|NOT COMPLETED|Overall Study||0
5076374|NCT01773135|12489630|P1|COMPLETED|Overall Study||262
5076375|NCT01773135|12489630|P1|STARTED|Overall Study||262
5076376|NCT01773122|12489639|P4|NOT COMPLETED|Overall Study||1
5076377|NCT01773122|12489640|P3|NOT COMPLETED|Overall Study||0
5076378|NCT01773122|12489641|P2|NOT COMPLETED|Overall Study||1
5076379|NCT01773122|12489642|P1|NOT COMPLETED|Overall Study||3
5076380|NCT01773122|12489639|P4|COMPLETED|Overall Study||18
5076381|NCT01773122|12489640|P3|COMPLETED|Overall Study||19
5076382|NCT01773122|12489641|P2|COMPLETED|Overall Study||18
5076383|NCT01773122|12489642|P1|COMPLETED|Overall Study||17
5076384|NCT01773122|12489639|P4|STARTED|Overall Study||19
5076385|NCT01773122|12489640|P3|STARTED|Overall Study||19
5076386|NCT01773122|12489641|P2|STARTED|Overall Study||19
5076387|NCT01773122|12489642|P1|STARTED|Overall Study||20
5076388|NCT01773109|12489656|P1|NOT COMPLETED|Overall Study||3
5076389|NCT01773109|12489656|P1|COMPLETED|Overall Study||37
5076390|NCT01773109|12489656|P1|STARTED|Overall Study||40
5076391|NCT01773070|12489660|P1|NOT COMPLETED|Overall Study||81
5076392|NCT01773070|12489660|P1|COMPLETED|Overall Study||397
5076393|NCT01773070|12489660|P1|STARTED|Overall Study||478
5076394|NCT01772823|12489670|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
5076395|NCT01772823|12489671|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
5076396|NCT01772823|12489670|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
5076397|NCT01772823|12489671|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
5076398|NCT01772823|12489670|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
5076399|NCT01772823|12489671|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
5076400|NCT01772823|12489670|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
5076401|NCT01772823|12489671|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
5076402|NCT01772823|12489670|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
5076403|NCT01772823|12489671|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
5076404|NCT01772823|12489670|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
5076405|NCT01772823|12489671|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
5076406|NCT01772823|12489670|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
5076407|NCT01772823|12489671|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
5076408|NCT01772823|12489670|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
5076409|NCT01772823|12489671|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
5076410|NCT01772823|12489670|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
5076411|NCT01772823|12489671|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
5076412|NCT01772758|12489771|P4|NOT COMPLETED|Overall Study||0
5076413|NCT01772758|12489772|P3|NOT COMPLETED|Overall Study||0
5076414|NCT01772758|12489773|P2|NOT COMPLETED|Overall Study||0
5076415|NCT01772758|12489774|P1|NOT COMPLETED|Overall Study||0
5076416|NCT01772758|12489771|P4|COMPLETED|Overall Study||17
5076417|NCT01772758|12489772|P3|COMPLETED|Overall Study||12
5076418|NCT01772758|12489773|P2|COMPLETED|Overall Study||17
5076419|NCT01772758|12489774|P1|COMPLETED|Overall Study||18
5076420|NCT01772758|12489771|P4|STARTED|Overall Study||17
5076421|NCT01772758|12489772|P3|STARTED|Overall Study||12
5076422|NCT01772758|12489773|P2|STARTED|Overall Study||17
5076423|NCT01772758|12489774|P1|STARTED|Overall Study||18
5076424|NCT01772719|12489784|P1|NOT COMPLETED|Overall Study||7
5076425|NCT01772719|12489784|P1|COMPLETED|Overall Study||0
5076426|NCT01772719|12489784|P1|STARTED|Overall Study||7
5076427|NCT01772654|12489797|P2|NOT COMPLETED|Overall Study||0
5076428|NCT01772654|12489798|P1|NOT COMPLETED|Overall Study||0
5076429|NCT01772654|12489797|P2|COMPLETED|Overall Study||15
5076430|NCT01772654|12489798|P1|COMPLETED|Overall Study||2
5076431|NCT01772654|12489797|P2|STARTED|Overall Study||15
5076432|NCT01772654|12489798|P1|STARTED|Overall Study||2
5076433|NCT01772576|12489804|P1|NOT COMPLETED|Overall Study||34
5076434|NCT01772576|12489804|P1|COMPLETED|Overall Study||133
5076435|NCT01772576|12489804|P1|STARTED|Overall Study||167
5076436|NCT01772550|12489816|P3|NOT COMPLETED|Overall Study||6
5076437|NCT01772550|12489817|P2|NOT COMPLETED|Overall Study||1
5076438|NCT01772550|12489818|P1|NOT COMPLETED|Overall Study||1
5076439|NCT01772550|12489816|P3|COMPLETED|Overall Study||27
5076440|NCT01772550|12489817|P2|COMPLETED|Overall Study||102
5076441|NCT01772550|12489818|P1|COMPLETED|Overall Study||101
5076442|NCT01772550|12489816|P3|CT Cardiac|Overall Study||1
5076443|NCT01772550|12489817|P2|CT Cardiac|Overall Study||7
5076444|NCT01772550|12489818|P1|CT Cardiac|Overall Study||7
5076445|NCT01772550|12489816|P3|CT Kidney|Overall Study||6
5076446|NCT01772550|12489817|P2|CT Kidney|Overall Study||19
5076447|NCT01772550|12489818|P1|CT Kidney|Overall Study||12
5076448|NCT01772550|12489816|P3|CT Liver|Overall Study||8
5076449|NCT01772550|12489817|P2|CT Liver|Overall Study||14
5076450|NCT01772550|12489818|P1|CT Liver|Overall Study||18
5076451|NCT01772550|12489816|P3|CT Angiogram|Overall Study||4
5076452|NCT01772550|12489817|P2|CT Angiogram|Overall Study||25
5076453|NCT01772550|12489818|P1|CT Angiogram|Overall Study||24
5076454|NCT01772550|12489816|P3|CT Pancreas|Overall Study||8
5076455|NCT01772550|12489817|P2|CT Pancreas|Overall Study||36
5076456|NCT01772550|12489818|P1|CT Pancreas|Overall Study||40
5076457|NCT01772550|12489816|P3|STARTED|Overall Study||33
5076458|NCT01772550|12489817|P2|STARTED|Overall Study||103
5076459|NCT01772550|12489818|P1|STARTED|Overall Study||102
5076460|NCT01772537|12489859|P3|NOT COMPLETED|Overall Study||0
5076461|NCT01772537|12489860|P2|NOT COMPLETED|Overall Study||0
5076462|NCT01772537|12489861|P1|NOT COMPLETED|Overall Study||1
5076463|NCT01772537|12489859|P3|COMPLETED|Overall Study||6
5076464|NCT01772537|12489860|P2|COMPLETED|Overall Study||3
5076465|NCT01772537|12489861|P1|COMPLETED|Overall Study||4
5076466|NCT01772537|12489859|P3|STARTED|Overall Study||6
5076467|NCT01772537|12489860|P2|STARTED|Overall Study||3
5076468|NCT01772537|12489861|P1|STARTED|Overall Study||5
5076469|NCT01772472|12489877|P2|NOT COMPLETED|Overall Study||743
5076470|NCT01772472|12489878|P1|NOT COMPLETED|Overall Study||743
5076471|NCT01772472|12489877|P2|COMPLETED|Overall Study||0
5076472|NCT01772472|12489878|P1|COMPLETED|Overall Study||0
5076473|NCT01772472|12489877|P2|STARTED|Overall Study||743
5076474|NCT01772472|12489878|P1|STARTED|Overall Study||743
5076475|NCT01772368|12489890|P1|NOT COMPLETED|Overall Study||7
5076476|NCT01772368|12489890|P1|COMPLETED|Overall Study||65
5076477|NCT01772368|12489890|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
5076478|NCT01772368|12489890|P1|Received FS MDPI 100/50 mcg|Overall Study||68
5076479|NCT01772368|12489890|P1|Received FS MDPI 100/25 mcg|Overall Study||67
5076480|NCT01772368|12489890|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
5076481|NCT01772368|12489890|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
5076482|NCT01772368|12489890|P1|Received Fp MDPI 100 mcg|Overall Study||67
5076483|NCT01772368|12489890|P1|STARTED|Overall Study||72
5076484|NCT01772316|12489936|P1|NOT COMPLETED|Overall Study||7
5076485|NCT01772316|12489936|P1|COMPLETED|Overall Study||40
5076486|NCT01772316|12489936|P1|STARTED|Overall Study||47
5076487|NCT01772160|12489954|P1|NOT COMPLETED|Overall Study||48
5076488|NCT01772160|12489954|P1|COMPLETED|Overall Study||346
5076489|NCT01772160|12489954|P1|STARTED|Overall Study||394
5076490|NCT01772147|12489977|P3|NOT COMPLETED|Overall Study||18
5076491|NCT01772147|12489978|P2|NOT COMPLETED|Overall Study||25
5076492|NCT01772147|12489979|P1|NOT COMPLETED|Overall Study||31
5076493|NCT01772147|12489977|P3|COMPLETED|Overall Study||184
5076494|NCT01772147|12489978|P2|COMPLETED|Overall Study||178
5076495|NCT01772147|12489979|P1|COMPLETED|Overall Study||170
5076496|NCT01772147|12489977|P3|STARTED|Overall Study||202
5076497|NCT01772147|12489978|P2|STARTED|Overall Study||203
5076498|NCT01772147|12489979|P1|STARTED|Overall Study||201
5076499|NCT01772134|12489999|P3|NOT COMPLETED|Overall Study||22
5076500|NCT01772134|12490000|P2|NOT COMPLETED|Overall Study||14
5076501|NCT01772134|12490001|P1|NOT COMPLETED|Overall Study||29
5076502|NCT01772134|12489999|P3|COMPLETED|Overall Study||184
5076503|NCT01772134|12490000|P2|COMPLETED|Overall Study||190
5076504|NCT01772134|12490001|P1|COMPLETED|Overall Study||178
5076505|NCT01772134|12489999|P3|Received Randomized Study Medication|Overall Study||205
5076506|NCT01772134|12490000|P2|Received Randomized Study Medication|Overall Study||204
5076507|NCT01772134|12490001|P1|Received Randomized Study Medication|Overall Study||205
5076508|NCT01772134|12489999|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
5076509|NCT01772134|12490000|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
5076510|NCT01772134|12490001|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
5076511|NCT01771991|12490020|P2|NOT COMPLETED|Overall Study||6
5076512|NCT01771991|12490021|P1|NOT COMPLETED|Overall Study||8
5076513|NCT01771991|12490020|P2|COMPLETED|Overall Study||30
5076514|NCT01771991|12490021|P1|COMPLETED|Overall Study||30
5076515|NCT01771991|12490020|P2|Started Treatment|Overall Study||34
5076516|NCT01771991|12490021|P1|Started Treatment|Overall Study||37
5076517|NCT01771991|12490020|P2|STARTED|Overall Study||36
5076518|NCT01771991|12490021|P1|STARTED|Overall Study||38
5076519|NCT01771965|12490035|P2|NOT COMPLETED|Overall Study||5
5076520|NCT01771965|12490036|P1|NOT COMPLETED|Overall Study||3
5076521|NCT01771965|12490035|P2|COMPLETED|Overall Study||4
5076522|NCT01771965|12490036|P1|COMPLETED|Overall Study||7
5076523|NCT01771965|12490035|P2|STARTED|Overall Study||9
5076524|NCT01771965|12490036|P1|STARTED|Overall Study||10
5076525|NCT01771913|12490044|P2|NOT COMPLETED|Overall Study||0
5076526|NCT01771913|12490045|P1|NOT COMPLETED|Overall Study||1
5076527|NCT01771913|12490044|P2|COMPLETED|Overall Study||11
5076528|NCT01771913|12490045|P1|COMPLETED|Overall Study||8
5076529|NCT01771913|12490044|P2|STARTED|Overall Study||11
5076530|NCT01771913|12490045|P1|STARTED|Overall Study||9
5076531|NCT01771809|12490057|P2|NOT COMPLETED|Overall Study||83
5076532|NCT01771809|12490058|P1|NOT COMPLETED|Overall Study||71
5076533|NCT01771809|12490057|P2|COMPLETED|Overall Study||83
5076534|NCT01771809|12490058|P1|COMPLETED|Overall Study||93
5076535|NCT01771809|12490057|P2|STARTED|Overall Study||166
5076536|NCT01771809|12490058|P1|STARTED|Overall Study||164
5076537|NCT01771666|12490072|P1|NOT COMPLETED|Overall Study||0
5076538|NCT01771666|12490072|P1|COMPLETED|Overall Study||23
5076539|NCT01771666|12490072|P1|STARTED|Overall Study||23
5076540|NCT01771250|12490077|P2|NOT COMPLETED|Period 2||0
5076541|NCT01771250|12490078|P1|NOT COMPLETED|Period 2||0
5076542|NCT01771250|12490077|P2|COMPLETED|Period 2||7
5076543|NCT01771250|12490078|P1|COMPLETED|Period 2||7
5076544|NCT01771250|12490077|P2|STARTED|Period 2||7
5076545|NCT01771250|12490078|P1|STARTED|Period 2||7
5076546|NCT01771250|12490077|P2|NOT COMPLETED|Period 1||0
5076547|NCT01771250|12490078|P1|NOT COMPLETED|Period 1||1
5076548|NCT01771250|12490077|P2|COMPLETED|Period 1||7
5076549|NCT01771250|12490078|P1|COMPLETED|Period 1||7
5076550|NCT01771250|12490077|P2|Received at Least One Dose of Study Drug|Period 1||7
5076551|NCT01771250|12490078|P1|Received at Least One Dose of Study Drug|Period 1||7
5076552|NCT01771250|12490077|P2|STARTED|Period 1||7
5076553|NCT01771250|12490078|P1|STARTED|Period 1||8
5076554|NCT01771172|12490090|P1|NOT COMPLETED|Overall Study||2
5076555|NCT01771172|12490090|P1|COMPLETED|Overall Study||46
5076556|NCT01771172|12490090|P1|STARTED|Overall Study||48
5076557|NCT01770860|12490094|P1|NOT COMPLETED|Overall Study||6
5076558|NCT01770860|12490094|P1|COMPLETED|Overall Study||40
5076559|NCT01770860|12490094|P1|Randomization|Overall Study|One participant withdrew before randomization|45
5076560|NCT01770860|12490094|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
5076561|NCT01770743|12490142|P5|NOT COMPLETED|Overall Study||2
5076562|NCT01770743|12490143|P4|NOT COMPLETED|Overall Study||2
5076563|NCT01770743|12490144|P3|NOT COMPLETED|Overall Study||1
5076564|NCT01770743|12490145|P2|NOT COMPLETED|Overall Study||3
5076565|NCT01770743|12490146|P1|NOT COMPLETED|Overall Study||2
5076566|NCT01770743|12490142|P5|COMPLETED|Overall Study||21
5076567|NCT01770743|12490143|P4|COMPLETED|Overall Study||42
5076568|NCT01770743|12490144|P3|COMPLETED|Overall Study||22
5076569|NCT01770743|12490145|P2|COMPLETED|Overall Study||31
5076570|NCT01770743|12490146|P1|COMPLETED|Overall Study||42
5076571|NCT01770743|12490142|P5|Treated|Overall Study||23
5076572|NCT01770743|12490143|P4|Treated|Overall Study||44
5076573|NCT01770743|12490144|P3|Treated|Overall Study||23
5076574|NCT01770743|12490145|P2|Treated|Overall Study||34
5076575|NCT01770743|12490146|P1|Treated|Overall Study||44
5076576|NCT01770743|12490142|P5|STARTED|Overall Study||23
5076577|NCT01770743|12490143|P4|STARTED|Overall Study||44
5076578|NCT01770743|12490144|P3|STARTED|Overall Study||23
5076579|NCT01770743|12490145|P2|STARTED|Overall Study||34
5076580|NCT01770743|12490146|P1|STARTED|Overall Study||44
5076581|NCT01770691|12490198|P1|NOT COMPLETED|Overall Study||0
5076582|NCT01770691|12490198|P1|COMPLETED|Overall Study||7
5076583|NCT01770691|12490198|P1|STARTED|Overall Study||7
5076584|NCT01770652|12490209|P4|NOT COMPLETED|Overall Study||0
5076585|NCT01770652|12490210|P3|NOT COMPLETED|Overall Study||0
5076586|NCT01770652|12490211|P2|NOT COMPLETED|Overall Study||0
5076587|NCT01770652|12490212|P1|NOT COMPLETED|Overall Study||0
5076588|NCT01770652|12490209|P4|COMPLETED|Overall Study||8
5076589|NCT01770652|12490210|P3|COMPLETED|Overall Study||8
5076590|NCT01770652|12490211|P2|COMPLETED|Overall Study||8
5076591|NCT01770652|12490212|P1|COMPLETED|Overall Study||8
5076592|NCT01770652|12490209|P4|STARTED|Overall Study||8
5076593|NCT01770652|12490210|P3|STARTED|Overall Study||8
5076594|NCT01770652|12490211|P2|STARTED|Overall Study||8
5076595|NCT01770652|12490212|P1|STARTED|Overall Study||8
5076596|NCT01770509|12490248|P2|NOT COMPLETED|Overall Study||3
5076597|NCT01770509|12490249|P1|NOT COMPLETED|Overall Study||1
5076598|NCT01770509|12490248|P2|COMPLETED|Overall Study||14
5076599|NCT01770509|12490249|P1|COMPLETED|Overall Study||11
5076600|NCT01770509|12490248|P2|STARTED|Overall Study||17
5076601|NCT01770509|12490249|P1|STARTED|Overall Study||12
5076602|NCT01770483|12490265|P2|NOT COMPLETED|Overall Study||0
5076603|NCT01770483|12490266|P1|NOT COMPLETED|Overall Study||0
5076604|NCT01770483|12490265|P2|COMPLETED|Overall Study||33
5076605|NCT01770483|12490266|P1|COMPLETED|Overall Study||33
5076606|NCT01770483|12490265|P2|STARTED|Overall Study||33
5076607|NCT01770483|12490266|P1|STARTED|Overall Study||33
5076608|NCT01770431|12490276|P2|NOT COMPLETED|Overall Study||32
5076609|NCT01770431|12490277|P1|NOT COMPLETED|Overall Study||10
5076610|NCT01770431|12490276|P2|COMPLETED|Overall Study||316
5076611|NCT01770431|12490277|P1|COMPLETED|Overall Study||686
5076612|NCT01770431|12490276|P2|STARTED|Overall Study||348
5076613|NCT01770431|12490277|P1|STARTED|Overall Study||696
5076614|NCT01770392|12490285|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
5076615|NCT01770392|12490285|P1|COMPLETED|Nintedanib+ Rifampicin||25
5076616|NCT01770392|12490285|P1|STARTED|Nintedanib+ Rifampicin||25
5076617|NCT01770392|12490285|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
5076618|NCT01770392|12490285|P1|COMPLETED|Washout Period of at Least 14 Days||25
5076619|NCT01770392|12490285|P1|STARTED|Washout Period of at Least 14 Days||26
5076620|NCT01770392|12490285|P1|NOT COMPLETED|Nintedanib||0
5076621|NCT01770392|12490285|P1|COMPLETED|Nintedanib||26
5076622|NCT01770392|12490285|P1|STARTED|Nintedanib||26
5076623|NCT01770379|12490300|P3|NOT COMPLETED|Overall Study||42
5076624|NCT01770379|12490301|P2|NOT COMPLETED|Overall Study||44
5076625|NCT01770379|12490302|P1|NOT COMPLETED|Overall Study||39
5076626|NCT01770379|12490300|P3|COMPLETED|Overall Study||39
5076627|NCT01770379|12490301|P2|COMPLETED|Overall Study||37
5076628|NCT01770379|12490302|P1|COMPLETED|Overall Study||41
5076629|NCT01770379|12490300|P3|STARTED|Overall Study||81
5076630|NCT01770379|12490301|P2|STARTED|Overall Study||81
5076631|NCT01770379|12490302|P1|STARTED|Overall Study||80
5076632|NCT01770366|12490321|P2|NOT COMPLETED|Overall Study||2
5076633|NCT01770366|12490322|P1|NOT COMPLETED|Overall Study||2
5076634|NCT01770366|12490321|P2|COMPLETED|Overall Study||4
5076635|NCT01770366|12490322|P1|COMPLETED|Overall Study||2
5076636|NCT01770366|12490321|P2|STARTED|Overall Study||6
5076637|NCT01770366|12490322|P1|STARTED|Overall Study||4
5076638|NCT01770353|12490330|P2|NOT COMPLETED|Overall Study||12
5076639|NCT01770353|12490331|P1|NOT COMPLETED|Overall Study||6
5076640|NCT01770353|12490330|P2|COMPLETED|Overall Study||18
5076641|NCT01770353|12490331|P1|COMPLETED|Overall Study||9
5076642|NCT01770353|12490330|P2|Received FMX and MM-398|Overall Study||29
5076643|NCT01770353|12490331|P1|Received FMX and MM-398|Overall Study||13
5076644|NCT01770353|12490330|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
5076645|NCT01770353|12490331|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
5076646|NCT01770353|12490330|P2|STARTED|Overall Study||30
5076647|NCT01770353|12490331|P1|STARTED|Overall Study||15
5076648|NCT01770314|12490381|P2|NOT COMPLETED|Overall Study||0
5076649|NCT01770314|12490382|P1|NOT COMPLETED|Overall Study||0
5076650|NCT01770314|12490381|P2|COMPLETED|Overall Study||90
5076651|NCT01770314|12490382|P1|COMPLETED|Overall Study||86
5076652|NCT01770314|12490381|P2|Contributed Data to One-month Follow-up|Overall Study||66
5076653|NCT01770314|12490382|P1|Contributed Data to One-month Follow-up|Overall Study||61
5076654|NCT01770314|12490381|P2|Contributed Data to Post-test|Overall Study||67
5076655|NCT01770314|12490382|P1|Contributed Data to Post-test|Overall Study||65
5076656|NCT01770314|12490381|P2|Contributed Data to Baseline|Overall Study||72
5076657|NCT01770314|12490382|P1|Contributed Data to Baseline|Overall Study||68
5076658|NCT01770314|12490381|P2|STARTED|Overall Study||90
5076659|NCT01770314|12490382|P1|STARTED|Overall Study||86
5076660|NCT01770145|12490390|P1|NOT COMPLETED|Treatment||4
5076661|NCT01770145|12490390|P1|COMPLETED|Treatment||97
5076662|NCT01770145|12490390|P1|STARTED|Treatment||101
5076663|NCT01770145|12490390|P1|NOT COMPLETED|Baseline||26
5076664|NCT01770145|12490390|P1|COMPLETED|Baseline||101
5076665|NCT01770145|12490390|P1|STARTED|Baseline||127
5076666|NCT01769612|12490395|P1|NOT COMPLETED|Overall Study||0
5076667|NCT01769612|12490395|P1|COMPLETED|Overall Study||168
5076668|NCT01769612|12490395|P1|STARTED|Overall Study||168
5076669|NCT01769586|12490403|P2|NOT COMPLETED|Overall Study||0
5076670|NCT01769586|12490404|P1|NOT COMPLETED|Overall Study||0
5076671|NCT01769586|12490403|P2|COMPLETED|Overall Study||100
5076672|NCT01769586|12490404|P1|COMPLETED|Overall Study||100
5076673|NCT01769586|12490403|P2|STARTED|Overall Study||100
5076674|NCT01769586|12490404|P1|STARTED|Overall Study||100
5076675|NCT01769573|12490415|P5|NOT COMPLETED|Overall Study||0
5076676|NCT01769573|12490416|P4|NOT COMPLETED|Overall Study||0
5076677|NCT01769573|12490417|P3|NOT COMPLETED|Overall Study||0
5076678|NCT01769573|12490418|P2|NOT COMPLETED|Overall Study||0
5076679|NCT01769573|12490419|P1|NOT COMPLETED|Overall Study||0
5076680|NCT01769573|12490415|P5|COMPLETED|Overall Study||10
5076681|NCT01769573|12490416|P4|COMPLETED|Overall Study||0
5076682|NCT01769573|12490417|P3|COMPLETED|Overall Study||10
5076683|NCT01769573|12490418|P2|COMPLETED|Overall Study||6
5076684|NCT01769573|12490419|P1|COMPLETED|Overall Study||10
5076685|NCT01769573|12490415|P5|STARTED|Overall Study||10
5076686|NCT01769573|12490416|P4|STARTED|Overall Study||0
5076687|NCT01769573|12490417|P3|STARTED|Overall Study||10
5076688|NCT01769573|12490418|P2|STARTED|Overall Study||6
5076689|NCT01769573|12490419|P1|STARTED|Overall Study||10
5076690|NCT01769508|12490446|P1|NOT COMPLETED|Overall Study||6
5076691|NCT01769508|12490446|P1|COMPLETED|Overall Study||6
5076692|NCT01769508|12490446|P1|STARTED|Overall Study||12
5076693|NCT01769469|12490455|P1|NOT COMPLETED|Overall Study||35
5076694|NCT01769469|12490455|P1|COMPLETED|Overall Study||66
5076695|NCT01769469|12490455|P1|STARTED|Overall Study||101
5076696|NCT01769456|12490615|P1|NOT COMPLETED|Overall Study||37
5076697|NCT01769456|12490615|P1|COMPLETED|Overall Study||41
5076698|NCT01769456|12490615|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
5076699|NCT01769443|12490636|P2|NOT COMPLETED|Overall Study||0
5076700|NCT01769443|12490637|P1|NOT COMPLETED|Overall Study||1
5076701|NCT01769443|12490636|P2|COMPLETED|Overall Study||1
5076702|NCT01769443|12490637|P1|COMPLETED|Overall Study||0
5076703|NCT01769443|12490636|P2|STARTED|Overall Study||1
5076704|NCT01769443|12490637|P1|STARTED|Overall Study||1
5076705|NCT01769404|12490679|P2|NOT COMPLETED|Treatment Period 2||0
5076706|NCT01769404|12490680|P1|NOT COMPLETED|Treatment Period 2||7
5076707|NCT01769404|12490679|P2|COMPLETED|Treatment Period 2||13
5076708|NCT01769404|12490680|P1|COMPLETED|Treatment Period 2||0
5076709|NCT01769404|12490679|P2|STARTED|Treatment Period 2||13
5076710|NCT01769404|12490680|P1|STARTED|Treatment Period 2||7
5076711|NCT01769404|12490679|P2|NOT COMPLETED|Treatment Period 1||0
5076712|NCT01769404|12490680|P1|NOT COMPLETED|Treatment Period 1||5
5076713|NCT01769404|12490679|P2|COMPLETED|Treatment Period 1||13
5076714|NCT01769404|12490680|P1|COMPLETED|Treatment Period 1||7
5076715|NCT01769404|12490679|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
5076716|NCT01769404|12490680|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
5076717|NCT01769404|12490679|P2|STARTED|Treatment Period 1||13
5076718|NCT01769404|12490680|P1|STARTED|Treatment Period 1||12
5076719|NCT01769391|12490702|P2|NOT COMPLETED|Overall Study||9
5076720|NCT01769391|12490703|P1|NOT COMPLETED|Overall Study||17
5076721|NCT01769391|12490702|P2|COMPLETED|Overall Study||48
5076722|NCT01769391|12490703|P1|COMPLETED|Overall Study||93
5076723|NCT01769391|12490702|P2|Received at Least One Dose of Study Drug|Overall Study||55
5076724|NCT01769391|12490703|P1|Received at Least One Dose of Study Drug|Overall Study||106
5076725|NCT01769391|12490702|P2|STARTED|Overall Study||57
5076726|NCT01769391|12490703|P1|STARTED|Overall Study||110
5076727|NCT01769378|12490722|P2|NOT COMPLETED|Overall Study||4
5076728|NCT01769378|12490723|P1|NOT COMPLETED|Overall Study||25
5076729|NCT01769378|12490722|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
5076730|NCT01769378|12490723|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
5076731|NCT01769378|12490722|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
5076732|NCT01769378|12490723|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
5076733|NCT01769378|12490722|P2|STARTED|Overall Study||60
5076734|NCT01769378|12490723|P1|STARTED|Overall Study||240
5076735|NCT01769365|12490761|P3|NOT COMPLETED|Overall Study||2
5076736|NCT01769365|12490762|P2|NOT COMPLETED|Overall Study||2
5076737|NCT01769365|12490763|P1|NOT COMPLETED|Overall Study||0
5076738|NCT01769365|12490761|P3|COMPLETED|Overall Study||101
5076739|NCT01769365|12490762|P2|COMPLETED|Overall Study||100
5076740|NCT01769365|12490763|P1|COMPLETED|Overall Study||102
5076741|NCT01769365|12490761|P3|STARTED|Overall Study||103
5076742|NCT01769365|12490762|P2|STARTED|Overall Study||102
5076743|NCT01769365|12490763|P1|STARTED|Overall Study||102
5076744|NCT01769352|12490775|P4|NOT COMPLETED|Overall Study||0
5076745|NCT01769352|12490776|P3|NOT COMPLETED|Overall Study||0
5076746|NCT01769352|12490777|P2|NOT COMPLETED|Overall Study||0
5076747|NCT01769352|12490778|P1|NOT COMPLETED|Overall Study||0
5076748|NCT01769352|12490775|P4|COMPLETED|Overall Study||8
5076749|NCT01769352|12490776|P3|COMPLETED|Overall Study||9
5076750|NCT01769352|12490777|P2|COMPLETED|Overall Study||12
5076751|NCT01769352|12490778|P1|COMPLETED|Overall Study||13
5076752|NCT01769352|12490775|P4|STARTED|Overall Study||8
5076753|NCT01769352|12490776|P3|STARTED|Overall Study||9
5076754|NCT01769352|12490777|P2|STARTED|Overall Study||12
5076755|NCT01769352|12490778|P1|STARTED|Overall Study||13
5076756|NCT01769339|12490803|P1|NOT COMPLETED|Overall Study||43
5076757|NCT01769339|12490803|P1|COMPLETED|Overall Study||72
5076758|NCT01769339|12490803|P1|STARTED|Overall Study||115
5076759|NCT01769326|12490814|P4|NOT COMPLETED|Overall Study||0
5076760|NCT01769326|12490815|P3|NOT COMPLETED|Overall Study||1
5076761|NCT01769326|12490816|P2|NOT COMPLETED|Overall Study||4
5076762|NCT01769326|12490817|P1|NOT COMPLETED|Overall Study||2
5076763|NCT01769326|12490814|P4|COMPLETED|Overall Study||8
5076764|NCT01769326|12490815|P3|COMPLETED|Overall Study||8
5076765|NCT01769326|12490816|P2|COMPLETED|Overall Study||8
5076766|NCT01769326|12490817|P1|COMPLETED|Overall Study||9
5076767|NCT01769326|12490814|P4|STARTED|Overall Study||8
5076768|NCT01769326|12490815|P3|STARTED|Overall Study||9
5076769|NCT01769326|12490816|P2|STARTED|Overall Study||12
5076770|NCT01769326|12490817|P1|STARTED|Overall Study||11
5076771|NCT01769274|12490827|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
5076772|NCT01769274|12490828|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
5076773|NCT01769274|12490829|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
5076774|NCT01769274|12490827|P3|COMPLETED|Part B:Treatment Session2-Period4||3
5076775|NCT01769274|12490828|P2|COMPLETED|Part B:Treatment Session2-Period4||2
5076776|NCT01769274|12490829|P1|COMPLETED|Part B:Treatment Session2-Period4||0
5076777|NCT01769274|12490827|P3|STARTED|Part B:Treatment Session2-Period4||3
5076778|NCT01769274|12490828|P2|STARTED|Part B:Treatment Session2-Period4||2
5076779|NCT01769274|12490829|P1|STARTED|Part B:Treatment Session2-Period4||0
5076780|NCT01769274|12490827|P3|NOT COMPLETED|Washout Period||0
5076781|NCT01769274|12490828|P2|NOT COMPLETED|Washout Period||0
5076782|NCT01769274|12490829|P1|NOT COMPLETED|Washout Period||0
5076783|NCT01769274|12490827|P3|COMPLETED|Washout Period||3
5076784|NCT01769274|12490828|P2|COMPLETED|Washout Period||2
5076785|NCT01769274|12490829|P1|COMPLETED|Washout Period||0
5076786|NCT01769274|12490827|P3|STARTED|Washout Period||3
5076787|NCT01769274|12490828|P2|STARTED|Washout Period||2
5076788|NCT01769274|12490829|P1|STARTED|Washout Period||0
5076789|NCT01769274|12490827|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
5076790|NCT01769274|12490828|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
5076791|NCT01769274|12490829|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
5076792|NCT01769274|12490827|P3|COMPLETED|Part B:Treatment Session2-Period3||3
5076793|NCT01769274|12490828|P2|COMPLETED|Part B:Treatment Session2-Period3||2
5076794|NCT01769274|12490829|P1|COMPLETED|Part B:Treatment Session2-Period3||0
5076795|NCT01769274|12490827|P3|STARTED|Part B:Treatment Session2-Period3||3
5076796|NCT01769274|12490828|P2|STARTED|Part B:Treatment Session2-Period3||2
5076797|NCT01769274|12490829|P1|STARTED|Part B:Treatment Session2-Period3||0
5076798|NCT01769274|12490827|P3|NOT COMPLETED|Washout Period||0
5076799|NCT01769274|12490828|P2|NOT COMPLETED|Washout Period||0
5076800|NCT01769274|12490829|P1|NOT COMPLETED|Washout Period||0
5076801|NCT01769274|12490827|P3|COMPLETED|Washout Period||3
5076802|NCT01769274|12490828|P2|COMPLETED|Washout Period||2
5076803|NCT01769274|12490829|P1|COMPLETED|Washout Period||0
5076804|NCT01769274|12490827|P3|STARTED|Washout Period||3
5076805|NCT01769274|12490828|P2|STARTED|Washout Period||2
5076806|NCT01769274|12490829|P1|STARTED|Washout Period||0
5076807|NCT01769274|12490827|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
5076808|NCT01769274|12490828|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
5076809|NCT01769274|12490829|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
5076810|NCT01769274|12490827|P3|COMPLETED|Part B:Treatment Session1-Period2||3
5076811|NCT01769274|12490828|P2|COMPLETED|Part B:Treatment Session1-Period2||2
5076812|NCT01769274|12490829|P1|COMPLETED|Part B:Treatment Session1-Period2||0
5076813|NCT01769274|12490827|P3|STARTED|Part B:Treatment Session1-Period2||3
5076814|NCT01769274|12490828|P2|STARTED|Part B:Treatment Session1-Period2||2
5076815|NCT01769274|12490829|P1|STARTED|Part B:Treatment Session1-Period2||0
5076816|NCT01769274|12490827|P3|NOT COMPLETED|Washout Period||0
5076817|NCT01769274|12490828|P2|NOT COMPLETED|Washout Period||0
5076818|NCT01769274|12490829|P1|NOT COMPLETED|Washout Period||0
5076819|NCT01769274|12490827|P3|COMPLETED|Washout Period||3
5076820|NCT01769274|12490828|P2|COMPLETED|Washout Period||2
5076821|NCT01769274|12490829|P1|COMPLETED|Washout Period||0
5076822|NCT01769274|12490827|P3|STARTED|Washout Period||3
5076823|NCT01769274|12490828|P2|STARTED|Washout Period||2
5076824|NCT01769274|12490829|P1|STARTED|Washout Period||0
5076825|NCT01769274|12490827|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
5076826|NCT01769274|12490828|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
5076827|NCT01769274|12490829|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
5076828|NCT01769274|12490827|P3|COMPLETED|Part B:Treatment Session1-Period1||3
5076829|NCT01769274|12490828|P2|COMPLETED|Part B:Treatment Session1-Period1||2
5076830|NCT01769274|12490829|P1|COMPLETED|Part B:Treatment Session1-Period1||0
5076831|NCT01769274|12490827|P3|STARTED|Part B:Treatment Session1-Period1||3
5076832|NCT01769274|12490828|P2|STARTED|Part B:Treatment Session1-Period1||2
5076833|NCT01769274|12490829|P1|STARTED|Part B:Treatment Session1-Period1||0
5076834|NCT01769274|12490827|P3|NOT COMPLETED|Part A||0
5076835|NCT01769274|12490828|P2|NOT COMPLETED|Part A||0
5076836|NCT01769274|12490829|P1|NOT COMPLETED|Part A||0
5076837|NCT01769274|12490827|P3|COMPLETED|Part A||0
5076838|NCT01769274|12490828|P2|COMPLETED|Part A||0
5076839|NCT01769274|12490829|P1|COMPLETED|Part A||5
5076840|NCT01769274|12490827|P3|STARTED|Part A||0
5076841|NCT01769274|12490828|P2|STARTED|Part A||0
5076842|NCT01769274|12490829|P1|STARTED|Part A||5
5076843|NCT01769248|12490921|P2|NOT COMPLETED|Overall Study||12
5076844|NCT01769248|12490922|P1|NOT COMPLETED|Overall Study||28
5076845|NCT01769248|12490921|P2|COMPLETED|Overall Study||58
5076846|NCT01769248|12490922|P1|COMPLETED|Overall Study||42
5076847|NCT01769248|12490921|P2|Participants Who Crossed-over|Overall Study||12
5076848|NCT01769248|12490922|P1|Participants Who Crossed-over|Overall Study||28
5076849|NCT01769248|12490921|P2|STARTED|Overall Study||70
5076850|NCT01769248|12490922|P1|STARTED|Overall Study||70
5076851|NCT01769222|12490934|P2|NOT COMPLETED|Overall Study||0
5076852|NCT01769222|12490935|P1|NOT COMPLETED|Overall Study||0
5076853|NCT01769222|12490934|P2|COMPLETED|Overall Study||0
5076854|NCT01769222|12490935|P1|COMPLETED|Overall Study||3
5076855|NCT01769222|12490934|P2|STARTED|Overall Study||0
5076856|NCT01769222|12490935|P1|STARTED|Overall Study||3
5076857|NCT01769209|12490949|P1|NOT COMPLETED|Overall Study||0
5076858|NCT01769209|12490949|P1|COMPLETED|Overall Study||18
5076859|NCT01769209|12490949|P1|STARTED|Overall Study||18
5076860|NCT01769196|12490962|P2|NOT COMPLETED|Overall Study||272
5076861|NCT01769196|12490963|P1|NOT COMPLETED|Overall Study||272
5076862|NCT01769196|12490962|P2|COMPLETED|Overall Study||0
5076863|NCT01769196|12490963|P1|COMPLETED|Overall Study||0
5076864|NCT01769196|12490962|P2|STARTED|Overall Study||272
5076865|NCT01769196|12490963|P1|STARTED|Overall Study||272
5076866|NCT01769105|12490993|P2|NOT COMPLETED|Cross-over||0
5076867|NCT01769105|12490994|P1|NOT COMPLETED|Cross-over||5
5076868|NCT01769105|12490993|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
5076869|NCT01769105|12490994|P1|COMPLETED|Cross-over||9
5076964|NCT01768000|12491297|P4|COMPLETED|Overall Study||8
5076870|NCT01769105|12490993|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
5076871|NCT01769105|12490994|P1|STARTED|Cross-over||14
5076872|NCT01769105|12490993|P2|NOT COMPLETED|First Intervention||2
5076873|NCT01769105|12490994|P1|NOT COMPLETED|First Intervention||2
5076874|NCT01769105|12490993|P2|COMPLETED|First Intervention||17
5076875|NCT01769105|12490994|P1|COMPLETED|First Intervention||14
5076876|NCT01769105|12490993|P2|STARTED|First Intervention||19
5076877|NCT01769105|12490994|P1|STARTED|First Intervention||16
5076878|NCT01768858|12491013|P1|NOT COMPLETED|Overall Study||22
5076879|NCT01768858|12491013|P1|COMPLETED|Overall Study||74
5076880|NCT01768858|12491013|P1|STARTED|Overall Study||96
5076881|NCT01768832|12491028|P3|NOT COMPLETED|Overall Study||9
5076882|NCT01768832|12491029|P2|NOT COMPLETED|Overall Study||4
5076883|NCT01768832|12491030|P1|NOT COMPLETED|Overall Study||10
5076884|NCT01768832|12491028|P3|COMPLETED|Overall Study||26
5076885|NCT01768832|12491029|P2|COMPLETED|Overall Study||39
5076886|NCT01768832|12491030|P1|COMPLETED|Overall Study||31
5076887|NCT01768832|12491028|P3|STARTED|Overall Study||35
5076888|NCT01768832|12491029|P2|STARTED|Overall Study||43
5076889|NCT01768832|12491030|P1|STARTED|Overall Study||41
5076890|NCT01768676|12491064|P2|NOT COMPLETED|Overall Study||31
5076891|NCT01768676|12491065|P1|NOT COMPLETED|Overall Study||24
5076892|NCT01768676|12491064|P2|COMPLETED|Overall Study||60
5076893|NCT01768676|12491065|P1|COMPLETED|Overall Study||66
5076894|NCT01768676|12491064|P2|STARTED|Overall Study||91
5076895|NCT01768676|12491065|P1|STARTED|Overall Study||90
5076896|NCT01768637|12491081|P2|NOT COMPLETED|Overall Study||7
5076897|NCT01768637|12491082|P1|NOT COMPLETED|Overall Study||3
5076898|NCT01768637|12491081|P2|COMPLETED|Overall Study||12
5076899|NCT01768637|12491082|P1|COMPLETED|Overall Study||26
5076900|NCT01768637|12491081|P2|Completed Visit 2|Overall Study||13
5076901|NCT01768637|12491082|P1|Completed Visit 2|Overall Study||26
5076902|NCT01768637|12491081|P2|Completed Visit 1|Overall Study||16
5076903|NCT01768637|12491082|P1|Completed Visit 1|Overall Study||28
5076904|NCT01768637|12491081|P2|STARTED|Overall Study||19
5076905|NCT01768637|12491082|P1|STARTED|Overall Study||29
5076906|NCT01768572|12491095|P3|NOT COMPLETED|Overall Study||6
5076907|NCT01768572|12491096|P2|NOT COMPLETED|Overall Study||12
5076908|NCT01768572|12491097|P1|NOT COMPLETED|Overall Study||9
5076909|NCT01768572|12491095|P3|COMPLETED|Overall Study||96
5076910|NCT01768572|12491096|P2|COMPLETED|Overall Study||39
5076911|NCT01768572|12491097|P1|COMPLETED|Overall Study||40
5076912|NCT01768572|12491095|P3|STARTED|Overall Study||102
5076913|NCT01768572|12491096|P2|STARTED|Overall Study||51
5076914|NCT01768572|12491097|P1|STARTED|Overall Study||49
5076915|NCT01768559|12491108|P3|NOT COMPLETED|Overall Study||13
5076916|NCT01768559|12491109|P2|NOT COMPLETED|Overall Study||17
5076917|NCT01768559|12491110|P1|NOT COMPLETED|Overall Study||30
5076918|NCT01768559|12491108|P3|COMPLETED|Overall Study||285
5076919|NCT01768559|12491109|P2|COMPLETED|Overall Study||281
5076920|NCT01768559|12491110|P1|COMPLETED|Overall Study||268
5076921|NCT01768559|12491108|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
5076922|NCT01768559|12491109|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
5076923|NCT01768559|12491110|P1|Treated|Overall Study||298
5076924|NCT01768559|12491108|P3|STARTED|Overall Study||298
5076925|NCT01768559|12491109|P2|STARTED|Overall Study||298
5076926|NCT01768559|12491110|P1|STARTED|Overall Study||298
5076927|NCT01768520|12491161|P3|NOT COMPLETED|Overall Study||9
5076928|NCT01768520|12491162|P2|NOT COMPLETED|Overall Study||26
5076929|NCT01768520|12491163|P1|NOT COMPLETED|Overall Study||32
5076930|NCT01768520|12491161|P3|COMPLETED|Overall Study||30
5076931|NCT01768520|12491162|P2|COMPLETED|Overall Study||121
5076932|NCT01768520|12491163|P1|COMPLETED|Overall Study||120
5076933|NCT01768520|12491161|P3|STARTED|Overall Study||39
5076934|NCT01768520|12491162|P2|STARTED|Overall Study||147
5076935|NCT01768520|12491163|P1|STARTED|Overall Study||152
5076936|NCT01768325|12491176|P2|NOT COMPLETED|Overall Study||0
5076937|NCT01768325|12491177|P1|NOT COMPLETED|Overall Study||0
5076938|NCT01768325|12491176|P2|COMPLETED|Overall Study||41
5076939|NCT01768325|12491177|P1|COMPLETED|Overall Study||37
5076940|NCT01768325|12491176|P2|STARTED|Overall Study||41
5076941|NCT01768325|12491177|P1|STARTED|Overall Study||37
5076942|NCT01768286|12491191|P4|NOT COMPLETED|Overall Study||1
5076943|NCT01768286|12491192|P3|NOT COMPLETED|Overall Study||2
5076944|NCT01768286|12491193|P2|NOT COMPLETED|Overall Study||4
5076945|NCT01768286|12491194|P1|NOT COMPLETED|Overall Study||7
5076946|NCT01768286|12491191|P4|COMPLETED|Overall Study||110
5076947|NCT01768286|12491192|P3|COMPLETED|Overall Study||108
5076948|NCT01768286|12491193|P2|COMPLETED|Overall Study||107
5076949|NCT01768286|12491194|P1|COMPLETED|Overall Study||102
5076950|NCT01768286|12491191|P4|STARTED|Overall Study||111
5076951|NCT01768286|12491192|P3|STARTED|Overall Study||110
5076952|NCT01768286|12491193|P2|STARTED|Overall Study||111
5076953|NCT01768286|12491194|P1|STARTED|Overall Study||109
5076954|NCT01768117|12491256|P1|NOT COMPLETED|Overall Study||6
5076955|NCT01768117|12491256|P1|COMPLETED|Overall Study||7
5076956|NCT01768117|12491256|P1|STARTED|Overall Study||13
5076957|NCT01768013|12491264|P1|NOT COMPLETED|Overall Study||0
5076958|NCT01768013|12491264|P1|COMPLETED|Overall Study||13
5076959|NCT01768013|12491264|P1|STARTED|Overall Study||13
5076960|NCT01768000|12491297|P4|NOT COMPLETED|Overall Study||2
5076961|NCT01768000|12491298|P3|NOT COMPLETED|Overall Study||1
5076962|NCT01768000|12491299|P2|NOT COMPLETED|Overall Study||2
5076963|NCT01768000|12491300|P1|NOT COMPLETED|Overall Study||1
5076965|NCT01768000|12491298|P3|COMPLETED|Overall Study||9
5076966|NCT01768000|12491299|P2|COMPLETED|Overall Study||8
5076967|NCT01768000|12491300|P1|COMPLETED|Overall Study||9
5076968|NCT01768000|12491297|P4|STARTED|Overall Study||10
5076969|NCT01768000|12491298|P3|STARTED|Overall Study||10
5076970|NCT01768000|12491299|P2|STARTED|Overall Study||10
5076971|NCT01768000|12491300|P1|STARTED|Overall Study||10
5076972|NCT01767987|12491320|P2|NOT COMPLETED|Overall Study||1
5076973|NCT01767987|12491321|P1|NOT COMPLETED|Overall Study||4
5076974|NCT01767987|12491320|P2|COMPLETED|Overall Study||1
5076975|NCT01767987|12491321|P1|COMPLETED|Overall Study||0
5076976|NCT01767987|12491320|P2|STARTED|Overall Study||2
5076977|NCT01767987|12491321|P1|STARTED|Overall Study||4
5076978|NCT01767935|12491343|P1|NOT COMPLETED|Overall Study||0
5076979|NCT01767935|12491343|P1|COMPLETED|Overall Study||1
5076980|NCT01767935|12491343|P1|STARTED|Overall Study||1
5076981|NCT01767909|12491353|P2|NOT COMPLETED|Overall Study||12
5076982|NCT01767909|12491354|P1|NOT COMPLETED|Overall Study||13
5076983|NCT01767909|12491353|P2|COMPLETED|Overall Study||107
5076984|NCT01767909|12491354|P1|COMPLETED|Overall Study||108
5076985|NCT01767909|12491353|P2|STARTED|Overall Study||119
5076986|NCT01767909|12491354|P1|STARTED|Overall Study||121
5076987|NCT01767792|12491370|P1|NOT COMPLETED|Overall Study||2
5076988|NCT01767792|12491370|P1|COMPLETED|Overall Study||20
5076989|NCT01767792|12491370|P1|STARTED|Overall Study||22
5076990|NCT01767701|12491380|P1|NOT COMPLETED|Overall Study||0
5076991|NCT01767701|12491380|P1|COMPLETED|Overall Study||20
5076992|NCT01767701|12491380|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
5076993|NCT01767688|12491393|P2|NOT COMPLETED|Overall Study||0
5076994|NCT01767688|12491394|P1|NOT COMPLETED|Overall Study||0
5076995|NCT01767688|12491393|P2|COMPLETED|Overall Study||8
5076996|NCT01767688|12491394|P1|COMPLETED|Overall Study||8
5076997|NCT01767688|12491393|P2|STARTED|Overall Study||8
5076998|NCT01767688|12491394|P1|STARTED|Overall Study||8
5076999|NCT01767636|12491414|P1|NOT COMPLETED|Overall Study||3
5077000|NCT01767636|12491414|P1|COMPLETED|Overall Study||35
5077001|NCT01767636|12491414|P1|STARTED|Overall Study||38
5077002|NCT01767597|12491424|P2|NOT COMPLETED|Overall Study||1
5077003|NCT01767597|12491425|P1|NOT COMPLETED|Overall Study||4
5077004|NCT01767597|12491424|P2|COMPLETED|Overall Study||499
5077005|NCT01767597|12491425|P1|COMPLETED|Overall Study||496
5077006|NCT01767597|12491424|P2|STARTED|Overall Study||500
5077007|NCT01767597|12491425|P1|STARTED|Overall Study||500
5077008|NCT01767519|12491434|P3|NOT COMPLETED|Overall Study||5
5077009|NCT01767519|12491435|P2|NOT COMPLETED|Overall Study||13
5077010|NCT01767519|12491436|P1|NOT COMPLETED|Overall Study||14
5077011|NCT01767519|12491434|P3|COMPLETED|Overall Study||55
5077012|NCT01767519|12491435|P2|COMPLETED|Overall Study||138
5077013|NCT01767519|12491436|P1|COMPLETED|Overall Study||131
5077014|NCT01767519|12491434|P3|STARTED|Overall Study||60
5077015|NCT01767519|12491435|P2|STARTED|Overall Study||151
5077016|NCT01767519|12491436|P1|STARTED|Overall Study||145
5077017|NCT01767506|12491464|P2|NOT COMPLETED|Overall Study||0
5077018|NCT01767506|12491465|P1|NOT COMPLETED|Overall Study||0
5077019|NCT01767506|12491464|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
5077020|NCT01767506|12491465|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
5077021|NCT01767506|12491464|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
5077022|NCT01767506|12491465|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
5077023|NCT01767467|12491477|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
5077024|NCT01767467|12491478|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
5077025|NCT01767467|12491477|P2|COMPLETED|End of Study Phase (up to Month 13)||216
5077026|NCT01767467|12491478|P1|COMPLETED|End of Study Phase (up to Month 13)||236
5077027|NCT01767467|12491477|P2|STARTED|End of Study Phase (up to Month 13)||279
5077028|NCT01767467|12491478|P1|STARTED|End of Study Phase (up to Month 13)||283
5077029|NCT01767467|12491477|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
5077030|NCT01767467|12491478|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
5077031|NCT01767467|12491477|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
5077032|NCT01767467|12491478|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
5077033|NCT01767467|12491477|P2|STARTED|Vaccination Phase (up to Month 2)||279
5077034|NCT01767467|12491478|P1|STARTED|Vaccination Phase (up to Month 2)||283
5077035|NCT01767415|12491526|P1|NOT COMPLETED|Overall Study||0
5077036|NCT01767415|12491526|P1|COMPLETED|Overall Study||10
5077037|NCT01767415|12491526|P1|STARTED|Overall Study||10
5077038|NCT01767376|12491534|P3|NOT COMPLETED|Overall Study||0
5077039|NCT01767376|12491535|P2|NOT COMPLETED|Overall Study||3
5077040|NCT01767376|12491536|P1|NOT COMPLETED|Overall Study||4
5077041|NCT01767376|12491534|P3|COMPLETED|Overall Study||232
5077042|NCT01767376|12491535|P2|COMPLETED|Overall Study||225
5077043|NCT01767376|12491536|P1|COMPLETED|Overall Study||227
5077044|NCT01767376|12491534|P3|STARTED|Overall Study||232
5077045|NCT01767376|12491535|P2|STARTED|Overall Study||228
5077046|NCT01767376|12491536|P1|STARTED|Overall Study||231
5077047|NCT01767285|12491583|P2|NOT COMPLETED|Overall Study||6
5077048|NCT01767285|12491584|P1|NOT COMPLETED|Overall Study||7
5077049|NCT01767285|12491583|P2|COMPLETED|Overall Study||24
5077050|NCT01767285|12491584|P1|COMPLETED|Overall Study||22
5077051|NCT01767285|12491583|P2|STARTED|Overall Study||30
5077052|NCT01767285|12491584|P1|STARTED|Overall Study||29
5077053|NCT01767194|12491602|P2|NOT COMPLETED|Overall Study||43
5077054|NCT01767194|12491603|P1|NOT COMPLETED|Overall Study||18
5077055|NCT01767194|12491602|P2|COMPLETED|Overall Study||11
5077056|NCT01767194|12491603|P1|COMPLETED|Overall Study||1
5077057|NCT01767194|12491602|P2|STARTED|Overall Study||54
5077058|NCT01767194|12491603|P1|STARTED|Overall Study||19
5077059|NCT01767155|12491612|P2|NOT COMPLETED|Overall Study||15
5077060|NCT01767155|12491613|P1|NOT COMPLETED|Overall Study||13
5077061|NCT01767155|12491612|P2|COMPLETED|Overall Study||240
5077062|NCT01767155|12491613|P1|COMPLETED|Overall Study||243
5077063|NCT01767155|12491612|P2|Safety Population (SAF)|Overall Study||249
5077064|NCT01767155|12491613|P1|Safety Population (SAF)|Overall Study||252
5077065|NCT01767155|12491612|P2|Modified ITT (mITT)|Overall Study||249
5077066|NCT01767155|12491613|P1|Modified ITT (mITT)|Overall Study||252
5077067|NCT01767155|12491612|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
5077068|NCT01767155|12491613|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
5077069|NCT01767116|12491627|P2|NOT COMPLETED|Overall Study||2
5077070|NCT01767116|12491628|P1|NOT COMPLETED|Overall Study||2
5077071|NCT01767116|12491627|P2|COMPLETED|Overall Study||207
5077072|NCT01767116|12491628|P1|COMPLETED|Overall Study||208
5077073|NCT01767116|12491627|P2|STARTED|Overall Study||209
5077074|NCT01767116|12491628|P1|STARTED|Overall Study||210
5077075|NCT01767103|12491647|P3|NOT COMPLETED|Overall Study||0
5077076|NCT01767103|12491648|P2|NOT COMPLETED|Overall Study||0
5077077|NCT01767103|12491649|P1|NOT COMPLETED|Overall Study||0
5077078|NCT01767103|12491647|P3|COMPLETED|Overall Study||7
5077079|NCT01767103|12491648|P2|COMPLETED|Overall Study||7
5077080|NCT01767103|12491649|P1|COMPLETED|Overall Study||7
5077081|NCT01767103|12491647|P3|STARTED|Overall Study||7
5077082|NCT01767103|12491648|P2|STARTED|Overall Study||7
5077083|NCT01767103|12491649|P1|STARTED|Overall Study||7
5077084|NCT01767064|12491677|P2|NOT COMPLETED|Overall Study||0
5077085|NCT01767064|12491678|P1|NOT COMPLETED|Overall Study||0
5077086|NCT01767064|12491677|P2|COMPLETED|Overall Study||7
5077087|NCT01767064|12491678|P1|COMPLETED|Overall Study||7
5077088|NCT01767064|12491677|P2|STARTED|Overall Study||7
5077089|NCT01767064|12491678|P1|STARTED|Overall Study||7
5077090|NCT01766921|12491686|P2|NOT COMPLETED|Overall Study||17
5077091|NCT01766921|12491687|P1|NOT COMPLETED|Overall Study||24
5077092|NCT01766921|12491686|P2|COMPLETED|Overall Study||676
5077093|NCT01766921|12491687|P1|COMPLETED|Overall Study||676
5077094|NCT01766921|12491686|P2|STARTED|Overall Study||693
5077095|NCT01766921|12491687|P1|STARTED|Overall Study||700
5077096|NCT01766817|12491709|P3|NOT COMPLETED|Overall Study||13
5077097|NCT01766817|12491710|P2|NOT COMPLETED|Overall Study||11
5077098|NCT01766817|12491711|P1|NOT COMPLETED|Overall Study||11
5077099|NCT01766817|12491709|P3|COMPLETED|Overall Study||34
5077100|NCT01766817|12491710|P2|COMPLETED|Overall Study||37
5077101|NCT01766817|12491711|P1|COMPLETED|Overall Study||37
5077102|NCT01766817|12491709|P3|STARTED|Overall Study||47
5077103|NCT01766817|12491710|P2|STARTED|Overall Study||48
5077104|NCT01766817|12491711|P1|STARTED|Overall Study||48
5077105|NCT01766778|12491762|P2|NOT COMPLETED|Overall Study||4
5077106|NCT01766778|12491763|P1|NOT COMPLETED|Overall Study||5
5077107|NCT01766778|12491762|P2|COMPLETED|Overall Study||57
5077108|NCT01766778|12491763|P1|COMPLETED|Overall Study||51
5077109|NCT01766778|12491762|P2|STARTED|Overall Study||61
5077110|NCT01766778|12491763|P1|STARTED|Overall Study|Intent to treat population|56
5077111|NCT01766713|12491781|P2|NOT COMPLETED|Overall Study||3
5077112|NCT01766713|12491782|P1|NOT COMPLETED|Overall Study||2
5077113|NCT01766713|12491781|P2|COMPLETED|Overall Study||22
5077114|NCT01766713|12491782|P1|COMPLETED|Overall Study||23
5077115|NCT01766713|12491781|P2|STARTED|Overall Study||25
5077116|NCT01766713|12491782|P1|STARTED|Overall Study||25
5077117|NCT01766466|12491790|P4|NOT COMPLETED|Day 5||0
5077118|NCT01766466|12491791|P3|NOT COMPLETED|Day 5||0
5077119|NCT01766466|12491792|P2|NOT COMPLETED|Day 5||0
5077120|NCT01766466|12491793|P1|NOT COMPLETED|Day 5||0
5077121|NCT01766466|12491790|P4|COMPLETED|Day 5||6
5077122|NCT01766466|12491791|P3|COMPLETED|Day 5||0
5077123|NCT01766466|12491792|P2|COMPLETED|Day 5||6
5077124|NCT01766466|12491793|P1|COMPLETED|Day 5||0
5077125|NCT01766466|12491790|P4|STARTED|Day 5||6
5077126|NCT01766466|12491791|P3|STARTED|Day 5||0
5077127|NCT01766466|12491792|P2|STARTED|Day 5||6
5077128|NCT01766466|12491793|P1|STARTED|Day 5||0
5077129|NCT01766466|12491790|P4|NOT COMPLETED|Day 1||0
5077130|NCT01766466|12491791|P3|NOT COMPLETED|Day 1||0
5077131|NCT01766466|12491792|P2|NOT COMPLETED|Day 1||0
5077132|NCT01766466|12491793|P1|NOT COMPLETED|Day 1||0
5077133|NCT01766466|12491790|P4|COMPLETED|Day 1||0
5077134|NCT01766466|12491791|P3|COMPLETED|Day 1||6
5077135|NCT01766466|12491792|P2|COMPLETED|Day 1||0
5077136|NCT01766466|12491793|P1|COMPLETED|Day 1||6
5077137|NCT01766466|12491790|P4|STARTED|Day 1||0
5077138|NCT01766466|12491791|P3|STARTED|Day 1||6
5077139|NCT01766466|12491792|P2|STARTED|Day 1||0
5077140|NCT01766466|12491793|P1|STARTED|Day 1||6
5077141|NCT01766440|12491806|P1|NOT COMPLETED|Overall Study||1
5077142|NCT01766440|12491806|P1|COMPLETED|Overall Study||17
5077143|NCT01766440|12491806|P1|STARTED|Overall Study||18
5077144|NCT01766401|12491817|P2|NOT COMPLETED|Overall Study||56
5077145|NCT01766401|12491818|P1|NOT COMPLETED|Overall Study||37
5077146|NCT01766401|12491817|P2|COMPLETED|Overall Study||144
5077147|NCT01766401|12491818|P1|COMPLETED|Overall Study||161
5077148|NCT01766401|12491817|P2|STARTED|Overall Study||200
5077149|NCT01766401|12491818|P1|STARTED|Overall Study||198
5077150|NCT01766336|12491828|P2|NOT COMPLETED|Overall Study||75
5077151|NCT01766336|12491829|P1|NOT COMPLETED|Overall Study||90
5077152|NCT01766336|12491828|P2|COMPLETED|Overall Study||71
5077153|NCT01766336|12491829|P1|COMPLETED|Overall Study||60
5077154|NCT01766336|12491828|P2|STARTED|Overall Study||146
5077155|NCT01766336|12491829|P1|STARTED|Overall Study||150
5077156|NCT01766310|12491837|P2|NOT COMPLETED|Overall Study||3
5077157|NCT01766310|12491838|P1|NOT COMPLETED|Overall Study||1
5077158|NCT01766310|12491837|P2|COMPLETED|Overall Study||23
5077159|NCT01766310|12491838|P1|COMPLETED|Overall Study||23
5077160|NCT01766310|12491837|P2|STARTED|Overall Study||26
5077161|NCT01766310|12491838|P1|STARTED|Overall Study||24
5077162|NCT01766219|12491849|P3|NOT COMPLETED|Overall Study||0
5077163|NCT01766219|12491850|P2|NOT COMPLETED|Overall Study||0
5077164|NCT01766219|12491851|P1|NOT COMPLETED|Overall Study||0
5077165|NCT01766219|12491849|P3|COMPLETED|Overall Study||11
5077166|NCT01766219|12491850|P2|COMPLETED|Overall Study||2
5077167|NCT01766219|12491851|P1|COMPLETED|Overall Study||4
5077168|NCT01766219|12491849|P3|STARTED|Overall Study||11
5077169|NCT01766219|12491850|P2|STARTED|Overall Study||2
5077170|NCT01766219|12491851|P1|STARTED|Overall Study||4
5077171|NCT01766206|12491868|P1|NOT COMPLETED|Overall Study||51
5077172|NCT01766206|12491868|P1|COMPLETED|Overall Study||3888
5077173|NCT01766206|12491868|P1|STARTED|Overall Study||3939
5077174|NCT01766102|12491877|P2|NOT COMPLETED|Overall Study||0
5077175|NCT01766102|12491878|P1|NOT COMPLETED|Overall Study||0
5077176|NCT01766102|12491877|P2|COMPLETED|Overall Study||36
5077177|NCT01766102|12491878|P1|COMPLETED|Overall Study||36
5077178|NCT01766102|12491877|P2|STARTED|Overall Study||36
5077179|NCT01766102|12491878|P1|STARTED|Overall Study||36
5077180|NCT01766076|12491888|P2|NOT COMPLETED|Overall Study||0
5077181|NCT01766076|12491889|P1|NOT COMPLETED|Overall Study||0
5077182|NCT01766076|12491888|P2|COMPLETED|Overall Study||15
5077183|NCT01766076|12491889|P1|COMPLETED|Overall Study||15
5077184|NCT01766076|12491888|P2|STARTED|Overall Study||15
5077185|NCT01766076|12491889|P1|STARTED|Overall Study||15
5077186|NCT01766050|12491895|P1|NOT COMPLETED|Overall Study||4
5077187|NCT01766050|12491895|P1|COMPLETED|Overall Study||18
5077188|NCT01766050|12491895|P1|STARTED|Overall Study||22
5077189|NCT01766037|12492030|P2|NOT COMPLETED|Overall Study||29
5077190|NCT01766037|12492031|P1|NOT COMPLETED|Overall Study||29
5077191|NCT01766037|12492030|P2|COMPLETED|Overall Study||31
5077192|NCT01766037|12492031|P1|COMPLETED|Overall Study||82
5077193|NCT01766037|12492030|P2|STARTED|Overall Study||60
5077194|NCT01766037|12492031|P1|STARTED|Overall Study||111
5077195|NCT01766024|12492068|P2|NOT COMPLETED|Overall Study||0
5077196|NCT01766024|12492069|P1|NOT COMPLETED|Overall Study||0
5077197|NCT01766024|12492068|P2|COMPLETED|Overall Study||16
5077198|NCT01766024|12492069|P1|COMPLETED|Overall Study||16
5077199|NCT01766024|12492068|P2|STARTED|Overall Study||16
5077200|NCT01766024|12492069|P1|STARTED|Overall Study||16
5077201|NCT01765972|12492079|P4|NOT COMPLETED|Overall Study||0
5077202|NCT01765972|12492080|P3|NOT COMPLETED|Overall Study||0
5077203|NCT01765972|12492081|P2|NOT COMPLETED|Overall Study||0
5077204|NCT01765972|12492082|P1|NOT COMPLETED|Overall Study||0
5077205|NCT01765972|12492079|P4|COMPLETED|Overall Study||6
5077206|NCT01765972|12492080|P3|COMPLETED|Overall Study||6
5077207|NCT01765972|12492081|P2|COMPLETED|Overall Study||6
5077208|NCT01765972|12492082|P1|COMPLETED|Overall Study||6
5077209|NCT01765972|12492079|P4|STARTED|Overall Study||6
5077210|NCT01765972|12492080|P3|STARTED|Overall Study||6
5077211|NCT01765972|12492081|P2|STARTED|Overall Study||6
5077212|NCT01765972|12492082|P1|STARTED|Overall Study||6
5077213|NCT01765803|12492092|P1|NOT COMPLETED|Overall Study||0
5077214|NCT01765803|12492092|P1|COMPLETED|Overall Study||6
5077215|NCT01765803|12492092|P1|STARTED|Overall Study||6
5077216|NCT01765764|12492100|P3|NOT COMPLETED|Post-treatment Period||0
5077217|NCT01765764|12492101|P2|NOT COMPLETED|Post-treatment Period||0
5077218|NCT01765764|12492102|P1|NOT COMPLETED|Post-treatment Period||0
5077219|NCT01765764|12492100|P3|COMPLETED|Post-treatment Period||112
5077220|NCT01765764|12492101|P2|COMPLETED|Post-treatment Period||107
5077221|NCT01765764|12492102|P1|COMPLETED|Post-treatment Period||114
5077222|NCT01765764|12492100|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
5077223|NCT01765764|12492101|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
5077224|NCT01765764|12492102|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
5077225|NCT01765764|12492100|P3|NOT COMPLETED|Treatment Period||6
5077226|NCT01765764|12492101|P2|NOT COMPLETED|Treatment Period||9
5077227|NCT01765764|12492102|P1|NOT COMPLETED|Treatment Period||3
5077228|NCT01765764|12492100|P3|COMPLETED|Treatment Period||115
5077229|NCT01765764|12492101|P2|COMPLETED|Treatment Period||109
5077230|NCT01765764|12492102|P1|COMPLETED|Treatment Period||115
5077231|NCT01765764|12492100|P3|STARTED|Treatment Period||121
5077232|NCT01765764|12492101|P2|STARTED|Treatment Period||118
5077233|NCT01765764|12492102|P1|STARTED|Treatment Period||118
5077234|NCT01765751|12492122|P3|NOT COMPLETED|Overall Study||1
5077235|NCT01765751|12492123|P2|NOT COMPLETED|Overall Study||2
5077236|NCT01765751|12492124|P1|NOT COMPLETED|Overall Study||0
5077237|NCT01765751|12492122|P3|COMPLETED|Overall Study||15
5077238|NCT01765751|12492123|P2|COMPLETED|Overall Study||14
5077239|NCT01765751|12492124|P1|COMPLETED|Overall Study||16
5077240|NCT01765751|12492122|P3|STARTED|Overall Study||16
5077241|NCT01765751|12492123|P2|STARTED|Overall Study||16
5077242|NCT01765751|12492124|P1|STARTED|Overall Study||16
5077243|NCT01765673|12492156|P1|NOT COMPLETED|Overall Study||1
5077244|NCT01765673|12492156|P1|COMPLETED|Overall Study||11
5077245|NCT01765673|12492156|P1|STARTED|Overall Study||12
5077246|NCT01765647|12492179|P1|NOT COMPLETED|Overall Study||0
5077247|NCT01765647|12492179|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
5077248|NCT01765647|12492179|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
5077249|NCT01765582|12492189|P3|NOT COMPLETED|Overall Study||95
5077250|NCT01765582|12492190|P2|NOT COMPLETED|Overall Study||92
5077251|NCT01765582|12492191|P1|NOT COMPLETED|Overall Study||93
5077252|NCT01765582|12492189|P3|COMPLETED|Overall Study||0
5077253|NCT01765582|12492190|P2|COMPLETED|Overall Study||0
5077254|NCT01765582|12492191|P1|COMPLETED|Overall Study||0
5077255|NCT01765582|12492189|P3|STARTED|Overall Study||95
5077256|NCT01765582|12492190|P2|STARTED|Overall Study||92
5077257|NCT01765582|12492191|P1|STARTED|Overall Study||93
5077258|NCT01765569|12492224|P1|NOT COMPLETED|Period C||1
5077259|NCT01765569|12492224|P1|COMPLETED|Period C||27
5077260|NCT01765569|12492224|P1|STARTED|Period C||28
5077261|NCT01765569|12492224|P1|NOT COMPLETED|Period B||1
5077262|NCT01765569|12492224|P1|COMPLETED|Period B||28
5077263|NCT01765569|12492224|P1|STARTED|Period B||29
5077264|NCT01765569|12492224|P1|NOT COMPLETED|Period A||0
5077265|NCT01765569|12492224|P1|COMPLETED|Period A||29
5077266|NCT01765569|12492224|P1|STARTED|Period A||29
5077267|NCT01765543|12492245|P1|NOT COMPLETED|Overall Study||3
5077268|NCT01765543|12492245|P1|COMPLETED|Overall Study||24
5077269|NCT01765543|12492245|P1|STARTED|Overall Study||27
5077270|NCT01765530|12492269|P2|NOT COMPLETED|Overall Study||1
5077271|NCT01765530|12492270|P1|NOT COMPLETED|Overall Study||1
5077272|NCT01765530|12492269|P2|COMPLETED|Overall Study||36
5077273|NCT01765530|12492270|P1|COMPLETED|Overall Study||36
5077274|NCT01765530|12492269|P2|STARTED|Overall Study||37
5077275|NCT01765530|12492270|P1|STARTED|Overall Study||37
5077276|NCT01765465|12492280|P2|NOT COMPLETED|Overall Study||4
5077277|NCT01765465|12492281|P1|NOT COMPLETED|Overall Study||7
5077278|NCT01765465|12492280|P2|COMPLETED|Overall Study||63
5077279|NCT01765465|12492281|P1|COMPLETED|Overall Study||64
5077280|NCT01765465|12492280|P2|STARTED|Overall Study||67
5077281|NCT01765465|12492281|P1|STARTED|Overall Study||71
5077282|NCT01765426|12492297|P4|NOT COMPLETED|Overall Study||0
5077283|NCT01765426|12492298|P3|NOT COMPLETED|Overall Study||0
5077284|NCT01765426|12492299|P2|NOT COMPLETED|Overall Study||1
5077285|NCT01765426|12492300|P1|NOT COMPLETED|Overall Study||0
5077286|NCT01765426|12492297|P4|COMPLETED|Overall Study||15
5077287|NCT01765426|12492298|P3|COMPLETED|Overall Study||17
5077288|NCT01765426|12492299|P2|COMPLETED|Overall Study||16
5077289|NCT01765426|12492300|P1|COMPLETED|Overall Study||18
5077290|NCT01765426|12492297|P4|Completed All Vaccinations|Overall Study||15
5077291|NCT01765426|12492298|P3|Completed All Vaccinations|Overall Study||17
5077292|NCT01765426|12492299|P2|Completed All Vaccinations|Overall Study||16
5077293|NCT01765426|12492300|P1|Completed All Vaccinations|Overall Study||17
5077294|NCT01765426|12492297|P4|STARTED|Overall Study||15
5077295|NCT01765426|12492298|P3|STARTED|Overall Study||17
5077296|NCT01765426|12492299|P2|STARTED|Overall Study||17
5077297|NCT01765426|12492300|P1|STARTED|Overall Study||18
5077298|NCT01765270|12492356|P2|NOT COMPLETED|Overall Study||1
5077299|NCT01765270|12492357|P1|NOT COMPLETED|Overall Study||1
5077300|NCT01765270|12492356|P2|COMPLETED|Overall Study||6
5077301|NCT01765270|12492357|P1|COMPLETED|Overall Study||4
5077302|NCT01765270|12492356|P2|STARTED|Overall Study||7
5077303|NCT01765270|12492357|P1|STARTED|Overall Study||5
5077304|NCT01765192|12492379|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
5077305|NCT01765192|12492380|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
5077306|NCT01765192|12492379|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
5077307|NCT01765192|12492380|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
5077308|NCT01765192|12492379|P2|STARTED|End of Treatment Period 2 to Final Visit||28
5077309|NCT01765192|12492380|P1|STARTED|End of Treatment Period 2 to Final Visit||30
5077310|NCT01765192|12492379|P2|NOT COMPLETED|Treatment Period 2||2
5077311|NCT01765192|12492380|P1|NOT COMPLETED|Treatment Period 2||0
5077312|NCT01765192|12492379|P2|COMPLETED|Treatment Period 2||28
5077313|NCT01765192|12492380|P1|COMPLETED|Treatment Period 2||30
5077314|NCT01765192|12492379|P2|STARTED|Treatment Period 2||30
5077315|NCT01765192|12492380|P1|STARTED|Treatment Period 2||30
5077316|NCT01765192|12492379|P2|NOT COMPLETED|Washout Period||1
5077317|NCT01765192|12492380|P1|NOT COMPLETED|Washout Period||2
5077318|NCT01765192|12492379|P2|COMPLETED|Washout Period||30
5077319|NCT01765192|12492380|P1|COMPLETED|Washout Period||30
5077320|NCT01765192|12492379|P2|STARTED|Washout Period||31
5077321|NCT01765192|12492380|P1|STARTED|Washout Period||32
5077322|NCT01765192|12492379|P2|NOT COMPLETED|Treatment Period 1||1
5077323|NCT01765192|12492380|P1|NOT COMPLETED|Treatment Period 1||0
5077324|NCT01765192|12492379|P2|COMPLETED|Treatment Period 1||31
5077325|NCT01765192|12492380|P1|COMPLETED|Treatment Period 1||32
5077326|NCT01765192|12492379|P2|STARTED|Treatment Period 1||32
5077327|NCT01765192|12492380|P1|STARTED|Treatment Period 1||32
5077328|NCT01765179|12492398|P1|NOT COMPLETED|Overall Study||27
5077329|NCT01765179|12492398|P1|COMPLETED|Overall Study||117
5077330|NCT01765179|12492398|P1|STARTED|Overall Study||144
5077331|NCT01765153|12492405|P2|NOT COMPLETED|Rest Phase 2||1
5077332|NCT01765153|12492406|P1|NOT COMPLETED|Rest Phase 2||2
5077333|NCT01765153|12492405|P2|COMPLETED|Rest Phase 2||7
5077334|NCT01765153|12492406|P1|COMPLETED|Rest Phase 2||8
5077335|NCT01765153|12492405|P2|STARTED|Rest Phase 2||8
5077336|NCT01765153|12492406|P1|STARTED|Rest Phase 2||10
5077337|NCT01765153|12492405|P2|NOT COMPLETED|Training Phase 2||1
5077338|NCT01765153|12492406|P1|NOT COMPLETED|Training Phase 2||0
5077339|NCT01765153|12492405|P2|COMPLETED|Training Phase 2||8
5077340|NCT01765153|12492406|P1|COMPLETED|Training Phase 2||10
5077341|NCT01765153|12492405|P2|STARTED|Training Phase 2||9
5077342|NCT01765153|12492406|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
5077343|NCT01765153|12492405|P2|NOT COMPLETED|Rest Phase 1||1
5077344|NCT01765153|12492406|P1|NOT COMPLETED|Rest Phase 1||0
5077345|NCT01765153|12492405|P2|COMPLETED|Rest Phase 1||9
5077346|NCT01765153|12492406|P1|COMPLETED|Rest Phase 1||9
5077347|NCT01765153|12492405|P2|STARTED|Rest Phase 1||10
5077348|NCT01765153|12492406|P1|STARTED|Rest Phase 1||9
5077349|NCT01765153|12492405|P2|NOT COMPLETED|Training Phase 1||1
5077350|NCT01765153|12492406|P1|NOT COMPLETED|Training Phase 1||1
5077351|NCT01765153|12492405|P2|COMPLETED|Training Phase 1||10
5077352|NCT01765153|12492406|P1|COMPLETED|Training Phase 1||9
5077353|NCT01765153|12492405|P2|STARTED|Training Phase 1||11
5077354|NCT01765153|12492406|P1|STARTED|Training Phase 1||10
5077355|NCT01764997|12492513|P5|NOT COMPLETED|Study Drug Treatment Period||36
5077356|NCT01764997|12492514|P4|NOT COMPLETED|Study Drug Treatment Period||0
5077357|NCT01764997|12492515|P3|NOT COMPLETED|Study Drug Treatment Period||0
5077358|NCT01764997|12492516|P2|NOT COMPLETED|Study Drug Treatment Period||1
5077359|NCT01764997|12492517|P1|NOT COMPLETED|Study Drug Treatment Period||0
5077360|NCT01764997|12492513|P5|COMPLETED|Study Drug Treatment Period||286
5077361|NCT01764997|12492514|P4|COMPLETED|Study Drug Treatment Period||13
5077362|NCT01764997|12492515|P3|COMPLETED|Study Drug Treatment Period||13
5077363|NCT01764997|12492516|P2|COMPLETED|Study Drug Treatment Period||16
5077364|NCT01764997|12492517|P1|COMPLETED|Study Drug Treatment Period||0
5077365|NCT01764997|12492513|P5|STARTED|Study Drug Treatment Period||322
5077366|NCT01764997|12492514|P4|STARTED|Study Drug Treatment Period||13
5077367|NCT01764997|12492515|P3|STARTED|Study Drug Treatment Period||13
5077368|NCT01764997|12492516|P2|STARTED|Study Drug Treatment Period||17
5077369|NCT01764997|12492517|P1|STARTED|Study Drug Treatment Period||0
5077370|NCT01764997|12492513|P5|NOT COMPLETED|Run-in Period||0
5077371|NCT01764997|12492514|P4|NOT COMPLETED|Run-in Period||0
5077372|NCT01764997|12492515|P3|NOT COMPLETED|Run-in Period||0
5077373|NCT01764997|12492516|P2|NOT COMPLETED|Run-in Period||0
5077374|NCT01764997|12492517|P1|NOT COMPLETED|Run-in Period||38
5077375|NCT01764997|12492513|P5|COMPLETED|Run-in Period||0
5077376|NCT01764997|12492514|P4|COMPLETED|Run-in Period||0
5077377|NCT01764997|12492515|P3|COMPLETED|Run-in Period||0
5077378|NCT01764997|12492516|P2|COMPLETED|Run-in Period||0
5077379|NCT01764997|12492517|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
5077380|NCT01764997|12492513|P5|STARTED|Run-in Period||0
5077381|NCT01764997|12492514|P4|STARTED|Run-in Period||0
5077382|NCT01764997|12492515|P3|STARTED|Run-in Period||0
5077383|NCT01764997|12492516|P2|STARTED|Run-in Period||0
5077384|NCT01764997|12492517|P1|STARTED|Run-in Period||776
5077385|NCT01764945|12492544|P8|NOT COMPLETED|Overall Study||0
5077386|NCT01764945|12492545|P7|NOT COMPLETED|Overall Study||1
5077387|NCT01764945|12492546|P6|NOT COMPLETED|Overall Study||0
5077388|NCT01764945|12492547|P5|NOT COMPLETED|Overall Study||0
5077389|NCT01764945|12492548|P4|NOT COMPLETED|Overall Study||0
5077390|NCT01764945|12492549|P3|NOT COMPLETED|Overall Study||0
5077391|NCT01764945|12492550|P2|NOT COMPLETED|Overall Study||1
5077392|NCT01764945|12492551|P1|NOT COMPLETED|Overall Study||0
5077393|NCT01764945|12492544|P8|COMPLETED|Overall Study||9
5077394|NCT01764945|12492545|P7|COMPLETED|Overall Study||8
5077395|NCT01764945|12492546|P6|COMPLETED|Overall Study||8
5077396|NCT01764945|12492547|P5|COMPLETED|Overall Study||10
5077397|NCT01764945|12492548|P4|COMPLETED|Overall Study||5
5077398|NCT01764945|12492549|P3|COMPLETED|Overall Study||5
5077399|NCT01764945|12492550|P2|COMPLETED|Overall Study||4
5077400|NCT01764945|12492551|P1|COMPLETED|Overall Study||5
5077401|NCT01764945|12492544|P8|STARTED|Overall Study||9
5077402|NCT01764945|12492545|P7|STARTED|Overall Study||9
5077403|NCT01764945|12492546|P6|STARTED|Overall Study||8
5077404|NCT01764945|12492547|P5|STARTED|Overall Study||10
5077405|NCT01764945|12492548|P4|STARTED|Overall Study||5
5077406|NCT01764945|12492549|P3|STARTED|Overall Study||5
5077407|NCT01764945|12492550|P2|STARTED|Overall Study||5
5077408|NCT01764945|12492551|P1|STARTED|Overall Study||5
5077409|NCT01764919|12492585|P1|NOT COMPLETED|Overall Study||0
5077410|NCT01764919|12492585|P1|COMPLETED|Overall Study||4
5077411|NCT01764919|12492585|P1|STARTED|Overall Study||4
5077412|NCT01764841|12492597|P4|NOT COMPLETED|Overall Study||19
5077413|NCT01764841|12492598|P3|NOT COMPLETED|Overall Study||14
5077414|NCT01764841|12492599|P2|NOT COMPLETED|Overall Study||26
5077415|NCT01764841|12492600|P1|NOT COMPLETED|Overall Study||23
5077416|NCT01764841|12492597|P4|COMPLETED|Overall Study||49
5077417|NCT01764841|12492598|P3|COMPLETED|Overall Study||56
5077418|NCT01764841|12492599|P2|COMPLETED|Overall Study||111
5077419|NCT01764841|12492600|P1|COMPLETED|Overall Study||118
5077420|NCT01764841|12492597|P4|Participants Received Treatment|Overall Study|safety population|68
5077421|NCT01764841|12492598|P3|Participants Received Treatment|Overall Study|safety population|69
5077422|NCT01764841|12492599|P2|Participants Received Treatment|Overall Study|safety population|136
5077423|NCT01764841|12492600|P1|Participants Received Treatment|Overall Study|safety population|141
5077424|NCT01764841|12492597|P4|STARTED|Overall Study||68
5077425|NCT01764841|12492598|P3|STARTED|Overall Study||70
5077426|NCT01764841|12492599|P2|STARTED|Overall Study||137
5077427|NCT01764841|12492600|P1|STARTED|Overall Study||141
5077428|NCT01764685|12492634|P2|NOT COMPLETED|Overall Study||1
5077429|NCT01764685|12492635|P1|NOT COMPLETED|Overall Study||0
5077430|NCT01764685|12492634|P2|COMPLETED|Overall Study||3
5077431|NCT01764685|12492635|P1|COMPLETED|Overall Study||0
5077432|NCT01764685|12492634|P2|STARTED|Overall Study||4
5077433|NCT01764685|12492635|P1|STARTED|Overall Study||0
5077434|NCT01764659|12492641|P1|NOT COMPLETED|Overall Study||2
5077435|NCT01764659|12492641|P1|COMPLETED|Overall Study||12
5077436|NCT01764659|12492641|P1|STARTED|Overall Study||14
5077437|NCT01764633|12492655|P2|NOT COMPLETED|Overall Study||93
5077438|NCT01764633|12492656|P1|NOT COMPLETED|Overall Study||118
5077439|NCT01764633|12492655|P2|COMPLETED|Overall Study||13691
5077440|NCT01764633|12492656|P1|COMPLETED|Overall Study||13662
5077441|NCT01764633|12492655|P2|Received Treatment|Overall Study||13769
5077442|NCT01764633|12492656|P1|Received Treatment|Overall Study||13756
5077443|NCT01764633|12492655|P2|STARTED|Overall Study||13784
5077444|NCT01764633|12492656|P1|STARTED|Overall Study||13780
5077445|NCT01764607|12492678|P1|NOT COMPLETED|Overall Study||0
5077446|NCT01764607|12492678|P1|COMPLETED|Overall Study||1
5077447|NCT01764607|12492678|P1|STARTED|Overall Study||1
5077448|NCT01764464|12492685|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
5077449|NCT01764464|12492686|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
5077450|NCT01764464|12492685|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
5077451|NCT01764464|12492686|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
5077452|NCT01764464|12492685|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
5077453|NCT01764464|12492686|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
5077454|NCT01764464|12492685|P2|NOT COMPLETED|First Intervention||3
5077455|NCT01764464|12492686|P1|NOT COMPLETED|First Intervention||2
5077456|NCT01764464|12492685|P2|COMPLETED|First Intervention|Completed Placebo|13
5077457|NCT01764464|12492686|P1|COMPLETED|First Intervention|Completed Gralise|14
5077458|NCT01764464|12492685|P2|STARTED|First Intervention|Started Placebo|16
5077459|NCT01764464|12492686|P1|STARTED|First Intervention|Started Gralise|16
5077460|NCT01764386|12492704|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
5077461|NCT01764386|12492705|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
5077462|NCT01764386|12492704|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
5077463|NCT01764386|12492705|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
5077464|NCT01764386|12492704|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
5077465|NCT01764386|12492705|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
5077466|NCT01764386|12492704|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
5077467|NCT01764386|12492705|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
5077468|NCT01764386|12492704|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
5077469|NCT01764386|12492705|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
5077470|NCT01764386|12492704|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
5077471|NCT01764386|12492705|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
5077472|NCT01764386|12492704|P2|STARTED|Controlled Treatment Period (CTP)||89
5077473|NCT01764386|12492705|P1|STARTED|Controlled Treatment Period (CTP)||153
5077474|NCT01764256|12492750|P4|NOT COMPLETED|Completed Study||1
5077475|NCT01764256|12492751|P3|NOT COMPLETED|Completed Study||0
5077476|NCT01764256|12492752|P2|NOT COMPLETED|Completed Study||0
5077477|NCT01764256|12492753|P1|NOT COMPLETED|Completed Study||0
5077478|NCT01764256|12492750|P4|COMPLETED|Completed Study||11
5077479|NCT01764256|12492751|P3|COMPLETED|Completed Study||11
5077480|NCT01764256|12492752|P2|COMPLETED|Completed Study||11
5077481|NCT01764256|12492753|P1|COMPLETED|Completed Study||10
5077482|NCT01764256|12492750|P4|STARTED|Completed Study||12
5077483|NCT01764256|12492751|P3|STARTED|Completed Study||11
5077484|NCT01764256|12492752|P2|STARTED|Completed Study||11
5077485|NCT01764256|12492753|P1|STARTED|Completed Study||10
5077486|NCT01764256|12492750|P4|NOT COMPLETED|Received All Vaccinations||0
5077487|NCT01764256|12492751|P3|NOT COMPLETED|Received All Vaccinations||1
5077488|NCT01764256|12492752|P2|NOT COMPLETED|Received All Vaccinations||1
5077489|NCT01764256|12492753|P1|NOT COMPLETED|Received All Vaccinations||2
5077490|NCT01764256|12492750|P4|COMPLETED|Received All Vaccinations||12
5077491|NCT01764256|12492751|P3|COMPLETED|Received All Vaccinations||11
5077492|NCT01764256|12492752|P2|COMPLETED|Received All Vaccinations||11
5077493|NCT01764256|12492753|P1|COMPLETED|Received All Vaccinations||10
5077494|NCT01764256|12492750|P4|STARTED|Received All Vaccinations||12
5077495|NCT01764256|12492751|P3|STARTED|Received All Vaccinations||12
5077496|NCT01764256|12492752|P2|STARTED|Received All Vaccinations||12
5077497|NCT01764256|12492753|P1|STARTED|Received All Vaccinations||12
5077498|NCT01764022|12492796|P2|NOT COMPLETED|Overall Study||14
5077499|NCT01764022|12492797|P1|NOT COMPLETED|Overall Study||8
5077500|NCT01764022|12492796|P2|COMPLETED|Overall Study||96
5077501|NCT01764022|12492797|P1|COMPLETED|Overall Study||107
5077502|NCT01764022|12492796|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
5077503|NCT01764022|12492797|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
5077504|NCT01764022|12492796|P2|STARTED|Overall Study||110
5077505|NCT01764022|12492797|P1|STARTED|Overall Study||115
5077506|NCT01763996|12492829|P2|NOT COMPLETED|Treatment Period 2||1
5077507|NCT01763996|12492830|P1|NOT COMPLETED|Treatment Period 2||0
5077508|NCT01763996|12492829|P2|COMPLETED|Treatment Period 2||14
5077509|NCT01763996|12492830|P1|COMPLETED|Treatment Period 2||15
5077510|NCT01763996|12492829|P2|STARTED|Treatment Period 2||15
5077511|NCT01763996|12492830|P1|STARTED|Treatment Period 2||15
5077512|NCT01763996|12492829|P2|NOT COMPLETED|Treatment Period 1||0
5077513|NCT01763996|12492830|P1|NOT COMPLETED|Treatment Period 1||0
5077514|NCT01763996|12492829|P2|COMPLETED|Treatment Period 1||15
5077515|NCT01763996|12492830|P1|COMPLETED|Treatment Period 1||15
5077516|NCT01763996|12492829|P2|STARTED|Treatment Period 1||15
5077517|NCT01763996|12492830|P1|STARTED|Treatment Period 1||15
5077518|NCT01763931|12492858|P2|NOT COMPLETED|Overall Study||1
5077519|NCT01763931|12492859|P1|NOT COMPLETED|Overall Study||0
5077520|NCT01763931|12492858|P2|COMPLETED|Overall Study||3
5077521|NCT01763931|12492859|P1|COMPLETED|Overall Study||2
5077522|NCT01763931|12492858|P2|STARTED|Overall Study||4
5077523|NCT01763931|12492859|P1|STARTED|Overall Study||2
5077524|NCT01763918|12492871|P4|NOT COMPLETED|Overall Study||2
5077525|NCT01763918|12492872|P3|NOT COMPLETED|Overall Study||10
5077526|NCT01763918|12492873|P2|NOT COMPLETED|Overall Study||1
5077527|NCT01763918|12492874|P1|NOT COMPLETED|Overall Study||6
5077528|NCT01763918|12492871|P4|COMPLETED|Overall Study||108
5077529|NCT01763918|12492872|P3|COMPLETED|Overall Study||101
5077530|NCT01763918|12492873|P2|COMPLETED|Overall Study||54
5077531|NCT01763918|12492874|P1|COMPLETED|Overall Study||49
5077532|NCT01763918|12492871|P4|Received Treatment|Overall Study||110
5077533|NCT01763918|12492872|P3|Received Treatment|Overall Study||110
5077534|NCT01763918|12492873|P2|Received Treatment|Overall Study||55
5077535|NCT01763918|12492874|P1|Received Treatment|Overall Study||54
5077536|NCT01763918|12492871|P4|STARTED|Overall Study||110
5077537|NCT01763918|12492872|P3|STARTED|Overall Study||111
5077538|NCT01763918|12492873|P2|STARTED|Overall Study||55
5077539|NCT01763918|12492874|P1|STARTED|Overall Study||55
5077540|NCT01763905|12492972|P4|NOT COMPLETED|Overall Study||1
5077541|NCT01763905|12492973|P3|NOT COMPLETED|Overall Study||9
5077542|NCT01763905|12492974|P2|NOT COMPLETED|Overall Study||1
5077543|NCT01763905|12492975|P1|NOT COMPLETED|Overall Study||6
5077544|NCT01763905|12492972|P4|COMPLETED|Overall Study||101
5077545|NCT01763905|12492973|P3|COMPLETED|Overall Study||94
5077546|NCT01763905|12492974|P2|COMPLETED|Overall Study||50
5077547|NCT01763905|12492975|P1|COMPLETED|Overall Study||45
5077548|NCT01763905|12492972|P4|STARTED|Overall Study||102
5077549|NCT01763905|12492973|P3|STARTED|Overall Study||103
5077550|NCT01763905|12492974|P2|STARTED|Overall Study||51
5077551|NCT01763905|12492975|P1|STARTED|Overall Study||51
5077552|NCT01763866|12493093|P24|NOT COMPLETED|Overall Study||2
5077553|NCT01763866|12493094|P23|NOT COMPLETED|Overall Study||3
5077554|NCT01763866|12493095|P22|NOT COMPLETED|Overall Study||1
5077555|NCT01763866|12493096|P21|NOT COMPLETED|Overall Study||4
5077556|NCT01763866|12493097|P20|NOT COMPLETED|Overall Study||2
5077557|NCT01763866|12493098|P19|NOT COMPLETED|Overall Study||6
5077558|NCT01763866|12493099|P18|NOT COMPLETED|Overall Study||1
5077559|NCT01763866|12493100|P17|NOT COMPLETED|Overall Study||1
5077560|NCT01763866|12493101|P16|NOT COMPLETED|Overall Study||3
5077561|NCT01763866|12493102|P15|NOT COMPLETED|Overall Study||12
5077562|NCT01763866|12493103|P14|NOT COMPLETED|Overall Study||0
5077563|NCT01763866|12493104|P13|NOT COMPLETED|Overall Study||4
5077564|NCT01763866|12493105|P12|NOT COMPLETED|Overall Study||2
5077565|NCT01763866|12493106|P11|NOT COMPLETED|Overall Study||8
5077566|NCT01763866|12493107|P10|NOT COMPLETED|Overall Study||1
5077567|NCT01763866|12493108|P9|NOT COMPLETED|Overall Study||3
5077568|NCT01763866|12493109|P8|NOT COMPLETED|Overall Study||0
5077569|NCT01763866|12493110|P7|NOT COMPLETED|Overall Study||7
5077570|NCT01763866|12493111|P6|NOT COMPLETED|Overall Study||3
5077571|NCT01763866|12493112|P5|NOT COMPLETED|Overall Study||2
5077572|NCT01763866|12493113|P4|NOT COMPLETED|Overall Study||0
5077573|NCT01763866|12493114|P3|NOT COMPLETED|Overall Study||5
5077574|NCT01763866|12493115|P2|NOT COMPLETED|Overall Study||1
5077575|NCT01763866|12493116|P1|NOT COMPLETED|Overall Study||2
5077576|NCT01763866|12493093|P24|COMPLETED|Overall Study||113
5077577|NCT01763866|12493094|P23|COMPLETED|Overall Study||109
5077578|NCT01763866|12493095|P22|COMPLETED|Overall Study||54
5077579|NCT01763866|12493096|P21|COMPLETED|Overall Study||52
5077580|NCT01763866|12493097|P20|COMPLETED|Overall Study||110
5077581|NCT01763866|12493098|P19|COMPLETED|Overall Study||105
5077582|NCT01763866|12493099|P18|COMPLETED|Overall Study||55
5077583|NCT01763866|12493100|P17|COMPLETED|Overall Study||55
5077584|NCT01763866|12493101|P16|COMPLETED|Overall Study||112
5077585|NCT01763866|12493102|P15|COMPLETED|Overall Study||102
5077586|NCT01763866|12493103|P14|COMPLETED|Overall Study||57
5077587|NCT01763866|12493104|P13|COMPLETED|Overall Study||54
5077588|NCT01763866|12493105|P12|COMPLETED|Overall Study||108
5077589|NCT01763866|12493106|P11|COMPLETED|Overall Study||102
5077590|NCT01763866|12493107|P10|COMPLETED|Overall Study||53
5077591|NCT01763866|12493108|P9|COMPLETED|Overall Study||53
5077592|NCT01763866|12493109|P8|COMPLETED|Overall Study||55
5077593|NCT01763866|12493110|P7|COMPLETED|Overall Study||48
5077594|NCT01763866|12493111|P6|COMPLETED|Overall Study||107
5077595|NCT01763866|12493112|P5|COMPLETED|Overall Study||108
5077596|NCT01763866|12493113|P4|COMPLETED|Overall Study||55
5077597|NCT01763866|12493114|P3|COMPLETED|Overall Study||51
5077598|NCT01763866|12493115|P2|COMPLETED|Overall Study||54
5077599|NCT01763866|12493116|P1|COMPLETED|Overall Study||54
5077600|NCT01763866|12493093|P24|Received Treatment|Overall Study||115
5077601|NCT01763866|12493094|P23|Received Treatment|Overall Study||112
5077602|NCT01763866|12493095|P22|Received Treatment|Overall Study||55
5077603|NCT01763866|12493096|P21|Received Treatment|Overall Study||56
5077604|NCT01763866|12493097|P20|Received Treatment|Overall Study||112
5077605|NCT01763866|12493098|P19|Received Treatment|Overall Study||111
5077606|NCT01763866|12493099|P18|Received Treatment|Overall Study||55
5077607|NCT01763866|12493100|P17|Received Treatment|Overall Study||56
5077608|NCT01763866|12493101|P16|Received Treatment|Overall Study||115
5077609|NCT01763866|12493102|P15|Received Treatment|Overall Study||113
5077610|NCT01763866|12493103|P14|Received Treatment|Overall Study||57
5077611|NCT01763866|12493104|P13|Received Treatment|Overall Study||58
5077612|NCT01763866|12493105|P12|Received Treatment|Overall Study||110
5077613|NCT01763866|12493106|P11|Received Treatment|Overall Study||109
5077614|NCT01763866|12493107|P10|Received Treatment|Overall Study||54
5077615|NCT01763866|12493108|P9|Received Treatment|Overall Study||56
5077616|NCT01763866|12493109|P8|Received Treatment|Overall Study||55
5077617|NCT01763866|12493110|P7|Received Treatment|Overall Study||55
5077618|NCT01763866|12493111|P6|Received Treatment|Overall Study||110
5077619|NCT01763866|12493112|P5|Received Treatment|Overall Study||110
5077620|NCT01763866|12493113|P4|Received Treatment|Overall Study||55
5077621|NCT01763866|12493114|P3|Received Treatment|Overall Study||56
5077622|NCT01763866|12493115|P2|Received Treatment|Overall Study||55
5077623|NCT01763866|12493116|P1|Received Treatment|Overall Study||56
5077624|NCT01763866|12493093|P24|STARTED|Overall Study||115
5077625|NCT01763866|12493094|P23|STARTED|Overall Study||112
5077626|NCT01763866|12493095|P22|STARTED|Overall Study||55
5077627|NCT01763866|12493096|P21|STARTED|Overall Study||56
5077628|NCT01763866|12493097|P20|STARTED|Overall Study||112
5077629|NCT01763866|12493098|P19|STARTED|Overall Study||111
5077630|NCT01763866|12493099|P18|STARTED|Overall Study||56
5077631|NCT01763866|12493100|P17|STARTED|Overall Study||56
5077632|NCT01763866|12493101|P16|STARTED|Overall Study||115
5077633|NCT01763866|12493102|P15|STARTED|Overall Study||114
5077634|NCT01763866|12493103|P14|STARTED|Overall Study||57
5077635|NCT01763866|12493104|P13|STARTED|Overall Study||58
5077636|NCT01763866|12493105|P12|STARTED|Overall Study||110
5077637|NCT01763866|12493106|P11|STARTED|Overall Study||110
5077638|NCT01763866|12493107|P10|STARTED|Overall Study||54
5077639|NCT01763866|12493108|P9|STARTED|Overall Study||56
5077640|NCT01763866|12493109|P8|STARTED|Overall Study||55
5077641|NCT01763866|12493110|P7|STARTED|Overall Study||55
5077642|NCT01763866|12493111|P6|STARTED|Overall Study||110
5077643|NCT01763866|12493112|P5|STARTED|Overall Study||110
5077644|NCT01763866|12493113|P4|STARTED|Overall Study||55
5077645|NCT01763866|12493114|P3|STARTED|Overall Study||56
5077646|NCT01763866|12493115|P2|STARTED|Overall Study||55
5077647|NCT01763866|12493116|P1|STARTED|Overall Study||56
5077648|NCT01763827|12493676|P6|NOT COMPLETED|Overall Study||2
5077649|NCT01763827|12493677|P5|NOT COMPLETED|Overall Study||6
5077650|NCT01763827|12493678|P4|NOT COMPLETED|Overall Study||1
5077651|NCT01763827|12493679|P3|NOT COMPLETED|Overall Study||4
5077652|NCT01763827|12493680|P2|NOT COMPLETED|Overall Study||1
5077653|NCT01763827|12493681|P1|NOT COMPLETED|Overall Study||3
5077654|NCT01763827|12493676|P6|COMPLETED|Overall Study||151
5077655|NCT01763827|12493677|P5|COMPLETED|Overall Study||147
5077656|NCT01763827|12493678|P4|COMPLETED|Overall Study||76
5077657|NCT01763827|12493679|P3|COMPLETED|Overall Study||73
5077658|NCT01763827|12493680|P2|COMPLETED|Overall Study||77
5077659|NCT01763827|12493681|P1|COMPLETED|Overall Study||74
5077660|NCT01763827|12493676|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
5077661|NCT01763827|12493677|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
5077662|NCT01763827|12493678|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
5077663|NCT01763827|12493679|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
5077664|NCT01763827|12493680|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
5077665|NCT01763827|12493681|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
5077666|NCT01763827|12493676|P6|STARTED|Overall Study||153
5077667|NCT01763827|12493677|P5|STARTED|Overall Study||153
5077668|NCT01763827|12493678|P4|STARTED|Overall Study||77
5077669|NCT01763827|12493679|P3|STARTED|Overall Study||77
5077670|NCT01763827|12493680|P2|STARTED|Overall Study||78
5077671|NCT01763827|12493681|P1|STARTED|Overall Study||77
5077672|NCT01763788|12493825|P4|NOT COMPLETED|Overall Study||0
5077673|NCT01763788|12493826|P3|NOT COMPLETED|Overall Study||1
5077674|NCT01763788|12493827|P2|NOT COMPLETED|Overall Study||0
5077675|NCT01763788|12493828|P1|NOT COMPLETED|Overall Study||0
5077676|NCT01763788|12493825|P4|COMPLETED|Overall Study||92
5077677|NCT01763788|12493826|P3|COMPLETED|Overall Study||90
5077678|NCT01763788|12493827|P2|COMPLETED|Overall Study||6
5077679|NCT01763788|12493828|P1|COMPLETED|Overall Study||3
5077680|NCT01763788|12493825|P4|Received at Least 1dose of Study Drug|Overall Study||91
5077681|NCT01763788|12493826|P3|Received at Least 1dose of Study Drug|Overall Study||90
5077682|NCT01763788|12493827|P2|Received at Least 1dose of Study Drug|Overall Study||6
5077683|NCT01763788|12493828|P1|Received at Least 1dose of Study Drug|Overall Study||3
5077684|NCT01763788|12493825|P4|STARTED|Overall Study||92
5077685|NCT01763788|12493826|P3|STARTED|Overall Study||91
5077686|NCT01763788|12493827|P2|STARTED|Overall Study||6
5077687|NCT01763788|12493828|P1|STARTED|Overall Study||3
5077688|NCT01763645|12493864|P2|NOT COMPLETED|Overall Study||24
5077689|NCT01763645|12493865|P1|NOT COMPLETED|Overall Study||26
5077690|NCT01763645|12493864|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
5077691|NCT01763645|12493865|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
5077692|NCT01763645|12493864|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
5077693|NCT01763645|12493865|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
5077694|NCT01763645|12493864|P2|STARTED|Overall Study||69
5077695|NCT01763645|12493865|P1|STARTED|Overall Study||69
5077696|NCT01763606|12493885|P2|NOT COMPLETED|Overall Study||0
5077697|NCT01763606|12493886|P1|NOT COMPLETED|Overall Study||0
5077698|NCT01763606|12493885|P2|COMPLETED|Overall Study||10
5077699|NCT01763606|12493886|P1|COMPLETED|Overall Study||10
5077700|NCT01763606|12493885|P2|STARTED|Overall Study||10
5077701|NCT01763606|12493886|P1|STARTED|Overall Study||10
5077702|NCT01763567|12493895|P1|NOT COMPLETED|Overall Study||0
5077703|NCT01763567|12493895|P1|COMPLETED|Overall Study||19
5077704|NCT01763567|12493895|P1|STARTED|Overall Study||19
5077705|NCT01763346|12493905|P2|NOT COMPLETED|Overall Study||8
5077706|NCT01763346|12493906|P1|NOT COMPLETED|Overall Study||10
5077707|NCT01763346|12493905|P2|COMPLETED|Overall Study||36
5077708|NCT01763346|12493906|P1|COMPLETED|Overall Study||34
5077709|NCT01763346|12493905|P2|Received Intervention|Overall Study||38
5077710|NCT01763346|12493906|P1|Received Intervention|Overall Study||39
5077711|NCT01763346|12493905|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
5077712|NCT01763346|12493906|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
5077713|NCT01763333|12493930|P14|NOT COMPLETED|Overall Study||0
5077714|NCT01763333|12493931|P13|NOT COMPLETED|Overall Study||0
5077715|NCT01763333|12493932|P12|NOT COMPLETED|Overall Study||0
5077716|NCT01763333|12493933|P11|NOT COMPLETED|Overall Study||0
5077717|NCT01763333|12493934|P10|NOT COMPLETED|Overall Study||0
5077718|NCT01763333|12493935|P9|NOT COMPLETED|Overall Study||0
5077719|NCT01763333|12493936|P8|NOT COMPLETED|Overall Study||0
5077720|NCT01763333|12493937|P7|NOT COMPLETED|Overall Study||0
5077721|NCT01763333|12493938|P6|NOT COMPLETED|Overall Study||0
5077722|NCT01763333|12493939|P5|NOT COMPLETED|Overall Study||0
5077723|NCT01763333|12493940|P4|NOT COMPLETED|Overall Study||0
5077724|NCT01763333|12493941|P3|NOT COMPLETED|Overall Study||0
5077725|NCT01763333|12493942|P2|NOT COMPLETED|Overall Study||0
5077726|NCT01763333|12493943|P1|NOT COMPLETED|Overall Study||0
5077727|NCT01763333|12493930|P14|COMPLETED|Overall Study||3
5077728|NCT01763333|12493931|P13|COMPLETED|Overall Study||3
5077729|NCT01763333|12493932|P12|COMPLETED|Overall Study||3
5077730|NCT01763333|12493933|P11|COMPLETED|Overall Study||3
5077731|NCT01763333|12493934|P10|COMPLETED|Overall Study||18
5077732|NCT01763333|12493935|P9|COMPLETED|Overall Study||5
5077733|NCT01763333|12493936|P8|COMPLETED|Overall Study||6
5077734|NCT01763333|12493937|P7|COMPLETED|Overall Study||5
5077735|NCT01763333|12493938|P6|COMPLETED|Overall Study||6
5077736|NCT01763333|12493939|P5|COMPLETED|Overall Study||4
5077737|NCT01763333|12493940|P4|COMPLETED|Overall Study||6
5077738|NCT01763333|12493941|P3|COMPLETED|Overall Study||6
5077739|NCT01763333|12493942|P2|COMPLETED|Overall Study||6
5077740|NCT01763333|12493943|P1|COMPLETED|Overall Study||6
5077741|NCT01763333|12493930|P14|STARTED|Overall Study||3
5077742|NCT01763333|12493931|P13|STARTED|Overall Study||3
5077743|NCT01763333|12493932|P12|STARTED|Overall Study||3
5077744|NCT01763333|12493933|P11|STARTED|Overall Study||3
5077745|NCT01763333|12493934|P10|STARTED|Overall Study||18
5077746|NCT01763333|12493935|P9|STARTED|Overall Study||5
5077747|NCT01763333|12493936|P8|STARTED|Overall Study||6
5077748|NCT01763333|12493937|P7|STARTED|Overall Study||5
5077749|NCT01763333|12493938|P6|STARTED|Overall Study||6
5077750|NCT01763333|12493939|P5|STARTED|Overall Study||4
5077751|NCT01763333|12493940|P4|STARTED|Overall Study||6
5077752|NCT01763333|12493941|P3|STARTED|Overall Study||6
5077753|NCT01763333|12493942|P2|STARTED|Overall Study||6
5077754|NCT01763333|12493943|P1|STARTED|Overall Study||6
5077755|NCT01763203|12494049|P2|NOT COMPLETED|Overall Study||42
5077756|NCT01763203|12494050|P1|NOT COMPLETED|Overall Study||33
5077757|NCT01763203|12494049|P2|COMPLETED|Overall Study||204
5077758|NCT01763203|12494050|P1|COMPLETED|Overall Study||208
5077759|NCT01763203|12494049|P2|STARTED|Overall Study||246
5077760|NCT01763203|12494050|P1|STARTED|Overall Study||241
5077761|NCT01763047|12494096|P2|NOT COMPLETED|Period 2||5
5077762|NCT01763047|12494097|P1|NOT COMPLETED|Period 2||4
5077763|NCT01763047|12494096|P2|COMPLETED|Period 2||121
5077764|NCT01763047|12494097|P1|COMPLETED|Period 2||126
5077765|NCT01763047|12494096|P2|Hyperopes|Period 2||54
5077766|NCT01763047|12494097|P1|Hyperopes|Period 2||56
5077767|NCT01763047|12494096|P2|Myopes|Period 2||72
5077768|NCT01763047|12494097|P1|Myopes|Period 2||74
5077769|NCT01763047|12494096|P2|STARTED|Period 2||126
5077770|NCT01763047|12494097|P1|STARTED|Period 2||130
5077771|NCT01763047|12494096|P2|NOT COMPLETED|Period 1||11
5077772|NCT01763047|12494097|P1|NOT COMPLETED|Period 1||9
5077773|NCT01763047|12494096|P2|COMPLETED|Period 1||126
5077774|NCT01763047|12494097|P1|COMPLETED|Period 1||130
5077775|NCT01763047|12494096|P2|Hyperopes|Period 1||61
5077776|NCT01763047|12494097|P1|Hyperopes|Period 1||62
5077777|NCT01763047|12494096|P2|Myopes|Period 1||76
5077778|NCT01763047|12494097|P1|Myopes|Period 1||77
5077779|NCT01763047|12494096|P2|STARTED|Period 1||137
5077780|NCT01763047|12494097|P1|STARTED|Period 1||139
5077781|NCT01762982|12494113|P1|NOT COMPLETED|Overall Study||0
5077782|NCT01762982|12494113|P1|COMPLETED|Overall Study||36
5077783|NCT01762982|12494113|P1|Received Empty Finn Chamber|Overall Study||36
5077784|NCT01762982|12494113|P1|Received SLS|Overall Study||36
5077785|NCT01762982|12494113|P1|Received Benzalkonium Chloride|Overall Study||36
5077786|NCT01762982|12494113|P1|Received Saline Water|Overall Study||36
5077787|NCT01762982|12494113|P1|STARTED|Overall Study||36
5077788|NCT01762943|12494136|P2|NOT COMPLETED|Overall Study||2
5077789|NCT01762943|12494137|P1|NOT COMPLETED|Overall Study||4
5077790|NCT01762943|12494136|P2|COMPLETED|Overall Study||15
5077791|NCT01762943|12494137|P1|COMPLETED|Overall Study||15
5077792|NCT01762943|12494136|P2|Withdrawal|Overall Study||15
5077793|NCT01762943|12494137|P1|Withdrawal|Overall Study||15
5077794|NCT01762943|12494136|P2|Addback|Overall Study||15
5077795|NCT01762943|12494137|P1|Addback|Overall Study||16
5077796|NCT01762943|12494136|P2|Hypogonadism|Overall Study||15
5077797|NCT01762943|12494137|P1|Hypogonadism|Overall Study||18
5077798|NCT01762943|12494136|P2|STARTED|Overall Study||17
5077799|NCT01762943|12494137|P1|STARTED|Overall Study||19
5077800|NCT01762904|12494145|P1|NOT COMPLETED|Overall Study||0
5077801|NCT01762904|12494145|P1|COMPLETED|Overall Study|October, 2013|135
5077802|NCT01762904|12494145|P1|STARTED|Overall Study|January, 2013|135
5077803|NCT01762800|12494154|P2|NOT COMPLETED|Overall Study||21
5077804|NCT01762800|12494155|P1|NOT COMPLETED|Overall Study||19
5077805|NCT01762800|12494154|P2|COMPLETED|Overall Study||183
5077806|NCT01762800|12494155|P1|COMPLETED|Overall Study||183
5077807|NCT01762800|12494154|P2|STARTED|Overall Study||204
5077808|NCT01762800|12494155|P1|STARTED|Overall Study||202
5077809|NCT01762761|12494229|P2|NOT COMPLETED|Overall Study||65
5077810|NCT01762761|12494230|P1|NOT COMPLETED|Overall Study||39
5077811|NCT01762761|12494229|P2|COMPLETED|Overall Study||39
5077812|NCT01762761|12494230|P1|COMPLETED|Overall Study||12
5077813|NCT01762761|12494229|P2|STARTED|Overall Study||104
5077814|NCT01762761|12494230|P1|STARTED|Overall Study||51
5077815|NCT01762722|12494286|P2|NOT COMPLETED|Overall Study||0
5077816|NCT01762722|12494287|P1|NOT COMPLETED|Overall Study||0
5077817|NCT01762722|12494286|P2|COMPLETED|Overall Study||11
5077818|NCT01762722|12494287|P1|COMPLETED|Overall Study||12
5077819|NCT01762722|12494286|P2|STARTED|Overall Study||11
5077820|NCT01762722|12494287|P1|STARTED|Overall Study||12
5077821|NCT01762631|12494295|P2|NOT COMPLETED|Overall Study||0
5077822|NCT01762631|12494296|P1|NOT COMPLETED|Overall Study||0
5077823|NCT01762631|12494295|P2|COMPLETED|Overall Study||22
5077824|NCT01762631|12494296|P1|COMPLETED|Overall Study||53
5077825|NCT01762631|12494295|P2|STARTED|Overall Study||22
5077826|NCT01762631|12494296|P1|STARTED|Overall Study||53
5077827|NCT01762501|12494314|P2|NOT COMPLETED|Overall Study||23
5077828|NCT01762501|12494315|P1|NOT COMPLETED|Overall Study||27
5077829|NCT01762501|12494314|P2|COMPLETED|Overall Study||336
5077830|NCT01762501|12494315|P1|COMPLETED|Overall Study||332
5077831|NCT01762501|12494314|P2|STARTED|Overall Study||359
5077832|NCT01762501|12494315|P1|STARTED|Overall Study||359
5077833|NCT01762345|12494329|P1|NOT COMPLETED|Overall Study||7
5077834|NCT01762345|12494329|P1|COMPLETED|Overall Study||76
5077835|NCT01762345|12494329|P1|STARTED|Overall Study||83
5077836|NCT01762059|12494339|P1|NOT COMPLETED|Overall Study||0
5077837|NCT01762059|12494339|P1|COMPLETED|Overall Study||20
5077838|NCT01762059|12494339|P1|STARTED|Overall Study||20
5077839|NCT01761747|12494366|P1|NOT COMPLETED|Overall Study||1
5077840|NCT01761747|12494366|P1|COMPLETED|Overall Study||2
5077841|NCT01761747|12494366|P1|STARTED|Overall Study||3
5077842|NCT01761643|12494379|P2|NOT COMPLETED|Overall Study||42
5077843|NCT01761643|12494380|P1|NOT COMPLETED|Overall Study||32
5077844|NCT01761643|12494379|P2|COMPLETED|Overall Study||158
5077845|NCT01761643|12494380|P1|COMPLETED|Overall Study||166
5077846|NCT01761643|12494379|P2|STARTED|Overall Study||200
5077847|NCT01761643|12494380|P1|STARTED|Overall Study||198
5077848|NCT01761565|12494390|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
5077849|NCT01761565|12494390|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
5077850|NCT01761565|12494390|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
5077851|NCT01761565|12494390|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
5077852|NCT01761565|12494390|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
5077853|NCT01761565|12494390|P1|STARTED|Single Dose of SUF NT 15 mcg||40
5077854|NCT01761292|12494402|P1|NOT COMPLETED|Extension 3||0
5077855|NCT01761292|12494402|P1|COMPLETED|Extension 3||18
5077856|NCT01761292|12494402|P1|STARTED|Extension 3||18
5077857|NCT01761292|12494402|P1|NOT COMPLETED|Extension 2||0
5077858|NCT01761292|12494402|P1|COMPLETED|Extension 2||18
5077859|NCT01761292|12494402|P1|STARTED|Extension 2||18
5077860|NCT01761292|12494402|P1|NOT COMPLETED|Extension 1||1
5077861|NCT01761292|12494402|P1|COMPLETED|Extension 1||18
5077862|NCT01761292|12494402|P1|STARTED|Extension 1||19
5077863|NCT01761292|12494402|P1|NOT COMPLETED|Part 2||0
5077864|NCT01761292|12494402|P1|COMPLETED|Part 2||19
5077865|NCT01761292|12494402|P1|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
5077866|NCT01761292|12494402|P1|NOT COMPLETED|Part 1||2
5077867|NCT01761292|12494402|P1|COMPLETED|Part 1||18
5077868|NCT01761292|12494402|P1|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
5077869|NCT01761292|12494402|P1|STARTED|Part 1||20
5077870|NCT01761279|12494421|P1|NOT COMPLETED|Overall Study||0
5077871|NCT01761279|12494421|P1|COMPLETED|Overall Study||84
5077872|NCT01761279|12494421|P1|STARTED|Overall Study||84
5077873|NCT01761266|12494436|P2|NOT COMPLETED|Overall Study||476
5077874|NCT01761266|12494437|P1|NOT COMPLETED|Overall Study||478
5077875|NCT01761266|12494436|P2|COMPLETED|Overall Study||0
5077876|NCT01761266|12494437|P1|COMPLETED|Overall Study||0
5077877|NCT01761266|12494436|P2|Treated|Overall Study||475
5077878|NCT01761266|12494437|P1|Treated|Overall Study||476
5077879|NCT01761266|12494436|P2|STARTED|Overall Study||476
5077880|NCT01761266|12494437|P1|STARTED|Overall Study||478
5077881|NCT01761175|12494465|P2|NOT COMPLETED|Overall Study||0
5077882|NCT01761175|12494466|P1|NOT COMPLETED|Overall Study||0
5077883|NCT01761175|12494465|P2|COMPLETED|Overall Study||112
5077884|NCT01761175|12494466|P1|COMPLETED|Overall Study||112
5077885|NCT01761175|12494465|P2|STARTED|Overall Study||112
5077886|NCT01761175|12494466|P1|STARTED|Overall Study||112
5077887|NCT01761162|12494494|P1|NOT COMPLETED|Overall Study||3
5077888|NCT01761162|12494494|P1|COMPLETED|Overall Study||226
5077889|NCT01761162|12494494|P1|STARTED|Overall Study||229
5077890|NCT01761084|12494504|P2|NOT COMPLETED|Overall Study||6
5077891|NCT01761084|12494505|P1|NOT COMPLETED|Overall Study||5
5077892|NCT01761084|12494504|P2|COMPLETED|Overall Study||64
5077893|NCT01761084|12494505|P1|COMPLETED|Overall Study||66
5077894|NCT01761084|12494504|P2|STARTED|Overall Study||70
5077895|NCT01761084|12494505|P1|STARTED|Overall Study||71
5077896|NCT01761019|12494554|P1|NOT COMPLETED|Overall Study||0
5077897|NCT01761019|12494554|P1|COMPLETED|Overall Study||8
5077898|NCT01761019|12494554|P1|STARTED|Overall Study||8
5077899|NCT01760993|12494562|P1|NOT COMPLETED|Overall Study||0
5077900|NCT01760993|12494562|P1|COMPLETED|Overall Study||0
5077901|NCT01760993|12494562|P1|STARTED|Overall Study||0
5077902|NCT01760954|12494583|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
5077903|NCT01760954|12494584|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
5077904|NCT01760954|12494585|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
5077905|NCT01760954|12494586|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
5077906|NCT01760954|12494583|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
5077907|NCT01760954|12494584|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
5077908|NCT01760954|12494585|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
5077909|NCT01760954|12494586|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
5077910|NCT01760954|12494583|P4|STARTED|Post-treatment Follow-up (12 Months)||87
5077911|NCT01760954|12494584|P3|STARTED|Post-treatment Follow-up (12 Months)||86
5077912|NCT01760954|12494585|P2|STARTED|Post-treatment Follow-up (12 Months)||118
5077913|NCT01760954|12494586|P1|STARTED|Post-treatment Follow-up (12 Months)||126
5077914|NCT01760954|12494583|P4|NOT COMPLETED|Treatment Period (6 Months)||26
5077915|NCT01760954|12494584|P3|NOT COMPLETED|Treatment Period (6 Months)||21
5077916|NCT01760954|12494585|P2|NOT COMPLETED|Treatment Period (6 Months)||28
5077917|NCT01760954|12494586|P1|NOT COMPLETED|Treatment Period (6 Months)||33
5077918|NCT01760954|12494583|P4|COMPLETED|Treatment Period (6 Months)||83
5077919|NCT01760954|12494584|P3|COMPLETED|Treatment Period (6 Months)||87
5077920|NCT01760954|12494585|P2|COMPLETED|Treatment Period (6 Months)||110
5077921|NCT01760954|12494586|P1|COMPLETED|Treatment Period (6 Months)||116
5077922|NCT01760954|12494583|P4|STARTED|Treatment Period (6 Months)||109
5077923|NCT01760954|12494584|P3|STARTED|Treatment Period (6 Months)||108
5077924|NCT01760954|12494585|P2|STARTED|Treatment Period (6 Months)||138
5077925|NCT01760954|12494586|P1|STARTED|Treatment Period (6 Months)||149
5077926|NCT01760941|12494664|P1|NOT COMPLETED|Overall Study||0
5077927|NCT01760941|12494664|P1|COMPLETED|Overall Study||1
5077928|NCT01760941|12494664|P1|STARTED|Overall Study||1
5077929|NCT01760889|12494674|P3|NOT COMPLETED|Overall Study||0
5077930|NCT01760889|12494675|P2|NOT COMPLETED|Overall Study||0
5077931|NCT01760889|12494676|P1|NOT COMPLETED|Overall Study||0
5077932|NCT01760889|12494674|P3|COMPLETED|Overall Study||0
5077933|NCT01760889|12494675|P2|COMPLETED|Overall Study||0
5077934|NCT01760889|12494676|P1|COMPLETED|Overall Study||0
5077935|NCT01760889|12494674|P3|STARTED|Overall Study||0
5077936|NCT01760889|12494675|P2|STARTED|Overall Study||0
5077937|NCT01760889|12494676|P1|STARTED|Overall Study||0
5077938|NCT01760876|12494723|P1|NOT COMPLETED|Overall Study||6
5077939|NCT01760876|12494723|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
5077940|NCT01760876|12494723|P1|STARTED|Overall Study||106
5077941|NCT01760785|12494729|P2|NOT COMPLETED|Overall Study||0
5077942|NCT01760785|12494730|P1|NOT COMPLETED|Overall Study||0
5077943|NCT01760785|12494729|P2|COMPLETED|Overall Study||27
5077944|NCT01760785|12494730|P1|COMPLETED|Overall Study||23
5077945|NCT01760785|12494729|P2|STARTED|Overall Study||27
5077946|NCT01760785|12494730|P1|STARTED|Overall Study||23
5077947|NCT01760733|12494738|P1|NOT COMPLETED|Transplanted||217
5077948|NCT01760733|12494738|P1|COMPLETED|Transplanted||0
5077949|NCT01760733|12494738|P1|STARTED|Transplanted||217
5077950|NCT01760733|12494738|P1|NOT COMPLETED|Waiting List||72
5077951|NCT01760733|12494738|P1|COMPLETED|Waiting List|217 patients have been transplanted|217
5077952|NCT01760733|12494738|P1|STARTED|Waiting List|All patients included started in the waiting list group.|289
5077953|NCT01760473|12494743|P1|NOT COMPLETED|Overall Study||15
5077954|NCT01760473|12494743|P1|COMPLETED|Overall Study||12
5077955|NCT01760473|12494743|P1|STARTED|Overall Study||27
5077956|NCT01760304|12494766|P2|NOT COMPLETED|Overall Study||0
5077957|NCT01760304|12494767|P1|NOT COMPLETED|Overall Study||0
5077958|NCT01760304|12494766|P2|COMPLETED|Overall Study||3
5077959|NCT01760304|12494767|P1|COMPLETED|Overall Study||2
5077960|NCT01760304|12494766|P2|STARTED|Overall Study||3
5077961|NCT01760304|12494767|P1|STARTED|Overall Study||2
5077962|NCT01760239|12494779|P2|NOT COMPLETED|Overall Study||14316
5077963|NCT01760239|12494780|P1|NOT COMPLETED|Overall Study||16741
5077964|NCT01760239|12494779|P2|COMPLETED|Overall Study||226
5077965|NCT01760239|12494780|P1|COMPLETED|Overall Study||296
5077966|NCT01760239|12494779|P2|STARTED|Overall Study||14542
5077967|NCT01760239|12494780|P1|STARTED|Overall Study||17037
5077968|NCT01760187|12494800|P5|NOT COMPLETED|Overall Study||0
5077969|NCT01760187|12494801|P4|NOT COMPLETED|Overall Study||2
5077970|NCT01760187|12494802|P3|NOT COMPLETED|Overall Study||0
5077971|NCT01760187|12494803|P2|NOT COMPLETED|Overall Study||0
5077972|NCT01760187|12494804|P1|NOT COMPLETED|Overall Study||1
5077973|NCT01760187|12494800|P5|COMPLETED|Overall Study||16
5077974|NCT01760187|12494801|P4|COMPLETED|Overall Study||10
5077975|NCT01760187|12494802|P3|COMPLETED|Overall Study||12
5077976|NCT01760187|12494803|P2|COMPLETED|Overall Study||12
5077977|NCT01760187|12494804|P1|COMPLETED|Overall Study||19
5077978|NCT01760187|12494800|P5|STARTED|Overall Study||16
5077979|NCT01760187|12494801|P4|STARTED|Overall Study||12
5077980|NCT01760187|12494802|P3|STARTED|Overall Study||12
5077981|NCT01760187|12494803|P2|STARTED|Overall Study||12
5077982|NCT01760187|12494804|P1|STARTED|Overall Study||20
5077983|NCT01759862|12495034|P2|NOT COMPLETED|Overall Study||2
5077984|NCT01759862|12495035|P1|NOT COMPLETED|Overall Study||3
5077985|NCT01759862|12495034|P2|COMPLETED|Overall Study||25
5077986|NCT01759862|12495035|P1|COMPLETED|Overall Study||20
5077987|NCT01759862|12495034|P2|STARTED|Overall Study||27
5077988|NCT01759862|12495035|P1|STARTED|Overall Study||23
5077989|NCT01759602|12495045|P1|NOT COMPLETED|Overall Study||0
5077990|NCT01759602|12495045|P1|COMPLETED|Overall Study||10
5077991|NCT01759602|12495045|P1|STARTED|Overall Study||10
5077992|NCT01759511|12495053|P1|NOT COMPLETED|Overall Study||34
5077993|NCT01759511|12495053|P1|COMPLETED|Overall Study||0
5077994|NCT01759511|12495053|P1|STARTED|Overall Study||34
5077995|NCT01759446|12495066|P5|NOT COMPLETED|Overall Study||0
5077996|NCT01759446|12495067|P4|NOT COMPLETED|Overall Study||1
5077997|NCT01759446|12495068|P3|NOT COMPLETED|Overall Study||1
5077998|NCT01759446|12495069|P2|NOT COMPLETED|Overall Study||1
5077999|NCT01759446|12495070|P1|NOT COMPLETED|Overall Study||1
5078000|NCT01759446|12495066|P5|COMPLETED|Overall Study||8
5078001|NCT01759446|12495067|P4|COMPLETED|Overall Study||8
5078002|NCT01759446|12495068|P3|COMPLETED|Overall Study||8
5078003|NCT01759446|12495069|P2|COMPLETED|Overall Study||8
5078004|NCT01759446|12495070|P1|COMPLETED|Overall Study||8
5078005|NCT01759446|12495066|P5|STARTED|Overall Study||8
5078006|NCT01759446|12495067|P4|STARTED|Overall Study||9
5078007|NCT01759446|12495068|P3|STARTED|Overall Study||9
5078008|NCT01759446|12495069|P2|STARTED|Overall Study||9
5078009|NCT01759446|12495070|P1|STARTED|Overall Study||9
5078010|NCT01759420|12495082|P1|NOT COMPLETED|Overall Study||6
5078011|NCT01759420|12495082|P1|COMPLETED|Overall Study||22
5078012|NCT01759420|12495082|P1|STARTED|Overall Study||28
5078013|NCT01759407|12495089|P2|NOT COMPLETED|Overall Study||2
5078014|NCT01759407|12495090|P1|NOT COMPLETED|Overall Study||0
5078015|NCT01759407|12495089|P2|COMPLETED|Overall Study||7
5078016|NCT01759407|12495090|P1|COMPLETED|Overall Study||10
5078017|NCT01759407|12495089|P2|STARTED|Overall Study||9
5078018|NCT01759407|12495090|P1|STARTED|Overall Study||10
5078019|NCT01759381|12495102|P2|NOT COMPLETED|Overall Study||0
5078020|NCT01759381|12495103|P1|NOT COMPLETED|Overall Study||1
5078021|NCT01759381|12495102|P2|COMPLETED|Overall Study||11
5078022|NCT01759381|12495103|P1|COMPLETED|Overall Study||7
5078023|NCT01759381|12495102|P2|STARTED|Overall Study||11
5078024|NCT01759381|12495103|P1|STARTED|Overall Study||8
5078025|NCT01759368|12495111|P2|NOT COMPLETED|Overall Study||0
5078026|NCT01759368|12495112|P1|NOT COMPLETED|Overall Study||1
5078027|NCT01759368|12495111|P2|COMPLETED|Overall Study||47
5078028|NCT01759368|12495112|P1|COMPLETED|Overall Study||46
5078029|NCT01759368|12495111|P2|STARTED|Overall Study||47
5078030|NCT01759368|12495112|P1|STARTED|Overall Study||47
5078031|NCT01759290|12495130|P1|NOT COMPLETED|Overall Study||81
5078032|NCT01759290|12495130|P1|COMPLETED|Overall Study||1719
5078033|NCT01759290|12495130|P1|STARTED|Overall Study||1800
5078034|NCT01759277|12495192|P2|NOT COMPLETED|Overall Study||0
5078035|NCT01759277|12495193|P1|NOT COMPLETED|Overall Study||0
5078036|NCT01759277|12495192|P2|COMPLETED|Overall Study||39
5078037|NCT01759277|12495193|P1|COMPLETED|Overall Study||41
5078038|NCT01759277|12495192|P2|STARTED|Overall Study||39
5078039|NCT01759277|12495193|P1|STARTED|Overall Study||41
5078040|NCT01759264|12495199|P1|NOT COMPLETED|Overall Study||10
5078041|NCT01759264|12495199|P1|COMPLETED|Overall Study||91
5078042|NCT01759264|12495199|P1|STARTED|Overall Study||101
5078043|NCT01759251|12495212|P1|NOT COMPLETED|Follow-up Period||0
5078044|NCT01759251|12495212|P1|COMPLETED|Follow-up Period||305
5078045|NCT01759251|12495212|P1|STARTED|Follow-up Period||305
5078046|NCT01759251|12495212|P1|NOT COMPLETED|60 Days Treatment Period||0
5078047|NCT01759251|12495212|P1|COMPLETED|60 Days Treatment Period||305
5078048|NCT01759251|12495212|P1|STARTED|60 Days Treatment Period||305
5078049|NCT01759251|12495212|P1|NOT COMPLETED|30 Days Treatment Period||4
5078050|NCT01759251|12495212|P1|COMPLETED|30 Days Treatment Period||305
5078051|NCT01759251|12495212|P1|STARTED|30 Days Treatment Period||309
5078052|NCT01759160|12495218|P2|NOT COMPLETED|Overall Study||0
5078053|NCT01759160|12495219|P1|NOT COMPLETED|Overall Study||0
5078054|NCT01759160|12495218|P2|COMPLETED|Overall Study||30
5078055|NCT01759160|12495219|P1|COMPLETED|Overall Study||30
5078056|NCT01759160|12495218|P2|STARTED|Overall Study||30
5078057|NCT01759160|12495219|P1|STARTED|Overall Study||30
5078058|NCT01758900|12495227|P2|NOT COMPLETED|Overall Study||8
5078059|NCT01758900|12495228|P1|NOT COMPLETED|Overall Study||7
5078060|NCT01758900|12495227|P2|COMPLETED|Overall Study||100
5078061|NCT01758900|12495228|P1|COMPLETED|Overall Study||99
5078062|NCT01758900|12495227|P2|STARTED|Overall Study||108
5078063|NCT01758900|12495228|P1|STARTED|Overall Study||106
5078064|NCT01758731|12495246|P1|NOT COMPLETED|Overall Study||1
5078065|NCT01758731|12495246|P1|COMPLETED|Overall Study||16
5078066|NCT01758731|12495246|P1|STARTED|Overall Study||17
5078067|NCT01758588|12495252|P2|NOT COMPLETED|Overall Study||0
5078068|NCT01758588|12495253|P1|NOT COMPLETED|Overall Study||0
5078069|NCT01758588|12495252|P2|COMPLETED|Overall Study||3
5078070|NCT01758588|12495253|P1|COMPLETED|Overall Study||5
5078071|NCT01758588|12495252|P2|STARTED|Overall Study||3
5078072|NCT01758588|12495253|P1|STARTED|Overall Study||5
5078073|NCT01758523|12495265|P2|NOT COMPLETED|Overall Study||14
5078074|NCT01758523|12495266|P1|NOT COMPLETED|Overall Study||21
5078075|NCT01758523|12495265|P2|COMPLETED|Overall Study||54
5078076|NCT01758523|12495266|P1|COMPLETED|Overall Study||53
5078077|NCT01758523|12495265|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
5078078|NCT01758523|12495266|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
5078079|NCT01758523|12495265|P2|STARTED|Overall Study||68
5078080|NCT01758523|12495266|P1|STARTED|Overall Study||74
5078081|NCT01758432|12495291|P7|NOT COMPLETED|Overall Study||0
5078082|NCT01758432|12495292|P6|NOT COMPLETED|Overall Study||0
5078083|NCT01758432|12495293|P5|NOT COMPLETED|Overall Study||0
5078084|NCT01758432|12495294|P4|NOT COMPLETED|Overall Study||0
5078085|NCT01758432|12495295|P3|NOT COMPLETED|Overall Study||0
5078086|NCT01758432|12495296|P2|NOT COMPLETED|Overall Study||0
5078087|NCT01758432|12495297|P1|NOT COMPLETED|Overall Study||0
5078088|NCT01758432|12495291|P7|COMPLETED|Overall Study||6
5078089|NCT01758432|12495292|P6|COMPLETED|Overall Study||6
5078090|NCT01758432|12495293|P5|COMPLETED|Overall Study||6
5078091|NCT01758432|12495294|P4|COMPLETED|Overall Study||6
5078092|NCT01758432|12495295|P3|COMPLETED|Overall Study||6
5078093|NCT01758432|12495296|P2|COMPLETED|Overall Study||6
5078094|NCT01758432|12495297|P1|COMPLETED|Overall Study||18
5078095|NCT01758432|12495291|P7|STARTED|Overall Study||6
5078096|NCT01758432|12495292|P6|STARTED|Overall Study||6
5078097|NCT01758432|12495293|P5|STARTED|Overall Study||6
5078098|NCT01758432|12495294|P4|STARTED|Overall Study||6
5078099|NCT01758432|12495295|P3|STARTED|Overall Study||6
5078100|NCT01758432|12495296|P2|STARTED|Overall Study||6
5078101|NCT01758432|12495297|P1|STARTED|Overall Study||18
5078102|NCT01758289|12495369|P1|NOT COMPLETED|Overall Study||53
5078103|NCT01758289|12495369|P1|COMPLETED|Overall Study||52
5078104|NCT01758289|12495369|P1|STARTED|Overall Study||105
5078105|NCT01757964|12495388|P2|NOT COMPLETED|Overall Study||0
5078106|NCT01757964|12495389|P1|NOT COMPLETED|Overall Study||0
5078107|NCT01757964|12495388|P2|COMPLETED|Overall Study||4
5078108|NCT01757964|12495389|P1|COMPLETED|Overall Study||9
5078109|NCT01757964|12495388|P2|STARTED|Overall Study||4
5078110|NCT01757964|12495389|P1|STARTED|Overall Study||9
5078111|NCT01757847|12495395|P2|NOT COMPLETED|Overall Study||4
5078112|NCT01757847|12495396|P1|NOT COMPLETED|Overall Study||3
5078113|NCT01757847|12495395|P2|COMPLETED|Overall Study||42
5078114|NCT01757847|12495396|P1|COMPLETED|Overall Study||41
5078115|NCT01757847|12495395|P2|STARTED|Overall Study||46
5078116|NCT01757847|12495396|P1|STARTED|Overall Study||44
5078117|NCT01757821|12495404|P1|NOT COMPLETED|Overall Study||1
5078118|NCT01757821|12495404|P1|COMPLETED|Overall Study|10 subjects|10
5078119|NCT01757821|12495404|P1|STARTED|Overall Study|11 subjects|11
5078120|NCT01757717|12495412|P1|NOT COMPLETED|Overall Study||0
5078121|NCT01757717|12495412|P1|COMPLETED|Overall Study||3
5078122|NCT01757717|12495412|P1|STARTED|Overall Study||3
5078123|NCT01757704|12495419|P2|NOT COMPLETED|Overall Study||3
5078124|NCT01757704|12495420|P1|NOT COMPLETED|Overall Study||1
5078125|NCT01757704|12495419|P2|COMPLETED|Overall Study||10
5078126|NCT01757704|12495420|P1|COMPLETED|Overall Study||10
5078127|NCT01757704|12495419|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
5078128|NCT01757704|12495420|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
5078129|NCT01757691|12495438|P2|NOT COMPLETED|Overall Study||0
5078130|NCT01757691|12495439|P1|NOT COMPLETED|Overall Study||2
5078131|NCT01757691|12495438|P2|COMPLETED|Overall Study||0
5078132|NCT01757691|12495439|P1|COMPLETED|Overall Study||0
5078133|NCT01757691|12495438|P2|STARTED|Overall Study||0
5078134|NCT01757691|12495439|P1|STARTED|Overall Study||2
5078135|NCT01757678|12495452|P1|NOT COMPLETED|Overall Study||0
5078136|NCT01757678|12495452|P1|COMPLETED|Overall Study||276
5078137|NCT01757678|12495452|P1|STARTED|Overall Study||276
5078138|NCT01757665|12495466|P2|NOT COMPLETED|Overall Study||83
5078139|NCT01757665|12495467|P1|NOT COMPLETED|Overall Study||694
5078140|NCT01757665|12495466|P2|COMPLETED|Overall Study||0
5078141|NCT01757665|12495467|P1|COMPLETED|Overall Study||0
5078142|NCT01757665|12495466|P2|Implanted With Device|Overall Study||82
5078143|NCT01757665|12495467|P1|Implanted With Device|Overall Study||689
5078144|NCT01757665|12495466|P2|STARTED|Overall Study||83
5078145|NCT01757665|12495467|P1|STARTED|Overall Study||694
5078146|NCT01757561|12495620|P4|NOT COMPLETED|Overall Study||9
5078147|NCT01757561|12495621|P3|NOT COMPLETED|Overall Study||7
5078148|NCT01757561|12495622|P2|NOT COMPLETED|Overall Study||6
5078149|NCT01757561|12495623|P1|NOT COMPLETED|Overall Study||6
5078150|NCT01757561|12495620|P4|COMPLETED|Overall Study||25
5078151|NCT01757561|12495621|P3|COMPLETED|Overall Study||31
5078152|NCT01757561|12495622|P2|COMPLETED|Overall Study||28
5078153|NCT01757561|12495623|P1|COMPLETED|Overall Study||32
5078154|NCT01757561|12495620|P4|STARTED|Overall Study||34
5078155|NCT01757561|12495621|P3|STARTED|Overall Study||38
5078156|NCT01757561|12495622|P2|STARTED|Overall Study||34
5078157|NCT01757561|12495623|P1|STARTED|Overall Study||38
5078158|NCT01757405|12495639|P2|NOT COMPLETED|Overall Study||2
5078159|NCT01757405|12495640|P1|NOT COMPLETED|Overall Study||1
5078160|NCT01757405|12495639|P2|COMPLETED|Overall Study||18
5078161|NCT01757405|12495640|P1|COMPLETED|Overall Study||17
5078162|NCT01757405|12495639|P2|STARTED|Overall Study||20
5078163|NCT01757405|12495640|P1|STARTED|Overall Study||18
5078164|NCT01757301|12495658|P2|NOT COMPLETED|Overall Study||14
5078165|NCT01757301|12495659|P1|NOT COMPLETED|Overall Study||13
5078166|NCT01757301|12495658|P2|COMPLETED|Overall Study||133
5078167|NCT01757301|12495659|P1|COMPLETED|Overall Study||134
5078168|NCT01757301|12495658|P2|STARTED|Overall Study||147
5078169|NCT01757301|12495659|P1|STARTED|Overall Study||147
5078170|NCT01757275|12495675|P2|NOT COMPLETED|Overall Study||13
5078171|NCT01757275|12495676|P1|NOT COMPLETED|Overall Study||9
5078172|NCT01757275|12495675|P2|COMPLETED|Overall Study||98
5078173|NCT01757275|12495676|P1|COMPLETED|Overall Study||102
5078174|NCT01757275|12495675|P2|STARTED|Overall Study||111
5078175|NCT01757275|12495676|P1|STARTED|Overall Study||111
5078176|NCT01757197|12495698|P1|NOT COMPLETED|Overall Study||2
5078177|NCT01757197|12495698|P1|COMPLETED|Overall Study||0
5078178|NCT01757197|12495698|P1|STARTED|Overall Study||2
5078179|NCT01757184|12495707|P4|NOT COMPLETED|Open-label Period||3
5078180|NCT01757184|12495708|P3|NOT COMPLETED|Open-label Period||4
5078181|NCT01757184|12495709|P2|NOT COMPLETED|Open-label Period||0
5078182|NCT01757184|12495710|P1|NOT COMPLETED|Open-label Period||0
5078183|NCT01757184|12495707|P4|COMPLETED|Open-label Period||27
5078184|NCT01757184|12495708|P3|COMPLETED|Open-label Period||32
5078185|NCT01757184|12495709|P2|COMPLETED|Open-label Period||0
5078186|NCT01757184|12495710|P1|COMPLETED|Open-label Period||0
5078187|NCT01757184|12495707|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
5078188|NCT01757184|12495708|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
5078189|NCT01757184|12495709|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
5078190|NCT01757184|12495710|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
5078191|NCT01757184|12495707|P4|STARTED|Open-label Period||30
5078192|NCT01757184|12495708|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
5078193|NCT01757184|12495709|P2|STARTED|Open-label Period||0
5078194|NCT01757184|12495710|P1|STARTED|Open-label Period||0
5078195|NCT01757184|12495707|P4|NOT COMPLETED|Double-blind Period||0
5078196|NCT01757184|12495708|P3|NOT COMPLETED|Double-blind Period||0
5078197|NCT01757184|12495709|P2|NOT COMPLETED|Double-blind Period||0
5078198|NCT01757184|12495710|P1|NOT COMPLETED|Double-blind Period||1
5078199|NCT01757184|12495707|P4|COMPLETED|Double-blind Period||0
5078200|NCT01757184|12495708|P3|COMPLETED|Double-blind Period||0
5078201|NCT01757184|12495709|P2|COMPLETED|Double-blind Period||30
5078202|NCT01757184|12495710|P1|COMPLETED|Double-blind Period||35
5078203|NCT01757184|12495707|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
5078204|NCT01757184|12495708|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
5078205|NCT01757184|12495709|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
5078206|NCT01757184|12495710|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
5078207|NCT01757184|12495707|P4|STARTED|Double-blind Period||0
5078208|NCT01757184|12495708|P3|STARTED|Double-blind Period||0
5078209|NCT01757184|12495709|P2|STARTED|Double-blind Period||30
5078210|NCT01757184|12495710|P1|STARTED|Double-blind Period||36
5078211|NCT01757171|12495754|P2|NOT COMPLETED|Overall Study||1
5078212|NCT01757171|12495755|P1|NOT COMPLETED|Overall Study||8
5078213|NCT01757171|12495754|P2|COMPLETED|Overall Study||23
5078214|NCT01757171|12495755|P1|COMPLETED|Overall Study||53
5078215|NCT01757171|12495754|P2|STARTED|Overall Study||24
5078216|NCT01757171|12495755|P1|STARTED|Overall Study||61
5078217|NCT01756976|12495769|P2|NOT COMPLETED|Overall Study||0
5078218|NCT01756976|12495770|P1|NOT COMPLETED|Overall Study||3
5078219|NCT01756976|12495769|P2|COMPLETED|Overall Study||8
5078220|NCT01756976|12495770|P1|COMPLETED|Overall Study||73
5078221|NCT01756976|12495769|P2|STARTED|Overall Study||8
5078222|NCT01756976|12495770|P1|STARTED|Overall Study||76
5078223|NCT01756885|12495778|P2|NOT COMPLETED|Overall Study||26
5078224|NCT01756885|12495779|P1|NOT COMPLETED|Overall Study||23
5078225|NCT01756885|12495778|P2|COMPLETED|Overall Study||79
5078226|NCT01756885|12495779|P1|COMPLETED|Overall Study||79
5078227|NCT01756885|12495778|P2|STARTED|Overall Study||105
5078228|NCT01756885|12495779|P1|STARTED|Overall Study||102
5078229|NCT01756846|12495791|P2|NOT COMPLETED|Overall Study||12
5078230|NCT01756846|12495792|P1|NOT COMPLETED|Overall Study||6
5078231|NCT01756846|12495791|P2|COMPLETED|Overall Study||1821
5078232|NCT01756846|12495792|P1|COMPLETED|Overall Study||1827
5078233|NCT01756846|12495791|P2|STARTED|Overall Study||1833
5078234|NCT01756846|12495792|P1|STARTED|Overall Study||1833
5078235|NCT01756586|12495802|P2|NOT COMPLETED|Overall Study||2
5078236|NCT01756586|12495803|P1|NOT COMPLETED|Overall Study||2
5078237|NCT01756586|12495802|P2|COMPLETED|Overall Study||0
5078238|NCT01756586|12495803|P1|COMPLETED|Overall Study||0
5078239|NCT01756586|12495802|P2|STARTED|Overall Study||2
5078240|NCT01756586|12495803|P1|STARTED|Overall Study||2
5078241|NCT01756573|12495812|P3|NOT COMPLETED|Overall Study||0
5078242|NCT01756573|12495813|P2|NOT COMPLETED|Overall Study||0
5078243|NCT01756573|12495814|P1|NOT COMPLETED|Overall Study||0
5078244|NCT01756573|12495812|P3|COMPLETED|Overall Study||1
5078245|NCT01756573|12495813|P2|COMPLETED|Overall Study||1
5078246|NCT01756573|12495814|P1|COMPLETED|Overall Study||3
5078247|NCT01756573|12495812|P3|STARTED|Overall Study||1
5078248|NCT01756573|12495813|P2|STARTED|Overall Study||1
5078249|NCT01756573|12495814|P1|STARTED|Overall Study||3
5078250|NCT01756560|12495824|P2|NOT COMPLETED|Overall Study||0
5078251|NCT01756560|12495825|P1|NOT COMPLETED|Overall Study||2
5078252|NCT01756560|12495824|P2|COMPLETED|Overall Study||0
5078253|NCT01756560|12495825|P1|COMPLETED|Overall Study||0
5078254|NCT01756560|12495824|P2|STARTED|Overall Study||0
5078255|NCT01756560|12495825|P1|STARTED|Overall Study||2
5078256|NCT01756456|12495837|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
5078257|NCT01756456|12495838|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
5078258|NCT01756456|12495839|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
5078259|NCT01756456|12495840|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
5078260|NCT01756456|12495841|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
5078261|NCT01756456|12495842|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
5078262|NCT01756456|12495837|P6|COMPLETED|Follow Up Period Phase I/II||15
5078263|NCT01756456|12495838|P5|COMPLETED|Follow Up Period Phase I/II||13
5078264|NCT01756456|12495839|P4|COMPLETED|Follow Up Period Phase I/II||12
5078265|NCT01756456|12495840|P3|COMPLETED|Follow Up Period Phase I/II||1
5078266|NCT01756456|12495841|P2|COMPLETED|Follow Up Period Phase I/II||5
5078267|NCT01756456|12495842|P1|COMPLETED|Follow Up Period Phase I/II||5
5078268|NCT01756456|12495837|P6|STARTED|Follow Up Period Phase I/II||48
5078269|NCT01756456|12495838|P5|STARTED|Follow Up Period Phase I/II||39
5078270|NCT01756456|12495839|P4|STARTED|Follow Up Period Phase I/II||45
5078271|NCT01756456|12495840|P3|STARTED|Follow Up Period Phase I/II||2
5078272|NCT01756456|12495841|P2|STARTED|Follow Up Period Phase I/II||6
5078273|NCT01756456|12495842|P1|STARTED|Follow Up Period Phase I/II||6
5078274|NCT01756456|12495837|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
5078275|NCT01756456|12495838|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
5078276|NCT01756456|12495839|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
5078277|NCT01756456|12495840|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
5078278|NCT01756456|12495841|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
5078279|NCT01756456|12495842|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
5078280|NCT01756456|12495837|P6|COMPLETED|Treatment Period: Phase I/II||48
5078281|NCT01756456|12495838|P5|COMPLETED|Treatment Period: Phase I/II||39
5078282|NCT01756456|12495839|P4|COMPLETED|Treatment Period: Phase I/II||45
5078283|NCT01756456|12495840|P3|COMPLETED|Treatment Period: Phase I/II||2
5078284|NCT01756456|12495841|P2|COMPLETED|Treatment Period: Phase I/II||6
5078285|NCT01756456|12495842|P1|COMPLETED|Treatment Period: Phase I/II||6
5078286|NCT01756456|12495837|P6|STARTED|Treatment Period: Phase I/II||52
5078287|NCT01756456|12495838|P5|STARTED|Treatment Period: Phase I/II||52
5078288|NCT01756456|12495839|P4|STARTED|Treatment Period: Phase I/II||52
5078289|NCT01756456|12495840|P3|STARTED|Treatment Period: Phase I/II||4
5078290|NCT01756456|12495841|P2|STARTED|Treatment Period: Phase I/II||7
5078291|NCT01756456|12495842|P1|STARTED|Treatment Period: Phase I/II||7
5078292|NCT01756391|12495940|P1|NOT COMPLETED|Overall Study||32
5078293|NCT01756391|12495940|P1|COMPLETED|Overall Study||319
5078294|NCT01756391|12495940|P1|STARTED|Overall Study||351
5078295|NCT01756352|12495944|P1|NOT COMPLETED|Overall Study||1
5078296|NCT01756352|12495944|P1|COMPLETED|Overall Study||12
5078297|NCT01756352|12495944|P1|STARTED|Overall Study||13
5078298|NCT01756300|12495949|P1|NOT COMPLETED|Overall Study||2
5078299|NCT01756300|12495949|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
5078300|NCT01756300|12495949|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
5078301|NCT01756274|12495971|P1|NOT COMPLETED|Overall Study||3
5078302|NCT01756274|12495971|P1|COMPLETED|Overall Study||159
5078303|NCT01756274|12495971|P1|STARTED|Overall Study||162
5078304|NCT01756235|12495978|P1|NOT COMPLETED|Overall Study||2
5078305|NCT01756235|12495978|P1|COMPLETED|Overall Study||460
5078306|NCT01756235|12495978|P1|STARTED|Overall Study||462
5078307|NCT01756209|12496003|P4|NOT COMPLETED|Overall Study||0
5078308|NCT01756209|12496004|P3|NOT COMPLETED|Overall Study||0
5078309|NCT01756209|12496005|P2|NOT COMPLETED|Overall Study||0
5078310|NCT01756209|12496006|P1|NOT COMPLETED|Overall Study||0
5078311|NCT01756209|12496003|P4|COMPLETED|Overall Study||40
5078312|NCT01756209|12496004|P3|COMPLETED|Overall Study||40
5078313|NCT01756209|12496005|P2|COMPLETED|Overall Study||40
5078314|NCT01756209|12496006|P1|COMPLETED|Overall Study||40
5078315|NCT01756209|12496003|P4|STARTED|Overall Study||40
5078316|NCT01756209|12496004|P3|STARTED|Overall Study||40
5078317|NCT01756209|12496005|P2|STARTED|Overall Study||40
5078318|NCT01756209|12496006|P1|STARTED|Overall Study||40
5078319|NCT01756157|12496016|P2|NOT COMPLETED|Second Intervention Period||0
5078320|NCT01756157|12496017|P1|NOT COMPLETED|Second Intervention Period||0
5078321|NCT01756157|12496016|P2|COMPLETED|Second Intervention Period||22
5078322|NCT01756157|12496017|P1|COMPLETED|Second Intervention Period||22
5078323|NCT01756157|12496016|P2|STARTED|Second Intervention Period||22
5078324|NCT01756157|12496017|P1|STARTED|Second Intervention Period||22
5078325|NCT01756157|12496016|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5078326|NCT01756157|12496017|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5078327|NCT01756157|12496016|P2|COMPLETED|Washout Period (at Least 7 Days)||22
5078328|NCT01756157|12496017|P1|COMPLETED|Washout Period (at Least 7 Days)||22
5078329|NCT01756157|12496016|P2|STARTED|Washout Period (at Least 7 Days)||22
5078330|NCT01756157|12496017|P1|STARTED|Washout Period (at Least 7 Days)||22
5078331|NCT01756157|12496016|P2|NOT COMPLETED|First Intervention Period||2
5078332|NCT01756157|12496017|P1|NOT COMPLETED|First Intervention Period||1
5078333|NCT01756157|12496016|P2|COMPLETED|First Intervention Period||22
5078334|NCT01756157|12496017|P1|COMPLETED|First Intervention Period||22
5078335|NCT01756157|12496016|P2|STARTED|First Intervention Period||24
5078336|NCT01756157|12496017|P1|STARTED|First Intervention Period||23
5078337|NCT01756079|12496031|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
5078338|NCT01756079|12496031|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
5078339|NCT01756079|12496031|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
5078340|NCT01756079|12496031|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
5078341|NCT01756079|12496031|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
5078342|NCT01756079|12496031|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
5078343|NCT01756079|12496031|P1|STARTED|Lead-in: Day 0 to Week 4||58
5078344|NCT01756053|12496037|P2|NOT COMPLETED|Period 2 (10 Days)||2
5078345|NCT01756053|12496038|P1|NOT COMPLETED|Period 2 (10 Days)||0
5078346|NCT01756053|12496037|P2|COMPLETED|Period 2 (10 Days)||6
5078347|NCT01756053|12496038|P1|COMPLETED|Period 2 (10 Days)||7
5078348|NCT01756053|12496037|P2|STARTED|Period 2 (10 Days)||8
5078349|NCT01756053|12496038|P1|STARTED|Period 2 (10 Days)||7
5078350|NCT01756053|12496037|P2|NOT COMPLETED|Washout Period (~21 Days)||0
5078351|NCT01756053|12496038|P1|NOT COMPLETED|Washout Period (~21 Days)||0
5078352|NCT01756053|12496037|P2|COMPLETED|Washout Period (~21 Days)||8
5078353|NCT01756053|12496038|P1|COMPLETED|Washout Period (~21 Days)||7
5078354|NCT01756053|12496037|P2|STARTED|Washout Period (~21 Days)||8
5078355|NCT01756053|12496038|P1|STARTED|Washout Period (~21 Days)||7
5078356|NCT01756053|12496037|P2|NOT COMPLETED|Period 1 (10 Days)||1
5078357|NCT01756053|12496038|P1|NOT COMPLETED|Period 1 (10 Days)||1
5078358|NCT01756053|12496037|P2|COMPLETED|Period 1 (10 Days)||8
5078359|NCT01756053|12496038|P1|COMPLETED|Period 1 (10 Days)||7
5078360|NCT01756053|12496037|P2|STARTED|Period 1 (10 Days)||9
5078361|NCT01756053|12496038|P1|STARTED|Period 1 (10 Days)||8
5078362|NCT01755949|12496064|P6|NOT COMPLETED|Overall Study||0
5078363|NCT01755949|12496065|P5|NOT COMPLETED|Overall Study||0
5078364|NCT01755949|12496066|P4|NOT COMPLETED|Overall Study||0
5078365|NCT01755949|12496067|P3|NOT COMPLETED|Overall Study||0
5078366|NCT01755949|12496068|P2|NOT COMPLETED|Overall Study||0
5078367|NCT01755949|12496069|P1|NOT COMPLETED|Overall Study||0
5078368|NCT01755949|12496064|P6|COMPLETED|Overall Study||3
5078369|NCT01755949|12496065|P5|COMPLETED|Overall Study||4
5078370|NCT01755949|12496066|P4|COMPLETED|Overall Study||5
5078371|NCT01755949|12496067|P3|COMPLETED|Overall Study||4
5078372|NCT01755949|12496068|P2|COMPLETED|Overall Study||5
5078373|NCT01755949|12496069|P1|COMPLETED|Overall Study||5
5078374|NCT01755949|12496064|P6|STARTED|Overall Study||3
5078375|NCT01755949|12496065|P5|STARTED|Overall Study||4
5078376|NCT01755949|12496066|P4|STARTED|Overall Study||5
5078377|NCT01755949|12496067|P3|STARTED|Overall Study||4
5078378|NCT01755949|12496068|P2|STARTED|Overall Study||5
5078379|NCT01755949|12496069|P1|STARTED|Overall Study||5
5078380|NCT01755767|12496099|P4|NOT COMPLETED|Overall Study||114
5078381|NCT01755767|12496100|P3|NOT COMPLETED|Overall Study||226
5078382|NCT01755767|12496101|P2|NOT COMPLETED|Overall Study||15
5078383|NCT01755767|12496102|P1|NOT COMPLETED|Overall Study||28
5078384|NCT01755767|12496099|P4|COMPLETED|Overall Study||0
5078385|NCT01755767|12496100|P3|COMPLETED|Overall Study||0
5078386|NCT01755767|12496101|P2|COMPLETED|Overall Study||0
5078387|NCT01755767|12496102|P1|COMPLETED|Overall Study||0
5078388|NCT01755767|12496099|P4|STARTED|Overall Study||114
5078389|NCT01755767|12496100|P3|STARTED|Overall Study||226
5078390|NCT01755767|12496101|P2|STARTED|Overall Study||15
5078391|NCT01755767|12496102|P1|STARTED|Overall Study||28
5078392|NCT01755702|12496118|P1|NOT COMPLETED|Period III||0
5078393|NCT01755702|12496118|P1|COMPLETED|Period III||58
5078394|NCT01755702|12496118|P1|Received Ibuprofen|Period III||18
5078395|NCT01755702|12496118|P1|Received Paracetamol/Caffeine|Period III||10
5078396|NCT01755702|12496118|P1|Received Placebo|Period III||13
5078397|NCT01755702|12496118|P1|Received Paracetamol|Period III||17
5078398|NCT01755702|12496118|P1|STARTED|Period III||58
5078399|NCT01755702|12496118|P1|NOT COMPLETED|Washout Period II||5
5078400|NCT01755702|12496118|P1|COMPLETED|Washout Period II||58
5078401|NCT01755702|12496118|P1|STARTED|Washout Period II||63
5078402|NCT01755702|12496118|P1|NOT COMPLETED|Period II||0
5078403|NCT01755702|12496118|P1|COMPLETED|Period II||63
5078404|NCT01755702|12496118|P1|Received Paracetamol|Period II||17
5078405|NCT01755702|12496118|P1|Received Paracetamol/Caffeine|Period II||20
5078406|NCT01755702|12496118|P1|Received Placebo|Period II||15
5078407|NCT01755702|12496118|P1|Received Ibuprofen|Period II||11
5078408|NCT01755702|12496118|P1|STARTED|Period II||63
5078409|NCT01755702|12496118|P1|NOT COMPLETED|Wash Out Period I||3
5078410|NCT01755702|12496118|P1|COMPLETED|Wash Out Period I||63
5078411|NCT01755702|12496118|P1|STARTED|Wash Out Period I||66
5078412|NCT01755702|12496118|P1|NOT COMPLETED|Period I||0
5078413|NCT01755702|12496118|P1|COMPLETED|Period I||66
5078414|NCT01755702|12496118|P1|Received Paracetamol/Caffeine|Period I||17
5078415|NCT01755702|12496118|P1|Received Ibuprofen|Period I||16
5078416|NCT01755702|12496118|P1|Received Placebo|Period I||17
5078417|NCT01755702|12496118|P1|Received Paracetamol|Period I||16
5078418|NCT01755702|12496118|P1|STARTED|Period I||66
5078419|NCT01755689|12496165|P5|NOT COMPLETED|Overall Study||6
5078420|NCT01755689|12496166|P4|NOT COMPLETED|Overall Study||6
5078421|NCT01755689|12496167|P3|NOT COMPLETED|Overall Study||6
5078422|NCT01755689|12496168|P2|NOT COMPLETED|Overall Study||5
5078423|NCT01755689|12496169|P1|NOT COMPLETED|Overall Study||3
5078424|NCT01755689|12496165|P5|COMPLETED|Overall Study||255
5078425|NCT01755689|12496166|P4|COMPLETED|Overall Study||254
5078426|NCT01755689|12496167|P3|COMPLETED|Overall Study||255
5078427|NCT01755689|12496168|P2|COMPLETED|Overall Study||254
5078428|NCT01755689|12496169|P1|COMPLETED|Overall Study||256
5078429|NCT01755689|12496165|P5|STARTED|Overall Study||261
5078430|NCT01755689|12496166|P4|STARTED|Overall Study||260
5078431|NCT01755689|12496167|P3|STARTED|Overall Study||261
5078432|NCT01755689|12496168|P2|STARTED|Overall Study||259
5078433|NCT01755689|12496169|P1|STARTED|Overall Study||259
5078434|NCT01755637|12496244|P2|NOT COMPLETED|Period 2||0
5078435|NCT01755637|12496245|P1|NOT COMPLETED|Period 2||0
5078436|NCT01755637|12496244|P2|COMPLETED|Period 2||27
5078437|NCT01755637|12496245|P1|COMPLETED|Period 2||28
5078438|NCT01755637|12496244|P2|STARTED|Period 2||27
5078439|NCT01755637|12496245|P1|STARTED|Period 2||28
5078440|NCT01755637|12496244|P2|NOT COMPLETED|Period 1||1
5078441|NCT01755637|12496245|P1|NOT COMPLETED|Period 1||0
5078442|NCT01755637|12496244|P2|COMPLETED|Period 1||27
5078443|NCT01755637|12496245|P1|COMPLETED|Period 1||28
5078444|NCT01755637|12496244|P2|STARTED|Period 1||28
5078445|NCT01755637|12496245|P1|STARTED|Period 1||28
5078446|NCT01755598|12496265|P2|NOT COMPLETED|Overall Study||283
5078447|NCT01755598|12496266|P1|NOT COMPLETED|Overall Study||265
5078448|NCT01755598|12496265|P2|COMPLETED|Overall Study||1504
5078449|NCT01755598|12496266|P1|COMPLETED|Overall Study||1521
5078450|NCT01755598|12496265|P2|STARTED|Overall Study||1787
5078451|NCT01755598|12496266|P1|STARTED|Overall Study||1786
5078452|NCT01755546|12496300|P1|NOT COMPLETED|Long Term Treatment||121
5078453|NCT01755546|12496300|P1|COMPLETED|Long Term Treatment||103
5078454|NCT01755546|12496300|P1|STARTED|Long Term Treatment||224
5078455|NCT01755546|12496300|P1|NOT COMPLETED|Titration Phase||70
5078456|NCT01755546|12496300|P1|COMPLETED|Titration Phase||224
5078457|NCT01755546|12496300|P1|STARTED|Titration Phase||294
5078458|NCT01755546|12496300|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
5078459|NCT01755546|12496300|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
5078460|NCT01755546|12496300|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
5078461|NCT01755455|12496304|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5078462|NCT01755455|12496305|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5078463|NCT01755455|12496304|P2|COMPLETED|Second Intervention (6 Weeks)||11
5078464|NCT01755455|12496305|P1|COMPLETED|Second Intervention (6 Weeks)||11
5078465|NCT01755455|12496304|P2|STARTED|Second Intervention (6 Weeks)||11
5078466|NCT01755455|12496305|P1|STARTED|Second Intervention (6 Weeks)||11
5078467|NCT01755455|12496304|P2|NOT COMPLETED|Washout (4 Weeks)||0
5078468|NCT01755455|12496305|P1|NOT COMPLETED|Washout (4 Weeks)||0
5078469|NCT01755455|12496304|P2|COMPLETED|Washout (4 Weeks)||11
5078470|NCT01755455|12496305|P1|COMPLETED|Washout (4 Weeks)||11
5078471|NCT01755455|12496304|P2|STARTED|Washout (4 Weeks)||11
5078472|NCT01755455|12496305|P1|STARTED|Washout (4 Weeks)||11
5078473|NCT01755455|12496304|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
5078474|NCT01755455|12496305|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5078475|NCT01755455|12496304|P2|COMPLETED|First Intervention (6 Weeks)||11
5078476|NCT01755455|12496305|P1|COMPLETED|First Intervention (6 Weeks)||11
5078477|NCT01755455|12496304|P2|STARTED|First Intervention (6 Weeks)||11
5078478|NCT01755455|12496305|P1|STARTED|First Intervention (6 Weeks)||11
5078479|NCT01755416|12496317|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
5078480|NCT01755416|12496318|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
5078481|NCT01755416|12496317|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
5078482|NCT01755416|12496318|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
5078483|NCT01755416|12496317|P2|STARTED|Second Intervention (Upto 2 Days)||7
5078484|NCT01755416|12496318|P1|STARTED|Second Intervention (Upto 2 Days)||8
5078485|NCT01755416|12496317|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
5078486|NCT01755416|12496318|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
5078487|NCT01755416|12496317|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
5078488|NCT01755416|12496318|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
5078489|NCT01755416|12496317|P2|STARTED|First Intervention ( Upto 2 Days)||9
5078490|NCT01755416|12496318|P1|STARTED|First Intervention ( Upto 2 Days)||9
5078491|NCT01755234|12496326|P2|NOT COMPLETED|Overall Study||8
5078492|NCT01755234|12496327|P1|NOT COMPLETED|Overall Study||15
5078493|NCT01755234|12496326|P2|COMPLETED|Overall Study||37
5078494|NCT01755234|12496327|P1|COMPLETED|Overall Study||30
5078495|NCT01755234|12496326|P2|STARTED|Overall Study||45
5078496|NCT01755234|12496327|P1|STARTED|Overall Study||45
5078497|NCT01755169|12496343|P4|NOT COMPLETED|Overall Study||0
5078498|NCT01755169|12496344|P3|NOT COMPLETED|Overall Study||0
5078499|NCT01755169|12496345|P2|NOT COMPLETED|Overall Study||0
5078500|NCT01755169|12496346|P1|NOT COMPLETED|Overall Study||0
5078501|NCT01755169|12496343|P4|COMPLETED|Overall Study||1
5078502|NCT01755169|12496344|P3|COMPLETED|Overall Study||0
5078503|NCT01755169|12496345|P2|COMPLETED|Overall Study||1
5078504|NCT01755169|12496346|P1|COMPLETED|Overall Study||2
5078505|NCT01755169|12496343|P4|STARTED|Overall Study||1
5078506|NCT01755169|12496344|P3|STARTED|Overall Study||0
5078507|NCT01755169|12496345|P2|STARTED|Overall Study||1
5078508|NCT01755169|12496346|P1|STARTED|Overall Study||2
5078509|NCT01755156|12496358|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
5078510|NCT01755156|12496359|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
5078511|NCT01755156|12496358|P2|COMPLETED|Phase B (Weeks 24-104)||141
5078512|NCT01755156|12496359|P1|COMPLETED|Phase B (Weeks 24-104)||144
5078513|NCT01755156|12496358|P2|STARTED|Phase B (Weeks 24-104)||177
5078514|NCT01755156|12496359|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
5078515|NCT01755156|12496358|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
5078516|NCT01755156|12496359|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
5078517|NCT01755156|12496358|P2|COMPLETED|Phase A (Weeks 0-24)||177
5078518|NCT01755156|12496359|P1|COMPLETED|Phase A (Weeks 0-24)||184
5078519|NCT01755156|12496358|P2|STARTED|Phase A (Weeks 0-24)||201
5078520|NCT01755156|12496359|P1|STARTED|Phase A (Weeks 0-24)||201
5078521|NCT01755143|12496405|P2|NOT COMPLETED|Overall Study||3
5078522|NCT01755143|12496406|P1|NOT COMPLETED|Overall Study||11
5078523|NCT01755143|12496405|P2|COMPLETED|Overall Study||86
5078524|NCT01755143|12496406|P1|COMPLETED|Overall Study||166
5078525|NCT01755143|12496405|P2|STARTED|Overall Study||89
5078526|NCT01755143|12496406|P1|STARTED|Overall Study||177
5078527|NCT01755091|12496423|P3|NOT COMPLETED|Overall Study||7
5078528|NCT01755091|12496424|P2|NOT COMPLETED|Overall Study||3
5078529|NCT01755091|12496425|P1|NOT COMPLETED|Overall Study||9
5078530|NCT01755091|12496423|P3|COMPLETED|Overall Study||20
5078531|NCT01755091|12496424|P2|COMPLETED|Overall Study||19
5078532|NCT01755091|12496425|P1|COMPLETED|Overall Study||17
5078533|NCT01755091|12496423|P3|STARTED|Overall Study||27
5078534|NCT01755091|12496424|P2|STARTED|Overall Study||22
5078535|NCT01755091|12496425|P1|STARTED|Overall Study||26
5078536|NCT01755026|12496450|P2|NOT COMPLETED|Overall Study||1
5078537|NCT01755026|12496451|P1|NOT COMPLETED|Overall Study||2
5078538|NCT01755026|12496450|P2|COMPLETED|Overall Study||11
5078539|NCT01755026|12496451|P1|COMPLETED|Overall Study||9
5078540|NCT01755026|12496450|P2|STARTED|Overall Study||12
5078541|NCT01755026|12496451|P1|STARTED|Overall Study||11
5078542|NCT01754987|12496459|P2|NOT COMPLETED|Overall Study||0
5078543|NCT01754987|12496460|P1|NOT COMPLETED|Overall Study||0
5078544|NCT01754987|12496459|P2|COMPLETED|Overall Study||0
5078545|NCT01754987|12496460|P1|COMPLETED|Overall Study||5
5078546|NCT01754987|12496459|P2|STARTED|Overall Study||0
5078547|NCT01754987|12496460|P1|STARTED|Overall Study||5
5078548|NCT01754922|12496474|P2|NOT COMPLETED|Overall Study||1
5078549|NCT01754922|12496475|P1|NOT COMPLETED|Overall Study||0
5078550|NCT01754922|12496474|P2|COMPLETED|Overall Study||17
5078551|NCT01754922|12496475|P1|COMPLETED|Overall Study||32
5078552|NCT01754922|12496474|P2|STARTED|Overall Study||18
5078553|NCT01754922|12496475|P1|STARTED|Overall Study||32
5078554|NCT01754909|12496487|P2|NOT COMPLETED|Overall Study||0
5078555|NCT01754909|12496488|P1|NOT COMPLETED|Overall Study||0
5078556|NCT01754909|12496487|P2|COMPLETED|Overall Study||23
5078557|NCT01754909|12496488|P1|COMPLETED|Overall Study||20
5078558|NCT01754909|12496487|P2|STARTED|Overall Study||23
5078559|NCT01754909|12496488|P1|STARTED|Overall Study||20
5078560|NCT01754766|12496501|P3|NOT COMPLETED|Overall Study||0
5078561|NCT01754766|12496502|P2|NOT COMPLETED|Overall Study||1
5078562|NCT01754766|12496503|P1|NOT COMPLETED|Overall Study||1
5078563|NCT01754766|12496501|P3|COMPLETED|Overall Study||30
5078564|NCT01754766|12496502|P2|COMPLETED|Overall Study||28
5078565|NCT01754766|12496503|P1|COMPLETED|Overall Study||30
5078566|NCT01754766|12496501|P3|STARTED|Overall Study||30
5078567|NCT01754766|12496502|P2|STARTED|Overall Study||29
5078568|NCT01754766|12496503|P1|STARTED|Overall Study||31
5078569|NCT01754727|12496517|P1|NOT COMPLETED|Overall Study||2
5078570|NCT01754727|12496517|P1|COMPLETED|Overall Study||450
5078571|NCT01754727|12496517|P1|STARTED|Overall Study||452
5078572|NCT01754714|12496535|P4|NOT COMPLETED|Overall Study||1
5078573|NCT01754714|12496536|P3|NOT COMPLETED|Overall Study||2
5078574|NCT01754714|12496537|P2|NOT COMPLETED|Overall Study||1
5078575|NCT01754714|12496538|P1|NOT COMPLETED|Overall Study||0
5078576|NCT01754714|12496535|P4|COMPLETED|Overall Study||27
5078577|NCT01754714|12496536|P3|COMPLETED|Overall Study||24
5078578|NCT01754714|12496537|P2|COMPLETED|Overall Study||26
5078579|NCT01754714|12496538|P1|COMPLETED|Overall Study||27
5078580|NCT01754714|12496535|P4|STARTED|Overall Study||28
5078581|NCT01754714|12496536|P3|STARTED|Overall Study||26
5078582|NCT01754714|12496537|P2|STARTED|Overall Study||27
5078583|NCT01754714|12496538|P1|STARTED|Overall Study||27
5078584|NCT01754688|12496628|P1|NOT COMPLETED|Overall Study||0
5078585|NCT01754688|12496628|P1|COMPLETED|Overall Study||624
5078586|NCT01754688|12496628|P1|STARTED|Overall Study||624
5078587|NCT01754623|12496633|P1|NOT COMPLETED|Overall Study||0
5078588|NCT01754623|12496633|P1|COMPLETED|Overall Study||9
5078589|NCT01754623|12496633|P1|STARTED|Overall Study||9
5078590|NCT01754519|12496640|P1|NOT COMPLETED|Overall Study||0
5078591|NCT01754519|12496640|P1|COMPLETED|Overall Study||1
5078592|NCT01754519|12496640|P1|STARTED|Overall Study||1
5078593|NCT01754493|12496649|P1|NOT COMPLETED|Overall Study||7
5078594|NCT01754493|12496649|P1|COMPLETED|Overall Study||10
5078595|NCT01754493|12496649|P1|STARTED|Overall Study||17
5078596|NCT01754480|12496659|P2|NOT COMPLETED|Primary Part II||11
5078597|NCT01754480|12496660|P1|NOT COMPLETED|Primary Part II||15
5078598|NCT01754480|12496659|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
5078599|NCT01754480|12496660|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
5078600|NCT01754480|12496659|P2|Completed Study up to Week 6|Primary Part II||108
5078601|NCT01754480|12496660|P1|Completed Study up to Week 6|Primary Part II||100
5078602|NCT01754480|12496659|P2|STARTED|Primary Part II||113
5078603|NCT01754480|12496660|P1|STARTED|Primary Part II||111
5078604|NCT01754480|12496659|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
5078605|NCT01754480|12496660|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
5078606|NCT01754480|12496659|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
5078607|NCT01754480|12496660|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
5078608|NCT01754480|12496659|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
5078609|NCT01754480|12496660|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
5078610|NCT01754480|12496659|P2|STARTED|Part I + Part II (Overall Study)||162
5078611|NCT01754480|12496660|P1|STARTED|Part I + Part II (Overall Study)||163
5078612|NCT01754467|12496674|P1|NOT COMPLETED|Overall Study||1
5078613|NCT01754467|12496674|P1|COMPLETED|Overall Study||8
5078614|NCT01754467|12496674|P1|STARTED|Overall Study||9
5078615|NCT01754402|12496684|P3|NOT COMPLETED|Overall Study||4
5078616|NCT01754402|12496685|P2|NOT COMPLETED|Overall Study||2
5078617|NCT01754402|12496686|P1|NOT COMPLETED|Overall Study||2
5078618|NCT01754402|12496684|P3|COMPLETED|Overall Study||26
5078619|NCT01754402|12496685|P2|COMPLETED|Overall Study||0
5078620|NCT01754402|12496686|P1|COMPLETED|Overall Study||4
5078621|NCT01754402|12496684|P3|STARTED|Overall Study||30
5078622|NCT01754402|12496685|P2|STARTED|Overall Study||2
5078623|NCT01754402|12496686|P1|STARTED|Overall Study||6
5078624|NCT01754389|12496698|P3|NOT COMPLETED|Overall Study||0
5078625|NCT01754389|12496699|P2|NOT COMPLETED|Overall Study||0
5078626|NCT01754389|12496700|P1|NOT COMPLETED|Overall Study||0
5078627|NCT01754389|12496698|P3|COMPLETED|Overall Study||47
5078628|NCT01754389|12496699|P2|COMPLETED|Overall Study||45
5078629|NCT01754389|12496700|P1|COMPLETED|Overall Study||46
5078630|NCT01754389|12496698|P3|STARTED|Overall Study||47
5078631|NCT01754389|12496699|P2|STARTED|Overall Study||45
5078632|NCT01754389|12496700|P1|STARTED|Overall Study||46
5078633|NCT01754376|12496720|P1|NOT COMPLETED|Overall Study||3
5078634|NCT01754376|12496720|P1|COMPLETED|Overall Study||3
5078635|NCT01754376|12496720|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
5078636|NCT01754376|12496720|P1|STARTED|Overall Study||6
5078637|NCT01754259|12496731|P2|NOT COMPLETED|Overall Study||6
5078638|NCT01754259|12496732|P1|NOT COMPLETED|Overall Study||5
5078639|NCT01754259|12496731|P2|COMPLETED|Overall Study||18
5078640|NCT01754259|12496732|P1|COMPLETED|Overall Study||18
5078641|NCT01754259|12496731|P2|STARTED|Overall Study||24
5078642|NCT01754259|12496732|P1|STARTED|Overall Study||23
5078643|NCT01754194|12496742|P2|NOT COMPLETED|Overall Study||27
5078644|NCT01754194|12496743|P1|NOT COMPLETED|Overall Study||52
5078645|NCT01754194|12496742|P2|COMPLETED|Overall Study||97
5078646|NCT01754194|12496743|P1|COMPLETED|Overall Study||117
5078647|NCT01754194|12496742|P2|STARTED|Overall Study||124
5078648|NCT01754194|12496743|P1|STARTED|Overall Study||169
5078649|NCT01754129|12496763|P1|NOT COMPLETED|Overall Study||33
5078650|NCT01754129|12496763|P1|COMPLETED|Overall Study||115
5078651|NCT01754129|12496763|P1|Visit 3 (Year 2)|Overall Study||115
5078652|NCT01754129|12496763|P1|Visit 2 (Year 1)|Overall Study||129
5078653|NCT01754129|12496763|P1|Visit 1 (Enrollment Day)|Overall Study||145
5078654|NCT01754129|12496763|P1|STARTED|Overall Study||148
5078655|NCT01753999|12496786|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
5078656|NCT01753999|12496787|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
5078657|NCT01753999|12496786|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
5078658|NCT01753999|12496787|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
5078659|NCT01753999|12496786|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
5078660|NCT01753999|12496787|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
5078661|NCT01753999|12496786|P2|STARTED|Period 2 -Cross to Alternate Arm||112
5078662|NCT01753999|12496787|P1|STARTED|Period 2 -Cross to Alternate Arm||116
5078663|NCT01753999|12496786|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
5078664|NCT01753999|12496787|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
5078665|NCT01753999|12496786|P2|COMPLETED|Period 1 - Initial Assignment||112
5078666|NCT01753999|12496787|P1|COMPLETED|Period 1 - Initial Assignment||116
5078667|NCT01753999|12496786|P2|Received Intervention|Period 1 - Initial Assignment||146
5078668|NCT01753999|12496787|P1|Received Intervention|Period 1 - Initial Assignment||144
5078669|NCT01753999|12496786|P2|STARTED|Period 1 - Initial Assignment||162
5078670|NCT01753999|12496787|P1|STARTED|Period 1 - Initial Assignment||155
5078671|NCT01753856|12496801|P2|NOT COMPLETED|Overall Study||2
5078672|NCT01753856|12496802|P1|NOT COMPLETED|Overall Study||3
5078673|NCT01753856|12496801|P2|COMPLETED|Overall Study||34
5078674|NCT01753856|12496802|P1|COMPLETED|Overall Study||30
5078675|NCT01753856|12496801|P2|Completed 3-Month Bone Biopsy|Overall Study||35
5078676|NCT01753856|12496802|P1|Completed 3-Month Bone Biopsy|Overall Study||31
5078677|NCT01753856|12496801|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
5078678|NCT01753856|12496802|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
5078679|NCT01753856|12496801|P2|STARTED|Overall Study||36
5078680|NCT01753856|12496802|P1|STARTED|Overall Study||33
5078681|NCT01753713|12496854|P2|NOT COMPLETED|Overall Study||0
5078682|NCT01753713|12496855|P1|NOT COMPLETED|Overall Study||0
5078683|NCT01753713|12496854|P2|COMPLETED|Overall Study||19
5078684|NCT01753713|12496855|P1|COMPLETED|Overall Study||14
5078685|NCT01753713|12496854|P2|STARTED|Overall Study||19
5078686|NCT01753713|12496855|P1|STARTED|Overall Study||14
5078687|NCT01753570|12496874|P3|NOT COMPLETED|Overall Study||1
5078688|NCT01753570|12496875|P2|NOT COMPLETED|Overall Study||5
5078689|NCT01753570|12496876|P1|NOT COMPLETED|Overall Study||2
5078690|NCT01753570|12496874|P3|COMPLETED|Overall Study||13
5078691|NCT01753570|12496875|P2|COMPLETED|Overall Study||25
5078692|NCT01753570|12496876|P1|COMPLETED|Overall Study||28
5078693|NCT01753570|12496874|P3|STARTED|Overall Study||14
5078694|NCT01753570|12496875|P2|STARTED|Overall Study||30
5078695|NCT01753570|12496876|P1|STARTED|Overall Study||30
5078696|NCT01753557|12496900|P2|NOT COMPLETED|Overall Study||0
5078697|NCT01753557|12496901|P1|NOT COMPLETED|Overall Study||0
5078698|NCT01753557|12496900|P2|COMPLETED|Overall Study||19
5078699|NCT01753557|12496901|P1|COMPLETED|Overall Study||35
5078700|NCT01753557|12496900|P2|STARTED|Overall Study||19
5078701|NCT01753557|12496901|P1|STARTED|Overall Study||35
5078702|NCT01753518|12496919|P2|NOT COMPLETED|Postpartum Follow-up||15
5078703|NCT01753518|12496920|P1|NOT COMPLETED|Postpartum Follow-up||22
5078704|NCT01753518|12496919|P2|COMPLETED|Postpartum Follow-up||88
5078705|NCT01753518|12496920|P1|COMPLETED|Postpartum Follow-up||81
5078706|NCT01753518|12496919|P2|STARTED|Postpartum Follow-up||103
5078707|NCT01753518|12496920|P1|STARTED|Postpartum Follow-up||103
5078708|NCT01753518|12496919|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
5078709|NCT01753518|12496920|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
5078710|NCT01753518|12496919|P2|COMPLETED|Intention-to-Treat Analysis||103
5078711|NCT01753518|12496920|P1|COMPLETED|Intention-to-Treat Analysis||103
5078712|NCT01753518|12496919|P2|STARTED|Intention-to-Treat Analysis||110
5078713|NCT01753518|12496920|P1|STARTED|Intention-to-Treat Analysis||110
5078714|NCT01753401|12496944|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
5078715|NCT01753401|12496945|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
5078716|NCT01753401|12496946|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
5078717|NCT01753401|12496947|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
5078718|NCT01753401|12496944|P4|COMPLETED|Open Label Period (44 Weeks)||13
5078719|NCT01753401|12496945|P3|COMPLETED|Open Label Period (44 Weeks)||7
5078720|NCT01753401|12496946|P2|COMPLETED|Open Label Period (44 Weeks)||0
5078721|NCT01753401|12496947|P1|COMPLETED|Open Label Period (44 Weeks)||0
5078722|NCT01753401|12496944|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
5078723|NCT01753401|12496945|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
5078724|NCT01753401|12496946|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
5078725|NCT01753401|12496947|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
5078726|NCT01753401|12496944|P4|mITT|Open Label Period (44 Weeks)||22
5078727|NCT01753401|12496945|P3|mITT|Open Label Period (44 Weeks)||11
5078728|NCT01753401|12496946|P2|mITT|Open Label Period (44 Weeks)||0
5078729|NCT01753401|12496947|P1|mITT|Open Label Period (44 Weeks)||0
5078730|NCT01753401|12496944|P4|STARTED|Open Label Period (44 Weeks)||22
5078731|NCT01753401|12496945|P3|STARTED|Open Label Period (44 Weeks)||11
5078732|NCT01753401|12496946|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
5078733|NCT01753401|12496947|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
5078734|NCT01753401|12496944|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
5078735|NCT01753401|12496945|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
5078736|NCT01753401|12496946|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
5078737|NCT01753401|12496947|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
5078738|NCT01753401|12496944|P4|COMPLETED|Double-blind Period (8 Weeks)||0
5078739|NCT01753401|12496945|P3|COMPLETED|Double-blind Period (8 Weeks)||0
5078740|NCT01753401|12496946|P2|COMPLETED|Double-blind Period (8 Weeks)||22
5078741|NCT01753401|12496947|P1|COMPLETED|Double-blind Period (8 Weeks)||11
5078742|NCT01753401|12496944|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
5078743|NCT01753401|12496945|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
5078744|NCT01753401|12496946|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
5078745|NCT01753401|12496947|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
5078746|NCT01753401|12496944|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
5078747|NCT01753401|12496945|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
5078748|NCT01753401|12496946|P2|STARTED|Double-blind Period (8 Weeks)||26
5078749|NCT01753401|12496947|P1|STARTED|Double-blind Period (8 Weeks)||12
5078750|NCT01753362|12496997|P2|NOT COMPLETED|Overall Study||8
5078751|NCT01753362|12496998|P1|NOT COMPLETED|Overall Study||10
5078752|NCT01753362|12496997|P2|COMPLETED|Overall Study||40
5078753|NCT01753362|12496998|P1|COMPLETED|Overall Study||26
5078754|NCT01753362|12496997|P2|STARTED|Overall Study||48
5078755|NCT01753362|12496998|P1|STARTED|Overall Study||36
5078756|NCT01753336|12497006|P1|NOT COMPLETED|Overall Study||20
5078757|NCT01753336|12497006|P1|COMPLETED|Overall Study||92
5078758|NCT01753336|12497006|P1|Cycle 3|Overall Study||93
5078759|NCT01753336|12497006|P1|Cycle 2|Overall Study||98
5078760|NCT01753336|12497006|P1|Cycle 1|Overall Study||112
5078761|NCT01753336|12497006|P1|STARTED|Overall Study||112
5078762|NCT01753323|12497018|P3|NOT COMPLETED|Overall Study||9
5078763|NCT01753323|12497019|P2|NOT COMPLETED|Overall Study||0
5078764|NCT01753323|12497020|P1|NOT COMPLETED|Overall Study||1
5078765|NCT01753323|12497018|P3|COMPLETED|Overall Study||13
5078766|NCT01753323|12497019|P2|COMPLETED|Overall Study||10
5078767|NCT01753323|12497020|P1|COMPLETED|Overall Study||10
5078768|NCT01753323|12497018|P3|Intent-to-treat Analysis Set|Overall Study||22
5078769|NCT01753323|12497019|P2|Intent-to-treat Analysis Set|Overall Study||10
5078770|NCT01753323|12497020|P1|Intent-to-treat Analysis Set|Overall Study||11
5078771|NCT01753323|12497018|P3|Safety Set|Overall Study||22
5078772|NCT01753323|12497019|P2|Safety Set|Overall Study||10
5078773|NCT01753323|12497020|P1|Safety Set|Overall Study||11
5078774|NCT01753323|12497018|P3|Pharmacokinetic(PK) Set|Overall Study||21
5078775|NCT01753323|12497019|P2|Pharmacokinetic(PK) Set|Overall Study||10
5078776|NCT01753323|12497020|P1|Pharmacokinetic(PK) Set|Overall Study||10
5078777|NCT01753323|12497018|P3|Pharmacodynamic (PD) Set|Overall Study||21
5078778|NCT01753323|12497019|P2|Pharmacodynamic (PD) Set|Overall Study||10
5078779|NCT01753323|12497020|P1|Pharmacodynamic (PD) Set|Overall Study||10
5078780|NCT01753323|12497018|P3|STARTED|Overall Study||22
5078781|NCT01753323|12497019|P2|STARTED|Overall Study||10
5078782|NCT01753323|12497020|P1|STARTED|Overall Study||11
5078783|NCT01753310|12497058|P2|NOT COMPLETED|Overall Study||24
5078784|NCT01753310|12497059|P1|NOT COMPLETED|Overall Study||32
5078785|NCT01753310|12497058|P2|COMPLETED|Overall Study||21
5078786|NCT01753310|12497059|P1|COMPLETED|Overall Study||57
5078787|NCT01753310|12497058|P2|STARTED|Overall Study||45
5078788|NCT01753310|12497059|P1|STARTED|Overall Study||89
5078789|NCT01753193|12497079|P1|NOT COMPLETED|Overall Study||46
5078790|NCT01753193|12497079|P1|COMPLETED|Overall Study||172
5078791|NCT01753193|12497079|P1|STARTED|Overall Study||218
5078792|NCT01753115|12497094|P3|NOT COMPLETED|Overall Study||14
5078793|NCT01753115|12497095|P2|NOT COMPLETED|Overall Study||15
5078794|NCT01753115|12497096|P1|NOT COMPLETED|Overall Study||12
5078795|NCT01753115|12497094|P3|COMPLETED|Overall Study||56
5078796|NCT01753115|12497095|P2|COMPLETED|Overall Study||25
5078797|NCT01753115|12497096|P1|COMPLETED|Overall Study||32
5078798|NCT01753115|12497094|P3|Treated|Overall Study||67
5078799|NCT01753115|12497095|P2|Treated|Overall Study||39
5078800|NCT01753115|12497096|P1|Treated|Overall Study||38
5078801|NCT01753115|12497094|P3|STARTED|Overall Study||70
5078802|NCT01753115|12497095|P2|STARTED|Overall Study||40
5078803|NCT01753115|12497096|P1|STARTED|Overall Study||44
5078804|NCT01753076|12497106|P2|NOT COMPLETED|Overall Study||46
5078805|NCT01753076|12497107|P1|NOT COMPLETED|Overall Study||41
5078806|NCT01753076|12497106|P2|COMPLETED|Overall Study||106
5078807|NCT01753076|12497107|P1|COMPLETED|Overall Study||110
5078808|NCT01753076|12497106|P2|STARTED|Overall Study||152
5078809|NCT01753076|12497107|P1|STARTED|Overall Study||151
5078810|NCT01752985|12497134|P3|NOT COMPLETED|Follow-up Period||0
5078811|NCT01752985|12497135|P2|NOT COMPLETED|Follow-up Period||0
5078812|NCT01752985|12497136|P1|NOT COMPLETED|Follow-up Period||0
5078813|NCT01752985|12497134|P3|COMPLETED|Follow-up Period||26
5078814|NCT01752985|12497135|P2|COMPLETED|Follow-up Period||27
5078815|NCT01752985|12497136|P1|COMPLETED|Follow-up Period||28
5078816|NCT01752985|12497134|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
5078817|NCT01752985|12497135|P2|STARTED|Follow-up Period||27
5078818|NCT01752985|12497136|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
5078819|NCT01752985|12497134|P3|NOT COMPLETED|Treatment Period||5
5078820|NCT01752985|12497135|P2|NOT COMPLETED|Treatment Period||3
5078821|NCT01752985|12497136|P1|NOT COMPLETED|Treatment Period||4
5078822|NCT01752985|12497134|P3|COMPLETED|Treatment Period||24
5078823|NCT01752985|12497135|P2|COMPLETED|Treatment Period||27
5078824|NCT01752985|12497136|P1|COMPLETED|Treatment Period||25
5078825|NCT01752985|12497134|P3|STARTED|Treatment Period||29
5078826|NCT01752985|12497135|P2|STARTED|Treatment Period||30
5078827|NCT01752985|12497136|P1|STARTED|Treatment Period||29
5078828|NCT01752933|12497164|P2|NOT COMPLETED|Overall Study and Follow-up||46
5078829|NCT01752933|12497165|P1|NOT COMPLETED|Overall Study and Follow-up||4
5078830|NCT01752933|12497164|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
5078831|NCT01752933|12497165|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
5078832|NCT01752933|12497164|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
5078833|NCT01752933|12497165|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
5078834|NCT01752933|12497164|P2|NOT COMPLETED|Treatment||46
5078835|NCT01752933|12497165|P1|NOT COMPLETED|Treatment||4
5078836|NCT01752933|12497164|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
5078837|NCT01752933|12497165|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
5078838|NCT01752933|12497164|P2|STARTED|Treatment|Includes all patients who received any treatment|46
5078839|NCT01752933|12497165|P1|STARTED|Treatment|Includes all patients who received any treatment|4
5078840|NCT01752907|12497183|P2|NOT COMPLETED|Overall Study||20
5078841|NCT01752907|12497184|P1|NOT COMPLETED|Overall Study||12
5078842|NCT01752907|12497183|P2|COMPLETED|Overall Study||133
5078843|NCT01752907|12497184|P1|COMPLETED|Overall Study||139
5078844|NCT01752907|12497183|P2|Received Pegfilgrastim|Overall Study||151
5078845|NCT01752907|12497184|P1|Received Pegfilgrastim|Overall Study||149
5078846|NCT01752907|12497183|P2|STARTED|Overall Study||153
5078847|NCT01752907|12497184|P1|STARTED|Overall Study||151
5078848|NCT01752855|12497204|P2|NOT COMPLETED|Overall Study||4
5078849|NCT01752855|12497205|P1|NOT COMPLETED|Overall Study||1
5078850|NCT01752855|12497204|P2|COMPLETED|Overall Study||40
5078851|NCT01752855|12497205|P1|COMPLETED|Overall Study||43
5078852|NCT01752855|12497204|P2|STARTED|Overall Study||44
5078853|NCT01752855|12497205|P1|STARTED|Overall Study||44
5078854|NCT01752842|12497221|P2|NOT COMPLETED|Overall Study||2
5078855|NCT01752842|12497222|P1|NOT COMPLETED|Overall Study||3
5078856|NCT01752842|12497221|P2|COMPLETED|Overall Study||34
5078857|NCT01752842|12497222|P1|COMPLETED|Overall Study||31
5078858|NCT01752842|12497221|P2|STARTED|Overall Study||36
5078859|NCT01752842|12497222|P1|STARTED|Overall Study||34
5078860|NCT01752712|12497234|P2|NOT COMPLETED|Overall Study||10
5078861|NCT01752712|12497235|P1|NOT COMPLETED|Overall Study||9
5078862|NCT01752712|12497234|P2|COMPLETED|Overall Study||21
5078863|NCT01752712|12497235|P1|COMPLETED|Overall Study||22
5078864|NCT01752712|12497234|P2|STARTED|Overall Study||31
5078865|NCT01752712|12497235|P1|STARTED|Overall Study||31
5078866|NCT01752634|12497257|P6|NOT COMPLETED|Week 24 to Week 260||0
5078867|NCT01752634|12497258|P5|NOT COMPLETED|Week 24 to Week 260||14
5078868|NCT01752634|12497259|P4|NOT COMPLETED|Week 24 to Week 260||14
5078869|NCT01752634|12497260|P3|NOT COMPLETED|Week 24 to Week 260||33
5078870|NCT01752634|12497261|P2|NOT COMPLETED|Week 24 to Week 260||30
5078871|NCT01752634|12497262|P1|NOT COMPLETED|Week 24 to Week 260||34
5078872|NCT01752634|12497257|P6|COMPLETED|Week 24 to Week 260||0
5078873|NCT01752634|12497258|P5|COMPLETED|Week 24 to Week 260||31
5078874|NCT01752634|12497259|P4|COMPLETED|Week 24 to Week 260||29
5078875|NCT01752634|12497260|P3|COMPLETED|Week 24 to Week 260||64
5078876|NCT01752634|12497261|P2|COMPLETED|Week 24 to Week 260||65
5078877|NCT01752634|12497262|P1|COMPLETED|Week 24 to Week 260||59
5078878|NCT01752634|12497257|P6|STARTED|Week 24 to Week 260||0
5078879|NCT01752634|12497258|P5|STARTED|Week 24 to Week 260||45
5078880|NCT01752634|12497259|P4|STARTED|Week 24 to Week 260||43
5078881|NCT01752634|12497260|P3|STARTED|Week 24 to Week 260||97
5078882|NCT01752634|12497261|P2|STARTED|Week 24 to Week 260||95
5078883|NCT01752634|12497262|P1|STARTED|Week 24 to Week 260||93
5078884|NCT01752634|12497257|P6|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
5078885|NCT01752634|12497258|P5|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
5078886|NCT01752634|12497259|P4|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
5078887|NCT01752634|12497260|P3|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
5078888|NCT01752634|12497261|P2|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
5078889|NCT01752634|12497262|P1|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
5078890|NCT01752634|12497257|P6|COMPLETED|Up to Week 24 (Primary Analysis)||0
5078891|NCT01752634|12497258|P5|COMPLETED|Up to Week 24 (Primary Analysis)||45
5078892|NCT01752634|12497259|P4|COMPLETED|Up to Week 24 (Primary Analysis)||43
5078893|NCT01752634|12497260|P3|COMPLETED|Up to Week 24 (Primary Analysis)||97
5078894|NCT01752634|12497261|P2|COMPLETED|Up to Week 24 (Primary Analysis)||95
5078895|NCT01752634|12497262|P1|COMPLETED|Up to Week 24 (Primary Analysis)||93
5078896|NCT01752634|12497257|P6|STARTED|Up to Week 24 (Primary Analysis)||10
5078897|NCT01752634|12497258|P5|STARTED|Up to Week 24 (Primary Analysis)||45
5078898|NCT01752634|12497259|P4|STARTED|Up to Week 24 (Primary Analysis)||43
5078899|NCT01752634|12497260|P3|STARTED|Up to Week 24 (Primary Analysis)||100
5078900|NCT01752634|12497261|P2|STARTED|Up to Week 24 (Primary Analysis)||100
5078901|NCT01752634|12497262|P1|STARTED|Up to Week 24 (Primary Analysis)||99
5078902|NCT01752426|12497304|P1|NOT COMPLETED|Overall Study||0
5078903|NCT01752426|12497304|P1|COMPLETED|Overall Study||30
5078904|NCT01752426|12497304|P1|STARTED|Overall Study||30
5078905|NCT01752400|12497309|P1|NOT COMPLETED|Overall Study||0
5078906|NCT01752400|12497309|P1|COMPLETED|Overall Study||6
5078907|NCT01752400|12497309|P1|STARTED|Overall Study||6
5078908|NCT01752036|12497320|P1|NOT COMPLETED|Overall Study||2
5078909|NCT01752036|12497320|P1|COMPLETED|Overall Study||31
5078910|NCT01752036|12497320|P1|STARTED|Overall Study||33
5078911|NCT01752023|12497333|P2|NOT COMPLETED|Overall Study||1
5078912|NCT01752023|12497334|P1|NOT COMPLETED|Overall Study||2
5078913|NCT01752023|12497333|P2|COMPLETED|Overall Study||0
5078914|NCT01752023|12497334|P1|COMPLETED|Overall Study||0
5078915|NCT01752023|12497333|P2|STARTED|Overall Study||1
5078916|NCT01752023|12497334|P1|STARTED|Overall Study||2
5078917|NCT01751971|12497352|P2|NOT COMPLETED|Overall Study||1
5078918|NCT01751971|12497353|P1|NOT COMPLETED|Overall Study||2
5078919|NCT01751971|12497352|P2|COMPLETED|Overall Study||24
5078920|NCT01751971|12497353|P1|COMPLETED|Overall Study||20
5078921|NCT01751971|12497352|P2|STARTED|Overall Study||25
5078922|NCT01751971|12497353|P1|STARTED|Overall Study||22
5078923|NCT01751906|12497370|P2|NOT COMPLETED|Overall Study||47
5078924|NCT01751906|12497371|P1|NOT COMPLETED|Overall Study||84
5078925|NCT01751906|12497370|P2|COMPLETED|Overall Study||639
5078926|NCT01751906|12497371|P1|COMPLETED|Overall Study||1238
5078927|NCT01751906|12497370|P2|STARTED|Overall Study||686
5078928|NCT01751906|12497371|P1|STARTED|Overall Study||1322
5078929|NCT01751867|12497575|P2|NOT COMPLETED|Overall Study||99
5078930|NCT01751867|12497576|P1|NOT COMPLETED|Overall Study||36
5078931|NCT01751867|12497575|P2|COMPLETED|Overall Study||0
5078932|NCT01751867|12497576|P1|COMPLETED|Overall Study||0
5078933|NCT01751867|12497575|P2|Treated|Overall Study||98
5078934|NCT01751867|12497576|P1|Treated|Overall Study||34
5078935|NCT01751867|12497575|P2|STARTED|Overall Study||99
5078936|NCT01751867|12497576|P1|STARTED|Overall Study||36
5078937|NCT01751802|12497596|P2|NOT COMPLETED|Overall Study||2
5078938|NCT01751802|12497597|P1|NOT COMPLETED|Overall Study||4
5078939|NCT01751802|12497596|P2|COMPLETED|Overall Study||2
5078940|NCT01751802|12497597|P1|COMPLETED|Overall Study||1
5078941|NCT01751802|12497596|P2|Completed Period 3|Overall Study||1
5078942|NCT01751802|12497597|P1|Completed Period 3|Overall Study||2
5078943|NCT01751802|12497596|P2|Completed Period 2|Overall Study||1
5078944|NCT01751802|12497597|P1|Completed Period 2|Overall Study||2
5078945|NCT01751802|12497596|P2|Completed Period 1|Overall Study||4
5078946|NCT01751802|12497597|P1|Completed Period 1|Overall Study||2
5078947|NCT01751802|12497596|P2|STARTED|Overall Study||4
5078948|NCT01751802|12497597|P1|STARTED|Overall Study||5
5078949|NCT01751724|12497611|P2|NOT COMPLETED|Overall Study||2
5078950|NCT01751724|12497612|P1|NOT COMPLETED|Overall Study||1
5078951|NCT01751724|12497611|P2|COMPLETED|Overall Study||42
5078952|NCT01751724|12497612|P1|COMPLETED|Overall Study||41
5078953|NCT01751724|12497611|P2|STARTED|Overall Study||44
5078954|NCT01751724|12497612|P1|STARTED|Overall Study||42
5078955|NCT01751646|12497640|P2|NOT COMPLETED|Overall Study||18
5078956|NCT01751646|12497641|P1|NOT COMPLETED|Overall Study||11
5078957|NCT01751646|12497640|P2|COMPLETED|Overall Study||87
5078958|NCT01751646|12497641|P1|COMPLETED|Overall Study||98
5078959|NCT01751646|12497640|P2|STARTED|Overall Study||105
5078960|NCT01751646|12497641|P1|STARTED|Overall Study||109
5078961|NCT01751412|12497789|P1|NOT COMPLETED|Overall Study||1
5078962|NCT01751412|12497789|P1|COMPLETED|Overall Study||11
5078963|NCT01751412|12497789|P1|STARTED|Overall Study||12
5078964|NCT01751399|12497803|P4|NOT COMPLETED|Overall Study||0
5078965|NCT01751399|12497804|P3|NOT COMPLETED|Overall Study||0
5078966|NCT01751399|12497805|P2|NOT COMPLETED|Overall Study||0
5078967|NCT01751399|12497806|P1|NOT COMPLETED|Overall Study||0
5078968|NCT01751399|12497803|P4|COMPLETED|Overall Study||7
5078969|NCT01751399|12497804|P3|COMPLETED|Overall Study||8
5078970|NCT01751399|12497805|P2|COMPLETED|Overall Study||8
5078971|NCT01751399|12497806|P1|COMPLETED|Overall Study||12
5078972|NCT01751399|12497803|P4|Received 1 Dose of Study Drug|Overall Study||7
5078973|NCT01751399|12497804|P3|Received 1 Dose of Study Drug|Overall Study||8
5078974|NCT01751399|12497805|P2|Received 1 Dose of Study Drug|Overall Study||8
5078975|NCT01751399|12497806|P1|Received 1 Dose of Study Drug|Overall Study||12
5078976|NCT01751399|12497803|P4|STARTED|Overall Study||7
5078977|NCT01751399|12497804|P3|STARTED|Overall Study||8
5078978|NCT01751399|12497805|P2|STARTED|Overall Study||8
5078979|NCT01751399|12497806|P1|STARTED|Overall Study||12
5078980|NCT01751386|12497822|P2|NOT COMPLETED|Overall Study||3
5078981|NCT01751386|12497823|P1|NOT COMPLETED|Overall Study||2
5078982|NCT01751386|12497822|P2|COMPLETED|Overall Study||16
5078983|NCT01751386|12497823|P1|COMPLETED|Overall Study||18
5078984|NCT01751386|12497822|P2|STARTED|Overall Study||19
5078985|NCT01751386|12497823|P1|STARTED|Overall Study||20
5078986|NCT01751308|12497834|P5|NOT COMPLETED|Phase 2||0
5078987|NCT01751308|12497835|P4|NOT COMPLETED|Phase 2||0
5078988|NCT01751308|12497836|P3|NOT COMPLETED|Phase 2||0
5078989|NCT01751308|12497837|P2|NOT COMPLETED|Phase 2||0
5078990|NCT01751308|12497838|P1|NOT COMPLETED|Phase 2||0
5078991|NCT01751308|12497834|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
5078992|NCT01751308|12497835|P4|COMPLETED|Phase 2||0
5078993|NCT01751308|12497836|P3|COMPLETED|Phase 2||0
5078994|NCT01751308|12497837|P2|COMPLETED|Phase 2||0
5078995|NCT01751308|12497838|P1|COMPLETED|Phase 2||0
5078996|NCT01751308|12497834|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
5078997|NCT01751308|12497835|P4|STARTED|Phase 2||0
5078998|NCT01751308|12497836|P3|STARTED|Phase 2||0
5078999|NCT01751308|12497837|P2|STARTED|Phase 2||0
5079000|NCT01751308|12497838|P1|STARTED|Phase 2||0
5079001|NCT01751308|12497834|P5|NOT COMPLETED|Phase 1||0
5079002|NCT01751308|12497835|P4|NOT COMPLETED|Phase 1||0
5079003|NCT01751308|12497836|P3|NOT COMPLETED|Phase 1||0
5079004|NCT01751308|12497837|P2|NOT COMPLETED|Phase 1||0
5079005|NCT01751308|12497838|P1|NOT COMPLETED|Phase 1||0
5079006|NCT01751308|12497834|P5|COMPLETED|Phase 1||0
5079007|NCT01751308|12497835|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
5079008|NCT01751308|12497836|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
5079009|NCT01751308|12497837|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
5079010|NCT01751308|12497838|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
5079011|NCT01751308|12497834|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
5079012|NCT01751308|12497835|P4|STARTED|Phase 1||7
5079013|NCT01751308|12497836|P3|STARTED|Phase 1||7
5079014|NCT01751308|12497837|P2|STARTED|Phase 1||3
5079015|NCT01751308|12497838|P1|STARTED|Phase 1||6
5079016|NCT01751230|12497877|P2|NOT COMPLETED|Overall Study||4
5079017|NCT01751230|12497878|P1|NOT COMPLETED|Overall Study||1
5079018|NCT01751230|12497877|P2|COMPLETED|Overall Study||16
5079019|NCT01751230|12497878|P1|COMPLETED|Overall Study||19
5079020|NCT01751230|12497877|P2|STARTED|Overall Study||20
5079021|NCT01751230|12497878|P1|STARTED|Overall Study||20
5079022|NCT01751178|12497899|P3|NOT COMPLETED|Overall Study||2
5079023|NCT01751178|12497900|P2|NOT COMPLETED|Overall Study||0
5079024|NCT01751178|12497901|P1|NOT COMPLETED|Overall Study||3
5079025|NCT01751178|12497899|P3|COMPLETED|Overall Study||105
5079026|NCT01751178|12497900|P2|COMPLETED|Overall Study||109
5079027|NCT01751178|12497901|P1|COMPLETED|Overall Study||105
5079028|NCT01751178|12497899|P3|STARTED|Overall Study||107
5079029|NCT01751178|12497900|P2|STARTED|Overall Study||109
5079030|NCT01751178|12497901|P1|STARTED|Overall Study||108
5079031|NCT01751165|12497921|P3|NOT COMPLETED|Overall Study||3
5079032|NCT01751165|12497922|P2|NOT COMPLETED|Overall Study||3
5079033|NCT01751165|12497923|P1|NOT COMPLETED|Overall Study||2
5079034|NCT01751165|12497921|P3|COMPLETED|Overall Study||113
5079035|NCT01751165|12497922|P2|COMPLETED|Overall Study||116
5079036|NCT01751165|12497923|P1|COMPLETED|Overall Study||117
5079037|NCT01751165|12497921|P3|STARTED|Overall Study||116
5079038|NCT01751165|12497922|P2|STARTED|Overall Study||119
5079039|NCT01751165|12497923|P1|STARTED|Overall Study||119
5079040|NCT01751139|12497963|P1|NOT COMPLETED|Overall Study||2267
5079041|NCT01751139|12497963|P1|COMPLETED|Overall Study||1033
5079042|NCT01751139|12497963|P1|STARTED|Overall Study||3300
5079043|NCT01751113|12497981|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
5079044|NCT01751113|12497982|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
5079045|NCT01751113|12497983|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
5079046|NCT01751113|12497984|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
5079047|NCT01751113|12497985|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
5079048|NCT01751113|12497986|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
5079049|NCT01751113|12497981|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
5079050|NCT01751113|12497982|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
5079051|NCT01751113|12497983|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
5079052|NCT01751113|12497984|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
5079053|NCT01751113|12497985|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
5079054|NCT01751113|12497986|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
5079055|NCT01751113|12497981|P6|STARTED|Treatment Period 3 (4 Weeks)||10
5079056|NCT01751113|12497982|P5|STARTED|Treatment Period 3 (4 Weeks)||8
5079057|NCT01751113|12497983|P4|STARTED|Treatment Period 3 (4 Weeks)||8
5079058|NCT01751113|12497984|P3|STARTED|Treatment Period 3 (4 Weeks)||9
5079059|NCT01751113|12497985|P2|STARTED|Treatment Period 3 (4 Weeks)||8
5079060|NCT01751113|12497986|P1|STARTED|Treatment Period 3 (4 Weeks)||8
5079061|NCT01751113|12497981|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079062|NCT01751113|12497982|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079063|NCT01751113|12497983|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079064|NCT01751113|12497984|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079065|NCT01751113|12497985|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079066|NCT01751113|12497986|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
5079067|NCT01751113|12497981|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
5079068|NCT01751113|12497982|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
5079069|NCT01751113|12497983|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
5079070|NCT01751113|12497984|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
5079071|NCT01751113|12497985|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
5079072|NCT01751113|12497986|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
5079073|NCT01751113|12497981|P6|STARTED|Washout Period 2 (2 Weeks)||10
5079074|NCT01751113|12497982|P5|STARTED|Washout Period 2 (2 Weeks)||8
5079075|NCT01751113|12497983|P4|STARTED|Washout Period 2 (2 Weeks)||8
5079076|NCT01751113|12497984|P3|STARTED|Washout Period 2 (2 Weeks)||9
5079077|NCT01751113|12497985|P2|STARTED|Washout Period 2 (2 Weeks)||8
5079078|NCT01751113|12497986|P1|STARTED|Washout Period 2 (2 Weeks)||8
5079079|NCT01751113|12497981|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079080|NCT01751113|12497982|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079081|NCT01751113|12497983|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079082|NCT01751113|12497984|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079083|NCT01751113|12497985|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079084|NCT01751113|12497986|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
5079085|NCT01751113|12497981|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
5079086|NCT01751113|12497982|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
5079087|NCT01751113|12497983|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
5079088|NCT01751113|12497984|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
5079089|NCT01751113|12497985|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
5079090|NCT01751113|12497986|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
5079091|NCT01751113|12497981|P6|STARTED|Treatment Period 2 (4 Weeks)||10
5079092|NCT01751113|12497982|P5|STARTED|Treatment Period 2 (4 Weeks)||8
5079093|NCT01751113|12497983|P4|STARTED|Treatment Period 2 (4 Weeks)||8
5079094|NCT01751113|12497984|P3|STARTED|Treatment Period 2 (4 Weeks)||9
5079095|NCT01751113|12497985|P2|STARTED|Treatment Period 2 (4 Weeks)||8
5079096|NCT01751113|12497986|P1|STARTED|Treatment Period 2 (4 Weeks)||8
5079097|NCT01751113|12497981|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079098|NCT01751113|12497982|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079099|NCT01751113|12497983|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079100|NCT01751113|12497984|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079101|NCT01751113|12497985|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079102|NCT01751113|12497986|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
5079103|NCT01751113|12497981|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
5079104|NCT01751113|12497982|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
5079105|NCT01751113|12497983|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
5079106|NCT01751113|12497984|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
5079107|NCT01751113|12497985|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
5079108|NCT01751113|12497986|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
5079109|NCT01751113|12497981|P6|STARTED|Washout Period 1 (2 Weeks)||10
5079110|NCT01751113|12497982|P5|STARTED|Washout Period 1 (2 Weeks)||8
5079111|NCT01751113|12497983|P4|STARTED|Washout Period 1 (2 Weeks)||8
5079112|NCT01751113|12497984|P3|STARTED|Washout Period 1 (2 Weeks)||9
5079113|NCT01751113|12497985|P2|STARTED|Washout Period 1 (2 Weeks)||8
5079114|NCT01751113|12497986|P1|STARTED|Washout Period 1 (2 Weeks)||8
5079115|NCT01751113|12497981|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
5079116|NCT01751113|12497982|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
5079117|NCT01751113|12497983|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
5079118|NCT01751113|12497984|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
5079119|NCT01751113|12497985|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
5079120|NCT01751113|12497986|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
5079121|NCT01751113|12497981|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
5079122|NCT01751113|12497982|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
5079123|NCT01751113|12497983|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
5079124|NCT01751113|12497984|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
5079125|NCT01751113|12497985|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
5079126|NCT01751113|12497986|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
5079127|NCT01751113|12497981|P6|STARTED|Treatment Period 1 (4 Weeks)||10
5079128|NCT01751113|12497982|P5|STARTED|Treatment Period 1 (4 Weeks)||9
5079129|NCT01751113|12497983|P4|STARTED|Treatment Period 1 (4 Weeks)||9
5079130|NCT01751113|12497984|P3|STARTED|Treatment Period 1 (4 Weeks)||9
5079131|NCT01751113|12497985|P2|STARTED|Treatment Period 1 (4 Weeks)||8
5079132|NCT01751113|12497986|P1|STARTED|Treatment Period 1 (4 Weeks)||8
5079133|NCT01751087|12498027|P3|NOT COMPLETED|Overall Study||1
5079134|NCT01751087|12498028|P2|NOT COMPLETED|Overall Study||0
5079135|NCT01751087|12498029|P1|NOT COMPLETED|Overall Study||1
5079136|NCT01751087|12498027|P3|COMPLETED|Overall Study||99
5079137|NCT01751087|12498028|P2|COMPLETED|Overall Study||100
5079138|NCT01751087|12498029|P1|COMPLETED|Overall Study||99
5079139|NCT01751087|12498027|P3|STARTED|Overall Study||100
5079140|NCT01751087|12498028|P2|STARTED|Overall Study||100
5079141|NCT01751087|12498029|P1|STARTED|Overall Study||100
5079142|NCT01751061|12498063|P2|NOT COMPLETED|Overall Study||34
5079143|NCT01751061|12498064|P1|NOT COMPLETED|Overall Study||56
5079144|NCT01751061|12498063|P2|COMPLETED|Overall Study||172
5079145|NCT01751061|12498064|P1|COMPLETED|Overall Study||154
5079146|NCT01751061|12498063|P2|STARTED|Overall Study||206
5079147|NCT01751061|12498064|P1|STARTED|Overall Study||210
5079148|NCT01751022|12498085|P3|NOT COMPLETED|Overall Study||27
5079149|NCT01751022|12498086|P2|NOT COMPLETED|Overall Study||44
5079150|NCT01751022|12498087|P1|NOT COMPLETED|Overall Study||56
5079151|NCT01751022|12498085|P3|COMPLETED|Overall Study|6 month visit|273
5079152|NCT01751022|12498086|P2|COMPLETED|Overall Study|6 month visit|282
5079153|NCT01751022|12498087|P1|COMPLETED|Overall Study|6 month visit|443
5079154|NCT01751022|12498085|P3|STARTED|Overall Study||300
5079155|NCT01751022|12498086|P2|STARTED|Overall Study||326
5079156|NCT01751022|12498087|P1|STARTED|Overall Study||499
5079157|NCT01750931|12498119|P2|NOT COMPLETED|Period 2||0
5079158|NCT01750931|12498120|P1|NOT COMPLETED|Period 2||0
5079159|NCT01750931|12498119|P2|COMPLETED|Period 2||14
5079160|NCT01750931|12498120|P1|COMPLETED|Period 2||14
5079161|NCT01750931|12498119|P2|STARTED|Period 2||14
5079162|NCT01750931|12498120|P1|STARTED|Period 2||14
5079163|NCT01750931|12498119|P2|NOT COMPLETED|Wash Out||0
5079164|NCT01750931|12498120|P1|NOT COMPLETED|Wash Out||0
5079165|NCT01750931|12498119|P2|COMPLETED|Wash Out||14
5079166|NCT01750931|12498120|P1|COMPLETED|Wash Out||14
5079167|NCT01750931|12498119|P2|STARTED|Wash Out||14
5079168|NCT01750931|12498120|P1|STARTED|Wash Out||14
5079169|NCT01750931|12498119|P2|NOT COMPLETED|Period 1||0
5079170|NCT01750931|12498120|P1|NOT COMPLETED|Period 1||0
5079171|NCT01750931|12498119|P2|COMPLETED|Period 1||14
5079172|NCT01750931|12498120|P1|COMPLETED|Period 1||14
5079173|NCT01750931|12498119|P2|STARTED|Period 1||14
5079174|NCT01750931|12498120|P1|STARTED|Period 1||14
5079175|NCT01750840|12498138|P1|NOT COMPLETED|Overall Study||4
5079176|NCT01750840|12498138|P1|COMPLETED|Overall Study||4
5079177|NCT01750840|12498138|P1|STARTED|Overall Study||8
5079178|NCT01750697|12498143|P1|NOT COMPLETED|Overall Study||9
5079179|NCT01750697|12498143|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
5079180|NCT01750697|12498143|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
5079181|NCT01750697|12498143|P1|Completed|Overall Study||25
5079182|NCT01750697|12498143|P1|STARTED|Overall Study||25
5079183|NCT01750684|12498155|P2|NOT COMPLETED|Overall Study||2
5079184|NCT01750684|12498156|P1|NOT COMPLETED|Overall Study||2
5079185|NCT01750684|12498155|P2|COMPLETED|Overall Study||5
5079186|NCT01750684|12498156|P1|COMPLETED|Overall Study||4
5079187|NCT01750684|12498155|P2|STARTED|Overall Study||7
5079188|NCT01750684|12498156|P1|STARTED|Overall Study||6
5079189|NCT01750502|12498166|P2|NOT COMPLETED|Overall Study||0
5079190|NCT01750502|12498167|P1|NOT COMPLETED|Overall Study||0
5079191|NCT01750502|12498166|P2|COMPLETED|Overall Study||186
5079192|NCT01750502|12498167|P1|COMPLETED|Overall Study||70
5079193|NCT01750502|12498166|P2|STARTED|Overall Study||186
5079194|NCT01750502|12498167|P1|STARTED|Overall Study||70
5079195|NCT01750398|12498180|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
5079196|NCT01750398|12498180|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
5079197|NCT01750398|12498180|P1|STARTED|Bipolar Androgen Thearpy Phase||29
5079198|NCT01750398|12498180|P1|NOT COMPLETED|ADT Lead In Phase||4
5079199|NCT01750398|12498180|P1|COMPLETED|ADT Lead In Phase||29
5079200|NCT01750398|12498180|P1|STARTED|ADT Lead In Phase||33
5079201|NCT01750346|12498193|P3|NOT COMPLETED|Overall Study||0
5079202|NCT01750346|12498194|P2|NOT COMPLETED|Overall Study||0
5079203|NCT01750346|12498195|P1|NOT COMPLETED|Overall Study||1
5079204|NCT01750346|12498193|P3|COMPLETED|Overall Study||3
5079205|NCT01750346|12498194|P2|COMPLETED|Overall Study||2
5079206|NCT01750346|12498195|P1|COMPLETED|Overall Study||2
5079207|NCT01750346|12498193|P3|STARTED|Overall Study||3
5079208|NCT01750346|12498194|P2|STARTED|Overall Study||2
5079209|NCT01750346|12498195|P1|STARTED|Overall Study||3
5079210|NCT01750294|12498221|P1|NOT COMPLETED|Overall Study||2
5079211|NCT01750294|12498221|P1|COMPLETED|Overall Study||12
5079212|NCT01750294|12498221|P1|STARTED|Overall Study||14
5079213|NCT01750281|12498228|P3|NOT COMPLETED|Overall Study||84
5079214|NCT01750281|12498229|P2|NOT COMPLETED|Overall Study||85
5079215|NCT01750281|12498230|P1|NOT COMPLETED|Overall Study||43
5079216|NCT01750281|12498228|P3|COMPLETED|Overall Study||0
5079217|NCT01750281|12498229|P2|COMPLETED|Overall Study||0
5079218|NCT01750281|12498230|P1|COMPLETED|Overall Study||0
5079219|NCT01750281|12498228|P3|Did Not Receive Treatment|Overall Study||0
5079220|NCT01750281|12498229|P2|Did Not Receive Treatment|Overall Study||1
5079221|NCT01750281|12498230|P1|Did Not Receive Treatment|Overall Study||0
5079222|NCT01750281|12498228|P3|Received Treatment|Overall Study||84
5079223|NCT01750281|12498229|P2|Received Treatment|Overall Study||84
5079224|NCT01750281|12498230|P1|Received Treatment|Overall Study||43
5079225|NCT01750281|12498228|P3|STARTED|Overall Study||84
5079226|NCT01750281|12498229|P2|STARTED|Overall Study||85
5079227|NCT01750281|12498230|P1|STARTED|Overall Study||43
5079228|NCT01750255|12498243|P2|NOT COMPLETED|Overall Study||5
5079229|NCT01750255|12498244|P1|NOT COMPLETED|Overall Study||6
5079230|NCT01750255|12498243|P2|COMPLETED|Overall Study||38
5079231|NCT01750255|12498244|P1|COMPLETED|Overall Study||43
5079232|NCT01750255|12498243|P2|STARTED|Overall Study||43
5079233|NCT01750255|12498244|P1|STARTED|Overall Study||49
5079234|NCT01750242|12498260|P1|NOT COMPLETED|Overall Study||3
5079235|NCT01750242|12498260|P1|COMPLETED|Overall Study||20
5079236|NCT01750242|12498260|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
5079237|NCT01750242|12498260|P1|STARTED|Overall Study||23
5079238|NCT01750229|12498265|P1|NOT COMPLETED|Long-term Follow-up Phase||3
5079239|NCT01750229|12498265|P1|COMPLETED|Long-term Follow-up Phase||25
5079240|NCT01750229|12498265|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
5079241|NCT01750229|12498265|P1|NOT COMPLETED|Randomized Crossover Phase||2
5079242|NCT01750229|12498265|P1|COMPLETED|Randomized Crossover Phase||28
5079243|NCT01750229|12498265|P1|Protocol Violation|Randomized Crossover Phase||4
5079244|NCT01750229|12498265|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
5079245|NCT01750229|12498265|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
5079246|NCT01750229|12498265|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
5079247|NCT01750229|12498265|P1|Subject Received Sham|Randomized Crossover Phase||24
5079248|NCT01750229|12498265|P1|STARTED|Randomized Crossover Phase||30
5079249|NCT01750086|12498277|P2|NOT COMPLETED|Overall Study||1
5079250|NCT01750086|12498278|P1|NOT COMPLETED|Overall Study||1
5079251|NCT01750086|12498277|P2|COMPLETED|Overall Study||13
5079252|NCT01750086|12498278|P1|COMPLETED|Overall Study||12
5079253|NCT01750086|12498277|P2|STARTED|Overall Study||14
5079254|NCT01750086|12498278|P1|STARTED|Overall Study||13
5079255|NCT01749995|12498284|P1|NOT COMPLETED|Overall Study||4
5079256|NCT01749995|12498284|P1|COMPLETED|Overall Study||196
5079257|NCT01749995|12498284|P1|STARTED|Overall Study||200
5079258|NCT01749982|12498292|P4|NOT COMPLETED|Overall Study||3
5079259|NCT01749982|12498293|P3|NOT COMPLETED|Overall Study||0
5079260|NCT01749982|12498294|P2|NOT COMPLETED|Overall Study||0
5079261|NCT01749982|12498295|P1|NOT COMPLETED|Overall Study||0
5079262|NCT01749982|12498292|P4|COMPLETED|Overall Study||12
5079263|NCT01749982|12498293|P3|COMPLETED|Overall Study||15
5079264|NCT01749982|12498294|P2|COMPLETED|Overall Study||15
5079265|NCT01749982|12498295|P1|COMPLETED|Overall Study||15
5079266|NCT01749982|12498292|P4|STARTED|Overall Study||15
5079267|NCT01749982|12498293|P3|STARTED|Overall Study||15
5079268|NCT01749982|12498294|P2|STARTED|Overall Study||15
5079269|NCT01749982|12498295|P1|STARTED|Overall Study||15
5079270|NCT01749956|12498313|P1|NOT COMPLETED|Overall Study||15
5079271|NCT01749956|12498313|P1|COMPLETED|Overall Study||24
5079272|NCT01749956|12498313|P1|STARTED|Overall Study||39
5079273|NCT01749930|12498325|P2|NOT COMPLETED|Overall Study||12
5079274|NCT01749930|12498326|P1|NOT COMPLETED|Overall Study||30
5079275|NCT01749930|12498325|P2|COMPLETED|Overall Study|randomized population|125
5079276|NCT01749930|12498326|P1|COMPLETED|Overall Study|randomized population|253
5079277|NCT01749930|12498325|P2|STARTED|Overall Study|randomized population|137
5079278|NCT01749930|12498326|P1|STARTED|Overall Study|randomized population|283
5079279|NCT01749904|12498342|P2|NOT COMPLETED|Overall Study||11
5079280|NCT01749904|12498343|P1|NOT COMPLETED|Overall Study||22
5079281|NCT01749904|12498342|P2|COMPLETED|Overall Study|randomized population|123
5079282|NCT01749904|12498343|P1|COMPLETED|Overall Study|randomized population|264
5079283|NCT01749904|12498342|P2|STARTED|Overall Study|randomized population|134
5079284|NCT01749904|12498343|P1|STARTED|Overall Study|randomized population|286
5079285|NCT01749826|12498359|P2|NOT COMPLETED|Overall Study||0
5079286|NCT01749826|12498360|P1|NOT COMPLETED|Overall Study||20
5079287|NCT01749826|12498359|P2|COMPLETED|Overall Study||0
5079288|NCT01749826|12498360|P1|COMPLETED|Overall Study||0
5079289|NCT01749826|12498359|P2|STARTED|Overall Study||0
5079290|NCT01749826|12498360|P1|STARTED|Overall Study||20
5079291|NCT01749800|12498375|P3|NOT COMPLETED|Overall Study||0
5079292|NCT01749800|12498376|P2|NOT COMPLETED|Overall Study||1
5079293|NCT01749800|12498377|P1|NOT COMPLETED|Overall Study||3
5079294|NCT01749800|12498375|P3|COMPLETED|Overall Study||0
5079295|NCT01749800|12498376|P2|COMPLETED|Overall Study||0
5079296|NCT01749800|12498377|P1|COMPLETED|Overall Study||3
5079297|NCT01749800|12498375|P3|STARTED|Overall Study||0
5079298|NCT01749800|12498376|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
5079299|NCT01749800|12498377|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
5079300|NCT01749735|12498387|P2|NOT COMPLETED|Overall Study||0
5079301|NCT01749735|12498388|P1|NOT COMPLETED|Overall Study||1
5079302|NCT01749735|12498387|P2|COMPLETED|Overall Study||0
5079303|NCT01749735|12498388|P1|COMPLETED|Overall Study||1
5079304|NCT01749735|12498387|P2|STARTED|Overall Study||0
5079305|NCT01749735|12498388|P1|STARTED|Overall Study||2
5079306|NCT01749631|12498396|P1|NOT COMPLETED|Overall Study||0
5079307|NCT01749631|12498396|P1|COMPLETED|Overall Study||97
5079308|NCT01749631|12498396|P1|STARTED|Overall Study||97
5079309|NCT01749605|12498408|P2|NOT COMPLETED|Overall Study||3
5079310|NCT01749605|12498409|P1|NOT COMPLETED|Overall Study||4
5079311|NCT01749605|12498408|P2|COMPLETED|Overall Study||14
5079312|NCT01749605|12498409|P1|COMPLETED|Overall Study||14
5079313|NCT01749605|12498408|P2|STARTED|Overall Study||17
5079314|NCT01749605|12498409|P1|STARTED|Overall Study||18
5079315|NCT01749501|12498417|P2|NOT COMPLETED|Overall Study||0
5079316|NCT01749501|12498418|P1|NOT COMPLETED|Overall Study||0
5079317|NCT01749501|12498417|P2|COMPLETED|Overall Study||23
5079318|NCT01749501|12498418|P1|COMPLETED|Overall Study||22
5079319|NCT01749501|12498417|P2|STARTED|Overall Study||23
5079320|NCT01749501|12498418|P1|STARTED|Overall Study||22
5079321|NCT01749410|12498426|P1|NOT COMPLETED|Overall Study||0
5079322|NCT01749410|12498426|P1|COMPLETED|Overall Study||33
5079323|NCT01749410|12498426|P1|STARTED|Overall Study||33
5079324|NCT01749293|12498430|P1|NOT COMPLETED|Overall Study||0
5079325|NCT01749293|12498430|P1|COMPLETED|Overall Study||3
5079326|NCT01749293|12498430|P1|STARTED|Overall Study||3
5079327|NCT01749033|12498439|P3|NOT COMPLETED|Overall Study||1
5079328|NCT01749033|12498440|P2|NOT COMPLETED|Overall Study||5
5079329|NCT01749033|12498441|P1|NOT COMPLETED|Overall Study||3
5079330|NCT01749033|12498439|P3|COMPLETED|Overall Study||149
5079331|NCT01749033|12498440|P2|COMPLETED|Overall Study||145
5079332|NCT01749033|12498441|P1|COMPLETED|Overall Study||147
5079333|NCT01749033|12498439|P3|STARTED|Overall Study||150
5079334|NCT01749033|12498440|P2|STARTED|Overall Study||150
5079335|NCT01749033|12498441|P1|STARTED|Overall Study||150
5079336|NCT01748955|12498466|P2|NOT COMPLETED|Overall Study||5
5079337|NCT01748955|12498467|P1|NOT COMPLETED|Overall Study||3
5079338|NCT01748955|12498466|P2|COMPLETED|Overall Study||4
5079339|NCT01748955|12498467|P1|COMPLETED|Overall Study||3
5079340|NCT01748955|12498466|P2|STARTED|Overall Study||9
5079341|NCT01748955|12498467|P1|STARTED|Overall Study||6
5079342|NCT01748942|12498477|P2|NOT COMPLETED|Overall Study||4
5079343|NCT01748942|12498478|P1|NOT COMPLETED|Overall Study||4
5079344|NCT01748942|12498477|P2|COMPLETED|Overall Study||33
5079345|NCT01748942|12498478|P1|COMPLETED|Overall Study||35
5079346|NCT01748942|12498477|P2|STARTED|Overall Study||37
5079347|NCT01748942|12498478|P1|STARTED|Overall Study||39
5079348|NCT01748916|12498498|P6|NOT COMPLETED|Overall Study||0
5079349|NCT01748916|12498499|P5|NOT COMPLETED|Overall Study||0
5079350|NCT01748916|12498500|P4|NOT COMPLETED|Overall Study||0
5079351|NCT01748916|12498501|P3|NOT COMPLETED|Overall Study||0
5079352|NCT01748916|12498502|P2|NOT COMPLETED|Overall Study||0
5079353|NCT01748916|12498503|P1|NOT COMPLETED|Overall Study||0
5079354|NCT01748916|12498498|P6|COMPLETED|Overall Study||3
5079355|NCT01748916|12498499|P5|COMPLETED|Overall Study||3
5079356|NCT01748916|12498500|P4|COMPLETED|Overall Study||3
5079357|NCT01748916|12498501|P3|COMPLETED|Overall Study||2
5079358|NCT01748916|12498502|P2|COMPLETED|Overall Study||3
5079359|NCT01748916|12498503|P1|COMPLETED|Overall Study||2
5079360|NCT01748916|12498498|P6|STARTED|Overall Study||3
5079361|NCT01748916|12498499|P5|STARTED|Overall Study||3
5079362|NCT01748916|12498500|P4|STARTED|Overall Study||3
5079363|NCT01748916|12498501|P3|STARTED|Overall Study||2
5079364|NCT01748916|12498502|P2|STARTED|Overall Study||3
5079365|NCT01748916|12498503|P1|STARTED|Overall Study||2
5079366|NCT01748890|12498511|P1|NOT COMPLETED|Overall Study||4
5079367|NCT01748890|12498511|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
5079368|NCT01748890|12498511|P1|STARTED|Overall Study||4
5079369|NCT01748799|12498523|P8|NOT COMPLETED|Overall Study||0
5079370|NCT01748799|12498524|P7|NOT COMPLETED|Overall Study||1
5079371|NCT01748799|12498525|P6|NOT COMPLETED|Overall Study||1
5079372|NCT01748799|12498526|P5|NOT COMPLETED|Overall Study||0
5079373|NCT01748799|12498527|P4|NOT COMPLETED|Overall Study||0
5079374|NCT01748799|12498528|P3|NOT COMPLETED|Overall Study||0
5079375|NCT01748799|12498529|P2|NOT COMPLETED|Overall Study||0
5079376|NCT01748799|12498530|P1|NOT COMPLETED|Overall Study||5
5079377|NCT01748799|12498523|P8|COMPLETED|Overall Study||1
5079378|NCT01748799|12498524|P7|COMPLETED|Overall Study||1
5079379|NCT01748799|12498525|P6|COMPLETED|Overall Study||1
5079380|NCT01748799|12498526|P5|COMPLETED|Overall Study||1
5079381|NCT01748799|12498527|P4|COMPLETED|Overall Study||2
5079382|NCT01748799|12498528|P3|COMPLETED|Overall Study||1
5079383|NCT01748799|12498529|P2|COMPLETED|Overall Study||1
5079384|NCT01748799|12498530|P1|COMPLETED|Overall Study||1
5079385|NCT01748799|12498523|P8|Completed Self-titrated Sativex|Overall Study||1
5079386|NCT01748799|12498524|P7|Completed Self-titrated Sativex|Overall Study||1
5079387|NCT01748799|12498525|P6|Completed Self-titrated Sativex|Overall Study||1
5079388|NCT01748799|12498526|P5|Completed Self-titrated Sativex|Overall Study||1
5079389|NCT01748799|12498527|P4|Completed Self-titrated Sativex|Overall Study||2
5079390|NCT01748799|12498528|P3|Completed Self-titrated Sativex|Overall Study||1
5079391|NCT01748799|12498529|P2|Completed Self-titrated Sativex|Overall Study||1
5079392|NCT01748799|12498530|P1|Completed Self-titrated Sativex|Overall Study||1
5079393|NCT01748799|12498523|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
5079394|NCT01748799|12498524|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
5079395|NCT01748799|12498525|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
5079396|NCT01748799|12498526|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
5079397|NCT01748799|12498527|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
5079398|NCT01748799|12498528|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
5079399|NCT01748799|12498529|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
5079400|NCT01748799|12498530|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
5079401|NCT01748799|12498523|P8|Completed Self-titrated Placebo|Overall Study||1
5079402|NCT01748799|12498524|P7|Completed Self-titrated Placebo|Overall Study||1
5079403|NCT01748799|12498525|P6|Completed Self-titrated Placebo|Overall Study||2
5079404|NCT01748799|12498526|P5|Completed Self-titrated Placebo|Overall Study||1
5079405|NCT01748799|12498527|P4|Completed Self-titrated Placebo|Overall Study||2
5079406|NCT01748799|12498528|P3|Completed Self-titrated Placebo|Overall Study||1
5079407|NCT01748799|12498529|P2|Completed Self-titrated Placebo|Overall Study||1
5079408|NCT01748799|12498530|P1|Completed Self-titrated Placebo|Overall Study||4
5079409|NCT01748799|12498523|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
5079410|NCT01748799|12498524|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
5079411|NCT01748799|12498525|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
5079412|NCT01748799|12498526|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
5079413|NCT01748799|12498527|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
5079414|NCT01748799|12498528|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
5079415|NCT01748799|12498529|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
5079416|NCT01748799|12498530|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
5079417|NCT01748799|12498523|P8|Completed Fixed Dose Sativex|Overall Study||1
5079418|NCT01748799|12498524|P7|Completed Fixed Dose Sativex|Overall Study||1
5079419|NCT01748799|12498525|P6|Completed Fixed Dose Sativex|Overall Study||1
5079420|NCT01748799|12498526|P5|Completed Fixed Dose Sativex|Overall Study||1
5079421|NCT01748799|12498527|P4|Completed Fixed Dose Sativex|Overall Study||2
5079422|NCT01748799|12498528|P3|Completed Fixed Dose Sativex|Overall Study||1
5079423|NCT01748799|12498529|P2|Completed Fixed Dose Sativex|Overall Study||1
5079424|NCT01748799|12498530|P1|Completed Fixed Dose Sativex|Overall Study||1
5079425|NCT01748799|12498523|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079426|NCT01748799|12498524|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079427|NCT01748799|12498525|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079428|NCT01748799|12498526|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079429|NCT01748799|12498527|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
5079430|NCT01748799|12498528|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079431|NCT01748799|12498529|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079432|NCT01748799|12498530|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
5079433|NCT01748799|12498523|P8|Completed Fixed Dose Placebo|Overall Study||1
5079434|NCT01748799|12498524|P7|Completed Fixed Dose Placebo|Overall Study||1
5079435|NCT01748799|12498525|P6|Completed Fixed Dose Placebo|Overall Study||1
5079436|NCT01748799|12498526|P5|Completed Fixed Dose Placebo|Overall Study||1
5079437|NCT01748799|12498527|P4|Completed Fixed Dose Placebo|Overall Study||2
5079438|NCT01748799|12498528|P3|Completed Fixed Dose Placebo|Overall Study||1
5079439|NCT01748799|12498529|P2|Completed Fixed Dose Placebo|Overall Study||1
5079440|NCT01748799|12498530|P1|Completed Fixed Dose Placebo|Overall Study||2
5079441|NCT01748799|12498523|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079442|NCT01748799|12498524|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079443|NCT01748799|12498525|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079444|NCT01748799|12498526|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079445|NCT01748799|12498527|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
5079446|NCT01748799|12498528|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079447|NCT01748799|12498529|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
5079448|NCT01748799|12498530|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
5079449|NCT01748799|12498523|P8|STARTED|Overall Study||1
5079450|NCT01748799|12498524|P7|STARTED|Overall Study||2
5079451|NCT01748799|12498525|P6|STARTED|Overall Study||2
5079452|NCT01748799|12498526|P5|STARTED|Overall Study||1
5079453|NCT01748799|12498527|P4|STARTED|Overall Study||2
5079454|NCT01748799|12498528|P3|STARTED|Overall Study||1
5079455|NCT01748799|12498529|P2|STARTED|Overall Study||1
5079456|NCT01748799|12498530|P1|STARTED|Overall Study||6
5079457|NCT01748760|12498566|P2|NOT COMPLETED|Overall Study||2
5079458|NCT01748760|12498567|P1|NOT COMPLETED|Overall Study||6
5079459|NCT01748760|12498566|P2|COMPLETED|Overall Study||23
5079460|NCT01748760|12498567|P1|COMPLETED|Overall Study||19
5079461|NCT01748760|12498566|P2|STARTED|Overall Study||25
5079462|NCT01748760|12498567|P1|STARTED|Overall Study||25
5079463|NCT01748695|12498573|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
5079464|NCT01748695|12498574|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5079465|NCT01748695|12498573|P2|COMPLETED|Second Intervention (4 Weeks)||11
5079466|NCT01748695|12498574|P1|COMPLETED|Second Intervention (4 Weeks)||14
5079467|NCT01748695|12498573|P2|STARTED|Second Intervention (4 Weeks)||11
5079468|NCT01748695|12498574|P1|STARTED|Second Intervention (4 Weeks)||14
5079469|NCT01748695|12498573|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
5079470|NCT01748695|12498574|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5079471|NCT01748695|12498573|P2|COMPLETED|First Intervention (4 Weeks)||11
5079472|NCT01748695|12498574|P1|COMPLETED|First Intervention (4 Weeks)||14
5079473|NCT01748695|12498573|P2|STARTED|First Intervention (4 Weeks)||11
5079474|NCT01748695|12498574|P1|STARTED|First Intervention (4 Weeks)||14
5079475|NCT01748643|12498584|P2|NOT COMPLETED|Overall Study||0
5079476|NCT01748643|12498585|P1|NOT COMPLETED|Overall Study||0
5079477|NCT01748643|12498584|P2|COMPLETED|Overall Study||30
5079478|NCT01748643|12498585|P1|COMPLETED|Overall Study||30
5079479|NCT01748643|12498584|P2|STARTED|Overall Study||30
5079480|NCT01748643|12498585|P1|STARTED|Overall Study||30
5079481|NCT01748552|12498613|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
5079482|NCT01748552|12498614|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
5079483|NCT01748552|12498615|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
5079484|NCT01748552|12498616|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
5079485|NCT01748552|12498617|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
5079486|NCT01748552|12498618|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
5079487|NCT01748552|12498619|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
5079488|NCT01748552|12498620|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
5079489|NCT01748552|12498621|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
5079490|NCT01748552|12498622|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
5079491|NCT01748552|12498623|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
5079492|NCT01748552|12498624|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
5079493|NCT01748552|12498613|P12|COMPLETED|Intervention Period 3 and Washout||3
5079494|NCT01748552|12498614|P11|COMPLETED|Intervention Period 3 and Washout||3
5079495|NCT01748552|12498615|P10|COMPLETED|Intervention Period 3 and Washout||3
5079496|NCT01748552|12498616|P9|COMPLETED|Intervention Period 3 and Washout||0
5079497|NCT01748552|12498617|P8|COMPLETED|Intervention Period 3 and Washout||0
5079498|NCT01748552|12498618|P7|COMPLETED|Intervention Period 3 and Washout||0
5079499|NCT01748552|12498619|P6|COMPLETED|Intervention Period 3 and Washout||3
5079500|NCT01748552|12498620|P5|COMPLETED|Intervention Period 3 and Washout||3
5079501|NCT01748552|12498621|P4|COMPLETED|Intervention Period 3 and Washout||3
5079502|NCT01748552|12498622|P3|COMPLETED|Intervention Period 3 and Washout||2
5079503|NCT01748552|12498623|P2|COMPLETED|Intervention Period 3 and Washout||3
5079504|NCT01748552|12498624|P1|COMPLETED|Intervention Period 3 and Washout||3
5079505|NCT01748552|12498613|P12|STARTED|Intervention Period 3 and Washout||3
5079506|NCT01748552|12498614|P11|STARTED|Intervention Period 3 and Washout||3
5079507|NCT01748552|12498615|P10|STARTED|Intervention Period 3 and Washout||3
5079508|NCT01748552|12498616|P9|STARTED|Intervention Period 3 and Washout||0
5079509|NCT01748552|12498617|P8|STARTED|Intervention Period 3 and Washout||0
5079510|NCT01748552|12498618|P7|STARTED|Intervention Period 3 and Washout||0
5079511|NCT01748552|12498619|P6|STARTED|Intervention Period 3 and Washout||3
5079512|NCT01748552|12498620|P5|STARTED|Intervention Period 3 and Washout||3
5079513|NCT01748552|12498621|P4|STARTED|Intervention Period 3 and Washout||3
5079514|NCT01748552|12498622|P3|STARTED|Intervention Period 3 and Washout||2
5079515|NCT01748552|12498623|P2|STARTED|Intervention Period 3 and Washout||3
5079516|NCT01748552|12498624|P1|STARTED|Intervention Period 3 and Washout||3
5079517|NCT01748552|12498613|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
5079518|NCT01748552|12498614|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
5079519|NCT01748552|12498615|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
5079520|NCT01748552|12498616|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
5079521|NCT01748552|12498617|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
5079522|NCT01748552|12498618|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
5079523|NCT01748552|12498619|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
5079524|NCT01748552|12498620|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
5079525|NCT01748552|12498621|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
5079526|NCT01748552|12498622|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
5079527|NCT01748552|12498623|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
5079528|NCT01748552|12498624|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
5079529|NCT01748552|12498613|P12|COMPLETED|Intervention Period 2 and Washout||3
5079530|NCT01748552|12498614|P11|COMPLETED|Intervention Period 2 and Washout||3
5079531|NCT01748552|12498615|P10|COMPLETED|Intervention Period 2 and Washout||3
5079532|NCT01748552|12498616|P9|COMPLETED|Intervention Period 2 and Washout||0
5079533|NCT01748552|12498617|P8|COMPLETED|Intervention Period 2 and Washout||0
5079534|NCT01748552|12498618|P7|COMPLETED|Intervention Period 2 and Washout||0
5079535|NCT01748552|12498619|P6|COMPLETED|Intervention Period 2 and Washout||3
5079536|NCT01748552|12498620|P5|COMPLETED|Intervention Period 2 and Washout||3
5079537|NCT01748552|12498621|P4|COMPLETED|Intervention Period 2 and Washout||3
5079538|NCT01748552|12498622|P3|COMPLETED|Intervention Period 2 and Washout||2
5079539|NCT01748552|12498623|P2|COMPLETED|Intervention Period 2 and Washout||3
5079540|NCT01748552|12498624|P1|COMPLETED|Intervention Period 2 and Washout||3
5079541|NCT01748552|12498613|P12|STARTED|Intervention Period 2 and Washout||3
5079542|NCT01748552|12498614|P11|STARTED|Intervention Period 2 and Washout||3
5079543|NCT01748552|12498615|P10|STARTED|Intervention Period 2 and Washout||3
5079544|NCT01748552|12498616|P9|STARTED|Intervention Period 2 and Washout||3
5079545|NCT01748552|12498617|P8|STARTED|Intervention Period 2 and Washout||3
5079546|NCT01748552|12498618|P7|STARTED|Intervention Period 2 and Washout||3
5079547|NCT01748552|12498619|P6|STARTED|Intervention Period 2 and Washout||3
5079548|NCT01748552|12498620|P5|STARTED|Intervention Period 2 and Washout||3
5079549|NCT01748552|12498621|P4|STARTED|Intervention Period 2 and Washout||3
5079550|NCT01748552|12498622|P3|STARTED|Intervention Period 2 and Washout||3
5079551|NCT01748552|12498623|P2|STARTED|Intervention Period 2 and Washout||3
5079552|NCT01748552|12498624|P1|STARTED|Intervention Period 2 and Washout||3
5079553|NCT01748552|12498613|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
5079554|NCT01748552|12498614|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
5079555|NCT01748552|12498615|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
5079556|NCT01748552|12498616|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
5079557|NCT01748552|12498617|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
5079558|NCT01748552|12498618|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
5079559|NCT01748552|12498619|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
5079560|NCT01748552|12498620|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
5079561|NCT01748552|12498621|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
5079562|NCT01748552|12498622|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
5079563|NCT01748552|12498623|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
5079564|NCT01748552|12498624|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
5079565|NCT01748552|12498613|P12|COMPLETED|Intervention Period 1 and Washout||3
5079566|NCT01748552|12498614|P11|COMPLETED|Intervention Period 1 and Washout||3
5079567|NCT01748552|12498615|P10|COMPLETED|Intervention Period 1 and Washout||3
5079568|NCT01748552|12498616|P9|COMPLETED|Intervention Period 1 and Washout||3
5079569|NCT01748552|12498617|P8|COMPLETED|Intervention Period 1 and Washout||3
5079570|NCT01748552|12498618|P7|COMPLETED|Intervention Period 1 and Washout||3
5079571|NCT01748552|12498619|P6|COMPLETED|Intervention Period 1 and Washout||3
5079572|NCT01748552|12498620|P5|COMPLETED|Intervention Period 1 and Washout||3
5079573|NCT01748552|12498621|P4|COMPLETED|Intervention Period 1 and Washout||3
5079574|NCT01748552|12498622|P3|COMPLETED|Intervention Period 1 and Washout||3
5079575|NCT01748552|12498623|P2|COMPLETED|Intervention Period 1 and Washout||3
5079576|NCT01748552|12498624|P1|COMPLETED|Intervention Period 1 and Washout||3
5079577|NCT01748552|12498613|P12|STARTED|Intervention Period 1 and Washout||3
5079578|NCT01748552|12498614|P11|STARTED|Intervention Period 1 and Washout||3
5079579|NCT01748552|12498615|P10|STARTED|Intervention Period 1 and Washout||3
5079580|NCT01748552|12498616|P9|STARTED|Intervention Period 1 and Washout||3
5079581|NCT01748552|12498617|P8|STARTED|Intervention Period 1 and Washout||3
5079582|NCT01748552|12498618|P7|STARTED|Intervention Period 1 and Washout||3
5079583|NCT01748552|12498619|P6|STARTED|Intervention Period 1 and Washout||3
5079584|NCT01748552|12498620|P5|STARTED|Intervention Period 1 and Washout||3
5079585|NCT01748552|12498621|P4|STARTED|Intervention Period 1 and Washout||3
5079586|NCT01748552|12498622|P3|STARTED|Intervention Period 1 and Washout||3
5079587|NCT01748552|12498623|P2|STARTED|Intervention Period 1 and Washout||3
5079588|NCT01748552|12498624|P1|STARTED|Intervention Period 1 and Washout||3
5079589|NCT01748292|12498694|P2|NOT COMPLETED|Overall Study||12
5079590|NCT01748292|12498695|P1|NOT COMPLETED|Overall Study||2
5079591|NCT01748292|12498694|P2|COMPLETED|Overall Study||28
5079592|NCT01748292|12498695|P1|COMPLETED|Overall Study||18
5079593|NCT01748292|12498694|P2|STARTED|Overall Study||40
5079594|NCT01748292|12498695|P1|STARTED|Overall Study||20
5079595|NCT01748240|12498715|P1|NOT COMPLETED|Overall Study||0
5079596|NCT01748240|12498715|P1|COMPLETED|Overall Study||21
5079597|NCT01748240|12498715|P1|STARTED|Overall Study||21
5079598|NCT01748227|12498719|P1|NOT COMPLETED|Overall Study||3
5079599|NCT01748227|12498719|P1|COMPLETED|Overall Study||17
5079600|NCT01748227|12498719|P1|STARTED|Overall Study||20
5079601|NCT01748162|12498729|P2|NOT COMPLETED|Overall Study||5
5079602|NCT01748162|12498730|P1|NOT COMPLETED|Overall Study||5
5079603|NCT01748162|12498729|P2|COMPLETED|Overall Study||0
5079604|NCT01748162|12498730|P1|COMPLETED|Overall Study||0
5079605|NCT01748162|12498729|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
5079606|NCT01748162|12498730|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
5079607|NCT01748162|12498729|P2|Completed 6 Month Initial Treatment|Overall Study||0
5079608|NCT01748162|12498730|P1|Completed 6 Month Initial Treatment|Overall Study||0
5079609|NCT01748162|12498729|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
5079610|NCT01748162|12498730|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
5079611|NCT01748162|12498729|P2|STARTED|Overall Study||5
5079612|NCT01748162|12498730|P1|STARTED|Overall Study||5
5079613|NCT01748071|12498741|P3|NOT COMPLETED|Overall Study||0
5079614|NCT01748071|12498742|P2|NOT COMPLETED|Overall Study||2
5079615|NCT01748071|12498743|P1|NOT COMPLETED|Overall Study||2
5079616|NCT01748071|12498741|P3|COMPLETED|Overall Study||40
5079617|NCT01748071|12498742|P2|COMPLETED|Overall Study||38
5079618|NCT01748071|12498743|P1|COMPLETED|Overall Study||38
5079619|NCT01748071|12498741|P3|STARTED|Overall Study||40
5079620|NCT01748071|12498742|P2|STARTED|Overall Study||40
5079621|NCT01748071|12498743|P1|STARTED|Overall Study||40
5079622|NCT01748045|12498765|P2|NOT COMPLETED|Overall Study||0
5079623|NCT01748045|12498766|P1|NOT COMPLETED|Overall Study||0
5079624|NCT01748045|12498765|P2|COMPLETED|Overall Study||1
5079625|NCT01748045|12498766|P1|COMPLETED|Overall Study||2
5079626|NCT01748045|12498765|P2|STARTED|Overall Study||1
5079627|NCT01748045|12498766|P1|STARTED|Overall Study||2
5079628|NCT01747928|12498792|P8|NOT COMPLETED|Overall Study||0
5079629|NCT01747928|12498793|P7|NOT COMPLETED|Overall Study||0
5079630|NCT01747928|12498794|P6|NOT COMPLETED|Overall Study||0
5079631|NCT01747928|12498795|P5|NOT COMPLETED|Overall Study||0
5079632|NCT01747928|12498796|P4|NOT COMPLETED|Overall Study||0
5079633|NCT01747928|12498797|P3|NOT COMPLETED|Overall Study||0
5079634|NCT01747928|12498798|P2|NOT COMPLETED|Overall Study||0
5079635|NCT01747928|12498799|P1|NOT COMPLETED|Overall Study||0
5079636|NCT01747928|12498792|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079637|NCT01747928|12498793|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079638|NCT01747928|12498794|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079639|NCT01747928|12498795|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079640|NCT01747928|12498796|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079641|NCT01747928|12498797|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079642|NCT01747928|12498798|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079643|NCT01747928|12498799|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
5079644|NCT01747928|12498792|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079645|NCT01747928|12498793|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079646|NCT01747928|12498794|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079647|NCT01747928|12498795|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079648|NCT01747928|12498796|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079649|NCT01747928|12498797|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079650|NCT01747928|12498798|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079651|NCT01747928|12498799|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
5079652|NCT01747915|12499006|P3|NOT COMPLETED|Overall Study||6
5079653|NCT01747915|12499007|P2|NOT COMPLETED|Overall Study||11
5079654|NCT01747915|12499008|P1|NOT COMPLETED|Overall Study||15
5079655|NCT01747915|12499006|P3|COMPLETED|Overall Study||66
5079656|NCT01747915|12499007|P2|COMPLETED|Overall Study||61
5079657|NCT01747915|12499008|P1|COMPLETED|Overall Study||60
5079658|NCT01747915|12499006|P3|STARTED|Overall Study||72
5079659|NCT01747915|12499007|P2|STARTED|Overall Study||72
5079660|NCT01747915|12499008|P1|STARTED|Overall Study||75
5079661|NCT01747876|12499022|P3|NOT COMPLETED|Overall Study||12
5079662|NCT01747876|12499023|P2|NOT COMPLETED|Overall Study||15
5079663|NCT01747876|12499024|P1|NOT COMPLETED|Overall Study||5
5079664|NCT01747876|12499022|P3|COMPLETED|Overall Study||0
5079665|NCT01747876|12499023|P2|COMPLETED|Overall Study||0
5079666|NCT01747876|12499024|P1|COMPLETED|Overall Study||0
5079667|NCT01747876|12499022|P3|STARTED|Overall Study||12
5079668|NCT01747876|12499023|P2|STARTED|Overall Study||15
5079669|NCT01747876|12499024|P1|STARTED|Overall Study||5
5079670|NCT01747850|12499053|P3|NOT COMPLETED|Overall Study||6
5079671|NCT01747850|12499054|P2|NOT COMPLETED|Overall Study||7
5079672|NCT01747850|12499055|P1|NOT COMPLETED|Overall Study||1
5079673|NCT01747850|12499053|P3|COMPLETED|Overall Study||14
5079674|NCT01747850|12499054|P2|COMPLETED|Overall Study||13
5079675|NCT01747850|12499055|P1|COMPLETED|Overall Study||4
5079676|NCT01747850|12499053|P3|STARTED|Overall Study||20
5079677|NCT01747850|12499054|P2|STARTED|Overall Study||20
5079678|NCT01747850|12499055|P1|STARTED|Overall Study||5
5079679|NCT01747837|12499077|P2|NOT COMPLETED|Overall Study||6
5079680|NCT01747837|12499078|P1|NOT COMPLETED|Overall Study||9
5079681|NCT01747837|12499077|P2|COMPLETED|Overall Study||17
5079682|NCT01747837|12499078|P1|COMPLETED|Overall Study||16
5079683|NCT01747837|12499077|P2|STARTED|Overall Study||23
5079684|NCT01747837|12499078|P1|STARTED|Overall Study||25
5079685|NCT01747811|12499108|P2|NOT COMPLETED|Overall Study||4
5079686|NCT01747811|12499109|P1|NOT COMPLETED|Overall Study||2
5079687|NCT01747811|12499108|P2|COMPLETED|Overall Study||12
5079688|NCT01747811|12499109|P1|COMPLETED|Overall Study||14
5079689|NCT01747811|12499108|P2|STARTED|Overall Study||16
5079690|NCT01747811|12499109|P1|STARTED|Overall Study||16
5079691|NCT01747772|12499125|P1|NOT COMPLETED|Overall Study||9
5079692|NCT01747772|12499125|P1|COMPLETED|Overall Study||171
5079693|NCT01747772|12499125|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
5079694|NCT01747772|12499125|P1|STARTED|Overall Study||180
5079695|NCT01747655|12499133|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
5079696|NCT01747655|12499134|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
5079697|NCT01747655|12499133|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
5079698|NCT01747655|12499134|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
5079699|NCT01747655|12499133|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
5079700|NCT01747655|12499134|P1|STARTED|PEG-J Period (Continued Treatment)||41
5079701|NCT01747655|12499133|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
5079702|NCT01747655|12499134|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
5079703|NCT01747655|12499133|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
5079704|NCT01747655|12499134|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
5079705|NCT01747655|12499133|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
5079706|NCT01747655|12499134|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
5079707|NCT01747655|12499133|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
5079708|NCT01747655|12499134|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
5079709|NCT01747655|12499133|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
5079710|NCT01747655|12499134|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
5079711|NCT01747655|12499133|P2|STARTED|Temporary Naso-jejunal Tube Period||0
5079712|NCT01747655|12499134|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
5079713|NCT01747629|12499164|P2|NOT COMPLETED|Overall Study||6
5079714|NCT01747629|12499165|P1|NOT COMPLETED|Overall Study||8
5079715|NCT01747629|12499164|P2|COMPLETED|Overall Study||69
5079716|NCT01747629|12499165|P1|COMPLETED|Overall Study||77
5079717|NCT01747629|12499164|P2|Treated|Overall Study|Safety set and full analysis set|75
5079718|NCT01747629|12499165|P1|Treated|Overall Study|Safety set and full analysis set|84
5079719|NCT01747629|12499164|P2|STARTED|Overall Study||75
5079720|NCT01747629|12499165|P1|STARTED|Overall Study||85
5079721|NCT01747551|12499199|P2|NOT COMPLETED|Overall Study||21
5079722|NCT01747551|12499200|P1|NOT COMPLETED|Overall Study||43
5079723|NCT01747551|12499199|P2|COMPLETED|Overall Study||0
5079724|NCT01747551|12499200|P1|COMPLETED|Overall Study||0
5079725|NCT01747551|12499199|P2|STARTED|Overall Study||21
5079726|NCT01747551|12499200|P1|STARTED|Overall Study||43
5079727|NCT01747499|12499217|P5|NOT COMPLETED|Overall Study||15
5079728|NCT01747499|12499218|P4|NOT COMPLETED|Overall Study||2
5079729|NCT01747499|12499219|P3|NOT COMPLETED|Overall Study||0
5079730|NCT01747499|12499220|P2|NOT COMPLETED|Overall Study||1
5079731|NCT01747499|12499221|P1|NOT COMPLETED|Overall Study||1
5079732|NCT01747499|12499217|P5|COMPLETED|Overall Study||24
5079733|NCT01747499|12499218|P4|COMPLETED|Overall Study||4
5079734|NCT01747499|12499219|P3|COMPLETED|Overall Study||3
5079735|NCT01747499|12499220|P2|COMPLETED|Overall Study||2
5079736|NCT01747499|12499221|P1|COMPLETED|Overall Study||2
5079737|NCT01747499|12499217|P5|STARTED|Overall Study||39
5079738|NCT01747499|12499218|P4|STARTED|Overall Study||6
5079739|NCT01747499|12499219|P3|STARTED|Overall Study||3
5079740|NCT01747499|12499220|P2|STARTED|Overall Study||3
5079741|NCT01747499|12499221|P1|STARTED|Overall Study||3
5079742|NCT01747486|12499257|P2|NOT COMPLETED|Stage 2||0
5079743|NCT01747486|12499258|P1|NOT COMPLETED|Stage 2||9
5079744|NCT01747486|12499257|P2|COMPLETED|Stage 2||0
5079745|NCT01747486|12499258|P1|COMPLETED|Stage 2||3
5079746|NCT01747486|12499257|P2|STARTED|Stage 2||0
5079747|NCT01747486|12499258|P1|STARTED|Stage 2||12
5079748|NCT01747486|12499257|P2|NOT COMPLETED|Stage 1||13
5079749|NCT01747486|12499258|P1|NOT COMPLETED|Stage 1||12
5079750|NCT01747486|12499257|P2|COMPLETED|Stage 1||2
5079751|NCT01747486|12499258|P1|COMPLETED|Stage 1||3
5079752|NCT01747486|12499257|P2|STARTED|Stage 1||15
5079753|NCT01747486|12499258|P1|STARTED|Stage 1||15
5079754|NCT01747343|12499264|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
5079755|NCT01747343|12499264|P1|COMPLETED|Underwear/Differential Reinforcement||4
5079756|NCT01747343|12499264|P1|STARTED|Underwear/Differential Reinforcement||4
5079757|NCT01747343|12499264|P1|NOT COMPLETED|Underwear||0
5079758|NCT01747343|12499264|P1|COMPLETED|Underwear||4
5079759|NCT01747343|12499264|P1|STARTED|Underwear||4
5079760|NCT01747343|12499264|P1|NOT COMPLETED|Baseline||0
5079761|NCT01747343|12499264|P1|COMPLETED|Baseline||4
5079762|NCT01747343|12499264|P1|STARTED|Baseline||4
5079763|NCT01747330|12499270|P1|NOT COMPLETED|Overall Study||0
5079764|NCT01747330|12499270|P1|COMPLETED|Overall Study||40
5079765|NCT01747330|12499270|P1|STARTED|Overall Study||40
5079766|NCT01746979|12499284|P2|NOT COMPLETED|Overall Study||347
5079767|NCT01746979|12499285|P1|NOT COMPLETED|Overall Study||346
5079768|NCT01746979|12499284|P2|COMPLETED|Overall Study||0
5079769|NCT01746979|12499285|P1|COMPLETED|Overall Study||0
5079770|NCT01746979|12499284|P2|STARTED|Overall Study||347
5079771|NCT01746979|12499285|P1|STARTED|Overall Study||346
5079772|NCT01746940|12499297|P4|NOT COMPLETED|Safety Second Phase||0
5079773|NCT01746940|12499298|P3|NOT COMPLETED|Safety Second Phase||0
5079774|NCT01746940|12499299|P2|NOT COMPLETED|Safety Second Phase||0
5079775|NCT01746940|12499300|P1|NOT COMPLETED|Safety Second Phase||0
5079776|NCT01746940|12499297|P4|COMPLETED|Safety Second Phase||0
5079777|NCT01746940|12499298|P3|COMPLETED|Safety Second Phase||0
5079778|NCT01746940|12499299|P2|COMPLETED|Safety Second Phase||18
5079779|NCT01746940|12499300|P1|COMPLETED|Safety Second Phase||18
5079780|NCT01746940|12499297|P4|STARTED|Safety Second Phase||0
5079781|NCT01746940|12499298|P3|STARTED|Safety Second Phase||0
5079782|NCT01746940|12499299|P2|STARTED|Safety Second Phase||18
5079783|NCT01746940|12499300|P1|STARTED|Safety Second Phase||18
5079784|NCT01746940|12499297|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
5079785|NCT01746940|12499298|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
5079786|NCT01746940|12499299|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
5079787|NCT01746940|12499300|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
5079788|NCT01746940|12499297|P4|COMPLETED|Safety and Efficacy First Phase||0
5079789|NCT01746940|12499298|P3|COMPLETED|Safety and Efficacy First Phase||40
5079790|NCT01746940|12499299|P2|COMPLETED|Safety and Efficacy First Phase||41
5079791|NCT01746940|12499300|P1|COMPLETED|Safety and Efficacy First Phase||39
5079792|NCT01746940|12499297|P4|STARTED|Safety and Efficacy First Phase||3
5079793|NCT01746940|12499298|P3|STARTED|Safety and Efficacy First Phase||40
5079794|NCT01746940|12499299|P2|STARTED|Safety and Efficacy First Phase||41
5079795|NCT01746940|12499300|P1|STARTED|Safety and Efficacy First Phase||39
5079796|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079797|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079798|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079799|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079800|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079801|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079802|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079803|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079804|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
5079805|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
5079806|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
5079807|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
5079808|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
5079809|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
5079810|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
5079811|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
5079812|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
5079813|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
5079814|NCT01746901|12499308|P9|STARTED|Treatment Phase: Sixth Intervention||5
5079815|NCT01746901|12499309|P8|STARTED|Treatment Phase: Sixth Intervention||6
5079816|NCT01746901|12499310|P7|STARTED|Treatment Phase: Sixth Intervention||5
5079817|NCT01746901|12499311|P6|STARTED|Treatment Phase: Sixth Intervention||5
5079818|NCT01746901|12499312|P5|STARTED|Treatment Phase: Sixth Intervention||6
5079819|NCT01746901|12499313|P4|STARTED|Treatment Phase: Sixth Intervention||5
5079820|NCT01746901|12499314|P3|STARTED|Treatment Phase: Sixth Intervention||0
5079821|NCT01746901|12499315|P2|STARTED|Treatment Phase: Sixth Intervention||0
5079822|NCT01746901|12499316|P1|STARTED|Treatment Phase: Sixth Intervention||0
5079823|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079824|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079825|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079826|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079827|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079828|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079829|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079830|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079831|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
5079832|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Washout Period 5||5
5079833|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Washout Period 5||6
5079834|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Washout Period 5||5
5079835|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Washout Period 5||5
5079836|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Washout Period 5||6
5079837|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Washout Period 5||5
5079838|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Washout Period 5||0
5079839|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Washout Period 5||0
5079840|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Washout Period 5||0
5079841|NCT01746901|12499308|P9|STARTED|Treatment Phase: Washout Period 5||5
5079842|NCT01746901|12499309|P8|STARTED|Treatment Phase: Washout Period 5||6
5079843|NCT01746901|12499310|P7|STARTED|Treatment Phase: Washout Period 5||5
5079844|NCT01746901|12499311|P6|STARTED|Treatment Phase: Washout Period 5||5
5079845|NCT01746901|12499312|P5|STARTED|Treatment Phase: Washout Period 5||6
5079846|NCT01746901|12499313|P4|STARTED|Treatment Phase: Washout Period 5||5
5079847|NCT01746901|12499314|P3|STARTED|Treatment Phase: Washout Period 5||0
5079848|NCT01746901|12499315|P2|STARTED|Treatment Phase: Washout Period 5||0
5079849|NCT01746901|12499316|P1|STARTED|Treatment Phase: Washout Period 5||0
5079850|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079851|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079852|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079853|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079854|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079855|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079856|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079857|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079858|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
5079859|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
5079860|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
5079861|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
5079862|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
5079863|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
5079864|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
5079865|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
5079866|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
5079867|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
5079868|NCT01746901|12499308|P9|STARTED|Treatment Phase: Fifth Intervention||5
5079869|NCT01746901|12499309|P8|STARTED|Treatment Phase: Fifth Intervention||6
5079870|NCT01746901|12499310|P7|STARTED|Treatment Phase: Fifth Intervention||5
5079871|NCT01746901|12499311|P6|STARTED|Treatment Phase: Fifth Intervention||5
5079872|NCT01746901|12499312|P5|STARTED|Treatment Phase: Fifth Intervention||6
5079873|NCT01746901|12499313|P4|STARTED|Treatment Phase: Fifth Intervention||5
5079874|NCT01746901|12499314|P3|STARTED|Treatment Phase: Fifth Intervention||0
5079875|NCT01746901|12499315|P2|STARTED|Treatment Phase: Fifth Intervention||0
5079876|NCT01746901|12499316|P1|STARTED|Treatment Phase: Fifth Intervention||0
5079877|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079878|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079879|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079880|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079881|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079882|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079883|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079884|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079885|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
5079886|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Washout Period 4||5
5079887|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Washout Period 4||6
5079888|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Washout Period 4||5
5079889|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Washout Period 4||5
5079890|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Washout Period 4||6
5079891|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Washout Period 4||5
5079892|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Washout Period 4||0
5079893|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Washout Period 4||0
5079894|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Washout Period 4||0
5079895|NCT01746901|12499308|P9|STARTED|Treatment Phase: Washout Period 4||5
5079896|NCT01746901|12499309|P8|STARTED|Treatment Phase: Washout Period 4||6
5079897|NCT01746901|12499310|P7|STARTED|Treatment Phase: Washout Period 4||5
5079898|NCT01746901|12499311|P6|STARTED|Treatment Phase: Washout Period 4||5
5079899|NCT01746901|12499312|P5|STARTED|Treatment Phase: Washout Period 4||6
5079900|NCT01746901|12499313|P4|STARTED|Treatment Phase: Washout Period 4||5
5079901|NCT01746901|12499314|P3|STARTED|Treatment Phase: Washout Period 4||0
5079902|NCT01746901|12499315|P2|STARTED|Treatment Phase: Washout Period 4||0
5079903|NCT01746901|12499316|P1|STARTED|Treatment Phase: Washout Period 4||0
5079904|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
5079905|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5079906|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
5079907|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
5079908|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5079909|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
5079910|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5079911|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5079912|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
5079913|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
5079914|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
5079915|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
5079916|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
5079917|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
5079918|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
5079919|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
5079920|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
5079921|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
5079922|NCT01746901|12499308|P9|STARTED|Treatment Phase: Fourth Intervention||7
5079923|NCT01746901|12499309|P8|STARTED|Treatment Phase: Fourth Intervention||6
5079924|NCT01746901|12499310|P7|STARTED|Treatment Phase: Fourth Intervention||6
5079925|NCT01746901|12499311|P6|STARTED|Treatment Phase: Fourth Intervention||6
5079926|NCT01746901|12499312|P5|STARTED|Treatment Phase: Fourth Intervention||6
5079927|NCT01746901|12499313|P4|STARTED|Treatment Phase: Fourth Intervention||6
5079928|NCT01746901|12499314|P3|STARTED|Treatment Phase: Fourth Intervention||0
5079929|NCT01746901|12499315|P2|STARTED|Treatment Phase: Fourth Intervention||0
5079930|NCT01746901|12499316|P1|STARTED|Treatment Phase: Fourth Intervention||0
5079931|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079932|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079933|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079934|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079935|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079936|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079937|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079938|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079939|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
5079940|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Washout Period 3||7
5079941|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Washout Period 3||6
5079942|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Washout Period 3||6
5079943|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Washout Period 3||6
5079944|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Washout Period 3||6
5079945|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Washout Period 3||6
5079946|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Washout Period 3||0
5079947|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Washout Period 3||0
5079948|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Washout Period 3||0
5079949|NCT01746901|12499308|P9|STARTED|Treatment Phase: Washout Period 3||7
5079950|NCT01746901|12499309|P8|STARTED|Treatment Phase: Washout Period 3||6
5079951|NCT01746901|12499310|P7|STARTED|Treatment Phase: Washout Period 3||6
5079952|NCT01746901|12499311|P6|STARTED|Treatment Phase: Washout Period 3||6
5079953|NCT01746901|12499312|P5|STARTED|Treatment Phase: Washout Period 3||6
5079954|NCT01746901|12499313|P4|STARTED|Treatment Phase: Washout Period 3||6
5079955|NCT01746901|12499314|P3|STARTED|Treatment Phase: Washout Period 3||0
5079956|NCT01746901|12499315|P2|STARTED|Treatment Phase: Washout Period 3||0
5079957|NCT01746901|12499316|P1|STARTED|Treatment Phase: Washout Period 3||0
5079958|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079959|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079960|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
5079961|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
5079962|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079963|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079964|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079965|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079966|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
5079967|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Third Intervention||7
5079968|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Third Intervention||6
5079969|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Third Intervention||6
5079970|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Third Intervention||6
5079971|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Third Intervention||6
5079972|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Third Intervention||6
5079973|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Third Intervention||0
5079974|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Third Intervention||0
5079975|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Third Intervention||0
5079976|NCT01746901|12499308|P9|STARTED|Treatment Phase: Third Intervention||7
5079977|NCT01746901|12499309|P8|STARTED|Treatment Phase: Third Intervention||6
5079978|NCT01746901|12499310|P7|STARTED|Treatment Phase: Third Intervention||7
5079979|NCT01746901|12499311|P6|STARTED|Treatment Phase: Third Intervention||7
5079980|NCT01746901|12499312|P5|STARTED|Treatment Phase: Third Intervention||6
5079981|NCT01746901|12499313|P4|STARTED|Treatment Phase: Third Intervention||6
5079982|NCT01746901|12499314|P3|STARTED|Treatment Phase: Third Intervention||0
5079983|NCT01746901|12499315|P2|STARTED|Treatment Phase: Third Intervention||0
5079984|NCT01746901|12499316|P1|STARTED|Treatment Phase: Third Intervention||0
5079985|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079986|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079987|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079988|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079989|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079990|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079991|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079992|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079993|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
5079994|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Washout Period 2||7
5079995|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Washout Period 2||6
5079996|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Washout Period 2||7
5079997|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Washout Period 2||7
5079998|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Washout Period 2||6
5079999|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Washout Period 2||6
5080000|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Washout Period 2||0
5080001|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Washout Period 2||0
5080002|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Washout Period 2||0
5080003|NCT01746901|12499308|P9|STARTED|Treatment Phase: Washout Period 2||7
5080004|NCT01746901|12499309|P8|STARTED|Treatment Phase: Washout Period 2||6
5080005|NCT01746901|12499310|P7|STARTED|Treatment Phase: Washout Period 2||7
5080006|NCT01746901|12499311|P6|STARTED|Treatment Phase: Washout Period 2||7
5080007|NCT01746901|12499312|P5|STARTED|Treatment Phase: Washout Period 2||6
5080008|NCT01746901|12499313|P4|STARTED|Treatment Phase: Washout Period 2||6
5080009|NCT01746901|12499314|P3|STARTED|Treatment Phase: Washout Period 2||0
5080010|NCT01746901|12499315|P2|STARTED|Treatment Phase: Washout Period 2||0
5080011|NCT01746901|12499316|P1|STARTED|Treatment Phase: Washout Period 2||0
5080012|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080013|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
5080014|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080015|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080016|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080017|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080018|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080019|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080020|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
5080021|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Second Intervention||7
5080022|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Second Intervention||6
5080023|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Second Intervention||7
5080024|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Second Intervention||7
5080025|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Second Intervention||6
5080026|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Second Intervention||6
5080027|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Second Intervention||0
5080028|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Second Intervention||0
5080029|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Second Intervention||0
5080030|NCT01746901|12499308|P9|STARTED|Treatment Phase: Second Intervention||7
5080031|NCT01746901|12499309|P8|STARTED|Treatment Phase: Second Intervention||7
5080032|NCT01746901|12499310|P7|STARTED|Treatment Phase: Second Intervention||7
5080033|NCT01746901|12499311|P6|STARTED|Treatment Phase: Second Intervention||7
5080034|NCT01746901|12499312|P5|STARTED|Treatment Phase: Second Intervention||6
5080035|NCT01746901|12499313|P4|STARTED|Treatment Phase: Second Intervention||6
5080036|NCT01746901|12499314|P3|STARTED|Treatment Phase: Second Intervention||0
5080037|NCT01746901|12499315|P2|STARTED|Treatment Phase: Second Intervention||0
5080038|NCT01746901|12499316|P1|STARTED|Treatment Phase: Second Intervention||0
5080039|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080040|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080041|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080042|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080043|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080044|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080045|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080046|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080047|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
5080048|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: Washout Period 1||7
5080049|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: Washout Period 1||7
5080050|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: Washout Period 1||7
5080051|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: Washout Period 1||7
5080052|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: Washout Period 1||6
5080053|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: Washout Period 1||6
5080054|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: Washout Period 1||0
5080055|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: Washout Period 1||0
5080056|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: Washout Period 1||0
5080057|NCT01746901|12499308|P9|STARTED|Treatment Phase: Washout Period 1||7
5080058|NCT01746901|12499309|P8|STARTED|Treatment Phase: Washout Period 1||7
5080059|NCT01746901|12499310|P7|STARTED|Treatment Phase: Washout Period 1||7
5080060|NCT01746901|12499311|P6|STARTED|Treatment Phase: Washout Period 1||7
5080061|NCT01746901|12499312|P5|STARTED|Treatment Phase: Washout Period 1||6
5080062|NCT01746901|12499313|P4|STARTED|Treatment Phase: Washout Period 1||6
5080063|NCT01746901|12499314|P3|STARTED|Treatment Phase: Washout Period 1||0
5080064|NCT01746901|12499315|P2|STARTED|Treatment Phase: Washout Period 1||0
5080065|NCT01746901|12499316|P1|STARTED|Treatment Phase: Washout Period 1||0
5080066|NCT01746901|12499308|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
5080067|NCT01746901|12499309|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
5080068|NCT01746901|12499310|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
5080069|NCT01746901|12499311|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
5080070|NCT01746901|12499312|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
5080071|NCT01746901|12499313|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
5080072|NCT01746901|12499314|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
5080073|NCT01746901|12499315|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
5080074|NCT01746901|12499316|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
5080075|NCT01746901|12499308|P9|COMPLETED|Treatment Phase: First Intervention||7
5080076|NCT01746901|12499309|P8|COMPLETED|Treatment Phase: First Intervention||7
5080077|NCT01746901|12499310|P7|COMPLETED|Treatment Phase: First Intervention||7
5080078|NCT01746901|12499311|P6|COMPLETED|Treatment Phase: First Intervention||7
5080079|NCT01746901|12499312|P5|COMPLETED|Treatment Phase: First Intervention||6
5080080|NCT01746901|12499313|P4|COMPLETED|Treatment Phase: First Intervention||6
5080081|NCT01746901|12499314|P3|COMPLETED|Treatment Phase: First Intervention||0
5080082|NCT01746901|12499315|P2|COMPLETED|Treatment Phase: First Intervention||0
5080083|NCT01746901|12499316|P1|COMPLETED|Treatment Phase: First Intervention||0
5080084|NCT01746901|12499308|P9|STARTED|Treatment Phase: First Intervention||7
5080085|NCT01746901|12499309|P8|STARTED|Treatment Phase: First Intervention||7
5080086|NCT01746901|12499310|P7|STARTED|Treatment Phase: First Intervention||8
5080087|NCT01746901|12499311|P6|STARTED|Treatment Phase: First Intervention||7
5080088|NCT01746901|12499312|P5|STARTED|Treatment Phase: First Intervention||6
5080089|NCT01746901|12499313|P4|STARTED|Treatment Phase: First Intervention||6
5080090|NCT01746901|12499314|P3|STARTED|Treatment Phase: First Intervention||0
5080091|NCT01746901|12499315|P2|STARTED|Treatment Phase: First Intervention||0
5080092|NCT01746901|12499316|P1|STARTED|Treatment Phase: First Intervention||0
5080093|NCT01746901|12499308|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080094|NCT01746901|12499309|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080095|NCT01746901|12499310|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080096|NCT01746901|12499311|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080097|NCT01746901|12499312|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080098|NCT01746901|12499313|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080099|NCT01746901|12499314|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
5080100|NCT01746901|12499315|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
5080101|NCT01746901|12499316|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5080102|NCT01746901|12499308|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
5080103|NCT01746901|12499309|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
5080104|NCT01746901|12499310|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
5080105|NCT01746901|12499311|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
5080106|NCT01746901|12499312|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
5080107|NCT01746901|12499313|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
5080108|NCT01746901|12499314|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
5080109|NCT01746901|12499315|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
5080110|NCT01746901|12499316|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
5080111|NCT01746901|12499308|P9|STARTED|Drug Discrimination Phase: Day 2||0
5080112|NCT01746901|12499309|P8|STARTED|Drug Discrimination Phase: Day 2||0
5080113|NCT01746901|12499310|P7|STARTED|Drug Discrimination Phase: Day 2||0
5080114|NCT01746901|12499311|P6|STARTED|Drug Discrimination Phase: Day 2||0
5080115|NCT01746901|12499312|P5|STARTED|Drug Discrimination Phase: Day 2||0
5080116|NCT01746901|12499313|P4|STARTED|Drug Discrimination Phase: Day 2||0
5080117|NCT01746901|12499314|P3|STARTED|Drug Discrimination Phase: Day 2||36
5080118|NCT01746901|12499315|P2|STARTED|Drug Discrimination Phase: Day 2||33
5080119|NCT01746901|12499316|P1|STARTED|Drug Discrimination Phase: Day 2||0
5080120|NCT01746901|12499308|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080121|NCT01746901|12499309|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080122|NCT01746901|12499310|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080123|NCT01746901|12499311|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080213|NCT01746732|12499705|P2|STARTED|Period 2||10
5080124|NCT01746901|12499312|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080125|NCT01746901|12499313|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080126|NCT01746901|12499314|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080127|NCT01746901|12499315|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
5080128|NCT01746901|12499316|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5080129|NCT01746901|12499308|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
5080130|NCT01746901|12499309|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
5080131|NCT01746901|12499310|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
5080132|NCT01746901|12499311|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
5080133|NCT01746901|12499312|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
5080134|NCT01746901|12499313|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
5080135|NCT01746901|12499314|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
5080136|NCT01746901|12499315|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
5080137|NCT01746901|12499316|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
5080138|NCT01746901|12499308|P9|STARTED|Drug Discrimination Phase: Day 1||0
5080139|NCT01746901|12499309|P8|STARTED|Drug Discrimination Phase: Day 1||0
5080140|NCT01746901|12499310|P7|STARTED|Drug Discrimination Phase: Day 1||0
5080141|NCT01746901|12499311|P6|STARTED|Drug Discrimination Phase: Day 1||0
5080142|NCT01746901|12499312|P5|STARTED|Drug Discrimination Phase: Day 1||0
5080143|NCT01746901|12499313|P4|STARTED|Drug Discrimination Phase: Day 1||0
5080144|NCT01746901|12499314|P3|STARTED|Drug Discrimination Phase: Day 1||36
5080145|NCT01746901|12499315|P2|STARTED|Drug Discrimination Phase: Day 1||36
5080146|NCT01746901|12499316|P1|STARTED|Drug Discrimination Phase: Day 1||0
5080147|NCT01746901|12499308|P9|NOT COMPLETED|Naloxone Challenge Phase||0
5080148|NCT01746901|12499309|P8|NOT COMPLETED|Naloxone Challenge Phase||0
5080149|NCT01746901|12499310|P7|NOT COMPLETED|Naloxone Challenge Phase||0
5080150|NCT01746901|12499311|P6|NOT COMPLETED|Naloxone Challenge Phase||0
5080151|NCT01746901|12499312|P5|NOT COMPLETED|Naloxone Challenge Phase||0
5080152|NCT01746901|12499313|P4|NOT COMPLETED|Naloxone Challenge Phase||0
5080153|NCT01746901|12499314|P3|NOT COMPLETED|Naloxone Challenge Phase||0
5080154|NCT01746901|12499315|P2|NOT COMPLETED|Naloxone Challenge Phase||0
5080155|NCT01746901|12499316|P1|NOT COMPLETED|Naloxone Challenge Phase||3
5080156|NCT01746901|12499308|P9|COMPLETED|Naloxone Challenge Phase||0
5080157|NCT01746901|12499309|P8|COMPLETED|Naloxone Challenge Phase||0
5080158|NCT01746901|12499310|P7|COMPLETED|Naloxone Challenge Phase||0
5080159|NCT01746901|12499311|P6|COMPLETED|Naloxone Challenge Phase||0
5080160|NCT01746901|12499312|P5|COMPLETED|Naloxone Challenge Phase||0
5080161|NCT01746901|12499313|P4|COMPLETED|Naloxone Challenge Phase||0
5080162|NCT01746901|12499314|P3|COMPLETED|Naloxone Challenge Phase||0
5080163|NCT01746901|12499315|P2|COMPLETED|Naloxone Challenge Phase||0
5080164|NCT01746901|12499316|P1|COMPLETED|Naloxone Challenge Phase||72
5080165|NCT01746901|12499308|P9|STARTED|Naloxone Challenge Phase||0
5080166|NCT01746901|12499309|P8|STARTED|Naloxone Challenge Phase||0
5080167|NCT01746901|12499310|P7|STARTED|Naloxone Challenge Phase||0
5080168|NCT01746901|12499311|P6|STARTED|Naloxone Challenge Phase||0
5080169|NCT01746901|12499312|P5|STARTED|Naloxone Challenge Phase||0
5080170|NCT01746901|12499313|P4|STARTED|Naloxone Challenge Phase||0
5080171|NCT01746901|12499314|P3|STARTED|Naloxone Challenge Phase||0
5080172|NCT01746901|12499315|P2|STARTED|Naloxone Challenge Phase||0
5080173|NCT01746901|12499316|P1|STARTED|Naloxone Challenge Phase||75
5080174|NCT01746862|12499639|P2|NOT COMPLETED|Overall Study||3
5080175|NCT01746862|12499640|P1|NOT COMPLETED|Overall Study||8
5080176|NCT01746862|12499639|P2|COMPLETED|Overall Study||27
5080177|NCT01746862|12499640|P1|COMPLETED|Overall Study||52
5080178|NCT01746862|12499639|P2|Treated|Overall Study||30
5080179|NCT01746862|12499640|P1|Treated|Overall Study||59
5080180|NCT01746862|12499639|P2|STARTED|Overall Study||30
5080181|NCT01746862|12499640|P1|STARTED|Overall Study||60
5080182|NCT01746784|12499665|P5|NOT COMPLETED|Overall Study||0
5080183|NCT01746784|12499666|P4|NOT COMPLETED|Overall Study||0
5080184|NCT01746784|12499667|P3|NOT COMPLETED|Overall Study||0
5080185|NCT01746784|12499668|P2|NOT COMPLETED|Overall Study||0
5080186|NCT01746784|12499669|P1|NOT COMPLETED|Overall Study||0
5080187|NCT01746784|12499665|P5|COMPLETED|Overall Study||19
5080188|NCT01746784|12499666|P4|COMPLETED|Overall Study||9
5080189|NCT01746784|12499667|P3|COMPLETED|Overall Study||9
5080190|NCT01746784|12499668|P2|COMPLETED|Overall Study||10
5080191|NCT01746784|12499669|P1|COMPLETED|Overall Study||19
5080192|NCT01746784|12499665|P5|Enrolled|Overall Study||19
5080193|NCT01746784|12499666|P4|Enrolled|Overall Study||9
5080194|NCT01746784|12499667|P3|Enrolled|Overall Study||9
5080195|NCT01746784|12499668|P2|Enrolled|Overall Study||10
5080196|NCT01746784|12499669|P1|Enrolled|Overall Study||19
5080197|NCT01746784|12499665|P5|STARTED|Overall Study||19
5080198|NCT01746784|12499666|P4|STARTED|Overall Study||9
5080199|NCT01746784|12499667|P3|STARTED|Overall Study||9
5080200|NCT01746784|12499668|P2|STARTED|Overall Study||10
5080201|NCT01746784|12499669|P1|STARTED|Overall Study||19
5080202|NCT01746745|12499691|P1|NOT COMPLETED|Overall Study||0
5080203|NCT01746745|12499691|P1|COMPLETED|Overall Study||6
5080204|NCT01746745|12499691|P1|Received Study Drug|Overall Study||6
5080205|NCT01746745|12499691|P1|STARTED|Overall Study||6
5080206|NCT01746732|12499704|P3|NOT COMPLETED|Period 2||4
5080207|NCT01746732|12499705|P2|NOT COMPLETED|Period 2||0
5080208|NCT01746732|12499706|P1|NOT COMPLETED|Period 2||0
5080209|NCT01746732|12499704|P3|COMPLETED|Period 2||7
5080210|NCT01746732|12499705|P2|COMPLETED|Period 2||10
5080211|NCT01746732|12499706|P1|COMPLETED|Period 2||0
5080212|NCT01746732|12499704|P3|STARTED|Period 2||11
5080214|NCT01746732|12499706|P1|STARTED|Period 2||0
5080215|NCT01746732|12499704|P3|NOT COMPLETED|Period 1||0
5080216|NCT01746732|12499705|P2|NOT COMPLETED|Period 1||1
5080217|NCT01746732|12499706|P1|NOT COMPLETED|Period 1||0
5080218|NCT01746732|12499704|P3|COMPLETED|Period 1||11
5080219|NCT01746732|12499705|P2|COMPLETED|Period 1||10
5080220|NCT01746732|12499706|P1|COMPLETED|Period 1||0
5080221|NCT01746732|12499704|P3|STARTED|Period 1||11
5080222|NCT01746732|12499705|P2|STARTED|Period 1||11
5080223|NCT01746732|12499706|P1|STARTED|Period 1||0
5080224|NCT01746732|12499704|P3|NOT COMPLETED|Lead-In Period||0
5080225|NCT01746732|12499705|P2|NOT COMPLETED|Lead-In Period||0
5080226|NCT01746732|12499706|P1|NOT COMPLETED|Lead-In Period||1
5080227|NCT01746732|12499704|P3|COMPLETED|Lead-In Period||0
5080228|NCT01746732|12499705|P2|COMPLETED|Lead-In Period||0
5080229|NCT01746732|12499706|P1|COMPLETED|Lead-In Period||22
5080230|NCT01746732|12499704|P3|Participants Received at Least 1 Dose|Lead-In Period||0
5080231|NCT01746732|12499705|P2|Participants Received at Least 1 Dose|Lead-In Period||0
5080232|NCT01746732|12499706|P1|Participants Received at Least 1 Dose|Lead-In Period||22
5080233|NCT01746732|12499704|P3|STARTED|Lead-In Period||0
5080234|NCT01746732|12499705|P2|STARTED|Lead-In Period||0
5080235|NCT01746732|12499706|P1|STARTED|Lead-In Period||23
5080236|NCT01746511|12499729|P2|NOT COMPLETED|Overall Study||0
5080237|NCT01746511|12499730|P1|NOT COMPLETED|Overall Study||0
5080238|NCT01746511|12499729|P2|COMPLETED|Overall Study||39
5080239|NCT01746511|12499730|P1|COMPLETED|Overall Study||40
5080240|NCT01746511|12499729|P2|STARTED|Overall Study||39
5080241|NCT01746511|12499730|P1|STARTED|Overall Study||40
5080242|NCT01746420|12499749|P5|NOT COMPLETED|Overall Study||0
5080243|NCT01746420|12499750|P4|NOT COMPLETED|Overall Study||0
5080244|NCT01746420|12499751|P3|NOT COMPLETED|Overall Study||3
5080245|NCT01746420|12499752|P2|NOT COMPLETED|Overall Study||2
5080246|NCT01746420|12499753|P1|NOT COMPLETED|Overall Study||3
5080247|NCT01746420|12499749|P5|COMPLETED|Overall Study||20
5080248|NCT01746420|12499750|P4|COMPLETED|Overall Study||20
5080249|NCT01746420|12499751|P3|COMPLETED|Overall Study||17
5080250|NCT01746420|12499752|P2|COMPLETED|Overall Study||18
5080251|NCT01746420|12499753|P1|COMPLETED|Overall Study||17
5080252|NCT01746420|12499749|P5|STARTED|Overall Study||20
5080253|NCT01746420|12499750|P4|STARTED|Overall Study||20
5080254|NCT01746420|12499751|P3|STARTED|Overall Study||20
5080255|NCT01746420|12499752|P2|STARTED|Overall Study||20
5080256|NCT01746420|12499753|P1|STARTED|Overall Study||20
5080257|NCT01746368|12499787|P2|NOT COMPLETED|Overall Study||1
5080258|NCT01746368|12499788|P1|NOT COMPLETED|Overall Study||2
5080259|NCT01746368|12499787|P2|COMPLETED|Overall Study||16
5080260|NCT01746368|12499788|P1|COMPLETED|Overall Study||31
5080261|NCT01746368|12499787|P2|Analyzed for Satisfaction|Overall Study||16
5080262|NCT01746368|12499788|P1|Analyzed for Satisfaction|Overall Study||30
5080263|NCT01746368|12499787|P2|Analyzed for AD Completion Rate|Overall Study||17
5080264|NCT01746368|12499788|P1|Analyzed for AD Completion Rate|Overall Study||32
5080265|NCT01746368|12499787|P2|Assessment Completed|Overall Study||16
5080266|NCT01746368|12499788|P1|Assessment Completed|Overall Study||31
5080267|NCT01746368|12499787|P2|Recieved Allocated Intervention|Overall Study||8
5080268|NCT01746368|12499788|P1|Recieved Allocated Intervention|Overall Study||31
5080269|NCT01746368|12499787|P2|STARTED|Overall Study||17
5080270|NCT01746368|12499788|P1|STARTED|Overall Study||33
5080271|NCT01746264|12499796|P1|NOT COMPLETED|Overall Study||0
5080272|NCT01746264|12499796|P1|COMPLETED|Overall Study||19
5080273|NCT01746264|12499796|P1|STARTED|Overall Study||19
5080274|NCT01746225|12499818|P3|NOT COMPLETED|Overall Study||43
5080275|NCT01746225|12499819|P2|NOT COMPLETED|Overall Study||46
5080276|NCT01746225|12499820|P1|NOT COMPLETED|Overall Study||40
5080277|NCT01746225|12499818|P3|COMPLETED|Overall Study||43
5080278|NCT01746225|12499819|P2|COMPLETED|Overall Study||40
5080279|NCT01746225|12499820|P1|COMPLETED|Overall Study||43
5080280|NCT01746225|12499818|P3|STARTED|Overall Study||86
5080281|NCT01746225|12499819|P2|STARTED|Overall Study||86
5080282|NCT01746225|12499820|P1|STARTED|Overall Study||83
5080283|NCT01746173|12499843|P1|NOT COMPLETED|Overall Study||2
5080284|NCT01746173|12499843|P1|COMPLETED|Overall Study||3
5080285|NCT01746173|12499843|P1|STARTED|Overall Study||5
5080286|NCT01746108|12499851|P3|NOT COMPLETED|Overall Study||0
5080287|NCT01746108|12499852|P2|NOT COMPLETED|Overall Study||4
5080288|NCT01746108|12499853|P1|NOT COMPLETED|Overall Study||0
5080289|NCT01746108|12499851|P3|COMPLETED|Overall Study||6
5080290|NCT01746108|12499852|P2|COMPLETED|Overall Study||24
5080291|NCT01746108|12499853|P1|COMPLETED|Overall Study||18
5080292|NCT01746108|12499851|P3|STARTED|Overall Study||6
5080293|NCT01746108|12499852|P2|STARTED|Overall Study||28
5080294|NCT01746108|12499853|P1|STARTED|Overall Study||18
5080295|NCT01746095|12499893|P4|NOT COMPLETED|Overall Study||8
5080296|NCT01746095|12499894|P3|NOT COMPLETED|Overall Study||13
5080297|NCT01746095|12499895|P2|NOT COMPLETED|Overall Study||4
5080298|NCT01746095|12499896|P1|NOT COMPLETED|Overall Study||4
5080299|NCT01746095|12499893|P4|COMPLETED|Overall Study||15
5080300|NCT01746095|12499894|P3|COMPLETED|Overall Study||11
5080301|NCT01746095|12499895|P2|COMPLETED|Overall Study||16
5080302|NCT01746095|12499896|P1|COMPLETED|Overall Study||16
5080303|NCT01746095|12499893|P4|STARTED|Overall Study||23
5080304|NCT01746095|12499894|P3|STARTED|Overall Study||24
5080305|NCT01746095|12499895|P2|STARTED|Overall Study||20
5080306|NCT01746095|12499896|P1|STARTED|Overall Study||20
5080307|NCT01746043|12499946|P4|NOT COMPLETED|Overall Study||0
5080308|NCT01746043|12499947|P3|NOT COMPLETED|Overall Study||0
5080309|NCT01746043|12499948|P2|NOT COMPLETED|Overall Study||0
5080310|NCT01746043|12499949|P1|NOT COMPLETED|Overall Study||0
5080311|NCT01746043|12499946|P4|COMPLETED|Overall Study||5
5080312|NCT01746043|12499947|P3|COMPLETED|Overall Study||5
5080313|NCT01746043|12499948|P2|COMPLETED|Overall Study||4
5080314|NCT01746043|12499949|P1|COMPLETED|Overall Study||5
5080315|NCT01746043|12499946|P4|STARTED|Overall Study||5
5080316|NCT01746043|12499947|P3|STARTED|Overall Study||5
5080317|NCT01746043|12499948|P2|STARTED|Overall Study||4
5080318|NCT01746043|12499949|P1|STARTED|Overall Study||5
5080319|NCT01746017|12499970|P11|NOT COMPLETED|Period 4||0
5080320|NCT01746017|12499971|P10|NOT COMPLETED|Period 4||0
5080321|NCT01746017|12499972|P9|NOT COMPLETED|Period 4||0
5080322|NCT01746017|12499973|P8|NOT COMPLETED|Period 4||0
5080323|NCT01746017|12499974|P7|NOT COMPLETED|Period 4||0
5080324|NCT01746017|12499975|P6|NOT COMPLETED|Period 4||0
5080325|NCT01746017|12499976|P5|NOT COMPLETED|Period 4||0
5080326|NCT01746017|12499977|P4|NOT COMPLETED|Period 4||0
5080327|NCT01746017|12499978|P3|NOT COMPLETED|Period 4||0
5080328|NCT01746017|12499979|P2|NOT COMPLETED|Period 4||0
5080329|NCT01746017|12499980|P1|NOT COMPLETED|Period 4||0
5080330|NCT01746017|12499970|P11|COMPLETED|Period 4||0
5080331|NCT01746017|12499971|P10|COMPLETED|Period 4||0
5080332|NCT01746017|12499972|P9|COMPLETED|Period 4||0
5080333|NCT01746017|12499973|P8|COMPLETED|Period 4||2
5080334|NCT01746017|12499974|P7|COMPLETED|Period 4||2
5080335|NCT01746017|12499975|P6|COMPLETED|Period 4||1
5080336|NCT01746017|12499976|P5|COMPLETED|Period 4||2
5080337|NCT01746017|12499977|P4|COMPLETED|Period 4||2
5080338|NCT01746017|12499978|P3|COMPLETED|Period 4||2
5080339|NCT01746017|12499979|P2|COMPLETED|Period 4||2
5080340|NCT01746017|12499980|P1|COMPLETED|Period 4||2
5080341|NCT01746017|12499970|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
5080342|NCT01746017|12499971|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
5080343|NCT01746017|12499972|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
5080344|NCT01746017|12499973|P8|STARTED|Period 4||2
5080345|NCT01746017|12499974|P7|STARTED|Period 4||2
5080346|NCT01746017|12499975|P6|STARTED|Period 4||1
5080347|NCT01746017|12499976|P5|STARTED|Period 4||2
5080348|NCT01746017|12499977|P4|STARTED|Period 4||2
5080349|NCT01746017|12499978|P3|STARTED|Period 4||2
5080350|NCT01746017|12499979|P2|STARTED|Period 4||2
5080351|NCT01746017|12499980|P1|STARTED|Period 4||2
5080352|NCT01746017|12499970|P11|NOT COMPLETED|Period 3||0
5080353|NCT01746017|12499971|P10|NOT COMPLETED|Period 3||0
5080354|NCT01746017|12499972|P9|NOT COMPLETED|Period 3||0
5080355|NCT01746017|12499973|P8|NOT COMPLETED|Period 3||0
5080356|NCT01746017|12499974|P7|NOT COMPLETED|Period 3||0
5080357|NCT01746017|12499975|P6|NOT COMPLETED|Period 3||1
5080358|NCT01746017|12499976|P5|NOT COMPLETED|Period 3||0
5080359|NCT01746017|12499977|P4|NOT COMPLETED|Period 3||0
5080360|NCT01746017|12499978|P3|NOT COMPLETED|Period 3||0
5080361|NCT01746017|12499979|P2|NOT COMPLETED|Period 3||0
5080362|NCT01746017|12499980|P1|NOT COMPLETED|Period 3||0
5080363|NCT01746017|12499970|P11|COMPLETED|Period 3||3
5080364|NCT01746017|12499971|P10|COMPLETED|Period 3||3
5080365|NCT01746017|12499972|P9|COMPLETED|Period 3||3
5080366|NCT01746017|12499973|P8|COMPLETED|Period 3||2
5080367|NCT01746017|12499974|P7|COMPLETED|Period 3||2
5080368|NCT01746017|12499975|P6|COMPLETED|Period 3||1
5080369|NCT01746017|12499976|P5|COMPLETED|Period 3||2
5080370|NCT01746017|12499977|P4|COMPLETED|Period 3||2
5080371|NCT01746017|12499978|P3|COMPLETED|Period 3||2
5080372|NCT01746017|12499979|P2|COMPLETED|Period 3||2
5080373|NCT01746017|12499980|P1|COMPLETED|Period 3||2
5080374|NCT01746017|12499970|P11|STARTED|Period 3||3
5080375|NCT01746017|12499971|P10|STARTED|Period 3||3
5080376|NCT01746017|12499972|P9|STARTED|Period 3||3
5080377|NCT01746017|12499973|P8|STARTED|Period 3||2
5080378|NCT01746017|12499974|P7|STARTED|Period 3||2
5080379|NCT01746017|12499975|P6|STARTED|Period 3||2
5080380|NCT01746017|12499976|P5|STARTED|Period 3||2
5080381|NCT01746017|12499977|P4|STARTED|Period 3||2
5080382|NCT01746017|12499978|P3|STARTED|Period 3||2
5080383|NCT01746017|12499979|P2|STARTED|Period 3||2
5080384|NCT01746017|12499980|P1|STARTED|Period 3||2
5080385|NCT01746017|12499970|P11|NOT COMPLETED|Period 2||0
5080386|NCT01746017|12499971|P10|NOT COMPLETED|Period 2||0
5080387|NCT01746017|12499972|P9|NOT COMPLETED|Period 2||0
5080388|NCT01746017|12499973|P8|NOT COMPLETED|Period 2||0
5080389|NCT01746017|12499974|P7|NOT COMPLETED|Period 2||0
5080390|NCT01746017|12499975|P6|NOT COMPLETED|Period 2||0
5080391|NCT01746017|12499976|P5|NOT COMPLETED|Period 2||0
5080392|NCT01746017|12499977|P4|NOT COMPLETED|Period 2||0
5080393|NCT01746017|12499978|P3|NOT COMPLETED|Period 2||0
5080394|NCT01746017|12499979|P2|NOT COMPLETED|Period 2||0
5080395|NCT01746017|12499980|P1|NOT COMPLETED|Period 2||0
5080396|NCT01746017|12499970|P11|COMPLETED|Period 2||3
5080397|NCT01746017|12499971|P10|COMPLETED|Period 2||3
5080398|NCT01746017|12499972|P9|COMPLETED|Period 2||3
5080399|NCT01746017|12499973|P8|COMPLETED|Period 2||2
5080400|NCT01746017|12499974|P7|COMPLETED|Period 2||2
5080401|NCT01746017|12499975|P6|COMPLETED|Period 2||2
5080402|NCT01746017|12499976|P5|COMPLETED|Period 2||2
5080403|NCT01746017|12499977|P4|COMPLETED|Period 2||2
5080404|NCT01746017|12499978|P3|COMPLETED|Period 2||2
5080405|NCT01746017|12499979|P2|COMPLETED|Period 2||2
5080406|NCT01746017|12499980|P1|COMPLETED|Period 2||2
5080407|NCT01746017|12499970|P11|STARTED|Period 2||3
5080408|NCT01746017|12499971|P10|STARTED|Period 2||3
5080409|NCT01746017|12499972|P9|STARTED|Period 2||3
5080410|NCT01746017|12499973|P8|STARTED|Period 2||2
5080411|NCT01746017|12499974|P7|STARTED|Period 2||2
5080412|NCT01746017|12499975|P6|STARTED|Period 2||2
5080413|NCT01746017|12499976|P5|STARTED|Period 2||2
5080414|NCT01746017|12499977|P4|STARTED|Period 2||2
5080415|NCT01746017|12499978|P3|STARTED|Period 2||2
5080416|NCT01746017|12499979|P2|STARTED|Period 2||2
5080417|NCT01746017|12499980|P1|STARTED|Period 2||2
5080418|NCT01746017|12499970|P11|NOT COMPLETED|Period 1||0
5080419|NCT01746017|12499971|P10|NOT COMPLETED|Period 1||0
5080420|NCT01746017|12499972|P9|NOT COMPLETED|Period 1||0
5080421|NCT01746017|12499973|P8|NOT COMPLETED|Period 1||0
5080422|NCT01746017|12499974|P7|NOT COMPLETED|Period 1||1
5080423|NCT01746017|12499975|P6|NOT COMPLETED|Period 1||0
5080424|NCT01746017|12499976|P5|NOT COMPLETED|Period 1||0
5080425|NCT01746017|12499977|P4|NOT COMPLETED|Period 1||0
5080426|NCT01746017|12499978|P3|NOT COMPLETED|Period 1||0
5080427|NCT01746017|12499979|P2|NOT COMPLETED|Period 1||0
5080428|NCT01746017|12499980|P1|NOT COMPLETED|Period 1||0
5080429|NCT01746017|12499970|P11|COMPLETED|Period 1||3
5080430|NCT01746017|12499971|P10|COMPLETED|Period 1||3
5080431|NCT01746017|12499972|P9|COMPLETED|Period 1||3
5080432|NCT01746017|12499973|P8|COMPLETED|Period 1||2
5080433|NCT01746017|12499974|P7|COMPLETED|Period 1||2
5080434|NCT01746017|12499975|P6|COMPLETED|Period 1||2
5080435|NCT01746017|12499976|P5|COMPLETED|Period 1||2
5080436|NCT01746017|12499977|P4|COMPLETED|Period 1||2
5080437|NCT01746017|12499978|P3|COMPLETED|Period 1||2
5080438|NCT01746017|12499979|P2|COMPLETED|Period 1||2
5080439|NCT01746017|12499980|P1|COMPLETED|Period 1||2
5080440|NCT01746017|12499970|P11|Received at Least 1 Dose of Study Drug|Period 1||3
5080441|NCT01746017|12499971|P10|Received at Least 1 Dose of Study Drug|Period 1||3
5080442|NCT01746017|12499972|P9|Received at Least 1 Dose of Study Drug|Period 1||3
5080443|NCT01746017|12499973|P8|Received at Least 1 Dose of Study Drug|Period 1||2
5080444|NCT01746017|12499974|P7|Received at Least 1 Dose of Study Drug|Period 1||3
5080445|NCT01746017|12499975|P6|Received at Least 1 Dose of Study Drug|Period 1||2
5080446|NCT01746017|12499976|P5|Received at Least 1 Dose of Study Drug|Period 1||2
5080447|NCT01746017|12499977|P4|Received at Least 1 Dose of Study Drug|Period 1||2
5080448|NCT01746017|12499978|P3|Received at Least 1 Dose of Study Drug|Period 1||2
5080449|NCT01746017|12499979|P2|Received at Least 1 Dose of Study Drug|Period 1||2
5080450|NCT01746017|12499980|P1|Received at Least 1 Dose of Study Drug|Period 1||2
5080451|NCT01746017|12499970|P11|STARTED|Period 1||3
5080452|NCT01746017|12499971|P10|STARTED|Period 1||3
5080453|NCT01746017|12499972|P9|STARTED|Period 1||3
5080454|NCT01746017|12499973|P8|STARTED|Period 1||2
5080455|NCT01746017|12499974|P7|STARTED|Period 1||3
5080456|NCT01746017|12499975|P6|STARTED|Period 1||2
5080457|NCT01746017|12499976|P5|STARTED|Period 1||2
5080458|NCT01746017|12499977|P4|STARTED|Period 1||2
5080459|NCT01746017|12499978|P3|STARTED|Period 1||2
5080460|NCT01746017|12499979|P2|STARTED|Period 1||2
5080461|NCT01746017|12499980|P1|STARTED|Period 1||2
5080462|NCT01745952|12500056|P3|NOT COMPLETED|Overall Study||0
5080463|NCT01745952|12500057|P2|NOT COMPLETED|Overall Study||1
5080464|NCT01745952|12500058|P1|NOT COMPLETED|Overall Study||1
5080465|NCT01745952|12500056|P3|COMPLETED|Overall Study||3
5080466|NCT01745952|12500057|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
5080467|NCT01745952|12500058|P1|COMPLETED|Overall Study||3
5080468|NCT01745952|12500056|P3|STARTED|Overall Study||3
5080469|NCT01745952|12500057|P2|STARTED|Overall Study||4
5080470|NCT01745952|12500058|P1|STARTED|Overall Study||4
5080471|NCT01745913|12500084|P2|NOT COMPLETED|Overall Study||1
5080472|NCT01745913|12500085|P1|NOT COMPLETED|Overall Study||1
5080473|NCT01745913|12500084|P2|COMPLETED|Overall Study||0
5080474|NCT01745913|12500085|P1|COMPLETED|Overall Study||0
5080475|NCT01745913|12500084|P2|STARTED|Overall Study||1
5080476|NCT01745913|12500085|P1|STARTED|Overall Study||1
5080477|NCT01745848|12500101|P1|NOT COMPLETED|Overall Study||6
5080478|NCT01745848|12500101|P1|COMPLETED|Overall Study||20
5080479|NCT01745848|12500101|P1|STARTED|Overall Study||26
5080480|NCT01745393|12500108|P2|NOT COMPLETED|12-month Follow-up||5
5080481|NCT01745393|12500109|P1|NOT COMPLETED|12-month Follow-up||6
5080482|NCT01745393|12500108|P2|COMPLETED|12-month Follow-up||151
5080483|NCT01745393|12500109|P1|COMPLETED|12-month Follow-up||136
5080484|NCT01745393|12500108|P2|STARTED|12-month Follow-up||156
5080485|NCT01745393|12500109|P1|STARTED|12-month Follow-up||142
5080486|NCT01745393|12500108|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
5080487|NCT01745393|12500109|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
5080488|NCT01745393|12500108|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
5080489|NCT01745393|12500109|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
5080490|NCT01745393|12500108|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
5080491|NCT01745393|12500109|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
5080492|NCT01745393|12500108|P2|STARTED|Treatment to End-of-treatment Assessment||164
5080493|NCT01745393|12500109|P1|STARTED|Treatment to End-of-treatment Assessment||163
5080494|NCT01745380|12500121|P2|NOT COMPLETED|Overall Study||1
5080495|NCT01745380|12500122|P1|NOT COMPLETED|Overall Study||1
5080496|NCT01745380|12500121|P2|COMPLETED|Overall Study||49
5080497|NCT01745380|12500122|P1|COMPLETED|Overall Study||99
5080498|NCT01745380|12500121|P2|STARTED|Overall Study||50
5080499|NCT01745380|12500122|P1|STARTED|Overall Study||100
5080500|NCT01745146|12500160|P2|NOT COMPLETED|Overall Study||3
5080501|NCT01745146|12500161|P1|NOT COMPLETED|Overall Study||3
5080502|NCT01745146|12500160|P2|COMPLETED|Overall Study||57
5080503|NCT01745146|12500161|P1|COMPLETED|Overall Study||27
5080504|NCT01745146|12500160|P2|Analysis|Overall Study||57
5080505|NCT01745146|12500161|P1|Analysis|Overall Study||27
5080506|NCT01745146|12500160|P2|Primary Outcome Assessment|Overall Study||57
5080507|NCT01745146|12500161|P1|Primary Outcome Assessment|Overall Study||27
5080508|NCT01745146|12500160|P2|Allocation to Intervention|Overall Study||60
5080509|NCT01745146|12500161|P1|Allocation to Intervention|Overall Study||30
5080510|NCT01745146|12500160|P2|STARTED|Overall Study||60
5080511|NCT01745146|12500161|P1|STARTED|Overall Study||30
5080512|NCT01745133|12500171|P3|NOT COMPLETED|Overall Study||4
5080513|NCT01745133|12500172|P2|NOT COMPLETED|Overall Study||4
5080514|NCT01745133|12500173|P1|NOT COMPLETED|Overall Study||6
5080515|NCT01745133|12500171|P3|COMPLETED|Overall Study||15
5080516|NCT01745133|12500172|P2|COMPLETED|Overall Study||16
5080517|NCT01745133|12500173|P1|COMPLETED|Overall Study||13
5080518|NCT01745133|12500171|P3|STARTED|Overall Study||19
5080519|NCT01745133|12500172|P2|STARTED|Overall Study||20
5080520|NCT01745133|12500173|P1|STARTED|Overall Study||19
5080521|NCT01745120|12500183|P2|NOT COMPLETED|Overall Study||0
5080522|NCT01745120|12500184|P1|NOT COMPLETED|Overall Study||1
5080523|NCT01745120|12500183|P2|COMPLETED|Overall Study||8
5080524|NCT01745120|12500184|P1|COMPLETED|Overall Study||10
5080525|NCT01745120|12500183|P2|STARTED|Overall Study||8
5080526|NCT01745120|12500184|P1|STARTED|Overall Study||11
5080527|NCT01745094|12500242|P4|NOT COMPLETED|Overall Study||3
5080528|NCT01745094|12500243|P3|NOT COMPLETED|Overall Study||12
5080529|NCT01745094|12500244|P2|NOT COMPLETED|Overall Study||0
5080530|NCT01745094|12500245|P1|NOT COMPLETED|Overall Study||5
5080531|NCT01745094|12500242|P4|COMPLETED|Overall Study||90
5080532|NCT01745094|12500243|P3|COMPLETED|Overall Study||46
5080533|NCT01745094|12500244|P2|COMPLETED|Overall Study||37
5080534|NCT01745094|12500245|P1|COMPLETED|Overall Study||30
5080535|NCT01745094|12500242|P4|STARTED|Overall Study||93
5080536|NCT01745094|12500243|P3|STARTED|Overall Study||58
5080537|NCT01745094|12500244|P2|STARTED|Overall Study||37
5080538|NCT01745094|12500245|P1|STARTED|Overall Study||35
5080539|NCT01745055|12500311|P1|NOT COMPLETED|Overall Study||0
5080540|NCT01745055|12500311|P1|COMPLETED|Overall Study||12
5080541|NCT01745055|12500311|P1|STARTED|Overall Study||12
5080542|NCT01744977|12500346|P2|NOT COMPLETED|Overall Study||5
5080543|NCT01744977|12500347|P1|NOT COMPLETED|Overall Study||11
5080544|NCT01744977|12500346|P2|COMPLETED|Overall Study||115
5080545|NCT01744977|12500347|P1|COMPLETED|Overall Study||109
5080546|NCT01744977|12500346|P2|6 Month Completed|Overall Study||115
5080547|NCT01744977|12500347|P1|6 Month Completed|Overall Study||113
5080548|NCT01744977|12500346|P2|STARTED|Overall Study||120
5080549|NCT01744977|12500347|P1|STARTED|Overall Study||120
5080550|NCT01744860|12500355|P1|NOT COMPLETED|Overall Study||0
5080551|NCT01744860|12500355|P1|COMPLETED|Overall Study||420
5080552|NCT01744860|12500355|P1|STARTED|Overall Study||420
5080553|NCT01744821|12500393|P4|NOT COMPLETED|Overall Study||0
5080554|NCT01744821|12500394|P3|NOT COMPLETED|Overall Study||0
5080555|NCT01744821|12500395|P2|NOT COMPLETED|Overall Study||0
5080556|NCT01744821|12500396|P1|NOT COMPLETED|Overall Study||0
5080557|NCT01744821|12500393|P4|COMPLETED|Overall Study||1
5080558|NCT01744821|12500394|P3|COMPLETED|Overall Study||2
5080559|NCT01744821|12500395|P2|COMPLETED|Overall Study||3
5080560|NCT01744821|12500396|P1|COMPLETED|Overall Study||1
5080561|NCT01744821|12500393|P4|STARTED|Overall Study||1
5080562|NCT01744821|12500394|P3|STARTED|Overall Study||2
5080563|NCT01744821|12500395|P2|STARTED|Overall Study||3
5080564|NCT01744821|12500396|P1|STARTED|Overall Study||1
5080565|NCT01744782|12500418|P1|NOT COMPLETED|Overall Study||1
5080566|NCT01744782|12500418|P1|COMPLETED|Overall Study||16
5080567|NCT01744782|12500418|P1|STARTED|Overall Study||17
5080568|NCT01744730|12500431|P5|NOT COMPLETED|Overall Study||0
5080569|NCT01744730|12500432|P4|NOT COMPLETED|Overall Study||0
5080570|NCT01744730|12500433|P3|NOT COMPLETED|Overall Study||0
5080571|NCT01744730|12500434|P2|NOT COMPLETED|Overall Study||0
5080572|NCT01744730|12500435|P1|NOT COMPLETED|Overall Study||0
5080573|NCT01744730|12500431|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
5080574|NCT01744730|12500432|P4|COMPLETED|Overall Study||11
5080575|NCT01744730|12500433|P3|COMPLETED|Overall Study||4
5080576|NCT01744730|12500434|P2|COMPLETED|Overall Study||3
5080577|NCT01744730|12500435|P1|COMPLETED|Overall Study||4
5080578|NCT01744730|12500431|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
5080579|NCT01744730|12500432|P4|STARTED|Overall Study||11
5080580|NCT01744730|12500433|P3|STARTED|Overall Study||4
5080581|NCT01744730|12500434|P2|STARTED|Overall Study||3
5080582|NCT01744730|12500435|P1|STARTED|Overall Study||4
5080583|NCT01744704|12500489|P12|NOT COMPLETED|Overall Study||0
5080584|NCT01744704|12500490|P11|NOT COMPLETED|Overall Study||0
5080585|NCT01744704|12500491|P10|NOT COMPLETED|Overall Study||0
5080586|NCT01744704|12500492|P9|NOT COMPLETED|Overall Study||0
5080587|NCT01744704|12500493|P8|NOT COMPLETED|Overall Study||0
5080588|NCT01744704|12500494|P7|NOT COMPLETED|Overall Study||0
5080589|NCT01744704|12500495|P6|NOT COMPLETED|Overall Study||0
5080590|NCT01744704|12500496|P5|NOT COMPLETED|Overall Study||0
5080591|NCT01744704|12500497|P4|NOT COMPLETED|Overall Study||0
5080592|NCT01744704|12500498|P3|NOT COMPLETED|Overall Study||0
5080593|NCT01744704|12500499|P2|NOT COMPLETED|Overall Study||0
5080594|NCT01744704|12500500|P1|NOT COMPLETED|Overall Study||0
5080595|NCT01744704|12500489|P12|COMPLETED|Overall Study||10
5080596|NCT01744704|12500490|P11|COMPLETED|Overall Study||9
5080597|NCT01744704|12500491|P10|COMPLETED|Overall Study||9
5080598|NCT01744704|12500492|P9|COMPLETED|Overall Study||3
5080599|NCT01744704|12500493|P8|COMPLETED|Overall Study||9
5080600|NCT01744704|12500494|P7|COMPLETED|Overall Study||6
5080601|NCT01744704|12500495|P6|COMPLETED|Overall Study||7
5080602|NCT01744704|12500496|P5|COMPLETED|Overall Study||6
5080603|NCT01744704|12500497|P4|COMPLETED|Overall Study||6
5080604|NCT01744704|12500498|P3|COMPLETED|Overall Study||3
5080605|NCT01744704|12500499|P2|COMPLETED|Overall Study||3
5080606|NCT01744704|12500500|P1|COMPLETED|Overall Study||3
5080607|NCT01744704|12500489|P12|STARTED|Overall Study||10
5080608|NCT01744704|12500490|P11|STARTED|Overall Study||9
5080609|NCT01744704|12500491|P10|STARTED|Overall Study||9
5080610|NCT01744704|12500492|P9|STARTED|Overall Study||3
5080611|NCT01744704|12500493|P8|STARTED|Overall Study||9
5080612|NCT01744704|12500494|P7|STARTED|Overall Study||6
5080613|NCT01744704|12500495|P6|STARTED|Overall Study||7
5080614|NCT01744704|12500496|P5|STARTED|Overall Study||6
5080615|NCT01744704|12500497|P4|STARTED|Overall Study||6
5080616|NCT01744704|12500498|P3|STARTED|Overall Study||3
5080617|NCT01744704|12500499|P2|STARTED|Overall Study||3
5080618|NCT01744704|12500500|P1|STARTED|Overall Study||3
5080619|NCT01744691|12500579|P1|NOT COMPLETED|Overall Study||43
5080620|NCT01744691|12500579|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
5080621|NCT01744691|12500579|P1|STARTED|Overall Study|Participants who received study treatment|144
5080622|NCT01744665|12500584|P1|NOT COMPLETED|Re-initiation Phase||13
5080623|NCT01744665|12500584|P1|COMPLETED|Re-initiation Phase||4
5080624|NCT01744665|12500584|P1|STARTED|Re-initiation Phase||17
5080625|NCT01744665|12500584|P1|NOT COMPLETED|Treatment Free Remission Phase||0
5080626|NCT01744665|12500584|P1|COMPLETED|Treatment Free Remission Phase||32
5080627|NCT01744665|12500584|P1|STARTED|Treatment Free Remission Phase||32
5080628|NCT01744665|12500584|P1|NOT COMPLETED|Consolidation Phase||19
5080629|NCT01744665|12500584|P1|COMPLETED|Consolidation Phase||22
5080630|NCT01744665|12500584|P1|STARTED|Consolidation Phase||41
5080631|NCT01744665|12500584|P1|NOT COMPLETED|Monitoring Phase||18
5080632|NCT01744665|12500584|P1|COMPLETED|Monitoring Phase||41
5080633|NCT01744665|12500584|P1|STARTED|Monitoring Phase||59
5080634|NCT01744574|12500615|P4|NOT COMPLETED|Overall Study||11
5080635|NCT01744574|12500616|P3|NOT COMPLETED|Overall Study||20
5080636|NCT01744574|12500617|P2|NOT COMPLETED|Overall Study||25
5080637|NCT01744574|12500618|P1|NOT COMPLETED|Overall Study||24
5080638|NCT01744574|12500615|P4|COMPLETED|Overall Study||40
5080639|NCT01744574|12500616|P3|COMPLETED|Overall Study||32
5080640|NCT01744574|12500617|P2|COMPLETED|Overall Study||31
5080641|NCT01744574|12500618|P1|COMPLETED|Overall Study||33
5080642|NCT01744574|12500615|P4|STARTED|Overall Study||51
5080643|NCT01744574|12500616|P3|STARTED|Overall Study||52
5080644|NCT01744574|12500617|P2|STARTED|Overall Study||56
5080645|NCT01744574|12500618|P1|STARTED|Overall Study||57
5080646|NCT01744496|12500654|P2|NOT COMPLETED|Maintenance Period||4
5080647|NCT01744496|12500655|P1|NOT COMPLETED|Maintenance Period||4
5080648|NCT01744496|12500654|P2|COMPLETED|Maintenance Period||29
5080649|NCT01744496|12500655|P1|COMPLETED|Maintenance Period||27
5080650|NCT01744496|12500654|P2|STARTED|Maintenance Period||33
5080651|NCT01744496|12500655|P1|STARTED|Maintenance Period||31
5080652|NCT01744496|12500654|P2|NOT COMPLETED|Titration Period||2
5080653|NCT01744496|12500655|P1|NOT COMPLETED|Titration Period||2
5080654|NCT01744496|12500654|P2|COMPLETED|Titration Period||33
5080655|NCT01744496|12500655|P1|COMPLETED|Titration Period||31
5080656|NCT01744496|12500654|P2|STARTED|Titration Period||35
5080657|NCT01744496|12500655|P1|STARTED|Titration Period||33
5080658|NCT01744483|12500676|P3|NOT COMPLETED|Overall Study||28
5080659|NCT01744483|12500677|P2|NOT COMPLETED|Overall Study||22
5080660|NCT01744483|12500678|P1|NOT COMPLETED|Overall Study||29
5080661|NCT01744483|12500676|P3|COMPLETED|Overall Study||10
5080662|NCT01744483|12500677|P2|COMPLETED|Overall Study||13
5080663|NCT01744483|12500678|P1|COMPLETED|Overall Study||15
5080664|NCT01744483|12500676|P3|STARTED|Overall Study||38
5080665|NCT01744483|12500677|P2|STARTED|Overall Study||35
5080666|NCT01744483|12500678|P1|STARTED|Overall Study||44
5080667|NCT01744392|12500686|P1|NOT COMPLETED|Overall Study||1
5080668|NCT01744392|12500686|P1|COMPLETED|Overall Study||22
5080669|NCT01744392|12500686|P1|STARTED|Overall Study||23
5080670|NCT01744353|12500702|P3|NOT COMPLETED|Overall Study||0
5080671|NCT01744353|12500703|P2|NOT COMPLETED|Overall Study||0
5080672|NCT01744353|12500704|P1|NOT COMPLETED|Overall Study||0
5080673|NCT01744353|12500702|P3|COMPLETED|Overall Study||3
5080674|NCT01744353|12500703|P2|COMPLETED|Overall Study||26
5080675|NCT01744353|12500704|P1|COMPLETED|Overall Study||6
5080676|NCT01744353|12500702|P3|STARTED|Overall Study||3
5080677|NCT01744353|12500703|P2|STARTED|Overall Study||26
5080678|NCT01744353|12500704|P1|STARTED|Overall Study||6
5080679|NCT01744340|12500715|P2|NOT COMPLETED|Overall Study||0
5080680|NCT01744340|12500716|P1|NOT COMPLETED|Overall Study||0
5080681|NCT01744340|12500715|P2|COMPLETED|Overall Study||15
5080682|NCT01744340|12500716|P1|COMPLETED|Overall Study||8
5080683|NCT01744340|12500715|P2|STARTED|Overall Study||15
5080684|NCT01744340|12500716|P1|STARTED|Overall Study||8
5080685|NCT01744197|12500726|P2|NOT COMPLETED|Overall Study||3
5080686|NCT01744197|12500727|P1|NOT COMPLETED|Overall Study||4
5080687|NCT01744197|12500726|P2|COMPLETED|Overall Study||26
5080688|NCT01744197|12500727|P1|COMPLETED|Overall Study||28
5080689|NCT01744197|12500726|P2|STARTED|Overall Study||29
5080690|NCT01744197|12500727|P1|STARTED|Overall Study||32
5080691|NCT01744093|12500739|P2|NOT COMPLETED|Overall Study||1
5080692|NCT01744093|12500740|P1|NOT COMPLETED|Overall Study||6
5080693|NCT01744093|12500739|P2|COMPLETED|Overall Study||8
5080694|NCT01744093|12500740|P1|COMPLETED|Overall Study||12
5080695|NCT01744093|12500739|P2|STARTED|Overall Study||9
5080696|NCT01744093|12500740|P1|STARTED|Overall Study||18
5080697|NCT01743963|12500750|P2|NOT COMPLETED|Overall Study||0
5080698|NCT01743963|12500751|P1|NOT COMPLETED|Overall Study||0
5080699|NCT01743963|12500750|P2|COMPLETED|Overall Study||17
5080700|NCT01743963|12500751|P1|COMPLETED|Overall Study||21
5080701|NCT01743963|12500750|P2|STARTED|Overall Study||17
5080702|NCT01743963|12500751|P1|STARTED|Overall Study||21
5080703|NCT01743859|12500757|P1|NOT COMPLETED|Overall Study||9
5080704|NCT01743859|12500757|P1|COMPLETED|Overall Study||28
5080705|NCT01743859|12500757|P1|STARTED|Overall Study||37
5080706|NCT01743729|12500769|P2|NOT COMPLETED|Overall Study||12
5080707|NCT01743729|12500770|P1|NOT COMPLETED|Overall Study||37
5080708|NCT01743729|12500769|P2|COMPLETED|Overall Study||348
5080709|NCT01743729|12500770|P1|COMPLETED|Overall Study||321
5080710|NCT01743729|12500769|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
5080711|NCT01743729|12500770|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
5080712|NCT01743560|12500778|P1|NOT COMPLETED|Overall Study||43
5080713|NCT01743560|12500778|P1|COMPLETED|Overall Study||9
5080714|NCT01743560|12500778|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
5080715|NCT01743560|12500778|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
5080716|NCT01743560|12500778|P1|STARTED|Overall Study||52
5080717|NCT01743521|12500805|P4|NOT COMPLETED|Overall Study||0
5080718|NCT01743521|12500806|P3|NOT COMPLETED|Overall Study||0
5080719|NCT01743521|12500807|P2|NOT COMPLETED|Overall Study||0
5080720|NCT01743521|12500808|P1|NOT COMPLETED|Overall Study||0
5080721|NCT01743521|12500805|P4|COMPLETED|Overall Study||2
5080722|NCT01743521|12500806|P3|COMPLETED|Overall Study||2
5080723|NCT01743521|12500807|P2|COMPLETED|Overall Study||3
5080724|NCT01743521|12500808|P1|COMPLETED|Overall Study||7
5080725|NCT01743521|12500805|P4|STARTED|Overall Study||2
5080726|NCT01743521|12500806|P3|STARTED|Overall Study||2
5080727|NCT01743521|12500807|P2|STARTED|Overall Study||3
5080728|NCT01743521|12500808|P1|STARTED|Overall Study||7
5080729|NCT01743469|12500862|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
5080730|NCT01743469|12500863|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
5080731|NCT01743469|12500864|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
5080732|NCT01743469|12500865|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
5080733|NCT01743469|12500862|P4|COMPLETED|Follow-up Period - Post-Treatment||5
5080734|NCT01743469|12500863|P3|COMPLETED|Follow-up Period - Post-Treatment||14
5080735|NCT01743469|12500864|P2|COMPLETED|Follow-up Period - Post-Treatment||5
5080736|NCT01743469|12500865|P1|COMPLETED|Follow-up Period - Post-Treatment||6
5080737|NCT01743469|12500862|P4|STARTED|Follow-up Period - Post-Treatment||21
5080738|NCT01743469|12500863|P3|STARTED|Follow-up Period - Post-Treatment||37
5080739|NCT01743469|12500864|P2|STARTED|Follow-up Period - Post-Treatment||53
5080740|NCT01743469|12500865|P1|STARTED|Follow-up Period - Post-Treatment||51
5080741|NCT01743469|12500862|P4|NOT COMPLETED|Active Treatment Phase||21
5080742|NCT01743469|12500863|P3|NOT COMPLETED|Active Treatment Phase||38
5080743|NCT01743469|12500864|P2|NOT COMPLETED|Active Treatment Phase||55
5080744|NCT01743469|12500865|P1|NOT COMPLETED|Active Treatment Phase||53
5080745|NCT01743469|12500862|P4|COMPLETED|Active Treatment Phase||0
5080746|NCT01743469|12500863|P3|COMPLETED|Active Treatment Phase||0
5080747|NCT01743469|12500864|P2|COMPLETED|Active Treatment Phase||0
5080748|NCT01743469|12500865|P1|COMPLETED|Active Treatment Phase||0
5080749|NCT01743469|12500862|P4|STARTED|Active Treatment Phase||21
5080750|NCT01743469|12500863|P3|STARTED|Active Treatment Phase||38
5080751|NCT01743469|12500864|P2|STARTED|Active Treatment Phase||55
5080752|NCT01743469|12500865|P1|STARTED|Active Treatment Phase||53
5080753|NCT01743131|12500907|P5|NOT COMPLETED|Overall Study||0
5080754|NCT01743131|12500908|P4|NOT COMPLETED|Overall Study||0
5080755|NCT01743131|12500909|P3|NOT COMPLETED|Overall Study||0
5080756|NCT01743131|12500910|P2|NOT COMPLETED|Overall Study||0
5080757|NCT01743131|12500911|P1|NOT COMPLETED|Overall Study||0
5080758|NCT01743131|12500907|P5|COMPLETED|Overall Study||127
5080759|NCT01743131|12500908|P4|COMPLETED|Overall Study||1
5080760|NCT01743131|12500909|P3|COMPLETED|Overall Study||43
5080761|NCT01743131|12500910|P2|COMPLETED|Overall Study||69
5080762|NCT01743131|12500911|P1|COMPLETED|Overall Study||73
5080763|NCT01743131|12500907|P5|Not Included in Analysis|Overall Study||0
5080764|NCT01743131|12500908|P4|Not Included in Analysis|Overall Study||1
5080765|NCT01743131|12500909|P3|Not Included in Analysis|Overall Study||0
5080766|NCT01743131|12500910|P2|Not Included in Analysis|Overall Study||0
5080767|NCT01743131|12500911|P1|Not Included in Analysis|Overall Study||0
5080768|NCT01743131|12500907|P5|STARTED|Overall Study||127
5080769|NCT01743131|12500908|P4|STARTED|Overall Study||1
5080770|NCT01743131|12500909|P3|STARTED|Overall Study||43
5080771|NCT01743131|12500910|P2|STARTED|Overall Study||69
5080772|NCT01743131|12500911|P1|STARTED|Overall Study||73
5080773|NCT01743092|12500930|P2|NOT COMPLETED|Overall Study||15
5080774|NCT01743092|12500931|P1|NOT COMPLETED|Overall Study||14
5080775|NCT01743092|12500930|P2|COMPLETED|Overall Study||11
5080776|NCT01743092|12500931|P1|COMPLETED|Overall Study||19
5080777|NCT01743092|12500930|P2|STARTED|Overall Study||26
5080778|NCT01743092|12500931|P1|STARTED|Overall Study||33
5080779|NCT01743040|12500939|P1|NOT COMPLETED|Overall Study||229
5080780|NCT01743040|12500939|P1|COMPLETED|Overall Study||785
5080781|NCT01743040|12500939|P1|CT and/or Standard Angiogram|Overall Study||785
5080782|NCT01743040|12500939|P1|Nuclear Stress Test|Overall Study||992
5080783|NCT01743040|12500939|P1|CADence Testing|Overall Study||1013
5080784|NCT01743040|12500939|P1|STARTED|Overall Study||1014
5080785|NCT01743027|12500947|P4|NOT COMPLETED|Overall Study||1
5080786|NCT01743027|12500948|P3|NOT COMPLETED|Overall Study||9
5080787|NCT01743027|12500949|P2|NOT COMPLETED|Overall Study||5
5080788|NCT01743027|12500950|P1|NOT COMPLETED|Overall Study||5
5080789|NCT01743027|12500947|P4|COMPLETED|Overall Study||48
5080790|NCT01743027|12500948|P3|COMPLETED|Overall Study||90
5080791|NCT01743027|12500949|P2|COMPLETED|Overall Study||94
5080792|NCT01743027|12500950|P1|COMPLETED|Overall Study||93
5080793|NCT01743027|12500947|P4|STARTED|Overall Study||49
5080794|NCT01743027|12500948|P3|STARTED|Overall Study||99
5080795|NCT01743027|12500949|P2|STARTED|Overall Study||99
5080796|NCT01743027|12500950|P1|STARTED|Overall Study||98
5080797|NCT01743001|12500990|P2|NOT COMPLETED|Overall Study||0
5080798|NCT01743001|12500991|P1|NOT COMPLETED|Overall Study||3
5080799|NCT01743001|12500990|P2|COMPLETED|Overall Study||112
5080800|NCT01743001|12500991|P1|COMPLETED|Overall Study||111
5080801|NCT01743001|12500990|P2|STARTED|Overall Study||112
5080802|NCT01743001|12500991|P1|STARTED|Overall Study||114
5080803|NCT01742949|12501003|P2|NOT COMPLETED|Overall Study||0
5080804|NCT01742949|12501004|P1|NOT COMPLETED|Overall Study||0
5080805|NCT01742949|12501003|P2|COMPLETED|Overall Study||20
5080806|NCT01742949|12501004|P1|COMPLETED|Overall Study||20
5080807|NCT01742949|12501003|P2|STARTED|Overall Study||20
5080808|NCT01742949|12501004|P1|STARTED|Overall Study||20
5080809|NCT01742936|12501025|P2|NOT COMPLETED|Overall Study||0
5080810|NCT01742936|12501026|P1|NOT COMPLETED|Overall Study||0
5080811|NCT01742936|12501025|P2|COMPLETED|Overall Study||50
5080812|NCT01742936|12501026|P1|COMPLETED|Overall Study||50
5080813|NCT01742936|12501025|P2|STARTED|Overall Study||50
5080814|NCT01742936|12501026|P1|STARTED|Overall Study||50
5080815|NCT01742897|12501034|P1|NOT COMPLETED|Overall Study||5
5080816|NCT01742897|12501034|P1|COMPLETED|Overall Study||30
5080817|NCT01742897|12501034|P1|Treated|Overall Study||33
5080818|NCT01742897|12501034|P1|STARTED|Overall Study||35
5080819|NCT01742832|12501040|P2|NOT COMPLETED|Overall Study||5
5080820|NCT01742832|12501041|P1|NOT COMPLETED|Overall Study||1
5080821|NCT01742832|12501040|P2|COMPLETED|Overall Study||23
5080822|NCT01742832|12501041|P1|COMPLETED|Overall Study||19
5080823|NCT01742832|12501040|P2|STARTED|Overall Study||28
5080824|NCT01742832|12501041|P1|STARTED|Overall Study||20
5080825|NCT01742364|12501051|P4|NOT COMPLETED|Overall Study||0
5080826|NCT01742364|12501052|P3|NOT COMPLETED|Overall Study||0
5080827|NCT01742364|12501053|P2|NOT COMPLETED|Overall Study||0
5080828|NCT01742364|12501054|P1|NOT COMPLETED|Overall Study||0
5080829|NCT01742364|12501051|P4|COMPLETED|Overall Study||15
5080830|NCT01742364|12501052|P3|COMPLETED|Overall Study||15
5080831|NCT01742364|12501053|P2|COMPLETED|Overall Study||33
5080832|NCT01742364|12501054|P1|COMPLETED|Overall Study||33
5080833|NCT01742364|12501051|P4|STARTED|Overall Study||15
5080834|NCT01742364|12501052|P3|STARTED|Overall Study||15
5080835|NCT01742364|12501053|P2|STARTED|Overall Study||33
5080836|NCT01742364|12501054|P1|STARTED|Overall Study||33
5080837|NCT01742286|12501087|P7|NOT COMPLETED|Expansion Phase||36
5080838|NCT01742286|12501088|P6|NOT COMPLETED|Expansion Phase||0
5080839|NCT01742286|12501089|P5|NOT COMPLETED|Expansion Phase||0
5080840|NCT01742286|12501090|P4|NOT COMPLETED|Expansion Phase||0
5080841|NCT01742286|12501091|P3|NOT COMPLETED|Expansion Phase||7
5080842|NCT01742286|12501092|P2|NOT COMPLETED|Expansion Phase||0
5080843|NCT01742286|12501093|P1|NOT COMPLETED|Expansion Phase||0
5080844|NCT01742286|12501087|P7|COMPLETED|Expansion Phase||0
5080845|NCT01742286|12501088|P6|COMPLETED|Expansion Phase||0
5080846|NCT01742286|12501089|P5|COMPLETED|Expansion Phase||0
5080847|NCT01742286|12501090|P4|COMPLETED|Expansion Phase||0
5080848|NCT01742286|12501091|P3|COMPLETED|Expansion Phase||0
5080849|NCT01742286|12501092|P2|COMPLETED|Expansion Phase||0
5080850|NCT01742286|12501093|P1|COMPLETED|Expansion Phase||0
5080851|NCT01742286|12501087|P7|End of Treatment = Not Ccompleted|Expansion Phase||36
5080852|NCT01742286|12501088|P6|End of Treatment = Not Ccompleted|Expansion Phase||0
5080853|NCT01742286|12501089|P5|End of Treatment = Not Ccompleted|Expansion Phase||0
5080854|NCT01742286|12501090|P4|End of Treatment = Not Ccompleted|Expansion Phase||0
5080855|NCT01742286|12501091|P3|End of Treatment = Not Ccompleted|Expansion Phase||7
5080856|NCT01742286|12501092|P2|End of Treatment = Not Ccompleted|Expansion Phase||0
5080857|NCT01742286|12501093|P1|End of Treatment = Not Ccompleted|Expansion Phase||0
5080858|NCT01742286|12501087|P7|STARTED|Expansion Phase||36
5080859|NCT01742286|12501088|P6|STARTED|Expansion Phase||0
5080860|NCT01742286|12501089|P5|STARTED|Expansion Phase||0
5080861|NCT01742286|12501090|P4|STARTED|Expansion Phase||0
5080862|NCT01742286|12501091|P3|STARTED|Expansion Phase||7
5080863|NCT01742286|12501092|P2|STARTED|Expansion Phase||0
5080864|NCT01742286|12501093|P1|STARTED|Expansion Phase||0
5080865|NCT01742286|12501087|P7|NOT COMPLETED|Escalation Phase||6
5080866|NCT01742286|12501088|P6|NOT COMPLETED|Escalation Phase||5
5080867|NCT01742286|12501089|P5|NOT COMPLETED|Escalation Phase||4
5080868|NCT01742286|12501090|P4|NOT COMPLETED|Escalation Phase||2
5080869|NCT01742286|12501091|P3|NOT COMPLETED|Escalation Phase||6
5080870|NCT01742286|12501092|P2|NOT COMPLETED|Escalation Phase||12
5080871|NCT01742286|12501093|P1|NOT COMPLETED|Escalation Phase||5
5080872|NCT01742286|12501087|P7|COMPLETED|Escalation Phase||0
5080873|NCT01742286|12501088|P6|COMPLETED|Escalation Phase||0
5080874|NCT01742286|12501089|P5|COMPLETED|Escalation Phase||0
5080875|NCT01742286|12501090|P4|COMPLETED|Escalation Phase||0
5080876|NCT01742286|12501091|P3|COMPLETED|Escalation Phase||0
5080877|NCT01742286|12501092|P2|COMPLETED|Escalation Phase||0
5080878|NCT01742286|12501093|P1|COMPLETED|Escalation Phase||0
5080879|NCT01742286|12501087|P7|Ended Treatment = Not Completed)|Escalation Phase||6
5080880|NCT01742286|12501088|P6|Ended Treatment = Not Completed)|Escalation Phase||5
5080881|NCT01742286|12501089|P5|Ended Treatment = Not Completed)|Escalation Phase||4
5080882|NCT01742286|12501090|P4|Ended Treatment = Not Completed)|Escalation Phase||2
5080883|NCT01742286|12501091|P3|Ended Treatment = Not Completed)|Escalation Phase||6
5080884|NCT01742286|12501092|P2|Ended Treatment = Not Completed)|Escalation Phase||12
5080885|NCT01742286|12501093|P1|Ended Treatment = Not Completed)|Escalation Phase||5
5080886|NCT01742286|12501087|P7|STARTED|Escalation Phase||6
5080887|NCT01742286|12501088|P6|STARTED|Escalation Phase||5
5080888|NCT01742286|12501089|P5|STARTED|Escalation Phase||4
5080889|NCT01742286|12501090|P4|STARTED|Escalation Phase||2
5080890|NCT01742286|12501091|P3|STARTED|Escalation Phase||6
5080891|NCT01742286|12501092|P2|STARTED|Escalation Phase||12
5080892|NCT01742286|12501093|P1|STARTED|Escalation Phase||5
5080893|NCT01742208|12501194|P3|NOT COMPLETED|Overall Study||0
5080894|NCT01742208|12501195|P2|NOT COMPLETED|Overall Study||0
5080895|NCT01742208|12501196|P1|NOT COMPLETED|Overall Study||0
5080896|NCT01742208|12501194|P3|COMPLETED|Overall Study||16
5080897|NCT01742208|12501195|P2|COMPLETED|Overall Study||17
5080898|NCT01742208|12501196|P1|COMPLETED|Overall Study||3
5080899|NCT01742208|12501194|P3|STARTED|Overall Study||16
5080900|NCT01742208|12501195|P2|STARTED|Overall Study||17
5080901|NCT01742208|12501196|P1|STARTED|Overall Study||3
5080902|NCT01742091|12501226|P6|NOT COMPLETED|Overall Study||2
5080903|NCT01742091|12501227|P5|NOT COMPLETED|Overall Study||1
5080904|NCT01742091|12501228|P4|NOT COMPLETED|Overall Study||1
5080905|NCT01742091|12501229|P3|NOT COMPLETED|Overall Study||0
5080906|NCT01742091|12501230|P2|NOT COMPLETED|Overall Study||0
5080907|NCT01742091|12501231|P1|NOT COMPLETED|Overall Study||0
5080908|NCT01742091|12501226|P6|COMPLETED|Overall Study||10
5080909|NCT01742091|12501227|P5|COMPLETED|Overall Study||7
5080910|NCT01742091|12501228|P4|COMPLETED|Overall Study||8
5080911|NCT01742091|12501229|P3|COMPLETED|Overall Study||10
5080912|NCT01742091|12501230|P2|COMPLETED|Overall Study||11
5080913|NCT01742091|12501231|P1|COMPLETED|Overall Study||9
5080914|NCT01742091|12501226|P6|RECEIVED STUDY DRUG|Overall Study||12
5080915|NCT01742091|12501227|P5|RECEIVED STUDY DRUG|Overall Study||8
5080916|NCT01742091|12501228|P4|RECEIVED STUDY DRUG|Overall Study||9
5080917|NCT01742091|12501229|P3|RECEIVED STUDY DRUG|Overall Study||10
5080918|NCT01742091|12501230|P2|RECEIVED STUDY DRUG|Overall Study||11
5080919|NCT01742091|12501231|P1|RECEIVED STUDY DRUG|Overall Study||9
5080920|NCT01742091|12501226|P6|STARTED|Overall Study||12
5080921|NCT01742091|12501227|P5|STARTED|Overall Study||8
5080922|NCT01742091|12501228|P4|STARTED|Overall Study||9
5080923|NCT01742091|12501229|P3|STARTED|Overall Study||10
5080924|NCT01742091|12501230|P2|STARTED|Overall Study||11
5080925|NCT01742091|12501231|P1|STARTED|Overall Study||9
5080926|NCT01742078|12501277|P9|NOT COMPLETED|Overall Study||0
5080927|NCT01742078|12501278|P8|NOT COMPLETED|Overall Study||0
5080928|NCT01742078|12501279|P7|NOT COMPLETED|Overall Study||0
5080929|NCT01742078|12501280|P6|NOT COMPLETED|Overall Study||0
5080930|NCT01742078|12501281|P5|NOT COMPLETED|Overall Study||0
5080931|NCT01742078|12501282|P4|NOT COMPLETED|Overall Study||1
5080932|NCT01742078|12501283|P3|NOT COMPLETED|Overall Study||0
5080933|NCT01742078|12501284|P2|NOT COMPLETED|Overall Study||0
5080934|NCT01742078|12501285|P1|NOT COMPLETED|Overall Study||0
5080935|NCT01742078|12501277|P9|COMPLETED|Overall Study||12
5080936|NCT01742078|12501278|P8|COMPLETED|Overall Study||6
5080937|NCT01742078|12501279|P7|COMPLETED|Overall Study||6
5080938|NCT01742078|12501280|P6|COMPLETED|Overall Study||6
5080939|NCT01742078|12501281|P5|COMPLETED|Overall Study||6
5080940|NCT01742078|12501282|P4|COMPLETED|Overall Study||5
5080941|NCT01742078|12501283|P3|COMPLETED|Overall Study||6
5080942|NCT01742078|12501284|P2|COMPLETED|Overall Study||6
5080943|NCT01742078|12501285|P1|COMPLETED|Overall Study||6
5080944|NCT01742078|12501277|P9|RECEIVED STUDY DRUG|Overall Study||12
5080945|NCT01742078|12501278|P8|RECEIVED STUDY DRUG|Overall Study||6
5080946|NCT01742078|12501279|P7|RECEIVED STUDY DRUG|Overall Study||6
5080947|NCT01742078|12501280|P6|RECEIVED STUDY DRUG|Overall Study||6
5080948|NCT01742078|12501281|P5|RECEIVED STUDY DRUG|Overall Study||6
5080949|NCT01742078|12501282|P4|RECEIVED STUDY DRUG|Overall Study||6
5080950|NCT01742078|12501283|P3|RECEIVED STUDY DRUG|Overall Study||6
5080951|NCT01742078|12501284|P2|RECEIVED STUDY DRUG|Overall Study||6
5080952|NCT01742078|12501285|P1|RECEIVED STUDY DRUG|Overall Study||6
5080953|NCT01742078|12501277|P9|STARTED|Overall Study||12
5080954|NCT01742078|12501278|P8|STARTED|Overall Study||6
5080955|NCT01742078|12501279|P7|STARTED|Overall Study||6
5080956|NCT01742078|12501280|P6|STARTED|Overall Study||6
5080957|NCT01742078|12501281|P5|STARTED|Overall Study||6
5080958|NCT01742078|12501282|P4|STARTED|Overall Study||6
5080959|NCT01742078|12501283|P3|STARTED|Overall Study||6
5080960|NCT01742078|12501284|P2|STARTED|Overall Study||6
5080961|NCT01742078|12501285|P1|STARTED|Overall Study||6
5080962|NCT01742065|12501342|P2|NOT COMPLETED|Overall Study||0
5080963|NCT01742065|12501343|P1|NOT COMPLETED|Overall Study||0
5080964|NCT01742065|12501342|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
5080965|NCT01742065|12501343|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
5080966|NCT01742065|12501342|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
5080967|NCT01742065|12501343|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
5080968|NCT01741792|12501354|P3|NOT COMPLETED|Overall Study||12
5080969|NCT01741792|12501355|P2|NOT COMPLETED|Overall Study||1
5080970|NCT01741792|12501356|P1|NOT COMPLETED|Overall Study||6
5080971|NCT01741792|12501354|P3|COMPLETED|Overall Study||2
5080972|NCT01741792|12501355|P2|COMPLETED|Overall Study||1
5080973|NCT01741792|12501356|P1|COMPLETED|Overall Study||3
5080974|NCT01741792|12501354|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
5080975|NCT01741792|12501355|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
5080976|NCT01741792|12501356|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
5080977|NCT01741792|12501354|P3|STARTED|Overall Study||14
5080978|NCT01741792|12501355|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
5080979|NCT01741792|12501356|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
5080980|NCT01741701|12501423|P2|NOT COMPLETED|Overall Study||2
5080981|NCT01741701|12501424|P1|NOT COMPLETED|Overall Study||5
5080982|NCT01741701|12501423|P2|COMPLETED|Overall Study||13
5080983|NCT01741701|12501424|P1|COMPLETED|Overall Study||13
5080984|NCT01741701|12501423|P2|STARTED|Overall Study||15
5080985|NCT01741701|12501424|P1|STARTED|Overall Study||18
5080986|NCT01741688|12501440|P1|NOT COMPLETED|Overall Study||3
5080987|NCT01741688|12501440|P1|COMPLETED|Overall Study||13
5080988|NCT01741688|12501440|P1|STARTED|Overall Study||16
5080989|NCT01741545|12501459|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
5080990|NCT01741545|12501460|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
5080991|NCT01741545|12501459|P2|COMPLETED|Follow-up Period (24 Weeks)||37
5080992|NCT01741545|12501460|P1|COMPLETED|Follow-up Period (24 Weeks)||11
5080993|NCT01741545|12501459|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
5080994|NCT01741545|12501460|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
5080995|NCT01741545|12501459|P2|NOT COMPLETED|Treatment Period||4
5080996|NCT01741545|12501460|P1|NOT COMPLETED|Treatment Period||1
5080997|NCT01741545|12501459|P2|COMPLETED|Treatment Period||35
5080998|NCT01741545|12501460|P1|COMPLETED|Treatment Period||11
5080999|NCT01741545|12501459|P2|STARTED|Treatment Period||39
5081000|NCT01741545|12501460|P1|STARTED|Treatment Period||12
5081001|NCT01741532|12501484|P2|NOT COMPLETED|Overall Study||3
5081002|NCT01741532|12501485|P1|NOT COMPLETED|Overall Study||10
5081003|NCT01741532|12501484|P2|COMPLETED|Overall Study||27
5081004|NCT01741532|12501485|P1|COMPLETED|Overall Study||49
5081005|NCT01741532|12501484|P2|Provided Post-baseline Efficacy Data|Overall Study||28
5081006|NCT01741532|12501485|P1|Provided Post-baseline Efficacy Data|Overall Study||58
5081007|NCT01741532|12501484|P2|Exposed|Overall Study||30
5081008|NCT01741532|12501485|P1|Exposed|Overall Study||58
5081009|NCT01741532|12501484|P2|STARTED|Overall Study||30
5081010|NCT01741532|12501485|P1|STARTED|Overall Study||59
5081011|NCT01741480|12501507|P2|NOT COMPLETED|Overall Study||0
5081012|NCT01741480|12501508|P1|NOT COMPLETED|Overall Study||0
5081013|NCT01741480|12501507|P2|COMPLETED|Overall Study||286
5081014|NCT01741480|12501508|P1|COMPLETED|Overall Study||285
5081015|NCT01741480|12501507|P2|STARTED|Overall Study||286
5081016|NCT01741480|12501508|P1|STARTED|Overall Study||285
5081017|NCT01741454|12501518|P4|NOT COMPLETED|Overall Study||22
5081018|NCT01741454|12501519|P3|NOT COMPLETED|Overall Study||17
5081019|NCT01741454|12501520|P2|NOT COMPLETED|Overall Study||6
5081020|NCT01741454|12501521|P1|NOT COMPLETED|Overall Study||13
5081021|NCT01741454|12501518|P4|COMPLETED|Overall Study||21
5081022|NCT01741454|12501519|P3|COMPLETED|Overall Study||22
5081023|NCT01741454|12501520|P2|COMPLETED|Overall Study||44
5081024|NCT01741454|12501521|P1|COMPLETED|Overall Study||36
5081025|NCT01741454|12501518|P4|STARTED|Overall Study||43
5081026|NCT01741454|12501519|P3|STARTED|Overall Study||39
5081027|NCT01741454|12501520|P2|STARTED|Overall Study||50
5081028|NCT01741454|12501521|P1|STARTED|Overall Study||49
5081029|NCT01741350|12501545|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
5081030|NCT01741350|12501546|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
5081031|NCT01741350|12501545|P2|COMPLETED|12-Month Follow-up Assessment||109
5081032|NCT01741350|12501546|P1|COMPLETED|12-Month Follow-up Assessment||111
5081033|NCT01741350|12501545|P2|STARTED|12-Month Follow-up Assessment||111
5081034|NCT01741350|12501546|P1|STARTED|12-Month Follow-up Assessment||114
5081035|NCT01741350|12501545|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
5081036|NCT01741350|12501546|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
5081037|NCT01741350|12501545|P2|COMPLETED|6-Month Follow-up Assessment||111
5081038|NCT01741350|12501546|P1|COMPLETED|6-Month Follow-up Assessment||114
5081039|NCT01741350|12501545|P2|STARTED|6-Month Follow-up Assessment||119
5081040|NCT01741350|12501546|P1|STARTED|6-Month Follow-up Assessment||129
5081041|NCT01741350|12501545|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
5081042|NCT01741350|12501546|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
5081043|NCT01741350|12501545|P2|COMPLETED|3-Month Follow-up Assessment||119
5081044|NCT01741350|12501546|P1|COMPLETED|3-Month Follow-up Assessment||129
5081045|NCT01741350|12501545|P2|STARTED|3-Month Follow-up Assessment||141
5081046|NCT01741350|12501546|P1|STARTED|3-Month Follow-up Assessment||135
5081047|NCT01741350|12501545|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
5081048|NCT01741350|12501546|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
5081049|NCT01741350|12501545|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
5081050|NCT01741350|12501546|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
5081051|NCT01741350|12501545|P2|STARTED|Post Intervention Assessment (at Week 4)||155
5081052|NCT01741350|12501546|P1|STARTED|Post Intervention Assessment (at Week 4)||149
5081053|NCT01741350|12501545|P2|NOT COMPLETED|Study Intervention||0
5081054|NCT01741350|12501546|P1|NOT COMPLETED|Study Intervention||0
5081055|NCT01741350|12501545|P2|COMPLETED|Study Intervention||155
5081056|NCT01741350|12501546|P1|COMPLETED|Study Intervention||149
5081057|NCT01741350|12501545|P2|STARTED|Study Intervention||155
5081058|NCT01741350|12501546|P1|STARTED|Study Intervention||149
5081059|NCT01741272|12501682|P2|NOT COMPLETED|Overall Study||0
5081060|NCT01741272|12501683|P1|NOT COMPLETED|Overall Study||0
5081061|NCT01741272|12501682|P2|COMPLETED|Overall Study||97
5081062|NCT01741272|12501683|P1|COMPLETED|Overall Study||92
5081063|NCT01741272|12501682|P2|STARTED|Overall Study||97
5081064|NCT01741272|12501683|P1|STARTED|Overall Study||92
5081065|NCT01741259|12501699|P2|NOT COMPLETED|Overall Study||6
5081066|NCT01741259|12501700|P1|NOT COMPLETED|Overall Study||6
5081067|NCT01741259|12501699|P2|COMPLETED|Overall Study||129
5081068|NCT01741259|12501700|P1|COMPLETED|Overall Study||127
5081069|NCT01741259|12501699|P2|STARTED|Overall Study||135
5081070|NCT01741259|12501700|P1|STARTED|Overall Study||133
5081071|NCT01741012|12501754|P1|NOT COMPLETED|Overall Study||3
5081072|NCT01741012|12501754|P1|COMPLETED|Overall Study||34
5081073|NCT01741012|12501754|P1|STARTED|Overall Study||37
5081074|NCT01740817|12501761|P2|NOT COMPLETED|Second Intervention (48 h)||0
5081075|NCT01740817|12501762|P1|NOT COMPLETED|Second Intervention (48 h)||0
5081076|NCT01740817|12501761|P2|COMPLETED|Second Intervention (48 h)||4
5081077|NCT01740817|12501762|P1|COMPLETED|Second Intervention (48 h)||8
5081078|NCT01740817|12501761|P2|STARTED|Second Intervention (48 h)||4
5081079|NCT01740817|12501762|P1|STARTED|Second Intervention (48 h)||8
5081080|NCT01740817|12501761|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
5081081|NCT01740817|12501762|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
5081082|NCT01740817|12501761|P2|COMPLETED|Washout (4-6 Weeks)||4
5081083|NCT01740817|12501762|P1|COMPLETED|Washout (4-6 Weeks)||8
5081084|NCT01740817|12501761|P2|STARTED|Washout (4-6 Weeks)||4
5081085|NCT01740817|12501762|P1|STARTED|Washout (4-6 Weeks)||8
5081086|NCT01740817|12501761|P2|NOT COMPLETED|First Intervention (48 h)||0
5081087|NCT01740817|12501762|P1|NOT COMPLETED|First Intervention (48 h)||0
5081088|NCT01740817|12501761|P2|COMPLETED|First Intervention (48 h)||4
5081089|NCT01740817|12501762|P1|COMPLETED|First Intervention (48 h)||8
5081090|NCT01740817|12501761|P2|STARTED|First Intervention (48 h)||4
5081091|NCT01740817|12501762|P1|STARTED|First Intervention (48 h)||8
5081092|NCT01740726|12501774|P2|NOT COMPLETED|Overall Study||0
5081093|NCT01740726|12501775|P1|NOT COMPLETED|Overall Study||0
5081094|NCT01740726|12501774|P2|COMPLETED|Overall Study||1
5081095|NCT01740726|12501775|P1|COMPLETED|Overall Study||0
5081096|NCT01740726|12501774|P2|STARTED|Overall Study||1
5081097|NCT01740726|12501775|P1|STARTED|Overall Study||0
5081098|NCT01740713|12501800|P3|NOT COMPLETED|Overall Study||1
5081099|NCT01740713|12501801|P2|NOT COMPLETED|Overall Study||2
5081100|NCT01740713|12501802|P1|NOT COMPLETED|Overall Study||0
5081101|NCT01740713|12501800|P3|COMPLETED|Overall Study||6
5081102|NCT01740713|12501801|P2|COMPLETED|Overall Study||6
5081103|NCT01740713|12501802|P1|COMPLETED|Overall Study||6
5081104|NCT01740713|12501800|P3|STARTED|Overall Study||7
5081105|NCT01740713|12501801|P2|STARTED|Overall Study||8
5081106|NCT01740713|12501802|P1|STARTED|Overall Study||6
5081107|NCT01740440|12501826|P1|NOT COMPLETED|Overall Study||3
5081108|NCT01740440|12501826|P1|COMPLETED|Overall Study||27
5081109|NCT01740440|12501826|P1|STARTED|Overall Study||30
5081110|NCT01740427|12501834|P2|NOT COMPLETED|Overall Study||222
5081111|NCT01740427|12501835|P1|NOT COMPLETED|Overall Study||444
5081112|NCT01740427|12501834|P2|COMPLETED|Overall Study||0
5081113|NCT01740427|12501835|P1|COMPLETED|Overall Study||0
5081114|NCT01740427|12501834|P2|STARTED|Overall Study||222
5081115|NCT01740427|12501835|P1|STARTED|Overall Study||444
5081116|NCT01740414|12501864|P2|NOT COMPLETED|Overall Study||8
5081117|NCT01740414|12501865|P1|NOT COMPLETED|Overall Study||9
5081118|NCT01740414|12501864|P2|COMPLETED|Overall Study||8
5081119|NCT01740414|12501865|P1|COMPLETED|Overall Study||3
5081120|NCT01740414|12501864|P2|STARTED|Overall Study||16
5081121|NCT01740414|12501865|P1|STARTED|Overall Study||12
5081122|NCT01740401|12501887|P1|NOT COMPLETED|Overall Study||10
5081123|NCT01740401|12501887|P1|COMPLETED|Overall Study||0
5081124|NCT01740401|12501887|P1|STARTED|Overall Study||10
5081125|NCT01740388|12501896|P2|NOT COMPLETED|Overall Study||44
5081126|NCT01740388|12501897|P1|NOT COMPLETED|Overall Study||46
5081127|NCT01740388|12501896|P2|COMPLETED|Overall Study||28
5081128|NCT01740388|12501897|P1|COMPLETED|Overall Study||18
5081129|NCT01740388|12501896|P2|STARTED|Overall Study||72
5081130|NCT01740388|12501897|P1|STARTED|Overall Study||64
5081131|NCT01740362|12501917|P4|NOT COMPLETED|Overall Study||0
5081132|NCT01740362|12501918|P3|NOT COMPLETED|Overall Study||0
5081133|NCT01740362|12501919|P2|NOT COMPLETED|Overall Study||0
5081134|NCT01740362|12501920|P1|NOT COMPLETED|Overall Study||0
5081135|NCT01740362|12501917|P4|COMPLETED|Overall Study||6
5081136|NCT01740362|12501918|P3|COMPLETED|Overall Study||6
5081137|NCT01740362|12501919|P2|COMPLETED|Overall Study||6
5081138|NCT01740362|12501920|P1|COMPLETED|Overall Study||6
5081139|NCT01740362|12501917|P4|STARTED|Overall Study||6
5081140|NCT01740362|12501918|P3|STARTED|Overall Study||6
5081141|NCT01740362|12501919|P2|STARTED|Overall Study||6
5081142|NCT01740362|12501920|P1|STARTED|Overall Study||6
5081143|NCT01740323|12501948|P2|NOT COMPLETED|Overall Study||0
5081144|NCT01740323|12501949|P1|NOT COMPLETED|Overall Study||2
5081145|NCT01740323|12501948|P2|COMPLETED|Overall Study||15
5081146|NCT01740323|12501949|P1|COMPLETED|Overall Study||13
5081147|NCT01740323|12501948|P2|STARTED|Overall Study||15
5081148|NCT01740323|12501949|P1|STARTED|Overall Study||15
5081149|NCT01740297|12501970|P3|NOT COMPLETED|Overall Study||98
5081150|NCT01740297|12501971|P2|NOT COMPLETED|Overall Study||100
5081151|NCT01740297|12501972|P1|NOT COMPLETED|Overall Study||19
5081152|NCT01740297|12501970|P3|COMPLETED|Overall Study||0
5081153|NCT01740297|12501971|P2|COMPLETED|Overall Study||0
5081154|NCT01740297|12501972|P1|COMPLETED|Overall Study||0
5081155|NCT01740297|12501970|P3|Received Ipilimumab|Overall Study||92
5081156|NCT01740297|12501971|P2|Received Ipilimumab|Overall Study||95
5081157|NCT01740297|12501972|P1|Received Ipilimumab|Overall Study||18
5081158|NCT01740297|12501970|P3|Received Talimogene Laherparepvec|Overall Study||95
5081159|NCT01740297|12501971|P2|Received Talimogene Laherparepvec|Overall Study||0
5081160|NCT01740297|12501972|P1|Received Talimogene Laherparepvec|Overall Study||19
5081161|NCT01740297|12501970|P3|STARTED|Overall Study||98
5081162|NCT01740297|12501971|P2|STARTED|Overall Study||100
5081163|NCT01740297|12501972|P1|STARTED|Overall Study||19
5081164|NCT01740206|12502004|P2|NOT COMPLETED|Overall Study||0
5081165|NCT01740206|12502005|P1|NOT COMPLETED|Overall Study||0
5081166|NCT01740206|12502004|P2|COMPLETED|Overall Study||34
5081167|NCT01740206|12502005|P1|COMPLETED|Overall Study||14
5081168|NCT01740206|12502004|P2|STARTED|Overall Study||34
5081169|NCT01740206|12502005|P1|STARTED|Overall Study||14
5081170|NCT01740154|12502021|P1|NOT COMPLETED|Overall Study||1
5081171|NCT01740154|12502021|P1|COMPLETED|Overall Study||12
5081172|NCT01740154|12502021|P1|STARTED|Overall Study||13
5081173|NCT01740128|12502029|P2|NOT COMPLETED|Overall Study||7
5081174|NCT01740128|12502030|P1|NOT COMPLETED|Overall Study||6
5081175|NCT01740128|12502029|P2|COMPLETED|Overall Study||4
5081176|NCT01740128|12502030|P1|COMPLETED|Overall Study||4
5081177|NCT01740128|12502029|P2|STARTED|Overall Study||11
5081178|NCT01740128|12502030|P1|STARTED|Overall Study||10
5081179|NCT01740089|12502059|P3|NOT COMPLETED|After 12 Weeks||11
5081180|NCT01740089|12502060|P2|NOT COMPLETED|After 12 Weeks||3
5081181|NCT01740089|12502061|P1|NOT COMPLETED|After 12 Weeks||7
5081182|NCT01740089|12502059|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
5081183|NCT01740089|12502060|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
5081184|NCT01740089|12502061|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
5081185|NCT01740089|12502059|P3|STARTED|After 12 Weeks||48
5081186|NCT01740089|12502060|P2|STARTED|After 12 Weeks||48
5081187|NCT01740089|12502061|P1|STARTED|After 12 Weeks||50
5081188|NCT01740089|12502059|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
5081189|NCT01740089|12502060|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
5081190|NCT01740089|12502061|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
5081191|NCT01740089|12502059|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
5081192|NCT01740089|12502060|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
5081193|NCT01740089|12502061|P1|COMPLETED|First 12 Weeks of Treatment||50
5081194|NCT01740089|12502059|P3|STARTED|First 12 Weeks of Treatment||50
5081195|NCT01740089|12502060|P2|STARTED|First 12 Weeks of Treatment||50
5081196|NCT01740089|12502061|P1|STARTED|First 12 Weeks of Treatment||50
5081197|NCT01739803|12502079|P2|NOT COMPLETED|Overall Study||6
5081198|NCT01739803|12502080|P1|NOT COMPLETED|Overall Study||9
5081199|NCT01739803|12502079|P2|COMPLETED|Overall Study||68
5081200|NCT01739803|12502080|P1|COMPLETED|Overall Study||67
5081201|NCT01739803|12502079|P2|STARTED|Overall Study||74
5081202|NCT01739803|12502080|P1|STARTED|Overall Study||76
5081203|NCT01739790|12502092|P2|NOT COMPLETED|Overall Study||4
5081204|NCT01739790|12502093|P1|NOT COMPLETED|Overall Study||2
5081205|NCT01739790|12502092|P2|COMPLETED|Overall Study||23
5081206|NCT01739790|12502093|P1|COMPLETED|Overall Study||22
5081207|NCT01739790|12502092|P2|STARTED|Overall Study||27
5081208|NCT01739790|12502093|P1|STARTED|Overall Study||24
5081209|NCT01739595|12502102|P3|NOT COMPLETED|Overall Study||2
5081210|NCT01739595|12502103|P2|NOT COMPLETED|Overall Study||1
5081211|NCT01739595|12502104|P1|NOT COMPLETED|Overall Study||13
5081212|NCT01739595|12502102|P3|COMPLETED|Overall Study||45
5081213|NCT01739595|12502103|P2|COMPLETED|Overall Study||21
5081214|NCT01739595|12502104|P1|COMPLETED|Overall Study||99
5081215|NCT01739595|12502102|P3|STARTED|Overall Study||47
5081216|NCT01739595|12502103|P2|STARTED|Overall Study||22
5081217|NCT01739595|12502104|P1|STARTED|Overall Study||112
5081218|NCT01739400|12502114|P2|NOT COMPLETED|Overall Study||9
5081219|NCT01739400|12502115|P1|NOT COMPLETED|Overall Study||17
5081220|NCT01739400|12502114|P2|COMPLETED|Overall Study||99
5081221|NCT01739400|12502115|P1|COMPLETED|Overall Study||92
5081222|NCT01739400|12502114|P2|Treated With 10 mg Macitentan|Overall Study||108
5081223|NCT01739400|12502115|P1|Treated With 10 mg Macitentan|Overall Study||109
5081224|NCT01739400|12502114|P2|STARTED|Overall Study||108
5081225|NCT01739400|12502115|P1|STARTED|Overall Study||109
5081226|NCT01739361|12502128|P2|NOT COMPLETED|Overall Study||1
5081227|NCT01739361|12502129|P1|NOT COMPLETED|Overall Study||3
5081228|NCT01739361|12502128|P2|COMPLETED|Overall Study||22
5081229|NCT01739361|12502129|P1|COMPLETED|Overall Study||18
5081230|NCT01739361|12502128|P2|STARTED|Overall Study||23
5081231|NCT01739361|12502129|P1|STARTED|Overall Study||21
5081232|NCT01739348|12502143|P4|NOT COMPLETED|Part II (Extension Study)||396
5081233|NCT01739348|12502144|P3|NOT COMPLETED|Part II (Extension Study)||61
5081234|NCT01739348|12502145|P2|NOT COMPLETED|Part II (Extension Study)||366
5081235|NCT01739348|12502146|P1|NOT COMPLETED|Part II (Extension Study)||379
5081236|NCT01739348|12502143|P4|COMPLETED|Part II (Extension Study)||0
5081237|NCT01739348|12502144|P3|COMPLETED|Part II (Extension Study)||0
5081238|NCT01739348|12502145|P2|COMPLETED|Part II (Extension Study)||0
5081239|NCT01739348|12502146|P1|COMPLETED|Part II (Extension Study)||0
5081240|NCT01739348|12502143|P4|Treated|Part II (Extension Study)||394
5081241|NCT01739348|12502144|P3|Treated|Part II (Extension Study)||61
5081242|NCT01739348|12502145|P2|Treated|Part II (Extension Study)||365
5081243|NCT01739348|12502146|P1|Treated|Part II (Extension Study)||379
5081244|NCT01739348|12502143|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
5081245|NCT01739348|12502144|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
5081246|NCT01739348|12502145|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
5081247|NCT01739348|12502146|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
5081248|NCT01739348|12502143|P4|NOT COMPLETED|Part I (Base Study)||189
5081249|NCT01739348|12502144|P3|NOT COMPLETED|Part I (Base Study)||26
5081250|NCT01739348|12502145|P2|NOT COMPLETED|Part I (Base Study)||203
5081251|NCT01739348|12502146|P1|NOT COMPLETED|Part I (Base Study)||202
5081252|NCT01739348|12502143|P4|COMPLETED|Part I (Base Study)||516
5081253|NCT01739348|12502144|P3|COMPLETED|Part I (Base Study)||77
5081254|NCT01739348|12502145|P2|COMPLETED|Part I (Base Study)||497
5081255|NCT01739348|12502146|P1|COMPLETED|Part I (Base Study)||501
5081256|NCT01739348|12502143|P4|Treated|Part I (Base Study)||705
5081257|NCT01739348|12502144|P3|Treated|Part I (Base Study)||103
5081258|NCT01739348|12502145|P2|Treated|Part I (Base Study)||700
5081259|NCT01739348|12502146|P1|Treated|Part I (Base Study)||702
5081260|NCT01739348|12502143|P4|STARTED|Part I (Base Study)||705
5081261|NCT01739348|12502144|P3|STARTED|Part I (Base Study)||103
5081262|NCT01739348|12502145|P2|STARTED|Part I (Base Study)||700
5081263|NCT01739348|12502146|P1|STARTED|Part I (Base Study)||703
5081264|NCT01739335|12502218|P2|NOT COMPLETED|Overall Study||5
5081265|NCT01739335|12502219|P1|NOT COMPLETED|Overall Study||7
5081266|NCT01739335|12502218|P2|COMPLETED|Overall Study||35
5081267|NCT01739335|12502219|P1|COMPLETED|Overall Study||34
5081268|NCT01739335|12502218|P2|STARTED|Overall Study||40
5081269|NCT01739335|12502219|P1|STARTED|Overall Study||41
5081270|NCT01739309|12502251|P1|NOT COMPLETED|Overall Study||3
5081271|NCT01739309|12502251|P1|COMPLETED|Overall Study||25
5081272|NCT01739309|12502251|P1|Alive and on Study, Off Treatment|Overall Study||8
5081273|NCT01739309|12502251|P1|Death Due to Any Cause|Overall Study||17
5081274|NCT01739309|12502251|P1|Received at Least One Dose of Study Drug|Overall Study||28
5081275|NCT01739309|12502251|P1|STARTED|Overall Study||28
5081276|NCT01739231|12502274|P4|NOT COMPLETED|Part B||2
5081277|NCT01739231|12502275|P3|NOT COMPLETED|Part B||2
5081278|NCT01739231|12502276|P2|NOT COMPLETED|Part B||5
5081279|NCT01739231|12502277|P1|NOT COMPLETED|Part B||7
5081280|NCT01739231|12502274|P4|COMPLETED|Part B||19
5081281|NCT01739231|12502275|P3|COMPLETED|Part B||10
5081282|NCT01739231|12502276|P2|COMPLETED|Part B||12
5081283|NCT01739231|12502277|P1|COMPLETED|Part B||13
5081284|NCT01739231|12502274|P4|Challenged|Part B||21
5081285|NCT01739231|12502275|P3|Challenged|Part B||10
5081286|NCT01739231|12502276|P2|Challenged|Part B||13
5081287|NCT01739231|12502277|P1|Challenged|Part B||13
5081288|NCT01739231|12502274|P4|STARTED|Part B||21
5081289|NCT01739231|12502275|P3|STARTED|Part B||12
5081290|NCT01739231|12502276|P2|STARTED|Part B||17
5081291|NCT01739231|12502277|P1|STARTED|Part B||20
5081292|NCT01739231|12502274|P4|NOT COMPLETED|Part A||0
5081293|NCT01739231|12502275|P3|NOT COMPLETED|Part A||0
5081294|NCT01739231|12502276|P2|NOT COMPLETED|Part A||7
5081295|NCT01739231|12502277|P1|NOT COMPLETED|Part A||4
5081296|NCT01739231|12502274|P4|COMPLETED|Part A||0
5081297|NCT01739231|12502275|P3|COMPLETED|Part A||12
5081298|NCT01739231|12502276|P2|COMPLETED|Part A||17
5081299|NCT01739231|12502277|P1|COMPLETED|Part A||20
5081300|NCT01739231|12502274|P4|Received All 3 Vaccinations|Part A||0
5081301|NCT01739231|12502275|P3|Received All 3 Vaccinations|Part A||12
5081302|NCT01739231|12502276|P2|Received All 3 Vaccinations|Part A||20
5081303|NCT01739231|12502277|P1|Received All 3 Vaccinations|Part A||21
5081304|NCT01739231|12502274|P4|STARTED|Part A||0
5081305|NCT01739231|12502275|P3|STARTED|Part A||12
5081306|NCT01739231|12502276|P2|STARTED|Part A||24
5081307|NCT01739231|12502277|P1|STARTED|Part A||24
5081308|NCT01738984|12502446|P2|NOT COMPLETED|Overall Study||39
5081309|NCT01738984|12502447|P1|NOT COMPLETED|Overall Study||64
5081310|NCT01738984|12502446|P2|COMPLETED|Overall Study||210
5081311|NCT01738984|12502447|P1|COMPLETED|Overall Study||186
5081312|NCT01738984|12502446|P2|STARTED|Overall Study||249
5081313|NCT01738984|12502447|P1|STARTED|Overall Study||250
5081314|NCT01738971|12502460|P3|NOT COMPLETED|Overall Study||17
5081315|NCT01738971|12502461|P2|NOT COMPLETED|Overall Study||30
5081316|NCT01738971|12502462|P1|NOT COMPLETED|Overall Study||19
5081317|NCT01738971|12502460|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
5081318|NCT01738971|12502461|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
5081319|NCT01738971|12502462|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
5081320|NCT01738971|12502460|P3|STARTED|Overall Study|56 participants recruited to this arm|56
5081321|NCT01738971|12502461|P2|STARTED|Overall Study|58 participants recruited to this arm|58
5081322|NCT01738971|12502462|P1|STARTED|Overall Study|54 participants recruited to this arm|54
5081323|NCT01738919|12502478|P2|NOT COMPLETED|Overall Study||3
5081324|NCT01738919|12502479|P1|NOT COMPLETED|Overall Study||1
5081325|NCT01738919|12502478|P2|COMPLETED|Overall Study||14
5081326|NCT01738919|12502479|P1|COMPLETED|Overall Study||14
5081327|NCT01738919|12502478|P2|STARTED|Overall Study||17
5081328|NCT01738919|12502479|P1|STARTED|Overall Study||15
5081329|NCT01738750|12502497|P2|NOT COMPLETED|Overall Study||0
5081330|NCT01738750|12502498|P1|NOT COMPLETED|Overall Study||0
5081331|NCT01738750|12502497|P2|COMPLETED|Overall Study||51
5081332|NCT01738750|12502498|P1|COMPLETED|Overall Study||49
5081333|NCT01738750|12502497|P2|STARTED|Overall Study||51
5081334|NCT01738750|12502498|P1|STARTED|Overall Study||49
5081335|NCT01738737|12502511|P5|NOT COMPLETED|Overall Study||4
5081336|NCT01738737|12502512|P4|NOT COMPLETED|Overall Study||4
5081337|NCT01738737|12502513|P3|NOT COMPLETED|Overall Study||4
5081338|NCT01738737|12502514|P2|NOT COMPLETED|Overall Study||4
5081339|NCT01738737|12502515|P1|NOT COMPLETED|Overall Study||4
5081340|NCT01738737|12502511|P5|COMPLETED|Overall Study||25
5081341|NCT01738737|12502512|P4|COMPLETED|Overall Study||25
5081342|NCT01738737|12502513|P3|COMPLETED|Overall Study||25
5081343|NCT01738737|12502514|P2|COMPLETED|Overall Study||25
5081344|NCT01738737|12502515|P1|COMPLETED|Overall Study||25
5081345|NCT01738737|12502511|P5|STARTED|Overall Study||29
5081346|NCT01738737|12502512|P4|STARTED|Overall Study||29
5081347|NCT01738737|12502513|P3|STARTED|Overall Study||29
5081348|NCT01738737|12502514|P2|STARTED|Overall Study||29
5081349|NCT01738737|12502515|P1|STARTED|Overall Study||29
5081350|NCT01738698|12502551|P4|NOT COMPLETED|Overall Study||0
5081351|NCT01738698|12502552|P3|NOT COMPLETED|Overall Study||0
5081352|NCT01738698|12502553|P2|NOT COMPLETED|Overall Study||0
5081353|NCT01738698|12502554|P1|NOT COMPLETED|Overall Study||0
5081354|NCT01738698|12502551|P4|COMPLETED|Overall Study||0
5081355|NCT01738698|12502552|P3|COMPLETED|Overall Study||0
5081356|NCT01738698|12502553|P2|COMPLETED|Overall Study||0
5081357|NCT01738698|12502554|P1|COMPLETED|Overall Study||0
5081358|NCT01738698|12502551|P4|STARTED|Overall Study||0
5081359|NCT01738698|12502552|P3|STARTED|Overall Study||0
5081360|NCT01738698|12502553|P2|STARTED|Overall Study||0
5081361|NCT01738698|12502554|P1|STARTED|Overall Study||0
5081362|NCT01738672|12502620|P1|NOT COMPLETED|Overall Study||5
5081363|NCT01738672|12502620|P1|COMPLETED|Overall Study||11
5081364|NCT01738672|12502620|P1|STARTED|Overall Study||16
5081365|NCT01738646|12502629|P1|NOT COMPLETED|Overall Study||2
5081366|NCT01738646|12502629|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
5081367|NCT01738646|12502629|P1|STARTED|Overall Study||40
5081368|NCT01738594|12502640|P8|NOT COMPLETED|Follow up for 1 Year||0
5081369|NCT01738594|12502641|P7|NOT COMPLETED|Follow up for 1 Year||0
5081370|NCT01738594|12502642|P6|NOT COMPLETED|Follow up for 1 Year||3
5081371|NCT01738594|12502643|P5|NOT COMPLETED|Follow up for 1 Year||0
5081372|NCT01738594|12502644|P4|NOT COMPLETED|Follow up for 1 Year||0
5081373|NCT01738594|12502645|P3|NOT COMPLETED|Follow up for 1 Year||0
5081374|NCT01738594|12502646|P2|NOT COMPLETED|Follow up for 1 Year||0
5081375|NCT01738594|12502647|P1|NOT COMPLETED|Follow up for 1 Year||0
5081376|NCT01738594|12502640|P8|COMPLETED|Follow up for 1 Year||0
5081377|NCT01738594|12502641|P7|COMPLETED|Follow up for 1 Year||0
5081378|NCT01738594|12502642|P6|COMPLETED|Follow up for 1 Year||0
5081379|NCT01738594|12502643|P5|COMPLETED|Follow up for 1 Year||1
5081380|NCT01738594|12502644|P4|COMPLETED|Follow up for 1 Year||0
5081381|NCT01738594|12502645|P3|COMPLETED|Follow up for 1 Year||0
5081382|NCT01738594|12502646|P2|COMPLETED|Follow up for 1 Year||2
5081383|NCT01738594|12502647|P1|COMPLETED|Follow up for 1 Year||0
5081384|NCT01738594|12502640|P8|STARTED|Follow up for 1 Year||0
5081385|NCT01738594|12502641|P7|STARTED|Follow up for 1 Year||0
5081386|NCT01738594|12502642|P6|STARTED|Follow up for 1 Year||3
5081387|NCT01738594|12502643|P5|STARTED|Follow up for 1 Year||1
5081388|NCT01738594|12502644|P4|STARTED|Follow up for 1 Year||0
5081389|NCT01738594|12502645|P3|STARTED|Follow up for 1 Year||0
5081390|NCT01738594|12502646|P2|STARTED|Follow up for 1 Year||2
5081391|NCT01738594|12502647|P1|STARTED|Follow up for 1 Year||0
5081392|NCT01738594|12502640|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081393|NCT01738594|12502641|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081394|NCT01738594|12502642|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
5081395|NCT01738594|12502643|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
5081396|NCT01738594|12502644|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081397|NCT01738594|12502645|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081398|NCT01738594|12502646|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081399|NCT01738594|12502647|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
5081400|NCT01738594|12502640|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081401|NCT01738594|12502641|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081402|NCT01738594|12502642|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081403|NCT01738594|12502643|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081404|NCT01738594|12502644|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081405|NCT01738594|12502645|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081406|NCT01738594|12502646|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081407|NCT01738594|12502647|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
5081408|NCT01738594|12502640|P8|STARTED|Went on to Continue Treatment Cycle 5||0
5081409|NCT01738594|12502641|P7|STARTED|Went on to Continue Treatment Cycle 5||0
5081410|NCT01738594|12502642|P6|STARTED|Went on to Continue Treatment Cycle 5||1
5081411|NCT01738594|12502643|P5|STARTED|Went on to Continue Treatment Cycle 5||1
5081412|NCT01738594|12502644|P4|STARTED|Went on to Continue Treatment Cycle 5||0
5081413|NCT01738594|12502645|P3|STARTED|Went on to Continue Treatment Cycle 5||0
5081414|NCT01738594|12502646|P2|STARTED|Went on to Continue Treatment Cycle 5||0
5081415|NCT01738594|12502647|P1|STARTED|Went on to Continue Treatment Cycle 5||0
5081416|NCT01738594|12502640|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081417|NCT01738594|12502641|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081418|NCT01738594|12502642|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
5081419|NCT01738594|12502643|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081420|NCT01738594|12502644|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081421|NCT01738594|12502645|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081422|NCT01738594|12502646|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
5081423|NCT01738594|12502647|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
5081424|NCT01738594|12502640|P8|COMPLETED|Completed 4 Cycles of Treatment||0
5081425|NCT01738594|12502641|P7|COMPLETED|Completed 4 Cycles of Treatment||0
5081426|NCT01738594|12502642|P6|COMPLETED|Completed 4 Cycles of Treatment||1
5081427|NCT01738594|12502643|P5|COMPLETED|Completed 4 Cycles of Treatment||1
5081428|NCT01738594|12502644|P4|COMPLETED|Completed 4 Cycles of Treatment||0
5081429|NCT01738594|12502645|P3|COMPLETED|Completed 4 Cycles of Treatment||0
5081430|NCT01738594|12502646|P2|COMPLETED|Completed 4 Cycles of Treatment||0
5081431|NCT01738594|12502647|P1|COMPLETED|Completed 4 Cycles of Treatment||0
5081432|NCT01738594|12502640|P8|STARTED|Completed 4 Cycles of Treatment||0
5081433|NCT01738594|12502641|P7|STARTED|Completed 4 Cycles of Treatment||0
5081434|NCT01738594|12502642|P6|STARTED|Completed 4 Cycles of Treatment||2
5081435|NCT01738594|12502643|P5|STARTED|Completed 4 Cycles of Treatment||1
5081436|NCT01738594|12502644|P4|STARTED|Completed 4 Cycles of Treatment||0
5081437|NCT01738594|12502645|P3|STARTED|Completed 4 Cycles of Treatment||0
5081438|NCT01738594|12502646|P2|STARTED|Completed 4 Cycles of Treatment||2
5081439|NCT01738594|12502647|P1|STARTED|Completed 4 Cycles of Treatment||0
5081440|NCT01738594|12502640|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081441|NCT01738594|12502641|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081442|NCT01738594|12502642|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
5081443|NCT01738594|12502643|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081444|NCT01738594|12502644|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081445|NCT01738594|12502645|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081446|NCT01738594|12502646|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081447|NCT01738594|12502647|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081448|NCT01738594|12502640|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081449|NCT01738594|12502641|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081450|NCT01738594|12502642|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
5081451|NCT01738594|12502643|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
5081452|NCT01738594|12502644|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081453|NCT01738594|12502645|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081454|NCT01738594|12502646|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
5081455|NCT01738594|12502647|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5081456|NCT01738594|12502640|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
5081457|NCT01738594|12502641|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
5081458|NCT01738594|12502642|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
5081459|NCT01738594|12502643|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
5081460|NCT01738594|12502644|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
5081461|NCT01738594|12502645|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
5081462|NCT01738594|12502646|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
5081463|NCT01738594|12502647|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
5081464|NCT01738594|12502640|P8|NOT COMPLETED|Registration and Treatment Start||0
5081465|NCT01738594|12502641|P7|NOT COMPLETED|Registration and Treatment Start||0
5081466|NCT01738594|12502642|P6|NOT COMPLETED|Registration and Treatment Start||0
5081467|NCT01738594|12502643|P5|NOT COMPLETED|Registration and Treatment Start||0
5081468|NCT01738594|12502644|P4|NOT COMPLETED|Registration and Treatment Start||0
5081469|NCT01738594|12502645|P3|NOT COMPLETED|Registration and Treatment Start||0
5081470|NCT01738594|12502646|P2|NOT COMPLETED|Registration and Treatment Start||1
5081471|NCT01738594|12502647|P1|NOT COMPLETED|Registration and Treatment Start||0
5081472|NCT01738594|12502640|P8|COMPLETED|Registration and Treatment Start||0
5081473|NCT01738594|12502641|P7|COMPLETED|Registration and Treatment Start||0
5081474|NCT01738594|12502642|P6|COMPLETED|Registration and Treatment Start||3
5081475|NCT01738594|12502643|P5|COMPLETED|Registration and Treatment Start||1
5081476|NCT01738594|12502644|P4|COMPLETED|Registration and Treatment Start||0
5081477|NCT01738594|12502645|P3|COMPLETED|Registration and Treatment Start||0
5081478|NCT01738594|12502646|P2|COMPLETED|Registration and Treatment Start||2
5081479|NCT01738594|12502647|P1|COMPLETED|Registration and Treatment Start||0
5081480|NCT01738594|12502640|P8|Treatment Started|Registration and Treatment Start||0
5081481|NCT01738594|12502641|P7|Treatment Started|Registration and Treatment Start||0
5081482|NCT01738594|12502642|P6|Treatment Started|Registration and Treatment Start||3
5081483|NCT01738594|12502643|P5|Treatment Started|Registration and Treatment Start||1
5081484|NCT01738594|12502644|P4|Treatment Started|Registration and Treatment Start||0
5081485|NCT01738594|12502645|P3|Treatment Started|Registration and Treatment Start||0
5081486|NCT01738594|12502646|P2|Treatment Started|Registration and Treatment Start||2
5081487|NCT01738594|12502647|P1|Treatment Started|Registration and Treatment Start||0
5081488|NCT01738594|12502640|P8|Registered to Study|Registration and Treatment Start||0
5081489|NCT01738594|12502641|P7|Registered to Study|Registration and Treatment Start||0
5081490|NCT01738594|12502642|P6|Registered to Study|Registration and Treatment Start||3
5081491|NCT01738594|12502643|P5|Registered to Study|Registration and Treatment Start||1
5081492|NCT01738594|12502644|P4|Registered to Study|Registration and Treatment Start||0
5081493|NCT01738594|12502645|P3|Registered to Study|Registration and Treatment Start||0
5081494|NCT01738594|12502646|P2|Registered to Study|Registration and Treatment Start||3
5081495|NCT01738594|12502647|P1|Registered to Study|Registration and Treatment Start||0
5081496|NCT01738594|12502640|P8|STARTED|Registration and Treatment Start||0
5081497|NCT01738594|12502641|P7|STARTED|Registration and Treatment Start||0
5081498|NCT01738594|12502642|P6|STARTED|Registration and Treatment Start||3
5081499|NCT01738594|12502643|P5|STARTED|Registration and Treatment Start||1
5081500|NCT01738594|12502644|P4|STARTED|Registration and Treatment Start||0
5081501|NCT01738594|12502645|P3|STARTED|Registration and Treatment Start||0
5081502|NCT01738594|12502646|P2|STARTED|Registration and Treatment Start||3
5081503|NCT01738594|12502647|P1|STARTED|Registration and Treatment Start||0
5081504|NCT01738581|12502665|P2|NOT COMPLETED|Overall Study||0
5081505|NCT01738581|12502666|P1|NOT COMPLETED|Overall Study||1
5081506|NCT01738581|12502665|P2|COMPLETED|Overall Study||4
5081507|NCT01738581|12502666|P1|COMPLETED|Overall Study||4
5081508|NCT01738581|12502665|P2|STARTED|Overall Study||4
5081509|NCT01738581|12502666|P1|STARTED|Overall Study||5
5081510|NCT01738503|12502690|P7|NOT COMPLETED|PET Imaging Sub-study||1
5081511|NCT01738503|12502691|P6|NOT COMPLETED|PET Imaging Sub-study||2
5081512|NCT01738503|12502692|P5|NOT COMPLETED|PET Imaging Sub-study||0
5081513|NCT01738503|12502693|P4|NOT COMPLETED|PET Imaging Sub-study||0
5081514|NCT01738503|12502694|P3|NOT COMPLETED|PET Imaging Sub-study||0
5081515|NCT01738503|12502695|P2|NOT COMPLETED|PET Imaging Sub-study||0
5081516|NCT01738503|12502696|P1|NOT COMPLETED|PET Imaging Sub-study||0
5081517|NCT01738503|12502690|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
5081518|NCT01738503|12502691|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
5081519|NCT01738503|12502692|P5|COMPLETED|PET Imaging Sub-study||0
5081520|NCT01738503|12502693|P4|COMPLETED|PET Imaging Sub-study||0
5081521|NCT01738503|12502694|P3|COMPLETED|PET Imaging Sub-study||0
5081522|NCT01738503|12502695|P2|COMPLETED|PET Imaging Sub-study||0
5081523|NCT01738503|12502696|P1|COMPLETED|PET Imaging Sub-study||0
5081524|NCT01738503|12502690|P7|STARTED|PET Imaging Sub-study||2
5081525|NCT01738503|12502691|P6|STARTED|PET Imaging Sub-study||3
5081526|NCT01738503|12502692|P5|STARTED|PET Imaging Sub-study||0
5081527|NCT01738503|12502693|P4|STARTED|PET Imaging Sub-study||0
5081528|NCT01738503|12502694|P3|STARTED|PET Imaging Sub-study||0
5081529|NCT01738503|12502695|P2|STARTED|PET Imaging Sub-study||0
5081530|NCT01738503|12502696|P1|STARTED|PET Imaging Sub-study||0
5081531|NCT01738503|12502690|P7|NOT COMPLETED|Treatment Period||8
5081532|NCT01738503|12502691|P6|NOT COMPLETED|Treatment Period||6
5081533|NCT01738503|12502692|P5|NOT COMPLETED|Treatment Period||8
5081534|NCT01738503|12502693|P4|NOT COMPLETED|Treatment Period||6
5081535|NCT01738503|12502694|P3|NOT COMPLETED|Treatment Period||5
5081536|NCT01738503|12502695|P2|NOT COMPLETED|Treatment Period||5
5081537|NCT01738503|12502696|P1|NOT COMPLETED|Treatment Period||0
5081538|NCT01738503|12502690|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
5081539|NCT01738503|12502691|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
5081540|NCT01738503|12502692|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
5081541|NCT01738503|12502693|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
5081542|NCT01738503|12502694|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
5081543|NCT01738503|12502695|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
5081544|NCT01738503|12502696|P1|COMPLETED|Treatment Period||0
5081545|NCT01738503|12502690|P7|STARTED|Treatment Period||14
5081546|NCT01738503|12502691|P6|STARTED|Treatment Period||15
5081547|NCT01738503|12502692|P5|STARTED|Treatment Period||15
5081548|NCT01738503|12502693|P4|STARTED|Treatment Period||15
5081549|NCT01738503|12502694|P3|STARTED|Treatment Period||15
5081550|NCT01738503|12502695|P2|STARTED|Treatment Period||15
5081551|NCT01738503|12502696|P1|STARTED|Treatment Period||0
5081552|NCT01738503|12502690|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081553|NCT01738503|12502691|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081554|NCT01738503|12502692|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081555|NCT01738503|12502693|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081556|NCT01738503|12502694|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081557|NCT01738503|12502695|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081558|NCT01738503|12502696|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
5081559|NCT01738503|12502690|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081560|NCT01738503|12502691|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081561|NCT01738503|12502692|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081562|NCT01738503|12502693|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081563|NCT01738503|12502694|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081564|NCT01738503|12502695|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
5081565|NCT01738503|12502696|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
5081566|NCT01738503|12502690|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081567|NCT01738503|12502691|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081568|NCT01738503|12502692|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081569|NCT01738503|12502693|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081570|NCT01738503|12502694|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081571|NCT01738503|12502695|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
5081572|NCT01738503|12502696|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
5081573|NCT01738477|12502894|P2|NOT COMPLETED|Overall Study||4
5081574|NCT01738477|12502895|P1|NOT COMPLETED|Overall Study||1
5081575|NCT01738477|12502894|P2|COMPLETED|Overall Study||124
5081576|NCT01738477|12502895|P1|COMPLETED|Overall Study||36
5081577|NCT01738477|12502894|P2|STARTED|Overall Study||128
5081578|NCT01738477|12502895|P1|STARTED|Overall Study||37
5081579|NCT01738438|12502923|P1|NOT COMPLETED|Overall Study||35
5081580|NCT01738438|12502923|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
5081581|NCT01738438|12502923|P1|STARTED|Overall Study||35
5081582|NCT01738321|12502931|P2|NOT COMPLETED|Overall Study||0
5081583|NCT01738321|12502932|P1|NOT COMPLETED|Overall Study||0
5081584|NCT01738321|12502931|P2|COMPLETED|Overall Study||30
5081585|NCT01738321|12502932|P1|COMPLETED|Overall Study||33
5081586|NCT01738321|12502931|P2|STARTED|Overall Study||30
5081587|NCT01738321|12502932|P1|STARTED|Overall Study||33
5081588|NCT01738191|12502940|P2|NOT COMPLETED|Overall Study||1
5081589|NCT01738191|12502941|P1|NOT COMPLETED|Overall Study||4
5081590|NCT01738191|12502940|P2|COMPLETED|Overall Study||14
5081591|NCT01738191|12502941|P1|COMPLETED|Overall Study||11
5081592|NCT01738191|12502940|P2|STARTED|Overall Study||15
5081593|NCT01738191|12502941|P1|STARTED|Overall Study||15
5081594|NCT01737996|12502964|P3|NOT COMPLETED|Overall Study||2
5081595|NCT01737996|12502965|P2|NOT COMPLETED|Overall Study||1
5081596|NCT01737996|12502966|P1|NOT COMPLETED|Overall Study||0
5081597|NCT01737996|12502964|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
5081598|NCT01737996|12502965|P2|COMPLETED|Overall Study||7
5081599|NCT01737996|12502966|P1|COMPLETED|Overall Study||8
5081600|NCT01737996|12502964|P3|STARTED|Overall Study||16
5081601|NCT01737996|12502965|P2|STARTED|Overall Study||8
5081602|NCT01737996|12502966|P1|STARTED|Overall Study||8
5081603|NCT01737944|12503007|P4|NOT COMPLETED|Overall Study||0
5081604|NCT01737944|12503008|P3|NOT COMPLETED|Overall Study||0
5081605|NCT01737944|12503009|P2|NOT COMPLETED|Overall Study||0
5081606|NCT01737944|12503010|P1|NOT COMPLETED|Overall Study||0
5081607|NCT01737944|12503007|P4|COMPLETED|Overall Study||9
5081608|NCT01737944|12503008|P3|COMPLETED|Overall Study||9
5081609|NCT01737944|12503009|P2|COMPLETED|Overall Study||9
5081610|NCT01737944|12503010|P1|COMPLETED|Overall Study||9
5081611|NCT01737944|12503007|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
5081612|NCT01737944|12503008|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
5081613|NCT01737944|12503009|P2|STARTED|Overall Study||9
5081614|NCT01737944|12503010|P1|STARTED|Overall Study||9
5081615|NCT01737931|12503028|P3|NOT COMPLETED|Overall Study||1
5081616|NCT01737931|12503029|P2|NOT COMPLETED|Overall Study||2
5081617|NCT01737931|12503030|P1|NOT COMPLETED|Overall Study||0
5081618|NCT01737931|12503028|P3|COMPLETED|Overall Study||38
5081619|NCT01737931|12503029|P2|COMPLETED|Overall Study||38
5081620|NCT01737931|12503030|P1|COMPLETED|Overall Study||38
5081621|NCT01737931|12503028|P3|STARTED|Overall Study||39
5081622|NCT01737931|12503029|P2|STARTED|Overall Study||40
5081623|NCT01737931|12503030|P1|STARTED|Overall Study||38
5081624|NCT01737879|12503045|P1|NOT COMPLETED|Overall Study||41
5081625|NCT01737879|12503045|P1|COMPLETED|Overall Study||0
5081626|NCT01737879|12503045|P1|Transitioned to Epoetin Alfa|Overall Study||0
5081627|NCT01737879|12503045|P1|Received Peginesatide|Overall Study||34
5081628|NCT01737879|12503045|P1|STARTED|Overall Study||41
5081629|NCT01737840|12503054|P2|NOT COMPLETED|Overall Study||2
5081630|NCT01737840|12503055|P1|NOT COMPLETED|Overall Study||2
5081631|NCT01737840|12503054|P2|COMPLETED|Overall Study||33
5081632|NCT01737840|12503055|P1|COMPLETED|Overall Study||33
5081633|NCT01737840|12503054|P2|STARTED|Overall Study||35
5081634|NCT01737840|12503055|P1|STARTED|Overall Study||35
5081635|NCT01737762|12503065|P2|NOT COMPLETED|Overall Study||17
5081636|NCT01737762|12503066|P1|NOT COMPLETED|Overall Study||20
5081637|NCT01737762|12503065|P2|COMPLETED|Overall Study||61
5081638|NCT01737762|12503066|P1|COMPLETED|Overall Study||57
5081639|NCT01737762|12503065|P2|STARTED|Overall Study||78
5081640|NCT01737762|12503066|P1|STARTED|Overall Study||77
5081641|NCT01737710|12503079|P5|NOT COMPLETED|Overall Study||0
5081642|NCT01737710|12503080|P4|NOT COMPLETED|Overall Study||0
5081643|NCT01737710|12503081|P3|NOT COMPLETED|Overall Study||3
5081644|NCT01737710|12503082|P2|NOT COMPLETED|Overall Study||4
5081645|NCT01737710|12503083|P1|NOT COMPLETED|Overall Study||2
5081646|NCT01737710|12503079|P5|COMPLETED|Overall Study||21
5081647|NCT01737710|12503080|P4|COMPLETED|Overall Study||23
5081648|NCT01737710|12503081|P3|COMPLETED|Overall Study||102
5081649|NCT01737710|12503082|P2|COMPLETED|Overall Study||101
5081650|NCT01737710|12503083|P1|COMPLETED|Overall Study||112
5081651|NCT01737710|12503079|P5|STARTED|Overall Study||21
5081652|NCT01737710|12503080|P4|STARTED|Overall Study||23
5081653|NCT01737710|12503081|P3|STARTED|Overall Study||105
5081654|NCT01737710|12503082|P2|STARTED|Overall Study||105
5081655|NCT01737710|12503083|P1|STARTED|Overall Study||114
5081656|NCT01737697|12503125|P15|NOT COMPLETED|Subacute Phase||1
5081657|NCT01737697|12503126|P14|NOT COMPLETED|Subacute Phase||2
5081658|NCT01737697|12503127|P13|NOT COMPLETED|Subacute Phase||2
5081659|NCT01737697|12503128|P12|NOT COMPLETED|Subacute Phase||3
5081660|NCT01737697|12503129|P11|NOT COMPLETED|Subacute Phase||6
5081661|NCT01737697|12503130|P10|NOT COMPLETED|Subacute Phase||2
5081662|NCT01737697|12503131|P9|NOT COMPLETED|Subacute Phase||2
5081663|NCT01737697|12503132|P8|NOT COMPLETED|Subacute Phase||3
5081664|NCT01737697|12503133|P7|NOT COMPLETED|Subacute Phase||1
5081665|NCT01737697|12503134|P6|NOT COMPLETED|Subacute Phase||3
5081666|NCT01737697|12503135|P5|NOT COMPLETED|Subacute Phase||0
5081667|NCT01737697|12503136|P4|NOT COMPLETED|Subacute Phase||0
5081668|NCT01737697|12503137|P3|NOT COMPLETED|Subacute Phase||0
5081669|NCT01737697|12503138|P2|NOT COMPLETED|Subacute Phase||0
5081670|NCT01737697|12503139|P1|NOT COMPLETED|Subacute Phase||0
5081671|NCT01737697|12503125|P15|COMPLETED|Subacute Phase||49
5081672|NCT01737697|12503126|P14|COMPLETED|Subacute Phase||44
5081673|NCT01737697|12503127|P13|COMPLETED|Subacute Phase||61
5081674|NCT01737697|12503128|P12|COMPLETED|Subacute Phase||58
5081675|NCT01737697|12503129|P11|COMPLETED|Subacute Phase||59
5081676|NCT01737697|12503130|P10|COMPLETED|Subacute Phase||66
5081677|NCT01737697|12503131|P9|COMPLETED|Subacute Phase||52
5081678|NCT01737697|12503132|P8|COMPLETED|Subacute Phase||43
5081679|NCT01737697|12503133|P7|COMPLETED|Subacute Phase||48
5081680|NCT01737697|12503134|P6|COMPLETED|Subacute Phase||38
5081681|NCT01737697|12503135|P5|COMPLETED|Subacute Phase||0
5081682|NCT01737697|12503136|P4|COMPLETED|Subacute Phase||0
5081683|NCT01737697|12503137|P3|COMPLETED|Subacute Phase||0
5081684|NCT01737697|12503138|P2|COMPLETED|Subacute Phase||0
5081685|NCT01737697|12503139|P1|COMPLETED|Subacute Phase||0
5081686|NCT01737697|12503125|P15|STARTED|Subacute Phase||50
5081687|NCT01737697|12503126|P14|STARTED|Subacute Phase||46
5081688|NCT01737697|12503127|P13|STARTED|Subacute Phase||63
5081689|NCT01737697|12503128|P12|STARTED|Subacute Phase||61
5081690|NCT01737697|12503129|P11|STARTED|Subacute Phase||65
5081691|NCT01737697|12503130|P10|STARTED|Subacute Phase||68
5081692|NCT01737697|12503131|P9|STARTED|Subacute Phase||54
5081693|NCT01737697|12503132|P8|STARTED|Subacute Phase||46
5081694|NCT01737697|12503133|P7|STARTED|Subacute Phase||49
5081695|NCT01737697|12503134|P6|STARTED|Subacute Phase||41
5081696|NCT01737697|12503135|P5|STARTED|Subacute Phase||0
5081697|NCT01737697|12503136|P4|STARTED|Subacute Phase||0
5081698|NCT01737697|12503137|P3|STARTED|Subacute Phase||0
5081699|NCT01737697|12503138|P2|STARTED|Subacute Phase||0
5081700|NCT01737697|12503139|P1|STARTED|Subacute Phase||0
5081701|NCT01737697|12503125|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081702|NCT01737697|12503126|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081703|NCT01737697|12503127|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081704|NCT01737697|12503128|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081705|NCT01737697|12503129|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081706|NCT01737697|12503130|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081707|NCT01737697|12503131|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081708|NCT01737697|12503132|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081709|NCT01737697|12503133|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081710|NCT01737697|12503134|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
5081711|NCT01737697|12503135|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
5081712|NCT01737697|12503136|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
5081713|NCT01737697|12503137|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
5081714|NCT01737697|12503138|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
5081715|NCT01737697|12503139|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
5081716|NCT01737697|12503125|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
5081717|NCT01737697|12503126|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
5081718|NCT01737697|12503127|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
5081719|NCT01737697|12503128|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
5081720|NCT01737697|12503129|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
5081721|NCT01737697|12503130|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
5081722|NCT01737697|12503131|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
5081723|NCT01737697|12503132|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
5081724|NCT01737697|12503133|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
5081725|NCT01737697|12503134|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
5081726|NCT01737697|12503135|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
5081727|NCT01737697|12503136|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
5081728|NCT01737697|12503137|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
5081729|NCT01737697|12503138|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
5081730|NCT01737697|12503139|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
5081731|NCT01737697|12503125|P15|STARTED|Acute Phase-Initial 48 Hours||0
5081732|NCT01737697|12503126|P14|STARTED|Acute Phase-Initial 48 Hours||0
5081733|NCT01737697|12503127|P13|STARTED|Acute Phase-Initial 48 Hours||0
5081734|NCT01737697|12503128|P12|STARTED|Acute Phase-Initial 48 Hours||0
5081735|NCT01737697|12503129|P11|STARTED|Acute Phase-Initial 48 Hours||0
5081736|NCT01737697|12503130|P10|STARTED|Acute Phase-Initial 48 Hours||0
5081737|NCT01737697|12503131|P9|STARTED|Acute Phase-Initial 48 Hours||0
5081738|NCT01737697|12503132|P8|STARTED|Acute Phase-Initial 48 Hours||0
5081739|NCT01737697|12503133|P7|STARTED|Acute Phase-Initial 48 Hours||0
5081740|NCT01737697|12503134|P6|STARTED|Acute Phase-Initial 48 Hours||0
5081741|NCT01737697|12503135|P5|STARTED|Acute Phase-Initial 48 Hours||143
5081742|NCT01737697|12503136|P4|STARTED|Acute Phase-Initial 48 Hours||158
5081743|NCT01737697|12503137|P3|STARTED|Acute Phase-Initial 48 Hours||141
5081744|NCT01737697|12503138|P2|STARTED|Acute Phase-Initial 48 Hours||154
5081745|NCT01737697|12503139|P1|STARTED|Acute Phase-Initial 48 Hours||158
5081746|NCT01737684|12503228|P3|NOT COMPLETED|Overall Study||0
5081747|NCT01737684|12503229|P2|NOT COMPLETED|Overall Study||0
5081748|NCT01737684|12503230|P1|NOT COMPLETED|Overall Study||0
5081749|NCT01737684|12503228|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
5081750|NCT01737684|12503229|P2|COMPLETED|Overall Study||8
5081751|NCT01737684|12503230|P1|COMPLETED|Overall Study||8
5081752|NCT01737684|12503228|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
5081753|NCT01737684|12503229|P2|STARTED|Overall Study||8
5081754|NCT01737684|12503230|P1|STARTED|Overall Study||8
5081755|NCT01737593|12503249|P3|NOT COMPLETED|Overall Study||0
5081756|NCT01737593|12503250|P2|NOT COMPLETED|Overall Study||0
5081757|NCT01737593|12503251|P1|NOT COMPLETED|Overall Study||0
5081758|NCT01737593|12503249|P3|COMPLETED|Overall Study||39
5081759|NCT01737593|12503250|P2|COMPLETED|Overall Study||32
5081760|NCT01737593|12503251|P1|COMPLETED|Overall Study||37
5081761|NCT01737593|12503249|P3|STARTED|Overall Study||39
5081762|NCT01737593|12503250|P2|STARTED|Overall Study||32
5081763|NCT01737593|12503251|P1|STARTED|Overall Study||37
5081764|NCT01737398|12503282|P2|NOT COMPLETED|Overall Study||8
5081765|NCT01737398|12503283|P1|NOT COMPLETED|Overall Study||26
5081766|NCT01737398|12503282|P2|COMPLETED|Overall Study||52
5081767|NCT01737398|12503283|P1|COMPLETED|Overall Study||87
5081768|NCT01737398|12503282|P2|Safety Set|Overall Study||60
5081769|NCT01737398|12503283|P1|Safety Set|Overall Study||112
5081770|NCT01737398|12503282|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
5081771|NCT01737398|12503283|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
5081772|NCT01737398|12503282|P2|STARTED|Overall Study||60
5081773|NCT01737398|12503283|P1|STARTED|Overall Study||113
5081774|NCT01737281|12503327|P2|NOT COMPLETED|Overall Study||280
5081775|NCT01737281|12503328|P1|NOT COMPLETED|Overall Study||366
5081776|NCT01737281|12503327|P2|COMPLETED|Overall Study||689
5081777|NCT01737281|12503328|P1|COMPLETED|Overall Study||603
5081778|NCT01737281|12503327|P2|STARTED|Overall Study||969
5081779|NCT01737281|12503328|P1|STARTED|Overall Study||969
5081780|NCT01737268|12503336|P1|NOT COMPLETED|Overall Study||9
5081781|NCT01737268|12503336|P1|COMPLETED|Overall Study||11
5081782|NCT01737268|12503336|P1|Treated|Overall Study||20
5081783|NCT01737268|12503336|P1|STARTED|Overall Study||20
5081784|NCT01737021|12503350|P2|NOT COMPLETED|Overall Study||3
5081785|NCT01737021|12503351|P1|NOT COMPLETED|Overall Study||5
5081786|NCT01737021|12503350|P2|COMPLETED|Overall Study||6
5081787|NCT01737021|12503351|P1|COMPLETED|Overall Study||17
5081788|NCT01737021|12503350|P2|STARTED|Overall Study||9
5081789|NCT01737021|12503351|P1|STARTED|Overall Study||22
5081790|NCT01736930|12503357|P1|NOT COMPLETED|Overall Study||1
5081791|NCT01736930|12503357|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
5081792|NCT01736930|12503357|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
5081793|NCT01736917|12503397|P1|NOT COMPLETED|Overall Study||11
5081794|NCT01736917|12503397|P1|COMPLETED|Overall Study||54
5081795|NCT01736917|12503397|P1|STARTED|Overall Study||65
5081796|NCT01736865|12503406|P2|NOT COMPLETED|Overall Study||0
5081797|NCT01736865|12503407|P1|NOT COMPLETED|Overall Study||0
5081798|NCT01736865|12503406|P2|COMPLETED|Overall Study||66
5081799|NCT01736865|12503407|P1|COMPLETED|Overall Study||61
5081800|NCT01736865|12503406|P2|STARTED|Overall Study||66
5081801|NCT01736865|12503407|P1|STARTED|Overall Study||61
5081802|NCT01736696|12503426|P7|NOT COMPLETED|Overall Study||0
5081803|NCT01736696|12503427|P6|NOT COMPLETED|Overall Study||0
5081804|NCT01736696|12503428|P5|NOT COMPLETED|Overall Study||0
5081805|NCT01736696|12503429|P4|NOT COMPLETED|Overall Study||0
5081806|NCT01736696|12503430|P3|NOT COMPLETED|Overall Study||1
5081807|NCT01736696|12503431|P2|NOT COMPLETED|Overall Study||0
5081808|NCT01736696|12503432|P1|NOT COMPLETED|Overall Study||0
5081809|NCT01736696|12503426|P7|COMPLETED|Overall Study||13
5081810|NCT01736696|12503427|P6|COMPLETED|Overall Study||8
5081811|NCT01736696|12503428|P5|COMPLETED|Overall Study||9
5081812|NCT01736696|12503429|P4|COMPLETED|Overall Study||9
5081813|NCT01736696|12503430|P3|COMPLETED|Overall Study||9
5081814|NCT01736696|12503431|P2|COMPLETED|Overall Study||5
5081815|NCT01736696|12503432|P1|COMPLETED|Overall Study||5
5081816|NCT01736696|12503426|P7|STARTED|Overall Study||13
5081817|NCT01736696|12503427|P6|STARTED|Overall Study||8
5081818|NCT01736696|12503428|P5|STARTED|Overall Study||9
5081819|NCT01736696|12503429|P4|STARTED|Overall Study||9
5081820|NCT01736696|12503430|P3|STARTED|Overall Study||10
5081821|NCT01736696|12503431|P2|STARTED|Overall Study||5
5081822|NCT01736696|12503432|P1|STARTED|Overall Study||5
5081823|NCT01736683|12503754|P5|NOT COMPLETED|Overall Study||5
5081824|NCT01736683|12503755|P4|NOT COMPLETED|Overall Study||35
5081825|NCT01736683|12503756|P3|NOT COMPLETED|Overall Study||21
5081826|NCT01736683|12503757|P2|NOT COMPLETED|Overall Study||6
5081827|NCT01736683|12503758|P1|NOT COMPLETED|Overall Study||7
5081828|NCT01736683|12503754|P5|COMPLETED|Overall Study|# who completed treatment|0
5081829|NCT01736683|12503755|P4|COMPLETED|Overall Study|# who completed treatment|0
5081830|NCT01736683|12503756|P3|COMPLETED|Overall Study|# who completed treatment|0
5081831|NCT01736683|12503757|P2|COMPLETED|Overall Study|# who completed treatment|0
5081832|NCT01736683|12503758|P1|COMPLETED|Overall Study|# who completed treatment|0
5081833|NCT01736683|12503754|P5|STARTED|Overall Study||5
5081834|NCT01736683|12503755|P4|STARTED|Overall Study||35
5081835|NCT01736683|12503756|P3|STARTED|Overall Study||21
5081836|NCT01736683|12503757|P2|STARTED|Overall Study||6
5081837|NCT01736683|12503758|P1|STARTED|Overall Study||7
5081838|NCT01736657|12503820|P1|NOT COMPLETED|Overall Study||1
5081839|NCT01736657|12503820|P1|COMPLETED|Overall Study||72
5081840|NCT01736657|12503820|P1|STARTED|Overall Study||73
5081841|NCT01736579|12503829|P2|NOT COMPLETED|Overall Study||2
5081842|NCT01736579|12503830|P1|NOT COMPLETED|Overall Study||2
5081843|NCT01736579|12503829|P2|COMPLETED|Overall Study||0
5081844|NCT01736579|12503830|P1|COMPLETED|Overall Study||0
5081845|NCT01736579|12503829|P2|STARTED|Overall Study||2
5081846|NCT01736579|12503830|P1|STARTED|Overall Study||2
5081847|NCT01736566|12503869|P5|NOT COMPLETED|Long Term Follow-up||1
5081848|NCT01736566|12503870|P4|NOT COMPLETED|Long Term Follow-up||0
5081849|NCT01736566|12503871|P3|NOT COMPLETED|Long Term Follow-up||49
5081850|NCT01736566|12503872|P2|NOT COMPLETED|Long Term Follow-up||0
5081851|NCT01736566|12503873|P1|NOT COMPLETED|Long Term Follow-up||42
5081852|NCT01736566|12503869|P5|COMPLETED|Long Term Follow-up||0
5081853|NCT01736566|12503870|P4|COMPLETED|Long Term Follow-up||0
5081854|NCT01736566|12503871|P3|COMPLETED|Long Term Follow-up||0
5081855|NCT01736566|12503872|P2|COMPLETED|Long Term Follow-up||0
5081856|NCT01736566|12503873|P1|COMPLETED|Long Term Follow-up||0
5081857|NCT01736566|12503869|P5|STARTED|Long Term Follow-up||1
5081858|NCT01736566|12503870|P4|STARTED|Long Term Follow-up||0
5081859|NCT01736566|12503871|P3|STARTED|Long Term Follow-up||49
5081860|NCT01736566|12503872|P2|STARTED|Long Term Follow-up||0
5081861|NCT01736566|12503873|P1|STARTED|Long Term Follow-up||42
5081862|NCT01736566|12503869|P5|NOT COMPLETED|Main Study||4
5081863|NCT01736566|12503870|P4|NOT COMPLETED|Main Study||1
5081864|NCT01736566|12503871|P3|NOT COMPLETED|Main Study||1
5081865|NCT01736566|12503872|P2|NOT COMPLETED|Main Study||0
5081866|NCT01736566|12503873|P1|NOT COMPLETED|Main Study||1
5081867|NCT01736566|12503869|P5|COMPLETED|Main Study||6
5081868|NCT01736566|12503870|P4|COMPLETED|Main Study||51
5081869|NCT01736566|12503871|P3|COMPLETED|Main Study||49
5081870|NCT01736566|12503872|P2|COMPLETED|Main Study||50
5081871|NCT01736566|12503873|P1|COMPLETED|Main Study||50
5081872|NCT01736566|12503869|P5|STARTED|Main Study||10
5081873|NCT01736566|12503870|P4|STARTED|Main Study||52
5081874|NCT01736566|12503871|P3|STARTED|Main Study||50
5081875|NCT01736566|12503872|P2|STARTED|Main Study||50
5081876|NCT01736566|12503873|P1|STARTED|Main Study||51
5081877|NCT01736553|12503958|P2|NOT COMPLETED|Overall Study||4
5081878|NCT01736553|12503959|P1|NOT COMPLETED|Overall Study||19
5081879|NCT01736553|12503958|P2|COMPLETED|Overall Study||23
5081880|NCT01736553|12503959|P1|COMPLETED|Overall Study||7
5081881|NCT01736553|12503958|P2|STARTED|Overall Study||27
5081882|NCT01736553|12503959|P1|STARTED|Overall Study||26
5081883|NCT01736540|12504010|P1|NOT COMPLETED|Overall Study||15
5081884|NCT01736540|12504010|P1|COMPLETED|Overall Study||228
5081885|NCT01736540|12504010|P1|STARTED|Overall Study||243
5081886|NCT01736527|12504067|P1|NOT COMPLETED|Overall Study||0
5081887|NCT01736527|12504067|P1|COMPLETED|Overall Study||12
5081888|NCT01736527|12504067|P1|STARTED|Overall Study||12
5081889|NCT01736475|12504076|P2|NOT COMPLETED|Overall Study||0
5081890|NCT01736475|12504077|P1|NOT COMPLETED|Overall Study||12
5081891|NCT01736475|12504076|P2|COMPLETED|Overall Study||17
5081892|NCT01736475|12504077|P1|COMPLETED|Overall Study||109
5081893|NCT01736475|12504076|P2|STARTED|Overall Study||17
5081894|NCT01736475|12504077|P1|STARTED|Overall Study||121
5081895|NCT01736397|12504132|P2|NOT COMPLETED|Overall Study||24
5081896|NCT01736397|12504133|P1|NOT COMPLETED|Overall Study||14
5081897|NCT01736397|12504132|P2|COMPLETED|Overall Study||50
5081898|NCT01736397|12504133|P1|COMPLETED|Overall Study||61
5081899|NCT01736397|12504132|P2|STARTED|Overall Study||74
5081900|NCT01736397|12504133|P1|STARTED|Overall Study||75
5081901|NCT01736358|12504147|P2|NOT COMPLETED|Overall Study||2
5081902|NCT01736358|12504148|P1|NOT COMPLETED|Overall Study||5
5081903|NCT01736358|12504147|P2|COMPLETED|Overall Study||23
5081904|NCT01736358|12504148|P1|COMPLETED|Overall Study||20
5081905|NCT01736358|12504147|P2|STARTED|Overall Study||25
5081906|NCT01736358|12504148|P1|STARTED|Overall Study||25
5081907|NCT01736267|12504162|P1|NOT COMPLETED|Overall Study||0
5081908|NCT01736267|12504162|P1|COMPLETED|Overall Study||3
5081909|NCT01736267|12504162|P1|STARTED|Overall Study||3
5081910|NCT01736254|12504166|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
5081911|NCT01736254|12504166|P1|COMPLETED|Period 3 (Days 13 to 23)||20
5081912|NCT01736254|12504166|P1|STARTED|Period 3 (Days 13 to 23)||21
5081913|NCT01736254|12504166|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
5081914|NCT01736254|12504166|P1|COMPLETED|Period 2 (Days 2 to 12)||21
5081915|NCT01736254|12504166|P1|STARTED|Period 2 (Days 2 to 12)||24
5081916|NCT01736254|12504166|P1|NOT COMPLETED|Period 1 (Day 1)||0
5081917|NCT01736254|12504166|P1|COMPLETED|Period 1 (Day 1)||24
5081918|NCT01736254|12504166|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
5081919|NCT01736254|12504166|P1|STARTED|Period 1 (Day 1)||24
5081920|NCT01736241|12504190|P7|NOT COMPLETED|Overall Study||0
5081921|NCT01736241|12504191|P6|NOT COMPLETED|Overall Study||0
5081922|NCT01736241|12504192|P5|NOT COMPLETED|Overall Study||0
5081923|NCT01736241|12504193|P4|NOT COMPLETED|Overall Study||0
5081924|NCT01736241|12504194|P3|NOT COMPLETED|Overall Study||0
5081925|NCT01736241|12504195|P2|NOT COMPLETED|Overall Study||0
5081926|NCT01736241|12504196|P1|NOT COMPLETED|Overall Study||0
5081927|NCT01736241|12504190|P7|COMPLETED|Overall Study||6
5081928|NCT01736241|12504191|P6|COMPLETED|Overall Study||6
5081929|NCT01736241|12504192|P5|COMPLETED|Overall Study||6
5081930|NCT01736241|12504193|P4|COMPLETED|Overall Study||5
5081931|NCT01736241|12504194|P3|COMPLETED|Overall Study||6
5081932|NCT01736241|12504195|P2|COMPLETED|Overall Study||6
5081933|NCT01736241|12504196|P1|COMPLETED|Overall Study||6
5081934|NCT01736241|12504190|P7|Received at Least One Dose of Study Drug|Overall Study||6
5081935|NCT01736241|12504191|P6|Received at Least One Dose of Study Drug|Overall Study||6
5081936|NCT01736241|12504192|P5|Received at Least One Dose of Study Drug|Overall Study||6
5081937|NCT01736241|12504193|P4|Received at Least One Dose of Study Drug|Overall Study||5
5081938|NCT01736241|12504194|P3|Received at Least One Dose of Study Drug|Overall Study||6
5081939|NCT01736241|12504195|P2|Received at Least One Dose of Study Drug|Overall Study||6
5081940|NCT01736241|12504196|P1|Received at Least One Dose of Study Drug|Overall Study||6
5081941|NCT01736241|12504190|P7|STARTED|Overall Study||6
5081942|NCT01736241|12504191|P6|STARTED|Overall Study||6
5081943|NCT01736241|12504192|P5|STARTED|Overall Study||6
5081944|NCT01736241|12504193|P4|STARTED|Overall Study||5
5081945|NCT01736241|12504194|P3|STARTED|Overall Study||6
5081946|NCT01736241|12504195|P2|STARTED|Overall Study||6
5081947|NCT01736241|12504196|P1|STARTED|Overall Study||6
5081948|NCT01736215|12504231|P1|NOT COMPLETED|Overall Study||14
5081949|NCT01736215|12504231|P1|COMPLETED|Overall Study||19
5081950|NCT01736215|12504231|P1|Treated|Overall Study||25
5081951|NCT01736215|12504231|P1|STARTED|Overall Study||33
5081952|NCT01736189|12504243|P1|NOT COMPLETED|Overall Study||46
5081953|NCT01736189|12504243|P1|COMPLETED|Overall Study||300
5081954|NCT01736189|12504243|P1|STARTED|Overall Study||346
5081955|NCT01736176|12504252|P1|NOT COMPLETED|Overall Study||11
5081956|NCT01736176|12504252|P1|COMPLETED|Overall Study||28
5081957|NCT01736176|12504252|P1|Received LCIG|Overall Study||38
5081958|NCT01736176|12504252|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
5081959|NCT01736085|12504302|P6|NOT COMPLETED|Overall Study||0
5081960|NCT01736085|12504303|P5|NOT COMPLETED|Overall Study||0
5081961|NCT01736085|12504304|P4|NOT COMPLETED|Overall Study||0
5081962|NCT01736085|12504305|P3|NOT COMPLETED|Overall Study||0
5081963|NCT01736085|12504306|P2|NOT COMPLETED|Overall Study||0
5081964|NCT01736085|12504307|P1|NOT COMPLETED|Overall Study||0
5081965|NCT01736085|12504302|P6|COMPLETED|Overall Study||794
5081966|NCT01736085|12504303|P5|COMPLETED|Overall Study||530
5081967|NCT01736085|12504304|P4|COMPLETED|Overall Study||530
5081968|NCT01736085|12504305|P3|COMPLETED|Overall Study||793
5081969|NCT01736085|12504306|P2|COMPLETED|Overall Study||530
5081970|NCT01736085|12504307|P1|COMPLETED|Overall Study||529
5081971|NCT01736085|12504302|P6|STARTED|Overall Study||794
5081972|NCT01736085|12504303|P5|STARTED|Overall Study||530
5081973|NCT01736085|12504304|P4|STARTED|Overall Study||530
5081974|NCT01736085|12504305|P3|STARTED|Overall Study||793
5081975|NCT01736085|12504306|P2|STARTED|Overall Study||530
5081976|NCT01736085|12504307|P1|STARTED|Overall Study||529
5081977|NCT01735994|12504323|P2|NOT COMPLETED|Overall Study||66
5081978|NCT01735994|12504324|P1|NOT COMPLETED|Overall Study||63
5081979|NCT01735994|12504323|P2|COMPLETED|Overall Study||152
5081980|NCT01735994|12504324|P1|COMPLETED|Overall Study||200
5081981|NCT01735994|12504323|P2|Follow-Up #2 (12 Months)|Overall Study||174
5081982|NCT01735994|12504324|P1|Follow-Up #2 (12 Months)|Overall Study||212
5081983|NCT01735994|12504323|P2|Follow-Up #1 (6 Months)|Overall Study||163
5081984|NCT01735994|12504324|P1|Follow-Up #1 (6 Months)|Overall Study||213
5081985|NCT01735994|12504323|P2|Post Intervention (3 Weeks)|Overall Study||198
5081986|NCT01735994|12504324|P1|Post Intervention (3 Weeks)|Overall Study||239
5081987|NCT01735994|12504323|P2|STARTED|Overall Study||218
5081988|NCT01735994|12504324|P1|STARTED|Overall Study||263
5081989|NCT01735916|12504339|P3|NOT COMPLETED|Overall Study||7
5081990|NCT01735916|12504340|P2|NOT COMPLETED|Overall Study||19
5081991|NCT01735916|12504341|P1|NOT COMPLETED|Overall Study||18
5081992|NCT01735916|12504339|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
5081993|NCT01735916|12504340|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
5081994|NCT01735916|12504341|P1|COMPLETED|Overall Study||0
5081995|NCT01735916|12504339|P3|STARTED|Overall Study||7
5081996|NCT01735916|12504340|P2|STARTED|Overall Study||19
5081997|NCT01735916|12504341|P1|STARTED|Overall Study||18
5081998|NCT01735877|12504362|P2|NOT COMPLETED|Overall Study||0
5081999|NCT01735877|12504363|P1|NOT COMPLETED|Overall Study||1
5082000|NCT01735877|12504362|P2|COMPLETED|Overall Study||21
5082001|NCT01735877|12504363|P1|COMPLETED|Overall Study||26
5082002|NCT01735877|12504362|P2|STARTED|Overall Study||21
5082003|NCT01735877|12504363|P1|STARTED|Overall Study||27
5082004|NCT01735630|12504379|P2|NOT COMPLETED|Overall Study||18
5082005|NCT01735630|12504380|P1|NOT COMPLETED|Overall Study||18
5082006|NCT01735630|12504379|P2|COMPLETED|Overall Study||157
5082007|NCT01735630|12504380|P1|COMPLETED|Overall Study||157
5082008|NCT01735630|12504379|P2|STARTED|Overall Study||175
5082009|NCT01735630|12504380|P1|STARTED|Overall Study||175
5082010|NCT01735617|12504394|P1|NOT COMPLETED|Overall Study||0
5082011|NCT01735617|12504394|P1|COMPLETED|Overall Study||16
5082012|NCT01735617|12504394|P1|STARTED|Overall Study||16
5082013|NCT01735396|12504407|P1|NOT COMPLETED|Overall Study||1
5082014|NCT01735396|12504407|P1|COMPLETED|Overall Study||10
5082015|NCT01735396|12504407|P1|STARTED|Overall Study||11
5082016|NCT01735214|12504416|P1|NOT COMPLETED|Overall Study||0
5082017|NCT01735214|12504416|P1|COMPLETED|Overall Study||358
5082018|NCT01735214|12504416|P1|STARTED|Overall Study||358
5082019|NCT01735201|12504436|P8|NOT COMPLETED|Overall Study||2
5082020|NCT01735201|12504437|P7|NOT COMPLETED|Overall Study||3
5082021|NCT01735201|12504438|P6|NOT COMPLETED|Overall Study||5
5082022|NCT01735201|12504439|P5|NOT COMPLETED|Overall Study||1
5082023|NCT01735201|12504440|P4|NOT COMPLETED|Overall Study||2
5082024|NCT01735201|12504441|P3|NOT COMPLETED|Overall Study||0
5082025|NCT01735201|12504442|P2|NOT COMPLETED|Overall Study||1
5082026|NCT01735201|12504443|P1|NOT COMPLETED|Overall Study||3
5082027|NCT01735201|12504436|P8|COMPLETED|Overall Study||42
5082028|NCT01735201|12504437|P7|COMPLETED|Overall Study||42
5082029|NCT01735201|12504438|P6|COMPLETED|Overall Study||40
5082030|NCT01735201|12504439|P5|COMPLETED|Overall Study||44
5082031|NCT01735201|12504440|P4|COMPLETED|Overall Study||42
5082032|NCT01735201|12504441|P3|COMPLETED|Overall Study||44
5082033|NCT01735201|12504442|P2|COMPLETED|Overall Study||43
5082034|NCT01735201|12504443|P1|COMPLETED|Overall Study||42
5082035|NCT01735201|12504436|P8|STARTED|Overall Study||44
5082036|NCT01735201|12504437|P7|STARTED|Overall Study||45
5082037|NCT01735201|12504438|P6|STARTED|Overall Study||45
5082038|NCT01735201|12504439|P5|STARTED|Overall Study||45
5082039|NCT01735201|12504440|P4|STARTED|Overall Study||44
5082040|NCT01735201|12504441|P3|STARTED|Overall Study||44
5082041|NCT01735201|12504442|P2|STARTED|Overall Study||44
5082042|NCT01735201|12504443|P1|STARTED|Overall Study||45
5082043|NCT01735175|12504479|P2|NOT COMPLETED|Overall Study||13
5082044|NCT01735175|12504480|P1|NOT COMPLETED|Overall Study||29
5082045|NCT01735175|12504479|P2|COMPLETED|Overall Study||144
5082046|NCT01735175|12504480|P1|COMPLETED|Overall Study||130
5082047|NCT01735175|12504479|P2|Completed the 6-month SFU Visit|Overall Study||138
5082048|NCT01735175|12504480|P1|Completed the 6-month SFU Visit|Overall Study||120
5082049|NCT01735175|12504479|P2|Completed All Treatments as Planned|Overall Study||150
5082050|NCT01735175|12504480|P1|Completed All Treatments as Planned|Overall Study||140
5082051|NCT01735175|12504479|P2|Completed All Cycles|Overall Study||150
5082052|NCT01735175|12504480|P1|Completed All Cycles|Overall Study||141
5082053|NCT01735175|12504479|P2|STARTED|Overall Study||157
5082054|NCT01735175|12504480|P1|STARTED|Overall Study||159
5082055|NCT01734993|12504500|P1|NOT COMPLETED|Overall Study||2
5082056|NCT01734993|12504500|P1|COMPLETED|Overall Study||9
5082057|NCT01734993|12504500|P1|STARTED|Overall Study||11
5082058|NCT01734902|12504528|P2|NOT COMPLETED|Overall Study||2
5082059|NCT01734902|12504529|P1|NOT COMPLETED|Overall Study||0
5082060|NCT01734902|12504528|P2|COMPLETED|Overall Study||14
5082061|NCT01734902|12504529|P1|COMPLETED|Overall Study||14
5082062|NCT01734902|12504528|P2|STARTED|Overall Study||16
5082063|NCT01734902|12504529|P1|STARTED|Overall Study||14
5082064|NCT01734889|12504539|P1|NOT COMPLETED|Overall Study||0
5082065|NCT01734889|12504539|P1|COMPLETED|Overall Study||18
5082066|NCT01734889|12504539|P1|STARTED|Overall Study||18
5082067|NCT01734785|12504550|P4|NOT COMPLETED|Double−Blind Period||0
5082068|NCT01734785|12504551|P3|NOT COMPLETED|Double−Blind Period||5
5082069|NCT01734785|12504552|P2|NOT COMPLETED|Double−Blind Period||9
5082070|NCT01734785|12504553|P1|NOT COMPLETED|Double−Blind Period||5
5082071|NCT01734785|12504550|P4|COMPLETED|Double−Blind Period||0
5082072|NCT01734785|12504551|P3|COMPLETED|Double−Blind Period||105
5082073|NCT01734785|12504552|P2|COMPLETED|Double−Blind Period||103
5082074|NCT01734785|12504553|P1|COMPLETED|Double−Blind Period||106
5082075|NCT01734785|12504550|P4|STARTED|Double−Blind Period||0
5082076|NCT01734785|12504551|P3|STARTED|Double−Blind Period||110
5082077|NCT01734785|12504552|P2|STARTED|Double−Blind Period||112
5082078|NCT01734785|12504553|P1|STARTED|Double−Blind Period||111
5082079|NCT01734785|12504550|P4|NOT COMPLETED|Open−Label Period||273
5082080|NCT01734785|12504551|P3|NOT COMPLETED|Open−Label Period||0
5082081|NCT01734785|12504552|P2|NOT COMPLETED|Open−Label Period||0
5082082|NCT01734785|12504553|P1|NOT COMPLETED|Open−Label Period||0
5082083|NCT01734785|12504550|P4|COMPLETED|Open−Label Period||333
5082084|NCT01734785|12504551|P3|COMPLETED|Open−Label Period||0
5082085|NCT01734785|12504552|P2|COMPLETED|Open−Label Period||0
5082086|NCT01734785|12504553|P1|COMPLETED|Open−Label Period||0
5082087|NCT01734785|12504550|P4|STARTED|Open−Label Period||606
5082088|NCT01734785|12504551|P3|STARTED|Open−Label Period||0
5082089|NCT01734785|12504552|P2|STARTED|Open−Label Period||0
5082090|NCT01734785|12504553|P1|STARTED|Open−Label Period||0
5082091|NCT01734772|12504570|P2|NOT COMPLETED|Overall Study||3
5082092|NCT01734772|12504571|P1|NOT COMPLETED|Overall Study||1
5082093|NCT01734772|12504570|P2|COMPLETED|Overall Study||21
5082094|NCT01734772|12504571|P1|COMPLETED|Overall Study||23
5082095|NCT01734772|12504570|P2|STARTED|Overall Study||24
5082096|NCT01734772|12504571|P1|STARTED|Overall Study||24
5082097|NCT01734746|12504588|P1|NOT COMPLETED|Overall Study||1
5082098|NCT01734746|12504588|P1|COMPLETED|Overall Study||21
5082099|NCT01734746|12504588|P1|STARTED|Overall Study||22
5082100|NCT01734655|12504594|P1|NOT COMPLETED|Overall Study||0
5082101|NCT01734655|12504594|P1|COMPLETED|Overall Study||40
5082102|NCT01734655|12504594|P1|STARTED|Overall Study||40
5082103|NCT01734551|12504605|P2|NOT COMPLETED|Overall Study||0
5082104|NCT01734551|12504606|P1|NOT COMPLETED|Overall Study||0
5082105|NCT01734551|12504605|P2|COMPLETED|Overall Study||16
5082106|NCT01734551|12504606|P1|COMPLETED|Overall Study||15
5082107|NCT01734551|12504605|P2|STARTED|Overall Study||16
5082108|NCT01734551|12504606|P1|STARTED|Overall Study||15
5082109|NCT01734525|12504618|P1|NOT COMPLETED|Overall Study||0
5082110|NCT01734525|12504618|P1|COMPLETED|Overall Study||85
5082111|NCT01734525|12504618|P1|STARTED|Overall Study||85
5082112|NCT01734434|12504626|P4|NOT COMPLETED|Overall Study||23
5082113|NCT01734434|12504627|P3|NOT COMPLETED|Overall Study||129
5082114|NCT01734434|12504628|P2|NOT COMPLETED|Overall Study||12
5082115|NCT01734434|12504629|P1|NOT COMPLETED|Overall Study||10
5082116|NCT01734434|12504626|P4|COMPLETED|Overall Study||228
5082117|NCT01734434|12504627|P3|COMPLETED|Overall Study||1863
5082118|NCT01734434|12504628|P2|COMPLETED|Overall Study||488
5082119|NCT01734434|12504629|P1|COMPLETED|Overall Study||490
5082120|NCT01734434|12504626|P4|STARTED|Overall Study||251
5082121|NCT01734434|12504627|P3|STARTED|Overall Study||1992
5082122|NCT01734434|12504628|P2|STARTED|Overall Study||500
5082123|NCT01734434|12504629|P1|STARTED|Overall Study||500
5082124|NCT01734395|12504651|P1|NOT COMPLETED|Overall Study||410
5082125|NCT01734395|12504651|P1|COMPLETED|Overall Study||1472
5082126|NCT01734395|12504651|P1|STARTED|Overall Study||1882
5082127|NCT01734382|12504660|P3|NOT COMPLETED|Part 2||7
5082128|NCT01734382|12504661|P2|NOT COMPLETED|Part 2||2
5082129|NCT01734382|12504662|P1|NOT COMPLETED|Part 2||0
5082130|NCT01734382|12504660|P3|COMPLETED|Part 2||8
5082131|NCT01734382|12504661|P2|COMPLETED|Part 2||5
5082132|NCT01734382|12504662|P1|COMPLETED|Part 2||0
5082133|NCT01734382|12504660|P3|STARTED|Part 2||15
5082134|NCT01734382|12504661|P2|STARTED|Part 2||7
5082135|NCT01734382|12504662|P1|STARTED|Part 2||0
5082136|NCT01734382|12504660|P3|NOT COMPLETED|Part 1||0
5082137|NCT01734382|12504661|P2|NOT COMPLETED|Part 1||0
5082138|NCT01734382|12504662|P1|NOT COMPLETED|Part 1||2
5082139|NCT01734382|12504660|P3|COMPLETED|Part 1||0
5082140|NCT01734382|12504661|P2|COMPLETED|Part 1||0
5082141|NCT01734382|12504662|P1|COMPLETED|Part 1||17
5082142|NCT01734382|12504660|P3|STARTED|Part 1||0
5082143|NCT01734382|12504661|P2|STARTED|Part 1||0
5082144|NCT01734382|12504662|P1|STARTED|Part 1||19
5082145|NCT01734317|12504722|P1|NOT COMPLETED|Overall Study||0
5082146|NCT01734317|12504722|P1|COMPLETED|Overall Study||10
5082147|NCT01734317|12504722|P1|STARTED|Overall Study||10
5082148|NCT01734239|12504729|P2|NOT COMPLETED|Overall Study||0
5082149|NCT01734239|12504730|P1|NOT COMPLETED|Overall Study||0
5082150|NCT01734239|12504729|P2|COMPLETED|Overall Study||50
5082151|NCT01734239|12504730|P1|COMPLETED|Overall Study||52
5082152|NCT01734239|12504729|P2|STARTED|Overall Study||50
5082153|NCT01734239|12504730|P1|STARTED|Overall Study||52
5082154|NCT01734161|12504745|P2|NOT COMPLETED|Overall Study||8
5082155|NCT01734161|12504746|P1|NOT COMPLETED|Overall Study||6
5082156|NCT01734161|12504745|P2|COMPLETED|Overall Study||53
5082157|NCT01734161|12504746|P1|COMPLETED|Overall Study||55
5082158|NCT01734161|12504745|P2|STARTED|Overall Study||61
5082159|NCT01734161|12504746|P1|STARTED|Overall Study||61
5082160|NCT01733953|12504754|P2|NOT COMPLETED|Overall Study||7
5082161|NCT01733953|12504755|P1|NOT COMPLETED|Overall Study||5
5082162|NCT01733953|12504754|P2|COMPLETED|Overall Study||6
5082163|NCT01733953|12504755|P1|COMPLETED|Overall Study||9
5082164|NCT01733953|12504754|P2|STARTED|Overall Study||13
5082165|NCT01733953|12504755|P1|STARTED|Overall Study||14
5082166|NCT01733758|12504775|P4|NOT COMPLETED|Overall Study||8
5082167|NCT01733758|12504776|P3|NOT COMPLETED|Overall Study||15
5082168|NCT01733758|12504777|P2|NOT COMPLETED|Overall Study||12
5082169|NCT01733758|12504778|P1|NOT COMPLETED|Overall Study||15
5082170|NCT01733758|12504775|P4|COMPLETED|Overall Study||95
5082171|NCT01733758|12504776|P3|COMPLETED|Overall Study||135
5082172|NCT01733758|12504777|P2|COMPLETED|Overall Study||148
5082173|NCT01733758|12504778|P1|COMPLETED|Overall Study||62
5082174|NCT01733758|12504775|P4|STARTED|Overall Study||103
5082175|NCT01733758|12504776|P3|STARTED|Overall Study||150
5082176|NCT01733758|12504777|P2|STARTED|Overall Study||160
5082177|NCT01733758|12504778|P1|STARTED|Overall Study||77
5082178|NCT01733745|12504831|P2|NOT COMPLETED|Overall Study||0
5082179|NCT01733745|12504832|P1|NOT COMPLETED|Overall Study||0
5082180|NCT01733745|12504831|P2|COMPLETED|Overall Study||13
5082181|NCT01733745|12504832|P1|COMPLETED|Overall Study||13
5082182|NCT01733745|12504831|P2|STARTED|Overall Study||13
5082183|NCT01733745|12504832|P1|STARTED|Overall Study||13
5082184|NCT01733732|12504844|P2|NOT COMPLETED|Overall Study||0
5082185|NCT01733732|12504845|P1|NOT COMPLETED|Overall Study||2
5082186|NCT01733732|12504844|P2|COMPLETED|Overall Study||27
5082187|NCT01733732|12504845|P1|COMPLETED|Overall Study||25
5082188|NCT01733732|12504844|P2|STARTED|Overall Study||27
5082189|NCT01733732|12504845|P1|STARTED|Overall Study||27
5082190|NCT01733680|12504881|P2|NOT COMPLETED|Overall Study||1
5082191|NCT01733680|12504882|P1|NOT COMPLETED|Overall Study||0
5082192|NCT01733680|12504881|P2|COMPLETED|Overall Study||0
5082193|NCT01733680|12504882|P1|COMPLETED|Overall Study||2
5082194|NCT01733680|12504881|P2|STARTED|Overall Study||1
5082195|NCT01733680|12504882|P1|STARTED|Overall Study||2
5082196|NCT01733628|12504892|P1|NOT COMPLETED|Overall Study||0
5082197|NCT01733628|12504892|P1|COMPLETED|Overall Study||143
5082198|NCT01733628|12504892|P1|STARTED|Overall Study||143
5082199|NCT01733472|12504901|P2|NOT COMPLETED|Overall Study||0
5082200|NCT01733472|12504902|P1|NOT COMPLETED|Overall Study||0
5082201|NCT01733472|12504901|P2|COMPLETED|Overall Study||60
5082202|NCT01733472|12504902|P1|COMPLETED|Overall Study||60
5082203|NCT01733472|12504901|P2|STARTED|Overall Study||60
5082204|NCT01733472|12504902|P1|STARTED|Overall Study||60
5082205|NCT01733407|12504914|P2|NOT COMPLETED|Overall Study||0
5082206|NCT01733407|12504915|P1|NOT COMPLETED|Overall Study||2
5082207|NCT01733407|12504914|P2|COMPLETED|Overall Study||9
5082208|NCT01733407|12504915|P1|COMPLETED|Overall Study||7
5082209|NCT01733407|12504914|P2|STARTED|Overall Study||9
5082210|NCT01733407|12504915|P1|STARTED|Overall Study||9
5082211|NCT01733368|12504931|P1|NOT COMPLETED|Overall Study||31
5082212|NCT01733368|12504931|P1|COMPLETED|Overall Study||167
5082213|NCT01733368|12504931|P1|STARTED|Overall Study||198
5082214|NCT01733329|12504941|P2|NOT COMPLETED|Overall Study||1
5082215|NCT01733329|12504942|P1|NOT COMPLETED|Overall Study||2
5082216|NCT01733329|12504941|P2|COMPLETED|Overall Study||60
5082217|NCT01733329|12504942|P1|COMPLETED|Overall Study||60
5082218|NCT01733329|12504941|P2|STARTED|Overall Study||61
5082219|NCT01733329|12504942|P1|STARTED|Overall Study||62
5082220|NCT01733316|12504954|P1|NOT COMPLETED|Long Term Extension Phase||5
5082221|NCT01733316|12504954|P1|COMPLETED|Long Term Extension Phase||33
5082222|NCT01733316|12504954|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
5082223|NCT01733316|12504954|P1|NOT COMPLETED|RP103 Phase||1
5082224|NCT01733316|12504954|P1|COMPLETED|RP103 Phase||40
5082225|NCT01733316|12504954|P1|STARTED|RP103 Phase||41
5082226|NCT01733316|12504954|P1|NOT COMPLETED|Cystagon® Phase||0
5082227|NCT01733316|12504954|P1|COMPLETED|Cystagon® Phase||41
5082228|NCT01733316|12504954|P1|STARTED|Cystagon® Phase||41
5082229|NCT01733277|12504970|P2|NOT COMPLETED|Overall Study||0
5082230|NCT01733277|12504971|P1|NOT COMPLETED|Overall Study||0
5082231|NCT01733277|12504970|P2|COMPLETED|Overall Study||25
5082232|NCT01733277|12504971|P1|COMPLETED|Overall Study||25
5082233|NCT01733277|12504970|P2|STARTED|Overall Study||25
5082234|NCT01733277|12504971|P1|STARTED|Overall Study||25
5082235|NCT01733238|12504981|P1|NOT COMPLETED|Overall Study||5
5082236|NCT01733238|12504981|P1|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
5082237|NCT01733238|12504981|P1|STARTED|Overall Study||13
5082238|NCT01733212|12504988|P2|NOT COMPLETED|Overall Study||0
5082239|NCT01733212|12504989|P1|NOT COMPLETED|Overall Study||0
5082240|NCT01733212|12504988|P2|COMPLETED|Overall Study||123
5082241|NCT01733212|12504989|P1|COMPLETED|Overall Study||116
5082242|NCT01733212|12504988|P2|STARTED|Overall Study||123
5082243|NCT01733212|12504989|P1|STARTED|Overall Study||116
5082244|NCT01733121|12504997|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
5082245|NCT01733121|12504998|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
5082246|NCT01733121|12504997|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
5082247|NCT01733121|12504998|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
5082248|NCT01733121|12504997|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
5082249|NCT01733121|12504998|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
5082250|NCT01733121|12504997|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
5082251|NCT01733121|12504998|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
5082252|NCT01733121|12504997|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
5082253|NCT01733121|12504998|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
5082254|NCT01733121|12504997|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
5082255|NCT01733121|12504998|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
5082256|NCT01733069|12505012|P2|NOT COMPLETED|Overall Study||0
5082257|NCT01733069|12505013|P1|NOT COMPLETED|Overall Study||0
5082258|NCT01733069|12505012|P2|COMPLETED|Overall Study||1598
5082259|NCT01733069|12505013|P1|COMPLETED|Overall Study||264
5082260|NCT01733069|12505012|P2|STARTED|Overall Study||1598
5082261|NCT01733069|12505013|P1|STARTED|Overall Study||264
5082262|NCT01733056|12505022|P3|NOT COMPLETED|Overall Study||0
5082263|NCT01733056|12505023|P2|NOT COMPLETED|Overall Study||0
5082264|NCT01733056|12505024|P1|NOT COMPLETED|Overall Study||0
5082265|NCT01733056|12505022|P3|COMPLETED|Overall Study||12
5082266|NCT01733056|12505023|P2|COMPLETED|Overall Study||10
5082267|NCT01733056|12505024|P1|COMPLETED|Overall Study||21
5082268|NCT01733056|12505022|P3|STARTED|Overall Study||12
5082269|NCT01733056|12505023|P2|STARTED|Overall Study||10
5082270|NCT01733056|12505024|P1|STARTED|Overall Study||21
5082271|NCT01732926|12505040|P2|NOT COMPLETED|Overall Study||110
5082272|NCT01732926|12505041|P1|NOT COMPLETED|Overall Study||267
5082273|NCT01732926|12505040|P2|COMPLETED|Overall Study||45
5082274|NCT01732926|12505041|P1|COMPLETED|Overall Study||53
5082275|NCT01732926|12505040|P2|STARTED|Overall Study||155
5082276|NCT01732926|12505041|P1|STARTED|Overall Study||320
5082277|NCT01732913|12505057|P2|NOT COMPLETED|Overall Study||69
5082278|NCT01732913|12505058|P1|NOT COMPLETED|Overall Study||156
5082279|NCT01732913|12505057|P2|COMPLETED|Overall Study||28
5082280|NCT01732913|12505058|P1|COMPLETED|Overall Study||42
5082281|NCT01732913|12505057|P2|STARTED|Overall Study||97
5082282|NCT01732913|12505058|P1|STARTED|Overall Study||198
5082283|NCT01732835|12505072|P1|NOT COMPLETED|2-year Extended Follow-up||5
5082284|NCT01732835|12505072|P1|COMPLETED|2-year Extended Follow-up||39
5082285|NCT01732835|12505072|P1|STARTED|2-year Extended Follow-up||44
5082286|NCT01732835|12505072|P1|NOT COMPLETED|6-month Primary Endpoint||24
5082287|NCT01732835|12505072|P1|COMPLETED|6-month Primary Endpoint||44
5082288|NCT01732835|12505072|P1|STARTED|6-month Primary Endpoint||68
5082289|NCT01732822|12505105|P2|NOT COMPLETED|Overall Study||113
5082290|NCT01732822|12505106|P1|NOT COMPLETED|Overall Study||123
5082381|NCT01732588|12505429|P2|COMPLETED|Second Intervention (7 Days)||2
5082291|NCT01732822|12505105|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
5082292|NCT01732822|12505106|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
5082293|NCT01732822|12505105|P2|STARTED|Overall Study||6955
5082294|NCT01732822|12505106|P1|STARTED|Overall Study||6930
5082295|NCT01732796|12505179|P3|NOT COMPLETED|Overall Study||13
5082296|NCT01732796|12505180|P2|NOT COMPLETED|Overall Study||42
5082297|NCT01732796|12505181|P1|NOT COMPLETED|Overall Study||46
5082298|NCT01732796|12505179|P3|COMPLETED|Overall Study||38
5082299|NCT01732796|12505180|P2|COMPLETED|Overall Study||169
5082300|NCT01732796|12505181|P1|COMPLETED|Overall Study||162
5082301|NCT01732796|12505179|P3|STARTED|Overall Study||51
5082302|NCT01732796|12505180|P2|STARTED|Overall Study||211
5082303|NCT01732796|12505181|P1|STARTED|Overall Study||208
5082304|NCT01732783|12505200|P3|NOT COMPLETED|Overall Study||10
5082305|NCT01732783|12505201|P2|NOT COMPLETED|Overall Study||32
5082306|NCT01732783|12505202|P1|NOT COMPLETED|Overall Study||135
5082307|NCT01732783|12505200|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
5082308|NCT01732783|12505201|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
5082309|NCT01732783|12505202|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
5082310|NCT01732783|12505200|P3|STARTED|Overall Study||12
5082311|NCT01732783|12505201|P2|STARTED|Overall Study||37
5082312|NCT01732783|12505202|P1|STARTED|Overall Study||164
5082313|NCT01732770|12505266|P2|NOT COMPLETED|Overall Study||8
5082314|NCT01732770|12505267|P1|NOT COMPLETED|Overall Study||10
5082315|NCT01732770|12505266|P2|COMPLETED|Overall Study||313
5082316|NCT01732770|12505267|P1|COMPLETED|Overall Study||312
5082317|NCT01732770|12505266|P2|Received Study Treatment|Overall Study||320
5082318|NCT01732770|12505267|P1|Received Study Treatment|Overall Study||320
5082319|NCT01732770|12505266|P2|STARTED|Overall Study||321
5082320|NCT01732770|12505267|P1|STARTED|Overall Study||322
5082321|NCT01732757|12505282|P3|NOT COMPLETED|Overall Study||0
5082322|NCT01732757|12505283|P2|NOT COMPLETED|Overall Study||0
5082323|NCT01732757|12505284|P1|NOT COMPLETED|Overall Study||1
5082324|NCT01732757|12505282|P3|COMPLETED|Overall Study||52
5082325|NCT01732757|12505283|P2|COMPLETED|Overall Study||52
5082326|NCT01732757|12505284|P1|COMPLETED|Overall Study||52
5082327|NCT01732757|12505282|P3|STARTED|Overall Study||52
5082328|NCT01732757|12505283|P2|STARTED|Overall Study||52
5082329|NCT01732757|12505284|P1|STARTED|Overall Study||53
5082330|NCT01732718|12505322|P2|NOT COMPLETED|Second Intervention||0
5082331|NCT01732718|12505323|P1|NOT COMPLETED|Second Intervention||0
5082332|NCT01732718|12505322|P2|COMPLETED|Second Intervention||6
5082333|NCT01732718|12505323|P1|COMPLETED|Second Intervention||7
5082334|NCT01732718|12505322|P2|STARTED|Second Intervention||6
5082335|NCT01732718|12505323|P1|STARTED|Second Intervention||7
5082336|NCT01732718|12505322|P2|NOT COMPLETED|Washout (4 Weeks)||0
5082337|NCT01732718|12505323|P1|NOT COMPLETED|Washout (4 Weeks)||0
5082338|NCT01732718|12505322|P2|COMPLETED|Washout (4 Weeks)||6
5082339|NCT01732718|12505323|P1|COMPLETED|Washout (4 Weeks)||7
5082340|NCT01732718|12505322|P2|STARTED|Washout (4 Weeks)||6
5082341|NCT01732718|12505323|P1|STARTED|Washout (4 Weeks)||7
5082342|NCT01732718|12505322|P2|NOT COMPLETED|First Intervention||0
5082343|NCT01732718|12505323|P1|NOT COMPLETED|First Intervention||0
5082344|NCT01732718|12505322|P2|COMPLETED|First Intervention||6
5082345|NCT01732718|12505323|P1|COMPLETED|First Intervention||7
5082346|NCT01732718|12505322|P2|STARTED|First Intervention||6
5082347|NCT01732718|12505323|P1|STARTED|First Intervention||7
5082348|NCT01732692|12505361|P2|NOT COMPLETED|Overall Study||1
5082349|NCT01732692|12505362|P1|NOT COMPLETED|Overall Study||0
5082350|NCT01732692|12505361|P2|COMPLETED|Overall Study||69
5082351|NCT01732692|12505362|P1|COMPLETED|Overall Study||70
5082352|NCT01732692|12505361|P2|STARTED|Overall Study||70
5082353|NCT01732692|12505362|P1|STARTED|Overall Study||70
5082354|NCT01732640|12505376|P2|NOT COMPLETED|Overall Study||2
5082355|NCT01732640|12505377|P1|NOT COMPLETED|Overall Study||0
5082356|NCT01732640|12505376|P2|COMPLETED|Overall Study||1
5082357|NCT01732640|12505377|P1|COMPLETED|Overall Study||6
5082358|NCT01732640|12505376|P2|STARTED|Overall Study||3
5082359|NCT01732640|12505377|P1|STARTED|Overall Study||6
5082360|NCT01732627|12505394|P2|NOT COMPLETED|Overall Study||0
5082361|NCT01732627|12505395|P1|NOT COMPLETED|Overall Study||1
5082362|NCT01732627|12505394|P2|COMPLETED|Overall Study||100
5082363|NCT01732627|12505395|P1|COMPLETED|Overall Study||200
5082364|NCT01732627|12505394|P2|Safety Analysis Set (SafAS)|Overall Study||100
5082365|NCT01732627|12505395|P1|Safety Analysis Set (SafAS)|Overall Study||199
5082366|NCT01732627|12505394|P2|STARTED|Overall Study||100
5082367|NCT01732627|12505395|P1|STARTED|Overall Study||201
5082368|NCT01732588|12505428|P3|NOT COMPLETED|Third Intervention (7 Days)||0
5082369|NCT01732588|12505429|P2|NOT COMPLETED|Third Intervention (7 Days)||0
5082370|NCT01732588|12505430|P1|NOT COMPLETED|Third Intervention (7 Days)||0
5082371|NCT01732588|12505428|P3|COMPLETED|Third Intervention (7 Days)||4
5082372|NCT01732588|12505429|P2|COMPLETED|Third Intervention (7 Days)||2
5082373|NCT01732588|12505430|P1|COMPLETED|Third Intervention (7 Days)||4
5082374|NCT01732588|12505428|P3|STARTED|Third Intervention (7 Days)||4
5082375|NCT01732588|12505429|P2|STARTED|Third Intervention (7 Days)||2
5082376|NCT01732588|12505430|P1|STARTED|Third Intervention (7 Days)||4
5082377|NCT01732588|12505428|P3|NOT COMPLETED|Second Intervention (7 Days)||0
5082378|NCT01732588|12505429|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5082379|NCT01732588|12505430|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5082380|NCT01732588|12505428|P3|COMPLETED|Second Intervention (7 Days)||4
5082382|NCT01732588|12505430|P1|COMPLETED|Second Intervention (7 Days)||4
5082383|NCT01732588|12505428|P3|STARTED|Second Intervention (7 Days)||4
5082384|NCT01732588|12505429|P2|STARTED|Second Intervention (7 Days)||2
5082385|NCT01732588|12505430|P1|STARTED|Second Intervention (7 Days)||4
5082386|NCT01732588|12505428|P3|NOT COMPLETED|First Intervention (7 Days)||0
5082387|NCT01732588|12505429|P2|NOT COMPLETED|First Intervention (7 Days)||1
5082388|NCT01732588|12505430|P1|NOT COMPLETED|First Intervention (7 Days)||0
5082389|NCT01732588|12505428|P3|COMPLETED|First Intervention (7 Days)||4
5082390|NCT01732588|12505429|P2|COMPLETED|First Intervention (7 Days)||2
5082391|NCT01732588|12505430|P1|COMPLETED|First Intervention (7 Days)||4
5082392|NCT01732588|12505428|P3|STARTED|First Intervention (7 Days)||4
5082393|NCT01732588|12505429|P2|STARTED|First Intervention (7 Days)||3
5082394|NCT01732588|12505430|P1|STARTED|First Intervention (7 Days)||4
5082395|NCT01732549|12505446|P2|NOT COMPLETED|Overall Study||73
5082396|NCT01732549|12505447|P1|NOT COMPLETED|Overall Study||71
5082397|NCT01732549|12505446|P2|COMPLETED|Overall Study||0
5082398|NCT01732549|12505447|P1|COMPLETED|Overall Study||0
5082399|NCT01732549|12505446|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
5082400|NCT01732549|12505447|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
5082401|NCT01732549|12505446|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
5082402|NCT01732549|12505447|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
5082403|NCT01732549|12505446|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
5082404|NCT01732549|12505447|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
5082405|NCT01732549|12505446|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
5082406|NCT01732549|12505447|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
5082407|NCT01732549|12505446|P2|STARTED|Overall Study||73
5082408|NCT01732549|12505447|P1|STARTED|Overall Study||71
5082409|NCT01732536|12505469|P2|NOT COMPLETED|Overall Study||1
5082410|NCT01732536|12505470|P1|NOT COMPLETED|Overall Study||1
5082411|NCT01732536|12505469|P2|COMPLETED|Overall Study||46
5082412|NCT01732536|12505470|P1|COMPLETED|Overall Study||52
5082413|NCT01732536|12505469|P2|STARTED|Overall Study||47
5082414|NCT01732536|12505470|P1|STARTED|Overall Study||53
5082415|NCT01732510|12505493|P7|NOT COMPLETED|Overall Study||8
5082416|NCT01732510|12505494|P6|NOT COMPLETED|Overall Study||13
5082417|NCT01732510|12505495|P5|NOT COMPLETED|Overall Study||5
5082418|NCT01732510|12505496|P4|NOT COMPLETED|Overall Study||5
5082419|NCT01732510|12505497|P3|NOT COMPLETED|Overall Study||4
5082420|NCT01732510|12505498|P2|NOT COMPLETED|Overall Study||5
5082421|NCT01732510|12505499|P1|NOT COMPLETED|Overall Study||1
5082422|NCT01732510|12505493|P7|COMPLETED|Overall Study||0
5082423|NCT01732510|12505494|P6|COMPLETED|Overall Study||0
5082424|NCT01732510|12505495|P5|COMPLETED|Overall Study||3
5082425|NCT01732510|12505496|P4|COMPLETED|Overall Study||5
5082426|NCT01732510|12505497|P3|COMPLETED|Overall Study||4
5082427|NCT01732510|12505498|P2|COMPLETED|Overall Study||4
5082428|NCT01732510|12505499|P1|COMPLETED|Overall Study||8
5082429|NCT01732510|12505493|P7|STARTED|Overall Study||8
5082430|NCT01732510|12505494|P6|STARTED|Overall Study||13
5082431|NCT01732510|12505495|P5|STARTED|Overall Study||8
5082432|NCT01732510|12505496|P4|STARTED|Overall Study||10
5082433|NCT01732510|12505497|P3|STARTED|Overall Study||8
5082434|NCT01732510|12505498|P2|STARTED|Overall Study||9
5082435|NCT01732510|12505499|P1|STARTED|Overall Study||9
5082436|NCT01732484|12505578|P1|NOT COMPLETED|Overall Study||26
5082437|NCT01732484|12505578|P1|COMPLETED|Overall Study||74
5082438|NCT01732484|12505578|P1|Allocation|Overall Study||100
5082439|NCT01732484|12505578|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
5082440|NCT01732484|12505578|P1|STARTED|Overall Study||100
5082441|NCT01732471|12505586|P1|NOT COMPLETED|Overall Study||1
5082442|NCT01732471|12505586|P1|COMPLETED|Overall Study||89
5082443|NCT01732471|12505586|P1|STARTED|Overall Study||90
5082444|NCT01732458|12505597|P4|NOT COMPLETED|Overall Study||2
5082445|NCT01732458|12505598|P3|NOT COMPLETED|Overall Study||3
5082446|NCT01732458|12505599|P2|NOT COMPLETED|Overall Study||5
5082447|NCT01732458|12505600|P1|NOT COMPLETED|Overall Study||3
5082448|NCT01732458|12505597|P4|COMPLETED|Overall Study||50
5082449|NCT01732458|12505598|P3|COMPLETED|Overall Study||55
5082450|NCT01732458|12505599|P2|COMPLETED|Overall Study||53
5082451|NCT01732458|12505600|P1|COMPLETED|Overall Study||57
5082452|NCT01732458|12505597|P4|Treated|Overall Study||52
5082453|NCT01732458|12505598|P3|Treated|Overall Study||56
5082454|NCT01732458|12505599|P2|Treated|Overall Study||55
5082455|NCT01732458|12505600|P1|Treated|Overall Study||57
5082456|NCT01732458|12505597|P4|STARTED|Overall Study||52
5082457|NCT01732458|12505598|P3|STARTED|Overall Study||58
5082458|NCT01732458|12505599|P2|STARTED|Overall Study||58
5082459|NCT01732458|12505600|P1|STARTED|Overall Study||60
5082460|NCT01732445|12505662|P1|NOT COMPLETED|Overall Study||0
5082461|NCT01732445|12505662|P1|COMPLETED|Overall Study||14
5082462|NCT01732445|12505662|P1|STARTED|Overall Study||14
5082463|NCT01732419|12505671|P2|NOT COMPLETED|Overall Study||4
5082464|NCT01732419|12505672|P1|NOT COMPLETED|Overall Study||8
5082465|NCT01732419|12505671|P2|COMPLETED|Overall Study||41
5082466|NCT01732419|12505672|P1|COMPLETED|Overall Study||37
5082467|NCT01732419|12505671|P2|STARTED|Overall Study||45
5082468|NCT01732419|12505672|P1|STARTED|Overall Study||45
5082469|NCT01732406|12505689|P3|NOT COMPLETED|Overall Study||0
5082470|NCT01732406|12505690|P2|NOT COMPLETED|Overall Study||0
5082471|NCT01732406|12505691|P1|NOT COMPLETED|Overall Study||0
5082472|NCT01732406|12505689|P3|COMPLETED|Overall Study||35
5082473|NCT01732406|12505690|P2|COMPLETED|Overall Study||60
5082474|NCT01732406|12505691|P1|COMPLETED|Overall Study||31
5082475|NCT01732406|12505689|P3|STARTED|Overall Study||35
5082476|NCT01732406|12505690|P2|STARTED|Overall Study||60
5082477|NCT01732406|12505691|P1|STARTED|Overall Study||31
5082478|NCT01732263|12505710|P2|NOT COMPLETED|Overall Study||0
5082479|NCT01732263|12505711|P1|NOT COMPLETED|Overall Study||0
5082480|NCT01732263|12505710|P2|COMPLETED|Overall Study||20
5082481|NCT01732263|12505711|P1|COMPLETED|Overall Study||23
5082482|NCT01732263|12505710|P2|STARTED|Overall Study||20
5082483|NCT01732263|12505711|P1|STARTED|Overall Study||23
5082484|NCT01732211|12505751|P1|NOT COMPLETED|Overall Study||0
5082485|NCT01732211|12505751|P1|COMPLETED|Overall Study||1
5082486|NCT01732211|12505751|P1|STARTED|Overall Study||1
5082487|NCT01732107|12505762|P1|NOT COMPLETED|Overall Study||13
5082488|NCT01732107|12505762|P1|COMPLETED|Overall Study||0
5082489|NCT01732107|12505762|P1|STARTED|Overall Study||13
5082490|NCT01731990|12505779|P2|NOT COMPLETED|Overall Study||8
5082491|NCT01731990|12505780|P1|NOT COMPLETED|Overall Study||4
5082492|NCT01731990|12505779|P2|COMPLETED|Overall Study||12
5082493|NCT01731990|12505780|P1|COMPLETED|Overall Study||14
5082494|NCT01731990|12505779|P2|STARTED|Overall Study||20
5082495|NCT01731990|12505780|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
5082496|NCT01731938|12505796|P2|NOT COMPLETED|Primary Part II||13
5082497|NCT01731938|12505797|P1|NOT COMPLETED|Primary Part II||13
5082498|NCT01731938|12505796|P2|COMPLETED|Primary Part II||95
5082499|NCT01731938|12505797|P1|COMPLETED|Primary Part II||103
5082500|NCT01731938|12505796|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
5082501|NCT01731938|12505797|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
5082502|NCT01731938|12505796|P2|NOT COMPLETED|Preliminary Part I||8
5082503|NCT01731938|12505797|P1|NOT COMPLETED|Preliminary Part I||3
5082504|NCT01731938|12505796|P2|COMPLETED|Preliminary Part I||44
5082505|NCT01731938|12505797|P1|COMPLETED|Preliminary Part I||48
5082506|NCT01731938|12505796|P2|STARTED|Preliminary Part I||52
5082507|NCT01731938|12505797|P1|STARTED|Preliminary Part I||51
5082508|NCT01731912|12505809|P1|NOT COMPLETED|Overall Study||2
5082509|NCT01731912|12505809|P1|COMPLETED|Overall Study||14
5082510|NCT01731912|12505809|P1|STARTED|Overall Study||16
5082511|NCT01731886|12505816|P2|NOT COMPLETED|Overall Study||1
5082512|NCT01731886|12505817|P1|NOT COMPLETED|Overall Study||2
5082513|NCT01731886|12505816|P2|COMPLETED|Overall Study||28
5082514|NCT01731886|12505817|P1|COMPLETED|Overall Study||29
5082515|NCT01731886|12505816|P2|STARTED|Overall Study||29
5082516|NCT01731886|12505817|P1|STARTED|Overall Study||31
5082517|NCT01731678|12505831|P1|NOT COMPLETED|Overall Study||7
5082518|NCT01731678|12505831|P1|COMPLETED|Overall Study||32
5082519|NCT01731678|12505831|P1|STARTED|Overall Study||39
5082520|NCT01731600|12505837|P2|NOT COMPLETED|Overall Study||0
5082521|NCT01731600|12505838|P1|NOT COMPLETED|Overall Study||6
5082522|NCT01731600|12505837|P2|COMPLETED|Overall Study||34
5082523|NCT01731600|12505838|P1|COMPLETED|Overall Study||28
5082524|NCT01731600|12505837|P2|STARTED|Overall Study||34
5082525|NCT01731600|12505838|P1|STARTED|Overall Study||34
5082526|NCT01731470|12505892|P1|NOT COMPLETED|Overall Study||2
5082527|NCT01731470|12505892|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
5082528|NCT01731470|12505892|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
5082529|NCT01731171|12505899|P2|NOT COMPLETED|Overall Study||7
5082530|NCT01731171|12505900|P1|NOT COMPLETED|Overall Study||7
5082531|NCT01731171|12505899|P2|COMPLETED|Overall Study||26
5082532|NCT01731171|12505900|P1|COMPLETED|Overall Study||26
5082533|NCT01731171|12505899|P2|STARTED|Overall Study||33
5082534|NCT01731171|12505900|P1|STARTED|Overall Study||33
5082535|NCT01731119|12505912|P1|NOT COMPLETED|Overall Study||2
5082536|NCT01731119|12505912|P1|COMPLETED|Overall Study||7
5082537|NCT01731119|12505912|P1|STARTED|Overall Study||9
5082538|NCT01731041|12505922|P2|NOT COMPLETED|Overall Study||0
5082539|NCT01731041|12505923|P1|NOT COMPLETED|Overall Study||0
5082540|NCT01731041|12505922|P2|COMPLETED|Overall Study||30
5082541|NCT01731041|12505923|P1|COMPLETED|Overall Study||30
5082542|NCT01731041|12505922|P2|STARTED|Overall Study||30
5082543|NCT01731041|12505923|P1|STARTED|Overall Study||30
5082544|NCT01731002|12505934|P3|NOT COMPLETED|Overall Study||3
5082545|NCT01731002|12505935|P2|NOT COMPLETED|Overall Study||4
5082546|NCT01731002|12505936|P1|NOT COMPLETED|Overall Study||4
5082547|NCT01731002|12505934|P3|COMPLETED|Overall Study||74
5082548|NCT01731002|12505935|P2|COMPLETED|Overall Study||68
5082549|NCT01731002|12505936|P1|COMPLETED|Overall Study||71
5082550|NCT01731002|12505934|P3|STARTED|Overall Study||77
5082551|NCT01731002|12505935|P2|STARTED|Overall Study||72
5082552|NCT01731002|12505936|P1|STARTED|Overall Study||75
5082553|NCT01730950|12505949|P2|NOT COMPLETED|Overall Study||6
5082554|NCT01730950|12505950|P1|NOT COMPLETED|Overall Study||6
5082555|NCT01730950|12505949|P2|COMPLETED|Overall Study||86
5082556|NCT01730950|12505950|P1|COMPLETED|Overall Study||84
5082557|NCT01730950|12505949|P2|Delayed Toxicity Population|Overall Study||83
5082558|NCT01730950|12505950|P1|Delayed Toxicity Population|Overall Study||0
5082559|NCT01730950|12505949|P2|6-month Progression-free Analysis|Overall Study||81
5082560|NCT01730950|12505950|P1|6-month Progression-free Analysis|Overall Study||79
5082561|NCT01730950|12505949|P2|Response Population|Overall Study||77
5082562|NCT01730950|12505950|P1|Response Population|Overall Study||78
5082563|NCT01730950|12505949|P2|Adverse Event Population|Overall Study||83
5082564|NCT01730950|12505950|P1|Adverse Event Population|Overall Study||76
5082565|NCT01730950|12505949|P2|Eligible Population|Overall Study||86
5082566|NCT01730950|12505950|P1|Eligible Population|Overall Study||84
5082567|NCT01730950|12505949|P2|STARTED|Overall Study||92
5082568|NCT01730950|12505950|P1|STARTED|Overall Study||90
5082569|NCT01730872|12505967|P3|NOT COMPLETED|Overall Study||0
5082570|NCT01730872|12505968|P2|NOT COMPLETED|Overall Study||0
5082571|NCT01730872|12505969|P1|NOT COMPLETED|Overall Study||0
5082572|NCT01730872|12505967|P3|COMPLETED|Overall Study||3
5082573|NCT01730872|12505968|P2|COMPLETED|Overall Study||5
5082574|NCT01730872|12505969|P1|COMPLETED|Overall Study||8
5082575|NCT01730872|12505967|P3|Full Analysis Set|Overall Study||0
5082576|NCT01730872|12505968|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
5082577|NCT01730872|12505969|P1|Full Analysis Set|Overall Study||8
5082578|NCT01730872|12505967|P3|STARTED|Overall Study||3
5082579|NCT01730872|12505968|P2|STARTED|Overall Study||5
5082580|NCT01730872|12505969|P1|STARTED|Overall Study||8
5082581|NCT01730846|12505983|P3|NOT COMPLETED|Overall Study||0
5082582|NCT01730846|12505984|P2|NOT COMPLETED|Overall Study||0
5082583|NCT01730846|12505985|P1|NOT COMPLETED|Overall Study||0
5082584|NCT01730846|12505983|P3|COMPLETED|Overall Study||13
5082585|NCT01730846|12505984|P2|COMPLETED|Overall Study||11
5082586|NCT01730846|12505985|P1|COMPLETED|Overall Study||11
5082587|NCT01730846|12505983|P3|STARTED|Overall Study||13
5082588|NCT01730846|12505984|P2|STARTED|Overall Study||11
5082589|NCT01730846|12505985|P1|STARTED|Overall Study||11
5082590|NCT01730729|12505996|P1|NOT COMPLETED|Overall Study||14
5082591|NCT01730729|12505996|P1|COMPLETED|Overall Study||6
5082592|NCT01730729|12505996|P1|Treated Cycle 3 and Beyond|Overall Study||6
5082593|NCT01730729|12505996|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
5082594|NCT01730729|12505996|P1|STARTED|Overall Study||20
5082595|NCT01730586|12506010|P1|NOT COMPLETED|Overall Study||13
5082596|NCT01730586|12506010|P1|COMPLETED|Overall Study||21
5082597|NCT01730586|12506010|P1|STARTED|Overall Study||34
5082598|NCT01730534|12506019|P2|NOT COMPLETED|Overall Study||145
5082599|NCT01730534|12506020|P1|NOT COMPLETED|Overall Study||109
5082600|NCT01730534|12506019|P2|COMPLETED|Overall Study||8433
5082601|NCT01730534|12506020|P1|COMPLETED|Overall Study||8473
5082602|NCT01730534|12506019|P2|STARTED|Overall Study||8578
5082603|NCT01730534|12506020|P1|STARTED|Overall Study||8582
5082604|NCT01730378|12506034|P2|NOT COMPLETED|Overall Study||0
5082605|NCT01730378|12506035|P1|NOT COMPLETED|Overall Study||1
5082606|NCT01730378|12506034|P2|COMPLETED|Overall Study||47
5082607|NCT01730378|12506035|P1|COMPLETED|Overall Study||83
5082608|NCT01730378|12506034|P2|STARTED|Overall Study||47
5082609|NCT01730378|12506035|P1|STARTED|Overall Study||84
5082610|NCT01730339|12506066|P2|NOT COMPLETED|Overall Study||3
5082611|NCT01730339|12506067|P1|NOT COMPLETED|Overall Study||5
5082612|NCT01730339|12506066|P2|COMPLETED|Overall Study||52
5082613|NCT01730339|12506067|P1|COMPLETED|Overall Study||40
5082614|NCT01730339|12506066|P2|STARTED|Overall Study||55
5082615|NCT01730339|12506067|P1|STARTED|Overall Study||45
5082616|NCT01730053|12506107|P6|NOT COMPLETED|Overall Study||13
5082617|NCT01730053|12506108|P5|NOT COMPLETED|Overall Study||9
5082618|NCT01730053|12506109|P4|NOT COMPLETED|Overall Study||8
5082619|NCT01730053|12506110|P3|NOT COMPLETED|Overall Study||11
5082620|NCT01730053|12506111|P2|NOT COMPLETED|Overall Study||14
5082621|NCT01730053|12506112|P1|NOT COMPLETED|Overall Study||5
5082622|NCT01730053|12506107|P6|COMPLETED|Overall Study||41
5082623|NCT01730053|12506108|P5|COMPLETED|Overall Study||44
5082624|NCT01730053|12506109|P4|COMPLETED|Overall Study||45
5082625|NCT01730053|12506110|P3|COMPLETED|Overall Study||38
5082626|NCT01730053|12506111|P2|COMPLETED|Overall Study||34
5082627|NCT01730053|12506112|P1|COMPLETED|Overall Study||43
5082628|NCT01730053|12506107|P6|Treated|Overall Study||54
5082629|NCT01730053|12506108|P5|Treated|Overall Study||53
5082630|NCT01730053|12506109|P4|Treated|Overall Study||53
5082631|NCT01730053|12506110|P3|Treated|Overall Study||49
5082632|NCT01730053|12506111|P2|Treated|Overall Study||48
5082633|NCT01730053|12506112|P1|Treated|Overall Study||48
5082634|NCT01730053|12506107|P6|STARTED|Overall Study||54
5082635|NCT01730053|12506108|P5|STARTED|Overall Study||53
5082636|NCT01730053|12506109|P4|STARTED|Overall Study||53
5082637|NCT01730053|12506110|P3|STARTED|Overall Study||49
5082638|NCT01730053|12506111|P2|STARTED|Overall Study||48
5082639|NCT01730053|12506112|P1|STARTED|Overall Study||48
5082640|NCT01730040|12506271|P7|NOT COMPLETED|Overall Study||9
5082641|NCT01730040|12506272|P6|NOT COMPLETED|Overall Study||7
5082642|NCT01730040|12506273|P5|NOT COMPLETED|Overall Study||6
5082643|NCT01730040|12506274|P4|NOT COMPLETED|Overall Study||8
5082644|NCT01730040|12506275|P3|NOT COMPLETED|Overall Study||11
5082645|NCT01730040|12506276|P2|NOT COMPLETED|Overall Study||15
5082646|NCT01730040|12506277|P1|NOT COMPLETED|Overall Study||13
5082647|NCT01730040|12506271|P7|COMPLETED|Overall Study||38
5082648|NCT01730040|12506272|P6|COMPLETED|Overall Study||40
5082649|NCT01730040|12506273|P5|COMPLETED|Overall Study||39
5082650|NCT01730040|12506274|P4|COMPLETED|Overall Study||39
5082651|NCT01730040|12506275|P3|COMPLETED|Overall Study||46
5082652|NCT01730040|12506276|P2|COMPLETED|Overall Study||40
5082653|NCT01730040|12506277|P1|COMPLETED|Overall Study||44
5082654|NCT01730040|12506271|P7|Treated|Overall Study||47
5082655|NCT01730040|12506272|P6|Treated|Overall Study||46
5082656|NCT01730040|12506273|P5|Treated|Overall Study||45
5082657|NCT01730040|12506274|P4|Treated|Overall Study||47
5082658|NCT01730040|12506275|P3|Treated|Overall Study||57
5082659|NCT01730040|12506276|P2|Treated|Overall Study||55
5082660|NCT01730040|12506277|P1|Treated|Overall Study||57
5082661|NCT01730040|12506271|P7|STARTED|Overall Study||47
5082662|NCT01730040|12506272|P6|STARTED|Overall Study||47
5082663|NCT01730040|12506273|P5|STARTED|Overall Study||45
5082664|NCT01730040|12506274|P4|STARTED|Overall Study||47
5082665|NCT01730040|12506275|P3|STARTED|Overall Study||57
5082666|NCT01730040|12506276|P2|STARTED|Overall Study||55
5082667|NCT01730040|12506277|P1|STARTED|Overall Study||57
5082668|NCT01729923|12506454|P1|NOT COMPLETED|Overall Study||27
5082669|NCT01729923|12506454|P1|COMPLETED|Overall Study||0
5082670|NCT01729923|12506454|P1|STARTED|Overall Study||27
5082671|NCT01729871|12506466|P2|NOT COMPLETED|Overall Study||23
5082672|NCT01729871|12506467|P1|NOT COMPLETED|Overall Study||12
5082673|NCT01729871|12506466|P2|COMPLETED|Overall Study||101
5082674|NCT01729871|12506467|P1|COMPLETED|Overall Study||112
5082675|NCT01729871|12506466|P2|STARTED|Overall Study||124
5082676|NCT01729871|12506467|P1|STARTED|Overall Study||124
5082677|NCT01729845|12506486|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
5082678|NCT01729845|12506487|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
5082679|NCT01729845|12506488|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
5082680|NCT01729845|12506486|P3|COMPLETED|Efficacy of Dec/MEC||0
5082681|NCT01729845|12506487|P2|COMPLETED|Efficacy of Dec/MEC||22
5082682|NCT01729845|12506488|P1|COMPLETED|Efficacy of Dec/MEC||0
5082683|NCT01729845|12506486|P3|STARTED|Efficacy of Dec/MEC||0
5082684|NCT01729845|12506487|P2|STARTED|Efficacy of Dec/MEC||22
5082685|NCT01729845|12506488|P1|STARTED|Efficacy of Dec/MEC||0
5082686|NCT01729845|12506486|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
5082687|NCT01729845|12506487|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
5082688|NCT01729845|12506488|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
5082689|NCT01729845|12506486|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
5082690|NCT01729845|12506487|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
5082691|NCT01729845|12506488|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
5082692|NCT01729845|12506486|P3|STARTED|Safety/Tolerability of Dec/MEC||12
5082693|NCT01729845|12506487|P2|STARTED|Safety/Tolerability of Dec/MEC||34
5082694|NCT01729845|12506488|P1|STARTED|Safety/Tolerability of Dec/MEC||6
5082695|NCT01729819|12506501|P2|NOT COMPLETED|Overall Study||7
5082696|NCT01729819|12506502|P1|NOT COMPLETED|Overall Study||6
5082697|NCT01729819|12506501|P2|COMPLETED|Overall Study||50
5082698|NCT01729819|12506502|P1|COMPLETED|Overall Study||43
5082699|NCT01729819|12506501|P2|STARTED|Overall Study||57
5082700|NCT01729819|12506502|P1|STARTED|Overall Study||49
5082701|NCT01729754|12506521|P10|NOT COMPLETED|Part 3||7
5082702|NCT01729754|12506522|P9|NOT COMPLETED|Part 3||1
5082703|NCT01729754|12506523|P8|NOT COMPLETED|Part 3||3
5082704|NCT01729754|12506524|P7|NOT COMPLETED|Part 3||0
5082705|NCT01729754|12506525|P6|NOT COMPLETED|Part 3||13
5082706|NCT01729754|12506526|P5|NOT COMPLETED|Part 3||4
5082707|NCT01729754|12506527|P4|NOT COMPLETED|Part 3||0
5082708|NCT01729754|12506528|P3|NOT COMPLETED|Part 3||5
5082709|NCT01729754|12506529|P2|NOT COMPLETED|Part 3||5
5082710|NCT01729754|12506530|P1|NOT COMPLETED|Part 3||0
5082711|NCT01729754|12506521|P10|COMPLETED|Part 3||114
5082712|NCT01729754|12506522|P9|COMPLETED|Part 3||65
5082713|NCT01729754|12506523|P8|COMPLETED|Part 3||66
5082714|NCT01729754|12506524|P7|COMPLETED|Part 3||0
5082715|NCT01729754|12506525|P6|COMPLETED|Part 3||224
5082716|NCT01729754|12506526|P5|COMPLETED|Part 3||17
5082717|NCT01729754|12506527|P4|COMPLETED|Part 3||0
5082718|NCT01729754|12506528|P3|COMPLETED|Part 3||105
5082719|NCT01729754|12506529|P2|COMPLETED|Part 3||165
5082720|NCT01729754|12506530|P1|COMPLETED|Part 3||0
5082721|NCT01729754|12506521|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
5082722|NCT01729754|12506522|P9|STARTED|Part 3||66
5082723|NCT01729754|12506523|P8|STARTED|Part 3||69
5082724|NCT01729754|12506524|P7|STARTED|Part 3||0
5082725|NCT01729754|12506525|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
5082726|NCT01729754|12506526|P5|STARTED|Part 3||21
5082727|NCT01729754|12506527|P4|STARTED|Part 3||0
5082728|NCT01729754|12506528|P3|STARTED|Part 3||110
5082729|NCT01729754|12506529|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
5082730|NCT01729754|12506530|P1|STARTED|Part 3||0
5082731|NCT01729754|12506521|P10|NOT COMPLETED|Part 2||12
5082732|NCT01729754|12506522|P9|NOT COMPLETED|Part 2||4
5082733|NCT01729754|12506523|P8|NOT COMPLETED|Part 2||3
5082734|NCT01729754|12506524|P7|NOT COMPLETED|Part 2||0
5082735|NCT01729754|12506525|P6|NOT COMPLETED|Part 2||0
5082736|NCT01729754|12506526|P5|NOT COMPLETED|Part 2||0
5082737|NCT01729754|12506527|P4|NOT COMPLETED|Part 2||5
5082738|NCT01729754|12506528|P3|NOT COMPLETED|Part 2||0
5082739|NCT01729754|12506529|P2|NOT COMPLETED|Part 2||0
5082740|NCT01729754|12506530|P1|NOT COMPLETED|Part 2||6
5082741|NCT01729754|12506521|P10|COMPLETED|Part 2||277
5082742|NCT01729754|12506522|P9|COMPLETED|Part 2||66
5082743|NCT01729754|12506523|P8|COMPLETED|Part 2||69
5082744|NCT01729754|12506524|P7|COMPLETED|Part 2||0
5082745|NCT01729754|12506525|P6|COMPLETED|Part 2||268
5082746|NCT01729754|12506526|P5|COMPLETED|Part 2||21
5082747|NCT01729754|12506527|P4|COMPLETED|Part 2||0
5082748|NCT01729754|12506528|P3|COMPLETED|Part 2||110
5082749|NCT01729754|12506529|P2|COMPLETED|Part 2||184
5082750|NCT01729754|12506530|P1|COMPLETED|Part 2||0
5082751|NCT01729754|12506521|P10|STARTED|Part 2||289
5082752|NCT01729754|12506522|P9|STARTED|Part 2||70
5082753|NCT01729754|12506523|P8|STARTED|Part 2||72
5082754|NCT01729754|12506524|P7|STARTED|Part 2||0
5082755|NCT01729754|12506525|P6|STARTED|Part 2||268
5082756|NCT01729754|12506526|P5|STARTED|Part 2||21
5082757|NCT01729754|12506527|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
5082758|NCT01729754|12506528|P3|STARTED|Part 2||110
5082759|NCT01729754|12506529|P2|STARTED|Part 2||184
5082760|NCT01729754|12506530|P1|STARTED|Part 2||6
5082761|NCT01729754|12506521|P10|NOT COMPLETED|Part 1||24
5082762|NCT01729754|12506522|P9|NOT COMPLETED|Part 1||0
5082763|NCT01729754|12506523|P8|NOT COMPLETED|Part 1||0
5082764|NCT01729754|12506524|P7|NOT COMPLETED|Part 1||14
5082765|NCT01729754|12506525|P6|NOT COMPLETED|Part 1||0
5082766|NCT01729754|12506526|P5|NOT COMPLETED|Part 1||0
5082767|NCT01729754|12506527|P4|NOT COMPLETED|Part 1||12
5082768|NCT01729754|12506528|P3|NOT COMPLETED|Part 1||0
5082769|NCT01729754|12506529|P2|NOT COMPLETED|Part 1||0
5082770|NCT01729754|12506530|P1|NOT COMPLETED|Part 1||14
5082771|NCT01729754|12506521|P10|COMPLETED|Part 1||289
5082772|NCT01729754|12506522|P9|COMPLETED|Part 1||70
5082773|NCT01729754|12506523|P8|COMPLETED|Part 1||72
5082774|NCT01729754|12506524|P7|COMPLETED|Part 1||0
5082775|NCT01729754|12506525|P6|COMPLETED|Part 1||268
5082776|NCT01729754|12506526|P5|COMPLETED|Part 1||21
5082777|NCT01729754|12506527|P4|COMPLETED|Part 1||6
5082778|NCT01729754|12506528|P3|COMPLETED|Part 1||110
5082779|NCT01729754|12506529|P2|COMPLETED|Part 1||184
5082780|NCT01729754|12506530|P1|COMPLETED|Part 1||6
5082781|NCT01729754|12506521|P10|STARTED|Part 1||313
5082782|NCT01729754|12506522|P9|STARTED|Part 1||70
5082783|NCT01729754|12506523|P8|STARTED|Part 1||72
5082784|NCT01729754|12506524|P7|STARTED|Part 1||14
5082785|NCT01729754|12506525|P6|STARTED|Part 1||268
5082786|NCT01729754|12506526|P5|STARTED|Part 1||21
5082787|NCT01729754|12506527|P4|STARTED|Part 1||18
5082788|NCT01729754|12506528|P3|STARTED|Part 1||110
5082789|NCT01729754|12506529|P2|STARTED|Part 1||184
5082790|NCT01729754|12506530|P1|STARTED|Part 1||20
5082791|NCT01729728|12506737|P3|NOT COMPLETED|Overall Study||1
5082792|NCT01729728|12506738|P2|NOT COMPLETED|Overall Study||6
5082793|NCT01729728|12506739|P1|NOT COMPLETED|Overall Study||1
5082794|NCT01729728|12506737|P3|COMPLETED|Overall Study||16
5082795|NCT01729728|12506738|P2|COMPLETED|Overall Study||22
5082796|NCT01729728|12506739|P1|COMPLETED|Overall Study||20
5082797|NCT01729728|12506737|P3|STARTED|Overall Study||17
5082798|NCT01729728|12506738|P2|STARTED|Overall Study||28
5082799|NCT01729728|12506739|P1|STARTED|Overall Study||21
5082800|NCT01729598|12506872|P2|NOT COMPLETED|Overall Study||0
5082801|NCT01729598|12506873|P1|NOT COMPLETED|Overall Study||0
5082802|NCT01729598|12506872|P2|COMPLETED|Overall Study||4
5082803|NCT01729598|12506873|P1|COMPLETED|Overall Study||10
5082804|NCT01729598|12506872|P2|STARTED|Overall Study||4
5082805|NCT01729598|12506873|P1|STARTED|Overall Study||10
5082806|NCT01729559|12506889|P2|NOT COMPLETED|Overall Study||28
5082807|NCT01729559|12506890|P1|NOT COMPLETED|Overall Study||31
5082808|NCT01729559|12506889|P2|COMPLETED|Overall Study||216
5082809|NCT01729559|12506890|P1|COMPLETED|Overall Study||220
5082810|NCT01729559|12506889|P2|STARTED|Overall Study||244
5082811|NCT01729559|12506890|P1|STARTED|Overall Study||251
5082812|NCT01729338|12506902|P1|NOT COMPLETED|Overall Study||2
5082813|NCT01729338|12506902|P1|COMPLETED|Overall Study||14
5082814|NCT01729338|12506902|P1|STARTED|Overall Study||16
5082815|NCT01729247|12506917|P1|NOT COMPLETED|Overall Study||0
5082816|NCT01729247|12506917|P1|COMPLETED|Overall Study||50
5082817|NCT01729247|12506917|P1|STARTED|Overall Study||50
5082818|NCT01729208|12506933|P2|NOT COMPLETED|36 Months Follow-up||4
5082819|NCT01729208|12506934|P1|NOT COMPLETED|36 Months Follow-up||3
5082820|NCT01729208|12506933|P2|COMPLETED|36 Months Follow-up||56
5082821|NCT01729208|12506934|P1|COMPLETED|36 Months Follow-up||52
5082822|NCT01729208|12506933|P2|STARTED|36 Months Follow-up||60
5082823|NCT01729208|12506934|P1|STARTED|36 Months Follow-up||55
5082824|NCT01729208|12506933|P2|NOT COMPLETED|24 Months Follow-up||0
5082825|NCT01729208|12506934|P1|NOT COMPLETED|24 Months Follow-up||3
5082826|NCT01729208|12506933|P2|COMPLETED|24 Months Follow-up||60
5082827|NCT01729208|12506934|P1|COMPLETED|24 Months Follow-up||55
5082828|NCT01729208|12506933|P2|STARTED|24 Months Follow-up||60
5082829|NCT01729208|12506934|P1|STARTED|24 Months Follow-up||58
5082830|NCT01729208|12506933|P2|NOT COMPLETED|12 Months Follow-up||10
5082831|NCT01729208|12506934|P1|NOT COMPLETED|12 Months Follow-up||7
5082832|NCT01729208|12506933|P2|COMPLETED|12 Months Follow-up||60
5082833|NCT01729208|12506934|P1|COMPLETED|12 Months Follow-up||58
5082834|NCT01729208|12506933|P2|STARTED|12 Months Follow-up||70
5082835|NCT01729208|12506934|P1|STARTED|12 Months Follow-up||65
5082836|NCT01729208|12506933|P2|NOT COMPLETED|Baseline||4
5082837|NCT01729208|12506934|P1|NOT COMPLETED|Baseline||5
5082838|NCT01729208|12506933|P2|COMPLETED|Baseline||70
5082839|NCT01729208|12506934|P1|COMPLETED|Baseline||65
5082840|NCT01729208|12506933|P2|STARTED|Baseline||74
5082841|NCT01729208|12506934|P1|STARTED|Baseline||70
5082842|NCT01729156|12506967|P3|NOT COMPLETED|Overall Study||0
5082843|NCT01729156|12506968|P2|NOT COMPLETED|Overall Study||0
5082844|NCT01729156|12506969|P1|NOT COMPLETED|Overall Study||1
5082845|NCT01729156|12506967|P3|COMPLETED|Overall Study||12
5082846|NCT01729156|12506968|P2|COMPLETED|Overall Study||12
5082847|NCT01729156|12506969|P1|COMPLETED|Overall Study||11
5082848|NCT01729156|12506967|P3|STARTED|Overall Study||12
5082849|NCT01729156|12506968|P2|STARTED|Overall Study||12
5082850|NCT01729156|12506969|P1|STARTED|Overall Study||12
5082851|NCT01729039|12506997|P2|NOT COMPLETED|Overall Study||12
5082852|NCT01729039|12506998|P1|NOT COMPLETED|Overall Study||10
5082853|NCT01729039|12506997|P2|COMPLETED|Overall Study||14
5082854|NCT01729039|12506998|P1|COMPLETED|Overall Study||13
5082855|NCT01729039|12506997|P2|STARTED|Overall Study||26
5082856|NCT01729039|12506998|P1|STARTED|Overall Study||23
5082857|NCT01729026|12507014|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
5082858|NCT01729026|12507015|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
5082859|NCT01729026|12507014|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
5082860|NCT01729026|12507015|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
5082861|NCT01729026|12507014|P2|STARTED|3-month to 6-month (Final) Follow-up||8
5082862|NCT01729026|12507015|P1|STARTED|3-month to 6-month (Final) Follow-up||7
5082863|NCT01729026|12507014|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
5082864|NCT01729026|12507015|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
5082865|NCT01729026|12507014|P2|COMPLETED|Randomization to 3-month Follow-up||8
5082866|NCT01729026|12507015|P1|COMPLETED|Randomization to 3-month Follow-up||7
5082867|NCT01729026|12507014|P2|STARTED|Randomization to 3-month Follow-up||10
5082868|NCT01729026|12507015|P1|STARTED|Randomization to 3-month Follow-up||9
5082869|NCT01728805|12507045|P3|NOT COMPLETED|Crossover Period||0
5082870|NCT01728805|12507046|P2|NOT COMPLETED|Crossover Period||0
5082871|NCT01728805|12507047|P1|NOT COMPLETED|Crossover Period||0
5082872|NCT01728805|12507045|P3|COMPLETED|Crossover Period||136
5082873|NCT01728805|12507046|P2|COMPLETED|Crossover Period||0
5082874|NCT01728805|12507047|P1|COMPLETED|Crossover Period||0
5082875|NCT01728805|12507045|P3|STARTED|Crossover Period||136
5082876|NCT01728805|12507046|P2|STARTED|Crossover Period||0
5082877|NCT01728805|12507047|P1|STARTED|Crossover Period||0
5082878|NCT01728805|12507045|P3|NOT COMPLETED|Randomization Period||0
5082879|NCT01728805|12507046|P2|NOT COMPLETED|Randomization Period||0
5082880|NCT01728805|12507047|P1|NOT COMPLETED|Randomization Period||0
5082881|NCT01728805|12507045|P3|COMPLETED|Randomization Period||0
5082882|NCT01728805|12507046|P2|COMPLETED|Randomization Period||186
5082883|NCT01728805|12507047|P1|COMPLETED|Randomization Period||186
5082884|NCT01728805|12507045|P3|STARTED|Randomization Period||0
5082885|NCT01728805|12507046|P2|STARTED|Randomization Period||186
5082886|NCT01728805|12507047|P1|STARTED|Randomization Period||186
5082887|NCT01728792|12507065|P5|NOT COMPLETED|Overall Study||0
5082888|NCT01728792|12507066|P4|NOT COMPLETED|Overall Study||3
5082889|NCT01728792|12507067|P3|NOT COMPLETED|Overall Study||4
5082890|NCT01728792|12507068|P2|NOT COMPLETED|Overall Study||2
5082891|NCT01728792|12507069|P1|NOT COMPLETED|Overall Study||3
5082892|NCT01728792|12507065|P5|COMPLETED|Overall Study||16
5082893|NCT01728792|12507066|P4|COMPLETED|Overall Study||14
5082894|NCT01728792|12507067|P3|COMPLETED|Overall Study||13
5082895|NCT01728792|12507068|P2|COMPLETED|Overall Study||14
5082896|NCT01728792|12507069|P1|COMPLETED|Overall Study||11
5082897|NCT01728792|12507065|P5|STARTED|Overall Study||16
5082898|NCT01728792|12507066|P4|STARTED|Overall Study||17
5082899|NCT01728792|12507067|P3|STARTED|Overall Study||17
5082900|NCT01728792|12507068|P2|STARTED|Overall Study||16
5082901|NCT01728792|12507069|P1|STARTED|Overall Study||14
5082902|NCT01728584|12507120|P4|NOT COMPLETED|Overall Study||1
5082903|NCT01728584|12507121|P3|NOT COMPLETED|Overall Study||1
5082904|NCT01728584|12507122|P2|NOT COMPLETED|Overall Study||0
5082905|NCT01728584|12507123|P1|NOT COMPLETED|Overall Study||8
5082906|NCT01728584|12507120|P4|COMPLETED|Overall Study||29
5082907|NCT01728584|12507121|P3|COMPLETED|Overall Study||30
5082908|NCT01728584|12507122|P2|COMPLETED|Overall Study||30
5082909|NCT01728584|12507123|P1|COMPLETED|Overall Study||28
5082910|NCT01728584|12507120|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
5082911|NCT01728584|12507121|P3|STARTED|Overall Study|Randomized|31
5082912|NCT01728584|12507122|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
5082913|NCT01728584|12507123|P1|STARTED|Overall Study|Randomized|36
5082914|NCT01728454|12507178|P3|NOT COMPLETED|Stage 3||4
5082915|NCT01728454|12507179|P2|NOT COMPLETED|Stage 3||4
5082916|NCT01728454|12507180|P1|NOT COMPLETED|Stage 3||3
5082917|NCT01728454|12507178|P3|COMPLETED|Stage 3||7
5082918|NCT01728454|12507179|P2|COMPLETED|Stage 3||1
5082919|NCT01728454|12507180|P1|COMPLETED|Stage 3||3
5082920|NCT01728454|12507178|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
5082921|NCT01728454|12507179|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
5082922|NCT01728454|12507180|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
5082923|NCT01728454|12507178|P3|NOT COMPLETED|Stage 1 and 2||4
5082924|NCT01728454|12507179|P2|NOT COMPLETED|Stage 1 and 2||4
5082925|NCT01728454|12507180|P1|NOT COMPLETED|Stage 1 and 2||5
5082926|NCT01728454|12507178|P3|COMPLETED|Stage 1 and 2||19
5082927|NCT01728454|12507179|P2|COMPLETED|Stage 1 and 2||16
5082928|NCT01728454|12507180|P1|COMPLETED|Stage 1 and 2||12
5082929|NCT01728454|12507178|P3|STARTED|Stage 1 and 2||23
5082930|NCT01728454|12507179|P2|STARTED|Stage 1 and 2||20
5082931|NCT01728454|12507180|P1|STARTED|Stage 1 and 2||17
5082932|NCT01728376|12507230|P6|NOT COMPLETED|Overall Study||2
5082933|NCT01728376|12507231|P5|NOT COMPLETED|Overall Study||2
5082934|NCT01728376|12507232|P4|NOT COMPLETED|Overall Study||2
5082935|NCT01728376|12507233|P3|NOT COMPLETED|Overall Study||2
5082936|NCT01728376|12507234|P2|NOT COMPLETED|Overall Study||2
5082937|NCT01728376|12507235|P1|NOT COMPLETED|Overall Study||4
5082938|NCT01728376|12507230|P6|COMPLETED|Overall Study||5
5082939|NCT01728376|12507231|P5|COMPLETED|Overall Study||12
5082940|NCT01728376|12507232|P4|COMPLETED|Overall Study||7
5082941|NCT01728376|12507233|P3|COMPLETED|Overall Study||17
5082942|NCT01728376|12507234|P2|COMPLETED|Overall Study||9
5082943|NCT01728376|12507235|P1|COMPLETED|Overall Study||18
5082944|NCT01728376|12507230|P6|Treated|Overall Study||7
5082945|NCT01728376|12507231|P5|Treated|Overall Study||14
5082946|NCT01728376|12507232|P4|Treated|Overall Study||9
5082947|NCT01728376|12507233|P3|Treated|Overall Study||19
5082948|NCT01728376|12507234|P2|Treated|Overall Study||10
5082949|NCT01728376|12507235|P1|Treated|Overall Study||22
5082950|NCT01728376|12507230|P6|STARTED|Overall Study||7
5082951|NCT01728376|12507231|P5|STARTED|Overall Study||14
5082952|NCT01728376|12507232|P4|STARTED|Overall Study||9
5082953|NCT01728376|12507233|P3|STARTED|Overall Study||19
5082954|NCT01728376|12507234|P2|STARTED|Overall Study||11
5082955|NCT01728376|12507235|P1|STARTED|Overall Study||22
5082956|NCT01728337|12507297|P1|NOT COMPLETED|Overall Study||0
5082957|NCT01728337|12507297|P1|COMPLETED|Overall Study||80
5082958|NCT01728337|12507297|P1|STARTED|Overall Study||80
5082959|NCT01728324|12507308|P3|NOT COMPLETED|Termination of RBV||15
5082960|NCT01728324|12507309|P2|NOT COMPLETED|Termination of RBV||37
5082961|NCT01728324|12507310|P1|NOT COMPLETED|Termination of RBV||39
5082962|NCT01728324|12507308|P3|COMPLETED|Termination of RBV||57
5082963|NCT01728324|12507309|P2|COMPLETED|Termination of RBV||176
5082964|NCT01728324|12507310|P1|COMPLETED|Termination of RBV||172
5082965|NCT01728324|12507308|P3|STARTED|Termination of RBV||72
5082966|NCT01728324|12507309|P2|STARTED|Termination of RBV||213
5082967|NCT01728324|12507310|P1|STARTED|Termination of RBV||211
5082968|NCT01728324|12507308|P3|NOT COMPLETED|Termination of FDV||14
5082969|NCT01728324|12507309|P2|NOT COMPLETED|Termination of FDV||36
5082970|NCT01728324|12507310|P1|NOT COMPLETED|Termination of FDV||38
5082971|NCT01728324|12507308|P3|COMPLETED|Termination of FDV||58
5082972|NCT01728324|12507309|P2|COMPLETED|Termination of FDV||177
5082973|NCT01728324|12507310|P1|COMPLETED|Termination of FDV||173
5082974|NCT01728324|12507308|P3|STARTED|Termination of FDV||72
5082975|NCT01728324|12507309|P2|STARTED|Termination of FDV||213
5082976|NCT01728324|12507310|P1|STARTED|Termination of FDV||211
5082977|NCT01728324|12507308|P3|NOT COMPLETED|Termination of DBV||14
5082978|NCT01728324|12507309|P2|NOT COMPLETED|Termination of DBV||36
5082979|NCT01728324|12507310|P1|NOT COMPLETED|Termination of DBV||38
5082980|NCT01728324|12507308|P3|COMPLETED|Termination of DBV||58
5082981|NCT01728324|12507309|P2|COMPLETED|Termination of DBV||177
5082982|NCT01728324|12507310|P1|COMPLETED|Termination of DBV||173
5082983|NCT01728324|12507308|P3|STARTED|Termination of DBV||72
5082984|NCT01728324|12507309|P2|STARTED|Termination of DBV||213
5082985|NCT01728324|12507310|P1|STARTED|Termination of DBV||211
5082986|NCT01728246|12507331|P2|NOT COMPLETED|Overall Study||36
5082987|NCT01728246|12507332|P1|NOT COMPLETED|Overall Study||36
5082988|NCT01728246|12507331|P2|COMPLETED|Overall Study||195
5082989|NCT01728246|12507332|P1|COMPLETED|Overall Study||206
5082990|NCT01728246|12507331|P2|STARTED|Overall Study||231
5082991|NCT01728246|12507332|P1|STARTED|Overall Study||242
5082992|NCT01728116|12507350|P2|NOT COMPLETED|Overall Study||47
5082993|NCT01728116|12507351|P1|NOT COMPLETED|Overall Study||161
5082994|NCT01728116|12507350|P2|COMPLETED|Overall Study|Completed to Week 52|60
5082995|NCT01728116|12507351|P1|COMPLETED|Overall Study|Completed to Week 78|52
5082996|NCT01728116|12507350|P2|STARTED|Overall Study|Sham mITT subjects|107
5082997|NCT01728116|12507351|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
5082998|NCT01728077|12507376|P2|NOT COMPLETED|Overall Study||5
5082999|NCT01728077|12507377|P1|NOT COMPLETED|Overall Study||8
5083000|NCT01728077|12507376|P2|COMPLETED|Overall Study||2
5083001|NCT01728077|12507377|P1|COMPLETED|Overall Study||11
5083002|NCT01728077|12507376|P2|STARTED|Overall Study||7
5083003|NCT01728077|12507377|P1|STARTED|Overall Study||19
5083004|NCT01727895|12507392|P2|NOT COMPLETED|Overall Study||0
5083005|NCT01727895|12507393|P1|NOT COMPLETED|Overall Study||0
5083006|NCT01727895|12507392|P2|COMPLETED|Overall Study||5
5083007|NCT01727895|12507393|P1|COMPLETED|Overall Study||10
5083008|NCT01727895|12507392|P2|STARTED|Overall Study||5
5083009|NCT01727895|12507393|P1|STARTED|Overall Study||10
5083010|NCT01727791|12507399|P1|NOT COMPLETED|Overall Study||0
5083011|NCT01727791|12507399|P1|COMPLETED|Overall Study||10
5083012|NCT01727791|12507399|P1|STARTED|Overall Study||10
5083013|NCT01727765|12507431|P2|NOT COMPLETED|Overall Study||0
5083014|NCT01727765|12507432|P1|NOT COMPLETED|Overall Study||0
5083015|NCT01727765|12507431|P2|COMPLETED|Overall Study||8
5083016|NCT01727765|12507432|P1|COMPLETED|Overall Study||8
5083017|NCT01727765|12507431|P2|STARTED|Overall Study||8
5083018|NCT01727765|12507432|P1|STARTED|Overall Study||8
5083019|NCT01727726|12507441|P3|NOT COMPLETED|Overall Study||20
5083020|NCT01727726|12507442|P2|NOT COMPLETED|Overall Study||14
5083021|NCT01727726|12507443|P1|NOT COMPLETED|Overall Study||26
5083022|NCT01727726|12507441|P3|COMPLETED|Overall Study||186
5083023|NCT01727726|12507442|P2|COMPLETED|Overall Study||86
5083024|NCT01727726|12507443|P1|COMPLETED|Overall Study||171
5083025|NCT01727726|12507441|P3|STARTED|Overall Study||206
5083026|NCT01727726|12507442|P2|STARTED|Overall Study||100
5083027|NCT01727726|12507443|P1|STARTED|Overall Study||197
5083028|NCT01727713|12507475|P1|NOT COMPLETED|Overall Study||35
5083029|NCT01727713|12507475|P1|COMPLETED|Overall Study||75
5083030|NCT01727713|12507475|P1|STARTED|Overall Study||110
5083031|NCT01727700|12507502|P3|NOT COMPLETED|Overall Study||2
5083032|NCT01727700|12507503|P2|NOT COMPLETED|Overall Study||10
5083033|NCT01727700|12507504|P1|NOT COMPLETED|Overall Study||2
5083034|NCT01727700|12507502|P3|COMPLETED|Overall Study||42
5083035|NCT01727700|12507503|P2|COMPLETED|Overall Study||35
5083036|NCT01727700|12507504|P1|COMPLETED|Overall Study||42
5083037|NCT01727700|12507502|P3|STARTED|Overall Study||44
5083038|NCT01727700|12507503|P2|STARTED|Overall Study||45
5083039|NCT01727700|12507504|P1|STARTED|Overall Study||44
5083040|NCT01727505|12507527|P2|NOT COMPLETED|Second 24 Hours||1
5083041|NCT01727505|12507528|P1|NOT COMPLETED|Second 24 Hours||0
5083042|NCT01727505|12507527|P2|COMPLETED|Second 24 Hours||10
5083043|NCT01727505|12507528|P1|COMPLETED|Second 24 Hours||14
5083044|NCT01727505|12507527|P2|STARTED|Second 24 Hours||11
5083045|NCT01727505|12507528|P1|STARTED|Second 24 Hours||14
5083046|NCT01727505|12507527|P2|NOT COMPLETED|First 24 Hours||1
5083047|NCT01727505|12507528|P1|NOT COMPLETED|First 24 Hours||0
5083048|NCT01727505|12507527|P2|COMPLETED|First 24 Hours||11
5083049|NCT01727505|12507528|P1|COMPLETED|First 24 Hours||14
5083050|NCT01727505|12507527|P2|STARTED|First 24 Hours||12
5083051|NCT01727505|12507528|P1|STARTED|First 24 Hours||14
5083052|NCT01727414|12507546|P2|NOT COMPLETED|Overall Study||0
5083053|NCT01727414|12507547|P1|NOT COMPLETED|Overall Study||3
5083054|NCT01727414|12507546|P2|COMPLETED|Overall Study||45
5083055|NCT01727414|12507547|P1|COMPLETED|Overall Study||123
5083056|NCT01727414|12507546|P2|STARTED|Overall Study||45
5083057|NCT01727414|12507547|P1|STARTED|Overall Study||126
5083058|NCT01727297|12507553|P2|NOT COMPLETED|Overall Study||51
5083059|NCT01727297|12507554|P1|NOT COMPLETED|Overall Study||102
5083060|NCT01727297|12507553|P2|COMPLETED|Overall Study||0
5083061|NCT01727297|12507554|P1|COMPLETED|Overall Study||293
5083062|NCT01727297|12507553|P2|STARTED|Overall Study||51
5083063|NCT01727297|12507554|P1|STARTED|Overall Study||395
5083064|NCT01727258|12507570|P3|NOT COMPLETED|Overall Study||1
5083065|NCT01727258|12507571|P2|NOT COMPLETED|Overall Study||3
5083066|NCT01727258|12507572|P1|NOT COMPLETED|Overall Study||2
5083067|NCT01727258|12507570|P3|COMPLETED|Overall Study||50
5083068|NCT01727258|12507571|P2|COMPLETED|Overall Study||48
5083069|NCT01727258|12507572|P1|COMPLETED|Overall Study||49
5083070|NCT01727258|12507570|P3|STARTED|Overall Study||51
5083071|NCT01727258|12507571|P2|STARTED|Overall Study||51
5083072|NCT01727258|12507572|P1|STARTED|Overall Study||51
5083073|NCT01727180|12507595|P1|NOT COMPLETED|Overall Study||0
5083074|NCT01727180|12507595|P1|COMPLETED|Overall Study||108
5083075|NCT01727180|12507595|P1|STARTED|Overall Study||108
5083076|NCT01727167|12507601|P2|NOT COMPLETED|Overall Study||0
5083077|NCT01727167|12507602|P1|NOT COMPLETED|Overall Study||0
5083078|NCT01727167|12507601|P2|COMPLETED|Overall Study||0
5083079|NCT01727167|12507602|P1|COMPLETED|Overall Study||1
5083080|NCT01727167|12507601|P2|STARTED|Overall Study||0
5083081|NCT01727167|12507602|P1|STARTED|Overall Study||1
5083082|NCT01727154|12507610|P1|NOT COMPLETED|Overall Study||59
5083083|NCT01727154|12507610|P1|COMPLETED|Overall Study||80
5083084|NCT01727154|12507610|P1|STARTED|Overall Study||139
5083085|NCT01727141|12507618|P4|NOT COMPLETED|Overall Study||15
5083086|NCT01727141|12507619|P3|NOT COMPLETED|Overall Study||3
5083087|NCT01727141|12507620|P2|NOT COMPLETED|Overall Study||9
5083088|NCT01727141|12507621|P1|NOT COMPLETED|Overall Study||5
5083089|NCT01727141|12507618|P4|COMPLETED|Overall Study||246
5083090|NCT01727141|12507619|P3|COMPLETED|Overall Study||258
5083091|NCT01727141|12507620|P2|COMPLETED|Overall Study||251
5083092|NCT01727141|12507621|P1|COMPLETED|Overall Study||255
5083093|NCT01727141|12507618|P4|Full Analysis Set|Overall Study||261
5083094|NCT01727141|12507619|P3|Full Analysis Set|Overall Study||261
5083095|NCT01727141|12507620|P2|Full Analysis Set|Overall Study||260
5083096|NCT01727141|12507621|P1|Full Analysis Set|Overall Study||258
5083097|NCT01727141|12507618|P4|Safety Set|Overall Study||260
5083098|NCT01727141|12507619|P3|Safety Set|Overall Study||262
5083099|NCT01727141|12507620|P2|Safety Set|Overall Study||260
5083100|NCT01727141|12507621|P1|Safety Set|Overall Study||258
5083101|NCT01727141|12507618|P4|STARTED|Overall Study||261
5083102|NCT01727141|12507619|P3|STARTED|Overall Study||261
5083103|NCT01727141|12507620|P2|STARTED|Overall Study||260
5083104|NCT01727141|12507621|P1|STARTED|Overall Study||260
5083105|NCT01727089|12507673|P2|NOT COMPLETED|Overall Study||0
5083106|NCT01727089|12507674|P1|NOT COMPLETED|Overall Study||0
5083107|NCT01727089|12507673|P2|COMPLETED|Overall Study||30
5083108|NCT01727089|12507674|P1|COMPLETED|Overall Study||29
5083109|NCT01727089|12507673|P2|STARTED|Overall Study||30
5083110|NCT01727089|12507674|P1|STARTED|Overall Study||29
5083111|NCT01727024|12507686|P2|NOT COMPLETED|Period 2||0
5083112|NCT01727024|12507687|P1|NOT COMPLETED|Period 2||0
5083113|NCT01727024|12507686|P2|COMPLETED|Period 2||64
5083114|NCT01727024|12507687|P1|COMPLETED|Period 2||68
5083115|NCT01727024|12507686|P2|STARTED|Period 2||64
5083116|NCT01727024|12507687|P1|STARTED|Period 2||68
5083117|NCT01727024|12507686|P2|NOT COMPLETED|Period 1||4
5083118|NCT01727024|12507687|P1|NOT COMPLETED|Period 1||3
5083119|NCT01727024|12507686|P2|COMPLETED|Period 1||64
5083120|NCT01727024|12507687|P1|COMPLETED|Period 1||68
5083121|NCT01727024|12507686|P2|STARTED|Period 1||68
5083122|NCT01727024|12507687|P1|STARTED|Period 1||71
5083123|NCT01726803|12507702|P2|NOT COMPLETED|Overall Study||1
5083124|NCT01726803|12507703|P1|NOT COMPLETED|Overall Study||7
5083125|NCT01726803|12507702|P2|COMPLETED|Overall Study||107
5083126|NCT01726803|12507703|P1|COMPLETED|Overall Study||105
5083127|NCT01726803|12507702|P2|STARTED|Overall Study||108
5083128|NCT01726803|12507703|P1|STARTED|Overall Study||112
5083129|NCT01726673|12507725|P2|NOT COMPLETED|Overall Study||3
5083130|NCT01726673|12507726|P1|NOT COMPLETED|Overall Study||6
5083131|NCT01726673|12507725|P2|COMPLETED|Overall Study||21
5083132|NCT01726673|12507726|P1|COMPLETED|Overall Study||24
5083133|NCT01726673|12507725|P2|STARTED|Overall Study||24
5083134|NCT01726673|12507726|P1|STARTED|Overall Study||30
5083135|NCT01726621|12507736|P1|NOT COMPLETED|Overall Study||4
5083136|NCT01726621|12507736|P1|COMPLETED|Overall Study||51
5083137|NCT01726621|12507736|P1|STARTED|Overall Study||55
5083138|NCT01726517|12507745|P5|NOT COMPLETED|Overall Study||0
5083139|NCT01726517|12507746|P4|NOT COMPLETED|Overall Study||0
5083140|NCT01726517|12507747|P3|NOT COMPLETED|Overall Study||1
5083141|NCT01726517|12507748|P2|NOT COMPLETED|Overall Study||0
5083142|NCT01726517|12507749|P1|NOT COMPLETED|Overall Study||0
5083143|NCT01726517|12507745|P5|COMPLETED|Overall Study||21
5083144|NCT01726517|12507746|P4|COMPLETED|Overall Study||19
5083145|NCT01726517|12507747|P3|COMPLETED|Overall Study||18
5083146|NCT01726517|12507748|P2|COMPLETED|Overall Study||21
5083147|NCT01726517|12507749|P1|COMPLETED|Overall Study||20
5083148|NCT01726517|12507745|P5|STARTED|Overall Study||21
5083149|NCT01726517|12507746|P4|STARTED|Overall Study||19
5083150|NCT01726517|12507747|P3|STARTED|Overall Study||19
5083151|NCT01726517|12507748|P2|STARTED|Overall Study||21
5083152|NCT01726517|12507749|P1|STARTED|Overall Study||20
5083153|NCT01726504|12507778|P2|NOT COMPLETED|Overall Study||28
5083154|NCT01726504|12507779|P1|NOT COMPLETED|Overall Study||12
5083155|NCT01726504|12507778|P2|COMPLETED|Overall Study||511
5083156|NCT01726504|12507779|P1|COMPLETED|Overall Study||524
5083157|NCT01726504|12507778|P2|STARTED|Overall Study||539
5083158|NCT01726504|12507779|P1|STARTED|Overall Study||536
5083159|NCT01726335|12507805|P1|NOT COMPLETED|Overall Study||24
5083160|NCT01726335|12507805|P1|COMPLETED|Overall Study||29
5083161|NCT01726335|12507805|P1|STARTED|Overall Study||53
5083162|NCT01726270|12507821|P1|NOT COMPLETED|Part 2, Actual-Use Phase||39
5083163|NCT01726270|12507821|P1|COMPLETED|Part 2, Actual-Use Phase||330
5083164|NCT01726270|12507821|P1|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
5083165|NCT01726270|12507821|P1|NOT COMPLETED|Eligibility for Part 2||20
5083166|NCT01726270|12507821|P1|COMPLETED|Eligibility for Part 2||369
5083167|NCT01726270|12507821|P1|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
5083168|NCT01726270|12507821|P1|NOT COMPLETED|Part 1, Self-Selection Phase||10
5083169|NCT01726270|12507821|P1|COMPLETED|Part 1, Self-Selection Phase||679
5083170|NCT01726270|12507821|P1|STARTED|Part 1, Self-Selection Phase||689
5083171|NCT01726049|12507834|P2|NOT COMPLETED|Overall Study||4
5083172|NCT01726049|12507835|P1|NOT COMPLETED|Overall Study||5
5083173|NCT01726049|12507834|P2|COMPLETED|Overall Study||22
5083174|NCT01726049|12507835|P1|COMPLETED|Overall Study||21
5083175|NCT01726049|12507834|P2|STARTED|Overall Study||26
5083176|NCT01726049|12507835|P1|STARTED|Overall Study||26
5083177|NCT01726036|12507849|P2|NOT COMPLETED|Overall Study||7
5083178|NCT01726036|12507850|P1|NOT COMPLETED|Overall Study||16
5083179|NCT01726036|12507849|P2|COMPLETED|Overall Study||130
5083180|NCT01726036|12507850|P1|COMPLETED|Overall Study||121
5083181|NCT01726036|12507849|P2|STARTED|Overall Study||137
5083182|NCT01726036|12507850|P1|STARTED|Overall Study||137
5083183|NCT01726023|12507860|P2|NOT COMPLETED|Overall Study||26
5083184|NCT01726023|12507861|P1|NOT COMPLETED|Overall Study||29
5083185|NCT01726023|12507860|P2|COMPLETED|Overall Study||196
5083186|NCT01726023|12507861|P1|COMPLETED|Overall Study||190
5083187|NCT01726023|12507860|P2|STARTED|Overall Study||222
5083188|NCT01726023|12507861|P1|STARTED|Overall Study||219
5083189|NCT01725984|12507953|P2|NOT COMPLETED|Overall Study||0
5083190|NCT01725984|12507954|P1|NOT COMPLETED|Overall Study||0
5083191|NCT01725984|12507953|P2|COMPLETED|Overall Study||41
5083192|NCT01725984|12507954|P1|COMPLETED|Overall Study||39
5083193|NCT01725984|12507953|P2|STARTED|Overall Study||41
5083194|NCT01725984|12507954|P1|STARTED|Overall Study||39
5083195|NCT01725815|12507980|P2|NOT COMPLETED|Overall Study||0
5083196|NCT01725815|12507981|P1|NOT COMPLETED|Overall Study||0
5083197|NCT01725815|12507980|P2|COMPLETED|Overall Study||202
5083198|NCT01725815|12507981|P1|COMPLETED|Overall Study||198
5083199|NCT01725815|12507980|P2|STARTED|Overall Study||202
5083200|NCT01725815|12507981|P1|STARTED|Overall Study||198
5083201|NCT01725750|12507995|P2|NOT COMPLETED|Overall Study||10
5083202|NCT01725750|12507996|P1|NOT COMPLETED|Overall Study||2
5083203|NCT01725750|12507995|P2|COMPLETED|Overall Study||34
5083204|NCT01725750|12507996|P1|COMPLETED|Overall Study||42
5083205|NCT01725750|12507995|P2|STARTED|Overall Study||44
5083206|NCT01725750|12507996|P1|STARTED|Overall Study||44
5083207|NCT01725529|12508029|P3|NOT COMPLETED|Overall Study||10
5083208|NCT01725529|12508030|P2|NOT COMPLETED|Overall Study||16
5083209|NCT01725529|12508031|P1|NOT COMPLETED|Overall Study||15
5083210|NCT01725529|12508029|P3|COMPLETED|Overall Study||142
5083211|NCT01725529|12508030|P2|COMPLETED|Overall Study||137
5083212|NCT01725529|12508031|P1|COMPLETED|Overall Study||137
5083213|NCT01725529|12508029|P3|STARTED|Overall Study||152
5083214|NCT01725529|12508030|P2|STARTED|Overall Study||153
5083215|NCT01725529|12508031|P1|STARTED|Overall Study||152
5083216|NCT01725451|12508057|P4|NOT COMPLETED|Period 6||0
5083217|NCT01725451|12508058|P3|NOT COMPLETED|Period 6||0
5083218|NCT01725451|12508059|P2|NOT COMPLETED|Period 6||0
5083219|NCT01725451|12508060|P1|NOT COMPLETED|Period 6||0
5083220|NCT01725451|12508057|P4|COMPLETED|Period 6||7
5083221|NCT01725451|12508058|P3|COMPLETED|Period 6||6
5083222|NCT01725451|12508059|P2|COMPLETED|Period 6||6
5083223|NCT01725451|12508060|P1|COMPLETED|Period 6||7
5083224|NCT01725451|12508057|P4|STARTED|Period 6||7
5083225|NCT01725451|12508058|P3|STARTED|Period 6||6
5083226|NCT01725451|12508059|P2|STARTED|Period 6||6
5083227|NCT01725451|12508060|P1|STARTED|Period 6||7
5083228|NCT01725451|12508057|P4|NOT COMPLETED|Washout From Period 5||0
5083229|NCT01725451|12508058|P3|NOT COMPLETED|Washout From Period 5||0
5083230|NCT01725451|12508059|P2|NOT COMPLETED|Washout From Period 5||0
5083231|NCT01725451|12508060|P1|NOT COMPLETED|Washout From Period 5||0
5083232|NCT01725451|12508057|P4|COMPLETED|Washout From Period 5||7
5083233|NCT01725451|12508058|P3|COMPLETED|Washout From Period 5||6
5083234|NCT01725451|12508059|P2|COMPLETED|Washout From Period 5||6
5083235|NCT01725451|12508060|P1|COMPLETED|Washout From Period 5||7
5083236|NCT01725451|12508057|P4|STARTED|Washout From Period 5||7
5083237|NCT01725451|12508058|P3|STARTED|Washout From Period 5||6
5083238|NCT01725451|12508059|P2|STARTED|Washout From Period 5||6
5083239|NCT01725451|12508060|P1|STARTED|Washout From Period 5||7
5083240|NCT01725451|12508057|P4|NOT COMPLETED|Period 5||0
5083241|NCT01725451|12508058|P3|NOT COMPLETED|Period 5||0
5083242|NCT01725451|12508059|P2|NOT COMPLETED|Period 5||0
5083243|NCT01725451|12508060|P1|NOT COMPLETED|Period 5||0
5083244|NCT01725451|12508057|P4|COMPLETED|Period 5||7
5083245|NCT01725451|12508058|P3|COMPLETED|Period 5||6
5083246|NCT01725451|12508059|P2|COMPLETED|Period 5||6
5083247|NCT01725451|12508060|P1|COMPLETED|Period 5||7
5083248|NCT01725451|12508057|P4|STARTED|Period 5||7
5083249|NCT01725451|12508058|P3|STARTED|Period 5||6
5083250|NCT01725451|12508059|P2|STARTED|Period 5||6
5083251|NCT01725451|12508060|P1|STARTED|Period 5||7
5083252|NCT01725451|12508057|P4|NOT COMPLETED|Washout From Period 4||0
5083253|NCT01725451|12508058|P3|NOT COMPLETED|Washout From Period 4||0
5083254|NCT01725451|12508059|P2|NOT COMPLETED|Washout From Period 4||0
5083255|NCT01725451|12508060|P1|NOT COMPLETED|Washout From Period 4||0
5083256|NCT01725451|12508057|P4|COMPLETED|Washout From Period 4||7
5083257|NCT01725451|12508058|P3|COMPLETED|Washout From Period 4||6
5083258|NCT01725451|12508059|P2|COMPLETED|Washout From Period 4||6
5083259|NCT01725451|12508060|P1|COMPLETED|Washout From Period 4||7
5083260|NCT01725451|12508057|P4|STARTED|Washout From Period 4||7
5083261|NCT01725451|12508058|P3|STARTED|Washout From Period 4||6
5083262|NCT01725451|12508059|P2|STARTED|Washout From Period 4||6
5083263|NCT01725451|12508060|P1|STARTED|Washout From Period 4||7
5083264|NCT01725451|12508057|P4|NOT COMPLETED|Period 4||0
5083265|NCT01725451|12508058|P3|NOT COMPLETED|Period 4||1
5083266|NCT01725451|12508059|P2|NOT COMPLETED|Period 4||0
5083267|NCT01725451|12508060|P1|NOT COMPLETED|Period 4||0
5083268|NCT01725451|12508057|P4|COMPLETED|Period 4||7
5083269|NCT01725451|12508058|P3|COMPLETED|Period 4||6
5083270|NCT01725451|12508059|P2|COMPLETED|Period 4||6
5083271|NCT01725451|12508060|P1|COMPLETED|Period 4||7
5083272|NCT01725451|12508057|P4|STARTED|Period 4||7
5083273|NCT01725451|12508058|P3|STARTED|Period 4||7
5083274|NCT01725451|12508059|P2|STARTED|Period 4||6
5083275|NCT01725451|12508060|P1|STARTED|Period 4||7
5083276|NCT01725451|12508057|P4|NOT COMPLETED|Washout From Period 3||0
5083277|NCT01725451|12508058|P3|NOT COMPLETED|Washout From Period 3||1
5083278|NCT01725451|12508059|P2|NOT COMPLETED|Washout From Period 3||1
5083279|NCT01725451|12508060|P1|NOT COMPLETED|Washout From Period 3||0
5083280|NCT01725451|12508057|P4|COMPLETED|Washout From Period 3||7
5083281|NCT01725451|12508058|P3|COMPLETED|Washout From Period 3||7
5083282|NCT01725451|12508059|P2|COMPLETED|Washout From Period 3||6
5083283|NCT01725451|12508060|P1|COMPLETED|Washout From Period 3||7
5083284|NCT01725451|12508057|P4|STARTED|Washout From Period 3||7
5083285|NCT01725451|12508058|P3|STARTED|Washout From Period 3||8
5083286|NCT01725451|12508059|P2|STARTED|Washout From Period 3||7
5083287|NCT01725451|12508060|P1|STARTED|Washout From Period 3||7
5083288|NCT01725451|12508057|P4|NOT COMPLETED|Period 3||0
5083289|NCT01725451|12508058|P3|NOT COMPLETED|Period 3||0
5083290|NCT01725451|12508059|P2|NOT COMPLETED|Period 3||0
5083291|NCT01725451|12508060|P1|NOT COMPLETED|Period 3||0
5083292|NCT01725451|12508057|P4|COMPLETED|Period 3||7
5083293|NCT01725451|12508058|P3|COMPLETED|Period 3||8
5083294|NCT01725451|12508059|P2|COMPLETED|Period 3||7
5083295|NCT01725451|12508060|P1|COMPLETED|Period 3||7
5083296|NCT01725451|12508057|P4|STARTED|Period 3||7
5083297|NCT01725451|12508058|P3|STARTED|Period 3||8
5083298|NCT01725451|12508059|P2|STARTED|Period 3||7
5083299|NCT01725451|12508060|P1|STARTED|Period 3||7
5083300|NCT01725451|12508057|P4|NOT COMPLETED|Washout From Period 2||0
5083301|NCT01725451|12508058|P3|NOT COMPLETED|Washout From Period 2||0
5083302|NCT01725451|12508059|P2|NOT COMPLETED|Washout From Period 2||0
5083303|NCT01725451|12508060|P1|NOT COMPLETED|Washout From Period 2||0
5083304|NCT01725451|12508057|P4|COMPLETED|Washout From Period 2||7
5083305|NCT01725451|12508058|P3|COMPLETED|Washout From Period 2||8
5083306|NCT01725451|12508059|P2|COMPLETED|Washout From Period 2||7
5083307|NCT01725451|12508060|P1|COMPLETED|Washout From Period 2||7
5083308|NCT01725451|12508057|P4|STARTED|Washout From Period 2||7
5083309|NCT01725451|12508058|P3|STARTED|Washout From Period 2||8
5083310|NCT01725451|12508059|P2|STARTED|Washout From Period 2||7
5083311|NCT01725451|12508060|P1|STARTED|Washout From Period 2||7
5083312|NCT01725451|12508057|P4|NOT COMPLETED|Period 2||0
5083313|NCT01725451|12508058|P3|NOT COMPLETED|Period 2||0
5083314|NCT01725451|12508059|P2|NOT COMPLETED|Period 2||0
5083315|NCT01725451|12508060|P1|NOT COMPLETED|Period 2||0
5083316|NCT01725451|12508057|P4|COMPLETED|Period 2||7
5083317|NCT01725451|12508058|P3|COMPLETED|Period 2||8
5083318|NCT01725451|12508059|P2|COMPLETED|Period 2||7
5083319|NCT01725451|12508060|P1|COMPLETED|Period 2||7
5083320|NCT01725451|12508057|P4|STARTED|Period 2||7
5083321|NCT01725451|12508058|P3|STARTED|Period 2||8
5083322|NCT01725451|12508059|P2|STARTED|Period 2||7
5083323|NCT01725451|12508060|P1|STARTED|Period 2||7
5083324|NCT01725451|12508057|P4|NOT COMPLETED|Washout From Period 1||0
5083325|NCT01725451|12508058|P3|NOT COMPLETED|Washout From Period 1||0
5083326|NCT01725451|12508059|P2|NOT COMPLETED|Washout From Period 1||0
5083327|NCT01725451|12508060|P1|NOT COMPLETED|Washout From Period 1||0
5083328|NCT01725451|12508057|P4|COMPLETED|Washout From Period 1||7
5083329|NCT01725451|12508058|P3|COMPLETED|Washout From Period 1||8
5083330|NCT01725451|12508059|P2|COMPLETED|Washout From Period 1||7
5083331|NCT01725451|12508060|P1|COMPLETED|Washout From Period 1||7
5083332|NCT01725451|12508057|P4|STARTED|Washout From Period 1||7
5083333|NCT01725451|12508058|P3|STARTED|Washout From Period 1||8
5083334|NCT01725451|12508059|P2|STARTED|Washout From Period 1||7
5083335|NCT01725451|12508060|P1|STARTED|Washout From Period 1||7
5083336|NCT01725451|12508057|P4|NOT COMPLETED|Period 1||0
5083337|NCT01725451|12508058|P3|NOT COMPLETED|Period 1||0
5083338|NCT01725451|12508059|P2|NOT COMPLETED|Period 1||0
5083339|NCT01725451|12508060|P1|NOT COMPLETED|Period 1||1
5083340|NCT01725451|12508057|P4|COMPLETED|Period 1||7
5083341|NCT01725451|12508058|P3|COMPLETED|Period 1||8
5083342|NCT01725451|12508059|P2|COMPLETED|Period 1||7
5083343|NCT01725451|12508060|P1|COMPLETED|Period 1||7
5083344|NCT01725451|12508057|P4|STARTED|Period 1||7
5083345|NCT01725451|12508058|P3|STARTED|Period 1||8
5083346|NCT01725451|12508059|P2|STARTED|Period 1||7
5083347|NCT01725451|12508060|P1|STARTED|Period 1||8
5083348|NCT01725386|12508082|P2|NOT COMPLETED|Overall Study||46
5083349|NCT01725386|12508083|P1|NOT COMPLETED|Overall Study||175
5083350|NCT01725386|12508082|P2|COMPLETED|Overall Study||17
5083351|NCT01725386|12508083|P1|COMPLETED|Overall Study||13
5083352|NCT01725386|12508082|P2|STARTED|Overall Study||63
5083353|NCT01725386|12508083|P1|STARTED|Overall Study||188
5083354|NCT01725308|12508102|P3|NOT COMPLETED|Treatment Period II||64
5083355|NCT01725308|12508103|P2|NOT COMPLETED|Treatment Period II||29
5083356|NCT01725308|12508104|P1|NOT COMPLETED|Treatment Period II||55
5083357|NCT01725308|12508102|P3|COMPLETED|Treatment Period II||74
5083358|NCT01725308|12508103|P2|COMPLETED|Treatment Period II||31
5083359|NCT01725308|12508104|P1|COMPLETED|Treatment Period II||79
5083360|NCT01725308|12508102|P3|Treated|Treatment Period II||130
5083361|NCT01725308|12508103|P2|Treated|Treatment Period II||53
5083362|NCT01725308|12508104|P1|Treated|Treatment Period II||120
5083363|NCT01725308|12508102|P3|STARTED|Treatment Period II||138
5083364|NCT01725308|12508103|P2|STARTED|Treatment Period II||60
5083365|NCT01725308|12508104|P1|STARTED|Treatment Period II||134
5083366|NCT01725308|12508102|P3|NOT COMPLETED|Treatment Period I||41
5083367|NCT01725308|12508103|P2|NOT COMPLETED|Treatment Period I||14
5083368|NCT01725308|12508104|P1|NOT COMPLETED|Treatment Period I||44
5083369|NCT01725308|12508102|P3|COMPLETED|Treatment Period I||138
5083370|NCT01725308|12508103|P2|COMPLETED|Treatment Period I||60
5083371|NCT01725308|12508104|P1|COMPLETED|Treatment Period I||134
5083372|NCT01725308|12508102|P3|Treated|Treatment Period I||179
5083373|NCT01725308|12508103|P2|Treated|Treatment Period I||74
5083374|NCT01725308|12508104|P1|Treated|Treatment Period I||177
5083375|NCT01725308|12508102|P3|STARTED|Treatment Period I||179
5083376|NCT01725308|12508103|P2|STARTED|Treatment Period I||74
5083377|NCT01725308|12508104|P1|STARTED|Treatment Period I||178
5083378|NCT01725282|12508251|P4|NOT COMPLETED|Overall Study||7
5083379|NCT01725282|12508252|P3|NOT COMPLETED|Overall Study||8
5083380|NCT01725282|12508253|P2|NOT COMPLETED|Overall Study||5
5083381|NCT01725282|12508254|P1|NOT COMPLETED|Overall Study||2
5083382|NCT01725282|12508251|P4|COMPLETED|Overall Study||36
5083383|NCT01725282|12508252|P3|COMPLETED|Overall Study||33
5083384|NCT01725282|12508253|P2|COMPLETED|Overall Study||39
5083385|NCT01725282|12508254|P1|COMPLETED|Overall Study||42
5083386|NCT01725282|12508251|P4|STARTED|Overall Study||43
5083387|NCT01725282|12508252|P3|STARTED|Overall Study||41
5083388|NCT01725282|12508253|P2|STARTED|Overall Study||44
5083389|NCT01725282|12508254|P1|STARTED|Overall Study||44
5083390|NCT01725217|12508287|P3|NOT COMPLETED|Overall Study||0
5083391|NCT01725217|12508288|P2|NOT COMPLETED|Overall Study||0
5083392|NCT01725217|12508289|P1|NOT COMPLETED|Overall Study||1
5083393|NCT01725217|12508287|P3|COMPLETED|Overall Study||66
5083394|NCT01725217|12508288|P2|COMPLETED|Overall Study||66
5083395|NCT01725217|12508289|P1|COMPLETED|Overall Study||65
5083396|NCT01725217|12508287|P3|STARTED|Overall Study||66
5083397|NCT01725217|12508288|P2|STARTED|Overall Study||66
5083398|NCT01725217|12508289|P1|STARTED|Overall Study||66
5083399|NCT01725126|12508323|P6|NOT COMPLETED|Overall Study||0
5083400|NCT01725126|12508324|P5|NOT COMPLETED|Overall Study||0
5083401|NCT01725126|12508325|P4|NOT COMPLETED|Overall Study||1
5083402|NCT01725126|12508326|P3|NOT COMPLETED|Overall Study||0
5083403|NCT01725126|12508327|P2|NOT COMPLETED|Overall Study||1
5083404|NCT01725126|12508328|P1|NOT COMPLETED|Overall Study||0
5083405|NCT01725126|12508323|P6|COMPLETED|Overall Study||12
5083406|NCT01725126|12508324|P5|COMPLETED|Overall Study||6
5083407|NCT01725126|12508325|P4|COMPLETED|Overall Study||13
5083408|NCT01725126|12508326|P3|COMPLETED|Overall Study||6
5083409|NCT01725126|12508327|P2|COMPLETED|Overall Study||10
5083410|NCT01725126|12508328|P1|COMPLETED|Overall Study||4
5083411|NCT01725126|12508323|P6|STARTED|Overall Study||12
5083412|NCT01725126|12508324|P5|STARTED|Overall Study||6
5083413|NCT01725126|12508325|P4|STARTED|Overall Study||14
5083414|NCT01725126|12508326|P3|STARTED|Overall Study||6
5083415|NCT01725126|12508327|P2|STARTED|Overall Study||11
5083416|NCT01725126|12508328|P1|STARTED|Overall Study||4
5083417|NCT01724528|12508526|P2|NOT COMPLETED|Overall Study||3
5083418|NCT01724528|12508527|P1|NOT COMPLETED|Overall Study||4
5083419|NCT01724528|12508526|P2|COMPLETED|Overall Study||170
5083420|NCT01724528|12508527|P1|COMPLETED|Overall Study||169
5083421|NCT01724528|12508526|P2|STARTED|Overall Study||173
5083422|NCT01724528|12508527|P1|STARTED|Overall Study||173
5083423|NCT01724489|12508543|P2|NOT COMPLETED|Overall Study||12
5083424|NCT01724489|12508544|P1|NOT COMPLETED|Overall Study||16
5083425|NCT01724489|12508543|P2|COMPLETED|Overall Study||26
5083426|NCT01724489|12508544|P1|COMPLETED|Overall Study||23
5083427|NCT01724489|12508543|P2|STARTED|Overall Study||38
5083428|NCT01724489|12508544|P1|STARTED|Overall Study||39
5083429|NCT01724359|12508550|P1|NOT COMPLETED|Overall Study||31
5083430|NCT01724359|12508550|P1|COMPLETED|Overall Study||64
5083431|NCT01724359|12508550|P1|STARTED|Overall Study||95
5083432|NCT01724216|12508563|P1|NOT COMPLETED|Overall Study||1
5083433|NCT01724216|12508563|P1|COMPLETED|Overall Study||10
5083434|NCT01724216|12508563|P1|STARTED|Overall Study||11
5083435|NCT01724177|12508567|P1|NOT COMPLETED|Overall Study||26
5083436|NCT01724177|12508567|P1|COMPLETED|Overall Study||0
5083437|NCT01724177|12508567|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
5083438|NCT01724177|12508567|P1|STARTED|Overall Study||26
5083439|NCT01724060|12508586|P8|NOT COMPLETED|Overall Study||0
5083440|NCT01724060|12508587|P7|NOT COMPLETED|Overall Study||0
5083441|NCT01724060|12508588|P6|NOT COMPLETED|Overall Study||0
5083442|NCT01724060|12508589|P5|NOT COMPLETED|Overall Study||0
5083443|NCT01724060|12508590|P4|NOT COMPLETED|Overall Study||0
5083444|NCT01724060|12508591|P3|NOT COMPLETED|Overall Study||0
5083445|NCT01724060|12508592|P2|NOT COMPLETED|Overall Study||0
5083446|NCT01724060|12508593|P1|NOT COMPLETED|Overall Study||0
5083447|NCT01724060|12508586|P8|COMPLETED|Overall Study||10
5083448|NCT01724060|12508587|P7|COMPLETED|Overall Study||10
5083449|NCT01724060|12508588|P6|COMPLETED|Overall Study||10
5083450|NCT01724060|12508589|P5|COMPLETED|Overall Study||10
5083451|NCT01724060|12508590|P4|COMPLETED|Overall Study||10
5083452|NCT01724060|12508591|P3|COMPLETED|Overall Study||10
5083453|NCT01724060|12508592|P2|COMPLETED|Overall Study||10
5083454|NCT01724060|12508593|P1|COMPLETED|Overall Study||10
5083455|NCT01724060|12508586|P8|STARTED|Overall Study||10
5083456|NCT01724060|12508587|P7|STARTED|Overall Study||10
5083457|NCT01724060|12508588|P6|STARTED|Overall Study||10
5083458|NCT01724060|12508589|P5|STARTED|Overall Study||10
5083459|NCT01724060|12508590|P4|STARTED|Overall Study||10
5083460|NCT01724060|12508591|P3|STARTED|Overall Study||10
5083461|NCT01724060|12508592|P2|STARTED|Overall Study||10
5083462|NCT01724060|12508593|P1|STARTED|Overall Study||10
5083463|NCT01724021|12508613|P2|NOT COMPLETED|Overall Study||133
5083464|NCT01724021|12508614|P1|NOT COMPLETED|Overall Study||127
5083465|NCT01724021|12508613|P2|COMPLETED|Overall Study||236
5083466|NCT01724021|12508614|P1|COMPLETED|Overall Study||244
5083467|NCT01724021|12508613|P2|STARTED|Overall Study||369
5083468|NCT01724021|12508614|P1|STARTED|Overall Study||371
5083469|NCT01723904|12508646|P1|NOT COMPLETED|Overall Study||11
5083470|NCT01723904|12508646|P1|COMPLETED|Overall Study||79
5083471|NCT01723904|12508646|P1|STARTED|Overall Study||90
5083472|NCT01723826|12508660|P4|NOT COMPLETED|Overall Study||90
5083473|NCT01723826|12508661|P3|NOT COMPLETED|Overall Study||57
5083474|NCT01723826|12508662|P2|NOT COMPLETED|Overall Study||36
5083475|NCT01723826|12508663|P1|NOT COMPLETED|Overall Study||27
5083476|NCT01723826|12508660|P4|COMPLETED|Overall Study||59
5083477|NCT01723826|12508661|P3|COMPLETED|Overall Study||44
5083478|NCT01723826|12508662|P2|COMPLETED|Overall Study||27
5083479|NCT01723826|12508663|P1|COMPLETED|Overall Study||20
5083480|NCT01723826|12508660|P4|STARTED|Overall Study||149
5083481|NCT01723826|12508661|P3|STARTED|Overall Study||101
5083482|NCT01723826|12508662|P2|STARTED|Overall Study||63
5083483|NCT01723826|12508663|P1|STARTED|Overall Study||47
5083484|NCT01723722|12508695|P2|NOT COMPLETED|Overall Study||0
5083485|NCT01723722|12508696|P1|NOT COMPLETED|Overall Study||0
5083486|NCT01723722|12508695|P2|COMPLETED|Overall Study||20
5083487|NCT01723722|12508696|P1|COMPLETED|Overall Study||20
5083488|NCT01723722|12508695|P2|STARTED|Overall Study||20
5083489|NCT01723722|12508696|P1|STARTED|Overall Study||20
5083490|NCT01723696|12508704|P2|NOT COMPLETED|Overall Study||13
5083491|NCT01723696|12508705|P1|NOT COMPLETED|Overall Study||17
5083492|NCT01723696|12508704|P2|COMPLETED|Overall Study||113
5083493|NCT01723696|12508705|P1|COMPLETED|Overall Study||109
5083494|NCT01723696|12508704|P2|STARTED|Overall Study||126
5083495|NCT01723696|12508705|P1|STARTED|Overall Study||126
5083496|NCT01723514|12508725|P8|NOT COMPLETED|Overall Study||0
5083497|NCT01723514|12508726|P7|NOT COMPLETED|Overall Study||0
5083498|NCT01723514|12508727|P6|NOT COMPLETED|Overall Study||0
5083499|NCT01723514|12508728|P5|NOT COMPLETED|Overall Study||0
5083500|NCT01723514|12508729|P4|NOT COMPLETED|Overall Study||0
5083501|NCT01723514|12508730|P3|NOT COMPLETED|Overall Study||0
5083502|NCT01723514|12508731|P2|NOT COMPLETED|Overall Study||0
5083503|NCT01723514|12508732|P1|NOT COMPLETED|Overall Study||0
5083504|NCT01723514|12508725|P8|COMPLETED|Overall Study||6
5083505|NCT01723514|12508726|P7|COMPLETED|Overall Study||6
5083506|NCT01723514|12508727|P6|COMPLETED|Overall Study||4
5083507|NCT01723514|12508728|P5|COMPLETED|Overall Study||6
5083508|NCT01723514|12508729|P4|COMPLETED|Overall Study||6
5083509|NCT01723514|12508730|P3|COMPLETED|Overall Study||6
5083510|NCT01723514|12508731|P2|COMPLETED|Overall Study||6
5083511|NCT01723514|12508732|P1|COMPLETED|Overall Study||8
5083512|NCT01723514|12508725|P8|STARTED|Overall Study||6
5083513|NCT01723514|12508726|P7|STARTED|Overall Study||6
5083514|NCT01723514|12508727|P6|STARTED|Overall Study||4
5083515|NCT01723514|12508728|P5|STARTED|Overall Study||6
5083516|NCT01723514|12508729|P4|STARTED|Overall Study||6
5083517|NCT01723514|12508730|P3|STARTED|Overall Study||6
5083518|NCT01723514|12508731|P2|STARTED|Overall Study||6
5083519|NCT01723514|12508732|P1|STARTED|Overall Study||8
5083520|NCT01723397|12508808|P2|NOT COMPLETED|Study Period 2||1
5083521|NCT01723397|12508809|P1|NOT COMPLETED|Study Period 2||0
5083522|NCT01723397|12508808|P2|COMPLETED|Study Period 2||5
5083523|NCT01723397|12508809|P1|COMPLETED|Study Period 2||7
5083524|NCT01723397|12508808|P2|STARTED|Study Period 2||6
5083525|NCT01723397|12508809|P1|STARTED|Study Period 2||7
5083526|NCT01723397|12508808|P2|NOT COMPLETED|Washout||0
5083527|NCT01723397|12508809|P1|NOT COMPLETED|Washout||0
5083528|NCT01723397|12508808|P2|COMPLETED|Washout||6
5083529|NCT01723397|12508809|P1|COMPLETED|Washout||7
5083530|NCT01723397|12508808|P2|STARTED|Washout||6
5083531|NCT01723397|12508809|P1|STARTED|Washout||7
5083532|NCT01723397|12508808|P2|NOT COMPLETED|Study Period 1||1
5083533|NCT01723397|12508809|P1|NOT COMPLETED|Study Period 1||0
5083534|NCT01723397|12508808|P2|COMPLETED|Study Period 1||6
5083535|NCT01723397|12508809|P1|COMPLETED|Study Period 1||7
5083536|NCT01723397|12508808|P2|STARTED|Study Period 1||7
5083537|NCT01723397|12508809|P1|STARTED|Study Period 1||7
5083538|NCT01723384|12508817|P2|NOT COMPLETED|Overall Study||0
5083539|NCT01723384|12508818|P1|NOT COMPLETED|Overall Study||0
5083540|NCT01723384|12508817|P2|COMPLETED|Overall Study||15
5083541|NCT01723384|12508818|P1|COMPLETED|Overall Study||15
5083542|NCT01723384|12508817|P2|STARTED|Overall Study||15
5083543|NCT01723384|12508818|P1|STARTED|Overall Study||15
5083544|NCT01723254|12508836|P8|NOT COMPLETED|Overall Study||3
5083545|NCT01723254|12508837|P7|NOT COMPLETED|Overall Study||1
5083546|NCT01723254|12508838|P6|NOT COMPLETED|Overall Study||2
5083547|NCT01723254|12508839|P5|NOT COMPLETED|Overall Study||2
5083548|NCT01723254|12508840|P4|NOT COMPLETED|Overall Study||2
5083549|NCT01723254|12508841|P3|NOT COMPLETED|Overall Study||3
5083550|NCT01723254|12508842|P2|NOT COMPLETED|Overall Study||3
5083551|NCT01723254|12508843|P1|NOT COMPLETED|Overall Study||1
5083552|NCT01723254|12508836|P8|COMPLETED|Overall Study||60
5083553|NCT01723254|12508837|P7|COMPLETED|Overall Study||19
5083554|NCT01723254|12508838|P6|COMPLETED|Overall Study||18
5083555|NCT01723254|12508839|P5|COMPLETED|Overall Study||18
5083556|NCT01723254|12508840|P4|COMPLETED|Overall Study||18
5083557|NCT01723254|12508841|P3|COMPLETED|Overall Study||17
5083558|NCT01723254|12508842|P2|COMPLETED|Overall Study||18
5083559|NCT01723254|12508843|P1|COMPLETED|Overall Study||5
5083560|NCT01723254|12508836|P8|STARTED|Overall Study||63
5083561|NCT01723254|12508837|P7|STARTED|Overall Study||20
5083562|NCT01723254|12508838|P6|STARTED|Overall Study||20
5083563|NCT01723254|12508839|P5|STARTED|Overall Study||20
5083564|NCT01723254|12508840|P4|STARTED|Overall Study||20
5083565|NCT01723254|12508841|P3|STARTED|Overall Study||20
5083566|NCT01723254|12508842|P2|STARTED|Overall Study||21
5083567|NCT01723254|12508843|P1|STARTED|Overall Study||6
5083568|NCT01723228|12508895|P2|NOT COMPLETED|Overall Study||11
5083569|NCT01723228|12508896|P1|NOT COMPLETED|Overall Study||8
5083570|NCT01723228|12508895|P2|COMPLETED|Overall Study||73
5083571|NCT01723228|12508896|P1|COMPLETED|Overall Study||78
5083572|NCT01723228|12508895|P2|STARTED|Overall Study||84
5083573|NCT01723228|12508896|P1|STARTED|Overall Study||86
5083574|NCT01723163|12508914|P2|NOT COMPLETED|12-Month Follow-up||28
5083575|NCT01723163|12508915|P1|NOT COMPLETED|12-Month Follow-up||24
5083576|NCT01723163|12508914|P2|COMPLETED|12-Month Follow-up||119
5083577|NCT01723163|12508915|P1|COMPLETED|12-Month Follow-up||111
5083578|NCT01723163|12508914|P2|STARTED|12-Month Follow-up||147
5083579|NCT01723163|12508915|P1|STARTED|12-Month Follow-up||135
5083580|NCT01723163|12508914|P2|NOT COMPLETED|6-Month Follow-up||15
5083581|NCT01723163|12508915|P1|NOT COMPLETED|6-Month Follow-up||18
5083582|NCT01723163|12508914|P2|COMPLETED|6-Month Follow-up||132
5083583|NCT01723163|12508915|P1|COMPLETED|6-Month Follow-up||118
5083584|NCT01723163|12508914|P2|STARTED|6-Month Follow-up||147
5083585|NCT01723163|12508915|P1|STARTED|6-Month Follow-up||136
5083586|NCT01723163|12508914|P2|NOT COMPLETED|3-Month Follow-up||19
5083587|NCT01723163|12508915|P1|NOT COMPLETED|3-Month Follow-up||13
5083588|NCT01723163|12508914|P2|COMPLETED|3-Month Follow-up||128
5083589|NCT01723163|12508915|P1|COMPLETED|3-Month Follow-up||124
5083590|NCT01723163|12508914|P2|STARTED|3-Month Follow-up||147
5083591|NCT01723163|12508915|P1|STARTED|3-Month Follow-up||137
5083592|NCT01723163|12508914|P2|NOT COMPLETED|Treatment Phase||7
5083593|NCT01723163|12508915|P1|NOT COMPLETED|Treatment Phase||19
5083594|NCT01723163|12508914|P2|COMPLETED|Treatment Phase||147
5083595|NCT01723163|12508915|P1|COMPLETED|Treatment Phase||137
5083596|NCT01723163|12508914|P2|STARTED|Treatment Phase||154
5083597|NCT01723163|12508915|P1|STARTED|Treatment Phase||156
5083598|NCT01723163|12508914|P2|NOT COMPLETED|Baseline||0
5083599|NCT01723163|12508915|P1|NOT COMPLETED|Baseline||0
5083600|NCT01723163|12508914|P2|COMPLETED|Baseline||154
5083601|NCT01723163|12508915|P1|COMPLETED|Baseline||156
5083602|NCT01723163|12508914|P2|STARTED|Baseline||154
5083603|NCT01723163|12508915|P1|STARTED|Baseline||156
5083604|NCT01722994|12508923|P2|NOT COMPLETED|Overall Study||17
5083605|NCT01722994|12508924|P1|NOT COMPLETED|Overall Study||25
5083606|NCT01722994|12508923|P2|COMPLETED|Overall Study||31
5083607|NCT01722994|12508924|P1|COMPLETED|Overall Study||24
5083608|NCT01722994|12508923|P2|STARTED|Overall Study||48
5083609|NCT01722994|12508924|P1|STARTED|Overall Study||49
5083610|NCT01722929|12508938|P1|NOT COMPLETED|Overall Study||0
5083611|NCT01722929|12508938|P1|COMPLETED|Overall Study||4
5083612|NCT01722929|12508938|P1|STARTED|Overall Study||4
5083613|NCT01722877|12508943|P1|NOT COMPLETED|Overall Study||2
5083614|NCT01722877|12508943|P1|COMPLETED|Overall Study||27
5083615|NCT01722877|12508943|P1|STARTED|Overall Study||29
5083616|NCT01722734|12508953|P3|NOT COMPLETED|Overall Study||2
5083617|NCT01722734|12508954|P2|NOT COMPLETED|Overall Study||1
5083618|NCT01722734|12508955|P1|NOT COMPLETED|Overall Study||2
5083619|NCT01722734|12508953|P3|COMPLETED|Overall Study||307
5083620|NCT01722734|12508954|P2|COMPLETED|Overall Study||276
5083621|NCT01722734|12508955|P1|COMPLETED|Overall Study||552
5083622|NCT01722734|12508953|P3|STARTED|Overall Study||309
5083623|NCT01722734|12508954|P2|STARTED|Overall Study||277
5083624|NCT01722734|12508955|P1|STARTED|Overall Study||554
5083625|NCT01722643|12508965|P2|NOT COMPLETED|Overall Study||1
5083626|NCT01722643|12508966|P1|NOT COMPLETED|Overall Study||0
5083627|NCT01722643|12508965|P2|COMPLETED|Overall Study||30
5083628|NCT01722643|12508966|P1|COMPLETED|Overall Study||30
5083629|NCT01722643|12508965|P2|STARTED|Overall Study||31
5083630|NCT01722643|12508966|P1|STARTED|Overall Study||30
5083631|NCT01722552|12508974|P1|NOT COMPLETED|Overall Study||4
5083632|NCT01722552|12508974|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
5083633|NCT01722552|12508974|P1|STARTED|Overall Study|Number of subjects enrolled|120
5083634|NCT01722487|12508984|P2|NOT COMPLETED|Overall Study||7
5083635|NCT01722487|12508985|P1|NOT COMPLETED|Overall Study||2
5083636|NCT01722487|12508984|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
5083637|NCT01722487|12508985|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
5083638|NCT01722487|12508984|P2|STARTED|Overall Study||133
5083639|NCT01722487|12508985|P1|STARTED|Overall Study||136
5083640|NCT01722435|12509003|P1|NOT COMPLETED|Overall Study||0
5083641|NCT01722435|12509003|P1|COMPLETED|Overall Study||78
5083642|NCT01722435|12509003|P1|STARTED|Overall Study||78
5083643|NCT01722331|12509014|P7|NOT COMPLETED|Part 3||2
5083644|NCT01722331|12509015|P6|NOT COMPLETED|Part 3||3
5083645|NCT01722331|12509016|P5|NOT COMPLETED|Part 3||0
5083646|NCT01722331|12509017|P4|NOT COMPLETED|Part 3||1
5083647|NCT01722331|12509018|P3|NOT COMPLETED|Part 3||0
5083648|NCT01722331|12509019|P2|NOT COMPLETED|Part 3||17
5083649|NCT01722331|12509020|P1|NOT COMPLETED|Part 3||15
5083650|NCT01722331|12509014|P7|COMPLETED|Part 3||65
5083651|NCT01722331|12509015|P6|COMPLETED|Part 3||59
5083652|NCT01722331|12509016|P5|COMPLETED|Part 3||0
5083653|NCT01722331|12509017|P4|COMPLETED|Part 3||18
5083654|NCT01722331|12509018|P3|COMPLETED|Part 3||0
5083655|NCT01722331|12509019|P2|COMPLETED|Part 3||232
5083656|NCT01722331|12509020|P1|COMPLETED|Part 3||264
5083657|NCT01722331|12509014|P7|STARTED|Part 3||67
5083658|NCT01722331|12509015|P6|STARTED|Part 3||62
5083659|NCT01722331|12509016|P5|STARTED|Part 3||0
5083660|NCT01722331|12509017|P4|STARTED|Part 3||19
5083661|NCT01722331|12509018|P3|STARTED|Part 3||0
5083662|NCT01722331|12509019|P2|STARTED|Part 3||249
5083663|NCT01722331|12509020|P1|STARTED|Part 3||279
5083664|NCT01722331|12509014|P7|NOT COMPLETED|Part 2||7
5083665|NCT01722331|12509015|P6|NOT COMPLETED|Part 2||10
5083666|NCT01722331|12509016|P5|NOT COMPLETED|Part 2||0
5083667|NCT01722331|12509017|P4|NOT COMPLETED|Part 2||0
5083668|NCT01722331|12509018|P3|NOT COMPLETED|Part 2||31
5083669|NCT01722331|12509019|P2|NOT COMPLETED|Part 2||0
5083670|NCT01722331|12509020|P1|NOT COMPLETED|Part 2||19
5083671|NCT01722331|12509014|P7|COMPLETED|Part 2||67
5083672|NCT01722331|12509015|P6|COMPLETED|Part 2||62
5083673|NCT01722331|12509016|P5|COMPLETED|Part 2||0
5083674|NCT01722331|12509017|P4|COMPLETED|Part 2||19
5083675|NCT01722331|12509018|P3|COMPLETED|Part 2||0
5083676|NCT01722331|12509019|P2|COMPLETED|Part 2||249
5083677|NCT01722331|12509020|P1|COMPLETED|Part 2||279
5083678|NCT01722331|12509014|P7|STARTED|Part 2||74
5083679|NCT01722331|12509015|P6|STARTED|Part 2||72
5083680|NCT01722331|12509016|P5|STARTED|Part 2||0
5083681|NCT01722331|12509017|P4|STARTED|Part 2||19
5083682|NCT01722331|12509018|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
5083683|NCT01722331|12509019|P2|STARTED|Part 2||249
5083684|NCT01722331|12509020|P1|STARTED|Part 2||298
5083685|NCT01722331|12509014|P7|NOT COMPLETED|Part 1||0
5083686|NCT01722331|12509015|P6|NOT COMPLETED|Part 1||0
5083687|NCT01722331|12509016|P5|NOT COMPLETED|Part 1||9
5083688|NCT01722331|12509017|P4|NOT COMPLETED|Part 1||0
5083689|NCT01722331|12509018|P3|NOT COMPLETED|Part 1||9
5083690|NCT01722331|12509019|P2|NOT COMPLETED|Part 1||0
5083691|NCT01722331|12509020|P1|NOT COMPLETED|Part 1||10
5083692|NCT01722331|12509014|P7|COMPLETED|Part 1||74
5083693|NCT01722331|12509015|P6|COMPLETED|Part 1||72
5083694|NCT01722331|12509016|P5|COMPLETED|Part 1||0
5083695|NCT01722331|12509017|P4|COMPLETED|Part 1||19
5083696|NCT01722331|12509018|P3|COMPLETED|Part 1||32
5083697|NCT01722331|12509019|P2|COMPLETED|Part 1||249
5083698|NCT01722331|12509020|P1|COMPLETED|Part 1||298
5083699|NCT01722331|12509014|P7|STARTED|Part 1||74
5083700|NCT01722331|12509015|P6|STARTED|Part 1||72
5083701|NCT01722331|12509016|P5|STARTED|Part 1||9
5083702|NCT01722331|12509017|P4|STARTED|Part 1||19
5083703|NCT01722331|12509018|P3|STARTED|Part 1||41
5083704|NCT01722331|12509019|P2|STARTED|Part 1||249
5083705|NCT01722331|12509020|P1|STARTED|Part 1||308
5083706|NCT01722318|12509064|P5|NOT COMPLETED|Overall Study||18
5083707|NCT01722318|12509065|P4|NOT COMPLETED|Overall Study||20
5083708|NCT01722318|12509066|P3|NOT COMPLETED|Overall Study||20
5083709|NCT01722318|12509067|P2|NOT COMPLETED|Overall Study||20
5083710|NCT01722318|12509068|P1|NOT COMPLETED|Overall Study||14
5083711|NCT01722318|12509064|P5|COMPLETED|Overall Study||68
5083712|NCT01722318|12509065|P4|COMPLETED|Overall Study||65
5083713|NCT01722318|12509066|P3|COMPLETED|Overall Study||66
5083714|NCT01722318|12509067|P2|COMPLETED|Overall Study||65
5083715|NCT01722318|12509068|P1|COMPLETED|Overall Study||72
5083716|NCT01722318|12509064|P5|STARTED|Overall Study||86
5083717|NCT01722318|12509065|P4|STARTED|Overall Study||85
5083718|NCT01722318|12509066|P3|STARTED|Overall Study||86
5083719|NCT01722318|12509067|P2|STARTED|Overall Study||85
5083720|NCT01722318|12509068|P1|STARTED|Overall Study||86
5083721|NCT01722292|12509098|P3|NOT COMPLETED|Overall Study||0
5083722|NCT01722292|12509099|P2|NOT COMPLETED|Overall Study||0
5083723|NCT01722292|12509100|P1|NOT COMPLETED|Overall Study||0
5083724|NCT01722292|12509098|P3|COMPLETED|Overall Study||14
5083725|NCT01722292|12509099|P2|COMPLETED|Overall Study||6
5083726|NCT01722292|12509100|P1|COMPLETED|Overall Study||6
5083727|NCT01722292|12509098|P3|Received at Least One Dose of Study Drug|Overall Study||14
5083728|NCT01722292|12509099|P2|Received at Least One Dose of Study Drug|Overall Study||6
5083729|NCT01722292|12509100|P1|Received at Least One Dose of Study Drug|Overall Study||6
5083730|NCT01722292|12509098|P3|STARTED|Overall Study||14
5083731|NCT01722292|12509099|P2|STARTED|Overall Study||6
5083732|NCT01722292|12509100|P1|STARTED|Overall Study||6
5083733|NCT01722266|12509136|P4|NOT COMPLETED|Overall Study||0
5083734|NCT01722266|12509137|P3|NOT COMPLETED|Overall Study||5
5083735|NCT01722266|12509138|P2|NOT COMPLETED|Overall Study||3
5083736|NCT01722266|12509139|P1|NOT COMPLETED|Overall Study||1
5083737|NCT01722266|12509136|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
5083738|NCT01722266|12509137|P3|COMPLETED|Overall Study||13
5083739|NCT01722266|12509138|P2|COMPLETED|Overall Study||15
5083740|NCT01722266|12509139|P1|COMPLETED|Overall Study||17
5083741|NCT01722266|12509136|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
5083742|NCT01722266|12509137|P3|STARTED|Overall Study||18
5083743|NCT01722266|12509138|P2|STARTED|Overall Study||18
5083744|NCT01722266|12509139|P1|STARTED|Overall Study||18
5083745|NCT01722162|12509167|P2|NOT COMPLETED|Overall Study||6
5083746|NCT01722162|12509168|P1|NOT COMPLETED|Overall Study||5
5083747|NCT01722162|12509167|P2|COMPLETED|Overall Study||18
5083748|NCT01722162|12509168|P1|COMPLETED|Overall Study||18
5083749|NCT01722162|12509167|P2|STARTED|Overall Study||24
5083750|NCT01722162|12509168|P1|STARTED|Overall Study||23
5083751|NCT01722097|12509178|P2|NOT COMPLETED|Overall Study||5
5083752|NCT01722097|12509179|P1|NOT COMPLETED|Overall Study||6
5083753|NCT01722097|12509178|P2|COMPLETED|Overall Study||50
5083754|NCT01722097|12509179|P1|COMPLETED|Overall Study||49
5083755|NCT01722097|12509178|P2|STARTED|Overall Study||55
5083756|NCT01722097|12509179|P1|STARTED|Overall Study||55
5083757|NCT01722071|12509187|P2|NOT COMPLETED|Overall Study||0
5083758|NCT01722071|12509188|P1|NOT COMPLETED|Overall Study||1
5083759|NCT01722071|12509187|P2|COMPLETED|Overall Study||10
5083760|NCT01722071|12509188|P1|COMPLETED|Overall Study||9
5083761|NCT01722071|12509187|P2|STARTED|Overall Study||10
5083762|NCT01722071|12509188|P1|STARTED|Overall Study||10
5083763|NCT01722045|12509194|P1|NOT COMPLETED|Overall Study||28
5083764|NCT01722045|12509194|P1|COMPLETED|Overall Study||126
5083765|NCT01722045|12509194|P1|STARTED|Overall Study||154
5083766|NCT01721967|12509204|P1|NOT COMPLETED|Overall Study||3
5083767|NCT01721967|12509204|P1|COMPLETED|Overall Study||11
5083768|NCT01721967|12509204|P1|STARTED|Overall Study||14
5083769|NCT01721954|12509215|P2|NOT COMPLETED|Overall Study||69
5083770|NCT01721954|12509216|P1|NOT COMPLETED|Overall Study||70
5083771|NCT01721954|12509215|P2|COMPLETED|Overall Study||35
5083772|NCT01721954|12509216|P1|COMPLETED|Overall Study||35
5083773|NCT01721954|12509215|P2|STARTED|Overall Study||104
5083774|NCT01721954|12509216|P1|STARTED|Overall Study||105
5083775|NCT01721837|12509224|P1|NOT COMPLETED|Overall Study||0
5083776|NCT01721837|12509224|P1|COMPLETED|Overall Study||2120
5083777|NCT01721837|12509224|P1|STARTED|Overall Study||2120
5083778|NCT01721772|12509230|P2|NOT COMPLETED|Overall Study||192
5083779|NCT01721772|12509231|P1|NOT COMPLETED|Overall Study||111
5083780|NCT01721772|12509230|P2|COMPLETED|Overall Study|Continuing in treatment period|13
5083781|NCT01721772|12509231|P1|COMPLETED|Overall Study|Continuing in treatment period|95
5083782|NCT01721772|12509230|P2|STARTED|Overall Study||205
5083783|NCT01721772|12509231|P1|STARTED|Overall Study||206
5083784|NCT01721759|12509251|P1|NOT COMPLETED|Overall Study||102
5083785|NCT01721759|12509251|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
5083786|NCT01721759|12509251|P1|STARTED|Overall Study||117
5083787|NCT01721746|12509259|P3|NOT COMPLETED|Follow-Up Period||0
5083788|NCT01721746|12509260|P2|NOT COMPLETED|Follow-Up Period||0
5083789|NCT01721746|12509261|P1|NOT COMPLETED|Follow-Up Period||0
5083790|NCT01721746|12509259|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
5083791|NCT01721746|12509260|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
5083792|NCT01721746|12509261|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
5083793|NCT01721746|12509259|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
5083794|NCT01721746|12509260|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
5083795|NCT01721746|12509261|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
5083796|NCT01721746|12509259|P3|NOT COMPLETED|Treatment Period||57
5083797|NCT01721746|12509260|P2|NOT COMPLETED|Treatment Period||45
5083798|NCT01721746|12509261|P1|NOT COMPLETED|Treatment Period||233
5083799|NCT01721746|12509259|P3|COMPLETED|Treatment Period||0
5083800|NCT01721746|12509260|P2|COMPLETED|Treatment Period||0
5083801|NCT01721746|12509261|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
5083802|NCT01721746|12509259|P3|STARTED|Treatment Period||57
5083803|NCT01721746|12509260|P2|STARTED|Treatment Period||45
5083804|NCT01721746|12509261|P1|STARTED|Treatment Period||268
5083805|NCT01721681|12509277|P1|NOT COMPLETED|Overall Study||0
5083806|NCT01721681|12509277|P1|COMPLETED|Overall Study||9
5083807|NCT01721681|12509277|P1|STARTED|Overall Study||9
5083808|NCT01721603|12509283|P1|NOT COMPLETED|Overall Study||0
5083809|NCT01721603|12509283|P1|COMPLETED|Overall Study||2
5083810|NCT01721603|12509283|P1|STARTED|Overall Study||2
5083811|NCT01721564|12509294|P1|NOT COMPLETED|Overall Study||0
5083812|NCT01721564|12509294|P1|COMPLETED|Overall Study||8
5083813|NCT01721564|12509294|P1|STARTED|Overall Study||8
5083814|NCT01721486|12509301|P2|NOT COMPLETED|Overall Study||1
5083815|NCT01721486|12509302|P1|NOT COMPLETED|Overall Study||1
5083816|NCT01721486|12509301|P2|COMPLETED|Overall Study||19
5083817|NCT01721486|12509302|P1|COMPLETED|Overall Study||20
5083818|NCT01721486|12509301|P2|STARTED|Overall Study||20
5083819|NCT01721486|12509302|P1|STARTED|Overall Study||21
5083820|NCT01721473|12509320|P6|NOT COMPLETED|Overall Study||0
5083821|NCT01721473|12509321|P5|NOT COMPLETED|Overall Study||0
5083822|NCT01721473|12509322|P4|NOT COMPLETED|Overall Study||0
5083823|NCT01721473|12509323|P3|NOT COMPLETED|Overall Study||0
5083824|NCT01721473|12509324|P2|NOT COMPLETED|Overall Study||0
5083825|NCT01721473|12509325|P1|NOT COMPLETED|Overall Study||0
5083826|NCT01721473|12509320|P6|COMPLETED|Overall Study||18
5083827|NCT01721473|12509321|P5|COMPLETED|Overall Study||22
5083828|NCT01721473|12509322|P4|COMPLETED|Overall Study||34
5083829|NCT01721473|12509323|P3|COMPLETED|Overall Study||41
5083830|NCT01721473|12509324|P2|COMPLETED|Overall Study||22
5083831|NCT01721473|12509325|P1|COMPLETED|Overall Study||47
5083832|NCT01721473|12509320|P6|STARTED|Overall Study||18
5083833|NCT01721473|12509321|P5|STARTED|Overall Study||22
5083834|NCT01721473|12509322|P4|STARTED|Overall Study||34
5083835|NCT01721473|12509323|P3|STARTED|Overall Study||41
5083836|NCT01721473|12509324|P2|STARTED|Overall Study||22
5083837|NCT01721473|12509325|P1|STARTED|Overall Study||47
5083838|NCT01721460|12509334|P1|NOT COMPLETED|Overall Study||1
5083839|NCT01721460|12509334|P1|COMPLETED|Overall Study||5
5083840|NCT01721460|12509334|P1|STARTED|Overall Study||6
5083841|NCT01721447|12509341|P1|NOT COMPLETED|Overall Study||0
5083842|NCT01721447|12509341|P1|COMPLETED|Overall Study||100
5083843|NCT01721447|12509341|P1|STARTED|Overall Study||100
5083844|NCT01721408|12509350|P2|NOT COMPLETED|Overall Study||24
5083845|NCT01721408|12509351|P1|NOT COMPLETED|Overall Study||36
5083846|NCT01721408|12509350|P2|COMPLETED|Overall Study||207
5083847|NCT01721408|12509351|P1|COMPLETED|Overall Study||196
5083848|NCT01721408|12509350|P2|STARTED|Overall Study|Number of participants treated.|231
5083849|NCT01721408|12509351|P1|STARTED|Overall Study|Number of participants treated.|232
5083850|NCT01721330|12509367|P2|NOT COMPLETED|Overall Study||1
5083851|NCT01721330|12509368|P1|NOT COMPLETED|Overall Study||0
5083852|NCT01721330|12509367|P2|COMPLETED|Overall Study||1
5083853|NCT01721330|12509368|P1|COMPLETED|Overall Study||1
5083854|NCT01721330|12509367|P2|STARTED|Overall Study||2
5083855|NCT01721330|12509368|P1|STARTED|Overall Study||1
5083856|NCT01721317|12509376|P2|NOT COMPLETED|Overall Study||4
5083857|NCT01721317|12509377|P1|NOT COMPLETED|Overall Study||2
5083858|NCT01721317|12509376|P2|COMPLETED|Overall Study||0
5083859|NCT01721317|12509377|P1|COMPLETED|Overall Study||0
5083860|NCT01721317|12509376|P2|STARTED|Overall Study||4
5083861|NCT01721317|12509377|P1|STARTED|Overall Study||2
5083862|NCT01721226|12509445|P2|NOT COMPLETED|Overall Study||7
5083863|NCT01721226|12509446|P1|NOT COMPLETED|Overall Study||5
5083864|NCT01721226|12509445|P2|COMPLETED|Overall Study||50
5083865|NCT01721226|12509446|P1|COMPLETED|Overall Study||50
5083866|NCT01721226|12509445|P2|Week 24|Overall Study||50
5083867|NCT01721226|12509446|P1|Week 24|Overall Study||50
5083868|NCT01721226|12509445|P2|Week 12|Overall Study||53
5083869|NCT01721226|12509446|P1|Week 12|Overall Study||48
5083870|NCT01721226|12509445|P2|Baseline|Overall Study||57
5083871|NCT01721226|12509446|P1|Baseline|Overall Study||53
5083872|NCT01721226|12509445|P2|STARTED|Overall Study||57
5083873|NCT01721226|12509446|P1|STARTED|Overall Study||55
5083874|NCT01721200|12509456|P2|NOT COMPLETED|Overall Study||5
5083875|NCT01721200|12509457|P1|NOT COMPLETED|Overall Study||3
5083876|NCT01721200|12509456|P2|COMPLETED|Overall Study||58
5083877|NCT01721200|12509457|P1|COMPLETED|Overall Study||59
5083878|NCT01721200|12509456|P2|Completed 2 Week Follow-up|Overall Study||61
5083879|NCT01721200|12509457|P1|Completed 2 Week Follow-up|Overall Study||60
5083880|NCT01721200|12509456|P2|STARTED|Overall Study||63
5083881|NCT01721200|12509457|P1|STARTED|Overall Study||62
5083882|NCT01721161|12509482|P2|NOT COMPLETED|Overall Study||7
5083883|NCT01721161|12509483|P1|NOT COMPLETED|Overall Study||4
5083884|NCT01721161|12509482|P2|COMPLETED|Overall Study||34
5083885|NCT01721161|12509483|P1|COMPLETED|Overall Study||37
5083886|NCT01721161|12509482|P2|STARTED|Overall Study||41
5083887|NCT01721161|12509483|P1|STARTED|Overall Study||41
5083888|NCT01721109|12509506|P1|NOT COMPLETED|Overall Study||7
5083889|NCT01721109|12509506|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
5083890|NCT01721109|12509506|P1|STARTED|Overall Study||50
5083891|NCT01721096|12509521|P2|NOT COMPLETED|Overall Study||204
5083892|NCT01721096|12509522|P1|NOT COMPLETED|Overall Study||320
5083893|NCT01721096|12509521|P2|COMPLETED|Overall Study||9
5083894|NCT01721096|12509522|P1|COMPLETED|Overall Study||3
5083895|NCT01721096|12509521|P2|STARTED|Overall Study||213
5083896|NCT01721096|12509522|P1|STARTED|Overall Study||323
5083897|NCT01721070|12509701|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
5083898|NCT01721070|12509701|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
5083899|NCT01721070|12509701|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
5083900|NCT01721070|12509701|P1|NOT COMPLETED|SUF NT 15 mcg||0
5083901|NCT01721070|12509701|P1|COMPLETED|SUF NT 15 mcg||19
5083902|NCT01721070|12509701|P1|STARTED|SUF NT 15 mcg||19
5083903|NCT01721057|12509712|P7|NOT COMPLETED|Follow Up||0
5083904|NCT01721057|12509713|P6|NOT COMPLETED|Follow Up||0
5083905|NCT01721057|12509714|P5|NOT COMPLETED|Follow Up||0
5083906|NCT01721057|12509715|P4|NOT COMPLETED|Follow Up||0
5083907|NCT01721057|12509716|P3|NOT COMPLETED|Follow Up||0
5083908|NCT01721057|12509717|P2|NOT COMPLETED|Follow Up||0
5083909|NCT01721057|12509718|P1|NOT COMPLETED|Follow Up||0
5083910|NCT01721057|12509712|P7|COMPLETED|Follow Up||22
5083911|NCT01721057|12509713|P6|COMPLETED|Follow Up||19
5083912|NCT01721057|12509714|P5|COMPLETED|Follow Up||17
5083913|NCT01721057|12509715|P4|COMPLETED|Follow Up||0
5083914|NCT01721057|12509716|P3|COMPLETED|Follow Up||0
5083915|NCT01721057|12509717|P2|COMPLETED|Follow Up||0
5083916|NCT01721057|12509718|P1|COMPLETED|Follow Up||0
5083917|NCT01721057|12509712|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
5083918|NCT01721057|12509713|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
5083919|NCT01721057|12509714|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
5083920|NCT01721057|12509715|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
5083921|NCT01721057|12509716|P3|STARTED|Follow Up||0
5083922|NCT01721057|12509717|P2|STARTED|Follow Up||0
5083923|NCT01721057|12509718|P1|STARTED|Follow Up||0
5083924|NCT01721057|12509712|P7|NOT COMPLETED|Rescue Period||0
5083925|NCT01721057|12509713|P6|NOT COMPLETED|Rescue Period||0
5083926|NCT01721057|12509714|P5|NOT COMPLETED|Rescue Period||0
5083927|NCT01721057|12509715|P4|NOT COMPLETED|Rescue Period||3
5083928|NCT01721057|12509716|P3|NOT COMPLETED|Rescue Period||0
5083929|NCT01721057|12509717|P2|NOT COMPLETED|Rescue Period||0
5083930|NCT01721057|12509718|P1|NOT COMPLETED|Rescue Period||0
5083931|NCT01721057|12509712|P7|COMPLETED|Rescue Period||0
5083932|NCT01721057|12509713|P6|COMPLETED|Rescue Period||0
5083933|NCT01721057|12509714|P5|COMPLETED|Rescue Period||0
5083934|NCT01721057|12509715|P4|COMPLETED|Rescue Period||88
5083935|NCT01721057|12509716|P3|COMPLETED|Rescue Period||0
5083936|NCT01721057|12509717|P2|COMPLETED|Rescue Period||0
5083937|NCT01721057|12509718|P1|COMPLETED|Rescue Period||0
5083938|NCT01721057|12509712|P7|STARTED|Rescue Period||0
5083939|NCT01721057|12509713|P6|STARTED|Rescue Period||0
5083940|NCT01721057|12509714|P5|STARTED|Rescue Period||0
5083941|NCT01721057|12509715|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
5083942|NCT01721057|12509716|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5083943|NCT01721057|12509717|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5083944|NCT01721057|12509718|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5083945|NCT01721057|12509712|P7|NOT COMPLETED|Treatment Period||0
5083946|NCT01721057|12509713|P6|NOT COMPLETED|Treatment Period||0
5083947|NCT01721057|12509714|P5|NOT COMPLETED|Treatment Period||0
5083948|NCT01721057|12509715|P4|NOT COMPLETED|Treatment Period||0
5083949|NCT01721057|12509716|P3|NOT COMPLETED|Treatment Period||23
5083950|NCT01721057|12509717|P2|NOT COMPLETED|Treatment Period||19
5083951|NCT01721057|12509718|P1|NOT COMPLETED|Treatment Period||28
5083952|NCT01721057|12509712|P7|COMPLETED|Treatment Period||0
5083953|NCT01721057|12509713|P6|COMPLETED|Treatment Period||0
5083954|NCT01721057|12509714|P5|COMPLETED|Treatment Period||0
5083955|NCT01721057|12509715|P4|COMPLETED|Treatment Period||0
5083956|NCT01721057|12509716|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
5083957|NCT01721057|12509717|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
5083958|NCT01721057|12509718|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
5083959|NCT01721057|12509712|P7|Rescued|Treatment Period||0
5083960|NCT01721057|12509713|P6|Rescued|Treatment Period||0
5083961|NCT01721057|12509714|P5|Rescued|Treatment Period||0
5083962|NCT01721057|12509715|P4|Rescued|Treatment Period||0
5083963|NCT01721057|12509716|P3|Rescued|Treatment Period||15
5083964|NCT01721057|12509717|P2|Rescued|Treatment Period||21
5083965|NCT01721057|12509718|P1|Rescued|Treatment Period||55
5083966|NCT01721057|12509712|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
5083967|NCT01721057|12509713|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
5083968|NCT01721057|12509714|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
5083969|NCT01721057|12509715|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
5083970|NCT01721057|12509716|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
5083971|NCT01721057|12509717|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
5083972|NCT01721057|12509718|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
5083973|NCT01721057|12509712|P7|STARTED|Treatment Period||0
5083974|NCT01721057|12509713|P6|STARTED|Treatment Period||0
5083975|NCT01721057|12509714|P5|STARTED|Treatment Period||0
5083976|NCT01721057|12509715|P4|STARTED|Treatment Period||0
5083977|NCT01721057|12509716|P3|STARTED|Treatment Period||227
5083978|NCT01721057|12509717|P2|STARTED|Treatment Period||229
5083979|NCT01721057|12509718|P1|STARTED|Treatment Period||228
5083980|NCT01721044|12509791|P3|NOT COMPLETED|Follow Up||0
5083981|NCT01721044|12509792|P2|NOT COMPLETED|Follow Up||0
5083982|NCT01721044|12509793|P1|NOT COMPLETED|Follow Up||0
5083983|NCT01721044|12509791|P3|COMPLETED|Follow Up||20
5083984|NCT01721044|12509792|P2|COMPLETED|Follow Up||9
5083985|NCT01721044|12509793|P1|COMPLETED|Follow Up||19
5083986|NCT01721044|12509791|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
5083987|NCT01721044|12509792|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
5083988|NCT01721044|12509793|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
5083989|NCT01721044|12509791|P3|NOT COMPLETED|Treatment Period||19
5083990|NCT01721044|12509792|P2|NOT COMPLETED|Treatment Period||17
5083991|NCT01721044|12509793|P1|NOT COMPLETED|Treatment Period||32
5083992|NCT01721044|12509791|P3|COMPLETED|Treatment Period||158
5083993|NCT01721044|12509792|P2|COMPLETED|Treatment Period||157
5083994|NCT01721044|12509793|P1|COMPLETED|Treatment Period||144
5083995|NCT01721044|12509791|P3|Rescue Week 16-24|Treatment Period||33
5083996|NCT01721044|12509792|P2|Rescue Week 16-24|Treatment Period||38
5083997|NCT01721044|12509793|P1|Rescue Week 16-24|Treatment Period||56
5083998|NCT01721044|12509791|P3|STARTED|Treatment Period||177
5083999|NCT01721044|12509792|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
5084000|NCT01721044|12509793|P1|STARTED|Treatment Period||176
5084001|NCT01720797|12509866|P2|NOT COMPLETED|Overall Study||0
5084002|NCT01720797|12509867|P1|NOT COMPLETED|Overall Study||3
5084003|NCT01720797|12509866|P2|COMPLETED|Overall Study||9
5084004|NCT01720797|12509867|P1|COMPLETED|Overall Study||9
5084005|NCT01720797|12509866|P2|STARTED|Overall Study||9
5084006|NCT01720797|12509867|P1|STARTED|Overall Study||12
5084007|NCT01720667|12509875|P2|NOT COMPLETED|Overall Study||1
5084008|NCT01720667|12509876|P1|NOT COMPLETED|Overall Study||4
5084009|NCT01720667|12509875|P2|COMPLETED|Overall Study||41
5084010|NCT01720667|12509876|P1|COMPLETED|Overall Study||60
5084011|NCT01720667|12509875|P2|Modified ITT|Overall Study||30
5084012|NCT01720667|12509876|P1|Modified ITT|Overall Study||53
5084013|NCT01720667|12509875|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
5084014|NCT01720667|12509876|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
5084015|NCT01720667|12509875|P2|Recieved Alternate Intervention|Overall Study||10
5084016|NCT01720667|12509876|P1|Recieved Alternate Intervention|Overall Study||45
5084017|NCT01720667|12509875|P2|Recieved Second Infusion of Same Drug|Overall Study||20
5084018|NCT01720667|12509876|P1|Recieved Second Infusion of Same Drug|Overall Study||50
5084019|NCT01720667|12509875|P2|STARTED|Overall Study||42
5084020|NCT01720667|12509876|P1|STARTED|Overall Study||64
5084021|NCT01720602|12509890|P1|NOT COMPLETED|Overall Study||5
5084022|NCT01720602|12509890|P1|COMPLETED|Overall Study||10
5084023|NCT01720602|12509890|P1|STARTED|Overall Study||15
5084024|NCT01720524|12509900|P2|NOT COMPLETED|Part B||14
5084025|NCT01720524|12509901|P1|NOT COMPLETED|Part B||7
5084026|NCT01720524|12509900|P2|COMPLETED|Part B||12
5084027|NCT01720524|12509901|P1|COMPLETED|Part B||20
5084028|NCT01720524|12509900|P2|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
5084029|NCT01720524|12509901|P1|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
5084030|NCT01720524|12509900|P2|NOT COMPLETED|Part A||12
5084031|NCT01720524|12509901|P1|NOT COMPLETED|Part A||7
5084032|NCT01720524|12509900|P2|COMPLETED|Part A||18
5084033|NCT01720524|12509901|P1|COMPLETED|Part A||22
5084034|NCT01720524|12509900|P2|STARTED|Part A||30
5084035|NCT01720524|12509901|P1|STARTED|Part A||29
5084036|NCT01720446|12509934|P4|NOT COMPLETED|Overall Study||20
5084037|NCT01720446|12509935|P3|NOT COMPLETED|Overall Study||20
5084038|NCT01720446|12509936|P2|NOT COMPLETED|Overall Study||11
5084039|NCT01720446|12509937|P1|NOT COMPLETED|Overall Study||14
5084040|NCT01720446|12509934|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
5084041|NCT01720446|12509935|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
5084042|NCT01720446|12509936|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
5084043|NCT01720446|12509937|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
5084044|NCT01720446|12509934|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
5084045|NCT01720446|12509935|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
5084046|NCT01720446|12509936|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
5084047|NCT01720446|12509937|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
5084048|NCT01720446|12509934|P4|STARTED|Overall Study||825
5084049|NCT01720446|12509935|P3|STARTED|Overall Study||824
5084050|NCT01720446|12509936|P2|STARTED|Overall Study||822
5084051|NCT01720446|12509937|P1|STARTED|Overall Study||826
5084052|NCT01720316|12509998|P2|NOT COMPLETED|Open-label Glycine||0
5084053|NCT01720316|12509999|P1|NOT COMPLETED|Open-label Glycine||0
5084054|NCT01720316|12509998|P2|COMPLETED|Open-label Glycine||1
5084055|NCT01720316|12509999|P1|COMPLETED|Open-label Glycine||1
5084056|NCT01720316|12509998|P2|STARTED|Open-label Glycine||1
5084057|NCT01720316|12509999|P1|STARTED|Open-label Glycine||1
5084058|NCT01720316|12509998|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
5084059|NCT01720316|12509999|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
5084060|NCT01720316|12509998|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
5084061|NCT01720316|12509999|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
5084062|NCT01720316|12509998|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
5084063|NCT01720316|12509999|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
5084064|NCT01720277|12510047|P2|NOT COMPLETED|Overall Study||558
5084065|NCT01720277|12510048|P1|NOT COMPLETED|Overall Study||503
5084066|NCT01720277|12510047|P2|COMPLETED|Overall Study|intent-to-treat approach|938
5084067|NCT01720277|12510048|P1|COMPLETED|Overall Study|intent-to-treat approach|958
5084068|NCT01720277|12510047|P2|STARTED|Overall Study||1496
5084069|NCT01720277|12510048|P1|STARTED|Overall Study||1461
5084070|NCT01720264|12510058|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
5084071|NCT01720264|12510058|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
5084072|NCT01720264|12510058|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
5084073|NCT01720264|12510058|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
5084074|NCT01720264|12510058|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
5084075|NCT01720264|12510058|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
5084076|NCT01720251|12510068|P3|NOT COMPLETED|Overall Study||0
5084077|NCT01720251|12510069|P2|NOT COMPLETED|Overall Study||2
5084078|NCT01720251|12510070|P1|NOT COMPLETED|Overall Study||1
5084079|NCT01720251|12510068|P3|COMPLETED|Overall Study||82
5084080|NCT01720251|12510069|P2|COMPLETED|Overall Study||77
5084081|NCT01720251|12510070|P1|COMPLETED|Overall Study||78
5084082|NCT01720251|12510068|P3|STARTED|Overall Study||82
5084083|NCT01720251|12510069|P2|STARTED|Overall Study||79
5084084|NCT01720251|12510070|P1|STARTED|Overall Study||79
5084085|NCT01720173|12510078|P1|NOT COMPLETED|Overall Study||0
5084086|NCT01720173|12510078|P1|COMPLETED|Overall Study||30
5084087|NCT01720173|12510078|P1|STARTED|Overall Study||30
5084088|NCT01720069|12510089|P3|NOT COMPLETED|Overall Study||15
5084089|NCT01720069|12510090|P2|NOT COMPLETED|Overall Study||15
5084090|NCT01720069|12510091|P1|NOT COMPLETED|Overall Study||5
5084091|NCT01720069|12510089|P3|COMPLETED|Overall Study||48
5084092|NCT01720069|12510090|P2|COMPLETED|Overall Study||56
5084093|NCT01720069|12510091|P1|COMPLETED|Overall Study||57
5084094|NCT01720069|12510089|P3|Full Anaylsis Set|Overall Study||63
5084095|NCT01720069|12510090|P2|Full Anaylsis Set|Overall Study||71
5084096|NCT01720069|12510091|P1|Full Anaylsis Set|Overall Study||62
5084097|NCT01720069|12510089|P3|STARTED|Overall Study||63
5084098|NCT01720069|12510090|P2|STARTED|Overall Study||71
5084099|NCT01720069|12510091|P1|STARTED|Overall Study||62
5084100|NCT01720043|12510117|P1|NOT COMPLETED|Overall Study||1
5084101|NCT01720043|12510117|P1|COMPLETED|Overall Study||7
5084102|NCT01720043|12510117|P1|STARTED|Overall Study||8
5084103|NCT01719900|12510123|P2|NOT COMPLETED|Overall Study||2
5084104|NCT01719900|12510124|P1|NOT COMPLETED|Overall Study||7
5084105|NCT01719900|12510123|P2|COMPLETED|Overall Study||22
5084106|NCT01719900|12510124|P1|COMPLETED|Overall Study||22
5084107|NCT01719900|12510123|P2|STARTED|Overall Study||24
5084108|NCT01719900|12510124|P1|STARTED|Overall Study||29
5084109|NCT01719861|12510146|P1|NOT COMPLETED|Cycle 2||1
5084110|NCT01719861|12510146|P1|COMPLETED|Cycle 2||1
5084111|NCT01719861|12510146|P1|STARTED|Cycle 2||2
5084112|NCT01719861|12510146|P1|NOT COMPLETED|Cycle 1||4
5084113|NCT01719861|12510146|P1|COMPLETED|Cycle 1||2
5084114|NCT01719861|12510146|P1|STARTED|Cycle 1||6
5084115|NCT01719783|12510156|P2|NOT COMPLETED|Dose 2||0
5084116|NCT01719783|12510157|P1|NOT COMPLETED|Dose 2||1
5084117|NCT01719783|12510156|P2|COMPLETED|Dose 2||10
5084118|NCT01719783|12510157|P1|COMPLETED|Dose 2||29
5084119|NCT01719783|12510156|P2|STARTED|Dose 2||10
5084120|NCT01719783|12510157|P1|STARTED|Dose 2||30
5084121|NCT01719783|12510156|P2|NOT COMPLETED|Dose 1||0
5084122|NCT01719783|12510157|P1|NOT COMPLETED|Dose 1||0
5084123|NCT01719783|12510156|P2|COMPLETED|Dose 1||10
5084124|NCT01719783|12510157|P1|COMPLETED|Dose 1||30
5084125|NCT01719783|12510156|P2|STARTED|Dose 1||10
5084126|NCT01719783|12510157|P1|STARTED|Dose 1||30
5084127|NCT01719757|12510243|P1|NOT COMPLETED|Overall Study||101
5084128|NCT01719757|12510243|P1|COMPLETED|Overall Study||258
5084129|NCT01719757|12510243|P1|STARTED|Overall Study||359
5084130|NCT01719744|12510251|P1|NOT COMPLETED|Overall Study||0
5084131|NCT01719744|12510251|P1|COMPLETED|Overall Study||25
5084132|NCT01719744|12510251|P1|STARTED|Overall Study||25
5084133|NCT01719653|12510262|P5|NOT COMPLETED|Overall Study||21
5084134|NCT01719653|12510263|P4|NOT COMPLETED|Overall Study||18
5084135|NCT01719653|12510264|P3|NOT COMPLETED|Overall Study||18
5084136|NCT01719653|12510265|P2|NOT COMPLETED|Overall Study||13
5084137|NCT01719653|12510266|P1|NOT COMPLETED|Overall Study||9
5084138|NCT01719653|12510262|P5|COMPLETED|Overall Study||200
5084139|NCT01719653|12510263|P4|COMPLETED|Overall Study||200
5084140|NCT01719653|12510264|P3|COMPLETED|Overall Study||200
5084141|NCT01719653|12510265|P2|COMPLETED|Overall Study||200
5084142|NCT01719653|12510266|P1|COMPLETED|Overall Study||200
5084143|NCT01719653|12510262|P5|STARTED|Overall Study||221
5084144|NCT01719653|12510263|P4|STARTED|Overall Study||218
5084145|NCT01719653|12510264|P3|STARTED|Overall Study||218
5084146|NCT01719653|12510265|P2|STARTED|Overall Study||213
5084147|NCT01719653|12510266|P1|STARTED|Overall Study||209
5084148|NCT01719367|12510288|P2|NOT COMPLETED|Overall Study||0
5084149|NCT01719367|12510289|P1|NOT COMPLETED|Overall Study||0
5084150|NCT01719367|12510288|P2|COMPLETED|Overall Study||19
5084151|NCT01719367|12510289|P1|COMPLETED|Overall Study||19
5084152|NCT01719367|12510288|P2|STARTED|Overall Study||19
5084153|NCT01719367|12510289|P1|STARTED|Overall Study||19
5084154|NCT01719224|12510297|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
5084155|NCT01719224|12510298|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
5084156|NCT01719224|12510297|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
5084157|NCT01719224|12510298|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
5084158|NCT01719224|12510297|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
5084159|NCT01719224|12510298|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
5084160|NCT01719224|12510297|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
5084161|NCT01719224|12510298|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
5084162|NCT01719224|12510297|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
5084163|NCT01719224|12510298|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
5084164|NCT01719224|12510297|P2|STARTED|Intervention 1: Sleeping Position 1||18
5084165|NCT01719224|12510298|P1|STARTED|Intervention 1: Sleeping Position 1||18
5084166|NCT01719172|12510307|P1|NOT COMPLETED|Overall Study||2
5084167|NCT01719172|12510307|P1|COMPLETED|Overall Study||28
5084168|NCT01719172|12510307|P1|STARTED|Overall Study||30
5084169|NCT01719003|12510321|P9|NOT COMPLETED|Overall Study||4
5084170|NCT01719003|12510322|P8|NOT COMPLETED|Overall Study||20
5084171|NCT01719003|12510323|P7|NOT COMPLETED|Overall Study||20
5084172|NCT01719003|12510324|P6|NOT COMPLETED|Overall Study||12
5084173|NCT01719003|12510325|P5|NOT COMPLETED|Overall Study||17
5084174|NCT01719003|12510326|P4|NOT COMPLETED|Overall Study||13
5084175|NCT01719003|12510327|P3|NOT COMPLETED|Overall Study||17
5084176|NCT01719003|12510328|P2|NOT COMPLETED|Overall Study||17
5084177|NCT01719003|12510329|P1|NOT COMPLETED|Overall Study||9
5084178|NCT01719003|12510321|P9|COMPLETED|Overall Study||49
5084179|NCT01719003|12510322|P8|COMPLETED|Overall Study||151
5084180|NCT01719003|12510323|P7|COMPLETED|Overall Study||150
5084181|NCT01719003|12510324|P6|COMPLETED|Overall Study||160
5084182|NCT01719003|12510325|P5|COMPLETED|Overall Study||150
5084183|NCT01719003|12510326|P4|COMPLETED|Overall Study||156
5084184|NCT01719003|12510327|P3|COMPLETED|Overall Study||154
5084185|NCT01719003|12510328|P2|COMPLETED|Overall Study||153
5084186|NCT01719003|12510329|P1|COMPLETED|Overall Study||161
5084187|NCT01719003|12510321|P9|STARTED|Overall Study||53
5084188|NCT01719003|12510322|P8|STARTED|Overall Study||171
5084189|NCT01719003|12510323|P7|STARTED|Overall Study||170
5084190|NCT01719003|12510324|P6|STARTED|Overall Study||172
5084191|NCT01719003|12510325|P5|STARTED|Overall Study||167
5084192|NCT01719003|12510326|P4|STARTED|Overall Study||169
5084193|NCT01719003|12510327|P3|STARTED|Overall Study||171
5084194|NCT01719003|12510328|P2|STARTED|Overall Study||170
5084195|NCT01719003|12510329|P1|STARTED|Overall Study||170
5084196|NCT01718691|12510366|P2|NOT COMPLETED|Overall Study||1
5084197|NCT01718691|12510367|P1|NOT COMPLETED|Overall Study||18
5084198|NCT01718691|12510366|P2|COMPLETED|Overall Study||9
5084199|NCT01718691|12510367|P1|COMPLETED|Overall Study||42
5084200|NCT01718691|12510366|P2|STARTED|Overall Study||10
5084201|NCT01718691|12510367|P1|STARTED|Overall Study||60
5084202|NCT01718535|12510410|P10|NOT COMPLETED|Overall Study||0
5084203|NCT01718535|12510411|P9|NOT COMPLETED|Overall Study||0
5084204|NCT01718535|12510412|P8|NOT COMPLETED|Overall Study||0
5084205|NCT01718535|12510413|P7|NOT COMPLETED|Overall Study||0
5084206|NCT01718535|12510414|P6|NOT COMPLETED|Overall Study||0
5084207|NCT01718535|12510415|P5|NOT COMPLETED|Overall Study||0
5084208|NCT01718535|12510416|P4|NOT COMPLETED|Overall Study||1
5084209|NCT01718535|12510417|P3|NOT COMPLETED|Overall Study||0
5084210|NCT01718535|12510418|P2|NOT COMPLETED|Overall Study||0
5084211|NCT01718535|12510419|P1|NOT COMPLETED|Overall Study||1
5084212|NCT01718535|12510410|P10|COMPLETED|Overall Study||1
5084213|NCT01718535|12510411|P9|COMPLETED|Overall Study||15
5084214|NCT01718535|12510412|P8|COMPLETED|Overall Study||6
5084215|NCT01718535|12510413|P7|COMPLETED|Overall Study||11
5084216|NCT01718535|12510414|P6|COMPLETED|Overall Study||40
5084217|NCT01718535|12510415|P5|COMPLETED|Overall Study||1
5084218|NCT01718535|12510416|P4|COMPLETED|Overall Study||7
5084219|NCT01718535|12510417|P3|COMPLETED|Overall Study||19
5084220|NCT01718535|12510418|P2|COMPLETED|Overall Study||95
5084221|NCT01718535|12510419|P1|COMPLETED|Overall Study||130
5084222|NCT01718535|12510410|P10|First Pass|Overall Study||1
5084223|NCT01718535|12510411|P9|First Pass|Overall Study||15
5084224|NCT01718535|12510412|P8|First Pass|Overall Study||6
5084225|NCT01718535|12510413|P7|First Pass|Overall Study||11
5084226|NCT01718535|12510414|P6|First Pass|Overall Study||39
5084227|NCT01718535|12510415|P5|First Pass|Overall Study||1
5084228|NCT01718535|12510416|P4|First Pass|Overall Study||7
5084229|NCT01718535|12510417|P3|First Pass|Overall Study||19
5084230|NCT01718535|12510418|P2|First Pass|Overall Study||94
5084231|NCT01718535|12510419|P1|First Pass|Overall Study||128
5084232|NCT01718535|12510410|P10|STARTED|Overall Study||1
5084233|NCT01718535|12510411|P9|STARTED|Overall Study||15
5084234|NCT01718535|12510412|P8|STARTED|Overall Study||6
5084235|NCT01718535|12510413|P7|STARTED|Overall Study||11
5084236|NCT01718535|12510414|P6|STARTED|Overall Study||40
5084237|NCT01718535|12510415|P5|STARTED|Overall Study||1
5084238|NCT01718535|12510416|P4|STARTED|Overall Study||8
5084239|NCT01718535|12510417|P3|STARTED|Overall Study||19
5084240|NCT01718535|12510418|P2|STARTED|Overall Study||95
5084241|NCT01718535|12510419|P1|STARTED|Overall Study||131
5084242|NCT01718522|12510441|P1|NOT COMPLETED|Overall Study||8
5084243|NCT01718522|12510441|P1|COMPLETED|Overall Study||67
5084244|NCT01718522|12510441|P1|STARTED|Overall Study||75
5084245|NCT01718509|12510457|P2|NOT COMPLETED|Overall Study||48
5084246|NCT01718509|12510458|P1|NOT COMPLETED|Overall Study||48
5084247|NCT01718509|12510457|P2|COMPLETED|Overall Study||147
5084248|NCT01718509|12510458|P1|COMPLETED|Overall Study||147
5084249|NCT01718509|12510457|P2|STARTED|Overall Study||195
5084250|NCT01718509|12510458|P1|STARTED|Overall Study||195
5084251|NCT01718483|12510504|P2|NOT COMPLETED|Overall Study||34
5084252|NCT01718483|12510505|P1|NOT COMPLETED|Overall Study||34
5084253|NCT01718483|12510504|P2|COMPLETED|Overall Study||158
5084254|NCT01718483|12510505|P1|COMPLETED|Overall Study||157
5084255|NCT01718483|12510504|P2|Treated|Overall Study||192
5084256|NCT01718483|12510505|P1|Treated|Overall Study||187
5084257|NCT01718483|12510504|P2|STARTED|Overall Study||192
5084258|NCT01718483|12510505|P1|STARTED|Overall Study||191
5084259|NCT01718353|12510551|P2|NOT COMPLETED|Overall Study||5
5084260|NCT01718353|12510552|P1|NOT COMPLETED|Overall Study||12
5084261|NCT01718353|12510551|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
5084262|NCT01718353|12510552|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
5084263|NCT01718353|12510551|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
5084264|NCT01718353|12510552|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
5084265|NCT01718353|12510551|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
5084266|NCT01718353|12510552|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
5084267|NCT01718353|12510551|P2|Treated|Overall Study||22
5084268|NCT01718353|12510552|P1|Treated|Overall Study||39
5084269|NCT01718353|12510551|P2|STARTED|Overall Study||22
5084270|NCT01718353|12510552|P1|STARTED|Overall Study||41
5084271|NCT01718028|12510570|P2|NOT COMPLETED|Overall Study||0
5084272|NCT01718028|12510571|P1|NOT COMPLETED|Overall Study||0
5084273|NCT01718028|12510570|P2|COMPLETED|Overall Study||24
5084274|NCT01718028|12510571|P1|COMPLETED|Overall Study||25
5084275|NCT01718028|12510570|P2|STARTED|Overall Study||24
5084276|NCT01718028|12510571|P1|STARTED|Overall Study||25
5084277|NCT01717989|12510583|P1|NOT COMPLETED|Overall Study||1066
5084278|NCT01717989|12510583|P1|COMPLETED|Overall Study||1182
5084279|NCT01717989|12510583|P1|STARTED|Overall Study||2248
5084280|NCT01717976|12510651|P2|NOT COMPLETED|Overall Study||1
5084281|NCT01717976|12510652|P1|NOT COMPLETED|Overall Study||0
5084282|NCT01717976|12510651|P2|COMPLETED|Overall Study||256
5084283|NCT01717976|12510652|P1|COMPLETED|Overall Study||257
5084284|NCT01717976|12510651|P2|STARTED|Overall Study||257
5084285|NCT01717976|12510652|P1|STARTED|Overall Study||257
5084286|NCT01717898|12510666|P4|NOT COMPLETED|Overall Study||0
5084287|NCT01717898|12510667|P3|NOT COMPLETED|Overall Study||0
5084288|NCT01717898|12510668|P2|NOT COMPLETED|Overall Study||0
5084289|NCT01717898|12510669|P1|NOT COMPLETED|Overall Study||6
5084290|NCT01717898|12510666|P4|COMPLETED|Overall Study||0
5084291|NCT01717898|12510667|P3|COMPLETED|Overall Study||0
5084292|NCT01717898|12510668|P2|COMPLETED|Overall Study||0
5084293|NCT01717898|12510669|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
5084294|NCT01717898|12510666|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
5084295|NCT01717898|12510667|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
5084296|NCT01717898|12510668|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
5084297|NCT01717898|12510669|P1|STARTED|Overall Study||6
5084298|NCT01717872|12510696|P2|NOT COMPLETED|Overall Study||0
5084299|NCT01717872|12510697|P1|NOT COMPLETED|Overall Study||0
5084300|NCT01717872|12510696|P2|COMPLETED|Overall Study||25
5084301|NCT01717872|12510697|P1|COMPLETED|Overall Study||25
5084302|NCT01717872|12510696|P2|STARTED|Overall Study||25
5084303|NCT01717872|12510697|P1|STARTED|Overall Study||25
5084304|NCT01717859|12510707|P1|NOT COMPLETED|Overall Study||10
5084305|NCT01717859|12510707|P1|COMPLETED|Overall Study||44
5084306|NCT01717859|12510707|P1|3 Month|Overall Study||50
5084307|NCT01717859|12510707|P1|STARTED|Overall Study||54
5084308|NCT01717768|12510728|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084309|NCT01717768|12510729|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084310|NCT01717768|12510730|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
5084311|NCT01717768|12510731|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084312|NCT01717768|12510732|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
5084313|NCT01717768|12510733|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084314|NCT01717768|12510734|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084315|NCT01717768|12510735|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084316|NCT01717768|12510736|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084317|NCT01717768|12510737|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084543|NCT01717768|12510735|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
5084318|NCT01717768|12510738|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084319|NCT01717768|12510739|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084320|NCT01717768|12510728|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084321|NCT01717768|12510729|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084322|NCT01717768|12510730|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
5084323|NCT01717768|12510731|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084324|NCT01717768|12510732|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
5084325|NCT01717768|12510733|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084326|NCT01717768|12510734|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084327|NCT01717768|12510735|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084328|NCT01717768|12510736|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084329|NCT01717768|12510737|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084330|NCT01717768|12510738|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084331|NCT01717768|12510739|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084332|NCT01717768|12510728|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084333|NCT01717768|12510729|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084334|NCT01717768|12510730|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
5084335|NCT01717768|12510731|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084336|NCT01717768|12510732|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
5084337|NCT01717768|12510733|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084338|NCT01717768|12510734|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084339|NCT01717768|12510735|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084340|NCT01717768|12510736|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084341|NCT01717768|12510737|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084342|NCT01717768|12510738|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084343|NCT01717768|12510739|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
5084344|NCT01717768|12510728|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
5084345|NCT01717768|12510729|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084346|NCT01717768|12510730|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084347|NCT01717768|12510731|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084348|NCT01717768|12510732|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084349|NCT01717768|12510733|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084350|NCT01717768|12510734|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084351|NCT01717768|12510735|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084352|NCT01717768|12510736|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084353|NCT01717768|12510737|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084354|NCT01717768|12510738|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084355|NCT01717768|12510739|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084356|NCT01717768|12510728|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
5084357|NCT01717768|12510729|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
5084358|NCT01717768|12510730|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084359|NCT01717768|12510731|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
5084360|NCT01717768|12510732|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084361|NCT01717768|12510733|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
5084362|NCT01717768|12510734|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084363|NCT01717768|12510735|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084364|NCT01717768|12510736|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084365|NCT01717768|12510737|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084366|NCT01717768|12510738|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084367|NCT01717768|12510739|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084368|NCT01717768|12510728|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
5084369|NCT01717768|12510729|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
5084370|NCT01717768|12510730|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084371|NCT01717768|12510731|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
5084372|NCT01717768|12510732|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084373|NCT01717768|12510733|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
5084374|NCT01717768|12510734|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084375|NCT01717768|12510735|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084376|NCT01717768|12510736|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084377|NCT01717768|12510737|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084378|NCT01717768|12510738|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084379|NCT01717768|12510739|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
5084380|NCT01717768|12510728|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084381|NCT01717768|12510729|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084382|NCT01717768|12510730|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084383|NCT01717768|12510731|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084384|NCT01717768|12510732|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084385|NCT01717768|12510733|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084386|NCT01717768|12510734|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084387|NCT01717768|12510735|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084388|NCT01717768|12510736|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084389|NCT01717768|12510737|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084390|NCT01717768|12510738|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084391|NCT01717768|12510739|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084392|NCT01717768|12510728|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084393|NCT01717768|12510729|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084394|NCT01717768|12510730|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084395|NCT01717768|12510731|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084396|NCT01717768|12510732|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084397|NCT01717768|12510733|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084398|NCT01717768|12510734|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
5084399|NCT01717768|12510735|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
5084400|NCT01717768|12510736|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
5084401|NCT01717768|12510737|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084402|NCT01717768|12510738|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084403|NCT01717768|12510739|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084404|NCT01717768|12510728|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084405|NCT01717768|12510729|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084406|NCT01717768|12510730|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084407|NCT01717768|12510731|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084408|NCT01717768|12510732|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084409|NCT01717768|12510733|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084410|NCT01717768|12510734|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
5084411|NCT01717768|12510735|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
5084412|NCT01717768|12510736|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
5084413|NCT01717768|12510737|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084414|NCT01717768|12510738|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084415|NCT01717768|12510739|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
5084416|NCT01717768|12510728|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084417|NCT01717768|12510729|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084418|NCT01717768|12510730|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084419|NCT01717768|12510731|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084420|NCT01717768|12510732|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084421|NCT01717768|12510733|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084422|NCT01717768|12510734|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084423|NCT01717768|12510735|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084424|NCT01717768|12510736|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084425|NCT01717768|12510737|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084426|NCT01717768|12510738|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084427|NCT01717768|12510739|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084428|NCT01717768|12510728|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084429|NCT01717768|12510729|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084430|NCT01717768|12510730|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084431|NCT01717768|12510731|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084432|NCT01717768|12510732|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084433|NCT01717768|12510733|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084434|NCT01717768|12510734|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
5084435|NCT01717768|12510735|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
5084436|NCT01717768|12510736|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
5084437|NCT01717768|12510737|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084438|NCT01717768|12510738|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084439|NCT01717768|12510739|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084440|NCT01717768|12510728|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084441|NCT01717768|12510729|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084442|NCT01717768|12510730|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084443|NCT01717768|12510731|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084444|NCT01717768|12510732|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084445|NCT01717768|12510733|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084446|NCT01717768|12510734|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
5084447|NCT01717768|12510735|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
5084448|NCT01717768|12510736|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
5084449|NCT01717768|12510737|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084450|NCT01717768|12510738|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084451|NCT01717768|12510739|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
5084452|NCT01717768|12510728|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084453|NCT01717768|12510729|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084454|NCT01717768|12510730|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084455|NCT01717768|12510731|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084456|NCT01717768|12510732|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084457|NCT01717768|12510733|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084458|NCT01717768|12510734|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084459|NCT01717768|12510735|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084460|NCT01717768|12510736|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084461|NCT01717768|12510737|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084462|NCT01717768|12510738|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084463|NCT01717768|12510739|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084464|NCT01717768|12510728|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084465|NCT01717768|12510729|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084466|NCT01717768|12510730|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084467|NCT01717768|12510731|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084468|NCT01717768|12510732|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084469|NCT01717768|12510733|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084470|NCT01717768|12510734|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
5084471|NCT01717768|12510735|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
5084472|NCT01717768|12510736|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
5084473|NCT01717768|12510737|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084474|NCT01717768|12510738|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084475|NCT01717768|12510739|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084476|NCT01717768|12510728|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084477|NCT01717768|12510729|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084478|NCT01717768|12510730|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084479|NCT01717768|12510731|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084480|NCT01717768|12510732|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084481|NCT01717768|12510733|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084482|NCT01717768|12510734|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
5084483|NCT01717768|12510735|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
5084484|NCT01717768|12510736|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
5084485|NCT01717768|12510737|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084486|NCT01717768|12510738|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084487|NCT01717768|12510739|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
5084488|NCT01717768|12510728|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084489|NCT01717768|12510729|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084490|NCT01717768|12510730|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084491|NCT01717768|12510731|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084492|NCT01717768|12510732|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084493|NCT01717768|12510733|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084494|NCT01717768|12510734|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084495|NCT01717768|12510735|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084496|NCT01717768|12510736|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084497|NCT01717768|12510737|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084498|NCT01717768|12510738|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084499|NCT01717768|12510739|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
5084500|NCT01717768|12510728|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
5084501|NCT01717768|12510729|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
5084502|NCT01717768|12510730|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
5084503|NCT01717768|12510731|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
5084504|NCT01717768|12510732|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
5084505|NCT01717768|12510733|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
5084506|NCT01717768|12510734|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
5084507|NCT01717768|12510735|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
5084508|NCT01717768|12510736|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
5084509|NCT01717768|12510737|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
5084510|NCT01717768|12510738|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
5084511|NCT01717768|12510739|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
5084512|NCT01717768|12510728|P12|STARTED|Part 2 (Duration of 15 Days)||0
5084513|NCT01717768|12510729|P11|STARTED|Part 2 (Duration of 15 Days)||0
5084514|NCT01717768|12510730|P10|STARTED|Part 2 (Duration of 15 Days)||0
5084515|NCT01717768|12510731|P9|STARTED|Part 2 (Duration of 15 Days)||0
5084516|NCT01717768|12510732|P8|STARTED|Part 2 (Duration of 15 Days)||0
5084517|NCT01717768|12510733|P7|STARTED|Part 2 (Duration of 15 Days)||0
5084518|NCT01717768|12510734|P6|STARTED|Part 2 (Duration of 15 Days)||0
5084519|NCT01717768|12510735|P5|STARTED|Part 2 (Duration of 15 Days)||0
5084520|NCT01717768|12510736|P4|STARTED|Part 2 (Duration of 15 Days)||0
5084521|NCT01717768|12510737|P3|STARTED|Part 2 (Duration of 15 Days)||17
5084522|NCT01717768|12510738|P2|STARTED|Part 2 (Duration of 15 Days)||0
5084523|NCT01717768|12510739|P1|STARTED|Part 2 (Duration of 15 Days)||0
5084524|NCT01717768|12510728|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084525|NCT01717768|12510729|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084526|NCT01717768|12510730|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084527|NCT01717768|12510731|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084528|NCT01717768|12510732|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084529|NCT01717768|12510733|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084530|NCT01717768|12510734|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084531|NCT01717768|12510735|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084532|NCT01717768|12510736|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084533|NCT01717768|12510737|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084534|NCT01717768|12510738|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
5084535|NCT01717768|12510739|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
5084536|NCT01717768|12510728|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
5084537|NCT01717768|12510729|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
5084538|NCT01717768|12510730|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
5084539|NCT01717768|12510731|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
5084540|NCT01717768|12510732|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
5084541|NCT01717768|12510733|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
5084542|NCT01717768|12510734|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
5084544|NCT01717768|12510736|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
5084545|NCT01717768|12510737|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
5084546|NCT01717768|12510738|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
5084547|NCT01717768|12510739|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
5084548|NCT01717768|12510728|P12|STARTED|Part 1 (Duration of 15 Days)||0
5084549|NCT01717768|12510729|P11|STARTED|Part 1 (Duration of 15 Days)||0
5084550|NCT01717768|12510730|P10|STARTED|Part 1 (Duration of 15 Days)||0
5084551|NCT01717768|12510731|P9|STARTED|Part 1 (Duration of 15 Days)||0
5084552|NCT01717768|12510732|P8|STARTED|Part 1 (Duration of 15 Days)||0
5084553|NCT01717768|12510733|P7|STARTED|Part 1 (Duration of 15 Days)||0
5084554|NCT01717768|12510734|P6|STARTED|Part 1 (Duration of 15 Days)||0
5084555|NCT01717768|12510735|P5|STARTED|Part 1 (Duration of 15 Days)||0
5084556|NCT01717768|12510736|P4|STARTED|Part 1 (Duration of 15 Days)||0
5084557|NCT01717768|12510737|P3|STARTED|Part 1 (Duration of 15 Days)||0
5084558|NCT01717768|12510738|P2|STARTED|Part 1 (Duration of 15 Days)||17
5084559|NCT01717768|12510739|P1|STARTED|Part 1 (Duration of 15 Days)||17
5084560|NCT01717742|12510779|P2|NOT COMPLETED|Overall Study||2
5084561|NCT01717742|12510780|P1|NOT COMPLETED|Overall Study||5
5084562|NCT01717742|12510779|P2|COMPLETED|Overall Study||47
5084563|NCT01717742|12510780|P1|COMPLETED|Overall Study||43
5084564|NCT01717742|12510779|P2|STARTED|Overall Study||49
5084565|NCT01717742|12510780|P1|STARTED|Overall Study||48
5084566|NCT01717638|12510819|P13|NOT COMPLETED|Overall Study||19
5084567|NCT01717638|12510820|P12|NOT COMPLETED|Overall Study||0
5084568|NCT01717638|12510821|P11|NOT COMPLETED|Overall Study||0
5084569|NCT01717638|12510822|P10|NOT COMPLETED|Overall Study||1
5084570|NCT01717638|12510823|P9|NOT COMPLETED|Overall Study||2
5084571|NCT01717638|12510824|P8|NOT COMPLETED|Overall Study||1
5084572|NCT01717638|12510825|P7|NOT COMPLETED|Overall Study||2
5084573|NCT01717638|12510826|P6|NOT COMPLETED|Overall Study||1
5084574|NCT01717638|12510827|P5|NOT COMPLETED|Overall Study||1
5084575|NCT01717638|12510828|P4|NOT COMPLETED|Overall Study||0
5084576|NCT01717638|12510829|P3|NOT COMPLETED|Overall Study||1
5084577|NCT01717638|12510830|P2|NOT COMPLETED|Overall Study||1
5084578|NCT01717638|12510831|P1|NOT COMPLETED|Overall Study||0
5084579|NCT01717638|12510819|P13|COMPLETED|Overall Study||190
5084580|NCT01717638|12510820|P12|COMPLETED|Overall Study||12
5084581|NCT01717638|12510821|P11|COMPLETED|Overall Study||11
5084582|NCT01717638|12510822|P10|COMPLETED|Overall Study||99
5084583|NCT01717638|12510823|P9|COMPLETED|Overall Study||26
5084584|NCT01717638|12510824|P8|COMPLETED|Overall Study||28
5084585|NCT01717638|12510825|P7|COMPLETED|Overall Study||41
5084586|NCT01717638|12510826|P6|COMPLETED|Overall Study||54
5084587|NCT01717638|12510827|P5|COMPLETED|Overall Study||63
5084588|NCT01717638|12510828|P4|COMPLETED|Overall Study||66
5084589|NCT01717638|12510829|P3|COMPLETED|Overall Study||59
5084590|NCT01717638|12510830|P2|COMPLETED|Overall Study||60
5084591|NCT01717638|12510831|P1|COMPLETED|Overall Study||67
5084592|NCT01717638|12510819|P13|STARTED|Overall Study||209
5084593|NCT01717638|12510820|P12|STARTED|Overall Study||12
5084594|NCT01717638|12510821|P11|STARTED|Overall Study||11
5084595|NCT01717638|12510822|P10|STARTED|Overall Study||100
5084596|NCT01717638|12510823|P9|STARTED|Overall Study||28
5084597|NCT01717638|12510824|P8|STARTED|Overall Study||29
5084598|NCT01717638|12510825|P7|STARTED|Overall Study||43
5084599|NCT01717638|12510826|P6|STARTED|Overall Study||55
5084600|NCT01717638|12510827|P5|STARTED|Overall Study||64
5084601|NCT01717638|12510828|P4|STARTED|Overall Study||66
5084602|NCT01717638|12510829|P3|STARTED|Overall Study||60
5084603|NCT01717638|12510830|P2|STARTED|Overall Study||61
5084604|NCT01717638|12510831|P1|STARTED|Overall Study||67
5084605|NCT01717521|12510973|P1|NOT COMPLETED|Overall Study||0
5084606|NCT01717521|12510973|P1|COMPLETED|Overall Study||20
5084607|NCT01717521|12510973|P1|STARTED|Overall Study||20
5084608|NCT01717482|12510992|P2|NOT COMPLETED|Overall Study||0
5084609|NCT01717482|12510993|P1|NOT COMPLETED|Overall Study||4
5084610|NCT01717482|12510992|P2|COMPLETED|Overall Study||2
5084611|NCT01717482|12510993|P1|COMPLETED|Overall Study||0
5084612|NCT01717482|12510992|P2|STARTED|Overall Study||2
5084613|NCT01717482|12510993|P1|STARTED|Overall Study||4
5084614|NCT01717456|12511007|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
5084615|NCT01717456|12511008|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
5084616|NCT01717456|12511007|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
5084617|NCT01717456|12511008|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
5084618|NCT01717456|12511007|P2|STARTED|Follow-Up 6 Months After End of Tx||6
5084619|NCT01717456|12511008|P1|STARTED|Follow-Up 6 Months After End of Tx||11
5084620|NCT01717456|12511007|P2|NOT COMPLETED|End of Treatment||2
5084621|NCT01717456|12511008|P1|NOT COMPLETED|End of Treatment||0
5084622|NCT01717456|12511007|P2|COMPLETED|End of Treatment||6
5084623|NCT01717456|12511008|P1|COMPLETED|End of Treatment||11
5084624|NCT01717456|12511007|P2|STARTED|End of Treatment||8
5084625|NCT01717456|12511008|P1|STARTED|End of Treatment||11
5084626|NCT01717391|12511076|P1|NOT COMPLETED|Overall Study||9
5084627|NCT01717391|12511076|P1|COMPLETED|Overall Study||27
5084628|NCT01717391|12511076|P1|STARTED|Overall Study||36
5084629|NCT01717326|12511105|P20|NOT COMPLETED|Overall Study||6
5084630|NCT01717326|12511106|P19|NOT COMPLETED|Overall Study||4
5084631|NCT01717326|12511107|P18|NOT COMPLETED|Overall Study||0
5084632|NCT01717326|12511108|P17|NOT COMPLETED|Overall Study||1
5084633|NCT01717326|12511109|P16|NOT COMPLETED|Overall Study||3
5084634|NCT01717326|12511110|P15|NOT COMPLETED|Overall Study||0
5084635|NCT01717326|12511111|P14|NOT COMPLETED|Overall Study||0
5084636|NCT01717326|12511112|P13|NOT COMPLETED|Overall Study||1
5084637|NCT01717326|12511113|P12|NOT COMPLETED|Overall Study||0
5084638|NCT01717326|12511114|P11|NOT COMPLETED|Overall Study||2
5084639|NCT01717326|12511115|P10|NOT COMPLETED|Overall Study||2
5084640|NCT01717326|12511116|P9|NOT COMPLETED|Overall Study||0
5084641|NCT01717326|12511117|P8|NOT COMPLETED|Overall Study||0
5084642|NCT01717326|12511118|P7|NOT COMPLETED|Overall Study||1
5084643|NCT01717326|12511119|P6|NOT COMPLETED|Overall Study||0
5084644|NCT01717326|12511120|P5|NOT COMPLETED|Overall Study||2
5084645|NCT01717326|12511121|P4|NOT COMPLETED|Overall Study||2
5084646|NCT01717326|12511122|P3|NOT COMPLETED|Overall Study||0
5084647|NCT01717326|12511123|P2|NOT COMPLETED|Overall Study||1
5084648|NCT01717326|12511124|P1|NOT COMPLETED|Overall Study||3
5084649|NCT01717326|12511105|P20|COMPLETED|Overall Study||15
5084650|NCT01717326|12511106|P19|COMPLETED|Overall Study||16
5084651|NCT01717326|12511107|P18|COMPLETED|Overall Study||31
5084652|NCT01717326|12511108|P17|COMPLETED|Overall Study||29
5084653|NCT01717326|12511109|P16|COMPLETED|Overall Study||27
5084654|NCT01717326|12511110|P15|COMPLETED|Overall Study||29
5084655|NCT01717326|12511111|P14|COMPLETED|Overall Study||32
5084656|NCT01717326|12511112|P13|COMPLETED|Overall Study||32
5084657|NCT01717326|12511113|P12|COMPLETED|Overall Study||33
5084658|NCT01717326|12511114|P11|COMPLETED|Overall Study||30
5084659|NCT01717326|12511115|P10|COMPLETED|Overall Study||29
5084660|NCT01717326|12511116|P9|COMPLETED|Overall Study||32
5084661|NCT01717326|12511117|P8|COMPLETED|Overall Study||29
5084662|NCT01717326|12511118|P7|COMPLETED|Overall Study||30
5084663|NCT01717326|12511119|P6|COMPLETED|Overall Study||31
5084664|NCT01717326|12511120|P5|COMPLETED|Overall Study||31
5084665|NCT01717326|12511121|P4|COMPLETED|Overall Study||28
5084666|NCT01717326|12511122|P3|COMPLETED|Overall Study||13
5084667|NCT01717326|12511123|P2|COMPLETED|Overall Study||26
5084668|NCT01717326|12511124|P1|COMPLETED|Overall Study||22
5084669|NCT01717326|12511105|P20|Treated|Overall Study||21
5084670|NCT01717326|12511106|P19|Treated|Overall Study||20
5084671|NCT01717326|12511107|P18|Treated|Overall Study||31
5084672|NCT01717326|12511108|P17|Treated|Overall Study||30
5084673|NCT01717326|12511109|P16|Treated|Overall Study||30
5084674|NCT01717326|12511110|P15|Treated|Overall Study||29
5084675|NCT01717326|12511111|P14|Treated|Overall Study||32
5084676|NCT01717326|12511112|P13|Treated|Overall Study||33
5084677|NCT01717326|12511113|P12|Treated|Overall Study||33
5084678|NCT01717326|12511114|P11|Treated|Overall Study||32
5084679|NCT01717326|12511115|P10|Treated|Overall Study||31
5084680|NCT01717326|12511116|P9|Treated|Overall Study||32
5084681|NCT01717326|12511117|P8|Treated|Overall Study||29
5084682|NCT01717326|12511118|P7|Treated|Overall Study||31
5084683|NCT01717326|12511119|P6|Treated|Overall Study||31
5084684|NCT01717326|12511120|P5|Treated|Overall Study||33
5084685|NCT01717326|12511121|P4|Treated|Overall Study||30
5084686|NCT01717326|12511122|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
5084687|NCT01717326|12511123|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
5084688|NCT01717326|12511124|P1|Treated|Overall Study||25
5084689|NCT01717326|12511105|P20|STARTED|Overall Study||21
5084690|NCT01717326|12511106|P19|STARTED|Overall Study||20
5084691|NCT01717326|12511107|P18|STARTED|Overall Study||31
5084692|NCT01717326|12511108|P17|STARTED|Overall Study||30
5084693|NCT01717326|12511109|P16|STARTED|Overall Study||30
5084694|NCT01717326|12511110|P15|STARTED|Overall Study||29
5084695|NCT01717326|12511111|P14|STARTED|Overall Study||32
5084696|NCT01717326|12511112|P13|STARTED|Overall Study||33
5084697|NCT01717326|12511113|P12|STARTED|Overall Study||33
5084698|NCT01717326|12511114|P11|STARTED|Overall Study||32
5084699|NCT01717326|12511115|P10|STARTED|Overall Study||31
5084700|NCT01717326|12511116|P9|STARTED|Overall Study||32
5084701|NCT01717326|12511117|P8|STARTED|Overall Study||29
5084702|NCT01717326|12511118|P7|STARTED|Overall Study||31
5084703|NCT01717326|12511119|P6|STARTED|Overall Study||31
5084704|NCT01717326|12511120|P5|STARTED|Overall Study||33
5084705|NCT01717326|12511121|P4|STARTED|Overall Study||30
5084706|NCT01717326|12511122|P3|STARTED|Overall Study||13
5084707|NCT01717326|12511123|P2|STARTED|Overall Study||27
5084708|NCT01717326|12511124|P1|STARTED|Overall Study||25
5084709|NCT01717313|12511388|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
5084710|NCT01717313|12511389|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
5084711|NCT01717313|12511388|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
5084712|NCT01717313|12511389|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
5084713|NCT01717313|12511388|P2|STARTED|Phase B (Weeks 24 to 54)||151
5084714|NCT01717313|12511389|P1|STARTED|Phase B (Weeks 24 to 54)||146
5084715|NCT01717313|12511388|P2|NOT COMPLETED|Interphase||0
5084716|NCT01717313|12511389|P1|NOT COMPLETED|Interphase||1
5084717|NCT01717313|12511388|P2|COMPLETED|Interphase||151
5084718|NCT01717313|12511389|P1|COMPLETED|Interphase||146
5084719|NCT01717313|12511388|P2|STARTED|Interphase||151
5084720|NCT01717313|12511389|P1|STARTED|Interphase||147
5084721|NCT01717313|12511388|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
5084722|NCT01717313|12511389|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
5084723|NCT01717313|12511388|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
5084724|NCT01717313|12511389|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
5084725|NCT01717313|12511388|P2|STARTED|Phase A (Weeks 0 to 24)||164
5084726|NCT01717313|12511389|P1|STARTED|Phase A (Weeks 0 to 24)||165
5084727|NCT01717287|12511427|P2|NOT COMPLETED|Overall Study||3
5084728|NCT01717287|12511428|P1|NOT COMPLETED|Overall Study||0
5084729|NCT01717287|12511427|P2|COMPLETED|Overall Study||25
5084730|NCT01717287|12511428|P1|COMPLETED|Overall Study||4
5084731|NCT01717287|12511427|P2|STARTED|Overall Study||28
5084732|NCT01717287|12511428|P1|STARTED|Overall Study||4
5084733|NCT01717209|12511450|P1|NOT COMPLETED|Overall Study||0
5084734|NCT01717209|12511450|P1|COMPLETED|Overall Study||14
5084735|NCT01717209|12511450|P1|STARTED|Overall Study||14
5084736|NCT01717053|12511459|P1|NOT COMPLETED|Overall Study||4
5084737|NCT01717053|12511459|P1|COMPLETED|Overall Study||33
5084738|NCT01717053|12511459|P1|STARTED|Overall Study||37
5084739|NCT01717040|12511468|P2|NOT COMPLETED|Overall Study||5
5084740|NCT01717040|12511469|P1|NOT COMPLETED|Overall Study||5
5084741|NCT01717040|12511468|P2|COMPLETED|Overall Study||15
5084742|NCT01717040|12511469|P1|COMPLETED|Overall Study||12
5084743|NCT01717040|12511468|P2|STARTED|Overall Study||20
5084744|NCT01717040|12511469|P1|STARTED|Overall Study||17
5084745|NCT01717014|12511475|P1|NOT COMPLETED|Overall Study||0
5084746|NCT01717014|12511475|P1|COMPLETED|Overall Study||8
5084747|NCT01717014|12511475|P1|STARTED|Overall Study||8
5084748|NCT01716754|12511487|P4|NOT COMPLETED|Overall Study||8
5084749|NCT01716754|12511488|P3|NOT COMPLETED|Overall Study||14
5084750|NCT01716754|12511489|P2|NOT COMPLETED|Overall Study||4
5084751|NCT01716754|12511490|P1|NOT COMPLETED|Overall Study||11
5084752|NCT01716754|12511487|P4|COMPLETED|Overall Study||89
5084753|NCT01716754|12511488|P3|COMPLETED|Overall Study||121
5084754|NCT01716754|12511489|P2|COMPLETED|Overall Study||36
5084755|NCT01716754|12511490|P1|COMPLETED|Overall Study||188
5084756|NCT01716754|12511487|P4|Safety Set|Overall Study||96
5084757|NCT01716754|12511488|P3|Safety Set|Overall Study||131
5084758|NCT01716754|12511489|P2|Safety Set|Overall Study||40
5084759|NCT01716754|12511490|P1|Safety Set|Overall Study||199
5084760|NCT01716754|12511487|P4|FAS|Overall Study||96
5084761|NCT01716754|12511488|P3|FAS|Overall Study||131
5084762|NCT01716754|12511489|P2|FAS|Overall Study||40
5084763|NCT01716754|12511490|P1|FAS|Overall Study||199
5084764|NCT01716754|12511487|P4|STARTED|Overall Study||97
5084765|NCT01716754|12511488|P3|STARTED|Overall Study||135
5084766|NCT01716754|12511489|P2|STARTED|Overall Study||40
5084767|NCT01716754|12511490|P1|STARTED|Overall Study||199
5084768|NCT01716715|12511513|P2|NOT COMPLETED|Overall Study||4
5084769|NCT01716715|12511514|P1|NOT COMPLETED|Overall Study||2
5084770|NCT01716715|12511513|P2|COMPLETED|Overall Study||50
5084771|NCT01716715|12511514|P1|COMPLETED|Overall Study||55
5084772|NCT01716715|12511513|P2|STARTED|Overall Study||54
5084773|NCT01716715|12511514|P1|STARTED|Overall Study||57
5084774|NCT01716663|12511530|P1|NOT COMPLETED|Overall Study||6
5084775|NCT01716663|12511530|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
5084776|NCT01716663|12511530|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
5084777|NCT01716663|12511530|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
5084778|NCT01716585|12511540|P2|NOT COMPLETED|Open-label Treatment||7
5084779|NCT01716585|12511541|P1|NOT COMPLETED|Open-label Treatment||0
5084780|NCT01716585|12511540|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
5084781|NCT01716585|12511541|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
5084782|NCT01716585|12511540|P2|STARTED|Open-label Treatment||157
5084783|NCT01716585|12511541|P1|STARTED|Open-label Treatment|not applicable to this arm|0
5084784|NCT01716585|12511540|P2|NOT COMPLETED|Double-blind Treatment||2
5084785|NCT01716585|12511541|P1|NOT COMPLETED|Double-blind Treatment||13
5084786|NCT01716585|12511540|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
5084787|NCT01716585|12511541|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
5084788|NCT01716585|12511540|P2|Randomized But Not Treated|Double-blind Treatment||1
5084789|NCT01716585|12511541|P1|Randomized But Not Treated|Double-blind Treatment||4
5084790|NCT01716585|12511540|P2|STARTED|Double-blind Treatment||159
5084791|NCT01716585|12511541|P1|STARTED|Double-blind Treatment||477
5084792|NCT01716559|12511553|P1|NOT COMPLETED|Overall Study||111
5084793|NCT01716559|12511553|P1|COMPLETED|Overall Study||49
5084794|NCT01716559|12511553|P1|STARTED|Overall Study||160
5084795|NCT01716533|12511565|P4|NOT COMPLETED|Overall Study||8
5084796|NCT01716533|12511566|P3|NOT COMPLETED|Overall Study||5
5084797|NCT01716533|12511567|P2|NOT COMPLETED|Overall Study||0
5084798|NCT01716533|12511568|P1|NOT COMPLETED|Overall Study||0
5084799|NCT01716533|12511565|P4|COMPLETED|Overall Study||1
5084800|NCT01716533|12511566|P3|COMPLETED|Overall Study||0
5084801|NCT01716533|12511567|P2|COMPLETED|Overall Study||25
5084802|NCT01716533|12511568|P1|COMPLETED|Overall Study||7
5084803|NCT01716533|12511565|P4|STARTED|Overall Study||9
5084804|NCT01716533|12511566|P3|STARTED|Overall Study||5
5084805|NCT01716533|12511567|P2|STARTED|Overall Study||25
5084806|NCT01716533|12511568|P1|STARTED|Overall Study||7
5084807|NCT01716520|12511622|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
5084808|NCT01716520|12511623|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5084809|NCT01716520|12511624|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5084810|NCT01716520|12511625|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5084811|NCT01716520|12511626|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5084812|NCT01716520|12511627|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5084813|NCT01716520|12511622|P6|COMPLETED|Treatment Period 3 (14 Days)||23
5084814|NCT01716520|12511623|P5|COMPLETED|Treatment Period 3 (14 Days)||29
5084815|NCT01716520|12511624|P4|COMPLETED|Treatment Period 3 (14 Days)||28
5084816|NCT01716520|12511625|P3|COMPLETED|Treatment Period 3 (14 Days)||25
5084817|NCT01716520|12511626|P2|COMPLETED|Treatment Period 3 (14 Days)||27
5084818|NCT01716520|12511627|P1|COMPLETED|Treatment Period 3 (14 Days)||27
5084819|NCT01716520|12511622|P6|STARTED|Treatment Period 3 (14 Days)||25
5084820|NCT01716520|12511623|P5|STARTED|Treatment Period 3 (14 Days)||29
5084821|NCT01716520|12511624|P4|STARTED|Treatment Period 3 (14 Days)||28
5084822|NCT01716520|12511625|P3|STARTED|Treatment Period 3 (14 Days)||26
5084823|NCT01716520|12511626|P2|STARTED|Treatment Period 3 (14 Days)||27
5084824|NCT01716520|12511627|P1|STARTED|Treatment Period 3 (14 Days)||27
5084825|NCT01716520|12511622|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
5084826|NCT01716520|12511623|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5084827|NCT01716520|12511624|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
5084828|NCT01716520|12511625|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
5084829|NCT01716520|12511626|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
5084830|NCT01716520|12511627|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
5084831|NCT01716520|12511622|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
5084832|NCT01716520|12511623|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
5084833|NCT01716520|12511624|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
5084834|NCT01716520|12511625|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
5084835|NCT01716520|12511626|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
5084836|NCT01716520|12511627|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
5084837|NCT01716520|12511622|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
5084838|NCT01716520|12511623|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
5084839|NCT01716520|12511624|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
5084840|NCT01716520|12511625|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
5084841|NCT01716520|12511626|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
5084842|NCT01716520|12511627|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
5084843|NCT01716520|12511622|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5084844|NCT01716520|12511623|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
5084845|NCT01716520|12511624|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5084846|NCT01716520|12511625|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5084847|NCT01716520|12511626|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5084848|NCT01716520|12511627|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5084849|NCT01716520|12511622|P6|COMPLETED|Treatment Period 2 (14 Days)||27
5084850|NCT01716520|12511623|P5|COMPLETED|Treatment Period 2 (14 Days)||29
5084851|NCT01716520|12511624|P4|COMPLETED|Treatment Period 2 (14 Days)||28
5084852|NCT01716520|12511625|P3|COMPLETED|Treatment Period 2 (14 Days)||27
5084853|NCT01716520|12511626|P2|COMPLETED|Treatment Period 2 (14 Days)||28
5084854|NCT01716520|12511627|P1|COMPLETED|Treatment Period 2 (14 Days)||29
5084855|NCT01716520|12511622|P6|STARTED|Treatment Period 2 (14 Days)||27
5084856|NCT01716520|12511623|P5|STARTED|Treatment Period 2 (14 Days)||31
5084857|NCT01716520|12511624|P4|STARTED|Treatment Period 2 (14 Days)||29
5084858|NCT01716520|12511625|P3|STARTED|Treatment Period 2 (14 Days)||27
5084859|NCT01716520|12511626|P2|STARTED|Treatment Period 2 (14 Days)||28
5084860|NCT01716520|12511627|P1|STARTED|Treatment Period 2 (14 Days)||29
5084861|NCT01716520|12511622|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
5084862|NCT01716520|12511623|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5084863|NCT01716520|12511624|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5084864|NCT01716520|12511625|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
5084865|NCT01716520|12511626|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
5084866|NCT01716520|12511627|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
5084867|NCT01716520|12511622|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
5084868|NCT01716520|12511623|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
5084869|NCT01716520|12511624|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
5084870|NCT01716520|12511625|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
5084871|NCT01716520|12511626|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
5084872|NCT01716520|12511627|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
5084873|NCT01716520|12511622|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
5084874|NCT01716520|12511623|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
5084875|NCT01716520|12511624|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
5084876|NCT01716520|12511625|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
5084877|NCT01716520|12511626|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
5084878|NCT01716520|12511627|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
5084879|NCT01716520|12511622|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5084880|NCT01716520|12511623|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5084881|NCT01716520|12511624|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5084882|NCT01716520|12511625|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5084883|NCT01716520|12511626|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5084884|NCT01716520|12511627|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5084885|NCT01716520|12511622|P6|COMPLETED|Treatment Period 1 (14 Days)||29
5084886|NCT01716520|12511623|P5|COMPLETED|Treatment Period 1 (14 Days)||31
5084887|NCT01716520|12511624|P4|COMPLETED|Treatment Period 1 (14 Days)||29
5084888|NCT01716520|12511625|P3|COMPLETED|Treatment Period 1 (14 Days)||28
5084889|NCT01716520|12511626|P2|COMPLETED|Treatment Period 1 (14 Days)||29
5084890|NCT01716520|12511627|P1|COMPLETED|Treatment Period 1 (14 Days)||29
5084891|NCT01716520|12511622|P6|STARTED|Treatment Period 1 (14 Days)||30
5084892|NCT01716520|12511623|P5|STARTED|Treatment Period 1 (14 Days)||31
5084893|NCT01716520|12511624|P4|STARTED|Treatment Period 1 (14 Days)||30
5084894|NCT01716520|12511625|P3|STARTED|Treatment Period 1 (14 Days)||30
5084895|NCT01716520|12511626|P2|STARTED|Treatment Period 1 (14 Days)||30
5084896|NCT01716520|12511627|P1|STARTED|Treatment Period 1 (14 Days)||31
5084897|NCT01716468|12511643|P1|NOT COMPLETED|Overall Study||6
5084898|NCT01716468|12511643|P1|COMPLETED|Overall Study||11
5084899|NCT01716468|12511643|P1|STARTED|Overall Study||17
5084900|NCT01716455|12511653|P6|NOT COMPLETED|Overall Study||0
5084901|NCT01716455|12511654|P5|NOT COMPLETED|Overall Study||0
5084902|NCT01716455|12511655|P4|NOT COMPLETED|Overall Study||0
5084903|NCT01716455|12511656|P3|NOT COMPLETED|Overall Study||0
5084904|NCT01716455|12511657|P2|NOT COMPLETED|Overall Study||0
5084905|NCT01716455|12511658|P1|NOT COMPLETED|Overall Study||0
5084906|NCT01716455|12511653|P6|COMPLETED|Overall Study||8
5084907|NCT01716455|12511654|P5|COMPLETED|Overall Study||26
5084908|NCT01716455|12511655|P4|COMPLETED|Overall Study||8
5084909|NCT01716455|12511656|P3|COMPLETED|Overall Study||8
5084910|NCT01716455|12511657|P2|COMPLETED|Overall Study||8
5084911|NCT01716455|12511658|P1|COMPLETED|Overall Study||8
5084912|NCT01716455|12511653|P6|STARTED|Overall Study||8
5084913|NCT01716455|12511654|P5|STARTED|Overall Study||26
5084914|NCT01716455|12511655|P4|STARTED|Overall Study||8
5084915|NCT01716455|12511656|P3|STARTED|Overall Study||8
5084916|NCT01716455|12511657|P2|STARTED|Overall Study||8
5084917|NCT01716455|12511658|P1|STARTED|Overall Study||8
5084918|NCT01716234|12511682|P7|NOT COMPLETED|Overall Study||0
5084919|NCT01716234|12511683|P6|NOT COMPLETED|Overall Study||14
5084920|NCT01716234|12511684|P5|NOT COMPLETED|Overall Study||5
5084921|NCT01716234|12511685|P4|NOT COMPLETED|Overall Study||12
5084922|NCT01716234|12511686|P3|NOT COMPLETED|Overall Study||5
5084923|NCT01716234|12511687|P2|NOT COMPLETED|Overall Study||10
5084924|NCT01716234|12511688|P1|NOT COMPLETED|Overall Study||10
5084925|NCT01716234|12511682|P7|COMPLETED|Overall Study||1
5084926|NCT01716234|12511683|P6|COMPLETED|Overall Study||18
5084927|NCT01716234|12511684|P5|COMPLETED|Overall Study||10
5084928|NCT01716234|12511685|P4|COMPLETED|Overall Study||16
5084929|NCT01716234|12511686|P3|COMPLETED|Overall Study||15
5084930|NCT01716234|12511687|P2|COMPLETED|Overall Study||12
5084931|NCT01716234|12511688|P1|COMPLETED|Overall Study||14
5084932|NCT01716234|12511682|P7|Treated|Overall Study||1
5084933|NCT01716234|12511683|P6|Treated|Overall Study||30
5084934|NCT01716234|12511684|P5|Treated|Overall Study||15
5084935|NCT01716234|12511685|P4|Treated|Overall Study||28
5084936|NCT01716234|12511686|P3|Treated|Overall Study||19
5084937|NCT01716234|12511687|P2|Treated|Overall Study||21
5084938|NCT01716234|12511688|P1|Treated|Overall Study||22
5084939|NCT01716234|12511682|P7|STARTED|Overall Study||1
5084940|NCT01716234|12511683|P6|STARTED|Overall Study||32
5084941|NCT01716234|12511684|P5|STARTED|Overall Study||15
5084942|NCT01716234|12511685|P4|STARTED|Overall Study||28
5084943|NCT01716234|12511686|P3|STARTED|Overall Study||20
5084944|NCT01716234|12511687|P2|STARTED|Overall Study||22
5084945|NCT01716234|12511688|P1|STARTED|Overall Study||24
5084946|NCT01716221|12511725|P1|NOT COMPLETED|Overall Study||0
5084947|NCT01716221|12511725|P1|COMPLETED|Overall Study||1
5084948|NCT01716221|12511725|P1|STARTED|Overall Study||1
5084949|NCT01716169|12511751|P1|NOT COMPLETED|Overall Study||4
5084950|NCT01716169|12511751|P1|COMPLETED|Overall Study||6
5084951|NCT01716169|12511751|P1|Standard of Care Dressings Used|Overall Study||7
5084952|NCT01716169|12511751|P1|STARTED|Overall Study||10
5084953|NCT01716156|12511760|P3|NOT COMPLETED|Overall Study||2
5084954|NCT01716156|12511761|P2|NOT COMPLETED|Overall Study||1
5084955|NCT01716156|12511762|P1|NOT COMPLETED|Overall Study||2
5084956|NCT01716156|12511760|P3|COMPLETED|Overall Study||11
5084957|NCT01716156|12511761|P2|COMPLETED|Overall Study||3
5084958|NCT01716156|12511762|P1|COMPLETED|Overall Study||7
5084959|NCT01716156|12511760|P3|STARTED|Overall Study||13
5084960|NCT01716156|12511761|P2|STARTED|Overall Study||4
5084961|NCT01716156|12511762|P1|STARTED|Overall Study||9
5084962|NCT01716117|12511788|P2|NOT COMPLETED|Overall Study||2
5084963|NCT01716117|12511789|P1|NOT COMPLETED|Overall Study||7
5084964|NCT01716117|12511788|P2|COMPLETED|Overall Study||31
5084965|NCT01716117|12511789|P1|COMPLETED|Overall Study||173
5084966|NCT01716117|12511788|P2|6-Month Visit|Overall Study||32
5084967|NCT01716117|12511789|P1|6-Month Visit|Overall Study||174
5084968|NCT01716117|12511788|P2|1-Month Visit|Overall Study||33
5084969|NCT01716117|12511789|P1|1-Month Visit|Overall Study||176
5084970|NCT01716117|12511788|P2|Discharge|Overall Study||33
5084971|NCT01716117|12511789|P1|Discharge|Overall Study||177
5084972|NCT01716117|12511788|P2|STARTED|Overall Study||33
5084973|NCT01716117|12511789|P1|STARTED|Overall Study||180
5084974|NCT01716104|12511808|P2|NOT COMPLETED|Overall Study||7
5084975|NCT01716104|12511809|P1|NOT COMPLETED|Overall Study||6
5084976|NCT01716104|12511808|P2|COMPLETED|Overall Study||117
5084977|NCT01716104|12511809|P1|COMPLETED|Overall Study||119
5084978|NCT01716104|12511808|P2|STARTED|Overall Study||124
5084979|NCT01716104|12511809|P1|STARTED|Overall Study||125
5084980|NCT01716052|12511835|P2|NOT COMPLETED|Overall Study||1
5084981|NCT01716052|12511836|P1|NOT COMPLETED|Overall Study||1
5084982|NCT01716052|12511835|P2|COMPLETED|Overall Study||0
5084983|NCT01716052|12511836|P1|COMPLETED|Overall Study||0
5084984|NCT01716052|12511835|P2|STARTED|Overall Study||1
5084985|NCT01716052|12511836|P1|STARTED|Overall Study||1
5084986|NCT01716013|12511844|P2|NOT COMPLETED|Overall Study||0
5084987|NCT01716013|12511845|P1|NOT COMPLETED|Overall Study||3
5084988|NCT01716013|12511844|P2|COMPLETED|Overall Study||54
5084989|NCT01716013|12511845|P1|COMPLETED|Overall Study||105
5084990|NCT01716013|12511844|P2|STARTED|Overall Study||54
5084991|NCT01716013|12511845|P1|STARTED|Overall Study||108
5084992|NCT01715948|12511857|P1|NOT COMPLETED|Overall Study||1
5084993|NCT01715948|12511857|P1|COMPLETED|Overall Study||8
5084994|NCT01715948|12511857|P1|STARTED|Overall Study||9
5084995|NCT01715896|12511878|P2|NOT COMPLETED|Overall Study||11
5084996|NCT01715896|12511879|P1|NOT COMPLETED|Overall Study||3
5084997|NCT01715896|12511878|P2|COMPLETED|Overall Study||59
5084998|NCT01715896|12511879|P1|COMPLETED|Overall Study||65
5084999|NCT01715896|12511878|P2|STARTED|Overall Study||70
5085000|NCT01715896|12511879|P1|STARTED|Overall Study||68
5085001|NCT01715883|12511942|P1|NOT COMPLETED|Overall Study||1
5085002|NCT01715883|12511942|P1|COMPLETED|Overall Study||2
5085003|NCT01715883|12511942|P1|STARTED|Overall Study||3
5085004|NCT01715857|12511952|P1|NOT COMPLETED|Overall Study||96
5085005|NCT01715857|12511952|P1|COMPLETED|Overall Study||4004
5085006|NCT01715857|12511952|P1|STARTED|Overall Study||4100
5085007|NCT01715831|12511962|P1|NOT COMPLETED|Overall Study||1
5085008|NCT01715831|12511962|P1|COMPLETED|Overall Study||25
5085009|NCT01715831|12511962|P1|STARTED|Overall Study||26
5085010|NCT01715805|12511978|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
5085011|NCT01715805|12511979|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
5085012|NCT01715805|12511980|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
5085013|NCT01715805|12511981|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
5085014|NCT01715805|12511978|P4|COMPLETED|Double-Blind or Continued Treatment||222
5085015|NCT01715805|12511979|P3|COMPLETED|Double-Blind or Continued Treatment||213
5085016|NCT01715805|12511980|P2|COMPLETED|Double-Blind or Continued Treatment||222
5085017|NCT01715805|12511981|P1|COMPLETED|Double-Blind or Continued Treatment||0
5085018|NCT01715805|12511978|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
5085019|NCT01715805|12511979|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
5085020|NCT01715805|12511980|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
5085021|NCT01715805|12511981|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
5085022|NCT01715805|12511978|P4|STARTED|Double-Blind or Continued Treatment||270
5085023|NCT01715805|12511979|P3|STARTED|Double-Blind or Continued Treatment||269
5085024|NCT01715805|12511980|P2|STARTED|Double-Blind or Continued Treatment||261
5085025|NCT01715805|12511981|P1|STARTED|Double-Blind or Continued Treatment||0
5085026|NCT01715805|12511978|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
5085027|NCT01715805|12511979|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
5085028|NCT01715805|12511980|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
5085029|NCT01715805|12511981|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
5085030|NCT01715805|12511978|P4|COMPLETED|Placebo + ADT Lead-in Period||0
5085031|NCT01715805|12511979|P3|COMPLETED|Placebo + ADT Lead-in Period||0
5085032|NCT01715805|12511980|P2|COMPLETED|Placebo + ADT Lead-in Period||0
5085033|NCT01715805|12511981|P1|COMPLETED|Placebo + ADT Lead-in Period||807
5085034|NCT01715805|12511978|P4|STARTED|Placebo + ADT Lead-in Period||0
5085035|NCT01715805|12511979|P3|STARTED|Placebo + ADT Lead-in Period||0
5085036|NCT01715805|12511980|P2|STARTED|Placebo + ADT Lead-in Period||0
5085037|NCT01715805|12511981|P1|STARTED|Placebo + ADT Lead-in Period||1022
5085038|NCT01715415|12511995|P2|NOT COMPLETED|Open-label Treatment||2
5085039|NCT01715415|12511996|P1|NOT COMPLETED|Open-label Treatment||0
5085040|NCT01715415|12511995|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
5085041|NCT01715415|12511996|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
5085042|NCT01715415|12511995|P2|STARTED|Open-label Treatment||96
5085043|NCT01715415|12511996|P1|STARTED|Open-label Treatment|not applicable to this arm|0
5085044|NCT01715415|12511995|P2|NOT COMPLETED|Double-blind Treatment||2
5085045|NCT01715415|12511996|P1|NOT COMPLETED|Double-blind Treatment||5
5085046|NCT01715415|12511995|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
5085047|NCT01715415|12511996|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
5085048|NCT01715415|12511995|P2|Randomized But Not Treated|Double-blind Treatment||1
5085049|NCT01715415|12511996|P1|Randomized But Not Treated|Double-blind Treatment||0
5085050|NCT01715415|12511995|P2|STARTED|Double-blind Treatment||98
5085051|NCT01715415|12511996|P1|STARTED|Double-blind Treatment||297
5085052|NCT01715298|12512010|P2|NOT COMPLETED|Overall Study||11
5085053|NCT01715298|12512011|P1|NOT COMPLETED|Overall Study||7
5085054|NCT01715298|12512010|P2|COMPLETED|Overall Study||205
5085055|NCT01715298|12512011|P1|COMPLETED|Overall Study||209
5085056|NCT01715298|12512010|P2|Full Analysis Set (FAS)|Overall Study||214
5085057|NCT01715298|12512011|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
5085058|NCT01715298|12512010|P2|STARTED|Overall Study||216
5085059|NCT01715298|12512011|P1|STARTED|Overall Study||216
5085060|NCT01715285|12512049|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
5085061|NCT01715285|12512050|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
5085062|NCT01715285|12512051|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
5085063|NCT01715285|12512049|P3|COMPLETED|Open-label (OL) Extension Phase||0
5085064|NCT01715285|12512050|P2|COMPLETED|Open-label (OL) Extension Phase||0
5085065|NCT01715285|12512051|P1|COMPLETED|Open-label (OL) Extension Phase||0
5085066|NCT01715285|12512049|P3|STARTED|Open-label (OL) Extension Phase||72
5085067|NCT01715285|12512050|P2|STARTED|Open-label (OL) Extension Phase||0
5085068|NCT01715285|12512051|P1|STARTED|Open-label (OL) Extension Phase||157
5085069|NCT01715285|12512049|P3|NOT COMPLETED|Treatment Period||0
5085070|NCT01715285|12512050|P2|NOT COMPLETED|Treatment Period||602
5085071|NCT01715285|12512051|P1|NOT COMPLETED|Treatment Period||597
5085072|NCT01715285|12512049|P3|COMPLETED|Treatment Period||0
5085073|NCT01715285|12512050|P2|COMPLETED|Treatment Period||0
5085074|NCT01715285|12512051|P1|COMPLETED|Treatment Period||0
5085075|NCT01715285|12512049|P3|Safety Population|Treatment Period||0
5085076|NCT01715285|12512050|P2|Safety Population|Treatment Period||602
5085077|NCT01715285|12512051|P1|Safety Population|Treatment Period||597
5085078|NCT01715285|12512049|P3|ITT Population|Treatment Period||0
5085079|NCT01715285|12512050|P2|ITT Population|Treatment Period||602
5085080|NCT01715285|12512051|P1|ITT Population|Treatment Period||597
5085081|NCT01715285|12512049|P3|STARTED|Treatment Period||0
5085082|NCT01715285|12512050|P2|STARTED|Treatment Period||602
5085083|NCT01715285|12512051|P1|STARTED|Treatment Period||597
5085084|NCT01715233|12512070|P1|NOT COMPLETED|Overall Study||0
5085085|NCT01715233|12512070|P1|COMPLETED|Overall Study||21
5085086|NCT01715233|12512070|P1|STARTED|Overall Study||21
5085087|NCT01715207|12512078|P2|NOT COMPLETED|Overall Study||1
5085088|NCT01715207|12512079|P1|NOT COMPLETED|Overall Study||1
5085089|NCT01715207|12512078|P2|COMPLETED|Overall Study||14
5085090|NCT01715207|12512079|P1|COMPLETED|Overall Study||14
5085091|NCT01715207|12512078|P2|STARTED|Overall Study||15
5085092|NCT01715207|12512079|P1|STARTED|Overall Study||15
5085093|NCT01715129|12512087|P1|NOT COMPLETED|Overall Study||9
5085094|NCT01715129|12512087|P1|COMPLETED|Overall Study||117
5085095|NCT01715129|12512087|P1|STARTED|Overall Study||126
5085096|NCT01715064|12512106|P2|NOT COMPLETED|Overall Study||0
5085097|NCT01715064|12512107|P1|NOT COMPLETED|Overall Study||0
5085098|NCT01715064|12512106|P2|COMPLETED|Overall Study||18
5085099|NCT01715064|12512107|P1|COMPLETED|Overall Study||18
5085100|NCT01715064|12512106|P2|STARTED|Overall Study||18
5085101|NCT01715064|12512107|P1|STARTED|Overall Study||18
5085102|NCT01714947|12512113|P1|NOT COMPLETED|Part B||3
5085103|NCT01714947|12512113|P1|COMPLETED|Part B||0
5085104|NCT01714947|12512113|P1|STARTED|Part B||3
5085105|NCT01714947|12512113|P1|NOT COMPLETED|Part A||0
5085106|NCT01714947|12512113|P1|COMPLETED|Part A||3
5085107|NCT01714947|12512113|P1|STARTED|Part A||3
5085108|NCT01714921|12512142|P1|NOT COMPLETED|Overall Study||193
5085109|NCT01714921|12512142|P1|COMPLETED|Overall Study||311
5085110|NCT01714921|12512142|P1|STARTED|Overall Study||504
5085111|NCT01714817|12512154|P2|NOT COMPLETED|Overall Study||42
5085112|NCT01714817|12512155|P1|NOT COMPLETED|Overall Study||48
5085113|NCT01714817|12512154|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
5085114|NCT01714817|12512155|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
5085115|NCT01714817|12512154|P2|Treated|Overall Study||203
5085116|NCT01714817|12512155|P1|Treated|Overall Study||202
5085117|NCT01714817|12512154|P2|STARTED|Overall Study||203
5085118|NCT01714817|12512155|P1|STARTED|Overall Study||203
5085119|NCT01714804|12512176|P2|NOT COMPLETED|Overall Study||0
5085120|NCT01714804|12512177|P1|NOT COMPLETED|Overall Study||1
5085121|NCT01714804|12512176|P2|COMPLETED|Overall Study||30
5085122|NCT01714804|12512177|P1|COMPLETED|Overall Study||29
5085123|NCT01714804|12512176|P2|STARTED|Overall Study||30
5085124|NCT01714804|12512177|P1|STARTED|Overall Study||30
5085125|NCT01714726|12512187|P4|NOT COMPLETED|Open-Label Period||28
5085126|NCT01714726|12512188|P3|NOT COMPLETED|Open-Label Period||19
5085127|NCT01714726|12512189|P2|NOT COMPLETED|Open-Label Period||0
5085128|NCT01714726|12512190|P1|NOT COMPLETED|Open-Label Period||0
5085129|NCT01714726|12512187|P4|COMPLETED|Open-Label Period||24
5085130|NCT01714726|12512188|P3|COMPLETED|Open-Label Period||33
5085131|NCT01714726|12512189|P2|COMPLETED|Open-Label Period||0
5085132|NCT01714726|12512190|P1|COMPLETED|Open-Label Period||0
5085133|NCT01714726|12512187|P4|STARTED|Open-Label Period||52
5085134|NCT01714726|12512188|P3|STARTED|Open-Label Period||52
5085135|NCT01714726|12512189|P2|STARTED|Open-Label Period||0
5085136|NCT01714726|12512190|P1|STARTED|Open-Label Period||0
5085137|NCT01714726|12512187|P4|NOT COMPLETED|Double-Blinded Induction Period||0
5085138|NCT01714726|12512188|P3|NOT COMPLETED|Double-Blinded Induction Period||0
5085139|NCT01714726|12512189|P2|NOT COMPLETED|Double-Blinded Induction Period||7
5085140|NCT01714726|12512190|P1|NOT COMPLETED|Double-Blinded Induction Period||8
5085141|NCT01714726|12512187|P4|COMPLETED|Double-Blinded Induction Period||0
5085142|NCT01714726|12512188|P3|COMPLETED|Double-Blinded Induction Period||0
5085143|NCT01714726|12512189|P2|COMPLETED|Double-Blinded Induction Period||52
5085144|NCT01714726|12512190|P1|COMPLETED|Double-Blinded Induction Period||52
5085145|NCT01714726|12512187|P4|STARTED|Double-Blinded Induction Period||0
5085146|NCT01714726|12512188|P3|STARTED|Double-Blinded Induction Period||0
5085147|NCT01714726|12512189|P2|STARTED|Double-Blinded Induction Period||59
5085148|NCT01714726|12512190|P1|STARTED|Double-Blinded Induction Period||60
5085149|NCT01714687|12512270|P2|NOT COMPLETED|Overall Study||4
5085150|NCT01714687|12512271|P1|NOT COMPLETED|Overall Study||3
5085151|NCT01714687|12512270|P2|COMPLETED|Overall Study||26
5085152|NCT01714687|12512271|P1|COMPLETED|Overall Study||26
5085153|NCT01714687|12512270|P2|STARTED|Overall Study||30
5085154|NCT01714687|12512271|P1|STARTED|Overall Study||29
5085155|NCT01714635|12512295|P3|NOT COMPLETED|Overall Study||2
5085156|NCT01714635|12512296|P2|NOT COMPLETED|Overall Study||0
5085157|NCT01714635|12512297|P1|NOT COMPLETED|Overall Study||2
5085158|NCT01714635|12512295|P3|COMPLETED|Overall Study||146
5085159|NCT01714635|12512296|P2|COMPLETED|Overall Study||150
5085160|NCT01714635|12512297|P1|COMPLETED|Overall Study||145
5085161|NCT01714635|12512295|P3|STARTED|Overall Study||148
5085162|NCT01714635|12512296|P2|STARTED|Overall Study||150
5085163|NCT01714635|12512297|P1|STARTED|Overall Study||147
5085164|NCT01714609|12512313|P2|NOT COMPLETED|Overall Study||0
5085165|NCT01714609|12512314|P1|NOT COMPLETED|Overall Study||1
5085166|NCT01714609|12512313|P2|COMPLETED|Overall Study||5
5085167|NCT01714609|12512314|P1|COMPLETED|Overall Study||4
5085168|NCT01714609|12512313|P2|STARTED|Overall Study||5
5085169|NCT01714609|12512314|P1|STARTED|Overall Study||5
5085170|NCT01714544|12512320|P1|NOT COMPLETED|Overall Study||3
5085171|NCT01714544|12512320|P1|COMPLETED|Overall Study||57
5085172|NCT01714544|12512320|P1|STARTED|Overall Study||60
5085173|NCT01714505|12512324|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
5085174|NCT01714505|12512325|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
5085175|NCT01714505|12512324|P2|COMPLETED|Admission 2 (40 Hours)||9
5085176|NCT01714505|12512325|P1|COMPLETED|Admission 2 (40 Hours)||9
5085177|NCT01714505|12512324|P2|STARTED|Admission 2 (40 Hours)||9
5085178|NCT01714505|12512325|P1|STARTED|Admission 2 (40 Hours)||9
5085179|NCT01714505|12512324|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
5085180|NCT01714505|12512325|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
5085181|NCT01714505|12512324|P2|COMPLETED|Admission 1 (40 Hours)||9
5085182|NCT01714505|12512325|P1|COMPLETED|Admission 1 (40 Hours)||9
5085183|NCT01714505|12512324|P2|STARTED|Admission 1 (40 Hours)||10
5085184|NCT01714505|12512325|P1|STARTED|Admission 1 (40 Hours)||10
5085185|NCT01714492|12512335|P1|NOT COMPLETED|Overall Study||0
5085186|NCT01714492|12512335|P1|COMPLETED|Overall Study||8
5085187|NCT01714492|12512335|P1|STARTED|Overall Study||8
5085188|NCT01714336|12512346|P2|NOT COMPLETED|Overall Study||0
5085189|NCT01714336|12512347|P1|NOT COMPLETED|Overall Study||0
5085190|NCT01714336|12512346|P2|COMPLETED|Overall Study||69
5085191|NCT01714336|12512347|P1|COMPLETED|Overall Study||69
5085192|NCT01714336|12512346|P2|STARTED|Overall Study||69
5085193|NCT01714336|12512347|P1|STARTED|Overall Study||69
5085194|NCT01714323|12512369|P2|NOT COMPLETED|Overall Study||172
5085195|NCT01714323|12512370|P1|NOT COMPLETED|Overall Study||164
5085196|NCT01714323|12512369|P2|COMPLETED|Overall Study||508
5085197|NCT01714323|12512370|P1|COMPLETED|Overall Study||513
5085198|NCT01714323|12512369|P2|STARTED|Overall Study||680
5085199|NCT01714323|12512370|P1|STARTED|Overall Study||677
5085200|NCT01714310|12512391|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
5085201|NCT01714310|12512392|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
5085202|NCT01714310|12512393|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
5085203|NCT01714310|12512391|P3|COMPLETED|Double Blind Adjunctive Treatment||0
5085204|NCT01714310|12512392|P2|COMPLETED|Double Blind Adjunctive Treatment||11
5085205|NCT01714310|12512393|P1|COMPLETED|Double Blind Adjunctive Treatment||10
5085206|NCT01714310|12512391|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
5085207|NCT01714310|12512392|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
5085208|NCT01714310|12512393|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
5085209|NCT01714310|12512391|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
5085210|NCT01714310|12512392|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
5085211|NCT01714310|12512393|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
5085212|NCT01714310|12512391|P3|COMPLETED|Open Lisdexamfetamine Titration||30
5085213|NCT01714310|12512392|P2|COMPLETED|Open Lisdexamfetamine Titration||0
5085214|NCT01714310|12512393|P1|COMPLETED|Open Lisdexamfetamine Titration||0
5085215|NCT01714310|12512391|P3|STARTED|Open Lisdexamfetamine Titration||34
5085216|NCT01714310|12512392|P2|STARTED|Open Lisdexamfetamine Titration||0
5085217|NCT01714310|12512393|P1|STARTED|Open Lisdexamfetamine Titration||0
5085218|NCT01714232|12512440|P1|NOT COMPLETED|Overall Study||0
5085219|NCT01714232|12512440|P1|COMPLETED|Overall Study||106
5085220|NCT01714232|12512440|P1|STARTED|Overall Study||106
5085221|NCT01714063|12512446|P1|NOT COMPLETED|Overall Study||2
5085222|NCT01714063|12512446|P1|COMPLETED|Overall Study||32
5085223|NCT01714063|12512446|P1|STARTED|Overall Study||34
5085224|NCT01714024|12512461|P3|NOT COMPLETED|Overall Study||3
5085225|NCT01714024|12512462|P2|NOT COMPLETED|Overall Study||6
5085226|NCT01714024|12512463|P1|NOT COMPLETED|Overall Study||1
5085227|NCT01714024|12512461|P3|COMPLETED|Overall Study||8
5085228|NCT01714024|12512462|P2|COMPLETED|Overall Study||12
5085229|NCT01714024|12512463|P1|COMPLETED|Overall Study||12
5085230|NCT01714024|12512461|P3|STARTED|Overall Study||11
5085231|NCT01714024|12512462|P2|STARTED|Overall Study||18
5085232|NCT01714024|12512463|P1|STARTED|Overall Study||13
5085233|NCT01713998|12512483|P3|NOT COMPLETED|Overall Study||2
5085234|NCT01713998|12512484|P2|NOT COMPLETED|Overall Study||0
5085235|NCT01713998|12512485|P1|NOT COMPLETED|Overall Study||3
5085236|NCT01713998|12512483|P3|COMPLETED|Overall Study||14
5085237|NCT01713998|12512484|P2|COMPLETED|Overall Study||15
5085238|NCT01713998|12512485|P1|COMPLETED|Overall Study||13
5085239|NCT01713998|12512483|P3|STARTED|Overall Study||16
5085240|NCT01713998|12512484|P2|STARTED|Overall Study||15
5085241|NCT01713998|12512485|P1|STARTED|Overall Study||16
5085242|NCT01713946|12512506|P3|NOT COMPLETED|Overall Study||44
5085243|NCT01713946|12512507|P2|NOT COMPLETED|Overall Study||45
5085244|NCT01713946|12512508|P1|NOT COMPLETED|Overall Study||43
5085245|NCT01713946|12512506|P3|COMPLETED|Overall Study||75
5085246|NCT01713946|12512507|P2|COMPLETED|Overall Study||85
5085247|NCT01713946|12512508|P1|COMPLETED|Overall Study||74
5085248|NCT01713946|12512506|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
5085249|NCT01713946|12512507|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
5085250|NCT01713946|12512508|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
5085251|NCT01713946|12512506|P3|Did Not Continue in Ext Phase|Overall Study||0
5085252|NCT01713946|12512507|P2|Did Not Continue in Ext Phase|Overall Study||3
5085253|NCT01713946|12512508|P1|Did Not Continue in Ext Phase|Overall Study||0
5085254|NCT01713946|12512506|P3|Completed Post-Ext Phase|Overall Study||75
5085255|NCT01713946|12512507|P2|Completed Post-Ext Phase|Overall Study||85
5085256|NCT01713946|12512508|P1|Completed Post-Ext Phase|Overall Study||74
5085257|NCT01713946|12512506|P3|Continued in Post-Ext. Phase|Overall Study||81
5085258|NCT01713946|12512507|P2|Continued in Post-Ext. Phase|Overall Study||90
5085259|NCT01713946|12512508|P1|Continued in Post-Ext. Phase|Overall Study||78
5085260|NCT01713946|12512506|P3|Completed Ext. Phase|Overall Study||81
5085261|NCT01713946|12512507|P2|Completed Ext. Phase|Overall Study||92
5085262|NCT01713946|12512508|P1|Completed Ext. Phase|Overall Study||79
5085263|NCT01713946|12512506|P3|Continued in Ext. Phase|Overall Study||114
5085264|NCT01713946|12512507|P2|Continued in Ext. Phase|Overall Study||119
5085265|NCT01713946|12512508|P1|Continued in Ext. Phase|Overall Study||110
5085266|NCT01713946|12512506|P3|Completed Core Phase|Overall Study||114
5085267|NCT01713946|12512507|P2|Completed Core Phase|Overall Study||122
5085268|NCT01713946|12512508|P1|Completed Core Phase|Overall Study||110
5085269|NCT01713946|12512506|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
5085270|NCT01713946|12512507|P2|STARTED|Overall Study||130
5085271|NCT01713946|12512508|P1|STARTED|Overall Study||117
5085272|NCT01713933|12512599|P1|NOT COMPLETED|Overall Study||6
5085273|NCT01713933|12512599|P1|COMPLETED|Overall Study||31
5085274|NCT01713933|12512599|P1|STARTED|Overall Study||37
5085275|NCT01713868|12512615|P4|NOT COMPLETED|Overall Study||95
5085276|NCT01713868|12512616|P3|NOT COMPLETED|Overall Study||80
5085277|NCT01713868|12512617|P2|NOT COMPLETED|Overall Study||65
5085278|NCT01713868|12512618|P1|NOT COMPLETED|Overall Study||97
5085279|NCT01713868|12512615|P4|COMPLETED|Overall Study||305
5085280|NCT01713868|12512616|P3|COMPLETED|Overall Study||320
5085281|NCT01713868|12512617|P2|COMPLETED|Overall Study||335
5085282|NCT01713868|12512618|P1|COMPLETED|Overall Study||303
5085283|NCT01713868|12512615|P4|STARTED|Overall Study||400
5085284|NCT01713868|12512616|P3|STARTED|Overall Study||400
5085285|NCT01713868|12512617|P2|STARTED|Overall Study||400
5085286|NCT01713868|12512618|P1|STARTED|Overall Study||400
5085287|NCT01713686|12512648|P1|NOT COMPLETED|Overall Study||15
5085288|NCT01713686|12512648|P1|COMPLETED|Overall Study||110
5085289|NCT01713686|12512648|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
5085290|NCT01713660|12512657|P1|NOT COMPLETED|Overall Study||0
5085291|NCT01713660|12512657|P1|COMPLETED|Overall Study||37
5085292|NCT01713660|12512657|P1|STARTED|Overall Study||37
5085293|NCT01713621|12512665|P2|NOT COMPLETED|Overall Study||16
5085294|NCT01713621|12512666|P1|NOT COMPLETED|Overall Study||7
5085295|NCT01713621|12512665|P2|COMPLETED|Overall Study||1
5085296|NCT01713621|12512666|P1|COMPLETED|Overall Study||1
5085297|NCT01713621|12512665|P2|STARTED|Overall Study||17
5085298|NCT01713621|12512666|P1|STARTED|Overall Study||8
5085299|NCT01713608|12512676|P4|NOT COMPLETED|Overall Study||0
5085300|NCT01713608|12512677|P3|NOT COMPLETED|Overall Study||0
5085301|NCT01713608|12512678|P2|NOT COMPLETED|Overall Study||0
5085302|NCT01713608|12512679|P1|NOT COMPLETED|Overall Study||0
5085303|NCT01713608|12512676|P4|COMPLETED|Overall Study||12
5085304|NCT01713608|12512677|P3|COMPLETED|Overall Study||8
5085305|NCT01713608|12512678|P2|COMPLETED|Overall Study||6
5085306|NCT01713608|12512679|P1|COMPLETED|Overall Study||8
5085307|NCT01713608|12512676|P4|STARTED|Overall Study||12
5085308|NCT01713608|12512677|P3|STARTED|Overall Study||8
5085309|NCT01713608|12512678|P2|STARTED|Overall Study||6
5085310|NCT01713608|12512679|P1|STARTED|Overall Study||8
5085311|NCT01713582|12512718|P21|NOT COMPLETED|Overall Study||15
5085312|NCT01713582|12512719|P20|NOT COMPLETED|Overall Study||5
5085313|NCT01713582|12512720|P19|NOT COMPLETED|Overall Study||5
5085314|NCT01713582|12512721|P18|NOT COMPLETED|Overall Study||3
5085315|NCT01713582|12512722|P17|NOT COMPLETED|Overall Study||7
5085316|NCT01713582|12512723|P16|NOT COMPLETED|Overall Study||6
5085317|NCT01713582|12512724|P15|NOT COMPLETED|Overall Study||7
5085318|NCT01713582|12512725|P14|NOT COMPLETED|Overall Study||4
5085319|NCT01713582|12512726|P13|NOT COMPLETED|Overall Study||3
5085320|NCT01713582|12512727|P12|NOT COMPLETED|Overall Study||5
5085321|NCT01713582|12512728|P11|NOT COMPLETED|Overall Study||16
5085322|NCT01713582|12512729|P10|NOT COMPLETED|Overall Study||18
5085323|NCT01713582|12512730|P9|NOT COMPLETED|Overall Study||6
5085324|NCT01713582|12512731|P8|NOT COMPLETED|Overall Study||6
5085325|NCT01713582|12512732|P7|NOT COMPLETED|Overall Study||7
5085326|NCT01713582|12512733|P6|NOT COMPLETED|Overall Study||8
5085327|NCT01713582|12512734|P5|NOT COMPLETED|Overall Study||4
5085328|NCT01713582|12512735|P4|NOT COMPLETED|Overall Study||3
5085329|NCT01713582|12512736|P3|NOT COMPLETED|Overall Study||4
5085330|NCT01713582|12512737|P2|NOT COMPLETED|Overall Study||3
5085331|NCT01713582|12512738|P1|NOT COMPLETED|Overall Study||3
5085332|NCT01713582|12512718|P21|COMPLETED|Overall Study||0
5085333|NCT01713582|12512719|P20|COMPLETED|Overall Study||0
5085334|NCT01713582|12512720|P19|COMPLETED|Overall Study||0
5085335|NCT01713582|12512721|P18|COMPLETED|Overall Study||0
5085336|NCT01713582|12512722|P17|COMPLETED|Overall Study||0
5085337|NCT01713582|12512723|P16|COMPLETED|Overall Study||0
5085338|NCT01713582|12512724|P15|COMPLETED|Overall Study||0
5085339|NCT01713582|12512725|P14|COMPLETED|Overall Study||0
5085340|NCT01713582|12512726|P13|COMPLETED|Overall Study||0
5085341|NCT01713582|12512727|P12|COMPLETED|Overall Study||0
5085342|NCT01713582|12512728|P11|COMPLETED|Overall Study||0
5085343|NCT01713582|12512729|P10|COMPLETED|Overall Study||0
5085344|NCT01713582|12512730|P9|COMPLETED|Overall Study||0
5085345|NCT01713582|12512731|P8|COMPLETED|Overall Study||0
5085346|NCT01713582|12512732|P7|COMPLETED|Overall Study||0
5085347|NCT01713582|12512733|P6|COMPLETED|Overall Study||0
5085348|NCT01713582|12512734|P5|COMPLETED|Overall Study||0
5085349|NCT01713582|12512735|P4|COMPLETED|Overall Study||0
5085350|NCT01713582|12512736|P3|COMPLETED|Overall Study||0
5085351|NCT01713582|12512737|P2|COMPLETED|Overall Study||0
5085352|NCT01713582|12512738|P1|COMPLETED|Overall Study||0
5085353|NCT01713582|12512718|P21|STARTED|Overall Study|Number treated|15
5085354|NCT01713582|12512719|P20|STARTED|Overall Study|Number treated|5
5085355|NCT01713582|12512720|P19|STARTED|Overall Study|Number treated|5
5085356|NCT01713582|12512721|P18|STARTED|Overall Study|Number treated|3
5085357|NCT01713582|12512722|P17|STARTED|Overall Study|Number treated|7
5085358|NCT01713582|12512723|P16|STARTED|Overall Study|Number treated|6
5085359|NCT01713582|12512724|P15|STARTED|Overall Study|Number treated|7
5085360|NCT01713582|12512725|P14|STARTED|Overall Study|Number treated|4
5085361|NCT01713582|12512726|P13|STARTED|Overall Study|Number treated|3
5085362|NCT01713582|12512727|P12|STARTED|Overall Study|Number treated|5
5085363|NCT01713582|12512728|P11|STARTED|Overall Study|Number treated|16
5085364|NCT01713582|12512729|P10|STARTED|Overall Study|Number treated|18
5085365|NCT01713582|12512730|P9|STARTED|Overall Study|Number treated|6
5085366|NCT01713582|12512731|P8|STARTED|Overall Study|Number treated|6
5085367|NCT01713582|12512732|P7|STARTED|Overall Study|Number treated|7
5085368|NCT01713582|12512733|P6|STARTED|Overall Study|Number treated|8
5085369|NCT01713582|12512734|P5|STARTED|Overall Study|Number treated|4
5085370|NCT01713582|12512735|P4|STARTED|Overall Study|Number treated|3
5085371|NCT01713582|12512736|P3|STARTED|Overall Study|Number treated|4
5085372|NCT01713582|12512737|P2|STARTED|Overall Study|Number treated|3
5085373|NCT01713582|12512738|P1|STARTED|Overall Study|Number treated|3
5085374|NCT01713530|12512901|P2|NOT COMPLETED|Overall Study||19
5085375|NCT01713530|12512902|P1|NOT COMPLETED|Overall Study||25
5085376|NCT01713530|12512901|P2|COMPLETED|Overall Study||117
5085377|NCT01713530|12512902|P1|COMPLETED|Overall Study||113
5085378|NCT01713530|12512901|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
5085379|NCT01713530|12512902|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
5085380|NCT01713530|12512901|P2|STARTED|Overall Study||136
5085381|NCT01713530|12512902|P1|STARTED|Overall Study||138
5085382|NCT01713400|12512920|P2|NOT COMPLETED|Overall Study||0
5085383|NCT01713400|12512921|P1|NOT COMPLETED|Overall Study||0
5085384|NCT01713400|12512920|P2|COMPLETED|Overall Study||15
5085385|NCT01713400|12512921|P1|COMPLETED|Overall Study||15
5085386|NCT01713400|12512920|P2|STARTED|Overall Study||15
5085387|NCT01713400|12512921|P1|STARTED|Overall Study||15
5085388|NCT01713348|12512933|P4|NOT COMPLETED|Overall Study||0
5085389|NCT01713348|12512934|P3|NOT COMPLETED|Overall Study||2
5085390|NCT01713348|12512935|P2|NOT COMPLETED|Overall Study||2
5085391|NCT01713348|12512936|P1|NOT COMPLETED|Overall Study||4
5085392|NCT01713348|12512933|P4|COMPLETED|Overall Study||15
5085393|NCT01713348|12512934|P3|COMPLETED|Overall Study||28
5085394|NCT01713348|12512935|P2|COMPLETED|Overall Study||11
5085395|NCT01713348|12512936|P1|COMPLETED|Overall Study||25
5085396|NCT01713348|12512933|P4|STARTED|Overall Study||15
5085397|NCT01713348|12512934|P3|STARTED|Overall Study||30
5085398|NCT01713348|12512935|P2|STARTED|Overall Study||13
5085399|NCT01713348|12512936|P1|STARTED|Overall Study||29
5085400|NCT01713283|12512966|P2|NOT COMPLETED|Overall Study||3
5085401|NCT01713283|12512967|P1|NOT COMPLETED|Overall Study||11
5085402|NCT01713283|12512966|P2|COMPLETED|Overall Study||26
5085403|NCT01713283|12512967|P1|COMPLETED|Overall Study||20
5085404|NCT01713283|12512966|P2|STARTED|Overall Study||29
5085405|NCT01713283|12512967|P1|STARTED|Overall Study||31
5085406|NCT01713036|12512989|P1|NOT COMPLETED|Overall Study||1
5085407|NCT01713036|12512989|P1|COMPLETED|Overall Study||5
5085408|NCT01713036|12512989|P1|STARTED|Overall Study||6
5085409|NCT01712984|12513029|P3|NOT COMPLETED|Overall Study||10
5085410|NCT01712984|12513030|P2|NOT COMPLETED|Overall Study||16
5085411|NCT01712984|12513031|P1|NOT COMPLETED|Overall Study||16
5085412|NCT01712984|12513029|P3|COMPLETED|Overall Study||836
5085413|NCT01712984|12513030|P2|COMPLETED|Overall Study||821
5085414|NCT01712984|12513031|P1|COMPLETED|Overall Study||1656
5085415|NCT01712984|12513029|P3|STARTED|Overall Study||846
5085416|NCT01712984|12513030|P2|STARTED|Overall Study||837
5085417|NCT01712984|12513031|P1|STARTED|Overall Study||1672
5085418|NCT01712854|12513051|P1|NOT COMPLETED|Overall Study||1
5085419|NCT01712854|12513051|P1|COMPLETED|Overall Study||8
5085420|NCT01712854|12513051|P1|STARTED|Overall Study||9
5085421|NCT01712776|12513058|P2|NOT COMPLETED|Overall Study||0
5085422|NCT01712776|12513059|P1|NOT COMPLETED|Overall Study||0
5085423|NCT01712776|12513058|P2|COMPLETED|Overall Study||50
5085424|NCT01712776|12513059|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
5085425|NCT01712776|12513058|P2|STARTED|Overall Study||50
5085426|NCT01712776|12513059|P1|STARTED|Overall Study||50
5085427|NCT01712711|12513067|P2|NOT COMPLETED|Overall Study||0
5085428|NCT01712711|12513068|P1|NOT COMPLETED|Overall Study||0
5085429|NCT01712711|12513067|P2|COMPLETED|Overall Study||20
5085430|NCT01712711|12513068|P1|COMPLETED|Overall Study||20
5085431|NCT01712711|12513067|P2|STARTED|Overall Study||20
5085432|NCT01712711|12513068|P1|STARTED|Overall Study||20
5085433|NCT01712685|12513074|P1|NOT COMPLETED|Overall Study||1
5085434|NCT01712685|12513074|P1|COMPLETED|Overall Study||11
5085435|NCT01712685|12513074|P1|STARTED|Overall Study||12
5085436|NCT01712516|12513090|P4|NOT COMPLETED|Overall Study||13
5085437|NCT01712516|12513091|P3|NOT COMPLETED|Overall Study||6
5085438|NCT01712516|12513092|P2|NOT COMPLETED|Overall Study||10
5085439|NCT01712516|12513093|P1|NOT COMPLETED|Overall Study||6
5085440|NCT01712516|12513090|P4|COMPLETED|Overall Study||236
5085441|NCT01712516|12513091|P3|COMPLETED|Overall Study||245
5085442|NCT01712516|12513092|P2|COMPLETED|Overall Study||241
5085443|NCT01712516|12513093|P1|COMPLETED|Overall Study||244
5085444|NCT01712516|12513090|P4|Full Analysis Set|Overall Study||247
5085445|NCT01712516|12513091|P3|Full Analysis Set|Overall Study||250
5085446|NCT01712516|12513092|P2|Full Analysis Set|Overall Study||251
5085447|NCT01712516|12513093|P1|Full Analysis Set|Overall Study||250
5085448|NCT01712516|12513090|P4|Safety Set|Overall Study||248
5085449|NCT01712516|12513091|P3|Safety Set|Overall Study||251
5085450|NCT01712516|12513092|P2|Safety Set|Overall Study||251
5085451|NCT01712516|12513093|P1|Safety Set|Overall Study||250
5085452|NCT01712516|12513090|P4|STARTED|Overall Study||249
5085453|NCT01712516|12513091|P3|STARTED|Overall Study||251
5085454|NCT01712516|12513092|P2|STARTED|Overall Study||251
5085455|NCT01712516|12513093|P1|STARTED|Overall Study||250
5085456|NCT01712490|12513145|P2|NOT COMPLETED|Overall Study||670
5085457|NCT01712490|12513146|P1|NOT COMPLETED|Overall Study||664
5085458|NCT01712490|12513145|P2|COMPLETED|Overall Study||0
5085459|NCT01712490|12513146|P1|COMPLETED|Overall Study||0
5085460|NCT01712490|12513145|P2|Treated|Overall Study||659
5085461|NCT01712490|12513146|P1|Treated|Overall Study||662
5085462|NCT01712490|12513145|P2|STARTED|Overall Study||670
5085463|NCT01712490|12513146|P1|STARTED|Overall Study||664
5085464|NCT01712438|12513183|P1|NOT COMPLETED|Overall Study||37
5085465|NCT01712438|12513183|P1|COMPLETED|Overall Study||73
5085466|NCT01712438|12513183|P1|SURG Population|Overall Study||24
5085467|NCT01712438|12513183|P1|BLEED Population|Overall Study||94
5085468|NCT01712438|12513183|P1|PROPH Population|Overall Study||103
5085469|NCT01712438|12513183|P1|PP Population|Overall Study||95
5085470|NCT01712438|12513183|P1|ITT Population|Overall Study||108
5085471|NCT01712438|12513183|P1|SAF Population|Overall Study||108
5085472|NCT01712438|12513183|P1|STARTED|Overall Study||110
5085473|NCT01712399|12513193|P1|NOT COMPLETED|Overall Study||397
5085474|NCT01712399|12513193|P1|COMPLETED|Overall Study||0
5085475|NCT01712399|12513193|P1|STARTED|Overall Study||397
5085476|NCT01712360|12513210|P4|NOT COMPLETED|Overall Study||2
5085477|NCT01712360|12513211|P3|NOT COMPLETED|Overall Study||0
5085478|NCT01712360|12513212|P2|NOT COMPLETED|Overall Study||1
5085479|NCT01712360|12513213|P1|NOT COMPLETED|Overall Study||0
5085480|NCT01712360|12513210|P4|COMPLETED|Overall Study||4
5085481|NCT01712360|12513211|P3|COMPLETED|Overall Study||6
5085482|NCT01712360|12513212|P2|COMPLETED|Overall Study||21
5085483|NCT01712360|12513213|P1|COMPLETED|Overall Study||22
5085484|NCT01712360|12513210|P4|STARTED|Overall Study||6
5085485|NCT01712360|12513211|P3|STARTED|Overall Study||6
5085486|NCT01712360|12513212|P2|STARTED|Overall Study||22
5085487|NCT01712360|12513213|P1|STARTED|Overall Study||22
5085488|NCT01712334|12513239|P2|NOT COMPLETED|Treatment Period 2||0
5085489|NCT01712334|12513240|P1|NOT COMPLETED|Treatment Period 2||0
5085490|NCT01712334|12513239|P2|COMPLETED|Treatment Period 2||41
5085491|NCT01712334|12513240|P1|COMPLETED|Treatment Period 2||44
5085492|NCT01712334|12513239|P2|STARTED|Treatment Period 2||41
5085493|NCT01712334|12513240|P1|STARTED|Treatment Period 2||44
5085494|NCT01712334|12513239|P2|NOT COMPLETED|Treatment Period 1||2
5085495|NCT01712334|12513240|P1|NOT COMPLETED|Treatment Period 1||0
5085496|NCT01712334|12513239|P2|COMPLETED|Treatment Period 1||41
5085497|NCT01712334|12513240|P1|COMPLETED|Treatment Period 1||44
5085498|NCT01712334|12513239|P2|Received Treatment|Treatment Period 1||41
5085499|NCT01712334|12513240|P1|Received Treatment|Treatment Period 1||44
5085500|NCT01712334|12513239|P2|STARTED|Treatment Period 1||43
5085501|NCT01712334|12513240|P1|STARTED|Treatment Period 1||44
5085502|NCT01712256|12513248|P1|NOT COMPLETED|Overall Study||1
5085503|NCT01712256|12513248|P1|COMPLETED|Overall Study||32
5085504|NCT01712256|12513248|P1|STARTED|Overall Study||33
5085505|NCT01712230|12513260|P3|NOT COMPLETED|Overall Study||7
5085506|NCT01712230|12513261|P2|NOT COMPLETED|Overall Study||4
5085507|NCT01712230|12513262|P1|NOT COMPLETED|Overall Study||2
5085508|NCT01712230|12513260|P3|COMPLETED|Overall Study||11
5085509|NCT01712230|12513261|P2|COMPLETED|Overall Study||14
5085510|NCT01712230|12513262|P1|COMPLETED|Overall Study||9
5085511|NCT01712230|12513260|P3|STARTED|Overall Study||18
5085512|NCT01712230|12513261|P2|STARTED|Overall Study||18
5085513|NCT01712230|12513262|P1|STARTED|Overall Study||11
5085514|NCT01712204|12513278|P2|NOT COMPLETED|Overall Study||5
5085515|NCT01712204|12513279|P1|NOT COMPLETED|Overall Study||8
5085516|NCT01712204|12513278|P2|COMPLETED|Overall Study||36
5085517|NCT01712204|12513279|P1|COMPLETED|Overall Study||33
5085518|NCT01712204|12513278|P2|STARTED|Overall Study||41
5085519|NCT01712204|12513279|P1|STARTED|Overall Study||41
5085520|NCT01712178|12513287|P2|NOT COMPLETED|Overall Study||3
5085521|NCT01712178|12513288|P1|NOT COMPLETED|Overall Study||1
5085522|NCT01712178|12513287|P2|COMPLETED|Overall Study||47
5085523|NCT01712178|12513288|P1|COMPLETED|Overall Study||49
5085524|NCT01712178|12513287|P2|STARTED|Overall Study||50
5085525|NCT01712178|12513288|P1|STARTED|Overall Study||50
5085526|NCT01712074|12513313|P3|NOT COMPLETED|Double Blind Period||8
5085527|NCT01712074|12513314|P2|NOT COMPLETED|Double Blind Period||14
5085528|NCT01712074|12513315|P1|NOT COMPLETED|Double Blind Period||0
5085529|NCT01712074|12513313|P3|COMPLETED|Double Blind Period||86
5085530|NCT01712074|12513314|P2|COMPLETED|Double Blind Period||77
5085531|NCT01712074|12513315|P1|COMPLETED|Double Blind Period||0
5085532|NCT01712074|12513313|P3|STARTED|Double Blind Period||94
5085533|NCT01712074|12513314|P2|STARTED|Double Blind Period||91
5085534|NCT01712074|12513315|P1|STARTED|Double Blind Period||0
5085535|NCT01712074|12513313|P3|NOT COMPLETED|Placebo Run-in Period||0
5085536|NCT01712074|12513314|P2|NOT COMPLETED|Placebo Run-in Period||0
5085537|NCT01712074|12513315|P1|NOT COMPLETED|Placebo Run-in Period||10
5085538|NCT01712074|12513313|P3|COMPLETED|Placebo Run-in Period||0
5085539|NCT01712074|12513314|P2|COMPLETED|Placebo Run-in Period||0
5085540|NCT01712074|12513315|P1|COMPLETED|Placebo Run-in Period||185
5085541|NCT01712074|12513313|P3|STARTED|Placebo Run-in Period||0
5085542|NCT01712074|12513314|P2|STARTED|Placebo Run-in Period||0
5085543|NCT01712074|12513315|P1|STARTED|Placebo Run-in Period||195
5085544|NCT01712061|12513371|P3|NOT COMPLETED|Overall Study||11
5085545|NCT01712061|12513372|P2|NOT COMPLETED|Overall Study||26
5085546|NCT01712061|12513373|P1|NOT COMPLETED|Overall Study||10
5085547|NCT01712061|12513371|P3|COMPLETED|Overall Study||45
5085548|NCT01712061|12513372|P2|COMPLETED|Overall Study||114
5085549|NCT01712061|12513373|P1|COMPLETED|Overall Study||20
5085550|NCT01712061|12513371|P3|STARTED|Overall Study||56
5085551|NCT01712061|12513372|P2|STARTED|Overall Study||140
5085552|NCT01712061|12513373|P1|STARTED|Overall Study||30
5085553|NCT01712009|12513413|P3|NOT COMPLETED|Overall Study||21
5085554|NCT01712009|12513414|P2|NOT COMPLETED|Overall Study||29
5085555|NCT01712009|12513415|P1|NOT COMPLETED|Overall Study||38
5085556|NCT01712009|12513413|P3|COMPLETED|Overall Study||181
5085557|NCT01712009|12513414|P2|COMPLETED|Overall Study||171
5085558|NCT01712009|12513415|P1|COMPLETED|Overall Study||160
5085559|NCT01712009|12513413|P3|Received Naproxen / Loratadine|Overall Study||198
5085560|NCT01712009|12513414|P2|Received Naproxen / Loratadine|Overall Study||193
5085561|NCT01712009|12513415|P1|Received Naproxen / Loratadine|Overall Study||0
5085562|NCT01712009|12513413|P3|Received Pegfilgrastim|Overall Study||200
5085563|NCT01712009|12513414|P2|Received Pegfilgrastim|Overall Study||196
5085564|NCT01712009|12513415|P1|Received Pegfilgrastim|Overall Study||191
5085565|NCT01712009|12513413|P3|STARTED|Overall Study||202
5085566|NCT01712009|12513414|P2|STARTED|Overall Study||200
5085567|NCT01712009|12513415|P1|STARTED|Overall Study||198
5085568|NCT01711918|12513441|P1|NOT COMPLETED|Overall Study||2
5085569|NCT01711918|12513441|P1|COMPLETED|Overall Study||7
5085570|NCT01711918|12513441|P1|STARTED|Overall Study||9
5085571|NCT01711866|12513449|P1|NOT COMPLETED|Overall Study||8
5085572|NCT01711866|12513449|P1|COMPLETED|Overall Study||79
5085573|NCT01711866|12513449|P1|STARTED|Overall Study||87
5085574|NCT01711853|12513454|P1|NOT COMPLETED|Overall Study||3
5085575|NCT01711853|12513454|P1|COMPLETED|Overall Study||16
5085576|NCT01711853|12513454|P1|STARTED|Overall Study||19
5085577|NCT01711736|12513461|P2|NOT COMPLETED|Overall Study||8
5085578|NCT01711736|12513462|P1|NOT COMPLETED|Overall Study||12
5085579|NCT01711736|12513461|P2|COMPLETED|Overall Study|Up to Day 180|294
5085580|NCT01711736|12513462|P1|COMPLETED|Overall Study|Up to Day 180|287
5085581|NCT01711736|12513461|P2|STARTED|Overall Study||302
5085582|NCT01711736|12513462|P1|STARTED|Overall Study||299
5085583|NCT01711645|12513490|P1|NOT COMPLETED|Overall Study||19
5085584|NCT01711645|12513490|P1|COMPLETED|Overall Study||36
5085585|NCT01711645|12513490|P1|STARTED|Overall Study||55
5085586|NCT01711619|12513527|P2|NOT COMPLETED|Overall Study||24
5085587|NCT01711619|12513528|P1|NOT COMPLETED|Overall Study||18
5085588|NCT01711619|12513527|P2|COMPLETED|Overall Study||36
5085589|NCT01711619|12513528|P1|COMPLETED|Overall Study||38
5085590|NCT01711619|12513527|P2|STARTED|Overall Study||60
5085591|NCT01711619|12513528|P1|STARTED|Overall Study||56
5085592|NCT01711541|12513545|P5|NOT COMPLETED|Overall Study||0
5085593|NCT01711541|12513546|P4|NOT COMPLETED|Overall Study||1
5085594|NCT01711541|12513547|P3|NOT COMPLETED|Overall Study||0
5085595|NCT01711541|12513548|P2|NOT COMPLETED|Overall Study||1
5085596|NCT01711541|12513549|P1|NOT COMPLETED|Overall Study||0
5085597|NCT01711541|12513545|P5|COMPLETED|Overall Study||7
5085598|NCT01711541|12513546|P4|COMPLETED|Overall Study||5
5085599|NCT01711541|12513547|P3|COMPLETED|Overall Study||3
5085600|NCT01711541|12513548|P2|COMPLETED|Overall Study||3
5085601|NCT01711541|12513549|P1|COMPLETED|Overall Study||4
5085602|NCT01711541|12513545|P5|STARTED|Overall Study||7
5085603|NCT01711541|12513546|P4|STARTED|Overall Study||6
5085604|NCT01711541|12513547|P3|STARTED|Overall Study||3
5085605|NCT01711541|12513548|P2|STARTED|Overall Study||4
5085606|NCT01711541|12513549|P1|STARTED|Overall Study||4
5085607|NCT01711424|12513578|P1|NOT COMPLETED|Overall Study||0
5085608|NCT01711424|12513578|P1|COMPLETED|Overall Study||1209
5085609|NCT01711424|12513578|P1|STARTED|Overall Study||1209
5085610|NCT01711372|12513587|P2|NOT COMPLETED|Overall Study||0
5085611|NCT01711372|12513588|P1|NOT COMPLETED|Overall Study||0
5085612|NCT01711372|12513587|P2|COMPLETED|Overall Study||47
5085613|NCT01711372|12513588|P1|COMPLETED|Overall Study||66
5085614|NCT01711372|12513587|P2|STARTED|Overall Study||47
5085615|NCT01711372|12513588|P1|STARTED|Overall Study||66
5085616|NCT01711359|12513598|P3|NOT COMPLETED|Follow Up||28
5085617|NCT01711359|12513599|P2|NOT COMPLETED|Follow Up||15
5085618|NCT01711359|12513600|P1|NOT COMPLETED|Follow Up||25
5085619|NCT01711359|12513598|P3|COMPLETED|Follow Up||0
5085620|NCT01711359|12513599|P2|COMPLETED|Follow Up||0
5085621|NCT01711359|12513600|P1|COMPLETED|Follow Up||0
5085622|NCT01711359|12513598|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
5085623|NCT01711359|12513599|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
5085624|NCT01711359|12513600|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
5085625|NCT01711359|12513598|P3|NOT COMPLETED|Treatment Period||42
5085626|NCT01711359|12513599|P2|NOT COMPLETED|Treatment Period||24
5085627|NCT01711359|12513600|P1|NOT COMPLETED|Treatment Period||52
5085628|NCT01711359|12513598|P3|COMPLETED|Treatment Period||173
5085629|NCT01711359|12513599|P2|COMPLETED|Treatment Period||136
5085630|NCT01711359|12513600|P1|COMPLETED|Treatment Period||161
5085631|NCT01711359|12513598|P3|Rescued|Treatment Period||6
5085632|NCT01711359|12513599|P2|Rescued|Treatment Period||7
5085633|NCT01711359|12513600|P1|Rescued|Treatment Period||26
5085634|NCT01711359|12513598|P3|Received at Least One Dose of Study Drug|Treatment Period||215
5085635|NCT01711359|12513599|P2|Received at Least One Dose of Study Drug|Treatment Period||159
5085636|NCT01711359|12513600|P1|Received at Least One Dose of Study Drug|Treatment Period||210
5085637|NCT01711359|12513598|P3|STARTED|Treatment Period||215
5085638|NCT01711359|12513599|P2|STARTED|Treatment Period||160
5085639|NCT01711359|12513600|P1|STARTED|Treatment Period||213
5085640|NCT01711216|12513671|P1|NOT COMPLETED|Overall Study||217
5085641|NCT01711216|12513671|P1|COMPLETED|Overall Study||782
5085642|NCT01711216|12513671|P1|STARTED|Overall Study||999
5085643|NCT01711177|12513695|P3|NOT COMPLETED|Overall Study||0
5085644|NCT01711177|12513696|P2|NOT COMPLETED|Overall Study||0
5085645|NCT01711177|12513697|P1|NOT COMPLETED|Overall Study||0
5085646|NCT01711177|12513695|P3|COMPLETED|Overall Study||3
5085647|NCT01711177|12513696|P2|COMPLETED|Overall Study||3
5085648|NCT01711177|12513697|P1|COMPLETED|Overall Study||10
5085649|NCT01711177|12513695|P3|STARTED|Overall Study||3
5085650|NCT01711177|12513696|P2|STARTED|Overall Study||3
5085651|NCT01711177|12513697|P1|STARTED|Overall Study||10
5085652|NCT01710891|12513707|P2|NOT COMPLETED|Overall Study||0
5085653|NCT01710891|12513708|P1|NOT COMPLETED|Overall Study||0
5085654|NCT01710891|12513707|P2|COMPLETED|Overall Study||103
5085655|NCT01710891|12513708|P1|COMPLETED|Overall Study||95
5085656|NCT01710891|12513707|P2|STARTED|Overall Study||103
5085657|NCT01710891|12513708|P1|STARTED|Overall Study||95
5085658|NCT01710839|12513726|P2|NOT COMPLETED|Overall Study||6
5085659|NCT01710839|12513727|P1|NOT COMPLETED|Overall Study||1
5085660|NCT01710839|12513726|P2|COMPLETED|Overall Study||0
5085661|NCT01710839|12513727|P1|COMPLETED|Overall Study||23
5085662|NCT01710839|12513726|P2|STARTED|Overall Study||6
5085663|NCT01710839|12513727|P1|STARTED|Overall Study||24
5085664|NCT01710800|12513749|P1|NOT COMPLETED|Overall Study||22
5085665|NCT01710800|12513749|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
5085666|NCT01710800|12513749|P1|Received Placebo Intervention|Overall Study||45
5085667|NCT01710800|12513749|P1|Received PPI Intervention|Overall Study||44
5085668|NCT01710800|12513749|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
5085669|NCT01710787|12513758|P3|NOT COMPLETED|Overall Study||0
5085670|NCT01710787|12513759|P2|NOT COMPLETED|Overall Study||0
5085671|NCT01710787|12513760|P1|NOT COMPLETED|Overall Study||0
5085672|NCT01710787|12513758|P3|COMPLETED|Overall Study||22
5085673|NCT01710787|12513759|P2|COMPLETED|Overall Study||44
5085674|NCT01710787|12513760|P1|COMPLETED|Overall Study||44
5085675|NCT01710787|12513758|P3|STARTED|Overall Study||22
5085676|NCT01710787|12513759|P2|STARTED|Overall Study||44
5085677|NCT01710787|12513760|P1|STARTED|Overall Study||44
5085678|NCT01710709|12513813|P1|NOT COMPLETED|Overall Study||173
5085679|NCT01710709|12513813|P1|COMPLETED|Overall Study||291
5085680|NCT01710709|12513813|P1|STARTED|Overall Study||464
5085681|NCT01710657|12513828|P3|NOT COMPLETED|Overall Study||32
5085682|NCT01710657|12513829|P2|NOT COMPLETED|Overall Study||12
5085683|NCT01710657|12513830|P1|NOT COMPLETED|Overall Study||18
5085684|NCT01710657|12513828|P3|COMPLETED|Overall Study||148
5085685|NCT01710657|12513829|P2|COMPLETED|Overall Study||171
5085686|NCT01710657|12513830|P1|COMPLETED|Overall Study||166
5085687|NCT01710657|12513828|P3|Maintenance Period (12 Weeks)|Overall Study||168
5085688|NCT01710657|12513829|P2|Maintenance Period (12 Weeks)|Overall Study||175
5085689|NCT01710657|12513830|P1|Maintenance Period (12 Weeks)|Overall Study||176
5085690|NCT01710657|12513828|P3|Titration Period (4 Weeks)|Overall Study||180
5085691|NCT01710657|12513829|P2|Titration Period (4 Weeks)|Overall Study||183
5085692|NCT01710657|12513830|P1|Titration Period (4 Weeks)|Overall Study||184
5085693|NCT01710657|12513828|P3|STARTED|Overall Study||180
5085694|NCT01710657|12513829|P2|STARTED|Overall Study||183
5085695|NCT01710657|12513830|P1|STARTED|Overall Study||184
5085696|NCT01710527|12513847|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
5085697|NCT01710527|12513848|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
5085698|NCT01710527|12513847|P2|COMPLETED|Period 3: Intervention Period 2||15
5085699|NCT01710527|12513848|P1|COMPLETED|Period 3: Intervention Period 2||16
5085700|NCT01710527|12513847|P2|STARTED|Period 3: Intervention Period 2||15
5085701|NCT01710527|12513848|P1|STARTED|Period 3: Intervention Period 2||16
5085702|NCT01710527|12513847|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
5085703|NCT01710527|12513848|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5085704|NCT01710527|12513847|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
5085705|NCT01710527|12513848|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
5085706|NCT01710527|12513847|P2|STARTED|Period 2: Washout Period (7 Days)||16
5085707|NCT01710527|12513848|P1|STARTED|Period 2: Washout Period (7 Days)||16
5085708|NCT01710527|12513847|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
5085709|NCT01710527|12513848|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
5085710|NCT01710527|12513847|P2|COMPLETED|Period 1: Intervention Period 1||16
5085711|NCT01710527|12513848|P1|COMPLETED|Period 1: Intervention Period 1||16
5085712|NCT01710527|12513847|P2|STARTED|Period 1: Intervention Period 1||16
5085713|NCT01710527|12513848|P1|STARTED|Period 1: Intervention Period 1||16
5085714|NCT01710514|12513874|P2|NOT COMPLETED|Overall Study||7
5085715|NCT01710514|12513875|P1|NOT COMPLETED|Overall Study||7
5085716|NCT01710514|12513874|P2|COMPLETED|Overall Study||47
5085717|NCT01710514|12513875|P1|COMPLETED|Overall Study||47
5085718|NCT01710514|12513874|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
5085719|NCT01710514|12513875|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
5085720|NCT01710514|12513874|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
5085721|NCT01710514|12513875|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
5085722|NCT01710514|12513874|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
5085723|NCT01710514|12513875|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
5085724|NCT01710514|12513874|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
5085725|NCT01710514|12513875|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
5085726|NCT01710514|12513874|P2|STARTED|Overall Study||54
5085727|NCT01710514|12513875|P1|STARTED|Overall Study||54
5085728|NCT01710501|12513896|P3|NOT COMPLETED|Overall Study||0
5085729|NCT01710501|12513897|P2|NOT COMPLETED|Overall Study||0
5085730|NCT01710501|12513898|P1|NOT COMPLETED|Overall Study||2
5085731|NCT01710501|12513896|P3|COMPLETED|Overall Study||30
5085732|NCT01710501|12513897|P2|COMPLETED|Overall Study||28
5085733|NCT01710501|12513898|P1|COMPLETED|Overall Study||27
5085734|NCT01710501|12513896|P3|STARTED|Overall Study||30
5085735|NCT01710501|12513897|P2|STARTED|Overall Study||28
5085736|NCT01710501|12513898|P1|STARTED|Overall Study||29
5085737|NCT01710358|12513930|P3|NOT COMPLETED|Follow-up Period||0
5085738|NCT01710358|12513931|P2|NOT COMPLETED|Follow-up Period||0
5085739|NCT01710358|12513932|P1|NOT COMPLETED|Follow-up Period||0
5085740|NCT01710358|12513930|P3|COMPLETED|Follow-up Period||20
5085741|NCT01710358|12513931|P2|COMPLETED|Follow-up Period||76
5085742|NCT01710358|12513932|P1|COMPLETED|Follow-up Period||33
5085743|NCT01710358|12513930|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
5085744|NCT01710358|12513931|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
5085745|NCT01710358|12513932|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
5085746|NCT01710358|12513930|P3|NOT COMPLETED|Rescue Period||0
5085747|NCT01710358|12513931|P2|NOT COMPLETED|Rescue Period||31
5085748|NCT01710358|12513932|P1|NOT COMPLETED|Rescue Period||0
5085749|NCT01710358|12513930|P3|COMPLETED|Rescue Period||0
5085750|NCT01710358|12513931|P2|COMPLETED|Rescue Period||196
5085751|NCT01710358|12513932|P1|COMPLETED|Rescue Period||0
5085752|NCT01710358|12513930|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5085753|NCT01710358|12513931|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
5085754|NCT01710358|12513932|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
5085755|NCT01710358|12513930|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
5085756|NCT01710358|12513931|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
5085757|NCT01710358|12513932|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
5085758|NCT01710358|12513930|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
5085759|NCT01710358|12513931|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
5085760|NCT01710358|12513932|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
5085761|NCT01710358|12513930|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
5085762|NCT01710358|12513931|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
5085763|NCT01710358|12513932|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
5085764|NCT01710358|12513930|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
5085765|NCT01710358|12513931|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
5085766|NCT01710358|12513932|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
5085767|NCT01710358|12513930|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
5085768|NCT01710358|12513931|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
5085769|NCT01710358|12513932|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
5085770|NCT01710358|12513930|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
5085771|NCT01710358|12513931|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
5085772|NCT01710358|12513932|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
5085773|NCT01710358|12513930|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
5085774|NCT01710358|12513931|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
5085775|NCT01710358|12513932|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
5085776|NCT01710358|12513930|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
5085777|NCT01710358|12513931|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
5085778|NCT01710358|12513932|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
5085779|NCT01710358|12513930|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
5085780|NCT01710358|12513931|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
5085781|NCT01710358|12513932|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
5085782|NCT01710358|12513930|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
5085783|NCT01710358|12513931|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
5085784|NCT01710358|12513932|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
5085785|NCT01710345|12514003|P3|NOT COMPLETED|Overall Study||1
5085786|NCT01710345|12514004|P2|NOT COMPLETED|Overall Study||5
5085787|NCT01710345|12514005|P1|NOT COMPLETED|Overall Study||3
5085788|NCT01710345|12514003|P3|COMPLETED|Overall Study||19
5085789|NCT01710345|12514004|P2|COMPLETED|Overall Study||35
5085790|NCT01710345|12514005|P1|COMPLETED|Overall Study||37
5085791|NCT01710345|12514003|P3|STARTED|Overall Study||20
5085792|NCT01710345|12514004|P2|STARTED|Overall Study||40
5085793|NCT01710345|12514005|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
5085794|NCT01710332|12514015|P2|NOT COMPLETED|Overall Study||0
5085795|NCT01710332|12514016|P1|NOT COMPLETED|Overall Study||0
5085796|NCT01710332|12514015|P2|COMPLETED|Overall Study||6
5085797|NCT01710332|12514016|P1|COMPLETED|Overall Study||6
5085798|NCT01710332|12514015|P2|STARTED|Overall Study||6
5085799|NCT01710332|12514016|P1|STARTED|Overall Study||6
5085800|NCT01710306|12514026|P2|NOT COMPLETED|Overall Study||30
5085801|NCT01710306|12514027|P1|NOT COMPLETED|Overall Study||18
5085802|NCT01710306|12514026|P2|COMPLETED|Overall Study||55
5085803|NCT01710306|12514027|P1|COMPLETED|Overall Study||68
5085804|NCT01710306|12514026|P2|STARTED|Overall Study||85
5085805|NCT01710306|12514027|P1|STARTED|Overall Study||86
5085806|NCT01710254|12514035|P1|NOT COMPLETED|Overall Study||0
5085807|NCT01710254|12514035|P1|COMPLETED|Overall Study||30
5085808|NCT01710254|12514035|P1|STARTED|Overall Study||30
5085809|NCT01710137|12514043|P2|NOT COMPLETED|Overall Study||14
5085810|NCT01710137|12514044|P1|NOT COMPLETED|Overall Study||24
5085811|NCT01710137|12514043|P2|COMPLETED|Overall Study||76
5085812|NCT01710137|12514044|P1|COMPLETED|Overall Study||65
5085813|NCT01710137|12514043|P2|STARTED|Overall Study||90
5085814|NCT01710137|12514044|P1|STARTED|Overall Study||89
5085815|NCT01710046|12514064|P2|NOT COMPLETED|Overall Study||0
5085816|NCT01710046|12514065|P1|NOT COMPLETED|Overall Study||1
5085817|NCT01710046|12514064|P2|COMPLETED|Overall Study||3
5085818|NCT01710046|12514065|P1|COMPLETED|Overall Study||8
5085819|NCT01710046|12514064|P2|STARTED|Overall Study||3
5085820|NCT01710046|12514065|P1|STARTED|Overall Study||9
5085821|NCT01710033|12514105|P5|NOT COMPLETED|Stage 2||1
5085822|NCT01710033|12514106|P4|NOT COMPLETED|Stage 2||0
5085823|NCT01710033|12514107|P3|NOT COMPLETED|Stage 2||0
5085824|NCT01710033|12514108|P2|NOT COMPLETED|Stage 2||0
5085825|NCT01710033|12514109|P1|NOT COMPLETED|Stage 2||0
5085826|NCT01710033|12514105|P5|COMPLETED|Stage 2||3
5085827|NCT01710033|12514106|P4|COMPLETED|Stage 2||0
5085828|NCT01710033|12514107|P3|COMPLETED|Stage 2||0
5085829|NCT01710033|12514108|P2|COMPLETED|Stage 2||0
5085830|NCT01710033|12514109|P1|COMPLETED|Stage 2||0
5085831|NCT01710033|12514105|P5|STARTED|Stage 2||4
5085832|NCT01710033|12514106|P4|STARTED|Stage 2||0
5085833|NCT01710033|12514107|P3|STARTED|Stage 2||0
5085834|NCT01710033|12514108|P2|STARTED|Stage 2||0
5085835|NCT01710033|12514109|P1|STARTED|Stage 2||0
5085836|NCT01710033|12514105|P5|NOT COMPLETED|Stage 1||0
5085837|NCT01710033|12514106|P4|NOT COMPLETED|Stage 1||0
5085838|NCT01710033|12514107|P3|NOT COMPLETED|Stage 1||0
5085839|NCT01710033|12514108|P2|NOT COMPLETED|Stage 1||0
5085840|NCT01710033|12514109|P1|NOT COMPLETED|Stage 1||0
5085841|NCT01710033|12514105|P5|COMPLETED|Stage 1||0
5085842|NCT01710033|12514106|P4|COMPLETED|Stage 1||6
5085843|NCT01710033|12514107|P3|COMPLETED|Stage 1||6
5085844|NCT01710033|12514108|P2|COMPLETED|Stage 1||6
5085845|NCT01710033|12514109|P1|COMPLETED|Stage 1||6
5085846|NCT01710033|12514105|P5|STARTED|Stage 1||0
5085847|NCT01710033|12514106|P4|STARTED|Stage 1||6
5085848|NCT01710033|12514107|P3|STARTED|Stage 1||6
5085849|NCT01710033|12514108|P2|STARTED|Stage 1||6
5085850|NCT01710033|12514109|P1|STARTED|Stage 1||6
5085851|NCT01710020|12514190|P1|NOT COMPLETED|Period 2||0
5085852|NCT01710020|12514190|P1|COMPLETED|Period 2||11
5085853|NCT01710020|12514190|P1|STARTED|Period 2||11
5085854|NCT01710020|12514190|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5085855|NCT01710020|12514190|P1|COMPLETED|Washout Period (at Least 14 Days)||11
5085856|NCT01710020|12514190|P1|STARTED|Washout Period (at Least 14 Days)||11
5085857|NCT01710020|12514190|P1|NOT COMPLETED|Period 1||1
5085858|NCT01710020|12514190|P1|COMPLETED|Period 1||11
5085859|NCT01710020|12514190|P1|STARTED|Period 1||12
5085860|NCT01709903|12514209|P2|NOT COMPLETED|Overall Study||39
5085861|NCT01709903|12514210|P1|NOT COMPLETED|Overall Study||29
5085862|NCT01709903|12514209|P2|COMPLETED|Overall Study||333
5085863|NCT01709903|12514210|P1|COMPLETED|Overall Study||343
5085864|NCT01709903|12514209|P2|STARTED|Overall Study|Randomized set|372
5085865|NCT01709903|12514210|P1|STARTED|Overall Study|Randomized set|372
5085866|NCT01709864|12514234|P2|NOT COMPLETED|Overall Study||11
5085867|NCT01709864|12514235|P1|NOT COMPLETED|Overall Study||7
5085868|NCT01709864|12514234|P2|COMPLETED|Overall Study||208
5085869|NCT01709864|12514235|P1|COMPLETED|Overall Study||215
5085870|NCT01709864|12514234|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
5085871|NCT01709864|12514235|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
5085872|NCT01709864|12514234|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
5085873|NCT01709864|12514235|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
5085874|NCT01709864|12514234|P2|STARTED|Overall Study||219
5085875|NCT01709864|12514235|P1|STARTED|Overall Study||222
5085876|NCT01709838|12514269|P1|NOT COMPLETED|Overall Study||67
5085877|NCT01709838|12514269|P1|COMPLETED|Overall Study||67
5085878|NCT01709838|12514269|P1|STARTED|Overall Study||134
5085879|NCT01709799|12514292|P3|NOT COMPLETED|Overall Study||3
5085880|NCT01709799|12514293|P2|NOT COMPLETED|Overall Study||3
5085881|NCT01709799|12514294|P1|NOT COMPLETED|Overall Study||3
5085882|NCT01709799|12514292|P3|COMPLETED|Overall Study||15
5085883|NCT01709799|12514293|P2|COMPLETED|Overall Study||18
5085884|NCT01709799|12514294|P1|COMPLETED|Overall Study||22
5085885|NCT01709799|12514292|P3|STARTED|Overall Study||18
5085886|NCT01709799|12514293|P2|STARTED|Overall Study||21
5085887|NCT01709799|12514294|P1|STARTED|Overall Study||25
5085888|NCT01709786|12514317|P1|NOT COMPLETED|Overall Study||0
5085889|NCT01709786|12514317|P1|COMPLETED|Overall Study||88
5085890|NCT01709786|12514317|P1|STARTED|Overall Study||88
5085891|NCT01709708|12514326|P2|NOT COMPLETED|Overall Study||2
5085892|NCT01709708|12514327|P1|NOT COMPLETED|Overall Study||1
5085893|NCT01709708|12514326|P2|COMPLETED|Overall Study||12
5085894|NCT01709708|12514327|P1|COMPLETED|Overall Study||26
5085895|NCT01709708|12514326|P2|STARTED|Overall Study||14
5085896|NCT01709708|12514327|P1|STARTED|Overall Study||27
5085897|NCT01709695|12514351|P2|NOT COMPLETED|Overall Study||1
5085898|NCT01709695|12514352|P1|NOT COMPLETED|Overall Study||1
5085899|NCT01709695|12514351|P2|COMPLETED|Overall Study||13
5085900|NCT01709695|12514352|P1|COMPLETED|Overall Study||12
5085901|NCT01709695|12514351|P2|STARTED|Overall Study||14
5085902|NCT01709695|12514352|P1|STARTED|Overall Study||13
5085903|NCT01709578|12514377|P3|NOT COMPLETED|Overall Study||51
5085904|NCT01709578|12514378|P2|NOT COMPLETED|Overall Study||56
5085905|NCT01709578|12514379|P1|NOT COMPLETED|Overall Study||80
5085906|NCT01709578|12514377|P3|COMPLETED|Overall Study||133
5085907|NCT01709578|12514378|P2|COMPLETED|Overall Study||125
5085908|NCT01709578|12514379|P1|COMPLETED|Overall Study||101
5085909|NCT01709578|12514377|P3|STARTED|Overall Study||184
5085910|NCT01709578|12514378|P2|STARTED|Overall Study||181
5085911|NCT01709578|12514379|P1|STARTED|Overall Study||181
5085912|NCT01709513|12514510|P3|NOT COMPLETED|Overall Study||30
5085913|NCT01709513|12514511|P2|NOT COMPLETED|Overall Study||43
5085914|NCT01709513|12514512|P1|NOT COMPLETED|Overall Study||21
5085915|NCT01709513|12514510|P3|COMPLETED|Overall Study||96
5085916|NCT01709513|12514511|P2|COMPLETED|Overall Study||82
5085917|NCT01709513|12514512|P1|COMPLETED|Overall Study||42
5085918|NCT01709513|12514510|P3|Treated|Overall Study||126
5085919|NCT01709513|12514511|P2|Treated|Overall Study||124
5085920|NCT01709513|12514512|P1|Treated|Overall Study||63
5085921|NCT01709513|12514510|P3|STARTED|Overall Study||126
5085922|NCT01709513|12514511|P2|STARTED|Overall Study||125
5085923|NCT01709513|12514512|P1|STARTED|Overall Study||63
5085924|NCT01709500|12514573|P2|NOT COMPLETED|Overall Study||82
5085925|NCT01709500|12514574|P1|NOT COMPLETED|Overall Study||167
5085926|NCT01709500|12514573|P2|COMPLETED|Overall Study||0
5085927|NCT01709500|12514574|P1|COMPLETED|Overall Study||0
5085928|NCT01709500|12514573|P2|Treated|Overall Study||81
5085929|NCT01709500|12514574|P1|Treated|Overall Study||167
5085930|NCT01709500|12514573|P2|STARTED|Overall Study||82
5085931|NCT01709500|12514574|P1|STARTED|Overall Study||167
5085932|NCT01709474|12514630|P2|NOT COMPLETED|Overall Study||0
5085933|NCT01709474|12514631|P1|NOT COMPLETED|Overall Study||0
5085934|NCT01709474|12514630|P2|COMPLETED|Overall Study||4
5085935|NCT01709474|12514631|P1|COMPLETED|Overall Study||3
5085936|NCT01709474|12514630|P2|STARTED|Overall Study||4
5085937|NCT01709474|12514631|P1|STARTED|Overall Study||3
5085938|NCT01709422|12514641|P2|NOT COMPLETED|Overall Study||0
5085939|NCT01709422|12514642|P1|NOT COMPLETED|Overall Study||0
5085940|NCT01709422|12514641|P2|COMPLETED|Overall Study||70
5085941|NCT01709422|12514642|P1|COMPLETED|Overall Study||70
5085942|NCT01709422|12514641|P2|STARTED|Overall Study||70
5085943|NCT01709422|12514642|P1|STARTED|Overall Study||70
5085944|NCT01709409|12514652|P2|NOT COMPLETED|Overall Study||0
5085945|NCT01709409|12514653|P1|NOT COMPLETED|Overall Study||1
5085946|NCT01709409|12514652|P2|COMPLETED|Overall Study||45
5085947|NCT01709409|12514653|P1|COMPLETED|Overall Study||42
5085948|NCT01709409|12514652|P2|STARTED|Overall Study||45
5085949|NCT01709409|12514653|P1|STARTED|Overall Study||43
5085950|NCT01709383|12514661|P2|NOT COMPLETED|Overall Study||0
5085951|NCT01709383|12514662|P1|NOT COMPLETED|Overall Study||1
5085952|NCT01709383|12514661|P2|COMPLETED|Overall Study||14
5085953|NCT01709383|12514662|P1|COMPLETED|Overall Study||23
5085954|NCT01709383|12514661|P2|Included in Analysis|Overall Study||13
5085955|NCT01709383|12514662|P1|Included in Analysis|Overall Study||22
5085956|NCT01709383|12514661|P2|Completed Follow-ups|Overall Study||14
5085957|NCT01709383|12514662|P1|Completed Follow-ups|Overall Study||23
5085958|NCT01709383|12514661|P2|Completed Treatment|Overall Study||14
5085959|NCT01709383|12514662|P1|Completed Treatment|Overall Study||24
5085960|NCT01709383|12514661|P2|STARTED|Overall Study||14
5085961|NCT01709383|12514662|P1|STARTED|Overall Study||24
5085962|NCT01709331|12514680|P1|NOT COMPLETED|Overall Study||1
5085963|NCT01709331|12514680|P1|COMPLETED|Overall Study||17
5085964|NCT01709331|12514680|P1|STARTED|Overall Study||18
5085965|NCT01709318|12514693|P7|NOT COMPLETED|Overall Study||11
5085966|NCT01709318|12514694|P6|NOT COMPLETED|Overall Study||4
5085967|NCT01709318|12514695|P5|NOT COMPLETED|Overall Study||4
5085968|NCT01709318|12514696|P4|NOT COMPLETED|Overall Study||6
5085969|NCT01709318|12514697|P3|NOT COMPLETED|Overall Study||6
5085970|NCT01709318|12514698|P2|NOT COMPLETED|Overall Study||7
5085971|NCT01709318|12514699|P1|NOT COMPLETED|Overall Study||9
5085972|NCT01709318|12514693|P7|COMPLETED|Overall Study||171
5085973|NCT01709318|12514694|P6|COMPLETED|Overall Study||80
5085974|NCT01709318|12514695|P5|COMPLETED|Overall Study||74
5085975|NCT01709318|12514696|P4|COMPLETED|Overall Study||72
5085976|NCT01709318|12514697|P3|COMPLETED|Overall Study||71
5085977|NCT01709318|12514698|P2|COMPLETED|Overall Study||78
5085978|NCT01709318|12514699|P1|COMPLETED|Overall Study||73
5085979|NCT01709318|12514693|P7|Treated|Overall Study||178
5085980|NCT01709318|12514694|P6|Treated|Overall Study||86
5085981|NCT01709318|12514695|P5|Treated|Overall Study||77
5085982|NCT01709318|12514696|P4|Treated|Overall Study||77
5085983|NCT01709318|12514697|P3|Treated|Overall Study||78
5085984|NCT01709318|12514698|P2|Treated|Overall Study||85
5085985|NCT01709318|12514699|P1|Treated|Overall Study||79
5085986|NCT01709318|12514693|P7|STARTED|Overall Study||182
5085987|NCT01709318|12514694|P6|STARTED|Overall Study||84
5085988|NCT01709318|12514695|P5|STARTED|Overall Study||78
5085989|NCT01709318|12514696|P4|STARTED|Overall Study||78
5085990|NCT01709318|12514697|P3|STARTED|Overall Study||77
5085991|NCT01709318|12514698|P2|STARTED|Overall Study||85
5085992|NCT01709318|12514699|P1|STARTED|Overall Study||82
5085993|NCT01709305|12514792|P5|NOT COMPLETED|Phase 2||47
5085994|NCT01709305|12514793|P4|NOT COMPLETED|Phase 2||48
5085995|NCT01709305|12514794|P3|NOT COMPLETED|Phase 2||45
5085996|NCT01709305|12514795|P2|NOT COMPLETED|Phase 2||52
5085997|NCT01709305|12514796|P1|NOT COMPLETED|Phase 2||0
5085998|NCT01709305|12514792|P5|COMPLETED|Phase 2||507
5085999|NCT01709305|12514793|P4|COMPLETED|Phase 2||508
5086000|NCT01709305|12514794|P3|COMPLETED|Phase 2||505
5086001|NCT01709305|12514795|P2|COMPLETED|Phase 2||500
5086002|NCT01709305|12514796|P1|COMPLETED|Phase 2||0
5086003|NCT01709305|12514792|P5|STARTED|Phase 2||554
5086004|NCT01709305|12514793|P4|STARTED|Phase 2||556
5086005|NCT01709305|12514794|P3|STARTED|Phase 2||550
5086006|NCT01709305|12514795|P2|STARTED|Phase 2||552
5086007|NCT01709305|12514796|P1|STARTED|Phase 2||0
5086008|NCT01709305|12514792|P5|NOT COMPLETED|Phase 1||0
5086009|NCT01709305|12514793|P4|NOT COMPLETED|Phase 1||0
5086010|NCT01709305|12514794|P3|NOT COMPLETED|Phase 1||0
5086011|NCT01709305|12514795|P2|NOT COMPLETED|Phase 1||0
5086012|NCT01709305|12514796|P1|NOT COMPLETED|Phase 1||637
5086013|NCT01709305|12514792|P5|COMPLETED|Phase 1||0
5086014|NCT01709305|12514793|P4|COMPLETED|Phase 1||0
5086015|NCT01709305|12514794|P3|COMPLETED|Phase 1||0
5086016|NCT01709305|12514795|P2|COMPLETED|Phase 1||0
5086017|NCT01709305|12514796|P1|COMPLETED|Phase 1||4933
5086018|NCT01709305|12514792|P5|STARTED|Phase 1||0
5086019|NCT01709305|12514793|P4|STARTED|Phase 1||0
5086020|NCT01709305|12514794|P3|STARTED|Phase 1||0
5086021|NCT01709305|12514795|P2|STARTED|Phase 1||0
5086022|NCT01709305|12514796|P1|STARTED|Phase 1||5570
5086023|NCT01709227|12514833|P2|NOT COMPLETED|Overall Study||9
5086024|NCT01709227|12514834|P1|NOT COMPLETED|Overall Study||1
5086025|NCT01709227|12514833|P2|COMPLETED|Overall Study||32
5086026|NCT01709227|12514834|P1|COMPLETED|Overall Study||31
5086027|NCT01709227|12514833|P2|STARTED|Overall Study||41
5086028|NCT01709227|12514834|P1|STARTED|Overall Study||32
5086029|NCT01709162|12514860|P2|NOT COMPLETED|Overall Study||5
5086030|NCT01709162|12514861|P1|NOT COMPLETED|Overall Study||6
5086031|NCT01709162|12514860|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
5086032|NCT01709162|12514861|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
5086033|NCT01709162|12514860|P2|Still Receiving Treatment|Overall Study||0
5086034|NCT01709162|12514861|P1|Still Receiving Treatment|Overall Study||0
5086035|NCT01709162|12514860|P2|Received Treatment|Overall Study||4
5086036|NCT01709162|12514861|P1|Received Treatment|Overall Study||18
5086037|NCT01709162|12514860|P2|STARTED|Overall Study|Randomized|5
5086038|NCT01709162|12514861|P1|STARTED|Overall Study|Randomized|18
5086039|NCT01709149|12514876|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
5086040|NCT01709149|12514877|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
5086041|NCT01709149|12514878|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
5086042|NCT01709149|12514876|P3|COMPLETED|Double-blind, Placebo-controlled Phase||204
5086043|NCT01709149|12514877|P2|COMPLETED|Double-blind, Placebo-controlled Phase||269
5086044|NCT01709149|12514878|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
5086045|NCT01709149|12514876|P3|STARTED|Double-blind, Placebo-controlled Phase||301
5086046|NCT01709149|12514877|P2|STARTED|Double-blind, Placebo-controlled Phase||295
5086047|NCT01709149|12514878|P1|STARTED|Double-blind, Placebo-controlled Phase||0
5086048|NCT01709149|12514876|P3|NOT COMPLETED|Open-label Lead-in Phase||0
5086049|NCT01709149|12514877|P2|NOT COMPLETED|Open-label Lead-in Phase||0
5086050|NCT01709149|12514878|P1|NOT COMPLETED|Open-label Lead-in Phase||115
5086051|NCT01709149|12514876|P3|COMPLETED|Open-label Lead-in Phase||0
5086052|NCT01709149|12514877|P2|COMPLETED|Open-label Lead-in Phase||0
5086053|NCT01709149|12514878|P1|COMPLETED|Open-label Lead-in Phase||596
5086054|NCT01709149|12514876|P3|STARTED|Open-label Lead-in Phase||0
5086055|NCT01709149|12514877|P2|STARTED|Open-label Lead-in Phase||0
5086056|NCT01709149|12514878|P1|STARTED|Open-label Lead-in Phase||711
5086057|NCT01709136|12514897|P1|NOT COMPLETED|Overall Study||0
5086058|NCT01709136|12514897|P1|COMPLETED|Overall Study||3
5086059|NCT01709136|12514897|P1|STARTED|Overall Study||3
5086060|NCT01709110|12514906|P2|NOT COMPLETED|Overall Study||168
5086061|NCT01709110|12514907|P1|NOT COMPLETED|Overall Study||185
5086062|NCT01709110|12514906|P2|COMPLETED|Overall Study||515
5086063|NCT01709110|12514907|P1|COMPLETED|Overall Study||498
5086064|NCT01709110|12514906|P2|Received at Least One Dose of Study Drug|Overall Study||680
5086065|NCT01709110|12514907|P1|Received at Least One Dose of Study Drug|Overall Study||680
5086066|NCT01709110|12514906|P2|STARTED|Overall Study||683
5086067|NCT01709110|12514907|P1|STARTED|Overall Study||683
5086068|NCT01709084|12514937|P2|NOT COMPLETED|Overall Study||15
5086069|NCT01709084|12514938|P1|NOT COMPLETED|Overall Study||16
5086070|NCT01709084|12514937|P2|COMPLETED|Overall Study||198
5086071|NCT01709084|12514938|P1|COMPLETED|Overall Study||197
5086072|NCT01709084|12514937|P2|Treated|Overall Study||211
5086073|NCT01709084|12514938|P1|Treated|Overall Study||213
5086074|NCT01709084|12514937|P2|STARTED|Overall Study||213
5086075|NCT01709084|12514938|P1|STARTED|Overall Study||213
5086076|NCT01709032|12514954|P1|NOT COMPLETED|Overall Study||3
5086077|NCT01709032|12514954|P1|COMPLETED|Overall Study||6
5086078|NCT01709032|12514954|P1|STARTED|Overall Study||9
5086079|NCT01708967|12514961|P2|NOT COMPLETED|Overall Study||7
5086080|NCT01708967|12514962|P1|NOT COMPLETED|Overall Study||0
5086081|NCT01708967|12514961|P2|COMPLETED|Overall Study||43
5086082|NCT01708967|12514962|P1|COMPLETED|Overall Study||50
5086083|NCT01708967|12514961|P2|STARTED|Overall Study||50
5086084|NCT01708967|12514962|P1|STARTED|Overall Study||50
5086085|NCT01708954|12514971|P3|NOT COMPLETED|Step 2||0
5086086|NCT01708954|12514972|P2|NOT COMPLETED|Step 2||7
5086087|NCT01708954|12514973|P1|NOT COMPLETED|Step 2||13
5086088|NCT01708954|12514971|P3|COMPLETED|Step 2||0
5086089|NCT01708954|12514972|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
5086090|NCT01708954|12514973|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
5086091|NCT01708954|12514971|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
5086092|NCT01708954|12514972|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
5086093|NCT01708954|12514973|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
5086094|NCT01708954|12514971|P3|NOT COMPLETED|Step 1||43
5086095|NCT01708954|12514972|P2|NOT COMPLETED|Step 1||40
5086096|NCT01708954|12514973|P1|NOT COMPLETED|Step 1||42
5086097|NCT01708954|12514971|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
5086098|NCT01708954|12514972|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
5086099|NCT01708954|12514973|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
5086100|NCT01708954|12514971|P3|Patients With MET Status Data Available|Step 1||24
5086101|NCT01708954|12514972|P2|Patients With MET Status Data Available|Step 1||32
5086102|NCT01708954|12514973|P1|Patients With MET Status Data Available|Step 1||30
5086103|NCT01708954|12514971|P3|Eligible and Treated|Step 1||35
5086104|NCT01708954|12514972|P2|Eligible and Treated|Step 1||38
5086105|NCT01708954|12514973|P1|Eligible and Treated|Step 1||38
5086106|NCT01708954|12514971|P3|Started Protocol Therapy|Step 1||39
5086107|NCT01708954|12514972|P2|Started Protocol Therapy|Step 1||40
5086108|NCT01708954|12514973|P1|Started Protocol Therapy|Step 1||40
5086109|NCT01708954|12514971|P3|STARTED|Step 1||43
5086110|NCT01708954|12514972|P2|STARTED|Step 1||40
5086111|NCT01708954|12514973|P1|STARTED|Step 1||42
5086112|NCT01708941|12514998|P4|NOT COMPLETED|Overall Study||18
5086113|NCT01708941|12514999|P3|NOT COMPLETED|Overall Study||19
5086114|NCT01708941|12515000|P2|NOT COMPLETED|Overall Study||18
5086115|NCT01708941|12515001|P1|NOT COMPLETED|Overall Study||18
5086116|NCT01708941|12514998|P4|COMPLETED|Overall Study||4
5086117|NCT01708941|12514999|P3|COMPLETED|Overall Study||3
5086118|NCT01708941|12515000|P2|COMPLETED|Overall Study||5
5086119|NCT01708941|12515001|P1|COMPLETED|Overall Study||3
5086120|NCT01708941|12514998|P4|Eligible and Started Treatment|Overall Study||22
5086121|NCT01708941|12514999|P3|Eligible and Started Treatment|Overall Study||19
5086122|NCT01708941|12515000|P2|Eligible and Started Treatment|Overall Study||22
5086123|NCT01708941|12515001|P1|Eligible and Started Treatment|Overall Study||18
5086124|NCT01708941|12514998|P4|STARTED|Overall Study||22
5086125|NCT01708941|12514999|P3|STARTED|Overall Study||22
5086126|NCT01708941|12515000|P2|STARTED|Overall Study||23
5086127|NCT01708941|12515001|P1|STARTED|Overall Study||21
5086128|NCT01708915|12515019|P4|NOT COMPLETED|Overall Study||33
5086129|NCT01708915|12515020|P3|NOT COMPLETED|Overall Study||46
5086130|NCT01708915|12515021|P2|NOT COMPLETED|Overall Study||62
5086131|NCT01708915|12515022|P1|NOT COMPLETED|Overall Study||86
5086132|NCT01708915|12515019|P4|COMPLETED|Overall Study||169
5086133|NCT01708915|12515020|P3|COMPLETED|Overall Study||152
5086134|NCT01708915|12515021|P2|COMPLETED|Overall Study||139
5086135|NCT01708915|12515022|P1|COMPLETED|Overall Study||118
5086136|NCT01708915|12515019|P4|STARTED|Overall Study||202
5086137|NCT01708915|12515020|P3|STARTED|Overall Study||198
5086138|NCT01708915|12515021|P2|STARTED|Overall Study||201
5086139|NCT01708915|12515022|P1|STARTED|Overall Study||204
5086140|NCT01708902|12515051|P7|NOT COMPLETED|Overall Study||7
5086141|NCT01708902|12515052|P6|NOT COMPLETED|Overall Study||7
5086142|NCT01708902|12515053|P5|NOT COMPLETED|Overall Study||16
5086143|NCT01708902|12515054|P4|NOT COMPLETED|Overall Study||10
5086144|NCT01708902|12515055|P3|NOT COMPLETED|Overall Study||17
5086145|NCT01708902|12515056|P2|NOT COMPLETED|Overall Study||8
5086146|NCT01708902|12515057|P1|NOT COMPLETED|Overall Study||17
5086147|NCT01708902|12515051|P7|COMPLETED|Overall Study||65
5086148|NCT01708902|12515052|P6|COMPLETED|Overall Study||64
5086149|NCT01708902|12515053|P5|COMPLETED|Overall Study||131
5086150|NCT01708902|12515054|P4|COMPLETED|Overall Study||137
5086151|NCT01708902|12515055|P3|COMPLETED|Overall Study||127
5086152|NCT01708902|12515056|P2|COMPLETED|Overall Study||137
5086153|NCT01708902|12515057|P1|COMPLETED|Overall Study||130
5086154|NCT01708902|12515051|P7|STARTED|Overall Study||72
5086155|NCT01708902|12515052|P6|STARTED|Overall Study||71
5086156|NCT01708902|12515053|P5|STARTED|Overall Study||147
5086157|NCT01708902|12515054|P4|STARTED|Overall Study||147
5086158|NCT01708902|12515055|P3|STARTED|Overall Study||144
5086159|NCT01708902|12515056|P2|STARTED|Overall Study||145
5086160|NCT01708902|12515057|P1|STARTED|Overall Study||147
5086161|NCT01708629|12515120|P4|NOT COMPLETED|Overall Study||14
5086162|NCT01708629|12515121|P3|NOT COMPLETED|Overall Study||10
5086163|NCT01708629|12515122|P2|NOT COMPLETED|Overall Study||25
5086164|NCT01708629|12515123|P1|NOT COMPLETED|Overall Study||16
5086165|NCT01708629|12515120|P4|COMPLETED|Overall Study||301
5086166|NCT01708629|12515121|P3|COMPLETED|Overall Study||303
5086167|NCT01708629|12515122|P2|COMPLETED|Overall Study||604
5086168|NCT01708629|12515123|P1|COMPLETED|Overall Study||608
5086169|NCT01708629|12515120|P4|STARTED|Overall Study||315
5086170|NCT01708629|12515121|P3|STARTED|Overall Study||313
5086171|NCT01708629|12515122|P2|STARTED|Overall Study||629
5086172|NCT01708629|12515123|P1|STARTED|Overall Study||624
5086173|NCT01708603|12515140|P4|NOT COMPLETED|Overall Study||9
5086174|NCT01708603|12515141|P3|NOT COMPLETED|Overall Study||9
5086175|NCT01708603|12515142|P2|NOT COMPLETED|Overall Study||22
5086176|NCT01708603|12515143|P1|NOT COMPLETED|Overall Study||15
5086177|NCT01708603|12515140|P4|COMPLETED|Overall Study||300
5086178|NCT01708603|12515141|P3|COMPLETED|Overall Study||291
5086179|NCT01708603|12515142|P2|COMPLETED|Overall Study||588
5086180|NCT01708603|12515143|P1|COMPLETED|Overall Study||597
5086181|NCT01708603|12515140|P4|STARTED|Overall Study||309
5086182|NCT01708603|12515141|P3|STARTED|Overall Study||300
5086183|NCT01708603|12515142|P2|STARTED|Overall Study||610
5086184|NCT01708603|12515143|P1|STARTED|Overall Study||612
5086185|NCT01708590|12515164|P7|NOT COMPLETED|Withdrawal Phase||9
5086186|NCT01708590|12515165|P6|NOT COMPLETED|Withdrawal Phase||82
5086187|NCT01708590|12515166|P5|NOT COMPLETED|Withdrawal Phase||12
5086188|NCT01708590|12515167|P4|NOT COMPLETED|Withdrawal Phase||53
5086189|NCT01708590|12515168|P3|NOT COMPLETED|Withdrawal Phase||0
5086190|NCT01708590|12515169|P2|NOT COMPLETED|Withdrawal Phase||0
5086191|NCT01708590|12515170|P1|NOT COMPLETED|Withdrawal Phase||0
5086192|NCT01708590|12515164|P7|COMPLETED|Withdrawal Phase||74
5086193|NCT01708590|12515165|P6|COMPLETED|Withdrawal Phase||2
5086194|NCT01708590|12515166|P5|COMPLETED|Withdrawal Phase||45
5086195|NCT01708590|12515167|P4|COMPLETED|Withdrawal Phase||6
5086196|NCT01708590|12515168|P3|COMPLETED|Withdrawal Phase||0
5086197|NCT01708590|12515169|P2|COMPLETED|Withdrawal Phase||0
5086198|NCT01708590|12515170|P1|COMPLETED|Withdrawal Phase||0
5086199|NCT01708590|12515164|P7|STARTED|Withdrawal Phase||83
5086200|NCT01708590|12515165|P6|STARTED|Withdrawal Phase||84
5086201|NCT01708590|12515166|P5|STARTED|Withdrawal Phase||57
5086202|NCT01708590|12515167|P4|STARTED|Withdrawal Phase||59
5086203|NCT01708590|12515168|P3|STARTED|Withdrawal Phase||0
5086204|NCT01708590|12515169|P2|STARTED|Withdrawal Phase||0
5086205|NCT01708590|12515170|P1|STARTED|Withdrawal Phase||0
5086206|NCT01708590|12515164|P7|NOT COMPLETED|Induction Phase||0
5086207|NCT01708590|12515165|P6|NOT COMPLETED|Induction Phase||0
5086208|NCT01708590|12515166|P5|NOT COMPLETED|Induction Phase||0
5086209|NCT01708590|12515167|P4|NOT COMPLETED|Induction Phase||0
5086210|NCT01708590|12515168|P3|NOT COMPLETED|Induction Phase||11
5086211|NCT01708590|12515169|P2|NOT COMPLETED|Induction Phase||7
5086212|NCT01708590|12515170|P1|NOT COMPLETED|Induction Phase||10
5086213|NCT01708590|12515164|P7|COMPLETED|Induction Phase||0
5086214|NCT01708590|12515165|P6|COMPLETED|Induction Phase||0
5086215|NCT01708590|12515166|P5|COMPLETED|Induction Phase||0
5086216|NCT01708590|12515167|P4|COMPLETED|Induction Phase||0
5086217|NCT01708590|12515168|P3|COMPLETED|Induction Phase||209
5086218|NCT01708590|12515169|P2|COMPLETED|Induction Phase||212
5086219|NCT01708590|12515170|P1|COMPLETED|Induction Phase||212
5086220|NCT01708590|12515164|P7|STARTED|Induction Phase||0
5086221|NCT01708590|12515165|P6|STARTED|Induction Phase||0
5086222|NCT01708590|12515166|P5|STARTED|Induction Phase||0
5086223|NCT01708590|12515167|P4|STARTED|Induction Phase||0
5086224|NCT01708590|12515168|P3|STARTED|Induction Phase||220
5086225|NCT01708590|12515169|P2|STARTED|Induction Phase||219
5086226|NCT01708590|12515170|P1|STARTED|Induction Phase||222
5086227|NCT01708525|12515185|P1|NOT COMPLETED|Overall Study||0
5086228|NCT01708525|12515185|P1|COMPLETED|Overall Study||2
5086229|NCT01708525|12515185|P1|STARTED|Overall Study||2
5086230|NCT01708317|12515190|P1|NOT COMPLETED|Final Education Period||0
5086231|NCT01708317|12515190|P1|COMPLETED|Final Education Period||909
5086232|NCT01708317|12515190|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
5086233|NCT01708317|12515190|P1|NOT COMPLETED|ACASI + Education Period||0
5086234|NCT01708317|12515190|P1|COMPLETED|ACASI + Education Period||2601
5086235|NCT01708317|12515190|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
5086236|NCT01708317|12515190|P1|NOT COMPLETED|Initial Education Period||0
5086237|NCT01708317|12515190|P1|COMPLETED|Initial Education Period||982
5086238|NCT01708317|12515190|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
5086239|NCT01708317|12515190|P1|NOT COMPLETED|2010 Control Period||0
5086240|NCT01708317|12515190|P1|COMPLETED|2010 Control Period||3929
5086241|NCT01708317|12515190|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
5086242|NCT01708291|12515199|P2|NOT COMPLETED|Overall Study||1
5086243|NCT01708291|12515200|P1|NOT COMPLETED|Overall Study||2
5086244|NCT01708291|12515199|P2|COMPLETED|Overall Study||20
5086245|NCT01708291|12515200|P1|COMPLETED|Overall Study||19
5086246|NCT01708291|12515199|P2|STARTED|Overall Study||21
5086247|NCT01708291|12515200|P1|STARTED|Overall Study||21
5086248|NCT01708278|12515212|P6|NOT COMPLETED|Overall Study||0
5086249|NCT01708278|12515213|P5|NOT COMPLETED|Overall Study||0
5086250|NCT01708278|12515214|P4|NOT COMPLETED|Overall Study||0
5086251|NCT01708278|12515215|P3|NOT COMPLETED|Overall Study||0
5086252|NCT01708278|12515216|P2|NOT COMPLETED|Overall Study||0
5086253|NCT01708278|12515217|P1|NOT COMPLETED|Overall Study||0
5086254|NCT01708278|12515212|P6|COMPLETED|Overall Study||1
5086255|NCT01708278|12515213|P5|COMPLETED|Overall Study||1
5086256|NCT01708278|12515214|P4|COMPLETED|Overall Study||2
5086257|NCT01708278|12515215|P3|COMPLETED|Overall Study||2
5086258|NCT01708278|12515216|P2|COMPLETED|Overall Study||2
5086259|NCT01708278|12515217|P1|COMPLETED|Overall Study||1
5086260|NCT01708278|12515212|P6|STARTED|Overall Study||1
5086261|NCT01708278|12515213|P5|STARTED|Overall Study||1
5086262|NCT01708278|12515214|P4|STARTED|Overall Study||2
5086263|NCT01708278|12515215|P3|STARTED|Overall Study||2
5086264|NCT01708278|12515216|P2|STARTED|Overall Study||2
5086265|NCT01708278|12515217|P1|STARTED|Overall Study||1
5086266|NCT01708213|12515231|P1|NOT COMPLETED|Overall Study||1
5086267|NCT01708213|12515231|P1|COMPLETED|Overall Study||71
5086268|NCT01708213|12515231|P1|STARTED|Overall Study||72
5086269|NCT01708187|12515239|P2|NOT COMPLETED|Overall Study||1
5086270|NCT01708187|12515240|P1|NOT COMPLETED|Overall Study||0
5086271|NCT01708187|12515239|P2|COMPLETED|Overall Study||0
5086272|NCT01708187|12515240|P1|COMPLETED|Overall Study||1
5086273|NCT01708187|12515239|P2|STARTED|Overall Study||1
5086274|NCT01708187|12515240|P1|STARTED|Overall Study||1
5086275|NCT01708174|12515249|P3|NOT COMPLETED|Survival Follow-up||0
5086276|NCT01708174|12515250|P2|NOT COMPLETED|Survival Follow-up||0
5086277|NCT01708174|12515251|P1|NOT COMPLETED|Survival Follow-up||0
5086278|NCT01708174|12515249|P3|COMPLETED|Survival Follow-up||0
5086279|NCT01708174|12515250|P2|COMPLETED|Survival Follow-up||10
5086280|NCT01708174|12515251|P1|COMPLETED|Survival Follow-up||1
5086281|NCT01708174|12515249|P3|STARTED|Survival Follow-up||0
5086282|NCT01708174|12515250|P2|STARTED|Survival Follow-up||10
5086283|NCT01708174|12515251|P1|STARTED|Survival Follow-up||1
5086284|NCT01708174|12515249|P3|NOT COMPLETED|Treatment Period||1
5086285|NCT01708174|12515250|P2|NOT COMPLETED|Treatment Period||2
5086286|NCT01708174|12515251|P1|NOT COMPLETED|Treatment Period||1
5086287|NCT01708174|12515249|P3|COMPLETED|Treatment Period||3
5086288|NCT01708174|12515250|P2|COMPLETED|Treatment Period||14
5086289|NCT01708174|12515251|P1|COMPLETED|Treatment Period||1
5086290|NCT01708174|12515249|P3|Pharmacokinetic Analysis Set|Treatment Period||0
5086291|NCT01708174|12515250|P2|Pharmacokinetic Analysis Set|Treatment Period||13
5086292|NCT01708174|12515251|P1|Pharmacokinetic Analysis Set|Treatment Period||2
5086293|NCT01708174|12515249|P3|STARTED|Treatment Period||4
5086294|NCT01708174|12515250|P2|STARTED|Treatment Period||16
5086295|NCT01708174|12515251|P1|STARTED|Treatment Period||2
5086296|NCT01708161|12515283|P6|NOT COMPLETED|Overall Study||1
5086297|NCT01708161|12515284|P5|NOT COMPLETED|Overall Study||6
5086298|NCT01708161|12515285|P4|NOT COMPLETED|Overall Study||16
5086299|NCT01708161|12515286|P3|NOT COMPLETED|Overall Study||10
5086300|NCT01708161|12515287|P2|NOT COMPLETED|Overall Study||10
5086301|NCT01708161|12515288|P1|NOT COMPLETED|Overall Study||4
5086302|NCT01708161|12515283|P6|COMPLETED|Overall Study||0
5086303|NCT01708161|12515284|P5|COMPLETED|Overall Study||0
5086304|NCT01708161|12515285|P4|COMPLETED|Overall Study||0
5086305|NCT01708161|12515286|P3|COMPLETED|Overall Study||0
5086306|NCT01708161|12515287|P2|COMPLETED|Overall Study||0
5086307|NCT01708161|12515288|P1|COMPLETED|Overall Study||0
5086308|NCT01708161|12515283|P6|STARTED|Overall Study||1
5086309|NCT01708161|12515284|P5|STARTED|Overall Study||6
5086310|NCT01708161|12515285|P4|STARTED|Overall Study||16
5086311|NCT01708161|12515286|P3|STARTED|Overall Study||10
5086312|NCT01708161|12515287|P2|STARTED|Overall Study||10
5086313|NCT01708161|12515288|P1|STARTED|Overall Study||4
5086314|NCT01708122|12515330|P2|NOT COMPLETED|Overall Study||0
5086315|NCT01708122|12515331|P1|NOT COMPLETED|Overall Study||0
5086316|NCT01708122|12515330|P2|COMPLETED|Overall Study||26
5086317|NCT01708122|12515331|P1|COMPLETED|Overall Study||27
5086318|NCT01708122|12515330|P2|STARTED|Overall Study||26
5086319|NCT01708122|12515331|P1|STARTED|Overall Study||27
5086320|NCT01708057|12515339|P3|NOT COMPLETED|Overall Study||1
5086321|NCT01708057|12515340|P2|NOT COMPLETED|Overall Study||1
5086322|NCT01708057|12515341|P1|NOT COMPLETED|Overall Study||1
5086323|NCT01708057|12515339|P3|COMPLETED|Overall Study||0
5086324|NCT01708057|12515340|P2|COMPLETED|Overall Study||0
5086325|NCT01708057|12515341|P1|COMPLETED|Overall Study||0
5086326|NCT01708057|12515339|P3|STARTED|Overall Study||1
5086327|NCT01708057|12515340|P2|STARTED|Overall Study||1
5086328|NCT01708057|12515341|P1|STARTED|Overall Study||1
5086329|NCT01707992|12515400|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
5086330|NCT01707992|12515401|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
5086331|NCT01707992|12515402|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
5086332|NCT01707992|12515403|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
5086333|NCT01707992|12515404|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
5086334|NCT01707992|12515405|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
5086335|NCT01707992|12515400|P6|COMPLETED|Active Treatment Phase (24 Months)||0
5086336|NCT01707992|12515401|P5|COMPLETED|Active Treatment Phase (24 Months)||10
5086337|NCT01707992|12515402|P4|COMPLETED|Active Treatment Phase (24 Months)||7
5086338|NCT01707992|12515403|P3|COMPLETED|Active Treatment Phase (24 Months)||0
5086339|NCT01707992|12515404|P2|COMPLETED|Active Treatment Phase (24 Months)||0
5086340|NCT01707992|12515405|P1|COMPLETED|Active Treatment Phase (24 Months)||0
5086341|NCT01707992|12515400|P6|STARTED|Active Treatment Phase (24 Months)||215
5086342|NCT01707992|12515401|P5|STARTED|Active Treatment Phase (24 Months)||504
5086343|NCT01707992|12515402|P4|STARTED|Active Treatment Phase (24 Months)||891
5086344|NCT01707992|12515403|P3|STARTED|Active Treatment Phase (24 Months)||0
5086345|NCT01707992|12515404|P2|STARTED|Active Treatment Phase (24 Months)||0
5086346|NCT01707992|12515405|P1|STARTED|Active Treatment Phase (24 Months)||0
5086347|NCT01707992|12515400|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086348|NCT01707992|12515401|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086349|NCT01707992|12515402|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086350|NCT01707992|12515403|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
5086351|NCT01707992|12515404|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
5086352|NCT01707992|12515405|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
5086353|NCT01707992|12515400|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086354|NCT01707992|12515401|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086355|NCT01707992|12515402|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
5086356|NCT01707992|12515403|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
5086357|NCT01707992|12515404|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
5086358|NCT01707992|12515405|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
5086359|NCT01707992|12515400|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
5086360|NCT01707992|12515401|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
5086361|NCT01707992|12515402|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
5086362|NCT01707992|12515403|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
5086363|NCT01707992|12515404|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
5086364|NCT01707992|12515405|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
5086365|NCT01707693|12515457|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
5086366|NCT01707693|12515458|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
5086367|NCT01707693|12515457|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
5086368|NCT01707693|12515458|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
5086369|NCT01707693|12515457|P2|STARTED|Time 3 Measures @ 6 Mth||54
5086370|NCT01707693|12515458|P1|STARTED|Time 3 Measures @ 6 Mth||46
5086371|NCT01707693|12515457|P2|NOT COMPLETED|Overall Study Allocation||8
5086372|NCT01707693|12515458|P1|NOT COMPLETED|Overall Study Allocation||13
5086373|NCT01707693|12515457|P2|COMPLETED|Overall Study Allocation||54
5086374|NCT01707693|12515458|P1|COMPLETED|Overall Study Allocation||46
5086375|NCT01707693|12515457|P2|STARTED|Overall Study Allocation||62
5086376|NCT01707693|12515458|P1|STARTED|Overall Study Allocation||59
5086377|NCT01707667|12515472|P2|NOT COMPLETED|Period 2||0
5086378|NCT01707667|12515473|P1|NOT COMPLETED|Period 2||0
5086379|NCT01707667|12515472|P2|COMPLETED|Period 2||6
5086380|NCT01707667|12515473|P1|COMPLETED|Period 2||6
5086381|NCT01707667|12515472|P2|STARTED|Period 2||6
5086382|NCT01707667|12515473|P1|STARTED|Period 2||6
5086383|NCT01707667|12515472|P2|NOT COMPLETED|Period 1||0
5086384|NCT01707667|12515473|P1|NOT COMPLETED|Period 1||1
5086385|NCT01707667|12515472|P2|COMPLETED|Period 1||6
5086386|NCT01707667|12515473|P1|COMPLETED|Period 1||6
5086387|NCT01707667|12515472|P2|STARTED|Period 1||6
5086388|NCT01707667|12515473|P1|STARTED|Period 1||7
5086389|NCT01707654|12515491|P1|NOT COMPLETED|Overall Study||0
5086390|NCT01707654|12515491|P1|COMPLETED|Overall Study||9
5086391|NCT01707654|12515491|P1|STARTED|Overall Study||9
5086392|NCT01707472|12515498|P3|NOT COMPLETED|Overall Study||0
5086393|NCT01707472|12515499|P2|NOT COMPLETED|Overall Study||0
5086394|NCT01707472|12515500|P1|NOT COMPLETED|Overall Study||0
5086395|NCT01707472|12515498|P3|COMPLETED|Overall Study||8
5086396|NCT01707472|12515499|P2|COMPLETED|Overall Study||6
5086397|NCT01707472|12515500|P1|COMPLETED|Overall Study||4
5086398|NCT01707472|12515498|P3|STARTED|Overall Study||8
5086399|NCT01707472|12515499|P2|STARTED|Overall Study||6
5086400|NCT01707472|12515500|P1|STARTED|Overall Study||4
5086401|NCT01707381|12515523|P2|NOT COMPLETED|Period 2||0
5086402|NCT01707381|12515524|P1|NOT COMPLETED|Period 2||0
5086403|NCT01707381|12515523|P2|COMPLETED|Period 2||11
5086404|NCT01707381|12515524|P1|COMPLETED|Period 2||10
5086405|NCT01707381|12515523|P2|STARTED|Period 2||11
5086406|NCT01707381|12515524|P1|STARTED|Period 2||10
5086407|NCT01707381|12515523|P2|NOT COMPLETED|Period 1||2
5086408|NCT01707381|12515524|P1|NOT COMPLETED|Period 1||2
5086409|NCT01707381|12515523|P2|COMPLETED|Period 1||11
5086410|NCT01707381|12515524|P1|COMPLETED|Period 1||10
5086411|NCT01707381|12515523|P2|STARTED|Period 1||13
5086412|NCT01707381|12515524|P1|STARTED|Period 1||12
5086413|NCT01707368|12515534|P1|NOT COMPLETED|Overall Study||168
5086414|NCT01707368|12515534|P1|COMPLETED|Overall Study||393
5086415|NCT01707368|12515534|P1|STARTED|Overall Study||561
5086416|NCT01707290|12515543|P2|NOT COMPLETED|Overall Study||1
5086417|NCT01707290|12515544|P1|NOT COMPLETED|Overall Study||86
5086418|NCT01707290|12515543|P2|COMPLETED|Overall Study||3
5086419|NCT01707290|12515544|P1|COMPLETED|Overall Study||35
5086420|NCT01707290|12515543|P2|STARTED|Overall Study||4
5086421|NCT01707290|12515544|P1|STARTED|Overall Study||121
5086422|NCT01707238|12515567|P2|NOT COMPLETED|Overall Study||0
5086423|NCT01707238|12515568|P1|NOT COMPLETED|Overall Study||0
5086424|NCT01707238|12515567|P2|COMPLETED|Overall Study||52
5086425|NCT01707238|12515568|P1|COMPLETED|Overall Study||48
5086426|NCT01707238|12515567|P2|STARTED|Overall Study||52
5086427|NCT01707238|12515568|P1|STARTED|Overall Study||48
5086428|NCT01707225|12515584|P1|NOT COMPLETED|Overall Study||0
5086429|NCT01707225|12515584|P1|COMPLETED|Overall Study||10
5086430|NCT01707225|12515584|P1|STARTED|Overall Study||10
5086431|NCT01707147|12515589|P1|NOT COMPLETED|Overall Study||100
5086432|NCT01707147|12515589|P1|COMPLETED|Overall Study||3119
5086433|NCT01707147|12515589|P1|STARTED|Overall Study||3219
5086434|NCT01707095|12515599|P2|NOT COMPLETED|Overall Study||0
5086435|NCT01707095|12515600|P1|NOT COMPLETED|Overall Study||0
5086436|NCT01707095|12515599|P2|COMPLETED|Overall Study||42
5086437|NCT01707095|12515600|P1|COMPLETED|Overall Study||42
5086438|NCT01707095|12515599|P2|STARTED|Overall Study||42
5086439|NCT01707095|12515600|P1|STARTED|Overall Study||42
5086440|NCT01707043|12515610|P2|NOT COMPLETED|Overall Study||0
5086441|NCT01707043|12515611|P1|NOT COMPLETED|Overall Study||0
5086442|NCT01707043|12515610|P2|COMPLETED|Overall Study||10
5086443|NCT01707043|12515611|P1|COMPLETED|Overall Study||10
5086444|NCT01707043|12515610|P2|STARTED|Overall Study||10
5086445|NCT01707043|12515611|P1|STARTED|Overall Study||10
5086446|NCT01707030|12515621|P2|NOT COMPLETED|Overall Study||17
5086447|NCT01707030|12515622|P1|NOT COMPLETED|Overall Study||11
5086448|NCT01707030|12515621|P2|COMPLETED|Overall Study||54
5086449|NCT01707030|12515622|P1|COMPLETED|Overall Study||56
5086450|NCT01707030|12515621|P2|STARTED|Overall Study||71
5086451|NCT01707030|12515622|P1|STARTED|Overall Study||67
5086452|NCT01707004|12515640|P1|NOT COMPLETED|Overall Study||3
5086453|NCT01707004|12515640|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
5086454|NCT01707004|12515640|P1|STARTED|Overall Study||20
5086455|NCT01706978|12515654|P2|NOT COMPLETED|Overall Study||6
5086456|NCT01706978|12515655|P1|NOT COMPLETED|Overall Study||9
5086457|NCT01706978|12515654|P2|COMPLETED|Overall Study||35
5086458|NCT01706978|12515655|P1|COMPLETED|Overall Study||38
5086459|NCT01706978|12515654|P2|STARTED|Overall Study||41
5086460|NCT01706978|12515655|P1|STARTED|Overall Study||47
5086461|NCT01706965|12515669|P2|NOT COMPLETED|Overall Study||1
5086462|NCT01706965|12515670|P1|NOT COMPLETED|Overall Study||1
5086463|NCT01706965|12515669|P2|COMPLETED|Overall Study||12
5086464|NCT01706965|12515670|P1|COMPLETED|Overall Study||13
5086465|NCT01706965|12515669|P2|STARTED|Overall Study||13
5086466|NCT01706965|12515670|P1|STARTED|Overall Study||14
5086467|NCT01706952|12515678|P1|NOT COMPLETED|Overall Study||8
5086468|NCT01706952|12515678|P1|COMPLETED|Overall Study||37
5086469|NCT01706952|12515678|P1|STARTED|Overall Study||45
5086470|NCT01706926|12515694|P4|NOT COMPLETED|Overall Study||5
5086471|NCT01706926|12515695|P3|NOT COMPLETED|Overall Study||6
5086472|NCT01706926|12515696|P2|NOT COMPLETED|Overall Study||4
5086473|NCT01706926|12515697|P1|NOT COMPLETED|Overall Study||6
5086474|NCT01706926|12515694|P4|COMPLETED|Overall Study||74
5086475|NCT01706926|12515695|P3|COMPLETED|Overall Study||79
5086476|NCT01706926|12515696|P2|COMPLETED|Overall Study||77
5086477|NCT01706926|12515697|P1|COMPLETED|Overall Study||75
5086478|NCT01706926|12515694|P4|STARTED|Overall Study||79
5086479|NCT01706926|12515695|P3|STARTED|Overall Study||85
5086480|NCT01706926|12515696|P2|STARTED|Overall Study||81
5086481|NCT01706926|12515697|P1|STARTED|Overall Study||81
5086482|NCT01706822|12515806|P1|NOT COMPLETED|Overall Study||0
5086483|NCT01706822|12515806|P1|COMPLETED|Overall Study||8
5086484|NCT01706822|12515806|P1|STARTED|Overall Study||8
5086485|NCT01706770|12515816|P2|NOT COMPLETED|Overall Study||0
5086486|NCT01706770|12515817|P1|NOT COMPLETED|Overall Study||2
5086487|NCT01706770|12515816|P2|COMPLETED|Overall Study||17
5086488|NCT01706770|12515817|P1|COMPLETED|Overall Study||31
5086489|NCT01706770|12515816|P2|STARTED|Overall Study||17
5086490|NCT01706770|12515817|P1|STARTED|Overall Study||33
5086491|NCT01706666|12515828|P3|NOT COMPLETED|Overall Study||0
5086492|NCT01706666|12515829|P2|NOT COMPLETED|Overall Study||0
5086493|NCT01706666|12515830|P1|NOT COMPLETED|Overall Study||0
5086494|NCT01706666|12515828|P3|COMPLETED|Overall Study||1
5086495|NCT01706666|12515829|P2|COMPLETED|Overall Study||1
5086496|NCT01706666|12515830|P1|COMPLETED|Overall Study||1
5086497|NCT01706666|12515828|P3|STARTED|Overall Study||1
5086498|NCT01706666|12515829|P2|STARTED|Overall Study||1
5086499|NCT01706666|12515830|P1|STARTED|Overall Study||1
5086500|NCT01706588|12515849|P5|NOT COMPLETED|Overall Study||0
5086501|NCT01706588|12515850|P4|NOT COMPLETED|Overall Study||0
5086502|NCT01706588|12515851|P3|NOT COMPLETED|Overall Study||0
5086503|NCT01706588|12515852|P2|NOT COMPLETED|Overall Study||0
5086504|NCT01706588|12515853|P1|NOT COMPLETED|Overall Study||0
5086505|NCT01706588|12515849|P5|COMPLETED|Overall Study||16
5086506|NCT01706588|12515850|P4|COMPLETED|Overall Study||14
5086507|NCT01706588|12515851|P3|COMPLETED|Overall Study||15
5086508|NCT01706588|12515852|P2|COMPLETED|Overall Study||15
5086509|NCT01706588|12515853|P1|COMPLETED|Overall Study||15
5086510|NCT01706588|12515849|P5|STARTED|Overall Study||16
5086511|NCT01706588|12515850|P4|STARTED|Overall Study||14
5086512|NCT01706588|12515851|P3|STARTED|Overall Study||15
5086513|NCT01706588|12515852|P2|STARTED|Overall Study||15
5086514|NCT01706588|12515853|P1|STARTED|Overall Study||15
5086515|NCT01706575|12515865|P1|NOT COMPLETED|Overall Study||12
5086516|NCT01706575|12515865|P1|COMPLETED|Overall Study||64
5086517|NCT01706575|12515865|P1|Treated|Overall Study||70
5086518|NCT01706575|12515865|P1|STARTED|Overall Study||76
5086519|NCT01706549|12515876|P1|NOT COMPLETED|Overall Study||0
5086520|NCT01706549|12515876|P1|COMPLETED|Overall Study||16
5086521|NCT01706549|12515876|P1|STARTED|Overall Study||16
5086522|NCT01706536|12515886|P5|NOT COMPLETED|Overall Study||2
5086523|NCT01706536|12515887|P4|NOT COMPLETED|Overall Study||4
5086524|NCT01706536|12515888|P3|NOT COMPLETED|Overall Study||5
5086525|NCT01706536|12515889|P2|NOT COMPLETED|Overall Study||4
5086526|NCT01706536|12515890|P1|NOT COMPLETED|Overall Study||4
5086527|NCT01706536|12515886|P5|COMPLETED|Overall Study||57
5086528|NCT01706536|12515887|P4|COMPLETED|Overall Study||53
5086529|NCT01706536|12515888|P3|COMPLETED|Overall Study||49
5086530|NCT01706536|12515889|P2|COMPLETED|Overall Study||51
5086531|NCT01706536|12515890|P1|COMPLETED|Overall Study||53
5086532|NCT01706536|12515886|P5|STARTED|Overall Study||59
5086533|NCT01706536|12515887|P4|STARTED|Overall Study||57
5086534|NCT01706536|12515888|P3|STARTED|Overall Study||54
5086535|NCT01706536|12515889|P2|STARTED|Overall Study||55
5086536|NCT01706536|12515890|P1|STARTED|Overall Study||57
5086537|NCT01706497|12515947|P1|NOT COMPLETED|Overall Study||0
5086538|NCT01706497|12515947|P1|COMPLETED|Overall Study||177
5086539|NCT01706497|12515947|P1|STARTED|Overall Study||177
5086540|NCT01706458|12515957|P2|NOT COMPLETED|Overall Study||4
5086541|NCT01706458|12515958|P1|NOT COMPLETED|Overall Study||3
5086542|NCT01706458|12515957|P2|COMPLETED|Overall Study||5
5086543|NCT01706458|12515958|P1|COMPLETED|Overall Study||6
5086544|NCT01706458|12515957|P2|STARTED|Overall Study||9
5086545|NCT01706458|12515958|P1|STARTED|Overall Study||9
5086546|NCT01706328|12515982|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
5086547|NCT01706328|12515983|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
5086548|NCT01706328|12515984|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
5086549|NCT01706328|12515982|P3|COMPLETED|12-week Double-blind Treatment Period||371
5086550|NCT01706328|12515983|P2|COMPLETED|12-week Double-blind Treatment Period||366
5086551|NCT01706328|12515984|P1|COMPLETED|12-week Double-blind Treatment Period||0
5086552|NCT01706328|12515982|P3|STARTED|12-week Double-blind Treatment Period||416
5086553|NCT01706328|12515983|P2|STARTED|12-week Double-blind Treatment Period||412
5086554|NCT01706328|12515984|P1|STARTED|12-week Double-blind Treatment Period||0
5086555|NCT01706328|12515982|P3|NOT COMPLETED|2-week Run-in Period||0
5086556|NCT01706328|12515983|P2|NOT COMPLETED|2-week Run-in Period||0
5086557|NCT01706328|12515984|P1|NOT COMPLETED|2-week Run-in Period||165
5086558|NCT01706328|12515982|P3|COMPLETED|2-week Run-in Period||0
5086559|NCT01706328|12515983|P2|COMPLETED|2-week Run-in Period||0
5086560|NCT01706328|12515984|P1|COMPLETED|2-week Run-in Period||828
5086561|NCT01706328|12515982|P3|STARTED|2-week Run-in Period||0
5086562|NCT01706328|12515983|P2|STARTED|2-week Run-in Period||0
5086563|NCT01706328|12515984|P1|STARTED|2-week Run-in Period||993
5086564|NCT01706263|12515994|P1|NOT COMPLETED|Overall Study||0
5086565|NCT01706263|12515994|P1|COMPLETED|Overall Study||28
5086566|NCT01706263|12515994|P1|STARTED|Overall Study||28
5086567|NCT01706250|12516003|P1|NOT COMPLETED|Overall Study||2
5086568|NCT01706250|12516003|P1|COMPLETED|Overall Study||18
5086569|NCT01706250|12516003|P1|STARTED|Overall Study||20
5086570|NCT01706198|12516034|P2|NOT COMPLETED|Overall Study||194
5086571|NCT01706198|12516035|P1|NOT COMPLETED|Overall Study||173
5086572|NCT01706198|12516034|P2|COMPLETED|Overall Study||1920
5086573|NCT01706198|12516035|P1|COMPLETED|Overall Study||1946
5086574|NCT01706198|12516034|P2|STARTED|Overall Study||2114
5086575|NCT01706198|12516035|P1|STARTED|Overall Study||2119
5086576|NCT01706159|12516087|P2|NOT COMPLETED|Overall Study||2
5086577|NCT01706159|12516088|P1|NOT COMPLETED|Overall Study||8
5086578|NCT01706159|12516087|P2|COMPLETED|Overall Study||4
5086579|NCT01706159|12516088|P1|COMPLETED|Overall Study||6
5086580|NCT01706159|12516087|P2|Completers (With Baron Score at Week 8)|Overall Study||3
5086581|NCT01706159|12516088|P1|Completers (With Baron Score at Week 8)|Overall Study||6
5086582|NCT01706159|12516087|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
5086583|NCT01706159|12516088|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
5086584|NCT01706159|12516087|P2|STARTED|Overall Study||6
5086585|NCT01706159|12516088|P1|STARTED|Overall Study||14
5086586|NCT01706146|12516102|P1|NOT COMPLETED|Overall Study||6
5086587|NCT01706146|12516102|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
5086588|NCT01706146|12516102|P1|STARTED|Overall Study||59
5086589|NCT01706081|12516109|P2|NOT COMPLETED|Overall Study||0
5086590|NCT01706081|12516110|P1|NOT COMPLETED|Overall Study||0
5086591|NCT01706081|12516109|P2|COMPLETED|Overall Study||42
5086592|NCT01706081|12516110|P1|COMPLETED|Overall Study||40
5086593|NCT01706081|12516109|P2|STARTED|Overall Study||42
5086594|NCT01706081|12516110|P1|STARTED|Overall Study||40
5086595|NCT01706003|12516122|P2|NOT COMPLETED|Overall Study||4
5086596|NCT01706003|12516123|P1|NOT COMPLETED|Overall Study||11
5086597|NCT01706003|12516122|P2|COMPLETED|Overall Study||18
5086598|NCT01706003|12516123|P1|COMPLETED|Overall Study||12
5086599|NCT01706003|12516122|P2|STARTED|Overall Study||22
5086600|NCT01706003|12516123|P1|STARTED|Overall Study||23
5086601|NCT01705977|12516131|P2|NOT COMPLETED|Overall Study||260
5086602|NCT01705977|12516132|P1|NOT COMPLETED|Overall Study||273
5086603|NCT01705977|12516131|P2|COMPLETED|Overall Study||1741
5086604|NCT01705977|12516132|P1|COMPLETED|Overall Study||1729
5086605|NCT01705977|12516131|P2|STARTED|Overall Study||2001
5086606|NCT01705977|12516132|P1|STARTED|Overall Study||2002
5086607|NCT01705730|12516150|P1|NOT COMPLETED|Overall Study||9
5086608|NCT01705730|12516150|P1|COMPLETED|Overall Study||59
5086609|NCT01705730|12516150|P1|STARTED|Overall Study|Participants who received study drug|68
5086610|NCT01705717|12516190|P2|NOT COMPLETED|Overall Study||5
5086611|NCT01705717|12516191|P1|NOT COMPLETED|Overall Study||2
5086612|NCT01705717|12516190|P2|COMPLETED|Overall Study||7
5086613|NCT01705717|12516191|P1|COMPLETED|Overall Study||35
5086614|NCT01705717|12516190|P2|STARTED|Overall Study||12
5086615|NCT01705717|12516191|P1|STARTED|Overall Study||37
5086616|NCT01705691|12516208|P2|NOT COMPLETED|Overall Study||6
5086617|NCT01705691|12516209|P1|NOT COMPLETED|Overall Study||3
5086618|NCT01705691|12516208|P2|COMPLETED|Overall Study||24
5086619|NCT01705691|12516209|P1|COMPLETED|Overall Study||16
5086620|NCT01705691|12516208|P2|STARTED|Overall Study||30
5086621|NCT01705691|12516209|P1|STARTED|Overall Study||19
5086622|NCT01705652|12516229|P2|NOT COMPLETED|Overall Study||3
5086623|NCT01705652|12516230|P1|NOT COMPLETED|Overall Study||3
5086624|NCT01705652|12516229|P2|COMPLETED|Overall Study||9
5086625|NCT01705652|12516230|P1|COMPLETED|Overall Study||6
5086626|NCT01705652|12516229|P2|STARTED|Overall Study||12
5086627|NCT01705652|12516230|P1|STARTED|Overall Study||9
5086628|NCT01705587|12516238|P2|NOT COMPLETED|Overall Study||1
5086629|NCT01705587|12516239|P1|NOT COMPLETED|Overall Study||0
5086630|NCT01705587|12516238|P2|COMPLETED|Overall Study||5
5086631|NCT01705587|12516239|P1|COMPLETED|Overall Study||7
5086632|NCT01705587|12516238|P2|STARTED|Overall Study||6
5086633|NCT01705587|12516239|P1|STARTED|Overall Study||7
5086634|NCT01705574|12516257|P4|NOT COMPLETED|Open-Label Extension Phase||5
5086635|NCT01705574|12516258|P3|NOT COMPLETED|Open-Label Extension Phase||11
5086636|NCT01705574|12516259|P2|NOT COMPLETED|Open-Label Extension Phase||0
5086637|NCT01705574|12516260|P1|NOT COMPLETED|Open-Label Extension Phase||15
5086638|NCT01705574|12516257|P4|COMPLETED|Open-Label Extension Phase||48
5086639|NCT01705574|12516258|P3|COMPLETED|Open-Label Extension Phase||148
5086640|NCT01705574|12516259|P2|COMPLETED|Open-Label Extension Phase||0
5086641|NCT01705574|12516260|P1|COMPLETED|Open-Label Extension Phase||231
5086642|NCT01705574|12516257|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
5086643|NCT01705574|12516258|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
5086644|NCT01705574|12516259|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
5086645|NCT01705574|12516260|P1|STARTED|Open-Label Extension Phase||246
5086646|NCT01705574|12516257|P4|NOT COMPLETED|Double-Blind Phase||0
5086647|NCT01705574|12516258|P3|NOT COMPLETED|Double-Blind Phase||0
5086648|NCT01705574|12516259|P2|NOT COMPLETED|Double-Blind Phase||41
5086649|NCT01705574|12516260|P1|NOT COMPLETED|Double-Blind Phase||33
5086650|NCT01705574|12516257|P4|COMPLETED|Double-Blind Phase||0
5086651|NCT01705574|12516258|P3|COMPLETED|Double-Blind Phase||0
5086652|NCT01705574|12516259|P2|COMPLETED|Double-Blind Phase||249
5086653|NCT01705574|12516260|P1|COMPLETED|Double-Blind Phase||260
5086654|NCT01705574|12516257|P4|STARTED|Double-Blind Phase||0
5086655|NCT01705574|12516258|P3|STARTED|Double-Blind Phase||0
5086656|NCT01705574|12516259|P2|STARTED|Double-Blind Phase||290
5086657|NCT01705574|12516260|P1|STARTED|Double-Blind Phase||293
5086658|NCT01705509|12516277|P1|NOT COMPLETED|CPET w/ Ranexa||2
5086659|NCT01705509|12516277|P1|COMPLETED|CPET w/ Ranexa||5
5086660|NCT01705509|12516277|P1|STARTED|CPET w/ Ranexa||7
5086661|NCT01705509|12516277|P1|NOT COMPLETED|Inclusion CPET||7
5086662|NCT01705509|12516277|P1|COMPLETED|Inclusion CPET||7
5086663|NCT01705509|12516277|P1|STARTED|Inclusion CPET||14
5086664|NCT01705496|12516281|P1|NOT COMPLETED|Overall Study||4
5086665|NCT01705496|12516281|P1|COMPLETED|Overall Study||19
5086666|NCT01705496|12516281|P1|STARTED|Overall Study||23
5086667|NCT01705288|12516293|P2|NOT COMPLETED|Overall Study||0
5086668|NCT01705288|12516294|P1|NOT COMPLETED|Overall Study||0
5086669|NCT01705288|12516293|P2|COMPLETED|Overall Study||51
5086670|NCT01705288|12516294|P1|COMPLETED|Overall Study||52
5086671|NCT01705288|12516293|P2|STARTED|Overall Study||51
5086672|NCT01705288|12516294|P1|STARTED|Overall Study||52
5086673|NCT01705236|12516304|P1|NOT COMPLETED|Overall Study||27
5086674|NCT01705236|12516304|P1|COMPLETED|Overall Study||60
5086675|NCT01705236|12516304|P1|STARTED|Overall Study||87
5086676|NCT01705145|12516313|P1|NOT COMPLETED|Part B||1
5086677|NCT01705145|12516313|P1|COMPLETED|Part B||33
5086678|NCT01705145|12516313|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
5086679|NCT01705145|12516313|P1|NOT COMPLETED|Part A||0
5086680|NCT01705145|12516313|P1|COMPLETED|Part A||9
5086681|NCT01705145|12516313|P1|STARTED|Part A||9
5086682|NCT01705106|12516341|P1|NOT COMPLETED|Overall Study||0
5086683|NCT01705106|12516341|P1|COMPLETED|Overall Study||21
5086684|NCT01705106|12516341|P1|STARTED|Overall Study||21
5086685|NCT01705080|12516353|P4|NOT COMPLETED|Overall Study||42
5086686|NCT01705080|12516354|P3|NOT COMPLETED|Overall Study||5
5086687|NCT01705080|12516355|P2|NOT COMPLETED|Overall Study||16
5086688|NCT01705080|12516356|P1|NOT COMPLETED|Overall Study||15
5086689|NCT01705080|12516353|P4|COMPLETED|Overall Study||9
5086690|NCT01705080|12516354|P3|COMPLETED|Overall Study||27
5086691|NCT01705080|12516355|P2|COMPLETED|Overall Study||98
5086692|NCT01705080|12516356|P1|COMPLETED|Overall Study||142
5086693|NCT01705080|12516353|P4|1 Month|Overall Study||10
5086694|NCT01705080|12516354|P3|1 Month|Overall Study||27
5086695|NCT01705080|12516355|P2|1 Month|Overall Study||97
5086696|NCT01705080|12516356|P1|1 Month|Overall Study||148
5086697|NCT01705080|12516353|P4|Procedure|Overall Study||10
5086698|NCT01705080|12516354|P3|Procedure|Overall Study||29
5086699|NCT01705080|12516355|P2|Procedure|Overall Study||103
5086700|NCT01705080|12516356|P1|Procedure|Overall Study||149
5086701|NCT01705080|12516353|P4|STARTED|Overall Study||51
5086702|NCT01705080|12516354|P3|STARTED|Overall Study||32
5086703|NCT01705080|12516355|P2|STARTED|Overall Study||114
5086704|NCT01705080|12516356|P1|STARTED|Overall Study||157
5086705|NCT01704976|12516468|P2|NOT COMPLETED|Overall Study||2
5086706|NCT01704976|12516469|P1|NOT COMPLETED|Overall Study||1
5086707|NCT01704976|12516468|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
5086708|NCT01704976|12516469|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
5086709|NCT01704976|12516468|P2|STARTED|Overall Study||13
5086710|NCT01704976|12516469|P1|STARTED|Overall Study||14
5086711|NCT01704846|12516485|P2|NOT COMPLETED|Treatment Period 4||0
5086712|NCT01704846|12516486|P1|NOT COMPLETED|Treatment Period 4||0
5086713|NCT01704846|12516485|P2|COMPLETED|Treatment Period 4||29
5086714|NCT01704846|12516486|P1|COMPLETED|Treatment Period 4||30
5086715|NCT01704846|12516485|P2|STARTED|Treatment Period 4||29
5086716|NCT01704846|12516486|P1|STARTED|Treatment Period 4||30
5086717|NCT01704846|12516485|P2|NOT COMPLETED|Treatment Period 3||0
5086718|NCT01704846|12516486|P1|NOT COMPLETED|Treatment Period 3||0
5086719|NCT01704846|12516485|P2|COMPLETED|Treatment Period 3||29
5086720|NCT01704846|12516486|P1|COMPLETED|Treatment Period 3||30
5086721|NCT01704846|12516485|P2|STARTED|Treatment Period 3||29
5086722|NCT01704846|12516486|P1|STARTED|Treatment Period 3||30
5086723|NCT01704846|12516485|P2|NOT COMPLETED|Treatment Period 2||1
5086724|NCT01704846|12516486|P1|NOT COMPLETED|Treatment Period 2||0
5086725|NCT01704846|12516485|P2|COMPLETED|Treatment Period 2||29
5086726|NCT01704846|12516486|P1|COMPLETED|Treatment Period 2||30
5086727|NCT01704846|12516485|P2|STARTED|Treatment Period 2||30
5086728|NCT01704846|12516486|P1|STARTED|Treatment Period 2||30
5086729|NCT01704846|12516485|P2|NOT COMPLETED|Treatment Period 1||0
5086730|NCT01704846|12516486|P1|NOT COMPLETED|Treatment Period 1||0
5086731|NCT01704846|12516485|P2|COMPLETED|Treatment Period 1||30
5086732|NCT01704846|12516486|P1|COMPLETED|Treatment Period 1||30
5086733|NCT01704846|12516485|P2|STARTED|Treatment Period 1||30
5086734|NCT01704846|12516486|P1|STARTED|Treatment Period 1||30
5086735|NCT01704781|12516509|P5|NOT COMPLETED|Overall Study||0
5086736|NCT01704781|12516510|P4|NOT COMPLETED|Overall Study||0
5086737|NCT01704781|12516511|P3|NOT COMPLETED|Overall Study||0
5086738|NCT01704781|12516512|P2|NOT COMPLETED|Overall Study||0
5086739|NCT01704781|12516513|P1|NOT COMPLETED|Overall Study||0
5086740|NCT01704781|12516509|P5|COMPLETED|Overall Study||12
5086741|NCT01704781|12516510|P4|COMPLETED|Overall Study||12
5086742|NCT01704781|12516511|P3|COMPLETED|Overall Study||6
5086743|NCT01704781|12516512|P2|COMPLETED|Overall Study||3
5086744|NCT01704781|12516513|P1|COMPLETED|Overall Study||3
5086745|NCT01704781|12516509|P5|STARTED|Overall Study||12
5086746|NCT01704781|12516510|P4|STARTED|Overall Study||12
5086747|NCT01704781|12516511|P3|STARTED|Overall Study||6
5086748|NCT01704781|12516512|P2|STARTED|Overall Study||3
5086749|NCT01704781|12516513|P1|STARTED|Overall Study||3
5086750|NCT01704755|12516541|P2|NOT COMPLETED|Overall Study||7
5086751|NCT01704755|12516542|P1|NOT COMPLETED|Overall Study||12
5086752|NCT01704755|12516541|P2|COMPLETED|Overall Study||165
5086753|NCT01704755|12516542|P1|COMPLETED|Overall Study||196
5086754|NCT01704755|12516541|P2|Completed Study Drug|Overall Study||163
5086755|NCT01704755|12516542|P1|Completed Study Drug|Overall Study||204
5086756|NCT01704755|12516541|P2|STARTED|Overall Study||172
5086757|NCT01704755|12516542|P1|STARTED|Overall Study||208
5086758|NCT01704651|12516556|P2|NOT COMPLETED|Overall Study||7
5086759|NCT01704651|12516557|P1|NOT COMPLETED|Overall Study||5
5086760|NCT01704651|12516556|P2|COMPLETED|Overall Study||68
5086761|NCT01704651|12516557|P1|COMPLETED|Overall Study||66
5086762|NCT01704651|12516556|P2|STARTED|Overall Study||75
5086763|NCT01704651|12516557|P1|STARTED|Overall Study||71
5086764|NCT01704599|12516565|P1|NOT COMPLETED|Overall Study||1
5086765|NCT01704599|12516565|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
5086766|NCT01704599|12516565|P1|STARTED|Overall Study|Study was started January 22, 2010|8
5086767|NCT01704521|12516594|P2|NOT COMPLETED|Overall Study||0
5086768|NCT01704521|12516595|P1|NOT COMPLETED|Overall Study||0
5086769|NCT01704521|12516594|P2|COMPLETED|Overall Study||2
5086770|NCT01704521|12516595|P1|COMPLETED|Overall Study||3
5086771|NCT01704521|12516594|P2|STARTED|Overall Study||2
5086772|NCT01704521|12516595|P1|STARTED|Overall Study||3
5086773|NCT01704495|12516605|P4|NOT COMPLETED|Optional Safety Extension||31
5086774|NCT01704495|12516606|P3|NOT COMPLETED|Optional Safety Extension||31
5086775|NCT01704495|12516607|P2|NOT COMPLETED|Optional Safety Extension||33
5086776|NCT01704495|12516608|P1|NOT COMPLETED|Optional Safety Extension||29
5086777|NCT01704495|12516605|P4|COMPLETED|Optional Safety Extension||85
5086778|NCT01704495|12516606|P3|COMPLETED|Optional Safety Extension||83
5086779|NCT01704495|12516607|P2|COMPLETED|Optional Safety Extension||88
5086780|NCT01704495|12516608|P1|COMPLETED|Optional Safety Extension||87
5086868|NCT01704079|12516927|P2|NOT COMPLETED|Overall Study||23
5086781|NCT01704495|12516605|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
5086782|NCT01704495|12516606|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
5086783|NCT01704495|12516607|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
5086784|NCT01704495|12516608|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
5086785|NCT01704495|12516605|P4|NOT COMPLETED|Subjects Randomized||17
5086786|NCT01704495|12516606|P3|NOT COMPLETED|Subjects Randomized||16
5086787|NCT01704495|12516607|P2|NOT COMPLETED|Subjects Randomized||15
5086788|NCT01704495|12516608|P1|NOT COMPLETED|Subjects Randomized||22
5086789|NCT01704495|12516605|P4|COMPLETED|Subjects Randomized||145
5086790|NCT01704495|12516606|P3|COMPLETED|Subjects Randomized||144
5086791|NCT01704495|12516607|P2|COMPLETED|Subjects Randomized||141
5086792|NCT01704495|12516608|P1|COMPLETED|Subjects Randomized||140
5086793|NCT01704495|12516605|P4|STARTED|Subjects Randomized||162
5086794|NCT01704495|12516606|P3|STARTED|Subjects Randomized||160
5086795|NCT01704495|12516607|P2|STARTED|Subjects Randomized||156
5086796|NCT01704495|12516608|P1|STARTED|Subjects Randomized||162
5086797|NCT01704456|12516784|P2|NOT COMPLETED|Overall Study||14
5086798|NCT01704456|12516785|P1|NOT COMPLETED|Overall Study||8
5086799|NCT01704456|12516784|P2|COMPLETED|Overall Study||49
5086800|NCT01704456|12516785|P1|COMPLETED|Overall Study||59
5086801|NCT01704456|12516784|P2|STARTED|Overall Study||63
5086802|NCT01704456|12516785|P1|STARTED|Overall Study||67
5086803|NCT01704404|12516805|P6|NOT COMPLETED|Overall Study||0
5086804|NCT01704404|12516806|P5|NOT COMPLETED|Overall Study||1
5086805|NCT01704404|12516807|P4|NOT COMPLETED|Overall Study||3
5086806|NCT01704404|12516808|P3|NOT COMPLETED|Overall Study||1
5086807|NCT01704404|12516809|P2|NOT COMPLETED|Overall Study||1
5086808|NCT01704404|12516810|P1|NOT COMPLETED|Overall Study||1
5086809|NCT01704404|12516805|P6|COMPLETED|Overall Study||9
5086810|NCT01704404|12516806|P5|COMPLETED|Overall Study||10
5086811|NCT01704404|12516807|P4|COMPLETED|Overall Study||8
5086812|NCT01704404|12516808|P3|COMPLETED|Overall Study||9
5086813|NCT01704404|12516809|P2|COMPLETED|Overall Study||9
5086814|NCT01704404|12516810|P1|COMPLETED|Overall Study||10
5086815|NCT01704404|12516805|P6|STARTED|Overall Study||9
5086816|NCT01704404|12516806|P5|STARTED|Overall Study||11
5086817|NCT01704404|12516807|P4|STARTED|Overall Study||11
5086818|NCT01704404|12516808|P3|STARTED|Overall Study||10
5086819|NCT01704404|12516809|P2|STARTED|Overall Study||10
5086820|NCT01704404|12516810|P1|STARTED|Overall Study||11
5086821|NCT01704287|12516847|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
5086822|NCT01704287|12516848|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
5086823|NCT01704287|12516849|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086824|NCT01704287|12516850|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086825|NCT01704287|12516851|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086826|NCT01704287|12516847|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
5086827|NCT01704287|12516848|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
5086828|NCT01704287|12516849|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086829|NCT01704287|12516850|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086830|NCT01704287|12516851|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
5086831|NCT01704287|12516847|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
5086832|NCT01704287|12516848|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
5086833|NCT01704287|12516849|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
5086834|NCT01704287|12516850|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
5086835|NCT01704287|12516851|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
5086836|NCT01704287|12516847|P5|NOT COMPLETED|Initial Treatment Period||0
5086837|NCT01704287|12516848|P4|NOT COMPLETED|Initial Treatment Period||0
5086838|NCT01704287|12516849|P3|NOT COMPLETED|Initial Treatment Period||173
5086839|NCT01704287|12516850|P2|NOT COMPLETED|Initial Treatment Period||134
5086840|NCT01704287|12516851|P1|NOT COMPLETED|Initial Treatment Period||147
5086841|NCT01704287|12516847|P5|COMPLETED|Initial Treatment Period||0
5086842|NCT01704287|12516848|P4|COMPLETED|Initial Treatment Period||0
5086843|NCT01704287|12516849|P3|COMPLETED|Initial Treatment Period||6
5086844|NCT01704287|12516850|P2|COMPLETED|Initial Treatment Period||47
5086845|NCT01704287|12516851|P1|COMPLETED|Initial Treatment Period||33
5086846|NCT01704287|12516847|P5|Treated|Initial Treatment Period||0
5086847|NCT01704287|12516848|P4|Treated|Initial Treatment Period||0
5086848|NCT01704287|12516849|P3|Treated|Initial Treatment Period||171
5086849|NCT01704287|12516850|P2|Treated|Initial Treatment Period||179
5086850|NCT01704287|12516851|P1|Treated|Initial Treatment Period||178
5086851|NCT01704287|12516847|P5|STARTED|Initial Treatment Period||0
5086852|NCT01704287|12516848|P4|STARTED|Initial Treatment Period||0
5086853|NCT01704287|12516849|P3|STARTED|Initial Treatment Period||179
5086854|NCT01704287|12516850|P2|STARTED|Initial Treatment Period||181
5086855|NCT01704287|12516851|P1|STARTED|Initial Treatment Period||180
5086856|NCT01704261|12516899|P2|NOT COMPLETED|Overall Study||15
5086857|NCT01704261|12516900|P1|NOT COMPLETED|Overall Study||13
5086858|NCT01704261|12516899|P2|COMPLETED|Overall Study||138
5086859|NCT01704261|12516900|P1|COMPLETED|Overall Study||141
5086860|NCT01704261|12516899|P2|STARTED|Overall Study||153
5086861|NCT01704261|12516900|P1|STARTED|Overall Study||154
5086862|NCT01704196|12516916|P2|NOT COMPLETED|Overall Study||24
5086863|NCT01704196|12516917|P1|NOT COMPLETED|Overall Study||19
5086864|NCT01704196|12516916|P2|COMPLETED|Overall Study||65
5086865|NCT01704196|12516917|P1|COMPLETED|Overall Study||71
5086866|NCT01704196|12516916|P2|STARTED|Overall Study||89
5086867|NCT01704196|12516917|P1|STARTED|Overall Study||90
5086869|NCT01704079|12516928|P1|NOT COMPLETED|Overall Study||14
5086870|NCT01704079|12516927|P2|COMPLETED|Overall Study||121
5086871|NCT01704079|12516928|P1|COMPLETED|Overall Study||58
5086872|NCT01704079|12516927|P2|Entered Extension Study|Overall Study||102
5086873|NCT01704079|12516928|P1|Entered Extension Study|Overall Study||53
5086874|NCT01704079|12516927|P2|STARTED|Overall Study||144
5086875|NCT01704079|12516928|P1|STARTED|Overall Study||72
5086876|NCT01703988|12516944|P4|NOT COMPLETED|Overall Study||1
5086877|NCT01703988|12516945|P3|NOT COMPLETED|Overall Study||0
5086878|NCT01703988|12516946|P2|NOT COMPLETED|Overall Study||0
5086879|NCT01703988|12516947|P1|NOT COMPLETED|Overall Study||0
5086880|NCT01703988|12516944|P4|COMPLETED|Overall Study||8
5086881|NCT01703988|12516945|P3|COMPLETED|Overall Study||9
5086882|NCT01703988|12516946|P2|COMPLETED|Overall Study||8
5086883|NCT01703988|12516947|P1|COMPLETED|Overall Study||8
5086884|NCT01703988|12516944|P4|STARTED|Overall Study||9
5086885|NCT01703988|12516945|P3|STARTED|Overall Study||9
5086886|NCT01703988|12516946|P2|STARTED|Overall Study||8
5086887|NCT01703988|12516947|P1|STARTED|Overall Study||8
5086888|NCT01703858|12516977|P3|NOT COMPLETED|Overall Study||0
5086889|NCT01703858|12516978|P2|NOT COMPLETED|Overall Study||1
5086890|NCT01703858|12516979|P1|NOT COMPLETED|Overall Study||0
5086891|NCT01703858|12516977|P3|COMPLETED|Overall Study||5
5086892|NCT01703858|12516978|P2|COMPLETED|Overall Study||4
5086893|NCT01703858|12516979|P1|COMPLETED|Overall Study||5
5086894|NCT01703858|12516977|P3|STARTED|Overall Study||5
5086895|NCT01703858|12516978|P2|STARTED|Overall Study||5
5086896|NCT01703858|12516979|P1|STARTED|Overall Study||5
5086897|NCT01703845|12517004|P2|NOT COMPLETED|Overall Study||0
5086898|NCT01703845|12517005|P1|NOT COMPLETED|Overall Study||3
5086899|NCT01703845|12517004|P2|COMPLETED|Overall Study||16
5086900|NCT01703845|12517005|P1|COMPLETED|Overall Study||13
5086901|NCT01703845|12517004|P2|STARTED|Overall Study|started are actually the randomized|16
5086902|NCT01703845|12517005|P1|STARTED|Overall Study|started are actually the randomized|16
5086903|NCT01703832|12517042|P2|NOT COMPLETED|Overall Study||0
5086904|NCT01703832|12517043|P1|NOT COMPLETED|Overall Study||1
5086905|NCT01703832|12517042|P2|COMPLETED|Overall Study||32
5086906|NCT01703832|12517043|P1|COMPLETED|Overall Study||32
5086907|NCT01703832|12517042|P2|STARTED|Overall Study||32
5086908|NCT01703832|12517043|P1|STARTED|Overall Study||33
5086909|NCT01703819|12517075|P2|NOT COMPLETED|Overall Study||2
5086910|NCT01703819|12517076|P1|NOT COMPLETED|Overall Study||0
5086911|NCT01703819|12517075|P2|COMPLETED|Overall Study||30
5086912|NCT01703819|12517076|P1|COMPLETED|Overall Study||34
5086913|NCT01703819|12517075|P2|STARTED|Overall Study||32
5086914|NCT01703819|12517076|P1|STARTED|Overall Study||34
5086915|NCT01703741|12517106|P1|NOT COMPLETED|Overall Study||18
5086916|NCT01703741|12517106|P1|COMPLETED|Overall Study||127
5086917|NCT01703741|12517106|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
5086918|NCT01703741|12517106|P1|STARTED|Overall Study||145
5086919|NCT01703702|12517124|P2|NOT COMPLETED|Overall Study||22
5086920|NCT01703702|12517125|P1|NOT COMPLETED|Overall Study||36
5086921|NCT01703702|12517124|P2|COMPLETED|Overall Study||288
5086922|NCT01703702|12517125|P1|COMPLETED|Overall Study||272
5086923|NCT01703702|12517124|P2|STARTED|Overall Study||310
5086924|NCT01703702|12517125|P1|STARTED|Overall Study||308
5086925|NCT01703663|12517142|P2|NOT COMPLETED|Second Treatment Period||0
5086926|NCT01703663|12517143|P1|NOT COMPLETED|Second Treatment Period||0
5086927|NCT01703663|12517142|P2|COMPLETED|Second Treatment Period||8
5086928|NCT01703663|12517143|P1|COMPLETED|Second Treatment Period||11
5086929|NCT01703663|12517142|P2|STARTED|Second Treatment Period||8
5086930|NCT01703663|12517143|P1|STARTED|Second Treatment Period||11
5086931|NCT01703663|12517142|P2|NOT COMPLETED|First Treatment Period||0
5086932|NCT01703663|12517143|P1|NOT COMPLETED|First Treatment Period||0
5086933|NCT01703663|12517142|P2|COMPLETED|First Treatment Period||20
5086934|NCT01703663|12517143|P1|COMPLETED|First Treatment Period||20
5086935|NCT01703663|12517142|P2|STARTED|First Treatment Period||20
5086936|NCT01703663|12517143|P1|STARTED|First Treatment Period||20
5086937|NCT01703598|12517149|P1|NOT COMPLETED|Overall Study||0
5086938|NCT01703598|12517149|P1|COMPLETED|Overall Study||69
5086939|NCT01703598|12517149|P1|STARTED|Overall Study||69
5086940|NCT01703507|12517155|P2|NOT COMPLETED|Overall Study||0
5086941|NCT01703507|12517156|P1|NOT COMPLETED|Overall Study||1
5086942|NCT01703507|12517155|P2|COMPLETED|Overall Study||11
5086943|NCT01703507|12517156|P1|COMPLETED|Overall Study||5
5086944|NCT01703507|12517155|P2|STARTED|Overall Study||11
5086945|NCT01703507|12517156|P1|STARTED|Overall Study||6
5086946|NCT01703286|12517172|P6|NOT COMPLETED|Period 3 Including Washout||0
5086947|NCT01703286|12517173|P5|NOT COMPLETED|Period 3 Including Washout||0
5086948|NCT01703286|12517174|P4|NOT COMPLETED|Period 3 Including Washout||0
5086949|NCT01703286|12517175|P3|NOT COMPLETED|Period 3 Including Washout||0
5086950|NCT01703286|12517176|P2|NOT COMPLETED|Period 3 Including Washout||0
5086951|NCT01703286|12517177|P1|NOT COMPLETED|Period 3 Including Washout||0
5086952|NCT01703286|12517172|P6|COMPLETED|Period 3 Including Washout||6
5086953|NCT01703286|12517173|P5|COMPLETED|Period 3 Including Washout||7
5086954|NCT01703286|12517174|P4|COMPLETED|Period 3 Including Washout||5
5086955|NCT01703286|12517175|P3|COMPLETED|Period 3 Including Washout||7
5086956|NCT01703286|12517176|P2|COMPLETED|Period 3 Including Washout||7
5086957|NCT01703286|12517177|P1|COMPLETED|Period 3 Including Washout||7
5086958|NCT01703286|12517172|P6|STARTED|Period 3 Including Washout||6
5086959|NCT01703286|12517173|P5|STARTED|Period 3 Including Washout||7
5086960|NCT01703286|12517174|P4|STARTED|Period 3 Including Washout||5
5086961|NCT01703286|12517175|P3|STARTED|Period 3 Including Washout||7
5086962|NCT01703286|12517176|P2|STARTED|Period 3 Including Washout||7
5086963|NCT01703286|12517177|P1|STARTED|Period 3 Including Washout||7
5086964|NCT01703286|12517172|P6|NOT COMPLETED|Period 2 Including Washout||0
5086965|NCT01703286|12517173|P5|NOT COMPLETED|Period 2 Including Washout||0
5086966|NCT01703286|12517174|P4|NOT COMPLETED|Period 2 Including Washout||1
5086967|NCT01703286|12517175|P3|NOT COMPLETED|Period 2 Including Washout||0
5086968|NCT01703286|12517176|P2|NOT COMPLETED|Period 2 Including Washout||0
5086969|NCT01703286|12517177|P1|NOT COMPLETED|Period 2 Including Washout||0
5086970|NCT01703286|12517172|P6|COMPLETED|Period 2 Including Washout||6
5086971|NCT01703286|12517173|P5|COMPLETED|Period 2 Including Washout||7
5086972|NCT01703286|12517174|P4|COMPLETED|Period 2 Including Washout||5
5086973|NCT01703286|12517175|P3|COMPLETED|Period 2 Including Washout||7
5086974|NCT01703286|12517176|P2|COMPLETED|Period 2 Including Washout||7
5086975|NCT01703286|12517177|P1|COMPLETED|Period 2 Including Washout||7
5086976|NCT01703286|12517172|P6|STARTED|Period 2 Including Washout||6
5086977|NCT01703286|12517173|P5|STARTED|Period 2 Including Washout||7
5086978|NCT01703286|12517174|P4|STARTED|Period 2 Including Washout||6
5086979|NCT01703286|12517175|P3|STARTED|Period 2 Including Washout||7
5086980|NCT01703286|12517176|P2|STARTED|Period 2 Including Washout||7
5086981|NCT01703286|12517177|P1|STARTED|Period 2 Including Washout||7
5086982|NCT01703286|12517172|P6|NOT COMPLETED|Period 1 Including Washout||1
5086983|NCT01703286|12517173|P5|NOT COMPLETED|Period 1 Including Washout||0
5086984|NCT01703286|12517174|P4|NOT COMPLETED|Period 1 Including Washout||1
5086985|NCT01703286|12517175|P3|NOT COMPLETED|Period 1 Including Washout||0
5086986|NCT01703286|12517176|P2|NOT COMPLETED|Period 1 Including Washout||0
5086987|NCT01703286|12517177|P1|NOT COMPLETED|Period 1 Including Washout||0
5086988|NCT01703286|12517172|P6|COMPLETED|Period 1 Including Washout||6
5086989|NCT01703286|12517173|P5|COMPLETED|Period 1 Including Washout||7
5086990|NCT01703286|12517174|P4|COMPLETED|Period 1 Including Washout||6
5086991|NCT01703286|12517175|P3|COMPLETED|Period 1 Including Washout||7
5086992|NCT01703286|12517176|P2|COMPLETED|Period 1 Including Washout||7
5086993|NCT01703286|12517177|P1|COMPLETED|Period 1 Including Washout||7
5086994|NCT01703286|12517172|P6|STARTED|Period 1 Including Washout||7
5086995|NCT01703286|12517173|P5|STARTED|Period 1 Including Washout||7
5086996|NCT01703286|12517174|P4|STARTED|Period 1 Including Washout||7
5086997|NCT01703286|12517175|P3|STARTED|Period 1 Including Washout||7
5086998|NCT01703286|12517176|P2|STARTED|Period 1 Including Washout||7
5086999|NCT01703286|12517177|P1|STARTED|Period 1 Including Washout||7
5087000|NCT01703260|12517200|P3|NOT COMPLETED|Overall Study||3
5087001|NCT01703260|12517201|P2|NOT COMPLETED|Overall Study||4
5087002|NCT01703260|12517202|P1|NOT COMPLETED|Overall Study||3
5087003|NCT01703260|12517200|P3|COMPLETED|Overall Study||3
5087004|NCT01703260|12517201|P2|COMPLETED|Overall Study||3
5087005|NCT01703260|12517202|P1|COMPLETED|Overall Study||4
5087006|NCT01703260|12517200|P3|STARTED|Overall Study||6
5087007|NCT01703260|12517201|P2|STARTED|Overall Study||7
5087008|NCT01703260|12517202|P1|STARTED|Overall Study||7
5087009|NCT01703221|12517228|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
5087010|NCT01703221|12517229|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
5087011|NCT01703221|12517230|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
5087012|NCT01703221|12517228|P3|COMPLETED|Phase B - (Week 25 to 52)||75
5087013|NCT01703221|12517229|P2|COMPLETED|Phase B - (Week 25 to 52)||147
5087014|NCT01703221|12517230|P1|COMPLETED|Phase B - (Week 25 to 52)||143
5087015|NCT01703221|12517228|P3|STARTED|Phase B - (Week 25 to 52)||80
5087016|NCT01703221|12517229|P2|STARTED|Phase B - (Week 25 to 52)||161
5087017|NCT01703221|12517230|P1|STARTED|Phase B - (Week 25 to 52)||159
5087018|NCT01703221|12517228|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
5087019|NCT01703221|12517229|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
5087020|NCT01703221|12517230|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
5087021|NCT01703221|12517228|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
5087022|NCT01703221|12517229|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
5087023|NCT01703221|12517230|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
5087024|NCT01703221|12517228|P3|STARTED|Phase A (Up to 24 Weeks)||83
5087025|NCT01703221|12517229|P2|STARTED|Phase A (Up to 24 Weeks)||165
5087026|NCT01703221|12517230|P1|STARTED|Phase A (Up to 24 Weeks)||166
5087027|NCT01703208|12517261|P2|NOT COMPLETED|Overall Study||2102
5087028|NCT01703208|12517262|P1|NOT COMPLETED|Overall Study||2100
5087029|NCT01703208|12517261|P2|COMPLETED|Overall Study||0
5087030|NCT01703208|12517262|P1|COMPLETED|Overall Study||0
5087031|NCT01703208|12517261|P2|Treated|Overall Study||2100
5087032|NCT01703208|12517262|P1|Treated|Overall Study||2092
5087033|NCT01703208|12517261|P2|STARTED|Overall Study||2102
5087034|NCT01703208|12517262|P1|STARTED|Overall Study||2100
5087035|NCT01703169|12517316|P1|NOT COMPLETED|Overall Study||0
5087036|NCT01703169|12517316|P1|COMPLETED|Overall Study||13
5087037|NCT01703169|12517316|P1|STARTED|Overall Study||13
5087038|NCT01703091|12517326|P2|NOT COMPLETED|Overall Study||4
5087039|NCT01703091|12517327|P1|NOT COMPLETED|Overall Study||9
5087040|NCT01703091|12517326|P2|COMPLETED|Overall Study||95
5087041|NCT01703091|12517327|P1|COMPLETED|Overall Study||89
5087042|NCT01703091|12517326|P2|Received at Least One Dose of Study Drug|Overall Study||98
5087043|NCT01703091|12517327|P1|Received at Least One Dose of Study Drug|Overall Study||94
5087044|NCT01703091|12517326|P2|STARTED|Overall Study||99
5087045|NCT01703091|12517327|P1|STARTED|Overall Study||98
5087046|NCT01703065|12517345|P2|NOT COMPLETED|Overall Study||0
5087047|NCT01703065|12517346|P1|NOT COMPLETED|Overall Study||1
5087048|NCT01703065|12517345|P2|COMPLETED|Overall Study||0
5087049|NCT01703065|12517346|P1|COMPLETED|Overall Study||8
5087050|NCT01703065|12517345|P2|STARTED|Overall Study||0
5087051|NCT01703065|12517346|P1|STARTED|Overall Study||9
5087052|NCT01703039|12517361|P2|NOT COMPLETED|Overall Study||5
5087053|NCT01703039|12517362|P1|NOT COMPLETED|Overall Study||3
5087054|NCT01703039|12517361|P2|COMPLETED|Overall Study||7
5087055|NCT01703039|12517362|P1|COMPLETED|Overall Study||6
5087056|NCT01703039|12517361|P2|STARTED|Overall Study||12
5087057|NCT01703039|12517362|P1|STARTED|Overall Study||9
5087058|NCT01703000|12517376|P1|NOT COMPLETED|Overall Study||1
5087059|NCT01703000|12517376|P1|COMPLETED|Overall Study||99
5087060|NCT01703000|12517376|P1|STARTED|Overall Study||100
5087061|NCT01702987|12517409|P2|NOT COMPLETED|Overall Study||0
5087062|NCT01702987|12517410|P1|NOT COMPLETED|Overall Study||1
5087063|NCT01702987|12517409|P2|COMPLETED|Overall Study||12
5087064|NCT01702987|12517410|P1|COMPLETED|Overall Study||9
5087065|NCT01702987|12517409|P2|STARTED|Overall Study||12
5087066|NCT01702987|12517410|P1|STARTED|Overall Study||10
5087067|NCT01702961|12517416|P1|NOT COMPLETED|Overall Study||47
5087068|NCT01702961|12517416|P1|COMPLETED|Overall Study||28
5087069|NCT01702961|12517416|P1|STARTED|Overall Study||75
5087070|NCT01702909|12517422|P1|NOT COMPLETED|Overall Study||0
5087071|NCT01702909|12517422|P1|COMPLETED|Overall Study||7
5087072|NCT01702909|12517422|P1|STARTED|Overall Study||7
5087073|NCT01702896|12517428|P1|NOT COMPLETED|Overall Study||8
5087074|NCT01702896|12517428|P1|COMPLETED|Overall Study||0
5087075|NCT01702896|12517428|P1|STARTED|Overall Study||8
5087076|NCT01702558|12517439|P5|NOT COMPLETED|Overall Study||42
5087077|NCT01702558|12517440|P4|NOT COMPLETED|Overall Study||47
5087078|NCT01702558|12517441|P3|NOT COMPLETED|Overall Study||5
5087079|NCT01702558|12517442|P2|NOT COMPLETED|Overall Study||4
5087080|NCT01702558|12517443|P1|NOT COMPLETED|Overall Study||4
5087081|NCT01702558|12517439|P5|COMPLETED|Overall Study||38
5087082|NCT01702558|12517440|P4|COMPLETED|Overall Study||34
5087083|NCT01702558|12517441|P3|COMPLETED|Overall Study||1
5087084|NCT01702558|12517442|P2|COMPLETED|Overall Study||1
5087085|NCT01702558|12517443|P1|COMPLETED|Overall Study||3
5087086|NCT01702558|12517439|P5|STARTED|Overall Study||80
5087087|NCT01702558|12517440|P4|STARTED|Overall Study||81
5087088|NCT01702558|12517441|P3|STARTED|Overall Study||6
5087089|NCT01702558|12517442|P2|STARTED|Overall Study||5
5087090|NCT01702558|12517443|P1|STARTED|Overall Study||7
5087091|NCT01702532|12517508|P2|NOT COMPLETED|Overall Study||1
5087092|NCT01702532|12517509|P1|NOT COMPLETED|Overall Study||0
5087093|NCT01702532|12517508|P2|COMPLETED|Overall Study||160
5087094|NCT01702532|12517509|P1|COMPLETED|Overall Study||161
5087095|NCT01702532|12517508|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
5087096|NCT01702532|12517509|P1|Safety Population|Overall Study||161
5087097|NCT01702532|12517508|P2|STARTED|Overall Study||161
5087098|NCT01702532|12517509|P1|STARTED|Overall Study||161
5087099|NCT01702519|12517519|P2|NOT COMPLETED|Period 2||0
5087100|NCT01702519|12517520|P1|NOT COMPLETED|Period 2||0
5087101|NCT01702519|12517519|P2|COMPLETED|Period 2||18
5087102|NCT01702519|12517520|P1|COMPLETED|Period 2||19
5087103|NCT01702519|12517519|P2|STARTED|Period 2||18
5087104|NCT01702519|12517520|P1|STARTED|Period 2||19
5087105|NCT01702519|12517519|P2|NOT COMPLETED|Washout Period||2
5087106|NCT01702519|12517520|P1|NOT COMPLETED|Washout Period||1
5087107|NCT01702519|12517519|P2|COMPLETED|Washout Period||18
5087108|NCT01702519|12517520|P1|COMPLETED|Washout Period||19
5087109|NCT01702519|12517519|P2|STARTED|Washout Period||20
5087110|NCT01702519|12517520|P1|STARTED|Washout Period||20
5087111|NCT01702519|12517519|P2|NOT COMPLETED|Period 1||0
5087112|NCT01702519|12517520|P1|NOT COMPLETED|Period 1||0
5087113|NCT01702519|12517519|P2|COMPLETED|Period 1||20
5087114|NCT01702519|12517520|P1|COMPLETED|Period 1||20
5087115|NCT01702519|12517519|P2|STARTED|Period 1||20
5087116|NCT01702519|12517520|P1|STARTED|Period 1||20
5087117|NCT01702454|12517538|P2|NOT COMPLETED|Overall Study||8
5087118|NCT01702454|12517539|P1|NOT COMPLETED|Overall Study||3
5087119|NCT01702454|12517538|P2|COMPLETED|Overall Study||221
5087120|NCT01702454|12517539|P1|COMPLETED|Overall Study||238
5087121|NCT01702454|12517538|P2|STARTED|Overall Study||229
5087122|NCT01702454|12517539|P1|STARTED|Overall Study||241
5087123|NCT01702428|12517621|P4|NOT COMPLETED|Overall Study||57
5087124|NCT01702428|12517622|P3|NOT COMPLETED|Overall Study||53
5087125|NCT01702428|12517623|P2|NOT COMPLETED|Overall Study||70
5087126|NCT01702428|12517624|P1|NOT COMPLETED|Overall Study||64
5087127|NCT01702428|12517621|P4|COMPLETED|Overall Study||1232
5087128|NCT01702428|12517622|P3|COMPLETED|Overall Study||1190
5087129|NCT01702428|12517623|P2|COMPLETED|Overall Study||1162
5087130|NCT01702428|12517624|P1|COMPLETED|Overall Study||1175
5087131|NCT01702428|12517621|P4|STARTED|Overall Study||1289
5087132|NCT01702428|12517622|P3|STARTED|Overall Study||1243
5087133|NCT01702428|12517623|P2|STARTED|Overall Study||1232
5087134|NCT01702428|12517624|P1|STARTED|Overall Study||1239
5087135|NCT01702363|12517711|P1|NOT COMPLETED|Overall Study||20
5087136|NCT01702363|12517711|P1|COMPLETED|Overall Study||111
5087137|NCT01702363|12517711|P1|STARTED|Overall Study||131
5087138|NCT01702311|12517728|P2|NOT COMPLETED|Overall Study||13
5087139|NCT01702311|12517729|P1|NOT COMPLETED|Overall Study||16
5087140|NCT01702311|12517728|P2|COMPLETED|Overall Study||100
5087141|NCT01702311|12517729|P1|COMPLETED|Overall Study||106
5087142|NCT01702311|12517728|P2|STARTED|Overall Study||113
5087143|NCT01702311|12517729|P1|STARTED|Overall Study||122
5087144|NCT01702298|12517759|P1|NOT COMPLETED|Overall Study||1
5087145|NCT01702298|12517759|P1|COMPLETED|Overall Study||41
5087146|NCT01702298|12517759|P1|STARTED|Overall Study||42
5087147|NCT01702259|12517772|P2|NOT COMPLETED|Overall Study||0
5087148|NCT01702259|12517773|P1|NOT COMPLETED|Overall Study||0
5087149|NCT01702259|12517772|P2|COMPLETED|Overall Study||34
5087150|NCT01702259|12517773|P1|COMPLETED|Overall Study||34
5087151|NCT01702259|12517772|P2|STARTED|Overall Study||34
5087152|NCT01702259|12517773|P1|STARTED|Overall Study||34
5087153|NCT01702246|12517787|P1|NOT COMPLETED|Overall Study||5
5087154|NCT01702246|12517787|P1|COMPLETED|Overall Study||19
5087155|NCT01702246|12517787|P1|STARTED|Overall Study||24
5087156|NCT01702233|12517799|P3|NOT COMPLETED|Overall Study||5
5087157|NCT01702233|12517800|P2|NOT COMPLETED|Overall Study||3
5087158|NCT01702233|12517801|P1|NOT COMPLETED|Overall Study||6
5087159|NCT01702233|12517799|P3|COMPLETED|Overall Study||31
5087160|NCT01702233|12517800|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
5087161|NCT01702233|12517801|P1|COMPLETED|Overall Study||66
5087162|NCT01702233|12517799|P3|Per Protocol Set|Overall Study||27
5087163|NCT01702233|12517800|P2|Per Protocol Set|Overall Study||58
5087164|NCT01702233|12517801|P1|Per Protocol Set|Overall Study||58
5087165|NCT01702233|12517799|P3|Full Analysis Set (ITT)|Overall Study||31
5087166|NCT01702233|12517800|P2|Full Analysis Set (ITT)|Overall Study||63
5087167|NCT01702233|12517801|P1|Full Analysis Set (ITT)|Overall Study||66
5087168|NCT01702233|12517799|P3|STARTED|Overall Study||36
5087169|NCT01702233|12517800|P2|STARTED|Overall Study||67
5087170|NCT01702233|12517801|P1|STARTED|Overall Study||72
5087171|NCT01702025|12517841|P4|NOT COMPLETED|Overall Study||0
5087172|NCT01702025|12517842|P3|NOT COMPLETED|Overall Study||1
5087173|NCT01702025|12517843|P2|NOT COMPLETED|Overall Study||1
5087174|NCT01702025|12517844|P1|NOT COMPLETED|Overall Study||2
5087175|NCT01702025|12517841|P4|COMPLETED|Overall Study||10
5087176|NCT01702025|12517842|P3|COMPLETED|Overall Study||9
5087177|NCT01702025|12517843|P2|COMPLETED|Overall Study||9
5087178|NCT01702025|12517844|P1|COMPLETED|Overall Study||9
5087179|NCT01702025|12517841|P4|STARTED|Overall Study||10
5087180|NCT01702025|12517842|P3|STARTED|Overall Study||10
5087181|NCT01702025|12517843|P2|STARTED|Overall Study||10
5087182|NCT01702025|12517844|P1|STARTED|Overall Study||11
5087183|NCT01701999|12517860|P2|NOT COMPLETED|Overall Study||0
5087184|NCT01701999|12517861|P1|NOT COMPLETED|Overall Study||0
5087185|NCT01701999|12517860|P2|COMPLETED|Overall Study||37
5087186|NCT01701999|12517861|P1|COMPLETED|Overall Study||8
5087187|NCT01701999|12517860|P2|STARTED|Overall Study||37
5087188|NCT01701999|12517861|P1|STARTED|Overall Study||8
5087189|NCT01701973|12517873|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087190|NCT01701973|12517874|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087191|NCT01701973|12517875|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087192|NCT01701973|12517876|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087193|NCT01701973|12517877|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087194|NCT01701973|12517878|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087195|NCT01701973|12517879|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087196|NCT01701973|12517880|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087197|NCT01701973|12517873|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
5087198|NCT01701973|12517874|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
5087199|NCT01701973|12517875|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
5087200|NCT01701973|12517876|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
5087201|NCT01701973|12517877|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
5087202|NCT01701973|12517878|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
5087203|NCT01701973|12517879|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087204|NCT01701973|12517880|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
5087205|NCT01701973|12517873|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
5087206|NCT01701973|12517874|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
5087207|NCT01701973|12517875|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
5087208|NCT01701973|12517876|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
5087209|NCT01701973|12517877|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
5087210|NCT01701973|12517878|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
5087211|NCT01701973|12517879|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
5087212|NCT01701973|12517880|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
5087213|NCT01701973|12517873|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087214|NCT01701973|12517874|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087215|NCT01701973|12517875|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087216|NCT01701973|12517876|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087217|NCT01701973|12517877|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087218|NCT01701973|12517878|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087219|NCT01701973|12517879|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087220|NCT01701973|12517880|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
5087221|NCT01701973|12517873|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
5087222|NCT01701973|12517874|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
5087223|NCT01701973|12517875|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
5087224|NCT01701973|12517876|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
5087225|NCT01701973|12517877|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
5087226|NCT01701973|12517878|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
5087227|NCT01701973|12517879|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
5087228|NCT01701973|12517880|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
5087229|NCT01701973|12517873|P8|STARTED|Aim 2: First Intervention (1 Day)||4
5087230|NCT01701973|12517874|P7|STARTED|Aim 2: First Intervention (1 Day)||5
5087231|NCT01701973|12517875|P6|STARTED|Aim 2: First Intervention (1 Day)||3
5087232|NCT01701973|12517876|P5|STARTED|Aim 2: First Intervention (1 Day)||2
5087233|NCT01701973|12517877|P4|STARTED|Aim 2: First Intervention (1 Day)||4
5087234|NCT01701973|12517878|P3|STARTED|Aim 2: First Intervention (1 Day)||5
5087235|NCT01701973|12517879|P2|STARTED|Aim 2: First Intervention (1 Day)||0
5087236|NCT01701973|12517880|P1|STARTED|Aim 2: First Intervention (1 Day)||0
5087237|NCT01701973|12517873|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087238|NCT01701973|12517874|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087239|NCT01701973|12517875|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087240|NCT01701973|12517876|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087241|NCT01701973|12517877|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087242|NCT01701973|12517878|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087243|NCT01701973|12517879|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087244|NCT01701973|12517880|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087245|NCT01701973|12517873|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087246|NCT01701973|12517874|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087247|NCT01701973|12517875|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087248|NCT01701973|12517876|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087249|NCT01701973|12517877|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087250|NCT01701973|12517878|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
5087251|NCT01701973|12517879|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
5087252|NCT01701973|12517880|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
5087253|NCT01701973|12517873|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
5087254|NCT01701973|12517874|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
5087255|NCT01701973|12517875|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
5087256|NCT01701973|12517876|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
5087257|NCT01701973|12517877|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
5087258|NCT01701973|12517878|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
5087259|NCT01701973|12517879|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
5087260|NCT01701973|12517880|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
5087261|NCT01701973|12517873|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087262|NCT01701973|12517874|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087263|NCT01701973|12517875|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087264|NCT01701973|12517876|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087265|NCT01701973|12517877|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087266|NCT01701973|12517878|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087267|NCT01701973|12517879|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
5087268|NCT01701973|12517880|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
5087269|NCT01701973|12517873|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087270|NCT01701973|12517874|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087271|NCT01701973|12517875|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087272|NCT01701973|12517876|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087273|NCT01701973|12517877|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087274|NCT01701973|12517878|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
5087275|NCT01701973|12517879|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
5087276|NCT01701973|12517880|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
5087277|NCT01701973|12517873|P8|STARTED|Aim 1: First Intervention (1 Day)||0
5087278|NCT01701973|12517874|P7|STARTED|Aim 1: First Intervention (1 Day)||0
5087279|NCT01701973|12517875|P6|STARTED|Aim 1: First Intervention (1 Day)||0
5087280|NCT01701973|12517876|P5|STARTED|Aim 1: First Intervention (1 Day)||0
5087281|NCT01701973|12517877|P4|STARTED|Aim 1: First Intervention (1 Day)||0
5087282|NCT01701973|12517878|P3|STARTED|Aim 1: First Intervention (1 Day)||0
5087283|NCT01701973|12517879|P2|STARTED|Aim 1: First Intervention (1 Day)||21
5087284|NCT01701973|12517880|P1|STARTED|Aim 1: First Intervention (1 Day)||23
5087285|NCT01701674|12517927|P1|NOT COMPLETED|Overall Study||1
5087286|NCT01701674|12517927|P1|COMPLETED|Overall Study||12
5087287|NCT01701674|12517927|P1|STARTED|Overall Study||13
5087288|NCT01701622|12517934|P1|NOT COMPLETED|Overall Study||0
5087289|NCT01701622|12517934|P1|COMPLETED|Overall Study||1
5087290|NCT01701622|12517934|P1|STARTED|Overall Study||1
5087291|NCT01701505|12517945|P6|NOT COMPLETED|Overall Study||0
5087292|NCT01701505|12517946|P5|NOT COMPLETED|Overall Study||0
5087293|NCT01701505|12517947|P4|NOT COMPLETED|Overall Study||0
5087294|NCT01701505|12517948|P3|NOT COMPLETED|Overall Study||0
5087295|NCT01701505|12517949|P2|NOT COMPLETED|Overall Study||0
5087296|NCT01701505|12517950|P1|NOT COMPLETED|Overall Study||0
5087297|NCT01701505|12517945|P6|COMPLETED|Overall Study||8
5087298|NCT01701505|12517946|P5|COMPLETED|Overall Study||8
5087299|NCT01701505|12517947|P4|COMPLETED|Overall Study||8
5087300|NCT01701505|12517948|P3|COMPLETED|Overall Study||8
5087301|NCT01701505|12517949|P2|COMPLETED|Overall Study||8
5087302|NCT01701505|12517950|P1|COMPLETED|Overall Study||8
5087303|NCT01701505|12517945|P6|STARTED|Overall Study||8
5087304|NCT01701505|12517946|P5|STARTED|Overall Study||8
5087305|NCT01701505|12517947|P4|STARTED|Overall Study||8
5087306|NCT01701505|12517948|P3|STARTED|Overall Study||8
5087307|NCT01701505|12517949|P2|STARTED|Overall Study||8
5087308|NCT01701505|12517950|P1|STARTED|Overall Study||8
5087309|NCT01701414|12518002|P2|NOT COMPLETED|Overall Study||1
5087310|NCT01701414|12518003|P1|NOT COMPLETED|Overall Study||1
5087311|NCT01701414|12518002|P2|COMPLETED|Overall Study||18
5087312|NCT01701414|12518003|P1|COMPLETED|Overall Study||18
5087313|NCT01701414|12518002|P2|STARTED|Overall Study||19
5087314|NCT01701414|12518003|P1|STARTED|Overall Study||19
5087315|NCT01701401|12518013|P4|NOT COMPLETED|Overall Study||6
5087316|NCT01701401|12518014|P3|NOT COMPLETED|Overall Study||5
5087317|NCT01701401|12518015|P2|NOT COMPLETED|Overall Study||9
5087318|NCT01701401|12518016|P1|NOT COMPLETED|Overall Study||10
5087319|NCT01701401|12518013|P4|COMPLETED|Overall Study||212
5087320|NCT01701401|12518014|P3|COMPLETED|Overall Study||212
5087321|NCT01701401|12518015|P2|COMPLETED|Overall Study||209
5087322|NCT01701401|12518016|P1|COMPLETED|Overall Study||207
5087323|NCT01701401|12518013|P4|STARTED|Overall Study||218
5087324|NCT01701401|12518014|P3|STARTED|Overall Study||217
5087325|NCT01701401|12518015|P2|STARTED|Overall Study||218
5087326|NCT01701401|12518016|P1|STARTED|Overall Study||217
5087327|NCT01701375|12518062|P1|NOT COMPLETED|Overall Study||0
5087328|NCT01701375|12518062|P1|COMPLETED|Overall Study||2
5087329|NCT01701375|12518062|P1|STARTED|Overall Study||2
5087330|NCT01701362|12518068|P2|NOT COMPLETED|Overall Study||56
5087331|NCT01701362|12518069|P1|NOT COMPLETED|Overall Study||42
5087332|NCT01701362|12518068|P2|COMPLETED|Overall Study||211
5087333|NCT01701362|12518069|P1|COMPLETED|Overall Study||233
5087334|NCT01701362|12518068|P2|TREATED|Overall Study||265
5087335|NCT01701362|12518069|P1|TREATED|Overall Study||274
5087336|NCT01701362|12518068|P2|STARTED|Overall Study||267
5087337|NCT01701362|12518069|P1|STARTED|Overall Study||275
5087338|NCT01701271|12518097|P1|NOT COMPLETED|Overall Study||0
5087339|NCT01701271|12518097|P1|COMPLETED|Overall Study||20
5087340|NCT01701271|12518097|P1|STARTED|Overall Study||20
5087341|NCT01701258|12518107|P13|NOT COMPLETED|EEG (Session 4)||0
5087342|NCT01701258|12518108|P12|NOT COMPLETED|EEG (Session 4)||0
5087343|NCT01701258|12518109|P11|NOT COMPLETED|EEG (Session 4)||0
5087344|NCT01701258|12518110|P10|NOT COMPLETED|EEG (Session 4)||0
5087345|NCT01701258|12518111|P9|NOT COMPLETED|EEG (Session 4)||0
5087346|NCT01701258|12518112|P8|NOT COMPLETED|EEG (Session 4)||0
5087347|NCT01701258|12518113|P7|NOT COMPLETED|EEG (Session 4)||0
5087348|NCT01701258|12518114|P6|NOT COMPLETED|EEG (Session 4)||0
5087349|NCT01701258|12518115|P5|NOT COMPLETED|EEG (Session 4)||0
5087350|NCT01701258|12518116|P4|NOT COMPLETED|EEG (Session 4)||0
5087351|NCT01701258|12518117|P3|NOT COMPLETED|EEG (Session 4)||0
5087352|NCT01701258|12518118|P2|NOT COMPLETED|EEG (Session 4)||0
5087353|NCT01701258|12518119|P1|NOT COMPLETED|EEG (Session 4)||0
5087354|NCT01701258|12518107|P13|COMPLETED|EEG (Session 4)||0
5087355|NCT01701258|12518108|P12|COMPLETED|EEG (Session 4)||0
5087356|NCT01701258|12518109|P11|COMPLETED|EEG (Session 4)||17
5087357|NCT01701258|12518110|P10|COMPLETED|EEG (Session 4)||0
5087358|NCT01701258|12518111|P9|COMPLETED|EEG (Session 4)||0
5087359|NCT01701258|12518112|P8|COMPLETED|EEG (Session 4)||16
5087360|NCT01701258|12518113|P7|COMPLETED|EEG (Session 4)||0
5087361|NCT01701258|12518114|P6|COMPLETED|EEG (Session 4)||0
5087362|NCT01701258|12518115|P5|COMPLETED|EEG (Session 4)||14
5087363|NCT01701258|12518116|P4|COMPLETED|EEG (Session 4)||0
5087364|NCT01701258|12518117|P3|COMPLETED|EEG (Session 4)||0
5087365|NCT01701258|12518118|P2|COMPLETED|EEG (Session 4)||19
5087366|NCT01701258|12518119|P1|COMPLETED|EEG (Session 4)||0
5087367|NCT01701258|12518107|P13|STARTED|EEG (Session 4)||0
5087368|NCT01701258|12518108|P12|STARTED|EEG (Session 4)||0
5087369|NCT01701258|12518109|P11|STARTED|EEG (Session 4)||17
5087370|NCT01701258|12518110|P10|STARTED|EEG (Session 4)||0
5087371|NCT01701258|12518111|P9|STARTED|EEG (Session 4)||0
5087372|NCT01701258|12518112|P8|STARTED|EEG (Session 4)||16
5087373|NCT01701258|12518113|P7|STARTED|EEG (Session 4)||0
5087374|NCT01701258|12518114|P6|STARTED|EEG (Session 4)||0
5087375|NCT01701258|12518115|P5|STARTED|EEG (Session 4)||14
5087376|NCT01701258|12518116|P4|STARTED|EEG (Session 4)||0
5087377|NCT01701258|12518117|P3|STARTED|EEG (Session 4)||0
5087378|NCT01701258|12518118|P2|STARTED|EEG (Session 4)||19
5087379|NCT01701258|12518119|P1|STARTED|EEG (Session 4)||0
5087380|NCT01701258|12518107|P13|NOT COMPLETED|PET (Session 3)||0
5087381|NCT01701258|12518108|P12|NOT COMPLETED|PET (Session 3)||0
5087382|NCT01701258|12518109|P11|NOT COMPLETED|PET (Session 3)||0
5087383|NCT01701258|12518110|P10|NOT COMPLETED|PET (Session 3)||0
5087384|NCT01701258|12518111|P9|NOT COMPLETED|PET (Session 3)||0
5087385|NCT01701258|12518112|P8|NOT COMPLETED|PET (Session 3)||0
5087386|NCT01701258|12518113|P7|NOT COMPLETED|PET (Session 3)||0
5087387|NCT01701258|12518114|P6|NOT COMPLETED|PET (Session 3)||0
5087388|NCT01701258|12518115|P5|NOT COMPLETED|PET (Session 3)||0
5087389|NCT01701258|12518116|P4|NOT COMPLETED|PET (Session 3)||0
5087390|NCT01701258|12518117|P3|NOT COMPLETED|PET (Session 3)||0
5087391|NCT01701258|12518118|P2|NOT COMPLETED|PET (Session 3)||0
5087392|NCT01701258|12518119|P1|NOT COMPLETED|PET (Session 3)||0
5087393|NCT01701258|12518107|P13|COMPLETED|PET (Session 3)||0
5087394|NCT01701258|12518108|P12|COMPLETED|PET (Session 3)||0
5087395|NCT01701258|12518109|P11|COMPLETED|PET (Session 3)||18
5087396|NCT01701258|12518110|P10|COMPLETED|PET (Session 3)||0
5087397|NCT01701258|12518111|P9|COMPLETED|PET (Session 3)||0
5087398|NCT01701258|12518112|P8|COMPLETED|PET (Session 3)||19
5087399|NCT01701258|12518113|P7|COMPLETED|PET (Session 3)||0
5087400|NCT01701258|12518114|P6|COMPLETED|PET (Session 3)||0
5087401|NCT01701258|12518115|P5|COMPLETED|PET (Session 3)||16
5087402|NCT01701258|12518116|P4|COMPLETED|PET (Session 3)||0
5087403|NCT01701258|12518117|P3|COMPLETED|PET (Session 3)||0
5087404|NCT01701258|12518118|P2|COMPLETED|PET (Session 3)||20
5087405|NCT01701258|12518119|P1|COMPLETED|PET (Session 3)||0
5087406|NCT01701258|12518107|P13|STARTED|PET (Session 3)||0
5087407|NCT01701258|12518108|P12|STARTED|PET (Session 3)||0
5087408|NCT01701258|12518109|P11|STARTED|PET (Session 3)||18
5087409|NCT01701258|12518110|P10|STARTED|PET (Session 3)||0
5087410|NCT01701258|12518111|P9|STARTED|PET (Session 3)||0
5087411|NCT01701258|12518112|P8|STARTED|PET (Session 3)||19
5087412|NCT01701258|12518113|P7|STARTED|PET (Session 3)||0
5087413|NCT01701258|12518114|P6|STARTED|PET (Session 3)||0
5087414|NCT01701258|12518115|P5|STARTED|PET (Session 3)||16
5087415|NCT01701258|12518116|P4|STARTED|PET (Session 3)||0
5087416|NCT01701258|12518117|P3|STARTED|PET (Session 3)||0
5087417|NCT01701258|12518118|P2|STARTED|PET (Session 3)||20
5087418|NCT01701258|12518119|P1|STARTED|PET (Session 3)||0
5087419|NCT01701258|12518107|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087420|NCT01701258|12518108|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087421|NCT01701258|12518109|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087422|NCT01701258|12518110|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087423|NCT01701258|12518111|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087424|NCT01701258|12518112|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087425|NCT01701258|12518113|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087426|NCT01701258|12518114|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087427|NCT01701258|12518115|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087428|NCT01701258|12518116|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087429|NCT01701258|12518117|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087430|NCT01701258|12518118|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087431|NCT01701258|12518119|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
5087432|NCT01701258|12518107|P13|COMPLETED|Drug+fMRI (Session 2)||7
5087433|NCT01701258|12518108|P12|COMPLETED|Drug+fMRI (Session 2)||10
5087434|NCT01701258|12518109|P11|COMPLETED|Drug+fMRI (Session 2)||0
5087435|NCT01701258|12518110|P10|COMPLETED|Drug+fMRI (Session 2)||6
5087436|NCT01701258|12518111|P9|COMPLETED|Drug+fMRI (Session 2)||6
5087437|NCT01701258|12518112|P8|COMPLETED|Drug+fMRI (Session 2)||0
5087438|NCT01701258|12518113|P7|COMPLETED|Drug+fMRI (Session 2)||8
5087439|NCT01701258|12518114|P6|COMPLETED|Drug+fMRI (Session 2)||9
5087440|NCT01701258|12518115|P5|COMPLETED|Drug+fMRI (Session 2)||0
5087441|NCT01701258|12518116|P4|COMPLETED|Drug+fMRI (Session 2)||11
5087442|NCT01701258|12518117|P3|COMPLETED|Drug+fMRI (Session 2)||11
5087443|NCT01701258|12518118|P2|COMPLETED|Drug+fMRI (Session 2)||0
5087444|NCT01701258|12518119|P1|COMPLETED|Drug+fMRI (Session 2)||0
5087445|NCT01701258|12518107|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
5087446|NCT01701258|12518108|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
5087447|NCT01701258|12518109|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
5087448|NCT01701258|12518110|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
5087449|NCT01701258|12518111|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
5087450|NCT01701258|12518112|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
5087451|NCT01701258|12518113|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
5087452|NCT01701258|12518114|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
5087453|NCT01701258|12518115|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
5087454|NCT01701258|12518116|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
5087455|NCT01701258|12518117|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
5087456|NCT01701258|12518118|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
5087457|NCT01701258|12518119|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
5087458|NCT01701258|12518107|P13|STARTED|Drug+fMRI (Session 2)||7
5087459|NCT01701258|12518108|P12|STARTED|Drug+fMRI (Session 2)||10
5087460|NCT01701258|12518109|P11|STARTED|Drug+fMRI (Session 2)||0
5087461|NCT01701258|12518110|P10|STARTED|Drug+fMRI (Session 2)||6
5087462|NCT01701258|12518111|P9|STARTED|Drug+fMRI (Session 2)||6
5087463|NCT01701258|12518112|P8|STARTED|Drug+fMRI (Session 2)||0
5087464|NCT01701258|12518113|P7|STARTED|Drug+fMRI (Session 2)||8
5087465|NCT01701258|12518114|P6|STARTED|Drug+fMRI (Session 2)||9
5087466|NCT01701258|12518115|P5|STARTED|Drug+fMRI (Session 2)||0
5087467|NCT01701258|12518116|P4|STARTED|Drug+fMRI (Session 2)||11
5087468|NCT01701258|12518117|P3|STARTED|Drug+fMRI (Session 2)||11
5087469|NCT01701258|12518118|P2|STARTED|Drug+fMRI (Session 2)||0
5087470|NCT01701258|12518119|P1|STARTED|Drug+fMRI (Session 2)||0
5087471|NCT01701258|12518107|P13|NOT COMPLETED|Assessment and Scheduling||0
5087472|NCT01701258|12518108|P12|NOT COMPLETED|Assessment and Scheduling||0
5087473|NCT01701258|12518109|P11|NOT COMPLETED|Assessment and Scheduling||0
5087474|NCT01701258|12518110|P10|NOT COMPLETED|Assessment and Scheduling||0
5087475|NCT01701258|12518111|P9|NOT COMPLETED|Assessment and Scheduling||0
5087476|NCT01701258|12518112|P8|NOT COMPLETED|Assessment and Scheduling||0
5087477|NCT01701258|12518113|P7|NOT COMPLETED|Assessment and Scheduling||0
5087478|NCT01701258|12518114|P6|NOT COMPLETED|Assessment and Scheduling||0
5087479|NCT01701258|12518115|P5|NOT COMPLETED|Assessment and Scheduling||0
5087480|NCT01701258|12518116|P4|NOT COMPLETED|Assessment and Scheduling||0
5087481|NCT01701258|12518117|P3|NOT COMPLETED|Assessment and Scheduling||0
5087482|NCT01701258|12518118|P2|NOT COMPLETED|Assessment and Scheduling||0
5087483|NCT01701258|12518119|P1|NOT COMPLETED|Assessment and Scheduling||83
5087484|NCT01701258|12518107|P13|COMPLETED|Assessment and Scheduling||0
5087485|NCT01701258|12518108|P12|COMPLETED|Assessment and Scheduling||0
5087486|NCT01701258|12518109|P11|COMPLETED|Assessment and Scheduling||0
5087487|NCT01701258|12518110|P10|COMPLETED|Assessment and Scheduling||0
5087488|NCT01701258|12518111|P9|COMPLETED|Assessment and Scheduling||0
5087489|NCT01701258|12518112|P8|COMPLETED|Assessment and Scheduling||0
5087490|NCT01701258|12518113|P7|COMPLETED|Assessment and Scheduling||0
5087491|NCT01701258|12518114|P6|COMPLETED|Assessment and Scheduling||0
5087492|NCT01701258|12518115|P5|COMPLETED|Assessment and Scheduling||0
5087493|NCT01701258|12518116|P4|COMPLETED|Assessment and Scheduling||0
5087494|NCT01701258|12518117|P3|COMPLETED|Assessment and Scheduling||0
5087495|NCT01701258|12518118|P2|COMPLETED|Assessment and Scheduling||0
5087496|NCT01701258|12518119|P1|COMPLETED|Assessment and Scheduling||70
5087497|NCT01701258|12518107|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087498|NCT01701258|12518108|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087499|NCT01701258|12518109|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087500|NCT01701258|12518110|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087501|NCT01701258|12518111|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087502|NCT01701258|12518112|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087503|NCT01701258|12518113|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087504|NCT01701258|12518114|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087505|NCT01701258|12518115|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087506|NCT01701258|12518116|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087507|NCT01701258|12518117|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087508|NCT01701258|12518118|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
5087509|NCT01701258|12518119|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
5087510|NCT01701258|12518107|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
5087511|NCT01701258|12518108|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
5087512|NCT01701258|12518109|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
5087513|NCT01701258|12518110|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
5087514|NCT01701258|12518111|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
5087515|NCT01701258|12518112|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
5087516|NCT01701258|12518113|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
5087517|NCT01701258|12518114|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
5087518|NCT01701258|12518115|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
5087519|NCT01701258|12518116|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
5087520|NCT01701258|12518117|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
5087521|NCT01701258|12518118|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
5087522|NCT01701258|12518119|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
5087523|NCT01701258|12518107|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087524|NCT01701258|12518108|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087525|NCT01701258|12518109|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087526|NCT01701258|12518110|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087527|NCT01701258|12518111|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087528|NCT01701258|12518112|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087529|NCT01701258|12518113|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087530|NCT01701258|12518114|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087531|NCT01701258|12518115|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087532|NCT01701258|12518116|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087533|NCT01701258|12518117|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087534|NCT01701258|12518118|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
5087535|NCT01701258|12518119|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
5087536|NCT01701258|12518107|P13|Eligible After Screening Visit|Assessment and Scheduling||0
5087537|NCT01701258|12518108|P12|Eligible After Screening Visit|Assessment and Scheduling||0
5087538|NCT01701258|12518109|P11|Eligible After Screening Visit|Assessment and Scheduling||0
5087539|NCT01701258|12518110|P10|Eligible After Screening Visit|Assessment and Scheduling||0
5087540|NCT01701258|12518111|P9|Eligible After Screening Visit|Assessment and Scheduling||0
5087541|NCT01701258|12518112|P8|Eligible After Screening Visit|Assessment and Scheduling||0
5087542|NCT01701258|12518113|P7|Eligible After Screening Visit|Assessment and Scheduling||0
5087543|NCT01701258|12518114|P6|Eligible After Screening Visit|Assessment and Scheduling||0
5087544|NCT01701258|12518115|P5|Eligible After Screening Visit|Assessment and Scheduling||0
5087545|NCT01701258|12518116|P4|Eligible After Screening Visit|Assessment and Scheduling||0
5087546|NCT01701258|12518117|P3|Eligible After Screening Visit|Assessment and Scheduling||0
5087547|NCT01701258|12518118|P2|Eligible After Screening Visit|Assessment and Scheduling||0
5087548|NCT01701258|12518119|P1|Eligible After Screening Visit|Assessment and Scheduling||96
5087549|NCT01701258|12518107|P13|STARTED|Assessment and Scheduling||0
5087550|NCT01701258|12518108|P12|STARTED|Assessment and Scheduling||0
5087551|NCT01701258|12518109|P11|STARTED|Assessment and Scheduling||0
5087552|NCT01701258|12518110|P10|STARTED|Assessment and Scheduling||0
5087553|NCT01701258|12518111|P9|STARTED|Assessment and Scheduling||0
5087554|NCT01701258|12518112|P8|STARTED|Assessment and Scheduling||0
5087555|NCT01701258|12518113|P7|STARTED|Assessment and Scheduling||0
5087556|NCT01701258|12518114|P6|STARTED|Assessment and Scheduling||0
5087557|NCT01701258|12518115|P5|STARTED|Assessment and Scheduling||0
5087558|NCT01701258|12518116|P4|STARTED|Assessment and Scheduling||0
5087559|NCT01701258|12518117|P3|STARTED|Assessment and Scheduling||0
5087560|NCT01701258|12518118|P2|STARTED|Assessment and Scheduling||0
5087561|NCT01701258|12518119|P1|STARTED|Assessment and Scheduling||153
5087562|NCT01701245|12518173|P2|NOT COMPLETED|Overall Study||15
5087563|NCT01701245|12518174|P1|NOT COMPLETED|Overall Study||12
5087564|NCT01701245|12518173|P2|COMPLETED|Overall Study||33
5087565|NCT01701245|12518174|P1|COMPLETED|Overall Study||37
5087566|NCT01701245|12518173|P2|FAS Matched Data|Overall Study||32
5087567|NCT01701245|12518174|P1|FAS Matched Data|Overall Study||42
5087568|NCT01701245|12518173|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
5087569|NCT01701245|12518174|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
5087570|NCT01701245|12518173|P2|STARTED|Overall Study||48
5087571|NCT01701245|12518174|P1|STARTED|Overall Study||49
5087572|NCT01701115|12518188|P2|NOT COMPLETED|Overall Study||0
5087573|NCT01701115|12518189|P1|NOT COMPLETED|Overall Study||2
5087574|NCT01701115|12518188|P2|COMPLETED|Overall Study||77
5087575|NCT01701115|12518189|P1|COMPLETED|Overall Study||75
5087576|NCT01701115|12518188|P2|STARTED|Overall Study||77
5087577|NCT01701115|12518189|P1|STARTED|Overall Study||77
5087578|NCT01701102|12518205|P4|NOT COMPLETED|Overall Study||0
5087579|NCT01701102|12518206|P3|NOT COMPLETED|Overall Study||0
5087580|NCT01701102|12518207|P2|NOT COMPLETED|Overall Study||0
5087581|NCT01701102|12518208|P1|NOT COMPLETED|Overall Study||0
5087582|NCT01701102|12518205|P4|COMPLETED|Overall Study||18
5087583|NCT01701102|12518206|P3|COMPLETED|Overall Study||10
5087584|NCT01701102|12518207|P2|COMPLETED|Overall Study||6
5087585|NCT01701102|12518208|P1|COMPLETED|Overall Study||22
5087586|NCT01701102|12518205|P4|STARTED|Overall Study||18
5087587|NCT01701102|12518206|P3|STARTED|Overall Study||10
5087588|NCT01701102|12518207|P2|STARTED|Overall Study||6
5087589|NCT01701102|12518208|P1|STARTED|Overall Study||22
5087590|NCT01701063|12518221|P3|NOT COMPLETED|Overall Study||2
5087591|NCT01701063|12518222|P2|NOT COMPLETED|Overall Study||1
5087592|NCT01701063|12518223|P1|NOT COMPLETED|Overall Study||0
5087593|NCT01701063|12518221|P3|COMPLETED|Overall Study||8
5087594|NCT01701063|12518222|P2|COMPLETED|Overall Study||18
5087595|NCT01701063|12518223|P1|COMPLETED|Overall Study||13
5087596|NCT01701063|12518221|P3|STARTED|Overall Study||10
5087597|NCT01701063|12518222|P2|STARTED|Overall Study||19
5087598|NCT01701063|12518223|P1|STARTED|Overall Study||13
5087599|NCT01701037|12518265|P1|NOT COMPLETED|Overall Study||0
5087600|NCT01701037|12518265|P1|COMPLETED|Overall Study||13
5087601|NCT01701037|12518265|P1|STARTED|Overall Study||13
5087602|NCT01701024|12518276|P2|NOT COMPLETED|Overall Study||9
5087603|NCT01701024|12518277|P1|NOT COMPLETED|Overall Study||10
5087604|NCT01701024|12518276|P2|COMPLETED|Overall Study||236
5087605|NCT01701024|12518277|P1|COMPLETED|Overall Study||243
5087606|NCT01701024|12518276|P2|STARTED|Overall Study||245
5087607|NCT01701024|12518277|P1|STARTED|Overall Study||253
5087608|NCT01701011|12518292|P3|NOT COMPLETED|Overall Study||34
5087609|NCT01701011|12518293|P2|NOT COMPLETED|Overall Study||24
5087610|NCT01701011|12518294|P1|NOT COMPLETED|Overall Study||35
5087611|NCT01701011|12518292|P3|COMPLETED|Overall Study||90
5087612|NCT01701011|12518293|P2|COMPLETED|Overall Study||102
5087613|NCT01701011|12518294|P1|COMPLETED|Overall Study||92
5087614|NCT01701011|12518292|P3|STARTED|Overall Study||124
5087615|NCT01701011|12518293|P2|STARTED|Overall Study||126
5087616|NCT01701011|12518294|P1|STARTED|Overall Study||127
5087617|NCT01700985|12518307|P2|NOT COMPLETED|Overall Study||1
5087618|NCT01700985|12518308|P1|NOT COMPLETED|Overall Study||0
5087619|NCT01700985|12518307|P2|COMPLETED|Overall Study||20
5087620|NCT01700985|12518308|P1|COMPLETED|Overall Study||23
5087621|NCT01700985|12518307|P2|STARTED|Overall Study||21
5087622|NCT01700985|12518308|P1|STARTED|Overall Study||23
5087623|NCT01700959|12518330|P6|NOT COMPLETED|Overall Study||25
5087624|NCT01700959|12518331|P5|NOT COMPLETED|Overall Study||27
5087625|NCT01700959|12518332|P4|NOT COMPLETED|Overall Study||35
5087626|NCT01700959|12518333|P3|NOT COMPLETED|Overall Study||40
5087627|NCT01700959|12518334|P2|NOT COMPLETED|Overall Study||24
5087628|NCT01700959|12518335|P1|NOT COMPLETED|Overall Study||27
5087629|NCT01700959|12518330|P6|COMPLETED|Overall Study||72
5087630|NCT01700959|12518331|P5|COMPLETED|Overall Study||69
5087631|NCT01700959|12518332|P4|COMPLETED|Overall Study||70
5087632|NCT01700959|12518333|P3|COMPLETED|Overall Study||65
5087633|NCT01700959|12518334|P2|COMPLETED|Overall Study||64
5087634|NCT01700959|12518335|P1|COMPLETED|Overall Study||62
5087635|NCT01700959|12518330|P6|STARTED|Overall Study||97
5087636|NCT01700959|12518331|P5|STARTED|Overall Study||96
5087637|NCT01700959|12518332|P4|STARTED|Overall Study||105
5087638|NCT01700959|12518333|P3|STARTED|Overall Study||105
5087639|NCT01700959|12518334|P2|STARTED|Overall Study||88
5087640|NCT01700959|12518335|P1|STARTED|Overall Study||89
5087641|NCT01700907|12518359|P2|NOT COMPLETED|Overall Study||0
5087642|NCT01700907|12518360|P1|NOT COMPLETED|Overall Study||0
5087643|NCT01700907|12518359|P2|COMPLETED|Overall Study||10
5087644|NCT01700907|12518360|P1|COMPLETED|Overall Study||10
5087645|NCT01700907|12518359|P2|STARTED|Overall Study||10
5087646|NCT01700907|12518360|P1|STARTED|Overall Study||10
5087647|NCT01700829|12518376|P2|NOT COMPLETED|Overall Study||1
5087648|NCT01700829|12518377|P1|NOT COMPLETED|Overall Study||1
5087649|NCT01700829|12518376|P2|COMPLETED|Overall Study||40
5087650|NCT01700829|12518377|P1|COMPLETED|Overall Study||40
5087651|NCT01700829|12518376|P2|STARTED|Overall Study||41
5087652|NCT01700829|12518377|P1|STARTED|Overall Study||41
5087653|NCT01700816|12518389|P2|NOT COMPLETED|Overall Study||0
5087654|NCT01700816|12518390|P1|NOT COMPLETED|Overall Study||0
5087655|NCT01700816|12518389|P2|COMPLETED|Overall Study||19
5087656|NCT01700816|12518390|P1|COMPLETED|Overall Study||21
5087657|NCT01700816|12518389|P2|STARTED|Overall Study||19
5087658|NCT01700816|12518390|P1|STARTED|Overall Study||21
5087659|NCT01700725|12518419|P3|NOT COMPLETED|Overall Study||0
5087660|NCT01700725|12518420|P2|NOT COMPLETED|Overall Study||0
5087661|NCT01700725|12518421|P1|NOT COMPLETED|Overall Study||0
5087662|NCT01700725|12518419|P3|COMPLETED|Overall Study||12
5087663|NCT01700725|12518420|P2|COMPLETED|Overall Study||14
5087664|NCT01700725|12518421|P1|COMPLETED|Overall Study||14
5087665|NCT01700725|12518419|P3|STARTED|Overall Study||12
5087666|NCT01700725|12518420|P2|STARTED|Overall Study||14
5087667|NCT01700725|12518421|P1|STARTED|Overall Study||14
5087668|NCT01700621|12518437|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
5087669|NCT01700621|12518438|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
5087670|NCT01700621|12518437|P2|COMPLETED|Analyzed for Immunogenicity||233
5087671|NCT01700621|12518438|P1|COMPLETED|Analyzed for Immunogenicity||227
5087672|NCT01700621|12518437|P2|STARTED|Analyzed for Immunogenicity||240
5087673|NCT01700621|12518438|P1|STARTED|Analyzed for Immunogenicity||240
5087674|NCT01700621|12518437|P2|NOT COMPLETED|Received Study Vaccines||0
5087675|NCT01700621|12518438|P1|NOT COMPLETED|Received Study Vaccines||0
5087676|NCT01700621|12518437|P2|COMPLETED|Received Study Vaccines||240
5087677|NCT01700621|12518438|P1|COMPLETED|Received Study Vaccines||240
5087678|NCT01700621|12518437|P2|STARTED|Received Study Vaccines||240
5087679|NCT01700621|12518438|P1|STARTED|Received Study Vaccines||240
5087680|NCT01700530|12518476|P3|NOT COMPLETED|Overall Study||1
5087681|NCT01700530|12518477|P2|NOT COMPLETED|Overall Study||3
5087682|NCT01700530|12518478|P1|NOT COMPLETED|Overall Study||0
5087683|NCT01700530|12518476|P3|COMPLETED|Overall Study||19
5087684|NCT01700530|12518477|P2|COMPLETED|Overall Study||18
5087685|NCT01700530|12518478|P1|COMPLETED|Overall Study||9
5087686|NCT01700530|12518476|P3|STARTED|Overall Study||20
5087687|NCT01700530|12518477|P2|STARTED|Overall Study||21
5087688|NCT01700530|12518478|P1|STARTED|Overall Study||9
5087689|NCT01700517|12518492|P3|NOT COMPLETED|Overall Study||0
5087690|NCT01700517|12518493|P2|NOT COMPLETED|Overall Study||0
5087691|NCT01700517|12518494|P1|NOT COMPLETED|Overall Study||0
5087692|NCT01700517|12518492|P3|COMPLETED|Overall Study||40
5087693|NCT01700517|12518493|P2|COMPLETED|Overall Study||40
5087694|NCT01700517|12518494|P1|COMPLETED|Overall Study||40
5087695|NCT01700517|12518492|P3|STARTED|Overall Study||40
5087696|NCT01700517|12518493|P2|STARTED|Overall Study||40
5087697|NCT01700517|12518494|P1|STARTED|Overall Study||40
5087698|NCT01700439|12518502|P1|NOT COMPLETED|Overall Study||889
5087699|NCT01700439|12518502|P1|COMPLETED|Overall Study||0
5087700|NCT01700439|12518502|P1|2 Year|Overall Study||215
5087701|NCT01700439|12518502|P1|1 Year|Overall Study||573
5087702|NCT01700439|12518502|P1|3 Month|Overall Study||778
5087703|NCT01700439|12518502|P1|Discharge|Overall Study||831
5087704|NCT01700439|12518502|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
5087705|NCT01700439|12518502|P1|STARTED|Overall Study||889
5087706|NCT01700387|12518527|P2|NOT COMPLETED|Overall Study||4
5087707|NCT01700387|12518528|P1|NOT COMPLETED|Overall Study||4
5087708|NCT01700387|12518527|P2|COMPLETED|Overall Study||6
5087709|NCT01700387|12518528|P1|COMPLETED|Overall Study||6
5087710|NCT01700387|12518527|P2|STARTED|Overall Study||10
5087711|NCT01700387|12518528|P1|STARTED|Overall Study||10
5087712|NCT01700348|12518538|P1|NOT COMPLETED|Overall Study||23
5087713|NCT01700348|12518538|P1|COMPLETED|Overall Study||93
5087714|NCT01700348|12518538|P1|STARTED|Overall Study||116
5087715|NCT01700335|12518547|P2|NOT COMPLETED|Overall Study||4
5087716|NCT01700335|12518548|P1|NOT COMPLETED|Overall Study||1
5087717|NCT01700335|12518547|P2|COMPLETED|Overall Study||2
5087718|NCT01700335|12518548|P1|COMPLETED|Overall Study||2
5087719|NCT01700335|12518547|P2|STARTED|Overall Study||6
5087720|NCT01700335|12518548|P1|STARTED|Overall Study||3
5087721|NCT01700205|12518561|P2|NOT COMPLETED|Overall Study||15
5087722|NCT01700205|12518562|P1|NOT COMPLETED|Overall Study||15
5087723|NCT01700205|12518561|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
5087724|NCT01700205|12518562|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
5087725|NCT01700205|12518561|P2|STARTED|Overall Study|Mother-Infant Dyads|54
5087726|NCT01700205|12518562|P1|STARTED|Overall Study|Mother-Infant Dyads|59
5087727|NCT01700192|12518584|P2|NOT COMPLETED|Overall Study||128
5087728|NCT01700192|12518585|P1|NOT COMPLETED|Overall Study||180
5087729|NCT01700192|12518584|P2|COMPLETED|Overall Study||613
5087730|NCT01700192|12518585|P1|COMPLETED|Overall Study||561
5087731|NCT01700192|12518584|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
5087732|NCT01700192|12518585|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
5087733|NCT01700192|12518584|P2|Treated|Overall Study||741
5087734|NCT01700192|12518585|P1|Treated|Overall Study||740
5087735|NCT01700192|12518584|P2|STARTED|Overall Study||741
5087736|NCT01700192|12518585|P1|STARTED|Overall Study||741
5087737|NCT01700179|12518603|P1|NOT COMPLETED|Overall Study||2
5087738|NCT01700179|12518603|P1|COMPLETED|Overall Study||6
5087739|NCT01700179|12518603|P1|STARTED|Overall Study||8
5087740|NCT01700140|12518610|P3|NOT COMPLETED|Overall Study||1
5087741|NCT01700140|12518611|P2|NOT COMPLETED|Overall Study||9
5087742|NCT01700140|12518612|P1|NOT COMPLETED|Overall Study||6
5087743|NCT01700140|12518610|P3|COMPLETED|Overall Study||61
5087744|NCT01700140|12518611|P2|COMPLETED|Overall Study||57
5087745|NCT01700140|12518612|P1|COMPLETED|Overall Study||55
5087746|NCT01700140|12518610|P3|STARTED|Overall Study||62
5087747|NCT01700140|12518611|P2|STARTED|Overall Study||66
5087748|NCT01700140|12518612|P1|STARTED|Overall Study||61
5087749|NCT01700049|12518644|P1|NOT COMPLETED|Overall Study||1
5087750|NCT01700049|12518644|P1|COMPLETED|Overall Study||27
5087751|NCT01700049|12518644|P1|STARTED|Overall Study||28
5087752|NCT01700036|12518650|P1|NOT COMPLETED|Overall Study||0
5087753|NCT01700036|12518650|P1|COMPLETED|Overall Study||40
5087754|NCT01700036|12518650|P1|STARTED|Overall Study||40
5087755|NCT01699867|12518659|P1|NOT COMPLETED|Overall Study||3
5087756|NCT01699867|12518659|P1|COMPLETED|Overall Study||47
5087757|NCT01699867|12518659|P1|STARTED|Overall Study||50
5087758|NCT01699815|12518666|P2|NOT COMPLETED|Overall Study||8
5087759|NCT01699815|12518667|P1|NOT COMPLETED|Overall Study||5
5087760|NCT01699815|12518666|P2|COMPLETED|Overall Study||56
5087761|NCT01699815|12518667|P1|COMPLETED|Overall Study||57
5087762|NCT01699815|12518666|P2|STARTED|Overall Study||64
5087763|NCT01699815|12518667|P1|STARTED|Overall Study||62
5087764|NCT01699789|12518679|P2|NOT COMPLETED|Overall Study||126
5087765|NCT01699789|12518680|P1|NOT COMPLETED|Overall Study||102
5087766|NCT01699789|12518679|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
5087767|NCT01699789|12518680|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
5087768|NCT01699789|12518679|P2|12-Month Follow-Up|Overall Study||369
5087769|NCT01699789|12518680|P1|12-Month Follow-Up|Overall Study||364
5087770|NCT01699789|12518679|P2|6-Month Follow-Up|Overall Study||379
5087771|NCT01699789|12518680|P1|6-Month Follow-Up|Overall Study||380
5087772|NCT01699789|12518679|P2|Baseline|Overall Study||488
5087773|NCT01699789|12518680|P1|Baseline|Overall Study||492
5087774|NCT01699789|12518679|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
5087775|NCT01699789|12518680|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
5087776|NCT01699763|12518742|P1|NOT COMPLETED|Overall Study||0
5087777|NCT01699763|12518742|P1|COMPLETED|Overall Study||112
5087778|NCT01699763|12518742|P1|STARTED|Overall Study||112
5087779|NCT01699750|12518750|P2|NOT COMPLETED|Overall Study||3
5087780|NCT01699750|12518751|P1|NOT COMPLETED|Overall Study||0
5087781|NCT01699750|12518750|P2|COMPLETED|Overall Study||33
5087782|NCT01699750|12518751|P1|COMPLETED|Overall Study||34
5087783|NCT01699750|12518750|P2|STARTED|Overall Study||36
5087784|NCT01699750|12518751|P1|STARTED|Overall Study||34
5087785|NCT01699698|12518775|P2|NOT COMPLETED|Overall Study||5
5087786|NCT01699698|12518776|P1|NOT COMPLETED|Overall Study||2
5087787|NCT01699698|12518775|P2|COMPLETED|Overall Study||56
5087788|NCT01699698|12518776|P1|COMPLETED|Overall Study||42
5087789|NCT01699698|12518775|P2|STARTED|Overall Study||61
5087790|NCT01699698|12518776|P1|STARTED|Overall Study||44
5087791|NCT01699685|12518786|P2|NOT COMPLETED|Period 2||0
5087792|NCT01699685|12518787|P1|NOT COMPLETED|Period 2||1
5087793|NCT01699685|12518786|P2|COMPLETED|Period 2||36
5087794|NCT01699685|12518787|P1|COMPLETED|Period 2||35
5087795|NCT01699685|12518786|P2|STARTED|Period 2||36
5087796|NCT01699685|12518787|P1|STARTED|Period 2||36
5087797|NCT01699685|12518786|P2|NOT COMPLETED|Period 1||3
5087798|NCT01699685|12518787|P1|NOT COMPLETED|Period 1||3
5087799|NCT01699685|12518786|P2|COMPLETED|Period 1||36
5087800|NCT01699685|12518787|P1|COMPLETED|Period 1||36
5087801|NCT01699685|12518786|P2|Full Analysis Population (FAS)|Period 1||38
5087802|NCT01699685|12518787|P1|Full Analysis Population (FAS)|Period 1||38
5087803|NCT01699685|12518786|P2|Safety Population|Period 1||38
5087804|NCT01699685|12518787|P1|Safety Population|Period 1||39
5087805|NCT01699685|12518786|P2|STARTED|Period 1||39
5087806|NCT01699685|12518787|P1|STARTED|Period 1||39
5087807|NCT01699607|12518805|P2|NOT COMPLETED|Overall Study||0
5087808|NCT01699607|12518806|P1|NOT COMPLETED|Overall Study||0
5087809|NCT01699607|12518805|P2|COMPLETED|Overall Study||4
5087810|NCT01699607|12518806|P1|COMPLETED|Overall Study||6
5087811|NCT01699607|12518805|P2|STARTED|Overall Study||4
5087812|NCT01699607|12518806|P1|STARTED|Overall Study||6
5087813|NCT01699503|12518813|P2|NOT COMPLETED|Overall Study||1005
5087814|NCT01699503|12518814|P1|NOT COMPLETED|Overall Study||1000
5087815|NCT01699503|12518813|P2|COMPLETED|Overall Study||992
5087816|NCT01699503|12518814|P1|COMPLETED|Overall Study||1008
5087817|NCT01699503|12518813|P2|6 Month Follow-up|Overall Study||893
5087818|NCT01699503|12518814|P1|6 Month Follow-up|Overall Study||903
5087819|NCT01699503|12518813|P2|1 Month Follow-up|Overall Study||1022
5087820|NCT01699503|12518814|P1|1 Month Follow-up|Overall Study||998
5087821|NCT01699503|12518813|P2|Baseline|Overall Study||1693
5087822|NCT01699503|12518814|P1|Baseline|Overall Study||1723
5087823|NCT01699503|12518813|P2|STARTED|Overall Study||1997
5087824|NCT01699503|12518814|P1|STARTED|Overall Study||2008
5087825|NCT01699373|12518830|P2|NOT COMPLETED|Overall Study||0
5087826|NCT01699373|12518831|P1|NOT COMPLETED|Overall Study||0
5087827|NCT01699373|12518830|P2|COMPLETED|Overall Study||85
5087828|NCT01699373|12518831|P1|COMPLETED|Overall Study||85
5087829|NCT01699373|12518830|P2|STARTED|Overall Study||85
5087830|NCT01699373|12518831|P1|STARTED|Overall Study||85
5087831|NCT01699178|12518839|P2|NOT COMPLETED|Overall Study||32
5087832|NCT01699178|12518840|P1|NOT COMPLETED|Overall Study||19
5087833|NCT01699178|12518839|P2|COMPLETED|Overall Study||62
5087834|NCT01699178|12518840|P1|COMPLETED|Overall Study||69
5087835|NCT01699178|12518839|P2|STARTED|Overall Study||94
5087836|NCT01699178|12518840|P1|STARTED|Overall Study||88
5087837|NCT01699087|12518856|P1|NOT COMPLETED|Overall Study||24
5087838|NCT01699087|12518856|P1|COMPLETED|Overall Study||152
5087839|NCT01699087|12518856|P1|Treated|Overall Study||161
5087840|NCT01699087|12518856|P1|STARTED|Overall Study||176
5087841|NCT01699022|12518870|P1|NOT COMPLETED|Overall Study||3
5087842|NCT01699022|12518870|P1|COMPLETED|Overall Study||14
5087843|NCT01699022|12518870|P1|STARTED|Overall Study||17
5087844|NCT01698814|12518885|P2|NOT COMPLETED|Overall Study||3
5087845|NCT01698814|12518886|P1|NOT COMPLETED|Overall Study||2
5087846|NCT01698814|12518885|P2|COMPLETED|Overall Study||166
5087847|NCT01698814|12518886|P1|COMPLETED|Overall Study||329
5087848|NCT01698814|12518885|P2|STARTED|Overall Study||169
5087849|NCT01698814|12518886|P1|STARTED|Overall Study||331
5087850|NCT01698801|12518892|P1|NOT COMPLETED|Follow Up Phase||5
5087851|NCT01698801|12518892|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
5087852|NCT01698801|12518892|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
5087853|NCT01698801|12518892|P1|NOT COMPLETED|Treatment Phase||11
5087854|NCT01698801|12518892|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
5087855|NCT01698801|12518892|P1|STARTED|Treatment Phase||26
5087856|NCT01698775|12518903|P2|NOT COMPLETED|Phase B||11
5087857|NCT01698775|12518904|P1|NOT COMPLETED|Phase B||14
5087858|NCT01698775|12518903|P2|COMPLETED|Phase B||86
5087859|NCT01698775|12518904|P1|COMPLETED|Phase B||84
5087860|NCT01698775|12518903|P2|STARTED|Phase B||97
5087861|NCT01698775|12518904|P1|STARTED|Phase B||98
5087862|NCT01698775|12518903|P2|NOT COMPLETED|Phase A||9
5087863|NCT01698775|12518904|P1|NOT COMPLETED|Phase A||9
5087864|NCT01698775|12518903|P2|COMPLETED|Phase A||97
5087865|NCT01698775|12518904|P1|COMPLETED|Phase A||98
5087866|NCT01698775|12518903|P2|STARTED|Phase A||106
5087867|NCT01698775|12518904|P1|STARTED|Phase A||107
5087868|NCT01698710|12518930|P1|NOT COMPLETED|Overall Study||0
5087869|NCT01698710|12518930|P1|COMPLETED|Overall Study||5
5087870|NCT01698710|12518930|P1|STARTED|Overall Study||5
5087871|NCT01698684|12518939|P3|NOT COMPLETED|Overall Study||21
5087872|NCT01698684|12518940|P2|NOT COMPLETED|Overall Study||23
5087873|NCT01698684|12518941|P1|NOT COMPLETED|Overall Study||29
5087874|NCT01698684|12518939|P3|COMPLETED|Overall Study||127
5087875|NCT01698684|12518940|P2|COMPLETED|Overall Study||124
5087876|NCT01698684|12518941|P1|COMPLETED|Overall Study||116
5087877|NCT01698684|12518939|P3|Safety Population|Overall Study||146
5087878|NCT01698684|12518940|P2|Safety Population|Overall Study||146
5087879|NCT01698684|12518941|P1|Safety Population|Overall Study||143
5087880|NCT01698684|12518939|P3|ITT Population|Overall Study||139
5087881|NCT01698684|12518940|P2|ITT Population|Overall Study||139
5087882|NCT01698684|12518941|P1|ITT Population|Overall Study||136
5087883|NCT01698684|12518939|P3|STARTED|Overall Study||148
5087884|NCT01698684|12518940|P2|STARTED|Overall Study||147
5087885|NCT01698684|12518941|P1|STARTED|Overall Study||145
5087886|NCT01698554|12518953|P4|NOT COMPLETED|Overall Study||2
5087887|NCT01698554|12518954|P3|NOT COMPLETED|Overall Study||2
5087888|NCT01698554|12518955|P2|NOT COMPLETED|Overall Study||10
5087889|NCT01698554|12518956|P1|NOT COMPLETED|Overall Study||6
5087890|NCT01698554|12518953|P4|COMPLETED|Overall Study||77
5087891|NCT01698554|12518954|P3|COMPLETED|Overall Study||73
5087892|NCT01698554|12518955|P2|COMPLETED|Overall Study||147
5087893|NCT01698554|12518956|P1|COMPLETED|Overall Study||147
5087894|NCT01698554|12518953|P4|STARTED|Overall Study||79
5087895|NCT01698554|12518954|P3|STARTED|Overall Study||75
5087896|NCT01698554|12518955|P2|STARTED|Overall Study||157
5087897|NCT01698554|12518956|P1|STARTED|Overall Study||153
5087898|NCT01698528|12518984|P2|NOT COMPLETED|Overall Study||4
5087899|NCT01698528|12518985|P1|NOT COMPLETED|Overall Study||1
5087900|NCT01698528|12518984|P2|COMPLETED|Overall Study||16
5087901|NCT01698528|12518985|P1|COMPLETED|Overall Study||19
5087902|NCT01698528|12518984|P2|STARTED|Overall Study||20
5087903|NCT01698528|12518985|P1|STARTED|Overall Study||20
5087904|NCT01698502|12519001|P2|NOT COMPLETED|Overall Study||0
5087905|NCT01698502|12519002|P1|NOT COMPLETED|Overall Study||0
5087906|NCT01698502|12519001|P2|COMPLETED|Overall Study||10
5087907|NCT01698502|12519002|P1|COMPLETED|Overall Study||11
5087908|NCT01698502|12519001|P2|STARTED|Overall Study||10
5087909|NCT01698502|12519002|P1|STARTED|Overall Study||11
5087910|NCT01698463|12519010|P1|NOT COMPLETED|Overall Study||0
5087911|NCT01698463|12519010|P1|COMPLETED|Overall Study||11
5087912|NCT01698463|12519010|P1|STARTED|Overall Study||11
5087913|NCT01698333|12519020|P1|NOT COMPLETED|Overall Study||0
5087914|NCT01698333|12519020|P1|COMPLETED|Overall Study||25
5087915|NCT01698333|12519020|P1|STARTED|Overall Study||25
5087916|NCT01698320|12519026|P3|NOT COMPLETED|40-Week Open-Label Period||10
5087917|NCT01698320|12519027|P2|NOT COMPLETED|40-Week Open-Label Period||19
5087918|NCT01698320|12519028|P1|NOT COMPLETED|40-Week Open-Label Period||0
5087919|NCT01698320|12519026|P3|COMPLETED|40-Week Open-Label Period||146
5087920|NCT01698320|12519027|P2|COMPLETED|40-Week Open-Label Period||146
5087921|NCT01698320|12519028|P1|COMPLETED|40-Week Open-Label Period||0
5087922|NCT01698320|12519026|P3|STARTED|40-Week Open-Label Period||156
5087923|NCT01698320|12519027|P2|STARTED|40-Week Open-Label Period||165
5087924|NCT01698320|12519028|P1|STARTED|40-Week Open-Label Period||0
5087925|NCT01698320|12519026|P3|NOT COMPLETED|12-Week Double-Blind Period||12
5087926|NCT01698320|12519027|P2|NOT COMPLETED|12-Week Double-Blind Period||4
5087927|NCT01698320|12519028|P1|NOT COMPLETED|12-Week Double-Blind Period||0
5087928|NCT01698320|12519026|P3|COMPLETED|12-Week Double-Blind Period||156
5087929|NCT01698320|12519027|P2|COMPLETED|12-Week Double-Blind Period||165
5087930|NCT01698320|12519028|P1|COMPLETED|12-Week Double-Blind Period||0
5087931|NCT01698320|12519026|P3|Safety Population|12-Week Double-Blind Period||168
5087932|NCT01698320|12519027|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
5087933|NCT01698320|12519028|P1|Safety Population|12-Week Double-Blind Period||0
5087934|NCT01698320|12519026|P3|STARTED|12-Week Double-Blind Period||168
5087935|NCT01698320|12519027|P2|STARTED|12-Week Double-Blind Period||169
5087936|NCT01698320|12519028|P1|STARTED|12-Week Double-Blind Period||0
5087937|NCT01698320|12519026|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
5087938|NCT01698320|12519027|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
5087939|NCT01698320|12519028|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
5087940|NCT01698320|12519026|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
5087941|NCT01698320|12519027|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
5087942|NCT01698320|12519028|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
5087943|NCT01698320|12519026|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
5087944|NCT01698320|12519027|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
5087945|NCT01698320|12519028|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
5087946|NCT01698268|12519048|P2|NOT COMPLETED|Overall Study||1
5087947|NCT01698268|12519049|P1|NOT COMPLETED|Overall Study||2
5087948|NCT01698268|12519048|P2|COMPLETED|Overall Study||24
5087949|NCT01698268|12519049|P1|COMPLETED|Overall Study||23
5087950|NCT01698268|12519048|P2|STARTED|Overall Study||25
5087951|NCT01698268|12519049|P1|STARTED|Overall Study||25
5087952|NCT01698008|12519057|P2|NOT COMPLETED|Overall Study||2
5087953|NCT01698008|12519058|P1|NOT COMPLETED|Overall Study||1
5087954|NCT01698008|12519057|P2|COMPLETED|Overall Study||0
5087955|NCT01698008|12519058|P1|COMPLETED|Overall Study||2
5087956|NCT01698008|12519057|P2|STARTED|Overall Study||2
5087957|NCT01698008|12519058|P1|STARTED|Overall Study||3
5087958|NCT01697969|12519064|P1|NOT COMPLETED|Overall Study||3
5087959|NCT01697969|12519064|P1|COMPLETED|Overall Study||10
5087960|NCT01697969|12519064|P1|STARTED|Overall Study||13
5087961|NCT01697956|12519071|P2|NOT COMPLETED|Overall Study||1
5087962|NCT01697956|12519072|P1|NOT COMPLETED|Overall Study||1
5087963|NCT01697956|12519071|P2|COMPLETED|Overall Study||31
5087964|NCT01697956|12519072|P1|COMPLETED|Overall Study||66
5087965|NCT01697956|12519071|P2|Per Protocol Population|Overall Study||31
5087966|NCT01697956|12519072|P1|Per Protocol Population|Overall Study||66
5087967|NCT01697956|12519071|P2|STARTED|Overall Study|enrolled and randomized|32
5087968|NCT01697956|12519072|P1|STARTED|Overall Study|enrolled and randomized|67
5087969|NCT01697800|12519102|P2|NOT COMPLETED|Overall Study||1
5087970|NCT01697800|12519103|P1|NOT COMPLETED|Overall Study||0
5087971|NCT01697800|12519102|P2|COMPLETED|Overall Study||24
5087972|NCT01697800|12519103|P1|COMPLETED|Overall Study||15
5087973|NCT01697800|12519102|P2|STARTED|Overall Study||25
5087974|NCT01697800|12519103|P1|STARTED|Overall Study||15
5087975|NCT01697748|12519111|P2|NOT COMPLETED|Overall Study||68
5087976|NCT01697748|12519112|P1|NOT COMPLETED|Overall Study||58
5087977|NCT01697748|12519111|P2|COMPLETED|Overall Study||260
5087978|NCT01697748|12519112|P1|COMPLETED|Overall Study||271
5087979|NCT01697748|12519111|P2|STARTED|Overall Study||328
5087980|NCT01697748|12519112|P1|STARTED|Overall Study||329
5087981|NCT01697709|12519130|P2|NOT COMPLETED|Overall Study||28
5087982|NCT01697709|12519131|P1|NOT COMPLETED|Overall Study||30
5087983|NCT01697709|12519130|P2|COMPLETED|Overall Study||38
5087984|NCT01697709|12519131|P1|COMPLETED|Overall Study||34
5087985|NCT01697709|12519130|P2|STARTED|Overall Study||66
5087986|NCT01697709|12519131|P1|STARTED|Overall Study||64
5087987|NCT01697696|12519141|P2|NOT COMPLETED|Overall Study||47
5087988|NCT01697696|12519142|P1|NOT COMPLETED|Overall Study||47
5087989|NCT01697696|12519141|P2|COMPLETED|Overall Study||210
5087990|NCT01697696|12519142|P1|COMPLETED|Overall Study||207
5087991|NCT01697696|12519141|P2|Full Analysis Set (FAS)|Overall Study||255
5087992|NCT01697696|12519142|P1|Full Analysis Set (FAS)|Overall Study||251
5087993|NCT01697696|12519141|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
5087994|NCT01697696|12519142|P1|Safety Set|Overall Study||251
5087995|NCT01697696|12519141|P2|STARTED|Overall Study||257
5087996|NCT01697696|12519142|P1|STARTED|Overall Study||254
5087997|NCT01697592|12519174|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
5087998|NCT01697592|12519175|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
5087999|NCT01697592|12519176|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
5088000|NCT01697592|12519177|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
5088001|NCT01697592|12519178|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
5088002|NCT01697592|12519179|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
5088003|NCT01697592|12519180|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
5088004|NCT01697592|12519181|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
5088005|NCT01697592|12519182|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
5088006|NCT01697592|12519183|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
5088007|NCT01697592|12519174|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
5088008|NCT01697592|12519175|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
5088009|NCT01697592|12519176|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
5088010|NCT01697592|12519177|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
5088011|NCT01697592|12519178|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
5088012|NCT01697592|12519179|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
5088013|NCT01697592|12519180|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
5088014|NCT01697592|12519181|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
5088015|NCT01697592|12519182|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
5088016|NCT01697592|12519183|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
5088017|NCT01697592|12519174|P10|STARTED|Phase B (Week 25 to Week 52)||30
5088018|NCT01697592|12519175|P9|STARTED|Phase B (Week 25 to Week 52)||34
5088019|NCT01697592|12519176|P8|STARTED|Phase B (Week 25 to Week 52)||33
5088020|NCT01697592|12519177|P7|STARTED|Phase B (Week 25 to Week 52)||32
5088021|NCT01697592|12519178|P6|STARTED|Phase B (Week 25 to Week 52)||62
5088022|NCT01697592|12519179|P5|STARTED|Phase B (Week 25 to Week 52)||67
5088023|NCT01697592|12519180|P4|STARTED|Phase B (Week 25 to Week 52)||63
5088024|NCT01697592|12519181|P3|STARTED|Phase B (Week 25 to Week 52)||65
5088025|NCT01697592|12519182|P2|STARTED|Phase B (Week 25 to Week 52)||62
5088026|NCT01697592|12519183|P1|STARTED|Phase B (Week 25 to Week 52)||123
5088027|NCT01697592|12519174|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
5088028|NCT01697592|12519175|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
5088029|NCT01697592|12519176|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
5088030|NCT01697592|12519177|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
5088031|NCT01697592|12519178|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
5088032|NCT01697592|12519179|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
5088033|NCT01697592|12519180|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
5088034|NCT01697592|12519181|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
5088035|NCT01697592|12519182|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
5088036|NCT01697592|12519183|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
5088037|NCT01697592|12519174|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
5088038|NCT01697592|12519175|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
5088039|NCT01697592|12519176|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
5088040|NCT01697592|12519177|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
5088041|NCT01697592|12519178|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
5088042|NCT01697592|12519179|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
5088043|NCT01697592|12519180|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
5088044|NCT01697592|12519181|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
5088045|NCT01697592|12519182|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
5088046|NCT01697592|12519183|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
5088047|NCT01697592|12519174|P10|STARTED|Phase A (Up to 24 Weeks)||32
5088048|NCT01697592|12519175|P9|STARTED|Phase A (Up to 24 Weeks)||34
5088049|NCT01697592|12519176|P8|STARTED|Phase A (Up to 24 Weeks)||33
5088050|NCT01697592|12519177|P7|STARTED|Phase A (Up to 24 Weeks)||34
5088051|NCT01697592|12519178|P6|STARTED|Phase A (Up to 24 Weeks)||63
5088052|NCT01697592|12519179|P5|STARTED|Phase A (Up to 24 Weeks)||67
5088053|NCT01697592|12519180|P4|STARTED|Phase A (Up to 24 Weeks)||65
5088054|NCT01697592|12519181|P3|STARTED|Phase A (Up to 24 Weeks)||66
5088055|NCT01697592|12519182|P2|STARTED|Phase A (Up to 24 Weeks)||65
5088056|NCT01697592|12519183|P1|STARTED|Phase A (Up to 24 Weeks)||126
5088057|NCT01697579|12519252|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
5088058|NCT01697579|12519253|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
5088059|NCT01697579|12519254|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
5088060|NCT01697579|12519255|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
5088061|NCT01697579|12519256|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
5088062|NCT01697579|12519257|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
5088063|NCT01697579|12519258|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
5088064|NCT01697579|12519252|P7|COMPLETED|Optional Extension-Cycles 2-6||37
5088065|NCT01697579|12519253|P6|COMPLETED|Optional Extension-Cycles 2-6||12
5088066|NCT01697579|12519254|P5|COMPLETED|Optional Extension-Cycles 2-6||0
5088067|NCT01697579|12519255|P4|COMPLETED|Optional Extension-Cycles 2-6||0
5088068|NCT01697579|12519256|P3|COMPLETED|Optional Extension-Cycles 2-6||0
5088069|NCT01697579|12519257|P2|COMPLETED|Optional Extension-Cycles 2-6||0
5088070|NCT01697579|12519258|P1|COMPLETED|Optional Extension-Cycles 2-6||0
5088071|NCT01697579|12519252|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
5088072|NCT01697579|12519253|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
5088073|NCT01697579|12519254|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
5088074|NCT01697579|12519255|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
5088075|NCT01697579|12519256|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
5088076|NCT01697579|12519257|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
5088077|NCT01697579|12519258|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
5088078|NCT01697579|12519252|P7|NOT COMPLETED|Base Study-Cycle 1||0
5088079|NCT01697579|12519253|P6|NOT COMPLETED|Base Study-Cycle 1||0
5088080|NCT01697579|12519254|P5|NOT COMPLETED|Base Study-Cycle 1||3
5088081|NCT01697579|12519255|P4|NOT COMPLETED|Base Study-Cycle 1||1
5088082|NCT01697579|12519256|P3|NOT COMPLETED|Base Study-Cycle 1||1
5088083|NCT01697579|12519257|P2|NOT COMPLETED|Base Study-Cycle 1||1
5088084|NCT01697579|12519258|P1|NOT COMPLETED|Base Study-Cycle 1||2
5088085|NCT01697579|12519252|P7|COMPLETED|Base Study-Cycle 1||0
5088086|NCT01697579|12519253|P6|COMPLETED|Base Study-Cycle 1||0
5088087|NCT01697579|12519254|P5|COMPLETED|Base Study-Cycle 1||35
5088088|NCT01697579|12519255|P4|COMPLETED|Base Study-Cycle 1||40
5088089|NCT01697579|12519256|P3|COMPLETED|Base Study-Cycle 1||43
5088090|NCT01697579|12519257|P2|COMPLETED|Base Study-Cycle 1||42
5088091|NCT01697579|12519258|P1|COMPLETED|Base Study-Cycle 1||72
5088092|NCT01697579|12519252|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
5088093|NCT01697579|12519253|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
5088094|NCT01697579|12519254|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
5088180|NCT01696773|12519621|P1|COMPLETED|Day 28, Second Intervention||5
5088095|NCT01697579|12519255|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
5088096|NCT01697579|12519256|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
5088097|NCT01697579|12519257|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
5088098|NCT01697579|12519258|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
5088099|NCT01697501|12519370|P1|NOT COMPLETED|Overall Study||2
5088100|NCT01697501|12519370|P1|COMPLETED|Overall Study||86
5088101|NCT01697501|12519370|P1|STARTED|Overall Study||88
5088102|NCT01697462|12519413|P1|NOT COMPLETED|Overall Study||77
5088103|NCT01697462|12519413|P1|COMPLETED|Overall Study||181
5088104|NCT01697462|12519413|P1|STARTED|Overall Study||258
5088105|NCT01697449|12519420|P1|NOT COMPLETED|Overall Study||90
5088106|NCT01697449|12519420|P1|COMPLETED|Overall Study||101
5088107|NCT01697449|12519420|P1|STARTED|Overall Study||191
5088108|NCT01697358|12519431|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
5088109|NCT01697358|12519432|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
5088110|NCT01697358|12519431|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
5088111|NCT01697358|12519432|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
5088112|NCT01697358|12519431|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
5088113|NCT01697358|12519432|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
5088114|NCT01697358|12519431|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
5088115|NCT01697358|12519432|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
5088116|NCT01697358|12519431|P2|COMPLETED|Period I: Randomization to 6 Months||107
5088117|NCT01697358|12519432|P1|COMPLETED|Period I: Randomization to 6 Months||97
5088118|NCT01697358|12519431|P2|STARTED|Period I: Randomization to 6 Months||108
5088119|NCT01697358|12519432|P1|STARTED|Period I: Randomization to 6 Months||110
5088120|NCT01697345|12519448|P1|NOT COMPLETED|Overall Study||1
5088121|NCT01697345|12519448|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
5088122|NCT01697345|12519448|P1|STARTED|Overall Study||13
5088123|NCT01697332|12519467|P1|NOT COMPLETED|Overall Study||0
5088124|NCT01697332|12519467|P1|COMPLETED|Overall Study||1
5088125|NCT01697332|12519467|P1|STARTED|Overall Study||1
5088126|NCT01697319|12519473|P1|NOT COMPLETED|Extension Phase||15
5088127|NCT01697319|12519473|P1|COMPLETED|Extension Phase||0
5088128|NCT01697319|12519473|P1|STARTED|Extension Phase||15
5088129|NCT01697319|12519473|P1|NOT COMPLETED|Primary Phase||1
5088130|NCT01697319|12519473|P1|COMPLETED|Primary Phase||15
5088131|NCT01697319|12519473|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
5088132|NCT01696994|12519482|P2|NOT COMPLETED|Overall Study||8437
5088133|NCT01696994|12519483|P1|NOT COMPLETED|Overall Study||5192
5088134|NCT01696994|12519482|P2|COMPLETED|Overall Study||30668
5088135|NCT01696994|12519483|P1|COMPLETED|Overall Study||33919
5088136|NCT01696994|12519482|P2|STARTED|Overall Study||39105
5088137|NCT01696994|12519483|P1|STARTED|Overall Study||39111
5088138|NCT01696981|12519511|P2|NOT COMPLETED|Overall Study||10374
5088139|NCT01696981|12519512|P1|NOT COMPLETED|Overall Study||1201
5088140|NCT01696981|12519511|P2|COMPLETED|Overall Study||67071
5088141|NCT01696981|12519512|P1|COMPLETED|Overall Study||76254
5088142|NCT01696981|12519511|P2|STARTED|Overall Study||77445
5088143|NCT01696981|12519512|P1|STARTED|Overall Study||77455
5088144|NCT01696968|12519532|P2|NOT COMPLETED|Overall Study||6812
5088145|NCT01696968|12519533|P1|NOT COMPLETED|Overall Study||1201
5088146|NCT01696968|12519532|P2|COMPLETED|Overall Study||70633
5088147|NCT01696968|12519533|P1|COMPLETED|Overall Study||76255
5088148|NCT01696968|12519532|P2|STARTED|Overall Study||77445
5088149|NCT01696968|12519533|P1|STARTED|Overall Study||77456
5088150|NCT01696955|12519555|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
5088151|NCT01696955|12519556|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
5088152|NCT01696955|12519555|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
5088153|NCT01696955|12519556|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
5088154|NCT01696955|12519555|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
5088155|NCT01696955|12519556|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
5088156|NCT01696955|12519555|P2|NOT COMPLETED|Main Study||1
5088157|NCT01696955|12519556|P1|NOT COMPLETED|Main Study||2
5088158|NCT01696955|12519555|P2|COMPLETED|Main Study||38
5088159|NCT01696955|12519556|P1|COMPLETED|Main Study||40
5088160|NCT01696955|12519555|P2|STARTED|Main Study||39
5088161|NCT01696955|12519556|P1|STARTED|Main Study||42
5088162|NCT01696942|12519581|P2|NOT COMPLETED|Overall Study||3
5088163|NCT01696942|12519582|P1|NOT COMPLETED|Overall Study||2
5088164|NCT01696942|12519581|P2|COMPLETED|Overall Study||2
5088165|NCT01696942|12519582|P1|COMPLETED|Overall Study||3
5088166|NCT01696942|12519581|P2|STARTED|Overall Study||5
5088167|NCT01696942|12519582|P1|STARTED|Overall Study||5
5088168|NCT01696929|12519590|P1|NOT COMPLETED|Overall Study||1
5088169|NCT01696929|12519590|P1|COMPLETED|Overall Study||5
5088170|NCT01696929|12519590|P1|STARTED|Overall Study||6
5088171|NCT01696877|12519597|P2|NOT COMPLETED|Overall Study||1
5088172|NCT01696877|12519598|P1|NOT COMPLETED|Overall Study||0
5088173|NCT01696877|12519597|P2|COMPLETED|Overall Study||13
5088174|NCT01696877|12519598|P1|COMPLETED|Overall Study||15
5088175|NCT01696877|12519597|P2|STARTED|Overall Study||14
5088176|NCT01696877|12519598|P1|STARTED|Overall Study||15
5088177|NCT01696773|12519620|P2|NOT COMPLETED|Day 28, Second Intervention||0
5088178|NCT01696773|12519621|P1|NOT COMPLETED|Day 28, Second Intervention||0
5088179|NCT01696773|12519620|P2|COMPLETED|Day 28, Second Intervention||6
5088181|NCT01696773|12519620|P2|STARTED|Day 28, Second Intervention||6
5088182|NCT01696773|12519621|P1|STARTED|Day 28, Second Intervention||5
5088183|NCT01696773|12519620|P2|NOT COMPLETED|Days 15-27, Washout||0
5088184|NCT01696773|12519621|P1|NOT COMPLETED|Days 15-27, Washout||1
5088185|NCT01696773|12519620|P2|COMPLETED|Days 15-27, Washout||6
5088186|NCT01696773|12519621|P1|COMPLETED|Days 15-27, Washout||5
5088187|NCT01696773|12519620|P2|STARTED|Days 15-27, Washout||6
5088188|NCT01696773|12519621|P1|STARTED|Days 15-27, Washout||6
5088189|NCT01696773|12519620|P2|NOT COMPLETED|Day 14, First Intervention||0
5088190|NCT01696773|12519621|P1|NOT COMPLETED|Day 14, First Intervention||0
5088191|NCT01696773|12519620|P2|COMPLETED|Day 14, First Intervention||6
5088192|NCT01696773|12519621|P1|COMPLETED|Day 14, First Intervention||6
5088193|NCT01696773|12519620|P2|STARTED|Day 14, First Intervention||6
5088194|NCT01696773|12519621|P1|STARTED|Day 14, First Intervention||6
5088195|NCT01696773|12519620|P2|NOT COMPLETED|Days 1-13, Washout||0
5088196|NCT01696773|12519621|P1|NOT COMPLETED|Days 1-13, Washout||0
5088197|NCT01696773|12519620|P2|COMPLETED|Days 1-13, Washout||6
5088198|NCT01696773|12519621|P1|COMPLETED|Days 1-13, Washout||6
5088199|NCT01696773|12519620|P2|STARTED|Days 1-13, Washout||6
5088200|NCT01696773|12519621|P1|STARTED|Days 1-13, Washout||6
5088201|NCT01696760|12519629|P2|NOT COMPLETED|Overall Study||0
5088202|NCT01696760|12519630|P1|NOT COMPLETED|Overall Study||0
5088203|NCT01696760|12519629|P2|COMPLETED|Overall Study||3
5088204|NCT01696760|12519630|P1|COMPLETED|Overall Study||9
5088205|NCT01696760|12519629|P2|STARTED|Overall Study||3
5088206|NCT01696760|12519630|P1|STARTED|Overall Study||9
5088207|NCT01696695|12519648|P1|NOT COMPLETED|Overall Study||882
5088208|NCT01696695|12519648|P1|COMPLETED|Overall Study||0
5088209|NCT01696695|12519648|P1|STARTED|Overall Study||882
5088210|NCT01696643|12519660|P2|NOT COMPLETED|Overall Study||535
5088211|NCT01696643|12519661|P1|NOT COMPLETED|Overall Study||529
5088212|NCT01696643|12519660|P2|COMPLETED|Overall Study||169
5088213|NCT01696643|12519661|P1|COMPLETED|Overall Study||174
5088214|NCT01696643|12519660|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
5088215|NCT01696643|12519661|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
5088216|NCT01696643|12519660|P2|STARTED|Overall Study||704
5088217|NCT01696643|12519661|P1|STARTED|Overall Study||703
5088218|NCT01696396|12519680|P4|NOT COMPLETED|Overall Study||14
5088219|NCT01696396|12519681|P3|NOT COMPLETED|Overall Study||26
5088220|NCT01696396|12519682|P2|NOT COMPLETED|Overall Study||7
5088221|NCT01696396|12519683|P1|NOT COMPLETED|Overall Study||31
5088222|NCT01696396|12519680|P4|COMPLETED|Overall Study||28
5088223|NCT01696396|12519681|P3|COMPLETED|Overall Study||59
5088224|NCT01696396|12519682|P2|COMPLETED|Overall Study||20
5088225|NCT01696396|12519683|P1|COMPLETED|Overall Study||69
5088226|NCT01696396|12519680|P4|Entered Open-label Period|Overall Study||37
5088227|NCT01696396|12519681|P3|Entered Open-label Period|Overall Study||75
5088228|NCT01696396|12519682|P2|Entered Open-label Period|Overall Study||21
5088229|NCT01696396|12519683|P1|Entered Open-label Period|Overall Study||84
5088230|NCT01696396|12519680|P4|Received Study Drug|Overall Study||41
5088231|NCT01696396|12519681|P3|Received Study Drug|Overall Study||84
5088232|NCT01696396|12519682|P2|Received Study Drug|Overall Study||26
5088233|NCT01696396|12519683|P1|Received Study Drug|Overall Study||98
5088234|NCT01696396|12519680|P4|STARTED|Overall Study||42
5088235|NCT01696396|12519681|P3|STARTED|Overall Study||85
5088236|NCT01696396|12519682|P2|STARTED|Overall Study||27
5088237|NCT01696396|12519683|P1|STARTED|Overall Study||100
5088238|NCT01696357|12519727|P2|NOT COMPLETED|Overall Study||1
5088239|NCT01696357|12519728|P1|NOT COMPLETED|Overall Study||2
5088240|NCT01696357|12519727|P2|COMPLETED|Overall Study||41
5088241|NCT01696357|12519728|P1|COMPLETED|Overall Study||40
5088242|NCT01696357|12519727|P2|STARTED|Overall Study||42
5088243|NCT01696357|12519728|P1|STARTED|Overall Study||42
5088244|NCT01696279|12519734|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
5088245|NCT01696279|12519735|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088246|NCT01696279|12519736|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088247|NCT01696279|12519737|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088248|NCT01696279|12519734|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
5088249|NCT01696279|12519735|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088250|NCT01696279|12519736|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088251|NCT01696279|12519737|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
5088252|NCT01696279|12519734|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
5088253|NCT01696279|12519735|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
5088254|NCT01696279|12519736|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
5088255|NCT01696279|12519737|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
5088256|NCT01696279|12519734|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088257|NCT01696279|12519735|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
5088258|NCT01696279|12519736|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088259|NCT01696279|12519737|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088260|NCT01696279|12519734|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088261|NCT01696279|12519735|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
5088262|NCT01696279|12519736|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088263|NCT01696279|12519737|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088264|NCT01696279|12519734|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088265|NCT01696279|12519735|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
5088266|NCT01696279|12519736|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088267|NCT01696279|12519737|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088268|NCT01696279|12519734|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088269|NCT01696279|12519735|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088270|NCT01696279|12519736|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088271|NCT01696279|12519737|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088272|NCT01696279|12519734|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088273|NCT01696279|12519735|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
5088274|NCT01696279|12519736|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088275|NCT01696279|12519737|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088276|NCT01696279|12519734|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088277|NCT01696279|12519735|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
5088278|NCT01696279|12519736|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088279|NCT01696279|12519737|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088280|NCT01696279|12519734|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088281|NCT01696279|12519735|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
5088282|NCT01696279|12519736|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088283|NCT01696279|12519737|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
5088284|NCT01696279|12519734|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088285|NCT01696279|12519735|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088286|NCT01696279|12519736|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
5088287|NCT01696279|12519737|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088288|NCT01696279|12519734|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088289|NCT01696279|12519735|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088290|NCT01696279|12519736|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
5088291|NCT01696279|12519737|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
5088292|NCT01696279|12519734|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
5088293|NCT01696279|12519735|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
5088294|NCT01696279|12519736|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
5088295|NCT01696279|12519737|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
5088296|NCT01696279|12519734|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
5088297|NCT01696279|12519735|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
5088298|NCT01696279|12519736|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
5088299|NCT01696279|12519737|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
5088300|NCT01696279|12519734|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
5088301|NCT01696279|12519735|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
5088302|NCT01696279|12519736|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
5088303|NCT01696279|12519737|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
5088304|NCT01696279|12519734|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088305|NCT01696279|12519735|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088306|NCT01696279|12519736|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
5088307|NCT01696279|12519737|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088308|NCT01696279|12519734|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088309|NCT01696279|12519735|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088310|NCT01696279|12519736|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
5088311|NCT01696279|12519737|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
5088312|NCT01696279|12519734|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
5088313|NCT01696279|12519735|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
5088314|NCT01696279|12519736|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
5088315|NCT01696279|12519737|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
5088316|NCT01696279|12519734|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088317|NCT01696279|12519735|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088318|NCT01696279|12519736|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088319|NCT01696279|12519737|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
5088320|NCT01696279|12519734|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088321|NCT01696279|12519735|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088322|NCT01696279|12519736|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
5088323|NCT01696279|12519737|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
5088324|NCT01696279|12519734|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
5088325|NCT01696279|12519735|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
5088326|NCT01696279|12519736|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
5088327|NCT01696279|12519737|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
5088328|NCT01696279|12519734|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
5088329|NCT01696279|12519735|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
5088330|NCT01696279|12519736|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
5088331|NCT01696279|12519737|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
5088332|NCT01696279|12519734|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
5088333|NCT01696279|12519735|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
5088334|NCT01696279|12519736|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
5088335|NCT01696279|12519737|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
5088336|NCT01696214|12519775|P4|NOT COMPLETED|Overall Study||0
5088337|NCT01696214|12519776|P3|NOT COMPLETED|Overall Study||0
5088338|NCT01696214|12519777|P2|NOT COMPLETED|Overall Study||0
5088339|NCT01696214|12519778|P1|NOT COMPLETED|Overall Study||1
5088340|NCT01696214|12519775|P4|COMPLETED|Overall Study||5
5088341|NCT01696214|12519776|P3|COMPLETED|Overall Study||5
5088342|NCT01696214|12519777|P2|COMPLETED|Overall Study||5
5088343|NCT01696214|12519778|P1|COMPLETED|Overall Study||4
5088344|NCT01696214|12519775|P4|STARTED|Overall Study||5
5088345|NCT01696214|12519776|P3|STARTED|Overall Study||5
5088346|NCT01696214|12519777|P2|STARTED|Overall Study||5
5088347|NCT01696214|12519778|P1|STARTED|Overall Study||5
5088348|NCT01696188|12519798|P2|NOT COMPLETED|Overall Study||1
5088349|NCT01696188|12519799|P1|NOT COMPLETED|Overall Study||1
5088350|NCT01696188|12519798|P2|COMPLETED|Overall Study||42
5088351|NCT01696188|12519799|P1|COMPLETED|Overall Study||40
5088352|NCT01696188|12519798|P2|STARTED|Overall Study||43
5088353|NCT01696188|12519799|P1|STARTED|Overall Study||41
5088354|NCT01696084|12519813|P2|NOT COMPLETED|Overall Study||146
5088355|NCT01696084|12519814|P1|NOT COMPLETED|Overall Study||131
5088356|NCT01696084|12519813|P2|COMPLETED|Overall Study||10
5088357|NCT01696084|12519814|P1|COMPLETED|Overall Study||22
5088358|NCT01696084|12519813|P2|STARTED|Overall Study||156
5088359|NCT01696084|12519814|P1|STARTED|Overall Study||153
5088360|NCT01696071|12519830|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
5088361|NCT01696071|12519831|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
5088362|NCT01696071|12519830|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
5088363|NCT01696071|12519831|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
5088364|NCT01696071|12519830|P2|STARTED|Treatment Period 2: 4 Weeks||47
5088365|NCT01696071|12519831|P1|STARTED|Treatment Period 2: 4 Weeks||51
5088366|NCT01696071|12519830|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
5088367|NCT01696071|12519831|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
5088368|NCT01696071|12519830|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
5088369|NCT01696071|12519831|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
5088370|NCT01696071|12519830|P2|STARTED|Treatment Period 1: 4 Weeks||47
5088371|NCT01696071|12519831|P1|STARTED|Treatment Period 1: 4 Weeks||51
5088372|NCT01696058|12519859|P2|NOT COMPLETED|Overall Study||31
5088373|NCT01696058|12519860|P1|NOT COMPLETED|Overall Study||43
5088374|NCT01696058|12519859|P2|COMPLETED|Overall Study||538
5088375|NCT01696058|12519860|P1|COMPLETED|Overall Study||523
5088376|NCT01696058|12519859|P2|STARTED|Overall Study||569
5088377|NCT01696058|12519860|P1|STARTED|Overall Study||566
5088378|NCT01696045|12519888|P2|NOT COMPLETED|Overall Study||7
5088379|NCT01696045|12519889|P1|NOT COMPLETED|Overall Study||3
5088380|NCT01696045|12519888|P2|COMPLETED|Overall Study||1
5088381|NCT01696045|12519889|P1|COMPLETED|Overall Study||1
5088382|NCT01696045|12519888|P2|STARTED|Overall Study||8
5088383|NCT01696045|12519889|P1|STARTED|Overall Study||4
5088384|NCT01695993|12519908|P3|NOT COMPLETED|Overall Study||6
5088385|NCT01695993|12519909|P2|NOT COMPLETED|Overall Study||5
5088386|NCT01695993|12519910|P1|NOT COMPLETED|Overall Study||5
5088387|NCT01695993|12519908|P3|COMPLETED|Overall Study||75
5088388|NCT01695993|12519909|P2|COMPLETED|Overall Study||75
5088389|NCT01695993|12519910|P1|COMPLETED|Overall Study||76
5088390|NCT01695993|12519908|P3|STARTED|Overall Study||81
5088391|NCT01695993|12519909|P2|STARTED|Overall Study||80
5088392|NCT01695993|12519910|P1|STARTED|Overall Study||81
5088393|NCT01695772|12519918|P1|NOT COMPLETED|Overall Study||38
5088394|NCT01695772|12519918|P1|COMPLETED|Overall Study||12
5088395|NCT01695772|12519918|P1|STARTED|Overall Study||50
5088396|NCT01695746|12519930|P1|NOT COMPLETED|Overall Study||12
5088397|NCT01695746|12519930|P1|COMPLETED|Overall Study||96
5088398|NCT01695746|12519930|P1|STARTED|Overall Study||108
5088399|NCT01695668|12519946|P2|NOT COMPLETED|Overall Study||17
5088400|NCT01695668|12519947|P1|NOT COMPLETED|Overall Study||15
5088401|NCT01695668|12519946|P2|COMPLETED|Overall Study||20
5088402|NCT01695668|12519947|P1|COMPLETED|Overall Study||23
5088403|NCT01695668|12519946|P2|STARTED|Overall Study||37
5088404|NCT01695668|12519947|P1|STARTED|Overall Study||38
5088405|NCT01695369|12519953|P1|NOT COMPLETED|Overall Study||0
5088406|NCT01695369|12519953|P1|COMPLETED|Overall Study||61
5088407|NCT01695369|12519953|P1|STARTED|Overall Study||61
5088408|NCT01695330|12519959|P2|NOT COMPLETED|Overall Study||0
5088409|NCT01695330|12519960|P1|NOT COMPLETED|Overall Study||47
5088410|NCT01695330|12519959|P2|COMPLETED|Overall Study||0
5088411|NCT01695330|12519960|P1|COMPLETED|Overall Study||5
5088412|NCT01695330|12519959|P2|STARTED|Overall Study||0
5088413|NCT01695330|12519960|P1|STARTED|Overall Study||52
5088414|NCT01695304|12519966|P2|NOT COMPLETED|Overall Study||0
5088415|NCT01695304|12519967|P1|NOT COMPLETED|Overall Study||0
5088416|NCT01695304|12519966|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
5088417|NCT01695304|12519967|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
5088418|NCT01695304|12519966|P2|STARTED|Overall Study||120
5088419|NCT01695304|12519967|P1|STARTED|Overall Study||120
5088420|NCT01695291|12519977|P2|NOT COMPLETED|Overall Study||7
5088421|NCT01695291|12519978|P1|NOT COMPLETED|Overall Study||2
5088422|NCT01695291|12519977|P2|COMPLETED|Overall Study||14
5088423|NCT01695291|12519978|P1|COMPLETED|Overall Study||8
5088424|NCT01695291|12519977|P2|STARTED|Overall Study||21
5088425|NCT01695291|12519978|P1|STARTED|Overall Study||10
5088426|NCT01695239|12519990|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
5088427|NCT01695239|12519991|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
5088428|NCT01695239|12519992|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
5088429|NCT01695239|12519993|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088430|NCT01695239|12519994|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088431|NCT01695239|12519995|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088432|NCT01695239|12519996|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088433|NCT01695239|12519997|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088434|NCT01695239|12519998|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088435|NCT01695239|12519999|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088436|NCT01695239|12520000|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088437|NCT01695239|12520001|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088438|NCT01695239|12520002|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088439|NCT01695239|12520003|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
5088440|NCT01695239|12519990|P14|COMPLETED|Post-Treatment Follow-Up Period||166
5088441|NCT01695239|12519991|P13|COMPLETED|Post-Treatment Follow-Up Period||156
5088442|NCT01695239|12519992|P12|COMPLETED|Post-Treatment Follow-Up Period||0
5088443|NCT01695239|12519993|P11|COMPLETED|Post-Treatment Follow-Up Period||20
5088444|NCT01695239|12519994|P10|COMPLETED|Post-Treatment Follow-Up Period||0
5088445|NCT01695239|12519995|P9|COMPLETED|Post-Treatment Follow-Up Period||0
5088446|NCT01695239|12519996|P8|COMPLETED|Post-Treatment Follow-Up Period||0
5088447|NCT01695239|12519997|P7|COMPLETED|Post-Treatment Follow-Up Period||0
5088448|NCT01695239|12519998|P6|COMPLETED|Post-Treatment Follow-Up Period||0
5088449|NCT01695239|12519999|P5|COMPLETED|Post-Treatment Follow-Up Period||0
5088450|NCT01695239|12520000|P4|COMPLETED|Post-Treatment Follow-Up Period||0
5088451|NCT01695239|12520001|P3|COMPLETED|Post-Treatment Follow-Up Period||0
5088452|NCT01695239|12520002|P2|COMPLETED|Post-Treatment Follow-Up Period||0
5088453|NCT01695239|12520003|P1|COMPLETED|Post-Treatment Follow-Up Period||0
5088454|NCT01695239|12519990|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
5088455|NCT01695239|12519991|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
5088456|NCT01695239|12519992|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
5088457|NCT01695239|12519993|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
5088458|NCT01695239|12519994|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
5088459|NCT01695239|12519995|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
5088460|NCT01695239|12519996|P8|STARTED|Post-Treatment Follow-Up Period||0
5088461|NCT01695239|12519997|P7|STARTED|Post-Treatment Follow-Up Period||0
5088462|NCT01695239|12519998|P6|STARTED|Post-Treatment Follow-Up Period||0
5088463|NCT01695239|12519999|P5|STARTED|Post-Treatment Follow-Up Period||0
5088464|NCT01695239|12520000|P4|STARTED|Post-Treatment Follow-Up Period||0
5088465|NCT01695239|12520001|P3|STARTED|Post-Treatment Follow-Up Period||0
5088466|NCT01695239|12520002|P2|STARTED|Post-Treatment Follow-Up Period||0
5088467|NCT01695239|12520003|P1|STARTED|Post-Treatment Follow-Up Period||0
5088468|NCT01695239|12519990|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088469|NCT01695239|12519991|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088470|NCT01695239|12519992|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088471|NCT01695239|12519993|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088472|NCT01695239|12519994|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
5088473|NCT01695239|12519995|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
5088474|NCT01695239|12519996|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088475|NCT01695239|12519997|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088476|NCT01695239|12519998|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088477|NCT01695239|12519999|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088478|NCT01695239|12520000|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088479|NCT01695239|12520001|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088480|NCT01695239|12520002|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088481|NCT01695239|12520003|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
5088482|NCT01695239|12519990|P14|COMPLETED|Extension Long-Term Extension Periods||0
5088483|NCT01695239|12519991|P13|COMPLETED|Extension Long-Term Extension Periods||0
5088484|NCT01695239|12519992|P12|COMPLETED|Extension Long-Term Extension Periods||0
5088485|NCT01695239|12519993|P11|COMPLETED|Extension Long-Term Extension Periods||0
5088486|NCT01695239|12519994|P10|COMPLETED|Extension Long-Term Extension Periods||122
5088487|NCT01695239|12519995|P9|COMPLETED|Extension Long-Term Extension Periods||121
5088488|NCT01695239|12519996|P8|COMPLETED|Extension Long-Term Extension Periods||0
5088489|NCT01695239|12519997|P7|COMPLETED|Extension Long-Term Extension Periods||0
5088490|NCT01695239|12519998|P6|COMPLETED|Extension Long-Term Extension Periods||0
5088491|NCT01695239|12519999|P5|COMPLETED|Extension Long-Term Extension Periods||0
5088492|NCT01695239|12520000|P4|COMPLETED|Extension Long-Term Extension Periods||0
5088493|NCT01695239|12520001|P3|COMPLETED|Extension Long-Term Extension Periods||0
5088494|NCT01695239|12520002|P2|COMPLETED|Extension Long-Term Extension Periods||0
5088495|NCT01695239|12520003|P1|COMPLETED|Extension Long-Term Extension Periods||0
5088496|NCT01695239|12519990|P14|STARTED|Extension Long-Term Extension Periods||0
5088497|NCT01695239|12519991|P13|STARTED|Extension Long-Term Extension Periods||0
5088498|NCT01695239|12519992|P12|STARTED|Extension Long-Term Extension Periods||0
5088499|NCT01695239|12519993|P11|STARTED|Extension Long-Term Extension Periods||0
5088570|NCT01695239|12519994|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088500|NCT01695239|12519994|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
5088501|NCT01695239|12519995|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
5088502|NCT01695239|12519996|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
5088503|NCT01695239|12519997|P7|STARTED|Extension Long-Term Extension Periods||0
5088504|NCT01695239|12519998|P6|STARTED|Extension Long-Term Extension Periods||0
5088505|NCT01695239|12519999|P5|STARTED|Extension Long-Term Extension Periods||0
5088506|NCT01695239|12520000|P4|STARTED|Extension Long-Term Extension Periods||0
5088507|NCT01695239|12520001|P3|STARTED|Extension Long-Term Extension Periods||0
5088508|NCT01695239|12520002|P2|STARTED|Extension Long-Term Extension Periods||0
5088509|NCT01695239|12520003|P1|STARTED|Extension Long-Term Extension Periods||0
5088510|NCT01695239|12519990|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088511|NCT01695239|12519991|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088512|NCT01695239|12519992|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088513|NCT01695239|12519993|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088514|NCT01695239|12519994|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088515|NCT01695239|12519995|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088516|NCT01695239|12519996|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
5088517|NCT01695239|12519997|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088518|NCT01695239|12519998|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088519|NCT01695239|12519999|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088520|NCT01695239|12520000|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088521|NCT01695239|12520001|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088522|NCT01695239|12520002|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088523|NCT01695239|12520003|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088524|NCT01695239|12519990|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088525|NCT01695239|12519991|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088526|NCT01695239|12519992|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088527|NCT01695239|12519993|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088528|NCT01695239|12519994|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088529|NCT01695239|12519995|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088530|NCT01695239|12519996|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
5088531|NCT01695239|12519997|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088532|NCT01695239|12519998|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088533|NCT01695239|12519999|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088534|NCT01695239|12520000|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088535|NCT01695239|12520001|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088536|NCT01695239|12520002|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088537|NCT01695239|12520003|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
5088538|NCT01695239|12519990|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088539|NCT01695239|12519991|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088540|NCT01695239|12519992|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088541|NCT01695239|12519993|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088542|NCT01695239|12519994|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088543|NCT01695239|12519995|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088544|NCT01695239|12519996|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
5088545|NCT01695239|12519997|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
5088546|NCT01695239|12519998|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
5088547|NCT01695239|12519999|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
5088548|NCT01695239|12520000|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088549|NCT01695239|12520001|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088550|NCT01695239|12520002|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088551|NCT01695239|12520003|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
5088552|NCT01695239|12519990|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088553|NCT01695239|12519991|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088554|NCT01695239|12519992|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088555|NCT01695239|12519993|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088556|NCT01695239|12519994|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088557|NCT01695239|12519995|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088558|NCT01695239|12519996|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088559|NCT01695239|12519997|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088560|NCT01695239|12519998|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088561|NCT01695239|12519999|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088562|NCT01695239|12520000|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088563|NCT01695239|12520001|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088564|NCT01695239|12520002|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088565|NCT01695239|12520003|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088566|NCT01695239|12519990|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088567|NCT01695239|12519991|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088568|NCT01695239|12519992|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088569|NCT01695239|12519993|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088571|NCT01695239|12519995|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088572|NCT01695239|12519996|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088573|NCT01695239|12519997|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
5088574|NCT01695239|12519998|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
5088575|NCT01695239|12519999|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
5088576|NCT01695239|12520000|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088577|NCT01695239|12520001|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088578|NCT01695239|12520002|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088579|NCT01695239|12520003|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
5088580|NCT01695239|12519990|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088581|NCT01695239|12519991|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088582|NCT01695239|12519992|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088583|NCT01695239|12519993|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088584|NCT01695239|12519994|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088585|NCT01695239|12519995|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088586|NCT01695239|12519996|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
5088587|NCT01695239|12519997|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
5088588|NCT01695239|12519998|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
5088589|NCT01695239|12519999|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
5088590|NCT01695239|12520000|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
5088591|NCT01695239|12520001|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
5088592|NCT01695239|12520002|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
5088593|NCT01695239|12520003|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
5088594|NCT01695239|12519990|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088595|NCT01695239|12519991|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088596|NCT01695239|12519992|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088597|NCT01695239|12519993|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088598|NCT01695239|12519994|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088599|NCT01695239|12519995|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088600|NCT01695239|12519996|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088601|NCT01695239|12519997|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088602|NCT01695239|12519998|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088603|NCT01695239|12519999|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5088604|NCT01695239|12520000|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
5088605|NCT01695239|12520001|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
5088606|NCT01695239|12520002|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
5088607|NCT01695239|12520003|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
5088608|NCT01695239|12519990|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
5088609|NCT01695239|12519991|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
5088610|NCT01695239|12519992|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
5088611|NCT01695239|12519993|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
5088612|NCT01695239|12519994|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
5088613|NCT01695239|12519995|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
5088614|NCT01695239|12519996|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
5088615|NCT01695239|12519997|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
5088616|NCT01695239|12519998|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
5088617|NCT01695239|12519999|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
5088618|NCT01695239|12520000|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
5088619|NCT01695239|12520001|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
5088620|NCT01695239|12520002|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
5088621|NCT01695239|12520003|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
5088622|NCT01695239|12519990|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088623|NCT01695239|12519991|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088624|NCT01695239|12519992|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088625|NCT01695239|12519993|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088626|NCT01695239|12519994|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088627|NCT01695239|12519995|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088628|NCT01695239|12519996|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088629|NCT01695239|12519997|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088630|NCT01695239|12519998|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088631|NCT01695239|12519999|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
5088632|NCT01695239|12520000|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
5088633|NCT01695239|12520001|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
5088634|NCT01695239|12520002|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
5088635|NCT01695239|12520003|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
5088636|NCT01695239|12519990|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088637|NCT01695239|12519991|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088638|NCT01695239|12519992|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088639|NCT01695239|12519993|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088640|NCT01695239|12519994|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088641|NCT01695239|12519995|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088642|NCT01695239|12519996|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088643|NCT01695239|12519997|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088644|NCT01695239|12519998|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088645|NCT01695239|12519999|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
5088646|NCT01695239|12520000|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
5088647|NCT01695239|12520001|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
5088648|NCT01695239|12520002|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
5088649|NCT01695239|12520003|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
5088650|NCT01695239|12519990|P14|STARTED|Double-Blind (DB) Treatment Period||0
5088651|NCT01695239|12519991|P13|STARTED|Double-Blind (DB) Treatment Period||0
5088652|NCT01695239|12519992|P12|STARTED|Double-Blind (DB) Treatment Period||0
5088653|NCT01695239|12519993|P11|STARTED|Double-Blind (DB) Treatment Period||0
5088654|NCT01695239|12519994|P10|STARTED|Double-Blind (DB) Treatment Period||0
5088655|NCT01695239|12519995|P9|STARTED|Double-Blind (DB) Treatment Period||0
5088656|NCT01695239|12519996|P8|STARTED|Double-Blind (DB) Treatment Period||0
5088657|NCT01695239|12519997|P7|STARTED|Double-Blind (DB) Treatment Period||0
5088658|NCT01695239|12519998|P6|STARTED|Double-Blind (DB) Treatment Period||0
5088659|NCT01695239|12519999|P5|STARTED|Double-Blind (DB) Treatment Period||0
5088660|NCT01695239|12520000|P4|STARTED|Double-Blind (DB) Treatment Period||103
5088661|NCT01695239|12520001|P3|STARTED|Double-Blind (DB) Treatment Period||107
5088662|NCT01695239|12520002|P2|STARTED|Double-Blind (DB) Treatment Period||101
5088663|NCT01695239|12520003|P1|STARTED|Double-Blind (DB) Treatment Period||106
5088664|NCT01695135|12520144|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
5088665|NCT01695135|12520145|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
5088666|NCT01695135|12520146|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
5088667|NCT01695135|12520147|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
5088668|NCT01695135|12520144|P4|COMPLETED|Open Label Extension Treatment Phase||10
5088669|NCT01695135|12520145|P3|COMPLETED|Open Label Extension Treatment Phase||9
5088670|NCT01695135|12520146|P2|COMPLETED|Open Label Extension Treatment Phase||0
5088671|NCT01695135|12520147|P1|COMPLETED|Open Label Extension Treatment Phase||0
5088672|NCT01695135|12520144|P4|STARTED|Open Label Extension Treatment Phase||80
5088673|NCT01695135|12520145|P3|STARTED|Open Label Extension Treatment Phase||49
5088674|NCT01695135|12520146|P2|STARTED|Open Label Extension Treatment Phase||0
5088675|NCT01695135|12520147|P1|STARTED|Open Label Extension Treatment Phase||0
5088676|NCT01695135|12520144|P4|NOT COMPLETED|Double-blind Treatment Phase||0
5088677|NCT01695135|12520145|P3|NOT COMPLETED|Double-blind Treatment Phase||0
5088678|NCT01695135|12520146|P2|NOT COMPLETED|Double-blind Treatment Phase||139
5088679|NCT01695135|12520147|P1|NOT COMPLETED|Double-blind Treatment Phase||71
5088680|NCT01695135|12520144|P4|COMPLETED|Double-blind Treatment Phase||0
5088681|NCT01695135|12520145|P3|COMPLETED|Double-blind Treatment Phase||0
5088682|NCT01695135|12520146|P2|COMPLETED|Double-blind Treatment Phase||4
5088683|NCT01695135|12520147|P1|COMPLETED|Double-blind Treatment Phase||0
5088684|NCT01695135|12520144|P4|STARTED|Double-blind Treatment Phase||0
5088685|NCT01695135|12520145|P3|STARTED|Double-blind Treatment Phase||0
5088686|NCT01695135|12520146|P2|STARTED|Double-blind Treatment Phase||143
5088687|NCT01695135|12520147|P1|STARTED|Double-blind Treatment Phase||71
5088688|NCT01695044|12520171|P1|NOT COMPLETED|Overall Study||102
5088689|NCT01695044|12520171|P1|COMPLETED|Overall Study||17
5088690|NCT01695044|12520171|P1|STARTED|Overall Study||119
5088691|NCT01694966|12520184|P3|NOT COMPLETED|Overall Study||34
5088692|NCT01694966|12520185|P2|NOT COMPLETED|Overall Study||15
5088693|NCT01694966|12520186|P1|NOT COMPLETED|Overall Study||34
5088694|NCT01694966|12520184|P3|COMPLETED|Overall Study||464
5088695|NCT01694966|12520185|P2|COMPLETED|Overall Study||232
5088696|NCT01694966|12520186|P1|COMPLETED|Overall Study||470
5088697|NCT01694966|12520184|P3|STARTED|Overall Study||498
5088698|NCT01694966|12520185|P2|STARTED|Overall Study||247
5088699|NCT01694966|12520186|P1|STARTED|Overall Study||504
5088700|NCT01694771|12520196|P2|NOT COMPLETED|Overall Study||40
5088701|NCT01694771|12520197|P1|NOT COMPLETED|Overall Study||40
5088702|NCT01694771|12520196|P2|COMPLETED|Overall Study||525
5088703|NCT01694771|12520197|P1|COMPLETED|Overall Study||527
5088704|NCT01694771|12520196|P2|STARTED|Overall Study||565
5088705|NCT01694771|12520197|P1|STARTED|Overall Study||567
5088706|NCT01694706|12520221|P3|NOT COMPLETED|Overall Study||0
5088707|NCT01694706|12520222|P2|NOT COMPLETED|Overall Study||1
5088708|NCT01694706|12520223|P1|NOT COMPLETED|Overall Study||1
5088709|NCT01694706|12520221|P3|COMPLETED|Overall Study||5
5088710|NCT01694706|12520222|P2|COMPLETED|Overall Study||4
5088711|NCT01694706|12520223|P1|COMPLETED|Overall Study||4
5088712|NCT01694706|12520221|P3|Received Faldaprevir Fed|Overall Study||5
5088713|NCT01694706|12520222|P2|Received Faldaprevir Fed|Overall Study||5
5088714|NCT01694706|12520223|P1|Received Faldaprevir Fed|Overall Study||4
5088715|NCT01694706|12520221|P3|Received Faldaprevir +OMP|Overall Study||5
5088716|NCT01694706|12520222|P2|Received Faldaprevir +OMP|Overall Study||5
5088717|NCT01694706|12520223|P1|Received Faldaprevir +OMP|Overall Study||5
5088718|NCT01694706|12520221|P3|Received Faldaprevir|Overall Study||5
5088719|NCT01694706|12520222|P2|Received Faldaprevir|Overall Study||5
5088720|NCT01694706|12520223|P1|Received Faldaprevir|Overall Study||5
5088721|NCT01694706|12520221|P3|STARTED|Overall Study||5
5088722|NCT01694706|12520222|P2|STARTED|Overall Study||5
5088723|NCT01694706|12520223|P1|STARTED|Overall Study||5
5088724|NCT01694667|12520240|P2|NOT COMPLETED|Overall Study||0
5088725|NCT01694667|12520241|P1|NOT COMPLETED|Overall Study||0
5088726|NCT01694667|12520240|P2|COMPLETED|Overall Study||28
5088727|NCT01694667|12520241|P1|COMPLETED|Overall Study||29
5088728|NCT01694667|12520240|P2|STARTED|Overall Study||28
5088729|NCT01694667|12520241|P1|STARTED|Overall Study||29
5088730|NCT01694641|12520259|P2|NOT COMPLETED|Overall Study||10
5088731|NCT01694641|12520260|P1|NOT COMPLETED|Overall Study||12
5088732|NCT01694641|12520259|P2|COMPLETED|Overall Study||71
5088733|NCT01694641|12520260|P1|COMPLETED|Overall Study||68
5088734|NCT01694641|12520259|P2|STARTED|Overall Study||81
5088735|NCT01694641|12520260|P1|STARTED|Overall Study||80
5088736|NCT01694563|12520268|P1|NOT COMPLETED|Overall Study||87
5088737|NCT01694563|12520268|P1|COMPLETED|Overall Study||278
5088738|NCT01694563|12520268|P1|STARTED|Overall Study||365
5088739|NCT01694485|12520280|P5|NOT COMPLETED|Overall Study||25
5088740|NCT01694485|12520281|P4|NOT COMPLETED|Overall Study||38
5088741|NCT01694485|12520282|P3|NOT COMPLETED|Overall Study||13
5088742|NCT01694485|12520283|P2|NOT COMPLETED|Overall Study||7
5088743|NCT01694485|12520284|P1|NOT COMPLETED|Overall Study||33
5088744|NCT01694485|12520280|P5|COMPLETED|Overall Study||55
5088745|NCT01694485|12520281|P4|COMPLETED|Overall Study||62
5088746|NCT01694485|12520282|P3|COMPLETED|Overall Study||27
5088747|NCT01694485|12520283|P2|COMPLETED|Overall Study||15
5088748|NCT01694485|12520284|P1|COMPLETED|Overall Study||84
5088749|NCT01694485|12520280|P5|Entered Open-label Period|Overall Study||68
5088750|NCT01694485|12520281|P4|Entered Open-label Period|Overall Study||88
5088751|NCT01694485|12520282|P3|Entered Open-label Period|Overall Study||36
5088752|NCT01694485|12520283|P2|Entered Open-label Period|Overall Study||19
5088753|NCT01694485|12520284|P1|Entered Open-label Period|Overall Study||100
5088754|NCT01694485|12520280|P5|Completed Week 8 Assessment|Overall Study||76
5088755|NCT01694485|12520281|P4|Completed Week 8 Assessment|Overall Study||94
5088756|NCT01694485|12520282|P3|Completed Week 8 Assessment|Overall Study||38
5088757|NCT01694485|12520283|P2|Completed Week 8 Assessment|Overall Study||18
5088758|NCT01694485|12520284|P1|Completed Week 8 Assessment|Overall Study||106
5088759|NCT01694485|12520280|P5|Received Treatment|Overall Study||79
5088760|NCT01694485|12520281|P4|Received Treatment|Overall Study||98
5088761|NCT01694485|12520282|P3|Received Treatment|Overall Study||40
5088762|NCT01694485|12520283|P2|Received Treatment|Overall Study||21
5088763|NCT01694485|12520284|P1|Received Treatment|Overall Study||116
5088764|NCT01694485|12520280|P5|STARTED|Overall Study||80
5088765|NCT01694485|12520281|P4|STARTED|Overall Study||100
5088766|NCT01694485|12520282|P3|STARTED|Overall Study||40
5088767|NCT01694485|12520283|P2|STARTED|Overall Study||22
5088768|NCT01694485|12520284|P1|STARTED|Overall Study||117
5088769|NCT01694433|12520318|P2|NOT COMPLETED|Overall Study||4
5088770|NCT01694433|12520319|P1|NOT COMPLETED|Overall Study||11
5088771|NCT01694433|12520318|P2|COMPLETED|Overall Study||29
5088772|NCT01694433|12520319|P1|COMPLETED|Overall Study||22
5088773|NCT01694433|12520318|P2|Baseline Visit|Overall Study||32
5088774|NCT01694433|12520319|P1|Baseline Visit|Overall Study||33
5088775|NCT01694433|12520318|P2|STARTED|Overall Study||33
5088776|NCT01694433|12520319|P1|STARTED|Overall Study||33
5088777|NCT01694420|12520327|P1|NOT COMPLETED|Overall Study||3
5088778|NCT01694420|12520327|P1|COMPLETED|Overall Study||30
5088779|NCT01694420|12520327|P1|STARTED|Overall Study||33
5088780|NCT01694199|12520338|P2|NOT COMPLETED|Overall Study||0
5088781|NCT01694199|12520339|P1|NOT COMPLETED|Overall Study||0
5088782|NCT01694199|12520338|P2|COMPLETED|Overall Study||68
5088783|NCT01694199|12520339|P1|COMPLETED|Overall Study||71
5088784|NCT01694199|12520338|P2|STARTED|Overall Study||68
5088785|NCT01694199|12520339|P1|STARTED|Overall Study||71
5088786|NCT01694186|12520355|P2|NOT COMPLETED|Overall Study||7
5088787|NCT01694186|12520356|P1|NOT COMPLETED|Overall Study||6
5088788|NCT01694186|12520355|P2|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
5088789|NCT01694186|12520356|P1|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
5088790|NCT01694186|12520355|P2|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
5088791|NCT01694186|12520356|P1|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
5088792|NCT01694121|12520364|P2|NOT COMPLETED|Overall Study||0
5088793|NCT01694121|12520365|P1|NOT COMPLETED|Overall Study||1
5088794|NCT01694121|12520364|P2|COMPLETED|Overall Study||227
5088795|NCT01694121|12520365|P1|COMPLETED|Overall Study||227
5088796|NCT01694121|12520364|P2|STARTED|Overall Study||227
5088797|NCT01694121|12520365|P1|STARTED|Overall Study||228
5088798|NCT01694108|12520379|P2|NOT COMPLETED|Overall Study||0
5088799|NCT01694108|12520380|P1|NOT COMPLETED|Overall Study||0
5088800|NCT01694108|12520379|P2|COMPLETED|Overall Study|100% follow-up|2133
5088801|NCT01694108|12520380|P1|COMPLETED|Overall Study|100% follow-up|2129
5088802|NCT01694108|12520379|P2|STARTED|Overall Study||2133
5088803|NCT01694108|12520380|P1|STARTED|Overall Study||2129
5088804|NCT01693900|12520436|P2|NOT COMPLETED|Overall Study||0
5088805|NCT01693900|12520437|P1|NOT COMPLETED|Overall Study||0
5088806|NCT01693900|12520436|P2|COMPLETED|Overall Study||25
5088807|NCT01693900|12520437|P1|COMPLETED|Overall Study||25
5088808|NCT01693900|12520436|P2|STARTED|Overall Study||25
5088809|NCT01693900|12520437|P1|STARTED|Overall Study||25
5088810|NCT01693653|12520451|P2|NOT COMPLETED|Overall Study||0
5088811|NCT01693653|12520452|P1|NOT COMPLETED|Overall Study||0
5088812|NCT01693653|12520451|P2|COMPLETED|Overall Study||0
5088813|NCT01693653|12520452|P1|COMPLETED|Overall Study||1
5088814|NCT01693653|12520451|P2|STARTED|Overall Study||0
5088815|NCT01693653|12520452|P1|STARTED|Overall Study||1
5088816|NCT01693614|12520479|P3|NOT COMPLETED|Overall Study||24
5088817|NCT01693614|12520480|P2|NOT COMPLETED|Overall Study||22
5088818|NCT01693614|12520481|P1|NOT COMPLETED|Overall Study||26
5088819|NCT01693614|12520479|P3|COMPLETED|Overall Study||0
5088820|NCT01693614|12520480|P2|COMPLETED|Overall Study||0
5088821|NCT01693614|12520481|P1|COMPLETED|Overall Study||0
5088822|NCT01693614|12520479|P3|STARTED|Overall Study||24
5088823|NCT01693614|12520480|P2|STARTED|Overall Study||22
5088824|NCT01693614|12520481|P1|STARTED|Overall Study||26
5088825|NCT01693523|12520506|P3|NOT COMPLETED|Overall Study||8
5088826|NCT01693523|12520507|P2|NOT COMPLETED|Overall Study||8
5088827|NCT01693523|12520508|P1|NOT COMPLETED|Overall Study||5
5088828|NCT01693523|12520506|P3|COMPLETED|Overall Study||27
5088829|NCT01693523|12520507|P2|COMPLETED|Overall Study||13
5088830|NCT01693523|12520508|P1|COMPLETED|Overall Study||18
5088831|NCT01693523|12520506|P3|STARTED|Overall Study||35
5088832|NCT01693523|12520507|P2|STARTED|Overall Study||21
5088833|NCT01693523|12520508|P1|STARTED|Overall Study||23
5088834|NCT01693484|12520518|P1|NOT COMPLETED|Overall Study||13
5088835|NCT01693484|12520518|P1|COMPLETED|Overall Study|Study closed by PI|0
5088836|NCT01693484|12520518|P1|STARTED|Overall Study||13
5088837|NCT01693367|12520524|P2|NOT COMPLETED|Overall Study||2
5088838|NCT01693367|12520525|P1|NOT COMPLETED|Overall Study||1
5088839|NCT01693367|12520524|P2|COMPLETED|Overall Study||1
5088840|NCT01693367|12520525|P1|COMPLETED|Overall Study||1
5088841|NCT01693367|12520524|P2|STARTED|Overall Study||3
5088842|NCT01693367|12520525|P1|STARTED|Overall Study||2
5088843|NCT01693250|12520543|P2|NOT COMPLETED|Overall Study||2
5088844|NCT01693250|12520544|P1|NOT COMPLETED|Overall Study||2
5088845|NCT01693250|12520543|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
5088846|NCT01693250|12520544|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
5088847|NCT01693250|12520543|P2|STARTED|Overall Study|three month post baseline assessment|17
5088848|NCT01693250|12520544|P1|STARTED|Overall Study|3 months post baseline assessment|23
5088849|NCT01693185|12520554|P2|NOT COMPLETED|Overall Study||6
5088850|NCT01693185|12520555|P1|NOT COMPLETED|Overall Study||0
5088851|NCT01693185|12520554|P2|COMPLETED|Overall Study||27
5088852|NCT01693185|12520555|P1|COMPLETED|Overall Study||27
5088853|NCT01693185|12520554|P2|STARTED|Overall Study||33
5088854|NCT01693185|12520555|P1|STARTED|Overall Study||27
5088855|NCT01693120|12520571|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
5088856|NCT01693120|12520571|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
5088857|NCT01693120|12520571|P1|STARTED|Phased RF Study Procedure and Follow-up||129
5088858|NCT01693120|12520571|P1|NOT COMPLETED|Enrollment||70
5088859|NCT01693120|12520571|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
5088860|NCT01693120|12520571|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
5088861|NCT01693068|12520580|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
5088862|NCT01693068|12520581|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
5088863|NCT01693068|12520582|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
5088864|NCT01693068|12520580|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
5088865|NCT01693068|12520581|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
5088866|NCT01693068|12520582|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
5088867|NCT01693068|12520580|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
5088868|NCT01693068|12520581|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
5088869|NCT01693068|12520582|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
5088870|NCT01693068|12520580|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
5088871|NCT01693068|12520581|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
5088872|NCT01693068|12520582|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
5088873|NCT01693068|12520580|P3|NOT COMPLETED|Randomization Period||0
5088874|NCT01693068|12520581|P2|NOT COMPLETED|Randomization Period||5
5088875|NCT01693068|12520582|P1|NOT COMPLETED|Randomization Period||2
5088876|NCT01693068|12520580|P3|COMPLETED|Randomization Period||0
5088877|NCT01693068|12520581|P2|COMPLETED|Randomization Period||125
5088878|NCT01693068|12520582|P1|COMPLETED|Randomization Period||62
5088879|NCT01693068|12520580|P3|Treated|Randomization Period||0
5088880|NCT01693068|12520581|P2|Treated|Randomization Period||130
5088881|NCT01693068|12520582|P1|Treated|Randomization Period||61
5088882|NCT01693068|12520580|P3|STARTED|Randomization Period||0
5088883|NCT01693068|12520581|P2|STARTED|Randomization Period||130
5088884|NCT01693068|12520582|P1|STARTED|Randomization Period||64
5088885|NCT01693029|12520614|P2|NOT COMPLETED|Overall Study||57
5088886|NCT01693029|12520615|P1|NOT COMPLETED|Overall Study||44
5088887|NCT01693029|12520614|P2|COMPLETED|Overall Study||161
5088888|NCT01693029|12520615|P1|COMPLETED|Overall Study||173
5088889|NCT01693029|12520614|P2|STARTED|Overall Study||218
5088890|NCT01693029|12520615|P1|STARTED|Overall Study||217
5088891|NCT01692951|12520631|P4|NOT COMPLETED|Overall Study||0
5088892|NCT01692951|12520632|P3|NOT COMPLETED|Overall Study||0
5088893|NCT01692951|12520633|P2|NOT COMPLETED|Overall Study||0
5088894|NCT01692951|12520634|P1|NOT COMPLETED|Overall Study||0
5088895|NCT01692951|12520631|P4|COMPLETED|Overall Study||54
5088896|NCT01692951|12520632|P3|COMPLETED|Overall Study||18
5088897|NCT01692951|12520633|P2|COMPLETED|Overall Study||111
5088898|NCT01692951|12520634|P1|COMPLETED|Overall Study||37
5088899|NCT01692951|12520631|P4|STARTED|Overall Study||54
5088900|NCT01692951|12520632|P3|STARTED|Overall Study||18
5088901|NCT01692951|12520633|P2|STARTED|Overall Study||111
5088902|NCT01692951|12520634|P1|STARTED|Overall Study||37
5088903|NCT01692938|12520646|P2|NOT COMPLETED|Overall Study||4
5088904|NCT01692938|12520647|P1|NOT COMPLETED|Overall Study||4
5088905|NCT01692938|12520646|P2|COMPLETED|Overall Study||12
5088906|NCT01692938|12520647|P1|COMPLETED|Overall Study||12
5088907|NCT01692938|12520646|P2|STARTED|Overall Study||16
5088908|NCT01692938|12520647|P1|STARTED|Overall Study||16
5088909|NCT01692782|12520658|P3|NOT COMPLETED|Overall Study||10
5088910|NCT01692782|12520659|P2|NOT COMPLETED|Overall Study||56
5088911|NCT01692782|12520660|P1|NOT COMPLETED|Overall Study||20
5088912|NCT01692782|12520658|P3|COMPLETED|Overall Study||100
5088913|NCT01692782|12520659|P2|COMPLETED|Overall Study||59
5088914|NCT01692782|12520660|P1|COMPLETED|Overall Study||96
5088915|NCT01692782|12520658|P3|STARTED|Overall Study||110
5088916|NCT01692782|12520659|P2|STARTED|Overall Study||115
5088917|NCT01692782|12520660|P1|STARTED|Overall Study||116
5088918|NCT01692756|12520687|P4|NOT COMPLETED|Overall Study||0
5088919|NCT01692756|12520688|P3|NOT COMPLETED|Overall Study||2
5088920|NCT01692756|12520689|P2|NOT COMPLETED|Overall Study||1
5088921|NCT01692756|12520690|P1|NOT COMPLETED|Overall Study||1
5088922|NCT01692756|12520687|P4|COMPLETED|Overall Study||12
5088923|NCT01692756|12520688|P3|COMPLETED|Overall Study||11
5088924|NCT01692756|12520689|P2|COMPLETED|Overall Study||11
5088925|NCT01692756|12520690|P1|COMPLETED|Overall Study||11
5088926|NCT01692756|12520687|P4|STARTED|Overall Study||12
5088927|NCT01692756|12520688|P3|STARTED|Overall Study||13
5088928|NCT01692756|12520689|P2|STARTED|Overall Study||12
5088929|NCT01692756|12520690|P1|STARTED|Overall Study||12
5088930|NCT01692743|12520751|P3|NOT COMPLETED|Overall Study||27
5088931|NCT01692743|12520752|P2|NOT COMPLETED|Overall Study||35
5088932|NCT01692743|12520753|P1|NOT COMPLETED|Overall Study||27
5088933|NCT01692743|12520751|P3|COMPLETED|Overall Study||88
5088934|NCT01692743|12520752|P2|COMPLETED|Overall Study||81
5088935|NCT01692743|12520753|P1|COMPLETED|Overall Study||90
5088936|NCT01692743|12520751|P3|STARTED|Overall Study||115
5088937|NCT01692743|12520752|P2|STARTED|Overall Study||116
5088938|NCT01692743|12520753|P1|STARTED|Overall Study||117
5088939|NCT01692730|12520769|P2|NOT COMPLETED|Overall Study||227
5088940|NCT01692730|12520770|P1|NOT COMPLETED|Overall Study||225
5088941|NCT01692730|12520769|P2|COMPLETED|Overall Study||502
5088942|NCT01692730|12520770|P1|COMPLETED|Overall Study||498
5088943|NCT01692730|12520769|P2|STARTED|Overall Study||729
5088944|NCT01692730|12520770|P1|STARTED|Overall Study||723
5088945|NCT01692691|12520778|P1|NOT COMPLETED|Overall Study||0
5088946|NCT01692691|12520778|P1|COMPLETED|Overall Study||1
5088947|NCT01692691|12520778|P1|STARTED|Overall Study||1
5088948|NCT01692626|12520784|P2|NOT COMPLETED|Overall Study||6
5088949|NCT01692626|12520785|P1|NOT COMPLETED|Overall Study||4
5088950|NCT01692626|12520784|P2|COMPLETED|Overall Study||1
5088951|NCT01692626|12520785|P1|COMPLETED|Overall Study||2
5088952|NCT01692626|12520784|P2|STARTED|Overall Study||7
5088953|NCT01692626|12520785|P1|STARTED|Overall Study||6
5088954|NCT01692496|12520790|P1|NOT COMPLETED|Overall Study||0
5088955|NCT01692496|12520790|P1|COMPLETED|Overall Study||52
5088956|NCT01692496|12520790|P1|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
5088957|NCT01692496|12520790|P1|STARTED|Overall Study||52
5088958|NCT01692340|12520803|P3|NOT COMPLETED|Overall Study||0
5088959|NCT01692340|12520804|P2|NOT COMPLETED|Overall Study||0
5088960|NCT01692340|12520805|P1|NOT COMPLETED|Overall Study||0
5088961|NCT01692340|12520803|P3|COMPLETED|Overall Study||0
5088962|NCT01692340|12520804|P2|COMPLETED|Overall Study||4
5088963|NCT01692340|12520805|P1|COMPLETED|Overall Study||8
5088964|NCT01692340|12520803|P3|STARTED|Overall Study||0
5088965|NCT01692340|12520804|P2|STARTED|Overall Study||4
5088966|NCT01692340|12520805|P1|STARTED|Overall Study||8
5088967|NCT01692301|12520820|P2|NOT COMPLETED|Overall Study||42
5088968|NCT01692301|12520821|P1|NOT COMPLETED|Overall Study||45
5088969|NCT01692301|12520820|P2|COMPLETED|Overall Study||183
5088970|NCT01692301|12520821|P1|COMPLETED|Overall Study||184
5088971|NCT01692301|12520820|P2|STARTED|Overall Study||225
5088972|NCT01692301|12520821|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
5088973|NCT01692275|12520853|P2|NOT COMPLETED|Overall Study||59
5088974|NCT01692275|12520854|P1|NOT COMPLETED|Overall Study||66
5088975|NCT01692275|12520853|P2|COMPLETED|Overall Study||316
5088976|NCT01692275|12520854|P1|COMPLETED|Overall Study||309
5088977|NCT01692275|12520853|P2|STARTED|Overall Study||375
5088978|NCT01692275|12520854|P1|STARTED|Overall Study||375
5088979|NCT01692197|12520914|P1|NOT COMPLETED|Overall Study||3
5088980|NCT01692197|12520914|P1|COMPLETED|Overall Study||40
5088981|NCT01692197|12520914|P1|STARTED|Overall Study||43
5088982|NCT01691950|12520923|P2|NOT COMPLETED|Overall Study||0
5088983|NCT01691950|12520924|P1|NOT COMPLETED|Overall Study||10
5088984|NCT01691950|12520923|P2|COMPLETED|Overall Study||10
5088985|NCT01691950|12520924|P1|COMPLETED|Overall Study||10
5088986|NCT01691950|12520923|P2|STARTED|Overall Study||10
5088987|NCT01691950|12520924|P1|STARTED|Overall Study||20
5088988|NCT01691898|12520936|P6|NOT COMPLETED|Overall Study||35
5088989|NCT01691898|12520937|P5|NOT COMPLETED|Overall Study||14
5088990|NCT01691898|12520938|P4|NOT COMPLETED|Overall Study||5
5088991|NCT01691898|12520939|P3|NOT COMPLETED|Overall Study||9
5088992|NCT01691898|12520940|P2|NOT COMPLETED|Overall Study||44
5088993|NCT01691898|12520941|P1|NOT COMPLETED|Overall Study||47
5088994|NCT01691898|12520936|P6|COMPLETED|Overall Study||5
5088995|NCT01691898|12520937|P5|COMPLETED|Overall Study||26
5088996|NCT01691898|12520938|P4|COMPLETED|Overall Study||4
5088997|NCT01691898|12520939|P3|COMPLETED|Overall Study||11
5088998|NCT01691898|12520940|P2|COMPLETED|Overall Study||15
5088999|NCT01691898|12520941|P1|COMPLETED|Overall Study||16
5089000|NCT01691898|12520936|P6|STARTED|Overall Study||40
5089001|NCT01691898|12520937|P5|STARTED|Overall Study||40
5089002|NCT01691898|12520938|P4|STARTED|Overall Study||9
5089003|NCT01691898|12520939|P3|STARTED|Overall Study||20
5089004|NCT01691898|12520940|P2|STARTED|Overall Study||59
5089005|NCT01691898|12520941|P1|STARTED|Overall Study||63
5089006|NCT01691885|12521095|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
5089007|NCT01691885|12521096|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
5089008|NCT01691885|12521095|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
5089009|NCT01691885|12521096|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
5089010|NCT01691885|12521095|P2|STARTED|Treatment Period 2 (7-14 Days)||21
5089011|NCT01691885|12521096|P1|STARTED|Treatment Period 2 (7-14 Days)||21
5089012|NCT01691885|12521095|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
5089013|NCT01691885|12521096|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
5089014|NCT01691885|12521095|P2|COMPLETED|Washout Period (7-9 Days)||21
5089015|NCT01691885|12521096|P1|COMPLETED|Washout Period (7-9 Days)||21
5089016|NCT01691885|12521095|P2|STARTED|Washout Period (7-9 Days)||22
5089017|NCT01691885|12521096|P1|STARTED|Washout Period (7-9 Days)||21
5089018|NCT01691885|12521095|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
5089019|NCT01691885|12521096|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
5089020|NCT01691885|12521095|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
5089021|NCT01691885|12521096|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
5089022|NCT01691885|12521095|P2|STARTED|Treatment Period 1(7-14 Days)||23
5089023|NCT01691885|12521096|P1|STARTED|Treatment Period 1(7-14 Days)||22
5089024|NCT01691859|12521102|P1|NOT COMPLETED|Overall Study||347
5089025|NCT01691859|12521102|P1|COMPLETED|Overall Study||0
5089026|NCT01691859|12521102|P1|STARTED|Overall Study||347
5089027|NCT01691833|12521124|P3|NOT COMPLETED|Overall Study||0
5089028|NCT01691833|12521125|P2|NOT COMPLETED|Overall Study||1
5089029|NCT01691833|12521126|P1|NOT COMPLETED|Overall Study||1
5089030|NCT01691833|12521124|P3|COMPLETED|Overall Study||13
5089031|NCT01691833|12521125|P2|COMPLETED|Overall Study||49
5089032|NCT01691833|12521126|P1|COMPLETED|Overall Study||49
5089033|NCT01691833|12521124|P3|STARTED|Overall Study||13
5089034|NCT01691833|12521125|P2|STARTED|Overall Study||50
5089035|NCT01691833|12521126|P1|STARTED|Overall Study||50
5089036|NCT01691820|12521149|P3|NOT COMPLETED|Overall Study||1
5089037|NCT01691820|12521150|P2|NOT COMPLETED|Overall Study||34
5089038|NCT01691820|12521151|P1|NOT COMPLETED|Overall Study||29
5089039|NCT01691820|12521149|P3|COMPLETED|Overall Study||2
5089040|NCT01691820|12521150|P2|COMPLETED|Overall Study||110
5089041|NCT01691820|12521151|P1|COMPLETED|Overall Study||187
5089042|NCT01691820|12521149|P3|STARTED|Overall Study||3
5089043|NCT01691820|12521150|P2|STARTED|Overall Study||144
5089044|NCT01691820|12521151|P1|STARTED|Overall Study||216
5089045|NCT01691794|12521189|P3|NOT COMPLETED|Overall Study||10
5089046|NCT01691794|12521190|P2|NOT COMPLETED|Overall Study||18
5089047|NCT01691794|12521191|P1|NOT COMPLETED|Overall Study||1
5089048|NCT01691794|12521189|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
5089049|NCT01691794|12521190|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
5089050|NCT01691794|12521191|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
5089051|NCT01691794|12521189|P3|STARTED|Overall Study||23
5089052|NCT01691794|12521190|P2|STARTED|Overall Study||33
5089053|NCT01691794|12521191|P1|STARTED|Overall Study||3
5089054|NCT01691781|12521207|P2|NOT COMPLETED|Overall Study||7
5089055|NCT01691781|12521208|P1|NOT COMPLETED|Overall Study||7
5089056|NCT01691781|12521207|P2|COMPLETED|Overall Study||15
5089057|NCT01691781|12521208|P1|COMPLETED|Overall Study||12
5089058|NCT01691781|12521207|P2|STARTED|Overall Study||22
5089059|NCT01691781|12521208|P1|STARTED|Overall Study||19
5089060|NCT01691768|12521220|P2|NOT COMPLETED|Overall Study||16
5089061|NCT01691768|12521221|P1|NOT COMPLETED|Overall Study||15
5089062|NCT01691768|12521220|P2|COMPLETED|Overall Study||167
5089063|NCT01691768|12521221|P1|COMPLETED|Overall Study||174
5089064|NCT01691768|12521220|P2|STARTED|Overall Study||183
5089065|NCT01691768|12521221|P1|STARTED|Overall Study||189
5089066|NCT01691690|12521245|P2|NOT COMPLETED|Overall Study||4
5089067|NCT01691690|12521246|P1|NOT COMPLETED|Overall Study||7
5089068|NCT01691690|12521245|P2|COMPLETED|Overall Study||121
5089069|NCT01691690|12521246|P1|COMPLETED|Overall Study||118
5089070|NCT01691690|12521245|P2|STARTED|Overall Study||125
5089071|NCT01691690|12521246|P1|STARTED|Overall Study||125
5089072|NCT01691612|12521256|P1|NOT COMPLETED|Overall Study||7
5089073|NCT01691612|12521256|P1|COMPLETED|Overall Study||7
5089074|NCT01691612|12521256|P1|Second Visit (Bronchoscopy)|Overall Study||7
5089075|NCT01691612|12521256|P1|First Visit (Allergen Challenge)|Overall Study||8
5089076|NCT01691612|12521256|P1|STARTED|Overall Study||14
5089077|NCT01691560|12521267|P4|NOT COMPLETED|Overall Study||0
5089078|NCT01691560|12521268|P3|NOT COMPLETED|Overall Study||0
5089079|NCT01691560|12521269|P2|NOT COMPLETED|Overall Study||0
5089080|NCT01691560|12521270|P1|NOT COMPLETED|Overall Study||0
5089081|NCT01691560|12521267|P4|COMPLETED|Overall Study||33
5089082|NCT01691560|12521268|P3|COMPLETED|Overall Study||34
5089083|NCT01691560|12521269|P2|COMPLETED|Overall Study||33
5089084|NCT01691560|12521270|P1|COMPLETED|Overall Study||34
5089085|NCT01691560|12521267|P4|STARTED|Overall Study||33
5089086|NCT01691560|12521268|P3|STARTED|Overall Study||34
5089087|NCT01691560|12521269|P2|STARTED|Overall Study||33
5089088|NCT01691560|12521270|P1|STARTED|Overall Study||34
5089089|NCT01691534|12521307|P7|NOT COMPLETED|Overall Study||1
5089090|NCT01691534|12521308|P6|NOT COMPLETED|Overall Study||1
5089091|NCT01691534|12521309|P5|NOT COMPLETED|Overall Study||0
5089092|NCT01691534|12521310|P4|NOT COMPLETED|Overall Study||1
5089093|NCT01691534|12521311|P3|NOT COMPLETED|Overall Study||1
5089094|NCT01691534|12521312|P2|NOT COMPLETED|Overall Study||1
5089095|NCT01691534|12521313|P1|NOT COMPLETED|Overall Study||0
5089096|NCT01691534|12521307|P7|COMPLETED|Overall Study||14
5089097|NCT01691534|12521308|P6|COMPLETED|Overall Study||14
5089098|NCT01691534|12521309|P5|COMPLETED|Overall Study||15
5089099|NCT01691534|12521310|P4|COMPLETED|Overall Study||14
5089100|NCT01691534|12521311|P3|COMPLETED|Overall Study||14
5089101|NCT01691534|12521312|P2|COMPLETED|Overall Study||14
5089102|NCT01691534|12521313|P1|COMPLETED|Overall Study||15
5089103|NCT01691534|12521307|P7|STARTED|Overall Study||15
5089104|NCT01691534|12521308|P6|STARTED|Overall Study||15
5089105|NCT01691534|12521309|P5|STARTED|Overall Study||15
5089106|NCT01691534|12521310|P4|STARTED|Overall Study||15
5089107|NCT01691534|12521311|P3|STARTED|Overall Study||15
5089108|NCT01691534|12521312|P2|STARTED|Overall Study||15
5089109|NCT01691534|12521313|P1|STARTED|Overall Study||15
5089110|NCT01691521|12521367|P3|NOT COMPLETED|Overall Study||9
5089111|NCT01691521|12521368|P2|NOT COMPLETED|Overall Study||16
5089112|NCT01691521|12521369|P1|NOT COMPLETED|Overall Study||12
5089113|NCT01691521|12521367|P3|COMPLETED|Overall Study||185
5089114|NCT01691521|12521368|P2|COMPLETED|Overall Study||175
5089115|NCT01691521|12521369|P1|COMPLETED|Overall Study||179
5089116|NCT01691521|12521367|P3|STARTED|Overall Study||194
5089117|NCT01691521|12521368|P2|STARTED|Overall Study||191
5089118|NCT01691521|12521369|P1|STARTED|Overall Study||191
5089119|NCT01691508|12521391|P2|NOT COMPLETED|Overall Study||3
5089120|NCT01691508|12521392|P1|NOT COMPLETED|Overall Study||4
5089121|NCT01691508|12521391|P2|COMPLETED|Overall Study||66
5089122|NCT01691508|12521392|P1|COMPLETED|Overall Study||62
5089123|NCT01691508|12521391|P2|STARTED|Overall Study||69
5089124|NCT01691508|12521392|P1|STARTED|Overall Study||66
5089125|NCT01691482|12521406|P2|NOT COMPLETED|Treatment Period 2||2
5089126|NCT01691482|12521407|P1|NOT COMPLETED|Treatment Period 2||1
5089127|NCT01691482|12521406|P2|COMPLETED|Treatment Period 2||26
5089128|NCT01691482|12521407|P1|COMPLETED|Treatment Period 2||27
5089129|NCT01691482|12521406|P2|STARTED|Treatment Period 2||28
5089130|NCT01691482|12521407|P1|STARTED|Treatment Period 2||28
5089131|NCT01691482|12521406|P2|NOT COMPLETED|Treatment Period 1||0
5089132|NCT01691482|12521407|P1|NOT COMPLETED|Treatment Period 1||0
5089133|NCT01691482|12521406|P2|COMPLETED|Treatment Period 1||28
5089134|NCT01691482|12521407|P1|COMPLETED|Treatment Period 1||28
5089135|NCT01691482|12521406|P2|STARTED|Treatment Period 1||28
5089136|NCT01691482|12521407|P1|STARTED|Treatment Period 1||28
5089137|NCT01691430|12521425|P2|NOT COMPLETED|Overall Study||20
5089138|NCT01691430|12521426|P1|NOT COMPLETED|Overall Study||22
5089139|NCT01691430|12521425|P2|COMPLETED|Overall Study||73
5089140|NCT01691430|12521426|P1|COMPLETED|Overall Study||70
5089141|NCT01691430|12521425|P2|Received Medication|Overall Study||93
5089142|NCT01691430|12521426|P1|Received Medication|Overall Study||92
5089143|NCT01691430|12521425|P2|STARTED|Overall Study||93
5089144|NCT01691430|12521426|P1|STARTED|Overall Study||92
5089145|NCT01691378|12521452|P2|NOT COMPLETED|Overall Study||2
5089146|NCT01691378|12521453|P1|NOT COMPLETED|Overall Study||7
5089147|NCT01691378|12521452|P2|COMPLETED|Overall Study||20
5089148|NCT01691378|12521453|P1|COMPLETED|Overall Study||15
5089149|NCT01691378|12521452|P2|STARTED|Overall Study||22
5089150|NCT01691378|12521453|P1|STARTED|Overall Study||22
5089151|NCT01691339|12521467|P4|NOT COMPLETED|Overall Study||0
5089152|NCT01691339|12521468|P3|NOT COMPLETED|Overall Study||0
5089153|NCT01691339|12521469|P2|NOT COMPLETED|Overall Study||0
5089154|NCT01691339|12521470|P1|NOT COMPLETED|Overall Study||0
5089155|NCT01691339|12521467|P4|COMPLETED|Overall Study||49
5089156|NCT01691339|12521468|P3|COMPLETED|Overall Study||51
5089157|NCT01691339|12521469|P2|COMPLETED|Overall Study||50
5089158|NCT01691339|12521470|P1|COMPLETED|Overall Study||50
5089159|NCT01691339|12521467|P4|STARTED|Overall Study||49
5089160|NCT01691339|12521468|P3|STARTED|Overall Study||51
5089161|NCT01691339|12521469|P2|STARTED|Overall Study||50
5089162|NCT01691339|12521470|P1|STARTED|Overall Study||50
5089163|NCT01691326|12521498|P2|NOT COMPLETED|Overall Study||0
5089164|NCT01691326|12521499|P1|NOT COMPLETED|Overall Study||0
5089165|NCT01691326|12521498|P2|COMPLETED|Overall Study||30
5089166|NCT01691326|12521499|P1|COMPLETED|Overall Study||30
5089167|NCT01691326|12521498|P2|STARTED|Overall Study||30
5089168|NCT01691326|12521499|P1|STARTED|Overall Study||30
5089169|NCT01691313|12521517|P4|NOT COMPLETED|Overall Study||0
5089170|NCT01691313|12521518|P3|NOT COMPLETED|Overall Study||0
5089171|NCT01691313|12521519|P2|NOT COMPLETED|Overall Study||0
5089172|NCT01691313|12521520|P1|NOT COMPLETED|Overall Study||0
5089173|NCT01691313|12521517|P4|COMPLETED|Overall Study||25
5089174|NCT01691313|12521518|P3|COMPLETED|Overall Study||25
5089175|NCT01691313|12521519|P2|COMPLETED|Overall Study||32
5089176|NCT01691313|12521520|P1|COMPLETED|Overall Study||22
5089177|NCT01691313|12521517|P4|STARTED|Overall Study||25
5089178|NCT01691313|12521518|P3|STARTED|Overall Study||25
5089179|NCT01691313|12521519|P2|STARTED|Overall Study||32
5089180|NCT01691313|12521520|P1|STARTED|Overall Study||22
5089181|NCT01691248|12521536|P2|NOT COMPLETED|Overall Study||114
5089182|NCT01691248|12521537|P1|NOT COMPLETED|Overall Study||111
5089183|NCT01691248|12521536|P2|COMPLETED|Overall Study||192
5089184|NCT01691248|12521537|P1|COMPLETED|Overall Study||194
5089185|NCT01691248|12521536|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
5089186|NCT01691248|12521537|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
5089187|NCT01691248|12521536|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
5089188|NCT01691248|12521537|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
5089189|NCT01691248|12521536|P2|STARTED|Overall Study|Randomized|306
5089190|NCT01691248|12521537|P1|STARTED|Overall Study|Randomized|305
5089191|NCT01691105|12521549|P2|NOT COMPLETED|12 Month Biochemical Verification||502
5089192|NCT01691105|12521550|P1|NOT COMPLETED|12 Month Biochemical Verification||424
5089193|NCT01691105|12521549|P2|COMPLETED|12 Month Biochemical Verification||65
5089194|NCT01691105|12521550|P1|COMPLETED|12 Month Biochemical Verification||53
5089195|NCT01691105|12521549|P2|STARTED|12 Month Biochemical Verification||567
5089196|NCT01691105|12521550|P1|STARTED|12 Month Biochemical Verification||477
5089197|NCT01691105|12521549|P2|NOT COMPLETED|12 Month Follow-up||101
5089198|NCT01691105|12521550|P1|NOT COMPLETED|12 Month Follow-up||72
5089199|NCT01691105|12521549|P2|COMPLETED|12 Month Follow-up||466
5089200|NCT01691105|12521550|P1|COMPLETED|12 Month Follow-up||405
5089201|NCT01691105|12521549|P2|STARTED|12 Month Follow-up||567
5089202|NCT01691105|12521550|P1|STARTED|12 Month Follow-up||477
5089203|NCT01691105|12521549|P2|NOT COMPLETED|6 Month Follow-up||71
5089204|NCT01691105|12521550|P1|NOT COMPLETED|6 Month Follow-up||52
5089205|NCT01691105|12521549|P2|COMPLETED|6 Month Follow-up||496
5089206|NCT01691105|12521550|P1|COMPLETED|6 Month Follow-up||425
5089207|NCT01691105|12521549|P2|STARTED|6 Month Follow-up||567
5089208|NCT01691105|12521550|P1|STARTED|6 Month Follow-up||477
5089209|NCT01691105|12521549|P2|NOT COMPLETED|1 Month Follow-up||41
5089210|NCT01691105|12521550|P1|NOT COMPLETED|1 Month Follow-up||43
5089211|NCT01691105|12521549|P2|COMPLETED|1 Month Follow-up||526
5089212|NCT01691105|12521550|P1|COMPLETED|1 Month Follow-up||434
5089213|NCT01691105|12521549|P2|STARTED|1 Month Follow-up||567
5089214|NCT01691105|12521550|P1|STARTED|1 Month Follow-up||477
5089215|NCT01691105|12521549|P2|NOT COMPLETED|Baseline||0
5089216|NCT01691105|12521550|P1|NOT COMPLETED|Baseline||0
5089217|NCT01691105|12521549|P2|COMPLETED|Baseline||567
5089218|NCT01691105|12521550|P1|COMPLETED|Baseline||477
5089219|NCT01691105|12521549|P2|STARTED|Baseline||567
5089220|NCT01691105|12521550|P1|STARTED|Baseline||477
5089221|NCT01691092|12521570|P1|NOT COMPLETED|Overall Study||41
5089222|NCT01691092|12521570|P1|COMPLETED|Overall Study||38
5089223|NCT01691092|12521570|P1|STARTED|Overall Study||79
5089224|NCT01691079|12521576|P2|NOT COMPLETED|Overall Study||0
5089225|NCT01691079|12521577|P1|NOT COMPLETED|Overall Study||0
5089226|NCT01691079|12521576|P2|COMPLETED|Overall Study||0
5089227|NCT01691079|12521577|P1|COMPLETED|Overall Study||0
5089228|NCT01691079|12521576|P2|STARTED|Overall Study||0
5089229|NCT01691079|12521577|P1|STARTED|Overall Study||0
5089230|NCT01691027|12521585|P1|NOT COMPLETED|Video Games Training||0
5089231|NCT01691027|12521585|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
5089232|NCT01691027|12521585|P1|STARTED|Video Games Training|Four subjects started video game training module|4
5089233|NCT01691027|12521585|P1|NOT COMPLETED|Line and Circle Tracing Training||0
5089234|NCT01691027|12521585|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
5089235|NCT01691027|12521585|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
5089236|NCT01691027|12521585|P1|NOT COMPLETED|Scotoma Awareness||0
5089237|NCT01691027|12521585|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
5089238|NCT01691027|12521585|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
5089239|NCT01691014|12521594|P4|NOT COMPLETED|Overall Study||5
5089240|NCT01691014|12521595|P3|NOT COMPLETED|Overall Study||11
5089241|NCT01691014|12521596|P2|NOT COMPLETED|Overall Study||15
5089242|NCT01691014|12521597|P1|NOT COMPLETED|Overall Study||3
5089243|NCT01691014|12521594|P4|COMPLETED|Overall Study||4
5089244|NCT01691014|12521595|P3|COMPLETED|Overall Study||25
5089245|NCT01691014|12521596|P2|COMPLETED|Overall Study||11
5089246|NCT01691014|12521597|P1|COMPLETED|Overall Study||5
5089247|NCT01691014|12521594|P4|STARTED|Overall Study||9
5089248|NCT01691014|12521595|P3|STARTED|Overall Study||36
5089249|NCT01691014|12521596|P2|STARTED|Overall Study||26
5089250|NCT01691014|12521597|P1|STARTED|Overall Study||8
5089251|NCT01690988|12521642|P3|NOT COMPLETED|Overall Study||7
5089252|NCT01690988|12521643|P2|NOT COMPLETED|Overall Study||5
5089253|NCT01690988|12521644|P1|NOT COMPLETED|Overall Study||6
5089254|NCT01690988|12521642|P3|COMPLETED|Overall Study||216
5089255|NCT01690988|12521643|P2|COMPLETED|Overall Study||217
5089256|NCT01690988|12521644|P1|COMPLETED|Overall Study||221
5089257|NCT01690988|12521642|P3|STARTED|Overall Study||223
5089258|NCT01690988|12521643|P2|STARTED|Overall Study||222
5089259|NCT01690988|12521644|P1|STARTED|Overall Study||227
5089260|NCT01690923|12521669|P2|NOT COMPLETED|Overall Study||1
5089261|NCT01690923|12521670|P1|NOT COMPLETED|Overall Study||0
5089262|NCT01690923|12521669|P2|COMPLETED|Overall Study||10
5089263|NCT01690923|12521670|P1|COMPLETED|Overall Study||10
5089264|NCT01690923|12521669|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
5089265|NCT01690923|12521670|P1|STARTED|Overall Study||10
5089266|NCT01690663|12521679|P4|NOT COMPLETED|Overall Study||4
5089267|NCT01690663|12521680|P3|NOT COMPLETED|Overall Study||3
5089268|NCT01690663|12521681|P2|NOT COMPLETED|Overall Study||3
5089269|NCT01690663|12521682|P1|NOT COMPLETED|Overall Study||3
5089270|NCT01690663|12521679|P4|COMPLETED|Overall Study||20
5089271|NCT01690663|12521680|P3|COMPLETED|Overall Study||19
5089272|NCT01690663|12521681|P2|COMPLETED|Overall Study||17
5089273|NCT01690663|12521682|P1|COMPLETED|Overall Study||20
5089274|NCT01690663|12521679|P4|STARTED|Overall Study||24
5089275|NCT01690663|12521680|P3|STARTED|Overall Study||22
5089276|NCT01690663|12521681|P2|STARTED|Overall Study||20
5089277|NCT01690663|12521682|P1|STARTED|Overall Study||23
5089278|NCT01690546|12521696|P1|NOT COMPLETED|Overall Study||9
5089279|NCT01690546|12521696|P1|COMPLETED|Overall Study||26
5089280|NCT01690546|12521696|P1|Extended Release Injectable NTX|Overall Study||27
5089281|NCT01690546|12521696|P1|STARTED|Overall Study||35
5089282|NCT01690299|12521712|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
5089283|NCT01690299|12521713|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
5089284|NCT01690299|12521714|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
5089285|NCT01690299|12521715|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089286|NCT01690299|12521716|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089287|NCT01690299|12521717|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089288|NCT01690299|12521712|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
5089289|NCT01690299|12521713|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
5089290|NCT01690299|12521714|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
5089291|NCT01690299|12521715|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089292|NCT01690299|12521716|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089293|NCT01690299|12521717|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
5089294|NCT01690299|12521712|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
5089295|NCT01690299|12521713|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
5089296|NCT01690299|12521714|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
5089297|NCT01690299|12521715|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
5089298|NCT01690299|12521716|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
5089299|NCT01690299|12521717|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
5089300|NCT01690299|12521712|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
5089301|NCT01690299|12521713|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
5089302|NCT01690299|12521714|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
5089303|NCT01690299|12521715|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
5089304|NCT01690299|12521716|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
5089305|NCT01690299|12521717|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
5089306|NCT01690299|12521712|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089307|NCT01690299|12521713|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089308|NCT01690299|12521714|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089309|NCT01690299|12521715|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
5089310|NCT01690299|12521716|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
5089311|NCT01690299|12521717|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
5089312|NCT01690299|12521712|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089313|NCT01690299|12521713|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089314|NCT01690299|12521714|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
5089315|NCT01690299|12521715|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
5089316|NCT01690299|12521716|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
5089317|NCT01690299|12521717|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
5089318|NCT01690299|12521712|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
5089319|NCT01690299|12521713|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
5089320|NCT01690299|12521714|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
5089321|NCT01690299|12521715|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
5089322|NCT01690299|12521716|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
5089323|NCT01690299|12521717|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
5089324|NCT01690299|12521712|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
5089325|NCT01690299|12521713|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
5089326|NCT01690299|12521714|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
5089327|NCT01690299|12521715|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
5089328|NCT01690299|12521716|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
5089329|NCT01690299|12521717|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
5089330|NCT01690273|12521762|P3|NOT COMPLETED|Overall Study||0
5089331|NCT01690273|12521763|P2|NOT COMPLETED|Overall Study||0
5089332|NCT01690273|12521764|P1|NOT COMPLETED|Overall Study||0
5089333|NCT01690273|12521762|P3|COMPLETED|Overall Study||20
5089334|NCT01690273|12521763|P2|COMPLETED|Overall Study||17
5089335|NCT01690273|12521764|P1|COMPLETED|Overall Study||18
5089336|NCT01690273|12521762|P3|STARTED|Overall Study||20
5089337|NCT01690273|12521763|P2|STARTED|Overall Study||17
5089338|NCT01690273|12521764|P1|STARTED|Overall Study||18
5089339|NCT01690143|12521814|P1|NOT COMPLETED|Overall Study||1
5089340|NCT01690143|12521814|P1|COMPLETED|Overall Study||44
5089341|NCT01690143|12521814|P1|STARTED|Overall Study||45
5089342|NCT01690130|12521824|P2|NOT COMPLETED|Overall Study||0
5089343|NCT01690130|12521825|P1|NOT COMPLETED|Overall Study||1
5089344|NCT01690130|12521824|P2|COMPLETED|Overall Study||9
5089345|NCT01690130|12521825|P1|COMPLETED|Overall Study||9
5089346|NCT01690130|12521824|P2|STARTED|Overall Study||9
5089347|NCT01690130|12521825|P1|STARTED|Overall Study||10
5089348|NCT01690117|12521835|P2|NOT COMPLETED|Overall Study||14
5089349|NCT01690117|12521836|P1|NOT COMPLETED|Overall Study||16
5089350|NCT01690117|12521835|P2|COMPLETED|Overall Study||31
5089351|NCT01690117|12521836|P1|COMPLETED|Overall Study||31
5089352|NCT01690117|12521835|P2|Post-Measurement|Overall Study||40
5089353|NCT01690117|12521836|P1|Post-Measurement|Overall Study||41
5089354|NCT01690117|12521835|P2|STARTED|Overall Study||45
5089355|NCT01690117|12521836|P1|STARTED|Overall Study||47
5089356|NCT01690052|12521872|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
5089357|NCT01690052|12521873|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
5089358|NCT01690052|12521872|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
5089359|NCT01690052|12521873|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
5089360|NCT01690052|12521872|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
5089361|NCT01690052|12521873|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
5089362|NCT01690052|12521872|P2|NOT COMPLETED|Washout Period of 1 Week||0
5089363|NCT01690052|12521873|P1|NOT COMPLETED|Washout Period of 1 Week||0
5089364|NCT01690052|12521872|P2|COMPLETED|Washout Period of 1 Week||6
5089365|NCT01690052|12521873|P1|COMPLETED|Washout Period of 1 Week||6
5089366|NCT01690052|12521872|P2|STARTED|Washout Period of 1 Week||6
5089367|NCT01690052|12521873|P1|STARTED|Washout Period of 1 Week||6
5089368|NCT01690052|12521872|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
5089369|NCT01690052|12521873|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
5089370|NCT01690052|12521872|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
5089371|NCT01690052|12521873|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
5089372|NCT01690052|12521872|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
5089373|NCT01690052|12521873|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
5089374|NCT01690000|12521881|P2|NOT COMPLETED|Overall Study||6
5089375|NCT01690000|12521882|P1|NOT COMPLETED|Overall Study||3
5089376|NCT01690000|12521881|P2|COMPLETED|Overall Study||35
5089377|NCT01690000|12521882|P1|COMPLETED|Overall Study||37
5089378|NCT01690000|12521881|P2|STARTED|Overall Study||41
5089379|NCT01690000|12521882|P1|STARTED|Overall Study||40
5089380|NCT01689974|12521890|P2|NOT COMPLETED|Overall Study||5
5089381|NCT01689974|12521891|P1|NOT COMPLETED|Overall Study||5
5089382|NCT01689974|12521890|P2|COMPLETED|Overall Study||0
5089383|NCT01689974|12521891|P1|COMPLETED|Overall Study||0
5089384|NCT01689974|12521890|P2|STARTED|Overall Study||5
5089385|NCT01689974|12521891|P1|STARTED|Overall Study||5
5089386|NCT01689909|12521899|P2|NOT COMPLETED|Overall Study||0
5089387|NCT01689909|12521900|P1|NOT COMPLETED|Overall Study||0
5089388|NCT01689909|12521899|P2|COMPLETED|Overall Study||52
5089389|NCT01689909|12521900|P1|COMPLETED|Overall Study||51
5089390|NCT01689909|12521899|P2|STARTED|Overall Study||52
5089391|NCT01689909|12521900|P1|STARTED|Overall Study||51
5089392|NCT01689857|12521922|P2|NOT COMPLETED|Overall Study||2
5089393|NCT01689857|12521923|P1|NOT COMPLETED|Overall Study||5
5089394|NCT01689857|12521922|P2|COMPLETED|Overall Study||18
5089395|NCT01689857|12521923|P1|COMPLETED|Overall Study||15
5089396|NCT01689857|12521922|P2|STARTED|Overall Study||20
5089397|NCT01689857|12521923|P1|STARTED|Overall Study||20
5089398|NCT01689779|12521931|P2|NOT COMPLETED|Overall Study||0
5089399|NCT01689779|12521932|P1|NOT COMPLETED|Overall Study||0
5089400|NCT01689779|12521931|P2|COMPLETED|Overall Study||32
5089401|NCT01689779|12521932|P1|COMPLETED|Overall Study||28
5089402|NCT01689779|12521931|P2|STARTED|Overall Study||32
5089403|NCT01689779|12521932|P1|STARTED|Overall Study||28
5089404|NCT01689701|12521950|P2|NOT COMPLETED|Overall Study||6
5089405|NCT01689701|12521951|P1|NOT COMPLETED|Overall Study||5
5089406|NCT01689701|12521950|P2|COMPLETED|Overall Study||21
5089407|NCT01689701|12521951|P1|COMPLETED|Overall Study||22
5089408|NCT01689701|12521950|P2|STARTED|Overall Study||27
5089409|NCT01689701|12521951|P1|STARTED|Overall Study||27
5089410|NCT01689649|12521971|P1|NOT COMPLETED|Overall Study||22
5089411|NCT01689649|12521971|P1|COMPLETED|Overall Study||117
5089412|NCT01689649|12521971|P1|STARTED|Overall Study||139
5089413|NCT01689532|12521983|P2|NOT COMPLETED|Overall Study||9
5089414|NCT01689532|12521984|P1|NOT COMPLETED|Overall Study||14
5089415|NCT01689532|12521983|P2|COMPLETED|Overall Study||52
5089416|NCT01689532|12521984|P1|COMPLETED|Overall Study||47
5089417|NCT01689532|12521983|P2|STARTED|Overall Study||61
5089418|NCT01689532|12521984|P1|STARTED|Overall Study||61
5089419|NCT01689519|12522048|P2|NOT COMPLETED|Overall Study||138
5089420|NCT01689519|12522049|P1|NOT COMPLETED|Overall Study||166
5089421|NCT01689519|12522048|P2|COMPLETED|Overall Study||109
5089422|NCT01689519|12522049|P1|COMPLETED|Overall Study||82
5089423|NCT01689519|12522048|P2|Received Treatment|Overall Study||246
5089424|NCT01689519|12522049|P1|Received Treatment|Overall Study||247
5089425|NCT01689519|12522048|P2|STARTED|Overall Study||247
5089426|NCT01689519|12522049|P1|STARTED|Overall Study||248
5089427|NCT01689441|12522065|P2|NOT COMPLETED|Overall Study||0
5089428|NCT01689441|12522066|P1|NOT COMPLETED|Overall Study||0
5089429|NCT01689441|12522065|P2|COMPLETED|Overall Study||31
5089430|NCT01689441|12522066|P1|COMPLETED|Overall Study||36
5089431|NCT01689441|12522065|P2|STARTED|Overall Study||31
5089432|NCT01689441|12522066|P1|STARTED|Overall Study||36
5089433|NCT01689363|12522076|P8|NOT COMPLETED|Overall Study||0
5089434|NCT01689363|12522077|P7|NOT COMPLETED|Overall Study||0
5089435|NCT01689363|12522078|P6|NOT COMPLETED|Overall Study||0
5089436|NCT01689363|12522079|P5|NOT COMPLETED|Overall Study||0
5089437|NCT01689363|12522080|P4|NOT COMPLETED|Overall Study||0
5089438|NCT01689363|12522081|P3|NOT COMPLETED|Overall Study||0
5089439|NCT01689363|12522082|P2|NOT COMPLETED|Overall Study||1
5089440|NCT01689363|12522083|P1|NOT COMPLETED|Overall Study||0
5089441|NCT01689363|12522076|P8|COMPLETED|Overall Study||32
5089442|NCT01689363|12522077|P7|COMPLETED|Overall Study||32
5089443|NCT01689363|12522078|P6|COMPLETED|Overall Study||31
5089444|NCT01689363|12522079|P5|COMPLETED|Overall Study||31
5089445|NCT01689363|12522080|P4|COMPLETED|Overall Study||31
5089446|NCT01689363|12522081|P3|COMPLETED|Overall Study||32
5089447|NCT01689363|12522082|P2|COMPLETED|Overall Study||31
5089448|NCT01689363|12522083|P1|COMPLETED|Overall Study||32
5089449|NCT01689363|12522076|P8|STARTED|Overall Study||32
5089450|NCT01689363|12522077|P7|STARTED|Overall Study||32
5089451|NCT01689363|12522078|P6|STARTED|Overall Study||31
5089452|NCT01689363|12522079|P5|STARTED|Overall Study||31
5089453|NCT01689363|12522080|P4|STARTED|Overall Study||31
5089454|NCT01689363|12522081|P3|STARTED|Overall Study||32
5089455|NCT01689363|12522082|P2|STARTED|Overall Study||32
5089456|NCT01689363|12522083|P1|STARTED|Overall Study||32
5089457|NCT01689350|12522129|P2|NOT COMPLETED|Overall Study||0
5089458|NCT01689350|12522130|P1|NOT COMPLETED|Overall Study||0
5089459|NCT01689350|12522129|P2|COMPLETED|Overall Study||45
5089460|NCT01689350|12522130|P1|COMPLETED|Overall Study||47
5089461|NCT01689350|12522129|P2|STARTED|Overall Study||45
5089462|NCT01689350|12522130|P1|STARTED|Overall Study||47
5089463|NCT01689337|12522138|P1|NOT COMPLETED|Overall Study||1
5089464|NCT01689337|12522138|P1|COMPLETED|Overall Study||0
5089465|NCT01689337|12522138|P1|STARTED|Overall Study||1
5089466|NCT01689324|12522153|P1|NOT COMPLETED|Overall Study||0
5089467|NCT01689324|12522153|P1|COMPLETED|Overall Study||43
5089468|NCT01689324|12522153|P1|STARTED|Overall Study||43
5089469|NCT01689207|12522177|P11|NOT COMPLETED|Overall Study||0
5089470|NCT01689207|12522178|P10|NOT COMPLETED|Overall Study||0
5089471|NCT01689207|12522179|P9|NOT COMPLETED|Overall Study||1
5089472|NCT01689207|12522180|P8|NOT COMPLETED|Overall Study||0
5089473|NCT01689207|12522181|P7|NOT COMPLETED|Overall Study||0
5089474|NCT01689207|12522182|P6|NOT COMPLETED|Overall Study||1
5089475|NCT01689207|12522183|P5|NOT COMPLETED|Overall Study||2
5089476|NCT01689207|12522184|P4|NOT COMPLETED|Overall Study||0
5089477|NCT01689207|12522185|P3|NOT COMPLETED|Overall Study||0
5089478|NCT01689207|12522186|P2|NOT COMPLETED|Overall Study||1
5089479|NCT01689207|12522187|P1|NOT COMPLETED|Overall Study||0
5089480|NCT01689207|12522177|P11|COMPLETED|Overall Study|Subjects completed study|8
5089481|NCT01689207|12522178|P10|COMPLETED|Overall Study|Subjects completed study|10
5089482|NCT01689207|12522179|P9|COMPLETED|Overall Study|Subjects completed study|5
5089483|NCT01689207|12522180|P8|COMPLETED|Overall Study|Subjects completed study|10
5089484|NCT01689207|12522181|P7|COMPLETED|Overall Study|Subjects completed study|10
5089485|NCT01689207|12522182|P6|COMPLETED|Overall Study|Subjects completed study|7
5089486|NCT01689207|12522183|P5|COMPLETED|Overall Study|Subjects completed study|2
5089487|NCT01689207|12522184|P4|COMPLETED|Overall Study|Subjects completed study|8
5089488|NCT01689207|12522185|P3|COMPLETED|Overall Study|Subjects completed study|16
5089489|NCT01689207|12522186|P2|COMPLETED|Overall Study|Subjects completed study|7
5089490|NCT01689207|12522187|P1|COMPLETED|Overall Study|Subjects completed study|4
5089491|NCT01689207|12522177|P11|STARTED|Overall Study|Subjects randomised|8
5089492|NCT01689207|12522178|P10|STARTED|Overall Study|Subjects randomised|10
5089493|NCT01689207|12522179|P9|STARTED|Overall Study|Subjects randomised|6
5089494|NCT01689207|12522180|P8|STARTED|Overall Study|Subjects randomised|10
5089495|NCT01689207|12522181|P7|STARTED|Overall Study|Subjects randomised|10
5089496|NCT01689207|12522182|P6|STARTED|Overall Study|Subjects randomised|8
5089497|NCT01689207|12522183|P5|STARTED|Overall Study|Subjects randomised|4
5089498|NCT01689207|12522184|P4|STARTED|Overall Study|Subjects randomised|8
5089499|NCT01689207|12522185|P3|STARTED|Overall Study|Subjects randomised|16
5089500|NCT01689207|12522186|P2|STARTED|Overall Study|Subjects randomised|8
5089501|NCT01689207|12522187|P1|STARTED|Overall Study|Subjects randomised|4
5089502|NCT01689155|12522283|P1|NOT COMPLETED|Overall Study||0
5089503|NCT01689155|12522283|P1|COMPLETED|Overall Study||116
5089504|NCT01689155|12522283|P1|STARTED|Overall Study||116
5089505|NCT01688973|12522294|P2|NOT COMPLETED|Overall Study||3
5089506|NCT01688973|12522295|P1|NOT COMPLETED|Overall Study||2
5089507|NCT01688973|12522294|P2|COMPLETED|Overall Study||25
5089508|NCT01688973|12522295|P1|COMPLETED|Overall Study||25
5089509|NCT01688973|12522294|P2|Eligible/Evaluable Patients|Overall Study||25
5089510|NCT01688973|12522295|P1|Eligible/Evaluable Patients|Overall Study||25
5089511|NCT01688973|12522294|P2|STARTED|Overall Study||28
5089512|NCT01688973|12522295|P1|STARTED|Overall Study||27
5089513|NCT01688921|12522309|P2|NOT COMPLETED|Overall Study||15
5089514|NCT01688921|12522310|P1|NOT COMPLETED|Overall Study||16
5089515|NCT01688921|12522309|P2|COMPLETED|Overall Study||608
5089516|NCT01688921|12522310|P1|COMPLETED|Overall Study||611
5089517|NCT01688921|12522309|P2|STARTED|Overall Study||623
5089518|NCT01688921|12522310|P1|STARTED|Overall Study||627
5089519|NCT01688895|12522333|P1|NOT COMPLETED|Overall Study||0
5089520|NCT01688895|12522333|P1|COMPLETED|Overall Study||150
5089521|NCT01688895|12522333|P1|STARTED|Overall Study||150
5089522|NCT01688882|12522342|P2|NOT COMPLETED|Overall Study||1
5089523|NCT01688882|12522343|P1|NOT COMPLETED|Overall Study||3
5089524|NCT01688882|12522342|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
5089525|NCT01688882|12522343|P1|COMPLETED|Overall Study||10
5089526|NCT01688882|12522342|P2|Safety Follow-up|Overall Study||5
5089527|NCT01688882|12522343|P1|Safety Follow-up|Overall Study||11
5089528|NCT01688882|12522342|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
5089529|NCT01688882|12522343|P1|STARTED|Overall Study||13
5089530|NCT01688856|12522360|P3|NOT COMPLETED|Overall Study||3
5089531|NCT01688856|12522361|P2|NOT COMPLETED|Overall Study||4
5089532|NCT01688856|12522362|P1|NOT COMPLETED|Overall Study||7
5089533|NCT01688856|12522360|P3|COMPLETED|Overall Study||8
5089534|NCT01688856|12522361|P2|COMPLETED|Overall Study||24
5089535|NCT01688856|12522362|P1|COMPLETED|Overall Study||21
5089536|NCT01688856|12522360|P3|STARTED|Overall Study||11
5089537|NCT01688856|12522361|P2|STARTED|Overall Study||28
5089538|NCT01688856|12522362|P1|STARTED|Overall Study||28
5089539|NCT01688843|12522382|P1|NOT COMPLETED|Overall Study||0
5089540|NCT01688843|12522382|P1|COMPLETED|Overall Study||1060
5089541|NCT01688843|12522382|P1|STARTED|Overall Study||1060
5089542|NCT01688830|12522414|P21|NOT COMPLETED|Overall Study||0
5089543|NCT01688830|12522415|P20|NOT COMPLETED|Overall Study||0
5089544|NCT01688830|12522416|P19|NOT COMPLETED|Overall Study||0
5089545|NCT01688830|12522417|P18|NOT COMPLETED|Overall Study||0
5089546|NCT01688830|12522418|P17|NOT COMPLETED|Overall Study||0
5089547|NCT01688830|12522419|P16|NOT COMPLETED|Overall Study||0
5089548|NCT01688830|12522420|P15|NOT COMPLETED|Overall Study||0
5089549|NCT01688830|12522421|P14|NOT COMPLETED|Overall Study||0
5089550|NCT01688830|12522422|P13|NOT COMPLETED|Overall Study||0
5089551|NCT01688830|12522423|P12|NOT COMPLETED|Overall Study||0
5089552|NCT01688830|12522424|P11|NOT COMPLETED|Overall Study||1
5089553|NCT01688830|12522425|P10|NOT COMPLETED|Overall Study||0
5089554|NCT01688830|12522426|P9|NOT COMPLETED|Overall Study||0
5089555|NCT01688830|12522427|P8|NOT COMPLETED|Overall Study||0
5089556|NCT01688830|12522428|P7|NOT COMPLETED|Overall Study||0
5089557|NCT01688830|12522429|P6|NOT COMPLETED|Overall Study||0
5089558|NCT01688830|12522430|P5|NOT COMPLETED|Overall Study||0
5089559|NCT01688830|12522431|P4|NOT COMPLETED|Overall Study||0
5089560|NCT01688830|12522432|P3|NOT COMPLETED|Overall Study||0
5089561|NCT01688830|12522433|P2|NOT COMPLETED|Overall Study||0
5089562|NCT01688830|12522434|P1|NOT COMPLETED|Overall Study||0
5089563|NCT01688830|12522414|P21|COMPLETED|Overall Study||9
5089564|NCT01688830|12522415|P20|COMPLETED|Overall Study||3
5089565|NCT01688830|12522416|P19|COMPLETED|Overall Study||8
5089566|NCT01688830|12522417|P18|COMPLETED|Overall Study||9
5089567|NCT01688830|12522418|P17|COMPLETED|Overall Study||9
5089568|NCT01688830|12522419|P16|COMPLETED|Overall Study||9
5089569|NCT01688830|12522420|P15|COMPLETED|Overall Study||6
5089570|NCT01688830|12522421|P14|COMPLETED|Overall Study||6
5089571|NCT01688830|12522422|P13|COMPLETED|Overall Study||6
5089572|NCT01688830|12522423|P12|COMPLETED|Overall Study||6
5089573|NCT01688830|12522424|P11|COMPLETED|Overall Study||5
5089574|NCT01688830|12522425|P10|COMPLETED|Overall Study||6
5089575|NCT01688830|12522426|P9|COMPLETED|Overall Study||6
5089576|NCT01688830|12522427|P8|COMPLETED|Overall Study||6
5089577|NCT01688830|12522428|P7|COMPLETED|Overall Study||12
5089578|NCT01688830|12522429|P6|COMPLETED|Overall Study||6
5089579|NCT01688830|12522430|P5|COMPLETED|Overall Study||5
5089580|NCT01688830|12522431|P4|COMPLETED|Overall Study||6
5089581|NCT01688830|12522432|P3|COMPLETED|Overall Study||6
5089582|NCT01688830|12522433|P2|COMPLETED|Overall Study||6
5089583|NCT01688830|12522434|P1|COMPLETED|Overall Study||21
5089584|NCT01688830|12522414|P21|STARTED|Overall Study||9
5089585|NCT01688830|12522415|P20|STARTED|Overall Study||3
5089586|NCT01688830|12522416|P19|STARTED|Overall Study||8
5089587|NCT01688830|12522417|P18|STARTED|Overall Study||9
5089588|NCT01688830|12522418|P17|STARTED|Overall Study||9
5089589|NCT01688830|12522419|P16|STARTED|Overall Study||9
5089590|NCT01688830|12522420|P15|STARTED|Overall Study||6
5089591|NCT01688830|12522421|P14|STARTED|Overall Study||6
5089592|NCT01688830|12522422|P13|STARTED|Overall Study||6
5089593|NCT01688830|12522423|P12|STARTED|Overall Study||6
5089594|NCT01688830|12522424|P11|STARTED|Overall Study||6
5089595|NCT01688830|12522425|P10|STARTED|Overall Study||6
5089596|NCT01688830|12522426|P9|STARTED|Overall Study||6
5089597|NCT01688830|12522427|P8|STARTED|Overall Study||6
5089598|NCT01688830|12522428|P7|STARTED|Overall Study||12
5089599|NCT01688830|12522429|P6|STARTED|Overall Study||6
5089600|NCT01688830|12522430|P5|STARTED|Overall Study||5
5089601|NCT01688830|12522431|P4|STARTED|Overall Study||6
5089602|NCT01688830|12522432|P3|STARTED|Overall Study||6
5089603|NCT01688830|12522433|P2|STARTED|Overall Study||6
5089604|NCT01688830|12522434|P1|STARTED|Overall Study||21
5089605|NCT01688739|12522588|P10|NOT COMPLETED|Overall Study||0
5089606|NCT01688739|12522589|P9|NOT COMPLETED|Overall Study||0
5089607|NCT01688739|12522590|P8|NOT COMPLETED|Overall Study||0
5089608|NCT01688739|12522591|P7|NOT COMPLETED|Overall Study||0
5089609|NCT01688739|12522592|P6|NOT COMPLETED|Overall Study||0
5089610|NCT01688739|12522593|P5|NOT COMPLETED|Overall Study||0
5089611|NCT01688739|12522594|P4|NOT COMPLETED|Overall Study||0
5089612|NCT01688739|12522595|P3|NOT COMPLETED|Overall Study||0
5089613|NCT01688739|12522596|P2|NOT COMPLETED|Overall Study||0
5089614|NCT01688739|12522597|P1|NOT COMPLETED|Overall Study||1
5089615|NCT01688739|12522588|P10|COMPLETED|Overall Study||6
5089616|NCT01688739|12522589|P9|COMPLETED|Overall Study||6
5089617|NCT01688739|12522590|P8|COMPLETED|Overall Study||6
5089618|NCT01688739|12522591|P7|COMPLETED|Overall Study||6
5089619|NCT01688739|12522592|P6|COMPLETED|Overall Study||6
5089620|NCT01688739|12522593|P5|COMPLETED|Overall Study||6
5089621|NCT01688739|12522594|P4|COMPLETED|Overall Study||6
5089622|NCT01688739|12522595|P3|COMPLETED|Overall Study||3
5089623|NCT01688739|12522596|P2|COMPLETED|Overall Study||3
5089624|NCT01688739|12522597|P1|COMPLETED|Overall Study||12
5089625|NCT01688739|12522588|P10|Received Study Drug|Overall Study||6
5089626|NCT01688739|12522589|P9|Received Study Drug|Overall Study||6
5089627|NCT01688739|12522590|P8|Received Study Drug|Overall Study||6
5089628|NCT01688739|12522591|P7|Received Study Drug|Overall Study||6
5089629|NCT01688739|12522592|P6|Received Study Drug|Overall Study||6
5089630|NCT01688739|12522593|P5|Received Study Drug|Overall Study||6
5089631|NCT01688739|12522594|P4|Received Study Drug|Overall Study||6
5089632|NCT01688739|12522595|P3|Received Study Drug|Overall Study||3
5089633|NCT01688739|12522596|P2|Received Study Drug|Overall Study||3
5089634|NCT01688739|12522597|P1|Received Study Drug|Overall Study||12
5089635|NCT01688739|12522588|P10|STARTED|Overall Study||6
5089636|NCT01688739|12522589|P9|STARTED|Overall Study||6
5089637|NCT01688739|12522590|P8|STARTED|Overall Study||6
5089638|NCT01688739|12522591|P7|STARTED|Overall Study||6
5089639|NCT01688739|12522592|P6|STARTED|Overall Study||6
5089640|NCT01688739|12522593|P5|STARTED|Overall Study||6
5089641|NCT01688739|12522594|P4|STARTED|Overall Study||6
5089642|NCT01688739|12522595|P3|STARTED|Overall Study||3
5089643|NCT01688739|12522596|P2|STARTED|Overall Study||3
5089644|NCT01688739|12522597|P1|STARTED|Overall Study||13
5089645|NCT01688726|12522673|P2|NOT COMPLETED|Overall Study||1
5089646|NCT01688726|12522674|P1|NOT COMPLETED|Overall Study||1
5089647|NCT01688726|12522673|P2|COMPLETED|Overall Study||44
5089648|NCT01688726|12522674|P1|COMPLETED|Overall Study||45
5089649|NCT01688726|12522673|P2|STARTED|Overall Study||45
5089650|NCT01688726|12522674|P1|STARTED|Overall Study||46
5089651|NCT01688635|12522686|P2|NOT COMPLETED|Period 4||0
5089652|NCT01688635|12522687|P1|NOT COMPLETED|Period 4||0
5089653|NCT01688635|12522686|P2|COMPLETED|Period 4||42
5089654|NCT01688635|12522687|P1|COMPLETED|Period 4||40
5089655|NCT01688635|12522686|P2|STARTED|Period 4||42
5089656|NCT01688635|12522687|P1|STARTED|Period 4||40
5089657|NCT01688635|12522686|P2|NOT COMPLETED|Washout 3||0
5089658|NCT01688635|12522687|P1|NOT COMPLETED|Washout 3||1
5089659|NCT01688635|12522686|P2|COMPLETED|Washout 3||42
5089660|NCT01688635|12522687|P1|COMPLETED|Washout 3||40
5089661|NCT01688635|12522686|P2|STARTED|Washout 3||42
5089662|NCT01688635|12522687|P1|STARTED|Washout 3||41
5089663|NCT01688635|12522686|P2|NOT COMPLETED|Period 3||0
5089664|NCT01688635|12522687|P1|NOT COMPLETED|Period 3||0
5089665|NCT01688635|12522686|P2|COMPLETED|Period 3||42
5089666|NCT01688635|12522687|P1|COMPLETED|Period 3||41
5089667|NCT01688635|12522686|P2|STARTED|Period 3||42
5089668|NCT01688635|12522687|P1|STARTED|Period 3||41
5089669|NCT01688635|12522686|P2|NOT COMPLETED|Washout 2||2
5089670|NCT01688635|12522687|P1|NOT COMPLETED|Washout 2||3
5089671|NCT01688635|12522686|P2|COMPLETED|Washout 2||42
5089672|NCT01688635|12522687|P1|COMPLETED|Washout 2||41
5089673|NCT01688635|12522686|P2|STARTED|Washout 2||44
5089674|NCT01688635|12522687|P1|STARTED|Washout 2||44
5089675|NCT01688635|12522686|P2|NOT COMPLETED|Period 2||0
5089676|NCT01688635|12522687|P1|NOT COMPLETED|Period 2||0
5089677|NCT01688635|12522686|P2|COMPLETED|Period 2||44
5089678|NCT01688635|12522687|P1|COMPLETED|Period 2||44
5089679|NCT01688635|12522686|P2|STARTED|Period 2||44
5089680|NCT01688635|12522687|P1|STARTED|Period 2||44
5089681|NCT01688635|12522686|P2|NOT COMPLETED|Washout 1||2
5089682|NCT01688635|12522687|P1|NOT COMPLETED|Washout 1||1
5089683|NCT01688635|12522686|P2|COMPLETED|Washout 1||44
5089684|NCT01688635|12522687|P1|COMPLETED|Washout 1||44
5089685|NCT01688635|12522686|P2|STARTED|Washout 1||46
5089686|NCT01688635|12522687|P1|STARTED|Washout 1||45
5089687|NCT01688635|12522686|P2|NOT COMPLETED|Period 1||0
5089688|NCT01688635|12522687|P1|NOT COMPLETED|Period 1||0
5089689|NCT01688635|12522686|P2|COMPLETED|Period 1||46
5089690|NCT01688635|12522687|P1|COMPLETED|Period 1||45
5089691|NCT01688635|12522686|P2|Received at Least 1 Dose of Study Drug|Period 1||46
5089692|NCT01688635|12522687|P1|Received at Least 1 Dose of Study Drug|Period 1||45
5089693|NCT01688635|12522686|P2|STARTED|Period 1||46
5089694|NCT01688635|12522687|P1|STARTED|Period 1||45
5089695|NCT01688609|12522699|P1|NOT COMPLETED|Overall Study||0
5089696|NCT01688609|12522699|P1|COMPLETED|Overall Study||18
5089697|NCT01688609|12522699|P1|STARTED|Overall Study||18
5089698|NCT01688596|12522709|P2|NOT COMPLETED|Overall Study||9
5089699|NCT01688596|12522710|P1|NOT COMPLETED|Overall Study||8
5089700|NCT01688596|12522709|P2|COMPLETED|Overall Study||59
5089701|NCT01688596|12522710|P1|COMPLETED|Overall Study||59
5089702|NCT01688596|12522709|P2|STARTED|Overall Study||68
5089703|NCT01688596|12522710|P1|STARTED|Overall Study||67
5089704|NCT01688466|12522734|P2|NOT COMPLETED|Overall Study||7
5089705|NCT01688466|12522735|P1|NOT COMPLETED|Overall Study||2
5089706|NCT01688466|12522734|P2|COMPLETED|Overall Study||10
5089707|NCT01688466|12522735|P1|COMPLETED|Overall Study||15
5089708|NCT01688466|12522734|P2|STARTED|Overall Study||17
5089709|NCT01688466|12522735|P1|STARTED|Overall Study||17
5089710|NCT01688336|12522743|P1|NOT COMPLETED|Overall Study||0
5089711|NCT01688336|12522743|P1|COMPLETED|Overall Study||9
5089712|NCT01688336|12522743|P1|STARTED|Overall Study||9
5089713|NCT01688310|12522755|P2|NOT COMPLETED|Overall Study||0
5089714|NCT01688310|12522756|P1|NOT COMPLETED|Overall Study||0
5089715|NCT01688310|12522755|P2|COMPLETED|Overall Study||100
5089716|NCT01688310|12522756|P1|COMPLETED|Overall Study||100
5089717|NCT01688310|12522755|P2|STARTED|Overall Study||100
5089718|NCT01688310|12522756|P1|STARTED|Overall Study||100
5089719|NCT01688141|12522776|P2|NOT COMPLETED|Overall Study||0
5089720|NCT01688141|12522777|P1|NOT COMPLETED|Overall Study||0
5089721|NCT01688141|12522776|P2|COMPLETED|Overall Study||11651
5089722|NCT01688141|12522777|P1|COMPLETED|Overall Study||11706
5089723|NCT01688141|12522776|P2|STARTED|Overall Study||11651
5089724|NCT01688141|12522777|P1|STARTED|Overall Study||11706
5089725|NCT01688102|12522797|P2|NOT COMPLETED|Overall Study||18
5089726|NCT01688102|12522798|P1|NOT COMPLETED|Overall Study||16
5089727|NCT01688102|12522797|P2|COMPLETED|Overall Study||40
5089728|NCT01688102|12522798|P1|COMPLETED|Overall Study||44
5089729|NCT01688102|12522797|P2|STARTED|Overall Study||58
5089730|NCT01688102|12522798|P1|STARTED|Overall Study||60
5089731|NCT01688050|12522826|P1|NOT COMPLETED|Overall Study||50
5089732|NCT01688050|12522826|P1|COMPLETED|Overall Study||0
5089733|NCT01688050|12522826|P1|30 Days|Overall Study||50
5089734|NCT01688050|12522826|P1|STARTED|Overall Study||50
5089735|NCT01688037|12522835|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
5089736|NCT01688037|12522836|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
5089737|NCT01688037|12522837|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
5089738|NCT01688037|12522835|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
5089739|NCT01688037|12522836|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
5089740|NCT01688037|12522837|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
5089741|NCT01688037|12522835|P3|STARTED|Follow-up Period (Week 12 to 16)||17
5089742|NCT01688037|12522836|P2|STARTED|Follow-up Period (Week 12 to 16)||22
5089743|NCT01688037|12522837|P1|STARTED|Follow-up Period (Week 12 to 16)||42
5089744|NCT01688037|12522835|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
5089745|NCT01688037|12522836|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
5089746|NCT01688037|12522837|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
5089747|NCT01688037|12522835|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
5089748|NCT01688037|12522836|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
5089749|NCT01688037|12522837|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
5089750|NCT01688037|12522835|P3|STARTED|Open-Label Period (Week 6 to 12)||21
5089751|NCT01688037|12522836|P2|STARTED|Open-Label Period (Week 6 to 12)||25
5089752|NCT01688037|12522837|P1|STARTED|Open-Label Period (Week 6 to 12)||47
5089753|NCT01688037|12522835|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
5089754|NCT01688037|12522836|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
5089755|NCT01688037|12522837|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
5089756|NCT01688037|12522835|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
5089757|NCT01688037|12522836|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
5089758|NCT01688037|12522837|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
5089759|NCT01688037|12522835|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
5089760|NCT01688037|12522836|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
5089761|NCT01688037|12522837|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
5089762|NCT01687998|12522853|P2|NOT COMPLETED|Overall Study||120
5089763|NCT01687998|12522854|P1|NOT COMPLETED|Overall Study||112
5089764|NCT01687998|12522853|P2|COMPLETED|Overall Study||5934
5089765|NCT01687998|12522854|P1|COMPLETED|Overall Study||5926
5089766|NCT01687998|12522853|P2|Received at Least One Dose of Study Drug|Overall Study||6052
5089767|NCT01687998|12522854|P1|Received at Least One Dose of Study Drug|Overall Study||6036
5089768|NCT01687998|12522853|P2|STARTED|Overall Study||6054
5089769|NCT01687998|12522854|P1|STARTED|Overall Study||6038
5089770|NCT01687972|12522872|P2|NOT COMPLETED|Overall Study||0
5089771|NCT01687972|12522873|P1|NOT COMPLETED|Overall Study||0
5089772|NCT01687972|12522872|P2|COMPLETED|Overall Study||44
5089773|NCT01687972|12522873|P1|COMPLETED|Overall Study||44
5089774|NCT01687972|12522872|P2|STARTED|Overall Study||44
5089775|NCT01687972|12522873|P1|STARTED|Overall Study||44
5089776|NCT01687790|12522883|P1|NOT COMPLETED|Overall Study||0
5089777|NCT01687790|12522883|P1|COMPLETED|Overall Study||60
5089778|NCT01687790|12522883|P1|STARTED|Overall Study||60
5089779|NCT01687712|12522890|P2|NOT COMPLETED|Cycle 3||24
5089780|NCT01687712|12522891|P1|NOT COMPLETED|Cycle 3||24
5089781|NCT01687712|12522890|P2|COMPLETED|Cycle 3||0
5089782|NCT01687712|12522891|P1|COMPLETED|Cycle 3||4
5089783|NCT01687712|12522890|P2|Clinical Pregnancy|Cycle 3||0
5089784|NCT01687712|12522891|P1|Clinical Pregnancy|Cycle 3||5
5089785|NCT01687712|12522890|P2|Biochemically Pregnant|Cycle 3||2
5089786|NCT01687712|12522891|P1|Biochemically Pregnant|Cycle 3||7
5089787|NCT01687712|12522890|P2|Embryo Transfer|Cycle 3||24
5089788|NCT01687712|12522891|P1|Embryo Transfer|Cycle 3||26
5089789|NCT01687712|12522890|P2|Fertilization Performed|Cycle 3||24
5089790|NCT01687712|12522891|P1|Fertilization Performed|Cycle 3||27
5089791|NCT01687712|12522890|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
5089792|NCT01687712|12522891|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
5089793|NCT01687712|12522890|P2|Received hCG|Cycle 3||24
5089794|NCT01687712|12522891|P1|Received hCG|Cycle 3||27
5089795|NCT01687712|12522890|P2|STARTED|Cycle 3||24
5089796|NCT01687712|12522891|P1|STARTED|Cycle 3||28
5089797|NCT01687712|12522890|P2|NOT COMPLETED|Cycle 2||95
5089798|NCT01687712|12522891|P1|NOT COMPLETED|Cycle 2||93
5089799|NCT01687712|12522890|P2|COMPLETED|Cycle 2||25
5089800|NCT01687712|12522891|P1|COMPLETED|Cycle 2||16
5089801|NCT01687712|12522890|P2|Clinical Pregnancy|Cycle 2||26
5089802|NCT01687712|12522891|P1|Clinical Pregnancy|Cycle 2||17
5089803|NCT01687712|12522890|P2|Biochemical Pregnancy|Cycle 2||43
5089804|NCT01687712|12522891|P1|Biochemical Pregnancy|Cycle 2||35
5089805|NCT01687712|12522890|P2|Embryo Transfer|Cycle 2||117
5089806|NCT01687712|12522891|P1|Embryo Transfer|Cycle 2||101
5089807|NCT01687712|12522890|P2|Fertilization Performed|Cycle 2||119
5089808|NCT01687712|12522891|P1|Fertilization Performed|Cycle 2||106
5089809|NCT01687712|12522890|P2|Oocyte/Ovum Pick Up|Cycle 2||119
5089810|NCT01687712|12522891|P1|Oocyte/Ovum Pick Up|Cycle 2||107
5089811|NCT01687712|12522890|P2|Received hCG|Cycle 2||119
5089812|NCT01687712|12522891|P1|Received hCG|Cycle 2||107
5089813|NCT01687712|12522890|P2|STARTED|Cycle 2||120
5089814|NCT01687712|12522891|P1|STARTED|Cycle 2||109
5089815|NCT01687712|12522890|P2|NOT COMPLETED|Cycle 1||429
5089816|NCT01687712|12522891|P1|NOT COMPLETED|Cycle 1||448
5089817|NCT01687712|12522890|P2|COMPLETED|Cycle 1||122
5089818|NCT01687712|12522891|P1|COMPLETED|Cycle 1||101
5089819|NCT01687712|12522890|P2|Clinical Pregnancy|Cycle 1||138
5089820|NCT01687712|12522891|P1|Clinical Pregnancy|Cycle 1||114
5089821|NCT01687712|12522890|P2|Biochemical Pregnancy|Cycle 1||203
5089822|NCT01687712|12522891|P1|Biochemical Pregnancy|Cycle 1||163
5089823|NCT01687712|12522890|P2|Embryo Transfer|Cycle 1||483
5089824|NCT01687712|12522891|P1|Embryo Transfer|Cycle 1||466
5089825|NCT01687712|12522890|P2|Fertilization Performed|Cycle 1||512
5089826|NCT01687712|12522891|P1|Fertilization Performed|Cycle 1||508
5089827|NCT01687712|12522890|P2|Oocyte/Ovum Pick Up|Cycle 1||517
5089828|NCT01687712|12522891|P1|Oocyte/Ovum Pick Up|Cycle 1||513
5089829|NCT01687712|12522890|P2|Received hCG|Cycle 1||520
5089830|NCT01687712|12522891|P1|Received hCG|Cycle 1||516
5089831|NCT01687712|12522890|P2|STARTED|Cycle 1||551
5089832|NCT01687712|12522891|P1|STARTED|Cycle 1||549
5089833|NCT01687478|12522931|P2|NOT COMPLETED|Overall Study||39
5089834|NCT01687478|12522932|P1|NOT COMPLETED|Overall Study||32
5089835|NCT01687478|12522931|P2|COMPLETED|Overall Study||49
5089836|NCT01687478|12522932|P1|COMPLETED|Overall Study||56
5089837|NCT01687478|12522931|P2|Safety Analysis Set|Overall Study||87
5089838|NCT01687478|12522932|P1|Safety Analysis Set|Overall Study||88
5089839|NCT01687478|12522931|P2|STARTED|Overall Study||88
5089840|NCT01687478|12522932|P1|STARTED|Overall Study||88
5089841|NCT01687400|12522954|P1|NOT COMPLETED|Overall Study||0
5089842|NCT01687400|12522954|P1|COMPLETED|Overall Study||114
5089843|NCT01687400|12522954|P1|STARTED|Overall Study||114
5089844|NCT01687387|12522968|P3|NOT COMPLETED|Overall Study||38
5089845|NCT01687387|12522969|P2|NOT COMPLETED|Overall Study||38
5089846|NCT01687387|12522970|P1|NOT COMPLETED|Overall Study||41
5089847|NCT01687387|12522968|P3|COMPLETED|Overall Study||13
5089848|NCT01687387|12522969|P2|COMPLETED|Overall Study||12
5089849|NCT01687387|12522970|P1|COMPLETED|Overall Study||10
5089850|NCT01687387|12522968|P3|STARTED|Overall Study||51
5089851|NCT01687387|12522969|P2|STARTED|Overall Study||50
5089852|NCT01687387|12522970|P1|STARTED|Overall Study||51
5089853|NCT01687296|12522983|P2|NOT COMPLETED|Overall Study||5
5089854|NCT01687296|12522984|P1|NOT COMPLETED|Overall Study||7
5089855|NCT01687296|12522983|P2|COMPLETED|Overall Study||123
5089856|NCT01687296|12522984|P1|COMPLETED|Overall Study||116
5089857|NCT01687296|12522983|P2|STARTED|Overall Study||128
5089858|NCT01687296|12522984|P1|STARTED|Overall Study||123
5089859|NCT01687283|12523006|P2|NOT COMPLETED|Overall Study||27
5089860|NCT01687283|12523007|P1|NOT COMPLETED|Overall Study||35
5089861|NCT01687283|12523006|P2|COMPLETED|Overall Study||130
5089862|NCT01687283|12523007|P1|COMPLETED|Overall Study||123
5089863|NCT01687283|12523006|P2|STARTED|Overall Study||157
5089864|NCT01687283|12523007|P1|STARTED|Overall Study||158
5089865|NCT01687270|12523030|P1|NOT COMPLETED|Overall Study||12
5089866|NCT01687270|12523030|P1|COMPLETED|Overall Study||28
5089867|NCT01687270|12523030|P1|STARTED|Overall Study||40
5089868|NCT01687257|12523041|P3|NOT COMPLETED|Overall Study||6
5089869|NCT01687257|12523042|P2|NOT COMPLETED|Overall Study||4
5089870|NCT01687257|12523043|P1|NOT COMPLETED|Overall Study||8
5089871|NCT01687257|12523041|P3|COMPLETED|Overall Study||15
5089872|NCT01687257|12523042|P2|COMPLETED|Overall Study||0
5089873|NCT01687257|12523043|P1|COMPLETED|Overall Study||17
5089874|NCT01687257|12523041|P3|STARTED|Overall Study||21
5089875|NCT01687257|12523042|P2|STARTED|Overall Study||4
5089876|NCT01687257|12523043|P1|STARTED|Overall Study||25
5089877|NCT01687244|12523071|P2|NOT COMPLETED|Overall Study||0
5089878|NCT01687244|12523072|P1|NOT COMPLETED|Overall Study||0
5089879|NCT01687244|12523071|P2|COMPLETED|Overall Study||19
5089880|NCT01687244|12523072|P1|COMPLETED|Overall Study||21
5089881|NCT01687244|12523071|P2|STARTED|Overall Study||19
5089882|NCT01687244|12523072|P1|STARTED|Overall Study||21
5089883|NCT01687218|12523108|P6|NOT COMPLETED|Overall Study||0
5089884|NCT01687218|12523109|P5|NOT COMPLETED|Overall Study||1
5089885|NCT01687218|12523110|P4|NOT COMPLETED|Overall Study||2
5089886|NCT01687218|12523111|P3|NOT COMPLETED|Overall Study||1
5089887|NCT01687218|12523112|P2|NOT COMPLETED|Overall Study||3
5089888|NCT01687218|12523113|P1|NOT COMPLETED|Overall Study||3
5089889|NCT01687218|12523108|P6|COMPLETED|Overall Study||32
5089890|NCT01687218|12523109|P5|COMPLETED|Overall Study||32
5089891|NCT01687218|12523110|P4|COMPLETED|Overall Study||32
5089892|NCT01687218|12523111|P3|COMPLETED|Overall Study||30
5089893|NCT01687218|12523112|P2|COMPLETED|Overall Study||29
5089894|NCT01687218|12523113|P1|COMPLETED|Overall Study||30
5089895|NCT01687218|12523108|P6|STARTED|Overall Study||32
5089896|NCT01687218|12523109|P5|STARTED|Overall Study||33
5089897|NCT01687218|12523110|P4|STARTED|Overall Study||34
5089898|NCT01687218|12523111|P3|STARTED|Overall Study||31
5089899|NCT01687218|12523112|P2|STARTED|Overall Study||32
5089900|NCT01687218|12523113|P1|STARTED|Overall Study||33
5089901|NCT01687179|12523154|P2|NOT COMPLETED|Overall Study||4
5089902|NCT01687179|12523155|P1|NOT COMPLETED|Overall Study||1
5089903|NCT01687179|12523154|P2|COMPLETED|Overall Study||6
5089904|NCT01687179|12523155|P1|COMPLETED|Overall Study||2
5089905|NCT01687179|12523154|P2|STARTED|Overall Study||10
5089906|NCT01687179|12523155|P1|STARTED|Overall Study||3
5089907|NCT01687166|12523165|P4|NOT COMPLETED|Overall Study||2
5089908|NCT01687166|12523166|P3|NOT COMPLETED|Overall Study||14
5089909|NCT01687166|12523167|P2|NOT COMPLETED|Overall Study||27
5089910|NCT01687166|12523168|P1|NOT COMPLETED|Overall Study||28
5089911|NCT01687166|12523165|P4|COMPLETED|Overall Study||1
5089912|NCT01687166|12523166|P3|COMPLETED|Overall Study||42
5089913|NCT01687166|12523167|P2|COMPLETED|Overall Study||145
5089914|NCT01687166|12523168|P1|COMPLETED|Overall Study||139
5089915|NCT01687166|12523165|P4|STARTED|Overall Study||3
5089916|NCT01687166|12523166|P3|STARTED|Overall Study||56
5089917|NCT01687166|12523167|P2|STARTED|Overall Study||172
5089918|NCT01687166|12523168|P1|STARTED|Overall Study||167
5089919|NCT01687114|12523180|P1|NOT COMPLETED|Overall Study||0
5089920|NCT01687114|12523180|P1|COMPLETED|Overall Study||5
5089921|NCT01687114|12523180|P1|STARTED|Overall Study||5
5089922|NCT01687101|12523184|P1|NOT COMPLETED|Overall Study||7
5089923|NCT01687101|12523184|P1|COMPLETED|Overall Study||25
5089924|NCT01687101|12523184|P1|STARTED|Overall Study||32
5089925|NCT01687088|12523190|P2|NOT COMPLETED|Overall Study||0
5089926|NCT01687088|12523191|P1|NOT COMPLETED|Overall Study||0
5089927|NCT01687088|12523190|P2|COMPLETED|Overall Study||50
5089928|NCT01687088|12523191|P1|COMPLETED|Overall Study||50
5089929|NCT01687088|12523190|P2|STARTED|Overall Study||50
5089930|NCT01687088|12523191|P1|STARTED|Overall Study||50
5089931|NCT01687036|12523197|P1|NOT COMPLETED|Overall Study||0
5089932|NCT01687036|12523197|P1|COMPLETED|Overall Study||10
5089933|NCT01687036|12523197|P1|STARTED|Overall Study||10
5089934|NCT01686958|12523209|P1|NOT COMPLETED|Overall Study||1
5089935|NCT01686958|12523209|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
5089936|NCT01686958|12523209|P1|STARTED|Overall Study||30
5089937|NCT01686932|12523222|P2|NOT COMPLETED|Period 2||0
5089938|NCT01686932|12523223|P1|NOT COMPLETED|Period 2||0
5089939|NCT01686932|12523222|P2|COMPLETED|Period 2||25
5089940|NCT01686932|12523223|P1|COMPLETED|Period 2||24
5089941|NCT01686932|12523222|P2|STARTED|Period 2||25
5089942|NCT01686932|12523223|P1|STARTED|Period 2||24
5089943|NCT01686932|12523222|P2|NOT COMPLETED|Period 1||1
5089944|NCT01686932|12523223|P1|NOT COMPLETED|Period 1||1
5089945|NCT01686932|12523222|P2|COMPLETED|Period 1||25
5089946|NCT01686932|12523223|P1|COMPLETED|Period 1||24
5089947|NCT01686932|12523222|P2|STARTED|Period 1||26
5089948|NCT01686932|12523223|P1|STARTED|Period 1||25
5089949|NCT01686828|12523253|P4|NOT COMPLETED|Overall Study||0
5089950|NCT01686828|12523254|P3|NOT COMPLETED|Overall Study||1
5089951|NCT01686828|12523255|P2|NOT COMPLETED|Overall Study||1
5089952|NCT01686828|12523256|P1|NOT COMPLETED|Overall Study||1
5089953|NCT01686828|12523253|P4|COMPLETED|Overall Study||13
5089954|NCT01686828|12523254|P3|COMPLETED|Overall Study||12
5089955|NCT01686828|12523255|P2|COMPLETED|Overall Study||13
5089956|NCT01686828|12523256|P1|COMPLETED|Overall Study||12
5089957|NCT01686828|12523253|P4|STARTED|Overall Study||13
5089958|NCT01686828|12523254|P3|STARTED|Overall Study||13
5089959|NCT01686828|12523255|P2|STARTED|Overall Study||14
5089960|NCT01686828|12523256|P1|STARTED|Overall Study||13
5089961|NCT01686750|12523276|P2|NOT COMPLETED|Overall Study||0
5089962|NCT01686750|12523277|P1|NOT COMPLETED|Overall Study||0
5089963|NCT01686750|12523276|P2|COMPLETED|Overall Study||10725
5089964|NCT01686750|12523277|P1|COMPLETED|Overall Study||11001
5089965|NCT01686750|12523276|P2|STARTED|Overall Study||10725
5089966|NCT01686750|12523277|P1|STARTED|Overall Study||11001
5089967|NCT01686646|12523317|P4|NOT COMPLETED|Overall Study||0
5089968|NCT01686646|12523318|P3|NOT COMPLETED|Overall Study||0
5089969|NCT01686646|12523319|P2|NOT COMPLETED|Overall Study||0
5089970|NCT01686646|12523320|P1|NOT COMPLETED|Overall Study||0
5089971|NCT01686646|12523317|P4|COMPLETED|Overall Study||75
5089972|NCT01686646|12523318|P3|COMPLETED|Overall Study||75
5089973|NCT01686646|12523319|P2|COMPLETED|Overall Study||45
5089974|NCT01686646|12523320|P1|COMPLETED|Overall Study||45
5089975|NCT01686646|12523317|P4|Safety Population|Overall Study||75
5089976|NCT01686646|12523318|P3|Safety Population|Overall Study||74
5089977|NCT01686646|12523319|P2|Safety Population|Overall Study||45
5089978|NCT01686646|12523320|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
5089979|NCT01686646|12523317|P4|Intent to Treat Population|Overall Study||75
5089980|NCT01686646|12523318|P3|Intent to Treat Population|Overall Study||75
5089981|NCT01686646|12523319|P2|Intent to Treat Population|Overall Study||45
5089982|NCT01686646|12523320|P1|Intent to Treat Population|Overall Study||45
5089983|NCT01686646|12523317|P4|STARTED|Overall Study||75
5089984|NCT01686646|12523318|P3|STARTED|Overall Study||75
5089985|NCT01686646|12523319|P2|STARTED|Overall Study||45
5089986|NCT01686646|12523320|P1|STARTED|Overall Study||45
5089987|NCT01686633|12523369|P3|NOT COMPLETED|Overall Study||25
5089988|NCT01686633|12523370|P2|NOT COMPLETED|Overall Study||32
5089989|NCT01686633|12523371|P1|NOT COMPLETED|Overall Study||51
5089990|NCT01686633|12523369|P3|COMPLETED|Overall Study||321
5089991|NCT01686633|12523370|P2|COMPLETED|Overall Study||314
5089992|NCT01686633|12523371|P1|COMPLETED|Overall Study||296
5089993|NCT01686633|12523369|P3|STARTED|Overall Study||346
5089994|NCT01686633|12523370|P2|STARTED|Overall Study||346
5089995|NCT01686633|12523371|P1|STARTED|Overall Study||347
5089996|NCT01686581|12523394|P1|NOT COMPLETED|Overall Study||177
5089997|NCT01686581|12523394|P1|COMPLETED|Overall Study||464
5089998|NCT01686581|12523394|P1|Completed 24 Months|Overall Study||128
5089999|NCT01686581|12523394|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
5090000|NCT01686581|12523394|P1|STARTED|Overall Study||641
5090001|NCT01686568|12523407|P2|NOT COMPLETED|Sub-Study||2
5090002|NCT01686568|12523408|P1|NOT COMPLETED|Sub-Study||2
5090003|NCT01686568|12523407|P2|COMPLETED|Sub-Study||9
5090004|NCT01686568|12523408|P1|COMPLETED|Sub-Study||12
5090005|NCT01686568|12523407|P2|STARTED|Sub-Study||11
5090006|NCT01686568|12523408|P1|STARTED|Sub-Study||14
5090007|NCT01686568|12523407|P2|NOT COMPLETED|Main Study||4
5090008|NCT01686568|12523408|P1|NOT COMPLETED|Main Study||2
5090009|NCT01686568|12523407|P2|COMPLETED|Main Study||11
5090010|NCT01686568|12523408|P1|COMPLETED|Main Study||14
5090011|NCT01686568|12523407|P2|STARTED|Main Study||15
5090012|NCT01686568|12523408|P1|STARTED|Main Study||16
5090013|NCT01686503|12523434|P4|NOT COMPLETED|Overall Study||1
5090014|NCT01686503|12523435|P3|NOT COMPLETED|Overall Study||2
5090015|NCT01686503|12523436|P2|NOT COMPLETED|Overall Study||3
5090016|NCT01686503|12523437|P1|NOT COMPLETED|Overall Study||1
5090017|NCT01686503|12523434|P4|COMPLETED|Overall Study||32
5090018|NCT01686503|12523435|P3|COMPLETED|Overall Study||64
5090019|NCT01686503|12523436|P2|COMPLETED|Overall Study||63
5090020|NCT01686503|12523437|P1|COMPLETED|Overall Study||65
5090021|NCT01686503|12523434|P4|STARTED|Overall Study||33
5090022|NCT01686503|12523435|P3|STARTED|Overall Study||66
5090023|NCT01686503|12523436|P2|STARTED|Overall Study||66
5090024|NCT01686503|12523437|P1|STARTED|Overall Study||66
5090025|NCT01686451|12523453|P2|NOT COMPLETED|Overall Study||0
5090026|NCT01686451|12523454|P1|NOT COMPLETED|Overall Study||0
5090027|NCT01686451|12523453|P2|COMPLETED|Overall Study||27
5090028|NCT01686451|12523454|P1|COMPLETED|Overall Study||33
5090029|NCT01686451|12523453|P2|STARTED|Overall Study||27
5090030|NCT01686451|12523454|P1|STARTED|Overall Study||33
5090031|NCT01686438|12523485|P3|NOT COMPLETED|Overall Study||13
5090032|NCT01686438|12523486|P2|NOT COMPLETED|Overall Study||9
5090033|NCT01686438|12523487|P1|NOT COMPLETED|Overall Study||8
5090034|NCT01686438|12523485|P3|COMPLETED|Overall Study||24
5090035|NCT01686438|12523486|P2|COMPLETED|Overall Study||26
5090036|NCT01686438|12523487|P1|COMPLETED|Overall Study||7
5090037|NCT01686438|12523485|P3|6-Month Follow Up|Overall Study||24
5090038|NCT01686438|12523486|P2|6-Month Follow Up|Overall Study||26
5090039|NCT01686438|12523487|P1|6-Month Follow Up|Overall Study||7
5090040|NCT01686438|12523485|P3|3-Month Follow Up|Overall Study||17
5090041|NCT01686438|12523486|P2|3-Month Follow Up|Overall Study||21
5090042|NCT01686438|12523487|P1|3-Month Follow Up|Overall Study||7
5090043|NCT01686438|12523485|P3|2-Week Follow Up|Overall Study||27
5090044|NCT01686438|12523486|P2|2-Week Follow Up|Overall Study||31
5090045|NCT01686438|12523487|P1|2-Week Follow Up|Overall Study||12
5090046|NCT01686438|12523485|P3|STARTED|Overall Study||37
5090047|NCT01686438|12523486|P2|STARTED|Overall Study||35
5090048|NCT01686438|12523487|P1|STARTED|Overall Study||15
5090049|NCT01686373|12523535|P2|NOT COMPLETED|Overall Study||2
5090050|NCT01686373|12523536|P1|NOT COMPLETED|Overall Study||3
5090051|NCT01686373|12523535|P2|COMPLETED|Overall Study||38
5090052|NCT01686373|12523536|P1|COMPLETED|Overall Study||31
5090053|NCT01686373|12523535|P2|Received 15 Treatment Sessions|Overall Study||39
5090054|NCT01686373|12523536|P1|Received 15 Treatment Sessions|Overall Study||33
5090055|NCT01686373|12523535|P2|STARTED|Overall Study||40
5090056|NCT01686373|12523536|P1|STARTED|Overall Study||34
5090057|NCT01686165|12523542|P1|NOT COMPLETED|Overall Study||0
5090058|NCT01686165|12523542|P1|COMPLETED|Overall Study||5
5090059|NCT01686165|12523542|P1|STARTED|Overall Study||5
5090060|NCT01685996|12523551|P2|NOT COMPLETED|Overall Study||13
5090061|NCT01685996|12523552|P1|NOT COMPLETED|Overall Study||16
5090062|NCT01685996|12523551|P2|COMPLETED|Overall Study||27
5090063|NCT01685996|12523552|P1|COMPLETED|Overall Study||18
5090064|NCT01685996|12523551|P2|STARTED|Overall Study||40
5090065|NCT01685996|12523552|P1|STARTED|Overall Study||34
5090066|NCT01685983|12523560|P1|NOT COMPLETED|Overall Study||82
5090067|NCT01685983|12523560|P1|COMPLETED|Overall Study||0
5090068|NCT01685983|12523560|P1|STARTED|Overall Study||82
5090069|NCT01685840|12523572|P2|NOT COMPLETED|Overall Study||332
5090070|NCT01685840|12523573|P1|NOT COMPLETED|Overall Study||329
5090071|NCT01685840|12523572|P2|COMPLETED|Overall Study||114
5090072|NCT01685840|12523573|P1|COMPLETED|Overall Study||119
5090073|NCT01685840|12523572|P2|STARTED|Overall Study||446
5090074|NCT01685840|12523573|P1|STARTED|Overall Study||448
5090075|NCT01685801|12523617|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
5090076|NCT01685801|12523618|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
5090077|NCT01685801|12523619|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
5090078|NCT01685801|12523620|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
5090079|NCT01685801|12523617|P4|COMPLETED|Open-label Period (8 Weeks)||4
5090080|NCT01685801|12523618|P3|COMPLETED|Open-label Period (8 Weeks)||7
5090081|NCT01685801|12523619|P2|COMPLETED|Open-label Period (8 Weeks)||5
5090082|NCT01685801|12523620|P1|COMPLETED|Open-label Period (8 Weeks)||5
5090083|NCT01685801|12523617|P4|STARTED|Open-label Period (8 Weeks)||4
5090084|NCT01685801|12523618|P3|STARTED|Open-label Period (8 Weeks)||7
5090085|NCT01685801|12523619|P2|STARTED|Open-label Period (8 Weeks)||5
5090086|NCT01685801|12523620|P1|STARTED|Open-label Period (8 Weeks)||5
5090087|NCT01685801|12523617|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
5090088|NCT01685801|12523618|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
5090089|NCT01685801|12523619|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
5090090|NCT01685801|12523620|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
5090091|NCT01685801|12523617|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
5090092|NCT01685801|12523618|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
5090093|NCT01685801|12523619|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
5090094|NCT01685801|12523620|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
5090095|NCT01685801|12523617|P4|STARTED|Washout Period 2 (4 Weeks)||4
5090096|NCT01685801|12523618|P3|STARTED|Washout Period 2 (4 Weeks)||7
5090097|NCT01685801|12523619|P2|STARTED|Washout Period 2 (4 Weeks)||5
5090098|NCT01685801|12523620|P1|STARTED|Washout Period 2 (4 Weeks)||5
5090099|NCT01685801|12523617|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
5090100|NCT01685801|12523618|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
5090101|NCT01685801|12523619|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
5090102|NCT01685801|12523620|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
5090103|NCT01685801|12523617|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
5090104|NCT01685801|12523618|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
5090105|NCT01685801|12523619|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
5090106|NCT01685801|12523620|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
5090107|NCT01685801|12523617|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
5090108|NCT01685801|12523618|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
5090109|NCT01685801|12523619|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
5090110|NCT01685801|12523620|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
5090111|NCT01685801|12523617|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
5090112|NCT01685801|12523618|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
5090113|NCT01685801|12523619|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
5090114|NCT01685801|12523620|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
5090115|NCT01685801|12523617|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
5090116|NCT01685801|12523618|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
5090117|NCT01685801|12523619|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
5090118|NCT01685801|12523620|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
5090119|NCT01685801|12523617|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
5090120|NCT01685801|12523618|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
5090121|NCT01685801|12523619|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
5090122|NCT01685801|12523620|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
5090123|NCT01685801|12523617|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
5090124|NCT01685801|12523618|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
5090125|NCT01685801|12523619|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
5090126|NCT01685801|12523620|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
5090127|NCT01685801|12523617|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
5090128|NCT01685801|12523618|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
5090129|NCT01685801|12523619|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
5090130|NCT01685801|12523620|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
5090131|NCT01685801|12523617|P4|STARTED|Washout Period 1 (4 Weeks)||5
5090132|NCT01685801|12523618|P3|STARTED|Washout Period 1 (4 Weeks)||7
5090133|NCT01685801|12523619|P2|STARTED|Washout Period 1 (4 Weeks)||6
5090134|NCT01685801|12523620|P1|STARTED|Washout Period 1 (4 Weeks)||5
5090135|NCT01685801|12523617|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
5090136|NCT01685801|12523618|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
5090137|NCT01685801|12523619|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
5090138|NCT01685801|12523620|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
5090139|NCT01685801|12523617|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
5090140|NCT01685801|12523618|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
5090141|NCT01685801|12523619|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
5090142|NCT01685801|12523620|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
5090143|NCT01685801|12523617|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
5090144|NCT01685801|12523618|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
5090145|NCT01685801|12523619|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
5090146|NCT01685801|12523620|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
5090147|NCT01685801|12523617|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
5090148|NCT01685801|12523618|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
5090149|NCT01685801|12523619|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
5090150|NCT01685801|12523620|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
5090151|NCT01685801|12523617|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
5090152|NCT01685801|12523618|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
5090153|NCT01685801|12523619|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
5090154|NCT01685801|12523620|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
5090155|NCT01685801|12523617|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
5090156|NCT01685801|12523618|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
5090157|NCT01685801|12523619|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
5090158|NCT01685801|12523620|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
5090159|NCT01685697|12523642|P2|NOT COMPLETED|Overall Study||3
5090160|NCT01685697|12523643|P1|NOT COMPLETED|Overall Study||3
5090161|NCT01685697|12523642|P2|COMPLETED|Overall Study||28
5090162|NCT01685697|12523643|P1|COMPLETED|Overall Study||28
5090163|NCT01685697|12523642|P2|STARTED|Overall Study||31
5090164|NCT01685697|12523643|P1|STARTED|Overall Study||31
5090165|NCT01685684|12523651|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
5090166|NCT01685684|12523652|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
5090167|NCT01685684|12523653|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
5090168|NCT01685684|12523651|P3|COMPLETED|Double-blind Maintenance Phase||100
5090169|NCT01685684|12523652|P2|COMPLETED|Double-blind Maintenance Phase||122
5090170|NCT01685684|12523653|P1|COMPLETED|Double-blind Maintenance Phase||0
5090171|NCT01685684|12523651|P3|STARTED|Double-blind Maintenance Phase||196
5090172|NCT01685684|12523652|P2|STARTED|Double-blind Maintenance Phase||193
5090173|NCT01685684|12523653|P1|STARTED|Double-blind Maintenance Phase||0
5090174|NCT01685684|12523651|P3|NOT COMPLETED|Titration Phase||0
5090175|NCT01685684|12523652|P2|NOT COMPLETED|Titration Phase||0
5090176|NCT01685684|12523653|P1|NOT COMPLETED|Titration Phase||351
5090177|NCT01685684|12523651|P3|COMPLETED|Titration Phase||0
5090178|NCT01685684|12523652|P2|COMPLETED|Titration Phase||0
5090179|NCT01685684|12523653|P1|COMPLETED|Titration Phase||389
5090180|NCT01685684|12523651|P3|STARTED|Titration Phase||0
5090181|NCT01685684|12523652|P2|STARTED|Titration Phase||0
5090182|NCT01685684|12523653|P1|STARTED|Titration Phase||740
5090183|NCT01685606|12523677|P1|NOT COMPLETED|Overall Study||1
5090184|NCT01685606|12523677|P1|COMPLETED|Overall Study||5
5090185|NCT01685606|12523677|P1|STARTED|Overall Study||6
5090186|NCT01685567|12523682|P1|NOT COMPLETED|Overall Study||0
5090187|NCT01685567|12523682|P1|COMPLETED|Overall Study||219
5090188|NCT01685567|12523682|P1|STARTED|Overall Study||219
5090189|NCT01685463|12523692|P2|NOT COMPLETED|Overall Study||0
5090190|NCT01685463|12523693|P1|NOT COMPLETED|Overall Study||0
5090191|NCT01685463|12523692|P2|COMPLETED|Overall Study||8
5090192|NCT01685463|12523693|P1|COMPLETED|Overall Study||10
5090193|NCT01685463|12523692|P2|STARTED|Overall Study||8
5090194|NCT01685463|12523693|P1|STARTED|Overall Study||10
5090195|NCT01685437|12523705|P1|NOT COMPLETED|Overall Study||31
5090196|NCT01685437|12523705|P1|COMPLETED|Overall Study||158
5090197|NCT01685437|12523705|P1|STARTED|Overall Study||189
5090198|NCT01685372|12523719|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
5090199|NCT01685372|12523720|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
5090200|NCT01685372|12523719|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
5090201|NCT01685372|12523720|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
5090202|NCT01685372|12523719|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
5090203|NCT01685372|12523720|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
5090204|NCT01685372|12523719|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
5090205|NCT01685372|12523720|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
5090206|NCT01685372|12523719|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
5090207|NCT01685372|12523720|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
5090208|NCT01685372|12523719|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
5090209|NCT01685372|12523720|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
5090210|NCT01685372|12523719|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
5090211|NCT01685372|12523720|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
5090212|NCT01685372|12523719|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
5090213|NCT01685372|12523720|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
5090214|NCT01685372|12523719|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
5090215|NCT01685372|12523720|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
5090216|NCT01685320|12523742|P2|NOT COMPLETED|Overall Study||0
5090217|NCT01685320|12523743|P1|NOT COMPLETED|Overall Study||0
5090218|NCT01685320|12523742|P2|COMPLETED|Overall Study||15
5090219|NCT01685320|12523743|P1|COMPLETED|Overall Study||15
5090220|NCT01685320|12523742|P2|STARTED|Overall Study||15
5090221|NCT01685320|12523743|P1|STARTED|Overall Study||15
5090222|NCT01685242|12523753|P2|NOT COMPLETED|Overall Study||3
5090223|NCT01685242|12523754|P1|NOT COMPLETED|Overall Study||1
5090224|NCT01685242|12523753|P2|COMPLETED|Overall Study||47
5090225|NCT01685242|12523754|P1|COMPLETED|Overall Study||49
5090226|NCT01685242|12523753|P2|STARTED|Overall Study||50
5090227|NCT01685242|12523754|P1|STARTED|Overall Study||50
5090228|NCT01685229|12523810|P2|NOT COMPLETED|Overall Study||16
5090229|NCT01685229|12523811|P1|NOT COMPLETED|Overall Study||26
5090230|NCT01685229|12523810|P2|COMPLETED|Overall Study||36
5090231|NCT01685229|12523811|P1|COMPLETED|Overall Study||120
5090232|NCT01685229|12523810|P2|STARTED|Overall Study||52
5090233|NCT01685229|12523811|P1|STARTED|Overall Study||146
5090234|NCT01685216|12523837|P1|NOT COMPLETED|Overall Study||1
5090235|NCT01685216|12523837|P1|COMPLETED|Overall Study||6
5090236|NCT01685216|12523837|P1|STARTED|Overall Study||7
5090237|NCT01685203|12523854|P7|NOT COMPLETED|Overall Study||0
5090238|NCT01685203|12523855|P6|NOT COMPLETED|Overall Study||3
5090239|NCT01685203|12523856|P5|NOT COMPLETED|Overall Study||0
5090240|NCT01685203|12523857|P4|NOT COMPLETED|Overall Study||1
5090241|NCT01685203|12523858|P3|NOT COMPLETED|Overall Study||0
5090242|NCT01685203|12523859|P2|NOT COMPLETED|Overall Study||3
5090243|NCT01685203|12523860|P1|NOT COMPLETED|Overall Study||4
5090244|NCT01685203|12523854|P7|COMPLETED|Overall Study||52
5090245|NCT01685203|12523855|P6|COMPLETED|Overall Study||44
5090246|NCT01685203|12523856|P5|COMPLETED|Overall Study||49
5090247|NCT01685203|12523857|P4|COMPLETED|Overall Study||41
5090248|NCT01685203|12523858|P3|COMPLETED|Overall Study||40
5090249|NCT01685203|12523859|P2|COMPLETED|Overall Study||39
5090250|NCT01685203|12523860|P1|COMPLETED|Overall Study||40
5090251|NCT01685203|12523854|P7|Completed Study Drug|Overall Study||52
5090252|NCT01685203|12523855|P6|Completed Study Drug|Overall Study||43
5090253|NCT01685203|12523856|P5|Completed Study Drug|Overall Study||49
5090254|NCT01685203|12523857|P4|Completed Study Drug|Overall Study||42
5090255|NCT01685203|12523858|P3|Completed Study Drug|Overall Study||39
5090256|NCT01685203|12523859|P2|Completed Study Drug|Overall Study||40
5090257|NCT01685203|12523860|P1|Completed Study Drug|Overall Study||42
5090258|NCT01685203|12523854|P7|STARTED|Overall Study||52
5090259|NCT01685203|12523855|P6|STARTED|Overall Study||47
5090260|NCT01685203|12523856|P5|STARTED|Overall Study||49
5090261|NCT01685203|12523857|P4|STARTED|Overall Study||42
5090262|NCT01685203|12523858|P3|STARTED|Overall Study||40
5090263|NCT01685203|12523859|P2|STARTED|Overall Study||42
5090264|NCT01685203|12523860|P1|STARTED|Overall Study||44
5090265|NCT01685138|12523904|P1|NOT COMPLETED|Overall Study||92
5090266|NCT01685138|12523904|P1|COMPLETED|Overall Study||32
5090267|NCT01685138|12523904|P1|Discontinued From Study|Overall Study||51
5090268|NCT01685138|12523904|P1|Entered Survival Follow-up|Overall Study||63
5090269|NCT01685138|12523904|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
5090270|NCT01685138|12523904|P1|Discontinued From Treatment Phase|Overall Study||124
5090271|NCT01685138|12523904|P1|STARTED|Overall Study||124
5090272|NCT01685073|12523920|P2|NOT COMPLETED|Overall Study||32
5090273|NCT01685073|12523921|P1|NOT COMPLETED|Overall Study||30
5090274|NCT01685073|12523920|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
5090275|NCT01685073|12523921|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
5090276|NCT01685073|12523920|P2|STARTED|Overall Study|Randomized|65
5090277|NCT01685073|12523921|P1|STARTED|Overall Study|Randomized|62
5090278|NCT01685060|12523929|P1|NOT COMPLETED|Overall Study||140
5090279|NCT01685060|12523929|P1|COMPLETED|Overall Study||0
5090280|NCT01685060|12523929|P1|Discontinued From Study|Overall Study||35
5090281|NCT01685060|12523929|P1|Entered Survival Follow up|Overall Study||98
5090282|NCT01685060|12523929|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
5090283|NCT01685060|12523929|P1|STARTED|Overall Study||140
5090284|NCT01685047|12523944|P1|NOT COMPLETED|Overall Study||85
5090285|NCT01685047|12523944|P1|COMPLETED|Overall Study||396
5090286|NCT01685047|12523944|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
5090287|NCT01685021|12523948|P1|NOT COMPLETED|Overall Study||16
5090288|NCT01685021|12523948|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
5090289|NCT01685021|12523948|P1|STARTED|Overall Study||22
5090290|NCT01684943|12523960|P3|NOT COMPLETED|Overall Study||1
5090291|NCT01684943|12523961|P2|NOT COMPLETED|Overall Study||1
5090292|NCT01684943|12523962|P1|NOT COMPLETED|Overall Study||9
5090293|NCT01684943|12523960|P3|COMPLETED|Overall Study||0
5090294|NCT01684943|12523961|P2|COMPLETED|Overall Study||2
5090295|NCT01684943|12523962|P1|COMPLETED|Overall Study||20
5090296|NCT01684943|12523960|P3|STARTED|Overall Study||1
5090297|NCT01684943|12523961|P2|STARTED|Overall Study||3
5090298|NCT01684943|12523962|P1|STARTED|Overall Study||29
5090299|NCT01684930|12523981|P2|NOT COMPLETED|Overall Study||1
5090300|NCT01684930|12523982|P1|NOT COMPLETED|Overall Study||3
5090301|NCT01684930|12523981|P2|COMPLETED|Overall Study||13
5090302|NCT01684930|12523982|P1|COMPLETED|Overall Study||9
5090303|NCT01684930|12523981|P2|STARTED|Overall Study||14
5090304|NCT01684930|12523982|P1|STARTED|Overall Study||12
5090305|NCT01684917|12524002|P4|NOT COMPLETED|Overall Study||0
5090306|NCT01684917|12524003|P3|NOT COMPLETED|Overall Study||0
5090307|NCT01684917|12524004|P2|NOT COMPLETED|Overall Study||0
5090308|NCT01684917|12524005|P1|NOT COMPLETED|Overall Study||0
5090309|NCT01684917|12524002|P4|COMPLETED|Overall Study||5
5090310|NCT01684917|12524003|P3|COMPLETED|Overall Study||13
5090311|NCT01684917|12524004|P2|COMPLETED|Overall Study||7
5090312|NCT01684917|12524005|P1|COMPLETED|Overall Study||11
5090313|NCT01684917|12524002|P4|STARTED|Overall Study||5
5090314|NCT01684917|12524003|P3|STARTED|Overall Study||13
5090315|NCT01684917|12524004|P2|STARTED|Overall Study||7
5090316|NCT01684917|12524005|P1|STARTED|Overall Study||11
5090317|NCT01684878|12524039|P4|NOT COMPLETED|Part 2: Randomized Phase||78
5090318|NCT01684878|12524040|P3|NOT COMPLETED|Part 2: Randomized Phase||78
5090319|NCT01684878|12524041|P2|NOT COMPLETED|Part 2: Randomized Phase||0
5090320|NCT01684878|12524042|P1|NOT COMPLETED|Part 2: Randomized Phase||0
5090321|NCT01684878|12524039|P4|COMPLETED|Part 2: Randomized Phase||0
5090322|NCT01684878|12524040|P3|COMPLETED|Part 2: Randomized Phase||0
5090323|NCT01684878|12524041|P2|COMPLETED|Part 2: Randomized Phase||0
5090324|NCT01684878|12524042|P1|COMPLETED|Part 2: Randomized Phase||0
5090325|NCT01684878|12524039|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
5090326|NCT01684878|12524040|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
5090327|NCT01684878|12524041|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
5090328|NCT01684878|12524042|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
5090329|NCT01684878|12524039|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
5090330|NCT01684878|12524040|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
5090331|NCT01684878|12524041|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
5090332|NCT01684878|12524042|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
5090333|NCT01684878|12524039|P4|STARTED|Part 2: Randomized Phase||78
5090334|NCT01684878|12524040|P3|STARTED|Part 2: Randomized Phase||78
5090335|NCT01684878|12524041|P2|STARTED|Part 2: Randomized Phase||0
5090336|NCT01684878|12524042|P1|STARTED|Part 2: Randomized Phase||0
5090337|NCT01684878|12524039|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
5090338|NCT01684878|12524040|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
5090339|NCT01684878|12524041|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
5090340|NCT01684878|12524042|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
5090341|NCT01684878|12524039|P4|COMPLETED|Part 1: Safety Run in Phase||0
5090342|NCT01684878|12524040|P3|COMPLETED|Part 1: Safety Run in Phase||0
5090343|NCT01684878|12524041|P2|COMPLETED|Part 1: Safety Run in Phase||5
5090344|NCT01684878|12524042|P1|COMPLETED|Part 1: Safety Run in Phase||6
5090345|NCT01684878|12524039|P4|STARTED|Part 1: Safety Run in Phase||0
5090346|NCT01684878|12524040|P3|STARTED|Part 1: Safety Run in Phase||0
5090347|NCT01684878|12524041|P2|STARTED|Part 1: Safety Run in Phase||28
5090348|NCT01684878|12524042|P1|STARTED|Part 1: Safety Run in Phase||22
5090349|NCT01684839|12524066|P1|NOT COMPLETED|Overall Study||0
5090350|NCT01684839|12524066|P1|COMPLETED|Overall Study||9
5090351|NCT01684839|12524066|P1|STARTED|Overall Study||9
5090352|NCT01684826|12524070|P1|NOT COMPLETED|Overall Study||10
5090353|NCT01684826|12524070|P1|COMPLETED|Overall Study||39
5090354|NCT01684826|12524070|P1|Collected Dose and Image Information|Overall Study||39
5090355|NCT01684826|12524070|P1|STARTED|Overall Study||49
5090356|NCT01684748|12524078|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
5090357|NCT01684748|12524079|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
5090358|NCT01684748|12524078|P2|COMPLETED|Second Intervention - 8 Weeks||8
5090359|NCT01684748|12524079|P1|COMPLETED|Second Intervention - 8 Weeks||8
5090360|NCT01684748|12524078|P2|STARTED|Second Intervention - 8 Weeks||8
5090361|NCT01684748|12524079|P1|STARTED|Second Intervention - 8 Weeks||8
5090362|NCT01684748|12524078|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
5090363|NCT01684748|12524079|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
5090364|NCT01684748|12524078|P2|COMPLETED|First Intervention - 8 Weeks||8
5090365|NCT01684748|12524079|P1|COMPLETED|First Intervention - 8 Weeks||8
5090366|NCT01684748|12524078|P2|STARTED|First Intervention - 8 Weeks||10
5090367|NCT01684748|12524079|P1|STARTED|First Intervention - 8 Weeks||10
5090368|NCT01684722|12524090|P4|NOT COMPLETED|Overall Study||110
5090369|NCT01684722|12524091|P3|NOT COMPLETED|Overall Study||94
5090370|NCT01684722|12524092|P2|NOT COMPLETED|Overall Study||77
5090371|NCT01684722|12524093|P1|NOT COMPLETED|Overall Study||97
5090372|NCT01684722|12524090|P4|COMPLETED|Overall Study||260
5090373|NCT01684722|12524091|P3|COMPLETED|Overall Study||226
5090374|NCT01684722|12524092|P2|COMPLETED|Overall Study||212
5090375|NCT01684722|12524093|P1|COMPLETED|Overall Study||236
5090376|NCT01684722|12524090|P4|STARTED|Overall Study||370
5090377|NCT01684722|12524091|P3|STARTED|Overall Study||320
5090378|NCT01684722|12524092|P2|STARTED|Overall Study||289
5090379|NCT01684722|12524093|P1|STARTED|Overall Study||333
5090380|NCT01684592|12524109|P2|NOT COMPLETED|Overall Study||24
5090381|NCT01684592|12524110|P1|NOT COMPLETED|Overall Study||26
5090382|NCT01684592|12524109|P2|COMPLETED|Overall Study||40
5090383|NCT01684592|12524110|P1|COMPLETED|Overall Study||38
5090384|NCT01684592|12524109|P2|STARTED|Overall Study||64
5090385|NCT01684592|12524110|P1|STARTED|Overall Study||64
5090386|NCT01684566|12524130|P2|NOT COMPLETED|Overall Study||7
5090387|NCT01684566|12524131|P1|NOT COMPLETED|Overall Study||16
5090388|NCT01684566|12524130|P2|COMPLETED|Overall Study||49
5090389|NCT01684566|12524131|P1|COMPLETED|Overall Study||44
5090390|NCT01684566|12524130|P2|Treated (ITT)|Overall Study||52
5090391|NCT01684566|12524131|P1|Treated (ITT)|Overall Study||57
5090392|NCT01684566|12524130|P2|STARTED|Overall Study||56
5090393|NCT01684566|12524131|P1|STARTED|Overall Study||60
5090394|NCT01684436|12524153|P1|NOT COMPLETED|Overall Study||1
5090395|NCT01684436|12524153|P1|COMPLETED|Overall Study||29
5090396|NCT01684436|12524153|P1|STARTED|Overall Study||30
5090397|NCT01684423|12524167|P5|NOT COMPLETED|Overall Study||0
5090398|NCT01684423|12524168|P4|NOT COMPLETED|Overall Study||0
5090399|NCT01684423|12524169|P3|NOT COMPLETED|Overall Study||1
5090400|NCT01684423|12524170|P2|NOT COMPLETED|Overall Study||0
5090401|NCT01684423|12524171|P1|NOT COMPLETED|Overall Study||0
5090402|NCT01684423|12524167|P5|COMPLETED|Overall Study||7
5090403|NCT01684423|12524168|P4|COMPLETED|Overall Study||19
5090404|NCT01684423|12524169|P3|COMPLETED|Overall Study||12
5090405|NCT01684423|12524170|P2|COMPLETED|Overall Study||13
5090406|NCT01684423|12524171|P1|COMPLETED|Overall Study||11
5090407|NCT01684423|12524167|P5|STARTED|Overall Study||7
5090408|NCT01684423|12524168|P4|STARTED|Overall Study||19
5090409|NCT01684423|12524169|P3|STARTED|Overall Study||13
5090410|NCT01684423|12524170|P2|STARTED|Overall Study||13
5090411|NCT01684423|12524171|P1|STARTED|Overall Study||11
5090412|NCT01684410|12524208|P3|NOT COMPLETED|Overall Study||0
5090413|NCT01684410|12524209|P2|NOT COMPLETED|Overall Study||0
5090414|NCT01684410|12524210|P1|NOT COMPLETED|Overall Study||0
5090415|NCT01684410|12524208|P3|COMPLETED|Overall Study||10
5090416|NCT01684410|12524209|P2|COMPLETED|Overall Study||10
5090417|NCT01684410|12524210|P1|COMPLETED|Overall Study||10
5090418|NCT01684410|12524208|P3|STARTED|Overall Study||10
5090419|NCT01684410|12524209|P2|STARTED|Overall Study||10
5090420|NCT01684410|12524210|P1|STARTED|Overall Study||10
5090421|NCT01684215|12524228|P4|NOT COMPLETED|Phase 2||43
5090422|NCT01684215|12524229|P3|NOT COMPLETED|Phase 2||0
5090423|NCT01684215|12524230|P2|NOT COMPLETED|Phase 2||0
5090424|NCT01684215|12524231|P1|NOT COMPLETED|Phase 2||0
5090425|NCT01684215|12524228|P4|COMPLETED|Phase 2||0
5090426|NCT01684215|12524229|P3|COMPLETED|Phase 2||0
5090427|NCT01684215|12524230|P2|COMPLETED|Phase 2||0
5090428|NCT01684215|12524231|P1|COMPLETED|Phase 2||0
5090429|NCT01684215|12524228|P4|Treated|Phase 2||42
5090430|NCT01684215|12524229|P3|Treated|Phase 2||0
5090431|NCT01684215|12524230|P2|Treated|Phase 2||0
5090432|NCT01684215|12524231|P1|Treated|Phase 2||0
5090433|NCT01684215|12524228|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
5090434|NCT01684215|12524229|P3|STARTED|Phase 2||0
5090435|NCT01684215|12524230|P2|STARTED|Phase 2||0
5090436|NCT01684215|12524231|P1|STARTED|Phase 2||0
5090437|NCT01684215|12524228|P4|NOT COMPLETED|Phase 1, Part 2||0
5090438|NCT01684215|12524229|P3|NOT COMPLETED|Phase 1, Part 2||6
5090439|NCT01684215|12524230|P2|NOT COMPLETED|Phase 1, Part 2||0
5090440|NCT01684215|12524231|P1|NOT COMPLETED|Phase 1, Part 2||0
5090441|NCT01684215|12524228|P4|COMPLETED|Phase 1, Part 2||0
5090442|NCT01684215|12524229|P3|COMPLETED|Phase 1, Part 2||0
5090443|NCT01684215|12524230|P2|COMPLETED|Phase 1, Part 2||0
5090444|NCT01684215|12524231|P1|COMPLETED|Phase 1, Part 2||0
5090445|NCT01684215|12524228|P4|STARTED|Phase 1, Part 2||0
5090446|NCT01684215|12524229|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
5090447|NCT01684215|12524230|P2|STARTED|Phase 1, Part 2||0
5090448|NCT01684215|12524231|P1|STARTED|Phase 1, Part 2||0
5090449|NCT01684215|12524228|P4|NOT COMPLETED|Phase 1, Part 1||0
5090450|NCT01684215|12524229|P3|NOT COMPLETED|Phase 1, Part 1||0
5090451|NCT01684215|12524230|P2|NOT COMPLETED|Phase 1, Part 1||6
5090452|NCT01684215|12524231|P1|NOT COMPLETED|Phase 1, Part 1||6
5090453|NCT01684215|12524228|P4|COMPLETED|Phase 1, Part 1||0
5090454|NCT01684215|12524229|P3|COMPLETED|Phase 1, Part 1||0
5090455|NCT01684215|12524230|P2|COMPLETED|Phase 1, Part 1||0
5090456|NCT01684215|12524231|P1|COMPLETED|Phase 1, Part 1||0
5090457|NCT01684215|12524228|P4|Treated|Phase 1, Part 1||0
5090458|NCT01684215|12524229|P3|Treated|Phase 1, Part 1||0
5090459|NCT01684215|12524230|P2|Treated|Phase 1, Part 1||6
5090460|NCT01684215|12524231|P1|Treated|Phase 1, Part 1||6
5090461|NCT01684215|12524228|P4|STARTED|Phase 1, Part 1||0
5090462|NCT01684215|12524229|P3|STARTED|Phase 1, Part 1||0
5090463|NCT01684215|12524230|P2|STARTED|Phase 1, Part 1||6
5090464|NCT01684215|12524231|P1|STARTED|Phase 1, Part 1||6
5090465|NCT01684046|12524305|P2|NOT COMPLETED|Period 2, Second 30 Days||0
5090466|NCT01684046|12524306|P1|NOT COMPLETED|Period 2, Second 30 Days||0
5090467|NCT01684046|12524305|P2|COMPLETED|Period 2, Second 30 Days||93
5090468|NCT01684046|12524306|P1|COMPLETED|Period 2, Second 30 Days||97
5090469|NCT01684046|12524305|P2|STARTED|Period 2, Second 30 Days||93
5090470|NCT01684046|12524306|P1|STARTED|Period 2, Second 30 Days||97
5090471|NCT01684046|12524305|P2|NOT COMPLETED|Period 1, First 30 Days||2
5090472|NCT01684046|12524306|P1|NOT COMPLETED|Period 1, First 30 Days||0
5090473|NCT01684046|12524305|P2|COMPLETED|Period 1, First 30 Days||93
5090474|NCT01684046|12524306|P1|COMPLETED|Period 1, First 30 Days||97
5090475|NCT01684046|12524305|P2|STARTED|Period 1, First 30 Days||95
5090476|NCT01684046|12524306|P1|STARTED|Period 1, First 30 Days||97
5090477|NCT01684033|12524312|P2|NOT COMPLETED|Period 2, Second 30 Days||0
5090478|NCT01684033|12524313|P1|NOT COMPLETED|Period 2, Second 30 Days||1
5090479|NCT01684033|12524312|P2|COMPLETED|Period 2, Second 30 Days||98
5090480|NCT01684033|12524313|P1|COMPLETED|Period 2, Second 30 Days||94
5090481|NCT01684033|12524312|P2|STARTED|Period 2, Second 30 Days||98
5090482|NCT01684033|12524313|P1|STARTED|Period 2, Second 30 Days||95
5090483|NCT01684033|12524312|P2|NOT COMPLETED|Period 1, First 30 Days||1
5090484|NCT01684033|12524313|P1|NOT COMPLETED|Period 1, First 30 Days||4
5090485|NCT01684033|12524312|P2|COMPLETED|Period 1, First 30 Days||98
5090486|NCT01684033|12524313|P1|COMPLETED|Period 1, First 30 Days||95
5090487|NCT01684033|12524312|P2|STARTED|Period 1, First 30 Days||99
5090488|NCT01684033|12524313|P1|STARTED|Period 1, First 30 Days||99
5090489|NCT01684007|12524323|P2|NOT COMPLETED|Overall Study||0
5090490|NCT01684007|12524324|P1|NOT COMPLETED|Overall Study||0
5090491|NCT01684007|12524323|P2|COMPLETED|Overall Study||50
5090492|NCT01684007|12524324|P1|COMPLETED|Overall Study||53
5090493|NCT01684007|12524323|P2|STARTED|Overall Study||50
5090494|NCT01684007|12524324|P1|STARTED|Overall Study||53
5090495|NCT01683994|12524337|P5|NOT COMPLETED|Overall Study||1
5090496|NCT01683994|12524338|P4|NOT COMPLETED|Overall Study||3
5090497|NCT01683994|12524339|P3|NOT COMPLETED|Overall Study||0
5090498|NCT01683994|12524340|P2|NOT COMPLETED|Overall Study||0
5090499|NCT01683994|12524341|P1|NOT COMPLETED|Overall Study||1
5090500|NCT01683994|12524337|P5|COMPLETED|Overall Study||12
5090501|NCT01683994|12524338|P4|COMPLETED|Overall Study||10
5090502|NCT01683994|12524339|P3|COMPLETED|Overall Study||7
5090503|NCT01683994|12524340|P2|COMPLETED|Overall Study||8
5090504|NCT01683994|12524341|P1|COMPLETED|Overall Study||3
5090505|NCT01683994|12524337|P5|# of Patients Who Received Treatment|Overall Study||13
5090506|NCT01683994|12524338|P4|# of Patients Who Received Treatment|Overall Study||12
5090507|NCT01683994|12524339|P3|# of Patients Who Received Treatment|Overall Study||7
5090508|NCT01683994|12524340|P2|# of Patients Who Received Treatment|Overall Study||8
5090509|NCT01683994|12524341|P1|# of Patients Who Received Treatment|Overall Study||4
5090510|NCT01683994|12524337|P5|STARTED|Overall Study||13
5090511|NCT01683994|12524338|P4|STARTED|Overall Study||13
5090512|NCT01683994|12524339|P3|STARTED|Overall Study||7
5090513|NCT01683994|12524340|P2|STARTED|Overall Study||8
5090514|NCT01683994|12524341|P1|STARTED|Overall Study||4
5090515|NCT01683864|12524370|P3|NOT COMPLETED|Overall Study||0
5090516|NCT01683864|12524371|P2|NOT COMPLETED|Overall Study||0
5090517|NCT01683864|12524372|P1|NOT COMPLETED|Overall Study||0
5090518|NCT01683864|12524370|P3|COMPLETED|Overall Study||0
5090519|NCT01683864|12524371|P2|COMPLETED|Overall Study||0
5090520|NCT01683864|12524372|P1|COMPLETED|Overall Study||0
5090521|NCT01683864|12524370|P3|STARTED|Overall Study||0
5090522|NCT01683864|12524371|P2|STARTED|Overall Study||0
5090523|NCT01683864|12524372|P1|STARTED|Overall Study||0
5090524|NCT01683838|12524382|P2|NOT COMPLETED|Overall Study||12
5090525|NCT01683838|12524383|P1|NOT COMPLETED|Overall Study||26
5090526|NCT01683838|12524382|P2|COMPLETED|Overall Study||88
5090527|NCT01683838|12524383|P1|COMPLETED|Overall Study||78
5090528|NCT01683838|12524382|P2|Efficacy Population|Overall Study||93
5090529|NCT01683838|12524383|P1|Efficacy Population|Overall Study||89
5090530|NCT01683838|12524382|P2|Safety Population|Overall Study||100
5090531|NCT01683838|12524383|P1|Safety Population|Overall Study||103
5090532|NCT01683838|12524382|P2|Intent to Treat (ITT) Population|Overall Study||100
5090533|NCT01683838|12524383|P1|Intent to Treat (ITT) Population|Overall Study||103
5090534|NCT01683838|12524382|P2|STARTED|Overall Study||100
5090535|NCT01683838|12524383|P1|STARTED|Overall Study||104
5090536|NCT01683812|12524405|P1|NOT COMPLETED|Overall Study||0
5090537|NCT01683812|12524405|P1|COMPLETED|Overall Study||23
5090538|NCT01683812|12524405|P1|STARTED|Overall Study||23
5090539|NCT01683630|12524412|P2|NOT COMPLETED|Overall Study||0
5090540|NCT01683630|12524413|P1|NOT COMPLETED|Overall Study||0
5090541|NCT01683630|12524412|P2|COMPLETED|Overall Study||445
5090542|NCT01683630|12524413|P1|COMPLETED|Overall Study||1404
5090543|NCT01683630|12524412|P2|STARTED|Overall Study||445
5090544|NCT01683630|12524413|P1|STARTED|Overall Study||1404
5090545|NCT01683604|12524423|P1|NOT COMPLETED|Overall Study||5
5090546|NCT01683604|12524423|P1|COMPLETED|Overall Study||32
5090547|NCT01683604|12524423|P1|STARTED|Overall Study||37
5090548|NCT01683565|12524588|P2|NOT COMPLETED|Overall Study||1
5090549|NCT01683565|12524589|P1|NOT COMPLETED|Overall Study||3
5090550|NCT01683565|12524588|P2|COMPLETED|Overall Study||15
5090551|NCT01683565|12524589|P1|COMPLETED|Overall Study||12
5090552|NCT01683565|12524588|P2|STARTED|Overall Study||16
5090553|NCT01683565|12524589|P1|STARTED|Overall Study||15
5090554|NCT01683526|12524603|P2|NOT COMPLETED|Overall Study||0
5090555|NCT01683526|12524604|P1|NOT COMPLETED|Overall Study||0
5090556|NCT01683526|12524603|P2|COMPLETED|Overall Study||57
5090557|NCT01683526|12524604|P1|COMPLETED|Overall Study||60
5090558|NCT01683526|12524603|P2|STARTED|Overall Study||57
5090559|NCT01683526|12524604|P1|STARTED|Overall Study||60
5090560|NCT01683409|12524623|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
5090561|NCT01683409|12524624|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
5090562|NCT01683409|12524625|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
5090563|NCT01683409|12524626|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
5090564|NCT01683409|12524627|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
5090565|NCT01683409|12524623|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
5090566|NCT01683409|12524624|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
5090567|NCT01683409|12524625|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
5090568|NCT01683409|12524626|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
5090569|NCT01683409|12524627|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
5090570|NCT01683409|12524623|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
5090571|NCT01683409|12524624|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
5090572|NCT01683409|12524625|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
5090573|NCT01683409|12524626|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
5090574|NCT01683409|12524627|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
5090575|NCT01683409|12524623|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
5090576|NCT01683409|12524624|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
5090577|NCT01683409|12524625|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
5090578|NCT01683409|12524626|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
5090579|NCT01683409|12524627|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
5090580|NCT01683409|12524623|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
5090581|NCT01683409|12524624|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
5090582|NCT01683409|12524625|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
5090583|NCT01683409|12524626|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
5090584|NCT01683409|12524627|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
5090585|NCT01683409|12524623|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
5090586|NCT01683409|12524624|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
5090587|NCT01683409|12524625|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
5090588|NCT01683409|12524626|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
5090589|NCT01683409|12524627|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
5090590|NCT01683409|12524623|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
5090591|NCT01683409|12524624|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
5090592|NCT01683409|12524625|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
5090593|NCT01683409|12524626|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
5090594|NCT01683409|12524627|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
5090595|NCT01683409|12524623|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
5090596|NCT01683409|12524624|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
5090597|NCT01683409|12524625|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
5090598|NCT01683409|12524626|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
5090599|NCT01683409|12524627|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
5090600|NCT01683409|12524623|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
5090601|NCT01683409|12524624|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
5090602|NCT01683409|12524625|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
5090603|NCT01683409|12524626|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
5090604|NCT01683409|12524627|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
5090605|NCT01683409|12524623|P5|STARTED|Treatment Period (Weeks 1-24)||25
5090606|NCT01683409|12524624|P4|STARTED|Treatment Period (Weeks 1-24)||26
5090607|NCT01683409|12524625|P3|STARTED|Treatment Period (Weeks 1-24)||27
5090608|NCT01683409|12524626|P2|STARTED|Treatment Period (Weeks 1-24)||25
5090609|NCT01683409|12524627|P1|STARTED|Treatment Period (Weeks 1-24)||27
5090610|NCT01683383|12524670|P2|NOT COMPLETED|Overall Study||0
5090611|NCT01683383|12524671|P1|NOT COMPLETED|Overall Study||1
5090612|NCT01683383|12524670|P2|COMPLETED|Overall Study||51
5090613|NCT01683383|12524671|P1|COMPLETED|Overall Study||49
5090614|NCT01683383|12524670|P2|Transported and Treated|Overall Study||51
5090615|NCT01683383|12524671|P1|Transported and Treated|Overall Study||49
5090616|NCT01683383|12524670|P2|STARTED|Overall Study||51
5090617|NCT01683383|12524671|P1|STARTED|Overall Study||50
5090618|NCT01683331|12524687|P2|NOT COMPLETED|Overall Study||0
5090619|NCT01683331|12524688|P1|NOT COMPLETED|Overall Study||0
5090620|NCT01683331|12524687|P2|COMPLETED|Overall Study||18
5090621|NCT01683331|12524688|P1|COMPLETED|Overall Study||18
5090622|NCT01683331|12524687|P2|24 Months|Overall Study||18
5090623|NCT01683331|12524688|P1|24 Months|Overall Study||18
5090624|NCT01683331|12524687|P2|12 Months|Overall Study||18
5090625|NCT01683331|12524688|P1|12 Months|Overall Study||18
5090626|NCT01683331|12524687|P2|Began Dosage|Overall Study||18
5090627|NCT01683331|12524688|P1|Began Dosage|Overall Study||18
5090628|NCT01683331|12524687|P2|STARTED|Overall Study||18
5090629|NCT01683331|12524688|P1|STARTED|Overall Study||18
5090630|NCT01683266|12524698|P2|NOT COMPLETED|Overall Study||50
5090631|NCT01683266|12524699|P1|NOT COMPLETED|Overall Study||55
5090632|NCT01683266|12524698|P2|COMPLETED|Overall Study||225
5090633|NCT01683266|12524699|P1|COMPLETED|Overall Study||219
5090634|NCT01683266|12524698|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
5090635|NCT01683266|12524699|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
5090636|NCT01683266|12524698|P2|STARTED|Overall Study||275
5090637|NCT01683266|12524699|P1|STARTED|Overall Study||274
5090638|NCT01683058|12524727|P1|NOT COMPLETED|Overall Study||29
5090639|NCT01683058|12524727|P1|COMPLETED|Overall Study||45
5090640|NCT01683058|12524727|P1|STARTED|Overall Study||74
5090641|NCT01683019|12524758|P3|NOT COMPLETED|Overall Study||4
5090642|NCT01683019|12524759|P2|NOT COMPLETED|Overall Study||1
5090643|NCT01683019|12524760|P1|NOT COMPLETED|Overall Study||2
5090644|NCT01683019|12524758|P3|COMPLETED|Overall Study||15
5090645|NCT01683019|12524759|P2|COMPLETED|Overall Study||14
5090646|NCT01683019|12524760|P1|COMPLETED|Overall Study||16
5090647|NCT01683019|12524758|P3|STARTED|Overall Study||19
5090648|NCT01683019|12524759|P2|STARTED|Overall Study||15
5090649|NCT01683019|12524760|P1|STARTED|Overall Study||18
5090650|NCT01682954|12524770|P2|NOT COMPLETED|Overall Study||5
5090651|NCT01682954|12524771|P1|NOT COMPLETED|Overall Study||5
5090652|NCT01682954|12524770|P2|COMPLETED|Overall Study||33
5090653|NCT01682954|12524771|P1|COMPLETED|Overall Study||35
5090654|NCT01682954|12524770|P2|STARTED|Overall Study||38
5090655|NCT01682954|12524771|P1|STARTED|Overall Study||40
5090656|NCT01682928|12524781|P2|NOT COMPLETED|Overall Study||0
5090657|NCT01682928|12524782|P1|NOT COMPLETED|Overall Study||0
5090658|NCT01682928|12524781|P2|COMPLETED|Overall Study||2
5090659|NCT01682928|12524782|P1|COMPLETED|Overall Study||2
5090660|NCT01682928|12524781|P2|STARTED|Overall Study|2 subjects in this Arm|2
5090661|NCT01682928|12524782|P1|STARTED|Overall Study|2 subjects in this Arm|2
5090662|NCT01682876|12524794|P4|NOT COMPLETED|Overall Study||19
5090663|NCT01682876|12524795|P3|NOT COMPLETED|Overall Study||11
5090664|NCT01682876|12524796|P2|NOT COMPLETED|Overall Study||20
5090665|NCT01682876|12524797|P1|NOT COMPLETED|Overall Study||21
5090666|NCT01682876|12524794|P4|COMPLETED|Overall Study||157
5090667|NCT01682876|12524795|P3|COMPLETED|Overall Study||169
5090668|NCT01682876|12524796|P2|COMPLETED|Overall Study||163
5090669|NCT01682876|12524797|P1|COMPLETED|Overall Study||155
5090670|NCT01682876|12524794|P4|STARTED|Overall Study||176
5090671|NCT01682876|12524795|P3|STARTED|Overall Study||180
5090672|NCT01682876|12524796|P2|STARTED|Overall Study||183
5090673|NCT01682876|12524797|P1|STARTED|Overall Study||176
5090674|NCT01682863|12524843|P3|NOT COMPLETED|Overall Study||24
5090675|NCT01682863|12524844|P2|NOT COMPLETED|Overall Study||17
5090676|NCT01682863|12524845|P1|NOT COMPLETED|Overall Study||27
5090677|NCT01682863|12524843|P3|COMPLETED|Overall Study||183
5090678|NCT01682863|12524844|P2|COMPLETED|Overall Study||187
5090679|NCT01682863|12524845|P1|COMPLETED|Overall Study||177
5090680|NCT01682863|12524843|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
5090681|NCT01682863|12524844|P2|Randomized Set|Overall Study||204
5090682|NCT01682863|12524845|P1|Randomized Set|Overall Study||204
5090683|NCT01682863|12524843|P3|Full Analysis Set (FAS)|Overall Study||206
5090684|NCT01682863|12524844|P2|Full Analysis Set (FAS)|Overall Study||204
5090685|NCT01682863|12524845|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
5090686|NCT01682863|12524843|P3|Safety Set|Overall Study||206
5090687|NCT01682863|12524844|P2|Safety Set|Overall Study||204
5090688|NCT01682863|12524845|P1|Safety Set|Overall Study||204
5090689|NCT01682863|12524843|P3|STARTED|Overall Study||207
5090690|NCT01682863|12524844|P2|STARTED|Overall Study||204
5090691|NCT01682863|12524845|P1|STARTED|Overall Study||204
5090692|NCT01682837|12524874|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
5090693|NCT01682837|12524874|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
5090694|NCT01682837|12524874|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
5090695|NCT01682837|12524874|P1|Received KCl|Fourth Intervention (4 Weeks)||8
5090696|NCT01682837|12524874|P1|Received KCit|Fourth Intervention (4 Weeks)||9
5090697|NCT01682837|12524874|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
5090698|NCT01682837|12524874|P1|STARTED|Fourth Intervention (4 Weeks)||30
5090699|NCT01682837|12524874|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
5090700|NCT01682837|12524874|P1|COMPLETED|Third Intervention (4 Weeks)||30
5090701|NCT01682837|12524874|P1|Received Placebo|Third Intervention (4 Weeks)||7
5090702|NCT01682837|12524874|P1|Received KCl|Third Intervention (4 Weeks)||7
5090703|NCT01682837|12524874|P1|Received KCit|Third Intervention (4 Weeks)||7
5090704|NCT01682837|12524874|P1|Received KMgCit|Third Intervention (4 Weeks)||9
5090705|NCT01682837|12524874|P1|STARTED|Third Intervention (4 Weeks)||30
5090706|NCT01682837|12524874|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5090707|NCT01682837|12524874|P1|COMPLETED|Second Intervention (4 Weeks)||30
5090708|NCT01682837|12524874|P1|Received Placebo|Second Intervention (4 Weeks)||9
5090709|NCT01682837|12524874|P1|Received KCl|Second Intervention (4 Weeks)||8
5090710|NCT01682837|12524874|P1|Received KCit|Second Intervention (4 Weeks)||6
5090711|NCT01682837|12524874|P1|Received KMgCit|Second Intervention (4 Weeks)||7
5090712|NCT01682837|12524874|P1|STARTED|Second Intervention (4 Weeks)||30
5090713|NCT01682837|12524874|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5090714|NCT01682837|12524874|P1|COMPLETED|First Intervention (4 Weeks)||30
5090715|NCT01682837|12524874|P1|Received Placebo|First Intervention (4 Weeks)||7
5090716|NCT01682837|12524874|P1|Received KCl|First Intervention (4 Weeks)||7
5090717|NCT01682837|12524874|P1|Received KCit|First Intervention (4 Weeks)||8
5090718|NCT01682837|12524874|P1|Received KMgCit|First Intervention (4 Weeks)||8
5090719|NCT01682837|12524874|P1|STARTED|First Intervention (4 Weeks)||30
5090720|NCT01682837|12524874|P1|NOT COMPLETED|Baseline||5
5090721|NCT01682837|12524874|P1|COMPLETED|Baseline||30
5090722|NCT01682837|12524874|P1|STARTED|Baseline||35
5090723|NCT01682759|12524918|P2|NOT COMPLETED|Overall Study||70
5090724|NCT01682759|12524919|P1|NOT COMPLETED|Overall Study||69
5090725|NCT01682759|12524918|P2|COMPLETED|Overall Study||305
5090726|NCT01682759|12524919|P1|COMPLETED|Overall Study||307
5090727|NCT01682759|12524918|P2|Treated|Overall Study||375
5090728|NCT01682759|12524919|P1|Treated|Overall Study||375
5090729|NCT01682759|12524918|P2|STARTED|Overall Study||375
5090730|NCT01682759|12524919|P1|STARTED|Overall Study||376
5090731|NCT01682720|12524943|P4|NOT COMPLETED|Overall Study||39
5090732|NCT01682720|12524944|P3|NOT COMPLETED|Overall Study||7
5090733|NCT01682720|12524945|P2|NOT COMPLETED|Overall Study||5
5090734|NCT01682720|12524946|P1|NOT COMPLETED|Overall Study||85
5090735|NCT01682720|12524943|P4|COMPLETED|Overall Study||211
5090736|NCT01682720|12524944|P3|COMPLETED|Overall Study||5
5090737|NCT01682720|12524945|P2|COMPLETED|Overall Study||69
5090738|NCT01682720|12524946|P1|COMPLETED|Overall Study||0
5090739|NCT01682720|12524943|P4|Included in Full Analysis Set|Overall Study||250
5090740|NCT01682720|12524944|P3|Included in Full Analysis Set|Overall Study||11
5090741|NCT01682720|12524945|P2|Included in Full Analysis Set|Overall Study||73
5090742|NCT01682720|12524946|P1|Included in Full Analysis Set|Overall Study||0
5090743|NCT01682720|12524943|P4|STARTED|Overall Study||250
5090744|NCT01682720|12524944|P3|STARTED|Overall Study||12
5090745|NCT01682720|12524945|P2|STARTED|Overall Study||74
5090746|NCT01682720|12524946|P1|STARTED|Overall Study||85
5090747|NCT01682681|12524963|P1|NOT COMPLETED|Overall Study||332
5090748|NCT01682681|12524963|P1|COMPLETED|Overall Study||902
5090749|NCT01682681|12524963|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
5090750|NCT01682681|12524963|P1|STARTED|Overall Study||1234
5090751|NCT01682642|12524973|P2|NOT COMPLETED|Overall Study||1
5090752|NCT01682642|12524974|P1|NOT COMPLETED|Overall Study||0
5090753|NCT01682642|12524973|P2|COMPLETED|Overall Study||58
5090754|NCT01682642|12524974|P1|COMPLETED|Overall Study||61
5090755|NCT01682642|12524973|P2|STARTED|Overall Study||59
5090756|NCT01682642|12524974|P1|STARTED|Overall Study||61
5090757|NCT01682603|12524992|P1|NOT COMPLETED|Overall Study||3
5090758|NCT01682603|12524992|P1|COMPLETED|Overall Study||34
5090759|NCT01682603|12524992|P1|STARTED|Overall Study||37
5090760|NCT01682538|12525006|P1|NOT COMPLETED|Overall Study||0
5090761|NCT01682538|12525006|P1|COMPLETED|Overall Study||12
5090762|NCT01682538|12525006|P1|STARTED|Overall Study||12
5090763|NCT01682512|12525037|P3|NOT COMPLETED|Overall Study||18
5090764|NCT01682512|12525038|P2|NOT COMPLETED|Overall Study||71
5090765|NCT01682512|12525039|P1|NOT COMPLETED|Overall Study||72
5090766|NCT01682512|12525037|P3|COMPLETED|Overall Study||48
5090767|NCT01682512|12525038|P2|COMPLETED|Overall Study||40
5090768|NCT01682512|12525039|P1|COMPLETED|Overall Study||44
5090769|NCT01682512|12525037|P3|Randomized in Part-II|Overall Study||0
5090770|NCT01682512|12525038|P2|Randomized in Part-II|Overall Study||46
5090771|NCT01682512|12525039|P1|Randomized in Part-II|Overall Study||50
5090772|NCT01682512|12525037|P3|Randomized in Part-I|Overall Study||66
5090773|NCT01682512|12525038|P2|Randomized in Part-I|Overall Study||65
5090774|NCT01682512|12525039|P1|Randomized in Part-I|Overall Study||66
5090775|NCT01682512|12525037|P3|STARTED|Overall Study||66
5090776|NCT01682512|12525038|P2|STARTED|Overall Study||111
5090777|NCT01682512|12525039|P1|STARTED|Overall Study||116
5090778|NCT01682460|12525064|P1|NOT COMPLETED|Overall Study||4
5090779|NCT01682460|12525064|P1|COMPLETED|Overall Study||11
5090780|NCT01682460|12525064|P1|STARTED|Overall Study||15
5090781|NCT01682213|12525079|P1|NOT COMPLETED|Overall Study||2
5090782|NCT01682213|12525079|P1|COMPLETED|Overall Study||21
5090783|NCT01682213|12525079|P1|STARTED|Overall Study||23
5090784|NCT01682148|12525087|P2|NOT COMPLETED|Overall Study||3
5090785|NCT01682148|12525088|P1|NOT COMPLETED|Overall Study||4
5090786|NCT01682148|12525087|P2|COMPLETED|Overall Study||41
5090787|NCT01682148|12525088|P1|COMPLETED|Overall Study||40
5090788|NCT01682148|12525087|P2|STARTED|Overall Study||44
5090789|NCT01682148|12525088|P1|STARTED|Overall Study||44
5090790|NCT01682135|12525112|P3|NOT COMPLETED|Overall Study||0
5090791|NCT01682135|12525113|P2|NOT COMPLETED|Overall Study||0
5090792|NCT01682135|12525114|P1|NOT COMPLETED|Overall Study||0
5090793|NCT01682135|12525112|P3|COMPLETED|Overall Study||12
5090794|NCT01682135|12525113|P2|COMPLETED|Overall Study||10
5090795|NCT01682135|12525114|P1|COMPLETED|Overall Study||6
5090796|NCT01682135|12525112|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
5090797|NCT01682135|12525113|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
5090798|NCT01682135|12525114|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5090799|NCT01682135|12525112|P3|STARTED|Overall Study||12
5090800|NCT01682135|12525113|P2|STARTED|Overall Study||10
5090801|NCT01682135|12525114|P1|STARTED|Overall Study||6
5090802|NCT01682083|12525148|P2|NOT COMPLETED|Overall Study||155
5090803|NCT01682083|12525149|P1|NOT COMPLETED|Overall Study||107
5090804|NCT01682083|12525148|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
5090805|NCT01682083|12525149|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
5090806|NCT01682083|12525148|P2|STARTED|Overall Study||432
5090807|NCT01682083|12525149|P1|STARTED|Overall Study||438
5090808|NCT01682044|12525161|P1|NOT COMPLETED|Overall Study||4
5090809|NCT01682044|12525161|P1|COMPLETED|Overall Study||16
5090810|NCT01682044|12525161|P1|STARTED|Overall Study||20
5090811|NCT01682031|12525173|P2|NOT COMPLETED|Overall Study||5
5090812|NCT01682031|12525174|P1|NOT COMPLETED|Overall Study||1
5090813|NCT01682031|12525173|P2|COMPLETED|Overall Study||5
5090814|NCT01682031|12525174|P1|COMPLETED|Overall Study||7
5090815|NCT01682031|12525173|P2|STARTED|Overall Study||10
5090816|NCT01682031|12525174|P1|STARTED|Overall Study||8
5090817|NCT01681992|12525197|P3|NOT COMPLETED|Overall Study||83
5090818|NCT01681992|12525198|P2|NOT COMPLETED|Overall Study||70
5090819|NCT01681992|12525199|P1|NOT COMPLETED|Overall Study||66
5090820|NCT01681992|12525197|P3|COMPLETED|Overall Study||1443
5090821|NCT01681992|12525198|P2|COMPLETED|Overall Study||1427
5090822|NCT01681992|12525199|P1|COMPLETED|Overall Study||1427
5090823|NCT01681992|12525197|P3|STARTED|Overall Study||1526
5090824|NCT01681992|12525198|P2|STARTED|Overall Study||1497
5090825|NCT01681992|12525199|P1|STARTED|Overall Study||1493
5090826|NCT01681849|12525288|P3|NOT COMPLETED|Overall Study||39
5090827|NCT01681849|12525289|P2|NOT COMPLETED|Overall Study||7
5090828|NCT01681849|12525290|P1|NOT COMPLETED|Overall Study||8
5090829|NCT01681849|12525288|P3|COMPLETED|Overall Study||17
5090830|NCT01681849|12525289|P2|COMPLETED|Overall Study||6
5090831|NCT01681849|12525290|P1|COMPLETED|Overall Study||7
5090832|NCT01681849|12525288|P3|STARTED|Overall Study||56
5090833|NCT01681849|12525289|P2|STARTED|Overall Study||13
5090834|NCT01681849|12525290|P1|STARTED|Overall Study||15
5090835|NCT01681836|12525299|P2|NOT COMPLETED|Second Intervention||1
5090836|NCT01681836|12525300|P1|NOT COMPLETED|Second Intervention||0
5090837|NCT01681836|12525299|P2|COMPLETED|Second Intervention||4
5090838|NCT01681836|12525300|P1|COMPLETED|Second Intervention||6
5090839|NCT01681836|12525299|P2|STARTED|Second Intervention||5
5090840|NCT01681836|12525300|P1|STARTED|Second Intervention||6
5090841|NCT01681836|12525299|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
5090842|NCT01681836|12525300|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
5090843|NCT01681836|12525299|P2|COMPLETED|Washout Period of 3-7 Days||5
5090844|NCT01681836|12525300|P1|COMPLETED|Washout Period of 3-7 Days||6
5090845|NCT01681836|12525299|P2|STARTED|Washout Period of 3-7 Days||5
5090846|NCT01681836|12525300|P1|STARTED|Washout Period of 3-7 Days||6
5090847|NCT01681836|12525299|P2|NOT COMPLETED|First Intervention||0
5090848|NCT01681836|12525300|P1|NOT COMPLETED|First Intervention||0
5090849|NCT01681836|12525299|P2|COMPLETED|First Intervention||5
5090850|NCT01681836|12525300|P1|COMPLETED|First Intervention||6
5090851|NCT01681836|12525299|P2|STARTED|First Intervention||5
5090852|NCT01681836|12525300|P1|STARTED|First Intervention||6
5090853|NCT01681810|12525324|P1|NOT COMPLETED|Overall Study||0
5090854|NCT01681810|12525324|P1|COMPLETED|Overall Study||20
5090855|NCT01681810|12525324|P1|STARTED|Overall Study||20
5090856|NCT01681771|12525334|P2|NOT COMPLETED|Overall Study||2
5090857|NCT01681771|12525335|P1|NOT COMPLETED|Overall Study||4
5090858|NCT01681771|12525334|P2|COMPLETED|Overall Study||23
5090859|NCT01681771|12525335|P1|COMPLETED|Overall Study||21
5090860|NCT01681771|12525334|P2|STARTED|Overall Study||25
5090861|NCT01681771|12525335|P1|STARTED|Overall Study||25
5090862|NCT01681628|12525343|P2|NOT COMPLETED|19 Months Follow-up||43
5090863|NCT01681628|12525344|P1|NOT COMPLETED|19 Months Follow-up||62
5090864|NCT01681628|12525343|P2|COMPLETED|19 Months Follow-up||64
5090865|NCT01681628|12525344|P1|COMPLETED|19 Months Follow-up||52
5090866|NCT01681628|12525343|P2|STARTED|19 Months Follow-up||107
5090867|NCT01681628|12525344|P1|STARTED|19 Months Follow-up||114
5090868|NCT01681628|12525343|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
5090869|NCT01681628|12525344|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
5090870|NCT01681628|12525343|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
5090871|NCT01681628|12525344|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
5090872|NCT01681628|12525343|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
5090873|NCT01681628|12525344|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
5090874|NCT01681628|12525343|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
5090875|NCT01681628|12525344|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
5090876|NCT01681628|12525343|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
5090877|NCT01681628|12525344|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
5090878|NCT01681628|12525343|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
5090879|NCT01681628|12525344|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
5090880|NCT01681576|12525357|P2|NOT COMPLETED|Period 2||1
5090881|NCT01681576|12525358|P1|NOT COMPLETED|Period 2||4
5090882|NCT01681576|12525357|P2|COMPLETED|Period 2||35
5090883|NCT01681576|12525358|P1|COMPLETED|Period 2||30
5090884|NCT01681576|12525357|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
5090885|NCT01681576|12525358|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
5090886|NCT01681576|12525357|P2|NOT COMPLETED|Period 1||0
5090887|NCT01681576|12525358|P1|NOT COMPLETED|Period 1||2
5090888|NCT01681576|12525357|P2|COMPLETED|Period 1||36
5090889|NCT01681576|12525358|P1|COMPLETED|Period 1||34
5090890|NCT01681576|12525357|P2|STARTED|Period 1||36
5090891|NCT01681576|12525358|P1|STARTED|Period 1||36
5090892|NCT01681511|12525374|P2|NOT COMPLETED|Overall Study||14
5090893|NCT01681511|12525375|P1|NOT COMPLETED|Overall Study||18
5090894|NCT01681511|12525374|P2|COMPLETED|Overall Study||35
5090895|NCT01681511|12525375|P1|COMPLETED|Overall Study||28
5090896|NCT01681511|12525374|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
5090897|NCT01681511|12525375|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
5090898|NCT01681511|12525374|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
5090899|NCT01681511|12525375|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
5090900|NCT01681511|12525374|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
5090901|NCT01681511|12525375|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
5090902|NCT01681472|12525393|P4|NOT COMPLETED|Overall Study||0
5090903|NCT01681472|12525394|P3|NOT COMPLETED|Overall Study||0
5090904|NCT01681472|12525395|P2|NOT COMPLETED|Overall Study||1
5090905|NCT01681472|12525396|P1|NOT COMPLETED|Overall Study||0
5090906|NCT01681472|12525393|P4|COMPLETED|Overall Study||8
5090907|NCT01681472|12525394|P3|COMPLETED|Overall Study||8
5090908|NCT01681472|12525395|P2|COMPLETED|Overall Study||7
5090909|NCT01681472|12525396|P1|COMPLETED|Overall Study||8
5090910|NCT01681472|12525393|P4|STARTED|Overall Study||8
5090911|NCT01681472|12525394|P3|STARTED|Overall Study||8
5090912|NCT01681472|12525395|P2|STARTED|Overall Study||8
5090913|NCT01681472|12525396|P1|STARTED|Overall Study||8
5090914|NCT01681433|12525576|P2|NOT COMPLETED|Overall Study||33
5090915|NCT01681433|12525577|P1|NOT COMPLETED|Overall Study||32
5090916|NCT01681433|12525576|P2|COMPLETED|Overall Study||3
5090917|NCT01681433|12525577|P1|COMPLETED|Overall Study||4
5090918|NCT01681433|12525576|P2|STARTED|Overall Study||36
5090919|NCT01681433|12525577|P1|STARTED|Overall Study||36
5090920|NCT01681368|12525595|P1|NOT COMPLETED|Overall Study||2
5090921|NCT01681368|12525595|P1|COMPLETED|Overall Study||9
5090922|NCT01681368|12525595|P1|STARTED|Overall Study||11
5090923|NCT01681277|12525612|P5|NOT COMPLETED|Overall Study||0
5090924|NCT01681277|12525613|P4|NOT COMPLETED|Overall Study||0
5090925|NCT01681277|12525614|P3|NOT COMPLETED|Overall Study||0
5090926|NCT01681277|12525615|P2|NOT COMPLETED|Overall Study||0
5090927|NCT01681277|12525616|P1|NOT COMPLETED|Overall Study||1
5090928|NCT01681277|12525612|P5|COMPLETED|Overall Study||9
5090929|NCT01681277|12525613|P4|COMPLETED|Overall Study||9
5090930|NCT01681277|12525614|P3|COMPLETED|Overall Study||9
5090931|NCT01681277|12525615|P2|COMPLETED|Overall Study||9
5090932|NCT01681277|12525616|P1|COMPLETED|Overall Study||11
5090933|NCT01681277|12525612|P5|STARTED|Overall Study||9
5090934|NCT01681277|12525613|P4|STARTED|Overall Study||9
5090935|NCT01681277|12525614|P3|STARTED|Overall Study||9
5090936|NCT01681277|12525615|P2|STARTED|Overall Study||9
5090937|NCT01681277|12525616|P1|STARTED|Overall Study||12
5090938|NCT01681212|12525657|P1|NOT COMPLETED|Overall Study||6
5090939|NCT01681212|12525657|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
5090940|NCT01681212|12525657|P1|Received Treatment|Overall Study||15
5090941|NCT01681212|12525657|P1|STARTED|Overall Study|Enrolled|21
5090942|NCT01681186|12525671|P8|NOT COMPLETED|Fourth Intervention||1
5090943|NCT01681186|12525672|P7|NOT COMPLETED|Fourth Intervention||0
5090944|NCT01681186|12525673|P6|NOT COMPLETED|Fourth Intervention||0
5090945|NCT01681186|12525674|P5|NOT COMPLETED|Fourth Intervention||0
5090946|NCT01681186|12525675|P4|NOT COMPLETED|Fourth Intervention||0
5090947|NCT01681186|12525676|P3|NOT COMPLETED|Fourth Intervention||0
5090948|NCT01681186|12525677|P2|NOT COMPLETED|Fourth Intervention||0
5090949|NCT01681186|12525678|P1|NOT COMPLETED|Fourth Intervention||0
5090950|NCT01681186|12525671|P8|COMPLETED|Fourth Intervention||5
5090951|NCT01681186|12525672|P7|COMPLETED|Fourth Intervention||5
5090952|NCT01681186|12525673|P6|COMPLETED|Fourth Intervention||0
5090953|NCT01681186|12525674|P5|COMPLETED|Fourth Intervention||0
5090954|NCT01681186|12525675|P4|COMPLETED|Fourth Intervention||0
5090955|NCT01681186|12525676|P3|COMPLETED|Fourth Intervention||0
5090956|NCT01681186|12525677|P2|COMPLETED|Fourth Intervention||0
5090957|NCT01681186|12525678|P1|COMPLETED|Fourth Intervention||0
5090958|NCT01681186|12525671|P8|STARTED|Fourth Intervention||6
5090959|NCT01681186|12525672|P7|STARTED|Fourth Intervention||5
5090960|NCT01681186|12525673|P6|STARTED|Fourth Intervention||0
5090961|NCT01681186|12525674|P5|STARTED|Fourth Intervention||0
5090962|NCT01681186|12525675|P4|STARTED|Fourth Intervention||0
5090963|NCT01681186|12525676|P3|STARTED|Fourth Intervention||0
5090964|NCT01681186|12525677|P2|STARTED|Fourth Intervention||0
5090965|NCT01681186|12525678|P1|STARTED|Fourth Intervention||0
5090966|NCT01681186|12525671|P8|NOT COMPLETED|Washout Period From Third Intervention||0
5090967|NCT01681186|12525672|P7|NOT COMPLETED|Washout Period From Third Intervention||1
5090968|NCT01681186|12525673|P6|NOT COMPLETED|Washout Period From Third Intervention||0
5090969|NCT01681186|12525674|P5|NOT COMPLETED|Washout Period From Third Intervention||0
5090970|NCT01681186|12525675|P4|NOT COMPLETED|Washout Period From Third Intervention||0
5090971|NCT01681186|12525676|P3|NOT COMPLETED|Washout Period From Third Intervention||0
5090972|NCT01681186|12525677|P2|NOT COMPLETED|Washout Period From Third Intervention||0
5090973|NCT01681186|12525678|P1|NOT COMPLETED|Washout Period From Third Intervention||0
5090974|NCT01681186|12525671|P8|COMPLETED|Washout Period From Third Intervention||6
5090975|NCT01681186|12525672|P7|COMPLETED|Washout Period From Third Intervention||5
5090976|NCT01681186|12525673|P6|COMPLETED|Washout Period From Third Intervention||0
5090977|NCT01681186|12525674|P5|COMPLETED|Washout Period From Third Intervention||0
5090978|NCT01681186|12525675|P4|COMPLETED|Washout Period From Third Intervention||0
5090979|NCT01681186|12525676|P3|COMPLETED|Washout Period From Third Intervention||0
5090980|NCT01681186|12525677|P2|COMPLETED|Washout Period From Third Intervention||0
5090981|NCT01681186|12525678|P1|COMPLETED|Washout Period From Third Intervention||0
5090982|NCT01681186|12525671|P8|STARTED|Washout Period From Third Intervention||6
5090983|NCT01681186|12525672|P7|STARTED|Washout Period From Third Intervention||6
5090984|NCT01681186|12525673|P6|STARTED|Washout Period From Third Intervention||0
5090985|NCT01681186|12525674|P5|STARTED|Washout Period From Third Intervention||0
5090986|NCT01681186|12525675|P4|STARTED|Washout Period From Third Intervention||0
5090987|NCT01681186|12525676|P3|STARTED|Washout Period From Third Intervention||0
5090988|NCT01681186|12525677|P2|STARTED|Washout Period From Third Intervention||0
5090989|NCT01681186|12525678|P1|STARTED|Washout Period From Third Intervention||0
5090990|NCT01681186|12525671|P8|NOT COMPLETED|Third Intervention||0
5090991|NCT01681186|12525672|P7|NOT COMPLETED|Third Intervention||0
5090992|NCT01681186|12525673|P6|NOT COMPLETED|Third Intervention||0
5090993|NCT01681186|12525674|P5|NOT COMPLETED|Third Intervention||0
5090994|NCT01681186|12525675|P4|NOT COMPLETED|Third Intervention||0
5090995|NCT01681186|12525676|P3|NOT COMPLETED|Third Intervention||0
5090996|NCT01681186|12525677|P2|NOT COMPLETED|Third Intervention||0
5090997|NCT01681186|12525678|P1|NOT COMPLETED|Third Intervention||0
5090998|NCT01681186|12525671|P8|COMPLETED|Third Intervention||6
5090999|NCT01681186|12525672|P7|COMPLETED|Third Intervention||6
5091000|NCT01681186|12525673|P6|COMPLETED|Third Intervention||0
5091001|NCT01681186|12525674|P5|COMPLETED|Third Intervention||0
5091002|NCT01681186|12525675|P4|COMPLETED|Third Intervention||0
5091003|NCT01681186|12525676|P3|COMPLETED|Third Intervention||0
5091004|NCT01681186|12525677|P2|COMPLETED|Third Intervention||0
5091005|NCT01681186|12525678|P1|COMPLETED|Third Intervention||0
5091006|NCT01681186|12525671|P8|STARTED|Third Intervention||6
5091007|NCT01681186|12525672|P7|STARTED|Third Intervention||6
5091008|NCT01681186|12525673|P6|STARTED|Third Intervention||0
5091009|NCT01681186|12525674|P5|STARTED|Third Intervention||0
5091010|NCT01681186|12525675|P4|STARTED|Third Intervention||0
5091011|NCT01681186|12525676|P3|STARTED|Third Intervention||0
5091012|NCT01681186|12525677|P2|STARTED|Third Intervention||0
5091013|NCT01681186|12525678|P1|STARTED|Third Intervention||0
5091014|NCT01681186|12525671|P8|NOT COMPLETED|Washout Period From Second Intervention||1
5091015|NCT01681186|12525672|P7|NOT COMPLETED|Washout Period From Second Intervention||1
5091016|NCT01681186|12525673|P6|NOT COMPLETED|Washout Period From Second Intervention||0
5091017|NCT01681186|12525674|P5|NOT COMPLETED|Washout Period From Second Intervention||0
5091018|NCT01681186|12525675|P4|NOT COMPLETED|Washout Period From Second Intervention||0
5091019|NCT01681186|12525676|P3|NOT COMPLETED|Washout Period From Second Intervention||0
5091020|NCT01681186|12525677|P2|NOT COMPLETED|Washout Period From Second Intervention||0
5091021|NCT01681186|12525678|P1|NOT COMPLETED|Washout Period From Second Intervention||0
5091022|NCT01681186|12525671|P8|COMPLETED|Washout Period From Second Intervention||6
5091023|NCT01681186|12525672|P7|COMPLETED|Washout Period From Second Intervention||6
5091024|NCT01681186|12525673|P6|COMPLETED|Washout Period From Second Intervention||0
5091025|NCT01681186|12525674|P5|COMPLETED|Washout Period From Second Intervention||0
5091026|NCT01681186|12525675|P4|COMPLETED|Washout Period From Second Intervention||0
5091027|NCT01681186|12525676|P3|COMPLETED|Washout Period From Second Intervention||0
5091028|NCT01681186|12525677|P2|COMPLETED|Washout Period From Second Intervention||0
5091029|NCT01681186|12525678|P1|COMPLETED|Washout Period From Second Intervention||0
5091030|NCT01681186|12525671|P8|STARTED|Washout Period From Second Intervention||7
5091031|NCT01681186|12525672|P7|STARTED|Washout Period From Second Intervention||7
5091032|NCT01681186|12525673|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091033|NCT01681186|12525674|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091034|NCT01681186|12525675|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091035|NCT01681186|12525676|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091036|NCT01681186|12525677|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091037|NCT01681186|12525678|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
5091038|NCT01681186|12525671|P8|NOT COMPLETED|Second Intervention||0
5091039|NCT01681186|12525672|P7|NOT COMPLETED|Second Intervention||0
5091040|NCT01681186|12525673|P6|NOT COMPLETED|Second Intervention||0
5091041|NCT01681186|12525674|P5|NOT COMPLETED|Second Intervention||0
5091042|NCT01681186|12525675|P4|NOT COMPLETED|Second Intervention||0
5091043|NCT01681186|12525676|P3|NOT COMPLETED|Second Intervention||0
5091044|NCT01681186|12525677|P2|NOT COMPLETED|Second Intervention||0
5091045|NCT01681186|12525678|P1|NOT COMPLETED|Second Intervention||0
5091046|NCT01681186|12525671|P8|COMPLETED|Second Intervention||7
5091047|NCT01681186|12525672|P7|COMPLETED|Second Intervention||7
5091048|NCT01681186|12525673|P6|COMPLETED|Second Intervention||2
5091049|NCT01681186|12525674|P5|COMPLETED|Second Intervention||3
5091050|NCT01681186|12525675|P4|COMPLETED|Second Intervention||3
5091051|NCT01681186|12525676|P3|COMPLETED|Second Intervention||2
5091052|NCT01681186|12525677|P2|COMPLETED|Second Intervention||2
5091053|NCT01681186|12525678|P1|COMPLETED|Second Intervention||4
5091054|NCT01681186|12525671|P8|STARTED|Second Intervention||7
5091055|NCT01681186|12525672|P7|STARTED|Second Intervention||7
5091056|NCT01681186|12525673|P6|STARTED|Second Intervention||2
5091057|NCT01681186|12525674|P5|STARTED|Second Intervention||3
5091058|NCT01681186|12525675|P4|STARTED|Second Intervention||3
5091059|NCT01681186|12525676|P3|STARTED|Second Intervention||2
5091060|NCT01681186|12525677|P2|STARTED|Second Intervention||2
5091061|NCT01681186|12525678|P1|STARTED|Second Intervention||4
5091062|NCT01681186|12525671|P8|NOT COMPLETED|Washout Period From First Intervention||0
5091063|NCT01681186|12525672|P7|NOT COMPLETED|Washout Period From First Intervention||0
5091064|NCT01681186|12525673|P6|NOT COMPLETED|Washout Period From First Intervention||0
5091065|NCT01681186|12525674|P5|NOT COMPLETED|Washout Period From First Intervention||0
5091066|NCT01681186|12525675|P4|NOT COMPLETED|Washout Period From First Intervention||0
5091067|NCT01681186|12525676|P3|NOT COMPLETED|Washout Period From First Intervention||0
5091068|NCT01681186|12525677|P2|NOT COMPLETED|Washout Period From First Intervention||0
5091069|NCT01681186|12525678|P1|NOT COMPLETED|Washout Period From First Intervention||0
5091070|NCT01681186|12525671|P8|COMPLETED|Washout Period From First Intervention||7
5091071|NCT01681186|12525672|P7|COMPLETED|Washout Period From First Intervention||7
5091072|NCT01681186|12525673|P6|COMPLETED|Washout Period From First Intervention||2
5091073|NCT01681186|12525674|P5|COMPLETED|Washout Period From First Intervention||3
5091074|NCT01681186|12525675|P4|COMPLETED|Washout Period From First Intervention||3
5091075|NCT01681186|12525676|P3|COMPLETED|Washout Period From First Intervention||2
5091076|NCT01681186|12525677|P2|COMPLETED|Washout Period From First Intervention||2
5091077|NCT01681186|12525678|P1|COMPLETED|Washout Period From First Intervention||4
5091078|NCT01681186|12525671|P8|STARTED|Washout Period From First Intervention||7
5091079|NCT01681186|12525672|P7|STARTED|Washout Period From First Intervention||7
5091080|NCT01681186|12525673|P6|STARTED|Washout Period From First Intervention||2
5091081|NCT01681186|12525674|P5|STARTED|Washout Period From First Intervention||3
5091082|NCT01681186|12525675|P4|STARTED|Washout Period From First Intervention||3
5091083|NCT01681186|12525676|P3|STARTED|Washout Period From First Intervention||2
5091084|NCT01681186|12525677|P2|STARTED|Washout Period From First Intervention||2
5091085|NCT01681186|12525678|P1|STARTED|Washout Period From First Intervention||4
5091086|NCT01681186|12525671|P8|NOT COMPLETED|First Intervention||0
5091087|NCT01681186|12525672|P7|NOT COMPLETED|First Intervention||0
5091088|NCT01681186|12525673|P6|NOT COMPLETED|First Intervention||0
5091089|NCT01681186|12525674|P5|NOT COMPLETED|First Intervention||0
5091090|NCT01681186|12525675|P4|NOT COMPLETED|First Intervention||0
5091091|NCT01681186|12525676|P3|NOT COMPLETED|First Intervention||0
5091092|NCT01681186|12525677|P2|NOT COMPLETED|First Intervention||0
5091093|NCT01681186|12525678|P1|NOT COMPLETED|First Intervention||0
5091094|NCT01681186|12525671|P8|COMPLETED|First Intervention||7
5091095|NCT01681186|12525672|P7|COMPLETED|First Intervention||7
5091096|NCT01681186|12525673|P6|COMPLETED|First Intervention||2
5091097|NCT01681186|12525674|P5|COMPLETED|First Intervention||3
5091098|NCT01681186|12525675|P4|COMPLETED|First Intervention||3
5091099|NCT01681186|12525676|P3|COMPLETED|First Intervention||2
5091100|NCT01681186|12525677|P2|COMPLETED|First Intervention||2
5091101|NCT01681186|12525678|P1|COMPLETED|First Intervention||4
5091102|NCT01681186|12525671|P8|STARTED|First Intervention||7
5091103|NCT01681186|12525672|P7|STARTED|First Intervention||7
5091104|NCT01681186|12525673|P6|STARTED|First Intervention||2
5091105|NCT01681186|12525674|P5|STARTED|First Intervention||3
5091106|NCT01681186|12525675|P4|STARTED|First Intervention||3
5091107|NCT01681186|12525676|P3|STARTED|First Intervention||2
5091108|NCT01681186|12525677|P2|STARTED|First Intervention||2
5091109|NCT01681186|12525678|P1|STARTED|First Intervention||4
5091110|NCT01681121|12525731|P2|NOT COMPLETED|Overall Study||11
5091111|NCT01681121|12525732|P1|NOT COMPLETED|Overall Study||8
5091112|NCT01681121|12525731|P2|COMPLETED|Overall Study||38
5091113|NCT01681121|12525732|P1|COMPLETED|Overall Study||36
5091114|NCT01681121|12525731|P2|STARTED|Overall Study||49
5091115|NCT01681121|12525732|P1|STARTED|Overall Study||44
5091116|NCT01681095|12525740|P2|NOT COMPLETED|Overall Study||0
5091117|NCT01681095|12525741|P1|NOT COMPLETED|Overall Study||0
5091118|NCT01681095|12525740|P2|COMPLETED|Overall Study||55
5091119|NCT01681095|12525741|P1|COMPLETED|Overall Study||55
5091120|NCT01681095|12525740|P2|STARTED|Overall Study||55
5091121|NCT01681095|12525741|P1|STARTED|Overall Study||55
5091122|NCT01681069|12525781|P2|NOT COMPLETED|Overall Study||7
5091123|NCT01681069|12525782|P1|NOT COMPLETED|Overall Study||5
5091124|NCT01681069|12525781|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
5091125|NCT01681069|12525782|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
5091126|NCT01681069|12525781|P2|Full Analysis Set (FAS)|Overall Study||60
5091127|NCT01681069|12525782|P1|Full Analysis Set (FAS)|Overall Study||57
5091128|NCT01681069|12525781|P2|STARTED|Overall Study||60
5091129|NCT01681069|12525782|P1|STARTED|Overall Study||60
5091130|NCT01681030|12525795|P3|NOT COMPLETED|Overall Study||0
5091131|NCT01681030|12525796|P2|NOT COMPLETED|Overall Study||0
5091132|NCT01681030|12525797|P1|NOT COMPLETED|Overall Study||0
5091133|NCT01681030|12525795|P3|COMPLETED|Overall Study||11
5091134|NCT01681030|12525796|P2|COMPLETED|Overall Study||18
5091135|NCT01681030|12525797|P1|COMPLETED|Overall Study||13
5091136|NCT01681030|12525795|P3|STARTED|Overall Study||11
5091137|NCT01681030|12525796|P2|STARTED|Overall Study||18
5091138|NCT01681030|12525797|P1|STARTED|Overall Study||13
5091139|NCT01681004|12525819|P2|NOT COMPLETED|Study Completion||8
5091140|NCT01681004|12525820|P1|NOT COMPLETED|Study Completion||12
5091141|NCT01681004|12525819|P2|COMPLETED|Study Completion||36
5091142|NCT01681004|12525820|P1|COMPLETED|Study Completion||89
5091143|NCT01681004|12525819|P2|STARTED|Study Completion||44
5091144|NCT01681004|12525820|P1|STARTED|Study Completion||101
5091145|NCT01681004|12525819|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
5091146|NCT01681004|12525820|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
5091147|NCT01681004|12525819|P2|COMPLETED|Primary Endpoint: 6 Months||44
5091148|NCT01681004|12525820|P1|COMPLETED|Primary Endpoint: 6 Months||101
5091149|NCT01681004|12525819|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
5091150|NCT01681004|12525820|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
5091151|NCT01681004|12525819|P2|STARTED|Primary Endpoint: 6 Months||46
5091152|NCT01681004|12525820|P1|STARTED|Primary Endpoint: 6 Months||102
5091153|NCT01680991|12525877|P3|NOT COMPLETED|Overall Study||4
5091154|NCT01680991|12525878|P2|NOT COMPLETED|Overall Study||19
5091155|NCT01680991|12525879|P1|NOT COMPLETED|Overall Study||8
5091156|NCT01680991|12525877|P3|COMPLETED|Overall Study||9
5091157|NCT01680991|12525878|P2|COMPLETED|Overall Study||4
5091158|NCT01680991|12525879|P1|COMPLETED|Overall Study||4
5091159|NCT01680991|12525877|P3|STARTED|Overall Study||13
5091160|NCT01680991|12525878|P2|STARTED|Overall Study||23
5091161|NCT01680991|12525879|P1|STARTED|Overall Study||12
5091162|NCT01680900|12525940|P2|NOT COMPLETED|Overall Study||1
5091163|NCT01680900|12525941|P1|NOT COMPLETED|Overall Study||4
5091164|NCT01680900|12525940|P2|COMPLETED|Overall Study||11
5091165|NCT01680900|12525941|P1|COMPLETED|Overall Study||20
5091166|NCT01680900|12525940|P2|STARTED|Overall Study||12
5091167|NCT01680900|12525941|P1|STARTED|Overall Study||24
5091168|NCT01680887|12525959|P2|NOT COMPLETED|Overall Study||24
5091169|NCT01680887|12525960|P1|NOT COMPLETED|Overall Study||29
5091170|NCT01680887|12525959|P2|COMPLETED|Overall Study||52
5091171|NCT01680887|12525960|P1|COMPLETED|Overall Study||51
5091172|NCT01680887|12525959|P2|STARTED|Overall Study||76
5091173|NCT01680887|12525960|P1|STARTED|Overall Study||80
5091174|NCT01680861|12525970|P2|NOT COMPLETED|First 12 Months Post-transplant||0
5091175|NCT01680861|12525971|P1|NOT COMPLETED|First 12 Months Post-transplant||0
5091176|NCT01680861|12525970|P2|COMPLETED|First 12 Months Post-transplant||15
5091177|NCT01680861|12525971|P1|COMPLETED|First 12 Months Post-transplant||15
5091178|NCT01680861|12525970|P2|STARTED|First 12 Months Post-transplant||15
5091179|NCT01680861|12525971|P1|STARTED|First 12 Months Post-transplant||15
5091180|NCT01680861|12525970|P2|NOT COMPLETED|Early Post-transplant Period||1
5091181|NCT01680861|12525971|P1|NOT COMPLETED|Early Post-transplant Period||1
5091182|NCT01680861|12525970|P2|COMPLETED|Early Post-transplant Period||15
5091183|NCT01680861|12525971|P1|COMPLETED|Early Post-transplant Period||15
5091184|NCT01680861|12525970|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
5091185|NCT01680861|12525971|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
5091186|NCT01680848|12525989|P1|NOT COMPLETED|Overall Study||93
5091187|NCT01680848|12525989|P1|COMPLETED|Overall Study||189
5091188|NCT01680848|12525989|P1|STARTED|Overall Study||282
5091189|NCT01680835|12525993|P1|NOT COMPLETED|Overall Study||25
5091190|NCT01680835|12525993|P1|COMPLETED|Overall Study||83
5091191|NCT01680835|12525993|P1|STARTED|Overall Study||108
5091192|NCT01680783|12526009|P2|NOT COMPLETED|Overall Study||0
5091193|NCT01680783|12526010|P1|NOT COMPLETED|Overall Study||0
5091194|NCT01680783|12526009|P2|COMPLETED|Overall Study||44
5091195|NCT01680783|12526010|P1|COMPLETED|Overall Study||39
5091196|NCT01680783|12526009|P2|STARTED|Overall Study||44
5091197|NCT01680783|12526010|P1|STARTED|Overall Study||39
5091198|NCT01680666|12526028|P2|NOT COMPLETED|Overall Study||0
5091199|NCT01680666|12526029|P1|NOT COMPLETED|Overall Study||0
5091200|NCT01680666|12526028|P2|COMPLETED|Overall Study||66
5091201|NCT01680666|12526029|P1|COMPLETED|Overall Study||84
5091202|NCT01680666|12526028|P2|STARTED|Overall Study||66
5091203|NCT01680666|12526029|P1|STARTED|Overall Study||84
5091204|NCT01680653|12526043|P1|NOT COMPLETED|Overall Study||0
5091205|NCT01680653|12526043|P1|COMPLETED|Overall Study||57
5091206|NCT01680653|12526043|P1|STARTED|Overall Study||57
5091207|NCT01680549|12526055|P2|NOT COMPLETED|Overall Study||8
5091208|NCT01680549|12526056|P1|NOT COMPLETED|Overall Study||5
5091209|NCT01680549|12526055|P2|COMPLETED|Overall Study||17
5091210|NCT01680549|12526056|P1|COMPLETED|Overall Study||20
5091211|NCT01680549|12526055|P2|STARTED|Overall Study||25
5091212|NCT01680549|12526056|P1|STARTED|Overall Study||25
5091213|NCT01680497|12526068|P1|NOT COMPLETED|Overall Study||2
5091214|NCT01680497|12526068|P1|COMPLETED|Overall Study||68
5091215|NCT01680497|12526068|P1|STARTED|Overall Study||70
5091216|NCT01680458|12526078|P1|NOT COMPLETED|Overall Study||3
5091217|NCT01680458|12526078|P1|COMPLETED|Overall Study||27
5091218|NCT01680458|12526078|P1|STARTED|Overall Study||30
5091219|NCT01680341|12526089|P2|NOT COMPLETED|Overall Study||17
5091220|NCT01680341|12526090|P1|NOT COMPLETED|Overall Study||21
5091221|NCT01680341|12526089|P2|COMPLETED|Overall Study||119
5091222|NCT01680341|12526090|P1|COMPLETED|Overall Study||115
5091223|NCT01680341|12526089|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
5091224|NCT01680341|12526090|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
5091225|NCT01680341|12526089|P2|STARTED|Overall Study||136
5091226|NCT01680341|12526090|P1|STARTED|Overall Study||136
5091227|NCT01680328|12526110|P1|NOT COMPLETED|Overall Study||2
5091228|NCT01680328|12526110|P1|COMPLETED|Overall Study||80
5091229|NCT01680328|12526110|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
5091230|NCT01680328|12526110|P1|STARTED|Overall Study||82
5091231|NCT01680172|12526148|P2|NOT COMPLETED|Overall Study||0
5091232|NCT01680172|12526149|P1|NOT COMPLETED|Overall Study||0
5091233|NCT01680172|12526148|P2|COMPLETED|Overall Study||2
5091234|NCT01680172|12526149|P1|COMPLETED|Overall Study||3
5091235|NCT01680172|12526148|P2|STARTED|Overall Study||2
5091236|NCT01680172|12526149|P1|STARTED|Overall Study||3
5091237|NCT01680159|12526161|P1|NOT COMPLETED|Increased Dose Period||8
5091238|NCT01680159|12526161|P1|COMPLETED|Increased Dose Period||43
5091239|NCT01680159|12526161|P1|STARTED|Increased Dose Period||51
5091240|NCT01680159|12526161|P1|NOT COMPLETED|Screening Period||7
5091241|NCT01680159|12526161|P1|COMPLETED|Screening Period||39
5091242|NCT01680159|12526161|P1|STARTED|Screening Period||46
5091243|NCT01680016|12526188|P4|NOT COMPLETED|Overall Study||5
5091244|NCT01680016|12526189|P3|NOT COMPLETED|Overall Study||5
5091245|NCT01680016|12526190|P2|NOT COMPLETED|Overall Study||8
5091246|NCT01680016|12526191|P1|NOT COMPLETED|Overall Study||6
5091247|NCT01680016|12526188|P4|COMPLETED|Overall Study||195
5091248|NCT01680016|12526189|P3|COMPLETED|Overall Study||196
5091249|NCT01680016|12526190|P2|COMPLETED|Overall Study||114
5091250|NCT01680016|12526191|P1|COMPLETED|Overall Study||115
5091251|NCT01680016|12526188|P4|STARTED|Overall Study||200
5091252|NCT01680016|12526189|P3|STARTED|Overall Study||201
5091253|NCT01680016|12526190|P2|STARTED|Overall Study||122
5091254|NCT01680016|12526191|P1|STARTED|Overall Study||121
5091255|NCT01679613|12526253|P4|NOT COMPLETED|Overall Study||2
5091256|NCT01679613|12526254|P3|NOT COMPLETED|Overall Study||2
5091257|NCT01679613|12526255|P2|NOT COMPLETED|Overall Study||1
5091258|NCT01679613|12526256|P1|NOT COMPLETED|Overall Study||0
5091259|NCT01679613|12526253|P4|COMPLETED|Overall Study||11
5091260|NCT01679613|12526254|P3|COMPLETED|Overall Study||11
5091261|NCT01679613|12526255|P2|COMPLETED|Overall Study||3
5091262|NCT01679613|12526256|P1|COMPLETED|Overall Study||4
5091263|NCT01679613|12526253|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
5091264|NCT01679613|12526254|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
5091265|NCT01679613|12526255|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
5091266|NCT01679613|12526256|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
5091267|NCT01679613|12526253|P4|Received Nintedanib (Main)|Overall Study||11
5091268|NCT01679613|12526254|P3|Received Nintedanib (Main)|Overall Study||13
5091269|NCT01679613|12526255|P2|Received Nintedanib (Main)|Overall Study||0
5091270|NCT01679613|12526256|P1|Received Nintedanib (Main)|Overall Study||0
5091271|NCT01679613|12526253|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
5091272|NCT01679613|12526254|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
5091273|NCT01679613|12526255|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
5091274|NCT01679613|12526256|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
5091275|NCT01679613|12526253|P4|Received Nintedanib (Pilot)|Overall Study||0
5091276|NCT01679613|12526254|P3|Received Nintedanib (Pilot)|Overall Study||0
5091277|NCT01679613|12526255|P2|Received Nintedanib (Pilot)|Overall Study||3
5091278|NCT01679613|12526256|P1|Received Nintedanib (Pilot)|Overall Study||4
5091279|NCT01679613|12526253|P4|STARTED|Overall Study||13
5091280|NCT01679613|12526254|P3|STARTED|Overall Study||13
5091281|NCT01679613|12526255|P2|STARTED|Overall Study||4
5091282|NCT01679613|12526256|P1|STARTED|Overall Study||4
5091283|NCT01679600|12526269|P2|NOT COMPLETED|Overall Study||0
5091284|NCT01679600|12526270|P1|NOT COMPLETED|Overall Study||0
5091285|NCT01679600|12526269|P2|COMPLETED|Overall Study||7
5091286|NCT01679600|12526270|P1|COMPLETED|Overall Study||7
5091287|NCT01679600|12526269|P2|STARTED|Overall Study||7
5091288|NCT01679600|12526270|P1|STARTED|Overall Study||7
5091289|NCT01679405|12526278|P2|NOT COMPLETED|Overall Study||5
5091290|NCT01679405|12526279|P1|NOT COMPLETED|Overall Study||2
5091291|NCT01679405|12526278|P2|COMPLETED|Overall Study||1
5091292|NCT01679405|12526279|P1|COMPLETED|Overall Study||1
5091293|NCT01679405|12526278|P2|STARTED|Overall Study||6
5091294|NCT01679405|12526279|P1|STARTED|Overall Study||3
5091295|NCT01679314|12526295|P2|NOT COMPLETED|Overall Study||0
5091296|NCT01679314|12526296|P1|NOT COMPLETED|Overall Study||2
5091297|NCT01679314|12526295|P2|COMPLETED|Overall Study||28
5091298|NCT01679314|12526296|P1|COMPLETED|Overall Study||24
5091299|NCT01679314|12526295|P2|STARTED|Overall Study||28
5091300|NCT01679314|12526296|P1|STARTED|Overall Study||26
5091301|NCT01679301|12526314|P3|NOT COMPLETED|Study Period||0
5091302|NCT01679301|12526315|P2|NOT COMPLETED|Study Period||0
5091303|NCT01679301|12526316|P1|NOT COMPLETED|Study Period||0
5091304|NCT01679301|12526314|P3|COMPLETED|Study Period||4
5091305|NCT01679301|12526315|P2|COMPLETED|Study Period||4
5091306|NCT01679301|12526316|P1|COMPLETED|Study Period||0
5091307|NCT01679301|12526314|P3|STARTED|Study Period||4
5091308|NCT01679301|12526315|P2|STARTED|Study Period||4
5091309|NCT01679301|12526316|P1|STARTED|Study Period||0
5091310|NCT01679301|12526314|P3|NOT COMPLETED|Screening Period||0
5091311|NCT01679301|12526315|P2|NOT COMPLETED|Screening Period||0
5091312|NCT01679301|12526316|P1|NOT COMPLETED|Screening Period||3
5091313|NCT01679301|12526314|P3|COMPLETED|Screening Period||0
5091314|NCT01679301|12526315|P2|COMPLETED|Screening Period||0
5091315|NCT01679301|12526316|P1|COMPLETED|Screening Period||8
5091316|NCT01679301|12526314|P3|STARTED|Screening Period||0
5091317|NCT01679301|12526315|P2|STARTED|Screening Period||0
5091318|NCT01679301|12526316|P1|STARTED|Screening Period||11
5091319|NCT01679236|12526324|P2|NOT COMPLETED|Overall Study||15
5091320|NCT01679236|12526325|P1|NOT COMPLETED|Overall Study||15
5091321|NCT01679236|12526324|P2|COMPLETED|Overall Study||10
5091322|NCT01679236|12526325|P1|COMPLETED|Overall Study||15
5091323|NCT01679236|12526324|P2|STARTED|Overall Study||25
5091324|NCT01679236|12526325|P1|STARTED|Overall Study||30
5091325|NCT01679197|12526331|P1|NOT COMPLETED|Overall Study||4
5091326|NCT01679197|12526331|P1|COMPLETED|Overall Study||19
5091327|NCT01679197|12526331|P1|STARTED|Overall Study||23
5091328|NCT01679028|12526350|P6|NOT COMPLETED|Overall Study||0
5091329|NCT01679028|12526351|P5|NOT COMPLETED|Overall Study||0
5091330|NCT01679028|12526352|P4|NOT COMPLETED|Overall Study||0
5091331|NCT01679028|12526353|P3|NOT COMPLETED|Overall Study||0
5091332|NCT01679028|12526354|P2|NOT COMPLETED|Overall Study||0
5091333|NCT01679028|12526355|P1|NOT COMPLETED|Overall Study||0
5091334|NCT01679028|12526350|P6|COMPLETED|Overall Study||6
5091335|NCT01679028|12526351|P5|COMPLETED|Overall Study||2
5091336|NCT01679028|12526352|P4|COMPLETED|Overall Study||4
5091337|NCT01679028|12526353|P3|COMPLETED|Overall Study||2
5091338|NCT01679028|12526354|P2|COMPLETED|Overall Study||4
5091339|NCT01679028|12526355|P1|COMPLETED|Overall Study||2
5091340|NCT01679028|12526350|P6|STARTED|Overall Study||6
5091341|NCT01679028|12526351|P5|STARTED|Overall Study||2
5091342|NCT01679028|12526352|P4|STARTED|Overall Study||4
5091343|NCT01679028|12526353|P3|STARTED|Overall Study||2
5091344|NCT01679028|12526354|P2|STARTED|Overall Study||4
5091345|NCT01679028|12526355|P1|STARTED|Overall Study||2
5091346|NCT01679002|12526372|P3|NOT COMPLETED|Overall Study||0
5091347|NCT01679002|12526373|P2|NOT COMPLETED|Overall Study||1
5091348|NCT01679002|12526374|P1|NOT COMPLETED|Overall Study||1
5091349|NCT01679002|12526372|P3|COMPLETED|Overall Study||4
5091350|NCT01679002|12526373|P2|COMPLETED|Overall Study||3
5091351|NCT01679002|12526374|P1|COMPLETED|Overall Study||3
5091352|NCT01679002|12526372|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
5091353|NCT01679002|12526373|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
5091354|NCT01679002|12526374|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
5091355|NCT01679002|12526372|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
5091356|NCT01679002|12526373|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
5091357|NCT01679002|12526374|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
5091358|NCT01679002|12526372|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
5091359|NCT01679002|12526373|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
5091360|NCT01679002|12526374|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
5091361|NCT01679002|12526372|P3|STARTED|Overall Study||4
5091362|NCT01679002|12526373|P2|STARTED|Overall Study||4
5091363|NCT01679002|12526374|P1|STARTED|Overall Study||4
5091364|NCT01678976|12526390|P2|NOT COMPLETED|Second Period||0
5091365|NCT01678976|12526391|P1|NOT COMPLETED|Second Period||0
5091366|NCT01678976|12526390|P2|COMPLETED|Second Period||6
5091367|NCT01678976|12526391|P1|COMPLETED|Second Period||6
5091368|NCT01678976|12526390|P2|STARTED|Second Period||6
5091369|NCT01678976|12526391|P1|STARTED|Second Period||6
5091370|NCT01678976|12526390|P2|NOT COMPLETED|First Period||1
5091371|NCT01678976|12526391|P1|NOT COMPLETED|First Period||0
5091372|NCT01678976|12526390|P2|COMPLETED|First Period||6
5091373|NCT01678976|12526391|P1|COMPLETED|First Period||6
5091374|NCT01678976|12526390|P2|STARTED|First Period||7
5091375|NCT01678976|12526391|P1|STARTED|First Period||6
5091376|NCT01678924|12526405|P4|NOT COMPLETED|Overall Study||18
5091377|NCT01678924|12526406|P3|NOT COMPLETED|Overall Study||2
5091378|NCT01678924|12526407|P2|NOT COMPLETED|Overall Study||12
5091379|NCT01678924|12526408|P1|NOT COMPLETED|Overall Study||10
5091380|NCT01678924|12526405|P4|COMPLETED|Overall Study||105
5091381|NCT01678924|12526406|P3|COMPLETED|Overall Study||28
5091382|NCT01678924|12526407|P2|COMPLETED|Overall Study||51
5091383|NCT01678924|12526408|P1|COMPLETED|Overall Study||54
5091384|NCT01678924|12526405|P4|STARTED|Overall Study||123
5091385|NCT01678924|12526406|P3|STARTED|Overall Study||30
5091386|NCT01678924|12526407|P2|STARTED|Overall Study||63
5091387|NCT01678924|12526408|P1|STARTED|Overall Study||64
5091388|NCT01678911|12526539|P2|NOT COMPLETED|Second Intervention||0
5091389|NCT01678911|12526540|P1|NOT COMPLETED|Second Intervention||2
5091390|NCT01678911|12526539|P2|COMPLETED|Second Intervention||1
5091391|NCT01678911|12526540|P1|COMPLETED|Second Intervention||2
5091392|NCT01678911|12526539|P2|STARTED|Second Intervention||1
5091393|NCT01678911|12526540|P1|STARTED|Second Intervention||4
5091394|NCT01678911|12526539|P2|NOT COMPLETED|First Intervention||0
5091395|NCT01678911|12526540|P1|NOT COMPLETED|First Intervention||0
5091396|NCT01678911|12526539|P2|COMPLETED|First Intervention||1
5091397|NCT01678911|12526540|P1|COMPLETED|First Intervention||4
5091398|NCT01678911|12526539|P2|Cross Over|First Intervention||1
5091399|NCT01678911|12526540|P1|Cross Over|First Intervention||4
5091400|NCT01678911|12526539|P2|STARTED|First Intervention||1
5091401|NCT01678911|12526540|P1|STARTED|First Intervention||4
5091402|NCT01678898|12526557|P3|NOT COMPLETED|PB-102-F02||0
5091403|NCT01678898|12526558|P2|NOT COMPLETED|PB-102-F02||0
5091404|NCT01678898|12526559|P1|NOT COMPLETED|PB-102-F02||0
5091405|NCT01678898|12526557|P3|COMPLETED|PB-102-F02||4
5091406|NCT01678898|12526558|P2|COMPLETED|PB-102-F02||6
5091407|NCT01678898|12526559|P1|COMPLETED|PB-102-F02||6
5091408|NCT01678898|12526557|P3|STARTED|PB-102-F02||4
5091409|NCT01678898|12526558|P2|STARTED|PB-102-F02||6
5091410|NCT01678898|12526559|P1|STARTED|PB-102-F02||6
5091411|NCT01678898|12526557|P3|NOT COMPLETED|PB-102-F01||0
5091412|NCT01678898|12526558|P2|NOT COMPLETED|PB-102-F01||2
5091413|NCT01678898|12526559|P1|NOT COMPLETED|PB-102-F01||0
5091414|NCT01678898|12526557|P3|COMPLETED|PB-102-F01||4
5091415|NCT01678898|12526558|P2|COMPLETED|PB-102-F01||6
5091416|NCT01678898|12526559|P1|COMPLETED|PB-102-F01||6
5091417|NCT01678898|12526557|P3|STARTED|PB-102-F01||4
5091418|NCT01678898|12526558|P2|STARTED|PB-102-F01||8
5091419|NCT01678898|12526559|P1|STARTED|PB-102-F01||6
5091420|NCT01678885|12526639|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
5091421|NCT01678885|12526640|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091422|NCT01678885|12526641|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091423|NCT01678885|12526642|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091424|NCT01678885|12526643|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091425|NCT01678885|12526639|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
5091426|NCT01678885|12526640|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091427|NCT01678885|12526641|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091428|NCT01678885|12526642|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091429|NCT01678885|12526643|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
5091430|NCT01678885|12526639|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
5091431|NCT01678885|12526640|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
5091432|NCT01678885|12526641|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
5091433|NCT01678885|12526642|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
5091434|NCT01678885|12526643|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
5091435|NCT01678885|12526639|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
5091436|NCT01678885|12526640|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
5091437|NCT01678885|12526641|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
5091438|NCT01678885|12526642|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
5091439|NCT01678885|12526643|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
5091440|NCT01678885|12526639|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
5091441|NCT01678885|12526640|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
5091442|NCT01678885|12526641|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
5091443|NCT01678885|12526642|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
5091444|NCT01678885|12526643|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
5091445|NCT01678885|12526639|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
5091446|NCT01678885|12526640|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
5091447|NCT01678885|12526641|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
5091448|NCT01678885|12526642|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
5091449|NCT01678885|12526643|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
5091450|NCT01678846|12526653|P2|NOT COMPLETED|Overall Study||0
5091451|NCT01678846|12526654|P1|NOT COMPLETED|Overall Study||0
5091452|NCT01678846|12526653|P2|COMPLETED|Overall Study||1899
5091453|NCT01678846|12526654|P1|COMPLETED|Overall Study||1921
5091454|NCT01678846|12526653|P2|STARTED|Overall Study||1899
5091455|NCT01678846|12526654|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
5091456|NCT01678820|12526669|P3|NOT COMPLETED|Overall Study||57
5091457|NCT01678820|12526670|P2|NOT COMPLETED|Overall Study||63
5091458|NCT01678820|12526671|P1|NOT COMPLETED|Overall Study||62
5091459|NCT01678820|12526669|P3|COMPLETED|Overall Study||43
5091460|NCT01678820|12526670|P2|COMPLETED|Overall Study||36
5091461|NCT01678820|12526671|P1|COMPLETED|Overall Study||38
5091462|NCT01678820|12526669|P3|Treated With Double-blind Study Drug|Overall Study||98
5091463|NCT01678820|12526670|P2|Treated With Double-blind Study Drug|Overall Study||97
5091464|NCT01678820|12526671|P1|Treated With Double-blind Study Drug|Overall Study||100
5091465|NCT01678820|12526669|P3|STARTED|Overall Study||100
5091466|NCT01678820|12526670|P2|STARTED|Overall Study||99
5091467|NCT01678820|12526671|P1|STARTED|Overall Study||100
5091468|NCT01678807|12526716|P3|NOT COMPLETED|Overall Study||0
5091469|NCT01678807|12526717|P2|NOT COMPLETED|Overall Study||5
5091470|NCT01678807|12526718|P1|NOT COMPLETED|Overall Study||4
5091471|NCT01678807|12526716|P3|COMPLETED|Overall Study||65
5091472|NCT01678807|12526717|P2|COMPLETED|Overall Study||60
5091473|NCT01678807|12526718|P1|COMPLETED|Overall Study||61
5091474|NCT01678807|12526716|P3|STARTED|Overall Study||65
5091475|NCT01678807|12526717|P2|STARTED|Overall Study||65
5091476|NCT01678807|12526718|P1|STARTED|Overall Study||65
5091477|NCT01678560|12526731|P2|NOT COMPLETED|Overall Study||6
5091478|NCT01678560|12526732|P1|NOT COMPLETED|Overall Study||4
5091479|NCT01678560|12526731|P2|COMPLETED|Overall Study||20
5091480|NCT01678560|12526732|P1|COMPLETED|Overall Study||22
5091481|NCT01678560|12526731|P2|STARTED|Overall Study||26
5091482|NCT01678560|12526732|P1|STARTED|Overall Study||26
5091483|NCT01678443|12526746|P1|NOT COMPLETED|Overall Study||0
5091484|NCT01678443|12526746|P1|COMPLETED|Overall Study||2
5091485|NCT01678443|12526746|P1|STARTED|Overall Study||2
5091486|NCT01678313|12526753|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
5091487|NCT01678313|12526754|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
5091488|NCT01678313|12526753|P2|COMPLETED|Prostate Biopsy at 3 Months||37
5091489|NCT01678313|12526754|P1|COMPLETED|Prostate Biopsy at 3 Months||45
5091490|NCT01678313|12526753|P2|STARTED|Prostate Biopsy at 3 Months||49
5091491|NCT01678313|12526754|P1|STARTED|Prostate Biopsy at 3 Months||56
5091492|NCT01678313|12526753|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
5091493|NCT01678313|12526754|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
5091494|NCT01678313|12526753|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
5091495|NCT01678313|12526754|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
5091496|NCT01678313|12526753|P2|STARTED|PSA >4 ng/dL at 3 Months||58
5091497|NCT01678313|12526754|P1|STARTED|PSA >4 ng/dL at 3 Months||64
5091498|NCT01678313|12526753|P2|NOT COMPLETED|Completed the 3-month Therapy||12
5091499|NCT01678313|12526754|P1|NOT COMPLETED|Completed the 3-month Therapy||6
5091500|NCT01678313|12526753|P2|COMPLETED|Completed the 3-month Therapy||58
5091501|NCT01678313|12526754|P1|COMPLETED|Completed the 3-month Therapy||64
5091502|NCT01678313|12526753|P2|STARTED|Completed the 3-month Therapy||70
5091503|NCT01678313|12526754|P1|STARTED|Completed the 3-month Therapy||70
5091504|NCT01678209|12526773|P3|NOT COMPLETED|Overall Study||18
5091505|NCT01678209|12526774|P2|NOT COMPLETED|Overall Study||18
5091506|NCT01678209|12526775|P1|NOT COMPLETED|Overall Study||17
5091507|NCT01678209|12526773|P3|COMPLETED|Overall Study||22
5091508|NCT01678209|12526774|P2|COMPLETED|Overall Study||22
5091509|NCT01678209|12526775|P1|COMPLETED|Overall Study||30
5091510|NCT01678209|12526773|P3|STARTED|Overall Study||40
5091511|NCT01678209|12526774|P2|STARTED|Overall Study||40
5091512|NCT01678209|12526775|P1|STARTED|Overall Study||47
5091513|NCT01678196|12526803|P2|NOT COMPLETED|Overall Study||0
5091514|NCT01678196|12526804|P1|NOT COMPLETED|Overall Study||0
5091515|NCT01678196|12526803|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
5091516|NCT01678196|12526804|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
5091517|NCT01678196|12526803|P2|STARTED|Overall Study||32
5091518|NCT01678196|12526804|P1|STARTED|Overall Study||34
5091519|NCT01678144|12526816|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
5091520|NCT01678144|12526816|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
5091521|NCT01678144|12526816|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
5091522|NCT01678144|12526816|P1|NOT COMPLETED|Stage 1: MAR Classic||1
5091523|NCT01678144|12526816|P1|COMPLETED|Stage 1: MAR Classic||6
5091524|NCT01678144|12526816|P1|STARTED|Stage 1: MAR Classic||7
5091525|NCT01678131|12526835|P3|NOT COMPLETED|Overall Study||2
5091526|NCT01678131|12526836|P2|NOT COMPLETED|Overall Study||1
5091527|NCT01678131|12526837|P1|NOT COMPLETED|Overall Study||0
5091528|NCT01678131|12526835|P3|COMPLETED|Overall Study||9
5091529|NCT01678131|12526836|P2|COMPLETED|Overall Study||9
5091530|NCT01678131|12526837|P1|COMPLETED|Overall Study||10
5091531|NCT01678131|12526835|P3|STARTED|Overall Study||11
5091532|NCT01678131|12526836|P2|STARTED|Overall Study||10
5091533|NCT01678131|12526837|P1|STARTED|Overall Study||10
5091534|NCT01677988|12526845|P1|NOT COMPLETED|Overall Study||2
5091535|NCT01677988|12526845|P1|COMPLETED|Overall Study||1
5091536|NCT01677988|12526845|P1|STARTED|Overall Study||3
5091537|NCT01677936|12526858|P2|NOT COMPLETED|Overall Study||5
5091538|NCT01677936|12526859|P1|NOT COMPLETED|Overall Study||9
5091539|NCT01677936|12526858|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
5091540|NCT01677936|12526859|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
5091541|NCT01677936|12526858|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
5091542|NCT01677936|12526859|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
5091543|NCT01677910|12526870|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
5091544|NCT01677910|12526871|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5091545|NCT01677910|12526872|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5091546|NCT01677910|12526873|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
5091547|NCT01677910|12526870|P4|COMPLETED|Open-Label Extension Period (OLE)||79
5091548|NCT01677910|12526871|P3|COMPLETED|Open-Label Extension Period (OLE)||0
5091549|NCT01677910|12526872|P2|COMPLETED|Open-Label Extension Period (OLE)||0
5091550|NCT01677910|12526873|P1|COMPLETED|Open-Label Extension Period (OLE)||0
5091551|NCT01677910|12526870|P4|STARTED|Open-Label Extension Period (OLE)||115
5091552|NCT01677910|12526871|P3|STARTED|Open-Label Extension Period (OLE)||0
5091553|NCT01677910|12526872|P2|STARTED|Open-Label Extension Period (OLE)||0
5091554|NCT01677910|12526873|P1|STARTED|Open-Label Extension Period (OLE)||0
5091555|NCT01677910|12526870|P4|NOT COMPLETED|Double-Blind Treatment Period||0
5091556|NCT01677910|12526871|P3|NOT COMPLETED|Double-Blind Treatment Period||7
5091557|NCT01677910|12526872|P2|NOT COMPLETED|Double-Blind Treatment Period||3
5091558|NCT01677910|12526873|P1|NOT COMPLETED|Double-Blind Treatment Period||7
5091559|NCT01677910|12526870|P4|COMPLETED|Double-Blind Treatment Period||0
5091560|NCT01677910|12526871|P3|COMPLETED|Double-Blind Treatment Period||38
5091561|NCT01677910|12526872|P2|COMPLETED|Double-Blind Treatment Period||42
5091562|NCT01677910|12526873|P1|COMPLETED|Double-Blind Treatment Period||38
5091563|NCT01677910|12526870|P4|STARTED|Double-Blind Treatment Period||0
5091564|NCT01677910|12526871|P3|STARTED|Double-Blind Treatment Period||45
5091565|NCT01677910|12526872|P2|STARTED|Double-Blind Treatment Period||45
5091566|NCT01677910|12526873|P1|STARTED|Double-Blind Treatment Period||45
5091567|NCT01677858|12526900|P5|NOT COMPLETED|Overall Study||85
5091568|NCT01677858|12526901|P4|NOT COMPLETED|Overall Study||6
5091569|NCT01677858|12526902|P3|NOT COMPLETED|Overall Study||14
5091570|NCT01677858|12526903|P2|NOT COMPLETED|Overall Study||2
5091571|NCT01677858|12526904|P1|NOT COMPLETED|Overall Study||3
5091572|NCT01677858|12526900|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
5091573|NCT01677858|12526901|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
5091574|NCT01677858|12526902|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
5091575|NCT01677858|12526903|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
5091576|NCT01677858|12526904|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
5091577|NCT01677858|12526900|P5|STARTED|Overall Study||89
5091578|NCT01677858|12526901|P4|STARTED|Overall Study||6
5091579|NCT01677858|12526902|P3|STARTED|Overall Study||15
5091580|NCT01677858|12526903|P2|STARTED|Overall Study||3
5091581|NCT01677858|12526904|P1|STARTED|Overall Study||3
5091582|NCT01677767|12526977|P1|NOT COMPLETED|Overall Study||22
5091583|NCT01677767|12526977|P1|COMPLETED|Overall Study||102
5091584|NCT01677767|12526977|P1|STARTED|Overall Study||124
5091585|NCT01677624|12526991|P1|NOT COMPLETED|Overall Study||1
5091586|NCT01677624|12526991|P1|COMPLETED|Overall Study||27
5091587|NCT01677624|12526991|P1|STARTED|Overall Study||28
5091588|NCT01677507|12526996|P2|NOT COMPLETED|Second Assigment||5
5091589|NCT01677507|12526997|P1|NOT COMPLETED|Second Assigment||3
5091590|NCT01677507|12526996|P2|COMPLETED|Second Assigment||51
5091591|NCT01677507|12526997|P1|COMPLETED|Second Assigment||60
5091592|NCT01677507|12526996|P2|STARTED|Second Assigment||56
5091593|NCT01677507|12526997|P1|STARTED|Second Assigment||63
5091594|NCT01677507|12526996|P2|NOT COMPLETED|Initial Assignment||2
5091595|NCT01677507|12526997|P1|NOT COMPLETED|Initial Assignment||0
5091596|NCT01677507|12526996|P2|COMPLETED|Initial Assignment||56
5091597|NCT01677507|12526997|P1|COMPLETED|Initial Assignment||63
5091598|NCT01677507|12526996|P2|STARTED|Initial Assignment||58
5091599|NCT01677507|12526997|P1|STARTED|Initial Assignment||63
5091600|NCT01677377|12527010|P3|NOT COMPLETED|Overall Study||6
5091601|NCT01677377|12527011|P2|NOT COMPLETED|Overall Study||1
5091602|NCT01677377|12527012|P1|NOT COMPLETED|Overall Study||1
5091603|NCT01677377|12527010|P3|COMPLETED|Overall Study||9
5091604|NCT01677377|12527011|P2|COMPLETED|Overall Study||14
5091605|NCT01677377|12527012|P1|COMPLETED|Overall Study||14
5091606|NCT01677377|12527010|P3|STARTED|Overall Study||15
5091607|NCT01677377|12527011|P2|STARTED|Overall Study||15
5091608|NCT01677377|12527012|P1|STARTED|Overall Study||15
5091609|NCT01677312|12527211|P2|NOT COMPLETED|Overall Study||0
5091610|NCT01677312|12527212|P1|NOT COMPLETED|Overall Study||0
5091611|NCT01677312|12527211|P2|COMPLETED|Overall Study||36
5091612|NCT01677312|12527212|P1|COMPLETED|Overall Study||36
5091613|NCT01677312|12527211|P2|STARTED|Overall Study||36
5091614|NCT01677312|12527212|P1|STARTED|Overall Study||36
5091615|NCT01677299|12527228|P4|NOT COMPLETED|Overall Study||1
5091616|NCT01677299|12527229|P3|NOT COMPLETED|Overall Study||1
5091617|NCT01677299|12527230|P2|NOT COMPLETED|Overall Study||3
5091618|NCT01677299|12527231|P1|NOT COMPLETED|Overall Study||0
5091619|NCT01677299|12527228|P4|COMPLETED|Overall Study||5
5091620|NCT01677299|12527229|P3|COMPLETED|Overall Study||5
5091621|NCT01677299|12527230|P2|COMPLETED|Overall Study||3
5091622|NCT01677299|12527231|P1|COMPLETED|Overall Study||6
5091623|NCT01677299|12527228|P4|STARTED|Overall Study||6
5091624|NCT01677299|12527229|P3|STARTED|Overall Study||6
5091625|NCT01677299|12527230|P2|STARTED|Overall Study||6
5091626|NCT01677299|12527231|P1|STARTED|Overall Study||6
5091627|NCT01677286|12527253|P1|NOT COMPLETED|Overall Study||11
5091628|NCT01677286|12527253|P1|COMPLETED|Overall Study||14
5091629|NCT01677286|12527253|P1|STARTED|Overall Study||25
5091630|NCT01677195|12527263|P3|NOT COMPLETED|Overall Study||30
5091631|NCT01677195|12527264|P2|NOT COMPLETED|Overall Study||32
5091632|NCT01677195|12527265|P1|NOT COMPLETED|Overall Study||29
5091633|NCT01677195|12527263|P3|COMPLETED|Overall Study||50
5091634|NCT01677195|12527264|P2|COMPLETED|Overall Study||51
5091635|NCT01677195|12527265|P1|COMPLETED|Overall Study||42
5091636|NCT01677195|12527263|P3|STARTED|Overall Study||80
5091637|NCT01677195|12527264|P2|STARTED|Overall Study||83
5091638|NCT01677195|12527265|P1|STARTED|Overall Study||71
5091639|NCT01677182|12527276|P3|NOT COMPLETED|Overall Study||39
5091640|NCT01677182|12527277|P2|NOT COMPLETED|Overall Study||28
5091641|NCT01677182|12527278|P1|NOT COMPLETED|Overall Study||34
5091642|NCT01677182|12527276|P3|COMPLETED|Overall Study||143
5091643|NCT01677182|12527277|P2|COMPLETED|Overall Study||141
5091644|NCT01677182|12527278|P1|COMPLETED|Overall Study||150
5091645|NCT01677182|12527276|P3|STARTED|Overall Study||182
5091646|NCT01677182|12527277|P2|STARTED|Overall Study||169
5091647|NCT01677182|12527278|P1|STARTED|Overall Study||184
5091648|NCT01676961|12527310|P1|NOT COMPLETED|Overall Study||5
5091649|NCT01676961|12527310|P1|COMPLETED|Overall Study||0
5091650|NCT01676961|12527310|P1|STARTED|Overall Study||5
5091651|NCT01676909|12527317|P2|NOT COMPLETED|Overall Study||14
5091652|NCT01676909|12527318|P1|NOT COMPLETED|Overall Study||18
5091653|NCT01676909|12527317|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
5091654|NCT01676909|12527318|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
5091655|NCT01676909|12527317|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
5091656|NCT01676909|12527318|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
5091657|NCT01676909|12527317|P2|STARTED|Overall Study||118
5091658|NCT01676909|12527318|P1|STARTED|Overall Study||124
5091659|NCT01676896|12527383|P3|NOT COMPLETED|Overall Study||19
5091660|NCT01676896|12527384|P2|NOT COMPLETED|Overall Study||7
5091661|NCT01676896|12527385|P1|NOT COMPLETED|Overall Study||12
5091662|NCT01676896|12527383|P3|COMPLETED|Overall Study||81
5091663|NCT01676896|12527384|P2|COMPLETED|Overall Study||89
5091664|NCT01676896|12527385|P1|COMPLETED|Overall Study||84
5091665|NCT01676896|12527383|P3|STARTED|Overall Study||100
5091666|NCT01676896|12527384|P2|STARTED|Overall Study||96
5091667|NCT01676896|12527385|P1|STARTED|Overall Study||96
5091668|NCT01676831|12527482|P2|NOT COMPLETED|Overall Study||1
5091669|NCT01676831|12527483|P1|NOT COMPLETED|Overall Study||0
5091670|NCT01676831|12527482|P2|COMPLETED|Overall Study||4
5091671|NCT01676831|12527483|P1|COMPLETED|Overall Study||8
5091672|NCT01676831|12527482|P2|STARTED|Overall Study||5
5091673|NCT01676831|12527483|P1|STARTED|Overall Study||8
5091674|NCT01676727|12527493|P1|NOT COMPLETED|Overall Study||32
5091675|NCT01676727|12527493|P1|COMPLETED|Overall Study||68
5091676|NCT01676727|12527493|P1|Implanted|Overall Study||92
5091677|NCT01676727|12527493|P1|STARTED|Overall Study||100
5091678|NCT01676714|12527498|P1|NOT COMPLETED|Overall Study||0
5091679|NCT01676714|12527498|P1|COMPLETED|Overall Study||10
5091680|NCT01676714|12527498|P1|STARTED|Overall Study||10
5091681|NCT01676701|12527507|P2|NOT COMPLETED|Overall Study||4
5091682|NCT01676701|12527508|P1|NOT COMPLETED|Overall Study||4
5091683|NCT01676701|12527507|P2|COMPLETED|Overall Study||0
5091684|NCT01676701|12527508|P1|COMPLETED|Overall Study||0
5091685|NCT01676701|12527507|P2|Completed Post-Treatment Follow-Up|Overall Study||4
5091686|NCT01676701|12527508|P1|Completed Post-Treatment Follow-Up|Overall Study||4
5091687|NCT01676701|12527507|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
5091688|NCT01676701|12527508|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5091689|NCT01676701|12527507|P2|STARTED|Overall Study||4
5091690|NCT01676701|12527508|P1|STARTED|Overall Study||4
5091691|NCT01676532|12527534|P1|NOT COMPLETED|Overall Study||0
5091692|NCT01676532|12527534|P1|COMPLETED|Overall Study||127
5091693|NCT01676532|12527534|P1|STARTED|Overall Study||127
5091694|NCT01676415|12527545|P2|NOT COMPLETED|Overall Study||0
5091695|NCT01676415|12527546|P1|NOT COMPLETED|Overall Study||0
5091696|NCT01676415|12527545|P2|COMPLETED|Overall Study||5
5091697|NCT01676415|12527546|P1|COMPLETED|Overall Study||4
5091698|NCT01676415|12527545|P2|STARTED|Overall Study||5
5091699|NCT01676415|12527546|P1|STARTED|Overall Study||4
5091700|NCT01676311|12527560|P2|NOT COMPLETED|Overall Study||2
5091701|NCT01676311|12527561|P1|NOT COMPLETED|Overall Study||0
5091702|NCT01676311|12527560|P2|COMPLETED|Overall Study||5
5091703|NCT01676311|12527561|P1|COMPLETED|Overall Study||7
5091704|NCT01676311|12527560|P2|STARTED|Overall Study||7
5091705|NCT01676311|12527561|P1|STARTED|Overall Study||7
5091706|NCT01676298|12527583|P8|NOT COMPLETED|Overall Study||0
5091707|NCT01676298|12527584|P7|NOT COMPLETED|Overall Study||0
5091708|NCT01676298|12527585|P6|NOT COMPLETED|Overall Study||0
5091709|NCT01676298|12527586|P5|NOT COMPLETED|Overall Study||0
5091710|NCT01676298|12527587|P4|NOT COMPLETED|Overall Study||0
5091711|NCT01676298|12527588|P3|NOT COMPLETED|Overall Study||0
5091712|NCT01676298|12527589|P2|NOT COMPLETED|Overall Study||0
5091713|NCT01676298|12527590|P1|NOT COMPLETED|Overall Study||0
5091714|NCT01676298|12527583|P8|COMPLETED|Overall Study||1
5091715|NCT01676298|12527584|P7|COMPLETED|Overall Study||1
5091716|NCT01676298|12527585|P6|COMPLETED|Overall Study||1
5091717|NCT01676298|12527586|P5|COMPLETED|Overall Study||1
5091718|NCT01676298|12527587|P4|COMPLETED|Overall Study||1
5091719|NCT01676298|12527588|P3|COMPLETED|Overall Study||1
5091720|NCT01676298|12527589|P2|COMPLETED|Overall Study||1
5091721|NCT01676298|12527590|P1|COMPLETED|Overall Study||1
5091722|NCT01676298|12527583|P8|Participated in All Tests|Overall Study||1
5091723|NCT01676298|12527584|P7|Participated in All Tests|Overall Study||1
5091724|NCT01676298|12527585|P6|Participated in All Tests|Overall Study||1
5091725|NCT01676298|12527586|P5|Participated in All Tests|Overall Study||1
5091726|NCT01676298|12527587|P4|Participated in All Tests|Overall Study||1
5091727|NCT01676298|12527588|P3|Participated in All Tests|Overall Study||1
5091728|NCT01676298|12527589|P2|Participated in All Tests|Overall Study||1
5091729|NCT01676298|12527590|P1|Participated in All Tests|Overall Study||1
5091730|NCT01676298|12527583|P8|All Genotypes Confirmed With Reference|Overall Study||1
5091731|NCT01676298|12527584|P7|All Genotypes Confirmed With Reference|Overall Study||1
5091732|NCT01676298|12527585|P6|All Genotypes Confirmed With Reference|Overall Study||1
5091733|NCT01676298|12527586|P5|All Genotypes Confirmed With Reference|Overall Study||1
5091734|NCT01676298|12527587|P4|All Genotypes Confirmed With Reference|Overall Study||1
5091735|NCT01676298|12527588|P3|All Genotypes Confirmed With Reference|Overall Study||1
5091736|NCT01676298|12527589|P2|All Genotypes Confirmed With Reference|Overall Study||1
5091737|NCT01676298|12527590|P1|All Genotypes Confirmed With Reference|Overall Study||1
5091738|NCT01676298|12527583|P8|STARTED|Overall Study||1
5091739|NCT01676298|12527584|P7|STARTED|Overall Study||1
5091740|NCT01676298|12527585|P6|STARTED|Overall Study||1
5091741|NCT01676298|12527586|P5|STARTED|Overall Study||1
5091742|NCT01676298|12527587|P4|STARTED|Overall Study||1
5091743|NCT01676298|12527588|P3|STARTED|Overall Study||1
5091744|NCT01676298|12527589|P2|STARTED|Overall Study||1
5091745|NCT01676298|12527590|P1|STARTED|Overall Study||1
5091746|NCT01676220|12527610|P2|NOT COMPLETED|Overall Study||125
5091747|NCT01676220|12527611|P1|NOT COMPLETED|Overall Study||102
5091748|NCT01676220|12527610|P2|COMPLETED|Overall Study||314
5091749|NCT01676220|12527611|P1|COMPLETED|Overall Study||337
5091750|NCT01676220|12527610|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
5091751|NCT01676220|12527611|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
5091752|NCT01676220|12527610|P2|Treated|Overall Study||438
5091753|NCT01676220|12527611|P1|Treated|Overall Study||435
5091754|NCT01676220|12527610|P2|STARTED|Overall Study||439
5091755|NCT01676220|12527611|P1|STARTED|Overall Study||439
5091756|NCT01676116|12527643|P2|NOT COMPLETED|Overall Study||29
5091757|NCT01676116|12527644|P1|NOT COMPLETED|Overall Study||16
5091758|NCT01676116|12527643|P2|COMPLETED|Overall Study||117
5091759|NCT01676116|12527644|P1|COMPLETED|Overall Study||276
5091760|NCT01676116|12527643|P2|STARTED|Overall Study||146
5091761|NCT01676116|12527644|P1|STARTED|Overall Study||292
5091762|NCT01676012|12527666|P1|NOT COMPLETED|Overall Study||3
5091763|NCT01676012|12527666|P1|COMPLETED|Overall Study||29
5091764|NCT01676012|12527666|P1|STARTED|Overall Study||32
5091765|NCT01675960|12527672|P2|NOT COMPLETED|Overall Study||0
5091766|NCT01675960|12527673|P1|NOT COMPLETED|Overall Study||0
5091767|NCT01675960|12527672|P2|COMPLETED|Overall Study||0
5091768|NCT01675960|12527673|P1|COMPLETED|Overall Study||2
5091769|NCT01675960|12527672|P2|STARTED|Overall Study||0
5091770|NCT01675960|12527673|P1|STARTED|Overall Study||2
5091771|NCT01675830|12527681|P1|NOT COMPLETED|Overall Study||0
5091772|NCT01675830|12527681|P1|COMPLETED|Overall Study||10
5091773|NCT01675830|12527681|P1|STARTED|Overall Study||10
5091774|NCT01675661|12527688|P2|NOT COMPLETED|Overall Study||46
5091775|NCT01675661|12527689|P1|NOT COMPLETED|Overall Study||40
5091776|NCT01675661|12527688|P2|COMPLETED|Overall Study||103
5091777|NCT01675661|12527689|P1|COMPLETED|Overall Study||113
5091778|NCT01675661|12527688|P2|STARTED|Overall Study||149
5091779|NCT01675661|12527689|P1|STARTED|Overall Study||153
5091780|NCT01675635|12527697|P2|NOT COMPLETED|Overall Study||0
5091781|NCT01675635|12527698|P1|NOT COMPLETED|Overall Study||0
5091782|NCT01675635|12527697|P2|COMPLETED|Overall Study||117
5091783|NCT01675635|12527698|P1|COMPLETED|Overall Study||117
5091784|NCT01675635|12527697|P2|STARTED|Overall Study||117
5091785|NCT01675635|12527698|P1|STARTED|Overall Study||117
5091786|NCT01675622|12527718|P2|NOT COMPLETED|Overall Study||24
5091787|NCT01675622|12527719|P1|NOT COMPLETED|Overall Study||26
5091788|NCT01675622|12527718|P2|COMPLETED|Overall Study||96
5091789|NCT01675622|12527719|P1|COMPLETED|Overall Study||96
5091790|NCT01675622|12527718|P2|STARTED|Overall Study||120
5091791|NCT01675622|12527719|P1|STARTED|Overall Study||122
5091792|NCT01675596|12527743|P1|NOT COMPLETED|Overall Study||8
5091793|NCT01675596|12527743|P1|COMPLETED|Overall Study||191
5091794|NCT01675596|12527743|P1|STARTED|Overall Study|One patient did not receive the study device.|199
5091795|NCT01675544|12527749|P1|NOT COMPLETED|Overall Study||2
5091796|NCT01675544|12527749|P1|COMPLETED|Overall Study||44
5091797|NCT01675544|12527749|P1|STARTED|Overall Study||46
5091798|NCT01675531|12527754|P1|NOT COMPLETED|Overall Study||25
5091799|NCT01675531|12527754|P1|COMPLETED|Overall Study||41
5091800|NCT01675531|12527754|P1|STARTED|Overall Study||66
5091801|NCT01675492|12527761|P1|NOT COMPLETED|Overall Study||42
5091802|NCT01675492|12527761|P1|COMPLETED|Overall Study||42
5091803|NCT01675492|12527761|P1|STARTED|Overall Study||84
5091804|NCT01675479|12527766|P1|NOT COMPLETED|Overall Study||11
5091805|NCT01675479|12527766|P1|COMPLETED|Overall Study||58
5091806|NCT01675479|12527766|P1|STARTED|Overall Study||69
5091807|NCT01675453|12527773|P2|NOT COMPLETED|Overall Study||0
5091808|NCT01675453|12527774|P1|NOT COMPLETED|Overall Study||0
5091809|NCT01675453|12527773|P2|COMPLETED|Overall Study||20
5091810|NCT01675453|12527774|P1|COMPLETED|Overall Study||20
5091811|NCT01675453|12527773|P2|STARTED|Overall Study||20
5091812|NCT01675453|12527774|P1|STARTED|Overall Study||20
5091813|NCT01675427|12527780|P1|NOT COMPLETED|Overall Study||34
5091814|NCT01675427|12527780|P1|COMPLETED|Overall Study||4732
5091815|NCT01675427|12527780|P1|STARTED|Overall Study||4766
5091816|NCT01675297|12528067|P2|NOT COMPLETED|Overall Study||48
5091817|NCT01675297|12528068|P1|NOT COMPLETED|Overall Study||164
5091818|NCT01675297|12528067|P2|COMPLETED|Overall Study||199
5091819|NCT01675297|12528068|P1|COMPLETED|Overall Study||642
5091820|NCT01675297|12528067|P2|STARTED|Overall Study||247
5091821|NCT01675297|12528068|P1|STARTED|Overall Study||806
5091822|NCT01675167|12528080|P3|NOT COMPLETED|Double-blind Treatment Phase||110
5091823|NCT01675167|12528081|P2|NOT COMPLETED|Double-blind Treatment Phase||48
5091824|NCT01675167|12528082|P1|NOT COMPLETED|Double-blind Treatment Phase||0
5091825|NCT01675167|12528080|P3|COMPLETED|Double-blind Treatment Phase||147
5091826|NCT01675167|12528081|P2|COMPLETED|Double-blind Treatment Phase||206
5091827|NCT01675167|12528082|P1|COMPLETED|Double-blind Treatment Phase||0
5091828|NCT01675167|12528080|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
5091829|NCT01675167|12528081|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
5091830|NCT01675167|12528082|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
5091831|NCT01675167|12528080|P3|NOT COMPLETED|Open-label Titration Phase||0
5091832|NCT01675167|12528081|P2|NOT COMPLETED|Open-label Titration Phase||0
5091833|NCT01675167|12528082|P1|NOT COMPLETED|Open-label Titration Phase||304
5091834|NCT01675167|12528080|P3|COMPLETED|Open-label Titration Phase||0
5091835|NCT01675167|12528081|P2|COMPLETED|Open-label Titration Phase||0
5091836|NCT01675167|12528082|P1|COMPLETED|Open-label Titration Phase||511
5091837|NCT01675167|12528080|P3|STARTED|Open-label Titration Phase||0
5091838|NCT01675167|12528081|P2|STARTED|Open-label Titration Phase||0
5091839|NCT01675167|12528082|P1|STARTED|Open-label Titration Phase||815
5091840|NCT01675141|12528104|P1|NOT COMPLETED|Overall Study||11
5091841|NCT01675141|12528104|P1|COMPLETED|Overall Study||0
5091842|NCT01675141|12528104|P1|STARTED|Overall Study||11
5091843|NCT01675128|12528117|P3|NOT COMPLETED|Overall Study||1
5091844|NCT01675128|12528118|P2|NOT COMPLETED|Overall Study||2
5091845|NCT01675128|12528119|P1|NOT COMPLETED|Overall Study||2
5091846|NCT01675128|12528117|P3|COMPLETED|Overall Study||9
5091847|NCT01675128|12528118|P2|COMPLETED|Overall Study||8
5091848|NCT01675128|12528119|P1|COMPLETED|Overall Study||2
5091849|NCT01675128|12528117|P3|STARTED|Overall Study||10
5091850|NCT01675128|12528118|P2|STARTED|Overall Study||10
5091851|NCT01675128|12528119|P1|STARTED|Overall Study||4
5091852|NCT01675063|12528141|P1|NOT COMPLETED|Overall Study||0
5091853|NCT01675063|12528141|P1|COMPLETED|Overall Study||77
5091854|NCT01675063|12528141|P1|STARTED|Overall Study||77
5091855|NCT01675050|12528147|P2|NOT COMPLETED|Second Period Treatment||0
5091856|NCT01675050|12528148|P1|NOT COMPLETED|Second Period Treatment||0
5091857|NCT01675050|12528147|P2|COMPLETED|Second Period Treatment||2
5091858|NCT01675050|12528148|P1|COMPLETED|Second Period Treatment||1
5091859|NCT01675050|12528147|P2|STARTED|Second Period Treatment||2
5091860|NCT01675050|12528148|P1|STARTED|Second Period Treatment||1
5091861|NCT01675050|12528147|P2|NOT COMPLETED|Wash Out Period||0
5091862|NCT01675050|12528148|P1|NOT COMPLETED|Wash Out Period||0
5091863|NCT01675050|12528147|P2|COMPLETED|Wash Out Period||2
5091864|NCT01675050|12528148|P1|COMPLETED|Wash Out Period||1
5091865|NCT01675050|12528147|P2|STARTED|Wash Out Period||2
5091866|NCT01675050|12528148|P1|STARTED|Wash Out Period||1
5091867|NCT01675050|12528147|P2|NOT COMPLETED|Period One Treatment||0
5091868|NCT01675050|12528148|P1|NOT COMPLETED|Period One Treatment||1
5091869|NCT01675050|12528147|P2|COMPLETED|Period One Treatment||2
5091870|NCT01675050|12528148|P1|COMPLETED|Period One Treatment||1
5091871|NCT01675050|12528147|P2|STARTED|Period One Treatment||2
5091872|NCT01675050|12528148|P1|STARTED|Period One Treatment||2
5091873|NCT01675011|12528158|P2|NOT COMPLETED|Overall Study||1
5091874|NCT01675011|12528159|P1|NOT COMPLETED|Overall Study||3
5091875|NCT01675011|12528158|P2|COMPLETED|Overall Study||0
5091876|NCT01675011|12528159|P1|COMPLETED|Overall Study||0
5091877|NCT01675011|12528158|P2|STARTED|Overall Study||1
5091878|NCT01675011|12528159|P1|STARTED|Overall Study||3
5091879|NCT01674725|12528167|P2|NOT COMPLETED|Overall Study||1
5091880|NCT01674725|12528168|P1|NOT COMPLETED|Overall Study||3
5091881|NCT01674725|12528167|P2|COMPLETED|Overall Study||94
5091882|NCT01674725|12528168|P1|COMPLETED|Overall Study||89
5091883|NCT01674725|12528167|P2|STARTED|Overall Study||95
5091884|NCT01674725|12528168|P1|STARTED|Overall Study||92
5091885|NCT01674712|12528187|P5|NOT COMPLETED|Overall Study||11
5091886|NCT01674712|12528188|P4|NOT COMPLETED|Overall Study||8
5091887|NCT01674712|12528189|P3|NOT COMPLETED|Overall Study||9
5091888|NCT01674712|12528190|P2|NOT COMPLETED|Overall Study||9
5091889|NCT01674712|12528191|P1|NOT COMPLETED|Overall Study||10
5091890|NCT01674712|12528187|P5|COMPLETED|Overall Study||102
5091891|NCT01674712|12528188|P4|COMPLETED|Overall Study||108
5091892|NCT01674712|12528189|P3|COMPLETED|Overall Study||106
5091893|NCT01674712|12528190|P2|COMPLETED|Overall Study||108
5091894|NCT01674712|12528191|P1|COMPLETED|Overall Study||104
5091895|NCT01674712|12528187|P5|Safety Subject Sample|Overall Study||112
5091896|NCT01674712|12528188|P4|Safety Subject Sample|Overall Study||115
5091897|NCT01674712|12528189|P3|Safety Subject Sample|Overall Study||113
5091898|NCT01674712|12528190|P2|Safety Subject Sample|Overall Study||117
5091899|NCT01674712|12528191|P1|Safety Subject Sample|Overall Study||111
5091900|NCT01674712|12528187|P5|Full Analysis Subject Sample|Overall Study||111
5091901|NCT01674712|12528188|P4|Full Analysis Subject Sample|Overall Study||112
5091902|NCT01674712|12528189|P3|Full Analysis Subject Sample|Overall Study||110
5091903|NCT01674712|12528190|P2|Full Analysis Subject Sample|Overall Study||114
5091904|NCT01674712|12528191|P1|Full Analysis Subject Sample|Overall Study||109
5091905|NCT01674712|12528187|P5|STARTED|Overall Study||113
5091906|NCT01674712|12528188|P4|STARTED|Overall Study||116
5091907|NCT01674712|12528189|P3|STARTED|Overall Study||115
5091908|NCT01674712|12528190|P2|STARTED|Overall Study||117
5091909|NCT01674712|12528191|P1|STARTED|Overall Study||114
5091910|NCT01674647|12528215|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
5091911|NCT01674647|12528216|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
5091912|NCT01674647|12528215|P2|COMPLETED|30-day Safety Follow-up Period||446
5091913|NCT01674647|12528216|P1|COMPLETED|30-day Safety Follow-up Period||924
5091914|NCT01674647|12528215|P2|STARTED|30-day Safety Follow-up Period||487
5091915|NCT01674647|12528216|P1|STARTED|30-day Safety Follow-up Period||982
5091916|NCT01674647|12528215|P2|NOT COMPLETED|Treatment Period||102
5091917|NCT01674647|12528216|P1|NOT COMPLETED|Treatment Period||156
5091918|NCT01674647|12528215|P2|COMPLETED|Treatment Period||400
5091919|NCT01674647|12528216|P1|COMPLETED|Treatment Period||846
5091920|NCT01674647|12528215|P2|Subjects Received Treatment|Treatment Period||499
5091921|NCT01674647|12528216|P1|Subjects Received Treatment|Treatment Period||988
5091922|NCT01674647|12528215|P2|STARTED|Treatment Period||502
5091923|NCT01674647|12528216|P1|STARTED|Treatment Period||1002
5091924|NCT01674634|12528242|P1|NOT COMPLETED|Overall Study||6
5091925|NCT01674634|12528242|P1|COMPLETED|Overall Study||709
5091926|NCT01674634|12528242|P1|STARTED|Overall Study||715
5091927|NCT01674621|12528262|P5|NOT COMPLETED|Overall Study||6
5091928|NCT01674621|12528263|P4|NOT COMPLETED|Overall Study||6
5091929|NCT01674621|12528264|P3|NOT COMPLETED|Overall Study||7
5091930|NCT01674621|12528265|P2|NOT COMPLETED|Overall Study||8
5091931|NCT01674621|12528266|P1|NOT COMPLETED|Overall Study||5
5091932|NCT01674621|12528262|P5|COMPLETED|Overall Study||44
5091933|NCT01674621|12528263|P4|COMPLETED|Overall Study||45
5091934|NCT01674621|12528264|P3|COMPLETED|Overall Study||41
5091935|NCT01674621|12528265|P2|COMPLETED|Overall Study||43
5091936|NCT01674621|12528266|P1|COMPLETED|Overall Study||45
5091937|NCT01674621|12528262|P5|Safety Population|Overall Study||50
5091938|NCT01674621|12528263|P4|Safety Population|Overall Study||51
5091939|NCT01674621|12528264|P3|Safety Population|Overall Study||47
5091940|NCT01674621|12528265|P2|Safety Population|Overall Study||51
5091941|NCT01674621|12528266|P1|Safety Population|Overall Study||50
5091942|NCT01674621|12528262|P5|Modified Intent-to-Treat Population|Overall Study||46
5091943|NCT01674621|12528263|P4|Modified Intent-to-Treat Population|Overall Study||49
5091944|NCT01674621|12528264|P3|Modified Intent-to-Treat Population|Overall Study||43
5091945|NCT01674621|12528265|P2|Modified Intent-to-Treat Population|Overall Study||46
5091946|NCT01674621|12528266|P1|Modified Intent-to-Treat Population|Overall Study||47
5091947|NCT01674621|12528262|P5|STARTED|Overall Study||50
5091948|NCT01674621|12528263|P4|STARTED|Overall Study||51
5091949|NCT01674621|12528264|P3|STARTED|Overall Study||48
5091950|NCT01674621|12528265|P2|STARTED|Overall Study||51
5091951|NCT01674621|12528266|P1|STARTED|Overall Study||50
5091952|NCT01674569|12528343|P6|NOT COMPLETED|Overall Study||2
5091953|NCT01674569|12528344|P5|NOT COMPLETED|Overall Study||2
5091954|NCT01674569|12528345|P4|NOT COMPLETED|Overall Study||1
5091955|NCT01674569|12528346|P3|NOT COMPLETED|Overall Study||2
5091956|NCT01674569|12528347|P2|NOT COMPLETED|Overall Study||3
5091957|NCT01674569|12528348|P1|NOT COMPLETED|Overall Study||0
5091958|NCT01674569|12528343|P6|COMPLETED|Overall Study||1
5091959|NCT01674569|12528344|P5|COMPLETED|Overall Study||5
5091960|NCT01674569|12528345|P4|COMPLETED|Overall Study||9
5091961|NCT01674569|12528346|P3|COMPLETED|Overall Study||2
5091962|NCT01674569|12528347|P2|COMPLETED|Overall Study||5
5091963|NCT01674569|12528348|P1|COMPLETED|Overall Study||3
5091964|NCT01674569|12528343|P6|STARTED|Overall Study||3
5091965|NCT01674569|12528344|P5|STARTED|Overall Study||7
5091966|NCT01674569|12528345|P4|STARTED|Overall Study||10
5091967|NCT01674569|12528346|P3|STARTED|Overall Study||4
5091968|NCT01674569|12528347|P2|STARTED|Overall Study||8
5091969|NCT01674569|12528348|P1|STARTED|Overall Study||3
5091970|NCT01674478|12528354|P2|NOT COMPLETED|Overall Study||0
5091971|NCT01674478|12528355|P1|NOT COMPLETED|Overall Study||0
5091972|NCT01674478|12528354|P2|COMPLETED|Overall Study||9
5091973|NCT01674478|12528355|P1|COMPLETED|Overall Study||9
5091974|NCT01674478|12528354|P2|STARTED|Overall Study||9
5091975|NCT01674478|12528355|P1|STARTED|Overall Study||9
5091976|NCT01674062|12528369|P2|NOT COMPLETED|Overall Study||29
5091977|NCT01674062|12528370|P1|NOT COMPLETED|Overall Study||66
5091978|NCT01674062|12528369|P2|COMPLETED|Overall Study||0
5091979|NCT01674062|12528370|P1|COMPLETED|Overall Study||0
5091980|NCT01674062|12528369|P2|STARTED|Overall Study||29
5091981|NCT01674062|12528370|P1|STARTED|Overall Study||66
5091982|NCT01674010|12528385|P3|NOT COMPLETED|Randomization Phase 2||61
5091983|NCT01674010|12528386|P2|NOT COMPLETED|Randomization Phase 2||62
5091984|NCT01674010|12528387|P1|NOT COMPLETED|Randomization Phase 2||0
5091985|NCT01674010|12528385|P3|COMPLETED|Randomization Phase 2||3
5091986|NCT01674010|12528386|P2|COMPLETED|Randomization Phase 2||3
5091987|NCT01674010|12528387|P1|COMPLETED|Randomization Phase 2||0
5091988|NCT01674010|12528385|P3|STARTED|Randomization Phase 2||64
5091989|NCT01674010|12528386|P2|STARTED|Randomization Phase 2||65
5091990|NCT01674010|12528387|P1|STARTED|Randomization Phase 2||0
5091991|NCT01674010|12528385|P3|NOT COMPLETED|Open Treatment Phase 1||0
5091992|NCT01674010|12528386|P2|NOT COMPLETED|Open Treatment Phase 1||0
5091993|NCT01674010|12528387|P1|NOT COMPLETED|Open Treatment Phase 1||180
5091994|NCT01674010|12528385|P3|COMPLETED|Open Treatment Phase 1||0
5091995|NCT01674010|12528386|P2|COMPLETED|Open Treatment Phase 1||0
5091996|NCT01674010|12528387|P1|COMPLETED|Open Treatment Phase 1||129
5091997|NCT01674010|12528385|P3|STARTED|Open Treatment Phase 1||0
5091998|NCT01674010|12528386|P2|STARTED|Open Treatment Phase 1||0
5091999|NCT01674010|12528387|P1|STARTED|Open Treatment Phase 1||309
5092000|NCT01673984|12528406|P2|NOT COMPLETED|Overall Study||6
5092001|NCT01673984|12528407|P1|NOT COMPLETED|Overall Study||10
5092002|NCT01673984|12528406|P2|COMPLETED|Overall Study||1
5092003|NCT01673984|12528407|P1|COMPLETED|Overall Study||4
5092004|NCT01673984|12528406|P2|STARTED|Overall Study||7
5092005|NCT01673984|12528407|P1|STARTED|Overall Study||14
5092006|NCT01673919|12528425|P1|NOT COMPLETED|Overall Study||0
5092007|NCT01673919|12528425|P1|COMPLETED|Overall Study||7
5092008|NCT01673919|12528425|P1|STARTED|Overall Study||7
5092009|NCT01673893|12528449|P1|NOT COMPLETED|Overall Study||0
5092010|NCT01673893|12528449|P1|COMPLETED|Overall Study||59
5092011|NCT01673893|12528449|P1|STARTED|Overall Study||59
5092012|NCT01673867|12528457|P2|NOT COMPLETED|Treatment||268
5092013|NCT01673867|12528458|P1|NOT COMPLETED|Treatment||244
5092014|NCT01673867|12528457|P2|COMPLETED|Treatment||0
5092015|NCT01673867|12528458|P1|COMPLETED|Treatment||43
5092016|NCT01673867|12528457|P2|STARTED|Treatment||268
5092017|NCT01673867|12528458|P1|STARTED|Treatment||287
5092018|NCT01673867|12528457|P2|NOT COMPLETED|Randomization||22
5092019|NCT01673867|12528458|P1|NOT COMPLETED|Randomization||5
5092020|NCT01673867|12528457|P2|COMPLETED|Randomization||268
5092021|NCT01673867|12528458|P1|COMPLETED|Randomization||287
5092022|NCT01673867|12528457|P2|STARTED|Randomization||290
5092023|NCT01673867|12528458|P1|STARTED|Randomization||292
5092024|NCT01673854|12528484|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
5092025|NCT01673854|12528484|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
5092026|NCT01673854|12528484|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
5092027|NCT01673854|12528484|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
5092028|NCT01673854|12528484|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
5092029|NCT01673854|12528484|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
5092030|NCT01673854|12528484|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
5092031|NCT01673854|12528484|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
5092032|NCT01673854|12528484|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
5092033|NCT01673828|12528494|P2|NOT COMPLETED|Overall Study||0
5092034|NCT01673828|12528495|P1|NOT COMPLETED|Overall Study||0
5092035|NCT01673828|12528494|P2|COMPLETED|Overall Study||6
5092036|NCT01673828|12528495|P1|COMPLETED|Overall Study||7
5092037|NCT01673828|12528494|P2|STARTED|Overall Study||6
5092038|NCT01673828|12528495|P1|STARTED|Overall Study||7
5092039|NCT01673802|12528501|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
5092040|NCT01673802|12528501|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
5092041|NCT01673802|12528501|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
5092042|NCT01673802|12528501|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
5092043|NCT01673802|12528501|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
5092044|NCT01673802|12528501|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
5092045|NCT01673698|12528507|P2|NOT COMPLETED|Overall Study||13
5092046|NCT01673698|12528508|P1|NOT COMPLETED|Overall Study||51
5092047|NCT01673698|12528507|P2|COMPLETED|Overall Study||126
5092048|NCT01673698|12528508|P1|COMPLETED|Overall Study||136
5092049|NCT01673698|12528507|P2|STARTED|Overall Study||139
5092050|NCT01673698|12528508|P1|STARTED|Overall Study||187
5092051|NCT01673646|12528519|P3|NOT COMPLETED|Overall Study||4
5092052|NCT01673646|12528520|P2|NOT COMPLETED|Overall Study||7
5092053|NCT01673646|12528521|P1|NOT COMPLETED|Overall Study||4
5092054|NCT01673646|12528519|P3|COMPLETED|Overall Study||7
5092055|NCT01673646|12528520|P2|COMPLETED|Overall Study||4
5092056|NCT01673646|12528521|P1|COMPLETED|Overall Study||7
5092057|NCT01673646|12528519|P3|Discontinued Beyond 24 Months|Overall Study||1
5092058|NCT01673646|12528520|P2|Discontinued Beyond 24 Months|Overall Study||4
5092059|NCT01673646|12528521|P1|Discontinued Beyond 24 Months|Overall Study||0
5092060|NCT01673646|12528519|P3|Treated Beyond 24 Months|Overall Study||8
5092061|NCT01673646|12528520|P2|Treated Beyond 24 Months|Overall Study||8
5092062|NCT01673646|12528521|P1|Treated Beyond 24 Months|Overall Study||7
5092063|NCT01673646|12528519|P3|Did Not Enter Ext. Phase|Overall Study||1
5092064|NCT01673646|12528520|P2|Did Not Enter Ext. Phase|Overall Study||1
5092065|NCT01673646|12528521|P1|Did Not Enter Ext. Phase|Overall Study||2
5092066|NCT01673646|12528519|P3|Entered Ext. Phase|Overall Study||9
5092067|NCT01673646|12528520|P2|Entered Ext. Phase|Overall Study||9
5092068|NCT01673646|12528521|P1|Entered Ext. Phase|Overall Study||7
5092069|NCT01673646|12528519|P3|Completed Core Phase|Overall Study||10
5092070|NCT01673646|12528520|P2|Completed Core Phase|Overall Study||10
5092071|NCT01673646|12528521|P1|Completed Core Phase|Overall Study||9
5092072|NCT01673646|12528519|P3|Entered/Treated in Core Phase|Overall Study||11
5092073|NCT01673646|12528520|P2|Entered/Treated in Core Phase|Overall Study||11
5092074|NCT01673646|12528521|P1|Entered/Treated in Core Phase|Overall Study||11
5092075|NCT01673646|12528519|P3|STARTED|Overall Study||11
5092076|NCT01673646|12528520|P2|STARTED|Overall Study||11
5092077|NCT01673646|12528521|P1|STARTED|Overall Study||11
5092078|NCT01673620|12528560|P2|NOT COMPLETED|Overall Study||0
5092079|NCT01673620|12528561|P1|NOT COMPLETED|Overall Study||1
5092080|NCT01673620|12528560|P2|COMPLETED|Overall Study||22
5092081|NCT01673620|12528561|P1|COMPLETED|Overall Study||46
5092082|NCT01673620|12528560|P2|STARTED|Overall Study||22
5092083|NCT01673620|12528561|P1|STARTED|Overall Study||47
5092084|NCT01673594|12528571|P2|NOT COMPLETED|Overall Study||6
5092085|NCT01673594|12528572|P1|NOT COMPLETED|Overall Study||6
5092086|NCT01673594|12528571|P2|COMPLETED|Overall Study||13
5092087|NCT01673594|12528572|P1|COMPLETED|Overall Study||12
5092088|NCT01673594|12528571|P2|STARTED|Overall Study||19
5092089|NCT01673594|12528572|P1|STARTED|Overall Study||18
5092090|NCT01673568|12528582|P2|NOT COMPLETED|Overall Study||0
5092091|NCT01673568|12528583|P1|NOT COMPLETED|Overall Study||0
5092092|NCT01673568|12528582|P2|COMPLETED|Overall Study||28
5092093|NCT01673568|12528583|P1|COMPLETED|Overall Study||28
5092094|NCT01673568|12528582|P2|STARTED|Overall Study||28
5092095|NCT01673568|12528583|P1|STARTED|Overall Study||28
5092096|NCT01673490|12528591|P1|NOT COMPLETED|Overall Study||7
5092097|NCT01673490|12528591|P1|COMPLETED|Overall Study||52
5092098|NCT01673490|12528591|P1|STARTED|Overall Study||59
5092099|NCT01673425|12528604|P1|NOT COMPLETED|Overall Study||1
5092100|NCT01673425|12528604|P1|COMPLETED|Overall Study||4
5092101|NCT01673425|12528604|P1|STARTED|Overall Study||5
5092102|NCT01673373|12528608|P1|NOT COMPLETED|Overall Study||2
5092103|NCT01673373|12528608|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
5092104|NCT01673373|12528608|P1|STARTED|Overall Study||68
5092105|NCT01673347|12528624|P1|NOT COMPLETED|Overall Study||7
5092106|NCT01673347|12528624|P1|COMPLETED|Overall Study||17
5092107|NCT01673347|12528624|P1|STARTED|Overall Study||24
5092108|NCT01673282|12528633|P2|NOT COMPLETED|Overall Study||26
5092109|NCT01673282|12528634|P1|NOT COMPLETED|Overall Study||33
5092110|NCT01673282|12528633|P2|COMPLETED|Overall Study||132
5092111|NCT01673282|12528634|P1|COMPLETED|Overall Study||120
5092112|NCT01673282|12528633|P2|STARTED|Overall Study||158
5092113|NCT01673282|12528634|P1|STARTED|Overall Study||153
5092114|NCT01673256|12528640|P1|NOT COMPLETED|Overall Study||0
5092115|NCT01673256|12528640|P1|COMPLETED|Overall Study||90
5092116|NCT01673256|12528640|P1|STARTED|Overall Study||90
5092117|NCT01673191|12528646|P2|NOT COMPLETED|Overall Study||0
5092118|NCT01673191|12528647|P1|NOT COMPLETED|Overall Study||0
5092119|NCT01673191|12528646|P2|COMPLETED|Overall Study||11
5092120|NCT01673191|12528647|P1|COMPLETED|Overall Study||26
5092121|NCT01673191|12528646|P2|STARTED|Overall Study||11
5092122|NCT01673191|12528647|P1|STARTED|Overall Study||26
5092123|NCT01673178|12528670|P5|NOT COMPLETED|Overall Study||2
5092124|NCT01673178|12528671|P4|NOT COMPLETED|Overall Study||8
5092125|NCT01673178|12528672|P3|NOT COMPLETED|Overall Study||3
5092126|NCT01673178|12528673|P2|NOT COMPLETED|Overall Study||2
5092127|NCT01673178|12528674|P1|NOT COMPLETED|Overall Study||3
5092128|NCT01673178|12528670|P5|COMPLETED|Overall Study||19
5092129|NCT01673178|12528671|P4|COMPLETED|Overall Study||14
5092130|NCT01673178|12528672|P3|COMPLETED|Overall Study||18
5092131|NCT01673178|12528673|P2|COMPLETED|Overall Study||19
5092132|NCT01673178|12528674|P1|COMPLETED|Overall Study||19
5092133|NCT01673178|12528670|P5|STARTED|Overall Study||21
5092134|NCT01673178|12528671|P4|STARTED|Overall Study||22
5092135|NCT01673178|12528672|P3|STARTED|Overall Study||21
5092136|NCT01673178|12528673|P2|STARTED|Overall Study||21
5092137|NCT01673178|12528674|P1|STARTED|Overall Study||22
5092138|NCT01673126|12528913|P2|NOT COMPLETED|Overall Study||3
5092139|NCT01673126|12528914|P1|NOT COMPLETED|Overall Study||4
5092140|NCT01673126|12528913|P2|COMPLETED|Overall Study||23
5092141|NCT01673126|12528914|P1|COMPLETED|Overall Study||32
5092142|NCT01673126|12528913|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
5092143|NCT01673126|12528914|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
5092144|NCT01673113|12528922|P2|NOT COMPLETED|Overall Study||0
5092145|NCT01673113|12528923|P1|NOT COMPLETED|Overall Study||0
5092146|NCT01673113|12528922|P2|COMPLETED|Overall Study||11
5092147|NCT01673113|12528923|P1|COMPLETED|Overall Study||11
5092148|NCT01673113|12528922|P2|STARTED|Overall Study||11
5092149|NCT01673113|12528923|P1|STARTED|Overall Study||11
5092150|NCT01673061|12528932|P2|NOT COMPLETED|Overall Study||0
5092151|NCT01673061|12528933|P1|NOT COMPLETED|Overall Study||0
5092152|NCT01673061|12528932|P2|COMPLETED|Overall Study||0
5092153|NCT01673061|12528933|P1|COMPLETED|Overall Study||0
5092154|NCT01673061|12528932|P2|STARTED|Overall Study||0
5092155|NCT01673061|12528933|P1|STARTED|Overall Study||0
5092156|NCT01673022|12528949|P1|NOT COMPLETED|Overall Study||8
5092157|NCT01673022|12528949|P1|COMPLETED|Overall Study||422
5092158|NCT01673022|12528949|P1|STARTED|Overall Study||430
5092159|NCT01673009|12528953|P1|NOT COMPLETED|Overall Study||13
5092160|NCT01673009|12528953|P1|COMPLETED|Overall Study||23
5092161|NCT01673009|12528953|P1|STARTED|Overall Study||36
5092162|NCT01672996|12528965|P3|NOT COMPLETED|Overall Study||0
5092163|NCT01672996|12528966|P2|NOT COMPLETED|Overall Study||0
5092164|NCT01672996|12528967|P1|NOT COMPLETED|Overall Study||0
5092165|NCT01672996|12528965|P3|COMPLETED|Overall Study||6
5092166|NCT01672996|12528966|P2|COMPLETED|Overall Study||30
5092167|NCT01672996|12528967|P1|COMPLETED|Overall Study||30
5092168|NCT01672996|12528965|P3|STARTED|Overall Study||6
5092169|NCT01672996|12528966|P2|STARTED|Overall Study||30
5092170|NCT01672996|12528967|P1|STARTED|Overall Study||30
5092171|NCT01672983|12529003|P6|NOT COMPLETED|Overall Study||0
5092172|NCT01672983|12529004|P5|NOT COMPLETED|Overall Study||0
5092173|NCT01672983|12529005|P4|NOT COMPLETED|Overall Study||0
5092174|NCT01672983|12529006|P3|NOT COMPLETED|Overall Study||0
5092175|NCT01672983|12529007|P2|NOT COMPLETED|Overall Study||0
5092176|NCT01672983|12529008|P1|NOT COMPLETED|Overall Study||0
5092177|NCT01672983|12529003|P6|COMPLETED|Overall Study||18
5092178|NCT01672983|12529004|P5|COMPLETED|Overall Study||19
5092179|NCT01672983|12529005|P4|COMPLETED|Overall Study||18
5092180|NCT01672983|12529006|P3|COMPLETED|Overall Study||19
5092181|NCT01672983|12529007|P2|COMPLETED|Overall Study||18
5092182|NCT01672983|12529008|P1|COMPLETED|Overall Study||18
5092183|NCT01672983|12529003|P6|Completed Study Drug|Overall Study||17
5092184|NCT01672983|12529004|P5|Completed Study Drug|Overall Study||12
5092185|NCT01672983|12529005|P4|Completed Study Drug|Overall Study||18
5092186|NCT01672983|12529006|P3|Completed Study Drug|Overall Study||18
5092187|NCT01672983|12529007|P2|Completed Study Drug|Overall Study||17
5092188|NCT01672983|12529008|P1|Completed Study Drug|Overall Study||18
5092189|NCT01672983|12529003|P6|STARTED|Overall Study||18
5092190|NCT01672983|12529004|P5|STARTED|Overall Study||19
5092191|NCT01672983|12529005|P4|STARTED|Overall Study||18
5092192|NCT01672983|12529006|P3|STARTED|Overall Study||19
5092193|NCT01672983|12529007|P2|STARTED|Overall Study||18
5092194|NCT01672983|12529008|P1|STARTED|Overall Study||18
5092195|NCT01672970|12529038|P1|NOT COMPLETED|Overall Study||47
5092196|NCT01672970|12529038|P1|COMPLETED|Overall Study||244
5092197|NCT01672970|12529038|P1|Treated|Overall Study||290
5092198|NCT01672970|12529038|P1|STARTED|Overall Study||291
5092199|NCT01672957|12529074|P1|NOT COMPLETED|Overall Study||55
5092200|NCT01672957|12529074|P1|COMPLETED|Overall Study||73
5092201|NCT01672957|12529074|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
5092202|NCT01672957|12529074|P1|STARTED|Overall Study||128
5092203|NCT01672892|12529089|P2|NOT COMPLETED|Overall Study||3
5092204|NCT01672892|12529090|P1|NOT COMPLETED|Overall Study||7
5092205|NCT01672892|12529089|P2|COMPLETED|Overall Study||149
5092206|NCT01672892|12529090|P1|COMPLETED|Overall Study||130
5092207|NCT01672892|12529089|P2|Adverse Event Population|Overall Study||144
5092208|NCT01672892|12529090|P1|Adverse Event Population|Overall Study||125
5092209|NCT01672892|12529089|P2|Eligible Population|Overall Study||149
5092210|NCT01672892|12529090|P1|Eligible Population|Overall Study||130
5092211|NCT01672892|12529089|P2|STARTED|Overall Study||152
5092212|NCT01672892|12529090|P1|STARTED|Overall Study||137
5092213|NCT01672879|12529119|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
5092214|NCT01672879|12529120|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
5092215|NCT01672879|12529121|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
5092216|NCT01672879|12529119|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
5092217|NCT01672879|12529120|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
5092218|NCT01672879|12529121|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
5092219|NCT01672879|12529119|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
5092220|NCT01672879|12529120|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
5092221|NCT01672879|12529121|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
5092222|NCT01672879|12529119|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
5092223|NCT01672879|12529120|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
5092224|NCT01672879|12529121|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
5092225|NCT01672879|12529119|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
5092226|NCT01672879|12529120|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
5092227|NCT01672879|12529121|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
5092228|NCT01672879|12529119|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
5092229|NCT01672879|12529120|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
5092230|NCT01672879|12529121|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
5092231|NCT01672866|12529136|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
5092232|NCT01672866|12529137|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
5092233|NCT01672866|12529138|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
5092234|NCT01672866|12529136|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
5092235|NCT01672866|12529137|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
5092236|NCT01672866|12529138|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
5092237|NCT01672866|12529136|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
5092238|NCT01672866|12529137|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
5092239|NCT01672866|12529138|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
5092240|NCT01672866|12529136|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
5092241|NCT01672866|12529137|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
5092242|NCT01672866|12529138|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
5092243|NCT01672866|12529136|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
5092244|NCT01672866|12529137|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
5092245|NCT01672866|12529138|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
5092246|NCT01672866|12529136|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
5092247|NCT01672866|12529137|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
5092248|NCT01672866|12529138|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
5092249|NCT01672853|12529153|P3|NOT COMPLETED|Overall Study||14
5092250|NCT01672853|12529154|P2|NOT COMPLETED|Overall Study||17
5092251|NCT01672853|12529155|P1|NOT COMPLETED|Overall Study||10
5092252|NCT01672853|12529153|P3|COMPLETED|Overall Study||65
5092253|NCT01672853|12529154|P2|COMPLETED|Overall Study||60
5092254|NCT01672853|12529155|P1|COMPLETED|Overall Study||69
5092255|NCT01672853|12529153|P3|STARTED|Overall Study||79
5092256|NCT01672853|12529154|P2|STARTED|Overall Study||77
5092257|NCT01672853|12529155|P1|STARTED|Overall Study||79
5092258|NCT01672827|12529172|P1|NOT COMPLETED|Overall Study||0
5092259|NCT01672827|12529172|P1|COMPLETED|Overall Study||276
5092260|NCT01672827|12529172|P1|STARTED|Overall Study||276
5092261|NCT01672788|12529178|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5092262|NCT01672788|12529179|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5092263|NCT01672788|12529180|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5092264|NCT01672788|12529181|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5092265|NCT01672788|12529178|P4|COMPLETED|Treatment Period 4 (3 Days)||8
5092266|NCT01672788|12529179|P3|COMPLETED|Treatment Period 4 (3 Days)||9
5092267|NCT01672788|12529180|P2|COMPLETED|Treatment Period 4 (3 Days)||9
5092268|NCT01672788|12529181|P1|COMPLETED|Treatment Period 4 (3 Days)||9
5092269|NCT01672788|12529178|P4|STARTED|Treatment Period 4 (3 Days)||8
5092270|NCT01672788|12529179|P3|STARTED|Treatment Period 4 (3 Days)||9
5092271|NCT01672788|12529180|P2|STARTED|Treatment Period 4 (3 Days)||9
5092272|NCT01672788|12529181|P1|STARTED|Treatment Period 4 (3 Days)||9
5092273|NCT01672788|12529178|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
5092274|NCT01672788|12529179|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
5092275|NCT01672788|12529180|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
5092276|NCT01672788|12529181|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
5092277|NCT01672788|12529178|P4|COMPLETED|Washout Period 3 (7 Days)||8
5092278|NCT01672788|12529179|P3|COMPLETED|Washout Period 3 (7 Days)||9
5092279|NCT01672788|12529180|P2|COMPLETED|Washout Period 3 (7 Days)||9
5092280|NCT01672788|12529181|P1|COMPLETED|Washout Period 3 (7 Days)||9
5092281|NCT01672788|12529178|P4|STARTED|Washout Period 3 (7 Days)||8
5092282|NCT01672788|12529179|P3|STARTED|Washout Period 3 (7 Days)||9
5092283|NCT01672788|12529180|P2|STARTED|Washout Period 3 (7 Days)||9
5092284|NCT01672788|12529181|P1|STARTED|Washout Period 3 (7 Days)||9
5092285|NCT01672788|12529178|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5092286|NCT01672788|12529179|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5092287|NCT01672788|12529180|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5092288|NCT01672788|12529181|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5092289|NCT01672788|12529178|P4|COMPLETED|Treatment Period 3 (3 Days)||8
5092290|NCT01672788|12529179|P3|COMPLETED|Treatment Period 3 (3 Days)||9
5092291|NCT01672788|12529180|P2|COMPLETED|Treatment Period 3 (3 Days)||9
5092292|NCT01672788|12529181|P1|COMPLETED|Treatment Period 3 (3 Days)||9
5092293|NCT01672788|12529178|P4|STARTED|Treatment Period 3 (3 Days)||8
5092294|NCT01672788|12529179|P3|STARTED|Treatment Period 3 (3 Days)||9
5092295|NCT01672788|12529180|P2|STARTED|Treatment Period 3 (3 Days)||9
5092296|NCT01672788|12529181|P1|STARTED|Treatment Period 3 (3 Days)||9
5092297|NCT01672788|12529178|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
5092298|NCT01672788|12529179|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5092299|NCT01672788|12529180|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5092300|NCT01672788|12529181|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5092301|NCT01672788|12529178|P4|COMPLETED|Washout Period 2 (7 Days)||8
5092302|NCT01672788|12529179|P3|COMPLETED|Washout Period 2 (7 Days)||9
5092303|NCT01672788|12529180|P2|COMPLETED|Washout Period 2 (7 Days)||9
5092304|NCT01672788|12529181|P1|COMPLETED|Washout Period 2 (7 Days)||9
5092305|NCT01672788|12529178|P4|STARTED|Washout Period 2 (7 Days)||9
5092306|NCT01672788|12529179|P3|STARTED|Washout Period 2 (7 Days)||9
5092307|NCT01672788|12529180|P2|STARTED|Washout Period 2 (7 Days)||9
5092308|NCT01672788|12529181|P1|STARTED|Washout Period 2 (7 Days)||9
5092309|NCT01672788|12529178|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5092310|NCT01672788|12529179|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5092311|NCT01672788|12529180|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5092312|NCT01672788|12529181|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5092313|NCT01672788|12529178|P4|COMPLETED|Treatment Period 2 (3 Days)||9
5092314|NCT01672788|12529179|P3|COMPLETED|Treatment Period 2 (3 Days)||9
5092315|NCT01672788|12529180|P2|COMPLETED|Treatment Period 2 (3 Days)||9
5092316|NCT01672788|12529181|P1|COMPLETED|Treatment Period 2 (3 Days)||9
5092317|NCT01672788|12529178|P4|STARTED|Treatment Period 2 (3 Days)||9
5092318|NCT01672788|12529179|P3|STARTED|Treatment Period 2 (3 Days)||9
5092319|NCT01672788|12529180|P2|STARTED|Treatment Period 2 (3 Days)||9
5092320|NCT01672788|12529181|P1|STARTED|Treatment Period 2 (3 Days)||9
5092321|NCT01672788|12529178|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5092322|NCT01672788|12529179|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
5092323|NCT01672788|12529180|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5092324|NCT01672788|12529181|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5092325|NCT01672788|12529178|P4|COMPLETED|Washout Period 1 (7 Days)||9
5092326|NCT01672788|12529179|P3|COMPLETED|Washout Period 1 (7 Days)||9
5092327|NCT01672788|12529180|P2|COMPLETED|Washout Period 1 (7 Days)||9
5092328|NCT01672788|12529181|P1|COMPLETED|Washout Period 1 (7 Days)||9
5092329|NCT01672788|12529178|P4|STARTED|Washout Period 1 (7 Days)||9
5092330|NCT01672788|12529179|P3|STARTED|Washout Period 1 (7 Days)||9
5092331|NCT01672788|12529180|P2|STARTED|Washout Period 1 (7 Days)||9
5092332|NCT01672788|12529181|P1|STARTED|Washout Period 1 (7 Days)||9
5092333|NCT01672788|12529178|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5092334|NCT01672788|12529179|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5092335|NCT01672788|12529180|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5092336|NCT01672788|12529181|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5092337|NCT01672788|12529178|P4|COMPLETED|Treatment Period 1 (3 Days)||9
5092338|NCT01672788|12529179|P3|COMPLETED|Treatment Period 1 (3 Days)||9
5092339|NCT01672788|12529180|P2|COMPLETED|Treatment Period 1 (3 Days)||9
5092340|NCT01672788|12529181|P1|COMPLETED|Treatment Period 1 (3 Days)||9
5092341|NCT01672788|12529178|P4|STARTED|Treatment Period 1 (3 Days)||9
5092342|NCT01672788|12529179|P3|STARTED|Treatment Period 1 (3 Days)||9
5092343|NCT01672788|12529180|P2|STARTED|Treatment Period 1 (3 Days)||9
5092344|NCT01672788|12529181|P1|STARTED|Treatment Period 1 (3 Days)||9
5092345|NCT01672736|12529211|P1|NOT COMPLETED|Overall Study||3
5092346|NCT01672736|12529211|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
5092347|NCT01672736|12529211|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
5092348|NCT01672723|12529215|P2|NOT COMPLETED|Second Intervention||0
5092349|NCT01672723|12529216|P1|NOT COMPLETED|Second Intervention||0
5092350|NCT01672723|12529215|P2|COMPLETED|Second Intervention||15
5092351|NCT01672723|12529216|P1|COMPLETED|Second Intervention||16
5092352|NCT01672723|12529215|P2|STARTED|Second Intervention||15
5092353|NCT01672723|12529216|P1|STARTED|Second Intervention||16
5092354|NCT01672723|12529215|P2|NOT COMPLETED|Washout Period of 10 Days||0
5092355|NCT01672723|12529216|P1|NOT COMPLETED|Washout Period of 10 Days||0
5092356|NCT01672723|12529215|P2|COMPLETED|Washout Period of 10 Days||15
5092357|NCT01672723|12529216|P1|COMPLETED|Washout Period of 10 Days||16
5092358|NCT01672723|12529215|P2|STARTED|Washout Period of 10 Days||15
5092359|NCT01672723|12529216|P1|STARTED|Washout Period of 10 Days||16
5092360|NCT01672723|12529215|P2|NOT COMPLETED|First Intervention||0
5092361|NCT01672723|12529216|P1|NOT COMPLETED|First Intervention||3
5092362|NCT01672723|12529215|P2|COMPLETED|First Intervention||15
5092363|NCT01672723|12529216|P1|COMPLETED|First Intervention||16
5092364|NCT01672723|12529215|P2|STARTED|First Intervention||15
5092365|NCT01672723|12529216|P1|STARTED|First Intervention||19
5092366|NCT01672710|12529228|P2|NOT COMPLETED|3 Month Follow up||4
5092367|NCT01672710|12529229|P1|NOT COMPLETED|3 Month Follow up||6
5092368|NCT01672710|12529228|P2|COMPLETED|3 Month Follow up||5
5092369|NCT01672710|12529229|P1|COMPLETED|3 Month Follow up||16
5092370|NCT01672710|12529228|P2|STARTED|3 Month Follow up||9
5092371|NCT01672710|12529229|P1|STARTED|3 Month Follow up||22
5092372|NCT01672710|12529228|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
5092373|NCT01672710|12529229|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
5092374|NCT01672710|12529228|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
5092375|NCT01672710|12529229|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
5092376|NCT01672710|12529228|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
5092377|NCT01672710|12529229|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
5092378|NCT01672710|12529228|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
5092379|NCT01672710|12529229|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
5092380|NCT01672710|12529228|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
5092381|NCT01672710|12529229|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
5092382|NCT01672710|12529228|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
5092383|NCT01672710|12529229|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
5092384|NCT01672658|12529239|P2|NOT COMPLETED|Overall Study||1
5092385|NCT01672658|12529240|P1|NOT COMPLETED|Overall Study||0
5092386|NCT01672658|12529239|P2|COMPLETED|Overall Study||14
5092387|NCT01672658|12529240|P1|COMPLETED|Overall Study||16
5092388|NCT01672658|12529239|P2|STARTED|Overall Study||15
5092389|NCT01672658|12529240|P1|STARTED|Overall Study||16
5092390|NCT01672294|12529264|P4|NOT COMPLETED|Overall Study||13
5092391|NCT01672294|12529265|P3|NOT COMPLETED|Overall Study||11
5092392|NCT01672294|12529266|P2|NOT COMPLETED|Overall Study||21
5092393|NCT01672294|12529267|P1|NOT COMPLETED|Overall Study||6
5092394|NCT01672294|12529264|P4|COMPLETED|Overall Study||59
5092395|NCT01672294|12529265|P3|COMPLETED|Overall Study||61
5092396|NCT01672294|12529266|P2|COMPLETED|Overall Study||50
5092397|NCT01672294|12529267|P1|COMPLETED|Overall Study||65
5092398|NCT01672294|12529264|P4|STARTED|Overall Study||72
5092399|NCT01672294|12529265|P3|STARTED|Overall Study||72
5092400|NCT01672294|12529266|P2|STARTED|Overall Study||71
5092401|NCT01672294|12529267|P1|STARTED|Overall Study||71
5092402|NCT01672242|12529289|P2|NOT COMPLETED|Period 2||0
5092403|NCT01672242|12529290|P1|NOT COMPLETED|Period 2||0
5092404|NCT01672242|12529289|P2|COMPLETED|Period 2||2
5092405|NCT01672242|12529290|P1|COMPLETED|Period 2||4
5092406|NCT01672242|12529289|P2|STARTED|Period 2||2
5092407|NCT01672242|12529290|P1|STARTED|Period 2||4
5092408|NCT01672242|12529289|P2|NOT COMPLETED|Period 1||0
5092409|NCT01672242|12529290|P1|NOT COMPLETED|Period 1||0
5092410|NCT01672242|12529289|P2|COMPLETED|Period 1||2
5092411|NCT01672242|12529290|P1|COMPLETED|Period 1||4
5092412|NCT01672242|12529289|P2|STARTED|Period 1||2
5092413|NCT01672242|12529290|P1|STARTED|Period 1||4
5092414|NCT01671839|12529296|P1|NOT COMPLETED|Overall Study||18
5092415|NCT01671839|12529296|P1|COMPLETED|Overall Study||37
5092416|NCT01671839|12529296|P1|5-year Follow-up|Overall Study||37
5092417|NCT01671839|12529296|P1|3-year Follow-up|Overall Study||45
5092418|NCT01671839|12529296|P1|STARTED|Overall Study||55
5092419|NCT01671748|12529312|P2|NOT COMPLETED|12 Week Treatment Phase||0
5092420|NCT01671748|12529313|P1|NOT COMPLETED|12 Week Treatment Phase||0
5092421|NCT01671748|12529312|P2|COMPLETED|12 Week Treatment Phase||17
5092422|NCT01671748|12529313|P1|COMPLETED|12 Week Treatment Phase||19
5092423|NCT01671748|12529312|P2|STARTED|12 Week Treatment Phase||17
5092424|NCT01671748|12529313|P1|STARTED|12 Week Treatment Phase||19
5092425|NCT01671748|12529312|P2|NOT COMPLETED|4 Week run-in Phase||0
5092426|NCT01671748|12529313|P1|NOT COMPLETED|4 Week run-in Phase||11
5092427|NCT01671748|12529312|P2|COMPLETED|4 Week run-in Phase||0
5092428|NCT01671748|12529313|P1|COMPLETED|4 Week run-in Phase||36
5092429|NCT01671748|12529312|P2|STARTED|4 Week run-in Phase||0
5092430|NCT01671748|12529313|P1|STARTED|4 Week run-in Phase||47
5092431|NCT01671605|12529333|P2|NOT COMPLETED|Overall Study||0
5092432|NCT01671605|12529334|P1|NOT COMPLETED|Overall Study||0
5092433|NCT01671605|12529333|P2|COMPLETED|Overall Study||31
5092434|NCT01671605|12529334|P1|COMPLETED|Overall Study||72
5092435|NCT01671605|12529333|P2|STARTED|Overall Study||31
5092436|NCT01671605|12529334|P1|STARTED|Overall Study||72
5092437|NCT01671488|12529340|P1|NOT COMPLETED|Overall Study||1
5092438|NCT01671488|12529340|P1|COMPLETED|Overall Study||10
5092439|NCT01671488|12529340|P1|STARTED|Overall Study||11
5092440|NCT01671345|12529348|P2|NOT COMPLETED|Overall Study||9
5092441|NCT01671345|12529349|P1|NOT COMPLETED|Overall Study||13
5092442|NCT01671345|12529348|P2|COMPLETED|Overall Study||83
5092443|NCT01671345|12529349|P1|COMPLETED|Overall Study||64
5092444|NCT01671345|12529348|P2|STARTED|Overall Study||92
5092445|NCT01671345|12529349|P1|STARTED|Overall Study||77
5092446|NCT01671332|12529363|P2|NOT COMPLETED|Overall Study||1
5092447|NCT01671332|12529364|P1|NOT COMPLETED|Overall Study||1
5092448|NCT01671332|12529363|P2|COMPLETED|Overall Study||39
5092449|NCT01671332|12529364|P1|COMPLETED|Overall Study||39
5092450|NCT01671332|12529363|P2|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
5092451|NCT01671332|12529364|P1|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
5092452|NCT01671332|12529363|P2|STARTED|Overall Study||40
5092453|NCT01671332|12529364|P1|STARTED|Overall Study||40
5092454|NCT01671319|12529378|P1|NOT COMPLETED|Overall Study||1
5092455|NCT01671319|12529378|P1|COMPLETED|Overall Study||41
5092456|NCT01671319|12529378|P1|STARTED|Overall Study||42
5092457|NCT01671293|12529386|P2|NOT COMPLETED|Overall Study||2
5092458|NCT01671293|12529387|P1|NOT COMPLETED|Overall Study||3
5092459|NCT01671293|12529386|P2|COMPLETED|Overall Study||32
5092460|NCT01671293|12529387|P1|COMPLETED|Overall Study||33
5092461|NCT01671293|12529386|P2|STARTED|Overall Study||34
5092462|NCT01671293|12529387|P1|STARTED|Overall Study||36
5092463|NCT01671280|12529393|P1|NOT COMPLETED|Overall Study||2
5092464|NCT01671280|12529393|P1|COMPLETED|Overall Study||401
5092465|NCT01671280|12529393|P1|STARTED|Overall Study|The number is enrollment.|403
5092466|NCT01671176|12529399|P1|NOT COMPLETED|Overall Study||0
5092467|NCT01671176|12529399|P1|COMPLETED|Overall Study||30
5092468|NCT01671176|12529399|P1|STARTED|Overall Study||30
5092469|NCT01671111|12529404|P1|NOT COMPLETED|Overall Study||30
5092470|NCT01671111|12529404|P1|COMPLETED|Overall Study||0
5092471|NCT01671111|12529404|P1|STARTED|Overall Study||30
5092472|NCT01671085|12529416|P2|NOT COMPLETED|Overall Study||0
5092473|NCT01671085|12529417|P1|NOT COMPLETED|Overall Study||1
5092474|NCT01671085|12529416|P2|COMPLETED|Overall Study||2
5092475|NCT01671085|12529417|P1|COMPLETED|Overall Study||10
5092476|NCT01671085|12529416|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
5092477|NCT01671085|12529417|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
5092478|NCT01671085|12529416|P2|STARTED|Overall Study||2
5092479|NCT01671085|12529417|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
5092480|NCT01671059|12529428|P1|NOT COMPLETED|Overall Study||5
5092481|NCT01671059|12529428|P1|COMPLETED|Overall Study||75
5092482|NCT01671059|12529428|P1|STARTED|Overall Study||80
5092483|NCT01670825|12529453|P2|NOT COMPLETED|Overall Study||0
5092484|NCT01670825|12529454|P1|NOT COMPLETED|Overall Study||0
5092485|NCT01670825|12529453|P2|COMPLETED|Overall Study||39
5092486|NCT01670825|12529454|P1|COMPLETED|Overall Study||42
5092487|NCT01670825|12529453|P2|STARTED|Overall Study||39
5092488|NCT01670825|12529454|P1|STARTED|Overall Study||42
5092489|NCT01670721|12529520|P1|NOT COMPLETED|Overall Study||53
5092490|NCT01670721|12529520|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
5092491|NCT01670721|12529520|P1|STARTED|Overall Study||175
5092492|NCT01670656|12529532|P5|NOT COMPLETED|Overall Study||11
5092493|NCT01670656|12529533|P4|NOT COMPLETED|Overall Study||6
5092494|NCT01670656|12529534|P3|NOT COMPLETED|Overall Study||8
5092495|NCT01670656|12529535|P2|NOT COMPLETED|Overall Study||7
5092496|NCT01670656|12529536|P1|NOT COMPLETED|Overall Study||3
5092497|NCT01670656|12529532|P5|COMPLETED|Overall Study||79
5092498|NCT01670656|12529533|P4|COMPLETED|Overall Study||79
5092499|NCT01670656|12529534|P3|COMPLETED|Overall Study||79
5092500|NCT01670656|12529535|P2|COMPLETED|Overall Study||84
5092501|NCT01670656|12529536|P1|COMPLETED|Overall Study||83
5092502|NCT01670656|12529532|P5|Treated|Overall Study||90
5092503|NCT01670656|12529533|P4|Treated|Overall Study||85
5092504|NCT01670656|12529534|P3|Treated|Overall Study||86
5092505|NCT01670656|12529535|P2|Treated|Overall Study||91
5092506|NCT01670656|12529536|P1|Treated|Overall Study||86
5092507|NCT01670656|12529532|P5|STARTED|Overall Study||90
5092508|NCT01670656|12529533|P4|STARTED|Overall Study||85
5092509|NCT01670656|12529534|P3|STARTED|Overall Study||87
5092510|NCT01670656|12529535|P2|STARTED|Overall Study||91
5092511|NCT01670656|12529536|P1|STARTED|Overall Study||86
5092512|NCT01670526|12529565|P2|NOT COMPLETED|Overall Study||6
5092513|NCT01670526|12529566|P1|NOT COMPLETED|Overall Study||12
5092514|NCT01670526|12529565|P2|COMPLETED|Overall Study||39
5092515|NCT01670526|12529566|P1|COMPLETED|Overall Study||37
5092516|NCT01670526|12529565|P2|STARTED|Overall Study||45
5092517|NCT01670526|12529566|P1|STARTED|Overall Study||49
5092518|NCT01670487|12529580|P2|NOT COMPLETED|Overall Study||0
5092519|NCT01670487|12529581|P1|NOT COMPLETED|Overall Study||0
5092520|NCT01670487|12529580|P2|COMPLETED|Overall Study||150
5092521|NCT01670487|12529581|P1|COMPLETED|Overall Study||150
5092522|NCT01670487|12529580|P2|STARTED|Overall Study||150
5092523|NCT01670487|12529581|P1|STARTED|Overall Study||150
5092524|NCT01670292|12529587|P1|NOT COMPLETED|Overall Study||14
5092525|NCT01670292|12529587|P1|COMPLETED|Overall Study||68
5092526|NCT01670292|12529587|P1|STARTED|Overall Study||82
5092527|NCT01670279|12529628|P4|NOT COMPLETED|Overall Study||1
5092528|NCT01670279|12529629|P3|NOT COMPLETED|Overall Study||0
5092529|NCT01670279|12529630|P2|NOT COMPLETED|Overall Study||2
5092530|NCT01670279|12529631|P1|NOT COMPLETED|Overall Study||0
5092531|NCT01670279|12529628|P4|COMPLETED|Overall Study||4
5092532|NCT01670279|12529629|P3|COMPLETED|Overall Study||0
5092533|NCT01670279|12529630|P2|COMPLETED|Overall Study||5
5092534|NCT01670279|12529631|P1|COMPLETED|Overall Study||6
5092535|NCT01670279|12529628|P4|STARTED|Overall Study||5
5092536|NCT01670279|12529629|P3|STARTED|Overall Study||0
5092537|NCT01670279|12529630|P2|STARTED|Overall Study||7
5092538|NCT01670279|12529631|P1|STARTED|Overall Study||6
5092539|NCT01670201|12529666|P1|NOT COMPLETED|Overall Study||0
5092540|NCT01670201|12529666|P1|COMPLETED|Overall Study||8
5092541|NCT01670201|12529666|P1|STARTED|Overall Study||8
5092542|NCT01670188|12529673|P2|NOT COMPLETED|Overall Study||1
5092543|NCT01670188|12529674|P1|NOT COMPLETED|Overall Study||0
5092544|NCT01670188|12529673|P2|COMPLETED|Overall Study||39
5092545|NCT01670188|12529674|P1|COMPLETED|Overall Study||38
5092546|NCT01670188|12529673|P2|STARTED|Overall Study||40
5092547|NCT01670188|12529674|P1|STARTED|Overall Study||38
5092548|NCT01670110|12529682|P2|NOT COMPLETED|Overall Study||3
5092549|NCT01670110|12529683|P1|NOT COMPLETED|Overall Study||4
5092550|NCT01670110|12529682|P2|COMPLETED|Overall Study||12
5092551|NCT01670110|12529683|P1|COMPLETED|Overall Study||29
5092552|NCT01670110|12529682|P2|STARTED|Overall Study||15
5092553|NCT01670110|12529683|P1|STARTED|Overall Study||33
5092554|NCT01670045|12529703|P1|NOT COMPLETED|Overall Study||16
5092555|NCT01670045|12529703|P1|COMPLETED|Overall Study||27
5092556|NCT01670045|12529703|P1|STARTED|Overall Study||43
5092557|NCT01670019|12529721|P2|NOT COMPLETED|Overall Study||0
5092558|NCT01670019|12529722|P1|NOT COMPLETED|Overall Study||9
5092559|NCT01670019|12529721|P2|COMPLETED|Overall Study||23
5092560|NCT01670019|12529722|P1|COMPLETED|Overall Study||14
5092561|NCT01670019|12529721|P2|STARTED|Overall Study||23
5092562|NCT01670019|12529722|P1|STARTED|Overall Study||23
5092563|NCT01669902|12529736|P1|NOT COMPLETED|Overall Study||29
5092564|NCT01669902|12529736|P1|COMPLETED|Overall Study||78
5092565|NCT01669902|12529736|P1|STARTED|Overall Study||107
5092566|NCT01669863|12529763|P1|NOT COMPLETED|Overall Study||0
5092567|NCT01669863|12529763|P1|COMPLETED|Overall Study||6
5092568|NCT01669863|12529763|P1|STARTED|Overall Study||6
5092569|NCT01669811|12529771|P2|NOT COMPLETED|Overall Study||11
5092570|NCT01669811|12529772|P1|NOT COMPLETED|Overall Study||3
5092571|NCT01669811|12529771|P2|COMPLETED|Overall Study||131
5092572|NCT01669811|12529772|P1|COMPLETED|Overall Study||142
5092573|NCT01669811|12529771|P2|STARTED|Overall Study||142
5092574|NCT01669811|12529772|P1|STARTED|Overall Study||145
5092575|NCT01669798|12529790|P1|NOT COMPLETED|Overall Study||5
5092576|NCT01669798|12529790|P1|COMPLETED|Overall Study||27
5092577|NCT01669798|12529790|P1|STARTED|Overall Study||32
5092578|NCT01669785|12529806|P3|NOT COMPLETED|Overall Study||0
5092579|NCT01669785|12529807|P2|NOT COMPLETED|Overall Study||0
5092580|NCT01669785|12529808|P1|NOT COMPLETED|Overall Study||0
5092581|NCT01669785|12529806|P3|COMPLETED|Overall Study||46
5092582|NCT01669785|12529807|P2|COMPLETED|Overall Study||48
5092583|NCT01669785|12529808|P1|COMPLETED|Overall Study||45
5092584|NCT01669785|12529806|P3|STARTED|Overall Study||46
5092585|NCT01669785|12529807|P2|STARTED|Overall Study||48
5092586|NCT01669785|12529808|P1|STARTED|Overall Study||45
5092587|NCT01669720|12529845|P2|NOT COMPLETED|Overall Study||0
5092588|NCT01669720|12529846|P1|NOT COMPLETED|Overall Study||0
5092589|NCT01669720|12529845|P2|COMPLETED|Overall Study||3
5092590|NCT01669720|12529846|P1|COMPLETED|Overall Study||7
5092591|NCT01669720|12529845|P2|STARTED|Overall Study||3
5092592|NCT01669720|12529846|P1|STARTED|Overall Study||7
5092593|NCT01669642|12529859|P6|NOT COMPLETED|Overall Study||10
5092594|NCT01669642|12529860|P5|NOT COMPLETED|Overall Study||0
5092595|NCT01669642|12529861|P4|NOT COMPLETED|Overall Study||1
5092596|NCT01669642|12529862|P3|NOT COMPLETED|Overall Study||0
5092597|NCT01669642|12529863|P2|NOT COMPLETED|Overall Study||0
5092598|NCT01669642|12529864|P1|NOT COMPLETED|Overall Study||0
5092599|NCT01669642|12529859|P6|COMPLETED|Overall Study||0
5092600|NCT01669642|12529860|P5|COMPLETED|Overall Study||20
5092601|NCT01669642|12529861|P4|COMPLETED|Overall Study||20
5092602|NCT01669642|12529862|P3|COMPLETED|Overall Study||20
5092603|NCT01669642|12529863|P2|COMPLETED|Overall Study||20
5092604|NCT01669642|12529864|P1|COMPLETED|Overall Study||20
5092605|NCT01669642|12529859|P6|STARTED|Overall Study||10
5092606|NCT01669642|12529860|P5|STARTED|Overall Study||20
5092607|NCT01669642|12529861|P4|STARTED|Overall Study||21
5092608|NCT01669642|12529862|P3|STARTED|Overall Study||20
5092609|NCT01669642|12529863|P2|STARTED|Overall Study||20
5092610|NCT01669642|12529864|P1|STARTED|Overall Study||20
5092611|NCT01669629|12529896|P2|NOT COMPLETED|Period 2||0
5092612|NCT01669629|12529897|P1|NOT COMPLETED|Period 2||0
5092613|NCT01669629|12529896|P2|COMPLETED|Period 2||89
5092614|NCT01669629|12529897|P1|COMPLETED|Period 2||91
5092615|NCT01669629|12529896|P2|STARTED|Period 2||89
5092616|NCT01669629|12529897|P1|STARTED|Period 2||91
5092617|NCT01669629|12529896|P2|NOT COMPLETED|Period 1||2
5092618|NCT01669629|12529897|P1|NOT COMPLETED|Period 1||1
5092619|NCT01669629|12529896|P2|COMPLETED|Period 1||89
5092620|NCT01669629|12529897|P1|COMPLETED|Period 1||91
5092621|NCT01669629|12529896|P2|STARTED|Period 1||91
5092622|NCT01669629|12529897|P1|STARTED|Period 1||92
5092623|NCT01669603|12529913|P2|NOT COMPLETED|Overall Study||38
5092624|NCT01669603|12529914|P1|NOT COMPLETED|Overall Study||37
5092625|NCT01669603|12529913|P2|COMPLETED|Overall Study||57
5092626|NCT01669603|12529914|P1|COMPLETED|Overall Study||58
5092627|NCT01669603|12529913|P2|STARTED|Overall Study||95
5092628|NCT01669603|12529914|P1|STARTED|Overall Study||95
5092629|NCT01669577|12529920|P1|NOT COMPLETED|Overall Study||134
5092630|NCT01669577|12529920|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
5092631|NCT01669577|12529920|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
5092632|NCT01669538|12529926|P2|NOT COMPLETED|Overall Study||9
5092633|NCT01669538|12529927|P1|NOT COMPLETED|Overall Study||12
5092634|NCT01669538|12529926|P2|COMPLETED|Overall Study||33
5092635|NCT01669538|12529927|P1|COMPLETED|Overall Study||28
5092636|NCT01669538|12529926|P2|STARTED|Overall Study||42
5092637|NCT01669538|12529927|P1|STARTED|Overall Study||40
5092638|NCT01669434|12529941|P2|NOT COMPLETED|Overall Study||7
5092639|NCT01669434|12529942|P1|NOT COMPLETED|Overall Study||9
5092640|NCT01669434|12529941|P2|COMPLETED|Overall Study||138
5092641|NCT01669434|12529942|P1|COMPLETED|Overall Study||137
5092642|NCT01669434|12529941|P2|STARTED|Overall Study||145
5092643|NCT01669434|12529942|P1|STARTED|Overall Study||146
5092644|NCT01669421|12529958|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
5092645|NCT01669421|12529958|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
5092646|NCT01669421|12529958|P1|STARTED|Phase 3: Standard Dose Therapy||8
5092647|NCT01669421|12529958|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
5092648|NCT01669421|12529958|P1|COMPLETED|Phase 2: Double Dose Therapy||8
5092649|NCT01669421|12529958|P1|STARTED|Phase 2: Double Dose Therapy||8
5092650|NCT01669421|12529958|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
5092651|NCT01669421|12529958|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
5092652|NCT01669421|12529958|P1|STARTED|Phase 1: Standard Dose Therapy||10
5092653|NCT01669174|12529977|P2|NOT COMPLETED|Overall Study||6
5092654|NCT01669174|12529978|P1|NOT COMPLETED|Overall Study||6
5092655|NCT01669174|12529977|P2|COMPLETED|Overall Study||28
5092656|NCT01669174|12529978|P1|COMPLETED|Overall Study||27
5092657|NCT01669174|12529977|P2|STARTED|Overall Study||34
5092658|NCT01669174|12529978|P1|STARTED|Overall Study||33
5092659|NCT01669148|12529989|P1|NOT COMPLETED|Overall Study||70
5092660|NCT01669148|12529989|P1|COMPLETED|Overall Study||426
5092661|NCT01669148|12529989|P1|STARTED|Overall Study||496
5092662|NCT01669122|12529994|P1|NOT COMPLETED|Period IV||0
5092663|NCT01669122|12529994|P1|COMPLETED|Period IV||37
5092664|NCT01669122|12529994|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
5092665|NCT01669122|12529994|P1|NOT COMPLETED|Period III||0
5092666|NCT01669122|12529994|P1|COMPLETED|Period III||37
5092667|NCT01669122|12529994|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
5092668|NCT01669122|12529994|P1|NOT COMPLETED|Washout Period III||0
5092669|NCT01669122|12529994|P1|COMPLETED|Washout Period III||37
5092670|NCT01669122|12529994|P1|STARTED|Washout Period III||37
5092671|NCT01669122|12529994|P1|NOT COMPLETED|Washout Period II||2
5092672|NCT01669122|12529994|P1|COMPLETED|Washout Period II||37
5092673|NCT01669122|12529994|P1|STARTED|Washout Period II||39
5092674|NCT01669122|12529994|P1|NOT COMPLETED|Period II||0
5092675|NCT01669122|12529994|P1|COMPLETED|Period II||39
5092676|NCT01669122|12529994|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
5092677|NCT01669122|12529994|P1|NOT COMPLETED|Washout Period I||0
5092678|NCT01669122|12529994|P1|COMPLETED|Washout Period I||39
5092679|NCT01669122|12529994|P1|STARTED|Washout Period I||39
5092680|NCT01669122|12529994|P1|NOT COMPLETED|Period I||1
5092681|NCT01669122|12529994|P1|COMPLETED|Period I||39
5092682|NCT01669122|12529994|P1|Safety Population|Period I||39
5092683|NCT01669122|12529994|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
5092684|NCT01669096|12530024|P1|NOT COMPLETED|Overall Study||0
5092685|NCT01669096|12530024|P1|COMPLETED|Overall Study||20
5092686|NCT01669096|12530024|P1|STARTED|Overall Study||20
5092687|NCT01668966|12530061|P1|NOT COMPLETED|Overall Study||4
5092688|NCT01668966|12530061|P1|COMPLETED|Overall Study||19
5092689|NCT01668966|12530061|P1|Treated|Overall Study||21
5092690|NCT01668966|12530061|P1|STARTED|Overall Study||23
5092691|NCT01668940|12530081|P4|NOT COMPLETED|Overall Study||0
5092692|NCT01668940|12530082|P3|NOT COMPLETED|Overall Study||0
5092693|NCT01668940|12530083|P2|NOT COMPLETED|Overall Study||0
5092694|NCT01668940|12530084|P1|NOT COMPLETED|Overall Study||0
5092695|NCT01668940|12530081|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
5092696|NCT01668940|12530082|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
5092697|NCT01668940|12530083|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
5092698|NCT01668940|12530084|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
5092699|NCT01668940|12530081|P4|STARTED|Overall Study||14
5092700|NCT01668940|12530082|P3|STARTED|Overall Study||9
5092701|NCT01668940|12530083|P2|STARTED|Overall Study||14
5092702|NCT01668940|12530084|P1|STARTED|Overall Study||17
5092703|NCT01668836|12530098|P4|NOT COMPLETED|Overall Study||0
5092704|NCT01668836|12530099|P3|NOT COMPLETED|Overall Study||0
5092705|NCT01668836|12530100|P2|NOT COMPLETED|Overall Study||0
5092706|NCT01668836|12530101|P1|NOT COMPLETED|Overall Study||0
5092707|NCT01668836|12530098|P4|COMPLETED|Overall Study||12
5092708|NCT01668836|12530099|P3|COMPLETED|Overall Study||12
5092709|NCT01668836|12530100|P2|COMPLETED|Overall Study||12
5092710|NCT01668836|12530101|P1|COMPLETED|Overall Study||12
5092711|NCT01668836|12530098|P4|STARTED|Overall Study||12
5092712|NCT01668836|12530099|P3|STARTED|Overall Study||12
5092713|NCT01668836|12530100|P2|STARTED|Overall Study||12
5092714|NCT01668836|12530101|P1|STARTED|Overall Study||12
5092715|NCT01668797|12530157|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
5092716|NCT01668797|12530158|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
5092717|NCT01668797|12530159|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
5092718|NCT01668797|12530160|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
5092719|NCT01668797|12530157|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
5092720|NCT01668797|12530158|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
5092721|NCT01668797|12530159|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
5092722|NCT01668797|12530160|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
5092723|NCT01668797|12530157|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
5092724|NCT01668797|12530158|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
5092725|NCT01668797|12530159|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
5092726|NCT01668797|12530160|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
5092727|NCT01668797|12530157|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
5092728|NCT01668797|12530158|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
5092729|NCT01668797|12530159|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
5092730|NCT01668797|12530160|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
5092731|NCT01668797|12530157|P4|COMPLETED|Phase B (Stabilization Phase)||0
5092732|NCT01668797|12530158|P3|COMPLETED|Phase B (Stabilization Phase)||0
5092733|NCT01668797|12530159|P2|COMPLETED|Phase B (Stabilization Phase)||202
5092734|NCT01668797|12530160|P1|COMPLETED|Phase B (Stabilization Phase)||0
5092735|NCT01668797|12530157|P4|STARTED|Phase B (Stabilization Phase)||0
5092736|NCT01668797|12530158|P3|STARTED|Phase B (Stabilization Phase)||0
5092737|NCT01668797|12530159|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
5092738|NCT01668797|12530160|P1|STARTED|Phase B (Stabilization Phase)||0
5092739|NCT01668797|12530157|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
5092740|NCT01668797|12530158|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
5092741|NCT01668797|12530159|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
5092742|NCT01668797|12530160|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
5092743|NCT01668797|12530157|P4|COMPLETED|Phase A (Conversion Phase)||0
5092744|NCT01668797|12530158|P3|COMPLETED|Phase A (Conversion Phase)||0
5092745|NCT01668797|12530159|P2|COMPLETED|Phase A (Conversion Phase)||0
5092746|NCT01668797|12530160|P1|COMPLETED|Phase A (Conversion Phase)||346
5092747|NCT01668797|12530157|P4|STARTED|Phase A (Conversion Phase)||0
5092748|NCT01668797|12530158|P3|STARTED|Phase A (Conversion Phase)||0
5092749|NCT01668797|12530159|P2|STARTED|Phase A (Conversion Phase)||0
5092750|NCT01668797|12530160|P1|STARTED|Phase A (Conversion Phase)||406
5092751|NCT01668784|12530225|P2|NOT COMPLETED|Treated (Overall)||369
5092752|NCT01668784|12530226|P1|NOT COMPLETED|Treated (Overall)||339
5092753|NCT01668784|12530225|P2|COMPLETED|Treated (Overall)||28
5092754|NCT01668784|12530226|P1|COMPLETED|Treated (Overall)||67
5092755|NCT01668784|12530225|P2|STARTED|Treated (Overall)||397
5092756|NCT01668784|12530226|P1|STARTED|Treated (Overall)||406
5092757|NCT01668784|12530225|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
5092758|NCT01668784|12530226|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
5092759|NCT01668784|12530225|P2|COMPLETED|Randomized (Pre-treatment)||397
5092760|NCT01668784|12530226|P1|COMPLETED|Randomized (Pre-treatment)||406
5092761|NCT01668784|12530225|P2|STARTED|Randomized (Pre-treatment)||411
5092762|NCT01668784|12530226|P1|STARTED|Randomized (Pre-treatment)||410
5092763|NCT01668667|12530254|P4|NOT COMPLETED|Overall Study||23
5092764|NCT01668667|12530255|P3|NOT COMPLETED|Overall Study||31
5092765|NCT01668667|12530256|P2|NOT COMPLETED|Overall Study||26
5092766|NCT01668667|12530257|P1|NOT COMPLETED|Overall Study||31
5092767|NCT01668667|12530254|P4|COMPLETED|Overall Study||102
5092768|NCT01668667|12530255|P3|COMPLETED|Overall Study||94
5092769|NCT01668667|12530256|P2|COMPLETED|Overall Study||99
5092770|NCT01668667|12530257|P1|COMPLETED|Overall Study||95
5092771|NCT01668667|12530254|P4|STARTED|Overall Study||125
5092772|NCT01668667|12530255|P3|STARTED|Overall Study||125
5092773|NCT01668667|12530256|P2|STARTED|Overall Study||125
5092774|NCT01668667|12530257|P1|STARTED|Overall Study||126
5092775|NCT01668654|12530279|P1|NOT COMPLETED|Overall Study||4
5092776|NCT01668654|12530279|P1|COMPLETED|Overall Study||0
5092777|NCT01668654|12530279|P1|STARTED|Overall Study||4
5092778|NCT01668628|12530322|P3|NOT COMPLETED|Overall Study||0
5092779|NCT01668628|12530323|P2|NOT COMPLETED|Overall Study||0
5092780|NCT01668628|12530324|P1|NOT COMPLETED|Overall Study||2
5092781|NCT01668628|12530322|P3|COMPLETED|Overall Study||367
5092782|NCT01668628|12530323|P2|COMPLETED|Overall Study||359
5092783|NCT01668628|12530324|P1|COMPLETED|Overall Study||347
5092784|NCT01668628|12530322|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
5092785|NCT01668628|12530323|P2|STARTED|Overall Study||359
5092786|NCT01668628|12530324|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
5092787|NCT01668589|12530340|P4|NOT COMPLETED|Overall Study||35
5092788|NCT01668589|12530341|P3|NOT COMPLETED|Overall Study||35
5092789|NCT01668589|12530342|P2|NOT COMPLETED|Overall Study||58
5092790|NCT01668589|12530343|P1|NOT COMPLETED|Overall Study||139
5092791|NCT01668589|12530340|P4|COMPLETED|Overall Study||266
5092792|NCT01668589|12530341|P3|COMPLETED|Overall Study||265
5092793|NCT01668589|12530342|P2|COMPLETED|Overall Study||242
5092794|NCT01668589|12530343|P1|COMPLETED|Overall Study||461
5092795|NCT01668589|12530340|P4|Received Denosumab|Overall Study||301
5092796|NCT01668589|12530341|P3|Received Denosumab|Overall Study||300
5092797|NCT01668589|12530342|P2|Received Denosumab|Overall Study||300
5092798|NCT01668589|12530343|P1|Received Denosumab|Overall Study||599
5092799|NCT01668589|12530340|P4|STARTED|Overall Study||301
5092800|NCT01668589|12530341|P3|STARTED|Overall Study||300
5092801|NCT01668589|12530342|P2|STARTED|Overall Study||300
5092802|NCT01668589|12530343|P1|STARTED|Overall Study||600
5092803|NCT01668355|12530383|P2|NOT COMPLETED|Overall Study||2
5092804|NCT01668355|12530384|P1|NOT COMPLETED|Overall Study||9
5092805|NCT01668355|12530383|P2|COMPLETED|Overall Study||165
5092806|NCT01668355|12530384|P1|COMPLETED|Overall Study||155
5092807|NCT01668355|12530383|P2|STARTED|Overall Study||167
5092808|NCT01668355|12530384|P1|STARTED|Overall Study||164
5092809|NCT01668173|12530404|P1|NOT COMPLETED|Overall Study||7
5092810|NCT01668173|12530404|P1|COMPLETED|Overall Study||0
5092811|NCT01668173|12530404|P1|STARTED|Overall Study||7
5092812|NCT01668147|12530408|P1|NOT COMPLETED|Overall Study||6
5092813|NCT01668147|12530408|P1|COMPLETED|Overall Study||7
5092814|NCT01668147|12530408|P1|STARTED|Overall Study||13
5092815|NCT01668030|12530416|P2|NOT COMPLETED|Overall Study||0
5092816|NCT01668030|12530417|P1|NOT COMPLETED|Overall Study||0
5092817|NCT01668030|12530416|P2|COMPLETED|Overall Study||10
5092818|NCT01668030|12530417|P1|COMPLETED|Overall Study||10
5092819|NCT01668030|12530416|P2|STARTED|Overall Study||10
5092820|NCT01668030|12530417|P1|STARTED|Overall Study||10
5092821|NCT01668017|12530427|P5|NOT COMPLETED|Overall Study||0
5092822|NCT01668017|12530428|P4|NOT COMPLETED|Overall Study||0
5092823|NCT01668017|12530429|P3|NOT COMPLETED|Overall Study||0
5092824|NCT01668017|12530430|P2|NOT COMPLETED|Overall Study||0
5092825|NCT01668017|12530431|P1|NOT COMPLETED|Overall Study||0
5092826|NCT01668017|12530427|P5|COMPLETED|Overall Study||2
5092827|NCT01668017|12530428|P4|COMPLETED|Overall Study||5
5092828|NCT01668017|12530429|P3|COMPLETED|Overall Study||6
5092829|NCT01668017|12530430|P2|COMPLETED|Overall Study||9
5092830|NCT01668017|12530431|P1|COMPLETED|Overall Study||4
5092831|NCT01668017|12530427|P5|STARTED|Overall Study||2
5092832|NCT01668017|12530428|P4|STARTED|Overall Study||5
5092833|NCT01668017|12530429|P3|STARTED|Overall Study||6
5092834|NCT01668017|12530430|P2|STARTED|Overall Study||9
5092835|NCT01668017|12530431|P1|STARTED|Overall Study||4
5092836|NCT01668004|12530538|P1|NOT COMPLETED|Overall Study||25
5092837|NCT01668004|12530538|P1|COMPLETED|Overall Study||76
5092838|NCT01668004|12530538|P1|Treated|Overall Study||101
5092839|NCT01668004|12530538|P1|STARTED|Overall Study||101
5092840|NCT01667978|12530551|P2|NOT COMPLETED|Overall Study||0
5092841|NCT01667978|12530552|P1|NOT COMPLETED|Overall Study||2
5092842|NCT01667978|12530551|P2|COMPLETED|Overall Study||17
5092843|NCT01667978|12530552|P1|COMPLETED|Overall Study||16
5092844|NCT01667978|12530551|P2|STARTED|Overall Study||17
5092845|NCT01667978|12530552|P1|STARTED|Overall Study||18
5092846|NCT01667926|12530560|P3|NOT COMPLETED|Overall Study||11
5092847|NCT01667926|12530561|P2|NOT COMPLETED|Overall Study||4
5092848|NCT01667926|12530562|P1|NOT COMPLETED|Overall Study||5
5092849|NCT01667926|12530560|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
5092850|NCT01667926|12530561|P2|COMPLETED|Overall Study||9
5092851|NCT01667926|12530562|P1|COMPLETED|Overall Study||8
5092852|NCT01667926|12530560|P3|STARTED|Overall Study||11
5092853|NCT01667926|12530561|P2|STARTED|Overall Study||13
5092854|NCT01667926|12530562|P1|STARTED|Overall Study||13
5092855|NCT01667900|12530575|P20|NOT COMPLETED|Part B||0
5092856|NCT01667900|12530576|P19|NOT COMPLETED|Part B||0
5092857|NCT01667900|12530577|P18|NOT COMPLETED|Part B||0
5092858|NCT01667900|12530578|P17|NOT COMPLETED|Part B||1
5092859|NCT01667900|12530579|P16|NOT COMPLETED|Part B||0
5092860|NCT01667900|12530580|P15|NOT COMPLETED|Part B||0
5092861|NCT01667900|12530581|P14|NOT COMPLETED|Part B||0
5092862|NCT01667900|12530582|P13|NOT COMPLETED|Part B||0
5092863|NCT01667900|12530583|P12|NOT COMPLETED|Part B||0
5092864|NCT01667900|12530584|P11|NOT COMPLETED|Part B||0
5092865|NCT01667900|12530585|P10|NOT COMPLETED|Part B||0
5092866|NCT01667900|12530586|P9|NOT COMPLETED|Part B||0
5092867|NCT01667900|12530587|P8|NOT COMPLETED|Part B||0
5092868|NCT01667900|12530588|P7|NOT COMPLETED|Part B||0
5092869|NCT01667900|12530589|P6|NOT COMPLETED|Part B||0
5092870|NCT01667900|12530590|P5|NOT COMPLETED|Part B||0
5092871|NCT01667900|12530591|P4|NOT COMPLETED|Part B||0
5092872|NCT01667900|12530592|P3|NOT COMPLETED|Part B||0
5092873|NCT01667900|12530593|P2|NOT COMPLETED|Part B||0
5092874|NCT01667900|12530594|P1|NOT COMPLETED|Part B||0
5092875|NCT01667900|12530575|P20|COMPLETED|Part B||10
5092876|NCT01667900|12530576|P19|COMPLETED|Part B||10
5092877|NCT01667900|12530577|P18|COMPLETED|Part B||11
5092878|NCT01667900|12530578|P17|COMPLETED|Part B||10
5092879|NCT01667900|12530579|P16|COMPLETED|Part B||0
5092880|NCT01667900|12530580|P15|COMPLETED|Part B||0
5092881|NCT01667900|12530581|P14|COMPLETED|Part B||0
5092882|NCT01667900|12530582|P13|COMPLETED|Part B||0
5092883|NCT01667900|12530583|P12|COMPLETED|Part B||0
5092884|NCT01667900|12530584|P11|COMPLETED|Part B||0
5092885|NCT01667900|12530585|P10|COMPLETED|Part B||0
5092886|NCT01667900|12530586|P9|COMPLETED|Part B||0
5092887|NCT01667900|12530587|P8|COMPLETED|Part B||0
5092888|NCT01667900|12530588|P7|COMPLETED|Part B||0
5092889|NCT01667900|12530589|P6|COMPLETED|Part B||0
5092890|NCT01667900|12530590|P5|COMPLETED|Part B||0
5092891|NCT01667900|12530591|P4|COMPLETED|Part B||0
5092892|NCT01667900|12530592|P3|COMPLETED|Part B||0
5092893|NCT01667900|12530593|P2|COMPLETED|Part B||0
5092894|NCT01667900|12530594|P1|COMPLETED|Part B||0
5092895|NCT01667900|12530575|P20|STARTED|Part B||10
5092896|NCT01667900|12530576|P19|STARTED|Part B||10
5092897|NCT01667900|12530577|P18|STARTED|Part B||11
5092898|NCT01667900|12530578|P17|STARTED|Part B||11
5092899|NCT01667900|12530579|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
5092900|NCT01667900|12530580|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
5092901|NCT01667900|12530581|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
5092902|NCT01667900|12530582|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
5092903|NCT01667900|12530583|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
5092904|NCT01667900|12530584|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
5092905|NCT01667900|12530585|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
5092906|NCT01667900|12530586|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
5092907|NCT01667900|12530587|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
5092908|NCT01667900|12530588|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
5092909|NCT01667900|12530589|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
5092910|NCT01667900|12530590|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
5092911|NCT01667900|12530591|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
5092912|NCT01667900|12530592|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
5092913|NCT01667900|12530593|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
5092914|NCT01667900|12530594|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
5092915|NCT01667900|12530575|P20|NOT COMPLETED|Part A, Period 3||0
5092916|NCT01667900|12530576|P19|NOT COMPLETED|Part A, Period 3||0
5092917|NCT01667900|12530577|P18|NOT COMPLETED|Part A, Period 3||0
5092918|NCT01667900|12530578|P17|NOT COMPLETED|Part A, Period 3||0
5092919|NCT01667900|12530579|P16|NOT COMPLETED|Part A, Period 3||0
5092920|NCT01667900|12530580|P15|NOT COMPLETED|Part A, Period 3||0
5092921|NCT01667900|12530581|P14|NOT COMPLETED|Part A, Period 3||0
5092922|NCT01667900|12530582|P13|NOT COMPLETED|Part A, Period 3||0
5092923|NCT01667900|12530583|P12|NOT COMPLETED|Part A, Period 3||0
5092924|NCT01667900|12530584|P11|NOT COMPLETED|Part A, Period 3||0
5092925|NCT01667900|12530585|P10|NOT COMPLETED|Part A, Period 3||0
5092926|NCT01667900|12530586|P9|NOT COMPLETED|Part A, Period 3||0
5092927|NCT01667900|12530587|P8|NOT COMPLETED|Part A, Period 3||0
5092928|NCT01667900|12530588|P7|NOT COMPLETED|Part A, Period 3||0
5092929|NCT01667900|12530589|P6|NOT COMPLETED|Part A, Period 3||0
5092930|NCT01667900|12530590|P5|NOT COMPLETED|Part A, Period 3||0
5092931|NCT01667900|12530591|P4|NOT COMPLETED|Part A, Period 3||0
5092932|NCT01667900|12530592|P3|NOT COMPLETED|Part A, Period 3||0
5092933|NCT01667900|12530593|P2|NOT COMPLETED|Part A, Period 3||0
5092934|NCT01667900|12530594|P1|NOT COMPLETED|Part A, Period 3||0
5092935|NCT01667900|12530575|P20|COMPLETED|Part A, Period 3||0
5092936|NCT01667900|12530576|P19|COMPLETED|Part A, Period 3||0
5092937|NCT01667900|12530577|P18|COMPLETED|Part A, Period 3||0
5092938|NCT01667900|12530578|P17|COMPLETED|Part A, Period 3||0
5092939|NCT01667900|12530579|P16|COMPLETED|Part A, Period 3||1
5092940|NCT01667900|12530580|P15|COMPLETED|Part A, Period 3||1
5092941|NCT01667900|12530581|P14|COMPLETED|Part A, Period 3||1
5092942|NCT01667900|12530582|P13|COMPLETED|Part A, Period 3||1
5092943|NCT01667900|12530583|P12|COMPLETED|Part A, Period 3||1
5092944|NCT01667900|12530584|P11|COMPLETED|Part A, Period 3||1
5092945|NCT01667900|12530585|P10|COMPLETED|Part A, Period 3||1
5092946|NCT01667900|12530586|P9|COMPLETED|Part A, Period 3||1
5092947|NCT01667900|12530587|P8|COMPLETED|Part A, Period 3||1
5092948|NCT01667900|12530588|P7|COMPLETED|Part A, Period 3||1
5092949|NCT01667900|12530589|P6|COMPLETED|Part A, Period 3||1
5092950|NCT01667900|12530590|P5|COMPLETED|Part A, Period 3||1
5092951|NCT01667900|12530591|P4|COMPLETED|Part A, Period 3||1
5092952|NCT01667900|12530592|P3|COMPLETED|Part A, Period 3||1
5092953|NCT01667900|12530593|P2|COMPLETED|Part A, Period 3||1
5092954|NCT01667900|12530594|P1|COMPLETED|Part A, Period 3||1
5092955|NCT01667900|12530575|P20|STARTED|Part A, Period 3||0
5092956|NCT01667900|12530576|P19|STARTED|Part A, Period 3||0
5092957|NCT01667900|12530577|P18|STARTED|Part A, Period 3||0
5092958|NCT01667900|12530578|P17|STARTED|Part A, Period 3||0
5092959|NCT01667900|12530579|P16|STARTED|Part A, Period 3||1
5092960|NCT01667900|12530580|P15|STARTED|Part A, Period 3||1
5092961|NCT01667900|12530581|P14|STARTED|Part A, Period 3||1
5092962|NCT01667900|12530582|P13|STARTED|Part A, Period 3||1
5092963|NCT01667900|12530583|P12|STARTED|Part A, Period 3||1
5092964|NCT01667900|12530584|P11|STARTED|Part A, Period 3||1
5092965|NCT01667900|12530585|P10|STARTED|Part A, Period 3||1
5092966|NCT01667900|12530586|P9|STARTED|Part A, Period 3||1
5092967|NCT01667900|12530587|P8|STARTED|Part A, Period 3||1
5092968|NCT01667900|12530588|P7|STARTED|Part A, Period 3||1
5092969|NCT01667900|12530589|P6|STARTED|Part A, Period 3||1
5092970|NCT01667900|12530590|P5|STARTED|Part A, Period 3||1
5092971|NCT01667900|12530591|P4|STARTED|Part A, Period 3||1
5092972|NCT01667900|12530592|P3|STARTED|Part A, Period 3||1
5092973|NCT01667900|12530593|P2|STARTED|Part A, Period 3||1
5092974|NCT01667900|12530594|P1|STARTED|Part A, Period 3||1
5092975|NCT01667900|12530575|P20|NOT COMPLETED|Part A, Washout 2||0
5092976|NCT01667900|12530576|P19|NOT COMPLETED|Part A, Washout 2||0
5092977|NCT01667900|12530577|P18|NOT COMPLETED|Part A, Washout 2||0
5092978|NCT01667900|12530578|P17|NOT COMPLETED|Part A, Washout 2||0
5092979|NCT01667900|12530579|P16|NOT COMPLETED|Part A, Washout 2||0
5092980|NCT01667900|12530580|P15|NOT COMPLETED|Part A, Washout 2||0
5092981|NCT01667900|12530581|P14|NOT COMPLETED|Part A, Washout 2||0
5092982|NCT01667900|12530582|P13|NOT COMPLETED|Part A, Washout 2||0
5092983|NCT01667900|12530583|P12|NOT COMPLETED|Part A, Washout 2||0
5092984|NCT01667900|12530584|P11|NOT COMPLETED|Part A, Washout 2||0
5092985|NCT01667900|12530585|P10|NOT COMPLETED|Part A, Washout 2||0
5092986|NCT01667900|12530586|P9|NOT COMPLETED|Part A, Washout 2||0
5092987|NCT01667900|12530587|P8|NOT COMPLETED|Part A, Washout 2||0
5092988|NCT01667900|12530588|P7|NOT COMPLETED|Part A, Washout 2||0
5092989|NCT01667900|12530589|P6|NOT COMPLETED|Part A, Washout 2||0
5092990|NCT01667900|12530590|P5|NOT COMPLETED|Part A, Washout 2||0
5092991|NCT01667900|12530591|P4|NOT COMPLETED|Part A, Washout 2||0
5092992|NCT01667900|12530592|P3|NOT COMPLETED|Part A, Washout 2||0
5092993|NCT01667900|12530593|P2|NOT COMPLETED|Part A, Washout 2||0
5092994|NCT01667900|12530594|P1|NOT COMPLETED|Part A, Washout 2||0
5092995|NCT01667900|12530575|P20|COMPLETED|Part A, Washout 2||0
5092996|NCT01667900|12530576|P19|COMPLETED|Part A, Washout 2||0
5092997|NCT01667900|12530577|P18|COMPLETED|Part A, Washout 2||0
5092998|NCT01667900|12530578|P17|COMPLETED|Part A, Washout 2||0
5092999|NCT01667900|12530579|P16|COMPLETED|Part A, Washout 2||1
5093000|NCT01667900|12530580|P15|COMPLETED|Part A, Washout 2||1
5093001|NCT01667900|12530581|P14|COMPLETED|Part A, Washout 2||1
5093002|NCT01667900|12530582|P13|COMPLETED|Part A, Washout 2||1
5093003|NCT01667900|12530583|P12|COMPLETED|Part A, Washout 2||1
5093004|NCT01667900|12530584|P11|COMPLETED|Part A, Washout 2||1
5093005|NCT01667900|12530585|P10|COMPLETED|Part A, Washout 2||1
5093006|NCT01667900|12530586|P9|COMPLETED|Part A, Washout 2||1
5093007|NCT01667900|12530587|P8|COMPLETED|Part A, Washout 2||1
5093008|NCT01667900|12530588|P7|COMPLETED|Part A, Washout 2||1
5093009|NCT01667900|12530589|P6|COMPLETED|Part A, Washout 2||1
5093010|NCT01667900|12530590|P5|COMPLETED|Part A, Washout 2||1
5093011|NCT01667900|12530591|P4|COMPLETED|Part A, Washout 2||1
5093012|NCT01667900|12530592|P3|COMPLETED|Part A, Washout 2||1
5093013|NCT01667900|12530593|P2|COMPLETED|Part A, Washout 2||1
5093014|NCT01667900|12530594|P1|COMPLETED|Part A, Washout 2||1
5093015|NCT01667900|12530575|P20|STARTED|Part A, Washout 2||0
5093016|NCT01667900|12530576|P19|STARTED|Part A, Washout 2||0
5093017|NCT01667900|12530577|P18|STARTED|Part A, Washout 2||0
5093018|NCT01667900|12530578|P17|STARTED|Part A, Washout 2||0
5093019|NCT01667900|12530579|P16|STARTED|Part A, Washout 2||1
5093020|NCT01667900|12530580|P15|STARTED|Part A, Washout 2||1
5093021|NCT01667900|12530581|P14|STARTED|Part A, Washout 2||1
5093022|NCT01667900|12530582|P13|STARTED|Part A, Washout 2||1
5093023|NCT01667900|12530583|P12|STARTED|Part A, Washout 2||1
5093024|NCT01667900|12530584|P11|STARTED|Part A, Washout 2||1
5093025|NCT01667900|12530585|P10|STARTED|Part A, Washout 2||1
5093026|NCT01667900|12530586|P9|STARTED|Part A, Washout 2||1
5093027|NCT01667900|12530587|P8|STARTED|Part A, Washout 2||1
5093028|NCT01667900|12530588|P7|STARTED|Part A, Washout 2||1
5093029|NCT01667900|12530589|P6|STARTED|Part A, Washout 2||1
5093030|NCT01667900|12530590|P5|STARTED|Part A, Washout 2||1
5093031|NCT01667900|12530591|P4|STARTED|Part A, Washout 2||1
5093032|NCT01667900|12530592|P3|STARTED|Part A, Washout 2||1
5093033|NCT01667900|12530593|P2|STARTED|Part A, Washout 2||1
5093034|NCT01667900|12530594|P1|STARTED|Part A, Washout 2||1
5093035|NCT01667900|12530575|P20|NOT COMPLETED|Part A, Period 2||0
5093036|NCT01667900|12530576|P19|NOT COMPLETED|Part A, Period 2||0
5093037|NCT01667900|12530577|P18|NOT COMPLETED|Part A, Period 2||0
5093038|NCT01667900|12530578|P17|NOT COMPLETED|Part A, Period 2||0
5093039|NCT01667900|12530579|P16|NOT COMPLETED|Part A, Period 2||0
5093040|NCT01667900|12530580|P15|NOT COMPLETED|Part A, Period 2||0
5093041|NCT01667900|12530581|P14|NOT COMPLETED|Part A, Period 2||0
5093042|NCT01667900|12530582|P13|NOT COMPLETED|Part A, Period 2||0
5093043|NCT01667900|12530583|P12|NOT COMPLETED|Part A, Period 2||0
5093044|NCT01667900|12530584|P11|NOT COMPLETED|Part A, Period 2||0
5093045|NCT01667900|12530585|P10|NOT COMPLETED|Part A, Period 2||0
5093046|NCT01667900|12530586|P9|NOT COMPLETED|Part A, Period 2||0
5093047|NCT01667900|12530587|P8|NOT COMPLETED|Part A, Period 2||0
5093048|NCT01667900|12530588|P7|NOT COMPLETED|Part A, Period 2||0
5093049|NCT01667900|12530589|P6|NOT COMPLETED|Part A, Period 2||0
5093050|NCT01667900|12530590|P5|NOT COMPLETED|Part A, Period 2||0
5093051|NCT01667900|12530591|P4|NOT COMPLETED|Part A, Period 2||0
5093052|NCT01667900|12530592|P3|NOT COMPLETED|Part A, Period 2||0
5093053|NCT01667900|12530593|P2|NOT COMPLETED|Part A, Period 2||0
5093054|NCT01667900|12530594|P1|NOT COMPLETED|Part A, Period 2||0
5093055|NCT01667900|12530575|P20|COMPLETED|Part A, Period 2||0
5093056|NCT01667900|12530576|P19|COMPLETED|Part A, Period 2||0
5093057|NCT01667900|12530577|P18|COMPLETED|Part A, Period 2||0
5093058|NCT01667900|12530578|P17|COMPLETED|Part A, Period 2||0
5093059|NCT01667900|12530579|P16|COMPLETED|Part A, Period 2||1
5093060|NCT01667900|12530580|P15|COMPLETED|Part A, Period 2||1
5093061|NCT01667900|12530581|P14|COMPLETED|Part A, Period 2||1
5093062|NCT01667900|12530582|P13|COMPLETED|Part A, Period 2||1
5093063|NCT01667900|12530583|P12|COMPLETED|Part A, Period 2||1
5093064|NCT01667900|12530584|P11|COMPLETED|Part A, Period 2||1
5093065|NCT01667900|12530585|P10|COMPLETED|Part A, Period 2||1
5093066|NCT01667900|12530586|P9|COMPLETED|Part A, Period 2||1
5093067|NCT01667900|12530587|P8|COMPLETED|Part A, Period 2||1
5093068|NCT01667900|12530588|P7|COMPLETED|Part A, Period 2||1
5093069|NCT01667900|12530589|P6|COMPLETED|Part A, Period 2||1
5093070|NCT01667900|12530590|P5|COMPLETED|Part A, Period 2||1
5093071|NCT01667900|12530591|P4|COMPLETED|Part A, Period 2||1
5093072|NCT01667900|12530592|P3|COMPLETED|Part A, Period 2||1
5093073|NCT01667900|12530593|P2|COMPLETED|Part A, Period 2||1
5093074|NCT01667900|12530594|P1|COMPLETED|Part A, Period 2||1
5093075|NCT01667900|12530575|P20|STARTED|Part A, Period 2||0
5093076|NCT01667900|12530576|P19|STARTED|Part A, Period 2||0
5093077|NCT01667900|12530577|P18|STARTED|Part A, Period 2||0
5093078|NCT01667900|12530578|P17|STARTED|Part A, Period 2||0
5093079|NCT01667900|12530579|P16|STARTED|Part A, Period 2||1
5093080|NCT01667900|12530580|P15|STARTED|Part A, Period 2||1
5093081|NCT01667900|12530581|P14|STARTED|Part A, Period 2||1
5093082|NCT01667900|12530582|P13|STARTED|Part A, Period 2||1
5093083|NCT01667900|12530583|P12|STARTED|Part A, Period 2||1
5093084|NCT01667900|12530584|P11|STARTED|Part A, Period 2||1
5093085|NCT01667900|12530585|P10|STARTED|Part A, Period 2||1
5093086|NCT01667900|12530586|P9|STARTED|Part A, Period 2||1
5093087|NCT01667900|12530587|P8|STARTED|Part A, Period 2||1
5093088|NCT01667900|12530588|P7|STARTED|Part A, Period 2||1
5093089|NCT01667900|12530589|P6|STARTED|Part A, Period 2||1
5093090|NCT01667900|12530590|P5|STARTED|Part A, Period 2||1
5093091|NCT01667900|12530591|P4|STARTED|Part A, Period 2||1
5093092|NCT01667900|12530592|P3|STARTED|Part A, Period 2||1
5093093|NCT01667900|12530593|P2|STARTED|Part A, Period 2||1
5093094|NCT01667900|12530594|P1|STARTED|Part A, Period 2||1
5093095|NCT01667900|12530575|P20|NOT COMPLETED|Part A, Washout 1||0
5093096|NCT01667900|12530576|P19|NOT COMPLETED|Part A, Washout 1||0
5093097|NCT01667900|12530577|P18|NOT COMPLETED|Part A, Washout 1||0
5093098|NCT01667900|12530578|P17|NOT COMPLETED|Part A, Washout 1||0
5093099|NCT01667900|12530579|P16|NOT COMPLETED|Part A, Washout 1||0
5093100|NCT01667900|12530580|P15|NOT COMPLETED|Part A, Washout 1||0
5093101|NCT01667900|12530581|P14|NOT COMPLETED|Part A, Washout 1||0
5093102|NCT01667900|12530582|P13|NOT COMPLETED|Part A, Washout 1||0
5093103|NCT01667900|12530583|P12|NOT COMPLETED|Part A, Washout 1||0
5093104|NCT01667900|12530584|P11|NOT COMPLETED|Part A, Washout 1||0
5093105|NCT01667900|12530585|P10|NOT COMPLETED|Part A, Washout 1||0
5093106|NCT01667900|12530586|P9|NOT COMPLETED|Part A, Washout 1||0
5093107|NCT01667900|12530587|P8|NOT COMPLETED|Part A, Washout 1||0
5093108|NCT01667900|12530588|P7|NOT COMPLETED|Part A, Washout 1||0
5093109|NCT01667900|12530589|P6|NOT COMPLETED|Part A, Washout 1||0
5093110|NCT01667900|12530590|P5|NOT COMPLETED|Part A, Washout 1||0
5093111|NCT01667900|12530591|P4|NOT COMPLETED|Part A, Washout 1||0
5093112|NCT01667900|12530592|P3|NOT COMPLETED|Part A, Washout 1||0
5093113|NCT01667900|12530593|P2|NOT COMPLETED|Part A, Washout 1||0
5093114|NCT01667900|12530594|P1|NOT COMPLETED|Part A, Washout 1||0
5093115|NCT01667900|12530575|P20|COMPLETED|Part A, Washout 1||0
5093116|NCT01667900|12530576|P19|COMPLETED|Part A, Washout 1||0
5093117|NCT01667900|12530577|P18|COMPLETED|Part A, Washout 1||0
5093118|NCT01667900|12530578|P17|COMPLETED|Part A, Washout 1||0
5093119|NCT01667900|12530579|P16|COMPLETED|Part A, Washout 1||1
5093120|NCT01667900|12530580|P15|COMPLETED|Part A, Washout 1||1
5093121|NCT01667900|12530581|P14|COMPLETED|Part A, Washout 1||1
5093122|NCT01667900|12530582|P13|COMPLETED|Part A, Washout 1||1
5093123|NCT01667900|12530583|P12|COMPLETED|Part A, Washout 1||1
5093124|NCT01667900|12530584|P11|COMPLETED|Part A, Washout 1||1
5093125|NCT01667900|12530585|P10|COMPLETED|Part A, Washout 1||1
5093126|NCT01667900|12530586|P9|COMPLETED|Part A, Washout 1||1
5093127|NCT01667900|12530587|P8|COMPLETED|Part A, Washout 1||1
5093128|NCT01667900|12530588|P7|COMPLETED|Part A, Washout 1||1
5093129|NCT01667900|12530589|P6|COMPLETED|Part A, Washout 1||1
5093130|NCT01667900|12530590|P5|COMPLETED|Part A, Washout 1||1
5093131|NCT01667900|12530591|P4|COMPLETED|Part A, Washout 1||1
5093132|NCT01667900|12530592|P3|COMPLETED|Part A, Washout 1||1
5093133|NCT01667900|12530593|P2|COMPLETED|Part A, Washout 1||1
5093134|NCT01667900|12530594|P1|COMPLETED|Part A, Washout 1||1
5093135|NCT01667900|12530575|P20|STARTED|Part A, Washout 1||0
5093136|NCT01667900|12530576|P19|STARTED|Part A, Washout 1||0
5093137|NCT01667900|12530577|P18|STARTED|Part A, Washout 1||0
5093138|NCT01667900|12530578|P17|STARTED|Part A, Washout 1||0
5093139|NCT01667900|12530579|P16|STARTED|Part A, Washout 1||1
5093140|NCT01667900|12530580|P15|STARTED|Part A, Washout 1||1
5093141|NCT01667900|12530581|P14|STARTED|Part A, Washout 1||1
5093142|NCT01667900|12530582|P13|STARTED|Part A, Washout 1||1
5093143|NCT01667900|12530583|P12|STARTED|Part A, Washout 1||1
5093144|NCT01667900|12530584|P11|STARTED|Part A, Washout 1||1
5093145|NCT01667900|12530585|P10|STARTED|Part A, Washout 1||1
5093146|NCT01667900|12530586|P9|STARTED|Part A, Washout 1||1
5093147|NCT01667900|12530587|P8|STARTED|Part A, Washout 1||1
5093148|NCT01667900|12530588|P7|STARTED|Part A, Washout 1||1
5093149|NCT01667900|12530589|P6|STARTED|Part A, Washout 1||1
5093150|NCT01667900|12530590|P5|STARTED|Part A, Washout 1||1
5093151|NCT01667900|12530591|P4|STARTED|Part A, Washout 1||1
5093152|NCT01667900|12530592|P3|STARTED|Part A, Washout 1||1
5093153|NCT01667900|12530593|P2|STARTED|Part A, Washout 1||1
5093154|NCT01667900|12530594|P1|STARTED|Part A, Washout 1||1
5093155|NCT01667900|12530575|P20|NOT COMPLETED|Part A, Period 1||0
5093156|NCT01667900|12530576|P19|NOT COMPLETED|Part A, Period 1||0
5093157|NCT01667900|12530577|P18|NOT COMPLETED|Part A, Period 1||0
5093158|NCT01667900|12530578|P17|NOT COMPLETED|Part A, Period 1||0
5093159|NCT01667900|12530579|P16|NOT COMPLETED|Part A, Period 1||0
5093160|NCT01667900|12530580|P15|NOT COMPLETED|Part A, Period 1||0
5093161|NCT01667900|12530581|P14|NOT COMPLETED|Part A, Period 1||0
5093162|NCT01667900|12530582|P13|NOT COMPLETED|Part A, Period 1||0
5093163|NCT01667900|12530583|P12|NOT COMPLETED|Part A, Period 1||0
5093164|NCT01667900|12530584|P11|NOT COMPLETED|Part A, Period 1||0
5093165|NCT01667900|12530585|P10|NOT COMPLETED|Part A, Period 1||0
5093166|NCT01667900|12530586|P9|NOT COMPLETED|Part A, Period 1||0
5093167|NCT01667900|12530587|P8|NOT COMPLETED|Part A, Period 1||0
5093168|NCT01667900|12530588|P7|NOT COMPLETED|Part A, Period 1||0
5093169|NCT01667900|12530589|P6|NOT COMPLETED|Part A, Period 1||0
5093170|NCT01667900|12530590|P5|NOT COMPLETED|Part A, Period 1||0
5093171|NCT01667900|12530591|P4|NOT COMPLETED|Part A, Period 1||0
5093172|NCT01667900|12530592|P3|NOT COMPLETED|Part A, Period 1||0
5093173|NCT01667900|12530593|P2|NOT COMPLETED|Part A, Period 1||0
5093174|NCT01667900|12530594|P1|NOT COMPLETED|Part A, Period 1||0
5093175|NCT01667900|12530575|P20|COMPLETED|Part A, Period 1||0
5093176|NCT01667900|12530576|P19|COMPLETED|Part A, Period 1||0
5093177|NCT01667900|12530577|P18|COMPLETED|Part A, Period 1||0
5093178|NCT01667900|12530578|P17|COMPLETED|Part A, Period 1||0
5093179|NCT01667900|12530579|P16|COMPLETED|Part A, Period 1||1
5093180|NCT01667900|12530580|P15|COMPLETED|Part A, Period 1||1
5093181|NCT01667900|12530581|P14|COMPLETED|Part A, Period 1||1
5093182|NCT01667900|12530582|P13|COMPLETED|Part A, Period 1||1
5093183|NCT01667900|12530583|P12|COMPLETED|Part A, Period 1||1
5093184|NCT01667900|12530584|P11|COMPLETED|Part A, Period 1||1
5093185|NCT01667900|12530585|P10|COMPLETED|Part A, Period 1||1
5093186|NCT01667900|12530586|P9|COMPLETED|Part A, Period 1||1
5093187|NCT01667900|12530587|P8|COMPLETED|Part A, Period 1||1
5093188|NCT01667900|12530588|P7|COMPLETED|Part A, Period 1||1
5093189|NCT01667900|12530589|P6|COMPLETED|Part A, Period 1||1
5093190|NCT01667900|12530590|P5|COMPLETED|Part A, Period 1||1
5093191|NCT01667900|12530591|P4|COMPLETED|Part A, Period 1||1
5093192|NCT01667900|12530592|P3|COMPLETED|Part A, Period 1||1
5093193|NCT01667900|12530593|P2|COMPLETED|Part A, Period 1||1
5093194|NCT01667900|12530594|P1|COMPLETED|Part A, Period 1||1
5093195|NCT01667900|12530575|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
5093196|NCT01667900|12530576|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
5093197|NCT01667900|12530577|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
5093198|NCT01667900|12530578|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
5093199|NCT01667900|12530579|P16|STARTED|Part A, Period 1||1
5093200|NCT01667900|12530580|P15|STARTED|Part A, Period 1||1
5093201|NCT01667900|12530581|P14|STARTED|Part A, Period 1||1
5093202|NCT01667900|12530582|P13|STARTED|Part A, Period 1||1
5093203|NCT01667900|12530583|P12|STARTED|Part A, Period 1||1
5093204|NCT01667900|12530584|P11|STARTED|Part A, Period 1||1
5093205|NCT01667900|12530585|P10|STARTED|Part A, Period 1||1
5093206|NCT01667900|12530586|P9|STARTED|Part A, Period 1||1
5093207|NCT01667900|12530587|P8|STARTED|Part A, Period 1||1
5093208|NCT01667900|12530588|P7|STARTED|Part A, Period 1||1
5093209|NCT01667900|12530589|P6|STARTED|Part A, Period 1||1
5093210|NCT01667900|12530590|P5|STARTED|Part A, Period 1||1
5093211|NCT01667900|12530591|P4|STARTED|Part A, Period 1||1
5093212|NCT01667900|12530592|P3|STARTED|Part A, Period 1||1
5093213|NCT01667900|12530593|P2|STARTED|Part A, Period 1||1
5093214|NCT01667900|12530594|P1|STARTED|Part A, Period 1||1
5093215|NCT01667848|12530634|P2|NOT COMPLETED|Overall Study||0
5093216|NCT01667848|12530635|P1|NOT COMPLETED|Overall Study||0
5093217|NCT01667848|12530634|P2|COMPLETED|Overall Study||81
5093218|NCT01667848|12530635|P1|COMPLETED|Overall Study||67
5093219|NCT01667848|12530634|P2|STARTED|Overall Study||81
5093220|NCT01667848|12530635|P1|STARTED|Overall Study||67
5093221|NCT01667796|12530645|P2|NOT COMPLETED|Overall Study||1
5093222|NCT01667796|12530646|P1|NOT COMPLETED|Overall Study||3
5093223|NCT01667796|12530645|P2|COMPLETED|Overall Study||29
5093224|NCT01667796|12530646|P1|COMPLETED|Overall Study||24
5093225|NCT01667796|12530645|P2|STARTED|Overall Study||30
5093226|NCT01667796|12530646|P1|STARTED|Overall Study||27
5093227|NCT01667731|12530664|P5|NOT COMPLETED|Overall Study||28
5093228|NCT01667731|12530665|P4|NOT COMPLETED|Overall Study||2
5093229|NCT01667731|12530666|P3|NOT COMPLETED|Overall Study||2
5093230|NCT01667731|12530667|P2|NOT COMPLETED|Overall Study||16
5093231|NCT01667731|12530668|P1|NOT COMPLETED|Overall Study||5
5093232|NCT01667731|12530664|P5|COMPLETED|Overall Study||87
5093233|NCT01667731|12530665|P4|COMPLETED|Overall Study||15
5093234|NCT01667731|12530666|P3|COMPLETED|Overall Study||22
5093235|NCT01667731|12530667|P2|COMPLETED|Overall Study||26
5093236|NCT01667731|12530668|P1|COMPLETED|Overall Study||21
5093237|NCT01667731|12530664|P5|STARTED|Overall Study||115
5093238|NCT01667731|12530665|P4|STARTED|Overall Study||17
5093239|NCT01667731|12530666|P3|STARTED|Overall Study||24
5093240|NCT01667731|12530667|P2|STARTED|Overall Study||42
5093241|NCT01667731|12530668|P1|STARTED|Overall Study||26
5093242|NCT01667679|12530723|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
5093243|NCT01667679|12530724|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
5093244|NCT01667679|12530723|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
5093245|NCT01667679|12530724|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
5093246|NCT01667679|12530723|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
5093247|NCT01667679|12530724|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
5093248|NCT01667679|12530723|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
5093249|NCT01667679|12530724|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
5093250|NCT01667679|12530723|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
5093251|NCT01667679|12530724|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
5093252|NCT01667679|12530723|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
5093253|NCT01667679|12530724|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
5093254|NCT01667562|12530782|P2|NOT COMPLETED|Erlotinib Phase||3
5093255|NCT01667562|12530783|P1|NOT COMPLETED|Erlotinib Phase||0
5093256|NCT01667562|12530782|P2|COMPLETED|Erlotinib Phase||27
5093257|NCT01667562|12530783|P1|COMPLETED|Erlotinib Phase||0
5093258|NCT01667562|12530782|P2|STARTED|Erlotinib Phase||30
5093259|NCT01667562|12530783|P1|STARTED|Erlotinib Phase||0
5093260|NCT01667562|12530782|P2|NOT COMPLETED|Diagnostic Phase||0
5093261|NCT01667562|12530783|P1|NOT COMPLETED|Diagnostic Phase||30
5093262|NCT01667562|12530782|P2|COMPLETED|Diagnostic Phase||0
5093263|NCT01667562|12530783|P1|COMPLETED|Diagnostic Phase||345
5093264|NCT01667562|12530782|P2|STARTED|Diagnostic Phase||0
5093265|NCT01667562|12530783|P1|STARTED|Diagnostic Phase||375
5093266|NCT01667549|12530797|P5|NOT COMPLETED|Overall Study||1
5093267|NCT01667549|12530798|P4|NOT COMPLETED|Overall Study||6
5093268|NCT01667549|12530799|P3|NOT COMPLETED|Overall Study||7
5093269|NCT01667549|12530800|P2|NOT COMPLETED|Overall Study||5
5093270|NCT01667549|12530801|P1|NOT COMPLETED|Overall Study||3
5093271|NCT01667549|12530797|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
5093272|NCT01667549|12530798|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
5093273|NCT01667549|12530799|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
5093274|NCT01667549|12530800|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
5093275|NCT01667549|12530801|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
5093276|NCT01667549|12530797|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
5093277|NCT01667549|12530798|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
5093278|NCT01667549|12530799|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
5093279|NCT01667549|12530800|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
5093280|NCT01667549|12530801|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
5093281|NCT01667536|12530833|P1|NOT COMPLETED|Overall Study||0
5093282|NCT01667536|12530833|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
5093283|NCT01667536|12530833|P1|STARTED|Overall Study||105
5093284|NCT01667471|12530844|P1|NOT COMPLETED|Overall Study||0
5093285|NCT01667471|12530844|P1|COMPLETED|Overall Study||7
5093286|NCT01667471|12530844|P1|STARTED|Overall Study||7
5093287|NCT01667432|12530860|P1|NOT COMPLETED|Overall Study||57
5093288|NCT01667432|12530860|P1|COMPLETED|Overall Study||84
5093289|NCT01667432|12530860|P1|STARTED|Overall Study||141
5093290|NCT01667419|12530869|P4|NOT COMPLETED|Overall Study||39
5093291|NCT01667419|12530870|P3|NOT COMPLETED|Overall Study||36
5093292|NCT01667419|12530871|P2|NOT COMPLETED|Overall Study||47
5093293|NCT01667419|12530872|P1|NOT COMPLETED|Overall Study||43
5093294|NCT01667419|12530869|P4|COMPLETED|Overall Study||52
5093295|NCT01667419|12530870|P3|COMPLETED|Overall Study||57
5093296|NCT01667419|12530871|P2|COMPLETED|Overall Study||110
5093297|NCT01667419|12530872|P1|COMPLETED|Overall Study||114
5093298|NCT01667419|12530869|P4|STARTED|Overall Study||91
5093299|NCT01667419|12530870|P3|STARTED|Overall Study||93
5093300|NCT01667419|12530871|P2|STARTED|Overall Study||157
5093301|NCT01667419|12530872|P1|STARTED|Overall Study||157
5093302|NCT01667250|12530902|P3|NOT COMPLETED|Randomised Period||0
5093303|NCT01667250|12530903|P2|NOT COMPLETED|Randomised Period||1
5093304|NCT01667250|12530904|P1|NOT COMPLETED|Randomised Period||1
5093305|NCT01667250|12530902|P3|COMPLETED|Randomised Period||0
5093306|NCT01667250|12530903|P2|COMPLETED|Randomised Period||28
5093307|NCT01667250|12530904|P1|COMPLETED|Randomised Period||29
5093308|NCT01667250|12530902|P3|STARTED|Randomised Period||0
5093309|NCT01667250|12530903|P2|STARTED|Randomised Period||29
5093310|NCT01667250|12530904|P1|STARTED|Randomised Period||30
5093311|NCT01667250|12530902|P3|NOT COMPLETED|Run-in (no Treatment)||14
5093312|NCT01667250|12530903|P2|NOT COMPLETED|Run-in (no Treatment)||0
5093313|NCT01667250|12530904|P1|NOT COMPLETED|Run-in (no Treatment)||0
5093314|NCT01667250|12530902|P3|COMPLETED|Run-in (no Treatment)||59
5093315|NCT01667250|12530903|P2|COMPLETED|Run-in (no Treatment)||0
5093316|NCT01667250|12530904|P1|COMPLETED|Run-in (no Treatment)||0
5093317|NCT01667250|12530902|P3|STARTED|Run-in (no Treatment)||73
5093318|NCT01667250|12530903|P2|STARTED|Run-in (no Treatment)||0
5093319|NCT01667250|12530904|P1|STARTED|Run-in (no Treatment)||0
5093320|NCT01667224|12530920|P2|NOT COMPLETED|Overall Study||2
5093321|NCT01667224|12530921|P1|NOT COMPLETED|Overall Study||4
5093322|NCT01667224|12530920|P2|COMPLETED|Overall Study||38
5093323|NCT01667224|12530921|P1|COMPLETED|Overall Study||36
5093324|NCT01667224|12530920|P2|STARTED|Overall Study||40
5093325|NCT01667224|12530921|P1|STARTED|Overall Study||40
5093326|NCT01667107|12530935|P2|NOT COMPLETED|Overall Study||7
5093327|NCT01667107|12530936|P1|NOT COMPLETED|Overall Study||4
5093328|NCT01667107|12530935|P2|COMPLETED|Overall Study||11
5093329|NCT01667107|12530936|P1|COMPLETED|Overall Study||4
5093330|NCT01667107|12530935|P2|STARTED|Overall Study||18
5093331|NCT01667107|12530936|P1|STARTED|Overall Study||8
5093332|NCT01667029|12530952|P2|NOT COMPLETED|Overall Study||1
5093333|NCT01667029|12530953|P1|NOT COMPLETED|Overall Study||1
5093334|NCT01667029|12530952|P2|COMPLETED|Overall Study||3
5093335|NCT01667029|12530953|P1|COMPLETED|Overall Study||3
5093336|NCT01667029|12530952|P2|STARTED|Overall Study||4
5093337|NCT01667029|12530953|P1|STARTED|Overall Study||4
5093338|NCT01666951|12530995|P2|NOT COMPLETED|Overall Study||1
5093339|NCT01666951|12530996|P1|NOT COMPLETED|Overall Study||1
5093340|NCT01666951|12530995|P2|COMPLETED|Overall Study||17
5093341|NCT01666951|12530996|P1|COMPLETED|Overall Study||17
5093342|NCT01666951|12530995|P2|STARTED|Overall Study||18
5093343|NCT01666951|12530996|P1|STARTED|Overall Study||18
5093344|NCT01666912|12531034|P2|NOT COMPLETED|Overall Study||11
5093345|NCT01666912|12531035|P1|NOT COMPLETED|Overall Study||21
5093346|NCT01666912|12531034|P2|COMPLETED|Overall Study||37
5093347|NCT01666912|12531035|P1|COMPLETED|Overall Study||27
5093348|NCT01666912|12531034|P2|STARTED|Overall Study||48
5093349|NCT01666912|12531035|P1|STARTED|Overall Study||48
5093350|NCT01666782|12531047|P2|NOT COMPLETED|Overall Study||1
5093351|NCT01666782|12531048|P1|NOT COMPLETED|Overall Study||4
5093352|NCT01666782|12531047|P2|COMPLETED|Overall Study||50
5093353|NCT01666782|12531048|P1|COMPLETED|Overall Study||50
5093354|NCT01666782|12531047|P2|STARTED|Overall Study||51
5093355|NCT01666782|12531048|P1|STARTED|Overall Study||54
5093356|NCT01666652|12531069|P5|NOT COMPLETED|Overall Study||1
5093357|NCT01666652|12531070|P4|NOT COMPLETED|Overall Study||4
5093358|NCT01666652|12531071|P3|NOT COMPLETED|Overall Study||1
5093359|NCT01666652|12531072|P2|NOT COMPLETED|Overall Study||1
5093360|NCT01666652|12531073|P1|NOT COMPLETED|Overall Study||2
5093361|NCT01666652|12531069|P5|COMPLETED|Overall Study||19
5093362|NCT01666652|12531070|P4|COMPLETED|Overall Study||16
5093363|NCT01666652|12531071|P3|COMPLETED|Overall Study||19
5093364|NCT01666652|12531072|P2|COMPLETED|Overall Study||19
5093365|NCT01666652|12531073|P1|COMPLETED|Overall Study||18
5093366|NCT01666652|12531069|P5|STARTED|Overall Study||20
5093367|NCT01666652|12531070|P4|STARTED|Overall Study||20
5093368|NCT01666652|12531071|P3|STARTED|Overall Study||20
5093369|NCT01666652|12531072|P2|STARTED|Overall Study||20
5093370|NCT01666652|12531073|P1|STARTED|Overall Study||20
5093371|NCT01666444|12531122|P2|NOT COMPLETED|Overall Study||1
5093372|NCT01666444|12531123|P1|NOT COMPLETED|Overall Study||2
5093373|NCT01666444|12531122|P2|COMPLETED|Overall Study||147
5093374|NCT01666444|12531123|P1|COMPLETED|Overall Study||147
5093375|NCT01666444|12531122|P2|STARTED|Overall Study||148
5093376|NCT01666444|12531123|P1|STARTED|Overall Study||149
5093377|NCT01666314|12531141|P4|NOT COMPLETED|Overall Study||36
5093378|NCT01666314|12531142|P3|NOT COMPLETED|Overall Study||36
5093379|NCT01666314|12531143|P2|NOT COMPLETED|Overall Study||32
5093380|NCT01666314|12531144|P1|NOT COMPLETED|Overall Study||33
5093381|NCT01666314|12531141|P4|COMPLETED|Overall Study||0
5093382|NCT01666314|12531142|P3|COMPLETED|Overall Study||0
5093383|NCT01666314|12531143|P2|COMPLETED|Overall Study||0
5093384|NCT01666314|12531144|P1|COMPLETED|Overall Study||0
5093385|NCT01666314|12531141|P4|STARTED|Overall Study||36
5093386|NCT01666314|12531142|P3|STARTED|Overall Study||36
5093387|NCT01666314|12531143|P2|STARTED|Overall Study||32
5093388|NCT01666314|12531144|P1|STARTED|Overall Study||33
5093389|NCT01666210|12531255|P2|NOT COMPLETED|Overall Study||1
5093390|NCT01666210|12531256|P1|NOT COMPLETED|Overall Study||2
5093391|NCT01666210|12531255|P2|COMPLETED|Overall Study||29
5093392|NCT01666210|12531256|P1|COMPLETED|Overall Study||28
5093393|NCT01666210|12531255|P2|STARTED|Overall Study||30
5093394|NCT01666210|12531256|P1|STARTED|Overall Study||30
5093395|NCT01666197|12531268|P2|NOT COMPLETED|Overall Study||0
5093396|NCT01666197|12531269|P1|NOT COMPLETED|Overall Study||0
5093397|NCT01666197|12531268|P2|COMPLETED|Overall Study||50
5093398|NCT01666197|12531269|P1|COMPLETED|Overall Study||50
5093399|NCT01666197|12531268|P2|STARTED|Overall Study||50
5093400|NCT01666197|12531269|P1|STARTED|Overall Study||50
5093401|NCT01666145|12531275|P1|NOT COMPLETED|Overall Study||0
5093402|NCT01666145|12531275|P1|COMPLETED|Overall Study||14
5093403|NCT01666145|12531275|P1|STARTED|Overall Study||14
5093404|NCT01666119|12531280|P1|NOT COMPLETED|Overall Study||52
5093405|NCT01666119|12531280|P1|COMPLETED|Overall Study||197
5093406|NCT01666119|12531280|P1|STARTED|Overall Study||249
5093407|NCT01666002|12531287|P2|NOT COMPLETED|Overall Study||0
5093408|NCT01666002|12531288|P1|NOT COMPLETED|Overall Study||5
5093409|NCT01666002|12531287|P2|COMPLETED|Overall Study||10
5093410|NCT01666002|12531288|P1|COMPLETED|Overall Study||12
5093411|NCT01666002|12531287|P2|STARTED|Overall Study||10
5093412|NCT01666002|12531288|P1|STARTED|Overall Study||17
5093413|NCT01665950|12531299|P3|NOT COMPLETED|Overall Study||1
5093414|NCT01665950|12531300|P2|NOT COMPLETED|Overall Study||0
5093415|NCT01665950|12531301|P1|NOT COMPLETED|Overall Study||1
5093416|NCT01665950|12531299|P3|COMPLETED|Overall Study||1
5093417|NCT01665950|12531300|P2|COMPLETED|Overall Study||0
5093418|NCT01665950|12531301|P1|COMPLETED|Overall Study||1
5093419|NCT01665950|12531299|P3|STARTED|Overall Study||2
5093420|NCT01665950|12531300|P2|STARTED|Overall Study||0
5093421|NCT01665950|12531301|P1|STARTED|Overall Study||2
5093422|NCT01665911|12531309|P1|NOT COMPLETED|Overall Study||6
5093423|NCT01665911|12531309|P1|COMPLETED|Overall Study||22
5093424|NCT01665911|12531309|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
5093425|NCT01665911|12531309|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
5093426|NCT01665911|12531309|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
5093427|NCT01665911|12531309|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
5093428|NCT01665911|12531309|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
5093429|NCT01665911|12531309|P1|STARTED|Overall Study||28
5093430|NCT01665872|12531317|P2|NOT COMPLETED|12 Month Follow-up||3
5093431|NCT01665872|12531318|P1|NOT COMPLETED|12 Month Follow-up||14
5093432|NCT01665872|12531317|P2|COMPLETED|12 Month Follow-up||47
5093433|NCT01665872|12531318|P1|COMPLETED|12 Month Follow-up||58
5093434|NCT01665872|12531317|P2|STARTED|12 Month Follow-up||50
5093435|NCT01665872|12531318|P1|STARTED|12 Month Follow-up||72
5093436|NCT01665872|12531317|P2|NOT COMPLETED|6 Month Follow-up||1
5093437|NCT01665872|12531318|P1|NOT COMPLETED|6 Month Follow-up||6
5093438|NCT01665872|12531317|P2|COMPLETED|6 Month Follow-up||49
5093439|NCT01665872|12531318|P1|COMPLETED|6 Month Follow-up||66
5093440|NCT01665872|12531317|P2|STARTED|6 Month Follow-up||50
5093441|NCT01665872|12531318|P1|STARTED|6 Month Follow-up||72
5093442|NCT01665872|12531317|P2|NOT COMPLETED|Treatment||17
5093443|NCT01665872|12531318|P1|NOT COMPLETED|Treatment||15
5093444|NCT01665872|12531317|P2|COMPLETED|Treatment||50
5093445|NCT01665872|12531318|P1|COMPLETED|Treatment||72
5093446|NCT01665872|12531317|P2|STARTED|Treatment||67
5093447|NCT01665872|12531318|P1|STARTED|Treatment||87
5093448|NCT01665872|12531317|P2|NOT COMPLETED|Screening||0
5093449|NCT01665872|12531318|P1|NOT COMPLETED|Screening||0
5093450|NCT01665872|12531317|P2|COMPLETED|Screening||172
5093451|NCT01665872|12531318|P1|COMPLETED|Screening||172
5093452|NCT01665872|12531317|P2|STARTED|Screening||172
5093453|NCT01665872|12531318|P1|STARTED|Screening||172
5093454|NCT01665807|12531335|P3|NOT COMPLETED|Overall Study||1
5093455|NCT01665807|12531336|P2|NOT COMPLETED|Overall Study||0
5093456|NCT01665807|12531337|P1|NOT COMPLETED|Overall Study||2
5093457|NCT01665807|12531335|P3|COMPLETED|Overall Study||401
5093458|NCT01665807|12531336|P2|COMPLETED|Overall Study||58
5093459|NCT01665807|12531337|P1|COMPLETED|Overall Study||409
5093460|NCT01665807|12531335|P3|STARTED|Overall Study||402
5093461|NCT01665807|12531336|P2|STARTED|Overall Study||58
5093462|NCT01665807|12531337|P1|STARTED|Overall Study||411
5093463|NCT01665768|12531348|P1|NOT COMPLETED|Overall Study||23
5093464|NCT01665768|12531348|P1|COMPLETED|Overall Study||26
5093465|NCT01665768|12531348|P1|STARTED|Overall Study||49
5093466|NCT01665599|12531353|P1|NOT COMPLETED|Overall Study||8
5093467|NCT01665599|12531353|P1|COMPLETED|Overall Study||172
5093468|NCT01665599|12531353|P1|STARTED|Overall Study||180
5093469|NCT01665508|12531373|P1|NOT COMPLETED|Overall Study||5
5093470|NCT01665508|12531373|P1|COMPLETED|Overall Study||7
5093471|NCT01665508|12531373|P1|STARTED|Overall Study||12
5093472|NCT01665430|12531389|P1|NOT COMPLETED|Overall Study||9
5093473|NCT01665430|12531389|P1|COMPLETED|Overall Study||29
5093474|NCT01665430|12531389|P1|STARTED|Overall Study||38
5093475|NCT01665170|12531405|P2|NOT COMPLETED|Overall Study||0
5093476|NCT01665170|12531406|P1|NOT COMPLETED|Overall Study||0
5093477|NCT01665170|12531405|P2|COMPLETED|Overall Study||30
5093478|NCT01665170|12531406|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
5093479|NCT01665170|12531405|P2|After TSST|Overall Study||30
5093480|NCT01665170|12531406|P1|After TSST|Overall Study||30
5093481|NCT01665170|12531405|P2|During TSST|Overall Study||30
5093482|NCT01665170|12531406|P1|During TSST|Overall Study||30
5093483|NCT01665170|12531405|P2|Bevore TSST|Overall Study||30
5093484|NCT01665170|12531406|P1|Bevore TSST|Overall Study||30
5093485|NCT01665170|12531405|P2|STARTED|Overall Study||30
5093486|NCT01665170|12531406|P1|STARTED|Overall Study|First patient in|30
5093487|NCT01665157|12531457|P3|NOT COMPLETED|Overall Study||0
5093488|NCT01665157|12531458|P2|NOT COMPLETED|Overall Study||0
5093489|NCT01665157|12531459|P1|NOT COMPLETED|Overall Study||0
5093490|NCT01665157|12531457|P3|COMPLETED|Overall Study||60
5093491|NCT01665157|12531458|P2|COMPLETED|Overall Study||60
5093492|NCT01665157|12531459|P1|COMPLETED|Overall Study||60
5093493|NCT01665157|12531457|P3|STARTED|Overall Study||60
5093494|NCT01665157|12531458|P2|STARTED|Overall Study||60
5093495|NCT01665157|12531459|P1|STARTED|Overall Study||60
5093496|NCT01665144|12531487|P2|NOT COMPLETED|Overall Study||122
5093497|NCT01665144|12531488|P1|NOT COMPLETED|Overall Study||202
5093498|NCT01665144|12531487|P2|COMPLETED|Overall Study||424
5093499|NCT01665144|12531488|P1|COMPLETED|Overall Study||903
5093500|NCT01665144|12531487|P2|Full Analysis Set|Overall Study||546
5093501|NCT01665144|12531488|P1|Full Analysis Set|Overall Study||1099
5093502|NCT01665144|12531487|P2|Safety Set|Overall Study||546
5093503|NCT01665144|12531488|P1|Safety Set|Overall Study||1099
5093504|NCT01665144|12531487|P2|STARTED|Overall Study||546
5093505|NCT01665144|12531488|P1|STARTED|Overall Study||1105
5093506|NCT01665092|12531498|P4|NOT COMPLETED|Overall Study||1
5093507|NCT01665092|12531499|P3|NOT COMPLETED|Overall Study||2
5093508|NCT01665092|12531500|P2|NOT COMPLETED|Overall Study||0
5093509|NCT01665092|12531501|P1|NOT COMPLETED|Overall Study||0
5093510|NCT01665092|12531498|P4|COMPLETED|Overall Study||105
5093511|NCT01665092|12531499|P3|COMPLETED|Overall Study||32
5093512|NCT01665092|12531500|P2|COMPLETED|Overall Study||35
5093513|NCT01665092|12531501|P1|COMPLETED|Overall Study||75
5093514|NCT01665092|12531498|P4|STARTED|Overall Study||106
5093515|NCT01665092|12531499|P3|STARTED|Overall Study||34
5093516|NCT01665092|12531500|P2|STARTED|Overall Study||35
5093517|NCT01665092|12531501|P1|STARTED|Overall Study||75
5093518|NCT01665053|12531513|P2|NOT COMPLETED|Overall Study||15
5093519|NCT01665053|12531514|P1|NOT COMPLETED|Overall Study||32
5093520|NCT01665053|12531513|P2|COMPLETED|Overall Study||831
5093521|NCT01665053|12531514|P1|COMPLETED|Overall Study||806
5093522|NCT01665053|12531513|P2|Death With No 12-month Clinical FU|Overall Study||9
5093523|NCT01665053|12531514|P1|Death With No 12-month Clinical FU|Overall Study||9
5093524|NCT01665053|12531513|P2|No 12-Month F/U|Overall Study||15
5093525|NCT01665053|12531514|P1|No 12-Month F/U|Overall Study||32
5093526|NCT01665053|12531513|P2|Completed 12-Month Clinical F/U|Overall Study||822
5093527|NCT01665053|12531514|P1|Completed 12-Month Clinical F/U|Overall Study||797
5093528|NCT01665053|12531513|P2|STARTED|Overall Study||846
5093529|NCT01665053|12531514|P1|STARTED|Overall Study||838
5093530|NCT01665040|12531552|P1|NOT COMPLETED|Overall Study||4
5093531|NCT01665040|12531552|P1|COMPLETED|Overall Study||36
5093532|NCT01665040|12531552|P1|STARTED|Overall Study||40
5093533|NCT01664975|12531559|P2|NOT COMPLETED|Overall Study||3
5093534|NCT01664975|12531560|P1|NOT COMPLETED|Overall Study||5
5093535|NCT01664975|12531559|P2|COMPLETED|Overall Study||51
5093536|NCT01664975|12531560|P1|COMPLETED|Overall Study||52
5093537|NCT01664975|12531559|P2|STARTED|Overall Study||54
5093538|NCT01664975|12531560|P1|STARTED|Overall Study||57
5093539|NCT01664949|12531568|P2|NOT COMPLETED|Overall Study||25
5093540|NCT01664949|12531569|P1|NOT COMPLETED|Overall Study||24
5093541|NCT01664949|12531568|P2|COMPLETED|Overall Study||211
5093542|NCT01664949|12531569|P1|COMPLETED|Overall Study||200
5093543|NCT01664949|12531568|P2|STARTED|Overall Study||236
5093544|NCT01664949|12531569|P1|STARTED|Overall Study||224
5093545|NCT01664923|12531585|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
5093546|NCT01664923|12531586|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
5093547|NCT01664923|12531585|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
5093548|NCT01664923|12531586|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
5093549|NCT01664923|12531585|P2|Treated|Period 2: Open-label Phase-36 Months||37
5093550|NCT01664923|12531586|P1|Treated|Period 2: Open-label Phase-36 Months||93
5093551|NCT01664923|12531585|P2|STARTED|Period 2: Open-label Phase-36 Months||38
5093552|NCT01664923|12531586|P1|STARTED|Period 2: Open-label Phase-36 Months||93
5093553|NCT01664923|12531585|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
5093554|NCT01664923|12531586|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
5093555|NCT01664923|12531585|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
5093556|NCT01664923|12531586|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
5093557|NCT01664923|12531585|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
5093558|NCT01664923|12531586|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
5093559|NCT01664923|12531585|P2|STARTED|Period1:Double Blind Phase-29 Months||198
5093560|NCT01664923|12531586|P1|STARTED|Period1:Double Blind Phase-29 Months||198
5093561|NCT01664897|12531606|P1|NOT COMPLETED|Overall Study||0
5093562|NCT01664897|12531606|P1|COMPLETED|Overall Study||29
5093563|NCT01664897|12531606|P1|STARTED|Overall Study||29
5093564|NCT01664858|12531617|P3|NOT COMPLETED|Overall Study||6
5093565|NCT01664858|12531618|P2|NOT COMPLETED|Overall Study||13
5093566|NCT01664858|12531619|P1|NOT COMPLETED|Overall Study||14
5093567|NCT01664858|12531617|P3|COMPLETED|Overall Study||234
5093568|NCT01664858|12531618|P2|COMPLETED|Overall Study||468
5093569|NCT01664858|12531619|P1|COMPLETED|Overall Study||467
5093570|NCT01664858|12531617|P3|STARTED|Overall Study||240
5093571|NCT01664858|12531618|P2|STARTED|Overall Study||481
5093572|NCT01664858|12531619|P1|STARTED|Overall Study||481
5093573|NCT01664806|12531635|P2|NOT COMPLETED|Overall Study||0
5093574|NCT01664806|12531636|P1|NOT COMPLETED|Overall Study||0
5093575|NCT01664806|12531635|P2|COMPLETED|Overall Study||20
5093576|NCT01664806|12531636|P1|COMPLETED|Overall Study||20
5093577|NCT01664806|12531635|P2|STARTED|Overall Study||20
5093578|NCT01664806|12531636|P1|STARTED|Overall Study||20
5093579|NCT01664793|12531646|P2|NOT COMPLETED|Overall Study||0
5093580|NCT01664793|12531647|P1|NOT COMPLETED|Overall Study||0
5093581|NCT01664793|12531646|P2|COMPLETED|Overall Study||38626
5093582|NCT01664793|12531647|P1|COMPLETED|Overall Study||49039
5093583|NCT01664793|12531646|P2|STARTED|Overall Study||38626
5093584|NCT01664793|12531647|P1|STARTED|Overall Study||49039
5093585|NCT01664741|12531658|P3|NOT COMPLETED|Overall Study||0
5093586|NCT01664741|12531659|P2|NOT COMPLETED|Overall Study||0
5093587|NCT01664741|12531660|P1|NOT COMPLETED|Overall Study||0
5093588|NCT01664741|12531658|P3|COMPLETED|Overall Study||13
5093589|NCT01664741|12531659|P2|COMPLETED|Overall Study||6
5093590|NCT01664741|12531660|P1|COMPLETED|Overall Study||6
5093591|NCT01664741|12531658|P3|STARTED|Overall Study||13
5093592|NCT01664741|12531659|P2|STARTED|Overall Study||6
5093593|NCT01664741|12531660|P1|STARTED|Overall Study||6
5093594|NCT01664624|12531677|P4|NOT COMPLETED|Overall Study||0
5093595|NCT01664624|12531678|P3|NOT COMPLETED|Overall Study||0
5093596|NCT01664624|12531679|P2|NOT COMPLETED|Overall Study||1
5093597|NCT01664624|12531680|P1|NOT COMPLETED|Overall Study||0
5093598|NCT01664624|12531677|P4|COMPLETED|Overall Study||9
5093599|NCT01664624|12531678|P3|COMPLETED|Overall Study||10
5093600|NCT01664624|12531679|P2|COMPLETED|Overall Study||10
5093601|NCT01664624|12531680|P1|COMPLETED|Overall Study||10
5093602|NCT01664624|12531677|P4|STARTED|Overall Study||9
5093603|NCT01664624|12531678|P3|STARTED|Overall Study||10
5093604|NCT01664624|12531679|P2|STARTED|Overall Study||11
5093605|NCT01664624|12531680|P1|STARTED|Overall Study||10
5093606|NCT01664559|12531712|P2|NOT COMPLETED|Overall Study||0
5093607|NCT01664559|12531713|P1|NOT COMPLETED|Overall Study||0
5093608|NCT01664559|12531712|P2|COMPLETED|Overall Study||33
5093609|NCT01664559|12531713|P1|COMPLETED|Overall Study||34
5093610|NCT01664559|12531712|P2|STARTED|Overall Study||33
5093611|NCT01664559|12531713|P1|STARTED|Overall Study||34
5093612|NCT01664533|12531727|P1|NOT COMPLETED|Overall Study||57
5093613|NCT01664533|12531727|P1|COMPLETED|Overall Study||0
5093614|NCT01664533|12531727|P1|STARTED|Overall Study||57
5093615|NCT01664494|12531735|P1|NOT COMPLETED|Overall Study||193
5093616|NCT01664494|12531735|P1|COMPLETED|Overall Study||370
5093617|NCT01664494|12531735|P1|STARTED|Overall Study||563
5093618|NCT01664247|12531742|P2|NOT COMPLETED|Overall Study||41
5093619|NCT01664247|12531743|P1|NOT COMPLETED|Overall Study||14
5093620|NCT01664247|12531742|P2|COMPLETED|Overall Study||131
5093621|NCT01664247|12531743|P1|COMPLETED|Overall Study||160
5093622|NCT01664247|12531742|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
5093623|NCT01664247|12531743|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
5093624|NCT01664247|12531742|P2|STARTED|Overall Study||172
5093625|NCT01664247|12531743|P1|STARTED|Overall Study||174
5093626|NCT01664130|12531765|P1|NOT COMPLETED|Overall Study||2
5093627|NCT01664130|12531765|P1|COMPLETED|Overall Study||33
5093628|NCT01664130|12531765|P1|STARTED|Overall Study||35
5093629|NCT01664117|12531788|P1|NOT COMPLETED|Overall Study||0
5093630|NCT01664117|12531788|P1|COMPLETED|Overall Study||209
5093631|NCT01664117|12531788|P1|STARTED|Overall Study||209
5093632|NCT01664104|12531843|P1|NOT COMPLETED|Overall Study||16
5093633|NCT01664104|12531843|P1|COMPLETED|Overall Study||120
5093634|NCT01664104|12531843|P1|STARTED|Overall Study||136
5093635|NCT01664091|12531910|P1|NOT COMPLETED|Overall Study||6
5093636|NCT01664091|12531910|P1|COMPLETED|Overall Study||26
5093637|NCT01664091|12531910|P1|STARTED|Overall Study||32
5093638|NCT01664052|12531920|P2|NOT COMPLETED|Phase 2||4
5093639|NCT01664052|12531921|P1|NOT COMPLETED|Phase 2||0
5093640|NCT01664052|12531920|P2|COMPLETED|Phase 2||31
5093641|NCT01664052|12531921|P1|COMPLETED|Phase 2||0
5093642|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
5093643|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
5093644|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
5093645|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
5093646|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
5093647|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
5093648|NCT01664052|12531920|P2|HSG 1 Hour Post Placement|Phase 2||31
5093649|NCT01664052|12531921|P1|HSG 1 Hour Post Placement|Phase 2||0
5093650|NCT01664052|12531920|P2|Insert Placed|Phase 2||31
5093651|NCT01664052|12531921|P1|Insert Placed|Phase 2||0
5093652|NCT01664052|12531920|P2|STARTED|Phase 2||35
5093653|NCT01664052|12531921|P1|STARTED|Phase 2|Screened and enrolled|0
5093654|NCT01664052|12531920|P2|NOT COMPLETED|Phase 1||0
5093655|NCT01664052|12531921|P1|NOT COMPLETED|Phase 1||7
5093656|NCT01664052|12531920|P2|COMPLETED|Phase 1||0
5093657|NCT01664052|12531921|P1|COMPLETED|Phase 1||24
5093658|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
5093659|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
5093660|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
5093661|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
5093662|NCT01664052|12531920|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
5093663|NCT01664052|12531921|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
5093664|NCT01664052|12531920|P2|HSG 1 Hour Post Placement|Phase 1||0
5093665|NCT01664052|12531921|P1|HSG 1 Hour Post Placement|Phase 1||24
5093666|NCT01664052|12531920|P2|Insert Placed in at Least One Tube|Phase 1||0
5093667|NCT01664052|12531921|P1|Insert Placed in at Least One Tube|Phase 1||25
5093668|NCT01664052|12531920|P2|STARTED|Phase 1||0
5093669|NCT01664052|12531921|P1|STARTED|Phase 1|Screening and enrollment|31
5093670|NCT01664039|12531939|P2|NOT COMPLETED|Overall Study||9
5093671|NCT01664039|12531940|P1|NOT COMPLETED|Overall Study||6
5093672|NCT01664039|12531939|P2|COMPLETED|Overall Study||43
5093673|NCT01664039|12531940|P1|COMPLETED|Overall Study||46
5093674|NCT01664039|12531939|P2|STARTED|Overall Study||52
5093675|NCT01664039|12531940|P1|STARTED|Overall Study||52
5093676|NCT01663987|12531962|P2|NOT COMPLETED|Overall Study||6
5093677|NCT01663987|12531963|P1|NOT COMPLETED|Overall Study||13
5093678|NCT01663987|12531962|P2|COMPLETED|Overall Study||34
5093679|NCT01663987|12531963|P1|COMPLETED|Overall Study||26
5093680|NCT01663987|12531962|P2|STARTED|Overall Study||40
5093681|NCT01663987|12531963|P1|STARTED|Overall Study||39
5093682|NCT01663935|12531991|P1|NOT COMPLETED|Overall Study||0
5093683|NCT01663935|12531991|P1|COMPLETED|Overall Study||20
5093684|NCT01663935|12531991|P1|STARTED|Overall Study||20
5093685|NCT01663922|12531996|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
5093686|NCT01663922|12531997|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
5093687|NCT01663922|12531996|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
5093688|NCT01663922|12531997|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
5093689|NCT01663922|12531996|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
5093690|NCT01663922|12531997|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
5093691|NCT01663922|12531996|P2|NOT COMPLETED|Washout (7 Days)||0
5093692|NCT01663922|12531997|P1|NOT COMPLETED|Washout (7 Days)||0
5093693|NCT01663922|12531996|P2|COMPLETED|Washout (7 Days)||9
5093694|NCT01663922|12531997|P1|COMPLETED|Washout (7 Days)||8
5093695|NCT01663922|12531996|P2|STARTED|Washout (7 Days)||9
5093696|NCT01663922|12531997|P1|STARTED|Washout (7 Days)||8
5093697|NCT01663922|12531996|P2|NOT COMPLETED|Second Intervention (14 Days)||0
5093698|NCT01663922|12531997|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5093699|NCT01663922|12531996|P2|COMPLETED|Second Intervention (14 Days)||9
5093700|NCT01663922|12531997|P1|COMPLETED|Second Intervention (14 Days)||8
5093701|NCT01663922|12531996|P2|STARTED|Second Intervention (14 Days)||9
5093702|NCT01663922|12531997|P1|STARTED|Second Intervention (14 Days)||8
5093703|NCT01663922|12531996|P2|NOT COMPLETED|Washout (7 Days)||0
5093704|NCT01663922|12531997|P1|NOT COMPLETED|Washout (7 Days)||0
5093705|NCT01663922|12531996|P2|COMPLETED|Washout (7 Days)||9
5093706|NCT01663922|12531997|P1|COMPLETED|Washout (7 Days)||8
5093707|NCT01663922|12531996|P2|STARTED|Washout (7 Days)||9
5093708|NCT01663922|12531997|P1|STARTED|Washout (7 Days)||8
5093709|NCT01663922|12531996|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
5093710|NCT01663922|12531997|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
5093711|NCT01663922|12531996|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
5093712|NCT01663922|12531997|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
5093713|NCT01663922|12531996|P2|STARTED|First Intervention (14 Days or 5 Days)||9
5093714|NCT01663922|12531997|P1|STARTED|First Intervention (14 Days or 5 Days)||8
5093715|NCT01663896|12532002|P1|NOT COMPLETED|Overall Study||43
5093716|NCT01663896|12532002|P1|COMPLETED|Overall Study||375
5093717|NCT01663896|12532002|P1|STARTED|Overall Study||418
5093718|NCT01663857|12532013|P4|NOT COMPLETED|Overall Study||4
5093719|NCT01663857|12532014|P3|NOT COMPLETED|Overall Study||10
5093720|NCT01663857|12532015|P2|NOT COMPLETED|Overall Study||1
5093721|NCT01663857|12532016|P1|NOT COMPLETED|Overall Study||0
5093722|NCT01663857|12532013|P4|COMPLETED|Overall Study||48
5093723|NCT01663857|12532014|P3|COMPLETED|Overall Study||48
5093724|NCT01663857|12532015|P2|COMPLETED|Overall Study||1
5093725|NCT01663857|12532016|P1|COMPLETED|Overall Study||6
5093726|NCT01663857|12532013|P4|Received at Least One Dose of Study Drug|Overall Study||52
5093727|NCT01663857|12532014|P3|Received at Least One Dose of Study Drug|Overall Study||58
5093728|NCT01663857|12532015|P2|Received at Least One Dose of Study Drug|Overall Study||2
5093729|NCT01663857|12532016|P1|Received at Least One Dose of Study Drug|Overall Study||6
5093730|NCT01663857|12532013|P4|STARTED|Overall Study||52
5093731|NCT01663857|12532014|P3|STARTED|Overall Study||58
5093732|NCT01663857|12532015|P2|STARTED|Overall Study||2
5093733|NCT01663857|12532016|P1|STARTED|Overall Study||6
5093734|NCT01663779|12532035|P2|NOT COMPLETED|Overall Study||0
5093735|NCT01663779|12532036|P1|NOT COMPLETED|Overall Study||0
5093736|NCT01663779|12532035|P2|COMPLETED|Overall Study||23
5093737|NCT01663779|12532036|P1|COMPLETED|Overall Study||27
5093738|NCT01663779|12532035|P2|STARTED|Overall Study||23
5093739|NCT01663779|12532036|P1|STARTED|Overall Study||27
5093740|NCT01663740|12532044|P2|NOT COMPLETED|Overall Study||8
5093741|NCT01663740|12532045|P1|NOT COMPLETED|Overall Study||16
5093742|NCT01663740|12532044|P2|COMPLETED|Overall Study||13
5093743|NCT01663740|12532045|P1|COMPLETED|Overall Study||22
5093744|NCT01663740|12532044|P2|STARTED|Overall Study|Safety Population|21
5093745|NCT01663740|12532045|P1|STARTED|Overall Study|Safety Population|38
5093746|NCT01663727|12532105|P2|NOT COMPLETED|Overall Study||238
5093747|NCT01663727|12532106|P1|NOT COMPLETED|Overall Study||242
5093748|NCT01663727|12532105|P2|COMPLETED|Overall Study||1
5093749|NCT01663727|12532106|P1|COMPLETED|Overall Study||0
5093750|NCT01663727|12532105|P2|STARTED|Overall Study||239
5093751|NCT01663727|12532106|P1|STARTED|Overall Study||242
5093752|NCT01663714|12532138|P1|NOT COMPLETED|Long-Term Follow-Up||6
5093753|NCT01663714|12532138|P1|COMPLETED|Long-Term Follow-Up||16
5093754|NCT01663714|12532138|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
5093755|NCT01663714|12532138|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
5093756|NCT01663714|12532138|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
5093757|NCT01663714|12532138|P1|STARTED|Dosimetric and Therapeutic Treatment||30
5093758|NCT01663636|12532167|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
5093759|NCT01663636|12532168|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
5093760|NCT01663636|12532167|P2|COMPLETED|Parent SMS Acceptability Assessment||130
5093761|NCT01663636|12532168|P1|COMPLETED|Parent SMS Acceptability Assessment||135
5093762|NCT01663636|12532167|P2|STARTED|Parent SMS Acceptability Assessment||130
5093763|NCT01663636|12532168|P1|STARTED|Parent SMS Acceptability Assessment||135
5093764|NCT01663636|12532167|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
5093765|NCT01663636|12532168|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
5093766|NCT01663636|12532167|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
5093767|NCT01663636|12532168|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
5093768|NCT01663636|12532167|P2|STARTED|Infant SMS Reminder Feasibility Study||161
5093769|NCT01663636|12532168|P1|STARTED|Infant SMS Reminder Feasibility Study||160
5093770|NCT01663623|12532176|P2|NOT COMPLETED|Overall Study||20
5093771|NCT01663623|12532177|P1|NOT COMPLETED|Overall Study||12
5093772|NCT01663623|12532176|P2|COMPLETED|Overall Study||33
5093773|NCT01663623|12532177|P1|COMPLETED|Overall Study||40
5093774|NCT01663623|12532176|P2|STARTED|Overall Study||53
5093775|NCT01663623|12532177|P1|STARTED|Overall Study||52
5093776|NCT01663532|12532187|P2|NOT COMPLETED|Overall Study||107
5093777|NCT01663532|12532188|P1|NOT COMPLETED|Overall Study||74
5093778|NCT01663532|12532187|P2|COMPLETED|Overall Study||65
5093779|NCT01663532|12532188|P1|COMPLETED|Overall Study||94
5093780|NCT01663532|12532187|P2|STARTED|Overall Study||172
5093781|NCT01663532|12532188|P1|STARTED|Overall Study||168
5093782|NCT01663506|12532206|P1|NOT COMPLETED|Overall Study||8
5093783|NCT01663506|12532206|P1|COMPLETED|Overall Study||15
5093784|NCT01663506|12532206|P1|STARTED|Overall Study||23
5093785|NCT01663402|12532237|P2|NOT COMPLETED|Overall Study||2084
5093786|NCT01663402|12532238|P1|NOT COMPLETED|Overall Study||1515
5093787|NCT01663402|12532237|P2|COMPLETED|Overall Study||7378
5093788|NCT01663402|12532238|P1|COMPLETED|Overall Study||7947
5093789|NCT01663402|12532237|P2|Treated|Overall Study||9451
5093790|NCT01663402|12532238|P1|Treated|Overall Study||9443
5093791|NCT01663402|12532237|P2|STARTED|Overall Study||9462
5093792|NCT01663402|12532238|P1|STARTED|Overall Study||9462
5093793|NCT01663363|12532272|P1|NOT COMPLETED|Overall Study||0
5093794|NCT01663363|12532272|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
5093795|NCT01663363|12532272|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
5093796|NCT01663285|12532277|P1|NOT COMPLETED|Overall Study||0
5093797|NCT01663285|12532277|P1|COMPLETED|Overall Study||1
5093798|NCT01663285|12532277|P1|STARTED|Overall Study||1
5093799|NCT01663272|12532283|P3|NOT COMPLETED|Overall Study||0
5093800|NCT01663272|12532284|P2|NOT COMPLETED|Overall Study||0
5093801|NCT01663272|12532285|P1|NOT COMPLETED|Overall Study||0
5093802|NCT01663272|12532283|P3|COMPLETED|Overall Study||1
5093803|NCT01663272|12532284|P2|COMPLETED|Overall Study||6
5093804|NCT01663272|12532285|P1|COMPLETED|Overall Study||5
5093805|NCT01663272|12532283|P3|STARTED|Overall Study||1
5093806|NCT01663272|12532284|P2|STARTED|Overall Study||6
5093807|NCT01663272|12532285|P1|STARTED|Overall Study||5
5093808|NCT01663233|12532292|P2|NOT COMPLETED|Overall Study||7
5093809|NCT01663233|12532293|P1|NOT COMPLETED|Overall Study||4
5093810|NCT01663233|12532292|P2|COMPLETED|Overall Study||129
5093811|NCT01663233|12532293|P1|COMPLETED|Overall Study||126
5093812|NCT01663233|12532292|P2|STARTED|Overall Study||136
5093813|NCT01663233|12532293|P1|STARTED|Overall Study||130
5093814|NCT01663103|12532317|P2|NOT COMPLETED|Overall Study||2
5093815|NCT01663103|12532318|P1|NOT COMPLETED|Overall Study||3
5093816|NCT01663103|12532317|P2|COMPLETED|Overall Study||19
5093817|NCT01663103|12532318|P1|COMPLETED|Overall Study||18
5093818|NCT01663103|12532317|P2|STARTED|Overall Study||21
5093819|NCT01663103|12532318|P1|STARTED|Overall Study||21
5093820|NCT01663012|12532334|P1|NOT COMPLETED|Overall Study||0
5093821|NCT01663012|12532334|P1|COMPLETED|Overall Study||20
5093822|NCT01663012|12532334|P1|STARTED|Overall Study||20
5093823|NCT01662999|12532346|P6|NOT COMPLETED|Period 3||0
5093824|NCT01662999|12532347|P5|NOT COMPLETED|Period 3||0
5093825|NCT01662999|12532348|P4|NOT COMPLETED|Period 3||0
5093826|NCT01662999|12532349|P3|NOT COMPLETED|Period 3||0
5093827|NCT01662999|12532350|P2|NOT COMPLETED|Period 3||1
5093828|NCT01662999|12532351|P1|NOT COMPLETED|Period 3||0
5093829|NCT01662999|12532346|P6|COMPLETED|Period 3||7
5093830|NCT01662999|12532347|P5|COMPLETED|Period 3||7
5093831|NCT01662999|12532348|P4|COMPLETED|Period 3||7
5093832|NCT01662999|12532349|P3|COMPLETED|Period 3||7
5093833|NCT01662999|12532350|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
5093834|NCT01662999|12532351|P1|COMPLETED|Period 3||7
5093835|NCT01662999|12532346|P6|STARTED|Period 3||7
5093836|NCT01662999|12532347|P5|STARTED|Period 3||7
5093837|NCT01662999|12532348|P4|STARTED|Period 3||7
5093838|NCT01662999|12532349|P3|STARTED|Period 3||7
5093839|NCT01662999|12532350|P2|STARTED|Period 3||7
5093840|NCT01662999|12532351|P1|STARTED|Period 3||7
5093841|NCT01662999|12532346|P6|NOT COMPLETED|Period 2||0
5093842|NCT01662999|12532347|P5|NOT COMPLETED|Period 2||0
5093843|NCT01662999|12532348|P4|NOT COMPLETED|Period 2||0
5093844|NCT01662999|12532349|P3|NOT COMPLETED|Period 2||0
5093845|NCT01662999|12532350|P2|NOT COMPLETED|Period 2||0
5093846|NCT01662999|12532351|P1|NOT COMPLETED|Period 2||0
5093847|NCT01662999|12532346|P6|COMPLETED|Period 2||7
5093848|NCT01662999|12532347|P5|COMPLETED|Period 2||7
5093849|NCT01662999|12532348|P4|COMPLETED|Period 2||7
5093850|NCT01662999|12532349|P3|COMPLETED|Period 2||7
5093851|NCT01662999|12532350|P2|COMPLETED|Period 2||7
5093852|NCT01662999|12532351|P1|COMPLETED|Period 2||7
5093853|NCT01662999|12532346|P6|STARTED|Period 2||7
5093854|NCT01662999|12532347|P5|STARTED|Period 2||7
5093855|NCT01662999|12532348|P4|STARTED|Period 2||7
5093856|NCT01662999|12532349|P3|STARTED|Period 2||7
5093857|NCT01662999|12532350|P2|STARTED|Period 2||7
5093858|NCT01662999|12532351|P1|STARTED|Period 2||7
5093859|NCT01662999|12532346|P6|NOT COMPLETED|Period 1||0
5093860|NCT01662999|12532347|P5|NOT COMPLETED|Period 1||0
5093861|NCT01662999|12532348|P4|NOT COMPLETED|Period 1||0
5093862|NCT01662999|12532349|P3|NOT COMPLETED|Period 1||0
5093863|NCT01662999|12532350|P2|NOT COMPLETED|Period 1||0
5093864|NCT01662999|12532351|P1|NOT COMPLETED|Period 1||0
5093865|NCT01662999|12532346|P6|COMPLETED|Period 1||7
5093866|NCT01662999|12532347|P5|COMPLETED|Period 1||7
5093867|NCT01662999|12532348|P4|COMPLETED|Period 1||7
5093868|NCT01662999|12532349|P3|COMPLETED|Period 1||7
5093869|NCT01662999|12532350|P2|COMPLETED|Period 1||7
5093870|NCT01662999|12532351|P1|COMPLETED|Period 1||7
5093871|NCT01662999|12532346|P6|STARTED|Period 1||7
5093872|NCT01662999|12532347|P5|STARTED|Period 1||7
5093873|NCT01662999|12532348|P4|STARTED|Period 1||7
5093874|NCT01662999|12532349|P3|STARTED|Period 1||7
5093875|NCT01662999|12532350|P2|STARTED|Period 1||7
5093876|NCT01662999|12532351|P1|STARTED|Period 1||7
5093877|NCT01662986|12532422|P2|NOT COMPLETED|Overall Study||13
5093878|NCT01662986|12532423|P1|NOT COMPLETED|Overall Study||18
5093879|NCT01662986|12532422|P2|COMPLETED|Overall Study||26
5093880|NCT01662986|12532423|P1|COMPLETED|Overall Study||22
5093881|NCT01662986|12532422|P2|STARTED|Overall Study||39
5093882|NCT01662986|12532423|P1|STARTED|Overall Study||40
5093883|NCT01662960|12532459|P4|NOT COMPLETED|3 Month Follow-up||2
5093884|NCT01662960|12532460|P3|NOT COMPLETED|3 Month Follow-up||3
5093885|NCT01662960|12532461|P2|NOT COMPLETED|3 Month Follow-up||3
5093886|NCT01662960|12532462|P1|NOT COMPLETED|3 Month Follow-up||3
5093887|NCT01662960|12532459|P4|COMPLETED|3 Month Follow-up||13
5093888|NCT01662960|12532460|P3|COMPLETED|3 Month Follow-up||5
5093889|NCT01662960|12532461|P2|COMPLETED|3 Month Follow-up||16
5093890|NCT01662960|12532462|P1|COMPLETED|3 Month Follow-up||21
5093891|NCT01662960|12532459|P4|STARTED|3 Month Follow-up||15
5093892|NCT01662960|12532460|P3|STARTED|3 Month Follow-up||8
5093893|NCT01662960|12532461|P2|STARTED|3 Month Follow-up||19
5093894|NCT01662960|12532462|P1|STARTED|3 Month Follow-up||24
5093895|NCT01662960|12532459|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
5093896|NCT01662960|12532460|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
5093897|NCT01662960|12532461|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
5093898|NCT01662960|12532462|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
5093899|NCT01662960|12532459|P4|COMPLETED|End of 4 Week Treatment Period||15
5093900|NCT01662960|12532460|P3|COMPLETED|End of 4 Week Treatment Period||8
5093901|NCT01662960|12532461|P2|COMPLETED|End of 4 Week Treatment Period||19
5093902|NCT01662960|12532462|P1|COMPLETED|End of 4 Week Treatment Period||24
5093903|NCT01662960|12532459|P4|STARTED|End of 4 Week Treatment Period||15
5093904|NCT01662960|12532460|P3|STARTED|End of 4 Week Treatment Period||9
5093905|NCT01662960|12532461|P2|STARTED|End of 4 Week Treatment Period||23
5093906|NCT01662960|12532462|P1|STARTED|End of 4 Week Treatment Period||25
5093907|NCT01662908|12532494|P2|NOT COMPLETED|Overall Study||5
5093908|NCT01662908|12532495|P1|NOT COMPLETED|Overall Study||6
5093909|NCT01662908|12532494|P2|COMPLETED|Overall Study||23
5093910|NCT01662908|12532495|P1|COMPLETED|Overall Study||50
5093911|NCT01662908|12532494|P2|STARTED|Overall Study||28
5093912|NCT01662908|12532495|P1|STARTED|Overall Study||56
5093913|NCT01662895|12532511|P2|NOT COMPLETED|Overall Study||1
5093914|NCT01662895|12532512|P1|NOT COMPLETED|Overall Study||0
5093915|NCT01662895|12532511|P2|COMPLETED|Overall Study||20
5093916|NCT01662895|12532512|P1|COMPLETED|Overall Study||21
5093917|NCT01662895|12532511|P2|Initiated Study Drug|Overall Study||21
5093918|NCT01662895|12532512|P1|Initiated Study Drug|Overall Study||21
5093919|NCT01662895|12532511|P2|STARTED|Overall Study||21
5093920|NCT01662895|12532512|P1|STARTED|Overall Study||21
5093921|NCT01662882|12532535|P3|NOT COMPLETED|Overall Study||0
5093922|NCT01662882|12532536|P2|NOT COMPLETED|Overall Study||0
5093923|NCT01662882|12532537|P1|NOT COMPLETED|Overall Study||0
5093924|NCT01662882|12532535|P3|COMPLETED|Overall Study||15
5093925|NCT01662882|12532536|P2|COMPLETED|Overall Study||18
5093926|NCT01662882|12532537|P1|COMPLETED|Overall Study||15
5093927|NCT01662882|12532535|P3|STARTED|Overall Study||15
5093928|NCT01662882|12532536|P2|STARTED|Overall Study||18
5093929|NCT01662882|12532537|P1|STARTED|Overall Study||15
5093930|NCT01662856|12532550|P2|NOT COMPLETED|Primary Part II||2
5093931|NCT01662856|12532551|P1|NOT COMPLETED|Primary Part II||10
5093932|NCT01662856|12532550|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
5093933|NCT01662856|12532551|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
5093934|NCT01662856|12532550|P2|Completed Study up to Week 6|Primary Part II||56
5093935|NCT01662856|12532551|P1|Completed Study up to Week 6|Primary Part II||106
5093936|NCT01662856|12532550|P2|STARTED|Primary Part II||57
5093937|NCT01662856|12532551|P1|STARTED|Primary Part II||109
5093938|NCT01662856|12532550|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
5093939|NCT01662856|12532551|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
5093940|NCT01662856|12532550|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
5093941|NCT01662856|12532551|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
5093942|NCT01662856|12532550|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
5093943|NCT01662856|12532551|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
5093944|NCT01662856|12532550|P2|STARTED|Part I + Part II (Overall Study)||57
5093945|NCT01662856|12532551|P1|STARTED|Part I + Part II (Overall Study)||168
5093946|NCT01662791|12532565|P2|NOT COMPLETED|Part 2 - Interventional||0
5093947|NCT01662791|12532566|P1|NOT COMPLETED|Part 2 - Interventional||0
5093948|NCT01662791|12532565|P2|COMPLETED|Part 2 - Interventional||0
5093949|NCT01662791|12532566|P1|COMPLETED|Part 2 - Interventional||8
5093950|NCT01662791|12532565|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
5093951|NCT01662791|12532566|P1|STARTED|Part 2 - Interventional||8
5093952|NCT01662791|12532565|P2|NOT COMPLETED|Part 1 - Observational||0
5093953|NCT01662791|12532566|P1|NOT COMPLETED|Part 1 - Observational||0
5093954|NCT01662791|12532565|P2|COMPLETED|Part 1 - Observational||41
5093955|NCT01662791|12532566|P1|COMPLETED|Part 1 - Observational||8
5093956|NCT01662791|12532565|P2|STARTED|Part 1 - Observational||41
5093957|NCT01662791|12532566|P1|STARTED|Part 1 - Observational||8
5093958|NCT01662778|12532588|P4|NOT COMPLETED|Period 4||0
5093959|NCT01662778|12532589|P3|NOT COMPLETED|Period 4||0
5093960|NCT01662778|12532590|P2|NOT COMPLETED|Period 4||0
5093961|NCT01662778|12532591|P1|NOT COMPLETED|Period 4||0
5093962|NCT01662778|12532588|P4|COMPLETED|Period 4||4
5093963|NCT01662778|12532589|P3|COMPLETED|Period 4||6
5093964|NCT01662778|12532590|P2|COMPLETED|Period 4||5
5093965|NCT01662778|12532591|P1|COMPLETED|Period 4||6
5093966|NCT01662778|12532588|P4|STARTED|Period 4||4
5093967|NCT01662778|12532589|P3|STARTED|Period 4||6
5093968|NCT01662778|12532590|P2|STARTED|Period 4||5
5093969|NCT01662778|12532591|P1|STARTED|Period 4||6
5093970|NCT01662778|12532588|P4|NOT COMPLETED|Period 3||0
5093971|NCT01662778|12532589|P3|NOT COMPLETED|Period 3||0
5093972|NCT01662778|12532590|P2|NOT COMPLETED|Period 3||0
5093973|NCT01662778|12532591|P1|NOT COMPLETED|Period 3||0
5093974|NCT01662778|12532588|P4|COMPLETED|Period 3||4
5093975|NCT01662778|12532589|P3|COMPLETED|Period 3||6
5093976|NCT01662778|12532590|P2|COMPLETED|Period 3||5
5093977|NCT01662778|12532591|P1|COMPLETED|Period 3||6
5093978|NCT01662778|12532588|P4|STARTED|Period 3||4
5093979|NCT01662778|12532589|P3|STARTED|Period 3||6
5093980|NCT01662778|12532590|P2|STARTED|Period 3||5
5093981|NCT01662778|12532591|P1|STARTED|Period 3||6
5093982|NCT01662778|12532588|P4|NOT COMPLETED|Period 2||0
5093983|NCT01662778|12532589|P3|NOT COMPLETED|Period 2||0
5093984|NCT01662778|12532590|P2|NOT COMPLETED|Period 2||0
5093985|NCT01662778|12532591|P1|NOT COMPLETED|Period 2||0
5093986|NCT01662778|12532588|P4|COMPLETED|Period 2||4
5093987|NCT01662778|12532589|P3|COMPLETED|Period 2||6
5093988|NCT01662778|12532590|P2|COMPLETED|Period 2||5
5093989|NCT01662778|12532591|P1|COMPLETED|Period 2||6
5093990|NCT01662778|12532588|P4|STARTED|Period 2||4
5093991|NCT01662778|12532589|P3|STARTED|Period 2||6
5093992|NCT01662778|12532590|P2|STARTED|Period 2||5
5093993|NCT01662778|12532591|P1|STARTED|Period 2||6
5093994|NCT01662778|12532588|P4|NOT COMPLETED|Period 1||0
5093995|NCT01662778|12532589|P3|NOT COMPLETED|Period 1||0
5093996|NCT01662778|12532590|P2|NOT COMPLETED|Period 1||0
5093997|NCT01662778|12532591|P1|NOT COMPLETED|Period 1||0
5093998|NCT01662778|12532588|P4|COMPLETED|Period 1||4
5093999|NCT01662778|12532589|P3|COMPLETED|Period 1||6
5094000|NCT01662778|12532590|P2|COMPLETED|Period 1||5
5094001|NCT01662778|12532591|P1|COMPLETED|Period 1||6
5094002|NCT01662778|12532588|P4|STARTED|Period 1||4
5094003|NCT01662778|12532589|P3|STARTED|Period 1||6
5094004|NCT01662778|12532590|P2|STARTED|Period 1||5
5094005|NCT01662778|12532591|P1|STARTED|Period 1||6
5094006|NCT01662765|12532615|P2|NOT COMPLETED|Overall Study||2
5094007|NCT01662765|12532616|P1|NOT COMPLETED|Overall Study||1
5094008|NCT01662765|12532615|P2|COMPLETED|Overall Study||40
5094009|NCT01662765|12532616|P1|COMPLETED|Overall Study||41
5094010|NCT01662765|12532615|P2|STARTED|Overall Study||42
5094011|NCT01662765|12532616|P1|STARTED|Overall Study||42
5094012|NCT01662752|12532628|P1|NOT COMPLETED|Overall Study||0
5094013|NCT01662752|12532628|P1|COMPLETED|Overall Study||30
5094014|NCT01662752|12532628|P1|STARTED|Overall Study||30
5094015|NCT01662648|12532636|P2|NOT COMPLETED|Overall Study||178
5094016|NCT01662648|12532637|P1|NOT COMPLETED|Overall Study||147
5094017|NCT01662648|12532636|P2|COMPLETED|Overall Study||419
5094018|NCT01662648|12532637|P1|COMPLETED|Overall Study||373
5094019|NCT01662648|12532636|P2|STARTED|Overall Study||597
5094020|NCT01662648|12532637|P1|STARTED|Overall Study||520
5094021|NCT01662635|12532659|P1|NOT COMPLETED|Overall Study||30
5094022|NCT01662635|12532659|P1|COMPLETED|Overall Study||200
5094023|NCT01662635|12532659|P1|STARTED|Overall Study||230
5094024|NCT01662583|12532668|P3|NOT COMPLETED|Overall Study||0
5094025|NCT01662583|12532669|P2|NOT COMPLETED|Overall Study||0
5094026|NCT01662583|12532670|P1|NOT COMPLETED|Overall Study||0
5094027|NCT01662583|12532668|P3|COMPLETED|Overall Study||219
5094028|NCT01662583|12532669|P2|COMPLETED|Overall Study||225
5094029|NCT01662583|12532670|P1|COMPLETED|Overall Study||216
5094030|NCT01662583|12532668|P3|STARTED|Overall Study||219
5094031|NCT01662583|12532669|P2|STARTED|Overall Study||225
5094032|NCT01662583|12532670|P1|STARTED|Overall Study||216
5094033|NCT01662531|12532683|P1|NOT COMPLETED|Overall Study||0
5094034|NCT01662531|12532683|P1|COMPLETED|Overall Study||27
5094035|NCT01662531|12532683|P1|STARTED|Overall Study||27
5094036|NCT01662505|12532710|P3|NOT COMPLETED|Overall Study||8
5094037|NCT01662505|12532711|P2|NOT COMPLETED|Overall Study||4
5094038|NCT01662505|12532712|P1|NOT COMPLETED|Overall Study||7
5094039|NCT01662505|12532710|P3|COMPLETED|Overall Study||0
5094040|NCT01662505|12532711|P2|COMPLETED|Overall Study||0
5094041|NCT01662505|12532712|P1|COMPLETED|Overall Study||0
5094042|NCT01662505|12532710|P3|STARTED|Overall Study||8
5094043|NCT01662505|12532711|P2|STARTED|Overall Study||4
5094044|NCT01662505|12532712|P1|STARTED|Overall Study||7
5094045|NCT01662492|12532736|P3|NOT COMPLETED|Overall Study||6
5094046|NCT01662492|12532737|P2|NOT COMPLETED|Overall Study||1
5094047|NCT01662492|12532738|P1|NOT COMPLETED|Overall Study||3
5094048|NCT01662492|12532736|P3|COMPLETED|Overall Study||31
5094049|NCT01662492|12532737|P2|COMPLETED|Overall Study||42
5094050|NCT01662492|12532738|P1|COMPLETED|Overall Study||42
5094051|NCT01662492|12532736|P3|STARTED|Overall Study||37
5094052|NCT01662492|12532737|P2|STARTED|Overall Study||43
5094053|NCT01662492|12532738|P1|STARTED|Overall Study||45
5094054|NCT01662440|12532762|P4|NOT COMPLETED|Overall Study||4
5094055|NCT01662440|12532763|P3|NOT COMPLETED|Overall Study||6
5094056|NCT01662440|12532764|P2|NOT COMPLETED|Overall Study||6
5094057|NCT01662440|12532765|P1|NOT COMPLETED|Overall Study||9
5094058|NCT01662440|12532762|P4|COMPLETED|Overall Study||52
5094059|NCT01662440|12532763|P3|COMPLETED|Overall Study||215
5094060|NCT01662440|12532764|P2|COMPLETED|Overall Study||211
5094061|NCT01662440|12532765|P1|COMPLETED|Overall Study||158
5094062|NCT01662440|12532762|P4|STARTED|Overall Study||56
5094063|NCT01662440|12532763|P3|STARTED|Overall Study||221
5094064|NCT01662440|12532764|P2|STARTED|Overall Study||217
5094065|NCT01662440|12532765|P1|STARTED|Overall Study||167
5094066|NCT01662362|12532813|P1|NOT COMPLETED|Overall Study||38
5094067|NCT01662362|12532813|P1|COMPLETED|Overall Study||25
5094068|NCT01662362|12532813|P1|STARTED|Overall Study||63
5094069|NCT01662336|12532818|P1|NOT COMPLETED|Overall Study||66
5094070|NCT01662336|12532818|P1|COMPLETED|Overall Study||107
5094071|NCT01662336|12532818|P1|Completed Month 12 Visit|Overall Study||109
5094072|NCT01662336|12532818|P1|Completed Month 6 Visit|Overall Study||142
5094073|NCT01662336|12532818|P1|STARTED|Overall Study||173
5094074|NCT01662310|12532844|P5|NOT COMPLETED|Open-Label Extension Phase||10
5094075|NCT01662310|12532845|P4|NOT COMPLETED|Open-Label Extension Phase||11
5094076|NCT01662310|12532846|P3|NOT COMPLETED|Open-Label Extension Phase||0
5094077|NCT01662310|12532847|P2|NOT COMPLETED|Open-Label Extension Phase||0
5094078|NCT01662310|12532848|P1|NOT COMPLETED|Open-Label Extension Phase||0
5094079|NCT01662310|12532844|P5|COMPLETED|Open-Label Extension Phase||49
5094080|NCT01662310|12532845|P4|COMPLETED|Open-Label Extension Phase||36
5094081|NCT01662310|12532846|P3|COMPLETED|Open-Label Extension Phase||0
5094082|NCT01662310|12532847|P2|COMPLETED|Open-Label Extension Phase||0
5094083|NCT01662310|12532848|P1|COMPLETED|Open-Label Extension Phase||0
5094084|NCT01662310|12532844|P5|STARTED|Open-Label Extension Phase||59
5094085|NCT01662310|12532845|P4|STARTED|Open-Label Extension Phase||47
5094086|NCT01662310|12532846|P3|STARTED|Open-Label Extension Phase||0
5094087|NCT01662310|12532847|P2|STARTED|Open-Label Extension Phase||0
5094088|NCT01662310|12532848|P1|STARTED|Open-Label Extension Phase||0
5094089|NCT01662310|12532844|P5|NOT COMPLETED|Double-Blind Phase||0
5094090|NCT01662310|12532845|P4|NOT COMPLETED|Double-Blind Phase||0
5094091|NCT01662310|12532846|P3|NOT COMPLETED|Double-Blind Phase||5
5094092|NCT01662310|12532847|P2|NOT COMPLETED|Double-Blind Phase||15
5094093|NCT01662310|12532848|P1|NOT COMPLETED|Double-Blind Phase||0
5094094|NCT01662310|12532844|P5|COMPLETED|Double-Blind Phase||0
5094095|NCT01662310|12532845|P4|COMPLETED|Double-Blind Phase||0
5094096|NCT01662310|12532846|P3|COMPLETED|Double-Blind Phase||66
5094097|NCT01662310|12532847|P2|COMPLETED|Double-Blind Phase||50
5094098|NCT01662310|12532848|P1|COMPLETED|Double-Blind Phase||0
5094099|NCT01662310|12532844|P5|Treated|Double-Blind Phase||0
5094100|NCT01662310|12532845|P4|Treated|Double-Blind Phase||0
5094101|NCT01662310|12532846|P3|Treated|Double-Blind Phase||71
5094102|NCT01662310|12532847|P2|Treated|Double-Blind Phase||64
5094103|NCT01662310|12532848|P1|Treated|Double-Blind Phase||0
5094104|NCT01662310|12532844|P5|STARTED|Double-Blind Phase||0
5094105|NCT01662310|12532845|P4|STARTED|Double-Blind Phase||0
5094106|NCT01662310|12532846|P3|STARTED|Double-Blind Phase||71
5094107|NCT01662310|12532847|P2|STARTED|Double-Blind Phase||65
5094108|NCT01662310|12532848|P1|STARTED|Double-Blind Phase||0
5094109|NCT01662310|12532844|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
5094110|NCT01662310|12532845|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
5094111|NCT01662310|12532846|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
5094112|NCT01662310|12532847|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
5094113|NCT01662310|12532848|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
5094114|NCT01662310|12532844|P5|COMPLETED|Run-In or Stabilization Phase||0
5094115|NCT01662310|12532845|P4|COMPLETED|Run-In or Stabilization Phase||0
5094116|NCT01662310|12532846|P3|COMPLETED|Run-In or Stabilization Phase||0
5094117|NCT01662310|12532847|P2|COMPLETED|Run-In or Stabilization Phase||0
5094118|NCT01662310|12532848|P1|COMPLETED|Run-In or Stabilization Phase||136
5094119|NCT01662310|12532844|P5|STARTED|Run-In or Stabilization Phase||0
5094120|NCT01662310|12532845|P4|STARTED|Run-In or Stabilization Phase||0
5094121|NCT01662310|12532846|P3|STARTED|Run-In or Stabilization Phase||0
5094122|NCT01662310|12532847|P2|STARTED|Run-In or Stabilization Phase||0
5094123|NCT01662310|12532848|P1|STARTED|Run-In or Stabilization Phase||201
5094124|NCT01662297|12532882|P2|NOT COMPLETED|Overall Study||0
5094125|NCT01662297|12532883|P1|NOT COMPLETED|Overall Study||0
5094126|NCT01662297|12532882|P2|COMPLETED|Overall Study||1
5094127|NCT01662297|12532883|P1|COMPLETED|Overall Study||0
5094128|NCT01662297|12532882|P2|STARTED|Overall Study||1
5094129|NCT01662297|12532883|P1|STARTED|Overall Study||0
5094130|NCT01662115|12532908|P3|NOT COMPLETED|Overall Study||0
5094131|NCT01662115|12532909|P2|NOT COMPLETED|Overall Study||0
5094132|NCT01662115|12532910|P1|NOT COMPLETED|Overall Study||0
5094133|NCT01662115|12532908|P3|COMPLETED|Overall Study||0
5094134|NCT01662115|12532909|P2|COMPLETED|Overall Study||2
5094135|NCT01662115|12532910|P1|COMPLETED|Overall Study||2
5094136|NCT01662115|12532908|P3|STARTED|Overall Study||0
5094137|NCT01662115|12532909|P2|STARTED|Overall Study||2
5094138|NCT01662115|12532910|P1|STARTED|Overall Study||2
5094139|NCT01662102|12532929|P2|NOT COMPLETED|Overall Study||0
5094140|NCT01662102|12532930|P1|NOT COMPLETED|Overall Study||1
5094141|NCT01662102|12532929|P2|COMPLETED|Overall Study||0
5094142|NCT01662102|12532930|P1|COMPLETED|Overall Study||0
5094143|NCT01662102|12532929|P2|STARTED|Overall Study||0
5094144|NCT01662102|12532930|P1|STARTED|Overall Study||1
5094145|NCT01662063|12532938|P3|NOT COMPLETED|Overall Study||1
5094146|NCT01662063|12532939|P2|NOT COMPLETED|Overall Study||29
5094147|NCT01662063|12532940|P1|NOT COMPLETED|Overall Study||5
5094148|NCT01662063|12532938|P3|COMPLETED|Overall Study||0
5094149|NCT01662063|12532939|P2|COMPLETED|Overall Study||144
5094150|NCT01662063|12532940|P1|COMPLETED|Overall Study||39
5094151|NCT01662063|12532938|P3|STARTED|Overall Study||1
5094152|NCT01662063|12532939|P2|STARTED|Overall Study||173
5094153|NCT01662063|12532940|P1|STARTED|Overall Study||44
5094154|NCT01662024|12533019|P1|NOT COMPLETED|Overall Study||5
5094155|NCT01662024|12533019|P1|COMPLETED|Overall Study||15
5094156|NCT01662024|12533019|P1|STARTED|Overall Study||20
5094157|NCT01661972|12533031|P2|NOT COMPLETED|Overall Study||4
5094158|NCT01661972|12533032|P1|NOT COMPLETED|Overall Study||2
5094159|NCT01661972|12533031|P2|COMPLETED|Overall Study||46
5094160|NCT01661972|12533032|P1|COMPLETED|Overall Study||11
5094161|NCT01661972|12533031|P2|STARTED|Overall Study||50
5094162|NCT01661972|12533032|P1|STARTED|Overall Study||13
5094163|NCT01661946|12533044|P2|NOT COMPLETED|Overall Study||0
5094164|NCT01661946|12533045|P1|NOT COMPLETED|Overall Study||0
5094165|NCT01661946|12533044|P2|COMPLETED|Overall Study||5
5094166|NCT01661946|12533045|P1|COMPLETED|Overall Study||5
5094167|NCT01661946|12533044|P2|STARTED|Overall Study||5
5094168|NCT01661946|12533045|P1|STARTED|Overall Study||5
5094169|NCT01661933|12533051|P1|NOT COMPLETED|High-dose Gluten Challenge||2
5094170|NCT01661933|12533051|P1|COMPLETED|High-dose Gluten Challenge||8
5094171|NCT01661933|12533051|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
5094172|NCT01661933|12533051|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
5094173|NCT01661933|12533051|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
5094174|NCT01661933|12533051|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
5094175|NCT01661933|12533051|P1|NOT COMPLETED|Gluten Micro-challenge||0
5094176|NCT01661933|12533051|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
5094177|NCT01661933|12533051|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
5094178|NCT01661881|12533058|P1|NOT COMPLETED|Overall Study||1
5094179|NCT01661881|12533058|P1|COMPLETED|Overall Study||22
5094180|NCT01661881|12533058|P1|STARTED|Overall Study||23
5094181|NCT01661790|12533066|P2|NOT COMPLETED|Overall Study||2
5094182|NCT01661790|12533067|P1|NOT COMPLETED|Overall Study||0
5094183|NCT01661790|12533066|P2|COMPLETED|Overall Study||34
5094184|NCT01661790|12533067|P1|COMPLETED|Overall Study||36
5094185|NCT01661790|12533066|P2|STARTED|Overall Study||36
5094186|NCT01661790|12533067|P1|STARTED|Overall Study||36
5094187|NCT01661764|12533079|P6|NOT COMPLETED|Overall Study||2
5094188|NCT01661764|12533080|P5|NOT COMPLETED|Overall Study||3
5094189|NCT01661764|12533081|P4|NOT COMPLETED|Overall Study||2
5094190|NCT01661764|12533082|P3|NOT COMPLETED|Overall Study||3
5094191|NCT01661764|12533083|P2|NOT COMPLETED|Overall Study||5
5094192|NCT01661764|12533084|P1|NOT COMPLETED|Overall Study||2
5094193|NCT01661764|12533079|P6|COMPLETED|Overall Study||18
5094194|NCT01661764|12533080|P5|COMPLETED|Overall Study||16
5094195|NCT01661764|12533081|P4|COMPLETED|Overall Study||24
5094196|NCT01661764|12533082|P3|COMPLETED|Overall Study||22
5094197|NCT01661764|12533083|P2|COMPLETED|Overall Study||20
5094198|NCT01661764|12533084|P1|COMPLETED|Overall Study||24
5094199|NCT01661764|12533079|P6|STARTED|Overall Study||20
5094200|NCT01661764|12533080|P5|STARTED|Overall Study||19
5094201|NCT01661764|12533081|P4|STARTED|Overall Study||26
5094202|NCT01661764|12533082|P3|STARTED|Overall Study||25
5094203|NCT01661764|12533083|P2|STARTED|Overall Study||25
5094204|NCT01661764|12533084|P1|STARTED|Overall Study||26
5094205|NCT01661712|12533148|P2|NOT COMPLETED|Overall Study||0
5094206|NCT01661712|12533149|P1|NOT COMPLETED|Overall Study||0
5094207|NCT01661712|12533148|P2|COMPLETED|Overall Study|sham stimulation night|18
5094208|NCT01661712|12533149|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
5094209|NCT01661712|12533148|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
5094210|NCT01661712|12533149|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
5094211|NCT01661712|12533148|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
5094212|NCT01661712|12533149|P1|STARTED|Overall Study|initial sham stimulation night|18
5094213|NCT01661686|12533167|P2|NOT COMPLETED|Overall Study||2
5094214|NCT01661686|12533168|P1|NOT COMPLETED|Overall Study||2
5094215|NCT01661686|12533167|P2|COMPLETED|Overall Study||47
5094216|NCT01661686|12533168|P1|COMPLETED|Overall Study||47
5094217|NCT01661686|12533167|P2|STARTED|Overall Study||49
5094218|NCT01661686|12533168|P1|STARTED|Overall Study||49
5094219|NCT01661621|12533184|P2|NOT COMPLETED|Overall Study||0
5094220|NCT01661621|12533185|P1|NOT COMPLETED|Overall Study||0
5094221|NCT01661621|12533184|P2|COMPLETED|Overall Study||279
5094222|NCT01661621|12533185|P1|COMPLETED|Overall Study||116
5094223|NCT01661621|12533184|P2|STARTED|Overall Study||279
5094224|NCT01661621|12533185|P1|STARTED|Overall Study||116
5094225|NCT01661595|12533209|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
5094226|NCT01661595|12533210|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
5094227|NCT01661595|12533211|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
5094228|NCT01661595|12533212|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
5094229|NCT01661595|12533209|P4|COMPLETED|Phase 2: Week 5-8.||4
5094230|NCT01661595|12533210|P3|COMPLETED|Phase 2: Week 5-8.||4
5094231|NCT01661595|12533211|P2|COMPLETED|Phase 2: Week 5-8.||4
5094232|NCT01661595|12533212|P1|COMPLETED|Phase 2: Week 5-8.||4
5094233|NCT01661595|12533209|P4|STARTED|Phase 2: Week 5-8.||4
5094234|NCT01661595|12533210|P3|STARTED|Phase 2: Week 5-8.||5
5094235|NCT01661595|12533211|P2|STARTED|Phase 2: Week 5-8.||4
5094236|NCT01661595|12533212|P1|STARTED|Phase 2: Week 5-8.||4
5094237|NCT01661595|12533209|P4|NOT COMPLETED|Phase 1: Week 0-4||0
5094238|NCT01661595|12533210|P3|NOT COMPLETED|Phase 1: Week 0-4||0
5094239|NCT01661595|12533211|P2|NOT COMPLETED|Phase 1: Week 0-4||0
5094240|NCT01661595|12533212|P1|NOT COMPLETED|Phase 1: Week 0-4||1
5094241|NCT01661595|12533209|P4|COMPLETED|Phase 1: Week 0-4||4
5094242|NCT01661595|12533210|P3|COMPLETED|Phase 1: Week 0-4||5
5094243|NCT01661595|12533211|P2|COMPLETED|Phase 1: Week 0-4||4
5094244|NCT01661595|12533212|P1|COMPLETED|Phase 1: Week 0-4||4
5094245|NCT01661595|12533209|P4|STARTED|Phase 1: Week 0-4||4
5094246|NCT01661595|12533210|P3|STARTED|Phase 1: Week 0-4||5
5094247|NCT01661595|12533211|P2|STARTED|Phase 1: Week 0-4||4
5094248|NCT01661595|12533212|P1|STARTED|Phase 1: Week 0-4||5
5094249|NCT01661283|12533317|P1|NOT COMPLETED|Overall Study||0
5094250|NCT01661283|12533317|P1|COMPLETED|Overall Study||25
5094251|NCT01661283|12533317|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
5094252|NCT01661270|12533328|P2|NOT COMPLETED|Overall Study||0
5094253|NCT01661270|12533329|P1|NOT COMPLETED|Overall Study||0
5094254|NCT01661270|12533328|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
5094255|NCT01661270|12533329|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
5094256|NCT01661270|12533328|P2|Other Reasons|Overall Study||2
5094257|NCT01661270|12533329|P1|Other Reasons|Overall Study||0
5094258|NCT01661270|12533328|P2|Participant’s Request|Overall Study|Met EOT criteria|48
5094259|NCT01661270|12533329|P1|Participant’s Request|Overall Study|Met EOT criteria|15
5094260|NCT01661270|12533328|P2|Physician Decision|Overall Study|Met EOT criteria|8
5094261|NCT01661270|12533329|P1|Physician Decision|Overall Study|Met EOT criteria|1
5094262|NCT01661270|12533328|P2|Disease Progression|Overall Study|Met EOT criteria|118
5094263|NCT01661270|12533329|P1|Disease Progression|Overall Study|Met EOT criteria|67
5094264|NCT01661270|12533328|P2|Adverse Event|Overall Study|Met EOT criteria|47
5094265|NCT01661270|12533329|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
5094266|NCT01661270|12533328|P2|STARTED|Overall Study||223
5094267|NCT01661270|12533329|P1|STARTED|Overall Study||109
5094268|NCT01661205|12533340|P1|NOT COMPLETED|Overall Study||2
5094269|NCT01661205|12533340|P1|COMPLETED|Overall Study||24
5094270|NCT01661205|12533340|P1|STARTED|Overall Study||26
5094271|NCT01661179|12533351|P1|NOT COMPLETED|Overall Study||6
5094272|NCT01661179|12533351|P1|COMPLETED|Overall Study||8
5094273|NCT01661179|12533351|P1|STARTED|Overall Study||14
5094274|NCT01661140|12533355|P3|NOT COMPLETED|Double-Blind Period||50
5094275|NCT01661140|12533356|P2|NOT COMPLETED|Double-Blind Period||41
5094276|NCT01661140|12533357|P1|NOT COMPLETED|Double-Blind Period||0
5094277|NCT01661140|12533355|P3|COMPLETED|Double-Blind Period||86
5094278|NCT01661140|12533356|P2|COMPLETED|Double-Blind Period||95
5094279|NCT01661140|12533357|P1|COMPLETED|Double-Blind Period||0
5094280|NCT01661140|12533355|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
5094281|NCT01661140|12533356|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
5094282|NCT01661140|12533357|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
5094283|NCT01661140|12533355|P3|NOT COMPLETED|Open-Label Period||0
5094284|NCT01661140|12533356|P2|NOT COMPLETED|Open-Label Period||0
5094285|NCT01661140|12533357|P1|NOT COMPLETED|Open-Label Period||76
5094286|NCT01661140|12533355|P3|COMPLETED|Open-Label Period||0
5094287|NCT01661140|12533356|P2|COMPLETED|Open-Label Period||0
5094288|NCT01661140|12533357|P1|COMPLETED|Open-Label Period||351
5094289|NCT01661140|12533355|P3|STARTED|Open-Label Period||0
5094290|NCT01661140|12533356|P2|STARTED|Open-Label Period||0
5094291|NCT01661140|12533357|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
5094292|NCT01661114|12533398|P1|NOT COMPLETED|Overall Study||0
5094293|NCT01661114|12533398|P1|COMPLETED|Overall Study||39
5094294|NCT01661114|12533398|P1|STARTED|Overall Study||39
5094295|NCT01661088|12533403|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
5094296|NCT01661088|12533403|P1|COMPLETED|IMRT With FDR Gemcitabine||19
5094297|NCT01661088|12533403|P1|STARTED|IMRT With FDR Gemcitabine||21
5094298|NCT01661088|12533403|P1|NOT COMPLETED|FOLFIRINOX||4
5094299|NCT01661088|12533403|P1|COMPLETED|FOLFIRINOX||21
5094300|NCT01661088|12533403|P1|STARTED|FOLFIRINOX||25
5094301|NCT01661062|12533409|P1|NOT COMPLETED|Overall Study||5
5094302|NCT01661062|12533409|P1|COMPLETED|Overall Study||18
5094303|NCT01661062|12533409|P1|STARTED|Overall Study||23
5094304|NCT01660906|12533414|P1|NOT COMPLETED|Overall Study||3
5094305|NCT01660906|12533414|P1|COMPLETED|Overall Study||36
5094306|NCT01660906|12533414|P1|STARTED|Overall Study||39
5094307|NCT01660893|12533426|P3|NOT COMPLETED|Overall Study||0
5094308|NCT01660893|12533427|P2|NOT COMPLETED|Overall Study||0
5094309|NCT01660893|12533428|P1|NOT COMPLETED|Overall Study||0
5094310|NCT01660893|12533426|P3|COMPLETED|Overall Study||6
5094311|NCT01660893|12533427|P2|COMPLETED|Overall Study||10
5094312|NCT01660893|12533428|P1|COMPLETED|Overall Study||10
5094313|NCT01660893|12533426|P3|STARTED|Overall Study||6
5094314|NCT01660893|12533427|P2|STARTED|Overall Study||10
5094315|NCT01660893|12533428|P1|STARTED|Overall Study||10
5094316|NCT01660815|12533475|P1|NOT COMPLETED|Overall Study||0
5094317|NCT01660815|12533475|P1|COMPLETED|Overall Study||7
5094318|NCT01660815|12533475|P1|STARTED|Overall Study||7
5094319|NCT01660802|12533482|P2|NOT COMPLETED|Overall Study||11
5094320|NCT01660802|12533483|P1|NOT COMPLETED|Overall Study||4
5094321|NCT01660802|12533482|P2|COMPLETED|Overall Study||121
5094322|NCT01660802|12533483|P1|COMPLETED|Overall Study||126
5094323|NCT01660802|12533482|P2|STARTED|Overall Study||132
5094324|NCT01660802|12533483|P1|STARTED|Overall Study||130
5094325|NCT01660763|12533497|P2|NOT COMPLETED|Overall Study||61
5094326|NCT01660763|12533498|P1|NOT COMPLETED|Overall Study||100
5094327|NCT01660763|12533497|P2|COMPLETED|Overall Study||43
5094328|NCT01660763|12533498|P1|COMPLETED|Overall Study||215
5094329|NCT01660763|12533497|P2|STARTED|Overall Study||104
5094330|NCT01660763|12533498|P1|STARTED|Overall Study||315
5094331|NCT01660737|12533504|P1|NOT COMPLETED|Overall Study||0
5094332|NCT01660737|12533504|P1|COMPLETED|Overall Study||123
5094333|NCT01660737|12533504|P1|STARTED|Overall Study||123
5094334|NCT01660698|12533521|P2|NOT COMPLETED|Overall Study||0
5094335|NCT01660698|12533522|P1|NOT COMPLETED|Overall Study||0
5094336|NCT01660698|12533521|P2|COMPLETED|Overall Study||10
5094337|NCT01660698|12533522|P1|COMPLETED|Overall Study||10
5094338|NCT01660698|12533521|P2|STARTED|Overall Study||10
5094339|NCT01660698|12533522|P1|STARTED|Overall Study||10
5094340|NCT01660672|12533532|P1|NOT COMPLETED|Overall Study||0
5094341|NCT01660672|12533532|P1|COMPLETED|Overall Study||7
5094342|NCT01660672|12533532|P1|STARTED|Overall Study||7
5094343|NCT01660451|12533546|P3|NOT COMPLETED|Overall Study||105
5094344|NCT01660451|12533547|P2|NOT COMPLETED|Overall Study||17
5094345|NCT01660451|12533548|P1|NOT COMPLETED|Overall Study||17
5094346|NCT01660451|12533546|P3|COMPLETED|Overall Study||37
5094347|NCT01660451|12533547|P2|COMPLETED|Overall Study||34
5094348|NCT01660451|12533548|P1|COMPLETED|Overall Study||16
5094349|NCT01660451|12533546|P3|STARTED|Overall Study||142
5094350|NCT01660451|12533547|P2|STARTED|Overall Study||51
5094351|NCT01660451|12533548|P1|STARTED|Overall Study||33
5094352|NCT01660412|12533576|P2|NOT COMPLETED|Overall Study||3
5094353|NCT01660412|12533577|P1|NOT COMPLETED|Overall Study||0
5094354|NCT01660412|12533576|P2|COMPLETED|Overall Study||28
5094355|NCT01660412|12533577|P1|COMPLETED|Overall Study||29
5094356|NCT01660412|12533576|P2|Injection 4|Overall Study||31
5094357|NCT01660412|12533577|P1|Injection 4|Overall Study||29
5094358|NCT01660412|12533576|P2|Injection 3|Overall Study||31
5094359|NCT01660412|12533577|P1|Injection 3|Overall Study||29
5094360|NCT01660412|12533576|P2|Injection 2|Overall Study||31
5094361|NCT01660412|12533577|P1|Injection 2|Overall Study||29
5094362|NCT01660412|12533576|P2|Injection 1|Overall Study||31
5094363|NCT01660412|12533577|P1|Injection 1|Overall Study||29
5094364|NCT01660412|12533576|P2|Other|Overall Study||4
5094365|NCT01660412|12533577|P1|Other|Overall Study||2
5094366|NCT01660412|12533576|P2|Appendicular Structures|Overall Study||11
5094367|NCT01660412|12533577|P1|Appendicular Structures|Overall Study||17
5094368|NCT01660412|12533576|P2|Thorax|Overall Study||9
5094369|NCT01660412|12533577|P1|Thorax|Overall Study||9
5094370|NCT01660412|12533576|P2|Head|Overall Study||4
5094371|NCT01660412|12533577|P1|Head|Overall Study||1
5094372|NCT01660412|12533576|P2|STARTED|Overall Study||31
5094373|NCT01660412|12533577|P1|STARTED|Overall Study||29
5094374|NCT01660334|12533583|P1|NOT COMPLETED|Overall Study||1
5094375|NCT01660334|12533583|P1|COMPLETED|Overall Study||12
5094376|NCT01660334|12533583|P1|STARTED|Overall Study||13
5094377|NCT01660321|12533588|P1|NOT COMPLETED|Overall Study||0
5094378|NCT01660321|12533588|P1|COMPLETED|Overall Study||26
5094379|NCT01660321|12533588|P1|STARTED|Overall Study||26
5094380|NCT01660230|12533612|P12|NOT COMPLETED|Overall Study||0
5094381|NCT01660230|12533613|P11|NOT COMPLETED|Overall Study||0
5094382|NCT01660230|12533614|P10|NOT COMPLETED|Overall Study||0
5094383|NCT01660230|12533615|P9|NOT COMPLETED|Overall Study||0
5094384|NCT01660230|12533616|P8|NOT COMPLETED|Overall Study||0
5094385|NCT01660230|12533617|P7|NOT COMPLETED|Overall Study||0
5094386|NCT01660230|12533618|P6|NOT COMPLETED|Overall Study||0
5094387|NCT01660230|12533619|P5|NOT COMPLETED|Overall Study||0
5094388|NCT01660230|12533620|P4|NOT COMPLETED|Overall Study||0
5094389|NCT01660230|12533621|P3|NOT COMPLETED|Overall Study||0
5094390|NCT01660230|12533622|P2|NOT COMPLETED|Overall Study||0
5094391|NCT01660230|12533623|P1|NOT COMPLETED|Overall Study||0
5094392|NCT01660230|12533612|P12|COMPLETED|Overall Study||14
5094393|NCT01660230|12533613|P11|COMPLETED|Overall Study||6
5094394|NCT01660230|12533614|P10|COMPLETED|Overall Study||6
5094395|NCT01660230|12533615|P9|COMPLETED|Overall Study||6
5094396|NCT01660230|12533616|P8|COMPLETED|Overall Study||6
5094397|NCT01660230|12533617|P7|COMPLETED|Overall Study||4
5094398|NCT01660230|12533618|P6|COMPLETED|Overall Study||2
5094399|NCT01660230|12533619|P5|COMPLETED|Overall Study||4
5094400|NCT01660230|12533620|P4|COMPLETED|Overall Study||4
5094401|NCT01660230|12533621|P3|COMPLETED|Overall Study||4
5094402|NCT01660230|12533622|P2|COMPLETED|Overall Study||4
5094403|NCT01660230|12533623|P1|COMPLETED|Overall Study||4
5094404|NCT01660230|12533612|P12|STARTED|Overall Study||14
5094405|NCT01660230|12533613|P11|STARTED|Overall Study||6
5094406|NCT01660230|12533614|P10|STARTED|Overall Study||6
5094407|NCT01660230|12533615|P9|STARTED|Overall Study||6
5094408|NCT01660230|12533616|P8|STARTED|Overall Study||6
5094409|NCT01660230|12533617|P7|STARTED|Overall Study||4
5094410|NCT01660230|12533618|P6|STARTED|Overall Study||2
5094411|NCT01660230|12533619|P5|STARTED|Overall Study||4
5094412|NCT01660230|12533620|P4|STARTED|Overall Study||4
5094413|NCT01660230|12533621|P3|STARTED|Overall Study||4
5094414|NCT01660230|12533622|P2|STARTED|Overall Study||4
5094415|NCT01660230|12533623|P1|STARTED|Overall Study||4
5094416|NCT01660191|12533795|P3|NOT COMPLETED|End of Treatment||1
5094417|NCT01660191|12533796|P2|NOT COMPLETED|End of Treatment||6
5094418|NCT01660191|12533797|P1|NOT COMPLETED|End of Treatment||1
5094419|NCT01660191|12533795|P3|COMPLETED|End of Treatment||43
5094420|NCT01660191|12533796|P2|COMPLETED|End of Treatment||39
5094421|NCT01660191|12533797|P1|COMPLETED|End of Treatment||44
5094422|NCT01660191|12533795|P3|STARTED|End of Treatment||44
5094423|NCT01660191|12533796|P2|STARTED|End of Treatment||45
5094424|NCT01660191|12533797|P1|STARTED|End of Treatment||45
5094425|NCT01660191|12533795|P3|NOT COMPLETED|Randomization||0
5094426|NCT01660191|12533796|P2|NOT COMPLETED|Randomization||0
5094427|NCT01660191|12533797|P1|NOT COMPLETED|Randomization||0
5094428|NCT01660191|12533795|P3|COMPLETED|Randomization||44
5094429|NCT01660191|12533796|P2|COMPLETED|Randomization||45
5094430|NCT01660191|12533797|P1|COMPLETED|Randomization||45
5094431|NCT01660191|12533795|P3|STARTED|Randomization||44
5094432|NCT01660191|12533796|P2|STARTED|Randomization||45
5094433|NCT01660191|12533797|P1|STARTED|Randomization||45
5094434|NCT01660191|12533795|P3|NOT COMPLETED|Enrollment and Washout||0
5094435|NCT01660191|12533796|P2|NOT COMPLETED|Enrollment and Washout||0
5094436|NCT01660191|12533797|P1|NOT COMPLETED|Enrollment and Washout||0
5094437|NCT01660191|12533795|P3|COMPLETED|Enrollment and Washout||44
5094438|NCT01660191|12533796|P2|COMPLETED|Enrollment and Washout||45
5094439|NCT01660191|12533797|P1|COMPLETED|Enrollment and Washout||45
5094440|NCT01660191|12533795|P3|STARTED|Enrollment and Washout||44
5094441|NCT01660191|12533796|P2|STARTED|Enrollment and Washout||45
5094442|NCT01660191|12533797|P1|STARTED|Enrollment and Washout||45
5094443|NCT01660022|12533826|P6|NOT COMPLETED|Second Sequence (42 Days)||0
5094444|NCT01660022|12533827|P5|NOT COMPLETED|Second Sequence (42 Days)||0
5094445|NCT01660022|12533828|P4|NOT COMPLETED|Second Sequence (42 Days)||0
5094446|NCT01660022|12533829|P3|NOT COMPLETED|Second Sequence (42 Days)||0
5094447|NCT01660022|12533830|P2|NOT COMPLETED|Second Sequence (42 Days)||0
5094448|NCT01660022|12533831|P1|NOT COMPLETED|Second Sequence (42 Days)||0
5094449|NCT01660022|12533826|P6|COMPLETED|Second Sequence (42 Days)||16
5094450|NCT01660022|12533827|P5|COMPLETED|Second Sequence (42 Days)||6
5094451|NCT01660022|12533828|P4|COMPLETED|Second Sequence (42 Days)||7
5094452|NCT01660022|12533829|P3|COMPLETED|Second Sequence (42 Days)||8
5094453|NCT01660022|12533830|P2|COMPLETED|Second Sequence (42 Days)||7
5094454|NCT01660022|12533831|P1|COMPLETED|Second Sequence (42 Days)||8
5094455|NCT01660022|12533826|P6|STARTED|Second Sequence (42 Days)||16
5094456|NCT01660022|12533827|P5|STARTED|Second Sequence (42 Days)||6
5094457|NCT01660022|12533828|P4|STARTED|Second Sequence (42 Days)||7
5094458|NCT01660022|12533829|P3|STARTED|Second Sequence (42 Days)||8
5094459|NCT01660022|12533830|P2|STARTED|Second Sequence (42 Days)||7
5094460|NCT01660022|12533831|P1|STARTED|Second Sequence (42 Days)||8
5094461|NCT01660022|12533826|P6|NOT COMPLETED|First Sequence (7 Days)||4
5094462|NCT01660022|12533827|P5|NOT COMPLETED|First Sequence (7 Days)||1
5094463|NCT01660022|12533828|P4|NOT COMPLETED|First Sequence (7 Days)||1
5094464|NCT01660022|12533829|P3|NOT COMPLETED|First Sequence (7 Days)||0
5094465|NCT01660022|12533830|P2|NOT COMPLETED|First Sequence (7 Days)||1
5094466|NCT01660022|12533831|P1|NOT COMPLETED|First Sequence (7 Days)||0
5094467|NCT01660022|12533826|P6|COMPLETED|First Sequence (7 Days)||16
5094468|NCT01660022|12533827|P5|COMPLETED|First Sequence (7 Days)||6
5094469|NCT01660022|12533828|P4|COMPLETED|First Sequence (7 Days)||7
5094470|NCT01660022|12533829|P3|COMPLETED|First Sequence (7 Days)||8
5094471|NCT01660022|12533830|P2|COMPLETED|First Sequence (7 Days)||7
5094472|NCT01660022|12533831|P1|COMPLETED|First Sequence (7 Days)||8
5094473|NCT01660022|12533826|P6|STARTED|First Sequence (7 Days)||20
5094474|NCT01660022|12533827|P5|STARTED|First Sequence (7 Days)||7
5094475|NCT01660022|12533828|P4|STARTED|First Sequence (7 Days)||8
5094476|NCT01660022|12533829|P3|STARTED|First Sequence (7 Days)||8
5094477|NCT01660022|12533830|P2|STARTED|First Sequence (7 Days)||8
5094478|NCT01660022|12533831|P1|STARTED|First Sequence (7 Days)||8
5094479|NCT01659996|12533890|P3|NOT COMPLETED|Overall Study||11
5094480|NCT01659996|12533891|P2|NOT COMPLETED|Overall Study||7
5094481|NCT01659996|12533892|P1|NOT COMPLETED|Overall Study||8
5094482|NCT01659996|12533890|P3|COMPLETED|Overall Study||461
5094483|NCT01659996|12533891|P2|COMPLETED|Overall Study||388
5094484|NCT01659996|12533892|P1|COMPLETED|Overall Study||413
5094485|NCT01659996|12533890|P3|STARTED|Overall Study||472
5094486|NCT01659996|12533891|P2|STARTED|Overall Study||395
5094487|NCT01659996|12533892|P1|STARTED|Overall Study||421
5094488|NCT01659866|12533926|P2|NOT COMPLETED|Overall Study||0
5094489|NCT01659866|12533927|P1|NOT COMPLETED|Overall Study||0
5094490|NCT01659866|12533926|P2|COMPLETED|Overall Study||80
5094491|NCT01659866|12533927|P1|COMPLETED|Overall Study||430
5094492|NCT01659866|12533926|P2|STARTED|Overall Study||80
5094493|NCT01659866|12533927|P1|STARTED|Overall Study||430
5094494|NCT01659853|12533933|P2|NOT COMPLETED|Treatment Period 2||0
5094495|NCT01659853|12533934|P1|NOT COMPLETED|Treatment Period 2||0
5094496|NCT01659853|12533933|P2|COMPLETED|Treatment Period 2||35
5094497|NCT01659853|12533934|P1|COMPLETED|Treatment Period 2||33
5094498|NCT01659853|12533933|P2|STARTED|Treatment Period 2||35
5094499|NCT01659853|12533934|P1|STARTED|Treatment Period 2||33
5094500|NCT01659853|12533933|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
5094501|NCT01659853|12533934|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
5094502|NCT01659853|12533933|P2|COMPLETED|Washout , 3 to 7 Days||35
5094503|NCT01659853|12533934|P1|COMPLETED|Washout , 3 to 7 Days||33
5094504|NCT01659853|12533933|P2|STARTED|Washout , 3 to 7 Days||35
5094505|NCT01659853|12533934|P1|STARTED|Washout , 3 to 7 Days||35
5094506|NCT01659853|12533933|P2|NOT COMPLETED|Treatment Period 1||0
5094507|NCT01659853|12533934|P1|NOT COMPLETED|Treatment Period 1||0
5094508|NCT01659853|12533933|P2|COMPLETED|Treatment Period 1||35
5094509|NCT01659853|12533934|P1|COMPLETED|Treatment Period 1||35
5094510|NCT01659853|12533933|P2|STARTED|Treatment Period 1||35
5094511|NCT01659853|12533934|P1|STARTED|Treatment Period 1||35
5094512|NCT01659736|12533944|P2|NOT COMPLETED|3-month Follow-up||1
5094513|NCT01659736|12533945|P1|NOT COMPLETED|3-month Follow-up||0
5094514|NCT01659736|12533944|P2|COMPLETED|3-month Follow-up||9
5094515|NCT01659736|12533945|P1|COMPLETED|3-month Follow-up||9
5094516|NCT01659736|12533944|P2|STARTED|3-month Follow-up||10
5094517|NCT01659736|12533945|P1|STARTED|3-month Follow-up||9
5094518|NCT01659736|12533944|P2|NOT COMPLETED|Treatment Period||2
5094519|NCT01659736|12533945|P1|NOT COMPLETED|Treatment Period||5
5094520|NCT01659736|12533944|P2|COMPLETED|Treatment Period||10
5094521|NCT01659736|12533945|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
5094522|NCT01659736|12533944|P2|STARTED|Treatment Period||12
5094523|NCT01659736|12533945|P1|STARTED|Treatment Period||14
5094524|NCT01659567|12533959|P1|NOT COMPLETED|Overall Study||123
5094525|NCT01659567|12533959|P1|COMPLETED|Overall Study||393
5094526|NCT01659567|12533959|P1|STARTED|Overall Study||516
5094527|NCT01659554|12533976|P1|NOT COMPLETED|Overall Study||4
5094528|NCT01659554|12533976|P1|COMPLETED|Overall Study||0
5094529|NCT01659554|12533976|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
5094530|NCT01659320|12533983|P1|NOT COMPLETED|Overall Study||3
5094531|NCT01659320|12533983|P1|COMPLETED|Overall Study||13
5094532|NCT01659320|12533983|P1|STARTED|Overall Study||16
5094533|NCT01659268|12533989|P2|NOT COMPLETED|Overall Study||0
5094534|NCT01659268|12533990|P1|NOT COMPLETED|Overall Study||0
5094535|NCT01659268|12533989|P2|COMPLETED|Overall Study||8
5094536|NCT01659268|12533990|P1|COMPLETED|Overall Study||9
5094537|NCT01659268|12533989|P2|STARTED|Overall Study||8
5094538|NCT01659268|12533990|P1|STARTED|Overall Study||9
5094539|NCT01659125|12534002|P1|NOT COMPLETED|Overall Study||14
5094540|NCT01659125|12534002|P1|COMPLETED|Overall Study||12
5094541|NCT01659125|12534002|P1|Completed 6-month Follow-up|Overall Study||12
5094542|NCT01659125|12534002|P1|Completed 3-month Follow-up|Overall Study||16
5094719|NCT01657903|12534247|P1|STARTED|Overall Study||56
5094543|NCT01659125|12534002|P1|Completed the Posttreatment Assessment|Overall Study||17
5094544|NCT01659125|12534002|P1|Initiated Treatment|Overall Study||24
5094545|NCT01659125|12534002|P1|STARTED|Overall Study||26
5094546|NCT01659021|12534009|P2|NOT COMPLETED|Long-Term Follow Up||4
5094547|NCT01659021|12534010|P1|NOT COMPLETED|Long-Term Follow Up||5
5094548|NCT01659021|12534009|P2|COMPLETED|Long-Term Follow Up||65
5094549|NCT01659021|12534010|P1|COMPLETED|Long-Term Follow Up||133
5094550|NCT01659021|12534009|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
5094551|NCT01659021|12534010|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
5094552|NCT01659021|12534009|P2|NOT COMPLETED|Main Study||37
5094553|NCT01659021|12534010|P1|NOT COMPLETED|Main Study||74
5094554|NCT01659021|12534009|P2|COMPLETED|Main Study||50
5094555|NCT01659021|12534010|P1|COMPLETED|Main Study||100
5094556|NCT01659021|12534009|P2|Randomized and Treated|Main Study||86
5094557|NCT01659021|12534010|P1|Randomized and Treated|Main Study||173
5094558|NCT01659021|12534009|P2|STARTED|Main Study||87
5094559|NCT01659021|12534010|P1|STARTED|Main Study||174
5094560|NCT01658943|12534028|P2|NOT COMPLETED|Overall Study||67
5094561|NCT01658943|12534029|P1|NOT COMPLETED|Overall Study||70
5094562|NCT01658943|12534028|P2|COMPLETED|Overall Study||0
5094563|NCT01658943|12534029|P1|COMPLETED|Overall Study||0
5094564|NCT01658943|12534028|P2|Eligible and Began Protocol Therapy|Overall Study||58
5094565|NCT01658943|12534029|P1|Eligible and Began Protocol Therapy|Overall Study||62
5094566|NCT01658943|12534028|P2|Eligible|Overall Study||58
5094567|NCT01658943|12534029|P1|Eligible|Overall Study||63
5094568|NCT01658943|12534028|P2|STARTED|Overall Study||67
5094569|NCT01658943|12534029|P1|STARTED|Overall Study||70
5094570|NCT01658904|12534044|P3|NOT COMPLETED|Overall Study||0
5094571|NCT01658904|12534045|P2|NOT COMPLETED|Overall Study||0
5094572|NCT01658904|12534046|P1|NOT COMPLETED|Overall Study||2
5094573|NCT01658904|12534044|P3|COMPLETED|Overall Study||0
5094574|NCT01658904|12534045|P2|COMPLETED|Overall Study||0
5094575|NCT01658904|12534046|P1|COMPLETED|Overall Study||1
5094576|NCT01658904|12534044|P3|STARTED|Overall Study||0
5094577|NCT01658904|12534045|P2|STARTED|Overall Study||0
5094578|NCT01658904|12534046|P1|STARTED|Overall Study||3
5094579|NCT01658839|12534063|P1|NOT COMPLETED|Overall Study||0
5094580|NCT01658839|12534063|P1|COMPLETED|Overall Study||25
5094581|NCT01658839|12534063|P1|STARTED|Overall Study||25
5094582|NCT01658813|12534072|P1|NOT COMPLETED|Overall Study||3
5094583|NCT01658813|12534072|P1|COMPLETED|Overall Study||15
5094584|NCT01658813|12534072|P1|Treated|Overall Study||18
5094585|NCT01658813|12534072|P1|Eligible|Overall Study||18
5094586|NCT01658813|12534072|P1|STARTED|Overall Study||18
5094587|NCT01658735|12534083|P3|NOT COMPLETED|Overall Study||4
5094588|NCT01658735|12534084|P2|NOT COMPLETED|Overall Study||7
5094589|NCT01658735|12534085|P1|NOT COMPLETED|Overall Study||5
5094590|NCT01658735|12534083|P3|COMPLETED|Overall Study||34
5094591|NCT01658735|12534084|P2|COMPLETED|Overall Study||29
5094592|NCT01658735|12534085|P1|COMPLETED|Overall Study||34
5094593|NCT01658735|12534083|P3|STARTED|Overall Study||38
5094594|NCT01658735|12534084|P2|STARTED|Overall Study||36
5094595|NCT01658735|12534085|P1|STARTED|Overall Study||39
5094596|NCT01658657|12534116|P2|NOT COMPLETED|Overall Study||3
5094597|NCT01658657|12534117|P1|NOT COMPLETED|Overall Study||3
5094598|NCT01658657|12534116|P2|COMPLETED|Overall Study||7
5094599|NCT01658657|12534117|P1|COMPLETED|Overall Study||4
5094600|NCT01658657|12534116|P2|STARTED|Overall Study||10
5094601|NCT01658657|12534117|P1|STARTED|Overall Study||7
5094602|NCT01658579|12534127|P4|NOT COMPLETED|Treatment Period B||1
5094603|NCT01658579|12534128|P3|NOT COMPLETED|Treatment Period B||0
5094604|NCT01658579|12534129|P2|NOT COMPLETED|Treatment Period B||0
5094605|NCT01658579|12534130|P1|NOT COMPLETED|Treatment Period B||0
5094606|NCT01658579|12534127|P4|COMPLETED|Treatment Period B||12
5094607|NCT01658579|12534128|P3|COMPLETED|Treatment Period B||14
5094608|NCT01658579|12534129|P2|COMPLETED|Treatment Period B||15
5094609|NCT01658579|12534130|P1|COMPLETED|Treatment Period B||14
5094610|NCT01658579|12534127|P4|STARTED|Treatment Period B||13
5094611|NCT01658579|12534128|P3|STARTED|Treatment Period B||14
5094612|NCT01658579|12534129|P2|STARTED|Treatment Period B||15
5094613|NCT01658579|12534130|P1|STARTED|Treatment Period B||14
5094614|NCT01658579|12534127|P4|NOT COMPLETED|Treatment Period A||1
5094615|NCT01658579|12534128|P3|NOT COMPLETED|Treatment Period A||1
5094616|NCT01658579|12534129|P2|NOT COMPLETED|Treatment Period A||0
5094617|NCT01658579|12534130|P1|NOT COMPLETED|Treatment Period A||1
5094618|NCT01658579|12534127|P4|COMPLETED|Treatment Period A||13
5094619|NCT01658579|12534128|P3|COMPLETED|Treatment Period A||14
5094620|NCT01658579|12534129|P2|COMPLETED|Treatment Period A||15
5094621|NCT01658579|12534130|P1|COMPLETED|Treatment Period A||14
5094622|NCT01658579|12534127|P4|STARTED|Treatment Period A||14
5094623|NCT01658579|12534128|P3|STARTED|Treatment Period A||15
5094624|NCT01658579|12534129|P2|STARTED|Treatment Period A||15
5094625|NCT01658579|12534130|P1|STARTED|Treatment Period A||15
5094626|NCT01658514|12534158|P3|NOT COMPLETED|Overall Study||2
5094627|NCT01658514|12534159|P2|NOT COMPLETED|Overall Study||0
5094628|NCT01658514|12534160|P1|NOT COMPLETED|Overall Study||1
5094629|NCT01658514|12534158|P3|COMPLETED|Overall Study||12
5094630|NCT01658514|12534159|P2|COMPLETED|Overall Study||11
5094631|NCT01658514|12534160|P1|COMPLETED|Overall Study||13
5094632|NCT01658514|12534158|P3|Completed - Severe RI Cohort Only|Overall Study||3
5094633|NCT01658514|12534159|P2|Completed - Severe RI Cohort Only|Overall Study||2
5094634|NCT01658514|12534160|P1|Completed - Severe RI Cohort Only|Overall Study||3
5094635|NCT01658514|12534158|P3|Started - Severe RI Cohort Only|Overall Study||3
5094636|NCT01658514|12534159|P2|Started - Severe RI Cohort Only|Overall Study||2
5094637|NCT01658514|12534160|P1|Started - Severe RI Cohort Only|Overall Study||3
5094638|NCT01658514|12534158|P3|Completed - Moderate RI Cohort Only|Overall Study||2
5094639|NCT01658514|12534159|P2|Completed - Moderate RI Cohort Only|Overall Study||4
5094640|NCT01658514|12534160|P1|Completed - Moderate RI Cohort Only|Overall Study||3
5094641|NCT01658514|12534158|P3|Started - Moderate RI Cohort Only|Overall Study||4
5094642|NCT01658514|12534159|P2|Started - Moderate RI Cohort Only|Overall Study||4
5094643|NCT01658514|12534160|P1|Started - Moderate RI Cohort Only|Overall Study||4
5094644|NCT01658514|12534158|P3|Completed - Mild RI Cohort Only|Overall Study||4
5094645|NCT01658514|12534159|P2|Completed - Mild RI Cohort Only|Overall Study||3
5094646|NCT01658514|12534160|P1|Completed - Mild RI Cohort Only|Overall Study||4
5094647|NCT01658514|12534158|P3|Started - Mild RI Cohort Only|Overall Study||4
5094648|NCT01658514|12534159|P2|Started - Mild RI Cohort Only|Overall Study||3
5094649|NCT01658514|12534160|P1|Started - Mild RI Cohort Only|Overall Study||4
5094650|NCT01658514|12534158|P3|Completed - Normal RF Cohort Only|Overall Study||3
5094651|NCT01658514|12534159|P2|Completed - Normal RF Cohort Only|Overall Study||2
5094652|NCT01658514|12534160|P1|Completed - Normal RF Cohort Only|Overall Study||3
5094653|NCT01658514|12534158|P3|Started - Normal RF Cohort Only|Overall Study||3
5094654|NCT01658514|12534159|P2|Started - Normal RF Cohort Only|Overall Study||2
5094655|NCT01658514|12534160|P1|Started - Normal RF Cohort Only|Overall Study||3
5094656|NCT01658514|12534158|P3|Completed Treatment C|Overall Study||12
5094657|NCT01658514|12534159|P2|Completed Treatment C|Overall Study||11
5094658|NCT01658514|12534160|P1|Completed Treatment C|Overall Study||13
5094659|NCT01658514|12534158|P3|Completed Treatment B|Overall Study||14
5094660|NCT01658514|12534159|P2|Completed Treatment B|Overall Study||11
5094661|NCT01658514|12534160|P1|Completed Treatment B|Overall Study||13
5094662|NCT01658514|12534158|P3|Completed Treatment A|Overall Study||12
5094663|NCT01658514|12534159|P2|Completed Treatment A|Overall Study||11
5094664|NCT01658514|12534160|P1|Completed Treatment A|Overall Study||14
5094665|NCT01658514|12534158|P3|STARTED|Overall Study||14
5094666|NCT01658514|12534159|P2|STARTED|Overall Study||11
5094667|NCT01658514|12534160|P1|STARTED|Overall Study||14
5094668|NCT01658436|12534171|P2|NOT COMPLETED|Overall Study||11
5094669|NCT01658436|12534172|P1|NOT COMPLETED|Overall Study||20
5094670|NCT01658436|12534171|P2|COMPLETED|Overall Study||0
5094671|NCT01658436|12534172|P1|COMPLETED|Overall Study||0
5094672|NCT01658436|12534171|P2|STARTED|Overall Study||11
5094673|NCT01658436|12534172|P1|STARTED|Overall Study||20
5094674|NCT01658228|12534181|P2|NOT COMPLETED|Overall Study||8
5094675|NCT01658228|12534182|P1|NOT COMPLETED|Overall Study||7
5094676|NCT01658228|12534181|P2|COMPLETED|Overall Study||23
5094677|NCT01658228|12534182|P1|COMPLETED|Overall Study||23
5094678|NCT01658228|12534181|P2|STARTED|Overall Study||31
5094679|NCT01658228|12534182|P1|STARTED|Overall Study||30
5094680|NCT01658150|12534192|P1|NOT COMPLETED|Overall Study||1
5094681|NCT01658150|12534192|P1|COMPLETED|Overall Study||10
5094682|NCT01658150|12534192|P1|STARTED|Overall Study||11
5094683|NCT01658072|12534214|P2|NOT COMPLETED|Overall Study||2
5094684|NCT01658072|12534215|P1|NOT COMPLETED|Overall Study||4
5094685|NCT01658072|12534214|P2|COMPLETED|Overall Study||43
5094686|NCT01658072|12534215|P1|COMPLETED|Overall Study||41
5094687|NCT01658072|12534214|P2|STARTED|Overall Study||45
5094688|NCT01658072|12534215|P1|STARTED|Overall Study||45
5094689|NCT01658059|12534221|P2|NOT COMPLETED|Second Intervention- 2 Days||0
5094690|NCT01658059|12534222|P1|NOT COMPLETED|Second Intervention- 2 Days||0
5094691|NCT01658059|12534221|P2|COMPLETED|Second Intervention- 2 Days||5
5094692|NCT01658059|12534222|P1|COMPLETED|Second Intervention- 2 Days||6
5094693|NCT01658059|12534221|P2|STARTED|Second Intervention- 2 Days||5
5094694|NCT01658059|12534222|P1|STARTED|Second Intervention- 2 Days||6
5094695|NCT01658059|12534221|P2|NOT COMPLETED|Washout Period- 14 Days||0
5094696|NCT01658059|12534222|P1|NOT COMPLETED|Washout Period- 14 Days||0
5094697|NCT01658059|12534221|P2|COMPLETED|Washout Period- 14 Days||5
5094698|NCT01658059|12534222|P1|COMPLETED|Washout Period- 14 Days||6
5094699|NCT01658059|12534221|P2|STARTED|Washout Period- 14 Days||5
5094700|NCT01658059|12534222|P1|STARTED|Washout Period- 14 Days||6
5094701|NCT01658059|12534221|P2|NOT COMPLETED|First Intervention- 2 Days||5
5094702|NCT01658059|12534222|P1|NOT COMPLETED|First Intervention- 2 Days||6
5094703|NCT01658059|12534221|P2|COMPLETED|First Intervention- 2 Days||5
5094704|NCT01658059|12534222|P1|COMPLETED|First Intervention- 2 Days||6
5094705|NCT01658059|12534221|P2|STARTED|First Intervention- 2 Days||10
5094706|NCT01658059|12534222|P1|STARTED|First Intervention- 2 Days||12
5094707|NCT01658020|12534230|P2|NOT COMPLETED|Overall Study||9
5094708|NCT01658020|12534231|P1|NOT COMPLETED|Overall Study||8
5094709|NCT01658020|12534230|P2|COMPLETED|Overall Study||158
5094710|NCT01658020|12534231|P1|COMPLETED|Overall Study||167
5094711|NCT01658020|12534230|P2|STARTED|Overall Study||167
5094712|NCT01658020|12534231|P1|STARTED|Overall Study||175
5094713|NCT01657903|12534247|P1|NOT COMPLETED|Overall Study||2
5094714|NCT01657903|12534247|P1|COMPLETED|Overall Study||54
5094715|NCT01657903|12534247|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
5094716|NCT01657903|12534247|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
5094717|NCT01657903|12534247|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
5094718|NCT01657903|12534247|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
5094720|NCT01657877|12534269|P1|NOT COMPLETED|Overall Study||14
5094721|NCT01657877|12534269|P1|COMPLETED|Overall Study||65
5094722|NCT01657877|12534269|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
5094723|NCT01657877|12534269|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
5094724|NCT01657877|12534269|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
5094725|NCT01657877|12534269|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
5094726|NCT01657877|12534269|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
5094727|NCT01657877|12534269|P1|STARTED|Overall Study||79
5094728|NCT01657799|12534289|P3|NOT COMPLETED|Overall Study||102
5094729|NCT01657799|12534290|P2|NOT COMPLETED|Overall Study||103
5094730|NCT01657799|12534291|P1|NOT COMPLETED|Overall Study||102
5094731|NCT01657799|12534289|P3|COMPLETED|Overall Study||0
5094732|NCT01657799|12534290|P2|COMPLETED|Overall Study||0
5094733|NCT01657799|12534291|P1|COMPLETED|Overall Study||0
5094734|NCT01657799|12534289|P3|Received Treatment|Overall Study||102
5094735|NCT01657799|12534290|P2|Received Treatment|Overall Study||103
5094736|NCT01657799|12534291|P1|Received Treatment|Overall Study||101
5094737|NCT01657799|12534289|P3|STARTED|Overall Study||102
5094738|NCT01657799|12534290|P2|STARTED|Overall Study||103
5094739|NCT01657799|12534291|P1|STARTED|Overall Study||102
5094740|NCT01657760|12534310|P4|NOT COMPLETED|Overall Study||3
5094741|NCT01657760|12534311|P3|NOT COMPLETED|Overall Study||1
5094742|NCT01657760|12534312|P2|NOT COMPLETED|Overall Study||1
5094743|NCT01657760|12534313|P1|NOT COMPLETED|Overall Study||1
5094744|NCT01657760|12534310|P4|COMPLETED|Overall Study||4
5094745|NCT01657760|12534311|P3|COMPLETED|Overall Study||6
5094746|NCT01657760|12534312|P2|COMPLETED|Overall Study||6
5094747|NCT01657760|12534313|P1|COMPLETED|Overall Study||4
5094748|NCT01657760|12534310|P4|STARTED|Overall Study||7
5094749|NCT01657760|12534311|P3|STARTED|Overall Study||7
5094750|NCT01657760|12534312|P2|STARTED|Overall Study||7
5094751|NCT01657760|12534313|P1|STARTED|Overall Study||5
5094752|NCT01657617|12534325|P1|NOT COMPLETED|Overall Study||0
5094753|NCT01657617|12534325|P1|COMPLETED|Overall Study||35
5094754|NCT01657617|12534325|P1|STARTED|Overall Study||35
5094755|NCT01657461|12534332|P2|NOT COMPLETED|Overall Study||20
5094756|NCT01657461|12534333|P1|NOT COMPLETED|Overall Study||10
5094757|NCT01657461|12534332|P2|COMPLETED|Overall Study||78
5094758|NCT01657461|12534333|P1|COMPLETED|Overall Study||88
5094759|NCT01657461|12534332|P2|STARTED|Overall Study||98
5094760|NCT01657461|12534333|P1|STARTED|Overall Study||98
5094761|NCT01657370|12534363|P6|NOT COMPLETED|Overall Study||4
5094762|NCT01657370|12534364|P5|NOT COMPLETED|Overall Study||7
5094763|NCT01657370|12534365|P4|NOT COMPLETED|Overall Study||5
5094764|NCT01657370|12534366|P3|NOT COMPLETED|Overall Study||7
5094765|NCT01657370|12534367|P2|NOT COMPLETED|Overall Study||4
5094766|NCT01657370|12534368|P1|NOT COMPLETED|Overall Study||6
5094767|NCT01657370|12534363|P6|COMPLETED|Overall Study||27
5094768|NCT01657370|12534364|P5|COMPLETED|Overall Study||27
5094769|NCT01657370|12534365|P4|COMPLETED|Overall Study||28
5094770|NCT01657370|12534366|P3|COMPLETED|Overall Study||25
5094771|NCT01657370|12534367|P2|COMPLETED|Overall Study||28
5094772|NCT01657370|12534368|P1|COMPLETED|Overall Study||27
5094773|NCT01657370|12534363|P6|STARTED|Overall Study||31
5094774|NCT01657370|12534364|P5|STARTED|Overall Study||34
5094775|NCT01657370|12534365|P4|STARTED|Overall Study||33
5094776|NCT01657370|12534366|P3|STARTED|Overall Study||32
5094777|NCT01657370|12534367|P2|STARTED|Overall Study||32
5094778|NCT01657370|12534368|P1|STARTED|Overall Study||33
5094779|NCT01657344|12534450|P7|NOT COMPLETED|Overall Study||0
5094780|NCT01657344|12534451|P6|NOT COMPLETED|Overall Study||0
5094781|NCT01657344|12534452|P5|NOT COMPLETED|Overall Study||0
5094782|NCT01657344|12534453|P4|NOT COMPLETED|Overall Study||0
5094783|NCT01657344|12534454|P3|NOT COMPLETED|Overall Study||0
5094784|NCT01657344|12534455|P2|NOT COMPLETED|Overall Study||0
5094785|NCT01657344|12534456|P1|NOT COMPLETED|Overall Study||0
5094786|NCT01657344|12534450|P7|COMPLETED|Overall Study||140776
5094787|NCT01657344|12534451|P6|COMPLETED|Overall Study||316477
5094788|NCT01657344|12534452|P5|COMPLETED|Overall Study||157802
5094789|NCT01657344|12534453|P4|COMPLETED|Overall Study||376517
5094790|NCT01657344|12534454|P3|COMPLETED|Overall Study||196300
5094791|NCT01657344|12534455|P2|COMPLETED|Overall Study||409967
5094792|NCT01657344|12534456|P1|COMPLETED|Overall Study||421622
5094793|NCT01657344|12534450|P7|STARTED|Overall Study||140776
5094794|NCT01657344|12534451|P6|STARTED|Overall Study||316477
5094795|NCT01657344|12534452|P5|STARTED|Overall Study||157802
5094796|NCT01657344|12534453|P4|STARTED|Overall Study||376517
5094797|NCT01657344|12534454|P3|STARTED|Overall Study||196300
5094798|NCT01657344|12534455|P2|STARTED|Overall Study||409967
5094799|NCT01657344|12534456|P1|STARTED|Overall Study||421622
5094800|NCT01657305|12534466|P1|NOT COMPLETED|Overall Study||25
5094801|NCT01657305|12534466|P1|COMPLETED|Overall Study||82
5094802|NCT01657305|12534466|P1|STARTED|Overall Study||107
5094803|NCT01657292|12534516|P1|NOT COMPLETED|Overall Study||10
5094804|NCT01657292|12534516|P1|COMPLETED|Overall Study||51
5094805|NCT01657292|12534516|P1|STARTED|Overall Study||61
5094806|NCT01657266|12534525|P2|NOT COMPLETED|Overall Study||5
5094807|NCT01657266|12534526|P1|NOT COMPLETED|Overall Study||4
5094808|NCT01657266|12534525|P2|COMPLETED|Overall Study||70
5094809|NCT01657266|12534526|P1|COMPLETED|Overall Study||69
5094810|NCT01657266|12534525|P2|STARTED|Overall Study||75
5094811|NCT01657266|12534526|P1|STARTED|Overall Study||73
5094812|NCT01657253|12534548|P2|NOT COMPLETED|Overall Study||18
5094813|NCT01657253|12534549|P1|NOT COMPLETED|Overall Study||17
5094814|NCT01657253|12534548|P2|COMPLETED|Overall Study||72
5094815|NCT01657253|12534549|P1|COMPLETED|Overall Study||76
5094816|NCT01657253|12534548|P2|STARTED|Overall Study||90
5094817|NCT01657253|12534549|P1|STARTED|Overall Study||93
5094818|NCT01657032|12534561|P2|NOT COMPLETED|Overall Study||7
5094819|NCT01657032|12534562|P1|NOT COMPLETED|Overall Study||0
5094820|NCT01657032|12534561|P2|COMPLETED|Overall Study||37
5094821|NCT01657032|12534562|P1|COMPLETED|Overall Study||44
5094822|NCT01657032|12534561|P2|STARTED|Overall Study||44
5094823|NCT01657032|12534562|P1|STARTED|Overall Study||44
5094824|NCT01657019|12534588|P1|NOT COMPLETED|Overall Study||235
5094825|NCT01657019|12534588|P1|COMPLETED|Overall Study||369
5094826|NCT01657019|12534588|P1|STARTED|Overall Study||604
5094827|NCT01656967|12534602|P2|NOT COMPLETED|Overall Study||2
5094828|NCT01656967|12534603|P1|NOT COMPLETED|Overall Study||4
5094829|NCT01656967|12534602|P2|COMPLETED|Overall Study||31
5094830|NCT01656967|12534603|P1|COMPLETED|Overall Study||29
5094831|NCT01656967|12534602|P2|ETT Insertion|Overall Study||31
5094832|NCT01656967|12534603|P1|ETT Insertion|Overall Study||29
5094833|NCT01656967|12534602|P2|SGA Placement|Overall Study||33
5094834|NCT01656967|12534603|P1|SGA Placement|Overall Study||32
5094835|NCT01656967|12534602|P2|STARTED|Overall Study||33
5094836|NCT01656967|12534603|P1|STARTED|Overall Study||33
5094837|NCT01656889|12534629|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
5094838|NCT01656889|12534630|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
5094839|NCT01656889|12534629|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
5094840|NCT01656889|12534630|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
5094841|NCT01656889|12534629|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
5094842|NCT01656889|12534630|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
5094843|NCT01656889|12534629|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
5094844|NCT01656889|12534630|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
5094845|NCT01656889|12534629|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
5094846|NCT01656889|12534630|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
5094847|NCT01656889|12534629|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
5094848|NCT01656889|12534630|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
5094849|NCT01656850|12534650|P2|NOT COMPLETED|Second Intervention (3 Months)||0
5094850|NCT01656850|12534651|P1|NOT COMPLETED|Second Intervention (3 Months)||0
5094851|NCT01656850|12534650|P2|COMPLETED|Second Intervention (3 Months)||16
5094852|NCT01656850|12534651|P1|COMPLETED|Second Intervention (3 Months)||17
5094853|NCT01656850|12534650|P2|STARTED|Second Intervention (3 Months)||16
5094854|NCT01656850|12534651|P1|STARTED|Second Intervention (3 Months)||17
5094855|NCT01656850|12534650|P2|NOT COMPLETED|Washout (2 Weeks)||0
5094856|NCT01656850|12534651|P1|NOT COMPLETED|Washout (2 Weeks)||0
5094857|NCT01656850|12534650|P2|COMPLETED|Washout (2 Weeks)||16
5094858|NCT01656850|12534651|P1|COMPLETED|Washout (2 Weeks)||17
5094859|NCT01656850|12534650|P2|STARTED|Washout (2 Weeks)||16
5094860|NCT01656850|12534651|P1|STARTED|Washout (2 Weeks)||17
5094861|NCT01656850|12534650|P2|NOT COMPLETED|First Intervention (3 Months)||4
5094862|NCT01656850|12534651|P1|NOT COMPLETED|First Intervention (3 Months)||3
5094863|NCT01656850|12534650|P2|COMPLETED|First Intervention (3 Months)||16
5094864|NCT01656850|12534651|P1|COMPLETED|First Intervention (3 Months)||17
5094865|NCT01656850|12534650|P2|STARTED|First Intervention (3 Months)||20
5094866|NCT01656850|12534651|P1|STARTED|First Intervention (3 Months)||20
5094867|NCT01656772|12534731|P2|NOT COMPLETED|Overall Study||0
5094868|NCT01656772|12534732|P1|NOT COMPLETED|Overall Study||0
5094869|NCT01656772|12534731|P2|COMPLETED|Overall Study||77
5094870|NCT01656772|12534732|P1|COMPLETED|Overall Study||43
5094871|NCT01656772|12534731|P2|STARTED|Overall Study||77
5094872|NCT01656772|12534732|P1|STARTED|Overall Study||43
5094873|NCT01656759|12534742|P2|NOT COMPLETED|Overall Study||3
5094874|NCT01656759|12534743|P1|NOT COMPLETED|Overall Study||2
5094875|NCT01656759|12534742|P2|COMPLETED|Overall Study||22
5094876|NCT01656759|12534743|P1|COMPLETED|Overall Study||25
5094877|NCT01656759|12534742|P2|STARTED|Overall Study||25
5094878|NCT01656759|12534743|P1|STARTED|Overall Study||27
5094879|NCT01656733|12534757|P2|NOT COMPLETED|Overall Study||4
5094880|NCT01656733|12534758|P1|NOT COMPLETED|Overall Study||0
5094881|NCT01656733|12534757|P2|COMPLETED|Overall Study||66
5094882|NCT01656733|12534758|P1|COMPLETED|Overall Study||67
5094883|NCT01656733|12534757|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
5094884|NCT01656733|12534758|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
5094885|NCT01656733|12534757|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
5094886|NCT01656733|12534758|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
5094887|NCT01656733|12534757|P2|Participants With Perinatal Outcomes|Overall Study||66
5094888|NCT01656733|12534758|P1|Participants With Perinatal Outcomes|Overall Study||67
5094889|NCT01656733|12534757|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
5094890|NCT01656733|12534758|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
5094891|NCT01656733|12534757|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
5094892|NCT01656733|12534758|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
5094893|NCT01656733|12534757|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
5094894|NCT01656733|12534758|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
5094895|NCT01656733|12534757|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
5094896|NCT01656733|12534758|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
5094897|NCT01656733|12534757|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
5094898|NCT01656733|12534758|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
5094899|NCT01656733|12534757|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
5094900|NCT01656733|12534758|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
5094901|NCT01656733|12534757|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
5094902|NCT01656733|12534758|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
5094903|NCT01656629|12534773|P3|NOT COMPLETED|Overall Study||2
5094904|NCT01656629|12534774|P2|NOT COMPLETED|Overall Study||2
5094905|NCT01656629|12534775|P1|NOT COMPLETED|Overall Study||5
5094906|NCT01656629|12534773|P3|COMPLETED|Overall Study||14
5094907|NCT01656629|12534774|P2|COMPLETED|Overall Study||16
5094908|NCT01656629|12534775|P1|COMPLETED|Overall Study||16
5094909|NCT01656629|12534773|P3|STARTED|Overall Study||16
5094910|NCT01656629|12534774|P2|STARTED|Overall Study||18
5094911|NCT01656629|12534775|P1|STARTED|Overall Study||21
5094912|NCT01656486|12534783|P1|NOT COMPLETED|Overall Study||0
5094913|NCT01656486|12534783|P1|COMPLETED|Overall Study||1
5094914|NCT01656486|12534783|P1|STARTED|Overall Study||1
5094915|NCT01656460|12534787|P4|NOT COMPLETED|Overall Study||0
5094916|NCT01656460|12534788|P3|NOT COMPLETED|Overall Study||0
5094917|NCT01656460|12534789|P2|NOT COMPLETED|Overall Study||0
5094918|NCT01656460|12534790|P1|NOT COMPLETED|Overall Study||0
5094919|NCT01656460|12534787|P4|COMPLETED|Overall Study||3
5094920|NCT01656460|12534788|P3|COMPLETED|Overall Study||3
5094921|NCT01656460|12534789|P2|COMPLETED|Overall Study||3
5094922|NCT01656460|12534790|P1|COMPLETED|Overall Study||3
5094923|NCT01656460|12534787|P4|STARTED|Overall Study||3
5094924|NCT01656460|12534788|P3|STARTED|Overall Study||3
5094925|NCT01656460|12534789|P2|STARTED|Overall Study||3
5094926|NCT01656460|12534790|P1|STARTED|Overall Study||3
5094927|NCT01656434|12534802|P2|NOT COMPLETED|Overall Study||580
5094928|NCT01656434|12534803|P1|NOT COMPLETED|Overall Study||2401
5094929|NCT01656434|12534802|P2|COMPLETED|Overall Study||40
5094930|NCT01656434|12534803|P1|COMPLETED|Overall Study||152
5094931|NCT01656434|12534802|P2|Treated|Overall Study||604
5094932|NCT01656434|12534803|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
5094933|NCT01656434|12534802|P2|STARTED|Overall Study||620
5094934|NCT01656434|12534803|P1|STARTED|Overall Study||2553
5094935|NCT01656408|12534829|P10|NOT COMPLETED|Overall Study||3
5094936|NCT01656408|12534830|P9|NOT COMPLETED|Overall Study||2
5094937|NCT01656408|12534831|P8|NOT COMPLETED|Overall Study||1
5094938|NCT01656408|12534832|P7|NOT COMPLETED|Overall Study||1
5094939|NCT01656408|12534833|P6|NOT COMPLETED|Overall Study||2
5094940|NCT01656408|12534834|P5|NOT COMPLETED|Overall Study||1
5094941|NCT01656408|12534835|P4|NOT COMPLETED|Overall Study||0
5094942|NCT01656408|12534836|P3|NOT COMPLETED|Overall Study||2
5094943|NCT01656408|12534837|P2|NOT COMPLETED|Overall Study||0
5094944|NCT01656408|12534838|P1|NOT COMPLETED|Overall Study||1
5094945|NCT01656408|12534829|P10|COMPLETED|Overall Study||15
5094946|NCT01656408|12534830|P9|COMPLETED|Overall Study||16
5094947|NCT01656408|12534831|P8|COMPLETED|Overall Study||7
5094948|NCT01656408|12534832|P7|COMPLETED|Overall Study||9
5094949|NCT01656408|12534833|P6|COMPLETED|Overall Study||7
5094950|NCT01656408|12534834|P5|COMPLETED|Overall Study||8
5094951|NCT01656408|12534835|P4|COMPLETED|Overall Study||7
5094952|NCT01656408|12534836|P3|COMPLETED|Overall Study||6
5094953|NCT01656408|12534837|P2|COMPLETED|Overall Study||8
5094954|NCT01656408|12534838|P1|COMPLETED|Overall Study||7
5094955|NCT01656408|12534829|P10|STARTED|Overall Study||18
5094956|NCT01656408|12534830|P9|STARTED|Overall Study||18
5094957|NCT01656408|12534831|P8|STARTED|Overall Study||8
5094958|NCT01656408|12534832|P7|STARTED|Overall Study||10
5094959|NCT01656408|12534833|P6|STARTED|Overall Study||9
5094960|NCT01656408|12534834|P5|STARTED|Overall Study||9
5094961|NCT01656408|12534835|P4|STARTED|Overall Study||7
5094962|NCT01656408|12534836|P3|STARTED|Overall Study||8
5094963|NCT01656408|12534837|P2|STARTED|Overall Study||8
5094964|NCT01656408|12534838|P1|STARTED|Overall Study||8
5094965|NCT01656395|12535033|P8|NOT COMPLETED|Overall Study||0
5094966|NCT01656395|12535034|P7|NOT COMPLETED|Overall Study||0
5094967|NCT01656395|12535035|P6|NOT COMPLETED|Overall Study||40
5094968|NCT01656395|12535036|P5|NOT COMPLETED|Overall Study||14
5094969|NCT01656395|12535037|P4|NOT COMPLETED|Overall Study||12
5094970|NCT01656395|12535038|P3|NOT COMPLETED|Overall Study||36
5094971|NCT01656395|12535039|P2|NOT COMPLETED|Overall Study||34
5094972|NCT01656395|12535040|P1|NOT COMPLETED|Overall Study||17
5094973|NCT01656395|12535033|P8|COMPLETED|Overall Study||0
5094974|NCT01656395|12535034|P7|COMPLETED|Overall Study||0
5094975|NCT01656395|12535035|P6|COMPLETED|Overall Study||94
5094976|NCT01656395|12535036|P5|COMPLETED|Overall Study||46
5094977|NCT01656395|12535037|P4|COMPLETED|Overall Study||41
5094978|NCT01656395|12535038|P3|COMPLETED|Overall Study||106
5094979|NCT01656395|12535039|P2|COMPLETED|Overall Study||93
5094980|NCT01656395|12535040|P1|COMPLETED|Overall Study||43
5094981|NCT01656395|12535033|P8|Treated Participants|Overall Study||0
5094982|NCT01656395|12535034|P7|Treated Participants|Overall Study||0
5094983|NCT01656395|12535035|P6|Treated Participants|Overall Study||126
5094984|NCT01656395|12535036|P5|Treated Participants|Overall Study||60
5094985|NCT01656395|12535037|P4|Treated Participants|Overall Study||52
5094986|NCT01656395|12535038|P3|Treated Participants|Overall Study||135
5094987|NCT01656395|12535039|P2|Treated Participants|Overall Study||126
5094988|NCT01656395|12535040|P1|Treated Participants|Overall Study||58
5094989|NCT01656395|12535033|P8|STARTED|Overall Study||0
5094990|NCT01656395|12535034|P7|STARTED|Overall Study||0
5094991|NCT01656395|12535035|P6|STARTED|Overall Study||134
5094992|NCT01656395|12535036|P5|STARTED|Overall Study||60
5094993|NCT01656395|12535037|P4|STARTED|Overall Study||53
5094994|NCT01656395|12535038|P3|STARTED|Overall Study||142
5094995|NCT01656395|12535039|P2|STARTED|Overall Study||127
5094996|NCT01656395|12535040|P1|STARTED|Overall Study||60
5094997|NCT01656304|12535126|P1|NOT COMPLETED|Overall Study||1
5094998|NCT01656304|12535126|P1|COMPLETED|Overall Study||15
5094999|NCT01656304|12535126|P1|STARTED|Overall Study||16
5095000|NCT01656252|12535135|P1|NOT COMPLETED|Phase II||0
5095001|NCT01656252|12535135|P1|COMPLETED|Phase II||0
5095002|NCT01656252|12535135|P1|STARTED|Phase II||0
5095003|NCT01656252|12535135|P1|NOT COMPLETED|Phase I||0
5095004|NCT01656252|12535135|P1|COMPLETED|Phase I||14
5095005|NCT01656252|12535135|P1|STARTED|Phase I||14
5095006|NCT01656200|12535167|P1|NOT COMPLETED|Overall Study||1
5095007|NCT01656200|12535167|P1|COMPLETED|Overall Study||16
5095008|NCT01656200|12535167|P1|STARTED|Overall Study||17
5095009|NCT01656187|12535175|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
5095010|NCT01656187|12535176|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
5095011|NCT01656187|12535175|P2|COMPLETED|Second Intervention (24 Weeks)||19
5095012|NCT01656187|12535176|P1|COMPLETED|Second Intervention (24 Weeks)||13
5095013|NCT01656187|12535175|P2|STARTED|Second Intervention (24 Weeks)||22
5095014|NCT01656187|12535176|P1|STARTED|Second Intervention (24 Weeks)||14
5095015|NCT01656187|12535175|P2|NOT COMPLETED|Washout (4 Weeks)||1
5095016|NCT01656187|12535176|P1|NOT COMPLETED|Washout (4 Weeks)||0
5095017|NCT01656187|12535175|P2|COMPLETED|Washout (4 Weeks)||22
5095018|NCT01656187|12535176|P1|COMPLETED|Washout (4 Weeks)||14
5095019|NCT01656187|12535175|P2|STARTED|Washout (4 Weeks)||23
5095020|NCT01656187|12535176|P1|STARTED|Washout (4 Weeks)||14
5095021|NCT01656187|12535175|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
5095022|NCT01656187|12535176|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
5095023|NCT01656187|12535175|P2|COMPLETED|First Intervention (24 Weeks)||23
5095024|NCT01656187|12535176|P1|COMPLETED|First Intervention (24 Weeks)||14
5095025|NCT01656187|12535175|P2|STARTED|First Intervention (24 Weeks)||26
5095026|NCT01656187|12535176|P1|STARTED|First Intervention (24 Weeks)||20
5095027|NCT01656161|12535182|P1|NOT COMPLETED|Overall Study||7
5095028|NCT01656161|12535182|P1|COMPLETED|Overall Study|Per protocol analysis set|113
5095029|NCT01656161|12535182|P1|Received Triptorelin at Day 169|Overall Study||115
5095030|NCT01656161|12535182|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
5095031|NCT01656161|12535182|P1|STARTED|Overall Study|Intention to treat analysis set|120
5095032|NCT01656031|12535196|P1|NOT COMPLETED|Overall Study||0
5095033|NCT01656031|12535196|P1|COMPLETED|Overall Study||39
5095034|NCT01656031|12535196|P1|STARTED|Overall Study||39
5095035|NCT01655901|12535200|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
5095036|NCT01655901|12535201|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
5095037|NCT01655901|12535202|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
5095038|NCT01655901|12535203|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
5095039|NCT01655901|12535204|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
5095040|NCT01655901|12535205|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
5095041|NCT01655901|12535200|P6|COMPLETED|Third Intervention (Hour 3)||5
5095042|NCT01655901|12535201|P5|COMPLETED|Third Intervention (Hour 3)||4
5095043|NCT01655901|12535202|P4|COMPLETED|Third Intervention (Hour 3)||5
5095044|NCT01655901|12535203|P3|COMPLETED|Third Intervention (Hour 3)||4
5095045|NCT01655901|12535204|P2|COMPLETED|Third Intervention (Hour 3)||4
5095046|NCT01655901|12535205|P1|COMPLETED|Third Intervention (Hour 3)||4
5095047|NCT01655901|12535200|P6|STARTED|Third Intervention (Hour 3)||5
5095048|NCT01655901|12535201|P5|STARTED|Third Intervention (Hour 3)||5
5095049|NCT01655901|12535202|P4|STARTED|Third Intervention (Hour 3)||5
5095050|NCT01655901|12535203|P3|STARTED|Third Intervention (Hour 3)||5
5095051|NCT01655901|12535204|P2|STARTED|Third Intervention (Hour 3)||5
5095052|NCT01655901|12535205|P1|STARTED|Third Intervention (Hour 3)||5
5095053|NCT01655901|12535200|P6|NOT COMPLETED|Washout (1 Week)||0
5095054|NCT01655901|12535201|P5|NOT COMPLETED|Washout (1 Week)||0
5095055|NCT01655901|12535202|P4|NOT COMPLETED|Washout (1 Week)||0
5095056|NCT01655901|12535203|P3|NOT COMPLETED|Washout (1 Week)||0
5095057|NCT01655901|12535204|P2|NOT COMPLETED|Washout (1 Week)||0
5095058|NCT01655901|12535205|P1|NOT COMPLETED|Washout (1 Week)||0
5095059|NCT01655901|12535200|P6|COMPLETED|Washout (1 Week)||5
5095060|NCT01655901|12535201|P5|COMPLETED|Washout (1 Week)||5
5095061|NCT01655901|12535202|P4|COMPLETED|Washout (1 Week)||5
5095062|NCT01655901|12535203|P3|COMPLETED|Washout (1 Week)||5
5095063|NCT01655901|12535204|P2|COMPLETED|Washout (1 Week)||5
5095064|NCT01655901|12535205|P1|COMPLETED|Washout (1 Week)||5
5095065|NCT01655901|12535200|P6|STARTED|Washout (1 Week)||5
5095066|NCT01655901|12535201|P5|STARTED|Washout (1 Week)||5
5095067|NCT01655901|12535202|P4|STARTED|Washout (1 Week)||5
5095068|NCT01655901|12535203|P3|STARTED|Washout (1 Week)||5
5095069|NCT01655901|12535204|P2|STARTED|Washout (1 Week)||5
5095070|NCT01655901|12535205|P1|STARTED|Washout (1 Week)||5
5095071|NCT01655901|12535200|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
5095072|NCT01655901|12535201|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
5095073|NCT01655901|12535202|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
5095074|NCT01655901|12535203|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
5095075|NCT01655901|12535204|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
5095076|NCT01655901|12535205|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
5095077|NCT01655901|12535200|P6|COMPLETED|Second Intervention (Hour 2)||5
5095078|NCT01655901|12535201|P5|COMPLETED|Second Intervention (Hour 2)||5
5095079|NCT01655901|12535202|P4|COMPLETED|Second Intervention (Hour 2)||5
5095080|NCT01655901|12535203|P3|COMPLETED|Second Intervention (Hour 2)||5
5095081|NCT01655901|12535204|P2|COMPLETED|Second Intervention (Hour 2)||5
5095082|NCT01655901|12535205|P1|COMPLETED|Second Intervention (Hour 2)||5
5095083|NCT01655901|12535200|P6|STARTED|Second Intervention (Hour 2)||5
5095084|NCT01655901|12535201|P5|STARTED|Second Intervention (Hour 2)||5
5095085|NCT01655901|12535202|P4|STARTED|Second Intervention (Hour 2)||5
5095086|NCT01655901|12535203|P3|STARTED|Second Intervention (Hour 2)||5
5095087|NCT01655901|12535204|P2|STARTED|Second Intervention (Hour 2)||5
5095088|NCT01655901|12535205|P1|STARTED|Second Intervention (Hour 2)||5
5095089|NCT01655901|12535200|P6|NOT COMPLETED|Washout (1 Week)||0
5095090|NCT01655901|12535201|P5|NOT COMPLETED|Washout (1 Week)||0
5095091|NCT01655901|12535202|P4|NOT COMPLETED|Washout (1 Week)||0
5095092|NCT01655901|12535203|P3|NOT COMPLETED|Washout (1 Week)||0
5095093|NCT01655901|12535204|P2|NOT COMPLETED|Washout (1 Week)||0
5095094|NCT01655901|12535205|P1|NOT COMPLETED|Washout (1 Week)||0
5095095|NCT01655901|12535200|P6|COMPLETED|Washout (1 Week)||5
5095096|NCT01655901|12535201|P5|COMPLETED|Washout (1 Week)||5
5095097|NCT01655901|12535202|P4|COMPLETED|Washout (1 Week)||5
5095098|NCT01655901|12535203|P3|COMPLETED|Washout (1 Week)||5
5095099|NCT01655901|12535204|P2|COMPLETED|Washout (1 Week)||5
5095100|NCT01655901|12535205|P1|COMPLETED|Washout (1 Week)||5
5095101|NCT01655901|12535200|P6|STARTED|Washout (1 Week)||5
5095102|NCT01655901|12535201|P5|STARTED|Washout (1 Week)||5
5095103|NCT01655901|12535202|P4|STARTED|Washout (1 Week)||5
5095104|NCT01655901|12535203|P3|STARTED|Washout (1 Week)||5
5095105|NCT01655901|12535204|P2|STARTED|Washout (1 Week)||5
5095106|NCT01655901|12535205|P1|STARTED|Washout (1 Week)||5
5095107|NCT01655901|12535200|P6|NOT COMPLETED|First Intervention (Hour 1)||0
5095108|NCT01655901|12535201|P5|NOT COMPLETED|First Intervention (Hour 1)||0
5095109|NCT01655901|12535202|P4|NOT COMPLETED|First Intervention (Hour 1)||0
5095110|NCT01655901|12535203|P3|NOT COMPLETED|First Intervention (Hour 1)||0
5095111|NCT01655901|12535204|P2|NOT COMPLETED|First Intervention (Hour 1)||0
5095112|NCT01655901|12535205|P1|NOT COMPLETED|First Intervention (Hour 1)||0
5095113|NCT01655901|12535200|P6|COMPLETED|First Intervention (Hour 1)||5
5095114|NCT01655901|12535201|P5|COMPLETED|First Intervention (Hour 1)||5
5095115|NCT01655901|12535202|P4|COMPLETED|First Intervention (Hour 1)||5
5095116|NCT01655901|12535203|P3|COMPLETED|First Intervention (Hour 1)||5
5095117|NCT01655901|12535204|P2|COMPLETED|First Intervention (Hour 1)||5
5095118|NCT01655901|12535205|P1|COMPLETED|First Intervention (Hour 1)||5
5095119|NCT01655901|12535200|P6|STARTED|First Intervention (Hour 1)||5
5095120|NCT01655901|12535201|P5|STARTED|First Intervention (Hour 1)||5
5095121|NCT01655901|12535202|P4|STARTED|First Intervention (Hour 1)||5
5095122|NCT01655901|12535203|P3|STARTED|First Intervention (Hour 1)||5
5095123|NCT01655901|12535204|P2|STARTED|First Intervention (Hour 1)||5
5095124|NCT01655901|12535205|P1|STARTED|First Intervention (Hour 1)||5
5095125|NCT01655823|12535219|P5|NOT COMPLETED|Overall Study||1
5095126|NCT01655823|12535220|P4|NOT COMPLETED|Overall Study||1
5095127|NCT01655823|12535221|P3|NOT COMPLETED|Overall Study||0
5095128|NCT01655823|12535222|P2|NOT COMPLETED|Overall Study||2
5095129|NCT01655823|12535223|P1|NOT COMPLETED|Overall Study||0
5095130|NCT01655823|12535219|P5|COMPLETED|Overall Study||25
5095131|NCT01655823|12535220|P4|COMPLETED|Overall Study||24
5095132|NCT01655823|12535221|P3|COMPLETED|Overall Study||24
5095133|NCT01655823|12535222|P2|COMPLETED|Overall Study||23
5095134|NCT01655823|12535223|P1|COMPLETED|Overall Study||25
5095135|NCT01655823|12535219|P5|STARTED|Overall Study||26
5095136|NCT01655823|12535220|P4|STARTED|Overall Study||25
5095137|NCT01655823|12535221|P3|STARTED|Overall Study||24
5095138|NCT01655823|12535222|P2|STARTED|Overall Study||25
5095139|NCT01655823|12535223|P1|STARTED|Overall Study||25
5095140|NCT01655719|12535235|P1|NOT COMPLETED|Overall Study||0
5095141|NCT01655719|12535235|P1|COMPLETED|Overall Study||1
5095142|NCT01655719|12535235|P1|STARTED|Overall Study||1
5095143|NCT01655563|12535243|P2|NOT COMPLETED|Overall Study||0
5095144|NCT01655563|12535244|P1|NOT COMPLETED|Overall Study||0
5095145|NCT01655563|12535243|P2|COMPLETED|Overall Study||35
5095146|NCT01655563|12535244|P1|COMPLETED|Overall Study||18
5095147|NCT01655563|12535243|P2|STARTED|Overall Study||35
5095148|NCT01655563|12535244|P1|STARTED|Overall Study||18
5095149|NCT01655498|12535254|P1|NOT COMPLETED|Overall Study||5
5095150|NCT01655498|12535254|P1|COMPLETED|Overall Study||56
5095151|NCT01655498|12535254|P1|STARTED|Overall Study||61
5095152|NCT01655381|12535261|P1|NOT COMPLETED|Overall Study||3
5095153|NCT01655381|12535261|P1|COMPLETED|Overall Study||12
5095154|NCT01655381|12535261|P1|STARTED|Overall Study||15
5095155|NCT01655329|12535281|P1|NOT COMPLETED|Overall Study||0
5095156|NCT01655329|12535281|P1|COMPLETED|Overall Study||10
5095157|NCT01655329|12535281|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
5095158|NCT01655069|12535301|P4|NOT COMPLETED|Overall Study||4
5095159|NCT01655069|12535302|P3|NOT COMPLETED|Overall Study||2
5095160|NCT01655069|12535303|P2|NOT COMPLETED|Overall Study||12
5095161|NCT01655069|12535304|P1|NOT COMPLETED|Overall Study||8
5095162|NCT01655069|12535301|P4|COMPLETED|Overall Study||11
5095163|NCT01655069|12535302|P3|COMPLETED|Overall Study||12
5095164|NCT01655069|12535303|P2|COMPLETED|Overall Study||46
5095165|NCT01655069|12535304|P1|COMPLETED|Overall Study||53
5095166|NCT01655069|12535301|P4|Full Analysis Set (FAS)|Overall Study||15
5095167|NCT01655069|12535302|P3|Full Analysis Set (FAS)|Overall Study||14
5095168|NCT01655069|12535303|P2|Full Analysis Set (FAS)|Overall Study||57
5095169|NCT01655069|12535304|P1|Full Analysis Set (FAS)|Overall Study||60
5095170|NCT01655069|12535301|P4|Safety Analysis Set (SAF)|Overall Study||15
5095171|NCT01655069|12535302|P3|Safety Analysis Set (SAF)|Overall Study||14
5095172|NCT01655069|12535303|P2|Safety Analysis Set (SAF)|Overall Study||57
5095173|NCT01655069|12535304|P1|Safety Analysis Set (SAF)|Overall Study||61
5095174|NCT01655069|12535301|P4|STARTED|Overall Study||15
5095175|NCT01655069|12535302|P3|STARTED|Overall Study||14
5095176|NCT01655069|12535303|P2|STARTED|Overall Study||58
5095177|NCT01655069|12535304|P1|STARTED|Overall Study||61
5095178|NCT01655043|12535319|P1|NOT COMPLETED|Overall Study||0
5095179|NCT01655043|12535319|P1|COMPLETED|Overall Study||20
5095180|NCT01655043|12535319|P1|STARTED|Overall Study||20
5095181|NCT01654887|12535325|P2|NOT COMPLETED|Overall Study||0
5095182|NCT01654887|12535326|P1|NOT COMPLETED|Overall Study||0
5095183|NCT01654887|12535325|P2|COMPLETED|Overall Study||88
5095184|NCT01654887|12535326|P1|COMPLETED|Overall Study||103
5095185|NCT01654887|12535325|P2|STARTED|Overall Study||88
5095186|NCT01654887|12535326|P1|STARTED|Overall Study||103
5095187|NCT01654861|12535342|P1|NOT COMPLETED|Overall Study||0
5095188|NCT01654861|12535342|P1|COMPLETED|Overall Study||3
5095189|NCT01654861|12535342|P1|STARTED|Overall Study||3
5095190|NCT01654796|12535350|P3|NOT COMPLETED|Overall Study||1
5095191|NCT01654796|12535351|P2|NOT COMPLETED|Overall Study||3
5095192|NCT01654796|12535352|P1|NOT COMPLETED|Overall Study||1
5095193|NCT01654796|12535350|P3|COMPLETED|Overall Study||28
5095194|NCT01654796|12535351|P2|COMPLETED|Overall Study||26
5095195|NCT01654796|12535352|P1|COMPLETED|Overall Study||25
5095196|NCT01654796|12535350|P3|STARTED|Overall Study||29
5095197|NCT01654796|12535351|P2|STARTED|Overall Study||29
5095198|NCT01654796|12535352|P1|STARTED|Overall Study||26
5095199|NCT01654666|12535364|P3|NOT COMPLETED|Overall Study||14
5095200|NCT01654666|12535365|P2|NOT COMPLETED|Overall Study||13
5095201|NCT01654666|12535366|P1|NOT COMPLETED|Overall Study||15
5095202|NCT01654666|12535364|P3|COMPLETED|Overall Study||49
5095203|NCT01654666|12535365|P2|COMPLETED|Overall Study||50
5095204|NCT01654666|12535366|P1|COMPLETED|Overall Study||48
5095205|NCT01654666|12535364|P3|Primary Analysis|Overall Study||54
5095206|NCT01654666|12535365|P2|Primary Analysis|Overall Study||56
5095207|NCT01654666|12535366|P1|Primary Analysis|Overall Study||52
5095208|NCT01654666|12535364|P3|STARTED|Overall Study||63
5095209|NCT01654666|12535365|P2|STARTED|Overall Study||63
5095210|NCT01654666|12535366|P1|STARTED|Overall Study||63
5095211|NCT01654601|12535391|P2|NOT COMPLETED|2nd Administration||1
5095212|NCT01654601|12535392|P1|NOT COMPLETED|2nd Administration||1
5095213|NCT01654601|12535391|P2|COMPLETED|2nd Administration||11
5095214|NCT01654601|12535392|P1|COMPLETED|2nd Administration||11
5095215|NCT01654601|12535391|P2|STARTED|2nd Administration||12
5095216|NCT01654601|12535392|P1|STARTED|2nd Administration||12
5095217|NCT01654601|12535391|P2|NOT COMPLETED|1st Administration||2
5095218|NCT01654601|12535392|P1|NOT COMPLETED|1st Administration||2
5095219|NCT01654601|12535391|P2|COMPLETED|1st Administration||12
5095220|NCT01654601|12535392|P1|COMPLETED|1st Administration||12
5095221|NCT01654601|12535391|P2|STARTED|1st Administration||14
5095222|NCT01654601|12535392|P1|STARTED|1st Administration||14
5095223|NCT01654549|12535406|P2|NOT COMPLETED|Overall Study||1
5095224|NCT01654549|12535407|P1|NOT COMPLETED|Overall Study||0
5095225|NCT01654549|12535406|P2|COMPLETED|Overall Study||19
5095226|NCT01654549|12535407|P1|COMPLETED|Overall Study||20
5095227|NCT01654549|12535406|P2|STARTED|Overall Study||20
5095228|NCT01654549|12535407|P1|STARTED|Overall Study||20
5095229|NCT01654536|12535419|P2|NOT COMPLETED|Overall Study||38
5095230|NCT01654536|12535420|P1|NOT COMPLETED|Overall Study||44
5095231|NCT01654536|12535419|P2|COMPLETED|Overall Study||331
5095232|NCT01654536|12535420|P1|COMPLETED|Overall Study||324
5095233|NCT01654536|12535419|P2|STARTED|Overall Study||369
5095234|NCT01654536|12535420|P1|STARTED|Overall Study||368
5095235|NCT01654523|12535456|P1|NOT COMPLETED|Overall Study||1
5095236|NCT01654523|12535456|P1|COMPLETED|Overall Study||19
5095237|NCT01654523|12535456|P1|STARTED|Overall Study||20
5095238|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Period 4||0
5095239|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Period 4||0
5095240|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Period 4||0
5095241|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Period 4||0
5095242|NCT01654380|12535462|P4|COMPLETED|Part B, Period 4||7
5095243|NCT01654380|12535463|P3|COMPLETED|Part B, Period 4||6
5095244|NCT01654380|12535464|P2|COMPLETED|Part B, Period 4||0
5095245|NCT01654380|12535465|P1|COMPLETED|Part B, Period 4||0
5095246|NCT01654380|12535462|P4|STARTED|Part B, Period 4||7
5095247|NCT01654380|12535463|P3|STARTED|Part B, Period 4||6
5095248|NCT01654380|12535464|P2|STARTED|Part B, Period 4||0
5095249|NCT01654380|12535465|P1|STARTED|Part B, Period 4||0
5095250|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095251|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095252|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095253|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095254|NCT01654380|12535462|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
5095255|NCT01654380|12535463|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
5095256|NCT01654380|12535464|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
5095257|NCT01654380|12535465|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
5095258|NCT01654380|12535462|P4|STARTED|Part B, Washout of at Least 6 Days||7
5095259|NCT01654380|12535463|P3|STARTED|Part B, Washout of at Least 6 Days||6
5095260|NCT01654380|12535464|P2|STARTED|Part B, Washout of at Least 6 Days||0
5095261|NCT01654380|12535465|P1|STARTED|Part B, Washout of at Least 6 Days||0
5095262|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Period 3||0
5095263|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Period 3||0
5095264|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Period 3||0
5095265|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Period 3||0
5095266|NCT01654380|12535462|P4|COMPLETED|Part B, Period 3||7
5095267|NCT01654380|12535463|P3|COMPLETED|Part B, Period 3||6
5095268|NCT01654380|12535464|P2|COMPLETED|Part B, Period 3||0
5095269|NCT01654380|12535465|P1|COMPLETED|Part B, Period 3||0
5095270|NCT01654380|12535462|P4|STARTED|Part B, Period 3||7
5095271|NCT01654380|12535463|P3|STARTED|Part B, Period 3||6
5095272|NCT01654380|12535464|P2|STARTED|Part B, Period 3||0
5095273|NCT01654380|12535465|P1|STARTED|Part B, Period 3||0
5095274|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095275|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095276|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095277|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095278|NCT01654380|12535462|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
5095279|NCT01654380|12535463|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
5095280|NCT01654380|12535464|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
5095281|NCT01654380|12535465|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
5095282|NCT01654380|12535462|P4|STARTED|Part B, Washout of at Least 6 Days||7
5095283|NCT01654380|12535463|P3|STARTED|Part B, Washout of at Least 6 Days||6
5095284|NCT01654380|12535464|P2|STARTED|Part B, Washout of at Least 6 Days||0
5095285|NCT01654380|12535465|P1|STARTED|Part B, Washout of at Least 6 Days||0
5095286|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Period 2||0
5095287|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Period 2||0
5095288|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Period 2||0
5095289|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Period 2||0
5095290|NCT01654380|12535462|P4|COMPLETED|Part B, Period 2||7
5095291|NCT01654380|12535463|P3|COMPLETED|Part B, Period 2||6
5095292|NCT01654380|12535464|P2|COMPLETED|Part B, Period 2||0
5095293|NCT01654380|12535465|P1|COMPLETED|Part B, Period 2||0
5095294|NCT01654380|12535462|P4|STARTED|Part B, Period 2||7
5095295|NCT01654380|12535463|P3|STARTED|Part B, Period 2||6
5095296|NCT01654380|12535464|P2|STARTED|Part B, Period 2||0
5095297|NCT01654380|12535465|P1|STARTED|Part B, Period 2||0
5095298|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095299|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095300|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095301|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
5095302|NCT01654380|12535462|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
5095303|NCT01654380|12535463|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
5095304|NCT01654380|12535464|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
5095305|NCT01654380|12535465|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
5095306|NCT01654380|12535462|P4|STARTED|Part B, Washout of at Least 6 Days||7
5095307|NCT01654380|12535463|P3|STARTED|Part B, Washout of at Least 6 Days||6
5095308|NCT01654380|12535464|P2|STARTED|Part B, Washout of at Least 6 Days||0
5095309|NCT01654380|12535465|P1|STARTED|Part B, Washout of at Least 6 Days||0
5095310|NCT01654380|12535462|P4|NOT COMPLETED|Part B, Period 1||0
5095311|NCT01654380|12535463|P3|NOT COMPLETED|Part B, Period 1||1
5095312|NCT01654380|12535464|P2|NOT COMPLETED|Part B, Period 1||0
5095313|NCT01654380|12535465|P1|NOT COMPLETED|Part B, Period 1||0
5095314|NCT01654380|12535462|P4|COMPLETED|Part B, Period 1||7
5095315|NCT01654380|12535463|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
5095316|NCT01654380|12535464|P2|COMPLETED|Part B, Period 1||0
5095317|NCT01654380|12535465|P1|COMPLETED|Part B, Period 1||0
5095318|NCT01654380|12535462|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
5095319|NCT01654380|12535463|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
5095320|NCT01654380|12535464|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
5095321|NCT01654380|12535465|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
5095322|NCT01654380|12535462|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
5095323|NCT01654380|12535463|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
5095324|NCT01654380|12535464|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
5095325|NCT01654380|12535465|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
5095326|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Period 4||0
5095327|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Period 4||0
5095328|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Period 4||0
5095329|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Period 4||0
5095330|NCT01654380|12535462|P4|COMPLETED|Part A, Period 4||0
5095331|NCT01654380|12535463|P3|COMPLETED|Part A, Period 4||0
5095332|NCT01654380|12535464|P2|COMPLETED|Part A, Period 4||4
5095333|NCT01654380|12535465|P1|COMPLETED|Part A, Period 4||4
5095334|NCT01654380|12535462|P4|STARTED|Part A, Period 4||0
5095335|NCT01654380|12535463|P3|STARTED|Part A, Period 4||0
5095336|NCT01654380|12535464|P2|STARTED|Part A, Period 4||4
5095337|NCT01654380|12535465|P1|STARTED|Part A, Period 4||4
5095338|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095339|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095340|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095341|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095342|NCT01654380|12535462|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
5095343|NCT01654380|12535463|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
5095344|NCT01654380|12535464|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
5095345|NCT01654380|12535465|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
5095346|NCT01654380|12535462|P4|STARTED|Part A, Washout of at Least 6 Days||0
5095347|NCT01654380|12535463|P3|STARTED|Part A, Washout of at Least 6 Days||0
5095348|NCT01654380|12535464|P2|STARTED|Part A, Washout of at Least 6 Days||4
5095349|NCT01654380|12535465|P1|STARTED|Part A, Washout of at Least 6 Days||4
5095350|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Period 3||0
5095351|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Period 3||0
5095352|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Period 3||0
5095353|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Period 3||0
5095354|NCT01654380|12535462|P4|COMPLETED|Part A, Period 3||0
5095355|NCT01654380|12535463|P3|COMPLETED|Part A, Period 3||0
5095356|NCT01654380|12535464|P2|COMPLETED|Part A, Period 3||4
5095357|NCT01654380|12535465|P1|COMPLETED|Part A, Period 3||4
5095358|NCT01654380|12535462|P4|STARTED|Part A, Period 3||0
5095359|NCT01654380|12535463|P3|STARTED|Part A, Period 3||0
5095360|NCT01654380|12535464|P2|STARTED|Part A, Period 3||4
5095361|NCT01654380|12535465|P1|STARTED|Part A, Period 3||4
5095362|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095363|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095364|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095365|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095366|NCT01654380|12535462|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
5095367|NCT01654380|12535463|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
5095368|NCT01654380|12535464|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
5095369|NCT01654380|12535465|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
5095370|NCT01654380|12535462|P4|STARTED|Part A, Washout of at Least 6 Days||0
5095371|NCT01654380|12535463|P3|STARTED|Part A, Washout of at Least 6 Days||0
5095372|NCT01654380|12535464|P2|STARTED|Part A, Washout of at Least 6 Days||4
5095373|NCT01654380|12535465|P1|STARTED|Part A, Washout of at Least 6 Days||4
5095374|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Period 2||0
5095375|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Period 2||0
5095376|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Period 2||0
5095377|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Period 2||0
5095378|NCT01654380|12535462|P4|COMPLETED|Part A, Period 2||0
5095379|NCT01654380|12535463|P3|COMPLETED|Part A, Period 2||0
5095380|NCT01654380|12535464|P2|COMPLETED|Part A, Period 2||4
5095381|NCT01654380|12535465|P1|COMPLETED|Part A, Period 2||4
5095382|NCT01654380|12535462|P4|STARTED|Part A, Period 2||0
5095383|NCT01654380|12535463|P3|STARTED|Part A, Period 2||0
5095384|NCT01654380|12535464|P2|STARTED|Part A, Period 2||4
5095385|NCT01654380|12535465|P1|STARTED|Part A, Period 2||4
5095386|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095387|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095388|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095389|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
5095390|NCT01654380|12535462|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
5095391|NCT01654380|12535463|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
5095392|NCT01654380|12535464|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
5095393|NCT01654380|12535465|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
5095394|NCT01654380|12535462|P4|STARTED|Part A, Washout of at Least 6 Days||0
5095395|NCT01654380|12535463|P3|STARTED|Part A, Washout of at Least 6 Days||0
5095396|NCT01654380|12535464|P2|STARTED|Part A, Washout of at Least 6 Days||4
5095397|NCT01654380|12535465|P1|STARTED|Part A, Washout of at Least 6 Days||4
5095398|NCT01654380|12535462|P4|NOT COMPLETED|Part A, Period 1||0
5095399|NCT01654380|12535463|P3|NOT COMPLETED|Part A, Period 1||0
5095400|NCT01654380|12535464|P2|NOT COMPLETED|Part A, Period 1||0
5095401|NCT01654380|12535465|P1|NOT COMPLETED|Part A, Period 1||0
5095402|NCT01654380|12535462|P4|COMPLETED|Part A, Period 1||0
5095403|NCT01654380|12535463|P3|COMPLETED|Part A, Period 1||0
5095404|NCT01654380|12535464|P2|COMPLETED|Part A, Period 1||4
5095405|NCT01654380|12535465|P1|COMPLETED|Part A, Period 1||4
5095406|NCT01654380|12535462|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
5095407|NCT01654380|12535463|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
5095408|NCT01654380|12535464|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
5095409|NCT01654380|12535465|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
5095410|NCT01654380|12535462|P4|STARTED|Part A, Period 1||0
5095411|NCT01654380|12535463|P3|STARTED|Part A, Period 1||0
5095412|NCT01654380|12535464|P2|STARTED|Part A, Period 1||4
5095413|NCT01654380|12535465|P1|STARTED|Part A, Period 1||4
5095414|NCT01654315|12535493|P3|NOT COMPLETED|Overall Study||0
5095415|NCT01654315|12535494|P2|NOT COMPLETED|Overall Study||0
5095416|NCT01654315|12535495|P1|NOT COMPLETED|Overall Study||0
5095417|NCT01654315|12535493|P3|COMPLETED|Overall Study||9
5095418|NCT01654315|12535494|P2|COMPLETED|Overall Study||10
5095419|NCT01654315|12535495|P1|COMPLETED|Overall Study||15
5095420|NCT01654315|12535493|P3|STARTED|Overall Study||9
5095421|NCT01654315|12535494|P2|STARTED|Overall Study||10
5095422|NCT01654315|12535495|P1|STARTED|Overall Study||15
5095423|NCT01654302|12535508|P2|NOT COMPLETED|Second Intervention (Day 7)||1
5095424|NCT01654302|12535509|P1|NOT COMPLETED|Second Intervention (Day 7)||1
5095425|NCT01654302|12535508|P2|COMPLETED|Second Intervention (Day 7)||19
5095426|NCT01654302|12535509|P1|COMPLETED|Second Intervention (Day 7)||19
5095427|NCT01654302|12535508|P2|STARTED|Second Intervention (Day 7)||20
5095428|NCT01654302|12535509|P1|STARTED|Second Intervention (Day 7)||20
5095429|NCT01654302|12535508|P2|NOT COMPLETED|First Intervention (Day 1)||0
5095430|NCT01654302|12535509|P1|NOT COMPLETED|First Intervention (Day 1)||0
5095431|NCT01654302|12535508|P2|COMPLETED|First Intervention (Day 1)||20
5095432|NCT01654302|12535509|P1|COMPLETED|First Intervention (Day 1)||20
5095433|NCT01654302|12535508|P2|STARTED|First Intervention (Day 1)||20
5095434|NCT01654302|12535509|P1|STARTED|First Intervention (Day 1)||20
5095435|NCT01654289|12535518|P3|NOT COMPLETED|Overall Study||5
5095436|NCT01654289|12535519|P2|NOT COMPLETED|Overall Study||28
5095437|NCT01654289|12535520|P1|NOT COMPLETED|Overall Study||27
5095438|NCT01654289|12535518|P3|COMPLETED|Overall Study||133
5095439|NCT01654289|12535519|P2|COMPLETED|Overall Study||109
5095440|NCT01654289|12535520|P1|COMPLETED|Overall Study||111
5095441|NCT01654289|12535518|P3|STARTED|Overall Study||138
5095442|NCT01654289|12535519|P2|STARTED|Overall Study||137
5095443|NCT01654289|12535520|P1|STARTED|Overall Study||138
5095444|NCT01654276|12535558|P1|NOT COMPLETED|Overall Study||6
5095445|NCT01654276|12535558|P1|COMPLETED|Overall Study||18
5095446|NCT01654276|12535558|P1|Visit 4 (6months)|Overall Study||18
5095447|NCT01654276|12535558|P1|Visit 3 (4 Months)|Overall Study||18
5095448|NCT01654276|12535558|P1|Visit 2 (2 Months)|Overall Study||19
5095449|NCT01654276|12535558|P1|STARTED|Overall Study||24
5095450|NCT01654263|12535582|P6|NOT COMPLETED|Overall Study||1
5095451|NCT01654263|12535583|P5|NOT COMPLETED|Overall Study||1
5095452|NCT01654263|12535584|P4|NOT COMPLETED|Overall Study||1
5095453|NCT01654263|12535585|P3|NOT COMPLETED|Overall Study||2
5095454|NCT01654263|12535586|P2|NOT COMPLETED|Overall Study||0
5095455|NCT01654263|12535587|P1|NOT COMPLETED|Overall Study||0
5095456|NCT01654263|12535582|P6|COMPLETED|Overall Study||148
5095457|NCT01654263|12535583|P5|COMPLETED|Overall Study||139
5095458|NCT01654263|12535584|P4|COMPLETED|Overall Study||144
5095459|NCT01654263|12535585|P3|COMPLETED|Overall Study||137
5095460|NCT01654263|12535586|P2|COMPLETED|Overall Study||147
5095461|NCT01654263|12535587|P1|COMPLETED|Overall Study||164
5095462|NCT01654263|12535582|P6|STARTED|Overall Study||149
5095463|NCT01654263|12535583|P5|STARTED|Overall Study||140
5095464|NCT01654263|12535584|P4|STARTED|Overall Study||145
5095465|NCT01654263|12535585|P3|STARTED|Overall Study||139
5095466|NCT01654263|12535586|P2|STARTED|Overall Study||147
5095467|NCT01654263|12535587|P1|STARTED|Overall Study||164
5095468|NCT01654250|12535612|P2|NOT COMPLETED|Overall Study||0
5095469|NCT01654250|12535613|P1|NOT COMPLETED|Overall Study||1
5095470|NCT01654250|12535612|P2|COMPLETED|Overall Study||42
5095471|NCT01654250|12535613|P1|COMPLETED|Overall Study||43
5095472|NCT01654250|12535612|P2|STARTED|Overall Study||42
5095473|NCT01654250|12535613|P1|STARTED|Overall Study||44
5095474|NCT01654224|12535630|P2|NOT COMPLETED|Overall Study||12
5095475|NCT01654224|12535631|P1|NOT COMPLETED|Overall Study||6
5095476|NCT01654224|12535630|P2|COMPLETED|Overall Study||98
5095477|NCT01654224|12535631|P1|COMPLETED|Overall Study||89
5095478|NCT01654224|12535630|P2|STARTED|Overall Study||110
5095479|NCT01654224|12535631|P1|STARTED|Overall Study||95
5095480|NCT01654107|12535643|P2|NOT COMPLETED|Overall Study||8
5095481|NCT01654107|12535644|P1|NOT COMPLETED|Overall Study||3
5095482|NCT01654107|12535643|P2|COMPLETED|Overall Study||22
5095483|NCT01654107|12535644|P1|COMPLETED|Overall Study||25
5095484|NCT01654107|12535643|P2|STARTED|Overall Study||30
5095485|NCT01654107|12535644|P1|STARTED|Overall Study||28
5095486|NCT01654068|12535650|P1|NOT COMPLETED|Overall Study||0
5095487|NCT01654068|12535650|P1|COMPLETED|Overall Study||14
5095488|NCT01654068|12535650|P1|STARTED|Overall Study||14
5095489|NCT01653964|12535656|P1|NOT COMPLETED|Overall Study||0
5095490|NCT01653964|12535656|P1|COMPLETED|Overall Study||82
5095491|NCT01653964|12535656|P1|STARTED|Overall Study||82
5095492|NCT01653912|12535662|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
5095493|NCT01653912|12535663|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
5095494|NCT01653912|12535664|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
5095495|NCT01653912|12535665|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
5095496|NCT01653912|12535666|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
5095497|NCT01653912|12535667|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
5095498|NCT01653912|12535662|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
5095499|NCT01653912|12535663|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
5095500|NCT01653912|12535664|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
5095501|NCT01653912|12535665|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
5095502|NCT01653912|12535666|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
5095503|NCT01653912|12535667|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
5095504|NCT01653912|12535662|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
5095505|NCT01653912|12535663|P5|STARTED|Phase 2: GSK2110183 125 mg||0
5095506|NCT01653912|12535664|P4|STARTED|Phase 2: GSK2110183 125 mg||0
5095507|NCT01653912|12535665|P3|STARTED|Phase 2: GSK2110183 125 mg||0
5095508|NCT01653912|12535666|P2|STARTED|Phase 2: GSK2110183 125 mg||0
5095509|NCT01653912|12535667|P1|STARTED|Phase 2: GSK2110183 125 mg||0
5095510|NCT01653912|12535662|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095511|NCT01653912|12535663|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095512|NCT01653912|12535664|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095513|NCT01653912|12535665|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095514|NCT01653912|12535666|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095683|NCT01653132|12536106|P2|COMPLETED|Second Intervention||5
5095515|NCT01653912|12535667|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095516|NCT01653912|12535662|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095517|NCT01653912|12535663|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
5095518|NCT01653912|12535664|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095519|NCT01653912|12535665|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095520|NCT01653912|12535666|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095521|NCT01653912|12535667|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095522|NCT01653912|12535662|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095523|NCT01653912|12535663|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
5095524|NCT01653912|12535664|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095525|NCT01653912|12535665|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095526|NCT01653912|12535666|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095527|NCT01653912|12535667|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
5095528|NCT01653912|12535662|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095529|NCT01653912|12535663|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095530|NCT01653912|12535664|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
5095531|NCT01653912|12535665|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095532|NCT01653912|12535666|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095533|NCT01653912|12535667|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095534|NCT01653912|12535662|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095535|NCT01653912|12535663|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095536|NCT01653912|12535664|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
5095537|NCT01653912|12535665|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095538|NCT01653912|12535666|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095539|NCT01653912|12535667|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095540|NCT01653912|12535662|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095541|NCT01653912|12535663|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095542|NCT01653912|12535664|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
5095543|NCT01653912|12535665|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095544|NCT01653912|12535666|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095545|NCT01653912|12535667|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
5095546|NCT01653912|12535662|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095547|NCT01653912|12535663|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095548|NCT01653912|12535664|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095549|NCT01653912|12535665|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
5095550|NCT01653912|12535666|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095551|NCT01653912|12535667|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095552|NCT01653912|12535662|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095553|NCT01653912|12535663|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095554|NCT01653912|12535664|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095555|NCT01653912|12535665|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
5095556|NCT01653912|12535666|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095557|NCT01653912|12535667|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095558|NCT01653912|12535662|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095559|NCT01653912|12535663|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095560|NCT01653912|12535664|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095561|NCT01653912|12535665|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
5095562|NCT01653912|12535666|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095563|NCT01653912|12535667|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
5095564|NCT01653912|12535662|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095565|NCT01653912|12535663|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095566|NCT01653912|12535664|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095567|NCT01653912|12535665|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095568|NCT01653912|12535666|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
5095569|NCT01653912|12535667|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095570|NCT01653912|12535662|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095571|NCT01653912|12535663|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095572|NCT01653912|12535664|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095573|NCT01653912|12535665|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095574|NCT01653912|12535666|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
5095575|NCT01653912|12535667|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095576|NCT01653912|12535662|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095577|NCT01653912|12535663|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095578|NCT01653912|12535664|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095579|NCT01653912|12535665|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095580|NCT01653912|12535666|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
5095581|NCT01653912|12535667|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
5095582|NCT01653912|12535662|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095583|NCT01653912|12535663|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095584|NCT01653912|12535664|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095585|NCT01653912|12535665|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095586|NCT01653912|12535666|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095587|NCT01653912|12535667|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095588|NCT01653912|12535662|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095589|NCT01653912|12535663|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095590|NCT01653912|12535664|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095684|NCT01653132|12536107|P1|COMPLETED|Second Intervention||4
5095591|NCT01653912|12535665|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095592|NCT01653912|12535666|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095593|NCT01653912|12535667|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
5095594|NCT01653912|12535662|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095595|NCT01653912|12535663|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095596|NCT01653912|12535664|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095597|NCT01653912|12535665|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095598|NCT01653912|12535666|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
5095599|NCT01653912|12535667|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
5095600|NCT01653782|12535685|P3|NOT COMPLETED|Overall Study||6
5095601|NCT01653782|12535686|P2|NOT COMPLETED|Overall Study||18
5095602|NCT01653782|12535687|P1|NOT COMPLETED|Overall Study||16
5095603|NCT01653782|12535685|P3|COMPLETED|Overall Study||46
5095604|NCT01653782|12535686|P2|COMPLETED|Overall Study||37
5095605|NCT01653782|12535687|P1|COMPLETED|Overall Study||36
5095606|NCT01653782|12535685|P3|STARTED|Overall Study||52
5095607|NCT01653782|12535686|P2|STARTED|Overall Study||55
5095608|NCT01653782|12535687|P1|STARTED|Overall Study||52
5095609|NCT01653743|12535697|P2|NOT COMPLETED|Overall Study||0
5095610|NCT01653743|12535698|P1|NOT COMPLETED|Overall Study||4
5095611|NCT01653743|12535697|P2|COMPLETED|Overall Study||27
5095612|NCT01653743|12535698|P1|COMPLETED|Overall Study||50
5095613|NCT01653743|12535697|P2|STARTED|Overall Study||27
5095614|NCT01653743|12535698|P1|STARTED|Overall Study||54
5095615|NCT01653704|12535714|P2|NOT COMPLETED|Overall Study||1
5095616|NCT01653704|12535715|P1|NOT COMPLETED|Overall Study||2
5095617|NCT01653704|12535714|P2|COMPLETED|Overall Study||20
5095618|NCT01653704|12535715|P1|COMPLETED|Overall Study||19
5095619|NCT01653704|12535714|P2|STARTED|Overall Study||21
5095620|NCT01653704|12535715|P1|STARTED|Overall Study||21
5095621|NCT01653587|12535723|P2|NOT COMPLETED|Overall Study||0
5095622|NCT01653587|12535724|P1|NOT COMPLETED|Overall Study||0
5095623|NCT01653587|12535723|P2|COMPLETED|Overall Study||120
5095624|NCT01653587|12535724|P1|COMPLETED|Overall Study||120
5095625|NCT01653587|12535723|P2|STARTED|Overall Study||120
5095626|NCT01653587|12535724|P1|STARTED|Overall Study||120
5095627|NCT01653509|12535736|P2|NOT COMPLETED|Overall Study||0
5095628|NCT01653509|12535737|P1|NOT COMPLETED|Overall Study||0
5095629|NCT01653509|12535736|P2|COMPLETED|Overall Study||13
5095630|NCT01653509|12535737|P1|COMPLETED|Overall Study||12
5095631|NCT01653509|12535736|P2|STARTED|Overall Study||13
5095632|NCT01653509|12535737|P1|STARTED|Overall Study||12
5095633|NCT01653418|12535755|P1|NOT COMPLETED|Overall Study||0
5095634|NCT01653418|12535755|P1|COMPLETED|Overall Study||10
5095635|NCT01653418|12535755|P1|STARTED|Overall Study||10
5095636|NCT01653405|12535769|P2|NOT COMPLETED|Overall Study||1068803
5095637|NCT01653405|12535770|P1|NOT COMPLETED|Overall Study||3765
5095638|NCT01653405|12535769|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
5095639|NCT01653405|12535770|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
5095640|NCT01653405|12535769|P2|STARTED|Overall Study||1248782
5095641|NCT01653405|12535770|P1|STARTED|Overall Study||11794
5095642|NCT01653327|12535784|P1|NOT COMPLETED|Overall Study||1
5095643|NCT01653327|12535784|P1|COMPLETED|Overall Study||10
5095644|NCT01653327|12535784|P1|STARTED|Overall Study||11
5095645|NCT01653288|12535794|P2|NOT COMPLETED|Overall Study||1
5095646|NCT01653288|12535795|P1|NOT COMPLETED|Overall Study||10
5095647|NCT01653288|12535794|P2|COMPLETED|Overall Study||35
5095648|NCT01653288|12535795|P1|COMPLETED|Overall Study||26
5095649|NCT01653288|12535794|P2|STARTED|Overall Study||36
5095650|NCT01653288|12535795|P1|STARTED|Overall Study||36
5095651|NCT01653262|12535809|P1|NOT COMPLETED|Overall Study||3
5095652|NCT01653262|12535809|P1|COMPLETED|Overall Study||26
5095653|NCT01653262|12535809|P1|STARTED|Overall Study||29
5095654|NCT01653210|12535822|P1|NOT COMPLETED|Overall Study||3
5095655|NCT01653210|12535822|P1|COMPLETED|Overall Study||12
5095656|NCT01653210|12535822|P1|STARTED|Overall Study||15
5095657|NCT01653158|12535827|P8|NOT COMPLETED|Overall Study||15
5095658|NCT01653158|12535828|P7|NOT COMPLETED|Overall Study||2
5095659|NCT01653158|12535829|P6|NOT COMPLETED|Overall Study||1
5095660|NCT01653158|12535830|P5|NOT COMPLETED|Overall Study||1
5095661|NCT01653158|12535831|P4|NOT COMPLETED|Overall Study||2
5095662|NCT01653158|12535832|P3|NOT COMPLETED|Overall Study||0
5095663|NCT01653158|12535833|P2|NOT COMPLETED|Overall Study||0
5095664|NCT01653158|12535834|P1|NOT COMPLETED|Overall Study||1
5095665|NCT01653158|12535827|P8|COMPLETED|Overall Study||4
5095666|NCT01653158|12535828|P7|COMPLETED|Overall Study||7
5095667|NCT01653158|12535829|P6|COMPLETED|Overall Study||2
5095668|NCT01653158|12535830|P5|COMPLETED|Overall Study||2
5095669|NCT01653158|12535831|P4|COMPLETED|Overall Study||1
5095670|NCT01653158|12535832|P3|COMPLETED|Overall Study||3
5095671|NCT01653158|12535833|P2|COMPLETED|Overall Study||3
5095672|NCT01653158|12535834|P1|COMPLETED|Overall Study||2
5095673|NCT01653158|12535827|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
5095674|NCT01653158|12535828|P7|STARTED|Overall Study||9
5095675|NCT01653158|12535829|P6|STARTED|Overall Study||3
5095676|NCT01653158|12535830|P5|STARTED|Overall Study||3
5095677|NCT01653158|12535831|P4|STARTED|Overall Study||3
5095678|NCT01653158|12535832|P3|STARTED|Overall Study||3
5095679|NCT01653158|12535833|P2|STARTED|Overall Study||3
5095680|NCT01653158|12535834|P1|STARTED|Overall Study||3
5095681|NCT01653132|12536106|P2|NOT COMPLETED|Second Intervention||0
5095682|NCT01653132|12536107|P1|NOT COMPLETED|Second Intervention||0
5095685|NCT01653132|12536106|P2|STARTED|Second Intervention||5
5095686|NCT01653132|12536107|P1|STARTED|Second Intervention||4
5095687|NCT01653132|12536106|P2|NOT COMPLETED|Washout 1-2 Months||0
5095688|NCT01653132|12536107|P1|NOT COMPLETED|Washout 1-2 Months||0
5095689|NCT01653132|12536106|P2|COMPLETED|Washout 1-2 Months||5
5095690|NCT01653132|12536107|P1|COMPLETED|Washout 1-2 Months||4
5095691|NCT01653132|12536106|P2|STARTED|Washout 1-2 Months||5
5095692|NCT01653132|12536107|P1|STARTED|Washout 1-2 Months||4
5095693|NCT01653132|12536106|P2|NOT COMPLETED|First Intervention||0
5095694|NCT01653132|12536107|P1|NOT COMPLETED|First Intervention||1
5095695|NCT01653132|12536106|P2|COMPLETED|First Intervention||5
5095696|NCT01653132|12536107|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
5095697|NCT01653132|12536106|P2|STARTED|First Intervention||5
5095698|NCT01653132|12536107|P1|STARTED|First Intervention||5
5095699|NCT01653028|12536126|P5|NOT COMPLETED|Overall Study||0
5095700|NCT01653028|12536127|P4|NOT COMPLETED|Overall Study||0
5095701|NCT01653028|12536128|P3|NOT COMPLETED|Overall Study||0
5095702|NCT01653028|12536129|P2|NOT COMPLETED|Overall Study||0
5095703|NCT01653028|12536130|P1|NOT COMPLETED|Overall Study||0
5095704|NCT01653028|12536126|P5|COMPLETED|Overall Study||29
5095705|NCT01653028|12536127|P4|COMPLETED|Overall Study||10
5095706|NCT01653028|12536128|P3|COMPLETED|Overall Study||11
5095707|NCT01653028|12536129|P2|COMPLETED|Overall Study||10
5095708|NCT01653028|12536130|P1|COMPLETED|Overall Study||12
5095709|NCT01653028|12536126|P5|STARTED|Overall Study||29
5095710|NCT01653028|12536127|P4|STARTED|Overall Study||10
5095711|NCT01653028|12536128|P3|STARTED|Overall Study||11
5095712|NCT01653028|12536129|P2|STARTED|Overall Study||10
5095713|NCT01653028|12536130|P1|STARTED|Overall Study||12
5095714|NCT01652976|12536157|P1|NOT COMPLETED|Overall Study||0
5095715|NCT01652976|12536157|P1|COMPLETED|Overall Study||44
5095716|NCT01652976|12536157|P1|STARTED|Overall Study||44
5095717|NCT01652885|12536171|P1|NOT COMPLETED|Overall Study||1
5095718|NCT01652885|12536171|P1|COMPLETED|Overall Study||22
5095719|NCT01652885|12536171|P1|STARTED|Overall Study||23
5095720|NCT01652872|12536198|P2|NOT COMPLETED|Overall Study||153
5095721|NCT01652872|12536199|P1|NOT COMPLETED|Overall Study||145
5095722|NCT01652872|12536198|P2|COMPLETED|Overall Study||226
5095723|NCT01652872|12536199|P1|COMPLETED|Overall Study||232
5095724|NCT01652872|12536198|P2|Received Investigational Product|Overall Study||377
5095725|NCT01652872|12536199|P1|Received Investigational Product|Overall Study||377
5095726|NCT01652872|12536198|P2|STARTED|Overall Study||379
5095727|NCT01652872|12536199|P1|STARTED|Overall Study||377
5095728|NCT01652729|12536216|P3|NOT COMPLETED|Overall Study||14
5095729|NCT01652729|12536217|P2|NOT COMPLETED|Overall Study||13
5095730|NCT01652729|12536218|P1|NOT COMPLETED|Overall Study||27
5095731|NCT01652729|12536216|P3|COMPLETED|Overall Study||47
5095732|NCT01652729|12536217|P2|COMPLETED|Overall Study||109
5095733|NCT01652729|12536218|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
5095734|NCT01652729|12536216|P3|Meal Test Evaluable|Overall Study||15
5095735|NCT01652729|12536217|P2|Meal Test Evaluable|Overall Study||31
5095736|NCT01652729|12536218|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
5095737|NCT01652729|12536216|P3|Meal Test Subjects|Overall Study||20
5095738|NCT01652729|12536217|P2|Meal Test Subjects|Overall Study||41
5095739|NCT01652729|12536218|P1|Meal Test Subjects|Overall Study||60
5095740|NCT01652729|12536216|P3|Evaluable|Overall Study||43
5095741|NCT01652729|12536217|P2|Evaluable|Overall Study||91
5095742|NCT01652729|12536218|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
5095743|NCT01652729|12536216|P3|Treated|Overall Study||61
5095744|NCT01652729|12536217|P2|Treated|Overall Study||122
5095745|NCT01652729|12536218|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
5095746|NCT01652729|12536216|P3|Modified Intent-to-Treat|Overall Study||61
5095747|NCT01652729|12536217|P2|Modified Intent-to-Treat|Overall Study||122
5095748|NCT01652729|12536218|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
5095749|NCT01652729|12536216|P3|STARTED|Overall Study||61
5095750|NCT01652729|12536217|P2|STARTED|Overall Study||122
5095751|NCT01652729|12536218|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
5095752|NCT01652716|12536240|P2|NOT COMPLETED|Overall Study||46
5095753|NCT01652716|12536241|P1|NOT COMPLETED|Overall Study||56
5095754|NCT01652716|12536240|P2|COMPLETED|Overall Study|* completed study|102
5095755|NCT01652716|12536241|P1|COMPLETED|Overall Study|* completed study|173
5095756|NCT01652716|12536240|P2|Completed 28-week|Overall Study||118
5095757|NCT01652716|12536241|P1|Completed 28-week|Overall Study||197
5095758|NCT01652716|12536240|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
5095759|NCT01652716|12536241|P1|STARTED|Overall Study||229
5095760|NCT01652703|12536261|P6|NOT COMPLETED|Overall Study||2
5095761|NCT01652703|12536262|P5|NOT COMPLETED|Overall Study||1
5095762|NCT01652703|12536263|P4|NOT COMPLETED|Overall Study||2
5095763|NCT01652703|12536264|P3|NOT COMPLETED|Overall Study||3
5095764|NCT01652703|12536265|P2|NOT COMPLETED|Overall Study||1
5095765|NCT01652703|12536266|P1|NOT COMPLETED|Overall Study||0
5095766|NCT01652703|12536261|P6|COMPLETED|Overall Study||51
5095767|NCT01652703|12536262|P5|COMPLETED|Overall Study||51
5095768|NCT01652703|12536263|P4|COMPLETED|Overall Study||50
5095769|NCT01652703|12536264|P3|COMPLETED|Overall Study||47
5095770|NCT01652703|12536265|P2|COMPLETED|Overall Study||50
5095771|NCT01652703|12536266|P1|COMPLETED|Overall Study||52
5095772|NCT01652703|12536261|P6|Received Treatment|Overall Study||53
5095773|NCT01652703|12536262|P5|Received Treatment|Overall Study||51
5095774|NCT01652703|12536263|P4|Received Treatment|Overall Study||52
5095775|NCT01652703|12536264|P3|Received Treatment|Overall Study||49
5095776|NCT01652703|12536265|P2|Received Treatment|Overall Study||50
5095777|NCT01652703|12536266|P1|Received Treatment|Overall Study||52
5095778|NCT01652703|12536261|P6|STARTED|Overall Study||53
5095779|NCT01652703|12536262|P5|STARTED|Overall Study||52
5095780|NCT01652703|12536263|P4|STARTED|Overall Study||52
5095781|NCT01652703|12536264|P3|STARTED|Overall Study||50
5095782|NCT01652703|12536265|P2|STARTED|Overall Study||51
5095783|NCT01652703|12536266|P1|STARTED|Overall Study||52
5095784|NCT01652690|12536324|P2|NOT COMPLETED|Overall Study||21
5095785|NCT01652690|12536325|P1|NOT COMPLETED|Overall Study||35
5095786|NCT01652690|12536324|P2|COMPLETED|Overall Study||279
5095787|NCT01652690|12536325|P1|COMPLETED|Overall Study||265
5095788|NCT01652690|12536324|P2|STARTED|Overall Study||300
5095789|NCT01652690|12536325|P1|STARTED|Overall Study||300
5095790|NCT01652664|12536359|P2|NOT COMPLETED|Overall Study||1
5095791|NCT01652664|12536360|P1|NOT COMPLETED|Overall Study||6
5095792|NCT01652664|12536359|P2|COMPLETED|Overall Study||74
5095793|NCT01652664|12536360|P1|COMPLETED|Overall Study||71
5095794|NCT01652664|12536359|P2|STARTED|Overall Study||75
5095795|NCT01652664|12536360|P1|STARTED|Overall Study||77
5095796|NCT01652573|12536369|P2|NOT COMPLETED|Overall Study||1
5095797|NCT01652573|12536370|P1|NOT COMPLETED|Overall Study||0
5095798|NCT01652573|12536369|P2|COMPLETED|Overall Study||10
5095799|NCT01652573|12536370|P1|COMPLETED|Overall Study||10
5095800|NCT01652573|12536369|P2|STARTED|Overall Study||11
5095801|NCT01652573|12536370|P1|STARTED|Overall Study||10
5095802|NCT01652534|12536412|P2|NOT COMPLETED|Overall Study||0
5095803|NCT01652534|12536413|P1|NOT COMPLETED|Overall Study||1
5095804|NCT01652534|12536412|P2|COMPLETED|Overall Study||1
5095805|NCT01652534|12536413|P1|COMPLETED|Overall Study||1
5095806|NCT01652534|12536412|P2|STARTED|Overall Study||1
5095807|NCT01652534|12536413|P1|STARTED|Overall Study||2
5095808|NCT01652495|12536441|P2|NOT COMPLETED|Overall Study||2
5095809|NCT01652495|12536442|P1|NOT COMPLETED|Overall Study||2
5095810|NCT01652495|12536441|P2|COMPLETED|Overall Study||20
5095811|NCT01652495|12536442|P1|COMPLETED|Overall Study||20
5095812|NCT01652495|12536441|P2|STARTED|Overall Study||22
5095813|NCT01652495|12536442|P1|STARTED|Overall Study||22
5095814|NCT01652469|12536454|P2|NOT COMPLETED|Overall Study||6
5095815|NCT01652469|12536455|P1|NOT COMPLETED|Overall Study||1
5095816|NCT01652469|12536454|P2|COMPLETED|Overall Study||36
5095817|NCT01652469|12536455|P1|COMPLETED|Overall Study||37
5095818|NCT01652469|12536454|P2|STARTED|Overall Study||42
5095819|NCT01652469|12536455|P1|STARTED|Overall Study||38
5095820|NCT01652287|12536471|P2|NOT COMPLETED|Overall Study||0
5095821|NCT01652287|12536472|P1|NOT COMPLETED|Overall Study||2
5095822|NCT01652287|12536471|P2|COMPLETED|Overall Study||31
5095823|NCT01652287|12536472|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
5095824|NCT01652287|12536471|P2|STARTED|Overall Study||31
5095825|NCT01652287|12536472|P1|STARTED|Overall Study||31
5095826|NCT01652040|12536480|P2|NOT COMPLETED|Overall Study||2
5095827|NCT01652040|12536481|P1|NOT COMPLETED|Overall Study||2
5095828|NCT01652040|12536480|P2|COMPLETED|Overall Study||11
5095829|NCT01652040|12536481|P1|COMPLETED|Overall Study||11
5095830|NCT01652040|12536480|P2|STARTED|Overall Study||13
5095831|NCT01652040|12536481|P1|STARTED|Overall Study||13
5095832|NCT01652001|12536491|P2|NOT COMPLETED|Overall Study||6
5095833|NCT01652001|12536492|P1|NOT COMPLETED|Overall Study||9
5095834|NCT01652001|12536491|P2|COMPLETED|Overall Study||79
5095835|NCT01652001|12536492|P1|COMPLETED|Overall Study||91
5095836|NCT01652001|12536491|P2|STARTED|Overall Study||85
5095837|NCT01652001|12536492|P1|STARTED|Overall Study||100
5095838|NCT01651949|12536503|P3|NOT COMPLETED|Overall Study||31
5095839|NCT01651949|12536504|P2|NOT COMPLETED|Overall Study||86
5095840|NCT01651949|12536505|P1|NOT COMPLETED|Overall Study||53
5095841|NCT01651949|12536503|P3|COMPLETED|Overall Study||282
5095842|NCT01651949|12536504|P2|COMPLETED|Overall Study||1015
5095843|NCT01651949|12536505|P1|COMPLETED|Overall Study||1053
5095844|NCT01651949|12536503|P3|Vaccination 3|Overall Study||291
5095845|NCT01651949|12536504|P2|Vaccination 3|Overall Study||1037
5095846|NCT01651949|12536505|P1|Vaccination 3|Overall Study||1067
5095847|NCT01651949|12536503|P3|Vaccination 2|Overall Study||298
5095848|NCT01651949|12536504|P2|Vaccination 2|Overall Study||1069
5095849|NCT01651949|12536505|P1|Vaccination 2|Overall Study||1089
5095850|NCT01651949|12536503|P3|Vaccination 1|Overall Study||313
5095851|NCT01651949|12536504|P2|Vaccination 1|Overall Study||1099
5095852|NCT01651949|12536505|P1|Vaccination 1|Overall Study||1103
5095853|NCT01651949|12536503|P3|STARTED|Overall Study||313
5095854|NCT01651949|12536504|P2|STARTED|Overall Study||1101
5095855|NCT01651949|12536505|P1|STARTED|Overall Study||1106
5095856|NCT01651936|12536525|P3|NOT COMPLETED|Extension Study||14
5095857|NCT01651936|12536526|P2|NOT COMPLETED|Extension Study||0
5095858|NCT01651936|12536527|P1|NOT COMPLETED|Extension Study||0
5095859|NCT01651936|12536525|P3|COMPLETED|Extension Study||0
5095860|NCT01651936|12536526|P2|COMPLETED|Extension Study||0
5095861|NCT01651936|12536527|P1|COMPLETED|Extension Study||0
5095862|NCT01651936|12536525|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
5095863|NCT01651936|12536526|P2|STARTED|Extension Study||0
5095864|NCT01651936|12536527|P1|STARTED|Extension Study||0
5095865|NCT01651936|12536525|P3|NOT COMPLETED|Base Study||0
5095866|NCT01651936|12536526|P2|NOT COMPLETED|Base Study||25
5095867|NCT01651936|12536527|P1|NOT COMPLETED|Base Study||27
5095868|NCT01651936|12536525|P3|COMPLETED|Base Study||0
5095869|NCT01651936|12536526|P2|COMPLETED|Base Study||1
5095870|NCT01651936|12536527|P1|COMPLETED|Base Study||3
5095871|NCT01651936|12536525|P3|STARTED|Base Study||0
5095872|NCT01651936|12536526|P2|STARTED|Base Study||26
5095873|NCT01651936|12536527|P1|STARTED|Base Study||30
5095874|NCT01651806|12536553|P5|NOT COMPLETED|Overall Study||0
5095875|NCT01651806|12536554|P4|NOT COMPLETED|Overall Study||0
5095876|NCT01651806|12536555|P3|NOT COMPLETED|Overall Study||0
5095877|NCT01651806|12536556|P2|NOT COMPLETED|Overall Study||0
5095878|NCT01651806|12536557|P1|NOT COMPLETED|Overall Study||0
5095879|NCT01651806|12536553|P5|COMPLETED|Overall Study||8
5095880|NCT01651806|12536554|P4|COMPLETED|Overall Study||7
5095881|NCT01651806|12536555|P3|COMPLETED|Overall Study||25
5095882|NCT01651806|12536556|P2|COMPLETED|Overall Study||12
5095883|NCT01651806|12536557|P1|COMPLETED|Overall Study||13
5095884|NCT01651806|12536553|P5|STARTED|Overall Study||8
5095885|NCT01651806|12536554|P4|STARTED|Overall Study||7
5095886|NCT01651806|12536555|P3|STARTED|Overall Study||25
5095887|NCT01651806|12536556|P2|STARTED|Overall Study||12
5095888|NCT01651806|12536557|P1|STARTED|Overall Study||13
5095889|NCT01651793|12536574|P4|NOT COMPLETED|Overall Study||1
5095890|NCT01651793|12536575|P3|NOT COMPLETED|Overall Study||0
5095891|NCT01651793|12536576|P2|NOT COMPLETED|Overall Study||0
5095892|NCT01651793|12536577|P1|NOT COMPLETED|Overall Study||0
5095893|NCT01651793|12536574|P4|COMPLETED|Overall Study||5
5095894|NCT01651793|12536575|P3|COMPLETED|Overall Study||6
5095895|NCT01651793|12536576|P2|COMPLETED|Overall Study||6
5095896|NCT01651793|12536577|P1|COMPLETED|Overall Study||6
5095897|NCT01651793|12536574|P4|STARTED|Overall Study||6
5095898|NCT01651793|12536575|P3|STARTED|Overall Study||6
5095899|NCT01651793|12536576|P2|STARTED|Overall Study||6
5095900|NCT01651793|12536577|P1|STARTED|Overall Study||6
5095901|NCT01651780|12536597|P2|NOT COMPLETED|Overall Study||10
5095902|NCT01651780|12536598|P1|NOT COMPLETED|Overall Study||11
5095903|NCT01651780|12536597|P2|COMPLETED|Overall Study||388
5095904|NCT01651780|12536598|P1|COMPLETED|Overall Study||394
5095905|NCT01651780|12536597|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
5095906|NCT01651780|12536598|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
5095907|NCT01651780|12536597|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
5095908|NCT01651780|12536598|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
5095909|NCT01651780|12536597|P2|Intent-To-Treat (ITT) Population|Overall Study||398
5095910|NCT01651780|12536598|P1|Intent-To-Treat (ITT) Population|Overall Study||404
5095911|NCT01651780|12536597|P2|STARTED|Overall Study||398
5095912|NCT01651780|12536598|P1|STARTED|Overall Study||405
5095913|NCT01651442|12536630|P6|NOT COMPLETED|Phase II Treatment||10
5095914|NCT01651442|12536631|P5|NOT COMPLETED|Phase II Treatment||6
5095915|NCT01651442|12536632|P4|NOT COMPLETED|Phase II Treatment||12
5095916|NCT01651442|12536633|P3|NOT COMPLETED|Phase II Treatment||2
5095917|NCT01651442|12536634|P2|NOT COMPLETED|Phase II Treatment||0
5095918|NCT01651442|12536635|P1|NOT COMPLETED|Phase II Treatment||0
5095919|NCT01651442|12536630|P6|COMPLETED|Phase II Treatment||17
5095920|NCT01651442|12536631|P5|COMPLETED|Phase II Treatment||21
5095921|NCT01651442|12536632|P4|COMPLETED|Phase II Treatment||15
5095922|NCT01651442|12536633|P3|COMPLETED|Phase II Treatment||25
5095923|NCT01651442|12536634|P2|COMPLETED|Phase II Treatment||0
5095924|NCT01651442|12536635|P1|COMPLETED|Phase II Treatment||0
5095925|NCT01651442|12536630|P6|STARTED|Phase II Treatment||27
5095926|NCT01651442|12536631|P5|STARTED|Phase II Treatment||27
5095927|NCT01651442|12536632|P4|STARTED|Phase II Treatment||27
5095928|NCT01651442|12536633|P3|STARTED|Phase II Treatment||27
5095929|NCT01651442|12536634|P2|STARTED|Phase II Treatment||0
5095930|NCT01651442|12536635|P1|STARTED|Phase II Treatment||0
5095931|NCT01651442|12536630|P6|NOT COMPLETED|Phase I Treatment||0
5095932|NCT01651442|12536631|P5|NOT COMPLETED|Phase I Treatment||0
5095933|NCT01651442|12536632|P4|NOT COMPLETED|Phase I Treatment||0
5095934|NCT01651442|12536633|P3|NOT COMPLETED|Phase I Treatment||0
5095935|NCT01651442|12536634|P2|NOT COMPLETED|Phase I Treatment||27
5095936|NCT01651442|12536635|P1|NOT COMPLETED|Phase I Treatment||16
5095937|NCT01651442|12536630|P6|COMPLETED|Phase I Treatment||0
5095938|NCT01651442|12536631|P5|COMPLETED|Phase I Treatment||0
5095939|NCT01651442|12536632|P4|COMPLETED|Phase I Treatment||0
5095940|NCT01651442|12536633|P3|COMPLETED|Phase I Treatment||0
5095941|NCT01651442|12536634|P2|COMPLETED|Phase I Treatment||80
5095942|NCT01651442|12536635|P1|COMPLETED|Phase I Treatment||88
5095943|NCT01651442|12536630|P6|STARTED|Phase I Treatment||0
5095944|NCT01651442|12536631|P5|STARTED|Phase I Treatment||0
5095945|NCT01651442|12536632|P4|STARTED|Phase I Treatment||0
5095946|NCT01651442|12536633|P3|STARTED|Phase I Treatment||0
5095947|NCT01651442|12536634|P2|STARTED|Phase I Treatment||107
5095948|NCT01651442|12536635|P1|STARTED|Phase I Treatment||104
5095949|NCT01651403|12536649|P2|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||16
5095950|NCT01651403|12536650|P1|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||27
5095951|NCT01651403|12536649|P2|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||9
5095952|NCT01651403|12536650|P1|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||29
5095953|NCT01651403|12536649|P2|STARTED|Open-Label Phase (Weeks 49/73-120/144)|1 participant completed the Double-Blind Period but did not enter the Open-Label Phase.|25
5095954|NCT01651403|12536650|P1|STARTED|Open-Label Phase (Weeks 49/73-120/144)||56
5095955|NCT01651403|12536649|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
5095956|NCT01651403|12536650|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
5095957|NCT01651403|12536649|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
5095958|NCT01651403|12536650|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
5095959|NCT01651403|12536649|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
5095960|NCT01651403|12536650|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
5095961|NCT01651351|12536682|P2|NOT COMPLETED|Overall Study||0
5095962|NCT01651351|12536683|P1|NOT COMPLETED|Overall Study||0
5095963|NCT01651351|12536682|P2|COMPLETED|Overall Study||15
5095964|NCT01651351|12536683|P1|COMPLETED|Overall Study||15
5095965|NCT01651351|12536682|P2|STARTED|Overall Study||15
5095966|NCT01651351|12536683|P1|STARTED|Overall Study||15
5095967|NCT01651260|12536700|P1|NOT COMPLETED|Overall Study||3
5095968|NCT01651260|12536700|P1|COMPLETED|Overall Study||62
5095969|NCT01651260|12536700|P1|STARTED|Overall Study||65
5095970|NCT01651208|12536707|P2|NOT COMPLETED|Overall Study||16
5095971|NCT01651208|12536708|P1|NOT COMPLETED|Overall Study||14
5095972|NCT01651208|12536707|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
5095973|NCT01651208|12536708|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
5095974|NCT01651208|12536707|P2|STARTED|Overall Study||225
5095975|NCT01651208|12536708|P1|STARTED|Overall Study||227
5095976|NCT01651117|12536720|P4|NOT COMPLETED|Overall Study||2
5095977|NCT01651117|12536721|P3|NOT COMPLETED|Overall Study||2
5095978|NCT01651117|12536722|P2|NOT COMPLETED|Overall Study||3
5095979|NCT01651117|12536723|P1|NOT COMPLETED|Overall Study||2
5095980|NCT01651117|12536720|P4|COMPLETED|Overall Study||68
5095981|NCT01651117|12536721|P3|COMPLETED|Overall Study||47
5095982|NCT01651117|12536722|P2|COMPLETED|Overall Study||202
5095983|NCT01651117|12536723|P1|COMPLETED|Overall Study||154
5095984|NCT01651117|12536720|P4|STARTED|Overall Study||70
5095985|NCT01651117|12536721|P3|STARTED|Overall Study||49
5095986|NCT01651117|12536722|P2|STARTED|Overall Study||205
5095987|NCT01651117|12536723|P1|STARTED|Overall Study||156
5095988|NCT01651104|12536789|P1|NOT COMPLETED|Overall Study||0
5095989|NCT01651104|12536789|P1|COMPLETED|Overall Study||63
5095990|NCT01651104|12536789|P1|STARTED|Overall Study||63
5095991|NCT01651078|12536796|P1|NOT COMPLETED|Overall Study||26
5095992|NCT01651078|12536796|P1|COMPLETED|Overall Study||16
5095993|NCT01651078|12536796|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
5095994|NCT01651052|12536803|P1|NOT COMPLETED|Overall Study||26
5095995|NCT01651052|12536803|P1|COMPLETED|Overall Study||107
5095996|NCT01651052|12536803|P1|Study Valve Group|Overall Study||133
5095997|NCT01651052|12536803|P1|STARTED|Overall Study||133
5095998|NCT01651039|12536823|P1|NOT COMPLETED|Overall Study||30
5095999|NCT01651039|12536823|P1|COMPLETED|Overall Study||2
5096000|NCT01651039|12536823|P1|STARTED|Overall Study||32
5096001|NCT01651000|12536836|P2|NOT COMPLETED|Overall Study||28
5096002|NCT01651000|12536837|P1|NOT COMPLETED|Overall Study||10
5096003|NCT01651000|12536836|P2|COMPLETED|Overall Study||113
5096004|NCT01651000|12536837|P1|COMPLETED|Overall Study||62
5096005|NCT01651000|12536836|P2|Entered Extension Study|Overall Study||93
5096006|NCT01651000|12536837|P1|Entered Extension Study|Overall Study||50
5096007|NCT01651000|12536836|P2|STARTED|Overall Study||141
5096008|NCT01651000|12536837|P1|STARTED|Overall Study||72
5096009|NCT01650844|12536851|P2|NOT COMPLETED|Overall Study||4
5096010|NCT01650844|12536852|P1|NOT COMPLETED|Overall Study||1
5096011|NCT01650844|12536851|P2|COMPLETED|Overall Study||196
5096012|NCT01650844|12536852|P1|COMPLETED|Overall Study||199
5096013|NCT01650844|12536851|P2|STARTED|Overall Study||200
5096014|NCT01650844|12536852|P1|STARTED|Overall Study||200
5096015|NCT01650831|12536858|P1|NOT COMPLETED|Overall Study||1
5096016|NCT01650831|12536858|P1|COMPLETED|Overall Study||112
5096017|NCT01650831|12536858|P1|STARTED|Overall Study||113
5096018|NCT01650805|12536868|P2|NOT COMPLETED|Overall Study||0
5096019|NCT01650805|12536869|P1|NOT COMPLETED|Overall Study||1
5096020|NCT01650805|12536868|P2|COMPLETED|Overall Study||152
5096021|NCT01650805|12536869|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
5096022|NCT01650805|12536868|P2|STARTED|Overall Study||152
5096023|NCT01650805|12536869|P1|STARTED|Overall Study|Started means patient has been randomized.|155
5096024|NCT01650779|12536879|P1|NOT COMPLETED|Overall Study||1
5096025|NCT01650779|12536879|P1|COMPLETED|Overall Study||14
5096026|NCT01650779|12536879|P1|STARTED|Overall Study||15
5096027|NCT01650636|12536888|P2|NOT COMPLETED|9 Month Visit||0
5096028|NCT01650636|12536889|P1|NOT COMPLETED|9 Month Visit||0
5096029|NCT01650636|12536888|P2|COMPLETED|9 Month Visit||129
5096030|NCT01650636|12536889|P1|COMPLETED|9 Month Visit||135
5096031|NCT01650636|12536888|P2|STARTED|9 Month Visit||129
5096032|NCT01650636|12536889|P1|STARTED|9 Month Visit||135
5096033|NCT01650636|12536888|P2|NOT COMPLETED|Washout up to 9 Months||3
5096034|NCT01650636|12536889|P1|NOT COMPLETED|Washout up to 9 Months||6
5096035|NCT01650636|12536888|P2|COMPLETED|Washout up to 9 Months||129
5096036|NCT01650636|12536889|P1|COMPLETED|Washout up to 9 Months||135
5096037|NCT01650636|12536888|P2|STARTED|Washout up to 9 Months||132
5096038|NCT01650636|12536889|P1|STARTED|Washout up to 9 Months||141
5096039|NCT01650636|12536888|P2|NOT COMPLETED|5 Month Visit||0
5096040|NCT01650636|12536889|P1|NOT COMPLETED|5 Month Visit||0
5096041|NCT01650636|12536888|P2|COMPLETED|5 Month Visit||132
5096042|NCT01650636|12536889|P1|COMPLETED|5 Month Visit||141
5096043|NCT01650636|12536888|P2|STARTED|5 Month Visit||132
5096044|NCT01650636|12536889|P1|STARTED|5 Month Visit||141
5096045|NCT01650636|12536888|P2|NOT COMPLETED|Washout up to 5 Months||18
5096046|NCT01650636|12536889|P1|NOT COMPLETED|Washout up to 5 Months||9
5096047|NCT01650636|12536888|P2|COMPLETED|Washout up to 5 Months||132
5096048|NCT01650636|12536889|P1|COMPLETED|Washout up to 5 Months||141
5096049|NCT01650636|12536888|P2|STARTED|Washout up to 5 Months||150
5096050|NCT01650636|12536889|P1|STARTED|Washout up to 5 Months||150
5096051|NCT01650636|12536888|P2|NOT COMPLETED|Intervention Phase||0
5096052|NCT01650636|12536889|P1|NOT COMPLETED|Intervention Phase||0
5096053|NCT01650636|12536888|P2|COMPLETED|Intervention Phase||150
5096054|NCT01650636|12536889|P1|COMPLETED|Intervention Phase||150
5096055|NCT01650636|12536888|P2|STARTED|Intervention Phase||150
5096056|NCT01650636|12536889|P1|STARTED|Intervention Phase||150
5096057|NCT01650545|12536909|P2|NOT COMPLETED|Overall Study||0
5096058|NCT01650545|12536910|P1|NOT COMPLETED|Overall Study||0
5096059|NCT01650545|12536909|P2|COMPLETED|Overall Study||10
5096060|NCT01650545|12536910|P1|COMPLETED|Overall Study||11
5096061|NCT01650545|12536909|P2|STARTED|Overall Study||10
5096062|NCT01650545|12536910|P1|STARTED|Overall Study||11
5096063|NCT01650519|12536922|P2|NOT COMPLETED|Overall Study||0
5096064|NCT01650519|12536923|P1|NOT COMPLETED|Overall Study||1
5096065|NCT01650519|12536922|P2|COMPLETED|Overall Study||31
5096066|NCT01650519|12536923|P1|COMPLETED|Overall Study||19
5096067|NCT01650519|12536922|P2|STARTED|Overall Study||31
5096068|NCT01650519|12536923|P1|STARTED|Overall Study||20
5096069|NCT01650350|12536941|P1|NOT COMPLETED|Overall Study||0
5096070|NCT01650350|12536941|P1|COMPLETED|Overall Study||7
5096071|NCT01650350|12536941|P1|STARTED|Overall Study||7
5096072|NCT01650324|12536952|P5|NOT COMPLETED|Overall Study||0
5096073|NCT01650324|12536953|P4|NOT COMPLETED|Overall Study||0
5096074|NCT01650324|12536954|P3|NOT COMPLETED|Overall Study||0
5096075|NCT01650324|12536955|P2|NOT COMPLETED|Overall Study||0
5096076|NCT01650324|12536956|P1|NOT COMPLETED|Overall Study||0
5096077|NCT01650324|12536952|P5|COMPLETED|Overall Study||6
5096078|NCT01650324|12536953|P4|COMPLETED|Overall Study||6
5096079|NCT01650324|12536954|P3|COMPLETED|Overall Study||6
5096080|NCT01650324|12536955|P2|COMPLETED|Overall Study||6
5096081|NCT01650324|12536956|P1|COMPLETED|Overall Study||8
5096082|NCT01650324|12536952|P5|STARTED|Overall Study||6
5096083|NCT01650324|12536953|P4|STARTED|Overall Study||6
5096084|NCT01650324|12536954|P3|STARTED|Overall Study||6
5096085|NCT01650324|12536955|P2|STARTED|Overall Study||6
5096086|NCT01650324|12536956|P1|STARTED|Overall Study||8
5096087|NCT01650285|12536985|P1|NOT COMPLETED|Overall Study||1
5096088|NCT01650285|12536985|P1|COMPLETED|Overall Study||4
5096089|NCT01650285|12536985|P1|STARTED|Overall Study||5
5096090|NCT01650259|12536992|P2|NOT COMPLETED|Overall Study||235
5096091|NCT01650259|12536993|P1|NOT COMPLETED|Overall Study||1043
5096092|NCT01650259|12536992|P2|COMPLETED|Overall Study||2128
5096093|NCT01650259|12536993|P1|COMPLETED|Overall Study||1470
5096094|NCT01650259|12536992|P2|STARTED|Overall Study|Started are the registered patients|2363
5096095|NCT01650259|12536993|P1|STARTED|Overall Study|Started are the registered patients|2513
5096096|NCT01650246|12536998|P1|NOT COMPLETED|Overall Study||143
5096097|NCT01650246|12536998|P1|COMPLETED|Overall Study||0
5096098|NCT01650246|12536998|P1|STARTED|Overall Study||143
5096099|NCT01650194|12537003|P1|NOT COMPLETED|Overall Study||47
5096100|NCT01650194|12537003|P1|COMPLETED|Overall Study||13
5096101|NCT01650194|12537003|P1|Treated|Overall Study||60
5096102|NCT01650194|12537003|P1|STARTED|Overall Study||60
5096103|NCT01649947|12537028|P2|NOT COMPLETED|Overall Study||18
5096104|NCT01649947|12537029|P1|NOT COMPLETED|Overall Study||12
5096105|NCT01649947|12537028|P2|COMPLETED|Overall Study||2
5096106|NCT01649947|12537029|P1|COMPLETED|Overall Study||0
5096107|NCT01649947|12537028|P2|STARTED|Overall Study||20
5096108|NCT01649947|12537029|P1|STARTED|Overall Study||12
5096109|NCT01649856|12537039|P2|NOT COMPLETED|Overall Study||78
5096110|NCT01649856|12537040|P1|NOT COMPLETED|Overall Study||139
5096111|NCT01649856|12537039|P2|COMPLETED|Overall Study||125
5096112|NCT01649856|12537040|P1|COMPLETED|Overall Study||230
5096113|NCT01649856|12537039|P2|STARTED|Overall Study||203
5096114|NCT01649856|12537040|P1|STARTED|Overall Study||369
5096115|NCT01649804|12537072|P1|NOT COMPLETED|Overall Study||8
5096116|NCT01649804|12537072|P1|COMPLETED|Overall Study||4
5096117|NCT01649804|12537072|P1|STARTED|Overall Study||12
5096118|NCT01649791|12537084|P1|NOT COMPLETED|Overall Study||3
5096119|NCT01649791|12537084|P1|COMPLETED|Overall Study||5
5096120|NCT01649791|12537084|P1|STARTED|Overall Study||8
5096121|NCT01649765|12537093|P2|NOT COMPLETED|Overall Study||8
5096122|NCT01649765|12537094|P1|NOT COMPLETED|Overall Study||9
5096123|NCT01649765|12537093|P2|COMPLETED|Overall Study||45
5096124|NCT01649765|12537094|P1|COMPLETED|Overall Study||31
5096125|NCT01649765|12537093|P2|STARTED|Overall Study||53
5096126|NCT01649765|12537094|P1|STARTED|Overall Study||40
5096127|NCT01649609|12537122|P2|NOT COMPLETED|Overall Study||0
5096128|NCT01649609|12537123|P1|NOT COMPLETED|Overall Study||0
5096129|NCT01649609|12537122|P2|COMPLETED|Overall Study||20
5096130|NCT01649609|12537123|P1|COMPLETED|Overall Study||20
5096131|NCT01649609|12537122|P2|STARTED|Overall Study||20
5096132|NCT01649609|12537123|P1|STARTED|Overall Study||20
5096133|NCT01649596|12537133|P2|NOT COMPLETED|Overall Study||0
5096134|NCT01649596|12537134|P1|NOT COMPLETED|Overall Study||0
5096135|NCT01649596|12537133|P2|COMPLETED|Overall Study||48
5096136|NCT01649596|12537134|P1|COMPLETED|Overall Study||46
5096137|NCT01649596|12537133|P2|STARTED|Overall Study||48
5096138|NCT01649596|12537134|P1|STARTED|Overall Study||46
5096139|NCT01649557|12537145|P3|NOT COMPLETED|Overall Study||9
5096140|NCT01649557|12537146|P2|NOT COMPLETED|Overall Study||14
5096141|NCT01649557|12537147|P1|NOT COMPLETED|Overall Study||44
5096142|NCT01649557|12537145|P3|COMPLETED|Overall Study||15
5096143|NCT01649557|12537146|P2|COMPLETED|Overall Study||27
5096144|NCT01649557|12537147|P1|COMPLETED|Overall Study||135
5096145|NCT01649557|12537145|P3|52-week Enrollers|Overall Study||2
5096146|NCT01649557|12537146|P2|52-week Enrollers|Overall Study||6
5096147|NCT01649557|12537147|P1|52-week Enrollers|Overall Study||20
5096148|NCT01649557|12537145|P3|6-week Enrollers|Overall Study||22
5096149|NCT01649557|12537146|P2|6-week Enrollers|Overall Study||35
5096150|NCT01649557|12537147|P1|6-week Enrollers|Overall Study||159
5096151|NCT01649557|12537145|P3|STARTED|Overall Study||24
5096152|NCT01649557|12537146|P2|STARTED|Overall Study||41
5096153|NCT01649557|12537147|P1|STARTED|Overall Study||179
5096154|NCT01649505|12537184|P2|NOT COMPLETED|Overall Study||1
5096155|NCT01649505|12537185|P1|NOT COMPLETED|Overall Study||1
5096156|NCT01649505|12537184|P2|COMPLETED|Overall Study||0
5096157|NCT01649505|12537185|P1|COMPLETED|Overall Study||0
5096158|NCT01649505|12537184|P2|STARTED|Overall Study||1
5096159|NCT01649505|12537185|P1|STARTED|Overall Study||1
5096160|NCT01649427|12537193|P2|NOT COMPLETED|Overall Study||12
5096161|NCT01649427|12537194|P1|NOT COMPLETED|Overall Study||11
5096162|NCT01649427|12537193|P2|COMPLETED|Overall Study||26
5096163|NCT01649427|12537194|P1|COMPLETED|Overall Study||24
5096164|NCT01649427|12537193|P2|STARTED|Overall Study||38
5096165|NCT01649427|12537194|P1|STARTED|Overall Study||35
5096166|NCT01649375|12537213|P5|NOT COMPLETED|Week 16 up to Week 260||5
5096167|NCT01649375|12537214|P4|NOT COMPLETED|Week 16 up to Week 260||12
5096168|NCT01649375|12537215|P3|NOT COMPLETED|Week 16 up to Week 260||0
5096169|NCT01649375|12537216|P2|NOT COMPLETED|Week 16 up to Week 260||13
5096170|NCT01649375|12537217|P1|NOT COMPLETED|Week 16 up to Week 260||20
5096171|NCT01649375|12537213|P5|COMPLETED|Week 16 up to Week 260||29
5096172|NCT01649375|12537214|P4|COMPLETED|Week 16 up to Week 260||20
5096173|NCT01649375|12537215|P3|COMPLETED|Week 16 up to Week 260||0
5096174|NCT01649375|12537216|P2|COMPLETED|Week 16 up to Week 260||53
5096175|NCT01649375|12537217|P1|COMPLETED|Week 16 up to Week 260||48
5096176|NCT01649375|12537213|P5|STARTED|Week 16 up to Week 260||34
5096177|NCT01649375|12537214|P4|STARTED|Week 16 up to Week 260||32
5096178|NCT01649375|12537215|P3|STARTED|Week 16 up to Week 260||0
5096179|NCT01649375|12537216|P2|STARTED|Week 16 up to Week 260||66
5096180|NCT01649375|12537217|P1|STARTED|Week 16 up to Week 260||68
5096181|NCT01649375|12537213|P5|NOT COMPLETED|Up to Week 16||0
5096182|NCT01649375|12537214|P4|NOT COMPLETED|Up to Week 16||0
5096183|NCT01649375|12537215|P3|NOT COMPLETED|Up to Week 16||8
5096184|NCT01649375|12537216|P2|NOT COMPLETED|Up to Week 16||6
5096185|NCT01649375|12537217|P1|NOT COMPLETED|Up to Week 16||5
5096186|NCT01649375|12537213|P5|COMPLETED|Up to Week 16||0
5096187|NCT01649375|12537214|P4|COMPLETED|Up to Week 16||0
5096188|NCT01649375|12537215|P3|COMPLETED|Up to Week 16||66
5096189|NCT01649375|12537216|P2|COMPLETED|Up to Week 16||66
5096190|NCT01649375|12537217|P1|COMPLETED|Up to Week 16||68
5096191|NCT01649375|12537213|P5|STARTED|Up to Week 16||0
5096192|NCT01649375|12537214|P4|STARTED|Up to Week 16||0
5096193|NCT01649375|12537215|P3|STARTED|Up to Week 16||74
5096194|NCT01649375|12537216|P2|STARTED|Up to Week 16||72
5096195|NCT01649375|12537217|P1|STARTED|Up to Week 16||73
5096196|NCT01649362|12537248|P2|NOT COMPLETED|Overall Study||14
5096197|NCT01649362|12537249|P1|NOT COMPLETED|Overall Study||1
5096198|NCT01649362|12537248|P2|COMPLETED|Overall Study||40
5096199|NCT01649362|12537249|P1|COMPLETED|Overall Study||46
5096200|NCT01649362|12537248|P2|STARTED|Overall Study||54
5096201|NCT01649362|12537249|P1|STARTED|Overall Study||47
5096202|NCT01649297|12537264|P5|NOT COMPLETED|Overall Study||4
5096203|NCT01649297|12537265|P4|NOT COMPLETED|Overall Study||19
5096204|NCT01649297|12537266|P3|NOT COMPLETED|Overall Study||17
5096205|NCT01649297|12537267|P2|NOT COMPLETED|Overall Study||13
5096206|NCT01649297|12537268|P1|NOT COMPLETED|Overall Study||14
5096207|NCT01649297|12537264|P5|COMPLETED|Overall Study||103
5096208|NCT01649297|12537265|P4|COMPLETED|Overall Study||201
5096209|NCT01649297|12537266|P3|COMPLETED|Overall Study||202
5096210|NCT01649297|12537267|P2|COMPLETED|Overall Study||205
5096211|NCT01649297|12537268|P1|COMPLETED|Overall Study||205
5096212|NCT01649297|12537264|P5|STARTED|Overall Study|randomised|107
5096213|NCT01649297|12537265|P4|STARTED|Overall Study|randomised|220
5096214|NCT01649297|12537266|P3|STARTED|Overall Study|randomised|219
5096215|NCT01649297|12537267|P2|STARTED|Overall Study|randomised|218
5096216|NCT01649297|12537268|P1|STARTED|Overall Study|randomised|219
5096217|NCT01649271|12537287|P2|NOT COMPLETED|Overall Study||7
5096218|NCT01649271|12537288|P1|NOT COMPLETED|Overall Study||6
5096219|NCT01649271|12537287|P2|COMPLETED|Overall Study||0
5096220|NCT01649271|12537288|P1|COMPLETED|Overall Study||0
5096221|NCT01649271|12537287|P2|STARTED|Overall Study||7
5096222|NCT01649271|12537288|P1|STARTED|Overall Study||6
5096223|NCT01649232|12537303|P2|NOT COMPLETED|Overall Study||0
5096224|NCT01649232|12537304|P1|NOT COMPLETED|Overall Study||2
5096225|NCT01649232|12537303|P2|COMPLETED|Overall Study||30
5096226|NCT01649232|12537304|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
5096227|NCT01649232|12537303|P2|STARTED|Overall Study||30
5096228|NCT01649232|12537304|P1|STARTED|Overall Study||30
5096229|NCT01649180|12537324|P1|NOT COMPLETED|Overall Study||0
5096230|NCT01649180|12537324|P1|COMPLETED|Overall Study||3
5096231|NCT01649180|12537324|P1|STARTED|Overall Study||3
5096232|NCT01648920|12537332|P1|NOT COMPLETED|Overall Study||0
5096233|NCT01648920|12537332|P1|COMPLETED|Overall Study||50
5096234|NCT01648920|12537332|P1|STARTED|Overall Study||50
5096235|NCT01648790|12537356|P5|NOT COMPLETED|Treatment 5||0
5096236|NCT01648790|12537357|P4|NOT COMPLETED|Treatment 5||0
5096237|NCT01648790|12537358|P3|NOT COMPLETED|Treatment 5||0
5096238|NCT01648790|12537359|P2|NOT COMPLETED|Treatment 5||0
5096239|NCT01648790|12537360|P1|NOT COMPLETED|Treatment 5||0
5096240|NCT01648790|12537356|P5|COMPLETED|Treatment 5||4
5096241|NCT01648790|12537357|P4|COMPLETED|Treatment 5||3
5096242|NCT01648790|12537358|P3|COMPLETED|Treatment 5||4
5096243|NCT01648790|12537359|P2|COMPLETED|Treatment 5||4
5096244|NCT01648790|12537360|P1|COMPLETED|Treatment 5||4
5096245|NCT01648790|12537356|P5|STARTED|Treatment 5||4
5096246|NCT01648790|12537357|P4|STARTED|Treatment 5||3
5096247|NCT01648790|12537358|P3|STARTED|Treatment 5||4
5096248|NCT01648790|12537359|P2|STARTED|Treatment 5||4
5096249|NCT01648790|12537360|P1|STARTED|Treatment 5||4
5096250|NCT01648790|12537356|P5|NOT COMPLETED|Treatment 4||0
5096251|NCT01648790|12537357|P4|NOT COMPLETED|Treatment 4||0
5096252|NCT01648790|12537358|P3|NOT COMPLETED|Treatment 4||0
5096253|NCT01648790|12537359|P2|NOT COMPLETED|Treatment 4||0
5096254|NCT01648790|12537360|P1|NOT COMPLETED|Treatment 4||0
5096255|NCT01648790|12537356|P5|COMPLETED|Treatment 4||4
5096256|NCT01648790|12537357|P4|COMPLETED|Treatment 4||3
5096257|NCT01648790|12537358|P3|COMPLETED|Treatment 4||4
5096258|NCT01648790|12537359|P2|COMPLETED|Treatment 4||4
5096259|NCT01648790|12537360|P1|COMPLETED|Treatment 4||4
5096260|NCT01648790|12537356|P5|STARTED|Treatment 4||4
5096261|NCT01648790|12537357|P4|STARTED|Treatment 4||3
5096262|NCT01648790|12537358|P3|STARTED|Treatment 4||4
5096263|NCT01648790|12537359|P2|STARTED|Treatment 4||4
5096264|NCT01648790|12537360|P1|STARTED|Treatment 4||4
5096265|NCT01648790|12537356|P5|NOT COMPLETED|Treatment 3||0
5096266|NCT01648790|12537357|P4|NOT COMPLETED|Treatment 3||1
5096267|NCT01648790|12537358|P3|NOT COMPLETED|Treatment 3||0
5096268|NCT01648790|12537359|P2|NOT COMPLETED|Treatment 3||0
5096269|NCT01648790|12537360|P1|NOT COMPLETED|Treatment 3||0
5096270|NCT01648790|12537356|P5|COMPLETED|Treatment 3||4
5096271|NCT01648790|12537357|P4|COMPLETED|Treatment 3||3
5096272|NCT01648790|12537358|P3|COMPLETED|Treatment 3||4
5096273|NCT01648790|12537359|P2|COMPLETED|Treatment 3||4
5096274|NCT01648790|12537360|P1|COMPLETED|Treatment 3||4
5096275|NCT01648790|12537356|P5|STARTED|Treatment 3||4
5096276|NCT01648790|12537357|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
5096277|NCT01648790|12537358|P3|STARTED|Treatment 3||4
5096278|NCT01648790|12537359|P2|STARTED|Treatment 3||4
5096279|NCT01648790|12537360|P1|STARTED|Treatment 3||4
5096280|NCT01648790|12537356|P5|NOT COMPLETED|Treatment 2||0
5096281|NCT01648790|12537357|P4|NOT COMPLETED|Treatment 2||0
5096282|NCT01648790|12537358|P3|NOT COMPLETED|Treatment 2||0
5096283|NCT01648790|12537359|P2|NOT COMPLETED|Treatment 2||0
5096284|NCT01648790|12537360|P1|NOT COMPLETED|Treatment 2||0
5096285|NCT01648790|12537356|P5|COMPLETED|Treatment 2||4
5096286|NCT01648790|12537357|P4|COMPLETED|Treatment 2||4
5096287|NCT01648790|12537358|P3|COMPLETED|Treatment 2||4
5096288|NCT01648790|12537359|P2|COMPLETED|Treatment 2||4
5096289|NCT01648790|12537360|P1|COMPLETED|Treatment 2||4
5096290|NCT01648790|12537356|P5|STARTED|Treatment 2||4
5096291|NCT01648790|12537357|P4|STARTED|Treatment 2||4
5096292|NCT01648790|12537358|P3|STARTED|Treatment 2||4
5096293|NCT01648790|12537359|P2|STARTED|Treatment 2||4
5096294|NCT01648790|12537360|P1|STARTED|Treatment 2||4
5096295|NCT01648790|12537356|P5|NOT COMPLETED|Treatment 1||0
5096296|NCT01648790|12537357|P4|NOT COMPLETED|Treatment 1||0
5096297|NCT01648790|12537358|P3|NOT COMPLETED|Treatment 1||0
5096298|NCT01648790|12537359|P2|NOT COMPLETED|Treatment 1||0
5096299|NCT01648790|12537360|P1|NOT COMPLETED|Treatment 1||0
5096300|NCT01648790|12537356|P5|COMPLETED|Treatment 1||4
5096301|NCT01648790|12537357|P4|COMPLETED|Treatment 1||4
5096302|NCT01648790|12537358|P3|COMPLETED|Treatment 1||4
5096303|NCT01648790|12537359|P2|COMPLETED|Treatment 1||4
5096304|NCT01648790|12537360|P1|COMPLETED|Treatment 1||4
5096305|NCT01648790|12537356|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
5096306|NCT01648790|12537357|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
5096307|NCT01648790|12537358|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
5096308|NCT01648790|12537359|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
5096309|NCT01648790|12537360|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
5096310|NCT01648790|12537356|P5|STARTED|Treatment 1||4
5096311|NCT01648790|12537357|P4|STARTED|Treatment 1||4
5096312|NCT01648790|12537358|P3|STARTED|Treatment 1||4
5096313|NCT01648790|12537359|P2|STARTED|Treatment 1||4
5096314|NCT01648790|12537360|P1|STARTED|Treatment 1||4
5096315|NCT01648764|12537395|P14|NOT COMPLETED|Overall Study||3
5096316|NCT01648764|12537396|P13|NOT COMPLETED|Overall Study||4
5096317|NCT01648764|12537397|P12|NOT COMPLETED|Overall Study||5
5096318|NCT01648764|12537398|P11|NOT COMPLETED|Overall Study||0
5096319|NCT01648764|12537399|P10|NOT COMPLETED|Overall Study||3
5096320|NCT01648764|12537400|P9|NOT COMPLETED|Overall Study||0
5096321|NCT01648764|12537401|P8|NOT COMPLETED|Overall Study||0
5096322|NCT01648764|12537402|P7|NOT COMPLETED|Overall Study||5
5096323|NCT01648764|12537403|P6|NOT COMPLETED|Overall Study||2
5096324|NCT01648764|12537404|P5|NOT COMPLETED|Overall Study||0
5096325|NCT01648764|12537405|P4|NOT COMPLETED|Overall Study||0
5096326|NCT01648764|12537406|P3|NOT COMPLETED|Overall Study||0
5096327|NCT01648764|12537407|P2|NOT COMPLETED|Overall Study||1
5096328|NCT01648764|12537408|P1|NOT COMPLETED|Overall Study||0
5096329|NCT01648764|12537395|P14|COMPLETED|Overall Study||9
5096330|NCT01648764|12537396|P13|COMPLETED|Overall Study||3
5096331|NCT01648764|12537397|P12|COMPLETED|Overall Study||4
5096332|NCT01648764|12537398|P11|COMPLETED|Overall Study||3
5096333|NCT01648764|12537399|P10|COMPLETED|Overall Study||4
5096334|NCT01648764|12537400|P9|COMPLETED|Overall Study||3
5096335|NCT01648764|12537401|P8|COMPLETED|Overall Study||3
5096336|NCT01648764|12537402|P7|COMPLETED|Overall Study||4
5096337|NCT01648764|12537403|P6|COMPLETED|Overall Study||3
5096338|NCT01648764|12537404|P5|COMPLETED|Overall Study||3
5096339|NCT01648764|12537405|P4|COMPLETED|Overall Study||3
5096340|NCT01648764|12537406|P3|COMPLETED|Overall Study||3
5096341|NCT01648764|12537407|P2|COMPLETED|Overall Study||2
5096342|NCT01648764|12537408|P1|COMPLETED|Overall Study||3
5096343|NCT01648764|12537395|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
5096344|NCT01648764|12537396|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
5096345|NCT01648764|12537397|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
5096346|NCT01648764|12537398|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
5096347|NCT01648764|12537399|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
5096348|NCT01648764|12537400|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
5096349|NCT01648764|12537401|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
5096350|NCT01648764|12537402|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
5096351|NCT01648764|12537403|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
5096352|NCT01648764|12537404|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5096353|NCT01648764|12537405|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5096354|NCT01648764|12537406|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5096355|NCT01648764|12537407|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5096356|NCT01648764|12537408|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5096357|NCT01648764|12537395|P14|STARTED|Overall Study||12
5096358|NCT01648764|12537396|P13|STARTED|Overall Study||7
5096359|NCT01648764|12537397|P12|STARTED|Overall Study||9
5096360|NCT01648764|12537398|P11|STARTED|Overall Study||3
5096361|NCT01648764|12537399|P10|STARTED|Overall Study||7
5096362|NCT01648764|12537400|P9|STARTED|Overall Study||3
5096363|NCT01648764|12537401|P8|STARTED|Overall Study||3
5096364|NCT01648764|12537402|P7|STARTED|Overall Study||9
5096365|NCT01648764|12537403|P6|STARTED|Overall Study||5
5096366|NCT01648764|12537404|P5|STARTED|Overall Study||3
5096367|NCT01648764|12537405|P4|STARTED|Overall Study||3
5096368|NCT01648764|12537406|P3|STARTED|Overall Study||3
5096369|NCT01648764|12537407|P2|STARTED|Overall Study||3
5096370|NCT01648764|12537408|P1|STARTED|Overall Study||3
5096371|NCT01648699|12537560|P1|NOT COMPLETED|Overall Study||5
5096372|NCT01648699|12537560|P1|COMPLETED|Overall Study||15
5096373|NCT01648699|12537560|P1|STARTED|Overall Study||20
5096374|NCT01648582|12537589|P3|NOT COMPLETED|Overall Study||32
5096375|NCT01648582|12537590|P2|NOT COMPLETED|Overall Study||38
5096376|NCT01648582|12537591|P1|NOT COMPLETED|Overall Study||32
5096377|NCT01648582|12537589|P3|COMPLETED|Overall Study||227
5096378|NCT01648582|12537590|P2|COMPLETED|Overall Study||219
5096379|NCT01648582|12537591|P1|COMPLETED|Overall Study||226
5096380|NCT01648582|12537589|P3|Modified Intent-to-Treat Population|Overall Study||250
5096381|NCT01648582|12537590|P2|Modified Intent-to-Treat Population|Overall Study||252
5096382|NCT01648582|12537591|P1|Modified Intent-to-Treat Population|Overall Study||253
5096383|NCT01648582|12537589|P3|Received at Least One Dose of Study Drug|Overall Study||259
5096384|NCT01648582|12537590|P2|Received at Least One Dose of Study Drug|Overall Study||257
5096385|NCT01648582|12537591|P1|Received at Least One Dose of Study Drug|Overall Study||258
5096386|NCT01648582|12537589|P3|STARTED|Overall Study||259
5096387|NCT01648582|12537590|P2|STARTED|Overall Study||257
5096388|NCT01648582|12537591|P1|STARTED|Overall Study||258
5096389|NCT01648530|12537660|P1|NOT COMPLETED|Overall Study||10874
5096390|NCT01648530|12537660|P1|COMPLETED|Overall Study||5915
5096391|NCT01648530|12537660|P1|STARTED|Overall Study||16789
5096392|NCT01648491|12537666|P1|NOT COMPLETED|Overall Study||0
5096393|NCT01648491|12537666|P1|COMPLETED|Overall Study||1
5096394|NCT01648491|12537666|P1|STARTED|Overall Study||1
5096395|NCT01648452|12537673|P1|NOT COMPLETED|Overall Study||0
5096396|NCT01648452|12537673|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
5096397|NCT01648452|12537673|P1|STARTED|Overall Study||5
5096398|NCT01648348|12537694|P6|NOT COMPLETED|Overall Study||6
5096399|NCT01648348|12537695|P5|NOT COMPLETED|Overall Study||3
5096400|NCT01648348|12537696|P4|NOT COMPLETED|Overall Study||0
5096401|NCT01648348|12537697|P3|NOT COMPLETED|Overall Study||1
5096402|NCT01648348|12537698|P2|NOT COMPLETED|Overall Study||0
5096403|NCT01648348|12537699|P1|NOT COMPLETED|Overall Study||2
5096404|NCT01648348|12537694|P6|COMPLETED|Overall Study||43
5096405|NCT01648348|12537695|P5|COMPLETED|Overall Study||49
5096406|NCT01648348|12537696|P4|COMPLETED|Overall Study||3
5096407|NCT01648348|12537697|P3|COMPLETED|Overall Study||3
5096408|NCT01648348|12537698|P2|COMPLETED|Overall Study||3
5096409|NCT01648348|12537699|P1|COMPLETED|Overall Study||3
5096410|NCT01648348|12537694|P6|STARTED|Overall Study||49
5096411|NCT01648348|12537695|P5|STARTED|Overall Study||52
5096412|NCT01648348|12537696|P4|STARTED|Overall Study||3
5096413|NCT01648348|12537697|P3|STARTED|Overall Study||4
5096414|NCT01648348|12537698|P2|STARTED|Overall Study||3
5096415|NCT01648348|12537699|P1|STARTED|Overall Study||5
5096416|NCT01648322|12537728|P4|NOT COMPLETED|Overall Study||4
5096417|NCT01648322|12537729|P3|NOT COMPLETED|Overall Study||5
5096418|NCT01648322|12537730|P2|NOT COMPLETED|Overall Study||5
5096419|NCT01648322|12537731|P1|NOT COMPLETED|Overall Study||2
5096420|NCT01648322|12537728|P4|COMPLETED|Overall Study||61
5096421|NCT01648322|12537729|P3|COMPLETED|Overall Study||60
5096422|NCT01648322|12537730|P2|COMPLETED|Overall Study||62
5096423|NCT01648322|12537731|P1|COMPLETED|Overall Study||33
5096424|NCT01648322|12537728|P4|STARTED|Overall Study||65
5096425|NCT01648322|12537729|P3|STARTED|Overall Study||65
5096426|NCT01648322|12537730|P2|STARTED|Overall Study||67
5096427|NCT01648322|12537731|P1|STARTED|Overall Study||35
5096428|NCT01648296|12537777|P2|NOT COMPLETED|Overall Study||0
5096429|NCT01648296|12537778|P1|NOT COMPLETED|Overall Study||0
5096430|NCT01648296|12537777|P2|COMPLETED|Overall Study||17
5096431|NCT01648296|12537778|P1|COMPLETED|Overall Study||11
5096432|NCT01648296|12537777|P2|STARTED|Overall Study||17
5096433|NCT01648296|12537778|P1|STARTED|Overall Study||11
5096434|NCT01648283|12537786|P1|NOT COMPLETED|Overall Study||14
5096435|NCT01648283|12537786|P1|COMPLETED|Overall Study||64
5096436|NCT01648283|12537786|P1|STARTED|Overall Study||78
5096437|NCT01648270|12537792|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
5096438|NCT01648270|12537792|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
5096439|NCT01648270|12537792|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
5096440|NCT01648270|12537792|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
5096441|NCT01648270|12537792|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
5096442|NCT01648270|12537792|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
5096443|NCT01648270|12537792|P1|NOT COMPLETED|Sublingual Buprenorphine||0
5096444|NCT01648270|12537792|P1|COMPLETED|Sublingual Buprenorphine||13
5096445|NCT01648270|12537792|P1|STARTED|Sublingual Buprenorphine||13
5096446|NCT01648270|12537792|P1|NOT COMPLETED|Intravenous Buprenorphine||12
5096447|NCT01648270|12537792|P1|COMPLETED|Intravenous Buprenorphine||13
5096448|NCT01648270|12537792|P1|STARTED|Intravenous Buprenorphine||25
5096449|NCT01648166|12537804|P2|NOT COMPLETED|Overall Study||100
5096450|NCT01648166|12537805|P1|NOT COMPLETED|Overall Study||53
5096451|NCT01648166|12537804|P2|COMPLETED|Overall Study||267
5096452|NCT01648166|12537805|P1|COMPLETED|Overall Study||100
5096453|NCT01648166|12537804|P2|STARTED|Overall Study||367
5096454|NCT01648166|12537805|P1|STARTED|Overall Study||153
5096455|NCT01648140|12537815|P4|NOT COMPLETED|Overall Study||2
5096456|NCT01648140|12537816|P3|NOT COMPLETED|Overall Study||8
5096457|NCT01648140|12537817|P2|NOT COMPLETED|Overall Study||12
5096458|NCT01648140|12537818|P1|NOT COMPLETED|Overall Study||12
5096459|NCT01648140|12537815|P4|COMPLETED|Overall Study||11
5096460|NCT01648140|12537816|P3|COMPLETED|Overall Study||9
5096461|NCT01648140|12537817|P2|COMPLETED|Overall Study||28
5096462|NCT01648140|12537818|P1|COMPLETED|Overall Study||29
5096463|NCT01648140|12537815|P4|STARTED|Overall Study||13
5096464|NCT01648140|12537816|P3|STARTED|Overall Study||17
5096465|NCT01648140|12537817|P2|STARTED|Overall Study||40
5096466|NCT01648140|12537818|P1|STARTED|Overall Study||41
5096467|NCT01648101|12537983|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
5096468|NCT01648101|12537984|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
5096469|NCT01648101|12537985|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
5096470|NCT01648101|12537983|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
5096471|NCT01648101|12537984|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
5096472|NCT01648101|12537985|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
5096473|NCT01648101|12537983|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
5096474|NCT01648101|12537984|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
5096475|NCT01648101|12537985|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
5096476|NCT01648101|12537983|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
5096477|NCT01648101|12537984|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
5096478|NCT01648101|12537985|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
5096479|NCT01648101|12537983|P3|COMPLETED|Transition Phase (4 Weeks)||5
5096480|NCT01648101|12537984|P2|COMPLETED|Transition Phase (4 Weeks)||13
5096481|NCT01648101|12537985|P1|COMPLETED|Transition Phase (4 Weeks)||12
5096482|NCT01648101|12537983|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
5096483|NCT01648101|12537984|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
5096484|NCT01648101|12537985|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
5096485|NCT01648101|12537983|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
5096486|NCT01648101|12537984|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
5096487|NCT01648101|12537985|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
5096488|NCT01648101|12537983|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
5096489|NCT01648101|12537984|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
5096490|NCT01648101|12537985|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
5096491|NCT01648101|12537983|P3|STARTED|Maintenance Phase (12 Weeks)||18
5096492|NCT01648101|12537984|P2|STARTED|Maintenance Phase (12 Weeks)||23
5096493|NCT01648101|12537985|P1|STARTED|Maintenance Phase (12 Weeks)||23
5096494|NCT01648101|12537983|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
5096495|NCT01648101|12537984|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
5096496|NCT01648101|12537985|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
5096497|NCT01648101|12537983|P3|COMPLETED|Titration Phase (4 Weeks)||18
5096498|NCT01648101|12537984|P2|COMPLETED|Titration Phase (4 Weeks)||23
5096499|NCT01648101|12537985|P1|COMPLETED|Titration Phase (4 Weeks)||23
5096500|NCT01648101|12537983|P3|STARTED|Titration Phase (4 Weeks)||24
5096501|NCT01648101|12537984|P2|STARTED|Titration Phase (4 Weeks)||26
5096502|NCT01648101|12537985|P1|STARTED|Titration Phase (4 Weeks)||25
5096503|NCT01647945|12538037|P4|NOT COMPLETED|Overall Study||1
5096504|NCT01647945|12538038|P3|NOT COMPLETED|Overall Study||2
5096505|NCT01647945|12538039|P2|NOT COMPLETED|Overall Study||0
5096506|NCT01647945|12538040|P1|NOT COMPLETED|Overall Study||0
5096507|NCT01647945|12538037|P4|COMPLETED|Overall Study||5
5096508|NCT01647945|12538038|P3|COMPLETED|Overall Study||3
5096509|NCT01647945|12538039|P2|COMPLETED|Overall Study||6
5096510|NCT01647945|12538040|P1|COMPLETED|Overall Study||6
5096511|NCT01647945|12538037|P4|STARTED|Overall Study||6
5096512|NCT01647945|12538038|P3|STARTED|Overall Study||5
5096513|NCT01647945|12538039|P2|STARTED|Overall Study||6
5096514|NCT01647945|12538040|P1|STARTED|Overall Study||6
5096515|NCT01647737|12538060|P2|NOT COMPLETED|Overall Study||5
5096516|NCT01647737|12538061|P1|NOT COMPLETED|Overall Study||4
5096517|NCT01647737|12538060|P2|COMPLETED|Overall Study||25
5096518|NCT01647737|12538061|P1|COMPLETED|Overall Study||26
5096519|NCT01647737|12538060|P2|STARTED|Overall Study||30
5096520|NCT01647737|12538061|P1|STARTED|Overall Study||30
5096521|NCT01647711|12538072|P5|NOT COMPLETED|Overall Study||6
5096522|NCT01647711|12538073|P4|NOT COMPLETED|Overall Study||11
5096523|NCT01647711|12538074|P3|NOT COMPLETED|Overall Study||9
5096524|NCT01647711|12538075|P2|NOT COMPLETED|Overall Study||3
5096525|NCT01647711|12538076|P1|NOT COMPLETED|Overall Study||6
5096526|NCT01647711|12538072|P5|COMPLETED|Overall Study||0
5096527|NCT01647711|12538073|P4|COMPLETED|Overall Study||0
5096528|NCT01647711|12538074|P3|COMPLETED|Overall Study||0
5096529|NCT01647711|12538075|P2|COMPLETED|Overall Study||0
5096530|NCT01647711|12538076|P1|COMPLETED|Overall Study||0
5096531|NCT01647711|12538072|P5|STARTED|Overall Study||6
5096532|NCT01647711|12538073|P4|STARTED|Overall Study||11
5096533|NCT01647711|12538074|P3|STARTED|Overall Study||9
5096534|NCT01647711|12538075|P2|STARTED|Overall Study||3
5096535|NCT01647711|12538076|P1|STARTED|Overall Study||6
5096536|NCT01647581|12538103|P2|NOT COMPLETED|Overall Study||31
5096537|NCT01647581|12538104|P1|NOT COMPLETED|Overall Study||17
5096538|NCT01647581|12538103|P2|COMPLETED|Overall Study||520
5096539|NCT01647581|12538104|P1|COMPLETED|Overall Study||530
5096540|NCT01647581|12538103|P2|STARTED|Overall Study||551
5096541|NCT01647581|12538104|P1|STARTED|Overall Study||547
5096542|NCT01647542|12538113|P3|NOT COMPLETED|Overall Study||72
5096543|NCT01647542|12538114|P2|NOT COMPLETED|Overall Study||73
5096544|NCT01647542|12538115|P1|NOT COMPLETED|Overall Study||76
5096545|NCT01647542|12538113|P3|COMPLETED|Overall Study||59
5096546|NCT01647542|12538114|P2|COMPLETED|Overall Study||58
5096547|NCT01647542|12538115|P1|COMPLETED|Overall Study||55
5096548|NCT01647542|12538113|P3|STARTED|Overall Study||131
5096549|NCT01647542|12538114|P2|STARTED|Overall Study||131
5096550|NCT01647542|12538115|P1|STARTED|Overall Study||131
5096551|NCT01647464|12538132|P1|NOT COMPLETED|Overall Study||0
5096552|NCT01647464|12538132|P1|COMPLETED|Overall Study||10
5096553|NCT01647464|12538132|P1|STARTED|Overall Study||10
5096554|NCT01647438|12538138|P2|NOT COMPLETED|Overall Study||0
5096555|NCT01647438|12538139|P1|NOT COMPLETED|Overall Study||0
5096556|NCT01647438|12538138|P2|COMPLETED|Overall Study||31
5096557|NCT01647438|12538139|P1|COMPLETED|Overall Study||32
5096558|NCT01647438|12538138|P2|STARTED|Overall Study||31
5096559|NCT01647438|12538139|P1|STARTED|Overall Study||32
5096560|NCT01647282|12538149|P2|NOT COMPLETED|Overall Study||5
5096561|NCT01647282|12538150|P1|NOT COMPLETED|Overall Study||7
5096562|NCT01647282|12538149|P2|COMPLETED|Overall Study||25
5096563|NCT01647282|12538150|P1|COMPLETED|Overall Study||23
5096564|NCT01647282|12538149|P2|STARTED|Overall Study||30
5096565|NCT01647282|12538150|P1|STARTED|Overall Study||30
5096566|NCT01647217|12538160|P2|NOT COMPLETED|Overall Study||1
5096567|NCT01647217|12538161|P1|NOT COMPLETED|Overall Study||1
5096568|NCT01647217|12538160|P2|COMPLETED|Overall Study||8
5096569|NCT01647217|12538161|P1|COMPLETED|Overall Study||7
5096570|NCT01647217|12538160|P2|STARTED|Overall Study||9
5096571|NCT01647217|12538161|P1|STARTED|Overall Study||8
5096572|NCT01646827|12538171|P2|NOT COMPLETED|Overall Study||5
5096573|NCT01646827|12538172|P1|NOT COMPLETED|Overall Study||2
5096574|NCT01646827|12538171|P2|COMPLETED|Overall Study||14
5096575|NCT01646827|12538172|P1|COMPLETED|Overall Study||16
5096576|NCT01646827|12538171|P2|STARTED|Overall Study||19
5096577|NCT01646827|12538172|P1|STARTED|Overall Study||18
5096578|NCT01646814|12538202|P2|NOT COMPLETED|Overall Study||6
5096579|NCT01646814|12538203|P1|NOT COMPLETED|Overall Study||11
5096580|NCT01646814|12538202|P2|COMPLETED|Overall Study||120
5096581|NCT01646814|12538203|P1|COMPLETED|Overall Study||110
5096582|NCT01646814|12538202|P2|STARTED|Overall Study||126
5096583|NCT01646814|12538203|P1|STARTED|Overall Study||121
5096584|NCT01646762|12538209|P1|NOT COMPLETED|Overall Study||0
5096585|NCT01646762|12538209|P1|COMPLETED|Overall Study||13
5096586|NCT01646762|12538209|P1|STARTED|Overall Study||13
5096587|NCT01646671|12538221|P3|NOT COMPLETED|Overall Study||0
5096588|NCT01646671|12538222|P2|NOT COMPLETED|Overall Study||0
5096589|NCT01646671|12538223|P1|NOT COMPLETED|Overall Study||0
5096590|NCT01646671|12538221|P3|COMPLETED|Overall Study||21
5096591|NCT01646671|12538222|P2|COMPLETED|Overall Study||11
5096592|NCT01646671|12538223|P1|COMPLETED|Overall Study||3
5096593|NCT01646671|12538221|P3|STARTED|Overall Study||21
5096594|NCT01646671|12538222|P2|STARTED|Overall Study||11
5096595|NCT01646671|12538223|P1|STARTED|Overall Study||3
5096596|NCT01646398|12538259|P2|NOT COMPLETED|Overall Study||0
5096597|NCT01646398|12538260|P1|NOT COMPLETED|Overall Study||1
5096598|NCT01646398|12538259|P2|COMPLETED|Overall Study||382
5096599|NCT01646398|12538260|P1|COMPLETED|Overall Study||381
5096600|NCT01646398|12538259|P2|STARTED|Overall Study||382
5096601|NCT01646398|12538260|P1|STARTED|Overall Study||382
5096602|NCT01646385|12538276|P2|NOT COMPLETED|Overall Study||871
5096603|NCT01646385|12538277|P1|NOT COMPLETED|Overall Study||838
5096604|NCT01646385|12538276|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
5096605|NCT01646385|12538277|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
5096606|NCT01646385|12538276|P2|STARTED|Overall Study||2864
5096607|NCT01646385|12538277|P1|STARTED|Overall Study||3529
5096608|NCT01646346|12538308|P1|NOT COMPLETED|Overall Study||0
5096609|NCT01646346|12538308|P1|COMPLETED|Overall Study||46
5096610|NCT01646346|12538308|P1|STARTED|Overall Study||46
5096611|NCT01646320|12538320|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
5096612|NCT01646320|12538321|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
5096613|NCT01646320|12538320|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
5096614|NCT01646320|12538321|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
5096615|NCT01646320|12538320|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
5096616|NCT01646320|12538321|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
5096617|NCT01646320|12538320|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
5096618|NCT01646320|12538321|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
5096619|NCT01646320|12538320|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
5096620|NCT01646320|12538321|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
5096621|NCT01646320|12538320|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
5096622|NCT01646320|12538321|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
5096623|NCT01646268|12538337|P2|NOT COMPLETED|Overall Study||16
5096624|NCT01646268|12538338|P1|NOT COMPLETED|Overall Study||11
5096625|NCT01646268|12538337|P2|COMPLETED|Overall Study||107
5096626|NCT01646268|12538338|P1|COMPLETED|Overall Study||113
5096627|NCT01646268|12538337|P2|STARTED|Overall Study||123
5096628|NCT01646268|12538338|P1|STARTED|Overall Study||124
5096629|NCT01646255|12538352|P2|NOT COMPLETED|Overall Study||14
5096630|NCT01646255|12538353|P1|NOT COMPLETED|Overall Study||21
5096631|NCT01646255|12538352|P2|COMPLETED|Overall Study||160
5096632|NCT01646255|12538353|P1|COMPLETED|Overall Study||151
5096633|NCT01646255|12538352|P2|STARTED|Overall Study||174
5096634|NCT01646255|12538353|P1|STARTED|Overall Study||172
5096635|NCT01646216|12538385|P2|NOT COMPLETED|Overall Study||13
5096636|NCT01646216|12538386|P1|NOT COMPLETED|Overall Study||11
5096637|NCT01646216|12538385|P2|COMPLETED|Overall Study||4
5096638|NCT01646216|12538386|P1|COMPLETED|Overall Study||6
5096639|NCT01646216|12538385|P2|STARTED|Overall Study||17
5096640|NCT01646216|12538386|P1|STARTED|Overall Study||17
5096641|NCT01646203|12538408|P3|NOT COMPLETED|Overall Study||1
5096642|NCT01646203|12538409|P2|NOT COMPLETED|Overall Study||2
5096643|NCT01646203|12538410|P1|NOT COMPLETED|Overall Study||2
5096644|NCT01646203|12538408|P3|COMPLETED|Overall Study||6
5096645|NCT01646203|12538409|P2|COMPLETED|Overall Study||3
5096646|NCT01646203|12538410|P1|COMPLETED|Overall Study||0
5096647|NCT01646203|12538408|P3|Received at Least One Dose of Study Drug|Overall Study||7
5096648|NCT01646203|12538409|P2|Received at Least One Dose of Study Drug|Overall Study||5
5096649|NCT01646203|12538410|P1|Received at Least One Dose of Study Drug|Overall Study||2
5096650|NCT01646203|12538408|P3|STARTED|Overall Study||7
5096651|NCT01646203|12538409|P2|STARTED|Overall Study||5
5096652|NCT01646203|12538410|P1|STARTED|Overall Study||2
5096653|NCT01646177|12538439|P12|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
5096654|NCT01646177|12538440|P11|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
5096655|NCT01646177|12538441|P10|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
5096656|NCT01646177|12538442|P9|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
5096657|NCT01646177|12538443|P8|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096658|NCT01646177|12538444|P7|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096659|NCT01646177|12538445|P6|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096660|NCT01646177|12538446|P5|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096661|NCT01646177|12538447|P4|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096662|NCT01646177|12538448|P3|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096663|NCT01646177|12538449|P2|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096664|NCT01646177|12538450|P1|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096665|NCT01646177|12538439|P12|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
5096666|NCT01646177|12538440|P11|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
5096667|NCT01646177|12538441|P10|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
5096668|NCT01646177|12538442|P9|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
5096669|NCT01646177|12538443|P8|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096670|NCT01646177|12538444|P7|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096671|NCT01646177|12538445|P6|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096672|NCT01646177|12538446|P5|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096673|NCT01646177|12538447|P4|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096674|NCT01646177|12538448|P3|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096675|NCT01646177|12538449|P2|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096676|NCT01646177|12538450|P1|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
5096677|NCT01646177|12538439|P12|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
5096678|NCT01646177|12538440|P11|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
5096679|NCT01646177|12538441|P10|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
5096680|NCT01646177|12538442|P9|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
5096681|NCT01646177|12538443|P8|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096682|NCT01646177|12538444|P7|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096683|NCT01646177|12538445|P6|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096684|NCT01646177|12538446|P5|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096685|NCT01646177|12538447|P4|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096686|NCT01646177|12538448|P3|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096687|NCT01646177|12538449|P2|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096688|NCT01646177|12538450|P1|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
5096689|NCT01646177|12538439|P12|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
5096690|NCT01646177|12538440|P11|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
5096691|NCT01646177|12538441|P10|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
5096692|NCT01646177|12538442|P9|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
5096693|NCT01646177|12538443|P8|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5096694|NCT01646177|12538444|P7|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5096695|NCT01646177|12538445|P6|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5096696|NCT01646177|12538446|P5|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5096697|NCT01646177|12538447|P4|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
5096698|NCT01646177|12538448|P3|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
5096699|NCT01646177|12538449|P2|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
5096700|NCT01646177|12538450|P1|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
5096701|NCT01646177|12538439|P12|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096702|NCT01646177|12538440|P11|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096703|NCT01646177|12538441|P10|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096704|NCT01646177|12538442|P9|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096705|NCT01646177|12538443|P8|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
5096706|NCT01646177|12538444|P7|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
5096707|NCT01646177|12538445|P6|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
5096708|NCT01646177|12538446|P5|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
5096709|NCT01646177|12538447|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096710|NCT01646177|12538448|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096711|NCT01646177|12538449|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096712|NCT01646177|12538450|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096713|NCT01646177|12538439|P12|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096714|NCT01646177|12538440|P11|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096715|NCT01646177|12538441|P10|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096716|NCT01646177|12538442|P9|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096717|NCT01646177|12538443|P8|COMPLETED|Long-Term Extension Period (Week 12-264)||255
5096718|NCT01646177|12538444|P7|COMPLETED|Long-Term Extension Period (Week 12-264)||244
5096719|NCT01646177|12538445|P6|COMPLETED|Long-Term Extension Period (Week 12-264)||256
5096720|NCT01646177|12538446|P5|COMPLETED|Long-Term Extension Period (Week 12-264)||135
5096721|NCT01646177|12538447|P4|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096722|NCT01646177|12538448|P3|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096723|NCT01646177|12538449|P2|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096724|NCT01646177|12538450|P1|COMPLETED|Long-Term Extension Period (Week 12-264)||0
5096725|NCT01646177|12538439|P12|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096726|NCT01646177|12538440|P11|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096727|NCT01646177|12538441|P10|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096728|NCT01646177|12538442|P9|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096729|NCT01646177|12538443|P8|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
5096730|NCT01646177|12538444|P7|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
5096731|NCT01646177|12538445|P6|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
5096732|NCT01646177|12538446|P5|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
5096733|NCT01646177|12538447|P4|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096734|NCT01646177|12538448|P3|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096800|NCT01646138|12538552|P5|NOT COMPLETED|Overall Study||2
5096735|NCT01646177|12538449|P2|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096736|NCT01646177|12538450|P1|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
5096737|NCT01646177|12538439|P12|STARTED|Long-Term Extension Period (Week 12-264)||0
5096738|NCT01646177|12538440|P11|STARTED|Long-Term Extension Period (Week 12-264)||0
5096739|NCT01646177|12538441|P10|STARTED|Long-Term Extension Period (Week 12-264)||0
5096740|NCT01646177|12538442|P9|STARTED|Long-Term Extension Period (Week 12-264)||0
5096741|NCT01646177|12538443|P8|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
5096742|NCT01646177|12538444|P7|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
5096743|NCT01646177|12538445|P6|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
5096744|NCT01646177|12538446|P5|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
5096745|NCT01646177|12538447|P4|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
5096746|NCT01646177|12538448|P3|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
5096747|NCT01646177|12538449|P2|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
5096748|NCT01646177|12538450|P1|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
5096749|NCT01646177|12538439|P12|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096750|NCT01646177|12538440|P11|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096751|NCT01646177|12538441|P10|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096752|NCT01646177|12538442|P9|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096753|NCT01646177|12538443|P8|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096754|NCT01646177|12538444|P7|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096755|NCT01646177|12538445|P6|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096756|NCT01646177|12538446|P5|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096757|NCT01646177|12538447|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
5096758|NCT01646177|12538448|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
5096759|NCT01646177|12538449|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
5096760|NCT01646177|12538450|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
5096761|NCT01646177|12538439|P12|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096762|NCT01646177|12538440|P11|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096763|NCT01646177|12538441|P10|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096764|NCT01646177|12538442|P9|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096765|NCT01646177|12538443|P8|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096766|NCT01646177|12538444|P7|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096767|NCT01646177|12538445|P6|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096768|NCT01646177|12538446|P5|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
5096769|NCT01646177|12538447|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
5096770|NCT01646177|12538448|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
5096771|NCT01646177|12538449|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
5096772|NCT01646177|12538450|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
5096773|NCT01646177|12538439|P12|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096774|NCT01646177|12538440|P11|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096775|NCT01646177|12538441|P10|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096776|NCT01646177|12538442|P9|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096777|NCT01646177|12538443|P8|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096778|NCT01646177|12538444|P7|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096779|NCT01646177|12538445|P6|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096780|NCT01646177|12538446|P5|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
5096781|NCT01646177|12538447|P4|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
5096782|NCT01646177|12538448|P3|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
5096783|NCT01646177|12538449|P2|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
5096784|NCT01646177|12538450|P1|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
5096785|NCT01646177|12538439|P12|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096786|NCT01646177|12538440|P11|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096787|NCT01646177|12538441|P10|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096788|NCT01646177|12538442|P9|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096789|NCT01646177|12538443|P8|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096790|NCT01646177|12538444|P7|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096791|NCT01646177|12538445|P6|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096792|NCT01646177|12538446|P5|STARTED|Blinded Induction Dosing (Week 0-12)||0
5096793|NCT01646177|12538447|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
5096794|NCT01646177|12538448|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
5096795|NCT01646177|12538449|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
5096796|NCT01646177|12538450|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
5096797|NCT01646151|12538536|P1|NOT COMPLETED|Overall Study||170
5096798|NCT01646151|12538536|P1|COMPLETED|Overall Study||2410
5096799|NCT01646151|12538536|P1|STARTED|Overall Study||2580
5096801|NCT01646138|12538553|P4|NOT COMPLETED|Overall Study||0
5096802|NCT01646138|12538554|P3|NOT COMPLETED|Overall Study||0
5096803|NCT01646138|12538555|P2|NOT COMPLETED|Overall Study||0
5096804|NCT01646138|12538556|P1|NOT COMPLETED|Overall Study||0
5096805|NCT01646138|12538552|P5|COMPLETED|Overall Study||13
5096806|NCT01646138|12538553|P4|COMPLETED|Overall Study||19
5096807|NCT01646138|12538554|P3|COMPLETED|Overall Study||5
5096808|NCT01646138|12538555|P2|COMPLETED|Overall Study||4
5096809|NCT01646138|12538556|P1|COMPLETED|Overall Study||5
5096810|NCT01646138|12538552|P5|STARTED|Overall Study||15
5096811|NCT01646138|12538553|P4|STARTED|Overall Study||19
5096812|NCT01646138|12538554|P3|STARTED|Overall Study||5
5096813|NCT01646138|12538555|P2|STARTED|Overall Study||4
5096814|NCT01646138|12538556|P1|STARTED|Overall Study||5
5096815|NCT01646125|12538570|P2|NOT COMPLETED|Overall Study||28
5096816|NCT01646125|12538571|P1|NOT COMPLETED|Overall Study||31
5096817|NCT01646125|12538570|P2|COMPLETED|Overall Study||0
5096818|NCT01646125|12538571|P1|COMPLETED|Overall Study||0
5096819|NCT01646125|12538570|P2|STARTED|Overall Study||28
5096820|NCT01646125|12538571|P1|STARTED|Overall Study||31
5096821|NCT01646073|12538596|P2|NOT COMPLETED|Period B (12 Weeks)||13
5096822|NCT01646073|12538597|P1|NOT COMPLETED|Period B (12 Weeks)||1
5096823|NCT01646073|12538596|P2|COMPLETED|Period B (12 Weeks)||320
5096824|NCT01646073|12538597|P1|COMPLETED|Period B (12 Weeks)||84
5096825|NCT01646073|12538596|P2|STARTED|Period B (12 Weeks)||333
5096826|NCT01646073|12538597|P1|STARTED|Period B (12 Weeks)||85
5096827|NCT01646073|12538596|P2|NOT COMPLETED|Period A (12 Weeks)||5
5096828|NCT01646073|12538597|P1|NOT COMPLETED|Period A (12 Weeks)||2
5096829|NCT01646073|12538596|P2|COMPLETED|Period A (12 Weeks)||333
5096830|NCT01646073|12538597|P1|COMPLETED|Period A (12 Weeks)||85
5096831|NCT01646073|12538596|P2|STARTED|Period A (12 Weeks)||338
5096832|NCT01646073|12538597|P1|STARTED|Period A (12 Weeks)||87
5096833|NCT01646021|12538638|P2|NOT COMPLETED|Overall Study||141
5096834|NCT01646021|12538639|P1|NOT COMPLETED|Overall Study||139
5096835|NCT01646021|12538638|P2|COMPLETED|Overall Study||0
5096836|NCT01646021|12538639|P1|COMPLETED|Overall Study||0
5096837|NCT01646021|12538638|P2|Treated|Overall Study||139
5096838|NCT01646021|12538639|P1|Treated|Overall Study||139
5096839|NCT01646021|12538638|P2|STARTED|Overall Study||141
5096840|NCT01646021|12538639|P1|STARTED|Overall Study||139
5096841|NCT01645930|12538676|P1|NOT COMPLETED|Overall Study||43
5096842|NCT01645930|12538676|P1|COMPLETED|Overall Study||0
5096843|NCT01645930|12538676|P1|STARTED|Overall Study||43
5096844|NCT01645735|12538693|P2|NOT COMPLETED|Overall Study||1
5096845|NCT01645735|12538694|P1|NOT COMPLETED|Overall Study||4
5096846|NCT01645735|12538693|P2|COMPLETED|Overall Study||16
5096847|NCT01645735|12538694|P1|COMPLETED|Overall Study||28
5096848|NCT01645735|12538693|P2|STARTED|Overall Study||17
5096849|NCT01645735|12538694|P1|STARTED|Overall Study||32
5096850|NCT01645709|12538708|P2|NOT COMPLETED|Overall Study||0
5096851|NCT01645709|12538709|P1|NOT COMPLETED|Overall Study||0
5096852|NCT01645709|12538708|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
5096853|NCT01645709|12538709|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
5096854|NCT01645709|12538708|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
5096855|NCT01645709|12538709|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
5096856|NCT01645280|12538736|P5|NOT COMPLETED|Overall Study||8
5096857|NCT01645280|12538737|P4|NOT COMPLETED|Overall Study||6
5096858|NCT01645280|12538738|P3|NOT COMPLETED|Overall Study||6
5096859|NCT01645280|12538739|P2|NOT COMPLETED|Overall Study||3
5096860|NCT01645280|12538740|P1|NOT COMPLETED|Overall Study||6
5096861|NCT01645280|12538736|P5|COMPLETED|Overall Study||47
5096862|NCT01645280|12538737|P4|COMPLETED|Overall Study||48
5096863|NCT01645280|12538738|P3|COMPLETED|Overall Study||49
5096864|NCT01645280|12538739|P2|COMPLETED|Overall Study||51
5096865|NCT01645280|12538740|P1|COMPLETED|Overall Study||49
5096866|NCT01645280|12538736|P5|STARTED|Overall Study||55
5096867|NCT01645280|12538737|P4|STARTED|Overall Study||54
5096868|NCT01645280|12538738|P3|STARTED|Overall Study||55
5096869|NCT01645280|12538739|P2|STARTED|Overall Study||54
5096870|NCT01645280|12538740|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
5096871|NCT01645176|12538768|P1|NOT COMPLETED|Overall Study||5
5096872|NCT01645176|12538768|P1|COMPLETED|Overall Study||16
5096873|NCT01645176|12538768|P1|STARTED|Overall Study||21
5096874|NCT01645111|12538772|P1|NOT COMPLETED|Overall Study||15
5096875|NCT01645111|12538772|P1|COMPLETED|Overall Study||35
5096876|NCT01645111|12538772|P1|STARTED|Overall Study||50
5096877|NCT01645098|12538778|P2|NOT COMPLETED|Overall Study||0
5096878|NCT01645098|12538779|P1|NOT COMPLETED|Overall Study||0
5096879|NCT01645098|12538778|P2|COMPLETED|Overall Study||29
5096880|NCT01645098|12538779|P1|COMPLETED|Overall Study||24
5096881|NCT01645098|12538778|P2|STARTED|Overall Study||29
5096882|NCT01645098|12538779|P1|STARTED|Overall Study||24
5096883|NCT01645059|12538793|P1|NOT COMPLETED|Overall Study||0
5096884|NCT01645059|12538793|P1|COMPLETED|Overall Study||129
5096885|NCT01645059|12538793|P1|STARTED|Overall Study||129
5096886|NCT01644890|12538813|P2|NOT COMPLETED|Overall Study||215
5096887|NCT01644890|12538814|P1|NOT COMPLETED|Overall Study||216
5096888|NCT01644890|12538813|P2|COMPLETED|Overall Study||3
5096889|NCT01644890|12538814|P1|COMPLETED|Overall Study||2
5096890|NCT01644890|12538813|P2|STARTED|Overall Study||218
5096891|NCT01644890|12538814|P1|STARTED|Overall Study||218
5096892|NCT01644734|12538824|P1|NOT COMPLETED|Overall Study||266
5096893|NCT01644734|12538824|P1|COMPLETED|Overall Study||1016
5096894|NCT01644734|12538824|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
5096895|NCT01644695|12538829|P1|NOT COMPLETED|Overall Study||0
5096896|NCT01644695|12538829|P1|COMPLETED|Overall Study||85
5096897|NCT01644695|12538829|P1|STARTED|Overall Study||85
5096898|NCT01644643|12538838|P4|NOT COMPLETED|Overall Study||10
5096899|NCT01644643|12538839|P3|NOT COMPLETED|Overall Study||5
5096900|NCT01644643|12538840|P2|NOT COMPLETED|Overall Study||0
5096901|NCT01644643|12538841|P1|NOT COMPLETED|Overall Study||2
5096902|NCT01644643|12538838|P4|COMPLETED|Overall Study||143
5096903|NCT01644643|12538839|P3|COMPLETED|Overall Study||148
5096904|NCT01644643|12538840|P2|COMPLETED|Overall Study||12
5096905|NCT01644643|12538841|P1|COMPLETED|Overall Study||13
5096906|NCT01644643|12538838|P4|STARTED|Overall Study||153
5096907|NCT01644643|12538839|P3|STARTED|Overall Study||153
5096908|NCT01644643|12538840|P2|STARTED|Overall Study||12
5096909|NCT01644643|12538841|P1|STARTED|Overall Study||15
5096910|NCT01644617|12539006|P3|NOT COMPLETED|Overall Study||7
5096911|NCT01644617|12539007|P2|NOT COMPLETED|Overall Study||5
5096912|NCT01644617|12539008|P1|NOT COMPLETED|Overall Study||6
5096913|NCT01644617|12539006|P3|COMPLETED|Overall Study||34
5096914|NCT01644617|12539007|P2|COMPLETED|Overall Study||36
5096915|NCT01644617|12539008|P1|COMPLETED|Overall Study||36
5096916|NCT01644617|12539006|P3|STARTED|Overall Study||41
5096917|NCT01644617|12539007|P2|STARTED|Overall Study||41
5096918|NCT01644617|12539008|P1|STARTED|Overall Study||42
5096919|NCT01644565|12539058|P9|NOT COMPLETED|Overall Study||1
5096920|NCT01644565|12539059|P8|NOT COMPLETED|Overall Study||2
5096921|NCT01644565|12539060|P7|NOT COMPLETED|Overall Study||0
5096922|NCT01644565|12539061|P6|NOT COMPLETED|Overall Study||0
5096923|NCT01644565|12539062|P5|NOT COMPLETED|Overall Study||1
5096924|NCT01644565|12539063|P4|NOT COMPLETED|Overall Study||1
5096925|NCT01644565|12539064|P3|NOT COMPLETED|Overall Study||0
5096926|NCT01644565|12539065|P2|NOT COMPLETED|Overall Study||0
5096927|NCT01644565|12539066|P1|NOT COMPLETED|Overall Study||1
5096928|NCT01644565|12539058|P9|COMPLETED|Overall Study||7
5096929|NCT01644565|12539059|P8|COMPLETED|Overall Study||8
5096930|NCT01644565|12539060|P7|COMPLETED|Overall Study||7
5096931|NCT01644565|12539061|P6|COMPLETED|Overall Study||7
5096932|NCT01644565|12539062|P5|COMPLETED|Overall Study||4
5096933|NCT01644565|12539063|P4|COMPLETED|Overall Study||4
5096934|NCT01644565|12539064|P3|COMPLETED|Overall Study||5
5096935|NCT01644565|12539065|P2|COMPLETED|Overall Study||5
5096936|NCT01644565|12539066|P1|COMPLETED|Overall Study||4
5096937|NCT01644565|12539058|P9|STARTED|Overall Study||8
5096938|NCT01644565|12539059|P8|STARTED|Overall Study||10
5096939|NCT01644565|12539060|P7|STARTED|Overall Study||7
5096940|NCT01644565|12539061|P6|STARTED|Overall Study||7
5096941|NCT01644565|12539062|P5|STARTED|Overall Study||5
5096942|NCT01644565|12539063|P4|STARTED|Overall Study||5
5096943|NCT01644565|12539064|P3|STARTED|Overall Study||5
5096944|NCT01644565|12539065|P2|STARTED|Overall Study||5
5096945|NCT01644565|12539066|P1|STARTED|Overall Study||5
5096946|NCT01644500|12539107|P3|NOT COMPLETED|Overall Study||15
5096947|NCT01644500|12539108|P2|NOT COMPLETED|Overall Study||24
5096948|NCT01644500|12539109|P1|NOT COMPLETED|Overall Study||22
5096949|NCT01644500|12539107|P3|COMPLETED|Overall Study||230
5096950|NCT01644500|12539108|P2|COMPLETED|Overall Study||224
5096951|NCT01644500|12539109|P1|COMPLETED|Overall Study||222
5096952|NCT01644500|12539107|P3|Modified Intent-to-treat Population|Overall Study||242
5096953|NCT01644500|12539108|P2|Modified Intent-to-treat Population|Overall Study||239
5096954|NCT01644500|12539109|P1|Modified Intent-to-treat Population|Overall Study||239
5096955|NCT01644500|12539107|P3|Received at Least One Dose of Study Drug|Overall Study||243
5096956|NCT01644500|12539108|P2|Received at Least One Dose of Study Drug|Overall Study||248
5096957|NCT01644500|12539109|P1|Received at Least One Dose of Study Drug|Overall Study||244
5096958|NCT01644500|12539107|P3|STARTED|Overall Study||245
5096959|NCT01644500|12539108|P2|STARTED|Overall Study||248
5096960|NCT01644500|12539109|P1|STARTED|Overall Study||244
5096961|NCT01644474|12539179|P2|NOT COMPLETED|Overall Study||8
5096962|NCT01644474|12539180|P1|NOT COMPLETED|Overall Study||7
5096963|NCT01644474|12539179|P2|COMPLETED|Overall Study||44
5096964|NCT01644474|12539180|P1|COMPLETED|Overall Study||44
5096965|NCT01644474|12539179|P2|Treated|Overall Study||52
5096966|NCT01644474|12539180|P1|Treated|Overall Study||51
5096967|NCT01644474|12539179|P2|STARTED|Overall Study|Randomized|52
5096968|NCT01644474|12539180|P1|STARTED|Overall Study|Randomized|51
5096969|NCT01644396|12539220|P1|NOT COMPLETED|Overall Study||0
5096970|NCT01644396|12539220|P1|COMPLETED|Overall Study||50
5096971|NCT01644396|12539220|P1|STARTED|Overall Study||50
5096972|NCT01644331|12539264|P2|NOT COMPLETED|Overall Study||10
5096973|NCT01644331|12539265|P1|NOT COMPLETED|Overall Study||11
5096974|NCT01644331|12539264|P2|COMPLETED|Overall Study||118
5096975|NCT01644331|12539265|P1|COMPLETED|Overall Study||118
5096976|NCT01644331|12539264|P2|STARTED|Overall Study||128
5096977|NCT01644331|12539265|P1|STARTED|Overall Study||129
5096978|NCT01644292|12539297|P1|NOT COMPLETED|Overall Study||0
5096979|NCT01644292|12539297|P1|COMPLETED|Overall Study||2
5096980|NCT01644292|12539297|P1|STARTED|Overall Study||2
5096981|NCT01644240|12539304|P3|NOT COMPLETED|Overall Study||0
5096982|NCT01644240|12539305|P2|NOT COMPLETED|Overall Study||0
5096983|NCT01644240|12539306|P1|NOT COMPLETED|Overall Study||0
5096984|NCT01644240|12539304|P3|COMPLETED|Overall Study||6
5096985|NCT01644240|12539305|P2|COMPLETED|Overall Study||4
5096986|NCT01644240|12539306|P1|COMPLETED|Overall Study||6
5096987|NCT01644240|12539304|P3|STARTED|Overall Study||6
5096988|NCT01644240|12539305|P2|STARTED|Overall Study||4
5096989|NCT01644240|12539306|P1|STARTED|Overall Study||6
5096990|NCT01644188|12539364|P2|NOT COMPLETED|Overall Study||75
5096991|NCT01644188|12539365|P1|NOT COMPLETED|Overall Study||122
5096992|NCT01644188|12539364|P2|COMPLETED|Overall Study||166
5096993|NCT01644188|12539365|P1|COMPLETED|Overall Study||357
5096994|NCT01644188|12539364|P2|Treated|Overall Study||241
5096995|NCT01644188|12539365|P1|Treated|Overall Study||479
5096996|NCT01644188|12539364|P2|STARTED|Overall Study|Randomized|241
5096997|NCT01644188|12539365|P1|STARTED|Overall Study|Randomized|479
5096998|NCT01644175|12539423|P2|NOT COMPLETED|Overall Study||53
5096999|NCT01644175|12539424|P1|NOT COMPLETED|Overall Study||32
5097000|NCT01644175|12539423|P2|COMPLETED|Overall Study||156
5097001|NCT01644175|12539424|P1|COMPLETED|Overall Study||75
5097002|NCT01644175|12539423|P2|Treated|Overall Study||207
5097003|NCT01644175|12539424|P1|Treated|Overall Study||107
5097004|NCT01644175|12539423|P2|STARTED|Overall Study|Randomized|209
5097005|NCT01644175|12539424|P1|STARTED|Overall Study|Randomized|107
5097006|NCT01644149|12539476|P2|NOT COMPLETED|Overall Study||1
5097007|NCT01644149|12539477|P1|NOT COMPLETED|Overall Study||4
5097008|NCT01644149|12539476|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
5097009|NCT01644149|12539477|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
5097010|NCT01644149|12539476|P2|STARTED|Overall Study||40
5097011|NCT01644149|12539477|P1|STARTED|Overall Study||43
5097012|NCT01644058|12539487|P1|NOT COMPLETED|Overall Study||0
5097013|NCT01644058|12539487|P1|COMPLETED|Overall Study||18
5097014|NCT01644058|12539487|P1|STARTED|Overall Study||18
5097015|NCT01643928|12539497|P5|NOT COMPLETED|Overall Study||2
5097016|NCT01643928|12539498|P4|NOT COMPLETED|Overall Study||3
5097017|NCT01643928|12539499|P3|NOT COMPLETED|Overall Study||3
5097018|NCT01643928|12539500|P2|NOT COMPLETED|Overall Study||2
5097019|NCT01643928|12539501|P1|NOT COMPLETED|Overall Study||10
5097020|NCT01643928|12539497|P5|COMPLETED|Overall Study||28
5097021|NCT01643928|12539498|P4|COMPLETED|Overall Study||27
5097022|NCT01643928|12539499|P3|COMPLETED|Overall Study||30
5097023|NCT01643928|12539500|P2|COMPLETED|Overall Study||30
5097024|NCT01643928|12539501|P1|COMPLETED|Overall Study||48
5097025|NCT01643928|12539497|P5|STARTED|Overall Study||30
5097026|NCT01643928|12539498|P4|STARTED|Overall Study||30
5097027|NCT01643928|12539499|P3|STARTED|Overall Study||33
5097028|NCT01643928|12539500|P2|STARTED|Overall Study||32
5097029|NCT01643928|12539501|P1|STARTED|Overall Study||58
5097030|NCT01643902|12539786|P1|NOT COMPLETED|Overall Study||0
5097031|NCT01643902|12539786|P1|COMPLETED|Overall Study||20
5097032|NCT01643902|12539786|P1|STARTED|Overall Study||20
5097033|NCT01643876|12539791|P1|NOT COMPLETED|Overall Study||0
5097034|NCT01643876|12539791|P1|COMPLETED|Overall Study||48
5097035|NCT01643876|12539791|P1|STARTED|Overall Study||48
5097036|NCT01643850|12539805|P9|NOT COMPLETED|Overall Study||1
5097037|NCT01643850|12539806|P8|NOT COMPLETED|Overall Study||0
5097038|NCT01643850|12539807|P7|NOT COMPLETED|Overall Study||1
5097039|NCT01643850|12539808|P6|NOT COMPLETED|Overall Study||0
5097040|NCT01643850|12539809|P5|NOT COMPLETED|Overall Study||3
5097041|NCT01643850|12539810|P4|NOT COMPLETED|Overall Study||0
5097042|NCT01643850|12539811|P3|NOT COMPLETED|Overall Study||1
5097043|NCT01643850|12539812|P2|NOT COMPLETED|Overall Study||0
5097044|NCT01643850|12539813|P1|NOT COMPLETED|Overall Study||0
5097045|NCT01643850|12539805|P9|COMPLETED|Overall Study||3
5097046|NCT01643850|12539806|P8|COMPLETED|Overall Study||4
5097047|NCT01643850|12539807|P7|COMPLETED|Overall Study||3
5097048|NCT01643850|12539808|P6|COMPLETED|Overall Study||3
5097049|NCT01643850|12539809|P5|COMPLETED|Overall Study||0
5097050|NCT01643850|12539810|P4|COMPLETED|Overall Study||3
5097051|NCT01643850|12539811|P3|COMPLETED|Overall Study||7
5097052|NCT01643850|12539812|P2|COMPLETED|Overall Study||2
5097053|NCT01643850|12539813|P1|COMPLETED|Overall Study||5
5097054|NCT01643850|12539805|P9|STARTED|Overall Study||4
5097055|NCT01643850|12539806|P8|STARTED|Overall Study||4
5097056|NCT01643850|12539807|P7|STARTED|Overall Study||4
5097057|NCT01643850|12539808|P6|STARTED|Overall Study||3
5097058|NCT01643850|12539809|P5|STARTED|Overall Study||3
5097059|NCT01643850|12539810|P4|STARTED|Overall Study||3
5097060|NCT01643850|12539811|P3|STARTED|Overall Study||8
5097061|NCT01643850|12539812|P2|STARTED|Overall Study||2
5097062|NCT01643850|12539813|P1|STARTED|Overall Study||5
5097063|NCT01643798|12539952|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
5097064|NCT01643798|12539953|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
5097065|NCT01643798|12539952|P2|COMPLETED|Pretreatment 2 and Stimulation||8
5097066|NCT01643798|12539953|P1|COMPLETED|Pretreatment 2 and Stimulation||6
5097067|NCT01643798|12539952|P2|STARTED|Pretreatment 2 and Stimulation||8
5097068|NCT01643798|12539953|P1|STARTED|Pretreatment 2 and Stimulation||6
5097069|NCT01643798|12539952|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
5097070|NCT01643798|12539953|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
5097071|NCT01643798|12539952|P2|COMPLETED|Pretreatment 1 and Stimulation||8
5097072|NCT01643798|12539953|P1|COMPLETED|Pretreatment 1 and Stimulation||6
5097073|NCT01643798|12539952|P2|STARTED|Pretreatment 1 and Stimulation||8
5097074|NCT01643798|12539953|P1|STARTED|Pretreatment 1 and Stimulation||7
5097075|NCT01643772|12539968|P4|NOT COMPLETED|Overall Study||2
5097076|NCT01643772|12539969|P3|NOT COMPLETED|Overall Study||0
5097077|NCT01643772|12539970|P2|NOT COMPLETED|Overall Study||0
5097078|NCT01643772|12539971|P1|NOT COMPLETED|Overall Study||0
5097079|NCT01643772|12539968|P4|COMPLETED|Overall Study||14
5097080|NCT01643772|12539969|P3|COMPLETED|Overall Study||15
5097081|NCT01643772|12539970|P2|COMPLETED|Overall Study||15
5097082|NCT01643772|12539971|P1|COMPLETED|Overall Study||15
5097083|NCT01643772|12539968|P4|STARTED|Overall Study||16
5097084|NCT01643772|12539969|P3|STARTED|Overall Study||15
5097085|NCT01643772|12539970|P2|STARTED|Overall Study||15
5097086|NCT01643772|12539971|P1|STARTED|Overall Study||15
5097087|NCT01643668|12540011|P1|NOT COMPLETED|Overall Study||1
5097088|NCT01643668|12540011|P1|COMPLETED|Overall Study||33
5097089|NCT01643668|12540011|P1|STARTED|Overall Study||34
5097090|NCT01643616|12540025|P2|NOT COMPLETED|Overall Study||0
5097091|NCT01643616|12540026|P1|NOT COMPLETED|Overall Study||0
5097092|NCT01643616|12540025|P2|COMPLETED|Overall Study||125
5097093|NCT01643616|12540026|P1|COMPLETED|Overall Study||125
5097094|NCT01643616|12540025|P2|STARTED|Overall Study||125
5097095|NCT01643616|12540026|P1|STARTED|Overall Study||125
5097096|NCT01643525|12540036|P1|NOT COMPLETED|Overall Study||0
5097097|NCT01643525|12540036|P1|COMPLETED|Overall Study||29
5097098|NCT01643525|12540036|P1|STARTED|Overall Study||29
5097099|NCT01643473|12540042|P2|NOT COMPLETED|Overall Study||0
5097100|NCT01643473|12540043|P1|NOT COMPLETED|Overall Study||1
5097101|NCT01643473|12540042|P2|COMPLETED|Overall Study||21
5097102|NCT01643473|12540043|P1|COMPLETED|Overall Study||20
5097103|NCT01643473|12540042|P2|STARTED|Overall Study||21
5097104|NCT01643473|12540043|P1|STARTED|Overall Study||21
5097105|NCT01643213|12540057|P2|NOT COMPLETED|Overall Study||0
5097106|NCT01643213|12540058|P1|NOT COMPLETED|Overall Study||1
5097107|NCT01643213|12540057|P2|COMPLETED|Overall Study||14
5097108|NCT01643213|12540058|P1|COMPLETED|Overall Study||12
5097109|NCT01643213|12540057|P2|STARTED|Overall Study||14
5097110|NCT01643213|12540058|P1|STARTED|Overall Study||13
5097111|NCT01643044|12540066|P2|NOT COMPLETED|Overall Study||5
5097112|NCT01643044|12540067|P1|NOT COMPLETED|Overall Study||4
5097113|NCT01643044|12540066|P2|COMPLETED|Overall Study||19
5097114|NCT01643044|12540067|P1|COMPLETED|Overall Study||20
5097115|NCT01643044|12540066|P2|STARTED|Overall Study||24
5097116|NCT01643044|12540067|P1|STARTED|Overall Study||24
5097117|NCT01642914|12540076|P3|NOT COMPLETED|Overall Study||40
5097118|NCT01642914|12540077|P2|NOT COMPLETED|Overall Study||32
5097119|NCT01642914|12540078|P1|NOT COMPLETED|Overall Study||46
5097120|NCT01642914|12540076|P3|COMPLETED|Overall Study||120
5097121|NCT01642914|12540077|P2|COMPLETED|Overall Study||122
5097122|NCT01642914|12540078|P1|COMPLETED|Overall Study||127
5097123|NCT01642914|12540076|P3|STARTED|Overall Study||160
5097124|NCT01642914|12540077|P2|STARTED|Overall Study||154
5097125|NCT01642914|12540078|P1|STARTED|Overall Study||173
5097126|NCT01642732|12540153|P1|NOT COMPLETED|Overall Study||1
5097127|NCT01642732|12540153|P1|COMPLETED|Overall Study||0
5097128|NCT01642732|12540153|P1|STARTED|Overall Study||1
5097129|NCT01642615|12540158|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
5097130|NCT01642615|12540159|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
5097131|NCT01642615|12540160|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
5097132|NCT01642615|12540158|P3|COMPLETED|Double Blind Maintenance Phase||20
5097133|NCT01642615|12540159|P2|COMPLETED|Double Blind Maintenance Phase||18
5097134|NCT01642615|12540160|P1|COMPLETED|Double Blind Maintenance Phase||0
5097135|NCT01642615|12540158|P3|STARTED|Double Blind Maintenance Phase||26
5097136|NCT01642615|12540159|P2|STARTED|Double Blind Maintenance Phase||25
5097137|NCT01642615|12540160|P1|STARTED|Double Blind Maintenance Phase||0
5097138|NCT01642615|12540158|P3|NOT COMPLETED|Open Label Maintenance Phase||0
5097139|NCT01642615|12540159|P2|NOT COMPLETED|Open Label Maintenance Phase||0
5097140|NCT01642615|12540160|P1|NOT COMPLETED|Open Label Maintenance Phase||5
5097141|NCT01642615|12540158|P3|COMPLETED|Open Label Maintenance Phase||0
5097142|NCT01642615|12540159|P2|COMPLETED|Open Label Maintenance Phase||0
5097143|NCT01642615|12540160|P1|COMPLETED|Open Label Maintenance Phase||58
5097144|NCT01642615|12540158|P3|Safety Analysis Set|Open Label Maintenance Phase||0
5097145|NCT01642615|12540159|P2|Safety Analysis Set|Open Label Maintenance Phase||0
5097146|NCT01642615|12540160|P1|Safety Analysis Set|Open Label Maintenance Phase||62
5097147|NCT01642615|12540158|P3|STARTED|Open Label Maintenance Phase||0
5097148|NCT01642615|12540159|P2|STARTED|Open Label Maintenance Phase||0
5097149|NCT01642615|12540160|P1|STARTED|Open Label Maintenance Phase||63
5097150|NCT01642602|12540174|P1|NOT COMPLETED|Overall Study||2
5097151|NCT01642602|12540174|P1|COMPLETED|Overall Study||102
5097152|NCT01642602|12540174|P1|STARTED|Overall Study||104
5097153|NCT01642589|12540181|P2|NOT COMPLETED|Overall Study||1
5097154|NCT01642589|12540182|P1|NOT COMPLETED|Overall Study||1
5097155|NCT01642589|12540181|P2|COMPLETED|Overall Study||99
5097156|NCT01642589|12540182|P1|COMPLETED|Overall Study||199
5097157|NCT01642589|12540181|P2|STARTED|Overall Study||100
5097158|NCT01642589|12540182|P1|STARTED|Overall Study||200
5097159|NCT01642485|12540196|P8|NOT COMPLETED|Period 2, Day 3||0
5097160|NCT01642485|12540197|P7|NOT COMPLETED|Period 2, Day 3||0
5097161|NCT01642485|12540198|P6|NOT COMPLETED|Period 2, Day 3||0
5097162|NCT01642485|12540199|P5|NOT COMPLETED|Period 2, Day 3||0
5097163|NCT01642485|12540200|P4|NOT COMPLETED|Period 2, Day 3||0
5097164|NCT01642485|12540201|P3|NOT COMPLETED|Period 2, Day 3||0
5097165|NCT01642485|12540202|P2|NOT COMPLETED|Period 2, Day 3||0
5097166|NCT01642485|12540203|P1|NOT COMPLETED|Period 2, Day 3||0
5097167|NCT01642485|12540196|P8|COMPLETED|Period 2, Day 3||4
5097168|NCT01642485|12540197|P7|COMPLETED|Period 2, Day 3||4
5097169|NCT01642485|12540198|P6|COMPLETED|Period 2, Day 3||4
5097170|NCT01642485|12540199|P5|COMPLETED|Period 2, Day 3||4
5097171|NCT01642485|12540200|P4|COMPLETED|Period 2, Day 3||4
5097172|NCT01642485|12540201|P3|COMPLETED|Period 2, Day 3||4
5097173|NCT01642485|12540202|P2|COMPLETED|Period 2, Day 3||4
5097174|NCT01642485|12540203|P1|COMPLETED|Period 2, Day 3||4
5097175|NCT01642485|12540196|P8|STARTED|Period 2, Day 3||4
5097176|NCT01642485|12540197|P7|STARTED|Period 2, Day 3||4
5097177|NCT01642485|12540198|P6|STARTED|Period 2, Day 3||4
5097178|NCT01642485|12540199|P5|STARTED|Period 2, Day 3||4
5097179|NCT01642485|12540200|P4|STARTED|Period 2, Day 3||4
5097180|NCT01642485|12540201|P3|STARTED|Period 2, Day 3||4
5097181|NCT01642485|12540202|P2|STARTED|Period 2, Day 3||4
5097182|NCT01642485|12540203|P1|STARTED|Period 2, Day 3||4
5097183|NCT01642485|12540196|P8|NOT COMPLETED|Period 2, Day 2||0
5097184|NCT01642485|12540197|P7|NOT COMPLETED|Period 2, Day 2||0
5097185|NCT01642485|12540198|P6|NOT COMPLETED|Period 2, Day 2||0
5097186|NCT01642485|12540199|P5|NOT COMPLETED|Period 2, Day 2||0
5097187|NCT01642485|12540200|P4|NOT COMPLETED|Period 2, Day 2||0
5097188|NCT01642485|12540201|P3|NOT COMPLETED|Period 2, Day 2||0
5097189|NCT01642485|12540202|P2|NOT COMPLETED|Period 2, Day 2||0
5097190|NCT01642485|12540203|P1|NOT COMPLETED|Period 2, Day 2||0
5097191|NCT01642485|12540196|P8|COMPLETED|Period 2, Day 2||4
5097192|NCT01642485|12540197|P7|COMPLETED|Period 2, Day 2||4
5097193|NCT01642485|12540198|P6|COMPLETED|Period 2, Day 2||4
5097194|NCT01642485|12540199|P5|COMPLETED|Period 2, Day 2||4
5097195|NCT01642485|12540200|P4|COMPLETED|Period 2, Day 2||4
5097196|NCT01642485|12540201|P3|COMPLETED|Period 2, Day 2||4
5097197|NCT01642485|12540202|P2|COMPLETED|Period 2, Day 2||4
5097198|NCT01642485|12540203|P1|COMPLETED|Period 2, Day 2||4
5097199|NCT01642485|12540196|P8|STARTED|Period 2, Day 2||4
5097200|NCT01642485|12540197|P7|STARTED|Period 2, Day 2||4
5097201|NCT01642485|12540198|P6|STARTED|Period 2, Day 2||4
5097202|NCT01642485|12540199|P5|STARTED|Period 2, Day 2||4
5097203|NCT01642485|12540200|P4|STARTED|Period 2, Day 2||4
5097204|NCT01642485|12540201|P3|STARTED|Period 2, Day 2||4
5097205|NCT01642485|12540202|P2|STARTED|Period 2, Day 2||4
5097206|NCT01642485|12540203|P1|STARTED|Period 2, Day 2||4
5097207|NCT01642485|12540196|P8|NOT COMPLETED|Period 2, Day 1||0
5097208|NCT01642485|12540197|P7|NOT COMPLETED|Period 2, Day 1||0
5097209|NCT01642485|12540198|P6|NOT COMPLETED|Period 2, Day 1||0
5097210|NCT01642485|12540199|P5|NOT COMPLETED|Period 2, Day 1||0
5097211|NCT01642485|12540200|P4|NOT COMPLETED|Period 2, Day 1||0
5097212|NCT01642485|12540201|P3|NOT COMPLETED|Period 2, Day 1||0
5097213|NCT01642485|12540202|P2|NOT COMPLETED|Period 2, Day 1||0
5097214|NCT01642485|12540203|P1|NOT COMPLETED|Period 2, Day 1||0
5097215|NCT01642485|12540196|P8|COMPLETED|Period 2, Day 1||4
5097216|NCT01642485|12540197|P7|COMPLETED|Period 2, Day 1||4
5097217|NCT01642485|12540198|P6|COMPLETED|Period 2, Day 1||4
5097218|NCT01642485|12540199|P5|COMPLETED|Period 2, Day 1||4
5097219|NCT01642485|12540200|P4|COMPLETED|Period 2, Day 1||4
5097220|NCT01642485|12540201|P3|COMPLETED|Period 2, Day 1||4
5097221|NCT01642485|12540202|P2|COMPLETED|Period 2, Day 1||4
5097222|NCT01642485|12540203|P1|COMPLETED|Period 2, Day 1||4
5097223|NCT01642485|12540196|P8|STARTED|Period 2, Day 1||4
5097224|NCT01642485|12540197|P7|STARTED|Period 2, Day 1||4
5097225|NCT01642485|12540198|P6|STARTED|Period 2, Day 1||4
5097226|NCT01642485|12540199|P5|STARTED|Period 2, Day 1||4
5097227|NCT01642485|12540200|P4|STARTED|Period 2, Day 1||4
5097228|NCT01642485|12540201|P3|STARTED|Period 2, Day 1||4
5097229|NCT01642485|12540202|P2|STARTED|Period 2, Day 1||4
5097230|NCT01642485|12540203|P1|STARTED|Period 2, Day 1||4
5097231|NCT01642485|12540196|P8|NOT COMPLETED|Period 1, Day 3||0
5097232|NCT01642485|12540197|P7|NOT COMPLETED|Period 1, Day 3||0
5097233|NCT01642485|12540198|P6|NOT COMPLETED|Period 1, Day 3||0
5097234|NCT01642485|12540199|P5|NOT COMPLETED|Period 1, Day 3||0
5097235|NCT01642485|12540200|P4|NOT COMPLETED|Period 1, Day 3||0
5097236|NCT01642485|12540201|P3|NOT COMPLETED|Period 1, Day 3||0
5097237|NCT01642485|12540202|P2|NOT COMPLETED|Period 1, Day 3||0
5097238|NCT01642485|12540203|P1|NOT COMPLETED|Period 1, Day 3||0
5097239|NCT01642485|12540196|P8|COMPLETED|Period 1, Day 3||4
5097240|NCT01642485|12540197|P7|COMPLETED|Period 1, Day 3||4
5097241|NCT01642485|12540198|P6|COMPLETED|Period 1, Day 3||4
5097242|NCT01642485|12540199|P5|COMPLETED|Period 1, Day 3||4
5097243|NCT01642485|12540200|P4|COMPLETED|Period 1, Day 3||4
5097244|NCT01642485|12540201|P3|COMPLETED|Period 1, Day 3||4
5097245|NCT01642485|12540202|P2|COMPLETED|Period 1, Day 3||4
5097246|NCT01642485|12540203|P1|COMPLETED|Period 1, Day 3||4
5097247|NCT01642485|12540196|P8|STARTED|Period 1, Day 3||4
5097248|NCT01642485|12540197|P7|STARTED|Period 1, Day 3||4
5097249|NCT01642485|12540198|P6|STARTED|Period 1, Day 3||4
5097250|NCT01642485|12540199|P5|STARTED|Period 1, Day 3||4
5097251|NCT01642485|12540200|P4|STARTED|Period 1, Day 3||4
5097252|NCT01642485|12540201|P3|STARTED|Period 1, Day 3||4
5097253|NCT01642485|12540202|P2|STARTED|Period 1, Day 3||4
5097254|NCT01642485|12540203|P1|STARTED|Period 1, Day 3||4
5097255|NCT01642485|12540196|P8|NOT COMPLETED|Period 1, Day 2||0
5097256|NCT01642485|12540197|P7|NOT COMPLETED|Period 1, Day 2||0
5097257|NCT01642485|12540198|P6|NOT COMPLETED|Period 1, Day 2||0
5097258|NCT01642485|12540199|P5|NOT COMPLETED|Period 1, Day 2||0
5097259|NCT01642485|12540200|P4|NOT COMPLETED|Period 1, Day 2||0
5097260|NCT01642485|12540201|P3|NOT COMPLETED|Period 1, Day 2||0
5097261|NCT01642485|12540202|P2|NOT COMPLETED|Period 1, Day 2||0
5097262|NCT01642485|12540203|P1|NOT COMPLETED|Period 1, Day 2||0
5097263|NCT01642485|12540196|P8|COMPLETED|Period 1, Day 2||4
5097264|NCT01642485|12540197|P7|COMPLETED|Period 1, Day 2||4
5097265|NCT01642485|12540198|P6|COMPLETED|Period 1, Day 2||4
5097266|NCT01642485|12540199|P5|COMPLETED|Period 1, Day 2||4
5097267|NCT01642485|12540200|P4|COMPLETED|Period 1, Day 2||4
5097268|NCT01642485|12540201|P3|COMPLETED|Period 1, Day 2||4
5097269|NCT01642485|12540202|P2|COMPLETED|Period 1, Day 2||4
5097270|NCT01642485|12540203|P1|COMPLETED|Period 1, Day 2||4
5097271|NCT01642485|12540196|P8|STARTED|Period 1, Day 2||4
5097272|NCT01642485|12540197|P7|STARTED|Period 1, Day 2||4
5097273|NCT01642485|12540198|P6|STARTED|Period 1, Day 2||4
5097274|NCT01642485|12540199|P5|STARTED|Period 1, Day 2||4
5097275|NCT01642485|12540200|P4|STARTED|Period 1, Day 2||4
5097276|NCT01642485|12540201|P3|STARTED|Period 1, Day 2||4
5097277|NCT01642485|12540202|P2|STARTED|Period 1, Day 2||4
5097278|NCT01642485|12540203|P1|STARTED|Period 1, Day 2||4
5097279|NCT01642485|12540196|P8|NOT COMPLETED|Period 1, Day 1||0
5097280|NCT01642485|12540197|P7|NOT COMPLETED|Period 1, Day 1||0
5097281|NCT01642485|12540198|P6|NOT COMPLETED|Period 1, Day 1||0
5097282|NCT01642485|12540199|P5|NOT COMPLETED|Period 1, Day 1||0
5097283|NCT01642485|12540200|P4|NOT COMPLETED|Period 1, Day 1||0
5097284|NCT01642485|12540201|P3|NOT COMPLETED|Period 1, Day 1||0
5097285|NCT01642485|12540202|P2|NOT COMPLETED|Period 1, Day 1||0
5097286|NCT01642485|12540203|P1|NOT COMPLETED|Period 1, Day 1||0
5097287|NCT01642485|12540196|P8|COMPLETED|Period 1, Day 1||4
5097288|NCT01642485|12540197|P7|COMPLETED|Period 1, Day 1||4
5097289|NCT01642485|12540198|P6|COMPLETED|Period 1, Day 1||4
5097290|NCT01642485|12540199|P5|COMPLETED|Period 1, Day 1||4
5097291|NCT01642485|12540200|P4|COMPLETED|Period 1, Day 1||4
5097292|NCT01642485|12540201|P3|COMPLETED|Period 1, Day 1||4
5097293|NCT01642485|12540202|P2|COMPLETED|Period 1, Day 1||4
5097294|NCT01642485|12540203|P1|COMPLETED|Period 1, Day 1||4
5097295|NCT01642485|12540196|P8|STARTED|Period 1, Day 1||4
5097296|NCT01642485|12540197|P7|STARTED|Period 1, Day 1||4
5097297|NCT01642485|12540198|P6|STARTED|Period 1, Day 1||4
5097298|NCT01642485|12540199|P5|STARTED|Period 1, Day 1||4
5097299|NCT01642485|12540200|P4|STARTED|Period 1, Day 1||4
5097300|NCT01642485|12540201|P3|STARTED|Period 1, Day 1||4
5097301|NCT01642485|12540202|P2|STARTED|Period 1, Day 1||4
5097302|NCT01642485|12540203|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
5097303|NCT01642407|12540221|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
5097304|NCT01642407|12540221|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
5097305|NCT01642407|12540221|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
5097306|NCT01642407|12540221|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
5097307|NCT01642407|12540221|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
5097308|NCT01642407|12540221|P1|STARTED|Part 1 (Screening Till Week 16)||6
5097309|NCT01642277|12540268|P2|NOT COMPLETED|Overall Study||0
5097310|NCT01642277|12540269|P1|NOT COMPLETED|Overall Study||24
5097311|NCT01642277|12540268|P2|COMPLETED|Overall Study||60
5097312|NCT01642277|12540269|P1|COMPLETED|Overall Study||50
5097313|NCT01642277|12540268|P2|STARTED|Overall Study||60
5097314|NCT01642277|12540269|P1|STARTED|Overall Study||74
5097315|NCT01642251|12540281|P4|NOT COMPLETED|Overall Study||23
5097316|NCT01642251|12540282|P3|NOT COMPLETED|Overall Study||22
5097317|NCT01642251|12540283|P2|NOT COMPLETED|Overall Study||0
5097318|NCT01642251|12540284|P1|NOT COMPLETED|Overall Study||0
5097319|NCT01642251|12540281|P4|COMPLETED|Overall Study||49
5097320|NCT01642251|12540282|P3|COMPLETED|Overall Study||53
5097321|NCT01642251|12540283|P2|COMPLETED|Overall Study||6
5097322|NCT01642251|12540284|P1|COMPLETED|Overall Study||3
5097323|NCT01642251|12540281|P4|Eligible and Treated|Overall Study||64
5097324|NCT01642251|12540282|P3|Eligible and Treated|Overall Study||64
5097325|NCT01642251|12540283|P2|Eligible and Treated|Overall Study||6
5097326|NCT01642251|12540284|P1|Eligible and Treated|Overall Study||3
5097327|NCT01642251|12540281|P4|Eligible|Overall Study||69
5097328|NCT01642251|12540282|P3|Eligible|Overall Study||72
5097329|NCT01642251|12540283|P2|Eligible|Overall Study||6
5097330|NCT01642251|12540284|P1|Eligible|Overall Study||3
5097331|NCT01642251|12540281|P4|Started Protocol Therapy|Overall Study||66
5097332|NCT01642251|12540282|P3|Started Protocol Therapy|Overall Study||66
5097333|NCT01642251|12540283|P2|Started Protocol Therapy|Overall Study||6
5097334|NCT01642251|12540284|P1|Started Protocol Therapy|Overall Study||3
5097335|NCT01642251|12540281|P4|STARTED|Overall Study||72
5097336|NCT01642251|12540282|P3|STARTED|Overall Study||75
5097337|NCT01642251|12540283|P2|STARTED|Overall Study||6
5097338|NCT01642251|12540284|P1|STARTED|Overall Study||3
5097339|NCT01642238|12540299|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5097340|NCT01642238|12540300|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5097341|NCT01642238|12540299|P2|COMPLETED|Second Intervention (1 Day)||8
5097342|NCT01642238|12540300|P1|COMPLETED|Second Intervention (1 Day)||7
5097343|NCT01642238|12540299|P2|STARTED|Second Intervention (1 Day)||8
5097344|NCT01642238|12540300|P1|STARTED|Second Intervention (1 Day)||7
5097345|NCT01642238|12540299|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
5097346|NCT01642238|12540300|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
5097347|NCT01642238|12540299|P2|COMPLETED|Washout (1-2 Weeks)||8
5097348|NCT01642238|12540300|P1|COMPLETED|Washout (1-2 Weeks)||7
5097349|NCT01642238|12540299|P2|STARTED|Washout (1-2 Weeks)||8
5097350|NCT01642238|12540300|P1|STARTED|Washout (1-2 Weeks)||7
5097351|NCT01642238|12540299|P2|NOT COMPLETED|First Intervention (1 Day)||0
5097352|NCT01642238|12540300|P1|NOT COMPLETED|First Intervention (1 Day)||0
5097353|NCT01642238|12540299|P2|COMPLETED|First Intervention (1 Day)||8
5097354|NCT01642238|12540300|P1|COMPLETED|First Intervention (1 Day)||7
5097355|NCT01642238|12540299|P2|STARTED|First Intervention (1 Day)||8
5097356|NCT01642238|12540300|P1|STARTED|First Intervention (1 Day)||7
5097357|NCT01642212|12540322|P5|NOT COMPLETED|Open-label Extension||8
5097358|NCT01642212|12540323|P4|NOT COMPLETED|Open-label Extension||10
5097359|NCT01642212|12540324|P3|NOT COMPLETED|Open-label Extension||0
5097360|NCT01642212|12540325|P2|NOT COMPLETED|Open-label Extension||0
5097361|NCT01642212|12540326|P1|NOT COMPLETED|Open-label Extension||0
5097362|NCT01642212|12540322|P5|COMPLETED|Open-label Extension||37
5097363|NCT01642212|12540323|P4|COMPLETED|Open-label Extension||27
5097364|NCT01642212|12540324|P3|COMPLETED|Open-label Extension||0
5097365|NCT01642212|12540325|P2|COMPLETED|Open-label Extension||0
5097366|NCT01642212|12540326|P1|COMPLETED|Open-label Extension||0
5097367|NCT01642212|12540322|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
5097368|NCT01642212|12540323|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
5097369|NCT01642212|12540324|P3|STARTED|Open-label Extension||0
5097370|NCT01642212|12540325|P2|STARTED|Open-label Extension||0
5097371|NCT01642212|12540326|P1|STARTED|Open-label Extension||0
5097372|NCT01642212|12540322|P5|NOT COMPLETED|Double-blind Treatment||0
5097373|NCT01642212|12540323|P4|NOT COMPLETED|Double-blind Treatment||0
5097374|NCT01642212|12540324|P3|NOT COMPLETED|Double-blind Treatment||2
5097375|NCT01642212|12540325|P2|NOT COMPLETED|Double-blind Treatment||3
5097376|NCT01642212|12540326|P1|NOT COMPLETED|Double-blind Treatment||0
5097377|NCT01642212|12540322|P5|COMPLETED|Double-blind Treatment||0
5097378|NCT01642212|12540323|P4|COMPLETED|Double-blind Treatment||0
5097379|NCT01642212|12540324|P3|COMPLETED|Double-blind Treatment||49
5097380|NCT01642212|12540325|P2|COMPLETED|Double-blind Treatment||39
5097381|NCT01642212|12540326|P1|COMPLETED|Double-blind Treatment||0
5097382|NCT01642212|12540322|P5|STARTED|Double-blind Treatment||0
5097383|NCT01642212|12540323|P4|STARTED|Double-blind Treatment||0
5097384|NCT01642212|12540324|P3|STARTED|Double-blind Treatment||51
5097385|NCT01642212|12540325|P2|STARTED|Double-blind Treatment||42
5097386|NCT01642212|12540326|P1|STARTED|Double-blind Treatment||0
5097387|NCT01642212|12540322|P5|NOT COMPLETED|Single-blind Baseline||0
5097388|NCT01642212|12540323|P4|NOT COMPLETED|Single-blind Baseline||0
5097389|NCT01642212|12540324|P3|NOT COMPLETED|Single-blind Baseline||0
5097390|NCT01642212|12540325|P2|NOT COMPLETED|Single-blind Baseline||0
5097391|NCT01642212|12540326|P1|NOT COMPLETED|Single-blind Baseline||26
5097392|NCT01642212|12540322|P5|COMPLETED|Single-blind Baseline||0
5097393|NCT01642212|12540323|P4|COMPLETED|Single-blind Baseline||0
5097394|NCT01642212|12540324|P3|COMPLETED|Single-blind Baseline||0
5097395|NCT01642212|12540325|P2|COMPLETED|Single-blind Baseline||0
5097396|NCT01642212|12540326|P1|COMPLETED|Single-blind Baseline||93
5097397|NCT01642212|12540322|P5|STARTED|Single-blind Baseline||0
5097398|NCT01642212|12540323|P4|STARTED|Single-blind Baseline||0
5097399|NCT01642212|12540324|P3|STARTED|Single-blind Baseline||0
5097400|NCT01642212|12540325|P2|STARTED|Single-blind Baseline||0
5097401|NCT01642212|12540326|P1|STARTED|Single-blind Baseline||119
5097402|NCT01642147|12540376|P2|NOT COMPLETED|Overall Study||0
5097403|NCT01642147|12540377|P1|NOT COMPLETED|Overall Study||0
5097404|NCT01642147|12540376|P2|COMPLETED|Overall Study||30
5097405|NCT01642147|12540377|P1|COMPLETED|Overall Study||30
5097406|NCT01642147|12540376|P2|STARTED|Overall Study||30
5097407|NCT01642147|12540377|P1|STARTED|Overall Study||30
5097408|NCT01642082|12540405|P1|NOT COMPLETED|Overall Study||0
5097409|NCT01642082|12540405|P1|COMPLETED|Overall Study||28
5097410|NCT01642082|12540405|P1|STARTED|Overall Study||28
5097411|NCT01642004|12540421|P2|NOT COMPLETED|Treatment||127
5097412|NCT01642004|12540422|P1|NOT COMPLETED|Treatment||110
5097413|NCT01642004|12540421|P2|COMPLETED|Treatment||2
5097414|NCT01642004|12540422|P1|COMPLETED|Treatment||21
5097415|NCT01642004|12540421|P2|STARTED|Treatment||129
5097416|NCT01642004|12540422|P1|STARTED|Treatment||131
5097417|NCT01642004|12540421|P2|NOT COMPLETED|Randomization||8
5097418|NCT01642004|12540422|P1|NOT COMPLETED|Randomization||4
5097419|NCT01642004|12540421|P2|COMPLETED|Randomization||129
5097420|NCT01642004|12540422|P1|COMPLETED|Randomization||131
5097421|NCT01642004|12540421|P2|STARTED|Randomization||137
5097422|NCT01642004|12540422|P1|STARTED|Randomization||135
5097423|NCT01641991|12540456|P4|NOT COMPLETED|Overall Study||16
5097424|NCT01641991|12540457|P3|NOT COMPLETED|Overall Study||17
5097425|NCT01641991|12540458|P2|NOT COMPLETED|Overall Study||8
5097426|NCT01641991|12540459|P1|NOT COMPLETED|Overall Study||9
5097427|NCT01641991|12540456|P4|COMPLETED|Overall Study||66
5097428|NCT01641991|12540457|P3|COMPLETED|Overall Study||65
5097429|NCT01641991|12540458|P2|COMPLETED|Overall Study||74
5097430|NCT01641991|12540459|P1|COMPLETED|Overall Study||73
5097431|NCT01641991|12540456|P4|STARTED|Overall Study||82
5097432|NCT01641991|12540457|P3|STARTED|Overall Study||82
5097433|NCT01641991|12540458|P2|STARTED|Overall Study||82
5097434|NCT01641991|12540459|P1|STARTED|Overall Study||82
5097435|NCT01641978|12540535|P1|NOT COMPLETED|Overall Study||0
5097436|NCT01641978|12540535|P1|COMPLETED|Overall Study||125
5097437|NCT01641978|12540535|P1|STARTED|Overall Study||125
5097438|NCT01641952|12540543|P1|NOT COMPLETED|Overall Study||34
5097439|NCT01641952|12540543|P1|COMPLETED|Overall Study||471
5097440|NCT01641952|12540543|P1|Treated|Overall Study||504
5097441|NCT01641952|12540543|P1|STARTED|Overall Study||505
5097442|NCT01641939|12540559|P3|NOT COMPLETED|Overall Study||70
5097443|NCT01641939|12540560|P2|NOT COMPLETED|Overall Study||228
5097444|NCT01641939|12540561|P1|NOT COMPLETED|Overall Study||117
5097445|NCT01641939|12540559|P3|COMPLETED|Overall Study||0
5097446|NCT01641939|12540560|P2|COMPLETED|Overall Study||0
5097447|NCT01641939|12540561|P1|COMPLETED|Overall Study||0
5097448|NCT01641939|12540559|P3|Stage 2|Overall Study||0
5097449|NCT01641939|12540560|P2|Stage 2|Overall Study||153
5097450|NCT01641939|12540561|P1|Stage 2|Overall Study||80
5097451|NCT01641939|12540559|P3|Stage 1|Overall Study||70
5097452|NCT01641939|12540560|P2|Stage 1|Overall Study||75
5097453|NCT01641939|12540561|P1|Stage 1|Overall Study||37
5097454|NCT01641939|12540559|P3|STARTED|Overall Study||70
5097455|NCT01641939|12540560|P2|STARTED|Overall Study||228
5097456|NCT01641939|12540561|P1|STARTED|Overall Study||117
5097457|NCT01641926|12540604|P4|NOT COMPLETED|Overall Study||4
5097458|NCT01641926|12540605|P3|NOT COMPLETED|Overall Study||11
5097459|NCT01641926|12540606|P2|NOT COMPLETED|Overall Study||15
5097460|NCT01641926|12540607|P1|NOT COMPLETED|Overall Study||28
5097461|NCT01641926|12540604|P4|COMPLETED|Overall Study||53
5097462|NCT01641926|12540605|P3|COMPLETED|Overall Study||46
5097463|NCT01641926|12540606|P2|COMPLETED|Overall Study||130
5097464|NCT01641926|12540607|P1|COMPLETED|Overall Study||115
5097465|NCT01641926|12540604|P4|Treated (All Participants as Treated)|Overall Study||57
5097466|NCT01641926|12540605|P3|Treated (All Participants as Treated)|Overall Study||56
5097467|NCT01641926|12540606|P2|Treated (All Participants as Treated)|Overall Study||144
5097468|NCT01641926|12540607|P1|Treated (All Participants as Treated)|Overall Study||142
5097469|NCT01641926|12540604|P4|STARTED|Overall Study||57
5097470|NCT01641926|12540605|P3|STARTED|Overall Study||57
5097471|NCT01641926|12540606|P2|STARTED|Overall Study||145
5097472|NCT01641926|12540607|P1|STARTED|Overall Study||143
5097473|NCT01641900|12540635|P2|NOT COMPLETED|Overall Study||2
5097474|NCT01641900|12540636|P1|NOT COMPLETED|Overall Study||2
5097475|NCT01641900|12540635|P2|COMPLETED|Overall Study||29
5097476|NCT01641900|12540636|P1|COMPLETED|Overall Study||26
5097477|NCT01641900|12540635|P2|Completed Drug Intervention|Overall Study||29
5097478|NCT01641900|12540636|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
5097479|NCT01641900|12540635|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
5097480|NCT01641900|12540636|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
5097481|NCT01641900|12540635|P2|STARTED|Overall Study||31
5097482|NCT01641900|12540636|P1|STARTED|Overall Study||28
5097483|NCT01641861|12540648|P2|NOT COMPLETED|Overall Study||25
5097484|NCT01641861|12540649|P1|NOT COMPLETED|Overall Study||35
5097485|NCT01641861|12540648|P2|COMPLETED|Overall Study||217
5097486|NCT01641861|12540649|P1|COMPLETED|Overall Study||211
5097487|NCT01641861|12540648|P2|STARTED|Overall Study||242
5097488|NCT01641861|12540649|P1|STARTED|Overall Study||246
5097489|NCT01641835|12540663|P1|NOT COMPLETED|Overall Study||0
5097490|NCT01641835|12540663|P1|COMPLETED|Overall Study||303
5097491|NCT01641835|12540663|P1|STARTED|Overall Study||303
5097492|NCT01641822|12540670|P3|NOT COMPLETED|Comparative Phase||10
5097493|NCT01641822|12540671|P2|NOT COMPLETED|Comparative Phase||6
5097494|NCT01641822|12540672|P1|NOT COMPLETED|Comparative Phase||0
5097495|NCT01641822|12540670|P3|COMPLETED|Comparative Phase||37
5097496|NCT01641822|12540671|P2|COMPLETED|Comparative Phase||37
5097497|NCT01641822|12540672|P1|COMPLETED|Comparative Phase||0
5097498|NCT01641822|12540670|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
5097499|NCT01641822|12540671|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
5097500|NCT01641822|12540672|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
5097501|NCT01641822|12540670|P3|STARTED|Comparative Phase||47
5097502|NCT01641822|12540671|P2|STARTED|Comparative Phase||43
5097503|NCT01641822|12540672|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
5097504|NCT01641822|12540670|P3|NOT COMPLETED|Run-in Phase||0
5097505|NCT01641822|12540671|P2|NOT COMPLETED|Run-in Phase||0
5097506|NCT01641822|12540672|P1|NOT COMPLETED|Run-in Phase||14
5097507|NCT01641822|12540670|P3|COMPLETED|Run-in Phase||0
5097508|NCT01641822|12540671|P2|COMPLETED|Run-in Phase||0
5097509|NCT01641822|12540672|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
5097510|NCT01641822|12540670|P3|STARTED|Run-in Phase||0
5097511|NCT01641822|12540671|P2|STARTED|Run-in Phase||0
5097512|NCT01641822|12540672|P1|STARTED|Run-in Phase||107
5097513|NCT01641809|12540693|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
5097514|NCT01641809|12540694|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
5097515|NCT01641809|12540695|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
5097516|NCT01641809|12540696|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
5097517|NCT01641809|12540693|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
5097518|NCT01641809|12540694|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
5097519|NCT01641809|12540695|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
5097520|NCT01641809|12540696|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
5097521|NCT01641809|12540693|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
5097522|NCT01641809|12540694|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
5097523|NCT01641809|12540695|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
5097524|NCT01641809|12540696|P1|STARTED|Open-label (Week 96 to Week 324)||46
5097525|NCT01641809|12540693|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
5097526|NCT01641809|12540694|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
5097527|NCT01641809|12540695|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
5097528|NCT01641809|12540696|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
5097529|NCT01641809|12540693|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
5097530|NCT01641809|12540694|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
5097531|NCT01641809|12540695|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
5097532|NCT01641809|12540696|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
5097533|NCT01641809|12540693|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
5097534|NCT01641809|12540694|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
5097535|NCT01641809|12540695|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
5097536|NCT01641809|12540696|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
5097537|NCT01641809|12540693|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
5097538|NCT01641809|12540694|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
5097539|NCT01641809|12540695|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
5097540|NCT01641809|12540696|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
5097541|NCT01641809|12540693|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
5097542|NCT01641809|12540694|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
5097543|NCT01641809|12540695|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
5097544|NCT01641809|12540696|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
5097545|NCT01641809|12540693|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
5097546|NCT01641809|12540694|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
5097547|NCT01641809|12540695|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
5097548|NCT01641809|12540696|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
5097549|NCT01641692|12540880|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
5097550|NCT01641692|12540881|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
5097551|NCT01641692|12540882|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
5097552|NCT01641692|12540883|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
5097553|NCT01641692|12540884|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
5097554|NCT01641692|12540885|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
5097555|NCT01641692|12540886|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
5097556|NCT01641692|12540887|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
5097557|NCT01641692|12540880|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
5097558|NCT01641692|12540881|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
5097559|NCT01641692|12540882|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
5097560|NCT01641692|12540883|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
5097561|NCT01641692|12540884|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
5097562|NCT01641692|12540885|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
5097563|NCT01641692|12540886|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
5097564|NCT01641692|12540887|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
5097565|NCT01641692|12540880|P8|STARTED|Washout Period 3 or Follow-up||38
5097566|NCT01641692|12540881|P7|STARTED|Washout Period 3 or Follow-up||33
5097567|NCT01641692|12540882|P6|STARTED|Washout Period 3 or Follow-up||39
5097568|NCT01641692|12540883|P5|STARTED|Washout Period 3 or Follow-up||40
5097569|NCT01641692|12540884|P4|STARTED|Washout Period 3 or Follow-up||42
5097570|NCT01641692|12540885|P3|STARTED|Washout Period 3 or Follow-up||37
5097571|NCT01641692|12540886|P2|STARTED|Washout Period 3 or Follow-up||32
5097572|NCT01641692|12540887|P1|STARTED|Washout Period 3 or Follow-up||43
5097573|NCT01641692|12540880|P8|NOT COMPLETED|Treatment Period 3||0
5097574|NCT01641692|12540881|P7|NOT COMPLETED|Treatment Period 3||2
5097575|NCT01641692|12540882|P6|NOT COMPLETED|Treatment Period 3||0
5097576|NCT01641692|12540883|P5|NOT COMPLETED|Treatment Period 3||0
5097577|NCT01641692|12540884|P4|NOT COMPLETED|Treatment Period 3||0
5097578|NCT01641692|12540885|P3|NOT COMPLETED|Treatment Period 3||1
5097579|NCT01641692|12540886|P2|NOT COMPLETED|Treatment Period 3||1
5097580|NCT01641692|12540887|P1|NOT COMPLETED|Treatment Period 3||0
5097581|NCT01641692|12540880|P8|COMPLETED|Treatment Period 3||38
5097582|NCT01641692|12540881|P7|COMPLETED|Treatment Period 3||33
5097583|NCT01641692|12540882|P6|COMPLETED|Treatment Period 3||39
5097584|NCT01641692|12540883|P5|COMPLETED|Treatment Period 3||40
5097585|NCT01641692|12540884|P4|COMPLETED|Treatment Period 3||42
5097586|NCT01641692|12540885|P3|COMPLETED|Treatment Period 3||37
5097587|NCT01641692|12540886|P2|COMPLETED|Treatment Period 3||32
5097588|NCT01641692|12540887|P1|COMPLETED|Treatment Period 3||43
5097589|NCT01641692|12540880|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
5097590|NCT01641692|12540881|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
5097591|NCT01641692|12540882|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
5097592|NCT01641692|12540883|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
5097593|NCT01641692|12540884|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
5097594|NCT01641692|12540885|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
5097595|NCT01641692|12540886|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
5097596|NCT01641692|12540887|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
5097597|NCT01641692|12540880|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
5097598|NCT01641692|12540881|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
5097599|NCT01641692|12540882|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
5097600|NCT01641692|12540883|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
5097601|NCT01641692|12540884|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
5097602|NCT01641692|12540885|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
5097603|NCT01641692|12540886|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
5097604|NCT01641692|12540887|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
5097605|NCT01641692|12540880|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
5097606|NCT01641692|12540881|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
5097607|NCT01641692|12540882|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
5097608|NCT01641692|12540883|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
5097609|NCT01641692|12540884|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
5097610|NCT01641692|12540885|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
5097611|NCT01641692|12540886|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
5097612|NCT01641692|12540887|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
5097613|NCT01641692|12540880|P8|STARTED|Washout Period 2 (12-14 Days)||35
5097614|NCT01641692|12540881|P7|STARTED|Washout Period 2 (12-14 Days)||43
5097615|NCT01641692|12540882|P6|STARTED|Washout Period 2 (12-14 Days)||43
5097616|NCT01641692|12540883|P5|STARTED|Washout Period 2 (12-14 Days)||37
5097617|NCT01641692|12540884|P4|STARTED|Washout Period 2 (12-14 Days)||41
5097618|NCT01641692|12540885|P3|STARTED|Washout Period 2 (12-14 Days)||40
5097619|NCT01641692|12540886|P2|STARTED|Washout Period 2 (12-14 Days)||46
5097620|NCT01641692|12540887|P1|STARTED|Washout Period 2 (12-14 Days)||30
5097621|NCT01641692|12540880|P8|NOT COMPLETED|Treatment Period 2||1
5097622|NCT01641692|12540881|P7|NOT COMPLETED|Treatment Period 2||0
5097623|NCT01641692|12540882|P6|NOT COMPLETED|Treatment Period 2||2
5097624|NCT01641692|12540883|P5|NOT COMPLETED|Treatment Period 2||0
5097625|NCT01641692|12540884|P4|NOT COMPLETED|Treatment Period 2||0
5097626|NCT01641692|12540885|P3|NOT COMPLETED|Treatment Period 2||0
5097627|NCT01641692|12540886|P2|NOT COMPLETED|Treatment Period 2||0
5097628|NCT01641692|12540887|P1|NOT COMPLETED|Treatment Period 2||3
5097629|NCT01641692|12540880|P8|COMPLETED|Treatment Period 2||35
5097630|NCT01641692|12540881|P7|COMPLETED|Treatment Period 2||43
5097631|NCT01641692|12540882|P6|COMPLETED|Treatment Period 2||43
5097632|NCT01641692|12540883|P5|COMPLETED|Treatment Period 2||37
5097633|NCT01641692|12540884|P4|COMPLETED|Treatment Period 2||41
5097634|NCT01641692|12540885|P3|COMPLETED|Treatment Period 2||40
5097635|NCT01641692|12540886|P2|COMPLETED|Treatment Period 2||46
5097636|NCT01641692|12540887|P1|COMPLETED|Treatment Period 2||30
5097637|NCT01641692|12540880|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
5097638|NCT01641692|12540881|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
5097639|NCT01641692|12540882|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
5097640|NCT01641692|12540883|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
5097641|NCT01641692|12540884|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
5097642|NCT01641692|12540885|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
5097643|NCT01641692|12540886|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
5097644|NCT01641692|12540887|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
5097645|NCT01641692|12540880|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
5097646|NCT01641692|12540881|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
5097647|NCT01641692|12540882|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
5097648|NCT01641692|12540883|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
5097649|NCT01641692|12540884|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
5097650|NCT01641692|12540885|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
5097651|NCT01641692|12540886|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
5097652|NCT01641692|12540887|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
5097653|NCT01641692|12540880|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
5097654|NCT01641692|12540881|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
5097655|NCT01641692|12540882|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
5097656|NCT01641692|12540883|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
5097657|NCT01641692|12540884|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
5097658|NCT01641692|12540885|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
5097744|NCT01641367|12541132|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
5097659|NCT01641692|12540886|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
5097660|NCT01641692|12540887|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
5097661|NCT01641692|12540880|P8|STARTED|Washout Period 1 (12-14 Days)||48
5097662|NCT01641692|12540881|P7|STARTED|Washout Period 1 (12-14 Days)||38
5097663|NCT01641692|12540882|P6|STARTED|Washout Period 1 (12-14 Days)||37
5097664|NCT01641692|12540883|P5|STARTED|Washout Period 1 (12-14 Days)||39
5097665|NCT01641692|12540884|P4|STARTED|Washout Period 1 (12-14 Days)||41
5097666|NCT01641692|12540885|P3|STARTED|Washout Period 1 (12-14 Days)||50
5097667|NCT01641692|12540886|P2|STARTED|Washout Period 1 (12-14 Days)||45
5097668|NCT01641692|12540887|P1|STARTED|Washout Period 1 (12-14 Days)||40
5097669|NCT01641692|12540880|P8|NOT COMPLETED|Treatment Period 1||3
5097670|NCT01641692|12540881|P7|NOT COMPLETED|Treatment Period 1||0
5097671|NCT01641692|12540882|P6|NOT COMPLETED|Treatment Period 1||2
5097672|NCT01641692|12540883|P5|NOT COMPLETED|Treatment Period 1||4
5097673|NCT01641692|12540884|P4|NOT COMPLETED|Treatment Period 1||0
5097674|NCT01641692|12540885|P3|NOT COMPLETED|Treatment Period 1||1
5097675|NCT01641692|12540886|P2|NOT COMPLETED|Treatment Period 1||0
5097676|NCT01641692|12540887|P1|NOT COMPLETED|Treatment Period 1||2
5097677|NCT01641692|12540880|P8|COMPLETED|Treatment Period 1||48
5097678|NCT01641692|12540881|P7|COMPLETED|Treatment Period 1||38
5097679|NCT01641692|12540882|P6|COMPLETED|Treatment Period 1||37
5097680|NCT01641692|12540883|P5|COMPLETED|Treatment Period 1||39
5097681|NCT01641692|12540884|P4|COMPLETED|Treatment Period 1||41
5097682|NCT01641692|12540885|P3|COMPLETED|Treatment Period 1||50
5097683|NCT01641692|12540886|P2|COMPLETED|Treatment Period 1||45
5097684|NCT01641692|12540887|P1|COMPLETED|Treatment Period 1||40
5097685|NCT01641692|12540880|P8|STARTED|Treatment Period 1||51
5097686|NCT01641692|12540881|P7|STARTED|Treatment Period 1||38
5097687|NCT01641692|12540882|P6|STARTED|Treatment Period 1||39
5097688|NCT01641692|12540883|P5|STARTED|Treatment Period 1||43
5097689|NCT01641692|12540884|P4|STARTED|Treatment Period 1||41
5097690|NCT01641692|12540885|P3|STARTED|Treatment Period 1||51
5097691|NCT01641692|12540886|P2|STARTED|Treatment Period 1||45
5097692|NCT01641692|12540887|P1|STARTED|Treatment Period 1||42
5097693|NCT01641653|12541076|P2|NOT COMPLETED|Overall Study||0
5097694|NCT01641653|12541077|P1|NOT COMPLETED|Overall Study||0
5097695|NCT01641653|12541076|P2|COMPLETED|Overall Study||30
5097696|NCT01641653|12541077|P1|COMPLETED|Overall Study||30
5097697|NCT01641653|12541076|P2|STARTED|Overall Study||30
5097698|NCT01641653|12541077|P1|STARTED|Overall Study||30
5097699|NCT01641640|12541087|P1|NOT COMPLETED|Overall Study||36
5097700|NCT01641640|12541087|P1|COMPLETED|Overall Study||292
5097701|NCT01641640|12541087|P1|Enrolled and Treated|Overall Study||327
5097702|NCT01641640|12541087|P1|STARTED|Overall Study||328
5097703|NCT01641471|12541098|P2|NOT COMPLETED|Overall Study||27
5097704|NCT01641471|12541099|P1|NOT COMPLETED|Overall Study||23
5097705|NCT01641471|12541098|P2|COMPLETED|Overall Study||31
5097706|NCT01641471|12541099|P1|COMPLETED|Overall Study||35
5097707|NCT01641471|12541098|P2|STARTED|Overall Study||58
5097708|NCT01641471|12541099|P1|STARTED|Overall Study||58
5097709|NCT01641380|12541113|P2|NOT COMPLETED|Third Injection Cycle||5
5097710|NCT01641380|12541114|P1|NOT COMPLETED|Third Injection Cycle||3
5097711|NCT01641380|12541113|P2|COMPLETED|Third Injection Cycle||33
5097712|NCT01641380|12541114|P1|COMPLETED|Third Injection Cycle||36
5097713|NCT01641380|12541113|P2|STARTED|Third Injection Cycle||38
5097714|NCT01641380|12541114|P1|STARTED|Third Injection Cycle||39
5097715|NCT01641380|12541113|P2|NOT COMPLETED|Second Injection Cycle||6
5097716|NCT01641380|12541114|P1|NOT COMPLETED|Second Injection Cycle||4
5097717|NCT01641380|12541113|P2|COMPLETED|Second Injection Cycle||38
5097718|NCT01641380|12541114|P1|COMPLETED|Second Injection Cycle||39
5097719|NCT01641380|12541113|P2|STARTED|Second Injection Cycle||44
5097720|NCT01641380|12541114|P1|STARTED|Second Injection Cycle||43
5097721|NCT01641380|12541113|P2|NOT COMPLETED|First Injection Cycle||6
5097722|NCT01641380|12541114|P1|NOT COMPLETED|First Injection Cycle||7
5097723|NCT01641380|12541113|P2|COMPLETED|First Injection Cycle||44
5097724|NCT01641380|12541114|P1|COMPLETED|First Injection Cycle||43
5097725|NCT01641380|12541113|P2|STARTED|First Injection Cycle||50
5097726|NCT01641380|12541114|P1|STARTED|First Injection Cycle||50
5097727|NCT01641367|12541131|P8|NOT COMPLETED|Randomized Adherence Intervention||24
5097728|NCT01641367|12541132|P7|NOT COMPLETED|Randomized Adherence Intervention||19
5097729|NCT01641367|12541133|P6|NOT COMPLETED|Randomized Adherence Intervention||0
5097730|NCT01641367|12541134|P5|NOT COMPLETED|Randomized Adherence Intervention||0
5097731|NCT01641367|12541135|P4|NOT COMPLETED|Randomized Adherence Intervention||0
5097732|NCT01641367|12541136|P3|NOT COMPLETED|Randomized Adherence Intervention||0
5097733|NCT01641367|12541137|P2|NOT COMPLETED|Randomized Adherence Intervention||0
5097734|NCT01641367|12541138|P1|NOT COMPLETED|Randomized Adherence Intervention||0
5097735|NCT01641367|12541131|P8|COMPLETED|Randomized Adherence Intervention||240
5097736|NCT01641367|12541132|P7|COMPLETED|Randomized Adherence Intervention||238
5097737|NCT01641367|12541133|P6|COMPLETED|Randomized Adherence Intervention||0
5097738|NCT01641367|12541134|P5|COMPLETED|Randomized Adherence Intervention||0
5097739|NCT01641367|12541135|P4|COMPLETED|Randomized Adherence Intervention||0
5097740|NCT01641367|12541136|P3|COMPLETED|Randomized Adherence Intervention||0
5097741|NCT01641367|12541137|P2|COMPLETED|Randomized Adherence Intervention||0
5097742|NCT01641367|12541138|P1|COMPLETED|Randomized Adherence Intervention||0
5097743|NCT01641367|12541131|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
5097745|NCT01641367|12541133|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097746|NCT01641367|12541134|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097747|NCT01641367|12541135|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097748|NCT01641367|12541136|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097749|NCT01641367|12541137|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097750|NCT01641367|12541138|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
5097751|NCT01641367|12541131|P8|STARTED|Randomized Adherence Intervention||264
5097752|NCT01641367|12541132|P7|STARTED|Randomized Adherence Intervention||257
5097753|NCT01641367|12541133|P6|STARTED|Randomized Adherence Intervention||0
5097754|NCT01641367|12541134|P5|STARTED|Randomized Adherence Intervention||0
5097755|NCT01641367|12541135|P4|STARTED|Randomized Adherence Intervention||0
5097756|NCT01641367|12541136|P3|STARTED|Randomized Adherence Intervention||0
5097757|NCT01641367|12541137|P2|STARTED|Randomized Adherence Intervention||0
5097758|NCT01641367|12541138|P1|STARTED|Randomized Adherence Intervention||0
5097759|NCT01641367|12541131|P8|NOT COMPLETED|Cohorts||0
5097760|NCT01641367|12541132|P7|NOT COMPLETED|Cohorts||0
5097761|NCT01641367|12541133|P6|NOT COMPLETED|Cohorts||1
5097762|NCT01641367|12541134|P5|NOT COMPLETED|Cohorts||3
5097763|NCT01641367|12541135|P4|NOT COMPLETED|Cohorts||0
5097764|NCT01641367|12541136|P3|NOT COMPLETED|Cohorts||4
5097765|NCT01641367|12541137|P2|NOT COMPLETED|Cohorts||1
5097766|NCT01641367|12541138|P1|NOT COMPLETED|Cohorts||34
5097767|NCT01641367|12541131|P8|COMPLETED|Cohorts||0
5097768|NCT01641367|12541132|P7|COMPLETED|Cohorts||0
5097769|NCT01641367|12541133|P6|COMPLETED|Cohorts||33
5097770|NCT01641367|12541134|P5|COMPLETED|Cohorts||67
5097771|NCT01641367|12541135|P4|COMPLETED|Cohorts||8
5097772|NCT01641367|12541136|P3|COMPLETED|Cohorts||68
5097773|NCT01641367|12541137|P2|COMPLETED|Cohorts||73
5097774|NCT01641367|12541138|P1|COMPLETED|Cohorts||253
5097775|NCT01641367|12541131|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
5097776|NCT01641367|12541132|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
5097777|NCT01641367|12541133|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
5097778|NCT01641367|12541134|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
5097779|NCT01641367|12541135|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
5097780|NCT01641367|12541136|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
5097781|NCT01641367|12541137|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
5097782|NCT01641367|12541138|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
5097783|NCT01641367|12541131|P8|STARTED|Cohorts||0
5097784|NCT01641367|12541132|P7|STARTED|Cohorts||0
5097785|NCT01641367|12541133|P6|STARTED|Cohorts||34
5097786|NCT01641367|12541134|P5|STARTED|Cohorts||70
5097787|NCT01641367|12541135|P4|STARTED|Cohorts||8
5097788|NCT01641367|12541136|P3|STARTED|Cohorts||72
5097789|NCT01641367|12541137|P2|STARTED|Cohorts||74
5097790|NCT01641367|12541138|P1|STARTED|Cohorts||287
5097791|NCT01641237|12541389|P4|NOT COMPLETED|Period IV||0
5097792|NCT01641237|12541390|P3|NOT COMPLETED|Period IV||0
5097793|NCT01641237|12541391|P2|NOT COMPLETED|Period IV||0
5097794|NCT01641237|12541392|P1|NOT COMPLETED|Period IV||0
5097795|NCT01641237|12541389|P4|COMPLETED|Period IV||15
5097796|NCT01641237|12541390|P3|COMPLETED|Period IV||15
5097797|NCT01641237|12541391|P2|COMPLETED|Period IV||15
5097798|NCT01641237|12541392|P1|COMPLETED|Period IV||15
5097799|NCT01641237|12541389|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
5097800|NCT01641237|12541390|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
5097801|NCT01641237|12541391|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
5097802|NCT01641237|12541392|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
5097803|NCT01641237|12541389|P4|NOT COMPLETED|Period III||0
5097804|NCT01641237|12541390|P3|NOT COMPLETED|Period III||0
5097805|NCT01641237|12541391|P2|NOT COMPLETED|Period III||0
5097806|NCT01641237|12541392|P1|NOT COMPLETED|Period III||1
5097807|NCT01641237|12541389|P4|COMPLETED|Period III||16
5097808|NCT01641237|12541390|P3|COMPLETED|Period III||15
5097809|NCT01641237|12541391|P2|COMPLETED|Period III||14
5097810|NCT01641237|12541392|P1|COMPLETED|Period III||15
5097811|NCT01641237|12541389|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
5097812|NCT01641237|12541390|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
5097813|NCT01641237|12541391|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
5097814|NCT01641237|12541392|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
5097815|NCT01641237|12541389|P4|NOT COMPLETED|Period II||0
5097816|NCT01641237|12541390|P3|NOT COMPLETED|Period II||0
5097817|NCT01641237|12541391|P2|NOT COMPLETED|Period II||0
5097818|NCT01641237|12541392|P1|NOT COMPLETED|Period II||1
5097819|NCT01641237|12541389|P4|COMPLETED|Period II||15
5097820|NCT01641237|12541390|P3|COMPLETED|Period II||16
5097821|NCT01641237|12541391|P2|COMPLETED|Period II||16
5097822|NCT01641237|12541392|P1|COMPLETED|Period II||14
5097823|NCT01641237|12541389|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
5097824|NCT01641237|12541390|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
5097825|NCT01641237|12541391|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
5097826|NCT01641237|12541392|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
5097827|NCT01641237|12541389|P4|NOT COMPLETED|Period I||0
5097828|NCT01641237|12541390|P3|NOT COMPLETED|Period I||0
5097829|NCT01641237|12541391|P2|NOT COMPLETED|Period I||0
5097830|NCT01641237|12541392|P1|NOT COMPLETED|Period I||0
5097831|NCT01641237|12541389|P4|COMPLETED|Period I||15
5097832|NCT01641237|12541390|P3|COMPLETED|Period I||15
5097833|NCT01641237|12541391|P2|COMPLETED|Period I||16
5097834|NCT01641237|12541392|P1|COMPLETED|Period I||16
5097835|NCT01641237|12541389|P4|STARTED|Period I||15
5097836|NCT01641237|12541390|P3|STARTED|Period I||15
5097837|NCT01641237|12541391|P2|STARTED|Period I||16
5097838|NCT01641237|12541392|P1|STARTED|Period I||16
5097839|NCT01641198|12541417|P3|NOT COMPLETED|At 15-20 Years of Function||2
5097840|NCT01641198|12541418|P2|NOT COMPLETED|At 15-20 Years of Function||1
5097841|NCT01641198|12541419|P1|NOT COMPLETED|At 15-20 Years of Function||6
5097842|NCT01641198|12541417|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
5097843|NCT01641198|12541418|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
5097844|NCT01641198|12541419|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
5097845|NCT01641198|12541417|P3|STARTED|At 15-20 Years of Function||11
5097846|NCT01641198|12541418|P2|STARTED|At 15-20 Years of Function||7
5097847|NCT01641198|12541419|P1|STARTED|At 15-20 Years of Function||12
5097848|NCT01641198|12541417|P3|NOT COMPLETED|After 24 Months of Function||6
5097849|NCT01641198|12541418|P2|NOT COMPLETED|After 24 Months of Function||9
5097850|NCT01641198|12541419|P1|NOT COMPLETED|After 24 Months of Function||4
5097851|NCT01641198|12541417|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
5097852|NCT01641198|12541418|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
5097853|NCT01641198|12541419|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
5097854|NCT01641198|12541417|P3|STARTED|After 24 Months of Function||17
5097855|NCT01641198|12541418|P2|STARTED|After 24 Months of Function||16
5097856|NCT01641198|12541419|P1|STARTED|After 24 Months of Function||16
5097857|NCT01641198|12541417|P3|NOT COMPLETED|After 12 Months of Function||2
5097858|NCT01641198|12541418|P2|NOT COMPLETED|After 12 Months of Function||3
5097859|NCT01641198|12541419|P1|NOT COMPLETED|After 12 Months of Function||4
5097860|NCT01641198|12541417|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
5097861|NCT01641198|12541418|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
5097862|NCT01641198|12541419|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
5097863|NCT01641198|12541417|P3|STARTED|After 12 Months of Function||19
5097864|NCT01641198|12541418|P2|STARTED|After 12 Months of Function||19
5097865|NCT01641198|12541419|P1|STARTED|After 12 Months of Function||20
5097866|NCT01641159|12541435|P2|NOT COMPLETED|Overall Study||2
5097867|NCT01641159|12541436|P1|NOT COMPLETED|Overall Study||2
5097868|NCT01641159|12541435|P2|COMPLETED|Overall Study||25
5097869|NCT01641159|12541436|P1|COMPLETED|Overall Study||33
5097870|NCT01641159|12541435|P2|STARTED|Overall Study||27
5097871|NCT01641159|12541436|P1|STARTED|Overall Study||35
5097872|NCT01641133|12541447|P3|NOT COMPLETED|Overall Study||8
5097873|NCT01641133|12541448|P2|NOT COMPLETED|Overall Study||9
5097874|NCT01641133|12541449|P1|NOT COMPLETED|Overall Study||10
5097875|NCT01641133|12541447|P3|COMPLETED|Overall Study||90
5097876|NCT01641133|12541448|P2|COMPLETED|Overall Study||90
5097877|NCT01641133|12541449|P1|COMPLETED|Overall Study||87
5097878|NCT01641133|12541447|P3|STARTED|Overall Study||98
5097879|NCT01641133|12541448|P2|STARTED|Overall Study||99
5097880|NCT01641133|12541449|P1|STARTED|Overall Study||97
5097881|NCT01641120|12541490|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
5097882|NCT01641120|12541490|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
5097883|NCT01641120|12541490|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
5097884|NCT01641120|12541490|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
5097885|NCT01641120|12541490|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
5097886|NCT01641120|12541490|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
5097887|NCT01641081|12541502|P10|NOT COMPLETED|Period 5||0
5097888|NCT01641081|12541503|P9|NOT COMPLETED|Period 5||0
5097889|NCT01641081|12541504|P8|NOT COMPLETED|Period 5||0
5097890|NCT01641081|12541505|P7|NOT COMPLETED|Period 5||0
5097891|NCT01641081|12541506|P6|NOT COMPLETED|Period 5||0
5097892|NCT01641081|12541507|P5|NOT COMPLETED|Period 5||0
5097893|NCT01641081|12541508|P4|NOT COMPLETED|Period 5||0
5097894|NCT01641081|12541509|P3|NOT COMPLETED|Period 5||2
5097895|NCT01641081|12541510|P2|NOT COMPLETED|Period 5||0
5097896|NCT01641081|12541511|P1|NOT COMPLETED|Period 5||0
5097897|NCT01641081|12541502|P10|COMPLETED|Period 5||14
5097898|NCT01641081|12541503|P9|COMPLETED|Period 5||14
5097899|NCT01641081|12541504|P8|COMPLETED|Period 5||14
5097900|NCT01641081|12541505|P7|COMPLETED|Period 5||16
5097901|NCT01641081|12541506|P6|COMPLETED|Period 5||18
5097902|NCT01641081|12541507|P5|COMPLETED|Period 5||16
5097903|NCT01641081|12541508|P4|COMPLETED|Period 5||20
5097904|NCT01641081|12541509|P3|COMPLETED|Period 5||12
5097905|NCT01641081|12541510|P2|COMPLETED|Period 5||17
5097906|NCT01641081|12541511|P1|COMPLETED|Period 5||16
5097907|NCT01641081|12541502|P10|STARTED|Period 5||14
5097908|NCT01641081|12541503|P9|STARTED|Period 5||14
5097909|NCT01641081|12541504|P8|STARTED|Period 5||14
5097910|NCT01641081|12541505|P7|STARTED|Period 5||16
5097911|NCT01641081|12541506|P6|STARTED|Period 5||18
5097912|NCT01641081|12541507|P5|STARTED|Period 5||16
5097913|NCT01641081|12541508|P4|STARTED|Period 5||20
5097914|NCT01641081|12541509|P3|STARTED|Period 5||14
5097915|NCT01641081|12541510|P2|STARTED|Period 5||17
5097916|NCT01641081|12541511|P1|STARTED|Period 5||16
5097917|NCT01641081|12541502|P10|NOT COMPLETED|Period 4||0
5097918|NCT01641081|12541503|P9|NOT COMPLETED|Period 4||0
5097919|NCT01641081|12541504|P8|NOT COMPLETED|Period 4||0
5097920|NCT01641081|12541505|P7|NOT COMPLETED|Period 4||0
5097921|NCT01641081|12541506|P6|NOT COMPLETED|Period 4||0
5097922|NCT01641081|12541507|P5|NOT COMPLETED|Period 4||0
5097923|NCT01641081|12541508|P4|NOT COMPLETED|Period 4||1
5097924|NCT01641081|12541509|P3|NOT COMPLETED|Period 4||0
5097925|NCT01641081|12541510|P2|NOT COMPLETED|Period 4||1
5097926|NCT01641081|12541511|P1|NOT COMPLETED|Period 4||0
5097927|NCT01641081|12541502|P10|COMPLETED|Period 4||14
5097928|NCT01641081|12541503|P9|COMPLETED|Period 4||14
5097929|NCT01641081|12541504|P8|COMPLETED|Period 4||14
5097930|NCT01641081|12541505|P7|COMPLETED|Period 4||16
5097931|NCT01641081|12541506|P6|COMPLETED|Period 4||18
5097932|NCT01641081|12541507|P5|COMPLETED|Period 4||16
5097933|NCT01641081|12541508|P4|COMPLETED|Period 4||20
5097934|NCT01641081|12541509|P3|COMPLETED|Period 4||14
5097935|NCT01641081|12541510|P2|COMPLETED|Period 4||17
5097936|NCT01641081|12541511|P1|COMPLETED|Period 4||16
5097937|NCT01641081|12541502|P10|STARTED|Period 4||14
5097938|NCT01641081|12541503|P9|STARTED|Period 4||14
5097939|NCT01641081|12541504|P8|STARTED|Period 4||14
5097940|NCT01641081|12541505|P7|STARTED|Period 4||16
5097941|NCT01641081|12541506|P6|STARTED|Period 4||18
5097942|NCT01641081|12541507|P5|STARTED|Period 4||16
5097943|NCT01641081|12541508|P4|STARTED|Period 4||21
5097944|NCT01641081|12541509|P3|STARTED|Period 4||14
5097945|NCT01641081|12541510|P2|STARTED|Period 4||18
5097946|NCT01641081|12541511|P1|STARTED|Period 4||16
5097947|NCT01641081|12541502|P10|NOT COMPLETED|Period 3||0
5097948|NCT01641081|12541503|P9|NOT COMPLETED|Period 3||1
5097949|NCT01641081|12541504|P8|NOT COMPLETED|Period 3||0
5097950|NCT01641081|12541505|P7|NOT COMPLETED|Period 3||0
5097951|NCT01641081|12541506|P6|NOT COMPLETED|Period 3||0
5097952|NCT01641081|12541507|P5|NOT COMPLETED|Period 3||0
5097953|NCT01641081|12541508|P4|NOT COMPLETED|Period 3||0
5097954|NCT01641081|12541509|P3|NOT COMPLETED|Period 3||1
5097955|NCT01641081|12541510|P2|NOT COMPLETED|Period 3||0
5097956|NCT01641081|12541511|P1|NOT COMPLETED|Period 3||0
5097957|NCT01641081|12541502|P10|COMPLETED|Period 3||14
5097958|NCT01641081|12541503|P9|COMPLETED|Period 3||14
5097959|NCT01641081|12541504|P8|COMPLETED|Period 3||14
5097960|NCT01641081|12541505|P7|COMPLETED|Period 3||16
5097961|NCT01641081|12541506|P6|COMPLETED|Period 3||18
5097962|NCT01641081|12541507|P5|COMPLETED|Period 3||16
5097963|NCT01641081|12541508|P4|COMPLETED|Period 3||21
5097964|NCT01641081|12541509|P3|COMPLETED|Period 3||14
5097965|NCT01641081|12541510|P2|COMPLETED|Period 3||18
5097966|NCT01641081|12541511|P1|COMPLETED|Period 3||16
5097967|NCT01641081|12541502|P10|STARTED|Period 3||14
5097968|NCT01641081|12541503|P9|STARTED|Period 3||15
5097969|NCT01641081|12541504|P8|STARTED|Period 3||14
5097970|NCT01641081|12541505|P7|STARTED|Period 3||16
5097971|NCT01641081|12541506|P6|STARTED|Period 3||18
5097972|NCT01641081|12541507|P5|STARTED|Period 3||16
5097973|NCT01641081|12541508|P4|STARTED|Period 3||21
5097974|NCT01641081|12541509|P3|STARTED|Period 3||15
5097975|NCT01641081|12541510|P2|STARTED|Period 3||18
5097976|NCT01641081|12541511|P1|STARTED|Period 3||16
5097977|NCT01641081|12541502|P10|NOT COMPLETED|Period 2||0
5097978|NCT01641081|12541503|P9|NOT COMPLETED|Period 2||0
5097979|NCT01641081|12541504|P8|NOT COMPLETED|Period 2||0
5097980|NCT01641081|12541505|P7|NOT COMPLETED|Period 2||2
5097981|NCT01641081|12541506|P6|NOT COMPLETED|Period 2||1
5097982|NCT01641081|12541507|P5|NOT COMPLETED|Period 2||0
5097983|NCT01641081|12541508|P4|NOT COMPLETED|Period 2||1
5097984|NCT01641081|12541509|P3|NOT COMPLETED|Period 2||0
5097985|NCT01641081|12541510|P2|NOT COMPLETED|Period 2||0
5097986|NCT01641081|12541511|P1|NOT COMPLETED|Period 2||1
5097987|NCT01641081|12541502|P10|COMPLETED|Period 2||14
5097988|NCT01641081|12541503|P9|COMPLETED|Period 2||15
5097989|NCT01641081|12541504|P8|COMPLETED|Period 2||14
5097990|NCT01641081|12541505|P7|COMPLETED|Period 2||16
5097991|NCT01641081|12541506|P6|COMPLETED|Period 2||18
5097992|NCT01641081|12541507|P5|COMPLETED|Period 2||16
5097993|NCT01641081|12541508|P4|COMPLETED|Period 2||21
5097994|NCT01641081|12541509|P3|COMPLETED|Period 2||15
5097995|NCT01641081|12541510|P2|COMPLETED|Period 2||18
5097996|NCT01641081|12541511|P1|COMPLETED|Period 2||16
5097997|NCT01641081|12541502|P10|STARTED|Period 2||14
5097998|NCT01641081|12541503|P9|STARTED|Period 2||15
5097999|NCT01641081|12541504|P8|STARTED|Period 2||14
5098000|NCT01641081|12541505|P7|STARTED|Period 2||18
5098001|NCT01641081|12541506|P6|STARTED|Period 2||19
5098002|NCT01641081|12541507|P5|STARTED|Period 2||16
5098003|NCT01641081|12541508|P4|STARTED|Period 2||22
5098004|NCT01641081|12541509|P3|STARTED|Period 2||15
5098005|NCT01641081|12541510|P2|STARTED|Period 2||18
5098006|NCT01641081|12541511|P1|STARTED|Period 2||17
5098007|NCT01641081|12541502|P10|NOT COMPLETED|Period 1||0
5098008|NCT01641081|12541503|P9|NOT COMPLETED|Period 1||0
5098009|NCT01641081|12541504|P8|NOT COMPLETED|Period 1||3
5098010|NCT01641081|12541505|P7|NOT COMPLETED|Period 1||1
5098011|NCT01641081|12541506|P6|NOT COMPLETED|Period 1||0
5098012|NCT01641081|12541507|P5|NOT COMPLETED|Period 1||1
5098013|NCT01641081|12541508|P4|NOT COMPLETED|Period 1||0
5098014|NCT01641081|12541509|P3|NOT COMPLETED|Period 1||0
5098015|NCT01641081|12541510|P2|NOT COMPLETED|Period 1||0
5098016|NCT01641081|12541511|P1|NOT COMPLETED|Period 1||1
5098017|NCT01641081|12541502|P10|COMPLETED|Period 1||14
5098018|NCT01641081|12541503|P9|COMPLETED|Period 1||15
5098019|NCT01641081|12541504|P8|COMPLETED|Period 1||14
5098020|NCT01641081|12541505|P7|COMPLETED|Period 1||18
5098021|NCT01641081|12541506|P6|COMPLETED|Period 1||19
5098022|NCT01641081|12541507|P5|COMPLETED|Period 1||16
5098023|NCT01641081|12541508|P4|COMPLETED|Period 1||22
5098024|NCT01641081|12541509|P3|COMPLETED|Period 1||15
5098025|NCT01641081|12541510|P2|COMPLETED|Period 1||18
5098026|NCT01641081|12541511|P1|COMPLETED|Period 1||17
5098027|NCT01641081|12541502|P10|STARTED|Period 1||14
5098028|NCT01641081|12541503|P9|STARTED|Period 1||15
5098029|NCT01641081|12541504|P8|STARTED|Period 1||17
5098030|NCT01641081|12541505|P7|STARTED|Period 1||19
5098031|NCT01641081|12541506|P6|STARTED|Period 1||19
5098032|NCT01641081|12541507|P5|STARTED|Period 1||17
5098033|NCT01641081|12541508|P4|STARTED|Period 1||22
5098034|NCT01641081|12541509|P3|STARTED|Period 1||15
5098035|NCT01641081|12541510|P2|STARTED|Period 1||18
5098036|NCT01641081|12541511|P1|STARTED|Period 1||18
5098037|NCT01641042|12541530|P2|NOT COMPLETED|Overall Study||0
5098038|NCT01641042|12541531|P1|NOT COMPLETED|Overall Study||0
5098039|NCT01641042|12541530|P2|COMPLETED|Overall Study||43
5098040|NCT01641042|12541531|P1|COMPLETED|Overall Study||43
5098041|NCT01641042|12541530|P2|STARTED|Overall Study||43
5098042|NCT01641042|12541531|P1|STARTED|Overall Study||43
5098043|NCT01640964|12541580|P3|NOT COMPLETED|Overall Study||3
5098044|NCT01640964|12541581|P2|NOT COMPLETED|Overall Study||1
5098045|NCT01640964|12541582|P1|NOT COMPLETED|Overall Study||1
5098046|NCT01640964|12541580|P3|COMPLETED|Overall Study||3
5098047|NCT01640964|12541581|P2|COMPLETED|Overall Study||19
5098048|NCT01640964|12541582|P1|COMPLETED|Overall Study||19
5098049|NCT01640964|12541580|P3|STARTED|Overall Study||6
5098050|NCT01640964|12541581|P2|STARTED|Overall Study||20
5098051|NCT01640964|12541582|P1|STARTED|Overall Study||20
5098052|NCT01640951|12541605|P8|NOT COMPLETED|Overall Study||16
5098053|NCT01640951|12541606|P7|NOT COMPLETED|Overall Study||18
5098054|NCT01640951|12541607|P6|NOT COMPLETED|Overall Study||47
5098055|NCT01640951|12541608|P5|NOT COMPLETED|Overall Study||13
5098056|NCT01640951|12541609|P4|NOT COMPLETED|Overall Study||45
5098057|NCT01640951|12541610|P3|NOT COMPLETED|Overall Study||42
5098058|NCT01640951|12541611|P2|NOT COMPLETED|Overall Study||15
5098059|NCT01640951|12541612|P1|NOT COMPLETED|Overall Study||46
5098060|NCT01640951|12541605|P8|COMPLETED|Overall Study||17
5098061|NCT01640951|12541606|P7|COMPLETED|Overall Study||94
5098062|NCT01640951|12541607|P6|COMPLETED|Overall Study||13
5098063|NCT01640951|12541608|P5|COMPLETED|Overall Study||82
5098064|NCT01640951|12541609|P4|COMPLETED|Overall Study||10
5098065|NCT01640951|12541610|P3|COMPLETED|Overall Study||126
5098066|NCT01640951|12541611|P2|COMPLETED|Overall Study||60
5098067|NCT01640951|12541612|P1|COMPLETED|Overall Study||31
5098068|NCT01640951|12541605|P8|STARTED|Overall Study||33
5098069|NCT01640951|12541606|P7|STARTED|Overall Study||112
5098070|NCT01640951|12541607|P6|STARTED|Overall Study||60
5098071|NCT01640951|12541608|P5|STARTED|Overall Study||95
5098072|NCT01640951|12541609|P4|STARTED|Overall Study||55
5098073|NCT01640951|12541610|P3|STARTED|Overall Study||168
5098074|NCT01640951|12541611|P2|STARTED|Overall Study||75
5098075|NCT01640951|12541612|P1|STARTED|Overall Study||77
5098076|NCT01640925|12541714|P2|NOT COMPLETED|Overall Study||11
5098077|NCT01640925|12541715|P1|NOT COMPLETED|Overall Study||14
5098078|NCT01640925|12541714|P2|COMPLETED|Overall Study||164
5098079|NCT01640925|12541715|P1|COMPLETED|Overall Study||161
5098080|NCT01640925|12541714|P2|STARTED|Overall Study||175
5098081|NCT01640925|12541715|P1|STARTED|Overall Study||175
5098082|NCT01640873|12541729|P2|NOT COMPLETED|Overall Study||1
5098083|NCT01640873|12541730|P1|NOT COMPLETED|Overall Study||2
5098084|NCT01640873|12541729|P2|COMPLETED|Overall Study||10
5098085|NCT01640873|12541730|P1|COMPLETED|Overall Study||20
5098086|NCT01640873|12541729|P2|STARTED|Overall Study||11
5098087|NCT01640873|12541730|P1|STARTED|Overall Study||22
5098088|NCT01640834|12541749|P3|NOT COMPLETED|Overall Study||0
5098089|NCT01640834|12541750|P2|NOT COMPLETED|Overall Study||0
5098090|NCT01640834|12541751|P1|NOT COMPLETED|Overall Study||0
5098091|NCT01640834|12541749|P3|COMPLETED|Overall Study||4
5098092|NCT01640834|12541750|P2|COMPLETED|Overall Study||8
5098093|NCT01640834|12541751|P1|COMPLETED|Overall Study||8
5098094|NCT01640834|12541749|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
5098095|NCT01640834|12541750|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
5098096|NCT01640834|12541751|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5098097|NCT01640834|12541749|P3|STARTED|Overall Study||4
5098098|NCT01640834|12541750|P2|STARTED|Overall Study||8
5098099|NCT01640834|12541751|P1|STARTED|Overall Study||8
5098100|NCT01640548|12541778|P1|NOT COMPLETED|Overall Study||0
5098101|NCT01640548|12541778|P1|COMPLETED|Overall Study||309
5098102|NCT01640548|12541778|P1|STARTED|Overall Study||309
5098103|NCT01640379|12541794|P2|NOT COMPLETED|Overall Study||12
5098104|NCT01640379|12541795|P1|NOT COMPLETED|Overall Study||14
5098105|NCT01640379|12541794|P2|COMPLETED|Overall Study||125
5098106|NCT01640379|12541795|P1|COMPLETED|Overall Study||135
5098107|NCT01640379|12541794|P2|STARTED|Overall Study||137
5098108|NCT01640379|12541795|P1|STARTED|Overall Study||149
5098109|NCT01640366|12541803|P1|NOT COMPLETED|Overall Study||22
5098110|NCT01640366|12541803|P1|COMPLETED|Overall Study||178
5098111|NCT01640366|12541803|P1|Day 90 Follow-up|Overall Study||178
5098112|NCT01640366|12541803|P1|Day 42 Follow-up|Overall Study||177
5098113|NCT01640366|12541803|P1|Day 21 Follow-up|Overall Study||185
5098114|NCT01640366|12541803|P1|STARTED|Overall Study||200
5098115|NCT01640353|12541816|P1|NOT COMPLETED|Overall Study||45
5098116|NCT01640353|12541816|P1|COMPLETED|Overall Study||149
5098117|NCT01640353|12541816|P1|Month 18|Overall Study||150
5098118|NCT01640353|12541816|P1|Month 12|Overall Study||160
5098119|NCT01640353|12541816|P1|Month 6|Overall Study||168
5098120|NCT01640353|12541816|P1|Month 3|Overall Study||169
5098121|NCT01640353|12541816|P1|Month 1|Overall Study||171
5098122|NCT01640353|12541816|P1|Treated|Overall Study||172
5098123|NCT01640353|12541816|P1|STARTED|Overall Study||194
5098124|NCT01640340|12541828|P2|NOT COMPLETED|Overall Study||0
5098125|NCT01640340|12541829|P1|NOT COMPLETED|Overall Study||0
5098126|NCT01640340|12541828|P2|COMPLETED|Overall Study||20
5098127|NCT01640340|12541829|P1|COMPLETED|Overall Study||20
5098128|NCT01640340|12541828|P2|Overall Complete Response Rate|Overall Study||20
5098129|NCT01640340|12541829|P1|Overall Complete Response Rate|Overall Study||20
5098130|NCT01640340|12541828|P2|STARTED|Overall Study||20
5098131|NCT01640340|12541829|P1|STARTED|Overall Study||20
5098132|NCT01640327|12541849|P2|NOT COMPLETED|Overall Study||0
5098133|NCT01640327|12541850|P1|NOT COMPLETED|Overall Study||0
5098134|NCT01640327|12541849|P2|COMPLETED|Overall Study||63
5098135|NCT01640327|12541850|P1|COMPLETED|Overall Study||63
5098136|NCT01640327|12541849|P2|STARTED|Overall Study||63
5098137|NCT01640327|12541850|P1|STARTED|Overall Study||63
5098138|NCT01640314|12541864|P2|NOT COMPLETED|Overall Study||1
5098139|NCT01640314|12541865|P1|NOT COMPLETED|Overall Study||0
5098140|NCT01640314|12541864|P2|COMPLETED|Overall Study||62
5098141|NCT01640314|12541865|P1|COMPLETED|Overall Study||63
5098142|NCT01640314|12541864|P2|STARTED|Overall Study||63
5098143|NCT01640314|12541865|P1|STARTED|Overall Study||63
5098144|NCT01640288|12541881|P2|NOT COMPLETED|Overall Study||23
5098145|NCT01640288|12541882|P1|NOT COMPLETED|Overall Study||30
5098146|NCT01640288|12541881|P2|COMPLETED|Overall Study||48
5098147|NCT01640288|12541882|P1|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
5098148|NCT01640288|12541881|P2|Did Not Receive Allocated Intervention|Overall Study||18
5098149|NCT01640288|12541882|P1|Did Not Receive Allocated Intervention|Overall Study||26
5098150|NCT01640288|12541881|P2|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
5098151|NCT01640288|12541882|P1|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
5098152|NCT01640288|12541881|P2|STARTED|Overall Study||71
5098153|NCT01640288|12541882|P1|STARTED|Overall Study||100
5098154|NCT01640249|12541899|P7|NOT COMPLETED|Period 3||0
5098155|NCT01640249|12541900|P6|NOT COMPLETED|Period 3||0
5098156|NCT01640249|12541901|P5|NOT COMPLETED|Period 3||0
5098157|NCT01640249|12541902|P4|NOT COMPLETED|Period 3||1
5098158|NCT01640249|12541903|P3|NOT COMPLETED|Period 3||0
5098159|NCT01640249|12541904|P2|NOT COMPLETED|Period 3||0
5098160|NCT01640249|12541905|P1|NOT COMPLETED|Period 3||0
5098161|NCT01640249|12541899|P7|COMPLETED|Period 3||0
5098162|NCT01640249|12541900|P6|COMPLETED|Period 3||0
5098163|NCT01640249|12541901|P5|COMPLETED|Period 3||0
5098164|NCT01640249|12541902|P4|COMPLETED|Period 3||1
5098165|NCT01640249|12541903|P3|COMPLETED|Period 3||2
5098166|NCT01640249|12541904|P2|COMPLETED|Period 3||2
5098167|NCT01640249|12541905|P1|COMPLETED|Period 3||2
5098168|NCT01640249|12541899|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
5098169|NCT01640249|12541900|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
5098170|NCT01640249|12541901|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
5098171|NCT01640249|12541902|P4|STARTED|Period 3||2
5098172|NCT01640249|12541903|P3|STARTED|Period 3||2
5098173|NCT01640249|12541904|P2|STARTED|Period 3||2
5098174|NCT01640249|12541905|P1|STARTED|Period 3||2
5098175|NCT01640249|12541899|P7|NOT COMPLETED|Period 2||0
5098176|NCT01640249|12541900|P6|NOT COMPLETED|Period 2||0
5098177|NCT01640249|12541901|P5|NOT COMPLETED|Period 2||0
5098178|NCT01640249|12541902|P4|NOT COMPLETED|Period 2||0
5098179|NCT01640249|12541903|P3|NOT COMPLETED|Period 2||0
5098180|NCT01640249|12541904|P2|NOT COMPLETED|Period 2||0
5098181|NCT01640249|12541905|P1|NOT COMPLETED|Period 2||0
5098182|NCT01640249|12541899|P7|COMPLETED|Period 2||2
5098183|NCT01640249|12541900|P6|COMPLETED|Period 2||4
5098184|NCT01640249|12541901|P5|COMPLETED|Period 2||2
5098185|NCT01640249|12541902|P4|COMPLETED|Period 2||2
5098186|NCT01640249|12541903|P3|COMPLETED|Period 2||2
5098187|NCT01640249|12541904|P2|COMPLETED|Period 2||2
5098188|NCT01640249|12541905|P1|COMPLETED|Period 2||2
5098189|NCT01640249|12541899|P7|STARTED|Period 2||2
5098190|NCT01640249|12541900|P6|STARTED|Period 2||4
5098191|NCT01640249|12541901|P5|STARTED|Period 2||2
5098192|NCT01640249|12541902|P4|STARTED|Period 2||2
5098193|NCT01640249|12541903|P3|STARTED|Period 2||2
5098194|NCT01640249|12541904|P2|STARTED|Period 2||2
5098195|NCT01640249|12541905|P1|STARTED|Period 2||2
5098196|NCT01640249|12541899|P7|NOT COMPLETED|Period 1||0
5098197|NCT01640249|12541900|P6|NOT COMPLETED|Period 1||1
5098198|NCT01640249|12541901|P5|NOT COMPLETED|Period 1||0
5098199|NCT01640249|12541902|P4|NOT COMPLETED|Period 1||0
5098200|NCT01640249|12541903|P3|NOT COMPLETED|Period 1||0
5098201|NCT01640249|12541904|P2|NOT COMPLETED|Period 1||0
5098202|NCT01640249|12541905|P1|NOT COMPLETED|Period 1||1
5098203|NCT01640249|12541899|P7|COMPLETED|Period 1||2
5098204|NCT01640249|12541900|P6|COMPLETED|Period 1||4
5098205|NCT01640249|12541901|P5|COMPLETED|Period 1||2
5098206|NCT01640249|12541902|P4|COMPLETED|Period 1||2
5098207|NCT01640249|12541903|P3|COMPLETED|Period 1||2
5098208|NCT01640249|12541904|P2|COMPLETED|Period 1||2
5098209|NCT01640249|12541905|P1|COMPLETED|Period 1||2
5098210|NCT01640249|12541899|P7|Received at Least 1 Dose of Study Drug|Period 1||2
5098211|NCT01640249|12541900|P6|Received at Least 1 Dose of Study Drug|Period 1||5
5098212|NCT01640249|12541901|P5|Received at Least 1 Dose of Study Drug|Period 1||2
5098213|NCT01640249|12541902|P4|Received at Least 1 Dose of Study Drug|Period 1||2
5098214|NCT01640249|12541903|P3|Received at Least 1 Dose of Study Drug|Period 1||2
5098215|NCT01640249|12541904|P2|Received at Least 1 Dose of Study Drug|Period 1||2
5098216|NCT01640249|12541905|P1|Received at Least 1 Dose of Study Drug|Period 1||3
5098217|NCT01640249|12541899|P7|STARTED|Period 1||2
5098218|NCT01640249|12541900|P6|STARTED|Period 1||5
5098219|NCT01640249|12541901|P5|STARTED|Period 1||2
5098220|NCT01640249|12541902|P4|STARTED|Period 1||2
5098221|NCT01640249|12541903|P3|STARTED|Period 1||2
5098222|NCT01640249|12541904|P2|STARTED|Period 1||2
5098223|NCT01640249|12541905|P1|STARTED|Period 1||3
5098224|NCT01640197|12541931|P2|NOT COMPLETED|Overall Study||0
5098225|NCT01640197|12541932|P1|NOT COMPLETED|Overall Study||0
5098226|NCT01640197|12541931|P2|COMPLETED|Overall Study||30
5098227|NCT01640197|12541932|P1|COMPLETED|Overall Study||30
5098228|NCT01640197|12541931|P2|STARTED|Overall Study||30
5098229|NCT01640197|12541932|P1|STARTED|Overall Study||30
5098230|NCT01640184|12541953|P3|NOT COMPLETED|Overall Study||2
5098231|NCT01640184|12541954|P2|NOT COMPLETED|Overall Study||2
5098232|NCT01640184|12541955|P1|NOT COMPLETED|Overall Study||8
5098233|NCT01640184|12541953|P3|COMPLETED|Overall Study||20
5098234|NCT01640184|12541954|P2|COMPLETED|Overall Study||21
5098235|NCT01640184|12541955|P1|COMPLETED|Overall Study||26
5098236|NCT01640184|12541953|P3|STARTED|Overall Study||22
5098237|NCT01640184|12541954|P2|STARTED|Overall Study||23
5098238|NCT01640184|12541955|P1|STARTED|Overall Study||34
5098239|NCT01640171|12541977|P1|NOT COMPLETED|Overall Study||0
5098240|NCT01640171|12541977|P1|COMPLETED|Overall Study||57
5098241|NCT01640171|12541977|P1|STARTED|Overall Study||57
5098242|NCT01640054|12541984|P1|NOT COMPLETED|Overall Study||6
5098243|NCT01640054|12541984|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
5098244|NCT01640054|12541984|P1|Did Not Receive Treatment|Overall Study||0
5098245|NCT01640054|12541984|P1|STARTED|Overall Study|Patients who received treatment|115
5098246|NCT01639872|12541994|P2|NOT COMPLETED|Overall Study||5
5098247|NCT01639872|12541995|P1|NOT COMPLETED|Overall Study||10
5098248|NCT01639872|12541994|P2|COMPLETED|Overall Study||20
5098249|NCT01639872|12541995|P1|COMPLETED|Overall Study||14
5098250|NCT01639872|12541994|P2|STARTED|Overall Study||25
5098251|NCT01639872|12541995|P1|STARTED|Overall Study||24
5098252|NCT01639833|12542005|P2|NOT COMPLETED|Overall Study||4
5098253|NCT01639833|12542006|P1|NOT COMPLETED|Overall Study||6
5098254|NCT01639833|12542005|P2|COMPLETED|Overall Study||41
5098255|NCT01639833|12542006|P1|COMPLETED|Overall Study||39
5098256|NCT01639833|12542005|P2|STARTED|Overall Study||45
5098257|NCT01639833|12542006|P1|STARTED|Overall Study||45
5098258|NCT01639755|12542014|P1|NOT COMPLETED|Overall Study||19
5098259|NCT01639755|12542014|P1|COMPLETED|Overall Study||0
5098260|NCT01639755|12542014|P1|STARTED|Overall Study||19
5098261|NCT01639742|12542022|P1|NOT COMPLETED|Overall Study||18
5098262|NCT01639742|12542022|P1|COMPLETED|Overall Study||0
5098263|NCT01639742|12542022|P1|STARTED|Overall Study||18
5098264|NCT01639729|12542030|P6|NOT COMPLETED|Overall Study||0
5098265|NCT01639729|12542031|P5|NOT COMPLETED|Overall Study||0
5098266|NCT01639729|12542032|P4|NOT COMPLETED|Overall Study||1
5098267|NCT01639729|12542033|P3|NOT COMPLETED|Overall Study||1
5098268|NCT01639729|12542034|P2|NOT COMPLETED|Overall Study||0
5098269|NCT01639729|12542035|P1|NOT COMPLETED|Overall Study||1
5098270|NCT01639729|12542030|P6|COMPLETED|Overall Study||4
5098271|NCT01639729|12542031|P5|COMPLETED|Overall Study||4
5098272|NCT01639729|12542032|P4|COMPLETED|Overall Study||4
5098273|NCT01639729|12542033|P3|COMPLETED|Overall Study||3
5098274|NCT01639729|12542034|P2|COMPLETED|Overall Study||4
5098275|NCT01639729|12542035|P1|COMPLETED|Overall Study||3
5098276|NCT01639729|12542030|P6|STARTED|Overall Study||4
5098277|NCT01639729|12542031|P5|STARTED|Overall Study||4
5098278|NCT01639729|12542032|P4|STARTED|Overall Study||5
5098279|NCT01639729|12542033|P3|STARTED|Overall Study||4
5098280|NCT01639729|12542034|P2|STARTED|Overall Study||4
5098281|NCT01639729|12542035|P1|STARTED|Overall Study||4
5098282|NCT01639703|12542057|P1|NOT COMPLETED|Overall Study||12
5098283|NCT01639703|12542057|P1|COMPLETED|Overall Study||84
5098284|NCT01639703|12542057|P1|STARTED|Overall Study||96
5098285|NCT01639560|12542100|P2|NOT COMPLETED|Overall Study||29
5098286|NCT01639560|12542101|P1|NOT COMPLETED|Overall Study||19
5098287|NCT01639560|12542100|P2|COMPLETED|Overall Study||19
5098288|NCT01639560|12542101|P1|COMPLETED|Overall Study||26
5098289|NCT01639560|12542100|P2|End of Treatment|Overall Study||20
5098290|NCT01639560|12542101|P1|End of Treatment|Overall Study||28
5098291|NCT01639560|12542100|P2|STARTED|Overall Study||48
5098292|NCT01639560|12542101|P1|STARTED|Overall Study||45
5098293|NCT01639495|12542113|P1|NOT COMPLETED|Overall Study||16
5098294|NCT01639495|12542113|P1|COMPLETED|Overall Study||132
5098295|NCT01639495|12542113|P1|Primary Effectiveness Cohort|Overall Study||138
5098296|NCT01639495|12542113|P1|Safety Cohort|Overall Study||144
5098297|NCT01639495|12542113|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
5098298|NCT01639469|12542123|P2|NOT COMPLETED|Overall Study||3
5098299|NCT01639469|12542124|P1|NOT COMPLETED|Overall Study||5
5098300|NCT01639469|12542123|P2|COMPLETED|Overall Study||77
5098301|NCT01639469|12542124|P1|COMPLETED|Overall Study||84
5098302|NCT01639469|12542123|P2|STARTED|Overall Study||80
5098303|NCT01639469|12542124|P1|STARTED|Overall Study||89
5098304|NCT01639443|12542132|P2|NOT COMPLETED|Overall Study||0
5098305|NCT01639443|12542133|P1|NOT COMPLETED|Overall Study||0
5098306|NCT01639443|12542132|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
5098307|NCT01639443|12542133|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
5098308|NCT01639443|12542132|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
5098309|NCT01639443|12542133|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
5098310|NCT01639352|12542149|P1|NOT COMPLETED|Overall Study||0
5098311|NCT01639352|12542149|P1|COMPLETED|Overall Study||20
5098312|NCT01639352|12542149|P1|STARTED|Overall Study||20
5098313|NCT01639339|12542160|P2|NOT COMPLETED|Overall Study||38
5098314|NCT01639339|12542161|P1|NOT COMPLETED|Overall Study||54
5098315|NCT01639339|12542160|P2|COMPLETED|Overall Study||186
5098316|NCT01639339|12542161|P1|COMPLETED|Overall Study||170
5098317|NCT01639339|12542160|P2|STARTED|Overall Study||224
5098318|NCT01639339|12542161|P1|STARTED|Overall Study||224
5098319|NCT01639222|12542179|P1|NOT COMPLETED|Overall Study||0
5098320|NCT01639222|12542179|P1|COMPLETED|Overall Study||55
5098321|NCT01639222|12542179|P1|STARTED|Overall Study||55
5098322|NCT01639157|12542189|P2|NOT COMPLETED|Overall Study||0
5098323|NCT01639157|12542190|P1|NOT COMPLETED|Overall Study||0
5098324|NCT01639157|12542189|P2|COMPLETED|Overall Study||5
5098325|NCT01639157|12542190|P1|COMPLETED|Overall Study||4
5098326|NCT01639157|12542189|P2|STARTED|Overall Study||5
5098327|NCT01639157|12542190|P1|STARTED|Overall Study||4
5098328|NCT01639144|12542250|P2|NOT COMPLETED|Overall Study||5
5098329|NCT01639144|12542251|P1|NOT COMPLETED|Overall Study||10
5098330|NCT01639144|12542250|P2|COMPLETED|Overall Study||250
5098331|NCT01639144|12542251|P1|COMPLETED|Overall Study||250
5098332|NCT01639144|12542250|P2|STARTED|Overall Study||255
5098333|NCT01639144|12542251|P1|STARTED|Overall Study||260
5098334|NCT01639040|12542259|P2|NOT COMPLETED|Overall Study||0
5098335|NCT01639040|12542260|P1|NOT COMPLETED|Overall Study||1
5098336|NCT01639040|12542259|P2|COMPLETED|Overall Study||21
5098337|NCT01639040|12542260|P1|COMPLETED|Overall Study||9
5098338|NCT01639040|12542259|P2|STARTED|Overall Study||21
5098339|NCT01639040|12542260|P1|STARTED|Overall Study||10
5098340|NCT01639001|12542278|P2|NOT COMPLETED|Overall Study||103
5098341|NCT01639001|12542279|P1|NOT COMPLETED|Overall Study||104
5098342|NCT01639001|12542278|P2|COMPLETED|Overall Study||0
5098343|NCT01639001|12542279|P1|COMPLETED|Overall Study||0
5098344|NCT01639001|12542278|P2|Treated|Overall Study||101
5098345|NCT01639001|12542279|P1|Treated|Overall Study||104
5098346|NCT01639001|12542278|P2|STARTED|Overall Study||103
5098347|NCT01639001|12542279|P1|STARTED|Overall Study||104
5098348|NCT01638819|12542325|P2|NOT COMPLETED|Overall Study||0
5098349|NCT01638819|12542326|P1|NOT COMPLETED|Overall Study||1
5098350|NCT01638819|12542325|P2|COMPLETED|Overall Study||15
5098351|NCT01638819|12542326|P1|COMPLETED|Overall Study||14
5098352|NCT01638819|12542325|P2|Second Intervention (24 Weeks)|Overall Study||15
5098353|NCT01638819|12542326|P1|Second Intervention (24 Weeks)|Overall Study||14
5098354|NCT01638819|12542325|P2|First Intervention (8 Weeks)|Overall Study||15
5098355|NCT01638819|12542326|P1|First Intervention (8 Weeks)|Overall Study||15
5098356|NCT01638819|12542325|P2|STARTED|Overall Study||15
5098357|NCT01638819|12542326|P1|STARTED|Overall Study||15
5098358|NCT01638559|12542335|P1|NOT COMPLETED|Overall Study||3
5098359|NCT01638559|12542335|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
5098360|NCT01638559|12542335|P1|STARTED|Overall Study||88
5098361|NCT01638546|12542353|P2|NOT COMPLETED|Overall Study||3
5098362|NCT01638546|12542354|P1|NOT COMPLETED|Overall Study||1
5098363|NCT01638546|12542353|P2|COMPLETED|Overall Study||42
5098364|NCT01638546|12542354|P1|COMPLETED|Overall Study||51
5098365|NCT01638546|12542353|P2|STARTED|Overall Study||45
5098366|NCT01638546|12542354|P1|STARTED|Overall Study||52
5098367|NCT01638507|12542366|P1|NOT COMPLETED|Overall Study||6
5098368|NCT01638507|12542366|P1|COMPLETED|Overall Study||224
5098369|NCT01638507|12542366|P1|STARTED|Overall Study||230
5098370|NCT01638468|12542379|P1|NOT COMPLETED|Overall Study||0
5098371|NCT01638468|12542379|P1|COMPLETED|Overall Study||7
5098372|NCT01638468|12542379|P1|STARTED|Overall Study||7
5098373|NCT01638429|12542393|P1|NOT COMPLETED|Overall Study||1
5098374|NCT01638429|12542393|P1|COMPLETED|Overall Study||11
5098375|NCT01638429|12542393|P1|Post-treatment Testing|Overall Study||11
5098376|NCT01638429|12542393|P1|Antibiotic Treatment|Overall Study||11
5098377|NCT01638429|12542393|P1|Pre-treatment Testing|Overall Study||11
5098378|NCT01638429|12542393|P1|STARTED|Overall Study||12
5098379|NCT01638390|12542421|P1|NOT COMPLETED|Overall Study||21
5098380|NCT01638390|12542421|P1|COMPLETED|Overall Study|treated eyes|336
5098381|NCT01638390|12542421|P1|STARTED|Overall Study|enrolled|357
5098382|NCT01638312|12542435|P2|NOT COMPLETED|Overall Study||0
5098383|NCT01638312|12542436|P1|NOT COMPLETED|Overall Study||0
5098384|NCT01638312|12542435|P2|COMPLETED|Overall Study||30
5098385|NCT01638312|12542436|P1|COMPLETED|Overall Study||20
5098386|NCT01638312|12542435|P2|STARTED|Overall Study||30
5098387|NCT01638312|12542436|P1|STARTED|Overall Study||20
5098388|NCT01638000|12542444|P2|NOT COMPLETED|Overall Study||71
5098389|NCT01638000|12542445|P1|NOT COMPLETED|Overall Study||60
5098390|NCT01638000|12542444|P2|COMPLETED|Overall Study||873
5098391|NCT01638000|12542445|P1|COMPLETED|Overall Study||883
5098392|NCT01638000|12542444|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
5098393|NCT01638000|12542445|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
5098394|NCT01638000|12542444|P2|STARTED|Overall Study||944
5098395|NCT01638000|12542445|P1|STARTED|Overall Study||943
5098396|NCT01637961|12542543|P1|NOT COMPLETED|Overall Study||2
5098397|NCT01637961|12542543|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
5098398|NCT01637961|12542543|P1|STARTED|Overall Study||23
5098399|NCT01637935|12542558|P2|NOT COMPLETED|Overall Study||0
5098400|NCT01637935|12542559|P1|NOT COMPLETED|Overall Study||0
5098401|NCT01637935|12542558|P2|COMPLETED|Overall Study||158918
5098402|NCT01637935|12542559|P1|COMPLETED|Overall Study||34181
5098403|NCT01637935|12542558|P2|STARTED|Overall Study||158918
5098404|NCT01637935|12542559|P1|STARTED|Overall Study||34181
5098405|NCT01637922|12542575|P2|NOT COMPLETED|Overall Study||5
5098406|NCT01637922|12542576|P1|NOT COMPLETED|Overall Study||2
5098407|NCT01637922|12542575|P2|COMPLETED|Overall Study||14
5098408|NCT01637922|12542576|P1|COMPLETED|Overall Study||13
5098409|NCT01637922|12542575|P2|STARTED|Overall Study||19
5098410|NCT01637922|12542576|P1|STARTED|Overall Study||15
5098411|NCT01637870|12542599|P1|NOT COMPLETED|Overall Study||0
5098412|NCT01637870|12542599|P1|COMPLETED|Overall Study||110
5098413|NCT01637870|12542599|P1|STARTED|Overall Study||110
5098414|NCT01637584|12542605|P2|NOT COMPLETED|Overall Study||3
5098415|NCT01637584|12542606|P1|NOT COMPLETED|Overall Study||1
5098416|NCT01637584|12542605|P2|COMPLETED|Overall Study||17
5098417|NCT01637584|12542606|P1|COMPLETED|Overall Study||19
5098418|NCT01637584|12542605|P2|STARTED|Overall Study||20
5098419|NCT01637584|12542606|P1|STARTED|Overall Study||20
5098420|NCT01637272|12542613|P1|NOT COMPLETED|Overall Study||20
5098421|NCT01637272|12542613|P1|COMPLETED|Overall Study||23
5098422|NCT01637272|12542613|P1|Completed Core But Did no Enter Ext..|Overall Study||4
5098423|NCT01637272|12542613|P1|Entered Extension Phase|Overall Study||27
5098424|NCT01637272|12542613|P1|Completed Core Phase (sc + LAR)|Overall Study||31
5098425|NCT01637272|12542613|P1|Completed sc Phase|Overall Study||33
5098426|NCT01637272|12542613|P1|STARTED|Overall Study||43
5098427|NCT01637246|12542675|P1|NOT COMPLETED|Overall Study||2139
5098428|NCT01637246|12542675|P1|COMPLETED|Overall Study||2246
5098429|NCT01637246|12542675|P1|STARTED|Overall Study||4385
5098430|NCT01637090|12542683|P1|NOT COMPLETED|Overall Study||3
5098431|NCT01637090|12542683|P1|COMPLETED|Overall Study||0
5098432|NCT01637090|12542683|P1|STARTED|Overall Study||3
5098433|NCT01637077|12542693|P2|NOT COMPLETED|Overall Study||1
5098434|NCT01637077|12542694|P1|NOT COMPLETED|Overall Study||4
5098435|NCT01637077|12542693|P2|COMPLETED|Overall Study||22
5098436|NCT01637077|12542694|P1|COMPLETED|Overall Study||19
5098437|NCT01637077|12542693|P2|STARTED|Overall Study||23
5098438|NCT01637077|12542694|P1|STARTED|Overall Study||23
5098439|NCT01636986|12542722|P2|NOT COMPLETED|Overall Study||2
5098440|NCT01636986|12542723|P1|NOT COMPLETED|Overall Study||0
5098441|NCT01636986|12542722|P2|COMPLETED|Overall Study||30
5098442|NCT01636986|12542723|P1|COMPLETED|Overall Study||30
5098443|NCT01636986|12542722|P2|STARTED|Overall Study||32
5098444|NCT01636986|12542723|P1|STARTED|Overall Study||30
5098445|NCT01636960|12542729|P1|NOT COMPLETED|Maintenance Phase||7
5098446|NCT01636960|12542729|P1|COMPLETED|Maintenance Phase||0
5098447|NCT01636960|12542729|P1|STARTED|Maintenance Phase||7
5098448|NCT01636960|12542729|P1|NOT COMPLETED|Induction Phase||2
5098449|NCT01636960|12542729|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
5098450|NCT01636960|12542729|P1|STARTED|Induction Phase||9
5098451|NCT01636947|12542737|P2|NOT COMPLETED|Overall Study||11
5098452|NCT01636947|12542738|P1|NOT COMPLETED|Overall Study||12
5098453|NCT01636947|12542737|P2|COMPLETED|Overall Study||239
5098454|NCT01636947|12542738|P1|COMPLETED|Overall Study||232
5098455|NCT01636947|12542737|P2|Treated|Overall Study||248
5098456|NCT01636947|12542738|P1|Treated|Overall Study||242
5098457|NCT01636947|12542737|P2|STARTED|Overall Study||250
5098458|NCT01636947|12542738|P1|STARTED|Overall Study||244
5098459|NCT01636934|12542760|P2|NOT COMPLETED|Overall Study||3
5098460|NCT01636934|12542761|P1|NOT COMPLETED|Overall Study||6
5098461|NCT01636934|12542760|P2|COMPLETED|Overall Study||21
5098462|NCT01636934|12542761|P1|COMPLETED|Overall Study||19
5098463|NCT01636934|12542760|P2|STARTED|Overall Study||24
5098464|NCT01636934|12542761|P1|STARTED|Overall Study||25
5098465|NCT01636882|12542769|P1|NOT COMPLETED|Overall Study||0
5098466|NCT01636882|12542769|P1|COMPLETED|Overall Study||16
5098467|NCT01636882|12542769|P1|STARTED|Overall Study||16
5098468|NCT01636778|12542773|P3|NOT COMPLETED|Follow-up Period After Part 2||4
5098469|NCT01636778|12542774|P2|NOT COMPLETED|Follow-up Period After Part 2||0
5098470|NCT01636778|12542775|P1|NOT COMPLETED|Follow-up Period After Part 2||0
5098471|NCT01636778|12542773|P3|COMPLETED|Follow-up Period After Part 2||37
5098472|NCT01636778|12542774|P2|COMPLETED|Follow-up Period After Part 2||0
5098473|NCT01636778|12542775|P1|COMPLETED|Follow-up Period After Part 2||0
5098474|NCT01636778|12542773|P3|STARTED|Follow-up Period After Part 2||41
5098475|NCT01636778|12542774|P2|STARTED|Follow-up Period After Part 2||0
5098476|NCT01636778|12542775|P1|STARTED|Follow-up Period After Part 2||0
5098477|NCT01636778|12542773|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
5098478|NCT01636778|12542774|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
5098479|NCT01636778|12542775|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
5098480|NCT01636778|12542773|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
5098481|NCT01636778|12542774|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
5098482|NCT01636778|12542775|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
5098483|NCT01636778|12542773|P3|STARTED|Antiviral Treatment Period (Part 2)||0
5098484|NCT01636778|12542774|P2|STARTED|Antiviral Treatment Period (Part 2)||41
5098485|NCT01636778|12542775|P1|STARTED|Antiviral Treatment Period (Part 2)||0
5098486|NCT01636778|12542773|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
5098487|NCT01636778|12542774|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
5098488|NCT01636778|12542775|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
5098489|NCT01636778|12542773|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
5098490|NCT01636778|12542774|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
5098491|NCT01636778|12542775|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
5098492|NCT01636778|12542773|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
5098493|NCT01636778|12542774|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
5098494|NCT01636778|12542775|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
5098495|NCT01636765|12542838|P1|NOT COMPLETED|Overall Study||0
5098496|NCT01636765|12542838|P1|COMPLETED|Overall Study||104
5098497|NCT01636765|12542838|P1|STARTED|Overall Study||104
5098498|NCT01636713|12542846|P3|NOT COMPLETED|Overall Study||23
5098499|NCT01636713|12542847|P2|NOT COMPLETED|Overall Study||28
5098500|NCT01636713|12542848|P1|NOT COMPLETED|Overall Study||32
5098501|NCT01636713|12542846|P3|COMPLETED|Overall Study||170
5098502|NCT01636713|12542847|P2|COMPLETED|Overall Study||166
5098503|NCT01636713|12542848|P1|COMPLETED|Overall Study||161
5098504|NCT01636713|12542846|P3|STARTED|Overall Study||193
5098505|NCT01636713|12542847|P2|STARTED|Overall Study||194
5098506|NCT01636713|12542848|P1|STARTED|Overall Study||193
5098507|NCT01636687|12542865|P5|NOT COMPLETED|Follow-up Period||1
5098508|NCT01636687|12542866|P4|NOT COMPLETED|Follow-up Period||0
5098509|NCT01636687|12542867|P3|NOT COMPLETED|Follow-up Period||0
5098510|NCT01636687|12542868|P2|NOT COMPLETED|Follow-up Period||0
5098511|NCT01636687|12542869|P1|NOT COMPLETED|Follow-up Period||1
5098512|NCT01636687|12542865|P5|COMPLETED|Follow-up Period||1
5098513|NCT01636687|12542866|P4|COMPLETED|Follow-up Period||20
5098514|NCT01636687|12542867|P3|COMPLETED|Follow-up Period||21
5098515|NCT01636687|12542868|P2|COMPLETED|Follow-up Period||45
5098516|NCT01636687|12542869|P1|COMPLETED|Follow-up Period||37
5098517|NCT01636687|12542865|P5|STARTED|Follow-up Period||2
5098518|NCT01636687|12542866|P4|STARTED|Follow-up Period||20
5098519|NCT01636687|12542867|P3|STARTED|Follow-up Period||21
5098520|NCT01636687|12542868|P2|STARTED|Follow-up Period||45
5098521|NCT01636687|12542869|P1|STARTED|Follow-up Period||38
5098522|NCT01636687|12542865|P5|NOT COMPLETED|Extension Period||0
5098523|NCT01636687|12542866|P4|NOT COMPLETED|Extension Period||28
5098524|NCT01636687|12542867|P3|NOT COMPLETED|Extension Period||25
5098525|NCT01636687|12542868|P2|NOT COMPLETED|Extension Period||54
5098526|NCT01636687|12542869|P1|NOT COMPLETED|Extension Period||47
5098527|NCT01636687|12542865|P5|COMPLETED|Extension Period||0
5098528|NCT01636687|12542866|P4|COMPLETED|Extension Period||0
5098529|NCT01636687|12542867|P3|COMPLETED|Extension Period||0
5098530|NCT01636687|12542868|P2|COMPLETED|Extension Period||0
5098531|NCT01636687|12542869|P1|COMPLETED|Extension Period||0
5098532|NCT01636687|12542865|P5|STARTED|Extension Period||0
5098533|NCT01636687|12542866|P4|STARTED|Extension Period||28
5098534|NCT01636687|12542867|P3|STARTED|Extension Period||25
5098535|NCT01636687|12542868|P2|STARTED|Extension Period||54
5098536|NCT01636687|12542869|P1|STARTED|Extension Period||47
5098537|NCT01636687|12542865|P5|NOT COMPLETED|Maintenance Period||2
5098538|NCT01636687|12542866|P4|NOT COMPLETED|Maintenance Period||0
5098539|NCT01636687|12542867|P3|NOT COMPLETED|Maintenance Period||2
5098540|NCT01636687|12542868|P2|NOT COMPLETED|Maintenance Period||2
5098541|NCT01636687|12542869|P1|NOT COMPLETED|Maintenance Period||8
5098542|NCT01636687|12542865|P5|COMPLETED|Maintenance Period||1
5098543|NCT01636687|12542866|P4|COMPLETED|Maintenance Period||28
5098544|NCT01636687|12542867|P3|COMPLETED|Maintenance Period||26
5098545|NCT01636687|12542868|P2|COMPLETED|Maintenance Period||58
5098546|NCT01636687|12542869|P1|COMPLETED|Maintenance Period||50
5098547|NCT01636687|12542865|P5|STARTED|Maintenance Period||3
5098548|NCT01636687|12542866|P4|STARTED|Maintenance Period||28
5098549|NCT01636687|12542867|P3|STARTED|Maintenance Period||28
5098550|NCT01636687|12542868|P2|STARTED|Maintenance Period||60
5098551|NCT01636687|12542869|P1|STARTED|Maintenance Period||58
5098552|NCT01636687|12542865|P5|NOT COMPLETED|Induction Period||2
5098553|NCT01636687|12542866|P4|NOT COMPLETED|Induction Period||0
5098554|NCT01636687|12542867|P3|NOT COMPLETED|Induction Period||0
5098555|NCT01636687|12542868|P2|NOT COMPLETED|Induction Period||0
5098556|NCT01636687|12542869|P1|NOT COMPLETED|Induction Period||3
5098557|NCT01636687|12542865|P5|COMPLETED|Induction Period||59
5098558|NCT01636687|12542866|P4|COMPLETED|Induction Period||0
5098559|NCT01636687|12542867|P3|COMPLETED|Induction Period||0
5098560|NCT01636687|12542868|P2|COMPLETED|Induction Period||60
5098561|NCT01636687|12542869|P1|COMPLETED|Induction Period||58
5098562|NCT01636687|12542865|P5|STARTED|Induction Period||61
5098563|NCT01636687|12542866|P4|STARTED|Induction Period||0
5098564|NCT01636687|12542867|P3|STARTED|Induction Period||0
5098565|NCT01636687|12542868|P2|STARTED|Induction Period||60
5098566|NCT01636687|12542869|P1|STARTED|Induction Period||61
5098567|NCT01636661|12542958|P2|NOT COMPLETED|Overall Study||0
5098568|NCT01636661|12542959|P1|NOT COMPLETED|Overall Study||0
5098569|NCT01636661|12542958|P2|COMPLETED|Overall Study||6
5098570|NCT01636661|12542959|P1|COMPLETED|Overall Study||5
5098571|NCT01636661|12542958|P2|STARTED|Overall Study||6
5098572|NCT01636661|12542959|P1|STARTED|Overall Study||5
5098573|NCT01636466|12542969|P2|NOT COMPLETED|Overall Study||0
5098574|NCT01636466|12542970|P1|NOT COMPLETED|Overall Study||1
5098575|NCT01636466|12542969|P2|COMPLETED|Overall Study||0
5098576|NCT01636466|12542970|P1|COMPLETED|Overall Study||0
5098577|NCT01636466|12542969|P2|STARTED|Overall Study||0
5098578|NCT01636466|12542970|P1|STARTED|Overall Study||1
5098579|NCT01636453|12542978|P1|NOT COMPLETED|Overall Study||8
5098580|NCT01636453|12542978|P1|COMPLETED|Overall Study||112
5098581|NCT01636453|12542978|P1|STARTED|Overall Study||120
5098582|NCT01636414|12542997|P3|NOT COMPLETED|Overall Study||9
5098583|NCT01636414|12542998|P2|NOT COMPLETED|Overall Study||6
5098584|NCT01636414|12542999|P1|NOT COMPLETED|Overall Study||3
5098585|NCT01636414|12542997|P3|COMPLETED|Overall Study||65
5098586|NCT01636414|12542998|P2|COMPLETED|Overall Study||60
5098587|NCT01636414|12542999|P1|COMPLETED|Overall Study||61
5098588|NCT01636414|12542997|P3|STARTED|Overall Study||74
5098589|NCT01636414|12542998|P2|STARTED|Overall Study||66
5098590|NCT01636414|12542999|P1|STARTED|Overall Study||64
5098591|NCT01636362|12543010|P1|NOT COMPLETED|Overall Study||8
5098592|NCT01636362|12543010|P1|COMPLETED|Overall Study||37
5098593|NCT01636362|12543010|P1|STARTED|Overall Study||45
5098594|NCT01636297|12543019|P3|NOT COMPLETED|Overall Study||1
5098595|NCT01636297|12543020|P2|NOT COMPLETED|Overall Study||4
5098596|NCT01636297|12543021|P1|NOT COMPLETED|Overall Study||4
5098597|NCT01636297|12543019|P3|COMPLETED|Overall Study||19
5098598|NCT01636297|12543020|P2|COMPLETED|Overall Study||36
5098599|NCT01636297|12543021|P1|COMPLETED|Overall Study||36
5098600|NCT01636297|12543019|P3|STARTED|Overall Study||20
5098601|NCT01636297|12543020|P2|STARTED|Overall Study||40
5098602|NCT01636297|12543021|P1|STARTED|Overall Study||40
5098603|NCT01636258|12543037|P2|NOT COMPLETED|Overall Study||0
5098604|NCT01636258|12543038|P1|NOT COMPLETED|Overall Study||1
5098605|NCT01636258|12543037|P2|COMPLETED|Overall Study||14
5098606|NCT01636258|12543038|P1|COMPLETED|Overall Study||12
5098607|NCT01636258|12543037|P2|STARTED|Overall Study||14
5098608|NCT01636258|12543038|P1|STARTED|Overall Study||13
5098609|NCT01636206|12543054|P2|NOT COMPLETED|Overall Study||51
5098610|NCT01636206|12543055|P1|NOT COMPLETED|Overall Study||19
5098611|NCT01636206|12543054|P2|COMPLETED|Overall Study||170
5098612|NCT01636206|12543055|P1|COMPLETED|Overall Study||92
5098613|NCT01636206|12543054|P2|STARTED|Overall Study||221
5098614|NCT01636206|12543055|P1|STARTED|Overall Study||111
5098615|NCT01636102|12543063|P2|NOT COMPLETED|Overall Study||0
5098616|NCT01636102|12543064|P1|NOT COMPLETED|Overall Study||0
5098617|NCT01636102|12543063|P2|COMPLETED|Overall Study||63
5098618|NCT01636102|12543064|P1|COMPLETED|Overall Study||63
5098619|NCT01636102|12543063|P2|STARTED|Overall Study||63
5098620|NCT01636102|12543064|P1|STARTED|Overall Study||63
5098621|NCT01636076|12543078|P2|NOT COMPLETED|Overall Study||25
5098622|NCT01636076|12543079|P1|NOT COMPLETED|Overall Study||17
5098623|NCT01636076|12543078|P2|COMPLETED|Overall Study||288
5098624|NCT01636076|12543079|P1|COMPLETED|Overall Study||299
5098625|NCT01636076|12543078|P2|STARTED|Overall Study||313
5098626|NCT01636076|12543079|P1|STARTED|Overall Study||316
5098627|NCT01636063|12543141|P2|NOT COMPLETED|Overall Study||0
5098628|NCT01636063|12543142|P1|NOT COMPLETED|Overall Study||0
5098629|NCT01636063|12543141|P2|COMPLETED|Overall Study||21
5098630|NCT01636063|12543142|P1|COMPLETED|Overall Study||21
5098631|NCT01636063|12543141|P2|STARTED|Overall Study||21
5098632|NCT01636063|12543142|P1|STARTED|Overall Study||21
5098633|NCT01635933|12543150|P2|NOT COMPLETED|Overall Study||8
5098634|NCT01635933|12543151|P1|NOT COMPLETED|Overall Study||2
5098635|NCT01635933|12543150|P2|COMPLETED|Overall Study||177
5098636|NCT01635933|12543151|P1|COMPLETED|Overall Study||176
5098637|NCT01635933|12543150|P2|STARTED|Overall Study||185
5098638|NCT01635933|12543151|P1|STARTED|Overall Study||178
5098639|NCT01635920|12543163|P2|NOT COMPLETED|Overall Study||1
5098640|NCT01635920|12543164|P1|NOT COMPLETED|Overall Study||3
5098641|NCT01635920|12543163|P2|COMPLETED|Overall Study||125
5098642|NCT01635920|12543164|P1|COMPLETED|Overall Study||122
5098643|NCT01635920|12543163|P2|STARTED|Overall Study||126
5098644|NCT01635920|12543164|P1|STARTED|Overall Study||125
5098645|NCT01635881|12543172|P1|NOT COMPLETED|Overall Study||0
5098646|NCT01635881|12543172|P1|COMPLETED|Overall Study||60
5098647|NCT01635881|12543172|P1|STARTED|Overall Study||60
5098648|NCT01635855|12543177|P1|NOT COMPLETED|Overall Study||4
5098649|NCT01635855|12543177|P1|COMPLETED|Overall Study||113
5098650|NCT01635855|12543177|P1|STARTED|Overall Study||117
5098651|NCT01635764|12543186|P1|NOT COMPLETED|Overall Study||273
5098652|NCT01635764|12543186|P1|COMPLETED|Overall Study||235
5098653|NCT01635764|12543186|P1|STARTED|Overall Study||508
5098654|NCT01635504|12543214|P1|NOT COMPLETED|Overall Study||0
5098655|NCT01635504|12543214|P1|COMPLETED|Overall Study||5
5098656|NCT01635504|12543214|P1|STARTED|Overall Study||5
5098657|NCT01635439|12543221|P2|NOT COMPLETED|Overall Study||0
5098658|NCT01635439|12543222|P1|NOT COMPLETED|Overall Study||0
5098659|NCT01635439|12543221|P2|COMPLETED|Overall Study||100
5098660|NCT01635439|12543222|P1|COMPLETED|Overall Study||100
5098661|NCT01635439|12543221|P2|STARTED|Overall Study||100
5098662|NCT01635439|12543222|P1|STARTED|Overall Study||100
5098663|NCT01635244|12543239|P3|NOT COMPLETED|Overall Study||2
5098664|NCT01635244|12543240|P2|NOT COMPLETED|Overall Study||1
5098665|NCT01635244|12543241|P1|NOT COMPLETED|Overall Study||1
5098666|NCT01635244|12543239|P3|COMPLETED|Overall Study||18
5098667|NCT01635244|12543240|P2|COMPLETED|Overall Study||21
5098668|NCT01635244|12543241|P1|COMPLETED|Overall Study||17
5098669|NCT01635244|12543239|P3|STARTED|Overall Study||20
5098670|NCT01635244|12543240|P2|STARTED|Overall Study||22
5098671|NCT01635244|12543241|P1|STARTED|Overall Study||18
5098672|NCT01635218|12543252|P3|NOT COMPLETED|Overall Study||6
5098673|NCT01635218|12543253|P2|NOT COMPLETED|Overall Study||7
5098674|NCT01635218|12543254|P1|NOT COMPLETED|Overall Study||3
5098675|NCT01635218|12543252|P3|COMPLETED|Overall Study||37
5098676|NCT01635218|12543253|P2|COMPLETED|Overall Study||39
5098677|NCT01635218|12543254|P1|COMPLETED|Overall Study||41
5098678|NCT01635218|12543252|P3|STARTED|Overall Study||43
5098679|NCT01635218|12543253|P2|STARTED|Overall Study||46
5098680|NCT01635218|12543254|P1|STARTED|Overall Study||44
5098681|NCT01635101|12543277|P3|NOT COMPLETED|Overall Study||17
5098682|NCT01635101|12543278|P2|NOT COMPLETED|Overall Study||12
5098683|NCT01635101|12543279|P1|NOT COMPLETED|Overall Study||9
5098684|NCT01635101|12543277|P3|COMPLETED|Overall Study||52
5098685|NCT01635101|12543278|P2|COMPLETED|Overall Study||55
5098686|NCT01635101|12543279|P1|COMPLETED|Overall Study||52
5098687|NCT01635101|12543277|P3|Pharmacokinetics Evaluable Population|Overall Study||58
5098688|NCT01635101|12543278|P2|Pharmacokinetics Evaluable Population|Overall Study||59
5098689|NCT01635101|12543279|P1|Pharmacokinetics Evaluable Population|Overall Study||50
5098690|NCT01635101|12543277|P3|Modified Intent to Treat (mITT)|Overall Study||69
5098691|NCT01635101|12543278|P2|Modified Intent to Treat (mITT)|Overall Study||67
5098692|NCT01635101|12543279|P1|Modified Intent to Treat (mITT)|Overall Study||61
5098693|NCT01635101|12543277|P3|Safety Population|Overall Study||69
5098694|NCT01635101|12543278|P2|Safety Population|Overall Study||67
5098695|NCT01635101|12543279|P1|Safety Population|Overall Study||61
5098696|NCT01635101|12543277|P3|STARTED|Overall Study||69
5098697|NCT01635101|12543278|P2|STARTED|Overall Study||67
5098698|NCT01635101|12543279|P1|STARTED|Overall Study||61
5098699|NCT01635062|12543304|P2|NOT COMPLETED|Overall Study||0
5098700|NCT01635062|12543305|P1|NOT COMPLETED|Overall Study||0
5098701|NCT01635062|12543304|P2|COMPLETED|Overall Study||9
5098702|NCT01635062|12543305|P1|COMPLETED|Overall Study||9
5098703|NCT01635062|12543304|P2|Post-Randomization Sodium Loaded|Overall Study||9
5098704|NCT01635062|12543305|P1|Post-Randomization Sodium Loaded|Overall Study||9
5098705|NCT01635062|12543304|P2|Post-randomization Sodium Restriction|Overall Study||9
5098706|NCT01635062|12543305|P1|Post-randomization Sodium Restriction|Overall Study||9
5098707|NCT01635062|12543304|P2|Sodium Loading Baseline Visit|Overall Study||9
5098708|NCT01635062|12543305|P1|Sodium Loading Baseline Visit|Overall Study||9
5098709|NCT01635062|12543304|P2|Sodium Restriction Baseline Visit|Overall Study||9
5098710|NCT01635062|12543305|P1|Sodium Restriction Baseline Visit|Overall Study||9
5098711|NCT01635062|12543304|P2|STARTED|Overall Study||9
5098712|NCT01635062|12543305|P1|STARTED|Overall Study||9
5098713|NCT01634854|12543317|P2|NOT COMPLETED|Overall Study||7
5098714|NCT01634854|12543318|P1|NOT COMPLETED|Overall Study||2
5098715|NCT01634854|12543317|P2|COMPLETED|Overall Study||59
5098716|NCT01634854|12543318|P1|COMPLETED|Overall Study||62
5098717|NCT01634854|12543317|P2|STARTED|Overall Study||66
5098718|NCT01634854|12543318|P1|STARTED|Overall Study||64
5098719|NCT01634659|12543338|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
5098720|NCT01634659|12543339|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
5098721|NCT01634659|12543338|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
5098722|NCT01634659|12543339|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
5098723|NCT01634659|12543338|P2|STARTED|Period 2 - Second 8 Days of Wear||158
5098724|NCT01634659|12543339|P1|STARTED|Period 2 - Second 8 Days of Wear||155
5098725|NCT01634659|12543338|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
5098726|NCT01634659|12543339|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
5098727|NCT01634659|12543338|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
5098728|NCT01634659|12543339|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
5098729|NCT01634659|12543338|P2|STARTED|Period 1 - First 8 Days of Wear||158
5098730|NCT01634659|12543339|P1|STARTED|Period 1 - First 8 Days of Wear||155
5098731|NCT01634620|12543349|P1|NOT COMPLETED|Overall Study||0
5098732|NCT01634620|12543349|P1|COMPLETED|Overall Study||200
5098733|NCT01634620|12543349|P1|STARTED|Overall Study||200
5098734|NCT01634555|12543369|P1|NOT COMPLETED|Overall Study||4
5098735|NCT01634555|12543369|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
5098736|NCT01634555|12543369|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
5098737|NCT01634555|12543369|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
5098738|NCT01634555|12543369|P1|STARTED|Overall Study||29
5098739|NCT01634360|12543380|P2|NOT COMPLETED|Overall Study||136
5098740|NCT01634360|12543381|P1|NOT COMPLETED|Overall Study||49
5098741|NCT01634360|12543380|P2|COMPLETED|Overall Study||0
5098742|NCT01634360|12543381|P1|COMPLETED|Overall Study||0
5098743|NCT01634360|12543380|P2|STARTED|Overall Study||136
5098744|NCT01634360|12543381|P1|STARTED|Overall Study||49
5098745|NCT01634269|12543391|P1|NOT COMPLETED|Overall Study||2
5098746|NCT01634269|12543391|P1|COMPLETED|Overall Study||18
5098747|NCT01634269|12543391|P1|24 Month|Overall Study||18
5098748|NCT01634269|12543391|P1|12 Month|Overall Study||20
5098749|NCT01634269|12543391|P1|6 Month|Overall Study||20
5098750|NCT01634269|12543391|P1|30 Days|Overall Study||20
5098751|NCT01634269|12543391|P1|STARTED|Overall Study||20
5098752|NCT01634256|12543438|P2|NOT COMPLETED|Overall Study||8
5098753|NCT01634256|12543439|P1|NOT COMPLETED|Overall Study||4
5098754|NCT01634256|12543438|P2|COMPLETED|Overall Study||22
5098755|NCT01634256|12543439|P1|COMPLETED|Overall Study||26
5098756|NCT01634256|12543438|P2|STARTED|Overall Study||30
5098757|NCT01634256|12543439|P1|STARTED|Overall Study||30
5098758|NCT01634243|12543455|P2|NOT COMPLETED|Overall Study||5
5098759|NCT01634243|12543456|P1|NOT COMPLETED|Overall Study||6
5098760|NCT01634243|12543455|P2|COMPLETED|Overall Study||38
5098761|NCT01634243|12543456|P1|COMPLETED|Overall Study||15
5098762|NCT01634243|12543455|P2|STARTED|Overall Study||43
5098763|NCT01634243|12543456|P1|STARTED|Overall Study||21
5098764|NCT01634165|12543482|P4|NOT COMPLETED|Period 4||0
5098765|NCT01634165|12543483|P3|NOT COMPLETED|Period 4||0
5098766|NCT01634165|12543484|P2|NOT COMPLETED|Period 4||0
5098767|NCT01634165|12543485|P1|NOT COMPLETED|Period 4||0
5098768|NCT01634165|12543482|P4|COMPLETED|Period 4||6
5098769|NCT01634165|12543483|P3|COMPLETED|Period 4||6
5098770|NCT01634165|12543484|P2|COMPLETED|Period 4||5
5098771|NCT01634165|12543485|P1|COMPLETED|Period 4||6
5098772|NCT01634165|12543482|P4|STARTED|Period 4||6
5098773|NCT01634165|12543483|P3|STARTED|Period 4||6
5098774|NCT01634165|12543484|P2|STARTED|Period 4||5
5098775|NCT01634165|12543485|P1|STARTED|Period 4||6
5098776|NCT01634165|12543482|P4|NOT COMPLETED|Period 3||0
5098777|NCT01634165|12543483|P3|NOT COMPLETED|Period 3||0
5098778|NCT01634165|12543484|P2|NOT COMPLETED|Period 3||0
5098779|NCT01634165|12543485|P1|NOT COMPLETED|Period 3||0
5098780|NCT01634165|12543482|P4|COMPLETED|Period 3||6
5098781|NCT01634165|12543483|P3|COMPLETED|Period 3||6
5098782|NCT01634165|12543484|P2|COMPLETED|Period 3||5
5098783|NCT01634165|12543485|P1|COMPLETED|Period 3||6
5098784|NCT01634165|12543482|P4|STARTED|Period 3||6
5098785|NCT01634165|12543483|P3|STARTED|Period 3||6
5098786|NCT01634165|12543484|P2|STARTED|Period 3||5
5098787|NCT01634165|12543485|P1|STARTED|Period 3||6
5098788|NCT01634165|12543482|P4|NOT COMPLETED|Period 2||0
5098789|NCT01634165|12543483|P3|NOT COMPLETED|Period 2||0
5098790|NCT01634165|12543484|P2|NOT COMPLETED|Period 2||1
5098791|NCT01634165|12543485|P1|NOT COMPLETED|Period 2||0
5098792|NCT01634165|12543482|P4|COMPLETED|Period 2||6
5098793|NCT01634165|12543483|P3|COMPLETED|Period 2||6
5098794|NCT01634165|12543484|P2|COMPLETED|Period 2||5
5098795|NCT01634165|12543485|P1|COMPLETED|Period 2||6
5098796|NCT01634165|12543482|P4|STARTED|Period 2||6
5098797|NCT01634165|12543483|P3|STARTED|Period 2||6
5098798|NCT01634165|12543484|P2|STARTED|Period 2||6
5098799|NCT01634165|12543485|P1|STARTED|Period 2||6
5098800|NCT01634165|12543482|P4|NOT COMPLETED|Period 1||0
5098801|NCT01634165|12543483|P3|NOT COMPLETED|Period 1||0
5098802|NCT01634165|12543484|P2|NOT COMPLETED|Period 1||0
5098803|NCT01634165|12543485|P1|NOT COMPLETED|Period 1||0
5098804|NCT01634165|12543482|P4|COMPLETED|Period 1||6
5098805|NCT01634165|12543483|P3|COMPLETED|Period 1||6
5098806|NCT01634165|12543484|P2|COMPLETED|Period 1||6
5098807|NCT01634165|12543485|P1|COMPLETED|Period 1||6
5098808|NCT01634165|12543482|P4|Received at Least 1 Dose of Study Drug|Period 1||6
5098809|NCT01634165|12543483|P3|Received at Least 1 Dose of Study Drug|Period 1||6
5098810|NCT01634165|12543484|P2|Received at Least 1 Dose of Study Drug|Period 1||6
5098811|NCT01634165|12543485|P1|Received at Least 1 Dose of Study Drug|Period 1||6
5098812|NCT01634165|12543482|P4|STARTED|Period 1||6
5098813|NCT01634165|12543483|P3|STARTED|Period 1||6
5098814|NCT01634165|12543484|P2|STARTED|Period 1||6
5098815|NCT01634165|12543485|P1|STARTED|Period 1||6
5098816|NCT01634152|12543518|P3|NOT COMPLETED|Overall Study||4
5098817|NCT01634152|12543519|P2|NOT COMPLETED|Overall Study||1
5098818|NCT01634152|12543520|P1|NOT COMPLETED|Overall Study||4
5098819|NCT01634152|12543518|P3|COMPLETED|Overall Study||126
5098820|NCT01634152|12543519|P2|COMPLETED|Overall Study||136
5098821|NCT01634152|12543520|P1|COMPLETED|Overall Study||130
5098822|NCT01634152|12543518|P3|STARTED|Overall Study||130
5098823|NCT01634152|12543519|P2|STARTED|Overall Study||137
5098824|NCT01634152|12543520|P1|STARTED|Overall Study||134
5098825|NCT01634139|12543603|P3|NOT COMPLETED|Overall Study||5
5098826|NCT01634139|12543604|P2|NOT COMPLETED|Overall Study||6
5098827|NCT01634139|12543605|P1|NOT COMPLETED|Overall Study||10
5098828|NCT01634139|12543603|P3|COMPLETED|Overall Study||130
5098829|NCT01634139|12543604|P2|COMPLETED|Overall Study||130
5098830|NCT01634139|12543605|P1|COMPLETED|Overall Study||122
5098831|NCT01634139|12543603|P3|STARTED|Overall Study||135
5098832|NCT01634139|12543604|P2|STARTED|Overall Study||136
5098833|NCT01634139|12543605|P1|STARTED|Overall Study||132
5098834|NCT01634113|12543706|P3|NOT COMPLETED|Overall Study||1
5098835|NCT01634113|12543707|P2|NOT COMPLETED|Overall Study||0
5098836|NCT01634113|12543708|P1|NOT COMPLETED|Overall Study||0
5098837|NCT01634113|12543706|P3|COMPLETED|Overall Study||31
5098838|NCT01634113|12543707|P2|COMPLETED|Overall Study||36
5098839|NCT01634113|12543708|P1|COMPLETED|Overall Study||34
5098840|NCT01634113|12543706|P3|STARTED|Overall Study||32
5098841|NCT01634113|12543707|P2|STARTED|Overall Study||36
5098842|NCT01634113|12543708|P1|STARTED|Overall Study||34
5098843|NCT01634100|12543752|P6|NOT COMPLETED|Overall Study||0
5098844|NCT01634100|12543753|P5|NOT COMPLETED|Overall Study||0
5098845|NCT01634100|12543754|P4|NOT COMPLETED|Overall Study||0
5098846|NCT01634100|12543755|P3|NOT COMPLETED|Overall Study||1
5098847|NCT01634100|12543756|P2|NOT COMPLETED|Overall Study||0
5098848|NCT01634100|12543757|P1|NOT COMPLETED|Overall Study||1
5098849|NCT01634100|12543752|P6|COMPLETED|Overall Study||3
5098850|NCT01634100|12543753|P5|COMPLETED|Overall Study||3
5098851|NCT01634100|12543754|P4|COMPLETED|Overall Study||3
5098852|NCT01634100|12543755|P3|COMPLETED|Overall Study||2
5098853|NCT01634100|12543756|P2|COMPLETED|Overall Study||3
5098854|NCT01634100|12543757|P1|COMPLETED|Overall Study||2
5098855|NCT01634100|12543752|P6|Received Empa + Probenecid|Overall Study||3
5098856|NCT01634100|12543753|P5|Received Empa + Probenecid|Overall Study||3
5098857|NCT01634100|12543754|P4|Received Empa + Probenecid|Overall Study||3
5098858|NCT01634100|12543755|P3|Received Empa + Probenecid|Overall Study||2
5098859|NCT01634100|12543756|P2|Received Empa + Probenecid|Overall Study||3
5098860|NCT01634100|12543757|P1|Received Empa + Probenecid|Overall Study||2
5098861|NCT01634100|12543752|P6|Received Empa + Rifampicin|Overall Study||3
5098862|NCT01634100|12543753|P5|Received Empa + Rifampicin|Overall Study||3
5098863|NCT01634100|12543754|P4|Received Empa + Rifampicin|Overall Study||3
5098864|NCT01634100|12543755|P3|Received Empa + Rifampicin|Overall Study||3
5098865|NCT01634100|12543756|P2|Received Empa + Rifampicin|Overall Study||3
5098866|NCT01634100|12543757|P1|Received Empa + Rifampicin|Overall Study||3
5098867|NCT01634100|12543752|P6|Received Empa Alone|Overall Study||3
5098868|NCT01634100|12543753|P5|Received Empa Alone|Overall Study||3
5098869|NCT01634100|12543754|P4|Received Empa Alone|Overall Study||3
5098870|NCT01634100|12543755|P3|Received Empa Alone|Overall Study||3
5098871|NCT01634100|12543756|P2|Received Empa Alone|Overall Study||3
5098872|NCT01634100|12543757|P1|Received Empa Alone|Overall Study||3
5098873|NCT01634100|12543752|P6|STARTED|Overall Study||3
5098874|NCT01634100|12543753|P5|STARTED|Overall Study||3
5098875|NCT01634100|12543754|P4|STARTED|Overall Study||3
5098876|NCT01634100|12543755|P3|STARTED|Overall Study||3
5098877|NCT01634100|12543756|P2|STARTED|Overall Study||3
5098878|NCT01634100|12543757|P1|STARTED|Overall Study||3
5098879|NCT01633944|12543773|P3|NOT COMPLETED|Double-blind Treatment Phase||58
5098880|NCT01633944|12543774|P2|NOT COMPLETED|Double-blind Treatment Phase||54
5098881|NCT01633944|12543775|P1|NOT COMPLETED|Double-blind Treatment Phase||0
5098882|NCT01633944|12543773|P3|COMPLETED|Double-blind Treatment Phase||174
5098883|NCT01633944|12543774|P2|COMPLETED|Double-blind Treatment Phase||176
5098884|NCT01633944|12543775|P1|COMPLETED|Double-blind Treatment Phase||0
5098885|NCT01633944|12543773|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
5098886|NCT01633944|12543774|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
5098887|NCT01633944|12543775|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
5098888|NCT01633944|12543773|P3|NOT COMPLETED|Open-label Titration Phase||0
5098889|NCT01633944|12543774|P2|NOT COMPLETED|Open-label Titration Phase||0
5098890|NCT01633944|12543775|P1|NOT COMPLETED|Open-label Titration Phase||290
5098891|NCT01633944|12543773|P3|COMPLETED|Open-label Titration Phase||0
5098892|NCT01633944|12543774|P2|COMPLETED|Open-label Titration Phase||0
5098893|NCT01633944|12543775|P1|COMPLETED|Open-label Titration Phase||462
5098894|NCT01633944|12543773|P3|STARTED|Open-label Titration Phase||0
5098895|NCT01633944|12543774|P2|STARTED|Open-label Titration Phase||0
5098896|NCT01633944|12543775|P1|STARTED|Open-label Titration Phase||752
5098897|NCT01633892|12543795|P1|NOT COMPLETED|Overall Study||0
5098898|NCT01633892|12543795|P1|COMPLETED|Overall Study||5
5098899|NCT01633892|12543795|P1|STARTED|Overall Study||5
5098900|NCT01633853|12543805|P2|NOT COMPLETED|Overall Study||0
5098901|NCT01633853|12543806|P1|NOT COMPLETED|Overall Study||0
5098902|NCT01633853|12543805|P2|COMPLETED|Overall Study||100
5098903|NCT01633853|12543806|P1|COMPLETED|Overall Study||104
5098904|NCT01633853|12543805|P2|STARTED|Overall Study||100
5098905|NCT01633853|12543806|P1|STARTED|Overall Study||104
5098906|NCT01633827|12543820|P2|NOT COMPLETED|Second Intervention||0
5098907|NCT01633827|12543821|P1|NOT COMPLETED|Second Intervention||0
5098908|NCT01633827|12543820|P2|COMPLETED|Second Intervention||11
5098909|NCT01633827|12543821|P1|COMPLETED|Second Intervention||11
5098910|NCT01633827|12543820|P2|STARTED|Second Intervention||11
5098911|NCT01633827|12543821|P1|STARTED|Second Intervention||11
5098912|NCT01633827|12543820|P2|NOT COMPLETED|Washout Period||0
5098913|NCT01633827|12543821|P1|NOT COMPLETED|Washout Period||0
5098914|NCT01633827|12543820|P2|COMPLETED|Washout Period||11
5098915|NCT01633827|12543821|P1|COMPLETED|Washout Period||11
5098916|NCT01633827|12543820|P2|STARTED|Washout Period||11
5098917|NCT01633827|12543821|P1|STARTED|Washout Period||11
5098918|NCT01633827|12543820|P2|NOT COMPLETED|First Intervention||0
5098919|NCT01633827|12543821|P1|NOT COMPLETED|First Intervention||0
5098920|NCT01633827|12543820|P2|COMPLETED|First Intervention||11
5098921|NCT01633827|12543821|P1|COMPLETED|First Intervention||11
5098922|NCT01633827|12543820|P2|STARTED|First Intervention||11
5098923|NCT01633827|12543821|P1|STARTED|First Intervention||11
5098924|NCT01633814|12543834|P1|NOT COMPLETED|Overall Study||0
5098925|NCT01633814|12543834|P1|COMPLETED|Overall Study||4
5098926|NCT01633814|12543834|P1|STARTED|Overall Study||4
5098927|NCT01633788|12543843|P4|NOT COMPLETED|Overall Study||13
5098928|NCT01633788|12543844|P3|NOT COMPLETED|Overall Study||10
5098929|NCT01633788|12543845|P2|NOT COMPLETED|Overall Study||8
5098930|NCT01633788|12543846|P1|NOT COMPLETED|Overall Study||7
5098931|NCT01633788|12543843|P4|COMPLETED|Overall Study||45
5098932|NCT01633788|12543844|P3|COMPLETED|Overall Study||49
5098933|NCT01633788|12543845|P2|COMPLETED|Overall Study||50
5098934|NCT01633788|12543846|P1|COMPLETED|Overall Study||50
5098935|NCT01633788|12543843|P4|STARTED|Overall Study||58
5098936|NCT01633788|12543844|P3|STARTED|Overall Study||59
5098937|NCT01633788|12543845|P2|STARTED|Overall Study||58
5098938|NCT01633788|12543846|P1|STARTED|Overall Study||57
5098939|NCT01633320|12543866|P2|NOT COMPLETED|Overall Study||0
5098940|NCT01633320|12543867|P1|NOT COMPLETED|Overall Study||0
5098941|NCT01633320|12543866|P2|COMPLETED|Overall Study||68
5098942|NCT01633320|12543867|P1|COMPLETED|Overall Study||132
5098943|NCT01633320|12543866|P2|STARTED|Overall Study||68
5098944|NCT01633320|12543867|P1|STARTED|Overall Study||132
5098945|NCT01633112|12543878|P3|NOT COMPLETED|Overall Study||92
5098946|NCT01633112|12543879|P2|NOT COMPLETED|Overall Study||60
5098947|NCT01633112|12543880|P1|NOT COMPLETED|Overall Study||53
5098948|NCT01633112|12543878|P3|COMPLETED|Overall Study||250
5098949|NCT01633112|12543879|P2|COMPLETED|Overall Study||310
5098950|NCT01633112|12543880|P1|COMPLETED|Overall Study||299
5098951|NCT01633112|12543878|P3|STARTED|Overall Study||342
5098952|NCT01633112|12543879|P2|STARTED|Overall Study||370
5098953|NCT01633112|12543880|P1|STARTED|Overall Study||352
5098954|NCT01633060|12543915|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
5098955|NCT01633060|12543916|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
5098956|NCT01633060|12543915|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
5098957|NCT01633060|12543916|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
5098958|NCT01633060|12543915|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
5098959|NCT01633060|12543916|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
5098960|NCT01633060|12543915|P2|NOT COMPLETED|Treatment Phase||140
5098961|NCT01633060|12543916|P1|NOT COMPLETED|Treatment Phase||288
5098962|NCT01633060|12543915|P2|COMPLETED|Treatment Phase||0
5098963|NCT01633060|12543916|P1|COMPLETED|Treatment Phase||0
5098964|NCT01633060|12543915|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
5098965|NCT01633060|12543916|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
5098966|NCT01633060|12543915|P2|Safety Set (SS)|Treatment Phase||140
5098967|NCT01633060|12543916|P1|Safety Set (SS)|Treatment Phase||288
5098968|NCT01633060|12543915|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
5098969|NCT01633060|12543916|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
5098970|NCT01633060|12543915|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
5098971|NCT01633060|12543916|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
5098972|NCT01633060|12543915|P2|STARTED|Treatment Phase||140
5098973|NCT01633060|12543916|P1|STARTED|Treatment Phase||288
5098974|NCT01633060|12543915|P2|NOT COMPLETED|Randomization Phase||3
5098975|NCT01633060|12543916|P1|NOT COMPLETED|Randomization Phase||1
5098976|NCT01633060|12543915|P2|COMPLETED|Randomization Phase||140
5098977|NCT01633060|12543916|P1|COMPLETED|Randomization Phase||288
5098978|NCT01633060|12543915|P2|STARTED|Randomization Phase|All randomized patients|143
5098979|NCT01633060|12543916|P1|STARTED|Randomization Phase|All randomized patients|289
5098980|NCT01632995|12543941|P1|NOT COMPLETED|Main Study Follow-up Period||120
5098981|NCT01632995|12543941|P1|COMPLETED|Main Study Follow-up Period||437
5098982|NCT01632995|12543941|P1|STARTED|Main Study Follow-up Period||557
5098983|NCT01632995|12543941|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
5098984|NCT01632995|12543941|P1|COMPLETED|Pre-screening to Enrollment Period||557
5098985|NCT01632995|12543941|P1|STARTED|Pre-screening to Enrollment Period||1069
5098986|NCT01632904|12543956|P2|NOT COMPLETED|Overall Study||6
5098987|NCT01632904|12543957|P1|NOT COMPLETED|Overall Study||7
5098988|NCT01632904|12543956|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
5098989|NCT01632904|12543957|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
5098990|NCT01632904|12543956|P2|STARTED|Overall Study||56
5098991|NCT01632904|12543957|P1|STARTED|Overall Study||54
5098992|NCT01632891|12543968|P2|NOT COMPLETED|Overall Study||1
5098993|NCT01632891|12543969|P1|NOT COMPLETED|Overall Study||1
5098994|NCT01632891|12543968|P2|COMPLETED|Overall Study||25
5098995|NCT01632891|12543969|P1|COMPLETED|Overall Study||25
5098996|NCT01632891|12543968|P2|STARTED|Overall Study||26
5098997|NCT01632891|12543969|P1|STARTED|Overall Study||26
5098998|NCT01632878|12543993|P1|NOT COMPLETED|Treatment||158
5098999|NCT01632878|12543993|P1|COMPLETED|Treatment||1105
5099000|NCT01632878|12543993|P1|STARTED|Treatment||1263
5099001|NCT01632878|12543993|P1|NOT COMPLETED|Screening||268
5099002|NCT01632878|12543993|P1|COMPLETED|Screening||1263
5099003|NCT01632878|12543993|P1|STARTED|Screening||1531
5099004|NCT01632800|12543997|P1|NOT COMPLETED|Overall Study||1
5099005|NCT01632800|12543997|P1|COMPLETED|Overall Study||25
5099006|NCT01632800|12543997|P1|STARTED|Overall Study||26
5099007|NCT01632735|12544003|P2|NOT COMPLETED|Overall Study||3
5099008|NCT01632735|12544004|P1|NOT COMPLETED|Overall Study||4
5099009|NCT01632735|12544003|P2|COMPLETED|Overall Study||37
5099010|NCT01632735|12544004|P1|COMPLETED|Overall Study||36
5099011|NCT01632735|12544003|P2|STARTED|Overall Study||40
5099012|NCT01632735|12544004|P1|STARTED|Overall Study||40
5099013|NCT01632709|12544020|P4|NOT COMPLETED|Overall Study||1
5099014|NCT01632709|12544021|P3|NOT COMPLETED|Overall Study||0
5099015|NCT01632709|12544022|P2|NOT COMPLETED|Overall Study||1
5099016|NCT01632709|12544023|P1|NOT COMPLETED|Overall Study||2
5099017|NCT01632709|12544020|P4|COMPLETED|Overall Study||3
5099018|NCT01632709|12544021|P3|COMPLETED|Overall Study||5
5099019|NCT01632709|12544022|P2|COMPLETED|Overall Study||2
5099020|NCT01632709|12544023|P1|COMPLETED|Overall Study||2
5099021|NCT01632709|12544020|P4|Completed Visit 2 (Received Injection)|Overall Study||3
5099022|NCT01632709|12544021|P3|Completed Visit 2 (Received Injection)|Overall Study||5
5099023|NCT01632709|12544022|P2|Completed Visit 2 (Received Injection)|Overall Study||2
5099024|NCT01632709|12544023|P1|Completed Visit 2 (Received Injection)|Overall Study||4
5099025|NCT01632709|12544020|P4|STARTED|Overall Study||4
5099026|NCT01632709|12544021|P3|STARTED|Overall Study||5
5099027|NCT01632709|12544022|P2|STARTED|Overall Study||3
5099028|NCT01632709|12544023|P1|STARTED|Overall Study||4
5099029|NCT01632683|12544049|P2|NOT COMPLETED|Overall Study||0
5099030|NCT01632683|12544050|P1|NOT COMPLETED|Overall Study||0
5099031|NCT01632683|12544049|P2|COMPLETED|Overall Study||552
5099032|NCT01632683|12544050|P1|COMPLETED|Overall Study||548
5099033|NCT01632683|12544049|P2|STARTED|Overall Study||552
5099034|NCT01632683|12544050|P1|STARTED|Overall Study||548
5099035|NCT01632579|12544064|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
5099036|NCT01632579|12544065|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
5099037|NCT01632579|12544066|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
5099038|NCT01632579|12544067|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
5099039|NCT01632579|12544068|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
5099040|NCT01632579|12544069|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
5099041|NCT01632579|12544070|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
5099042|NCT01632579|12544071|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
5099043|NCT01632579|12544072|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
5099044|NCT01632579|12544064|P9|COMPLETED|Period 3 (Third Intervention)||2
5099045|NCT01632579|12544065|P8|COMPLETED|Period 3 (Third Intervention)||6
5099046|NCT01632579|12544066|P7|COMPLETED|Period 3 (Third Intervention)||2
5099047|NCT01632579|12544067|P6|COMPLETED|Period 3 (Third Intervention)||2
5099048|NCT01632579|12544068|P5|COMPLETED|Period 3 (Third Intervention)||6
5099049|NCT01632579|12544069|P4|COMPLETED|Period 3 (Third Intervention)||2
5099050|NCT01632579|12544070|P3|COMPLETED|Period 3 (Third Intervention)||2
5099051|NCT01632579|12544071|P2|COMPLETED|Period 3 (Third Intervention)||6
5099052|NCT01632579|12544072|P1|COMPLETED|Period 3 (Third Intervention)||0
5099053|NCT01632579|12544064|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
5099054|NCT01632579|12544065|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
5099055|NCT01632579|12544066|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
5099056|NCT01632579|12544067|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
5099057|NCT01632579|12544068|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
5099058|NCT01632579|12544069|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
5099059|NCT01632579|12544070|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
5099060|NCT01632579|12544071|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
5099061|NCT01632579|12544072|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
5099062|NCT01632579|12544064|P9|STARTED|Period 3 (Third Intervention)||2
5099063|NCT01632579|12544065|P8|STARTED|Period 3 (Third Intervention)||6
5099064|NCT01632579|12544066|P7|STARTED|Period 3 (Third Intervention)||2
5099065|NCT01632579|12544067|P6|STARTED|Period 3 (Third Intervention)||2
5099066|NCT01632579|12544068|P5|STARTED|Period 3 (Third Intervention)||6
5099067|NCT01632579|12544069|P4|STARTED|Period 3 (Third Intervention)||2
5099068|NCT01632579|12544070|P3|STARTED|Period 3 (Third Intervention)||2
5099069|NCT01632579|12544071|P2|STARTED|Period 3 (Third Intervention)||6
5099070|NCT01632579|12544072|P1|STARTED|Period 3 (Third Intervention)||0
5099071|NCT01632579|12544064|P9|NOT COMPLETED|Washout Period||0
5099072|NCT01632579|12544065|P8|NOT COMPLETED|Washout Period||0
5099073|NCT01632579|12544066|P7|NOT COMPLETED|Washout Period||0
5099074|NCT01632579|12544067|P6|NOT COMPLETED|Washout Period||0
5099075|NCT01632579|12544068|P5|NOT COMPLETED|Washout Period||0
5099076|NCT01632579|12544069|P4|NOT COMPLETED|Washout Period||0
5099077|NCT01632579|12544070|P3|NOT COMPLETED|Washout Period||0
5099078|NCT01632579|12544071|P2|NOT COMPLETED|Washout Period||0
5099079|NCT01632579|12544072|P1|NOT COMPLETED|Washout Period||0
5099080|NCT01632579|12544064|P9|COMPLETED|Washout Period||2
5099081|NCT01632579|12544065|P8|COMPLETED|Washout Period||6
5099082|NCT01632579|12544066|P7|COMPLETED|Washout Period||2
5099083|NCT01632579|12544067|P6|COMPLETED|Washout Period||2
5099084|NCT01632579|12544068|P5|COMPLETED|Washout Period||6
5099085|NCT01632579|12544069|P4|COMPLETED|Washout Period||2
5099086|NCT01632579|12544070|P3|COMPLETED|Washout Period||2
5099087|NCT01632579|12544071|P2|COMPLETED|Washout Period||6
5099088|NCT01632579|12544072|P1|COMPLETED|Washout Period||0
5099089|NCT01632579|12544064|P9|STARTED|Washout Period||2
5099090|NCT01632579|12544065|P8|STARTED|Washout Period||6
5099091|NCT01632579|12544066|P7|STARTED|Washout Period||2
5099092|NCT01632579|12544067|P6|STARTED|Washout Period||2
5099093|NCT01632579|12544068|P5|STARTED|Washout Period||6
5099094|NCT01632579|12544069|P4|STARTED|Washout Period||2
5099095|NCT01632579|12544070|P3|STARTED|Washout Period||2
5099096|NCT01632579|12544071|P2|STARTED|Washout Period||6
5099097|NCT01632579|12544072|P1|STARTED|Washout Period||0
5099098|NCT01632579|12544064|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
5099099|NCT01632579|12544065|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
5099100|NCT01632579|12544066|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
5099101|NCT01632579|12544067|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
5099102|NCT01632579|12544068|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
5099103|NCT01632579|12544069|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
5099104|NCT01632579|12544070|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
5099105|NCT01632579|12544071|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
5099106|NCT01632579|12544072|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
5099107|NCT01632579|12544064|P9|COMPLETED|Period 2 (Second Intervention)||2
5099108|NCT01632579|12544065|P8|COMPLETED|Period 2 (Second Intervention)||6
5099109|NCT01632579|12544066|P7|COMPLETED|Period 2 (Second Intervention)||2
5099110|NCT01632579|12544067|P6|COMPLETED|Period 2 (Second Intervention)||2
5099111|NCT01632579|12544068|P5|COMPLETED|Period 2 (Second Intervention)||6
5099112|NCT01632579|12544069|P4|COMPLETED|Period 2 (Second Intervention)||2
5099113|NCT01632579|12544070|P3|COMPLETED|Period 2 (Second Intervention)||2
5099114|NCT01632579|12544071|P2|COMPLETED|Period 2 (Second Intervention)||6
5099115|NCT01632579|12544072|P1|COMPLETED|Period 2 (Second Intervention)||0
5099116|NCT01632579|12544064|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
5099117|NCT01632579|12544065|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
5099118|NCT01632579|12544066|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
5099119|NCT01632579|12544067|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
5099120|NCT01632579|12544068|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
5099121|NCT01632579|12544069|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
5099122|NCT01632579|12544070|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
5099123|NCT01632579|12544071|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
5099124|NCT01632579|12544072|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
5099125|NCT01632579|12544064|P9|STARTED|Period 2 (Second Intervention)||2
5099126|NCT01632579|12544065|P8|STARTED|Period 2 (Second Intervention)||6
5099127|NCT01632579|12544066|P7|STARTED|Period 2 (Second Intervention)||2
5099128|NCT01632579|12544067|P6|STARTED|Period 2 (Second Intervention)||2
5099129|NCT01632579|12544068|P5|STARTED|Period 2 (Second Intervention)||6
5099130|NCT01632579|12544069|P4|STARTED|Period 2 (Second Intervention)||2
5099131|NCT01632579|12544070|P3|STARTED|Period 2 (Second Intervention)||2
5099132|NCT01632579|12544071|P2|STARTED|Period 2 (Second Intervention)||6
5099133|NCT01632579|12544072|P1|STARTED|Period 2 (Second Intervention)||1
5099134|NCT01632579|12544064|P9|NOT COMPLETED|Washout Period||0
5099135|NCT01632579|12544065|P8|NOT COMPLETED|Washout Period||0
5099136|NCT01632579|12544066|P7|NOT COMPLETED|Washout Period||0
5099137|NCT01632579|12544067|P6|NOT COMPLETED|Washout Period||0
5099138|NCT01632579|12544068|P5|NOT COMPLETED|Washout Period||0
5099139|NCT01632579|12544069|P4|NOT COMPLETED|Washout Period||0
5099140|NCT01632579|12544070|P3|NOT COMPLETED|Washout Period||0
5099141|NCT01632579|12544071|P2|NOT COMPLETED|Washout Period||0
5099142|NCT01632579|12544072|P1|NOT COMPLETED|Washout Period||1
5099143|NCT01632579|12544064|P9|COMPLETED|Washout Period||2
5099144|NCT01632579|12544065|P8|COMPLETED|Washout Period||6
5099145|NCT01632579|12544066|P7|COMPLETED|Washout Period||2
5099146|NCT01632579|12544067|P6|COMPLETED|Washout Period||2
5099147|NCT01632579|12544068|P5|COMPLETED|Washout Period||6
5099148|NCT01632579|12544069|P4|COMPLETED|Washout Period||2
5099149|NCT01632579|12544070|P3|COMPLETED|Washout Period||2
5099150|NCT01632579|12544071|P2|COMPLETED|Washout Period||6
5099151|NCT01632579|12544072|P1|COMPLETED|Washout Period||1
5099152|NCT01632579|12544064|P9|STARTED|Washout Period||2
5099153|NCT01632579|12544065|P8|STARTED|Washout Period||6
5099154|NCT01632579|12544066|P7|STARTED|Washout Period||2
5099155|NCT01632579|12544067|P6|STARTED|Washout Period||2
5099156|NCT01632579|12544068|P5|STARTED|Washout Period||6
5099157|NCT01632579|12544069|P4|STARTED|Washout Period||2
5099158|NCT01632579|12544070|P3|STARTED|Washout Period||2
5099159|NCT01632579|12544071|P2|STARTED|Washout Period||6
5099160|NCT01632579|12544072|P1|STARTED|Washout Period||2
5099161|NCT01632579|12544064|P9|NOT COMPLETED|Period 1 (First Intervention)||0
5099162|NCT01632579|12544065|P8|NOT COMPLETED|Period 1 (First Intervention)||0
5099163|NCT01632579|12544066|P7|NOT COMPLETED|Period 1 (First Intervention)||0
5099164|NCT01632579|12544067|P6|NOT COMPLETED|Period 1 (First Intervention)||0
5099165|NCT01632579|12544068|P5|NOT COMPLETED|Period 1 (First Intervention)||0
5099166|NCT01632579|12544069|P4|NOT COMPLETED|Period 1 (First Intervention)||0
5099167|NCT01632579|12544070|P3|NOT COMPLETED|Period 1 (First Intervention)||0
5099168|NCT01632579|12544071|P2|NOT COMPLETED|Period 1 (First Intervention)||0
5099169|NCT01632579|12544072|P1|NOT COMPLETED|Period 1 (First Intervention)||0
5099170|NCT01632579|12544064|P9|COMPLETED|Period 1 (First Intervention)||2
5099171|NCT01632579|12544065|P8|COMPLETED|Period 1 (First Intervention)||6
5099172|NCT01632579|12544066|P7|COMPLETED|Period 1 (First Intervention)||2
5099173|NCT01632579|12544067|P6|COMPLETED|Period 1 (First Intervention)||2
5099174|NCT01632579|12544068|P5|COMPLETED|Period 1 (First Intervention)||6
5099175|NCT01632579|12544069|P4|COMPLETED|Period 1 (First Intervention)||2
5099176|NCT01632579|12544070|P3|COMPLETED|Period 1 (First Intervention)||2
5099177|NCT01632579|12544071|P2|COMPLETED|Period 1 (First Intervention)||6
5099178|NCT01632579|12544072|P1|COMPLETED|Period 1 (First Intervention)||2
5099179|NCT01632579|12544064|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099180|NCT01632579|12544065|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
5099181|NCT01632579|12544066|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099182|NCT01632579|12544067|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099183|NCT01632579|12544068|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
5099184|NCT01632579|12544069|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099185|NCT01632579|12544070|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099186|NCT01632579|12544071|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
5099187|NCT01632579|12544072|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
5099188|NCT01632579|12544064|P9|STARTED|Period 1 (First Intervention)||2
5099189|NCT01632579|12544065|P8|STARTED|Period 1 (First Intervention)||6
5099190|NCT01632579|12544066|P7|STARTED|Period 1 (First Intervention)||2
5099191|NCT01632579|12544067|P6|STARTED|Period 1 (First Intervention)||2
5099192|NCT01632579|12544068|P5|STARTED|Period 1 (First Intervention)||6
5099193|NCT01632579|12544069|P4|STARTED|Period 1 (First Intervention)||2
5099194|NCT01632579|12544070|P3|STARTED|Period 1 (First Intervention)||2
5099195|NCT01632579|12544071|P2|STARTED|Period 1 (First Intervention)||6
5099196|NCT01632579|12544072|P1|STARTED|Period 1 (First Intervention)||2
5099197|NCT01632566|12544139|P5|NOT COMPLETED|Overall Study||2
5099198|NCT01632566|12544140|P4|NOT COMPLETED|Overall Study||2
5099199|NCT01632566|12544141|P3|NOT COMPLETED|Overall Study||9
5099200|NCT01632566|12544142|P2|NOT COMPLETED|Overall Study||3
5099201|NCT01632566|12544143|P1|NOT COMPLETED|Overall Study||0
5099202|NCT01632566|12544139|P5|COMPLETED|Overall Study||4
5099203|NCT01632566|12544140|P4|COMPLETED|Overall Study||4
5099204|NCT01632566|12544141|P3|COMPLETED|Overall Study||0
5099205|NCT01632566|12544142|P2|COMPLETED|Overall Study||7
5099206|NCT01632566|12544143|P1|COMPLETED|Overall Study||8
5099207|NCT01632566|12544139|P5|Received at Least One Dose Simvastatin|Overall Study||4
5099208|NCT01632566|12544140|P4|Received at Least One Dose Simvastatin|Overall Study||4
5099209|NCT01632566|12544141|P3|Received at Least One Dose Simvastatin|Overall Study||9
5099210|NCT01632566|12544142|P2|Received at Least One Dose Simvastatin|Overall Study||10
5099211|NCT01632566|12544143|P1|Received at Least One Dose Simvastatin|Overall Study||0
5099212|NCT01632566|12544139|P5|Received at Least One Dose LY3031207|Overall Study||0
5099213|NCT01632566|12544140|P4|Received at Least One Dose LY3031207|Overall Study||0
5099214|NCT01632566|12544141|P3|Received at Least One Dose LY3031207|Overall Study||9
5099215|NCT01632566|12544142|P2|Received at Least One Dose LY3031207|Overall Study||10
5099216|NCT01632566|12544143|P1|Received at Least One Dose LY3031207|Overall Study||8
5099217|NCT01632566|12544139|P5|STARTED|Overall Study||6
5099218|NCT01632566|12544140|P4|STARTED|Overall Study||6
5099219|NCT01632566|12544141|P3|STARTED|Overall Study||9
5099220|NCT01632566|12544142|P2|STARTED|Overall Study||10
5099221|NCT01632566|12544143|P1|STARTED|Overall Study||8
5099222|NCT01632423|12544181|P1|NOT COMPLETED|Overall Study||246
5099223|NCT01632423|12544181|P1|COMPLETED|Overall Study||10091
5099224|NCT01632423|12544181|P1|STARTED|Overall Study||10337
5099225|NCT01632345|12544194|P7|NOT COMPLETED|Treatment: Part II||11
5099226|NCT01632345|12544195|P6|NOT COMPLETED|Treatment: Part II||11
5099227|NCT01632345|12544196|P5|NOT COMPLETED|Treatment: Part II||0
5099228|NCT01632345|12544197|P4|NOT COMPLETED|Treatment: Part II||0
5099229|NCT01632345|12544198|P3|NOT COMPLETED|Treatment: Part II||0
5099230|NCT01632345|12544199|P2|NOT COMPLETED|Treatment: Part II||0
5099231|NCT01632345|12544200|P1|NOT COMPLETED|Treatment: Part II||0
5099232|NCT01632345|12544194|P7|COMPLETED|Treatment: Part II||55
5099233|NCT01632345|12544195|P6|COMPLETED|Treatment: Part II||55
5099234|NCT01632345|12544196|P5|COMPLETED|Treatment: Part II||0
5099235|NCT01632345|12544197|P4|COMPLETED|Treatment: Part II||0
5099236|NCT01632345|12544198|P3|COMPLETED|Treatment: Part II||0
5099237|NCT01632345|12544199|P2|COMPLETED|Treatment: Part II||0
5099238|NCT01632345|12544200|P1|COMPLETED|Treatment: Part II||0
5099239|NCT01632345|12544194|P7|Treated|Treatment: Part II||66
5099240|NCT01632345|12544195|P6|Treated|Treatment: Part II||66
5099241|NCT01632345|12544196|P5|Treated|Treatment: Part II||0
5099242|NCT01632345|12544197|P4|Treated|Treatment: Part II||0
5099243|NCT01632345|12544198|P3|Treated|Treatment: Part II||0
5099244|NCT01632345|12544199|P2|Treated|Treatment: Part II||0
5099245|NCT01632345|12544200|P1|Treated|Treatment: Part II||0
5099246|NCT01632345|12544194|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
5099247|NCT01632345|12544195|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
5099248|NCT01632345|12544196|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
5099249|NCT01632345|12544197|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
5099250|NCT01632345|12544198|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
5099251|NCT01632345|12544199|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
5099252|NCT01632345|12544200|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
5099253|NCT01632345|12544194|P7|NOT COMPLETED|Treatment: Part I||0
5099254|NCT01632345|12544195|P6|NOT COMPLETED|Treatment: Part I||0
5099255|NCT01632345|12544196|P5|NOT COMPLETED|Treatment: Part I||13
5099256|NCT01632345|12544197|P4|NOT COMPLETED|Treatment: Part I||8
5099257|NCT01632345|12544198|P3|NOT COMPLETED|Treatment: Part I||10
5099258|NCT01632345|12544199|P2|NOT COMPLETED|Treatment: Part I||15
5099259|NCT01632345|12544200|P1|NOT COMPLETED|Treatment: Part I||12
5099260|NCT01632345|12544194|P7|COMPLETED|Treatment: Part I||0
5099261|NCT01632345|12544195|P6|COMPLETED|Treatment: Part I||0
5099262|NCT01632345|12544196|P5|COMPLETED|Treatment: Part I||30
5099263|NCT01632345|12544197|P4|COMPLETED|Treatment: Part I||33
5099264|NCT01632345|12544198|P3|COMPLETED|Treatment: Part I||32
5099265|NCT01632345|12544199|P2|COMPLETED|Treatment: Part I||28
5099266|NCT01632345|12544200|P1|COMPLETED|Treatment: Part I||29
5099267|NCT01632345|12544194|P7|Treated|Treatment: Part I||0
5099268|NCT01632345|12544195|P6|Treated|Treatment: Part I||0
5099269|NCT01632345|12544196|P5|Treated|Treatment: Part I||43
5099270|NCT01632345|12544197|P4|Treated|Treatment: Part I||41
5099271|NCT01632345|12544198|P3|Treated|Treatment: Part I||42
5099272|NCT01632345|12544199|P2|Treated|Treatment: Part I||43
5099273|NCT01632345|12544200|P1|Treated|Treatment: Part I||40
5099274|NCT01632345|12544194|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
5099275|NCT01632345|12544195|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
5099276|NCT01632345|12544196|P5|STARTED|Treatment: Part I||43
5099277|NCT01632345|12544197|P4|STARTED|Treatment: Part I||41
5099278|NCT01632345|12544198|P3|STARTED|Treatment: Part I||42
5099279|NCT01632345|12544199|P2|STARTED|Treatment: Part I||43
5099280|NCT01632345|12544200|P1|STARTED|Treatment: Part I||41
5099281|NCT01632345|12544194|P7|NOT COMPLETED|Randomized Participants||0
5099282|NCT01632345|12544195|P6|NOT COMPLETED|Randomized Participants||0
5099283|NCT01632345|12544196|P5|NOT COMPLETED|Randomized Participants||0
5099284|NCT01632345|12544197|P4|NOT COMPLETED|Randomized Participants||0
5099285|NCT01632345|12544198|P3|NOT COMPLETED|Randomized Participants||0
5099286|NCT01632345|12544199|P2|NOT COMPLETED|Randomized Participants||0
5099287|NCT01632345|12544200|P1|NOT COMPLETED|Randomized Participants||0
5099288|NCT01632345|12544194|P7|COMPLETED|Randomized Participants||66
5099289|NCT01632345|12544195|P6|COMPLETED|Randomized Participants||66
5099290|NCT01632345|12544196|P5|COMPLETED|Randomized Participants||43
5099291|NCT01632345|12544197|P4|COMPLETED|Randomized Participants||41
5099292|NCT01632345|12544198|P3|COMPLETED|Randomized Participants||42
5099293|NCT01632345|12544199|P2|COMPLETED|Randomized Participants||43
5099294|NCT01632345|12544200|P1|COMPLETED|Randomized Participants||41
5099295|NCT01632345|12544194|P7|STARTED|Randomized Participants||66
5099296|NCT01632345|12544195|P6|STARTED|Randomized Participants||66
5099297|NCT01632345|12544196|P5|STARTED|Randomized Participants||43
5099298|NCT01632345|12544197|P4|STARTED|Randomized Participants||41
5099299|NCT01632345|12544198|P3|STARTED|Randomized Participants||42
5099300|NCT01632345|12544199|P2|STARTED|Randomized Participants||43
5099301|NCT01632345|12544200|P1|STARTED|Randomized Participants||41
5099302|NCT01632306|12544262|P3|NOT COMPLETED|Overall Study||0
5099303|NCT01632306|12544263|P2|NOT COMPLETED|Overall Study||0
5099304|NCT01632306|12544264|P1|NOT COMPLETED|Overall Study||1
5099305|NCT01632306|12544262|P3|COMPLETED|Overall Study||0
5099306|NCT01632306|12544263|P2|COMPLETED|Overall Study||10
5099307|NCT01632306|12544264|P1|COMPLETED|Overall Study||2
5099308|NCT01632306|12544262|P3|Received at Least One Dose of Study Drug|Overall Study||0
5099309|NCT01632306|12544263|P2|Received at Least One Dose of Study Drug|Overall Study||10
5099310|NCT01632306|12544264|P1|Received at Least One Dose of Study Drug|Overall Study||3
5099311|NCT01632306|12544262|P3|STARTED|Overall Study||0
5099312|NCT01632306|12544263|P2|STARTED|Overall Study||10
5099313|NCT01632306|12544264|P1|STARTED|Overall Study||3
5099314|NCT01632280|12544280|P2|NOT COMPLETED|Overall Study||0
5099315|NCT01632280|12544281|P1|NOT COMPLETED|Overall Study||1
5099316|NCT01632280|12544280|P2|COMPLETED|Overall Study||6
5099317|NCT01632280|12544281|P1|COMPLETED|Overall Study||5
5099318|NCT01632280|12544280|P2|STARTED|Overall Study||6
5099319|NCT01632280|12544281|P1|STARTED|Overall Study||6
5099320|NCT01632267|12544291|P1|NOT COMPLETED|Overall Study||7
5099321|NCT01632267|12544291|P1|COMPLETED|Overall Study||97
5099322|NCT01632267|12544291|P1|STARTED|Overall Study||104
5099323|NCT01632241|12544297|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
5099324|NCT01632241|12544298|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
5099325|NCT01632241|12544297|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
5099326|NCT01632241|12544298|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
5099327|NCT01632241|12544297|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
5099328|NCT01632241|12544298|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
5099329|NCT01632241|12544297|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
5099330|NCT01632241|12544298|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
5099331|NCT01632241|12544297|P2|COMPLETED|Double-blinded (Up to Week 52)||252
5099332|NCT01632241|12544298|P1|COMPLETED|Double-blinded (Up to Week 52)||121
5099333|NCT01632241|12544297|P2|STARTED|Double-blinded (Up to Week 52)||331
5099334|NCT01632241|12544298|P1|STARTED|Double-blinded (Up to Week 52)||165
5099335|NCT01632215|12544348|P2|NOT COMPLETED|Overall Study||1
5099336|NCT01632215|12544349|P1|NOT COMPLETED|Overall Study||2
5099337|NCT01632215|12544348|P2|COMPLETED|Overall Study||19
5099338|NCT01632215|12544349|P1|COMPLETED|Overall Study||18
5099339|NCT01632215|12544348|P2|STARTED|Overall Study||20
5099340|NCT01632215|12544349|P1|STARTED|Overall Study||20
5099341|NCT01632150|12544357|P1|NOT COMPLETED|Overall Study||40
5099342|NCT01632150|12544357|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
5099343|NCT01632150|12544357|P1|Received Cyclophosphamide|Overall Study||11
5099344|NCT01632150|12544357|P1|STARTED|Overall Study||40
5099345|NCT01632020|12544366|P2|NOT COMPLETED|Overall Study||0
5099346|NCT01632020|12544367|P1|NOT COMPLETED|Overall Study||2
5099347|NCT01632020|12544366|P2|COMPLETED|Overall Study||3
5099348|NCT01632020|12544367|P1|COMPLETED|Overall Study||2
5099349|NCT01632020|12544366|P2|STARTED|Overall Study||3
5099350|NCT01632020|12544367|P1|STARTED|Overall Study||4
5099351|NCT01631929|12544377|P2|NOT COMPLETED|Overall Study||0
5099352|NCT01631929|12544378|P1|NOT COMPLETED|Overall Study||0
5099353|NCT01631929|12544377|P2|COMPLETED|Overall Study||6
5099354|NCT01631929|12544378|P1|COMPLETED|Overall Study||6
5099355|NCT01631929|12544377|P2|STARTED|Overall Study||6
5099356|NCT01631929|12544378|P1|STARTED|Overall Study||6
5099357|NCT01631864|12544386|P2|NOT COMPLETED|Overall Study||4
5099358|NCT01631864|12544387|P1|NOT COMPLETED|Overall Study||2
5099359|NCT01631864|12544386|P2|COMPLETED|Overall Study||44
5099360|NCT01631864|12544387|P1|COMPLETED|Overall Study||48
5099361|NCT01631864|12544386|P2|STARTED|Overall Study||48
5099362|NCT01631864|12544387|P1|STARTED|Overall Study||50
5099363|NCT01631825|12544399|P1|NOT COMPLETED|Overall Study||65
5099364|NCT01631825|12544399|P1|COMPLETED|Overall Study||256
5099365|NCT01631825|12544399|P1|STARTED|Overall Study||321
5099366|NCT01631812|12544419|P1|NOT COMPLETED|Overall Study||37
5099367|NCT01631812|12544419|P1|COMPLETED|Overall Study||93
5099368|NCT01631812|12544419|P1|STARTED|Overall Study||130
5099369|NCT01631747|12544429|P2|NOT COMPLETED|One Year Infant Outcomes||9
5099370|NCT01631747|12544430|P1|NOT COMPLETED|One Year Infant Outcomes||13
5099371|NCT01631747|12544429|P2|COMPLETED|One Year Infant Outcomes||130
5099372|NCT01631747|12544430|P1|COMPLETED|One Year Infant Outcomes||123
5099373|NCT01631747|12544429|P2|STARTED|One Year Infant Outcomes||139
5099374|NCT01631747|12544430|P1|STARTED|One Year Infant Outcomes||136
5099375|NCT01631747|12544429|P2|NOT COMPLETED|Live Birth||1
5099376|NCT01631747|12544430|P1|NOT COMPLETED|Live Birth||4
5099377|NCT01631747|12544429|P2|COMPLETED|Live Birth||139
5099378|NCT01631747|12544430|P1|COMPLETED|Live Birth||136
5099379|NCT01631747|12544429|P2|STARTED|Live Birth||140
5099380|NCT01631747|12544430|P1|STARTED|Live Birth||140
5099381|NCT01631747|12544429|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
5099382|NCT01631747|12544430|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
5099383|NCT01631747|12544429|P2|COMPLETED|Randomization Through End of Pregnancy||140
5099384|NCT01631747|12544430|P1|COMPLETED|Randomization Through End of Pregnancy||140
5099385|NCT01631747|12544429|P2|STARTED|Randomization Through End of Pregnancy||140
5099386|NCT01631747|12544430|P1|STARTED|Randomization Through End of Pregnancy||141
5099387|NCT01631682|12544472|P4|NOT COMPLETED|Overall Study||2
5099388|NCT01631682|12544473|P3|NOT COMPLETED|Overall Study||31
5099389|NCT01631682|12544474|P2|NOT COMPLETED|Overall Study||45
5099390|NCT01631682|12544475|P1|NOT COMPLETED|Overall Study||31
5099391|NCT01631682|12544472|P4|COMPLETED|Overall Study||5
5099392|NCT01631682|12544473|P3|COMPLETED|Overall Study||13
5099393|NCT01631682|12544474|P2|COMPLETED|Overall Study||21
5099394|NCT01631682|12544475|P1|COMPLETED|Overall Study||24
5099395|NCT01631682|12544472|P4|STARTED|Overall Study||7
5099396|NCT01631682|12544473|P3|STARTED|Overall Study||44
5099397|NCT01631682|12544474|P2|STARTED|Overall Study||66
5099398|NCT01631682|12544475|P1|STARTED|Overall Study||55
5099399|NCT01631656|12544487|P2|NOT COMPLETED|Overall Study||0
5099400|NCT01631656|12544488|P1|NOT COMPLETED|Overall Study||0
5099401|NCT01631656|12544487|P2|COMPLETED|Overall Study||5
5099402|NCT01631656|12544488|P1|COMPLETED|Overall Study||5
5099403|NCT01631656|12544487|P2|STARTED|Overall Study||5
5099404|NCT01631656|12544488|P1|STARTED|Overall Study||5
5099405|NCT01631630|12544496|P2|NOT COMPLETED|Overall Study||0
5099406|NCT01631630|12544497|P1|NOT COMPLETED|Overall Study||3
5099407|NCT01631630|12544496|P2|COMPLETED|Overall Study||8
5099408|NCT01631630|12544497|P1|COMPLETED|Overall Study||5
5099409|NCT01631630|12544496|P2|STARTED|Overall Study||8
5099410|NCT01631630|12544497|P1|STARTED|Overall Study||8
5099411|NCT01631435|12544607|P1|NOT COMPLETED|Overall Study||9
5099412|NCT01631435|12544607|P1|COMPLETED|Overall Study||66
5099413|NCT01631435|12544607|P1|STARTED|Overall Study||75
5099414|NCT01631331|12544612|P1|NOT COMPLETED|Overall Study||4
5099415|NCT01631331|12544612|P1|COMPLETED|Overall Study||11
5099416|NCT01631331|12544612|P1|STARTED|Overall Study||15
5099417|NCT01631227|12544621|P2|NOT COMPLETED|Overall Study||22
5099418|NCT01631227|12544622|P1|NOT COMPLETED|Overall Study||30
5099419|NCT01631227|12544621|P2|COMPLETED|Overall Study||310
5099420|NCT01631227|12544622|P1|COMPLETED|Overall Study||303
5099421|NCT01631227|12544621|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
5099422|NCT01631227|12544622|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
5099423|NCT01631227|12544621|P2|Safety Subject Sample|Overall Study||332
5099424|NCT01631227|12544622|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
5099425|NCT01631227|12544621|P2|STARTED|Overall Study||332
5099426|NCT01631227|12544622|P1|STARTED|Overall Study||333
5099427|NCT01631214|12544630|P2|NOT COMPLETED|Overall Study||523
5099428|NCT01631214|12544631|P1|NOT COMPLETED|Overall Study||544
5099429|NCT01631214|12544630|P2|COMPLETED|Overall Study||1523
5099430|NCT01631214|12544631|P1|COMPLETED|Overall Study||1503
5099431|NCT01631214|12544630|P2|Completed Primary Analysis Period|Overall Study||1574
5099432|NCT01631214|12544631|P1|Completed Primary Analysis Period|Overall Study||1576
5099433|NCT01631214|12544630|P2|Completed Double-blind Period|Overall Study||1831
5099434|NCT01631214|12544631|P1|Completed Double-blind Period|Overall Study||1823
5099435|NCT01631214|12544630|P2|Received Double-blind Treatment|Overall Study||2038
5099436|NCT01631214|12544631|P1|Received Double-blind Treatment|Overall Study||2040
5099437|NCT01631214|12544630|P2|STARTED|Overall Study||2046
5099438|NCT01631214|12544631|P1|STARTED|Overall Study||2047
5099439|NCT01631149|12544695|P2|NOT COMPLETED|Overall Study||0
5099440|NCT01631149|12544696|P1|NOT COMPLETED|Overall Study||0
5099441|NCT01631149|12544695|P2|COMPLETED|Overall Study||12
5099442|NCT01631149|12544696|P1|COMPLETED|Overall Study||12
5099443|NCT01631149|12544695|P2|STARTED|Overall Study||12
5099444|NCT01631149|12544696|P1|STARTED|Overall Study||12
5099445|NCT01631110|12544712|P2|NOT COMPLETED|Overall Study||0
5099446|NCT01631110|12544713|P1|NOT COMPLETED|Overall Study||0
5099447|NCT01631110|12544712|P2|COMPLETED|Overall Study||55
5099448|NCT01631110|12544713|P1|COMPLETED|Overall Study||55
5099449|NCT01631110|12544712|P2|STARTED|Overall Study||55
5099450|NCT01631110|12544713|P1|STARTED|Overall Study||55
5099451|NCT01631071|12544727|P2|NOT COMPLETED|Overall Study||0
5099452|NCT01631071|12544728|P1|NOT COMPLETED|Overall Study||0
5099453|NCT01631071|12544727|P2|COMPLETED|Overall Study||55
5099454|NCT01631071|12544728|P1|COMPLETED|Overall Study||55
5099455|NCT01631071|12544727|P2|STARTED|Overall Study||55
5099456|NCT01631071|12544728|P1|STARTED|Overall Study||55
5099457|NCT01630811|12544740|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
5099458|NCT01630811|12544741|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
5099459|NCT01630811|12544740|P2|COMPLETED|Second Washout (4 Weeks)||6
5099460|NCT01630811|12544741|P1|COMPLETED|Second Washout (4 Weeks)||6
5099461|NCT01630811|12544740|P2|STARTED|Second Washout (4 Weeks)||6
5099462|NCT01630811|12544741|P1|STARTED|Second Washout (4 Weeks)||6
5099463|NCT01630811|12544740|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
5099464|NCT01630811|12544741|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
5099465|NCT01630811|12544740|P2|COMPLETED|Second Intervention (8 Weeks)||6
5099466|NCT01630811|12544741|P1|COMPLETED|Second Intervention (8 Weeks)||6
5099467|NCT01630811|12544740|P2|STARTED|Second Intervention (8 Weeks)||6
5099468|NCT01630811|12544741|P1|STARTED|Second Intervention (8 Weeks)||7
5099469|NCT01630811|12544740|P2|NOT COMPLETED|Washout (4 Weeks)||0
5099470|NCT01630811|12544741|P1|NOT COMPLETED|Washout (4 Weeks)||0
5099471|NCT01630811|12544740|P2|COMPLETED|Washout (4 Weeks)||6
5099472|NCT01630811|12544741|P1|COMPLETED|Washout (4 Weeks)||7
5099473|NCT01630811|12544740|P2|STARTED|Washout (4 Weeks)||6
5099474|NCT01630811|12544741|P1|STARTED|Washout (4 Weeks)||7
5099475|NCT01630811|12544740|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
5099476|NCT01630811|12544741|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
5099477|NCT01630811|12544740|P2|COMPLETED|First Intervention (8 Weeks)||6
5099478|NCT01630811|12544741|P1|COMPLETED|First Intervention (8 Weeks)||7
5099479|NCT01630811|12544740|P2|STARTED|First Intervention (8 Weeks)||6
5099480|NCT01630811|12544741|P1|STARTED|First Intervention (8 Weeks)||7
5099481|NCT01630694|12544753|P2|NOT COMPLETED|Overall Study||0
5099482|NCT01630694|12544754|P1|NOT COMPLETED|Overall Study||0
5099483|NCT01630694|12544753|P2|COMPLETED|Overall Study||16
5099484|NCT01630694|12544754|P1|COMPLETED|Overall Study||12
5099485|NCT01630694|12544753|P2|STARTED|Overall Study||16
5099486|NCT01630694|12544754|P1|STARTED|Overall Study||12
5099487|NCT01630616|12544768|P6|NOT COMPLETED|Overall Study||0
5099488|NCT01630616|12544769|P5|NOT COMPLETED|Overall Study||0
5099489|NCT01630616|12544770|P4|NOT COMPLETED|Overall Study||3
5099490|NCT01630616|12544771|P3|NOT COMPLETED|Overall Study||0
5099491|NCT01630616|12544772|P2|NOT COMPLETED|Overall Study||0
5099492|NCT01630616|12544773|P1|NOT COMPLETED|Overall Study||0
5099493|NCT01630616|12544768|P6|COMPLETED|Overall Study||2
5099494|NCT01630616|12544769|P5|COMPLETED|Overall Study||6
5099495|NCT01630616|12544770|P4|COMPLETED|Overall Study||9
5099496|NCT01630616|12544771|P3|COMPLETED|Overall Study||3
5099497|NCT01630616|12544772|P2|COMPLETED|Overall Study||3
5099498|NCT01630616|12544773|P1|COMPLETED|Overall Study||5
5099499|NCT01630616|12544768|P6|STARTED|Overall Study||2
5099500|NCT01630616|12544769|P5|STARTED|Overall Study||6
5099501|NCT01630616|12544770|P4|STARTED|Overall Study||12
5099502|NCT01630616|12544771|P3|STARTED|Overall Study||3
5099503|NCT01630616|12544772|P2|STARTED|Overall Study||3
5099504|NCT01630616|12544773|P1|STARTED|Overall Study||5
5099505|NCT01630200|12544848|P2|NOT COMPLETED|Overall Study||6
5099506|NCT01630200|12544849|P1|NOT COMPLETED|Overall Study||7
5099507|NCT01630200|12544848|P2|COMPLETED|Overall Study||34
5099508|NCT01630200|12544849|P1|COMPLETED|Overall Study||33
5099509|NCT01630200|12544848|P2|STARTED|Overall Study||40
5099510|NCT01630200|12544849|P1|STARTED|Overall Study||40
5099511|NCT01630135|12544873|P2|NOT COMPLETED|Overall Study||2
5099512|NCT01630135|12544874|P1|NOT COMPLETED|Overall Study||0
5099513|NCT01630135|12544873|P2|COMPLETED|Overall Study||128
5099514|NCT01630135|12544874|P1|COMPLETED|Overall Study||131
5099515|NCT01630135|12544873|P2|STARTED|Overall Study||130
5099516|NCT01630135|12544874|P1|STARTED|Overall Study||131
5099517|NCT01630109|12544913|P3|NOT COMPLETED|Overall Study||0
5099518|NCT01630109|12544914|P2|NOT COMPLETED|Overall Study||0
5099519|NCT01630109|12544915|P1|NOT COMPLETED|Overall Study||0
5099520|NCT01630109|12544913|P3|COMPLETED|Overall Study||3
5099521|NCT01630109|12544914|P2|COMPLETED|Overall Study||1
5099522|NCT01630109|12544915|P1|COMPLETED|Overall Study||1
5099523|NCT01630109|12544913|P3|STARTED|Overall Study||3
5099524|NCT01630109|12544914|P2|STARTED|Overall Study||1
5099525|NCT01630109|12544915|P1|STARTED|Overall Study||1
5099526|NCT01629966|12544938|P3|NOT COMPLETED|Overall Study||66
5099527|NCT01629966|12544939|P2|NOT COMPLETED|Overall Study||52
5099528|NCT01629966|12544940|P1|NOT COMPLETED|Overall Study||41
5099529|NCT01629966|12544938|P3|COMPLETED|Overall Study||159
5099530|NCT01629966|12544939|P2|COMPLETED|Overall Study||175
5099531|NCT01629966|12544940|P1|COMPLETED|Overall Study||180
5099532|NCT01629966|12544938|P3|STARTED|Overall Study||225
5099533|NCT01629966|12544939|P2|STARTED|Overall Study||227
5099534|NCT01629966|12544940|P1|STARTED|Overall Study||221
5099535|NCT01629953|12544953|P2|NOT COMPLETED|Overall Study||15
5099536|NCT01629953|12544954|P1|NOT COMPLETED|Overall Study||13
5099537|NCT01629953|12544953|P2|COMPLETED|Overall Study||60
5099538|NCT01629953|12544954|P1|COMPLETED|Overall Study||52
5099539|NCT01629953|12544953|P2|STARTED|Overall Study||75
5099540|NCT01629953|12544954|P1|STARTED|Overall Study||65
5099541|NCT01629862|12544964|P2|NOT COMPLETED|Overall Study||2
5099542|NCT01629862|12544965|P1|NOT COMPLETED|Overall Study||2
5099543|NCT01629862|12544964|P2|COMPLETED|Overall Study||23
5099544|NCT01629862|12544965|P1|COMPLETED|Overall Study||26
5099545|NCT01629862|12544964|P2|STARTED|Overall Study||25
5099546|NCT01629862|12544965|P1|STARTED|Overall Study||28
5099547|NCT01629823|12544974|P3|NOT COMPLETED|Washout Period||0
5099548|NCT01629823|12544975|P2|NOT COMPLETED|Washout Period||6
5099549|NCT01629823|12544976|P1|NOT COMPLETED|Washout Period||3
5099550|NCT01629823|12544974|P3|COMPLETED|Washout Period||50
5099551|NCT01629823|12544975|P2|COMPLETED|Washout Period||51
5099552|NCT01629823|12544976|P1|COMPLETED|Washout Period||51
5099553|NCT01629823|12544974|P3|STARTED|Washout Period||50
5099554|NCT01629823|12544975|P2|STARTED|Washout Period||57
5099555|NCT01629823|12544976|P1|STARTED|Washout Period||54
5099556|NCT01629823|12544974|P3|NOT COMPLETED|Trial Period||10
5099557|NCT01629823|12544975|P2|NOT COMPLETED|Trial Period||13
5099558|NCT01629823|12544976|P1|NOT COMPLETED|Trial Period||13
5099559|NCT01629823|12544974|P3|COMPLETED|Trial Period||49
5099560|NCT01629823|12544975|P2|COMPLETED|Trial Period||56
5099561|NCT01629823|12544976|P1|COMPLETED|Trial Period||53
5099562|NCT01629823|12544974|P3|STARTED|Trial Period||59
5099563|NCT01629823|12544975|P2|STARTED|Trial Period||69
5099564|NCT01629823|12544976|P1|STARTED|Trial Period||66
5099565|NCT01629797|12544984|P1|NOT COMPLETED|Overall Study||18
5099566|NCT01629797|12544984|P1|COMPLETED|Overall Study||82
5099567|NCT01629797|12544984|P1|STARTED|Overall Study||100
5099568|NCT01629784|12544991|P1|NOT COMPLETED|Overall Study||6
5099569|NCT01629784|12544991|P1|COMPLETED|Overall Study||25
5099570|NCT01629784|12544991|P1|STARTED|Overall Study||31
5099571|NCT01629771|12545000|P2|NOT COMPLETED|Overall Study||0
5099572|NCT01629771|12545001|P1|NOT COMPLETED|Overall Study||0
5099573|NCT01629771|12545000|P2|COMPLETED|Overall Study||36
5099574|NCT01629771|12545001|P1|COMPLETED|Overall Study||36
5099575|NCT01629771|12545000|P2|STARTED|Overall Study||36
5099576|NCT01629771|12545001|P1|STARTED|Overall Study||36
5099577|NCT01629706|12545011|P1|NOT COMPLETED|Phase 2 Habitual||10
5099578|NCT01629706|12545011|P1|COMPLETED|Phase 2 Habitual||48
5099579|NCT01629706|12545011|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
5099580|NCT01629706|12545011|P1|NOT COMPLETED|Phase 1 PureVision||9
5099581|NCT01629706|12545011|P1|COMPLETED|Phase 1 PureVision||35
5099582|NCT01629706|12545011|P1|STARTED|Phase 1 PureVision||44
5099583|NCT01629693|12545039|P2|NOT COMPLETED|Overall Study||10
5099584|NCT01629693|12545040|P1|NOT COMPLETED|Overall Study||5
5099585|NCT01629693|12545039|P2|COMPLETED|Overall Study||178
5099586|NCT01629693|12545040|P1|COMPLETED|Overall Study||188
5099587|NCT01629693|12545039|P2|STARTED|Overall Study||188
5099588|NCT01629693|12545040|P1|STARTED|Overall Study||193
5099589|NCT01629667|12545049|P3|NOT COMPLETED|Overall Study||45
5099590|NCT01629667|12545050|P2|NOT COMPLETED|Overall Study||41
5099591|NCT01629667|12545051|P1|NOT COMPLETED|Overall Study||47
5099592|NCT01629667|12545049|P3|COMPLETED|Overall Study||14
5099593|NCT01629667|12545050|P2|COMPLETED|Overall Study||17
5099594|NCT01629667|12545051|P1|COMPLETED|Overall Study||12
5099595|NCT01629667|12545049|P3|Randomized and Treated|Overall Study||59
5099596|NCT01629667|12545050|P2|Randomized and Treated|Overall Study||57
5099597|NCT01629667|12545051|P1|Randomized and Treated|Overall Study||57
5099598|NCT01629667|12545049|P3|STARTED|Overall Study||59
5099599|NCT01629667|12545050|P2|STARTED|Overall Study||58
5099600|NCT01629667|12545051|P1|STARTED|Overall Study||59
5099601|NCT01629589|12545135|P2|NOT COMPLETED|Overall Study||7
5099602|NCT01629589|12545136|P1|NOT COMPLETED|Overall Study||8
5099603|NCT01629589|12545135|P2|COMPLETED|Overall Study||204
5099604|NCT01629589|12545136|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
5099605|NCT01629589|12545135|P2|STARTED|Overall Study||211
5099606|NCT01629589|12545136|P1|STARTED|Overall Study||212
5099607|NCT01629563|12545154|P2|NOT COMPLETED|Overall Study||53
5099608|NCT01629563|12545155|P1|NOT COMPLETED|Overall Study||61
5099609|NCT01629563|12545154|P2|COMPLETED|Overall Study||170
5099610|NCT01629563|12545155|P1|COMPLETED|Overall Study||167
5099611|NCT01629563|12545154|P2|Started Treatment Course 4|Overall Study||176
5099612|NCT01629563|12545155|P1|Started Treatment Course 4|Overall Study||178
5099613|NCT01629563|12545154|P2|Started Treatment Course 3|Overall Study||190
5099614|NCT01629563|12545155|P1|Started Treatment Course 3|Overall Study||191
5099615|NCT01629563|12545154|P2|Started Treatment Course 2|Overall Study||207
5099616|NCT01629563|12545155|P1|Started Treatment Course 2|Overall Study||213
5099617|NCT01629563|12545154|P2|Safety Population|Overall Study||221
5099618|NCT01629563|12545155|P1|Safety Population|Overall Study||230
5099619|NCT01629563|12545154|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
5099620|NCT01629563|12545155|P1|STARTED|Overall Study||228
5099621|NCT01629511|12545177|P4|NOT COMPLETED|Overall Study||0
5099622|NCT01629511|12545178|P3|NOT COMPLETED|Overall Study||0
5099623|NCT01629511|12545179|P2|NOT COMPLETED|Overall Study||0
5099624|NCT01629511|12545180|P1|NOT COMPLETED|Overall Study||0
5099625|NCT01629511|12545177|P4|COMPLETED|Overall Study||3
5099626|NCT01629511|12545178|P3|COMPLETED|Overall Study||8
5099627|NCT01629511|12545179|P2|COMPLETED|Overall Study||0
5099628|NCT01629511|12545180|P1|COMPLETED|Overall Study||4
5099629|NCT01629511|12545177|P4|STARTED|Overall Study||3
5099630|NCT01629511|12545178|P3|STARTED|Overall Study||8
5099631|NCT01629511|12545179|P2|STARTED|Overall Study||0
5099632|NCT01629511|12545180|P1|STARTED|Overall Study||4
5099633|NCT01629329|12545212|P2|NOT COMPLETED|Overall Study||0
5099634|NCT01629329|12545213|P1|NOT COMPLETED|Overall Study||0
5099635|NCT01629329|12545212|P2|COMPLETED|Overall Study||0
5099636|NCT01629329|12545213|P1|COMPLETED|Overall Study||0
5099637|NCT01629329|12545212|P2|STARTED|Overall Study||0
5099638|NCT01629329|12545213|P1|STARTED|Overall Study||0
5099639|NCT01629290|12545221|P1|NOT COMPLETED|Overall Study||0
5099640|NCT01629290|12545221|P1|COMPLETED|Overall Study||15
5099641|NCT01629290|12545221|P1|STARTED|Overall Study||15
5099642|NCT01629134|12545231|P1|NOT COMPLETED|Overall Study||0
5099643|NCT01629134|12545231|P1|COMPLETED|Overall Study||62
5099644|NCT01629134|12545231|P1|STARTED|Overall Study||62
5099645|NCT01628965|12545244|P1|NOT COMPLETED|Overall Study||49
5099646|NCT01628965|12545244|P1|COMPLETED|Overall Study||94
5099647|NCT01628965|12545244|P1|STARTED|Overall Study||143
5099648|NCT01628926|12545253|P3|NOT COMPLETED|Overall Study||17
5099649|NCT01628926|12545254|P2|NOT COMPLETED|Overall Study||23
5099650|NCT01628926|12545255|P1|NOT COMPLETED|Overall Study||26
5099651|NCT01628926|12545253|P3|COMPLETED|Overall Study||68
5099652|NCT01628926|12545254|P2|COMPLETED|Overall Study||144
5099653|NCT01628926|12545255|P1|COMPLETED|Overall Study||142
5099654|NCT01628926|12545253|P3|STARTED|Overall Study||85
5099655|NCT01628926|12545254|P2|STARTED|Overall Study||167
5099656|NCT01628926|12545255|P1|STARTED|Overall Study||168
5099657|NCT01628913|12545304|P2|NOT COMPLETED|Overall Study||31
5099658|NCT01628913|12545305|P1|NOT COMPLETED|Overall Study||31
5099659|NCT01628913|12545304|P2|COMPLETED|Overall Study||0
5099660|NCT01628913|12545305|P1|COMPLETED|Overall Study||0
5099661|NCT01628913|12545304|P2|STARTED|Overall Study||31
5099662|NCT01628913|12545305|P1|STARTED|Overall Study||31
5099663|NCT01628874|12545319|P2|NOT COMPLETED|Overall Study||3
5099664|NCT01628874|12545320|P1|NOT COMPLETED|Overall Study||5
5099665|NCT01628874|12545319|P2|COMPLETED|Overall Study||29
5099666|NCT01628874|12545320|P1|COMPLETED|Overall Study||29
5099667|NCT01628874|12545319|P2|STARTED|Overall Study||32
5099668|NCT01628874|12545320|P1|STARTED|Overall Study||34
5099669|NCT01628848|12545336|P2|NOT COMPLETED|Overall Study||14
5099670|NCT01628848|12545337|P1|NOT COMPLETED|Overall Study||12
5099671|NCT01628848|12545336|P2|COMPLETED|Overall Study||73
5099672|NCT01628848|12545337|P1|COMPLETED|Overall Study||75
5099673|NCT01628848|12545336|P2|STARTED|Overall Study||87
5099674|NCT01628848|12545337|P1|STARTED|Overall Study||87
5099675|NCT01628718|12545367|P2|NOT COMPLETED|Overall Study||25
5099676|NCT01628718|12545368|P1|NOT COMPLETED|Overall Study||27
5099677|NCT01628718|12545367|P2|COMPLETED|Overall Study||37
5099678|NCT01628718|12545368|P1|COMPLETED|Overall Study||33
5099679|NCT01628718|12545367|P2|STARTED|Overall Study||62
5099680|NCT01628718|12545368|P1|STARTED|Overall Study||60
5099681|NCT01628692|12545380|P6|NOT COMPLETED|Overall Study||9
5099682|NCT01628692|12545381|P5|NOT COMPLETED|Overall Study||4
5099683|NCT01628692|12545382|P4|NOT COMPLETED|Overall Study||1
5099684|NCT01628692|12545383|P3|NOT COMPLETED|Overall Study||8
5099685|NCT01628692|12545384|P2|NOT COMPLETED|Overall Study||6
5099686|NCT01628692|12545385|P1|NOT COMPLETED|Overall Study||7
5099687|NCT01628692|12545380|P6|COMPLETED|Overall Study||0
5099688|NCT01628692|12545381|P5|COMPLETED|Overall Study||8
5099689|NCT01628692|12545382|P4|COMPLETED|Overall Study||19
5099690|NCT01628692|12545383|P3|COMPLETED|Overall Study||43
5099691|NCT01628692|12545384|P2|COMPLETED|Overall Study||17
5099692|NCT01628692|12545385|P1|COMPLETED|Overall Study||46
5099693|NCT01628692|12545380|P6|STARTED|Overall Study||9
5099694|NCT01628692|12545381|P5|STARTED|Overall Study||12
5099695|NCT01628692|12545382|P4|STARTED|Overall Study||20
5099696|NCT01628692|12545383|P3|STARTED|Overall Study||51
5099697|NCT01628692|12545384|P2|STARTED|Overall Study||23
5099698|NCT01628692|12545385|P1|STARTED|Overall Study||53
5099699|NCT01628614|12545429|P1|NOT COMPLETED|Overall Study||1775
5099700|NCT01628614|12545429|P1|COMPLETED|Overall Study||3037
5099701|NCT01628614|12545429|P1|STARTED|Overall Study||4812
5099702|NCT01628601|12545435|P1|NOT COMPLETED|Overall Study||41
5099703|NCT01628601|12545435|P1|COMPLETED|Overall Study||351
5099704|NCT01628601|12545435|P1|STARTED|Overall Study||392
5099705|NCT01628588|12545443|P1|NOT COMPLETED|Overall Study||16
5099706|NCT01628588|12545443|P1|COMPLETED|Overall Study||838
5099707|NCT01628588|12545443|P1|STARTED|Overall Study||854
5099708|NCT01628549|12545455|P4|NOT COMPLETED|Overall Study||9
5099709|NCT01628549|12545456|P3|NOT COMPLETED|Overall Study||10
5099710|NCT01628549|12545457|P2|NOT COMPLETED|Overall Study||12
5099711|NCT01628549|12545458|P1|NOT COMPLETED|Overall Study||9
5099712|NCT01628549|12545455|P4|COMPLETED|Overall Study||57
5099713|NCT01628549|12545456|P3|COMPLETED|Overall Study||60
5099714|NCT01628549|12545457|P2|COMPLETED|Overall Study||64
5099715|NCT01628549|12545458|P1|COMPLETED|Overall Study||64
5099716|NCT01628549|12545455|P4|STARTED|Overall Study||66
5099717|NCT01628549|12545456|P3|STARTED|Overall Study||70
5099718|NCT01628549|12545457|P2|STARTED|Overall Study||76
5099719|NCT01628549|12545458|P1|STARTED|Overall Study||73
5099720|NCT01628523|12545492|P1|NOT COMPLETED|Overall Study||0
5099721|NCT01628523|12545492|P1|COMPLETED|Overall Study||219
5099722|NCT01628523|12545492|P1|STARTED|Overall Study||219
5099723|NCT01628510|12545499|P2|NOT COMPLETED|Overall Study||5
5099724|NCT01628510|12545500|P1|NOT COMPLETED|Overall Study||3
5099725|NCT01628510|12545499|P2|COMPLETED|Overall Study||44
5099726|NCT01628510|12545500|P1|COMPLETED|Overall Study||48
5099727|NCT01628510|12545499|P2|STARTED|Overall Study||49
5099728|NCT01628510|12545500|P1|STARTED|Overall Study||51
5099729|NCT01628367|12545510|P2|NOT COMPLETED|Overall Study||0
5099730|NCT01628367|12545511|P1|NOT COMPLETED|Overall Study||1
5099731|NCT01628367|12545510|P2|COMPLETED|Overall Study||16
5099732|NCT01628367|12545511|P1|COMPLETED|Overall Study||15
5099733|NCT01628367|12545510|P2|STARTED|Overall Study||16
5099734|NCT01628367|12545511|P1|STARTED|Overall Study||16
5099735|NCT01628250|12545523|P2|NOT COMPLETED|Overall Study||0
5099736|NCT01628250|12545524|P1|NOT COMPLETED|Overall Study||0
5099737|NCT01628250|12545523|P2|COMPLETED|Overall Study||50
5099738|NCT01628250|12545524|P1|COMPLETED|Overall Study||49
5099739|NCT01628250|12545523|P2|STARTED|Overall Study||50
5099740|NCT01628250|12545524|P1|STARTED|Overall Study||49
5099741|NCT01628198|12545530|P1|NOT COMPLETED|Overall Study||18
5099742|NCT01628198|12545530|P1|COMPLETED|Overall Study||20
5099743|NCT01628198|12545530|P1|STARTED|Overall Study||38
5099744|NCT01628159|12545543|P1|NOT COMPLETED|Overall Study||164
5099745|NCT01628159|12545543|P1|COMPLETED|Overall Study||493
5099746|NCT01628159|12545543|P1|STARTED|Overall Study||657
5099747|NCT01628120|12545557|P1|NOT COMPLETED|Overall Study||44
5099748|NCT01628120|12545557|P1|COMPLETED|Overall Study||129
5099749|NCT01628120|12545557|P1|Treated|Overall Study||170
5099750|NCT01628120|12545557|P1|STARTED|Overall Study||173
5099751|NCT01628107|12545582|P1|NOT COMPLETED|Overall Study||119
5099752|NCT01628107|12545582|P1|COMPLETED|Overall Study||295
5099753|NCT01628107|12545582|P1|Treated|Overall Study||406
5099754|NCT01628107|12545582|P1|STARTED|Overall Study||414
5099755|NCT01628042|12545611|P4|NOT COMPLETED|Overall Study||0
5099756|NCT01628042|12545612|P3|NOT COMPLETED|Overall Study||0
5099757|NCT01628042|12545613|P2|NOT COMPLETED|Overall Study||0
5099758|NCT01628042|12545614|P1|NOT COMPLETED|Overall Study||0
5099759|NCT01628042|12545611|P4|COMPLETED|Overall Study||8
5099760|NCT01628042|12545612|P3|COMPLETED|Overall Study||8
5099761|NCT01628042|12545613|P2|COMPLETED|Overall Study||8
5099762|NCT01628042|12545614|P1|COMPLETED|Overall Study||8
5099763|NCT01628042|12545611|P4|STARTED|Overall Study||8
5099764|NCT01628042|12545612|P3|STARTED|Overall Study||8
5099765|NCT01628042|12545613|P2|STARTED|Overall Study||8
5099766|NCT01628042|12545614|P1|STARTED|Overall Study||8
5099767|NCT01628016|12545635|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
5099768|NCT01628016|12545636|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
5099769|NCT01628016|12545637|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
5099770|NCT01628016|12545635|P3|COMPLETED|Posttraining to 5 Follow-ups||18
5099771|NCT01628016|12545636|P2|COMPLETED|Posttraining to 5 Follow-ups||20
5099772|NCT01628016|12545637|P1|COMPLETED|Posttraining to 5 Follow-ups||23
5099773|NCT01628016|12545635|P3|STARTED|Posttraining to 5 Follow-ups||23
5099774|NCT01628016|12545636|P2|STARTED|Posttraining to 5 Follow-ups||27
5099775|NCT01628016|12545637|P1|STARTED|Posttraining to 5 Follow-ups||27
5099776|NCT01628016|12545635|P3|NOT COMPLETED|Pretraining to Posttraining||0
5099777|NCT01628016|12545636|P2|NOT COMPLETED|Pretraining to Posttraining||0
5099778|NCT01628016|12545637|P1|NOT COMPLETED|Pretraining to Posttraining||0
5099779|NCT01628016|12545635|P3|COMPLETED|Pretraining to Posttraining||23
5099780|NCT01628016|12545636|P2|COMPLETED|Pretraining to Posttraining||27
5099781|NCT01628016|12545637|P1|COMPLETED|Pretraining to Posttraining||27
5099782|NCT01628016|12545635|P3|STARTED|Pretraining to Posttraining||23
5099783|NCT01628016|12545636|P2|STARTED|Pretraining to Posttraining||27
5099784|NCT01628016|12545637|P1|STARTED|Pretraining to Posttraining||27
5099785|NCT01627899|12545648|P1|NOT COMPLETED|Overall Study||5
5099786|NCT01627899|12545648|P1|COMPLETED|Overall Study||0
5099787|NCT01627899|12545648|P1|STARTED|Overall Study||5
5099788|NCT01627860|12545658|P2|NOT COMPLETED|Overall Study||6
5099789|NCT01627860|12545659|P1|NOT COMPLETED|Overall Study||12
5099790|NCT01627860|12545658|P2|COMPLETED|Overall Study||14
5099791|NCT01627860|12545659|P1|COMPLETED|Overall Study||23
5099792|NCT01627860|12545658|P2|STARTED|Overall Study||20
5099793|NCT01627860|12545659|P1|STARTED|Overall Study||35
5099794|NCT01627782|12545673|P4|NOT COMPLETED|Overall Study||6
5099795|NCT01627782|12545674|P3|NOT COMPLETED|Overall Study||15
5099796|NCT01627782|12545675|P2|NOT COMPLETED|Overall Study||6
5099797|NCT01627782|12545676|P1|NOT COMPLETED|Overall Study||16
5099798|NCT01627782|12545673|P4|COMPLETED|Overall Study||11
5099799|NCT01627782|12545674|P3|COMPLETED|Overall Study||1
5099800|NCT01627782|12545675|P2|COMPLETED|Overall Study||12
5099801|NCT01627782|12545676|P1|COMPLETED|Overall Study||1
5099802|NCT01627782|12545673|P4|Treated|Overall Study||17
5099803|NCT01627782|12545674|P3|Treated|Overall Study||16
5099804|NCT01627782|12545675|P2|Treated|Overall Study||18
5099805|NCT01627782|12545676|P1|Treated|Overall Study||16
5099806|NCT01627782|12545673|P4|STARTED|Overall Study||17
5099807|NCT01627782|12545674|P3|STARTED|Overall Study||16
5099808|NCT01627782|12545675|P2|STARTED|Overall Study||18
5099809|NCT01627782|12545676|P1|STARTED|Overall Study||17
5099810|NCT01627691|12545732|P1|NOT COMPLETED|Overall Study||18
5099811|NCT01627691|12545732|P1|COMPLETED|Overall Study||232
5099812|NCT01627691|12545732|P1|Primary Endpoint (30days)|Overall Study||239
5099813|NCT01627691|12545732|P1|STARTED|Overall Study||250
5099814|NCT01627561|12545745|P2|NOT COMPLETED|Overall Study||3
5099815|NCT01627561|12545746|P1|NOT COMPLETED|Overall Study||1
5099816|NCT01627561|12545745|P2|COMPLETED|Overall Study||71
5099817|NCT01627561|12545746|P1|COMPLETED|Overall Study||73
5099818|NCT01627561|12545745|P2|STARTED|Overall Study||74
5099819|NCT01627561|12545746|P1|STARTED|Overall Study||74
5099820|NCT01627340|12545812|P2|NOT COMPLETED|Overall Study||4
5099821|NCT01627340|12545813|P1|NOT COMPLETED|Overall Study||12
5099822|NCT01627340|12545812|P2|COMPLETED|Overall Study||254
5099823|NCT01627340|12545813|P1|COMPLETED|Overall Study||404
5099824|NCT01627340|12545812|P2|STARTED|Overall Study||258
5099825|NCT01627340|12545813|P1|STARTED|Overall Study||416
5099826|NCT01627327|12545831|P2|NOT COMPLETED|Overall Study||39
5099827|NCT01627327|12545832|P1|NOT COMPLETED|Overall Study||19
5099828|NCT01627327|12545831|P2|COMPLETED|Overall Study||274
5099829|NCT01627327|12545832|P1|COMPLETED|Overall Study||291
5099830|NCT01627327|12545831|P2|STARTED|Overall Study||313
5099831|NCT01627327|12545832|P1|STARTED|Overall Study||310
5099832|NCT01627288|12545846|P4|NOT COMPLETED|Overall Study||0
5099833|NCT01627288|12545847|P3|NOT COMPLETED|Overall Study||0
5099834|NCT01627288|12545848|P2|NOT COMPLETED|Overall Study||0
5099835|NCT01627288|12545849|P1|NOT COMPLETED|Overall Study||0
5099836|NCT01627288|12545846|P4|COMPLETED|Overall Study||0
5099837|NCT01627288|12545847|P3|COMPLETED|Overall Study||6
5099838|NCT01627288|12545848|P2|COMPLETED|Overall Study||3
5099839|NCT01627288|12545849|P1|COMPLETED|Overall Study||3
5099840|NCT01627288|12545846|P4|STARTED|Overall Study||0
5099841|NCT01627288|12545847|P3|STARTED|Overall Study||6
5099842|NCT01627288|12545848|P2|STARTED|Overall Study||3
5099843|NCT01627288|12545849|P1|STARTED|Overall Study||3
5099844|NCT01627249|12545882|P3|NOT COMPLETED|Overall Study||12
5099845|NCT01627249|12545883|P2|NOT COMPLETED|Overall Study||12
5099846|NCT01627249|12545884|P1|NOT COMPLETED|Overall Study||16
5099847|NCT01627249|12545882|P3|COMPLETED|Overall Study||206
5099848|NCT01627249|12545883|P2|COMPLETED|Overall Study||206
5099849|NCT01627249|12545884|P1|COMPLETED|Overall Study||208
5099850|NCT01627249|12545882|P3|STARTED|Overall Study||218
5099851|NCT01627249|12545883|P2|STARTED|Overall Study||218
5099852|NCT01627249|12545884|P1|STARTED|Overall Study||224
5099853|NCT01627067|12545919|P1|NOT COMPLETED|Overall Study||1
5099854|NCT01627067|12545919|P1|COMPLETED|Overall Study||22
5099855|NCT01627067|12545919|P1|STARTED|Overall Study||23
5099856|NCT01627002|12545929|P9|NOT COMPLETED|Overall Study||0
5099857|NCT01627002|12545930|P8|NOT COMPLETED|Overall Study||0
5099858|NCT01627002|12545931|P7|NOT COMPLETED|Overall Study||0
5099859|NCT01627002|12545932|P6|NOT COMPLETED|Overall Study||0
5099860|NCT01627002|12545933|P5|NOT COMPLETED|Overall Study||0
5099861|NCT01627002|12545934|P4|NOT COMPLETED|Overall Study||0
5099862|NCT01627002|12545935|P3|NOT COMPLETED|Overall Study||0
5099863|NCT01627002|12545936|P2|NOT COMPLETED|Overall Study||0
5099864|NCT01627002|12545937|P1|NOT COMPLETED|Overall Study||0
5099865|NCT01627002|12545929|P9|COMPLETED|Overall Study||7
5099866|NCT01627002|12545930|P8|COMPLETED|Overall Study||5
5099867|NCT01627002|12545931|P7|COMPLETED|Overall Study||10
5099868|NCT01627002|12545932|P6|COMPLETED|Overall Study||9
5099869|NCT01627002|12545933|P5|COMPLETED|Overall Study||2
5099870|NCT01627002|12545934|P4|COMPLETED|Overall Study||4
5099871|NCT01627002|12545935|P3|COMPLETED|Overall Study||4
5099872|NCT01627002|12545936|P2|COMPLETED|Overall Study||4
5099873|NCT01627002|12545937|P1|COMPLETED|Overall Study||4
5099874|NCT01627002|12545929|P9|STARTED|Overall Study||7
5099875|NCT01627002|12545930|P8|STARTED|Overall Study||5
5099876|NCT01627002|12545931|P7|STARTED|Overall Study||10
5099877|NCT01627002|12545932|P6|STARTED|Overall Study||9
5099878|NCT01627002|12545933|P5|STARTED|Overall Study||2
5099879|NCT01627002|12545934|P4|STARTED|Overall Study||4
5099880|NCT01627002|12545935|P3|STARTED|Overall Study||4
5099881|NCT01627002|12545936|P2|STARTED|Overall Study||4
5099882|NCT01627002|12545937|P1|STARTED|Overall Study||4
5099883|NCT01626989|12545988|P3|NOT COMPLETED|Second Intervention (Night 2)||0
5099884|NCT01626989|12545989|P2|NOT COMPLETED|Second Intervention (Night 2)||0
5099885|NCT01626989|12545990|P1|NOT COMPLETED|Second Intervention (Night 2)||0
5099886|NCT01626989|12545988|P3|COMPLETED|Second Intervention (Night 2)||12
5099887|NCT01626989|12545989|P2|COMPLETED|Second Intervention (Night 2)||15
5099888|NCT01626989|12545990|P1|COMPLETED|Second Intervention (Night 2)||0
5099889|NCT01626989|12545988|P3|STARTED|Second Intervention (Night 2)||12
5099890|NCT01626989|12545989|P2|STARTED|Second Intervention (Night 2)||15
5099891|NCT01626989|12545990|P1|STARTED|Second Intervention (Night 2)||0
5099892|NCT01626989|12545988|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
5099893|NCT01626989|12545989|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
5099894|NCT01626989|12545990|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
5099895|NCT01626989|12545988|P3|COMPLETED|Fist Intervention (Night 1)||12
5099896|NCT01626989|12545989|P2|COMPLETED|Fist Intervention (Night 1)||15
5099897|NCT01626989|12545990|P1|COMPLETED|Fist Intervention (Night 1)||0
5099898|NCT01626989|12545988|P3|STARTED|Fist Intervention (Night 1)||12
5099899|NCT01626989|12545989|P2|STARTED|Fist Intervention (Night 1)||15
5099900|NCT01626989|12545990|P1|STARTED|Fist Intervention (Night 1)||0
5099901|NCT01626989|12545988|P3|NOT COMPLETED|Screening Period||0
5099902|NCT01626989|12545989|P2|NOT COMPLETED|Screening Period||0
5099903|NCT01626989|12545990|P1|NOT COMPLETED|Screening Period||17
5099904|NCT01626989|12545988|P3|COMPLETED|Screening Period||0
5099905|NCT01626989|12545989|P2|COMPLETED|Screening Period||0
5099906|NCT01626989|12545990|P1|COMPLETED|Screening Period||27
5099907|NCT01626989|12545988|P3|STARTED|Screening Period||0
5099908|NCT01626989|12545989|P2|STARTED|Screening Period||0
5099909|NCT01626989|12545990|P1|STARTED|Screening Period||44
5099910|NCT01626820|12546039|P2|NOT COMPLETED|Overall Study||0
5099911|NCT01626820|12546040|P1|NOT COMPLETED|Overall Study||0
5099912|NCT01626820|12546039|P2|COMPLETED|Overall Study||57
5099913|NCT01626820|12546040|P1|COMPLETED|Overall Study||56
5099914|NCT01626820|12546039|P2|STARTED|Overall Study||57
5099915|NCT01626820|12546040|P1|STARTED|Overall Study||56
5099916|NCT01626690|12546062|P2|NOT COMPLETED|Overall Study||0
5099917|NCT01626690|12546063|P1|NOT COMPLETED|Overall Study||2
5099918|NCT01626690|12546062|P2|COMPLETED|Overall Study||51
5099919|NCT01626690|12546063|P1|COMPLETED|Overall Study||47
5099920|NCT01626690|12546062|P2|STARTED|Overall Study||51
5099921|NCT01626690|12546063|P1|STARTED|Overall Study||49
5099922|NCT01626664|12546085|P3|NOT COMPLETED|Crossover Period||0
5099923|NCT01626664|12546086|P2|NOT COMPLETED|Crossover Period||0
5099924|NCT01626664|12546087|P1|NOT COMPLETED|Crossover Period||0
5099925|NCT01626664|12546085|P3|COMPLETED|Crossover Period||18
5099926|NCT01626664|12546086|P2|COMPLETED|Crossover Period||0
5099927|NCT01626664|12546087|P1|COMPLETED|Crossover Period||0
5099928|NCT01626664|12546085|P3|STARTED|Crossover Period||18
5099929|NCT01626664|12546086|P2|STARTED|Crossover Period||0
5099930|NCT01626664|12546087|P1|STARTED|Crossover Period||0
5099931|NCT01626664|12546085|P3|NOT COMPLETED|Randomization Period||0
5099932|NCT01626664|12546086|P2|NOT COMPLETED|Randomization Period||0
5099933|NCT01626664|12546087|P1|NOT COMPLETED|Randomization Period||0
5099934|NCT01626664|12546085|P3|COMPLETED|Randomization Period||0
5099935|NCT01626664|12546086|P2|COMPLETED|Randomization Period||24
5099936|NCT01626664|12546087|P1|COMPLETED|Randomization Period||47
5099937|NCT01626664|12546085|P3|STARTED|Randomization Period||0
5099938|NCT01626664|12546086|P2|STARTED|Randomization Period||24
5099939|NCT01626664|12546087|P1|STARTED|Randomization Period||47
5099940|NCT01626495|12546100|P1|NOT COMPLETED|Overall Study||52
5099941|NCT01626495|12546100|P1|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
5099942|NCT01626495|12546100|P1|Intervention|Overall Study||62
5099943|NCT01626495|12546100|P1|STARTED|Overall Study|Number of enrolled subjects|73
5099944|NCT01626456|12546109|P2|NOT COMPLETED|Overall Study||117
5099945|NCT01626456|12546110|P1|NOT COMPLETED|Overall Study||35
5099946|NCT01626456|12546109|P2|COMPLETED|Overall Study||251
5099947|NCT01626456|12546110|P1|COMPLETED|Overall Study||75
5099948|NCT01626456|12546109|P2|STARTED|Overall Study||368
5099949|NCT01626456|12546110|P1|STARTED|Overall Study||110
5099950|NCT01626391|12546140|P2|NOT COMPLETED|Overall Study||0
5099951|NCT01626391|12546141|P1|NOT COMPLETED|Overall Study||2
5099952|NCT01626391|12546140|P2|COMPLETED|Overall Study||4
5099953|NCT01626391|12546141|P1|COMPLETED|Overall Study||3
5099954|NCT01626391|12546140|P2|STARTED|Overall Study||4
5099955|NCT01626391|12546141|P1|STARTED|Overall Study||5
5099956|NCT01626352|12546147|P1|NOT COMPLETED|Overall Study||10
5099957|NCT01626352|12546147|P1|COMPLETED|Overall Study||12
5099958|NCT01626352|12546147|P1|STARTED|Overall Study||22
5099959|NCT01626118|12546161|P4|NOT COMPLETED|Overall Study||3
5099960|NCT01626118|12546162|P3|NOT COMPLETED|Overall Study||2
5099961|NCT01626118|12546163|P2|NOT COMPLETED|Overall Study||2
5099962|NCT01626118|12546164|P1|NOT COMPLETED|Overall Study||2
5099963|NCT01626118|12546161|P4|COMPLETED|Overall Study||91
5099964|NCT01626118|12546162|P3|COMPLETED|Overall Study||90
5099965|NCT01626118|12546163|P2|COMPLETED|Overall Study||91
5099966|NCT01626118|12546164|P1|COMPLETED|Overall Study||92
5099967|NCT01626118|12546161|P4|STARTED|Overall Study||94
5099968|NCT01626118|12546162|P3|STARTED|Overall Study||92
5099969|NCT01626118|12546163|P2|STARTED|Overall Study||93
5099970|NCT01626118|12546164|P1|STARTED|Overall Study||94
5099971|NCT01626092|12546202|P1|NOT COMPLETED|Overall Study||0
5099972|NCT01626092|12546202|P1|COMPLETED|Overall Study||3
5099973|NCT01626092|12546202|P1|STARTED|Overall Study||3
5099974|NCT01626079|12546210|P2|NOT COMPLETED|Overall Study||216
5099975|NCT01626079|12546211|P1|NOT COMPLETED|Overall Study||167
5099976|NCT01626079|12546210|P2|COMPLETED|Overall Study||96
5099977|NCT01626079|12546211|P1|COMPLETED|Overall Study||135
5099978|NCT01626079|12546210|P2|STARTED|Overall Study||312
5099979|NCT01626079|12546211|P1|STARTED|Overall Study||302
5099980|NCT01625988|12546584|P2|NOT COMPLETED|Overall Study||13
5099981|NCT01625988|12546585|P1|NOT COMPLETED|Overall Study||14
5099982|NCT01625988|12546584|P2|COMPLETED|Overall Study||97
5099983|NCT01625988|12546585|P1|COMPLETED|Overall Study||94
5099984|NCT01625988|12546584|P2|Received at Least One Dose of Study Drug|Overall Study||110
5099985|NCT01625988|12546585|P1|Received at Least One Dose of Study Drug|Overall Study||107
5099986|NCT01625988|12546584|P2|STARTED|Overall Study||110
5099987|NCT01625988|12546585|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
5099988|NCT01625923|12546599|P1|NOT COMPLETED|Overall Study||0
5099989|NCT01625923|12546599|P1|COMPLETED|Overall Study||3
5099990|NCT01625923|12546599|P1|STARTED|Overall Study||3
5099991|NCT01625910|12546609|P2|NOT COMPLETED|Overall Study||4
5099992|NCT01625910|12546610|P1|NOT COMPLETED|Overall Study||3
5099993|NCT01625910|12546609|P2|COMPLETED|Overall Study||33
5099994|NCT01625910|12546610|P1|COMPLETED|Overall Study||32
5099995|NCT01625910|12546609|P2|STARTED|Overall Study||37
5099996|NCT01625910|12546610|P1|STARTED|Overall Study||35
5099997|NCT01625845|12546620|P2|NOT COMPLETED|Overall Study||3
5099998|NCT01625845|12546621|P1|NOT COMPLETED|Overall Study||5
5099999|NCT01625845|12546620|P2|COMPLETED|Overall Study||3
5100000|NCT01625845|12546621|P1|COMPLETED|Overall Study||5
5100001|NCT01625845|12546620|P2|STARTED|Overall Study||6
5100002|NCT01625845|12546621|P1|STARTED|Overall Study||10
5100003|NCT01625689|12546641|P2|NOT COMPLETED|Overall Study||1
5100004|NCT01625689|12546642|P1|NOT COMPLETED|Overall Study||2
5100005|NCT01625689|12546641|P2|COMPLETED|Overall Study||149
5100006|NCT01625689|12546642|P1|COMPLETED|Overall Study||148
5100007|NCT01625689|12546641|P2|STARTED|Overall Study||150
5100008|NCT01625689|12546642|P1|STARTED|Overall Study||150
5100009|NCT01625507|12546652|P1|NOT COMPLETED|Overall Study||10
5100010|NCT01625507|12546652|P1|COMPLETED|Overall Study||63
5100011|NCT01625507|12546652|P1|STARTED|Overall Study||73
5100012|NCT01625455|12546667|P2|NOT COMPLETED|Overall Study||0
5100013|NCT01625455|12546668|P1|NOT COMPLETED|Overall Study||0
5100014|NCT01625455|12546667|P2|COMPLETED|Overall Study||3
5100015|NCT01625455|12546668|P1|COMPLETED|Overall Study||2
5100016|NCT01625455|12546667|P2|STARTED|Overall Study||3
5100017|NCT01625455|12546668|P1|STARTED|Overall Study||2
5100018|NCT01625416|12546678|P2|NOT COMPLETED|Overall Study||7
5100019|NCT01625416|12546679|P1|NOT COMPLETED|Overall Study||9
5100020|NCT01625416|12546678|P2|COMPLETED|Overall Study||54
5100021|NCT01625416|12546679|P1|COMPLETED|Overall Study||51
5100022|NCT01625416|12546678|P2|STARTED|Overall Study||61
5100023|NCT01625416|12546679|P1|STARTED|Overall Study||60
5100024|NCT01625377|12546697|P2|NOT COMPLETED|Overall Study||22
5100025|NCT01625377|12546698|P1|NOT COMPLETED|Overall Study||7
5100026|NCT01625377|12546697|P2|COMPLETED|Overall Study||71
5100027|NCT01625377|12546698|P1|COMPLETED|Overall Study||88
5100028|NCT01625377|12546697|P2|Intent to Treat Population|Overall Study||90
5100029|NCT01625377|12546698|P1|Intent to Treat Population|Overall Study||93
5100030|NCT01625377|12546697|P2|Safety Set of Population|Overall Study||90
5100031|NCT01625377|12546698|P1|Safety Set of Population|Overall Study||94
5100032|NCT01625377|12546697|P2|STARTED|Overall Study||93
5100033|NCT01625377|12546698|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
5100034|NCT01625338|12546731|P3|NOT COMPLETED|Overall Study||39
5100035|NCT01625338|12546732|P2|NOT COMPLETED|Overall Study||44
5100036|NCT01625338|12546733|P1|NOT COMPLETED|Overall Study||32
5100037|NCT01625338|12546731|P3|COMPLETED|Overall Study||181
5100038|NCT01625338|12546732|P2|COMPLETED|Overall Study||156
5100039|NCT01625338|12546733|P1|COMPLETED|Overall Study||82
5100040|NCT01625338|12546731|P3|STARTED|Overall Study||220
5100041|NCT01625338|12546732|P2|STARTED|Overall Study||200
5100042|NCT01625338|12546733|P1|STARTED|Overall Study||114
5100043|NCT01625286|12546760|P7|NOT COMPLETED|Overall Study||56
5100044|NCT01625286|12546761|P6|NOT COMPLETED|Overall Study||54
5100045|NCT01625286|12546762|P5|NOT COMPLETED|Overall Study||6
5100046|NCT01625286|12546763|P4|NOT COMPLETED|Overall Study||7
5100047|NCT01625286|12546764|P3|NOT COMPLETED|Overall Study||5
5100048|NCT01625286|12546765|P2|NOT COMPLETED|Overall Study||8
5100049|NCT01625286|12546766|P1|NOT COMPLETED|Overall Study||12
5100050|NCT01625286|12546760|P7|COMPLETED|Overall Study||0
5100051|NCT01625286|12546761|P6|COMPLETED|Overall Study||0
5100052|NCT01625286|12546762|P5|COMPLETED|Overall Study||0
5100053|NCT01625286|12546763|P4|COMPLETED|Overall Study||0
5100054|NCT01625286|12546764|P3|COMPLETED|Overall Study||0
5100055|NCT01625286|12546765|P2|COMPLETED|Overall Study||0
5100056|NCT01625286|12546766|P1|COMPLETED|Overall Study||0
5100057|NCT01625286|12546760|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
5100058|NCT01625286|12546761|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100059|NCT01625286|12546762|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100060|NCT01625286|12546763|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100061|NCT01625286|12546764|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100062|NCT01625286|12546765|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100063|NCT01625286|12546766|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
5100064|NCT01625286|12546760|P7|Received AZD5363/Placebo Treatment|Overall Study||55
5100065|NCT01625286|12546761|P6|Received AZD5363/Placebo Treatment|Overall Study||54
5100066|NCT01625286|12546762|P5|Received AZD5363/Placebo Treatment|Overall Study||6
5100067|NCT01625286|12546763|P4|Received AZD5363/Placebo Treatment|Overall Study||7
5100068|NCT01625286|12546764|P3|Received AZD5363/Placebo Treatment|Overall Study||5
5100069|NCT01625286|12546765|P2|Received AZD5363/Placebo Treatment|Overall Study||8
5100070|NCT01625286|12546766|P1|Received AZD5363/Placebo Treatment|Overall Study||12
5100071|NCT01625286|12546760|P7|STARTED|Overall Study||56
5100072|NCT01625286|12546761|P6|STARTED|Overall Study||54
5100073|NCT01625286|12546762|P5|STARTED|Overall Study||6
5100074|NCT01625286|12546763|P4|STARTED|Overall Study||7
5100075|NCT01625286|12546764|P3|STARTED|Overall Study||5
5100076|NCT01625286|12546765|P2|STARTED|Overall Study||8
5100077|NCT01625286|12546766|P1|STARTED|Overall Study||12
5100078|NCT01625221|12546845|P1|NOT COMPLETED|Overall Study||7
5100079|NCT01625221|12546845|P1|COMPLETED|Overall Study||28
5100080|NCT01625221|12546845|P1|STARTED|Overall Study||35
5100081|NCT01625182|12546852|P2|NOT COMPLETED|Overall Study||11
5100082|NCT01625182|12546853|P1|NOT COMPLETED|Overall Study||20
5100083|NCT01625182|12546852|P2|COMPLETED|Overall Study||41
5100084|NCT01625182|12546853|P1|COMPLETED|Overall Study||34
5100085|NCT01625182|12546852|P2|STARTED|Overall Study||52
5100086|NCT01625182|12546853|P1|STARTED|Overall Study||54
5100087|NCT01625169|12546866|P1|NOT COMPLETED|Overall Study||0
5100088|NCT01625169|12546866|P1|COMPLETED|Overall Study||9
5100089|NCT01625169|12546866|P1|STARTED|Overall Study||9
5100090|NCT01625104|12546881|P2|NOT COMPLETED|Overall Study||0
5100091|NCT01625104|12546882|P1|NOT COMPLETED|Overall Study||0
5100092|NCT01625104|12546881|P2|COMPLETED|Overall Study||434
5100093|NCT01625104|12546882|P1|COMPLETED|Overall Study||448
5100094|NCT01625104|12546881|P2|STARTED|Overall Study||434
5100095|NCT01625104|12546882|P1|STARTED|Overall Study||448
5100096|NCT01625091|12546890|P2|NOT COMPLETED|Post-intervention||2
5100097|NCT01625091|12546891|P1|NOT COMPLETED|Post-intervention||4
5100098|NCT01625091|12546890|P2|COMPLETED|Post-intervention||85
5100099|NCT01625091|12546891|P1|COMPLETED|Post-intervention||81
5100100|NCT01625091|12546890|P2|7 Months|Post-intervention||85
5100101|NCT01625091|12546891|P1|7 Months|Post-intervention||81
5100102|NCT01625091|12546890|P2|STARTED|Post-intervention||87
5100103|NCT01625091|12546891|P1|STARTED|Post-intervention||85
5100104|NCT01625091|12546890|P2|NOT COMPLETED|Intervention||11
5100105|NCT01625091|12546891|P1|NOT COMPLETED|Intervention||11
5100106|NCT01625091|12546890|P2|COMPLETED|Intervention||87
5100107|NCT01625091|12546891|P1|COMPLETED|Intervention||85
5100108|NCT01625091|12546890|P2|4 Months|Intervention||87
5100109|NCT01625091|12546891|P1|4 Months|Intervention||85
5100110|NCT01625091|12546890|P2|2 Months|Intervention||93
5100111|NCT01625091|12546891|P1|2 Months|Intervention||90
5100112|NCT01625091|12546890|P2|STARTED|Intervention||98
5100113|NCT01625091|12546891|P1|STARTED|Intervention||96
5100114|NCT01625013|12546903|P1|NOT COMPLETED|Overall Study||32
5100115|NCT01625013|12546903|P1|COMPLETED|Overall Study||48
5100116|NCT01625013|12546903|P1|STARTED|Overall Study||80
5100117|NCT01624974|12546909|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
5100118|NCT01624974|12546910|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
5100119|NCT01624974|12546909|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
5100120|NCT01624974|12546910|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
5100121|NCT01624974|12546909|P2|STARTED|Period V of Treatment (4 Weeks)||42
5100122|NCT01624974|12546910|P1|STARTED|Period V of Treatment (4 Weeks)||44
5100123|NCT01624974|12546909|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
5100124|NCT01624974|12546910|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
5100125|NCT01624974|12546909|P2|COMPLETED|Period IV Washout (4 Weeks)||42
5100126|NCT01624974|12546910|P1|COMPLETED|Period IV Washout (4 Weeks)||44
5100127|NCT01624974|12546909|P2|STARTED|Period IV Washout (4 Weeks)||45
5100128|NCT01624974|12546910|P1|STARTED|Period IV Washout (4 Weeks)||47
5100129|NCT01624974|12546909|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
5100130|NCT01624974|12546910|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
5100131|NCT01624974|12546909|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
5100132|NCT01624974|12546910|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
5100133|NCT01624974|12546909|P2|STARTED|Period III of Treatment (4 Weeks)||53
5100134|NCT01624974|12546910|P1|STARTED|Period III of Treatment (4 Weeks)||54
5100135|NCT01624948|12546934|P2|NOT COMPLETED|Overall Study||0
5100136|NCT01624948|12546935|P1|NOT COMPLETED|Overall Study||0
5100137|NCT01624948|12546934|P2|COMPLETED|Overall Study||20
5100138|NCT01624948|12546935|P1|COMPLETED|Overall Study||20
5100139|NCT01624948|12546934|P2|STARTED|Overall Study||20
5100140|NCT01624948|12546935|P1|STARTED|Overall Study||20
5100141|NCT01624870|12546951|P1|NOT COMPLETED|Overall Study||27
5100142|NCT01624870|12546951|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
5100143|NCT01624870|12546951|P1|STARTED|Overall Study|provided informed consent|200
5100144|NCT01624740|12546959|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
5100145|NCT01624740|12546960|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
5100146|NCT01624740|12546959|P2|COMPLETED|Second Intervention (3-4 Days)||9
5100147|NCT01624740|12546960|P1|COMPLETED|Second Intervention (3-4 Days)||8
5100148|NCT01624740|12546959|P2|STARTED|Second Intervention (3-4 Days)||9
5100149|NCT01624740|12546960|P1|STARTED|Second Intervention (3-4 Days)||9
5100150|NCT01624740|12546959|P2|NOT COMPLETED|Washout (1 Hour)||0
5100151|NCT01624740|12546960|P1|NOT COMPLETED|Washout (1 Hour)||0
5100152|NCT01624740|12546959|P2|COMPLETED|Washout (1 Hour)||9
5100153|NCT01624740|12546960|P1|COMPLETED|Washout (1 Hour)||9
5100154|NCT01624740|12546959|P2|STARTED|Washout (1 Hour)||9
5100155|NCT01624740|12546960|P1|STARTED|Washout (1 Hour)||9
5100156|NCT01624740|12546959|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
5100157|NCT01624740|12546960|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
5100158|NCT01624740|12546959|P2|COMPLETED|First Intervention (3-4 Days)||9
5100159|NCT01624740|12546960|P1|COMPLETED|First Intervention (3-4 Days)||9
5100160|NCT01624740|12546959|P2|STARTED|First Intervention (3-4 Days)||9
5100161|NCT01624740|12546960|P1|STARTED|First Intervention (3-4 Days)||9
5100162|NCT01624662|12546971|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
5100163|NCT01624662|12546972|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
5100164|NCT01624662|12546973|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
5100165|NCT01624662|12546974|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
5100166|NCT01624662|12546971|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
5100167|NCT01624662|12546972|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
5100168|NCT01624662|12546973|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
5100169|NCT01624662|12546974|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
5100170|NCT01624662|12546971|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
5100171|NCT01624662|12546972|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
5100172|NCT01624662|12546973|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
5100173|NCT01624662|12546974|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
5100174|NCT01624662|12546971|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
5100175|NCT01624662|12546972|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
5100176|NCT01624662|12546973|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
5100177|NCT01624662|12546974|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
5100178|NCT01624662|12546971|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
5100179|NCT01624662|12546972|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
5100180|NCT01624662|12546973|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
5100181|NCT01624662|12546974|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
5100182|NCT01624662|12546971|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
5100183|NCT01624662|12546972|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
5100184|NCT01624662|12546973|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
5100185|NCT01624662|12546974|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
5100186|NCT01624467|12547045|P1|NOT COMPLETED|Overall Study||31
5100187|NCT01624467|12547045|P1|COMPLETED|Overall Study||44
5100188|NCT01624467|12547045|P1|Received at Least One Dose of Study Drug|Overall Study||75
5100189|NCT01624467|12547045|P1|STARTED|Overall Study||75
5100190|NCT01624363|12547058|P1|NOT COMPLETED|Overall Study||0
5100191|NCT01624363|12547058|P1|COMPLETED|Overall Study||341
5100192|NCT01624363|12547058|P1|STARTED|Overall Study||341
5100193|NCT01624350|12547062|P1|NOT COMPLETED|Overall Study||25
5100194|NCT01624350|12547062|P1|COMPLETED|Overall Study||75
5100195|NCT01624350|12547062|P1|STARTED|Overall Study||100
5100196|NCT01624259|12547084|P2|NOT COMPLETED|Overall Study||31
5100197|NCT01624259|12547085|P1|NOT COMPLETED|Overall Study||30
5100198|NCT01624259|12547084|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
5100199|NCT01624259|12547085|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
5100200|NCT01624259|12547084|P2|Received at Least One Dose of Study Drug|Overall Study||300
5100201|NCT01624259|12547085|P1|Received at Least One Dose of Study Drug|Overall Study||299
5100202|NCT01624259|12547084|P2|STARTED|Overall Study||300
5100203|NCT01624259|12547085|P1|STARTED|Overall Study||299
5100204|NCT01624233|12547134|P1|NOT COMPLETED|Period 6: Follow-up||9
5100205|NCT01624233|12547134|P1|COMPLETED|Period 6: Follow-up||79
5100206|NCT01624233|12547134|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
5100207|NCT01624233|12547134|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
5100208|NCT01624233|12547134|P1|COMPLETED|Period 5 - Retreatment Period||70
5100209|NCT01624233|12547134|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
5100210|NCT01624233|12547134|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
5100211|NCT01624233|12547134|P1|COMPLETED|Period 4 - Drug Free Period||9
5100212|NCT01624233|12547134|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
5100213|NCT01624233|12547134|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
5100214|NCT01624233|12547134|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
5100215|NCT01624233|12547134|P1|NOT COMPLETED|Period 3 - Maintenance||7
5100216|NCT01624233|12547134|P1|COMPLETED|Period 3 - Maintenance||83
5100217|NCT01624233|12547134|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
5100218|NCT01624233|12547134|P1|STARTED|Period 3 - Maintenance||90
5100219|NCT01624233|12547134|P1|NOT COMPLETED|Period 2 - Induction||1
5100220|NCT01624233|12547134|P1|COMPLETED|Period 2 - Induction||90
5100221|NCT01624233|12547134|P1|Plaque Ps|Period 2 - Induction||78
5100222|NCT01624233|12547134|P1|Pustular Ps|Period 2 - Induction||5
5100223|NCT01624233|12547134|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
5100224|NCT01624233|12547134|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
5100225|NCT01624233|12547134|P1|STARTED|Period 2 - Induction||91
5100226|NCT01624194|12547166|P2|NOT COMPLETED|Overall Study||0
5100227|NCT01624194|12547167|P1|NOT COMPLETED|Overall Study||2
5100228|NCT01624194|12547166|P2|COMPLETED|Overall Study||18
5100229|NCT01624194|12547167|P1|COMPLETED|Overall Study||14
5100230|NCT01624194|12547166|P2|STARTED|Overall Study||18
5100231|NCT01624194|12547167|P1|STARTED|Overall Study||16
5100232|NCT01624168|12547208|P3|NOT COMPLETED|Overall Study||6
5100233|NCT01624168|12547209|P2|NOT COMPLETED|Overall Study||12
5100234|NCT01624168|12547210|P1|NOT COMPLETED|Overall Study||4
5100235|NCT01624168|12547208|P3|COMPLETED|Overall Study||22
5100236|NCT01624168|12547209|P2|COMPLETED|Overall Study||16
5100237|NCT01624168|12547210|P1|COMPLETED|Overall Study||15
5100238|NCT01624168|12547208|P3|STARTED|Overall Study||28
5100239|NCT01624168|12547209|P2|STARTED|Overall Study||28
5100240|NCT01624168|12547210|P1|STARTED|Overall Study||19
5100241|NCT01624142|12547235|P2|NOT COMPLETED|Overall Study||16
5100242|NCT01624142|12547236|P1|NOT COMPLETED|Overall Study||32
5100243|NCT01624142|12547235|P2|COMPLETED|Overall Study||178
5100244|NCT01624142|12547236|P1|COMPLETED|Overall Study||74
5100245|NCT01624142|12547235|P2|STARTED|Overall Study||194
5100246|NCT01624142|12547236|P1|STARTED|Overall Study||106
5100247|NCT01624090|12547261|P4|NOT COMPLETED|Overall Study||0
5100248|NCT01624090|12547262|P3|NOT COMPLETED|Overall Study||7
5100249|NCT01624090|12547263|P2|NOT COMPLETED|Overall Study||2
5100250|NCT01624090|12547264|P1|NOT COMPLETED|Overall Study||0
5100251|NCT01624090|12547261|P4|COMPLETED|Overall Study||2
5100252|NCT01624090|12547262|P3|COMPLETED|Overall Study||3
5100253|NCT01624090|12547263|P2|COMPLETED|Overall Study||0
5100254|NCT01624090|12547264|P1|COMPLETED|Overall Study||2
5100255|NCT01624090|12547261|P4|STARTED|Overall Study||2
5100256|NCT01624090|12547262|P3|STARTED|Overall Study||10
5100257|NCT01624090|12547263|P2|STARTED|Overall Study||2
5100258|NCT01624090|12547264|P1|STARTED|Overall Study||2
5100259|NCT01623869|12547278|P1|NOT COMPLETED|Overall Study||0
5100260|NCT01623869|12547278|P1|COMPLETED|Overall Study||16
5100261|NCT01623869|12547278|P1|STARTED|Overall Study||16
5100262|NCT01623830|12547286|P2|NOT COMPLETED|Overall Study||9
5100263|NCT01623830|12547287|P1|NOT COMPLETED|Overall Study||7
5100264|NCT01623830|12547286|P2|COMPLETED|Overall Study||35
5100265|NCT01623830|12547287|P1|COMPLETED|Overall Study||38
5100266|NCT01623830|12547286|P2|STARTED|Overall Study||44
5100267|NCT01623830|12547287|P1|STARTED|Overall Study||45
5100268|NCT01623752|12547304|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
5100269|NCT01623752|12547305|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
5100270|NCT01623752|12547306|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
5100271|NCT01623752|12547304|P3|COMPLETED|Phase 2 (78 Weeks)||0
5100272|NCT01623752|12547305|P2|COMPLETED|Phase 2 (78 Weeks)||98
5100273|NCT01623752|12547306|P1|COMPLETED|Phase 2 (78 Weeks)||225
5100274|NCT01623752|12547304|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
5100275|NCT01623752|12547305|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
5100276|NCT01623752|12547306|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
5100277|NCT01623752|12547304|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
5100278|NCT01623752|12547305|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
5100279|NCT01623752|12547306|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
5100280|NCT01623752|12547304|P3|COMPLETED|Phase 1 (78 Weeks)||1
5100281|NCT01623752|12547305|P2|COMPLETED|Phase 1 (78 Weeks)||233
5100282|NCT01623752|12547306|P1|COMPLETED|Phase 1 (78 Weeks)||747
5100283|NCT01623752|12547304|P3|STARTED|Phase 1 (78 Weeks)||3
5100284|NCT01623752|12547305|P2|STARTED|Phase 1 (78 Weeks)||440
5100285|NCT01623752|12547306|P1|STARTED|Phase 1 (78 Weeks)||1378
5100286|NCT01623739|12547391|P2|NOT COMPLETED|Overall Study||4
5100287|NCT01623739|12547392|P1|NOT COMPLETED|Overall Study||2
5100288|NCT01623739|12547391|P2|COMPLETED|Overall Study||15
5100289|NCT01623739|12547392|P1|COMPLETED|Overall Study||17
5100290|NCT01623739|12547391|P2|STARTED|Overall Study||19
5100291|NCT01623739|12547392|P1|STARTED|Overall Study||19
5100292|NCT01623596|12547409|P2|NOT COMPLETED|Overall Study||100
5100293|NCT01623596|12547410|P1|NOT COMPLETED|Overall Study||62
5100294|NCT01623596|12547409|P2|COMPLETED|Overall Study||339
5100295|NCT01623596|12547410|P1|COMPLETED|Overall Study||374
5100296|NCT01623596|12547409|P2|On Switched Treatment|Overall Study||214
5100297|NCT01623596|12547410|P1|On Switched Treatment|Overall Study||22
5100298|NCT01623596|12547409|P2|On Randomized Treatment|Overall Study||125
5100299|NCT01623596|12547410|P1|On Randomized Treatment|Overall Study||352
5100300|NCT01623596|12547409|P2|STARTED|Overall Study||439
5100301|NCT01623596|12547410|P1|STARTED|Overall Study||436
5100302|NCT01623531|12547428|P2|NOT COMPLETED|Overall Study||2
5100303|NCT01623531|12547429|P1|NOT COMPLETED|Overall Study||4
5100304|NCT01623531|12547428|P2|COMPLETED|Overall Study||29
5100305|NCT01623531|12547429|P1|COMPLETED|Overall Study||27
5100306|NCT01623531|12547428|P2|STARTED|Overall Study||31
5100307|NCT01623531|12547429|P1|STARTED|Overall Study||31
5100308|NCT01623479|12547469|P1|NOT COMPLETED|Overall Study||0
5100309|NCT01623479|12547469|P1|COMPLETED|Overall Study||585
5100310|NCT01623479|12547469|P1|STARTED|Overall Study||585
5100311|NCT01623466|12547477|P2|NOT COMPLETED|Overall Study||0
5100312|NCT01623466|12547478|P1|NOT COMPLETED|Overall Study||1
5100313|NCT01623466|12547477|P2|COMPLETED|Overall Study||18
5100314|NCT01623466|12547478|P1|COMPLETED|Overall Study||17
5100315|NCT01623466|12547477|P2|STARTED|Overall Study||18
5100316|NCT01623466|12547478|P1|STARTED|Overall Study||18
5100317|NCT01623323|12547492|P1|NOT COMPLETED|Overall Study||104
5100318|NCT01623323|12547492|P1|COMPLETED|Overall Study||601
5100319|NCT01623323|12547492|P1|STARTED|Overall Study||705
5100320|NCT01623310|12547496|P1|NOT COMPLETED|Overall Study||79
5100321|NCT01623310|12547496|P1|COMPLETED|Overall Study||144
5100322|NCT01623310|12547496|P1|STARTED|Overall Study||223
5100323|NCT01623271|12547505|P1|NOT COMPLETED|Overall Study||2
5100324|NCT01623271|12547505|P1|COMPLETED|Overall Study||3
5100325|NCT01623271|12547505|P1|STARTED|Overall Study||5
5100326|NCT01623167|12547512|P3|NOT COMPLETED|Overall Study||13
5100327|NCT01623167|12547513|P2|NOT COMPLETED|Overall Study||14
5100328|NCT01623167|12547514|P1|NOT COMPLETED|Overall Study||17
5100329|NCT01623167|12547512|P3|COMPLETED|Overall Study||18
5100330|NCT01623167|12547513|P2|COMPLETED|Overall Study||17
5100331|NCT01623167|12547514|P1|COMPLETED|Overall Study||13
5100332|NCT01623167|12547512|P3|STARTED|Overall Study||31
5100333|NCT01623167|12547513|P2|STARTED|Overall Study||31
5100334|NCT01623167|12547514|P1|STARTED|Overall Study||30
5100335|NCT01623154|12547522|P1|NOT COMPLETED|Overall Study||4
5100336|NCT01623154|12547522|P1|COMPLETED|Overall Study||95
5100337|NCT01623154|12547522|P1|Available for Analysis|Overall Study||95
5100338|NCT01623154|12547522|P1|STARTED|Overall Study||99
5100339|NCT01623115|12547530|P2|NOT COMPLETED|Overall Study||77
5100340|NCT01623115|12547531|P1|NOT COMPLETED|Overall Study||33
5100341|NCT01623115|12547530|P2|COMPLETED|Overall Study||246
5100342|NCT01623115|12547531|P1|COMPLETED|Overall Study||130
5100343|NCT01623115|12547530|P2|Treated|Overall Study||322
5100344|NCT01623115|12547531|P1|Treated|Overall Study||163
5100345|NCT01623115|12547530|P2|STARTED|Overall Study|Randomized|323
5100346|NCT01623115|12547531|P1|STARTED|Overall Study|Randomized|163
5100347|NCT01623050|12547591|P1|NOT COMPLETED|Overall Study||9
5100348|NCT01623050|12547591|P1|COMPLETED|Overall Study||27
5100349|NCT01623050|12547591|P1|Treated|Overall Study||34
5100350|NCT01623050|12547591|P1|STARTED|Overall Study||36
5100351|NCT01622699|12547601|P2|NOT COMPLETED|Overall Study||0
5100352|NCT01622699|12547602|P1|NOT COMPLETED|Overall Study||0
5100353|NCT01622699|12547601|P2|COMPLETED|Overall Study||217
5100354|NCT01622699|12547602|P1|COMPLETED|Overall Study||213
5100355|NCT01622699|12547601|P2|STARTED|Overall Study||217
5100356|NCT01622699|12547602|P1|STARTED|Overall Study||213
5100357|NCT01622673|12547620|P6|NOT COMPLETED|Treatment Period 5||0
5100358|NCT01622673|12547621|P5|NOT COMPLETED|Treatment Period 5||0
5100359|NCT01622673|12547622|P4|NOT COMPLETED|Treatment Period 5||0
5100360|NCT01622673|12547623|P3|NOT COMPLETED|Treatment Period 5||0
5100361|NCT01622673|12547624|P2|NOT COMPLETED|Treatment Period 5||0
5100362|NCT01622673|12547625|P1|NOT COMPLETED|Treatment Period 5||0
5100363|NCT01622673|12547620|P6|COMPLETED|Treatment Period 5||4
5100364|NCT01622673|12547621|P5|COMPLETED|Treatment Period 5||4
5100365|NCT01622673|12547622|P4|COMPLETED|Treatment Period 5||4
5100366|NCT01622673|12547623|P3|COMPLETED|Treatment Period 5||4
5100367|NCT01622673|12547624|P2|COMPLETED|Treatment Period 5||3
5100368|NCT01622673|12547625|P1|COMPLETED|Treatment Period 5||4
5100369|NCT01622673|12547620|P6|STARTED|Treatment Period 5||4
5100370|NCT01622673|12547621|P5|STARTED|Treatment Period 5||4
5100371|NCT01622673|12547622|P4|STARTED|Treatment Period 5||4
5100372|NCT01622673|12547623|P3|STARTED|Treatment Period 5||4
5100373|NCT01622673|12547624|P2|STARTED|Treatment Period 5||3
5100374|NCT01622673|12547625|P1|STARTED|Treatment Period 5||4
5100375|NCT01622673|12547620|P6|NOT COMPLETED|Treatment Period 4||0
5100376|NCT01622673|12547621|P5|NOT COMPLETED|Treatment Period 4||0
5100377|NCT01622673|12547622|P4|NOT COMPLETED|Treatment Period 4||0
5100378|NCT01622673|12547623|P3|NOT COMPLETED|Treatment Period 4||0
5100379|NCT01622673|12547624|P2|NOT COMPLETED|Treatment Period 4||0
5100380|NCT01622673|12547625|P1|NOT COMPLETED|Treatment Period 4||0
5100381|NCT01622673|12547620|P6|COMPLETED|Treatment Period 4||4
5100382|NCT01622673|12547621|P5|COMPLETED|Treatment Period 4||4
5100383|NCT01622673|12547622|P4|COMPLETED|Treatment Period 4||4
5100384|NCT01622673|12547623|P3|COMPLETED|Treatment Period 4||4
5100385|NCT01622673|12547624|P2|COMPLETED|Treatment Period 4||3
5100386|NCT01622673|12547625|P1|COMPLETED|Treatment Period 4||4
5100387|NCT01622673|12547620|P6|STARTED|Treatment Period 4||4
5100388|NCT01622673|12547621|P5|STARTED|Treatment Period 4||4
5100389|NCT01622673|12547622|P4|STARTED|Treatment Period 4||4
5100390|NCT01622673|12547623|P3|STARTED|Treatment Period 4||4
5100391|NCT01622673|12547624|P2|STARTED|Treatment Period 4||3
5100392|NCT01622673|12547625|P1|STARTED|Treatment Period 4||4
5100393|NCT01622673|12547620|P6|NOT COMPLETED|Treatment Period 3||0
5100394|NCT01622673|12547621|P5|NOT COMPLETED|Treatment Period 3||0
5100395|NCT01622673|12547622|P4|NOT COMPLETED|Treatment Period 3||0
5100396|NCT01622673|12547623|P3|NOT COMPLETED|Treatment Period 3||0
5100397|NCT01622673|12547624|P2|NOT COMPLETED|Treatment Period 3||1
5100398|NCT01622673|12547625|P1|NOT COMPLETED|Treatment Period 3||0
5100399|NCT01622673|12547620|P6|COMPLETED|Treatment Period 3||4
5100400|NCT01622673|12547621|P5|COMPLETED|Treatment Period 3||4
5100401|NCT01622673|12547622|P4|COMPLETED|Treatment Period 3||4
5100402|NCT01622673|12547623|P3|COMPLETED|Treatment Period 3||4
5100403|NCT01622673|12547624|P2|COMPLETED|Treatment Period 3||3
5100404|NCT01622673|12547625|P1|COMPLETED|Treatment Period 3||4
5100405|NCT01622673|12547620|P6|STARTED|Treatment Period 3||4
5100406|NCT01622673|12547621|P5|STARTED|Treatment Period 3||4
5100407|NCT01622673|12547622|P4|STARTED|Treatment Period 3||4
5100408|NCT01622673|12547623|P3|STARTED|Treatment Period 3||4
5100409|NCT01622673|12547624|P2|STARTED|Treatment Period 3||4
5100410|NCT01622673|12547625|P1|STARTED|Treatment Period 3||4
5100411|NCT01622673|12547620|P6|NOT COMPLETED|Treatment Period 2||0
5100412|NCT01622673|12547621|P5|NOT COMPLETED|Treatment Period 2||0
5100413|NCT01622673|12547622|P4|NOT COMPLETED|Treatment Period 2||1
5100414|NCT01622673|12547623|P3|NOT COMPLETED|Treatment Period 2||0
5100415|NCT01622673|12547624|P2|NOT COMPLETED|Treatment Period 2||0
5100416|NCT01622673|12547625|P1|NOT COMPLETED|Treatment Period 2||0
5100417|NCT01622673|12547620|P6|COMPLETED|Treatment Period 2||4
5100418|NCT01622673|12547621|P5|COMPLETED|Treatment Period 2||4
5100419|NCT01622673|12547622|P4|COMPLETED|Treatment Period 2||4
5100420|NCT01622673|12547623|P3|COMPLETED|Treatment Period 2||4
5100421|NCT01622673|12547624|P2|COMPLETED|Treatment Period 2||4
5100422|NCT01622673|12547625|P1|COMPLETED|Treatment Period 2||4
5100423|NCT01622673|12547620|P6|STARTED|Treatment Period 2||4
5100424|NCT01622673|12547621|P5|STARTED|Treatment Period 2||4
5100425|NCT01622673|12547622|P4|STARTED|Treatment Period 2||5
5100426|NCT01622673|12547623|P3|STARTED|Treatment Period 2||4
5100427|NCT01622673|12547624|P2|STARTED|Treatment Period 2||4
5100428|NCT01622673|12547625|P1|STARTED|Treatment Period 2||4
5100429|NCT01622673|12547620|P6|NOT COMPLETED|Treatment Period 1||0
5100430|NCT01622673|12547621|P5|NOT COMPLETED|Treatment Period 1||0
5100431|NCT01622673|12547622|P4|NOT COMPLETED|Treatment Period 1||1
5100432|NCT01622673|12547623|P3|NOT COMPLETED|Treatment Period 1||0
5100433|NCT01622673|12547624|P2|NOT COMPLETED|Treatment Period 1||1
5100434|NCT01622673|12547625|P1|NOT COMPLETED|Treatment Period 1||0
5100435|NCT01622673|12547620|P6|COMPLETED|Treatment Period 1||4
5100436|NCT01622673|12547621|P5|COMPLETED|Treatment Period 1||4
5100437|NCT01622673|12547622|P4|COMPLETED|Treatment Period 1||5
5100438|NCT01622673|12547623|P3|COMPLETED|Treatment Period 1||4
5100439|NCT01622673|12547624|P2|COMPLETED|Treatment Period 1||4
5100440|NCT01622673|12547625|P1|COMPLETED|Treatment Period 1||4
5100441|NCT01622673|12547620|P6|STARTED|Treatment Period 1||4
5100442|NCT01622673|12547621|P5|STARTED|Treatment Period 1||4
5100443|NCT01622673|12547622|P4|STARTED|Treatment Period 1||6
5100444|NCT01622673|12547623|P3|STARTED|Treatment Period 1||4
5100445|NCT01622673|12547624|P2|STARTED|Treatment Period 1||5
5100446|NCT01622673|12547625|P1|STARTED|Treatment Period 1||4
5100447|NCT01622660|12547660|P1|NOT COMPLETED|Overall Study||1
5100448|NCT01622660|12547660|P1|COMPLETED|Overall Study||1
5100449|NCT01622660|12547660|P1|STARTED|Overall Study||2
5100450|NCT01622569|12547668|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
5100451|NCT01622569|12547669|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
5100452|NCT01622569|12547670|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
5100453|NCT01622569|12547671|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
5100454|NCT01622569|12547668|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
5100455|NCT01622569|12547669|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
5100456|NCT01622569|12547670|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
5100457|NCT01622569|12547671|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
5100458|NCT01622569|12547668|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
5100459|NCT01622569|12547669|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
5100460|NCT01622569|12547670|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
5100461|NCT01622569|12547671|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
5100462|NCT01622569|12547668|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
5100463|NCT01622569|12547669|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
5100464|NCT01622569|12547670|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
5100465|NCT01622569|12547671|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
5100466|NCT01622569|12547668|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
5100467|NCT01622569|12547669|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
5100468|NCT01622569|12547670|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
5100469|NCT01622569|12547671|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
5100470|NCT01622569|12547668|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
5100471|NCT01622569|12547669|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
5100472|NCT01622569|12547670|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
5100473|NCT01622569|12547671|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
5100474|NCT01622543|12547740|P2|NOT COMPLETED|Overall Study||0
5100475|NCT01622543|12547741|P1|NOT COMPLETED|Overall Study||0
5100476|NCT01622543|12547740|P2|COMPLETED|Overall Study||52
5100477|NCT01622543|12547741|P1|COMPLETED|Overall Study||51
5100478|NCT01622543|12547740|P2|STARTED|Overall Study||52
5100479|NCT01622543|12547741|P1|STARTED|Overall Study||51
5100480|NCT01622348|12547756|P3|NOT COMPLETED|Overall Study||1
5100481|NCT01622348|12547757|P2|NOT COMPLETED|Overall Study||0
5100482|NCT01622348|12547758|P1|NOT COMPLETED|Overall Study||1
5100483|NCT01622348|12547756|P3|COMPLETED|Overall Study||14
5100484|NCT01622348|12547757|P2|COMPLETED|Overall Study||14
5100485|NCT01622348|12547758|P1|COMPLETED|Overall Study||14
5100486|NCT01622348|12547756|P3|STARTED|Overall Study||15
5100487|NCT01622348|12547757|P2|STARTED|Overall Study||14
5100488|NCT01622348|12547758|P1|STARTED|Overall Study||15
5100489|NCT01622296|12547766|P2|NOT COMPLETED|Second Intervention||0
5100490|NCT01622296|12547767|P1|NOT COMPLETED|Second Intervention||0
5100491|NCT01622296|12547766|P2|COMPLETED|Second Intervention||10
5100492|NCT01622296|12547767|P1|COMPLETED|Second Intervention||10
5100493|NCT01622296|12547766|P2|STARTED|Second Intervention||10
5100494|NCT01622296|12547767|P1|STARTED|Second Intervention||10
5100495|NCT01622296|12547766|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
5100496|NCT01622296|12547767|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
5100497|NCT01622296|12547766|P2|COMPLETED|Washout Period of at Least 1 Week||10
5100498|NCT01622296|12547767|P1|COMPLETED|Washout Period of at Least 1 Week||10
5100499|NCT01622296|12547766|P2|STARTED|Washout Period of at Least 1 Week||10
5100500|NCT01622296|12547767|P1|STARTED|Washout Period of at Least 1 Week||10
5100501|NCT01622296|12547766|P2|NOT COMPLETED|First Intervention||0
5100502|NCT01622296|12547767|P1|NOT COMPLETED|First Intervention||0
5100503|NCT01622296|12547766|P2|COMPLETED|First Intervention||10
5100504|NCT01622296|12547767|P1|COMPLETED|First Intervention||10
5100505|NCT01622296|12547766|P2|STARTED|First Intervention||10
5100506|NCT01622296|12547767|P1|STARTED|First Intervention||10
5100507|NCT01622257|12547775|P3|NOT COMPLETED|Overall Study||0
5100508|NCT01622257|12547776|P2|NOT COMPLETED|Overall Study||0
5100509|NCT01622257|12547777|P1|NOT COMPLETED|Overall Study||0
5100510|NCT01622257|12547775|P3|COMPLETED|Overall Study||66
5100511|NCT01622257|12547776|P2|COMPLETED|Overall Study||66
5100512|NCT01622257|12547777|P1|COMPLETED|Overall Study||66
5100513|NCT01622257|12547775|P3|STARTED|Overall Study||66
5100514|NCT01622257|12547776|P2|STARTED|Overall Study||66
5100515|NCT01622257|12547777|P1|STARTED|Overall Study||66
5100516|NCT01622231|12547797|P1|NOT COMPLETED|Overall Study||2
5100517|NCT01622231|12547797|P1|COMPLETED|Overall Study||59
5100518|NCT01622231|12547797|P1|STARTED|Overall Study||61
5100519|NCT01621880|12547827|P2|NOT COMPLETED|Overall Study||5
5100520|NCT01621880|12547828|P1|NOT COMPLETED|Overall Study||10
5100521|NCT01621880|12547827|P2|COMPLETED|Overall Study||49
5100522|NCT01621880|12547828|P1|COMPLETED|Overall Study||48
5100523|NCT01621880|12547827|P2|STARTED|Overall Study||54
5100524|NCT01621880|12547828|P1|STARTED|Overall Study||58
5100525|NCT01621802|12547842|P6|NOT COMPLETED|Overall Study||12
5100526|NCT01621802|12547843|P5|NOT COMPLETED|Overall Study||35
5100527|NCT01621802|12547844|P4|NOT COMPLETED|Overall Study||11
5100528|NCT01621802|12547845|P3|NOT COMPLETED|Overall Study||33
5100529|NCT01621802|12547846|P2|NOT COMPLETED|Overall Study||23
5100530|NCT01621802|12547847|P1|NOT COMPLETED|Overall Study||47
5100531|NCT01621802|12547842|P6|COMPLETED|Overall Study||477
5100532|NCT01621802|12547843|P5|COMPLETED|Overall Study||1284
5100533|NCT01621802|12547844|P4|COMPLETED|Overall Study||292
5100534|NCT01621802|12547845|P3|COMPLETED|Overall Study||763
5100535|NCT01621802|12547846|P2|COMPLETED|Overall Study||275
5100536|NCT01621802|12547847|P1|COMPLETED|Overall Study||755
5100537|NCT01621802|12547842|P6|STARTED|Overall Study||489
5100538|NCT01621802|12547843|P5|STARTED|Overall Study||1319
5100539|NCT01621802|12547844|P4|STARTED|Overall Study||303
5100540|NCT01621802|12547845|P3|STARTED|Overall Study||796
5100541|NCT01621802|12547846|P2|STARTED|Overall Study||298
5100542|NCT01621802|12547847|P1|STARTED|Overall Study||802
5100543|NCT01621776|12547954|P3|NOT COMPLETED|Overall Study||0
5100544|NCT01621776|12547955|P2|NOT COMPLETED|Overall Study||0
5100545|NCT01621776|12547956|P1|NOT COMPLETED|Overall Study||0
5100546|NCT01621776|12547954|P3|COMPLETED|Overall Study||18
5100547|NCT01621776|12547955|P2|COMPLETED|Overall Study||40
5100548|NCT01621776|12547956|P1|COMPLETED|Overall Study||41
5100549|NCT01621776|12547954|P3|STARTED|Overall Study||18
5100550|NCT01621776|12547955|P2|STARTED|Overall Study||40
5100551|NCT01621776|12547956|P1|STARTED|Overall Study||41
5100552|NCT01621737|12547970|P1|NOT COMPLETED|Overall Study||0
5100553|NCT01621737|12547970|P1|COMPLETED|Overall Study||0
5100554|NCT01621737|12547970|P1|STARTED|Overall Study||0
5100555|NCT01621672|12547990|P2|NOT COMPLETED|Overall Study||0
5100556|NCT01621672|12547991|P1|NOT COMPLETED|Overall Study||0
5100557|NCT01621672|12547990|P2|COMPLETED|Overall Study||17
5100558|NCT01621672|12547991|P1|COMPLETED|Overall Study||25
5100559|NCT01621672|12547990|P2|STARTED|Overall Study||17
5100560|NCT01621672|12547991|P1|STARTED|Overall Study||25
5100561|NCT01621633|12548001|P4|NOT COMPLETED|Overall Study||0
5100562|NCT01621633|12548002|P3|NOT COMPLETED|Overall Study||0
5100563|NCT01621633|12548003|P2|NOT COMPLETED|Overall Study||0
5100564|NCT01621633|12548004|P1|NOT COMPLETED|Overall Study||0
5100565|NCT01621633|12548001|P4|COMPLETED|Overall Study||8
5100566|NCT01621633|12548002|P3|COMPLETED|Overall Study||8
5100567|NCT01621633|12548003|P2|COMPLETED|Overall Study||8
5100568|NCT01621633|12548004|P1|COMPLETED|Overall Study||8
5100569|NCT01621633|12548001|P4|STARTED|Overall Study||8
5100570|NCT01621633|12548002|P3|STARTED|Overall Study||8
5100571|NCT01621633|12548003|P2|STARTED|Overall Study||8
5100572|NCT01621633|12548004|P1|STARTED|Overall Study||8
5100573|NCT01621542|12548032|P6|NOT COMPLETED|Overall Study||9
5100574|NCT01621542|12548033|P5|NOT COMPLETED|Overall Study||9
5100575|NCT01621542|12548034|P4|NOT COMPLETED|Overall Study||28
5100576|NCT01621542|12548035|P3|NOT COMPLETED|Overall Study||6
5100577|NCT01621542|12548036|P2|NOT COMPLETED|Overall Study||5
5100578|NCT01621542|12548037|P1|NOT COMPLETED|Overall Study||5
5100579|NCT01621542|12548032|P6|COMPLETED|Overall Study||0
5100580|NCT01621542|12548033|P5|COMPLETED|Overall Study||0
5100581|NCT01621542|12548034|P4|COMPLETED|Overall Study||0
5100582|NCT01621542|12548035|P3|COMPLETED|Overall Study||0
5100583|NCT01621542|12548036|P2|COMPLETED|Overall Study||0
5100584|NCT01621542|12548037|P1|COMPLETED|Overall Study||0
5100585|NCT01621542|12548032|P6|STARTED|Overall Study||9
5100586|NCT01621542|12548033|P5|STARTED|Overall Study||9
5100587|NCT01621542|12548034|P4|STARTED|Overall Study||28
5100588|NCT01621542|12548035|P3|STARTED|Overall Study||6
5100589|NCT01621542|12548036|P2|STARTED|Overall Study||5
5100590|NCT01621542|12548037|P1|STARTED|Overall Study||5
5100591|NCT01621490|12548078|P9|NOT COMPLETED|Overall Study||8
5100592|NCT01621490|12548079|P8|NOT COMPLETED|Overall Study||10
5100593|NCT01621490|12548080|P7|NOT COMPLETED|Overall Study||11
5100594|NCT01621490|12548081|P6|NOT COMPLETED|Overall Study||24
5100595|NCT01621490|12548082|P5|NOT COMPLETED|Overall Study||6
5100596|NCT01621490|12548083|P4|NOT COMPLETED|Overall Study||9
5100597|NCT01621490|12548084|P3|NOT COMPLETED|Overall Study||11
5100598|NCT01621490|12548085|P2|NOT COMPLETED|Overall Study||44
5100599|NCT01621490|12548086|P1|NOT COMPLETED|Overall Study||41
5100600|NCT01621490|12548078|P9|COMPLETED|Overall Study||2
5100601|NCT01621490|12548079|P8|COMPLETED|Overall Study||0
5100602|NCT01621490|12548080|P7|COMPLETED|Overall Study||0
5100603|NCT01621490|12548081|P6|COMPLETED|Overall Study||1
5100604|NCT01621490|12548082|P5|COMPLETED|Overall Study||0
5100605|NCT01621490|12548083|P4|COMPLETED|Overall Study||1
5100606|NCT01621490|12548084|P3|COMPLETED|Overall Study||0
5100607|NCT01621490|12548085|P2|COMPLETED|Overall Study||0
5100608|NCT01621490|12548086|P1|COMPLETED|Overall Study||0
5100609|NCT01621490|12548078|P9|STARTED|Overall Study||10
5100610|NCT01621490|12548079|P8|STARTED|Overall Study||10
5100611|NCT01621490|12548080|P7|STARTED|Overall Study||11
5100612|NCT01621490|12548081|P6|STARTED|Overall Study||25
5100613|NCT01621490|12548082|P5|STARTED|Overall Study||6
5100614|NCT01621490|12548083|P4|STARTED|Overall Study||10
5100615|NCT01621490|12548084|P3|STARTED|Overall Study||11
5100616|NCT01621490|12548085|P2|STARTED|Overall Study||44
5100617|NCT01621490|12548086|P1|STARTED|Overall Study||41
5100618|NCT01621477|12548312|P1|NOT COMPLETED|Overall Study||0
5100619|NCT01621477|12548312|P1|COMPLETED|Overall Study||17
5100620|NCT01621477|12548312|P1|STARTED|Overall Study||17
5100621|NCT01621191|12548322|P1|NOT COMPLETED|Overall Study||25
5100622|NCT01621191|12548322|P1|COMPLETED|Overall Study||124
5100623|NCT01621191|12548322|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
5100624|NCT01621191|12548322|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
5100625|NCT01621191|12548322|P1|STARTED|Overall Study||149
5100626|NCT01621178|12548336|P3|NOT COMPLETED|Overall Study||36
5100627|NCT01621178|12548337|P2|NOT COMPLETED|Overall Study||30
5100628|NCT01621178|12548338|P1|NOT COMPLETED|Overall Study||31
5100629|NCT01621178|12548336|P3|COMPLETED|Overall Study||157
5100630|NCT01621178|12548337|P2|COMPLETED|Overall Study||160
5100631|NCT01621178|12548338|P1|COMPLETED|Overall Study||163
5100632|NCT01621178|12548336|P3|Modified Intent to Treat Population|Overall Study||183
5100633|NCT01621178|12548337|P2|Modified Intent to Treat Population|Overall Study||180
5100634|NCT01621178|12548338|P1|Modified Intent to Treat Population|Overall Study||186
5100635|NCT01621178|12548336|P3|Received at Least One Dose of Study Drug|Overall Study||192
5100636|NCT01621178|12548337|P2|Received at Least One Dose of Study Drug|Overall Study||190
5100637|NCT01621178|12548338|P1|Received at Least One Dose of Study Drug|Overall Study||194
5100638|NCT01621178|12548336|P3|STARTED|Overall Study||193
5100639|NCT01621178|12548337|P2|STARTED|Overall Study||190
5100640|NCT01621178|12548338|P1|STARTED|Overall Study||194
5100641|NCT01621126|12548430|P1|NOT COMPLETED|Overall Study||6
5100642|NCT01621126|12548430|P1|COMPLETED|Overall Study||34
5100643|NCT01621126|12548430|P1|STARTED|Overall Study||40
5100644|NCT01621009|12548438|P4|NOT COMPLETED|Overall Study||53
5100645|NCT01621009|12548439|P3|NOT COMPLETED|Overall Study||63
5100646|NCT01621009|12548440|P2|NOT COMPLETED|Overall Study||51
5100647|NCT01621009|12548441|P1|NOT COMPLETED|Overall Study||43
5100648|NCT01621009|12548438|P4|COMPLETED|Overall Study||60
5100649|NCT01621009|12548439|P3|COMPLETED|Overall Study||58
5100650|NCT01621009|12548440|P2|COMPLETED|Overall Study||65
5100651|NCT01621009|12548441|P1|COMPLETED|Overall Study||70
5100652|NCT01621009|12548438|P4|STARTED|Overall Study||113
5100653|NCT01621009|12548439|P3|STARTED|Overall Study||121
5100654|NCT01621009|12548440|P2|STARTED|Overall Study||116
5100655|NCT01621009|12548441|P1|STARTED|Overall Study||113
5100656|NCT01620983|12548452|P3|NOT COMPLETED|Overall Study||15
5100657|NCT01620983|12548453|P2|NOT COMPLETED|Overall Study||22
5100658|NCT01620983|12548454|P1|NOT COMPLETED|Overall Study||19
5100659|NCT01620983|12548452|P3|COMPLETED|Overall Study||122
5100660|NCT01620983|12548453|P2|COMPLETED|Overall Study||113
5100661|NCT01620983|12548454|P1|COMPLETED|Overall Study||111
5100662|NCT01620983|12548452|P3|STARTED|Overall Study||137
5100663|NCT01620983|12548453|P2|STARTED|Overall Study||135
5100664|NCT01620983|12548454|P1|STARTED|Overall Study||130
5100665|NCT01620762|12548483|P3|NOT COMPLETED|Overall Study||53
5100666|NCT01620762|12548484|P2|NOT COMPLETED|Overall Study||58
5100667|NCT01620762|12548485|P1|NOT COMPLETED|Overall Study||48
5100668|NCT01620762|12548483|P3|COMPLETED|Overall Study||417
5100669|NCT01620762|12548484|P2|COMPLETED|Overall Study||412
5100670|NCT01620762|12548485|P1|COMPLETED|Overall Study||420
5100671|NCT01620762|12548483|P3|STARTED|Overall Study||470
5100672|NCT01620762|12548484|P2|STARTED|Overall Study||470
5100673|NCT01620762|12548485|P1|STARTED|Overall Study||468
5100674|NCT01620593|12548513|P2|NOT COMPLETED|Overall Study||1
5100675|NCT01620593|12548514|P1|NOT COMPLETED|Overall Study||4
5100676|NCT01620593|12548513|P2|COMPLETED|Overall Study||19
5100677|NCT01620593|12548514|P1|COMPLETED|Overall Study||17
5100678|NCT01620593|12548513|P2|STARTED|Overall Study||20
5100679|NCT01620593|12548514|P1|STARTED|Overall Study||21
5100680|NCT01620567|12548530|P2|NOT COMPLETED|Overall Study||5
5100681|NCT01620567|12548531|P1|NOT COMPLETED|Overall Study||3
5100682|NCT01620567|12548530|P2|COMPLETED|Overall Study||20
5100683|NCT01620567|12548531|P1|COMPLETED|Overall Study||20
5100684|NCT01620567|12548530|P2|STARTED|Overall Study||25
5100685|NCT01620567|12548531|P1|STARTED|Overall Study||23
5100686|NCT01620528|12548546|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
5100687|NCT01620528|12548547|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
5100688|NCT01620528|12548548|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
5100689|NCT01620528|12548546|P3|COMPLETED|Post-Treatment Follow-Up Period||37
5100690|NCT01620528|12548547|P2|COMPLETED|Post-Treatment Follow-Up Period||31
5100691|NCT01620528|12548548|P1|COMPLETED|Post-Treatment Follow-Up Period||48
5100692|NCT01620528|12548546|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
5100693|NCT01620528|12548547|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
5100694|NCT01620528|12548548|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
5100695|NCT01620528|12548546|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
5100696|NCT01620528|12548547|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
5100697|NCT01620528|12548548|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
5100698|NCT01620528|12548546|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
5100699|NCT01620528|12548547|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
5100700|NCT01620528|12548548|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
5100701|NCT01620528|12548546|P3|NOT COMPLETED|Treatment Period||66
5100702|NCT01620528|12548547|P2|NOT COMPLETED|Treatment Period||53
5100703|NCT01620528|12548548|P1|NOT COMPLETED|Treatment Period||100
5100704|NCT01620528|12548546|P3|COMPLETED|Treatment Period||183
5100705|NCT01620528|12548547|P2|COMPLETED|Treatment Period||196
5100706|NCT01620528|12548548|P1|COMPLETED|Treatment Period||274
5100707|NCT01620528|12548546|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
5100708|NCT01620528|12548547|P2|STARTED|Treatment Period||249
5100709|NCT01620528|12548548|P1|STARTED|Treatment Period||374
5100710|NCT01620489|12548888|P2|NOT COMPLETED|Overall Study||34
5100711|NCT01620489|12548889|P1|NOT COMPLETED|Overall Study||35
5100712|NCT01620489|12548888|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
5100713|NCT01620489|12548889|P1|COMPLETED|Overall Study||105
5100714|NCT01620489|12548888|P2|Exposed|Overall Study|2 subjects did not take trial product|137
5100715|NCT01620489|12548889|P1|Exposed|Overall Study||140
5100716|NCT01620489|12548888|P2|STARTED|Overall Study||139
5100717|NCT01620489|12548889|P1|STARTED|Overall Study||140
5100718|NCT01620255|12548910|P5|NOT COMPLETED|Overall Study||6
5100719|NCT01620255|12548911|P4|NOT COMPLETED|Overall Study||3
5100720|NCT01620255|12548912|P3|NOT COMPLETED|Overall Study||2
5100721|NCT01620255|12548913|P2|NOT COMPLETED|Overall Study||6
5100722|NCT01620255|12548914|P1|NOT COMPLETED|Overall Study||4
5100723|NCT01620255|12548910|P5|COMPLETED|Overall Study||64
5100724|NCT01620255|12548911|P4|COMPLETED|Overall Study||70
5100725|NCT01620255|12548912|P3|COMPLETED|Overall Study||68
5100726|NCT01620255|12548913|P2|COMPLETED|Overall Study||65
5100727|NCT01620255|12548914|P1|COMPLETED|Overall Study||69
5100728|NCT01620255|12548910|P5|Treated|Overall Study||70
5100729|NCT01620255|12548911|P4|Treated|Overall Study||73
5100730|NCT01620255|12548912|P3|Treated|Overall Study||70
5100731|NCT01620255|12548913|P2|Treated|Overall Study||71
5100732|NCT01620255|12548914|P1|Treated|Overall Study||73
5100733|NCT01620255|12548910|P5|STARTED|Overall Study||70
5100734|NCT01620255|12548911|P4|STARTED|Overall Study||73
5100735|NCT01620255|12548912|P3|STARTED|Overall Study||70
5100736|NCT01620255|12548913|P2|STARTED|Overall Study||71
5100737|NCT01620255|12548914|P1|STARTED|Overall Study||73
5100738|NCT01620177|12548991|P1|NOT COMPLETED|Overall Study||79
5100739|NCT01620177|12548991|P1|COMPLETED|Overall Study||19
5100740|NCT01620177|12548991|P1|STARTED|Overall Study||98
5100741|NCT01620138|12549016|P2|NOT COMPLETED|Overall Study||0
5100742|NCT01620138|12549017|P1|NOT COMPLETED|Overall Study||6
5100743|NCT01620138|12549016|P2|COMPLETED|Overall Study||9
5100744|NCT01620138|12549017|P1|COMPLETED|Overall Study||6
5100745|NCT01620138|12549016|P2|STARTED|Overall Study||9
5100746|NCT01620138|12549017|P1|STARTED|Overall Study||12
5100747|NCT01620086|12549025|P3|NOT COMPLETED|Overall Study||0
5100748|NCT01620086|12549026|P2|NOT COMPLETED|Overall Study||7
5100749|NCT01620086|12549027|P1|NOT COMPLETED|Overall Study||5
5100750|NCT01620086|12549025|P3|COMPLETED|Overall Study||2
5100751|NCT01620086|12549026|P2|COMPLETED|Overall Study||4
5100752|NCT01620086|12549027|P1|COMPLETED|Overall Study||8
5100753|NCT01620086|12549025|P3|STARTED|Overall Study||2
5100754|NCT01620086|12549026|P2|STARTED|Overall Study||11
5100755|NCT01620086|12549027|P1|STARTED|Overall Study||13
5100756|NCT01620060|12549046|P1|NOT COMPLETED|Overall Study||15
5100757|NCT01620060|12549046|P1|COMPLETED|Overall Study||90
5100758|NCT01620060|12549046|P1|STARTED|Overall Study||105
5100759|NCT01620047|12549055|P3|NOT COMPLETED|Overall Study||0
5100760|NCT01620047|12549056|P2|NOT COMPLETED|Overall Study||0
5100761|NCT01620047|12549057|P1|NOT COMPLETED|Overall Study||0
5100762|NCT01620047|12549055|P3|COMPLETED|Overall Study||20
5100763|NCT01620047|12549056|P2|COMPLETED|Overall Study||20
5100764|NCT01620047|12549057|P1|COMPLETED|Overall Study||20
5100765|NCT01620047|12549055|P3|STARTED|Overall Study||20
5100766|NCT01620047|12549056|P2|STARTED|Overall Study||20
5100767|NCT01620047|12549057|P1|STARTED|Overall Study||20
5100768|NCT01619982|12549067|P2|NOT COMPLETED|Overall Study||0
5100769|NCT01619982|12549068|P1|NOT COMPLETED|Overall Study||0
5100770|NCT01619982|12549067|P2|COMPLETED|Overall Study||12
5100771|NCT01619982|12549068|P1|COMPLETED|Overall Study||20
5100772|NCT01619982|12549067|P2|STARTED|Overall Study||12
5100773|NCT01619982|12549068|P1|STARTED|Overall Study||20
5100774|NCT01619878|12549084|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
5100775|NCT01619878|12549084|P1|COMPLETED|Follow-up at 12 Months of Age||17
5100776|NCT01619878|12549084|P1|STARTED|Follow-up at 12 Months of Age||20
5100777|NCT01619878|12549084|P1|NOT COMPLETED|6 Week Follow-up Phase||1
5100778|NCT01619878|12549084|P1|COMPLETED|6 Week Follow-up Phase||19
5100779|NCT01619878|12549084|P1|STARTED|6 Week Follow-up Phase||20
5100780|NCT01619852|12549098|P2|NOT COMPLETED|3 Month Follow up||34
5100781|NCT01619852|12549099|P1|NOT COMPLETED|3 Month Follow up||31
5100782|NCT01619852|12549098|P2|COMPLETED|3 Month Follow up||40
5100783|NCT01619852|12549099|P1|COMPLETED|3 Month Follow up||43
5100784|NCT01619852|12549098|P2|STARTED|3 Month Follow up||74
5100785|NCT01619852|12549099|P1|STARTED|3 Month Follow up||74
5100786|NCT01619852|12549098|P2|NOT COMPLETED|24 Hour Assessment||1
5100787|NCT01619852|12549099|P1|NOT COMPLETED|24 Hour Assessment||1
5100788|NCT01619852|12549098|P2|COMPLETED|24 Hour Assessment||74
5100789|NCT01619852|12549099|P1|COMPLETED|24 Hour Assessment||74
5100790|NCT01619852|12549098|P2|STARTED|24 Hour Assessment||75
5100791|NCT01619852|12549099|P1|STARTED|24 Hour Assessment||75
5100792|NCT01619800|12549115|P2|NOT COMPLETED|Overall Study||0
5100793|NCT01619800|12549116|P1|NOT COMPLETED|Overall Study||2
5100794|NCT01619800|12549115|P2|COMPLETED|Overall Study||0
5100795|NCT01619800|12549116|P1|COMPLETED|Overall Study||0
5100796|NCT01619800|12549115|P2|STARTED|Overall Study||0
5100797|NCT01619800|12549116|P1|STARTED|Overall Study||2
5100798|NCT01619787|12549124|P1|NOT COMPLETED|Overall Study||5
5100799|NCT01619787|12549124|P1|COMPLETED|Overall Study||212
5100800|NCT01619787|12549124|P1|STARTED|Overall Study||217
5100801|NCT01619774|12549133|P1|NOT COMPLETED|Overall Study||0
5100802|NCT01619774|12549133|P1|COMPLETED|Overall Study||23
5100803|NCT01619774|12549133|P1|STARTED|Overall Study||23
5100804|NCT01619579|12549141|P2|NOT COMPLETED|Overall Study||3
5100805|NCT01619579|12549142|P1|NOT COMPLETED|Overall Study||0
5100806|NCT01619579|12549141|P2|COMPLETED|Overall Study||14
5100807|NCT01619579|12549142|P1|COMPLETED|Overall Study||5
5100808|NCT01619579|12549141|P2|STARTED|Overall Study||17
5100809|NCT01619579|12549142|P1|STARTED|Overall Study||5
5100810|NCT01619423|12549156|P4|NOT COMPLETED|Part 2b||0
5100811|NCT01619423|12549157|P3|NOT COMPLETED|Part 2b||0
5100812|NCT01619423|12549158|P2|NOT COMPLETED|Part 2b||0
5100813|NCT01619423|12549159|P1|NOT COMPLETED|Part 2b||0
5100814|NCT01619423|12549156|P4|COMPLETED|Part 2b||0
5100815|NCT01619423|12549157|P3|COMPLETED|Part 2b||45
5100816|NCT01619423|12549158|P2|COMPLETED|Part 2b||44
5100817|NCT01619423|12549159|P1|COMPLETED|Part 2b||45
5100818|NCT01619423|12549156|P4|STARTED|Part 2b||0
5100819|NCT01619423|12549157|P3|STARTED|Part 2b||45
5100820|NCT01619423|12549158|P2|STARTED|Part 2b||44
5100821|NCT01619423|12549159|P1|STARTED|Part 2b||45
5100822|NCT01619423|12549156|P4|NOT COMPLETED|Part 2a||0
5100823|NCT01619423|12549157|P3|NOT COMPLETED|Part 2a||0
5100824|NCT01619423|12549158|P2|NOT COMPLETED|Part 2a||0
5100825|NCT01619423|12549159|P1|NOT COMPLETED|Part 2a||0
5100826|NCT01619423|12549156|P4|COMPLETED|Part 2a||11
5100827|NCT01619423|12549157|P3|COMPLETED|Part 2a||0
5100828|NCT01619423|12549158|P2|COMPLETED|Part 2a||13
5100829|NCT01619423|12549159|P1|COMPLETED|Part 2a||15
5100830|NCT01619423|12549156|P4|STARTED|Part 2a||11
5100831|NCT01619423|12549157|P3|STARTED|Part 2a||0
5100832|NCT01619423|12549158|P2|STARTED|Part 2a||13
5100833|NCT01619423|12549159|P1|STARTED|Part 2a||15
5100834|NCT01619423|12549156|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
5100835|NCT01619423|12549157|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
5100836|NCT01619423|12549158|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
5100837|NCT01619423|12549159|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
5100838|NCT01619423|12549156|P4|COMPLETED|Part 1 (Dose Escalation)||5
5100839|NCT01619423|12549157|P3|COMPLETED|Part 1 (Dose Escalation)||3
5100840|NCT01619423|12549158|P2|COMPLETED|Part 1 (Dose Escalation)||3
5100841|NCT01619423|12549159|P1|COMPLETED|Part 1 (Dose Escalation)||0
5100842|NCT01619423|12549156|P4|STARTED|Part 1 (Dose Escalation)||5
5100843|NCT01619423|12549157|P3|STARTED|Part 1 (Dose Escalation)||3
5100844|NCT01619423|12549158|P2|STARTED|Part 1 (Dose Escalation)||5
5100845|NCT01619423|12549159|P1|STARTED|Part 1 (Dose Escalation)||0
5100846|NCT01619410|12549172|P2|NOT COMPLETED|Overall Study||4
5100847|NCT01619410|12549173|P1|NOT COMPLETED|Overall Study||7
5100848|NCT01619410|12549172|P2|COMPLETED|Overall Study||7
5100849|NCT01619410|12549173|P1|COMPLETED|Overall Study||7
5100850|NCT01619410|12549172|P2|STARTED|Overall Study||11
5100851|NCT01619410|12549173|P1|STARTED|Overall Study||14
5100852|NCT01619085|12549185|P1|NOT COMPLETED|Overall Study||369
5100853|NCT01619085|12549185|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
5100854|NCT01619085|12549185|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
5100855|NCT01619059|12549191|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
5100856|NCT01619059|12549192|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
5100857|NCT01619059|12549191|P2|COMPLETED|Long-Term (LT) Treatment Period||133
5100858|NCT01619059|12549192|P1|COMPLETED|Long-Term (LT) Treatment Period||147
5100859|NCT01619059|12549191|P2|STARTED|Long-Term (LT) Treatment Period||142
5100860|NCT01619059|12549192|P1|STARTED|Long-Term (LT) Treatment Period||155
5100861|NCT01619059|12549191|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
5100862|NCT01619059|12549192|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
5100863|NCT01619059|12549191|P2|COMPLETED|Short-Term (ST) Treatment Period||142
5100864|NCT01619059|12549192|P1|COMPLETED|Short-Term (ST) Treatment Period||156
5100865|NCT01619059|12549191|P2|STARTED|Short-Term (ST) Treatment Period||153
5100866|NCT01619059|12549192|P1|STARTED|Short-Term (ST) Treatment Period||162
5100867|NCT01618968|12549208|P4|NOT COMPLETED|Overall Study||1
5100868|NCT01618968|12549209|P3|NOT COMPLETED|Overall Study||0
5100869|NCT01618968|12549210|P2|NOT COMPLETED|Overall Study||0
5100870|NCT01618968|12549211|P1|NOT COMPLETED|Overall Study||1
5100871|NCT01618968|12549208|P4|COMPLETED|Overall Study||11
5100872|NCT01618968|12549209|P3|COMPLETED|Overall Study||12
5100873|NCT01618968|12549210|P2|COMPLETED|Overall Study||12
5100874|NCT01618968|12549211|P1|COMPLETED|Overall Study||12
5100875|NCT01618968|12549208|P4|Received Treatment C|Overall Study||11
5100876|NCT01618968|12549209|P3|Received Treatment C|Overall Study||12
5100877|NCT01618968|12549210|P2|Received Treatment C|Overall Study||12
5100878|NCT01618968|12549211|P1|Received Treatment C|Overall Study||12
5100879|NCT01618968|12549208|P4|Received Treatment B|Overall Study||12
5100880|NCT01618968|12549209|P3|Received Treatment B|Overall Study||12
5100881|NCT01618968|12549210|P2|Received Treatment B|Overall Study||12
5100882|NCT01618968|12549211|P1|Received Treatment B|Overall Study||13
5100883|NCT01618968|12549208|P4|Received Treatment A|Overall Study||11
5100884|NCT01618968|12549209|P3|Received Treatment A|Overall Study||12
5100885|NCT01618968|12549210|P2|Received Treatment A|Overall Study||12
5100886|NCT01618968|12549211|P1|Received Treatment A|Overall Study||12
5100887|NCT01618968|12549208|P4|STARTED|Overall Study||12
5100888|NCT01618968|12549209|P3|STARTED|Overall Study||12
5100889|NCT01618968|12549210|P2|STARTED|Overall Study||12
5100890|NCT01618968|12549211|P1|STARTED|Overall Study||13
5100891|NCT01618955|12549230|P4|NOT COMPLETED|Overall Study||0
5100892|NCT01618955|12549231|P3|NOT COMPLETED|Overall Study||0
5100893|NCT01618955|12549232|P2|NOT COMPLETED|Overall Study||0
5100894|NCT01618955|12549233|P1|NOT COMPLETED|Overall Study||0
5100895|NCT01618955|12549230|P4|COMPLETED|Overall Study||20
5100896|NCT01618955|12549231|P3|COMPLETED|Overall Study||31
5100897|NCT01618955|12549232|P2|COMPLETED|Overall Study||30
5100898|NCT01618955|12549233|P1|COMPLETED|Overall Study||20
5100899|NCT01618955|12549230|P4|STARTED|Overall Study||20
5100900|NCT01618955|12549231|P3|STARTED|Overall Study||31
5100901|NCT01618955|12549232|P2|STARTED|Overall Study||30
5100902|NCT01618955|12549233|P1|STARTED|Overall Study||20
5100903|NCT01618942|12549257|P2|NOT COMPLETED|Overall Study||0
5100904|NCT01618942|12549258|P1|NOT COMPLETED|Overall Study||0
5100905|NCT01618942|12549257|P2|COMPLETED|Overall Study||50
5100906|NCT01618942|12549258|P1|COMPLETED|Overall Study||50
5100907|NCT01618942|12549257|P2|STARTED|Overall Study||50
5100908|NCT01618942|12549258|P1|STARTED|Overall Study||50
5100909|NCT01618916|12549284|P6|NOT COMPLETED|Overall Study||0
5100910|NCT01618916|12549285|P5|NOT COMPLETED|Overall Study||1
5100911|NCT01618916|12549286|P4|NOT COMPLETED|Overall Study||2
5100912|NCT01618916|12549287|P3|NOT COMPLETED|Overall Study||1
5100913|NCT01618916|12549288|P2|NOT COMPLETED|Overall Study||1
5100914|NCT01618916|12549289|P1|NOT COMPLETED|Overall Study||2
5100915|NCT01618916|12549284|P6|COMPLETED|Overall Study||4
5100916|NCT01618916|12549285|P5|COMPLETED|Overall Study||4
5100917|NCT01618916|12549286|P4|COMPLETED|Overall Study||7
5100918|NCT01618916|12549287|P3|COMPLETED|Overall Study||10
5100919|NCT01618916|12549288|P2|COMPLETED|Overall Study||9
5100920|NCT01618916|12549289|P1|COMPLETED|Overall Study||10
5100921|NCT01618916|12549284|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
5100922|NCT01618916|12549285|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
5100923|NCT01618916|12549286|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
5100924|NCT01618916|12549287|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
5100925|NCT01618916|12549288|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
5100926|NCT01618916|12549289|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
5100927|NCT01618916|12549284|P6|STARTED|Overall Study||4
5100928|NCT01618916|12549285|P5|STARTED|Overall Study||5
5100929|NCT01618916|12549286|P4|STARTED|Overall Study||9
5100930|NCT01618916|12549287|P3|STARTED|Overall Study||11
5100931|NCT01618916|12549288|P2|STARTED|Overall Study||10
5100932|NCT01618916|12549289|P1|STARTED|Overall Study||12
5100933|NCT01618864|12549319|P1|NOT COMPLETED|Overall Study||4
5100934|NCT01618864|12549319|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
5100935|NCT01618864|12549319|P1|Completed 2 Weeks|Overall Study||19
5100936|NCT01618864|12549319|P1|STARTED|Overall Study||23
5100937|NCT01618838|12549328|P1|NOT COMPLETED|Overall Study||4
5100938|NCT01618838|12549328|P1|COMPLETED|Overall Study||0
5100939|NCT01618838|12549328|P1|STARTED|Overall Study||4
5100940|NCT01618708|12549336|P2|NOT COMPLETED|Overall Study||46
5100941|NCT01618708|12549337|P1|NOT COMPLETED|Overall Study||44
5100942|NCT01618708|12549336|P2|COMPLETED|Overall Study||136
5100943|NCT01618708|12549337|P1|COMPLETED|Overall Study||131
5100944|NCT01618708|12549336|P2|Treated|Overall Study||180
5100945|NCT01618708|12549337|P1|Treated|Overall Study||172
5100946|NCT01618708|12549336|P2|STARTED|Overall Study||182
5100947|NCT01618708|12549337|P1|STARTED|Overall Study||175
5100948|NCT01618695|12549353|P4|NOT COMPLETED|Overall Study||36
5100949|NCT01618695|12549354|P3|NOT COMPLETED|Overall Study||30
5100950|NCT01618695|12549355|P2|NOT COMPLETED|Overall Study||20
5100951|NCT01618695|12549356|P1|NOT COMPLETED|Overall Study||25
5100952|NCT01618695|12549353|P4|COMPLETED|Overall Study||144
5100953|NCT01618695|12549354|P3|COMPLETED|Overall Study||147
5100954|NCT01618695|12549355|P2|COMPLETED|Overall Study||156
5100955|NCT01618695|12549356|P1|COMPLETED|Overall Study||152
5100956|NCT01618695|12549353|P4|Treated (Safety Analysis Set)|Overall Study||180
5100957|NCT01618695|12549354|P3|Treated (Safety Analysis Set)|Overall Study||175
5100958|NCT01618695|12549355|P2|Treated (Safety Analysis Set)|Overall Study||176
5100959|NCT01618695|12549356|P1|Treated (Safety Analysis Set)|Overall Study||176
5100960|NCT01618695|12549353|P4|STARTED|Overall Study||180
5100961|NCT01618695|12549354|P3|STARTED|Overall Study||177
5100962|NCT01618695|12549355|P2|STARTED|Overall Study||176
5100963|NCT01618695|12549356|P1|STARTED|Overall Study||177
5100964|NCT01618669|12549380|P2|NOT COMPLETED|Overall Study||23
5100965|NCT01618669|12549381|P1|NOT COMPLETED|Overall Study||34
5100966|NCT01618669|12549380|P2|COMPLETED|Overall Study||546
5100967|NCT01618669|12549381|P1|COMPLETED|Overall Study||544
5100968|NCT01618669|12549380|P2|Received Treatment|Overall Study||567
5100969|NCT01618669|12549381|P1|Received Treatment|Overall Study||575
5100970|NCT01618669|12549380|P2|STARTED|Overall Study||569
5100971|NCT01618669|12549381|P1|STARTED|Overall Study||578
5100972|NCT01618422|12549427|P2|NOT COMPLETED|Overall Study||0
5100973|NCT01618422|12549428|P1|NOT COMPLETED|Overall Study||0
5100974|NCT01618422|12549427|P2|COMPLETED|Overall Study||111
5100975|NCT01618422|12549428|P1|COMPLETED|Overall Study||114
5100976|NCT01618422|12549427|P2|STARTED|Overall Study||111
5100977|NCT01618422|12549428|P1|STARTED|Overall Study||114
5100978|NCT01618344|12549434|P1|NOT COMPLETED|Overall Study||9
5100979|NCT01618344|12549434|P1|COMPLETED|Overall Study||23
5100980|NCT01618344|12549434|P1|STARTED|Overall Study||32
5100981|NCT01618305|12549440|P2|NOT COMPLETED|Overall Study||10
5100982|NCT01618305|12549441|P1|NOT COMPLETED|Overall Study||15
5100983|NCT01618305|12549440|P2|COMPLETED|Overall Study||196
5100984|NCT01618305|12549441|P1|COMPLETED|Overall Study||187
5100985|NCT01618305|12549440|P2|STARTED|Overall Study||206
5100986|NCT01618305|12549441|P1|STARTED|Overall Study||202
5100987|NCT01618266|12549483|P1|NOT COMPLETED|Overall Study||96
5100988|NCT01618266|12549483|P1|COMPLETED|Overall Study||279
5100989|NCT01618266|12549483|P1|STARTED|Overall Study||375
5100990|NCT01618240|12549498|P1|NOT COMPLETED|Overall Study||0
5100991|NCT01618240|12549498|P1|COMPLETED|Overall Study||30
5100992|NCT01618240|12549498|P1|STARTED|Overall Study||30
5100993|NCT01618227|12549505|P2|NOT COMPLETED|Overall Study||2
5100994|NCT01618227|12549506|P1|NOT COMPLETED|Overall Study||0
5100995|NCT01618227|12549505|P2|COMPLETED|Overall Study||0
5100996|NCT01618227|12549506|P1|COMPLETED|Overall Study||2
5100997|NCT01618227|12549505|P2|STARTED|Overall Study||2
5100998|NCT01618227|12549506|P1|STARTED|Overall Study||2
5100999|NCT01618214|12549520|P2|NOT COMPLETED|Overall Study||13
5101000|NCT01618214|12549521|P1|NOT COMPLETED|Overall Study||10
5101001|NCT01618214|12549520|P2|COMPLETED|Overall Study||159
5101002|NCT01618214|12549521|P1|COMPLETED|Overall Study||162
5101003|NCT01618214|12549520|P2|Exposed|Overall Study||172
5101004|NCT01618214|12549521|P1|Exposed|Overall Study||172
5101005|NCT01618214|12549520|P2|STARTED|Overall Study||172
5101006|NCT01618214|12549521|P1|STARTED|Overall Study||172
5101007|NCT01618162|12549537|P2|NOT COMPLETED|Overall Study||35
5101008|NCT01618162|12549538|P1|NOT COMPLETED|Overall Study||38
5101009|NCT01618162|12549537|P2|COMPLETED|Overall Study||111
5101010|NCT01618162|12549538|P1|COMPLETED|Overall Study||251
5101011|NCT01618162|12549537|P2|Exposed|Overall Study||146
5101012|NCT01618162|12549538|P1|Exposed|Overall Study||288
5101013|NCT01618162|12549537|P2|STARTED|Overall Study||146
5101014|NCT01618162|12549538|P1|STARTED|Overall Study||289
5101015|NCT01618019|12549558|P2|NOT COMPLETED|Overall Study||14
5101016|NCT01618019|12549559|P1|NOT COMPLETED|Overall Study||14
5101017|NCT01618019|12549558|P2|COMPLETED|Overall Study||40
5101018|NCT01618019|12549559|P1|COMPLETED|Overall Study||41
5101019|NCT01618019|12549558|P2|STARTED|Overall Study||54
5101020|NCT01618019|12549559|P1|STARTED|Overall Study||55
5101021|NCT01617967|12549585|P6|NOT COMPLETED|Overall Study||1
5101022|NCT01617967|12549586|P5|NOT COMPLETED|Overall Study||0
5101023|NCT01617967|12549587|P4|NOT COMPLETED|Overall Study||1
5101024|NCT01617967|12549588|P3|NOT COMPLETED|Overall Study||0
5101025|NCT01617967|12549589|P2|NOT COMPLETED|Overall Study||0
5101026|NCT01617967|12549590|P1|NOT COMPLETED|Overall Study||1
5101027|NCT01617967|12549585|P6|COMPLETED|Overall Study||8
5101028|NCT01617967|12549586|P5|COMPLETED|Overall Study||3
5101029|NCT01617967|12549587|P4|COMPLETED|Overall Study||6
5101030|NCT01617967|12549588|P3|COMPLETED|Overall Study||3
5101031|NCT01617967|12549589|P2|COMPLETED|Overall Study||3
5101032|NCT01617967|12549590|P1|COMPLETED|Overall Study||3
5101033|NCT01617967|12549585|P6|STARTED|Overall Study||9
5101034|NCT01617967|12549586|P5|STARTED|Overall Study||3
5101035|NCT01617967|12549587|P4|STARTED|Overall Study||7
5101036|NCT01617967|12549588|P3|STARTED|Overall Study||3
5101037|NCT01617967|12549589|P2|STARTED|Overall Study||3
5101038|NCT01617967|12549590|P1|STARTED|Overall Study||4
5101039|NCT01617681|12549644|P5|NOT COMPLETED|Period 2 Open Label||6
5101040|NCT01617681|12549645|P4|NOT COMPLETED|Period 2 Open Label||0
5101041|NCT01617681|12549646|P3|NOT COMPLETED|Period 2 Open Label||0
5101042|NCT01617681|12549647|P2|NOT COMPLETED|Period 2 Open Label||0
5101043|NCT01617681|12549648|P1|NOT COMPLETED|Period 2 Open Label||0
5101044|NCT01617681|12549644|P5|COMPLETED|Period 2 Open Label||114
5101045|NCT01617681|12549645|P4|COMPLETED|Period 2 Open Label||0
5101046|NCT01617681|12549646|P3|COMPLETED|Period 2 Open Label||0
5101047|NCT01617681|12549647|P2|COMPLETED|Period 2 Open Label||0
5101048|NCT01617681|12549648|P1|COMPLETED|Period 2 Open Label||0
5101049|NCT01617681|12549644|P5|STARTED|Period 2 Open Label||120
5101050|NCT01617681|12549645|P4|STARTED|Period 2 Open Label||0
5101051|NCT01617681|12549646|P3|STARTED|Period 2 Open Label||0
5101052|NCT01617681|12549647|P2|STARTED|Period 2 Open Label||0
5101053|NCT01617681|12549648|P1|STARTED|Period 2 Open Label||0
5101054|NCT01617681|12549644|P5|NOT COMPLETED|Period 1 Double Blind||0
5101055|NCT01617681|12549645|P4|NOT COMPLETED|Period 1 Double Blind||2
5101056|NCT01617681|12549646|P3|NOT COMPLETED|Period 1 Double Blind||1
5101057|NCT01617681|12549647|P2|NOT COMPLETED|Period 1 Double Blind||1
5101058|NCT01617681|12549648|P1|NOT COMPLETED|Period 1 Double Blind||3
5101059|NCT01617681|12549644|P5|COMPLETED|Period 1 Double Blind||0
5101060|NCT01617681|12549645|P4|COMPLETED|Period 1 Double Blind||29
5101061|NCT01617681|12549646|P3|COMPLETED|Period 1 Double Blind||32
5101062|NCT01617681|12549647|P2|COMPLETED|Period 1 Double Blind||30
5101063|NCT01617681|12549648|P1|COMPLETED|Period 1 Double Blind||29
5101064|NCT01617681|12549644|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
5101065|NCT01617681|12549645|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
5101066|NCT01617681|12549646|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
5101067|NCT01617681|12549647|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
5101068|NCT01617681|12549648|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
5101069|NCT01617681|12549644|P5|STARTED|Period 1 Double Blind||0
5101070|NCT01617681|12549645|P4|STARTED|Period 1 Double Blind||31
5101071|NCT01617681|12549646|P3|STARTED|Period 1 Double Blind||33
5101072|NCT01617681|12549647|P2|STARTED|Period 1 Double Blind||31
5101073|NCT01617681|12549648|P1|STARTED|Period 1 Double Blind||32
5101074|NCT01617668|12549669|P4|NOT COMPLETED|Overall Study||15
5101075|NCT01617668|12549670|P3|NOT COMPLETED|Overall Study||23
5101076|NCT01617668|12549671|P2|NOT COMPLETED|Overall Study||9
5101077|NCT01617668|12549672|P1|NOT COMPLETED|Overall Study||13
5101078|NCT01617668|12549669|P4|COMPLETED|Overall Study||38
5101079|NCT01617668|12549670|P3|COMPLETED|Overall Study||32
5101080|NCT01617668|12549671|P2|COMPLETED|Overall Study||41
5101081|NCT01617668|12549672|P1|COMPLETED|Overall Study||38
5101082|NCT01617668|12549669|P4|Randomized Patients|Overall Study||55
5101083|NCT01617668|12549670|P3|Randomized Patients|Overall Study||55
5101084|NCT01617668|12549671|P2|Randomized Patients|Overall Study||54
5101085|NCT01617668|12549672|P1|Randomized Patients|Overall Study||51
5101086|NCT01617668|12549669|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
5101087|NCT01617668|12549670|P3|STARTED|Overall Study||55
5101088|NCT01617668|12549671|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
5101089|NCT01617668|12549672|P1|STARTED|Overall Study||51
5101090|NCT01617655|12549713|P2|NOT COMPLETED|Overall Study||29
5101091|NCT01617655|12549714|P1|NOT COMPLETED|Overall Study||9
5101092|NCT01617655|12549713|P2|COMPLETED|Overall Study||43
5101093|NCT01617655|12549714|P1|COMPLETED|Overall Study||26
5101094|NCT01617655|12549713|P2|Treated|Overall Study||72
5101095|NCT01617655|12549714|P1|Treated|Overall Study||35
5101096|NCT01617655|12549713|P2|STARTED|Overall Study|Randomized|72
5101097|NCT01617655|12549714|P1|STARTED|Overall Study|Randomized|35
5101098|NCT01617629|12549774|P1|NOT COMPLETED|Overall Study||6
5101099|NCT01617629|12549774|P1|COMPLETED|Overall Study||3
5101100|NCT01617629|12549774|P1|STARTED|Overall Study||9
5101101|NCT01617603|12549782|P3|NOT COMPLETED|Overall Study||1
5101102|NCT01617603|12549783|P2|NOT COMPLETED|Overall Study||2
5101103|NCT01617603|12549784|P1|NOT COMPLETED|Overall Study||3
5101104|NCT01617603|12549782|P3|COMPLETED|Overall Study||20
5101105|NCT01617603|12549783|P2|COMPLETED|Overall Study||19
5101106|NCT01617603|12549784|P1|COMPLETED|Overall Study||17
5101107|NCT01617603|12549782|P3|STARTED|Overall Study||21
5101108|NCT01617603|12549783|P2|STARTED|Overall Study||21
5101109|NCT01617603|12549784|P1|STARTED|Overall Study||20
5101110|NCT01617577|12549794|P2|NOT COMPLETED|Overall Study||0
5101111|NCT01617577|12549795|P1|NOT COMPLETED|Overall Study||0
5101112|NCT01617577|12549794|P2|COMPLETED|Overall Study||3
5101113|NCT01617577|12549795|P1|COMPLETED|Overall Study||5
5101114|NCT01617577|12549794|P2|STARTED|Overall Study||3
5101115|NCT01617577|12549795|P1|STARTED|Overall Study||5
5101116|NCT01617460|12549802|P1|NOT COMPLETED|Overall Study||40
5101117|NCT01617460|12549802|P1|COMPLETED|Overall Study||46
5101118|NCT01617460|12549802|P1|STARTED|Overall Study||86
5101119|NCT01617447|12549808|P2|NOT COMPLETED|Overall Study||3
5101120|NCT01617447|12549809|P1|NOT COMPLETED|Overall Study||0
5101121|NCT01617447|12549808|P2|COMPLETED|Overall Study||42
5101122|NCT01617447|12549809|P1|COMPLETED|Overall Study||47
5101123|NCT01617447|12549808|P2|STARTED|Overall Study||45
5101124|NCT01617447|12549809|P1|STARTED|Overall Study||47
5101125|NCT01617434|12549817|P2|NOT COMPLETED|Overall Study||51
5101126|NCT01617434|12549818|P1|NOT COMPLETED|Overall Study||35
5101127|NCT01617434|12549817|P2|COMPLETED|Overall Study||174
5101128|NCT01617434|12549818|P1|COMPLETED|Overall Study||191
5101129|NCT01617434|12549817|P2|Exposed|Overall Study||225
5101130|NCT01617434|12549818|P1|Exposed|Overall Study||225
5101131|NCT01617434|12549817|P2|STARTED|Overall Study||225
5101132|NCT01617434|12549818|P1|STARTED|Overall Study||226
5101133|NCT01617421|12549840|P1|NOT COMPLETED|Overall Study||6
5101134|NCT01617421|12549840|P1|COMPLETED|Overall Study||12
5101135|NCT01617421|12549840|P1|STARTED|Overall Study||18
5101136|NCT01617369|12549847|P1|NOT COMPLETED|Overall Study||0
5101137|NCT01617369|12549847|P1|COMPLETED|Overall Study||12
5101138|NCT01617369|12549847|P1|STARTED|Overall Study||12
5101139|NCT01617187|12549857|P4|NOT COMPLETED|Treatment Through Study Completion||10
5101140|NCT01617187|12549858|P3|NOT COMPLETED|Treatment Through Study Completion||5
5101141|NCT01617187|12549859|P2|NOT COMPLETED|Treatment Through Study Completion||11
5101142|NCT01617187|12549860|P1|NOT COMPLETED|Treatment Through Study Completion||11
5101143|NCT01617187|12549857|P4|COMPLETED|Treatment Through Study Completion||91
5101144|NCT01617187|12549858|P3|COMPLETED|Treatment Through Study Completion||41
5101145|NCT01617187|12549859|P2|COMPLETED|Treatment Through Study Completion||102
5101146|NCT01617187|12549860|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
5101147|NCT01617187|12549857|P4|STARTED|Treatment Through Study Completion|Treated|101
5101148|NCT01617187|12549858|P3|STARTED|Treatment Through Study Completion|Treated|46
5101149|NCT01617187|12549859|P2|STARTED|Treatment Through Study Completion|Treated|113
5101150|NCT01617187|12549860|P1|STARTED|Treatment Through Study Completion|Treated|97
5101151|NCT01617187|12549857|P4|NOT COMPLETED|Randomization Through Start Treatment||2
5101152|NCT01617187|12549858|P3|NOT COMPLETED|Randomization Through Start Treatment||0
5101153|NCT01617187|12549859|P2|NOT COMPLETED|Randomization Through Start Treatment||0
5101154|NCT01617187|12549860|P1|NOT COMPLETED|Randomization Through Start Treatment||1
5101155|NCT01617187|12549857|P4|COMPLETED|Randomization Through Start Treatment||101
5101156|NCT01617187|12549858|P3|COMPLETED|Randomization Through Start Treatment||46
5101157|NCT01617187|12549859|P2|COMPLETED|Randomization Through Start Treatment||113
5101158|NCT01617187|12549860|P1|COMPLETED|Randomization Through Start Treatment||97
5101159|NCT01617187|12549857|P4|STARTED|Randomization Through Start Treatment|Randomized|103
5101160|NCT01617187|12549858|P3|STARTED|Randomization Through Start Treatment|Randomized|46
5101161|NCT01617187|12549859|P2|STARTED|Randomization Through Start Treatment|Randomized|113
5101162|NCT01617187|12549860|P1|STARTED|Randomization Through Start Treatment|Randomized|98
5101163|NCT01617148|12549930|P1|NOT COMPLETED|Overall Study||0
5101164|NCT01617148|12549930|P1|COMPLETED|Overall Study||26
5101165|NCT01617148|12549930|P1|STARTED|Overall Study||26
5101166|NCT01617083|12549944|P3|NOT COMPLETED|Overall Study||0
5101167|NCT01617083|12549945|P2|NOT COMPLETED|Overall Study||0
5101168|NCT01617083|12549946|P1|NOT COMPLETED|Overall Study||0
5101169|NCT01617083|12549944|P3|COMPLETED|Overall Study||15
5101170|NCT01617083|12549945|P2|COMPLETED|Overall Study||14
5101171|NCT01617083|12549946|P1|COMPLETED|Overall Study||18
5101172|NCT01617083|12549944|P3|STARTED|Overall Study||15
5101173|NCT01617083|12549945|P2|STARTED|Overall Study||14
5101174|NCT01617083|12549946|P1|STARTED|Overall Study||18
5101175|NCT01617070|12549957|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
5101176|NCT01617070|12549957|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
5101177|NCT01617070|12549957|P1|STARTED|BH4 and LNAA (4 Weeks)||10
5101178|NCT01617070|12549957|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
5101179|NCT01617070|12549957|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
5101180|NCT01617070|12549957|P1|STARTED|BH4 Therapy (4 Weeks)||10
5101181|NCT01617070|12549957|P1|NOT COMPLETED|Washout (4 Weeks)||0
5101182|NCT01617070|12549957|P1|COMPLETED|Washout (4 Weeks)||10
5101183|NCT01617070|12549957|P1|STARTED|Washout (4 Weeks)||10
5101184|NCT01617070|12549957|P1|NOT COMPLETED|LNAA (4 Weeks)||0
5101185|NCT01617070|12549957|P1|COMPLETED|LNAA (4 Weeks)||10
5101186|NCT01617070|12549957|P1|STARTED|LNAA (4 Weeks)||10
5101187|NCT01617005|12549975|P1|NOT COMPLETED|Overall Study||2
5101188|NCT01617005|12549975|P1|COMPLETED|Overall Study||48
5101189|NCT01617005|12549975|P1|STARTED|Overall Study||50
5101190|NCT01616953|12549984|P2|NOT COMPLETED|Overall Study||0
5101191|NCT01616953|12549985|P1|NOT COMPLETED|Overall Study||2
5101192|NCT01616953|12549984|P2|COMPLETED|Overall Study||8
5101193|NCT01616953|12549985|P1|COMPLETED|Overall Study||8
5101194|NCT01616953|12549984|P2|6 Months Post-loading|Overall Study||8
5101195|NCT01616953|12549985|P1|6 Months Post-loading|Overall Study||8
5101196|NCT01616953|12549984|P2|Implant Uncovery|Overall Study||8
5101197|NCT01616953|12549985|P1|Implant Uncovery|Overall Study||8
5101198|NCT01616953|12549984|P2|Implant Placement Surgery|Overall Study||8
5101199|NCT01616953|12549985|P1|Implant Placement Surgery|Overall Study||9
5101200|NCT01616953|12549984|P2|STARTED|Overall Study||8
5101201|NCT01616953|12549985|P1|STARTED|Overall Study||10
5101202|NCT01616771|12549993|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
5101203|NCT01616771|12549993|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
5101204|NCT01616771|12549993|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
5101205|NCT01616771|12549993|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
5101206|NCT01616771|12549993|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
5101207|NCT01616771|12549993|P1|STARTED|GVL Selected by Weight for 5 Sec||23
5101208|NCT01616771|12549993|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
5101209|NCT01616771|12549993|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
5101210|NCT01616771|12549993|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
5101211|NCT01616693|12550006|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
5101212|NCT01616693|12550007|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
5101213|NCT01616693|12550008|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
5101214|NCT01616693|12550009|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
5101215|NCT01616693|12550006|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
5101216|NCT01616693|12550007|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
5101217|NCT01616693|12550008|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
5101218|NCT01616693|12550009|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
5101219|NCT01616693|12550006|P4|STARTED|Blood Analyzed for Immunogenicity||136
5101220|NCT01616693|12550007|P3|STARTED|Blood Analyzed for Immunogenicity||142
5101221|NCT01616693|12550008|P2|STARTED|Blood Analyzed for Immunogenicity||145
5101222|NCT01616693|12550009|P1|STARTED|Blood Analyzed for Immunogenicity||141
5101223|NCT01616693|12550006|P4|NOT COMPLETED|Received Both Vaccines||19
5101224|NCT01616693|12550007|P3|NOT COMPLETED|Received Both Vaccines||12
5101225|NCT01616693|12550008|P2|NOT COMPLETED|Received Both Vaccines||10
5101226|NCT01616693|12550009|P1|NOT COMPLETED|Received Both Vaccines||13
5101227|NCT01616693|12550006|P4|COMPLETED|Received Both Vaccines||136
5101228|NCT01616693|12550007|P3|COMPLETED|Received Both Vaccines||142
5101229|NCT01616693|12550008|P2|COMPLETED|Received Both Vaccines||145
5101230|NCT01616693|12550009|P1|COMPLETED|Received Both Vaccines||141
5101231|NCT01616693|12550006|P4|STARTED|Received Both Vaccines||155
5101232|NCT01616693|12550007|P3|STARTED|Received Both Vaccines||154
5101233|NCT01616693|12550008|P2|STARTED|Received Both Vaccines||155
5101234|NCT01616693|12550009|P1|STARTED|Received Both Vaccines||154
5101235|NCT01616693|12550006|P4|NOT COMPLETED|Evaluated for Safety||0
5101236|NCT01616693|12550007|P3|NOT COMPLETED|Evaluated for Safety||1
5101237|NCT01616693|12550008|P2|NOT COMPLETED|Evaluated for Safety||0
5101238|NCT01616693|12550009|P1|NOT COMPLETED|Evaluated for Safety||1
5101239|NCT01616693|12550006|P4|COMPLETED|Evaluated for Safety||155
5101240|NCT01616693|12550007|P3|COMPLETED|Evaluated for Safety||154
5101241|NCT01616693|12550008|P2|COMPLETED|Evaluated for Safety||155
5101242|NCT01616693|12550009|P1|COMPLETED|Evaluated for Safety||154
5101243|NCT01616693|12550006|P4|STARTED|Evaluated for Safety||155
5101244|NCT01616693|12550007|P3|STARTED|Evaluated for Safety||155
5101245|NCT01616693|12550008|P2|STARTED|Evaluated for Safety||155
5101246|NCT01616693|12550009|P1|STARTED|Evaluated for Safety||155
5101247|NCT01616576|12550061|P2|NOT COMPLETED|Overall Study||0
5101248|NCT01616576|12550062|P1|NOT COMPLETED|Overall Study||0
5101249|NCT01616576|12550061|P2|COMPLETED|Overall Study||18
5101250|NCT01616576|12550062|P1|COMPLETED|Overall Study||18
5101251|NCT01616576|12550061|P2|STARTED|Overall Study||18
5101252|NCT01616576|12550062|P1|STARTED|Overall Study||18
5101253|NCT01616459|12550075|P4|NOT COMPLETED|Overall Study||8
5101254|NCT01616459|12550076|P3|NOT COMPLETED|Overall Study||10
5101255|NCT01616459|12550077|P2|NOT COMPLETED|Overall Study||17
5101256|NCT01616459|12550078|P1|NOT COMPLETED|Overall Study||4
5101257|NCT01616459|12550075|P4|COMPLETED|Overall Study||233
5101258|NCT01616459|12550076|P3|COMPLETED|Overall Study||220
5101259|NCT01616459|12550077|P2|COMPLETED|Overall Study||223
5101260|NCT01616459|12550078|P1|COMPLETED|Overall Study||236
5101261|NCT01616459|12550075|P4|STARTED|Overall Study||241
5101262|NCT01616459|12550076|P3|STARTED|Overall Study||230
5101263|NCT01616459|12550077|P2|STARTED|Overall Study||240
5101264|NCT01616459|12550078|P1|STARTED|Overall Study||240
5101265|NCT01616173|12550179|P3|NOT COMPLETED|Overall Study||0
5101266|NCT01616173|12550180|P2|NOT COMPLETED|Overall Study||2
5101267|NCT01616173|12550181|P1|NOT COMPLETED|Overall Study||0
5101268|NCT01616173|12550179|P3|COMPLETED|Overall Study||27
5101269|NCT01616173|12550180|P2|COMPLETED|Overall Study||24
5101270|NCT01616173|12550181|P1|COMPLETED|Overall Study||27
5101271|NCT01616173|12550179|P3|STARTED|Overall Study||27
5101272|NCT01616173|12550180|P2|STARTED|Overall Study||26
5101273|NCT01616173|12550181|P1|STARTED|Overall Study||27
5101274|NCT01616160|12550195|P1|NOT COMPLETED|Overall Study||2
5101275|NCT01616160|12550195|P1|COMPLETED|Overall Study||9
5101276|NCT01616160|12550195|P1|STARTED|Overall Study||11
5101277|NCT01616056|12550200|P1|NOT COMPLETED|Overall Study||1
5101278|NCT01616056|12550200|P1|COMPLETED|Overall Study||19
5101279|NCT01616056|12550200|P1|STARTED|Overall Study||20
5101280|NCT01615939|12550214|P2|NOT COMPLETED|Overall Study||0
5101281|NCT01615939|12550215|P1|NOT COMPLETED|Overall Study||5
5101282|NCT01615939|12550214|P2|COMPLETED|Overall Study||4
5101283|NCT01615939|12550215|P1|COMPLETED|Overall Study||8
5101284|NCT01615939|12550214|P2|STARTED|Overall Study||4
5101285|NCT01615939|12550215|P1|STARTED|Overall Study||13
5101286|NCT01615822|12550228|P3|NOT COMPLETED|Period 2||2
5101287|NCT01615822|12550229|P2|NOT COMPLETED|Period 2||1
5101288|NCT01615822|12550230|P1|NOT COMPLETED|Period 2||0
5101289|NCT01615822|12550228|P3|COMPLETED|Period 2||4
5101290|NCT01615822|12550229|P2|COMPLETED|Period 2||8
5101291|NCT01615822|12550230|P1|COMPLETED|Period 2||7
5101292|NCT01615822|12550228|P3|STARTED|Period 2||6
5101293|NCT01615822|12550229|P2|STARTED|Period 2||9
5101294|NCT01615822|12550230|P1|STARTED|Period 2||7
5101295|NCT01615822|12550228|P3|NOT COMPLETED|Period 1||0
5101296|NCT01615822|12550229|P2|NOT COMPLETED|Period 1||2
5101297|NCT01615822|12550230|P1|NOT COMPLETED|Period 1||1
5101298|NCT01615822|12550228|P3|COMPLETED|Period 1||6
5101299|NCT01615822|12550229|P2|COMPLETED|Period 1||9
5101300|NCT01615822|12550230|P1|COMPLETED|Period 1||7
5101301|NCT01615822|12550228|P3|STARTED|Period 1||6
5101302|NCT01615822|12550229|P2|STARTED|Period 1||11
5101303|NCT01615822|12550230|P1|STARTED|Period 1||8
5101304|NCT01615809|12550247|P1|NOT COMPLETED|Overall Study||10
5101305|NCT01615809|12550247|P1|COMPLETED|Overall Study||22
5101306|NCT01615809|12550247|P1|STARTED|Overall Study|basal visit|32
5101307|NCT01615731|12550255|P2|NOT COMPLETED|Overall Study||2
5101308|NCT01615731|12550256|P1|NOT COMPLETED|Overall Study||3
5101309|NCT01615731|12550255|P2|COMPLETED|Overall Study||24
5101310|NCT01615731|12550256|P1|COMPLETED|Overall Study||21
5101311|NCT01615731|12550255|P2|STARTED|Overall Study||26
5101312|NCT01615731|12550256|P1|STARTED|Overall Study||24
5101313|NCT01615484|12550278|P2|NOT COMPLETED|Overall Study||0
5101314|NCT01615484|12550279|P1|NOT COMPLETED|Overall Study||0
5101315|NCT01615484|12550278|P2|COMPLETED|Overall Study||24
5101316|NCT01615484|12550279|P1|COMPLETED|Overall Study||0
5101317|NCT01615484|12550278|P2|STARTED|Overall Study||24
5101318|NCT01615484|12550279|P1|STARTED|Overall Study||0
5101319|NCT01615367|12550297|P2|NOT COMPLETED|Overall Study||6
5101320|NCT01615367|12550298|P1|NOT COMPLETED|Overall Study||5
5101321|NCT01615367|12550297|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
5101322|NCT01615367|12550298|P1|COMPLETED|Overall Study||14
5101323|NCT01615367|12550297|P2|STARTED|Overall Study||19
5101324|NCT01615367|12550298|P1|STARTED|Overall Study||19
5101325|NCT01615328|12550318|P2|NOT COMPLETED|Overall Study||5
5101326|NCT01615328|12550319|P1|NOT COMPLETED|Overall Study||3
5101327|NCT01615328|12550318|P2|COMPLETED|Overall Study||38
5101328|NCT01615328|12550319|P1|COMPLETED|Overall Study||39
5101329|NCT01615328|12550318|P2|STARTED|Overall Study||43
5101330|NCT01615328|12550319|P1|STARTED|Overall Study||42
5101331|NCT01615263|12550331|P2|NOT COMPLETED|Overall Study||2
5101332|NCT01615263|12550332|P1|NOT COMPLETED|Overall Study||0
5101333|NCT01615263|12550331|P2|COMPLETED|Overall Study||18
5101334|NCT01615263|12550332|P1|COMPLETED|Overall Study||20
5101335|NCT01615263|12550331|P2|STARTED|Overall Study||20
5101336|NCT01615263|12550332|P1|STARTED|Overall Study||20
5101337|NCT01615198|12550346|P2|NOT COMPLETED|Overall Study||19
5101338|NCT01615198|12550347|P1|NOT COMPLETED|Overall Study||24
5101339|NCT01615198|12550346|P2|COMPLETED|Overall Study||273
5101340|NCT01615198|12550347|P1|COMPLETED|Overall Study||272
5101341|NCT01615198|12550346|P2|ABPM Dipper Status Subset|Overall Study||84
5101342|NCT01615198|12550347|P1|ABPM Dipper Status Subset|Overall Study||82
5101343|NCT01615198|12550346|P2|Safety Set|Overall Study||292
5101344|NCT01615198|12550347|P1|Safety Set|Overall Study||296
5101345|NCT01615198|12550346|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
5101346|NCT01615198|12550347|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
5101347|NCT01615198|12550346|P2|Full Analysis Set|Overall Study||292
5101348|NCT01615198|12550347|P1|Full Analysis Set|Overall Study||296
5101349|NCT01615198|12550346|P2|STARTED|Overall Study||292
5101350|NCT01615198|12550347|P1|STARTED|Overall Study||296
5101351|NCT01615029|12550380|P5|NOT COMPLETED|Overall Study||32
5101352|NCT01615029|12550381|P4|NOT COMPLETED|Overall Study||3
5101353|NCT01615029|12550382|P3|NOT COMPLETED|Overall Study||4
5101354|NCT01615029|12550383|P2|NOT COMPLETED|Overall Study||3
5101355|NCT01615029|12550384|P1|NOT COMPLETED|Overall Study||3
5101356|NCT01615029|12550380|P5|COMPLETED|Overall Study||0
5101357|NCT01615029|12550381|P4|COMPLETED|Overall Study||0
5101358|NCT01615029|12550382|P3|COMPLETED|Overall Study||0
5101359|NCT01615029|12550383|P2|COMPLETED|Overall Study||0
5101360|NCT01615029|12550384|P1|COMPLETED|Overall Study||0
5101361|NCT01615029|12550380|P5|STARTED|Overall Study||32
5101362|NCT01615029|12550381|P4|STARTED|Overall Study||3
5101363|NCT01615029|12550382|P3|STARTED|Overall Study||4
5101364|NCT01615029|12550383|P2|STARTED|Overall Study||3
5101365|NCT01615029|12550384|P1|STARTED|Overall Study||3
5101366|NCT01614912|12550405|P1|NOT COMPLETED|Overall Study||125
5101367|NCT01614912|12550405|P1|COMPLETED|Overall Study||159
5101368|NCT01614912|12550405|P1|STARTED|Overall Study||284
5101369|NCT01614899|12550419|P3|NOT COMPLETED|Overall Study||42
5101370|NCT01614899|12550420|P2|NOT COMPLETED|Overall Study||39
5101371|NCT01614899|12550421|P1|NOT COMPLETED|Overall Study||44
5101372|NCT01614899|12550419|P3|COMPLETED|Overall Study||110
5101373|NCT01614899|12550420|P2|COMPLETED|Overall Study||116
5101374|NCT01614899|12550421|P1|COMPLETED|Overall Study||106
5101375|NCT01614899|12550419|P3|STARTED|Overall Study||152
5101376|NCT01614899|12550420|P2|STARTED|Overall Study||155
5101377|NCT01614899|12550421|P1|STARTED|Overall Study||150
5101378|NCT01614886|12550452|P2|NOT COMPLETED|Overall Study||26
5101379|NCT01614886|12550453|P1|NOT COMPLETED|Overall Study||20
5101380|NCT01614886|12550452|P2|COMPLETED|Overall Study||83
5101381|NCT01614886|12550453|P1|COMPLETED|Overall Study||87
5101382|NCT01614886|12550452|P2|Full Analysis Set (FAS)|Overall Study||105
5101383|NCT01614886|12550453|P1|Full Analysis Set (FAS)|Overall Study||104
5101384|NCT01614886|12550452|P2|Safety Population (SAF)|Overall Study||108
5101385|NCT01614886|12550453|P1|Safety Population (SAF)|Overall Study||107
5101386|NCT01614886|12550452|P2|STARTED|Overall Study||109
5101387|NCT01614886|12550453|P1|STARTED|Overall Study||107
5101388|NCT01614847|12550469|P2|NOT COMPLETED|Day 2 (24 Hours Later)||0
5101389|NCT01614847|12550470|P1|NOT COMPLETED|Day 2 (24 Hours Later)||0
5101390|NCT01614847|12550469|P2|COMPLETED|Day 2 (24 Hours Later)||4
5101391|NCT01614847|12550470|P1|COMPLETED|Day 2 (24 Hours Later)||4
5101392|NCT01614847|12550469|P2|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
5101393|NCT01614847|12550470|P1|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
5101394|NCT01614847|12550469|P2|NOT COMPLETED|Day 1||0
5101395|NCT01614847|12550470|P1|NOT COMPLETED|Day 1||0
5101396|NCT01614847|12550469|P2|COMPLETED|Day 1|See Arm 1 comments.|4
5101397|NCT01614847|12550470|P1|COMPLETED|Day 1||4
5101398|NCT01614847|12550469|P2|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
5101399|NCT01614847|12550470|P1|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
5101400|NCT01614821|12550481|P1|NOT COMPLETED|Overall Study||0
5101401|NCT01614821|12550481|P1|COMPLETED|Overall Study||63
5101402|NCT01614821|12550481|P1|STARTED|Overall Study||63
5101403|NCT01614795|12550494|P4|NOT COMPLETED|Overall Study||12
5101404|NCT01614795|12550495|P3|NOT COMPLETED|Overall Study||11
5101405|NCT01614795|12550496|P2|NOT COMPLETED|Overall Study||12
5101406|NCT01614795|12550497|P1|NOT COMPLETED|Overall Study||11
5101407|NCT01614795|12550494|P4|COMPLETED|Overall Study||0
5101408|NCT01614795|12550495|P3|COMPLETED|Overall Study||0
5101409|NCT01614795|12550496|P2|COMPLETED|Overall Study||0
5101410|NCT01614795|12550497|P1|COMPLETED|Overall Study||0
5101411|NCT01614795|12550494|P4|STARTED|Overall Study||12
5101412|NCT01614795|12550495|P3|STARTED|Overall Study||11
5101413|NCT01614795|12550496|P2|STARTED|Overall Study||12
5101414|NCT01614795|12550497|P1|STARTED|Overall Study||11
5101415|NCT01614769|12550517|P6|NOT COMPLETED|Period 3||0
5101416|NCT01614769|12550518|P5|NOT COMPLETED|Period 3||0
5101417|NCT01614769|12550519|P4|NOT COMPLETED|Period 3||0
5101418|NCT01614769|12550520|P3|NOT COMPLETED|Period 3||1
5101419|NCT01614769|12550521|P2|NOT COMPLETED|Period 3||0
5101420|NCT01614769|12550522|P1|NOT COMPLETED|Period 3||0
5101421|NCT01614769|12550517|P6|COMPLETED|Period 3||1
5101422|NCT01614769|12550518|P5|COMPLETED|Period 3||1
5101423|NCT01614769|12550519|P4|COMPLETED|Period 3||0
5101424|NCT01614769|12550520|P3|COMPLETED|Period 3||1
5101425|NCT01614769|12550521|P2|COMPLETED|Period 3||1
5101426|NCT01614769|12550522|P1|COMPLETED|Period 3||1
5101427|NCT01614769|12550517|P6|STARTED|Period 3||1
5101428|NCT01614769|12550518|P5|STARTED|Period 3||1
5101429|NCT01614769|12550519|P4|STARTED|Period 3||0
5101430|NCT01614769|12550520|P3|STARTED|Period 3||2
5101431|NCT01614769|12550521|P2|STARTED|Period 3||1
5101432|NCT01614769|12550522|P1|STARTED|Period 3||1
5101433|NCT01614769|12550517|P6|NOT COMPLETED|7-Day Washout||0
5101434|NCT01614769|12550518|P5|NOT COMPLETED|7-Day Washout||0
5101435|NCT01614769|12550519|P4|NOT COMPLETED|7-Day Washout||0
5101436|NCT01614769|12550520|P3|NOT COMPLETED|7-Day Washout||0
5101437|NCT01614769|12550521|P2|NOT COMPLETED|7-Day Washout||0
5101438|NCT01614769|12550522|P1|NOT COMPLETED|7-Day Washout||0
5101439|NCT01614769|12550517|P6|COMPLETED|7-Day Washout||1
5101440|NCT01614769|12550518|P5|COMPLETED|7-Day Washout||1
5101441|NCT01614769|12550519|P4|COMPLETED|7-Day Washout||0
5101442|NCT01614769|12550520|P3|COMPLETED|7-Day Washout||2
5101443|NCT01614769|12550521|P2|COMPLETED|7-Day Washout||1
5101444|NCT01614769|12550522|P1|COMPLETED|7-Day Washout||1
5101445|NCT01614769|12550517|P6|STARTED|7-Day Washout||1
5101446|NCT01614769|12550518|P5|STARTED|7-Day Washout||1
5101447|NCT01614769|12550519|P4|STARTED|7-Day Washout||0
5101448|NCT01614769|12550520|P3|STARTED|7-Day Washout||2
5101449|NCT01614769|12550521|P2|STARTED|7-Day Washout||1
5101450|NCT01614769|12550522|P1|STARTED|7-Day Washout||1
5101451|NCT01614769|12550517|P6|NOT COMPLETED|Period 2||0
5101452|NCT01614769|12550518|P5|NOT COMPLETED|Period 2||0
5101453|NCT01614769|12550519|P4|NOT COMPLETED|Period 2||0
5101454|NCT01614769|12550520|P3|NOT COMPLETED|Period 2||0
5101455|NCT01614769|12550521|P2|NOT COMPLETED|Period 2||0
5101456|NCT01614769|12550522|P1|NOT COMPLETED|Period 2||0
5101457|NCT01614769|12550517|P6|COMPLETED|Period 2||1
5101458|NCT01614769|12550518|P5|COMPLETED|Period 2||1
5101459|NCT01614769|12550519|P4|COMPLETED|Period 2||0
5101460|NCT01614769|12550520|P3|COMPLETED|Period 2||2
5101461|NCT01614769|12550521|P2|COMPLETED|Period 2||1
5101462|NCT01614769|12550522|P1|COMPLETED|Period 2||1
5101463|NCT01614769|12550517|P6|STARTED|Period 2||1
5101464|NCT01614769|12550518|P5|STARTED|Period 2||1
5101465|NCT01614769|12550519|P4|STARTED|Period 2||0
5101466|NCT01614769|12550520|P3|STARTED|Period 2||2
5101467|NCT01614769|12550521|P2|STARTED|Period 2||1
5101468|NCT01614769|12550522|P1|STARTED|Period 2||1
5101469|NCT01614769|12550517|P6|NOT COMPLETED|7-Day Washout||0
5101470|NCT01614769|12550518|P5|NOT COMPLETED|7-Day Washout||0
5101471|NCT01614769|12550519|P4|NOT COMPLETED|7-Day Washout||0
5101472|NCT01614769|12550520|P3|NOT COMPLETED|7-Day Washout||0
5101473|NCT01614769|12550521|P2|NOT COMPLETED|7-Day Washout||0
5101474|NCT01614769|12550522|P1|NOT COMPLETED|7-Day Washout||0
5101475|NCT01614769|12550517|P6|COMPLETED|7-Day Washout||1
5101476|NCT01614769|12550518|P5|COMPLETED|7-Day Washout||1
5101477|NCT01614769|12550519|P4|COMPLETED|7-Day Washout||0
5101478|NCT01614769|12550520|P3|COMPLETED|7-Day Washout||2
5101479|NCT01614769|12550521|P2|COMPLETED|7-Day Washout||1
5101480|NCT01614769|12550522|P1|COMPLETED|7-Day Washout||1
5101481|NCT01614769|12550517|P6|STARTED|7-Day Washout||1
5101482|NCT01614769|12550518|P5|STARTED|7-Day Washout||1
5101483|NCT01614769|12550519|P4|STARTED|7-Day Washout||0
5101484|NCT01614769|12550520|P3|STARTED|7-Day Washout||2
5101485|NCT01614769|12550521|P2|STARTED|7-Day Washout||1
5101486|NCT01614769|12550522|P1|STARTED|7-Day Washout||1
5101487|NCT01614769|12550517|P6|NOT COMPLETED|Period 1||1
5101488|NCT01614769|12550518|P5|NOT COMPLETED|Period 1||0
5101489|NCT01614769|12550519|P4|NOT COMPLETED|Period 1||2
5101490|NCT01614769|12550520|P3|NOT COMPLETED|Period 1||0
5101491|NCT01614769|12550521|P2|NOT COMPLETED|Period 1||0
5101492|NCT01614769|12550522|P1|NOT COMPLETED|Period 1||1
5101493|NCT01614769|12550517|P6|COMPLETED|Period 1||1
5101494|NCT01614769|12550518|P5|COMPLETED|Period 1||1
5101495|NCT01614769|12550519|P4|COMPLETED|Period 1||0
5101496|NCT01614769|12550520|P3|COMPLETED|Period 1||2
5101497|NCT01614769|12550521|P2|COMPLETED|Period 1||1
5101498|NCT01614769|12550522|P1|COMPLETED|Period 1||1
5101499|NCT01614769|12550517|P6|STARTED|Period 1||2
5101500|NCT01614769|12550518|P5|STARTED|Period 1||1
5101501|NCT01614769|12550519|P4|STARTED|Period 1||2
5101502|NCT01614769|12550520|P3|STARTED|Period 1||2
5101503|NCT01614769|12550521|P2|STARTED|Period 1||1
5101504|NCT01614769|12550522|P1|STARTED|Period 1||2
5101505|NCT01614613|12550536|P1|NOT COMPLETED|Overall Study||0
5101506|NCT01614613|12550536|P1|COMPLETED|Overall Study||146
5101507|NCT01614613|12550536|P1|STARTED|Overall Study||146
5101508|NCT01614600|12550544|P1|NOT COMPLETED|Overall Study||4
5101509|NCT01614600|12550544|P1|COMPLETED|Overall Study||84
5101510|NCT01614600|12550544|P1|STARTED|Overall Study||88
5101511|NCT01614574|12550548|P1|NOT COMPLETED|Overall Study||0
5101512|NCT01614574|12550548|P1|COMPLETED|Overall Study||6
5101513|NCT01614574|12550548|P1|STARTED|Overall Study||6
5101514|NCT01614509|12550564|P2|NOT COMPLETED|Overall Study||3
5101515|NCT01614509|12550565|P1|NOT COMPLETED|Overall Study||1
5101516|NCT01614509|12550564|P2|COMPLETED|Overall Study||18
5101517|NCT01614509|12550565|P1|COMPLETED|Overall Study||23
5101518|NCT01614509|12550564|P2|STARTED|Overall Study||21
5101519|NCT01614509|12550565|P1|STARTED|Overall Study||24
5101520|NCT01614470|12550575|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
5101521|NCT01614470|12550576|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
5101522|NCT01614470|12550577|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
5101523|NCT01614470|12550575|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
5101524|NCT01614470|12550576|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
5101525|NCT01614470|12550577|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
5101526|NCT01614470|12550575|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
5101527|NCT01614470|12550576|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
5101528|NCT01614470|12550577|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
5101529|NCT01614470|12550575|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
5101530|NCT01614470|12550576|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
5101531|NCT01614470|12550577|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
5101532|NCT01614470|12550575|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
5101533|NCT01614470|12550576|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
5101534|NCT01614470|12550577|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
5101535|NCT01614470|12550575|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
5101536|NCT01614470|12550576|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
5101537|NCT01614470|12550577|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
5101538|NCT01614470|12550575|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
5101539|NCT01614470|12550576|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
5101540|NCT01614470|12550577|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
5101541|NCT01614470|12550575|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
5101542|NCT01614470|12550576|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
5101543|NCT01614470|12550577|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
5101544|NCT01614470|12550575|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
5101545|NCT01614470|12550576|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
5101546|NCT01614470|12550577|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
5101547|NCT01614470|12550575|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
5101548|NCT01614470|12550576|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
5101549|NCT01614470|12550577|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
5101550|NCT01614470|12550575|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
5101551|NCT01614470|12550576|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
5101552|NCT01614470|12550577|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
5101553|NCT01614470|12550575|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
5101554|NCT01614470|12550576|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
5101555|NCT01614470|12550577|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
5101556|NCT01614457|12550599|P2|NOT COMPLETED|Overall Study||0
5101557|NCT01614457|12550600|P1|NOT COMPLETED|Overall Study||2
5101558|NCT01614457|12550599|P2|COMPLETED|Overall Study||35
5101559|NCT01614457|12550600|P1|COMPLETED|Overall Study||32
5101560|NCT01614457|12550599|P2|STARTED|Overall Study||35
5101561|NCT01614457|12550600|P1|STARTED|Overall Study||34
5101562|NCT01614392|12550618|P2|NOT COMPLETED|Overall Study||3
5101563|NCT01614392|12550619|P1|NOT COMPLETED|Overall Study||1
5101564|NCT01614392|12550618|P2|COMPLETED|Overall Study||24
5101565|NCT01614392|12550619|P1|COMPLETED|Overall Study||24
5101566|NCT01614392|12550618|P2|STARTED|Overall Study||27
5101567|NCT01614392|12550619|P1|STARTED|Overall Study||25
5101568|NCT01614249|12550627|P2|NOT COMPLETED|Overall Study||23
5101569|NCT01614249|12550628|P1|NOT COMPLETED|Overall Study||11
5101570|NCT01614249|12550627|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
5101571|NCT01614249|12550628|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
5101572|NCT01614249|12550627|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
5101573|NCT01614249|12550628|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
5101574|NCT01614249|12550627|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
5101575|NCT01614249|12550628|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
5101576|NCT01614249|12550627|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
5101577|NCT01614249|12550628|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
5101578|NCT01614210|12550634|P1|NOT COMPLETED|Overall Study||0
5101579|NCT01614210|12550634|P1|COMPLETED|Overall Study||52
5101580|NCT01614210|12550634|P1|STARTED|Overall Study||52
5101581|NCT01614093|12550642|P1|NOT COMPLETED|Overall Study||1
5101582|NCT01614093|12550642|P1|COMPLETED|Overall Study||16
5101583|NCT01614093|12550642|P1|STARTED|Overall Study||17
5101584|NCT01613768|12550647|P1|NOT COMPLETED|Overall Study||0
5101585|NCT01613768|12550647|P1|COMPLETED|Overall Study||29
5101586|NCT01613768|12550647|P1|STARTED|Overall Study||29
5101587|NCT01613716|12550655|P1|NOT COMPLETED|Overall Study||7
5101588|NCT01613716|12550655|P1|COMPLETED|Overall Study||23
5101589|NCT01613716|12550655|P1|STARTED|Overall Study||30
5101590|NCT01613599|12550660|P1|NOT COMPLETED|Overall Study||25
5101591|NCT01613599|12550660|P1|COMPLETED|Overall Study||72
5101592|NCT01613599|12550660|P1|STARTED|Overall Study||97
5101593|NCT01613417|12550675|P2|NOT COMPLETED|Second Injection||0
5101594|NCT01613417|12550676|P1|NOT COMPLETED|Second Injection||0
5101595|NCT01613417|12550675|P2|COMPLETED|Second Injection||109
5101596|NCT01613417|12550676|P1|COMPLETED|Second Injection||100
5101597|NCT01613417|12550675|P2|STARTED|Second Injection||109
5101598|NCT01613417|12550676|P1|STARTED|Second Injection||100
5101599|NCT01613417|12550675|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
5101600|NCT01613417|12550676|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
5101601|NCT01613417|12550675|P2|COMPLETED|Washout (no Second Injection/MRI)||109
5101602|NCT01613417|12550676|P1|COMPLETED|Washout (no Second Injection/MRI)||100
5101603|NCT01613417|12550675|P2|STARTED|Washout (no Second Injection/MRI)||116
5101604|NCT01613417|12550676|P1|STARTED|Washout (no Second Injection/MRI)||113
5101605|NCT01613417|12550675|P2|NOT COMPLETED|First Injection||0
5101606|NCT01613417|12550676|P1|NOT COMPLETED|First Injection||0
5101607|NCT01613417|12550675|P2|COMPLETED|First Injection||116
5101608|NCT01613417|12550676|P1|COMPLETED|First Injection||113
5101609|NCT01613417|12550675|P2|STARTED|First Injection||116
5101610|NCT01613417|12550676|P1|STARTED|First Injection||113
5101611|NCT01613378|12550713|P1|NOT COMPLETED|Overall Study||39
5101612|NCT01613378|12550713|P1|COMPLETED|Overall Study||161
5101613|NCT01613378|12550713|P1|STARTED|Overall Study||200
5101614|NCT01613339|12550731|P2|NOT COMPLETED|Overall Study||1
5101615|NCT01613339|12550732|P1|NOT COMPLETED|Overall Study||3
5101616|NCT01613339|12550731|P2|COMPLETED|Overall Study||21
5101617|NCT01613339|12550732|P1|COMPLETED|Overall Study||21
5101618|NCT01613339|12550731|P2|STARTED|Overall Study||22
5101619|NCT01613339|12550732|P1|STARTED|Overall Study||24
5101620|NCT01613326|12550743|P2|NOT COMPLETED|Overall Study||14
5101621|NCT01613326|12550744|P1|NOT COMPLETED|Overall Study||13
5101622|NCT01613326|12550743|P2|COMPLETED|Overall Study||316
5101623|NCT01613326|12550744|P1|COMPLETED|Overall Study||314
5101624|NCT01613326|12550743|P2|STARTED|Overall Study||330
5101625|NCT01613326|12550744|P1|STARTED|Overall Study||327
5101626|NCT01613313|12550778|P4|NOT COMPLETED|Overall Study||0
5101627|NCT01613313|12550779|P3|NOT COMPLETED|Overall Study||0
5101628|NCT01613313|12550780|P2|NOT COMPLETED|Overall Study||0
5101629|NCT01613313|12550781|P1|NOT COMPLETED|Overall Study||0
5101630|NCT01613313|12550778|P4|COMPLETED|Overall Study||4
5101631|NCT01613313|12550779|P3|COMPLETED|Overall Study||4
5101632|NCT01613313|12550780|P2|COMPLETED|Overall Study||4
5101633|NCT01613313|12550781|P1|COMPLETED|Overall Study||2
5101634|NCT01613313|12550778|P4|STARTED|Overall Study||4
5101635|NCT01613313|12550779|P3|STARTED|Overall Study||4
5101636|NCT01613313|12550780|P2|STARTED|Overall Study||4
5101637|NCT01613313|12550781|P1|STARTED|Overall Study||2
5101638|NCT01613248|12550801|P6|NOT COMPLETED|Overall Study||38
5101639|NCT01613248|12550802|P5|NOT COMPLETED|Overall Study||35
5101640|NCT01613248|12550803|P4|NOT COMPLETED|Overall Study||38
5101641|NCT01613248|12550804|P3|NOT COMPLETED|Overall Study||33
5101642|NCT01613248|12550805|P2|NOT COMPLETED|Overall Study||34
5101643|NCT01613248|12550806|P1|NOT COMPLETED|Overall Study||29
5101644|NCT01613248|12550801|P6|COMPLETED|Overall Study||102
5101645|NCT01613248|12550802|P5|COMPLETED|Overall Study||104
5101646|NCT01613248|12550803|P4|COMPLETED|Overall Study||101
5101647|NCT01613248|12550804|P3|COMPLETED|Overall Study||106
5101648|NCT01613248|12550805|P2|COMPLETED|Overall Study||104
5101649|NCT01613248|12550806|P1|COMPLETED|Overall Study||110
5101650|NCT01613248|12550801|P6|STARTED|Overall Study||140
5101651|NCT01613248|12550802|P5|STARTED|Overall Study||139
5101652|NCT01613248|12550803|P4|STARTED|Overall Study||139
5101653|NCT01613248|12550804|P3|STARTED|Overall Study||139
5101654|NCT01613248|12550805|P2|STARTED|Overall Study||138
5101655|NCT01613248|12550806|P1|STARTED|Overall Study||139
5101656|NCT01613222|12550904|P1|NOT COMPLETED|Overall Study||12
5101657|NCT01613222|12550904|P1|COMPLETED|Overall Study||51
5101658|NCT01613222|12550904|P1|STARTED|Overall Study||63
5101659|NCT01613131|12550919|P2|NOT COMPLETED|Overall Study||5
5101660|NCT01613131|12550920|P1|NOT COMPLETED|Overall Study||3
5101661|NCT01613131|12550919|P2|COMPLETED|Overall Study||13
5101662|NCT01613131|12550920|P1|COMPLETED|Overall Study||17
5101663|NCT01613131|12550919|P2|STARTED|Overall Study||18
5101664|NCT01613131|12550920|P1|STARTED|Overall Study||20
5101665|NCT01613027|12550948|P1|NOT COMPLETED|Overall Study||8
5101666|NCT01613027|12550948|P1|COMPLETED|Overall Study||127
5101667|NCT01613027|12550948|P1|STARTED|Overall Study||135
5101668|NCT01613014|12550969|P2|NOT COMPLETED|Overall Study||12
5101669|NCT01613014|12550970|P1|NOT COMPLETED|Overall Study||18
5101670|NCT01613014|12550969|P2|COMPLETED|Overall Study||63
5101671|NCT01613014|12550970|P1|COMPLETED|Overall Study||57
5101672|NCT01613014|12550969|P2|STARTED|Overall Study||75
5101673|NCT01613014|12550970|P1|STARTED|Overall Study||75
5101674|NCT01612884|12550978|P2|NOT COMPLETED|Overall Study||0
5101675|NCT01612884|12550979|P1|NOT COMPLETED|Overall Study||0
5101676|NCT01612884|12550978|P2|COMPLETED|Overall Study||18
5101677|NCT01612884|12550979|P1|COMPLETED|Overall Study||19
5101678|NCT01612884|12550978|P2|STARTED|Overall Study||18
5101679|NCT01612884|12550979|P1|STARTED|Overall Study||19
5101680|NCT01612858|12550991|P2|NOT COMPLETED|Overall Study||1
5101681|NCT01612858|12550992|P1|NOT COMPLETED|Overall Study||5
5101682|NCT01612858|12550991|P2|COMPLETED|Overall Study||3
5101683|NCT01612858|12550992|P1|COMPLETED|Overall Study||11
5101684|NCT01612858|12550991|P2|STARTED|Overall Study||4
5101685|NCT01612858|12550992|P1|STARTED|Overall Study||16
5101686|NCT01612793|12551002|P2|NOT COMPLETED|Overall Study||0
5101687|NCT01612793|12551003|P1|NOT COMPLETED|Overall Study||0
5101688|NCT01612793|12551002|P2|COMPLETED|Overall Study||2
5101689|NCT01612793|12551003|P1|COMPLETED|Overall Study||2
5101690|NCT01612793|12551002|P2|STARTED|Overall Study||2
5101691|NCT01612793|12551003|P1|STARTED|Overall Study||2
5101692|NCT01612767|12551009|P1|NOT COMPLETED|Overall Study||42
5101693|NCT01612767|12551009|P1|COMPLETED|Overall Study||287
5101694|NCT01612767|12551009|P1|STARTED|Overall Study||329
5101695|NCT01612702|12551065|P2|NOT COMPLETED|Overall Study||11
5101696|NCT01612702|12551066|P1|NOT COMPLETED|Overall Study||11
5101697|NCT01612702|12551065|P2|COMPLETED|Overall Study||134
5101698|NCT01612702|12551066|P1|COMPLETED|Overall Study||135
5101699|NCT01612702|12551065|P2|STARTED|Overall Study||145
5101700|NCT01612702|12551066|P1|STARTED|Overall Study||146
5101701|NCT01612676|12551080|P4|NOT COMPLETED|Overall Study||3
5101702|NCT01612676|12551081|P3|NOT COMPLETED|Overall Study||1
5101703|NCT01612676|12551082|P2|NOT COMPLETED|Overall Study||4
5101704|NCT01612676|12551083|P1|NOT COMPLETED|Overall Study||2
5101705|NCT01612676|12551080|P4|COMPLETED|Overall Study||10
5101706|NCT01612676|12551081|P3|COMPLETED|Overall Study||4
5101707|NCT01612676|12551082|P2|COMPLETED|Overall Study||3
5101708|NCT01612676|12551083|P1|COMPLETED|Overall Study||4
5101709|NCT01612676|12551080|P4|Dosed|Overall Study||13
5101710|NCT01612676|12551081|P3|Dosed|Overall Study||5
5101711|NCT01612676|12551082|P2|Dosed|Overall Study||7
5101712|NCT01612676|12551083|P1|Dosed|Overall Study||5
5101713|NCT01612676|12551080|P4|STARTED|Overall Study||13
5101714|NCT01612676|12551081|P3|STARTED|Overall Study||5
5101715|NCT01612676|12551082|P2|STARTED|Overall Study||7
5101716|NCT01612676|12551083|P1|STARTED|Overall Study||6
5101717|NCT01612546|12551139|P1|NOT COMPLETED|Overall Study||0
5101718|NCT01612546|12551139|P1|COMPLETED|Overall Study||10
5101719|NCT01612546|12551139|P1|STARTED|Overall Study||10
5101720|NCT01612494|12551149|P2|NOT COMPLETED|Overall Study||0
5101721|NCT01612494|12551150|P1|NOT COMPLETED|Overall Study||0
5101722|NCT01612494|12551149|P2|COMPLETED|Overall Study||23
5101723|NCT01612494|12551150|P1|COMPLETED|Overall Study||21
5101724|NCT01612494|12551149|P2|STARTED|Overall Study||23
5101725|NCT01612494|12551150|P1|STARTED|Overall Study||21
5101726|NCT01612351|12551156|P1|NOT COMPLETED|Post-Operative Treatment||0
5101727|NCT01612351|12551156|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
5101728|NCT01612351|12551156|P1|STARTED|Post-Operative Treatment||39
5101729|NCT01612351|12551156|P1|NOT COMPLETED|Transoral Surgery||0
5101730|NCT01612351|12551156|P1|COMPLETED|Transoral Surgery||39
5101731|NCT01612351|12551156|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
5101732|NCT01612351|12551156|P1|NOT COMPLETED|Chemotherapy||0
5101733|NCT01612351|12551156|P1|COMPLETED|Chemotherapy||40
5101734|NCT01612351|12551156|P1|STARTED|Chemotherapy||40
5101735|NCT01612221|12551170|P2|NOT COMPLETED|Overall Study||0
5101736|NCT01612221|12551171|P1|NOT COMPLETED|Overall Study||0
5101737|NCT01612221|12551170|P2|COMPLETED|Overall Study||50
5101738|NCT01612221|12551171|P1|COMPLETED|Overall Study||50
5101739|NCT01612221|12551170|P2|STARTED|Overall Study||50
5101740|NCT01612221|12551171|P1|STARTED|Overall Study||50
5101741|NCT01612156|12551181|P2|NOT COMPLETED|Overall Study||0
5101742|NCT01612156|12551182|P1|NOT COMPLETED|Overall Study||2
5101743|NCT01612156|12551181|P2|COMPLETED|Overall Study||48
5101744|NCT01612156|12551182|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
5101745|NCT01612156|12551181|P2|STARTED|Overall Study||48
5101746|NCT01612156|12551182|P1|STARTED|Overall Study||42
5101747|NCT01612000|12551194|P4|NOT COMPLETED|Overall Study||10
5101748|NCT01612000|12551195|P3|NOT COMPLETED|Overall Study||7
5101749|NCT01612000|12551196|P2|NOT COMPLETED|Overall Study||5
5101750|NCT01612000|12551197|P1|NOT COMPLETED|Overall Study||9
5101751|NCT01612000|12551194|P4|COMPLETED|Overall Study||76
5101752|NCT01612000|12551195|P3|COMPLETED|Overall Study||78
5101753|NCT01612000|12551196|P2|COMPLETED|Overall Study||81
5101754|NCT01612000|12551197|P1|COMPLETED|Overall Study||75
5101755|NCT01612000|12551194|P4|STARTED|Overall Study||86
5101756|NCT01612000|12551195|P3|STARTED|Overall Study||85
5101757|NCT01612000|12551196|P2|STARTED|Overall Study||86
5101758|NCT01612000|12551197|P1|STARTED|Overall Study||84
5101759|NCT01611974|12551222|P3|NOT COMPLETED|Overall Study||16
5101760|NCT01611974|12551223|P2|NOT COMPLETED|Overall Study||15
5101761|NCT01611974|12551224|P1|NOT COMPLETED|Overall Study||15
5101762|NCT01611974|12551222|P3|COMPLETED|Overall Study||24
5101763|NCT01611974|12551223|P2|COMPLETED|Overall Study||25
5101764|NCT01611974|12551224|P1|COMPLETED|Overall Study||25
5101765|NCT01611974|12551222|P3|STARTED|Overall Study||40
5101766|NCT01611974|12551223|P2|STARTED|Overall Study||40
5101767|NCT01611974|12551224|P1|STARTED|Overall Study||40
5101768|NCT01611948|12551261|P2|NOT COMPLETED|Overall Study||12
5101769|NCT01611948|12551262|P1|NOT COMPLETED|Overall Study||14
5101770|NCT01611948|12551261|P2|COMPLETED|Overall Study||26
5101771|NCT01611948|12551262|P1|COMPLETED|Overall Study||18
5101772|NCT01611948|12551261|P2|STARTED|Overall Study||38
5101773|NCT01611948|12551262|P1|STARTED|Overall Study||32
5101774|NCT01611935|12551270|P2|NOT COMPLETED|Overall Study||0
5101775|NCT01611935|12551271|P1|NOT COMPLETED|Overall Study||1
5101776|NCT01611935|12551270|P2|COMPLETED|Overall Study||51
5101777|NCT01611935|12551271|P1|COMPLETED|Overall Study||49
5101778|NCT01611935|12551270|P2|STARTED|Overall Study||51
5101779|NCT01611935|12551271|P1|STARTED|Overall Study||50
5101780|NCT01611883|12551283|P2|NOT COMPLETED|Overall Study||1
5101781|NCT01611883|12551284|P1|NOT COMPLETED|Overall Study||1
5101782|NCT01611883|12551283|P2|COMPLETED|Overall Study||76
5101783|NCT01611883|12551284|P1|COMPLETED|Overall Study||74
5101784|NCT01611883|12551283|P2|STARTED|Overall Study||77
5101785|NCT01611883|12551284|P1|STARTED|Overall Study||75
5101786|NCT01611857|12551310|P2|NOT COMPLETED|Overall Study||2
5101787|NCT01611857|12551311|P1|NOT COMPLETED|Overall Study||0
5101788|NCT01611857|12551310|P2|COMPLETED|Overall Study||32
5101789|NCT01611857|12551311|P1|COMPLETED|Overall Study||15
5101790|NCT01611857|12551310|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
5101791|NCT01611857|12551311|P1|Tivantinib 360 mg|Overall Study||7
5101792|NCT01611857|12551310|P2|Tivantinib 240 mg|Overall Study||0
5101793|NCT01611857|12551311|P1|Tivantinib 240 mg|Overall Study||3
5101794|NCT01611857|12551310|P2|Tivantinib 120 mg|Overall Study||0
5101795|NCT01611857|12551311|P1|Tivantinib 120 mg|Overall Study||5
5101796|NCT01611857|12551310|P2|STARTED|Overall Study||34
5101797|NCT01611857|12551311|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
5101798|NCT01611792|12551323|P2|NOT COMPLETED|Followup: at 6 Months||13
5101799|NCT01611792|12551324|P1|NOT COMPLETED|Followup: at 6 Months||6
5101800|NCT01611792|12551323|P2|COMPLETED|Followup: at 6 Months||7
5101801|NCT01611792|12551324|P1|COMPLETED|Followup: at 6 Months||11
5101802|NCT01611792|12551323|P2|STARTED|Followup: at 6 Months||20
5101803|NCT01611792|12551324|P1|STARTED|Followup: at 6 Months||17
5101804|NCT01611792|12551323|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
5101805|NCT01611792|12551324|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
5101806|NCT01611792|12551323|P2|COMPLETED|Follow-up: at 11 Weeks||20
5101807|NCT01611792|12551324|P1|COMPLETED|Follow-up: at 11 Weeks||17
5101808|NCT01611792|12551323|P2|STARTED|Follow-up: at 11 Weeks||20
5101809|NCT01611792|12551324|P1|STARTED|Follow-up: at 11 Weeks||17
5101810|NCT01611792|12551323|P2|NOT COMPLETED|Initial Period: Time 0||9
5101811|NCT01611792|12551324|P1|NOT COMPLETED|Initial Period: Time 0||12
5101812|NCT01611792|12551323|P2|COMPLETED|Initial Period: Time 0||20
5101813|NCT01611792|12551324|P1|COMPLETED|Initial Period: Time 0||17
5101814|NCT01611792|12551323|P2|STARTED|Initial Period: Time 0||29
5101815|NCT01611792|12551324|P1|STARTED|Initial Period: Time 0||29
5101816|NCT01611779|12551340|P1|NOT COMPLETED|Overall Study||0
5101817|NCT01611779|12551340|P1|COMPLETED|Overall Study||5
5101818|NCT01611779|12551340|P1|STARTED|Overall Study||5
5101819|NCT01611662|12551349|P1|NOT COMPLETED|Overall Study||1
5101820|NCT01611662|12551349|P1|COMPLETED|Overall Study||31
5101821|NCT01611662|12551349|P1|STARTED|Overall Study||32
5101822|NCT01611571|12551356|P3|NOT COMPLETED|Overall Study||1
5101823|NCT01611571|12551357|P2|NOT COMPLETED|Overall Study||0
5101824|NCT01611571|12551358|P1|NOT COMPLETED|Overall Study||1
5101825|NCT01611571|12551356|P3|COMPLETED|Overall Study||9
5101826|NCT01611571|12551357|P2|COMPLETED|Overall Study||10
5101827|NCT01611571|12551358|P1|COMPLETED|Overall Study||10
5101828|NCT01611571|12551356|P3|STARTED|Overall Study||10
5101829|NCT01611571|12551357|P2|STARTED|Overall Study||10
5101830|NCT01611571|12551358|P1|STARTED|Overall Study||11
5101831|NCT01611558|12551378|P1|NOT COMPLETED|Maintenance Phase||2
5101832|NCT01611558|12551378|P1|COMPLETED|Maintenance Phase||0
5101833|NCT01611558|12551378|P1|STARTED|Maintenance Phase||2
5101834|NCT01611558|12551378|P1|NOT COMPLETED|Induction Phase||38
5101835|NCT01611558|12551378|P1|COMPLETED|Induction Phase||2
5101836|NCT01611558|12551378|P1|STARTED|Induction Phase||40
5101837|NCT01611298|12551384|P1|NOT COMPLETED|Overall Study||2
5101838|NCT01611298|12551384|P1|COMPLETED|Overall Study||5
5101839|NCT01611298|12551384|P1|STARTED|Overall Study||7
5101840|NCT01611259|12551389|P1|NOT COMPLETED|Overall Study||14
5101841|NCT01611259|12551389|P1|COMPLETED|Overall Study||34
5101842|NCT01611259|12551389|P1|STARTED|Overall Study||48
5101843|NCT01611194|12551395|P2|NOT COMPLETED|Overall Study||3
5101844|NCT01611194|12551396|P1|NOT COMPLETED|Overall Study||0
5101845|NCT01611194|12551395|P2|COMPLETED|Overall Study||32
5101846|NCT01611194|12551396|P1|COMPLETED|Overall Study||36
5101847|NCT01611194|12551395|P2|STARTED|Overall Study||35
5101848|NCT01611194|12551396|P1|STARTED|Overall Study||36
5101849|NCT01611155|12551434|P2|NOT COMPLETED|Overall Study||7
5101850|NCT01611155|12551435|P1|NOT COMPLETED|Overall Study||9
5101851|NCT01611155|12551434|P2|COMPLETED|Overall Study||18
5101852|NCT01611155|12551435|P1|COMPLETED|Overall Study||16
5101853|NCT01611155|12551434|P2|Received Treatment|Overall Study||25
5101854|NCT01611155|12551435|P1|Received Treatment|Overall Study||25
5101855|NCT01611155|12551434|P2|STARTED|Overall Study||25
5101856|NCT01611155|12551435|P1|STARTED|Overall Study||25
5101857|NCT01611090|12551445|P3|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
5101858|NCT01611090|12551446|P2|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
5101859|NCT01611090|12551447|P1|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
5101860|NCT01611090|12551445|P3|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
5101861|NCT01611090|12551446|P2|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
5101862|NCT01611090|12551447|P1|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
5101863|NCT01611090|12551445|P3|Treated|Cross Over (Placebo to Ibrutinib)||183
5101864|NCT01611090|12551446|P2|Treated|Cross Over (Placebo to Ibrutinib)||0
5101865|NCT01611090|12551447|P1|Treated|Cross Over (Placebo to Ibrutinib)||0
5101866|NCT01611090|12551445|P3|STARTED|Cross Over (Placebo to Ibrutinib)||183
5101867|NCT01611090|12551446|P2|STARTED|Cross Over (Placebo to Ibrutinib)||0
5101868|NCT01611090|12551447|P1|STARTED|Cross Over (Placebo to Ibrutinib)||0
5101869|NCT01611090|12551445|P3|NOT COMPLETED|Randomized Period||0
5101870|NCT01611090|12551446|P2|NOT COMPLETED|Randomized Period||29
5101871|NCT01611090|12551447|P1|NOT COMPLETED|Randomized Period||30
5101872|NCT01611090|12551445|P3|COMPLETED|Randomized Period||0
5101873|NCT01611090|12551446|P2|COMPLETED|Randomized Period||260
5101874|NCT01611090|12551447|P1|COMPLETED|Randomized Period||259
5101875|NCT01611090|12551445|P3|Treated|Randomized Period||0
5101876|NCT01611090|12551446|P2|Treated|Randomized Period||287
5101877|NCT01611090|12551447|P1|Treated|Randomized Period||287
5101878|NCT01611090|12551445|P3|STARTED|Randomized Period||0
5101879|NCT01611090|12551446|P2|STARTED|Randomized Period||289
5101880|NCT01611090|12551447|P1|STARTED|Randomized Period||289
5101881|NCT01610791|12551480|P1|NOT COMPLETED|Overall Study||21
5101882|NCT01610791|12551480|P1|COMPLETED|Overall Study||100
5101883|NCT01610791|12551480|P1|STARTED|Overall Study||121
5101884|NCT01610752|12551504|P3|NOT COMPLETED|Overall Study||4
5101885|NCT01610752|12551505|P2|NOT COMPLETED|Overall Study||0
5101886|NCT01610752|12551506|P1|NOT COMPLETED|Overall Study||0
5101887|NCT01610752|12551504|P3|COMPLETED|Overall Study||13
5101888|NCT01610752|12551505|P2|COMPLETED|Overall Study||19
5101889|NCT01610752|12551506|P1|COMPLETED|Overall Study||18
5101890|NCT01610752|12551504|P3|STARTED|Overall Study||17
5101891|NCT01610752|12551505|P2|STARTED|Overall Study||19
5101892|NCT01610752|12551506|P1|STARTED|Overall Study||18
5101893|NCT01610713|12551528|P2|NOT COMPLETED|Overall Study||1
5101894|NCT01610713|12551529|P1|NOT COMPLETED|Overall Study||6
5101895|NCT01610713|12551528|P2|COMPLETED|Overall Study||76
5101896|NCT01610713|12551529|P1|COMPLETED|Overall Study||71
5101897|NCT01610713|12551528|P2|STARTED|Overall Study||77
5101898|NCT01610713|12551529|P1|STARTED|Overall Study||77
5101899|NCT01610700|12551587|P2|NOT COMPLETED|Overall Study||3
5101900|NCT01610700|12551588|P1|NOT COMPLETED|Overall Study||3
5101901|NCT01610700|12551587|P2|COMPLETED|Overall Study||77
5101902|NCT01610700|12551588|P1|COMPLETED|Overall Study||77
5101903|NCT01610700|12551587|P2|STARTED|Overall Study||80
5101904|NCT01610700|12551588|P1|STARTED|Overall Study||80
5101905|NCT01610687|12551642|P1|NOT COMPLETED|Overall Study||67
5101906|NCT01610687|12551642|P1|COMPLETED|Overall Study||70
5101907|NCT01610687|12551642|P1|STARTED|Overall Study||137
5101908|NCT01610596|12551655|P2|NOT COMPLETED|Overall Study||1
5101909|NCT01610596|12551656|P1|NOT COMPLETED|Overall Study||0
5101910|NCT01610596|12551655|P2|COMPLETED|Overall Study||35
5101911|NCT01610596|12551656|P1|COMPLETED|Overall Study||36
5101912|NCT01610596|12551655|P2|STARTED|Overall Study||36
5101913|NCT01610596|12551656|P1|STARTED|Overall Study||36
5101914|NCT01610570|12551672|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101915|NCT01610570|12551673|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101916|NCT01610570|12551674|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101917|NCT01610570|12551675|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101918|NCT01610570|12551672|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101919|NCT01610570|12551673|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101920|NCT01610570|12551674|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101921|NCT01610570|12551675|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
5101922|NCT01610570|12551672|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
5101923|NCT01610570|12551673|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
5101924|NCT01610570|12551674|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
5101925|NCT01610570|12551675|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
5101926|NCT01610570|12551672|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101927|NCT01610570|12551673|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101928|NCT01610570|12551674|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101929|NCT01610570|12551675|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101930|NCT01610570|12551672|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
5101931|NCT01610570|12551673|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101932|NCT01610570|12551674|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101933|NCT01610570|12551675|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
5101934|NCT01610570|12551672|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
5101935|NCT01610570|12551673|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
5101936|NCT01610570|12551674|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
5101937|NCT01610570|12551675|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
5101938|NCT01610570|12551672|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101939|NCT01610570|12551673|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101940|NCT01610570|12551674|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101941|NCT01610570|12551675|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101942|NCT01610570|12551672|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101943|NCT01610570|12551673|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101944|NCT01610570|12551674|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
5101945|NCT01610570|12551675|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
5101946|NCT01610570|12551672|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
5101947|NCT01610570|12551673|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
5101948|NCT01610570|12551674|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
5101949|NCT01610570|12551675|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
5101950|NCT01610557|12551714|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
5101951|NCT01610557|12551715|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
5101952|NCT01610557|12551716|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
5101953|NCT01610557|12551717|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
5101954|NCT01610557|12551718|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
5101955|NCT01610557|12551714|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
5101956|NCT01610557|12551715|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101957|NCT01610557|12551716|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101958|NCT01610557|12551717|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101959|NCT01610557|12551718|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101960|NCT01610557|12551714|P5|STARTED|Post-36-Week Extension Phase||55
5101961|NCT01610557|12551715|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101962|NCT01610557|12551716|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101963|NCT01610557|12551717|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101964|NCT01610557|12551718|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
5101965|NCT01610557|12551714|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
5101966|NCT01610557|12551715|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
5101967|NCT01610557|12551716|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
5101968|NCT01610557|12551717|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
5101969|NCT01610557|12551718|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
5101970|NCT01610557|12551714|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
5101971|NCT01610557|12551715|P4|COMPLETED|36-Week Randomized Crossover Phase||13
5101972|NCT01610557|12551716|P3|COMPLETED|36-Week Randomized Crossover Phase||14
5101973|NCT01610557|12551717|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
5101974|NCT01610557|12551718|P1|COMPLETED|36-Week Randomized Crossover Phase||16
5101975|NCT01610557|12551714|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
5101976|NCT01610557|12551715|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
5101977|NCT01610557|12551716|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
5101978|NCT01610557|12551717|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
5101979|NCT01610557|12551718|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
5101980|NCT01610492|12551731|P1|NOT COMPLETED|Overall Study||6
5101981|NCT01610492|12551731|P1|COMPLETED|Overall Study||8
5101982|NCT01610492|12551731|P1|STARTED|Overall Study||14
5101983|NCT01610453|12551775|P1|NOT COMPLETED|Overall Study||0
5101984|NCT01610453|12551775|P1|COMPLETED|Overall Study||150
5101985|NCT01610453|12551775|P1|STARTED|Overall Study||150
5101986|NCT01610427|12551780|P1|NOT COMPLETED|Overall Study||0
5101987|NCT01610427|12551780|P1|COMPLETED|Overall Study||22
5101988|NCT01610427|12551780|P1|STARTED|Overall Study||22
5101989|NCT01610414|12551797|P2|NOT COMPLETED|After Month 25||53
5101990|NCT01610414|12551798|P1|NOT COMPLETED|After Month 25||48
5101991|NCT01610414|12551797|P2|COMPLETED|After Month 25||871
5101992|NCT01610414|12551798|P1|COMPLETED|After Month 25||874
5101993|NCT01610414|12551797|P2|STARTED|After Month 25||924
5101994|NCT01610414|12551798|P1|STARTED|After Month 25||922
5101995|NCT01610414|12551797|P2|NOT COMPLETED|Month 13 - Month 25||70
5101996|NCT01610414|12551798|P1|NOT COMPLETED|Month 13 - Month 25||65
5101997|NCT01610414|12551797|P2|COMPLETED|Month 13 - Month 25||854
5101998|NCT01610414|12551798|P1|COMPLETED|Month 13 - Month 25||857
5101999|NCT01610414|12551797|P2|STARTED|Month 13 - Month 25||924
5102000|NCT01610414|12551798|P1|STARTED|Month 13 - Month 25||922
5102001|NCT01610414|12551797|P2|NOT COMPLETED|Study Start - Month 13||129
5102002|NCT01610414|12551798|P1|NOT COMPLETED|Study Start - Month 13||115
5102003|NCT01610414|12551797|P2|COMPLETED|Study Start - Month 13||795
5102004|NCT01610414|12551798|P1|COMPLETED|Study Start - Month 13||807
5102005|NCT01610414|12551797|P2|STARTED|Study Start - Month 13||924
5102006|NCT01610414|12551798|P1|STARTED|Study Start - Month 13||922
5102007|NCT01610297|12551827|P1|NOT COMPLETED|Overall Study||1
5102008|NCT01610297|12551827|P1|COMPLETED|Overall Study||26
5102009|NCT01610297|12551827|P1|STARTED|Overall Study||27
5102010|NCT01610284|12551837|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
5102011|NCT01610284|12551838|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
5102012|NCT01610284|12551837|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
5102013|NCT01610284|12551838|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
5102014|NCT01610284|12551837|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
5102015|NCT01610284|12551838|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
5102016|NCT01610284|12551837|P2|NOT COMPLETED|Treatment Phase||569
5102017|NCT01610284|12551838|P1|NOT COMPLETED|Treatment Phase||574
5102018|NCT01610284|12551837|P2|COMPLETED|Treatment Phase||0
5102019|NCT01610284|12551838|P1|COMPLETED|Treatment Phase||0
5102020|NCT01610284|12551837|P2|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
5102021|NCT01610284|12551838|P1|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
5102022|NCT01610284|12551837|P2|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
5102023|NCT01610284|12551838|P1|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
5102024|NCT01610284|12551837|P2|STARTED|Treatment Phase||569
5102025|NCT01610284|12551838|P1|STARTED|Treatment Phase||574
5102026|NCT01610284|12551837|P2|NOT COMPLETED|Randomization Phase||2
5102027|NCT01610284|12551838|P1|NOT COMPLETED|Randomization Phase||2
5102028|NCT01610284|12551837|P2|COMPLETED|Randomization Phase||569
5102029|NCT01610284|12551838|P1|COMPLETED|Randomization Phase||574
5102030|NCT01610284|12551837|P2|Safety Set (SS)|Randomization Phase||570
5102031|NCT01610284|12551838|P1|Safety Set (SS)|Randomization Phase||573
5102032|NCT01610284|12551837|P2|STARTED|Randomization Phase||571
5102033|NCT01610284|12551838|P1|STARTED|Randomization Phase||576
5102034|NCT01610271|12551860|P2|NOT COMPLETED|Overall Study||4
5102035|NCT01610271|12551861|P1|NOT COMPLETED|Overall Study||2
5102036|NCT01610271|12551860|P2|COMPLETED|Overall Study||146
5102037|NCT01610271|12551861|P1|COMPLETED|Overall Study||148
5102038|NCT01610271|12551860|P2|STARTED|Overall Study||150
5102039|NCT01610271|12551861|P1|STARTED|Overall Study||150
5102040|NCT01610167|12551876|P3|NOT COMPLETED|Overall Study||2
5102041|NCT01610167|12551877|P2|NOT COMPLETED|Overall Study||0
5102042|NCT01610167|12551878|P1|NOT COMPLETED|Overall Study||0
5102043|NCT01610167|12551876|P3|COMPLETED|Overall Study||48
5102044|NCT01610167|12551877|P2|COMPLETED|Overall Study||49
5102045|NCT01610167|12551878|P1|COMPLETED|Overall Study||52
5102046|NCT01610167|12551876|P3|STARTED|Overall Study||50
5102047|NCT01610167|12551877|P2|STARTED|Overall Study||49
5102048|NCT01610167|12551878|P1|STARTED|Overall Study||52
5102049|NCT01610154|12551898|P1|NOT COMPLETED|Overall Study||1
5102050|NCT01610154|12551898|P1|COMPLETED|Overall Study||84
5102051|NCT01610154|12551898|P1|STARTED|Overall Study||85
5102052|NCT01610076|12551915|P2|NOT COMPLETED|Overall Study||5
5102053|NCT01610076|12551916|P1|NOT COMPLETED|Overall Study||3
5102054|NCT01610076|12551915|P2|COMPLETED|Overall Study||100
5102055|NCT01610076|12551916|P1|COMPLETED|Overall Study||100
5102056|NCT01610076|12551915|P2|STARTED|Overall Study||105
5102057|NCT01610076|12551916|P1|STARTED|Overall Study||103
5102058|NCT01610063|12551927|P2|NOT COMPLETED|Overall Study||20
5102059|NCT01610063|12551928|P1|NOT COMPLETED|Overall Study||42
5102060|NCT01610063|12551927|P2|COMPLETED|Overall Study||93
5102061|NCT01610063|12551928|P1|COMPLETED|Overall Study||72
5102062|NCT01610063|12551927|P2|Completed 8-week|Overall Study||93
5102063|NCT01610063|12551928|P1|Completed 8-week|Overall Study||72
5102064|NCT01610063|12551927|P2|Completed 4-week|Overall Study||98
5102065|NCT01610063|12551928|P1|Completed 4-week|Overall Study||86
5102066|NCT01610063|12551927|P2|Completed 2-week|Overall Study||105
5102067|NCT01610063|12551928|P1|Completed 2-week|Overall Study||97
5102068|NCT01610063|12551927|P2|Baseline|Overall Study||113
5102069|NCT01610063|12551928|P1|Baseline|Overall Study||114
5102070|NCT01610063|12551927|P2|STARTED|Overall Study||113
5102071|NCT01610063|12551928|P1|STARTED|Overall Study||114
5102072|NCT01610037|12551951|P3|NOT COMPLETED|Treatment and Follow up Period||26
5102073|NCT01610037|12551952|P2|NOT COMPLETED|Treatment and Follow up Period||28
5102074|NCT01610037|12551953|P1|NOT COMPLETED|Treatment and Follow up Period||25
5102075|NCT01610037|12551951|P3|COMPLETED|Treatment and Follow up Period||378
5102076|NCT01610037|12551952|P2|COMPLETED|Treatment and Follow up Period||377
5102077|NCT01610037|12551953|P1|COMPLETED|Treatment and Follow up Period||382
5102078|NCT01610037|12551951|P3|STARTED|Treatment and Follow up Period||404
5102079|NCT01610037|12551952|P2|STARTED|Treatment and Follow up Period||405
5102080|NCT01610037|12551953|P1|STARTED|Treatment and Follow up Period||407
5102081|NCT01610037|12551951|P3|NOT COMPLETED|All Patients||84
5102082|NCT01610037|12551952|P2|NOT COMPLETED|All Patients||51
5102083|NCT01610037|12551953|P1|NOT COMPLETED|All Patients||59
5102084|NCT01610037|12551951|P3|COMPLETED|All Patients||320
5102085|NCT01610037|12551952|P2|COMPLETED|All Patients||354
5102086|NCT01610037|12551953|P1|COMPLETED|All Patients||348
5102087|NCT01610037|12551951|P3|Full Analysis Set (FAS)|All Patients||403
5102088|NCT01610037|12551952|P2|Full Analysis Set (FAS)|All Patients||405
5102089|NCT01610037|12551953|P1|Full Analysis Set (FAS)|All Patients||407
5102090|NCT01610037|12551951|P3|Randomized Set (RAN)|All Patients||404
5102091|NCT01610037|12551952|P2|Randomized Set (RAN)|All Patients||405
5102092|NCT01610037|12551953|P1|Randomized Set (RAN)|All Patients||407
5102093|NCT01610037|12551951|P3|STARTED|All Patients||404
5102094|NCT01610037|12551952|P2|STARTED|All Patients||405
5102095|NCT01610037|12551953|P1|STARTED|All Patients||407
5102096|NCT01610011|12551996|P2|NOT COMPLETED|Overall Study||0
5102097|NCT01610011|12551997|P1|NOT COMPLETED|Overall Study||10
5102098|NCT01610011|12551996|P2|COMPLETED|Overall Study||2
5102099|NCT01610011|12551997|P1|COMPLETED|Overall Study||9
5102100|NCT01610011|12551996|P2|STARTED|Overall Study||2
5102101|NCT01610011|12551997|P1|STARTED|Overall Study||19
5102102|NCT01609933|12552003|P1|NOT COMPLETED|Overall Study||4
5102103|NCT01609933|12552003|P1|COMPLETED|Overall Study||28
5102104|NCT01609933|12552003|P1|STARTED|Overall Study||32
5102105|NCT01609842|12552014|P2|NOT COMPLETED|Concurrent Intervention Control||0
5102106|NCT01609842|12552015|P1|NOT COMPLETED|Concurrent Intervention Control||2
5102107|NCT01609842|12552014|P2|COMPLETED|Concurrent Intervention Control||4869
5102108|NCT01609842|12552015|P1|COMPLETED|Concurrent Intervention Control||706
5102109|NCT01609842|12552014|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
5102110|NCT01609842|12552015|P1|STARTED|Concurrent Intervention Control||708
5102111|NCT01609842|12552014|P2|NOT COMPLETED|Post-Intervention Control||0
5102112|NCT01609842|12552015|P1|NOT COMPLETED|Post-Intervention Control||0
5102113|NCT01609842|12552014|P2|COMPLETED|Post-Intervention Control||2917
5102114|NCT01609842|12552015|P1|COMPLETED|Post-Intervention Control||0
5102115|NCT01609842|12552014|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
5102116|NCT01609842|12552015|P1|STARTED|Post-Intervention Control||0
5102117|NCT01609842|12552014|P2|NOT COMPLETED|Pre-Intervention Control||0
5102118|NCT01609842|12552015|P1|NOT COMPLETED|Pre-Intervention Control||0
5102119|NCT01609842|12552014|P2|COMPLETED|Pre-Intervention Control||6081
5102120|NCT01609842|12552015|P1|COMPLETED|Pre-Intervention Control||0
5102121|NCT01609842|12552014|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
5102122|NCT01609842|12552015|P1|STARTED|Pre-Intervention Control||0
5102123|NCT01609790|12552042|P3|NOT COMPLETED|Overall Study||8
5102124|NCT01609790|12552043|P2|NOT COMPLETED|Overall Study||7
5102125|NCT01609790|12552044|P1|NOT COMPLETED|Overall Study||1
5102126|NCT01609790|12552042|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
5102127|NCT01609790|12552043|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
5102128|NCT01609790|12552044|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
5102129|NCT01609790|12552042|P3|STARTED|Overall Study||65
5102130|NCT01609790|12552043|P2|STARTED|Overall Study||65
5102131|NCT01609790|12552044|P1|STARTED|Overall Study||7
5102132|NCT01609582|12552063|P2|NOT COMPLETED|Overall Study||1604
5102133|NCT01609582|12552064|P1|NOT COMPLETED|Overall Study||1603
5102134|NCT01609582|12552063|P2|COMPLETED|Overall Study||0
5102135|NCT01609582|12552064|P1|COMPLETED|Overall Study||0
5102136|NCT01609582|12552063|P2|Treated|Overall Study||1601
5102137|NCT01609582|12552064|P1|Treated|Overall Study||1603
5102138|NCT01609582|12552063|P2|STARTED|Overall Study||1604
5102139|NCT01609582|12552064|P1|STARTED|Overall Study||1603
5102140|NCT01609543|12552072|P1|NOT COMPLETED|Overall Study||42
5102141|NCT01609543|12552072|P1|COMPLETED|Overall Study||20
5102142|NCT01609543|12552072|P1|STARTED|Overall Study||62
5102143|NCT01609478|12552081|P3|NOT COMPLETED|Overall Study||9
5102144|NCT01609478|12552082|P2|NOT COMPLETED|Overall Study||2
5102145|NCT01609478|12552083|P1|NOT COMPLETED|Overall Study||7
5102146|NCT01609478|12552081|P3|COMPLETED|Overall Study||107
5102147|NCT01609478|12552082|P2|COMPLETED|Overall Study||106
5102148|NCT01609478|12552083|P1|COMPLETED|Overall Study||104
5102149|NCT01609478|12552081|P3|Full Analysis Set (FAS)|Overall Study||115
5102150|NCT01609478|12552082|P2|Full Analysis Set (FAS)|Overall Study||108
5102151|NCT01609478|12552083|P1|Full Analysis Set (FAS)|Overall Study||110
5102152|NCT01609478|12552081|P3|STARTED|Overall Study||116
5102153|NCT01609478|12552082|P2|STARTED|Overall Study||108
5102154|NCT01609478|12552083|P1|STARTED|Overall Study||111
5102155|NCT01609348|12552149|P2|NOT COMPLETED|Overall Study||0
5102156|NCT01609348|12552150|P1|NOT COMPLETED|Overall Study||0
5102157|NCT01609348|12552149|P2|COMPLETED|Overall Study||2
5102158|NCT01609348|12552150|P1|COMPLETED|Overall Study||3
5102159|NCT01609348|12552149|P2|STARTED|Overall Study||2
5102160|NCT01609348|12552150|P1|STARTED|Overall Study||3
5102161|NCT01609296|12552156|P1|NOT COMPLETED|Overall Study||120
5102162|NCT01609296|12552156|P1|COMPLETED|Overall Study||1286
5102163|NCT01609296|12552156|P1|STARTED|Overall Study||1406
5102164|NCT01609257|12552169|P2|NOT COMPLETED|Overall Study||8
5102165|NCT01609257|12552170|P1|NOT COMPLETED|Overall Study||6
5102166|NCT01609257|12552169|P2|COMPLETED|Overall Study||57
5102167|NCT01609257|12552170|P1|COMPLETED|Overall Study||61
5102168|NCT01609257|12552169|P2|Received Challenge Product|Overall Study||53
5102169|NCT01609257|12552170|P1|Received Challenge Product|Overall Study||56
5102170|NCT01609257|12552169|P2|Received 2 Doses|Overall Study||64
5102171|NCT01609257|12552170|P1|Received 2 Doses|Overall Study||63
5102172|NCT01609257|12552169|P2|STARTED|Overall Study||65
5102173|NCT01609257|12552170|P1|STARTED|Overall Study||67
5102174|NCT01609231|12552242|P2|NOT COMPLETED|Overall Study||3
5102175|NCT01609231|12552243|P1|NOT COMPLETED|Overall Study||3
5102176|NCT01609231|12552242|P2|COMPLETED|Overall Study||2
5102177|NCT01609231|12552243|P1|COMPLETED|Overall Study||3
5102178|NCT01609231|12552242|P2|STARTED|Overall Study||5
5102179|NCT01609231|12552243|P1|STARTED|Overall Study||6
5102180|NCT01609062|12552253|P2|NOT COMPLETED|Extension Phase||10
5102181|NCT01609062|12552254|P1|NOT COMPLETED|Extension Phase||15
5102182|NCT01609062|12552253|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
5102183|NCT01609062|12552254|P1|COMPLETED|Extension Phase||0
5102184|NCT01609062|12552253|P2|STARTED|Extension Phase||10
5102185|NCT01609062|12552254|P1|STARTED|Extension Phase||15
5102186|NCT01609062|12552253|P2|NOT COMPLETED|Primary Phase||0
5102187|NCT01609062|12552254|P1|NOT COMPLETED|Primary Phase||0
5102188|NCT01609062|12552253|P2|COMPLETED|Primary Phase||10
5102189|NCT01609062|12552254|P1|COMPLETED|Primary Phase||15
5102190|NCT01609062|12552253|P2|STARTED|Primary Phase||10
5102191|NCT01609062|12552254|P1|STARTED|Primary Phase||15
5102192|NCT01609023|12552297|P1|NOT COMPLETED|Overall Study||33
5102193|NCT01609023|12552297|P1|COMPLETED|Overall Study||34
5102194|NCT01609023|12552297|P1|STARTED|Overall Study||67
5102195|NCT01609010|12552309|P2|NOT COMPLETED|Overall Study||37
5102196|NCT01609010|12552310|P1|NOT COMPLETED|Overall Study||43
5102197|NCT01609010|12552309|P2|COMPLETED|Overall Study||120
5102198|NCT01609010|12552310|P1|COMPLETED|Overall Study||113
5102199|NCT01609010|12552309|P2|Entering Cycle 2|Overall Study||124
5102200|NCT01609010|12552310|P1|Entering Cycle 2|Overall Study||120
5102201|NCT01609010|12552309|P2|STARTED|Overall Study||157
5102202|NCT01609010|12552310|P1|STARTED|Overall Study||156
5102203|NCT01608971|12552336|P2|NOT COMPLETED|Overall Study||0
5102204|NCT01608971|12552337|P1|NOT COMPLETED|Overall Study||0
5102205|NCT01608971|12552336|P2|COMPLETED|Overall Study||15
5102206|NCT01608971|12552337|P1|COMPLETED|Overall Study||15
5102207|NCT01608971|12552336|P2|STARTED|Overall Study||15
5102208|NCT01608971|12552337|P1|STARTED|Overall Study||15
5102209|NCT01608815|12552352|P3|NOT COMPLETED|Overall Study||0
5102210|NCT01608815|12552353|P2|NOT COMPLETED|Overall Study||0
5102211|NCT01608815|12552354|P1|NOT COMPLETED|Overall Study||0
5102212|NCT01608815|12552352|P3|COMPLETED|Overall Study||5
5102213|NCT01608815|12552353|P2|COMPLETED|Overall Study||7
5102214|NCT01608815|12552354|P1|COMPLETED|Overall Study||188
5102215|NCT01608815|12552352|P3|STARTED|Overall Study||5
5102216|NCT01608815|12552353|P2|STARTED|Overall Study||7
5102217|NCT01608815|12552354|P1|STARTED|Overall Study||188
5102218|NCT01608724|12552371|P1|NOT COMPLETED|Overall Study||243
5102219|NCT01608724|12552371|P1|COMPLETED|Overall Study||1180
5102220|NCT01608724|12552371|P1|Treated|Overall Study||1361
5102221|NCT01608724|12552371|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
5102222|NCT01608672|12552378|P1|NOT COMPLETED|Overall Study||0
5102223|NCT01608672|12552378|P1|COMPLETED|Overall Study||207
5102224|NCT01608672|12552378|P1|STARTED|Overall Study||207
5102225|NCT01608659|12552384|P1|NOT COMPLETED|Overall Study||16
5102226|NCT01608659|12552384|P1|COMPLETED|Overall Study||94
5102227|NCT01608659|12552384|P1|STARTED|Overall Study||110
5102228|NCT01608490|12552392|P2|NOT COMPLETED|Overall Study||0
5102229|NCT01608490|12552393|P1|NOT COMPLETED|Overall Study||0
5102230|NCT01608490|12552392|P2|COMPLETED|Overall Study||157
5102231|NCT01608490|12552393|P1|COMPLETED|Overall Study||158
5102232|NCT01608490|12552392|P2|STARTED|Overall Study||157
5102233|NCT01608490|12552393|P1|STARTED|Overall Study||158
5102234|NCT01608321|12552403|P2|NOT COMPLETED|Overall Study||0
5102235|NCT01608321|12552404|P1|NOT COMPLETED|Overall Study||1
5102236|NCT01608321|12552403|P2|COMPLETED|Overall Study||4
5102237|NCT01608321|12552404|P1|COMPLETED|Overall Study||12
5102238|NCT01608321|12552403|P2|STARTED|Overall Study||4
5102239|NCT01608321|12552404|P1|STARTED|Overall Study||13
5102240|NCT01608308|12552412|P2|NOT COMPLETED|Overall Study||2
5102241|NCT01608308|12552413|P1|NOT COMPLETED|Overall Study||0
5102242|NCT01608308|12552412|P2|COMPLETED|Overall Study||29
5102243|NCT01608308|12552413|P1|COMPLETED|Overall Study||31
5102244|NCT01608308|12552412|P2|STARTED|Overall Study||31
5102245|NCT01608308|12552413|P1|STARTED|Overall Study||31
5102246|NCT01608295|12552437|P2|NOT COMPLETED|Overall Study||5
5102247|NCT01608295|12552438|P1|NOT COMPLETED|Overall Study||6
5102248|NCT01608295|12552437|P2|COMPLETED|Overall Study||25
5102249|NCT01608295|12552438|P1|COMPLETED|Overall Study||20
5102250|NCT01608295|12552437|P2|STARTED|Overall Study||30
5102251|NCT01608295|12552438|P1|STARTED|Overall Study||26
5102252|NCT01608100|12552449|P1|NOT COMPLETED|Overall Study||0
5102253|NCT01608100|12552449|P1|COMPLETED|Overall Study||1101
5102254|NCT01608100|12552449|P1|STARTED|Overall Study||1101
5102255|NCT01608087|12552476|P3|NOT COMPLETED|Overall Study||0
5102256|NCT01608087|12552477|P2|NOT COMPLETED|Overall Study||2
5102257|NCT01608087|12552478|P1|NOT COMPLETED|Overall Study||0
5102258|NCT01608087|12552476|P3|COMPLETED|Overall Study||31
5102259|NCT01608087|12552477|P2|COMPLETED|Overall Study||28
5102260|NCT01608087|12552478|P1|COMPLETED|Overall Study||30
5102261|NCT01608087|12552476|P3|STARTED|Overall Study||31
5102262|NCT01608087|12552477|P2|STARTED|Overall Study||30
5102263|NCT01608087|12552478|P1|STARTED|Overall Study||30
5102264|NCT01607957|12552494|P2|NOT COMPLETED|Overall Study||215
5102265|NCT01607957|12552495|P1|NOT COMPLETED|Overall Study||372
5102266|NCT01607957|12552494|P2|COMPLETED|Overall Study||51
5102267|NCT01607957|12552495|P1|COMPLETED|Overall Study||162
5102268|NCT01607957|12552494|P2|Treated|Overall Study||265
5102269|NCT01607957|12552495|P1|Treated|Overall Study||533
5102270|NCT01607957|12552494|P2|STARTED|Overall Study||266
5102271|NCT01607957|12552495|P1|STARTED|Overall Study||534
5102272|NCT01607853|12552505|P1|NOT COMPLETED|Overall Study||0
5102273|NCT01607853|12552505|P1|COMPLETED|Overall Study||24
5102274|NCT01607853|12552505|P1|STARTED|Overall Study||24
5102275|NCT01607658|12552616|P4|NOT COMPLETED|Overall Study||11
5102276|NCT01607658|12552617|P3|NOT COMPLETED|Overall Study||11
5102277|NCT01607658|12552618|P2|NOT COMPLETED|Overall Study||11
5102278|NCT01607658|12552619|P1|NOT COMPLETED|Overall Study||9
5102279|NCT01607658|12552616|P4|COMPLETED|Overall Study||52
5102280|NCT01607658|12552617|P3|COMPLETED|Overall Study||47
5102281|NCT01607658|12552618|P2|COMPLETED|Overall Study||56
5102282|NCT01607658|12552619|P1|COMPLETED|Overall Study||56
5102283|NCT01607658|12552616|P4|STARTED|Overall Study||63
5102284|NCT01607658|12552617|P3|STARTED|Overall Study||58
5102285|NCT01607658|12552618|P2|STARTED|Overall Study||67
5102286|NCT01607658|12552619|P1|STARTED|Overall Study||65
5102287|NCT01607645|12552643|P2|NOT COMPLETED|Overall Study||0
5102288|NCT01607645|12552644|P1|NOT COMPLETED|Overall Study||0
5102289|NCT01607645|12552643|P2|COMPLETED|Overall Study||3
5102290|NCT01607645|12552644|P1|COMPLETED|Overall Study||4
5102291|NCT01607645|12552643|P2|STARTED|Overall Study||3
5102292|NCT01607645|12552644|P1|STARTED|Overall Study||4
5102293|NCT01607593|12552674|P1|NOT COMPLETED|Overall Study||93
5102294|NCT01607593|12552674|P1|COMPLETED|Overall Study||29
5102295|NCT01607593|12552674|P1|STARTED|Overall Study||122
5102296|NCT01607554|12552680|P1|NOT COMPLETED|Overall Study||2
5102297|NCT01607554|12552680|P1|COMPLETED|Overall Study||0
5102298|NCT01607554|12552680|P1|STARTED|Overall Study||2
5102299|NCT01607476|12552693|P3|NOT COMPLETED|Overall Study||3
5102300|NCT01607476|12552694|P2|NOT COMPLETED|Overall Study||0
5102301|NCT01607476|12552695|P1|NOT COMPLETED|Overall Study||1
5102302|NCT01607476|12552693|P3|COMPLETED|Overall Study||30
5102303|NCT01607476|12552694|P2|COMPLETED|Overall Study||30
5102304|NCT01607476|12552695|P1|COMPLETED|Overall Study||24
5102305|NCT01607476|12552693|P3|STARTED|Overall Study||33
5102306|NCT01607476|12552694|P2|STARTED|Overall Study||30
5102307|NCT01607476|12552695|P1|STARTED|Overall Study||25
5102308|NCT01607450|12552713|P7|NOT COMPLETED|Overall Study||0
5102309|NCT01607450|12552714|P6|NOT COMPLETED|Overall Study||0
5102310|NCT01607450|12552715|P5|NOT COMPLETED|Overall Study||0
5102311|NCT01607450|12552716|P4|NOT COMPLETED|Overall Study||0
5102312|NCT01607450|12552717|P3|NOT COMPLETED|Overall Study||0
5102313|NCT01607450|12552718|P2|NOT COMPLETED|Overall Study||0
5102314|NCT01607450|12552719|P1|NOT COMPLETED|Overall Study||0
5102315|NCT01607450|12552713|P7|COMPLETED|Overall Study||0
5102316|NCT01607450|12552714|P6|COMPLETED|Overall Study||0
5102317|NCT01607450|12552715|P5|COMPLETED|Overall Study||1
5102318|NCT01607450|12552716|P4|COMPLETED|Overall Study||11
5102319|NCT01607450|12552717|P3|COMPLETED|Overall Study||7
5102320|NCT01607450|12552718|P2|COMPLETED|Overall Study||8
5102321|NCT01607450|12552719|P1|COMPLETED|Overall Study||6
5102322|NCT01607450|12552713|P7|STARTED|Overall Study||0
5102323|NCT01607450|12552714|P6|STARTED|Overall Study||0
5102324|NCT01607450|12552715|P5|STARTED|Overall Study||1
5102325|NCT01607450|12552716|P4|STARTED|Overall Study||11
5102326|NCT01607450|12552717|P3|STARTED|Overall Study||7
5102327|NCT01607450|12552718|P2|STARTED|Overall Study||8
5102328|NCT01607450|12552719|P1|STARTED|Overall Study||6
5102329|NCT01607411|12552763|P4|NOT COMPLETED|Period IV||0
5102330|NCT01607411|12552764|P3|NOT COMPLETED|Period IV||0
5102331|NCT01607411|12552765|P2|NOT COMPLETED|Period IV||0
5102332|NCT01607411|12552766|P1|NOT COMPLETED|Period IV||0
5102333|NCT01607411|12552763|P4|COMPLETED|Period IV||14
5102334|NCT01607411|12552764|P3|COMPLETED|Period IV||14
5102335|NCT01607411|12552765|P2|COMPLETED|Period IV||14
5102336|NCT01607411|12552766|P1|COMPLETED|Period IV||13
5102337|NCT01607411|12552763|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
5102338|NCT01607411|12552764|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
5102339|NCT01607411|12552765|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
5102340|NCT01607411|12552766|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
5102341|NCT01607411|12552763|P4|NOT COMPLETED|Period III||0
5102342|NCT01607411|12552764|P3|NOT COMPLETED|Period III||0
5102343|NCT01607411|12552765|P2|NOT COMPLETED|Period III||0
5102344|NCT01607411|12552766|P1|NOT COMPLETED|Period III||0
5102345|NCT01607411|12552763|P4|COMPLETED|Period III||13
5102346|NCT01607411|12552764|P3|COMPLETED|Period III||14
5102347|NCT01607411|12552765|P2|COMPLETED|Period III||14
5102348|NCT01607411|12552766|P1|COMPLETED|Period III||14
5102349|NCT01607411|12552763|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
5102350|NCT01607411|12552764|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
5102351|NCT01607411|12552765|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
5102352|NCT01607411|12552766|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
5102353|NCT01607411|12552763|P4|NOT COMPLETED|Period II||0
5102354|NCT01607411|12552764|P3|NOT COMPLETED|Period II||0
5102355|NCT01607411|12552765|P2|NOT COMPLETED|Period II||0
5102356|NCT01607411|12552766|P1|NOT COMPLETED|Period II||0
5102357|NCT01607411|12552763|P4|COMPLETED|Period II||14
5102358|NCT01607411|12552764|P3|COMPLETED|Period II||13
5102359|NCT01607411|12552765|P2|COMPLETED|Period II||14
5102360|NCT01607411|12552766|P1|COMPLETED|Period II||14
5102361|NCT01607411|12552763|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
5102362|NCT01607411|12552764|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
5102363|NCT01607411|12552765|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
5102364|NCT01607411|12552766|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
5102365|NCT01607411|12552763|P4|NOT COMPLETED|Period I||0
5102366|NCT01607411|12552764|P3|NOT COMPLETED|Period I||0
5102367|NCT01607411|12552765|P2|NOT COMPLETED|Period I||0
5102368|NCT01607411|12552766|P1|NOT COMPLETED|Period I||0
5102369|NCT01607411|12552763|P4|COMPLETED|Period I||14
5102370|NCT01607411|12552764|P3|COMPLETED|Period I||14
5102371|NCT01607411|12552765|P2|COMPLETED|Period I||13
5102372|NCT01607411|12552766|P1|COMPLETED|Period I||14
5102373|NCT01607411|12552763|P4|STARTED|Period I||14
5102374|NCT01607411|12552764|P3|STARTED|Period I||14
5102375|NCT01607411|12552765|P2|STARTED|Period I||13
5102376|NCT01607411|12552766|P1|STARTED|Period I||14
5102377|NCT01607398|12552789|P2|NOT COMPLETED|Overall Study||2
5102378|NCT01607398|12552790|P1|NOT COMPLETED|Overall Study||2
5102379|NCT01607398|12552789|P2|COMPLETED|Overall Study||26
5102380|NCT01607398|12552790|P1|COMPLETED|Overall Study||26
5102381|NCT01607398|12552789|P2|STARTED|Overall Study||28
5102382|NCT01607398|12552790|P1|STARTED|Overall Study||28
5102383|NCT01607346|12552834|P1|NOT COMPLETED|Overall Study||3
5102384|NCT01607346|12552834|P1|COMPLETED|Overall Study||7
5102385|NCT01607346|12552834|P1|STARTED|Overall Study||10
5102386|NCT01607320|12552850|P2|NOT COMPLETED|Overall Study||0
5102387|NCT01607320|12552851|P1|NOT COMPLETED|Overall Study||0
5102388|NCT01607320|12552850|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
5102389|NCT01607320|12552851|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
5102390|NCT01607320|12552850|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
5102391|NCT01607320|12552851|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
5102392|NCT01607255|12552859|P3|NOT COMPLETED|Overall Study||0
5102393|NCT01607255|12552860|P2|NOT COMPLETED|Overall Study||0
5102394|NCT01607255|12552861|P1|NOT COMPLETED|Overall Study||0
5102395|NCT01607255|12552859|P3|COMPLETED|Overall Study||159
5102396|NCT01607255|12552860|P2|COMPLETED|Overall Study||160
5102397|NCT01607255|12552861|P1|COMPLETED|Overall Study||161
5102398|NCT01607255|12552859|P3|STARTED|Overall Study||159
5102399|NCT01607255|12552860|P2|STARTED|Overall Study||160
5102400|NCT01607255|12552861|P1|STARTED|Overall Study||161
5102401|NCT01607203|12552871|P2|NOT COMPLETED|Overall Study||0
5102402|NCT01607203|12552872|P1|NOT COMPLETED|Overall Study||0
5102403|NCT01607203|12552871|P2|COMPLETED|Overall Study||61
5102404|NCT01607203|12552872|P1|COMPLETED|Overall Study||59
5102405|NCT01607203|12552871|P2|STARTED|Overall Study||61
5102406|NCT01607203|12552872|P1|STARTED|Overall Study||59
5102407|NCT01607112|12552884|P2|NOT COMPLETED|Overall Study||0
5102408|NCT01607112|12552885|P1|NOT COMPLETED|Overall Study||0
5102409|NCT01607112|12552884|P2|COMPLETED|Overall Study||59
5102410|NCT01607112|12552885|P1|COMPLETED|Overall Study||60
5102411|NCT01607112|12552884|P2|STARTED|Overall Study||59
5102412|NCT01607112|12552885|P1|STARTED|Overall Study||60
5102413|NCT01606852|12552921|P2|NOT COMPLETED|Overall Study||0
5102414|NCT01606852|12552922|P1|NOT COMPLETED|Overall Study||0
5102415|NCT01606852|12552921|P2|COMPLETED|Overall Study||8
5102416|NCT01606852|12552922|P1|COMPLETED|Overall Study||7
5102417|NCT01606852|12552921|P2|STARTED|Overall Study||8
5102418|NCT01606852|12552922|P1|STARTED|Overall Study||7
5102419|NCT01606800|12552932|P2|NOT COMPLETED|Overall Study||2
5102420|NCT01606800|12552933|P1|NOT COMPLETED|Overall Study||5
5102421|NCT01606800|12552932|P2|COMPLETED|Overall Study||21
5102422|NCT01606800|12552933|P1|COMPLETED|Overall Study||17
5102423|NCT01606800|12552932|P2|Treated|Overall Study||23
5102424|NCT01606800|12552933|P1|Treated|Overall Study||22
5102425|NCT01606800|12552932|P2|STARTED|Overall Study||23
5102426|NCT01606800|12552933|P1|STARTED|Overall Study||22
5102427|NCT01606787|12552941|P2|NOT COMPLETED|Overall Study||7
5102428|NCT01606787|12552942|P1|NOT COMPLETED|Overall Study||4
5102429|NCT01606787|12552941|P2|COMPLETED|Overall Study||98
5102430|NCT01606787|12552942|P1|COMPLETED|Overall Study||101
5102431|NCT01606787|12552941|P2|STARTED|Overall Study||105
5102432|NCT01606787|12552942|P1|STARTED|Overall Study||105
5102433|NCT01606761|12552953|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
5102434|NCT01606761|12552954|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
5102435|NCT01606761|12552955|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
5102436|NCT01606761|12552956|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
5102437|NCT01606761|12552957|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
5102438|NCT01606761|12552953|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
5102439|NCT01606761|12552954|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
5102440|NCT01606761|12552955|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
5102441|NCT01606761|12552956|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
5102442|NCT01606761|12552957|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
5102443|NCT01606761|12552953|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
5102444|NCT01606761|12552954|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
5102445|NCT01606761|12552955|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
5102446|NCT01606761|12552956|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
5102447|NCT01606761|12552957|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
5102448|NCT01606761|12552953|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
5102449|NCT01606761|12552954|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
5102450|NCT01606761|12552955|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
5102451|NCT01606761|12552956|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
5102452|NCT01606761|12552957|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
5102453|NCT01606761|12552953|P5|NOT COMPLETED|Week 24 to Week 52||20
5102454|NCT01606761|12552954|P4|NOT COMPLETED|Week 24 to Week 52||17
5102455|NCT01606761|12552955|P3|NOT COMPLETED|Week 24 to Week 52||33
5102456|NCT01606761|12552956|P2|NOT COMPLETED|Week 24 to Week 52||33
5102457|NCT01606761|12552957|P1|NOT COMPLETED|Week 24 to Week 52||0
5102458|NCT01606761|12552953|P5|COMPLETED|Week 24 to Week 52||106
5102459|NCT01606761|12552954|P4|COMPLETED|Week 24 to Week 52||109
5102460|NCT01606761|12552955|P3|COMPLETED|Week 24 to Week 52||212
5102461|NCT01606761|12552956|P2|COMPLETED|Week 24 to Week 52||204
5102462|NCT01606761|12552957|P1|COMPLETED|Week 24 to Week 52||0
5102463|NCT01606761|12552953|P5|Treated|Week 24 to Week 52||126
5102464|NCT01606761|12552954|P4|Treated|Week 24 to Week 52||124
5102465|NCT01606761|12552955|P3|Treated|Week 24 to Week 52||245
5102466|NCT01606761|12552956|P2|Treated|Week 24 to Week 52||237
5102467|NCT01606761|12552957|P1|Treated|Week 24 to Week 52||0
5102468|NCT01606761|12552953|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
5102469|NCT01606761|12552954|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
5102470|NCT01606761|12552955|P3|STARTED|Week 24 to Week 52||245
5102471|NCT01606761|12552956|P2|STARTED|Week 24 to Week 52||237
5102472|NCT01606761|12552957|P1|STARTED|Week 24 to Week 52||0
5102473|NCT01606761|12552953|P5|NOT COMPLETED|Prior to Week 24||0
5102474|NCT01606761|12552954|P4|NOT COMPLETED|Prior to Week 24||0
5102475|NCT01606761|12552955|P3|NOT COMPLETED|Prior to Week 24||47
5102476|NCT01606761|12552956|P2|NOT COMPLETED|Prior to Week 24||55
5102477|NCT01606761|12552957|P1|NOT COMPLETED|Prior to Week 24||42
5102478|NCT01606761|12552953|P5|COMPLETED|Prior to Week 24||0
5102479|NCT01606761|12552954|P4|COMPLETED|Prior to Week 24||0
5102480|NCT01606761|12552955|P3|COMPLETED|Prior to Week 24||245
5102481|NCT01606761|12552956|P2|COMPLETED|Prior to Week 24||237
5102482|NCT01606761|12552957|P1|COMPLETED|Prior to Week 24||252
5102483|NCT01606761|12552953|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
5102484|NCT01606761|12552954|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
5102485|NCT01606761|12552955|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
5102486|NCT01606761|12552956|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
5102487|NCT01606761|12552957|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
5102488|NCT01606761|12552953|P5|STARTED|Prior to Week 24||0
5102489|NCT01606761|12552954|P4|STARTED|Prior to Week 24||0
5102490|NCT01606761|12552955|P3|STARTED|Prior to Week 24||292
5102491|NCT01606761|12552956|P2|STARTED|Prior to Week 24||292
5102492|NCT01606761|12552957|P1|STARTED|Prior to Week 24||294
5102493|NCT01606748|12552983|P2|NOT COMPLETED|Overall Study||0
5102494|NCT01606748|12552984|P1|NOT COMPLETED|Overall Study||3
5102495|NCT01606748|12552983|P2|COMPLETED|Overall Study||17
5102496|NCT01606748|12552984|P1|COMPLETED|Overall Study||15
5102497|NCT01606748|12552983|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
5102498|NCT01606748|12552984|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
5102499|NCT01606748|12552983|P2|STARTED|Overall Study||17
5102500|NCT01606748|12552984|P1|STARTED|Overall Study||18
5102501|NCT01606735|12553015|P3|NOT COMPLETED|Overall Study||0
5102502|NCT01606735|12553016|P2|NOT COMPLETED|Overall Study||0
5102503|NCT01606735|12553017|P1|NOT COMPLETED|Overall Study||0
5102504|NCT01606735|12553015|P3|COMPLETED|Overall Study||58
5102505|NCT01606735|12553016|P2|COMPLETED|Overall Study||56
5102506|NCT01606735|12553017|P1|COMPLETED|Overall Study||58
5102507|NCT01606735|12553015|P3|STARTED|Overall Study||58
5102508|NCT01606735|12553016|P2|STARTED|Overall Study||56
5102509|NCT01606735|12553017|P1|STARTED|Overall Study||58
5102510|NCT01606709|12553027|P2|NOT COMPLETED|Overall Study||0
5102511|NCT01606709|12553028|P1|NOT COMPLETED|Overall Study||0
5102512|NCT01606709|12553027|P2|COMPLETED|Overall Study||3
5102513|NCT01606709|12553028|P1|COMPLETED|Overall Study||4
5102514|NCT01606709|12553027|P2|STARTED|Overall Study||3
5102515|NCT01606709|12553028|P1|STARTED|Overall Study||4
5102516|NCT01606670|12553036|P1|NOT COMPLETED|Overall Study||16
5102517|NCT01606670|12553036|P1|COMPLETED|Overall Study||77
5102518|NCT01606670|12553036|P1|Full Analysis Set|Overall Study||70
5102519|NCT01606670|12553036|P1|Safety Set|Overall Study||93
5102520|NCT01606670|12553036|P1|STARTED|Overall Study||93
5102521|NCT01606319|12553046|P2|NOT COMPLETED|Overall Study||40
5102522|NCT01606319|12553047|P1|NOT COMPLETED|Overall Study||34
5102523|NCT01606319|12553046|P2|COMPLETED|Overall Study||110
5102524|NCT01606319|12553047|P1|COMPLETED|Overall Study||116
5102525|NCT01606319|12553046|P2|STARTED|Overall Study||150
5102526|NCT01606319|12553047|P1|STARTED|Overall Study||150
5102527|NCT01606306|12553065|P6|NOT COMPLETED|Overall Study||11
5102528|NCT01606306|12553066|P5|NOT COMPLETED|Overall Study||11
5102529|NCT01606306|12553067|P4|NOT COMPLETED|Overall Study||13
5102530|NCT01606306|12553068|P3|NOT COMPLETED|Overall Study||14
5102531|NCT01606306|12553069|P2|NOT COMPLETED|Overall Study||10
5102532|NCT01606306|12553070|P1|NOT COMPLETED|Overall Study||15
5102533|NCT01606306|12553065|P6|COMPLETED|Overall Study||36
5102534|NCT01606306|12553066|P5|COMPLETED|Overall Study||41
5102535|NCT01606306|12553067|P4|COMPLETED|Overall Study||38
5102536|NCT01606306|12553068|P3|COMPLETED|Overall Study||37
5102537|NCT01606306|12553069|P2|COMPLETED|Overall Study||39
5102538|NCT01606306|12553070|P1|COMPLETED|Overall Study||35
5102539|NCT01606306|12553065|P6|Completed Third Treatment Period|Overall Study||36
5102540|NCT01606306|12553066|P5|Completed Third Treatment Period|Overall Study||41
5102541|NCT01606306|12553067|P4|Completed Third Treatment Period|Overall Study||38
5102542|NCT01606306|12553068|P3|Completed Third Treatment Period|Overall Study||37
5102543|NCT01606306|12553069|P2|Completed Third Treatment Period|Overall Study||39
5102544|NCT01606306|12553070|P1|Completed Third Treatment Period|Overall Study||35
5102545|NCT01606306|12553065|P6|Completed Second Treatment Period|Overall Study||41
5102546|NCT01606306|12553066|P5|Completed Second Treatment Period|Overall Study||46
5102547|NCT01606306|12553067|P4|Completed Second Treatment Period|Overall Study||44
5102548|NCT01606306|12553068|P3|Completed Second Treatment Period|Overall Study||43
5102549|NCT01606306|12553069|P2|Completed Second Treatment Period|Overall Study||38
5102550|NCT01606306|12553070|P1|Completed Second Treatment Period|Overall Study||41
5102551|NCT01606306|12553065|P6|Completed First Treatment Period|Overall Study||44
5102552|NCT01606306|12553066|P5|Completed First Treatment Period|Overall Study||47
5102553|NCT01606306|12553067|P4|Completed First Treatment Period|Overall Study||45
5102554|NCT01606306|12553068|P3|Completed First Treatment Period|Overall Study||47
5102555|NCT01606306|12553069|P2|Completed First Treatment Period|Overall Study||47
5102556|NCT01606306|12553070|P1|Completed First Treatment Period|Overall Study||43
5102557|NCT01606306|12553065|P6|STARTED|Overall Study||47
5102558|NCT01606306|12553066|P5|STARTED|Overall Study||52
5102559|NCT01606306|12553067|P4|STARTED|Overall Study||51
5102560|NCT01606306|12553068|P3|STARTED|Overall Study||51
5102561|NCT01606306|12553069|P2|STARTED|Overall Study||49
5102562|NCT01606306|12553070|P1|STARTED|Overall Study||50
5102563|NCT01606254|12553080|P4|NOT COMPLETED|Overall Study||3
5102564|NCT01606254|12553081|P3|NOT COMPLETED|Overall Study||0
5102565|NCT01606254|12553082|P2|NOT COMPLETED|Overall Study||4
5102566|NCT01606254|12553083|P1|NOT COMPLETED|Overall Study||2
5102567|NCT01606254|12553080|P4|COMPLETED|Overall Study||11
5102568|NCT01606254|12553081|P3|COMPLETED|Overall Study||14
5102569|NCT01606254|12553082|P2|COMPLETED|Overall Study||10
5102570|NCT01606254|12553083|P1|COMPLETED|Overall Study||12
5102571|NCT01606254|12553080|P4|STARTED|Overall Study||14
5102572|NCT01606254|12553081|P3|STARTED|Overall Study||14
5102573|NCT01606254|12553082|P2|STARTED|Overall Study||14
5102574|NCT01606254|12553083|P1|STARTED|Overall Study||14
5102575|NCT01606228|12553165|P1|NOT COMPLETED|Overall Study||29
5102576|NCT01606228|12553165|P1|COMPLETED|Overall Study||159
5102577|NCT01606228|12553165|P1|STARTED|Overall Study||188
5102578|NCT01606202|12553182|P2|NOT COMPLETED|Overall Study||3
5102579|NCT01606202|12553183|P1|NOT COMPLETED|Overall Study||7
5102580|NCT01606202|12553182|P2|COMPLETED|Overall Study||57
5102581|NCT01606202|12553183|P1|COMPLETED|Overall Study||49
5102582|NCT01606202|12553182|P2|STARTED|Overall Study||60
5102583|NCT01606202|12553183|P1|STARTED|Overall Study||56
5102584|NCT01606189|12553215|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
5102585|NCT01606189|12553216|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
5102586|NCT01606189|12553217|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
5102587|NCT01606189|12553218|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
5102588|NCT01606189|12553219|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
5102589|NCT01606189|12553220|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
5102590|NCT01606189|12553215|P6|COMPLETED|Third Intenvention (14-20 Days)||6
5102591|NCT01606189|12553216|P5|COMPLETED|Third Intenvention (14-20 Days)||8
5102592|NCT01606189|12553217|P4|COMPLETED|Third Intenvention (14-20 Days)||8
5102593|NCT01606189|12553218|P3|COMPLETED|Third Intenvention (14-20 Days)||8
5102594|NCT01606189|12553219|P2|COMPLETED|Third Intenvention (14-20 Days)||8
5102595|NCT01606189|12553220|P1|COMPLETED|Third Intenvention (14-20 Days)||8
5102596|NCT01606189|12553215|P6|STARTED|Third Intenvention (14-20 Days)||7
5102597|NCT01606189|12553216|P5|STARTED|Third Intenvention (14-20 Days)||8
5102598|NCT01606189|12553217|P4|STARTED|Third Intenvention (14-20 Days)||8
5102599|NCT01606189|12553218|P3|STARTED|Third Intenvention (14-20 Days)||8
5102600|NCT01606189|12553219|P2|STARTED|Third Intenvention (14-20 Days)||8
5102601|NCT01606189|12553220|P1|STARTED|Third Intenvention (14-20 Days)||8
5102602|NCT01606189|12553215|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
5102603|NCT01606189|12553216|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
5102604|NCT01606189|12553217|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
5102605|NCT01606189|12553218|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
5102606|NCT01606189|12553219|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
5102607|NCT01606189|12553220|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
5102608|NCT01606189|12553215|P6|COMPLETED|Second Intenvention (14-20 Days)||7
5102609|NCT01606189|12553216|P5|COMPLETED|Second Intenvention (14-20 Days)||8
5102610|NCT01606189|12553217|P4|COMPLETED|Second Intenvention (14-20 Days)||8
5102611|NCT01606189|12553218|P3|COMPLETED|Second Intenvention (14-20 Days)||8
5102612|NCT01606189|12553219|P2|COMPLETED|Second Intenvention (14-20 Days)||8
5102613|NCT01606189|12553220|P1|COMPLETED|Second Intenvention (14-20 Days)||8
5102614|NCT01606189|12553215|P6|STARTED|Second Intenvention (14-20 Days)||8
5102615|NCT01606189|12553216|P5|STARTED|Second Intenvention (14-20 Days)||8
5102616|NCT01606189|12553217|P4|STARTED|Second Intenvention (14-20 Days)||8
5102617|NCT01606189|12553218|P3|STARTED|Second Intenvention (14-20 Days)||8
5102618|NCT01606189|12553219|P2|STARTED|Second Intenvention (14-20 Days)||8
5102619|NCT01606189|12553220|P1|STARTED|Second Intenvention (14-20 Days)||8
5102620|NCT01606189|12553215|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102621|NCT01606189|12553216|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102622|NCT01606189|12553217|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102623|NCT01606189|12553218|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102624|NCT01606189|12553219|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102625|NCT01606189|12553220|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
5102626|NCT01606189|12553215|P6|COMPLETED|First Intenvention (14-20 Days)||8
5102627|NCT01606189|12553216|P5|COMPLETED|First Intenvention (14-20 Days)||8
5102628|NCT01606189|12553217|P4|COMPLETED|First Intenvention (14-20 Days)||8
5102629|NCT01606189|12553218|P3|COMPLETED|First Intenvention (14-20 Days)||8
5102630|NCT01606189|12553219|P2|COMPLETED|First Intenvention (14-20 Days)||8
5102631|NCT01606189|12553220|P1|COMPLETED|First Intenvention (14-20 Days)||8
5102632|NCT01606189|12553215|P6|STARTED|First Intenvention (14-20 Days)||8
5102633|NCT01606189|12553216|P5|STARTED|First Intenvention (14-20 Days)||8
5102634|NCT01606189|12553217|P4|STARTED|First Intenvention (14-20 Days)||8
5102635|NCT01606189|12553218|P3|STARTED|First Intenvention (14-20 Days)||8
5102636|NCT01606189|12553219|P2|STARTED|First Intenvention (14-20 Days)||8
5102637|NCT01606189|12553220|P1|STARTED|First Intenvention (14-20 Days)||8
5102638|NCT01606176|12553254|P2|NOT COMPLETED|Overall Study||3
5102639|NCT01606176|12553255|P1|NOT COMPLETED|Overall Study||4
5102640|NCT01606176|12553254|P2|COMPLETED|Overall Study||31
5102641|NCT01606176|12553255|P1|COMPLETED|Overall Study||32
5102642|NCT01606176|12553254|P2|STARTED|Overall Study||34
5102643|NCT01606176|12553255|P1|STARTED|Overall Study||36
5102644|NCT01606150|12553291|P2|NOT COMPLETED|Overall Study||0
5102645|NCT01606150|12553292|P1|NOT COMPLETED|Overall Study||0
5102646|NCT01606150|12553291|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
5102647|NCT01606150|12553292|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
5102648|NCT01606150|12553291|P2|STARTED|Overall Study||0
5102649|NCT01606150|12553292|P1|STARTED|Overall Study||0
5102650|NCT01606137|12553300|P1|NOT COMPLETED|Overall Study||262
5102651|NCT01606137|12553300|P1|COMPLETED|Overall Study||245
5102652|NCT01606137|12553300|P1|STARTED|Overall Study||507
5102653|NCT01606124|12553322|P2|NOT COMPLETED|Overall Study||0
5102654|NCT01606124|12553323|P1|NOT COMPLETED|Overall Study||0
5102655|NCT01606124|12553322|P2|COMPLETED|Overall Study||20
5102656|NCT01606124|12553323|P1|COMPLETED|Overall Study||19
5102657|NCT01606124|12553322|P2|STARTED|Overall Study||20
5102658|NCT01606124|12553323|P1|STARTED|Overall Study||19
5102659|NCT01606007|12553334|P3|NOT COMPLETED|Overall Study||10
5102660|NCT01606007|12553335|P2|NOT COMPLETED|Overall Study||19
5102661|NCT01606007|12553336|P1|NOT COMPLETED|Overall Study||15
5102662|NCT01606007|12553334|P3|COMPLETED|Overall Study||169
5102663|NCT01606007|12553335|P2|COMPLETED|Overall Study||160
5102664|NCT01606007|12553336|P1|COMPLETED|Overall Study||161
5102665|NCT01606007|12553334|P3|STARTED|Overall Study||179
5102666|NCT01606007|12553335|P2|STARTED|Overall Study||179
5102667|NCT01606007|12553336|P1|STARTED|Overall Study||176
5102668|NCT01605942|12553358|P2|NOT COMPLETED|Overall Study||0
5102669|NCT01605942|12553359|P1|NOT COMPLETED|Overall Study||0
5102670|NCT01605942|12553358|P2|COMPLETED|Overall Study||2
5102671|NCT01605942|12553359|P1|COMPLETED|Overall Study||6
5102672|NCT01605942|12553358|P2|STARTED|Overall Study||2
5102673|NCT01605942|12553359|P1|STARTED|Overall Study||6
5102674|NCT01605916|12553371|P5|NOT COMPLETED|Overall Study||6
5102675|NCT01605916|12553372|P4|NOT COMPLETED|Overall Study||6
5102676|NCT01605916|12553373|P3|NOT COMPLETED|Overall Study||3
5102677|NCT01605916|12553374|P2|NOT COMPLETED|Overall Study||4
5102678|NCT01605916|12553375|P1|NOT COMPLETED|Overall Study||4
5102679|NCT01605916|12553371|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
5102680|NCT01605916|12553372|P4|COMPLETED|Overall Study||0
5102681|NCT01605916|12553373|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
5102682|NCT01605916|12553374|P2|COMPLETED|Overall Study||0
5102683|NCT01605916|12553375|P1|COMPLETED|Overall Study||0
5102684|NCT01605916|12553371|P5|STARTED|Overall Study||7
5102685|NCT01605916|12553372|P4|STARTED|Overall Study||6
5102686|NCT01605916|12553373|P3|STARTED|Overall Study||4
5102687|NCT01605916|12553374|P2|STARTED|Overall Study||4
5102688|NCT01605916|12553375|P1|STARTED|Overall Study||4
5102689|NCT01605903|12553450|P2|NOT COMPLETED|Overall Study||0
5102690|NCT01605903|12553451|P1|NOT COMPLETED|Overall Study||0
5102691|NCT01605903|12553450|P2|COMPLETED|Overall Study||343
5102692|NCT01605903|12553451|P1|COMPLETED|Overall Study||345
5102693|NCT01605903|12553450|P2|STARTED|Overall Study||343
5102694|NCT01605903|12553451|P1|STARTED|Overall Study||345
5102695|NCT01605890|12553457|P1|NOT COMPLETED|Overall Study||2
5102696|NCT01605890|12553457|P1|COMPLETED|Overall Study||28
5102697|NCT01605890|12553457|P1|STARTED|Overall Study||30
5102698|NCT01605877|12553472|P1|NOT COMPLETED|Overall Study||1
5102699|NCT01605877|12553472|P1|COMPLETED|Overall Study||63
5102700|NCT01605877|12553472|P1|STARTED|Overall Study||64
5102701|NCT01605825|12553536|P2|NOT COMPLETED|Overall Study||3
5102702|NCT01605825|12553537|P1|NOT COMPLETED|Overall Study||10
5102703|NCT01605825|12553536|P2|COMPLETED|Overall Study||25
5102704|NCT01605825|12553537|P1|COMPLETED|Overall Study||45
5102705|NCT01605825|12553536|P2|STARTED|Overall Study||28
5102706|NCT01605825|12553537|P1|STARTED|Overall Study||55
5102707|NCT01605799|12553545|P2|NOT COMPLETED|Overall Study||1
5102708|NCT01605799|12553546|P1|NOT COMPLETED|Overall Study||2
5102709|NCT01605799|12553545|P2|COMPLETED|Overall Study||15
5102710|NCT01605799|12553546|P1|COMPLETED|Overall Study||15
5102711|NCT01605799|12553545|P2|STARTED|Overall Study||16
5102712|NCT01605799|12553546|P1|STARTED|Overall Study||17
5102713|NCT01605669|12553554|P1|NOT COMPLETED|Overall Study||0
5102714|NCT01605669|12553554|P1|COMPLETED|Overall Study||50
5102715|NCT01605669|12553554|P1|STARTED|Overall Study||50
5102716|NCT01605617|12553561|P2|NOT COMPLETED|Second Intervention||0
5102717|NCT01605617|12553562|P1|NOT COMPLETED|Second Intervention||0
5102718|NCT01605617|12553561|P2|COMPLETED|Second Intervention||0
5102719|NCT01605617|12553562|P1|COMPLETED|Second Intervention||0
5102720|NCT01605617|12553561|P2|STARTED|Second Intervention||0
5102721|NCT01605617|12553562|P1|STARTED|Second Intervention||0
5102722|NCT01605617|12553561|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
5102723|NCT01605617|12553562|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
5102724|NCT01605617|12553561|P2|COMPLETED|Washout Period of 4 Weeks||0
5102725|NCT01605617|12553562|P1|COMPLETED|Washout Period of 4 Weeks||0
5102726|NCT01605617|12553561|P2|STARTED|Washout Period of 4 Weeks||1
5102727|NCT01605617|12553562|P1|STARTED|Washout Period of 4 Weeks||2
5102728|NCT01605617|12553561|P2|NOT COMPLETED|First Intervention||1
5102729|NCT01605617|12553562|P1|NOT COMPLETED|First Intervention||0
5102730|NCT01605617|12553561|P2|COMPLETED|First Intervention||1
5102731|NCT01605617|12553562|P1|COMPLETED|First Intervention||2
5102732|NCT01605617|12553561|P2|STARTED|First Intervention||2
5102733|NCT01605617|12553562|P1|STARTED|First Intervention||2
5102734|NCT01605552|12553582|P2|NOT COMPLETED|Overall Study||2
5102735|NCT01605552|12553583|P1|NOT COMPLETED|Overall Study||6
5102736|NCT01605552|12553582|P2|COMPLETED|Overall Study||14
5102737|NCT01605552|12553583|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
5102738|NCT01605552|12553582|P2|STARTED|Overall Study||16
5102739|NCT01605552|12553583|P1|STARTED|Overall Study||13
5102740|NCT01605539|12553597|P3|NOT COMPLETED|Overall Study||0
5102741|NCT01605539|12553598|P2|NOT COMPLETED|Overall Study||1
5102742|NCT01605539|12553599|P1|NOT COMPLETED|Overall Study||0
5102743|NCT01605539|12553597|P3|COMPLETED|Overall Study||4
5102744|NCT01605539|12553598|P2|COMPLETED|Overall Study||2
5102745|NCT01605539|12553599|P1|COMPLETED|Overall Study||3
5102746|NCT01605539|12553597|P3|STARTED|Overall Study||4
5102747|NCT01605539|12553598|P2|STARTED|Overall Study||3
5102748|NCT01605539|12553599|P1|STARTED|Overall Study||3
5102749|NCT01605461|12553621|P1|NOT COMPLETED|Overall Study||4
5102750|NCT01605461|12553621|P1|COMPLETED|Overall Study||8
5102751|NCT01605461|12553621|P1|STARTED|Overall Study||12
5102752|NCT01605435|12553630|P2|NOT COMPLETED|Overall Study||0
5102753|NCT01605435|12553631|P1|NOT COMPLETED|Overall Study||0
5102754|NCT01605435|12553630|P2|COMPLETED|Overall Study||3
5102755|NCT01605435|12553631|P1|COMPLETED|Overall Study||2
5102756|NCT01605435|12553630|P2|STARTED|Overall Study||3
5102757|NCT01605435|12553631|P1|STARTED|Overall Study||2
5102758|NCT01605396|12553680|P2|NOT COMPLETED|Overall Study||40
5102759|NCT01605396|12553681|P1|NOT COMPLETED|Overall Study||40
5102760|NCT01605396|12553680|P2|COMPLETED|Overall Study||0
5102761|NCT01605396|12553681|P1|COMPLETED|Overall Study||0
5102762|NCT01605396|12553680|P2|Treated|Overall Study||40
5102763|NCT01605396|12553681|P1|Treated|Overall Study||39
5102764|NCT01605396|12553680|P2|STARTED|Overall Study||40
5102765|NCT01605396|12553681|P1|STARTED|Overall Study||40
5102766|NCT01605370|12553695|P2|NOT COMPLETED|Overall Study||0
5102767|NCT01605370|12553696|P1|NOT COMPLETED|Overall Study||1
5102768|NCT01605370|12553695|P2|COMPLETED|Overall Study||0
5102769|NCT01605370|12553696|P1|COMPLETED|Overall Study||0
5102770|NCT01605370|12553695|P2|STARTED|Overall Study||0
5102771|NCT01605370|12553696|P1|STARTED|Overall Study||1
5102772|NCT01605292|12553704|P2|NOT COMPLETED|Overall Study||0
5102773|NCT01605292|12553705|P1|NOT COMPLETED|Overall Study||0
5102774|NCT01605292|12553704|P2|COMPLETED|Overall Study||347
5102775|NCT01605292|12553705|P1|COMPLETED|Overall Study||351
5102776|NCT01605292|12553704|P2|STARTED|Overall Study||347
5102777|NCT01605292|12553705|P1|STARTED|Overall Study||351
5102778|NCT01605227|12553731|P2|NOT COMPLETED|Overall Study||329
5102779|NCT01605227|12553732|P1|NOT COMPLETED|Overall Study||621
5102780|NCT01605227|12553731|P2|COMPLETED|Overall Study||17
5102781|NCT01605227|12553732|P1|COMPLETED|Overall Study||61
5102782|NCT01605227|12553731|P2|STARTED|Overall Study||346
5102783|NCT01605227|12553732|P1|STARTED|Overall Study||682
5102784|NCT01605136|12553744|P2|NOT COMPLETED|Safety Follow-Up Period||2
5102785|NCT01605136|12553745|P1|NOT COMPLETED|Safety Follow-Up Period||1
5102786|NCT01605136|12553744|P2|COMPLETED|Safety Follow-Up Period||40
5102787|NCT01605136|12553745|P1|COMPLETED|Safety Follow-Up Period||44
5102788|NCT01605136|12553744|P2|STARTED|Safety Follow-Up Period||42
5102789|NCT01605136|12553745|P1|STARTED|Safety Follow-Up Period||45
5102790|NCT01605136|12553744|P2|NOT COMPLETED|Study Period||3
5102791|NCT01605136|12553745|P1|NOT COMPLETED|Study Period||3
5102792|NCT01605136|12553744|P2|COMPLETED|Study Period||42
5102793|NCT01605136|12553745|P1|COMPLETED|Study Period||45
5102794|NCT01605136|12553744|P2|STARTED|Study Period||45
5102795|NCT01605136|12553745|P1|STARTED|Study Period||48
5102796|NCT01605019|12553765|P2|NOT COMPLETED|Overall Study||0
5102797|NCT01605019|12553766|P1|NOT COMPLETED|Overall Study||3
5102798|NCT01605019|12553765|P2|COMPLETED|Overall Study||0
5102799|NCT01605019|12553766|P1|COMPLETED|Overall Study||1
5102800|NCT01605019|12553765|P2|STARTED|Overall Study||0
5102801|NCT01605019|12553766|P1|STARTED|Overall Study||4
5102802|NCT01604941|12553776|P6|NOT COMPLETED|Overall Study||7
5102803|NCT01604941|12553777|P5|NOT COMPLETED|Overall Study||1
5102804|NCT01604941|12553778|P4|NOT COMPLETED|Overall Study||3
5102805|NCT01604941|12553779|P3|NOT COMPLETED|Overall Study||3
5102806|NCT01604941|12553780|P2|NOT COMPLETED|Overall Study||4
5102807|NCT01604941|12553781|P1|NOT COMPLETED|Overall Study||11
5102808|NCT01604941|12553776|P6|COMPLETED|Overall Study||0
5102809|NCT01604941|12553777|P5|COMPLETED|Overall Study||3
5102810|NCT01604941|12553778|P4|COMPLETED|Overall Study||0
5102811|NCT01604941|12553779|P3|COMPLETED|Overall Study||0
5102812|NCT01604941|12553780|P2|COMPLETED|Overall Study||0
5102813|NCT01604941|12553781|P1|COMPLETED|Overall Study||0
5102814|NCT01604941|12553776|P6|STARTED|Overall Study||7
5102815|NCT01604941|12553777|P5|STARTED|Overall Study||4
5102816|NCT01604941|12553778|P4|STARTED|Overall Study||3
5102817|NCT01604941|12553779|P3|STARTED|Overall Study||3
5102818|NCT01604941|12553780|P2|STARTED|Overall Study||4
5102819|NCT01604941|12553781|P1|STARTED|Overall Study||11
5102820|NCT01604850|12553809|P2|NOT COMPLETED|Overall Study||30
5102821|NCT01604850|12553810|P1|NOT COMPLETED|Overall Study||52
5102822|NCT01604850|12553809|P2|COMPLETED|Overall Study||69
5102823|NCT01604850|12553810|P1|COMPLETED|Overall Study||51
5102824|NCT01604850|12553809|P2|Enrolled and Treated|Overall Study||98
5102825|NCT01604850|12553810|P1|Enrolled and Treated|Overall Study||103
5102826|NCT01604850|12553809|P2|STARTED|Overall Study||99
5102827|NCT01604850|12553810|P1|STARTED|Overall Study||103
5102828|NCT01604824|12553830|P6|NOT COMPLETED|Open-label Extension (OLE) Period||0
5102829|NCT01604824|12553831|P5|NOT COMPLETED|Open-label Extension (OLE) Period||3
5102830|NCT01604824|12553832|P4|NOT COMPLETED|Open-label Extension (OLE) Period||0
5102831|NCT01604824|12553833|P3|NOT COMPLETED|Open-label Extension (OLE) Period||0
5102832|NCT01604824|12553834|P2|NOT COMPLETED|Open-label Extension (OLE) Period||0
5102833|NCT01604824|12553835|P1|NOT COMPLETED|Open-label Extension (OLE) Period||0
5102834|NCT01604824|12553830|P6|COMPLETED|Open-label Extension (OLE) Period||10
5102835|NCT01604824|12553831|P5|COMPLETED|Open-label Extension (OLE) Period||10
5102836|NCT01604824|12553832|P4|COMPLETED|Open-label Extension (OLE) Period||0
5102837|NCT01604824|12553833|P3|COMPLETED|Open-label Extension (OLE) Period||0
5102838|NCT01604824|12553834|P2|COMPLETED|Open-label Extension (OLE) Period||0
5102839|NCT01604824|12553835|P1|COMPLETED|Open-label Extension (OLE) Period||0
5102840|NCT01604824|12553830|P6|Completed Study|Open-label Extension (OLE) Period||10
5102841|NCT01604824|12553831|P5|Completed Study|Open-label Extension (OLE) Period||10
5102842|NCT01604824|12553832|P4|Completed Study|Open-label Extension (OLE) Period||0
5102843|NCT01604824|12553833|P3|Completed Study|Open-label Extension (OLE) Period||0
5102844|NCT01604824|12553834|P2|Completed Study|Open-label Extension (OLE) Period||0
5102845|NCT01604824|12553835|P1|Completed Study|Open-label Extension (OLE) Period||0
5102846|NCT01604824|12553830|P6|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
5102847|NCT01604824|12553831|P5|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
5102848|NCT01604824|12553832|P4|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
5102849|NCT01604824|12553833|P3|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
5102850|NCT01604824|12553834|P2|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
5102851|NCT01604824|12553835|P1|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
5102852|NCT01604824|12553830|P6|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
5102853|NCT01604824|12553831|P5|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
5102854|NCT01604824|12553832|P4|STARTED|Open-label Extension (OLE) Period||0
5102855|NCT01604824|12553833|P3|STARTED|Open-label Extension (OLE) Period||0
5102856|NCT01604824|12553834|P2|STARTED|Open-label Extension (OLE) Period||0
5102857|NCT01604824|12553835|P1|STARTED|Open-label Extension (OLE) Period||0
5102858|NCT01604824|12553830|P6|NOT COMPLETED|Double-blind (DB) Period||0
5102859|NCT01604824|12553831|P5|NOT COMPLETED|Double-blind (DB) Period||0
5102860|NCT01604824|12553832|P4|NOT COMPLETED|Double-blind (DB) Period||0
5102861|NCT01604824|12553833|P3|NOT COMPLETED|Double-blind (DB) Period||0
5102862|NCT01604824|12553834|P2|NOT COMPLETED|Double-blind (DB) Period||0
5102863|NCT01604824|12553835|P1|NOT COMPLETED|Double-blind (DB) Period||0
5102864|NCT01604824|12553830|P6|COMPLETED|Double-blind (DB) Period||0
5102865|NCT01604824|12553831|P5|COMPLETED|Double-blind (DB) Period||0
5102866|NCT01604824|12553832|P4|COMPLETED|Double-blind (DB) Period||5
5102867|NCT01604824|12553833|P3|COMPLETED|Double-blind (DB) Period||5
5102868|NCT01604824|12553834|P2|COMPLETED|Double-blind (DB) Period||7
5102869|NCT01604824|12553835|P1|COMPLETED|Double-blind (DB) Period||6
5102870|NCT01604824|12553830|P6|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
5102871|NCT01604824|12553831|P5|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
5102872|NCT01604824|12553832|P4|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
5102873|NCT01604824|12553833|P3|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
5102874|NCT01604824|12553834|P2|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
5102875|NCT01604824|12553835|P1|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
5102876|NCT01604824|12553830|P6|Completed DB Period (Day 99)|Double-blind (DB) Period||0
5102877|NCT01604824|12553831|P5|Completed DB Period (Day 99)|Double-blind (DB) Period||0
5102878|NCT01604824|12553832|P4|Completed DB Period (Day 99)|Double-blind (DB) Period||5
5102879|NCT01604824|12553833|P3|Completed DB Period (Day 99)|Double-blind (DB) Period||5
5102880|NCT01604824|12553834|P2|Completed DB Period (Day 99)|Double-blind (DB) Period||7
5102881|NCT01604824|12553835|P1|Completed DB Period (Day 99)|Double-blind (DB) Period||6
5102882|NCT01604824|12553830|P6|STARTED|Double-blind (DB) Period||0
5102883|NCT01604824|12553831|P5|STARTED|Double-blind (DB) Period||0
5102884|NCT01604824|12553832|P4|STARTED|Double-blind (DB) Period||5
5102885|NCT01604824|12553833|P3|STARTED|Double-blind (DB) Period||5
5102886|NCT01604824|12553834|P2|STARTED|Double-blind (DB) Period||7
5102887|NCT01604824|12553835|P1|STARTED|Double-blind (DB) Period||6
5102888|NCT01604785|12553865|P2|NOT COMPLETED|Overall Study||1
5102889|NCT01604785|12553866|P1|NOT COMPLETED|Overall Study||7
5102890|NCT01604785|12553865|P2|COMPLETED|Overall Study||36
5102891|NCT01604785|12553866|P1|COMPLETED|Overall Study||30
5102892|NCT01604785|12553865|P2|STARTED|Overall Study||37
5102893|NCT01604785|12553866|P1|STARTED|Overall Study||37
5102894|NCT01604772|12553876|P1|NOT COMPLETED|Overall Study||0
5102895|NCT01604772|12553876|P1|COMPLETED|Overall Study||16
5102896|NCT01604772|12553876|P1|STARTED|Overall Study||16
5102897|NCT01604408|12553885|P2|NOT COMPLETED|Observation Period||3
5102898|NCT01604408|12553886|P1|NOT COMPLETED|Observation Period||1
5102899|NCT01604408|12553885|P2|COMPLETED|Observation Period||84
5102900|NCT01604408|12553886|P1|COMPLETED|Observation Period||85
5102901|NCT01604408|12553885|P2|STARTED|Observation Period||87
5102902|NCT01604408|12553886|P1|STARTED|Observation Period||86
5102903|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 6||2
5102904|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 6||2
5102905|NCT01604408|12553885|P2|COMPLETED|Treatment Period 6||87
5102906|NCT01604408|12553886|P1|COMPLETED|Treatment Period 6||86
5102907|NCT01604408|12553885|P2|STARTED|Treatment Period 6||89
5102908|NCT01604408|12553886|P1|STARTED|Treatment Period 6||88
5102909|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 5||0
5102910|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 5||4
5102911|NCT01604408|12553885|P2|COMPLETED|Treatment Period 5||89
5102912|NCT01604408|12553886|P1|COMPLETED|Treatment Period 5||88
5102913|NCT01604408|12553885|P2|STARTED|Treatment Period 5||89
5102914|NCT01604408|12553886|P1|STARTED|Treatment Period 5||92
5102915|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 4||2
5102916|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 4||3
5102917|NCT01604408|12553885|P2|COMPLETED|Treatment Period 4||89
5102918|NCT01604408|12553886|P1|COMPLETED|Treatment Period 4||92
5102919|NCT01604408|12553885|P2|STARTED|Treatment Period 4||91
5102920|NCT01604408|12553886|P1|STARTED|Treatment Period 4||95
5102921|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 3||5
5102922|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 3||5
5102923|NCT01604408|12553885|P2|COMPLETED|Treatment Period 3||91
5102924|NCT01604408|12553886|P1|COMPLETED|Treatment Period 3||95
5102925|NCT01604408|12553885|P2|STARTED|Treatment Period 3||96
5102926|NCT01604408|12553886|P1|STARTED|Treatment Period 3||100
5102927|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 2||2
5102928|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 2||2
5102929|NCT01604408|12553885|P2|COMPLETED|Treatment Period 2||96
5102930|NCT01604408|12553886|P1|COMPLETED|Treatment Period 2||100
5102931|NCT01604408|12553885|P2|STARTED|Treatment Period 2||98
5102932|NCT01604408|12553886|P1|STARTED|Treatment Period 2||102
5102933|NCT01604408|12553885|P2|NOT COMPLETED|Treatment Period 1||1
5102934|NCT01604408|12553886|P1|NOT COMPLETED|Treatment Period 1||0
5102935|NCT01604408|12553885|P2|COMPLETED|Treatment Period 1||98
5102936|NCT01604408|12553886|P1|COMPLETED|Treatment Period 1||102
5102937|NCT01604408|12553885|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
5102938|NCT01604408|12553886|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
5102939|NCT01604408|12553885|P2|STARTED|Treatment Period 1||99
5102940|NCT01604408|12553886|P1|STARTED|Treatment Period 1||102
5102941|NCT01604343|12553901|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
5102942|NCT01604343|12553902|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
5102943|NCT01604343|12553903|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
5102944|NCT01604343|12553904|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
5102945|NCT01604343|12553905|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
5102946|NCT01604343|12553901|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
5102947|NCT01604343|12553902|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
5102948|NCT01604343|12553903|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
5102949|NCT01604343|12553904|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
5102950|NCT01604343|12553905|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
5102951|NCT01604343|12553901|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
5102952|NCT01604343|12553902|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
5102953|NCT01604343|12553903|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
5102954|NCT01604343|12553904|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
5102955|NCT01604343|12553905|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
5102956|NCT01604343|12553901|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
5102957|NCT01604343|12553902|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
5102958|NCT01604343|12553903|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
5102959|NCT01604343|12553904|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
5102960|NCT01604343|12553905|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
5102961|NCT01604343|12553901|P5|NOT COMPLETED|Week 52 to Week 104||41
5102962|NCT01604343|12553902|P4|NOT COMPLETED|Week 52 to Week 104||46
5102963|NCT01604343|12553903|P3|NOT COMPLETED|Week 52 to Week 104||67
5102964|NCT01604343|12553904|P2|NOT COMPLETED|Week 52 to Week 104||43
5102965|NCT01604343|12553905|P1|NOT COMPLETED|Week 52 to Week 104||0
5102966|NCT01604343|12553901|P5|COMPLETED|Week 52 to Week 104||429
5102967|NCT01604343|12553902|P4|COMPLETED|Week 52 to Week 104||195
5102968|NCT01604343|12553903|P3|COMPLETED|Week 52 to Week 104||414
5102969|NCT01604343|12553904|P2|COMPLETED|Week 52 to Week 104||200
5102970|NCT01604343|12553905|P1|COMPLETED|Week 52 to Week 104||0
5102971|NCT01604343|12553901|P5|Treated|Week 52 to Week 104||470
5102972|NCT01604343|12553902|P4|Treated|Week 52 to Week 104||241
5102973|NCT01604343|12553903|P3|Treated|Week 52 to Week 104||481
5102974|NCT01604343|12553904|P2|Treated|Week 52 to Week 104||242
5102975|NCT01604343|12553905|P1|Treated|Week 52 to Week 104||0
5102976|NCT01604343|12553901|P5|STARTED|Week 52 to Week 104||470
5102977|NCT01604343|12553902|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
5102978|NCT01604343|12553903|P3|STARTED|Week 52 to Week 104||481
5102979|NCT01604343|12553904|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
5102980|NCT01604343|12553905|P1|STARTED|Week 52 to Week 104||0
5102981|NCT01604343|12553901|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
5102982|NCT01604343|12553902|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
5102983|NCT01604343|12553903|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
5102984|NCT01604343|12553904|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
5102985|NCT01604343|12553905|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
5102986|NCT01604343|12553901|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
5102987|NCT01604343|12553902|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
5102988|NCT01604343|12553903|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
5102989|NCT01604343|12553904|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
5102990|NCT01604343|12553905|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
5102991|NCT01604343|12553901|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
5102992|NCT01604343|12553902|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
5102993|NCT01604343|12553903|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
5102994|NCT01604343|12553904|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
5102995|NCT01604343|12553905|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
5102996|NCT01604343|12553901|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
5102997|NCT01604343|12553902|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
5102998|NCT01604343|12553903|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
5102999|NCT01604343|12553904|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
5103000|NCT01604343|12553905|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
5103001|NCT01604343|12553901|P5|STARTED|Prior to W52 Administration(Through W52)||557
5103002|NCT01604343|12553902|P4|STARTED|Prior to W52 Administration(Through W52)||0
5103003|NCT01604343|12553903|P3|STARTED|Prior to W52 Administration(Through W52)||557
5103004|NCT01604343|12553904|P2|STARTED|Prior to W52 Administration(Through W52)||0
5103005|NCT01604343|12553905|P1|STARTED|Prior to W52 Administration(Through W52)||556
5103006|NCT01604291|12554018|P4|NOT COMPLETED|Overall Study||0
5103007|NCT01604291|12554019|P3|NOT COMPLETED|Overall Study||0
5103008|NCT01604291|12554020|P2|NOT COMPLETED|Overall Study||0
5103009|NCT01604291|12554021|P1|NOT COMPLETED|Overall Study||0
5103010|NCT01604291|12554018|P4|COMPLETED|Overall Study||44
5103011|NCT01604291|12554019|P3|COMPLETED|Overall Study||193
5103012|NCT01604291|12554020|P2|COMPLETED|Overall Study||443
5103013|NCT01604291|12554021|P1|COMPLETED|Overall Study||311
5103014|NCT01604291|12554018|P4|STARTED|Overall Study||44
5103015|NCT01604291|12554019|P3|STARTED|Overall Study||193
5103016|NCT01604291|12554020|P2|STARTED|Overall Study||443
5103017|NCT01604291|12554021|P1|STARTED|Overall Study||311
5103018|NCT01604278|12554070|P2|NOT COMPLETED|Overall Study||13
5103019|NCT01604278|12554071|P1|NOT COMPLETED|Overall Study||14
5103020|NCT01604278|12554070|P2|COMPLETED|Overall Study||210
5103021|NCT01604278|12554071|P1|COMPLETED|Overall Study||212
5103022|NCT01604278|12554070|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
5103023|NCT01604278|12554071|P1|Full Analysis Set|Overall Study||226
5103024|NCT01604278|12554070|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
5103025|NCT01604278|12554071|P1|Safety Set|Overall Study||226
5103026|NCT01604278|12554070|P2|STARTED|Overall Study||223
5103027|NCT01604278|12554071|P1|STARTED|Overall Study||226
5103028|NCT01604265|12554097|P2|NOT COMPLETED|Overall Study||0
5103029|NCT01604265|12554098|P1|NOT COMPLETED|Overall Study||2
5103030|NCT01604265|12554097|P2|COMPLETED|Overall Study||32
5103031|NCT01604265|12554098|P1|COMPLETED|Overall Study||32
5103032|NCT01604265|12554097|P2|STARTED|Overall Study||32
5103033|NCT01604265|12554098|P1|STARTED|Overall Study||34
5103034|NCT01604122|12554134|P2|NOT COMPLETED|Overall Study||0
5103035|NCT01604122|12554135|P1|NOT COMPLETED|Overall Study||0
5103036|NCT01604122|12554134|P2|COMPLETED|Overall Study||32
5103037|NCT01604122|12554135|P1|COMPLETED|Overall Study||60
5103038|NCT01604122|12554134|P2|STARTED|Overall Study||32
5103039|NCT01604122|12554135|P1|STARTED|Overall Study||60
5103040|NCT01604109|12554182|P2|NOT COMPLETED|Overall Study||34
5103041|NCT01604109|12554183|P1|NOT COMPLETED|Overall Study||33
5103042|NCT01604109|12554182|P2|COMPLETED|Overall Study||112
5103043|NCT01604109|12554183|P1|COMPLETED|Overall Study||117
5103044|NCT01604109|12554182|P2|STARTED|Overall Study||146
5103045|NCT01604109|12554183|P1|STARTED|Overall Study||150
5103046|NCT01603940|12554191|P2|NOT COMPLETED|Overall Study||0
5103047|NCT01603940|12554192|P1|NOT COMPLETED|Overall Study||0
5103048|NCT01603940|12554191|P2|COMPLETED|Overall Study||14
5103049|NCT01603940|12554192|P1|COMPLETED|Overall Study||16
5103050|NCT01603940|12554191|P2|STARTED|Overall Study||14
5103051|NCT01603940|12554192|P1|STARTED|Overall Study||16
5103052|NCT01603875|12554209|P3|NOT COMPLETED|Overall Study||9
5103053|NCT01603875|12554210|P2|NOT COMPLETED|Overall Study||8
5103054|NCT01603875|12554211|P1|NOT COMPLETED|Overall Study||7
5103055|NCT01603875|12554209|P3|COMPLETED|Overall Study||26
5103056|NCT01603875|12554210|P2|COMPLETED|Overall Study||27
5103057|NCT01603875|12554211|P1|COMPLETED|Overall Study||28
5103058|NCT01603875|12554209|P3|STARTED|Overall Study||35
5103059|NCT01603875|12554210|P2|STARTED|Overall Study||35
5103060|NCT01603875|12554211|P1|STARTED|Overall Study||35
5103061|NCT01603641|12554231|P1|NOT COMPLETED|Overall Study||35
5103062|NCT01603641|12554231|P1|COMPLETED|Overall Study||335
5103063|NCT01603641|12554231|P1|Modified Intent-to-treat Population|Overall Study||366
5103064|NCT01603641|12554231|P1|Safety Population (Treated)|Overall Study||367
5103065|NCT01603641|12554231|P1|STARTED|Overall Study||370
5103066|NCT01603628|12554238|P3|NOT COMPLETED|Overall Study||2
5103067|NCT01603628|12554239|P2|NOT COMPLETED|Overall Study||3
5103068|NCT01603628|12554240|P1|NOT COMPLETED|Overall Study||3
5103069|NCT01603628|12554238|P3|COMPLETED|Overall Study||128
5103070|NCT01603628|12554239|P2|COMPLETED|Overall Study||123
5103071|NCT01603628|12554240|P1|COMPLETED|Overall Study||125
5103072|NCT01603628|12554238|P3|Safety Population: Received Treatment|Overall Study||128
5103073|NCT01603628|12554239|P2|Safety Population: Received Treatment|Overall Study||126
5103074|NCT01603628|12554240|P1|Safety Population: Received Treatment|Overall Study||128
5103075|NCT01603628|12554238|P3|STARTED|Overall Study||130
5103076|NCT01603628|12554239|P2|STARTED|Overall Study||126
5103077|NCT01603628|12554240|P1|STARTED|Overall Study||128
5103078|NCT01603615|12554257|P1|NOT COMPLETED|Overall Study||34
5103079|NCT01603615|12554257|P1|COMPLETED|Overall Study||186
5103080|NCT01603615|12554257|P1|Safety Population (Treated)|Overall Study||213
5103081|NCT01603615|12554257|P1|STARTED|Overall Study||220
5103082|NCT01603602|12554264|P3|NOT COMPLETED|Overall Study||1
5103083|NCT01603602|12554265|P2|NOT COMPLETED|Overall Study||0
5103084|NCT01603602|12554266|P1|NOT COMPLETED|Overall Study||2
5103085|NCT01603602|12554264|P3|COMPLETED|Overall Study||79
5103086|NCT01603602|12554265|P2|COMPLETED|Overall Study||78
5103087|NCT01603602|12554266|P1|COMPLETED|Overall Study||75
5103088|NCT01603602|12554264|P3|STARTED|Overall Study||80
5103089|NCT01603602|12554265|P2|STARTED|Overall Study||78
5103090|NCT01603602|12554266|P1|STARTED|Overall Study||77
5103091|NCT01603459|12554286|P1|NOT COMPLETED|Overall Study||18
5103092|NCT01603459|12554286|P1|COMPLETED|Overall Study||137
5103093|NCT01603459|12554286|P1|STARTED|Overall Study||155
5103094|NCT01603420|12554408|P2|NOT COMPLETED|Overall Study||0
5103095|NCT01603420|12554409|P1|NOT COMPLETED|Overall Study||0
5103096|NCT01603420|12554408|P2|COMPLETED|Overall Study||1
5103097|NCT01603420|12554409|P1|COMPLETED|Overall Study||1
5103098|NCT01603420|12554408|P2|STARTED|Overall Study||1
5103099|NCT01603420|12554409|P1|STARTED|Overall Study||1
5103100|NCT01603394|12554437|P1|NOT COMPLETED|Overall Study||1
5103101|NCT01603394|12554437|P1|COMPLETED|Overall Study||8
5103102|NCT01603394|12554437|P1|STARTED|Overall Study||9
5103103|NCT01603368|12554454|P2|NOT COMPLETED|Overall Study||0
5103104|NCT01603368|12554455|P1|NOT COMPLETED|Overall Study||0
5103105|NCT01603368|12554454|P2|COMPLETED|Overall Study||66
5103106|NCT01603368|12554455|P1|COMPLETED|Overall Study||68
5103107|NCT01603368|12554454|P2|STARTED|Overall Study||66
5103108|NCT01603368|12554455|P1|STARTED|Overall Study||68
5103109|NCT01603355|12554491|P1|NOT COMPLETED|Overall Study||2
5103110|NCT01603355|12554491|P1|COMPLETED|Overall Study||1
5103111|NCT01603355|12554491|P1|STARTED|Overall Study||3
5103112|NCT01603277|12554497|P2|NOT COMPLETED|Overall Study||18
5103113|NCT01603277|12554498|P1|NOT COMPLETED|Overall Study||14
5103114|NCT01603277|12554497|P2|COMPLETED|Overall Study||64
5103115|NCT01603277|12554498|P1|COMPLETED|Overall Study||64
5103116|NCT01603277|12554497|P2|STARTED|Overall Study||82
5103117|NCT01603277|12554498|P1|STARTED|Overall Study||78
5103118|NCT01603121|12554504|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
5103119|NCT01603121|12554505|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
5103120|NCT01603121|12554504|P2|COMPLETED|Second Intervention, 10 Hours||0
5103121|NCT01603121|12554505|P1|COMPLETED|Second Intervention, 10 Hours||0
5103122|NCT01603121|12554504|P2|STARTED|Second Intervention, 10 Hours||0
5103123|NCT01603121|12554505|P1|STARTED|Second Intervention, 10 Hours||1
5103124|NCT01603121|12554504|P2|NOT COMPLETED|First Intervention, 10 Hours||0
5103125|NCT01603121|12554505|P1|NOT COMPLETED|First Intervention, 10 Hours||0
5103126|NCT01603121|12554504|P2|COMPLETED|First Intervention, 10 Hours||0
5103127|NCT01603121|12554505|P1|COMPLETED|First Intervention, 10 Hours||1
5103128|NCT01603121|12554504|P2|STARTED|First Intervention, 10 Hours||0
5103129|NCT01603121|12554505|P1|STARTED|First Intervention, 10 Hours||1
5103130|NCT01603082|12554517|P2|NOT COMPLETED|Overall Study||1
5103131|NCT01603082|12554518|P1|NOT COMPLETED|Overall Study||2
5103132|NCT01603082|12554517|P2|COMPLETED|Overall Study|Completed the study|48
5103133|NCT01603082|12554518|P1|COMPLETED|Overall Study|Completed the study.|49
5103134|NCT01603082|12554517|P2|STARTED|Overall Study|Randomized|49
5103135|NCT01603082|12554518|P1|STARTED|Overall Study|Randomized|51
5103136|NCT01603056|12554528|P2|NOT COMPLETED|Overall Study||14
5103137|NCT01603056|12554529|P1|NOT COMPLETED|Overall Study||34
5103138|NCT01603056|12554528|P2|COMPLETED|Overall Study||190
5103139|NCT01603056|12554529|P1|COMPLETED|Overall Study||379
5103140|NCT01603056|12554528|P2|STARTED|Overall Study||204
5103141|NCT01603056|12554529|P1|STARTED|Overall Study||413
5103142|NCT01603043|12554559|P2|NOT COMPLETED|Overall Study||3
5103143|NCT01603043|12554560|P1|NOT COMPLETED|Overall Study||7
5103144|NCT01603043|12554559|P2|COMPLETED|Overall Study||0
5103145|NCT01603043|12554560|P1|COMPLETED|Overall Study||0
5103146|NCT01603043|12554559|P2|STARTED|Overall Study||3
5103147|NCT01603043|12554560|P1|STARTED|Overall Study||7
5103148|NCT01602965|12554572|P2|NOT COMPLETED|Overall Study||2
5103149|NCT01602965|12554573|P1|NOT COMPLETED|Overall Study||4
5103150|NCT01602965|12554572|P2|COMPLETED|Overall Study||18
5103151|NCT01602965|12554573|P1|COMPLETED|Overall Study||16
5103152|NCT01602965|12554572|P2|STARTED|Overall Study||20
5103153|NCT01602965|12554573|P1|STARTED|Overall Study||20
5103154|NCT01602744|12554581|P2|NOT COMPLETED|Overall Study||23
5103155|NCT01602744|12554582|P1|NOT COMPLETED|Overall Study||30
5103156|NCT01602744|12554581|P2|COMPLETED|Overall Study||160
5103157|NCT01602744|12554582|P1|COMPLETED|Overall Study||146
5103158|NCT01602744|12554581|P2|STARTED|Overall Study||183
5103159|NCT01602744|12554582|P1|STARTED|Overall Study||176
5103160|NCT01602731|12554598|P1|NOT COMPLETED|Overall Study||30
5103161|NCT01602731|12554598|P1|COMPLETED|Overall Study||15
5103162|NCT01602731|12554598|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
5103163|NCT01602731|12554598|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
5103164|NCT01602731|12554598|P1|STARTED|Overall Study||45
5103165|NCT01602679|12554606|P2|NOT COMPLETED|Overall Study||0
5103166|NCT01602679|12554607|P1|NOT COMPLETED|Overall Study||0
5103167|NCT01602679|12554606|P2|COMPLETED|Overall Study||3
5103168|NCT01602679|12554607|P1|COMPLETED|Overall Study||4
5103169|NCT01602679|12554606|P2|STARTED|Overall Study||3
5103170|NCT01602679|12554607|P1|STARTED|Overall Study||4
5103171|NCT01602614|12554621|P4|NOT COMPLETED|Overall Study||0
5103172|NCT01602614|12554622|P3|NOT COMPLETED|Overall Study||0
5103173|NCT01602614|12554623|P2|NOT COMPLETED|Overall Study||0
5103174|NCT01602614|12554624|P1|NOT COMPLETED|Overall Study||0
5103175|NCT01602614|12554621|P4|COMPLETED|Overall Study||0
5103176|NCT01602614|12554622|P3|COMPLETED|Overall Study||8
5103177|NCT01602614|12554623|P2|COMPLETED|Overall Study||10
5103178|NCT01602614|12554624|P1|COMPLETED|Overall Study||0
5103179|NCT01602614|12554621|P4|STARTED|Overall Study||0
5103180|NCT01602614|12554622|P3|STARTED|Overall Study||8
5103181|NCT01602614|12554623|P2|STARTED|Overall Study||10
5103182|NCT01602614|12554624|P1|STARTED|Overall Study||0
5103183|NCT01602562|12554692|P2|NOT COMPLETED|Overall Study||3
5103184|NCT01602562|12554693|P1|NOT COMPLETED|Overall Study||5
5103185|NCT01602562|12554692|P2|COMPLETED|Overall Study||16
5103186|NCT01602562|12554693|P1|COMPLETED|Overall Study||16
5103187|NCT01602562|12554692|P2|STARTED|Overall Study||19
5103188|NCT01602562|12554693|P1|STARTED|Overall Study||21
5103189|NCT01602549|12554729|P2|NOT COMPLETED|Overall Study||1
5103190|NCT01602549|12554730|P1|NOT COMPLETED|Overall Study||1
5103191|NCT01602549|12554729|P2|COMPLETED|Overall Study||37
5103192|NCT01602549|12554730|P1|COMPLETED|Overall Study||18
5103193|NCT01602549|12554729|P2|STARTED|Overall Study||38
5103194|NCT01602549|12554730|P1|STARTED|Overall Study||19
5103195|NCT01602510|12554809|P3|NOT COMPLETED|Randomized Phase||73
5103196|NCT01602510|12554810|P2|NOT COMPLETED|Randomized Phase||74
5103197|NCT01602510|12554811|P1|NOT COMPLETED|Randomized Phase||0
5103198|NCT01602510|12554809|P3|COMPLETED|Randomized Phase||58
5103199|NCT01602510|12554810|P2|COMPLETED|Randomized Phase||59
5103200|NCT01602510|12554811|P1|COMPLETED|Randomized Phase||0
5103201|NCT01602510|12554809|P3|STARTED|Randomized Phase||131
5103202|NCT01602510|12554810|P2|STARTED|Randomized Phase||133
5103203|NCT01602510|12554811|P1|STARTED|Randomized Phase||0
5103204|NCT01602510|12554809|P3|NOT COMPLETED|Open Label Phase||0
5103205|NCT01602510|12554810|P2|NOT COMPLETED|Open Label Phase||0
5103206|NCT01602510|12554811|P1|NOT COMPLETED|Open Label Phase||303
5103207|NCT01602510|12554809|P3|COMPLETED|Open Label Phase||0
5103208|NCT01602510|12554810|P2|COMPLETED|Open Label Phase||0
5103209|NCT01602510|12554811|P1|COMPLETED|Open Label Phase||117
5103210|NCT01602510|12554809|P3|STARTED|Open Label Phase||0
5103211|NCT01602510|12554810|P2|STARTED|Open Label Phase||0
5103212|NCT01602510|12554811|P1|STARTED|Open Label Phase||420
5103213|NCT01602484|12554837|P2|NOT COMPLETED|Overall Study||1
5103214|NCT01602484|12554838|P1|NOT COMPLETED|Overall Study||0
5103215|NCT01602484|12554837|P2|COMPLETED|Overall Study||24
5103216|NCT01602484|12554838|P1|COMPLETED|Overall Study||25
5103217|NCT01602484|12554837|P2|STARTED|Overall Study||25
5103218|NCT01602484|12554838|P1|STARTED|Overall Study||25
5103219|NCT01602471|12554850|P1|NOT COMPLETED|Overall Study||0
5103220|NCT01602471|12554850|P1|COMPLETED|Overall Study||4
5103221|NCT01602471|12554850|P1|STARTED|Overall Study||4
5103222|NCT01602419|12554854|P1|NOT COMPLETED|Overall Study||29
5103223|NCT01602419|12554854|P1|COMPLETED|Overall Study||91
5103224|NCT01602419|12554854|P1|EFF Population|Overall Study||91
5103225|NCT01602419|12554854|P1|ITT Population|Overall Study||102
5103226|NCT01602419|12554854|P1|SAF Population|Overall Study||111
5103227|NCT01602419|12554854|P1|STARTED|Overall Study||120
5103228|NCT01602380|12554909|P2|NOT COMPLETED|Overall Study||101
5103229|NCT01602380|12554910|P1|NOT COMPLETED|Overall Study||93
5103230|NCT01602380|12554909|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
5103231|NCT01602380|12554910|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
5103232|NCT01602380|12554909|P2|STARTED|Overall Study||232
5103233|NCT01602380|12554910|P1|STARTED|Overall Study||230
5103234|NCT01602341|12554934|P2|NOT COMPLETED|Overall Study||1
5103235|NCT01602341|12554935|P1|NOT COMPLETED|Overall Study||0
5103236|NCT01602341|12554934|P2|COMPLETED|Overall Study||41
5103237|NCT01602341|12554935|P1|COMPLETED|Overall Study||44
5103238|NCT01602341|12554934|P2|STARTED|Overall Study||42
5103239|NCT01602341|12554935|P1|STARTED|Overall Study||44
5103240|NCT01602315|12554976|P7|NOT COMPLETED|Overall Study||29
5103241|NCT01602315|12554977|P6|NOT COMPLETED|Overall Study||35
5103242|NCT01602315|12554978|P5|NOT COMPLETED|Overall Study||71
5103243|NCT01602315|12554979|P4|NOT COMPLETED|Overall Study||6
5103244|NCT01602315|12554980|P3|NOT COMPLETED|Overall Study||18
5103245|NCT01602315|12554981|P2|NOT COMPLETED|Overall Study||5
5103246|NCT01602315|12554982|P1|NOT COMPLETED|Overall Study||16
5103247|NCT01602315|12554976|P7|COMPLETED|Overall Study||0
5103248|NCT01602315|12554977|P6|COMPLETED|Overall Study||0
5103249|NCT01602315|12554978|P5|COMPLETED|Overall Study||0
5103250|NCT01602315|12554979|P4|COMPLETED|Overall Study||0
5103251|NCT01602315|12554980|P3|COMPLETED|Overall Study||0
5103252|NCT01602315|12554981|P2|COMPLETED|Overall Study||0
5103253|NCT01602315|12554982|P1|COMPLETED|Overall Study||0
5103254|NCT01602315|12554976|P7|STARTED|Overall Study||29
5103255|NCT01602315|12554977|P6|STARTED|Overall Study||35
5103256|NCT01602315|12554978|P5|STARTED|Overall Study||71
5103257|NCT01602315|12554979|P4|STARTED|Overall Study||6
5103258|NCT01602315|12554980|P3|STARTED|Overall Study||18
5103259|NCT01602315|12554981|P2|STARTED|Overall Study||5
5103260|NCT01602315|12554982|P1|STARTED|Overall Study||16
5103261|NCT01602224|12555071|P3|NOT COMPLETED|Overall Study||6
5103262|NCT01602224|12555072|P2|NOT COMPLETED|Overall Study||8
5103263|NCT01602224|12555073|P1|NOT COMPLETED|Overall Study||8
5103264|NCT01602224|12555071|P3|COMPLETED|Overall Study||66
5103265|NCT01602224|12555072|P2|COMPLETED|Overall Study||66
5103266|NCT01602224|12555073|P1|COMPLETED|Overall Study||66
5103267|NCT01602224|12555071|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
5103268|NCT01602224|12555072|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
5103269|NCT01602224|12555073|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
5103270|NCT01602224|12555071|P3|STARTED|Overall Study||72
5103271|NCT01602224|12555072|P2|STARTED|Overall Study||74
5103272|NCT01602224|12555073|P1|STARTED|Overall Study||74
5103273|NCT01602198|12555119|P2|NOT COMPLETED|Overall Study||0
5103274|NCT01602198|12555120|P1|NOT COMPLETED|Overall Study||0
5103275|NCT01602198|12555119|P2|COMPLETED|Overall Study||1
5103276|NCT01602198|12555120|P1|COMPLETED|Overall Study||0
5103277|NCT01602198|12555119|P2|STARTED|Overall Study||1
5103278|NCT01602198|12555120|P1|STARTED|Overall Study||0
5103279|NCT01602172|12555129|P3|NOT COMPLETED|Overall Study||0
5103280|NCT01602172|12555130|P2|NOT COMPLETED|Overall Study||6
5103281|NCT01602172|12555131|P1|NOT COMPLETED|Overall Study||5
5103282|NCT01602172|12555129|P3|COMPLETED|Overall Study||22
5103283|NCT01602172|12555130|P2|COMPLETED|Overall Study||17
5103284|NCT01602172|12555131|P1|COMPLETED|Overall Study||32
5103285|NCT01602172|12555129|P3|STARTED|Overall Study||22
5103286|NCT01602172|12555130|P2|STARTED|Overall Study||23
5103287|NCT01602172|12555131|P1|STARTED|Overall Study||37
5103288|NCT01602120|12555158|P4|NOT COMPLETED|Overall Study||53
5103289|NCT01602120|12555159|P3|NOT COMPLETED|Overall Study||17
5103290|NCT01602120|12555160|P2|NOT COMPLETED|Overall Study||60
5103291|NCT01602120|12555161|P1|NOT COMPLETED|Overall Study||29
5103292|NCT01602120|12555158|P4|COMPLETED|Overall Study||0
5103293|NCT01602120|12555159|P3|COMPLETED|Overall Study||0
5103294|NCT01602120|12555160|P2|COMPLETED|Overall Study||0
5103295|NCT01602120|12555161|P1|COMPLETED|Overall Study||0
5103296|NCT01602120|12555158|P4|STARTED|Overall Study||53
5103297|NCT01602120|12555159|P3|STARTED|Overall Study||17
5103298|NCT01602120|12555160|P2|STARTED|Overall Study||60
5103299|NCT01602120|12555161|P1|STARTED|Overall Study||29
5103300|NCT01602068|12555175|P2|NOT COMPLETED|Overall Study||0
5103301|NCT01602068|12555176|P1|NOT COMPLETED|Overall Study||0
5103302|NCT01602068|12555175|P2|COMPLETED|Overall Study||22
5103303|NCT01602068|12555176|P1|COMPLETED|Overall Study||23
5103304|NCT01602068|12555175|P2|STARTED|Overall Study|Day before surgery|22
5103305|NCT01602068|12555176|P1|STARTED|Overall Study|Day before surgery|23
5103306|NCT01602016|12555182|P1|NOT COMPLETED|Overall Study||0
5103307|NCT01602016|12555182|P1|COMPLETED|Overall Study||0
5103308|NCT01602016|12555182|P1|STARTED|Overall Study||0
5103309|NCT01601977|12555189|P1|NOT COMPLETED|Overall Study||0
5103310|NCT01601977|12555189|P1|COMPLETED|Overall Study||10
5103407|NCT01601431|12555478|P1|COMPLETED|Overall Study||211
5103311|NCT01601977|12555189|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
5103312|NCT01601873|12555209|P2|NOT COMPLETED|Overall Study||3
5103313|NCT01601873|12555210|P1|NOT COMPLETED|Overall Study||2
5103314|NCT01601873|12555209|P2|COMPLETED|Overall Study||44
5103315|NCT01601873|12555210|P1|COMPLETED|Overall Study||48
5103316|NCT01601873|12555209|P2|STARTED|Overall Study||47
5103317|NCT01601873|12555210|P1|STARTED|Overall Study||50
5103318|NCT01601847|12555236|P2|NOT COMPLETED|Overall Study||10
5103319|NCT01601847|12555237|P1|NOT COMPLETED|Overall Study||13
5103320|NCT01601847|12555236|P2|COMPLETED|Overall Study||137
5103321|NCT01601847|12555237|P1|COMPLETED|Overall Study||140
5103322|NCT01601847|12555236|P2|STARTED|Overall Study||147
5103323|NCT01601847|12555237|P1|STARTED|Overall Study||153
5103324|NCT01601821|12555249|P2|NOT COMPLETED|Overall Study||29
5103325|NCT01601821|12555250|P1|NOT COMPLETED|Overall Study||29
5103326|NCT01601821|12555249|P2|COMPLETED|Overall Study||91
5103327|NCT01601821|12555250|P1|COMPLETED|Overall Study||96
5103328|NCT01601821|12555249|P2|STARTED|Overall Study||120
5103329|NCT01601821|12555250|P1|STARTED|Overall Study||125
5103330|NCT01601782|12555280|P1|NOT COMPLETED|Overall Study||0
5103331|NCT01601782|12555280|P1|COMPLETED|Overall Study||16
5103332|NCT01601782|12555280|P1|STARTED|Overall Study||16
5103333|NCT01601704|12555286|P2|NOT COMPLETED|Overall Study||4
5103334|NCT01601704|12555287|P1|NOT COMPLETED|Overall Study||1
5103335|NCT01601704|12555286|P2|COMPLETED|Overall Study||4450
5103336|NCT01601704|12555287|P1|COMPLETED|Overall Study||4455
5103337|NCT01601704|12555286|P2|Treated|Overall Study||4450
5103338|NCT01601704|12555287|P1|Treated|Overall Study||4455
5103339|NCT01601704|12555286|P2|STARTED|Overall Study||4454
5103340|NCT01601704|12555287|P1|STARTED|Overall Study||4456
5103341|NCT01601691|12555301|P1|NOT COMPLETED|Overall Study||0
5103342|NCT01601691|12555301|P1|COMPLETED|Overall Study||10
5103343|NCT01601691|12555301|P1|STARTED|Overall Study||10
5103344|NCT01601626|12555308|P3|NOT COMPLETED|Overall Study||2
5103345|NCT01601626|12555309|P2|NOT COMPLETED|Overall Study||5
5103346|NCT01601626|12555310|P1|NOT COMPLETED|Overall Study||3
5103347|NCT01601626|12555308|P3|COMPLETED|Overall Study||21
5103348|NCT01601626|12555309|P2|COMPLETED|Overall Study||19
5103349|NCT01601626|12555310|P1|COMPLETED|Overall Study||21
5103350|NCT01601626|12555308|P3|STARTED|Overall Study||23
5103351|NCT01601626|12555309|P2|STARTED|Overall Study||24
5103352|NCT01601626|12555310|P1|STARTED|Overall Study||24
5103353|NCT01601535|12555399|P6|NOT COMPLETED|Phase 2||12
5103354|NCT01601535|12555400|P5|NOT COMPLETED|Phase 2||19
5103355|NCT01601535|12555401|P4|NOT COMPLETED|Phase 2||0
5103356|NCT01601535|12555402|P3|NOT COMPLETED|Phase 2||0
5103357|NCT01601535|12555403|P2|NOT COMPLETED|Phase 2||0
5103358|NCT01601535|12555404|P1|NOT COMPLETED|Phase 2||0
5103359|NCT01601535|12555399|P6|COMPLETED|Phase 2||0
5103360|NCT01601535|12555400|P5|COMPLETED|Phase 2||1
5103361|NCT01601535|12555401|P4|COMPLETED|Phase 2||0
5103362|NCT01601535|12555402|P3|COMPLETED|Phase 2||0
5103363|NCT01601535|12555403|P2|COMPLETED|Phase 2||0
5103364|NCT01601535|12555404|P1|COMPLETED|Phase 2||0
5103365|NCT01601535|12555399|P6|STARTED|Phase 2||12
5103366|NCT01601535|12555400|P5|STARTED|Phase 2||20
5103367|NCT01601535|12555401|P4|STARTED|Phase 2||0
5103368|NCT01601535|12555402|P3|STARTED|Phase 2||0
5103369|NCT01601535|12555403|P2|STARTED|Phase 2||0
5103370|NCT01601535|12555404|P1|STARTED|Phase 2||0
5103371|NCT01601535|12555399|P6|NOT COMPLETED|Phase 1||0
5103372|NCT01601535|12555400|P5|NOT COMPLETED|Phase 1||0
5103373|NCT01601535|12555401|P4|NOT COMPLETED|Phase 1||4
5103374|NCT01601535|12555402|P3|NOT COMPLETED|Phase 1||5
5103375|NCT01601535|12555403|P2|NOT COMPLETED|Phase 1||6
5103376|NCT01601535|12555404|P1|NOT COMPLETED|Phase 1||6
5103377|NCT01601535|12555399|P6|COMPLETED|Phase 1||0
5103378|NCT01601535|12555400|P5|COMPLETED|Phase 1||0
5103379|NCT01601535|12555401|P4|COMPLETED|Phase 1||0
5103380|NCT01601535|12555402|P3|COMPLETED|Phase 1||1
5103381|NCT01601535|12555403|P2|COMPLETED|Phase 1||0
5103382|NCT01601535|12555404|P1|COMPLETED|Phase 1||0
5103383|NCT01601535|12555399|P6|STARTED|Phase 1||0
5103384|NCT01601535|12555400|P5|STARTED|Phase 1||0
5103385|NCT01601535|12555401|P4|STARTED|Phase 1||4
5103386|NCT01601535|12555402|P3|STARTED|Phase 1||6
5103387|NCT01601535|12555403|P2|STARTED|Phase 1||6
5103388|NCT01601535|12555404|P1|STARTED|Phase 1||6
5103389|NCT01601470|12555460|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
5103390|NCT01601470|12555460|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
5103391|NCT01601470|12555460|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
5103392|NCT01601470|12555460|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
5103393|NCT01601470|12555460|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
5103394|NCT01601470|12555460|P1|NOT COMPLETED|Period 2 - LCZ696||1
5103395|NCT01601470|12555460|P1|COMPLETED|Period 2 - LCZ696||27
5103396|NCT01601470|12555460|P1|Safety Set|Period 2 - LCZ696||27
5103397|NCT01601470|12555460|P1|PK Analysis Set|Period 2 - LCZ696||27
5103398|NCT01601470|12555460|P1|STARTED|Period 2 - LCZ696||28
5103399|NCT01601470|12555460|P1|NOT COMPLETED|Period 1 - Sildenafil||0
5103400|NCT01601470|12555460|P1|COMPLETED|Period 1 - Sildenafil||28
5103401|NCT01601470|12555460|P1|Safety Set|Period 1 - Sildenafil||28
5103402|NCT01601470|12555460|P1|PK Analysis Set|Period 1 - Sildenafil||28
5103403|NCT01601470|12555460|P1|STARTED|Period 1 - Sildenafil||28
5103404|NCT01601431|12555477|P2|NOT COMPLETED|Overall Study||3
5103405|NCT01601431|12555478|P1|NOT COMPLETED|Overall Study||12
5103406|NCT01601431|12555477|P2|COMPLETED|Overall Study||214
5103408|NCT01601431|12555477|P2|STARTED|Overall Study||217
5103409|NCT01601431|12555478|P1|STARTED|Overall Study||223
5103410|NCT01601236|12555490|P6|NOT COMPLETED|Overall Study||1
5103411|NCT01601236|12555491|P5|NOT COMPLETED|Overall Study||3
5103412|NCT01601236|12555492|P4|NOT COMPLETED|Overall Study||2
5103413|NCT01601236|12555493|P3|NOT COMPLETED|Overall Study||6
5103414|NCT01601236|12555494|P2|NOT COMPLETED|Overall Study||1
5103415|NCT01601236|12555495|P1|NOT COMPLETED|Overall Study||5
5103416|NCT01601236|12555490|P6|COMPLETED|Overall Study||0
5103417|NCT01601236|12555491|P5|COMPLETED|Overall Study||0
5103418|NCT01601236|12555492|P4|COMPLETED|Overall Study||4
5103419|NCT01601236|12555493|P3|COMPLETED|Overall Study||8
5103420|NCT01601236|12555494|P2|COMPLETED|Overall Study||2
5103421|NCT01601236|12555495|P1|COMPLETED|Overall Study||2
5103422|NCT01601236|12555490|P6|STARTED|Overall Study||1
5103423|NCT01601236|12555491|P5|STARTED|Overall Study||3
5103424|NCT01601236|12555492|P4|STARTED|Overall Study||6
5103425|NCT01601236|12555493|P3|STARTED|Overall Study||14
5103426|NCT01601236|12555494|P2|STARTED|Overall Study||3
5103427|NCT01601236|12555495|P1|STARTED|Overall Study||7
5103428|NCT01601132|12555531|P1|NOT COMPLETED|Overall Study||2
5103429|NCT01601132|12555531|P1|COMPLETED|Overall Study||28
5103430|NCT01601132|12555531|P1|STARTED|Overall Study||30
5103431|NCT01601067|12555550|P2|NOT COMPLETED|Overall Study||22
5103432|NCT01601067|12555551|P1|NOT COMPLETED|Overall Study||33
5103433|NCT01601067|12555550|P2|COMPLETED|Overall Study||34
5103434|NCT01601067|12555551|P1|COMPLETED|Overall Study||30
5103435|NCT01601067|12555550|P2|STARTED|Overall Study||56
5103436|NCT01601067|12555551|P1|STARTED|Overall Study||63
5103437|NCT01600950|12555559|P2|NOT COMPLETED|Period 2||0
5103438|NCT01600950|12555560|P1|NOT COMPLETED|Period 2||0
5103439|NCT01600950|12555559|P2|COMPLETED|Period 2||10
5103440|NCT01600950|12555560|P1|COMPLETED|Period 2||10
5103441|NCT01600950|12555559|P2|STARTED|Period 2||10
5103442|NCT01600950|12555560|P1|STARTED|Period 2||10
5103443|NCT01600950|12555559|P2|NOT COMPLETED|Period 1||0
5103444|NCT01600950|12555560|P1|NOT COMPLETED|Period 1||0
5103445|NCT01600950|12555559|P2|COMPLETED|Period 1||10
5103446|NCT01600950|12555560|P1|COMPLETED|Period 1||10
5103447|NCT01600950|12555559|P2|STARTED|Period 1||10
5103448|NCT01600950|12555560|P1|STARTED|Period 1||10
5103449|NCT01600885|12555576|P2|NOT COMPLETED|Second Period||0
5103450|NCT01600885|12555577|P1|NOT COMPLETED|Second Period||0
5103451|NCT01600885|12555576|P2|COMPLETED|Second Period||8
5103452|NCT01600885|12555577|P1|COMPLETED|Second Period||8
5103453|NCT01600885|12555576|P2|STARTED|Second Period||8
5103454|NCT01600885|12555577|P1|STARTED|Second Period||8
5103455|NCT01600885|12555576|P2|NOT COMPLETED|Wash Out Period||0
5103456|NCT01600885|12555577|P1|NOT COMPLETED|Wash Out Period||0
5103457|NCT01600885|12555576|P2|COMPLETED|Wash Out Period||8
5103458|NCT01600885|12555577|P1|COMPLETED|Wash Out Period||8
5103459|NCT01600885|12555576|P2|STARTED|Wash Out Period||8
5103460|NCT01600885|12555577|P1|STARTED|Wash Out Period||8
5103461|NCT01600885|12555576|P2|NOT COMPLETED|First Period||1
5103462|NCT01600885|12555577|P1|NOT COMPLETED|First Period||2
5103463|NCT01600885|12555576|P2|COMPLETED|First Period||8
5103464|NCT01600885|12555577|P1|COMPLETED|First Period||8
5103465|NCT01600885|12555576|P2|STARTED|First Period||9
5103466|NCT01600885|12555577|P1|STARTED|First Period||10
5103467|NCT01600729|12555587|P1|NOT COMPLETED|Overall Study||1
5103468|NCT01600729|12555587|P1|COMPLETED|Overall Study||65
5103469|NCT01600729|12555587|P1|STARTED|Overall Study||66
5103470|NCT01600716|12555594|P2|NOT COMPLETED|Overall Study||7
5103471|NCT01600716|12555595|P1|NOT COMPLETED|Overall Study||7
5103472|NCT01600716|12555594|P2|COMPLETED|Overall Study||71
5103473|NCT01600716|12555595|P1|COMPLETED|Overall Study||59
5103474|NCT01600716|12555594|P2|STARTED|Overall Study||78
5103475|NCT01600716|12555595|P1|STARTED|Overall Study||66
5103476|NCT01600703|12555611|P2|NOT COMPLETED|Second Intervention||0
5103477|NCT01600703|12555612|P1|NOT COMPLETED|Second Intervention||0
5103478|NCT01600703|12555611|P2|COMPLETED|Second Intervention||8
5103479|NCT01600703|12555612|P1|COMPLETED|Second Intervention||7
5103480|NCT01600703|12555611|P2|STARTED|Second Intervention||8
5103481|NCT01600703|12555612|P1|STARTED|Second Intervention||7
5103482|NCT01600703|12555611|P2|NOT COMPLETED|First Intervention||0
5103483|NCT01600703|12555612|P1|NOT COMPLETED|First Intervention||0
5103484|NCT01600703|12555611|P2|COMPLETED|First Intervention||8
5103485|NCT01600703|12555612|P1|COMPLETED|First Intervention||7
5103486|NCT01600703|12555611|P2|STARTED|First Intervention||8
5103487|NCT01600703|12555612|P1|STARTED|First Intervention||7
5103488|NCT01600677|12555622|P2|NOT COMPLETED|Overall Study||0
5103489|NCT01600677|12555623|P1|NOT COMPLETED|Overall Study||0
5103490|NCT01600677|12555622|P2|COMPLETED|Overall Study||4
5103491|NCT01600677|12555623|P1|COMPLETED|Overall Study||7
5103492|NCT01600677|12555622|P2|STARTED|Overall Study||4
5103493|NCT01600677|12555623|P1|STARTED|Overall Study||7
5103494|NCT01600586|12555635|P2|NOT COMPLETED|Overall Study||3
5103495|NCT01600586|12555636|P1|NOT COMPLETED|Overall Study||3
5103496|NCT01600586|12555635|P2|COMPLETED|Overall Study||48
5103497|NCT01600586|12555636|P1|COMPLETED|Overall Study||46
5103498|NCT01600586|12555635|P2|STARTED|Overall Study||51
5103499|NCT01600586|12555636|P1|STARTED|Overall Study||49
5103500|NCT01600495|12555652|P2|NOT COMPLETED|Overall Study||0
5103501|NCT01600495|12555653|P1|NOT COMPLETED|Overall Study||0
5103502|NCT01600495|12555652|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
5103678|NCT01598896|12556267|P2|COMPLETED|Overall Study||2
5103503|NCT01600495|12555653|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
5103504|NCT01600495|12555652|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
5103505|NCT01600495|12555653|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
5103506|NCT01600482|12555667|P2|NOT COMPLETED|Overall Study||0
5103507|NCT01600482|12555668|P1|NOT COMPLETED|Overall Study||0
5103508|NCT01600482|12555667|P2|COMPLETED|Overall Study||59
5103509|NCT01600482|12555668|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
5103510|NCT01600482|12555667|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
5103511|NCT01600482|12555668|P1|STARTED|Overall Study||148
5103512|NCT01600326|12555688|P2|NOT COMPLETED|Overall Study||1
5103513|NCT01600326|12555689|P1|NOT COMPLETED|Overall Study||1
5103514|NCT01600326|12555688|P2|COMPLETED|Overall Study||14
5103515|NCT01600326|12555689|P1|COMPLETED|Overall Study||14
5103516|NCT01600326|12555688|P2|Primary Outcome Measure Data Collection|Overall Study||15
5103517|NCT01600326|12555689|P1|Primary Outcome Measure Data Collection|Overall Study||15
5103518|NCT01600326|12555688|P2|STARTED|Overall Study||15
5103519|NCT01600326|12555689|P1|STARTED|Overall Study||15
5103520|NCT01600287|12555699|P2|NOT COMPLETED|Overall Study||0
5103521|NCT01600287|12555700|P1|NOT COMPLETED|Overall Study||0
5103522|NCT01600287|12555699|P2|COMPLETED|Overall Study||20
5103523|NCT01600287|12555700|P1|COMPLETED|Overall Study||20
5103524|NCT01600287|12555699|P2|STARTED|Overall Study||20
5103525|NCT01600287|12555700|P1|STARTED|Overall Study||20
5103526|NCT01600222|12555740|P1|NOT COMPLETED|Overall Study||2
5103527|NCT01600222|12555740|P1|COMPLETED|Overall Study||35
5103528|NCT01600222|12555740|P1|STARTED|Overall Study||37
5103529|NCT01600105|12555765|P2|NOT COMPLETED|Sub Study V||0
5103530|NCT01600105|12555766|P1|NOT COMPLETED|Sub Study V||2
5103531|NCT01600105|12555765|P2|COMPLETED|Sub Study V||0
5103532|NCT01600105|12555766|P1|COMPLETED|Sub Study V||50
5103533|NCT01600105|12555765|P2|STARTED|Sub Study V||0
5103534|NCT01600105|12555766|P1|STARTED|Sub Study V||52
5103535|NCT01600105|12555765|P2|NOT COMPLETED|Sub Study IV||0
5103536|NCT01600105|12555766|P1|NOT COMPLETED|Sub Study IV||0
5103537|NCT01600105|12555765|P2|COMPLETED|Sub Study IV||8
5103538|NCT01600105|12555766|P1|COMPLETED|Sub Study IV||41
5103539|NCT01600105|12555765|P2|STARTED|Sub Study IV||8
5103540|NCT01600105|12555766|P1|STARTED|Sub Study IV||41
5103541|NCT01600105|12555765|P2|NOT COMPLETED|Sub Study III||0
5103542|NCT01600105|12555766|P1|NOT COMPLETED|Sub Study III||5
5103543|NCT01600105|12555765|P2|COMPLETED|Sub Study III||0
5103544|NCT01600105|12555766|P1|COMPLETED|Sub Study III||34
5103545|NCT01600105|12555765|P2|STARTED|Sub Study III||0
5103546|NCT01600105|12555766|P1|STARTED|Sub Study III||39
5103547|NCT01600105|12555765|P2|NOT COMPLETED|Sub Study II||0
5103548|NCT01600105|12555766|P1|NOT COMPLETED|Sub Study II||5
5103549|NCT01600105|12555765|P2|COMPLETED|Sub Study II||0
5103550|NCT01600105|12555766|P1|COMPLETED|Sub Study II||60
5103551|NCT01600105|12555765|P2|STARTED|Sub Study II||0
5103552|NCT01600105|12555766|P1|STARTED|Sub Study II||65
5103553|NCT01600105|12555765|P2|NOT COMPLETED|Sub Study I||10
5103554|NCT01600105|12555766|P1|NOT COMPLETED|Sub Study I||0
5103555|NCT01600105|12555765|P2|COMPLETED|Sub Study I||11
5103556|NCT01600105|12555766|P1|COMPLETED|Sub Study I||19
5103557|NCT01600105|12555765|P2|STARTED|Sub Study I||21
5103558|NCT01600105|12555766|P1|STARTED|Sub Study I||19
5103559|NCT01600105|12555765|P2|NOT COMPLETED|Total Participants||10
5103560|NCT01600105|12555766|P1|NOT COMPLETED|Total Participants||41
5103561|NCT01600105|12555765|P2|COMPLETED|Total Participants||11
5103562|NCT01600105|12555766|P1|COMPLETED|Total Participants||214
5103563|NCT01600105|12555765|P2|STARTED|Total Participants||21
5103564|NCT01600105|12555766|P1|STARTED|Total Participants||255
5103565|NCT01600092|12555794|P2|NOT COMPLETED|Overall Study||16
5103566|NCT01600092|12555795|P1|NOT COMPLETED|Overall Study||18
5103567|NCT01600092|12555794|P2|COMPLETED|Overall Study||491
5103568|NCT01600092|12555795|P1|COMPLETED|Overall Study||495
5103569|NCT01600092|12555794|P2|Received All 3 Vaccinations|Overall Study||494
5103570|NCT01600092|12555795|P1|Received All 3 Vaccinations|Overall Study||500
5103571|NCT01600092|12555794|P2|Received at Least 1 Vaccination|Overall Study||504
5103572|NCT01600092|12555795|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
5103573|NCT01600092|12555794|P2|STARTED|Overall Study||507
5103574|NCT01600092|12555795|P1|STARTED|Overall Study||513
5103575|NCT01600053|12555809|P1|NOT COMPLETED|Overall Study||11
5103576|NCT01600053|12555809|P1|COMPLETED|Overall Study||0
5103577|NCT01600053|12555809|P1|STARTED|Overall Study||11
5103578|NCT01600014|12555814|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
5103579|NCT01600014|12555815|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
5103580|NCT01600014|12555814|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
5103581|NCT01600014|12555815|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
5103582|NCT01600014|12555814|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
5103583|NCT01600014|12555815|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
5103584|NCT01600014|12555814|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
5103585|NCT01600014|12555815|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
5103586|NCT01600014|12555814|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
5103587|NCT01600014|12555815|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
5103588|NCT01600014|12555814|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
5103589|NCT01600014|12555815|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
5103590|NCT01600014|12555814|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
5103591|NCT01600014|12555815|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
5103592|NCT01600014|12555814|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
5103593|NCT01600014|12555815|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
5103594|NCT01600014|12555814|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
5103595|NCT01600014|12555815|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
5103596|NCT01599832|12555833|P1|NOT COMPLETED|Overall Study||0
5103597|NCT01599832|12555833|P1|COMPLETED|Overall Study||20
5103598|NCT01599832|12555833|P1|STARTED|Overall Study||20
5103599|NCT01599806|12555843|P2|NOT COMPLETED|Overall Study||41
5103600|NCT01599806|12555844|P1|NOT COMPLETED|Overall Study||43
5103601|NCT01599806|12555843|P2|COMPLETED|Overall Study||476
5103602|NCT01599806|12555844|P1|COMPLETED|Overall Study||473
5103603|NCT01599806|12555843|P2|STARTED|Overall Study||517
5103604|NCT01599806|12555844|P1|STARTED|Overall Study||516
5103605|NCT01599793|12555968|P1|NOT COMPLETED|Overall Study||2
5103606|NCT01599793|12555968|P1|COMPLETED|Overall Study||17
5103607|NCT01599793|12555968|P1|STARTED|Overall Study||19
5103608|NCT01599754|12555980|P2|NOT COMPLETED|Overall Study||360
5103609|NCT01599754|12555981|P1|NOT COMPLETED|Overall Study||363
5103610|NCT01599754|12555980|P2|COMPLETED|Overall Study||1
5103611|NCT01599754|12555981|P1|COMPLETED|Overall Study||0
5103612|NCT01599754|12555980|P2|Treated|Overall Study||360
5103613|NCT01599754|12555981|P1|Treated|Overall Study||360
5103614|NCT01599754|12555980|P2|STARTED|Overall Study||361
5103615|NCT01599754|12555981|P1|STARTED|Overall Study||363
5103616|NCT01599741|12556003|P1|NOT COMPLETED|Overall Study||3
5103617|NCT01599741|12556003|P1|COMPLETED|Overall Study||48
5103618|NCT01599741|12556003|P1|Collected Dose and Image Information|Overall Study||48
5103619|NCT01599741|12556003|P1|STARTED|Overall Study||51
5103620|NCT01599650|12556012|P3|NOT COMPLETED|Overall Study||27
5103621|NCT01599650|12556013|P2|NOT COMPLETED|Overall Study||26
5103622|NCT01599650|12556014|P1|NOT COMPLETED|Overall Study||22
5103623|NCT01599650|12556012|P3|COMPLETED|Overall Study||65
5103624|NCT01599650|12556013|P2|COMPLETED|Overall Study||154
5103625|NCT01599650|12556014|P1|COMPLETED|Overall Study||161
5103626|NCT01599650|12556012|P3|Completed 6 Mos|Overall Study||80
5103627|NCT01599650|12556013|P2|Completed 6 Mos|Overall Study||170
5103628|NCT01599650|12556014|P1|Completed 6 Mos|Overall Study||174
5103629|NCT01599650|12556012|P3|STARTED|Overall Study||92
5103630|NCT01599650|12556013|P2|STARTED|Overall Study||180
5103631|NCT01599650|12556014|P1|STARTED|Overall Study||183
5103632|NCT01599637|12556053|P3|NOT COMPLETED|Overall Study||0
5103633|NCT01599637|12556054|P2|NOT COMPLETED|Overall Study||2
5103634|NCT01599637|12556055|P1|NOT COMPLETED|Overall Study||1
5103635|NCT01599637|12556053|P3|COMPLETED|Overall Study||10
5103636|NCT01599637|12556054|P2|COMPLETED|Overall Study||8
5103637|NCT01599637|12556055|P1|COMPLETED|Overall Study||19
5103638|NCT01599637|12556053|P3|STARTED|Overall Study||10
5103639|NCT01599637|12556054|P2|STARTED|Overall Study||10
5103640|NCT01599637|12556055|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
5103641|NCT01599585|12556102|P2|NOT COMPLETED|Overall Study||17
5103642|NCT01599585|12556103|P1|NOT COMPLETED|Overall Study||22
5103643|NCT01599585|12556102|P2|COMPLETED|Overall Study||42
5103644|NCT01599585|12556103|P1|COMPLETED|Overall Study||40
5103645|NCT01599585|12556102|P2|STARTED|Overall Study||59
5103646|NCT01599585|12556103|P1|STARTED|Overall Study||62
5103647|NCT01599325|12556141|P1|NOT COMPLETED|Extension Phase||15
5103648|NCT01599325|12556141|P1|COMPLETED|Extension Phase||0
5103649|NCT01599325|12556141|P1|STARTED|Extension Phase||15
5103650|NCT01599325|12556141|P1|NOT COMPLETED|Primary Parent Phase||57
5103651|NCT01599325|12556141|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
5103652|NCT01599325|12556141|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
5103653|NCT01599325|12556141|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
5103654|NCT01599325|12556141|P1|STARTED|Primary Parent Phase||72
5103655|NCT01599234|12556165|P2|NOT COMPLETED|Overall Study||15
5103656|NCT01599234|12556166|P1|NOT COMPLETED|Overall Study||17
5103657|NCT01599234|12556165|P2|COMPLETED|Overall Study||155
5103658|NCT01599234|12556166|P1|COMPLETED|Overall Study||150
5103659|NCT01599234|12556165|P2|STARTED|Overall Study||170
5103660|NCT01599234|12556166|P1|STARTED|Overall Study||167
5103661|NCT01599104|12556191|P3|NOT COMPLETED|Overall Study||26
5103662|NCT01599104|12556192|P2|NOT COMPLETED|Overall Study||14
5103663|NCT01599104|12556193|P1|NOT COMPLETED|Overall Study||16
5103664|NCT01599104|12556191|P3|COMPLETED|Overall Study||363
5103665|NCT01599104|12556192|P2|COMPLETED|Overall Study||371
5103666|NCT01599104|12556193|P1|COMPLETED|Overall Study||371
5103667|NCT01599104|12556191|P3|STARTED|Overall Study||389
5103668|NCT01599104|12556192|P2|STARTED|Overall Study||385
5103669|NCT01599104|12556193|P1|STARTED|Overall Study||387
5103670|NCT01598987|12556231|P1|NOT COMPLETED|Baseline to 24 Month||8
5103671|NCT01598987|12556231|P1|COMPLETED|Baseline to 24 Month||48
5103672|NCT01598987|12556231|P1|STARTED|Baseline to 24 Month||56
5103673|NCT01598987|12556231|P1|NOT COMPLETED|Baseline to Month 12||6
5103674|NCT01598987|12556231|P1|COMPLETED|Baseline to Month 12||50
5103675|NCT01598987|12556231|P1|STARTED|Baseline to Month 12||56
5103676|NCT01598896|12556267|P2|NOT COMPLETED|Overall Study||2
5103677|NCT01598896|12556268|P1|NOT COMPLETED|Overall Study||0
5103679|NCT01598896|12556268|P1|COMPLETED|Overall Study||3
5103680|NCT01598896|12556267|P2|STARTED|Overall Study||4
5103681|NCT01598896|12556268|P1|STARTED|Overall Study||3
5103682|NCT01598831|12556282|P2|NOT COMPLETED|Overall Study||136
5103683|NCT01598831|12556283|P1|NOT COMPLETED|Overall Study||119
5103684|NCT01598831|12556282|P2|COMPLETED|Overall Study||278
5103685|NCT01598831|12556283|P1|COMPLETED|Overall Study||283
5103686|NCT01598831|12556282|P2|Received at Least 1 Dose Study Treatment|Overall Study||405
5103687|NCT01598831|12556283|P1|Received at Least 1 Dose Study Treatment|Overall Study||395
5103688|NCT01598831|12556282|P2|STARTED|Overall Study||414
5103689|NCT01598831|12556283|P1|STARTED|Overall Study||402
5103690|NCT01598779|12556299|P1|NOT COMPLETED|Overall Study||0
5103691|NCT01598779|12556299|P1|COMPLETED|Overall Study||150
5103692|NCT01598779|12556299|P1|STARTED|Overall Study||150
5103693|NCT01598753|12556307|P4|NOT COMPLETED|Overall Study||15
5103694|NCT01598753|12556308|P3|NOT COMPLETED|Overall Study||8
5103695|NCT01598753|12556309|P2|NOT COMPLETED|Overall Study||15
5103696|NCT01598753|12556310|P1|NOT COMPLETED|Overall Study||12
5103697|NCT01598753|12556307|P4|COMPLETED|Overall Study||19
5103698|NCT01598753|12556308|P3|COMPLETED|Overall Study||24
5103699|NCT01598753|12556309|P2|COMPLETED|Overall Study||16
5103700|NCT01598753|12556310|P1|COMPLETED|Overall Study||25
5103701|NCT01598753|12556307|P4|STARTED|Overall Study||34
5103702|NCT01598753|12556308|P3|STARTED|Overall Study||32
5103703|NCT01598753|12556309|P2|STARTED|Overall Study||31
5103704|NCT01598753|12556310|P1|STARTED|Overall Study||37
5103705|NCT01598740|12556322|P2|NOT COMPLETED|Period 2||0
5103706|NCT01598740|12556323|P1|NOT COMPLETED|Period 2||1
5103707|NCT01598740|12556322|P2|COMPLETED|Period 2||9
5103708|NCT01598740|12556323|P1|COMPLETED|Period 2||7
5103709|NCT01598740|12556322|P2|STARTED|Period 2||9
5103710|NCT01598740|12556323|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
5103711|NCT01598740|12556322|P2|NOT COMPLETED|Period 1||0
5103712|NCT01598740|12556323|P1|NOT COMPLETED|Period 1||0
5103713|NCT01598740|12556322|P2|COMPLETED|Period 1||9
5103714|NCT01598740|12556323|P1|COMPLETED|Period 1||9
5103715|NCT01598740|12556322|P2|STARTED|Period 1||9
5103716|NCT01598740|12556323|P1|STARTED|Period 1||9
5103717|NCT01598701|12556333|P2|NOT COMPLETED|Overall Study||9
5103718|NCT01598701|12556334|P1|NOT COMPLETED|Overall Study||5
5103719|NCT01598701|12556333|P2|COMPLETED|Overall Study||41
5103720|NCT01598701|12556334|P1|COMPLETED|Overall Study||45
5103721|NCT01598701|12556333|P2|STARTED|Overall Study||50
5103722|NCT01598701|12556334|P1|STARTED|Overall Study||50
5103723|NCT01598662|12556350|P2|NOT COMPLETED|Overall Study||21
5103724|NCT01598662|12556351|P1|NOT COMPLETED|Overall Study||11
5103725|NCT01598662|12556350|P2|COMPLETED|Overall Study||0
5103726|NCT01598662|12556351|P1|COMPLETED|Overall Study||0
5103727|NCT01598662|12556350|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
5103728|NCT01598662|12556351|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
5103729|NCT01598662|12556350|P2|Patients Who Received IUD|Overall Study||18
5103730|NCT01598662|12556351|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
5103731|NCT01598662|12556350|P2|STARTED|Overall Study||21
5103732|NCT01598662|12556351|P1|STARTED|Overall Study||11
5103733|NCT01598610|12556357|P1|NOT COMPLETED|Overall Study||1
5103734|NCT01598610|12556357|P1|COMPLETED|Overall Study||219
5103735|NCT01598610|12556357|P1|STARTED|Overall Study||220
5103736|NCT01598545|12556366|P1|NOT COMPLETED|Overall Study||0
5103737|NCT01598545|12556366|P1|COMPLETED|Overall Study||20
5103738|NCT01598545|12556366|P1|STARTED|Overall Study||20
5103739|NCT01598532|12556374|P1|NOT COMPLETED|Overall Study||11
5103740|NCT01598532|12556374|P1|COMPLETED|Overall Study||11
5103741|NCT01598532|12556374|P1|STARTED|Overall Study||22
5103742|NCT01598506|12556383|P1|NOT COMPLETED|Overall Study||2
5103743|NCT01598506|12556383|P1|COMPLETED|Overall Study||20
5103744|NCT01598506|12556383|P1|STARTED|Overall Study||22
5103745|NCT01598428|12556388|P1|NOT COMPLETED|Overall Study||0
5103746|NCT01598428|12556388|P1|COMPLETED|Overall Study||20
5103747|NCT01598428|12556388|P1|STARTED|Overall Study||20
5103748|NCT01598350|12556397|P1|NOT COMPLETED|Overall Study||0
5103749|NCT01598350|12556397|P1|COMPLETED|Overall Study||6
5103750|NCT01598350|12556397|P1|STARTED|Overall Study||6
5103751|NCT01598311|12556403|P2|NOT COMPLETED|Overall Study||61
5103752|NCT01598311|12556404|P1|NOT COMPLETED|Overall Study||47
5103753|NCT01598311|12556403|P2|COMPLETED|Overall Study||244
5103754|NCT01598311|12556404|P1|COMPLETED|Overall Study||256
5103755|NCT01598311|12556403|P2|Treated and Confirmed CDAD|Overall Study||292
5103756|NCT01598311|12556404|P1|Treated and Confirmed CDAD|Overall Study||285
5103757|NCT01598311|12556403|P2|Treated|Overall Study||301
5103758|NCT01598311|12556404|P1|Treated|Overall Study||294
5103759|NCT01598311|12556403|P2|STARTED|Overall Study||305
5103760|NCT01598311|12556404|P1|STARTED|Overall Study||303
5103761|NCT01598298|12556420|P2|NOT COMPLETED|Overall Study||41
5103762|NCT01598298|12556421|P1|NOT COMPLETED|Overall Study||40
5103763|NCT01598298|12556420|P2|COMPLETED|Overall Study||108
5103764|NCT01598298|12556421|P1|COMPLETED|Overall Study||110
5103765|NCT01598298|12556420|P2|Patients Evaluable for Adverse Events|Overall Study||141
5103766|NCT01598298|12556421|P1|Patients Evaluable for Adverse Events|Overall Study||138
5103767|NCT01598298|12556420|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
5103768|NCT01598298|12556421|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
5103769|NCT01598298|12556420|P2|STARTED|Overall Study||149
5103770|NCT01598298|12556421|P1|STARTED|Overall Study||150
5103771|NCT01598207|12556433|P2|NOT COMPLETED|Overall Study||0
5103772|NCT01598207|12556434|P1|NOT COMPLETED|Overall Study||1
5103773|NCT01598207|12556433|P2|COMPLETED|Overall Study||6
5103774|NCT01598207|12556434|P1|COMPLETED|Overall Study||6
5103775|NCT01598207|12556433|P2|STARTED|Overall Study||6
5103776|NCT01598207|12556434|P1|STARTED|Overall Study||7
5103777|NCT01598194|12556454|P2|NOT COMPLETED|Overall Study||0
5103778|NCT01598194|12556455|P1|NOT COMPLETED|Overall Study||0
5103779|NCT01598194|12556454|P2|COMPLETED|Overall Study||30
5103780|NCT01598194|12556455|P1|COMPLETED|Overall Study||30
5103781|NCT01598194|12556454|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
5103782|NCT01598194|12556455|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
5103783|NCT01598194|12556454|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
5103784|NCT01598194|12556455|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
5103785|NCT01598194|12556454|P2|2 Passes With 25G for Cytology|Overall Study||30
5103786|NCT01598194|12556455|P1|2 Passes With 25G for Cytology|Overall Study||30
5103787|NCT01598194|12556454|P2|STARTED|Overall Study||30
5103788|NCT01598194|12556455|P1|STARTED|Overall Study||30
5103789|NCT01598129|12556465|P1|NOT COMPLETED|Overall Study||9
5103790|NCT01598129|12556465|P1|COMPLETED|Overall Study||3
5103791|NCT01598129|12556465|P1|STARTED|Overall Study||12
5103792|NCT01598090|12556477|P3|NOT COMPLETED|Follow-up Period||28
5103793|NCT01598090|12556478|P2|NOT COMPLETED|Follow-up Period||35
5103794|NCT01598090|12556479|P1|NOT COMPLETED|Follow-up Period||5
5103795|NCT01598090|12556477|P3|COMPLETED|Follow-up Period||171
5103796|NCT01598090|12556478|P2|COMPLETED|Follow-up Period||364
5103797|NCT01598090|12556479|P1|COMPLETED|Follow-up Period||21
5103798|NCT01598090|12556477|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
5103799|NCT01598090|12556478|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
5103800|NCT01598090|12556479|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
5103801|NCT01598090|12556477|P3|NOT COMPLETED|Treatment Period||35
5103802|NCT01598090|12556478|P2|NOT COMPLETED|Treatment Period||72
5103803|NCT01598090|12556479|P1|NOT COMPLETED|Treatment Period||11
5103804|NCT01598090|12556477|P3|COMPLETED|Treatment Period||171
5103805|NCT01598090|12556478|P2|COMPLETED|Treatment Period||339
5103806|NCT01598090|12556479|P1|COMPLETED|Treatment Period||16
5103807|NCT01598090|12556477|P3|STARTED|Treatment Period||206
5103808|NCT01598090|12556478|P2|STARTED|Treatment Period||411
5103809|NCT01598090|12556479|P1|STARTED|Treatment Period||27
5103810|NCT01598064|12556505|P2|NOT COMPLETED|Overall Study||0
5103811|NCT01598064|12556506|P1|NOT COMPLETED|Overall Study||0
5103812|NCT01598064|12556505|P2|COMPLETED|Overall Study||24
5103813|NCT01598064|12556506|P1|COMPLETED|Overall Study||25
5103814|NCT01598064|12556505|P2|STARTED|Overall Study||24
5103815|NCT01598064|12556506|P1|STARTED|Overall Study||25
5103816|NCT01598025|12556516|P2|NOT COMPLETED|Overall Study||3
5103817|NCT01598025|12556517|P1|NOT COMPLETED|Overall Study||0
5103818|NCT01598025|12556516|P2|COMPLETED|Overall Study||0
5103819|NCT01598025|12556517|P1|COMPLETED|Overall Study||0
5103820|NCT01598025|12556516|P2|STARTED|Overall Study||3
5103821|NCT01598025|12556517|P1|STARTED|Overall Study||0
5103822|NCT01597908|12556526|P2|NOT COMPLETED|Overall Study||352
5103823|NCT01597908|12556527|P1|NOT COMPLETED|Overall Study||352
5103824|NCT01597908|12556526|P2|COMPLETED|Overall Study||0
5103825|NCT01597908|12556527|P1|COMPLETED|Overall Study||0
5103826|NCT01597908|12556526|P2|Ongoing|Overall Study||202
5103827|NCT01597908|12556527|P1|Ongoing|Overall Study||236
5103828|NCT01597908|12556526|P2|STARTED|Overall Study||352
5103829|NCT01597908|12556527|P1|STARTED|Overall Study||352
5103830|NCT01597856|12556542|P3|NOT COMPLETED|Overall Study||54
5103831|NCT01597856|12556543|P2|NOT COMPLETED|Overall Study||26
5103832|NCT01597856|12556544|P1|NOT COMPLETED|Overall Study||22
5103833|NCT01597856|12556542|P3|COMPLETED|Overall Study||120
5103834|NCT01597856|12556543|P2|COMPLETED|Overall Study||61
5103835|NCT01597856|12556544|P1|COMPLETED|Overall Study||63
5103836|NCT01597856|12556542|P3|Week 4 Follow-up|Overall Study||129
5103837|NCT01597856|12556543|P2|Week 4 Follow-up|Overall Study||67
5103838|NCT01597856|12556544|P1|Week 4 Follow-up|Overall Study||62
5103839|NCT01597856|12556542|P3|STARTED|Overall Study||174
5103840|NCT01597856|12556543|P2|STARTED|Overall Study||87
5103841|NCT01597856|12556544|P1|STARTED|Overall Study||85
5103842|NCT01597843|12556561|P3|NOT COMPLETED|Overall Study||0
5103843|NCT01597843|12556562|P2|NOT COMPLETED|Overall Study||0
5103844|NCT01597843|12556563|P1|NOT COMPLETED|Overall Study||0
5103845|NCT01597843|12556561|P3|COMPLETED|Overall Study||81
5103846|NCT01597843|12556562|P2|COMPLETED|Overall Study||122
5103847|NCT01597843|12556563|P1|COMPLETED|Overall Study||79
5103848|NCT01597843|12556561|P3|Survey 3 Responses|Overall Study||76
5103849|NCT01597843|12556562|P2|Survey 3 Responses|Overall Study||56
5103850|NCT01597843|12556563|P1|Survey 3 Responses|Overall Study||65
5103851|NCT01597843|12556561|P3|Survey 2 Responses|Overall Study||58
5103852|NCT01597843|12556562|P2|Survey 2 Responses|Overall Study||42
5103853|NCT01597843|12556563|P1|Survey 2 Responses|Overall Study||52
5103854|NCT01597843|12556561|P3|Survey 1 Responses|Overall Study||59
5103855|NCT01597843|12556562|P2|Survey 1 Responses|Overall Study||71
5103856|NCT01597843|12556563|P1|Survey 1 Responses|Overall Study||45
5103857|NCT01597843|12556561|P3|STARTED|Overall Study||81
5103858|NCT01597843|12556562|P2|STARTED|Overall Study||122
5103859|NCT01597843|12556563|P1|STARTED|Overall Study||79
5103860|NCT01597791|12556573|P2|NOT COMPLETED|Overall Study||10
5103861|NCT01597791|12556574|P1|NOT COMPLETED|Overall Study||8
5103862|NCT01597791|12556573|P2|COMPLETED|Overall Study||18
5103863|NCT01597791|12556574|P1|COMPLETED|Overall Study||20
5103864|NCT01597791|12556573|P2|STARTED|Overall Study||28
5103865|NCT01597791|12556574|P1|STARTED|Overall Study||28
5103866|NCT01597687|12556583|P3|NOT COMPLETED|Overall Study||0
5103867|NCT01597687|12556584|P2|NOT COMPLETED|Overall Study||0
5103868|NCT01597687|12556585|P1|NOT COMPLETED|Overall Study||0
5103869|NCT01597687|12556583|P3|COMPLETED|Overall Study||147
5103870|NCT01597687|12556584|P2|COMPLETED|Overall Study||89
5103871|NCT01597687|12556585|P1|COMPLETED|Overall Study||76
5103872|NCT01597687|12556583|P3|STARTED|Overall Study||147
5103873|NCT01597687|12556584|P2|STARTED|Overall Study||89
5103874|NCT01597687|12556585|P1|STARTED|Overall Study||76
5103875|NCT01597635|12556661|P3|NOT COMPLETED|Part B||4
5103876|NCT01597635|12556662|P2|NOT COMPLETED|Part B||6
5103877|NCT01597635|12556663|P1|NOT COMPLETED|Part B||0
5103878|NCT01597635|12556661|P3|COMPLETED|Part B||15
5103879|NCT01597635|12556662|P2|COMPLETED|Part B||14
5103880|NCT01597635|12556663|P1|COMPLETED|Part B||0
5103881|NCT01597635|12556661|P3|STARTED|Part B||19
5103882|NCT01597635|12556662|P2|STARTED|Part B||20
5103883|NCT01597635|12556663|P1|STARTED|Part B||0
5103884|NCT01597635|12556661|P3|NOT COMPLETED|Part A||0
5103885|NCT01597635|12556662|P2|NOT COMPLETED|Part A||0
5103886|NCT01597635|12556663|P1|NOT COMPLETED|Part A||3
5103887|NCT01597635|12556661|P3|COMPLETED|Part A||0
5103888|NCT01597635|12556662|P2|COMPLETED|Part A||0
5103889|NCT01597635|12556663|P1|COMPLETED|Part A||2
5103890|NCT01597635|12556661|P3|STARTED|Part A||0
5103891|NCT01597635|12556662|P2|STARTED|Part A||0
5103892|NCT01597635|12556663|P1|STARTED|Part A||5
5103893|NCT01597622|12556726|P1|NOT COMPLETED|Overall Study||38
5103894|NCT01597622|12556726|P1|COMPLETED|Overall Study||104
5103895|NCT01597622|12556726|P1|STARTED|Overall Study||142
5103896|NCT01597596|12556733|P2|NOT COMPLETED|Overall Study||1
5103897|NCT01597596|12556734|P1|NOT COMPLETED|Overall Study||1
5103898|NCT01597596|12556733|P2|COMPLETED|Overall Study||2
5103899|NCT01597596|12556734|P1|COMPLETED|Overall Study||0
5103900|NCT01597596|12556733|P2|STARTED|Overall Study||3
5103901|NCT01597596|12556734|P1|STARTED|Overall Study||1
5103902|NCT01597505|12556748|P2|NOT COMPLETED|Overall Study||33
5103903|NCT01597505|12556749|P1|NOT COMPLETED|Overall Study||44
5103904|NCT01597505|12556748|P2|COMPLETED|Overall Study||265
5103905|NCT01597505|12556749|P1|COMPLETED|Overall Study||264
5103906|NCT01597505|12556748|P2|Treated|Overall Study||286
5103907|NCT01597505|12556749|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
5103908|NCT01597505|12556748|P2|STARTED|Overall Study|Randomized participants|298
5103909|NCT01597505|12556749|P1|STARTED|Overall Study|Randomized participants|308
5103910|NCT01597492|12556783|P2|NOT COMPLETED|Overall Study||4
5103911|NCT01597492|12556784|P1|NOT COMPLETED|Overall Study||6
5103912|NCT01597492|12556783|P2|COMPLETED|Overall Study||41
5103913|NCT01597492|12556784|P1|COMPLETED|Overall Study||28
5103914|NCT01597492|12556783|P2|STARTED|Overall Study||45
5103915|NCT01597492|12556784|P1|STARTED|Overall Study||34
5103916|NCT01597479|12556792|P2|NOT COMPLETED|Overall Study||0
5103917|NCT01597479|12556793|P1|NOT COMPLETED|Overall Study||2
5103918|NCT01597479|12556792|P2|COMPLETED|Overall Study||26
5103919|NCT01597479|12556793|P1|COMPLETED|Overall Study||24
5103920|NCT01597479|12556792|P2|STARTED|Overall Study||26
5103921|NCT01597479|12556793|P1|STARTED|Overall Study||26
5103922|NCT01597440|12556802|P2|NOT COMPLETED|Overall Study||0
5103923|NCT01597440|12556803|P1|NOT COMPLETED|Overall Study||0
5103924|NCT01597440|12556802|P2|COMPLETED|Overall Study||0
5103925|NCT01597440|12556803|P1|COMPLETED|Overall Study||1
5103926|NCT01597440|12556802|P2|STARTED|Overall Study||0
5103927|NCT01597440|12556803|P1|STARTED|Overall Study||1
5103928|NCT01597388|12556820|P9|NOT COMPLETED|Overall Study||0
5103929|NCT01597388|12556821|P8|NOT COMPLETED|Overall Study||0
5103930|NCT01597388|12556822|P7|NOT COMPLETED|Overall Study||0
5103931|NCT01597388|12556823|P6|NOT COMPLETED|Overall Study||0
5103932|NCT01597388|12556824|P5|NOT COMPLETED|Overall Study||0
5103933|NCT01597388|12556825|P4|NOT COMPLETED|Overall Study||0
5103934|NCT01597388|12556826|P3|NOT COMPLETED|Overall Study||0
5103935|NCT01597388|12556827|P2|NOT COMPLETED|Overall Study||0
5103936|NCT01597388|12556828|P1|NOT COMPLETED|Overall Study||0
5103937|NCT01597388|12556820|P9|COMPLETED|Overall Study||2
5103938|NCT01597388|12556821|P8|COMPLETED|Overall Study||5
5103939|NCT01597388|12556822|P7|COMPLETED|Overall Study||8
5103940|NCT01597388|12556823|P6|COMPLETED|Overall Study||4
5103941|NCT01597388|12556824|P5|COMPLETED|Overall Study||37
5103942|NCT01597388|12556825|P4|COMPLETED|Overall Study||10
5103943|NCT01597388|12556826|P3|COMPLETED|Overall Study||14
5103944|NCT01597388|12556827|P2|COMPLETED|Overall Study||13
5103945|NCT01597388|12556828|P1|COMPLETED|Overall Study||6
5103946|NCT01597388|12556820|P9|STARTED|Overall Study||2
5103947|NCT01597388|12556821|P8|STARTED|Overall Study||5
5103948|NCT01597388|12556822|P7|STARTED|Overall Study||8
5103949|NCT01597388|12556823|P6|STARTED|Overall Study||4
5103950|NCT01597388|12556824|P5|STARTED|Overall Study||37
5103951|NCT01597388|12556825|P4|STARTED|Overall Study||10
5103952|NCT01597388|12556826|P3|STARTED|Overall Study||14
5103953|NCT01597388|12556827|P2|STARTED|Overall Study||13
5103954|NCT01597388|12556828|P1|STARTED|Overall Study||6
5103955|NCT01597375|12557079|P2|NOT COMPLETED|Second Intervention||1
5103956|NCT01597375|12557080|P1|NOT COMPLETED|Second Intervention||1
5103957|NCT01597375|12557079|P2|COMPLETED|Second Intervention||21
5103958|NCT01597375|12557080|P1|COMPLETED|Second Intervention||19
5103959|NCT01597375|12557079|P2|STARTED|Second Intervention||22
5103960|NCT01597375|12557080|P1|STARTED|Second Intervention||20
5103961|NCT01597375|12557079|P2|NOT COMPLETED|Washout (2 Weeks)||0
5103962|NCT01597375|12557080|P1|NOT COMPLETED|Washout (2 Weeks)||1
5103963|NCT01597375|12557079|P2|COMPLETED|Washout (2 Weeks)||22
5103964|NCT01597375|12557080|P1|COMPLETED|Washout (2 Weeks)||20
5103965|NCT01597375|12557079|P2|STARTED|Washout (2 Weeks)||22
5103966|NCT01597375|12557080|P1|STARTED|Washout (2 Weeks)||21
5103967|NCT01597375|12557079|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
5103968|NCT01597375|12557080|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
5103969|NCT01597375|12557079|P2|COMPLETED|First Intervention (4 Weeks)||22
5103970|NCT01597375|12557080|P1|COMPLETED|First Intervention (4 Weeks)||21
5103971|NCT01597375|12557079|P2|STARTED|First Intervention (4 Weeks)||23
5103972|NCT01597375|12557080|P1|STARTED|First Intervention (4 Weeks)||23
5103973|NCT01597258|12557097|P1|NOT COMPLETED|Overall Study||1
5103974|NCT01597258|12557097|P1|COMPLETED|Overall Study||2028
5103975|NCT01597258|12557097|P1|STARTED|Overall Study||2029
5103976|NCT01597245|12557106|P21|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
5103977|NCT01597245|12557107|P20|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
5103978|NCT01597245|12557108|P19|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
5103979|NCT01597245|12557109|P18|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
5103980|NCT01597245|12557110|P17|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
5103981|NCT01597245|12557111|P16|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103982|NCT01597245|12557112|P15|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103983|NCT01597245|12557113|P14|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103984|NCT01597245|12557114|P13|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103985|NCT01597245|12557115|P12|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103986|NCT01597245|12557116|P11|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103987|NCT01597245|12557117|P10|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103988|NCT01597245|12557118|P9|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103989|NCT01597245|12557119|P8|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103990|NCT01597245|12557120|P7|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103991|NCT01597245|12557121|P6|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103992|NCT01597245|12557122|P5|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103993|NCT01597245|12557123|P4|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103994|NCT01597245|12557124|P3|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103995|NCT01597245|12557125|P2|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103996|NCT01597245|12557126|P1|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5103997|NCT01597245|12557106|P21|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
5103998|NCT01597245|12557107|P20|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
5103999|NCT01597245|12557108|P19|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
5104000|NCT01597245|12557109|P18|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104001|NCT01597245|12557110|P17|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104002|NCT01597245|12557111|P16|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104003|NCT01597245|12557112|P15|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104004|NCT01597245|12557113|P14|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104005|NCT01597245|12557114|P13|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104006|NCT01597245|12557115|P12|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104007|NCT01597245|12557116|P11|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104008|NCT01597245|12557117|P10|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104009|NCT01597245|12557118|P9|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104010|NCT01597245|12557119|P8|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104011|NCT01597245|12557120|P7|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104012|NCT01597245|12557121|P6|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104013|NCT01597245|12557122|P5|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104014|NCT01597245|12557123|P4|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104015|NCT01597245|12557124|P3|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104016|NCT01597245|12557125|P2|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104017|NCT01597245|12557126|P1|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104018|NCT01597245|12557106|P21|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
5104019|NCT01597245|12557107|P20|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
5104020|NCT01597245|12557108|P19|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
5104021|NCT01597245|12557109|P18|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
5104022|NCT01597245|12557110|P17|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
5104023|NCT01597245|12557111|P16|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5104024|NCT01597245|12557112|P15|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
5104025|NCT01597245|12557113|P14|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104026|NCT01597245|12557114|P13|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104027|NCT01597245|12557115|P12|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104028|NCT01597245|12557116|P11|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104029|NCT01597245|12557117|P10|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104030|NCT01597245|12557118|P9|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104031|NCT01597245|12557119|P8|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104032|NCT01597245|12557120|P7|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104033|NCT01597245|12557121|P6|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104034|NCT01597245|12557122|P5|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104035|NCT01597245|12557123|P4|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104036|NCT01597245|12557124|P3|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104037|NCT01597245|12557125|P2|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104038|NCT01597245|12557126|P1|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
5104039|NCT01597245|12557106|P21|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104040|NCT01597245|12557107|P20|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104041|NCT01597245|12557108|P19|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104042|NCT01597245|12557109|P18|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104043|NCT01597245|12557110|P17|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104044|NCT01597245|12557111|P16|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
5104045|NCT01597245|12557112|P15|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
5104046|NCT01597245|12557113|P14|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
5104047|NCT01597245|12557114|P13|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104048|NCT01597245|12557115|P12|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104049|NCT01597245|12557116|P11|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104050|NCT01597245|12557117|P10|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104051|NCT01597245|12557118|P9|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104052|NCT01597245|12557119|P8|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104053|NCT01597245|12557120|P7|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104054|NCT01597245|12557121|P6|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104055|NCT01597245|12557122|P5|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104056|NCT01597245|12557123|P4|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104057|NCT01597245|12557124|P3|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104058|NCT01597245|12557125|P2|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104059|NCT01597245|12557126|P1|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104060|NCT01597245|12557106|P21|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104061|NCT01597245|12557107|P20|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104062|NCT01597245|12557108|P19|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104063|NCT01597245|12557109|P18|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104064|NCT01597245|12557110|P17|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104065|NCT01597245|12557111|P16|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
5104066|NCT01597245|12557112|P15|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
5104067|NCT01597245|12557113|P14|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104068|NCT01597245|12557114|P13|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104069|NCT01597245|12557115|P12|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104070|NCT01597245|12557116|P11|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104071|NCT01597245|12557117|P10|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104072|NCT01597245|12557118|P9|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104073|NCT01597245|12557119|P8|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104074|NCT01597245|12557120|P7|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104075|NCT01597245|12557121|P6|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104076|NCT01597245|12557122|P5|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104077|NCT01597245|12557123|P4|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104078|NCT01597245|12557124|P3|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104079|NCT01597245|12557125|P2|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104080|NCT01597245|12557126|P1|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
5104081|NCT01597245|12557106|P21|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104082|NCT01597245|12557107|P20|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104083|NCT01597245|12557108|P19|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104084|NCT01597245|12557109|P18|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104085|NCT01597245|12557110|P17|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104086|NCT01597245|12557111|P16|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
5104087|NCT01597245|12557112|P15|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
5104088|NCT01597245|12557113|P14|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
5104089|NCT01597245|12557114|P13|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104090|NCT01597245|12557115|P12|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104091|NCT01597245|12557116|P11|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104092|NCT01597245|12557117|P10|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104093|NCT01597245|12557118|P9|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104094|NCT01597245|12557119|P8|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104095|NCT01597245|12557120|P7|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104096|NCT01597245|12557121|P6|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104097|NCT01597245|12557122|P5|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
5104098|NCT01597245|12557123|P4|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104099|NCT01597245|12557124|P3|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104100|NCT01597245|12557125|P2|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104101|NCT01597245|12557126|P1|STARTED|Long Term Extension (Week 60 - Week 264)||0
5104102|NCT01597245|12557106|P21|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104103|NCT01597245|12557107|P20|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104104|NCT01597245|12557108|P19|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104105|NCT01597245|12557109|P18|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104106|NCT01597245|12557110|P17|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104107|NCT01597245|12557111|P16|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104108|NCT01597245|12557112|P15|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104109|NCT01597245|12557113|P14|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104110|NCT01597245|12557114|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
5104111|NCT01597245|12557115|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
5104112|NCT01597245|12557116|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
5104113|NCT01597245|12557117|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
5104114|NCT01597245|12557118|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
5104115|NCT01597245|12557119|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
5104116|NCT01597245|12557120|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
5104117|NCT01597245|12557121|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
5104118|NCT01597245|12557122|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
5104119|NCT01597245|12557123|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104120|NCT01597245|12557124|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104121|NCT01597245|12557125|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104122|NCT01597245|12557126|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104123|NCT01597245|12557106|P21|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104124|NCT01597245|12557107|P20|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104125|NCT01597245|12557108|P19|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104126|NCT01597245|12557109|P18|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104127|NCT01597245|12557110|P17|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104128|NCT01597245|12557111|P16|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104129|NCT01597245|12557112|P15|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104130|NCT01597245|12557113|P14|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104131|NCT01597245|12557114|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
5104132|NCT01597245|12557115|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
5104133|NCT01597245|12557116|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
5104134|NCT01597245|12557117|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
5104135|NCT01597245|12557118|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
5104136|NCT01597245|12557119|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104137|NCT01597245|12557120|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
5104138|NCT01597245|12557121|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
5104139|NCT01597245|12557122|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
5104140|NCT01597245|12557123|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104141|NCT01597245|12557124|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104142|NCT01597245|12557125|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104143|NCT01597245|12557126|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
5104144|NCT01597245|12557106|P21|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104145|NCT01597245|12557107|P20|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104146|NCT01597245|12557108|P19|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104147|NCT01597245|12557109|P18|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104148|NCT01597245|12557110|P17|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104149|NCT01597245|12557111|P16|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104150|NCT01597245|12557112|P15|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104151|NCT01597245|12557113|P14|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104152|NCT01597245|12557114|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
5104153|NCT01597245|12557115|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
5104154|NCT01597245|12557116|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
5104155|NCT01597245|12557117|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
5104156|NCT01597245|12557118|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
5104157|NCT01597245|12557119|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
5104158|NCT01597245|12557120|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
5104159|NCT01597245|12557121|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
5104160|NCT01597245|12557122|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
5104161|NCT01597245|12557123|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104162|NCT01597245|12557124|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104163|NCT01597245|12557125|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104164|NCT01597245|12557126|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
5104165|NCT01597245|12557106|P21|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104166|NCT01597245|12557107|P20|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104167|NCT01597245|12557108|P19|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104168|NCT01597245|12557109|P18|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104169|NCT01597245|12557110|P17|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104170|NCT01597245|12557111|P16|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104171|NCT01597245|12557112|P15|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104172|NCT01597245|12557113|P14|STARTED|Maintenance Period (Week 12 to Week 60)||0
5104173|NCT01597245|12557114|P13|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
5104174|NCT01597245|12557115|P12|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
5104175|NCT01597245|12557116|P11|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
5104176|NCT01597245|12557117|P10|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
5104177|NCT01597245|12557118|P9|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
5104178|NCT01597245|12557119|P8|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
5104179|NCT01597245|12557120|P7|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
5104180|NCT01597245|12557121|P6|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
5104181|NCT01597245|12557122|P5|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
5104182|NCT01597245|12557123|P4|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
5104183|NCT01597245|12557124|P3|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
5104184|NCT01597245|12557125|P2|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
5104185|NCT01597245|12557126|P1|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
5104186|NCT01597245|12557106|P21|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104187|NCT01597245|12557107|P20|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104188|NCT01597245|12557108|P19|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104189|NCT01597245|12557109|P18|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104190|NCT01597245|12557110|P17|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104191|NCT01597245|12557111|P16|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104192|NCT01597245|12557112|P15|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104193|NCT01597245|12557113|P14|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104194|NCT01597245|12557114|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104195|NCT01597245|12557115|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104196|NCT01597245|12557116|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104197|NCT01597245|12557117|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104198|NCT01597245|12557118|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104199|NCT01597245|12557119|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104200|NCT01597245|12557120|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104201|NCT01597245|12557121|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104202|NCT01597245|12557122|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
5104203|NCT01597245|12557123|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
5104204|NCT01597245|12557124|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
5104205|NCT01597245|12557125|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
5104206|NCT01597245|12557126|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
5104207|NCT01597245|12557106|P21|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104208|NCT01597245|12557107|P20|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104209|NCT01597245|12557108|P19|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104210|NCT01597245|12557109|P18|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104211|NCT01597245|12557110|P17|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104212|NCT01597245|12557111|P16|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104213|NCT01597245|12557112|P15|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104214|NCT01597245|12557113|P14|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104215|NCT01597245|12557114|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104216|NCT01597245|12557115|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104217|NCT01597245|12557116|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104218|NCT01597245|12557117|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104219|NCT01597245|12557118|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104220|NCT01597245|12557119|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104221|NCT01597245|12557120|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104222|NCT01597245|12557121|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104223|NCT01597245|12557122|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
5104224|NCT01597245|12557123|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
5104225|NCT01597245|12557124|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
5104226|NCT01597245|12557125|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
5104227|NCT01597245|12557126|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
5104228|NCT01597245|12557106|P21|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104229|NCT01597245|12557107|P20|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104230|NCT01597245|12557108|P19|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104231|NCT01597245|12557109|P18|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104232|NCT01597245|12557110|P17|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104233|NCT01597245|12557111|P16|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104234|NCT01597245|12557112|P15|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104235|NCT01597245|12557113|P14|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104236|NCT01597245|12557114|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104237|NCT01597245|12557115|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104238|NCT01597245|12557116|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104239|NCT01597245|12557117|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104240|NCT01597245|12557118|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104241|NCT01597245|12557119|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104242|NCT01597245|12557120|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104243|NCT01597245|12557121|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104244|NCT01597245|12557122|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
5104245|NCT01597245|12557123|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
5104246|NCT01597245|12557124|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
5104247|NCT01597245|12557125|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
5104248|NCT01597245|12557126|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
5104249|NCT01597245|12557106|P21|STARTED|Induction Period (Week 0 - Week 12)||0
5104250|NCT01597245|12557107|P20|STARTED|Induction Period (Week 0 - Week 12)||0
5104251|NCT01597245|12557108|P19|STARTED|Induction Period (Week 0 - Week 12)||0
5104252|NCT01597245|12557109|P18|STARTED|Induction Period (Week 0 - Week 12)||0
5104253|NCT01597245|12557110|P17|STARTED|Induction Period (Week 0 - Week 12)||0
5104254|NCT01597245|12557111|P16|STARTED|Induction Period (Week 0 - Week 12)||0
5104255|NCT01597245|12557112|P15|STARTED|Induction Period (Week 0 - Week 12)||0
5104256|NCT01597245|12557113|P14|STARTED|Induction Period (Week 0 - Week 12)||0
5104257|NCT01597245|12557114|P13|STARTED|Induction Period (Week 0 - Week 12)||0
5104258|NCT01597245|12557115|P12|STARTED|Induction Period (Week 0 - Week 12)||0
5104259|NCT01597245|12557116|P11|STARTED|Induction Period (Week 0 - Week 12)||0
5104260|NCT01597245|12557117|P10|STARTED|Induction Period (Week 0 - Week 12)||0
5104261|NCT01597245|12557118|P9|STARTED|Induction Period (Week 0 - Week 12)||0
5104262|NCT01597245|12557119|P8|STARTED|Induction Period (Week 0 - Week 12)||0
5104263|NCT01597245|12557120|P7|STARTED|Induction Period (Week 0 - Week 12)||0
5104264|NCT01597245|12557121|P6|STARTED|Induction Period (Week 0 - Week 12)||0
5104265|NCT01597245|12557122|P5|STARTED|Induction Period (Week 0 - Week 12)||0
5104266|NCT01597245|12557123|P4|STARTED|Induction Period (Week 0 - Week 12)||351
5104267|NCT01597245|12557124|P3|STARTED|Induction Period (Week 0 - Week 12)||347
5104268|NCT01597245|12557125|P2|STARTED|Induction Period (Week 0 - Week 12)||358
5104269|NCT01597245|12557126|P1|STARTED|Induction Period (Week 0 - Week 12)||168
5104270|NCT01597193|12557224|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
5104271|NCT01597193|12557225|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
5104272|NCT01597193|12557226|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
5104273|NCT01597193|12557227|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
5104274|NCT01597193|12557228|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
5104275|NCT01597193|12557229|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104276|NCT01597193|12557230|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104277|NCT01597193|12557224|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104278|NCT01597193|12557225|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104279|NCT01597193|12557226|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104280|NCT01597193|12557227|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104281|NCT01597193|12557228|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104282|NCT01597193|12557229|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104283|NCT01597193|12557230|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
5104284|NCT01597193|12557224|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
5104285|NCT01597193|12557225|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
5104286|NCT01597193|12557226|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
5104287|NCT01597193|12557227|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
5104288|NCT01597193|12557228|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
5104289|NCT01597193|12557229|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
5104290|NCT01597193|12557230|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
5104291|NCT01597193|12557224|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104292|NCT01597193|12557225|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104293|NCT01597193|12557226|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104294|NCT01597193|12557227|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104295|NCT01597193|12557228|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104296|NCT01597193|12557229|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
5104297|NCT01597193|12557230|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
5104298|NCT01597193|12557224|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104299|NCT01597193|12557225|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104300|NCT01597193|12557226|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104301|NCT01597193|12557227|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104302|NCT01597193|12557228|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104303|NCT01597193|12557229|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104304|NCT01597193|12557230|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
5104305|NCT01597193|12557224|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
5104306|NCT01597193|12557225|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
5104307|NCT01597193|12557226|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
5104308|NCT01597193|12557227|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
5104309|NCT01597193|12557228|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
5104310|NCT01597193|12557229|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
5104311|NCT01597193|12557230|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
5104312|NCT01597141|12557311|P2|NOT COMPLETED|Overall Study||0
5104313|NCT01597141|12557312|P1|NOT COMPLETED|Overall Study||0
5104314|NCT01597141|12557311|P2|COMPLETED|Overall Study||50
5104315|NCT01597141|12557312|P1|COMPLETED|Overall Study||50
5104316|NCT01597141|12557311|P2|STARTED|Overall Study||50
5104317|NCT01597141|12557312|P1|STARTED|Overall Study||50
5104318|NCT01597128|12557322|P2|NOT COMPLETED|Overall Study||0
5104319|NCT01597128|12557323|P1|NOT COMPLETED|Overall Study||0
5104320|NCT01597128|12557322|P2|COMPLETED|Overall Study||17
5104321|NCT01597128|12557323|P1|COMPLETED|Overall Study||18
5104322|NCT01597128|12557322|P2|STARTED|Overall Study||17
5104323|NCT01597128|12557323|P1|STARTED|Overall Study||18
5104324|NCT01597050|12557349|P2|NOT COMPLETED|Overall Study||0
5104325|NCT01597050|12557350|P1|NOT COMPLETED|Overall Study||1
5104326|NCT01597050|12557349|P2|COMPLETED|Overall Study||18
5104327|NCT01597050|12557350|P1|COMPLETED|Overall Study||35
5104328|NCT01597050|12557349|P2|STARTED|Overall Study||18
5104329|NCT01597050|12557350|P1|STARTED|Overall Study||36
5104330|NCT01596972|12557358|P2|NOT COMPLETED|Overall Study||14
5104331|NCT01596972|12557359|P1|NOT COMPLETED|Overall Study||1
5104332|NCT01596972|12557358|P2|COMPLETED|Overall Study||12
5104333|NCT01596972|12557359|P1|COMPLETED|Overall Study||24
5104334|NCT01596972|12557358|P2|STARTED|Overall Study||26
5104335|NCT01596972|12557359|P1|STARTED|Overall Study||25
5104336|NCT01596842|12557371|P2|NOT COMPLETED|Overall Study||0
5104337|NCT01596842|12557372|P1|NOT COMPLETED|Overall Study||2
5104338|NCT01596842|12557371|P2|COMPLETED|Overall Study||7
5104339|NCT01596842|12557372|P1|COMPLETED|Overall Study||8
5104340|NCT01596842|12557371|P2|STARTED|Overall Study||7
5104341|NCT01596842|12557372|P1|STARTED|Overall Study||10
5104342|NCT01596751|12557388|P8|NOT COMPLETED|Overall Study||0
5104343|NCT01596751|12557389|P7|NOT COMPLETED|Overall Study||0
5104344|NCT01596751|12557390|P6|NOT COMPLETED|Overall Study||0
5104345|NCT01596751|12557391|P5|NOT COMPLETED|Overall Study||0
5104346|NCT01596751|12557392|P4|NOT COMPLETED|Overall Study||0
5104347|NCT01596751|12557393|P3|NOT COMPLETED|Overall Study||0
5104348|NCT01596751|12557394|P2|NOT COMPLETED|Overall Study||0
5104349|NCT01596751|12557395|P1|NOT COMPLETED|Overall Study||0
5104350|NCT01596751|12557388|P8|COMPLETED|Overall Study||22
5104351|NCT01596751|12557389|P7|COMPLETED|Overall Study||17
5104352|NCT01596751|12557390|P6|COMPLETED|Overall Study||6
5104353|NCT01596751|12557391|P5|COMPLETED|Overall Study||4
5104354|NCT01596751|12557392|P4|COMPLETED|Overall Study||6
5104355|NCT01596751|12557393|P3|COMPLETED|Overall Study||3
5104356|NCT01596751|12557394|P2|COMPLETED|Overall Study||4
5104357|NCT01596751|12557395|P1|COMPLETED|Overall Study||5
5104358|NCT01596751|12557388|P8|STARTED|Overall Study||22
5104359|NCT01596751|12557389|P7|STARTED|Overall Study||17
5104360|NCT01596751|12557390|P6|STARTED|Overall Study||6
5104361|NCT01596751|12557391|P5|STARTED|Overall Study||4
5104362|NCT01596751|12557392|P4|STARTED|Overall Study||6
5104363|NCT01596751|12557393|P3|STARTED|Overall Study||3
5104364|NCT01596751|12557394|P2|STARTED|Overall Study||4
5104365|NCT01596751|12557395|P1|STARTED|Overall Study||5
5104366|NCT01596699|12557418|P2|NOT COMPLETED|Overall Study||0
5104367|NCT01596699|12557419|P1|NOT COMPLETED|Overall Study||0
5104368|NCT01596699|12557418|P2|COMPLETED|Overall Study||6
5104369|NCT01596699|12557419|P1|COMPLETED|Overall Study||10
5104370|NCT01596699|12557418|P2|STARTED|Overall Study||6
5104371|NCT01596699|12557419|P1|STARTED|Overall Study||10
5104372|NCT01596582|12557431|P2|NOT COMPLETED|Overall Study||7
5104373|NCT01596582|12557432|P1|NOT COMPLETED|Overall Study||4
5104374|NCT01596582|12557431|P2|COMPLETED|Overall Study||173
5104375|NCT01596582|12557432|P1|COMPLETED|Overall Study||168
5104376|NCT01596582|12557431|P2|STARTED|Overall Study||180
5104377|NCT01596582|12557432|P1|STARTED|Overall Study||172
5104378|NCT01596504|12557459|P3|NOT COMPLETED|Overall Study||1
5104379|NCT01596504|12557460|P2|NOT COMPLETED|Overall Study||3
5104380|NCT01596504|12557461|P1|NOT COMPLETED|Overall Study||2
5104381|NCT01596504|12557459|P3|COMPLETED|Overall Study||46
5104382|NCT01596504|12557460|P2|COMPLETED|Overall Study||44
5104383|NCT01596504|12557461|P1|COMPLETED|Overall Study||46
5104384|NCT01596504|12557459|P3|STARTED|Overall Study||47
5104385|NCT01596504|12557460|P2|STARTED|Overall Study||47
5104386|NCT01596504|12557461|P1|STARTED|Overall Study||48
5104387|NCT01596335|12557519|P2|NOT COMPLETED|Overall Study||9
5104388|NCT01596335|12557520|P1|NOT COMPLETED|Overall Study||5
5104389|NCT01596335|12557519|P2|COMPLETED|Overall Study||6
5104390|NCT01596335|12557520|P1|COMPLETED|Overall Study||11
5104391|NCT01596335|12557519|P2|STARTED|Overall Study||15
5104392|NCT01596335|12557520|P1|STARTED|Overall Study||16
5104393|NCT01596283|12557532|P2|NOT COMPLETED|Overall Study||0
5104394|NCT01596283|12557533|P1|NOT COMPLETED|Overall Study||0
5104395|NCT01596283|12557532|P2|COMPLETED|Overall Study||66
5104396|NCT01596283|12557533|P1|COMPLETED|Overall Study||69
5104397|NCT01596283|12557532|P2|STARTED|Overall Study||66
5104398|NCT01596283|12557533|P1|STARTED|Overall Study||69
5104399|NCT01596231|12557549|P2|NOT COMPLETED|Overall Study||0
5104400|NCT01596231|12557550|P1|NOT COMPLETED|Overall Study||0
5104401|NCT01596231|12557549|P2|COMPLETED|Overall Study||10
5104402|NCT01596231|12557550|P1|COMPLETED|Overall Study||10
5104403|NCT01596231|12557549|P2|STARTED|Overall Study||10
5104404|NCT01596231|12557550|P1|STARTED|Overall Study||10
5104405|NCT01596127|12557556|P1|NOT COMPLETED|Overall Study||1
5104406|NCT01596127|12557556|P1|COMPLETED|Overall Study||3
5104407|NCT01596127|12557556|P1|STARTED|Overall Study||4
5104408|NCT01596088|12557561|P1|NOT COMPLETED|Overall Study||0
5104409|NCT01596088|12557561|P1|COMPLETED|Overall Study||2
5104410|NCT01596088|12557561|P1|STARTED|Overall Study||2
5104411|NCT01596062|12557568|P3|NOT COMPLETED|Overall Study||3
5104412|NCT01596062|12557569|P2|NOT COMPLETED|Overall Study||0
5104413|NCT01596062|12557570|P1|NOT COMPLETED|Overall Study||1
5104414|NCT01596062|12557568|P3|COMPLETED|Overall Study||4
5104415|NCT01596062|12557569|P2|COMPLETED|Overall Study||6
5104416|NCT01596062|12557570|P1|COMPLETED|Overall Study||2
5104417|NCT01596062|12557568|P3|STARTED|Overall Study||7
5104418|NCT01596062|12557569|P2|STARTED|Overall Study||6
5104419|NCT01596062|12557570|P1|STARTED|Overall Study||3
5104420|NCT01595854|12557607|P5|NOT COMPLETED|Overall Study||0
5104421|NCT01595854|12557608|P4|NOT COMPLETED|Overall Study||0
5104422|NCT01595854|12557609|P3|NOT COMPLETED|Overall Study||0
5104423|NCT01595854|12557610|P2|NOT COMPLETED|Overall Study||0
5104424|NCT01595854|12557611|P1|NOT COMPLETED|Overall Study||0
5104425|NCT01595854|12557607|P5|COMPLETED|Overall Study||12
5104426|NCT01595854|12557608|P4|COMPLETED|Overall Study||4
5104427|NCT01595854|12557609|P3|COMPLETED|Overall Study||8
5104428|NCT01595854|12557610|P2|COMPLETED|Overall Study||4
5104429|NCT01595854|12557611|P1|COMPLETED|Overall Study||8
5104430|NCT01595854|12557607|P5|STARTED|Overall Study||12
5104431|NCT01595854|12557608|P4|STARTED|Overall Study||4
5104432|NCT01595854|12557609|P3|STARTED|Overall Study||8
5104433|NCT01595854|12557610|P2|STARTED|Overall Study||4
5104434|NCT01595854|12557611|P1|STARTED|Overall Study||8
5104435|NCT01595646|12557634|P3|NOT COMPLETED|Overall Study||0
5104436|NCT01595646|12557635|P2|NOT COMPLETED|Overall Study||0
5104437|NCT01595646|12557636|P1|NOT COMPLETED|Overall Study||1
5104438|NCT01595646|12557634|P3|COMPLETED|Overall Study||12
5104439|NCT01595646|12557635|P2|COMPLETED|Overall Study||12
5104440|NCT01595646|12557636|P1|COMPLETED|Overall Study||12
5104441|NCT01595646|12557634|P3|STARTED|Overall Study||12
5104442|NCT01595646|12557635|P2|STARTED|Overall Study||12
5104443|NCT01595646|12557636|P1|STARTED|Overall Study||13
5104444|NCT01595529|12557658|P2|NOT COMPLETED|Overall Study||20
5104445|NCT01595529|12557659|P1|NOT COMPLETED|Overall Study||24
5104446|NCT01595529|12557658|P2|COMPLETED|Overall Study||325
5104447|NCT01595529|12557659|P1|COMPLETED|Overall Study||324
5104448|NCT01595529|12557658|P2|Completed All Milestones|Overall Study||318
5104449|NCT01595529|12557659|P1|Completed All Milestones|Overall Study||318
5104450|NCT01595529|12557658|P2|Per-protocol With Stool Sample at TOC|Overall Study||289
5104451|NCT01595529|12557659|P1|Per-protocol With Stool Sample at TOC|Overall Study||280
5104452|NCT01595529|12557658|P2|Per-protocol Without Treatment Failure|Overall Study||305
5104453|NCT01595529|12557659|P1|Per-protocol Without Treatment Failure|Overall Study||306
5104454|NCT01595529|12557658|P2|Per-protocol, Completed 80% of Dose|Overall Study||314
5104455|NCT01595529|12557659|P1|Per-protocol, Completed 80% of Dose|Overall Study||308
5104456|NCT01595529|12557658|P2|ITT With Stool Sample at TOC|Overall Study||310
5104457|NCT01595529|12557659|P1|ITT With Stool Sample at TOC|Overall Study||298
5104458|NCT01595529|12557658|P2|ITT Without Treatment Failure|Overall Study||322
5104459|NCT01595529|12557659|P1|ITT Without Treatment Failure|Overall Study||326
5104460|NCT01595529|12557658|P2|Evaluated for Primary Endpoint, ITT|Overall Study||336
5104461|NCT01595529|12557659|P1|Evaluated for Primary Endpoint, ITT|Overall Study||328
5104462|NCT01595529|12557658|P2|Treated|Overall Study||340
5104463|NCT01595529|12557659|P1|Treated|Overall Study||337
5104464|NCT01595529|12557658|P2|STARTED|Overall Study||345
5104465|NCT01595529|12557659|P1|STARTED|Overall Study||348
5104466|NCT01595516|12557690|P3|NOT COMPLETED|Overall Study||0
5104467|NCT01595516|12557691|P2|NOT COMPLETED|Overall Study||0
5104468|NCT01595516|12557692|P1|NOT COMPLETED|Overall Study||0
5104469|NCT01595516|12557690|P3|COMPLETED|Overall Study||12
5104470|NCT01595516|12557691|P2|COMPLETED|Overall Study||16
5104471|NCT01595516|12557692|P1|COMPLETED|Overall Study||16
5104472|NCT01595516|12557690|P3|STARTED|Overall Study||12
5104473|NCT01595516|12557691|P2|STARTED|Overall Study||16
5104474|NCT01595516|12557692|P1|STARTED|Overall Study||16
5104475|NCT01595438|12557722|P2|NOT COMPLETED|Overall Study||41
5104476|NCT01595438|12557723|P1|NOT COMPLETED|Overall Study||43
5104477|NCT01595438|12557722|P2|COMPLETED|Overall Study||476
5104478|NCT01595438|12557723|P1|COMPLETED|Overall Study||473
5104479|NCT01595438|12557722|P2|STARTED|Overall Study||517
5104480|NCT01595438|12557723|P1|STARTED|Overall Study||516
5104481|NCT01595386|12557849|P2|NOT COMPLETED|Overall Study||0
5104482|NCT01595386|12557850|P1|NOT COMPLETED|Overall Study||0
5104483|NCT01595386|12557849|P2|COMPLETED|Overall Study||19
5104484|NCT01595386|12557850|P1|COMPLETED|Overall Study||21
5104485|NCT01595386|12557849|P2|STARTED|Overall Study||19
5104486|NCT01595386|12557850|P1|STARTED|Overall Study||21
5104487|NCT01595282|12557878|P2|NOT COMPLETED|Overall Study||0
5104488|NCT01595282|12557879|P1|NOT COMPLETED|Overall Study||0
5104489|NCT01595282|12557878|P2|COMPLETED|Overall Study||47
5104490|NCT01595282|12557879|P1|COMPLETED|Overall Study||47
5104491|NCT01595282|12557878|P2|STARTED|Overall Study||47
5104492|NCT01595282|12557879|P1|STARTED|Overall Study||47
5104493|NCT01595009|12557891|P4|NOT COMPLETED|Extension||11
5104494|NCT01595009|12557892|P3|NOT COMPLETED|Extension||4
5104495|NCT01595009|12557893|P2|NOT COMPLETED|Extension||0
5104496|NCT01595009|12557894|P1|NOT COMPLETED|Extension||0
5104497|NCT01595009|12557891|P4|COMPLETED|Extension||0
5104498|NCT01595009|12557892|P3|COMPLETED|Extension||0
5104499|NCT01595009|12557893|P2|COMPLETED|Extension||0
5104500|NCT01595009|12557894|P1|COMPLETED|Extension||0
5104501|NCT01595009|12557891|P4|STARTED|Extension||11
5104502|NCT01595009|12557892|P3|STARTED|Extension||4
5104503|NCT01595009|12557893|P2|STARTED|Extension||0
5104504|NCT01595009|12557894|P1|STARTED|Extension||0
5104505|NCT01595009|12557891|P4|NOT COMPLETED|Core||0
5104506|NCT01595009|12557892|P3|NOT COMPLETED|Core||0
5104507|NCT01595009|12557893|P2|NOT COMPLETED|Core||120
5104508|NCT01595009|12557894|P1|NOT COMPLETED|Core||126
5104509|NCT01595009|12557891|P4|COMPLETED|Core||0
5104510|NCT01595009|12557892|P3|COMPLETED|Core||0
5104511|NCT01595009|12557893|P2|COMPLETED|Core||0
5104512|NCT01595009|12557894|P1|COMPLETED|Core||0
5104513|NCT01595009|12557891|P4|STARTED|Core||0
5104514|NCT01595009|12557892|P3|STARTED|Core||0
5104515|NCT01595009|12557893|P2|STARTED|Core||120
5104516|NCT01595009|12557894|P1|STARTED|Core||126
5104517|NCT01594970|12557929|P3|NOT COMPLETED|Overall Study||66
5104518|NCT01594970|12557930|P2|NOT COMPLETED|Overall Study||82
5104519|NCT01594970|12557931|P1|NOT COMPLETED|Overall Study||75
5104520|NCT01594970|12557929|P3|COMPLETED|Overall Study||191
5104521|NCT01594970|12557930|P2|COMPLETED|Overall Study||166
5104522|NCT01594970|12557931|P1|COMPLETED|Overall Study||220
5104523|NCT01594970|12557929|P3|STARTED|Overall Study||257
5104524|NCT01594970|12557930|P2|STARTED|Overall Study||248
5104525|NCT01594970|12557931|P1|STARTED|Overall Study||295
5104526|NCT01594853|12557950|P2|NOT COMPLETED|Overall Study||3
5104527|NCT01594853|12557951|P1|NOT COMPLETED|Overall Study||2
5104528|NCT01594853|12557950|P2|COMPLETED|Overall Study||12
5104529|NCT01594853|12557951|P1|COMPLETED|Overall Study||14
5104530|NCT01594853|12557950|P2|STARTED|Overall Study||15
5104531|NCT01594853|12557951|P1|STARTED|Overall Study||16
5104532|NCT01594827|12557959|P2|NOT COMPLETED|Overall Study||0
5104533|NCT01594827|12557960|P1|NOT COMPLETED|Overall Study||4
5104534|NCT01594827|12557959|P2|COMPLETED|Overall Study||15
5104535|NCT01594827|12557960|P1|COMPLETED|Overall Study||10
5104536|NCT01594827|12557959|P2|STARTED|Overall Study||15
5104537|NCT01594827|12557960|P1|STARTED|Overall Study||14
5104538|NCT01594762|12557984|P2|NOT COMPLETED|Overall Study||10
5104539|NCT01594762|12557985|P1|NOT COMPLETED|Overall Study||11
5104540|NCT01594762|12557984|P2|COMPLETED|Overall Study||93
5104541|NCT01594762|12557985|P1|COMPLETED|Overall Study||86
5104542|NCT01594762|12557984|P2|STARTED|Overall Study||103
5104543|NCT01594762|12557985|P1|STARTED|Overall Study||97
5104544|NCT01594749|12557997|P2|NOT COMPLETED|Overall Study||18
5104545|NCT01594749|12557998|P1|NOT COMPLETED|Overall Study||22
5104546|NCT01594749|12557997|P2|COMPLETED|Overall Study||490
5104547|NCT01594749|12557998|P1|COMPLETED|Overall Study||485
5104548|NCT01594749|12557997|P2|Treated|Overall Study||498
5104549|NCT01594749|12557998|P1|Treated|Overall Study||503
5104550|NCT01594749|12557997|P2|STARTED|Overall Study||508
5104551|NCT01594749|12557998|P1|STARTED|Overall Study||507
5104552|NCT01594528|12558017|P3|NOT COMPLETED|Overall Study||0
5104553|NCT01594528|12558018|P2|NOT COMPLETED|Overall Study||0
5104554|NCT01594528|12558019|P1|NOT COMPLETED|Overall Study||0
5104555|NCT01594528|12558017|P3|COMPLETED|Overall Study||16
5104556|NCT01594528|12558018|P2|COMPLETED|Overall Study||17
5104557|NCT01594528|12558019|P1|COMPLETED|Overall Study||16
5104558|NCT01594528|12558017|P3|STARTED|Overall Study||16
5104559|NCT01594528|12558018|P2|STARTED|Overall Study||17
5104560|NCT01594528|12558019|P1|STARTED|Overall Study||16
5104561|NCT01594515|12558035|P10|NOT COMPLETED|Overall Study||0
5104562|NCT01594515|12558036|P9|NOT COMPLETED|Overall Study||0
5104563|NCT01594515|12558037|P8|NOT COMPLETED|Overall Study||0
5104564|NCT01594515|12558038|P7|NOT COMPLETED|Overall Study||0
5104565|NCT01594515|12558039|P6|NOT COMPLETED|Overall Study||0
5104566|NCT01594515|12558040|P5|NOT COMPLETED|Overall Study||0
5104567|NCT01594515|12558041|P4|NOT COMPLETED|Overall Study||0
5104568|NCT01594515|12558042|P3|NOT COMPLETED|Overall Study||0
5104569|NCT01594515|12558043|P2|NOT COMPLETED|Overall Study||0
5104570|NCT01594515|12558044|P1|NOT COMPLETED|Overall Study||0
5104571|NCT01594515|12558035|P10|COMPLETED|Overall Study||16
5104572|NCT01594515|12558036|P9|COMPLETED|Overall Study||6
5104573|NCT01594515|12558037|P8|COMPLETED|Overall Study||6
5104574|NCT01594515|12558038|P7|COMPLETED|Overall Study||6
5104575|NCT01594515|12558039|P6|COMPLETED|Overall Study||6
5104576|NCT01594515|12558040|P5|COMPLETED|Overall Study||6
5104577|NCT01594515|12558041|P4|COMPLETED|Overall Study||6
5104578|NCT01594515|12558042|P3|COMPLETED|Overall Study||6
5104579|NCT01594515|12558043|P2|COMPLETED|Overall Study||6
5104580|NCT01594515|12558044|P1|COMPLETED|Overall Study||6
5104581|NCT01594515|12558035|P10|STARTED|Overall Study||16
5104582|NCT01594515|12558036|P9|STARTED|Overall Study||6
5104583|NCT01594515|12558037|P8|STARTED|Overall Study||6
5104584|NCT01594515|12558038|P7|STARTED|Overall Study||6
5104585|NCT01594515|12558039|P6|STARTED|Overall Study||6
5104586|NCT01594515|12558040|P5|STARTED|Overall Study||6
5104587|NCT01594515|12558041|P4|STARTED|Overall Study||6
5104588|NCT01594515|12558042|P3|STARTED|Overall Study||6
5104589|NCT01594515|12558043|P2|STARTED|Overall Study||6
5104590|NCT01594515|12558044|P1|STARTED|Overall Study||6
5104591|NCT01594476|12558136|P2|NOT COMPLETED|Overall Study||3
5104592|NCT01594476|12558137|P1|NOT COMPLETED|Overall Study||1
5104593|NCT01594476|12558136|P2|COMPLETED|Overall Study||97
5104594|NCT01594476|12558137|P1|COMPLETED|Overall Study||100
5104595|NCT01594476|12558136|P2|Pregnant|Overall Study||5
5104596|NCT01594476|12558137|P1|Pregnant|Overall Study||2
5104597|NCT01594476|12558136|P2|IUD Expulsion|Overall Study||0
5104598|NCT01594476|12558137|P1|IUD Expulsion|Overall Study||2
5104599|NCT01594476|12558136|P2|IUD Removal|Overall Study||5
5104600|NCT01594476|12558137|P1|IUD Removal|Overall Study||3
5104601|NCT01594476|12558136|P2|Excluded After Allocation|Overall Study||3
5104602|NCT01594476|12558137|P1|Excluded After Allocation|Overall Study||1
5104603|NCT01594476|12558136|P2|Received Intervention|Overall Study||73
5104604|NCT01594476|12558137|P1|Received Intervention|Overall Study||66
5104605|NCT01594476|12558136|P2|STARTED|Overall Study||100
5104606|NCT01594476|12558137|P1|STARTED|Overall Study||101
5104607|NCT01594424|12558155|P1|NOT COMPLETED|Overall Study||2
5104608|NCT01594424|12558155|P1|COMPLETED|Overall Study||8
5104609|NCT01594424|12558155|P1|STARTED|Overall Study||10
5104610|NCT01594411|12558159|P1|NOT COMPLETED|Overall Study||2
5104611|NCT01594411|12558159|P1|COMPLETED|Overall Study||249
5104612|NCT01594411|12558159|P1|STARTED|Overall Study||251
5104613|NCT01594385|12558168|P2|NOT COMPLETED|Overall Study||0
5104614|NCT01594385|12558169|P1|NOT COMPLETED|Overall Study||0
5104615|NCT01594385|12558168|P2|COMPLETED|Overall Study||13
5104616|NCT01594385|12558169|P1|COMPLETED|Overall Study||17
5104617|NCT01594385|12558168|P2|STARTED|Overall Study||13
5104618|NCT01594385|12558169|P1|STARTED|Overall Study||17
5104619|NCT01594333|12558193|P2|NOT COMPLETED|Overall Study||151
5104620|NCT01594333|12558194|P1|NOT COMPLETED|Overall Study||161
5104621|NCT01594333|12558193|P2|COMPLETED|Overall Study||2244
5104622|NCT01594333|12558194|P1|COMPLETED|Overall Study||2230
5104623|NCT01594333|12558193|P2|STARTED|Overall Study||2395
5104624|NCT01594333|12558194|P1|STARTED|Overall Study||2391
5104625|NCT01594294|12558222|P2|NOT COMPLETED|Overall Study||4
5104626|NCT01594294|12558223|P1|NOT COMPLETED|Overall Study||3
5104627|NCT01594294|12558222|P2|COMPLETED|Overall Study||36
5104628|NCT01594294|12558223|P1|COMPLETED|Overall Study||36
5104629|NCT01594294|12558222|P2|STARTED|Overall Study||40
5104630|NCT01594294|12558223|P1|STARTED|Overall Study||39
5104631|NCT01594281|12558240|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
5104632|NCT01594281|12558241|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
5104633|NCT01594281|12558242|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
5104634|NCT01594281|12558240|P3|COMPLETED|Non-Interventional Follow Up Phase||23
5104635|NCT01594281|12558241|P2|COMPLETED|Non-Interventional Follow Up Phase||19
5104636|NCT01594281|12558242|P1|COMPLETED|Non-Interventional Follow Up Phase||25
5104637|NCT01594281|12558240|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
5104638|NCT01594281|12558241|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
5104639|NCT01594281|12558242|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
5104640|NCT01594281|12558240|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
5104641|NCT01594281|12558241|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
5104642|NCT01594281|12558242|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
5104643|NCT01594281|12558240|P3|NOT COMPLETED|Interventional Core Phase||8
5104644|NCT01594281|12558241|P2|NOT COMPLETED|Interventional Core Phase||10
5104645|NCT01594281|12558242|P1|NOT COMPLETED|Interventional Core Phase||7
5104646|NCT01594281|12558240|P3|COMPLETED|Interventional Core Phase||28
5104647|NCT01594281|12558241|P2|COMPLETED|Interventional Core Phase||26
5104648|NCT01594281|12558242|P1|COMPLETED|Interventional Core Phase||29
5104649|NCT01594281|12558240|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
5104650|NCT01594281|12558241|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
5104651|NCT01594281|12558242|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
5104652|NCT01594281|12558240|P3|STARTED|Interventional Core Phase||36
5104653|NCT01594281|12558241|P2|STARTED|Interventional Core Phase||36
5104654|NCT01594281|12558242|P1|STARTED|Interventional Core Phase||36
5104655|NCT01594125|12558282|P5|NOT COMPLETED|Overall Study||7
5104656|NCT01594125|12558283|P4|NOT COMPLETED|Overall Study||4
5104657|NCT01594125|12558284|P3|NOT COMPLETED|Overall Study||3
5104658|NCT01594125|12558285|P2|NOT COMPLETED|Overall Study||12
5104659|NCT01594125|12558286|P1|NOT COMPLETED|Overall Study||4
5104660|NCT01594125|12558282|P5|COMPLETED|Overall Study||0
5104661|NCT01594125|12558283|P4|COMPLETED|Overall Study||0
5104662|NCT01594125|12558284|P3|COMPLETED|Overall Study||0
5104663|NCT01594125|12558285|P2|COMPLETED|Overall Study||0
5104664|NCT01594125|12558286|P1|COMPLETED|Overall Study||0
5104665|NCT01594125|12558282|P5|STARTED|Overall Study||7
5104666|NCT01594125|12558283|P4|STARTED|Overall Study||4
5104667|NCT01594125|12558284|P3|STARTED|Overall Study||3
5104668|NCT01594125|12558285|P2|STARTED|Overall Study||12
5104669|NCT01594125|12558286|P1|STARTED|Overall Study||4
5104670|NCT01593852|12558320|P2|NOT COMPLETED|Overall Study||0
5104671|NCT01593852|12558321|P1|NOT COMPLETED|Overall Study||0
5104672|NCT01593852|12558320|P2|COMPLETED|Overall Study||68
5104673|NCT01593852|12558321|P1|COMPLETED|Overall Study||68
5104674|NCT01593852|12558320|P2|STARTED|Overall Study||68
5104675|NCT01593852|12558321|P1|STARTED|Overall Study||68
5104676|NCT01593787|12558346|P3|NOT COMPLETED|Overall Study||0
5104677|NCT01593787|12558347|P2|NOT COMPLETED|Overall Study||0
5104678|NCT01593787|12558348|P1|NOT COMPLETED|Overall Study||1
5104679|NCT01593787|12558346|P3|COMPLETED|Overall Study||18
5104680|NCT01593787|12558347|P2|COMPLETED|Overall Study||8
5104681|NCT01593787|12558348|P1|COMPLETED|Overall Study||5
5104682|NCT01593787|12558346|P3|STARTED|Overall Study||18
5104683|NCT01593787|12558347|P2|STARTED|Overall Study||8
5104684|NCT01593787|12558348|P1|STARTED|Overall Study||6
5104685|NCT01593748|12558388|P2|NOT COMPLETED|Overall Study||0
5104686|NCT01593748|12558389|P1|NOT COMPLETED|Overall Study||0
5104687|NCT01593748|12558388|P2|COMPLETED|Overall Study||45
5104688|NCT01593748|12558389|P1|COMPLETED|Overall Study||45
5104689|NCT01593748|12558388|P2|STARTED|Overall Study||45
5104690|NCT01593748|12558389|P1|STARTED|Overall Study||45
5104691|NCT01593722|12558405|P2|NOT COMPLETED|Overall Study||0
5104692|NCT01593722|12558406|P1|NOT COMPLETED|Overall Study||0
5104693|NCT01593722|12558405|P2|COMPLETED|Overall Study||6
5104694|NCT01593722|12558406|P1|COMPLETED|Overall Study||6
5104695|NCT01593722|12558405|P2|STARTED|Overall Study||6
5104696|NCT01593722|12558406|P1|STARTED|Overall Study||6
5104697|NCT01593670|12558420|P1|NOT COMPLETED|Overall Study||0
5104698|NCT01593670|12558420|P1|COMPLETED|Overall Study||9
5104699|NCT01593670|12558420|P1|STARTED|Overall Study||9
5104700|NCT01593592|12558430|P2|NOT COMPLETED|Overall Study||0
5104701|NCT01593592|12558431|P1|NOT COMPLETED|Overall Study||0
5104702|NCT01593592|12558430|P2|COMPLETED|Overall Study||35
5104703|NCT01593592|12558431|P1|COMPLETED|Overall Study||35
5104704|NCT01593592|12558430|P2|STARTED|Overall Study||35
5104705|NCT01593592|12558431|P1|STARTED|Overall Study||35
5104706|NCT01593254|12558443|P2|NOT COMPLETED|Follow-Up Period||11
5104707|NCT01593254|12558444|P1|NOT COMPLETED|Follow-Up Period||3
5104708|NCT01593254|12558443|P2|COMPLETED|Follow-Up Period||17
5104709|NCT01593254|12558444|P1|COMPLETED|Follow-Up Period||11
5104710|NCT01593254|12558443|P2|STARTED|Follow-Up Period||28
5104711|NCT01593254|12558444|P1|STARTED|Follow-Up Period||14
5104712|NCT01593254|12558443|P2|NOT COMPLETED|Treatment Period||31
5104713|NCT01593254|12558444|P1|NOT COMPLETED|Treatment Period||14
5104714|NCT01593254|12558443|P2|COMPLETED|Treatment Period||143
5104715|NCT01593254|12558444|P1|COMPLETED|Treatment Period||72
5104716|NCT01593254|12558443|P2|Crossed Over to Dasatinib|Treatment Period||0
5104717|NCT01593254|12558444|P1|Crossed Over to Dasatinib|Treatment Period||42
5104718|NCT01593254|12558443|P2|STARTED|Treatment Period||174
5104719|NCT01593254|12558444|P1|STARTED|Treatment Period||86
5104720|NCT01593215|12558453|P2|NOT COMPLETED|Overall Study||0
5104721|NCT01593215|12558454|P1|NOT COMPLETED|Overall Study||1
5104722|NCT01593215|12558453|P2|COMPLETED|Overall Study||25
5104723|NCT01593215|12558454|P1|COMPLETED|Overall Study||24
5104724|NCT01593215|12558453|P2|STARTED|Overall Study||25
5104725|NCT01593215|12558454|P1|STARTED|Overall Study||25
5104726|NCT01592864|12558462|P2|NOT COMPLETED|Overall Study||1
5104727|NCT01592864|12558463|P1|NOT COMPLETED|Overall Study||0
5104728|NCT01592864|12558462|P2|COMPLETED|Overall Study||57
5104729|NCT01592864|12558463|P1|COMPLETED|Overall Study||60
5104730|NCT01592864|12558462|P2|STARTED|Overall Study||58
5104731|NCT01592864|12558463|P1|STARTED|Overall Study||60
5104732|NCT01592851|12558477|P2|NOT COMPLETED|Overall Study||0
5104733|NCT01592851|12558478|P1|NOT COMPLETED|Overall Study||0
5104734|NCT01592851|12558477|P2|COMPLETED|Overall Study||57
5104735|NCT01592851|12558478|P1|COMPLETED|Overall Study||56
5104736|NCT01592851|12558477|P2|STARTED|Overall Study||57
5104737|NCT01592851|12558478|P1|STARTED|Overall Study||56
5104738|NCT01592799|12558494|P1|NOT COMPLETED|Overall Study||0
5104739|NCT01592799|12558494|P1|COMPLETED|Overall Study||501
5104740|NCT01592799|12558494|P1|STARTED|Overall Study||501
5104741|NCT01592786|12558524|P1|NOT COMPLETED|Overall Study||138
5104742|NCT01592786|12558524|P1|COMPLETED|Overall Study||765
5104743|NCT01592786|12558524|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
5104744|NCT01592773|12558528|P1|NOT COMPLETED|Overall Study||666
5104745|NCT01592773|12558528|P1|COMPLETED|Overall Study||81
5104746|NCT01592773|12558528|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
5104747|NCT01592760|12558535|P3|NOT COMPLETED|24-hour Follow-Up||2
5104748|NCT01592760|12558536|P2|NOT COMPLETED|24-hour Follow-Up||3
5104749|NCT01592760|12558537|P1|NOT COMPLETED|24-hour Follow-Up||4
5104750|NCT01592760|12558535|P3|COMPLETED|24-hour Follow-Up||43
5104751|NCT01592760|12558536|P2|COMPLETED|24-hour Follow-Up||87
5104752|NCT01592760|12558537|P1|COMPLETED|24-hour Follow-Up||86
5104753|NCT01592760|12558535|P3|STARTED|24-hour Follow-Up||45
5104754|NCT01592760|12558536|P2|STARTED|24-hour Follow-Up||90
5104755|NCT01592760|12558537|P1|STARTED|24-hour Follow-Up||90
5104756|NCT01592760|12558535|P3|NOT COMPLETED|Perioperative to Discharge||0
5104757|NCT01592760|12558536|P2|NOT COMPLETED|Perioperative to Discharge||0
5104758|NCT01592760|12558537|P1|NOT COMPLETED|Perioperative to Discharge||0
5104759|NCT01592760|12558535|P3|COMPLETED|Perioperative to Discharge||45
5104760|NCT01592760|12558536|P2|COMPLETED|Perioperative to Discharge||90
5104761|NCT01592760|12558537|P1|COMPLETED|Perioperative to Discharge||90
5104762|NCT01592760|12558535|P3|STARTED|Perioperative to Discharge||45
5104763|NCT01592760|12558536|P2|STARTED|Perioperative to Discharge||90
5104764|NCT01592760|12558537|P1|STARTED|Perioperative to Discharge||90
5104765|NCT01592747|12558581|P3|NOT COMPLETED|Overall Study||108
5104766|NCT01592747|12558582|P2|NOT COMPLETED|Overall Study||111
5104767|NCT01592747|12558583|P1|NOT COMPLETED|Overall Study||116
5104768|NCT01592747|12558581|P3|COMPLETED|Overall Study||50
5104769|NCT01592747|12558582|P2|COMPLETED|Overall Study||50
5104770|NCT01592747|12558583|P1|COMPLETED|Overall Study||44
5104771|NCT01592747|12558581|P3|STARTED|Overall Study|Based on Randomized Population|158
5104772|NCT01592747|12558582|P2|STARTED|Overall Study|Based on Randomized Population|161
5104773|NCT01592747|12558583|P1|STARTED|Overall Study|Based on Randomized Population|160
5104774|NCT01592708|12558626|P2|NOT COMPLETED|Overall Study||0
5104775|NCT01592708|12558627|P1|NOT COMPLETED|Overall Study||3
5104776|NCT01592708|12558626|P2|COMPLETED|Overall Study||137
5104777|NCT01592708|12558627|P1|COMPLETED|Overall Study||93
5104778|NCT01592708|12558626|P2|STARTED|Overall Study||137
5104779|NCT01592708|12558627|P1|STARTED|Overall Study||96
5104780|NCT01592695|12558643|P2|NOT COMPLETED|Overall Study||4
5104781|NCT01592695|12558644|P1|NOT COMPLETED|Overall Study||8
5104782|NCT01592695|12558643|P2|COMPLETED|Overall Study||28
5104783|NCT01592695|12558644|P1|COMPLETED|Overall Study||23
5104784|NCT01592695|12558643|P2|STARTED|Overall Study||32
5104785|NCT01592695|12558644|P1|STARTED|Overall Study||31
5104786|NCT01592500|12558666|P4|NOT COMPLETED|Overall Study||2
5104787|NCT01592500|12558667|P3|NOT COMPLETED|Overall Study||0
5104788|NCT01592500|12558668|P2|NOT COMPLETED|Overall Study||0
5104789|NCT01592500|12558669|P1|NOT COMPLETED|Overall Study||1
5104790|NCT01592500|12558666|P4|COMPLETED|Overall Study||11
5104791|NCT01592500|12558667|P3|COMPLETED|Overall Study||14
5104792|NCT01592500|12558668|P2|COMPLETED|Overall Study||15
5104793|NCT01592500|12558669|P1|COMPLETED|Overall Study||13
5104794|NCT01592500|12558666|P4|STARTED|Overall Study|Randomized Participants|13
5104795|NCT01592500|12558667|P3|STARTED|Overall Study||14
5104796|NCT01592500|12558668|P2|STARTED|Overall Study||15
5104797|NCT01592500|12558669|P1|STARTED|Overall Study|Randomized Participants|14
5104798|NCT01592435|12558691|P1|NOT COMPLETED|Overall Study||0
5104799|NCT01592435|12558691|P1|COMPLETED|Overall Study||76
5104800|NCT01592435|12558691|P1|STARTED|Overall Study||76
5104801|NCT01592409|12558699|P2|NOT COMPLETED|Overall Study||1
5104802|NCT01592409|12558700|P1|NOT COMPLETED|Overall Study||0
5104803|NCT01592409|12558699|P2|COMPLETED|Overall Study||31
5104804|NCT01592409|12558700|P1|COMPLETED|Overall Study||67
5104805|NCT01592409|12558699|P2|STARTED|Overall Study||32
5104806|NCT01592409|12558700|P1|STARTED|Overall Study||67
5104807|NCT01592396|12558708|P2|NOT COMPLETED|Overall Study||0
5104808|NCT01592396|12558709|P1|NOT COMPLETED|Overall Study||0
5104809|NCT01592396|12558708|P2|COMPLETED|Overall Study||10
5104810|NCT01592396|12558709|P1|COMPLETED|Overall Study||10
5104811|NCT01592396|12558708|P2|STARTED|Overall Study||10
5104812|NCT01592396|12558709|P1|STARTED|Overall Study||10
5104813|NCT01592383|12558724|P1|NOT COMPLETED|Overall Study||1
5104814|NCT01592383|12558724|P1|COMPLETED|Overall Study||1
5104815|NCT01592383|12558724|P1|STARTED|Overall Study||2
5104816|NCT01592344|12558735|P2|NOT COMPLETED|Overall Study||5
5104817|NCT01592344|12558736|P1|NOT COMPLETED|Overall Study||4
5104818|NCT01592344|12558735|P2|COMPLETED|Overall Study||44
5104819|NCT01592344|12558736|P1|COMPLETED|Overall Study||41
5104820|NCT01592344|12558735|P2|STARTED|Overall Study||49
5104821|NCT01592344|12558736|P1|STARTED|Overall Study||45
5104822|NCT01592292|12558750|P4|NOT COMPLETED|Overall Study||1
5104823|NCT01592292|12558751|P3|NOT COMPLETED|Overall Study||3
5104824|NCT01592292|12558752|P2|NOT COMPLETED|Overall Study||5
5104825|NCT01592292|12558753|P1|NOT COMPLETED|Overall Study||6
5104826|NCT01592292|12558750|P4|COMPLETED|Overall Study||10
5104827|NCT01592292|12558751|P3|COMPLETED|Overall Study||10
5104828|NCT01592292|12558752|P2|COMPLETED|Overall Study||15
5104829|NCT01592292|12558753|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
5104830|NCT01592292|12558750|P4|Standard Population Set (SPS)|Overall Study||7
5104831|NCT01592292|12558751|P3|Standard Population Set (SPS)|Overall Study||7
5104832|NCT01592292|12558752|P2|Standard Population Set (SPS)|Overall Study||10
5104833|NCT01592292|12558753|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
5104834|NCT01592292|12558750|P4|Intention to Treat (ITT) Set|Overall Study||8
5104835|NCT01592292|12558751|P3|Intention to Treat (ITT) Set|Overall Study||10
5104836|NCT01592292|12558752|P2|Intention to Treat (ITT) Set|Overall Study||13
5104837|NCT01592292|12558753|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
5104838|NCT01592292|12558750|P4|STARTED|Overall Study||11
5104839|NCT01592292|12558751|P3|STARTED|Overall Study||13
5104840|NCT01592292|12558752|P2|STARTED|Overall Study||20
5104841|NCT01592292|12558753|P1|STARTED|Overall Study||46
5104842|NCT01592240|12558792|P7|NOT COMPLETED|Overall Study||3
5104843|NCT01592240|12558793|P6|NOT COMPLETED|Overall Study||3
5104844|NCT01592240|12558794|P5|NOT COMPLETED|Overall Study||7
5104845|NCT01592240|12558795|P4|NOT COMPLETED|Overall Study||3
5104846|NCT01592240|12558796|P3|NOT COMPLETED|Overall Study||7
5104847|NCT01592240|12558797|P2|NOT COMPLETED|Overall Study||11
5104848|NCT01592240|12558798|P1|NOT COMPLETED|Overall Study||3
5104849|NCT01592240|12558792|P7|COMPLETED|Overall Study||48
5104850|NCT01592240|12558793|P6|COMPLETED|Overall Study||47
5104851|NCT01592240|12558794|P5|COMPLETED|Overall Study||44
5104852|NCT01592240|12558795|P4|COMPLETED|Overall Study||47
5104853|NCT01592240|12558796|P3|COMPLETED|Overall Study||45
5104854|NCT01592240|12558797|P2|COMPLETED|Overall Study||39
5104855|NCT01592240|12558798|P1|COMPLETED|Overall Study||47
5104856|NCT01592240|12558792|P7|STARTED|Overall Study||51
5104857|NCT01592240|12558793|P6|STARTED|Overall Study||50
5104858|NCT01592240|12558794|P5|STARTED|Overall Study||51
5104859|NCT01592240|12558795|P4|STARTED|Overall Study||50
5104860|NCT01592240|12558796|P3|STARTED|Overall Study||52
5104861|NCT01592240|12558797|P2|STARTED|Overall Study||50
5104862|NCT01592240|12558798|P1|STARTED|Overall Study||50
5104863|NCT01592071|12558978|P1|NOT COMPLETED|Overall Study||0
5104864|NCT01592071|12558978|P1|COMPLETED|Overall Study||120
5104865|NCT01592071|12558978|P1|STARTED|Overall Study||120
5104866|NCT01592045|12558991|P2|NOT COMPLETED|Overall Study||2
5104867|NCT01592045|12558992|P1|NOT COMPLETED|Overall Study||5
5104868|NCT01592045|12558991|P2|COMPLETED|Overall Study||12
5104869|NCT01592045|12558992|P1|COMPLETED|Overall Study||9
5104870|NCT01592045|12558991|P2|Completed Course 5|Overall Study||12
5104871|NCT01592045|12558992|P1|Completed Course 5|Overall Study||9
5104872|NCT01592045|12558991|P2|Completed Course 4|Overall Study||12
5104873|NCT01592045|12558992|P1|Completed Course 4|Overall Study||11
5104874|NCT01592045|12558991|P2|Completed Course 3|Overall Study||13
5104875|NCT01592045|12558992|P1|Completed Course 3|Overall Study||11
5104876|NCT01592045|12558991|P2|Completed Course 2|Overall Study||13
5104877|NCT01592045|12558992|P1|Completed Course 2|Overall Study||13
5104878|NCT01592045|12558991|P2|Completed Course 1|Overall Study||14
5104879|NCT01592045|12558992|P1|Completed Course 1|Overall Study||13
5104880|NCT01592045|12558991|P2|STARTED|Overall Study||14
5104881|NCT01592045|12558992|P1|STARTED|Overall Study||14
5104882|NCT01592006|12559000|P1|NOT COMPLETED|Overall Study||0
5104883|NCT01592006|12559000|P1|COMPLETED|Overall Study||3
5104884|NCT01592006|12559000|P1|STARTED|Overall Study||3
5104885|NCT01591954|12559005|P1|NOT COMPLETED|Overall Study||0
5104886|NCT01591954|12559005|P1|COMPLETED|Overall Study||1
5104887|NCT01591954|12559005|P1|STARTED|Overall Study||1
5104888|NCT01591863|12559010|P1|NOT COMPLETED|Overall Study||14
5104889|NCT01591863|12559010|P1|COMPLETED|Overall Study||24
5104890|NCT01591863|12559010|P1|STARTED|Overall Study||38
5104891|NCT01591837|12559022|P2|NOT COMPLETED|Overall Study||0
5104892|NCT01591837|12559023|P1|NOT COMPLETED|Overall Study||0
5104893|NCT01591837|12559022|P2|COMPLETED|Overall Study||60
5104894|NCT01591837|12559023|P1|COMPLETED|Overall Study||60
5104895|NCT01591837|12559022|P2|STARTED|Overall Study||60
5104896|NCT01591837|12559023|P1|STARTED|Overall Study||60
5104897|NCT01591746|12559039|P2|NOT COMPLETED|Overall Study||0
5104898|NCT01591746|12559040|P1|NOT COMPLETED|Overall Study||0
5104899|NCT01591746|12559039|P2|COMPLETED|Overall Study||63
5104900|NCT01591746|12559040|P1|COMPLETED|Overall Study||68
5104901|NCT01591746|12559039|P2|STARTED|Overall Study||63
5104902|NCT01591746|12559040|P1|STARTED|Overall Study||68
5104903|NCT01591733|12559056|P1|NOT COMPLETED|Overall Study||0
5104904|NCT01591733|12559056|P1|COMPLETED|Overall Study||48
5104905|NCT01591733|12559056|P1|STARTED|Overall Study||48
5104906|NCT01591681|12559067|P1|NOT COMPLETED|Overall Study||4
5104907|NCT01591681|12559067|P1|COMPLETED|Overall Study||45
5104908|NCT01591681|12559067|P1|STARTED|Overall Study||49
5104909|NCT01591616|12559093|P1|NOT COMPLETED|Overall Study||1
5104910|NCT01591616|12559093|P1|COMPLETED|Overall Study||15
5104911|NCT01591616|12559093|P1|STARTED|Overall Study||16
5104912|NCT01591499|12559234|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
5104913|NCT01591499|12559235|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
5104914|NCT01591499|12559236|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
5104915|NCT01591499|12559237|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
5104916|NCT01591499|12559234|P4|COMPLETED|Second Intervention (up to 24 Days)||34
5104917|NCT01591499|12559235|P3|COMPLETED|Second Intervention (up to 24 Days)||28
5104918|NCT01591499|12559236|P2|COMPLETED|Second Intervention (up to 24 Days)||34
5104919|NCT01591499|12559237|P1|COMPLETED|Second Intervention (up to 24 Days)||27
5104920|NCT01591499|12559234|P4|STARTED|Second Intervention (up to 24 Days)||37
5104921|NCT01591499|12559235|P3|STARTED|Second Intervention (up to 24 Days)||31
5104922|NCT01591499|12559236|P2|STARTED|Second Intervention (up to 24 Days)||37
5104923|NCT01591499|12559237|P1|STARTED|Second Intervention (up to 24 Days)||33
5104924|NCT01591499|12559234|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
5104925|NCT01591499|12559235|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
5104926|NCT01591499|12559236|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
5104927|NCT01591499|12559237|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
5104928|NCT01591499|12559234|P4|COMPLETED|First Intervention (up to 24 Days)||37
5104929|NCT01591499|12559235|P3|COMPLETED|First Intervention (up to 24 Days)||31
5104930|NCT01591499|12559236|P2|COMPLETED|First Intervention (up to 24 Days)||37
5104931|NCT01591499|12559237|P1|COMPLETED|First Intervention (up to 24 Days)||33
5104932|NCT01591499|12559234|P4|STARTED|First Intervention (up to 24 Days)||37
5104933|NCT01591499|12559235|P3|STARTED|First Intervention (up to 24 Days)||31
5104934|NCT01591499|12559236|P2|STARTED|First Intervention (up to 24 Days)||37
5104935|NCT01591499|12559237|P1|STARTED|First Intervention (up to 24 Days)||33
5104936|NCT01591499|12559234|P4|NOT COMPLETED|Baseline Visit||2
5104937|NCT01591499|12559235|P3|NOT COMPLETED|Baseline Visit||0
5104938|NCT01591499|12559236|P2|NOT COMPLETED|Baseline Visit||2
5104939|NCT01591499|12559237|P1|NOT COMPLETED|Baseline Visit||0
5104940|NCT01591499|12559234|P4|COMPLETED|Baseline Visit||37
5104941|NCT01591499|12559235|P3|COMPLETED|Baseline Visit||31
5104942|NCT01591499|12559236|P2|COMPLETED|Baseline Visit||37
5104943|NCT01591499|12559237|P1|COMPLETED|Baseline Visit||33
5104944|NCT01591499|12559234|P4|STARTED|Baseline Visit||39
5104945|NCT01591499|12559235|P3|STARTED|Baseline Visit||31
5104946|NCT01591499|12559236|P2|STARTED|Baseline Visit||39
5104947|NCT01591499|12559237|P1|STARTED|Baseline Visit||33
5104948|NCT01591460|12559303|P1|NOT COMPLETED|Overall Study||26
5104949|NCT01591460|12559303|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
5104950|NCT01591460|12559303|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
5104951|NCT01591408|12559385|P2|NOT COMPLETED|Overall Study||8
5104952|NCT01591408|12559386|P1|NOT COMPLETED|Overall Study||12
5104953|NCT01591408|12559385|P2|COMPLETED|Overall Study||24
5104954|NCT01591408|12559386|P1|COMPLETED|Overall Study||24
5104955|NCT01591408|12559385|P2|STARTED|Overall Study||32
5104956|NCT01591408|12559386|P1|STARTED|Overall Study||36
5104957|NCT01591382|12559394|P2|NOT COMPLETED|Overall Study||2
5104958|NCT01591382|12559395|P1|NOT COMPLETED|Overall Study||3
5104959|NCT01591382|12559394|P2|COMPLETED|Overall Study||30
5104960|NCT01591382|12559395|P1|COMPLETED|Overall Study||29
5104961|NCT01591382|12559394|P2|STARTED|Overall Study||32
5104962|NCT01591382|12559395|P1|STARTED|Overall Study||32
5104963|NCT01591317|12559412|P3|NOT COMPLETED|Overall Study||0
5104964|NCT01591317|12559413|P2|NOT COMPLETED|Overall Study||0
5104965|NCT01591317|12559414|P1|NOT COMPLETED|Overall Study||0
5104966|NCT01591317|12559412|P3|COMPLETED|Overall Study||10
5104967|NCT01591317|12559413|P2|COMPLETED|Overall Study||10
5104968|NCT01591317|12559414|P1|COMPLETED|Overall Study||10
5104969|NCT01591317|12559412|P3|STARTED|Overall Study||10
5104970|NCT01591317|12559413|P2|STARTED|Overall Study||10
5104971|NCT01591317|12559414|P1|STARTED|Overall Study||10
5104972|NCT01591096|12559440|P1|NOT COMPLETED|Overall Study||1
5104973|NCT01591096|12559440|P1|COMPLETED|Overall Study||0
5104974|NCT01591096|12559440|P1|STARTED|Overall Study||1
5104975|NCT01591044|12559449|P3|NOT COMPLETED|Overall Study||4
5104976|NCT01591044|12559450|P2|NOT COMPLETED|Overall Study||9
5104977|NCT01591044|12559451|P1|NOT COMPLETED|Overall Study||7
5104978|NCT01591044|12559449|P3|COMPLETED|Overall Study||96
5104979|NCT01591044|12559450|P2|COMPLETED|Overall Study||91
5104980|NCT01591044|12559451|P1|COMPLETED|Overall Study||94
5104981|NCT01591044|12559449|P3|STARTED|Overall Study||100
5104982|NCT01591044|12559450|P2|STARTED|Overall Study||100
5104983|NCT01591044|12559451|P1|STARTED|Overall Study||101
5104984|NCT01591018|12559461|P2|NOT COMPLETED|Overall Study||0
5104985|NCT01591018|12559462|P1|NOT COMPLETED|Overall Study||0
5104986|NCT01591018|12559461|P2|COMPLETED|Overall Study||60
5104987|NCT01591018|12559462|P1|COMPLETED|Overall Study||60
5104988|NCT01591018|12559461|P2|STARTED|Overall Study||60
5104989|NCT01591018|12559462|P1|STARTED|Overall Study||60
5104990|NCT01591005|12559476|P4|NOT COMPLETED|Overall Study||0
5104991|NCT01591005|12559477|P3|NOT COMPLETED|Overall Study||0
5104992|NCT01591005|12559478|P2|NOT COMPLETED|Overall Study||0
5104993|NCT01591005|12559479|P1|NOT COMPLETED|Overall Study||0
5104994|NCT01591005|12559476|P4|COMPLETED|Overall Study||68
5104995|NCT01591005|12559477|P3|COMPLETED|Overall Study||68
5104996|NCT01591005|12559478|P2|COMPLETED|Overall Study||53
5104997|NCT01591005|12559479|P1|COMPLETED|Overall Study||53
5104998|NCT01591005|12559476|P4|STARTED|Overall Study||68
5104999|NCT01591005|12559477|P3|STARTED|Overall Study||68
5105000|NCT01591005|12559478|P2|STARTED|Overall Study||53
5105001|NCT01591005|12559479|P1|STARTED|Overall Study||53
5105002|NCT01590979|12559515|P2|NOT COMPLETED|Overall Study||0
5105003|NCT01590979|12559516|P1|NOT COMPLETED|Overall Study||0
5105004|NCT01590979|12559515|P2|COMPLETED|Overall Study||27
5105005|NCT01590979|12559516|P1|COMPLETED|Overall Study||27
5105006|NCT01590979|12559515|P2|STARTED|Overall Study||27
5105007|NCT01590979|12559516|P1|STARTED|Overall Study||27
5105008|NCT01590888|12559525|P3|NOT COMPLETED|Overall Study||1
5105009|NCT01590888|12559526|P2|NOT COMPLETED|Overall Study||0
5105010|NCT01590888|12559527|P1|NOT COMPLETED|Overall Study||4
5105011|NCT01590888|12559525|P3|COMPLETED|Overall Study||34
5105012|NCT01590888|12559526|P2|COMPLETED|Overall Study||38
5105013|NCT01590888|12559527|P1|COMPLETED|Overall Study||32
5105014|NCT01590888|12559525|P3|STARTED|Overall Study||35
5105015|NCT01590888|12559526|P2|STARTED|Overall Study||38
5105016|NCT01590888|12559527|P1|STARTED|Overall Study||36
5105017|NCT01590875|12559573|P2|NOT COMPLETED|Overall Study||0
5105018|NCT01590875|12559574|P1|NOT COMPLETED|Overall Study||0
5105019|NCT01590875|12559573|P2|COMPLETED|Overall Study||10
5105020|NCT01590875|12559574|P1|COMPLETED|Overall Study||10
5105021|NCT01590875|12559573|P2|STARTED|Overall Study||10
5105022|NCT01590875|12559574|P1|STARTED|Overall Study||10
5105023|NCT01590810|12559587|P5|NOT COMPLETED|Overall Study||0
5105024|NCT01590810|12559588|P4|NOT COMPLETED|Overall Study||0
5105025|NCT01590810|12559589|P3|NOT COMPLETED|Overall Study||1
5105026|NCT01590810|12559590|P2|NOT COMPLETED|Overall Study||1
5105027|NCT01590810|12559591|P1|NOT COMPLETED|Overall Study||0
5105028|NCT01590810|12559587|P5|COMPLETED|Overall Study||2
5105029|NCT01590810|12559588|P4|COMPLETED|Overall Study||8
5105030|NCT01590810|12559589|P3|COMPLETED|Overall Study||7
5105031|NCT01590810|12559590|P2|COMPLETED|Overall Study||7
5105032|NCT01590810|12559591|P1|COMPLETED|Overall Study||8
5105033|NCT01590810|12559587|P5|STARTED|Overall Study||2
5105034|NCT01590810|12559588|P4|STARTED|Overall Study||8
5105035|NCT01590810|12559589|P3|STARTED|Overall Study||8
5105036|NCT01590810|12559590|P2|STARTED|Overall Study||8
5105037|NCT01590810|12559591|P1|STARTED|Overall Study||8
5105038|NCT01590797|12559736|P2|NOT COMPLETED|Overall Study||16
5105039|NCT01590797|12559737|P1|NOT COMPLETED|Overall Study||17
5105040|NCT01590797|12559736|P2|COMPLETED|Overall Study||217
5105041|NCT01590797|12559737|P1|COMPLETED|Overall Study||217
5105042|NCT01590797|12559736|P2|STARTED|Overall Study||233
5105043|NCT01590797|12559737|P1|STARTED|Overall Study||234
5105044|NCT01590771|12559753|P2|NOT COMPLETED|Overall Study||39
5105045|NCT01590771|12559754|P1|NOT COMPLETED|Overall Study||19
5105046|NCT01590771|12559753|P2|COMPLETED|Overall Study||210
5105047|NCT01590771|12559754|P1|COMPLETED|Overall Study||230
5105048|NCT01590771|12559753|P2|STARTED|Overall Study||249
5105049|NCT01590771|12559754|P1|STARTED|Overall Study||249
5105050|NCT01590758|12559782|P2|NOT COMPLETED|Overall Study||7
5105051|NCT01590758|12559783|P1|NOT COMPLETED|Overall Study||5
5105052|NCT01590758|12559782|P2|COMPLETED|Overall Study||97
5105053|NCT01590758|12559783|P1|COMPLETED|Overall Study||80
5105054|NCT01590758|12559782|P2|STARTED|Overall Study||104
5105055|NCT01590758|12559783|P1|STARTED|Overall Study||85
5105056|NCT01590563|12559793|P1|NOT COMPLETED|Overall Study||1
5105057|NCT01590563|12559793|P1|COMPLETED|Overall Study||14
5105058|NCT01590563|12559793|P1|STARTED|Overall Study||15
5105059|NCT01590550|12559799|P1|NOT COMPLETED|Overall Study||0
5105060|NCT01590550|12559799|P1|COMPLETED|Overall Study||18
5105061|NCT01590550|12559799|P1|STARTED|Overall Study||18
5105062|NCT01590433|12559807|P2|NOT COMPLETED|Overall Study||22
5105063|NCT01590433|12559808|P1|NOT COMPLETED|Overall Study||52
5105064|NCT01590433|12559807|P2|COMPLETED|Overall Study||33
5105065|NCT01590433|12559808|P1|COMPLETED|Overall Study||75
5105066|NCT01590433|12559807|P2|STARTED|Overall Study||55
5105067|NCT01590433|12559808|P1|STARTED|Overall Study||127
5105068|NCT01590394|12559814|P1|NOT COMPLETED|Overall Study||0
5105069|NCT01590394|12559814|P1|COMPLETED|Overall Study||3
5105070|NCT01590394|12559814|P1|STARTED|Overall Study||3
5105071|NCT01590264|12559818|P1|NOT COMPLETED|Overall Study||0
5105072|NCT01590264|12559818|P1|COMPLETED|Overall Study||5
5105073|NCT01590264|12559818|P1|STARTED|Overall Study||5
5105074|NCT01590238|12559823|P1|NOT COMPLETED|Overall Study||2
5105075|NCT01590238|12559823|P1|COMPLETED|Overall Study||13
5105076|NCT01590238|12559823|P1|STARTED|Overall Study||15
5105077|NCT01590212|12559830|P3|NOT COMPLETED|Overall Study||5
5105078|NCT01590212|12559831|P2|NOT COMPLETED|Overall Study||4
5105079|NCT01590212|12559832|P1|NOT COMPLETED|Overall Study||3
5105080|NCT01590212|12559830|P3|COMPLETED|Overall Study||9
5105081|NCT01590212|12559831|P2|COMPLETED|Overall Study||5
5105082|NCT01590212|12559832|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
5105083|NCT01590212|12559830|P3|Post-intervention|Overall Study|failed contact=1|10
5105084|NCT01590212|12559831|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
5105085|NCT01590212|12559832|P1|Post-intervention|Overall Study|failed contact=3|7
5105086|NCT01590212|12559830|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
5105087|NCT01590212|12559831|P2|Baseline (Pre-intervention)|Overall Study||9
5105088|NCT01590212|12559832|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
5105089|NCT01590212|12559830|P3|STARTED|Overall Study||14
5105090|NCT01590212|12559831|P2|STARTED|Overall Study||9
5105091|NCT01590212|12559832|P1|STARTED|Overall Study||12
5105092|NCT01590017|12559849|P1|NOT COMPLETED|Overall Study||4
5105093|NCT01590017|12559849|P1|COMPLETED|Overall Study||37
5105094|NCT01590017|12559849|P1|STARTED|Overall Study||41
5105095|NCT01589978|12559854|P1|NOT COMPLETED|Overall Study||0
5105096|NCT01589978|12559854|P1|COMPLETED|Overall Study||2681
5105097|NCT01589978|12559854|P1|STARTED|Overall Study||2681
5105098|NCT01589926|12559880|P2|NOT COMPLETED|Overall Study||0
5105099|NCT01589926|12559881|P1|NOT COMPLETED|Overall Study||0
5105100|NCT01589926|12559880|P2|COMPLETED|Overall Study||0
5105101|NCT01589926|12559881|P1|COMPLETED|Overall Study||0
5105102|NCT01589926|12559880|P2|STARTED|Overall Study||0
5105103|NCT01589926|12559881|P1|STARTED|Overall Study||0
5105104|NCT01589822|12559902|P3|NOT COMPLETED|Overall Study||1
5105105|NCT01589822|12559903|P2|NOT COMPLETED|Overall Study||3
5105106|NCT01589822|12559904|P1|NOT COMPLETED|Overall Study||4
5105107|NCT01589822|12559902|P3|COMPLETED|Overall Study||40
5105108|NCT01589822|12559903|P2|COMPLETED|Overall Study||86
5105109|NCT01589822|12559904|P1|COMPLETED|Overall Study||80
5105110|NCT01589822|12559902|P3|STARTED|Overall Study||41
5105111|NCT01589822|12559903|P2|STARTED|Overall Study||89
5105112|NCT01589822|12559904|P1|STARTED|Overall Study||84
5105113|NCT01589770|12559923|P2|NOT COMPLETED|Overall Study||5
5105114|NCT01589770|12559924|P1|NOT COMPLETED|Overall Study||8
5105115|NCT01589770|12559923|P2|COMPLETED|Overall Study||56
5105116|NCT01589770|12559924|P1|COMPLETED|Overall Study||59
5105117|NCT01589770|12559923|P2|STARTED|Overall Study||61
5105118|NCT01589770|12559924|P1|STARTED|Overall Study||67
5105119|NCT01589653|12559934|P2|NOT COMPLETED|Overall Study||11
5105120|NCT01589653|12559935|P1|NOT COMPLETED|Overall Study||7
5105121|NCT01589653|12559934|P2|COMPLETED|Overall Study||68
5105122|NCT01589653|12559935|P1|COMPLETED|Overall Study||69
5105123|NCT01589653|12559934|P2|Exposed|Overall Study||78
5105124|NCT01589653|12559935|P1|Exposed|Overall Study||76
5105125|NCT01589653|12559934|P2|STARTED|Overall Study||79
5105126|NCT01589653|12559935|P1|STARTED|Overall Study||76
5105127|NCT01589601|12559951|P2|NOT COMPLETED|Overall Study||49
5105128|NCT01589601|12559952|P1|NOT COMPLETED|Overall Study||47
5105129|NCT01589601|12559951|P2|COMPLETED|Overall Study||26
5105130|NCT01589601|12559952|P1|COMPLETED|Overall Study||28
5105131|NCT01589601|12559951|P2|STARTED|Overall Study||75
5105132|NCT01589601|12559952|P1|STARTED|Overall Study||75
5105133|NCT01589510|12559970|P1|NOT COMPLETED|Overall Study||33
5105134|NCT01589510|12559970|P1|COMPLETED|Overall Study||386
5105135|NCT01589510|12559970|P1|STARTED|Overall Study||419
5105136|NCT01589497|12559985|P4|NOT COMPLETED|Overall Study||1
5105137|NCT01589497|12559986|P3|NOT COMPLETED|Overall Study||1
5105138|NCT01589497|12559987|P2|NOT COMPLETED|Overall Study||1
5105139|NCT01589497|12559988|P1|NOT COMPLETED|Overall Study||1
5105140|NCT01589497|12559985|P4|COMPLETED|Overall Study||17
5105141|NCT01589497|12559986|P3|COMPLETED|Overall Study||15
5105142|NCT01589497|12559987|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
5105143|NCT01589497|12559988|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
5105144|NCT01589497|12559985|P4|STARTED|Overall Study||18
5105145|NCT01589497|12559986|P3|STARTED|Overall Study||16
5105146|NCT01589497|12559987|P2|STARTED|Overall Study||17
5105147|NCT01589497|12559988|P1|STARTED|Overall Study||18
5105148|NCT01589484|12560089|P1|NOT COMPLETED|Overall Study||4
5105149|NCT01589484|12560089|P1|COMPLETED|Overall Study||100
5105150|NCT01589484|12560089|P1|STARTED|Overall Study||104
5105151|NCT01589445|12560094|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
5105152|NCT01589445|12560094|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
5105153|NCT01589445|12560094|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
5105154|NCT01589445|12560094|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
5105155|NCT01589445|12560094|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
5105156|NCT01589445|12560094|P1|STARTED|001 (Pioglitazone) -3 Months||77
5105157|NCT01589315|12560110|P1|NOT COMPLETED|Overall Study||1
5105158|NCT01589315|12560110|P1|COMPLETED|Overall Study||16
5105159|NCT01589315|12560110|P1|STARTED|Overall Study||17
5105160|NCT01589302|12560114|P1|NOT COMPLETED|Overall Study||2
5105161|NCT01589302|12560114|P1|COMPLETED|Overall Study||152
5105162|NCT01589302|12560114|P1|Non-Del17p Patients|Overall Study||76
5105163|NCT01589302|12560114|P1|Del17p Patients|Overall Study||76
5105164|NCT01589302|12560114|P1|STARTED|Overall Study||154
5105165|NCT01589237|12560137|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
5105166|NCT01589237|12560138|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
5105167|NCT01589237|12560139|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
5105168|NCT01589237|12560140|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
5105169|NCT01589237|12560137|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
5105170|NCT01589237|12560138|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
5105171|NCT01589237|12560139|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
5105172|NCT01589237|12560140|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
5105173|NCT01589237|12560137|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
5105174|NCT01589237|12560138|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
5105175|NCT01589237|12560139|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
5105176|NCT01589237|12560140|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
5105177|NCT01589237|12560137|P4|NOT COMPLETED|Part A (52 Weeks)||0
5105178|NCT01589237|12560138|P3|NOT COMPLETED|Part A (52 Weeks)||2
5105179|NCT01589237|12560139|P2|NOT COMPLETED|Part A (52 Weeks)||3
5105180|NCT01589237|12560140|P1|NOT COMPLETED|Part A (52 Weeks)||2
5105181|NCT01589237|12560137|P4|COMPLETED|Part A (52 Weeks)||5
5105182|NCT01589237|12560138|P3|COMPLETED|Part A (52 Weeks)||8
5105183|NCT01589237|12560139|P2|COMPLETED|Part A (52 Weeks)||9
5105184|NCT01589237|12560140|P1|COMPLETED|Part A (52 Weeks)||9
5105185|NCT01589237|12560137|P4|STARTED|Part A (52 Weeks)||5
5105186|NCT01589237|12560138|P3|STARTED|Part A (52 Weeks)||10
5105187|NCT01589237|12560139|P2|STARTED|Part A (52 Weeks)||12
5105188|NCT01589237|12560140|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
5105189|NCT01589185|12560191|P5|NOT COMPLETED|Overall Study||1
5105190|NCT01589185|12560192|P4|NOT COMPLETED|Overall Study||3
5105191|NCT01589185|12560193|P3|NOT COMPLETED|Overall Study||4
5105192|NCT01589185|12560194|P2|NOT COMPLETED|Overall Study||2
5105193|NCT01589185|12560195|P1|NOT COMPLETED|Overall Study||2
5105194|NCT01589185|12560191|P5|COMPLETED|Overall Study||15
5105195|NCT01589185|12560192|P4|COMPLETED|Overall Study||5
5105196|NCT01589185|12560193|P3|COMPLETED|Overall Study||6
5105197|NCT01589185|12560194|P2|COMPLETED|Overall Study||6
5105198|NCT01589185|12560195|P1|COMPLETED|Overall Study||4
5105199|NCT01589185|12560191|P5|STARTED|Overall Study||16
5105200|NCT01589185|12560192|P4|STARTED|Overall Study||8
5105201|NCT01589185|12560193|P3|STARTED|Overall Study||10
5105202|NCT01589185|12560194|P2|STARTED|Overall Study||8
5105203|NCT01589185|12560195|P1|STARTED|Overall Study||6
5105204|NCT01589094|12560228|P1|NOT COMPLETED|Overall Study||2
5105205|NCT01589094|12560228|P1|COMPLETED|Overall Study||49
5105206|NCT01589094|12560228|P1|STARTED|Overall Study||51
5105207|NCT01588990|12560235|P1|NOT COMPLETED|Phase B||16
5105208|NCT01588990|12560235|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
5105209|NCT01588990|12560235|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
5105210|NCT01588990|12560235|P1|NOT COMPLETED|Phase A||70
5105211|NCT01588990|12560235|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
5105212|NCT01588990|12560235|P1|STARTED|Phase A||128
5105213|NCT01588951|12560263|P3|NOT COMPLETED|Overall Study||1
5105214|NCT01588951|12560264|P2|NOT COMPLETED|Overall Study||0
5105215|NCT01588951|12560265|P1|NOT COMPLETED|Overall Study||0
5105216|NCT01588951|12560263|P3|COMPLETED|Overall Study||5
5105217|NCT01588951|12560264|P2|COMPLETED|Overall Study||2
5105218|NCT01588951|12560265|P1|COMPLETED|Overall Study||2
5105219|NCT01588951|12560263|P3|STARTED|Overall Study||6
5105220|NCT01588951|12560264|P2|STARTED|Overall Study||2
5105221|NCT01588951|12560265|P1|STARTED|Overall Study||2
5105222|NCT01588821|12560273|P1|NOT COMPLETED|Overall Study||0
5105223|NCT01588821|12560273|P1|COMPLETED|Overall Study||37
5105224|NCT01588821|12560273|P1|STARTED|Overall Study||37
5105225|NCT01588561|12560278|P2|NOT COMPLETED|Overall Study||0
5105226|NCT01588561|12560279|P1|NOT COMPLETED|Overall Study||0
5105227|NCT01588561|12560278|P2|COMPLETED|Overall Study||1
5105228|NCT01588561|12560279|P1|COMPLETED|Overall Study||14
5105229|NCT01588561|12560278|P2|Second Injection (Visit 2)|Overall Study||1
5105230|NCT01588561|12560279|P1|Second Injection (Visit 2)|Overall Study||14
5105231|NCT01588561|12560278|P2|Rest Period|Overall Study||1
5105232|NCT01588561|12560279|P1|Rest Period|Overall Study||14
5105233|NCT01588561|12560278|P2|First Injection (Visit 1)|Overall Study||1
5105234|NCT01588561|12560279|P1|First Injection (Visit 1)|Overall Study||14
5105235|NCT01588561|12560278|P2|STARTED|Overall Study||1
5105236|NCT01588561|12560279|P1|STARTED|Overall Study||14
5105237|NCT01588548|12560296|P6|NOT COMPLETED|Overall Study||6
5105238|NCT01588548|12560297|P5|NOT COMPLETED|Overall Study||6
5105239|NCT01588548|12560298|P4|NOT COMPLETED|Overall Study||7
5105240|NCT01588548|12560299|P3|NOT COMPLETED|Overall Study||6
5105241|NCT01588548|12560300|P2|NOT COMPLETED|Overall Study||7
5105242|NCT01588548|12560301|P1|NOT COMPLETED|Overall Study||3
5105243|NCT01588548|12560296|P6|COMPLETED|Overall Study||0
5105244|NCT01588548|12560297|P5|COMPLETED|Overall Study||0
5105245|NCT01588548|12560298|P4|COMPLETED|Overall Study||0
5105246|NCT01588548|12560299|P3|COMPLETED|Overall Study||0
5105247|NCT01588548|12560300|P2|COMPLETED|Overall Study||0
5105248|NCT01588548|12560301|P1|COMPLETED|Overall Study||0
5105249|NCT01588548|12560296|P6|Cycle 1 Day 21|Overall Study||3
5105250|NCT01588548|12560297|P5|Cycle 1 Day 21|Overall Study||3
5105251|NCT01588548|12560298|P4|Cycle 1 Day 21|Overall Study||5
5105252|NCT01588548|12560299|P3|Cycle 1 Day 21|Overall Study||2
5105253|NCT01588548|12560300|P2|Cycle 1 Day 21|Overall Study||5
5105254|NCT01588548|12560301|P1|Cycle 1 Day 21|Overall Study||3
5105255|NCT01588548|12560296|P6|STARTED|Overall Study||6
5105256|NCT01588548|12560297|P5|STARTED|Overall Study||6
5105257|NCT01588548|12560298|P4|STARTED|Overall Study||7
5105258|NCT01588548|12560299|P3|STARTED|Overall Study||6
5105259|NCT01588548|12560300|P2|STARTED|Overall Study||7
5105260|NCT01588548|12560301|P1|STARTED|Overall Study||3
5105261|NCT01588509|12560317|P2|NOT COMPLETED|Overall Study||0
5105262|NCT01588509|12560318|P1|NOT COMPLETED|Overall Study||1
5105263|NCT01588509|12560317|P2|COMPLETED|Overall Study||30
5105264|NCT01588509|12560318|P1|COMPLETED|Overall Study||29
5105265|NCT01588509|12560317|P2|Received Treatment|Overall Study||30
5105266|NCT01588509|12560318|P1|Received Treatment|Overall Study||30
5105267|NCT01588509|12560317|P2|STARTED|Overall Study||30
5105268|NCT01588509|12560318|P1|STARTED|Overall Study||30
5105269|NCT01588496|12560341|P3|NOT COMPLETED|Overall Study||0
5105270|NCT01588496|12560342|P2|NOT COMPLETED|Overall Study||1
5105271|NCT01588496|12560343|P1|NOT COMPLETED|Overall Study||0
5105272|NCT01588496|12560341|P3|COMPLETED|Overall Study||33
5105273|NCT01588496|12560342|P2|COMPLETED|Overall Study||16
5105274|NCT01588496|12560343|P1|COMPLETED|Overall Study||8
5105275|NCT01588496|12560341|P3|Received Treatment|Overall Study||33
5105276|NCT01588496|12560342|P2|Received Treatment|Overall Study||16
5105277|NCT01588496|12560343|P1|Received Treatment|Overall Study||8
5105278|NCT01588496|12560341|P3|STARTED|Overall Study||33
5105279|NCT01588496|12560342|P2|STARTED|Overall Study||17
5105280|NCT01588496|12560343|P1|STARTED|Overall Study||8
5105281|NCT01588470|12560368|P1|NOT COMPLETED|Overall Study||80
5105282|NCT01588470|12560368|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
5105283|NCT01588470|12560368|P1|STARTED|Overall Study|First enrolled April 2007|130
5105284|NCT01588444|12560379|P2|NOT COMPLETED|Overall Study||0
5105285|NCT01588444|12560380|P1|NOT COMPLETED|Overall Study||0
5105286|NCT01588444|12560379|P2|COMPLETED|Overall Study||20
5105287|NCT01588444|12560380|P1|COMPLETED|Overall Study||20
5105288|NCT01588444|12560379|P2|STARTED|Overall Study||20
5105289|NCT01588444|12560380|P1|STARTED|Overall Study||20
5105290|NCT01588418|12560386|P2|NOT COMPLETED|Overall Study||0
5105291|NCT01588418|12560387|P1|NOT COMPLETED|Overall Study||0
5105292|NCT01588418|12560386|P2|COMPLETED|Overall Study||4
5105293|NCT01588418|12560387|P1|COMPLETED|Overall Study||11
5105294|NCT01588418|12560386|P2|STARTED|Overall Study||4
5105295|NCT01588418|12560387|P1|STARTED|Overall Study||11
5105296|NCT01588405|12560393|P1|NOT COMPLETED|Overall Study||2
5105297|NCT01588405|12560393|P1|COMPLETED|Overall Study||31
5105298|NCT01588405|12560393|P1|STARTED|Overall Study||33
5105299|NCT01588366|12560422|P6|NOT COMPLETED|Overall Study||2
5105300|NCT01588366|12560423|P5|NOT COMPLETED|Overall Study||0
5105301|NCT01588366|12560424|P4|NOT COMPLETED|Overall Study||1
5105302|NCT01588366|12560425|P3|NOT COMPLETED|Overall Study||0
5105303|NCT01588366|12560426|P2|NOT COMPLETED|Overall Study||1
5105304|NCT01588366|12560427|P1|NOT COMPLETED|Overall Study||0
5105305|NCT01588366|12560422|P6|COMPLETED|Overall Study||7
5105306|NCT01588366|12560423|P5|COMPLETED|Overall Study||3
5105307|NCT01588366|12560424|P4|COMPLETED|Overall Study||6
5105308|NCT01588366|12560425|P3|COMPLETED|Overall Study||2
5105309|NCT01588366|12560426|P2|COMPLETED|Overall Study||6
5105310|NCT01588366|12560427|P1|COMPLETED|Overall Study||2
5105311|NCT01588366|12560422|P6|Received at Least One Dose of Study Drug|Overall Study||9
5105312|NCT01588366|12560423|P5|Received at Least One Dose of Study Drug|Overall Study||3
5105313|NCT01588366|12560424|P4|Received at Least One Dose of Study Drug|Overall Study||7
5105314|NCT01588366|12560425|P3|Received at Least One Dose of Study Drug|Overall Study||2
5105315|NCT01588366|12560426|P2|Received at Least One Dose of Study Drug|Overall Study||7
5105316|NCT01588366|12560427|P1|Received at Least One Dose of Study Drug|Overall Study||2
5105317|NCT01588366|12560422|P6|STARTED|Overall Study||9
5105318|NCT01588366|12560423|P5|STARTED|Overall Study||3
5105319|NCT01588366|12560424|P4|STARTED|Overall Study||7
5105320|NCT01588366|12560425|P3|STARTED|Overall Study||2
5105321|NCT01588366|12560426|P2|STARTED|Overall Study||7
5105322|NCT01588366|12560427|P1|STARTED|Overall Study||2
5105323|NCT01588353|12560455|P3|NOT COMPLETED|Step3||2
5105324|NCT01588353|12560456|P2|NOT COMPLETED|Step3||0
5105325|NCT01588353|12560457|P1|NOT COMPLETED|Step3||0
5105326|NCT01588353|12560455|P3|COMPLETED|Step3||23
5105327|NCT01588353|12560456|P2|COMPLETED|Step3||0
5105328|NCT01588353|12560457|P1|COMPLETED|Step3||0
5105329|NCT01588353|12560455|P3|STARTED|Step3||25
5105330|NCT01588353|12560456|P2|STARTED|Step3||0
5105331|NCT01588353|12560457|P1|STARTED|Step3||0
5105332|NCT01588353|12560455|P3|NOT COMPLETED|Step2||0
5105333|NCT01588353|12560456|P2|NOT COMPLETED|Step2||1
5105334|NCT01588353|12560457|P1|NOT COMPLETED|Step2||0
5105335|NCT01588353|12560455|P3|COMPLETED|Step2||0
5105336|NCT01588353|12560456|P2|COMPLETED|Step2||70
5105337|NCT01588353|12560457|P1|COMPLETED|Step2||0
5105338|NCT01588353|12560455|P3|STARTED|Step2||0
5105339|NCT01588353|12560456|P2|STARTED|Step2||71
5105340|NCT01588353|12560457|P1|STARTED|Step2||0
5105341|NCT01588353|12560455|P3|NOT COMPLETED|Step1||0
5105342|NCT01588353|12560456|P2|NOT COMPLETED|Step1||0
5105343|NCT01588353|12560457|P1|NOT COMPLETED|Step1||0
5105344|NCT01588353|12560455|P3|COMPLETED|Step1||0
5105345|NCT01588353|12560456|P2|COMPLETED|Step1||0
5105346|NCT01588353|12560457|P1|COMPLETED|Step1||6
5105347|NCT01588353|12560455|P3|STARTED|Step1||0
5105348|NCT01588353|12560456|P2|STARTED|Step1||0
5105349|NCT01588353|12560457|P1|STARTED|Step1||6
5105350|NCT01588236|12560476|P3|NOT COMPLETED|Overall Study||25
5105351|NCT01588236|12560477|P2|NOT COMPLETED|Overall Study||28
5105352|NCT01588236|12560478|P1|NOT COMPLETED|Overall Study||16
5105353|NCT01588236|12560476|P3|COMPLETED|Overall Study||69
5105354|NCT01588236|12560477|P2|COMPLETED|Overall Study||66
5105355|NCT01588236|12560478|P1|COMPLETED|Overall Study||76
5105356|NCT01588236|12560476|P3|STARTED|Overall Study||94
5105357|NCT01588236|12560477|P2|STARTED|Overall Study||94
5105358|NCT01588236|12560478|P1|STARTED|Overall Study||92
5105359|NCT01588197|12560506|P2|NOT COMPLETED|Overall Study||1
5105360|NCT01588197|12560507|P1|NOT COMPLETED|Overall Study||1
5105361|NCT01588197|12560506|P2|COMPLETED|Overall Study||9
5105362|NCT01588197|12560507|P1|COMPLETED|Overall Study||9
5105363|NCT01588197|12560506|P2|STARTED|Overall Study||10
5105364|NCT01588197|12560507|P1|STARTED|Overall Study||10
5105365|NCT01588158|12560519|P2|NOT COMPLETED|Overall Study||0
5105366|NCT01588158|12560520|P1|NOT COMPLETED|Overall Study||0
5105367|NCT01588158|12560519|P2|COMPLETED|Overall Study||3
5105368|NCT01588158|12560520|P1|COMPLETED|Overall Study||4
5105369|NCT01588158|12560519|P2|STARTED|Overall Study||3
5105370|NCT01588158|12560520|P1|STARTED|Overall Study||4
5105371|NCT01588106|12560544|P2|NOT COMPLETED|Overall Study||4
5105372|NCT01588106|12560545|P1|NOT COMPLETED|Overall Study||5
5105373|NCT01588106|12560544|P2|COMPLETED|Overall Study||72
5105374|NCT01588106|12560545|P1|COMPLETED|Overall Study||73
5105375|NCT01588106|12560544|P2|STARTED|Overall Study||76
5105376|NCT01588106|12560545|P1|STARTED|Overall Study||78
5105377|NCT01587989|12560553|P3|NOT COMPLETED|Randomized Study Treatment||1
5105378|NCT01587989|12560554|P2|NOT COMPLETED|Randomized Study Treatment||2
5105379|NCT01587989|12560555|P1|NOT COMPLETED|Randomized Study Treatment||0
5105380|NCT01587989|12560553|P3|COMPLETED|Randomized Study Treatment||32
5105381|NCT01587989|12560554|P2|COMPLETED|Randomized Study Treatment||30
5105382|NCT01587989|12560555|P1|COMPLETED|Randomized Study Treatment||0
5105383|NCT01587989|12560553|P3|STARTED|Randomized Study Treatment||33
5105384|NCT01587989|12560554|P2|STARTED|Randomized Study Treatment||32
5105385|NCT01587989|12560555|P1|STARTED|Randomized Study Treatment||0
5105386|NCT01587989|12560553|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
5105387|NCT01587989|12560554|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
5105388|NCT01587989|12560555|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
5105389|NCT01587989|12560553|P3|COMPLETED|12-Week Open-Label Run-In Period||0
5105390|NCT01587989|12560554|P2|COMPLETED|12-Week Open-Label Run-In Period||0
5105391|NCT01587989|12560555|P1|COMPLETED|12-Week Open-Label Run-In Period||65
5105392|NCT01587989|12560553|P3|STARTED|12-Week Open-Label Run-In Period||0
5105393|NCT01587989|12560554|P2|STARTED|12-Week Open-Label Run-In Period||0
5105394|NCT01587989|12560555|P1|STARTED|12-Week Open-Label Run-In Period||77
5105395|NCT01587963|12560579|P2|NOT COMPLETED|Overall Study||0
5105396|NCT01587963|12560580|P1|NOT COMPLETED|Overall Study||1
5105397|NCT01587963|12560579|P2|COMPLETED|Overall Study||4
5105398|NCT01587963|12560580|P1|COMPLETED|Overall Study||6
5105399|NCT01587963|12560579|P2|STARTED|Overall Study||4
5105400|NCT01587963|12560580|P1|STARTED|Overall Study||7
5105401|NCT01587950|12560586|P1|NOT COMPLETED|Period 3||0
5105402|NCT01587950|12560586|P1|COMPLETED|Period 3||12
5105403|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
5105404|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
5105405|NCT01587950|12560586|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
5105406|NCT01587950|12560586|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
5105407|NCT01587950|12560586|P1|Received Sterile Water (5 Minutes)|Period 3||5
5105408|NCT01587950|12560586|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
5105409|NCT01587950|12560586|P1|Received Sterile Water (2 Minutes)|Period 3||2
5105410|NCT01587950|12560586|P1|Received Sterile Water (10 Minutes)|Period 3||5
5105411|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
5105412|NCT01587950|12560586|P1|STARTED|Period 3||12
5105413|NCT01587950|12560586|P1|NOT COMPLETED|Washout 2||0
5105414|NCT01587950|12560586|P1|COMPLETED|Washout 2||12
5105415|NCT01587950|12560586|P1|STARTED|Washout 2||12
5105416|NCT01587950|12560586|P1|NOT COMPLETED|Period 2||0
5105417|NCT01587950|12560586|P1|COMPLETED|Period 2||12
5105418|NCT01587950|12560586|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
5105419|NCT01587950|12560586|P1|Received Sterile Water (10 Minutes)|Period 2||2
5105420|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
5105421|NCT01587950|12560586|P1|Received Sterile Water (5 Minutes)|Period 2||2
5105422|NCT01587950|12560586|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
5105423|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
5105424|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
5105425|NCT01587950|12560586|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
5105426|NCT01587950|12560586|P1|Received Sterile Water (2 Minutes)|Period 2||8
5105427|NCT01587950|12560586|P1|STARTED|Period 2||12
5105428|NCT01587950|12560586|P1|NOT COMPLETED|Washout 1||0
5105429|NCT01587950|12560586|P1|COMPLETED|Washout 1||12
5105430|NCT01587950|12560586|P1|STARTED|Washout 1||12
5105431|NCT01587950|12560586|P1|NOT COMPLETED|Period 1||0
5105432|NCT01587950|12560586|P1|COMPLETED|Period 1||12
5105433|NCT01587950|12560586|P1|Received Sterile Water (5 Minutes)|Period 1||5
5105434|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
5105435|NCT01587950|12560586|P1|Received Sterile Water (10 Minutes)|Period 1||5
5105436|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
5105437|NCT01587950|12560586|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
5105438|NCT01587950|12560586|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
5105439|NCT01587950|12560586|P1|Received Sterile Water (2 Minutes)|Period 1||2
5105440|NCT01587950|12560586|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
5105441|NCT01587950|12560586|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
5105442|NCT01587950|12560586|P1|STARTED|Period 1||12
5105443|NCT01587924|12560620|P4|NOT COMPLETED|Overall Study||1
5105444|NCT01587924|12560621|P3|NOT COMPLETED|Overall Study||4
5105445|NCT01587924|12560622|P2|NOT COMPLETED|Overall Study||4
5105446|NCT01587924|12560623|P1|NOT COMPLETED|Overall Study||4
5105447|NCT01587924|12560620|P4|COMPLETED|Overall Study||19
5105448|NCT01587924|12560621|P3|COMPLETED|Overall Study||17
5105449|NCT01587924|12560622|P2|COMPLETED|Overall Study||17
5105450|NCT01587924|12560623|P1|COMPLETED|Overall Study||17
5105451|NCT01587924|12560620|P4|STARTED|Overall Study||20
5105452|NCT01587924|12560621|P3|STARTED|Overall Study||21
5105453|NCT01587924|12560622|P2|STARTED|Overall Study||21
5105454|NCT01587924|12560623|P1|STARTED|Overall Study||21
5105455|NCT01587898|12560724|P4|NOT COMPLETED|Overall Study||2
5105456|NCT01587898|12560725|P3|NOT COMPLETED|Overall Study||2
5105457|NCT01587898|12560726|P2|NOT COMPLETED|Overall Study||5
5105458|NCT01587898|12560727|P1|NOT COMPLETED|Overall Study||4
5105459|NCT01587898|12560724|P4|COMPLETED|Overall Study||17
5105460|NCT01587898|12560725|P3|COMPLETED|Overall Study||16
5105461|NCT01587898|12560726|P2|COMPLETED|Overall Study||12
5105462|NCT01587898|12560727|P1|COMPLETED|Overall Study||14
5105463|NCT01587898|12560724|P4|STARTED|Overall Study||19
5105464|NCT01587898|12560725|P3|STARTED|Overall Study||18
5105465|NCT01587898|12560726|P2|STARTED|Overall Study||17
5105466|NCT01587898|12560727|P1|STARTED|Overall Study||18
5105467|NCT01587885|12560903|P2|NOT COMPLETED|Treatment Period 2||0
5105468|NCT01587885|12560904|P1|NOT COMPLETED|Treatment Period 2||0
5105469|NCT01587885|12560903|P2|COMPLETED|Treatment Period 2||19
5105470|NCT01587885|12560904|P1|COMPLETED|Treatment Period 2||26
5105471|NCT01587885|12560903|P2|STARTED|Treatment Period 2||19
5105472|NCT01587885|12560904|P1|STARTED|Treatment Period 2||26
5105473|NCT01587885|12560903|P2|NOT COMPLETED|Treatment Period 1||3
5105474|NCT01587885|12560904|P1|NOT COMPLETED|Treatment Period 1||0
5105475|NCT01587885|12560903|P2|COMPLETED|Treatment Period 1||19
5105476|NCT01587885|12560904|P1|COMPLETED|Treatment Period 1||26
5105477|NCT01587885|12560903|P2|STARTED|Treatment Period 1||22
5105478|NCT01587885|12560904|P1|STARTED|Treatment Period 1||26
5105479|NCT01587703|12560935|P19|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105480|NCT01587703|12560936|P18|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105481|NCT01587703|12560937|P17|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
5105482|NCT01587703|12560938|P16|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
5105483|NCT01587703|12560939|P15|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
5105484|NCT01587703|12560940|P14|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
5105485|NCT01587703|12560941|P13|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
5105486|NCT01587703|12560942|P12|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
5105487|NCT01587703|12560943|P11|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105488|NCT01587703|12560944|P10|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105489|NCT01587703|12560945|P9|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105490|NCT01587703|12560946|P8|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105491|NCT01587703|12560947|P7|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105492|NCT01587703|12560948|P6|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105493|NCT01587703|12560949|P5|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105494|NCT01587703|12560950|P4|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105495|NCT01587703|12560951|P3|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105496|NCT01587703|12560952|P2|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105497|NCT01587703|12560953|P1|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105498|NCT01587703|12560935|P19|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105499|NCT01587703|12560936|P18|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105500|NCT01587703|12560937|P17|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105501|NCT01587703|12560938|P16|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105502|NCT01587703|12560939|P15|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105503|NCT01587703|12560940|P14|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
5105504|NCT01587703|12560941|P13|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105505|NCT01587703|12560942|P12|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105506|NCT01587703|12560943|P11|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105507|NCT01587703|12560944|P10|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105508|NCT01587703|12560945|P9|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105509|NCT01587703|12560946|P8|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105510|NCT01587703|12560947|P7|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105511|NCT01587703|12560948|P6|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105512|NCT01587703|12560949|P5|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105513|NCT01587703|12560950|P4|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105514|NCT01587703|12560951|P3|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105515|NCT01587703|12560952|P2|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105516|NCT01587703|12560953|P1|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
5105517|NCT01587703|12560935|P19|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105518|NCT01587703|12560936|P18|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105519|NCT01587703|12560937|P17|STARTED|Part2(Median Exposure of 1.41 Months)||13
5105520|NCT01587703|12560938|P16|STARTED|Part2(Median Exposure of 1.41 Months)||21
5105521|NCT01587703|12560939|P15|STARTED|Part2(Median Exposure of 1.41 Months)||19
5105522|NCT01587703|12560940|P14|STARTED|Part2(Median Exposure of 1.41 Months)||23
5105523|NCT01587703|12560941|P13|STARTED|Part2(Median Exposure of 1.41 Months)||14
5105524|NCT01587703|12560942|P12|STARTED|Part2(Median Exposure of 1.41 Months)||12
5105525|NCT01587703|12560943|P11|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105526|NCT01587703|12560944|P10|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105527|NCT01587703|12560945|P9|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105528|NCT01587703|12560946|P8|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105529|NCT01587703|12560947|P7|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105530|NCT01587703|12560948|P6|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105531|NCT01587703|12560949|P5|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105532|NCT01587703|12560950|P4|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105533|NCT01587703|12560951|P3|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105534|NCT01587703|12560952|P2|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105535|NCT01587703|12560953|P1|STARTED|Part2(Median Exposure of 1.41 Months)||0
5105536|NCT01587703|12560935|P19|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
5105537|NCT01587703|12560936|P18|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
5105538|NCT01587703|12560937|P17|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105539|NCT01587703|12560938|P16|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105540|NCT01587703|12560939|P15|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105541|NCT01587703|12560940|P14|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105542|NCT01587703|12560941|P13|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105543|NCT01587703|12560942|P12|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105544|NCT01587703|12560943|P11|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105545|NCT01587703|12560944|P10|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105546|NCT01587703|12560945|P9|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105547|NCT01587703|12560946|P8|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105548|NCT01587703|12560947|P7|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105549|NCT01587703|12560948|P6|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105550|NCT01587703|12560949|P5|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105551|NCT01587703|12560950|P4|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105552|NCT01587703|12560951|P3|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105553|NCT01587703|12560952|P2|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105554|NCT01587703|12560953|P1|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105555|NCT01587703|12560935|P19|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105556|NCT01587703|12560936|P18|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105557|NCT01587703|12560937|P17|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105558|NCT01587703|12560938|P16|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105559|NCT01587703|12560939|P15|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105560|NCT01587703|12560940|P14|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105561|NCT01587703|12560941|P13|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105562|NCT01587703|12560942|P12|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105563|NCT01587703|12560943|P11|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105564|NCT01587703|12560944|P10|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105565|NCT01587703|12560945|P9|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105566|NCT01587703|12560946|P8|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105567|NCT01587703|12560947|P7|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105568|NCT01587703|12560948|P6|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105569|NCT01587703|12560949|P5|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105570|NCT01587703|12560950|P4|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105571|NCT01587703|12560951|P3|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105572|NCT01587703|12560952|P2|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105573|NCT01587703|12560953|P1|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
5105574|NCT01587703|12560935|P19|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
5105575|NCT01587703|12560936|P18|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
5105576|NCT01587703|12560937|P17|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105577|NCT01587703|12560938|P16|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105578|NCT01587703|12560939|P15|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105579|NCT01587703|12560940|P14|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105580|NCT01587703|12560941|P13|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105581|NCT01587703|12560942|P12|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105582|NCT01587703|12560943|P11|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105583|NCT01587703|12560944|P10|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105584|NCT01587703|12560945|P9|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105585|NCT01587703|12560946|P8|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105586|NCT01587703|12560947|P7|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105587|NCT01587703|12560948|P6|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105588|NCT01587703|12560949|P5|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105589|NCT01587703|12560950|P4|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105590|NCT01587703|12560951|P3|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105591|NCT01587703|12560952|P2|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105592|NCT01587703|12560953|P1|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
5105593|NCT01587703|12560935|P19|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105594|NCT01587703|12560936|P18|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105595|NCT01587703|12560937|P17|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105596|NCT01587703|12560938|P16|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105597|NCT01587703|12560939|P15|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105598|NCT01587703|12560940|P14|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105599|NCT01587703|12560941|P13|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105600|NCT01587703|12560942|P12|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105601|NCT01587703|12560943|P11|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105602|NCT01587703|12560944|P10|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105603|NCT01587703|12560945|P9|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105604|NCT01587703|12560946|P8|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105605|NCT01587703|12560947|P7|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105606|NCT01587703|12560948|P6|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105607|NCT01587703|12560949|P5|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105608|NCT01587703|12560950|P4|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105609|NCT01587703|12560951|P3|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105610|NCT01587703|12560952|P2|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105611|NCT01587703|12560953|P1|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105612|NCT01587703|12560935|P19|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
5105613|NCT01587703|12560936|P18|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
5105614|NCT01587703|12560937|P17|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105615|NCT01587703|12560938|P16|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105616|NCT01587703|12560939|P15|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105617|NCT01587703|12560940|P14|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105618|NCT01587703|12560941|P13|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105619|NCT01587703|12560942|P12|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105620|NCT01587703|12560943|P11|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105621|NCT01587703|12560944|P10|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105622|NCT01587703|12560945|P9|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105623|NCT01587703|12560946|P8|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105624|NCT01587703|12560947|P7|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105625|NCT01587703|12560948|P6|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105626|NCT01587703|12560949|P5|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105627|NCT01587703|12560950|P4|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105628|NCT01587703|12560951|P3|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105629|NCT01587703|12560952|P2|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105630|NCT01587703|12560953|P1|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
5105631|NCT01587703|12560935|P19|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
5105632|NCT01587703|12560936|P18|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
5105633|NCT01587703|12560937|P17|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105634|NCT01587703|12560938|P16|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105635|NCT01587703|12560939|P15|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105636|NCT01587703|12560940|P14|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105637|NCT01587703|12560941|P13|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105638|NCT01587703|12560942|P12|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105639|NCT01587703|12560943|P11|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105640|NCT01587703|12560944|P10|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105641|NCT01587703|12560945|P9|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105642|NCT01587703|12560946|P8|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105643|NCT01587703|12560947|P7|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105644|NCT01587703|12560948|P6|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105645|NCT01587703|12560949|P5|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105646|NCT01587703|12560950|P4|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105647|NCT01587703|12560951|P3|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105648|NCT01587703|12560952|P2|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105649|NCT01587703|12560953|P1|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
5105650|NCT01587703|12560935|P19|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105651|NCT01587703|12560936|P18|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105652|NCT01587703|12560937|P17|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105653|NCT01587703|12560938|P16|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105654|NCT01587703|12560939|P15|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105655|NCT01587703|12560940|P14|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105656|NCT01587703|12560941|P13|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105657|NCT01587703|12560942|P12|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105658|NCT01587703|12560943|P11|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105659|NCT01587703|12560944|P10|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105660|NCT01587703|12560945|P9|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105661|NCT01587703|12560946|P8|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105662|NCT01587703|12560947|P7|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105663|NCT01587703|12560948|P6|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105664|NCT01587703|12560949|P5|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105665|NCT01587703|12560950|P4|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105666|NCT01587703|12560951|P3|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105667|NCT01587703|12560952|P2|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105668|NCT01587703|12560953|P1|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105669|NCT01587703|12560935|P19|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
5105670|NCT01587703|12560936|P18|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
5105671|NCT01587703|12560937|P17|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105672|NCT01587703|12560938|P16|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105673|NCT01587703|12560939|P15|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105674|NCT01587703|12560940|P14|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105675|NCT01587703|12560941|P13|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105676|NCT01587703|12560942|P12|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105677|NCT01587703|12560943|P11|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105678|NCT01587703|12560944|P10|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105679|NCT01587703|12560945|P9|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105680|NCT01587703|12560946|P8|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105681|NCT01587703|12560947|P7|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105682|NCT01587703|12560948|P6|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105683|NCT01587703|12560949|P5|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105684|NCT01587703|12560950|P4|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105685|NCT01587703|12560951|P3|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105686|NCT01587703|12560952|P2|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105687|NCT01587703|12560953|P1|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
5105688|NCT01587703|12560935|P19|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
5105689|NCT01587703|12560936|P18|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
5105690|NCT01587703|12560937|P17|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105691|NCT01587703|12560938|P16|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105692|NCT01587703|12560939|P15|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105693|NCT01587703|12560940|P14|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105694|NCT01587703|12560941|P13|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105695|NCT01587703|12560942|P12|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105696|NCT01587703|12560943|P11|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105697|NCT01587703|12560944|P10|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105698|NCT01587703|12560945|P9|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105699|NCT01587703|12560946|P8|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105700|NCT01587703|12560947|P7|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105701|NCT01587703|12560948|P6|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105702|NCT01587703|12560949|P5|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105703|NCT01587703|12560950|P4|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105704|NCT01587703|12560951|P3|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105705|NCT01587703|12560952|P2|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105706|NCT01587703|12560953|P1|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
5105707|NCT01587703|12560935|P19|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105708|NCT01587703|12560936|P18|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105709|NCT01587703|12560937|P17|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105710|NCT01587703|12560938|P16|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105711|NCT01587703|12560939|P15|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105712|NCT01587703|12560940|P14|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105713|NCT01587703|12560941|P13|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105714|NCT01587703|12560942|P12|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105715|NCT01587703|12560943|P11|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105716|NCT01587703|12560944|P10|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105717|NCT01587703|12560945|P9|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105718|NCT01587703|12560946|P8|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105719|NCT01587703|12560947|P7|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105720|NCT01587703|12560948|P6|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105721|NCT01587703|12560949|P5|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105722|NCT01587703|12560950|P4|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105723|NCT01587703|12560951|P3|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105724|NCT01587703|12560952|P2|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105725|NCT01587703|12560953|P1|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105726|NCT01587703|12560935|P19|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
5105727|NCT01587703|12560936|P18|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
5105728|NCT01587703|12560937|P17|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105729|NCT01587703|12560938|P16|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105730|NCT01587703|12560939|P15|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105731|NCT01587703|12560940|P14|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105732|NCT01587703|12560941|P13|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105733|NCT01587703|12560942|P12|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105734|NCT01587703|12560943|P11|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105735|NCT01587703|12560944|P10|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105736|NCT01587703|12560945|P9|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105737|NCT01587703|12560946|P8|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105738|NCT01587703|12560947|P7|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105739|NCT01587703|12560948|P6|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105740|NCT01587703|12560949|P5|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105741|NCT01587703|12560950|P4|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105742|NCT01587703|12560951|P3|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105743|NCT01587703|12560952|P2|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105744|NCT01587703|12560953|P1|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105745|NCT01587703|12560935|P19|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
5105746|NCT01587703|12560936|P18|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
5105747|NCT01587703|12560937|P17|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105748|NCT01587703|12560938|P16|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105749|NCT01587703|12560939|P15|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105750|NCT01587703|12560940|P14|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105751|NCT01587703|12560941|P13|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105752|NCT01587703|12560942|P12|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105753|NCT01587703|12560943|P11|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105754|NCT01587703|12560944|P10|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105755|NCT01587703|12560945|P9|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105756|NCT01587703|12560946|P8|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105757|NCT01587703|12560947|P7|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105758|NCT01587703|12560948|P6|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105759|NCT01587703|12560949|P5|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105760|NCT01587703|12560950|P4|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105761|NCT01587703|12560951|P3|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105762|NCT01587703|12560952|P2|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105763|NCT01587703|12560953|P1|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
5105764|NCT01587703|12560935|P19|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105765|NCT01587703|12560936|P18|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105766|NCT01587703|12560937|P17|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105767|NCT01587703|12560938|P16|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105768|NCT01587703|12560939|P15|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105769|NCT01587703|12560940|P14|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105770|NCT01587703|12560941|P13|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105771|NCT01587703|12560942|P12|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105772|NCT01587703|12560943|P11|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
5105773|NCT01587703|12560944|P10|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
5105774|NCT01587703|12560945|P9|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
5105775|NCT01587703|12560946|P8|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105776|NCT01587703|12560947|P7|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105777|NCT01587703|12560948|P6|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105778|NCT01587703|12560949|P5|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105779|NCT01587703|12560950|P4|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105780|NCT01587703|12560951|P3|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105781|NCT01587703|12560952|P2|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105782|NCT01587703|12560953|P1|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105783|NCT01587703|12560935|P19|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105784|NCT01587703|12560936|P18|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105785|NCT01587703|12560937|P17|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105786|NCT01587703|12560938|P16|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105787|NCT01587703|12560939|P15|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105788|NCT01587703|12560940|P14|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105789|NCT01587703|12560941|P13|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105790|NCT01587703|12560942|P12|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105791|NCT01587703|12560943|P11|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105792|NCT01587703|12560944|P10|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105793|NCT01587703|12560945|P9|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
5105794|NCT01587703|12560946|P8|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105795|NCT01587703|12560947|P7|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105796|NCT01587703|12560948|P6|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105797|NCT01587703|12560949|P5|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105798|NCT01587703|12560950|P4|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105799|NCT01587703|12560951|P3|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105800|NCT01587703|12560952|P2|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105801|NCT01587703|12560953|P1|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
5105802|NCT01587703|12560935|P19|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105803|NCT01587703|12560936|P18|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105804|NCT01587703|12560937|P17|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105805|NCT01587703|12560938|P16|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105806|NCT01587703|12560939|P15|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105807|NCT01587703|12560940|P14|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105808|NCT01587703|12560941|P13|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105809|NCT01587703|12560942|P12|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105810|NCT01587703|12560943|P11|STARTED|Part1 BID(Median Exposure of 1.41months)||5
5105811|NCT01587703|12560944|P10|STARTED|Part1 BID(Median Exposure of 1.41months)||10
5105812|NCT01587703|12560945|P9|STARTED|Part1 BID(Median Exposure of 1.41months)||4
5105813|NCT01587703|12560946|P8|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105814|NCT01587703|12560947|P7|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105815|NCT01587703|12560948|P6|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105816|NCT01587703|12560949|P5|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105817|NCT01587703|12560950|P4|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105818|NCT01587703|12560951|P3|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105819|NCT01587703|12560952|P2|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105820|NCT01587703|12560953|P1|STARTED|Part1 BID(Median Exposure of 1.41months)||0
5105821|NCT01587703|12560935|P19|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105822|NCT01587703|12560936|P18|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105823|NCT01587703|12560937|P17|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105824|NCT01587703|12560938|P16|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105825|NCT01587703|12560939|P15|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105826|NCT01587703|12560940|P14|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105827|NCT01587703|12560941|P13|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105828|NCT01587703|12560942|P12|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105829|NCT01587703|12560943|P11|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105830|NCT01587703|12560944|P10|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105831|NCT01587703|12560945|P9|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105832|NCT01587703|12560946|P8|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
5105833|NCT01587703|12560947|P7|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
5105834|NCT01587703|12560948|P6|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
5105835|NCT01587703|12560949|P5|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
5105836|NCT01587703|12560950|P4|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
5105837|NCT01587703|12560951|P3|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
5105838|NCT01587703|12560952|P2|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
5105839|NCT01587703|12560953|P1|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
5105840|NCT01587703|12560935|P19|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105841|NCT01587703|12560936|P18|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105842|NCT01587703|12560937|P17|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105843|NCT01587703|12560938|P16|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105844|NCT01587703|12560939|P15|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105845|NCT01587703|12560940|P14|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105846|NCT01587703|12560941|P13|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105847|NCT01587703|12560942|P12|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105848|NCT01587703|12560943|P11|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105849|NCT01587703|12560944|P10|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105850|NCT01587703|12560945|P9|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105851|NCT01587703|12560946|P8|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105852|NCT01587703|12560947|P7|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105853|NCT01587703|12560948|P6|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
5105854|NCT01587703|12560949|P5|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105855|NCT01587703|12560950|P4|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105856|NCT01587703|12560951|P3|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105857|NCT01587703|12560952|P2|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105858|NCT01587703|12560953|P1|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
5105859|NCT01587703|12560935|P19|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105860|NCT01587703|12560936|P18|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105861|NCT01587703|12560937|P17|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105862|NCT01587703|12560938|P16|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105863|NCT01587703|12560939|P15|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105864|NCT01587703|12560940|P14|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105865|NCT01587703|12560941|P13|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105866|NCT01587703|12560942|P12|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105867|NCT01587703|12560943|P11|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105868|NCT01587703|12560944|P10|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105869|NCT01587703|12560945|P9|STARTED|Part1 QD(Median Exposure of 1.38months)||0
5105870|NCT01587703|12560946|P8|STARTED|Part1 QD(Median Exposure of 1.38months)||9
5105871|NCT01587703|12560947|P7|STARTED|Part1 QD(Median Exposure of 1.38months)||32
5105872|NCT01587703|12560948|P6|STARTED|Part1 QD(Median Exposure of 1.38months)||9
5105873|NCT01587703|12560949|P5|STARTED|Part1 QD(Median Exposure of 1.38months)||4
5105874|NCT01587703|12560950|P4|STARTED|Part1 QD(Median Exposure of 1.38months)||3
5105875|NCT01587703|12560951|P3|STARTED|Part1 QD(Median Exposure of 1.38months)||1
5105876|NCT01587703|12560952|P2|STARTED|Part1 QD(Median Exposure of 1.38months)||4
5105877|NCT01587703|12560953|P1|STARTED|Part1 QD(Median Exposure of 1.38months)||3
5105878|NCT01587651|12561360|P3|NOT COMPLETED|Overall Study||1
5105879|NCT01587651|12561361|P2|NOT COMPLETED|Overall Study||3
5105880|NCT01587651|12561362|P1|NOT COMPLETED|Overall Study||0
5105881|NCT01587651|12561360|P3|COMPLETED|Overall Study||34
5105882|NCT01587651|12561361|P2|COMPLETED|Overall Study||38
5105883|NCT01587651|12561362|P1|COMPLETED|Overall Study||34
5105884|NCT01587651|12561360|P3|STARTED|Overall Study||35
5105885|NCT01587651|12561361|P2|STARTED|Overall Study||41
5105886|NCT01587651|12561362|P1|STARTED|Overall Study||34
5105887|NCT01587274|12561392|P3|NOT COMPLETED|Overall Study||3
5105888|NCT01587274|12561393|P2|NOT COMPLETED|Overall Study||5
5105889|NCT01587274|12561394|P1|NOT COMPLETED|Overall Study||4
5105890|NCT01587274|12561392|P3|COMPLETED|Overall Study||104
5105891|NCT01587274|12561393|P2|COMPLETED|Overall Study||103
5105892|NCT01587274|12561394|P1|COMPLETED|Overall Study||104
5105893|NCT01587274|12561392|P3|STARTED|Overall Study||107
5105894|NCT01587274|12561393|P2|STARTED|Overall Study||108
5105895|NCT01587274|12561394|P1|STARTED|Overall Study||108
5105896|NCT01587118|12561402|P1|NOT COMPLETED|Overall Study||7
5105897|NCT01587118|12561402|P1|COMPLETED|Overall Study||11
5105898|NCT01587118|12561402|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
5105899|NCT01587105|12561409|P2|NOT COMPLETED|Overall Study||43
5105900|NCT01587105|12561410|P1|NOT COMPLETED|Overall Study||6
5105901|NCT01587105|12561409|P2|COMPLETED|Overall Study||138
5105902|NCT01587105|12561410|P1|COMPLETED|Overall Study||144
5105903|NCT01587105|12561409|P2|STARTED|Overall Study||181
5105904|NCT01587105|12561410|P1|STARTED|Overall Study||150
5105905|NCT01587079|12561426|P1|NOT COMPLETED|Overall Study||39
5105906|NCT01587079|12561426|P1|COMPLETED|Overall Study||120
5105907|NCT01587079|12561426|P1|STARTED|Overall Study||159
5105908|NCT01587040|12561552|P4|NOT COMPLETED|Overall Study||4
5105909|NCT01587040|12561553|P3|NOT COMPLETED|Overall Study||37
5105910|NCT01587040|12561554|P2|NOT COMPLETED|Overall Study||3
5105911|NCT01587040|12561555|P1|NOT COMPLETED|Overall Study||17
5105912|NCT01587040|12561552|P4|COMPLETED|Overall Study||0
5105913|NCT01587040|12561553|P3|COMPLETED|Overall Study||0
5105914|NCT01587040|12561554|P2|COMPLETED|Overall Study||0
5105915|NCT01587040|12561555|P1|COMPLETED|Overall Study||0
5105916|NCT01587040|12561552|P4|STARTED|Overall Study||4
5105917|NCT01587040|12561553|P3|STARTED|Overall Study||37
5105918|NCT01587040|12561554|P2|STARTED|Overall Study||3
5105919|NCT01587040|12561555|P1|STARTED|Overall Study||17
5105920|NCT01587027|12561575|P2|NOT COMPLETED|Discharge (1 Day)||0
5105921|NCT01587027|12561576|P1|NOT COMPLETED|Discharge (1 Day)||0
5105922|NCT01587027|12561575|P2|COMPLETED|Discharge (1 Day)||8
5105923|NCT01587027|12561576|P1|COMPLETED|Discharge (1 Day)||8
5105924|NCT01587027|12561575|P2|STARTED|Discharge (1 Day)||8
5105925|NCT01587027|12561576|P1|STARTED|Discharge (1 Day)||8
5105926|NCT01587027|12561575|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5105927|NCT01587027|12561576|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5105928|NCT01587027|12561575|P2|COMPLETED|Third Intervention (1 Day)||8
5105929|NCT01587027|12561576|P1|COMPLETED|Third Intervention (1 Day)||8
5105930|NCT01587027|12561575|P2|STARTED|Third Intervention (1 Day)||8
5105931|NCT01587027|12561576|P1|STARTED|Third Intervention (1 Day)||8
5105932|NCT01587027|12561575|P2|NOT COMPLETED|Washout (1 Day)||0
5105933|NCT01587027|12561576|P1|NOT COMPLETED|Washout (1 Day)||0
5105934|NCT01587027|12561575|P2|COMPLETED|Washout (1 Day)||8
5105935|NCT01587027|12561576|P1|COMPLETED|Washout (1 Day)||8
5105936|NCT01587027|12561575|P2|STARTED|Washout (1 Day)||8
5105937|NCT01587027|12561576|P1|STARTED|Washout (1 Day)||8
5105938|NCT01587027|12561575|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5105939|NCT01587027|12561576|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5105940|NCT01587027|12561575|P2|COMPLETED|Second Intervention (1 Day)||8
5105941|NCT01587027|12561576|P1|COMPLETED|Second Intervention (1 Day)||8
5105942|NCT01587027|12561575|P2|STARTED|Second Intervention (1 Day)||8
5105943|NCT01587027|12561576|P1|STARTED|Second Intervention (1 Day)||8
5105944|NCT01587027|12561575|P2|NOT COMPLETED|Washout (1 Day)||0
5105945|NCT01587027|12561576|P1|NOT COMPLETED|Washout (1 Day)||0
5105946|NCT01587027|12561575|P2|COMPLETED|Washout (1 Day)||8
5105947|NCT01587027|12561576|P1|COMPLETED|Washout (1 Day)||8
5105948|NCT01587027|12561575|P2|STARTED|Washout (1 Day)||8
5105949|NCT01587027|12561576|P1|STARTED|Washout (1 Day)||8
5105950|NCT01587027|12561575|P2|NOT COMPLETED|First Intervention (1 Day)||0
5105951|NCT01587027|12561576|P1|NOT COMPLETED|First Intervention (1 Day)||0
5105952|NCT01587027|12561575|P2|COMPLETED|First Intervention (1 Day)||8
5105953|NCT01587027|12561576|P1|COMPLETED|First Intervention (1 Day)||8
5105954|NCT01587027|12561575|P2|STARTED|First Intervention (1 Day)||8
5105955|NCT01587027|12561576|P1|STARTED|First Intervention (1 Day)||8
5105956|NCT01587014|12561582|P1|NOT COMPLETED|Overall Study||2
5105957|NCT01587014|12561582|P1|COMPLETED|Overall Study||24
5105958|NCT01587014|12561582|P1|STARTED|Overall Study||26
5105959|NCT01587001|12561589|P2|NOT COMPLETED|Overall Study||1
5105960|NCT01587001|12561590|P1|NOT COMPLETED|Overall Study||6
5105961|NCT01587001|12561589|P2|COMPLETED|Overall Study||2
5105962|NCT01587001|12561590|P1|COMPLETED|Overall Study||8
5105963|NCT01587001|12561589|P2|STARTED|Overall Study||3
5105964|NCT01587001|12561590|P1|STARTED|Overall Study||14
5105965|NCT01586975|12561601|P3|NOT COMPLETED|Overall Study||0
5105966|NCT01586975|12561602|P2|NOT COMPLETED|Overall Study||0
5105967|NCT01586975|12561603|P1|NOT COMPLETED|Overall Study||0
5105968|NCT01586975|12561601|P3|COMPLETED|Overall Study||46
5105969|NCT01586975|12561602|P2|COMPLETED|Overall Study||32
5105970|NCT01586975|12561603|P1|COMPLETED|Overall Study||15
5105971|NCT01586975|12561601|P3|STARTED|Overall Study||46
5105972|NCT01586975|12561602|P2|STARTED|Overall Study||32
5105973|NCT01586975|12561603|P1|STARTED|Overall Study||15
5105974|NCT01586962|12561611|P1|NOT COMPLETED|Overall Study||0
5105975|NCT01586962|12561611|P1|COMPLETED|Overall Study||56
5105976|NCT01586962|12561611|P1|STARTED|Overall Study||56
5105977|NCT01586910|12561619|P2|NOT COMPLETED|Overall Study||71
5105978|NCT01586910|12561620|P1|NOT COMPLETED|Overall Study||15
5105979|NCT01586910|12561619|P2|COMPLETED|Overall Study||796
5105980|NCT01586910|12561620|P1|COMPLETED|Overall Study||864
5105981|NCT01586910|12561619|P2|STARTED|Overall Study||867
5105982|NCT01586910|12561620|P1|STARTED|Overall Study||879
5105983|NCT01586897|12561675|P2|NOT COMPLETED|Overall Study||0
5105984|NCT01586897|12561676|P1|NOT COMPLETED|Overall Study||0
5105985|NCT01586897|12561675|P2|COMPLETED|Overall Study||26
5105986|NCT01586897|12561676|P1|COMPLETED|Overall Study||26
5105987|NCT01586897|12561675|P2|STARTED|Overall Study||26
5105988|NCT01586897|12561676|P1|STARTED|Overall Study||26
5105989|NCT01586819|12561694|P2|NOT COMPLETED|Overall Study||0
5105990|NCT01586819|12561695|P1|NOT COMPLETED|Overall Study||1
5105991|NCT01586819|12561694|P2|COMPLETED|Overall Study||14
5105992|NCT01586819|12561695|P1|COMPLETED|Overall Study||11
5105993|NCT01586819|12561694|P2|STARTED|Overall Study||14
5105994|NCT01586819|12561695|P1|STARTED|Overall Study||12
5105995|NCT01586806|12561706|P3|NOT COMPLETED|Overall Study||2
5105996|NCT01586806|12561707|P2|NOT COMPLETED|Overall Study||4
5105997|NCT01586806|12561708|P1|NOT COMPLETED|Overall Study||3
5105998|NCT01586806|12561706|P3|COMPLETED|Overall Study||63
5105999|NCT01586806|12561707|P2|COMPLETED|Overall Study||61
5106000|NCT01586806|12561708|P1|COMPLETED|Overall Study||62
5106001|NCT01586806|12561706|P3|STARTED|Overall Study||65
5106002|NCT01586806|12561707|P2|STARTED|Overall Study||65
5106003|NCT01586806|12561708|P1|STARTED|Overall Study||65
5106004|NCT01586364|12561728|P1|NOT COMPLETED|Overall Study||117
5106005|NCT01586364|12561728|P1|COMPLETED|Overall Study||184
5106006|NCT01586364|12561728|P1|STARTED|Overall Study||301
5106007|NCT01586338|12561781|P1|NOT COMPLETED|Overall Study||8
5106008|NCT01586338|12561781|P1|COMPLETED|Overall Study||229
5106009|NCT01586338|12561781|P1|STARTED|Overall Study||237
5106010|NCT01586312|12561793|P2|NOT COMPLETED|Overall Study||0
5106011|NCT01586312|12561794|P1|NOT COMPLETED|Overall Study||0
5106012|NCT01586312|12561793|P2|COMPLETED|Overall Study||15
5106013|NCT01586312|12561794|P1|COMPLETED|Overall Study||15
5106014|NCT01586312|12561793|P2|STARTED|Overall Study||15
5106015|NCT01586312|12561794|P1|STARTED|Overall Study||15
5106016|NCT01586195|12561804|P1|NOT COMPLETED|Overall Study||26
5106017|NCT01586195|12561804|P1|COMPLETED|Overall Study||5
5106018|NCT01586195|12561804|P1|STARTED|Overall Study||31
5106019|NCT01586156|12561818|P3|NOT COMPLETED|Overall Study||0
5106020|NCT01586156|12561819|P2|NOT COMPLETED|Overall Study||1
5106021|NCT01586156|12561820|P1|NOT COMPLETED|Overall Study||0
5106022|NCT01586156|12561818|P3|COMPLETED|Overall Study||10
5106023|NCT01586156|12561819|P2|COMPLETED|Overall Study||9
5106024|NCT01586156|12561820|P1|COMPLETED|Overall Study||10
5106025|NCT01586156|12561818|P3|STARTED|Overall Study||10
5106026|NCT01586156|12561819|P2|STARTED|Overall Study||10
5106027|NCT01586156|12561820|P1|STARTED|Overall Study||10
5106028|NCT01586091|12561849|P3|NOT COMPLETED|Overall Study||0
5106029|NCT01586091|12561850|P2|NOT COMPLETED|Overall Study||0
5106030|NCT01586091|12561851|P1|NOT COMPLETED|Overall Study||0
5106031|NCT01586091|12561849|P3|COMPLETED|Overall Study||6
5106032|NCT01586091|12561850|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
5106033|NCT01586091|12561851|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
5106034|NCT01586091|12561849|P3|STARTED|Overall Study||6
5106035|NCT01586091|12561850|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
5106036|NCT01586091|12561851|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
5106037|NCT01586026|12561865|P3|NOT COMPLETED|Overall Study||0
5106038|NCT01586026|12561866|P2|NOT COMPLETED|Overall Study||0
5106039|NCT01586026|12561867|P1|NOT COMPLETED|Overall Study||0
5106040|NCT01586026|12561865|P3|COMPLETED|Overall Study||271
5106041|NCT01586026|12561866|P2|COMPLETED|Overall Study||414
5106042|NCT01586026|12561867|P1|COMPLETED|Overall Study||350
5106043|NCT01586026|12561865|P3|STARTED|Overall Study||271
5106044|NCT01586026|12561866|P2|STARTED|Overall Study||414
5106045|NCT01586026|12561867|P1|STARTED|Overall Study||350
5106046|NCT01585987|12561877|P2|NOT COMPLETED|Treated||49
5106047|NCT01585987|12561878|P1|NOT COMPLETED|Treated||54
5106048|NCT01585987|12561877|P2|COMPLETED|Treated||2
5106049|NCT01585987|12561878|P1|COMPLETED|Treated||3
5106050|NCT01585987|12561877|P2|STARTED|Treated||51
5106051|NCT01585987|12561878|P1|STARTED|Treated||57
5106052|NCT01585987|12561877|P2|NOT COMPLETED|Randomized||6
5106053|NCT01585987|12561878|P1|NOT COMPLETED|Randomized||0
5106054|NCT01585987|12561877|P2|COMPLETED|Randomized||51
5106055|NCT01585987|12561878|P1|COMPLETED|Randomized||57
5106056|NCT01585987|12561877|P2|STARTED|Randomized||57
5106057|NCT01585987|12561878|P1|STARTED|Randomized||57
5106058|NCT01585961|12561893|P1|NOT COMPLETED|Overall Study||33
5106059|NCT01585961|12561893|P1|COMPLETED|Overall Study||478
5106060|NCT01585961|12561893|P1|Safety|Overall Study|Patients ablated with study catheter|508
5106061|NCT01585961|12561893|P1|STARTED|Overall Study||511
5106062|NCT01585779|12561910|P2|NOT COMPLETED|Overall Study||7
5106063|NCT01585779|12561911|P1|NOT COMPLETED|Overall Study||10
5106064|NCT01585779|12561910|P2|COMPLETED|Overall Study||21
5106065|NCT01585779|12561911|P1|COMPLETED|Overall Study||26
5106066|NCT01585779|12561910|P2|STARTED|Overall Study||28
5106067|NCT01585779|12561911|P1|STARTED|Overall Study||36
5106068|NCT01585766|12561971|P6|NOT COMPLETED|Overall Study||0
5106069|NCT01585766|12561972|P5|NOT COMPLETED|Overall Study||0
5106070|NCT01585766|12561973|P4|NOT COMPLETED|Overall Study||0
5106071|NCT01585766|12561974|P3|NOT COMPLETED|Overall Study||2
5106072|NCT01585766|12561975|P2|NOT COMPLETED|Overall Study||2
5106073|NCT01585766|12561976|P1|NOT COMPLETED|Overall Study||0
5106074|NCT01585766|12561971|P6|COMPLETED|Overall Study||6
5106075|NCT01585766|12561972|P5|COMPLETED|Overall Study||3
5106076|NCT01585766|12561973|P4|COMPLETED|Overall Study||4
5106077|NCT01585766|12561974|P3|COMPLETED|Overall Study||1
5106078|NCT01585766|12561975|P2|COMPLETED|Overall Study||3
5106079|NCT01585766|12561976|P1|COMPLETED|Overall Study||7
5106080|NCT01585766|12561971|P6|STARTED|Overall Study||6
5106081|NCT01585766|12561972|P5|STARTED|Overall Study||3
5106082|NCT01585766|12561973|P4|STARTED|Overall Study||4
5106083|NCT01585766|12561974|P3|STARTED|Overall Study||3
5106084|NCT01585766|12561975|P2|STARTED|Overall Study||5
5106085|NCT01585766|12561976|P1|STARTED|Overall Study||7
5106086|NCT01585597|12562075|P1|NOT COMPLETED|Overall Study||0
5106087|NCT01585597|12562075|P1|COMPLETED|Overall Study||20
5106088|NCT01585597|12562075|P1|STARTED|Overall Study||20
5106089|NCT01585584|12562080|P1|NOT COMPLETED|Overall Study||4
5106090|NCT01585584|12562080|P1|COMPLETED|Overall Study||6
5106091|NCT01585584|12562080|P1|STARTED|Overall Study||10
5106092|NCT01585558|12562087|P3|NOT COMPLETED|Overall Study||15
5106093|NCT01585558|12562088|P2|NOT COMPLETED|Overall Study||12
5106094|NCT01585558|12562089|P1|NOT COMPLETED|Overall Study||13
5106095|NCT01585558|12562087|P3|COMPLETED|Overall Study||34
5106096|NCT01585558|12562088|P2|COMPLETED|Overall Study||57
5106097|NCT01585558|12562089|P1|COMPLETED|Overall Study||49
5106098|NCT01585558|12562087|P3|STARTED|Overall Study||49
5106099|NCT01585558|12562088|P2|STARTED|Overall Study||69
5106100|NCT01585558|12562089|P1|STARTED|Overall Study||62
5106101|NCT01585441|12562270|P2|NOT COMPLETED|Overall Study||0
5106102|NCT01585441|12562271|P1|NOT COMPLETED|Overall Study||0
5106103|NCT01585441|12562270|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
5106104|NCT01585441|12562271|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
5106105|NCT01585441|12562270|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
5106106|NCT01585441|12562271|P1|Final Study Safety Visit|Overall Study||3
5106107|NCT01585441|12562270|P2|Received Finasteride at Month 3|Overall Study||2
5106108|NCT01585441|12562271|P1|Received Finasteride at Month 3|Overall Study||2
5106109|NCT01585441|12562270|P2|Month 3|Overall Study||3
5106110|NCT01585441|12562271|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
5106111|NCT01585441|12562270|P2|STARTED|Overall Study||3
5106112|NCT01585441|12562271|P1|STARTED|Overall Study||3
5106113|NCT01585428|12562323|P2|NOT COMPLETED|Overall Study||0
5106114|NCT01585428|12562324|P1|NOT COMPLETED|Overall Study||1
5106115|NCT01585428|12562323|P2|COMPLETED|Overall Study||11
5106116|NCT01585428|12562324|P1|COMPLETED|Overall Study||17
5106117|NCT01585428|12562323|P2|STARTED|Overall Study||11
5106118|NCT01585428|12562324|P1|STARTED|Overall Study||18
5106119|NCT01585324|12562332|P1|NOT COMPLETED|Overall Study||0
5106120|NCT01585324|12562332|P1|COMPLETED|Overall Study||30
5106121|NCT01585324|12562332|P1|STARTED|Overall Study||30
5106122|NCT01585298|12562348|P1|NOT COMPLETED|Overall Study||37
5106123|NCT01585298|12562348|P1|COMPLETED|Overall Study||6961
5106124|NCT01585298|12562348|P1|STARTED|Overall Study||6998
5106125|NCT01585272|12562356|P1|NOT COMPLETED|Overall Study||39
5106126|NCT01585272|12562356|P1|COMPLETED|Overall Study||82
5106127|NCT01585272|12562356|P1|Exelon Patch 10 cm2|Overall Study||96
5106128|NCT01585272|12562356|P1|Exelon Patch 5 cm2|Overall Study||114
5106129|NCT01585272|12562356|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
5106130|NCT01585272|12562356|P1|STARTED|Overall Study||121
5106131|NCT01585246|12562369|P5|NOT COMPLETED|Overall Study||2
5106132|NCT01585246|12562370|P4|NOT COMPLETED|Overall Study||4
5106133|NCT01585246|12562371|P3|NOT COMPLETED|Overall Study||4
5106134|NCT01585246|12562372|P2|NOT COMPLETED|Overall Study||1
5106135|NCT01585246|12562373|P1|NOT COMPLETED|Overall Study||0
5106136|NCT01585246|12562369|P5|COMPLETED|Overall Study||9
5106137|NCT01585246|12562370|P4|COMPLETED|Overall Study||6
5106138|NCT01585246|12562371|P3|COMPLETED|Overall Study||16
5106139|NCT01585246|12562372|P2|COMPLETED|Overall Study||3
5106140|NCT01585246|12562373|P1|COMPLETED|Overall Study||3
5106141|NCT01585246|12562369|P5|STARTED|Overall Study||11
5106142|NCT01585246|12562370|P4|STARTED|Overall Study||10
5106143|NCT01585246|12562371|P3|STARTED|Overall Study||20
5106144|NCT01585246|12562372|P2|STARTED|Overall Study||4
5106145|NCT01585246|12562373|P1|STARTED|Overall Study||3
5106146|NCT01585207|12562388|P1|NOT COMPLETED|Overall Study||0
5106147|NCT01585207|12562388|P1|COMPLETED|Overall Study||4
5106148|NCT01585207|12562388|P1|STARTED|Overall Study||4
5106149|NCT01585168|12562394|P4|NOT COMPLETED|Overall Study||1
5106150|NCT01585168|12562395|P3|NOT COMPLETED|Overall Study||1
5106151|NCT01585168|12562396|P2|NOT COMPLETED|Overall Study||1
5106152|NCT01585168|12562397|P1|NOT COMPLETED|Overall Study||3
5106153|NCT01585168|12562394|P4|COMPLETED|Overall Study||18
5106154|NCT01585168|12562395|P3|COMPLETED|Overall Study||15
5106155|NCT01585168|12562396|P2|COMPLETED|Overall Study||17
5106156|NCT01585168|12562397|P1|COMPLETED|Overall Study||15
5106157|NCT01585168|12562394|P4|STARTED|Overall Study||19
5106158|NCT01585168|12562395|P3|STARTED|Overall Study||16
5106159|NCT01585168|12562396|P2|STARTED|Overall Study||18
5106160|NCT01585168|12562397|P1|STARTED|Overall Study||18
5106161|NCT01585155|12562417|P1|NOT COMPLETED|Overall Study||5
5106162|NCT01585155|12562417|P1|COMPLETED|Overall Study||16
5106163|NCT01585155|12562417|P1|STARTED|Overall Study||21
5106164|NCT01585129|12562426|P2|NOT COMPLETED|Overall Study||0
5106165|NCT01585129|12562427|P1|NOT COMPLETED|Overall Study||0
5106166|NCT01585129|12562426|P2|COMPLETED|Overall Study||39
5106167|NCT01585129|12562427|P1|COMPLETED|Overall Study||41
5106168|NCT01585129|12562426|P2|STARTED|Overall Study||39
5106169|NCT01585129|12562427|P1|STARTED|Overall Study||41
5106170|NCT01585038|12562439|P2|NOT COMPLETED|Overall Study||2
5106171|NCT01585038|12562440|P1|NOT COMPLETED|Overall Study||2
5106172|NCT01585038|12562439|P2|COMPLETED|Overall Study||18
5106173|NCT01585038|12562440|P1|COMPLETED|Overall Study||18
5106174|NCT01585038|12562439|P2|STARTED|Overall Study||20
5106175|NCT01585038|12562440|P1|STARTED|Overall Study||20
5106176|NCT01585025|12562455|P3|NOT COMPLETED|Overall Study||4
5106177|NCT01585025|12562456|P2|NOT COMPLETED|Overall Study||3
5106178|NCT01585025|12562457|P1|NOT COMPLETED|Overall Study||0
5106179|NCT01585025|12562455|P3|COMPLETED|Overall Study||8
5106180|NCT01585025|12562456|P2|COMPLETED|Overall Study||10
5106181|NCT01585025|12562457|P1|COMPLETED|Overall Study||10
5106182|NCT01585025|12562455|P3|STARTED|Overall Study||12
5106183|NCT01585025|12562456|P2|STARTED|Overall Study||13
5106184|NCT01585025|12562457|P1|STARTED|Overall Study||10
5106185|NCT01584843|12562487|P6|NOT COMPLETED|Second Treatment Period||1
5106186|NCT01584843|12562488|P5|NOT COMPLETED|Second Treatment Period||0
5106187|NCT01584843|12562489|P4|NOT COMPLETED|Second Treatment Period||0
5106188|NCT01584843|12562490|P3|NOT COMPLETED|Second Treatment Period||0
5106189|NCT01584843|12562491|P2|NOT COMPLETED|Second Treatment Period||0
5106190|NCT01584843|12562492|P1|NOT COMPLETED|Second Treatment Period||0
5106191|NCT01584843|12562487|P6|COMPLETED|Second Treatment Period||0
5106192|NCT01584843|12562488|P5|COMPLETED|Second Treatment Period||3
5106193|NCT01584843|12562489|P4|COMPLETED|Second Treatment Period||6
5106194|NCT01584843|12562490|P3|COMPLETED|Second Treatment Period||2
5106195|NCT01584843|12562491|P2|COMPLETED|Second Treatment Period||1
5106196|NCT01584843|12562492|P1|COMPLETED|Second Treatment Period||2
5106197|NCT01584843|12562487|P6|STARTED|Second Treatment Period||1
5106198|NCT01584843|12562488|P5|STARTED|Second Treatment Period||3
5106199|NCT01584843|12562489|P4|STARTED|Second Treatment Period||6
5106200|NCT01584843|12562490|P3|STARTED|Second Treatment Period||2
5106201|NCT01584843|12562491|P2|STARTED|Second Treatment Period||1
5106202|NCT01584843|12562492|P1|STARTED|Second Treatment Period||2
5106203|NCT01584843|12562487|P6|NOT COMPLETED|First Treatment Period||2
5106204|NCT01584843|12562488|P5|NOT COMPLETED|First Treatment Period||0
5106205|NCT01584843|12562489|P4|NOT COMPLETED|First Treatment Period||0
5106206|NCT01584843|12562490|P3|NOT COMPLETED|First Treatment Period||1
5106207|NCT01584843|12562491|P2|NOT COMPLETED|First Treatment Period||0
5106208|NCT01584843|12562492|P1|NOT COMPLETED|First Treatment Period||0
5106209|NCT01584843|12562487|P6|COMPLETED|First Treatment Period||9
5106210|NCT01584843|12562488|P5|COMPLETED|First Treatment Period||10
5106211|NCT01584843|12562489|P4|COMPLETED|First Treatment Period||10
5106212|NCT01584843|12562490|P3|COMPLETED|First Treatment Period||2
5106213|NCT01584843|12562491|P2|COMPLETED|First Treatment Period||4
5106214|NCT01584843|12562492|P1|COMPLETED|First Treatment Period||3
5106215|NCT01584843|12562487|P6|STARTED|First Treatment Period||11
5106216|NCT01584843|12562488|P5|STARTED|First Treatment Period||10
5106217|NCT01584843|12562489|P4|STARTED|First Treatment Period||10
5106218|NCT01584843|12562490|P3|STARTED|First Treatment Period||3
5106219|NCT01584843|12562491|P2|STARTED|First Treatment Period||4
5106220|NCT01584843|12562492|P1|STARTED|First Treatment Period||3
5106221|NCT01584648|12562603|P2|NOT COMPLETED|Overall Study||212
5106222|NCT01584648|12562604|P1|NOT COMPLETED|Overall Study||211
5106223|NCT01584648|12562603|P2|COMPLETED|Overall Study||0
5106224|NCT01584648|12562604|P1|COMPLETED|Overall Study||0
5106225|NCT01584648|12562603|P2|Ongoing|Overall Study||147
5106226|NCT01584648|12562604|P1|Ongoing|Overall Study||154
5106227|NCT01584648|12562603|P2|STARTED|Overall Study||212
5106228|NCT01584648|12562604|P1|STARTED|Overall Study||211
5106229|NCT01584609|12562644|P2|NOT COMPLETED|Overall Study||4
5106230|NCT01584609|12562645|P1|NOT COMPLETED|Overall Study||12
5106231|NCT01584609|12562644|P2|COMPLETED|Overall Study||96
5106232|NCT01584609|12562645|P1|COMPLETED|Overall Study||86
5106233|NCT01584609|12562644|P2|STARTED|Overall Study||100
5106234|NCT01584609|12562645|P1|STARTED|Overall Study||98
5106235|NCT01584544|12562670|P5|NOT COMPLETED|Overall Study||0
5106236|NCT01584544|12562671|P4|NOT COMPLETED|Overall Study||0
5106237|NCT01584544|12562672|P3|NOT COMPLETED|Overall Study||0
5106238|NCT01584544|12562673|P2|NOT COMPLETED|Overall Study||0
5106239|NCT01584544|12562674|P1|NOT COMPLETED|Overall Study||0
5106240|NCT01584544|12562670|P5|COMPLETED|Overall Study||6
5106241|NCT01584544|12562671|P4|COMPLETED|Overall Study||3
5106242|NCT01584544|12562672|P3|COMPLETED|Overall Study||6
5106243|NCT01584544|12562673|P2|COMPLETED|Overall Study||6
5106244|NCT01584544|12562674|P1|COMPLETED|Overall Study||3
5106245|NCT01584544|12562670|P5|STARTED|Overall Study||6
5106246|NCT01584544|12562671|P4|STARTED|Overall Study||3
5106247|NCT01584544|12562672|P3|STARTED|Overall Study||6
5106248|NCT01584544|12562673|P2|STARTED|Overall Study||6
5106249|NCT01584544|12562674|P1|STARTED|Overall Study||3
5106250|NCT01584518|12562688|P2|NOT COMPLETED|Overall Study||0
5106251|NCT01584518|12562689|P1|NOT COMPLETED|Overall Study||0
5106252|NCT01584518|12562688|P2|COMPLETED|Overall Study||25
5106253|NCT01584518|12562689|P1|COMPLETED|Overall Study||25
5106254|NCT01584518|12562688|P2|STARTED|Overall Study||25
5106255|NCT01584518|12562689|P1|STARTED|Overall Study||25
5106256|NCT01584479|12562699|P4|NOT COMPLETED|Overall Study||0
5106257|NCT01584479|12562700|P3|NOT COMPLETED|Overall Study||0
5106258|NCT01584479|12562701|P2|NOT COMPLETED|Overall Study||0
5106259|NCT01584479|12562702|P1|NOT COMPLETED|Overall Study||0
5106260|NCT01584479|12562699|P4|COMPLETED|Overall Study||1847
5106261|NCT01584479|12562700|P3|COMPLETED|Overall Study||852
5106262|NCT01584479|12562701|P2|COMPLETED|Overall Study||1686
5106263|NCT01584479|12562702|P1|COMPLETED|Overall Study||732
5106264|NCT01584479|12562699|P4|STARTED|Overall Study||1847
5106265|NCT01584479|12562700|P3|STARTED|Overall Study||852
5106266|NCT01584479|12562701|P2|STARTED|Overall Study||1686
5106267|NCT01584479|12562702|P1|STARTED|Overall Study||732
5106268|NCT01584388|12562712|P1|NOT COMPLETED|Overall Study||0
5106269|NCT01584388|12562712|P1|COMPLETED|Overall Study||30
5106270|NCT01584388|12562712|P1|STARTED|Overall Study||30
5106271|NCT01584232|12562732|P2|NOT COMPLETED|Overall Study||3
5106272|NCT01584232|12562733|P1|NOT COMPLETED|Overall Study||8
5106273|NCT01584232|12562732|P2|COMPLETED|Overall Study||177
5106274|NCT01584232|12562733|P1|COMPLETED|Overall Study||173
5106275|NCT01584232|12562732|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
5106276|NCT01584232|12562733|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
5106277|NCT01584232|12562732|P2|STARTED|Overall Study||180
5106278|NCT01584232|12562733|P1|STARTED|Overall Study||181
5106279|NCT01584024|12562749|P1|NOT COMPLETED|Overall Study||13
5106280|NCT01584024|12562749|P1|COMPLETED|Overall Study||29
5106281|NCT01584024|12562749|P1|STARTED|Overall Study||42
5106282|NCT01583985|12562758|P2|NOT COMPLETED|Overall Study||3
5106283|NCT01583985|12562759|P1|NOT COMPLETED|Overall Study||3
5106284|NCT01583985|12562758|P2|COMPLETED|Overall Study||117
5106285|NCT01583985|12562759|P1|COMPLETED|Overall Study||117
5106286|NCT01583985|12562758|P2|Included in Primary Analysis|Overall Study||119
5106287|NCT01583985|12562759|P1|Included in Primary Analysis|Overall Study||119
5106288|NCT01583985|12562758|P2|STARTED|Overall Study||120
5106289|NCT01583985|12562759|P1|STARTED|Overall Study||120
5106290|NCT01583894|12562773|P1|NOT COMPLETED|Overall Study||15
5106291|NCT01583894|12562773|P1|COMPLETED|Overall Study||813
5106292|NCT01583894|12562773|P1|STARTED|Overall Study||828
5106293|NCT01583686|12562782|P5|NOT COMPLETED|Overall Study||0
5106294|NCT01583686|12562783|P4|NOT COMPLETED|Overall Study||0
5106295|NCT01583686|12562784|P3|NOT COMPLETED|Overall Study||0
5106296|NCT01583686|12562785|P2|NOT COMPLETED|Overall Study||0
5106297|NCT01583686|12562786|P1|NOT COMPLETED|Overall Study||0
5106298|NCT01583686|12562782|P5|COMPLETED|Overall Study||3
5106299|NCT01583686|12562783|P4|COMPLETED|Overall Study||3
5106300|NCT01583686|12562784|P3|COMPLETED|Overall Study||3
5106301|NCT01583686|12562785|P2|COMPLETED|Overall Study||3
5106302|NCT01583686|12562786|P1|COMPLETED|Overall Study||3
5106303|NCT01583686|12562782|P5|STARTED|Overall Study||3
5106304|NCT01583686|12562783|P4|STARTED|Overall Study||3
5106305|NCT01583686|12562784|P3|STARTED|Overall Study||3
5106306|NCT01583686|12562785|P2|STARTED|Overall Study||3
5106307|NCT01583686|12562786|P1|STARTED|Overall Study||3
5106308|NCT01583647|12562803|P2|NOT COMPLETED|Overall Study||0
5106309|NCT01583647|12562804|P1|NOT COMPLETED|Overall Study||0
5106310|NCT01583647|12562803|P2|COMPLETED|Overall Study||0
5106311|NCT01583647|12562804|P1|COMPLETED|Overall Study||10
5106312|NCT01583647|12562803|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
5106313|NCT01583647|12562804|P1|STARTED|Overall Study||10
5106314|NCT01583543|12562816|P1|NOT COMPLETED|Overall Study||0
5106315|NCT01583543|12562816|P1|COMPLETED|Overall Study||12
5106316|NCT01583543|12562816|P1|STARTED|Overall Study||12
5106317|NCT01583530|12562829|P6|NOT COMPLETED|Overall Study||3
5106318|NCT01583530|12562830|P5|NOT COMPLETED|Overall Study||5
5106319|NCT01583530|12562831|P4|NOT COMPLETED|Overall Study||1
5106320|NCT01583530|12562832|P3|NOT COMPLETED|Overall Study||0
5106321|NCT01583530|12562833|P2|NOT COMPLETED|Overall Study||3
5106322|NCT01583530|12562834|P1|NOT COMPLETED|Overall Study||0
5106323|NCT01583530|12562829|P6|COMPLETED|Overall Study||17
5106324|NCT01583530|12562830|P5|COMPLETED|Overall Study||15
5106325|NCT01583530|12562831|P4|COMPLETED|Overall Study||18
5106326|NCT01583530|12562832|P3|COMPLETED|Overall Study||20
5106327|NCT01583530|12562833|P2|COMPLETED|Overall Study||17
5106328|NCT01583530|12562834|P1|COMPLETED|Overall Study||19
5106329|NCT01583530|12562829|P6|STARTED|Overall Study||20
5106330|NCT01583530|12562830|P5|STARTED|Overall Study||20
5106331|NCT01583530|12562831|P4|STARTED|Overall Study||19
5106332|NCT01583530|12562832|P3|STARTED|Overall Study||20
5106333|NCT01583530|12562833|P2|STARTED|Overall Study||20
5106334|NCT01583530|12562834|P1|STARTED|Overall Study||19
5106335|NCT01583452|12562880|P2|NOT COMPLETED|Overall Study||0
5106336|NCT01583452|12562881|P1|NOT COMPLETED|Overall Study||0
5106337|NCT01583452|12562880|P2|COMPLETED|Overall Study||20
5106338|NCT01583452|12562881|P1|COMPLETED|Overall Study||21
5106339|NCT01583452|12562880|P2|STARTED|Overall Study||20
5106340|NCT01583452|12562881|P1|STARTED|Overall Study||21
5106341|NCT01583374|12562896|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
5106342|NCT01583374|12562897|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
5106343|NCT01583374|12562898|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
5106344|NCT01583374|12562899|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
5106345|NCT01583374|12562900|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
5106346|NCT01583374|12562901|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
5106347|NCT01583374|12562902|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
5106348|NCT01583374|12562903|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
5106349|NCT01583374|12562904|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
5106350|NCT01583374|12562896|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
5106351|NCT01583374|12562897|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
5106352|NCT01583374|12562898|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
5106353|NCT01583374|12562899|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
5106354|NCT01583374|12562900|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
5106355|NCT01583374|12562901|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
5106356|NCT01583374|12562902|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
5106357|NCT01583374|12562903|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
5106358|NCT01583374|12562904|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
5106359|NCT01583374|12562896|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
5106360|NCT01583374|12562897|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
5106361|NCT01583374|12562898|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
5106362|NCT01583374|12562899|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
5106363|NCT01583374|12562900|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
5106364|NCT01583374|12562901|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
5106365|NCT01583374|12562902|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
5106366|NCT01583374|12562903|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
5106367|NCT01583374|12562904|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
5106368|NCT01583374|12562896|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
5106369|NCT01583374|12562897|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
5106370|NCT01583374|12562898|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
5106371|NCT01583374|12562899|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
5106372|NCT01583374|12562900|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
5106373|NCT01583374|12562901|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
5106374|NCT01583374|12562902|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
5106375|NCT01583374|12562903|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
5106376|NCT01583374|12562904|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
5106377|NCT01583374|12562896|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
5106378|NCT01583374|12562897|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
5106379|NCT01583374|12562898|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
5106380|NCT01583374|12562899|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
5106381|NCT01583374|12562900|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
5106382|NCT01583374|12562901|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
5106383|NCT01583374|12562902|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
5106384|NCT01583374|12562903|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
5106385|NCT01583374|12562904|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
5106386|NCT01583374|12562896|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
5106387|NCT01583374|12562897|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
5106388|NCT01583374|12562898|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
5106389|NCT01583374|12562899|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
5106390|NCT01583374|12562900|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
5106391|NCT01583374|12562901|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
5106392|NCT01583374|12562902|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
5106393|NCT01583374|12562903|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
5106394|NCT01583374|12562904|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
5106395|NCT01583374|12562896|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106396|NCT01583374|12562897|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106397|NCT01583374|12562898|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106398|NCT01583374|12562899|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106399|NCT01583374|12562900|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106400|NCT01583374|12562901|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106401|NCT01583374|12562902|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
5106402|NCT01583374|12562903|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
5106403|NCT01583374|12562904|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
5106404|NCT01583374|12562896|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106405|NCT01583374|12562897|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106406|NCT01583374|12562898|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106407|NCT01583374|12562899|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106408|NCT01583374|12562900|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106409|NCT01583374|12562901|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5106410|NCT01583374|12562902|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
5106411|NCT01583374|12562903|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
5106412|NCT01583374|12562904|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
5106413|NCT01583374|12562896|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106414|NCT01583374|12562897|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106415|NCT01583374|12562898|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106416|NCT01583374|12562899|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106417|NCT01583374|12562900|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106418|NCT01583374|12562901|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5106419|NCT01583374|12562902|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
5106420|NCT01583374|12562903|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
5106421|NCT01583374|12562904|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
5106422|NCT01583374|12562896|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106423|NCT01583374|12562897|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106424|NCT01583374|12562898|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106425|NCT01583374|12562899|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106426|NCT01583374|12562900|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106427|NCT01583374|12562901|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5106428|NCT01583374|12562902|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
5106429|NCT01583374|12562903|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
5106430|NCT01583374|12562904|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
5106431|NCT01583374|12562896|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106432|NCT01583374|12562897|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106433|NCT01583374|12562898|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106434|NCT01583374|12562899|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106435|NCT01583374|12562900|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106436|NCT01583374|12562901|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5106437|NCT01583374|12562902|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
5106438|NCT01583374|12562903|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
5106439|NCT01583374|12562904|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
5106440|NCT01583374|12562896|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106441|NCT01583374|12562897|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106442|NCT01583374|12562898|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106443|NCT01583374|12562899|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106444|NCT01583374|12562900|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106445|NCT01583374|12562901|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
5106446|NCT01583374|12562902|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
5106447|NCT01583374|12562903|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
5106448|NCT01583374|12562904|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
5106449|NCT01583218|12562946|P2|NOT COMPLETED|Overall Study||283
5106450|NCT01583218|12562947|P1|NOT COMPLETED|Overall Study||289
5106451|NCT01583218|12562946|P2|COMPLETED|Overall Study||3471
5106452|NCT01583218|12562947|P1|COMPLETED|Overall Study||3470
5106453|NCT01583218|12562946|P2|STARTED|Overall Study||3754
5106454|NCT01583218|12562947|P1|STARTED|Overall Study||3759
5106455|NCT01583179|12562967|P2|NOT COMPLETED|Overall Study||2
5106456|NCT01583179|12562968|P1|NOT COMPLETED|Overall Study||1
5106457|NCT01583179|12562967|P2|COMPLETED|Overall Study||10
5106458|NCT01583179|12562968|P1|COMPLETED|Overall Study||13
5106459|NCT01583179|12562967|P2|STARTED|Overall Study||12
5106460|NCT01583179|12562968|P1|STARTED|Overall Study||14
5106461|NCT01583166|12562978|P2|NOT COMPLETED|Overall Study||6
5106462|NCT01583166|12562979|P1|NOT COMPLETED|Overall Study||4
5106463|NCT01583166|12562978|P2|COMPLETED|Overall Study||39
5106464|NCT01583166|12562979|P1|COMPLETED|Overall Study||41
5106465|NCT01583166|12562978|P2|STARTED|Overall Study||45
5106466|NCT01583166|12562979|P1|STARTED|Overall Study||45
5106467|NCT01583101|12562993|P2|NOT COMPLETED|Overall Study||0
5106468|NCT01583101|12562994|P1|NOT COMPLETED|Overall Study||0
5106469|NCT01583101|12562993|P2|COMPLETED|Overall Study||1161
5106470|NCT01583101|12562994|P1|COMPLETED|Overall Study||1076
5106471|NCT01583101|12562993|P2|STARTED|Overall Study||1161
5106472|NCT01583101|12562994|P1|STARTED|Overall Study||1076
5106473|NCT01582971|12563002|P2|NOT COMPLETED|Overall Study||37
5106474|NCT01582971|12563003|P1|NOT COMPLETED|Overall Study||39
5106475|NCT01582971|12563002|P2|COMPLETED|Overall Study||91
5106476|NCT01582971|12563003|P1|COMPLETED|Overall Study||89
5106477|NCT01582971|12563002|P2|STARTED|Overall Study||128
5106478|NCT01582971|12563003|P1|STARTED|Overall Study||128
5106479|NCT01582945|12563021|P1|NOT COMPLETED|Overall Study||2
5106480|NCT01582945|12563021|P1|COMPLETED|Overall Study||12
5106481|NCT01582945|12563021|P1|STARTED|Overall Study||14
5106482|NCT01582880|12563025|P1|NOT COMPLETED|Overall Study||0
5106483|NCT01582880|12563025|P1|COMPLETED|Overall Study||1
5106484|NCT01582880|12563025|P1|STARTED|Overall Study||1
5106485|NCT01582854|12563035|P2|NOT COMPLETED|Overall Study||34
5106486|NCT01582854|12563036|P1|NOT COMPLETED|Overall Study||36
5106487|NCT01582854|12563035|P2|COMPLETED|Overall Study||221
5106488|NCT01582854|12563036|P1|COMPLETED|Overall Study||212
5106489|NCT01582854|12563035|P2|STARTED|Overall Study||255
5106490|NCT01582854|12563036|P1|STARTED|Overall Study||248
5106491|NCT01582789|12563064|P2|NOT COMPLETED|Second Intervention (14 Days)||0
5106492|NCT01582789|12563065|P1|NOT COMPLETED|Second Intervention (14 Days)||1
5106493|NCT01582789|12563064|P2|COMPLETED|Second Intervention (14 Days)||27
5106494|NCT01582789|12563065|P1|COMPLETED|Second Intervention (14 Days)||33
5106495|NCT01582789|12563064|P2|STARTED|Second Intervention (14 Days)||27
5106496|NCT01582789|12563065|P1|STARTED|Second Intervention (14 Days)||34
5106497|NCT01582789|12563064|P2|NOT COMPLETED|First Intervention (14 Days)||0
5106498|NCT01582789|12563065|P1|NOT COMPLETED|First Intervention (14 Days)||0
5106499|NCT01582789|12563064|P2|COMPLETED|First Intervention (14 Days)||27
5106500|NCT01582789|12563065|P1|COMPLETED|First Intervention (14 Days)||34
5106501|NCT01582789|12563064|P2|STARTED|First Intervention (14 Days)||27
5106502|NCT01582789|12563065|P1|STARTED|First Intervention (14 Days)||34
5106503|NCT01582490|12563083|P2|NOT COMPLETED|Overall Study||1
5106504|NCT01582490|12563084|P1|NOT COMPLETED|Overall Study||1
5106505|NCT01582490|12563083|P2|COMPLETED|Overall Study||9
5106506|NCT01582490|12563084|P1|COMPLETED|Overall Study||8
5106507|NCT01582490|12563083|P2|STARTED|Overall Study||10
5106508|NCT01582490|12563084|P1|STARTED|Overall Study||9
5106509|NCT01582477|12563106|P2|NOT COMPLETED|Overall Study||0
5106510|NCT01582477|12563107|P1|NOT COMPLETED|Overall Study||0
5106511|NCT01582477|12563106|P2|COMPLETED|Overall Study||12
5106512|NCT01582477|12563107|P1|COMPLETED|Overall Study||12
5106513|NCT01582477|12563106|P2|STARTED|Overall Study||12
5106514|NCT01582477|12563107|P1|STARTED|Overall Study||12
5106515|NCT01582451|12563125|P2|NOT COMPLETED|Overall Study||20
5106516|NCT01582451|12563126|P1|NOT COMPLETED|Overall Study||32
5106517|NCT01582451|12563125|P2|COMPLETED|Overall Study||139
5106518|NCT01582451|12563126|P1|COMPLETED|Overall Study||275
5106519|NCT01582451|12563125|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
5106520|NCT01582451|12563126|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
5106521|NCT01582451|12563125|P2|STARTED|Overall Study||159
5106522|NCT01582451|12563126|P1|STARTED|Overall Study||307
5106523|NCT01582308|12563168|P10|NOT COMPLETED|Period 5||0
5106524|NCT01582308|12563169|P9|NOT COMPLETED|Period 5||0
5106525|NCT01582308|12563170|P8|NOT COMPLETED|Period 5||0
5106526|NCT01582308|12563171|P7|NOT COMPLETED|Period 5||0
5106527|NCT01582308|12563172|P6|NOT COMPLETED|Period 5||0
5106528|NCT01582308|12563173|P5|NOT COMPLETED|Period 5||0
5106529|NCT01582308|12563174|P4|NOT COMPLETED|Period 5||0
5106530|NCT01582308|12563175|P3|NOT COMPLETED|Period 5||0
5106531|NCT01582308|12563176|P2|NOT COMPLETED|Period 5||0
5106532|NCT01582308|12563177|P1|NOT COMPLETED|Period 5||0
5106533|NCT01582308|12563168|P10|COMPLETED|Period 5||1
5106534|NCT01582308|12563169|P9|COMPLETED|Period 5||2
5106535|NCT01582308|12563170|P8|COMPLETED|Period 5||2
5106536|NCT01582308|12563171|P7|COMPLETED|Period 5||2
5106537|NCT01582308|12563172|P6|COMPLETED|Period 5||1
5106538|NCT01582308|12563173|P5|COMPLETED|Period 5||2
5106539|NCT01582308|12563174|P4|COMPLETED|Period 5||2
5106540|NCT01582308|12563175|P3|COMPLETED|Period 5||2
5106541|NCT01582308|12563176|P2|COMPLETED|Period 5||2
5106542|NCT01582308|12563177|P1|COMPLETED|Period 5||1
5106543|NCT01582308|12563168|P10|STARTED|Period 5||1
5106544|NCT01582308|12563169|P9|STARTED|Period 5||2
5106545|NCT01582308|12563170|P8|STARTED|Period 5||2
5106546|NCT01582308|12563171|P7|STARTED|Period 5||2
5106547|NCT01582308|12563172|P6|STARTED|Period 5||1
5106548|NCT01582308|12563173|P5|STARTED|Period 5||2
5106549|NCT01582308|12563174|P4|STARTED|Period 5||2
5106550|NCT01582308|12563175|P3|STARTED|Period 5||2
5106551|NCT01582308|12563176|P2|STARTED|Period 5||2
5106552|NCT01582308|12563177|P1|STARTED|Period 5||1
5106553|NCT01582308|12563168|P10|NOT COMPLETED|10-day Washout Following Period 4||0
5106554|NCT01582308|12563169|P9|NOT COMPLETED|10-day Washout Following Period 4||0
5106555|NCT01582308|12563170|P8|NOT COMPLETED|10-day Washout Following Period 4||0
5106556|NCT01582308|12563171|P7|NOT COMPLETED|10-day Washout Following Period 4||0
5106557|NCT01582308|12563172|P6|NOT COMPLETED|10-day Washout Following Period 4||0
5106558|NCT01582308|12563173|P5|NOT COMPLETED|10-day Washout Following Period 4||0
5106559|NCT01582308|12563174|P4|NOT COMPLETED|10-day Washout Following Period 4||0
5106560|NCT01582308|12563175|P3|NOT COMPLETED|10-day Washout Following Period 4||0
5106561|NCT01582308|12563176|P2|NOT COMPLETED|10-day Washout Following Period 4||0
5106562|NCT01582308|12563177|P1|NOT COMPLETED|10-day Washout Following Period 4||0
5106563|NCT01582308|12563168|P10|COMPLETED|10-day Washout Following Period 4||1
5106564|NCT01582308|12563169|P9|COMPLETED|10-day Washout Following Period 4||2
5106565|NCT01582308|12563170|P8|COMPLETED|10-day Washout Following Period 4||2
5106566|NCT01582308|12563171|P7|COMPLETED|10-day Washout Following Period 4||2
5106567|NCT01582308|12563172|P6|COMPLETED|10-day Washout Following Period 4||1
5106568|NCT01582308|12563173|P5|COMPLETED|10-day Washout Following Period 4||2
5106569|NCT01582308|12563174|P4|COMPLETED|10-day Washout Following Period 4||2
5106570|NCT01582308|12563175|P3|COMPLETED|10-day Washout Following Period 4||2
5106571|NCT01582308|12563176|P2|COMPLETED|10-day Washout Following Period 4||2
5106572|NCT01582308|12563177|P1|COMPLETED|10-day Washout Following Period 4||1
5106573|NCT01582308|12563168|P10|STARTED|10-day Washout Following Period 4||1
5106574|NCT01582308|12563169|P9|STARTED|10-day Washout Following Period 4||2
5106575|NCT01582308|12563170|P8|STARTED|10-day Washout Following Period 4||2
5106576|NCT01582308|12563171|P7|STARTED|10-day Washout Following Period 4||2
5106577|NCT01582308|12563172|P6|STARTED|10-day Washout Following Period 4||1
5106578|NCT01582308|12563173|P5|STARTED|10-day Washout Following Period 4||2
5106579|NCT01582308|12563174|P4|STARTED|10-day Washout Following Period 4||2
5106580|NCT01582308|12563175|P3|STARTED|10-day Washout Following Period 4||2
5106581|NCT01582308|12563176|P2|STARTED|10-day Washout Following Period 4||2
5106582|NCT01582308|12563177|P1|STARTED|10-day Washout Following Period 4||1
5106583|NCT01582308|12563168|P10|NOT COMPLETED|Period 4||1
5106584|NCT01582308|12563169|P9|NOT COMPLETED|Period 4||0
5106585|NCT01582308|12563170|P8|NOT COMPLETED|Period 4||0
5106586|NCT01582308|12563171|P7|NOT COMPLETED|Period 4||0
5106587|NCT01582308|12563172|P6|NOT COMPLETED|Period 4||1
5106588|NCT01582308|12563173|P5|NOT COMPLETED|Period 4||0
5106589|NCT01582308|12563174|P4|NOT COMPLETED|Period 4||0
5106590|NCT01582308|12563175|P3|NOT COMPLETED|Period 4||0
5106591|NCT01582308|12563176|P2|NOT COMPLETED|Period 4||0
5106592|NCT01582308|12563177|P1|NOT COMPLETED|Period 4||1
5106593|NCT01582308|12563168|P10|COMPLETED|Period 4||1
5106594|NCT01582308|12563169|P9|COMPLETED|Period 4||2
5106595|NCT01582308|12563170|P8|COMPLETED|Period 4||2
5106596|NCT01582308|12563171|P7|COMPLETED|Period 4||2
5106597|NCT01582308|12563172|P6|COMPLETED|Period 4||1
5106598|NCT01582308|12563173|P5|COMPLETED|Period 4||2
5106599|NCT01582308|12563174|P4|COMPLETED|Period 4||2
5106600|NCT01582308|12563175|P3|COMPLETED|Period 4||2
5106601|NCT01582308|12563176|P2|COMPLETED|Period 4||2
5106602|NCT01582308|12563177|P1|COMPLETED|Period 4||1
5106603|NCT01582308|12563168|P10|STARTED|Period 4||2
5106604|NCT01582308|12563169|P9|STARTED|Period 4||2
5106605|NCT01582308|12563170|P8|STARTED|Period 4||2
5106606|NCT01582308|12563171|P7|STARTED|Period 4||2
5106607|NCT01582308|12563172|P6|STARTED|Period 4||2
5106608|NCT01582308|12563173|P5|STARTED|Period 4||2
5106609|NCT01582308|12563174|P4|STARTED|Period 4||2
5106610|NCT01582308|12563175|P3|STARTED|Period 4||2
5106611|NCT01582308|12563176|P2|STARTED|Period 4||2
5106612|NCT01582308|12563177|P1|STARTED|Period 4||2
5106613|NCT01582308|12563168|P10|NOT COMPLETED|10-day Washout Following Period 3||0
5106614|NCT01582308|12563169|P9|NOT COMPLETED|10-day Washout Following Period 3||0
5106615|NCT01582308|12563170|P8|NOT COMPLETED|10-day Washout Following Period 3||0
5106616|NCT01582308|12563171|P7|NOT COMPLETED|10-day Washout Following Period 3||0
5106617|NCT01582308|12563172|P6|NOT COMPLETED|10-day Washout Following Period 3||0
5106618|NCT01582308|12563173|P5|NOT COMPLETED|10-day Washout Following Period 3||0
5106619|NCT01582308|12563174|P4|NOT COMPLETED|10-day Washout Following Period 3||0
5106620|NCT01582308|12563175|P3|NOT COMPLETED|10-day Washout Following Period 3||0
5106621|NCT01582308|12563176|P2|NOT COMPLETED|10-day Washout Following Period 3||0
5106622|NCT01582308|12563177|P1|NOT COMPLETED|10-day Washout Following Period 3||0
5106623|NCT01582308|12563168|P10|COMPLETED|10-day Washout Following Period 3||2
5106624|NCT01582308|12563169|P9|COMPLETED|10-day Washout Following Period 3||2
5106625|NCT01582308|12563170|P8|COMPLETED|10-day Washout Following Period 3||2
5106626|NCT01582308|12563171|P7|COMPLETED|10-day Washout Following Period 3||2
5106627|NCT01582308|12563172|P6|COMPLETED|10-day Washout Following Period 3||2
5106628|NCT01582308|12563173|P5|COMPLETED|10-day Washout Following Period 3||2
5106629|NCT01582308|12563174|P4|COMPLETED|10-day Washout Following Period 3||2
5106630|NCT01582308|12563175|P3|COMPLETED|10-day Washout Following Period 3||2
5106631|NCT01582308|12563176|P2|COMPLETED|10-day Washout Following Period 3||2
5106632|NCT01582308|12563177|P1|COMPLETED|10-day Washout Following Period 3||2
5106633|NCT01582308|12563168|P10|STARTED|10-day Washout Following Period 3||2
5106634|NCT01582308|12563169|P9|STARTED|10-day Washout Following Period 3||2
5106635|NCT01582308|12563170|P8|STARTED|10-day Washout Following Period 3||2
5106636|NCT01582308|12563171|P7|STARTED|10-day Washout Following Period 3||2
5106637|NCT01582308|12563172|P6|STARTED|10-day Washout Following Period 3||2
5106638|NCT01582308|12563173|P5|STARTED|10-day Washout Following Period 3||2
5106639|NCT01582308|12563174|P4|STARTED|10-day Washout Following Period 3||2
5106640|NCT01582308|12563175|P3|STARTED|10-day Washout Following Period 3||2
5106641|NCT01582308|12563176|P2|STARTED|10-day Washout Following Period 3||2
5106642|NCT01582308|12563177|P1|STARTED|10-day Washout Following Period 3||2
5106643|NCT01582308|12563168|P10|NOT COMPLETED|Period 3||0
5106644|NCT01582308|12563169|P9|NOT COMPLETED|Period 3||0
5106645|NCT01582308|12563170|P8|NOT COMPLETED|Period 3||0
5106646|NCT01582308|12563171|P7|NOT COMPLETED|Period 3||0
5106647|NCT01582308|12563172|P6|NOT COMPLETED|Period 3||0
5106648|NCT01582308|12563173|P5|NOT COMPLETED|Period 3||0
5106649|NCT01582308|12563174|P4|NOT COMPLETED|Period 3||0
5106650|NCT01582308|12563175|P3|NOT COMPLETED|Period 3||0
5106651|NCT01582308|12563176|P2|NOT COMPLETED|Period 3||0
5106652|NCT01582308|12563177|P1|NOT COMPLETED|Period 3||0
5106653|NCT01582308|12563168|P10|COMPLETED|Period 3||2
5106654|NCT01582308|12563169|P9|COMPLETED|Period 3||2
5106655|NCT01582308|12563170|P8|COMPLETED|Period 3||2
5106656|NCT01582308|12563171|P7|COMPLETED|Period 3||2
5106657|NCT01582308|12563172|P6|COMPLETED|Period 3||2
5106658|NCT01582308|12563173|P5|COMPLETED|Period 3||2
5106659|NCT01582308|12563174|P4|COMPLETED|Period 3||2
5106660|NCT01582308|12563175|P3|COMPLETED|Period 3||2
5106661|NCT01582308|12563176|P2|COMPLETED|Period 3||2
5106662|NCT01582308|12563177|P1|COMPLETED|Period 3||2
5106663|NCT01582308|12563168|P10|STARTED|Period 3||2
5106664|NCT01582308|12563169|P9|STARTED|Period 3||2
5106665|NCT01582308|12563170|P8|STARTED|Period 3||2
5106666|NCT01582308|12563171|P7|STARTED|Period 3||2
5106667|NCT01582308|12563172|P6|STARTED|Period 3||2
5106668|NCT01582308|12563173|P5|STARTED|Period 3||2
5106669|NCT01582308|12563174|P4|STARTED|Period 3||2
5106670|NCT01582308|12563175|P3|STARTED|Period 3||2
5106671|NCT01582308|12563176|P2|STARTED|Period 3||2
5106672|NCT01582308|12563177|P1|STARTED|Period 3||2
5106673|NCT01582308|12563168|P10|NOT COMPLETED|10-day Washout Following Period 2||0
5106674|NCT01582308|12563169|P9|NOT COMPLETED|10-day Washout Following Period 2||0
5106675|NCT01582308|12563170|P8|NOT COMPLETED|10-day Washout Following Period 2||0
5106676|NCT01582308|12563171|P7|NOT COMPLETED|10-day Washout Following Period 2||0
5106677|NCT01582308|12563172|P6|NOT COMPLETED|10-day Washout Following Period 2||0
5106678|NCT01582308|12563173|P5|NOT COMPLETED|10-day Washout Following Period 2||0
5106679|NCT01582308|12563174|P4|NOT COMPLETED|10-day Washout Following Period 2||0
5106680|NCT01582308|12563175|P3|NOT COMPLETED|10-day Washout Following Period 2||0
5106681|NCT01582308|12563176|P2|NOT COMPLETED|10-day Washout Following Period 2||0
5106682|NCT01582308|12563177|P1|NOT COMPLETED|10-day Washout Following Period 2||0
5106683|NCT01582308|12563168|P10|COMPLETED|10-day Washout Following Period 2||2
5106684|NCT01582308|12563169|P9|COMPLETED|10-day Washout Following Period 2||2
5106685|NCT01582308|12563170|P8|COMPLETED|10-day Washout Following Period 2||2
5106686|NCT01582308|12563171|P7|COMPLETED|10-day Washout Following Period 2||2
5106687|NCT01582308|12563172|P6|COMPLETED|10-day Washout Following Period 2||2
5106688|NCT01582308|12563173|P5|COMPLETED|10-day Washout Following Period 2||2
5106689|NCT01582308|12563174|P4|COMPLETED|10-day Washout Following Period 2||2
5106690|NCT01582308|12563175|P3|COMPLETED|10-day Washout Following Period 2||2
5106691|NCT01582308|12563176|P2|COMPLETED|10-day Washout Following Period 2||2
5106692|NCT01582308|12563177|P1|COMPLETED|10-day Washout Following Period 2||2
5106693|NCT01582308|12563168|P10|STARTED|10-day Washout Following Period 2||2
5106694|NCT01582308|12563169|P9|STARTED|10-day Washout Following Period 2||2
5106695|NCT01582308|12563170|P8|STARTED|10-day Washout Following Period 2||2
5106696|NCT01582308|12563171|P7|STARTED|10-day Washout Following Period 2||2
5106697|NCT01582308|12563172|P6|STARTED|10-day Washout Following Period 2||2
5106698|NCT01582308|12563173|P5|STARTED|10-day Washout Following Period 2||2
5106699|NCT01582308|12563174|P4|STARTED|10-day Washout Following Period 2||2
5106700|NCT01582308|12563175|P3|STARTED|10-day Washout Following Period 2||2
5106701|NCT01582308|12563176|P2|STARTED|10-day Washout Following Period 2||2
5106702|NCT01582308|12563177|P1|STARTED|10-day Washout Following Period 2||2
5106703|NCT01582308|12563168|P10|NOT COMPLETED|Period 2||0
5106704|NCT01582308|12563169|P9|NOT COMPLETED|Period 2||0
5106705|NCT01582308|12563170|P8|NOT COMPLETED|Period 2||0
5106706|NCT01582308|12563171|P7|NOT COMPLETED|Period 2||0
5106707|NCT01582308|12563172|P6|NOT COMPLETED|Period 2||0
5106708|NCT01582308|12563173|P5|NOT COMPLETED|Period 2||0
5106709|NCT01582308|12563174|P4|NOT COMPLETED|Period 2||0
5106710|NCT01582308|12563175|P3|NOT COMPLETED|Period 2||0
5106711|NCT01582308|12563176|P2|NOT COMPLETED|Period 2||0
5106712|NCT01582308|12563177|P1|NOT COMPLETED|Period 2||0
5106713|NCT01582308|12563168|P10|COMPLETED|Period 2||2
5106714|NCT01582308|12563169|P9|COMPLETED|Period 2||2
5106715|NCT01582308|12563170|P8|COMPLETED|Period 2||2
5106716|NCT01582308|12563171|P7|COMPLETED|Period 2||2
5106717|NCT01582308|12563172|P6|COMPLETED|Period 2||2
5106718|NCT01582308|12563173|P5|COMPLETED|Period 2||2
5106719|NCT01582308|12563174|P4|COMPLETED|Period 2||2
5106720|NCT01582308|12563175|P3|COMPLETED|Period 2||2
5106721|NCT01582308|12563176|P2|COMPLETED|Period 2||2
5106722|NCT01582308|12563177|P1|COMPLETED|Period 2||2
5106723|NCT01582308|12563168|P10|STARTED|Period 2||2
5106724|NCT01582308|12563169|P9|STARTED|Period 2||2
5106725|NCT01582308|12563170|P8|STARTED|Period 2||2
5106726|NCT01582308|12563171|P7|STARTED|Period 2||2
5106727|NCT01582308|12563172|P6|STARTED|Period 2||2
5106728|NCT01582308|12563173|P5|STARTED|Period 2||2
5106729|NCT01582308|12563174|P4|STARTED|Period 2||2
5106730|NCT01582308|12563175|P3|STARTED|Period 2||2
5106731|NCT01582308|12563176|P2|STARTED|Period 2||2
5106732|NCT01582308|12563177|P1|STARTED|Period 2||2
5106733|NCT01582308|12563168|P10|NOT COMPLETED|10-day Washout Following Period 1||0
5106734|NCT01582308|12563169|P9|NOT COMPLETED|10-day Washout Following Period 1||0
5106735|NCT01582308|12563170|P8|NOT COMPLETED|10-day Washout Following Period 1||0
5106736|NCT01582308|12563171|P7|NOT COMPLETED|10-day Washout Following Period 1||0
5106737|NCT01582308|12563172|P6|NOT COMPLETED|10-day Washout Following Period 1||0
5106738|NCT01582308|12563173|P5|NOT COMPLETED|10-day Washout Following Period 1||1
5106739|NCT01582308|12563174|P4|NOT COMPLETED|10-day Washout Following Period 1||0
5106740|NCT01582308|12563175|P3|NOT COMPLETED|10-day Washout Following Period 1||0
5106741|NCT01582308|12563176|P2|NOT COMPLETED|10-day Washout Following Period 1||0
5106742|NCT01582308|12563177|P1|NOT COMPLETED|10-day Washout Following Period 1||0
5106743|NCT01582308|12563168|P10|COMPLETED|10-day Washout Following Period 1||2
5106744|NCT01582308|12563169|P9|COMPLETED|10-day Washout Following Period 1||2
5106745|NCT01582308|12563170|P8|COMPLETED|10-day Washout Following Period 1||2
5106746|NCT01582308|12563171|P7|COMPLETED|10-day Washout Following Period 1||2
5106747|NCT01582308|12563172|P6|COMPLETED|10-day Washout Following Period 1||2
5106748|NCT01582308|12563173|P5|COMPLETED|10-day Washout Following Period 1||2
5106749|NCT01582308|12563174|P4|COMPLETED|10-day Washout Following Period 1||2
5106750|NCT01582308|12563175|P3|COMPLETED|10-day Washout Following Period 1||2
5106751|NCT01582308|12563176|P2|COMPLETED|10-day Washout Following Period 1||2
5106752|NCT01582308|12563177|P1|COMPLETED|10-day Washout Following Period 1||2
5106753|NCT01582308|12563168|P10|STARTED|10-day Washout Following Period 1||2
5106754|NCT01582308|12563169|P9|STARTED|10-day Washout Following Period 1||2
5106755|NCT01582308|12563170|P8|STARTED|10-day Washout Following Period 1||2
5106756|NCT01582308|12563171|P7|STARTED|10-day Washout Following Period 1||2
5106757|NCT01582308|12563172|P6|STARTED|10-day Washout Following Period 1||2
5106758|NCT01582308|12563173|P5|STARTED|10-day Washout Following Period 1||3
5106759|NCT01582308|12563174|P4|STARTED|10-day Washout Following Period 1||2
5106760|NCT01582308|12563175|P3|STARTED|10-day Washout Following Period 1||2
5106761|NCT01582308|12563176|P2|STARTED|10-day Washout Following Period 1||2
5106762|NCT01582308|12563177|P1|STARTED|10-day Washout Following Period 1||2
5106763|NCT01582308|12563168|P10|NOT COMPLETED|Period 1||0
5106764|NCT01582308|12563169|P9|NOT COMPLETED|Period 1||0
5106765|NCT01582308|12563170|P8|NOT COMPLETED|Period 1||0
5106766|NCT01582308|12563171|P7|NOT COMPLETED|Period 1||1
5106767|NCT01582308|12563172|P6|NOT COMPLETED|Period 1||0
5106768|NCT01582308|12563173|P5|NOT COMPLETED|Period 1||0
5106769|NCT01582308|12563174|P4|NOT COMPLETED|Period 1||0
5106770|NCT01582308|12563175|P3|NOT COMPLETED|Period 1||0
5106771|NCT01582308|12563176|P2|NOT COMPLETED|Period 1||0
5106772|NCT01582308|12563177|P1|NOT COMPLETED|Period 1||0
5106773|NCT01582308|12563168|P10|COMPLETED|Period 1||2
5106774|NCT01582308|12563169|P9|COMPLETED|Period 1||2
5106775|NCT01582308|12563170|P8|COMPLETED|Period 1||2
5106776|NCT01582308|12563171|P7|COMPLETED|Period 1||2
5106777|NCT01582308|12563172|P6|COMPLETED|Period 1||2
5106778|NCT01582308|12563173|P5|COMPLETED|Period 1||3
5106779|NCT01582308|12563174|P4|COMPLETED|Period 1||2
5106780|NCT01582308|12563175|P3|COMPLETED|Period 1||2
5106781|NCT01582308|12563176|P2|COMPLETED|Period 1||2
5106782|NCT01582308|12563177|P1|COMPLETED|Period 1||2
5106783|NCT01582308|12563168|P10|STARTED|Period 1||2
5106784|NCT01582308|12563169|P9|STARTED|Period 1||2
5106785|NCT01582308|12563170|P8|STARTED|Period 1||2
5106786|NCT01582308|12563171|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
5106787|NCT01582308|12563172|P6|STARTED|Period 1||2
5106788|NCT01582308|12563173|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
5106789|NCT01582308|12563174|P4|STARTED|Period 1||2
5106790|NCT01582308|12563175|P3|STARTED|Period 1||2
5106791|NCT01582308|12563176|P2|STARTED|Period 1||2
5106792|NCT01582308|12563177|P1|STARTED|Period 1||2
5106793|NCT01582282|12563205|P3|NOT COMPLETED|Overall Study||0
5106794|NCT01582282|12563206|P2|NOT COMPLETED|Overall Study||2
5106795|NCT01582282|12563207|P1|NOT COMPLETED|Overall Study||2
5106796|NCT01582282|12563205|P3|COMPLETED|Overall Study||8
5106797|NCT01582282|12563206|P2|COMPLETED|Overall Study||12
5106798|NCT01582282|12563207|P1|COMPLETED|Overall Study||13
5106799|NCT01582282|12563205|P3|STARTED|Overall Study||8
5106800|NCT01582282|12563206|P2|STARTED|Overall Study||14
5106801|NCT01582282|12563207|P1|STARTED|Overall Study||15
5106802|NCT01582243|12563230|P1|NOT COMPLETED|Overall Study||3
5106803|NCT01582243|12563230|P1|COMPLETED|Overall Study||37
5106804|NCT01582243|12563230|P1|STARTED|Overall Study||40
5106805|NCT01582178|12563241|P2|NOT COMPLETED|Overall Study||5
5106806|NCT01582178|12563242|P1|NOT COMPLETED|Overall Study||6
5106807|NCT01582178|12563241|P2|COMPLETED|Overall Study||101
5106808|NCT01582178|12563242|P1|COMPLETED|Overall Study||100
5106809|NCT01582178|12563241|P2|STARTED|Overall Study||106
5106810|NCT01582178|12563242|P1|STARTED|Overall Study||106
5106811|NCT01582152|12563250|P2|NOT COMPLETED|Overall Study||6
5106812|NCT01582152|12563251|P1|NOT COMPLETED|Overall Study||6
5106813|NCT01582152|12563250|P2|COMPLETED|Overall Study||0
5106814|NCT01582152|12563251|P1|COMPLETED|Overall Study||0
5106815|NCT01582152|12563250|P2|STARTED|Overall Study||6
5106816|NCT01582152|12563251|P1|STARTED|Overall Study||6
5106817|NCT01582139|12563261|P2|NOT COMPLETED|Overall Study||0
5106818|NCT01582139|12563262|P1|NOT COMPLETED|Overall Study||0
5106819|NCT01582139|12563261|P2|COMPLETED|Overall Study||6
5106820|NCT01582139|12563262|P1|COMPLETED|Overall Study||6
5106821|NCT01582139|12563261|P2|STARTED|Overall Study||6
5106822|NCT01582139|12563262|P1|STARTED|Overall Study||6
5106823|NCT01582100|12563274|P1|NOT COMPLETED|Overall Study||2
5106824|NCT01582100|12563274|P1|COMPLETED|Overall Study||0
5106825|NCT01582100|12563274|P1|STARTED|Overall Study||2
5106826|NCT01582061|12563280|P2|NOT COMPLETED|Overall Study||36
5106827|NCT01582061|12563281|P1|NOT COMPLETED|Overall Study||28
5106828|NCT01582061|12563280|P2|COMPLETED|Overall Study||19
5106829|NCT01582061|12563281|P1|COMPLETED|Overall Study||21
5106830|NCT01582061|12563280|P2|STARTED|Overall Study||55
5106831|NCT01582061|12563281|P1|STARTED|Overall Study||49
5106832|NCT01582009|12563331|P1|NOT COMPLETED|Overall Study||2
5106833|NCT01582009|12563331|P1|COMPLETED|Overall Study||24
5106834|NCT01582009|12563331|P1|STARTED|Overall Study||26
5106835|NCT01581970|12563339|P1|NOT COMPLETED|Overall Study||0
5106836|NCT01581970|12563339|P1|COMPLETED|Overall Study||7
5106837|NCT01581970|12563339|P1|STARTED|Overall Study||7
5106838|NCT01581931|12563348|P2|NOT COMPLETED|Second Period||0
5106839|NCT01581931|12563349|P1|NOT COMPLETED|Second Period||0
5106840|NCT01581931|12563348|P2|COMPLETED|Second Period||15
5106841|NCT01581931|12563349|P1|COMPLETED|Second Period||16
5106842|NCT01581931|12563348|P2|STARTED|Second Period||15
5106843|NCT01581931|12563349|P1|STARTED|Second Period||16
5106844|NCT01581931|12563348|P2|NOT COMPLETED|Washout||1
5106845|NCT01581931|12563349|P1|NOT COMPLETED|Washout||0
5106846|NCT01581931|12563348|P2|COMPLETED|Washout||15
5106847|NCT01581931|12563349|P1|COMPLETED|Washout||16
5106848|NCT01581931|12563348|P2|STARTED|Washout||16
5106849|NCT01581931|12563349|P1|STARTED|Washout||16
5106850|NCT01581931|12563348|P2|NOT COMPLETED|First Period||0
5106851|NCT01581931|12563349|P1|NOT COMPLETED|First Period||0
5106852|NCT01581931|12563348|P2|COMPLETED|First Period||16
5106853|NCT01581931|12563349|P1|COMPLETED|First Period||16
5106854|NCT01581931|12563348|P2|STARTED|First Period||16
5106855|NCT01581931|12563349|P1|STARTED|First Period||16
5106856|NCT01581710|12563363|P2|NOT COMPLETED|Second Intervention (14days)||2
5106857|NCT01581710|12563364|P1|NOT COMPLETED|Second Intervention (14days)||0
5106858|NCT01581710|12563363|P2|COMPLETED|Second Intervention (14days)||12
5106859|NCT01581710|12563364|P1|COMPLETED|Second Intervention (14days)||18
5106860|NCT01581710|12563363|P2|STARTED|Second Intervention (14days)||14
5106861|NCT01581710|12563364|P1|STARTED|Second Intervention (14days)||18
5106862|NCT01581710|12563363|P2|NOT COMPLETED|Washout Period (14days)||0
5106863|NCT01581710|12563364|P1|NOT COMPLETED|Washout Period (14days)||0
5106864|NCT01581710|12563363|P2|COMPLETED|Washout Period (14days)||14
5106865|NCT01581710|12563364|P1|COMPLETED|Washout Period (14days)||18
5106866|NCT01581710|12563363|P2|STARTED|Washout Period (14days)||14
5106867|NCT01581710|12563364|P1|STARTED|Washout Period (14days)||18
5106868|NCT01581710|12563363|P2|NOT COMPLETED|First Intervention (14days)||0
5106869|NCT01581710|12563364|P1|NOT COMPLETED|First Intervention (14days)||0
5106870|NCT01581710|12563363|P2|COMPLETED|First Intervention (14days)||14
5106871|NCT01581710|12563364|P1|COMPLETED|First Intervention (14days)||18
5106872|NCT01581710|12563363|P2|STARTED|First Intervention (14days)||14
5106873|NCT01581710|12563364|P1|STARTED|First Intervention (14days)||18
5106874|NCT01581684|12563402|P10|NOT COMPLETED|Overall Study||0
5106875|NCT01581684|12563403|P9|NOT COMPLETED|Overall Study||1
5106876|NCT01581684|12563404|P8|NOT COMPLETED|Overall Study||0
5106877|NCT01581684|12563405|P7|NOT COMPLETED|Overall Study||0
5106878|NCT01581684|12563406|P6|NOT COMPLETED|Overall Study||0
5106879|NCT01581684|12563407|P5|NOT COMPLETED|Overall Study||0
5106880|NCT01581684|12563408|P4|NOT COMPLETED|Overall Study||0
5106881|NCT01581684|12563409|P3|NOT COMPLETED|Overall Study||0
5106882|NCT01581684|12563410|P2|NOT COMPLETED|Overall Study||0
5106883|NCT01581684|12563411|P1|NOT COMPLETED|Overall Study||0
5106884|NCT01581684|12563402|P10|COMPLETED|Overall Study||5
5106885|NCT01581684|12563403|P9|COMPLETED|Overall Study||0
5106886|NCT01581684|12563404|P8|COMPLETED|Overall Study||6
5106887|NCT01581684|12563405|P7|COMPLETED|Overall Study||6
5106888|NCT01581684|12563406|P6|COMPLETED|Overall Study||6
5106889|NCT01581684|12563407|P5|COMPLETED|Overall Study||6
5106890|NCT01581684|12563408|P4|COMPLETED|Overall Study||6
5106891|NCT01581684|12563409|P3|COMPLETED|Overall Study||6
5106892|NCT01581684|12563410|P2|COMPLETED|Overall Study||6
5106893|NCT01581684|12563411|P1|COMPLETED|Overall Study||14
5106894|NCT01581684|12563402|P10|STARTED|Overall Study||5
5106895|NCT01581684|12563403|P9|STARTED|Overall Study||1
5106896|NCT01581684|12563404|P8|STARTED|Overall Study||6
5106897|NCT01581684|12563405|P7|STARTED|Overall Study||6
5106898|NCT01581684|12563406|P6|STARTED|Overall Study||6
5106899|NCT01581684|12563407|P5|STARTED|Overall Study||6
5106900|NCT01581684|12563408|P4|STARTED|Overall Study||6
5106901|NCT01581684|12563409|P3|STARTED|Overall Study||6
5106902|NCT01581684|12563410|P2|STARTED|Overall Study||6
5106903|NCT01581684|12563411|P1|STARTED|Overall Study||14
5106904|NCT01581658|12563486|P4|NOT COMPLETED|Overall Study||0
5106905|NCT01581658|12563487|P3|NOT COMPLETED|Overall Study||0
5106906|NCT01581658|12563488|P2|NOT COMPLETED|Overall Study||0
5106907|NCT01581658|12563489|P1|NOT COMPLETED|Overall Study||0
5106908|NCT01581658|12563486|P4|COMPLETED|Overall Study||8
5106909|NCT01581658|12563487|P3|COMPLETED|Overall Study||8
5106910|NCT01581658|12563488|P2|COMPLETED|Overall Study||8
5106911|NCT01581658|12563489|P1|COMPLETED|Overall Study||8
5106912|NCT01581658|12563486|P4|STARTED|Overall Study||8
5106913|NCT01581658|12563487|P3|STARTED|Overall Study||8
5106914|NCT01581658|12563488|P2|STARTED|Overall Study||8
5106915|NCT01581658|12563489|P1|STARTED|Overall Study||8
5106916|NCT01581619|12563507|P1|NOT COMPLETED|Overall Study||2
5106917|NCT01581619|12563507|P1|COMPLETED|Overall Study||52
5106918|NCT01581619|12563507|P1|STARTED|Overall Study||54
5106919|NCT01581541|12563515|P11|NOT COMPLETED|Overall Study||0
5106920|NCT01581541|12563516|P10|NOT COMPLETED|Overall Study||0
5106921|NCT01581541|12563517|P9|NOT COMPLETED|Overall Study||0
5106922|NCT01581541|12563518|P8|NOT COMPLETED|Overall Study||0
5106923|NCT01581541|12563519|P7|NOT COMPLETED|Overall Study||0
5106924|NCT01581541|12563520|P6|NOT COMPLETED|Overall Study||0
5106925|NCT01581541|12563521|P5|NOT COMPLETED|Overall Study||0
5106926|NCT01581541|12563522|P4|NOT COMPLETED|Overall Study||0
5106927|NCT01581541|12563523|P3|NOT COMPLETED|Overall Study||0
5106928|NCT01581541|12563524|P2|NOT COMPLETED|Overall Study||0
5106929|NCT01581541|12563525|P1|NOT COMPLETED|Overall Study||0
5106930|NCT01581541|12563515|P11|COMPLETED|Overall Study||1
5106931|NCT01581541|12563516|P10|COMPLETED|Overall Study||3
5106932|NCT01581541|12563517|P9|COMPLETED|Overall Study||1
5106933|NCT01581541|12563518|P8|COMPLETED|Overall Study||2
5106934|NCT01581541|12563519|P7|COMPLETED|Overall Study||1
5106935|NCT01581541|12563520|P6|COMPLETED|Overall Study||3
5106936|NCT01581541|12563521|P5|COMPLETED|Overall Study||2
5106937|NCT01581541|12563522|P4|COMPLETED|Overall Study||1
5106938|NCT01581541|12563523|P3|COMPLETED|Overall Study||1
5106939|NCT01581541|12563524|P2|COMPLETED|Overall Study||1
5106940|NCT01581541|12563525|P1|COMPLETED|Overall Study||1
5106941|NCT01581541|12563515|P11|STARTED|Overall Study||1
5106942|NCT01581541|12563516|P10|STARTED|Overall Study||3
5106943|NCT01581541|12563517|P9|STARTED|Overall Study||1
5106944|NCT01581541|12563518|P8|STARTED|Overall Study||2
5106945|NCT01581541|12563519|P7|STARTED|Overall Study||1
5106946|NCT01581541|12563520|P6|STARTED|Overall Study||3
5106947|NCT01581541|12563521|P5|STARTED|Overall Study||2
5106948|NCT01581541|12563522|P4|STARTED|Overall Study||1
5106949|NCT01581541|12563523|P3|STARTED|Overall Study||1
5106950|NCT01581541|12563524|P2|STARTED|Overall Study||1
5106951|NCT01581541|12563525|P1|STARTED|Overall Study||1
5106952|NCT01581437|12563649|P1|NOT COMPLETED|Overall Study||0
5106953|NCT01581437|12563649|P1|COMPLETED|Overall Study||78
5106954|NCT01581437|12563649|P1|STARTED|Overall Study||78
5106955|NCT01581307|12563660|P1|NOT COMPLETED|Overall Study||1
5106956|NCT01581307|12563660|P1|COMPLETED|Overall Study||8
5106957|NCT01581307|12563660|P1|STARTED|Overall Study||9
5106958|NCT01581281|12563669|P3|NOT COMPLETED|Overall Study||12
5106959|NCT01581281|12563670|P2|NOT COMPLETED|Overall Study||6
5106960|NCT01581281|12563671|P1|NOT COMPLETED|Overall Study||15
5106961|NCT01581281|12563669|P3|COMPLETED|Overall Study||132
5106962|NCT01581281|12563670|P2|COMPLETED|Overall Study||66
5106963|NCT01581281|12563671|P1|COMPLETED|Overall Study||130
5106964|NCT01581281|12563669|P3|STARTED|Overall Study||144
5106965|NCT01581281|12563670|P2|STARTED|Overall Study||72
5106966|NCT01581281|12563671|P1|STARTED|Overall Study||145
5106967|NCT01581021|12563693|P2|NOT COMPLETED|Overall Study||11
5106968|NCT01581021|12563694|P1|NOT COMPLETED|Overall Study||10
5106969|NCT01581021|12563693|P2|COMPLETED|Overall Study||18
5106970|NCT01581021|12563694|P1|COMPLETED|Overall Study||19
5106971|NCT01581021|12563693|P2|STARTED|Overall Study||29
5106972|NCT01581021|12563694|P1|STARTED|Overall Study||29
5106973|NCT01581008|12563708|P2|NOT COMPLETED|Overall Study||6
5106974|NCT01581008|12563709|P1|NOT COMPLETED|Overall Study||1
5106975|NCT01581008|12563708|P2|COMPLETED|Overall Study||7
5106976|NCT01581008|12563709|P1|COMPLETED|Overall Study||16
5106977|NCT01581008|12563708|P2|STARTED|Overall Study||13
5106978|NCT01581008|12563709|P1|STARTED|Overall Study||17
5106979|NCT01580995|12563721|P2|NOT COMPLETED|Overall Study||2
5106980|NCT01580995|12563722|P1|NOT COMPLETED|Overall Study||2
5106981|NCT01580995|12563721|P2|COMPLETED|Overall Study||7
5106982|NCT01580995|12563722|P1|COMPLETED|Overall Study||8
5106983|NCT01580995|12563721|P2|STARTED|Overall Study||9
5106984|NCT01580995|12563722|P1|STARTED|Overall Study||10
5106985|NCT01580969|12563731|P3|NOT COMPLETED|Overall Study||0
5106986|NCT01580969|12563732|P2|NOT COMPLETED|Overall Study||0
5106987|NCT01580969|12563733|P1|NOT COMPLETED|Overall Study||3
5106988|NCT01580969|12563731|P3|COMPLETED|Overall Study||13
5106989|NCT01580969|12563732|P2|COMPLETED|Overall Study||3
5106990|NCT01580969|12563733|P1|COMPLETED|Overall Study||3
5106991|NCT01580969|12563731|P3|STARTED|Overall Study||13
5106992|NCT01580969|12563732|P2|STARTED|Overall Study||3
5106993|NCT01580969|12563733|P1|STARTED|Overall Study||6
5106994|NCT01580904|12563767|P2|NOT COMPLETED|Overall Study||7
5106995|NCT01580904|12563768|P1|NOT COMPLETED|Overall Study||4
5106996|NCT01580904|12563767|P2|COMPLETED|Overall Study||42
5106997|NCT01580904|12563768|P1|COMPLETED|Overall Study||47
5106998|NCT01580904|12563767|P2|STARTED|Overall Study||49
5106999|NCT01580904|12563768|P1|STARTED|Overall Study||51
5107000|NCT01580670|12563780|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
5107001|NCT01580670|12563780|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
5107002|NCT01580670|12563780|P1|STARTED|Maintenance Period (Week 14 to 54)||14
5107003|NCT01580670|12563780|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
5107004|NCT01580670|12563780|P1|COMPLETED|Induction Period (Week 0 to 14)||14
5107005|NCT01580670|12563780|P1|STARTED|Induction Period (Week 0 to 14)||14
5107006|NCT01580618|12563791|P2|NOT COMPLETED|Overall Study||0
5107007|NCT01580618|12563792|P1|NOT COMPLETED|Overall Study||1
5107008|NCT01580618|12563791|P2|COMPLETED|Overall Study||12
5107009|NCT01580618|12563792|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
5107010|NCT01580618|12563791|P2|STARTED|Overall Study||12
5107011|NCT01580618|12563792|P1|STARTED|Overall Study||8
5107012|NCT01580592|12563808|P3|NOT COMPLETED|Overall Study||0
5107013|NCT01580592|12563809|P2|NOT COMPLETED|Overall Study||0
5107014|NCT01580592|12563810|P1|NOT COMPLETED|Overall Study||0
5107015|NCT01580592|12563808|P3|COMPLETED|Overall Study||12
5107016|NCT01580592|12563809|P2|COMPLETED|Overall Study||9
5107017|NCT01580592|12563810|P1|COMPLETED|Overall Study||10
5107018|NCT01580592|12563808|P3|STARTED|Overall Study||12
5107019|NCT01580592|12563809|P2|STARTED|Overall Study||9
5107020|NCT01580592|12563810|P1|STARTED|Overall Study||10
5107021|NCT01580488|12563821|P1|NOT COMPLETED|Overall Study||1
5107022|NCT01580488|12563821|P1|COMPLETED|Overall Study||23
5107023|NCT01580488|12563821|P1|STARTED|Overall Study||24
5107024|NCT01580423|12563865|P2|NOT COMPLETED|Second Intervention||0
5107025|NCT01580423|12563866|P1|NOT COMPLETED|Second Intervention||0
5107026|NCT01580423|12563865|P2|COMPLETED|Second Intervention||8
5107027|NCT01580423|12563866|P1|COMPLETED|Second Intervention||8
5107028|NCT01580423|12563865|P2|STARTED|Second Intervention||8
5107029|NCT01580423|12563866|P1|STARTED|Second Intervention||8
5107030|NCT01580423|12563865|P2|NOT COMPLETED|First Intervention||0
5107031|NCT01580423|12563866|P1|NOT COMPLETED|First Intervention||0
5107032|NCT01580423|12563865|P2|COMPLETED|First Intervention||8
5107033|NCT01580423|12563866|P1|COMPLETED|First Intervention||8
5107034|NCT01580423|12563865|P2|STARTED|First Intervention||8
5107035|NCT01580423|12563866|P1|STARTED|First Intervention||8
5107036|NCT01580410|12563878|P2|NOT COMPLETED|Overall Study||8
5107037|NCT01580410|12563879|P1|NOT COMPLETED|Overall Study||11
5107038|NCT01580410|12563878|P2|COMPLETED|Overall Study||60
5107039|NCT01580410|12563879|P1|COMPLETED|Overall Study||57
5107040|NCT01580410|12563878|P2|STARTED|Overall Study||68
5107041|NCT01580410|12563879|P1|STARTED|Overall Study||68
5107042|NCT01580306|12563895|P4|NOT COMPLETED|Overall Study||0
5107043|NCT01580306|12563896|P3|NOT COMPLETED|Overall Study||0
5107044|NCT01580306|12563897|P2|NOT COMPLETED|Overall Study||0
5107045|NCT01580306|12563898|P1|NOT COMPLETED|Overall Study||0
5107046|NCT01580306|12563895|P4|COMPLETED|Overall Study||8
5107047|NCT01580306|12563896|P3|COMPLETED|Overall Study||8
5107048|NCT01580306|12563897|P2|COMPLETED|Overall Study||8
5107049|NCT01580306|12563898|P1|COMPLETED|Overall Study||8
5107050|NCT01580306|12563895|P4|STARTED|Overall Study||8
5107051|NCT01580306|12563896|P3|STARTED|Overall Study||8
5107052|NCT01580306|12563897|P2|STARTED|Overall Study||8
5107053|NCT01580306|12563898|P1|STARTED|Overall Study||8
5107054|NCT01580293|12563927|P3|NOT COMPLETED|Part B||3
5107055|NCT01580293|12563928|P2|NOT COMPLETED|Part B||0
5107056|NCT01580293|12563929|P1|NOT COMPLETED|Part B||0
5107057|NCT01580293|12563927|P3|COMPLETED|Part B||16
5107058|NCT01580293|12563928|P2|COMPLETED|Part B||0
5107059|NCT01580293|12563929|P1|COMPLETED|Part B||0
5107060|NCT01580293|12563927|P3|Part B Ongoing|Part B||1
5107061|NCT01580293|12563928|P2|Part B Ongoing|Part B||0
5107062|NCT01580293|12563929|P1|Part B Ongoing|Part B||0
5107063|NCT01580293|12563927|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
5107064|NCT01580293|12563928|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
5107065|NCT01580293|12563929|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
5107066|NCT01580293|12563927|P3|NOT COMPLETED|Part A_Extension||0
5107067|NCT01580293|12563928|P2|NOT COMPLETED|Part A_Extension||75
5107068|NCT01580293|12563929|P1|NOT COMPLETED|Part A_Extension||9
5107069|NCT01580293|12563927|P3|COMPLETED|Part A_Extension||0
5107070|NCT01580293|12563928|P2|COMPLETED|Part A_Extension||32
5107071|NCT01580293|12563929|P1|COMPLETED|Part A_Extension||5
5107072|NCT01580293|12563927|P3|Extension Ongoing|Part A_Extension||0
5107073|NCT01580293|12563928|P2|Extension Ongoing|Part A_Extension||69
5107074|NCT01580293|12563929|P1|Extension Ongoing|Part A_Extension||9
5107075|NCT01580293|12563927|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
5107076|NCT01580293|12563928|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
5107077|NCT01580293|12563929|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
5107078|NCT01580293|12563927|P3|NOT COMPLETED|Part A_Main Trial||0
5107079|NCT01580293|12563928|P2|NOT COMPLETED|Part A_Main Trial||6
5107080|NCT01580293|12563929|P1|NOT COMPLETED|Part A_Main Trial||2
5107081|NCT01580293|12563927|P3|COMPLETED|Part A_Main Trial||0
5107082|NCT01580293|12563928|P2|COMPLETED|Part A_Main Trial||108
5107083|NCT01580293|12563929|P1|COMPLETED|Part A_Main Trial||18
5107084|NCT01580293|12563927|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
5107085|NCT01580293|12563928|P2|STARTED|Part A_Main Trial||114
5107086|NCT01580293|12563929|P1|STARTED|Part A_Main Trial||20
5107087|NCT01580098|12564014|P3|NOT COMPLETED|Overall Study||3
5107088|NCT01580098|12564015|P2|NOT COMPLETED|Overall Study||13
5107089|NCT01580098|12564016|P1|NOT COMPLETED|Overall Study||15
5107090|NCT01580098|12564014|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
5107091|NCT01580098|12564015|P2|COMPLETED|Overall Study||101
5107092|NCT01580098|12564016|P1|COMPLETED|Overall Study||61
5107093|NCT01580098|12564014|P3|STARTED|Overall Study||3
5107094|NCT01580098|12564015|P2|STARTED|Overall Study||114
5107095|NCT01580098|12564016|P1|STARTED|Overall Study||76
5107096|NCT01580072|12564039|P3|NOT COMPLETED|Overall Study||0
5107097|NCT01580072|12564040|P2|NOT COMPLETED|Overall Study||9
5107098|NCT01580072|12564041|P1|NOT COMPLETED|Overall Study||12
5107099|NCT01580072|12564039|P3|COMPLETED|Overall Study||0
5107100|NCT01580072|12564040|P2|COMPLETED|Overall Study||28
5107101|NCT01580072|12564041|P1|COMPLETED|Overall Study||16
5107102|NCT01580072|12564039|P3|STARTED|Overall Study||0
5107103|NCT01580072|12564040|P2|STARTED|Overall Study||37
5107104|NCT01580072|12564041|P1|STARTED|Overall Study||28
5107105|NCT01580020|12564069|P4|NOT COMPLETED|Overall Study||2
5107106|NCT01580020|12564070|P3|NOT COMPLETED|Overall Study||4
5107107|NCT01580020|12564071|P2|NOT COMPLETED|Overall Study||7
5107108|NCT01580020|12564072|P1|NOT COMPLETED|Overall Study||1
5107109|NCT01580020|12564069|P4|COMPLETED|Overall Study||20
5107110|NCT01580020|12564070|P3|COMPLETED|Overall Study||57
5107111|NCT01580020|12564071|P2|COMPLETED|Overall Study||33
5107112|NCT01580020|12564072|P1|COMPLETED|Overall Study||51
5107113|NCT01580020|12564069|P4|STARTED|Overall Study||22
5107114|NCT01580020|12564070|P3|STARTED|Overall Study||61
5107115|NCT01580020|12564071|P2|STARTED|Overall Study||40
5107116|NCT01580020|12564072|P1|STARTED|Overall Study||52
5107117|NCT01579916|12564116|P2|NOT COMPLETED|Overall Study||2
5107118|NCT01579916|12564117|P1|NOT COMPLETED|Overall Study||8
5107119|NCT01579916|12564116|P2|COMPLETED|Overall Study||59
5107120|NCT01579916|12564117|P1|COMPLETED|Overall Study||234
5107121|NCT01579916|12564116|P2|STARTED|Overall Study||61
5107122|NCT01579916|12564117|P1|STARTED|Overall Study||242
5107123|NCT01579812|12564143|P1|NOT COMPLETED|Overall Study||52
5107124|NCT01579812|12564143|P1|COMPLETED|Overall Study||38
5107125|NCT01579812|12564143|P1|STARTED|Overall Study||90
5107126|NCT01579747|12564153|P2|NOT COMPLETED|Overall Study||0
5107127|NCT01579747|12564154|P1|NOT COMPLETED|Overall Study||0
5107128|NCT01579747|12564153|P2|COMPLETED|Overall Study||12
5107129|NCT01579747|12564154|P1|COMPLETED|Overall Study||12
5107130|NCT01579747|12564153|P2|STARTED|Overall Study||12
5107131|NCT01579747|12564154|P1|STARTED|Overall Study||12
5107132|NCT01579669|12564164|P2|NOT COMPLETED|Overall Study||0
5107133|NCT01579669|12564165|P1|NOT COMPLETED|Overall Study||36
5107134|NCT01579669|12564164|P2|COMPLETED|Overall Study||41
5107135|NCT01579669|12564165|P1|COMPLETED|Overall Study||134
5107136|NCT01579669|12564164|P2|STARTED|Overall Study||41
5107137|NCT01579669|12564165|P1|STARTED|Overall Study||170
5107138|NCT01579578|12564177|P2|NOT COMPLETED|Overall Study||12
5107139|NCT01579578|12564178|P1|NOT COMPLETED|Overall Study||13
5107140|NCT01579578|12564177|P2|COMPLETED|Overall Study||0
5107141|NCT01579578|12564178|P1|COMPLETED|Overall Study||0
5107142|NCT01579578|12564177|P2|Ongoing|Overall Study||0
5107143|NCT01579578|12564178|P1|Ongoing|Overall Study||3
5107144|NCT01579578|12564177|P2|STARTED|Overall Study||12
5107145|NCT01579578|12564178|P1|STARTED|Overall Study||13
5107146|NCT01579565|12564190|P2|NOT COMPLETED|Treated||3
5107147|NCT01579565|12564191|P1|NOT COMPLETED|Treated||2
5107148|NCT01579565|12564190|P2|COMPLETED|Treated||201
5107149|NCT01579565|12564191|P1|COMPLETED|Treated||200
5107150|NCT01579565|12564190|P2|STARTED|Treated||204
5107151|NCT01579565|12564191|P1|STARTED|Treated||202
5107152|NCT01579565|12564190|P2|NOT COMPLETED|Randomized||5
5107153|NCT01579565|12564191|P1|NOT COMPLETED|Randomized||5
5107154|NCT01579565|12564190|P2|COMPLETED|Randomized||204
5107155|NCT01579565|12564191|P1|COMPLETED|Randomized||202
5107156|NCT01579565|12564190|P2|STARTED|Randomized||209
5107157|NCT01579565|12564191|P1|STARTED|Randomized||207
5107158|NCT01579513|12564221|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
5107159|NCT01579513|12564222|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
5107160|NCT01579513|12564221|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
5107161|NCT01579513|12564222|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
5107162|NCT01579513|12564221|P2|STARTED|1 Year Neurodevelopmental Follow up||95
5107163|NCT01579513|12564222|P1|STARTED|1 Year Neurodevelopmental Follow up||81
5107164|NCT01579513|12564221|P2|NOT COMPLETED|Primary Hospitalization||4
5107165|NCT01579513|12564222|P1|NOT COMPLETED|Primary Hospitalization||10
5107166|NCT01579513|12564221|P2|COMPLETED|Primary Hospitalization||95
5107167|NCT01579513|12564222|P1|COMPLETED|Primary Hospitalization||81
5107168|NCT01579513|12564221|P2|STARTED|Primary Hospitalization||99
5107169|NCT01579513|12564222|P1|STARTED|Primary Hospitalization||91
5107170|NCT01579474|12564242|P6|NOT COMPLETED|Overall Study||1
5107171|NCT01579474|12564243|P5|NOT COMPLETED|Overall Study||1
5107172|NCT01579474|12564244|P4|NOT COMPLETED|Overall Study||0
5107173|NCT01579474|12564245|P3|NOT COMPLETED|Overall Study||2
5107174|NCT01579474|12564246|P2|NOT COMPLETED|Overall Study||13
5107175|NCT01579474|12564247|P1|NOT COMPLETED|Overall Study||3
5107176|NCT01579474|12564242|P6|COMPLETED|Overall Study||1
5107177|NCT01579474|12564243|P5|COMPLETED|Overall Study||9
5107178|NCT01579474|12564244|P4|COMPLETED|Overall Study||3
5107179|NCT01579474|12564245|P3|COMPLETED|Overall Study||27
5107180|NCT01579474|12564246|P2|COMPLETED|Overall Study||30
5107181|NCT01579474|12564247|P1|COMPLETED|Overall Study||41
5107182|NCT01579474|12564242|P6|STARTED|Overall Study||2
5107183|NCT01579474|12564243|P5|STARTED|Overall Study||10
5107184|NCT01579474|12564244|P4|STARTED|Overall Study||3
5107185|NCT01579474|12564245|P3|STARTED|Overall Study||29
5107186|NCT01579474|12564246|P2|STARTED|Overall Study||43
5107187|NCT01579474|12564247|P1|STARTED|Overall Study||44
5107188|NCT01579318|12564321|P1|NOT COMPLETED|Overall Study||1
5107189|NCT01579318|12564321|P1|COMPLETED|Overall Study||1
5107190|NCT01579318|12564321|P1|STARTED|Overall Study||2
5107191|NCT01579305|12564334|P2|NOT COMPLETED|Overall Study||27
5107192|NCT01579305|12564335|P1|NOT COMPLETED|Overall Study||21
5107193|NCT01579305|12564334|P2|COMPLETED|Overall Study||115
5107194|NCT01579305|12564335|P1|COMPLETED|Overall Study||118
5107195|NCT01579305|12564334|P2|Continued After Treatment|Overall Study||141
5107196|NCT01579305|12564335|P1|Continued After Treatment|Overall Study||139
5107197|NCT01579305|12564334|P2|Discontinued Before Treatment|Overall Study||1
5107198|NCT01579305|12564335|P1|Discontinued Before Treatment|Overall Study||0
5107199|NCT01579305|12564334|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
5107200|NCT01579305|12564335|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
5107201|NCT01579214|12564343|P2|NOT COMPLETED|Overall Study||0
5107202|NCT01579214|12564344|P1|NOT COMPLETED|Overall Study||0
5107203|NCT01579214|12564343|P2|COMPLETED|Overall Study||138
5107204|NCT01579214|12564344|P1|COMPLETED|Overall Study||45
5107205|NCT01579214|12564343|P2|STARTED|Overall Study||138
5107206|NCT01579214|12564344|P1|STARTED|Overall Study||45
5107207|NCT01579084|12564362|P10|NOT COMPLETED|Overall Study||0
5107208|NCT01579084|12564363|P9|NOT COMPLETED|Overall Study||0
5107209|NCT01579084|12564364|P8|NOT COMPLETED|Overall Study||0
5107210|NCT01579084|12564365|P7|NOT COMPLETED|Overall Study||0
5107211|NCT01579084|12564366|P6|NOT COMPLETED|Overall Study||0
5107212|NCT01579084|12564367|P5|NOT COMPLETED|Overall Study||0
5107213|NCT01579084|12564368|P4|NOT COMPLETED|Overall Study||0
5107214|NCT01579084|12564369|P3|NOT COMPLETED|Overall Study||0
5107215|NCT01579084|12564370|P2|NOT COMPLETED|Overall Study||0
5107216|NCT01579084|12564371|P1|NOT COMPLETED|Overall Study||0
5107217|NCT01579084|12564362|P10|COMPLETED|Overall Study||4
5107218|NCT01579084|12564363|P9|COMPLETED|Overall Study||4
5107219|NCT01579084|12564364|P8|COMPLETED|Overall Study||4
5107220|NCT01579084|12564365|P7|COMPLETED|Overall Study||4
5107221|NCT01579084|12564366|P6|COMPLETED|Overall Study||8
5107222|NCT01579084|12564367|P5|COMPLETED|Overall Study||8
5107223|NCT01579084|12564368|P4|COMPLETED|Overall Study||8
5107224|NCT01579084|12564369|P3|COMPLETED|Overall Study||8
5107225|NCT01579084|12564370|P2|COMPLETED|Overall Study||8
5107226|NCT01579084|12564371|P1|COMPLETED|Overall Study||8
5107227|NCT01579084|12564362|P10|STARTED|Overall Study||4
5107228|NCT01579084|12564363|P9|STARTED|Overall Study||4
5107229|NCT01579084|12564364|P8|STARTED|Overall Study||4
5107230|NCT01579084|12564365|P7|STARTED|Overall Study||4
5107231|NCT01579084|12564366|P6|STARTED|Overall Study||8
5107232|NCT01579084|12564367|P5|STARTED|Overall Study||8
5107233|NCT01579084|12564368|P4|STARTED|Overall Study||8
5107234|NCT01579084|12564369|P3|STARTED|Overall Study||8
5107235|NCT01579084|12564370|P2|STARTED|Overall Study||8
5107236|NCT01579084|12564371|P1|STARTED|Overall Study||8
5107237|NCT01579045|12564399|P1|NOT COMPLETED|Overall Study||0
5107238|NCT01579045|12564399|P1|COMPLETED|Overall Study||24
5107239|NCT01579045|12564399|P1|STARTED|Overall Study||24
5107240|NCT01579006|12564416|P1|NOT COMPLETED|Overall Study||33
5107241|NCT01579006|12564416|P1|COMPLETED|Overall Study||151
5107242|NCT01579006|12564416|P1|STARTED|Overall Study||184
5107243|NCT01578993|12564455|P1|NOT COMPLETED|Overall Study||0
5107244|NCT01578993|12564455|P1|COMPLETED|Overall Study||101
5107245|NCT01578993|12564455|P1|STARTED|Overall Study||101
5107246|NCT01578980|12564459|P1|NOT COMPLETED|Overall Study||0
5107247|NCT01578980|12564459|P1|COMPLETED|Overall Study||20
5107248|NCT01578980|12564459|P1|STARTED|Overall Study||20
5107249|NCT01578967|12564464|P1|NOT COMPLETED|Overall Study||0
5107250|NCT01578967|12564464|P1|COMPLETED|Overall Study||41
5107251|NCT01578967|12564464|P1|STARTED|Overall Study||41
5107252|NCT01578850|12564475|P3|NOT COMPLETED|Period 2||14
5107253|NCT01578850|12564476|P2|NOT COMPLETED|Period 2||13
5107254|NCT01578850|12564477|P1|NOT COMPLETED|Period 2||0
5107255|NCT01578850|12564475|P3|COMPLETED|Period 2||162
5107256|NCT01578850|12564476|P2|COMPLETED|Period 2||154
5107257|NCT01578850|12564477|P1|COMPLETED|Period 2||0
5107258|NCT01578850|12564475|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
5107259|NCT01578850|12564476|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
5107260|NCT01578850|12564477|P1|STARTED|Period 2||0
5107261|NCT01578850|12564475|P3|NOT COMPLETED|Period 1||0
5107262|NCT01578850|12564476|P2|NOT COMPLETED|Period 1||0
5107263|NCT01578850|12564477|P1|NOT COMPLETED|Period 1||37
5107264|NCT01578850|12564475|P3|COMPLETED|Period 1||0
5107265|NCT01578850|12564476|P2|COMPLETED|Period 1||0
5107266|NCT01578850|12564477|P1|COMPLETED|Period 1||452
5107267|NCT01578850|12564475|P3|STARTED|Period 1||0
5107268|NCT01578850|12564476|P2|STARTED|Period 1||0
5107269|NCT01578850|12564477|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
5107270|NCT01578785|12564529|P2|NOT COMPLETED|Overall Study||119
5107271|NCT01578785|12564530|P1|NOT COMPLETED|Overall Study||59
5107272|NCT01578785|12564529|P2|COMPLETED|Overall Study||0
5107273|NCT01578785|12564530|P1|COMPLETED|Overall Study||0
5107274|NCT01578785|12564529|P2|STARTED|Overall Study||119
5107275|NCT01578785|12564530|P1|STARTED|Overall Study||59
5107276|NCT01578772|12564542|P1|NOT COMPLETED|Overall Study||0
5107277|NCT01578772|12564542|P1|COMPLETED|Overall Study||17
5107278|NCT01578772|12564542|P1|STARTED|Overall Study||17
5107279|NCT01578707|12564551|P2|NOT COMPLETED|Overall Study||0
5107280|NCT01578707|12564552|P1|NOT COMPLETED|Overall Study||0
5107281|NCT01578707|12564551|P2|COMPLETED|Overall Study||195
5107282|NCT01578707|12564552|P1|COMPLETED|Overall Study||196
5107283|NCT01578707|12564551|P2|STARTED|Overall Study||195
5107284|NCT01578707|12564552|P1|STARTED|Overall Study||196
5107285|NCT01578577|12564571|P3|NOT COMPLETED|Overall Study||35
5107286|NCT01578577|12564572|P2|NOT COMPLETED|Overall Study||40
5107287|NCT01578577|12564573|P1|NOT COMPLETED|Overall Study||51
5107288|NCT01578577|12564571|P3|COMPLETED|Overall Study||278
5107289|NCT01578577|12564572|P2|COMPLETED|Overall Study||262
5107290|NCT01578577|12564573|P1|COMPLETED|Overall Study||254
5107291|NCT01578577|12564571|P3|STARTED|Overall Study||313
5107292|NCT01578577|12564572|P2|STARTED|Overall Study||302
5107293|NCT01578577|12564573|P1|STARTED|Overall Study||305
5107294|NCT01578551|12564595|P2|NOT COMPLETED|Overall Study||0
5107295|NCT01578551|12564596|P1|NOT COMPLETED|Overall Study||1
5107296|NCT01578551|12564595|P2|COMPLETED|Overall Study||6
5107297|NCT01578551|12564596|P1|COMPLETED|Overall Study||18
5107298|NCT01578551|12564595|P2|STARTED|Overall Study||6
5107299|NCT01578551|12564596|P1|STARTED|Overall Study||19
5107300|NCT01578499|12564608|P2|NOT COMPLETED|Overall Study||43
5107301|NCT01578499|12564609|P1|NOT COMPLETED|Overall Study||34
5107302|NCT01578499|12564608|P2|COMPLETED|Overall Study||22
5107303|NCT01578499|12564609|P1|COMPLETED|Overall Study||32
5107304|NCT01578499|12564608|P2|Intent to Treat Population: CD30+|Overall Study||64
5107305|NCT01578499|12564609|P1|Intent to Treat Population: CD30+|Overall Study||64
5107306|NCT01578499|12564608|P2|Safety Population: Treated|Overall Study||62
5107307|NCT01578499|12564609|P1|Safety Population: Treated|Overall Study||66
5107308|NCT01578499|12564608|P2|STARTED|Overall Study||65
5107309|NCT01578499|12564609|P1|STARTED|Overall Study||66
5107310|NCT01578486|12564643|P1|NOT COMPLETED|Overall Study||5
5107311|NCT01578486|12564643|P1|COMPLETED|Overall Study||8
5107312|NCT01578486|12564643|P1|STARTED|Overall Study||13
5107313|NCT01578330|12564654|P1|NOT COMPLETED|Overall Study||7
5107314|NCT01578330|12564654|P1|COMPLETED|Overall Study||35
5107315|NCT01578330|12564654|P1|Per Protocol Population|Overall Study||35
5107316|NCT01578330|12564654|P1|STARTED|Overall Study||42
5107317|NCT01578317|12564663|P2|NOT COMPLETED|Overall Study||1
5107318|NCT01578317|12564664|P1|NOT COMPLETED|Overall Study||0
5107319|NCT01578317|12564663|P2|COMPLETED|Overall Study||20
5107320|NCT01578317|12564664|P1|COMPLETED|Overall Study||22
5107321|NCT01578317|12564663|P2|Analysis Population|Overall Study||20
5107322|NCT01578317|12564664|P1|Analysis Population|Overall Study||22
5107323|NCT01578317|12564663|P2|STARTED|Overall Study||21
5107324|NCT01578317|12564664|P1|STARTED|Overall Study||22
5107325|NCT01578239|12564672|P2|NOT COMPLETED|Overall Study||25
5107326|NCT01578239|12564673|P1|NOT COMPLETED|Overall Study||22
5107327|NCT01578239|12564672|P2|COMPLETED|Overall Study||88
5107328|NCT01578239|12564673|P1|COMPLETED|Overall Study||94
5107329|NCT01578239|12564672|P2|STARTED|Overall Study||113
5107330|NCT01578239|12564673|P1|STARTED|Overall Study||116
5107331|NCT01578187|12564679|P1|NOT COMPLETED|Usability Phase||1
5107332|NCT01578187|12564679|P1|COMPLETED|Usability Phase||47
5107333|NCT01578187|12564679|P1|STARTED|Usability Phase||48
5107334|NCT01578187|12564679|P1|NOT COMPLETED|Label Comprehension Phase||0
5107335|NCT01578187|12564679|P1|COMPLETED|Label Comprehension Phase||63
5107336|NCT01578187|12564679|P1|STARTED|Label Comprehension Phase||63
5107337|NCT01578044|12564687|P2|NOT COMPLETED|Overall Study||0
5107338|NCT01578044|12564688|P1|NOT COMPLETED|Overall Study||0
5107339|NCT01578044|12564687|P2|COMPLETED|Overall Study||6
5107340|NCT01578044|12564688|P1|COMPLETED|Overall Study||6
5107341|NCT01578044|12564687|P2|STARTED|Overall Study||6
5107342|NCT01578044|12564688|P1|STARTED|Overall Study||6
5107343|NCT01578031|12564698|P4|NOT COMPLETED|Overall Study||0
5107344|NCT01578031|12564699|P3|NOT COMPLETED|Overall Study||0
5107345|NCT01578031|12564700|P2|NOT COMPLETED|Overall Study||34
5107346|NCT01578031|12564701|P1|NOT COMPLETED|Overall Study||62
5107347|NCT01578031|12564698|P4|COMPLETED|Overall Study|Only baseline data collected|30
5107348|NCT01578031|12564699|P3|COMPLETED|Overall Study|Only baseline data collected|12
5107349|NCT01578031|12564700|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
5107350|NCT01578031|12564701|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
5107351|NCT01578031|12564698|P4|STARTED|Overall Study||30
5107352|NCT01578031|12564699|P3|STARTED|Overall Study||12
5107353|NCT01578031|12564700|P2|STARTED|Overall Study||69
5107354|NCT01578031|12564701|P1|STARTED|Overall Study||129
5107355|NCT01577966|12564717|P1|NOT COMPLETED|Overall Study||0
5107356|NCT01577966|12564717|P1|COMPLETED|Overall Study||9
5107357|NCT01577966|12564717|P1|STARTED|Overall Study||9
5107358|NCT01577758|12564721|P8|NOT COMPLETED|mCRC Expansion Phase||25
5107359|NCT01577758|12564722|P7|NOT COMPLETED|mCRC Expansion Phase||0
5107360|NCT01577758|12564723|P6|NOT COMPLETED|mCRC Expansion Phase||0
5107361|NCT01577758|12564724|P5|NOT COMPLETED|mCRC Expansion Phase||0
5107362|NCT01577758|12564725|P4|NOT COMPLETED|mCRC Expansion Phase||0
5107363|NCT01577758|12564726|P3|NOT COMPLETED|mCRC Expansion Phase||0
5107364|NCT01577758|12564727|P2|NOT COMPLETED|mCRC Expansion Phase||0
5107365|NCT01577758|12564728|P1|NOT COMPLETED|mCRC Expansion Phase||0
5107366|NCT01577758|12564721|P8|COMPLETED|mCRC Expansion Phase||0
5107367|NCT01577758|12564722|P7|COMPLETED|mCRC Expansion Phase||0
5107368|NCT01577758|12564723|P6|COMPLETED|mCRC Expansion Phase||0
5107369|NCT01577758|12564724|P5|COMPLETED|mCRC Expansion Phase||0
5107370|NCT01577758|12564725|P4|COMPLETED|mCRC Expansion Phase||0
5107371|NCT01577758|12564726|P3|COMPLETED|mCRC Expansion Phase||0
5107372|NCT01577758|12564727|P2|COMPLETED|mCRC Expansion Phase||0
5107373|NCT01577758|12564728|P1|COMPLETED|mCRC Expansion Phase||0
5107374|NCT01577758|12564721|P8|STARTED|mCRC Expansion Phase||25
5107375|NCT01577758|12564722|P7|STARTED|mCRC Expansion Phase||0
5107376|NCT01577758|12564723|P6|STARTED|mCRC Expansion Phase||0
5107377|NCT01577758|12564724|P5|STARTED|mCRC Expansion Phase||0
5107378|NCT01577758|12564725|P4|STARTED|mCRC Expansion Phase||0
5107379|NCT01577758|12564726|P3|STARTED|mCRC Expansion Phase||0
5107380|NCT01577758|12564727|P2|STARTED|mCRC Expansion Phase||0
5107381|NCT01577758|12564728|P1|STARTED|mCRC Expansion Phase||0
5107382|NCT01577758|12564721|P8|NOT COMPLETED|Dose Escalation Phase||0
5107383|NCT01577758|12564722|P7|NOT COMPLETED|Dose Escalation Phase||1
5107384|NCT01577758|12564723|P6|NOT COMPLETED|Dose Escalation Phase||4
5107385|NCT01577758|12564724|P5|NOT COMPLETED|Dose Escalation Phase||6
5107386|NCT01577758|12564725|P4|NOT COMPLETED|Dose Escalation Phase||2
5107387|NCT01577758|12564726|P3|NOT COMPLETED|Dose Escalation Phase||2
5107388|NCT01577758|12564727|P2|NOT COMPLETED|Dose Escalation Phase||2
5107389|NCT01577758|12564728|P1|NOT COMPLETED|Dose Escalation Phase||2
5107390|NCT01577758|12564721|P8|COMPLETED|Dose Escalation Phase||0
5107391|NCT01577758|12564722|P7|COMPLETED|Dose Escalation Phase||0
5107392|NCT01577758|12564723|P6|COMPLETED|Dose Escalation Phase||0
5107393|NCT01577758|12564724|P5|COMPLETED|Dose Escalation Phase||0
5107394|NCT01577758|12564725|P4|COMPLETED|Dose Escalation Phase||0
5107395|NCT01577758|12564726|P3|COMPLETED|Dose Escalation Phase||0
5107396|NCT01577758|12564727|P2|COMPLETED|Dose Escalation Phase||0
5107397|NCT01577758|12564728|P1|COMPLETED|Dose Escalation Phase||0
5107398|NCT01577758|12564721|P8|STARTED|Dose Escalation Phase||0
5107399|NCT01577758|12564722|P7|STARTED|Dose Escalation Phase||1
5107400|NCT01577758|12564723|P6|STARTED|Dose Escalation Phase||4
5107401|NCT01577758|12564724|P5|STARTED|Dose Escalation Phase||6
5107402|NCT01577758|12564725|P4|STARTED|Dose Escalation Phase||2
5107403|NCT01577758|12564726|P3|STARTED|Dose Escalation Phase||2
5107404|NCT01577758|12564727|P2|STARTED|Dose Escalation Phase||2
5107405|NCT01577758|12564728|P1|STARTED|Dose Escalation Phase||2
5107406|NCT01577745|12564767|P6|NOT COMPLETED|Overall Study||4
5107407|NCT01577745|12564768|P5|NOT COMPLETED|Overall Study||5
5107408|NCT01577745|12564769|P4|NOT COMPLETED|Overall Study||6
5107409|NCT01577745|12564770|P3|NOT COMPLETED|Overall Study||2
5107410|NCT01577745|12564771|P2|NOT COMPLETED|Overall Study||3
5107411|NCT01577745|12564772|P1|NOT COMPLETED|Overall Study||3
5107412|NCT01577745|12564767|P6|COMPLETED|Overall Study||1
5107413|NCT01577745|12564768|P5|COMPLETED|Overall Study||0
5107414|NCT01577745|12564769|P4|COMPLETED|Overall Study||0
5107415|NCT01577745|12564770|P3|COMPLETED|Overall Study||1
5107416|NCT01577745|12564771|P2|COMPLETED|Overall Study||0
5107417|NCT01577745|12564772|P1|COMPLETED|Overall Study||0
5107418|NCT01577745|12564767|P6|STARTED|Overall Study||5
5107419|NCT01577745|12564768|P5|STARTED|Overall Study||5
5107420|NCT01577745|12564769|P4|STARTED|Overall Study||6
5107421|NCT01577745|12564770|P3|STARTED|Overall Study||3
5107422|NCT01577745|12564771|P2|STARTED|Overall Study||3
5107423|NCT01577745|12564772|P1|STARTED|Overall Study||3
5107424|NCT01577732|12564889|P1|NOT COMPLETED|Overall Study||0
5107425|NCT01577732|12564889|P1|COMPLETED|Overall Study||300
5107426|NCT01577732|12564889|P1|STARTED|Overall Study||300
5107427|NCT01577706|12564896|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5107428|NCT01577706|12564897|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5107429|NCT01577706|12564898|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5107430|NCT01577706|12564896|P3|COMPLETED|Third Intervention (1 Day)||3
5107431|NCT01577706|12564897|P2|COMPLETED|Third Intervention (1 Day)||1
5107432|NCT01577706|12564898|P1|COMPLETED|Third Intervention (1 Day)||3
5107433|NCT01577706|12564896|P3|STARTED|Third Intervention (1 Day)||3
5107434|NCT01577706|12564897|P2|STARTED|Third Intervention (1 Day)||1
5107435|NCT01577706|12564898|P1|STARTED|Third Intervention (1 Day)||3
5107436|NCT01577706|12564896|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
5107437|NCT01577706|12564897|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
5107438|NCT01577706|12564898|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
5107439|NCT01577706|12564896|P3|COMPLETED|Washout (at Least 1 Week)||3
5107440|NCT01577706|12564897|P2|COMPLETED|Washout (at Least 1 Week)||1
5107441|NCT01577706|12564898|P1|COMPLETED|Washout (at Least 1 Week)||3
5107442|NCT01577706|12564896|P3|STARTED|Washout (at Least 1 Week)||3
5107443|NCT01577706|12564897|P2|STARTED|Washout (at Least 1 Week)||1
5107444|NCT01577706|12564898|P1|STARTED|Washout (at Least 1 Week)||3
5107445|NCT01577706|12564896|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5107446|NCT01577706|12564897|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5107447|NCT01577706|12564898|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5107448|NCT01577706|12564896|P3|COMPLETED|Second Intervention (1 Day)||3
5107449|NCT01577706|12564897|P2|COMPLETED|Second Intervention (1 Day)||1
5107450|NCT01577706|12564898|P1|COMPLETED|Second Intervention (1 Day)||3
5107451|NCT01577706|12564896|P3|STARTED|Second Intervention (1 Day)||3
5107452|NCT01577706|12564897|P2|STARTED|Second Intervention (1 Day)||1
5107453|NCT01577706|12564898|P1|STARTED|Second Intervention (1 Day)||3
5107454|NCT01577706|12564896|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
5107455|NCT01577706|12564897|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
5107456|NCT01577706|12564898|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
5107457|NCT01577706|12564896|P3|COMPLETED|Washout (at Least 1 Week)||3
5107458|NCT01577706|12564897|P2|COMPLETED|Washout (at Least 1 Week)||1
5107459|NCT01577706|12564898|P1|COMPLETED|Washout (at Least 1 Week)||3
5107460|NCT01577706|12564896|P3|STARTED|Washout (at Least 1 Week)||3
5107461|NCT01577706|12564897|P2|STARTED|Washout (at Least 1 Week)||1
5107462|NCT01577706|12564898|P1|STARTED|Washout (at Least 1 Week)||3
5107463|NCT01577706|12564896|P3|NOT COMPLETED|First Intervention (1 Day)||0
5107464|NCT01577706|12564897|P2|NOT COMPLETED|First Intervention (1 Day)||0
5107465|NCT01577706|12564898|P1|NOT COMPLETED|First Intervention (1 Day)||0
5107466|NCT01577706|12564896|P3|COMPLETED|First Intervention (1 Day)||3
5107467|NCT01577706|12564897|P2|COMPLETED|First Intervention (1 Day)||1
5107468|NCT01577706|12564898|P1|COMPLETED|First Intervention (1 Day)||3
5107469|NCT01577706|12564896|P3|STARTED|First Intervention (1 Day)||3
5107470|NCT01577706|12564897|P2|STARTED|First Intervention (1 Day)||1
5107471|NCT01577706|12564898|P1|STARTED|First Intervention (1 Day)||3
5107472|NCT01577628|12564926|P3|NOT COMPLETED|Overall Study||2
5107473|NCT01577628|12564927|P2|NOT COMPLETED|Overall Study||0
5107474|NCT01577628|12564928|P1|NOT COMPLETED|Overall Study||0
5107475|NCT01577628|12564926|P3|COMPLETED|Overall Study||0
5107476|NCT01577628|12564927|P2|COMPLETED|Overall Study||0
5107477|NCT01577628|12564928|P1|COMPLETED|Overall Study||0
5107478|NCT01577628|12564926|P3|STARTED|Overall Study||2
5107479|NCT01577628|12564927|P2|STARTED|Overall Study||0
5107480|NCT01577628|12564928|P1|STARTED|Overall Study||0
5107481|NCT01577537|12564954|P2|NOT COMPLETED|Overall Study||7
5107482|NCT01577537|12564955|P1|NOT COMPLETED|Overall Study||8
5107483|NCT01577537|12564954|P2|COMPLETED|Overall Study||116
5107484|NCT01577537|12564955|P1|COMPLETED|Overall Study||120
5107485|NCT01577537|12564954|P2|STARTED|Overall Study||123
5107486|NCT01577537|12564955|P1|STARTED|Overall Study||128
5107487|NCT01577381|12564973|P4|NOT COMPLETED|Overall Study||2
5107488|NCT01577381|12564974|P3|NOT COMPLETED|Overall Study||3
5107489|NCT01577381|12564975|P2|NOT COMPLETED|Overall Study||3
5107490|NCT01577381|12564976|P1|NOT COMPLETED|Overall Study||2
5107491|NCT01577381|12564973|P4|COMPLETED|Overall Study||0
5107492|NCT01577381|12564974|P3|COMPLETED|Overall Study||0
5107493|NCT01577381|12564975|P2|COMPLETED|Overall Study||0
5107494|NCT01577381|12564976|P1|COMPLETED|Overall Study||0
5107495|NCT01577381|12564973|P4|STARTED|Overall Study||2
5107496|NCT01577381|12564974|P3|STARTED|Overall Study||3
5107497|NCT01577381|12564975|P2|STARTED|Overall Study||3
5107498|NCT01577381|12564976|P1|STARTED|Overall Study||2
5107499|NCT01577329|12565107|P2|NOT COMPLETED|Overall Study||0
5107500|NCT01577329|12565108|P1|NOT COMPLETED|Overall Study||3
5107501|NCT01577329|12565107|P2|COMPLETED|Overall Study||22
5107502|NCT01577329|12565108|P1|COMPLETED|Overall Study||16
5107503|NCT01577329|12565107|P2|STARTED|Overall Study||22
5107504|NCT01577329|12565108|P1|STARTED|Overall Study||19
5107505|NCT01577238|12565116|P2|NOT COMPLETED|Overall Study||12
5107506|NCT01577238|12565117|P1|NOT COMPLETED|Overall Study||10
5107507|NCT01577238|12565116|P2|COMPLETED|Overall Study||111
5107508|NCT01577238|12565117|P1|COMPLETED|Overall Study||117
5107509|NCT01577238|12565116|P2|STARTED|Overall Study||123
5107510|NCT01577238|12565117|P1|STARTED|Overall Study||127
5107511|NCT01577186|12565131|P1|NOT COMPLETED|Overall Study||130
5107512|NCT01577186|12565131|P1|COMPLETED|Overall Study||350
5107513|NCT01577186|12565131|P1|STARTED|Overall Study||480
5107514|NCT01577160|12565139|P1|NOT COMPLETED|Overall Study||98
5107515|NCT01577160|12565139|P1|COMPLETED|Overall Study||255
5107516|NCT01577160|12565139|P1|STARTED|Overall Study||353
5107517|NCT01577108|12565149|P2|NOT COMPLETED|Overall Study||6
5107518|NCT01577108|12565150|P1|NOT COMPLETED|Overall Study||5
5107519|NCT01577108|12565149|P2|COMPLETED|Overall Study||50
5107520|NCT01577108|12565150|P1|COMPLETED|Overall Study||49
5107521|NCT01577108|12565149|P2|STARTED|Overall Study||56
5107522|NCT01577108|12565150|P1|STARTED|Overall Study||54
5107523|NCT01576952|12565158|P2|NOT COMPLETED|Overall Study||55
5107524|NCT01576952|12565159|P1|NOT COMPLETED|Overall Study||41
5107525|NCT01576952|12565158|P2|COMPLETED|Overall Study||33
5107526|NCT01576952|12565159|P1|COMPLETED|Overall Study||139
5107527|NCT01576952|12565158|P2|mITT Population|Overall Study||85
5107528|NCT01576952|12565159|P1|mITT Population|Overall Study||168
5107529|NCT01576952|12565158|P2|Safety Population|Overall Study||85
5107530|NCT01576952|12565159|P1|Safety Population|Overall Study||169
5107531|NCT01576952|12565158|P2|STARTED|Overall Study||88
5107532|NCT01576952|12565159|P1|STARTED|Overall Study||180
5107533|NCT01576939|12565165|P1|NOT COMPLETED|Overall Study||0
5107534|NCT01576939|12565165|P1|COMPLETED|Overall Study||30
5107535|NCT01576939|12565165|P1|STARTED|Overall Study||30
5107536|NCT01576874|12565175|P2|NOT COMPLETED|Overall Study||0
5107537|NCT01576874|12565176|P1|NOT COMPLETED|Overall Study||0
5107538|NCT01576874|12565175|P2|COMPLETED|Overall Study||72
5107539|NCT01576874|12565176|P1|COMPLETED|Overall Study||72
5107540|NCT01576874|12565175|P2|STARTED|Overall Study||72
5107541|NCT01576874|12565176|P1|STARTED|Overall Study||72
5107542|NCT01576809|12565186|P1|NOT COMPLETED|Overall Study||0
5107543|NCT01576809|12565186|P1|COMPLETED|Overall Study||51
5107544|NCT01576809|12565186|P1|STARTED|Overall Study||51
5107545|NCT01576783|12565194|P2|NOT COMPLETED|Overall Study||17
5107546|NCT01576783|12565195|P1|NOT COMPLETED|Overall Study||20
5107547|NCT01576783|12565194|P2|COMPLETED|Overall Study||171
5107548|NCT01576783|12565195|P1|COMPLETED|Overall Study||169
5107549|NCT01576783|12565194|P2|STARTED|Overall Study||188
5107550|NCT01576783|12565195|P1|STARTED|Overall Study||189
5107551|NCT01576718|12565221|P7|NOT COMPLETED|Treatment Period||30
5107552|NCT01576718|12565222|P6|NOT COMPLETED|Treatment Period||48
5107553|NCT01576718|12565223|P5|NOT COMPLETED|Treatment Period||27
5107554|NCT01576718|12565224|P4|NOT COMPLETED|Treatment Period||31
5107555|NCT01576718|12565225|P3|NOT COMPLETED|Treatment Period||20
5107556|NCT01576718|12565226|P2|NOT COMPLETED|Treatment Period||25
5107557|NCT01576718|12565227|P1|NOT COMPLETED|Treatment Period||0
5107558|NCT01576718|12565221|P7|COMPLETED|Treatment Period||77
5107559|NCT01576718|12565222|P6|COMPLETED|Treatment Period||58
5107560|NCT01576718|12565223|P5|COMPLETED|Treatment Period||80
5107561|NCT01576718|12565224|P4|COMPLETED|Treatment Period||75
5107562|NCT01576718|12565225|P3|COMPLETED|Treatment Period||87
5107563|NCT01576718|12565226|P2|COMPLETED|Treatment Period||82
5107564|NCT01576718|12565227|P1|COMPLETED|Treatment Period||0
5107565|NCT01576718|12565221|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
5107566|NCT01576718|12565222|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
5107567|NCT01576718|12565223|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
5107568|NCT01576718|12565224|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
5107569|NCT01576718|12565225|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
5107570|NCT01576718|12565226|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
5107571|NCT01576718|12565227|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
5107572|NCT01576718|12565221|P7|Safety Population|Treatment Period||106
5107573|NCT01576718|12565222|P6|Safety Population|Treatment Period||106
5107574|NCT01576718|12565223|P5|Safety Population|Treatment Period||107
5107575|NCT01576718|12565224|P4|Safety Population|Treatment Period||106
5107576|NCT01576718|12565225|P3|Safety Population|Treatment Period||107
5107577|NCT01576718|12565226|P2|Safety Population|Treatment Period||107
5107578|NCT01576718|12565227|P1|Safety Population|Treatment Period||0
5107579|NCT01576718|12565221|P7|STARTED|Treatment Period||107
5107580|NCT01576718|12565222|P6|STARTED|Treatment Period||106
5107581|NCT01576718|12565223|P5|STARTED|Treatment Period||107
5107582|NCT01576718|12565224|P4|STARTED|Treatment Period||106
5107583|NCT01576718|12565225|P3|STARTED|Treatment Period||107
5107584|NCT01576718|12565226|P2|STARTED|Treatment Period||107
5107585|NCT01576718|12565227|P1|STARTED|Treatment Period||0
5107586|NCT01576718|12565221|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107587|NCT01576718|12565222|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107588|NCT01576718|12565223|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107589|NCT01576718|12565224|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107590|NCT01576718|12565225|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107591|NCT01576718|12565226|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107592|NCT01576718|12565227|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
5107593|NCT01576718|12565221|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107594|NCT01576718|12565222|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107595|NCT01576718|12565223|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107596|NCT01576718|12565224|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107597|NCT01576718|12565225|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107598|NCT01576718|12565226|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5107599|NCT01576718|12565227|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
5107600|NCT01576718|12565221|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107601|NCT01576718|12565222|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107602|NCT01576718|12565223|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107603|NCT01576718|12565224|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107604|NCT01576718|12565225|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107605|NCT01576718|12565226|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5107606|NCT01576718|12565227|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
5107607|NCT01576705|12565323|P4|NOT COMPLETED|Overall Study||3
5107608|NCT01576705|12565324|P3|NOT COMPLETED|Overall Study||5
5107609|NCT01576705|12565325|P2|NOT COMPLETED|Overall Study||8
5107610|NCT01576705|12565326|P1|NOT COMPLETED|Overall Study||3
5107611|NCT01576705|12565323|P4|COMPLETED|Overall Study||41
5107612|NCT01576705|12565324|P3|COMPLETED|Overall Study||38
5107613|NCT01576705|12565325|P2|COMPLETED|Overall Study||37
5107614|NCT01576705|12565326|P1|COMPLETED|Overall Study||40
5107615|NCT01576705|12565323|P4|STARTED|Overall Study||44
5107616|NCT01576705|12565324|P3|STARTED|Overall Study||43
5107617|NCT01576705|12565325|P2|STARTED|Overall Study||45
5107618|NCT01576705|12565326|P1|STARTED|Overall Study||43
5107619|NCT01576588|12565340|P1|NOT COMPLETED|Overall Study||2
5107620|NCT01576588|12565340|P1|COMPLETED|Overall Study||23
5107621|NCT01576588|12565340|P1|STARTED|Overall Study||25
5107622|NCT01576575|12565347|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
5107623|NCT01576575|12565347|P1|COMPLETED|Buprenorphine + Ketoconazole||14
5107624|NCT01576575|12565347|P1|STARTED|Buprenorphine + Ketoconazole||14
5107625|NCT01576575|12565347|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
5107626|NCT01576575|12565347|P1|COMPLETED|Buprenorphine + Grapefruit||14
5107627|NCT01576575|12565347|P1|STARTED|Buprenorphine + Grapefruit||15
5107628|NCT01576575|12565347|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
5107629|NCT01576575|12565347|P1|COMPLETED|Buprenorphine + Rifampin||15
5107630|NCT01576575|12565347|P1|STARTED|Buprenorphine + Rifampin||18
5107631|NCT01576575|12565347|P1|NOT COMPLETED|Buprenorphine Control||3
5107632|NCT01576575|12565347|P1|COMPLETED|Buprenorphine Control||18
5107633|NCT01576575|12565347|P1|STARTED|Buprenorphine Control||21
5107634|NCT01576549|12565357|P1|NOT COMPLETED|Overall Study||2
5107635|NCT01576549|12565357|P1|COMPLETED|Overall Study||0
5107636|NCT01576549|12565357|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
5107637|NCT01576549|12565357|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
5107638|NCT01576549|12565357|P1|STARTED|Overall Study||2
5107639|NCT01576536|12565365|P1|NOT COMPLETED|Overall Study||0
5107640|NCT01576536|12565365|P1|COMPLETED|Overall Study||117
5107641|NCT01576536|12565365|P1|STARTED|Overall Study||117
5107642|NCT01576471|12565373|P2|NOT COMPLETED|Overall Study||9
5107643|NCT01576471|12565374|P1|NOT COMPLETED|Overall Study||8
5107644|NCT01576471|12565373|P2|COMPLETED|Overall Study||116
5107645|NCT01576471|12565374|P1|COMPLETED|Overall Study||117
5107646|NCT01576471|12565373|P2|STARTED|Overall Study||125
5107647|NCT01576471|12565374|P1|STARTED|Overall Study||125
5107648|NCT01576406|12565386|P6|NOT COMPLETED|Overall Study||12
5107649|NCT01576406|12565387|P5|NOT COMPLETED|Overall Study||8
5107650|NCT01576406|12565388|P4|NOT COMPLETED|Overall Study||9
5107651|NCT01576406|12565389|P3|NOT COMPLETED|Overall Study||16
5107652|NCT01576406|12565390|P2|NOT COMPLETED|Overall Study||8
5107653|NCT01576406|12565391|P1|NOT COMPLETED|Overall Study||6
5107654|NCT01576406|12565386|P6|COMPLETED|Overall Study||4
5107655|NCT01576406|12565387|P5|COMPLETED|Overall Study||8
5107656|NCT01576406|12565388|P4|COMPLETED|Overall Study||1
5107657|NCT01576406|12565389|P3|COMPLETED|Overall Study||4
5107658|NCT01576406|12565390|P2|COMPLETED|Overall Study||7
5107659|NCT01576406|12565391|P1|COMPLETED|Overall Study||5
5107660|NCT01576406|12565386|P6|STARTED|Overall Study||16
5107661|NCT01576406|12565387|P5|STARTED|Overall Study||16
5107662|NCT01576406|12565388|P4|STARTED|Overall Study||10
5107663|NCT01576406|12565389|P3|STARTED|Overall Study||20
5107664|NCT01576406|12565390|P2|STARTED|Overall Study||15
5107665|NCT01576406|12565391|P1|STARTED|Overall Study||11
5107666|NCT01576367|12565639|P1|NOT COMPLETED|Overall Study||3
5107667|NCT01576367|12565639|P1|COMPLETED|Overall Study||14
5107668|NCT01576367|12565639|P1|STARTED|Overall Study||17
5107669|NCT01576341|12565647|P1|NOT COMPLETED|Overall Study||93
5107670|NCT01576341|12565647|P1|COMPLETED|Overall Study||324
5107671|NCT01576341|12565647|P1|STARTED|Overall Study||417
5107672|NCT01576276|12565656|P2|NOT COMPLETED|Overall Study||11
5107673|NCT01576276|12565657|P1|NOT COMPLETED|Overall Study||8
5107674|NCT01576276|12565656|P2|COMPLETED|Overall Study||18
5107675|NCT01576276|12565657|P1|COMPLETED|Overall Study||14
5107676|NCT01576276|12565656|P2|STARTED|Overall Study||29
5107677|NCT01576276|12565657|P1|STARTED|Overall Study||22
5107678|NCT01576159|12565668|P4|NOT COMPLETED|Overall Study||1
5107679|NCT01576159|12565669|P3|NOT COMPLETED|Overall Study||1
5107680|NCT01576159|12565670|P2|NOT COMPLETED|Overall Study||1
5107681|NCT01576159|12565671|P1|NOT COMPLETED|Overall Study||1
5107682|NCT01576159|12565668|P4|COMPLETED|Overall Study||11
5107683|NCT01576159|12565669|P3|COMPLETED|Overall Study||11
5107684|NCT01576159|12565670|P2|COMPLETED|Overall Study||11
5107685|NCT01576159|12565671|P1|COMPLETED|Overall Study||11
5107686|NCT01576159|12565668|P4|STARTED|Overall Study||12
5107687|NCT01576159|12565669|P3|STARTED|Overall Study||12
5107688|NCT01576159|12565670|P2|STARTED|Overall Study||12
5107689|NCT01576159|12565671|P1|STARTED|Overall Study||12
5107690|NCT01576146|12565689|P1|NOT COMPLETED|Extension Period 2||17
5107691|NCT01576146|12565689|P1|COMPLETED|Extension Period 2||0
5107692|NCT01576146|12565689|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
5107693|NCT01576146|12565689|P1|NOT COMPLETED|Extension Period 1||10
5107694|NCT01576146|12565689|P1|COMPLETED|Extension Period 1||20
5107695|NCT01576146|12565689|P1|STARTED|Extension Period 1||30
5107696|NCT01576120|12565698|P2|NOT COMPLETED|Overall Study||0
5107697|NCT01576120|12565699|P1|NOT COMPLETED|Overall Study||0
5107698|NCT01576120|12565698|P2|COMPLETED|Overall Study||19
5107699|NCT01576120|12565699|P1|COMPLETED|Overall Study||21
5107700|NCT01576120|12565698|P2|STARTED|Overall Study||19
5107701|NCT01576120|12565699|P1|STARTED|Overall Study||21
5107702|NCT01576055|12565707|P2|NOT COMPLETED|Overall Study||6
5107703|NCT01576055|12565708|P1|NOT COMPLETED|Overall Study||19
5107704|NCT01576055|12565707|P2|COMPLETED|Overall Study||64
5107705|NCT01576055|12565708|P1|COMPLETED|Overall Study||178
5107706|NCT01576055|12565707|P2|STARTED|Overall Study||70
5107707|NCT01576055|12565708|P1|STARTED|Overall Study||197
5107708|NCT01576042|12565722|P2|NOT COMPLETED|Overall Study||0
5107709|NCT01576042|12565723|P1|NOT COMPLETED|Overall Study||2
5107710|NCT01576042|12565722|P2|COMPLETED|Overall Study||14
5107711|NCT01576042|12565723|P1|COMPLETED|Overall Study||11
5107712|NCT01576042|12565722|P2|Switched to the Other Arm|Overall Study||1
5107713|NCT01576042|12565723|P1|Switched to the Other Arm|Overall Study||5
5107714|NCT01576042|12565722|P2|STARTED|Overall Study||14
5107715|NCT01576042|12565723|P1|STARTED|Overall Study||13
5107716|NCT01576003|12565746|P3|NOT COMPLETED|Overall Study||0
5107717|NCT01576003|12565747|P2|NOT COMPLETED|Overall Study||2
5107718|NCT01576003|12565748|P1|NOT COMPLETED|Overall Study||1
5107719|NCT01576003|12565746|P3|COMPLETED|Overall Study||4
5107720|NCT01576003|12565747|P2|COMPLETED|Overall Study||1
5107721|NCT01576003|12565748|P1|COMPLETED|Overall Study||1
5107722|NCT01576003|12565746|P3|STARTED|Overall Study||4
5107723|NCT01576003|12565747|P2|STARTED|Overall Study||3
5107724|NCT01576003|12565748|P1|STARTED|Overall Study||2
5107725|NCT01575912|12565766|P3|NOT COMPLETED|Overall Study||0
5107726|NCT01575912|12565767|P2|NOT COMPLETED|Overall Study||0
5107727|NCT01575912|12565768|P1|NOT COMPLETED|Overall Study||0
5107728|NCT01575912|12565766|P3|COMPLETED|Overall Study||30
5107729|NCT01575912|12565767|P2|COMPLETED|Overall Study||32
5107730|NCT01575912|12565768|P1|COMPLETED|Overall Study||30
5107731|NCT01575912|12565766|P3|STARTED|Overall Study||30
5107732|NCT01575912|12565767|P2|STARTED|Overall Study||32
5107733|NCT01575912|12565768|P1|STARTED|Overall Study||30
5107734|NCT01575899|12565779|P3|NOT COMPLETED|Overall Study||2
5107735|NCT01575899|12565780|P2|NOT COMPLETED|Overall Study||5
5107736|NCT01575899|12565781|P1|NOT COMPLETED|Overall Study||5
5107737|NCT01575899|12565779|P3|COMPLETED|Overall Study||60
5107738|NCT01575899|12565780|P2|COMPLETED|Overall Study||68
5107739|NCT01575899|12565781|P1|COMPLETED|Overall Study||68
5107740|NCT01575899|12565779|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
5107741|NCT01575899|12565780|P2|STARTED|Overall Study||73
5107742|NCT01575899|12565781|P1|STARTED|Overall Study||73
5107743|NCT01575873|12565795|P4|NOT COMPLETED|Overall Study||67
5107744|NCT01575873|12565796|P3|NOT COMPLETED|Overall Study||74
5107745|NCT01575873|12565797|P2|NOT COMPLETED|Overall Study||36
5107746|NCT01575873|12565798|P1|NOT COMPLETED|Overall Study||28
5107747|NCT01575873|12565795|P4|COMPLETED|Overall Study||186
5107748|NCT01575873|12565796|P3|COMPLETED|Overall Study||178
5107749|NCT01575873|12565797|P2|COMPLETED|Overall Study||109
5107750|NCT01575873|12565798|P1|COMPLETED|Overall Study||117
5107751|NCT01575873|12565795|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
5107752|NCT01575873|12565796|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
5107753|NCT01575873|12565797|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
5107754|NCT01575873|12565798|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
5107755|NCT01575873|12565795|P4|STARTED|Overall Study||253
5107756|NCT01575873|12565796|P3|STARTED|Overall Study||252
5107757|NCT01575873|12565797|P2|STARTED|Overall Study||145
5107758|NCT01575873|12565798|P1|STARTED|Overall Study||145
5107759|NCT01575834|12565824|P2|NOT COMPLETED|Overall Study||738
5107760|NCT01575834|12565825|P1|NOT COMPLETED|Overall Study||699
5107761|NCT01575834|12565824|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
5107762|NCT01575834|12565825|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
5107763|NCT01575834|12565824|P2|Completed 24-month Study Period|Overall Study||2994
5107764|NCT01575834|12565825|P1|Completed 24-month Study Period|Overall Study||3032
5107765|NCT01575834|12565824|P2|Completed Double-blind Period|Overall Study||3185
5107766|NCT01575834|12565825|P1|Completed Double-blind Period|Overall Study||3205
5107767|NCT01575834|12565824|P2|Received Double-blind Treatment|Overall Study||3575
5107768|NCT01575834|12565825|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
5107769|NCT01575834|12565824|P2|STARTED|Overall Study||3589
5107770|NCT01575834|12565825|P1|STARTED|Overall Study||3591
5107771|NCT01575808|12565877|P2|NOT COMPLETED|Overall Study||0
5107772|NCT01575808|12565878|P1|NOT COMPLETED|Overall Study||3
5107773|NCT01575808|12565877|P2|COMPLETED|Overall Study||68
5107774|NCT01575808|12565878|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
5107775|NCT01575808|12565877|P2|STARTED|Overall Study||68
5107776|NCT01575808|12565878|P1|STARTED|Overall Study||103
5107777|NCT01575769|12565925|P1|NOT COMPLETED|Overall Study||41
5107778|NCT01575769|12565925|P1|COMPLETED|Overall Study||0
5107779|NCT01575769|12565925|P1|STARTED|Overall Study||41
5107780|NCT01575756|12565951|P2|NOT COMPLETED|Treatment Period 2||0
5107781|NCT01575756|12565952|P1|NOT COMPLETED|Treatment Period 2||0
5107782|NCT01575756|12565951|P2|COMPLETED|Treatment Period 2||11
5107783|NCT01575756|12565952|P1|COMPLETED|Treatment Period 2||11
5107784|NCT01575756|12565951|P2|STARTED|Treatment Period 2||11
5107785|NCT01575756|12565952|P1|STARTED|Treatment Period 2||11
5107786|NCT01575756|12565951|P2|NOT COMPLETED|Treatment Period 1||0
5107787|NCT01575756|12565952|P1|NOT COMPLETED|Treatment Period 1||0
5107788|NCT01575756|12565951|P2|COMPLETED|Treatment Period 1||11
5107789|NCT01575756|12565952|P1|COMPLETED|Treatment Period 1||11
5107790|NCT01575756|12565951|P2|STARTED|Treatment Period 1||11
5107791|NCT01575756|12565952|P1|STARTED|Treatment Period 1||11
5107792|NCT01575561|12565983|P1|NOT COMPLETED|Overall Study||39
5107793|NCT01575561|12565983|P1|COMPLETED|Overall Study||338
5107794|NCT01575561|12565983|P1|STARTED|Overall Study||377
5107795|NCT01575522|12565995|P1|NOT COMPLETED|Overall Study||0
5107796|NCT01575522|12565995|P1|COMPLETED|Overall Study||22
5107797|NCT01575522|12565995|P1|STARTED|Overall Study||22
5107798|NCT01575275|12566003|P1|NOT COMPLETED|Overall Study||0
5107799|NCT01575275|12566003|P1|COMPLETED|Overall Study||8
5107800|NCT01575275|12566003|P1|STARTED|Overall Study||8
5107801|NCT01575197|12566013|P3|NOT COMPLETED|Overall Study||6
5107802|NCT01575197|12566014|P2|NOT COMPLETED|Overall Study||9
5107803|NCT01575197|12566015|P1|NOT COMPLETED|Overall Study||3
5107804|NCT01575197|12566013|P3|COMPLETED|Overall Study||146
5107805|NCT01575197|12566014|P2|COMPLETED|Overall Study||143
5107806|NCT01575197|12566015|P1|COMPLETED|Overall Study||149
5107807|NCT01575197|12566013|P3|STARTED|Overall Study||152
5107808|NCT01575197|12566014|P2|STARTED|Overall Study||152
5107809|NCT01575197|12566015|P1|STARTED|Overall Study||152
5107810|NCT01575106|12566028|P1|NOT COMPLETED|Overall Study||14
5107811|NCT01575106|12566028|P1|COMPLETED|Overall Study||24
5107812|NCT01575106|12566028|P1|STARTED|Overall Study||38
5107813|NCT01575080|12566034|P1|NOT COMPLETED|Overall Study||0
5107814|NCT01575080|12566034|P1|COMPLETED|Overall Study||102
5107815|NCT01575080|12566034|P1|STARTED|Overall Study||102
5107816|NCT01575054|12566043|P2|NOT COMPLETED|Overall Study||26
5107817|NCT01575054|12566044|P1|NOT COMPLETED|Overall Study||29
5107818|NCT01575054|12566043|P2|COMPLETED|Overall Study||209
5107819|NCT01575054|12566044|P1|COMPLETED|Overall Study||204
5107820|NCT01575054|12566043|P2|STARTED|Overall Study||235
5107821|NCT01575054|12566044|P1|STARTED|Overall Study||233
5107822|NCT01575028|12566060|P2|NOT COMPLETED|Overall Study||1
5107823|NCT01575028|12566061|P1|NOT COMPLETED|Overall Study||0
5107824|NCT01575028|12566060|P2|COMPLETED|Overall Study||0
5107825|NCT01575028|12566061|P1|COMPLETED|Overall Study||2
5107826|NCT01575028|12566060|P2|STARTED|Overall Study||1
5107827|NCT01575028|12566061|P1|STARTED|Overall Study||2
5107828|NCT01574716|12566072|P5|NOT COMPLETED|Part 2||70
5107829|NCT01574716|12566073|P4|NOT COMPLETED|Part 2||137
5107830|NCT01574716|12566074|P3|NOT COMPLETED|Part 2||0
5107831|NCT01574716|12566075|P2|NOT COMPLETED|Part 2||0
5107832|NCT01574716|12566076|P1|NOT COMPLETED|Part 2||0
5107833|NCT01574716|12566072|P5|COMPLETED|Part 2||0
5107834|NCT01574716|12566073|P4|COMPLETED|Part 2||2
5107835|NCT01574716|12566074|P3|COMPLETED|Part 2||0
5107836|NCT01574716|12566075|P2|COMPLETED|Part 2||0
5107837|NCT01574716|12566076|P1|COMPLETED|Part 2||0
5107838|NCT01574716|12566072|P5|Treated Participants|Part 2||67
5107839|NCT01574716|12566073|P4|Treated Participants|Part 2||140
5107840|NCT01574716|12566074|P3|Treated Participants|Part 2||0
5107841|NCT01574716|12566075|P2|Treated Participants|Part 2||0
5107842|NCT01574716|12566076|P1|Treated Participants|Part 2||0
5107843|NCT01574716|12566072|P5|STARTED|Part 2||70
5107844|NCT01574716|12566073|P4|STARTED|Part 2||139
5107845|NCT01574716|12566074|P3|STARTED|Part 2||0
5107846|NCT01574716|12566075|P2|STARTED|Part 2||0
5107847|NCT01574716|12566076|P1|STARTED|Part 2||0
5107848|NCT01574716|12566072|P5|NOT COMPLETED|Part 1||0
5107849|NCT01574716|12566073|P4|NOT COMPLETED|Part 1||0
5107850|NCT01574716|12566074|P3|NOT COMPLETED|Part 1||9
5107851|NCT01574716|12566075|P2|NOT COMPLETED|Part 1||4
5107852|NCT01574716|12566076|P1|NOT COMPLETED|Part 1||3
5107853|NCT01574716|12566072|P5|COMPLETED|Part 1||0
5107854|NCT01574716|12566073|P4|COMPLETED|Part 1||0
5107855|NCT01574716|12566074|P3|COMPLETED|Part 1||0
5107856|NCT01574716|12566075|P2|COMPLETED|Part 1||0
5107857|NCT01574716|12566076|P1|COMPLETED|Part 1||0
5107858|NCT01574716|12566072|P5|STARTED|Part 1||0
5107859|NCT01574716|12566073|P4|STARTED|Part 1||0
5107860|NCT01574716|12566074|P3|STARTED|Part 1||9
5107861|NCT01574716|12566075|P2|STARTED|Part 1||4
5107862|NCT01574716|12566076|P1|STARTED|Part 1||3
5107863|NCT01574703|12566099|P4|NOT COMPLETED|Overall Study||114
5107864|NCT01574703|12566100|P3|NOT COMPLETED|Overall Study||105
5107865|NCT01574703|12566101|P2|NOT COMPLETED|Overall Study||112
5107866|NCT01574703|12566102|P1|NOT COMPLETED|Overall Study||125
5107867|NCT01574703|12566099|P4|COMPLETED|Overall Study||1007
5107868|NCT01574703|12566100|P3|COMPLETED|Overall Study||1011
5107869|NCT01574703|12566101|P2|COMPLETED|Overall Study||1054
5107870|NCT01574703|12566102|P1|COMPLETED|Overall Study||1067
5107871|NCT01574703|12566099|P4|STARTED|Overall Study||1121
5107872|NCT01574703|12566100|P3|STARTED|Overall Study||1116
5107873|NCT01574703|12566101|P2|STARTED|Overall Study||1166
5107874|NCT01574703|12566102|P1|STARTED|Overall Study||1192
5107875|NCT01574651|12566146|P2|NOT COMPLETED|Overall Study||52
5107876|NCT01574651|12566147|P1|NOT COMPLETED|Overall Study||61
5107877|NCT01574651|12566146|P2|COMPLETED|Overall Study||406
5107878|NCT01574651|12566147|P1|COMPLETED|Overall Study||415
5107879|NCT01574651|12566146|P2|Per Protocol Set (PPS)|Overall Study||374
5107880|NCT01574651|12566147|P1|Per Protocol Set (PPS)|Overall Study||373
5107881|NCT01574651|12566146|P2|Full Analysis Set (FAS)|Overall Study||458
5107882|NCT01574651|12566147|P1|Full Analysis Set (FAS)|Overall Study||476
5107883|NCT01574651|12566146|P2|STARTED|Overall Study||458
5107884|NCT01574651|12566147|P1|STARTED|Overall Study||476
5107885|NCT01574612|12566169|P1|NOT COMPLETED|Overall Study||8
5107886|NCT01574612|12566169|P1|COMPLETED|Overall Study||46
5107887|NCT01574612|12566169|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
5107888|NCT01574326|12566175|P2|NOT COMPLETED|Overall Study||19
5107889|NCT01574326|12566176|P1|NOT COMPLETED|Overall Study||16
5107890|NCT01574326|12566175|P2|COMPLETED|Overall Study||31
5107891|NCT01574326|12566176|P1|COMPLETED|Overall Study||35
5107892|NCT01574326|12566175|P2|Treated|Overall Study||49
5107893|NCT01574326|12566176|P1|Treated|Overall Study||51
5107894|NCT01574326|12566175|P2|STARTED|Overall Study||50
5107895|NCT01574326|12566176|P1|STARTED|Overall Study||51
5107896|NCT01574287|12566187|P1|NOT COMPLETED|Overall Study||0
5107897|NCT01574287|12566187|P1|COMPLETED|Overall Study||4
5107898|NCT01574287|12566187|P1|STARTED|Overall Study||4
5107899|NCT01574248|12566194|P2|NOT COMPLETED|Overall Study||0
5107900|NCT01574248|12566195|P1|NOT COMPLETED|Overall Study||3
5107901|NCT01574248|12566194|P2|COMPLETED|Overall Study||18
5107902|NCT01574248|12566195|P1|COMPLETED|Overall Study||12
5107903|NCT01574248|12566194|P2|STARTED|Overall Study||18
5107904|NCT01574248|12566195|P1|STARTED|Overall Study||15
5107905|NCT01574183|12566215|P2|NOT COMPLETED|Overall Study||18
5107906|NCT01574183|12566216|P1|NOT COMPLETED|Overall Study||27
5107907|NCT01574183|12566215|P2|COMPLETED|Overall Study||17
5107908|NCT01574183|12566216|P1|COMPLETED|Overall Study||14
5107909|NCT01574183|12566215|P2|STARTED|Overall Study||35
5107910|NCT01574183|12566216|P1|STARTED|Overall Study||41
5107911|NCT01574157|12566228|P2|NOT COMPLETED|Overall Study||8
5107912|NCT01574157|12566229|P1|NOT COMPLETED|Overall Study||4
5107913|NCT01574157|12566228|P2|COMPLETED|Overall Study||31
5107914|NCT01574157|12566229|P1|COMPLETED|Overall Study||31
5107915|NCT01574157|12566228|P2|Month 3|Overall Study||33
5107916|NCT01574157|12566229|P1|Month 3|Overall Study||31
5107917|NCT01574157|12566228|P2|STARTED|Overall Study||39
5107918|NCT01574157|12566229|P1|STARTED|Overall Study||35
5107919|NCT01574144|12566245|P1|NOT COMPLETED|Overall Study||0
5107920|NCT01574144|12566245|P1|COMPLETED|Overall Study||70
5107921|NCT01574144|12566245|P1|STARTED|Overall Study||70
5107922|NCT01574105|12566252|P2|NOT COMPLETED|Overall Study||0
5107923|NCT01574105|12566253|P1|NOT COMPLETED|Overall Study||0
5107924|NCT01574105|12566252|P2|COMPLETED|Overall Study||37
5107925|NCT01574105|12566253|P1|COMPLETED|Overall Study||29
5107926|NCT01574105|12566252|P2|STARTED|Overall Study||37
5107927|NCT01574105|12566253|P1|STARTED|Overall Study||29
5107928|NCT01574079|12566263|P2|NOT COMPLETED|Overall Study||2
5107929|NCT01574079|12566264|P1|NOT COMPLETED|Overall Study||1
5107930|NCT01574079|12566263|P2|COMPLETED|Overall Study||13
5107931|NCT01574079|12566264|P1|COMPLETED|Overall Study||17
5107932|NCT01574079|12566263|P2|STARTED|Overall Study||15
5107933|NCT01574079|12566264|P1|STARTED|Overall Study||18
5107934|NCT01573910|12566276|P2|NOT COMPLETED|Overall Study||17
5107935|NCT01573910|12566277|P1|NOT COMPLETED|Overall Study||20
5107936|NCT01573910|12566276|P2|COMPLETED|Overall Study||476
5107937|NCT01573910|12566277|P1|COMPLETED|Overall Study||469
5107938|NCT01573910|12566276|P2|STARTED|Overall Study||493
5107939|NCT01573910|12566277|P1|STARTED|Overall Study||489
5107940|NCT01573767|12566289|P4|NOT COMPLETED|Overall Study||24
5107941|NCT01573767|12566290|P3|NOT COMPLETED|Overall Study||14
5107942|NCT01573767|12566291|P2|NOT COMPLETED|Overall Study||21
5107943|NCT01573767|12566292|P1|NOT COMPLETED|Overall Study||22
5107944|NCT01573767|12566289|P4|COMPLETED|Overall Study||90
5107945|NCT01573767|12566290|P3|COMPLETED|Overall Study||99
5107946|NCT01573767|12566291|P2|COMPLETED|Overall Study||93
5107947|NCT01573767|12566292|P1|COMPLETED|Overall Study||93
5107948|NCT01573767|12566289|P4|STARTED|Overall Study||114
5107949|NCT01573767|12566290|P3|STARTED|Overall Study||113
5107950|NCT01573767|12566291|P2|STARTED|Overall Study||114
5107951|NCT01573767|12566292|P1|STARTED|Overall Study||115
5107952|NCT01573624|12566326|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
5107953|NCT01573624|12566327|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
5107954|NCT01573624|12566328|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
5107955|NCT01573624|12566329|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
5107956|NCT01573624|12566330|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
5107957|NCT01573624|12566331|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
5107958|NCT01573624|12566332|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
5107959|NCT01573624|12566326|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
5107960|NCT01573624|12566327|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
5107961|NCT01573624|12566328|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
5107962|NCT01573624|12566329|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
5107963|NCT01573624|12566330|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
5107964|NCT01573624|12566331|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
5107965|NCT01573624|12566332|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
5107966|NCT01573624|12566326|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
5107967|NCT01573624|12566327|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
5107968|NCT01573624|12566328|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
5107969|NCT01573624|12566329|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
5107970|NCT01573624|12566330|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
5107971|NCT01573624|12566331|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
5107972|NCT01573624|12566332|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
5107973|NCT01573624|12566326|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
5107974|NCT01573624|12566327|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
5107975|NCT01573624|12566328|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
5107976|NCT01573624|12566329|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
5107977|NCT01573624|12566330|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
5107978|NCT01573624|12566331|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
5107979|NCT01573624|12566332|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
5107980|NCT01573624|12566326|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
5107981|NCT01573624|12566327|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
5107982|NCT01573624|12566328|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
5107983|NCT01573624|12566329|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
5107984|NCT01573624|12566330|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
5107985|NCT01573624|12566331|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
5107986|NCT01573624|12566332|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
5107987|NCT01573624|12566326|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
5107988|NCT01573624|12566327|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
5107989|NCT01573624|12566328|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
5107990|NCT01573624|12566329|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
5107991|NCT01573624|12566330|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
5107992|NCT01573624|12566331|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
5107993|NCT01573624|12566332|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
5107994|NCT01573624|12566326|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
5107995|NCT01573624|12566327|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
5107996|NCT01573624|12566328|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
5107997|NCT01573624|12566329|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
5107998|NCT01573624|12566330|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
5107999|NCT01573624|12566331|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
5108000|NCT01573624|12566332|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
5108001|NCT01573624|12566326|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
5108002|NCT01573624|12566327|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
5108003|NCT01573624|12566328|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
5108004|NCT01573624|12566329|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
5108005|NCT01573624|12566330|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
5108006|NCT01573624|12566331|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
5108007|NCT01573624|12566332|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
5108008|NCT01573624|12566326|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
5108009|NCT01573624|12566327|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
5108010|NCT01573624|12566328|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
5108011|NCT01573624|12566329|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
5108012|NCT01573624|12566330|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
5108013|NCT01573624|12566331|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
5108014|NCT01573624|12566332|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
5108015|NCT01573624|12566326|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
5108016|NCT01573624|12566327|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
5108017|NCT01573624|12566328|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
5108018|NCT01573624|12566329|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
5108019|NCT01573624|12566330|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
5108020|NCT01573624|12566331|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
5108021|NCT01573624|12566332|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
5108022|NCT01573624|12566326|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
5108023|NCT01573624|12566327|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
5108024|NCT01573624|12566328|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
5108025|NCT01573624|12566329|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
5108026|NCT01573624|12566330|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
5108027|NCT01573624|12566331|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
5108028|NCT01573624|12566332|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
5108029|NCT01573624|12566326|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
5108030|NCT01573624|12566327|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
5108031|NCT01573624|12566328|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
5108032|NCT01573624|12566329|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
5108033|NCT01573624|12566330|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
5108034|NCT01573624|12566331|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
5108035|NCT01573624|12566332|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
5108036|NCT01573624|12566326|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
5108037|NCT01573624|12566327|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
5108038|NCT01573624|12566328|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
5108039|NCT01573624|12566329|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
5108040|NCT01573624|12566330|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
5108041|NCT01573624|12566331|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
5108042|NCT01573624|12566332|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
5108043|NCT01573624|12566326|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
5108044|NCT01573624|12566327|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
5108045|NCT01573624|12566328|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
5108046|NCT01573624|12566329|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
5108047|NCT01573624|12566330|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
5108048|NCT01573624|12566331|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
5108049|NCT01573624|12566332|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
5108050|NCT01573624|12566326|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
5108051|NCT01573624|12566327|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
5108052|NCT01573624|12566328|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
5108053|NCT01573624|12566329|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
5108054|NCT01573624|12566330|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
5108055|NCT01573624|12566331|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
5108056|NCT01573624|12566332|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
5108057|NCT01573624|12566326|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
5108058|NCT01573624|12566327|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
5108059|NCT01573624|12566328|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
5108060|NCT01573624|12566329|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
5108061|NCT01573624|12566330|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
5108062|NCT01573624|12566331|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
5108063|NCT01573624|12566332|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
5108064|NCT01573624|12566326|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
5108065|NCT01573624|12566327|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
5108066|NCT01573624|12566328|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
5108067|NCT01573624|12566329|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
5108068|NCT01573624|12566330|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
5108069|NCT01573624|12566331|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
5108070|NCT01573624|12566332|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
5108071|NCT01573624|12566326|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
5108072|NCT01573624|12566327|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
5108073|NCT01573624|12566328|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
5108074|NCT01573624|12566329|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
5108075|NCT01573624|12566330|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
5108076|NCT01573624|12566331|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
5108077|NCT01573624|12566332|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
5108078|NCT01573533|12566379|P1|NOT COMPLETED|Overall Study||0
5108079|NCT01573533|12566379|P1|COMPLETED|Overall Study||9
5108080|NCT01573533|12566379|P1|STARTED|Overall Study||9
5108081|NCT01573442|12566388|P2|NOT COMPLETED|Overall Study||10
5108082|NCT01573442|12566389|P1|NOT COMPLETED|Overall Study||9
5108083|NCT01573442|12566388|P2|COMPLETED|Overall Study||104
5108084|NCT01573442|12566389|P1|COMPLETED|Overall Study||104
5108085|NCT01573442|12566388|P2|STARTED|Overall Study||114
5108086|NCT01573442|12566389|P1|STARTED|Overall Study||113
5108087|NCT01573325|12566425|P1|NOT COMPLETED|Overall Study||0
5108088|NCT01573325|12566425|P1|COMPLETED|Overall Study||50
5108089|NCT01573325|12566425|P1|STARTED|Overall Study||50
5108090|NCT01573273|12566434|P12|NOT COMPLETED|MRI 2||0
5108091|NCT01573273|12566435|P11|NOT COMPLETED|MRI 2||0
5108092|NCT01573273|12566436|P10|NOT COMPLETED|MRI 2||0
5108093|NCT01573273|12566437|P9|NOT COMPLETED|MRI 2||0
5108094|NCT01573273|12566438|P8|NOT COMPLETED|MRI 2||0
5108095|NCT01573273|12566439|P7|NOT COMPLETED|MRI 2||0
5108096|NCT01573273|12566440|P6|NOT COMPLETED|MRI 2||0
5108097|NCT01573273|12566441|P5|NOT COMPLETED|MRI 2||0
5108098|NCT01573273|12566442|P4|NOT COMPLETED|MRI 2||0
5108099|NCT01573273|12566443|P3|NOT COMPLETED|MRI 2||0
5108100|NCT01573273|12566444|P2|NOT COMPLETED|MRI 2||0
5108101|NCT01573273|12566445|P1|NOT COMPLETED|MRI 2||0
5108102|NCT01573273|12566434|P12|COMPLETED|MRI 2||28
5108103|NCT01573273|12566435|P11|COMPLETED|MRI 2||27
5108104|NCT01573273|12566436|P10|COMPLETED|MRI 2||0
5108105|NCT01573273|12566437|P9|COMPLETED|MRI 2||0
5108106|NCT01573273|12566438|P8|COMPLETED|MRI 2||0
5108107|NCT01573273|12566439|P7|COMPLETED|MRI 2||0
5108108|NCT01573273|12566440|P6|COMPLETED|MRI 2||18
5108109|NCT01573273|12566441|P5|COMPLETED|MRI 2||23
5108110|NCT01573273|12566442|P4|COMPLETED|MRI 2||0
5108111|NCT01573273|12566443|P3|COMPLETED|MRI 2||0
5108112|NCT01573273|12566444|P2|COMPLETED|MRI 2||0
5108113|NCT01573273|12566445|P1|COMPLETED|MRI 2||0
5108114|NCT01573273|12566434|P12|STARTED|MRI 2||28
5108115|NCT01573273|12566435|P11|STARTED|MRI 2||27
5108116|NCT01573273|12566436|P10|STARTED|MRI 2||0
5108117|NCT01573273|12566437|P9|STARTED|MRI 2||0
5108118|NCT01573273|12566438|P8|STARTED|MRI 2||0
5108119|NCT01573273|12566439|P7|STARTED|MRI 2||0
5108120|NCT01573273|12566440|P6|STARTED|MRI 2||18
5108121|NCT01573273|12566441|P5|STARTED|MRI 2||23
5108122|NCT01573273|12566442|P4|STARTED|MRI 2||0
5108123|NCT01573273|12566443|P3|STARTED|MRI 2||0
5108124|NCT01573273|12566444|P2|STARTED|MRI 2||0
5108125|NCT01573273|12566445|P1|STARTED|MRI 2||0
5108126|NCT01573273|12566434|P12|NOT COMPLETED|MRI 1||0
5108127|NCT01573273|12566435|P11|NOT COMPLETED|MRI 1||0
5108128|NCT01573273|12566436|P10|NOT COMPLETED|MRI 1||0
5108129|NCT01573273|12566437|P9|NOT COMPLETED|MRI 1||0
5108130|NCT01573273|12566438|P8|NOT COMPLETED|MRI 1||0
5108131|NCT01573273|12566439|P7|NOT COMPLETED|MRI 1||0
5108132|NCT01573273|12566440|P6|NOT COMPLETED|MRI 1||0
5108133|NCT01573273|12566441|P5|NOT COMPLETED|MRI 1||0
5108134|NCT01573273|12566442|P4|NOT COMPLETED|MRI 1||0
5108135|NCT01573273|12566443|P3|NOT COMPLETED|MRI 1||0
5108136|NCT01573273|12566444|P2|NOT COMPLETED|MRI 1||0
5108137|NCT01573273|12566445|P1|NOT COMPLETED|MRI 1||0
5108138|NCT01573273|12566434|P12|COMPLETED|MRI 1||0
5108139|NCT01573273|12566435|P11|COMPLETED|MRI 1||0
5108140|NCT01573273|12566436|P10|COMPLETED|MRI 1||29
5108141|NCT01573273|12566437|P9|COMPLETED|MRI 1||28
5108142|NCT01573273|12566438|P8|COMPLETED|MRI 1||0
5108143|NCT01573273|12566439|P7|COMPLETED|MRI 1||0
5108144|NCT01573273|12566440|P6|COMPLETED|MRI 1||0
5108145|NCT01573273|12566441|P5|COMPLETED|MRI 1||0
5108146|NCT01573273|12566442|P4|COMPLETED|MRI 1||23
5108147|NCT01573273|12566443|P3|COMPLETED|MRI 1||19
5108148|NCT01573273|12566444|P2|COMPLETED|MRI 1||0
5108149|NCT01573273|12566445|P1|COMPLETED|MRI 1||0
5108150|NCT01573273|12566434|P12|STARTED|MRI 1||0
5108151|NCT01573273|12566435|P11|STARTED|MRI 1||0
5108152|NCT01573273|12566436|P10|STARTED|MRI 1||29
5108153|NCT01573273|12566437|P9|STARTED|MRI 1||28
5108154|NCT01573273|12566438|P8|STARTED|MRI 1||0
5108155|NCT01573273|12566439|P7|STARTED|MRI 1||0
5108156|NCT01573273|12566440|P6|STARTED|MRI 1||0
5108157|NCT01573273|12566441|P5|STARTED|MRI 1||0
5108158|NCT01573273|12566442|P4|STARTED|MRI 1||23
5108159|NCT01573273|12566443|P3|STARTED|MRI 1||19
5108160|NCT01573273|12566444|P2|STARTED|MRI 1||0
5108161|NCT01573273|12566445|P1|STARTED|MRI 1||0
5108162|NCT01573273|12566434|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108163|NCT01573273|12566435|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108164|NCT01573273|12566436|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108165|NCT01573273|12566437|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108166|NCT01573273|12566438|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108167|NCT01573273|12566439|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108168|NCT01573273|12566440|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108169|NCT01573273|12566441|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108170|NCT01573273|12566442|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108171|NCT01573273|12566443|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108172|NCT01573273|12566444|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108173|NCT01573273|12566445|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
5108174|NCT01573273|12566434|P12|COMPLETED|TSST : Trier Social Stress Task||0
5108175|NCT01573273|12566435|P11|COMPLETED|TSST : Trier Social Stress Task||0
5108176|NCT01573273|12566436|P10|COMPLETED|TSST : Trier Social Stress Task||0
5108177|NCT01573273|12566437|P9|COMPLETED|TSST : Trier Social Stress Task||0
5108178|NCT01573273|12566438|P8|COMPLETED|TSST : Trier Social Stress Task||31
5108179|NCT01573273|12566439|P7|COMPLETED|TSST : Trier Social Stress Task||32
5108180|NCT01573273|12566440|P6|COMPLETED|TSST : Trier Social Stress Task||0
5108181|NCT01573273|12566441|P5|COMPLETED|TSST : Trier Social Stress Task||0
5108182|NCT01573273|12566442|P4|COMPLETED|TSST : Trier Social Stress Task||0
5108183|NCT01573273|12566443|P3|COMPLETED|TSST : Trier Social Stress Task||0
5108184|NCT01573273|12566444|P2|COMPLETED|TSST : Trier Social Stress Task||25
5108185|NCT01573273|12566445|P1|COMPLETED|TSST : Trier Social Stress Task||24
5108186|NCT01573273|12566434|P12|STARTED|TSST : Trier Social Stress Task||0
5108187|NCT01573273|12566435|P11|STARTED|TSST : Trier Social Stress Task||0
5108188|NCT01573273|12566436|P10|STARTED|TSST : Trier Social Stress Task||0
5108189|NCT01573273|12566437|P9|STARTED|TSST : Trier Social Stress Task||0
5108190|NCT01573273|12566438|P8|STARTED|TSST : Trier Social Stress Task||31
5108191|NCT01573273|12566439|P7|STARTED|TSST : Trier Social Stress Task||32
5108192|NCT01573273|12566440|P6|STARTED|TSST : Trier Social Stress Task||0
5108193|NCT01573273|12566441|P5|STARTED|TSST : Trier Social Stress Task||0
5108194|NCT01573273|12566442|P4|STARTED|TSST : Trier Social Stress Task||0
5108195|NCT01573273|12566443|P3|STARTED|TSST : Trier Social Stress Task||0
5108196|NCT01573273|12566444|P2|STARTED|TSST : Trier Social Stress Task||25
5108197|NCT01573273|12566445|P1|STARTED|TSST : Trier Social Stress Task||24
5108198|NCT01573260|12566485|P2|NOT COMPLETED|Overall Study||0
5108199|NCT01573260|12566486|P1|NOT COMPLETED|Overall Study||0
5108200|NCT01573260|12566485|P2|COMPLETED|Overall Study||15
5108201|NCT01573260|12566486|P1|COMPLETED|Overall Study||18
5108202|NCT01573260|12566485|P2|STARTED|Overall Study||15
5108203|NCT01573260|12566486|P1|STARTED|Overall Study||18
5108204|NCT01573000|12566520|P2|NOT COMPLETED|Long-Term Follow-Up||1
5108205|NCT01573000|12566521|P1|NOT COMPLETED|Long-Term Follow-Up||3
5108206|NCT01573000|12566520|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
5108207|NCT01573000|12566521|P1|COMPLETED|Long-Term Follow-Up||11
5108208|NCT01573000|12566520|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
5108209|NCT01573000|12566521|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
5108210|NCT01573000|12566520|P2|NOT COMPLETED|Crossover Phase||18
5108211|NCT01573000|12566521|P1|NOT COMPLETED|Crossover Phase||0
5108212|NCT01573000|12566520|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
5108213|NCT01573000|12566521|P1|COMPLETED|Crossover Phase||0
5108214|NCT01573000|12566520|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
5108215|NCT01573000|12566521|P1|STARTED|Crossover Phase||0
5108216|NCT01573000|12566520|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
5108217|NCT01573000|12566521|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
5108218|NCT01573000|12566520|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
5108219|NCT01573000|12566521|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
5108220|NCT01573000|12566520|P2|STARTED|Dosimetric and Therapeutic Treatment||36
5108221|NCT01573000|12566521|P1|STARTED|Dosimetric and Therapeutic Treatment||42
5108222|NCT01572948|12566617|P2|NOT COMPLETED|Overall Study||1
5108223|NCT01572948|12566618|P1|NOT COMPLETED|Overall Study||1
5108224|NCT01572948|12566617|P2|COMPLETED|Overall Study||15
5108225|NCT01572948|12566618|P1|COMPLETED|Overall Study||10
5108226|NCT01572948|12566617|P2|STARTED|Overall Study||16
5108227|NCT01572948|12566618|P1|STARTED|Overall Study||11
5108228|NCT01572922|12566634|P1|NOT COMPLETED|Overall Study||3
5108229|NCT01572922|12566634|P1|COMPLETED|Overall Study||139
5108230|NCT01572922|12566634|P1|STARTED|Overall Study||142
5108231|NCT01572909|12566646|P2|NOT COMPLETED|Overall Study||25
5108232|NCT01572909|12566647|P1|NOT COMPLETED|Overall Study||32
5108233|NCT01572909|12566646|P2|COMPLETED|Overall Study||123
5108234|NCT01572909|12566647|P1|COMPLETED|Overall Study||120
5108235|NCT01572909|12566646|P2|STARTED|Overall Study||148
5108236|NCT01572909|12566647|P1|STARTED|Overall Study||152
5108237|NCT01572844|12566691|P2|NOT COMPLETED|Overall Study||1
5108238|NCT01572844|12566692|P1|NOT COMPLETED|Overall Study||1
5108239|NCT01572844|12566691|P2|COMPLETED|Overall Study||2
5108240|NCT01572844|12566692|P1|COMPLETED|Overall Study||2
5108241|NCT01572844|12566691|P2|STARTED|Overall Study||3
5108242|NCT01572844|12566692|P1|STARTED|Overall Study||3
5108243|NCT01572792|12566710|P5|NOT COMPLETED|Extension Study||32
5108244|NCT01572792|12566711|P4|NOT COMPLETED|Extension Study||29
5108245|NCT01572792|12566712|P3|NOT COMPLETED|Extension Study||26
5108246|NCT01572792|12566713|P2|NOT COMPLETED|Extension Study||29
5108247|NCT01572792|12566714|P1|NOT COMPLETED|Extension Study||25
5108248|NCT01572792|12566710|P5|COMPLETED|Extension Study||160
5108249|NCT01572792|12566711|P4|COMPLETED|Extension Study||165
5108250|NCT01572792|12566712|P3|COMPLETED|Extension Study||179
5108251|NCT01572792|12566713|P2|COMPLETED|Extension Study||155
5108252|NCT01572792|12566714|P1|COMPLETED|Extension Study||121
5108253|NCT01572792|12566710|P5|STARTED|Extension Study||192
5108254|NCT01572792|12566711|P4|STARTED|Extension Study||194
5108255|NCT01572792|12566712|P3|STARTED|Extension Study||205
5108256|NCT01572792|12566713|P2|STARTED|Extension Study||184
5108257|NCT01572792|12566714|P1|STARTED|Extension Study||146
5108258|NCT01572792|12566710|P5|NOT COMPLETED|Lead-in Study||69
5108259|NCT01572792|12566711|P4|NOT COMPLETED|Lead-in Study||72
5108260|NCT01572792|12566712|P3|NOT COMPLETED|Lead-in Study||62
5108261|NCT01572792|12566713|P2|NOT COMPLETED|Lead-in Study||66
5108262|NCT01572792|12566714|P1|NOT COMPLETED|Lead-in Study||101
5108263|NCT01572792|12566710|P5|COMPLETED|Lead-in Study||270
5108264|NCT01572792|12566711|P4|COMPLETED|Lead-in Study||268
5108265|NCT01572792|12566712|P3|COMPLETED|Lead-in Study||276
5108266|NCT01572792|12566713|P2|COMPLETED|Lead-in Study||272
5108267|NCT01572792|12566714|P1|COMPLETED|Lead-in Study||236
5108268|NCT01572792|12566710|P5|STARTED|Lead-in Study||339
5108269|NCT01572792|12566711|P4|STARTED|Lead-in Study||340
5108270|NCT01572792|12566712|P3|STARTED|Lead-in Study||338
5108271|NCT01572792|12566713|P2|STARTED|Lead-in Study||338
5108272|NCT01572792|12566714|P1|STARTED|Lead-in Study||337
5108273|NCT01572740|12566763|P2|NOT COMPLETED|Overall Study||5
5108274|NCT01572740|12566764|P1|NOT COMPLETED|Overall Study||6
5108275|NCT01572740|12566763|P2|COMPLETED|Overall Study||125
5108276|NCT01572740|12566764|P1|COMPLETED|Overall Study||121
5108277|NCT01572740|12566763|P2|STARTED|Overall Study||130
5108278|NCT01572740|12566764|P1|STARTED|Overall Study||127
5108279|NCT01572727|12566794|P2|NOT COMPLETED|Overall Study||209
5108280|NCT01572727|12566795|P1|NOT COMPLETED|Overall Study||207
5108281|NCT01572727|12566794|P2|COMPLETED|Overall Study||0
5108282|NCT01572727|12566795|P1|COMPLETED|Overall Study||0
5108283|NCT01572727|12566794|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
5108284|NCT01572727|12566795|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
5108285|NCT01572727|12566794|P2|STARTED|Overall Study||209
5108286|NCT01572727|12566795|P1|STARTED|Overall Study||207
5108287|NCT01572675|12566817|P2|NOT COMPLETED|Overall Study||223
5108288|NCT01572675|12566818|P1|NOT COMPLETED|Overall Study||237
5108289|NCT01572675|12566817|P2|COMPLETED|Overall Study||56
5108290|NCT01572675|12566818|P1|COMPLETED|Overall Study||31
5108291|NCT01572675|12566817|P2|STARTED|Overall Study||279
5108292|NCT01572675|12566818|P1|STARTED|Overall Study||268
5108293|NCT01572428|12566917|P2|NOT COMPLETED|Overall Study||1
5108294|NCT01572428|12566918|P1|NOT COMPLETED|Overall Study||3
5108295|NCT01572428|12566917|P2|COMPLETED|Overall Study||401
5108296|NCT01572428|12566918|P1|COMPLETED|Overall Study||399
5108297|NCT01572428|12566917|P2|STARTED|Overall Study||402
5108298|NCT01572428|12566918|P1|STARTED|Overall Study||402
5108299|NCT01572389|12566936|P2|NOT COMPLETED|Overall Study||21
5108300|NCT01572389|12566937|P1|NOT COMPLETED|Overall Study||46
5108301|NCT01572389|12566936|P2|COMPLETED|Overall Study||68
5108302|NCT01572389|12566937|P1|COMPLETED|Overall Study||90
5108303|NCT01572389|12566936|P2|STARTED|Overall Study||89
5108304|NCT01572389|12566937|P1|STARTED|Overall Study||136
5108305|NCT01572298|12566947|P2|NOT COMPLETED|Overall Study||1
5108306|NCT01572298|12566948|P1|NOT COMPLETED|Overall Study||2
5108307|NCT01572298|12566947|P2|COMPLETED|Overall Study||12
5108308|NCT01572298|12566948|P1|COMPLETED|Overall Study||12
5108309|NCT01572298|12566947|P2|STARTED|Overall Study||13
5108310|NCT01572298|12566948|P1|STARTED|Overall Study||14
5108311|NCT01572207|12566958|P2|NOT COMPLETED|Overall Study||3
5108312|NCT01572207|12566959|P1|NOT COMPLETED|Overall Study||2
5108313|NCT01572207|12566958|P2|COMPLETED|Overall Study||13
5108314|NCT01572207|12566959|P1|COMPLETED|Overall Study||12
5108315|NCT01572207|12566958|P2|STARTED|Overall Study||16
5108316|NCT01572207|12566959|P1|STARTED|Overall Study||14
5108317|NCT01571557|12566969|P1|NOT COMPLETED|Overall Study||0
5108318|NCT01571557|12566969|P1|COMPLETED|Overall Study||573
5108319|NCT01571557|12566969|P1|STARTED|Overall Study||573
5108320|NCT01571453|12566978|P2|NOT COMPLETED|Overall Study||62
5108321|NCT01571453|12566979|P1|NOT COMPLETED|Overall Study||38
5108322|NCT01571453|12566978|P2|COMPLETED|Overall Study||164
5108323|NCT01571453|12566979|P1|COMPLETED|Overall Study||173
5108324|NCT01571453|12566978|P2|STARTED|Overall Study||226
5108325|NCT01571453|12566979|P1|STARTED|Overall Study||211
5108326|NCT01571427|12566997|P2|NOT COMPLETED|Overall Study||0
5108327|NCT01571427|12566998|P1|NOT COMPLETED|Overall Study||0
5108328|NCT01571427|12566997|P2|COMPLETED|Overall Study||42
5108329|NCT01571427|12566998|P1|COMPLETED|Overall Study||41
5108330|NCT01571427|12566997|P2|STARTED|Overall Study||42
5108331|NCT01571427|12566998|P1|STARTED|Overall Study||41
5108332|NCT01571362|12567026|P3|NOT COMPLETED|Double-Blind Treatment Period||39
5108333|NCT01571362|12567027|P2|NOT COMPLETED|Double-Blind Treatment Period||53
5108334|NCT01571362|12567028|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5108335|NCT01571362|12567026|P3|COMPLETED|Double-Blind Treatment Period||107
5108336|NCT01571362|12567027|P2|COMPLETED|Double-Blind Treatment Period||81
5108337|NCT01571362|12567028|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
5108338|NCT01571362|12567026|P3|STARTED|Double-Blind Treatment Period||146
5108339|NCT01571362|12567027|P2|STARTED|Double-Blind Treatment Period||134
5108340|NCT01571362|12567028|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
5108341|NCT01571362|12567026|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
5108342|NCT01571362|12567027|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
5108343|NCT01571362|12567028|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
5108344|NCT01571362|12567026|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
5108345|NCT01571362|12567027|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
5108346|NCT01571362|12567028|P1|COMPLETED|Open-Label Conversion + Titration Period||281
5108347|NCT01571362|12567026|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
5108348|NCT01571362|12567027|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
5108349|NCT01571362|12567028|P1|STARTED|Open-Label Conversion + Titration Period||410
5108350|NCT01571284|12567198|P1|NOT COMPLETED|Overall Study||169
5108351|NCT01571284|12567198|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
5108352|NCT01571284|12567198|P1|Safety Population|Overall Study||779
5108353|NCT01571284|12567198|P1|STARTED|Overall Study||781
5108354|NCT01571232|12567221|P2|NOT COMPLETED|Overall Study||1
5108355|NCT01571232|12567222|P1|NOT COMPLETED|Overall Study||1
5108356|NCT01571232|12567221|P2|COMPLETED|Overall Study||9
5108357|NCT01571232|12567222|P1|COMPLETED|Overall Study||9
5108358|NCT01571232|12567221|P2|STARTED|Overall Study||10
5108359|NCT01571232|12567222|P1|STARTED|Overall Study||10
5108360|NCT01570868|12567234|P2|NOT COMPLETED|Overall Study||8
5108361|NCT01570868|12567235|P1|NOT COMPLETED|Overall Study||43
5108362|NCT01570868|12567234|P2|COMPLETED|Overall Study||0
5108363|NCT01570868|12567235|P1|COMPLETED|Overall Study||0
5108364|NCT01570868|12567234|P2|STARTED|Overall Study||8
5108365|NCT01570868|12567235|P1|STARTED|Overall Study||43
5108366|NCT01570751|12567247|P2|NOT COMPLETED|Period B (16 Weeks)||1
5108367|NCT01570751|12567248|P1|NOT COMPLETED|Period B (16 Weeks)||1
5108368|NCT01570751|12567247|P2|COMPLETED|Period B (16 Weeks)||66
5108369|NCT01570751|12567248|P1|COMPLETED|Period B (16 Weeks)||69
5108370|NCT01570751|12567247|P2|Exposed|Period B (16 Weeks)||67
5108371|NCT01570751|12567248|P1|Exposed|Period B (16 Weeks)||70
5108372|NCT01570751|12567247|P2|STARTED|Period B (16 Weeks)||67
5108373|NCT01570751|12567248|P1|STARTED|Period B (16 Weeks)||70
5108374|NCT01570751|12567247|P2|NOT COMPLETED|Period A (16 Weeks)||5
5108375|NCT01570751|12567248|P1|NOT COMPLETED|Period A (16 Weeks)||3
5108376|NCT01570751|12567247|P2|COMPLETED|Period A (16 Weeks)||67
5108377|NCT01570751|12567248|P1|COMPLETED|Period A (16 Weeks)||70
5108378|NCT01570751|12567247|P2|Exposed|Period A (16 Weeks)||72
5108379|NCT01570751|12567248|P1|Exposed|Period A (16 Weeks)||73
5108380|NCT01570751|12567247|P2|STARTED|Period A (16 Weeks)||72
5108381|NCT01570751|12567248|P1|STARTED|Period A (16 Weeks)||73
5108382|NCT01570686|12567266|P2|NOT COMPLETED|Overall Study||16
5108383|NCT01570686|12567267|P1|NOT COMPLETED|Overall Study||22
5108384|NCT01570686|12567266|P2|COMPLETED|Overall Study||278
5108385|NCT01570686|12567267|P1|COMPLETED|Overall Study||274
5108386|NCT01570686|12567266|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
5108387|NCT01570686|12567267|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
5108388|NCT01570686|12567266|P2|STARTED|Overall Study||294
5108389|NCT01570686|12567267|P1|STARTED|Overall Study||296
5108390|NCT01570634|12567293|P1|NOT COMPLETED|Overall Study||0
5108391|NCT01570634|12567293|P1|COMPLETED|Overall Study||2
5108392|NCT01570634|12567293|P1|STARTED|Overall Study||2
5108393|NCT01570491|12567303|P2|NOT COMPLETED|Overall Study||1
5108394|NCT01570491|12567304|P1|NOT COMPLETED|Overall Study||5
5108395|NCT01570491|12567303|P2|COMPLETED|Overall Study||18
5108396|NCT01570491|12567304|P1|COMPLETED|Overall Study||14
5108397|NCT01570491|12567303|P2|STARTED|Overall Study||19
5108398|NCT01570491|12567304|P1|STARTED|Overall Study||19
5108399|NCT01570387|12567320|P4|NOT COMPLETED|Overall Study||2
5108400|NCT01570387|12567321|P3|NOT COMPLETED|Overall Study||0
5108401|NCT01570387|12567322|P2|NOT COMPLETED|Overall Study||0
5108402|NCT01570387|12567323|P1|NOT COMPLETED|Overall Study||1
5108403|NCT01570387|12567320|P4|COMPLETED|Overall Study||10
5108404|NCT01570387|12567321|P3|COMPLETED|Overall Study||6
5108405|NCT01570387|12567322|P2|COMPLETED|Overall Study||3
5108406|NCT01570387|12567323|P1|COMPLETED|Overall Study||5
5108407|NCT01570387|12567320|P4|Response to Maximal Tolerated Dose|Overall Study||6
5108408|NCT01570387|12567321|P3|Response to Maximal Tolerated Dose|Overall Study||3
5108409|NCT01570387|12567322|P2|Response to Maximal Tolerated Dose|Overall Study||0
5108410|NCT01570387|12567323|P1|Response to Maximal Tolerated Dose|Overall Study||0
5108411|NCT01570387|12567320|P4|Dose Limiting Toxicity|Overall Study||12
5108412|NCT01570387|12567321|P3|Dose Limiting Toxicity|Overall Study||6
5108413|NCT01570387|12567322|P2|Dose Limiting Toxicity|Overall Study||0
5108414|NCT01570387|12567323|P1|Dose Limiting Toxicity|Overall Study||0
5108415|NCT01570387|12567320|P4|STARTED|Overall Study||12
5108416|NCT01570387|12567321|P3|STARTED|Overall Study||6
5108417|NCT01570387|12567322|P2|STARTED|Overall Study||3
5108418|NCT01570387|12567323|P1|STARTED|Overall Study||6
5108419|NCT01570361|12567335|P2|NOT COMPLETED|Overall Study||75
5108420|NCT01570361|12567336|P1|NOT COMPLETED|Overall Study||82
5108421|NCT01570361|12567335|P2|COMPLETED|Overall Study||52
5108422|NCT01570361|12567336|P1|COMPLETED|Overall Study||46
5108423|NCT01570361|12567335|P2|AAD Therapy Only|Overall Study||108
5108424|NCT01570361|12567336|P1|AAD Therapy Only|Overall Study||0
5108425|NCT01570361|12567335|P2|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
5108426|NCT01570361|12567336|P1|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
5108427|NCT01570361|12567335|P2|Received Study Treatment|Overall Study||123
5108428|NCT01570361|12567336|P1|Received Study Treatment|Overall Study||102
5108429|NCT01570361|12567335|P2|STARTED|Overall Study||127
5108430|NCT01570361|12567336|P1|STARTED|Overall Study||128
5108431|NCT01570348|12567363|P1|NOT COMPLETED|Overall Study||0
5108432|NCT01570348|12567363|P1|COMPLETED|Overall Study||2
5108433|NCT01570348|12567363|P1|STARTED|Overall Study||2
5108434|NCT01570309|12567379|P2|NOT COMPLETED|Overall Study||3
5108435|NCT01570309|12567380|P1|NOT COMPLETED|Overall Study||3
5108436|NCT01570309|12567379|P2|COMPLETED|Overall Study||45
5108437|NCT01570309|12567380|P1|COMPLETED|Overall Study||45
5108438|NCT01570309|12567379|P2|STARTED|Overall Study||48
5108439|NCT01570309|12567380|P1|STARTED|Overall Study||48
5108440|NCT01570283|12567397|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
5108441|NCT01570283|12567398|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
5108442|NCT01570283|12567399|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
5108443|NCT01570283|12567400|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
5108444|NCT01570283|12567401|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
5108445|NCT01570283|12567402|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
5108446|NCT01570283|12567397|P6|COMPLETED|Cohort 3: Dose Level 3||10
5108447|NCT01570283|12567398|P5|COMPLETED|Cohort 3: Dose Level 3||1
5108448|NCT01570283|12567399|P4|COMPLETED|Cohort 3: Dose Level 3||0
5108449|NCT01570283|12567400|P3|COMPLETED|Cohort 3: Dose Level 3||0
5108450|NCT01570283|12567401|P2|COMPLETED|Cohort 3: Dose Level 3||0
5108451|NCT01570283|12567402|P1|COMPLETED|Cohort 3: Dose Level 3||0
5108452|NCT01570283|12567397|P6|STARTED|Cohort 3: Dose Level 3||12
5108453|NCT01570283|12567398|P5|STARTED|Cohort 3: Dose Level 3||1
5108454|NCT01570283|12567399|P4|STARTED|Cohort 3: Dose Level 3||0
5108455|NCT01570283|12567400|P3|STARTED|Cohort 3: Dose Level 3||0
5108456|NCT01570283|12567401|P2|STARTED|Cohort 3: Dose Level 3||0
5108457|NCT01570283|12567402|P1|STARTED|Cohort 3: Dose Level 3||0
5108458|NCT01570283|12567397|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
5108459|NCT01570283|12567398|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
5108460|NCT01570283|12567399|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
5108461|NCT01570283|12567400|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
5108462|NCT01570283|12567401|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
5108463|NCT01570283|12567402|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
5108464|NCT01570283|12567397|P6|COMPLETED|Cohort 2: Dose Level 2||0
5108465|NCT01570283|12567398|P5|COMPLETED|Cohort 2: Dose Level 2||0
5108466|NCT01570283|12567399|P4|COMPLETED|Cohort 2: Dose Level 2||1
5108467|NCT01570283|12567400|P3|COMPLETED|Cohort 2: Dose Level 2||1
5108468|NCT01570283|12567401|P2|COMPLETED|Cohort 2: Dose Level 2||0
5108469|NCT01570283|12567402|P1|COMPLETED|Cohort 2: Dose Level 2||0
5108470|NCT01570283|12567397|P6|STARTED|Cohort 2: Dose Level 2||0
5108471|NCT01570283|12567398|P5|STARTED|Cohort 2: Dose Level 2||0
5108472|NCT01570283|12567399|P4|STARTED|Cohort 2: Dose Level 2||2
5108473|NCT01570283|12567400|P3|STARTED|Cohort 2: Dose Level 2||2
5108474|NCT01570283|12567401|P2|STARTED|Cohort 2: Dose Level 2||0
5108475|NCT01570283|12567402|P1|STARTED|Cohort 2: Dose Level 2||0
5108476|NCT01570283|12567397|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
5108477|NCT01570283|12567398|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
5108478|NCT01570283|12567399|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
5108479|NCT01570283|12567400|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
5108480|NCT01570283|12567401|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
5108481|NCT01570283|12567402|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
5108482|NCT01570283|12567397|P6|COMPLETED|Cohort 1: Dose Level 1||0
5108483|NCT01570283|12567398|P5|COMPLETED|Cohort 1: Dose Level 1||0
5108484|NCT01570283|12567399|P4|COMPLETED|Cohort 1: Dose Level 1||0
5108485|NCT01570283|12567400|P3|COMPLETED|Cohort 1: Dose Level 1||0
5108486|NCT01570283|12567401|P2|COMPLETED|Cohort 1: Dose Level 1||1
5108487|NCT01570283|12567402|P1|COMPLETED|Cohort 1: Dose Level 1||1
5108488|NCT01570283|12567397|P6|STARTED|Cohort 1: Dose Level 1||0
5108489|NCT01570283|12567398|P5|STARTED|Cohort 1: Dose Level 1||0
5108490|NCT01570283|12567399|P4|STARTED|Cohort 1: Dose Level 1||0
5108491|NCT01570283|12567400|P3|STARTED|Cohort 1: Dose Level 1||0
5108492|NCT01570283|12567401|P2|STARTED|Cohort 1: Dose Level 1||3
5108493|NCT01570283|12567402|P1|STARTED|Cohort 1: Dose Level 1||1
5108494|NCT01570244|12567419|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
5108495|NCT01570244|12567419|P1|COMPLETED|Microgynon+Faldaprevir||15
5108496|NCT01570244|12567419|P1|STARTED|Microgynon+Faldaprevir||16
5108497|NCT01570244|12567419|P1|NOT COMPLETED|Microgynon||0
5108498|NCT01570244|12567419|P1|COMPLETED|Microgynon||16
5108499|NCT01570244|12567419|P1|STARTED|Microgynon||16
5108500|NCT01570192|12567441|P2|NOT COMPLETED|Overall Study||13
5108501|NCT01570192|12567442|P1|NOT COMPLETED|Overall Study||7
5108502|NCT01570192|12567441|P2|COMPLETED|Overall Study||17
5108503|NCT01570192|12567442|P1|COMPLETED|Overall Study||6
5108504|NCT01570192|12567441|P2|STARTED|Overall Study||30
5108505|NCT01570192|12567442|P1|STARTED|Overall Study||13
5108506|NCT01569841|12567480|P2|NOT COMPLETED|Period B (6 Weeks)||0
5108507|NCT01569841|12567481|P1|NOT COMPLETED|Period B (6 Weeks)||0
5108508|NCT01569841|12567480|P2|COMPLETED|Period B (6 Weeks)||11
5108509|NCT01569841|12567481|P1|COMPLETED|Period B (6 Weeks)||12
5108510|NCT01569841|12567480|P2|Exposed|Period B (6 Weeks)||11
5108511|NCT01569841|12567481|P1|Exposed|Period B (6 Weeks)||12
5108512|NCT01569841|12567480|P2|STARTED|Period B (6 Weeks)||11
5108513|NCT01569841|12567481|P1|STARTED|Period B (6 Weeks)||12
5108514|NCT01569841|12567480|P2|NOT COMPLETED|Period A (6 Weeks)||1
5108515|NCT01569841|12567481|P1|NOT COMPLETED|Period A (6 Weeks)||0
5108516|NCT01569841|12567480|P2|COMPLETED|Period A (6 Weeks)||11
5108517|NCT01569841|12567481|P1|COMPLETED|Period A (6 Weeks)||12
5108518|NCT01569841|12567480|P2|Exposed|Period A (6 Weeks)||12
5108519|NCT01569841|12567481|P1|Exposed|Period A (6 Weeks)||12
5108520|NCT01569841|12567480|P2|STARTED|Period A (6 Weeks)||12
5108521|NCT01569841|12567481|P1|STARTED|Period A (6 Weeks)||12
5108522|NCT01569828|12567499|P2|NOT COMPLETED|Overall Study||0
5108523|NCT01569828|12567500|P1|NOT COMPLETED|Overall Study||0
5108524|NCT01569828|12567499|P2|COMPLETED|Overall Study||6
5108525|NCT01569828|12567500|P1|COMPLETED|Overall Study||6
5108526|NCT01569828|12567499|P2|STARTED|Overall Study||6
5108527|NCT01569828|12567500|P1|STARTED|Overall Study||6
5108528|NCT01569815|12567522|P4|NOT COMPLETED|Overall Study||0
5108529|NCT01569815|12567523|P3|NOT COMPLETED|Overall Study||0
5108530|NCT01569815|12567524|P2|NOT COMPLETED|Overall Study||0
5108531|NCT01569815|12567525|P1|NOT COMPLETED|Overall Study||0
5108532|NCT01569815|12567522|P4|COMPLETED|Overall Study||8
5108533|NCT01569815|12567523|P3|COMPLETED|Overall Study||8
5108534|NCT01569815|12567524|P2|COMPLETED|Overall Study||8
5108535|NCT01569815|12567525|P1|COMPLETED|Overall Study||8
5108536|NCT01569815|12567522|P4|STARTED|Overall Study||8
5108537|NCT01569815|12567523|P3|STARTED|Overall Study||8
5108538|NCT01569815|12567524|P2|STARTED|Overall Study||8
5108539|NCT01569815|12567525|P1|STARTED|Overall Study||8
5108540|NCT01569763|12567570|P2|NOT COMPLETED|Overall Study||7
5108541|NCT01569763|12567571|P1|NOT COMPLETED|Overall Study||3
5108542|NCT01569763|12567570|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
5108543|NCT01569763|12567571|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
5108544|NCT01569763|12567570|P2|Treated|Overall Study||51
5108545|NCT01569763|12567571|P1|Treated|Overall Study||102
5108546|NCT01569763|12567570|P2|STARTED|Overall Study||51
5108547|NCT01569763|12567571|P1|STARTED|Overall Study||102
5108548|NCT01569737|12567581|P1|NOT COMPLETED|Overall Study||3
5108549|NCT01569737|12567581|P1|COMPLETED|Overall Study||95
5108550|NCT01569737|12567581|P1|STARTED|Overall Study||98
5108551|NCT01569607|12567587|P2|NOT COMPLETED|Overall Study||1
5108552|NCT01569607|12567588|P1|NOT COMPLETED|Overall Study||1
5108553|NCT01569607|12567587|P2|COMPLETED|Overall Study||10
5108554|NCT01569607|12567588|P1|COMPLETED|Overall Study||10
5108555|NCT01569607|12567587|P2|STARTED|Overall Study||11
5108556|NCT01569607|12567588|P1|STARTED|Overall Study||11
5108557|NCT01569594|12567610|P1|NOT COMPLETED|Overall Study||67
5108558|NCT01569594|12567610|P1|COMPLETED|Overall Study||163
5108559|NCT01569594|12567610|P1|STARTED|Overall Study||230
5108560|NCT01569568|12567616|P2|NOT COMPLETED|Overall Study||2
5108561|NCT01569568|12567617|P1|NOT COMPLETED|Overall Study||0
5108562|NCT01569568|12567616|P2|COMPLETED|Overall Study||27
5108563|NCT01569568|12567617|P1|COMPLETED|Overall Study||20
5108564|NCT01569568|12567616|P2|STARTED|Overall Study||29
5108565|NCT01569568|12567617|P1|STARTED|Overall Study||20
5108566|NCT01569529|12567631|P2|NOT COMPLETED|Overall Study||0
5108567|NCT01569529|12567632|P1|NOT COMPLETED|Overall Study||0
5108568|NCT01569529|12567631|P2|COMPLETED|Overall Study||394
5108569|NCT01569529|12567632|P1|COMPLETED|Overall Study||2676
5108570|NCT01569529|12567631|P2|STARTED|Overall Study||394
5108571|NCT01569529|12567632|P1|STARTED|Overall Study||2676
5108572|NCT01569464|12567640|P2|NOT COMPLETED|Overall Study||5
5108573|NCT01569464|12567641|P1|NOT COMPLETED|Overall Study||10
5108574|NCT01569464|12567640|P2|COMPLETED|Overall Study||44
5108575|NCT01569464|12567641|P1|COMPLETED|Overall Study||91
5108576|NCT01569464|12567640|P2|STARTED|Overall Study||49
5108577|NCT01569464|12567641|P1|STARTED|Overall Study||101
5108578|NCT01569451|12567679|P2|NOT COMPLETED|Overall Study||13
5108579|NCT01569451|12567680|P1|NOT COMPLETED|Overall Study||14
5108580|NCT01569451|12567679|P2|COMPLETED|Overall Study||14
5108581|NCT01569451|12567680|P1|COMPLETED|Overall Study||12
5108582|NCT01569451|12567679|P2|STARTED|Overall Study||27
5108583|NCT01569451|12567680|P1|STARTED|Overall Study||26
5108584|NCT01569438|12567708|P2|NOT COMPLETED|Overall Study||9
5108585|NCT01569438|12567709|P1|NOT COMPLETED|Overall Study||2
5108586|NCT01569438|12567708|P2|COMPLETED|Overall Study||27
5108587|NCT01569438|12567709|P1|COMPLETED|Overall Study||36
5108588|NCT01569438|12567708|P2|STARTED|Overall Study||36
5108589|NCT01569438|12567709|P1|STARTED|Overall Study||38
5108590|NCT01569295|12567723|P2|NOT COMPLETED|Overall Study||209
5108591|NCT01569295|12567724|P1|NOT COMPLETED|Overall Study||207
5108592|NCT01569295|12567723|P2|COMPLETED|Overall Study||0
5108593|NCT01569295|12567724|P1|COMPLETED|Overall Study||0
5108594|NCT01569295|12567723|P2|Long-Term Follow-up|Overall Study||161
5108595|NCT01569295|12567724|P1|Long-Term Follow-up|Overall Study||109
5108596|NCT01569295|12567723|P2|STARTED|Overall Study||209
5108597|NCT01569295|12567724|P1|STARTED|Overall Study||207
5108598|NCT01569191|12567740|P2|NOT COMPLETED|Overall Study||0
5108599|NCT01569191|12567741|P1|NOT COMPLETED|Overall Study||0
5108600|NCT01569191|12567740|P2|COMPLETED|Overall Study||7
5108601|NCT01569191|12567741|P1|COMPLETED|Overall Study||11
5108602|NCT01569191|12567740|P2|STARTED|Overall Study||7
5108603|NCT01569191|12567741|P1|STARTED|Overall Study||11
5108604|NCT01569152|12567761|P3|NOT COMPLETED|Safety Extension, Period 3||55
5108605|NCT01569152|12567762|P2|NOT COMPLETED|Safety Extension, Period 3||0
5108606|NCT01569152|12567763|P1|NOT COMPLETED|Safety Extension, Period 3||0
5108607|NCT01569152|12567761|P3|COMPLETED|Safety Extension, Period 3||0
5108608|NCT01569152|12567762|P2|COMPLETED|Safety Extension, Period 3||0
5108609|NCT01569152|12567763|P1|COMPLETED|Safety Extension, Period 3||0
5108610|NCT01569152|12567761|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
5108611|NCT01569152|12567762|P2|STARTED|Safety Extension, Period 3||0
5108612|NCT01569152|12567763|P1|STARTED|Safety Extension, Period 3||0
5108613|NCT01569152|12567761|P3|NOT COMPLETED|Phase IIa, Period 1||0
5108614|NCT01569152|12567762|P2|NOT COMPLETED|Phase IIa, Period 1||32
5108615|NCT01569152|12567763|P1|NOT COMPLETED|Phase IIa, Period 1||21
5108616|NCT01569152|12567761|P3|COMPLETED|Phase IIa, Period 1||0
5108617|NCT01569152|12567762|P2|COMPLETED|Phase IIa, Period 1||9
5108618|NCT01569152|12567763|P1|COMPLETED|Phase IIa, Period 1||20
5108619|NCT01569152|12567761|P3|STARTED|Phase IIa, Period 1||0
5108620|NCT01569152|12567762|P2|STARTED|Phase IIa, Period 1||41
5108621|NCT01569152|12567763|P1|STARTED|Phase IIa, Period 1||41
5108622|NCT01569126|12567826|P6|NOT COMPLETED|Overall Study||0
5108623|NCT01569126|12567827|P5|NOT COMPLETED|Overall Study||0
5108624|NCT01569126|12567828|P4|NOT COMPLETED|Overall Study||0
5108625|NCT01569126|12567829|P3|NOT COMPLETED|Overall Study||0
5108626|NCT01569126|12567830|P2|NOT COMPLETED|Overall Study||0
5108627|NCT01569126|12567831|P1|NOT COMPLETED|Overall Study||0
5108628|NCT01569126|12567826|P6|COMPLETED|Overall Study||12
5108629|NCT01569126|12567827|P5|COMPLETED|Overall Study||12
5108630|NCT01569126|12567828|P4|COMPLETED|Overall Study||8
5108631|NCT01569126|12567829|P3|COMPLETED|Overall Study||8
5108632|NCT01569126|12567830|P2|COMPLETED|Overall Study||8
5108633|NCT01569126|12567831|P1|COMPLETED|Overall Study||8
5108634|NCT01569126|12567826|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
5108635|NCT01569126|12567827|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
5108636|NCT01569126|12567828|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
5108637|NCT01569126|12567829|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
5108638|NCT01569126|12567830|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
5108639|NCT01569126|12567831|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5108640|NCT01569126|12567826|P6|STARTED|Overall Study||12
5108641|NCT01569126|12567827|P5|STARTED|Overall Study||12
5108642|NCT01569126|12567828|P4|STARTED|Overall Study||8
5108643|NCT01569126|12567829|P3|STARTED|Overall Study||8
5108644|NCT01569126|12567830|P2|STARTED|Overall Study||8
5108645|NCT01569126|12567831|P1|STARTED|Overall Study||8
5108646|NCT01569087|12567869|P3|NOT COMPLETED|Overall Study||1
5108647|NCT01569087|12567870|P2|NOT COMPLETED|Overall Study||0
5108648|NCT01569087|12567871|P1|NOT COMPLETED|Overall Study||1
5108649|NCT01569087|12567869|P3|COMPLETED|Overall Study||18
5108650|NCT01569087|12567870|P2|COMPLETED|Overall Study||20
5108651|NCT01569087|12567871|P1|COMPLETED|Overall Study||20
5108652|NCT01569087|12567869|P3|STARTED|Overall Study||19
5108653|NCT01569087|12567870|P2|STARTED|Overall Study||20
5108654|NCT01569087|12567871|P1|STARTED|Overall Study||21
5108655|NCT01569074|12567899|P5|NOT COMPLETED|Overall Study||8
5108656|NCT01569074|12567900|P4|NOT COMPLETED|Overall Study||8
5108657|NCT01569074|12567901|P3|NOT COMPLETED|Overall Study||12
5108658|NCT01569074|12567902|P2|NOT COMPLETED|Overall Study||9
5108659|NCT01569074|12567903|P1|NOT COMPLETED|Overall Study||7
5108660|NCT01569074|12567899|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
5108661|NCT01569074|12567900|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
5108662|NCT01569074|12567901|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
5108663|NCT01569074|12567902|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
5108664|NCT01569074|12567903|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
5108665|NCT01569074|12567899|P5|Randomised But Did Not Receive Treatment|Overall Study||0
5108666|NCT01569074|12567900|P4|Randomised But Did Not Receive Treatment|Overall Study||0
5108667|NCT01569074|12567901|P3|Randomised But Did Not Receive Treatment|Overall Study||0
5108668|NCT01569074|12567902|P2|Randomised But Did Not Receive Treatment|Overall Study||0
5108669|NCT01569074|12567903|P1|Randomised But Did Not Receive Treatment|Overall Study||0
5108670|NCT01569074|12567899|P5|STARTED|Overall Study|Patients who received treatment|33
5108671|NCT01569074|12567900|P4|STARTED|Overall Study|Patients who received treatment|33
5108672|NCT01569074|12567901|P3|STARTED|Overall Study|Patients who received treatment|33
5108673|NCT01569074|12567902|P2|STARTED|Overall Study|Patients who received treatment|33
5108674|NCT01569074|12567903|P1|STARTED|Overall Study|Patients who received treatment|31
5108675|NCT01569022|12567959|P2|NOT COMPLETED|Second Intervention||2
5108676|NCT01569022|12567960|P1|NOT COMPLETED|Second Intervention||2
5108677|NCT01569022|12567959|P2|COMPLETED|Second Intervention||18
5108678|NCT01569022|12567960|P1|COMPLETED|Second Intervention||17
5108679|NCT01569022|12567959|P2|STARTED|Second Intervention||20
5108680|NCT01569022|12567960|P1|STARTED|Second Intervention||19
5108681|NCT01569022|12567959|P2|NOT COMPLETED|First Intervention||1
5108682|NCT01569022|12567960|P1|NOT COMPLETED|First Intervention||2
5108683|NCT01569022|12567959|P2|COMPLETED|First Intervention||20
5108684|NCT01569022|12567960|P1|COMPLETED|First Intervention||19
5108685|NCT01569022|12567959|P2|STARTED|First Intervention||21
5108686|NCT01569022|12567960|P1|STARTED|First Intervention||21
5108687|NCT01568944|12567974|P2|NOT COMPLETED|Overall Study||0
5108688|NCT01568944|12567975|P1|NOT COMPLETED|Overall Study||0
5108689|NCT01568944|12567974|P2|COMPLETED|Overall Study||10
5108690|NCT01568944|12567975|P1|COMPLETED|Overall Study||8
5108691|NCT01568944|12567974|P2|STARTED|Overall Study||10
5108692|NCT01568944|12567975|P1|STARTED|Overall Study||8
5108693|NCT01568905|12567994|P3|NOT COMPLETED|Overall Study||0
5108694|NCT01568905|12567995|P2|NOT COMPLETED|Overall Study||0
5108695|NCT01568905|12567996|P1|NOT COMPLETED|Overall Study||1
5108696|NCT01568905|12567994|P3|COMPLETED|Overall Study||12
5108697|NCT01568905|12567995|P2|COMPLETED|Overall Study||11
5108698|NCT01568905|12567996|P1|COMPLETED|Overall Study||12
5108699|NCT01568905|12567994|P3|STARTED|Overall Study||12
5108700|NCT01568905|12567995|P2|STARTED|Overall Study||11
5108701|NCT01568905|12567996|P1|STARTED|Overall Study||13
5108702|NCT01568892|12568015|P2|NOT COMPLETED|Open-label Phase||3
5108703|NCT01568892|12568016|P1|NOT COMPLETED|Open-label Phase||6
5108704|NCT01568892|12568015|P2|COMPLETED|Open-label Phase||13
5108705|NCT01568892|12568016|P1|COMPLETED|Open-label Phase||7
5108706|NCT01568892|12568015|P2|STARTED|Open-label Phase||16
5108707|NCT01568892|12568016|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
5108708|NCT01568892|12568015|P2|NOT COMPLETED|Double-blind Phase||0
5108709|NCT01568892|12568016|P1|NOT COMPLETED|Double-blind Phase||0
5108710|NCT01568892|12568015|P2|COMPLETED|Double-blind Phase||16
5108711|NCT01568892|12568016|P1|COMPLETED|Double-blind Phase||14
5108712|NCT01568892|12568015|P2|STARTED|Double-blind Phase||16
5108713|NCT01568892|12568016|P1|STARTED|Double-blind Phase||14
5108714|NCT01568866|12568086|P2|NOT COMPLETED|Overall Study||416
5108715|NCT01568866|12568087|P1|NOT COMPLETED|Overall Study||438
5108716|NCT01568866|12568086|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
5108717|NCT01568866|12568087|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
5108718|NCT01568866|12568086|P2|Received Treatment|Overall Study||463
5108719|NCT01568866|12568087|P1|Received Treatment|Overall Study||456
5108720|NCT01568866|12568086|P2|STARTED|Overall Study||464
5108721|NCT01568866|12568087|P1|STARTED|Overall Study||465
5108722|NCT01568827|12568109|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
5108723|NCT01568827|12568110|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
5108724|NCT01568827|12568109|P2|COMPLETED|Intervention 2 (5 Days)||5
5108725|NCT01568827|12568110|P1|COMPLETED|Intervention 2 (5 Days)||5
5108726|NCT01568827|12568109|P2|STARTED|Intervention 2 (5 Days)||5
5108727|NCT01568827|12568110|P1|STARTED|Intervention 2 (5 Days)||5
5108728|NCT01568827|12568109|P2|NOT COMPLETED|Washout (2 Days)||0
5108729|NCT01568827|12568110|P1|NOT COMPLETED|Washout (2 Days)||0
5108730|NCT01568827|12568109|P2|COMPLETED|Washout (2 Days)||5
5108731|NCT01568827|12568110|P1|COMPLETED|Washout (2 Days)||5
5108732|NCT01568827|12568109|P2|STARTED|Washout (2 Days)||5
5108733|NCT01568827|12568110|P1|STARTED|Washout (2 Days)||5
5108734|NCT01568827|12568109|P2|NOT COMPLETED|First Intervention (6 Days)||0
5108735|NCT01568827|12568110|P1|NOT COMPLETED|First Intervention (6 Days)||0
5108736|NCT01568827|12568109|P2|COMPLETED|First Intervention (6 Days)||5
5108737|NCT01568827|12568110|P1|COMPLETED|First Intervention (6 Days)||5
5108738|NCT01568827|12568109|P2|STARTED|First Intervention (6 Days)||5
5108739|NCT01568827|12568110|P1|STARTED|First Intervention (6 Days)||5
5108740|NCT01568606|12568116|P1|NOT COMPLETED|Overall Study||0
5108741|NCT01568606|12568116|P1|COMPLETED|Overall Study||20
5108742|NCT01568606|12568116|P1|STARTED|Overall Study||20
5108743|NCT01568593|12568122|P2|NOT COMPLETED|Overall Study||3
5108744|NCT01568593|12568123|P1|NOT COMPLETED|Overall Study||7
5108745|NCT01568593|12568122|P2|COMPLETED|Overall Study||42
5108746|NCT01568593|12568123|P1|COMPLETED|Overall Study||41
5108747|NCT01568593|12568122|P2|STARTED|Overall Study||45
5108748|NCT01568593|12568123|P1|STARTED|Overall Study||48
5108749|NCT01568528|12568132|P3|NOT COMPLETED|Overall Study||0
5108750|NCT01568528|12568133|P2|NOT COMPLETED|Overall Study||0
5108751|NCT01568528|12568134|P1|NOT COMPLETED|Overall Study||0
5108752|NCT01568528|12568132|P3|COMPLETED|Overall Study||9
5108753|NCT01568528|12568133|P2|COMPLETED|Overall Study||11
5108754|NCT01568528|12568134|P1|COMPLETED|Overall Study||19
5108755|NCT01568528|12568132|P3|STARTED|Overall Study||9
5108756|NCT01568528|12568133|P2|STARTED|Overall Study||11
5108757|NCT01568528|12568134|P1|STARTED|Overall Study||19
5108758|NCT01568424|12568154|P1|NOT COMPLETED|Overall Study||0
5108759|NCT01568424|12568154|P1|COMPLETED|Overall Study||25
5108760|NCT01568424|12568154|P1|STARTED|Overall Study||25
5108761|NCT01568112|12568168|P4|NOT COMPLETED|Overall Study||12
5108762|NCT01568112|12568169|P3|NOT COMPLETED|Overall Study||7
5108763|NCT01568112|12568170|P2|NOT COMPLETED|Overall Study||8
5108764|NCT01568112|12568171|P1|NOT COMPLETED|Overall Study||5
5108765|NCT01568112|12568168|P4|COMPLETED|Overall Study||30
5108766|NCT01568112|12568169|P3|COMPLETED|Overall Study||36
5108767|NCT01568112|12568170|P2|COMPLETED|Overall Study||36
5108768|NCT01568112|12568171|P1|COMPLETED|Overall Study||39
5108769|NCT01568112|12568168|P4|STARTED|Overall Study||42
5108770|NCT01568112|12568169|P3|STARTED|Overall Study||43
5108771|NCT01568112|12568170|P2|STARTED|Overall Study||44
5108772|NCT01568112|12568171|P1|STARTED|Overall Study||44
5108773|NCT01568073|12568294|P5|NOT COMPLETED|Overall Study||9
5108774|NCT01568073|12568295|P4|NOT COMPLETED|Overall Study||11
5108775|NCT01568073|12568296|P3|NOT COMPLETED|Overall Study||12
5108776|NCT01568073|12568297|P2|NOT COMPLETED|Overall Study||15
5108777|NCT01568073|12568298|P1|NOT COMPLETED|Overall Study||11
5108778|NCT01568073|12568294|P5|COMPLETED|Overall Study||107
5108779|NCT01568073|12568295|P4|COMPLETED|Overall Study||108
5108780|NCT01568073|12568296|P3|COMPLETED|Overall Study||110
5108781|NCT01568073|12568297|P2|COMPLETED|Overall Study||107
5108782|NCT01568073|12568298|P1|COMPLETED|Overall Study||110
5108783|NCT01568073|12568294|P5|STARTED|Overall Study||116
5108784|NCT01568073|12568295|P4|STARTED|Overall Study||119
5108785|NCT01568073|12568296|P3|STARTED|Overall Study||122
5108786|NCT01568073|12568297|P2|STARTED|Overall Study||122
5108787|NCT01568073|12568298|P1|STARTED|Overall Study||121
5108788|NCT01568047|12568329|P4|NOT COMPLETED|Overall Study||1
5108789|NCT01568047|12568330|P3|NOT COMPLETED|Overall Study||1
5108790|NCT01568047|12568331|P2|NOT COMPLETED|Overall Study||1
5108791|NCT01568047|12568332|P1|NOT COMPLETED|Overall Study||1
5108792|NCT01568047|12568329|P4|COMPLETED|Overall Study||9
5108793|NCT01568047|12568330|P3|COMPLETED|Overall Study||9
5108794|NCT01568047|12568331|P2|COMPLETED|Overall Study||9
5108795|NCT01568047|12568332|P1|COMPLETED|Overall Study||9
5108796|NCT01568047|12568329|P4|STARTED|Overall Study||10
5108797|NCT01568047|12568330|P3|STARTED|Overall Study||10
5108798|NCT01568047|12568331|P2|STARTED|Overall Study||10
5108799|NCT01568047|12568332|P1|STARTED|Overall Study||10
5108800|NCT01568034|12568350|P4|NOT COMPLETED|Overall Study||0
5108801|NCT01568034|12568351|P3|NOT COMPLETED|Overall Study||0
5108802|NCT01568034|12568352|P2|NOT COMPLETED|Overall Study||0
5108803|NCT01568034|12568353|P1|NOT COMPLETED|Overall Study||1
5108804|NCT01568034|12568350|P4|COMPLETED|Overall Study||3
5108805|NCT01568034|12568351|P3|COMPLETED|Overall Study||3
5108806|NCT01568034|12568352|P2|COMPLETED|Overall Study||2
5108807|NCT01568034|12568353|P1|COMPLETED|Overall Study||1
5108808|NCT01568034|12568350|P4|Placebo|Overall Study||3
5108809|NCT01568034|12568351|P3|Placebo|Overall Study||3
5108810|NCT01568034|12568352|P2|Placebo|Overall Study||2
5108811|NCT01568034|12568353|P1|Placebo|Overall Study||1
5108812|NCT01568034|12568350|P4|100 mg BIA 9-1067|Overall Study||3
5108813|NCT01568034|12568351|P3|100 mg BIA 9-1067|Overall Study||3
5108814|NCT01568034|12568352|P2|100 mg BIA 9-1067|Overall Study||2
5108815|NCT01568034|12568353|P1|100 mg BIA 9-1067|Overall Study||2
5108816|NCT01568034|12568350|P4|50 mg BIA 9-1067|Overall Study||3
5108817|NCT01568034|12568351|P3|50 mg BIA 9-1067|Overall Study||3
5108818|NCT01568034|12568352|P2|50 mg BIA 9-1067|Overall Study||2
5108819|NCT01568034|12568353|P1|50 mg BIA 9-1067|Overall Study||2
5108820|NCT01568034|12568350|P4|25 mg BIA 9-1067|Overall Study||3
5108821|NCT01568034|12568351|P3|25 mg BIA 9-1067|Overall Study||3
5108822|NCT01568034|12568352|P2|25 mg BIA 9-1067|Overall Study||2
5108823|NCT01568034|12568353|P1|25 mg BIA 9-1067|Overall Study||2
5108824|NCT01568034|12568350|P4|STARTED|Overall Study||3
5108825|NCT01568034|12568351|P3|STARTED|Overall Study||3
5108826|NCT01568034|12568352|P2|STARTED|Overall Study||2
5108827|NCT01568034|12568353|P1|STARTED|Overall Study||2
5108828|NCT01568021|12568371|P1|NOT COMPLETED|Overall Study||16
5108829|NCT01568021|12568371|P1|COMPLETED|Overall Study||83
5108830|NCT01568021|12568371|P1|STARTED|Overall Study||99
5108831|NCT01568008|12568377|P1|NOT COMPLETED|Overall Study||234
5108832|NCT01568008|12568377|P1|COMPLETED|Overall Study||699
5108833|NCT01568008|12568377|P1|STARTED|Overall Study||933
5108834|NCT01567943|12568388|P3|NOT COMPLETED|Overall Study||0
5108835|NCT01567943|12568389|P2|NOT COMPLETED|Overall Study||10
5108836|NCT01567943|12568390|P1|NOT COMPLETED|Overall Study||14
5108837|NCT01567943|12568388|P3|COMPLETED|Overall Study||44
5108838|NCT01567943|12568389|P2|COMPLETED|Overall Study||29
5108839|NCT01567943|12568390|P1|COMPLETED|Overall Study||26
5108840|NCT01567943|12568388|P3|STARTED|Overall Study||44
5108841|NCT01567943|12568389|P2|STARTED|Overall Study||39
5108842|NCT01567943|12568390|P1|STARTED|Overall Study||40
5108843|NCT01567891|12568398|P1|NOT COMPLETED|Overall Study||3
5108844|NCT01567891|12568398|P1|COMPLETED|Overall Study||6
5108845|NCT01567891|12568398|P1|Received T-cell|Overall Study||6
5108846|NCT01567891|12568398|P1|STARTED|Overall Study||9
5108847|NCT01567865|12568416|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
5108848|NCT01567865|12568417|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
5108849|NCT01567865|12568418|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
5108850|NCT01567865|12568419|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
5108851|NCT01567865|12568416|P4|COMPLETED|Evaluated for Immunogenicity||194
5108852|NCT01567865|12568417|P3|COMPLETED|Evaluated for Immunogenicity||192
5108853|NCT01567865|12568418|P2|COMPLETED|Evaluated for Immunogenicity||195
5108854|NCT01567865|12568419|P1|COMPLETED|Evaluated for Immunogenicity||146
5108855|NCT01567865|12568416|P4|STARTED|Evaluated for Immunogenicity||224
5108856|NCT01567865|12568417|P3|STARTED|Evaluated for Immunogenicity||211
5108857|NCT01567865|12568418|P2|STARTED|Evaluated for Immunogenicity||220
5108858|NCT01567865|12568419|P1|STARTED|Evaluated for Immunogenicity||163
5108859|NCT01567865|12568416|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
5108860|NCT01567865|12568417|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
5108861|NCT01567865|12568418|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
5108862|NCT01567865|12568419|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
5108863|NCT01567865|12568416|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
5108864|NCT01567865|12568417|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
5108865|NCT01567865|12568418|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
5108866|NCT01567865|12568419|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
5108867|NCT01567865|12568416|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
5108868|NCT01567865|12568417|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
5108869|NCT01567865|12568418|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
5108870|NCT01567865|12568419|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
5108871|NCT01567852|12568449|P2|NOT COMPLETED|Overall Study||7
5108872|NCT01567852|12568450|P1|NOT COMPLETED|Overall Study||4
5108873|NCT01567852|12568449|P2|COMPLETED|Overall Study||5
5108874|NCT01567852|12568450|P1|COMPLETED|Overall Study||4
5108875|NCT01567852|12568449|P2|STARTED|Overall Study||12
5108876|NCT01567852|12568450|P1|STARTED|Overall Study||8
5108877|NCT01567839|12568458|P1|NOT COMPLETED|Overall Study||0
5108878|NCT01567839|12568458|P1|COMPLETED|Overall Study||60
5108879|NCT01567839|12568458|P1|STARTED|Overall Study||60
5108880|NCT01567826|12568468|P2|NOT COMPLETED|Overall Study||2
5108881|NCT01567826|12568469|P1|NOT COMPLETED|Overall Study||3
5108882|NCT01567826|12568468|P2|COMPLETED|Overall Study||42
5108883|NCT01567826|12568469|P1|COMPLETED|Overall Study||40
5108884|NCT01567826|12568468|P2|STARTED|Overall Study||44
5108885|NCT01567826|12568469|P1|STARTED|Overall Study||43
5108886|NCT01567527|12568495|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
5108887|NCT01567527|12568496|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
5108888|NCT01567527|12568497|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
5108889|NCT01567527|12568498|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
5108890|NCT01567527|12568499|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
5108891|NCT01567527|12568495|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
5108892|NCT01567527|12568496|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
5108893|NCT01567527|12568497|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
5108894|NCT01567527|12568498|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
5108895|NCT01567527|12568499|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
5108896|NCT01567527|12568495|P5|STARTED|Double-blind, Placebo-controlled Phase||133
5108897|NCT01567527|12568496|P4|STARTED|Double-blind, Placebo-controlled Phase||133
5108898|NCT01567527|12568497|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
5108899|NCT01567527|12568498|P2|STARTED|Double-blind, Placebo-controlled Phase||0
5108900|NCT01567527|12568499|P1|STARTED|Double-blind, Placebo-controlled Phase||0
5108901|NCT01567527|12568495|P5|NOT COMPLETED|IM Depot Stabilization.||0
5108902|NCT01567527|12568496|P4|NOT COMPLETED|IM Depot Stabilization.||0
5108903|NCT01567527|12568497|P3|NOT COMPLETED|IM Depot Stabilization.||159
5108904|NCT01567527|12568498|P2|NOT COMPLETED|IM Depot Stabilization.||0
5108905|NCT01567527|12568499|P1|NOT COMPLETED|IM Depot Stabilization.||0
5108906|NCT01567527|12568495|P5|COMPLETED|IM Depot Stabilization.||0
5108907|NCT01567527|12568496|P4|COMPLETED|IM Depot Stabilization.||0
5108908|NCT01567527|12568497|P3|COMPLETED|IM Depot Stabilization.||266
5108909|NCT01567527|12568498|P2|COMPLETED|IM Depot Stabilization.||0
5108910|NCT01567527|12568499|P1|COMPLETED|IM Depot Stabilization.||0
5108911|NCT01567527|12568495|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
5108912|NCT01567527|12568496|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
5108913|NCT01567527|12568497|P3|STARTED|IM Depot Stabilization.||425
5108914|NCT01567527|12568498|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
5108915|NCT01567527|12568499|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
5108916|NCT01567527|12568495|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108917|NCT01567527|12568496|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108918|NCT01567527|12568497|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108919|NCT01567527|12568498|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
5108920|NCT01567527|12568499|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108921|NCT01567527|12568495|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108922|NCT01567527|12568496|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108923|NCT01567527|12568497|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108924|NCT01567527|12568498|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
5108925|NCT01567527|12568499|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
5108926|NCT01567527|12568495|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108927|NCT01567527|12568496|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108928|NCT01567527|12568497|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108929|NCT01567527|12568498|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
5108930|NCT01567527|12568499|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108931|NCT01567527|12568495|P5|NOT COMPLETED|Conversion Phase.||0
5108932|NCT01567527|12568496|P4|NOT COMPLETED|Conversion Phase.||0
5108933|NCT01567527|12568497|P3|NOT COMPLETED|Conversion Phase.||0
5108934|NCT01567527|12568498|P2|NOT COMPLETED|Conversion Phase.||0
5108935|NCT01567527|12568499|P1|NOT COMPLETED|Conversion Phase.||99
5108936|NCT01567527|12568495|P5|COMPLETED|Conversion Phase.||0
5108937|NCT01567527|12568496|P4|COMPLETED|Conversion Phase.||0
5108938|NCT01567527|12568497|P3|COMPLETED|Conversion Phase.||0
5108939|NCT01567527|12568498|P2|COMPLETED|Conversion Phase.||0
5108940|NCT01567527|12568499|P1|COMPLETED|Conversion Phase.||367
5108941|NCT01567527|12568495|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108942|NCT01567527|12568496|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108943|NCT01567527|12568497|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108944|NCT01567527|12568498|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
5108945|NCT01567527|12568499|P1|STARTED|Conversion Phase.||466
5108946|NCT01567462|12568516|P2|NOT COMPLETED|Overall Study||7
5108947|NCT01567462|12568517|P1|NOT COMPLETED|Overall Study||4
5108948|NCT01567462|12568516|P2|COMPLETED|Overall Study||38
5108949|NCT01567462|12568517|P1|COMPLETED|Overall Study||41
5108950|NCT01567462|12568516|P2|STARTED|Overall Study||45
5108951|NCT01567462|12568517|P1|STARTED|Overall Study||45
5108952|NCT01567371|12568529|P1|NOT COMPLETED|Overall Study||0
5108953|NCT01567371|12568529|P1|COMPLETED|Overall Study||30
5108954|NCT01567371|12568529|P1|STARTED|Overall Study||30
5108955|NCT01567306|12568540|P6|NOT COMPLETED|Overall Study||3
5108956|NCT01567306|12568541|P5|NOT COMPLETED|Overall Study||7
5108957|NCT01567306|12568542|P4|NOT COMPLETED|Overall Study||5
5108958|NCT01567306|12568543|P3|NOT COMPLETED|Overall Study||0
5108959|NCT01567306|12568544|P2|NOT COMPLETED|Overall Study||2
5108960|NCT01567306|12568545|P1|NOT COMPLETED|Overall Study||3
5108961|NCT01567306|12568540|P6|COMPLETED|Overall Study||23
5108962|NCT01567306|12568541|P5|COMPLETED|Overall Study||18
5108963|NCT01567306|12568542|P4|COMPLETED|Overall Study||19
5108964|NCT01567306|12568543|P3|COMPLETED|Overall Study||24
5108965|NCT01567306|12568544|P2|COMPLETED|Overall Study||23
5108966|NCT01567306|12568545|P1|COMPLETED|Overall Study||24
5108967|NCT01567306|12568540|P6|STARTED|Overall Study||26
5108968|NCT01567306|12568541|P5|STARTED|Overall Study||25
5108969|NCT01567306|12568542|P4|STARTED|Overall Study||24
5108970|NCT01567306|12568543|P3|STARTED|Overall Study||24
5108971|NCT01567306|12568544|P2|STARTED|Overall Study||25
5108972|NCT01567306|12568545|P1|STARTED|Overall Study||27
5108973|NCT01567163|12568559|P1|NOT COMPLETED|Overall Study||4
5108974|NCT01567163|12568559|P1|COMPLETED|Overall Study||18
5108975|NCT01567163|12568559|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
5108976|NCT01567163|12568559|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
5108977|NCT01567163|12568559|P1|STARTED|Overall Study||22
5108978|NCT01567150|12568571|P2|NOT COMPLETED|Overall Study||2
5108979|NCT01567150|12568572|P1|NOT COMPLETED|Overall Study||2
5108980|NCT01567150|12568571|P2|COMPLETED|Overall Study||16
5108981|NCT01567150|12568572|P1|COMPLETED|Overall Study||19
5108982|NCT01567150|12568571|P2|STARTED|Overall Study||18
5108983|NCT01567150|12568572|P1|STARTED|Overall Study||21
5108984|NCT01567085|12568580|P1|NOT COMPLETED|Overall Study||20
5108985|NCT01567085|12568580|P1|COMPLETED|Overall Study||60
5108986|NCT01567085|12568580|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
5108987|NCT01567085|12568580|P1|STARTED|Overall Study||80
5108988|NCT01567020|12568590|P4|NOT COMPLETED|Overall Study||1
5108989|NCT01567020|12568591|P3|NOT COMPLETED|Overall Study||2
5108990|NCT01567020|12568592|P2|NOT COMPLETED|Overall Study||5
5108991|NCT01567020|12568593|P1|NOT COMPLETED|Overall Study||7
5108992|NCT01567020|12568590|P4|COMPLETED|Overall Study||10
5108993|NCT01567020|12568591|P3|COMPLETED|Overall Study||18
5108994|NCT01567020|12568592|P2|COMPLETED|Overall Study||41
5108995|NCT01567020|12568593|P1|COMPLETED|Overall Study||21
5108996|NCT01567020|12568590|P4|STARTED|Overall Study||11
5108997|NCT01567020|12568591|P3|STARTED|Overall Study||20
5108998|NCT01567020|12568592|P2|STARTED|Overall Study||46
5108999|NCT01567020|12568593|P1|STARTED|Overall Study||28
5109000|NCT01566981|12568617|P2|NOT COMPLETED|Overall Study||8
5109001|NCT01566981|12568618|P1|NOT COMPLETED|Overall Study||5
5109002|NCT01566981|12568617|P2|COMPLETED|Overall Study||54
5109003|NCT01566981|12568618|P1|COMPLETED|Overall Study||53
5109004|NCT01566981|12568617|P2|STARTED|Overall Study||62
5109005|NCT01566981|12568618|P1|STARTED|Overall Study||58
5109006|NCT01566838|12568630|P2|NOT COMPLETED|Overall Study||0
5109007|NCT01566838|12568631|P1|NOT COMPLETED|Overall Study||3
5109008|NCT01566838|12568630|P2|COMPLETED|Overall Study||42
5109009|NCT01566838|12568631|P1|COMPLETED|Overall Study||38
5109010|NCT01566838|12568630|P2|STARTED|Overall Study||42
5109011|NCT01566838|12568631|P1|STARTED|Overall Study||41
5109012|NCT01566773|12568647|P1|NOT COMPLETED|Overall Study||30
5109013|NCT01566773|12568647|P1|COMPLETED|Overall Study||110
5109014|NCT01566773|12568647|P1|Spiriva® Handihaler®|Overall Study||62
5109015|NCT01566773|12568647|P1|Placebo MDI|Overall Study||62
5109016|NCT01566773|12568647|P1|GP MDI 0.6 µg BID|Overall Study||59
5109017|NCT01566773|12568647|P1|GP MDI 1.2 µg BID|Overall Study||57
5109018|NCT01566773|12568647|P1|GP MDI 2.4 µg BID|Overall Study||64
5109019|NCT01566773|12568647|P1|GP MDI 4.6 µg BID|Overall Study||62
5109020|NCT01566773|12568647|P1|GP MDI 9 µg BID|Overall Study||64
5109021|NCT01566773|12568647|P1|GP MDI 18 µg BID|Overall Study||64
5109022|NCT01566773|12568647|P1|STARTED|Overall Study||140
5109023|NCT01566721|12568856|P2|NOT COMPLETED|Overall Study||710
5109024|NCT01566721|12568857|P1|NOT COMPLETED|Overall Study||1867
5109025|NCT01566721|12568856|P2|COMPLETED|Overall Study||0
5109026|NCT01566721|12568857|P1|COMPLETED|Overall Study||0
5109027|NCT01566721|12568856|P2|Received Treatment|Overall Study||709
5109028|NCT01566721|12568857|P1|Received Treatment|Overall Study||1864
5109029|NCT01566721|12568856|P2|STARTED|Overall Study||710
5109030|NCT01566721|12568857|P1|STARTED|Overall Study||1867
5109031|NCT01566695|12568882|P2|NOT COMPLETED|Overall Study||99
5109032|NCT01566695|12568883|P1|NOT COMPLETED|Overall Study||95
5109033|NCT01566695|12568882|P2|COMPLETED|Overall Study||10
5109034|NCT01566695|12568883|P1|COMPLETED|Overall Study||12
5109035|NCT01566695|12568882|P2|STARTED|Overall Study||109
5109036|NCT01566695|12568883|P1|STARTED|Overall Study||107
5109037|NCT01566682|12568985|P1|NOT COMPLETED|Overall Study||46
5109038|NCT01566682|12568985|P1|COMPLETED|Overall Study||374
5109039|NCT01566682|12568985|P1|STARTED|Overall Study||420
5109040|NCT01566630|12568991|P2|NOT COMPLETED|Overall Study||0
5109041|NCT01566630|12568992|P1|NOT COMPLETED|Overall Study||0
5109042|NCT01566630|12568991|P2|COMPLETED|Overall Study||1
5109043|NCT01566630|12568992|P1|COMPLETED|Overall Study||2
5109044|NCT01566630|12568991|P2|STARTED|Overall Study||1
5109045|NCT01566630|12568992|P1|STARTED|Overall Study||2
5109046|NCT01566604|12569048|P2|NOT COMPLETED|Overall Study||11
5109047|NCT01566604|12569049|P1|NOT COMPLETED|Overall Study||24
5109048|NCT01566604|12569048|P2|COMPLETED|Overall Study||143
5109049|NCT01566604|12569049|P1|COMPLETED|Overall Study||282
5109050|NCT01566604|12569048|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
5109051|NCT01566604|12569049|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
5109052|NCT01566604|12569048|P2|Full Analysis Set (FAS)|Overall Study||154
5109053|NCT01566604|12569049|P1|Full Analysis Set (FAS)|Overall Study||305
5109054|NCT01566604|12569048|P2|Safety Set|Overall Study||154
5109055|NCT01566604|12569049|P1|Safety Set|Overall Study||305
5109056|NCT01566604|12569048|P2|STARTED|Overall Study||154
5109057|NCT01566604|12569049|P1|STARTED|Overall Study||306
5109058|NCT01566539|12569083|P9|NOT COMPLETED|Within Subject Group||0
5109059|NCT01566539|12569084|P8|NOT COMPLETED|Within Subject Group||0
5109060|NCT01566539|12569085|P7|NOT COMPLETED|Within Subject Group||0
5109061|NCT01566539|12569086|P6|NOT COMPLETED|Within Subject Group||0
5109062|NCT01566539|12569087|P5|NOT COMPLETED|Within Subject Group||0
5109063|NCT01566539|12569088|P4|NOT COMPLETED|Within Subject Group||3
5109064|NCT01566539|12569089|P3|NOT COMPLETED|Within Subject Group||0
5109065|NCT01566539|12569090|P2|NOT COMPLETED|Within Subject Group||0
5109066|NCT01566539|12569091|P1|NOT COMPLETED|Within Subject Group||0
5109067|NCT01566539|12569083|P9|COMPLETED|Within Subject Group||0
5109068|NCT01566539|12569084|P8|COMPLETED|Within Subject Group||0
5109069|NCT01566539|12569085|P7|COMPLETED|Within Subject Group||0
5109070|NCT01566539|12569086|P6|COMPLETED|Within Subject Group||0
5109071|NCT01566539|12569087|P5|COMPLETED|Within Subject Group||0
5109072|NCT01566539|12569088|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
5109073|NCT01566539|12569089|P3|COMPLETED|Within Subject Group||0
5109074|NCT01566539|12569090|P2|COMPLETED|Within Subject Group||0
5109075|NCT01566539|12569091|P1|COMPLETED|Within Subject Group||0
5109076|NCT01566539|12569083|P9|STARTED|Within Subject Group||0
5109077|NCT01566539|12569084|P8|STARTED|Within Subject Group||0
5109078|NCT01566539|12569085|P7|STARTED|Within Subject Group||0
5109079|NCT01566539|12569086|P6|STARTED|Within Subject Group||0
5109080|NCT01566539|12569087|P5|STARTED|Within Subject Group||0
5109081|NCT01566539|12569088|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
5109082|NCT01566539|12569089|P3|STARTED|Within Subject Group||0
5109083|NCT01566539|12569090|P2|STARTED|Within Subject Group||0
5109084|NCT01566539|12569091|P1|STARTED|Within Subject Group||0
5109085|NCT01566539|12569083|P9|NOT COMPLETED|Main Study Period||0
5109086|NCT01566539|12569084|P8|NOT COMPLETED|Main Study Period||0
5109087|NCT01566539|12569085|P7|NOT COMPLETED|Main Study Period||0
5109088|NCT01566539|12569086|P6|NOT COMPLETED|Main Study Period||3
5109089|NCT01566539|12569087|P5|NOT COMPLETED|Main Study Period||0
5109090|NCT01566539|12569088|P4|NOT COMPLETED|Main Study Period||0
5109091|NCT01566539|12569089|P3|NOT COMPLETED|Main Study Period||0
5109092|NCT01566539|12569090|P2|NOT COMPLETED|Main Study Period||0
5109093|NCT01566539|12569091|P1|NOT COMPLETED|Main Study Period||1
5109094|NCT01566539|12569083|P9|COMPLETED|Main Study Period||1
5109095|NCT01566539|12569084|P8|COMPLETED|Main Study Period||30
5109096|NCT01566539|12569085|P7|COMPLETED|Main Study Period||30
5109097|NCT01566539|12569086|P6|COMPLETED|Main Study Period||40
5109098|NCT01566539|12569087|P5|COMPLETED|Main Study Period||40
5109099|NCT01566539|12569088|P4|COMPLETED|Main Study Period||0
5109100|NCT01566539|12569089|P3|COMPLETED|Main Study Period||104
5109101|NCT01566539|12569090|P2|COMPLETED|Main Study Period||100
5109102|NCT01566539|12569091|P1|COMPLETED|Main Study Period||100
5109103|NCT01566539|12569083|P9|STARTED|Main Study Period||1
5109104|NCT01566539|12569084|P8|STARTED|Main Study Period||30
5109105|NCT01566539|12569085|P7|STARTED|Main Study Period||30
5109106|NCT01566539|12569086|P6|STARTED|Main Study Period||43
5109107|NCT01566539|12569087|P5|STARTED|Main Study Period||40
5109108|NCT01566539|12569088|P4|STARTED|Main Study Period||0
5109109|NCT01566539|12569089|P3|STARTED|Main Study Period||104
5109110|NCT01566539|12569090|P2|STARTED|Main Study Period||100
5109111|NCT01566539|12569091|P1|STARTED|Main Study Period||101
5109112|NCT01566526|12569144|P1|NOT COMPLETED|Overall Study||0
5109113|NCT01566526|12569144|P1|COMPLETED|Overall Study||26
5109114|NCT01566526|12569144|P1|STARTED|Overall Study||26
5109115|NCT01566500|12569154|P1|NOT COMPLETED|Overall Study||0
5109116|NCT01566500|12569154|P1|COMPLETED|Overall Study||140
5109117|NCT01566500|12569154|P1|STARTED|Overall Study||140
5109118|NCT01566461|12569160|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
5109119|NCT01566461|12569161|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
5109120|NCT01566461|12569160|P2|COMPLETED|IN.PACT SFA II Phase||55
5109121|NCT01566461|12569161|P1|COMPLETED|IN.PACT SFA II Phase||109
5109122|NCT01566461|12569160|P2|STARTED|IN.PACT SFA II Phase||60
5109123|NCT01566461|12569161|P1|STARTED|IN.PACT SFA II Phase||121
5109124|NCT01566461|12569160|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
5109125|NCT01566461|12569161|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
5109126|NCT01566461|12569160|P2|COMPLETED|IN.PACT SFA I Phase||49
5109127|NCT01566461|12569161|P1|COMPLETED|IN.PACT SFA I Phase||88
5109128|NCT01566461|12569160|P2|STARTED|IN.PACT SFA I Phase||51
5109129|NCT01566461|12569161|P1|STARTED|IN.PACT SFA I Phase||99
5109130|NCT01566435|12569205|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
5109131|NCT01566435|12569205|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
5109132|NCT01566435|12569205|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
5109133|NCT01566435|12569205|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
5109134|NCT01566435|12569205|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
5109135|NCT01566435|12569205|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
5109136|NCT01566435|12569205|P1|NOT COMPLETED|ACF Induction Therapy||0
5109137|NCT01566435|12569205|P1|COMPLETED|ACF Induction Therapy||30
5109138|NCT01566435|12569205|P1|STARTED|ACF Induction Therapy||30
5109139|NCT01566409|12569221|P2|NOT COMPLETED|Overall Study||5
5109140|NCT01566409|12569222|P1|NOT COMPLETED|Overall Study||2
5109141|NCT01566409|12569221|P2|COMPLETED|Overall Study||48
5109142|NCT01566409|12569222|P1|COMPLETED|Overall Study||47
5109143|NCT01566409|12569221|P2|STARTED|Overall Study||53
5109144|NCT01566409|12569222|P1|STARTED|Overall Study||49
5109145|NCT01566370|12569230|P2|NOT COMPLETED|Overall Study||1
5109146|NCT01566370|12569231|P1|NOT COMPLETED|Overall Study||2
5109147|NCT01566370|12569230|P2|COMPLETED|Overall Study||0
5109148|NCT01566370|12569231|P1|COMPLETED|Overall Study||0
5109149|NCT01566370|12569230|P2|STARTED|Overall Study||1
5109150|NCT01566370|12569231|P1|STARTED|Overall Study||2
5109151|NCT01566331|12569257|P2|NOT COMPLETED|Overall Study||0
5109152|NCT01566331|12569258|P1|NOT COMPLETED|Overall Study||0
5109153|NCT01566331|12569257|P2|COMPLETED|Overall Study||40
5109154|NCT01566331|12569258|P1|COMPLETED|Overall Study||40
5109155|NCT01566331|12569257|P2|STARTED|Overall Study||40
5109156|NCT01566331|12569258|P1|STARTED|Overall Study||40
5109157|NCT01566214|12569266|P2|NOT COMPLETED|Overall Study||0
5109158|NCT01566214|12569267|P1|NOT COMPLETED|Overall Study||3
5109159|NCT01566214|12569266|P2|COMPLETED|Overall Study||6
5109160|NCT01566214|12569267|P1|COMPLETED|Overall Study||3
5109161|NCT01566214|12569266|P2|STARTED|Overall Study||6
5109162|NCT01566214|12569267|P1|STARTED|Overall Study||6
5109163|NCT01566162|12569297|P1|NOT COMPLETED|Overall Study||36
5109164|NCT01566162|12569297|P1|COMPLETED|Overall Study||155
5109165|NCT01566162|12569297|P1|STARTED|Overall Study||191
5109166|NCT01566149|12569311|P2|NOT COMPLETED|Overall Study||2
5109167|NCT01566149|12569312|P1|NOT COMPLETED|Overall Study||3
5109168|NCT01566149|12569311|P2|COMPLETED|Overall Study||23
5109169|NCT01566149|12569312|P1|COMPLETED|Overall Study||21
5109170|NCT01566149|12569311|P2|STARTED|Overall Study||25
5109171|NCT01566149|12569312|P1|STARTED|Overall Study||24
5109172|NCT01566084|12569328|P2|NOT COMPLETED|Overall Study||0
5109173|NCT01566084|12569329|P1|NOT COMPLETED|Overall Study||0
5109174|NCT01566084|12569328|P2|COMPLETED|Overall Study||10
5109175|NCT01566084|12569329|P1|COMPLETED|Overall Study||7
5109176|NCT01566084|12569328|P2|STARTED|Overall Study||10
5109177|NCT01566084|12569329|P1|STARTED|Overall Study||7
5109178|NCT01565993|12569345|P2|NOT COMPLETED|Overall Study||3
5109179|NCT01565993|12569346|P1|NOT COMPLETED|Overall Study||0
5109180|NCT01565993|12569345|P2|COMPLETED|Overall Study||39
5109181|NCT01565993|12569346|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
5109182|NCT01565993|12569345|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
5109183|NCT01565993|12569346|P1|STARTED|Overall Study||66
5109184|NCT01565980|12569354|P2|NOT COMPLETED|Overall Study||4
5109185|NCT01565980|12569355|P1|NOT COMPLETED|Overall Study||4
5109186|NCT01565980|12569354|P2|COMPLETED|Overall Study||16
5109187|NCT01565980|12569355|P1|COMPLETED|Overall Study||16
5109188|NCT01565980|12569354|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
5109189|NCT01565980|12569355|P1|STARTED|Overall Study||20
5109190|NCT01565941|12569375|P2|NOT COMPLETED|Overall Study||4
5109191|NCT01565941|12569376|P1|NOT COMPLETED|Overall Study||11
5109192|NCT01565941|12569375|P2|COMPLETED|Overall Study||349
5109193|NCT01565941|12569376|P1|COMPLETED|Overall Study||349
5109194|NCT01565941|12569375|P2|STARTED|Overall Study||353
5109195|NCT01565941|12569376|P1|STARTED|Overall Study||360
5109196|NCT01565928|12569418|P1|NOT COMPLETED|Overall Study||22
5109197|NCT01565928|12569418|P1|COMPLETED|Overall Study||0
5109198|NCT01565928|12569418|P1|STARTED|Overall Study||22
5109199|NCT01565902|12569435|P4|NOT COMPLETED|Overall Study||0
5109200|NCT01565902|12569436|P3|NOT COMPLETED|Overall Study||0
5109201|NCT01565902|12569437|P2|NOT COMPLETED|Overall Study||0
5109202|NCT01565902|12569438|P1|NOT COMPLETED|Overall Study||0
5109203|NCT01565902|12569435|P4|COMPLETED|Overall Study||16
5109204|NCT01565902|12569436|P3|COMPLETED|Overall Study||8
5109205|NCT01565902|12569437|P2|COMPLETED|Overall Study||8
5109206|NCT01565902|12569438|P1|COMPLETED|Overall Study||8
5109207|NCT01565902|12569435|P4|STARTED|Overall Study||16
5109208|NCT01565902|12569436|P3|STARTED|Overall Study||8
5109209|NCT01565902|12569437|P2|STARTED|Overall Study||8
5109210|NCT01565902|12569438|P1|STARTED|Overall Study||8
5109211|NCT01565889|12569472|P6|NOT COMPLETED|Part B||4
5109212|NCT01565889|12569473|P5|NOT COMPLETED|Part B||0
5109213|NCT01565889|12569474|P4|NOT COMPLETED|Part B||0
5109214|NCT01565889|12569475|P3|NOT COMPLETED|Part B||0
5109215|NCT01565889|12569476|P2|NOT COMPLETED|Part B||0
5109216|NCT01565889|12569477|P1|NOT COMPLETED|Part B||0
5109217|NCT01565889|12569472|P6|COMPLETED|Part B||19
5109218|NCT01565889|12569473|P5|COMPLETED|Part B||0
5109219|NCT01565889|12569474|P4|COMPLETED|Part B||0
5109220|NCT01565889|12569475|P3|COMPLETED|Part B||0
5109221|NCT01565889|12569476|P2|COMPLETED|Part B||0
5109222|NCT01565889|12569477|P1|COMPLETED|Part B||0
5109223|NCT01565889|12569472|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
5109224|NCT01565889|12569473|P5|STARTED|Part B||0
5109225|NCT01565889|12569474|P4|STARTED|Part B||0
5109226|NCT01565889|12569475|P3|STARTED|Part B||0
5109227|NCT01565889|12569476|P2|STARTED|Part B||0
5109228|NCT01565889|12569477|P1|STARTED|Part B||0
5109229|NCT01565889|12569472|P6|NOT COMPLETED|Part A||0
5109230|NCT01565889|12569473|P5|NOT COMPLETED|Part A||0
5109231|NCT01565889|12569474|P4|NOT COMPLETED|Part A||0
5109232|NCT01565889|12569475|P3|NOT COMPLETED|Part A||0
5109233|NCT01565889|12569476|P2|NOT COMPLETED|Part A||0
5109234|NCT01565889|12569477|P1|NOT COMPLETED|Part A||1
5109235|NCT01565889|12569472|P6|COMPLETED|Part A||0
5109236|NCT01565889|12569473|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
5109237|NCT01565889|12569474|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
5109238|NCT01565889|12569475|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
5109239|NCT01565889|12569476|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
5109240|NCT01565889|12569477|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
5109241|NCT01565889|12569472|P6|STARTED|Part A||0
5109242|NCT01565889|12569473|P5|STARTED|Part A||7
5109243|NCT01565889|12569474|P4|STARTED|Part A||7
5109244|NCT01565889|12569475|P3|STARTED|Part A||8
5109245|NCT01565889|12569476|P2|STARTED|Part A||4
5109246|NCT01565889|12569477|P1|STARTED|Part A||12
5109247|NCT01565850|12569508|P2|NOT COMPLETED|Overall Study||8
5109248|NCT01565850|12569509|P1|NOT COMPLETED|Overall Study||20
5109249|NCT01565850|12569508|P2|COMPLETED|Overall Study||42
5109250|NCT01565850|12569509|P1|COMPLETED|Overall Study||83
5109251|NCT01565850|12569508|P2|STARTED|Overall Study||50
5109252|NCT01565850|12569509|P1|STARTED|Overall Study||103
5109253|NCT01565707|12569529|P4|NOT COMPLETED|Overall Study||5
5109254|NCT01565707|12569530|P3|NOT COMPLETED|Overall Study||3
5109255|NCT01565707|12569531|P2|NOT COMPLETED|Overall Study||8
5109256|NCT01565707|12569532|P1|NOT COMPLETED|Overall Study||9
5109257|NCT01565707|12569529|P4|COMPLETED|Overall Study||17
5109258|NCT01565707|12569530|P3|COMPLETED|Overall Study||16
5109259|NCT01565707|12569531|P2|COMPLETED|Overall Study||65
5109260|NCT01565707|12569532|P1|COMPLETED|Overall Study||66
5109261|NCT01565707|12569529|P4|Treated|Overall Study||22
5109262|NCT01565707|12569530|P3|Treated|Overall Study||19
5109263|NCT01565707|12569531|P2|Treated|Overall Study||73
5109264|NCT01565707|12569532|P1|Treated|Overall Study||73
5109265|NCT01565707|12569529|P4|STARTED|Overall Study||22
5109266|NCT01565707|12569530|P3|STARTED|Overall Study||19
5109267|NCT01565707|12569531|P2|STARTED|Overall Study||73
5109268|NCT01565707|12569532|P1|STARTED|Overall Study||75
5109269|NCT01565694|12569623|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
5109270|NCT01565694|12569623|P1|COMPLETED|Fixed-Dose Assessment Period||58
5109271|NCT01565694|12569623|P1|STARTED|Fixed-Dose Assessment Period||62
5109272|NCT01565694|12569623|P1|NOT COMPLETED|Dose-Titration Period||14
5109273|NCT01565694|12569623|P1|COMPLETED|Dose-Titration Period||62
5109274|NCT01565694|12569623|P1|STARTED|Dose-Titration Period||76
5109275|NCT01565668|12569644|P2|NOT COMPLETED|Overall Study||38
5109276|NCT01565668|12569645|P1|NOT COMPLETED|Overall Study||38
5109277|NCT01565668|12569644|P2|COMPLETED|Overall Study||0
5109278|NCT01565668|12569645|P1|COMPLETED|Overall Study||0
5109279|NCT01565668|12569644|P2|Completed Long-term Follow-up|Overall Study||0
5109280|NCT01565668|12569645|P1|Completed Long-term Follow-up|Overall Study||0
5109281|NCT01565668|12569644|P2|Started Long-term Follow-up|Overall Study||33
5109282|NCT01565668|12569645|P1|Started Long-term Follow-up|Overall Study||36
5109283|NCT01565668|12569644|P2|Completed 30-day Follow-up|Overall Study||5
5109284|NCT01565668|12569645|P1|Completed 30-day Follow-up|Overall Study||11
5109285|NCT01565668|12569644|P2|Started 30-day Follow-up|Overall Study||37
5109286|NCT01565668|12569645|P1|Started 30-day Follow-up|Overall Study||37
5109287|NCT01565668|12569644|P2|Completed Treatment Per Protocol|Overall Study||0
5109288|NCT01565668|12569645|P1|Completed Treatment Per Protocol|Overall Study||0
5109289|NCT01565668|12569644|P2|STARTED|Overall Study||38
5109290|NCT01565668|12569645|P1|STARTED|Overall Study||38
5109291|NCT01565642|12569669|P2|NOT COMPLETED|Overall Study||1
5109292|NCT01565642|12569670|P1|NOT COMPLETED|Overall Study||2
5109293|NCT01565642|12569669|P2|COMPLETED|Overall Study||150
5109294|NCT01565642|12569670|P1|COMPLETED|Overall Study||149
5109295|NCT01565642|12569669|P2|STARTED|Overall Study||151
5109296|NCT01565642|12569670|P1|STARTED|Overall Study||151
5109297|NCT01565616|12569692|P1|NOT COMPLETED|Overall Study||0
5109298|NCT01565616|12569692|P1|COMPLETED|Overall Study||22
5109299|NCT01565616|12569692|P1|Second Component: Related or Unrelated|Overall Study||17
5109300|NCT01565616|12569692|P1|First Component: 5 Related Donors|Overall Study||5
5109301|NCT01565616|12569692|P1|STARTED|Overall Study||22
5109302|NCT01565564|12569705|P2|NOT COMPLETED|Overall Study||1
5109303|NCT01565564|12569706|P1|NOT COMPLETED|Overall Study||5
5109304|NCT01565564|12569705|P2|COMPLETED|Overall Study||361
5109305|NCT01565564|12569706|P1|COMPLETED|Overall Study||339
5109306|NCT01565564|12569705|P2|STARTED|Overall Study||362
5109307|NCT01565564|12569706|P1|STARTED|Overall Study||344
5109308|NCT01565551|12569716|P2|NOT COMPLETED|Overall Study||0
5109309|NCT01565551|12569717|P1|NOT COMPLETED|Overall Study||0
5109310|NCT01565551|12569716|P2|COMPLETED|Overall Study||51
5109311|NCT01565551|12569717|P1|COMPLETED|Overall Study||586
5109312|NCT01565551|12569716|P2|6-Month Outcomes|Overall Study||30
5109313|NCT01565551|12569717|P1|6-Month Outcomes|Overall Study||412
5109314|NCT01565551|12569716|P2|Neuroimaging|Overall Study||25
5109315|NCT01565551|12569717|P1|Neuroimaging|Overall Study||233
5109316|NCT01565551|12569716|P2|Biospecimens/Biomarkers|Overall Study||22
5109317|NCT01565551|12569717|P1|Biospecimens/Biomarkers|Overall Study||479
5109318|NCT01565551|12569716|P2|Clinical/Demographics|Overall Study||51
5109319|NCT01565551|12569717|P1|Clinical/Demographics|Overall Study||586
5109320|NCT01565551|12569716|P2|STARTED|Overall Study||51
5109321|NCT01565551|12569717|P1|STARTED|Overall Study||586
5109322|NCT01565538|12569725|P2|NOT COMPLETED|Overall Study||0
5109323|NCT01565538|12569726|P1|NOT COMPLETED|Overall Study||0
5109324|NCT01565538|12569725|P2|COMPLETED|Overall Study||62
5109325|NCT01565538|12569726|P1|COMPLETED|Overall Study||61
5109326|NCT01565538|12569725|P2|STARTED|Overall Study||62
5109327|NCT01565538|12569726|P1|STARTED|Overall Study||61
5109328|NCT01565382|12569736|P2|NOT COMPLETED|Overall Study||0
5109329|NCT01565382|12569737|P1|NOT COMPLETED|Overall Study||0
5109330|NCT01565382|12569736|P2|COMPLETED|Overall Study||7
5109331|NCT01565382|12569737|P1|COMPLETED|Overall Study||40
5109332|NCT01565382|12569736|P2|STARTED|Overall Study||7
5109333|NCT01565382|12569737|P1|STARTED|Overall Study||40
5109334|NCT01565369|12569742|P1|NOT COMPLETED|Overall Study||0
5109335|NCT01565369|12569742|P1|COMPLETED|Overall Study||35
5109336|NCT01565369|12569742|P1|STARTED|Overall Study||35
5109337|NCT01565356|12569748|P1|NOT COMPLETED|Overall Study||0
5109338|NCT01565356|12569748|P1|COMPLETED|Overall Study||41
5109339|NCT01565356|12569748|P1|STARTED|Overall Study||41
5109340|NCT01565343|12569756|P3|NOT COMPLETED|Overall Study||0
5109341|NCT01565343|12569757|P2|NOT COMPLETED|Overall Study||0
5109342|NCT01565343|12569758|P1|NOT COMPLETED|Overall Study||1
5109343|NCT01565343|12569756|P3|COMPLETED|Overall Study||10
5109344|NCT01565343|12569757|P2|COMPLETED|Overall Study||4
5109345|NCT01565343|12569758|P1|COMPLETED|Overall Study||10
5109346|NCT01565343|12569756|P3|STARTED|Overall Study||10
5109347|NCT01565343|12569757|P2|STARTED|Overall Study||4
5109348|NCT01565343|12569758|P1|STARTED|Overall Study||11
5109349|NCT01565330|12569769|P4|NOT COMPLETED|Overall Study||0
5109350|NCT01565330|12569770|P3|NOT COMPLETED|Overall Study||0
5109351|NCT01565330|12569771|P2|NOT COMPLETED|Overall Study||0
5109352|NCT01565330|12569772|P1|NOT COMPLETED|Overall Study||0
5109353|NCT01565330|12569769|P4|COMPLETED|Overall Study||7
5109354|NCT01565330|12569770|P3|COMPLETED|Overall Study||4
5109355|NCT01565330|12569771|P2|COMPLETED|Overall Study||4
5109356|NCT01565330|12569772|P1|COMPLETED|Overall Study||5
5109357|NCT01565330|12569769|P4|STARTED|Overall Study||7
5109358|NCT01565330|12569770|P3|STARTED|Overall Study||4
5109359|NCT01565330|12569771|P2|STARTED|Overall Study||4
5109360|NCT01565330|12569772|P1|STARTED|Overall Study||5
5109361|NCT01565291|12569788|P2|NOT COMPLETED|Overall Study||0
5109362|NCT01565291|12569789|P1|NOT COMPLETED|Overall Study||1
5109363|NCT01565291|12569788|P2|COMPLETED|Overall Study||16
5109364|NCT01565291|12569789|P1|COMPLETED|Overall Study||15
5109365|NCT01565291|12569788|P2|STARTED|Overall Study||16
5109366|NCT01565291|12569789|P1|STARTED|Overall Study||16
5109367|NCT01565148|12569801|P4|NOT COMPLETED|Overall Study||13
5109368|NCT01565148|12569802|P3|NOT COMPLETED|Overall Study||7
5109369|NCT01565148|12569803|P2|NOT COMPLETED|Overall Study||15
5109370|NCT01565148|12569804|P1|NOT COMPLETED|Overall Study||15
5109371|NCT01565148|12569801|P4|COMPLETED|Overall Study||32
5109372|NCT01565148|12569802|P3|COMPLETED|Overall Study||40
5109373|NCT01565148|12569803|P2|COMPLETED|Overall Study||31
5109374|NCT01565148|12569804|P1|COMPLETED|Overall Study||32
5109375|NCT01565148|12569801|P4|STARTED|Overall Study||45
5109376|NCT01565148|12569802|P3|STARTED|Overall Study||47
5109377|NCT01565148|12569803|P2|STARTED|Overall Study||46
5109378|NCT01565148|12569804|P1|STARTED|Overall Study||47
5109379|NCT01565083|12569840|P2|NOT COMPLETED|Overall Study||39
5109380|NCT01565083|12569841|P1|NOT COMPLETED|Overall Study||33
5109381|NCT01565083|12569840|P2|COMPLETED|Overall Study||68
5109382|NCT01565083|12569841|P1|COMPLETED|Overall Study||73
5109383|NCT01565083|12569840|P2|STARTED|Overall Study||107
5109384|NCT01565083|12569841|P1|STARTED|Overall Study||106
5109385|NCT01564953|12569867|P1|NOT COMPLETED|Overall Study||0
5109386|NCT01564953|12569867|P1|COMPLETED|Overall Study||143
5109387|NCT01564953|12569867|P1|STARTED|Overall Study||143
5109388|NCT01564914|12569877|P2|NOT COMPLETED|Overall Study||0
5109389|NCT01564914|12569878|P1|NOT COMPLETED|Overall Study||0
5109390|NCT01564914|12569877|P2|COMPLETED|Overall Study||6
5109391|NCT01564914|12569878|P1|COMPLETED|Overall Study||16
5109392|NCT01564914|12569877|P2|STARTED|Overall Study||6
5109393|NCT01564914|12569878|P1|STARTED|Overall Study||16
5109394|NCT01564862|12569892|P3|NOT COMPLETED|Overall Study||30
5109395|NCT01564862|12569893|P2|NOT COMPLETED|Overall Study||34
5109396|NCT01564862|12569894|P1|NOT COMPLETED|Overall Study||30
5109397|NCT01564862|12569892|P3|COMPLETED|Overall Study||164
5109398|NCT01564862|12569893|P2|COMPLETED|Overall Study||176
5109399|NCT01564862|12569894|P1|COMPLETED|Overall Study||168
5109400|NCT01564862|12569892|P3|Received Treatment|Overall Study||191
5109401|NCT01564862|12569893|P2|Received Treatment|Overall Study||207
5109402|NCT01564862|12569894|P1|Received Treatment|Overall Study||196
5109403|NCT01564862|12569892|P3|STARTED|Overall Study||194
5109404|NCT01564862|12569893|P2|STARTED|Overall Study||210
5109405|NCT01564862|12569894|P1|STARTED|Overall Study||198
5109406|NCT01564784|12569945|P2|NOT COMPLETED|Overall Study||133
5109407|NCT01564784|12569946|P1|NOT COMPLETED|Overall Study||134
5109408|NCT01564784|12569945|P2|COMPLETED|Overall Study||10
5109409|NCT01564784|12569946|P1|COMPLETED|Overall Study||30
5109410|NCT01564784|12569945|P2|STARTED|Overall Study|Treated (162 randomized)|143
5109411|NCT01564784|12569946|P1|STARTED|Overall Study|Treated (164 randomized)|164
5109412|NCT01564758|12569973|P1|NOT COMPLETED|Overall Study||14
5109413|NCT01564758|12569973|P1|COMPLETED|Overall Study||85
5109414|NCT01564758|12569973|P1|STARTED|Overall Study||99
5109415|NCT01564732|12569980|P2|NOT COMPLETED|Overall Study||5
5109416|NCT01564732|12569981|P1|NOT COMPLETED|Overall Study||6
5109417|NCT01564732|12569980|P2|COMPLETED|Overall Study||0
5109418|NCT01564732|12569981|P1|COMPLETED|Overall Study||0
5109419|NCT01564732|12569980|P2|STARTED|Overall Study||5
5109420|NCT01564732|12569981|P1|STARTED|Overall Study||6
5109421|NCT01564706|12569997|P1|NOT COMPLETED|Overall Study||0
5109422|NCT01564706|12569997|P1|COMPLETED|Overall Study||9
5109423|NCT01564706|12569997|P1|STARTED|Overall Study||9
5109424|NCT01564693|12570004|P3|NOT COMPLETED|Overall Study||0
5109425|NCT01564693|12570005|P2|NOT COMPLETED|Overall Study||0
5109426|NCT01564693|12570006|P1|NOT COMPLETED|Overall Study||0
5109427|NCT01564693|12570004|P3|COMPLETED|Overall Study||2
5109428|NCT01564693|12570005|P2|COMPLETED|Overall Study||4
5109429|NCT01564693|12570006|P1|COMPLETED|Overall Study||9
5109430|NCT01564693|12570004|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
5109431|NCT01564693|12570005|P2|STARTED|Overall Study||4
5109432|NCT01564693|12570006|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
5109433|NCT01564628|12570014|P3|NOT COMPLETED|Overall Study||2
5109434|NCT01564628|12570015|P2|NOT COMPLETED|Overall Study||2
5109435|NCT01564628|12570016|P1|NOT COMPLETED|Overall Study||4
5109436|NCT01564628|12570014|P3|COMPLETED|Overall Study||61
5109437|NCT01564628|12570015|P2|COMPLETED|Overall Study||56
5109438|NCT01564628|12570016|P1|COMPLETED|Overall Study||181
5109439|NCT01564628|12570014|P3|STARTED|Overall Study||63
5109440|NCT01564628|12570015|P2|STARTED|Overall Study||58
5109441|NCT01564628|12570016|P1|STARTED|Overall Study||185
5109442|NCT01564537|12570022|P2|NOT COMPLETED|Overall Study||6
5109443|NCT01564537|12570023|P1|NOT COMPLETED|Overall Study||6
5109444|NCT01564537|12570022|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
5109445|NCT01564537|12570023|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
5109446|NCT01564537|12570022|P2|Safety Population: Received Study Drug|Overall Study||360
5109447|NCT01564537|12570023|P1|Safety Population: Received Study Drug|Overall Study||360
5109448|NCT01564537|12570022|P2|STARTED|Overall Study||362
5109449|NCT01564537|12570023|P1|STARTED|Overall Study||360
5109450|NCT01564459|12570046|P3|NOT COMPLETED|Double-blind Treatment||1
5109451|NCT01564459|12570047|P2|NOT COMPLETED|Double-blind Treatment||0
5109452|NCT01564459|12570048|P1|NOT COMPLETED|Double-blind Treatment||0
5109453|NCT01564459|12570046|P3|COMPLETED|Double-blind Treatment||82
5109454|NCT01564459|12570047|P2|COMPLETED|Double-blind Treatment||87
5109455|NCT01564459|12570048|P1|COMPLETED|Double-blind Treatment||0
5109456|NCT01564459|12570046|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
5109457|NCT01564459|12570047|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
5109458|NCT01564459|12570048|P1|STARTED|Double-blind Treatment||0
5109459|NCT01564459|12570046|P3|NOT COMPLETED|Run-In||0
5109460|NCT01564459|12570047|P2|NOT COMPLETED|Run-In||0
5109461|NCT01564459|12570048|P1|NOT COMPLETED|Run-In||12
5109462|NCT01564459|12570046|P3|COMPLETED|Run-In||83
5109463|NCT01564459|12570047|P2|COMPLETED|Run-In||87
5109464|NCT01564459|12570048|P1|COMPLETED|Run-In||0
5109465|NCT01564459|12570046|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
5109466|NCT01564459|12570047|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
5109467|NCT01564459|12570048|P1|STARTED|Run-In||12
5109468|NCT01564407|12570072|P5|NOT COMPLETED|Overall Study||0
5109469|NCT01564407|12570073|P4|NOT COMPLETED|Overall Study||1
5109470|NCT01564407|12570074|P3|NOT COMPLETED|Overall Study||0
5109471|NCT01564407|12570075|P2|NOT COMPLETED|Overall Study||2
5109472|NCT01564407|12570076|P1|NOT COMPLETED|Overall Study||0
5109473|NCT01564407|12570072|P5|COMPLETED|Overall Study||0
5109474|NCT01564407|12570073|P4|COMPLETED|Overall Study||1
5109475|NCT01564407|12570074|P3|COMPLETED|Overall Study||4
5109476|NCT01564407|12570075|P2|COMPLETED|Overall Study||3
5109477|NCT01564407|12570076|P1|COMPLETED|Overall Study||4
5109478|NCT01564407|12570072|P5|STARTED|Overall Study||0
5109479|NCT01564407|12570073|P4|STARTED|Overall Study||2
5109480|NCT01564407|12570074|P3|STARTED|Overall Study||4
5109481|NCT01564407|12570075|P2|STARTED|Overall Study||5
5109482|NCT01564407|12570076|P1|STARTED|Overall Study||4
5109483|NCT01564394|12570117|P2|NOT COMPLETED|Overall Study||10
5109484|NCT01564394|12570118|P1|NOT COMPLETED|Overall Study||6
5109485|NCT01564394|12570117|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
5109486|NCT01564394|12570118|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
5109487|NCT01564394|12570117|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
5109488|NCT01564394|12570118|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
5109489|NCT01564277|12570132|P2|NOT COMPLETED|Overall Study||1
5109490|NCT01564277|12570133|P1|NOT COMPLETED|Overall Study||1
5109491|NCT01564277|12570132|P2|COMPLETED|Overall Study||11
5109492|NCT01564277|12570133|P1|COMPLETED|Overall Study||11
5109493|NCT01564277|12570132|P2|STARTED|Overall Study||12
5109494|NCT01564277|12570133|P1|STARTED|Overall Study||12
5109495|NCT01563978|12570151|P2|NOT COMPLETED|Overall Study||2
5109496|NCT01563978|12570152|P1|NOT COMPLETED|Overall Study||4
5109497|NCT01563978|12570151|P2|COMPLETED|Overall Study||65
5109498|NCT01563978|12570152|P1|COMPLETED|Overall Study||64
5109499|NCT01563978|12570151|P2|Randomised But Did Not Receive Treatment|Overall Study||0
5109500|NCT01563978|12570152|P1|Randomised But Did Not Receive Treatment|Overall Study||0
5109501|NCT01563978|12570151|P2|STARTED|Overall Study|Patients who received treatment.|67
5109502|NCT01563978|12570152|P1|STARTED|Overall Study|Patients who received treatment.|68
5109503|NCT01563913|12570178|P2|NOT COMPLETED|Overall Study||0
5109504|NCT01563913|12570179|P1|NOT COMPLETED|Overall Study||2
5109505|NCT01563913|12570178|P2|COMPLETED|Overall Study||15
5109506|NCT01563913|12570179|P1|COMPLETED|Overall Study||13
5109507|NCT01563913|12570178|P2|STARTED|Overall Study||15
5109508|NCT01563913|12570179|P1|STARTED|Overall Study||15
5109509|NCT01563536|12570191|P2|NOT COMPLETED|Overall Study||2
5109510|NCT01563536|12570192|P1|NOT COMPLETED|Overall Study||1
5109511|NCT01563536|12570191|P2|COMPLETED|Overall Study||4
5109512|NCT01563536|12570192|P1|COMPLETED|Overall Study||5
5109513|NCT01563536|12570191|P2|STARTED|Overall Study||6
5109514|NCT01563536|12570192|P1|STARTED|Overall Study||6
5109515|NCT01563406|12570224|P4|NOT COMPLETED|Overall Study||0
5109516|NCT01563406|12570225|P3|NOT COMPLETED|Overall Study||0
5109517|NCT01563406|12570226|P2|NOT COMPLETED|Overall Study||0
5109518|NCT01563406|12570227|P1|NOT COMPLETED|Overall Study||0
5109519|NCT01563406|12570224|P4|COMPLETED|Overall Study|112 hubs|29
5109520|NCT01563406|12570225|P3|COMPLETED|Overall Study|101 hubs|30
5109521|NCT01563406|12570226|P2|COMPLETED|Overall Study|102 hubs|30
5109522|NCT01563406|12570227|P1|COMPLETED|Overall Study|194 hubs|60
5109523|NCT01563406|12570224|P4|STARTED|Overall Study|112 hubs|29
5109524|NCT01563406|12570225|P3|STARTED|Overall Study|101 hubs|30
5109525|NCT01563406|12570226|P2|STARTED|Overall Study|102 hubs|30
5109526|NCT01563406|12570227|P1|STARTED|Overall Study|194 hubs|60
5109527|NCT01563198|12570245|P1|NOT COMPLETED|After Training||0
5109528|NCT01563198|12570245|P1|COMPLETED|After Training||47979
5109529|NCT01563198|12570245|P1|STARTED|After Training||47979
5109530|NCT01563198|12570245|P1|NOT COMPLETED|Baseline||0
5109531|NCT01563198|12570245|P1|COMPLETED|Baseline||49733
5109532|NCT01563198|12570245|P1|STARTED|Baseline||49733
5109533|NCT01563185|12570251|P1|NOT COMPLETED|Overall Study||2
5109534|NCT01563185|12570251|P1|COMPLETED|Overall Study||10
5109535|NCT01563185|12570251|P1|STARTED|Overall Study||12
5109536|NCT01563172|12570265|P1|NOT COMPLETED|Overall Study||13
5109537|NCT01563172|12570265|P1|COMPLETED|Overall Study||52
5109538|NCT01563172|12570265|P1|Control Dentifrice|Overall Study||60
5109539|NCT01563172|12570265|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
5109540|NCT01563172|12570265|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
5109541|NCT01563172|12570265|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
5109542|NCT01563172|12570265|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
5109543|NCT01563172|12570265|P1|STARTED|Overall Study||65
5109544|NCT01563081|12570294|P2|NOT COMPLETED|Overall Study||0
5109545|NCT01563081|12570295|P1|NOT COMPLETED|Overall Study||0
5109546|NCT01563081|12570294|P2|COMPLETED|Overall Study||30
5109547|NCT01563081|12570295|P1|COMPLETED|Overall Study||30
5109548|NCT01563081|12570294|P2|STARTED|Overall Study||30
5109549|NCT01563081|12570295|P1|STARTED|Overall Study||30
5109550|NCT01563055|12570308|P1|NOT COMPLETED|Overall Study||0
5109551|NCT01563055|12570308|P1|COMPLETED|Overall Study||10
5109552|NCT01563055|12570308|P1|STARTED|Overall Study||10
5109553|NCT01563029|12570371|P5|NOT COMPLETED|Overall Study||29
5109554|NCT01563029|12570372|P4|NOT COMPLETED|Overall Study||33
5109555|NCT01563029|12570373|P3|NOT COMPLETED|Overall Study||33
5109556|NCT01563029|12570374|P2|NOT COMPLETED|Overall Study||24
5109557|NCT01563029|12570375|P1|NOT COMPLETED|Overall Study||53
5109558|NCT01563029|12570371|P5|COMPLETED|Overall Study||89
5109559|NCT01563029|12570372|P4|COMPLETED|Overall Study||85
5109560|NCT01563029|12570373|P3|COMPLETED|Overall Study||87
5109561|NCT01563029|12570374|P2|COMPLETED|Overall Study||94
5109562|NCT01563029|12570375|P1|COMPLETED|Overall Study||66
5109563|NCT01563029|12570371|P5|STARTED|Overall Study||118
5109564|NCT01563029|12570372|P4|STARTED|Overall Study||118
5109565|NCT01563029|12570373|P3|STARTED|Overall Study||120
5109566|NCT01563029|12570374|P2|STARTED|Overall Study||118
5109567|NCT01563029|12570375|P1|STARTED|Overall Study||119
5109568|NCT01563003|12570425|P2|NOT COMPLETED|Overall Study||0
5109569|NCT01563003|12570426|P1|NOT COMPLETED|Overall Study||0
5109570|NCT01563003|12570425|P2|COMPLETED|Overall Study||15
5109571|NCT01563003|12570426|P1|COMPLETED|Overall Study||16
5109572|NCT01563003|12570425|P2|STARTED|Overall Study||15
5109573|NCT01563003|12570426|P1|STARTED|Overall Study||16
5109574|NCT01562886|12570436|P1|NOT COMPLETED|Overall Study||1
5109575|NCT01562886|12570436|P1|COMPLETED|Overall Study||13
5109576|NCT01562886|12570436|P1|STARTED|Overall Study||14
5109577|NCT01562873|12570441|P2|NOT COMPLETED|Overall Study||0
5109578|NCT01562873|12570442|P1|NOT COMPLETED|Overall Study||21
5109579|NCT01562873|12570441|P2|COMPLETED|Overall Study||0
5109580|NCT01562873|12570442|P1|COMPLETED|Overall Study||0
5109581|NCT01562873|12570441|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
5109582|NCT01562873|12570442|P1|STARTED|Overall Study||21
5109583|NCT01562782|12570451|P2|NOT COMPLETED|Overall Study||5
5109584|NCT01562782|12570452|P1|NOT COMPLETED|Overall Study||4
5109585|NCT01562782|12570451|P2|COMPLETED|Overall Study||15
5109586|NCT01562782|12570452|P1|COMPLETED|Overall Study||15
5109587|NCT01562782|12570451|P2|STARTED|Overall Study||20
5109588|NCT01562782|12570452|P1|STARTED|Overall Study||19
5109589|NCT01562756|12570476|P1|NOT COMPLETED|Overall Study||0
5109590|NCT01562756|12570476|P1|COMPLETED|Overall Study||6
5109591|NCT01562756|12570476|P1|STARTED|Overall Study||6
5109592|NCT01562743|12570481|P1|NOT COMPLETED|Overall Study||52
5109593|NCT01562743|12570481|P1|COMPLETED|Overall Study||133
5109594|NCT01562743|12570481|P1|STARTED|Overall Study||185
5109595|NCT01562678|12570493|P2|NOT COMPLETED|Overall Study||2
5109596|NCT01562678|12570494|P1|NOT COMPLETED|Overall Study||6
5109597|NCT01562678|12570493|P2|COMPLETED|Overall Study||12
5109598|NCT01562678|12570494|P1|COMPLETED|Overall Study||8
5109599|NCT01562678|12570493|P2|STARTED|Overall Study||14
5109600|NCT01562678|12570494|P1|STARTED|Overall Study||14
5109601|NCT01562613|12570500|P1|NOT COMPLETED|Overall Study||4
5109602|NCT01562613|12570500|P1|COMPLETED|Overall Study||529
5109603|NCT01562613|12570500|P1|STARTED|Overall Study||533
5109604|NCT01562548|12570510|P4|NOT COMPLETED|Overall Study||0
5109605|NCT01562548|12570511|P3|NOT COMPLETED|Overall Study||1
5109606|NCT01562548|12570512|P2|NOT COMPLETED|Overall Study||0
5109607|NCT01562548|12570513|P1|NOT COMPLETED|Overall Study||0
5109608|NCT01562548|12570510|P4|COMPLETED|Overall Study||14
5109609|NCT01562548|12570511|P3|COMPLETED|Overall Study||24
5109610|NCT01562548|12570512|P2|COMPLETED|Overall Study||15
5109611|NCT01562548|12570513|P1|COMPLETED|Overall Study||25
5109612|NCT01562548|12570510|P4|STARTED|Overall Study||14
5109613|NCT01562548|12570511|P3|STARTED|Overall Study||25
5109614|NCT01562548|12570512|P2|STARTED|Overall Study||15
5109615|NCT01562548|12570513|P1|STARTED|Overall Study||25
5109616|NCT01562444|12570566|P3|NOT COMPLETED|Overall Study||7
5109617|NCT01562444|12570567|P2|NOT COMPLETED|Overall Study||2
5109618|NCT01562444|12570568|P1|NOT COMPLETED|Overall Study||5
5109619|NCT01562444|12570566|P3|COMPLETED|Overall Study||99
5109620|NCT01562444|12570567|P2|COMPLETED|Overall Study||49
5109621|NCT01562444|12570568|P1|COMPLETED|Overall Study||43
5109622|NCT01562444|12570566|P3|STARTED|Overall Study||106
5109623|NCT01562444|12570567|P2|STARTED|Overall Study||51
5109624|NCT01562444|12570568|P1|STARTED|Overall Study||48
5109625|NCT01562379|12570818|P5|NOT COMPLETED|Overall Study||40
5109626|NCT01562379|12570819|P4|NOT COMPLETED|Overall Study||57
5109627|NCT01562379|12570820|P3|NOT COMPLETED|Overall Study||62
5109628|NCT01562379|12570821|P2|NOT COMPLETED|Overall Study||97
5109629|NCT01562379|12570822|P1|NOT COMPLETED|Overall Study||126
5109630|NCT01562379|12570818|P5|COMPLETED|Overall Study||785
5109631|NCT01562379|12570819|P4|COMPLETED|Overall Study||786
5109632|NCT01562379|12570820|P3|COMPLETED|Overall Study||789
5109633|NCT01562379|12570821|P2|COMPLETED|Overall Study||1395
5109634|NCT01562379|12570822|P1|COMPLETED|Overall Study||1312
5109635|NCT01562379|12570818|P5|STARTED|Overall Study||825
5109636|NCT01562379|12570819|P4|STARTED|Overall Study||843
5109637|NCT01562379|12570820|P3|STARTED|Overall Study||851
5109638|NCT01562379|12570821|P2|STARTED|Overall Study||1492
5109639|NCT01562379|12570822|P1|STARTED|Overall Study||1438
5109640|NCT01562327|12570834|P1|NOT COMPLETED|Overall Study||8
5109641|NCT01562327|12570834|P1|COMPLETED|Overall Study||42
5109642|NCT01562327|12570834|P1|STARTED|Overall Study||50
5109643|NCT01562314|12570864|P2|NOT COMPLETED|Overall Study||8
5109644|NCT01562314|12570865|P1|NOT COMPLETED|Overall Study||13
5109645|NCT01562314|12570864|P2|COMPLETED|Overall Study||23
5109646|NCT01562314|12570865|P1|COMPLETED|Overall Study||16
5109647|NCT01562314|12570864|P2|Per Protocol (PP) Analysis Set|Overall Study||27
5109648|NCT01562314|12570865|P1|Per Protocol (PP) Analysis Set|Overall Study||17
5109649|NCT01562314|12570864|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
5109650|NCT01562314|12570865|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
5109651|NCT01562314|12570864|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
5109652|NCT01562314|12570865|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
5109653|NCT01562314|12570864|P2|STARTED|Overall Study||31
5109654|NCT01562314|12570865|P1|STARTED|Overall Study||29
5109655|NCT01562275|12570922|P13|NOT COMPLETED|Stage 2||5
5109656|NCT01562275|12570923|P12|NOT COMPLETED|Stage 2||14
5109657|NCT01562275|12570924|P11|NOT COMPLETED|Stage 2||0
5109658|NCT01562275|12570925|P10|NOT COMPLETED|Stage 2||0
5109659|NCT01562275|12570926|P9|NOT COMPLETED|Stage 2||0
5109660|NCT01562275|12570927|P8|NOT COMPLETED|Stage 2||0
5109661|NCT01562275|12570928|P7|NOT COMPLETED|Stage 2||0
5109662|NCT01562275|12570929|P6|NOT COMPLETED|Stage 2||0
5109663|NCT01562275|12570930|P5|NOT COMPLETED|Stage 2||0
5109664|NCT01562275|12570931|P4|NOT COMPLETED|Stage 2||0
5109665|NCT01562275|12570932|P3|NOT COMPLETED|Stage 2||0
5109666|NCT01562275|12570933|P2|NOT COMPLETED|Stage 2||0
5109667|NCT01562275|12570934|P1|NOT COMPLETED|Stage 2||0
5109668|NCT01562275|12570922|P13|COMPLETED|Stage 2||0
5109669|NCT01562275|12570923|P12|COMPLETED|Stage 2||0
5109670|NCT01562275|12570924|P11|COMPLETED|Stage 2||0
5109671|NCT01562275|12570925|P10|COMPLETED|Stage 2||0
5109672|NCT01562275|12570926|P9|COMPLETED|Stage 2||0
5109673|NCT01562275|12570927|P8|COMPLETED|Stage 2||0
5109674|NCT01562275|12570928|P7|COMPLETED|Stage 2||0
5109675|NCT01562275|12570929|P6|COMPLETED|Stage 2||0
5109676|NCT01562275|12570930|P5|COMPLETED|Stage 2||0
5109677|NCT01562275|12570931|P4|COMPLETED|Stage 2||0
5109678|NCT01562275|12570932|P3|COMPLETED|Stage 2||0
5109679|NCT01562275|12570933|P2|COMPLETED|Stage 2||0
5109680|NCT01562275|12570934|P1|COMPLETED|Stage 2||0
5109681|NCT01562275|12570922|P13|STARTED|Stage 2||5
5109682|NCT01562275|12570923|P12|STARTED|Stage 2||14
5109683|NCT01562275|12570924|P11|STARTED|Stage 2||0
5109684|NCT01562275|12570925|P10|STARTED|Stage 2||0
5109685|NCT01562275|12570926|P9|STARTED|Stage 2||0
5109686|NCT01562275|12570927|P8|STARTED|Stage 2||0
5109687|NCT01562275|12570928|P7|STARTED|Stage 2||0
5109688|NCT01562275|12570929|P6|STARTED|Stage 2||0
5109689|NCT01562275|12570930|P5|STARTED|Stage 2||0
5109690|NCT01562275|12570931|P4|STARTED|Stage 2||0
5109691|NCT01562275|12570932|P3|STARTED|Stage 2||0
5109692|NCT01562275|12570933|P2|STARTED|Stage 2||0
5109693|NCT01562275|12570934|P1|STARTED|Stage 2||0
5109694|NCT01562275|12570922|P13|NOT COMPLETED|Stage 1||0
5109695|NCT01562275|12570923|P12|NOT COMPLETED|Stage 1||0
5109696|NCT01562275|12570924|P11|NOT COMPLETED|Stage 1||3
5109697|NCT01562275|12570925|P10|NOT COMPLETED|Stage 1||7
5109698|NCT01562275|12570926|P9|NOT COMPLETED|Stage 1||3
5109699|NCT01562275|12570927|P8|NOT COMPLETED|Stage 1||7
5109700|NCT01562275|12570928|P7|NOT COMPLETED|Stage 1||3
5109701|NCT01562275|12570929|P6|NOT COMPLETED|Stage 1||4
5109702|NCT01562275|12570930|P5|NOT COMPLETED|Stage 1||4
5109703|NCT01562275|12570931|P4|NOT COMPLETED|Stage 1||4
5109704|NCT01562275|12570932|P3|NOT COMPLETED|Stage 1||3
5109705|NCT01562275|12570933|P2|NOT COMPLETED|Stage 1||7
5109706|NCT01562275|12570934|P1|NOT COMPLETED|Stage 1||3
5109707|NCT01562275|12570922|P13|COMPLETED|Stage 1||0
5109708|NCT01562275|12570923|P12|COMPLETED|Stage 1||0
5109709|NCT01562275|12570924|P11|COMPLETED|Stage 1||0
5109710|NCT01562275|12570925|P10|COMPLETED|Stage 1||0
5109711|NCT01562275|12570926|P9|COMPLETED|Stage 1||0
5109712|NCT01562275|12570927|P8|COMPLETED|Stage 1||0
5109713|NCT01562275|12570928|P7|COMPLETED|Stage 1||0
5109714|NCT01562275|12570929|P6|COMPLETED|Stage 1||0
5109715|NCT01562275|12570930|P5|COMPLETED|Stage 1||0
5109716|NCT01562275|12570931|P4|COMPLETED|Stage 1||0
5109717|NCT01562275|12570932|P3|COMPLETED|Stage 1||0
5109718|NCT01562275|12570933|P2|COMPLETED|Stage 1||0
5109719|NCT01562275|12570934|P1|COMPLETED|Stage 1||0
5109720|NCT01562275|12570922|P13|STARTED|Stage 1||0
5109721|NCT01562275|12570923|P12|STARTED|Stage 1||0
5109722|NCT01562275|12570924|P11|STARTED|Stage 1||3
5109723|NCT01562275|12570925|P10|STARTED|Stage 1||7
5109724|NCT01562275|12570926|P9|STARTED|Stage 1||3
5109725|NCT01562275|12570927|P8|STARTED|Stage 1||7
5109726|NCT01562275|12570928|P7|STARTED|Stage 1||3
5109727|NCT01562275|12570929|P6|STARTED|Stage 1||4
5109728|NCT01562275|12570930|P5|STARTED|Stage 1||4
5109729|NCT01562275|12570931|P4|STARTED|Stage 1||4
5109730|NCT01562275|12570932|P3|STARTED|Stage 1||3
5109731|NCT01562275|12570933|P2|STARTED|Stage 1||7
5109732|NCT01562275|12570934|P1|STARTED|Stage 1||3
5109733|NCT01562132|12571066|P2|NOT COMPLETED|Overall Study||0
5109734|NCT01562132|12571067|P1|NOT COMPLETED|Overall Study||0
5109735|NCT01562132|12571066|P2|COMPLETED|Overall Study||3
5109736|NCT01562132|12571067|P1|COMPLETED|Overall Study||3
5109737|NCT01562132|12571066|P2|STARTED|Overall Study||3
5109738|NCT01562132|12571067|P1|STARTED|Overall Study||3
5109739|NCT01562028|12571075|P2|NOT COMPLETED|Overall Study||2
5109740|NCT01562028|12571076|P1|NOT COMPLETED|Overall Study||3
5109741|NCT01562028|12571075|P2|COMPLETED|Overall Study||70
5109742|NCT01562028|12571076|P1|COMPLETED|Overall Study||34
5109743|NCT01562028|12571075|P2|STARTED|Overall Study||72
5109744|NCT01562028|12571076|P1|STARTED|Overall Study||37
5109745|NCT01561989|12571096|P2|NOT COMPLETED|Overall Study||6
5109746|NCT01561989|12571097|P1|NOT COMPLETED|Overall Study||5
5109747|NCT01561989|12571096|P2|COMPLETED|Overall Study||0
5109748|NCT01561989|12571097|P1|COMPLETED|Overall Study||0
5109749|NCT01561989|12571096|P2|STARTED|Overall Study||6
5109750|NCT01561989|12571097|P1|STARTED|Overall Study||5
5109751|NCT01561976|12571119|P6|NOT COMPLETED|Period 3||0
5109752|NCT01561976|12571120|P5|NOT COMPLETED|Period 3||0
5109753|NCT01561976|12571121|P4|NOT COMPLETED|Period 3||0
5109754|NCT01561976|12571122|P3|NOT COMPLETED|Period 3||0
5109755|NCT01561976|12571123|P2|NOT COMPLETED|Period 3||0
5109756|NCT01561976|12571124|P1|NOT COMPLETED|Period 3||0
5109757|NCT01561976|12571119|P6|COMPLETED|Period 3||4
5109758|NCT01561976|12571120|P5|COMPLETED|Period 3||5
5109759|NCT01561976|12571121|P4|COMPLETED|Period 3||4
5109760|NCT01561976|12571122|P3|COMPLETED|Period 3||3
5109761|NCT01561976|12571123|P2|COMPLETED|Period 3||5
5109762|NCT01561976|12571124|P1|COMPLETED|Period 3||4
5109763|NCT01561976|12571119|P6|STARTED|Period 3||4
5109764|NCT01561976|12571120|P5|STARTED|Period 3||5
5109765|NCT01561976|12571121|P4|STARTED|Period 3||4
5109766|NCT01561976|12571122|P3|STARTED|Period 3||3
5109767|NCT01561976|12571123|P2|STARTED|Period 3||5
5109768|NCT01561976|12571124|P1|STARTED|Period 3||4
5109769|NCT01561976|12571119|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5109770|NCT01561976|12571120|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5109771|NCT01561976|12571121|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5109772|NCT01561976|12571122|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
5109773|NCT01561976|12571123|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5109774|NCT01561976|12571124|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
5109775|NCT01561976|12571119|P6|COMPLETED|Washout Period 2 (7 Days)||4
5109776|NCT01561976|12571120|P5|COMPLETED|Washout Period 2 (7 Days)||5
5109777|NCT01561976|12571121|P4|COMPLETED|Washout Period 2 (7 Days)||4
5109778|NCT01561976|12571122|P3|COMPLETED|Washout Period 2 (7 Days)||3
5109779|NCT01561976|12571123|P2|COMPLETED|Washout Period 2 (7 Days)||5
5109780|NCT01561976|12571124|P1|COMPLETED|Washout Period 2 (7 Days)||4
5109781|NCT01561976|12571119|P6|STARTED|Washout Period 2 (7 Days)||4
5109782|NCT01561976|12571120|P5|STARTED|Washout Period 2 (7 Days)||5
5109783|NCT01561976|12571121|P4|STARTED|Washout Period 2 (7 Days)||4
5109784|NCT01561976|12571122|P3|STARTED|Washout Period 2 (7 Days)||4
5109785|NCT01561976|12571123|P2|STARTED|Washout Period 2 (7 Days)||5
5109786|NCT01561976|12571124|P1|STARTED|Washout Period 2 (7 Days)||5
5109787|NCT01561976|12571119|P6|NOT COMPLETED|Period 2||0
5109788|NCT01561976|12571120|P5|NOT COMPLETED|Period 2||0
5109789|NCT01561976|12571121|P4|NOT COMPLETED|Period 2||0
5109790|NCT01561976|12571122|P3|NOT COMPLETED|Period 2||0
5109791|NCT01561976|12571123|P2|NOT COMPLETED|Period 2||0
5109792|NCT01561976|12571124|P1|NOT COMPLETED|Period 2||0
5109793|NCT01561976|12571119|P6|COMPLETED|Period 2||4
5109794|NCT01561976|12571120|P5|COMPLETED|Period 2||5
5109795|NCT01561976|12571121|P4|COMPLETED|Period 2||4
5109796|NCT01561976|12571122|P3|COMPLETED|Period 2||4
5109797|NCT01561976|12571123|P2|COMPLETED|Period 2||5
5109798|NCT01561976|12571124|P1|COMPLETED|Period 2||5
5109799|NCT01561976|12571119|P6|STARTED|Period 2||4
5109800|NCT01561976|12571120|P5|STARTED|Period 2||5
5109801|NCT01561976|12571121|P4|STARTED|Period 2||4
5109802|NCT01561976|12571122|P3|STARTED|Period 2||4
5109803|NCT01561976|12571123|P2|STARTED|Period 2||5
5109804|NCT01561976|12571124|P1|STARTED|Period 2||5
5109805|NCT01561976|12571119|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
5109806|NCT01561976|12571120|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5109807|NCT01561976|12571121|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
5109808|NCT01561976|12571122|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
5109809|NCT01561976|12571123|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5109810|NCT01561976|12571124|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5109811|NCT01561976|12571119|P6|COMPLETED|Washout Period 1 (7 Days)||4
5109812|NCT01561976|12571120|P5|COMPLETED|Washout Period 1 (7 Days)||5
5109813|NCT01561976|12571121|P4|COMPLETED|Washout Period 1 (7 Days)||4
5109814|NCT01561976|12571122|P3|COMPLETED|Washout Period 1 (7 Days)||4
5109815|NCT01561976|12571123|P2|COMPLETED|Washout Period 1 (7 Days)||5
5109816|NCT01561976|12571124|P1|COMPLETED|Washout Period 1 (7 Days)||5
5109817|NCT01561976|12571119|P6|STARTED|Washout Period 1 (7 Days)||5
5109818|NCT01561976|12571120|P5|STARTED|Washout Period 1 (7 Days)||5
5109819|NCT01561976|12571121|P4|STARTED|Washout Period 1 (7 Days)||5
5109820|NCT01561976|12571122|P3|STARTED|Washout Period 1 (7 Days)||4
5109821|NCT01561976|12571123|P2|STARTED|Washout Period 1 (7 Days)||5
5109822|NCT01561976|12571124|P1|STARTED|Washout Period 1 (7 Days)||5
5109823|NCT01561976|12571119|P6|NOT COMPLETED|Period 1||0
5109824|NCT01561976|12571120|P5|NOT COMPLETED|Period 1||0
5109825|NCT01561976|12571121|P4|NOT COMPLETED|Period 1||0
5109826|NCT01561976|12571122|P3|NOT COMPLETED|Period 1||1
5109827|NCT01561976|12571123|P2|NOT COMPLETED|Period 1||0
5109828|NCT01561976|12571124|P1|NOT COMPLETED|Period 1||0
5109829|NCT01561976|12571119|P6|COMPLETED|Period 1||5
5109830|NCT01561976|12571120|P5|COMPLETED|Period 1||5
5109831|NCT01561976|12571121|P4|COMPLETED|Period 1||5
5109832|NCT01561976|12571122|P3|COMPLETED|Period 1||4
5109833|NCT01561976|12571123|P2|COMPLETED|Period 1||5
5109834|NCT01561976|12571124|P1|COMPLETED|Period 1||5
5109835|NCT01561976|12571119|P6|STARTED|Period 1||5
5109836|NCT01561976|12571120|P5|STARTED|Period 1||5
5109837|NCT01561976|12571121|P4|STARTED|Period 1||5
5109838|NCT01561976|12571122|P3|STARTED|Period 1||5
5109839|NCT01561976|12571123|P2|STARTED|Period 1||5
5109840|NCT01561976|12571124|P1|STARTED|Period 1||5
5109841|NCT01561898|12571157|P4|NOT COMPLETED|Overall Study||20
5109842|NCT01561898|12571158|P3|NOT COMPLETED|Overall Study||44
5109843|NCT01561898|12571159|P2|NOT COMPLETED|Overall Study||41
5109844|NCT01561898|12571160|P1|NOT COMPLETED|Overall Study||2
5109845|NCT01561898|12571157|P4|COMPLETED|Overall Study||12
5109846|NCT01561898|12571158|P3|COMPLETED|Overall Study||53
5109847|NCT01561898|12571159|P2|COMPLETED|Overall Study||51
5109848|NCT01561898|12571160|P1|COMPLETED|Overall Study||5
5109849|NCT01561898|12571157|P4|STARTED|Overall Study||32
5109850|NCT01561898|12571158|P3|STARTED|Overall Study||97
5109851|NCT01561898|12571159|P2|STARTED|Overall Study||92
5109852|NCT01561898|12571160|P1|STARTED|Overall Study||7
5109853|NCT01561755|12571174|P2|NOT COMPLETED|Overall Study||1
5109854|NCT01561755|12571175|P1|NOT COMPLETED|Overall Study||0
5109855|NCT01561755|12571174|P2|COMPLETED|Overall Study||5
5109856|NCT01561755|12571175|P1|COMPLETED|Overall Study||6
5109857|NCT01561755|12571174|P2|STARTED|Overall Study||6
5109858|NCT01561755|12571175|P1|STARTED|Overall Study||6
5109859|NCT01561716|12571199|P6|NOT COMPLETED|Overall Study||0
5109860|NCT01561716|12571200|P5|NOT COMPLETED|Overall Study||0
5109861|NCT01561716|12571201|P4|NOT COMPLETED|Overall Study||0
5109862|NCT01561716|12571202|P3|NOT COMPLETED|Overall Study||0
5109863|NCT01561716|12571203|P2|NOT COMPLETED|Overall Study||0
5109864|NCT01561716|12571204|P1|NOT COMPLETED|Overall Study||0
5109865|NCT01561716|12571199|P6|COMPLETED|Overall Study||5
5109866|NCT01561716|12571200|P5|COMPLETED|Overall Study||5
5109867|NCT01561716|12571201|P4|COMPLETED|Overall Study||5
5109868|NCT01561716|12571202|P3|COMPLETED|Overall Study||5
5109869|NCT01561716|12571203|P2|COMPLETED|Overall Study||5
5109870|NCT01561716|12571204|P1|COMPLETED|Overall Study||5
5109871|NCT01561716|12571199|P6|STARTED|Overall Study||5
5109872|NCT01561716|12571200|P5|STARTED|Overall Study||5
5109873|NCT01561716|12571201|P4|STARTED|Overall Study||5
5109874|NCT01561716|12571202|P3|STARTED|Overall Study||5
5109875|NCT01561716|12571203|P2|STARTED|Overall Study||5
5109876|NCT01561716|12571204|P1|STARTED|Overall Study||5
5109877|NCT01561703|12571220|P2|NOT COMPLETED|Overall Study||6
5109878|NCT01561703|12571221|P1|NOT COMPLETED|Overall Study||8
5109879|NCT01561703|12571220|P2|COMPLETED|Overall Study||24
5109880|NCT01561703|12571221|P1|COMPLETED|Overall Study||20
5109881|NCT01561703|12571220|P2|STARTED|Overall Study||30
5109882|NCT01561703|12571221|P1|STARTED|Overall Study||28
5109883|NCT01561560|12571227|P2|NOT COMPLETED|Second Two Weeks of Wear||1
5109884|NCT01561560|12571228|P1|NOT COMPLETED|Second Two Weeks of Wear||0
5109885|NCT01561560|12571227|P2|COMPLETED|Second Two Weeks of Wear||58
5109886|NCT01561560|12571228|P1|COMPLETED|Second Two Weeks of Wear||60
5109887|NCT01561560|12571227|P2|STARTED|Second Two Weeks of Wear||59
5109888|NCT01561560|12571228|P1|STARTED|Second Two Weeks of Wear||60
5109889|NCT01561560|12571227|P2|NOT COMPLETED|First Two Weeks of Wear||2
5109890|NCT01561560|12571228|P1|NOT COMPLETED|First Two Weeks of Wear||0
5109891|NCT01561560|12571227|P2|COMPLETED|First Two Weeks of Wear||59
5109892|NCT01561560|12571228|P1|COMPLETED|First Two Weeks of Wear||60
5109893|NCT01561560|12571227|P2|STARTED|First Two Weeks of Wear||61
5109894|NCT01561560|12571228|P1|STARTED|First Two Weeks of Wear||60
5109895|NCT01561495|12571234|P1|NOT COMPLETED|Overall Study||0
5109896|NCT01561495|12571234|P1|COMPLETED|Overall Study||1
5109897|NCT01561495|12571234|P1|STARTED|Overall Study||1
5109898|NCT01561469|12571240|P2|NOT COMPLETED|Overall Study||0
5109899|NCT01561469|12571241|P1|NOT COMPLETED|Overall Study||0
5109900|NCT01561469|12571240|P2|COMPLETED|Overall Study||87
5109901|NCT01561469|12571241|P1|COMPLETED|Overall Study||101
5109902|NCT01561469|12571240|P2|STARTED|Overall Study||87
5109903|NCT01561469|12571241|P1|STARTED|Overall Study||101
5109904|NCT01561430|12571263|P4|NOT COMPLETED|Overall Study||13
5109905|NCT01561430|12571264|P3|NOT COMPLETED|Overall Study||17
5109906|NCT01561430|12571265|P2|NOT COMPLETED|Overall Study||15
5109907|NCT01561430|12571266|P1|NOT COMPLETED|Overall Study||1
5109908|NCT01561430|12571263|P4|COMPLETED|Overall Study||7
5109909|NCT01561430|12571264|P3|COMPLETED|Overall Study||1
5109910|NCT01561430|12571265|P2|COMPLETED|Overall Study||8
5109911|NCT01561430|12571266|P1|COMPLETED|Overall Study||8
5109912|NCT01561430|12571263|P4|Received at Least One Dose of Study Drug|Overall Study||20
5109913|NCT01561430|12571264|P3|Received at Least One Dose of Study Drug|Overall Study||18
5109914|NCT01561430|12571265|P2|Received at Least One Dose of Study Drug|Overall Study||23
5109915|NCT01561430|12571266|P1|Received at Least One Dose of Study Drug|Overall Study||9
5109916|NCT01561430|12571263|P4|STARTED|Overall Study||20
5109917|NCT01561430|12571264|P3|STARTED|Overall Study||18
5109918|NCT01561430|12571265|P2|STARTED|Overall Study||23
5109919|NCT01561430|12571266|P1|STARTED|Overall Study||9
5109920|NCT01561313|12571306|P2|NOT COMPLETED|Overall Study||0
5109921|NCT01561313|12571307|P1|NOT COMPLETED|Overall Study||2
5109922|NCT01561313|12571306|P2|COMPLETED|Overall Study||31
5109923|NCT01561313|12571307|P1|COMPLETED|Overall Study||31
5109924|NCT01561313|12571306|P2|STARTED|Overall Study||31
5109925|NCT01561313|12571307|P1|STARTED|Overall Study||33
5109926|NCT01561300|12571325|P2|NOT COMPLETED|Second Intervention||0
5109927|NCT01561300|12571326|P1|NOT COMPLETED|Second Intervention||0
5109928|NCT01561300|12571325|P2|COMPLETED|Second Intervention||15
5109929|NCT01561300|12571326|P1|COMPLETED|Second Intervention||14
5109930|NCT01561300|12571325|P2|STARTED|Second Intervention||15
5109931|NCT01561300|12571326|P1|STARTED|Second Intervention||14
5109932|NCT01561300|12571325|P2|NOT COMPLETED|Washout on Placebo||0
5109933|NCT01561300|12571326|P1|NOT COMPLETED|Washout on Placebo||0
5109934|NCT01561300|12571325|P2|COMPLETED|Washout on Placebo||15
5109935|NCT01561300|12571326|P1|COMPLETED|Washout on Placebo||14
5109936|NCT01561300|12571325|P2|STARTED|Washout on Placebo||15
5109937|NCT01561300|12571326|P1|STARTED|Washout on Placebo||14
5109938|NCT01561300|12571325|P2|NOT COMPLETED|First Intervention||0
5109939|NCT01561300|12571326|P1|NOT COMPLETED|First Intervention||0
5109940|NCT01561300|12571325|P2|COMPLETED|First Intervention||15
5109941|NCT01561300|12571326|P1|COMPLETED|First Intervention||14
5109942|NCT01561300|12571325|P2|STARTED|First Intervention||15
5109943|NCT01561300|12571326|P1|STARTED|First Intervention||14
5109944|NCT01561300|12571325|P2|NOT COMPLETED|Run in on Placebo||0
5109945|NCT01561300|12571326|P1|NOT COMPLETED|Run in on Placebo||1
5109946|NCT01561300|12571325|P2|COMPLETED|Run in on Placebo||15
5109947|NCT01561300|12571326|P1|COMPLETED|Run in on Placebo||14
5109948|NCT01561300|12571325|P2|STARTED|Run in on Placebo||15
5109949|NCT01561300|12571326|P1|STARTED|Run in on Placebo||15
5109950|NCT01561079|12571337|P1|NOT COMPLETED|Overall Study||78
5109951|NCT01561079|12571337|P1|COMPLETED|Overall Study||49
5109952|NCT01561079|12571337|P1|STARTED|Overall Study||127
5109953|NCT01561053|12571384|P4|NOT COMPLETED|Overall Study||23
5109954|NCT01561053|12571385|P3|NOT COMPLETED|Overall Study||21
5109955|NCT01561053|12571386|P2|NOT COMPLETED|Overall Study||36
5109956|NCT01561053|12571387|P1|NOT COMPLETED|Overall Study||35
5109957|NCT01561053|12571384|P4|COMPLETED|Overall Study||64
5109958|NCT01561053|12571385|P3|COMPLETED|Overall Study||61
5109959|NCT01561053|12571386|P2|COMPLETED|Overall Study||56
5109960|NCT01561053|12571387|P1|COMPLETED|Overall Study||51
5109961|NCT01561053|12571384|P4|Evaluable Subjects|Overall Study||80
5109962|NCT01561053|12571385|P3|Evaluable Subjects|Overall Study||78
5109963|NCT01561053|12571386|P2|Evaluable Subjects|Overall Study||86
5109964|NCT01561053|12571387|P1|Evaluable Subjects|Overall Study||78
5109965|NCT01561053|12571384|P4|Randomized Not Treated|Overall Study||7
5109966|NCT01561053|12571385|P3|Randomized Not Treated|Overall Study||4
5109967|NCT01561053|12571386|P2|Randomized Not Treated|Overall Study||6
5109968|NCT01561053|12571387|P1|Randomized Not Treated|Overall Study||8
5109969|NCT01561053|12571384|P4|Patients With Baseline MMSE:22-26|Overall Study||45
5109970|NCT01561053|12571385|P3|Patients With Baseline MMSE:22-26|Overall Study||35
5109971|NCT01561053|12571386|P2|Patients With Baseline MMSE:22-26|Overall Study||52
5109972|NCT01561053|12571387|P1|Patients With Baseline MMSE:22-26|Overall Study||39
5109973|NCT01561053|12571384|P4|Patients With Baseline MMSE:18-21|Overall Study||42
5109974|NCT01561053|12571385|P3|Patients With Baseline MMSE:18-21|Overall Study||47
5109975|NCT01561053|12571386|P2|Patients With Baseline MMSE:18-21|Overall Study||40
5109976|NCT01561053|12571387|P1|Patients With Baseline MMSE:18-21|Overall Study||47
5109977|NCT01561053|12571384|P4|STARTED|Overall Study||87
5109978|NCT01561053|12571385|P3|STARTED|Overall Study||82
5109979|NCT01561053|12571386|P2|STARTED|Overall Study||92
5109980|NCT01561053|12571387|P1|STARTED|Overall Study||86
5109981|NCT01560988|12571423|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
5109982|NCT01560988|12571424|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
5109983|NCT01560988|12571423|P2|COMPLETED|Second Intervention (Six Weeks)||22
5109984|NCT01560988|12571424|P1|COMPLETED|Second Intervention (Six Weeks)||18
5109985|NCT01560988|12571423|P2|STARTED|Second Intervention (Six Weeks)||24
5109986|NCT01560988|12571424|P1|STARTED|Second Intervention (Six Weeks)||20
5109987|NCT01560988|12571423|P2|NOT COMPLETED|Washout (Six Weeks)||2
5109988|NCT01560988|12571424|P1|NOT COMPLETED|Washout (Six Weeks)||2
5109989|NCT01560988|12571423|P2|COMPLETED|Washout (Six Weeks)||24
5109990|NCT01560988|12571424|P1|COMPLETED|Washout (Six Weeks)||20
5109991|NCT01560988|12571423|P2|STARTED|Washout (Six Weeks)||26
5109992|NCT01560988|12571424|P1|STARTED|Washout (Six Weeks)||22
5109993|NCT01560988|12571423|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
5109994|NCT01560988|12571424|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
5109995|NCT01560988|12571423|P2|COMPLETED|First Intervention (Six Weeks)||26
5109996|NCT01560988|12571424|P1|COMPLETED|First Intervention (Six Weeks)||22
5109997|NCT01560988|12571423|P2|STARTED|First Intervention (Six Weeks)||30
5109998|NCT01560988|12571424|P1|STARTED|First Intervention (Six Weeks)||32
5109999|NCT01560975|12571447|P1|NOT COMPLETED|Overall Study||0
5110000|NCT01560975|12571447|P1|COMPLETED|Overall Study||10
5110001|NCT01560975|12571447|P1|STARTED|Overall Study||10
5110002|NCT01560923|12571462|P2|NOT COMPLETED|Overall Study||0
5110003|NCT01560923|12571463|P1|NOT COMPLETED|Overall Study||0
5110004|NCT01560923|12571462|P2|COMPLETED|Overall Study||22
5110005|NCT01560923|12571463|P1|COMPLETED|Overall Study||24
5110006|NCT01560923|12571462|P2|STARTED|Overall Study||22
5110007|NCT01560923|12571463|P1|STARTED|Overall Study||24
5110008|NCT01560871|12571481|P2|NOT COMPLETED|Overall Study||2
5110009|NCT01560871|12571482|P1|NOT COMPLETED|Overall Study||6
5110010|NCT01560871|12571481|P2|COMPLETED|Overall Study||5
5110011|NCT01560871|12571482|P1|COMPLETED|Overall Study||3
5110012|NCT01560871|12571481|P2|STARTED|Overall Study||7
5110013|NCT01560871|12571482|P1|STARTED|Overall Study||9
5110014|NCT01560819|12571498|P2|NOT COMPLETED|Overall Study||0
5110015|NCT01560819|12571499|P1|NOT COMPLETED|Overall Study||1
5110016|NCT01560819|12571498|P2|COMPLETED|Overall Study||10
5110017|NCT01560819|12571499|P1|COMPLETED|Overall Study||9
5110018|NCT01560819|12571498|P2|STARTED|Overall Study||10
5110019|NCT01560819|12571499|P1|STARTED|Overall Study||10
5110020|NCT01560780|12571505|P2|NOT COMPLETED|Overall Study||12
5110021|NCT01560780|12571506|P1|NOT COMPLETED|Overall Study||13
5110022|NCT01560780|12571505|P2|COMPLETED|Overall Study||30
5110023|NCT01560780|12571506|P1|COMPLETED|Overall Study||29
5110024|NCT01560780|12571505|P2|Completed Study Drug for 12 Months|Overall Study||27
5110025|NCT01560780|12571506|P1|Completed Study Drug for 12 Months|Overall Study||27
5110026|NCT01560780|12571505|P2|Clinical Follow-Up at 12 Months|Overall Study||42
5110027|NCT01560780|12571506|P1|Clinical Follow-Up at 12 Months|Overall Study||42
5110028|NCT01560780|12571505|P2|STARTED|Overall Study||42
5110029|NCT01560780|12571506|P1|STARTED|Overall Study||42
5110030|NCT01560624|12571526|P2|NOT COMPLETED|Overall Study||189
5110031|NCT01560624|12571527|P1|NOT COMPLETED|Overall Study||198
5110032|NCT01560624|12571526|P2|COMPLETED|Overall Study||155
5110033|NCT01560624|12571527|P1|COMPLETED|Overall Study||148
5110034|NCT01560624|12571526|P2|Early Discontinuation From Treatment|Overall Study||56
5110035|NCT01560624|12571527|P1|Early Discontinuation From Treatment|Overall Study||107
5110036|NCT01560624|12571526|P2|Clinical Worsening Event|Overall Study||133
5110037|NCT01560624|12571527|P1|Clinical Worsening Event|Overall Study||91
5110038|NCT01560624|12571526|P2|STARTED|Overall Study||344
5110039|NCT01560624|12571527|P1|STARTED|Overall Study||346
5110040|NCT01560507|12571542|P3|NOT COMPLETED|Overall Study||2
5110041|NCT01560507|12571543|P2|NOT COMPLETED|Overall Study||2
5110042|NCT01560507|12571544|P1|NOT COMPLETED|Overall Study||4
5110043|NCT01560507|12571542|P3|COMPLETED|Overall Study||0
5110044|NCT01560507|12571543|P2|COMPLETED|Overall Study||0
5110045|NCT01560507|12571544|P1|COMPLETED|Overall Study||1
5110046|NCT01560507|12571542|P3|STARTED|Overall Study||2
5110047|NCT01560507|12571543|P2|STARTED|Overall Study||2
5110048|NCT01560507|12571544|P1|STARTED|Overall Study||5
5110049|NCT01560429|12571557|P2|NOT COMPLETED|Overall Study||6
5110050|NCT01560429|12571558|P1|NOT COMPLETED|Overall Study||3
5110051|NCT01560429|12571557|P2|COMPLETED|Overall Study||20
5110052|NCT01560429|12571558|P1|COMPLETED|Overall Study||23
5110053|NCT01560429|12571557|P2|STARTED|Overall Study||26
5110054|NCT01560429|12571558|P1|STARTED|Overall Study||26
5110055|NCT01560416|12571568|P2|NOT COMPLETED|Crossover Phase||0
5110056|NCT01560416|12571569|P1|NOT COMPLETED|Crossover Phase||0
5110057|NCT01560416|12571568|P2|COMPLETED|Crossover Phase||0
5110058|NCT01560416|12571569|P1|COMPLETED|Crossover Phase||7
5110059|NCT01560416|12571568|P2|STARTED|Crossover Phase||0
5110060|NCT01560416|12571569|P1|STARTED|Crossover Phase||7
5110061|NCT01560416|12571568|P2|NOT COMPLETED|Randomized Phase||0
5110062|NCT01560416|12571569|P1|NOT COMPLETED|Randomized Phase||7
5110063|NCT01560416|12571568|P2|COMPLETED|Randomized Phase||35
5110064|NCT01560416|12571569|P1|COMPLETED|Randomized Phase||8
5110065|NCT01560416|12571568|P2|STARTED|Randomized Phase||35
5110066|NCT01560416|12571569|P1|STARTED|Randomized Phase||15
5110067|NCT01560403|12571587|P2|NOT COMPLETED|Overall Study||1
5110068|NCT01560403|12571588|P1|NOT COMPLETED|Overall Study||0
5110069|NCT01560403|12571587|P2|COMPLETED|Overall Study||8
5110070|NCT01560403|12571588|P1|COMPLETED|Overall Study||5
5110071|NCT01560403|12571587|P2|STARTED|Overall Study||9
5110072|NCT01560403|12571588|P1|STARTED|Overall Study||5
5110073|NCT01560377|12571594|P1|NOT COMPLETED|Overall Study||0
5110074|NCT01560377|12571594|P1|COMPLETED|Overall Study||147
5110075|NCT01560377|12571594|P1|Eligible for Analysis|Overall Study||139
5110076|NCT01560377|12571594|P1|STARTED|Overall Study||147
5110077|NCT01560286|12571599|P1|NOT COMPLETED|Overall Study||0
5110078|NCT01560286|12571599|P1|COMPLETED|Overall Study||24
5110079|NCT01560286|12571599|P1|STARTED|Overall Study||24
5110080|NCT01560260|12571612|P1|NOT COMPLETED|Overall Study||0
5110081|NCT01560260|12571612|P1|COMPLETED|Overall Study||20
5110082|NCT01560260|12571612|P1|STARTED|Overall Study||20
5110083|NCT01560234|12571636|P8|NOT COMPLETED|Overall Study||2
5110084|NCT01560234|12571637|P7|NOT COMPLETED|Overall Study||0
5110085|NCT01560234|12571638|P6|NOT COMPLETED|Overall Study||2
5110086|NCT01560234|12571639|P5|NOT COMPLETED|Overall Study||0
5110087|NCT01560234|12571640|P4|NOT COMPLETED|Overall Study||0
5110088|NCT01560234|12571641|P3|NOT COMPLETED|Overall Study||1
5110089|NCT01560234|12571642|P2|NOT COMPLETED|Overall Study||0
5110090|NCT01560234|12571643|P1|NOT COMPLETED|Overall Study||3
5110091|NCT01560234|12571636|P8|COMPLETED|Overall Study||6
5110092|NCT01560234|12571637|P7|COMPLETED|Overall Study||4
5110093|NCT01560234|12571638|P6|COMPLETED|Overall Study||2
5110094|NCT01560234|12571639|P5|COMPLETED|Overall Study||4
5110095|NCT01560234|12571640|P4|COMPLETED|Overall Study||3
5110096|NCT01560234|12571641|P3|COMPLETED|Overall Study||3
5110097|NCT01560234|12571642|P2|COMPLETED|Overall Study||4
5110098|NCT01560234|12571643|P1|COMPLETED|Overall Study||13
5110099|NCT01560234|12571636|P8|STARTED|Overall Study||8
5110100|NCT01560234|12571637|P7|STARTED|Overall Study||4
5110101|NCT01560234|12571638|P6|STARTED|Overall Study||4
5110102|NCT01560234|12571639|P5|STARTED|Overall Study||4
5110103|NCT01560234|12571640|P4|STARTED|Overall Study||3
5110104|NCT01560234|12571641|P3|STARTED|Overall Study||4
5110105|NCT01560234|12571642|P2|STARTED|Overall Study||4
5110106|NCT01560234|12571643|P1|STARTED|Overall Study||16
5110107|NCT01560143|12571717|P1|NOT COMPLETED|Overall Study||0
5110108|NCT01560143|12571717|P1|COMPLETED|Overall Study||12
5110109|NCT01560143|12571717|P1|STARTED|Overall Study||12
5110110|NCT01559948|12571723|P2|NOT COMPLETED|Overall Study||0
5110111|NCT01559948|12571724|P1|NOT COMPLETED|Overall Study||0
5110112|NCT01559948|12571723|P2|COMPLETED|Overall Study||15
5110113|NCT01559948|12571724|P1|COMPLETED|Overall Study||15
5110114|NCT01559948|12571723|P2|STARTED|Overall Study||15
5110115|NCT01559948|12571724|P1|STARTED|Overall Study||15
5110116|NCT01559935|12571738|P1|NOT COMPLETED|Maintenance Phase||54
5110117|NCT01559935|12571738|P1|COMPLETED|Maintenance Phase||0
5110118|NCT01559935|12571738|P1|STARTED|Maintenance Phase||54
5110119|NCT01559935|12571738|P1|NOT COMPLETED|BiRD Phase||4
5110120|NCT01559935|12571738|P1|COMPLETED|BiRD Phase||54
5110121|NCT01559935|12571738|P1|STARTED|BiRD Phase||58
5110122|NCT01559935|12571738|P1|NOT COMPLETED|Car Phase||14
5110123|NCT01559935|12571738|P1|COMPLETED|Car Phase||58
5110124|NCT01559935|12571738|P1|STARTED|Car Phase||72
5110125|NCT01559922|12571748|P2|NOT COMPLETED|Overall Study||10
5110126|NCT01559922|12571749|P1|NOT COMPLETED|Overall Study||4
5110127|NCT01559922|12571748|P2|COMPLETED|Overall Study||87
5110128|NCT01559922|12571749|P1|COMPLETED|Overall Study||46
5110129|NCT01559922|12571748|P2|STARTED|Overall Study||97
5110130|NCT01559922|12571749|P1|STARTED|Overall Study||50
5110131|NCT01559857|12571757|P2|NOT COMPLETED|Overall Study||0
5110132|NCT01559857|12571758|P1|NOT COMPLETED|Overall Study||0
5110133|NCT01559857|12571757|P2|COMPLETED|Overall Study||18
5110134|NCT01559857|12571758|P1|COMPLETED|Overall Study||19
5110135|NCT01559857|12571757|P2|STARTED|Overall Study||18
5110136|NCT01559857|12571758|P1|STARTED|Overall Study||19
5110137|NCT01559844|12571774|P1|NOT COMPLETED|Overall Study||25
5110138|NCT01559844|12571774|P1|COMPLETED|Overall Study||36
5110139|NCT01559844|12571774|P1|STARTED|Overall Study||61
5110140|NCT01559675|12571787|P2|NOT COMPLETED|Overall Study||14
5110141|NCT01559675|12571788|P1|NOT COMPLETED|Overall Study||15
5110142|NCT01559675|12571787|P2|COMPLETED|Overall Study||49
5110143|NCT01559675|12571788|P1|COMPLETED|Overall Study||43
5110144|NCT01559675|12571787|P2|STARTED|Overall Study||63
5110145|NCT01559675|12571788|P1|STARTED|Overall Study||58
5110146|NCT01559649|12571796|P2|NOT COMPLETED|Overall Study||6
5110147|NCT01559649|12571797|P1|NOT COMPLETED|Overall Study||19
5110148|NCT01559649|12571796|P2|COMPLETED|Overall Study||9
5110149|NCT01559649|12571797|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
5110150|NCT01559649|12571796|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
5110151|NCT01559649|12571797|P1|STARTED|Overall Study||269
5110152|NCT01559506|12571810|P2|NOT COMPLETED|Overall Study||3
5110153|NCT01559506|12571811|P1|NOT COMPLETED|Overall Study||0
5110154|NCT01559506|12571810|P2|COMPLETED|Overall Study||18
5110155|NCT01559506|12571811|P1|COMPLETED|Overall Study||20
5110156|NCT01559506|12571810|P2|STARTED|Overall Study||21
5110157|NCT01559506|12571811|P1|STARTED|Overall Study||20
5110158|NCT01559454|12571819|P2|NOT COMPLETED|Overall Study||6
5110159|NCT01559454|12571820|P1|NOT COMPLETED|Overall Study||3
5110160|NCT01559454|12571819|P2|COMPLETED|Overall Study||4
5110161|NCT01559454|12571820|P1|COMPLETED|Overall Study||6
5110162|NCT01559454|12571819|P2|STARTED|Overall Study||10
5110163|NCT01559454|12571820|P1|STARTED|Overall Study||9
5110164|NCT01559389|12571838|P2|NOT COMPLETED|Overall Study||20
5110165|NCT01559389|12571839|P1|NOT COMPLETED|Overall Study||20
5110166|NCT01559389|12571838|P2|COMPLETED|Overall Study||49
5110167|NCT01559389|12571839|P1|COMPLETED|Overall Study||49
5110168|NCT01559389|12571838|P2|STARTED|Overall Study||69
5110169|NCT01559389|12571839|P1|STARTED|Overall Study||69
5110170|NCT01559311|12571852|P3|NOT COMPLETED|Overall Study||8
5110171|NCT01559311|12571853|P2|NOT COMPLETED|Overall Study||6
5110172|NCT01559311|12571854|P1|NOT COMPLETED|Overall Study||3
5110173|NCT01559311|12571852|P3|COMPLETED|Overall Study|12-Month|26
5110174|NCT01559311|12571853|P2|COMPLETED|Overall Study|12-Month|28
5110175|NCT01559311|12571854|P1|COMPLETED|Overall Study|12-Month|27
5110176|NCT01559311|12571852|P3|6-Month|Overall Study||28
5110177|NCT01559311|12571853|P2|6-Month|Overall Study||33
5110178|NCT01559311|12571854|P1|6-Month|Overall Study||27
5110179|NCT01559311|12571852|P3|3-Month|Overall Study||29
5110180|NCT01559311|12571853|P2|3-Month|Overall Study||34
5110181|NCT01559311|12571854|P1|3-Month|Overall Study||27
5110182|NCT01559311|12571852|P3|1-Month|Overall Study||29
5110183|NCT01559311|12571853|P2|1-Month|Overall Study||34
5110184|NCT01559311|12571854|P1|1-Month|Overall Study||27
5110185|NCT01559311|12571852|P3|Implant|Overall Study||32
5110186|NCT01559311|12571853|P2|Implant|Overall Study||34
5110187|NCT01559311|12571854|P1|Implant|Overall Study||28
5110188|NCT01559311|12571852|P3|STARTED|Overall Study|Enrollment & Baseline|34
5110189|NCT01559311|12571853|P2|STARTED|Overall Study|Enrollment & Baseline|34
5110190|NCT01559311|12571854|P1|STARTED|Overall Study|Enrollment & Baseline|30
5110191|NCT01559259|12571870|P5|NOT COMPLETED|Overall Study||0
5110192|NCT01559259|12571871|P4|NOT COMPLETED|Overall Study||1
5110193|NCT01559259|12571872|P3|NOT COMPLETED|Overall Study||1
5110194|NCT01559259|12571873|P2|NOT COMPLETED|Overall Study||1
5110195|NCT01559259|12571874|P1|NOT COMPLETED|Overall Study||0
5110196|NCT01559259|12571870|P5|COMPLETED|Overall Study||92
5110197|NCT01559259|12571871|P4|COMPLETED|Overall Study||88
5110198|NCT01559259|12571872|P3|COMPLETED|Overall Study||92
5110199|NCT01559259|12571873|P2|COMPLETED|Overall Study||89
5110200|NCT01559259|12571874|P1|COMPLETED|Overall Study||30
5110201|NCT01559259|12571870|P5|STARTED|Overall Study||92
5110202|NCT01559259|12571871|P4|STARTED|Overall Study||89
5110203|NCT01559259|12571872|P3|STARTED|Overall Study||93
5110204|NCT01559259|12571873|P2|STARTED|Overall Study||90
5110205|NCT01559259|12571874|P1|STARTED|Overall Study||30
5110206|NCT01559129|12571963|P2|NOT COMPLETED|Open-label Extension Period||2
5110207|NCT01559129|12571964|P1|NOT COMPLETED|Open-label Extension Period||6
5110208|NCT01559129|12571963|P2|COMPLETED|Open-label Extension Period||0
5110209|NCT01559129|12571964|P1|COMPLETED|Open-label Extension Period||0
5110210|NCT01559129|12571963|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
5110211|NCT01559129|12571964|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
5110212|NCT01559129|12571963|P2|NOT COMPLETED|Treatment Phase||7
5110213|NCT01559129|12571964|P1|NOT COMPLETED|Treatment Phase||5
5110214|NCT01559129|12571963|P2|COMPLETED|Treatment Phase||4
5110215|NCT01559129|12571964|P1|COMPLETED|Treatment Phase||7
5110216|NCT01559129|12571963|P2|Received Treatment|Treatment Phase||10
5110217|NCT01559129|12571964|P1|Received Treatment|Treatment Phase||12
5110218|NCT01559129|12571963|P2|STARTED|Treatment Phase||11
5110219|NCT01559129|12571964|P1|STARTED|Treatment Phase||12
5110220|NCT01559116|12572040|P1|NOT COMPLETED|Overall Study||26
5110221|NCT01559116|12572040|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
5110222|NCT01559116|12572040|P1|STARTED|Overall Study|Randomised|219
5110223|NCT01559090|12572111|P3|NOT COMPLETED|Stage II||0
5110224|NCT01559090|12572112|P2|NOT COMPLETED|Stage II||0
5110225|NCT01559090|12572113|P1|NOT COMPLETED|Stage II||1
5110226|NCT01559090|12572111|P3|COMPLETED|Stage II||2
5110227|NCT01559090|12572112|P2|COMPLETED|Stage II||3
5110228|NCT01559090|12572113|P1|COMPLETED|Stage II||3
5110229|NCT01559090|12572111|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
5110230|NCT01559090|12572112|P2|STARTED|Stage II||3
5110231|NCT01559090|12572113|P1|STARTED|Stage II||4
5110232|NCT01559090|12572111|P3|NOT COMPLETED|Stage I||3
5110233|NCT01559090|12572112|P2|NOT COMPLETED|Stage I||2
5110234|NCT01559090|12572113|P1|NOT COMPLETED|Stage I||2
5110235|NCT01559090|12572111|P3|COMPLETED|Stage I||3
5110236|NCT01559090|12572112|P2|COMPLETED|Stage I||3
5110237|NCT01559090|12572113|P1|COMPLETED|Stage I||4
5110238|NCT01559090|12572111|P3|STARTED|Stage I||6
5110239|NCT01559090|12572112|P2|STARTED|Stage I||5
5110240|NCT01559090|12572113|P1|STARTED|Stage I||6
5110241|NCT01559064|12572133|P3|NOT COMPLETED|Overall Study||2
5110242|NCT01559064|12572134|P2|NOT COMPLETED|Overall Study||1
5110243|NCT01559064|12572135|P1|NOT COMPLETED|Overall Study||1
5110244|NCT01559064|12572133|P3|COMPLETED|Overall Study||57
5110245|NCT01559064|12572134|P2|COMPLETED|Overall Study||39
5110246|NCT01559064|12572135|P1|COMPLETED|Overall Study||15
5110247|NCT01559064|12572133|P3|STARTED|Overall Study||59
5110248|NCT01559064|12572134|P2|STARTED|Overall Study||40
5110249|NCT01559064|12572135|P1|STARTED|Overall Study||16
5110250|NCT01559012|12572145|P2|NOT COMPLETED|Overall Study||1
5110251|NCT01559012|12572146|P1|NOT COMPLETED|Overall Study||0
5110252|NCT01559012|12572145|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
5110253|NCT01559012|12572146|P1|COMPLETED|Overall Study||6
5110254|NCT01559012|12572145|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
5110255|NCT01559012|12572146|P1|STARTED|Overall Study||6
5110256|NCT01558791|12572171|P2|NOT COMPLETED|Overall Study||0
5110257|NCT01558791|12572172|P1|NOT COMPLETED|Overall Study||0
5110258|NCT01558791|12572171|P2|COMPLETED|Overall Study||629
5110259|NCT01558791|12572172|P1|COMPLETED|Overall Study||607
5110260|NCT01558791|12572171|P2|STARTED|Overall Study||629
5110261|NCT01558791|12572172|P1|STARTED|Overall Study||607
5110262|NCT01558739|12572184|P1|NOT COMPLETED|Overall Study||17
5110263|NCT01558739|12572184|P1|COMPLETED|Overall Study||31
5110264|NCT01558739|12572184|P1|STARTED|Overall Study||48
5110265|NCT01558700|12572198|P2|NOT COMPLETED|Overall Study||0
5110266|NCT01558700|12572199|P1|NOT COMPLETED|Overall Study||0
5110267|NCT01558700|12572198|P2|COMPLETED|Overall Study||21
5110268|NCT01558700|12572199|P1|COMPLETED|Overall Study||19
5110269|NCT01558700|12572198|P2|STARTED|Overall Study||21
5110270|NCT01558700|12572199|P1|STARTED|Overall Study||19
5110271|NCT01558674|12572209|P2|NOT COMPLETED|Part 2||0
5110272|NCT01558674|12572210|P1|NOT COMPLETED|Part 2||0
5110273|NCT01558674|12572209|P2|COMPLETED|Part 2||0
5110274|NCT01558674|12572210|P1|COMPLETED|Part 2||0
5110275|NCT01558674|12572209|P2|STARTED|Part 2||0
5110276|NCT01558674|12572210|P1|STARTED|Part 2||0
5110277|NCT01558674|12572209|P2|NOT COMPLETED|Part 1||0
5110278|NCT01558674|12572210|P1|NOT COMPLETED|Part 1||11
5110279|NCT01558674|12572209|P2|COMPLETED|Part 1||0
5110280|NCT01558674|12572210|P1|COMPLETED|Part 1||0
5110281|NCT01558674|12572209|P2|STARTED|Part 1||0
5110282|NCT01558674|12572210|P1|STARTED|Part 1||11
5110283|NCT01558661|12572254|P1|NOT COMPLETED|Overall Study||0
5110284|NCT01558661|12572254|P1|COMPLETED|Overall Study||33
5110285|NCT01558661|12572254|P1|Second Stage|Overall Study||15
5110286|NCT01558661|12572254|P1|First Stage|Overall Study||18
5110287|NCT01558661|12572254|P1|STARTED|Overall Study||33
5110288|NCT01558635|12572261|P1|NOT COMPLETED|Overall Study||6
5110289|NCT01558635|12572261|P1|COMPLETED|Overall Study||11
5110290|NCT01558635|12572261|P1|6 Months Post-procedure|Overall Study||14
5110291|NCT01558635|12572261|P1|3 Months Post-procedure|Overall Study||14
5110292|NCT01558635|12572261|P1|Discharge /1 Month Post-procedure|Overall Study||15
5110293|NCT01558635|12572261|P1|Treated|Overall Study||17
5110294|NCT01558635|12572261|P1|STARTED|Overall Study||17
5110295|NCT01558596|12572278|P2|NOT COMPLETED|Overall Study||1
5110296|NCT01558596|12572279|P1|NOT COMPLETED|Overall Study||3
5110297|NCT01558596|12572278|P2|COMPLETED|Overall Study||100
5110298|NCT01558596|12572279|P1|COMPLETED|Overall Study||101
5110299|NCT01558596|12572278|P2|STARTED|Overall Study||101
5110300|NCT01558596|12572279|P1|STARTED|Overall Study||104
5110301|NCT01558492|12572285|P1|NOT COMPLETED|Overall Study||0
5110302|NCT01558492|12572285|P1|COMPLETED|Overall Study||3
5110303|NCT01558492|12572285|P1|STARTED|Overall Study||3
5110304|NCT01558297|12572294|P3|NOT COMPLETED|Overall Study||1
5110305|NCT01558297|12572295|P2|NOT COMPLETED|Overall Study||2
5110306|NCT01558297|12572296|P1|NOT COMPLETED|Overall Study||2
5110307|NCT01558297|12572294|P3|COMPLETED|Overall Study||29
5110308|NCT01558297|12572295|P2|COMPLETED|Overall Study||27
5110309|NCT01558297|12572296|P1|COMPLETED|Overall Study||28
5110310|NCT01558297|12572294|P3|STARTED|Overall Study||30
5110311|NCT01558297|12572295|P2|STARTED|Overall Study||29
5110312|NCT01558297|12572296|P1|STARTED|Overall Study||30
5110313|NCT01558271|12572313|P3|NOT COMPLETED|Overall Study||17
5110314|NCT01558271|12572314|P2|NOT COMPLETED|Overall Study||11
5110315|NCT01558271|12572315|P1|NOT COMPLETED|Overall Study||18
5110316|NCT01558271|12572313|P3|COMPLETED|Overall Study||124
5110317|NCT01558271|12572314|P2|COMPLETED|Overall Study||59
5110318|NCT01558271|12572315|P1|COMPLETED|Overall Study||263
5110319|NCT01558271|12572313|P3|Completed 26 Weeks|Overall Study||128
5110320|NCT01558271|12572314|P2|Completed 26 Weeks|Overall Study||63
5110321|NCT01558271|12572315|P1|Completed 26 Weeks|Overall Study||271
5110322|NCT01558271|12572313|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
5110323|NCT01558271|12572314|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
5110324|NCT01558271|12572315|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
5110325|NCT01558271|12572313|P3|STARTED|Overall Study||141
5110326|NCT01558271|12572314|P2|STARTED|Overall Study||70
5110327|NCT01558271|12572315|P1|STARTED|Overall Study||281
5110328|NCT01558128|12572377|P1|NOT COMPLETED|Overall Study||0
5110329|NCT01558128|12572377|P1|COMPLETED|Overall Study||1
5110330|NCT01558128|12572377|P1|STARTED|Overall Study||1
5110331|NCT01558089|12572381|P1|NOT COMPLETED|Overall Study||13
5110332|NCT01558089|12572381|P1|COMPLETED|Overall Study||63
5110333|NCT01558089|12572381|P1|STARTED|Overall Study||76
5110334|NCT01558063|12572398|P6|NOT COMPLETED|Overall Study||0
5110335|NCT01558063|12572399|P5|NOT COMPLETED|Overall Study||0
5110336|NCT01558063|12572400|P4|NOT COMPLETED|Overall Study||0
5110337|NCT01558063|12572401|P3|NOT COMPLETED|Overall Study||0
5110338|NCT01558063|12572402|P2|NOT COMPLETED|Overall Study||0
5110339|NCT01558063|12572403|P1|NOT COMPLETED|Overall Study||0
5110340|NCT01558063|12572398|P6|COMPLETED|Overall Study||5
5110341|NCT01558063|12572399|P5|COMPLETED|Overall Study||9
5110342|NCT01558063|12572400|P4|COMPLETED|Overall Study||5
5110343|NCT01558063|12572401|P3|COMPLETED|Overall Study||8
5110344|NCT01558063|12572402|P2|COMPLETED|Overall Study||6
5110345|NCT01558063|12572403|P1|COMPLETED|Overall Study||5
5110346|NCT01558063|12572398|P6|STARTED|Overall Study||5
5110347|NCT01558063|12572399|P5|STARTED|Overall Study||9
5110348|NCT01558063|12572400|P4|STARTED|Overall Study||5
5110349|NCT01558063|12572401|P3|STARTED|Overall Study||8
5110350|NCT01558063|12572402|P2|STARTED|Overall Study||6
5110351|NCT01558063|12572403|P1|STARTED|Overall Study||5
5110352|NCT01557959|12572424|P1|NOT COMPLETED|Overall Study||0
5110353|NCT01557959|12572424|P1|COMPLETED|Overall Study||45
5110354|NCT01557959|12572424|P1|STARTED|Overall Study||45
5110355|NCT01557946|12572434|P2|NOT COMPLETED|Overall Study||0
5110356|NCT01557946|12572435|P1|NOT COMPLETED|Overall Study||3
5110357|NCT01557946|12572434|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
5110358|NCT01557946|12572435|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
5110359|NCT01557946|12572434|P2|STARTED|Overall Study||12
5110360|NCT01557946|12572435|P1|STARTED|Overall Study||20
5110361|NCT01557920|12572441|P2|NOT COMPLETED|Overall Study||3
5110362|NCT01557920|12572442|P1|NOT COMPLETED|Overall Study||3
5110363|NCT01557920|12572441|P2|COMPLETED|Overall Study||6
5110364|NCT01557920|12572442|P1|COMPLETED|Overall Study||6
5110365|NCT01557920|12572441|P2|STARTED|Overall Study||9
5110366|NCT01557920|12572442|P1|STARTED|Overall Study||9
5110367|NCT01557894|12572477|P2|NOT COMPLETED|Overall Study||5
5110368|NCT01557894|12572478|P1|NOT COMPLETED|Overall Study||3
5110369|NCT01557894|12572477|P2|COMPLETED|Overall Study||33
5110370|NCT01557894|12572478|P1|COMPLETED|Overall Study||35
5110371|NCT01557894|12572477|P2|STARTED|Overall Study||38
5110372|NCT01557894|12572478|P1|STARTED|Overall Study||38
5110373|NCT01557881|12572492|P1|NOT COMPLETED|Overall Study||0
5110374|NCT01557881|12572492|P1|COMPLETED|Overall Study||98
5110375|NCT01557881|12572492|P1|STARTED|Overall Study||98
5110376|NCT01557868|12572500|P2|NOT COMPLETED|Overall Study||30
5110377|NCT01557868|12572501|P1|NOT COMPLETED|Overall Study||27
5110378|NCT01557868|12572500|P2|COMPLETED|Overall Study||65
5110379|NCT01557868|12572501|P1|COMPLETED|Overall Study||76
5110380|NCT01557868|12572500|P2|STARTED|Overall Study||95
5110381|NCT01557868|12572501|P1|STARTED|Overall Study||103
5110382|NCT01557842|12572511|P2|NOT COMPLETED|Overall Study||6
5110383|NCT01557842|12572512|P1|NOT COMPLETED|Overall Study||9
5110384|NCT01557842|12572511|P2|COMPLETED|Overall Study||0
5110385|NCT01557842|12572512|P1|COMPLETED|Overall Study||0
5110386|NCT01557842|12572511|P2|STARTED|Overall Study||6
5110387|NCT01557842|12572512|P1|STARTED|Overall Study||9
5110388|NCT01557790|12572520|P1|NOT COMPLETED|Overall Study||1
5110389|NCT01557790|12572520|P1|COMPLETED|Overall Study||4
5110390|NCT01557790|12572520|P1|STARTED|Overall Study||5
5110391|NCT01557751|12572524|P1|NOT COMPLETED|Overall Study||3
5110392|NCT01557751|12572524|P1|COMPLETED|Overall Study||153
5110393|NCT01557751|12572524|P1|STARTED|Overall Study||156
5110394|NCT01557699|12572531|P3|NOT COMPLETED|Overall Study||0
5110395|NCT01557699|12572532|P2|NOT COMPLETED|Overall Study||0
5110396|NCT01557699|12572533|P1|NOT COMPLETED|Overall Study||0
5110397|NCT01557699|12572531|P3|COMPLETED|Overall Study||20
5110398|NCT01557699|12572532|P2|COMPLETED|Overall Study||20
5110399|NCT01557699|12572533|P1|COMPLETED|Overall Study||20
5110400|NCT01557699|12572531|P3|STARTED|Overall Study||20
5110401|NCT01557699|12572532|P2|STARTED|Overall Study||20
5110402|NCT01557699|12572533|P1|STARTED|Overall Study||20
5110403|NCT01557595|12572565|P1|NOT COMPLETED|Overall Study||8
5110404|NCT01557595|12572565|P1|COMPLETED|Overall Study||14
5110405|NCT01557595|12572565|P1|STARTED|Overall Study||22
5110406|NCT01557582|12572569|P1|NOT COMPLETED|Overall Study||6
5110407|NCT01557582|12572569|P1|COMPLETED|Overall Study||97
5110408|NCT01557582|12572569|P1|STARTED|Overall Study||103
5110409|NCT01557569|12572577|P2|NOT COMPLETED|Overall Study||7
5110410|NCT01557569|12572578|P1|NOT COMPLETED|Overall Study||5
5110411|NCT01557569|12572577|P2|COMPLETED|Overall Study||0
5110412|NCT01557569|12572578|P1|COMPLETED|Overall Study||1
5110413|NCT01557569|12572577|P2|Completed 2-wk Residential Stay|Overall Study||1
5110414|NCT01557569|12572578|P1|Completed 2-wk Residential Stay|Overall Study||3
5110415|NCT01557569|12572577|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
5110416|NCT01557569|12572578|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
5110417|NCT01557517|12572586|P2|NOT COMPLETED|Overall Study||4
5110418|NCT01557517|12572587|P1|NOT COMPLETED|Overall Study||2
5110419|NCT01557517|12572586|P2|COMPLETED|Overall Study||17
5110420|NCT01557517|12572587|P1|COMPLETED|Overall Study||17
5110421|NCT01557517|12572586|P2|STARTED|Overall Study||21
5110422|NCT01557517|12572587|P1|STARTED|Overall Study||19
5110423|NCT01557504|12572613|P2|NOT COMPLETED|Overall Study||0
5110424|NCT01557504|12572614|P1|NOT COMPLETED|Overall Study||1
5110425|NCT01557504|12572613|P2|COMPLETED|Overall Study||12
5110426|NCT01557504|12572614|P1|COMPLETED|Overall Study||12
5110427|NCT01557504|12572613|P2|STARTED|Overall Study||12
5110428|NCT01557504|12572614|P1|STARTED|Overall Study||13
5110429|NCT01557348|12572639|P2|NOT COMPLETED|Overall Study||90
5110430|NCT01557348|12572640|P1|NOT COMPLETED|Overall Study||80
5110431|NCT01557348|12572639|P2|COMPLETED|Overall Study||417
5110432|NCT01557348|12572640|P1|COMPLETED|Overall Study||524
5110433|NCT01557348|12572639|P2|Safety Population|Overall Study||507
5110434|NCT01557348|12572640|P1|Safety Population|Overall Study||604
5110435|NCT01557348|12572639|P2|STARTED|Overall Study||507
5110436|NCT01557348|12572640|P1|STARTED|Overall Study||604
5110437|NCT01557322|12572682|P2|NOT COMPLETED|Overall Study||0
5110438|NCT01557322|12572683|P1|NOT COMPLETED|Overall Study||0
5110439|NCT01557322|12572682|P2|COMPLETED|Overall Study||1543
5110440|NCT01557322|12572683|P1|COMPLETED|Overall Study||211
5110441|NCT01557322|12572682|P2|STARTED|Overall Study||1543
5110442|NCT01557322|12572683|P1|STARTED|Overall Study||211
5110443|NCT01557283|12572757|P1|NOT COMPLETED|Overall Study||44
5110444|NCT01557283|12572757|P1|COMPLETED|Overall Study||96
5110445|NCT01557283|12572757|P1|STARTED|Overall Study||140
5110446|NCT01557166|12572769|P2|NOT COMPLETED|Overall Study||37
5110447|NCT01557166|12572770|P1|NOT COMPLETED|Overall Study||46
5110448|NCT01557166|12572769|P2|COMPLETED|Overall Study||142
5110449|NCT01557166|12572770|P1|COMPLETED|Overall Study||134
5110450|NCT01557166|12572769|P2|Exposed|Overall Study||179
5110451|NCT01557166|12572770|P1|Exposed|Overall Study||176
5110452|NCT01557166|12572769|P2|STARTED|Overall Study||179
5110453|NCT01557166|12572770|P1|STARTED|Overall Study||180
5110454|NCT01556997|12572785|P3|NOT COMPLETED|Overall Study||32
5110455|NCT01556997|12572786|P2|NOT COMPLETED|Overall Study||28
5110456|NCT01556997|12572787|P1|NOT COMPLETED|Overall Study||26
5110457|NCT01556997|12572785|P3|COMPLETED|Overall Study||246
5110458|NCT01556997|12572786|P2|COMPLETED|Overall Study||252
5110459|NCT01556997|12572787|P1|COMPLETED|Overall Study||253
5110460|NCT01556997|12572785|P3|STARTED|Overall Study||278
5110461|NCT01556997|12572786|P2|STARTED|Overall Study||280
5110462|NCT01556997|12572787|P1|STARTED|Overall Study||279
5110463|NCT01556932|12572798|P2|NOT COMPLETED|Second Treament||0
5110464|NCT01556932|12572799|P1|NOT COMPLETED|Second Treament||0
5110465|NCT01556932|12572798|P2|COMPLETED|Second Treament||8
5110466|NCT01556932|12572799|P1|COMPLETED|Second Treament||12
5110467|NCT01556932|12572798|P2|Recieved|Second Treament||8
5110468|NCT01556932|12572799|P1|Recieved|Second Treament||12
5110469|NCT01556932|12572798|P2|STARTED|Second Treament||8
5110470|NCT01556932|12572799|P1|STARTED|Second Treament||12
5110471|NCT01556932|12572798|P2|NOT COMPLETED|Time Point 60 Minutes||1
5110472|NCT01556932|12572799|P1|NOT COMPLETED|Time Point 60 Minutes||1
5110473|NCT01556932|12572798|P2|COMPLETED|Time Point 60 Minutes||8
5110474|NCT01556932|12572799|P1|COMPLETED|Time Point 60 Minutes||12
5110475|NCT01556932|12572798|P2|Recieved|Time Point 60 Minutes||8
5110476|NCT01556932|12572799|P1|Recieved|Time Point 60 Minutes||12
5110477|NCT01556932|12572798|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
5110478|NCT01556932|12572799|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
5110479|NCT01556932|12572798|P2|NOT COMPLETED|Baseline First Treatment||0
5110480|NCT01556932|12572799|P1|NOT COMPLETED|Baseline First Treatment||0
5110481|NCT01556932|12572798|P2|COMPLETED|Baseline First Treatment||9
5110482|NCT01556932|12572799|P1|COMPLETED|Baseline First Treatment||13
5110483|NCT01556932|12572798|P2|Recieved|Baseline First Treatment||9
5110484|NCT01556932|12572799|P1|Recieved|Baseline First Treatment||13
5110485|NCT01556932|12572798|P2|STARTED|Baseline First Treatment||9
5110486|NCT01556932|12572799|P1|STARTED|Baseline First Treatment||13
5110487|NCT01556906|12572804|P1|NOT COMPLETED|Overall Study||0
5110488|NCT01556906|12572804|P1|COMPLETED|Overall Study||6
5110489|NCT01556906|12572804|P1|STARTED|Overall Study||6
5110490|NCT01556763|12572825|P3|NOT COMPLETED|Overall Study||0
5110491|NCT01556763|12572826|P2|NOT COMPLETED|Overall Study||1
5110492|NCT01556763|12572827|P1|NOT COMPLETED|Overall Study||0
5110493|NCT01556763|12572825|P3|COMPLETED|Overall Study||8
5110494|NCT01556763|12572826|P2|COMPLETED|Overall Study||8
5110495|NCT01556763|12572827|P1|COMPLETED|Overall Study||4
5110496|NCT01556763|12572825|P3|STARTED|Overall Study||8
5110497|NCT01556763|12572826|P2|STARTED|Overall Study||9
5110498|NCT01556763|12572827|P1|STARTED|Overall Study||4
5110499|NCT01556724|12572865|P2|NOT COMPLETED|Overall Study||0
5110500|NCT01556724|12572866|P1|NOT COMPLETED|Overall Study||0
5110501|NCT01556724|12572865|P2|COMPLETED|Overall Study||14
5110502|NCT01556724|12572866|P1|COMPLETED|Overall Study||16
5110503|NCT01556724|12572865|P2|STARTED|Overall Study||14
5110504|NCT01556724|12572866|P1|STARTED|Overall Study||16
5110505|NCT01556633|12572882|P2|NOT COMPLETED|Overall Study||0
5110506|NCT01556633|12572883|P1|NOT COMPLETED|Overall Study||0
5110507|NCT01556633|12572882|P2|COMPLETED|Overall Study||6
5110508|NCT01556633|12572883|P1|COMPLETED|Overall Study||10
5110509|NCT01556633|12572882|P2|STARTED|Overall Study||6
5110510|NCT01556633|12572883|P1|STARTED|Overall Study||10
5110511|NCT01556594|12572908|P3|NOT COMPLETED|Overall Study||0
5110512|NCT01556594|12572909|P2|NOT COMPLETED|Overall Study||0
5110513|NCT01556594|12572910|P1|NOT COMPLETED|Overall Study||0
5110514|NCT01556594|12572908|P3|COMPLETED|Overall Study||6
5110515|NCT01556594|12572909|P2|COMPLETED|Overall Study||2
5110516|NCT01556594|12572910|P1|COMPLETED|Overall Study||10
5110517|NCT01556594|12572908|P3|STARTED|Overall Study||6
5110518|NCT01556594|12572909|P2|STARTED|Overall Study||2
5110519|NCT01556594|12572910|P1|STARTED|Overall Study||10
5110520|NCT01556581|12572946|P2|NOT COMPLETED|Overall Study||0
5110521|NCT01556581|12572947|P1|NOT COMPLETED|Overall Study||0
5110522|NCT01556581|12572946|P2|COMPLETED|Overall Study||58
5110523|NCT01556581|12572947|P1|COMPLETED|Overall Study||61
5110524|NCT01556581|12572946|P2|STARTED|Overall Study||58
5110525|NCT01556581|12572947|P1|STARTED|Overall Study||61
5110526|NCT01556451|12572957|P1|NOT COMPLETED|Overall Study||0
5110527|NCT01556451|12572957|P1|COMPLETED|Overall Study||180
5110528|NCT01556451|12572957|P1|STARTED|Overall Study||180
5110529|NCT01556438|12572966|P2|NOT COMPLETED|Overall Study||11
5110530|NCT01556438|12572967|P1|NOT COMPLETED|Overall Study||4
5110531|NCT01556438|12572966|P2|COMPLETED|Overall Study||1
5110532|NCT01556438|12572967|P1|COMPLETED|Overall Study||0
5110533|NCT01556438|12572966|P2|Received BTZ SC|Overall Study||8
5110534|NCT01556438|12572967|P1|Received BTZ SC|Overall Study||0
5110535|NCT01556438|12572966|P2|Received BTZ IV|Overall Study||4
5110536|NCT01556438|12572967|P1|Received BTZ IV|Overall Study||4
5110537|NCT01556438|12572966|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
5110538|NCT01556438|12572967|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
5110539|NCT01556438|12572966|P2|STARTED|Overall Study||12
5110540|NCT01556438|12572967|P1|STARTED|Overall Study||4
5110541|NCT01556425|12572996|P4|NOT COMPLETED|Overall Study||0
5110542|NCT01556425|12572997|P3|NOT COMPLETED|Overall Study||0
5110543|NCT01556425|12572998|P2|NOT COMPLETED|Overall Study||0
5110544|NCT01556425|12572999|P1|NOT COMPLETED|Overall Study||0
5110545|NCT01556425|12572996|P4|COMPLETED|Overall Study||18
5110546|NCT01556425|12572997|P3|COMPLETED|Overall Study||18
5110547|NCT01556425|12572998|P2|COMPLETED|Overall Study||23
5110548|NCT01556425|12572999|P1|COMPLETED|Overall Study||25
5110549|NCT01556425|12572996|P4|STARTED|Overall Study||18
5110550|NCT01556425|12572997|P3|STARTED|Overall Study||18
5110551|NCT01556425|12572998|P2|STARTED|Overall Study||23
5110552|NCT01556425|12572999|P1|STARTED|Overall Study||25
5110553|NCT01556347|12573013|P1|NOT COMPLETED|Recovery Phase||0
5110554|NCT01556347|12573013|P1|COMPLETED|Recovery Phase||2
5110555|NCT01556347|12573013|P1|STARTED|Recovery Phase||2
5110556|NCT01556347|12573013|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
5110557|NCT01556347|12573013|P1|COMPLETED|Bortezomib Treatment Phase||2
5110558|NCT01556347|12573013|P1|STARTED|Bortezomib Treatment Phase||2
5110559|NCT01556347|12573013|P1|NOT COMPLETED|Induction Immunotherapy||0
5110560|NCT01556347|12573013|P1|COMPLETED|Induction Immunotherapy||2
5110561|NCT01556347|12573013|P1|STARTED|Induction Immunotherapy||2
5110562|NCT01556204|12573043|P2|NOT COMPLETED|Overall Study||0
5110563|NCT01556204|12573044|P1|NOT COMPLETED|Overall Study||0
5110564|NCT01556204|12573043|P2|COMPLETED|Overall Study||38
5110565|NCT01556204|12573044|P1|COMPLETED|Overall Study||35
5110566|NCT01556204|12573043|P2|STARTED|Overall Study||38
5110567|NCT01556204|12573044|P1|STARTED|Overall Study||35
5110568|NCT01556165|12573054|P2|NOT COMPLETED|Overall Study||7
5110569|NCT01556165|12573055|P1|NOT COMPLETED|Overall Study||12
5110570|NCT01556165|12573054|P2|COMPLETED|Overall Study||58
5110571|NCT01556165|12573055|P1|COMPLETED|Overall Study||53
5110572|NCT01556165|12573054|P2|STARTED|Overall Study||65
5110573|NCT01556165|12573055|P1|STARTED|Overall Study||65
5110574|NCT01556100|12573067|P1|NOT COMPLETED|Overall Study||6
5110575|NCT01556100|12573067|P1|COMPLETED|Overall Study||34
5110576|NCT01556100|12573067|P1|STARTED|Overall Study||40
5110577|NCT01556061|12573074|P2|NOT COMPLETED|Overall Study||0
5110578|NCT01556061|12573075|P1|NOT COMPLETED|Overall Study||0
5110579|NCT01556061|12573074|P2|COMPLETED|Overall Study||25
5110580|NCT01556061|12573075|P1|COMPLETED|Overall Study||25
5110581|NCT01556061|12573074|P2|STARTED|Overall Study||25
5110582|NCT01556061|12573075|P1|STARTED|Overall Study||25
5110583|NCT01555983|12573085|P6|NOT COMPLETED|Overall Study||1
5110584|NCT01555983|12573086|P5|NOT COMPLETED|Overall Study||1
5110585|NCT01555983|12573087|P4|NOT COMPLETED|Overall Study||0
5110586|NCT01555983|12573088|P3|NOT COMPLETED|Overall Study||0
5110587|NCT01555983|12573089|P2|NOT COMPLETED|Overall Study||0
5110588|NCT01555983|12573090|P1|NOT COMPLETED|Overall Study||1
5110589|NCT01555983|12573085|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
5110590|NCT01555983|12573086|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
5110591|NCT01555983|12573087|P4|COMPLETED|Overall Study||7
5110592|NCT01555983|12573088|P3|COMPLETED|Overall Study||7
5110593|NCT01555983|12573089|P2|COMPLETED|Overall Study||7
5110594|NCT01555983|12573090|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
5110595|NCT01555983|12573085|P6|STARTED|Overall Study||7
5110596|NCT01555983|12573086|P5|STARTED|Overall Study||5
5110597|NCT01555983|12573087|P4|STARTED|Overall Study||7
5110598|NCT01555983|12573088|P3|STARTED|Overall Study||7
5110599|NCT01555983|12573089|P2|STARTED|Overall Study||7
5110600|NCT01555983|12573090|P1|STARTED|Overall Study||9
5110601|NCT01555931|12573100|P2|NOT COMPLETED|Overall Study||5
5110602|NCT01555931|12573101|P1|NOT COMPLETED|Overall Study||2
5110603|NCT01555931|12573100|P2|COMPLETED|Overall Study||13
5110604|NCT01555931|12573101|P1|COMPLETED|Overall Study||15
5110605|NCT01555931|12573100|P2|STARTED|Overall Study||18
5110606|NCT01555931|12573101|P1|STARTED|Overall Study||17
5110607|NCT01555762|12573109|P1|NOT COMPLETED|Overall Study||274
5110608|NCT01555762|12573109|P1|COMPLETED|Overall Study||128
5110609|NCT01555762|12573109|P1|Efficacy Population|Overall Study||358
5110610|NCT01555762|12573109|P1|Safety Population|Overall Study||383
5110611|NCT01555762|12573109|P1|STARTED|Overall Study||402
5110612|NCT01555567|12573123|P4|NOT COMPLETED|Return to Activity||1
5110613|NCT01555567|12573124|P3|NOT COMPLETED|Return to Activity||0
5110614|NCT01555567|12573125|P2|NOT COMPLETED|Return to Activity||2
5110615|NCT01555567|12573126|P1|NOT COMPLETED|Return to Activity||1
5110616|NCT01555567|12573123|P4|COMPLETED|Return to Activity||8
5110617|NCT01555567|12573124|P3|COMPLETED|Return to Activity||8
5110618|NCT01555567|12573125|P2|COMPLETED|Return to Activity||10
5110619|NCT01555567|12573126|P1|COMPLETED|Return to Activity||10
5110620|NCT01555567|12573123|P4|STARTED|Return to Activity||9
5110621|NCT01555567|12573124|P3|STARTED|Return to Activity||8
5110622|NCT01555567|12573125|P2|STARTED|Return to Activity||12
5110623|NCT01555567|12573126|P1|STARTED|Return to Activity||11
5110624|NCT01555567|12573123|P4|NOT COMPLETED|12 Week||0
5110625|NCT01555567|12573124|P3|NOT COMPLETED|12 Week||1
5110626|NCT01555567|12573125|P2|NOT COMPLETED|12 Week||1
5110627|NCT01555567|12573126|P1|NOT COMPLETED|12 Week||1
5110628|NCT01555567|12573123|P4|COMPLETED|12 Week||9
5110629|NCT01555567|12573124|P3|COMPLETED|12 Week||8
5110630|NCT01555567|12573125|P2|COMPLETED|12 Week||12
5110631|NCT01555567|12573126|P1|COMPLETED|12 Week||11
5110632|NCT01555567|12573123|P4|STARTED|12 Week||9
5110633|NCT01555567|12573124|P3|STARTED|12 Week||9
5110634|NCT01555567|12573125|P2|STARTED|12 Week||13
5110635|NCT01555567|12573126|P1|STARTED|12 Week||12
5110636|NCT01555541|12573140|P1|NOT COMPLETED|Autologous Stem Cell Transplantation||0
5110637|NCT01555541|12573140|P1|COMPLETED|Autologous Stem Cell Transplantation||12
5110638|NCT01555541|12573140|P1|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
5110639|NCT01555541|12573140|P1|NOT COMPLETED|OVA Treatment||0
5110640|NCT01555541|12573140|P1|COMPLETED|OVA Treatment||19
5110641|NCT01555541|12573140|P1|STARTED|OVA Treatment||19
5110642|NCT01555541|12573140|P1|NOT COMPLETED|Salvage Response Assessment||0
5110643|NCT01555541|12573140|P1|COMPLETED|Salvage Response Assessment||19
5110644|NCT01555541|12573140|P1|STARTED|Salvage Response Assessment||19
5110645|NCT01555489|12573147|P1|NOT COMPLETED|Overall Study||0
5110646|NCT01555489|12573147|P1|COMPLETED|Overall Study||11
5110647|NCT01555489|12573147|P1|STARTED|Overall Study||11
5110648|NCT01555463|12573154|P2|NOT COMPLETED|Follow up||45
5110649|NCT01555463|12573155|P1|NOT COMPLETED|Follow up||38
5110650|NCT01555463|12573154|P2|COMPLETED|Follow up||394
5110651|NCT01555463|12573155|P1|COMPLETED|Follow up||409
5110652|NCT01555463|12573154|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
5110653|NCT01555463|12573155|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
5110654|NCT01555463|12573154|P2|NOT COMPLETED|Treatment||79
5110655|NCT01555463|12573155|P1|NOT COMPLETED|Treatment||64
5110656|NCT01555463|12573154|P2|COMPLETED|Treatment||399
5110657|NCT01555463|12573155|P1|COMPLETED|Treatment||419
5110658|NCT01555463|12573154|P2|STARTED|Treatment||478
5110659|NCT01555463|12573155|P1|STARTED|Treatment||483
5110660|NCT01555164|12573197|P2|NOT COMPLETED|Overall Study||35
5110661|NCT01555164|12573198|P1|NOT COMPLETED|Overall Study||40
5110662|NCT01555164|12573197|P2|COMPLETED|Overall Study||185
5110663|NCT01555164|12573198|P1|COMPLETED|Overall Study||182
5110664|NCT01555164|12573197|P2|STARTED|Overall Study||220
5110665|NCT01555164|12573198|P1|STARTED|Overall Study||222
5110666|NCT01555151|12573212|P4|NOT COMPLETED|Overall Study||10
5110667|NCT01555151|12573213|P3|NOT COMPLETED|Overall Study||6
5110668|NCT01555151|12573214|P2|NOT COMPLETED|Overall Study||8
5110669|NCT01555151|12573215|P1|NOT COMPLETED|Overall Study||13
5110670|NCT01555151|12573212|P4|COMPLETED|Overall Study||176
5110671|NCT01555151|12573213|P3|COMPLETED|Overall Study||178
5110672|NCT01555151|12573214|P2|COMPLETED|Overall Study||173
5110673|NCT01555151|12573215|P1|COMPLETED|Overall Study||175
5110674|NCT01555151|12573212|P4|Safety Set (SAF)|Overall Study||186
5110675|NCT01555151|12573213|P3|Safety Set (SAF)|Overall Study||183
5110676|NCT01555151|12573214|P2|Safety Set (SAF)|Overall Study||180
5110677|NCT01555151|12573215|P1|Safety Set (SAF)|Overall Study||186
5110678|NCT01555151|12573212|P4|STARTED|Overall Study||186
5110679|NCT01555151|12573213|P3|STARTED|Overall Study||184
5110680|NCT01555151|12573214|P2|STARTED|Overall Study||181
5110681|NCT01555151|12573215|P1|STARTED|Overall Study||188
5110682|NCT01555138|12573268|P2|NOT COMPLETED|Overall Study||38
5110683|NCT01555138|12573269|P1|NOT COMPLETED|Overall Study||47
5110684|NCT01555138|12573268|P2|COMPLETED|Overall Study||250
5110685|NCT01555138|12573269|P1|COMPLETED|Overall Study||246
5110686|NCT01555138|12573268|P2|STARTED|Overall Study||288
5110687|NCT01555138|12573269|P1|STARTED|Overall Study||293
5110688|NCT01555125|12573298|P5|NOT COMPLETED|Follow-Up Period||0
5110689|NCT01555125|12573299|P4|NOT COMPLETED|Follow-Up Period||1
5110690|NCT01555125|12573300|P3|NOT COMPLETED|Follow-Up Period||1
5110691|NCT01555125|12573301|P2|NOT COMPLETED|Follow-Up Period||1
5110692|NCT01555125|12573302|P1|NOT COMPLETED|Follow-Up Period||4
5110693|NCT01555125|12573298|P5|COMPLETED|Follow-Up Period||0
5110694|NCT01555125|12573299|P4|COMPLETED|Follow-Up Period||17
5110695|NCT01555125|12573300|P3|COMPLETED|Follow-Up Period||18
5110696|NCT01555125|12573301|P2|COMPLETED|Follow-Up Period||30
5110697|NCT01555125|12573302|P1|COMPLETED|Follow-Up Period||32
5110698|NCT01555125|12573298|P5|STARTED|Follow-Up Period||0
5110699|NCT01555125|12573299|P4|STARTED|Follow-Up Period||18
5110700|NCT01555125|12573300|P3|STARTED|Follow-Up Period||19
5110701|NCT01555125|12573301|P2|STARTED|Follow-Up Period||31
5110702|NCT01555125|12573302|P1|STARTED|Follow-Up Period||36
5110703|NCT01555125|12573298|P5|NOT COMPLETED|Extension||0
5110704|NCT01555125|12573299|P4|NOT COMPLETED|Extension||22
5110705|NCT01555125|12573300|P3|NOT COMPLETED|Extension||23
5110706|NCT01555125|12573301|P2|NOT COMPLETED|Extension||51
5110707|NCT01555125|12573302|P1|NOT COMPLETED|Extension||45
5110708|NCT01555125|12573298|P5|COMPLETED|Extension||0
5110709|NCT01555125|12573299|P4|COMPLETED|Extension||1
5110710|NCT01555125|12573300|P3|COMPLETED|Extension||0
5110711|NCT01555125|12573301|P2|COMPLETED|Extension||0
5110712|NCT01555125|12573302|P1|COMPLETED|Extension||1
5110713|NCT01555125|12573298|P5|STARTED|Extension||0
5110714|NCT01555125|12573299|P4|STARTED|Extension||23
5110715|NCT01555125|12573300|P3|STARTED|Extension||23
5110716|NCT01555125|12573301|P2|STARTED|Extension||51
5110717|NCT01555125|12573302|P1|STARTED|Extension||46
5110718|NCT01555125|12573298|P5|NOT COMPLETED|Maintenance Period||0
5110719|NCT01555125|12573299|P4|NOT COMPLETED|Maintenance Period||2
5110720|NCT01555125|12573300|P3|NOT COMPLETED|Maintenance Period||4
5110721|NCT01555125|12573301|P2|NOT COMPLETED|Maintenance Period||4
5110722|NCT01555125|12573302|P1|NOT COMPLETED|Maintenance Period||10
5110723|NCT01555125|12573298|P5|COMPLETED|Maintenance Period||0
5110724|NCT01555125|12573299|P4|COMPLETED|Maintenance Period||25
5110725|NCT01555125|12573300|P3|COMPLETED|Maintenance Period||25
5110726|NCT01555125|12573301|P2|COMPLETED|Maintenance Period||52
5110727|NCT01555125|12573302|P1|COMPLETED|Maintenance Period||48
5110728|NCT01555125|12573298|P5|STARTED|Maintenance Period||0
5110729|NCT01555125|12573299|P4|STARTED|Maintenance Period||27
5110730|NCT01555125|12573300|P3|STARTED|Maintenance Period||29
5110731|NCT01555125|12573301|P2|STARTED|Maintenance Period||56
5110732|NCT01555125|12573302|P1|STARTED|Maintenance Period||58
5110733|NCT01555125|12573298|P5|NOT COMPLETED|Induction Period||3
5110734|NCT01555125|12573299|P4|NOT COMPLETED|Induction Period||0
5110735|NCT01555125|12573300|P3|NOT COMPLETED|Induction Period||0
5110736|NCT01555125|12573301|P2|NOT COMPLETED|Induction Period||3
5110737|NCT01555125|12573302|P1|NOT COMPLETED|Induction Period||1
5110738|NCT01555125|12573298|P5|COMPLETED|Induction Period||56
5110739|NCT01555125|12573299|P4|COMPLETED|Induction Period||0
5110740|NCT01555125|12573300|P3|COMPLETED|Induction Period||0
5110741|NCT01555125|12573301|P2|COMPLETED|Induction Period||56
5110742|NCT01555125|12573302|P1|COMPLETED|Induction Period||58
5110743|NCT01555125|12573298|P5|STARTED|Induction Period||59
5110744|NCT01555125|12573299|P4|STARTED|Induction Period||0
5110745|NCT01555125|12573300|P3|STARTED|Induction Period||0
5110746|NCT01555125|12573301|P2|STARTED|Induction Period||59
5110747|NCT01555125|12573302|P1|STARTED|Induction Period||59
5110748|NCT01555073|12573395|P4|NOT COMPLETED|Overall Study||5
5110749|NCT01555073|12573396|P3|NOT COMPLETED|Overall Study||0
5110750|NCT01555073|12573397|P2|NOT COMPLETED|Overall Study||2
5110751|NCT01555073|12573398|P1|NOT COMPLETED|Overall Study||1
5110752|NCT01555073|12573395|P4|COMPLETED|Overall Study||1
5110753|NCT01555073|12573396|P3|COMPLETED|Overall Study||7
5110754|NCT01555073|12573397|P2|COMPLETED|Overall Study||1
5110755|NCT01555073|12573398|P1|COMPLETED|Overall Study||6
5110756|NCT01555073|12573395|P4|STARTED|Overall Study||6
5110757|NCT01555073|12573396|P3|STARTED|Overall Study||7
5110758|NCT01555073|12573397|P2|STARTED|Overall Study||3
5110759|NCT01555073|12573398|P1|STARTED|Overall Study||7
5110760|NCT01555021|12573414|P2|NOT COMPLETED|Overall Study||2
5110761|NCT01555021|12573415|P1|NOT COMPLETED|Overall Study||1
5110762|NCT01555021|12573414|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
5110763|NCT01555021|12573415|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
5110764|NCT01555021|12573414|P2|STARTED|Overall Study||2
5110765|NCT01555021|12573415|P1|STARTED|Overall Study||2
5110766|NCT01554982|12573427|P1|NOT COMPLETED|Overall Study||43
5110767|NCT01554982|12573427|P1|COMPLETED|Overall Study||125
5110768|NCT01554982|12573427|P1|Received Drug|Overall Study||166
5110769|NCT01554982|12573427|P1|STARTED|Overall Study||168
5110770|NCT01554904|12573440|P1|NOT COMPLETED|Overall Study||4
5110771|NCT01554904|12573440|P1|COMPLETED|Overall Study||14
5110772|NCT01554904|12573440|P1|Home Sleep Study 2|Overall Study||14
5110773|NCT01554904|12573440|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
5110774|NCT01554904|12573440|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
5110775|NCT01554904|12573440|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
5110776|NCT01554904|12573440|P1|STARTED|Overall Study||18
5110777|NCT01554891|12573448|P3|NOT COMPLETED|Overall Study||2
5110778|NCT01554891|12573449|P2|NOT COMPLETED|Overall Study||5
5110779|NCT01554891|12573450|P1|NOT COMPLETED|Overall Study||7
5110780|NCT01554891|12573448|P3|COMPLETED|Overall Study||55
5110781|NCT01554891|12573449|P2|COMPLETED|Overall Study||115
5110782|NCT01554891|12573450|P1|COMPLETED|Overall Study||98
5110783|NCT01554891|12573448|P3|STARTED|Overall Study||57
5110784|NCT01554891|12573449|P2|STARTED|Overall Study||120
5110785|NCT01554891|12573450|P1|STARTED|Overall Study||105
5110786|NCT01554683|12573458|P6|NOT COMPLETED|Overall Study||0
5110787|NCT01554683|12573459|P5|NOT COMPLETED|Overall Study||0
5110788|NCT01554683|12573460|P4|NOT COMPLETED|Overall Study||0
5110789|NCT01554683|12573461|P3|NOT COMPLETED|Overall Study||0
5110790|NCT01554683|12573462|P2|NOT COMPLETED|Overall Study||0
5110791|NCT01554683|12573463|P1|NOT COMPLETED|Overall Study||0
5110792|NCT01554683|12573458|P6|COMPLETED|Overall Study||0
5110793|NCT01554683|12573459|P5|COMPLETED|Overall Study||1
5110794|NCT01554683|12573460|P4|COMPLETED|Overall Study||2
5110795|NCT01554683|12573461|P3|COMPLETED|Overall Study||3
5110796|NCT01554683|12573462|P2|COMPLETED|Overall Study||1
5110797|NCT01554683|12573463|P1|COMPLETED|Overall Study||2
5110798|NCT01554683|12573458|P6|STARTED|Overall Study||0
5110799|NCT01554683|12573459|P5|STARTED|Overall Study||1
5110800|NCT01554683|12573460|P4|STARTED|Overall Study||2
5110801|NCT01554683|12573461|P3|STARTED|Overall Study||3
5110802|NCT01554683|12573462|P2|STARTED|Overall Study||1
5110803|NCT01554683|12573463|P1|STARTED|Overall Study||2
5110804|NCT01554579|12573485|P2|NOT COMPLETED|Overall Study||27
5110805|NCT01554579|12573486|P1|NOT COMPLETED|Overall Study||10
5110806|NCT01554579|12573485|P2|COMPLETED|Overall Study||58
5110807|NCT01554579|12573486|P1|COMPLETED|Overall Study||76
5110808|NCT01554579|12573485|P2|STARTED|Overall Study||85
5110809|NCT01554579|12573486|P1|STARTED|Overall Study||86
5110810|NCT01554527|12573499|P3|NOT COMPLETED|Overall Study||8
5110811|NCT01554527|12573500|P2|NOT COMPLETED|Overall Study||0
5110812|NCT01554527|12573501|P1|NOT COMPLETED|Overall Study||1
5110813|NCT01554527|12573499|P3|COMPLETED|Overall Study||25
5110814|NCT01554527|12573500|P2|COMPLETED|Overall Study||38
5110815|NCT01554527|12573501|P1|COMPLETED|Overall Study||33
5110816|NCT01554527|12573499|P3|Completed as a Control|Overall Study||1
5110817|NCT01554527|12573500|P2|Completed as a Control|Overall Study||0
5110818|NCT01554527|12573501|P1|Completed as a Control|Overall Study||33
5110819|NCT01554527|12573499|P3|Initiated CPAP Treatment at Home|Overall Study||28
5110820|NCT01554527|12573500|P2|Initiated CPAP Treatment at Home|Overall Study||38
5110821|NCT01554527|12573501|P1|Initiated CPAP Treatment at Home|Overall Study||0
5110822|NCT01554527|12573499|P3|Had CPAP Titration|Overall Study||30
5110823|NCT01554527|12573500|P2|Had CPAP Titration|Overall Study||38
5110824|NCT01554527|12573501|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
5110825|NCT01554527|12573499|P3|Crossed Over to Control|Overall Study||2
5110826|NCT01554527|12573500|P2|Crossed Over to Control|Overall Study||0
5110827|NCT01554527|12573501|P1|Crossed Over to Control|Overall Study||0
5110828|NCT01554527|12573499|P3|STARTED|Overall Study||33
5110829|NCT01554527|12573500|P2|STARTED|Overall Study||38
5110830|NCT01554527|12573501|P1|STARTED|Overall Study||34
5110831|NCT01554488|12573530|P2|NOT COMPLETED|Overall Study||3
5110832|NCT01554488|12573531|P1|NOT COMPLETED|Overall Study||1
5110833|NCT01554488|12573530|P2|COMPLETED|Overall Study||9
5110834|NCT01554488|12573531|P1|COMPLETED|Overall Study||12
5110835|NCT01554488|12573530|P2|STARTED|Overall Study||12
5110836|NCT01554488|12573531|P1|STARTED|Overall Study||13
5110837|NCT01554241|12573557|P4|NOT COMPLETED|Overall Study||1
5110838|NCT01554241|12573558|P3|NOT COMPLETED|Overall Study||4
5110839|NCT01554241|12573559|P2|NOT COMPLETED|Overall Study||1
5110840|NCT01554241|12573560|P1|NOT COMPLETED|Overall Study||3
5110841|NCT01554241|12573557|P4|COMPLETED|Overall Study||13
5110842|NCT01554241|12573558|P3|COMPLETED|Overall Study||20
5110843|NCT01554241|12573559|P2|COMPLETED|Overall Study||19
5110844|NCT01554241|12573560|P1|COMPLETED|Overall Study||20
5110845|NCT01554241|12573557|P4|STARTED|Overall Study||14
5110846|NCT01554241|12573558|P3|STARTED|Overall Study||24
5110847|NCT01554241|12573559|P2|STARTED|Overall Study||20
5110848|NCT01554241|12573560|P1|STARTED|Overall Study||23
5110849|NCT01554176|12573576|P5|NOT COMPLETED|Run-out Phase||0
5110850|NCT01554176|12573577|P4|NOT COMPLETED|Run-out Phase||1
5110851|NCT01554176|12573578|P3|NOT COMPLETED|Run-out Phase||0
5110852|NCT01554176|12573579|P2|NOT COMPLETED|Run-out Phase||0
5110853|NCT01554176|12573580|P1|NOT COMPLETED|Run-out Phase||0
5110854|NCT01554176|12573576|P5|COMPLETED|Run-out Phase||59
5110855|NCT01554176|12573577|P4|COMPLETED|Run-out Phase||27
5110856|NCT01554176|12573578|P3|COMPLETED|Run-out Phase||29
5110857|NCT01554176|12573579|P2|COMPLETED|Run-out Phase||0
5110858|NCT01554176|12573580|P1|COMPLETED|Run-out Phase||0
5110859|NCT01554176|12573576|P5|Treated|Run-out Phase||59
5110860|NCT01554176|12573577|P4|Treated|Run-out Phase||28
5110861|NCT01554176|12573578|P3|Treated|Run-out Phase||29
5110862|NCT01554176|12573579|P2|Treated|Run-out Phase||0
5110863|NCT01554176|12573580|P1|Treated|Run-out Phase||0
5110864|NCT01554176|12573576|P5|STARTED|Run-out Phase||59
5110865|NCT01554176|12573577|P4|STARTED|Run-out Phase||28
5110866|NCT01554176|12573578|P3|STARTED|Run-out Phase||29
5110867|NCT01554176|12573579|P2|STARTED|Run-out Phase||0
5110868|NCT01554176|12573580|P1|STARTED|Run-out Phase||0
5110869|NCT01554176|12573576|P5|NOT COMPLETED|Treatment Phase||0
5110870|NCT01554176|12573577|P4|NOT COMPLETED|Treatment Phase||0
5110871|NCT01554176|12573578|P3|NOT COMPLETED|Treatment Phase||0
5110872|NCT01554176|12573579|P2|NOT COMPLETED|Treatment Phase||5
5110873|NCT01554176|12573580|P1|NOT COMPLETED|Treatment Phase||8
5110874|NCT01554176|12573576|P5|COMPLETED|Treatment Phase||0
5110875|NCT01554176|12573577|P4|COMPLETED|Treatment Phase||0
5110876|NCT01554176|12573578|P3|COMPLETED|Treatment Phase||0
5110877|NCT01554176|12573579|P2|COMPLETED|Treatment Phase||59
5110878|NCT01554176|12573580|P1|COMPLETED|Treatment Phase||57
5110879|NCT01554176|12573576|P5|Treated|Treatment Phase||0
5110880|NCT01554176|12573577|P4|Treated|Treatment Phase||0
5110881|NCT01554176|12573578|P3|Treated|Treatment Phase||0
5110882|NCT01554176|12573579|P2|Treated|Treatment Phase||64
5110883|NCT01554176|12573580|P1|Treated|Treatment Phase||64
5110884|NCT01554176|12573576|P5|STARTED|Treatment Phase||0
5110885|NCT01554176|12573577|P4|STARTED|Treatment Phase||0
5110886|NCT01554176|12573578|P3|STARTED|Treatment Phase||0
5110887|NCT01554176|12573579|P2|STARTED|Treatment Phase||64
5110888|NCT01554176|12573580|P1|STARTED|Treatment Phase||65
5110889|NCT01554163|12573607|P2|NOT COMPLETED|Overall Study||10
5110890|NCT01554163|12573608|P1|NOT COMPLETED|Overall Study||8
5110891|NCT01554163|12573607|P2|COMPLETED|Overall Study||109
5110892|NCT01554163|12573608|P1|COMPLETED|Overall Study||112
5110893|NCT01554163|12573607|P2|Number Treated|Overall Study||119
5110894|NCT01554163|12573608|P1|Number Treated|Overall Study||119
5110895|NCT01554163|12573607|P2|STARTED|Overall Study||119
5110896|NCT01554163|12573608|P1|STARTED|Overall Study||120
5110897|NCT01553916|12573626|P1|NOT COMPLETED|Overall Study||3
5110898|NCT01553916|12573626|P1|COMPLETED|Overall Study||16
5110899|NCT01553916|12573626|P1|STARTED|Overall Study||19
5110900|NCT01553851|12573643|P1|NOT COMPLETED|Overall Study||3
5110901|NCT01553851|12573643|P1|COMPLETED|Overall Study||17
5110902|NCT01553851|12573643|P1|STARTED|Overall Study||20
5110903|NCT01553747|12573658|P3|NOT COMPLETED|Overall Study||109
5110904|NCT01553747|12573659|P2|NOT COMPLETED|Overall Study||119
5110905|NCT01553747|12573660|P1|NOT COMPLETED|Overall Study||131
5110906|NCT01553747|12573658|P3|COMPLETED|Overall Study||273
5110907|NCT01553747|12573659|P2|COMPLETED|Overall Study||264
5110908|NCT01553747|12573660|P1|COMPLETED|Overall Study||250
5110909|NCT01553747|12573658|P3|Participated in Blinded-Placebo Period|Overall Study||272
5110910|NCT01553747|12573659|P2|Participated in Blinded-Placebo Period|Overall Study||253
5110911|NCT01553747|12573660|P1|Participated in Blinded-Placebo Period|Overall Study||246
5110912|NCT01553747|12573658|P3|Attended Week 26 Visit|Overall Study||278
5110913|NCT01553747|12573659|P2|Attended Week 26 Visit|Overall Study||271
5110914|NCT01553747|12573660|P1|Attended Week 26 Visit|Overall Study||259
5110915|NCT01553747|12573658|P3|Attended Week 12 Visit|Overall Study||312
5110916|NCT01553747|12573659|P2|Attended Week 12 Visit|Overall Study||301
5110917|NCT01553747|12573660|P1|Attended Week 12 Visit|Overall Study||296
5110918|NCT01553747|12573658|P3|STARTED|Overall Study||382
5110919|NCT01553747|12573659|P2|STARTED|Overall Study||383
5110920|NCT01553747|12573660|P1|STARTED|Overall Study||381
5110921|NCT01553708|12573712|P2|NOT COMPLETED|Overall Study||0
5110922|NCT01553708|12573713|P1|NOT COMPLETED|Overall Study||0
5110923|NCT01553708|12573712|P2|COMPLETED|Overall Study||17
5110924|NCT01553708|12573713|P1|COMPLETED|Overall Study||17
5110925|NCT01553708|12573712|P2|STARTED|Overall Study||17
5110926|NCT01553708|12573713|P1|STARTED|Overall Study||17
5110927|NCT01553591|12573722|P3|NOT COMPLETED|Overall Study||158
5110928|NCT01553591|12573723|P2|NOT COMPLETED|Overall Study||169
5110929|NCT01553591|12573724|P1|NOT COMPLETED|Overall Study||172
5110930|NCT01553591|12573722|P3|COMPLETED|Overall Study||269
5110931|NCT01553591|12573723|P2|COMPLETED|Overall Study||257
5110932|NCT01553591|12573724|P1|COMPLETED|Overall Study||257
5110933|NCT01553591|12573722|P3|Attended Week 26 Visit|Overall Study||290
5110934|NCT01553591|12573723|P2|Attended Week 26 Visit|Overall Study||291
5110935|NCT01553591|12573724|P1|Attended Week 26 Visit|Overall Study||289
5110936|NCT01553591|12573722|P3|Attended Week 12 Visit|Overall Study||342
5110937|NCT01553591|12573723|P2|Attended Week 12 Visit|Overall Study||330
5110938|NCT01553591|12573724|P1|Attended Week 12 Visit|Overall Study||341
5110939|NCT01553591|12573722|P3|STARTED|Overall Study||427
5110940|NCT01553591|12573723|P2|STARTED|Overall Study||426
5110941|NCT01553591|12573724|P1|STARTED|Overall Study||429
5110942|NCT01553539|12573774|P1|NOT COMPLETED|Overall Study||0
5110943|NCT01553539|12573774|P1|COMPLETED|Overall Study||20
5110944|NCT01553539|12573774|P1|STARTED|Overall Study||20
5110945|NCT01553318|12573784|P2|NOT COMPLETED|Overall Study||2
5110946|NCT01553318|12573785|P1|NOT COMPLETED|Overall Study||3
5110947|NCT01553318|12573784|P2|COMPLETED|Overall Study||25
5110948|NCT01553318|12573785|P1|COMPLETED|Overall Study||21
5110949|NCT01553318|12573784|P2|STARTED|Overall Study||27
5110950|NCT01553318|12573785|P1|STARTED|Overall Study||24
5110951|NCT01553292|12573797|P1|NOT COMPLETED|Overall Study||0
5110952|NCT01553292|12573797|P1|COMPLETED|Overall Study||21
5110953|NCT01553292|12573797|P1|STARTED|Overall Study||21
5110954|NCT01553279|12573815|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
5110955|NCT01553279|12573816|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
5110956|NCT01553279|12573815|P2|COMPLETED|Period 2: Toddler Vaccinations||132
5110957|NCT01553279|12573816|P1|COMPLETED|Period 2: Toddler Vaccinations||134
5110958|NCT01553279|12573815|P2|STARTED|Period 2: Toddler Vaccinations||139
5110959|NCT01553279|12573816|P1|STARTED|Period 2: Toddler Vaccinations||137
5110960|NCT01553279|12573815|P2|NOT COMPLETED|Interim Period||2
5110961|NCT01553279|12573816|P1|NOT COMPLETED|Interim Period||3
5110962|NCT01553279|12573815|P2|COMPLETED|Interim Period||139
5110963|NCT01553279|12573816|P1|COMPLETED|Interim Period||137
5110964|NCT01553279|12573815|P2|STARTED|Interim Period||141
5110965|NCT01553279|12573816|P1|STARTED|Interim Period||140
5110966|NCT01553279|12573815|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
5110967|NCT01553279|12573816|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
5110968|NCT01553279|12573815|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
5110969|NCT01553279|12573816|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
5110970|NCT01553279|12573815|P2|STARTED|Part 1 (Infant Vaccinations)||142
5110971|NCT01553279|12573816|P1|STARTED|Part 1 (Infant Vaccinations)||142
5110972|NCT01553240|12573873|P1|NOT COMPLETED|Overall Study||0
5110973|NCT01553240|12573873|P1|COMPLETED|Overall Study||0
5110974|NCT01553240|12573873|P1|STARTED|Overall Study||0
5110975|NCT01553201|12573880|P2|NOT COMPLETED|Overall Study||0
5110976|NCT01553201|12573881|P1|NOT COMPLETED|Overall Study||0
5110977|NCT01553201|12573880|P2|COMPLETED|Overall Study||15
5110978|NCT01553201|12573881|P1|COMPLETED|Overall Study||15
5110979|NCT01553201|12573880|P2|STARTED|Overall Study||15
5110980|NCT01553201|12573881|P1|STARTED|Overall Study||15
5110981|NCT01553188|12573891|P4|NOT COMPLETED|Overall Study||0
5110982|NCT01553188|12573892|P3|NOT COMPLETED|Overall Study||2
5110983|NCT01553188|12573893|P2|NOT COMPLETED|Overall Study||1
5110984|NCT01553188|12573894|P1|NOT COMPLETED|Overall Study||1
5110985|NCT01553188|12573891|P4|COMPLETED|Overall Study||11
5110986|NCT01553188|12573892|P3|COMPLETED|Overall Study||14
5110987|NCT01553188|12573893|P2|COMPLETED|Overall Study||5
5110988|NCT01553188|12573894|P1|COMPLETED|Overall Study||2
5110989|NCT01553188|12573891|P4|STARTED|Overall Study||11
5110990|NCT01553188|12573892|P3|STARTED|Overall Study||16
5110991|NCT01553188|12573893|P2|STARTED|Overall Study||6
5110992|NCT01553188|12573894|P1|STARTED|Overall Study||3
5110993|NCT01553136|12573921|P2|NOT COMPLETED|Overall Study||22
5110994|NCT01553136|12573922|P1|NOT COMPLETED|Overall Study||16
5110995|NCT01553136|12573921|P2|COMPLETED|Overall Study||45
5110996|NCT01553136|12573922|P1|COMPLETED|Overall Study||48
5110997|NCT01553136|12573921|P2|Completed Treatment|Overall Study||52
5110998|NCT01553136|12573922|P1|Completed Treatment|Overall Study||55
5110999|NCT01553136|12573921|P2|STARTED|Overall Study||67
5111000|NCT01553136|12573922|P1|STARTED|Overall Study||64
5111001|NCT01553084|12573939|P3|NOT COMPLETED|Overall Study||35
5111002|NCT01553084|12573940|P2|NOT COMPLETED|Overall Study||13
5111003|NCT01553084|12573941|P1|NOT COMPLETED|Overall Study||15
5111004|NCT01553084|12573939|P3|COMPLETED|Overall Study||389
5111005|NCT01553084|12573940|P2|COMPLETED|Overall Study||408
5111006|NCT01553084|12573941|P1|COMPLETED|Overall Study||226
5111007|NCT01553084|12573939|P3|STARTED|Overall Study||424
5111008|NCT01553084|12573940|P2|STARTED|Overall Study||421
5111009|NCT01553084|12573941|P1|STARTED|Overall Study||241
5111010|NCT01553058|12573960|P3|NOT COMPLETED|Overall Study||3
5111011|NCT01553058|12573961|P2|NOT COMPLETED|Overall Study||1
5111012|NCT01553058|12573962|P1|NOT COMPLETED|Overall Study||1
5111013|NCT01553058|12573960|P3|COMPLETED|Overall Study||30
5111014|NCT01553058|12573961|P2|COMPLETED|Overall Study||30
5111015|NCT01553058|12573962|P1|COMPLETED|Overall Study||32
5111016|NCT01553058|12573960|P3|STARTED|Overall Study||33
5111017|NCT01553058|12573961|P2|STARTED|Overall Study||31
5111018|NCT01553058|12573962|P1|STARTED|Overall Study||33
5111019|NCT01552954|12574023|P2|NOT COMPLETED|Overall Study||6
5111020|NCT01552954|12574024|P1|NOT COMPLETED|Overall Study||5
5111021|NCT01552954|12574023|P2|COMPLETED|Overall Study||119
5111022|NCT01552954|12574024|P1|COMPLETED|Overall Study||126
5111023|NCT01552954|12574023|P2|STARTED|Overall Study||125
5111024|NCT01552954|12574024|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
5111025|NCT01552928|12574040|P4|NOT COMPLETED|Period 4||0
5111026|NCT01552928|12574041|P3|NOT COMPLETED|Period 4||0
5111027|NCT01552928|12574042|P2|NOT COMPLETED|Period 4||0
5111028|NCT01552928|12574043|P1|NOT COMPLETED|Period 4||0
5111029|NCT01552928|12574040|P4|COMPLETED|Period 4||16
5111030|NCT01552928|12574041|P3|COMPLETED|Period 4||14
5111031|NCT01552928|12574042|P2|COMPLETED|Period 4||15
5111032|NCT01552928|12574043|P1|COMPLETED|Period 4||14
5111033|NCT01552928|12574040|P4|STARTED|Period 4||16
5111034|NCT01552928|12574041|P3|STARTED|Period 4||14
5111035|NCT01552928|12574042|P2|STARTED|Period 4||15
5111036|NCT01552928|12574043|P1|STARTED|Period 4||14
5111037|NCT01552928|12574040|P4|NOT COMPLETED|Period 3||0
5111038|NCT01552928|12574041|P3|NOT COMPLETED|Period 3||1
5111039|NCT01552928|12574042|P2|NOT COMPLETED|Period 3||0
5111040|NCT01552928|12574043|P1|NOT COMPLETED|Period 3||0
5111041|NCT01552928|12574040|P4|COMPLETED|Period 3||16
5111042|NCT01552928|12574041|P3|COMPLETED|Period 3||14
5111043|NCT01552928|12574042|P2|COMPLETED|Period 3||15
5111044|NCT01552928|12574043|P1|COMPLETED|Period 3||14
5111045|NCT01552928|12574040|P4|STARTED|Period 3||16
5111046|NCT01552928|12574041|P3|STARTED|Period 3||15
5111047|NCT01552928|12574042|P2|STARTED|Period 3||15
5111048|NCT01552928|12574043|P1|STARTED|Period 3||14
5111049|NCT01552928|12574040|P4|NOT COMPLETED|Period 2||0
5111050|NCT01552928|12574041|P3|NOT COMPLETED|Period 2||0
5111051|NCT01552928|12574042|P2|NOT COMPLETED|Period 2||0
5111052|NCT01552928|12574043|P1|NOT COMPLETED|Period 2||0
5111053|NCT01552928|12574040|P4|COMPLETED|Period 2||16
5111054|NCT01552928|12574041|P3|COMPLETED|Period 2||15
5111055|NCT01552928|12574042|P2|COMPLETED|Period 2||15
5111056|NCT01552928|12574043|P1|COMPLETED|Period 2||14
5111057|NCT01552928|12574040|P4|STARTED|Period 2||16
5111058|NCT01552928|12574041|P3|STARTED|Period 2||15
5111059|NCT01552928|12574042|P2|STARTED|Period 2||15
5111060|NCT01552928|12574043|P1|STARTED|Period 2||14
5111061|NCT01552928|12574040|P4|NOT COMPLETED|Period 1||0
5111062|NCT01552928|12574041|P3|NOT COMPLETED|Period 1||0
5111063|NCT01552928|12574042|P2|NOT COMPLETED|Period 1||0
5111064|NCT01552928|12574043|P1|NOT COMPLETED|Period 1||0
5111065|NCT01552928|12574040|P4|COMPLETED|Period 1||16
5111066|NCT01552928|12574041|P3|COMPLETED|Period 1||15
5111067|NCT01552928|12574042|P2|COMPLETED|Period 1||15
5111068|NCT01552928|12574043|P1|COMPLETED|Period 1||14
5111069|NCT01552928|12574040|P4|STARTED|Period 1||16
5111070|NCT01552928|12574041|P3|STARTED|Period 1||15
5111071|NCT01552928|12574042|P2|STARTED|Period 1||15
5111072|NCT01552928|12574043|P1|STARTED|Period 1||14
5111073|NCT01552915|12574090|P3|NOT COMPLETED|Overall Study||27
5111074|NCT01552915|12574091|P2|NOT COMPLETED|Overall Study||29
5111075|NCT01552915|12574092|P1|NOT COMPLETED|Overall Study||23
5111076|NCT01552915|12574090|P3|COMPLETED|Overall Study||157
5111077|NCT01552915|12574091|P2|COMPLETED|Overall Study||155
5111078|NCT01552915|12574092|P1|COMPLETED|Overall Study||68
5111079|NCT01552915|12574090|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
5111080|NCT01552915|12574091|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
5111081|NCT01552915|12574092|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
5111082|NCT01552902|12574115|P3|NOT COMPLETED|Overall Study||33
5111083|NCT01552902|12574116|P2|NOT COMPLETED|Overall Study||37
5111084|NCT01552902|12574117|P1|NOT COMPLETED|Overall Study||13
5111085|NCT01552902|12574115|P3|COMPLETED|Overall Study||186
5111086|NCT01552902|12574116|P2|COMPLETED|Overall Study||181
5111087|NCT01552902|12574117|P1|COMPLETED|Overall Study||97
5111088|NCT01552902|12574115|P3|STARTED|Overall Study||219
5111089|NCT01552902|12574116|P2|STARTED|Overall Study||218
5111090|NCT01552902|12574117|P1|STARTED|Overall Study||110
5111091|NCT01552889|12574139|P2|NOT COMPLETED|Overall Study||5
5111092|NCT01552889|12574140|P1|NOT COMPLETED|Overall Study||11
5111093|NCT01552889|12574139|P2|COMPLETED|Overall Study||95
5111094|NCT01552889|12574140|P1|COMPLETED|Overall Study||90
5111095|NCT01552889|12574139|P2|STARTED|Overall Study||100
5111096|NCT01552889|12574140|P1|STARTED|Overall Study||101
5111097|NCT01552876|12574150|P2|NOT COMPLETED|Overall Study||0
5111098|NCT01552876|12574151|P1|NOT COMPLETED|Overall Study||0
5111099|NCT01552876|12574150|P2|COMPLETED|Overall Study||20
5111100|NCT01552876|12574151|P1|COMPLETED|Overall Study||20
5111101|NCT01552876|12574150|P2|STARTED|Overall Study||20
5111102|NCT01552876|12574151|P1|STARTED|Overall Study||20
5111103|NCT01552772|12574167|P1|NOT COMPLETED|Overall Study||4
5111104|NCT01552772|12574167|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
5111105|NCT01552772|12574167|P1|STARTED|Overall Study||60
5111106|NCT01552694|12574183|P2|NOT COMPLETED|Overall Study||2
5111107|NCT01552694|12574184|P1|NOT COMPLETED|Overall Study||0
5111108|NCT01552694|12574183|P2|COMPLETED|Overall Study||18
5111109|NCT01552694|12574184|P1|COMPLETED|Overall Study||18
5111110|NCT01552694|12574183|P2|STARTED|Overall Study||20
5111111|NCT01552694|12574184|P1|STARTED|Overall Study||18
5111112|NCT01552681|12574200|P2|NOT COMPLETED|Overall Study||1
5111113|NCT01552681|12574201|P1|NOT COMPLETED|Overall Study||5
5111114|NCT01552681|12574200|P2|COMPLETED|Overall Study||18
5111115|NCT01552681|12574201|P1|COMPLETED|Overall Study||28
5111116|NCT01552681|12574200|P2|STARTED|Overall Study||19
5111117|NCT01552681|12574201|P1|STARTED|Overall Study||33
5111118|NCT01552603|12574249|P1|NOT COMPLETED|Overall Study||1
5111119|NCT01552603|12574249|P1|COMPLETED|Overall Study||13
5111120|NCT01552603|12574249|P1|STARTED|Overall Study||14
5111121|NCT01552408|12574256|P2|NOT COMPLETED|Overall Study||2
5111122|NCT01552408|12574257|P1|NOT COMPLETED|Overall Study||4
5111123|NCT01552408|12574256|P2|COMPLETED|Overall Study||18
5111124|NCT01552408|12574257|P1|COMPLETED|Overall Study||16
5111125|NCT01552408|12574256|P2|STARTED|Overall Study||20
5111126|NCT01552408|12574257|P1|STARTED|Overall Study||20
5111127|NCT01552369|12574279|P2|NOT COMPLETED|Overall Study||9
5111128|NCT01552369|12574280|P1|NOT COMPLETED|Overall Study||8
5111129|NCT01552369|12574279|P2|COMPLETED|Overall Study||96
5111130|NCT01552369|12574280|P1|COMPLETED|Overall Study||92
5111131|NCT01552369|12574279|P2|Final Follow up|Overall Study||96
5111132|NCT01552369|12574280|P1|Final Follow up|Overall Study||92
5111133|NCT01552369|12574279|P2|One Year|Overall Study||105
5111134|NCT01552369|12574280|P1|One Year|Overall Study||100
5111135|NCT01552369|12574279|P2|STARTED|Overall Study||105
5111136|NCT01552369|12574280|P1|STARTED|Overall Study||100
5111137|NCT01552343|12574308|P2|NOT COMPLETED|Overall Study||0
5111138|NCT01552343|12574309|P1|NOT COMPLETED|Overall Study||0
5111139|NCT01552343|12574308|P2|COMPLETED|Overall Study||27
5111140|NCT01552343|12574309|P1|COMPLETED|Overall Study||29
5111141|NCT01552343|12574308|P2|STARTED|Overall Study||27
5111142|NCT01552343|12574309|P1|STARTED|Overall Study||29
5111143|NCT01552213|12574332|P2|NOT COMPLETED|Overall Study||8
5111144|NCT01552213|12574333|P1|NOT COMPLETED|Overall Study||13
5111145|NCT01552213|12574332|P2|COMPLETED|Overall Study||37
5111146|NCT01552213|12574333|P1|COMPLETED|Overall Study||37
5111147|NCT01552213|12574332|P2|Analyzed|Overall Study||41
5111148|NCT01552213|12574333|P1|Analyzed|Overall Study||42
5111149|NCT01552213|12574332|P2|STARTED|Overall Study||45
5111150|NCT01552213|12574333|P1|STARTED|Overall Study||50
5111151|NCT01552057|12574369|P2|NOT COMPLETED|Overall Study||48
5111152|NCT01552057|12574370|P1|NOT COMPLETED|Overall Study||30
5111153|NCT01552057|12574369|P2|COMPLETED|Overall Study||149
5111154|NCT01552057|12574370|P1|COMPLETED|Overall Study||166
5111155|NCT01552057|12574369|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
5111156|NCT01552057|12574370|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
5111157|NCT01552057|12574369|P2|STARTED|Overall Study||197
5111158|NCT01552057|12574370|P1|STARTED|Overall Study||196
5111159|NCT01551979|12574404|P2|NOT COMPLETED|Overall Study||2
5111160|NCT01551979|12574405|P1|NOT COMPLETED|Overall Study||2
5111161|NCT01551979|12574404|P2|COMPLETED|Overall Study||5
5111162|NCT01551979|12574405|P1|COMPLETED|Overall Study||8
5111163|NCT01551979|12574404|P2|1 Week Post Treatment|Overall Study||6
5111164|NCT01551979|12574405|P1|1 Week Post Treatment|Overall Study||10
5111165|NCT01551979|12574404|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
5111166|NCT01551979|12574405|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
5111167|NCT01551979|12574404|P2|STARTED|Overall Study||7
5111168|NCT01551979|12574405|P1|STARTED|Overall Study||10
5111169|NCT01551888|12574421|P2|NOT COMPLETED|Period 2||0
5111170|NCT01551888|12574422|P1|NOT COMPLETED|Period 2||0
5111171|NCT01551888|12574421|P2|COMPLETED|Period 2||12
5111172|NCT01551888|12574422|P1|COMPLETED|Period 2||12
5111173|NCT01551888|12574421|P2|STARTED|Period 2||12
5111174|NCT01551888|12574422|P1|STARTED|Period 2||12
5111175|NCT01551888|12574421|P2|NOT COMPLETED|Period 1||0
5111176|NCT01551888|12574422|P1|NOT COMPLETED|Period 1||0
5111177|NCT01551888|12574421|P2|COMPLETED|Period 1||12
5111178|NCT01551888|12574422|P1|COMPLETED|Period 1||12
5111179|NCT01551888|12574421|P2|STARTED|Period 1||12
5111180|NCT01551888|12574422|P1|STARTED|Period 1||12
5111181|NCT01551758|12574436|P2|NOT COMPLETED|Overall Study||105
5111182|NCT01551758|12574437|P1|NOT COMPLETED|Overall Study||94
5111183|NCT01551758|12574436|P2|COMPLETED|Overall Study||1291
5111184|NCT01551758|12574437|P1|COMPLETED|Overall Study||1309
5111185|NCT01551758|12574436|P2|STARTED|Overall Study||1396
5111186|NCT01551758|12574437|P1|STARTED|Overall Study||1403
5111187|NCT01551745|12574475|P1|NOT COMPLETED|Overall Study||3
5111188|NCT01551745|12574475|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
5111189|NCT01551745|12574475|P1|STARTED|Overall Study||5
5111190|NCT01551693|12574484|P2|NOT COMPLETED|Overall Study||2
5111191|NCT01551693|12574485|P1|NOT COMPLETED|Overall Study||1
5111192|NCT01551693|12574484|P2|COMPLETED|Overall Study||0
5111193|NCT01551693|12574485|P1|COMPLETED|Overall Study||0
5111194|NCT01551693|12574484|P2|STARTED|Overall Study||2
5111195|NCT01551693|12574485|P1|STARTED|Overall Study||1
5111196|NCT01551550|12574497|P2|NOT COMPLETED|Overall Study||1
5111197|NCT01551550|12574498|P1|NOT COMPLETED|Overall Study||0
5111198|NCT01551550|12574497|P2|COMPLETED|Overall Study||40
5111199|NCT01551550|12574498|P1|COMPLETED|Overall Study||41
5111200|NCT01551550|12574497|P2|STARTED|Overall Study||41
5111201|NCT01551550|12574498|P1|STARTED|Overall Study||41
5111202|NCT01551420|12574506|P2|NOT COMPLETED|Home Use (Part B)||1
5111203|NCT01551420|12574507|P1|NOT COMPLETED|Home Use (Part B)||6
5111204|NCT01551420|12574506|P2|COMPLETED|Home Use (Part B)||7
5111205|NCT01551420|12574507|P1|COMPLETED|Home Use (Part B)||18
5111206|NCT01551420|12574506|P2|STARTED|Home Use (Part B)||8
5111207|NCT01551420|12574507|P1|STARTED|Home Use (Part B)||24
5111208|NCT01551420|12574506|P2|NOT COMPLETED|Screened for Part B Eligibility||3
5111209|NCT01551420|12574507|P1|NOT COMPLETED|Screened for Part B Eligibility||9
5111210|NCT01551420|12574506|P2|COMPLETED|Screened for Part B Eligibility||8
5111211|NCT01551420|12574507|P1|COMPLETED|Screened for Part B Eligibility||24
5111212|NCT01551420|12574506|P2|STARTED|Screened for Part B Eligibility||11
5111213|NCT01551420|12574507|P1|STARTED|Screened for Part B Eligibility||33
5111214|NCT01551420|12574506|P2|NOT COMPLETED|In-laboratory (Part A)||2
5111215|NCT01551420|12574507|P1|NOT COMPLETED|In-laboratory (Part A)||6
5111216|NCT01551420|12574506|P2|COMPLETED|In-laboratory (Part A)||11
5111217|NCT01551420|12574507|P1|COMPLETED|In-laboratory (Part A)||33
5111218|NCT01551420|12574506|P2|STARTED|In-laboratory (Part A)||13
5111219|NCT01551420|12574507|P1|STARTED|In-laboratory (Part A)||39
5111220|NCT01551355|12574537|P6|NOT COMPLETED|Overall Study||6
5111221|NCT01551355|12574538|P5|NOT COMPLETED|Overall Study||9
5111222|NCT01551355|12574539|P4|NOT COMPLETED|Overall Study||24
5111223|NCT01551355|12574540|P3|NOT COMPLETED|Overall Study||34
5111224|NCT01551355|12574541|P2|NOT COMPLETED|Overall Study||49
5111225|NCT01551355|12574542|P1|NOT COMPLETED|Overall Study||51
5111226|NCT01551355|12574537|P6|COMPLETED|Overall Study||65
5111227|NCT01551355|12574538|P5|COMPLETED|Overall Study||55
5111228|NCT01551355|12574539|P4|COMPLETED|Overall Study||411
5111229|NCT01551355|12574540|P3|COMPLETED|Overall Study||459
5111230|NCT01551355|12574541|P2|COMPLETED|Overall Study||545
5111231|NCT01551355|12574542|P1|COMPLETED|Overall Study||571
5111232|NCT01551355|12574537|P6|STARTED|Overall Study||71
5111233|NCT01551355|12574538|P5|STARTED|Overall Study||64
5111234|NCT01551355|12574539|P4|STARTED|Overall Study||435
5111235|NCT01551355|12574540|P3|STARTED|Overall Study||493
5111236|NCT01551355|12574541|P2|STARTED|Overall Study||594
5111237|NCT01551355|12574542|P1|STARTED|Overall Study||622
5111238|NCT01551303|12574556|P2|NOT COMPLETED|Overall Study||7
5111239|NCT01551303|12574557|P1|NOT COMPLETED|Overall Study||4
5111240|NCT01551303|12574556|P2|COMPLETED|Overall Study||15
5111241|NCT01551303|12574557|P1|COMPLETED|Overall Study||21
5111242|NCT01551303|12574556|P2|STARTED|Overall Study||22
5111243|NCT01551303|12574557|P1|STARTED|Overall Study||25
5111244|NCT01551212|12574565|P2|NOT COMPLETED|Overall Study||20
5111245|NCT01551212|12574566|P1|NOT COMPLETED|Overall Study||5
5111246|NCT01551212|12574565|P2|COMPLETED|Overall Study||148
5111247|NCT01551212|12574566|P1|COMPLETED|Overall Study||166
5111248|NCT01551212|12574565|P2|Per Protocol Set (PP)|Overall Study||101
5111249|NCT01551212|12574566|P1|Per Protocol Set (PP)|Overall Study||110
5111250|NCT01551212|12574565|P2|Safety Set|Overall Study||164
5111251|NCT01551212|12574566|P1|Safety Set|Overall Study||169
5111252|NCT01551212|12574565|P2|Full Anylsis Set (FAS)|Overall Study||164
5111253|NCT01551212|12574566|P1|Full Anylsis Set (FAS)|Overall Study||169
5111254|NCT01551212|12574565|P2|STARTED|Overall Study||168
5111255|NCT01551212|12574566|P1|STARTED|Overall Study||171
5111256|NCT01551199|12574584|P1|NOT COMPLETED|Overall Study||5
5111257|NCT01551199|12574584|P1|COMPLETED|Overall Study||2
5111258|NCT01551199|12574584|P1|STARTED|Overall Study||7
5111259|NCT01551186|12574592|P2|NOT COMPLETED|Overall Study||13
5111260|NCT01551186|12574593|P1|NOT COMPLETED|Overall Study||20
5111261|NCT01551186|12574592|P2|COMPLETED|Overall Study||40
5111262|NCT01551186|12574593|P1|COMPLETED|Overall Study||30
5111263|NCT01551186|12574592|P2|STARTED|Overall Study||53
5111264|NCT01551186|12574593|P1|STARTED|Overall Study||50
5111265|NCT01551173|12574601|P2|NOT COMPLETED|Overall Study||32
5111266|NCT01551173|12574602|P1|NOT COMPLETED|Overall Study||28
5111267|NCT01551173|12574601|P2|COMPLETED|Overall Study||186
5111268|NCT01551173|12574602|P1|COMPLETED|Overall Study||190
5111269|NCT01551173|12574601|P2|Full Analysis Set (FAS)|Overall Study||214
5111270|NCT01551173|12574602|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
5111271|NCT01551173|12574601|P2|STARTED|Overall Study||218
5111272|NCT01551173|12574602|P1|STARTED|Overall Study|"Started indicates randomized"|218
5111273|NCT01551095|12574613|P1|NOT COMPLETED|Overall Study||0
5111274|NCT01551095|12574613|P1|COMPLETED|Overall Study||7
5111275|NCT01551095|12574613|P1|STARTED|Overall Study||7
5111276|NCT01551082|12574618|P1|NOT COMPLETED|Overall Study||0
5111277|NCT01551082|12574618|P1|COMPLETED|Overall Study||12
5111278|NCT01551082|12574618|P1|STARTED|Overall Study||12
5111279|NCT01551056|12574624|P2|NOT COMPLETED|Overall Study||0
5111280|NCT01551056|12574625|P1|NOT COMPLETED|Overall Study||2
5111281|NCT01551056|12574624|P2|COMPLETED|Overall Study||45
5111282|NCT01551056|12574625|P1|COMPLETED|Overall Study||44
5111283|NCT01551056|12574624|P2|STARTED|Overall Study||45
5111284|NCT01551056|12574625|P1|STARTED|Overall Study||46
5111285|NCT01550965|12574679|P1|NOT COMPLETED|Overall Study||110
5111286|NCT01550965|12574679|P1|COMPLETED|Overall Study||353
5111287|NCT01550965|12574679|P1|STARTED|Overall Study||463
5111288|NCT01550952|12574698|P1|NOT COMPLETED|Overall Study||0
5111289|NCT01550952|12574698|P1|COMPLETED|Overall Study||10
5111290|NCT01550952|12574698|P1|STARTED|Overall Study||10
5111291|NCT01550809|12574708|P2|NOT COMPLETED|Overall Study||0
5111292|NCT01550809|12574709|P1|NOT COMPLETED|Overall Study||0
5111293|NCT01550809|12574708|P2|COMPLETED|Overall Study||6
5111294|NCT01550809|12574709|P1|COMPLETED|Overall Study||6
5111295|NCT01550809|12574708|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
5111296|NCT01550809|12574709|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
5111297|NCT01550757|12574723|P4|NOT COMPLETED|Overall Study||54
5111298|NCT01550757|12574724|P3|NOT COMPLETED|Overall Study||45
5111299|NCT01550757|12574725|P2|NOT COMPLETED|Overall Study||14
5111300|NCT01550757|12574726|P1|NOT COMPLETED|Overall Study||23
5111301|NCT01550757|12574723|P4|COMPLETED|Overall Study||90
5111302|NCT01550757|12574724|P3|COMPLETED|Overall Study||85
5111303|NCT01550757|12574725|P2|COMPLETED|Overall Study||38
5111304|NCT01550757|12574726|P1|COMPLETED|Overall Study||33
5111305|NCT01550757|12574723|P4|STARTED|Overall Study||144
5111306|NCT01550757|12574724|P3|STARTED|Overall Study||130
5111307|NCT01550757|12574725|P2|STARTED|Overall Study||52
5111308|NCT01550757|12574726|P1|STARTED|Overall Study||56
5111309|NCT01550744|12574736|P3|NOT COMPLETED|Double-Blind||67
5111310|NCT01550744|12574737|P2|NOT COMPLETED|Double-Blind||17
5111311|NCT01550744|12574738|P1|NOT COMPLETED|Double-Blind||0
5111312|NCT01550744|12574736|P3|COMPLETED|Double-Blind||235
5111313|NCT01550744|12574737|P2|COMPLETED|Double-Blind||59
5111314|NCT01550744|12574738|P1|COMPLETED|Double-Blind||0
5111315|NCT01550744|12574736|P3|STARTED|Double-Blind||302
5111316|NCT01550744|12574737|P2|STARTED|Double-Blind||76
5111317|NCT01550744|12574738|P1|STARTED|Double-Blind||0
5111318|NCT01550744|12574736|P3|NOT COMPLETED|Open-Label||0
5111319|NCT01550744|12574737|P2|NOT COMPLETED|Open-Label||0
5111320|NCT01550744|12574738|P1|NOT COMPLETED|Open-Label||100
5111321|NCT01550744|12574736|P3|COMPLETED|Open-Label||0
5111322|NCT01550744|12574737|P2|COMPLETED|Open-Label||0
5111323|NCT01550744|12574738|P1|COMPLETED|Open-Label||378
5111324|NCT01550744|12574736|P3|STARTED|Open-Label||0
5111325|NCT01550744|12574737|P2|STARTED|Open-Label||0
5111326|NCT01550744|12574738|P1|STARTED|Open-Label||478
5111327|NCT01550731|12574753|P2|NOT COMPLETED|Overall Study||0
5111328|NCT01550731|12574754|P1|NOT COMPLETED|Overall Study||0
5111329|NCT01550731|12574753|P2|COMPLETED|Overall Study||209
5111330|NCT01550731|12574754|P1|COMPLETED|Overall Study||205
5111331|NCT01550731|12574753|P2|STARTED|Overall Study||209
5111332|NCT01550731|12574754|P1|STARTED|Overall Study||205
5111333|NCT01550705|12574762|P1|NOT COMPLETED|Overall Study||1
5111334|NCT01550705|12574762|P1|COMPLETED|Overall Study||10
5111335|NCT01550705|12574762|P1|STARTED|Overall Study||11
5111336|NCT01550549|12574767|P1|NOT COMPLETED|Overall Study||0
5111337|NCT01550549|12574767|P1|COMPLETED|Overall Study||151
5111338|NCT01550549|12574767|P1|STARTED|Overall Study||151
5111339|NCT01550510|12574781|P2|NOT COMPLETED|Overall Study||0
5111340|NCT01550510|12574782|P1|NOT COMPLETED|Overall Study||0
5111341|NCT01550510|12574781|P2|COMPLETED|Overall Study||0
5111342|NCT01550510|12574782|P1|COMPLETED|Overall Study||4
5111343|NCT01550510|12574781|P2|STARTED|Overall Study||0
5111344|NCT01550510|12574782|P1|STARTED|Overall Study||4
5111345|NCT01550367|12574790|P1|NOT COMPLETED|Overall Study||0
5111346|NCT01550367|12574790|P1|COMPLETED|Overall Study||30
5111347|NCT01550367|12574790|P1|600 mg/d HCQ|Overall Study||17
5111348|NCT01550367|12574790|P1|1200 mg/d HCQ|Overall Study||13
5111349|NCT01550367|12574790|P1|STARTED|Overall Study||30
5111350|NCT01550341|12574817|P2|NOT COMPLETED|Overall Study||0
5111351|NCT01550341|12574818|P1|NOT COMPLETED|Overall Study||0
5111352|NCT01550341|12574817|P2|COMPLETED|Overall Study||18
5111353|NCT01550341|12574818|P1|COMPLETED|Overall Study||32
5111354|NCT01550341|12574817|P2|STARTED|Overall Study||18
5111355|NCT01550341|12574818|P1|STARTED|Overall Study||32
5111356|NCT01550302|12574852|P2|NOT COMPLETED|Overall Study||0
5111357|NCT01550302|12574853|P1|NOT COMPLETED|Overall Study||0
5111358|NCT01550302|12574852|P2|COMPLETED|Overall Study||5
5111359|NCT01550302|12574853|P1|COMPLETED|Overall Study||5
5111360|NCT01550302|12574852|P2|STARTED|Overall Study||5
5111361|NCT01550302|12574853|P1|STARTED|Overall Study||5
5111362|NCT01550289|12574873|P2|NOT COMPLETED|Overall Study||4
5111363|NCT01550289|12574874|P1|NOT COMPLETED|Overall Study||13
5111364|NCT01550289|12574873|P2|COMPLETED|Overall Study||57
5111365|NCT01550289|12574874|P1|COMPLETED|Overall Study||115
5111366|NCT01550289|12574873|P2|STARTED|Overall Study||61
5111367|NCT01550289|12574874|P1|STARTED|Overall Study||128
5111368|NCT01550224|12574906|P2|NOT COMPLETED|Overall Study||0
5111369|NCT01550224|12574907|P1|NOT COMPLETED|Overall Study||0
5111370|NCT01550224|12574906|P2|COMPLETED|Overall Study||20
5111371|NCT01550224|12574907|P1|COMPLETED|Overall Study||3
5111372|NCT01550224|12574906|P2|STARTED|Overall Study||20
5111373|NCT01550224|12574907|P1|STARTED|Overall Study||3
5111374|NCT01549977|12574931|P2|NOT COMPLETED|Overall Study||0
5111375|NCT01549977|12574932|P1|NOT COMPLETED|Overall Study||0
5111376|NCT01549977|12574931|P2|COMPLETED|Overall Study||0
5111377|NCT01549977|12574932|P1|COMPLETED|Overall Study||1
5111378|NCT01549977|12574931|P2|STARTED|Overall Study||0
5111379|NCT01549977|12574932|P1|STARTED|Overall Study||1
5111380|NCT01549964|12574950|P4|NOT COMPLETED|80-Week Extension Period||137
5111381|NCT01549964|12574951|P3|NOT COMPLETED|80-Week Extension Period||140
5111382|NCT01549964|12574952|P2|NOT COMPLETED|80-Week Extension Period||138
5111383|NCT01549964|12574953|P1|NOT COMPLETED|80-Week Extension Period||66
5111384|NCT01549964|12574950|P4|COMPLETED|80-Week Extension Period||0
5111385|NCT01549964|12574951|P3|COMPLETED|80-Week Extension Period||0
5111386|NCT01549964|12574952|P2|COMPLETED|80-Week Extension Period||0
5111387|NCT01549964|12574953|P1|COMPLETED|80-Week Extension Period||0
5111388|NCT01549964|12574950|P4|STARTED|80-Week Extension Period||137
5111389|NCT01549964|12574951|P3|STARTED|80-Week Extension Period||140
5111390|NCT01549964|12574952|P2|STARTED|80-Week Extension Period||138
5111391|NCT01549964|12574953|P1|STARTED|80-Week Extension Period||66
5111392|NCT01549964|12574950|P4|NOT COMPLETED|24-Week Treatment Period||121
5111393|NCT01549964|12574951|P3|NOT COMPLETED|24-Week Treatment Period||116
5111394|NCT01549964|12574952|P2|NOT COMPLETED|24-Week Treatment Period||111
5111395|NCT01549964|12574953|P1|NOT COMPLETED|24-Week Treatment Period||61
5111396|NCT01549964|12574950|P4|COMPLETED|24-Week Treatment Period||140
5111397|NCT01549964|12574951|P3|COMPLETED|24-Week Treatment Period||147
5111398|NCT01549964|12574952|P2|COMPLETED|24-Week Treatment Period||149
5111399|NCT01549964|12574953|P1|COMPLETED|24-Week Treatment Period||71
5111400|NCT01549964|12574950|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
5111401|NCT01549964|12574951|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
5111402|NCT01549964|12574952|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
5111403|NCT01549964|12574953|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
5111404|NCT01549964|12574950|P4|STARTED|24-Week Treatment Period||261
5111405|NCT01549964|12574951|P3|STARTED|24-Week Treatment Period||263
5111406|NCT01549964|12574952|P2|STARTED|24-Week Treatment Period||260
5111407|NCT01549964|12574953|P1|STARTED|24-Week Treatment Period||132
5111408|NCT01549951|12574971|P1|NOT COMPLETED|Overall Study||50
5111409|NCT01549951|12574971|P1|COMPLETED|Overall Study||0
5111410|NCT01549951|12574971|P1|Primary Reason Off Study Treatment|Overall Study||50
5111411|NCT01549951|12574971|P1|STARTED|Overall Study||50
5111412|NCT01549925|12574989|P2|NOT COMPLETED|Overall Study||0
5111413|NCT01549925|12574990|P1|NOT COMPLETED|Overall Study||0
5111414|NCT01549925|12574989|P2|COMPLETED|Overall Study||25
5111415|NCT01549925|12574990|P1|COMPLETED|Overall Study||25
5111416|NCT01549925|12574989|P2|STARTED|Overall Study||25
5111417|NCT01549925|12574990|P1|STARTED|Overall Study||25
5111418|NCT01549873|12574998|P2|NOT COMPLETED|Overall Study||1
5111419|NCT01549873|12574999|P1|NOT COMPLETED|Overall Study||0
5111420|NCT01549873|12574998|P2|COMPLETED|Overall Study||14
5111421|NCT01549873|12574999|P1|COMPLETED|Overall Study||15
5111422|NCT01549873|12574998|P2|STARTED|Overall Study||15
5111423|NCT01549873|12574999|P1|STARTED|Overall Study||15
5111424|NCT01549860|12575011|P2|NOT COMPLETED|Overall Study||1
5111425|NCT01549860|12575012|P1|NOT COMPLETED|Overall Study||2
5111426|NCT01549860|12575011|P2|COMPLETED|Overall Study||40
5111427|NCT01549860|12575012|P1|COMPLETED|Overall Study||38
5111428|NCT01549860|12575011|P2|STARTED|Overall Study||41
5111429|NCT01549860|12575012|P1|STARTED|Overall Study||40
5111430|NCT01549652|12575025|P4|NOT COMPLETED|Overall Study||11
5111431|NCT01549652|12575026|P3|NOT COMPLETED|Overall Study||17
5111432|NCT01549652|12575027|P2|NOT COMPLETED|Overall Study||12
5111433|NCT01549652|12575028|P1|NOT COMPLETED|Overall Study||12
5111434|NCT01549652|12575025|P4|COMPLETED|Overall Study||25
5111435|NCT01549652|12575026|P3|COMPLETED|Overall Study||23
5111436|NCT01549652|12575027|P2|COMPLETED|Overall Study||18
5111437|NCT01549652|12575028|P1|COMPLETED|Overall Study||15
5111438|NCT01549652|12575025|P4|STARTED|Overall Study||36
5111439|NCT01549652|12575026|P3|STARTED|Overall Study||40
5111440|NCT01549652|12575027|P2|STARTED|Overall Study||30
5111441|NCT01549652|12575028|P1|STARTED|Overall Study||27
5111442|NCT01549613|12575046|P2|NOT COMPLETED|Overall Study||11
5111443|NCT01549613|12575047|P1|NOT COMPLETED|Overall Study||11
5111444|NCT01549613|12575046|P2|COMPLETED|Overall Study||39
5111445|NCT01549613|12575047|P1|COMPLETED|Overall Study||39
5111446|NCT01549613|12575046|P2|STARTED|Overall Study||50
5111447|NCT01549613|12575047|P1|STARTED|Overall Study||50
5111448|NCT01549405|12575055|P2|NOT COMPLETED|Overall Study||0
5111449|NCT01549405|12575056|P1|NOT COMPLETED|Overall Study||0
5111450|NCT01549405|12575055|P2|COMPLETED|Overall Study||20
5111451|NCT01549405|12575056|P1|COMPLETED|Overall Study||20
5111452|NCT01549405|12575055|P2|STARTED|Overall Study||20
5111453|NCT01549405|12575056|P1|STARTED|Overall Study||20
5111454|NCT01549392|12575066|P2|NOT COMPLETED|Overall Study||0
5111455|NCT01549392|12575067|P1|NOT COMPLETED|Overall Study||1
5111456|NCT01549392|12575066|P2|COMPLETED|Overall Study||0
5111457|NCT01549392|12575067|P1|COMPLETED|Overall Study||2
5111458|NCT01549392|12575066|P2|STARTED|Overall Study||0
5111459|NCT01549392|12575067|P1|STARTED|Overall Study||3
5111460|NCT01549340|12575073|P1|NOT COMPLETED|Overall Study||8405
5111461|NCT01549340|12575073|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
5111462|NCT01549340|12575073|P1|Started AIT|Overall Study||3182
5111463|NCT01549340|12575073|P1|STARTED|Overall Study|Advised to receive AIT|8790
5111464|NCT01549314|12575087|P3|NOT COMPLETED|Overall Study||2
5111465|NCT01549314|12575088|P2|NOT COMPLETED|Overall Study||5
5111466|NCT01549314|12575089|P1|NOT COMPLETED|Overall Study||4
5111467|NCT01549314|12575087|P3|COMPLETED|Overall Study||24
5111468|NCT01549314|12575088|P2|COMPLETED|Overall Study||21
5111469|NCT01549314|12575089|P1|COMPLETED|Overall Study||23
5111470|NCT01549314|12575087|P3|STARTED|Overall Study||26
5111471|NCT01549314|12575088|P2|STARTED|Overall Study||26
5111472|NCT01549314|12575089|P1|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
5111473|NCT01549275|12575105|P2|NOT COMPLETED|Overall Study||0
5111474|NCT01549275|12575106|P1|NOT COMPLETED|Overall Study||1
5111475|NCT01549275|12575105|P2|COMPLETED|Overall Study||29
5111476|NCT01549275|12575106|P1|COMPLETED|Overall Study||75
5111477|NCT01549275|12575105|P2|STARTED|Overall Study||29
5111478|NCT01549275|12575106|P1|STARTED|Overall Study||76
5111479|NCT01549223|12575118|P2|NOT COMPLETED|Overall Study||0
5111480|NCT01549223|12575119|P1|NOT COMPLETED|Overall Study||0
5111481|NCT01549223|12575118|P2|COMPLETED|Overall Study||30
5111482|NCT01549223|12575119|P1|COMPLETED|Overall Study||30
5111483|NCT01549223|12575118|P2|STARTED|Overall Study||30
5111484|NCT01549223|12575119|P1|STARTED|Overall Study||30
5111485|NCT01549041|12575129|P2|NOT COMPLETED|Overall Study||8
5111486|NCT01549041|12575130|P1|NOT COMPLETED|Overall Study||2
5111487|NCT01549041|12575129|P2|COMPLETED|Overall Study||10
5111488|NCT01549041|12575130|P1|COMPLETED|Overall Study||10
5111489|NCT01549041|12575129|P2|STARTED|Overall Study||18
5111490|NCT01549041|12575130|P1|STARTED|Overall Study||12
5111491|NCT01549002|12575140|P2|NOT COMPLETED|Overall Study||4
5111492|NCT01549002|12575141|P1|NOT COMPLETED|Overall Study||0
5111493|NCT01549002|12575140|P2|COMPLETED|Overall Study||6
5111494|NCT01549002|12575141|P1|COMPLETED|Overall Study||10
5111495|NCT01549002|12575140|P2|STARTED|Overall Study||10
5111496|NCT01549002|12575141|P1|STARTED|Overall Study||10
5111497|NCT01548885|12575151|P1|NOT COMPLETED|Overall Study||0
5111498|NCT01548885|12575151|P1|COMPLETED|Overall Study||146
5111499|NCT01548885|12575151|P1|STARTED|Overall Study||146
5111500|NCT01548833|12575156|P1|NOT COMPLETED|Overall Study||0
5111501|NCT01548833|12575156|P1|COMPLETED|Overall Study||39
5111502|NCT01548833|12575156|P1|STARTED|Overall Study||39
5111503|NCT01548742|12575166|P2|NOT COMPLETED|Overall Study||4
5111504|NCT01548742|12575167|P1|NOT COMPLETED|Overall Study||13
5111505|NCT01548742|12575166|P2|COMPLETED|Overall Study||54
5111506|NCT01548742|12575167|P1|COMPLETED|Overall Study||45
5111507|NCT01548742|12575166|P2|STARTED|Overall Study||58
5111508|NCT01548742|12575167|P1|STARTED|Overall Study||58
5111509|NCT01548690|12575185|P4|NOT COMPLETED|Overall Study||5
5111510|NCT01548690|12575186|P3|NOT COMPLETED|Overall Study||5
5111511|NCT01548690|12575187|P2|NOT COMPLETED|Overall Study||3
5111512|NCT01548690|12575188|P1|NOT COMPLETED|Overall Study||0
5111513|NCT01548690|12575185|P4|COMPLETED|Overall Study||10
5111514|NCT01548690|12575186|P3|COMPLETED|Overall Study||8
5111515|NCT01548690|12575187|P2|COMPLETED|Overall Study||7
5111516|NCT01548690|12575188|P1|COMPLETED|Overall Study||9
5111517|NCT01548690|12575185|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
5111518|NCT01548690|12575186|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
5111519|NCT01548690|12575187|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
5111520|NCT01548690|12575188|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
5111521|NCT01548690|12575185|P4|STARTED|Overall Study||15
5111522|NCT01548690|12575186|P3|STARTED|Overall Study||13
5111523|NCT01548690|12575187|P2|STARTED|Overall Study||10
5111524|NCT01548690|12575188|P1|STARTED|Overall Study||9
5111525|NCT01548651|12575216|P2|NOT COMPLETED|Overall Study||0
5111526|NCT01548651|12575217|P1|NOT COMPLETED|Overall Study||1
5111527|NCT01548651|12575216|P2|COMPLETED|Overall Study||4
5111528|NCT01548651|12575217|P1|COMPLETED|Overall Study||3
5111529|NCT01548651|12575216|P2|STARTED|Overall Study||4
5111530|NCT01548651|12575217|P1|STARTED|Overall Study||4
5111531|NCT01548638|12575227|P1|NOT COMPLETED|Overall Study||4
5111532|NCT01548638|12575227|P1|COMPLETED|Overall Study||9
5111533|NCT01548638|12575227|P1|STARTED|Overall Study||13
5111534|NCT01548599|12575239|P2|NOT COMPLETED|Overall Study||2
5111535|NCT01548599|12575240|P1|NOT COMPLETED|Overall Study||6
5111536|NCT01548599|12575239|P2|COMPLETED|Overall Study||66
5111537|NCT01548599|12575240|P1|COMPLETED|Overall Study||66
5111538|NCT01548599|12575239|P2|STARTED|Overall Study||68
5111539|NCT01548599|12575240|P1|STARTED|Overall Study||72
5111540|NCT01548573|12575256|P1|NOT COMPLETED|Overall Study||5
5111541|NCT01548573|12575256|P1|COMPLETED|Overall Study||14
5111542|NCT01548573|12575256|P1|STARTED|Overall Study||19
5111543|NCT01548417|12575265|P2|NOT COMPLETED|Overall Study||2
5111544|NCT01548417|12575266|P1|NOT COMPLETED|Overall Study||0
5111545|NCT01548417|12575265|P2|COMPLETED|Overall Study||26
5111546|NCT01548417|12575266|P1|COMPLETED|Overall Study||28
5111547|NCT01548417|12575265|P2|STARTED|Overall Study||28
5111548|NCT01548417|12575266|P1|STARTED|Overall Study||28
5111549|NCT01548404|12575276|P2|NOT COMPLETED|Overall Study||14
5111550|NCT01548404|12575277|P1|NOT COMPLETED|Overall Study||30
5111551|NCT01548404|12575276|P2|COMPLETED|Overall Study||41
5111552|NCT01548404|12575277|P1|COMPLETED|Overall Study||24
5111553|NCT01548404|12575276|P2|STARTED|Overall Study||55
5111554|NCT01548404|12575277|P1|STARTED|Overall Study||54
5111555|NCT01548339|12575301|P2|NOT COMPLETED|Overall Study||1
5111556|NCT01548339|12575302|P1|NOT COMPLETED|Overall Study||6
5111557|NCT01548339|12575301|P2|COMPLETED|Overall Study||41
5111558|NCT01548339|12575302|P1|COMPLETED|Overall Study||38
5111559|NCT01548339|12575301|P2|STARTED|Overall Study||42
5111560|NCT01548339|12575302|P1|STARTED|Overall Study||44
5111561|NCT01548287|12575316|P5|NOT COMPLETED|Randomized Period||0
5111562|NCT01548287|12575317|P4|NOT COMPLETED|Randomized Period||0
5111563|NCT01548287|12575318|P3|NOT COMPLETED|Randomized Period||7
5111564|NCT01548287|12575319|P2|NOT COMPLETED|Randomized Period||2
5111565|NCT01548287|12575320|P1|NOT COMPLETED|Randomized Period||0
5111566|NCT01548287|12575316|P5|COMPLETED|Randomized Period||0
5111567|NCT01548287|12575317|P4|COMPLETED|Randomized Period||20
5111568|NCT01548287|12575318|P3|COMPLETED|Randomized Period||13
5111569|NCT01548287|12575319|P2|COMPLETED|Randomized Period||20
5111570|NCT01548287|12575320|P1|COMPLETED|Randomized Period||19
5111571|NCT01548287|12575316|P5|STARTED|Randomized Period||0
5111572|NCT01548287|12575317|P4|STARTED|Randomized Period||20
5111573|NCT01548287|12575318|P3|STARTED|Randomized Period||20
5111574|NCT01548287|12575319|P2|STARTED|Randomized Period||22
5111575|NCT01548287|12575320|P1|STARTED|Randomized Period||19
5111576|NCT01548287|12575316|P5|NOT COMPLETED|Screening||83
5111577|NCT01548287|12575317|P4|NOT COMPLETED|Screening||0
5111578|NCT01548287|12575318|P3|NOT COMPLETED|Screening||0
5111579|NCT01548287|12575319|P2|NOT COMPLETED|Screening||0
5111580|NCT01548287|12575320|P1|NOT COMPLETED|Screening||0
5111581|NCT01548287|12575316|P5|COMPLETED|Screening||0
5111582|NCT01548287|12575317|P4|COMPLETED|Screening||20
5111583|NCT01548287|12575318|P3|COMPLETED|Screening||20
5111584|NCT01548287|12575319|P2|COMPLETED|Screening||22
5111585|NCT01548287|12575320|P1|COMPLETED|Screening||19
5111586|NCT01548287|12575316|P5|STARTED|Screening||83
5111587|NCT01548287|12575317|P4|STARTED|Screening||20
5111588|NCT01548287|12575318|P3|STARTED|Screening||20
5111589|NCT01548287|12575319|P2|STARTED|Screening||22
5111590|NCT01548287|12575320|P1|STARTED|Screening||19
5111591|NCT01548040|12575352|P2|NOT COMPLETED|Overall Study||10
5111592|NCT01548040|12575353|P1|NOT COMPLETED|Overall Study||13
5111593|NCT01548040|12575352|P2|COMPLETED|Overall Study||45
5111594|NCT01548040|12575353|P1|COMPLETED|Overall Study||43
5111595|NCT01548040|12575352|P2|STARTED|Overall Study||55
5111596|NCT01548040|12575353|P1|STARTED|Overall Study||56
5111597|NCT01547806|12575361|P1|NOT COMPLETED|Overall Study||0
5111598|NCT01547806|12575361|P1|COMPLETED|Overall Study||49
5111599|NCT01547806|12575361|P1|STARTED|Overall Study||49
5111600|NCT01547728|12575377|P1|NOT COMPLETED|Overall Study||41
5111601|NCT01547728|12575377|P1|COMPLETED|Overall Study||1
5111602|NCT01547728|12575377|P1|STARTED|Overall Study||42
5111603|NCT01547715|12575384|P3|NOT COMPLETED|Overall Study||0
5111604|NCT01547715|12575385|P2|NOT COMPLETED|Overall Study||0
5111605|NCT01547715|12575386|P1|NOT COMPLETED|Overall Study||0
5111606|NCT01547715|12575384|P3|COMPLETED|Overall Study||60
5111607|NCT01547715|12575385|P2|COMPLETED|Overall Study||60
5111608|NCT01547715|12575386|P1|COMPLETED|Overall Study||60
5111609|NCT01547715|12575384|P3|STARTED|Overall Study||60
5111610|NCT01547715|12575385|P2|STARTED|Overall Study||60
5111611|NCT01547715|12575386|P1|STARTED|Overall Study||60
5111612|NCT01547598|12575486|P2|NOT COMPLETED|Overall Study||5
5111613|NCT01547598|12575487|P1|NOT COMPLETED|Overall Study||6
5111614|NCT01547598|12575486|P2|COMPLETED|Overall Study||63
5111615|NCT01547598|12575487|P1|COMPLETED|Overall Study||61
5111616|NCT01547598|12575486|P2|STARTED|Overall Study||68
5111617|NCT01547598|12575487|P1|STARTED|Overall Study||67
5111618|NCT01547390|12575504|P2|NOT COMPLETED|Overall Study||10
5111619|NCT01547390|12575505|P1|NOT COMPLETED|Overall Study||13
5111620|NCT01547390|12575504|P2|COMPLETED|Overall Study||16
5111621|NCT01547390|12575505|P1|COMPLETED|Overall Study||14
5111622|NCT01547390|12575504|P2|STARTED|Overall Study||26
5111623|NCT01547390|12575505|P1|STARTED|Overall Study||27
5111624|NCT01547299|12575515|P2|NOT COMPLETED|Overall Study||2
5111625|NCT01547299|12575516|P1|NOT COMPLETED|Overall Study||2
5111626|NCT01547299|12575515|P2|COMPLETED|Overall Study||25
5111627|NCT01547299|12575516|P1|COMPLETED|Overall Study||23
5111628|NCT01547299|12575515|P2|STARTED|Overall Study||27
5111629|NCT01547299|12575516|P1|STARTED|Overall Study||25
5111630|NCT01547286|12575582|P1|NOT COMPLETED|Overall Study||2
5111631|NCT01547286|12575582|P1|COMPLETED|Overall Study||5
5111632|NCT01547286|12575582|P1|STARTED|Overall Study||7
5111633|NCT01547247|12575591|P2|NOT COMPLETED|Overall Study||6
5111634|NCT01547247|12575592|P1|NOT COMPLETED|Overall Study||6
5111635|NCT01547247|12575591|P2|COMPLETED|Overall Study||98
5111636|NCT01547247|12575592|P1|COMPLETED|Overall Study||98
5111637|NCT01547247|12575591|P2|STARTED|Overall Study||104
5111638|NCT01547247|12575592|P1|STARTED|Overall Study||104
5111639|NCT01547130|12575602|P2|NOT COMPLETED|Overall Study||5
5111640|NCT01547130|12575603|P1|NOT COMPLETED|Overall Study||9
5111641|NCT01547130|12575602|P2|COMPLETED|Overall Study||68
5111642|NCT01547130|12575603|P1|COMPLETED|Overall Study||65
5111643|NCT01547130|12575602|P2|STARTED|Overall Study||73
5111644|NCT01547130|12575603|P1|STARTED|Overall Study||74
5111645|NCT01547000|12575619|P2|NOT COMPLETED|Overall Study||0
5111646|NCT01547000|12575620|P1|NOT COMPLETED|Overall Study||0
5111647|NCT01547000|12575619|P2|COMPLETED|Overall Study||16
5111648|NCT01547000|12575620|P1|COMPLETED|Overall Study||18
5111649|NCT01547000|12575619|P2|STARTED|Overall Study||16
5111650|NCT01547000|12575620|P1|STARTED|Overall Study||18
5111651|NCT01546922|12575626|P2|NOT COMPLETED|Second Period of 10 Weeks||3
5111652|NCT01546922|12575627|P1|NOT COMPLETED|Second Period of 10 Weeks||3
5111653|NCT01546922|12575626|P2|COMPLETED|Second Period of 10 Weeks||25
5111654|NCT01546922|12575627|P1|COMPLETED|Second Period of 10 Weeks||22
5111655|NCT01546922|12575626|P2|STARTED|Second Period of 10 Weeks||28
5111656|NCT01546922|12575627|P1|STARTED|Second Period of 10 Weeks||25
5111657|NCT01546922|12575626|P2|NOT COMPLETED|First Period of 10 Weeks||2
5111658|NCT01546922|12575627|P1|NOT COMPLETED|First Period of 10 Weeks||5
5111659|NCT01546922|12575626|P2|COMPLETED|First Period of 10 Weeks||28
5111660|NCT01546922|12575627|P1|COMPLETED|First Period of 10 Weeks||25
5111661|NCT01546922|12575626|P2|STARTED|First Period of 10 Weeks||30
5111662|NCT01546922|12575627|P1|STARTED|First Period of 10 Weeks||30
5111663|NCT01546883|12575633|P1|NOT COMPLETED|Overall Study||12
5111664|NCT01546883|12575633|P1|COMPLETED|Overall Study||2
5111665|NCT01546883|12575633|P1|STARTED|Overall Study||14
5111666|NCT01546688|12575639|P2|NOT COMPLETED|Overall Study||5
5111667|NCT01546688|12575640|P1|NOT COMPLETED|Overall Study||3
5111668|NCT01546688|12575639|P2|COMPLETED|Overall Study||28
5111669|NCT01546688|12575640|P1|COMPLETED|Overall Study||15
5111670|NCT01546688|12575639|P2|STARTED|Overall Study||33
5111671|NCT01546688|12575640|P1|STARTED|Overall Study||18
5111672|NCT01546675|12575654|P2|NOT COMPLETED|Overall Study||0
5111673|NCT01546675|12575655|P1|NOT COMPLETED|Overall Study||0
5111674|NCT01546675|12575654|P2|COMPLETED|Overall Study||1
5111675|NCT01546675|12575655|P1|COMPLETED|Overall Study||1
5111676|NCT01546675|12575654|P2|STARTED|Overall Study||1
5111677|NCT01546675|12575655|P1|STARTED|Overall Study||1
5111678|NCT01546649|12575672|P2|NOT COMPLETED|Overall Study||9
5111679|NCT01546649|12575673|P1|NOT COMPLETED|Overall Study||8
5111680|NCT01546649|12575672|P2|COMPLETED|Overall Study||75
5111681|NCT01546649|12575673|P1|COMPLETED|Overall Study||75
5111682|NCT01546649|12575672|P2|STARTED|Overall Study||84
5111683|NCT01546649|12575673|P1|STARTED|Overall Study||83
5111684|NCT01546636|12575695|P2|NOT COMPLETED|Overall Study||0
5111685|NCT01546636|12575696|P1|NOT COMPLETED|Overall Study||0
5111686|NCT01546636|12575695|P2|COMPLETED|Overall Study||34
5111687|NCT01546636|12575696|P1|COMPLETED|Overall Study||36
5111688|NCT01546636|12575695|P2|STARTED|Overall Study||34
5111689|NCT01546636|12575696|P1|STARTED|Overall Study||36
5111690|NCT01546623|12575708|P2|NOT COMPLETED|Overall Study||6
5111691|NCT01546623|12575709|P1|NOT COMPLETED|Overall Study||6
5111692|NCT01546623|12575708|P2|COMPLETED|Overall Study||74
5111693|NCT01546623|12575709|P1|COMPLETED|Overall Study||76
5111694|NCT01546623|12575708|P2|Received Study Drug|Overall Study||79
5111695|NCT01546623|12575709|P1|Received Study Drug|Overall Study||81
5111696|NCT01546623|12575708|P2|STARTED|Overall Study||80
5111697|NCT01546623|12575709|P1|STARTED|Overall Study||82
5111698|NCT01546519|12575739|P4|NOT COMPLETED|Overall Study||6
5111699|NCT01546519|12575740|P3|NOT COMPLETED|Overall Study||8
5111700|NCT01546519|12575741|P2|NOT COMPLETED|Overall Study||8
5111701|NCT01546519|12575742|P1|NOT COMPLETED|Overall Study||9
5111702|NCT01546519|12575739|P4|COMPLETED|Overall Study||0
5111703|NCT01546519|12575740|P3|COMPLETED|Overall Study||0
5111704|NCT01546519|12575741|P2|COMPLETED|Overall Study||0
5111705|NCT01546519|12575742|P1|COMPLETED|Overall Study||0
5111706|NCT01546519|12575739|P4|Safety-Evaluable Participants|Overall Study||6
5111707|NCT01546519|12575740|P3|Safety-Evaluable Participants|Overall Study||8
5111708|NCT01546519|12575741|P2|Safety-Evaluable Participants|Overall Study||8
5111709|NCT01546519|12575742|P1|Safety-Evaluable Participants|Overall Study||9
5111710|NCT01546519|12575739|P4|STARTED|Overall Study||6
5111711|NCT01546519|12575740|P3|STARTED|Overall Study||8
5111712|NCT01546519|12575741|P2|STARTED|Overall Study||8
5111713|NCT01546519|12575742|P1|STARTED|Overall Study||9
5111714|NCT01546454|12575784|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
5111715|NCT01546454|12575784|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
5111716|NCT01546454|12575784|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
5111717|NCT01546454|12575784|P1|NOT COMPLETED|Eligard Treatment||0
5111718|NCT01546454|12575784|P1|COMPLETED|Eligard Treatment||4
5111719|NCT01546454|12575784|P1|STARTED|Eligard Treatment||4
5111720|NCT01546454|12575784|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
5111721|NCT01546454|12575784|P1|COMPLETED|Oral Contraceptive Cycle||4
5111722|NCT01546454|12575784|P1|STARTED|Oral Contraceptive Cycle||4
5111723|NCT01546454|12575784|P1|NOT COMPLETED|Natural Menstrual Cycle||0
5111724|NCT01546454|12575784|P1|COMPLETED|Natural Menstrual Cycle||4
5111725|NCT01546454|12575784|P1|STARTED|Natural Menstrual Cycle||4
5111726|NCT01546402|12575792|P2|NOT COMPLETED|Overall Study||0
5111727|NCT01546402|12575793|P1|NOT COMPLETED|Overall Study||0
5111728|NCT01546402|12575792|P2|COMPLETED|Overall Study||10
5111729|NCT01546402|12575793|P1|COMPLETED|Overall Study||10
5111730|NCT01546402|12575792|P2|STARTED|Overall Study||10
5111731|NCT01546402|12575793|P1|STARTED|Overall Study||10
5111732|NCT01546285|12575801|P1|NOT COMPLETED|Overall Study||0
5111733|NCT01546285|12575801|P1|COMPLETED|Overall Study||66
5111734|NCT01546285|12575801|P1|STARTED|Overall Study||66
5111735|NCT01546207|12575807|P1|NOT COMPLETED|Overall Study||1
5111736|NCT01546207|12575807|P1|COMPLETED|Overall Study||3
5111737|NCT01546207|12575807|P1|STARTED|Overall Study||4
5111738|NCT01546194|12575813|P2|NOT COMPLETED|Overall Study||35
5111739|NCT01546194|12575814|P1|NOT COMPLETED|Overall Study||36
5111740|NCT01546194|12575813|P2|COMPLETED|Overall Study||65
5111741|NCT01546194|12575814|P1|COMPLETED|Overall Study||64
5111742|NCT01546194|12575813|P2|STARTED|Overall Study||100
5111743|NCT01546194|12575814|P1|STARTED|Overall Study||100
5111744|NCT01546168|12575822|P2|NOT COMPLETED|Overall Study||0
5111745|NCT01546168|12575823|P1|NOT COMPLETED|Overall Study||4
5111746|NCT01546168|12575822|P2|COMPLETED|Overall Study||33
5111747|NCT01546168|12575823|P1|COMPLETED|Overall Study||51
5111748|NCT01546168|12575822|P2|STARTED|Overall Study||33
5111749|NCT01546168|12575823|P1|STARTED|Overall Study||55
5111750|NCT01546155|12575835|P1|NOT COMPLETED|Overall Study||3
5111751|NCT01546155|12575835|P1|COMPLETED|Overall Study||8
5111752|NCT01546155|12575835|P1|STARTED|Overall Study||11
5111753|NCT01546142|12575841|P2|NOT COMPLETED|Overall Study||34
5111754|NCT01546142|12575842|P1|NOT COMPLETED|Overall Study||44
5111755|NCT01546142|12575841|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
5111851|NCT01545583|12576153|P1|NOT COMPLETED|Overall Study||0
5111756|NCT01546142|12575842|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
5111757|NCT01546142|12575841|P2|Received Treatment|Overall Study||257
5111758|NCT01546142|12575842|P1|Received Treatment|Overall Study||257
5111759|NCT01546142|12575841|P2|STARTED|Overall Study||258
5111760|NCT01546142|12575842|P1|STARTED|Overall Study||258
5111761|NCT01546038|12575860|P9|NOT COMPLETED|Overall Study||43
5111762|NCT01546038|12575861|P8|NOT COMPLETED|Overall Study||84
5111763|NCT01546038|12575862|P7|NOT COMPLETED|Overall Study||53
5111764|NCT01546038|12575863|P6|NOT COMPLETED|Overall Study||4
5111765|NCT01546038|12575864|P5|NOT COMPLETED|Overall Study||10
5111766|NCT01546038|12575865|P4|NOT COMPLETED|Overall Study||3
5111767|NCT01546038|12575866|P3|NOT COMPLETED|Overall Study||4
5111768|NCT01546038|12575867|P2|NOT COMPLETED|Overall Study||6
5111769|NCT01546038|12575868|P1|NOT COMPLETED|Overall Study||16
5111770|NCT01546038|12575860|P9|COMPLETED|Overall Study||1
5111771|NCT01546038|12575861|P8|COMPLETED|Overall Study||4
5111772|NCT01546038|12575862|P7|COMPLETED|Overall Study||18
5111773|NCT01546038|12575863|P6|COMPLETED|Overall Study||2
5111774|NCT01546038|12575864|P5|COMPLETED|Overall Study||6
5111775|NCT01546038|12575865|P4|COMPLETED|Overall Study||0
5111776|NCT01546038|12575866|P3|COMPLETED|Overall Study||0
5111777|NCT01546038|12575867|P2|COMPLETED|Overall Study||0
5111778|NCT01546038|12575868|P1|COMPLETED|Overall Study||1
5111779|NCT01546038|12575860|P9|Received Treatment|Overall Study||41
5111780|NCT01546038|12575861|P8|Received Treatment|Overall Study||84
5111781|NCT01546038|12575862|P7|Received Treatment|Overall Study||69
5111782|NCT01546038|12575863|P6|Received Treatment|Overall Study||6
5111783|NCT01546038|12575864|P5|Received Treatment|Overall Study||16
5111784|NCT01546038|12575865|P4|Received Treatment|Overall Study||3
5111785|NCT01546038|12575866|P3|Received Treatment|Overall Study||4
5111786|NCT01546038|12575867|P2|Received Treatment|Overall Study||6
5111787|NCT01546038|12575868|P1|Received Treatment|Overall Study||17
5111788|NCT01546038|12575860|P9|STARTED|Overall Study||44
5111789|NCT01546038|12575861|P8|STARTED|Overall Study||88
5111790|NCT01546038|12575862|P7|STARTED|Overall Study||71
5111791|NCT01546038|12575863|P6|STARTED|Overall Study||6
5111792|NCT01546038|12575864|P5|STARTED|Overall Study||16
5111793|NCT01546038|12575865|P4|STARTED|Overall Study||3
5111794|NCT01546038|12575866|P3|STARTED|Overall Study||4
5111795|NCT01546038|12575867|P2|STARTED|Overall Study||6
5111796|NCT01546038|12575868|P1|STARTED|Overall Study||17
5111797|NCT01545843|12576031|P3|NOT COMPLETED|Overall Study||4
5111798|NCT01545843|12576032|P2|NOT COMPLETED|Overall Study||7
5111799|NCT01545843|12576033|P1|NOT COMPLETED|Overall Study||3
5111800|NCT01545843|12576031|P3|COMPLETED|Overall Study||21
5111801|NCT01545843|12576032|P2|COMPLETED|Overall Study||17
5111802|NCT01545843|12576033|P1|COMPLETED|Overall Study||16
5111803|NCT01545843|12576031|P3|STARTED|Overall Study||25
5111804|NCT01545843|12576032|P2|STARTED|Overall Study||24
5111805|NCT01545843|12576033|P1|STARTED|Overall Study||19
5111806|NCT01545817|12576062|P2|NOT COMPLETED|Everolimus||38
5111807|NCT01545817|12576063|P1|NOT COMPLETED|Everolimus||0
5111808|NCT01545817|12576062|P2|COMPLETED|Everolimus||0
5111809|NCT01545817|12576063|P1|COMPLETED|Everolimus||0
5111810|NCT01545817|12576062|P2|STARTED|Everolimus||38
5111811|NCT01545817|12576063|P1|STARTED|Everolimus||0
5111812|NCT01545817|12576062|P2|NOT COMPLETED|Pazopanib||0
5111813|NCT01545817|12576063|P1|NOT COMPLETED|Pazopanib||74
5111814|NCT01545817|12576062|P2|COMPLETED|Pazopanib||0
5111815|NCT01545817|12576063|P1|COMPLETED|Pazopanib||0
5111816|NCT01545817|12576062|P2|STARTED|Pazopanib||0
5111817|NCT01545817|12576063|P1|STARTED|Pazopanib||74
5111818|NCT01545765|12576074|P1|NOT COMPLETED|Overall Study||0
5111819|NCT01545765|12576074|P1|COMPLETED|Overall Study||31
5111820|NCT01545765|12576074|P1|STARTED|Overall Study||31
5111821|NCT01545700|12576091|P6|NOT COMPLETED|Overall Study||0
5111822|NCT01545700|12576092|P5|NOT COMPLETED|Overall Study||1
5111823|NCT01545700|12576093|P4|NOT COMPLETED|Overall Study||0
5111824|NCT01545700|12576094|P3|NOT COMPLETED|Overall Study||2
5111825|NCT01545700|12576095|P2|NOT COMPLETED|Overall Study||1
5111826|NCT01545700|12576096|P1|NOT COMPLETED|Overall Study||1
5111827|NCT01545700|12576091|P6|COMPLETED|Overall Study||33
5111828|NCT01545700|12576092|P5|COMPLETED|Overall Study||32
5111829|NCT01545700|12576093|P4|COMPLETED|Overall Study||34
5111830|NCT01545700|12576094|P3|COMPLETED|Overall Study||31
5111831|NCT01545700|12576095|P2|COMPLETED|Overall Study||32
5111832|NCT01545700|12576096|P1|COMPLETED|Overall Study||33
5111833|NCT01545700|12576091|P6|STARTED|Overall Study||33
5111834|NCT01545700|12576092|P5|STARTED|Overall Study||33
5111835|NCT01545700|12576093|P4|STARTED|Overall Study||34
5111836|NCT01545700|12576094|P3|STARTED|Overall Study||33
5111837|NCT01545700|12576095|P2|STARTED|Overall Study||33
5111838|NCT01545700|12576096|P1|STARTED|Overall Study||34
5111839|NCT01545648|12576130|P1|NOT COMPLETED|Overall Study||0
5111840|NCT01545648|12576130|P1|COMPLETED|Overall Study||4
5111841|NCT01545648|12576130|P1|6 Months of Treatment|Overall Study||4
5111842|NCT01545648|12576130|P1|STARTED|Overall Study||4
5111843|NCT01545583|12576145|P9|NOT COMPLETED|Overall Study||0
5111844|NCT01545583|12576146|P8|NOT COMPLETED|Overall Study||0
5111845|NCT01545583|12576147|P7|NOT COMPLETED|Overall Study||0
5111846|NCT01545583|12576148|P6|NOT COMPLETED|Overall Study||0
5111847|NCT01545583|12576149|P5|NOT COMPLETED|Overall Study||0
5111848|NCT01545583|12576150|P4|NOT COMPLETED|Overall Study||0
5111849|NCT01545583|12576151|P3|NOT COMPLETED|Overall Study||0
5111850|NCT01545583|12576152|P2|NOT COMPLETED|Overall Study||0
5111852|NCT01545583|12576145|P9|COMPLETED|Overall Study||6
5111853|NCT01545583|12576146|P8|COMPLETED|Overall Study||6
5111854|NCT01545583|12576147|P7|COMPLETED|Overall Study||6
5111855|NCT01545583|12576148|P6|COMPLETED|Overall Study||6
5111856|NCT01545583|12576149|P5|COMPLETED|Overall Study||6
5111857|NCT01545583|12576150|P4|COMPLETED|Overall Study||6
5111858|NCT01545583|12576151|P3|COMPLETED|Overall Study||6
5111859|NCT01545583|12576152|P2|COMPLETED|Overall Study||2
5111860|NCT01545583|12576153|P1|COMPLETED|Overall Study||12
5111861|NCT01545583|12576145|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
5111862|NCT01545583|12576146|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
5111863|NCT01545583|12576147|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5111864|NCT01545583|12576148|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
5111865|NCT01545583|12576149|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5111866|NCT01545583|12576150|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5111867|NCT01545583|12576151|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5111868|NCT01545583|12576152|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
5111869|NCT01545583|12576153|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
5111870|NCT01545583|12576145|P9|STARTED|Overall Study||6
5111871|NCT01545583|12576146|P8|STARTED|Overall Study||6
5111872|NCT01545583|12576147|P7|STARTED|Overall Study||6
5111873|NCT01545583|12576148|P6|STARTED|Overall Study||6
5111874|NCT01545583|12576149|P5|STARTED|Overall Study||6
5111875|NCT01545583|12576150|P4|STARTED|Overall Study||6
5111876|NCT01545583|12576151|P3|STARTED|Overall Study||6
5111877|NCT01545583|12576152|P2|STARTED|Overall Study||2
5111878|NCT01545583|12576153|P1|STARTED|Overall Study||12
5111879|NCT01545518|12576205|P1|NOT COMPLETED|Overall Study||0
5111880|NCT01545518|12576205|P1|COMPLETED|Overall Study||20
5111881|NCT01545518|12576205|P1|STARTED|Overall Study||20
5111882|NCT01545388|12576212|P3|NOT COMPLETED|Overall Study||8
5111883|NCT01545388|12576213|P2|NOT COMPLETED|Overall Study||11
5111884|NCT01545388|12576214|P1|NOT COMPLETED|Overall Study||8
5111885|NCT01545388|12576212|P3|COMPLETED|Overall Study||58
5111886|NCT01545388|12576213|P2|COMPLETED|Overall Study||122
5111887|NCT01545388|12576214|P1|COMPLETED|Overall Study||130
5111888|NCT01545388|12576212|P3|STARTED|Overall Study||66
5111889|NCT01545388|12576213|P2|STARTED|Overall Study||133
5111890|NCT01545388|12576214|P1|STARTED|Overall Study||138
5111891|NCT01545375|12576233|P2|NOT COMPLETED|Overall Study||90
5111892|NCT01545375|12576234|P1|NOT COMPLETED|Overall Study||97
5111893|NCT01545375|12576233|P2|COMPLETED|Overall Study||813
5111894|NCT01545375|12576234|P1|COMPLETED|Overall Study||803
5111895|NCT01545375|12576233|P2|STARTED|Overall Study||903
5111896|NCT01545375|12576234|P1|STARTED|Overall Study||900
5111897|NCT01545336|12576290|P2|NOT COMPLETED|Overall Study||0
5111898|NCT01545336|12576291|P1|NOT COMPLETED|Overall Study||0
5111899|NCT01545336|12576290|P2|COMPLETED|Overall Study||6
5111900|NCT01545336|12576291|P1|COMPLETED|Overall Study||12
5111901|NCT01545336|12576290|P2|STARTED|Overall Study||6
5111902|NCT01545336|12576291|P1|STARTED|Overall Study||12
5111903|NCT01545232|12576303|P2|NOT COMPLETED|Overall Study||0
5111904|NCT01545232|12576304|P1|NOT COMPLETED|Overall Study||0
5111905|NCT01545232|12576303|P2|COMPLETED|Overall Study||342
5111906|NCT01545232|12576304|P1|COMPLETED|Overall Study||338
5111907|NCT01545232|12576303|P2|STARTED|Overall Study||342
5111908|NCT01545232|12576304|P1|STARTED|Overall Study||338
5111909|NCT01545193|12576336|P2|NOT COMPLETED|Overall Study||1
5111910|NCT01545193|12576337|P1|NOT COMPLETED|Overall Study||0
5111911|NCT01545193|12576336|P2|COMPLETED|Overall Study||149
5111912|NCT01545193|12576337|P1|COMPLETED|Overall Study||150
5111913|NCT01545193|12576336|P2|STARTED|Overall Study||150
5111914|NCT01545193|12576337|P1|STARTED|Overall Study||150
5111915|NCT01545076|12576349|P5|NOT COMPLETED|IgPro10 Rescue Period||0
5111916|NCT01545076|12576350|P4|NOT COMPLETED|IgPro10 Rescue Period||0
5111917|NCT01545076|12576351|P3|NOT COMPLETED|IgPro10 Rescue Period||0
5111918|NCT01545076|12576352|P2|NOT COMPLETED|IgPro10 Rescue Period||0
5111919|NCT01545076|12576353|P1|NOT COMPLETED|IgPro10 Rescue Period||0
5111920|NCT01545076|12576349|P5|COMPLETED|IgPro10 Rescue Period||60
5111921|NCT01545076|12576350|P4|COMPLETED|IgPro10 Rescue Period||0
5111922|NCT01545076|12576351|P3|COMPLETED|IgPro10 Rescue Period||0
5111923|NCT01545076|12576352|P2|COMPLETED|IgPro10 Rescue Period||0
5111924|NCT01545076|12576353|P1|COMPLETED|IgPro10 Rescue Period||0
5111925|NCT01545076|12576349|P5|STARTED|IgPro10 Rescue Period||60
5111926|NCT01545076|12576350|P4|STARTED|IgPro10 Rescue Period||0
5111927|NCT01545076|12576351|P3|STARTED|IgPro10 Rescue Period||0
5111928|NCT01545076|12576352|P2|STARTED|IgPro10 Rescue Period||0
5111929|NCT01545076|12576353|P1|STARTED|IgPro10 Rescue Period||0
5111930|NCT01545076|12576349|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
5111931|NCT01545076|12576350|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
5111932|NCT01545076|12576351|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
5111933|NCT01545076|12576352|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
5111934|NCT01545076|12576353|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
5111935|NCT01545076|12576349|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
5111936|NCT01545076|12576350|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
5111937|NCT01545076|12576351|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
5111938|NCT01545076|12576352|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
5111939|NCT01545076|12576353|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
5111940|NCT01545076|12576349|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
5111941|NCT01545076|12576350|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
5111942|NCT01545076|12576351|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
5111943|NCT01545076|12576352|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
5111944|NCT01545076|12576353|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
5111945|NCT01545076|12576349|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
5111946|NCT01545076|12576350|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
5111947|NCT01545076|12576351|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
5111948|NCT01545076|12576352|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
5111949|NCT01545076|12576353|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
5111950|NCT01545076|12576349|P5|COMPLETED|IgPro10 Restabilization Period||0
5111951|NCT01545076|12576350|P4|COMPLETED|IgPro10 Restabilization Period||0
5111952|NCT01545076|12576351|P3|COMPLETED|IgPro10 Restabilization Period||0
5111953|NCT01545076|12576352|P2|COMPLETED|IgPro10 Restabilization Period||0
5111954|NCT01545076|12576353|P1|COMPLETED|IgPro10 Restabilization Period||172
5111955|NCT01545076|12576349|P5|STARTED|IgPro10 Restabilization Period||0
5111956|NCT01545076|12576350|P4|STARTED|IgPro10 Restabilization Period||0
5111957|NCT01545076|12576351|P3|STARTED|IgPro10 Restabilization Period||0
5111958|NCT01545076|12576352|P2|STARTED|IgPro10 Restabilization Period||0
5111959|NCT01545076|12576353|P1|STARTED|IgPro10 Restabilization Period||208
5111960|NCT01544998|12576403|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
5111961|NCT01544998|12576404|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
5111962|NCT01544998|12576403|P2|COMPLETED|Second Intervention (3 Hours)||15
5111963|NCT01544998|12576404|P1|COMPLETED|Second Intervention (3 Hours)||26
5111964|NCT01544998|12576403|P2|STARTED|Second Intervention (3 Hours)||15
5111965|NCT01544998|12576404|P1|STARTED|Second Intervention (3 Hours)||26
5111966|NCT01544998|12576403|P2|NOT COMPLETED|Washout (1 Week)||0
5111967|NCT01544998|12576404|P1|NOT COMPLETED|Washout (1 Week)||0
5111968|NCT01544998|12576403|P2|COMPLETED|Washout (1 Week)||15
5111969|NCT01544998|12576404|P1|COMPLETED|Washout (1 Week)||26
5111970|NCT01544998|12576403|P2|STARTED|Washout (1 Week)||15
5111971|NCT01544998|12576404|P1|STARTED|Washout (1 Week)||26
5111972|NCT01544998|12576403|P2|NOT COMPLETED|First Intervention (3 Hours)||0
5111973|NCT01544998|12576404|P1|NOT COMPLETED|First Intervention (3 Hours)||0
5111974|NCT01544998|12576403|P2|COMPLETED|First Intervention (3 Hours)||15
5111975|NCT01544998|12576404|P1|COMPLETED|First Intervention (3 Hours)||26
5111976|NCT01544998|12576403|P2|STARTED|First Intervention (3 Hours)||15
5111977|NCT01544998|12576404|P1|STARTED|First Intervention (3 Hours)||26
5111978|NCT01544920|12576424|P2|NOT COMPLETED|Overall Study||23
5111979|NCT01544920|12576425|P1|NOT COMPLETED|Overall Study||19
5111980|NCT01544920|12576424|P2|COMPLETED|Overall Study||346
5111981|NCT01544920|12576425|P1|COMPLETED|Overall Study||349
5111982|NCT01544920|12576424|P2|STARTED|Overall Study||369
5111983|NCT01544920|12576425|P1|STARTED|Overall Study||368
5111984|NCT01544595|12576439|P6|NOT COMPLETED|Status at Week 156||15
5111985|NCT01544595|12576440|P5|NOT COMPLETED|Status at Week 156||38
5111986|NCT01544595|12576441|P4|NOT COMPLETED|Status at Week 156||166
5111987|NCT01544595|12576442|P3|NOT COMPLETED|Status at Week 156||140
5111988|NCT01544595|12576443|P2|NOT COMPLETED|Status at Week 156||78
5111989|NCT01544595|12576444|P1|NOT COMPLETED|Status at Week 156||117
5111990|NCT01544595|12576439|P6|COMPLETED|Status at Week 156||38
5111991|NCT01544595|12576440|P5|COMPLETED|Status at Week 156||60
5111992|NCT01544595|12576441|P4|COMPLETED|Status at Week 156||15
5111993|NCT01544595|12576442|P3|COMPLETED|Status at Week 156||10
5111994|NCT01544595|12576443|P2|COMPLETED|Status at Week 156||285
5111995|NCT01544595|12576444|P1|COMPLETED|Status at Week 156||184
5111996|NCT01544595|12576439|P6|STARTED|Status at Week 156||53
5111997|NCT01544595|12576440|P5|STARTED|Status at Week 156||98
5111998|NCT01544595|12576441|P4|STARTED|Status at Week 156||181
5111999|NCT01544595|12576442|P3|STARTED|Status at Week 156||150
5112000|NCT01544595|12576443|P2|STARTED|Status at Week 156||363
5112001|NCT01544595|12576444|P1|STARTED|Status at Week 156||301
5112002|NCT01544595|12576439|P6|NOT COMPLETED|Status at Week 68||0
5112003|NCT01544595|12576440|P5|NOT COMPLETED|Status at Week 68||0
5112004|NCT01544595|12576441|P4|NOT COMPLETED|Status at Week 68||51
5112005|NCT01544595|12576442|P3|NOT COMPLETED|Status at Week 68||63
5112006|NCT01544595|12576443|P2|NOT COMPLETED|Status at Week 68||17
5112007|NCT01544595|12576444|P1|NOT COMPLETED|Status at Week 68||39
5112008|NCT01544595|12576439|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
5112009|NCT01544595|12576440|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
5112010|NCT01544595|12576441|P4|COMPLETED|Status at Week 68||130
5112011|NCT01544595|12576442|P3|COMPLETED|Status at Week 68||87
5112012|NCT01544595|12576443|P2|COMPLETED|Status at Week 68||346
5112013|NCT01544595|12576444|P1|COMPLETED|Status at Week 68||262
5112014|NCT01544595|12576439|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
5112015|NCT01544595|12576440|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
5112016|NCT01544595|12576441|P4|STARTED|Status at Week 68||181
5112017|NCT01544595|12576442|P3|STARTED|Status at Week 68||150
5112018|NCT01544595|12576443|P2|STARTED|Status at Week 68||363
5112019|NCT01544595|12576444|P1|STARTED|Status at Week 68||301
5112020|NCT01544582|12576520|P4|NOT COMPLETED|Analysis Population||39
5112021|NCT01544582|12576521|P3|NOT COMPLETED|Analysis Population||102
5112022|NCT01544582|12576522|P2|NOT COMPLETED|Analysis Population||118
5112023|NCT01544582|12576523|P1|NOT COMPLETED|Analysis Population||0
5112024|NCT01544582|12576520|P4|COMPLETED|Analysis Population||35
5112025|NCT01544582|12576521|P3|COMPLETED|Analysis Population||205
5112026|NCT01544582|12576522|P2|COMPLETED|Analysis Population||180
5112027|NCT01544582|12576523|P1|COMPLETED|Analysis Population||0
5112028|NCT01544582|12576520|P4|STARTED|Analysis Population||74
5112029|NCT01544582|12576521|P3|STARTED|Analysis Population||307
5112030|NCT01544582|12576522|P2|STARTED|Analysis Population||298
5112031|NCT01544582|12576523|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
5112032|NCT01544582|12576520|P4|NOT COMPLETED|Screening/Eligibility||0
5112033|NCT01544582|12576521|P3|NOT COMPLETED|Screening/Eligibility||0
5112034|NCT01544582|12576522|P2|NOT COMPLETED|Screening/Eligibility||0
5112035|NCT01544582|12576523|P1|NOT COMPLETED|Screening/Eligibility||34
5112036|NCT01544582|12576520|P4|COMPLETED|Screening/Eligibility||0
5112037|NCT01544582|12576521|P3|COMPLETED|Screening/Eligibility||0
5112038|NCT01544582|12576522|P2|COMPLETED|Screening/Eligibility||0
5112039|NCT01544582|12576523|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
5112040|NCT01544582|12576520|P4|Analysis Population|Screening/Eligibility||0
5112041|NCT01544582|12576521|P3|Analysis Population|Screening/Eligibility||0
5112042|NCT01544582|12576522|P2|Analysis Population|Screening/Eligibility||0
5112043|NCT01544582|12576523|P1|Analysis Population|Screening/Eligibility||679
5112044|NCT01544582|12576520|P4|STARTED|Screening/Eligibility||0
5112045|NCT01544582|12576521|P3|STARTED|Screening/Eligibility||0
5112046|NCT01544582|12576522|P2|STARTED|Screening/Eligibility||0
5112047|NCT01544582|12576523|P1|STARTED|Screening/Eligibility||713
5112048|NCT01544491|12576583|P2|NOT COMPLETED|Overall Study||3
5112049|NCT01544491|12576584|P1|NOT COMPLETED|Overall Study||5
5112050|NCT01544491|12576583|P2|COMPLETED|Overall Study||51
5112051|NCT01544491|12576584|P1|COMPLETED|Overall Study||47
5112052|NCT01544491|12576583|P2|STARTED|Overall Study||54
5112053|NCT01544491|12576584|P1|STARTED|Overall Study||52
5112054|NCT01544478|12576610|P1|NOT COMPLETED|Overall Study||118
5112055|NCT01544478|12576610|P1|COMPLETED|Overall Study||912
5112056|NCT01544478|12576610|P1|Vaccination 3|Overall Study||1019
5112057|NCT01544478|12576610|P1|Vaccination 2|Overall Study||1026
5112058|NCT01544478|12576610|P1|Vaccination 1|Overall Study||1030
5112059|NCT01544478|12576610|P1|STARTED|Overall Study||1030
5112060|NCT01544361|12576619|P5|NOT COMPLETED|Overall Study||0
5112061|NCT01544361|12576620|P4|NOT COMPLETED|Overall Study||0
5112062|NCT01544361|12576621|P3|NOT COMPLETED|Overall Study||0
5112063|NCT01544361|12576622|P2|NOT COMPLETED|Overall Study||0
5112064|NCT01544361|12576623|P1|NOT COMPLETED|Overall Study||0
5112065|NCT01544361|12576619|P5|COMPLETED|Overall Study||6
5112066|NCT01544361|12576620|P4|COMPLETED|Overall Study||6
5112067|NCT01544361|12576621|P3|COMPLETED|Overall Study||6
5112068|NCT01544361|12576622|P2|COMPLETED|Overall Study||6
5112069|NCT01544361|12576623|P1|COMPLETED|Overall Study||8
5112070|NCT01544361|12576619|P5|STARTED|Overall Study||6
5112071|NCT01544361|12576620|P4|STARTED|Overall Study||6
5112072|NCT01544361|12576621|P3|STARTED|Overall Study||6
5112073|NCT01544361|12576622|P2|STARTED|Overall Study||6
5112074|NCT01544361|12576623|P1|STARTED|Overall Study||8
5112075|NCT01544348|12576653|P8|NOT COMPLETED|Overall Study||0
5112076|NCT01544348|12576654|P7|NOT COMPLETED|Overall Study||2
5112077|NCT01544348|12576655|P6|NOT COMPLETED|Overall Study||3
5112078|NCT01544348|12576656|P5|NOT COMPLETED|Overall Study||1
5112079|NCT01544348|12576657|P4|NOT COMPLETED|Overall Study||0
5112080|NCT01544348|12576658|P3|NOT COMPLETED|Overall Study||0
5112081|NCT01544348|12576659|P2|NOT COMPLETED|Overall Study||0
5112082|NCT01544348|12576660|P1|NOT COMPLETED|Overall Study||2
5112083|NCT01544348|12576653|P8|COMPLETED|Overall Study||8
5112084|NCT01544348|12576654|P7|COMPLETED|Overall Study||12
5112085|NCT01544348|12576655|P6|COMPLETED|Overall Study||16
5112086|NCT01544348|12576656|P5|COMPLETED|Overall Study||15
5112087|NCT01544348|12576657|P4|COMPLETED|Overall Study||3
5112088|NCT01544348|12576658|P3|COMPLETED|Overall Study||3
5112089|NCT01544348|12576659|P2|COMPLETED|Overall Study||6
5112090|NCT01544348|12576660|P1|COMPLETED|Overall Study||15
5112091|NCT01544348|12576653|P8|Treated|Overall Study||8
5112092|NCT01544348|12576654|P7|Treated|Overall Study||14
5112093|NCT01544348|12576655|P6|Treated|Overall Study||18
5112094|NCT01544348|12576656|P5|Treated|Overall Study||15
5112095|NCT01544348|12576657|P4|Treated|Overall Study||3
5112096|NCT01544348|12576658|P3|Treated|Overall Study||3
5112097|NCT01544348|12576659|P2|Treated|Overall Study||6
5112098|NCT01544348|12576660|P1|Treated|Overall Study||17
5112099|NCT01544348|12576653|P8|STARTED|Overall Study||8
5112100|NCT01544348|12576654|P7|STARTED|Overall Study||14
5112101|NCT01544348|12576655|P6|STARTED|Overall Study||19
5112102|NCT01544348|12576656|P5|STARTED|Overall Study||16
5112103|NCT01544348|12576657|P4|STARTED|Overall Study||3
5112104|NCT01544348|12576658|P3|STARTED|Overall Study||3
5112105|NCT01544348|12576659|P2|STARTED|Overall Study||6
5112106|NCT01544348|12576660|P1|STARTED|Overall Study||17
5112107|NCT01544309|12576702|P2|NOT COMPLETED|Overall Study||11
5112108|NCT01544309|12576703|P1|NOT COMPLETED|Overall Study||20
5112109|NCT01544309|12576702|P2|COMPLETED|Overall Study||514
5112110|NCT01544309|12576703|P1|COMPLETED|Overall Study||504
5112111|NCT01544309|12576702|P2|STARTED|Overall Study||525
5112112|NCT01544309|12576703|P1|STARTED|Overall Study||524
5112113|NCT01544179|12576741|P2|NOT COMPLETED|Overall Study||46
5112114|NCT01544179|12576742|P1|NOT COMPLETED|Overall Study||63
5112115|NCT01544179|12576741|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
5112116|NCT01544179|12576742|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
5112117|NCT01544179|12576741|P2|Did Not Receive Treatment|Overall Study||0
5112118|NCT01544179|12576742|P1|Did Not Receive Treatment|Overall Study||1
5112119|NCT01544179|12576741|P2|Received Treatment|Overall Study||132
5112120|NCT01544179|12576742|P1|Received Treatment|Overall Study||132
5112121|NCT01544179|12576741|P2|STARTED|Overall Study||132
5112122|NCT01544179|12576742|P1|STARTED|Overall Study||133
5112123|NCT01544166|12576770|P1|NOT COMPLETED|Overall Study||0
5112124|NCT01544166|12576770|P1|COMPLETED|Overall Study||44
5112125|NCT01544166|12576770|P1|STARTED|Overall Study||44
5112126|NCT01544153|12576835|P4|NOT COMPLETED|Overall Study||0
5112127|NCT01544153|12576836|P3|NOT COMPLETED|Overall Study||1
5112128|NCT01544153|12576837|P2|NOT COMPLETED|Overall Study||1
5112129|NCT01544153|12576838|P1|NOT COMPLETED|Overall Study||0
5112130|NCT01544153|12576835|P4|COMPLETED|Overall Study||1317
5112131|NCT01544153|12576836|P3|COMPLETED|Overall Study||1313
5112132|NCT01544153|12576837|P2|COMPLETED|Overall Study||1323
5112133|NCT01544153|12576838|P1|COMPLETED|Overall Study||1337
5112134|NCT01544153|12576835|P4|STARTED|Overall Study||1317
5112135|NCT01544153|12576836|P3|STARTED|Overall Study||1314
5112136|NCT01544153|12576837|P2|STARTED|Overall Study||1324
5112137|NCT01544153|12576838|P1|STARTED|Overall Study||1337
5112138|NCT01544127|12576855|P3|NOT COMPLETED|Overall Study||14
5112139|NCT01544127|12576856|P2|NOT COMPLETED|Overall Study||6
5112140|NCT01544127|12576857|P1|NOT COMPLETED|Overall Study||11
5112141|NCT01544127|12576855|P3|COMPLETED|Overall Study||52
5112142|NCT01544127|12576856|P2|COMPLETED|Overall Study||27
5112143|NCT01544127|12576857|P1|COMPLETED|Overall Study||22
5112144|NCT01544127|12576855|P3|STARTED|Overall Study||66
5112145|NCT01544127|12576856|P2|STARTED|Overall Study||33
5112146|NCT01544127|12576857|P1|STARTED|Overall Study||33
5112147|NCT01544114|12576877|P3|NOT COMPLETED|Overall Study||5
5112148|NCT01544114|12576878|P2|NOT COMPLETED|Overall Study||4
5112149|NCT01544114|12576879|P1|NOT COMPLETED|Overall Study||1
5112150|NCT01544114|12576877|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
5112151|NCT01544114|12576878|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
5112152|NCT01544114|12576879|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
5112153|NCT01544114|12576877|P3|STARTED|Overall Study||22
5112154|NCT01544114|12576878|P2|STARTED|Overall Study||20
5112155|NCT01544114|12576879|P1|STARTED|Overall Study||4
5112156|NCT01544088|12576910|P2|NOT COMPLETED|Overall Study||21
5112157|NCT01544088|12576911|P1|NOT COMPLETED|Overall Study||37
5112158|NCT01544088|12576910|P2|COMPLETED|Overall Study||79
5112159|NCT01544088|12576911|P1|COMPLETED|Overall Study||61
5112160|NCT01544088|12576910|P2|STARTED|Overall Study||100
5112161|NCT01544088|12576911|P1|STARTED|Overall Study||98
5112162|NCT01544062|12576925|P2|NOT COMPLETED|Overall Study||0
5112163|NCT01544062|12576926|P1|NOT COMPLETED|Overall Study||0
5112164|NCT01544062|12576925|P2|COMPLETED|Overall Study||35
5112165|NCT01544062|12576926|P1|COMPLETED|Overall Study||33
5112166|NCT01544062|12576925|P2|STARTED|Overall Study||35
5112167|NCT01544062|12576926|P1|STARTED|Overall Study||33
5112168|NCT01544023|12576972|P1|NOT COMPLETED|Overall Study||0
5112169|NCT01544023|12576972|P1|COMPLETED|Overall Study||207
5112170|NCT01544023|12576972|P1|STARTED|Overall Study|retrospective|207
5112171|NCT01543958|12576977|P1|NOT COMPLETED|Overall Study||4
5112172|NCT01543958|12576977|P1|COMPLETED|Overall Study||36
5112173|NCT01543958|12576977|P1|STARTED|Overall Study||40
5112174|NCT01543828|12577032|P2|NOT COMPLETED|Treatment 2||0
5112175|NCT01543828|12577033|P1|NOT COMPLETED|Treatment 2||1
5112176|NCT01543828|12577032|P2|COMPLETED|Treatment 2||19
5112177|NCT01543828|12577033|P1|COMPLETED|Treatment 2||19
5112178|NCT01543828|12577032|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
5112179|NCT01543828|12577033|P1|STARTED|Treatment 2||20
5112180|NCT01543828|12577032|P2|NOT COMPLETED|Treatment 1||0
5112181|NCT01543828|12577033|P1|NOT COMPLETED|Treatment 1||0
5112182|NCT01543828|12577032|P2|COMPLETED|Treatment 1||20
5112183|NCT01543828|12577033|P1|COMPLETED|Treatment 1||20
5112184|NCT01543828|12577032|P2|STARTED|Treatment 1||20
5112185|NCT01543828|12577033|P1|STARTED|Treatment 1||20
5112186|NCT01543776|12577043|P2|NOT COMPLETED|Overall Study||2
5112187|NCT01543776|12577044|P1|NOT COMPLETED|Overall Study||2
5112188|NCT01543776|12577043|P2|COMPLETED|Overall Study||34
5112189|NCT01543776|12577044|P1|COMPLETED|Overall Study||34
5112190|NCT01543776|12577043|P2|STARTED|Overall Study||36
5112191|NCT01543776|12577044|P1|STARTED|Overall Study||36
5112192|NCT01543685|12577063|P5|NOT COMPLETED|Overall Study||4
5112193|NCT01543685|12577064|P4|NOT COMPLETED|Overall Study||0
5112194|NCT01543685|12577065|P3|NOT COMPLETED|Overall Study||2
5112195|NCT01543685|12577066|P2|NOT COMPLETED|Overall Study||3
5112196|NCT01543685|12577067|P1|NOT COMPLETED|Overall Study||3
5112197|NCT01543685|12577063|P5|COMPLETED|Overall Study||90
5112198|NCT01543685|12577064|P4|COMPLETED|Overall Study||93
5112199|NCT01543685|12577065|P3|COMPLETED|Overall Study||89
5112200|NCT01543685|12577066|P2|COMPLETED|Overall Study||88
5112201|NCT01543685|12577067|P1|COMPLETED|Overall Study||90
5112202|NCT01543685|12577063|P5|STARTED|Overall Study||94
5112203|NCT01543685|12577064|P4|STARTED|Overall Study||93
5112204|NCT01543685|12577065|P3|STARTED|Overall Study||91
5112205|NCT01543685|12577066|P2|STARTED|Overall Study||91
5112206|NCT01543685|12577067|P1|STARTED|Overall Study||93
5112207|NCT01543607|12577114|P1|NOT COMPLETED|Overall Study||0
5112208|NCT01543607|12577114|P1|COMPLETED|Overall Study||1
5112209|NCT01543607|12577114|P1|STARTED|Overall Study||1
5112210|NCT01543581|12577120|P2|NOT COMPLETED|Overall Study||0
5112211|NCT01543581|12577121|P1|NOT COMPLETED|Overall Study||0
5112212|NCT01543581|12577120|P2|COMPLETED|Overall Study||0
5112213|NCT01543581|12577121|P1|COMPLETED|Overall Study||1
5112214|NCT01543581|12577120|P2|STARTED|Overall Study||0
5112215|NCT01543581|12577121|P1|STARTED|Overall Study||1
5112216|NCT01543568|12577127|P1|NOT COMPLETED|Overall Study||1
5112217|NCT01543568|12577127|P1|COMPLETED|Overall Study||45
5112218|NCT01543568|12577127|P1|STARTED|Overall Study||46
5112219|NCT01543503|12577139|P2|NOT COMPLETED|Overall Study||87
5112220|NCT01543503|12577140|P1|NOT COMPLETED|Overall Study||76
5112221|NCT01543503|12577139|P2|COMPLETED|Overall Study||711
5112222|NCT01543503|12577140|P1|COMPLETED|Overall Study||350
5112223|NCT01543503|12577139|P2|STARTED|Overall Study||798
5112224|NCT01543503|12577140|P1|STARTED|Overall Study||426
5112225|NCT01543204|12577184|P1|NOT COMPLETED|Overall Study||8
5112226|NCT01543204|12577184|P1|COMPLETED|Overall Study||56
5112227|NCT01543204|12577184|P1|STARTED|Overall Study||64
5112228|NCT01543178|12577231|P3|NOT COMPLETED|Double-blind Period||37
5112229|NCT01543178|12577232|P2|NOT COMPLETED|Double-blind Period||44
5112230|NCT01543178|12577233|P1|NOT COMPLETED|Double-blind Period||0
5112231|NCT01543178|12577231|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
5112232|NCT01543178|12577232|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
5112233|NCT01543178|12577233|P1|COMPLETED|Double-blind Period||0
5112234|NCT01543178|12577231|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
5112235|NCT01543178|12577232|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
5112236|NCT01543178|12577233|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
5112237|NCT01543178|12577231|P3|NOT COMPLETED|Open-label Period||0
5112238|NCT01543178|12577232|P2|NOT COMPLETED|Open-label Period||0
5112239|NCT01543178|12577233|P1|NOT COMPLETED|Open-label Period||1947
5112240|NCT01543178|12577231|P3|COMPLETED|Open-label Period||0
5112241|NCT01543178|12577232|P2|COMPLETED|Open-label Period||0
5112242|NCT01543178|12577233|P1|COMPLETED|Open-label Period||636
5112243|NCT01543178|12577231|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
5112244|NCT01543178|12577232|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
5112245|NCT01543178|12577233|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
5112246|NCT01543087|12577246|P6|NOT COMPLETED|Booster Stage (26 Months)||0
5112247|NCT01543087|12577247|P5|NOT COMPLETED|Booster Stage (26 Months)||2
5112248|NCT01543087|12577248|P4|NOT COMPLETED|Booster Stage (26 Months)||0
5112249|NCT01543087|12577249|P3|NOT COMPLETED|Booster Stage (26 Months)||1
5112250|NCT01543087|12577250|P2|NOT COMPLETED|Booster Stage (26 Months)||1
5112251|NCT01543087|12577251|P1|NOT COMPLETED|Booster Stage (26 Months)||0
5112252|NCT01543087|12577246|P6|COMPLETED|Booster Stage (26 Months)||32
5112253|NCT01543087|12577247|P5|COMPLETED|Booster Stage (26 Months)||54
5112254|NCT01543087|12577248|P4|COMPLETED|Booster Stage (26 Months)||64
5112255|NCT01543087|12577249|P3|COMPLETED|Booster Stage (26 Months)||91
5112256|NCT01543087|12577250|P2|COMPLETED|Booster Stage (26 Months)||59
5112257|NCT01543087|12577251|P1|COMPLETED|Booster Stage (26 Months)||0
5112258|NCT01543087|12577246|P6|Vaccinated|Booster Stage (26 Months)||32
5112259|NCT01543087|12577247|P5|Vaccinated|Booster Stage (26 Months)||54
5112260|NCT01543087|12577248|P4|Vaccinated|Booster Stage (26 Months)||64
5112261|NCT01543087|12577249|P3|Vaccinated|Booster Stage (26 Months)||92
5112262|NCT01543087|12577250|P2|Vaccinated|Booster Stage (26 Months)||59
5112263|NCT01543087|12577251|P1|Vaccinated|Booster Stage (26 Months)||0
5112264|NCT01543087|12577246|P6|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
5112265|NCT01543087|12577247|P5|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
5112266|NCT01543087|12577248|P4|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
5112267|NCT01543087|12577249|P3|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
5112268|NCT01543087|12577250|P2|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
5112269|NCT01543087|12577251|P1|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
5112270|NCT01543087|12577246|P6|NOT COMPLETED|Stage 1 (48 Months)||0
5112271|NCT01543087|12577247|P5|NOT COMPLETED|Stage 1 (48 Months)||3
5112272|NCT01543087|12577248|P4|NOT COMPLETED|Stage 1 (48 Months)||8
5112273|NCT01543087|12577249|P3|NOT COMPLETED|Stage 1 (48 Months)||40
5112274|NCT01543087|12577250|P2|NOT COMPLETED|Stage 1 (48 Months)||10
5112275|NCT01543087|12577251|P1|NOT COMPLETED|Stage 1 (48 Months)||14
5112276|NCT01543087|12577246|P6|COMPLETED|Stage 1 (48 Months)||46
5112277|NCT01543087|12577247|P5|COMPLETED|Stage 1 (48 Months)||83
5112278|NCT01543087|12577248|P4|COMPLETED|Stage 1 (48 Months)||108
5112279|NCT01543087|12577249|P3|COMPLETED|Stage 1 (48 Months)||237
5112280|NCT01543087|12577250|P2|COMPLETED|Stage 1 (48 Months)||93
5112281|NCT01543087|12577251|P1|COMPLETED|Stage 1 (48 Months)||56
5112282|NCT01543087|12577246|P6|Safety Population|Stage 1 (48 Months)||46
5112283|NCT01543087|12577247|P5|Safety Population|Stage 1 (48 Months)||86
5112284|NCT01543087|12577248|P4|Safety Population|Stage 1 (48 Months)||116
5112285|NCT01543087|12577249|P3|Safety Population|Stage 1 (48 Months)||277
5112286|NCT01543087|12577250|P2|Safety Population|Stage 1 (48 Months)||101
5112287|NCT01543087|12577251|P1|Safety Population|Stage 1 (48 Months)||70
5112288|NCT01543087|12577246|P6|STARTED|Stage 1 (48 Months)||46
5112289|NCT01543087|12577247|P5|STARTED|Stage 1 (48 Months)||86
5112290|NCT01543087|12577248|P4|STARTED|Stage 1 (48 Months)||116
5112291|NCT01543087|12577249|P3|STARTED|Stage 1 (48 Months)||277
5112292|NCT01543087|12577250|P2|STARTED|Stage 1 (48 Months)||103
5112293|NCT01543087|12577251|P1|STARTED|Stage 1 (48 Months)||70
5112294|NCT01543074|12577392|P4|NOT COMPLETED|Overall Study||0
5112295|NCT01543074|12577393|P3|NOT COMPLETED|Overall Study||0
5112296|NCT01543074|12577394|P2|NOT COMPLETED|Overall Study||0
5112297|NCT01543074|12577395|P1|NOT COMPLETED|Overall Study||0
5112298|NCT01543074|12577392|P4|COMPLETED|Overall Study||6
5112299|NCT01543074|12577393|P3|COMPLETED|Overall Study||5
5112300|NCT01543074|12577394|P2|COMPLETED|Overall Study||7
5112301|NCT01543074|12577395|P1|COMPLETED|Overall Study||5
5112302|NCT01543074|12577392|P4|STARTED|Overall Study||6
5112303|NCT01543074|12577393|P3|STARTED|Overall Study||5
5112304|NCT01543074|12577394|P2|STARTED|Overall Study||7
5112305|NCT01543074|12577395|P1|STARTED|Overall Study||5
5112306|NCT01542957|12577415|P2|NOT COMPLETED|12-month Follow-up||13
5112307|NCT01542957|12577416|P1|NOT COMPLETED|12-month Follow-up||16
5112308|NCT01542957|12577415|P2|COMPLETED|12-month Follow-up||40
5112309|NCT01542957|12577416|P1|COMPLETED|12-month Follow-up||37
5112310|NCT01542957|12577415|P2|STARTED|12-month Follow-up||53
5112311|NCT01542957|12577416|P1|STARTED|12-month Follow-up||53
5112312|NCT01542957|12577415|P2|NOT COMPLETED|3-month Follow-up||8
5112313|NCT01542957|12577416|P1|NOT COMPLETED|3-month Follow-up||3
5112314|NCT01542957|12577415|P2|COMPLETED|3-month Follow-up||45
5112315|NCT01542957|12577416|P1|COMPLETED|3-month Follow-up||50
5112316|NCT01542957|12577415|P2|STARTED|3-month Follow-up||53
5112317|NCT01542957|12577416|P1|STARTED|3-month Follow-up||53
5112318|NCT01542957|12577415|P2|NOT COMPLETED|End of Therapy||10
5112319|NCT01542957|12577416|P1|NOT COMPLETED|End of Therapy||12
5112320|NCT01542957|12577415|P2|COMPLETED|End of Therapy||53
5112321|NCT01542957|12577416|P1|COMPLETED|End of Therapy||53
5112322|NCT01542957|12577415|P2|STARTED|End of Therapy||63
5112323|NCT01542957|12577416|P1|STARTED|End of Therapy||65
5112324|NCT01542788|12577428|P2|NOT COMPLETED|Overall Study||71
5112325|NCT01542788|12577429|P1|NOT COMPLETED|Overall Study||55
5112326|NCT01542788|12577428|P2|COMPLETED|Overall Study||0
5112327|NCT01542788|12577429|P1|COMPLETED|Overall Study||154
5112328|NCT01542788|12577428|P2|Randomized and Treated|Overall Study||71
5112329|NCT01542788|12577429|P1|Randomized and Treated|Overall Study||207
5112330|NCT01542788|12577428|P2|STARTED|Overall Study||71
5112331|NCT01542788|12577429|P1|STARTED|Overall Study||209
5112332|NCT01542684|12577445|P1|NOT COMPLETED|Overall Study||0
5112333|NCT01542684|12577445|P1|COMPLETED|Overall Study||8
5112334|NCT01542684|12577445|P1|STARTED|Overall Study||8
5112335|NCT01542645|12577451|P2|NOT COMPLETED|Overall Study||3
5112336|NCT01542645|12577452|P1|NOT COMPLETED|Overall Study||5
5112337|NCT01542645|12577451|P2|COMPLETED|Overall Study||79
5112338|NCT01542645|12577452|P1|COMPLETED|Overall Study||77
5112339|NCT01542645|12577451|P2|STARTED|Overall Study||82
5112340|NCT01542645|12577452|P1|STARTED|Overall Study||82
5112341|NCT01542632|12577476|P6|NOT COMPLETED|Overall Study||0
5112342|NCT01542632|12577477|P5|NOT COMPLETED|Overall Study||4
5112343|NCT01542632|12577478|P4|NOT COMPLETED|Overall Study||2
5112344|NCT01542632|12577479|P3|NOT COMPLETED|Overall Study||1
5112345|NCT01542632|12577480|P2|NOT COMPLETED|Overall Study||1
5112346|NCT01542632|12577481|P1|NOT COMPLETED|Overall Study||0
5112347|NCT01542632|12577476|P6|COMPLETED|Overall Study||24
5112348|NCT01542632|12577477|P5|COMPLETED|Overall Study||17
5112349|NCT01542632|12577478|P4|COMPLETED|Overall Study||19
5112350|NCT01542632|12577479|P3|COMPLETED|Overall Study||23
5112351|NCT01542632|12577480|P2|COMPLETED|Overall Study||24
5112352|NCT01542632|12577481|P1|COMPLETED|Overall Study||25
5112353|NCT01542632|12577476|P6|STARTED|Overall Study||24
5112354|NCT01542632|12577477|P5|STARTED|Overall Study||21
5112355|NCT01542632|12577478|P4|STARTED|Overall Study||21
5112356|NCT01542632|12577479|P3|STARTED|Overall Study||24
5112357|NCT01542632|12577480|P2|STARTED|Overall Study||25
5112358|NCT01542632|12577481|P1|STARTED|Overall Study||25
5112359|NCT01542541|12577527|P2|NOT COMPLETED|Overall Study||0
5112360|NCT01542541|12577528|P1|NOT COMPLETED|Overall Study||8
5112361|NCT01542541|12577527|P2|COMPLETED|Overall Study||30
5112362|NCT01542541|12577528|P1|COMPLETED|Overall Study||30
5112363|NCT01542541|12577527|P2|STARTED|Overall Study||30
5112364|NCT01542541|12577528|P1|STARTED|Overall Study||38
5112365|NCT01542528|12577538|P2|NOT COMPLETED|Overall Study||7
5112366|NCT01542528|12577539|P1|NOT COMPLETED|Overall Study||12
5112367|NCT01542528|12577538|P2|COMPLETED|Overall Study||49
5112368|NCT01542528|12577539|P1|COMPLETED|Overall Study||49
5112369|NCT01542528|12577538|P2|STARTED|Overall Study||56
5112370|NCT01542528|12577539|P1|STARTED|Overall Study||61
5112371|NCT01542502|12577547|P2|NOT COMPLETED|Overall Study||0
5112372|NCT01542502|12577548|P1|NOT COMPLETED|Overall Study||0
5112373|NCT01542502|12577547|P2|COMPLETED|Overall Study||6
5112374|NCT01542502|12577548|P1|COMPLETED|Overall Study||6
5112375|NCT01542502|12577547|P2|STARTED|Overall Study||6
5112376|NCT01542502|12577548|P1|STARTED|Overall Study||6
5112377|NCT01542398|12577558|P2|NOT COMPLETED|Overall Study||13
5112378|NCT01542398|12577559|P1|NOT COMPLETED|Overall Study||8
5112379|NCT01542398|12577558|P2|COMPLETED|Overall Study||67
5112380|NCT01542398|12577559|P1|COMPLETED|Overall Study||71
5112381|NCT01542398|12577558|P2|Post-Intervention Assessment|Overall Study||80
5112382|NCT01542398|12577559|P1|Post-Intervention Assessment|Overall Study||78
5112383|NCT01542398|12577558|P2|STARTED|Overall Study||80
5112384|NCT01542398|12577559|P1|STARTED|Overall Study||79
5112385|NCT01542372|12577567|P2|NOT COMPLETED|Overall Study||0
5112386|NCT01542372|12577568|P1|NOT COMPLETED|Overall Study||0
5112387|NCT01542372|12577567|P2|COMPLETED|Overall Study||11
5112388|NCT01542372|12577568|P1|COMPLETED|Overall Study||11
5112389|NCT01542372|12577567|P2|STARTED|Overall Study||11
5112390|NCT01542372|12577568|P1|STARTED|Overall Study||11
5112391|NCT01542307|12577583|P2|NOT COMPLETED|Overall Study||0
5112392|NCT01542307|12577584|P1|NOT COMPLETED|Overall Study||0
5112393|NCT01542307|12577583|P2|COMPLETED|Overall Study||22
5112394|NCT01542307|12577584|P1|COMPLETED|Overall Study||22
5112395|NCT01542307|12577583|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
5112396|NCT01542307|12577584|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
5112397|NCT01542255|12577604|P1|NOT COMPLETED|Overall Study||0
5112398|NCT01542255|12577604|P1|COMPLETED|Overall Study||7
5112399|NCT01542255|12577604|P1|Analyzed for Time to Progression|Overall Study||7
5112400|NCT01542255|12577604|P1|STARTED|Overall Study||7
5112401|NCT01542229|12577611|P2|NOT COMPLETED|Overall Study||36
5112402|NCT01542229|12577612|P1|NOT COMPLETED|Overall Study||23
5112403|NCT01542229|12577611|P2|COMPLETED|Overall Study||30
5112404|NCT01542229|12577612|P1|COMPLETED|Overall Study||45
5112405|NCT01542229|12577611|P2|STARTED|Overall Study||66
5112406|NCT01542229|12577612|P1|STARTED|Overall Study||68
5112407|NCT01542125|12577638|P2|NOT COMPLETED|Overall Study||0
5112408|NCT01542125|12577639|P1|NOT COMPLETED|Overall Study||0
5112409|NCT01542125|12577638|P2|COMPLETED|Overall Study||141
5112410|NCT01542125|12577639|P1|COMPLETED|Overall Study||140
5112411|NCT01542125|12577638|P2|STARTED|Overall Study||141
5112412|NCT01542125|12577639|P1|STARTED|Overall Study||140
5112413|NCT01542034|12577647|P2|NOT COMPLETED|Overall Study||23
5112414|NCT01542034|12577648|P1|NOT COMPLETED|Overall Study||30
5112415|NCT01542034|12577647|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
5112416|NCT01542034|12577648|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
5112417|NCT01542034|12577647|P2|Received Treatment|Overall Study||249
5112418|NCT01542034|12577648|P1|Received Treatment|Overall Study||256
5112419|NCT01542034|12577647|P2|STARTED|Overall Study||250
5112420|NCT01542034|12577648|P1|STARTED|Overall Study||256
5112421|NCT01541969|12577662|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
5112422|NCT01541969|12577663|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
5112423|NCT01541969|12577662|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
5112424|NCT01541969|12577663|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
5112425|NCT01541969|12577662|P2|STARTED|Open Label Extension (12-36 Weeks)||48
5112426|NCT01541969|12577663|P1|STARTED|Open Label Extension (12-36 Weeks)||44
5112427|NCT01541969|12577662|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
5112428|NCT01541969|12577663|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
5112429|NCT01541969|12577662|P2|COMPLETED|Double-blind (0-12 Weeks)||48
5112430|NCT01541969|12577663|P1|COMPLETED|Double-blind (0-12 Weeks)||44
5112431|NCT01541969|12577662|P2|STARTED|Double-blind (0-12 Weeks)||50
5112432|NCT01541969|12577663|P1|STARTED|Double-blind (0-12 Weeks)||50
5112433|NCT01541930|12577679|P1|NOT COMPLETED|Overall Study||1
5112434|NCT01541930|12577679|P1|COMPLETED|Overall Study||20
5112435|NCT01541930|12577679|P1|STARTED|Overall Study||21
5112436|NCT01541917|12577701|P2|NOT COMPLETED|Overall Study||9
5112437|NCT01541917|12577702|P1|NOT COMPLETED|Overall Study||15
5112438|NCT01541917|12577701|P2|COMPLETED|Overall Study||136
5112439|NCT01541917|12577702|P1|COMPLETED|Overall Study||129
5112440|NCT01541917|12577701|P2|STARTED|Overall Study||145
5112441|NCT01541917|12577702|P1|STARTED|Overall Study||144
5112442|NCT01541891|12577720|P2|NOT COMPLETED|Overall Study||1
5112443|NCT01541891|12577721|P1|NOT COMPLETED|Overall Study||1
5112444|NCT01541891|12577720|P2|COMPLETED|Overall Study||14
5112445|NCT01541891|12577721|P1|COMPLETED|Overall Study||14
5112446|NCT01541891|12577720|P2|STARTED|Overall Study||15
5112447|NCT01541891|12577721|P1|STARTED|Overall Study||15
5112448|NCT01541865|12577731|P1|NOT COMPLETED|Overall Study||22
5112449|NCT01541865|12577731|P1|COMPLETED|Overall Study||124
5112450|NCT01541865|12577731|P1|STARTED|Overall Study||146
5112451|NCT01541826|12577749|P3|NOT COMPLETED|Overall Study||0
5112452|NCT01541826|12577750|P2|NOT COMPLETED|Overall Study||3
5112453|NCT01541826|12577751|P1|NOT COMPLETED|Overall Study||4
5112454|NCT01541826|12577749|P3|COMPLETED|Overall Study||6
5112455|NCT01541826|12577750|P2|COMPLETED|Overall Study||25
5112456|NCT01541826|12577751|P1|COMPLETED|Overall Study||24
5112457|NCT01541826|12577749|P3|STARTED|Overall Study||6
5112458|NCT01541826|12577750|P2|STARTED|Overall Study||28
5112459|NCT01541826|12577751|P1|STARTED|Overall Study||28
5112460|NCT01541748|12577818|P1|NOT COMPLETED|Overall Study||31
5112461|NCT01541748|12577818|P1|COMPLETED|Overall Study||43
5112462|NCT01541748|12577818|P1|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
5112463|NCT01541735|12577841|P2|NOT COMPLETED|Overall Study||0
5112464|NCT01541735|12577842|P1|NOT COMPLETED|Overall Study||0
5112465|NCT01541735|12577841|P2|COMPLETED|Overall Study||7
5112466|NCT01541735|12577842|P1|COMPLETED|Overall Study||7
5112467|NCT01541735|12577841|P2|STARTED|Overall Study||7
5112468|NCT01541735|12577842|P1|STARTED|Overall Study||7
5112469|NCT01541644|12577854|P1|NOT COMPLETED|Overall Study||3
5112470|NCT01541644|12577854|P1|COMPLETED|Overall Study||24
5112471|NCT01541644|12577854|P1|STARTED|Overall Study||27
5112472|NCT01541553|12577860|P2|NOT COMPLETED|Overall Study||14
5112473|NCT01541553|12577861|P1|NOT COMPLETED|Overall Study||12
5112474|NCT01541553|12577860|P2|COMPLETED|Overall Study||148
5112475|NCT01541553|12577861|P1|COMPLETED|Overall Study||155
5112476|NCT01541553|12577860|P2|STARTED|Overall Study||162
5112477|NCT01541553|12577861|P1|STARTED|Overall Study||167
5112478|NCT01541397|12577873|P2|NOT COMPLETED|Overall Study||2
5112479|NCT01541397|12577874|P1|NOT COMPLETED|Overall Study||4
5112480|NCT01541397|12577873|P2|COMPLETED|Overall Study||0
5112481|NCT01541397|12577874|P1|COMPLETED|Overall Study||0
5112482|NCT01541397|12577873|P2|STARTED|Overall Study||2
5112483|NCT01541397|12577874|P1|STARTED|Overall Study||4
5112484|NCT01541384|12577889|P3|NOT COMPLETED|Overall Study||2
5112485|NCT01541384|12577890|P2|NOT COMPLETED|Overall Study||1
5112486|NCT01541384|12577891|P1|NOT COMPLETED|Overall Study||0
5112487|NCT01541384|12577889|P3|COMPLETED|Overall Study||38
5112488|NCT01541384|12577890|P2|COMPLETED|Overall Study||39
5112489|NCT01541384|12577891|P1|COMPLETED|Overall Study||40
5112490|NCT01541384|12577889|P3|STARTED|Overall Study||40
5112491|NCT01541384|12577890|P2|STARTED|Overall Study||40
5112492|NCT01541384|12577891|P1|STARTED|Overall Study||40
5112493|NCT01541371|12577899|P1|NOT COMPLETED|Overall Study||77
5112494|NCT01541371|12577899|P1|COMPLETED|Overall Study||326
5112495|NCT01541371|12577899|P1|Full Analysis Set|Overall Study||394
5112496|NCT01541371|12577899|P1|STARTED|Overall Study||403
5112497|NCT01541358|12577922|P1|NOT COMPLETED|Overall Study||0
5112498|NCT01541358|12577922|P1|COMPLETED|Overall Study||2
5112499|NCT01541358|12577922|P1|STARTED|Overall Study||2
5112500|NCT01541254|12577928|P1|NOT COMPLETED|Overall Study||6
5112501|NCT01541254|12577928|P1|COMPLETED|Overall Study||30
5112502|NCT01541254|12577928|P1|STARTED|Overall Study||36
5112503|NCT01541215|12577935|P2|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
5112504|NCT01541215|12577936|P1|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
5112505|NCT01541215|12577935|P2|COMPLETED|Follow up 1 (Weeks 53-104)||0
5112506|NCT01541215|12577936|P1|COMPLETED|Follow up 1 (Weeks 53-104)||50
5112507|NCT01541215|12577935|P2|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
5112508|NCT01541215|12577936|P1|STARTED|Follow up 1 (Weeks 53-104)|Subjects who provided safety follow up data were included.|52
5112509|NCT01541215|12577935|P2|NOT COMPLETED|Treatment Period (52 Weeks)||16
5112510|NCT01541215|12577936|P1|NOT COMPLETED|Treatment Period (52 Weeks)||10
5112511|NCT01541215|12577935|P2|COMPLETED|Treatment Period (52 Weeks)||53
5112512|NCT01541215|12577936|P1|COMPLETED|Treatment Period (52 Weeks)||56
5112513|NCT01541215|12577935|P2|Exposed|Treatment Period (52 Weeks)||68
5112514|NCT01541215|12577936|P1|Exposed|Treatment Period (52 Weeks)||66
5112515|NCT01541215|12577935|P2|STARTED|Treatment Period (52 Weeks)||69
5112516|NCT01541215|12577936|P1|STARTED|Treatment Period (52 Weeks)||66
5112517|NCT01540981|12578082|P2|NOT COMPLETED|Overall Study||0
5112518|NCT01540981|12578083|P1|NOT COMPLETED|Overall Study||1
5112519|NCT01540981|12578082|P2|COMPLETED|Overall Study||6
5112520|NCT01540981|12578083|P1|COMPLETED|Overall Study||5
5112521|NCT01540981|12578082|P2|STARTED|Overall Study||6
5112522|NCT01540981|12578083|P1|STARTED|Overall Study||6
5112523|NCT01540851|12578093|P2|NOT COMPLETED|Overall Study||18
5112524|NCT01540851|12578094|P1|NOT COMPLETED|Overall Study||21
5112525|NCT01540851|12578093|P2|COMPLETED|Overall Study||136
5112526|NCT01540851|12578094|P1|COMPLETED|Overall Study||133
5112527|NCT01540851|12578093|P2|STARTED|Overall Study||154
5112528|NCT01540851|12578094|P1|STARTED|Overall Study||154
5112529|NCT01540838|12578106|P2|NOT COMPLETED|Overall Study||23
5112530|NCT01540838|12578107|P1|NOT COMPLETED|Overall Study||22
5112531|NCT01540838|12578106|P2|COMPLETED|Overall Study||164
5112532|NCT01540838|12578107|P1|COMPLETED|Overall Study||166
5112533|NCT01540838|12578106|P2|STARTED|Overall Study||187
5112534|NCT01540838|12578107|P1|STARTED|Overall Study||188
5112535|NCT01540825|12578140|P11|NOT COMPLETED|Overall Study||0
5112536|NCT01540825|12578141|P10|NOT COMPLETED|Overall Study||0
5112537|NCT01540825|12578142|P9|NOT COMPLETED|Overall Study||0
5112538|NCT01540825|12578143|P8|NOT COMPLETED|Overall Study||0
5112539|NCT01540825|12578144|P7|NOT COMPLETED|Overall Study||0
5112540|NCT01540825|12578145|P6|NOT COMPLETED|Overall Study||0
5112541|NCT01540825|12578146|P5|NOT COMPLETED|Overall Study||0
5112542|NCT01540825|12578147|P4|NOT COMPLETED|Overall Study||0
5112543|NCT01540825|12578148|P3|NOT COMPLETED|Overall Study||0
5112544|NCT01540825|12578149|P2|NOT COMPLETED|Overall Study||0
5112545|NCT01540825|12578150|P1|NOT COMPLETED|Overall Study||0
5112546|NCT01540825|12578140|P11|COMPLETED|Overall Study||6
5112547|NCT01540825|12578141|P10|COMPLETED|Overall Study||6
5112548|NCT01540825|12578142|P9|COMPLETED|Overall Study||6
5112549|NCT01540825|12578143|P8|COMPLETED|Overall Study||6
5112550|NCT01540825|12578144|P7|COMPLETED|Overall Study||6
5112551|NCT01540825|12578145|P6|COMPLETED|Overall Study||6
5112552|NCT01540825|12578146|P5|COMPLETED|Overall Study||6
5112553|NCT01540825|12578147|P4|COMPLETED|Overall Study||6
5112554|NCT01540825|12578148|P3|COMPLETED|Overall Study||6
5112555|NCT01540825|12578149|P2|COMPLETED|Overall Study||6
5112556|NCT01540825|12578150|P1|COMPLETED|Overall Study||20
5112557|NCT01540825|12578140|P11|STARTED|Overall Study||6
5112558|NCT01540825|12578141|P10|STARTED|Overall Study||6
5112559|NCT01540825|12578142|P9|STARTED|Overall Study||6
5112560|NCT01540825|12578143|P8|STARTED|Overall Study||6
5112561|NCT01540825|12578144|P7|STARTED|Overall Study||6
5112562|NCT01540825|12578145|P6|STARTED|Overall Study||6
5112563|NCT01540825|12578146|P5|STARTED|Overall Study||6
5112564|NCT01540825|12578147|P4|STARTED|Overall Study||6
5112565|NCT01540825|12578148|P3|STARTED|Overall Study||6
5112566|NCT01540825|12578149|P2|STARTED|Overall Study||6
5112567|NCT01540825|12578150|P1|STARTED|Overall Study||20
5112568|NCT01540773|12578246|P2|NOT COMPLETED|Second Intervention||0
5112569|NCT01540773|12578247|P1|NOT COMPLETED|Second Intervention||0
5112570|NCT01540773|12578246|P2|COMPLETED|Second Intervention||8
5112571|NCT01540773|12578247|P1|COMPLETED|Second Intervention||8
5112572|NCT01540773|12578246|P2|STARTED|Second Intervention||8
5112573|NCT01540773|12578247|P1|STARTED|Second Intervention||8
5112574|NCT01540773|12578246|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
5112575|NCT01540773|12578247|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
5112576|NCT01540773|12578246|P2|COMPLETED|Wash Out Period of 1 Week||8
5112577|NCT01540773|12578247|P1|COMPLETED|Wash Out Period of 1 Week||8
5112578|NCT01540773|12578246|P2|STARTED|Wash Out Period of 1 Week||8
5112579|NCT01540773|12578247|P1|STARTED|Wash Out Period of 1 Week||8
5112580|NCT01540773|12578246|P2|NOT COMPLETED|First Intervention||0
5112581|NCT01540773|12578247|P1|NOT COMPLETED|First Intervention||0
5112582|NCT01540773|12578246|P2|COMPLETED|First Intervention||8
5112583|NCT01540773|12578247|P1|COMPLETED|First Intervention||8
5112584|NCT01540773|12578246|P2|STARTED|First Intervention||8
5112585|NCT01540773|12578247|P1|STARTED|First Intervention||8
5112586|NCT01540565|12578257|P1|NOT COMPLETED|Overall Study||2
5112587|NCT01540565|12578257|P1|COMPLETED|Overall Study||50
5112588|NCT01540565|12578257|P1|STARTED|Overall Study||52
5112589|NCT01540513|12578267|P1|NOT COMPLETED|Overall Study||0
5112590|NCT01540513|12578267|P1|COMPLETED|Overall Study||12
5112591|NCT01540513|12578267|P1|STARTED|Overall Study||12
5112592|NCT01540487|12578276|P2|NOT COMPLETED|Overall Study||0
5112593|NCT01540487|12578277|P1|NOT COMPLETED|Overall Study||1
5112594|NCT01540487|12578276|P2|COMPLETED|Overall Study||24
5112595|NCT01540487|12578277|P1|COMPLETED|Overall Study||23
5112596|NCT01540487|12578276|P2|STARTED|Overall Study||24
5112597|NCT01540487|12578277|P1|STARTED|Overall Study||24
5112598|NCT01540409|12578313|P2|NOT COMPLETED|Overall Study||0
5112599|NCT01540409|12578314|P1|NOT COMPLETED|Overall Study||0
5112600|NCT01540409|12578313|P2|COMPLETED|Overall Study||6
5112601|NCT01540409|12578314|P1|COMPLETED|Overall Study||6
5112602|NCT01540409|12578313|P2|STARTED|Overall Study||6
5112603|NCT01540409|12578314|P1|STARTED|Overall Study||6
5112604|NCT01540370|12578323|P1|NOT COMPLETED|Overall Study||2
5112605|NCT01540370|12578323|P1|COMPLETED|Overall Study||100
5112606|NCT01540370|12578323|P1|STARTED|Overall Study||102
5112607|NCT01540266|12578334|P6|NOT COMPLETED|Overall Study||0
5112608|NCT01540266|12578335|P5|NOT COMPLETED|Overall Study||0
5112609|NCT01540266|12578336|P4|NOT COMPLETED|Overall Study||0
5112610|NCT01540266|12578337|P3|NOT COMPLETED|Overall Study||1
5112611|NCT01540266|12578338|P2|NOT COMPLETED|Overall Study||1
5112612|NCT01540266|12578339|P1|NOT COMPLETED|Overall Study||6
5112613|NCT01540266|12578334|P6|COMPLETED|Overall Study||19
5112614|NCT01540266|12578335|P5|COMPLETED|Overall Study||20
5112615|NCT01540266|12578336|P4|COMPLETED|Overall Study||38
5112616|NCT01540266|12578337|P3|COMPLETED|Overall Study||59
5112617|NCT01540266|12578338|P2|COMPLETED|Overall Study||41
5112618|NCT01540266|12578339|P1|COMPLETED|Overall Study||57
5112619|NCT01540266|12578334|P6|STARTED|Overall Study||19
5112620|NCT01540266|12578335|P5|STARTED|Overall Study||20
5112621|NCT01540266|12578336|P4|STARTED|Overall Study||38
5112622|NCT01540266|12578337|P3|STARTED|Overall Study||60
5112623|NCT01540266|12578338|P2|STARTED|Overall Study||42
5112624|NCT01540266|12578339|P1|STARTED|Overall Study||63
5112625|NCT01540162|12578355|P2|NOT COMPLETED|Overall Study||0
5112626|NCT01540162|12578356|P1|NOT COMPLETED|Overall Study||0
5112627|NCT01540162|12578355|P2|COMPLETED|Overall Study||32
5112628|NCT01540162|12578356|P1|COMPLETED|Overall Study||30
5112629|NCT01540162|12578355|P2|STARTED|Overall Study||32
5112630|NCT01540162|12578356|P1|STARTED|Overall Study||30
5112631|NCT01540045|12578366|P1|NOT COMPLETED|Overall Study||0
5112632|NCT01540045|12578366|P1|COMPLETED|Overall Study||40
5112633|NCT01540045|12578366|P1|STARTED|Overall Study||40
5112634|NCT01539980|12578405|P1|NOT COMPLETED|Overall Study||0
5112635|NCT01539980|12578405|P1|COMPLETED|Overall Study||30
5112636|NCT01539980|12578405|P1|STARTED|Overall Study||30
5112637|NCT01539837|12578416|P3|NOT COMPLETED|Overall Study||2
5112638|NCT01539837|12578417|P2|NOT COMPLETED|Overall Study||1
5112639|NCT01539837|12578418|P1|NOT COMPLETED|Overall Study||0
5112640|NCT01539837|12578416|P3|COMPLETED|Overall Study||5
5112641|NCT01539837|12578417|P2|COMPLETED|Overall Study||6
5112642|NCT01539837|12578418|P1|COMPLETED|Overall Study||8
5112643|NCT01539837|12578416|P3|STARTED|Overall Study||7
5112644|NCT01539837|12578417|P2|STARTED|Overall Study||7
5112645|NCT01539837|12578418|P1|STARTED|Overall Study||8
5112646|NCT01539811|12578431|P2|NOT COMPLETED|Overall Study||0
5112647|NCT01539811|12578432|P1|NOT COMPLETED|Overall Study||0
5112648|NCT01539811|12578431|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
5112649|NCT01539811|12578432|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
5112650|NCT01539811|12578431|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
5112651|NCT01539811|12578432|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
5112652|NCT01539759|12578440|P2|NOT COMPLETED|Overall Study||8
5112653|NCT01539759|12578441|P1|NOT COMPLETED|Overall Study||6
5112654|NCT01539759|12578440|P2|COMPLETED|Overall Study||48
5112655|NCT01539759|12578441|P1|COMPLETED|Overall Study||50
5112656|NCT01539759|12578440|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
5112657|NCT01539759|12578441|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
5112658|NCT01539759|12578440|P2|IUD Removal|Overall Study||7
5112659|NCT01539759|12578441|P1|IUD Removal|Overall Study||2
5112660|NCT01539759|12578440|P2|IUD Expulsion|Overall Study||4
5112661|NCT01539759|12578441|P1|IUD Expulsion|Overall Study||1
5112662|NCT01539759|12578440|P2|Had Successful IUD Placement|Overall Study||53
5112663|NCT01539759|12578441|P1|Had Successful IUD Placement|Overall Study||34
5112664|NCT01539759|12578440|P2|STARTED|Overall Study||56
5112665|NCT01539759|12578441|P1|STARTED|Overall Study||56
5112666|NCT01539642|12578453|P2|NOT COMPLETED|Overall Study||31
5112667|NCT01539642|12578454|P1|NOT COMPLETED|Overall Study||36
5112668|NCT01539642|12578453|P2|COMPLETED|Overall Study||27
5112669|NCT01539642|12578454|P1|COMPLETED|Overall Study||78
5112670|NCT01539642|12578453|P2|STARTED|Overall Study||58
5112671|NCT01539642|12578454|P1|STARTED|Overall Study||114
5112672|NCT01539590|12578462|P2|NOT COMPLETED|Overall Study||0
5112673|NCT01539590|12578463|P1|NOT COMPLETED|Overall Study||3
5112674|NCT01539590|12578462|P2|COMPLETED|Overall Study||2
5112675|NCT01539590|12578463|P1|COMPLETED|Overall Study||0
5112676|NCT01539590|12578462|P2|Complete Study Treatment|Overall Study||2
5112677|NCT01539590|12578463|P1|Complete Study Treatment|Overall Study||1
5112678|NCT01539590|12578462|P2|STARTED|Overall Study||2
5112679|NCT01539590|12578463|P1|STARTED|Overall Study||3
5112680|NCT01539538|12578471|P2|NOT COMPLETED|Overall Study||44
5112681|NCT01539538|12578472|P1|NOT COMPLETED|Overall Study||31
5112682|NCT01539538|12578471|P2|COMPLETED|Overall Study||136
5112683|NCT01539538|12578472|P1|COMPLETED|Overall Study||146
5112684|NCT01539538|12578471|P2|STARTED|Overall Study||180
5112685|NCT01539538|12578472|P1|STARTED|Overall Study||177
5112686|NCT01539525|12578481|P3|NOT COMPLETED|Overall Study||17
5112687|NCT01539525|12578482|P2|NOT COMPLETED|Overall Study||16
5112688|NCT01539525|12578483|P1|NOT COMPLETED|Overall Study||20
5112689|NCT01539525|12578481|P3|COMPLETED|Overall Study||134
5112690|NCT01539525|12578482|P2|COMPLETED|Overall Study||127
5112691|NCT01539525|12578483|P1|COMPLETED|Overall Study||125
5112692|NCT01539525|12578481|P3|STARTED|Overall Study||151
5112693|NCT01539525|12578482|P2|STARTED|Overall Study||143
5112694|NCT01539525|12578483|P1|STARTED|Overall Study||145
5112695|NCT01539512|12578502|P2|NOT COMPLETED|Overall Study||13
5112696|NCT01539512|12578503|P1|NOT COMPLETED|Overall Study||23
5112697|NCT01539512|12578502|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
5112698|NCT01539512|12578503|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
5112699|NCT01539512|12578502|P2|STARTED|Overall Study||110
5112700|NCT01539512|12578503|P1|STARTED|Overall Study||110
5112701|NCT01539317|12578519|P2|NOT COMPLETED|Overall Study||0
5112702|NCT01539317|12578520|P1|NOT COMPLETED|Overall Study||1
5112703|NCT01539317|12578519|P2|COMPLETED|Overall Study||25
5112704|NCT01539317|12578520|P1|COMPLETED|Overall Study||24
5112705|NCT01539317|12578519|P2|STARTED|Overall Study||25
5112706|NCT01539317|12578520|P1|STARTED|Overall Study||25
5112707|NCT01539291|12578538|P4|NOT COMPLETED|Study GS-US-312-0117||26
5112708|NCT01539291|12578539|P3|NOT COMPLETED|Study GS-US-312-0117||22
5112709|NCT01539291|12578540|P2|NOT COMPLETED|Study GS-US-312-0117||2
5112710|NCT01539291|12578541|P1|NOT COMPLETED|Study GS-US-312-0117||41
5112711|NCT01539291|12578538|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
5112712|NCT01539291|12578539|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
5112713|NCT01539291|12578540|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
5112714|NCT01539291|12578541|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
5112715|NCT01539291|12578538|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
5112716|NCT01539291|12578539|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
5112717|NCT01539291|12578540|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
5112718|NCT01539291|12578541|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
5112719|NCT01539291|12578538|P4|NOT COMPLETED|Study GS-US-312-0116||0
5112720|NCT01539291|12578539|P3|NOT COMPLETED|Study GS-US-312-0116||0
5112721|NCT01539291|12578540|P2|NOT COMPLETED|Study GS-US-312-0116||0
5112722|NCT01539291|12578541|P1|NOT COMPLETED|Study GS-US-312-0116||25
5112723|NCT01539291|12578538|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
5112724|NCT01539291|12578539|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
5112725|NCT01539291|12578540|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
5112726|NCT01539291|12578541|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
5112727|NCT01539291|12578538|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
5112728|NCT01539291|12578539|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
5112729|NCT01539291|12578540|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
5112730|NCT01539291|12578541|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
5112731|NCT01539239|12578613|P2|NOT COMPLETED|Overall Study||17
5112732|NCT01539239|12578614|P1|NOT COMPLETED|Overall Study||12
5112733|NCT01539239|12578613|P2|COMPLETED|Overall Study||170
5112734|NCT01539239|12578614|P1|COMPLETED|Overall Study||357
5112735|NCT01539239|12578613|P2|STARTED|Overall Study||187
5112736|NCT01539239|12578614|P1|STARTED|Overall Study||369
5112737|NCT01539135|12578624|P2|NOT COMPLETED|Overall Study||0
5112738|NCT01539135|12578625|P1|NOT COMPLETED|Overall Study||0
5112739|NCT01539135|12578624|P2|COMPLETED|Overall Study||37
5112740|NCT01539135|12578625|P1|COMPLETED|Overall Study||43
5112741|NCT01539135|12578624|P2|STARTED|Overall Study||37
5112742|NCT01539135|12578625|P1|STARTED|Overall Study||43
5112743|NCT01539083|12578637|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
5112744|NCT01539083|12578638|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
5112745|NCT01539083|12578639|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
5112746|NCT01539083|12578637|P3|COMPLETED|After Randomization (TP and VTP)||80
5112747|NCT01539083|12578638|P2|COMPLETED|After Randomization (TP and VTP)||79
5112748|NCT01539083|12578639|P1|COMPLETED|After Randomization (TP and VTP)||0
5112749|NCT01539083|12578637|P3|Safety Population|After Randomization (TP and VTP)||103
5112750|NCT01539083|12578638|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
5112751|NCT01539083|12578639|P1|Safety Population|After Randomization (TP and VTP)||0
5112752|NCT01539083|12578637|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
5112753|NCT01539083|12578638|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
5112754|NCT01539083|12578639|P1|STARTED|After Randomization (TP and VTP)||0
5112755|NCT01539083|12578637|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
5112756|NCT01539083|12578638|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
5112757|NCT01539083|12578639|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
5112758|NCT01539083|12578637|P3|COMPLETED|Before Randomization (VCD Induction)||0
5112759|NCT01539083|12578638|P2|COMPLETED|Before Randomization (VCD Induction)||0
5112760|NCT01539083|12578639|P1|COMPLETED|Before Randomization (VCD Induction)||203
5112761|NCT01539083|12578637|P3|Treated|Before Randomization (VCD Induction)||0
5112762|NCT01539083|12578638|P2|Treated|Before Randomization (VCD Induction)||0
5112763|NCT01539083|12578639|P1|Treated|Before Randomization (VCD Induction)||254
5112764|NCT01539083|12578637|P3|STARTED|Before Randomization (VCD Induction)||0
5112765|NCT01539083|12578638|P2|STARTED|Before Randomization (VCD Induction)||0
5112766|NCT01539083|12578639|P1|STARTED|Before Randomization (VCD Induction)||256
5112767|NCT01539070|12578662|P2|NOT COMPLETED|Overall Study||39
5112768|NCT01539070|12578663|P1|NOT COMPLETED|Overall Study||59
5112769|NCT01539070|12578662|P2|COMPLETED|Overall Study||99
5112770|NCT01539070|12578663|P1|COMPLETED|Overall Study||109
5112771|NCT01539070|12578662|P2|STARTED|Overall Study||138
5112772|NCT01539070|12578663|P1|STARTED|Overall Study||168
5112773|NCT01538862|12578675|P1|NOT COMPLETED|Overall Study||0
5112774|NCT01538862|12578675|P1|COMPLETED|Overall Study||7
5112775|NCT01538862|12578675|P1|STARTED|Overall Study||7
5112776|NCT01538719|12578683|P2|NOT COMPLETED|Overall Study||0
5112777|NCT01538719|12578684|P1|NOT COMPLETED|Overall Study||2
5112778|NCT01538719|12578683|P2|COMPLETED|Overall Study||12
5112779|NCT01538719|12578684|P1|COMPLETED|Overall Study||5
5112780|NCT01538719|12578683|P2|STARTED|Overall Study||12
5112781|NCT01538719|12578684|P1|STARTED|Overall Study||7
5112782|NCT01538615|12578694|P2|NOT COMPLETED|Overall Study||12
5112783|NCT01538615|12578695|P1|NOT COMPLETED|Overall Study||22
5112784|NCT01538615|12578694|P2|COMPLETED|Overall Study||146
5112785|NCT01538615|12578695|P1|COMPLETED|Overall Study||140
5112786|NCT01538615|12578694|P2|STARTED|Overall Study||158
5112787|NCT01538615|12578695|P1|STARTED|Overall Study||162
5112788|NCT01538472|12578707|P1|NOT COMPLETED|Overall Study||4
5112789|NCT01538472|12578707|P1|COMPLETED|Overall Study||36
5112790|NCT01538472|12578707|P1|STARTED|Overall Study||40
5112791|NCT01538199|12578718|P4|NOT COMPLETED|Overall Study||2
5112792|NCT01538199|12578719|P3|NOT COMPLETED|Overall Study||1
5112793|NCT01538199|12578720|P2|NOT COMPLETED|Overall Study||3
5112794|NCT01538199|12578721|P1|NOT COMPLETED|Overall Study||2
5112795|NCT01538199|12578718|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
5112796|NCT01538199|12578719|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
5112797|NCT01538199|12578720|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
5112798|NCT01538199|12578721|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
5112799|NCT01538199|12578718|P4|STARTED|Overall Study||3
5112800|NCT01538199|12578719|P3|STARTED|Overall Study||4
5112801|NCT01538199|12578720|P2|STARTED|Overall Study||11
5112802|NCT01538199|12578721|P1|STARTED|Overall Study||10
5112803|NCT01537900|12578744|P1|NOT COMPLETED|Overall Study||0
5112804|NCT01537900|12578744|P1|COMPLETED|Overall Study||4
5112805|NCT01537900|12578744|P1|STARTED|Overall Study||4
5112806|NCT01537887|12578755|P6|NOT COMPLETED|Period 3||0
5112807|NCT01537887|12578756|P5|NOT COMPLETED|Period 3||0
5112808|NCT01537887|12578757|P4|NOT COMPLETED|Period 3||0
5112809|NCT01537887|12578758|P3|NOT COMPLETED|Period 3||1
5112810|NCT01537887|12578759|P2|NOT COMPLETED|Period 3||1
5112811|NCT01537887|12578760|P1|NOT COMPLETED|Period 3||0
5112812|NCT01537887|12578755|P6|COMPLETED|Period 3||11
5112813|NCT01537887|12578756|P5|COMPLETED|Period 3||11
5112814|NCT01537887|12578757|P4|COMPLETED|Period 3||12
5112815|NCT01537887|12578758|P3|COMPLETED|Period 3||10
5112816|NCT01537887|12578759|P2|COMPLETED|Period 3||10
5112817|NCT01537887|12578760|P1|COMPLETED|Period 3||12
5112818|NCT01537887|12578755|P6|STARTED|Period 3||11
5112819|NCT01537887|12578756|P5|STARTED|Period 3||11
5112820|NCT01537887|12578757|P4|STARTED|Period 3||12
5112821|NCT01537887|12578758|P3|STARTED|Period 3||11
5112822|NCT01537887|12578759|P2|STARTED|Period 3||11
5112823|NCT01537887|12578760|P1|STARTED|Period 3||12
5112824|NCT01537887|12578755|P6|NOT COMPLETED|Period 2||0
5112825|NCT01537887|12578756|P5|NOT COMPLETED|Period 2||0
5112826|NCT01537887|12578757|P4|NOT COMPLETED|Period 2||0
5112827|NCT01537887|12578758|P3|NOT COMPLETED|Period 2||0
5112828|NCT01537887|12578759|P2|NOT COMPLETED|Period 2||1
5112829|NCT01537887|12578760|P1|NOT COMPLETED|Period 2||0
5112830|NCT01537887|12578755|P6|COMPLETED|Period 2||11
5112831|NCT01537887|12578756|P5|COMPLETED|Period 2||11
5112832|NCT01537887|12578757|P4|COMPLETED|Period 2||12
5112833|NCT01537887|12578758|P3|COMPLETED|Period 2||11
5112834|NCT01537887|12578759|P2|COMPLETED|Period 2||11
5112835|NCT01537887|12578760|P1|COMPLETED|Period 2||12
5112836|NCT01537887|12578755|P6|STARTED|Period 2||11
5112837|NCT01537887|12578756|P5|STARTED|Period 2||11
5112838|NCT01537887|12578757|P4|STARTED|Period 2||12
5112839|NCT01537887|12578758|P3|STARTED|Period 2||11
5112840|NCT01537887|12578759|P2|STARTED|Period 2||12
5112841|NCT01537887|12578760|P1|STARTED|Period 2||12
5112842|NCT01537887|12578755|P6|NOT COMPLETED|Period 1||1
5112843|NCT01537887|12578756|P5|NOT COMPLETED|Period 1||1
5112844|NCT01537887|12578757|P4|NOT COMPLETED|Period 1||0
5112845|NCT01537887|12578758|P3|NOT COMPLETED|Period 1||1
5112846|NCT01537887|12578759|P2|NOT COMPLETED|Period 1||0
5112847|NCT01537887|12578760|P1|NOT COMPLETED|Period 1||0
5112848|NCT01537887|12578755|P6|COMPLETED|Period 1||11
5112849|NCT01537887|12578756|P5|COMPLETED|Period 1||11
5112850|NCT01537887|12578757|P4|COMPLETED|Period 1||12
5112851|NCT01537887|12578758|P3|COMPLETED|Period 1||11
5112852|NCT01537887|12578759|P2|COMPLETED|Period 1||12
5112853|NCT01537887|12578760|P1|COMPLETED|Period 1||12
5112854|NCT01537887|12578755|P6|Received at Least 1 Dose of Study Drug|Period 1||12
5112855|NCT01537887|12578756|P5|Received at Least 1 Dose of Study Drug|Period 1||12
5112856|NCT01537887|12578757|P4|Received at Least 1 Dose of Study Drug|Period 1||12
5112857|NCT01537887|12578758|P3|Received at Least 1 Dose of Study Drug|Period 1||11
5112858|NCT01537887|12578759|P2|Received at Least 1 Dose of Study Drug|Period 1||12
5112859|NCT01537887|12578760|P1|Received at Least 1 Dose of Study Drug|Period 1||12
5112860|NCT01537887|12578755|P6|STARTED|Period 1||12
5112861|NCT01537887|12578756|P5|STARTED|Period 1||12
5112862|NCT01537887|12578757|P4|STARTED|Period 1||12
5112863|NCT01537887|12578758|P3|STARTED|Period 1||12
5112864|NCT01537887|12578759|P2|STARTED|Period 1||12
5112865|NCT01537887|12578760|P1|STARTED|Period 1||12
5112866|NCT01537835|12578774|P3|NOT COMPLETED|Overall Study||0
5112867|NCT01537835|12578775|P2|NOT COMPLETED|Overall Study||0
5112868|NCT01537835|12578776|P1|NOT COMPLETED|Overall Study||0
5112869|NCT01537835|12578774|P3|COMPLETED|Overall Study||35
5112870|NCT01537835|12578775|P2|COMPLETED|Overall Study||37
5112871|NCT01537835|12578776|P1|COMPLETED|Overall Study||37
5112872|NCT01537835|12578774|P3|STARTED|Overall Study||35
5112873|NCT01537835|12578775|P2|STARTED|Overall Study||37
5112874|NCT01537835|12578776|P1|STARTED|Overall Study||37
5112875|NCT01537783|12578789|P2|NOT COMPLETED|Overall Study||2
5112876|NCT01537783|12578790|P1|NOT COMPLETED|Overall Study||11
5112877|NCT01537783|12578789|P2|COMPLETED|Overall Study||23
5112878|NCT01537783|12578790|P1|COMPLETED|Overall Study||14
5112879|NCT01537783|12578789|P2|STARTED|Overall Study||25
5112880|NCT01537783|12578790|P1|STARTED|Overall Study||25
5112881|NCT01537666|12578800|P4|NOT COMPLETED|Overall Study||0
5112882|NCT01537666|12578801|P3|NOT COMPLETED|Overall Study||0
5112883|NCT01537666|12578802|P2|NOT COMPLETED|Overall Study||0
5112884|NCT01537666|12578803|P1|NOT COMPLETED|Overall Study||0
5112885|NCT01537666|12578800|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
5112886|NCT01537666|12578801|P3|COMPLETED|Overall Study||6
5112887|NCT01537666|12578802|P2|COMPLETED|Overall Study||6
5112888|NCT01537666|12578803|P1|COMPLETED|Overall Study||6
5112889|NCT01537666|12578800|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
5112890|NCT01537666|12578801|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
5112891|NCT01537666|12578802|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
5112892|NCT01537666|12578803|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
5112893|NCT01537549|12578841|P1|NOT COMPLETED|Overall Study||3
5112894|NCT01537549|12578841|P1|COMPLETED|Overall Study||8
5112895|NCT01537549|12578841|P1|STARTED|Overall Study||11
5112896|NCT01537432|12578849|P2|NOT COMPLETED|Overall Study||2
5112897|NCT01537432|12578850|P1|NOT COMPLETED|Overall Study||6
5112898|NCT01537432|12578849|P2|COMPLETED|Overall Study||10
5112899|NCT01537432|12578850|P1|COMPLETED|Overall Study||18
5112900|NCT01537432|12578849|P2|STARTED|Overall Study||12
5112901|NCT01537432|12578850|P1|STARTED|Overall Study||24
5112902|NCT01537419|12578860|P2|NOT COMPLETED|Overall Study||12
5112903|NCT01537419|12578861|P1|NOT COMPLETED|Overall Study||11
5112904|NCT01537419|12578860|P2|COMPLETED|Overall Study||54
5112905|NCT01537419|12578861|P1|COMPLETED|Overall Study||52
5112906|NCT01537419|12578860|P2|STARTED|Overall Study||66
5112907|NCT01537419|12578861|P1|STARTED|Overall Study||63
5112908|NCT01537393|12578873|P2|NOT COMPLETED|Overall Study||191
5112909|NCT01537393|12578874|P1|NOT COMPLETED|Overall Study||154
5112910|NCT01537393|12578873|P2|COMPLETED|Overall Study||507
5112911|NCT01537393|12578874|P1|COMPLETED|Overall Study||553
5112912|NCT01537393|12578873|P2|STARTED|Overall Study||698
5112913|NCT01537393|12578874|P1|STARTED|Overall Study||707
5112914|NCT01537367|12578885|P3|NOT COMPLETED|Overall Study||0
5112915|NCT01537367|12578886|P2|NOT COMPLETED|Overall Study||0
5112916|NCT01537367|12578887|P1|NOT COMPLETED|Overall Study||0
5112917|NCT01537367|12578885|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
5112918|NCT01537367|12578886|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
5112919|NCT01537367|12578887|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
5112920|NCT01537367|12578885|P3|STARTED|Overall Study||613
5112921|NCT01537367|12578886|P2|STARTED|Overall Study||610
5112922|NCT01537367|12578887|P1|STARTED|Overall Study||615
5112923|NCT01537315|12578903|P2|NOT COMPLETED|Overall Study||0
5112924|NCT01537315|12578904|P1|NOT COMPLETED|Overall Study||0
5112925|NCT01537315|12578903|P2|COMPLETED|Overall Study||7
5112926|NCT01537315|12578904|P1|COMPLETED|Overall Study||1
5112927|NCT01537315|12578903|P2|STARTED|Overall Study||7
5112928|NCT01537315|12578904|P1|STARTED|Overall Study||1
5112929|NCT01537302|12578910|P1|NOT COMPLETED|Overall Study||2
5112930|NCT01537302|12578910|P1|COMPLETED|Overall Study||199
5112931|NCT01537302|12578910|P1|STARTED|Overall Study||201
5112932|NCT01537211|12578919|P2|NOT COMPLETED|Overall Study||1
5112933|NCT01537211|12578920|P1|NOT COMPLETED|Overall Study||0
5112934|NCT01537211|12578919|P2|COMPLETED|Overall Study||5
5112935|NCT01537211|12578920|P1|COMPLETED|Overall Study||4
5112936|NCT01537211|12578919|P2|STARTED|Overall Study||6
5112937|NCT01537211|12578920|P1|STARTED|Overall Study||4
5112938|NCT01537198|12578954|P1|NOT COMPLETED|Overall Study||154
5112939|NCT01537198|12578954|P1|COMPLETED|Overall Study||463
5112940|NCT01537198|12578954|P1|STARTED|Overall Study||617
5112941|NCT01537185|12578962|P4|NOT COMPLETED|Overall Study||2
5112942|NCT01537185|12578963|P3|NOT COMPLETED|Overall Study||6
5112943|NCT01537185|12578964|P2|NOT COMPLETED|Overall Study||6
5112944|NCT01537185|12578965|P1|NOT COMPLETED|Overall Study||3
5112945|NCT01537185|12578962|P4|COMPLETED|Overall Study||8
5112946|NCT01537185|12578963|P3|COMPLETED|Overall Study||4
5112947|NCT01537185|12578964|P2|COMPLETED|Overall Study||6
5112948|NCT01537185|12578965|P1|COMPLETED|Overall Study||7
5112949|NCT01537185|12578962|P4|STARTED|Overall Study||10
5112950|NCT01537185|12578963|P3|STARTED|Overall Study||10
5112951|NCT01537185|12578964|P2|STARTED|Overall Study||12
5112952|NCT01537185|12578965|P1|STARTED|Overall Study||10
5112953|NCT01537133|12578983|P4|NOT COMPLETED|Overall Study||0
5112954|NCT01537133|12578984|P3|NOT COMPLETED|Overall Study||0
5112955|NCT01537133|12578985|P2|NOT COMPLETED|Overall Study||0
5112956|NCT01537133|12578986|P1|NOT COMPLETED|Overall Study||3
5112957|NCT01537133|12578983|P4|COMPLETED|Overall Study||21
5112958|NCT01537133|12578984|P3|COMPLETED|Overall Study||21
5112959|NCT01537133|12578985|P2|COMPLETED|Overall Study||14
5112960|NCT01537133|12578986|P1|COMPLETED|Overall Study||25
5112961|NCT01537133|12578983|P4|STARTED|Overall Study||21
5112962|NCT01537133|12578984|P3|STARTED|Overall Study||21
5112963|NCT01537133|12578985|P2|STARTED|Overall Study||14
5112964|NCT01537133|12578986|P1|STARTED|Overall Study||28
5112965|NCT01537120|12579002|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
5112966|NCT01537120|12579002|P1|COMPLETED|12 Weeks Vildagliptin||23
5112967|NCT01537120|12579002|P1|STARTED|12 Weeks Vildagliptin||23
5112968|NCT01537120|12579002|P1|NOT COMPLETED|3 Weeks Placebo||1
5112969|NCT01537120|12579002|P1|COMPLETED|3 Weeks Placebo||23
5112970|NCT01537120|12579002|P1|STARTED|3 Weeks Placebo||24
5112971|NCT01537120|12579002|P1|NOT COMPLETED|8 Weeks Washout||1
5112972|NCT01537120|12579002|P1|COMPLETED|8 Weeks Washout||24
5112973|NCT01537120|12579002|P1|STARTED|8 Weeks Washout||25
5112974|NCT01537120|12579002|P1|NOT COMPLETED|Enrolled||0
5112975|NCT01537120|12579002|P1|COMPLETED|Enrolled||25
5112976|NCT01537120|12579002|P1|STARTED|Enrolled||25
5112977|NCT01537081|12579015|P3|NOT COMPLETED|Overall Study||16
5112978|NCT01537081|12579016|P2|NOT COMPLETED|Overall Study||38
5112979|NCT01537081|12579017|P1|NOT COMPLETED|Overall Study||39
5112980|NCT01537081|12579015|P3|COMPLETED|Overall Study||547
5112981|NCT01537081|12579016|P2|COMPLETED|Overall Study||1086
5112982|NCT01537081|12579017|P1|COMPLETED|Overall Study||1084
5112983|NCT01537081|12579015|P3|Modified Intent to Treat Population|Overall Study||556
5112984|NCT01537081|12579016|P2|Modified Intent to Treat Population|Overall Study||1109
5112985|NCT01537081|12579017|P1|Modified Intent to Treat Population|Overall Study||1106
5112986|NCT01537081|12579015|P3|Safety Population|Overall Study||561
5112987|NCT01537081|12579016|P2|Safety Population|Overall Study||1122
5112988|NCT01537081|12579017|P1|Safety Population|Overall Study||1122
5112989|NCT01537081|12579015|P3|STARTED|Overall Study||563
5112990|NCT01537081|12579016|P2|STARTED|Overall Study||1124
5112991|NCT01537081|12579017|P1|STARTED|Overall Study||1123
5112992|NCT01537068|12579030|P2|NOT COMPLETED|Overall Study||3
5112993|NCT01537068|12579031|P1|NOT COMPLETED|Overall Study||4
5112994|NCT01537068|12579030|P2|COMPLETED|Overall Study||26
5112995|NCT01537068|12579031|P1|COMPLETED|Overall Study||26
5112996|NCT01537068|12579030|P2|STARTED|Overall Study||29
5112997|NCT01537068|12579031|P1|STARTED|Overall Study||30
5112998|NCT01537042|12579043|P2|NOT COMPLETED|Overall Study||5
5112999|NCT01537042|12579044|P1|NOT COMPLETED|Overall Study||0
5113000|NCT01537042|12579043|P2|COMPLETED|Overall Study||15
5113001|NCT01537042|12579044|P1|COMPLETED|Overall Study||10
5113002|NCT01537042|12579043|P2|STARTED|Overall Study||20
5113003|NCT01537042|12579044|P1|STARTED|Overall Study||10
5113004|NCT01537029|12579080|P1|NOT COMPLETED|Overall Study||0
5113005|NCT01537029|12579080|P1|COMPLETED|Overall Study||15
5113006|NCT01537029|12579080|P1|STARTED|Overall Study||15
5113007|NCT01536951|12579086|P9|NOT COMPLETED|Third Intervention||0
5113008|NCT01536951|12579087|P8|NOT COMPLETED|Third Intervention||0
5113009|NCT01536951|12579088|P7|NOT COMPLETED|Third Intervention||0
5113010|NCT01536951|12579089|P6|NOT COMPLETED|Third Intervention||0
5113011|NCT01536951|12579090|P5|NOT COMPLETED|Third Intervention||0
5113012|NCT01536951|12579091|P4|NOT COMPLETED|Third Intervention||0
5113013|NCT01536951|12579092|P3|NOT COMPLETED|Third Intervention||0
5113014|NCT01536951|12579093|P2|NOT COMPLETED|Third Intervention||0
5113015|NCT01536951|12579094|P1|NOT COMPLETED|Third Intervention||0
5113016|NCT01536951|12579086|P9|COMPLETED|Third Intervention||9
5113017|NCT01536951|12579087|P8|COMPLETED|Third Intervention||8
5113018|NCT01536951|12579088|P7|COMPLETED|Third Intervention||9
5113019|NCT01536951|12579089|P6|COMPLETED|Third Intervention||9
5113020|NCT01536951|12579090|P5|COMPLETED|Third Intervention||9
5113021|NCT01536951|12579091|P4|COMPLETED|Third Intervention||8
5113022|NCT01536951|12579092|P3|COMPLETED|Third Intervention||2
5113023|NCT01536951|12579093|P2|COMPLETED|Third Intervention||3
5113024|NCT01536951|12579094|P1|COMPLETED|Third Intervention||3
5113025|NCT01536951|12579086|P9|STARTED|Third Intervention||9
5113026|NCT01536951|12579087|P8|STARTED|Third Intervention||8
5113027|NCT01536951|12579088|P7|STARTED|Third Intervention||9
5113028|NCT01536951|12579089|P6|STARTED|Third Intervention||9
5113029|NCT01536951|12579090|P5|STARTED|Third Intervention||9
5113030|NCT01536951|12579091|P4|STARTED|Third Intervention||8
5113031|NCT01536951|12579092|P3|STARTED|Third Intervention||2
5113032|NCT01536951|12579093|P2|STARTED|Third Intervention||3
5113033|NCT01536951|12579094|P1|STARTED|Third Intervention||3
5113034|NCT01536951|12579086|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113035|NCT01536951|12579087|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
5113036|NCT01536951|12579088|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113037|NCT01536951|12579089|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113038|NCT01536951|12579090|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113039|NCT01536951|12579091|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113040|NCT01536951|12579092|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113041|NCT01536951|12579093|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113042|NCT01536951|12579094|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
5113043|NCT01536951|12579086|P9|COMPLETED|Second Intervention and Washout Period 2||9
5113044|NCT01536951|12579087|P8|COMPLETED|Second Intervention and Washout Period 2||8
5113045|NCT01536951|12579088|P7|COMPLETED|Second Intervention and Washout Period 2||9
5113046|NCT01536951|12579089|P6|COMPLETED|Second Intervention and Washout Period 2||9
5113047|NCT01536951|12579090|P5|COMPLETED|Second Intervention and Washout Period 2||9
5113048|NCT01536951|12579091|P4|COMPLETED|Second Intervention and Washout Period 2||8
5113049|NCT01536951|12579092|P3|COMPLETED|Second Intervention and Washout Period 2||2
5113050|NCT01536951|12579093|P2|COMPLETED|Second Intervention and Washout Period 2||3
5113051|NCT01536951|12579094|P1|COMPLETED|Second Intervention and Washout Period 2||3
5113052|NCT01536951|12579086|P9|STARTED|Second Intervention and Washout Period 2||9
5113053|NCT01536951|12579087|P8|STARTED|Second Intervention and Washout Period 2||9
5113054|NCT01536951|12579088|P7|STARTED|Second Intervention and Washout Period 2||9
5113055|NCT01536951|12579089|P6|STARTED|Second Intervention and Washout Period 2||9
5113056|NCT01536951|12579090|P5|STARTED|Second Intervention and Washout Period 2||9
5113057|NCT01536951|12579091|P4|STARTED|Second Intervention and Washout Period 2||8
5113058|NCT01536951|12579092|P3|STARTED|Second Intervention and Washout Period 2||2
5113059|NCT01536951|12579093|P2|STARTED|Second Intervention and Washout Period 2||3
5113060|NCT01536951|12579094|P1|STARTED|Second Intervention and Washout Period 2||3
5113061|NCT01536951|12579086|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
5113062|NCT01536951|12579087|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
5113063|NCT01536951|12579088|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
5113064|NCT01536951|12579089|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
5113065|NCT01536951|12579090|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
5113066|NCT01536951|12579091|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
5113067|NCT01536951|12579092|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
5113068|NCT01536951|12579093|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
5113069|NCT01536951|12579094|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
5113070|NCT01536951|12579086|P9|COMPLETED|First Intervention and Washout Period 1||9
5113071|NCT01536951|12579087|P8|COMPLETED|First Intervention and Washout Period 1||9
5113072|NCT01536951|12579088|P7|COMPLETED|First Intervention and Washout Period 1||9
5113073|NCT01536951|12579089|P6|COMPLETED|First Intervention and Washout Period 1||9
5113074|NCT01536951|12579090|P5|COMPLETED|First Intervention and Washout Period 1||9
5113075|NCT01536951|12579091|P4|COMPLETED|First Intervention and Washout Period 1||8
5113076|NCT01536951|12579092|P3|COMPLETED|First Intervention and Washout Period 1||2
5113077|NCT01536951|12579093|P2|COMPLETED|First Intervention and Washout Period 1||3
5113078|NCT01536951|12579094|P1|COMPLETED|First Intervention and Washout Period 1||3
5113079|NCT01536951|12579086|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
5113080|NCT01536951|12579087|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
5113081|NCT01536951|12579088|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
5113082|NCT01536951|12579089|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
5113083|NCT01536951|12579090|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
5113084|NCT01536951|12579091|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
5113085|NCT01536951|12579092|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
5113086|NCT01536951|12579093|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
5113087|NCT01536951|12579094|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
5113088|NCT01536951|12579086|P9|STARTED|First Intervention and Washout Period 1||9
5113089|NCT01536951|12579087|P8|STARTED|First Intervention and Washout Period 1||9
5113090|NCT01536951|12579088|P7|STARTED|First Intervention and Washout Period 1||9
5113091|NCT01536951|12579089|P6|STARTED|First Intervention and Washout Period 1||9
5113092|NCT01536951|12579090|P5|STARTED|First Intervention and Washout Period 1||9
5113093|NCT01536951|12579091|P4|STARTED|First Intervention and Washout Period 1||8
5113094|NCT01536951|12579092|P3|STARTED|First Intervention and Washout Period 1||3
5113095|NCT01536951|12579093|P2|STARTED|First Intervention and Washout Period 1||3
5113096|NCT01536951|12579094|P1|STARTED|First Intervention and Washout Period 1||3
5113097|NCT01536938|12579124|P3|NOT COMPLETED|Overall Study||8
5113098|NCT01536938|12579125|P2|NOT COMPLETED|Overall Study||7
5113099|NCT01536938|12579126|P1|NOT COMPLETED|Overall Study||6
5113100|NCT01536938|12579124|P3|COMPLETED|Overall Study||93
5113101|NCT01536938|12579125|P2|COMPLETED|Overall Study||94
5113102|NCT01536938|12579126|P1|COMPLETED|Overall Study||94
5113103|NCT01536938|12579124|P3|STARTED|Overall Study||101
5113104|NCT01536938|12579125|P2|STARTED|Overall Study||101
5113105|NCT01536938|12579126|P1|STARTED|Overall Study||100
5113106|NCT01536886|12579138|P4|NOT COMPLETED|Overall Study||3
5113107|NCT01536886|12579139|P3|NOT COMPLETED|Overall Study||2
5113108|NCT01536886|12579140|P2|NOT COMPLETED|Overall Study||8
5113109|NCT01536886|12579141|P1|NOT COMPLETED|Overall Study||5
5113110|NCT01536886|12579138|P4|COMPLETED|Overall Study||48
5113111|NCT01536886|12579139|P3|COMPLETED|Overall Study||47
5113112|NCT01536886|12579140|P2|COMPLETED|Overall Study||127
5113113|NCT01536886|12579141|P1|COMPLETED|Overall Study||136
5113114|NCT01536886|12579138|P4|STARTED|Overall Study||51
5113115|NCT01536886|12579139|P3|STARTED|Overall Study||49
5113116|NCT01536886|12579140|P2|STARTED|Overall Study||135
5113117|NCT01536886|12579141|P1|STARTED|Overall Study||141
5113118|NCT01536860|12579151|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5113119|NCT01536860|12579152|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5113120|NCT01536860|12579153|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5113121|NCT01536860|12579151|P3|COMPLETED|Third Intervention (1 Day)||4
5113122|NCT01536860|12579152|P2|COMPLETED|Third Intervention (1 Day)||4
5113123|NCT01536860|12579153|P1|COMPLETED|Third Intervention (1 Day)||3
5113124|NCT01536860|12579151|P3|STARTED|Third Intervention (1 Day)||4
5113125|NCT01536860|12579152|P2|STARTED|Third Intervention (1 Day)||4
5113126|NCT01536860|12579153|P1|STARTED|Third Intervention (1 Day)||3
5113127|NCT01536860|12579151|P3|NOT COMPLETED|Washout Period (3 Days)||0
5113128|NCT01536860|12579152|P2|NOT COMPLETED|Washout Period (3 Days)||0
5113129|NCT01536860|12579153|P1|NOT COMPLETED|Washout Period (3 Days)||1
5113130|NCT01536860|12579151|P3|COMPLETED|Washout Period (3 Days)||4
5113131|NCT01536860|12579152|P2|COMPLETED|Washout Period (3 Days)||4
5113132|NCT01536860|12579153|P1|COMPLETED|Washout Period (3 Days)||3
5113133|NCT01536860|12579151|P3|STARTED|Washout Period (3 Days)||4
5113134|NCT01536860|12579152|P2|STARTED|Washout Period (3 Days)||4
5113135|NCT01536860|12579153|P1|STARTED|Washout Period (3 Days)||4
5113136|NCT01536860|12579151|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5113137|NCT01536860|12579152|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5113138|NCT01536860|12579153|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5113139|NCT01536860|12579151|P3|COMPLETED|Second Intervention (1 Day)||4
5113140|NCT01536860|12579152|P2|COMPLETED|Second Intervention (1 Day)||4
5113141|NCT01536860|12579153|P1|COMPLETED|Second Intervention (1 Day)||4
5113142|NCT01536860|12579151|P3|STARTED|Second Intervention (1 Day)||4
5113143|NCT01536860|12579152|P2|STARTED|Second Intervention (1 Day)||4
5113144|NCT01536860|12579153|P1|STARTED|Second Intervention (1 Day)||4
5113145|NCT01536860|12579151|P3|NOT COMPLETED|Washout Period (3 Days)||0
5113146|NCT01536860|12579152|P2|NOT COMPLETED|Washout Period (3 Days)||0
5113147|NCT01536860|12579153|P1|NOT COMPLETED|Washout Period (3 Days)||0
5113148|NCT01536860|12579151|P3|COMPLETED|Washout Period (3 Days)||4
5113149|NCT01536860|12579152|P2|COMPLETED|Washout Period (3 Days)||4
5113150|NCT01536860|12579153|P1|COMPLETED|Washout Period (3 Days)||4
5113151|NCT01536860|12579151|P3|STARTED|Washout Period (3 Days)||4
5113152|NCT01536860|12579152|P2|STARTED|Washout Period (3 Days)||4
5113153|NCT01536860|12579153|P1|STARTED|Washout Period (3 Days)||4
5113154|NCT01536860|12579151|P3|NOT COMPLETED|First Intervention (1 Day)||0
5113155|NCT01536860|12579152|P2|NOT COMPLETED|First Intervention (1 Day)||0
5113156|NCT01536860|12579153|P1|NOT COMPLETED|First Intervention (1 Day)||0
5113157|NCT01536860|12579151|P3|COMPLETED|First Intervention (1 Day)||4
5113158|NCT01536860|12579152|P2|COMPLETED|First Intervention (1 Day)||4
5113159|NCT01536860|12579153|P1|COMPLETED|First Intervention (1 Day)||4
5113160|NCT01536860|12579151|P3|STARTED|First Intervention (1 Day)||4
5113161|NCT01536860|12579152|P2|STARTED|First Intervention (1 Day)||4
5113162|NCT01536860|12579153|P1|STARTED|First Intervention (1 Day)||4
5113163|NCT01536704|12579161|P4|NOT COMPLETED|Period 4||0
5113164|NCT01536704|12579162|P3|NOT COMPLETED|Period 4||0
5113165|NCT01536704|12579163|P2|NOT COMPLETED|Period 4||0
5113166|NCT01536704|12579164|P1|NOT COMPLETED|Period 4||0
5113167|NCT01536704|12579161|P4|COMPLETED|Period 4||10
5113168|NCT01536704|12579162|P3|COMPLETED|Period 4||10
5113169|NCT01536704|12579163|P2|COMPLETED|Period 4||11
5113170|NCT01536704|12579164|P1|COMPLETED|Period 4||12
5113171|NCT01536704|12579161|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
5113172|NCT01536704|12579162|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
5113173|NCT01536704|12579163|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
5113174|NCT01536704|12579164|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
5113175|NCT01536704|12579161|P4|NOT COMPLETED|Washout Period 3||0
5113176|NCT01536704|12579162|P3|NOT COMPLETED|Washout Period 3||1
5113177|NCT01536704|12579163|P2|NOT COMPLETED|Washout Period 3||0
5113178|NCT01536704|12579164|P1|NOT COMPLETED|Washout Period 3||0
5113179|NCT01536704|12579161|P4|COMPLETED|Washout Period 3||10
5113180|NCT01536704|12579162|P3|COMPLETED|Washout Period 3||11
5113181|NCT01536704|12579163|P2|COMPLETED|Washout Period 3||12
5113182|NCT01536704|12579164|P1|COMPLETED|Washout Period 3||10
5113183|NCT01536704|12579161|P4|STARTED|Washout Period 3||10
5113184|NCT01536704|12579162|P3|STARTED|Washout Period 3||12
5113185|NCT01536704|12579163|P2|STARTED|Washout Period 3||12
5113186|NCT01536704|12579164|P1|STARTED|Washout Period 3||10
5113187|NCT01536704|12579161|P4|NOT COMPLETED|Period 3||1
5113188|NCT01536704|12579162|P3|NOT COMPLETED|Period 3||0
5113189|NCT01536704|12579163|P2|NOT COMPLETED|Period 3||0
5113190|NCT01536704|12579164|P1|NOT COMPLETED|Period 3||0
5113191|NCT01536704|12579161|P4|COMPLETED|Period 3||10
5113192|NCT01536704|12579162|P3|COMPLETED|Period 3||12
5113193|NCT01536704|12579163|P2|COMPLETED|Period 3||12
5113194|NCT01536704|12579164|P1|COMPLETED|Period 3||10
5113195|NCT01536704|12579161|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
5113196|NCT01536704|12579162|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
5113197|NCT01536704|12579163|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
5113198|NCT01536704|12579164|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
5113199|NCT01536704|12579161|P4|NOT COMPLETED|Washout Period 2||1
5113200|NCT01536704|12579162|P3|NOT COMPLETED|Washout Period 2||0
5113201|NCT01536704|12579163|P2|NOT COMPLETED|Washout Period 2||0
5113202|NCT01536704|12579164|P1|NOT COMPLETED|Washout Period 2||1
5113203|NCT01536704|12579161|P4|COMPLETED|Washout Period 2||12
5113204|NCT01536704|12579162|P3|COMPLETED|Washout Period 2||10
5113205|NCT01536704|12579163|P2|COMPLETED|Washout Period 2||11
5113206|NCT01536704|12579164|P1|COMPLETED|Washout Period 2||12
5113207|NCT01536704|12579161|P4|STARTED|Washout Period 2||13
5113208|NCT01536704|12579162|P3|STARTED|Washout Period 2||10
5113209|NCT01536704|12579163|P2|STARTED|Washout Period 2||11
5113210|NCT01536704|12579164|P1|STARTED|Washout Period 2||13
5113211|NCT01536704|12579161|P4|NOT COMPLETED|Period 2||0
5113212|NCT01536704|12579162|P3|NOT COMPLETED|Period 2||0
5113213|NCT01536704|12579163|P2|NOT COMPLETED|Period 2||0
5113214|NCT01536704|12579164|P1|NOT COMPLETED|Period 2||0
5113215|NCT01536704|12579161|P4|COMPLETED|Period 2||13
5113216|NCT01536704|12579162|P3|COMPLETED|Period 2||10
5113217|NCT01536704|12579163|P2|COMPLETED|Period 2||11
5113218|NCT01536704|12579164|P1|COMPLETED|Period 2||13
5113219|NCT01536704|12579161|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
5113220|NCT01536704|12579162|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
5113221|NCT01536704|12579163|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
5113222|NCT01536704|12579164|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
5113223|NCT01536704|12579161|P4|NOT COMPLETED|Washout Period 1||0
5113224|NCT01536704|12579162|P3|NOT COMPLETED|Washout Period 1||0
5113225|NCT01536704|12579163|P2|NOT COMPLETED|Washout Period 1||2
5113226|NCT01536704|12579164|P1|NOT COMPLETED|Washout Period 1||1
5113227|NCT01536704|12579161|P4|COMPLETED|Washout Period 1||13
5113228|NCT01536704|12579162|P3|COMPLETED|Washout Period 1||13
5113229|NCT01536704|12579163|P2|COMPLETED|Washout Period 1||10
5113230|NCT01536704|12579164|P1|COMPLETED|Washout Period 1||11
5113231|NCT01536704|12579161|P4|STARTED|Washout Period 1||13
5113232|NCT01536704|12579162|P3|STARTED|Washout Period 1||13
5113233|NCT01536704|12579163|P2|STARTED|Washout Period 1||12
5113234|NCT01536704|12579164|P1|STARTED|Washout Period 1||12
5113235|NCT01536704|12579161|P4|NOT COMPLETED|Period 1||0
5113236|NCT01536704|12579162|P3|NOT COMPLETED|Period 1||0
5113237|NCT01536704|12579163|P2|NOT COMPLETED|Period 1||0
5113238|NCT01536704|12579164|P1|NOT COMPLETED|Period 1||0
5113239|NCT01536704|12579161|P4|COMPLETED|Period 1||13
5113240|NCT01536704|12579162|P3|COMPLETED|Period 1||13
5113241|NCT01536704|12579163|P2|COMPLETED|Period 1||12
5113242|NCT01536704|12579164|P1|COMPLETED|Period 1||12
5113243|NCT01536704|12579161|P4|STARTED|Period 1||13
5113244|NCT01536704|12579162|P3|STARTED|Period 1||13
5113245|NCT01536704|12579163|P2|STARTED|Period 1||12
5113246|NCT01536704|12579164|P1|STARTED|Period 1||12
5113247|NCT01536587|12579194|P1|NOT COMPLETED|Overall Study||2
5113248|NCT01536587|12579194|P1|COMPLETED|Overall Study||30
5113249|NCT01536587|12579194|P1|STARTED|Overall Study||32
5113250|NCT01536574|12579233|P2|NOT COMPLETED|Overall Study||7
5113251|NCT01536574|12579234|P1|NOT COMPLETED|Overall Study||6
5113252|NCT01536574|12579233|P2|COMPLETED|Overall Study||126
5113253|NCT01536574|12579234|P1|COMPLETED|Overall Study||156
5113254|NCT01536574|12579233|P2|STARTED|Overall Study||133
5113255|NCT01536574|12579234|P1|STARTED|Overall Study||162
5113256|NCT01536561|12579252|P1|NOT COMPLETED|Long-Term Follow-Up||0
5113257|NCT01536561|12579252|P1|COMPLETED|Long-Term Follow-Up||13
5113258|NCT01536561|12579252|P1|STARTED|Long-Term Follow-Up||13
5113259|NCT01536561|12579252|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
5113260|NCT01536561|12579252|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
5113261|NCT01536561|12579252|P1|STARTED|Dosimetric and Therapeutic Treatment||59
5113262|NCT01536535|12579292|P2|NOT COMPLETED|Overall Study||13
5113263|NCT01536535|12579293|P1|NOT COMPLETED|Overall Study||15
5113264|NCT01536535|12579292|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
5113265|NCT01536535|12579293|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
5113266|NCT01536535|12579292|P2|STARTED|Overall Study||250
5113267|NCT01536535|12579293|P1|STARTED|Overall Study||178
5113268|NCT01536496|12579305|P2|NOT COMPLETED|Overall Study||1
5113269|NCT01536496|12579306|P1|NOT COMPLETED|Overall Study||2
5113270|NCT01536496|12579305|P2|COMPLETED|Overall Study||56
5113271|NCT01536496|12579306|P1|COMPLETED|Overall Study||55
5113272|NCT01536496|12579305|P2|STARTED|Overall Study||57
5113273|NCT01536496|12579306|P1|STARTED|Overall Study||57
5113274|NCT01536418|12579342|P2|NOT COMPLETED|Overall Study||66
5113275|NCT01536418|12579343|P1|NOT COMPLETED|Overall Study||69
5113276|NCT01536418|12579342|P2|COMPLETED|Overall Study||60
5113277|NCT01536418|12579343|P1|COMPLETED|Overall Study||58
5113278|NCT01536418|12579342|P2|STARTED|Overall Study||126
5113279|NCT01536418|12579343|P1|STARTED|Overall Study||127
5113280|NCT01536405|12579363|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
5113281|NCT01536405|12579364|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
5113282|NCT01536405|12579363|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
5113283|NCT01536405|12579364|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
5113284|NCT01536405|12579363|P2|STARTED|Visit 4 to Extended Study Follow-up||618
5113285|NCT01536405|12579364|P1|STARTED|Visit 4 to Extended Study Follow-up||615
5113286|NCT01536405|12579363|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
5113287|NCT01536405|12579364|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
5113288|NCT01536405|12579363|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
5113289|NCT01536405|12579364|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
5113290|NCT01536405|12579363|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
5113291|NCT01536405|12579364|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
5113292|NCT01536405|12579363|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
5113293|NCT01536405|12579364|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
5113294|NCT01536405|12579363|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
5113295|NCT01536405|12579364|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
5113296|NCT01536405|12579363|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
5113297|NCT01536405|12579364|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
5113298|NCT01536405|12579363|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
5113299|NCT01536405|12579364|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
5113300|NCT01536405|12579363|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
5113301|NCT01536405|12579364|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
5113302|NCT01536405|12579363|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
5113303|NCT01536405|12579364|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
5113304|NCT01536405|12579363|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
5113305|NCT01536405|12579364|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
5113306|NCT01536405|12579363|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
5113307|NCT01536405|12579364|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
5113308|NCT01536405|12579363|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
5113309|NCT01536405|12579364|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
5113310|NCT01536405|12579363|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
5113311|NCT01536405|12579364|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
5113312|NCT01536405|12579363|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
5113313|NCT01536405|12579364|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
5113314|NCT01536379|12579402|P2|NOT COMPLETED|Overall Study||3
5113315|NCT01536379|12579403|P1|NOT COMPLETED|Overall Study||2
5113316|NCT01536379|12579402|P2|COMPLETED|Overall Study||9
5113317|NCT01536379|12579403|P1|COMPLETED|Overall Study||11
5113318|NCT01536379|12579402|P2|STARTED|Overall Study||12
5113319|NCT01536379|12579403|P1|STARTED|Overall Study||13
5113320|NCT01536366|12579479|P2|NOT COMPLETED|Overall Study||4
5113321|NCT01536366|12579480|P1|NOT COMPLETED|Overall Study||13
5113322|NCT01536366|12579479|P2|COMPLETED|Overall Study||9
5113323|NCT01536366|12579480|P1|COMPLETED|Overall Study||1
5113324|NCT01536366|12579479|P2|Follow-up|Overall Study||9
5113325|NCT01536366|12579480|P1|Follow-up|Overall Study||13
5113326|NCT01536366|12579479|P2|Repaglinide|Overall Study||13
5113327|NCT01536366|12579480|P1|Repaglinide|Overall Study||14
5113328|NCT01536366|12579479|P2|BIA 9-1067 + Repaglinide|Overall Study||10
5113329|NCT01536366|12579480|P1|BIA 9-1067 + Repaglinide|Overall Study||14
5113330|NCT01536366|12579479|P2|STARTED|Overall Study||13
5113331|NCT01536366|12579480|P1|STARTED|Overall Study||14
5113332|NCT01536262|12579495|P3|NOT COMPLETED|Overall Study||2
5113333|NCT01536262|12579496|P2|NOT COMPLETED|Overall Study||2
5113334|NCT01536262|12579497|P1|NOT COMPLETED|Overall Study||8
5113335|NCT01536262|12579495|P3|COMPLETED|Overall Study||39
5113336|NCT01536262|12579496|P2|COMPLETED|Overall Study||38
5113337|NCT01536262|12579497|P1|COMPLETED|Overall Study||33
5113338|NCT01536262|12579495|P3|STARTED|Overall Study||41
5113339|NCT01536262|12579496|P2|STARTED|Overall Study||40
5113340|NCT01536262|12579497|P1|STARTED|Overall Study||41
5113341|NCT01536197|12579513|P2|NOT COMPLETED|Overall Study||0
5113342|NCT01536197|12579514|P1|NOT COMPLETED|Overall Study||0
5113343|NCT01536197|12579513|P2|COMPLETED|Overall Study||10
5113344|NCT01536197|12579514|P1|COMPLETED|Overall Study||23
5113345|NCT01536197|12579513|P2|STARTED|Overall Study||10
5113346|NCT01536197|12579514|P1|STARTED|Overall Study||23
5113347|NCT01536184|12579524|P2|NOT COMPLETED|Overall Study||0
5113348|NCT01536184|12579525|P1|NOT COMPLETED|Overall Study||0
5113349|NCT01536184|12579524|P2|COMPLETED|Overall Study||4
5113350|NCT01536184|12579525|P1|COMPLETED|Overall Study||8
5113351|NCT01536184|12579524|P2|STARTED|Overall Study||4
5113352|NCT01536184|12579525|P1|STARTED|Overall Study||8
5113353|NCT01536171|12579539|P1|NOT COMPLETED|Overall Study||1
5113354|NCT01536171|12579539|P1|COMPLETED|Overall Study||21
5113355|NCT01536171|12579539|P1|STARTED|Overall Study||22
5113356|NCT01536145|12579544|P11|NOT COMPLETED|Overall Study||10
5113357|NCT01536145|12579545|P10|NOT COMPLETED|Overall Study||6
5113358|NCT01536145|12579546|P9|NOT COMPLETED|Overall Study||3
5113359|NCT01536145|12579547|P8|NOT COMPLETED|Overall Study||4
5113360|NCT01536145|12579548|P7|NOT COMPLETED|Overall Study||2
5113361|NCT01536145|12579549|P6|NOT COMPLETED|Overall Study||3
5113362|NCT01536145|12579550|P5|NOT COMPLETED|Overall Study||2
5113363|NCT01536145|12579551|P4|NOT COMPLETED|Overall Study||2
5113364|NCT01536145|12579552|P3|NOT COMPLETED|Overall Study||2
5113365|NCT01536145|12579553|P2|NOT COMPLETED|Overall Study||4
5113366|NCT01536145|12579554|P1|NOT COMPLETED|Overall Study||3
5113367|NCT01536145|12579544|P11|COMPLETED|Overall Study||0
5113368|NCT01536145|12579545|P10|COMPLETED|Overall Study||1
5113369|NCT01536145|12579546|P9|COMPLETED|Overall Study||0
5113370|NCT01536145|12579547|P8|COMPLETED|Overall Study||0
5113371|NCT01536145|12579548|P7|COMPLETED|Overall Study||1
5113372|NCT01536145|12579549|P6|COMPLETED|Overall Study||0
5113373|NCT01536145|12579550|P5|COMPLETED|Overall Study||2
5113374|NCT01536145|12579551|P4|COMPLETED|Overall Study||1
5113375|NCT01536145|12579552|P3|COMPLETED|Overall Study||1
5113376|NCT01536145|12579553|P2|COMPLETED|Overall Study||0
5113377|NCT01536145|12579554|P1|COMPLETED|Overall Study||0
5113378|NCT01536145|12579544|P11|STARTED|Overall Study||10
5113379|NCT01536145|12579545|P10|STARTED|Overall Study||7
5113380|NCT01536145|12579546|P9|STARTED|Overall Study||3
5113381|NCT01536145|12579547|P8|STARTED|Overall Study||4
5113382|NCT01536145|12579548|P7|STARTED|Overall Study||3
5113383|NCT01536145|12579549|P6|STARTED|Overall Study||3
5113384|NCT01536145|12579550|P5|STARTED|Overall Study||4
5113385|NCT01536145|12579551|P4|STARTED|Overall Study||3
5113386|NCT01536145|12579552|P3|STARTED|Overall Study||3
5113387|NCT01536145|12579553|P2|STARTED|Overall Study||4
5113388|NCT01536145|12579554|P1|STARTED|Overall Study||3
5113389|NCT01536119|12579661|P2|NOT COMPLETED|Overall Study||14
5113390|NCT01536119|12579662|P1|NOT COMPLETED|Overall Study||17
5113391|NCT01536119|12579661|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
5113392|NCT01536119|12579662|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
5113393|NCT01536119|12579661|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
5113394|NCT01536119|12579662|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
5113395|NCT01536093|12579688|P2|NOT COMPLETED|Overall Study||3
5113396|NCT01536093|12579689|P1|NOT COMPLETED|Overall Study||3
5113397|NCT01536093|12579688|P2|COMPLETED|Overall Study||21
5113398|NCT01536093|12579689|P1|COMPLETED|Overall Study||21
5113399|NCT01536093|12579688|P2|STARTED|Overall Study||24
5113400|NCT01536093|12579689|P1|STARTED|Overall Study||24
5113401|NCT01536067|12579705|P1|NOT COMPLETED|Overall Study||1
5113402|NCT01536067|12579705|P1|COMPLETED|Overall Study||2
5113403|NCT01536067|12579705|P1|STARTED|Overall Study||3
5113404|NCT01536015|12579718|P2|NOT COMPLETED|Overall Study||10
5113405|NCT01536015|12579719|P1|NOT COMPLETED|Overall Study||8
5113406|NCT01536015|12579718|P2|COMPLETED|Overall Study||3
5113407|NCT01536015|12579719|P1|COMPLETED|Overall Study||4
5113408|NCT01536015|12579718|P2|STARTED|Overall Study||13
5113409|NCT01536015|12579719|P1|STARTED|Overall Study||12
5113410|NCT01535976|12579737|P2|NOT COMPLETED|Overall Study||1
5113411|NCT01535976|12579738|P1|NOT COMPLETED|Overall Study||1
5113412|NCT01535976|12579737|P2|COMPLETED|Overall Study||26
5113413|NCT01535976|12579738|P1|COMPLETED|Overall Study||26
5113414|NCT01535976|12579737|P2|STARTED|Overall Study||27
5113415|NCT01535976|12579738|P1|STARTED|Overall Study||27
5113416|NCT01535937|12579746|P2|NOT COMPLETED|Overall Study||0
5113417|NCT01535937|12579747|P1|NOT COMPLETED|Overall Study||0
5113418|NCT01535937|12579746|P2|COMPLETED|Overall Study||28
5113419|NCT01535937|12579747|P1|COMPLETED|Overall Study||27
5113420|NCT01535937|12579746|P2|STARTED|Overall Study||28
5113421|NCT01535937|12579747|P1|STARTED|Overall Study||27
5113422|NCT01535807|12579757|P2|NOT COMPLETED|Overall Study||2
5113423|NCT01535807|12579758|P1|NOT COMPLETED|Overall Study||2
5113424|NCT01535807|12579757|P2|COMPLETED|Overall Study||20
5113425|NCT01535807|12579758|P1|COMPLETED|Overall Study||20
5113426|NCT01535807|12579757|P2|STARTED|Overall Study||22
5113427|NCT01535807|12579758|P1|STARTED|Overall Study||22
5113428|NCT01535729|12579764|P1|NOT COMPLETED|Overall Study||416
5113429|NCT01535729|12579764|P1|COMPLETED|Overall Study||49
5113430|NCT01535729|12579764|P1|Treated|Overall Study||385
5113431|NCT01535729|12579764|P1|STARTED|Overall Study||465
5113432|NCT01535664|12579791|P1|NOT COMPLETED|Overall Study||0
5113433|NCT01535664|12579791|P1|COMPLETED|Overall Study||20
5113434|NCT01535664|12579791|P1|STARTED|Overall Study||20
5113435|NCT01535638|12579805|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
5113436|NCT01535638|12579806|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
5113437|NCT01535638|12579807|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
5113438|NCT01535638|12579808|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
5113439|NCT01535638|12579809|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
5113440|NCT01535638|12579810|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
5113441|NCT01535638|12579805|P6|COMPLETED|Treatment 3 (Single Dose)||2
5113442|NCT01535638|12579806|P5|COMPLETED|Treatment 3 (Single Dose)||3
5113443|NCT01535638|12579807|P4|COMPLETED|Treatment 3 (Single Dose)||2
5113444|NCT01535638|12579808|P3|COMPLETED|Treatment 3 (Single Dose)||3
5113445|NCT01535638|12579809|P2|COMPLETED|Treatment 3 (Single Dose)||3
5113446|NCT01535638|12579810|P1|COMPLETED|Treatment 3 (Single Dose)||3
5113447|NCT01535638|12579805|P6|STARTED|Treatment 3 (Single Dose)||2
5113448|NCT01535638|12579806|P5|STARTED|Treatment 3 (Single Dose)||3
5113449|NCT01535638|12579807|P4|STARTED|Treatment 3 (Single Dose)||3
5113450|NCT01535638|12579808|P3|STARTED|Treatment 3 (Single Dose)||3
5113451|NCT01535638|12579809|P2|STARTED|Treatment 3 (Single Dose)||3
5113452|NCT01535638|12579810|P1|STARTED|Treatment 3 (Single Dose)||3
5113453|NCT01535638|12579805|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113454|NCT01535638|12579806|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113455|NCT01535638|12579807|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113456|NCT01535638|12579808|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113457|NCT01535638|12579809|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113458|NCT01535638|12579810|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
5113459|NCT01535638|12579805|P6|COMPLETED|Treatment 2 (Single Dose)||2
5113460|NCT01535638|12579806|P5|COMPLETED|Treatment 2 (Single Dose)||3
5113461|NCT01535638|12579807|P4|COMPLETED|Treatment 2 (Single Dose)||3
5113462|NCT01535638|12579808|P3|COMPLETED|Treatment 2 (Single Dose)||3
5113463|NCT01535638|12579809|P2|COMPLETED|Treatment 2 (Single Dose)||3
5113464|NCT01535638|12579810|P1|COMPLETED|Treatment 2 (Single Dose)||3
5113465|NCT01535638|12579805|P6|STARTED|Treatment 2 (Single Dose)||2
5113466|NCT01535638|12579806|P5|STARTED|Treatment 2 (Single Dose)||3
5113467|NCT01535638|12579807|P4|STARTED|Treatment 2 (Single Dose)||3
5113468|NCT01535638|12579808|P3|STARTED|Treatment 2 (Single Dose)||3
5113469|NCT01535638|12579809|P2|STARTED|Treatment 2 (Single Dose)||3
5113470|NCT01535638|12579810|P1|STARTED|Treatment 2 (Single Dose)||3
5113471|NCT01535638|12579805|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
5113472|NCT01535638|12579806|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
5113473|NCT01535638|12579807|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
5113474|NCT01535638|12579808|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
5113475|NCT01535638|12579809|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
5113476|NCT01535638|12579810|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
5113477|NCT01535638|12579805|P6|COMPLETED|Treatment 1 (Single Dose)||2
5113478|NCT01535638|12579806|P5|COMPLETED|Treatment 1 (Single Dose)||3
5113479|NCT01535638|12579807|P4|COMPLETED|Treatment 1 (Single Dose)||3
5113480|NCT01535638|12579808|P3|COMPLETED|Treatment 1 (Single Dose)||3
5113481|NCT01535638|12579809|P2|COMPLETED|Treatment 1 (Single Dose)||3
5113482|NCT01535638|12579810|P1|COMPLETED|Treatment 1 (Single Dose)||3
5113483|NCT01535638|12579805|P6|STARTED|Treatment 1 (Single Dose)||3
5113484|NCT01535638|12579806|P5|STARTED|Treatment 1 (Single Dose)||3
5113485|NCT01535638|12579807|P4|STARTED|Treatment 1 (Single Dose)||3
5113486|NCT01535638|12579808|P3|STARTED|Treatment 1 (Single Dose)||3
5113487|NCT01535638|12579809|P2|STARTED|Treatment 1 (Single Dose)||3
5113488|NCT01535638|12579810|P1|STARTED|Treatment 1 (Single Dose)||3
5113489|NCT01535599|12579824|P2|NOT COMPLETED|Overall Study||96
5113490|NCT01535599|12579825|P1|NOT COMPLETED|Overall Study||50
5113491|NCT01535599|12579824|P2|COMPLETED|Overall Study||250
5113492|NCT01535599|12579825|P1|COMPLETED|Overall Study||297
5113493|NCT01535599|12579824|P2|STARTED|Overall Study||346
5113494|NCT01535599|12579825|P1|STARTED|Overall Study||347
5113495|NCT01535560|12579837|P2|NOT COMPLETED|Overall Study||96
5113496|NCT01535560|12579838|P1|NOT COMPLETED|Overall Study||37
5113497|NCT01535560|12579837|P2|COMPLETED|Overall Study||179
5113498|NCT01535560|12579838|P1|COMPLETED|Overall Study||237
5113499|NCT01535560|12579837|P2|STARTED|Overall Study||275
5113500|NCT01535560|12579838|P1|STARTED|Overall Study||274
5113501|NCT01535443|12579848|P1|NOT COMPLETED|Overall Study||3
5113502|NCT01535443|12579848|P1|COMPLETED|Overall Study||32
5113503|NCT01535443|12579848|P1|STARTED|Overall Study||35
5113504|NCT01535365|12579865|P2|NOT COMPLETED|Overall Study||0
5113505|NCT01535365|12579866|P1|NOT COMPLETED|Overall Study||0
5113506|NCT01535365|12579865|P2|COMPLETED|Overall Study||29
5113507|NCT01535365|12579866|P1|COMPLETED|Overall Study||31
5113508|NCT01535365|12579865|P2|STARTED|Overall Study||29
5113509|NCT01535365|12579866|P1|STARTED|Overall Study||31
5113510|NCT01535326|12579877|P3|NOT COMPLETED|Overall Study||0
5113511|NCT01535326|12579878|P2|NOT COMPLETED|Overall Study||0
5113512|NCT01535326|12579879|P1|NOT COMPLETED|Overall Study||0
5113513|NCT01535326|12579877|P3|COMPLETED|Overall Study||90
5113514|NCT01535326|12579878|P2|COMPLETED|Overall Study||90
5113515|NCT01535326|12579879|P1|COMPLETED|Overall Study||90
5113516|NCT01535326|12579877|P3|STARTED|Overall Study||90
5113517|NCT01535326|12579878|P2|STARTED|Overall Study||90
5113518|NCT01535326|12579879|P1|STARTED|Overall Study||90
5113519|NCT01535287|12579898|P2|NOT COMPLETED|Overall Study||6
5113520|NCT01535287|12579899|P1|NOT COMPLETED|Overall Study||5
5113521|NCT01535287|12579898|P2|COMPLETED|Overall Study||64
5113522|NCT01535287|12579899|P1|COMPLETED|Overall Study||65
5113523|NCT01535287|12579898|P2|STARTED|Overall Study||70
5113524|NCT01535287|12579899|P1|STARTED|Overall Study||70
5113525|NCT01535261|12579915|P1|NOT COMPLETED|Overall Study||50
5113526|NCT01535261|12579915|P1|COMPLETED|Overall Study||307
5113527|NCT01535261|12579915|P1|STARTED|Overall Study||357
5113528|NCT01535235|12579928|P2|NOT COMPLETED|Overall Study||0
5113529|NCT01535235|12579929|P1|NOT COMPLETED|Overall Study||1
5113530|NCT01535235|12579928|P2|COMPLETED|Overall Study||15
5113531|NCT01535235|12579929|P1|COMPLETED|Overall Study||15
5113532|NCT01535235|12579928|P2|STARTED|Overall Study||15
5113533|NCT01535235|12579929|P1|STARTED|Overall Study||16
5113534|NCT01535222|12579943|P6|NOT COMPLETED|Overall Study||0
5113535|NCT01535222|12579944|P5|NOT COMPLETED|Overall Study||0
5113536|NCT01535222|12579945|P4|NOT COMPLETED|Overall Study||0
5113537|NCT01535222|12579946|P3|NOT COMPLETED|Overall Study||1
5113538|NCT01535222|12579947|P2|NOT COMPLETED|Overall Study||0
5113539|NCT01535222|12579948|P1|NOT COMPLETED|Overall Study||0
5113540|NCT01535222|12579943|P6|COMPLETED|Overall Study||8
5113541|NCT01535222|12579944|P5|COMPLETED|Overall Study||6
5113542|NCT01535222|12579945|P4|COMPLETED|Overall Study||6
5113543|NCT01535222|12579946|P3|COMPLETED|Overall Study||6
5113544|NCT01535222|12579947|P2|COMPLETED|Overall Study||3
5113545|NCT01535222|12579948|P1|COMPLETED|Overall Study||3
5113546|NCT01535222|12579943|P6|STARTED|Overall Study||8
5113547|NCT01535222|12579944|P5|STARTED|Overall Study||6
5113548|NCT01535222|12579945|P4|STARTED|Overall Study||6
5113549|NCT01535222|12579946|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
5113550|NCT01535222|12579947|P2|STARTED|Overall Study||3
5113551|NCT01535222|12579948|P1|STARTED|Overall Study||3
5113552|NCT01535118|12579968|P1|NOT COMPLETED|Overall Study||0
5113553|NCT01535118|12579968|P1|COMPLETED|Overall Study||2765
5113554|NCT01535118|12579968|P1|STARTED|Overall Study||2765
5113555|NCT01535053|12579979|P2|NOT COMPLETED|Overall Study||2
5113556|NCT01535053|12579980|P1|NOT COMPLETED|Overall Study||1
5113557|NCT01535053|12579979|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
5113558|NCT01535053|12579980|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
5113559|NCT01535053|12579979|P2|STARTED|Overall Study||28
5113560|NCT01535053|12579980|P1|STARTED|Overall Study||29
5113561|NCT01535040|12579998|P2|NOT COMPLETED|Overall Study||21
5113562|NCT01535040|12579999|P1|NOT COMPLETED|Overall Study||30
5113563|NCT01535040|12579998|P2|COMPLETED|Overall Study||44
5113564|NCT01535040|12579999|P1|COMPLETED|Overall Study||35
5113565|NCT01535040|12579998|P2|STARTED|Overall Study||65
5113566|NCT01535040|12579999|P1|STARTED|Overall Study||65
5113567|NCT01535014|12580015|P4|NOT COMPLETED|Overall Study||0
5113568|NCT01535014|12580016|P3|NOT COMPLETED|Overall Study||1
5113569|NCT01535014|12580017|P2|NOT COMPLETED|Overall Study||6
5113570|NCT01535014|12580018|P1|NOT COMPLETED|Overall Study||2
5113571|NCT01535014|12580015|P4|COMPLETED|Overall Study||33
5113572|NCT01535014|12580016|P3|COMPLETED|Overall Study||49
5113573|NCT01535014|12580017|P2|COMPLETED|Overall Study||194
5113574|NCT01535014|12580018|P1|COMPLETED|Overall Study||208
5113575|NCT01535014|12580015|P4|STARTED|Overall Study||33
5113576|NCT01535014|12580016|P3|STARTED|Overall Study||50
5113577|NCT01535014|12580017|P2|STARTED|Overall Study||200
5113578|NCT01535014|12580018|P1|STARTED|Overall Study||210
5113579|NCT01535001|12580052|P2|NOT COMPLETED|Overall Study||6
5113580|NCT01535001|12580053|P1|NOT COMPLETED|Overall Study||3
5113581|NCT01535001|12580052|P2|COMPLETED|Overall Study||44
5113582|NCT01535001|12580053|P1|COMPLETED|Overall Study||47
5113583|NCT01535001|12580052|P2|STARTED|Overall Study||50
5113584|NCT01535001|12580053|P1|STARTED|Overall Study||50
5113585|NCT01534975|12580079|P4|NOT COMPLETED|Overall Study||0
5113586|NCT01534975|12580080|P3|NOT COMPLETED|Overall Study||0
5113587|NCT01534975|12580081|P2|NOT COMPLETED|Overall Study||0
5113588|NCT01534975|12580082|P1|NOT COMPLETED|Overall Study||0
5113589|NCT01534975|12580079|P4|COMPLETED|Overall Study||84
5113590|NCT01534975|12580080|P3|COMPLETED|Overall Study||160
5113591|NCT01534975|12580081|P2|COMPLETED|Overall Study||133
5113592|NCT01534975|12580082|P1|COMPLETED|Overall Study||136
5113593|NCT01534975|12580079|P4|STARTED|Overall Study||84
5113594|NCT01534975|12580080|P3|STARTED|Overall Study||160
5113595|NCT01534975|12580081|P2|STARTED|Overall Study||133
5113596|NCT01534975|12580082|P1|STARTED|Overall Study||136
5113597|NCT01534962|12580096|P4|NOT COMPLETED|Overall Study||32
5113598|NCT01534962|12580097|P3|NOT COMPLETED|Overall Study||24
5113599|NCT01534962|12580098|P2|NOT COMPLETED|Overall Study||26
5113600|NCT01534962|12580099|P1|NOT COMPLETED|Overall Study||37
5113601|NCT01534962|12580096|P4|COMPLETED|Overall Study||24
5113602|NCT01534962|12580097|P3|COMPLETED|Overall Study||34
5113603|NCT01534962|12580098|P2|COMPLETED|Overall Study||34
5113604|NCT01534962|12580099|P1|COMPLETED|Overall Study||30
5113605|NCT01534962|12580096|P4|STARTED|Overall Study||56
5113606|NCT01534962|12580097|P3|STARTED|Overall Study||58
5113607|NCT01534962|12580098|P2|STARTED|Overall Study||60
5113608|NCT01534962|12580099|P1|STARTED|Overall Study||67
5113609|NCT01534910|12580131|P2|NOT COMPLETED|Overall Study||4
5113610|NCT01534910|12580132|P1|NOT COMPLETED|Overall Study||4
5113611|NCT01534910|12580131|P2|COMPLETED|Overall Study||28
5113612|NCT01534910|12580132|P1|COMPLETED|Overall Study||29
5113613|NCT01534910|12580131|P2|STARTED|Overall Study||32
5113614|NCT01534910|12580132|P1|STARTED|Overall Study||33
5113615|NCT01534897|12580140|P1|NOT COMPLETED|Overall Study||0
5113616|NCT01534897|12580140|P1|COMPLETED|Overall Study||10
5113617|NCT01534897|12580140|P1|Day 37 Iodine-131 Treatment|Overall Study||6
5113618|NCT01534897|12580140|P1|Day 25 Iodine-131 Scan|Overall Study||10
5113619|NCT01534897|12580140|P1|STARTED|Overall Study||10
5113620|NCT01534689|12580148|P1|NOT COMPLETED|Overall Study||0
5113621|NCT01534689|12580148|P1|COMPLETED|Overall Study||105
5113622|NCT01534689|12580148|P1|STARTED|Overall Study||105
5113623|NCT01534676|12580156|P2|NOT COMPLETED|Overall Study||1
5113624|NCT01534676|12580157|P1|NOT COMPLETED|Overall Study||2
5113625|NCT01534676|12580156|P2|COMPLETED|Overall Study||0
5113626|NCT01534676|12580157|P1|COMPLETED|Overall Study||0
5113627|NCT01534676|12580156|P2|STARTED|Overall Study||1
5113628|NCT01534676|12580157|P1|STARTED|Overall Study||2
5113629|NCT01534637|12580163|P1|NOT COMPLETED|Overall Study||9
5113630|NCT01534637|12580163|P1|COMPLETED|Overall Study||13
5113631|NCT01534637|12580163|P1|STARTED|Overall Study||22
5113632|NCT01534533|12580173|P4|NOT COMPLETED|Overall Study||4
5113633|NCT01534533|12580174|P3|NOT COMPLETED|Overall Study||8
5113634|NCT01534533|12580175|P2|NOT COMPLETED|Overall Study||3
5113635|NCT01534533|12580176|P1|NOT COMPLETED|Overall Study||8
5113636|NCT01534533|12580173|P4|COMPLETED|Overall Study||44
5113637|NCT01534533|12580174|P3|COMPLETED|Overall Study||40
5113638|NCT01534533|12580175|P2|COMPLETED|Overall Study||45
5113639|NCT01534533|12580176|P1|COMPLETED|Overall Study||40
5113640|NCT01534533|12580173|P4|STARTED|Overall Study||48
5113641|NCT01534533|12580174|P3|STARTED|Overall Study||48
5113642|NCT01534533|12580175|P2|STARTED|Overall Study||48
5113643|NCT01534533|12580176|P1|STARTED|Overall Study||48
5113644|NCT01534520|12580204|P2|NOT COMPLETED|Overall Study||1
5113645|NCT01534520|12580205|P1|NOT COMPLETED|Overall Study||0
5113646|NCT01534520|12580204|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
5113647|NCT01534520|12580205|P1|COMPLETED|Overall Study||30
5113648|NCT01534520|12580204|P2|STARTED|Overall Study||29
5113649|NCT01534520|12580205|P1|STARTED|Overall Study||30
5113650|NCT01534416|12580219|P2|NOT COMPLETED|Overall Study||0
5113651|NCT01534416|12580220|P1|NOT COMPLETED|Overall Study||0
5113652|NCT01534416|12580219|P2|COMPLETED|Overall Study||64
5113653|NCT01534416|12580220|P1|COMPLETED|Overall Study||68
5113654|NCT01534416|12580219|P2|STARTED|Overall Study||64
5113655|NCT01534416|12580220|P1|STARTED|Overall Study||68
5113656|NCT01534351|12580239|P3|NOT COMPLETED|Overall Study||0
5113657|NCT01534351|12580240|P2|NOT COMPLETED|Overall Study||0
5113658|NCT01534351|12580241|P1|NOT COMPLETED|Overall Study||1
5113659|NCT01534351|12580239|P3|COMPLETED|Overall Study||0
5113660|NCT01534351|12580240|P2|COMPLETED|Overall Study||0
5113661|NCT01534351|12580241|P1|COMPLETED|Overall Study||0
5113662|NCT01534351|12580239|P3|STARTED|Overall Study||0
5113663|NCT01534351|12580240|P2|STARTED|Overall Study||0
5113664|NCT01534351|12580241|P1|STARTED|Overall Study||1
5113665|NCT01534273|12580262|P7|NOT COMPLETED|Period 2||0
5113666|NCT01534273|12580263|P6|NOT COMPLETED|Period 2||0
5113667|NCT01534273|12580264|P5|NOT COMPLETED|Period 2||0
5113668|NCT01534273|12580265|P4|NOT COMPLETED|Period 2||0
5113669|NCT01534273|12580266|P3|NOT COMPLETED|Period 2||0
5113670|NCT01534273|12580267|P2|NOT COMPLETED|Period 2||0
5113671|NCT01534273|12580268|P1|NOT COMPLETED|Period 2||0
5113672|NCT01534273|12580262|P7|COMPLETED|Period 2||0
5113673|NCT01534273|12580263|P6|COMPLETED|Period 2||0
5113674|NCT01534273|12580264|P5|COMPLETED|Period 2||0
5113675|NCT01534273|12580265|P4|COMPLETED|Period 2||6
5113676|NCT01534273|12580266|P3|COMPLETED|Period 2||2
5113677|NCT01534273|12580267|P2|COMPLETED|Period 2||0
5113678|NCT01534273|12580268|P1|COMPLETED|Period 2||0
5113679|NCT01534273|12580262|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
5113680|NCT01534273|12580263|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
5113681|NCT01534273|12580264|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
5113682|NCT01534273|12580265|P4|STARTED|Period 2||6
5113683|NCT01534273|12580266|P3|STARTED|Period 2||2
5113684|NCT01534273|12580267|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
5113685|NCT01534273|12580268|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
5113686|NCT01534273|12580262|P7|NOT COMPLETED|Period 1||0
5113687|NCT01534273|12580263|P6|NOT COMPLETED|Period 1||0
5113688|NCT01534273|12580264|P5|NOT COMPLETED|Period 1||0
5113689|NCT01534273|12580265|P4|NOT COMPLETED|Period 1||1
5113690|NCT01534273|12580266|P3|NOT COMPLETED|Period 1||0
5113691|NCT01534273|12580267|P2|NOT COMPLETED|Period 1||0
5113692|NCT01534273|12580268|P1|NOT COMPLETED|Period 1||0
5113693|NCT01534273|12580262|P7|COMPLETED|Period 1||6
5113694|NCT01534273|12580263|P6|COMPLETED|Period 1||3
5113695|NCT01534273|12580264|P5|COMPLETED|Period 1||3
5113696|NCT01534273|12580265|P4|COMPLETED|Period 1||6
5113697|NCT01534273|12580266|P3|COMPLETED|Period 1||2
5113698|NCT01534273|12580267|P2|COMPLETED|Period 1||6
5113699|NCT01534273|12580268|P1|COMPLETED|Period 1||3
5113700|NCT01534273|12580262|P7|Received at Least 1 Dose of Study Drug|Period 1||6
5113701|NCT01534273|12580263|P6|Received at Least 1 Dose of Study Drug|Period 1||3
5113702|NCT01534273|12580264|P5|Received at Least 1 Dose of Study Drug|Period 1||3
5113703|NCT01534273|12580265|P4|Received at Least 1 Dose of Study Drug|Period 1||7
5113704|NCT01534273|12580266|P3|Received at Least 1 Dose of Study Drug|Period 1||2
5113705|NCT01534273|12580267|P2|Received at Least 1 Dose of Study Drug|Period 1||6
5113706|NCT01534273|12580268|P1|Received at Least 1 Dose of Study Drug|Period 1||3
5113707|NCT01534273|12580262|P7|STARTED|Period 1||6
5113708|NCT01534273|12580263|P6|STARTED|Period 1||3
5113709|NCT01534273|12580264|P5|STARTED|Period 1||3
5113710|NCT01534273|12580265|P4|STARTED|Period 1||7
5113711|NCT01534273|12580266|P3|STARTED|Period 1||2
5113712|NCT01534273|12580267|P2|STARTED|Period 1||6
5113713|NCT01534273|12580268|P1|STARTED|Period 1||3
5113714|NCT01534260|12580295|P2|NOT COMPLETED|Overall Study||20
5113715|NCT01534260|12580296|P1|NOT COMPLETED|Overall Study||16
5113716|NCT01534260|12580295|P2|COMPLETED|Overall Study||0
5113717|NCT01534260|12580296|P1|COMPLETED|Overall Study||1
5113718|NCT01534260|12580295|P2|STARTED|Overall Study||20
5113719|NCT01534260|12580296|P1|STARTED|Overall Study||17
5113720|NCT01534208|12580306|P2|NOT COMPLETED|Overall Study||49
5113721|NCT01534208|12580307|P1|NOT COMPLETED|Overall Study||57
5113722|NCT01534208|12580306|P2|COMPLETED|Overall Study||234
5113723|NCT01534208|12580307|P1|COMPLETED|Overall Study||159
5113724|NCT01534208|12580306|P2|STARTED|Overall Study||283
5113725|NCT01534208|12580307|P1|STARTED|Overall Study||216
5113726|NCT01534195|12580325|P2|NOT COMPLETED|Overall Study||1
5113727|NCT01534195|12580326|P1|NOT COMPLETED|Overall Study||1
5113728|NCT01534195|12580325|P2|COMPLETED|Overall Study||5
5113729|NCT01534195|12580326|P1|COMPLETED|Overall Study||4
5113730|NCT01534195|12580325|P2|STARTED|Overall Study||6
5113731|NCT01534195|12580326|P1|STARTED|Overall Study||5
5113732|NCT01534182|12580340|P2|NOT COMPLETED|Overall Study||10
5113733|NCT01534182|12580341|P1|NOT COMPLETED|Overall Study||12
5113734|NCT01534182|12580340|P2|COMPLETED|Overall Study||58
5113735|NCT01534182|12580341|P1|COMPLETED|Overall Study||218
5113736|NCT01534182|12580340|P2|Full Analysis Set|Overall Study||62
5113737|NCT01534182|12580341|P1|Full Analysis Set|Overall Study||229
5113738|NCT01534182|12580340|P2|Safety Set|Overall Study||64
5113739|NCT01534182|12580341|P1|Safety Set|Overall Study||230
5113740|NCT01534182|12580340|P2|STARTED|Overall Study||68
5113741|NCT01534182|12580341|P1|STARTED|Overall Study||230
5113742|NCT01534143|12580356|P1|NOT COMPLETED|Overall Study||0
5113743|NCT01534143|12580356|P1|COMPLETED|Overall Study||1
5113744|NCT01534143|12580356|P1|STARTED|Overall Study||1
5113745|NCT01534078|12580372|P1|NOT COMPLETED|Overall Study||2
5113746|NCT01534078|12580372|P1|COMPLETED|Overall Study||32
5113747|NCT01534078|12580372|P1|STARTED|Overall Study||34
5113748|NCT01534052|12580379|P1|NOT COMPLETED|Overall Study||0
5113749|NCT01534052|12580379|P1|COMPLETED|Overall Study||52
5113750|NCT01534052|12580379|P1|Treatment Received|Overall Study||52
5113751|NCT01534052|12580379|P1|STARTED|Overall Study||52
5113752|NCT01534013|12580385|P2|NOT COMPLETED|Overall Study||0
5113753|NCT01534013|12580386|P1|NOT COMPLETED|Overall Study||2
5113754|NCT01534013|12580385|P2|COMPLETED|Overall Study||6
5113755|NCT01534013|12580386|P1|COMPLETED|Overall Study||6
5113756|NCT01534013|12580385|P2|STARTED|Overall Study||6
5113757|NCT01534013|12580386|P1|STARTED|Overall Study||8
5113758|NCT01533974|12580394|P2|NOT COMPLETED|Overall Study||50
5113759|NCT01533974|12580395|P1|NOT COMPLETED|Overall Study||51
5113760|NCT01533974|12580394|P2|COMPLETED|Overall Study||176
5113761|NCT01533974|12580395|P1|COMPLETED|Overall Study||173
5113762|NCT01533974|12580394|P2|STARTED|Overall Study||226
5113763|NCT01533974|12580395|P1|STARTED|Overall Study||224
5113764|NCT01533948|12580401|P1|NOT COMPLETED|Overall Study||0
5113765|NCT01533948|12580401|P1|COMPLETED|Overall Study||25
5113766|NCT01533948|12580401|P1|STARTED|Overall Study||25
5113767|NCT01533935|12580409|P5|NOT COMPLETED|Overall Study||8
5113768|NCT01533935|12580410|P4|NOT COMPLETED|Overall Study||7
5113769|NCT01533935|12580411|P3|NOT COMPLETED|Overall Study||8
5113770|NCT01533935|12580412|P2|NOT COMPLETED|Overall Study||13
5113771|NCT01533935|12580413|P1|NOT COMPLETED|Overall Study||6
5113772|NCT01533935|12580409|P5|COMPLETED|Overall Study|All treatment periods|50
5113773|NCT01533935|12580410|P4|COMPLETED|Overall Study|All treatment periods|52
5113774|NCT01533935|12580411|P3|COMPLETED|Overall Study|All treatment periods|50
5113775|NCT01533935|12580412|P2|COMPLETED|Overall Study|All treatment periods|45
5113776|NCT01533935|12580413|P1|COMPLETED|Overall Study|All treatment periods|52
5113777|NCT01533935|12580409|P5|Received Tio+Olo 5/5|Overall Study||55
5113778|NCT01533935|12580410|P4|Received Tio+Olo 5/5|Overall Study||54
5113779|NCT01533935|12580411|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
5113780|NCT01533935|12580412|P2|Received Tio+Olo 5/5|Overall Study||58
5113781|NCT01533935|12580413|P1|Received Tio+Olo 5/5|Overall Study||56
5113782|NCT01533935|12580409|P5|Received Tio+Olo 2.5/5|Overall Study||56
5113783|NCT01533935|12580410|P4|Received Tio+Olo 2.5/5|Overall Study||56
5113784|NCT01533935|12580411|P3|Received Tio+Olo 2.5/5|Overall Study||49
5113785|NCT01533935|12580412|P2|Received Tio+Olo 2.5/5|Overall Study||0
5113786|NCT01533935|12580413|P1|Received Tio+Olo 2.5/5|Overall Study||58
5113787|NCT01533935|12580409|P5|Received Tio 5|Overall Study||52
5113788|NCT01533935|12580410|P4|Received Tio 5|Overall Study||0
5113789|NCT01533935|12580411|P3|Received Tio 5|Overall Study||58
5113790|NCT01533935|12580412|P2|Received Tio 5|Overall Study||54
5113791|NCT01533935|12580413|P1|Received Tio 5|Overall Study||54
5113792|NCT01533935|12580409|P5|Received Olo 5|Overall Study||0
5113793|NCT01533935|12580410|P4|Received Olo 5|Overall Study||59
5113794|NCT01533935|12580411|P3|Received Olo 5|Overall Study||55
5113795|NCT01533935|12580412|P2|Received Olo 5|Overall Study||52
5113796|NCT01533935|12580413|P1|Received Olo 5|Overall Study||52
5113797|NCT01533935|12580409|P5|Received Placebo|Overall Study||58
5113798|NCT01533935|12580410|P4|Received Placebo|Overall Study||57
5113799|NCT01533935|12580411|P3|Received Placebo|Overall Study||52
5113800|NCT01533935|12580412|P2|Received Placebo|Overall Study||47
5113801|NCT01533935|12580413|P1|Received Placebo|Overall Study||0
5113802|NCT01533935|12580409|P5|STARTED|Overall Study||58
5113803|NCT01533935|12580410|P4|STARTED|Overall Study||59
5113804|NCT01533935|12580411|P3|STARTED|Overall Study||58
5113805|NCT01533935|12580412|P2|STARTED|Overall Study||58
5113806|NCT01533935|12580413|P1|STARTED|Overall Study||58
5113807|NCT01533922|12580440|P5|NOT COMPLETED|Overall Study||6
5113808|NCT01533922|12580441|P4|NOT COMPLETED|Overall Study||5
5113809|NCT01533922|12580442|P3|NOT COMPLETED|Overall Study||10
5113810|NCT01533922|12580443|P2|NOT COMPLETED|Overall Study||12
5113811|NCT01533922|12580444|P1|NOT COMPLETED|Overall Study||10
5113812|NCT01533922|12580440|P5|COMPLETED|Overall Study|Completed all treatment arms|53
5113813|NCT01533922|12580441|P4|COMPLETED|Overall Study|Completed all treatment arms|53
5113814|NCT01533922|12580442|P3|COMPLETED|Overall Study|Completed all treatment arms|50
5113815|NCT01533922|12580443|P2|COMPLETED|Overall Study|Completed all treatment arms|47
5113816|NCT01533922|12580444|P1|COMPLETED|Overall Study|Completed all treatment arms|49
5113817|NCT01533922|12580440|P5|Received Tio+Olo 5/5|Overall Study||56
5113818|NCT01533922|12580441|P4|Received Tio+Olo 5/5|Overall Study||53
5113819|NCT01533922|12580442|P3|Received Tio+Olo 5/5|Overall Study||0
5113820|NCT01533922|12580443|P2|Received Tio+Olo 5/5|Overall Study||59
5113821|NCT01533922|12580444|P1|Received Tio+Olo 5/5|Overall Study||58
5113822|NCT01533922|12580440|P5|Received Tio+Olo 2.5/5|Overall Study||56
5113823|NCT01533922|12580441|P4|Received Tio+Olo 2.5/5|Overall Study||55
5113824|NCT01533922|12580442|P3|Received Tio+Olo 2.5/5|Overall Study||52
5113825|NCT01533922|12580443|P2|Received Tio+Olo 2.5/5|Overall Study||0
5113826|NCT01533922|12580444|P1|Received Tio+Olo 2.5/5|Overall Study||59
5113827|NCT01533922|12580440|P5|Received Tio 5|Overall Study||54
5113828|NCT01533922|12580441|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
5113829|NCT01533922|12580442|P3|Received Tio 5|Overall Study||59
5113830|NCT01533922|12580443|P2|Received Tio 5|Overall Study||58
5113831|NCT01533922|12580444|P1|Received Tio 5|Overall Study||54
5113832|NCT01533922|12580440|P5|Received Olo 5|Overall Study||0
5113833|NCT01533922|12580441|P4|Received Olo 5|Overall Study||57
5113834|NCT01533922|12580442|P3|Received Olo 5|Overall Study||57
5113835|NCT01533922|12580443|P2|Received Olo 5|Overall Study||52
5113836|NCT01533922|12580444|P1|Received Olo 5|Overall Study||51
5113837|NCT01533922|12580440|P5|Received Placebo|Overall Study||59
5113838|NCT01533922|12580441|P4|Received Placebo|Overall Study||57
5113839|NCT01533922|12580442|P3|Received Placebo|Overall Study||57
5113840|NCT01533922|12580443|P2|Received Placebo|Overall Study||49
5113841|NCT01533922|12580444|P1|Received Placebo|Overall Study||0
5113842|NCT01533922|12580440|P5|STARTED|Overall Study||59
5113843|NCT01533922|12580441|P4|STARTED|Overall Study||58
5113844|NCT01533922|12580442|P3|STARTED|Overall Study||60
5113845|NCT01533922|12580443|P2|STARTED|Overall Study||59
5113846|NCT01533922|12580444|P1|STARTED|Overall Study||59
5113847|NCT01533753|12580473|P2|NOT COMPLETED|Overall Study||0
5113848|NCT01533753|12580474|P1|NOT COMPLETED|Overall Study||0
5113849|NCT01533753|12580473|P2|COMPLETED|Overall Study||3
5113850|NCT01533753|12580474|P1|COMPLETED|Overall Study||2
5113851|NCT01533753|12580473|P2|STARTED|Overall Study||3
5113852|NCT01533753|12580474|P1|STARTED|Overall Study||2
5113853|NCT01533688|12580489|P3|NOT COMPLETED|Overall Study||8
5113854|NCT01533688|12580490|P2|NOT COMPLETED|Overall Study||10
5113855|NCT01533688|12580491|P1|NOT COMPLETED|Overall Study||8
5113856|NCT01533688|12580489|P3|COMPLETED|Overall Study||63
5113857|NCT01533688|12580490|P2|COMPLETED|Overall Study||60
5113858|NCT01533688|12580491|P1|COMPLETED|Overall Study||63
5113859|NCT01533688|12580489|P3|STARTED|Overall Study||71
5113860|NCT01533688|12580490|P2|STARTED|Overall Study||70
5113861|NCT01533688|12580491|P1|STARTED|Overall Study||71
5113862|NCT01533597|12580504|P2|NOT COMPLETED|Overall Study||10
5113863|NCT01533597|12580505|P1|NOT COMPLETED|Overall Study||6
5113864|NCT01533597|12580504|P2|COMPLETED|Overall Study||25
5113865|NCT01533597|12580505|P1|COMPLETED|Overall Study||29
5113866|NCT01533597|12580504|P2|STARTED|Overall Study||35
5113867|NCT01533597|12580505|P1|STARTED|Overall Study||35
5113868|NCT01533493|12580523|P2|NOT COMPLETED|Overall Study||3
5113869|NCT01533493|12580524|P1|NOT COMPLETED|Overall Study||5
5113870|NCT01533493|12580523|P2|COMPLETED|Overall Study||11
5113871|NCT01533493|12580524|P1|COMPLETED|Overall Study||7
5113872|NCT01533493|12580523|P2|STARTED|Overall Study||14
5113873|NCT01533493|12580524|P1|STARTED|Overall Study||12
5113874|NCT01533428|12580532|P2|NOT COMPLETED|Overall Study||8
5113875|NCT01533428|12580533|P1|NOT COMPLETED|Overall Study||9
5113876|NCT01533428|12580532|P2|COMPLETED|Overall Study||175
5113877|NCT01533428|12580533|P1|COMPLETED|Overall Study||177
5113878|NCT01533428|12580532|P2|STARTED|Overall Study||183
5113879|NCT01533428|12580533|P1|STARTED|Overall Study||186
5113880|NCT01533259|12580573|P1|NOT COMPLETED|Overall Study||0
5113881|NCT01533259|12580573|P1|COMPLETED|Overall Study||48
5113882|NCT01533259|12580573|P1|STARTED|Overall Study||48
5113883|NCT01533246|12580579|P1|NOT COMPLETED|Overall Study||2
5113884|NCT01533246|12580579|P1|COMPLETED|Overall Study||15
5113885|NCT01533246|12580579|P1|STARTED|Overall Study||17
5113886|NCT01533207|12580590|P2|NOT COMPLETED|Overall Study||0
5113887|NCT01533207|12580591|P1|NOT COMPLETED|Overall Study||0
5113888|NCT01533207|12580590|P2|COMPLETED|Overall Study||18
5113889|NCT01533207|12580591|P1|COMPLETED|Overall Study||20
5113890|NCT01533207|12580590|P2|STARTED|Overall Study||18
5113891|NCT01533207|12580591|P1|STARTED|Overall Study||20
5113892|NCT01533181|12580603|P2|NOT COMPLETED|Overall Study||1
5113893|NCT01533181|12580604|P1|NOT COMPLETED|Overall Study||1
5113894|NCT01533181|12580603|P2|COMPLETED|Overall Study||28
5113895|NCT01533181|12580604|P1|COMPLETED|Overall Study||14
5113896|NCT01533181|12580603|P2|STARTED|Overall Study||29
5113897|NCT01533181|12580604|P1|STARTED|Overall Study||15
5113898|NCT01533116|12580620|P4|NOT COMPLETED|Overall Study||0
5113899|NCT01533116|12580621|P3|NOT COMPLETED|Overall Study||1
5113900|NCT01533116|12580622|P2|NOT COMPLETED|Overall Study||1
5113901|NCT01533116|12580623|P1|NOT COMPLETED|Overall Study||2
5113902|NCT01533116|12580620|P4|COMPLETED|Overall Study||12
5113903|NCT01533116|12580621|P3|COMPLETED|Overall Study||12
5113904|NCT01533116|12580622|P2|COMPLETED|Overall Study||12
5113905|NCT01533116|12580623|P1|COMPLETED|Overall Study||12
5113906|NCT01533116|12580620|P4|STARTED|Overall Study||12
5113907|NCT01533116|12580621|P3|STARTED|Overall Study||13
5113908|NCT01533116|12580622|P2|STARTED|Overall Study||13
5113909|NCT01533116|12580623|P1|STARTED|Overall Study||14
5113910|NCT01533077|12580653|P4|NOT COMPLETED|Overall Study||0
5113911|NCT01533077|12580654|P3|NOT COMPLETED|Overall Study||0
5113912|NCT01533077|12580655|P2|NOT COMPLETED|Overall Study||1
5113913|NCT01533077|12580656|P1|NOT COMPLETED|Overall Study||1
5113914|NCT01533077|12580653|P4|COMPLETED|Overall Study||4
5113915|NCT01533077|12580654|P3|COMPLETED|Overall Study||4
5113916|NCT01533077|12580655|P2|COMPLETED|Overall Study||4
5113917|NCT01533077|12580656|P1|COMPLETED|Overall Study||4
5113918|NCT01533077|12580653|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
5113919|NCT01533077|12580654|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
5113920|NCT01533077|12580655|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
5113921|NCT01533077|12580656|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
5113922|NCT01533077|12580653|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
5113923|NCT01533077|12580654|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
5113924|NCT01533077|12580655|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
5113925|NCT01533077|12580656|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
5113926|NCT01533077|12580653|P4|Sinemet® 100/25|Overall Study||4
5113927|NCT01533077|12580654|P3|Sinemet® 100/25|Overall Study||4
5113928|NCT01533077|12580655|P2|Sinemet® 100/25|Overall Study||5
5113929|NCT01533077|12580656|P1|Sinemet® 100/25|Overall Study||4
5113930|NCT01533077|12580653|P4|BIA 9-1067 50 mg|Overall Study||4
5113931|NCT01533077|12580654|P3|BIA 9-1067 50 mg|Overall Study||4
5113932|NCT01533077|12580655|P2|BIA 9-1067 50 mg|Overall Study||5
5113933|NCT01533077|12580656|P1|BIA 9-1067 50 mg|Overall Study||5
5113934|NCT01533077|12580653|P4|STARTED|Overall Study||4
5113935|NCT01533077|12580654|P3|STARTED|Overall Study||4
5113936|NCT01533077|12580655|P2|STARTED|Overall Study||5
5113937|NCT01533077|12580656|P1|STARTED|Overall Study||5
5113938|NCT01533038|12580712|P2|NOT COMPLETED|Overall Study||1
5113939|NCT01533038|12580713|P1|NOT COMPLETED|Overall Study||0
5113940|NCT01533038|12580712|P2|COMPLETED|Overall Study||34
5113941|NCT01533038|12580713|P1|COMPLETED|Overall Study||45
5113942|NCT01533038|12580712|P2|STARTED|Overall Study||35
5113943|NCT01533038|12580713|P1|STARTED|Overall Study||45
5113944|NCT01532999|12580721|P2|NOT COMPLETED|Overall Study||18
5113945|NCT01532999|12580722|P1|NOT COMPLETED|Overall Study||31
5113946|NCT01532999|12580721|P2|COMPLETED|Overall Study||77
5113947|NCT01532999|12580722|P1|COMPLETED|Overall Study||65
5113948|NCT01532999|12580721|P2|STARTED|Overall Study||95
5113949|NCT01532999|12580722|P1|STARTED|Overall Study||96
5113950|NCT01532986|12580746|P2|NOT COMPLETED|Overall Study||24
5113951|NCT01532986|12580747|P1|NOT COMPLETED|Overall Study||23
5113952|NCT01532986|12580746|P2|COMPLETED|Overall Study||138
5113953|NCT01532986|12580747|P1|COMPLETED|Overall Study||143
5113954|NCT01532986|12580746|P2|STARTED|Overall Study||162
5113955|NCT01532986|12580747|P1|STARTED|Overall Study||166
5113956|NCT01532973|12580780|P10|NOT COMPLETED|Part 3||0
5113957|NCT01532973|12580781|P9|NOT COMPLETED|Part 3||0
5113958|NCT01532973|12580782|P8|NOT COMPLETED|Part 3||0
5113959|NCT01532973|12580783|P7|NOT COMPLETED|Part 3||0
5113960|NCT01532973|12580784|P6|NOT COMPLETED|Part 3||0
5113961|NCT01532973|12580785|P5|NOT COMPLETED|Part 3||0
5113962|NCT01532973|12580786|P4|NOT COMPLETED|Part 3||0
5113963|NCT01532973|12580787|P3|NOT COMPLETED|Part 3||0
5113964|NCT01532973|12580788|P2|NOT COMPLETED|Part 3||0
5113965|NCT01532973|12580789|P1|NOT COMPLETED|Part 3||0
5113966|NCT01532973|12580780|P10|COMPLETED|Part 3||6
5113967|NCT01532973|12580781|P9|COMPLETED|Part 3||6
5113968|NCT01532973|12580782|P8|COMPLETED|Part 3||0
5113969|NCT01532973|12580783|P7|COMPLETED|Part 3||0
5113970|NCT01532973|12580784|P6|COMPLETED|Part 3||0
5113971|NCT01532973|12580785|P5|COMPLETED|Part 3||0
5113972|NCT01532973|12580786|P4|COMPLETED|Part 3||0
5113973|NCT01532973|12580787|P3|COMPLETED|Part 3||0
5113974|NCT01532973|12580788|P2|COMPLETED|Part 3||0
5113975|NCT01532973|12580789|P1|COMPLETED|Part 3||0
5113976|NCT01532973|12580780|P10|STARTED|Part 3||6
5113977|NCT01532973|12580781|P9|STARTED|Part 3||6
5113978|NCT01532973|12580782|P8|STARTED|Part 3||0
5113979|NCT01532973|12580783|P7|STARTED|Part 3||0
5113980|NCT01532973|12580784|P6|STARTED|Part 3||0
5113981|NCT01532973|12580785|P5|STARTED|Part 3||0
5113982|NCT01532973|12580786|P4|STARTED|Part 3||0
5113983|NCT01532973|12580787|P3|STARTED|Part 3||0
5113984|NCT01532973|12580788|P2|STARTED|Part 3||0
5113985|NCT01532973|12580789|P1|STARTED|Part 3||0
5113986|NCT01532973|12580780|P10|NOT COMPLETED|Part 2||0
5113987|NCT01532973|12580781|P9|NOT COMPLETED|Part 2||0
5113988|NCT01532973|12580782|P8|NOT COMPLETED|Part 2||0
5113989|NCT01532973|12580783|P7|NOT COMPLETED|Part 2||0
5113990|NCT01532973|12580784|P6|NOT COMPLETED|Part 2||0
5113991|NCT01532973|12580785|P5|NOT COMPLETED|Part 2||0
5113992|NCT01532973|12580786|P4|NOT COMPLETED|Part 2||0
5113993|NCT01532973|12580787|P3|NOT COMPLETED|Part 2||0
5113994|NCT01532973|12580788|P2|NOT COMPLETED|Part 2||0
5113995|NCT01532973|12580789|P1|NOT COMPLETED|Part 2||0
5113996|NCT01532973|12580780|P10|COMPLETED|Part 2||0
5113997|NCT01532973|12580781|P9|COMPLETED|Part 2||0
5113998|NCT01532973|12580782|P8|COMPLETED|Part 2||0
5113999|NCT01532973|12580783|P7|COMPLETED|Part 2||6
5114000|NCT01532973|12580784|P6|COMPLETED|Part 2||6
5114001|NCT01532973|12580785|P5|COMPLETED|Part 2||6
5114002|NCT01532973|12580786|P4|COMPLETED|Part 2||0
5114003|NCT01532973|12580787|P3|COMPLETED|Part 2||0
5114004|NCT01532973|12580788|P2|COMPLETED|Part 2||0
5114005|NCT01532973|12580789|P1|COMPLETED|Part 2||0
5114006|NCT01532973|12580780|P10|STARTED|Part 2||0
5114007|NCT01532973|12580781|P9|STARTED|Part 2||0
5114008|NCT01532973|12580782|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
5114009|NCT01532973|12580783|P7|STARTED|Part 2||6
5114010|NCT01532973|12580784|P6|STARTED|Part 2||6
5114011|NCT01532973|12580785|P5|STARTED|Part 2||6
5114012|NCT01532973|12580786|P4|STARTED|Part 2||0
5114013|NCT01532973|12580787|P3|STARTED|Part 2||0
5114014|NCT01532973|12580788|P2|STARTED|Part 2||0
5114015|NCT01532973|12580789|P1|STARTED|Part 2||0
5114016|NCT01532973|12580780|P10|NOT COMPLETED|Part 1||0
5114017|NCT01532973|12580781|P9|NOT COMPLETED|Part 1||0
5114018|NCT01532973|12580782|P8|NOT COMPLETED|Part 1||0
5114019|NCT01532973|12580783|P7|NOT COMPLETED|Part 1||0
5114020|NCT01532973|12580784|P6|NOT COMPLETED|Part 1||0
5114021|NCT01532973|12580785|P5|NOT COMPLETED|Part 1||0
5114022|NCT01532973|12580786|P4|NOT COMPLETED|Part 1||0
5114023|NCT01532973|12580787|P3|NOT COMPLETED|Part 1||0
5114024|NCT01532973|12580788|P2|NOT COMPLETED|Part 1||0
5114025|NCT01532973|12580789|P1|NOT COMPLETED|Part 1||0
5114026|NCT01532973|12580780|P10|COMPLETED|Part 1||0
5114027|NCT01532973|12580781|P9|COMPLETED|Part 1||0
5114028|NCT01532973|12580782|P8|COMPLETED|Part 1||0
5114029|NCT01532973|12580783|P7|COMPLETED|Part 1||0
5114030|NCT01532973|12580784|P6|COMPLETED|Part 1||0
5114031|NCT01532973|12580785|P5|COMPLETED|Part 1||0
5114032|NCT01532973|12580786|P4|COMPLETED|Part 1||0
5114033|NCT01532973|12580787|P3|COMPLETED|Part 1||6
5114034|NCT01532973|12580788|P2|COMPLETED|Part 1||6
5114035|NCT01532973|12580789|P1|COMPLETED|Part 1||6
5114036|NCT01532973|12580780|P10|STARTED|Part 1||0
5114037|NCT01532973|12580781|P9|STARTED|Part 1||0
5114038|NCT01532973|12580782|P8|STARTED|Part 1||0
5114039|NCT01532973|12580783|P7|STARTED|Part 1||0
5114040|NCT01532973|12580784|P6|STARTED|Part 1||0
5114041|NCT01532973|12580785|P5|STARTED|Part 1||0
5114042|NCT01532973|12580786|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
5114043|NCT01532973|12580787|P3|STARTED|Part 1||6
5114044|NCT01532973|12580788|P2|STARTED|Part 1||6
5114045|NCT01532973|12580789|P1|STARTED|Part 1||6
5114046|NCT01532934|12580831|P2|NOT COMPLETED|Overall Study||13
5114047|NCT01532934|12580832|P1|NOT COMPLETED|Overall Study||14
5114048|NCT01532934|12580831|P2|COMPLETED|Overall Study||39
5114049|NCT01532934|12580832|P1|COMPLETED|Overall Study||39
5114050|NCT01532934|12580831|P2|STARTED|Overall Study||52
5114051|NCT01532934|12580832|P1|STARTED|Overall Study||53
5114052|NCT01532921|12580842|P1|NOT COMPLETED|Overall Study||16
5114053|NCT01532921|12580842|P1|COMPLETED|Overall Study||69
5114054|NCT01532921|12580842|P1|6 Months Follow Up|Overall Study||68
5114055|NCT01532921|12580842|P1|Discharge|Overall Study||75
5114056|NCT01532921|12580842|P1|Implantation Procedure|Overall Study||76
5114057|NCT01532921|12580842|P1|STARTED|Overall Study||85
5114058|NCT01532869|12580864|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
5114059|NCT01532869|12580865|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
5114060|NCT01532869|12580864|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
5114061|NCT01532869|12580865|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
5114062|NCT01532869|12580864|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
5114063|NCT01532869|12580865|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
5114064|NCT01532869|12580864|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
5114065|NCT01532869|12580865|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
5114066|NCT01532869|12580864|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
5114156|NCT01532128|12581059|P2|NOT COMPLETED|Overall Study||0
5114067|NCT01532869|12580865|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
5114068|NCT01532869|12580864|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
5114069|NCT01532869|12580865|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
5114070|NCT01532869|12580864|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
5114071|NCT01532869|12580865|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
5114072|NCT01532869|12580864|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
5114073|NCT01532869|12580865|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
5114074|NCT01532869|12580864|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
5114075|NCT01532869|12580865|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
5114076|NCT01532830|12580902|P1|NOT COMPLETED|Overall Study||4
5114077|NCT01532830|12580902|P1|COMPLETED|Overall Study||26
5114078|NCT01532830|12580902|P1|STARTED|Overall Study||30
5114079|NCT01532817|12580911|P1|NOT COMPLETED|Overall Study||0
5114080|NCT01532817|12580911|P1|COMPLETED|Overall Study||30
5114081|NCT01532817|12580911|P1|STARTED|Overall Study||30
5114082|NCT01532700|12580915|P1|NOT COMPLETED|Overall Study||0
5114083|NCT01532700|12580915|P1|COMPLETED|Overall Study||28
5114084|NCT01532700|12580915|P1|STARTED|Overall Study||28
5114085|NCT01532648|12580924|P2|NOT COMPLETED|Overall Study||17
5114086|NCT01532648|12580925|P1|NOT COMPLETED|Overall Study||36
5114087|NCT01532648|12580924|P2|COMPLETED|Overall Study||238
5114088|NCT01532648|12580925|P1|COMPLETED|Overall Study||219
5114089|NCT01532648|12580924|P2|Intent-To-Treat Population|Overall Study||228
5114090|NCT01532648|12580925|P1|Intent-To-Treat Population|Overall Study||230
5114091|NCT01532648|12580924|P2|Safety Population|Overall Study||255
5114092|NCT01532648|12580925|P1|Safety Population|Overall Study||255
5114093|NCT01532648|12580924|P2|STARTED|Overall Study||255
5114094|NCT01532648|12580925|P1|STARTED|Overall Study||255
5114095|NCT01532635|12580943|P1|NOT COMPLETED|Overall Study||0
5114096|NCT01532635|12580943|P1|COMPLETED|Overall Study||4
5114097|NCT01532635|12580943|P1|STARTED|Overall Study||4
5114098|NCT01532570|12580959|P4|NOT COMPLETED|Overall Study||0
5114099|NCT01532570|12580960|P3|NOT COMPLETED|Overall Study||0
5114100|NCT01532570|12580961|P2|NOT COMPLETED|Overall Study||1
5114101|NCT01532570|12580962|P1|NOT COMPLETED|Overall Study||1
5114102|NCT01532570|12580959|P4|COMPLETED|Overall Study||4
5114103|NCT01532570|12580960|P3|COMPLETED|Overall Study||1
5114104|NCT01532570|12580961|P2|COMPLETED|Overall Study||1
5114105|NCT01532570|12580962|P1|COMPLETED|Overall Study||10
5114106|NCT01532570|12580959|P4|STARTED|Overall Study||4
5114107|NCT01532570|12580960|P3|STARTED|Overall Study||1
5114108|NCT01532570|12580961|P2|STARTED|Overall Study||2
5114109|NCT01532570|12580962|P1|STARTED|Overall Study||11
5114110|NCT01532453|12580995|P2|NOT COMPLETED|Overall Study||70
5114111|NCT01532453|12580996|P1|NOT COMPLETED|Overall Study||27
5114112|NCT01532453|12580995|P2|COMPLETED|Overall Study||90
5114113|NCT01532453|12580996|P1|COMPLETED|Overall Study||54
5114114|NCT01532453|12580995|P2|STARTED|Overall Study||160
5114115|NCT01532453|12580996|P1|STARTED|Overall Study||81
5114116|NCT01532414|12581007|P3|NOT COMPLETED|Overall Study||3
5114117|NCT01532414|12581008|P2|NOT COMPLETED|Overall Study||2
5114118|NCT01532414|12581009|P1|NOT COMPLETED|Overall Study||7
5114119|NCT01532414|12581007|P3|COMPLETED|Overall Study||35
5114120|NCT01532414|12581008|P2|COMPLETED|Overall Study||19
5114121|NCT01532414|12581009|P1|COMPLETED|Overall Study||85
5114122|NCT01532414|12581007|P3|STARTED|Overall Study||38
5114123|NCT01532414|12581008|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
5114124|NCT01532414|12581009|P1|STARTED|Overall Study||92
5114125|NCT01532362|12581019|P2|NOT COMPLETED|Overall Study||0
5114126|NCT01532362|12581020|P1|NOT COMPLETED|Overall Study||0
5114127|NCT01532362|12581019|P2|COMPLETED|Overall Study||0
5114128|NCT01532362|12581020|P1|COMPLETED|Overall Study||1
5114129|NCT01532362|12581019|P2|STARTED|Overall Study||0
5114130|NCT01532362|12581020|P1|STARTED|Overall Study||1
5114131|NCT01532349|12581028|P2|NOT COMPLETED|Overall Study||5
5114132|NCT01532349|12581029|P1|NOT COMPLETED|Overall Study||2
5114133|NCT01532349|12581028|P2|COMPLETED|Overall Study||12
5114134|NCT01532349|12581029|P1|COMPLETED|Overall Study||15
5114135|NCT01532349|12581028|P2|STARTED|Overall Study||17
5114136|NCT01532349|12581029|P1|STARTED|Overall Study||17
5114137|NCT01532141|12581038|P3|NOT COMPLETED|Overall Study||0
5114138|NCT01532141|12581039|P2|NOT COMPLETED|Overall Study||0
5114139|NCT01532141|12581040|P1|NOT COMPLETED|Overall Study||1
5114140|NCT01532141|12581038|P3|COMPLETED|Overall Study||8
5114141|NCT01532141|12581039|P2|COMPLETED|Overall Study||8
5114142|NCT01532141|12581040|P1|COMPLETED|Overall Study||8
5114143|NCT01532141|12581038|P3|Period 3|Overall Study||8
5114144|NCT01532141|12581039|P2|Period 3|Overall Study||8
5114145|NCT01532141|12581040|P1|Period 3|Overall Study||8
5114146|NCT01532141|12581038|P3|Period 2|Overall Study||8
5114147|NCT01532141|12581039|P2|Period 2|Overall Study||8
5114148|NCT01532141|12581040|P1|Period 2|Overall Study||8
5114149|NCT01532141|12581038|P3|Period 1|Overall Study||8
5114150|NCT01532141|12581039|P2|Period 1|Overall Study||8
5114151|NCT01532141|12581040|P1|Period 1|Overall Study||9
5114152|NCT01532141|12581038|P3|STARTED|Overall Study||8
5114153|NCT01532141|12581039|P2|STARTED|Overall Study||8
5114154|NCT01532141|12581040|P1|STARTED|Overall Study||9
5114155|NCT01532128|12581058|P3|NOT COMPLETED|Overall Study||0
5114157|NCT01532128|12581060|P1|NOT COMPLETED|Overall Study||0
5114158|NCT01532128|12581058|P3|COMPLETED|Overall Study||8
5114159|NCT01532128|12581059|P2|COMPLETED|Overall Study||8
5114160|NCT01532128|12581060|P1|COMPLETED|Overall Study||8
5114161|NCT01532128|12581058|P3|STARTED|Overall Study||8
5114162|NCT01532128|12581059|P2|STARTED|Overall Study||8
5114163|NCT01532128|12581060|P1|STARTED|Overall Study||8
5114164|NCT01532089|12581077|P2|NOT COMPLETED|Overall Study||0
5114165|NCT01532089|12581078|P1|NOT COMPLETED|Overall Study||0
5114166|NCT01532089|12581077|P2|COMPLETED|Overall Study||43
5114167|NCT01532089|12581078|P1|COMPLETED|Overall Study||45
5114168|NCT01532089|12581077|P2|STARTED|Overall Study||43
5114169|NCT01532089|12581078|P1|STARTED|Overall Study||45
5114170|NCT01531998|12581092|P1|NOT COMPLETED|Overall Study||3
5114171|NCT01531998|12581092|P1|COMPLETED|Overall Study||8
5114172|NCT01531998|12581092|P1|STARTED|Overall Study||11
5114173|NCT01531894|12581097|P1|NOT COMPLETED|Overall Study||9
5114174|NCT01531894|12581097|P1|COMPLETED|Overall Study||2
5114175|NCT01531894|12581097|P1|STARTED|Overall Study||11
5114176|NCT01531725|12581101|P1|NOT COMPLETED|Overall Study||5
5114177|NCT01531725|12581101|P1|COMPLETED|Overall Study||197
5114178|NCT01531725|12581101|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
5114179|NCT01531673|12581119|P13|NOT COMPLETED|Overall Study||0
5114180|NCT01531673|12581120|P12|NOT COMPLETED|Overall Study||0
5114181|NCT01531673|12581121|P11|NOT COMPLETED|Overall Study||0
5114182|NCT01531673|12581122|P10|NOT COMPLETED|Overall Study||1
5114183|NCT01531673|12581123|P9|NOT COMPLETED|Overall Study||0
5114184|NCT01531673|12581124|P8|NOT COMPLETED|Overall Study||0
5114185|NCT01531673|12581125|P7|NOT COMPLETED|Overall Study||0
5114186|NCT01531673|12581126|P6|NOT COMPLETED|Overall Study||1
5114187|NCT01531673|12581127|P5|NOT COMPLETED|Overall Study||1
5114188|NCT01531673|12581128|P4|NOT COMPLETED|Overall Study||1
5114189|NCT01531673|12581129|P3|NOT COMPLETED|Overall Study||0
5114190|NCT01531673|12581130|P2|NOT COMPLETED|Overall Study||1
5114191|NCT01531673|12581131|P1|NOT COMPLETED|Overall Study||0
5114192|NCT01531673|12581119|P13|COMPLETED|Overall Study||14
5114193|NCT01531673|12581120|P12|COMPLETED|Overall Study||4
5114194|NCT01531673|12581121|P11|COMPLETED|Overall Study||16
5114195|NCT01531673|12581122|P10|COMPLETED|Overall Study||18
5114196|NCT01531673|12581123|P9|COMPLETED|Overall Study||17
5114197|NCT01531673|12581124|P8|COMPLETED|Overall Study||9
5114198|NCT01531673|12581125|P7|COMPLETED|Overall Study||17
5114199|NCT01531673|12581126|P6|COMPLETED|Overall Study||18
5114200|NCT01531673|12581127|P5|COMPLETED|Overall Study||7
5114201|NCT01531673|12581128|P4|COMPLETED|Overall Study||17
5114202|NCT01531673|12581129|P3|COMPLETED|Overall Study||8
5114203|NCT01531673|12581130|P2|COMPLETED|Overall Study||7
5114204|NCT01531673|12581131|P1|COMPLETED|Overall Study||33
5114205|NCT01531673|12581119|P13|STARTED|Overall Study||14
5114206|NCT01531673|12581120|P12|STARTED|Overall Study||4
5114207|NCT01531673|12581121|P11|STARTED|Overall Study||16
5114208|NCT01531673|12581122|P10|STARTED|Overall Study||19
5114209|NCT01531673|12581123|P9|STARTED|Overall Study||17
5114210|NCT01531673|12581124|P8|STARTED|Overall Study||9
5114211|NCT01531673|12581125|P7|STARTED|Overall Study||17
5114212|NCT01531673|12581126|P6|STARTED|Overall Study||19
5114213|NCT01531673|12581127|P5|STARTED|Overall Study||8
5114214|NCT01531673|12581128|P4|STARTED|Overall Study||18
5114215|NCT01531673|12581129|P3|STARTED|Overall Study||8
5114216|NCT01531673|12581130|P2|STARTED|Overall Study||8
5114217|NCT01531673|12581131|P1|STARTED|Overall Study||33
5114218|NCT01531387|12581242|P2|NOT COMPLETED|Overall Study||11
5114219|NCT01531387|12581243|P1|NOT COMPLETED|Overall Study||11
5114220|NCT01531387|12581242|P2|COMPLETED|Overall Study||0
5114221|NCT01531387|12581243|P1|COMPLETED|Overall Study||0
5114222|NCT01531387|12581242|P2|STARTED|Overall Study||11
5114223|NCT01531387|12581243|P1|STARTED|Overall Study||11
5114224|NCT01531374|12581260|P3|NOT COMPLETED|Overall Study||283
5114225|NCT01531374|12581261|P2|NOT COMPLETED|Overall Study||142
5114226|NCT01531374|12581262|P1|NOT COMPLETED|Overall Study||364
5114227|NCT01531374|12581260|P3|COMPLETED|Overall Study||836
5114228|NCT01531374|12581261|P2|COMPLETED|Overall Study||231
5114229|NCT01531374|12581262|P1|COMPLETED|Overall Study||921
5114230|NCT01531374|12581260|P3|STARTED|Overall Study||1119
5114231|NCT01531374|12581261|P2|STARTED|Overall Study||373
5114232|NCT01531374|12581262|P1|STARTED|Overall Study||1285
5114233|NCT01531335|12581326|P2|NOT COMPLETED|Overall Study||0
5114234|NCT01531335|12581327|P1|NOT COMPLETED|Overall Study||0
5114235|NCT01531335|12581326|P2|COMPLETED|Overall Study||40
5114236|NCT01531335|12581327|P1|COMPLETED|Overall Study||40
5114237|NCT01531335|12581326|P2|STARTED|Overall Study||40
5114238|NCT01531335|12581327|P1|STARTED|Overall Study||40
5114239|NCT01531205|12581335|P1|NOT COMPLETED|Overall Study||1
5114240|NCT01531205|12581335|P1|COMPLETED|Overall Study||1
5114241|NCT01531205|12581335|P1|STARTED|Overall Study||2
5114242|NCT01531153|12581347|P3|NOT COMPLETED|Overall Study||15
5114243|NCT01531153|12581348|P2|NOT COMPLETED|Overall Study||9
5114244|NCT01531153|12581349|P1|NOT COMPLETED|Overall Study||10
5114245|NCT01531153|12581347|P3|COMPLETED|Overall Study||15
5114246|NCT01531153|12581348|P2|COMPLETED|Overall Study||22
5114247|NCT01531153|12581349|P1|COMPLETED|Overall Study||22
5114248|NCT01531153|12581347|P3|STARTED|Overall Study||30
5114249|NCT01531153|12581348|P2|STARTED|Overall Study||31
5114250|NCT01531153|12581349|P1|STARTED|Overall Study||32
5114251|NCT01530997|12581405|P1|NOT COMPLETED|Overall Study||2
5114252|NCT01530997|12581405|P1|COMPLETED|Overall Study||43
5114253|NCT01530997|12581405|P1|STARTED|Overall Study||45
5114254|NCT01530880|12581425|P1|NOT COMPLETED|Overall Study||0
5114255|NCT01530880|12581425|P1|COMPLETED|Overall Study||35
5114256|NCT01530880|12581425|P1|STARTED|Overall Study||35
5114257|NCT01530477|12581439|P3|NOT COMPLETED|Overall Study||0
5114258|NCT01530477|12581440|P2|NOT COMPLETED|Overall Study||0
5114259|NCT01530477|12581441|P1|NOT COMPLETED|Overall Study||0
5114260|NCT01530477|12581439|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
5114261|NCT01530477|12581440|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
5114262|NCT01530477|12581441|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
5114263|NCT01530477|12581439|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
5114264|NCT01530477|12581440|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
5114265|NCT01530477|12581441|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
5114266|NCT01530464|12581449|P2|NOT COMPLETED|Washout (24h)||1
5114267|NCT01530464|12581450|P1|NOT COMPLETED|Washout (24h)||0
5114268|NCT01530464|12581449|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
5114269|NCT01530464|12581450|P1|COMPLETED|Washout (24h)||9
5114270|NCT01530464|12581449|P2|STARTED|Washout (24h)||8
5114271|NCT01530464|12581450|P1|STARTED|Washout (24h)||9
5114272|NCT01530464|12581449|P2|NOT COMPLETED|Third Intervention (24h)||0
5114273|NCT01530464|12581450|P1|NOT COMPLETED|Third Intervention (24h)||0
5114274|NCT01530464|12581449|P2|COMPLETED|Third Intervention (24h)||8
5114275|NCT01530464|12581450|P1|COMPLETED|Third Intervention (24h)||9
5114276|NCT01530464|12581449|P2|STARTED|Third Intervention (24h)||8
5114277|NCT01530464|12581450|P1|STARTED|Third Intervention (24h)||9
5114278|NCT01530464|12581449|P2|NOT COMPLETED|Washout (24h)||0
5114279|NCT01530464|12581450|P1|NOT COMPLETED|Washout (24h)||1
5114280|NCT01530464|12581449|P2|COMPLETED|Washout (24h)||8
5114281|NCT01530464|12581450|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
5114282|NCT01530464|12581449|P2|STARTED|Washout (24h)||8
5114283|NCT01530464|12581450|P1|STARTED|Washout (24h)||10
5114284|NCT01530464|12581449|P2|NOT COMPLETED|Second Intervention (24h)||0
5114285|NCT01530464|12581450|P1|NOT COMPLETED|Second Intervention (24h)||0
5114286|NCT01530464|12581449|P2|COMPLETED|Second Intervention (24h)||8
5114287|NCT01530464|12581450|P1|COMPLETED|Second Intervention (24h)||10
5114288|NCT01530464|12581449|P2|STARTED|Second Intervention (24h)||8
5114289|NCT01530464|12581450|P1|STARTED|Second Intervention (24h)||10
5114290|NCT01530464|12581449|P2|NOT COMPLETED|Washout (24h)||0
5114291|NCT01530464|12581450|P1|NOT COMPLETED|Washout (24h)||0
5114292|NCT01530464|12581449|P2|COMPLETED|Washout (24h)||8
5114293|NCT01530464|12581450|P1|COMPLETED|Washout (24h)||10
5114294|NCT01530464|12581449|P2|STARTED|Washout (24h)||8
5114295|NCT01530464|12581450|P1|STARTED|Washout (24h)||10
5114296|NCT01530464|12581449|P2|NOT COMPLETED|First Intervention (24h)||0
5114297|NCT01530464|12581450|P1|NOT COMPLETED|First Intervention (24h)||0
5114298|NCT01530464|12581449|P2|COMPLETED|First Intervention (24h)||8
5114299|NCT01530464|12581450|P1|COMPLETED|First Intervention (24h)||10
5114300|NCT01530464|12581449|P2|STARTED|First Intervention (24h)||8
5114301|NCT01530464|12581450|P1|STARTED|First Intervention (24h)||10
5114302|NCT01530399|12581483|P6|NOT COMPLETED|Overall Study||1
5114303|NCT01530399|12581484|P5|NOT COMPLETED|Overall Study||0
5114304|NCT01530399|12581485|P4|NOT COMPLETED|Overall Study||0
5114305|NCT01530399|12581486|P3|NOT COMPLETED|Overall Study||1
5114306|NCT01530399|12581487|P2|NOT COMPLETED|Overall Study||2
5114307|NCT01530399|12581488|P1|NOT COMPLETED|Overall Study||1
5114308|NCT01530399|12581483|P6|COMPLETED|Overall Study||6
5114309|NCT01530399|12581484|P5|COMPLETED|Overall Study||6
5114310|NCT01530399|12581485|P4|COMPLETED|Overall Study||10
5114311|NCT01530399|12581486|P3|COMPLETED|Overall Study||7
5114312|NCT01530399|12581487|P2|COMPLETED|Overall Study||8
5114313|NCT01530399|12581488|P1|COMPLETED|Overall Study||7
5114314|NCT01530399|12581483|P6|STARTED|Overall Study||7
5114315|NCT01530399|12581484|P5|STARTED|Overall Study||6
5114316|NCT01530399|12581485|P4|STARTED|Overall Study||10
5114317|NCT01530399|12581486|P3|STARTED|Overall Study||8
5114318|NCT01530399|12581487|P2|STARTED|Overall Study||10
5114319|NCT01530399|12581488|P1|STARTED|Overall Study||8
5114320|NCT01530334|12581502|P1|NOT COMPLETED|Overall Study||51
5114321|NCT01530334|12581502|P1|COMPLETED|Overall Study||10
5114322|NCT01530334|12581502|P1|STARTED|Overall Study||61
5114323|NCT01530243|12581515|P4|NOT COMPLETED|Overall Study||2
5114324|NCT01530243|12581516|P3|NOT COMPLETED|Overall Study||3
5114325|NCT01530243|12581517|P2|NOT COMPLETED|Overall Study||3
5114326|NCT01530243|12581518|P1|NOT COMPLETED|Overall Study||2
5114327|NCT01530243|12581515|P4|COMPLETED|Overall Study||24
5114328|NCT01530243|12581516|P3|COMPLETED|Overall Study||23
5114329|NCT01530243|12581517|P2|COMPLETED|Overall Study||23
5114330|NCT01530243|12581518|P1|COMPLETED|Overall Study||24
5114331|NCT01530243|12581515|P4|STARTED|Overall Study||26
5114332|NCT01530243|12581516|P3|STARTED|Overall Study||26
5114333|NCT01530243|12581517|P2|STARTED|Overall Study||26
5114334|NCT01530243|12581518|P1|STARTED|Overall Study||26
5114335|NCT01530178|12581538|P2|NOT COMPLETED|Overall Study||0
5114336|NCT01530178|12581539|P1|NOT COMPLETED|Overall Study||0
5114337|NCT01530178|12581538|P2|COMPLETED|Overall Study||6
5114338|NCT01530178|12581539|P1|COMPLETED|Overall Study||2
5114339|NCT01530178|12581538|P2|STARTED|Overall Study||6
5114340|NCT01530178|12581539|P1|STARTED|Overall Study||2
5114341|NCT01530087|12581549|P1|NOT COMPLETED|Overall Study||2
5114342|NCT01530087|12581549|P1|COMPLETED|Overall Study||1
5114343|NCT01530087|12581549|P1|STARTED|Overall Study||3
5114344|NCT01529827|12581554|P1|NOT COMPLETED|Overall Study||0
5114345|NCT01529827|12581554|P1|COMPLETED|Overall Study||94
5114346|NCT01529827|12581554|P1|STARTED|Overall Study||94
5114347|NCT01529749|12581565|P4|NOT COMPLETED|Overall Study||2
5114348|NCT01529749|12581566|P3|NOT COMPLETED|Overall Study||2
5114349|NCT01529749|12581567|P2|NOT COMPLETED|Overall Study||2
5114350|NCT01529749|12581568|P1|NOT COMPLETED|Overall Study||0
5114351|NCT01529749|12581565|P4|COMPLETED|Overall Study||10
5114352|NCT01529749|12581566|P3|COMPLETED|Overall Study||10
5114353|NCT01529749|12581567|P2|COMPLETED|Overall Study||10
5114354|NCT01529749|12581568|P1|COMPLETED|Overall Study||12
5114355|NCT01529749|12581565|P4|STARTED|Overall Study||12
5114356|NCT01529749|12581566|P3|STARTED|Overall Study||12
5114357|NCT01529749|12581567|P2|STARTED|Overall Study||12
5114358|NCT01529749|12581568|P1|STARTED|Overall Study||12
5114359|NCT01529645|12581652|P10|NOT COMPLETED|Overall Study||0
5114360|NCT01529645|12581653|P9|NOT COMPLETED|Overall Study||1
5114361|NCT01529645|12581654|P8|NOT COMPLETED|Overall Study||0
5114362|NCT01529645|12581655|P7|NOT COMPLETED|Overall Study||2
5114363|NCT01529645|12581656|P6|NOT COMPLETED|Overall Study||1
5114364|NCT01529645|12581657|P5|NOT COMPLETED|Overall Study||2
5114365|NCT01529645|12581658|P4|NOT COMPLETED|Overall Study||2
5114366|NCT01529645|12581659|P3|NOT COMPLETED|Overall Study||2
5114367|NCT01529645|12581660|P2|NOT COMPLETED|Overall Study||1
5114368|NCT01529645|12581661|P1|NOT COMPLETED|Overall Study||2
5114369|NCT01529645|12581652|P10|COMPLETED|Overall Study||42
5114370|NCT01529645|12581653|P9|COMPLETED|Overall Study||41
5114371|NCT01529645|12581654|P8|COMPLETED|Overall Study||42
5114372|NCT01529645|12581655|P7|COMPLETED|Overall Study||40
5114373|NCT01529645|12581656|P6|COMPLETED|Overall Study||41
5114374|NCT01529645|12581657|P5|COMPLETED|Overall Study||40
5114375|NCT01529645|12581658|P4|COMPLETED|Overall Study||40
5114376|NCT01529645|12581659|P3|COMPLETED|Overall Study||40
5114377|NCT01529645|12581660|P2|COMPLETED|Overall Study||41
5114378|NCT01529645|12581661|P1|COMPLETED|Overall Study||40
5114379|NCT01529645|12581652|P10|STARTED|Overall Study||42
5114380|NCT01529645|12581653|P9|STARTED|Overall Study||42
5114381|NCT01529645|12581654|P8|STARTED|Overall Study||42
5114382|NCT01529645|12581655|P7|STARTED|Overall Study||42
5114383|NCT01529645|12581656|P6|STARTED|Overall Study||42
5114384|NCT01529645|12581657|P5|STARTED|Overall Study||42
5114385|NCT01529645|12581658|P4|STARTED|Overall Study||42
5114386|NCT01529645|12581659|P3|STARTED|Overall Study||42
5114387|NCT01529645|12581660|P2|STARTED|Overall Study||42
5114388|NCT01529645|12581661|P1|STARTED|Overall Study||42
5114389|NCT01529632|12581759|P2|NOT COMPLETED|Overall Study||3
5114390|NCT01529632|12581760|P1|NOT COMPLETED|Overall Study||3
5114391|NCT01529632|12581759|P2|COMPLETED|Overall Study||100
5114392|NCT01529632|12581760|P1|COMPLETED|Overall Study||87
5114393|NCT01529632|12581759|P2|STARTED|Overall Study||103
5114394|NCT01529632|12581760|P1|STARTED|Overall Study||90
5114395|NCT01529606|12581780|P2|NOT COMPLETED|Overall Study||18
5114396|NCT01529606|12581781|P1|NOT COMPLETED|Overall Study||21
5114397|NCT01529606|12581780|P2|COMPLETED|Overall Study||29
5114398|NCT01529606|12581781|P1|COMPLETED|Overall Study||34
5114399|NCT01529606|12581780|P2|STARTED|Overall Study||47
5114400|NCT01529606|12581781|P1|STARTED|Overall Study||55
5114401|NCT01529515|12581793|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
5114402|NCT01529515|12581794|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
5114403|NCT01529515|12581795|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
5114404|NCT01529515|12581796|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
5114405|NCT01529515|12581793|P4|COMPLETED|DOUBLE BLIND PHASE||148
5114406|NCT01529515|12581794|P3|COMPLETED|DOUBLE BLIND PHASE||122
5114407|NCT01529515|12581795|P2|COMPLETED|DOUBLE BLIND PHASE||0
5114408|NCT01529515|12581796|P1|COMPLETED|DOUBLE BLIND PHASE||0
5114409|NCT01529515|12581793|P4|STARTED|DOUBLE BLIND PHASE||160
5114410|NCT01529515|12581794|P3|STARTED|DOUBLE BLIND PHASE||145
5114411|NCT01529515|12581795|P2|STARTED|DOUBLE BLIND PHASE||0
5114412|NCT01529515|12581796|P1|STARTED|DOUBLE BLIND PHASE||0
5114413|NCT01529515|12581793|P4|NOT COMPLETED|MAINTENANCE PHASE||0
5114414|NCT01529515|12581794|P3|NOT COMPLETED|MAINTENANCE PHASE||0
5114415|NCT01529515|12581795|P2|NOT COMPLETED|MAINTENANCE PHASE||74
5114416|NCT01529515|12581796|P1|NOT COMPLETED|MAINTENANCE PHASE||0
5114417|NCT01529515|12581793|P4|COMPLETED|MAINTENANCE PHASE||0
5114418|NCT01529515|12581794|P3|COMPLETED|MAINTENANCE PHASE||0
5114419|NCT01529515|12581795|P2|COMPLETED|MAINTENANCE PHASE||305
5114420|NCT01529515|12581796|P1|COMPLETED|MAINTENANCE PHASE||0
5114421|NCT01529515|12581793|P4|STARTED|MAINTENANCE PHASE||0
5114422|NCT01529515|12581794|P3|STARTED|MAINTENANCE PHASE||0
5114423|NCT01529515|12581795|P2|STARTED|MAINTENANCE PHASE||379
5114424|NCT01529515|12581796|P1|STARTED|MAINTENANCE PHASE||0
5114425|NCT01529515|12581793|P4|NOT COMPLETED|TRANSITION PHASE||0
5114426|NCT01529515|12581794|P3|NOT COMPLETED|TRANSITION PHASE||0
5114427|NCT01529515|12581795|P2|NOT COMPLETED|TRANSITION PHASE||0
5114428|NCT01529515|12581796|P1|NOT COMPLETED|TRANSITION PHASE||127
5114429|NCT01529515|12581793|P4|COMPLETED|TRANSITION PHASE||0
5114430|NCT01529515|12581794|P3|COMPLETED|TRANSITION PHASE||0
5114431|NCT01529515|12581795|P2|COMPLETED|TRANSITION PHASE||0
5114432|NCT01529515|12581796|P1|COMPLETED|TRANSITION PHASE||379
5114433|NCT01529515|12581793|P4|STARTED|TRANSITION PHASE||0
5114434|NCT01529515|12581794|P3|STARTED|TRANSITION PHASE||0
5114435|NCT01529515|12581795|P2|STARTED|TRANSITION PHASE||0
5114436|NCT01529515|12581796|P1|STARTED|TRANSITION PHASE||506
5114437|NCT01529502|12581815|P6|NOT COMPLETED|Overall Study||0
5114438|NCT01529502|12581816|P5|NOT COMPLETED|Overall Study||0
5114439|NCT01529502|12581817|P4|NOT COMPLETED|Overall Study||2
5114440|NCT01529502|12581818|P3|NOT COMPLETED|Overall Study||0
5114441|NCT01529502|12581819|P2|NOT COMPLETED|Overall Study||0
5114442|NCT01529502|12581820|P1|NOT COMPLETED|Overall Study||0
5114443|NCT01529502|12581815|P6|COMPLETED|Overall Study||2
5114444|NCT01529502|12581816|P5|COMPLETED|Overall Study||2
5114445|NCT01529502|12581817|P4|COMPLETED|Overall Study||1
5114446|NCT01529502|12581818|P3|COMPLETED|Overall Study||2
5114447|NCT01529502|12581819|P2|COMPLETED|Overall Study||3
5114448|NCT01529502|12581820|P1|COMPLETED|Overall Study||2
5114449|NCT01529502|12581815|P6|STARTED|Overall Study||2
5114450|NCT01529502|12581816|P5|STARTED|Overall Study||2
5114451|NCT01529502|12581817|P4|STARTED|Overall Study||3
5114452|NCT01529502|12581818|P3|STARTED|Overall Study||2
5114453|NCT01529502|12581819|P2|STARTED|Overall Study||3
5114454|NCT01529502|12581820|P1|STARTED|Overall Study||2
5114455|NCT01529450|12581833|P2|NOT COMPLETED|Overall Study||2
5114456|NCT01529450|12581834|P1|NOT COMPLETED|Overall Study||0
5114457|NCT01529450|12581833|P2|COMPLETED|Overall Study||6
5114458|NCT01529450|12581834|P1|COMPLETED|Overall Study||3
5114459|NCT01529450|12581833|P2|STARTED|Overall Study||8
5114460|NCT01529450|12581834|P1|STARTED|Overall Study||3
5114461|NCT01529385|12581843|P2|NOT COMPLETED|Overall Study||1
5114462|NCT01529385|12581844|P1|NOT COMPLETED|Overall Study||2
5114463|NCT01529385|12581843|P2|COMPLETED|Overall Study||39
5114464|NCT01529385|12581844|P1|COMPLETED|Overall Study||38
5114465|NCT01529385|12581843|P2|Received Intervention|Overall Study||40
5114466|NCT01529385|12581844|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
5114467|NCT01529385|12581843|P2|STARTED|Overall Study||40
5114468|NCT01529385|12581844|P1|STARTED|Overall Study||40
5114469|NCT01529346|12581873|P5|NOT COMPLETED|Overall Study||0
5114470|NCT01529346|12581874|P4|NOT COMPLETED|Overall Study||0
5114471|NCT01529346|12581875|P3|NOT COMPLETED|Overall Study||2
5114472|NCT01529346|12581876|P2|NOT COMPLETED|Overall Study||1
5114473|NCT01529346|12581877|P1|NOT COMPLETED|Overall Study||2
5114474|NCT01529346|12581873|P5|COMPLETED|Overall Study||36
5114475|NCT01529346|12581874|P4|COMPLETED|Overall Study||36
5114476|NCT01529346|12581875|P3|COMPLETED|Overall Study||52
5114477|NCT01529346|12581876|P2|COMPLETED|Overall Study||53
5114478|NCT01529346|12581877|P1|COMPLETED|Overall Study||53
5114479|NCT01529346|12581873|P5|STARTED|Overall Study||36
5114480|NCT01529346|12581874|P4|STARTED|Overall Study||36
5114481|NCT01529346|12581875|P3|STARTED|Overall Study||54
5114482|NCT01529346|12581876|P2|STARTED|Overall Study||54
5114483|NCT01529346|12581877|P1|STARTED|Overall Study||55
5114484|NCT01529268|12581965|P2|NOT COMPLETED|Overall Study||3
5114485|NCT01529268|12581966|P1|NOT COMPLETED|Overall Study||12
5114486|NCT01529268|12581965|P2|COMPLETED|Overall Study||78
5114487|NCT01529268|12581966|P1|COMPLETED|Overall Study||76
5114488|NCT01529268|12581965|P2|Completed 52-week Biopsy|Overall Study||75
5114489|NCT01529268|12581966|P1|Completed 52-week Biopsy|Overall Study||71
5114490|NCT01529268|12581965|P2|STARTED|Overall Study||81
5114491|NCT01529268|12581966|P1|STARTED|Overall Study||88
5114492|NCT01529203|12582020|P1|NOT COMPLETED|Overall Study||3
5114493|NCT01529203|12582020|P1|COMPLETED|Overall Study||57
5114494|NCT01529203|12582020|P1|STARTED|Overall Study||60
5114495|NCT01529112|12582028|P2|NOT COMPLETED|Overall Study||41
5114496|NCT01529112|12582029|P1|NOT COMPLETED|Overall Study||69
5114497|NCT01529112|12582028|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
5114498|NCT01529112|12582029|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
5114499|NCT01529112|12582028|P2|STARTED|Overall Study||46
5114500|NCT01529112|12582029|P1|STARTED|Overall Study||89
5114501|NCT01529060|12582056|P2|NOT COMPLETED|Overall Study||0
5114502|NCT01529060|12582057|P1|NOT COMPLETED|Overall Study||0
5114503|NCT01529060|12582056|P2|COMPLETED|Overall Study||10
5114504|NCT01529060|12582057|P1|COMPLETED|Overall Study||10
5114505|NCT01529060|12582056|P2|STARTED|Overall Study||10
5114506|NCT01529060|12582057|P1|STARTED|Overall Study||10
5114507|NCT01529034|12582065|P1|NOT COMPLETED|Overall Study||174
5114508|NCT01529034|12582065|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
5114509|NCT01529034|12582065|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
5114510|NCT01529034|12582065|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
5114511|NCT01528969|12582080|P2|NOT COMPLETED|Overall Study||0
5114512|NCT01528969|12582081|P1|NOT COMPLETED|Overall Study||2
5114513|NCT01528969|12582080|P2|COMPLETED|Overall Study||38
5114514|NCT01528969|12582081|P1|COMPLETED|Overall Study||35
5114515|NCT01528969|12582080|P2|STARTED|Overall Study||38
5114516|NCT01528969|12582081|P1|STARTED|Overall Study||37
5114517|NCT01528891|12582089|P2|NOT COMPLETED|Overall Study||0
5114518|NCT01528891|12582090|P1|NOT COMPLETED|Overall Study||0
5114519|NCT01528891|12582089|P2|COMPLETED|Overall Study||200
5114520|NCT01528891|12582090|P1|COMPLETED|Overall Study||200
5114521|NCT01528891|12582089|P2|STARTED|Overall Study||200
5114522|NCT01528891|12582090|P1|STARTED|Overall Study||200
5114523|NCT01528878|12582102|P1|NOT COMPLETED|Overall Study||0
5114524|NCT01528878|12582102|P1|COMPLETED|Overall Study||30
5114525|NCT01528878|12582102|P1|STARTED|Overall Study||30
5114526|NCT01528787|12582114|P4|NOT COMPLETED|Overall Study||1
5114527|NCT01528787|12582115|P3|NOT COMPLETED|Overall Study||1
5114528|NCT01528787|12582116|P2|NOT COMPLETED|Overall Study||0
5114529|NCT01528787|12582117|P1|NOT COMPLETED|Overall Study||0
5114530|NCT01528787|12582114|P4|COMPLETED|Overall Study||22
5114531|NCT01528787|12582115|P3|COMPLETED|Overall Study||18
5114532|NCT01528787|12582116|P2|COMPLETED|Overall Study||21
5114533|NCT01528787|12582117|P1|COMPLETED|Overall Study||22
5114534|NCT01528787|12582114|P4|STARTED|Overall Study||23
5114535|NCT01528787|12582115|P3|STARTED|Overall Study||19
5114536|NCT01528787|12582116|P2|STARTED|Overall Study||21
5114537|NCT01528787|12582117|P1|STARTED|Overall Study||22
5114538|NCT01528735|12582129|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
5114539|NCT01528735|12582130|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
5114540|NCT01528735|12582129|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
5114541|NCT01528735|12582130|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
5114542|NCT01528735|12582129|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
5114543|NCT01528735|12582130|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
5114544|NCT01528735|12582129|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
5114545|NCT01528735|12582130|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
5114546|NCT01528735|12582129|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
5114547|NCT01528735|12582130|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
5114548|NCT01528735|12582129|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
5114549|NCT01528735|12582130|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
5114550|NCT01528709|12582232|P2|NOT COMPLETED|Overall Study||15
5114551|NCT01528709|12582233|P1|NOT COMPLETED|Overall Study||13
5114552|NCT01528709|12582232|P2|COMPLETED|Overall Study||72
5114553|NCT01528709|12582233|P1|COMPLETED|Overall Study||73
5114554|NCT01528709|12582232|P2|STARTED|Overall Study||87
5114555|NCT01528709|12582233|P1|STARTED|Overall Study||86
5114556|NCT01528696|12582243|P2|NOT COMPLETED|Overall Study||19
5114557|NCT01528696|12582244|P1|NOT COMPLETED|Overall Study||18
5114558|NCT01528696|12582243|P2|COMPLETED|Overall Study||0
5114559|NCT01528696|12582244|P1|COMPLETED|Overall Study||0
5114560|NCT01528696|12582243|P2|Hospital Stay (2-5 Days)|Overall Study||19
5114561|NCT01528696|12582244|P1|Hospital Stay (2-5 Days)|Overall Study||18
5114562|NCT01528696|12582243|P2|STARTED|Overall Study||19
5114563|NCT01528696|12582244|P1|STARTED|Overall Study||18
5114564|NCT01528605|12582260|P6|NOT COMPLETED|Overall Study||0
5114565|NCT01528605|12582261|P5|NOT COMPLETED|Overall Study||0
5114566|NCT01528605|12582262|P4|NOT COMPLETED|Overall Study||1
5114567|NCT01528605|12582263|P3|NOT COMPLETED|Overall Study||1
5114568|NCT01528605|12582264|P2|NOT COMPLETED|Overall Study||0
5114569|NCT01528605|12582265|P1|NOT COMPLETED|Overall Study||2
5114570|NCT01528605|12582260|P6|COMPLETED|Overall Study||28
5114571|NCT01528605|12582261|P5|COMPLETED|Overall Study||28
5114572|NCT01528605|12582262|P4|COMPLETED|Overall Study||27
5114573|NCT01528605|12582263|P3|COMPLETED|Overall Study||27
5114574|NCT01528605|12582264|P2|COMPLETED|Overall Study||28
5114575|NCT01528605|12582265|P1|COMPLETED|Overall Study||26
5114576|NCT01528605|12582260|P6|STARTED|Overall Study||28
5114577|NCT01528605|12582261|P5|STARTED|Overall Study||28
5114578|NCT01528605|12582262|P4|STARTED|Overall Study||28
5114579|NCT01528605|12582263|P3|STARTED|Overall Study||28
5114580|NCT01528605|12582264|P2|STARTED|Overall Study||28
5114581|NCT01528605|12582265|P1|STARTED|Overall Study||28
5114582|NCT01528592|12582289|P1|NOT COMPLETED|Overall Study||0
5114583|NCT01528592|12582289|P1|COMPLETED|Overall Study||18
5114584|NCT01528592|12582289|P1|STARTED|Overall Study||18
5114585|NCT01528345|12582295|P2|NOT COMPLETED|Overall Study||50
5114586|NCT01528345|12582296|P1|NOT COMPLETED|Overall Study||47
5114587|NCT01528345|12582295|P2|COMPLETED|Overall Study||0
5114588|NCT01528345|12582296|P1|COMPLETED|Overall Study||0
5114589|NCT01528345|12582295|P2|STARTED|Overall Study||50
5114590|NCT01528345|12582296|P1|STARTED|Overall Study||47
5114591|NCT01528332|12582314|P2|NOT COMPLETED|Overall Study||2
5114592|NCT01528332|12582315|P1|NOT COMPLETED|Overall Study||4
5114593|NCT01528332|12582314|P2|COMPLETED|Overall Study||84
5114594|NCT01528332|12582315|P1|COMPLETED|Overall Study||81
5114595|NCT01528332|12582314|P2|STARTED|Overall Study||86
5114596|NCT01528332|12582315|P1|STARTED|Overall Study||85
5114597|NCT01528319|12582321|P1|NOT COMPLETED|Overall Study||1
5114598|NCT01528319|12582321|P1|COMPLETED|Overall Study||23
5114599|NCT01528319|12582321|P1|12 Weeks After Surgery|Overall Study||24
5114600|NCT01528319|12582321|P1|STARTED|Overall Study||24
5114601|NCT01528293|12582332|P2|NOT COMPLETED|Overall Study||0
5114602|NCT01528293|12582333|P1|NOT COMPLETED|Overall Study||1
5114603|NCT01528293|12582332|P2|COMPLETED|Overall Study||1
5114604|NCT01528293|12582333|P1|COMPLETED|Overall Study||0
5114605|NCT01528293|12582332|P2|STARTED|Overall Study||1
5114606|NCT01528293|12582333|P1|STARTED|Overall Study||1
5114607|NCT01528254|12582347|P2|NOT COMPLETED|Overall Study||216
5114608|NCT01528254|12582348|P1|NOT COMPLETED|Overall Study||187
5114609|NCT01528254|12582347|P2|COMPLETED|Overall Study||787
5114610|NCT01528254|12582348|P1|COMPLETED|Overall Study||811
5114611|NCT01528254|12582347|P2|Completed Treatment Period 3|Overall Study||115
5114612|NCT01528254|12582348|P1|Completed Treatment Period 3|Overall Study||109
5114613|NCT01528254|12582347|P2|Completed Treatment Period 2|Overall Study||399
5114614|NCT01528254|12582348|P1|Completed Treatment Period 2|Overall Study||244
5114615|NCT01528254|12582347|P2|Completed Treatment Period 1|Overall Study||273
5114616|NCT01528254|12582348|P1|Completed Treatment Period 1|Overall Study||458
5114617|NCT01528254|12582347|P2|Full Analysis Set (FAS)|Overall Study||989
5114618|NCT01528254|12582348|P1|Full Analysis Set (FAS)|Overall Study||983
5114619|NCT01528254|12582347|P2|Safety Set|Overall Study||1001
5114620|NCT01528254|12582348|P1|Safety Set|Overall Study||998
5114621|NCT01528254|12582347|P2|STARTED|Overall Study||1003
5114622|NCT01528254|12582348|P1|STARTED|Overall Study||998
5114623|NCT01528228|12582371|P2|NOT COMPLETED|Overall Study||1
5114624|NCT01528228|12582372|P1|NOT COMPLETED|Overall Study||1
5114625|NCT01528228|12582371|P2|COMPLETED|Overall Study||9
5114626|NCT01528228|12582372|P1|COMPLETED|Overall Study||9
5114627|NCT01528228|12582371|P2|STARTED|Overall Study||10
5114628|NCT01528228|12582372|P1|STARTED|Overall Study||10
5114629|NCT01528215|12582380|P2|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
5114630|NCT01528215|12582381|P1|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
5114631|NCT01528215|12582380|P2|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
5114632|NCT01528215|12582381|P1|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
5114633|NCT01528215|12582380|P2|STARTED|1 Year Follow-up to 5 Year Follow-up||60
5114634|NCT01528215|12582381|P1|STARTED|1 Year Follow-up to 5 Year Follow-up||55
5114635|NCT01528215|12582380|P2|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
5114636|NCT01528215|12582381|P1|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
5114637|NCT01528215|12582380|P2|COMPLETED|Enrollment to 1 Year Follow-up||60
5114638|NCT01528215|12582381|P1|COMPLETED|Enrollment to 1 Year Follow-up||55
5114639|NCT01528215|12582380|P2|STARTED|Enrollment to 1 Year Follow-up||61
5114640|NCT01528215|12582381|P1|STARTED|Enrollment to 1 Year Follow-up||59
5114641|NCT01528150|12582389|P1|NOT COMPLETED|Overall Study||44
5114642|NCT01528150|12582389|P1|COMPLETED|Overall Study||422
5114643|NCT01528150|12582389|P1|STARTED|Overall Study||466
5114644|NCT01528124|12582400|P7|NOT COMPLETED|Overall Study||0
5114645|NCT01528124|12582401|P6|NOT COMPLETED|Overall Study||0
5114646|NCT01528124|12582402|P5|NOT COMPLETED|Overall Study||0
5114647|NCT01528124|12582403|P4|NOT COMPLETED|Overall Study||0
5114648|NCT01528124|12582404|P3|NOT COMPLETED|Overall Study||0
5114649|NCT01528124|12582405|P2|NOT COMPLETED|Overall Study||0
5114650|NCT01528124|12582406|P1|NOT COMPLETED|Overall Study||0
5114651|NCT01528124|12582400|P7|COMPLETED|Overall Study||6
5114652|NCT01528124|12582401|P6|COMPLETED|Overall Study||6
5114653|NCT01528124|12582402|P5|COMPLETED|Overall Study||5
5114654|NCT01528124|12582403|P4|COMPLETED|Overall Study||6
5114655|NCT01528124|12582404|P3|COMPLETED|Overall Study||6
5114656|NCT01528124|12582405|P2|COMPLETED|Overall Study||6
5114657|NCT01528124|12582406|P1|COMPLETED|Overall Study||6
5114658|NCT01528124|12582400|P7|Received Study Drug|Overall Study||6
5114659|NCT01528124|12582401|P6|Received Study Drug|Overall Study||6
5114660|NCT01528124|12582402|P5|Received Study Drug|Overall Study||5
5114661|NCT01528124|12582403|P4|Received Study Drug|Overall Study||6
5114662|NCT01528124|12582404|P3|Received Study Drug|Overall Study||6
5114663|NCT01528124|12582405|P2|Received Study Drug|Overall Study||6
5114664|NCT01528124|12582406|P1|Received Study Drug|Overall Study||6
5114665|NCT01528124|12582400|P7|STARTED|Overall Study||6
5114666|NCT01528124|12582401|P6|STARTED|Overall Study||6
5114667|NCT01528124|12582402|P5|STARTED|Overall Study||5
5114668|NCT01528124|12582403|P4|STARTED|Overall Study||6
5114669|NCT01528124|12582404|P3|STARTED|Overall Study||6
5114670|NCT01528124|12582405|P2|STARTED|Overall Study||6
5114671|NCT01528124|12582406|P1|STARTED|Overall Study||6
5114672|NCT01528072|12582440|P1|NOT COMPLETED|Overall Study||74
5114673|NCT01528072|12582440|P1|COMPLETED|Overall Study||66
5114674|NCT01528072|12582440|P1|STARTED|Overall Study||140
5114675|NCT01528033|12582446|P2|NOT COMPLETED|Follow Up||44
5114676|NCT01528033|12582447|P1|NOT COMPLETED|Follow Up||46
5114677|NCT01528033|12582446|P2|COMPLETED|Follow Up||207
5114678|NCT01528033|12582447|P1|COMPLETED|Follow Up||210
5114679|NCT01528033|12582446|P2|STARTED|Follow Up||251
5114680|NCT01528033|12582447|P1|STARTED|Follow Up||256
5114681|NCT01528033|12582446|P2|NOT COMPLETED|Primary Endpoint Assessment ITT||15
5114682|NCT01528033|12582447|P1|NOT COMPLETED|Primary Endpoint Assessment ITT||17
5114683|NCT01528033|12582446|P2|COMPLETED|Primary Endpoint Assessment ITT||251
5114684|NCT01528033|12582447|P1|COMPLETED|Primary Endpoint Assessment ITT||256
5114685|NCT01528033|12582446|P2|STARTED|Primary Endpoint Assessment ITT||266
5114686|NCT01528033|12582447|P1|STARTED|Primary Endpoint Assessment ITT||273
5114687|NCT01527942|12582459|P2|NOT COMPLETED|Overall Study||0
5114688|NCT01527942|12582460|P1|NOT COMPLETED|Overall Study||0
5114689|NCT01527942|12582459|P2|COMPLETED|Overall Study||18
5114690|NCT01527942|12582460|P1|COMPLETED|Overall Study||16
5114691|NCT01527942|12582459|P2|STARTED|Overall Study||18
5114692|NCT01527942|12582460|P1|STARTED|Overall Study||16
5114693|NCT01527682|12582470|P1|NOT COMPLETED|Overall Study||8
5114694|NCT01527682|12582470|P1|COMPLETED|Overall Study||29
5114695|NCT01527682|12582470|P1|STARTED|Overall Study||37
5114696|NCT01527513|12582478|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
5114697|NCT01527513|12582479|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
5114698|NCT01527513|12582478|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
5114699|NCT01527513|12582479|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
5114700|NCT01527513|12582478|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
5114701|NCT01527513|12582479|P1|STARTED|Eligible for 1-Year Open Label Period||0
5114702|NCT01527513|12582478|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
5114703|NCT01527513|12582479|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
5114704|NCT01527513|12582478|P2|COMPLETED|Double Blind Period (DB) - Part I||75
5114705|NCT01527513|12582479|P1|COMPLETED|Double Blind Period (DB) - Part I||37
5114706|NCT01527513|12582478|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
5114707|NCT01527513|12582479|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
5114708|NCT01527513|12582478|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
5114709|NCT01527513|12582479|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
5114710|NCT01527513|12582478|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
5114711|NCT01527513|12582479|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
5114712|NCT01527513|12582478|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
5114713|NCT01527513|12582479|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
5114714|NCT01527513|12582478|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
5114715|NCT01527513|12582479|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
5114716|NCT01527513|12582478|P2|Safety Population|Double Blind Period (DB) - Part I||83
5114717|NCT01527513|12582479|P1|Safety Population|Double Blind Period (DB) - Part I||40
5114718|NCT01527513|12582478|P2|Randomized|Double Blind Period (DB) - Part I||83
5114719|NCT01527513|12582479|P1|Randomized|Double Blind Period (DB) - Part I||40
5114720|NCT01527513|12582478|P2|STARTED|Double Blind Period (DB) - Part I||83
5114721|NCT01527513|12582479|P1|STARTED|Double Blind Period (DB) - Part I||40
5114722|NCT01527500|12582493|P2|NOT COMPLETED|Part B||0
5114723|NCT01527500|12582494|P1|NOT COMPLETED|Part B||1
5114724|NCT01527500|12582493|P2|COMPLETED|Part B||1
5114725|NCT01527500|12582494|P1|COMPLETED|Part B||6
5114726|NCT01527500|12582493|P2|STARTED|Part B||1
5114727|NCT01527500|12582494|P1|STARTED|Part B||7
5114728|NCT01527500|12582493|P2|NOT COMPLETED|Part A||13
5114729|NCT01527500|12582494|P1|NOT COMPLETED|Part A||30
5114730|NCT01527500|12582493|P2|COMPLETED|Part A||38
5114731|NCT01527500|12582494|P1|COMPLETED|Part A||69
5114732|NCT01527500|12582493|P2|STARTED|Part A||51
5114733|NCT01527500|12582494|P1|STARTED|Part A||99
5114734|NCT01527487|12582524|P2|NOT COMPLETED|Overall Study||7
5114735|NCT01527487|12582525|P1|NOT COMPLETED|Overall Study||8
5114736|NCT01527487|12582524|P2|COMPLETED|Overall Study||15
5114737|NCT01527487|12582525|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
5114738|NCT01527487|12582524|P2|STARTED|Overall Study||22
5114739|NCT01527487|12582525|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
5114740|NCT01527383|12582539|P2|NOT COMPLETED|Overall Study||4
5114741|NCT01527383|12582540|P1|NOT COMPLETED|Overall Study||15
5114742|NCT01527383|12582539|P2|COMPLETED|Overall Study||58
5114743|NCT01527383|12582540|P1|COMPLETED|Overall Study||277
5114744|NCT01527383|12582539|P2|Vaccination 4 (~Day 90)|Overall Study||58
5114745|NCT01527383|12582540|P1|Vaccination 4 (~Day 90)|Overall Study||277
5114746|NCT01527383|12582539|P2|Vaccination 3 (~Day 60)|Overall Study||58
5114747|NCT01527383|12582540|P1|Vaccination 3 (~Day 60)|Overall Study||278
5114748|NCT01527383|12582539|P2|Vaccination 2 (~Day 30)|Overall Study||61
5114749|NCT01527383|12582540|P1|Vaccination 2 (~Day 30)|Overall Study||283
5114750|NCT01527383|12582539|P2|Vaccination 1 (Day 1)|Overall Study||62
5114751|NCT01527383|12582540|P1|Vaccination 1 (Day 1)|Overall Study||291
5114752|NCT01527383|12582539|P2|STARTED|Overall Study||62
5114753|NCT01527383|12582540|P1|STARTED|Overall Study||292
5114754|NCT01527370|12582554|P1|NOT COMPLETED|Overall Study||6
5114755|NCT01527370|12582554|P1|COMPLETED|Overall Study||244
5114756|NCT01527370|12582554|P1|STARTED|Overall Study||250
5114757|NCT01527357|12582562|P2|NOT COMPLETED|Overall Study||9
5114758|NCT01527357|12582563|P1|NOT COMPLETED|Overall Study||17
5114759|NCT01527357|12582562|P2|COMPLETED|Overall Study||230
5114760|NCT01527357|12582563|P1|COMPLETED|Overall Study||465
5114761|NCT01527357|12582562|P2|Efficacy Population|Overall Study||239
5114762|NCT01527357|12582563|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
5114763|NCT01527357|12582562|P2|STARTED|Overall Study||239
5114764|NCT01527357|12582563|P1|STARTED|Overall Study||482
5114765|NCT01527292|12582585|P2|NOT COMPLETED|Overall Study||3
5114766|NCT01527292|12582586|P1|NOT COMPLETED|Overall Study||0
5114767|NCT01527292|12582585|P2|COMPLETED|Overall Study||0
5114768|NCT01527292|12582586|P1|COMPLETED|Overall Study||0
5114769|NCT01527292|12582585|P2|STARTED|Overall Study||3
5114770|NCT01527292|12582586|P1|STARTED|Overall Study||0
5114771|NCT01527162|12582602|P2|NOT COMPLETED|Overall Study||0
5114772|NCT01527162|12582603|P1|NOT COMPLETED|Overall Study||0
5114773|NCT01527162|12582602|P2|COMPLETED|Overall Study||5
5114774|NCT01527162|12582603|P1|COMPLETED|Overall Study||6
5114775|NCT01527162|12582602|P2|STARTED|Overall Study||5
5114776|NCT01527162|12582603|P1|STARTED|Overall Study||6
5114777|NCT01527149|12582613|P1|NOT COMPLETED|Overall Study||2
5114778|NCT01527149|12582613|P1|COMPLETED|Overall Study||35
5114779|NCT01527149|12582613|P1|STARTED|Overall Study||37
5114780|NCT01527110|12582628|P1|NOT COMPLETED|Overall Study||1
5114781|NCT01527110|12582628|P1|COMPLETED|Overall Study||20
5114782|NCT01527110|12582628|P1|STARTED|Overall Study||21
5114783|NCT01527045|12582676|P3|NOT COMPLETED|Overall Study||0
5114784|NCT01527045|12582677|P2|NOT COMPLETED|Overall Study||0
5114785|NCT01527045|12582678|P1|NOT COMPLETED|Overall Study||1
5114786|NCT01527045|12582676|P3|COMPLETED|Overall Study||12
5114787|NCT01527045|12582677|P2|COMPLETED|Overall Study||5
5114788|NCT01527045|12582678|P1|COMPLETED|Overall Study||29
5114789|NCT01527045|12582676|P3|STARTED|Overall Study||12
5114790|NCT01527045|12582677|P2|STARTED|Overall Study||5
5114791|NCT01527045|12582678|P1|STARTED|Overall Study||30
5114792|NCT01527006|12582709|P2|NOT COMPLETED|Extension Phase||8
5114793|NCT01527006|12582710|P1|NOT COMPLETED|Extension Phase||6
5114794|NCT01527006|12582709|P2|COMPLETED|Extension Phase||14
5114795|NCT01527006|12582710|P1|COMPLETED|Extension Phase||13
5114796|NCT01527006|12582709|P2|STARTED|Extension Phase||22
5114797|NCT01527006|12582710|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
5114798|NCT01527006|12582709|P2|NOT COMPLETED|Core Study||6
5114799|NCT01527006|12582710|P1|NOT COMPLETED|Core Study||2
5114800|NCT01527006|12582709|P2|COMPLETED|Core Study||22
5114801|NCT01527006|12582710|P1|COMPLETED|Core Study||20
5114802|NCT01527006|12582709|P2|STARTED|Core Study||28
5114803|NCT01527006|12582710|P1|STARTED|Core Study||22
5114804|NCT01526928|12582766|P6|NOT COMPLETED|Overall Study||6
5114805|NCT01526928|12582767|P5|NOT COMPLETED|Overall Study||95
5114806|NCT01526928|12582768|P4|NOT COMPLETED|Overall Study||245
5114807|NCT01526928|12582769|P3|NOT COMPLETED|Overall Study||209
5114808|NCT01526928|12582770|P2|NOT COMPLETED|Overall Study||19
5114809|NCT01526928|12582771|P1|NOT COMPLETED|Overall Study||38
5114810|NCT01526928|12582766|P6|COMPLETED|Overall Study||0
5114811|NCT01526928|12582767|P5|COMPLETED|Overall Study||0
5114812|NCT01526928|12582768|P4|COMPLETED|Overall Study||0
5114813|NCT01526928|12582769|P3|COMPLETED|Overall Study||0
5114814|NCT01526928|12582770|P2|COMPLETED|Overall Study||0
5114815|NCT01526928|12582771|P1|COMPLETED|Overall Study||0
5114816|NCT01526928|12582766|P6|Started Phase 2|Overall Study||0
5114817|NCT01526928|12582767|P5|Started Phase 2|Overall Study||82
5114818|NCT01526928|12582768|P4|Started Phase 2|Overall Study||228
5114819|NCT01526928|12582769|P3|Started Phase 2|Overall Study||191
5114820|NCT01526928|12582770|P2|Started Phase 2|Overall Study||0
5114821|NCT01526928|12582771|P1|Started Phase 2|Overall Study||0
5114822|NCT01526928|12582766|P6|Started Phase 1|Overall Study||6
5114823|NCT01526928|12582767|P5|Started Phase 1|Overall Study||13
5114824|NCT01526928|12582768|P4|Started Phase 1|Overall Study||17
5114825|NCT01526928|12582769|P3|Started Phase 1|Overall Study||18
5114826|NCT01526928|12582770|P2|Started Phase 1|Overall Study||19
5114827|NCT01526928|12582771|P1|Started Phase 1|Overall Study||38
5114828|NCT01526928|12582766|P6|STARTED|Overall Study||6
5114829|NCT01526928|12582767|P5|STARTED|Overall Study||95
5114830|NCT01526928|12582768|P4|STARTED|Overall Study||245
5114831|NCT01526928|12582769|P3|STARTED|Overall Study||209
5114832|NCT01526928|12582770|P2|STARTED|Overall Study||19
5114833|NCT01526928|12582771|P1|STARTED|Overall Study||38
5114834|NCT01526902|12582890|P2|NOT COMPLETED|Overall Study||0
5114835|NCT01526902|12582891|P1|NOT COMPLETED|Overall Study||0
5114836|NCT01526902|12582890|P2|COMPLETED|Overall Study||24
5114837|NCT01526902|12582891|P1|COMPLETED|Overall Study||25
5114838|NCT01526902|12582890|P2|STARTED|Overall Study||24
5114839|NCT01526902|12582891|P1|STARTED|Overall Study||25
5114840|NCT01526889|12582909|P2|NOT COMPLETED|Treatment Extension Period||0
5114841|NCT01526889|12582910|P1|NOT COMPLETED|Treatment Extension Period||1
5114842|NCT01526889|12582909|P2|COMPLETED|Treatment Extension Period||0
5114843|NCT01526889|12582910|P1|COMPLETED|Treatment Extension Period||4
5114844|NCT01526889|12582909|P2|STARTED|Treatment Extension Period||0
5114845|NCT01526889|12582910|P1|STARTED|Treatment Extension Period||5
5114846|NCT01526889|12582909|P2|NOT COMPLETED|Treatment Period||0
5114847|NCT01526889|12582910|P1|NOT COMPLETED|Treatment Period||2
5114848|NCT01526889|12582909|P2|COMPLETED|Treatment Period||7
5114849|NCT01526889|12582910|P1|COMPLETED|Treatment Period||16
5114850|NCT01526889|12582909|P2|STARTED|Treatment Period||7
5114851|NCT01526889|12582910|P1|STARTED|Treatment Period||18
5114852|NCT01526785|12582931|P1|NOT COMPLETED|Overall Study||13
5114853|NCT01526785|12582931|P1|COMPLETED|Overall Study||100
5114854|NCT01526785|12582931|P1|STARTED|Overall Study||113
5114855|NCT01526733|12582941|P2|NOT COMPLETED|Phase 2||0
5114856|NCT01526733|12582942|P1|NOT COMPLETED|Phase 2||0
5114857|NCT01526733|12582941|P2|COMPLETED|Phase 2||12
5114858|NCT01526733|12582942|P1|COMPLETED|Phase 2||10
5114859|NCT01526733|12582941|P2|STARTED|Phase 2||12
5114860|NCT01526733|12582942|P1|STARTED|Phase 2||10
5114861|NCT01526733|12582941|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
5114862|NCT01526733|12582942|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
5114863|NCT01526733|12582941|P2|COMPLETED|Washout Period of 5 to 21 Days||12
5114864|NCT01526733|12582942|P1|COMPLETED|Washout Period of 5 to 21 Days||10
5114865|NCT01526733|12582941|P2|STARTED|Washout Period of 5 to 21 Days||12
5114866|NCT01526733|12582942|P1|STARTED|Washout Period of 5 to 21 Days||10
5114867|NCT01526733|12582941|P2|NOT COMPLETED|Phase 1||1
5114868|NCT01526733|12582942|P1|NOT COMPLETED|Phase 1||2
5114869|NCT01526733|12582941|P2|COMPLETED|Phase 1||12
5114870|NCT01526733|12582942|P1|COMPLETED|Phase 1||10
5114871|NCT01526733|12582941|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
5114872|NCT01526733|12582942|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
5114873|NCT01526733|12582941|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
5114874|NCT01526733|12582942|P1|STARTED|Phase 1||12
5114875|NCT01526629|12582960|P1|NOT COMPLETED|Overall Study||46
5114876|NCT01526629|12582960|P1|COMPLETED|Overall Study||308
5114877|NCT01526629|12582960|P1|STARTED|Overall Study||354
5114878|NCT01526577|12582969|P5|NOT COMPLETED|Overall Study||2
5114879|NCT01526577|12582970|P4|NOT COMPLETED|Overall Study||1
5114880|NCT01526577|12582971|P3|NOT COMPLETED|Overall Study||1
5114881|NCT01526577|12582972|P2|NOT COMPLETED|Overall Study||0
5114882|NCT01526577|12582973|P1|NOT COMPLETED|Overall Study||1
5114883|NCT01526577|12582969|P5|COMPLETED|Overall Study||8
5114884|NCT01526577|12582970|P4|COMPLETED|Overall Study||8
5114885|NCT01526577|12582971|P3|COMPLETED|Overall Study||32
5114886|NCT01526577|12582972|P2|COMPLETED|Overall Study||12
5114887|NCT01526577|12582973|P1|COMPLETED|Overall Study||48
5114888|NCT01526577|12582969|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
5114889|NCT01526577|12582970|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
5114890|NCT01526577|12582971|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
5114891|NCT01526577|12582972|P2|STARTED|Overall Study||12
5114892|NCT01526577|12582973|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
5114893|NCT01526551|12582981|P1|NOT COMPLETED|Overall Study||424
5114894|NCT01526551|12582981|P1|COMPLETED|Overall Study||511
5114895|NCT01526551|12582981|P1|STARTED|Overall Study||935
5114896|NCT01526538|12582988|P2|NOT COMPLETED|Overall Study||4
5114897|NCT01526538|12582989|P1|NOT COMPLETED|Overall Study||9
5114898|NCT01526538|12582988|P2|COMPLETED|Overall Study||18
5114899|NCT01526538|12582989|P1|COMPLETED|Overall Study||21
5114900|NCT01526538|12582988|P2|STARTED|Overall Study||22
5114901|NCT01526538|12582989|P1|STARTED|Overall Study||30
5114902|NCT01526343|12582999|P1|NOT COMPLETED|Overall Study||0
5114903|NCT01526343|12582999|P1|COMPLETED|Overall Study||47
5114904|NCT01526343|12582999|P1|STARTED|Overall Study||47
5114905|NCT01526213|12583010|P6|NOT COMPLETED|Period 3 (5 Days)||0
5114906|NCT01526213|12583011|P5|NOT COMPLETED|Period 3 (5 Days)||0
5114907|NCT01526213|12583012|P4|NOT COMPLETED|Period 3 (5 Days)||0
5114908|NCT01526213|12583013|P3|NOT COMPLETED|Period 3 (5 Days)||0
5114909|NCT01526213|12583014|P2|NOT COMPLETED|Period 3 (5 Days)||0
5114910|NCT01526213|12583015|P1|NOT COMPLETED|Period 3 (5 Days)||0
5114911|NCT01526213|12583010|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114912|NCT01526213|12583011|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114913|NCT01526213|12583012|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114914|NCT01526213|12583013|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114915|NCT01526213|12583014|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114916|NCT01526213|12583015|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114917|NCT01526213|12583010|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114918|NCT01526213|12583011|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114919|NCT01526213|12583012|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114920|NCT01526213|12583013|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114921|NCT01526213|12583014|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114922|NCT01526213|12583015|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114923|NCT01526213|12583010|P6|NOT COMPLETED|Washout 2 (10 Days)||0
5114924|NCT01526213|12583011|P5|NOT COMPLETED|Washout 2 (10 Days)||0
5114925|NCT01526213|12583012|P4|NOT COMPLETED|Washout 2 (10 Days)||0
5114926|NCT01526213|12583013|P3|NOT COMPLETED|Washout 2 (10 Days)||0
5114927|NCT01526213|12583014|P2|NOT COMPLETED|Washout 2 (10 Days)||0
5114928|NCT01526213|12583015|P1|NOT COMPLETED|Washout 2 (10 Days)||0
5114929|NCT01526213|12583010|P6|COMPLETED|Washout 2 (10 Days)||3
5114930|NCT01526213|12583011|P5|COMPLETED|Washout 2 (10 Days)||3
5114931|NCT01526213|12583012|P4|COMPLETED|Washout 2 (10 Days)||3
5114932|NCT01526213|12583013|P3|COMPLETED|Washout 2 (10 Days)||3
5114933|NCT01526213|12583014|P2|COMPLETED|Washout 2 (10 Days)||3
5114934|NCT01526213|12583015|P1|COMPLETED|Washout 2 (10 Days)||3
5114935|NCT01526213|12583010|P6|STARTED|Washout 2 (10 Days)||3
5114936|NCT01526213|12583011|P5|STARTED|Washout 2 (10 Days)||3
5114937|NCT01526213|12583012|P4|STARTED|Washout 2 (10 Days)||3
5114938|NCT01526213|12583013|P3|STARTED|Washout 2 (10 Days)||3
5114939|NCT01526213|12583014|P2|STARTED|Washout 2 (10 Days)||3
5114940|NCT01526213|12583015|P1|STARTED|Washout 2 (10 Days)||3
5114941|NCT01526213|12583010|P6|NOT COMPLETED|Period 2 (5 Days)||0
5114942|NCT01526213|12583011|P5|NOT COMPLETED|Period 2 (5 Days)||0
5114943|NCT01526213|12583012|P4|NOT COMPLETED|Period 2 (5 Days)||0
5114944|NCT01526213|12583013|P3|NOT COMPLETED|Period 2 (5 Days)||0
5114945|NCT01526213|12583014|P2|NOT COMPLETED|Period 2 (5 Days)||0
5114946|NCT01526213|12583015|P1|NOT COMPLETED|Period 2 (5 Days)||0
5114947|NCT01526213|12583010|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
5114948|NCT01526213|12583011|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
5114949|NCT01526213|12583012|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
5114950|NCT01526213|12583013|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
5114951|NCT01526213|12583014|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114952|NCT01526213|12583015|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114953|NCT01526213|12583010|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114954|NCT01526213|12583011|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114955|NCT01526213|12583012|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114956|NCT01526213|12583013|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114957|NCT01526213|12583014|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114958|NCT01526213|12583015|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114959|NCT01526213|12583010|P6|NOT COMPLETED|Washout 1 (10 Days)||0
5114960|NCT01526213|12583011|P5|NOT COMPLETED|Washout 1 (10 Days)||0
5114961|NCT01526213|12583012|P4|NOT COMPLETED|Washout 1 (10 Days)||0
5114962|NCT01526213|12583013|P3|NOT COMPLETED|Washout 1 (10 Days)||0
5114963|NCT01526213|12583014|P2|NOT COMPLETED|Washout 1 (10 Days)||0
5114964|NCT01526213|12583015|P1|NOT COMPLETED|Washout 1 (10 Days)||0
5114965|NCT01526213|12583010|P6|COMPLETED|Washout 1 (10 Days)||3
5114966|NCT01526213|12583011|P5|COMPLETED|Washout 1 (10 Days)||3
5114967|NCT01526213|12583012|P4|COMPLETED|Washout 1 (10 Days)||3
5114968|NCT01526213|12583013|P3|COMPLETED|Washout 1 (10 Days)||3
5114969|NCT01526213|12583014|P2|COMPLETED|Washout 1 (10 Days)||3
5114970|NCT01526213|12583015|P1|COMPLETED|Washout 1 (10 Days)||3
5114971|NCT01526213|12583010|P6|STARTED|Washout 1 (10 Days)||3
5114972|NCT01526213|12583011|P5|STARTED|Washout 1 (10 Days)||3
5114973|NCT01526213|12583012|P4|STARTED|Washout 1 (10 Days)||3
5114974|NCT01526213|12583013|P3|STARTED|Washout 1 (10 Days)||3
5114975|NCT01526213|12583014|P2|STARTED|Washout 1 (10 Days)||3
5114976|NCT01526213|12583015|P1|STARTED|Washout 1 (10 Days)||3
5114977|NCT01526213|12583010|P6|NOT COMPLETED|Period 1 (5 Days)||0
5114978|NCT01526213|12583011|P5|NOT COMPLETED|Period 1 (5 Days)||0
5114979|NCT01526213|12583012|P4|NOT COMPLETED|Period 1 (5 Days)||0
5114980|NCT01526213|12583013|P3|NOT COMPLETED|Period 1 (5 Days)||0
5114981|NCT01526213|12583014|P2|NOT COMPLETED|Period 1 (5 Days)||0
5114982|NCT01526213|12583015|P1|NOT COMPLETED|Period 1 (5 Days)||0
5114983|NCT01526213|12583010|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114984|NCT01526213|12583011|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114985|NCT01526213|12583012|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114986|NCT01526213|12583013|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114987|NCT01526213|12583014|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114988|NCT01526213|12583015|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
5114989|NCT01526213|12583010|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
5114990|NCT01526213|12583011|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114991|NCT01526213|12583012|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114992|NCT01526213|12583013|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114993|NCT01526213|12583014|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114994|NCT01526213|12583015|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
5114995|NCT01526148|12583028|P2|NOT COMPLETED|Overall Study||13
5114996|NCT01526148|12583029|P1|NOT COMPLETED|Overall Study||14
5114997|NCT01526148|12583028|P2|COMPLETED|Overall Study||11
5114998|NCT01526148|12583029|P1|COMPLETED|Overall Study||4
5114999|NCT01526148|12583028|P2|STARTED|Overall Study||24
5115000|NCT01526148|12583029|P1|STARTED|Overall Study||18
5115001|NCT01526057|12583040|P3|NOT COMPLETED|Overall Study||6
5115002|NCT01526057|12583041|P2|NOT COMPLETED|Overall Study||3
5115003|NCT01526057|12583042|P1|NOT COMPLETED|Overall Study||9
5115004|NCT01526057|12583040|P3|COMPLETED|Overall Study||67
5115005|NCT01526057|12583041|P2|COMPLETED|Overall Study||71
5115006|NCT01526057|12583042|P1|COMPLETED|Overall Study||64
5115007|NCT01526057|12583040|P3|STARTED|Overall Study||73
5115008|NCT01526057|12583041|P2|STARTED|Overall Study||74
5115009|NCT01526057|12583042|P1|STARTED|Overall Study||73
5115010|NCT01525927|12583127|P1|NOT COMPLETED|Overall Study||0
5115011|NCT01525927|12583127|P1|COMPLETED|Overall Study||0
5115012|NCT01525927|12583127|P1|STARTED|Overall Study||0
5115013|NCT01525875|12583141|P2|NOT COMPLETED|Open-label Period||2
5115014|NCT01525875|12583142|P1|NOT COMPLETED|Open-label Period||0
5115015|NCT01525875|12583141|P2|COMPLETED|Open-label Period||18
5115016|NCT01525875|12583142|P1|COMPLETED|Open-label Period||21
5115017|NCT01525875|12583141|P2|STARTED|Open-label Period||20
5115018|NCT01525875|12583142|P1|STARTED|Open-label Period||21
5115019|NCT01525875|12583141|P2|NOT COMPLETED|Placebo-controlled Period||2
5115020|NCT01525875|12583142|P1|NOT COMPLETED|Placebo-controlled Period||1
5115021|NCT01525875|12583141|P2|COMPLETED|Placebo-controlled Period||20
5115022|NCT01525875|12583142|P1|COMPLETED|Placebo-controlled Period||21
5115023|NCT01525875|12583141|P2|STARTED|Placebo-controlled Period||22
5115024|NCT01525875|12583142|P1|STARTED|Placebo-controlled Period||22
5115025|NCT01525849|12583158|P2|NOT COMPLETED|Overall Study||16
5115026|NCT01525849|12583159|P1|NOT COMPLETED|Overall Study||5
5115027|NCT01525849|12583158|P2|COMPLETED|Overall Study||59
5115028|NCT01525849|12583159|P1|COMPLETED|Overall Study||71
5115029|NCT01525849|12583158|P2|6-Months|Overall Study||60
5115030|NCT01525849|12583159|P1|6-Months|Overall Study||73
5115031|NCT01525849|12583158|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
5115125|NCT01525329|12583531|P1|NOT COMPLETED|Overall Study||0
5115032|NCT01525849|12583159|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
5115033|NCT01525849|12583158|P2|STARTED|Overall Study||75
5115034|NCT01525849|12583159|P1|STARTED|Overall Study||76
5115035|NCT01525745|12583175|P2|NOT COMPLETED|Overall Study||1
5115036|NCT01525745|12583176|P1|NOT COMPLETED|Overall Study||1
5115037|NCT01525745|12583175|P2|COMPLETED|Overall Study||1
5115038|NCT01525745|12583176|P1|COMPLETED|Overall Study||3
5115039|NCT01525745|12583175|P2|STARTED|Overall Study||2
5115040|NCT01525745|12583176|P1|STARTED|Overall Study||4
5115041|NCT01525667|12583193|P3|NOT COMPLETED|Overall Study||0
5115042|NCT01525667|12583194|P2|NOT COMPLETED|Overall Study||0
5115043|NCT01525667|12583195|P1|NOT COMPLETED|Overall Study||0
5115044|NCT01525667|12583193|P3|COMPLETED|Overall Study||7
5115045|NCT01525667|12583194|P2|COMPLETED|Overall Study||6
5115046|NCT01525667|12583195|P1|COMPLETED|Overall Study||7
5115047|NCT01525667|12583193|P3|STARTED|Overall Study||7
5115048|NCT01525667|12583194|P2|STARTED|Overall Study||6
5115049|NCT01525667|12583195|P1|STARTED|Overall Study||7
5115050|NCT01525641|12583215|P1|NOT COMPLETED|Overall Study||180
5115051|NCT01525641|12583215|P1|COMPLETED|Overall Study||435
5115052|NCT01525641|12583215|P1|STARTED|Overall Study||615
5115053|NCT01525628|12583229|P5|NOT COMPLETED|Overall Study||3
5115054|NCT01525628|12583230|P4|NOT COMPLETED|Overall Study||4
5115055|NCT01525628|12583231|P3|NOT COMPLETED|Overall Study||5
5115056|NCT01525628|12583232|P2|NOT COMPLETED|Overall Study||5
5115057|NCT01525628|12583233|P1|NOT COMPLETED|Overall Study||2
5115058|NCT01525628|12583229|P5|COMPLETED|Overall Study||4
5115059|NCT01525628|12583230|P4|COMPLETED|Overall Study||10
5115060|NCT01525628|12583231|P3|COMPLETED|Overall Study||11
5115061|NCT01525628|12583232|P2|COMPLETED|Overall Study||14
5115062|NCT01525628|12583233|P1|COMPLETED|Overall Study||14
5115063|NCT01525628|12583229|P5|STARTED|Overall Study||7
5115064|NCT01525628|12583230|P4|STARTED|Overall Study||14
5115065|NCT01525628|12583231|P3|STARTED|Overall Study||16
5115066|NCT01525628|12583232|P2|STARTED|Overall Study||19
5115067|NCT01525628|12583233|P1|STARTED|Overall Study||16
5115068|NCT01525615|12583300|P3|NOT COMPLETED|Overall Study||6
5115069|NCT01525615|12583301|P2|NOT COMPLETED|Overall Study||7
5115070|NCT01525615|12583302|P1|NOT COMPLETED|Overall Study||14
5115071|NCT01525615|12583300|P3|COMPLETED|Overall Study||133
5115072|NCT01525615|12583301|P2|COMPLETED|Overall Study||126
5115073|NCT01525615|12583302|P1|COMPLETED|Overall Study||118
5115074|NCT01525615|12583300|P3|STARTED|Overall Study||139
5115075|NCT01525615|12583301|P2|STARTED|Overall Study||133
5115076|NCT01525615|12583302|P1|STARTED|Overall Study||132
5115077|NCT01525602|12583354|P8|NOT COMPLETED|Overall Study||7
5115078|NCT01525602|12583355|P7|NOT COMPLETED|Overall Study||6
5115079|NCT01525602|12583356|P6|NOT COMPLETED|Overall Study||7
5115080|NCT01525602|12583357|P5|NOT COMPLETED|Overall Study||33
5115081|NCT01525602|12583358|P4|NOT COMPLETED|Overall Study||6
5115082|NCT01525602|12583359|P3|NOT COMPLETED|Overall Study||3
5115083|NCT01525602|12583360|P2|NOT COMPLETED|Overall Study||3
5115084|NCT01525602|12583361|P1|NOT COMPLETED|Overall Study||9
5115085|NCT01525602|12583354|P8|COMPLETED|Overall Study||0
5115086|NCT01525602|12583355|P7|COMPLETED|Overall Study||0
5115087|NCT01525602|12583356|P6|COMPLETED|Overall Study||0
5115088|NCT01525602|12583357|P5|COMPLETED|Overall Study||0
5115089|NCT01525602|12583358|P4|COMPLETED|Overall Study||0
5115090|NCT01525602|12583359|P3|COMPLETED|Overall Study||0
5115091|NCT01525602|12583360|P2|COMPLETED|Overall Study||0
5115092|NCT01525602|12583361|P1|COMPLETED|Overall Study||0
5115093|NCT01525602|12583354|P8|STARTED|Overall Study||7
5115094|NCT01525602|12583355|P7|STARTED|Overall Study||6
5115095|NCT01525602|12583356|P6|STARTED|Overall Study||7
5115096|NCT01525602|12583357|P5|STARTED|Overall Study||33
5115097|NCT01525602|12583358|P4|STARTED|Overall Study||6
5115098|NCT01525602|12583359|P3|STARTED|Overall Study||3
5115099|NCT01525602|12583360|P2|STARTED|Overall Study||3
5115100|NCT01525602|12583361|P1|STARTED|Overall Study||9
5115101|NCT01525563|12583429|P1|NOT COMPLETED|Overall Study||212
5115102|NCT01525563|12583429|P1|COMPLETED|Overall Study|6 Months Follow-up|788
5115103|NCT01525563|12583429|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
5115104|NCT01525563|12583429|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
5115105|NCT01525563|12583429|P1|STARTED|Overall Study||1000
5115106|NCT01525550|12583441|P2|NOT COMPLETED|Overall Study||45
5115107|NCT01525550|12583442|P1|NOT COMPLETED|Overall Study||61
5115108|NCT01525550|12583441|P2|COMPLETED|Overall Study||0
5115109|NCT01525550|12583442|P1|COMPLETED|Overall Study||0
5115110|NCT01525550|12583441|P2|STARTED|Overall Study||45
5115111|NCT01525550|12583442|P1|STARTED|Overall Study||61
5115112|NCT01525420|12583504|P2|NOT COMPLETED|Overall Study||24
5115113|NCT01525420|12583505|P1|NOT COMPLETED|Overall Study||16
5115114|NCT01525420|12583504|P2|COMPLETED|Overall Study||38
5115115|NCT01525420|12583505|P1|COMPLETED|Overall Study||43
5115116|NCT01525420|12583504|P2|STARTED|Overall Study||62
5115117|NCT01525420|12583505|P1|STARTED|Overall Study||59
5115118|NCT01525407|12583513|P2|NOT COMPLETED|Overall Study||4
5115119|NCT01525407|12583514|P1|NOT COMPLETED|Overall Study||3
5115120|NCT01525407|12583513|P2|COMPLETED|Overall Study||38
5115121|NCT01525407|12583514|P1|COMPLETED|Overall Study||38
5115122|NCT01525407|12583513|P2|STARTED|Overall Study||42
5115123|NCT01525407|12583514|P1|STARTED|Overall Study||41
5115124|NCT01525329|12583530|P2|NOT COMPLETED|Overall Study||0
5115126|NCT01525329|12583530|P2|COMPLETED|Overall Study||14
5115127|NCT01525329|12583531|P1|COMPLETED|Overall Study||4
5115128|NCT01525329|12583530|P2|STARTED|Overall Study||14
5115129|NCT01525329|12583531|P1|STARTED|Overall Study||4
5115130|NCT01525238|12583548|P3|NOT COMPLETED|Overall Study||0
5115131|NCT01525238|12583549|P2|NOT COMPLETED|Overall Study||0
5115132|NCT01525238|12583550|P1|NOT COMPLETED|Overall Study||1
5115133|NCT01525238|12583548|P3|COMPLETED|Overall Study||8
5115134|NCT01525238|12583549|P2|COMPLETED|Overall Study||8
5115135|NCT01525238|12583550|P1|COMPLETED|Overall Study||7
5115136|NCT01525238|12583548|P3|STARTED|Overall Study||8
5115137|NCT01525238|12583549|P2|STARTED|Overall Study||8
5115138|NCT01525238|12583550|P1|STARTED|Overall Study||8
5115139|NCT01525225|12583615|P1|NOT COMPLETED|Treated||0
5115140|NCT01525225|12583615|P1|COMPLETED|Treated||2
5115141|NCT01525225|12583615|P1|STARTED|Treated||2
5115142|NCT01525225|12583615|P1|NOT COMPLETED|Enrollment||2
5115143|NCT01525225|12583615|P1|COMPLETED|Enrollment||2
5115144|NCT01525225|12583615|P1|STARTED|Enrollment||4
5115145|NCT01525173|12583622|P2|NOT COMPLETED|Overall Study||5
5115146|NCT01525173|12583623|P1|NOT COMPLETED|Overall Study||7
5115147|NCT01525173|12583622|P2|COMPLETED|Overall Study||62
5115148|NCT01525173|12583623|P1|COMPLETED|Overall Study||63
5115149|NCT01525173|12583622|P2|STARTED|Overall Study||67
5115150|NCT01525173|12583623|P1|STARTED|Overall Study||70
5115151|NCT01524991|12583629|P1|NOT COMPLETED|Overall Study||34
5115152|NCT01524991|12583629|P1|COMPLETED|Overall Study||2
5115153|NCT01524991|12583629|P1|STARTED|Overall Study||36
5115154|NCT01524978|12583647|P11|NOT COMPLETED|Overall Study||28
5115155|NCT01524978|12583648|P10|NOT COMPLETED|Overall Study||9
5115156|NCT01524978|12583649|P9|NOT COMPLETED|Overall Study||12
5115157|NCT01524978|12583650|P8|NOT COMPLETED|Overall Study||12
5115158|NCT01524978|12583651|P7|NOT COMPLETED|Overall Study||26
5115159|NCT01524978|12583652|P6|NOT COMPLETED|Overall Study||9
5115160|NCT01524978|12583653|P5|NOT COMPLETED|Overall Study||9
5115161|NCT01524978|12583654|P4|NOT COMPLETED|Overall Study||27
5115162|NCT01524978|12583655|P3|NOT COMPLETED|Overall Study||10
5115163|NCT01524978|12583656|P2|NOT COMPLETED|Overall Study||4
5115164|NCT01524978|12583657|P1|NOT COMPLETED|Overall Study||62
5115165|NCT01524978|12583647|P11|COMPLETED|Overall Study||0
5115166|NCT01524978|12583648|P10|COMPLETED|Overall Study||0
5115167|NCT01524978|12583649|P9|COMPLETED|Overall Study||0
5115168|NCT01524978|12583650|P8|COMPLETED|Overall Study||0
5115169|NCT01524978|12583651|P7|COMPLETED|Overall Study||0
5115170|NCT01524978|12583652|P6|COMPLETED|Overall Study||0
5115171|NCT01524978|12583653|P5|COMPLETED|Overall Study||0
5115172|NCT01524978|12583654|P4|COMPLETED|Overall Study||0
5115173|NCT01524978|12583655|P3|COMPLETED|Overall Study||0
5115174|NCT01524978|12583656|P2|COMPLETED|Overall Study||0
5115175|NCT01524978|12583657|P1|COMPLETED|Overall Study||0
5115176|NCT01524978|12583647|P11|STARTED|Overall Study||28
5115177|NCT01524978|12583648|P10|STARTED|Overall Study||9
5115178|NCT01524978|12583649|P9|STARTED|Overall Study||12
5115179|NCT01524978|12583650|P8|STARTED|Overall Study||12
5115180|NCT01524978|12583651|P7|STARTED|Overall Study||26
5115181|NCT01524978|12583652|P6|STARTED|Overall Study||9
5115182|NCT01524978|12583653|P5|STARTED|Overall Study||9
5115183|NCT01524978|12583654|P4|STARTED|Overall Study||27
5115184|NCT01524978|12583655|P3|STARTED|Overall Study||10
5115185|NCT01524978|12583656|P2|STARTED|Overall Study||4
5115186|NCT01524978|12583657|P1|STARTED|Overall Study||62
5115187|NCT01524913|12583785|P3|NOT COMPLETED|Overall Study||0
5115188|NCT01524913|12583786|P2|NOT COMPLETED|Overall Study||0
5115189|NCT01524913|12583787|P1|NOT COMPLETED|Overall Study||4
5115190|NCT01524913|12583785|P3|COMPLETED|Overall Study||31
5115191|NCT01524913|12583786|P2|COMPLETED|Overall Study||36
5115192|NCT01524913|12583787|P1|COMPLETED|Overall Study||31
5115193|NCT01524913|12583785|P3|STARTED|Overall Study||31
5115194|NCT01524913|12583786|P2|STARTED|Overall Study||36
5115195|NCT01524913|12583787|P1|STARTED|Overall Study||35
5115196|NCT01524900|12583809|P5|NOT COMPLETED|Overall Study||0
5115197|NCT01524900|12583810|P4|NOT COMPLETED|Overall Study||1
5115198|NCT01524900|12583811|P3|NOT COMPLETED|Overall Study||1
5115199|NCT01524900|12583812|P2|NOT COMPLETED|Overall Study||14
5115200|NCT01524900|12583813|P1|NOT COMPLETED|Overall Study||6
5115201|NCT01524900|12583809|P5|COMPLETED|Overall Study||40
5115202|NCT01524900|12583810|P4|COMPLETED|Overall Study||21
5115203|NCT01524900|12583811|P3|COMPLETED|Overall Study||29
5115204|NCT01524900|12583812|P2|COMPLETED|Overall Study||232
5115205|NCT01524900|12583813|P1|COMPLETED|Overall Study||43
5115206|NCT01524900|12583809|P5|STARTED|Overall Study||40
5115207|NCT01524900|12583810|P4|STARTED|Overall Study||22
5115208|NCT01524900|12583811|P3|STARTED|Overall Study||30
5115209|NCT01524900|12583812|P2|STARTED|Overall Study||246
5115210|NCT01524900|12583813|P1|STARTED|Overall Study||49
5115211|NCT01524887|12583858|P3|NOT COMPLETED|Overall Study||86
5115212|NCT01524887|12583859|P2|NOT COMPLETED|Overall Study||90
5115213|NCT01524887|12583860|P1|NOT COMPLETED|Overall Study||85
5115214|NCT01524887|12583858|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
5115215|NCT01524887|12583859|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
5115216|NCT01524887|12583860|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
5115217|NCT01524887|12583858|P3|Received Treatment|Overall Study||83
5115218|NCT01524887|12583859|P2|Received Treatment|Overall Study||85
5115219|NCT01524887|12583860|P1|Received Treatment|Overall Study||83
5115220|NCT01524887|12583858|P3|STARTED|Overall Study||86
5115221|NCT01524887|12583859|P2|STARTED|Overall Study||90
5115222|NCT01524887|12583860|P1|STARTED|Overall Study||85
5115223|NCT01524796|12583904|P1|NOT COMPLETED|Overall Study||28
5115224|NCT01524796|12583904|P1|COMPLETED|Overall Study||100
5115225|NCT01524796|12583904|P1|STARTED|Overall Study||128
5115226|NCT01524783|12583919|P2|NOT COMPLETED|Randomized and Treated||84
5115227|NCT01524783|12583920|P1|NOT COMPLETED|Randomized and Treated||155
5115228|NCT01524783|12583919|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
5115229|NCT01524783|12583920|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
5115230|NCT01524783|12583919|P2|STARTED|Randomized and Treated||97
5115231|NCT01524783|12583920|P1|STARTED|Randomized and Treated||203
5115232|NCT01524783|12583919|P2|NOT COMPLETED|Randomized But Not Treated||0
5115233|NCT01524783|12583920|P1|NOT COMPLETED|Randomized But Not Treated||2
5115234|NCT01524783|12583919|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
5115235|NCT01524783|12583920|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
5115236|NCT01524783|12583919|P2|STARTED|Randomized But Not Treated||97
5115237|NCT01524783|12583920|P1|STARTED|Randomized But Not Treated||205
5115238|NCT01524770|12583928|P2|NOT COMPLETED|Second Intervention||0
5115239|NCT01524770|12583929|P1|NOT COMPLETED|Second Intervention||0
5115240|NCT01524770|12583928|P2|COMPLETED|Second Intervention||23
5115241|NCT01524770|12583929|P1|COMPLETED|Second Intervention||23
5115242|NCT01524770|12583928|P2|STARTED|Second Intervention||23
5115243|NCT01524770|12583929|P1|STARTED|Second Intervention||23
5115244|NCT01524770|12583928|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
5115245|NCT01524770|12583929|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
5115246|NCT01524770|12583928|P2|COMPLETED|Washout Period of at Least 28 Days||23
5115247|NCT01524770|12583929|P1|COMPLETED|Washout Period of at Least 28 Days||23
5115248|NCT01524770|12583928|P2|STARTED|Washout Period of at Least 28 Days||23
5115249|NCT01524770|12583929|P1|STARTED|Washout Period of at Least 28 Days||23
5115250|NCT01524770|12583928|P2|NOT COMPLETED|First Intervention||1
5115251|NCT01524770|12583929|P1|NOT COMPLETED|First Intervention||3
5115252|NCT01524770|12583928|P2|COMPLETED|First Intervention||23
5115253|NCT01524770|12583929|P1|COMPLETED|First Intervention||23
5115254|NCT01524770|12583928|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
5115255|NCT01524770|12583929|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
5115256|NCT01524770|12583928|P2|STARTED|First Intervention||24
5115257|NCT01524770|12583929|P1|STARTED|First Intervention||26
5115258|NCT01524692|12583939|P1|NOT COMPLETED|Overall Study||3
5115259|NCT01524692|12583939|P1|COMPLETED|Overall Study||32
5115260|NCT01524692|12583939|P1|STARTED|Overall Study||35
5115261|NCT01524679|12583949|P2|NOT COMPLETED|Overall Study||9
5115262|NCT01524679|12583950|P1|NOT COMPLETED|Overall Study||23
5115263|NCT01524679|12583949|P2|COMPLETED|Overall Study||49
5115264|NCT01524679|12583950|P1|COMPLETED|Overall Study||89
5115265|NCT01524679|12583949|P2|STARTED|Overall Study||58
5115266|NCT01524679|12583950|P1|STARTED|Overall Study||112
5115267|NCT01524627|12583962|P2|NOT COMPLETED|Overall Study||2
5115268|NCT01524627|12583963|P1|NOT COMPLETED|Overall Study||1
5115269|NCT01524627|12583962|P2|COMPLETED|Overall Study||19
5115270|NCT01524627|12583963|P1|COMPLETED|Overall Study||21
5115271|NCT01524627|12583962|P2|STARTED|Overall Study||21
5115272|NCT01524627|12583963|P1|STARTED|Overall Study||22
5115273|NCT01524302|12583971|P2|NOT COMPLETED|Overall Study||0
5115274|NCT01524302|12583972|P1|NOT COMPLETED|Overall Study||0
5115275|NCT01524302|12583971|P2|COMPLETED|Overall Study||6
5115276|NCT01524302|12583972|P1|COMPLETED|Overall Study||6
5115277|NCT01524302|12583971|P2|STARTED|Overall Study||6
5115278|NCT01524302|12583972|P1|STARTED|Overall Study||6
5115279|NCT01524289|12583990|P2|NOT COMPLETED|Overall Study||14
5115280|NCT01524289|12583991|P1|NOT COMPLETED|Overall Study||30
5115281|NCT01524289|12583990|P2|COMPLETED|Overall Study||88
5115282|NCT01524289|12583991|P1|COMPLETED|Overall Study||174
5115283|NCT01524289|12583990|P2|Treated|Overall Study||102
5115284|NCT01524289|12583991|P1|Treated|Overall Study||203
5115285|NCT01524289|12583990|P2|STARTED|Overall Study||102
5115286|NCT01524289|12583991|P1|STARTED|Overall Study||204
5115287|NCT01524224|12584049|P8|NOT COMPLETED|Overall Study||6
5115288|NCT01524224|12584050|P7|NOT COMPLETED|Overall Study||3
5115289|NCT01524224|12584051|P6|NOT COMPLETED|Overall Study||2
5115290|NCT01524224|12584052|P5|NOT COMPLETED|Overall Study||4
5115291|NCT01524224|12584053|P4|NOT COMPLETED|Overall Study||2
5115292|NCT01524224|12584054|P3|NOT COMPLETED|Overall Study||2
5115293|NCT01524224|12584055|P2|NOT COMPLETED|Overall Study||1
5115294|NCT01524224|12584056|P1|NOT COMPLETED|Overall Study||3
5115295|NCT01524224|12584049|P8|COMPLETED|Overall Study||0
5115296|NCT01524224|12584050|P7|COMPLETED|Overall Study||0
5115297|NCT01524224|12584051|P6|COMPLETED|Overall Study||1
5115298|NCT01524224|12584052|P5|COMPLETED|Overall Study||0
5115299|NCT01524224|12584053|P4|COMPLETED|Overall Study||1
5115300|NCT01524224|12584054|P3|COMPLETED|Overall Study||1
5115301|NCT01524224|12584055|P2|COMPLETED|Overall Study||2
5115302|NCT01524224|12584056|P1|COMPLETED|Overall Study||1
5115303|NCT01524224|12584049|P8|Received at Least One Dose of Study Drug|Overall Study||6
5115304|NCT01524224|12584050|P7|Received at Least One Dose of Study Drug|Overall Study||3
5115305|NCT01524224|12584051|P6|Received at Least One Dose of Study Drug|Overall Study||3
5115306|NCT01524224|12584052|P5|Received at Least One Dose of Study Drug|Overall Study||4
5115307|NCT01524224|12584053|P4|Received at Least One Dose of Study Drug|Overall Study||3
5115308|NCT01524224|12584054|P3|Received at Least One Dose of Study Drug|Overall Study||3
5115309|NCT01524224|12584055|P2|Received at Least One Dose of Study Drug|Overall Study||3
5115310|NCT01524224|12584056|P1|Received at Least One Dose of Study Drug|Overall Study||4
5115311|NCT01524224|12584049|P8|STARTED|Overall Study||6
5115312|NCT01524224|12584050|P7|STARTED|Overall Study||3
5115313|NCT01524224|12584051|P6|STARTED|Overall Study||3
5115314|NCT01524224|12584052|P5|STARTED|Overall Study||4
5115315|NCT01524224|12584053|P4|STARTED|Overall Study||3
5115316|NCT01524224|12584054|P3|STARTED|Overall Study||3
5115317|NCT01524224|12584055|P2|STARTED|Overall Study||3
5115318|NCT01524224|12584056|P1|STARTED|Overall Study||4
5115319|NCT01524198|12584092|P2|NOT COMPLETED|Overall Study||16
5115320|NCT01524198|12584093|P1|NOT COMPLETED|Overall Study||23
5115321|NCT01524198|12584092|P2|COMPLETED|Overall Study||458
5115322|NCT01524198|12584093|P1|COMPLETED|Overall Study||448
5115323|NCT01524198|12584092|P2|STARTED|Overall Study||474
5115324|NCT01524198|12584093|P1|STARTED|Overall Study||471
5115325|NCT01524133|12584104|P3|NOT COMPLETED|Overall Study 52 Weeks||27
5115326|NCT01524133|12584105|P2|NOT COMPLETED|Overall Study 52 Weeks||20
5115327|NCT01524133|12584106|P1|NOT COMPLETED|Overall Study 52 Weeks||21
5115328|NCT01524133|12584104|P3|COMPLETED|Overall Study 52 Weeks||40
5115329|NCT01524133|12584105|P2|COMPLETED|Overall Study 52 Weeks||49
5115330|NCT01524133|12584106|P1|COMPLETED|Overall Study 52 Weeks||50
5115331|NCT01524133|12584104|P3|STARTED|Overall Study 52 Weeks||67
5115332|NCT01524133|12584105|P2|STARTED|Overall Study 52 Weeks||69
5115333|NCT01524133|12584106|P1|STARTED|Overall Study 52 Weeks||71
5115334|NCT01524133|12584104|P3|NOT COMPLETED|Treatment Phase||36
5115335|NCT01524133|12584105|P2|NOT COMPLETED|Treatment Phase||32
5115336|NCT01524133|12584106|P1|NOT COMPLETED|Treatment Phase||19
5115337|NCT01524133|12584104|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
5115338|NCT01524133|12584105|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
5115339|NCT01524133|12584106|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
5115340|NCT01524133|12584104|P3|STARTED|Treatment Phase||67
5115341|NCT01524133|12584105|P2|STARTED|Treatment Phase||69
5115342|NCT01524133|12584106|P1|STARTED|Treatment Phase||71
5115343|NCT01523964|12584121|P4|NOT COMPLETED|Overall Study||0
5115344|NCT01523964|12584122|P3|NOT COMPLETED|Overall Study||0
5115345|NCT01523964|12584123|P2|NOT COMPLETED|Overall Study||0
5115346|NCT01523964|12584124|P1|NOT COMPLETED|Overall Study||0
5115347|NCT01523964|12584121|P4|COMPLETED|Overall Study||15
5115348|NCT01523964|12584122|P3|COMPLETED|Overall Study||16
5115349|NCT01523964|12584123|P2|COMPLETED|Overall Study||30
5115350|NCT01523964|12584124|P1|COMPLETED|Overall Study||31
5115351|NCT01523964|12584121|P4|STARTED|Overall Study||15
5115352|NCT01523964|12584122|P3|STARTED|Overall Study||16
5115353|NCT01523964|12584123|P2|STARTED|Overall Study||30
5115354|NCT01523964|12584124|P1|STARTED|Overall Study||31
5115355|NCT01523899|12584136|P2|NOT COMPLETED|Overall Study||0
5115356|NCT01523899|12584137|P1|NOT COMPLETED|Overall Study||0
5115357|NCT01523899|12584136|P2|COMPLETED|Overall Study||126
5115358|NCT01523899|12584137|P1|COMPLETED|Overall Study||126
5115359|NCT01523899|12584136|P2|STARTED|Overall Study||126
5115360|NCT01523899|12584137|P1|STARTED|Overall Study||126
5115361|NCT01523886|12584149|P2|NOT COMPLETED|Overall Study||1
5115362|NCT01523886|12584150|P1|NOT COMPLETED|Overall Study||0
5115363|NCT01523886|12584149|P2|COMPLETED|Overall Study||23
5115364|NCT01523886|12584150|P1|COMPLETED|Overall Study||25
5115365|NCT01523886|12584149|P2|STARTED|Overall Study||24
5115366|NCT01523886|12584150|P1|STARTED|Overall Study||25
5115367|NCT01523873|12584156|P1|NOT COMPLETED|Overall Study||422
5115368|NCT01523873|12584156|P1|COMPLETED|Overall Study||35499
5115369|NCT01523873|12584156|P1|Administered With Dotarem|Overall Study||35474
5115370|NCT01523873|12584156|P1|STARTED|Overall Study||35921
5115371|NCT01523834|12584163|P1|NOT COMPLETED|Overall Study||31
5115372|NCT01523834|12584163|P1|COMPLETED|Overall Study||4
5115373|NCT01523834|12584163|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
5115374|NCT01523834|12584163|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
5115375|NCT01523834|12584163|P1|STARTED|Overall Study|Started Induction Phase|35
5115376|NCT01523821|12584174|P3|NOT COMPLETED|Overall Study||0
5115377|NCT01523821|12584175|P2|NOT COMPLETED|Overall Study||0
5115378|NCT01523821|12584176|P1|NOT COMPLETED|Overall Study||0
5115379|NCT01523821|12584174|P3|COMPLETED|Overall Study||6
5115380|NCT01523821|12584175|P2|COMPLETED|Overall Study||6
5115381|NCT01523821|12584176|P1|COMPLETED|Overall Study||8
5115382|NCT01523821|12584174|P3|STARTED|Overall Study||6
5115383|NCT01523821|12584175|P2|STARTED|Overall Study||6
5115384|NCT01523821|12584176|P1|STARTED|Overall Study||8
5115385|NCT01523782|12584202|P3|NOT COMPLETED|Overall Study||5
5115386|NCT01523782|12584203|P2|NOT COMPLETED|Overall Study||0
5115387|NCT01523782|12584204|P1|NOT COMPLETED|Overall Study||1
5115388|NCT01523782|12584202|P3|COMPLETED|Overall Study||9
5115389|NCT01523782|12584203|P2|COMPLETED|Overall Study||13
5115390|NCT01523782|12584204|P1|COMPLETED|Overall Study||2
5115391|NCT01523782|12584202|P3|STARTED|Overall Study||14
5115392|NCT01523782|12584203|P2|STARTED|Overall Study||13
5115393|NCT01523782|12584204|P1|STARTED|Overall Study||3
5115394|NCT01523756|12584251|P2|NOT COMPLETED|Test Period 2||1
5115395|NCT01523756|12584252|P1|NOT COMPLETED|Test Period 2||0
5115396|NCT01523756|12584251|P2|COMPLETED|Test Period 2||7
5115397|NCT01523756|12584252|P1|COMPLETED|Test Period 2||10
5115398|NCT01523756|12584251|P2|STARTED|Test Period 2||8
5115399|NCT01523756|12584252|P1|STARTED|Test Period 2||10
5115400|NCT01523756|12584251|P2|NOT COMPLETED|Test Period 1||0
5115401|NCT01523756|12584252|P1|NOT COMPLETED|Test Period 1||1
5115402|NCT01523756|12584251|P2|COMPLETED|Test Period 1||8
5115403|NCT01523756|12584252|P1|COMPLETED|Test Period 1||10
5115404|NCT01523756|12584251|P2|STARTED|Test Period 1||8
5115405|NCT01523756|12584252|P1|STARTED|Test Period 1||11
5115406|NCT01523756|12584251|P2|NOT COMPLETED|Baseline Period||1
5115407|NCT01523756|12584252|P1|NOT COMPLETED|Baseline Period||0
5115408|NCT01523756|12584251|P2|COMPLETED|Baseline Period||8
5115409|NCT01523756|12584252|P1|COMPLETED|Baseline Period||11
5115410|NCT01523756|12584251|P2|STARTED|Baseline Period||9
5115411|NCT01523756|12584252|P1|STARTED|Baseline Period||11
5115412|NCT01523743|12584260|P2|NOT COMPLETED|Period 2||2
5115413|NCT01523743|12584261|P1|NOT COMPLETED|Period 2||1
5115414|NCT01523743|12584260|P2|COMPLETED|Period 2||58
5115415|NCT01523743|12584261|P1|COMPLETED|Period 2||52
5115416|NCT01523743|12584260|P2|STARTED|Period 2||60
5115417|NCT01523743|12584261|P1|STARTED|Period 2||53
5115418|NCT01523743|12584260|P2|NOT COMPLETED|Period 1||2
5115419|NCT01523743|12584261|P1|NOT COMPLETED|Period 1||10
5115420|NCT01523743|12584260|P2|COMPLETED|Period 1||60
5115421|NCT01523743|12584261|P1|COMPLETED|Period 1||53
5115422|NCT01523743|12584260|P2|STARTED|Period 1||62
5115423|NCT01523743|12584261|P1|STARTED|Period 1||63
5115424|NCT01523613|12584270|P3|NOT COMPLETED|Overall Study||12
5115425|NCT01523613|12584271|P2|NOT COMPLETED|Overall Study||5
5115426|NCT01523613|12584272|P1|NOT COMPLETED|Overall Study||7
5115427|NCT01523613|12584270|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
5115428|NCT01523613|12584271|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
5115429|NCT01523613|12584272|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
5115430|NCT01523613|12584270|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
5115431|NCT01523613|12584271|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
5115432|NCT01523613|12584272|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
5115433|NCT01523587|12584284|P2|NOT COMPLETED|Overall Study||397
5115434|NCT01523587|12584285|P1|NOT COMPLETED|Overall Study||398
5115435|NCT01523587|12584284|P2|COMPLETED|Overall Study||0
5115436|NCT01523587|12584285|P1|COMPLETED|Overall Study||0
5115437|NCT01523587|12584284|P2|Treated|Overall Study||395
5115438|NCT01523587|12584285|P1|Treated|Overall Study||392
5115439|NCT01523587|12584284|P2|STARTED|Overall Study||397
5115440|NCT01523587|12584285|P1|STARTED|Overall Study||398
5115441|NCT01523496|12584309|P4|NOT COMPLETED|Overall Study||3
5115442|NCT01523496|12584310|P3|NOT COMPLETED|Overall Study||12
5115443|NCT01523496|12584311|P2|NOT COMPLETED|Overall Study||4
5115444|NCT01523496|12584312|P1|NOT COMPLETED|Overall Study||10
5115445|NCT01523496|12584309|P4|COMPLETED|Overall Study||27
5115446|NCT01523496|12584310|P3|COMPLETED|Overall Study||46
5115447|NCT01523496|12584311|P2|COMPLETED|Overall Study||32
5115448|NCT01523496|12584312|P1|COMPLETED|Overall Study||56
5115449|NCT01523496|12584309|P4|STARTED|Overall Study||30
5115450|NCT01523496|12584310|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
5115451|NCT01523496|12584311|P2|STARTED|Overall Study||36
5115452|NCT01523496|12584312|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
5115453|NCT01523457|12584328|P2|NOT COMPLETED|Overall Study||2
5115454|NCT01523457|12584329|P1|NOT COMPLETED|Overall Study||7
5115455|NCT01523457|12584328|P2|COMPLETED|Overall Study||29
5115456|NCT01523457|12584329|P1|COMPLETED|Overall Study||37
5115457|NCT01523457|12584328|P2|STARTED|Overall Study||31
5115458|NCT01523457|12584329|P1|STARTED|Overall Study||44
5115459|NCT01523392|12584347|P2|NOT COMPLETED|Treatment Period 2||0
5115460|NCT01523392|12584348|P1|NOT COMPLETED|Treatment Period 2||0
5115461|NCT01523392|12584347|P2|COMPLETED|Treatment Period 2||14
5115462|NCT01523392|12584348|P1|COMPLETED|Treatment Period 2||17
5115463|NCT01523392|12584347|P2|STARTED|Treatment Period 2||14
5115464|NCT01523392|12584348|P1|STARTED|Treatment Period 2||17
5115465|NCT01523392|12584347|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
5115466|NCT01523392|12584348|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
5115467|NCT01523392|12584347|P2|COMPLETED|Washout Period - 10 to 14 Days||14
5115468|NCT01523392|12584348|P1|COMPLETED|Washout Period - 10 to 14 Days||17
5115469|NCT01523392|12584347|P2|STARTED|Washout Period - 10 to 14 Days||14
5115470|NCT01523392|12584348|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
5115471|NCT01523392|12584347|P2|NOT COMPLETED|Treatment Period 1||0
5115472|NCT01523392|12584348|P1|NOT COMPLETED|Treatment Period 1||3
5115473|NCT01523392|12584347|P2|COMPLETED|Treatment Period 1||14
5115474|NCT01523392|12584348|P1|COMPLETED|Treatment Period 1||17
5115475|NCT01523392|12584347|P2|STARTED|Treatment Period 1||14
5115476|NCT01523392|12584348|P1|STARTED|Treatment Period 1||20
5115477|NCT01523366|12584364|P2|NOT COMPLETED|Treatment Period 2||0
5115478|NCT01523366|12584365|P1|NOT COMPLETED|Treatment Period 2||1
5115479|NCT01523366|12584364|P2|COMPLETED|Treatment Period 2||20
5115480|NCT01523366|12584365|P1|COMPLETED|Treatment Period 2||18
5115481|NCT01523366|12584364|P2|STARTED|Treatment Period 2||20
5115482|NCT01523366|12584365|P1|STARTED|Treatment Period 2||19
5115483|NCT01523366|12584364|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
5115484|NCT01523366|12584365|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
5115485|NCT01523366|12584364|P2|COMPLETED|Washout Period - 10-14 Days||20
5115486|NCT01523366|12584365|P1|COMPLETED|Washout Period - 10-14 Days||19
5115487|NCT01523366|12584364|P2|STARTED|Washout Period - 10-14 Days||20
5115488|NCT01523366|12584365|P1|STARTED|Washout Period - 10-14 Days||19
5115489|NCT01523366|12584364|P2|NOT COMPLETED|Treatment Period 1||0
5115490|NCT01523366|12584365|P1|NOT COMPLETED|Treatment Period 1||1
5115491|NCT01523366|12584364|P2|COMPLETED|Treatment Period 1||20
5115492|NCT01523366|12584365|P1|COMPLETED|Treatment Period 1||19
5115493|NCT01523366|12584364|P2|STARTED|Treatment Period 1||20
5115494|NCT01523366|12584365|P1|STARTED|Treatment Period 1||20
5115495|NCT01523301|12584381|P2|NOT COMPLETED|Overall Study||32
5115496|NCT01523301|12584382|P1|NOT COMPLETED|Overall Study||35
5115497|NCT01523301|12584381|P2|COMPLETED|Overall Study||164
5115498|NCT01523301|12584382|P1|COMPLETED|Overall Study||149
5115499|NCT01523301|12584381|P2|STARTED|Overall Study||196
5115500|NCT01523301|12584382|P1|STARTED|Overall Study||184
5115501|NCT01523275|12584402|P2|NOT COMPLETED|Overall Study||2
5115502|NCT01523275|12584403|P1|NOT COMPLETED|Overall Study||2
5115503|NCT01523275|12584402|P2|COMPLETED|Overall Study||7
5115504|NCT01523275|12584403|P1|COMPLETED|Overall Study||4
5115505|NCT01523275|12584402|P2|STARTED|Overall Study||9
5115506|NCT01523275|12584403|P1|STARTED|Overall Study||6
5115507|NCT01522976|12584416|P3|NOT COMPLETED|Overall Study||93
5115508|NCT01522976|12584417|P2|NOT COMPLETED|Overall Study||92
5115509|NCT01522976|12584418|P1|NOT COMPLETED|Overall Study||97
5115510|NCT01522976|12584416|P3|COMPLETED|Overall Study||0
5115511|NCT01522976|12584417|P2|COMPLETED|Overall Study||0
5115512|NCT01522976|12584418|P1|COMPLETED|Overall Study||0
5115513|NCT01522976|12584416|P3|STARTED|Overall Study||93
5115514|NCT01522976|12584417|P2|STARTED|Overall Study||92
5115515|NCT01522976|12584418|P1|STARTED|Overall Study||97
5115516|NCT01522963|12584445|P4|NOT COMPLETED|Overall Study||6
5115517|NCT01522963|12584446|P3|NOT COMPLETED|Overall Study||3
5115518|NCT01522963|12584447|P2|NOT COMPLETED|Overall Study||3
5115519|NCT01522963|12584448|P1|NOT COMPLETED|Overall Study||2
5115520|NCT01522963|12584445|P4|COMPLETED|Overall Study||18
5115521|NCT01522963|12584446|P3|COMPLETED|Overall Study||22
5115522|NCT01522963|12584447|P2|COMPLETED|Overall Study||22
5115523|NCT01522963|12584448|P1|COMPLETED|Overall Study||22
5115524|NCT01522963|12584445|P4|STARTED|Overall Study||24
5115525|NCT01522963|12584446|P3|STARTED|Overall Study||25
5115526|NCT01522963|12584447|P2|STARTED|Overall Study||25
5115527|NCT01522963|12584448|P1|STARTED|Overall Study||24
5115528|NCT01522950|12584463|P3|NOT COMPLETED|Overall Study||5
5115529|NCT01522950|12584464|P2|NOT COMPLETED|Overall Study||5
5115530|NCT01522950|12584465|P1|NOT COMPLETED|Overall Study||6
5115531|NCT01522950|12584463|P3|COMPLETED|Overall Study||22
5115532|NCT01522950|12584464|P2|COMPLETED|Overall Study||18
5115533|NCT01522950|12584465|P1|COMPLETED|Overall Study||20
5115534|NCT01522950|12584463|P3|STARTED|Overall Study||27
5115535|NCT01522950|12584464|P2|STARTED|Overall Study||23
5115536|NCT01522950|12584465|P1|STARTED|Overall Study||26
5115537|NCT01522937|12584482|P1|NOT COMPLETED|Overall Study||0
5115538|NCT01522937|12584482|P1|COMPLETED|Overall Study||146
5115539|NCT01522937|12584482|P1|STARTED|Overall Study||146
5115540|NCT01522924|12584492|P2|NOT COMPLETED|Overall Study||0
5115541|NCT01522924|12584493|P1|NOT COMPLETED|Overall Study||0
5115542|NCT01522924|12584492|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
5115543|NCT01522924|12584493|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
5115544|NCT01522924|12584492|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
5115545|NCT01522924|12584493|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
5115546|NCT01522755|12584511|P1|NOT COMPLETED|Overall Study||0
5115547|NCT01522755|12584511|P1|COMPLETED|Overall Study||409
5115548|NCT01522755|12584511|P1|STARTED|Overall Study||409
5115549|NCT01522703|12584521|P2|NOT COMPLETED|Overall Study||6
5115550|NCT01522703|12584522|P1|NOT COMPLETED|Overall Study||5
5115551|NCT01522703|12584521|P2|COMPLETED|Overall Study||20
5115552|NCT01522703|12584522|P1|COMPLETED|Overall Study||20
5115553|NCT01522703|12584521|P2|STARTED|Overall Study||26
5115554|NCT01522703|12584522|P1|STARTED|Overall Study||25
5115555|NCT01522456|12584528|P1|NOT COMPLETED|Overall Study||8
5115556|NCT01522456|12584528|P1|COMPLETED|Overall Study||65
5115557|NCT01522456|12584528|P1|STARTED|Overall Study||73
5115558|NCT01522443|12584591|P2|NOT COMPLETED|Overall Study||55
5115559|NCT01522443|12584592|P1|NOT COMPLETED|Overall Study||53
5115560|NCT01522443|12584591|P2|COMPLETED|Overall Study||3
5115561|NCT01522443|12584592|P1|COMPLETED|Overall Study||8
5115562|NCT01522443|12584591|P2|STARTED|Overall Study||58
5115563|NCT01522443|12584592|P1|STARTED|Overall Study||61
5115564|NCT01522404|12584604|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
5115565|NCT01522404|12584605|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
5115566|NCT01522404|12584604|P2|COMPLETED|Second Intervention (up to Week 58)||19
5115567|NCT01522404|12584605|P1|COMPLETED|Second Intervention (up to Week 58)||17
5115568|NCT01522404|12584604|P2|STARTED|Second Intervention (up to Week 58)||19
5115569|NCT01522404|12584605|P1|STARTED|Second Intervention (up to Week 58)||18
5115570|NCT01522404|12584604|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
5115571|NCT01522404|12584605|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
5115572|NCT01522404|12584604|P2|COMPLETED|First Intervention (up to Week 29)||19
5115573|NCT01522404|12584605|P1|COMPLETED|First Intervention (up to Week 29)||18
5115574|NCT01522404|12584604|P2|STARTED|First Intervention (up to Week 29)||19
5115575|NCT01522404|12584605|P1|STARTED|First Intervention (up to Week 29)||20
5115576|NCT01522391|12584623|P2|NOT COMPLETED|Overall Study||1
5115577|NCT01522391|12584624|P1|NOT COMPLETED|Overall Study||1
5115578|NCT01522391|12584623|P2|COMPLETED|Overall Study||20
5115579|NCT01522391|12584624|P1|COMPLETED|Overall Study||19
5115580|NCT01522391|12584623|P2|STARTED|Overall Study||21
5115581|NCT01522391|12584624|P1|STARTED|Overall Study||20
5115582|NCT01522339|12584684|P1|NOT COMPLETED|Overall Study||0
5115583|NCT01522339|12584684|P1|COMPLETED|Overall Study||15
5115584|NCT01522339|12584684|P1|STARTED|Overall Study||15
5115585|NCT01522248|12584691|P2|NOT COMPLETED|Overall Study||0
5115586|NCT01522248|12584692|P1|NOT COMPLETED|Overall Study||1
5115587|NCT01522248|12584691|P2|COMPLETED|Overall Study||10
5115588|NCT01522248|12584692|P1|COMPLETED|Overall Study||9
5115589|NCT01522248|12584691|P2|STARTED|Overall Study||10
5115590|NCT01522248|12584692|P1|STARTED|Overall Study||10
5115591|NCT01522235|12584707|P2|NOT COMPLETED|Overall Study||1
5115592|NCT01522235|12584708|P1|NOT COMPLETED|Overall Study||1
5115593|NCT01522235|12584707|P2|COMPLETED|Overall Study||2
5115594|NCT01522235|12584708|P1|COMPLETED|Overall Study||2
5115595|NCT01522235|12584707|P2|Randomized|Overall Study||3
5115596|NCT01522235|12584708|P1|Randomized|Overall Study||2
5115597|NCT01522235|12584707|P2|STARTED|Overall Study||3
5115598|NCT01522235|12584708|P1|STARTED|Overall Study||3
5115599|NCT01522131|12584726|P2|NOT COMPLETED|Overall Study||0
5115600|NCT01522131|12584727|P1|NOT COMPLETED|Overall Study||2
5115601|NCT01522131|12584726|P2|COMPLETED|Overall Study||17
5115602|NCT01522131|12584727|P1|COMPLETED|Overall Study||14
5115603|NCT01522131|12584726|P2|STARTED|Overall Study||17
5115604|NCT01522131|12584727|P1|STARTED|Overall Study||16
5115605|NCT01521949|12584735|P1|NOT COMPLETED|Overall Study||0
5115606|NCT01521949|12584735|P1|COMPLETED|Overall Study||21
5115607|NCT01521949|12584735|P1|STARTED|Overall Study||21
5115608|NCT01521923|12584744|P4|NOT COMPLETED|Overall Study||13
5115609|NCT01521923|12584745|P3|NOT COMPLETED|Overall Study||15
5115610|NCT01521923|12584746|P2|NOT COMPLETED|Overall Study||9
5115611|NCT01521923|12584747|P1|NOT COMPLETED|Overall Study||7
5115612|NCT01521923|12584744|P4|COMPLETED|Overall Study||70
5115613|NCT01521923|12584745|P3|COMPLETED|Overall Study||112
5115614|NCT01521923|12584746|P2|COMPLETED|Overall Study||72
5115615|NCT01521923|12584747|P1|COMPLETED|Overall Study||59
5115616|NCT01521923|12584744|P4|STARTED|Overall Study||83
5115617|NCT01521923|12584745|P3|STARTED|Overall Study||127
5115618|NCT01521923|12584746|P2|STARTED|Overall Study||81
5115619|NCT01521923|12584747|P1|STARTED|Overall Study||66
5115620|NCT01521897|12584867|P1|NOT COMPLETED|Overall Study||23
5115621|NCT01521897|12584867|P1|COMPLETED|Overall Study||1120
5115622|NCT01521897|12584867|P1|STARTED|Overall Study||1143
5115623|NCT01521884|12584879|P1|NOT COMPLETED|Overall Study||27
5115624|NCT01521884|12584879|P1|COMPLETED|Overall Study||35
5115625|NCT01521884|12584879|P1|STARTED|Overall Study||62
5115626|NCT01521871|12584898|P2|NOT COMPLETED|Overall Study||0
5115627|NCT01521871|12584899|P1|NOT COMPLETED|Overall Study||0
5115628|NCT01521871|12584898|P2|COMPLETED|Overall Study||32
5115629|NCT01521871|12584899|P1|COMPLETED|Overall Study||32
5115630|NCT01521871|12584898|P2|STARTED|Overall Study||32
5115631|NCT01521871|12584899|P1|STARTED|Overall Study||32
5115632|NCT01521845|12584939|P2|NOT COMPLETED|Overall Study||5
5115633|NCT01521845|12584940|P1|NOT COMPLETED|Overall Study||9
5115634|NCT01521845|12584939|P2|COMPLETED|Overall Study||47
5115635|NCT01521845|12584940|P1|COMPLETED|Overall Study||43
5115636|NCT01521845|12584939|P2|STARTED|Overall Study||52
5115637|NCT01521845|12584940|P1|STARTED|Overall Study||52
5115638|NCT01521780|12584950|P3|NOT COMPLETED|Overall Study||0
5115639|NCT01521780|12584951|P2|NOT COMPLETED|Overall Study||0
5115640|NCT01521780|12584952|P1|NOT COMPLETED|Overall Study||0
5115641|NCT01521780|12584950|P3|COMPLETED|Overall Study||2
5115642|NCT01521780|12584951|P2|COMPLETED|Overall Study||1
5115643|NCT01521780|12584952|P1|COMPLETED|Overall Study||9
5115644|NCT01521780|12584950|P3|STARTED|Overall Study||2
5115645|NCT01521780|12584951|P2|STARTED|Overall Study||1
5115646|NCT01521780|12584952|P1|STARTED|Overall Study||9
5115647|NCT01521559|12584976|P2|NOT COMPLETED|Overall Study||18
5115648|NCT01521559|12584977|P1|NOT COMPLETED|Overall Study||15
5115649|NCT01521559|12584976|P2|COMPLETED|Overall Study||73
5115650|NCT01521559|12584977|P1|COMPLETED|Overall Study||77
5115651|NCT01521559|12584976|P2|Completed Week 52|Overall Study||73
5115652|NCT01521559|12584977|P1|Completed Week 52|Overall Study||77
5115653|NCT01521559|12584976|P2|Completed Week 24|Overall Study||85
5115654|NCT01521559|12584977|P1|Completed Week 24|Overall Study||83
5115655|NCT01521559|12584976|P2|STARTED|Overall Study||91
5115656|NCT01521559|12584977|P1|STARTED|Overall Study||92
5115657|NCT01521546|12584991|P2|NOT COMPLETED|Overall Study||0
5115658|NCT01521546|12584992|P1|NOT COMPLETED|Overall Study||2
5115659|NCT01521546|12584991|P2|COMPLETED|Overall Study||20
5115660|NCT01521546|12584992|P1|COMPLETED|Overall Study||20
5115661|NCT01521546|12584991|P2|STARTED|Overall Study||20
5115662|NCT01521546|12584992|P1|STARTED|Overall Study||22
5115663|NCT01521507|12585000|P2|NOT COMPLETED|Stage 2: Observational Design||2
5115664|NCT01521507|12585001|P1|NOT COMPLETED|Stage 2: Observational Design||4
5115665|NCT01521507|12585000|P2|COMPLETED|Stage 2: Observational Design||92
5115666|NCT01521507|12585001|P1|COMPLETED|Stage 2: Observational Design||94
5115667|NCT01521507|12585000|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
5115668|NCT01521507|12585001|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
5115669|NCT01521507|12585000|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
5115670|NCT01521507|12585001|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
5115671|NCT01521507|12585000|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
5115672|NCT01521507|12585001|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
5115673|NCT01521507|12585000|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
5115674|NCT01521507|12585001|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
5115675|NCT01521507|12585000|P2|STARTED|Stage 2: Observational Design||94
5115676|NCT01521507|12585001|P1|STARTED|Stage 2: Observational Design||98
5115677|NCT01521507|12585000|P2|NOT COMPLETED|Stage 1: Randomized Design||5
5115678|NCT01521507|12585001|P1|NOT COMPLETED|Stage 1: Randomized Design||3
5115679|NCT01521507|12585000|P2|COMPLETED|Stage 1: Randomized Design||94
5115680|NCT01521507|12585001|P1|COMPLETED|Stage 1: Randomized Design||98
5115681|NCT01521507|12585000|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
5115682|NCT01521507|12585001|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
5115683|NCT01521507|12585000|P2|STARTED|Stage 1: Randomized Design||99
5115684|NCT01521507|12585001|P1|STARTED|Stage 1: Randomized Design||101
5115685|NCT01521494|12585023|P5|NOT COMPLETED|Overall Study||7
5115686|NCT01521494|12585024|P4|NOT COMPLETED|Overall Study||21
5115687|NCT01521494|12585025|P3|NOT COMPLETED|Overall Study||12
5115688|NCT01521494|12585026|P2|NOT COMPLETED|Overall Study||5
5115689|NCT01521494|12585027|P1|NOT COMPLETED|Overall Study||2
5115690|NCT01521494|12585023|P5|COMPLETED|Overall Study||30
5115691|NCT01521494|12585024|P4|COMPLETED|Overall Study||15
5115692|NCT01521494|12585025|P3|COMPLETED|Overall Study||23
5115693|NCT01521494|12585026|P2|COMPLETED|Overall Study||31
5115694|NCT01521494|12585027|P1|COMPLETED|Overall Study||37
5115695|NCT01521494|12585023|P5|STARTED|Overall Study||37
5115696|NCT01521494|12585024|P4|STARTED|Overall Study||36
5115697|NCT01521494|12585025|P3|STARTED|Overall Study||35
5115698|NCT01521494|12585026|P2|STARTED|Overall Study||36
5115699|NCT01521494|12585027|P1|STARTED|Overall Study||39
5115700|NCT01521364|12585049|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
5115701|NCT01521364|12585049|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
5115702|NCT01521364|12585049|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
5115703|NCT01521364|12585049|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
5115704|NCT01521364|12585049|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
5115705|NCT01521364|12585049|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
5115706|NCT01521364|12585049|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
5115707|NCT01521364|12585049|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
5115708|NCT01521364|12585049|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
5115709|NCT01521260|12585062|P2|NOT COMPLETED|Overall Study||0
5115710|NCT01521260|12585063|P1|NOT COMPLETED|Overall Study||0
5115711|NCT01521260|12585062|P2|COMPLETED|Overall Study||15
5115712|NCT01521260|12585063|P1|COMPLETED|Overall Study||15
5115713|NCT01521260|12585062|P2|STARTED|Overall Study||15
5115714|NCT01521260|12585063|P1|STARTED|Overall Study||15
5115715|NCT01521143|12585073|P4|NOT COMPLETED|Overall Study||7
5115716|NCT01521143|12585074|P3|NOT COMPLETED|Overall Study||8
5115717|NCT01521143|12585075|P2|NOT COMPLETED|Overall Study||26
5115718|NCT01521143|12585076|P1|NOT COMPLETED|Overall Study||29
5115719|NCT01521143|12585073|P4|COMPLETED|Overall Study||0
5115720|NCT01521143|12585074|P3|COMPLETED|Overall Study||0
5115721|NCT01521143|12585075|P2|COMPLETED|Overall Study||10
5115722|NCT01521143|12585076|P1|COMPLETED|Overall Study||11
5115723|NCT01521143|12585073|P4|Received Treatment|Overall Study||4
5115724|NCT01521143|12585074|P3|Received Treatment|Overall Study||3
5115725|NCT01521143|12585075|P2|Received Treatment|Overall Study||20
5115726|NCT01521143|12585076|P1|Received Treatment|Overall Study||20
5115727|NCT01521143|12585073|P4|STARTED|Overall Study||7
5115728|NCT01521143|12585074|P3|STARTED|Overall Study||8
5115729|NCT01521143|12585075|P2|STARTED|Overall Study||36
5115730|NCT01521143|12585076|P1|STARTED|Overall Study||40
5115731|NCT01521026|12585108|P2|NOT COMPLETED|Overall Study||3
5115732|NCT01521026|12585109|P1|NOT COMPLETED|Overall Study||15
5115733|NCT01521026|12585108|P2|COMPLETED|Overall Study||28
5115734|NCT01521026|12585109|P1|COMPLETED|Overall Study||23
5115735|NCT01521026|12585108|P2|STARTED|Overall Study||31
5115736|NCT01521026|12585109|P1|STARTED|Overall Study||38
5115737|NCT01520987|12585125|P8|NOT COMPLETED|Overall Study||0
5115738|NCT01520987|12585126|P7|NOT COMPLETED|Overall Study||0
5115739|NCT01520987|12585127|P6|NOT COMPLETED|Overall Study||1
5115740|NCT01520987|12585128|P5|NOT COMPLETED|Overall Study||0
5115741|NCT01520987|12585129|P4|NOT COMPLETED|Overall Study||0
5115742|NCT01520987|12585130|P3|NOT COMPLETED|Overall Study||0
5115743|NCT01520987|12585131|P2|NOT COMPLETED|Overall Study||0
5115744|NCT01520987|12585132|P1|NOT COMPLETED|Overall Study||1
5115745|NCT01520987|12585125|P8|COMPLETED|Overall Study||14
5115746|NCT01520987|12585126|P7|COMPLETED|Overall Study||12
5115747|NCT01520987|12585127|P6|COMPLETED|Overall Study||13
5115748|NCT01520987|12585128|P5|COMPLETED|Overall Study||14
5115749|NCT01520987|12585129|P4|COMPLETED|Overall Study||15
5115750|NCT01520987|12585130|P3|COMPLETED|Overall Study||11
5115751|NCT01520987|12585131|P2|COMPLETED|Overall Study||12
5115752|NCT01520987|12585132|P1|COMPLETED|Overall Study||12
5115753|NCT01520987|12585125|P8|Dosed|Overall Study||14
5115754|NCT01520987|12585126|P7|Dosed|Overall Study||12
5115755|NCT01520987|12585127|P6|Dosed|Overall Study||14
5115756|NCT01520987|12585128|P5|Dosed|Overall Study||14
5115757|NCT01520987|12585129|P4|Dosed|Overall Study||15
5115758|NCT01520987|12585130|P3|Dosed|Overall Study||11
5115759|NCT01520987|12585131|P2|Dosed|Overall Study||12
5115760|NCT01520987|12585132|P1|Dosed|Overall Study||13
5115761|NCT01520987|12585125|P8|STARTED|Overall Study||14
5115762|NCT01520987|12585126|P7|STARTED|Overall Study||12
5115763|NCT01520987|12585127|P6|STARTED|Overall Study||14
5115764|NCT01520987|12585128|P5|STARTED|Overall Study||14
5115765|NCT01520987|12585129|P4|STARTED|Overall Study||15
5115766|NCT01520987|12585130|P3|STARTED|Overall Study||11
5115767|NCT01520987|12585131|P2|STARTED|Overall Study||12
5115768|NCT01520987|12585132|P1|STARTED|Overall Study||13
5115769|NCT01520922|12585192|P2|NOT COMPLETED|Survival Follow-up||0
5115770|NCT01520922|12585193|P1|NOT COMPLETED|Survival Follow-up||1
5115771|NCT01520922|12585192|P2|COMPLETED|Survival Follow-up||40
5115772|NCT01520922|12585193|P1|COMPLETED|Survival Follow-up||20
5115773|NCT01520922|12585192|P2|STARTED|Survival Follow-up||40
5115774|NCT01520922|12585193|P1|STARTED|Survival Follow-up||21
5115775|NCT01520922|12585192|P2|NOT COMPLETED|Follow up||1
5115776|NCT01520922|12585193|P1|NOT COMPLETED|Follow up||0
5115777|NCT01520922|12585192|P2|COMPLETED|Follow up||44
5115778|NCT01520922|12585193|P1|COMPLETED|Follow up||44
5115779|NCT01520922|12585192|P2|STARTED|Follow up||45
5115780|NCT01520922|12585193|P1|STARTED|Follow up||44
5115781|NCT01520922|12585192|P2|NOT COMPLETED|Treatment Phase||8
5115782|NCT01520922|12585193|P1|NOT COMPLETED|Treatment Phase||5
5115783|NCT01520922|12585192|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
5115784|NCT01520922|12585193|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
5115785|NCT01520922|12585192|P2|STARTED|Treatment Phase||53
5115786|NCT01520922|12585193|P1|STARTED|Treatment Phase||44
5115787|NCT01520909|12585255|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
5115788|NCT01520909|12585256|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
5115789|NCT01520909|12585257|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
5115790|NCT01520909|12585255|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
5115791|NCT01520909|12585256|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
5115792|NCT01520909|12585257|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
5115793|NCT01520909|12585255|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
5115794|NCT01520909|12585256|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
5115795|NCT01520909|12585257|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
5115796|NCT01520909|12585255|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
5115797|NCT01520909|12585256|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
5115798|NCT01520909|12585257|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
5115799|NCT01520909|12585255|P3|COMPLETED|Part 1 (Randomized Period)||0
5115800|NCT01520909|12585256|P2|COMPLETED|Part 1 (Randomized Period)||61
5115801|NCT01520909|12585257|P1|COMPLETED|Part 1 (Randomized Period)||28
5115802|NCT01520909|12585255|P3|STARTED|Part 1 (Randomized Period)||0
5115803|NCT01520909|12585256|P2|STARTED|Part 1 (Randomized Period)||63
5115804|NCT01520909|12585257|P1|STARTED|Part 1 (Randomized Period)||29
5115805|NCT01520727|12585328|P9|NOT COMPLETED|Overall Study||0
5115806|NCT01520727|12585329|P8|NOT COMPLETED|Overall Study||0
5115807|NCT01520727|12585330|P7|NOT COMPLETED|Overall Study||0
5115808|NCT01520727|12585331|P6|NOT COMPLETED|Overall Study||0
5115809|NCT01520727|12585332|P5|NOT COMPLETED|Overall Study||0
5115810|NCT01520727|12585333|P4|NOT COMPLETED|Overall Study||0
5115811|NCT01520727|12585334|P3|NOT COMPLETED|Overall Study||0
5115812|NCT01520727|12585335|P2|NOT COMPLETED|Overall Study||0
5115813|NCT01520727|12585336|P1|NOT COMPLETED|Overall Study||0
5115814|NCT01520727|12585328|P9|COMPLETED|Overall Study||16
5115815|NCT01520727|12585329|P8|COMPLETED|Overall Study||6
5115816|NCT01520727|12585330|P7|COMPLETED|Overall Study||6
5115817|NCT01520727|12585331|P6|COMPLETED|Overall Study||6
5115818|NCT01520727|12585332|P5|COMPLETED|Overall Study||6
5115819|NCT01520727|12585333|P4|COMPLETED|Overall Study||6
5115820|NCT01520727|12585334|P3|COMPLETED|Overall Study||6
5115821|NCT01520727|12585335|P2|COMPLETED|Overall Study||6
5115822|NCT01520727|12585336|P1|COMPLETED|Overall Study||6
5115823|NCT01520727|12585328|P9|STARTED|Overall Study||16
5115824|NCT01520727|12585329|P8|STARTED|Overall Study||6
5115825|NCT01520727|12585330|P7|STARTED|Overall Study||6
5115826|NCT01520727|12585331|P6|STARTED|Overall Study||6
5115827|NCT01520727|12585332|P5|STARTED|Overall Study||6
5115828|NCT01520727|12585333|P4|STARTED|Overall Study||6
5115829|NCT01520727|12585334|P3|STARTED|Overall Study||6
5115830|NCT01520727|12585335|P2|STARTED|Overall Study||6
5115831|NCT01520727|12585336|P1|STARTED|Overall Study||6
5115832|NCT01520714|12585374|P2|NOT COMPLETED|Overall Study||6
5115833|NCT01520714|12585375|P1|NOT COMPLETED|Overall Study||0
5115834|NCT01520714|12585374|P2|COMPLETED|Overall Study||5
5115835|NCT01520714|12585375|P1|COMPLETED|Overall Study||0
5115836|NCT01520714|12585374|P2|STARTED|Overall Study||11
5115837|NCT01520714|12585375|P1|STARTED|Overall Study||0
5115838|NCT01520558|12585384|P3|NOT COMPLETED|Overall Study||3
5115839|NCT01520558|12585385|P2|NOT COMPLETED|Overall Study||2
5115840|NCT01520558|12585386|P1|NOT COMPLETED|Overall Study||2
5115841|NCT01520558|12585384|P3|COMPLETED|Overall Study||3
5115842|NCT01520558|12585385|P2|COMPLETED|Overall Study||1
5115843|NCT01520558|12585386|P1|COMPLETED|Overall Study||1
5115844|NCT01520558|12585384|P3|STARTED|Overall Study||6
5115845|NCT01520558|12585385|P2|STARTED|Overall Study||3
5115846|NCT01520558|12585386|P1|STARTED|Overall Study||3
5115847|NCT01520532|12585394|P1|NOT COMPLETED|Overall Study||0
5115848|NCT01520532|12585394|P1|COMPLETED|Overall Study||60
5115849|NCT01520532|12585394|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
5115850|NCT01520519|12585400|P1|NOT COMPLETED|Overall Study||0
5115851|NCT01520519|12585400|P1|COMPLETED|Overall Study||40
5115852|NCT01520519|12585400|P1|STARTED|Overall Study||40
5115853|NCT01520506|12585405|P1|NOT COMPLETED|Overall Study||6
5115854|NCT01520506|12585405|P1|COMPLETED|Overall Study||44
5115855|NCT01520506|12585405|P1|STARTED|Overall Study||50
5115856|NCT01520454|12585415|P4|NOT COMPLETED|Overall Study||0
5115857|NCT01520454|12585416|P3|NOT COMPLETED|Overall Study||0
5115858|NCT01520454|12585417|P2|NOT COMPLETED|Overall Study||0
5115859|NCT01520454|12585418|P1|NOT COMPLETED|Overall Study||0
5115860|NCT01520454|12585415|P4|COMPLETED|Overall Study||6
5115861|NCT01520454|12585416|P3|COMPLETED|Overall Study||5
5115862|NCT01520454|12585417|P2|COMPLETED|Overall Study||6
5115863|NCT01520454|12585418|P1|COMPLETED|Overall Study||9
5115864|NCT01520454|12585415|P4|STARTED|Overall Study||6
5115865|NCT01520454|12585416|P3|STARTED|Overall Study||5
5115866|NCT01520454|12585417|P2|STARTED|Overall Study||6
5115867|NCT01520454|12585418|P1|STARTED|Overall Study||9
5115868|NCT01520402|12585460|P1|NOT COMPLETED|Overall Study||5
5115869|NCT01520402|12585460|P1|COMPLETED|Overall Study||30
5115870|NCT01520402|12585460|P1|STARTED|Overall Study||35
5115871|NCT01520363|12585473|P2|NOT COMPLETED|Overall Study||0
5115872|NCT01520363|12585474|P1|NOT COMPLETED|Overall Study||2
5115873|NCT01520363|12585473|P2|COMPLETED|Overall Study||26
5115874|NCT01520363|12585474|P1|COMPLETED|Overall Study||24
5115875|NCT01520363|12585473|P2|STARTED|Overall Study||26
5115876|NCT01520363|12585474|P1|STARTED|Overall Study||26
5115877|NCT01520324|12585548|P1|NOT COMPLETED|Overall Study||1
5115878|NCT01520324|12585548|P1|COMPLETED|Overall Study||52
5115879|NCT01520324|12585548|P1|STARTED|Overall Study||53
5115880|NCT01520207|12585561|P2|NOT COMPLETED|Overall Study||0
5115881|NCT01520207|12585562|P1|NOT COMPLETED|Overall Study||2
5115882|NCT01520207|12585561|P2|COMPLETED|Overall Study||25
5115883|NCT01520207|12585562|P1|COMPLETED|Overall Study||25
5115884|NCT01520207|12585561|P2|STARTED|Overall Study||25
5115885|NCT01520207|12585562|P1|STARTED|Overall Study||27
5115886|NCT01520038|12585568|P1|NOT COMPLETED|Overall Study||1
5115887|NCT01520038|12585568|P1|COMPLETED|Overall Study||1
5115888|NCT01520038|12585568|P1|STARTED|Overall Study||2
5115889|NCT01519960|12585577|P3|NOT COMPLETED|Overall Study||10
5115890|NCT01519960|12585578|P2|NOT COMPLETED|Overall Study||50
5115891|NCT01519960|12585579|P1|NOT COMPLETED|Overall Study||101
5115892|NCT01519960|12585577|P3|COMPLETED|Overall Study||0
5115893|NCT01519960|12585578|P2|COMPLETED|Overall Study||0
5115894|NCT01519960|12585579|P1|COMPLETED|Overall Study||0
5115895|NCT01519960|12585577|P3|Completed FU Week 24|Overall Study||10
5115896|NCT01519960|12585578|P2|Completed FU Week 24|Overall Study||15
5115897|NCT01519960|12585579|P1|Completed FU Week 24|Overall Study||101
5115898|NCT01519960|12585577|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
5115899|NCT01519960|12585578|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
5115900|NCT01519960|12585579|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
5115901|NCT01519960|12585577|P3|Completed Week 48|Overall Study||10
5115902|NCT01519960|12585578|P2|Completed Week 48|Overall Study||47
5115903|NCT01519960|12585579|P1|Completed Week 48|Overall Study||99
5115904|NCT01519960|12585577|P3|STARTED|Overall Study||10
5115905|NCT01519960|12585578|P2|STARTED|Overall Study||50
5115906|NCT01519960|12585579|P1|STARTED|Overall Study||101
5115907|NCT01519947|12585689|P4|NOT COMPLETED|Overall Study||8
5115908|NCT01519947|12585690|P3|NOT COMPLETED|Overall Study||7
5115909|NCT01519947|12585691|P2|NOT COMPLETED|Overall Study||4
5115910|NCT01519947|12585692|P1|NOT COMPLETED|Overall Study||2
5115911|NCT01519947|12585689|P4|COMPLETED|Overall Study||34
5115912|NCT01519947|12585690|P3|COMPLETED|Overall Study||8
5115913|NCT01519947|12585691|P2|COMPLETED|Overall Study||7
5115914|NCT01519947|12585692|P1|COMPLETED|Overall Study||17
5115915|NCT01519947|12585689|P4|STARTED|Overall Study||42
5115916|NCT01519947|12585690|P3|STARTED|Overall Study||15
5115917|NCT01519947|12585691|P2|STARTED|Overall Study||11
5115918|NCT01519947|12585692|P1|STARTED|Overall Study||19
5115919|NCT01519934|12585722|P1|NOT COMPLETED|Overall Study||3
5115920|NCT01519934|12585722|P1|COMPLETED|Overall Study||45
5115921|NCT01519934|12585722|P1|STARTED|Overall Study||48
5115922|NCT01519921|12585731|P2|NOT COMPLETED|Overall Study||15
5115923|NCT01519921|12585732|P1|NOT COMPLETED|Overall Study||21
5115924|NCT01519921|12585731|P2|COMPLETED|Overall Study||49
5115925|NCT01519921|12585732|P1|COMPLETED|Overall Study||65
5115926|NCT01519921|12585731|P2|STARTED|Overall Study||64
5115927|NCT01519921|12585732|P1|STARTED|Overall Study||86
5115928|NCT01519882|12585756|P2|NOT COMPLETED|Overall Study||0
5115929|NCT01519882|12585757|P1|NOT COMPLETED|Overall Study||0
5115930|NCT01519882|12585756|P2|COMPLETED|Overall Study||0
5115931|NCT01519882|12585757|P1|COMPLETED|Overall Study||1
5115932|NCT01519882|12585756|P2|STARTED|Overall Study||0
5115933|NCT01519882|12585757|P1|STARTED|Overall Study||1
5115934|NCT01519817|12585781|P4|NOT COMPLETED|Overall Study||1
5115935|NCT01519817|12585782|P3|NOT COMPLETED|Overall Study||0
5115936|NCT01519817|12585783|P2|NOT COMPLETED|Overall Study||0
5115937|NCT01519817|12585784|P1|NOT COMPLETED|Overall Study||1
5115938|NCT01519817|12585781|P4|COMPLETED|Overall Study||10
5115939|NCT01519817|12585782|P3|COMPLETED|Overall Study||16
5115940|NCT01519817|12585783|P2|COMPLETED|Overall Study||3
5115941|NCT01519817|12585784|P1|COMPLETED|Overall Study||3
5115942|NCT01519817|12585781|P4|STARTED|Overall Study||11
5115943|NCT01519817|12585782|P3|STARTED|Overall Study||16
5115944|NCT01519817|12585783|P2|STARTED|Overall Study||3
5115945|NCT01519817|12585784|P1|STARTED|Overall Study||4
5115946|NCT01519791|12585824|P2|NOT COMPLETED|Overall Study||368
5115947|NCT01519791|12585825|P1|NOT COMPLETED|Overall Study||152
5115948|NCT01519791|12585824|P2|COMPLETED|Overall Study||292
5115949|NCT01519791|12585825|P1|COMPLETED|Overall Study||67
5115950|NCT01519791|12585824|P2|Completed Week 52|Overall Study||500
5115951|NCT01519791|12585825|P1|Completed Week 52|Overall Study||143
5115952|NCT01519791|12585824|P2|STARTED|Overall Study||660
5115953|NCT01519791|12585825|P1|STARTED|Overall Study||219
5115954|NCT01519778|12585889|P1|NOT COMPLETED|Overall Study||14
5115955|NCT01519778|12585889|P1|COMPLETED|Overall Study||186
5115956|NCT01519778|12585889|P1|STARTED|Overall Study||200
5115957|NCT01519765|12585895|P2|NOT COMPLETED|Overall Study||2
5115958|NCT01519765|12585896|P1|NOT COMPLETED|Overall Study||3
5115959|NCT01519765|12585895|P2|COMPLETED|Overall Study||34
5115960|NCT01519765|12585896|P1|COMPLETED|Overall Study||34
5115961|NCT01519765|12585895|P2|STARTED|Overall Study||36
5115962|NCT01519765|12585896|P1|STARTED|Overall Study||37
5115963|NCT01519713|12585945|P3|NOT COMPLETED|Overall Study||0
5115964|NCT01519713|12585946|P2|NOT COMPLETED|Overall Study||0
5115965|NCT01519713|12585947|P1|NOT COMPLETED|Overall Study||0
5115966|NCT01519713|12585945|P3|COMPLETED|Overall Study||4
5115967|NCT01519713|12585946|P2|COMPLETED|Overall Study||2
5115968|NCT01519713|12585947|P1|COMPLETED|Overall Study||194
5115969|NCT01519713|12585945|P3|STARTED|Overall Study||4
5115970|NCT01519713|12585946|P2|STARTED|Overall Study||2
5115971|NCT01519713|12585947|P1|STARTED|Overall Study||194
5115972|NCT01519700|12585974|P4|NOT COMPLETED|Overall Study||7
5115973|NCT01519700|12585975|P3|NOT COMPLETED|Overall Study||7
5115974|NCT01519700|12585976|P2|NOT COMPLETED|Overall Study||6
5115975|NCT01519700|12585977|P1|NOT COMPLETED|Overall Study||9
5115976|NCT01519700|12585974|P4|COMPLETED|Overall Study||47
5115977|NCT01519700|12585975|P3|COMPLETED|Overall Study||48
5115978|NCT01519700|12585976|P2|COMPLETED|Overall Study||49
5115979|NCT01519700|12585977|P1|COMPLETED|Overall Study||45
5115980|NCT01519700|12585974|P4|Treated Cycle 6 Neupogen|Overall Study||49
5115981|NCT01519700|12585975|P3|Treated Cycle 6 Neupogen|Overall Study||0
5115982|NCT01519700|12585976|P2|Treated Cycle 6 Neupogen|Overall Study||49
5115983|NCT01519700|12585977|P1|Treated Cycle 6 Neupogen|Overall Study||0
5115984|NCT01519700|12585974|P4|Treated Cycle 6 EP2006|Overall Study||0
5115985|NCT01519700|12585975|P3|Treated Cycle 6 EP2006|Overall Study||48
5115986|NCT01519700|12585976|P2|Treated Cycle 6 EP2006|Overall Study||0
5115987|NCT01519700|12585977|P1|Treated Cycle 6 EP2006|Overall Study||45
5115988|NCT01519700|12585974|P4|Treated Cycle 5 Neupogen|Overall Study||50
5115989|NCT01519700|12585975|P3|Treated Cycle 5 Neupogen|Overall Study||48
5115990|NCT01519700|12585976|P2|Treated Cycle 5 Neupogen|Overall Study||0
5115991|NCT01519700|12585977|P1|Treated Cycle 5 Neupogen|Overall Study||0
5115992|NCT01519700|12585974|P4|Treated Cycle 5 EP2006|Overall Study||0
5115993|NCT01519700|12585975|P3|Treated Cycle 5 EP2006|Overall Study||0
5115994|NCT01519700|12585976|P2|Treated Cycle 5 EP2006|Overall Study||49
5115995|NCT01519700|12585977|P1|Treated Cycle 5 EP2006|Overall Study||46
5115996|NCT01519700|12585974|P4|Treated Cycle 4 Neupogen|Overall Study||50
5115997|NCT01519700|12585975|P3|Treated Cycle 4 Neupogen|Overall Study||0
5115998|NCT01519700|12585976|P2|Treated Cycle 4 Neupogen|Overall Study||51
5115999|NCT01519700|12585977|P1|Treated Cycle 4 Neupogen|Overall Study||0
5116000|NCT01519700|12585974|P4|Treated Cycle 4 EP2006|Overall Study||0
5116001|NCT01519700|12585975|P3|Treated Cycle 4 EP2006|Overall Study||50
5116002|NCT01519700|12585976|P2|Treated Cycle 4 EP2006|Overall Study||0
5116003|NCT01519700|12585977|P1|Treated Cycle 4 EP2006|Overall Study||51
5116004|NCT01519700|12585974|P4|Treated Cycle 3 Neupogen|Overall Study||51
5116005|NCT01519700|12585975|P3|Treated Cycle 3 Neupogen|Overall Study||54
5116006|NCT01519700|12585976|P2|Treated Cycle 3 Neupogen|Overall Study||0
5116007|NCT01519700|12585977|P1|Treated Cycle 3 Neupogen|Overall Study||0
5116008|NCT01519700|12585974|P4|Treated Cycle 3 EP2006|Overall Study||0
5116009|NCT01519700|12585975|P3|Treated Cycle 3 EP2006|Overall Study||0
5116010|NCT01519700|12585976|P2|Treated Cycle 3 EP2006|Overall Study||51
5116011|NCT01519700|12585977|P1|Treated Cycle 3 EP2006|Overall Study||51
5116012|NCT01519700|12585974|P4|Treated Cycle 2 Neupogen|Overall Study||51
5116013|NCT01519700|12585975|P3|Treated Cycle 2 Neupogen|Overall Study||0
5116014|NCT01519700|12585976|P2|Treated Cycle 2 Neupogen|Overall Study||52
5116015|NCT01519700|12585977|P1|Treated Cycle 2 Neupogen|Overall Study||0
5116016|NCT01519700|12585974|P4|Treated Cycle 2 EP2006|Overall Study||0
5116017|NCT01519700|12585975|P3|Treated Cycle 2 EP2006|Overall Study||55
5116018|NCT01519700|12585976|P2|Treated Cycle 2 EP2006|Overall Study||0
5116019|NCT01519700|12585977|P1|Treated Cycle 2 EP2006|Overall Study||52
5116020|NCT01519700|12585974|P4|Treated Cycle 1 Neupogen|Overall Study||52
5116021|NCT01519700|12585975|P3|Treated Cycle 1 Neupogen|Overall Study||55
5116022|NCT01519700|12585976|P2|Treated Cycle 1 Neupogen|Overall Study||0
5116023|NCT01519700|12585977|P1|Treated Cycle 1 Neupogen|Overall Study||0
5116024|NCT01519700|12585974|P4|Treated Cycle 1 EP2006|Overall Study||0
5116025|NCT01519700|12585975|P3|Treated Cycle 1 EP2006|Overall Study||0
5116026|NCT01519700|12585976|P2|Treated Cycle 1 EP2006|Overall Study||54
5116027|NCT01519700|12585977|P1|Treated Cycle 1 EP2006|Overall Study||53
5116028|NCT01519700|12585974|P4|STARTED|Overall Study||54
5116029|NCT01519700|12585975|P3|STARTED|Overall Study||55
5116030|NCT01519700|12585976|P2|STARTED|Overall Study||55
5116031|NCT01519700|12585977|P1|STARTED|Overall Study||54
5116032|NCT01519674|12586012|P3|NOT COMPLETED|Overall Study||12
5116033|NCT01519674|12586013|P2|NOT COMPLETED|Overall Study||13
5116034|NCT01519674|12586014|P1|NOT COMPLETED|Overall Study||21
5116035|NCT01519674|12586012|P3|COMPLETED|Overall Study||181
5116036|NCT01519674|12586013|P2|COMPLETED|Overall Study||182
5116037|NCT01519674|12586014|P1|COMPLETED|Overall Study||173
5116038|NCT01519674|12586012|P3|Exposed|Overall Study||190
5116039|NCT01519674|12586013|P2|Exposed|Overall Study||193
5116040|NCT01519674|12586014|P1|Exposed|Overall Study||192
5116041|NCT01519674|12586012|P3|STARTED|Overall Study||193
5116042|NCT01519674|12586013|P2|STARTED|Overall Study||195
5116043|NCT01519674|12586014|P1|STARTED|Overall Study||194
5116044|NCT01519661|12586052|P1|NOT COMPLETED|Overall Study||61
5116045|NCT01519661|12586052|P1|COMPLETED|Overall Study||96
5116046|NCT01519661|12586052|P1|STARTED|Overall Study||157
5116047|NCT01519648|12586069|P2|NOT COMPLETED|Overall Study||0
5116048|NCT01519648|12586070|P1|NOT COMPLETED|Overall Study||0
5116049|NCT01519648|12586069|P2|COMPLETED|Overall Study||306
5116050|NCT01519648|12586070|P1|COMPLETED|Overall Study||502
5116051|NCT01519648|12586069|P2|STARTED|Overall Study||306
5116052|NCT01519648|12586070|P1|STARTED|Overall Study||502
5116053|NCT01519635|12586078|P2|NOT COMPLETED|Overall Study||3
5116054|NCT01519635|12586079|P1|NOT COMPLETED|Overall Study||1
5116055|NCT01519635|12586078|P2|COMPLETED|Overall Study||9
5116056|NCT01519635|12586079|P1|COMPLETED|Overall Study||11
5116057|NCT01519635|12586078|P2|STARTED|Overall Study||12
5116058|NCT01519635|12586079|P1|STARTED|Overall Study||12
5116059|NCT01519570|12586087|P2|NOT COMPLETED|Overall Study||0
5116060|NCT01519570|12586088|P1|NOT COMPLETED|Overall Study||0
5116061|NCT01519570|12586087|P2|COMPLETED|Overall Study||2089
5116062|NCT01519570|12586088|P1|COMPLETED|Overall Study||500
5116063|NCT01519570|12586087|P2|STARTED|Overall Study||2089
5116064|NCT01519570|12586088|P1|STARTED|Overall Study||500
5116065|NCT01519518|12586096|P2|NOT COMPLETED|Overall Study||10
5116066|NCT01519518|12586097|P1|NOT COMPLETED|Overall Study||7
5116067|NCT01519518|12586096|P2|COMPLETED|Overall Study||905
5116068|NCT01519518|12586097|P1|COMPLETED|Overall Study||907
5116069|NCT01519518|12586096|P2|STARTED|Overall Study||915
5116070|NCT01519518|12586097|P1|STARTED|Overall Study||914
5116071|NCT01519466|12586111|P2|NOT COMPLETED|Overall Study||0
5116072|NCT01519466|12586112|P1|NOT COMPLETED|Overall Study||0
5116073|NCT01519466|12586111|P2|COMPLETED|Overall Study||16
5116074|NCT01519466|12586112|P1|COMPLETED|Overall Study||33
5116075|NCT01519466|12586111|P2|STARTED|Overall Study||16
5116076|NCT01519466|12586112|P1|STARTED|Overall Study||33
5116077|NCT01519427|12586122|P1|NOT COMPLETED|Overall Study||2
5116078|NCT01519427|12586122|P1|COMPLETED|Overall Study||0
5116079|NCT01519427|12586122|P1|STARTED|Overall Study||2
5116080|NCT01519414|12586131|P3|NOT COMPLETED|Post Cross-over||0
5116081|NCT01519414|12586132|P2|NOT COMPLETED|Post Cross-over||0
5116082|NCT01519414|12586133|P1|NOT COMPLETED|Post Cross-over||0
5116083|NCT01519414|12586131|P3|COMPLETED|Post Cross-over||12
5116084|NCT01519414|12586132|P2|COMPLETED|Post Cross-over||14
5116085|NCT01519414|12586133|P1|COMPLETED|Post Cross-over||52
5116086|NCT01519414|12586131|P3|STARTED|Post Cross-over||12
5116087|NCT01519414|12586132|P2|STARTED|Post Cross-over||14
5116088|NCT01519414|12586133|P1|STARTED|Post Cross-over||52
5116089|NCT01519414|12586131|P3|NOT COMPLETED|Pre Cross-over||0
5116090|NCT01519414|12586132|P2|NOT COMPLETED|Pre Cross-over||0
5116091|NCT01519414|12586133|P1|NOT COMPLETED|Pre Cross-over||0
5116092|NCT01519414|12586131|P3|COMPLETED|Pre Cross-over||0
5116093|NCT01519414|12586132|P2|COMPLETED|Pre Cross-over||26
5116094|NCT01519414|12586133|P1|COMPLETED|Pre Cross-over||52
5116095|NCT01519414|12586131|P3|STARTED|Pre Cross-over||0
5116096|NCT01519414|12586132|P2|STARTED|Pre Cross-over||26
5116097|NCT01519414|12586133|P1|STARTED|Pre Cross-over||52
5116098|NCT01519323|12586154|P2|NOT COMPLETED|Overall Study||3
5116099|NCT01519323|12586155|P1|NOT COMPLETED|Overall Study||3
5116100|NCT01519323|12586154|P2|COMPLETED|Overall Study||0
5116101|NCT01519323|12586155|P1|COMPLETED|Overall Study||0
5116102|NCT01519323|12586154|P2|STARTED|Overall Study||3
5116103|NCT01519323|12586155|P1|STARTED|Overall Study||3
5116104|NCT01519284|12586171|P5|NOT COMPLETED|Overall Study||0
5116105|NCT01519284|12586172|P4|NOT COMPLETED|Overall Study||0
5116106|NCT01519284|12586173|P3|NOT COMPLETED|Overall Study||2
5116107|NCT01519284|12586174|P2|NOT COMPLETED|Overall Study||0
5116108|NCT01519284|12586175|P1|NOT COMPLETED|Overall Study||0
5116109|NCT01519284|12586171|P5|COMPLETED|Overall Study||16
5116110|NCT01519284|12586172|P4|COMPLETED|Overall Study||16
5116111|NCT01519284|12586173|P3|COMPLETED|Overall Study||16
5116112|NCT01519284|12586174|P2|COMPLETED|Overall Study||16
5116113|NCT01519284|12586175|P1|COMPLETED|Overall Study||16
5116114|NCT01519284|12586171|P5|STARTED|Overall Study||16
5116115|NCT01519284|12586172|P4|STARTED|Overall Study||16
5116116|NCT01519284|12586173|P3|STARTED|Overall Study||18
5116117|NCT01519284|12586174|P2|STARTED|Overall Study||16
5116118|NCT01519284|12586175|P1|STARTED|Overall Study||16
5116119|NCT01519271|12586204|P2|NOT COMPLETED|Phase 2||0
5116120|NCT01519271|12586205|P1|NOT COMPLETED|Phase 2||0
5116121|NCT01519271|12586204|P2|COMPLETED|Phase 2||14
5116122|NCT01519271|12586205|P1|COMPLETED|Phase 2||12
5116123|NCT01519271|12586204|P2|STARTED|Phase 2||14
5116124|NCT01519271|12586205|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
5116125|NCT01519271|12586204|P2|NOT COMPLETED|Phase 1||1
5116126|NCT01519271|12586205|P1|NOT COMPLETED|Phase 1||0
5116127|NCT01519271|12586204|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
5116128|NCT01519271|12586205|P1|COMPLETED|Phase 1||14
5116129|NCT01519271|12586204|P2|STARTED|Phase 1||14
5116130|NCT01519271|12586205|P1|STARTED|Phase 1||14
5116131|NCT01519245|12586215|P2|NOT COMPLETED|Overall Study||2
5116132|NCT01519245|12586216|P1|NOT COMPLETED|Overall Study||1
5116133|NCT01519245|12586215|P2|COMPLETED|Overall Study||18
5116134|NCT01519245|12586216|P1|COMPLETED|Overall Study||23
5116135|NCT01519245|12586215|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
5116136|NCT01519245|12586216|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
5116137|NCT01519245|12586215|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
5116138|NCT01519245|12586216|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
5116139|NCT01519245|12586215|P2|STARTED|Overall Study||20
5116140|NCT01519245|12586216|P1|STARTED|Overall Study||24
5116141|NCT01519206|12586228|P1|NOT COMPLETED|Overall Study||5
5116142|NCT01519206|12586228|P1|COMPLETED|Overall Study||27
5116143|NCT01519206|12586228|P1|STARTED|Overall Study||32
5116144|NCT01519167|12586242|P2|NOT COMPLETED|Overall Study||8
5116145|NCT01519167|12586243|P1|NOT COMPLETED|Overall Study||0
5116146|NCT01519167|12586242|P2|COMPLETED|Overall Study||81
5116147|NCT01519167|12586243|P1|COMPLETED|Overall Study||1
5116148|NCT01519167|12586242|P2|STARTED|Overall Study||89
5116149|NCT01519167|12586243|P1|STARTED|Overall Study||1
5116150|NCT01519089|12586269|P2|NOT COMPLETED|Overall Study||15
5116151|NCT01519089|12586270|P1|NOT COMPLETED|Overall Study||7
5116152|NCT01519089|12586269|P2|COMPLETED|Overall Study||33
5116153|NCT01519089|12586270|P1|COMPLETED|Overall Study||40
5116154|NCT01519089|12586269|P2|Received Treatment|Overall Study||47
5116155|NCT01519089|12586270|P1|Received Treatment|Overall Study||47
5116156|NCT01519089|12586269|P2|STARTED|Overall Study||48
5116157|NCT01519089|12586270|P1|STARTED|Overall Study||47
5116158|NCT01519063|12586391|P2|NOT COMPLETED|Overall Study||5
5116159|NCT01519063|12586392|P1|NOT COMPLETED|Overall Study||7
5116160|NCT01519063|12586391|P2|COMPLETED|Overall Study||25
5116161|NCT01519063|12586392|P1|COMPLETED|Overall Study||19
5116162|NCT01519063|12586391|P2|STARTED|Overall Study||30
5116163|NCT01519063|12586392|P1|STARTED|Overall Study||26
5116164|NCT01518946|12586412|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
5116165|NCT01518946|12586413|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
5116166|NCT01518946|12586414|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
5116167|NCT01518946|12586412|P3|COMPLETED|Randomized Phase (Second Intervention)||10
5116168|NCT01518946|12586413|P2|COMPLETED|Randomized Phase (Second Intervention)||9
5116169|NCT01518946|12586414|P1|COMPLETED|Randomized Phase (Second Intervention)||0
5116170|NCT01518946|12586412|P3|STARTED|Randomized Phase (Second Intervention)||10
5116171|NCT01518946|12586413|P2|STARTED|Randomized Phase (Second Intervention)||9
5116172|NCT01518946|12586414|P1|STARTED|Randomized Phase (Second Intervention)||0
5116173|NCT01518946|12586412|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
5116174|NCT01518946|12586413|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
5116175|NCT01518946|12586414|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
5116176|NCT01518946|12586412|P3|COMPLETED|Randomized Phase (First Intervention)||10
5116177|NCT01518946|12586413|P2|COMPLETED|Randomized Phase (First Intervention)||9
5116178|NCT01518946|12586414|P1|COMPLETED|Randomized Phase (First Intervention)||0
5116179|NCT01518946|12586412|P3|STARTED|Randomized Phase (First Intervention)||10
5116180|NCT01518946|12586413|P2|STARTED|Randomized Phase (First Intervention)||10
5116181|NCT01518946|12586414|P1|STARTED|Randomized Phase (First Intervention)||0
5116182|NCT01518946|12586412|P3|NOT COMPLETED|Open-label Phase||0
5116183|NCT01518946|12586413|P2|NOT COMPLETED|Open-label Phase||0
5116184|NCT01518946|12586414|P1|NOT COMPLETED|Open-label Phase||4
5116185|NCT01518946|12586412|P3|COMPLETED|Open-label Phase||0
5116186|NCT01518946|12586413|P2|COMPLETED|Open-label Phase||0
5116187|NCT01518946|12586414|P1|COMPLETED|Open-label Phase||20
5116188|NCT01518946|12586412|P3|STARTED|Open-label Phase||0
5116189|NCT01518946|12586413|P2|STARTED|Open-label Phase||0
5116190|NCT01518946|12586414|P1|STARTED|Open-label Phase||24
5116191|NCT01518530|12586421|P1|NOT COMPLETED|Post-Treatment Follow-up||0
5116192|NCT01518530|12586421|P1|COMPLETED|Post-Treatment Follow-up||9
5116193|NCT01518530|12586421|P1|STARTED|Post-Treatment Follow-up||9
5116194|NCT01518530|12586421|P1|NOT COMPLETED|Active Treatment Period||1
5116195|NCT01518530|12586421|P1|COMPLETED|Active Treatment Period||9
5116196|NCT01518530|12586421|P1|STARTED|Active Treatment Period||10
5116197|NCT01518374|12586425|P1|NOT COMPLETED|Overall Study||7
5116198|NCT01518374|12586425|P1|COMPLETED|Overall Study||1761
5116199|NCT01518374|12586425|P1|STARTED|Overall Study||1768
5116200|NCT01518322|12586429|P1|NOT COMPLETED|Overall Study||13
5116201|NCT01518322|12586429|P1|COMPLETED|Overall Study||222
5116202|NCT01518322|12586429|P1|STARTED|Overall Study||235
5116203|NCT01518270|12586442|P1|NOT COMPLETED|Overall Study||0
5116204|NCT01518270|12586442|P1|COMPLETED|Overall Study||179
5116205|NCT01518270|12586442|P1|STARTED|Overall Study||179
5116206|NCT01518257|12586450|P2|NOT COMPLETED|Overall Study||0
5116207|NCT01518257|12586451|P1|NOT COMPLETED|Overall Study||2
5116208|NCT01518257|12586450|P2|COMPLETED|Overall Study||60
5116209|NCT01518257|12586451|P1|COMPLETED|Overall Study||59
5116210|NCT01518257|12586450|P2|STARTED|Overall Study||60
5116211|NCT01518257|12586451|P1|STARTED|Overall Study||61
5116212|NCT01518244|12586473|P1|NOT COMPLETED|Overall Study||3
5116213|NCT01518244|12586473|P1|COMPLETED|Overall Study||47
5116214|NCT01518244|12586473|P1|STARTED|Overall Study||50
5116215|NCT01518192|12586481|P3|NOT COMPLETED|Overall Study||35
5116216|NCT01518192|12586482|P2|NOT COMPLETED|Overall Study||26
5116217|NCT01518192|12586483|P1|NOT COMPLETED|Overall Study||29
5116218|NCT01518192|12586481|P3|COMPLETED|Overall Study||224
5116219|NCT01518192|12586482|P2|COMPLETED|Overall Study||114
5116220|NCT01518192|12586483|P1|COMPLETED|Overall Study||116
5116221|NCT01518192|12586481|P3|STARTED|Overall Study||259
5116222|NCT01518192|12586482|P2|STARTED|Overall Study||140
5116223|NCT01518192|12586483|P1|STARTED|Overall Study||145
5116224|NCT01518153|12586504|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
5116225|NCT01518153|12586505|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
5116226|NCT01518153|12586506|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
5116227|NCT01518153|12586504|P3|COMPLETED|Donor Lymphocyte Infusion||3
5116228|NCT01518153|12586505|P2|COMPLETED|Donor Lymphocyte Infusion||1
5116229|NCT01518153|12586506|P1|COMPLETED|Donor Lymphocyte Infusion||0
5116230|NCT01518153|12586504|P3|STARTED|Donor Lymphocyte Infusion||4
5116231|NCT01518153|12586505|P2|STARTED|Donor Lymphocyte Infusion||3
5116232|NCT01518153|12586506|P1|STARTED|Donor Lymphocyte Infusion||0
5116233|NCT01518153|12586504|P3|NOT COMPLETED|Stem Cell Transplant||0
5116234|NCT01518153|12586505|P2|NOT COMPLETED|Stem Cell Transplant||0
5116235|NCT01518153|12586506|P1|NOT COMPLETED|Stem Cell Transplant||9
5116236|NCT01518153|12586504|P3|COMPLETED|Stem Cell Transplant||0
5116237|NCT01518153|12586505|P2|COMPLETED|Stem Cell Transplant||0
5116238|NCT01518153|12586506|P1|COMPLETED|Stem Cell Transplant||7
5116239|NCT01518153|12586504|P3|STARTED|Stem Cell Transplant||0
5116240|NCT01518153|12586505|P2|STARTED|Stem Cell Transplant||0
5116241|NCT01518153|12586506|P1|STARTED|Stem Cell Transplant||16
5116242|NCT01517984|12586517|P4|NOT COMPLETED|Overall Study||1
5116243|NCT01517984|12586518|P3|NOT COMPLETED|Overall Study||4
5116244|NCT01517984|12586519|P2|NOT COMPLETED|Overall Study||23
5116245|NCT01517984|12586520|P1|NOT COMPLETED|Overall Study||5
5116246|NCT01517984|12586517|P4|COMPLETED|Overall Study||6
5116247|NCT01517984|12586518|P3|COMPLETED|Overall Study||10
5116248|NCT01517984|12586519|P2|COMPLETED|Overall Study||3
5116249|NCT01517984|12586520|P1|COMPLETED|Overall Study||0
5116250|NCT01517984|12586517|P4|STARTED|Overall Study||7
5116251|NCT01517984|12586518|P3|STARTED|Overall Study||14
5116252|NCT01517984|12586519|P2|STARTED|Overall Study||26
5116253|NCT01517984|12586520|P1|STARTED|Overall Study||5
5116254|NCT01517893|12586546|P2|NOT COMPLETED|Overall Study||0
5116255|NCT01517893|12586547|P1|NOT COMPLETED|Overall Study||3
5116256|NCT01517893|12586546|P2|COMPLETED|Overall Study||7
5116257|NCT01517893|12586547|P1|COMPLETED|Overall Study||5
5116258|NCT01517893|12586546|P2|STARTED|Overall Study||7
5116259|NCT01517893|12586547|P1|STARTED|Overall Study||8
5116260|NCT01517867|12586569|P2|NOT COMPLETED|Overall Study||65
5116261|NCT01517867|12586570|P1|NOT COMPLETED|Overall Study||63
5116262|NCT01517867|12586569|P2|COMPLETED|Overall Study||15
5116263|NCT01517867|12586570|P1|COMPLETED|Overall Study||18
5116264|NCT01517867|12586569|P2|STARTED|Overall Study||80
5116265|NCT01517867|12586570|P1|STARTED|Overall Study||81
5116266|NCT01517763|12586581|P3|NOT COMPLETED|Overall Study||0
5116267|NCT01517763|12586582|P2|NOT COMPLETED|Overall Study||0
5116268|NCT01517763|12586583|P1|NOT COMPLETED|Overall Study||0
5116269|NCT01517763|12586581|P3|COMPLETED|Overall Study||0
5116270|NCT01517763|12586582|P2|COMPLETED|Overall Study||0
5116271|NCT01517763|12586583|P1|COMPLETED|Overall Study||0
5116272|NCT01517763|12586581|P3|STARTED|Overall Study||0
5116273|NCT01517763|12586582|P2|STARTED|Overall Study||0
5116274|NCT01517763|12586583|P1|STARTED|Overall Study||0
5116275|NCT01517750|12586598|P4|NOT COMPLETED|Overall Study||1
5116276|NCT01517750|12586599|P3|NOT COMPLETED|Overall Study||4
5116277|NCT01517750|12586600|P2|NOT COMPLETED|Overall Study||2
5116278|NCT01517750|12586601|P1|NOT COMPLETED|Overall Study||1
5116279|NCT01517750|12586598|P4|COMPLETED|Overall Study||18
5116280|NCT01517750|12586599|P3|COMPLETED|Overall Study||17
5116281|NCT01517750|12586600|P2|COMPLETED|Overall Study||17
5116282|NCT01517750|12586601|P1|COMPLETED|Overall Study||20
5116283|NCT01517750|12586598|P4|STARTED|Overall Study||19
5116284|NCT01517750|12586599|P3|STARTED|Overall Study||21
5116285|NCT01517750|12586600|P2|STARTED|Overall Study||19
5116286|NCT01517750|12586601|P1|STARTED|Overall Study||21
5116287|NCT01517529|12586631|P1|NOT COMPLETED|Overall Study||0
5116288|NCT01517529|12586631|P1|COMPLETED|Overall Study||10
5116289|NCT01517529|12586631|P1|STARTED|Overall Study||10
5116290|NCT01517412|12586638|P2|NOT COMPLETED|Overall Study||24
5116291|NCT01517412|12586639|P1|NOT COMPLETED|Overall Study||36
5116292|NCT01517412|12586638|P2|COMPLETED|Overall Study||202
5116293|NCT01517412|12586639|P1|COMPLETED|Overall Study||189
5116294|NCT01517412|12586638|P2|STARTED|Overall Study||226
5116295|NCT01517412|12586639|P1|STARTED|Overall Study||225
5116296|NCT01517373|12586668|P6|NOT COMPLETED|Treatment Period||7
5116297|NCT01517373|12586669|P5|NOT COMPLETED|Treatment Period||6
5116298|NCT01517373|12586670|P4|NOT COMPLETED|Treatment Period||7
5116299|NCT01517373|12586671|P3|NOT COMPLETED|Treatment Period||6
5116300|NCT01517373|12586672|P2|NOT COMPLETED|Treatment Period||4
5116301|NCT01517373|12586673|P1|NOT COMPLETED|Treatment Period||0
5116302|NCT01517373|12586668|P6|COMPLETED|Treatment Period||54
5116303|NCT01517373|12586669|P5|COMPLETED|Treatment Period||55
5116304|NCT01517373|12586670|P4|COMPLETED|Treatment Period||54
5116305|NCT01517373|12586671|P3|COMPLETED|Treatment Period||54
5116306|NCT01517373|12586672|P2|COMPLETED|Treatment Period||57
5116307|NCT01517373|12586673|P1|COMPLETED|Treatment Period||0
5116308|NCT01517373|12586668|P6|STARTED|Treatment Period||61
5116309|NCT01517373|12586669|P5|STARTED|Treatment Period||61
5116310|NCT01517373|12586670|P4|STARTED|Treatment Period||61
5116311|NCT01517373|12586671|P3|STARTED|Treatment Period||60
5116312|NCT01517373|12586672|P2|STARTED|Treatment Period||61
5116313|NCT01517373|12586673|P1|STARTED|Treatment Period||0
5116314|NCT01517373|12586668|P6|NOT COMPLETED|Run-in Period||0
5116315|NCT01517373|12586669|P5|NOT COMPLETED|Run-in Period||0
5116316|NCT01517373|12586670|P4|NOT COMPLETED|Run-in Period||0
5116317|NCT01517373|12586671|P3|NOT COMPLETED|Run-in Period||0
5116318|NCT01517373|12586672|P2|NOT COMPLETED|Run-in Period||0
5116319|NCT01517373|12586673|P1|NOT COMPLETED|Run-in Period||57
5116320|NCT01517373|12586668|P6|COMPLETED|Run-in Period||0
5116321|NCT01517373|12586669|P5|COMPLETED|Run-in Period||0
5116322|NCT01517373|12586670|P4|COMPLETED|Run-in Period||0
5116323|NCT01517373|12586671|P3|COMPLETED|Run-in Period||0
5116324|NCT01517373|12586672|P2|COMPLETED|Run-in Period||0
5116325|NCT01517373|12586673|P1|COMPLETED|Run-in Period||304
5116326|NCT01517373|12586668|P6|STARTED|Run-in Period||0
5116327|NCT01517373|12586669|P5|STARTED|Run-in Period||0
5116328|NCT01517373|12586670|P4|STARTED|Run-in Period||0
5116329|NCT01517373|12586671|P3|STARTED|Run-in Period||0
5116330|NCT01517373|12586672|P2|STARTED|Run-in Period||0
5116331|NCT01517373|12586673|P1|STARTED|Run-in Period||361
5116332|NCT01517295|12586743|P2|NOT COMPLETED|Overall Study||0
5116333|NCT01517295|12586744|P1|NOT COMPLETED|Overall Study||1
5116334|NCT01517295|12586743|P2|COMPLETED|Overall Study||14
5116335|NCT01517295|12586744|P1|COMPLETED|Overall Study||15
5116336|NCT01517295|12586743|P2|STARTED|Overall Study||14
5116337|NCT01517295|12586744|P1|STARTED|Overall Study||16
5116338|NCT01517282|12586758|P4|NOT COMPLETED|Overall Study||1
5116339|NCT01517282|12586759|P3|NOT COMPLETED|Overall Study||1
5116340|NCT01517282|12586760|P2|NOT COMPLETED|Overall Study||1
5116341|NCT01517282|12586761|P1|NOT COMPLETED|Overall Study||1
5116342|NCT01517282|12586758|P4|COMPLETED|Overall Study||5
5116343|NCT01517282|12586759|P3|COMPLETED|Overall Study||8
5116344|NCT01517282|12586760|P2|COMPLETED|Overall Study||7
5116345|NCT01517282|12586761|P1|COMPLETED|Overall Study||8
5116346|NCT01517282|12586758|P4|STARTED|Overall Study||6
5116347|NCT01517282|12586759|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
5116348|NCT01517282|12586760|P2|STARTED|Overall Study||8
5116349|NCT01517282|12586761|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
5116350|NCT01517178|12586795|P2|NOT COMPLETED|Period 2||2
5116351|NCT01517178|12586796|P1|NOT COMPLETED|Period 2||6
5116352|NCT01517178|12586795|P2|COMPLETED|Period 2||4
5116353|NCT01517178|12586796|P1|COMPLETED|Period 2||5
5116354|NCT01517178|12586795|P2|STARTED|Period 2||6
5116355|NCT01517178|12586796|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
5116356|NCT01517178|12586795|P2|NOT COMPLETED|Period 1||5
5116357|NCT01517178|12586796|P1|NOT COMPLETED|Period 1||4
5116358|NCT01517178|12586795|P2|COMPLETED|Period 1||6
5116359|NCT01517178|12586796|P1|COMPLETED|Period 1||12
5116360|NCT01517178|12586795|P2|STARTED|Period 1||11
5116361|NCT01517178|12586796|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
5116362|NCT01517074|12586802|P1|NOT COMPLETED|Overall Study||0
5116363|NCT01517074|12586802|P1|COMPLETED|Overall Study||5
5116364|NCT01517074|12586802|P1|STARTED|Overall Study||5
5116365|NCT01516970|12586824|P2|NOT COMPLETED|Overall Study||21
5116366|NCT01516970|12586825|P1|NOT COMPLETED|Overall Study||18
5116367|NCT01516970|12586824|P2|COMPLETED|Overall Study||132
5116368|NCT01516970|12586825|P1|COMPLETED|Overall Study||141
5116369|NCT01516970|12586824|P2|STARTED|Overall Study||153
5116370|NCT01516970|12586825|P1|STARTED|Overall Study||159
5116371|NCT01516892|12586837|P1|NOT COMPLETED|Overall Study||343
5116372|NCT01516892|12586837|P1|COMPLETED|Overall Study||373
5116373|NCT01516892|12586837|P1|STARTED|Overall Study||716
5116374|NCT01516879|12586845|P2|NOT COMPLETED|Overall Study||34
5116375|NCT01516879|12586846|P1|NOT COMPLETED|Overall Study||16
5116376|NCT01516879|12586845|P2|COMPLETED|Overall Study||568
5116377|NCT01516879|12586846|P1|COMPLETED|Overall Study||287
5116378|NCT01516879|12586845|P2|Received Treatment|Overall Study||599
5116379|NCT01516879|12586846|P1|Received Treatment|Overall Study||302
5116380|NCT01516879|12586845|P2|STARTED|Overall Study||602
5116381|NCT01516879|12586846|P1|STARTED|Overall Study||303
5116382|NCT01516749|12586880|P1|NOT COMPLETED|Follow-up Off Therapy||1
5116383|NCT01516749|12586880|P1|COMPLETED|Follow-up Off Therapy||4
5116384|NCT01516749|12586880|P1|STARTED|Follow-up Off Therapy||5
5116385|NCT01516749|12586880|P1|NOT COMPLETED|Active Therapy||1
5116386|NCT01516749|12586880|P1|COMPLETED|Active Therapy||5
5116387|NCT01516749|12586880|P1|STARTED|Active Therapy||6
5116388|NCT01516736|12586889|P2|NOT COMPLETED|Overall Study||13
5116389|NCT01516736|12586890|P1|NOT COMPLETED|Overall Study||20
5116390|NCT01516736|12586889|P2|COMPLETED|Overall Study||140
5116391|NCT01516736|12586890|P1|COMPLETED|Overall Study||135
5116392|NCT01516736|12586889|P2|STARTED|Overall Study||153
5116393|NCT01516736|12586890|P1|STARTED|Overall Study||155
5116394|NCT01516684|12586912|P2|NOT COMPLETED|Overall Study||0
5116395|NCT01516684|12586913|P1|NOT COMPLETED|Overall Study||0
5116396|NCT01516684|12586912|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|0
5116397|NCT01516684|12586913|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
5116486|NCT01515865|12587135|P1|COMPLETED|Part A (Open-label)||95
5116487|NCT01515865|12587133|P3|STARTED|Part A (Open-label)||0
5116398|NCT01516684|12586912|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
5116399|NCT01516684|12586913|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
5116400|NCT01516632|12586929|P2|NOT COMPLETED|Overall Study||15
5116401|NCT01516632|12586930|P1|NOT COMPLETED|Overall Study||24
5116402|NCT01516632|12586929|P2|COMPLETED|Overall Study||48
5116403|NCT01516632|12586930|P1|COMPLETED|Overall Study||77
5116404|NCT01516632|12586929|P2|STARTED|Overall Study||63
5116405|NCT01516632|12586930|P1|STARTED|Overall Study||101
5116406|NCT01516437|12586944|P4|NOT COMPLETED|Overall Study||1
5116407|NCT01516437|12586945|P3|NOT COMPLETED|Overall Study||1
5116408|NCT01516437|12586946|P2|NOT COMPLETED|Overall Study||0
5116409|NCT01516437|12586947|P1|NOT COMPLETED|Overall Study||0
5116410|NCT01516437|12586944|P4|COMPLETED|Overall Study||6
5116411|NCT01516437|12586945|P3|COMPLETED|Overall Study||14
5116412|NCT01516437|12586946|P2|COMPLETED|Overall Study||24
5116413|NCT01516437|12586947|P1|COMPLETED|Overall Study||24
5116414|NCT01516437|12586944|P4|STARTED|Overall Study||7
5116415|NCT01516437|12586945|P3|STARTED|Overall Study||15
5116416|NCT01516437|12586946|P2|STARTED|Overall Study||24
5116417|NCT01516437|12586947|P1|STARTED|Overall Study||24
5116418|NCT01516424|12587003|P2|NOT COMPLETED|Overall Study||22
5116419|NCT01516424|12587004|P1|NOT COMPLETED|Overall Study||35
5116420|NCT01516424|12587003|P2|COMPLETED|Overall Study||114
5116421|NCT01516424|12587004|P1|COMPLETED|Overall Study||96
5116422|NCT01516424|12587003|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
5116423|NCT01516424|12587004|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
5116424|NCT01516268|12587012|P2|NOT COMPLETED|Overall Study||0
5116425|NCT01516268|12587013|P1|NOT COMPLETED|Overall Study||0
5116426|NCT01516268|12587012|P2|COMPLETED|Overall Study||25
5116427|NCT01516268|12587013|P1|COMPLETED|Overall Study||25
5116428|NCT01516268|12587012|P2|STARTED|Overall Study||25
5116429|NCT01516268|12587013|P1|STARTED|Overall Study||25
5116430|NCT01516034|12587019|P1|NOT COMPLETED|Overall Study||8
5116431|NCT01516034|12587019|P1|COMPLETED|Overall Study||0
5116432|NCT01516034|12587019|P1|STARTED|Overall Study||8
5116433|NCT01516008|12587026|P3|NOT COMPLETED|Overall Study||18
5116434|NCT01516008|12587027|P2|NOT COMPLETED|Overall Study||16
5116435|NCT01516008|12587028|P1|NOT COMPLETED|Overall Study||45
5116436|NCT01516008|12587026|P3|COMPLETED|Overall Study||99
5116437|NCT01516008|12587027|P2|COMPLETED|Overall Study||105
5116438|NCT01516008|12587028|P1|COMPLETED|Overall Study||69
5116439|NCT01516008|12587026|P3|STARTED|Overall Study||117
5116440|NCT01516008|12587027|P2|STARTED|Overall Study||121
5116441|NCT01516008|12587028|P1|STARTED|Overall Study||114
5116442|NCT01515995|12587062|P2|NOT COMPLETED|Overall Study||4
5116443|NCT01515995|12587063|P1|NOT COMPLETED|Overall Study||3
5116444|NCT01515995|12587062|P2|COMPLETED|Overall Study||21
5116445|NCT01515995|12587063|P1|COMPLETED|Overall Study||22
5116446|NCT01515995|12587062|P2|STARTED|Overall Study||25
5116447|NCT01515995|12587063|P1|STARTED|Overall Study||25
5116448|NCT01515956|12587069|P1|NOT COMPLETED|Overall Study||0
5116449|NCT01515956|12587069|P1|COMPLETED|Overall Study||15
5116450|NCT01515956|12587069|P1|STARTED|Overall Study||15
5116451|NCT01515943|12587078|P3|NOT COMPLETED|Overall Study||13
5116452|NCT01515943|12587079|P2|NOT COMPLETED|Overall Study||16
5116453|NCT01515943|12587080|P1|NOT COMPLETED|Overall Study||6
5116454|NCT01515943|12587078|P3|COMPLETED|Overall Study||31
5116455|NCT01515943|12587079|P2|COMPLETED|Overall Study||69
5116456|NCT01515943|12587080|P1|COMPLETED|Overall Study||69
5116457|NCT01515943|12587078|P3|STARTED|Overall Study||44
5116458|NCT01515943|12587079|P2|STARTED|Overall Study||85
5116459|NCT01515943|12587080|P1|STARTED|Overall Study||75
5116460|NCT01515891|12587126|P1|NOT COMPLETED|Overall Study||0
5116461|NCT01515891|12587126|P1|COMPLETED|Overall Study||4
5116462|NCT01515891|12587126|P1|STARTED|Overall Study||4
5116463|NCT01515865|12587133|P3|NOT COMPLETED|Part C (Randomized)||0
5116464|NCT01515865|12587134|P2|NOT COMPLETED|Part C (Randomized)||0
5116465|NCT01515865|12587135|P1|NOT COMPLETED|Part C (Randomized)||0
5116466|NCT01515865|12587133|P3|COMPLETED|Part C (Randomized)||34
5116467|NCT01515865|12587134|P2|COMPLETED|Part C (Randomized)||33
5116468|NCT01515865|12587135|P1|COMPLETED|Part C (Randomized)||0
5116469|NCT01515865|12587133|P3|STARTED|Part C (Randomized)||34
5116470|NCT01515865|12587134|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
5116471|NCT01515865|12587135|P1|STARTED|Part C (Randomized)||0
5116472|NCT01515865|12587133|P3|NOT COMPLETED|Part B (Open-label)||0
5116473|NCT01515865|12587134|P2|NOT COMPLETED|Part B (Open-label)||0
5116474|NCT01515865|12587135|P1|NOT COMPLETED|Part B (Open-label)||2
5116475|NCT01515865|12587133|P3|COMPLETED|Part B (Open-label)||0
5116476|NCT01515865|12587134|P2|COMPLETED|Part B (Open-label)||0
5116477|NCT01515865|12587135|P1|COMPLETED|Part B (Open-label)||69
5116478|NCT01515865|12587133|P3|STARTED|Part B (Open-label)||0
5116479|NCT01515865|12587134|P2|STARTED|Part B (Open-label)||0
5116480|NCT01515865|12587135|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
5116481|NCT01515865|12587133|P3|NOT COMPLETED|Part A (Open-label)||0
5116482|NCT01515865|12587134|P2|NOT COMPLETED|Part A (Open-label)||0
5116483|NCT01515865|12587135|P1|NOT COMPLETED|Part A (Open-label)||3
5116484|NCT01515865|12587133|P3|COMPLETED|Part A (Open-label)||0
5116485|NCT01515865|12587134|P2|COMPLETED|Part A (Open-label)||0
5116488|NCT01515865|12587134|P2|STARTED|Part A (Open-label)||0
5116489|NCT01515865|12587135|P1|STARTED|Part A (Open-label)||98
5116490|NCT01515748|12587145|P2|NOT COMPLETED|Overall Study||135
5116491|NCT01515748|12587146|P1|NOT COMPLETED|Overall Study||120
5116492|NCT01515748|12587145|P2|COMPLETED|Overall Study||131
5116493|NCT01515748|12587146|P1|COMPLETED|Overall Study||144
5116494|NCT01515748|12587145|P2|Treated|Overall Study||241
5116495|NCT01515748|12587146|P1|Treated|Overall Study||195
5116496|NCT01515748|12587145|P2|STARTED|Overall Study||266
5116497|NCT01515748|12587146|P1|STARTED|Overall Study||264
5116498|NCT01515696|12587169|P2|NOT COMPLETED|Overall Study||10
5116499|NCT01515696|12587170|P1|NOT COMPLETED|Overall Study||8
5116500|NCT01515696|12587169|P2|COMPLETED|Overall Study||39
5116501|NCT01515696|12587170|P1|COMPLETED|Overall Study||39
5116502|NCT01515696|12587169|P2|STARTED|Overall Study||49
5116503|NCT01515696|12587170|P1|STARTED|Overall Study||47
5116504|NCT01515657|12587180|P3|NOT COMPLETED|Third Intervention||0
5116505|NCT01515657|12587181|P2|NOT COMPLETED|Third Intervention||0
5116506|NCT01515657|12587182|P1|NOT COMPLETED|Third Intervention||1
5116507|NCT01515657|12587180|P3|COMPLETED|Third Intervention||13
5116508|NCT01515657|12587181|P2|COMPLETED|Third Intervention||11
5116509|NCT01515657|12587182|P1|COMPLETED|Third Intervention||13
5116510|NCT01515657|12587180|P3|STARTED|Third Intervention||13
5116511|NCT01515657|12587181|P2|STARTED|Third Intervention||11
5116512|NCT01515657|12587182|P1|STARTED|Third Intervention||14
5116513|NCT01515657|12587180|P3|NOT COMPLETED|Second Intervention||0
5116514|NCT01515657|12587181|P2|NOT COMPLETED|Second Intervention||1
5116515|NCT01515657|12587182|P1|NOT COMPLETED|Second Intervention||0
5116516|NCT01515657|12587180|P3|COMPLETED|Second Intervention||13
5116517|NCT01515657|12587181|P2|COMPLETED|Second Intervention||11
5116518|NCT01515657|12587182|P1|COMPLETED|Second Intervention||14
5116519|NCT01515657|12587180|P3|STARTED|Second Intervention||13
5116520|NCT01515657|12587181|P2|STARTED|Second Intervention||12
5116521|NCT01515657|12587182|P1|STARTED|Second Intervention||14
5116522|NCT01515657|12587180|P3|NOT COMPLETED|First Intervention||0
5116523|NCT01515657|12587181|P2|NOT COMPLETED|First Intervention||1
5116524|NCT01515657|12587182|P1|NOT COMPLETED|First Intervention||0
5116525|NCT01515657|12587180|P3|COMPLETED|First Intervention||13
5116526|NCT01515657|12587181|P2|COMPLETED|First Intervention||12
5116527|NCT01515657|12587182|P1|COMPLETED|First Intervention||14
5116528|NCT01515657|12587180|P3|STARTED|First Intervention||13
5116529|NCT01515657|12587181|P2|STARTED|First Intervention||13
5116530|NCT01515657|12587182|P1|STARTED|First Intervention||14
5116531|NCT01515566|12587192|P2|NOT COMPLETED|Overall Study||0
5116532|NCT01515566|12587193|P1|NOT COMPLETED|Overall Study||0
5116533|NCT01515566|12587192|P2|COMPLETED|Overall Study||10
5116534|NCT01515566|12587193|P1|COMPLETED|Overall Study||10
5116535|NCT01515566|12587192|P2|STARTED|Overall Study||10
5116536|NCT01515566|12587193|P1|STARTED|Overall Study||10
5116537|NCT01515540|12587205|P2|NOT COMPLETED|Overall Study||3
5116538|NCT01515540|12587206|P1|NOT COMPLETED|Overall Study||5
5116539|NCT01515540|12587205|P2|COMPLETED|Overall Study||15
5116540|NCT01515540|12587206|P1|COMPLETED|Overall Study||15
5116541|NCT01515540|12587205|P2|STARTED|Overall Study||18
5116542|NCT01515540|12587206|P1|STARTED|Overall Study||20
5116543|NCT01515488|12587214|P2|NOT COMPLETED|Overall Study||0
5116544|NCT01515488|12587215|P1|NOT COMPLETED|Overall Study||0
5116545|NCT01515488|12587214|P2|COMPLETED|Overall Study||200
5116546|NCT01515488|12587215|P1|COMPLETED|Overall Study||200
5116547|NCT01515488|12587214|P2|STARTED|Overall Study||200
5116548|NCT01515488|12587215|P1|STARTED|Overall Study||200
5116549|NCT01515475|12587229|P4|NOT COMPLETED|Overall Study||12
5116550|NCT01515475|12587230|P3|NOT COMPLETED|Overall Study||12
5116551|NCT01515475|12587231|P2|NOT COMPLETED|Overall Study||15
5116552|NCT01515475|12587232|P1|NOT COMPLETED|Overall Study||20
5116553|NCT01515475|12587229|P4|COMPLETED|Overall Study||53
5116554|NCT01515475|12587230|P3|COMPLETED|Overall Study||53
5116555|NCT01515475|12587231|P2|COMPLETED|Overall Study||43
5116556|NCT01515475|12587232|P1|COMPLETED|Overall Study||41
5116557|NCT01515475|12587229|P4|STARTED|Overall Study||65
5116558|NCT01515475|12587230|P3|STARTED|Overall Study||65
5116559|NCT01515475|12587231|P2|STARTED|Overall Study||58
5116560|NCT01515475|12587232|P1|STARTED|Overall Study||61
5116561|NCT01515423|12587306|P3|NOT COMPLETED|DOUBLE BLIND||92
5116562|NCT01515423|12587307|P2|NOT COMPLETED|DOUBLE BLIND||82
5116563|NCT01515423|12587308|P1|NOT COMPLETED|DOUBLE BLIND||0
5116564|NCT01515423|12587306|P3|COMPLETED|DOUBLE BLIND||420
5116565|NCT01515423|12587307|P2|COMPLETED|DOUBLE BLIND||422
5116566|NCT01515423|12587308|P1|COMPLETED|DOUBLE BLIND||0
5116567|NCT01515423|12587306|P3|STARTED|DOUBLE BLIND||512
5116568|NCT01515423|12587307|P2|STARTED|DOUBLE BLIND||504
5116569|NCT01515423|12587308|P1|STARTED|DOUBLE BLIND||0
5116570|NCT01515423|12587306|P3|NOT COMPLETED|Open Label Phase||0
5116571|NCT01515423|12587307|P2|NOT COMPLETED|Open Label Phase||0
5116572|NCT01515423|12587308|P1|NOT COMPLETED|Open Label Phase||413
5116573|NCT01515423|12587306|P3|COMPLETED|Open Label Phase||0
5116574|NCT01515423|12587307|P2|COMPLETED|Open Label Phase||0
5116575|NCT01515423|12587308|P1|COMPLETED|Open Label Phase||1016
5116576|NCT01515423|12587306|P3|STARTED|Open Label Phase||0
5116577|NCT01515423|12587307|P2|STARTED|Open Label Phase||0
5116578|NCT01515423|12587308|P1|STARTED|Open Label Phase||1429
5116579|NCT01515410|12587327|P2|NOT COMPLETED|Overall Study||0
5116580|NCT01515410|12587328|P1|NOT COMPLETED|Overall Study||0
5116581|NCT01515410|12587327|P2|COMPLETED|Overall Study||15
5116582|NCT01515410|12587328|P1|COMPLETED|Overall Study||19
5116583|NCT01515410|12587327|P2|STARTED|Overall Study||15
5116584|NCT01515410|12587328|P1|STARTED|Overall Study||19
5116585|NCT01515345|12587336|P2|NOT COMPLETED|Overall Study||0
5116586|NCT01515345|12587337|P1|NOT COMPLETED|Overall Study||1
5116587|NCT01515345|12587336|P2|COMPLETED|Overall Study||343
5116588|NCT01515345|12587337|P1|COMPLETED|Overall Study||664
5116589|NCT01515345|12587336|P2|STARTED|Overall Study||343
5116590|NCT01515345|12587337|P1|STARTED|Overall Study||665
5116591|NCT01515306|12587349|P2|NOT COMPLETED|Overall Study||14
5116592|NCT01515306|12587350|P1|NOT COMPLETED|Overall Study||12
5116593|NCT01515306|12587349|P2|COMPLETED|Overall Study||2
5116594|NCT01515306|12587350|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
5116595|NCT01515306|12587349|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
5116596|NCT01515306|12587350|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
5116597|NCT01515306|12587349|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
5116598|NCT01515306|12587350|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
5116599|NCT01515306|12587349|P2|STARTED|Overall Study||16
5116600|NCT01515306|12587350|P1|STARTED|Overall Study||24
5116601|NCT01515189|12587363|P2|NOT COMPLETED|First Re-Induction Phase||15
5116602|NCT01515189|12587364|P1|NOT COMPLETED|First Re-Induction Phase||14
5116603|NCT01515189|12587363|P2|COMPLETED|First Re-Induction Phase||17
5116604|NCT01515189|12587364|P1|COMPLETED|First Re-Induction Phase||9
5116605|NCT01515189|12587363|P2|STARTED|First Re-Induction Phase||32
5116606|NCT01515189|12587364|P1|STARTED|First Re-Induction Phase||23
5116607|NCT01515189|12587363|P2|NOT COMPLETED|Induction||232
5116608|NCT01515189|12587364|P1|NOT COMPLETED|Induction||237
5116609|NCT01515189|12587363|P2|COMPLETED|Induction||130
5116610|NCT01515189|12587364|P1|COMPLETED|Induction||128
5116611|NCT01515189|12587363|P2|STARTED|Induction||362
5116612|NCT01515189|12587364|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
5116613|NCT01515176|12587386|P2|NOT COMPLETED|Overall Study||0
5116614|NCT01515176|12587387|P1|NOT COMPLETED|Overall Study||0
5116615|NCT01515176|12587386|P2|COMPLETED|Overall Study||32
5116616|NCT01515176|12587387|P1|COMPLETED|Overall Study||4
5116617|NCT01515176|12587386|P2|STARTED|Overall Study||32
5116618|NCT01515176|12587387|P1|STARTED|Overall Study||4
5116619|NCT01515072|12587401|P2|NOT COMPLETED|Overall Study||0
5116620|NCT01515072|12587402|P1|NOT COMPLETED|Overall Study||0
5116621|NCT01515072|12587401|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
5116622|NCT01515072|12587402|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
5116623|NCT01515072|12587401|P2|STARTED|Overall Study||155
5116624|NCT01515072|12587402|P1|STARTED|Overall Study||166
5116625|NCT01515046|12587442|P1|NOT COMPLETED|Overall Study||0
5116626|NCT01515046|12587442|P1|COMPLETED|Overall Study||1
5116627|NCT01515046|12587442|P1|STARTED|Overall Study||1
5116628|NCT01514864|12587452|P2|NOT COMPLETED|Overall Study||5
5116629|NCT01514864|12587453|P1|NOT COMPLETED|Overall Study||9
5116630|NCT01514864|12587452|P2|COMPLETED|Overall Study||0
5116631|NCT01514864|12587453|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
5116632|NCT01514864|12587452|P2|STARTED|Overall Study||5
5116633|NCT01514864|12587453|P1|STARTED|Overall Study||9
5116634|NCT01514786|12587471|P2|NOT COMPLETED|Overall Study||0
5116635|NCT01514786|12587472|P1|NOT COMPLETED|Overall Study||0
5116636|NCT01514786|12587471|P2|COMPLETED|Overall Study||284
5116637|NCT01514786|12587472|P1|COMPLETED|Overall Study||286
5116638|NCT01514786|12587471|P2|STARTED|Overall Study||284
5116639|NCT01514786|12587472|P1|STARTED|Overall Study||286
5116640|NCT01514760|12587478|P1|NOT COMPLETED|Overall Study||2
5116641|NCT01514760|12587478|P1|COMPLETED|Overall Study||20
5116642|NCT01514760|12587478|P1|STARTED|Overall Study||22
5116643|NCT01514734|12587485|P1|NOT COMPLETED|Overall Study||0
5116644|NCT01514734|12587485|P1|COMPLETED|Overall Study||9
5116645|NCT01514734|12587485|P1|STARTED|Overall Study||9
5116646|NCT01514682|12587491|P2|NOT COMPLETED|Overall Study||6
5116647|NCT01514682|12587492|P1|NOT COMPLETED|Overall Study||6
5116648|NCT01514682|12587491|P2|COMPLETED|Overall Study||14
5116649|NCT01514682|12587492|P1|COMPLETED|Overall Study||13
5116650|NCT01514682|12587491|P2|STARTED|Overall Study||20
5116651|NCT01514682|12587492|P1|STARTED|Overall Study||19
5116652|NCT01514630|12587508|P1|NOT COMPLETED|Overall Study||3
5116653|NCT01514630|12587508|P1|COMPLETED|Overall Study||11
5116654|NCT01514630|12587508|P1|STARTED|Overall Study||14
5116655|NCT01514513|12587514|P2|NOT COMPLETED|Overall Study||1
5116656|NCT01514513|12587515|P1|NOT COMPLETED|Overall Study||1
5116657|NCT01514513|12587514|P2|COMPLETED|Overall Study||20
5116658|NCT01514513|12587515|P1|COMPLETED|Overall Study||20
5116659|NCT01514513|12587514|P2|STARTED|Overall Study||21
5116660|NCT01514513|12587515|P1|STARTED|Overall Study||21
5116661|NCT01514461|12587526|P3|NOT COMPLETED|Overall Study||4
5116662|NCT01514461|12587527|P2|NOT COMPLETED|Overall Study||3
5116663|NCT01514461|12587528|P1|NOT COMPLETED|Overall Study||5
5116664|NCT01514461|12587526|P3|COMPLETED|Overall Study||11
5116665|NCT01514461|12587527|P2|COMPLETED|Overall Study||12
5116666|NCT01514461|12587528|P1|COMPLETED|Overall Study||10
5116667|NCT01514461|12587526|P3|STARTED|Overall Study||15
5116668|NCT01514461|12587527|P2|STARTED|Overall Study||15
5116669|NCT01514461|12587528|P1|STARTED|Overall Study||15
5116670|NCT01514448|12587567|P2|NOT COMPLETED|Overall Study||8
5116671|NCT01514448|12587568|P1|NOT COMPLETED|Overall Study||12
5116672|NCT01514448|12587567|P2|COMPLETED|Overall Study||5
5116673|NCT01514448|12587568|P1|COMPLETED|Overall Study||4
5116674|NCT01514448|12587567|P2|Full Analysis Set (FAS)|Overall Study||13
5116675|NCT01514448|12587568|P1|Full Analysis Set (FAS)|Overall Study||12
5116676|NCT01514448|12587567|P2|STARTED|Overall Study||13
5116677|NCT01514448|12587568|P1|STARTED|Overall Study||16
5116678|NCT01514422|12587583|P1|NOT COMPLETED|Overall Study||1
5116679|NCT01514422|12587583|P1|COMPLETED|Overall Study||19
5116680|NCT01514422|12587583|P1|STARTED|Overall Study||20
5116681|NCT01514396|12587589|P1|NOT COMPLETED|Overall Study||0
5116682|NCT01514396|12587589|P1|COMPLETED|Overall Study||8
5116683|NCT01514396|12587589|P1|STARTED|Overall Study||8
5116684|NCT01514383|12587594|P1|NOT COMPLETED|Overall Study||0
5116685|NCT01514383|12587594|P1|COMPLETED|Overall Study||34
5116686|NCT01514383|12587594|P1|STARTED|Overall Study||34
5116687|NCT01514370|12587601|P2|NOT COMPLETED|Overall Study||16
5116688|NCT01514370|12587602|P1|NOT COMPLETED|Overall Study||11
5116689|NCT01514370|12587601|P2|COMPLETED|Overall Study||24
5116690|NCT01514370|12587602|P1|COMPLETED|Overall Study||29
5116691|NCT01514370|12587601|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
5116692|NCT01514370|12587602|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
5116693|NCT01514370|12587601|P2|STARTED|Overall Study||40
5116694|NCT01514370|12587602|P1|STARTED|Overall Study||40
5116695|NCT01514357|12587648|P2|NOT COMPLETED|Overall Study||0
5116696|NCT01514357|12587649|P1|NOT COMPLETED|Overall Study||4
5116697|NCT01514357|12587648|P2|COMPLETED|Overall Study||0
5116698|NCT01514357|12587649|P1|COMPLETED|Overall Study||8
5116699|NCT01514357|12587648|P2|STARTED|Overall Study||0
5116700|NCT01514357|12587649|P1|STARTED|Overall Study||12
5116701|NCT01514318|12587655|P1|NOT COMPLETED|Overall Study||0
5116702|NCT01514318|12587655|P1|COMPLETED|Overall Study||8
5116703|NCT01514318|12587655|P1|STARTED|Overall Study||8
5116704|NCT01514292|12587661|P1|NOT COMPLETED|Overall Study||0
5116705|NCT01514292|12587661|P1|COMPLETED|Overall Study||72
5116706|NCT01514292|12587661|P1|STARTED|Overall Study||72
5116707|NCT01514240|12587667|P2|NOT COMPLETED|Overall Study||11
5116708|NCT01514240|12587668|P1|NOT COMPLETED|Overall Study||6
5116709|NCT01514240|12587667|P2|COMPLETED|Overall Study||45
5116710|NCT01514240|12587668|P1|COMPLETED|Overall Study||50
5116711|NCT01514240|12587667|P2|STARTED|Overall Study||56
5116712|NCT01514240|12587668|P1|STARTED|Overall Study||56
5116713|NCT01514201|12587746|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
5116714|NCT01514201|12587747|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116715|NCT01514201|12587748|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116716|NCT01514201|12587749|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116717|NCT01514201|12587746|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
5116718|NCT01514201|12587747|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116719|NCT01514201|12587748|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116720|NCT01514201|12587749|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
5116721|NCT01514201|12587746|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
5116722|NCT01514201|12587747|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
5116723|NCT01514201|12587748|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
5116724|NCT01514201|12587749|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
5116725|NCT01514201|12587746|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
5116726|NCT01514201|12587747|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116727|NCT01514201|12587748|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116728|NCT01514201|12587749|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116729|NCT01514201|12587746|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
5116730|NCT01514201|12587747|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116731|NCT01514201|12587748|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116732|NCT01514201|12587749|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
5116733|NCT01514201|12587746|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
5116734|NCT01514201|12587747|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
5116735|NCT01514201|12587748|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
5116736|NCT01514201|12587749|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
5116737|NCT01514201|12587746|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
5116738|NCT01514201|12587747|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
5116739|NCT01514201|12587748|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
5116740|NCT01514201|12587749|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
5116741|NCT01514201|12587746|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
5116742|NCT01514201|12587747|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
5116743|NCT01514201|12587748|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
5116744|NCT01514201|12587749|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
5116745|NCT01514201|12587746|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
5116746|NCT01514201|12587747|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
5116747|NCT01514201|12587748|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
5116748|NCT01514201|12587749|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
5116749|NCT01514201|12587746|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
5116750|NCT01514201|12587747|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
5116751|NCT01514201|12587748|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
5116752|NCT01514201|12587749|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
5116753|NCT01514201|12587746|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
5116754|NCT01514201|12587747|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
5116755|NCT01514201|12587748|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
5116756|NCT01514201|12587749|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
5116757|NCT01514201|12587746|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
5116758|NCT01514201|12587747|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
5116759|NCT01514201|12587748|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
5116760|NCT01514201|12587749|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
5116761|NCT01514162|12587808|P1|NOT COMPLETED|Overall Study||85
5116762|NCT01514162|12587808|P1|COMPLETED|Overall Study||160
5116763|NCT01514162|12587808|P1|STARTED|Overall Study||245
5116764|NCT01514149|12587819|P5|NOT COMPLETED|Overall Study||1
5116765|NCT01514149|12587820|P4|NOT COMPLETED|Overall Study||1
5116766|NCT01514149|12587821|P3|NOT COMPLETED|Overall Study||3
5116767|NCT01514149|12587822|P2|NOT COMPLETED|Overall Study||1
5116768|NCT01514149|12587823|P1|NOT COMPLETED|Overall Study||3
5116769|NCT01514149|12587819|P5|COMPLETED|Overall Study||14
5116770|NCT01514149|12587820|P4|COMPLETED|Overall Study||13
5116771|NCT01514149|12587821|P3|COMPLETED|Overall Study||11
5116772|NCT01514149|12587822|P2|COMPLETED|Overall Study||14
5116773|NCT01514149|12587823|P1|COMPLETED|Overall Study||12
5116774|NCT01514149|12587819|P5|STARTED|Overall Study||15
5116775|NCT01514149|12587820|P4|STARTED|Overall Study||14
5116776|NCT01514149|12587821|P3|STARTED|Overall Study||14
5116777|NCT01514149|12587822|P2|STARTED|Overall Study||15
5116778|NCT01514149|12587823|P1|STARTED|Overall Study||15
5116779|NCT01514136|12587847|P8|NOT COMPLETED|Test Period; Test D*||0
5116780|NCT01514136|12587848|P7|NOT COMPLETED|Test Period; Test D*||0
5116781|NCT01514136|12587849|P6|NOT COMPLETED|Test Period; Test D*||0
5116782|NCT01514136|12587850|P5|NOT COMPLETED|Test Period; Test D*||0
5116783|NCT01514136|12587851|P4|NOT COMPLETED|Test Period; Test D*||0
5116784|NCT01514136|12587852|P3|NOT COMPLETED|Test Period; Test D*||0
5116785|NCT01514136|12587853|P2|NOT COMPLETED|Test Period; Test D*||0
5116786|NCT01514136|12587854|P1|NOT COMPLETED|Test Period; Test D*||0
5116787|NCT01514136|12587847|P8|COMPLETED|Test Period; Test D*||23
5116788|NCT01514136|12587848|P7|COMPLETED|Test Period; Test D*||0
5116789|NCT01514136|12587849|P6|COMPLETED|Test Period; Test D*||0
5116790|NCT01514136|12587850|P5|COMPLETED|Test Period; Test D*||0
5116791|NCT01514136|12587851|P4|COMPLETED|Test Period; Test D*||0
5116792|NCT01514136|12587852|P3|COMPLETED|Test Period; Test D*||0
5116793|NCT01514136|12587853|P2|COMPLETED|Test Period; Test D*||0
5116794|NCT01514136|12587854|P1|COMPLETED|Test Period; Test D*||0
5116795|NCT01514136|12587847|P8|STARTED|Test Period; Test D*||23
5116796|NCT01514136|12587848|P7|STARTED|Test Period; Test D*||0
5116797|NCT01514136|12587849|P6|STARTED|Test Period; Test D*||0
5116798|NCT01514136|12587850|P5|STARTED|Test Period; Test D*||0
5116799|NCT01514136|12587851|P4|STARTED|Test Period; Test D*||0
5116800|NCT01514136|12587852|P3|STARTED|Test Period; Test D*||0
5116801|NCT01514136|12587853|P2|STARTED|Test Period; Test D*||0
5116802|NCT01514136|12587854|P1|STARTED|Test Period; Test D*||0
5116803|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 2; Test C*||0
5116804|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 2; Test C*||3
5116805|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 2; Test C*||0
5116806|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 2; Test C*||0
5116807|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 2; Test C*||0
5116808|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 2; Test C*||0
5116809|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 2; Test C*||0
5116810|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 2; Test C*||0
5116811|NCT01514136|12587847|P8|COMPLETED|Test Period 2; Test C*||0
5116812|NCT01514136|12587848|P7|COMPLETED|Test Period 2; Test C*||23
5116813|NCT01514136|12587849|P6|COMPLETED|Test Period 2; Test C*||0
5116814|NCT01514136|12587850|P5|COMPLETED|Test Period 2; Test C*||0
5116815|NCT01514136|12587851|P4|COMPLETED|Test Period 2; Test C*||0
5116816|NCT01514136|12587852|P3|COMPLETED|Test Period 2; Test C*||0
5116817|NCT01514136|12587853|P2|COMPLETED|Test Period 2; Test C*||0
5116818|NCT01514136|12587854|P1|COMPLETED|Test Period 2; Test C*||0
5116819|NCT01514136|12587847|P8|STARTED|Test Period 2; Test C*||0
5116820|NCT01514136|12587848|P7|STARTED|Test Period 2; Test C*||26
5116821|NCT01514136|12587849|P6|STARTED|Test Period 2; Test C*||0
5116822|NCT01514136|12587850|P5|STARTED|Test Period 2; Test C*||0
5116823|NCT01514136|12587851|P4|STARTED|Test Period 2; Test C*||0
5116824|NCT01514136|12587852|P3|STARTED|Test Period 2; Test C*||0
5116825|NCT01514136|12587853|P2|STARTED|Test Period 2; Test C*||0
5116826|NCT01514136|12587854|P1|STARTED|Test Period 2; Test C*||0
5116827|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 2; Test B*||0
5116828|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 2; Test B*||0
5116829|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 2; Test B*||2
5116830|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 2; Test B*||0
5116831|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 2; Test B*||0
5116832|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 2; Test B*||0
5116833|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 2; Test B*||0
5116834|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 2; Test B*||0
5116835|NCT01514136|12587847|P8|COMPLETED|Test Period 2; Test B*||0
5116836|NCT01514136|12587848|P7|COMPLETED|Test Period 2; Test B*||0
5116837|NCT01514136|12587849|P6|COMPLETED|Test Period 2; Test B*||26
5116838|NCT01514136|12587850|P5|COMPLETED|Test Period 2; Test B*||0
5116839|NCT01514136|12587851|P4|COMPLETED|Test Period 2; Test B*||0
5116840|NCT01514136|12587852|P3|COMPLETED|Test Period 2; Test B*||0
5116841|NCT01514136|12587853|P2|COMPLETED|Test Period 2; Test B*||0
5116842|NCT01514136|12587854|P1|COMPLETED|Test Period 2; Test B*||0
5116843|NCT01514136|12587847|P8|STARTED|Test Period 2; Test B*||0
5116844|NCT01514136|12587848|P7|STARTED|Test Period 2; Test B*||0
5116845|NCT01514136|12587849|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
5116846|NCT01514136|12587850|P5|STARTED|Test Period 2; Test B*||0
5116847|NCT01514136|12587851|P4|STARTED|Test Period 2; Test B*||0
5116848|NCT01514136|12587852|P3|STARTED|Test Period 2; Test B*||0
5116849|NCT01514136|12587853|P2|STARTED|Test Period 2; Test B*||0
5116850|NCT01514136|12587854|P1|STARTED|Test Period 2; Test B*||0
5116851|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 2; Test A*||0
5116852|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 2; Test A*||0
5116853|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 2; Test A*||0
5116854|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 2; Test A*||2
5116855|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 2; Test A*||0
5116856|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 2; Test A*||0
5116857|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 2; Test A*||0
5116858|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 2; Test A*||0
5116859|NCT01514136|12587847|P8|COMPLETED|Test Period 2; Test A*||0
5116860|NCT01514136|12587848|P7|COMPLETED|Test Period 2; Test A*||0
5116861|NCT01514136|12587849|P6|COMPLETED|Test Period 2; Test A*||0
5116862|NCT01514136|12587850|P5|COMPLETED|Test Period 2; Test A*||26
5116863|NCT01514136|12587851|P4|COMPLETED|Test Period 2; Test A*||0
5116864|NCT01514136|12587852|P3|COMPLETED|Test Period 2; Test A*||0
5116865|NCT01514136|12587853|P2|COMPLETED|Test Period 2; Test A*||0
5116866|NCT01514136|12587854|P1|COMPLETED|Test Period 2; Test A*||0
5116867|NCT01514136|12587847|P8|STARTED|Test Period 2; Test A*||0
5116868|NCT01514136|12587848|P7|STARTED|Test Period 2; Test A*||0
5116869|NCT01514136|12587849|P6|STARTED|Test Period 2; Test A*||0
5116870|NCT01514136|12587850|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
5116871|NCT01514136|12587851|P4|STARTED|Test Period 2; Test A*||0
5116872|NCT01514136|12587852|P3|STARTED|Test Period 2; Test A*||0
5116873|NCT01514136|12587853|P2|STARTED|Test Period 2; Test A*||0
5116874|NCT01514136|12587854|P1|STARTED|Test Period 2; Test A*||0
5116875|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 1; Test D||0
5116876|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 1; Test D||0
5116877|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 1; Test D||0
5116878|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 1; Test D||0
5116879|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 1; Test D||2
5116880|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 1; Test D||0
5116881|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 1; Test D||0
5116882|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 1; Test D||0
5116883|NCT01514136|12587847|P8|COMPLETED|Test Period 1; Test D||0
5116884|NCT01514136|12587848|P7|COMPLETED|Test Period 1; Test D||0
5116885|NCT01514136|12587849|P6|COMPLETED|Test Period 1; Test D||0
5116886|NCT01514136|12587850|P5|COMPLETED|Test Period 1; Test D||0
5116887|NCT01514136|12587851|P4|COMPLETED|Test Period 1; Test D||24
5116888|NCT01514136|12587852|P3|COMPLETED|Test Period 1; Test D||0
5116889|NCT01514136|12587853|P2|COMPLETED|Test Period 1; Test D||0
5116890|NCT01514136|12587854|P1|COMPLETED|Test Period 1; Test D||0
5116891|NCT01514136|12587847|P8|STARTED|Test Period 1; Test D||0
5116892|NCT01514136|12587848|P7|STARTED|Test Period 1; Test D||0
5116893|NCT01514136|12587849|P6|STARTED|Test Period 1; Test D||0
5116894|NCT01514136|12587850|P5|STARTED|Test Period 1; Test D||0
5116895|NCT01514136|12587851|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
5116896|NCT01514136|12587852|P3|STARTED|Test Period 1; Test D||0
5116897|NCT01514136|12587853|P2|STARTED|Test Period 1; Test D||0
5116898|NCT01514136|12587854|P1|STARTED|Test Period 1; Test D||0
5116899|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 1; Test C||0
5116900|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 1; Test C||0
5116901|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 1; Test C||0
5116902|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 1; Test C||0
5116903|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 1; Test C||0
5116904|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 1; Test C||0
5116905|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 1; Test C||0
5116906|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 1; Test C||0
5116907|NCT01514136|12587847|P8|COMPLETED|Test Period 1; Test C||0
5116908|NCT01514136|12587848|P7|COMPLETED|Test Period 1; Test C||0
5116909|NCT01514136|12587849|P6|COMPLETED|Test Period 1; Test C||0
5116910|NCT01514136|12587850|P5|COMPLETED|Test Period 1; Test C||0
5116911|NCT01514136|12587851|P4|COMPLETED|Test Period 1; Test C||0
5116912|NCT01514136|12587852|P3|COMPLETED|Test Period 1; Test C||24
5116913|NCT01514136|12587853|P2|COMPLETED|Test Period 1; Test C||0
5116914|NCT01514136|12587854|P1|COMPLETED|Test Period 1; Test C||0
5116915|NCT01514136|12587847|P8|STARTED|Test Period 1; Test C||0
5116916|NCT01514136|12587848|P7|STARTED|Test Period 1; Test C||0
5116917|NCT01514136|12587849|P6|STARTED|Test Period 1; Test C||0
5116918|NCT01514136|12587850|P5|STARTED|Test Period 1; Test C||0
5116919|NCT01514136|12587851|P4|STARTED|Test Period 1; Test C||0
5116920|NCT01514136|12587852|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
5116921|NCT01514136|12587853|P2|STARTED|Test Period 1; Test C||0
5116922|NCT01514136|12587854|P1|STARTED|Test Period 1; Test C||0
5116923|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 1; Test B||0
5116924|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 1; Test B||0
5116925|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 1; Test B||0
5116926|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 1; Test B||0
5116927|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 1; Test B||0
5116928|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 1; Test B||0
5116929|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 1; Test B||1
5116930|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 1; Test B||0
5116931|NCT01514136|12587847|P8|COMPLETED|Test Period 1; Test B||0
5116932|NCT01514136|12587848|P7|COMPLETED|Test Period 1; Test B||0
5116933|NCT01514136|12587849|P6|COMPLETED|Test Period 1; Test B||0
5116934|NCT01514136|12587850|P5|COMPLETED|Test Period 1; Test B||0
5116935|NCT01514136|12587851|P4|COMPLETED|Test Period 1; Test B||0
5116936|NCT01514136|12587852|P3|COMPLETED|Test Period 1; Test B||0
5116937|NCT01514136|12587853|P2|COMPLETED|Test Period 1; Test B||23
5116938|NCT01514136|12587854|P1|COMPLETED|Test Period 1; Test B||0
5116939|NCT01514136|12587847|P8|STARTED|Test Period 1; Test B||0
5116940|NCT01514136|12587848|P7|STARTED|Test Period 1; Test B||0
5116941|NCT01514136|12587849|P6|STARTED|Test Period 1; Test B||0
5116942|NCT01514136|12587850|P5|STARTED|Test Period 1; Test B||0
5116943|NCT01514136|12587851|P4|STARTED|Test Period 1; Test B||0
5116944|NCT01514136|12587852|P3|STARTED|Test Period 1; Test B||0
5116945|NCT01514136|12587853|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
5116946|NCT01514136|12587854|P1|STARTED|Test Period 1; Test B||0
5116947|NCT01514136|12587847|P8|NOT COMPLETED|Test Period 1; Test A||0
5116948|NCT01514136|12587848|P7|NOT COMPLETED|Test Period 1; Test A||0
5116949|NCT01514136|12587849|P6|NOT COMPLETED|Test Period 1; Test A||0
5116950|NCT01514136|12587850|P5|NOT COMPLETED|Test Period 1; Test A||0
5116951|NCT01514136|12587851|P4|NOT COMPLETED|Test Period 1; Test A||0
5116952|NCT01514136|12587852|P3|NOT COMPLETED|Test Period 1; Test A||0
5116953|NCT01514136|12587853|P2|NOT COMPLETED|Test Period 1; Test A||0
5116954|NCT01514136|12587854|P1|NOT COMPLETED|Test Period 1; Test A||3
5116955|NCT01514136|12587847|P8|COMPLETED|Test Period 1; Test A||0
5116956|NCT01514136|12587848|P7|COMPLETED|Test Period 1; Test A||0
5116957|NCT01514136|12587849|P6|COMPLETED|Test Period 1; Test A||0
5116958|NCT01514136|12587850|P5|COMPLETED|Test Period 1; Test A||0
5116959|NCT01514136|12587851|P4|COMPLETED|Test Period 1; Test A||0
5116960|NCT01514136|12587852|P3|COMPLETED|Test Period 1; Test A||0
5116961|NCT01514136|12587853|P2|COMPLETED|Test Period 1; Test A||0
5116962|NCT01514136|12587854|P1|COMPLETED|Test Period 1; Test A||22
5116963|NCT01514136|12587847|P8|STARTED|Test Period 1; Test A||0
5116964|NCT01514136|12587848|P7|STARTED|Test Period 1; Test A||0
5116965|NCT01514136|12587849|P6|STARTED|Test Period 1; Test A||0
5116966|NCT01514136|12587850|P5|STARTED|Test Period 1; Test A||0
5116967|NCT01514136|12587851|P4|STARTED|Test Period 1; Test A||0
5116968|NCT01514136|12587852|P3|STARTED|Test Period 1; Test A||0
5116969|NCT01514136|12587853|P2|STARTED|Test Period 1; Test A||0
5116970|NCT01514136|12587854|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
5116971|NCT01513967|12587888|P8|NOT COMPLETED|Overall Study||2
5116972|NCT01513967|12587889|P7|NOT COMPLETED|Overall Study||2
5116973|NCT01513967|12587890|P6|NOT COMPLETED|Overall Study||1
5116974|NCT01513967|12587891|P5|NOT COMPLETED|Overall Study||0
5116975|NCT01513967|12587892|P4|NOT COMPLETED|Overall Study||0
5116976|NCT01513967|12587893|P3|NOT COMPLETED|Overall Study||0
5116977|NCT01513967|12587894|P2|NOT COMPLETED|Overall Study||0
5116978|NCT01513967|12587895|P1|NOT COMPLETED|Overall Study||0
5116979|NCT01513967|12587888|P8|COMPLETED|Overall Study||6
5116980|NCT01513967|12587889|P7|COMPLETED|Overall Study||3
5116981|NCT01513967|12587890|P6|COMPLETED|Overall Study||3
5116982|NCT01513967|12587891|P5|COMPLETED|Overall Study||4
5116983|NCT01513967|12587892|P4|COMPLETED|Overall Study||6
5116984|NCT01513967|12587893|P3|COMPLETED|Overall Study||4
5116985|NCT01513967|12587894|P2|COMPLETED|Overall Study||4
5116986|NCT01513967|12587895|P1|COMPLETED|Overall Study||4
5116987|NCT01513967|12587888|P8|STARTED|Overall Study||8
5116988|NCT01513967|12587889|P7|STARTED|Overall Study||5
5116989|NCT01513967|12587890|P6|STARTED|Overall Study||4
5116990|NCT01513967|12587891|P5|STARTED|Overall Study||4
5116991|NCT01513967|12587892|P4|STARTED|Overall Study||6
5116992|NCT01513967|12587893|P3|STARTED|Overall Study||4
5116993|NCT01513967|12587894|P2|STARTED|Overall Study||4
5116994|NCT01513967|12587895|P1|STARTED|Overall Study||4
5116995|NCT01513902|12587916|P3|NOT COMPLETED|Overall Study||0
5116996|NCT01513902|12587917|P2|NOT COMPLETED|Overall Study||0
5116997|NCT01513902|12587918|P1|NOT COMPLETED|Overall Study||0
5116998|NCT01513902|12587916|P3|COMPLETED|Overall Study||9
5116999|NCT01513902|12587917|P2|COMPLETED|Overall Study||9
5117000|NCT01513902|12587918|P1|COMPLETED|Overall Study||8
5117001|NCT01513902|12587916|P3|STARTED|Overall Study||9
5117002|NCT01513902|12587917|P2|STARTED|Overall Study||9
5117003|NCT01513902|12587918|P1|STARTED|Overall Study||8
5117004|NCT01513759|12587953|P1|NOT COMPLETED|Overall Study||5
5117005|NCT01513759|12587953|P1|COMPLETED|Overall Study||145
5117006|NCT01513759|12587953|P1|At Least One Device Successfully Placed|Overall Study||149
5117007|NCT01513759|12587953|P1|STARTED|Overall Study||150
5117008|NCT01513590|12587964|P2|NOT COMPLETED|Overall Study||13
5117009|NCT01513590|12587965|P1|NOT COMPLETED|Overall Study||10
5117010|NCT01513590|12587964|P2|COMPLETED|Overall Study||184
5117011|NCT01513590|12587965|P1|COMPLETED|Overall Study||187
5117012|NCT01513590|12587964|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
5117013|NCT01513590|12587965|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
5117014|NCT01513590|12587964|P2|STARTED|Overall Study||197
5117015|NCT01513590|12587965|P1|STARTED|Overall Study||197
5117016|NCT01513551|12587986|P3|NOT COMPLETED|Overall Study||5
5117017|NCT01513551|12587987|P2|NOT COMPLETED|Overall Study||6
5117018|NCT01513551|12587988|P1|NOT COMPLETED|Overall Study||4
5117019|NCT01513551|12587986|P3|COMPLETED|Overall Study||226
5117020|NCT01513551|12587987|P2|COMPLETED|Overall Study||225
5117021|NCT01513551|12587988|P1|COMPLETED|Overall Study||226
5117022|NCT01513551|12587986|P3|Vaccinated|Overall Study||230
5117023|NCT01513551|12587987|P2|Vaccinated|Overall Study||231
5117024|NCT01513551|12587988|P1|Vaccinated|Overall Study||230
5117025|NCT01513551|12587986|P3|STARTED|Overall Study||231
5117026|NCT01513551|12587987|P2|STARTED|Overall Study||231
5117027|NCT01513551|12587988|P1|STARTED|Overall Study||230
5117028|NCT01513538|12588014|P1|NOT COMPLETED|Overall Study||5
5117029|NCT01513538|12588014|P1|COMPLETED|Overall Study||573
5117030|NCT01513538|12588014|P1|STARTED|Overall Study||578
5117031|NCT01513473|12588020|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
5117032|NCT01513473|12588021|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
5117033|NCT01513473|12588020|P2|COMPLETED|Extension Trial (26 Weeks)||122
5117034|NCT01513473|12588021|P1|COMPLETED|Extension Trial (26 Weeks)||151
5117035|NCT01513473|12588020|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
5117036|NCT01513473|12588021|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
5117037|NCT01513473|12588020|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
5117038|NCT01513473|12588021|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
5117039|NCT01513473|12588020|P2|COMPLETED|Main Trial (26 Weeks)||165
5117040|NCT01513473|12588021|P1|COMPLETED|Main Trial (26 Weeks)||170
5117041|NCT01513473|12588020|P2|Exposed|Main Trial (26 Weeks)||175
5117042|NCT01513473|12588021|P1|Exposed|Main Trial (26 Weeks)||174
5117043|NCT01513473|12588020|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
5117044|NCT01513473|12588021|P1|STARTED|Main Trial (26 Weeks)||174
5117045|NCT01513460|12588048|P3|NOT COMPLETED|Overall Study||56
5117046|NCT01513460|12588049|P2|NOT COMPLETED|Overall Study||32
5117047|NCT01513460|12588050|P1|NOT COMPLETED|Overall Study||29
5117048|NCT01513460|12588048|P3|COMPLETED|Overall Study||201
5117049|NCT01513460|12588049|P2|COMPLETED|Overall Study||226
5117050|NCT01513460|12588050|P1|COMPLETED|Overall Study||229
5117051|NCT01513460|12588048|P3|Per-protocol Set|Overall Study||166
5117052|NCT01513460|12588049|P2|Per-protocol Set|Overall Study||186
5117053|NCT01513460|12588050|P1|Per-protocol Set|Overall Study||196
5117054|NCT01513460|12588048|P3|Full Analysis Set|Overall Study||257
5117055|NCT01513460|12588049|P2|Full Analysis Set|Overall Study||258
5117056|NCT01513460|12588050|P1|Full Analysis Set|Overall Study||257
5117057|NCT01513460|12588048|P3|STARTED|Overall Study||257
5117058|NCT01513460|12588049|P2|STARTED|Overall Study||258
5117059|NCT01513460|12588050|P1|STARTED|Overall Study||258
5117060|NCT01513447|12588076|P2|NOT COMPLETED|Overall Study||0
5117061|NCT01513447|12588077|P1|NOT COMPLETED|Overall Study||0
5117062|NCT01513447|12588076|P2|COMPLETED|Overall Study||5
5117063|NCT01513447|12588077|P1|COMPLETED|Overall Study||3
5117064|NCT01513447|12588076|P2|STARTED|Overall Study||5
5117065|NCT01513447|12588077|P1|STARTED|Overall Study||3
5117066|NCT01513330|12588085|P2|NOT COMPLETED|Standard Care First,||4
5117067|NCT01513330|12588086|P1|NOT COMPLETED|Standard Care First,||4
5117068|NCT01513330|12588085|P2|COMPLETED|Standard Care First,||52
5117069|NCT01513330|12588086|P1|COMPLETED|Standard Care First,||56
5117070|NCT01513330|12588085|P2|STARTED|Standard Care First,||56
5117071|NCT01513330|12588086|P1|STARTED|Standard Care First,||60
5117072|NCT01513330|12588085|P2|NOT COMPLETED|SenSura Mio First,||2
5117073|NCT01513330|12588086|P1|NOT COMPLETED|SenSura Mio First,||4
5117074|NCT01513330|12588085|P2|COMPLETED|SenSura Mio First,||56
5117075|NCT01513330|12588086|P1|COMPLETED|SenSura Mio First,||60
5117076|NCT01513330|12588085|P2|STARTED|SenSura Mio First,||58
5117077|NCT01513330|12588086|P1|STARTED|SenSura Mio First,||64
5117078|NCT01513317|12588094|P2|NOT COMPLETED|Overall Study||24
5117079|NCT01513317|12588095|P1|NOT COMPLETED|Overall Study||34
5117080|NCT01513317|12588094|P2|COMPLETED|Overall Study||2
5117081|NCT01513317|12588095|P1|COMPLETED|Overall Study||16
5117082|NCT01513317|12588094|P2|STARTED|Overall Study||26
5117083|NCT01513317|12588095|P1|STARTED|Overall Study||50
5117084|NCT01513291|12588113|P5|NOT COMPLETED|Run-out Period||0
5117085|NCT01513291|12588114|P4|NOT COMPLETED|Run-out Period||2
5117086|NCT01513291|12588115|P3|NOT COMPLETED|Run-out Period||0
5117087|NCT01513291|12588116|P2|NOT COMPLETED|Run-out Period||0
5117088|NCT01513291|12588117|P1|NOT COMPLETED|Run-out Period||0
5117089|NCT01513291|12588113|P5|COMPLETED|Run-out Period||101
5117090|NCT01513291|12588114|P4|COMPLETED|Run-out Period||45
5117091|NCT01513291|12588115|P3|COMPLETED|Run-out Period||50
5117092|NCT01513291|12588116|P2|COMPLETED|Run-out Period||0
5117093|NCT01513291|12588117|P1|COMPLETED|Run-out Period||0
5117094|NCT01513291|12588113|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
5117095|NCT01513291|12588114|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
5117096|NCT01513291|12588115|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
5117097|NCT01513291|12588116|P2|STARTED|Run-out Period||0
5117098|NCT01513291|12588117|P1|STARTED|Run-out Period||0
5117099|NCT01513291|12588113|P5|NOT COMPLETED|Treatment Period||0
5117100|NCT01513291|12588114|P4|NOT COMPLETED|Treatment Period||0
5117101|NCT01513291|12588115|P3|NOT COMPLETED|Treatment Period||0
5117102|NCT01513291|12588116|P2|NOT COMPLETED|Treatment Period||16
5117103|NCT01513291|12588117|P1|NOT COMPLETED|Treatment Period||23
5117104|NCT01513291|12588113|P5|COMPLETED|Treatment Period||0
5117105|NCT01513291|12588114|P4|COMPLETED|Treatment Period||0
5117106|NCT01513291|12588115|P3|COMPLETED|Treatment Period||0
5117107|NCT01513291|12588116|P2|COMPLETED|Treatment Period||101
5117108|NCT01513291|12588117|P1|COMPLETED|Treatment Period||97
5117109|NCT01513291|12588113|P5|Treated|Treatment Period||0
5117110|NCT01513291|12588114|P4|Treated|Treatment Period||0
5117111|NCT01513291|12588115|P3|Treated|Treatment Period||0
5117112|NCT01513291|12588116|P2|Treated|Treatment Period||115
5117113|NCT01513291|12588117|P1|Treated|Treatment Period||120
5117114|NCT01513291|12588113|P5|STARTED|Treatment Period||0
5117115|NCT01513291|12588114|P4|STARTED|Treatment Period||0
5117116|NCT01513291|12588115|P3|STARTED|Treatment Period||0
5117117|NCT01513291|12588116|P2|STARTED|Treatment Period||117
5117118|NCT01513291|12588117|P1|STARTED|Treatment Period||120
5117119|NCT01513239|12588145|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
5117120|NCT01513239|12588146|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
5117121|NCT01513239|12588147|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
5117122|NCT01513239|12588148|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
5117123|NCT01513239|12588149|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
5117124|NCT01513239|12588150|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
5117125|NCT01513239|12588145|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
5117126|NCT01513239|12588146|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
5117127|NCT01513239|12588147|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
5117128|NCT01513239|12588148|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
5117129|NCT01513239|12588149|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
5117130|NCT01513239|12588150|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
5117131|NCT01513239|12588145|P6|STARTED|Period 2: 9 Month Extension Phase||83
5117132|NCT01513239|12588146|P5|STARTED|Period 2: 9 Month Extension Phase||100
5117133|NCT01513239|12588147|P4|STARTED|Period 2: 9 Month Extension Phase||112
5117134|NCT01513239|12588148|P3|STARTED|Period 2: 9 Month Extension Phase||0
5117135|NCT01513239|12588149|P2|STARTED|Period 2: 9 Month Extension Phase||0
5117136|NCT01513239|12588150|P1|STARTED|Period 2: 9 Month Extension Phase||0
5117137|NCT01513239|12588145|P6|NOT COMPLETED|Period 1: Main Phase||0
5117138|NCT01513239|12588146|P5|NOT COMPLETED|Period 1: Main Phase||0
5117139|NCT01513239|12588147|P4|NOT COMPLETED|Period 1: Main Phase||0
5117140|NCT01513239|12588148|P3|NOT COMPLETED|Period 1: Main Phase||88
5117141|NCT01513239|12588149|P2|NOT COMPLETED|Period 1: Main Phase||70
5117142|NCT01513239|12588150|P1|NOT COMPLETED|Period 1: Main Phase||75
5117143|NCT01513239|12588145|P6|COMPLETED|Period 1: Main Phase||0
5117144|NCT01513239|12588146|P5|COMPLETED|Period 1: Main Phase||0
5117145|NCT01513239|12588147|P4|COMPLETED|Period 1: Main Phase||0
5117146|NCT01513239|12588148|P3|COMPLETED|Period 1: Main Phase||311
5117147|NCT01513239|12588149|P2|COMPLETED|Period 1: Main Phase||337
5117148|NCT01513239|12588150|P1|COMPLETED|Period 1: Main Phase||322
5117149|NCT01513239|12588145|P6|All Participants as Treated|Period 1: Main Phase||0
5117150|NCT01513239|12588146|P5|All Participants as Treated|Period 1: Main Phase||0
5117151|NCT01513239|12588147|P4|All Participants as Treated|Period 1: Main Phase||0
5117152|NCT01513239|12588148|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
5117153|NCT01513239|12588149|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
5117154|NCT01513239|12588150|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
5117155|NCT01513239|12588145|P6|Treated|Period 1: Main Phase||0
5117156|NCT01513239|12588146|P5|Treated|Period 1: Main Phase||0
5117157|NCT01513239|12588147|P4|Treated|Period 1: Main Phase||0
5117158|NCT01513239|12588148|P3|Treated|Period 1: Main Phase|Treated participants|381
5117159|NCT01513239|12588149|P2|Treated|Period 1: Main Phase|Treated participants|396
5117160|NCT01513239|12588150|P1|Treated|Period 1: Main Phase|Treated participants|391
5117161|NCT01513239|12588145|P6|STARTED|Period 1: Main Phase||0
5117162|NCT01513239|12588146|P5|STARTED|Period 1: Main Phase||0
5117163|NCT01513239|12588147|P4|STARTED|Period 1: Main Phase||0
5117164|NCT01513239|12588148|P3|STARTED|Period 1: Main Phase|Randomized participants|399
5117165|NCT01513239|12588149|P2|STARTED|Period 1: Main Phase|Randomized participants|407
5117166|NCT01513239|12588150|P1|STARTED|Period 1: Main Phase|Randomized participants|397
5117167|NCT01513148|12588203|P2|NOT COMPLETED|Overall Study||2
5117168|NCT01513148|12588204|P1|NOT COMPLETED|Overall Study||2
5117169|NCT01513148|12588203|P2|COMPLETED|Overall Study||14
5117170|NCT01513148|12588204|P1|COMPLETED|Overall Study||14
5117171|NCT01513148|12588203|P2|STARTED|Overall Study||16
5117172|NCT01513148|12588204|P1|STARTED|Overall Study||16
5117173|NCT01513122|12588252|P2|NOT COMPLETED|Overall Study||3
5117174|NCT01513122|12588253|P1|NOT COMPLETED|Overall Study||11
5117175|NCT01513122|12588252|P2|COMPLETED|Overall Study||105
5117176|NCT01513122|12588253|P1|COMPLETED|Overall Study||91
5117177|NCT01513122|12588252|P2|STARTED|Overall Study||108
5117178|NCT01513122|12588253|P1|STARTED|Overall Study||102
5117179|NCT01512979|12588271|P2|NOT COMPLETED|Overall Study||22
5117180|NCT01512979|12588272|P1|NOT COMPLETED|Overall Study||19
5117181|NCT01512979|12588271|P2|COMPLETED|Overall Study||135
5117182|NCT01512979|12588272|P1|COMPLETED|Overall Study||140
5117183|NCT01512979|12588271|P2|STARTED|Overall Study|Randomised and treated|157
5117184|NCT01512979|12588272|P1|STARTED|Overall Study|Randomised and treated|159
5117185|NCT01512849|12588292|P4|NOT COMPLETED|Crossover Period 2||0
5117186|NCT01512849|12588293|P3|NOT COMPLETED|Crossover Period 2||0
5117187|NCT01512849|12588294|P2|NOT COMPLETED|Crossover Period 2||0
5117188|NCT01512849|12588295|P1|NOT COMPLETED|Crossover Period 2||0
5117189|NCT01512849|12588292|P4|COMPLETED|Crossover Period 2||6
5117190|NCT01512849|12588293|P3|COMPLETED|Crossover Period 2||6
5117191|NCT01512849|12588294|P2|COMPLETED|Crossover Period 2||6
5117192|NCT01512849|12588295|P1|COMPLETED|Crossover Period 2||6
5117193|NCT01512849|12588292|P4|STARTED|Crossover Period 2||6
5117194|NCT01512849|12588293|P3|STARTED|Crossover Period 2||6
5117195|NCT01512849|12588294|P2|STARTED|Crossover Period 2||6
5117196|NCT01512849|12588295|P1|STARTED|Crossover Period 2||6
5117197|NCT01512849|12588292|P4|NOT COMPLETED|Crossover Period 1||0
5117198|NCT01512849|12588293|P3|NOT COMPLETED|Crossover Period 1||0
5117199|NCT01512849|12588294|P2|NOT COMPLETED|Crossover Period 1||0
5117200|NCT01512849|12588295|P1|NOT COMPLETED|Crossover Period 1||0
5117201|NCT01512849|12588292|P4|COMPLETED|Crossover Period 1||6
5117202|NCT01512849|12588293|P3|COMPLETED|Crossover Period 1||6
5117203|NCT01512849|12588294|P2|COMPLETED|Crossover Period 1||6
5117204|NCT01512849|12588295|P1|COMPLETED|Crossover Period 1||6
5117205|NCT01512849|12588292|P4|STARTED|Crossover Period 1||6
5117206|NCT01512849|12588293|P3|STARTED|Crossover Period 1||6
5117207|NCT01512849|12588294|P2|STARTED|Crossover Period 1||6
5117208|NCT01512849|12588295|P1|STARTED|Crossover Period 1||6
5117209|NCT01512797|12588319|P2|NOT COMPLETED|Overall Study||0
5117210|NCT01512797|12588320|P1|NOT COMPLETED|Overall Study||0
5117211|NCT01512797|12588319|P2|COMPLETED|Overall Study||16
5117212|NCT01512797|12588320|P1|COMPLETED|Overall Study||16
5117213|NCT01512797|12588319|P2|STARTED|Overall Study||16
5117214|NCT01512797|12588320|P1|STARTED|Overall Study||16
5117215|NCT01512758|12588336|P2|NOT COMPLETED|Overall Study||0
5117216|NCT01512758|12588337|P1|NOT COMPLETED|Overall Study||0
5117217|NCT01512758|12588336|P2|COMPLETED|Overall Study||6
5117218|NCT01512758|12588337|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
5117219|NCT01512758|12588336|P2|STARTED|Overall Study||6
5117220|NCT01512758|12588337|P1|STARTED|Overall Study||30
5117221|NCT01512745|12588372|P2|NOT COMPLETED|Overall Study||20
5117222|NCT01512745|12588373|P1|NOT COMPLETED|Overall Study||40
5117223|NCT01512745|12588372|P2|COMPLETED|Overall Study||71
5117224|NCT01512745|12588373|P1|COMPLETED|Overall Study||136
5117225|NCT01512745|12588372|P2|STARTED|Overall Study||91
5117226|NCT01512745|12588373|P1|STARTED|Overall Study||176
5117227|NCT01512693|12588389|P2|NOT COMPLETED|Overall Study||1
5117228|NCT01512693|12588390|P1|NOT COMPLETED|Overall Study||0
5117229|NCT01512693|12588389|P2|COMPLETED|Overall Study||8
5117230|NCT01512693|12588390|P1|COMPLETED|Overall Study||8
5117231|NCT01512693|12588389|P2|STARTED|Overall Study||9
5117232|NCT01512693|12588390|P1|STARTED|Overall Study||8
5117233|NCT01512667|12588404|P2|NOT COMPLETED|Overall Study||0
5117234|NCT01512667|12588405|P1|NOT COMPLETED|Overall Study||0
5117235|NCT01512667|12588404|P2|COMPLETED|Overall Study||12
5117236|NCT01512667|12588405|P1|COMPLETED|Overall Study||13
5117237|NCT01512667|12588404|P2|Unmatched Participants|Overall Study||0
5117238|NCT01512667|12588405|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
5117239|NCT01512667|12588404|P2|Matched Participants|Overall Study||12
5117240|NCT01512667|12588405|P1|Matched Participants|Overall Study||12
5117241|NCT01512667|12588404|P2|STARTED|Overall Study||12
5117242|NCT01512667|12588405|P1|STARTED|Overall Study||13
5117243|NCT01512446|12588419|P2|NOT COMPLETED|Overall Study||215
5117244|NCT01512446|12588420|P1|NOT COMPLETED|Overall Study||221
5117245|NCT01512446|12588419|P2|COMPLETED|Overall Study||0
5117246|NCT01512446|12588420|P1|COMPLETED|Overall Study||0
5117247|NCT01512446|12588419|P2|Safety Analysis Set|Overall Study||188
5117248|NCT01512446|12588420|P1|Safety Analysis Set|Overall Study||197
5117249|NCT01512446|12588419|P2|STARTED|Overall Study||215
5117250|NCT01512446|12588420|P1|STARTED|Overall Study||221
5117251|NCT01512368|12588430|P1|NOT COMPLETED|Overall Study||3
5117252|NCT01512368|12588430|P1|COMPLETED|Overall Study||60
5117253|NCT01512368|12588430|P1|STARTED|Overall Study||63
5117254|NCT01512264|12588443|P4|NOT COMPLETED|Overall Study||1
5117255|NCT01512264|12588444|P3|NOT COMPLETED|Overall Study||0
5117256|NCT01512264|12588445|P2|NOT COMPLETED|Overall Study||0
5117257|NCT01512264|12588446|P1|NOT COMPLETED|Overall Study||0
5117258|NCT01512264|12588443|P4|COMPLETED|Overall Study||6
5117259|NCT01512264|12588444|P3|COMPLETED|Overall Study||7
5117260|NCT01512264|12588445|P2|COMPLETED|Overall Study||7
5117261|NCT01512264|12588446|P1|COMPLETED|Overall Study||7
5117262|NCT01512264|12588443|P4|STARTED|Overall Study||7
5117263|NCT01512264|12588444|P3|STARTED|Overall Study||7
5117264|NCT01512264|12588445|P2|STARTED|Overall Study||7
5117265|NCT01512264|12588446|P1|STARTED|Overall Study||7
5117266|NCT01512251|12588538|P2|NOT COMPLETED|Phase II||0
5117267|NCT01512251|12588539|P1|NOT COMPLETED|Phase II||0
5117268|NCT01512251|12588538|P2|COMPLETED|Phase II||0
5117269|NCT01512251|12588539|P1|COMPLETED|Phase II||0
5117270|NCT01512251|12588538|P2|STARTED|Phase II||0
5117271|NCT01512251|12588539|P1|STARTED|Phase II||0
5117272|NCT01512251|12588538|P2|NOT COMPLETED|Phase I, Dose 4||0
5117273|NCT01512251|12588539|P1|NOT COMPLETED|Phase I, Dose 4||0
5117274|NCT01512251|12588538|P2|COMPLETED|Phase I, Dose 4||0
5117275|NCT01512251|12588539|P1|COMPLETED|Phase I, Dose 4||0
5117276|NCT01512251|12588538|P2|STARTED|Phase I, Dose 4||0
5117277|NCT01512251|12588539|P1|STARTED|Phase I, Dose 4||0
5117278|NCT01512251|12588538|P2|NOT COMPLETED|Phase I, Dose 3||0
5117279|NCT01512251|12588539|P1|NOT COMPLETED|Phase I, Dose 3||0
5117280|NCT01512251|12588538|P2|COMPLETED|Phase I, Dose 3||0
5117281|NCT01512251|12588539|P1|COMPLETED|Phase I, Dose 3||0
5117282|NCT01512251|12588538|P2|STARTED|Phase I, Dose 3||0
5117283|NCT01512251|12588539|P1|STARTED|Phase I, Dose 3||0
5117284|NCT01512251|12588538|P2|NOT COMPLETED|Phase I, Dose 2||0
5117285|NCT01512251|12588539|P1|NOT COMPLETED|Phase I, Dose 2||0
5117286|NCT01512251|12588538|P2|COMPLETED|Phase I, Dose 2||0
5117287|NCT01512251|12588539|P1|COMPLETED|Phase I, Dose 2||0
5117288|NCT01512251|12588538|P2|STARTED|Phase I, Dose 2||0
5117289|NCT01512251|12588539|P1|STARTED|Phase I, Dose 2||0
5117290|NCT01512251|12588538|P2|NOT COMPLETED|Phase I, Dose 1||5
5117291|NCT01512251|12588539|P1|NOT COMPLETED|Phase I, Dose 1||3
5117292|NCT01512251|12588538|P2|COMPLETED|Phase I, Dose 1||0
5117293|NCT01512251|12588539|P1|COMPLETED|Phase I, Dose 1||0
5117294|NCT01512251|12588538|P2|STARTED|Phase I, Dose 1||5
5117295|NCT01512251|12588539|P1|STARTED|Phase I, Dose 1||3
5117296|NCT01512251|12588538|P2|NOT COMPLETED|Dose Level -1||0
5117297|NCT01512251|12588539|P1|NOT COMPLETED|Dose Level -1||0
5117298|NCT01512251|12588538|P2|COMPLETED|Dose Level -1||5
5117299|NCT01512251|12588539|P1|COMPLETED|Dose Level -1||3
5117300|NCT01512251|12588538|P2|STARTED|Dose Level -1||5
5117301|NCT01512251|12588539|P1|STARTED|Dose Level -1||3
5117302|NCT01512225|12588560|P2|NOT COMPLETED|Overall Study||0
5117303|NCT01512225|12588561|P1|NOT COMPLETED|Overall Study||0
5117304|NCT01512225|12588560|P2|COMPLETED|Overall Study||45
5117305|NCT01512225|12588561|P1|COMPLETED|Overall Study||45
5117306|NCT01512225|12588560|P2|Provided Day 14 Volume|Overall Study||40
5117307|NCT01512225|12588561|P1|Provided Day 14 Volume|Overall Study||45
5117308|NCT01512225|12588560|P2|STARTED|Overall Study||45
5117309|NCT01512225|12588561|P1|STARTED|Overall Study||45
5117310|NCT01512160|12588585|P4|NOT COMPLETED|Overall Study||1
5117311|NCT01512160|12588586|P3|NOT COMPLETED|Overall Study||0
5117312|NCT01512160|12588587|P2|NOT COMPLETED|Overall Study||0
5117313|NCT01512160|12588588|P1|NOT COMPLETED|Overall Study||2
5117314|NCT01512160|12588585|P4|COMPLETED|Overall Study||22
5117315|NCT01512160|12588586|P3|COMPLETED|Overall Study||22
5117316|NCT01512160|12588587|P2|COMPLETED|Overall Study||23
5117317|NCT01512160|12588588|P1|COMPLETED|Overall Study||20
5117318|NCT01512160|12588585|P4|STARTED|Overall Study||23
5117319|NCT01512160|12588586|P3|STARTED|Overall Study||22
5117320|NCT01512160|12588587|P2|STARTED|Overall Study||23
5117321|NCT01512160|12588588|P1|STARTED|Overall Study||22
5117322|NCT01512108|12588680|P2|NOT COMPLETED|Overall Study||9
5117323|NCT01512108|12588681|P1|NOT COMPLETED|Overall Study||22
5117324|NCT01512108|12588680|P2|COMPLETED|Overall Study||111
5117325|NCT01512108|12588681|P1|COMPLETED|Overall Study||221
5117326|NCT01512108|12588680|P2|Exposed|Overall Study||120
5117327|NCT01512108|12588681|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
5117328|NCT01512108|12588680|P2|STARTED|Overall Study||120
5117329|NCT01512108|12588681|P1|STARTED|Overall Study||243
5117330|NCT01511978|12588695|P2|NOT COMPLETED|Overall Study||0
5117331|NCT01511978|12588696|P1|NOT COMPLETED|Overall Study||0
5117332|NCT01511978|12588695|P2|COMPLETED|Overall Study||18
5117333|NCT01511978|12588696|P1|COMPLETED|Overall Study||14
5117334|NCT01511978|12588695|P2|STARTED|Overall Study||18
5117335|NCT01511978|12588696|P1|STARTED|Overall Study||14
5117336|NCT01511939|12588707|P3|NOT COMPLETED|Overall Study||0
5117337|NCT01511939|12588708|P2|NOT COMPLETED|Overall Study||1
5117338|NCT01511939|12588709|P1|NOT COMPLETED|Overall Study||2
5117339|NCT01511939|12588707|P3|COMPLETED|Overall Study||8
5117340|NCT01511939|12588708|P2|COMPLETED|Overall Study||4
5117341|NCT01511939|12588709|P1|COMPLETED|Overall Study||7
5117342|NCT01511939|12588707|P3|STARTED|Overall Study||8
5117343|NCT01511939|12588708|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
5117344|NCT01511939|12588709|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
5117345|NCT01511809|12588728|P2|NOT COMPLETED|Overall Study||7
5117346|NCT01511809|12588729|P1|NOT COMPLETED|Overall Study||7
5117347|NCT01511809|12588728|P2|COMPLETED|Overall Study||52
5117348|NCT01511809|12588729|P1|COMPLETED|Overall Study||51
5117349|NCT01511809|12588728|P2|STARTED|Overall Study||59
5117350|NCT01511809|12588729|P1|STARTED|Overall Study||58
5117351|NCT01511536|12588738|P3|NOT COMPLETED|Phase 2||9
5117352|NCT01511536|12588739|P2|NOT COMPLETED|Phase 2||0
5117353|NCT01511536|12588740|P1|NOT COMPLETED|Phase 2||0
5117354|NCT01511536|12588738|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
5117355|NCT01511536|12588739|P2|COMPLETED|Phase 2||0
5117356|NCT01511536|12588740|P1|COMPLETED|Phase 2||0
5117357|NCT01511536|12588738|P3|STARTED|Phase 2||27
5117358|NCT01511536|12588739|P2|STARTED|Phase 2||0
5117359|NCT01511536|12588740|P1|STARTED|Phase 2||0
5117360|NCT01511536|12588738|P3|NOT COMPLETED|Phase 1||0
5117361|NCT01511536|12588739|P2|NOT COMPLETED|Phase 1||1
5117362|NCT01511536|12588740|P1|NOT COMPLETED|Phase 1||0
5117363|NCT01511536|12588738|P3|COMPLETED|Phase 1||0
5117364|NCT01511536|12588739|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
5117365|NCT01511536|12588740|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
5117366|NCT01511536|12588738|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
5117367|NCT01511536|12588739|P2|STARTED|Phase 1||7
5117368|NCT01511536|12588740|P1|STARTED|Phase 1||3
5117369|NCT01511445|12588762|P2|NOT COMPLETED|Overall Study||4
5117370|NCT01511445|12588763|P1|NOT COMPLETED|Overall Study||5
5117371|NCT01511445|12588762|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
5117372|NCT01511445|12588763|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
5117373|NCT01511445|12588762|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
5117374|NCT01511445|12588763|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
5117375|NCT01511445|12588762|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
5117376|NCT01511445|12588763|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
5117377|NCT01511445|12588762|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
5117378|NCT01511445|12588763|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
5117379|NCT01511445|12588762|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
5117380|NCT01511445|12588763|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
5117381|NCT01511419|12588773|P2|NOT COMPLETED|Dose 2||0
5117382|NCT01511419|12588774|P1|NOT COMPLETED|Dose 2||1
5117383|NCT01511419|12588773|P2|COMPLETED|Dose 2||10
5117384|NCT01511419|12588774|P1|COMPLETED|Dose 2||29
5117385|NCT01511419|12588773|P2|STARTED|Dose 2||10
5117386|NCT01511419|12588774|P1|STARTED|Dose 2||30
5117387|NCT01511419|12588773|P2|NOT COMPLETED|Dose 1||0
5117388|NCT01511419|12588774|P1|NOT COMPLETED|Dose 1||0
5117389|NCT01511419|12588773|P2|COMPLETED|Dose 1||10
5117390|NCT01511419|12588774|P1|COMPLETED|Dose 1||30
5117391|NCT01511419|12588773|P2|STARTED|Dose 1||10
5117392|NCT01511419|12588774|P1|STARTED|Dose 1||30
5117393|NCT01511315|12588866|P1|NOT COMPLETED|Overall Study||4
5117394|NCT01511315|12588866|P1|COMPLETED|Overall Study||32
5117395|NCT01511315|12588866|P1|STARTED|Overall Study||36
5117396|NCT01511250|12588886|P10|NOT COMPLETED|Overall Study||5
5117397|NCT01511250|12588887|P9|NOT COMPLETED|Overall Study||14
5117398|NCT01511250|12588888|P8|NOT COMPLETED|Overall Study||4
5117399|NCT01511250|12588889|P7|NOT COMPLETED|Overall Study||2
5117400|NCT01511250|12588890|P6|NOT COMPLETED|Overall Study||0
5117401|NCT01511250|12588891|P5|NOT COMPLETED|Overall Study||0
5117402|NCT01511250|12588892|P4|NOT COMPLETED|Overall Study||3
5117403|NCT01511250|12588893|P3|NOT COMPLETED|Overall Study||4
5117404|NCT01511250|12588894|P2|NOT COMPLETED|Overall Study||5
5117405|NCT01511250|12588895|P1|NOT COMPLETED|Overall Study||9
5117406|NCT01511250|12588886|P10|COMPLETED|Overall Study||48
5117407|NCT01511250|12588887|P9|COMPLETED|Overall Study||145
5117408|NCT01511250|12588888|P8|COMPLETED|Overall Study||9
5117409|NCT01511250|12588889|P7|COMPLETED|Overall Study||21
5117410|NCT01511250|12588890|P6|COMPLETED|Overall Study||17
5117411|NCT01511250|12588891|P5|COMPLETED|Overall Study||21
5117412|NCT01511250|12588892|P4|COMPLETED|Overall Study||11
5117413|NCT01511250|12588893|P3|COMPLETED|Overall Study||18
5117414|NCT01511250|12588894|P2|COMPLETED|Overall Study||9
5117415|NCT01511250|12588895|P1|COMPLETED|Overall Study||15
5117416|NCT01511250|12588886|P10|STARTED|Overall Study||53
5117417|NCT01511250|12588887|P9|STARTED|Overall Study||159
5117418|NCT01511250|12588888|P8|STARTED|Overall Study||13
5117419|NCT01511250|12588889|P7|STARTED|Overall Study||23
5117420|NCT01511250|12588890|P6|STARTED|Overall Study||17
5117421|NCT01511250|12588891|P5|STARTED|Overall Study||21
5117422|NCT01511250|12588892|P4|STARTED|Overall Study||14
5117423|NCT01511250|12588893|P3|STARTED|Overall Study||22
5117424|NCT01511250|12588894|P2|STARTED|Overall Study||14
5117425|NCT01511250|12588895|P1|STARTED|Overall Study||24
5117426|NCT01511107|12589043|P2|NOT COMPLETED|Overall Study||41
5117427|NCT01511107|12589044|P1|NOT COMPLETED|Overall Study||22
5117428|NCT01511107|12589043|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
5117429|NCT01511107|12589044|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
5117430|NCT01511107|12589043|P2|STARTED|Overall Study|Randomized to the treatment group.|260
5117431|NCT01511107|12589044|P1|STARTED|Overall Study|Randomized to the treatment group.|260
5117432|NCT01511081|12589094|P2|NOT COMPLETED|Overall Study||0
5117433|NCT01511081|12589095|P1|NOT COMPLETED|Overall Study||0
5117434|NCT01511081|12589094|P2|COMPLETED|Overall Study||9
5117435|NCT01511081|12589095|P1|COMPLETED|Overall Study||8
5117436|NCT01511081|12589094|P2|STARTED|Overall Study||9
5117437|NCT01511081|12589095|P1|STARTED|Overall Study||8
5117438|NCT01511016|12589105|P2|NOT COMPLETED|Overall Study||2
5117439|NCT01511016|12589106|P1|NOT COMPLETED|Overall Study||2
5117440|NCT01511016|12589105|P2|COMPLETED|Overall Study||7
5117441|NCT01511016|12589106|P1|COMPLETED|Overall Study||6
5117442|NCT01511016|12589105|P2|STARTED|Overall Study||9
5117443|NCT01511016|12589106|P1|STARTED|Overall Study||8
5117444|NCT01510912|12589122|P1|NOT COMPLETED|Overall Study||242
5117445|NCT01510912|12589122|P1|COMPLETED|Overall Study||360
5117446|NCT01510912|12589122|P1|STARTED|Overall Study||602
5117447|NCT01510834|12589128|P1|NOT COMPLETED|Overall Study||33
5117448|NCT01510834|12589128|P1|COMPLETED|Overall Study||57
5117449|NCT01510834|12589128|P1|STARTED|Overall Study||90
5117450|NCT01510769|12589138|P3|NOT COMPLETED|Overall Study||22
5117451|NCT01510769|12589139|P2|NOT COMPLETED|Overall Study||25
5117452|NCT01510769|12589140|P1|NOT COMPLETED|Overall Study||27
5117453|NCT01510769|12589138|P3|COMPLETED|Overall Study||87
5117454|NCT01510769|12589139|P2|COMPLETED|Overall Study||84
5117455|NCT01510769|12589140|P1|COMPLETED|Overall Study||79
5117456|NCT01510769|12589138|P3|STARTED|Overall Study||109
5117457|NCT01510769|12589139|P2|STARTED|Overall Study||109
5117458|NCT01510769|12589140|P1|STARTED|Overall Study||106
5117459|NCT01510756|12589157|P1|NOT COMPLETED|Overall Study||4
5117460|NCT01510756|12589157|P1|COMPLETED|Overall Study||0
5117461|NCT01510756|12589157|P1|STARTED|Overall Study||4
5117462|NCT01510717|12589165|P2|NOT COMPLETED|Overall Study||5
5117463|NCT01510717|12589166|P1|NOT COMPLETED|Overall Study||2
5117464|NCT01510717|12589165|P2|COMPLETED|Overall Study||160
5117465|NCT01510717|12589166|P1|COMPLETED|Overall Study||153
5117466|NCT01510717|12589165|P2|STARTED|Overall Study||165
5117467|NCT01510717|12589166|P1|STARTED|Overall Study||155
5117468|NCT01510704|12589194|P4|NOT COMPLETED|Overall Study||0
5117469|NCT01510704|12589195|P3|NOT COMPLETED|Overall Study||0
5117470|NCT01510704|12589196|P2|NOT COMPLETED|Overall Study||0
5117471|NCT01510704|12589197|P1|NOT COMPLETED|Overall Study||0
5117472|NCT01510704|12589194|P4|COMPLETED|Overall Study||53
5117473|NCT01510704|12589195|P3|COMPLETED|Overall Study||50
5117474|NCT01510704|12589196|P2|COMPLETED|Overall Study||58
5117475|NCT01510704|12589197|P1|COMPLETED|Overall Study||54
5117476|NCT01510704|12589194|P4|STARTED|Overall Study||53
5117477|NCT01510704|12589195|P3|STARTED|Overall Study||50
5117478|NCT01510704|12589196|P2|STARTED|Overall Study||58
5117479|NCT01510704|12589197|P1|STARTED|Overall Study||54
5117480|NCT01510652|12589209|P2|NOT COMPLETED|Overall Study||67
5117481|NCT01510652|12589210|P1|NOT COMPLETED|Overall Study||92
5117482|NCT01510652|12589209|P2|COMPLETED|Overall Study||288
5117483|NCT01510652|12589210|P1|COMPLETED|Overall Study||627
5117484|NCT01510652|12589209|P2|Baseline|Overall Study||348
5117485|NCT01510652|12589210|P1|Baseline|Overall Study||718
5117486|NCT01510652|12589209|P2|STARTED|Overall Study||355
5117487|NCT01510652|12589210|P1|STARTED|Overall Study||719
5117488|NCT01510457|12589222|P2|NOT COMPLETED|Overall Study||3
5117489|NCT01510457|12589223|P1|NOT COMPLETED|Overall Study||5
5117490|NCT01510457|12589222|P2|COMPLETED|Overall Study||26
5117491|NCT01510457|12589223|P1|COMPLETED|Overall Study||12
5117492|NCT01510457|12589222|P2|STARTED|Overall Study||29
5117493|NCT01510457|12589223|P1|STARTED|Overall Study||17
5117494|NCT01510379|12589243|P2|NOT COMPLETED|Overall Study||0
5117495|NCT01510379|12589244|P1|NOT COMPLETED|Overall Study||0
5117496|NCT01510379|12589243|P2|COMPLETED|Overall Study||51
5117497|NCT01510379|12589244|P1|COMPLETED|Overall Study||49
5117498|NCT01510379|12589243|P2|STARTED|Overall Study||51
5117499|NCT01510379|12589244|P1|STARTED|Overall Study||49
5117500|NCT01510327|12589252|P1|NOT COMPLETED|Overall Study||0
5117501|NCT01510327|12589252|P1|COMPLETED|Overall Study||22
5117502|NCT01510327|12589252|P1|STARTED|Overall Study||22
5117503|NCT01510158|12589286|P3|NOT COMPLETED|Overall Study||50
5117504|NCT01510158|12589287|P2|NOT COMPLETED|Overall Study||53
5117505|NCT01510158|12589288|P1|NOT COMPLETED|Overall Study||51
5117506|NCT01510158|12589286|P3|COMPLETED|Overall Study||152
5117507|NCT01510158|12589287|P2|COMPLETED|Overall Study||150
5117508|NCT01510158|12589288|P1|COMPLETED|Overall Study||151
5117509|NCT01510158|12589286|P3|STARTED|Overall Study||202
5117510|NCT01510158|12589287|P2|STARTED|Overall Study||203
5117511|NCT01510158|12589288|P1|STARTED|Overall Study||202
5117512|NCT01510145|12589302|P1|NOT COMPLETED|Overall Study||18
5117513|NCT01510145|12589302|P1|COMPLETED|Overall Study||173
5117514|NCT01510145|12589302|P1|STARTED|Overall Study||191
5117515|NCT01510028|12589311|P4|NOT COMPLETED|Overall Study||0
5117516|NCT01510028|12589312|P3|NOT COMPLETED|Overall Study||0
5117517|NCT01510028|12589313|P2|NOT COMPLETED|Overall Study||0
5117518|NCT01510028|12589314|P1|NOT COMPLETED|Overall Study||1
5117519|NCT01510028|12589311|P4|COMPLETED|Overall Study||6
5117520|NCT01510028|12589312|P3|COMPLETED|Overall Study||6
5117521|NCT01510028|12589313|P2|COMPLETED|Overall Study||6
5117522|NCT01510028|12589314|P1|COMPLETED|Overall Study||5
5117523|NCT01510028|12589311|P4|STARTED|Overall Study||6
5117524|NCT01510028|12589312|P3|STARTED|Overall Study||6
5117525|NCT01510028|12589313|P2|STARTED|Overall Study||6
5117526|NCT01510028|12589314|P1|STARTED|Overall Study||6
5117527|NCT01509950|12589430|P3|NOT COMPLETED|Overall Study||0
5117528|NCT01509950|12589431|P2|NOT COMPLETED|Overall Study||0
5117529|NCT01509950|12589432|P1|NOT COMPLETED|Overall Study||0
5117530|NCT01509950|12589430|P3|COMPLETED|Overall Study||0
5117531|NCT01509950|12589431|P2|COMPLETED|Overall Study||8
5117532|NCT01509950|12589432|P1|COMPLETED|Overall Study||7
5117533|NCT01509950|12589430|P3|STARTED|Overall Study||0
5117534|NCT01509950|12589431|P2|STARTED|Overall Study||8
5117535|NCT01509950|12589432|P1|STARTED|Overall Study||7
5117536|NCT01509872|12589460|P2|NOT COMPLETED|Overall Study||0
5117537|NCT01509872|12589461|P1|NOT COMPLETED|Overall Study||1
5117538|NCT01509872|12589460|P2|COMPLETED|Overall Study||24
5117539|NCT01509872|12589461|P1|COMPLETED|Overall Study||25
5117540|NCT01509872|12589460|P2|Post-Intervention Assessment|Overall Study||24
5117541|NCT01509872|12589461|P1|Post-Intervention Assessment|Overall Study||26
5117542|NCT01509872|12589460|P2|STARTED|Overall Study||24
5117543|NCT01509872|12589461|P1|STARTED|Overall Study||26
5117544|NCT01509807|12589475|P2|NOT COMPLETED|Overall Study||1
5117545|NCT01509807|12589476|P1|NOT COMPLETED|Overall Study||1
5117546|NCT01509807|12589475|P2|COMPLETED|Overall Study||16
5117547|NCT01509807|12589476|P1|COMPLETED|Overall Study||15
5117548|NCT01509807|12589475|P2|STARTED|Overall Study||17
5117549|NCT01509807|12589476|P1|STARTED|Overall Study||16
5117550|NCT01509677|12589502|P2|NOT COMPLETED|Overall Study||6
5117551|NCT01509677|12589503|P1|NOT COMPLETED|Overall Study||3
5117552|NCT01509677|12589502|P2|COMPLETED|Overall Study||73
5117553|NCT01509677|12589503|P1|COMPLETED|Overall Study||76
5117554|NCT01509677|12589502|P2|STARTED|Overall Study||79
5117555|NCT01509677|12589503|P1|STARTED|Overall Study||79
5117556|NCT01509664|12589575|P2|NOT COMPLETED|Overall Study||21
5117557|NCT01509664|12589576|P1|NOT COMPLETED|Overall Study||15
5117558|NCT01509664|12589575|P2|COMPLETED|Overall Study||28
5117559|NCT01509664|12589576|P1|COMPLETED|Overall Study||34
5117560|NCT01509664|12589575|P2|T3 Follow-up|Overall Study||33
5117561|NCT01509664|12589576|P1|T3 Follow-up|Overall Study||40
5117562|NCT01509664|12589575|P2|T2 Follow-up|Overall Study||38
5117563|NCT01509664|12589576|P1|T2 Follow-up|Overall Study||45
5117564|NCT01509664|12589575|P2|STARTED|Overall Study||49
5117565|NCT01509664|12589576|P1|STARTED|Overall Study||49
5117566|NCT01509638|12589584|P2|NOT COMPLETED|Overall Study||2
5117567|NCT01509638|12589585|P1|NOT COMPLETED|Overall Study||3
5117568|NCT01509638|12589584|P2|COMPLETED|Overall Study||24
5117569|NCT01509638|12589585|P1|COMPLETED|Overall Study||20
5117570|NCT01509638|12589584|P2|STARTED|Overall Study||26
5117571|NCT01509638|12589585|P1|STARTED|Overall Study||23
5117572|NCT01509625|12589609|P1|NOT COMPLETED|Overall Study||9
5117573|NCT01509625|12589609|P1|COMPLETED|Overall Study||263
5117574|NCT01509625|12589609|P1|STARTED|Overall Study||272
5117575|NCT01509586|12589627|P2|NOT COMPLETED|Overall Study||0
5117576|NCT01509586|12589628|P1|NOT COMPLETED|Overall Study||0
5117577|NCT01509586|12589627|P2|COMPLETED|Overall Study|final intent to treat sample|610
5117578|NCT01509586|12589628|P1|COMPLETED|Overall Study|final intent to treat sample|626
5117579|NCT01509586|12589627|P2|Week 58 (Month 12)|Overall Study||499
5117580|NCT01509586|12589628|P1|Week 58 (Month 12)|Overall Study||492
5117581|NCT01509586|12589627|P2|Week 46|Overall Study||494
5117582|NCT01509586|12589628|P1|Week 46|Overall Study||483
5117583|NCT01509586|12589627|P2|Week 32 (Month 6)|Overall Study||523
5117584|NCT01509586|12589628|P1|Week 32 (Month 6)|Overall Study||504
5117585|NCT01509586|12589627|P2|Week18|Overall Study||555
5117586|NCT01509586|12589628|P1|Week18|Overall Study||529
5117587|NCT01509586|12589627|P2|Week 14|Overall Study||566
5117588|NCT01509586|12589628|P1|Week 14|Overall Study||528
5117589|NCT01509586|12589627|P2|Week 10|Overall Study||574
5117590|NCT01509586|12589628|P1|Week 10|Overall Study||537
5117591|NCT01509586|12589627|P2|Week 6|Overall Study||585
5117592|NCT01509586|12589628|P1|Week 6|Overall Study||551
5117593|NCT01509586|12589627|P2|Week 3|Overall Study||585
5117594|NCT01509586|12589628|P1|Week 3|Overall Study||574
5117595|NCT01509586|12589627|P2|STARTED|Overall Study|Week 0|610
5117596|NCT01509586|12589628|P1|STARTED|Overall Study|Week 0|626
5117597|NCT01509547|12589636|P2|NOT COMPLETED|Overall Study||39
5117598|NCT01509547|12589637|P1|NOT COMPLETED|Overall Study||35
5117599|NCT01509547|12589636|P2|COMPLETED|Overall Study||41
5117600|NCT01509547|12589637|P1|COMPLETED|Overall Study||42
5117601|NCT01509547|12589636|P2|STARTED|Overall Study||80
5117602|NCT01509547|12589637|P1|STARTED|Overall Study||77
5117603|NCT01509404|12589655|P2|NOT COMPLETED|Overall Study||0
5117604|NCT01509404|12589656|P1|NOT COMPLETED|Overall Study||0
5117605|NCT01509404|12589655|P2|COMPLETED|Overall Study||20
5117606|NCT01509404|12589656|P1|COMPLETED|Overall Study||20
5117607|NCT01509404|12589655|P2|STARTED|Overall Study||20
5117608|NCT01509404|12589656|P1|STARTED|Overall Study||20
5117609|NCT01509183|12589678|P2|NOT COMPLETED|Overall Study||111
5117610|NCT01509183|12589679|P1|NOT COMPLETED|Overall Study||109
5117611|NCT01509183|12589678|P2|COMPLETED|Overall Study||134
5117612|NCT01509183|12589679|P1|COMPLETED|Overall Study||141
5117613|NCT01509183|12589678|P2|STARTED|Overall Study||245
5117614|NCT01509183|12589679|P1|STARTED|Overall Study||250
5117615|NCT01509105|12589687|P1|NOT COMPLETED|Overall Study||0
5117616|NCT01509105|12589687|P1|COMPLETED|Overall Study||649
5117617|NCT01509105|12589687|P1|STARTED|Overall Study||649
5117618|NCT01509079|12589704|P2|NOT COMPLETED|Overall Study||3
5117619|NCT01509079|12589705|P1|NOT COMPLETED|Overall Study||0
5117620|NCT01509079|12589704|P2|COMPLETED|Overall Study||56
5117621|NCT01509079|12589705|P1|COMPLETED|Overall Study||57
5117622|NCT01509079|12589704|P2|STARTED|Overall Study||59
5117623|NCT01509079|12589705|P1|STARTED|Overall Study||57
5117624|NCT01509053|12589725|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
5117625|NCT01509053|12589725|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
5117626|NCT01509053|12589725|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
5117627|NCT01509053|12589725|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
5117628|NCT01509053|12589725|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
5117629|NCT01509053|12589725|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
5117630|NCT01509053|12589725|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
5117631|NCT01509053|12589725|P1|COMPLETED|Oral Aripirazole (Phase A)||8
5117632|NCT01509053|12589725|P1|STARTED|Oral Aripirazole (Phase A)||19
5117633|NCT01509040|12589739|P3|NOT COMPLETED|Overall Study||0
5117634|NCT01509040|12589740|P2|NOT COMPLETED|Overall Study||1
5117635|NCT01509040|12589741|P1|NOT COMPLETED|Overall Study||0
5117636|NCT01509040|12589739|P3|COMPLETED|Overall Study||0
5117637|NCT01509040|12589740|P2|COMPLETED|Overall Study||1
5117638|NCT01509040|12589741|P1|COMPLETED|Overall Study||0
5117639|NCT01509040|12589739|P3|STARTED|Overall Study||0
5117640|NCT01509040|12589740|P2|STARTED|Overall Study||2
5117641|NCT01509040|12589741|P1|STARTED|Overall Study||0
5117642|NCT01508936|12589787|P2|NOT COMPLETED|Overall Study||79
5117643|NCT01508936|12589788|P1|NOT COMPLETED|Overall Study||23
5117644|NCT01508936|12589787|P2|COMPLETED|Overall Study||330
5117645|NCT01508936|12589788|P1|COMPLETED|Overall Study||79
5117646|NCT01508936|12589787|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
5117647|NCT01508936|12589788|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
5117648|NCT01508936|12589787|P2|Full Analysis Set|Overall Study||395
5117649|NCT01508936|12589788|P1|Full Analysis Set|Overall Study||97
5117650|NCT01508936|12589787|P2|Safety Analysis Set|Overall Study||395
5117651|NCT01508936|12589788|P1|Safety Analysis Set|Overall Study||97
5117652|NCT01508936|12589787|P2|Randomized, Not Treated|Overall Study||3
5117653|NCT01508936|12589788|P1|Randomized, Not Treated|Overall Study||1
5117654|NCT01508936|12589787|P2|Randomized|Overall Study||398
5117655|NCT01508936|12589788|P1|Randomized|Overall Study||98
5117656|NCT01508936|12589787|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
5117657|NCT01508936|12589788|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
5117658|NCT01508936|12589787|P2|STARTED|Overall Study||409
5117659|NCT01508936|12589788|P1|STARTED|Overall Study||102
5117660|NCT01508910|12589827|P4|NOT COMPLETED|Treatment||3
5117661|NCT01508910|12589828|P3|NOT COMPLETED|Treatment||10
5117662|NCT01508910|12589829|P2|NOT COMPLETED|Treatment||4
5117663|NCT01508910|12589830|P1|NOT COMPLETED|Treatment||2
5117664|NCT01508910|12589827|P4|COMPLETED|Treatment||3
5117665|NCT01508910|12589828|P3|COMPLETED|Treatment||18
5117666|NCT01508910|12589829|P2|COMPLETED|Treatment||24
5117667|NCT01508910|12589830|P1|COMPLETED|Treatment||48
5117668|NCT01508910|12589827|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
5117669|NCT01508910|12589828|P3|STARTED|Treatment||28
5117670|NCT01508910|12589829|P2|STARTED|Treatment||28
5117671|NCT01508910|12589830|P1|STARTED|Treatment||50
5117672|NCT01508910|12589827|P4|NOT COMPLETED|Randomization||0
5117673|NCT01508910|12589828|P3|NOT COMPLETED|Randomization||0
5117674|NCT01508910|12589829|P2|NOT COMPLETED|Randomization||0
5117675|NCT01508910|12589830|P1|NOT COMPLETED|Randomization||0
5117676|NCT01508910|12589827|P4|COMPLETED|Randomization||0
5117677|NCT01508910|12589828|P3|COMPLETED|Randomization||28
5117678|NCT01508910|12589829|P2|COMPLETED|Randomization||27
5117679|NCT01508910|12589830|P1|COMPLETED|Randomization||57
5117680|NCT01508910|12589827|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
5117681|NCT01508910|12589828|P3|STARTED|Randomization||28
5117682|NCT01508910|12589829|P2|STARTED|Randomization||27
5117683|NCT01508910|12589830|P1|STARTED|Randomization||57
5117684|NCT01508832|12589854|P2|NOT COMPLETED|Overall Study||0
5117685|NCT01508832|12589855|P1|NOT COMPLETED|Overall Study||0
5117686|NCT01508832|12589854|P2|COMPLETED|Overall Study||6
5117687|NCT01508832|12589855|P1|COMPLETED|Overall Study||6
5117688|NCT01508832|12589854|P2|STARTED|Overall Study||6
5117689|NCT01508832|12589855|P1|STARTED|Overall Study||6
5117690|NCT01508702|12589863|P2|NOT COMPLETED|Overall Study||13
5117691|NCT01508702|12589864|P1|NOT COMPLETED|Overall Study||23
5117692|NCT01508702|12589863|P2|COMPLETED|Overall Study||94
5117693|NCT01508702|12589864|P1|COMPLETED|Overall Study||84
5117694|NCT01508702|12589863|P2|STARTED|Overall Study||107
5117695|NCT01508702|12589864|P1|STARTED|Overall Study||107
5117696|NCT01508676|12589872|P2|NOT COMPLETED|Phase II (2 Weeks)||1
5117697|NCT01508676|12589873|P1|NOT COMPLETED|Phase II (2 Weeks)||1
5117698|NCT01508676|12589872|P2|COMPLETED|Phase II (2 Weeks)||13
5117699|NCT01508676|12589873|P1|COMPLETED|Phase II (2 Weeks)||15
5117700|NCT01508676|12589872|P2|STARTED|Phase II (2 Weeks)||14
5117701|NCT01508676|12589873|P1|STARTED|Phase II (2 Weeks)||16
5117702|NCT01508676|12589872|P2|NOT COMPLETED|Washout Period (1 Week)||0
5117703|NCT01508676|12589873|P1|NOT COMPLETED|Washout Period (1 Week)||0
5117704|NCT01508676|12589872|P2|COMPLETED|Washout Period (1 Week)||14
5117705|NCT01508676|12589873|P1|COMPLETED|Washout Period (1 Week)||16
5117706|NCT01508676|12589872|P2|STARTED|Washout Period (1 Week)||14
5117707|NCT01508676|12589873|P1|STARTED|Washout Period (1 Week)||16
5117708|NCT01508676|12589872|P2|NOT COMPLETED|Phase I (2 Weeks)||3
5117709|NCT01508676|12589873|P1|NOT COMPLETED|Phase I (2 Weeks)||2
5117710|NCT01508676|12589872|P2|COMPLETED|Phase I (2 Weeks)||14
5117711|NCT01508676|12589873|P1|COMPLETED|Phase I (2 Weeks)||16
5117712|NCT01508676|12589872|P2|STARTED|Phase I (2 Weeks)||17
5117713|NCT01508676|12589873|P1|STARTED|Phase I (2 Weeks)||18
5117714|NCT01508650|12589885|P2|NOT COMPLETED|Overall Study||3
5117715|NCT01508650|12589886|P1|NOT COMPLETED|Overall Study||0
5117716|NCT01508650|12589885|P2|COMPLETED|Overall Study||12
5117717|NCT01508650|12589886|P1|COMPLETED|Overall Study||12
5117718|NCT01508650|12589885|P2|STARTED|Overall Study||15
5117719|NCT01508650|12589886|P1|STARTED|Overall Study||12
5117720|NCT01508455|12589894|P1|NOT COMPLETED|Overall Study||0
5117721|NCT01508455|12589894|P1|COMPLETED|Overall Study||6
5117722|NCT01508455|12589894|P1|STARTED|Overall Study||6
5117723|NCT01508325|12589905|P2|NOT COMPLETED|Overall Study||21
5117724|NCT01508325|12589906|P1|NOT COMPLETED|Overall Study||18
5117725|NCT01508325|12589905|P2|COMPLETED|Overall Study||72
5117726|NCT01508325|12589906|P1|COMPLETED|Overall Study||75
5117727|NCT01508325|12589905|P2|STARTED|Overall Study||93
5117728|NCT01508325|12589906|P1|STARTED|Overall Study||93
5117729|NCT01508169|12589936|P2|NOT COMPLETED|Overall Study||2
5117730|NCT01508169|12589937|P1|NOT COMPLETED|Overall Study||3
5117731|NCT01508169|12589936|P2|COMPLETED|Overall Study||45
5117732|NCT01508169|12589937|P1|COMPLETED|Overall Study||44
5117733|NCT01508169|12589936|P2|STARTED|Overall Study||47
5117734|NCT01508169|12589937|P1|STARTED|Overall Study||47
5117735|NCT01508130|12589951|P2|NOT COMPLETED|Overall Study||69
5117736|NCT01508130|12589952|P1|NOT COMPLETED|Overall Study||227
5117737|NCT01508130|12589951|P2|COMPLETED|Overall Study||73
5117738|NCT01508130|12589952|P1|COMPLETED|Overall Study||266
5117739|NCT01508130|12589951|P2|mTRT|Overall Study||142
5117740|NCT01508130|12589952|P1|mTRT|Overall Study||493
5117741|NCT01508130|12589951|P2|STARTED|Overall Study||142
5117742|NCT01508130|12589952|P1|STARTED|Overall Study||493
5117743|NCT01508117|12589994|P1|NOT COMPLETED|Overall Study||0
5117744|NCT01508117|12589994|P1|COMPLETED|Overall Study||1
5117745|NCT01508117|12589994|P1|STARTED|Overall Study||1
5117746|NCT01508052|12590000|P2|NOT COMPLETED|Overall Study||0
5117747|NCT01508052|12590001|P1|NOT COMPLETED|Overall Study||0
5117748|NCT01508052|12590000|P2|COMPLETED|Overall Study||20
5117749|NCT01508052|12590001|P1|COMPLETED|Overall Study||20
5117750|NCT01508052|12590000|P2|STARTED|Overall Study||20
5117751|NCT01508052|12590001|P1|STARTED|Overall Study||20
5117752|NCT01508013|12590009|P2|NOT COMPLETED|Overall Study||23
5117753|NCT01508013|12590010|P1|NOT COMPLETED|Overall Study||32
5117754|NCT01508013|12590009|P2|COMPLETED|Overall Study||206
5117755|NCT01508013|12590010|P1|COMPLETED|Overall Study||182
5117756|NCT01508013|12590009|P2|STARTED|Overall Study||229
5117757|NCT01508013|12590010|P1|STARTED|Overall Study||214
5117758|NCT01507896|12590020|P1|NOT COMPLETED|Overall Study||2
5117759|NCT01507896|12590020|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
5117760|NCT01507896|12590020|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
5117761|NCT01507831|12590063|P2|NOT COMPLETED|Overall Study||440
5117762|NCT01507831|12590064|P1|NOT COMPLETED|Overall Study||193
5117763|NCT01507831|12590063|P2|COMPLETED|Overall Study||1113
5117764|NCT01507831|12590064|P1|COMPLETED|Overall Study||595
5117765|NCT01507831|12590063|P2|Treated|Overall Study||1550
5117766|NCT01507831|12590064|P1|Treated|Overall Study||788
5117767|NCT01507831|12590063|P2|STARTED|Overall Study|Randomized|1553
5117768|NCT01507831|12590064|P1|STARTED|Overall Study|Randomized|788
5117769|NCT01507779|12590134|P2|NOT COMPLETED|Overall Study||0
5117770|NCT01507779|12590135|P1|NOT COMPLETED|Overall Study||0
5117771|NCT01507779|12590134|P2|COMPLETED|Overall Study||25
5117772|NCT01507779|12590135|P1|COMPLETED|Overall Study||23
5117773|NCT01507779|12590134|P2|STARTED|Overall Study||25
5117774|NCT01507779|12590135|P1|STARTED|Overall Study||23
5117775|NCT01507688|12590175|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
5117776|NCT01507688|12590176|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
5117777|NCT01507688|12590175|P2|COMPLETED|6 Month to 12 Month Assessment||116
5117778|NCT01507688|12590176|P1|COMPLETED|6 Month to 12 Month Assessment||108
5117779|NCT01507688|12590175|P2|STARTED|6 Month to 12 Month Assessment||119
5117780|NCT01507688|12590176|P1|STARTED|6 Month to 12 Month Assessment||113
5117781|NCT01507688|12590175|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
5117782|NCT01507688|12590176|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
5117783|NCT01507688|12590175|P2|COMPLETED|Baseline to 6 Month Assessment||119
5117784|NCT01507688|12590176|P1|COMPLETED|Baseline to 6 Month Assessment||113
5117785|NCT01507688|12590175|P2|STARTED|Baseline to 6 Month Assessment||129
5117786|NCT01507688|12590176|P1|STARTED|Baseline to 6 Month Assessment||129
5117787|NCT01507662|12590184|P2|NOT COMPLETED|Overall Study||831
5117788|NCT01507662|12590185|P1|NOT COMPLETED|Overall Study||816
5117789|NCT01507662|12590184|P2|COMPLETED|Overall Study||3020
5117790|NCT01507662|12590185|P1|COMPLETED|Overall Study||3082
5117791|NCT01507662|12590184|P2|STARTED|Overall Study||3851
5117792|NCT01507662|12590185|P1|STARTED|Overall Study||3898
5117793|NCT01507584|12590191|P1|NOT COMPLETED|Overall Study||0
5117794|NCT01507584|12590191|P1|COMPLETED|Overall Study||0
5117795|NCT01507584|12590191|P1|STARTED|Overall Study||0
5117796|NCT01507493|12590199|P2|NOT COMPLETED|Overall Study||0
5117797|NCT01507493|12590200|P1|NOT COMPLETED|Overall Study||0
5117798|NCT01507493|12590199|P2|COMPLETED|Overall Study||178
5117799|NCT01507493|12590200|P1|COMPLETED|Overall Study||22
5117800|NCT01507493|12590199|P2|STARTED|Overall Study||178
5117801|NCT01507493|12590200|P1|STARTED|Overall Study||22
5117802|NCT01507298|12590216|P2|NOT COMPLETED|Overall Study||6
5117803|NCT01507298|12590217|P1|NOT COMPLETED|Overall Study||0
5117804|NCT01507298|12590216|P2|COMPLETED|Overall Study||14
5117805|NCT01507298|12590217|P1|COMPLETED|Overall Study||1
5117806|NCT01507298|12590216|P2|STARTED|Overall Study||20
5117807|NCT01507298|12590217|P1|STARTED|Overall Study||1
5117808|NCT01507246|12590227|P2|NOT COMPLETED|Overall Study||1
5117809|NCT01507246|12590228|P1|NOT COMPLETED|Overall Study||2
5117810|NCT01507246|12590227|P2|COMPLETED|Overall Study||21
5117811|NCT01507246|12590228|P1|COMPLETED|Overall Study||18
5117812|NCT01507246|12590227|P2|STARTED|Overall Study||22
5117813|NCT01507246|12590228|P1|STARTED|Overall Study||20
5117814|NCT01507233|12590242|P2|NOT COMPLETED|Overall Study||0
5117815|NCT01507233|12590243|P1|NOT COMPLETED|Overall Study||0
5117816|NCT01507233|12590242|P2|COMPLETED|Overall Study||0
5117817|NCT01507233|12590243|P1|COMPLETED|Overall Study||5
5117818|NCT01507233|12590242|P2|STARTED|Overall Study||0
5117819|NCT01507233|12590243|P1|STARTED|Overall Study||5
5117820|NCT01507220|12590255|P2|NOT COMPLETED|Overall Study||0
5117821|NCT01507220|12590256|P1|NOT COMPLETED|Overall Study||0
5117822|NCT01507220|12590255|P2|COMPLETED|Overall Study||0
5117823|NCT01507220|12590256|P1|COMPLETED|Overall Study||2
5117824|NCT01507220|12590255|P2|STARTED|Overall Study||0
5117825|NCT01507220|12590256|P1|STARTED|Overall Study||2
5117826|NCT01507181|12590270|P2|NOT COMPLETED|Overall Study||0
5117827|NCT01507181|12590271|P1|NOT COMPLETED|Overall Study||0
5117828|NCT01507181|12590270|P2|COMPLETED|Overall Study||12
5117829|NCT01507181|12590271|P1|COMPLETED|Overall Study||12
5117830|NCT01507181|12590270|P2|STARTED|Overall Study||12
5117831|NCT01507181|12590271|P1|STARTED|Overall Study||12
5117832|NCT01507155|12590291|P2|NOT COMPLETED|Overall Study||0
5117833|NCT01507155|12590292|P1|NOT COMPLETED|Overall Study||0
5117834|NCT01507155|12590291|P2|COMPLETED|Overall Study||60
5117835|NCT01507155|12590292|P1|COMPLETED|Overall Study||625
5117836|NCT01507155|12590291|P2|STARTED|Overall Study||60
5117837|NCT01507155|12590292|P1|STARTED|Overall Study||625
5117838|NCT01507103|12590301|P3|NOT COMPLETED|Overall Study||0
5117839|NCT01507103|12590302|P2|NOT COMPLETED|Overall Study||0
5117840|NCT01507103|12590303|P1|NOT COMPLETED|Overall Study||0
5117841|NCT01507103|12590301|P3|COMPLETED|Overall Study||42
5117842|NCT01507103|12590302|P2|COMPLETED|Overall Study||41
5117843|NCT01507103|12590303|P1|COMPLETED|Overall Study||41
5117844|NCT01507103|12590301|P3|STARTED|Overall Study||42
5117845|NCT01507103|12590302|P2|STARTED|Overall Study||41
5117846|NCT01507103|12590303|P1|STARTED|Overall Study||41
5117847|NCT01507090|12590326|P1|NOT COMPLETED|Overall Study||18
5117848|NCT01507090|12590326|P1|COMPLETED|Overall Study||624
5117849|NCT01507090|12590326|P1|STARTED|Overall Study||642
5117850|NCT01507051|12590365|P4|NOT COMPLETED|Overall Study||7
5117851|NCT01507051|12590366|P3|NOT COMPLETED|Overall Study||1
5117852|NCT01507051|12590367|P2|NOT COMPLETED|Overall Study||3
5117853|NCT01507051|12590368|P1|NOT COMPLETED|Overall Study||2
5117854|NCT01507051|12590365|P4|COMPLETED|Overall Study||0
5117855|NCT01507051|12590366|P3|COMPLETED|Overall Study||28
5117856|NCT01507051|12590367|P2|COMPLETED|Overall Study||28
5117857|NCT01507051|12590368|P1|COMPLETED|Overall Study||27
5117858|NCT01507051|12590365|P4|Received Placebo or Rivaroxaban|Overall Study||0
5117859|NCT01507051|12590366|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
5117860|NCT01507051|12590367|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
5117861|NCT01507051|12590368|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
5117862|NCT01507051|12590365|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
5117863|NCT01507051|12590366|P3|Warfarin run-in Phase|Overall Study||0
5117864|NCT01507051|12590367|P2|Warfarin run-in Phase|Overall Study||28
5117865|NCT01507051|12590368|P1|Warfarin run-in Phase|Overall Study||28
5117866|NCT01507051|12590365|P4|STARTED|Overall Study||7
5117867|NCT01507051|12590366|P3|STARTED|Overall Study||29
5117868|NCT01507051|12590367|P2|STARTED|Overall Study||31
5117869|NCT01507051|12590368|P1|STARTED|Overall Study||29
5117870|NCT01506960|12590486|P1|NOT COMPLETED|Overall Study||47
5117871|NCT01506960|12590486|P1|COMPLETED|Overall Study||17
5117872|NCT01506960|12590486|P1|STARTED|Overall Study||64
5117873|NCT01506947|12590492|P1|NOT COMPLETED|Overall Study||16
5117874|NCT01506947|12590492|P1|COMPLETED|Overall Study||49
5117875|NCT01506947|12590492|P1|STARTED|Overall Study||65
5117876|NCT01506908|12590510|P2|NOT COMPLETED|Overall Study||0
5117877|NCT01506908|12590511|P1|NOT COMPLETED|Overall Study||1
5117878|NCT01506908|12590510|P2|COMPLETED|Overall Study||161
5117879|NCT01506908|12590511|P1|COMPLETED|Overall Study||161
5117880|NCT01506908|12590510|P2|STARTED|Overall Study||161
5117881|NCT01506908|12590511|P1|STARTED|Overall Study||162
5117882|NCT01506882|12590529|P2|NOT COMPLETED|Overall Study||7
5117883|NCT01506882|12590530|P1|NOT COMPLETED|Overall Study||22
5117884|NCT01506882|12590529|P2|COMPLETED|Overall Study||3
5117885|NCT01506882|12590530|P1|COMPLETED|Overall Study||39
5117886|NCT01506882|12590529|P2|STARTED|Overall Study||10
5117887|NCT01506882|12590530|P1|STARTED|Overall Study||61
5117888|NCT01506726|12590544|P2|NOT COMPLETED|Overall Study||2
5117889|NCT01506726|12590545|P1|NOT COMPLETED|Overall Study||1
5117890|NCT01506726|12590544|P2|COMPLETED|Overall Study||3
5117891|NCT01506726|12590545|P1|COMPLETED|Overall Study||5
5117892|NCT01506726|12590544|P2|STARTED|Overall Study||5
5117893|NCT01506726|12590545|P1|STARTED|Overall Study||6
5117894|NCT01506596|12590585|P1|NOT COMPLETED|Overall Study||1
5117895|NCT01506596|12590585|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
5117896|NCT01506596|12590585|P1|STARTED|Overall Study||42
5117897|NCT01506479|12590596|P3|NOT COMPLETED|Overall Study||3
5117898|NCT01506479|12590597|P2|NOT COMPLETED|Overall Study||5
5117899|NCT01506479|12590598|P1|NOT COMPLETED|Overall Study||3
5117900|NCT01506479|12590596|P3|COMPLETED|Overall Study||42
5117901|NCT01506479|12590597|P2|COMPLETED|Overall Study||38
5117902|NCT01506479|12590598|P1|COMPLETED|Overall Study||37
5117903|NCT01506479|12590596|P3|STARTED|Overall Study||45
5117904|NCT01506479|12590597|P2|STARTED|Overall Study||43
5117905|NCT01506479|12590598|P1|STARTED|Overall Study||40
5117906|NCT01506453|12590612|P2|NOT COMPLETED|Overall Study||2
5117907|NCT01506453|12590613|P1|NOT COMPLETED|Overall Study||0
5117908|NCT01506453|12590612|P2|COMPLETED|Overall Study||24
5117909|NCT01506453|12590613|P1|COMPLETED|Overall Study||25
5117910|NCT01506453|12590612|P2|STARTED|Overall Study||26
5117911|NCT01506453|12590613|P1|STARTED|Overall Study||25
5117912|NCT01506362|12590623|P1|NOT COMPLETED|Overall Study||6
5117913|NCT01506362|12590623|P1|COMPLETED|Overall Study||16
5117914|NCT01506362|12590623|P1|STARTED|Overall Study||22
5117915|NCT01506323|12590629|P2|NOT COMPLETED|Overall Study||13
5117916|NCT01506323|12590630|P1|NOT COMPLETED|Overall Study||24
5117917|NCT01506323|12590629|P2|COMPLETED|Overall Study||71
5117918|NCT01506323|12590630|P1|COMPLETED|Overall Study||65
5117919|NCT01506323|12590629|P2|Post-treatment Completed CAPS|Overall Study||72
5117920|NCT01506323|12590630|P1|Post-treatment Completed CAPS|Overall Study||68
5117921|NCT01506323|12590629|P2|Post-treatment Completers|Overall Study||72
5117922|NCT01506323|12590630|P1|Post-treatment Completers|Overall Study||69
5117923|NCT01506323|12590629|P2|STARTED|Overall Study||84
5117924|NCT01506323|12590630|P1|STARTED|Overall Study||89
5117925|NCT01506271|12590659|P3|NOT COMPLETED|Overall Study||3
5117926|NCT01506271|12590660|P2|NOT COMPLETED|Overall Study||7
5117927|NCT01506271|12590661|P1|NOT COMPLETED|Overall Study||4
5117928|NCT01506271|12590659|P3|COMPLETED|Overall Study||114
5117929|NCT01506271|12590660|P2|COMPLETED|Overall Study||109
5117930|NCT01506271|12590661|P1|COMPLETED|Overall Study||114
5117931|NCT01506271|12590659|P3|Treated|Overall Study||114
5117932|NCT01506271|12590660|P2|Treated|Overall Study||116
5117933|NCT01506271|12590661|P1|Treated|Overall Study||117
5117934|NCT01506271|12590659|P3|STARTED|Overall Study||117
5117935|NCT01506271|12590660|P2|STARTED|Overall Study||116
5117936|NCT01506271|12590661|P1|STARTED|Overall Study||118
5117937|NCT01506193|12590723|P3|NOT COMPLETED|Overall Study||14
5117938|NCT01506193|12590724|P2|NOT COMPLETED|Overall Study||4
5117939|NCT01506193|12590725|P1|NOT COMPLETED|Overall Study||14
5117940|NCT01506193|12590723|P3|COMPLETED|Overall Study||168
5117941|NCT01506193|12590724|P2|COMPLETED|Overall Study||179
5117942|NCT01506193|12590725|P1|COMPLETED|Overall Study||337
5117943|NCT01506193|12590723|P3|STARTED|Overall Study||182
5117944|NCT01506193|12590724|P2|STARTED|Overall Study||183
5117945|NCT01506193|12590725|P1|STARTED|Overall Study||351
5117946|NCT01505933|12590758|P2|NOT COMPLETED|Overall Study||0
5117947|NCT01505933|12590759|P1|NOT COMPLETED|Overall Study||0
5117948|NCT01505933|12590758|P2|COMPLETED|Overall Study||14
5117949|NCT01505933|12590759|P1|COMPLETED|Overall Study||10
5117950|NCT01505933|12590758|P2|STARTED|Overall Study||14
5117951|NCT01505933|12590759|P1|STARTED|Overall Study||10
5117952|NCT01505881|12590771|P2|NOT COMPLETED|Overall Study||1
5117953|NCT01505881|12590772|P1|NOT COMPLETED|Overall Study||4
5117954|NCT01505881|12590771|P2|COMPLETED|Overall Study||58
5117955|NCT01505881|12590772|P1|COMPLETED|Overall Study||95
5117956|NCT01505881|12590771|P2|STARTED|Overall Study||59
5117957|NCT01505881|12590772|P1|STARTED|Overall Study||99
5117958|NCT01505764|12590786|P2|NOT COMPLETED|Overall Study||1
5117959|NCT01505764|12590787|P1|NOT COMPLETED|Overall Study||3
5117960|NCT01505764|12590786|P2|COMPLETED|Overall Study||2
5117961|NCT01505764|12590787|P1|COMPLETED|Overall Study||3
5117962|NCT01505764|12590786|P2|STARTED|Overall Study||3
5117963|NCT01505764|12590787|P1|STARTED|Overall Study||6
5117964|NCT01505673|12590817|P2|NOT COMPLETED|Overall Study||2
5117965|NCT01505673|12590818|P1|NOT COMPLETED|Overall Study||3
5117966|NCT01505673|12590817|P2|COMPLETED|Overall Study||34
5117967|NCT01505673|12590818|P1|COMPLETED|Overall Study||32
5117968|NCT01505673|12590817|P2|STARTED|Overall Study||36
5117969|NCT01505673|12590818|P1|STARTED|Overall Study||35
5117970|NCT01505647|12590878|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
5117971|NCT01505647|12590879|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
5117972|NCT01505647|12590878|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
5117973|NCT01505647|12590879|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
5117974|NCT01505647|12590878|P2|STARTED|Day 43 Through Day 182 Follow-up||166
5117975|NCT01505647|12590879|P1|STARTED|Day 43 Through Day 182 Follow-up||329
5117976|NCT01505647|12590878|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
5117977|NCT01505647|12590879|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
5117978|NCT01505647|12590878|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
5117979|NCT01505647|12590879|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
5117980|NCT01505647|12590878|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
5117981|NCT01505647|12590879|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
5117982|NCT01505647|12590878|P2|STARTED|Day 1 Through Day 42 Follow-up||166
5117983|NCT01505647|12590879|P1|STARTED|Day 1 Through Day 42 Follow-up||332
5117984|NCT01505634|12590896|P3|NOT COMPLETED|Overall Study||6
5117985|NCT01505634|12590897|P2|NOT COMPLETED|Overall Study||10
5117986|NCT01505634|12590898|P1|NOT COMPLETED|Overall Study||9
5117987|NCT01505634|12590896|P3|COMPLETED|Overall Study||94
5117988|NCT01505634|12590897|P2|COMPLETED|Overall Study||91
5117989|NCT01505634|12590898|P1|COMPLETED|Overall Study||92
5117990|NCT01505634|12590896|P3|Treated|Overall Study||100
5117991|NCT01505634|12590897|P2|Treated|Overall Study||99
5117992|NCT01505634|12590898|P1|Treated|Overall Study||99
5117993|NCT01505634|12590896|P3|STARTED|Overall Study||100
5117994|NCT01505634|12590897|P2|STARTED|Overall Study||101
5117995|NCT01505634|12590898|P1|STARTED|Overall Study||101
5117996|NCT01505608|12590953|P2|NOT COMPLETED|Phase II||2
5117997|NCT01505608|12590954|P1|NOT COMPLETED|Phase II||2
5117998|NCT01505608|12590953|P2|COMPLETED|Phase II||2
5117999|NCT01505608|12590954|P1|COMPLETED|Phase II||0
5118000|NCT01505608|12590953|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
5118001|NCT01505608|12590954|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
5118002|NCT01505608|12590953|P2|NOT COMPLETED|Phase I||6
5118003|NCT01505608|12590954|P1|NOT COMPLETED|Phase I||0
5118004|NCT01505608|12590953|P2|COMPLETED|Phase I||2
5118005|NCT01505608|12590954|P1|COMPLETED|Phase I||0
5118006|NCT01505608|12590953|P2|STARTED|Phase I||8
5118007|NCT01505608|12590954|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
5118008|NCT01505530|12590973|P3|NOT COMPLETED|Overall Study||41
5118009|NCT01505530|12590974|P2|NOT COMPLETED|Overall Study||43
5118010|NCT01505530|12590975|P1|NOT COMPLETED|Overall Study||41
5118011|NCT01505530|12590973|P3|COMPLETED|Overall Study||0
5118012|NCT01505530|12590974|P2|COMPLETED|Overall Study||0
5118013|NCT01505530|12590975|P1|COMPLETED|Overall Study||0
5118014|NCT01505530|12590973|P3|Completed One Cycle of Study Drug|Overall Study||31
5118015|NCT01505530|12590974|P2|Completed One Cycle of Study Drug|Overall Study||27
5118016|NCT01505530|12590975|P1|Completed One Cycle of Study Drug|Overall Study||29
5118017|NCT01505530|12590973|P3|Received At Least One Dose of Study Drug|Overall Study||41
5118018|NCT01505530|12590974|P2|Received At Least One Dose of Study Drug|Overall Study||42
5118019|NCT01505530|12590975|P1|Received At Least One Dose of Study Drug|Overall Study||41
5118020|NCT01505530|12590973|P3|STARTED|Overall Study||41
5118021|NCT01505530|12590974|P2|STARTED|Overall Study||43
5118022|NCT01505530|12590975|P1|STARTED|Overall Study||41
5118023|NCT01505491|12591019|P3|NOT COMPLETED|Overall Study||5
5118024|NCT01505491|12591020|P2|NOT COMPLETED|Overall Study||1
5118025|NCT01505491|12591021|P1|NOT COMPLETED|Overall Study||2
5118026|NCT01505491|12591019|P3|COMPLETED|Overall Study||59
5118027|NCT01505491|12591020|P2|COMPLETED|Overall Study||61
5118028|NCT01505491|12591021|P1|COMPLETED|Overall Study||65
5118029|NCT01505491|12591019|P3|STARTED|Overall Study||64
5118030|NCT01505491|12591020|P2|STARTED|Overall Study||62
5118031|NCT01505491|12591021|P1|STARTED|Overall Study||67
5118032|NCT01505465|12591043|P2|NOT COMPLETED|Overall Study||7
5118033|NCT01505465|12591044|P1|NOT COMPLETED|Overall Study||6
5118034|NCT01505465|12591043|P2|COMPLETED|Overall Study||18
5118035|NCT01505465|12591044|P1|COMPLETED|Overall Study||19
5118036|NCT01505465|12591043|P2|STARTED|Overall Study||25
5118037|NCT01505465|12591044|P1|STARTED|Overall Study||25
5118038|NCT01505387|12591060|P2|NOT COMPLETED|Overall Study||1
5118039|NCT01505387|12591061|P1|NOT COMPLETED|Overall Study||2
5118040|NCT01505387|12591060|P2|COMPLETED|Overall Study||24
5118041|NCT01505387|12591061|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
5118042|NCT01505387|12591060|P2|Treated|Overall Study||24
5118043|NCT01505387|12591061|P1|Treated|Overall Study||24
5118044|NCT01505387|12591060|P2|STARTED|Overall Study||25
5118045|NCT01505387|12591061|P1|STARTED|Overall Study||25
5118046|NCT01505374|12591067|P2|NOT COMPLETED|Overall Study||0
5118047|NCT01505374|12591068|P1|NOT COMPLETED|Overall Study||1
5118048|NCT01505374|12591067|P2|COMPLETED|Overall Study||30
5118049|NCT01505374|12591068|P1|COMPLETED|Overall Study||29
5118050|NCT01505374|12591067|P2|STARTED|Overall Study||30
5118051|NCT01505374|12591068|P1|STARTED|Overall Study||30
5118052|NCT01505179|12591084|P2|NOT COMPLETED|Overall Study||0
5118053|NCT01505179|12591085|P1|NOT COMPLETED|Overall Study||0
5118054|NCT01505179|12591084|P2|COMPLETED|Overall Study||4
5118055|NCT01505179|12591085|P1|COMPLETED|Overall Study||6
5118056|NCT01505179|12591084|P2|STARTED|Overall Study||4
5118057|NCT01505179|12591085|P1|STARTED|Overall Study||6
5118058|NCT01505166|12591100|P3|NOT COMPLETED|Overall Study||0
5118059|NCT01505166|12591101|P2|NOT COMPLETED|Overall Study||0
5118060|NCT01505166|12591102|P1|NOT COMPLETED|Overall Study||0
5118061|NCT01505166|12591100|P3|COMPLETED|Overall Study||0
5118062|NCT01505166|12591101|P2|COMPLETED|Overall Study||0
5118063|NCT01505166|12591102|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
5118064|NCT01505166|12591100|P3|STARTED|Overall Study||0
5118065|NCT01505166|12591101|P2|STARTED|Overall Study||0
5118066|NCT01505166|12591102|P1|STARTED|Overall Study||3
5118067|NCT01505114|12591118|P4|NOT COMPLETED|Overall Study||23
5118068|NCT01505114|12591119|P3|NOT COMPLETED|Overall Study||18
5118069|NCT01505114|12591120|P2|NOT COMPLETED|Overall Study||13
5118070|NCT01505114|12591121|P1|NOT COMPLETED|Overall Study||25
5118071|NCT01505114|12591118|P4|COMPLETED|Overall Study||128
5118072|NCT01505114|12591119|P3|COMPLETED|Overall Study||129
5118073|NCT01505114|12591120|P2|COMPLETED|Overall Study||135
5118074|NCT01505114|12591121|P1|COMPLETED|Overall Study||123
5118075|NCT01505114|12591118|P4|STARTED|Overall Study||151
5118076|NCT01505114|12591119|P3|STARTED|Overall Study||147
5118077|NCT01505114|12591120|P2|STARTED|Overall Study||148
5118078|NCT01505114|12591121|P1|STARTED|Overall Study||148
5118079|NCT01505062|12591134|P3|NOT COMPLETED|Overall Study||0
5118080|NCT01505062|12591135|P2|NOT COMPLETED|Overall Study||0
5118081|NCT01505062|12591136|P1|NOT COMPLETED|Overall Study||0
5118082|NCT01505062|12591134|P3|COMPLETED|Overall Study||3
5118083|NCT01505062|12591135|P2|COMPLETED|Overall Study||3
5118084|NCT01505062|12591136|P1|COMPLETED|Overall Study||3
5118085|NCT01505062|12591134|P3|STARTED|Overall Study||3
5118086|NCT01505062|12591135|P2|STARTED|Overall Study||3
5118087|NCT01505062|12591136|P1|STARTED|Overall Study||3
5118088|NCT01505010|12591149|P2|NOT COMPLETED|Overall Study||2
5118089|NCT01505010|12591150|P1|NOT COMPLETED|Overall Study||0
5118090|NCT01505010|12591149|P2|COMPLETED|Overall Study||6
5118091|NCT01505010|12591150|P1|COMPLETED|Overall Study||9
5118092|NCT01505010|12591149|P2|STARTED|Overall Study||8
5118093|NCT01505010|12591150|P1|STARTED|Overall Study||9
5118094|NCT01504997|12591160|P1|NOT COMPLETED|Overall Study||0
5118095|NCT01504997|12591160|P1|COMPLETED|Overall Study||18
5118096|NCT01504997|12591160|P1|STARTED|Overall Study||18
5118097|NCT01504971|12591164|P1|NOT COMPLETED|Overall Study||13
5118098|NCT01504971|12591164|P1|COMPLETED|Overall Study||82
5118099|NCT01504971|12591164|P1|STARTED|Overall Study||95
5118100|NCT01504958|12591175|P3|NOT COMPLETED|Overall Study||0
5118101|NCT01504958|12591176|P2|NOT COMPLETED|Overall Study||0
5118102|NCT01504958|12591177|P1|NOT COMPLETED|Overall Study||0
5118103|NCT01504958|12591175|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
5118104|NCT01504958|12591176|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
5118105|NCT01504958|12591177|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
5118106|NCT01504958|12591175|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
5118107|NCT01504958|12591176|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
5118108|NCT01504958|12591177|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
5118109|NCT01504867|12591193|P2|NOT COMPLETED|Overall Study||3
5118110|NCT01504867|12591194|P1|NOT COMPLETED|Overall Study||7
5118111|NCT01504867|12591193|P2|COMPLETED|Overall Study||195
5118112|NCT01504867|12591194|P1|COMPLETED|Overall Study||195
5118113|NCT01504867|12591193|P2|STARTED|Overall Study||198
5118114|NCT01504867|12591194|P1|STARTED|Overall Study||202
5118115|NCT01504854|12591214|P2|NOT COMPLETED|Overall Study||7
5118116|NCT01504854|12591215|P1|NOT COMPLETED|Overall Study||8
5118117|NCT01504854|12591214|P2|COMPLETED|Overall Study||48
5118118|NCT01504854|12591215|P1|COMPLETED|Overall Study||56
5118119|NCT01504854|12591214|P2|STARTED|Overall Study||55
5118120|NCT01504854|12591215|P1|STARTED|Overall Study||64
5118121|NCT01504841|12591232|P3|NOT COMPLETED|Overall Study||0
5118122|NCT01504841|12591233|P2|NOT COMPLETED|Overall Study||4
5118123|NCT01504841|12591234|P1|NOT COMPLETED|Overall Study||16
5118124|NCT01504841|12591232|P3|COMPLETED|Overall Study||0
5118125|NCT01504841|12591233|P2|COMPLETED|Overall Study||2
5118126|NCT01504841|12591234|P1|COMPLETED|Overall Study||4
5118127|NCT01504841|12591232|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
5118128|NCT01504841|12591233|P2|STARTED|Overall Study||6
5118129|NCT01504841|12591234|P1|STARTED|Overall Study||20
5118130|NCT01504477|12591267|P1|NOT COMPLETED|Overall Study||0
5118131|NCT01504477|12591267|P1|COMPLETED|Overall Study||6
5118132|NCT01504477|12591267|P1|STARTED|Overall Study||6
5118133|NCT01504412|12591280|P5|NOT COMPLETED|Overall Study||13
5118134|NCT01504412|12591281|P4|NOT COMPLETED|Overall Study||19
5118135|NCT01504412|12591282|P3|NOT COMPLETED|Overall Study||4
5118136|NCT01504412|12591283|P2|NOT COMPLETED|Overall Study||12
5118137|NCT01504412|12591284|P1|NOT COMPLETED|Overall Study||5
5118138|NCT01504412|12591280|P5|COMPLETED|Overall Study||77
5118139|NCT01504412|12591281|P4|COMPLETED|Overall Study||75
5118140|NCT01504412|12591282|P3|COMPLETED|Overall Study||86
5118141|NCT01504412|12591283|P2|COMPLETED|Overall Study||75
5118142|NCT01504412|12591284|P1|COMPLETED|Overall Study||84
5118143|NCT01504412|12591280|P5|STARTED|Overall Study||90
5118144|NCT01504412|12591281|P4|STARTED|Overall Study||94
5118145|NCT01504412|12591282|P3|STARTED|Overall Study||90
5118146|NCT01504412|12591283|P2|STARTED|Overall Study||87
5118147|NCT01504412|12591284|P1|STARTED|Overall Study||89
5118148|NCT01504204|12591303|P2|NOT COMPLETED|Overall Study||1
5118149|NCT01504204|12591304|P1|NOT COMPLETED|Overall Study||1
5118150|NCT01504204|12591303|P2|COMPLETED|Overall Study||9
5118151|NCT01504204|12591304|P1|COMPLETED|Overall Study||9
5118152|NCT01504204|12591303|P2|STARTED|Overall Study||10
5118153|NCT01504204|12591304|P1|STARTED|Overall Study||10
5118154|NCT01503749|12591317|P3|NOT COMPLETED|Overall Study||0
5118155|NCT01503749|12591318|P2|NOT COMPLETED|Overall Study||0
5118156|NCT01503749|12591319|P1|NOT COMPLETED|Overall Study||0
5118157|NCT01503749|12591317|P3|COMPLETED|Overall Study||3
5118158|NCT01503749|12591318|P2|COMPLETED|Overall Study||3
5118159|NCT01503749|12591319|P1|COMPLETED|Overall Study||3
5118160|NCT01503749|12591317|P3|STARTED|Overall Study||3
5118161|NCT01503749|12591318|P2|STARTED|Overall Study||3
5118162|NCT01503749|12591319|P1|STARTED|Overall Study||3
5118163|NCT01503333|12591332|P2|NOT COMPLETED|Overall Study||305
5118164|NCT01503333|12591333|P1|NOT COMPLETED|Overall Study||340
5118165|NCT01503333|12591332|P2|COMPLETED|Overall Study||461
5118166|NCT01503333|12591333|P1|COMPLETED|Overall Study||437
5118167|NCT01503333|12591332|P2|Completed Post-intervention|Overall Study||706
5118168|NCT01503333|12591333|P1|Completed Post-intervention|Overall Study||680
5118169|NCT01503333|12591332|P2|Completed Baseline|Overall Study||753
5118170|NCT01503333|12591333|P1|Completed Baseline|Overall Study||766
5118171|NCT01503333|12591332|P2|STARTED|Overall Study||766
5118172|NCT01503333|12591333|P1|STARTED|Overall Study||777
5118173|NCT01503164|12591361|P2|NOT COMPLETED|Overall Study||1
5118174|NCT01503164|12591362|P1|NOT COMPLETED|Overall Study||2
5118175|NCT01503164|12591361|P2|COMPLETED|Overall Study||55
5118176|NCT01503164|12591362|P1|COMPLETED|Overall Study||53
5118177|NCT01503164|12591361|P2|STARTED|Overall Study||56
5118178|NCT01503164|12591362|P1|STARTED|Overall Study||55
5118179|NCT01503021|12591392|P2|NOT COMPLETED|Overall Study||26
5118180|NCT01503021|12591393|P1|NOT COMPLETED|Overall Study||27
5118181|NCT01503021|12591392|P2|COMPLETED|Overall Study||332
5118182|NCT01503021|12591393|P1|COMPLETED|Overall Study||333
5118183|NCT01503021|12591392|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
5118184|NCT01503021|12591393|P1|Completed Treatment|Overall Study||333
5118185|NCT01503021|12591392|P2|Dosed|Overall Study||352
5118186|NCT01503021|12591393|P1|Dosed|Overall Study||351
5118187|NCT01503021|12591392|P2|STARTED|Overall Study||358
5118188|NCT01503021|12591393|P1|STARTED|Overall Study||360
5118189|NCT01502956|12591442|P2|NOT COMPLETED|Overall Study||26
5118190|NCT01502956|12591443|P1|NOT COMPLETED|Overall Study||24
5118191|NCT01502956|12591442|P2|COMPLETED|Overall Study||168
5118192|NCT01502956|12591443|P1|COMPLETED|Overall Study||168
5118193|NCT01502956|12591442|P2|STARTED|Overall Study||194
5118194|NCT01502956|12591443|P1|STARTED|Overall Study||192
5118195|NCT01502787|12591467|P2|NOT COMPLETED|Overall Study||0
5118196|NCT01502787|12591468|P1|NOT COMPLETED|Overall Study||0
5118197|NCT01502787|12591467|P2|COMPLETED|Overall Study||10
5118198|NCT01502787|12591468|P1|COMPLETED|Overall Study||11
5118199|NCT01502787|12591467|P2|STARTED|Overall Study||10
5118200|NCT01502787|12591468|P1|STARTED|Overall Study||11
5118201|NCT01502761|12591482|P4|NOT COMPLETED|Overall Study||0
5118202|NCT01502761|12591483|P3|NOT COMPLETED|Overall Study||0
5118203|NCT01502761|12591484|P2|NOT COMPLETED|Overall Study||0
5118204|NCT01502761|12591485|P1|NOT COMPLETED|Overall Study||0
5118205|NCT01502761|12591482|P4|COMPLETED|Overall Study||0
5118206|NCT01502761|12591483|P3|COMPLETED|Overall Study||0
5118207|NCT01502761|12591484|P2|COMPLETED|Overall Study||0
5118208|NCT01502761|12591485|P1|COMPLETED|Overall Study||4
5118209|NCT01502761|12591482|P4|STARTED|Overall Study||0
5118210|NCT01502761|12591483|P3|STARTED|Overall Study||0
5118211|NCT01502761|12591484|P2|STARTED|Overall Study||0
5118212|NCT01502761|12591485|P1|STARTED|Overall Study||4
5118213|NCT01502709|12591501|P2|NOT COMPLETED|Overall Study||0
5118214|NCT01502709|12591502|P1|NOT COMPLETED|Overall Study||4
5118215|NCT01502709|12591501|P2|COMPLETED|Overall Study||0
5118216|NCT01502709|12591502|P1|COMPLETED|Overall Study||1
5118217|NCT01502709|12591501|P2|STARTED|Overall Study||0
5118218|NCT01502709|12591502|P1|STARTED|Overall Study||5
5118219|NCT01502644|12591515|P4|NOT COMPLETED|Assigned to NA Groups||8
5118220|NCT01502644|12591516|P3|NOT COMPLETED|Assigned to NA Groups||3
5118221|NCT01502644|12591517|P2|NOT COMPLETED|Assigned to NA Groups||6
5118222|NCT01502644|12591518|P1|NOT COMPLETED|Assigned to NA Groups||0
5118223|NCT01502644|12591515|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
5118224|NCT01502644|12591516|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
5118225|NCT01502644|12591517|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
5118226|NCT01502644|12591518|P1|COMPLETED|Assigned to NA Groups||0
5118227|NCT01502644|12591515|P4|STARTED|Assigned to NA Groups||32
5118228|NCT01502644|12591516|P3|STARTED|Assigned to NA Groups||10
5118229|NCT01502644|12591517|P2|STARTED|Assigned to NA Groups||30
5118230|NCT01502644|12591518|P1|STARTED|Assigned to NA Groups||0
5118231|NCT01502644|12591515|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118232|NCT01502644|12591516|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118233|NCT01502644|12591517|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118234|NCT01502644|12591518|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
5118235|NCT01502644|12591515|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118236|NCT01502644|12591516|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118237|NCT01502644|12591517|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
5118238|NCT01502644|12591518|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
5118239|NCT01502644|12591515|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
5118240|NCT01502644|12591516|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
5118241|NCT01502644|12591517|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
5118242|NCT01502644|12591518|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
5118243|NCT01502423|12591528|P2|NOT COMPLETED|Overall Study||1
5118244|NCT01502423|12591529|P1|NOT COMPLETED|Overall Study||0
5118245|NCT01502423|12591528|P2|COMPLETED|Overall Study||29
5118246|NCT01502423|12591529|P1|COMPLETED|Overall Study||31
5118247|NCT01502423|12591528|P2|STARTED|Overall Study||30
5118248|NCT01502423|12591529|P1|STARTED|Overall Study||31
5118249|NCT01502410|12591551|P4|NOT COMPLETED|Overall Study||0
5118250|NCT01502410|12591552|P3|NOT COMPLETED|Overall Study||0
5118251|NCT01502410|12591553|P2|NOT COMPLETED|Overall Study||10
5118252|NCT01502410|12591554|P1|NOT COMPLETED|Overall Study||10
5118253|NCT01502410|12591551|P4|COMPLETED|Overall Study||0
5118254|NCT01502410|12591552|P3|COMPLETED|Overall Study||0
5118255|NCT01502410|12591553|P2|COMPLETED|Overall Study||0
5118256|NCT01502410|12591554|P1|COMPLETED|Overall Study||0
5118257|NCT01502410|12591551|P4|STARTED|Overall Study||0
5118258|NCT01502410|12591552|P3|STARTED|Overall Study||0
5118259|NCT01502410|12591553|P2|STARTED|Overall Study||10
5118260|NCT01502410|12591554|P1|STARTED|Overall Study||10
5118261|NCT01502371|12591572|P5|NOT COMPLETED|Overall Study||52
5118262|NCT01502371|12591573|P4|NOT COMPLETED|Overall Study||37
5118263|NCT01502371|12591574|P3|NOT COMPLETED|Overall Study||25
5118264|NCT01502371|12591575|P2|NOT COMPLETED|Overall Study||32
5118265|NCT01502371|12591576|P1|NOT COMPLETED|Overall Study||41
5118266|NCT01502371|12591572|P5|COMPLETED|Overall Study||60
5118267|NCT01502371|12591573|P4|COMPLETED|Overall Study||88
5118268|NCT01502371|12591574|P3|COMPLETED|Overall Study||83
5118269|NCT01502371|12591575|P2|COMPLETED|Overall Study||81
5118270|NCT01502371|12591576|P1|COMPLETED|Overall Study||79
5118271|NCT01502371|12591572|P5|STARTED|Overall Study||112
5118272|NCT01502371|12591573|P4|STARTED|Overall Study||125
5118273|NCT01502371|12591574|P3|STARTED|Overall Study||108
5118274|NCT01502371|12591575|P2|STARTED|Overall Study||113
5118275|NCT01502371|12591576|P1|STARTED|Overall Study||120
5118276|NCT01502332|12591601|P2|NOT COMPLETED|Overall Study||0
5118277|NCT01502332|12591602|P1|NOT COMPLETED|Overall Study||0
5118278|NCT01502332|12591601|P2|COMPLETED|Overall Study||163
5118279|NCT01502332|12591602|P1|COMPLETED|Overall Study||157
5118280|NCT01502332|12591601|P2|STARTED|Overall Study||163
5118281|NCT01502332|12591602|P1|STARTED|Overall Study||157
5118282|NCT01502306|12591619|P3|NOT COMPLETED|Overall Study||0
5118283|NCT01502306|12591620|P2|NOT COMPLETED|Overall Study||0
5118284|NCT01502306|12591621|P1|NOT COMPLETED|Overall Study||0
5118285|NCT01502306|12591619|P3|COMPLETED|Overall Study||1407
5118286|NCT01502306|12591620|P2|COMPLETED|Overall Study||1405
5118287|NCT01502306|12591621|P1|COMPLETED|Overall Study||1004
5118288|NCT01502306|12591619|P3|STARTED|Overall Study||1407
5118289|NCT01502306|12591620|P2|STARTED|Overall Study||1405
5118290|NCT01502306|12591621|P1|STARTED|Overall Study||1004
5118291|NCT01502293|12591641|P3|NOT COMPLETED|Overall Study||4
5118292|NCT01502293|12591642|P2|NOT COMPLETED|Overall Study||17
5118293|NCT01502293|12591643|P1|NOT COMPLETED|Overall Study||25
5118294|NCT01502293|12591641|P3|COMPLETED|Overall Study||0
5118295|NCT01502293|12591642|P2|COMPLETED|Overall Study||0
5118296|NCT01502293|12591643|P1|COMPLETED|Overall Study||5
5118297|NCT01502293|12591641|P3|STARTED|Overall Study||4
5118298|NCT01502293|12591642|P2|STARTED|Overall Study||17
5118299|NCT01502293|12591643|P1|STARTED|Overall Study||30
5118300|NCT01502228|12591672|P1|NOT COMPLETED|Overall Study||1
5118301|NCT01502228|12591672|P1|COMPLETED|Overall Study||13
5118302|NCT01502228|12591672|P1|STARTED|Overall Study||14
5118303|NCT01502033|12591677|P1|NOT COMPLETED|Overall Study||3
5118304|NCT01502033|12591677|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
5118305|NCT01502033|12591677|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
5118306|NCT01501955|12591685|P2|NOT COMPLETED|Overall Study||3
5118307|NCT01501955|12591686|P1|NOT COMPLETED|Overall Study||2
5118308|NCT01501955|12591685|P2|COMPLETED|Overall Study||6
5118309|NCT01501955|12591686|P1|COMPLETED|Overall Study||9
5118310|NCT01501955|12591685|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
5118311|NCT01501955|12591686|P1|2 Years Postop|Overall Study||9
5118312|NCT01501955|12591685|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
5118313|NCT01501955|12591686|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
5118314|NCT01501955|12591685|P2|6 Weeks Postop|Overall Study||9
5118315|NCT01501955|12591686|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
5118316|NCT01501955|12591685|P2|Surgery|Overall Study||9
5118317|NCT01501955|12591686|P1|Surgery|Overall Study||11
5118318|NCT01501955|12591685|P2|STARTED|Overall Study||9
5118319|NCT01501955|12591686|P1|STARTED|Overall Study||11
5118320|NCT01501929|12591728|P2|NOT COMPLETED|Second Intervention||0
5118321|NCT01501929|12591729|P1|NOT COMPLETED|Second Intervention||0
5118322|NCT01501929|12591728|P2|COMPLETED|Second Intervention||17
5118323|NCT01501929|12591729|P1|COMPLETED|Second Intervention||8
5118324|NCT01501929|12591728|P2|STARTED|Second Intervention||17
5118325|NCT01501929|12591729|P1|STARTED|Second Intervention||8
5118326|NCT01501929|12591728|P2|NOT COMPLETED|First Intervention||0
5118327|NCT01501929|12591729|P1|NOT COMPLETED|First Intervention||0
5118328|NCT01501929|12591728|P2|COMPLETED|First Intervention||17
5118329|NCT01501929|12591729|P1|COMPLETED|First Intervention||8
5118330|NCT01501929|12591728|P2|STARTED|First Intervention||17
5118331|NCT01501929|12591729|P1|STARTED|First Intervention||8
5118332|NCT01501162|12591739|P2|NOT COMPLETED|Overall Study||5
5118333|NCT01501162|12591740|P1|NOT COMPLETED|Overall Study||8
5118334|NCT01501162|12591739|P2|COMPLETED|Overall Study||60
5118335|NCT01501162|12591740|P1|COMPLETED|Overall Study||57
5118336|NCT01501162|12591739|P2|STARTED|Overall Study||65
5118337|NCT01501162|12591740|P1|STARTED|Overall Study||65
5118338|NCT01501110|12591750|P2|NOT COMPLETED|Overall Study||1
5118339|NCT01501110|12591751|P1|NOT COMPLETED|Overall Study||0
5118340|NCT01501110|12591750|P2|COMPLETED|Overall Study||33
5118341|NCT01501110|12591751|P1|COMPLETED|Overall Study||34
5118342|NCT01501110|12591750|P2|STARTED|Overall Study||34
5118343|NCT01501110|12591751|P1|STARTED|Overall Study||34
5118344|NCT01500772|12591757|P1|NOT COMPLETED|Overall Study||6
5118345|NCT01500772|12591757|P1|COMPLETED|Overall Study||0
5118346|NCT01500772|12591757|P1|STARTED|Overall Study||6
5118347|NCT01500759|12591766|P2|NOT COMPLETED|Overall Study||0
5118348|NCT01500759|12591767|P1|NOT COMPLETED|Overall Study||0
5118349|NCT01500759|12591766|P2|COMPLETED|Overall Study||3190
5118350|NCT01500759|12591767|P1|COMPLETED|Overall Study||3686
5118351|NCT01500759|12591766|P2|STARTED|Overall Study||3190
5118352|NCT01500759|12591767|P1|STARTED|Overall Study||3686
5118353|NCT01500746|12591818|P2|NOT COMPLETED|Overall Study||0
5118354|NCT01500746|12591819|P1|NOT COMPLETED|Overall Study||0
5118355|NCT01500746|12591818|P2|COMPLETED|Overall Study||4
5118356|NCT01500746|12591819|P1|COMPLETED|Overall Study||4
5118357|NCT01500746|12591818|P2|STARTED|Overall Study||4
5118358|NCT01500746|12591819|P1|STARTED|Overall Study||4
5118359|NCT01500733|12591827|P2|NOT COMPLETED|Overall Study||3
5118360|NCT01500733|12591828|P1|NOT COMPLETED|Overall Study||2
5118361|NCT01500733|12591827|P2|COMPLETED|Overall Study||48
5118362|NCT01500733|12591828|P1|COMPLETED|Overall Study||33
5118363|NCT01500733|12591827|P2|STARTED|Overall Study||51
5118364|NCT01500733|12591828|P1|STARTED|Overall Study||35
5118365|NCT01500720|12591836|P2|NOT COMPLETED|Overall Study||9
5118366|NCT01500720|12591837|P1|NOT COMPLETED|Overall Study||5
5118367|NCT01500720|12591836|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
5118368|NCT01500720|12591837|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
5118369|NCT01500720|12591836|P2|Treated|Overall Study||88
5118370|NCT01500720|12591837|P1|Treated|Overall Study||89
5118371|NCT01500720|12591836|P2|STARTED|Overall Study|Randomized|89
5118372|NCT01500720|12591837|P1|STARTED|Overall Study|Randomized|90
5118373|NCT01500694|12591851|P2|NOT COMPLETED|Overall Study||29
5118374|NCT01500694|12591852|P1|NOT COMPLETED|Overall Study||52
5118375|NCT01500694|12591851|P2|COMPLETED|Overall Study||54
5118376|NCT01500694|12591852|P1|COMPLETED|Overall Study||79
5118377|NCT01500694|12591851|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
5118378|NCT01500694|12591852|P1|STARTED|Overall Study||131
5118379|NCT01500629|12591878|P2|NOT COMPLETED|Period 2 (Single Dose)||0
5118380|NCT01500629|12591879|P1|NOT COMPLETED|Period 2 (Single Dose)||0
5118381|NCT01500629|12591878|P2|COMPLETED|Period 2 (Single Dose)||10
5118382|NCT01500629|12591879|P1|COMPLETED|Period 2 (Single Dose)||10
5118383|NCT01500629|12591878|P2|STARTED|Period 2 (Single Dose)||10
5118384|NCT01500629|12591879|P1|STARTED|Period 2 (Single Dose)||10
5118385|NCT01500629|12591878|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
5118386|NCT01500629|12591879|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
5118387|NCT01500629|12591878|P2|COMPLETED|Washout Period of 14 to 30 Days||10
5118388|NCT01500629|12591879|P1|COMPLETED|Washout Period of 14 to 30 Days||10
5118389|NCT01500629|12591878|P2|STARTED|Washout Period of 14 to 30 Days||10
5118390|NCT01500629|12591879|P1|STARTED|Washout Period of 14 to 30 Days||11
5118391|NCT01500629|12591878|P2|NOT COMPLETED|Period 1 (Single Dose)||0
5118392|NCT01500629|12591879|P1|NOT COMPLETED|Period 1 (Single Dose)||0
5118393|NCT01500629|12591878|P2|COMPLETED|Period 1 (Single Dose)||10
5118394|NCT01500629|12591879|P1|COMPLETED|Period 1 (Single Dose)||11
5118395|NCT01500629|12591878|P2|STARTED|Period 1 (Single Dose)||10
5118396|NCT01500629|12591879|P1|STARTED|Period 1 (Single Dose)||11
5118397|NCT01500434|12591963|P1|NOT COMPLETED|Overall Study||7
5118398|NCT01500434|12591963|P1|COMPLETED|Overall Study||95
5118399|NCT01500434|12591963|P1|STARTED|Overall Study||102
5118400|NCT01500382|12591996|P4|NOT COMPLETED|Treatment Period 2||0
5118401|NCT01500382|12591997|P3|NOT COMPLETED|Treatment Period 2||0
5118402|NCT01500382|12591998|P2|NOT COMPLETED|Treatment Period 2||0
5118403|NCT01500382|12591999|P1|NOT COMPLETED|Treatment Period 2||0
5118404|NCT01500382|12591996|P4|COMPLETED|Treatment Period 2||1
5118405|NCT01500382|12591997|P3|COMPLETED|Treatment Period 2||0
5118406|NCT01500382|12591998|P2|COMPLETED|Treatment Period 2||1
5118407|NCT01500382|12591999|P1|COMPLETED|Treatment Period 2||1
5118408|NCT01500382|12591996|P4|STARTED|Treatment Period 2||1
5118409|NCT01500382|12591997|P3|STARTED|Treatment Period 2||0
5118410|NCT01500382|12591998|P2|STARTED|Treatment Period 2||1
5118411|NCT01500382|12591999|P1|STARTED|Treatment Period 2||1
5118412|NCT01500382|12591996|P4|NOT COMPLETED|Washout Period||0
5118413|NCT01500382|12591997|P3|NOT COMPLETED|Washout Period||1
5118414|NCT01500382|12591998|P2|NOT COMPLETED|Washout Period||0
5118415|NCT01500382|12591999|P1|NOT COMPLETED|Washout Period||0
5118416|NCT01500382|12591996|P4|COMPLETED|Washout Period||1
5118417|NCT01500382|12591997|P3|COMPLETED|Washout Period||0
5118418|NCT01500382|12591998|P2|COMPLETED|Washout Period||1
5118419|NCT01500382|12591999|P1|COMPLETED|Washout Period||1
5118420|NCT01500382|12591996|P4|STARTED|Washout Period||1
5118421|NCT01500382|12591997|P3|STARTED|Washout Period||1
5118422|NCT01500382|12591998|P2|STARTED|Washout Period||1
5118423|NCT01500382|12591999|P1|STARTED|Washout Period||1
5118424|NCT01500382|12591996|P4|NOT COMPLETED|Treatment Period 1||0
5118425|NCT01500382|12591997|P3|NOT COMPLETED|Treatment Period 1||0
5118426|NCT01500382|12591998|P2|NOT COMPLETED|Treatment Period 1||0
5118427|NCT01500382|12591999|P1|NOT COMPLETED|Treatment Period 1||0
5118428|NCT01500382|12591996|P4|COMPLETED|Treatment Period 1||1
5118429|NCT01500382|12591997|P3|COMPLETED|Treatment Period 1||1
5118430|NCT01500382|12591998|P2|COMPLETED|Treatment Period 1||1
5118431|NCT01500382|12591999|P1|COMPLETED|Treatment Period 1||1
5118432|NCT01500382|12591996|P4|STARTED|Treatment Period 1||1
5118433|NCT01500382|12591997|P3|STARTED|Treatment Period 1||1
5118434|NCT01500382|12591998|P2|STARTED|Treatment Period 1||1
5118435|NCT01500382|12591999|P1|STARTED|Treatment Period 1||1
5118436|NCT01500317|12592024|P3|NOT COMPLETED|Overall Study||0
5118437|NCT01500317|12592025|P2|NOT COMPLETED|Overall Study||2
5118438|NCT01500317|12592026|P1|NOT COMPLETED|Overall Study||3
5118439|NCT01500317|12592024|P3|COMPLETED|Overall Study||13
5118440|NCT01500317|12592025|P2|COMPLETED|Overall Study||10
5118441|NCT01500317|12592026|P1|COMPLETED|Overall Study||10
5118442|NCT01500317|12592024|P3|STARTED|Overall Study||13
5118443|NCT01500317|12592025|P2|STARTED|Overall Study||12
5118444|NCT01500317|12592026|P1|STARTED|Overall Study||13
5118445|NCT01500278|12592048|P2|NOT COMPLETED|Week 13 - Week 104||126
5118446|NCT01500278|12592049|P1|NOT COMPLETED|Week 13 - Week 104||139
5118447|NCT01500278|12592048|P2|COMPLETED|Week 13 - Week 104||302
5118448|NCT01500278|12592049|P1|COMPLETED|Week 13 - Week 104||287
5118449|NCT01500278|12592048|P2|STARTED|Week 13 - Week 104||428
5118450|NCT01500278|12592049|P1|STARTED|Week 13 - Week 104||426
5118451|NCT01500278|12592048|P2|NOT COMPLETED|Week 0 - Week 12||30
5118452|NCT01500278|12592049|P1|NOT COMPLETED|Week 0 - Week 12||31
5118453|NCT01500278|12592048|P2|COMPLETED|Week 0 - Week 12||428
5118454|NCT01500278|12592049|P1|COMPLETED|Week 0 - Week 12||426
5118455|NCT01500278|12592048|P2|STARTED|Week 0 - Week 12||458
5118456|NCT01500278|12592049|P1|STARTED|Week 0 - Week 12||457
5118457|NCT01500252|12592073|P2|NOT COMPLETED|Overall Study||6
5118458|NCT01500252|12592074|P1|NOT COMPLETED|Overall Study||9
5118459|NCT01500252|12592073|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
5118460|NCT01500252|12592074|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
5118461|NCT01500252|12592073|P2|Ten Years|Overall Study||11
5118462|NCT01500252|12592074|P1|Ten Years|Overall Study||12
5118463|NCT01500252|12592073|P2|Five Years|Overall Study||13
5118464|NCT01500252|12592074|P1|Five Years|Overall Study||17
5118465|NCT01500252|12592073|P2|One Years|Overall Study||16
5118466|NCT01500252|12592074|P1|One Years|Overall Study||20
5118467|NCT01500252|12592073|P2|STARTED|Overall Study||17
5118468|NCT01500252|12592074|P1|STARTED|Overall Study||21
5118469|NCT01500226|12592100|P2|NOT COMPLETED|Overall Study||494
5118470|NCT01500226|12592101|P1|NOT COMPLETED|Overall Study||499
5118471|NCT01500226|12592100|P2|COMPLETED|Overall Study||191
5118472|NCT01500226|12592101|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
5118473|NCT01500226|12592100|P2|STARTED|Overall Study||685
5118474|NCT01500226|12592101|P1|STARTED|Overall Study|Number of randomized patients|684
5118475|NCT01500213|12592113|P2|NOT COMPLETED|Overall Study||224
5118476|NCT01500213|12592114|P1|NOT COMPLETED|Overall Study||217
5118477|NCT01500213|12592113|P2|COMPLETED|Overall Study||53
5118478|NCT01500213|12592114|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
5118479|NCT01500213|12592113|P2|STARTED|Overall Study||277
5118480|NCT01500213|12592114|P1|STARTED|Overall Study|Number of randomized patients|278
5118481|NCT01500200|12592127|P6|NOT COMPLETED|Stage 2||4
5118482|NCT01500200|12592128|P5|NOT COMPLETED|Stage 2||5
5118483|NCT01500200|12592129|P4|NOT COMPLETED|Stage 2||0
5118484|NCT01500200|12592130|P3|NOT COMPLETED|Stage 2||0
5118485|NCT01500200|12592131|P2|NOT COMPLETED|Stage 2||0
5118486|NCT01500200|12592132|P1|NOT COMPLETED|Stage 2||0
5118487|NCT01500200|12592127|P6|COMPLETED|Stage 2||18
5118488|NCT01500200|12592128|P5|COMPLETED|Stage 2||18
5118489|NCT01500200|12592129|P4|COMPLETED|Stage 2||20
5118490|NCT01500200|12592130|P3|COMPLETED|Stage 2||0
5118491|NCT01500200|12592131|P2|COMPLETED|Stage 2||0
5118492|NCT01500200|12592132|P1|COMPLETED|Stage 2||0
5118493|NCT01500200|12592127|P6|STARTED|Stage 2||22
5118494|NCT01500200|12592128|P5|STARTED|Stage 2||23
5118495|NCT01500200|12592129|P4|STARTED|Stage 2||20
5118496|NCT01500200|12592130|P3|STARTED|Stage 2||0
5118497|NCT01500200|12592131|P2|STARTED|Stage 2||0
5118498|NCT01500200|12592132|P1|STARTED|Stage 2||0
5118499|NCT01500200|12592127|P6|NOT COMPLETED|Stage 1||0
5118500|NCT01500200|12592128|P5|NOT COMPLETED|Stage 1||0
5118501|NCT01500200|12592129|P4|NOT COMPLETED|Stage 1||0
5118502|NCT01500200|12592130|P3|NOT COMPLETED|Stage 1||6
5118503|NCT01500200|12592131|P2|NOT COMPLETED|Stage 1||6
5118504|NCT01500200|12592132|P1|NOT COMPLETED|Stage 1||8
5118505|NCT01500200|12592127|P6|COMPLETED|Stage 1||0
5118506|NCT01500200|12592128|P5|COMPLETED|Stage 1||0
5118507|NCT01500200|12592129|P4|COMPLETED|Stage 1||0
5118508|NCT01500200|12592130|P3|COMPLETED|Stage 1||13
5118509|NCT01500200|12592131|P2|COMPLETED|Stage 1||18
5118510|NCT01500200|12592132|P1|COMPLETED|Stage 1||90
5118511|NCT01500200|12592127|P6|STARTED|Stage 1||0
5118512|NCT01500200|12592128|P5|STARTED|Stage 1||0
5118513|NCT01500200|12592129|P4|STARTED|Stage 1||0
5118514|NCT01500200|12592130|P3|STARTED|Stage 1||19
5118515|NCT01500200|12592131|P2|STARTED|Stage 1||24
5118516|NCT01500200|12592132|P1|STARTED|Stage 1||98
5118517|NCT01500187|12592166|P2|NOT COMPLETED|Overall Study||0
5118518|NCT01500187|12592167|P1|NOT COMPLETED|Overall Study||6
5118519|NCT01500187|12592166|P2|COMPLETED|Overall Study||15
5118520|NCT01500187|12592167|P1|COMPLETED|Overall Study||17
5118521|NCT01500187|12592166|P2|STARTED|Overall Study||15
5118522|NCT01500187|12592167|P1|STARTED|Overall Study||23
5118523|NCT01500135|12592175|P2|NOT COMPLETED|Overall Study||11
5118524|NCT01500135|12592176|P1|NOT COMPLETED|Overall Study||17
5118525|NCT01500135|12592175|P2|COMPLETED|Overall Study||39
5118526|NCT01500135|12592176|P1|COMPLETED|Overall Study||83
5118527|NCT01500135|12592175|P2|STARTED|Overall Study||50
5118528|NCT01500135|12592176|P1|STARTED|Overall Study||100
5118529|NCT01500109|12592189|P3|NOT COMPLETED|Overall Study||0
5118530|NCT01500109|12592190|P2|NOT COMPLETED|Overall Study||0
5118531|NCT01500109|12592191|P1|NOT COMPLETED|Overall Study||0
5118532|NCT01500109|12592189|P3|COMPLETED|Overall Study||16
5118533|NCT01500109|12592190|P2|COMPLETED|Overall Study||14
5118534|NCT01500109|12592191|P1|COMPLETED|Overall Study||15
5118535|NCT01500109|12592189|P3|STARTED|Overall Study||16
5118536|NCT01500109|12592190|P2|STARTED|Overall Study||14
5118537|NCT01500109|12592191|P1|STARTED|Overall Study||15
5118538|NCT01500096|12592203|P4|NOT COMPLETED|Overall Study||2
5118539|NCT01500096|12592204|P3|NOT COMPLETED|Overall Study||0
5118540|NCT01500096|12592205|P2|NOT COMPLETED|Overall Study||0
5118541|NCT01500096|12592206|P1|NOT COMPLETED|Overall Study||1
5118542|NCT01500096|12592203|P4|COMPLETED|Overall Study||14
5118543|NCT01500096|12592204|P3|COMPLETED|Overall Study||31
5118544|NCT01500096|12592205|P2|COMPLETED|Overall Study||17
5118545|NCT01500096|12592206|P1|COMPLETED|Overall Study||31
5118546|NCT01500096|12592203|P4|STARTED|Overall Study||16
5118547|NCT01500096|12592204|P3|STARTED|Overall Study||31
5118548|NCT01500096|12592205|P2|STARTED|Overall Study||17
5118549|NCT01500096|12592206|P1|STARTED|Overall Study||32
5118550|NCT01500083|12592262|P2|NOT COMPLETED|Overall Study||43
5118551|NCT01500083|12592263|P1|NOT COMPLETED|Overall Study||12
5118552|NCT01500083|12592262|P2|COMPLETED|Overall Study||31
5118553|NCT01500083|12592263|P1|COMPLETED|Overall Study||4
5118554|NCT01500083|12592262|P2|STARTED|Overall Study||74
5118555|NCT01500083|12592263|P1|STARTED|Overall Study||16
5118556|NCT01500057|12592271|P2|NOT COMPLETED|Overall Study||4
5118557|NCT01500057|12592272|P1|NOT COMPLETED|Overall Study||6
5118558|NCT01500057|12592271|P2|COMPLETED|Overall Study||31
5118559|NCT01500057|12592272|P1|COMPLETED|Overall Study||25
5118560|NCT01500057|12592271|P2|STARTED|Overall Study||35
5118561|NCT01500057|12592272|P1|STARTED|Overall Study||31
5118562|NCT01500031|12592282|P1|NOT COMPLETED|Overall Study||5
5118563|NCT01500031|12592282|P1|COMPLETED|Overall Study||87
5118564|NCT01500031|12592282|P1|STARTED|Overall Study||92
5118565|NCT01499862|12592297|P1|NOT COMPLETED|Overall Study||0
5118566|NCT01499862|12592297|P1|COMPLETED|Overall Study||3
5118567|NCT01499862|12592297|P1|STARTED|Overall Study||3
5118568|NCT01499849|12592317|P2|NOT COMPLETED|Overall Study||226
5118569|NCT01499849|12592318|P1|NOT COMPLETED|Overall Study||224
5118570|NCT01499849|12592317|P2|COMPLETED|Overall Study||40
5118571|NCT01499849|12592318|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
5118572|NCT01499849|12592317|P2|STARTED|Overall Study||266
5118573|NCT01499849|12592318|P1|STARTED|Overall Study|Number of randomized patients|266
5118574|NCT01499810|12592328|P1|NOT COMPLETED|Overall Study||12
5118575|NCT01499810|12592328|P1|COMPLETED|Overall Study||41
5118576|NCT01499810|12592328|P1|STARTED|Overall Study||53
5118577|NCT01499667|12592378|P3|NOT COMPLETED|Overall Study||10
5118578|NCT01499667|12592379|P2|NOT COMPLETED|Overall Study||11
5118579|NCT01499667|12592380|P1|NOT COMPLETED|Overall Study||9
5118580|NCT01499667|12592378|P3|COMPLETED|Overall Study||40
5118581|NCT01499667|12592379|P2|COMPLETED|Overall Study||31
5118582|NCT01499667|12592380|P1|COMPLETED|Overall Study||41
5118583|NCT01499667|12592378|P3|Modified Full Analysis Set|Overall Study||39
5118584|NCT01499667|12592379|P2|Modified Full Analysis Set|Overall Study||29
5118585|NCT01499667|12592380|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
5118586|NCT01499667|12592378|P3|Full Analysis Set (FAS)|Overall Study||50
5118587|NCT01499667|12592379|P2|Full Analysis Set (FAS)|Overall Study||42
5118588|NCT01499667|12592380|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
5118589|NCT01499667|12592378|P3|STARTED|Overall Study||50
5118590|NCT01499667|12592379|P2|STARTED|Overall Study||42
5118591|NCT01499667|12592380|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
5118592|NCT01499654|12592409|P1|NOT COMPLETED|Overall Study||0
5118593|NCT01499654|12592409|P1|COMPLETED|Overall Study||64
5118594|NCT01499654|12592409|P1|STARTED|Overall Study||64
5118595|NCT01499576|12592428|P1|NOT COMPLETED|Overall Study||21
5118596|NCT01499576|12592428|P1|COMPLETED|Overall Study||105
5118597|NCT01499576|12592428|P1|STARTED|Overall Study||126
5118598|NCT01499511|12592436|P2|NOT COMPLETED|Overall Study||0
5118599|NCT01499511|12592437|P1|NOT COMPLETED|Overall Study||1
5118600|NCT01499511|12592436|P2|COMPLETED|Overall Study||833
5118601|NCT01499511|12592437|P1|COMPLETED|Overall Study||884
5118602|NCT01499511|12592436|P2|STARTED|Overall Study||833
5118603|NCT01499511|12592437|P1|STARTED|Overall Study||885
5118604|NCT01499498|12592454|P1|NOT COMPLETED|Overall Study||0
5118605|NCT01499498|12592454|P1|COMPLETED|Overall Study||13
5118606|NCT01499498|12592454|P1|STARTED|Overall Study||13
5118607|NCT01499355|12592462|P4|NOT COMPLETED|Double-Blind Period||23
5118608|NCT01499355|12592463|P3|NOT COMPLETED|Double-Blind Period||25
5118609|NCT01499355|12592464|P2|NOT COMPLETED|Double-Blind Period||23
5118610|NCT01499355|12592465|P1|NOT COMPLETED|Double-Blind Period||0
5118611|NCT01499355|12592462|P4|COMPLETED|Double-Blind Period||39
5118612|NCT01499355|12592463|P3|COMPLETED|Double-Blind Period||38
5118613|NCT01499355|12592464|P2|COMPLETED|Double-Blind Period||40
5118614|NCT01499355|12592465|P1|COMPLETED|Double-Blind Period||0
5118615|NCT01499355|12592462|P4|STARTED|Double-Blind Period||62
5118616|NCT01499355|12592463|P3|STARTED|Double-Blind Period||63
5118617|NCT01499355|12592464|P2|STARTED|Double-Blind Period||63
5118618|NCT01499355|12592465|P1|STARTED|Double-Blind Period||0
5118619|NCT01499355|12592462|P4|NOT COMPLETED|Run-In Period||0
5118620|NCT01499355|12592463|P3|NOT COMPLETED|Run-In Period||0
5118621|NCT01499355|12592464|P2|NOT COMPLETED|Run-In Period||0
5118622|NCT01499355|12592465|P1|NOT COMPLETED|Run-In Period||31
5118623|NCT01499355|12592462|P4|COMPLETED|Run-In Period||0
5118624|NCT01499355|12592463|P3|COMPLETED|Run-In Period||0
5118625|NCT01499355|12592464|P2|COMPLETED|Run-In Period||0
5118626|NCT01499355|12592465|P1|COMPLETED|Run-In Period||245
5118627|NCT01499355|12592462|P4|STARTED|Run-In Period||0
5118628|NCT01499355|12592463|P3|STARTED|Run-In Period||0
5118629|NCT01499355|12592464|P2|STARTED|Run-In Period||0
5118630|NCT01499355|12592465|P1|STARTED|Run-In Period||276
5118631|NCT01499303|12592498|P2|NOT COMPLETED|Overall Study||7
5118632|NCT01499303|12592499|P1|NOT COMPLETED|Overall Study||3
5118633|NCT01499303|12592498|P2|COMPLETED|Overall Study||40
5118634|NCT01499303|12592499|P1|COMPLETED|Overall Study||18
5118635|NCT01499303|12592498|P2|STARTED|Overall Study||47
5118636|NCT01499303|12592499|P1|STARTED|Overall Study||21
5118637|NCT01499290|12592507|P2|NOT COMPLETED|Overall Study||35
5118638|NCT01499290|12592508|P1|NOT COMPLETED|Overall Study||55
5118639|NCT01499290|12592507|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
5118640|NCT01499290|12592508|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
5118641|NCT01499290|12592507|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
5118642|NCT01499290|12592508|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
5118643|NCT01499277|12592558|P2|NOT COMPLETED|Overall Study||32
5118644|NCT01499277|12592559|P1|NOT COMPLETED|Overall Study||47
5118645|NCT01499277|12592558|P2|COMPLETED|Overall Study||223
5118646|NCT01499277|12592559|P1|COMPLETED|Overall Study||459
5118647|NCT01499277|12592558|P2|STARTED|Overall Study||255
5118648|NCT01499277|12592559|P1|STARTED|Overall Study||506
5118649|NCT01499199|12592581|P1|NOT COMPLETED|Overall Study||2
5118650|NCT01499199|12592581|P1|COMPLETED|Overall Study||11
5118651|NCT01499199|12592581|P1|STARTED|Overall Study||13
5118652|NCT01499173|12592600|P1|NOT COMPLETED|Overall Study||37
5118653|NCT01499173|12592600|P1|COMPLETED|Overall Study||64
5118654|NCT01499173|12592600|P1|STARTED|Overall Study||101
5118655|NCT01499160|12592610|P1|NOT COMPLETED|Overall Study||2
5118656|NCT01499160|12592610|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
5118657|NCT01499160|12592610|P1|STARTED|Overall Study||7
5118658|NCT01499147|12592617|P2|NOT COMPLETED|Overall Study||5
5118659|NCT01499147|12592618|P1|NOT COMPLETED|Overall Study||15
5118660|NCT01499147|12592617|P2|COMPLETED|Overall Study||12
5118661|NCT01499147|12592618|P1|COMPLETED|Overall Study||18
5118662|NCT01499147|12592617|P2|STARTED|Overall Study||17
5118663|NCT01499147|12592618|P1|STARTED|Overall Study||33
5118664|NCT01499134|12592633|P2|NOT COMPLETED|Overall Study||1
5118665|NCT01499134|12592634|P1|NOT COMPLETED|Overall Study||0
5118666|NCT01499134|12592633|P2|COMPLETED|Overall Study||7
5118667|NCT01499134|12592634|P1|COMPLETED|Overall Study||9
5118668|NCT01499134|12592633|P2|STARTED|Overall Study||8
5118669|NCT01499134|12592634|P1|STARTED|Overall Study||9
5118670|NCT01499095|12592656|P2|NOT COMPLETED|Overall Study||93
5118671|NCT01499095|12592657|P1|NOT COMPLETED|Overall Study||89
5118672|NCT01499095|12592656|P2|COMPLETED|Overall Study||314
5118673|NCT01499095|12592657|P1|COMPLETED|Overall Study||315
5118674|NCT01499095|12592656|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
5118675|NCT01499095|12592657|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
5118676|NCT01499095|12592656|P2|Participated in Substudy|Overall Study||0
5118677|NCT01499095|12592657|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
5118678|NCT01499095|12592656|P2|Treated|Overall Study||406
5118679|NCT01499095|12592657|P1|Treated|Overall Study||403
5118680|NCT01499095|12592656|P2|STARTED|Overall Study||407
5118681|NCT01499095|12592657|P1|STARTED|Overall Study||404
5118682|NCT01499082|12592687|P2|NOT COMPLETED|Overall Study||48
5118683|NCT01499082|12592688|P1|NOT COMPLETED|Overall Study||45
5118684|NCT01499082|12592687|P2|COMPLETED|Overall Study||355
5118685|NCT01499082|12592688|P1|COMPLETED|Overall Study||359
5118686|NCT01499082|12592687|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
5118687|NCT01499082|12592688|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
5118688|NCT01499082|12592687|P2|Participated in Substudy|Overall Study||0
5118689|NCT01499082|12592688|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
5118690|NCT01499082|12592687|P2|Treated|Overall Study||402
5118691|NCT01499082|12592688|P1|Treated|Overall Study||404
5118692|NCT01499082|12592687|P2|STARTED|Overall Study||403
5118693|NCT01499082|12592688|P1|STARTED|Overall Study||404
5118694|NCT01499043|12592716|P1|NOT COMPLETED|Overall Study||6
5118695|NCT01499043|12592716|P1|COMPLETED|Overall Study||0
5118696|NCT01499043|12592716|P1|STARTED|Overall Study||6
5118697|NCT01498991|12592726|P1|NOT COMPLETED|Overall Study||0
5118698|NCT01498991|12592726|P1|COMPLETED|Overall Study||2
5118699|NCT01498991|12592726|P1|STARTED|Overall Study||2
5118700|NCT01498978|12592737|P1|NOT COMPLETED|Overall Study||2
5118701|NCT01498978|12592737|P1|COMPLETED|Overall Study||8
5118702|NCT01498978|12592737|P1|STARTED|Overall Study||10
5118703|NCT01498952|12592759|P5|NOT COMPLETED|Overall Study||0
5118704|NCT01498952|12592760|P4|NOT COMPLETED|Overall Study||0
5118705|NCT01498952|12592761|P3|NOT COMPLETED|Overall Study||0
5118706|NCT01498952|12592762|P2|NOT COMPLETED|Overall Study||2
5118707|NCT01498952|12592763|P1|NOT COMPLETED|Overall Study||2
5118708|NCT01498952|12592759|P5|COMPLETED|Overall Study||0
5118709|NCT01498952|12592760|P4|COMPLETED|Overall Study||0
5118710|NCT01498952|12592761|P3|COMPLETED|Overall Study||0
5118711|NCT01498952|12592762|P2|COMPLETED|Overall Study||1
5118712|NCT01498952|12592763|P1|COMPLETED|Overall Study||1
5118713|NCT01498952|12592759|P5|STARTED|Overall Study||0
5118714|NCT01498952|12592760|P4|STARTED|Overall Study||0
5118715|NCT01498952|12592761|P3|STARTED|Overall Study||0
5118716|NCT01498952|12592762|P2|STARTED|Overall Study||3
5118717|NCT01498952|12592763|P1|STARTED|Overall Study||3
5118718|NCT01498887|12592805|P2|NOT COMPLETED|Overall Study||11
5118719|NCT01498887|12592806|P1|NOT COMPLETED|Overall Study||16
5118720|NCT01498887|12592805|P2|COMPLETED|Overall Study||136
5118721|NCT01498887|12592806|P1|COMPLETED|Overall Study||184
5118722|NCT01498887|12592805|P2|Intent-to-treat|Overall Study||135
5118723|NCT01498887|12592806|P1|Intent-to-treat|Overall Study||185
5118724|NCT01498887|12592805|P2|Safety Set|Overall Study||147
5118725|NCT01498887|12592806|P1|Safety Set|Overall Study||200
5118726|NCT01498887|12592805|P2|STARTED|Overall Study||147
5118727|NCT01498887|12592806|P1|STARTED|Overall Study||200
5118728|NCT01498822|12592827|P2|NOT COMPLETED|Overall Study||56
5118729|NCT01498822|12592828|P1|NOT COMPLETED|Overall Study||54
5118730|NCT01498822|12592827|P2|COMPLETED|Overall Study||122
5118731|NCT01498822|12592828|P1|COMPLETED|Overall Study||121
5118732|NCT01498822|12592827|P2|STARTED|Overall Study||178
5118733|NCT01498822|12592828|P1|STARTED|Overall Study||175
5118734|NCT01498744|12592842|P2|NOT COMPLETED|Overall Study||0
5118735|NCT01498744|12592843|P1|NOT COMPLETED|Overall Study||0
5118736|NCT01498744|12592842|P2|COMPLETED|Overall Study||31
5118737|NCT01498744|12592843|P1|COMPLETED|Overall Study||22
5118738|NCT01498744|12592842|P2|STARTED|Overall Study||31
5118739|NCT01498744|12592843|P1|STARTED|Overall Study||22
5118740|NCT01498692|12592855|P1|NOT COMPLETED|Overall Study||8
5118741|NCT01498692|12592855|P1|COMPLETED|Overall Study||86
5118742|NCT01498692|12592855|P1|STARTED|Overall Study||94
5118743|NCT01498679|12592886|P2|NOT COMPLETED|Overall Study||22
5118744|NCT01498679|12592887|P1|NOT COMPLETED|Overall Study||89
5118745|NCT01498679|12592886|P2|COMPLETED|Overall Study||131
5118746|NCT01498679|12592887|P1|COMPLETED|Overall Study||65
5118747|NCT01498679|12592886|P2|STARTED|Overall Study||153
5118748|NCT01498679|12592887|P1|STARTED|Overall Study||154
5118749|NCT01498653|12592903|P2|NOT COMPLETED|Overall Study||35
5118750|NCT01498653|12592904|P1|NOT COMPLETED|Overall Study||19
5118751|NCT01498653|12592903|P2|COMPLETED|Overall Study||119
5118752|NCT01498653|12592904|P1|COMPLETED|Overall Study||136
5118753|NCT01498653|12592903|P2|STARTED|Overall Study||154
5118754|NCT01498653|12592904|P1|STARTED|Overall Study||155
5118755|NCT01498640|12592918|P1|NOT COMPLETED|Overall Study||5
5118756|NCT01498640|12592918|P1|COMPLETED|Overall Study||47
5118757|NCT01498640|12592918|P1|STARTED|Overall Study||52
5118758|NCT01498601|12592934|P2|NOT COMPLETED|Overall Study||0
5118759|NCT01498601|12592935|P1|NOT COMPLETED|Overall Study||0
5118760|NCT01498601|12592934|P2|COMPLETED|Overall Study||32
5118761|NCT01498601|12592935|P1|COMPLETED|Overall Study||51
5118762|NCT01498601|12592934|P2|STARTED|Overall Study||32
5118763|NCT01498601|12592935|P1|STARTED|Overall Study||51
5118764|NCT01498588|12592941|P1|NOT COMPLETED|Overall Study||0
5118765|NCT01498588|12592941|P1|COMPLETED|Overall Study||7
5118766|NCT01498588|12592941|P1|STARTED|Overall Study||7
5118767|NCT01498575|12592948|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
5118768|NCT01498575|12592949|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
5118769|NCT01498575|12592948|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
5118770|NCT01498575|12592949|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
5118771|NCT01498575|12592948|P2|STARTED|On the Road Driving Assessment (ODA)||89
5118772|NCT01498575|12592949|P1|STARTED|On the Road Driving Assessment (ODA)||128
5118773|NCT01498575|12592948|P2|NOT COMPLETED|Overall Sample||14
5118774|NCT01498575|12592949|P1|NOT COMPLETED|Overall Sample||60
5118775|NCT01498575|12592948|P2|COMPLETED|Overall Sample||400
5118776|NCT01498575|12592949|P1|COMPLETED|Overall Sample||550
5118777|NCT01498575|12592948|P2|STARTED|Overall Sample||414
5118778|NCT01498575|12592949|P1|STARTED|Overall Sample||610
5118779|NCT01498549|12592955|P1|NOT COMPLETED|Overall Study||4
5118780|NCT01498549|12592955|P1|COMPLETED|Overall Study||35
5118781|NCT01498549|12592955|P1|Sugar Pill 0 mg|Overall Study||36
5118782|NCT01498549|12592955|P1|Atomoxetine 80 mg|Overall Study||37
5118783|NCT01498549|12592955|P1|Atomoxetine 40 mg|Overall Study||39
5118784|NCT01498549|12592955|P1|STARTED|Overall Study||39
5118785|NCT01498458|12592966|P1|NOT COMPLETED|Overall Study||7
5118786|NCT01498458|12592966|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
5118787|NCT01498458|12592966|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
5118788|NCT01498419|12592979|P4|NOT COMPLETED|Overall Study||19
5118789|NCT01498419|12592980|P3|NOT COMPLETED|Overall Study||18
5118790|NCT01498419|12592981|P2|NOT COMPLETED|Overall Study||23
5118791|NCT01498419|12592982|P1|NOT COMPLETED|Overall Study||18
5118792|NCT01498419|12592979|P4|COMPLETED|Overall Study||7
5118793|NCT01498419|12592980|P3|COMPLETED|Overall Study||41
5118794|NCT01498419|12592981|P2|COMPLETED|Overall Study||39
5118795|NCT01498419|12592982|P1|COMPLETED|Overall Study||42
5118796|NCT01498419|12592979|P4|STARTED|Overall Study||26
5118797|NCT01498419|12592980|P3|STARTED|Overall Study||59
5118798|NCT01498419|12592981|P2|STARTED|Overall Study||62
5118799|NCT01498419|12592982|P1|STARTED|Overall Study||60
5118800|NCT01498289|12593018|P2|NOT COMPLETED|Overall Study||104
5118801|NCT01498289|12593019|P1|NOT COMPLETED|Overall Study||98
5118802|NCT01498289|12593018|P2|COMPLETED|Overall Study||0
5118803|NCT01498289|12593019|P1|COMPLETED|Overall Study||0
5118804|NCT01498289|12593018|P2|Participants Assessed for AEs|Overall Study||98
5118805|NCT01498289|12593019|P1|Participants Assessed for AEs|Overall Study||91
5118806|NCT01498289|12593018|P2|STARTED|Overall Study||104
5118807|NCT01498289|12593019|P1|STARTED|Overall Study||98
5118808|NCT01498185|12593040|P5|NOT COMPLETED|Overall Study||3
5118809|NCT01498185|12593041|P4|NOT COMPLETED|Overall Study||3
5118810|NCT01498185|12593042|P3|NOT COMPLETED|Overall Study||0
5118811|NCT01498185|12593043|P2|NOT COMPLETED|Overall Study||1
5118812|NCT01498185|12593044|P1|NOT COMPLETED|Overall Study||1
5118813|NCT01498185|12593040|P5|COMPLETED|Overall Study||12
5118814|NCT01498185|12593041|P4|COMPLETED|Overall Study||11
5118815|NCT01498185|12593042|P3|COMPLETED|Overall Study||15
5118816|NCT01498185|12593043|P2|COMPLETED|Overall Study||12
5118817|NCT01498185|12593044|P1|COMPLETED|Overall Study||12
5118818|NCT01498185|12593040|P5|STARTED|Overall Study||15
5118819|NCT01498185|12593041|P4|STARTED|Overall Study||14
5118820|NCT01498185|12593042|P3|STARTED|Overall Study||15
5118821|NCT01498185|12593043|P2|STARTED|Overall Study||13
5118822|NCT01498185|12593044|P1|STARTED|Overall Study||13
5118823|NCT01498120|12593084|P1|NOT COMPLETED|Overall Study||13
5118824|NCT01498120|12593084|P1|COMPLETED|Overall Study||1
5118825|NCT01498120|12593084|P1|STARTED|Overall Study||14
5118826|NCT01498068|12593091|P2|NOT COMPLETED|Overall Study||1
5118827|NCT01498068|12593092|P1|NOT COMPLETED|Overall Study||1
5118828|NCT01498068|12593091|P2|COMPLETED|Overall Study||19
5118829|NCT01498068|12593092|P1|COMPLETED|Overall Study||15
5118830|NCT01498068|12593091|P2|STARTED|Overall Study||20
5118831|NCT01498068|12593092|P1|STARTED|Overall Study||16
5118832|NCT01497938|12593110|P2|NOT COMPLETED|Overall Study||2
5118833|NCT01497938|12593111|P1|NOT COMPLETED|Overall Study||5
5118834|NCT01497938|12593110|P2|COMPLETED|Overall Study||124
5118835|NCT01497938|12593111|P1|COMPLETED|Overall Study||116
5118836|NCT01497938|12593110|P2|STARTED|Overall Study||126
5118837|NCT01497938|12593111|P1|STARTED|Overall Study||121
5118838|NCT01497899|12593123|P4|NOT COMPLETED|Open-Label Extension Phase||5
5118839|NCT01497899|12593124|P3|NOT COMPLETED|Open-Label Extension Phase||9
5118840|NCT01497899|12593125|P2|NOT COMPLETED|Open-Label Extension Phase||7
5118841|NCT01497899|12593126|P1|NOT COMPLETED|Open-Label Extension Phase||19
5118842|NCT01497899|12593123|P4|COMPLETED|Open-Label Extension Phase||33
5118843|NCT01497899|12593124|P3|COMPLETED|Open-Label Extension Phase||61
5118844|NCT01497899|12593125|P2|COMPLETED|Open-Label Extension Phase||46
5118845|NCT01497899|12593126|P1|COMPLETED|Open-Label Extension Phase||86
5118846|NCT01497899|12593123|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
5118847|NCT01497899|12593124|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
5118848|NCT01497899|12593125|P2|STARTED|Open-Label Extension Phase||53
5118849|NCT01497899|12593126|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
5118850|NCT01497899|12593123|P4|NOT COMPLETED|Double-Blind Phase||0
5118851|NCT01497899|12593124|P3|NOT COMPLETED|Double-Blind Phase||0
5118852|NCT01497899|12593125|P2|NOT COMPLETED|Double-Blind Phase||5
5118853|NCT01497899|12593126|P1|NOT COMPLETED|Double-Blind Phase||6
5118854|NCT01497899|12593123|P4|COMPLETED|Double-Blind Phase||0
5118855|NCT01497899|12593124|P3|COMPLETED|Double-Blind Phase||0
5118856|NCT01497899|12593125|P2|COMPLETED|Double-Blind Phase||53
5118857|NCT01497899|12593126|P1|COMPLETED|Double-Blind Phase||107
5118858|NCT01497899|12593123|P4|STARTED|Double-Blind Phase||0
5118859|NCT01497899|12593124|P3|STARTED|Double-Blind Phase||0
5118860|NCT01497899|12593125|P2|STARTED|Double-Blind Phase||58
5118861|NCT01497899|12593126|P1|STARTED|Double-Blind Phase||113
5118862|NCT01497860|12593139|P1|NOT COMPLETED|Overall Study||0
5118863|NCT01497860|12593139|P1|COMPLETED|Overall Study||12
5118864|NCT01497860|12593139|P1|STARTED|Overall Study||12
5118865|NCT01497756|12593143|P1|NOT COMPLETED|Overall Study||0
5118866|NCT01497756|12593143|P1|COMPLETED|Overall Study||10
5118867|NCT01497756|12593143|P1|STARTED|Overall Study||10
5118868|NCT01497665|12593148|P1|NOT COMPLETED|Overall Study||0
5118869|NCT01497665|12593148|P1|COMPLETED|Overall Study||16
5118870|NCT01497665|12593148|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
5118871|NCT01497665|12593148|P1|STARTED|Overall Study||16
5118872|NCT01497613|12593158|P2|NOT COMPLETED|Overall Study||19
5118873|NCT01497613|12593159|P1|NOT COMPLETED|Overall Study||37
5118874|NCT01497613|12593158|P2|COMPLETED|Overall Study||131
5118875|NCT01497613|12593159|P1|COMPLETED|Overall Study||113
5118876|NCT01497613|12593158|P2|STARTED|Overall Study||150
5118877|NCT01497613|12593159|P1|STARTED|Overall Study||150
5118878|NCT01497366|12593197|P2|NOT COMPLETED|Overall Study||88
5118879|NCT01497366|12593198|P1|NOT COMPLETED|Overall Study||39
5118880|NCT01497366|12593197|P2|COMPLETED|Overall Study||176
5118881|NCT01497366|12593198|P1|COMPLETED|Overall Study||224
5118882|NCT01497366|12593197|P2|Randomized But Not Treated|Overall Study||21
5118883|NCT01497366|12593198|P1|Randomized But Not Treated|Overall Study||7
5118884|NCT01497366|12593197|P2|STARTED|Overall Study||264
5118885|NCT01497366|12593198|P1|STARTED|Overall Study||263
5118886|NCT01497275|12593216|P1|NOT COMPLETED|Overall Study||2
5118887|NCT01497275|12593216|P1|COMPLETED|Overall Study||3
5118888|NCT01497275|12593216|P1|STARTED|Overall Study||5
5118889|NCT01497262|12593223|P1|NOT COMPLETED|Overall Study||11
5118890|NCT01497262|12593223|P1|COMPLETED|Overall Study||151
5118891|NCT01497262|12593223|P1|STARTED|Overall Study||162
5118892|NCT01497197|12593230|P2|NOT COMPLETED|Overall Study||15
5118893|NCT01497197|12593231|P1|NOT COMPLETED|Overall Study||17
5118894|NCT01497197|12593230|P2|COMPLETED|Overall Study||70
5118895|NCT01497197|12593231|P1|COMPLETED|Overall Study||72
5118896|NCT01497197|12593230|P2|STARTED|Overall Study||85
5118897|NCT01497197|12593231|P1|STARTED|Overall Study||89
5118898|NCT01497171|12593259|P2|NOT COMPLETED|Overall Study||0
5118899|NCT01497171|12593260|P1|NOT COMPLETED|Overall Study||0
5118900|NCT01497171|12593259|P2|COMPLETED|Overall Study||3
5118901|NCT01497171|12593260|P1|COMPLETED|Overall Study||2
5118902|NCT01497171|12593259|P2|STARTED|Overall Study||3
5118903|NCT01497171|12593260|P1|STARTED|Overall Study||2
5118904|NCT01497067|12593266|P1|NOT COMPLETED|Overall Study||82
5118905|NCT01497067|12593266|P1|COMPLETED|Overall Study||575
5118906|NCT01497067|12593266|P1|STARTED|Overall Study||657
5118907|NCT01496846|12593277|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118908|NCT01496846|12593278|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118909|NCT01496846|12593279|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118910|NCT01496846|12593280|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118911|NCT01496846|12593281|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118912|NCT01496846|12593282|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
5118913|NCT01496846|12593277|P6|COMPLETED|Supplemental Buccal Infiltration||38
5118914|NCT01496846|12593278|P5|COMPLETED|Supplemental Buccal Infiltration||35
5118915|NCT01496846|12593279|P4|COMPLETED|Supplemental Buccal Infiltration||40
5118916|NCT01496846|12593280|P3|COMPLETED|Supplemental Buccal Infiltration||36
5118917|NCT01496846|12593281|P2|COMPLETED|Supplemental Buccal Infiltration||0
5118918|NCT01496846|12593282|P1|COMPLETED|Supplemental Buccal Infiltration||0
5118919|NCT01496846|12593277|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
5118920|NCT01496846|12593278|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
5118921|NCT01496846|12593279|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
5118922|NCT01496846|12593280|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
5118923|NCT01496846|12593281|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
5118924|NCT01496846|12593282|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
5118925|NCT01496846|12593277|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
5118926|NCT01496846|12593278|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
5118927|NCT01496846|12593279|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
5118928|NCT01496846|12593280|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
5118929|NCT01496846|12593281|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
5118930|NCT01496846|12593282|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
5118931|NCT01496846|12593277|P6|COMPLETED|IANB Articaine (All Participants)||38
5118932|NCT01496846|12593278|P5|COMPLETED|IANB Articaine (All Participants)||35
5118933|NCT01496846|12593279|P4|COMPLETED|IANB Articaine (All Participants)||40
5118934|NCT01496846|12593280|P3|COMPLETED|IANB Articaine (All Participants)||36
5118935|NCT01496846|12593281|P2|COMPLETED|IANB Articaine (All Participants)||23
5118936|NCT01496846|12593282|P1|COMPLETED|IANB Articaine (All Participants)||27
5118937|NCT01496846|12593277|P6|STARTED|IANB Articaine (All Participants)||38
5118938|NCT01496846|12593278|P5|STARTED|IANB Articaine (All Participants)||35
5118939|NCT01496846|12593279|P4|STARTED|IANB Articaine (All Participants)||40
5118940|NCT01496846|12593280|P3|STARTED|IANB Articaine (All Participants)||36
5118941|NCT01496846|12593281|P2|STARTED|IANB Articaine (All Participants)||24
5118942|NCT01496846|12593282|P1|STARTED|IANB Articaine (All Participants)||28
5118943|NCT01496807|12593293|P1|NOT COMPLETED|Overall Study||30
5118944|NCT01496807|12593293|P1|COMPLETED|Overall Study||1
5118945|NCT01496807|12593293|P1|STARTED|Overall Study||31
5118946|NCT01496469|12593305|P2|NOT COMPLETED|Overall Study||8
5118947|NCT01496469|12593306|P1|NOT COMPLETED|Overall Study||10
5118948|NCT01496469|12593305|P2|COMPLETED|Overall Study||53
5118949|NCT01496469|12593306|P1|COMPLETED|Overall Study||50
5118950|NCT01496469|12593305|P2|STARTED|Overall Study||61
5118951|NCT01496469|12593306|P1|STARTED|Overall Study||60
5118952|NCT01496456|12593316|P1|NOT COMPLETED|Overall Study||8
5118953|NCT01496456|12593316|P1|COMPLETED|Overall Study||9
5118954|NCT01496456|12593316|P1|3-yr Final Recall|Overall Study||9
5118955|NCT01496456|12593316|P1|2-yr Recall|Overall Study||10
5118956|NCT01496456|12593316|P1|1-yr Recall|Overall Study||12
5118957|NCT01496456|12593316|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
5118958|NCT01496456|12593316|P1|STARTED|Overall Study||17
5118959|NCT01496430|12593329|P3|NOT COMPLETED|Overall Study||10
5118960|NCT01496430|12593330|P2|NOT COMPLETED|Overall Study||5
5118961|NCT01496430|12593331|P1|NOT COMPLETED|Overall Study||6
5118962|NCT01496430|12593329|P3|COMPLETED|Overall Study||25
5118963|NCT01496430|12593330|P2|COMPLETED|Overall Study||30
5118964|NCT01496430|12593331|P1|COMPLETED|Overall Study||29
5118965|NCT01496430|12593329|P3|STARTED|Overall Study||35
5118966|NCT01496430|12593330|P2|STARTED|Overall Study||35
5118967|NCT01496430|12593331|P1|STARTED|Overall Study||35
5118968|NCT01496352|12593407|P2|NOT COMPLETED|Overall Study||0
5118969|NCT01496352|12593408|P1|NOT COMPLETED|Overall Study||0
5118970|NCT01496352|12593407|P2|COMPLETED|Overall Study||6
5118971|NCT01496352|12593408|P1|COMPLETED|Overall Study||24
5118972|NCT01496352|12593407|P2|STARTED|Overall Study||6
5118973|NCT01496352|12593408|P1|STARTED|Overall Study||24
5118974|NCT01496313|12593426|P2|NOT COMPLETED|Overall Study||15
5118975|NCT01496313|12593427|P1|NOT COMPLETED|Overall Study||5
5118976|NCT01496313|12593426|P2|COMPLETED|Overall Study||26
5118977|NCT01496313|12593427|P1|COMPLETED|Overall Study||35
5118978|NCT01496313|12593426|P2|STARTED|Overall Study||41
5118979|NCT01496313|12593427|P1|STARTED|Overall Study||40
5118980|NCT01496287|12593443|P1|NOT COMPLETED|Overall Study||6
5118981|NCT01496287|12593443|P1|COMPLETED|Overall Study||64
5118982|NCT01496287|12593443|P1|STARTED|Overall Study||70
5118983|NCT01496274|12593453|P2|NOT COMPLETED|Overall Study||5
5118984|NCT01496274|12593454|P1|NOT COMPLETED|Overall Study||3
5118985|NCT01496274|12593453|P2|COMPLETED|Overall Study||18
5118986|NCT01496274|12593454|P1|COMPLETED|Overall Study||37
5118987|NCT01496274|12593453|P2|STARTED|Overall Study||23
5118988|NCT01496274|12593454|P1|STARTED|Overall Study||40
5118989|NCT01496248|12593486|P1|NOT COMPLETED|Overall Study||10
5118990|NCT01496248|12593486|P1|COMPLETED|Overall Study||25
5118991|NCT01496248|12593486|P1|STARTED|Overall Study||35
5118992|NCT01496183|12593499|P2|NOT COMPLETED|Overall Study||2
5118993|NCT01496183|12593500|P1|NOT COMPLETED|Overall Study||3
5118994|NCT01496183|12593499|P2|COMPLETED|Overall Study||13
5118995|NCT01496183|12593500|P1|COMPLETED|Overall Study||6
5118996|NCT01496183|12593499|P2|STARTED|Overall Study||15
5118997|NCT01496183|12593500|P1|STARTED|Overall Study||9
5118998|NCT01496157|12593530|P1|NOT COMPLETED|Overall Study||0
5118999|NCT01496157|12593530|P1|COMPLETED|Overall Study||13
5119000|NCT01496157|12593530|P1|STARTED|Overall Study||13
5119001|NCT01496131|12593537|P2|NOT COMPLETED|Overall Study||0
5119002|NCT01496131|12593538|P1|NOT COMPLETED|Overall Study||0
5119003|NCT01496131|12593537|P2|COMPLETED|Overall Study||14
5119004|NCT01496131|12593538|P1|COMPLETED|Overall Study||14
5119005|NCT01496131|12593537|P2|STARTED|Overall Study||14
5119006|NCT01496131|12593538|P1|STARTED|Overall Study||14
5119007|NCT01496066|12593552|P2|NOT COMPLETED|Overall Study||9
5119008|NCT01496066|12593553|P1|NOT COMPLETED|Overall Study||12
5119009|NCT01496066|12593552|P2|COMPLETED|Overall Study||188
5119010|NCT01496066|12593553|P1|COMPLETED|Overall Study||391
5119011|NCT01496066|12593552|P2|STARTED|Overall Study||197
5119012|NCT01496066|12593553|P1|STARTED|Overall Study||403
5119013|NCT01495988|12593576|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119014|NCT01495988|12593577|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119015|NCT01495988|12593578|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119016|NCT01495988|12593579|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119017|NCT01495988|12593576|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119018|NCT01495988|12593577|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119019|NCT01495988|12593578|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
5119020|NCT01495988|12593579|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119021|NCT01495988|12593576|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119022|NCT01495988|12593577|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119023|NCT01495988|12593578|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
5119024|NCT01495988|12593579|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
5119025|NCT01495988|12593576|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119026|NCT01495988|12593577|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119027|NCT01495988|12593578|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119028|NCT01495988|12593579|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119029|NCT01495988|12593576|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
5119030|NCT01495988|12593577|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
5119031|NCT01495988|12593578|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119032|NCT01495988|12593579|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
5119033|NCT01495988|12593576|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
5119034|NCT01495988|12593577|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
5119035|NCT01495988|12593578|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
5119036|NCT01495988|12593579|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
5119037|NCT01495975|12593615|P2|NOT COMPLETED|Overall Study||0
5119038|NCT01495975|12593616|P1|NOT COMPLETED|Overall Study||1
5119039|NCT01495975|12593615|P2|COMPLETED|Overall Study||14
5119040|NCT01495975|12593616|P1|COMPLETED|Overall Study||14
5119041|NCT01495975|12593615|P2|STARTED|Overall Study||14
5119042|NCT01495975|12593616|P1|STARTED|Overall Study||15
5119043|NCT01495923|12593624|P2|NOT COMPLETED|Overall Study||0
5119044|NCT01495923|12593625|P1|NOT COMPLETED|Overall Study||0
5119045|NCT01495923|12593624|P2|COMPLETED|Overall Study||72
5119046|NCT01495923|12593625|P1|COMPLETED|Overall Study||73
5119047|NCT01495923|12593624|P2|STARTED|Overall Study||72
5119048|NCT01495923|12593625|P1|STARTED|Overall Study||73
5119049|NCT01495858|12593658|P3|NOT COMPLETED|Overall Study||0
5119050|NCT01495858|12593659|P2|NOT COMPLETED|Overall Study||0
5119051|NCT01495858|12593660|P1|NOT COMPLETED|Overall Study||0
5119052|NCT01495858|12593658|P3|COMPLETED|Overall Study||54
5119053|NCT01495858|12593659|P2|COMPLETED|Overall Study||106
5119054|NCT01495858|12593660|P1|COMPLETED|Overall Study||107
5119055|NCT01495858|12593658|P3|STARTED|Overall Study||54
5119056|NCT01495858|12593659|P2|STARTED|Overall Study||106
5119057|NCT01495858|12593660|P1|STARTED|Overall Study||107
5119058|NCT01495793|12593740|P1|NOT COMPLETED|Overall Study||2
5119059|NCT01495793|12593740|P1|COMPLETED|Overall Study||22
5119060|NCT01495793|12593740|P1|STARTED|Overall Study||24
5119061|NCT01495702|12593753|P2|NOT COMPLETED|Extension Phase||0
5119062|NCT01495702|12593754|P1|NOT COMPLETED|Extension Phase||0
5119063|NCT01495702|12593753|P2|COMPLETED|Extension Phase||2
5119064|NCT01495702|12593754|P1|COMPLETED|Extension Phase||26
5119065|NCT01495702|12593753|P2|STARTED|Extension Phase||2
5119066|NCT01495702|12593754|P1|STARTED|Extension Phase||26
5119067|NCT01495702|12593753|P2|NOT COMPLETED|Randomized Phase||28
5119068|NCT01495702|12593754|P1|NOT COMPLETED|Randomized Phase||26
5119069|NCT01495702|12593753|P2|COMPLETED|Randomized Phase||119
5119070|NCT01495702|12593754|P1|COMPLETED|Randomized Phase||266
5119071|NCT01495702|12593753|P2|STARTED|Randomized Phase||147
5119072|NCT01495702|12593754|P1|STARTED|Randomized Phase||292
5119073|NCT01495689|12593769|P2|NOT COMPLETED|Overall Study||7
5119074|NCT01495689|12593770|P1|NOT COMPLETED|Overall Study||10
5119075|NCT01495689|12593769|P2|COMPLETED|Overall Study||16
5119076|NCT01495689|12593770|P1|COMPLETED|Overall Study||16
5119077|NCT01495689|12593769|P2|STARTED|Overall Study||23
5119078|NCT01495689|12593770|P1|STARTED|Overall Study||26
5119079|NCT01495585|12593779|P3|NOT COMPLETED|Overall Study||0
5119080|NCT01495585|12593780|P2|NOT COMPLETED|Overall Study||0
5119081|NCT01495585|12593781|P1|NOT COMPLETED|Overall Study||0
5119082|NCT01495585|12593779|P3|COMPLETED|Overall Study||4
5119083|NCT01495585|12593780|P2|COMPLETED|Overall Study||6
5119084|NCT01495585|12593781|P1|COMPLETED|Overall Study||4
5119085|NCT01495585|12593779|P3|Open Label Lonafarnib 200 mg|Overall Study||0
5119086|NCT01495585|12593780|P2|Open Label Lonafarnib 200 mg|Overall Study||0
5119087|NCT01495585|12593781|P1|Open Label Lonafarnib 200 mg|Overall Study||2
5119088|NCT01495585|12593779|P3|STARTED|Overall Study||4
5119089|NCT01495585|12593780|P2|STARTED|Overall Study||6
5119090|NCT01495585|12593781|P1|STARTED|Overall Study||4
5119091|NCT01495572|12593794|P2|NOT COMPLETED|Overall Study||0
5119092|NCT01495572|12593795|P1|NOT COMPLETED|Overall Study||0
5119093|NCT01495572|12593794|P2|COMPLETED|Overall Study||5
5119094|NCT01495572|12593795|P1|COMPLETED|Overall Study||0
5119095|NCT01495572|12593794|P2|STARTED|Overall Study||5
5119096|NCT01495572|12593795|P1|STARTED|Overall Study||0
5119097|NCT01495481|12593803|P1|NOT COMPLETED|Dexmedetomidine||0
5119098|NCT01495481|12593803|P1|COMPLETED|Dexmedetomidine||22
5119099|NCT01495481|12593803|P1|STARTED|Dexmedetomidine||22
5119100|NCT01495481|12593803|P1|NOT COMPLETED|Washout||0
5119101|NCT01495481|12593803|P1|COMPLETED|Washout||22
5119102|NCT01495481|12593803|P1|STARTED|Washout||22
5119103|NCT01495481|12593803|P1|NOT COMPLETED|Adenosine||0
5119104|NCT01495481|12593803|P1|COMPLETED|Adenosine||22
5119105|NCT01495481|12593803|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
5119106|NCT01495286|12593815|P1|NOT COMPLETED|Overall Study||0
5119107|NCT01495286|12593815|P1|COMPLETED|Overall Study||30
5119108|NCT01495286|12593815|P1|STARTED|Overall Study||30
5119109|NCT01495221|12593823|P1|NOT COMPLETED|Overall Study||0
5119110|NCT01495221|12593823|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
5119111|NCT01495221|12593823|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
5119112|NCT01495000|12593832|P2|NOT COMPLETED|Overall Study||12
5119113|NCT01495000|12593833|P1|NOT COMPLETED|Overall Study||13
5119114|NCT01495000|12593832|P2|COMPLETED|Overall Study||114
5119115|NCT01495000|12593833|P1|COMPLETED|Overall Study||111
5119116|NCT01495000|12593832|P2|STARTED|Overall Study||126
5119117|NCT01495000|12593833|P1|STARTED|Overall Study||124
5119118|NCT01494987|12593875|P2|NOT COMPLETED|Overall Study||28
5119119|NCT01494987|12593876|P1|NOT COMPLETED|Overall Study||28
5119120|NCT01494987|12593875|P2|COMPLETED|Overall Study||187
5119121|NCT01494987|12593876|P1|COMPLETED|Overall Study||188
5119122|NCT01494987|12593875|P2|STARTED|Overall Study||215
5119123|NCT01494987|12593876|P1|STARTED|Overall Study||216
5119124|NCT01494818|12593890|P2|NOT COMPLETED|Overall Study||2
5119125|NCT01494818|12593891|P1|NOT COMPLETED|Overall Study||2
5119126|NCT01494818|12593890|P2|COMPLETED|Overall Study||37
5119127|NCT01494818|12593891|P1|COMPLETED|Overall Study||37
5119128|NCT01494818|12593890|P2|STARTED|Overall Study||39
5119129|NCT01494818|12593891|P1|STARTED|Overall Study||39
5119130|NCT01494753|12593913|P2|NOT COMPLETED|Day42-Day84||0
5119131|NCT01494753|12593914|P1|NOT COMPLETED|Day42-Day84||0
5119132|NCT01494753|12593913|P2|COMPLETED|Day42-Day84||15
5119133|NCT01494753|12593914|P1|COMPLETED|Day42-Day84||15
5119134|NCT01494753|12593913|P2|STARTED|Day42-Day84||15
5119135|NCT01494753|12593914|P1|STARTED|Day42-Day84||15
5119136|NCT01494753|12593913|P2|NOT COMPLETED|Day0-Day42||0
5119137|NCT01494753|12593914|P1|NOT COMPLETED|Day0-Day42||0
5119138|NCT01494753|12593913|P2|COMPLETED|Day0-Day42||15
5119139|NCT01494753|12593914|P1|COMPLETED|Day0-Day42||15
5119140|NCT01494753|12593913|P2|STARTED|Day0-Day42||15
5119141|NCT01494753|12593914|P1|STARTED|Day0-Day42||15
5119142|NCT01494649|12593922|P2|NOT COMPLETED|Overall Study||1
5119143|NCT01494649|12593923|P1|NOT COMPLETED|Overall Study||0
5119144|NCT01494649|12593922|P2|COMPLETED|Overall Study||58
5119145|NCT01494649|12593923|P1|COMPLETED|Overall Study||59
5119146|NCT01494649|12593922|P2|STARTED|Overall Study||59
5119147|NCT01494649|12593923|P1|STARTED|Overall Study||59
5119148|NCT01494610|12593939|P2|NOT COMPLETED|Period 4||0
5119149|NCT01494610|12593940|P1|NOT COMPLETED|Period 4||1
5119150|NCT01494610|12593939|P2|COMPLETED|Period 4||28
5119151|NCT01494610|12593940|P1|COMPLETED|Period 4||27
5119152|NCT01494610|12593939|P2|STARTED|Period 4||28
5119153|NCT01494610|12593940|P1|STARTED|Period 4||28
5119154|NCT01494610|12593939|P2|NOT COMPLETED|Period 3||0
5119155|NCT01494610|12593940|P1|NOT COMPLETED|Period 3||2
5119156|NCT01494610|12593939|P2|COMPLETED|Period 3||28
5119157|NCT01494610|12593940|P1|COMPLETED|Period 3||28
5119158|NCT01494610|12593939|P2|STARTED|Period 3||28
5119159|NCT01494610|12593940|P1|STARTED|Period 3||30
5119160|NCT01494610|12593939|P2|NOT COMPLETED|Period 2||0
5119161|NCT01494610|12593940|P1|NOT COMPLETED|Period 2||0
5119162|NCT01494610|12593939|P2|COMPLETED|Period 2||28
5119163|NCT01494610|12593940|P1|COMPLETED|Period 2||30
5119164|NCT01494610|12593939|P2|STARTED|Period 2||28
5119165|NCT01494610|12593940|P1|STARTED|Period 2||30
5119166|NCT01494610|12593939|P2|NOT COMPLETED|Period 1||1
5119167|NCT01494610|12593940|P1|NOT COMPLETED|Period 1||1
5119168|NCT01494610|12593939|P2|COMPLETED|Period 1||28
5119169|NCT01494610|12593940|P1|COMPLETED|Period 1||30
5119170|NCT01494610|12593939|P2|STARTED|Period 1||29
5119171|NCT01494610|12593940|P1|STARTED|Period 1||31
5119172|NCT01494584|12594008|P1|NOT COMPLETED|Overall Study||1
5119173|NCT01494584|12594008|P1|COMPLETED|Overall Study||4
5119174|NCT01494584|12594008|P1|STARTED|Overall Study||5
5119175|NCT01494545|12594097|P1|NOT COMPLETED|Overall Study||10
5119176|NCT01494545|12594097|P1|COMPLETED|Overall Study||92
5119177|NCT01494545|12594097|P1|STARTED|Overall Study||102
5119178|NCT01494532|12594140|P6|NOT COMPLETED|Overall Study||0
5119179|NCT01494532|12594141|P5|NOT COMPLETED|Overall Study||12
5119180|NCT01494532|12594142|P4|NOT COMPLETED|Overall Study||15
5119181|NCT01494532|12594143|P3|NOT COMPLETED|Overall Study||17
5119182|NCT01494532|12594144|P2|NOT COMPLETED|Overall Study||4
5119183|NCT01494532|12594145|P1|NOT COMPLETED|Overall Study||10
5119184|NCT01494532|12594140|P6|COMPLETED|Overall Study||25
5119185|NCT01494532|12594141|P5|COMPLETED|Overall Study||64
5119186|NCT01494532|12594142|P4|COMPLETED|Overall Study||60
5119187|NCT01494532|12594143|P3|COMPLETED|Overall Study||59
5119188|NCT01494532|12594144|P2|COMPLETED|Overall Study||21
5119189|NCT01494532|12594145|P1|COMPLETED|Overall Study||65
5119190|NCT01494532|12594140|P6|STARTED|Overall Study||25
5119191|NCT01494532|12594141|P5|STARTED|Overall Study||76
5119192|NCT01494532|12594142|P4|STARTED|Overall Study||75
5119193|NCT01494532|12594143|P3|STARTED|Overall Study||76
5119194|NCT01494532|12594144|P2|STARTED|Overall Study||25
5119195|NCT01494532|12594145|P1|STARTED|Overall Study||75
5119196|NCT01494506|12594300|P3|NOT COMPLETED|Overall Study||103
5119197|NCT01494506|12594301|P2|NOT COMPLETED|Overall Study||143
5119198|NCT01494506|12594302|P1|NOT COMPLETED|Overall Study||148
5119199|NCT01494506|12594300|P3|COMPLETED|Overall Study||14
5119200|NCT01494506|12594301|P2|COMPLETED|Overall Study||6
5119201|NCT01494506|12594302|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
5119202|NCT01494506|12594300|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
5119203|NCT01494506|12594301|P2|Treated Population|Overall Study||134
5119204|NCT01494506|12594302|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
5119205|NCT01494506|12594300|P3|STARTED|Overall Study||117
5119206|NCT01494506|12594301|P2|STARTED|Overall Study||149
5119207|NCT01494506|12594302|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
5119208|NCT01494467|12594339|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
5119209|NCT01494467|12594340|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
5119210|NCT01494467|12594339|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
5119211|NCT01494467|12594340|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
5119212|NCT01494467|12594339|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
5119213|NCT01494467|12594340|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
5119214|NCT01494467|12594339|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
5119215|NCT01494467|12594340|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
5119216|NCT01494467|12594339|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
5119217|NCT01494467|12594340|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
5119218|NCT01494467|12594339|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
5119219|NCT01494467|12594340|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
5119220|NCT01494467|12594339|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
5119221|NCT01494467|12594340|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
5119222|NCT01494467|12594339|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
5119223|NCT01494467|12594340|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
5119224|NCT01494467|12594339|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
5119225|NCT01494467|12594340|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
5119226|NCT01494350|12594356|P1|NOT COMPLETED|Overall Study||1
5119227|NCT01494350|12594356|P1|COMPLETED|Overall Study||49
5119228|NCT01494350|12594356|P1|STARTED|Overall Study||50
5119229|NCT01494298|12594366|P2|NOT COMPLETED|Overall Study||8
5119230|NCT01494298|12594367|P1|NOT COMPLETED|Overall Study||2
5119231|NCT01494298|12594366|P2|COMPLETED|Overall Study||47
5119232|NCT01494298|12594367|P1|COMPLETED|Overall Study||54
5119233|NCT01494298|12594366|P2|STARTED|Overall Study||55
5119234|NCT01494298|12594367|P1|STARTED|Overall Study||56
5119235|NCT01494051|12594379|P2|NOT COMPLETED|Overall Study||0
5119236|NCT01494051|12594380|P1|NOT COMPLETED|Overall Study||0
5119237|NCT01494051|12594379|P2|COMPLETED|Overall Study||7
5119238|NCT01494051|12594380|P1|COMPLETED|Overall Study||6
5119239|NCT01494051|12594379|P2|STARTED|Overall Study||7
5119240|NCT01494051|12594380|P1|STARTED|Overall Study||6
5119241|NCT01494038|12594390|P2|NOT COMPLETED|Overall Study||83
5119242|NCT01494038|12594391|P1|NOT COMPLETED|Overall Study||88
5119243|NCT01494038|12594390|P2|COMPLETED|Overall Study||396
5119244|NCT01494038|12594391|P1|COMPLETED|Overall Study||389
5119245|NCT01494038|12594390|P2|STARTED|Overall Study||479
5119246|NCT01494038|12594391|P1|STARTED|Overall Study||477
5119247|NCT01493960|12594479|P2|NOT COMPLETED|Overall Study||18
5119248|NCT01493960|12594480|P1|NOT COMPLETED|Overall Study||32
5119249|NCT01493960|12594479|P2|COMPLETED|Overall Study||26
5119250|NCT01493960|12594480|P1|COMPLETED|Overall Study||55
5119251|NCT01493960|12594479|P2|Received Study Drug|Overall Study||43
5119252|NCT01493960|12594480|P1|Received Study Drug|Overall Study||87
5119253|NCT01493960|12594479|P2|STARTED|Overall Study||44
5119254|NCT01493960|12594480|P1|STARTED|Overall Study||87
5119255|NCT01493947|12594500|P2|NOT COMPLETED|Period B Extension Period||32
5119256|NCT01493947|12594501|P1|NOT COMPLETED|Period B Extension Period||33
5119257|NCT01493947|12594500|P2|COMPLETED|Period B Extension Period||326
5119258|NCT01493947|12594501|P1|COMPLETED|Period B Extension Period||366
5119259|NCT01493947|12594500|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
5119260|NCT01493947|12594501|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
5119261|NCT01493947|12594500|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
5119262|NCT01493947|12594501|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
5119263|NCT01493947|12594500|P2|COMPLETED|Period A Efficacy and Safety Data||456
5119264|NCT01493947|12594501|P1|COMPLETED|Period A Efficacy and Safety Data||446
5119265|NCT01493947|12594500|P2|STARTED|Period A Efficacy and Safety Data||484
5119266|NCT01493947|12594501|P1|STARTED|Period A Efficacy and Safety Data||478
5119267|NCT01493778|12594511|P1|NOT COMPLETED|Overall Study||8
5119268|NCT01493778|12594511|P1|COMPLETED|Overall Study||52
5119269|NCT01493778|12594511|P1|STARTED|Overall Study||60
5119270|NCT01493687|12594573|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
5119271|NCT01493687|12594574|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
5119272|NCT01493687|12594573|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
5119273|NCT01493687|12594574|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
5119274|NCT01493687|12594573|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
5119275|NCT01493687|12594574|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
5119276|NCT01493687|12594573|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
5119277|NCT01493687|12594574|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
5119278|NCT01493687|12594573|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
5119279|NCT01493687|12594574|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
5119280|NCT01493687|12594573|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
5119281|NCT01493687|12594574|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
5119282|NCT01493687|12594573|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
5119283|NCT01493687|12594574|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
5119284|NCT01493687|12594573|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
5119285|NCT01493687|12594574|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
5119286|NCT01493687|12594573|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
5119287|NCT01493687|12594574|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
5119288|NCT01493557|12594593|P3|NOT COMPLETED|Adding the Second Strategy||0
5119289|NCT01493557|12594594|P2|NOT COMPLETED|Adding the Second Strategy||4
5119290|NCT01493557|12594595|P1|NOT COMPLETED|Adding the Second Strategy||2
5119291|NCT01493557|12594593|P3|COMPLETED|Adding the Second Strategy||0
5119292|NCT01493557|12594594|P2|COMPLETED|Adding the Second Strategy||11
5119293|NCT01493557|12594595|P1|COMPLETED|Adding the Second Strategy||12
5119294|NCT01493557|12594593|P3|STARTED|Adding the Second Strategy||0
5119295|NCT01493557|12594594|P2|STARTED|Adding the Second Strategy||15
5119296|NCT01493557|12594595|P1|STARTED|Adding the Second Strategy||14
5119297|NCT01493557|12594593|P3|NOT COMPLETED|Randomized to Management Strategies||0
5119298|NCT01493557|12594594|P2|NOT COMPLETED|Randomized to Management Strategies||11
5119299|NCT01493557|12594595|P1|NOT COMPLETED|Randomized to Management Strategies||15
5119300|NCT01493557|12594593|P3|COMPLETED|Randomized to Management Strategies||0
5119301|NCT01493557|12594594|P2|COMPLETED|Randomized to Management Strategies||47
5119302|NCT01493557|12594595|P1|COMPLETED|Randomized to Management Strategies||44
5119303|NCT01493557|12594593|P3|STARTED|Randomized to Management Strategies||0
5119304|NCT01493557|12594594|P2|STARTED|Randomized to Management Strategies||58
5119305|NCT01493557|12594595|P1|STARTED|Randomized to Management Strategies||59
5119306|NCT01493557|12594593|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
5119307|NCT01493557|12594594|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
5119308|NCT01493557|12594595|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
5119309|NCT01493557|12594593|P3|COMPLETED|Not Randomized to Management Strategies||816
5119310|NCT01493557|12594594|P2|COMPLETED|Not Randomized to Management Strategies||0
5119311|NCT01493557|12594595|P1|COMPLETED|Not Randomized to Management Strategies||0
5119312|NCT01493557|12594593|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
5119313|NCT01493557|12594594|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
5119314|NCT01493557|12594595|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
5119315|NCT01493557|12594593|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
5119316|NCT01493557|12594594|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
5119317|NCT01493557|12594595|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
5119318|NCT01493557|12594593|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
5119319|NCT01493557|12594594|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
5119320|NCT01493557|12594595|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
5119321|NCT01493557|12594593|P3|STARTED|Not Randomized to Management Strategies||950
5119322|NCT01493557|12594594|P2|STARTED|Not Randomized to Management Strategies||0
5119323|NCT01493557|12594595|P1|STARTED|Not Randomized to Management Strategies||0
5119324|NCT01493531|12594623|P3|NOT COMPLETED|Overall Study||48
5119325|NCT01493531|12594624|P2|NOT COMPLETED|Overall Study||50
5119326|NCT01493531|12594625|P1|NOT COMPLETED|Overall Study||41
5119327|NCT01493531|12594623|P3|COMPLETED|Overall Study||158
5119328|NCT01493531|12594624|P2|COMPLETED|Overall Study||150
5119329|NCT01493531|12594625|P1|COMPLETED|Overall Study||163
5119330|NCT01493531|12594623|P3|STARTED|Overall Study||206
5119331|NCT01493531|12594624|P2|STARTED|Overall Study||200
5119332|NCT01493531|12594625|P1|STARTED|Overall Study||204
5119333|NCT01493427|12594639|P1|NOT COMPLETED|Overall Study||20
5119334|NCT01493427|12594639|P1|COMPLETED|Overall Study||179
5119335|NCT01493427|12594639|P1|STARTED|Overall Study||199
5119336|NCT01493414|12594644|P1|NOT COMPLETED|Overall Study||950
5119337|NCT01493414|12594644|P1|COMPLETED|Overall Study||1283
5119338|NCT01493414|12594644|P1|STARTED|Overall Study||2233
5119339|NCT01493284|12594657|P1|NOT COMPLETED|Overall Study||61
5119340|NCT01493284|12594657|P1|COMPLETED|Overall Study||161
5119341|NCT01493284|12594657|P1|STARTED|Overall Study||222
5119342|NCT01493180|12594666|P2|NOT COMPLETED|Overall Study||2
5119343|NCT01493180|12594667|P1|NOT COMPLETED|Overall Study||3
5119344|NCT01493180|12594666|P2|COMPLETED|Overall Study||49
5119345|NCT01493180|12594667|P1|COMPLETED|Overall Study||48
5119346|NCT01493180|12594666|P2|STARTED|Overall Study||51
5119347|NCT01493180|12594667|P1|STARTED|Overall Study||51
5119348|NCT01493167|12594673|P1|NOT COMPLETED|Overall Study||0
5119349|NCT01493167|12594673|P1|COMPLETED|Overall Study||97
5119350|NCT01493167|12594673|P1|STARTED|Overall Study||97
5119351|NCT01493089|12594679|P2|NOT COMPLETED|Overall Study||3
5119352|NCT01493089|12594680|P1|NOT COMPLETED|Overall Study||3
5119353|NCT01493089|12594679|P2|COMPLETED|Overall Study||114
5119354|NCT01493089|12594680|P1|COMPLETED|Overall Study||119
5119355|NCT01493089|12594679|P2|STARTED|Overall Study||117
5119356|NCT01493089|12594680|P1|STARTED|Overall Study||122
5119357|NCT01493024|12594700|P4|NOT COMPLETED|Overall Study||0
5119358|NCT01493024|12594701|P3|NOT COMPLETED|Overall Study||0
5119359|NCT01493024|12594702|P2|NOT COMPLETED|Overall Study||0
5119360|NCT01493024|12594703|P1|NOT COMPLETED|Overall Study||0
5119361|NCT01493024|12594700|P4|COMPLETED|Overall Study||24
5119362|NCT01493024|12594701|P3|COMPLETED|Overall Study||24
5119363|NCT01493024|12594702|P2|COMPLETED|Overall Study||12
5119364|NCT01493024|12594703|P1|COMPLETED|Overall Study||30
5119365|NCT01493024|12594700|P4|STARTED|Overall Study||24
5119366|NCT01493024|12594701|P3|STARTED|Overall Study||24
5119367|NCT01493024|12594702|P2|STARTED|Overall Study||12
5119368|NCT01493024|12594703|P1|STARTED|Overall Study||30
5119369|NCT01492686|12594779|P2|NOT COMPLETED|Open-label Phase||18
5119370|NCT01492686|12594780|P1|NOT COMPLETED|Open-label Phase||12
5119371|NCT01492686|12594779|P2|COMPLETED|Open-label Phase||40
5119372|NCT01492686|12594780|P1|COMPLETED|Open-label Phase||53
5119373|NCT01492686|12594779|P2|STARTED|Open-label Phase||58
5119374|NCT01492686|12594780|P1|STARTED|Open-label Phase||65
5119375|NCT01492686|12594779|P2|NOT COMPLETED|Double-blind Phase||8
5119376|NCT01492686|12594780|P1|NOT COMPLETED|Double-blind Phase||2
5119377|NCT01492686|12594779|P2|COMPLETED|Double-blind Phase||60
5119378|NCT01492686|12594780|P1|COMPLETED|Double-blind Phase||67
5119379|NCT01492686|12594779|P2|STARTED|Double-blind Phase||68
5119380|NCT01492686|12594780|P1|STARTED|Double-blind Phase||69
5119381|NCT01492673|12594804|P1|NOT COMPLETED|Overall Study||0
5119382|NCT01492673|12594804|P1|COMPLETED|Overall Study||9
5119383|NCT01492673|12594804|P1|STARTED|Overall Study||9
5119384|NCT01492582|12594811|P2|NOT COMPLETED|Overall Study||64
5119385|NCT01492582|12594812|P1|NOT COMPLETED|Overall Study||69
5119386|NCT01492582|12594811|P2|COMPLETED|Overall Study|Returned evaluable survey|982
5119387|NCT01492582|12594812|P1|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
5119388|NCT01492582|12594811|P2|Received First Nonavalent Vaccine Dose|Overall Study||0
5119389|NCT01492582|12594812|P1|Received First Nonavalent Vaccine Dose|Overall Study||182
5119390|NCT01492582|12594811|P2|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
5119391|NCT01492582|12594812|P1|Received First Quadrivalent Vaccine Dose|Overall Study||254
5119392|NCT01492582|12594811|P2|STARTED|Overall Study|Consented to the survey arm of the study|1046
5119393|NCT01492582|12594812|P1|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
5119394|NCT01492439|12594837|P2|NOT COMPLETED|Overall Study||9
5119395|NCT01492439|12594838|P1|NOT COMPLETED|Overall Study||4
5119396|NCT01492439|12594837|P2|COMPLETED|Overall Study||9
5119397|NCT01492439|12594838|P1|COMPLETED|Overall Study||15
5119398|NCT01492439|12594837|P2|Post-intervention|Overall Study||13
5119399|NCT01492439|12594838|P1|Post-intervention|Overall Study||18
5119400|NCT01492439|12594837|P2|STARTED|Overall Study||18
5119401|NCT01492439|12594838|P1|STARTED|Overall Study||19
5119402|NCT01492426|12594886|P2|NOT COMPLETED|Follow-Up||10
5119403|NCT01492426|12594887|P1|NOT COMPLETED|Follow-Up||25
5119404|NCT01492426|12594886|P2|COMPLETED|Follow-Up||181
5119405|NCT01492426|12594887|P1|COMPLETED|Follow-Up||359
5119406|NCT01492426|12594886|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
5119407|NCT01492426|12594887|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
5119408|NCT01492426|12594886|P2|NOT COMPLETED|Treatment||40
5119409|NCT01492426|12594887|P1|NOT COMPLETED|Treatment||83
5119410|NCT01492426|12594886|P2|COMPLETED|Treatment||160
5119411|NCT01492426|12594887|P1|COMPLETED|Treatment||319
5119412|NCT01492426|12594886|P2|STARTED|Treatment||200
5119413|NCT01492426|12594887|P1|STARTED|Treatment||402
5119414|NCT01492400|12594905|P2|NOT COMPLETED|Overall Study||16
5119415|NCT01492400|12594906|P1|NOT COMPLETED|Overall Study||16
5119416|NCT01492400|12594905|P2|COMPLETED|Overall Study||166
5119417|NCT01492400|12594906|P1|COMPLETED|Overall Study||165
5119418|NCT01492400|12594905|P2|STARTED|Overall Study||182
5119419|NCT01492400|12594906|P1|STARTED|Overall Study||181
5119420|NCT01492309|12594918|P2|NOT COMPLETED|Overall Study||0
5119421|NCT01492309|12594919|P1|NOT COMPLETED|Overall Study||0
5119422|NCT01492309|12594918|P2|COMPLETED|Overall Study||11
5119423|NCT01492309|12594919|P1|COMPLETED|Overall Study||11
5119424|NCT01492309|12594918|P2|STARTED|Overall Study||11
5119425|NCT01492309|12594919|P1|STARTED|Overall Study||11
5119426|NCT01492088|12594930|P3|NOT COMPLETED|Overall Study||14
5119427|NCT01492088|12594931|P2|NOT COMPLETED|Overall Study||14
5119428|NCT01492088|12594932|P1|NOT COMPLETED|Overall Study||3
5119429|NCT01492088|12594930|P3|COMPLETED|Overall Study||3
5119430|NCT01492088|12594931|P2|COMPLETED|Overall Study||2
5119431|NCT01492088|12594932|P1|COMPLETED|Overall Study||0
5119432|NCT01492088|12594930|P3|STARTED|Overall Study||17
5119433|NCT01492088|12594931|P2|STARTED|Overall Study||16
5119434|NCT01492088|12594932|P1|STARTED|Overall Study||3
5119435|NCT01491984|12594992|P2|NOT COMPLETED|Overall Study||1
5119436|NCT01491984|12594993|P1|NOT COMPLETED|Overall Study||2
5119437|NCT01491984|12594992|P2|COMPLETED|Overall Study||44
5119438|NCT01491984|12594993|P1|COMPLETED|Overall Study||47
5119439|NCT01491984|12594992|P2|STARTED|Overall Study||45
5119440|NCT01491984|12594993|P1|STARTED|Overall Study||49
5119441|NCT01491958|12595001|P2|NOT COMPLETED|Overall Study||0
5119442|NCT01491958|12595002|P1|NOT COMPLETED|Overall Study||0
5119443|NCT01491958|12595001|P2|COMPLETED|Overall Study||40
5119444|NCT01491958|12595002|P1|COMPLETED|Overall Study||40
5119445|NCT01491958|12595001|P2|STARTED|Overall Study||40
5119446|NCT01491958|12595002|P1|STARTED|Overall Study||40
5119447|NCT01491919|12595013|P3|NOT COMPLETED|Overall Study||1
5119448|NCT01491919|12595014|P2|NOT COMPLETED|Overall Study||2
5119449|NCT01491919|12595015|P1|NOT COMPLETED|Overall Study||1
5119450|NCT01491919|12595013|P3|COMPLETED|Overall Study||2
5119451|NCT01491919|12595014|P2|COMPLETED|Overall Study||8
5119452|NCT01491919|12595015|P1|COMPLETED|Overall Study||12
5119453|NCT01491919|12595013|P3|STARTED|Overall Study||3
5119454|NCT01491919|12595014|P2|STARTED|Overall Study||10
5119455|NCT01491919|12595015|P1|STARTED|Overall Study||13
5119456|NCT01491893|12595061|P10|NOT COMPLETED|Overall Study||0
5119457|NCT01491893|12595062|P9|NOT COMPLETED|Overall Study||0
5119458|NCT01491893|12595063|P8|NOT COMPLETED|Overall Study||0
5119459|NCT01491893|12595064|P7|NOT COMPLETED|Overall Study||0
5119460|NCT01491893|12595065|P6|NOT COMPLETED|Overall Study||0
5119461|NCT01491893|12595066|P5|NOT COMPLETED|Overall Study||0
5119462|NCT01491893|12595067|P4|NOT COMPLETED|Overall Study||0
5119463|NCT01491893|12595068|P3|NOT COMPLETED|Overall Study||0
5119464|NCT01491893|12595069|P2|NOT COMPLETED|Overall Study||0
5119465|NCT01491893|12595070|P1|NOT COMPLETED|Overall Study||0
5119466|NCT01491893|12595061|P10|COMPLETED|Overall Study||7
5119467|NCT01491893|12595062|P9|COMPLETED|Overall Study||15
5119468|NCT01491893|12595063|P8|COMPLETED|Overall Study||24
5119469|NCT01491893|12595064|P7|COMPLETED|Overall Study||6
5119470|NCT01491893|12595065|P6|COMPLETED|Overall Study||1
5119471|NCT01491893|12595066|P5|COMPLETED|Overall Study||4
5119472|NCT01491893|12595067|P4|COMPLETED|Overall Study||1
5119473|NCT01491893|12595068|P3|COMPLETED|Overall Study||1
5119474|NCT01491893|12595069|P2|COMPLETED|Overall Study||1
5119475|NCT01491893|12595070|P1|COMPLETED|Overall Study||1
5119476|NCT01491893|12595061|P10|STARTED|Overall Study||7
5119477|NCT01491893|12595062|P9|STARTED|Overall Study||15
5119478|NCT01491893|12595063|P8|STARTED|Overall Study||24
5119479|NCT01491893|12595064|P7|STARTED|Overall Study||6
5119480|NCT01491893|12595065|P6|STARTED|Overall Study||1
5119481|NCT01491893|12595066|P5|STARTED|Overall Study||4
5119482|NCT01491893|12595067|P4|STARTED|Overall Study||1
5119483|NCT01491893|12595068|P3|STARTED|Overall Study||1
5119484|NCT01491893|12595069|P2|STARTED|Overall Study||1
5119485|NCT01491893|12595070|P1|STARTED|Overall Study||1
5119486|NCT01491854|12595086|P1|NOT COMPLETED|Overall Study||130
5119487|NCT01491854|12595086|P1|COMPLETED|Overall Study||0
5119488|NCT01491854|12595086|P1|STARTED|Overall Study||130
5119489|NCT01491841|12595097|P1|NOT COMPLETED|Overall Study||11
5119490|NCT01491841|12595097|P1|COMPLETED|Overall Study||22
5119491|NCT01491841|12595097|P1|STARTED|Overall Study||33
5119492|NCT01491802|12595111|P2|NOT COMPLETED|Overall Study||2
5119493|NCT01491802|12595112|P1|NOT COMPLETED|Overall Study||1
5119494|NCT01491802|12595111|P2|COMPLETED|Overall Study||6
5119495|NCT01491802|12595112|P1|COMPLETED|Overall Study||8
5119496|NCT01491802|12595111|P2|STARTED|Overall Study||8
5119497|NCT01491802|12595112|P1|STARTED|Overall Study||9
5119498|NCT01491737|12595139|P2|NOT COMPLETED|Overall Study||50
5119499|NCT01491737|12595140|P1|NOT COMPLETED|Overall Study||49
5119500|NCT01491737|12595139|P2|COMPLETED|Overall Study||79
5119501|NCT01491737|12595140|P1|COMPLETED|Overall Study||80
5119502|NCT01491737|12595139|P2|STARTED|Overall Study||129
5119503|NCT01491737|12595140|P1|STARTED|Overall Study||129
5119504|NCT01491672|12595163|P3|NOT COMPLETED|Overall Study||11
5119505|NCT01491672|12595164|P2|NOT COMPLETED|Overall Study||60
5119506|NCT01491672|12595165|P1|NOT COMPLETED|Overall Study||56
5119507|NCT01491672|12595163|P3|COMPLETED|Overall Study||3
5119508|NCT01491672|12595164|P2|COMPLETED|Overall Study||2
5119509|NCT01491672|12595165|P1|COMPLETED|Overall Study||2
5119510|NCT01491672|12595163|P3|Safety Set|Overall Study||14
5119511|NCT01491672|12595164|P2|Safety Set|Overall Study||61
5119512|NCT01491672|12595165|P1|Safety Set|Overall Study||58
5119513|NCT01491672|12595163|P3|STARTED|Overall Study||14
5119514|NCT01491672|12595164|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
5119515|NCT01491672|12595165|P1|STARTED|Overall Study||58
5119516|NCT01491633|12595190|P1|NOT COMPLETED|Overall Study||5
5119517|NCT01491633|12595190|P1|COMPLETED|Overall Study||0
5119518|NCT01491633|12595190|P1|STARTED|Overall Study||5
5119519|NCT01491607|12595202|P1|NOT COMPLETED|Overall Study||10
5119520|NCT01491607|12595202|P1|COMPLETED|Overall Study||190
5119521|NCT01491607|12595202|P1|STARTED|Overall Study||200
5119522|NCT01491490|12595300|P2|NOT COMPLETED|Overall Study||0
5119523|NCT01491490|12595301|P1|NOT COMPLETED|Overall Study||0
5119524|NCT01491490|12595300|P2|COMPLETED|Overall Study||1
5119525|NCT01491490|12595301|P1|COMPLETED|Overall Study||1
5119526|NCT01491490|12595300|P2|STARTED|Overall Study||1
5119527|NCT01491490|12595301|P1|STARTED|Overall Study||1
5119528|NCT01491178|12595307|P1|NOT COMPLETED|Overall Study||2794
5119619|NCT01490814|12595566|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
5119529|NCT01491178|12595307|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
5119530|NCT01491178|12595307|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
5119531|NCT01491113|12595317|P5|NOT COMPLETED|Overall Study||0
5119532|NCT01491113|12595318|P4|NOT COMPLETED|Overall Study||0
5119533|NCT01491113|12595319|P3|NOT COMPLETED|Overall Study||0
5119534|NCT01491113|12595320|P2|NOT COMPLETED|Overall Study||0
5119535|NCT01491113|12595321|P1|NOT COMPLETED|Overall Study||0
5119536|NCT01491113|12595317|P5|COMPLETED|Overall Study||6
5119537|NCT01491113|12595318|P4|COMPLETED|Overall Study||6
5119538|NCT01491113|12595319|P3|COMPLETED|Overall Study||6
5119539|NCT01491113|12595320|P2|COMPLETED|Overall Study||6
5119540|NCT01491113|12595321|P1|COMPLETED|Overall Study||6
5119541|NCT01491113|12595317|P5|STARTED|Overall Study||6
5119542|NCT01491113|12595318|P4|STARTED|Overall Study||6
5119543|NCT01491113|12595319|P3|STARTED|Overall Study||6
5119544|NCT01491113|12595320|P2|STARTED|Overall Study||6
5119545|NCT01491113|12595321|P1|STARTED|Overall Study||6
5119546|NCT01491035|12595416|P8|NOT COMPLETED|Overall Study||0
5119547|NCT01491035|12595417|P7|NOT COMPLETED|Overall Study||0
5119548|NCT01491035|12595418|P6|NOT COMPLETED|Overall Study||0
5119549|NCT01491035|12595419|P5|NOT COMPLETED|Overall Study||1
5119550|NCT01491035|12595420|P4|NOT COMPLETED|Overall Study||0
5119551|NCT01491035|12595421|P3|NOT COMPLETED|Overall Study||0
5119552|NCT01491035|12595422|P2|NOT COMPLETED|Overall Study||0
5119553|NCT01491035|12595423|P1|NOT COMPLETED|Overall Study||0
5119554|NCT01491035|12595416|P8|COMPLETED|Overall Study||6
5119555|NCT01491035|12595417|P7|COMPLETED|Overall Study||6
5119556|NCT01491035|12595418|P6|COMPLETED|Overall Study||6
5119557|NCT01491035|12595419|P5|COMPLETED|Overall Study||5
5119558|NCT01491035|12595420|P4|COMPLETED|Overall Study||6
5119559|NCT01491035|12595421|P3|COMPLETED|Overall Study||6
5119560|NCT01491035|12595422|P2|COMPLETED|Overall Study||6
5119561|NCT01491035|12595423|P1|COMPLETED|Overall Study||6
5119562|NCT01491035|12595416|P8|STARTED|Overall Study||6
5119563|NCT01491035|12595417|P7|STARTED|Overall Study||6
5119564|NCT01491035|12595418|P6|STARTED|Overall Study||6
5119565|NCT01491035|12595419|P5|STARTED|Overall Study||6
5119566|NCT01491035|12595420|P4|STARTED|Overall Study||6
5119567|NCT01491035|12595421|P3|STARTED|Overall Study||6
5119568|NCT01491035|12595422|P2|STARTED|Overall Study||6
5119569|NCT01491035|12595423|P1|STARTED|Overall Study||6
5119570|NCT01491022|12595491|P2|NOT COMPLETED|Intervention 2||0
5119571|NCT01491022|12595492|P1|NOT COMPLETED|Intervention 2||1
5119572|NCT01491022|12595491|P2|COMPLETED|Intervention 2||11
5119573|NCT01491022|12595492|P1|COMPLETED|Intervention 2||8
5119574|NCT01491022|12595491|P2|STARTED|Intervention 2||11
5119575|NCT01491022|12595492|P1|STARTED|Intervention 2||9
5119576|NCT01491022|12595491|P2|NOT COMPLETED|2 Week Washout||0
5119577|NCT01491022|12595492|P1|NOT COMPLETED|2 Week Washout||0
5119578|NCT01491022|12595491|P2|COMPLETED|2 Week Washout||11
5119579|NCT01491022|12595492|P1|COMPLETED|2 Week Washout||9
5119580|NCT01491022|12595491|P2|STARTED|2 Week Washout||11
5119581|NCT01491022|12595492|P1|STARTED|2 Week Washout||9
5119582|NCT01491022|12595491|P2|NOT COMPLETED|Intervention 1||1
5119583|NCT01491022|12595492|P1|NOT COMPLETED|Intervention 1||1
5119584|NCT01491022|12595491|P2|COMPLETED|Intervention 1||11
5119585|NCT01491022|12595492|P1|COMPLETED|Intervention 1||9
5119586|NCT01491022|12595491|P2|STARTED|Intervention 1||12
5119587|NCT01491022|12595492|P1|STARTED|Intervention 1||10
5119588|NCT01490931|12595508|P1|NOT COMPLETED|Overall Study||0
5119589|NCT01490931|12595508|P1|COMPLETED|Overall Study||25
5119590|NCT01490931|12595508|P1|STARTED|Overall Study||25
5119591|NCT01490892|12595524|P1|NOT COMPLETED|Overall Study||0
5119592|NCT01490892|12595524|P1|COMPLETED|Overall Study||219
5119593|NCT01490892|12595524|P1|STARTED|Overall Study||219
5119594|NCT01490866|12595529|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
5119595|NCT01490866|12595529|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
5119596|NCT01490866|12595529|P1|STARTED|Axitinib Maintenance Therapy||49
5119597|NCT01490866|12595529|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
5119598|NCT01490866|12595529|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
5119599|NCT01490866|12595529|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
5119600|NCT01490840|12595540|P2|NOT COMPLETED|Phase 2||6
5119601|NCT01490840|12595541|P1|NOT COMPLETED|Phase 2||6
5119602|NCT01490840|12595540|P2|COMPLETED|Phase 2||68
5119603|NCT01490840|12595541|P1|COMPLETED|Phase 2||75
5119604|NCT01490840|12595540|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
5119605|NCT01490840|12595541|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
5119606|NCT01490840|12595540|P2|NOT COMPLETED|Phase 1||6
5119607|NCT01490840|12595541|P1|NOT COMPLETED|Phase 1||10
5119608|NCT01490840|12595540|P2|COMPLETED|Phase 1||78
5119609|NCT01490840|12595541|P1|COMPLETED|Phase 1||84
5119610|NCT01490840|12595540|P2|Modified Full Analysis Set|Phase 1||83
5119611|NCT01490840|12595541|P1|Modified Full Analysis Set|Phase 1||56
5119612|NCT01490840|12595540|P2|STARTED|Phase 1||84
5119613|NCT01490840|12595541|P1|STARTED|Phase 1||94
5119614|NCT01490814|12595565|P2|NOT COMPLETED|Overall Study||8
5119615|NCT01490814|12595566|P1|NOT COMPLETED|Overall Study||4
5119616|NCT01490814|12595565|P2|COMPLETED|Overall Study|376 received ablation|376
5119617|NCT01490814|12595566|P1|COMPLETED|Overall Study|374 received ablation|374
5119618|NCT01490814|12595565|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
5119620|NCT01490788|12595586|P6|NOT COMPLETED|Overall Study||0
5119621|NCT01490788|12595587|P5|NOT COMPLETED|Overall Study||0
5119622|NCT01490788|12595588|P4|NOT COMPLETED|Overall Study||0
5119623|NCT01490788|12595589|P3|NOT COMPLETED|Overall Study||0
5119624|NCT01490788|12595590|P2|NOT COMPLETED|Overall Study||0
5119625|NCT01490788|12595591|P1|NOT COMPLETED|Overall Study||1
5119626|NCT01490788|12595586|P6|COMPLETED|Overall Study||5
5119627|NCT01490788|12595587|P5|COMPLETED|Overall Study||5
5119628|NCT01490788|12595588|P4|COMPLETED|Overall Study||5
5119629|NCT01490788|12595589|P3|COMPLETED|Overall Study||5
5119630|NCT01490788|12595590|P2|COMPLETED|Overall Study||5
5119631|NCT01490788|12595591|P1|COMPLETED|Overall Study||4
5119632|NCT01490788|12595586|P6|STARTED|Overall Study||5
5119633|NCT01490788|12595587|P5|STARTED|Overall Study||5
5119634|NCT01490788|12595588|P4|STARTED|Overall Study||5
5119635|NCT01490788|12595589|P3|STARTED|Overall Study||5
5119636|NCT01490788|12595590|P2|STARTED|Overall Study||5
5119637|NCT01490788|12595591|P1|STARTED|Overall Study||5
5119638|NCT01490723|12595602|P1|NOT COMPLETED|Overall Study||0
5119639|NCT01490723|12595602|P1|COMPLETED|Overall Study||20
5119640|NCT01490723|12595602|P1|STARTED|Overall Study||20
5119641|NCT01490697|12595609|P2|NOT COMPLETED|Overall Study||2
5119642|NCT01490697|12595610|P1|NOT COMPLETED|Overall Study||1
5119643|NCT01490697|12595609|P2|COMPLETED|Overall Study||16
5119644|NCT01490697|12595610|P1|COMPLETED|Overall Study||15
5119645|NCT01490697|12595609|P2|STARTED|Overall Study||18
5119646|NCT01490697|12595610|P1|STARTED|Overall Study||16
5119647|NCT01490684|12595618|P1|NOT COMPLETED|Overall Study||0
5119648|NCT01490684|12595618|P1|COMPLETED|Overall Study||162
5119649|NCT01490684|12595618|P1|STARTED|Overall Study||162
5119650|NCT01490632|12595630|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
5119651|NCT01490632|12595631|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
5119652|NCT01490632|12595632|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
5119653|NCT01490632|12595633|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
5119654|NCT01490632|12595634|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
5119655|NCT01490632|12595635|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
5119656|NCT01490632|12595636|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
5119657|NCT01490632|12595637|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
5119658|NCT01490632|12595638|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
5119659|NCT01490632|12595639|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
5119660|NCT01490632|12595640|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
5119661|NCT01490632|12595641|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
5119662|NCT01490632|12595642|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
5119663|NCT01490632|12595643|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
5119664|NCT01490632|12595644|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
5119665|NCT01490632|12595645|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
5119666|NCT01490632|12595646|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
5119667|NCT01490632|12595647|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
5119668|NCT01490632|12595648|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
5119669|NCT01490632|12595649|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
5119670|NCT01490632|12595630|P20|COMPLETED|Part D: Re-Treatment Period||30
5119671|NCT01490632|12595631|P19|COMPLETED|Part D: Re-Treatment Period||12
5119672|NCT01490632|12595632|P18|COMPLETED|Part D: Re-Treatment Period||8
5119673|NCT01490632|12595633|P17|COMPLETED|Part D: Re-Treatment Period||3
5119674|NCT01490632|12595634|P16|COMPLETED|Part D: Re-Treatment Period||0
5119675|NCT01490632|12595635|P15|COMPLETED|Part D: Re-Treatment Period||0
5119676|NCT01490632|12595636|P14|COMPLETED|Part D: Re-Treatment Period||0
5119677|NCT01490632|12595637|P13|COMPLETED|Part D: Re-Treatment Period||0
5119678|NCT01490632|12595638|P12|COMPLETED|Part D: Re-Treatment Period||0
5119679|NCT01490632|12595639|P11|COMPLETED|Part D: Re-Treatment Period||0
5119680|NCT01490632|12595640|P10|COMPLETED|Part D: Re-Treatment Period||0
5119681|NCT01490632|12595641|P9|COMPLETED|Part D: Re-Treatment Period||0
5119682|NCT01490632|12595642|P8|COMPLETED|Part D: Re-Treatment Period||0
5119683|NCT01490632|12595643|P7|COMPLETED|Part D: Re-Treatment Period||0
5119684|NCT01490632|12595644|P6|COMPLETED|Part D: Re-Treatment Period||0
5119685|NCT01490632|12595645|P5|COMPLETED|Part D: Re-Treatment Period||0
5119686|NCT01490632|12595646|P4|COMPLETED|Part D: Re-Treatment Period||0
5119687|NCT01490632|12595647|P3|COMPLETED|Part D: Re-Treatment Period||0
5119688|NCT01490632|12595648|P2|COMPLETED|Part D: Re-Treatment Period||0
5119689|NCT01490632|12595649|P1|COMPLETED|Part D: Re-Treatment Period||0
5119690|NCT01490632|12595630|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
5119691|NCT01490632|12595631|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
5119692|NCT01490632|12595632|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
5119693|NCT01490632|12595633|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
5119694|NCT01490632|12595634|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
5119695|NCT01490632|12595635|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
5119696|NCT01490632|12595636|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
5119697|NCT01490632|12595637|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
5119698|NCT01490632|12595638|P12|STARTED|Part D: Re-Treatment Period||0
5119699|NCT01490632|12595639|P11|STARTED|Part D: Re-Treatment Period||0
5119700|NCT01490632|12595640|P10|STARTED|Part D: Re-Treatment Period||0
5119701|NCT01490632|12595641|P9|STARTED|Part D: Re-Treatment Period||0
5119702|NCT01490632|12595642|P8|STARTED|Part D: Re-Treatment Period||0
5119703|NCT01490632|12595643|P7|STARTED|Part D: Re-Treatment Period||0
5119704|NCT01490632|12595644|P6|STARTED|Part D: Re-Treatment Period||0
5119705|NCT01490632|12595645|P5|STARTED|Part D: Re-Treatment Period||0
5119706|NCT01490632|12595646|P4|STARTED|Part D: Re-Treatment Period||0
5119707|NCT01490632|12595647|P3|STARTED|Part D: Re-Treatment Period||0
5119708|NCT01490632|12595648|P2|STARTED|Part D: Re-Treatment Period||0
5119709|NCT01490632|12595649|P1|STARTED|Part D: Re-Treatment Period||0
5119710|NCT01490632|12595630|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119711|NCT01490632|12595631|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119712|NCT01490632|12595632|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119713|NCT01490632|12595633|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119714|NCT01490632|12595634|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
5119715|NCT01490632|12595635|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
5119716|NCT01490632|12595636|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
5119717|NCT01490632|12595637|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
5119718|NCT01490632|12595638|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119719|NCT01490632|12595639|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119720|NCT01490632|12595640|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119721|NCT01490632|12595641|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119722|NCT01490632|12595642|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119723|NCT01490632|12595643|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119724|NCT01490632|12595644|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119725|NCT01490632|12595645|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119726|NCT01490632|12595646|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119727|NCT01490632|12595647|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119728|NCT01490632|12595648|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119729|NCT01490632|12595649|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
5119730|NCT01490632|12595630|P20|COMPLETED|Part C: Washout or Step-Down Period||0
5119731|NCT01490632|12595631|P19|COMPLETED|Part C: Washout or Step-Down Period||0
5119732|NCT01490632|12595632|P18|COMPLETED|Part C: Washout or Step-Down Period||0
5119733|NCT01490632|12595633|P17|COMPLETED|Part C: Washout or Step-Down Period||0
5119734|NCT01490632|12595634|P16|COMPLETED|Part C: Washout or Step-Down Period||18
5119735|NCT01490632|12595635|P15|COMPLETED|Part C: Washout or Step-Down Period||37
5119736|NCT01490632|12595636|P14|COMPLETED|Part C: Washout or Step-Down Period||6
5119737|NCT01490632|12595637|P13|COMPLETED|Part C: Washout or Step-Down Period||10
5119738|NCT01490632|12595638|P12|COMPLETED|Part C: Washout or Step-Down Period||0
5119739|NCT01490632|12595639|P11|COMPLETED|Part C: Washout or Step-Down Period||0
5119740|NCT01490632|12595640|P10|COMPLETED|Part C: Washout or Step-Down Period||0
5119741|NCT01490632|12595641|P9|COMPLETED|Part C: Washout or Step-Down Period||0
5119742|NCT01490632|12595642|P8|COMPLETED|Part C: Washout or Step-Down Period||0
5119743|NCT01490632|12595643|P7|COMPLETED|Part C: Washout or Step-Down Period||0
5119744|NCT01490632|12595644|P6|COMPLETED|Part C: Washout or Step-Down Period||0
5119745|NCT01490632|12595645|P5|COMPLETED|Part C: Washout or Step-Down Period||0
5119746|NCT01490632|12595646|P4|COMPLETED|Part C: Washout or Step-Down Period||0
5119747|NCT01490632|12595647|P3|COMPLETED|Part C: Washout or Step-Down Period||0
5119748|NCT01490632|12595648|P2|COMPLETED|Part C: Washout or Step-Down Period||0
5119749|NCT01490632|12595649|P1|COMPLETED|Part C: Washout or Step-Down Period||0
5119750|NCT01490632|12595630|P20|STARTED|Part C: Washout or Step-Down Period||0
5119751|NCT01490632|12595631|P19|STARTED|Part C: Washout or Step-Down Period||0
5119752|NCT01490632|12595632|P18|STARTED|Part C: Washout or Step-Down Period||0
5119753|NCT01490632|12595633|P17|STARTED|Part C: Washout or Step-Down Period||0
5119754|NCT01490632|12595634|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
5119755|NCT01490632|12595635|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
5119756|NCT01490632|12595636|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
5119757|NCT01490632|12595637|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
5119758|NCT01490632|12595638|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
5119759|NCT01490632|12595639|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
5119760|NCT01490632|12595640|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
5119761|NCT01490632|12595641|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
5119762|NCT01490632|12595642|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
5119763|NCT01490632|12595643|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
5119764|NCT01490632|12595644|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
5119765|NCT01490632|12595645|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
5119766|NCT01490632|12595646|P4|STARTED|Part C: Washout or Step-Down Period||0
5119767|NCT01490632|12595647|P3|STARTED|Part C: Washout or Step-Down Period||0
5119768|NCT01490632|12595648|P2|STARTED|Part C: Washout or Step-Down Period||0
5119769|NCT01490632|12595649|P1|STARTED|Part C: Washout or Step-Down Period||0
5119770|NCT01490632|12595630|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119771|NCT01490632|12595631|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119772|NCT01490632|12595632|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119773|NCT01490632|12595633|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119774|NCT01490632|12595634|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119775|NCT01490632|12595635|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119776|NCT01490632|12595636|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119777|NCT01490632|12595637|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119778|NCT01490632|12595638|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
5119779|NCT01490632|12595639|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
5119780|NCT01490632|12595640|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
5119781|NCT01490632|12595641|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
5119782|NCT01490632|12595642|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
5119783|NCT01490632|12595643|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
5119784|NCT01490632|12595644|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
5119785|NCT01490632|12595645|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119786|NCT01490632|12595646|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119787|NCT01490632|12595647|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119788|NCT01490632|12595648|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119789|NCT01490632|12595649|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
5119790|NCT01490632|12595630|P20|COMPLETED|Part B: Extension or Step-Up Period||0
5119791|NCT01490632|12595631|P19|COMPLETED|Part B: Extension or Step-Up Period||0
5119792|NCT01490632|12595632|P18|COMPLETED|Part B: Extension or Step-Up Period||0
5119793|NCT01490632|12595633|P17|COMPLETED|Part B: Extension or Step-Up Period||0
5119794|NCT01490632|12595634|P16|COMPLETED|Part B: Extension or Step-Up Period||0
5119795|NCT01490632|12595635|P15|COMPLETED|Part B: Extension or Step-Up Period||0
5119796|NCT01490632|12595636|P14|COMPLETED|Part B: Extension or Step-Up Period||0
5119797|NCT01490632|12595637|P13|COMPLETED|Part B: Extension or Step-Up Period||0
5119798|NCT01490632|12595638|P12|COMPLETED|Part B: Extension or Step-Up Period||0
5119799|NCT01490632|12595639|P11|COMPLETED|Part B: Extension or Step-Up Period||22
5119800|NCT01490632|12595640|P10|COMPLETED|Part B: Extension or Step-Up Period||25
5119801|NCT01490632|12595641|P9|COMPLETED|Part B: Extension or Step-Up Period||6
5119802|NCT01490632|12595642|P8|COMPLETED|Part B: Extension or Step-Up Period||13
5119803|NCT01490632|12595643|P7|COMPLETED|Part B: Extension or Step-Up Period||51
5119804|NCT01490632|12595644|P6|COMPLETED|Part B: Extension or Step-Up Period||25
5119805|NCT01490632|12595645|P5|COMPLETED|Part B: Extension or Step-Up Period||0
5119806|NCT01490632|12595646|P4|COMPLETED|Part B: Extension or Step-Up Period||0
5119807|NCT01490632|12595647|P3|COMPLETED|Part B: Extension or Step-Up Period||0
5119808|NCT01490632|12595648|P2|COMPLETED|Part B: Extension or Step-Up Period||0
5119809|NCT01490632|12595649|P1|COMPLETED|Part B: Extension or Step-Up Period||0
5119810|NCT01490632|12595630|P20|STARTED|Part B: Extension or Step-Up Period||0
5119811|NCT01490632|12595631|P19|STARTED|Part B: Extension or Step-Up Period||0
5119812|NCT01490632|12595632|P18|STARTED|Part B: Extension or Step-Up Period||0
5119813|NCT01490632|12595633|P17|STARTED|Part B: Extension or Step-Up Period||0
5119814|NCT01490632|12595634|P16|STARTED|Part B: Extension or Step-Up Period||0
5119815|NCT01490632|12595635|P15|STARTED|Part B: Extension or Step-Up Period||0
5119816|NCT01490632|12595636|P14|STARTED|Part B: Extension or Step-Up Period||0
5119817|NCT01490632|12595637|P13|STARTED|Part B: Extension or Step-Up Period||0
5119818|NCT01490632|12595638|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
5119819|NCT01490632|12595639|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
5119820|NCT01490632|12595640|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
5119821|NCT01490632|12595641|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
5119822|NCT01490632|12595642|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
5119823|NCT01490632|12595643|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
5119824|NCT01490632|12595644|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
5119825|NCT01490632|12595645|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
5119826|NCT01490632|12595646|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
5119827|NCT01490632|12595647|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
5119828|NCT01490632|12595648|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
5119829|NCT01490632|12595649|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
5119830|NCT01490632|12595630|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
5119831|NCT01490632|12595631|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
5119832|NCT01490632|12595632|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
5119833|NCT01490632|12595633|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
5119834|NCT01490632|12595634|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
5119835|NCT01490632|12595635|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
5119836|NCT01490632|12595636|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
5119837|NCT01490632|12595637|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
5119838|NCT01490632|12595638|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
5119839|NCT01490632|12595639|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
5119840|NCT01490632|12595640|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
5119841|NCT01490632|12595641|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
5119842|NCT01490632|12595642|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
5119843|NCT01490632|12595643|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
5119844|NCT01490632|12595644|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
5119845|NCT01490632|12595645|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
5119846|NCT01490632|12595646|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
5119847|NCT01490632|12595647|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
5119848|NCT01490632|12595648|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
5119849|NCT01490632|12595649|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
5119850|NCT01490632|12595630|P20|COMPLETED|Part A: Initial Treatment Period||0
5119851|NCT01490632|12595631|P19|COMPLETED|Part A: Initial Treatment Period||0
5119852|NCT01490632|12595632|P18|COMPLETED|Part A: Initial Treatment Period||0
5119853|NCT01490632|12595633|P17|COMPLETED|Part A: Initial Treatment Period||0
5119854|NCT01490632|12595634|P16|COMPLETED|Part A: Initial Treatment Period||0
5119855|NCT01490632|12595635|P15|COMPLETED|Part A: Initial Treatment Period||0
5119856|NCT01490632|12595636|P14|COMPLETED|Part A: Initial Treatment Period||0
5119857|NCT01490632|12595637|P13|COMPLETED|Part A: Initial Treatment Period||0
5119858|NCT01490632|12595638|P12|COMPLETED|Part A: Initial Treatment Period||0
5119859|NCT01490632|12595639|P11|COMPLETED|Part A: Initial Treatment Period||0
5119860|NCT01490632|12595640|P10|COMPLETED|Part A: Initial Treatment Period||0
5119861|NCT01490632|12595641|P9|COMPLETED|Part A: Initial Treatment Period||0
5119862|NCT01490632|12595642|P8|COMPLETED|Part A: Initial Treatment Period||0
5119863|NCT01490632|12595643|P7|COMPLETED|Part A: Initial Treatment Period||0
5119864|NCT01490632|12595644|P6|COMPLETED|Part A: Initial Treatment Period||0
5119865|NCT01490632|12595645|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
5119866|NCT01490632|12595646|P4|COMPLETED|Part A: Initial Treatment Period||55
5119867|NCT01490632|12595647|P3|COMPLETED|Part A: Initial Treatment Period||67
5119868|NCT01490632|12595648|P2|COMPLETED|Part A: Initial Treatment Period||28
5119869|NCT01490632|12595649|P1|COMPLETED|Part A: Initial Treatment Period||27
5119870|NCT01490632|12595630|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119871|NCT01490632|12595631|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119872|NCT01490632|12595632|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119873|NCT01490632|12595633|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119874|NCT01490632|12595634|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119875|NCT01490632|12595635|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119876|NCT01490632|12595636|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119877|NCT01490632|12595637|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119878|NCT01490632|12595638|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119879|NCT01490632|12595639|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119880|NCT01490632|12595640|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119881|NCT01490632|12595641|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119882|NCT01490632|12595642|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119883|NCT01490632|12595643|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119884|NCT01490632|12595644|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
5119885|NCT01490632|12595645|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
5119886|NCT01490632|12595646|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
5119887|NCT01490632|12595647|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
5119888|NCT01490632|12595648|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
5119889|NCT01490632|12595649|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
5119890|NCT01490632|12595630|P20|STARTED|Part A: Initial Treatment Period||0
5119891|NCT01490632|12595631|P19|STARTED|Part A: Initial Treatment Period||0
5119892|NCT01490632|12595632|P18|STARTED|Part A: Initial Treatment Period||0
5119893|NCT01490632|12595633|P17|STARTED|Part A: Initial Treatment Period||0
5119894|NCT01490632|12595634|P16|STARTED|Part A: Initial Treatment Period||0
5119895|NCT01490632|12595635|P15|STARTED|Part A: Initial Treatment Period||0
5119896|NCT01490632|12595636|P14|STARTED|Part A: Initial Treatment Period||0
5119897|NCT01490632|12595637|P13|STARTED|Part A: Initial Treatment Period||0
5119898|NCT01490632|12595638|P12|STARTED|Part A: Initial Treatment Period||0
5119899|NCT01490632|12595639|P11|STARTED|Part A: Initial Treatment Period||0
5119900|NCT01490632|12595640|P10|STARTED|Part A: Initial Treatment Period||0
5119901|NCT01490632|12595641|P9|STARTED|Part A: Initial Treatment Period||0
5119902|NCT01490632|12595642|P8|STARTED|Part A: Initial Treatment Period||0
5119903|NCT01490632|12595643|P7|STARTED|Part A: Initial Treatment Period||0
5119904|NCT01490632|12595644|P6|STARTED|Part A: Initial Treatment Period||0
5119905|NCT01490632|12595645|P5|STARTED|Part A: Initial Treatment Period||69
5119906|NCT01490632|12595646|P4|STARTED|Part A: Initial Treatment Period||64
5119907|NCT01490632|12595647|P3|STARTED|Part A: Initial Treatment Period||72
5119908|NCT01490632|12595648|P2|STARTED|Part A: Initial Treatment Period||32
5119909|NCT01490632|12595649|P1|STARTED|Part A: Initial Treatment Period||34
5119910|NCT01490580|12595779|P2|NOT COMPLETED|Overall Study||2
5119911|NCT01490580|12595780|P1|NOT COMPLETED|Overall Study||0
5119912|NCT01490580|12595779|P2|COMPLETED|Overall Study||89
5119913|NCT01490580|12595780|P1|COMPLETED|Overall Study||82
5119914|NCT01490580|12595779|P2|STARTED|Overall Study||91
5119915|NCT01490580|12595780|P1|STARTED|Overall Study||82
5119916|NCT01490359|12595802|P2|NOT COMPLETED|Overall Study||17
5119917|NCT01490359|12595803|P1|NOT COMPLETED|Overall Study||24
5119918|NCT01490359|12595802|P2|COMPLETED|Overall Study||555
5119919|NCT01490359|12595803|P1|COMPLETED|Overall Study||585
5119920|NCT01490359|12595802|P2|Followed-up at 12 mo|Overall Study||537
5119921|NCT01490359|12595803|P1|Followed-up at 12 mo|Overall Study||569
5119922|NCT01490359|12595802|P2|Followed-up at 6 mo|Overall Study||535
5119923|NCT01490359|12595803|P1|Followed-up at 6 mo|Overall Study||558
5119924|NCT01490359|12595802|P2|STARTED|Overall Study||572
5119925|NCT01490359|12595803|P1|STARTED|Overall Study||609
5119926|NCT01490294|12595827|P4|NOT COMPLETED|Overall Study||1
5119927|NCT01490294|12595828|P3|NOT COMPLETED|Overall Study||1
5119928|NCT01490294|12595829|P2|NOT COMPLETED|Overall Study||0
5119929|NCT01490294|12595830|P1|NOT COMPLETED|Overall Study||5
5119930|NCT01490294|12595827|P4|COMPLETED|Overall Study||54
5119931|NCT01490294|12595828|P3|COMPLETED|Overall Study||58
5119932|NCT01490294|12595829|P2|COMPLETED|Overall Study||60
5119933|NCT01490294|12595830|P1|COMPLETED|Overall Study||53
5119934|NCT01490294|12595827|P4|Participant Received Treatment|Overall Study||54
5119935|NCT01490294|12595828|P3|Participant Received Treatment|Overall Study||58
5119936|NCT01490294|12595829|P2|Participant Received Treatment|Overall Study||60
5119937|NCT01490294|12595830|P1|Participant Received Treatment|Overall Study||54
5119938|NCT01490294|12595827|P4|STARTED|Overall Study||55
5119939|NCT01490294|12595828|P3|STARTED|Overall Study||59
5119940|NCT01490294|12595829|P2|STARTED|Overall Study||60
5119941|NCT01490294|12595830|P1|STARTED|Overall Study||58
5119942|NCT01490190|12596064|P1|NOT COMPLETED|Overall Study||48
5119943|NCT01490190|12596064|P1|COMPLETED|Overall Study||204
5119944|NCT01490190|12596064|P1|STARTED|Overall Study||252
5119945|NCT01490151|12596085|P1|NOT COMPLETED|Overall Study||0
5119946|NCT01490151|12596085|P1|COMPLETED|Overall Study||22
5119947|NCT01490151|12596085|P1|STARTED|Overall Study||22
5119948|NCT01490125|12596091|P6|NOT COMPLETED|Period III||0
5119949|NCT01490125|12596092|P5|NOT COMPLETED|Period III||1
5119950|NCT01490125|12596093|P4|NOT COMPLETED|Period III||2
5119951|NCT01490125|12596094|P3|NOT COMPLETED|Period III||0
5119952|NCT01490125|12596095|P2|NOT COMPLETED|Period III||1
5119953|NCT01490125|12596096|P1|NOT COMPLETED|Period III||3
5119954|NCT01490125|12596091|P6|COMPLETED|Period III||35
5119955|NCT01490125|12596092|P5|COMPLETED|Period III||31
5119956|NCT01490125|12596093|P4|COMPLETED|Period III||28
5119957|NCT01490125|12596094|P3|COMPLETED|Period III||34
5119958|NCT01490125|12596095|P2|COMPLETED|Period III||32
5119959|NCT01490125|12596096|P1|COMPLETED|Period III||31
5119960|NCT01490125|12596091|P6|STARTED|Period III||35
5119961|NCT01490125|12596092|P5|STARTED|Period III||32
5119962|NCT01490125|12596093|P4|STARTED|Period III||30
5119963|NCT01490125|12596094|P3|STARTED|Period III||34
5119964|NCT01490125|12596095|P2|STARTED|Period III||33
5119965|NCT01490125|12596096|P1|STARTED|Period III||34
5119966|NCT01490125|12596091|P6|NOT COMPLETED|Period II||2
5119967|NCT01490125|12596092|P5|NOT COMPLETED|Period II||4
5119968|NCT01490125|12596093|P4|NOT COMPLETED|Period II||3
5119969|NCT01490125|12596094|P3|NOT COMPLETED|Period II||3
5119970|NCT01490125|12596095|P2|NOT COMPLETED|Period II||4
5119971|NCT01490125|12596096|P1|NOT COMPLETED|Period II||3
5119972|NCT01490125|12596091|P6|COMPLETED|Period II||35
5119973|NCT01490125|12596092|P5|COMPLETED|Period II||32
5119974|NCT01490125|12596093|P4|COMPLETED|Period II||30
5119975|NCT01490125|12596094|P3|COMPLETED|Period II||34
5119976|NCT01490125|12596095|P2|COMPLETED|Period II||33
5119977|NCT01490125|12596096|P1|COMPLETED|Period II||34
5119978|NCT01490125|12596091|P6|STARTED|Period II||37
5119979|NCT01490125|12596092|P5|STARTED|Period II||36
5119980|NCT01490125|12596093|P4|STARTED|Period II||33
5119981|NCT01490125|12596094|P3|STARTED|Period II||37
5119982|NCT01490125|12596095|P2|STARTED|Period II||37
5119983|NCT01490125|12596096|P1|STARTED|Period II||37
5119984|NCT01490125|12596091|P6|NOT COMPLETED|Period I||5
5119985|NCT01490125|12596092|P5|NOT COMPLETED|Period I||4
5119986|NCT01490125|12596093|P4|NOT COMPLETED|Period I||5
5119987|NCT01490125|12596094|P3|NOT COMPLETED|Period I||4
5119988|NCT01490125|12596095|P2|NOT COMPLETED|Period I||5
5119989|NCT01490125|12596096|P1|NOT COMPLETED|Period I||6
5119990|NCT01490125|12596091|P6|COMPLETED|Period I||37
5119991|NCT01490125|12596092|P5|COMPLETED|Period I||36
5119992|NCT01490125|12596093|P4|COMPLETED|Period I||33
5119993|NCT01490125|12596094|P3|COMPLETED|Period I||37
5119994|NCT01490125|12596095|P2|COMPLETED|Period I||37
5119995|NCT01490125|12596096|P1|COMPLETED|Period I||37
5119996|NCT01490125|12596091|P6|STARTED|Period I||42
5119997|NCT01490125|12596092|P5|STARTED|Period I||40
5119998|NCT01490125|12596093|P4|STARTED|Period I||38
5119999|NCT01490125|12596094|P3|STARTED|Period I||41
5120000|NCT01490125|12596095|P2|STARTED|Period I||42
5120001|NCT01490125|12596096|P1|STARTED|Period I||43
5120002|NCT01490086|12596124|P5|NOT COMPLETED|Overall Study||11
5120003|NCT01490086|12596125|P4|NOT COMPLETED|Overall Study||7
5120004|NCT01490086|12596126|P3|NOT COMPLETED|Overall Study||7
5120005|NCT01490086|12596127|P2|NOT COMPLETED|Overall Study||15
5120006|NCT01490086|12596128|P1|NOT COMPLETED|Overall Study||8
5120007|NCT01490086|12596124|P5|COMPLETED|Overall Study||28
5120008|NCT01490086|12596125|P4|COMPLETED|Overall Study||13
5120009|NCT01490086|12596126|P3|COMPLETED|Overall Study||51
5120010|NCT01490086|12596127|P2|COMPLETED|Overall Study||44
5120011|NCT01490086|12596128|P1|COMPLETED|Overall Study||50
5120012|NCT01490086|12596124|P5|STARTED|Overall Study||39
5120013|NCT01490086|12596125|P4|STARTED|Overall Study||20
5120014|NCT01490086|12596126|P3|STARTED|Overall Study||58
5120015|NCT01490086|12596127|P2|STARTED|Overall Study||59
5120016|NCT01490086|12596128|P1|STARTED|Overall Study||58
5120017|NCT01490073|12596162|P2|NOT COMPLETED|Overall Study||0
5120018|NCT01490073|12596163|P1|NOT COMPLETED|Overall Study||0
5120019|NCT01490073|12596162|P2|COMPLETED|Overall Study||12
5120020|NCT01490073|12596163|P1|COMPLETED|Overall Study||12
5120021|NCT01490073|12596162|P2|STARTED|Overall Study||12
5120022|NCT01490073|12596163|P1|STARTED|Overall Study||12
5120023|NCT01490060|12596173|P4|NOT COMPLETED|Cycle 2||0
5120024|NCT01490060|12596174|P3|NOT COMPLETED|Cycle 2||1
5120025|NCT01490060|12596175|P2|NOT COMPLETED|Cycle 2||1
5120026|NCT01490060|12596176|P1|NOT COMPLETED|Cycle 2||2
5120027|NCT01490060|12596173|P4|COMPLETED|Cycle 2||8
5120028|NCT01490060|12596174|P3|COMPLETED|Cycle 2||8
5120029|NCT01490060|12596175|P2|COMPLETED|Cycle 2||11
5120030|NCT01490060|12596176|P1|COMPLETED|Cycle 2||9
5120031|NCT01490060|12596173|P4|STARTED|Cycle 2||8
5120032|NCT01490060|12596174|P3|STARTED|Cycle 2||9
5120033|NCT01490060|12596175|P2|STARTED|Cycle 2||12
5120034|NCT01490060|12596176|P1|STARTED|Cycle 2||11
5120035|NCT01490060|12596173|P4|NOT COMPLETED|Cycle 1||3
5120036|NCT01490060|12596174|P3|NOT COMPLETED|Cycle 1||3
5120037|NCT01490060|12596175|P2|NOT COMPLETED|Cycle 1||1
5120038|NCT01490060|12596176|P1|NOT COMPLETED|Cycle 1||0
5120039|NCT01490060|12596173|P4|COMPLETED|Cycle 1||8
5120040|NCT01490060|12596174|P3|COMPLETED|Cycle 1||9
5120041|NCT01490060|12596175|P2|COMPLETED|Cycle 1||12
5120042|NCT01490060|12596176|P1|COMPLETED|Cycle 1||11
5120043|NCT01490060|12596173|P4|STARTED|Cycle 1||11
5120044|NCT01490060|12596174|P3|STARTED|Cycle 1||12
5120045|NCT01490060|12596175|P2|STARTED|Cycle 1||13
5120046|NCT01490060|12596176|P1|STARTED|Cycle 1||11
5120047|NCT01489969|12596187|P3|NOT COMPLETED|Overall Study||1
5120048|NCT01489969|12596188|P2|NOT COMPLETED|Overall Study||4
5120049|NCT01489969|12596189|P1|NOT COMPLETED|Overall Study||5
5120050|NCT01489969|12596187|P3|COMPLETED|Overall Study||44
5120051|NCT01489969|12596188|P2|COMPLETED|Overall Study||43
5120052|NCT01489969|12596189|P1|COMPLETED|Overall Study||40
5120053|NCT01489969|12596187|P3|STARTED|Overall Study||45
5120054|NCT01489969|12596188|P2|STARTED|Overall Study||47
5120055|NCT01489969|12596189|P1|STARTED|Overall Study||45
5120056|NCT01489956|12596205|P3|NOT COMPLETED|Overall Study||1
5120057|NCT01489956|12596206|P2|NOT COMPLETED|Overall Study||0
5120058|NCT01489956|12596207|P1|NOT COMPLETED|Overall Study||1
5120059|NCT01489956|12596205|P3|COMPLETED|Overall Study||5
5120060|NCT01489956|12596206|P2|COMPLETED|Overall Study||0
5120061|NCT01489956|12596207|P1|COMPLETED|Overall Study||12
5120062|NCT01489956|12596205|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
5120063|NCT01489956|12596206|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
5120064|NCT01489956|12596207|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
5120065|NCT01489891|12596244|P2|NOT COMPLETED|Overall Study||0
5120066|NCT01489891|12596245|P1|NOT COMPLETED|Overall Study||1
5120067|NCT01489891|12596244|P2|COMPLETED|Overall Study||60
5120068|NCT01489891|12596245|P1|COMPLETED|Overall Study||59
5120069|NCT01489891|12596244|P2|STARTED|Overall Study||60
5120070|NCT01489891|12596245|P1|STARTED|Overall Study||60
5120071|NCT01489826|12596266|P9|NOT COMPLETED|Overall Study||0
5120072|NCT01489826|12596267|P8|NOT COMPLETED|Overall Study||0
5120073|NCT01489826|12596268|P7|NOT COMPLETED|Overall Study||0
5120074|NCT01489826|12596269|P6|NOT COMPLETED|Overall Study||0
5120075|NCT01489826|12596270|P5|NOT COMPLETED|Overall Study||0
5120076|NCT01489826|12596271|P4|NOT COMPLETED|Overall Study||0
5120077|NCT01489826|12596272|P3|NOT COMPLETED|Overall Study||0
5120078|NCT01489826|12596273|P2|NOT COMPLETED|Overall Study||0
5120079|NCT01489826|12596274|P1|NOT COMPLETED|Overall Study||0
5120080|NCT01489826|12596266|P9|COMPLETED|Overall Study||6
5120081|NCT01489826|12596267|P8|COMPLETED|Overall Study||3
5120082|NCT01489826|12596268|P7|COMPLETED|Overall Study||9
5120083|NCT01489826|12596269|P6|COMPLETED|Overall Study||3
5120084|NCT01489826|12596270|P5|COMPLETED|Overall Study||3
5120085|NCT01489826|12596271|P4|COMPLETED|Overall Study||7
5120086|NCT01489826|12596272|P3|COMPLETED|Overall Study||3
5120087|NCT01489826|12596273|P2|COMPLETED|Overall Study||3
5120088|NCT01489826|12596274|P1|COMPLETED|Overall Study||3
5120089|NCT01489826|12596266|P9|STARTED|Overall Study||6
5120090|NCT01489826|12596267|P8|STARTED|Overall Study||3
5120091|NCT01489826|12596268|P7|STARTED|Overall Study||9
5120092|NCT01489826|12596269|P6|STARTED|Overall Study||3
5120093|NCT01489826|12596270|P5|STARTED|Overall Study||3
5120094|NCT01489826|12596271|P4|STARTED|Overall Study||7
5120095|NCT01489826|12596272|P3|STARTED|Overall Study||3
5120096|NCT01489826|12596273|P2|STARTED|Overall Study||3
5120097|NCT01489826|12596274|P1|STARTED|Overall Study||3
5120098|NCT01489670|12596371|P1|NOT COMPLETED|Overall Study||53
5120099|NCT01489670|12596371|P1|COMPLETED|Overall Study||334
5120100|NCT01489670|12596371|P1|STARTED|Overall Study||387
5120101|NCT01489579|12596383|P2|NOT COMPLETED|Overall Study||7
5120102|NCT01489579|12596384|P1|NOT COMPLETED|Overall Study||9
5120103|NCT01489579|12596383|P2|COMPLETED|Overall Study||57
5120104|NCT01489579|12596384|P1|COMPLETED|Overall Study||47
5120105|NCT01489579|12596383|P2|STARTED|Overall Study||64
5120106|NCT01489579|12596384|P1|STARTED|Overall Study||56
5120107|NCT01489527|12596400|P2|NOT COMPLETED|Overall Study||26
5120108|NCT01489527|12596401|P1|NOT COMPLETED|Overall Study||22
5120109|NCT01489527|12596400|P2|COMPLETED|Overall Study||175
5120110|NCT01489527|12596401|P1|COMPLETED|Overall Study||183
5120111|NCT01489527|12596400|P2|STARTED|Overall Study||201
5120112|NCT01489527|12596401|P1|STARTED|Overall Study||205
5120113|NCT01489358|12596418|P3|NOT COMPLETED|Overall Study||2
5120114|NCT01489358|12596419|P2|NOT COMPLETED|Overall Study||0
5120115|NCT01489358|12596420|P1|NOT COMPLETED|Overall Study||0
5120116|NCT01489358|12596418|P3|COMPLETED|Overall Study||8
5120117|NCT01489358|12596419|P2|COMPLETED|Overall Study||10
5120118|NCT01489358|12596420|P1|COMPLETED|Overall Study||5
5120119|NCT01489358|12596418|P3|STARTED|Overall Study||10
5120120|NCT01489358|12596419|P2|STARTED|Overall Study||10
5120121|NCT01489358|12596420|P1|STARTED|Overall Study||5
5120122|NCT01489254|12596470|P4|NOT COMPLETED|Open-label Extension Part||58
5120123|NCT01489254|12596471|P3|NOT COMPLETED|Open-label Extension Part||0
5120124|NCT01489254|12596472|P2|NOT COMPLETED|Open-label Extension Part||0
5120125|NCT01489254|12596473|P1|NOT COMPLETED|Open-label Extension Part||0
5120126|NCT01489254|12596470|P4|COMPLETED|Open-label Extension Part||670
5120127|NCT01489254|12596471|P3|COMPLETED|Open-label Extension Part||0
5120128|NCT01489254|12596472|P2|COMPLETED|Open-label Extension Part||0
5120129|NCT01489254|12596473|P1|COMPLETED|Open-label Extension Part||0
5120130|NCT01489254|12596470|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
5120131|NCT01489254|12596471|P3|STARTED|Open-label Extension Part||0
5120132|NCT01489254|12596472|P2|STARTED|Open-label Extension Part||0
5120133|NCT01489254|12596473|P1|STARTED|Open-label Extension Part||0
5120134|NCT01489254|12596470|P4|NOT COMPLETED|Double-blind Part||0
5120135|NCT01489254|12596471|P3|NOT COMPLETED|Double-blind Part||3
5120136|NCT01489254|12596472|P2|NOT COMPLETED|Double-blind Part||33
5120137|NCT01489254|12596473|P1|NOT COMPLETED|Double-blind Part||25
5120138|NCT01489254|12596470|P4|COMPLETED|Double-blind Part||0
5120139|NCT01489254|12596471|P3|COMPLETED|Double-blind Part||81
5120140|NCT01489254|12596472|P2|COMPLETED|Double-blind Part||324
5120141|NCT01489254|12596473|P1|COMPLETED|Double-blind Part||330
5120142|NCT01489254|12596470|P4|STARTED|Double-blind Part||0
5120143|NCT01489254|12596471|P3|STARTED|Double-blind Part||84
5120144|NCT01489254|12596472|P2|STARTED|Double-blind Part||357
5120145|NCT01489254|12596473|P1|STARTED|Double-blind Part||355
5120146|NCT01489189|12596484|P2|NOT COMPLETED|Overall Study||35
5120147|NCT01489189|12596485|P1|NOT COMPLETED|Overall Study||31
5120148|NCT01489189|12596484|P2|COMPLETED|Overall Study|Number of Eyes|168
5120149|NCT01489189|12596485|P1|COMPLETED|Overall Study|Number of Eyes|160
5120150|NCT01489189|12596484|P2|STARTED|Overall Study|Number of Eyes|203
5120151|NCT01489189|12596485|P1|STARTED|Overall Study|Number of Eyes|191
5120152|NCT01489111|12596510|P1|NOT COMPLETED|Overall Study||1
5120153|NCT01489111|12596510|P1|COMPLETED|Overall Study||35
5120154|NCT01489111|12596510|P1|STARTED|Overall Study||36
5120155|NCT01489020|12596531|P6|NOT COMPLETED|Overall Study||0
5120156|NCT01489020|12596532|P5|NOT COMPLETED|Overall Study||6
5120157|NCT01489020|12596533|P4|NOT COMPLETED|Overall Study||0
5120158|NCT01489020|12596534|P3|NOT COMPLETED|Overall Study||3
5120159|NCT01489020|12596535|P2|NOT COMPLETED|Overall Study||0
5120160|NCT01489020|12596536|P1|NOT COMPLETED|Overall Study||1
5120161|NCT01489020|12596531|P6|COMPLETED|Overall Study||4
5120162|NCT01489020|12596532|P5|COMPLETED|Overall Study||6
5120163|NCT01489020|12596533|P4|COMPLETED|Overall Study||4
5120164|NCT01489020|12596534|P3|COMPLETED|Overall Study||9
5120165|NCT01489020|12596535|P2|COMPLETED|Overall Study||4
5120166|NCT01489020|12596536|P1|COMPLETED|Overall Study||11
5120167|NCT01489020|12596531|P6|STARTED|Overall Study||4
5120168|NCT01489020|12596532|P5|STARTED|Overall Study||12
5120169|NCT01489020|12596533|P4|STARTED|Overall Study||4
5120170|NCT01489020|12596534|P3|STARTED|Overall Study||12
5120171|NCT01489020|12596535|P2|STARTED|Overall Study||4
5120172|NCT01489020|12596536|P1|STARTED|Overall Study||12
5120173|NCT01488994|12596570|P2|NOT COMPLETED|Overall Study||1
5120174|NCT01488994|12596571|P1|NOT COMPLETED|Overall Study||0
5120175|NCT01488994|12596570|P2|COMPLETED|Overall Study||11
5120176|NCT01488994|12596571|P1|COMPLETED|Overall Study||11
5120177|NCT01488994|12596570|P2|STARTED|Overall Study||12
5120178|NCT01488994|12596571|P1|STARTED|Overall Study||11
5120179|NCT01488890|12596662|P4|NOT COMPLETED|Overall Study||5
5120180|NCT01488890|12596663|P3|NOT COMPLETED|Overall Study||35
5120181|NCT01488890|12596664|P2|NOT COMPLETED|Overall Study||20
5120182|NCT01488890|12596665|P1|NOT COMPLETED|Overall Study||32
5120183|NCT01488890|12596662|P4|COMPLETED|Overall Study||25
5120184|NCT01488890|12596663|P3|COMPLETED|Overall Study||85
5120185|NCT01488890|12596664|P2|COMPLETED|Overall Study||100
5120186|NCT01488890|12596665|P1|COMPLETED|Overall Study||88
5120187|NCT01488890|12596662|P4|Treated|Overall Study||30
5120188|NCT01488890|12596663|P3|Treated|Overall Study||119
5120189|NCT01488890|12596664|P2|Treated|Overall Study||120
5120190|NCT01488890|12596665|P1|Treated|Overall Study||120
5120191|NCT01488890|12596662|P4|STARTED|Overall Study||30
5120192|NCT01488890|12596663|P3|STARTED|Overall Study||120
5120193|NCT01488890|12596664|P2|STARTED|Overall Study||120
5120194|NCT01488890|12596665|P1|STARTED|Overall Study||120
5120195|NCT01488877|12596703|P3|NOT COMPLETED|Re-randomization||0
5120196|NCT01488877|12596704|P2|NOT COMPLETED|Re-randomization||0
5120197|NCT01488877|12596705|P1|NOT COMPLETED|Re-randomization||0
5120198|NCT01488877|12596703|P3|COMPLETED|Re-randomization||3
5120199|NCT01488877|12596704|P2|COMPLETED|Re-randomization||0
5120200|NCT01488877|12596705|P1|COMPLETED|Re-randomization||0
5120201|NCT01488877|12596703|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
5120202|NCT01488877|12596704|P2|STARTED|Re-randomization||0
5120203|NCT01488877|12596705|P1|STARTED|Re-randomization||0
5120204|NCT01488877|12596703|P3|NOT COMPLETED|Initial Randomization||0
5120205|NCT01488877|12596704|P2|NOT COMPLETED|Initial Randomization||0
5120206|NCT01488877|12596705|P1|NOT COMPLETED|Initial Randomization||0
5120207|NCT01488877|12596703|P3|COMPLETED|Initial Randomization||0
5120208|NCT01488877|12596704|P2|COMPLETED|Initial Randomization||5
5120209|NCT01488877|12596705|P1|COMPLETED|Initial Randomization||1
5120210|NCT01488877|12596703|P3|STARTED|Initial Randomization||0
5120211|NCT01488877|12596704|P2|STARTED|Initial Randomization||5
5120212|NCT01488877|12596705|P1|STARTED|Initial Randomization||1
5120213|NCT01488708|12596722|P2|NOT COMPLETED|Overall Study||578
5120214|NCT01488708|12596723|P1|NOT COMPLETED|Overall Study||940
5120215|NCT01488708|12596722|P2|COMPLETED|Overall Study||0
5120216|NCT01488708|12596723|P1|COMPLETED|Overall Study||0
5120217|NCT01488708|12596722|P2|Participated in Follow Up|Overall Study||526
5120218|NCT01488708|12596723|P1|Participated in Follow Up|Overall Study||810
5120219|NCT01488708|12596722|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
5120220|NCT01488708|12596723|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
5120221|NCT01488708|12596722|P2|STARTED|Overall Study||578
5120222|NCT01488708|12596723|P1|STARTED|Overall Study||940
5120223|NCT01488578|12596743|P1|NOT COMPLETED|Overall Study||1836
5120224|NCT01488578|12596743|P1|COMPLETED|Overall Study||9321
5120225|NCT01488578|12596743|P1|STARTED|Overall Study||11157
5120226|NCT01488487|12596777|P1|NOT COMPLETED|Overall Study||9
5120227|NCT01488487|12596777|P1|COMPLETED|Overall Study||15
5120228|NCT01488487|12596777|P1|Received Treatment|Overall Study||24
5120229|NCT01488487|12596777|P1|STARTED|Overall Study||24
5120230|NCT01488448|12596786|P2|NOT COMPLETED|Overall Study||17
5120231|NCT01488448|12596787|P1|NOT COMPLETED|Overall Study||20
5120232|NCT01488448|12596786|P2|COMPLETED|Overall Study||97
5120233|NCT01488448|12596787|P1|COMPLETED|Overall Study||93
5120234|NCT01488448|12596786|P2|STARTED|Overall Study||114
5120235|NCT01488448|12596787|P1|STARTED|Overall Study||113
5120236|NCT01488409|12596811|P2|NOT COMPLETED|Overall Study||4
5120237|NCT01488409|12596812|P1|NOT COMPLETED|Overall Study||4
5120238|NCT01488409|12596811|P2|COMPLETED|Overall Study||15
5120239|NCT01488409|12596812|P1|COMPLETED|Overall Study||16
5120240|NCT01488409|12596811|P2|STARTED|Overall Study||19
5120241|NCT01488409|12596812|P1|STARTED|Overall Study||20
5120242|NCT01488370|12596829|P3|NOT COMPLETED|Overall Study||1
5120243|NCT01488370|12596830|P2|NOT COMPLETED|Overall Study||1
5120244|NCT01488370|12596831|P1|NOT COMPLETED|Overall Study||0
5120245|NCT01488370|12596829|P3|COMPLETED|Overall Study||19
5120246|NCT01488370|12596830|P2|COMPLETED|Overall Study||22
5120247|NCT01488370|12596831|P1|COMPLETED|Overall Study||22
5120248|NCT01488370|12596829|P3|STARTED|Overall Study||20
5120249|NCT01488370|12596830|P2|STARTED|Overall Study||23
5120250|NCT01488370|12596831|P1|STARTED|Overall Study||22
5120251|NCT01488318|12596851|P1|NOT COMPLETED|Overall Study||0
5120252|NCT01488318|12596851|P1|COMPLETED|Overall Study||14
5120253|NCT01488318|12596851|P1|STARTED|Overall Study||14
5120254|NCT01488279|12596860|P2|NOT COMPLETED|Overall Study||0
5120255|NCT01488279|12596861|P1|NOT COMPLETED|Overall Study||0
5120256|NCT01488279|12596860|P2|COMPLETED|Overall Study||5
5120257|NCT01488279|12596861|P1|COMPLETED|Overall Study||5
5120258|NCT01488279|12596860|P2|STARTED|Overall Study||5
5120259|NCT01488279|12596861|P1|STARTED|Overall Study||5
5120260|NCT01488188|12596877|P2|NOT COMPLETED|Overall Study||0
5120261|NCT01488188|12596878|P1|NOT COMPLETED|Overall Study||0
5120262|NCT01488188|12596877|P2|COMPLETED|Overall Study||20
5120263|NCT01488188|12596878|P1|COMPLETED|Overall Study||20
5120264|NCT01488188|12596877|P2|STARTED|Overall Study||20
5120265|NCT01488188|12596878|P1|STARTED|Overall Study||20
5120266|NCT01488097|12596890|P1|NOT COMPLETED|Overall Study||1
5120267|NCT01488097|12596890|P1|COMPLETED|Overall Study||7
5120268|NCT01488097|12596890|P1|Received Study Drug in Extension Study|Overall Study||8
5120269|NCT01488097|12596890|P1|STARTED|Overall Study||8
5120270|NCT01488071|12596903|P2|NOT COMPLETED|Overall Study||63
5120271|NCT01488071|12596904|P1|NOT COMPLETED|Overall Study||53
5120272|NCT01488071|12596903|P2|COMPLETED|Overall Study||179
5120273|NCT01488071|12596904|P1|COMPLETED|Overall Study||200
5120274|NCT01488071|12596903|P2|STARTED|Overall Study|APTS|242
5120275|NCT01488071|12596904|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
5120276|NCT01488019|12596938|P2|NOT COMPLETED|Overall Study||304
5120277|NCT01488019|12596939|P1|NOT COMPLETED|Overall Study||247
5120278|NCT01488019|12596938|P2|COMPLETED|Overall Study||226
5120279|NCT01488019|12596939|P1|COMPLETED|Overall Study||294
5120280|NCT01488019|12596938|P2|STARTED|Overall Study||530
5120281|NCT01488019|12596939|P1|STARTED|Overall Study||541
5120282|NCT01487954|12596973|P2|NOT COMPLETED|Overall Study||0
5120283|NCT01487954|12596974|P1|NOT COMPLETED|Overall Study||0
5120284|NCT01487954|12596973|P2|COMPLETED|Overall Study||16
5120285|NCT01487954|12596974|P1|COMPLETED|Overall Study||29
5120375|NCT01486446|12597277|P2|NOT COMPLETED|Overall Study||0
5120286|NCT01487954|12596973|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
5120287|NCT01487954|12596974|P1|Safety lead-in|Overall Study||10
5120288|NCT01487954|12596973|P2|STARTED|Overall Study||16
5120289|NCT01487954|12596974|P1|STARTED|Overall Study||29
5120290|NCT01487863|12596984|P2|NOT COMPLETED|Overall Study||19
5120291|NCT01487863|12596985|P1|NOT COMPLETED|Overall Study||19
5120292|NCT01487863|12596984|P2|COMPLETED|Overall Study||15
5120293|NCT01487863|12596985|P1|COMPLETED|Overall Study||16
5120294|NCT01487863|12596984|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
5120295|NCT01487863|12596985|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
5120296|NCT01487863|12596984|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
5120297|NCT01487863|12596985|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
5120298|NCT01487863|12596984|P2|STARTED|Overall Study||34
5120299|NCT01487863|12596985|P1|STARTED|Overall Study||35
5120300|NCT01487668|12596993|P2|NOT COMPLETED|Overall Study||17
5120301|NCT01487668|12596994|P1|NOT COMPLETED|Overall Study||25
5120302|NCT01487668|12596993|P2|COMPLETED|Overall Study||124
5120303|NCT01487668|12596994|P1|COMPLETED|Overall Study||121
5120304|NCT01487668|12596993|P2|STARTED|Overall Study||141
5120305|NCT01487668|12596994|P1|STARTED|Overall Study||146
5120306|NCT01487577|12597002|P1|NOT COMPLETED|Overall Study||1
5120307|NCT01487577|12597002|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
5120308|NCT01487577|12597002|P1|STARTED|Overall Study||19
5120309|NCT01487525|12597016|P2|NOT COMPLETED|Overall Study||1
5120310|NCT01487525|12597017|P1|NOT COMPLETED|Overall Study||0
5120311|NCT01487525|12597016|P2|COMPLETED|Overall Study||19
5120312|NCT01487525|12597017|P1|COMPLETED|Overall Study||22
5120313|NCT01487525|12597016|P2|STARTED|Overall Study||20
5120314|NCT01487525|12597017|P1|STARTED|Overall Study||22
5120315|NCT01487499|12597027|P1|NOT COMPLETED|Overall Study||0
5120316|NCT01487499|12597027|P1|COMPLETED|Overall Study||4
5120317|NCT01487499|12597027|P1|STARTED|Overall Study||4
5120318|NCT01487265|12597033|P1|NOT COMPLETED|Overall Study||37
5120319|NCT01487265|12597033|P1|COMPLETED|Overall Study||0
5120320|NCT01487265|12597033|P1|STARTED|Overall Study||37
5120321|NCT01487200|12597045|P4|NOT COMPLETED|Overall Study||0
5120322|NCT01487200|12597046|P3|NOT COMPLETED|Overall Study||0
5120323|NCT01487200|12597047|P2|NOT COMPLETED|Overall Study||1
5120324|NCT01487200|12597048|P1|NOT COMPLETED|Overall Study||0
5120325|NCT01487200|12597045|P4|COMPLETED|Overall Study||5
5120326|NCT01487200|12597046|P3|COMPLETED|Overall Study||7
5120327|NCT01487200|12597047|P2|COMPLETED|Overall Study||6
5120328|NCT01487200|12597048|P1|COMPLETED|Overall Study||5
5120329|NCT01487200|12597045|P4|STARTED|Overall Study||5
5120330|NCT01487200|12597046|P3|STARTED|Overall Study||7
5120331|NCT01487200|12597047|P2|STARTED|Overall Study||7
5120332|NCT01487200|12597048|P1|STARTED|Overall Study||5
5120333|NCT01487161|12597078|P4|NOT COMPLETED|Overall Study||2
5120334|NCT01487161|12597079|P3|NOT COMPLETED|Overall Study||1
5120335|NCT01487161|12597080|P2|NOT COMPLETED|Overall Study||2
5120336|NCT01487161|12597081|P1|NOT COMPLETED|Overall Study||2
5120337|NCT01487161|12597078|P4|COMPLETED|Overall Study||50
5120338|NCT01487161|12597079|P3|COMPLETED|Overall Study||59
5120339|NCT01487161|12597080|P2|COMPLETED|Overall Study||57
5120340|NCT01487161|12597081|P1|COMPLETED|Overall Study||56
5120341|NCT01487161|12597078|P4|STARTED|Overall Study||52
5120342|NCT01487161|12597079|P3|STARTED|Overall Study||60
5120343|NCT01487161|12597080|P2|STARTED|Overall Study||59
5120344|NCT01487161|12597081|P1|STARTED|Overall Study||58
5120345|NCT01486966|12597146|P2|NOT COMPLETED|Overall Study||2
5120346|NCT01486966|12597147|P1|NOT COMPLETED|Overall Study||0
5120347|NCT01486966|12597146|P2|COMPLETED|Overall Study||27
5120348|NCT01486966|12597147|P1|COMPLETED|Overall Study||29
5120349|NCT01486966|12597146|P2|STARTED|Overall Study||29
5120350|NCT01486966|12597147|P1|STARTED|Overall Study||29
5120351|NCT01486927|12597171|P1|NOT COMPLETED|Overall Study||13
5120352|NCT01486927|12597171|P1|COMPLETED|Overall Study||161
5120353|NCT01486927|12597171|P1|STARTED|Overall Study||174
5120354|NCT01486810|12597202|P1|NOT COMPLETED|Overall Study||8
5120355|NCT01486810|12597202|P1|COMPLETED|Overall Study||9
5120356|NCT01486810|12597202|P1|STARTED|Overall Study||17
5120357|NCT01486758|12597209|P2|NOT COMPLETED|Overall Study||1
5120358|NCT01486758|12597210|P1|NOT COMPLETED|Overall Study||0
5120359|NCT01486758|12597209|P2|COMPLETED|Overall Study||19
5120360|NCT01486758|12597210|P1|COMPLETED|Overall Study||20
5120361|NCT01486758|12597209|P2|STARTED|Overall Study||20
5120362|NCT01486758|12597210|P1|STARTED|Overall Study||20
5120363|NCT01486615|12597234|P4|NOT COMPLETED|Overall Study||2
5120364|NCT01486615|12597235|P3|NOT COMPLETED|Overall Study||2
5120365|NCT01486615|12597236|P2|NOT COMPLETED|Overall Study||1
5120366|NCT01486615|12597237|P1|NOT COMPLETED|Overall Study||0
5120367|NCT01486615|12597234|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
5120368|NCT01486615|12597235|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
5120369|NCT01486615|12597236|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
5120370|NCT01486615|12597237|P1|COMPLETED|Overall Study||20
5120371|NCT01486615|12597234|P4|STARTED|Overall Study||20
5120372|NCT01486615|12597235|P3|STARTED|Overall Study||20
5120373|NCT01486615|12597236|P2|STARTED|Overall Study||20
5120374|NCT01486615|12597237|P1|STARTED|Overall Study||20
5120376|NCT01486446|12597278|P1|NOT COMPLETED|Overall Study||1
5120377|NCT01486446|12597277|P2|COMPLETED|Overall Study||1
5120378|NCT01486446|12597278|P1|COMPLETED|Overall Study||6
5120379|NCT01486446|12597277|P2|STARTED|Overall Study||1
5120380|NCT01486446|12597278|P1|STARTED|Overall Study||7
5120381|NCT01486316|12597301|P4|NOT COMPLETED|Overall Study||2
5120382|NCT01486316|12597302|P3|NOT COMPLETED|Overall Study||5
5120383|NCT01486316|12597303|P2|NOT COMPLETED|Overall Study||3
5120384|NCT01486316|12597304|P1|NOT COMPLETED|Overall Study||4
5120385|NCT01486316|12597301|P4|COMPLETED|Overall Study||0
5120386|NCT01486316|12597302|P3|COMPLETED|Overall Study||0
5120387|NCT01486316|12597303|P2|COMPLETED|Overall Study||7
5120388|NCT01486316|12597304|P1|COMPLETED|Overall Study||3
5120389|NCT01486316|12597301|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
5120390|NCT01486316|12597302|P3|STARTED|Overall Study|Exited prior to implant|5
5120391|NCT01486316|12597303|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
5120392|NCT01486316|12597304|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
5120393|NCT01486264|12597316|P2|NOT COMPLETED|Overall Study||47
5120394|NCT01486264|12597317|P1|NOT COMPLETED|Overall Study||29
5120395|NCT01486264|12597316|P2|COMPLETED|Overall Study||94
5120396|NCT01486264|12597317|P1|COMPLETED|Overall Study||113
5120397|NCT01486264|12597316|P2|Treated|Overall Study||140
5120398|NCT01486264|12597317|P1|Treated|Overall Study||142
5120399|NCT01486264|12597316|P2|STARTED|Overall Study||141
5120400|NCT01486264|12597317|P1|STARTED|Overall Study||142
5120401|NCT01486238|12597349|P2|NOT COMPLETED|Overall Study||6
5120402|NCT01486238|12597350|P1|NOT COMPLETED|Overall Study||2
5120403|NCT01486238|12597349|P2|COMPLETED|Overall Study||43
5120404|NCT01486238|12597350|P1|COMPLETED|Overall Study||21
5120405|NCT01486238|12597349|P2|STARTED|Overall Study||49
5120406|NCT01486238|12597350|P1|STARTED|Overall Study||23
5120407|NCT01486199|12597358|P2|NOT COMPLETED|Study Day at t= 2 Years||0
5120408|NCT01486199|12597359|P1|NOT COMPLETED|Study Day at t= 2 Years||0
5120409|NCT01486199|12597358|P2|COMPLETED|Study Day at t= 2 Years||0
5120410|NCT01486199|12597359|P1|COMPLETED|Study Day at t= 2 Years||9
5120411|NCT01486199|12597358|P2|STARTED|Study Day at t= 2 Years||0
5120412|NCT01486199|12597359|P1|STARTED|Study Day at t= 2 Years||9
5120413|NCT01486199|12597358|P2|NOT COMPLETED|Two Year Period Between Study Days||0
5120414|NCT01486199|12597359|P1|NOT COMPLETED|Two Year Period Between Study Days||1
5120415|NCT01486199|12597358|P2|COMPLETED|Two Year Period Between Study Days||0
5120416|NCT01486199|12597359|P1|COMPLETED|Two Year Period Between Study Days||9
5120417|NCT01486199|12597358|P2|STARTED|Two Year Period Between Study Days||0
5120418|NCT01486199|12597359|P1|STARTED|Two Year Period Between Study Days||10
5120419|NCT01486199|12597358|P2|NOT COMPLETED|Baseline Study Day||1
5120420|NCT01486199|12597359|P1|NOT COMPLETED|Baseline Study Day||0
5120421|NCT01486199|12597358|P2|COMPLETED|Baseline Study Day||9
5120422|NCT01486199|12597359|P1|COMPLETED|Baseline Study Day||10
5120423|NCT01486199|12597358|P2|STARTED|Baseline Study Day||10
5120424|NCT01486199|12597359|P1|STARTED|Baseline Study Day||10
5120425|NCT01486043|12597371|P1|NOT COMPLETED|Overall Study||2
5120426|NCT01486043|12597371|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
5120427|NCT01486043|12597371|P1|STARTED|Overall Study||4
5120428|NCT01485991|12597379|P2|NOT COMPLETED|Overall Study||36
5120429|NCT01485991|12597380|P1|NOT COMPLETED|Overall Study||32
5120430|NCT01485991|12597379|P2|COMPLETED|Overall Study||350
5120431|NCT01485991|12597380|P1|COMPLETED|Overall Study||353
5120432|NCT01485991|12597379|P2|Treated|Overall Study||384
5120433|NCT01485991|12597380|P1|Treated|Overall Study||379
5120434|NCT01485991|12597379|P2|STARTED|Overall Study||386
5120435|NCT01485991|12597380|P1|STARTED|Overall Study||385
5120436|NCT01485887|12597390|P1|NOT COMPLETED|Overall Study||12
5120437|NCT01485887|12597390|P1|COMPLETED|Overall Study||38
5120438|NCT01485887|12597390|P1|STARTED|Overall Study||50
5120439|NCT01485796|12597402|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
5120440|NCT01485796|12597402|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
5120441|NCT01485796|12597402|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
5120442|NCT01485796|12597402|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
5120443|NCT01485796|12597402|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
5120444|NCT01485796|12597402|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
5120445|NCT01485796|12597402|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
5120446|NCT01485796|12597402|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
5120447|NCT01485796|12597402|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
5120448|NCT01485796|12597402|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
5120449|NCT01485796|12597402|P1|NOT COMPLETED|Period 2: Epoch 2||35
5120450|NCT01485796|12597402|P1|COMPLETED|Period 2: Epoch 2||1
5120451|NCT01485796|12597402|P1|Treated in Epoch 2|Period 2: Epoch 2||36
5120452|NCT01485796|12597402|P1|STARTED|Period 2: Epoch 2||36
5120453|NCT01485796|12597402|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
5120454|NCT01485796|12597402|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
5120455|NCT01485796|12597402|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
5120456|NCT01485796|12597402|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
5120457|NCT01485640|12597424|P1|NOT COMPLETED|Overall Study||122
5120458|NCT01485640|12597424|P1|COMPLETED|Overall Study||40
5120459|NCT01485640|12597424|P1|STARTED|Overall Study||162
5120460|NCT01485627|12597431|P2|NOT COMPLETED|Overall Study||57
5120461|NCT01485627|12597432|P1|NOT COMPLETED|Overall Study||66
5120462|NCT01485627|12597431|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
5120463|NCT01485627|12597432|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
5120464|NCT01485627|12597431|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
5120465|NCT01485627|12597432|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
5120466|NCT01485627|12597431|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
5120467|NCT01485627|12597432|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
5120468|NCT01485627|12597431|P2|Bereaved Caregivers: 1 Month|Overall Study||51
5120469|NCT01485627|12597432|P1|Bereaved Caregivers: 1 Month|Overall Study||51
5120470|NCT01485627|12597431|P2|Bereaved Caregivers: Total|Overall Study||64
5120471|NCT01485627|12597432|P1|Bereaved Caregivers: Total|Overall Study||63
5120472|NCT01485627|12597431|P2|Allocated Caregivers: Total|Overall Study||99
5120473|NCT01485627|12597432|P1|Allocated Caregivers: Total|Overall Study||105
5120474|NCT01485627|12597431|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
5120475|NCT01485627|12597432|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
5120476|NCT01485536|12597450|P1|NOT COMPLETED|Overall Study||4
5120477|NCT01485536|12597450|P1|COMPLETED|Overall Study||17
5120478|NCT01485536|12597450|P1|STARTED|Overall Study||21
5120479|NCT01485393|12597455|P2|NOT COMPLETED|Overall Study||0
5120480|NCT01485393|12597456|P1|NOT COMPLETED|Overall Study||0
5120481|NCT01485393|12597455|P2|COMPLETED|Overall Study||5
5120482|NCT01485393|12597456|P1|COMPLETED|Overall Study||5
5120483|NCT01485393|12597455|P2|STARTED|Overall Study||5
5120484|NCT01485393|12597456|P1|STARTED|Overall Study||5
5120485|NCT01485380|12597464|P1|NOT COMPLETED|Overall Study||3
5120486|NCT01485380|12597464|P1|COMPLETED|Overall Study||17
5120487|NCT01485380|12597464|P1|STARTED|Overall Study||20
5120488|NCT01485354|12597468|P1|NOT COMPLETED|Overall Study||5
5120489|NCT01485354|12597468|P1|COMPLETED|Overall Study||12
5120490|NCT01485354|12597468|P1|STARTED|Overall Study||17
5120491|NCT01485172|12597482|P6|NOT COMPLETED|Overall Study||4
5120492|NCT01485172|12597483|P5|NOT COMPLETED|Overall Study||5
5120493|NCT01485172|12597484|P4|NOT COMPLETED|Overall Study||8
5120494|NCT01485172|12597485|P3|NOT COMPLETED|Overall Study||7
5120495|NCT01485172|12597486|P2|NOT COMPLETED|Overall Study||1
5120496|NCT01485172|12597487|P1|NOT COMPLETED|Overall Study||7
5120497|NCT01485172|12597482|P6|COMPLETED|Overall Study||9
5120498|NCT01485172|12597483|P5|COMPLETED|Overall Study||34
5120499|NCT01485172|12597484|P4|COMPLETED|Overall Study||32
5120500|NCT01485172|12597485|P3|COMPLETED|Overall Study||34
5120501|NCT01485172|12597486|P2|COMPLETED|Overall Study||12
5120502|NCT01485172|12597487|P1|COMPLETED|Overall Study||33
5120503|NCT01485172|12597482|P6|STARTED|Overall Study||13
5120504|NCT01485172|12597483|P5|STARTED|Overall Study||39
5120505|NCT01485172|12597484|P4|STARTED|Overall Study||40
5120506|NCT01485172|12597485|P3|STARTED|Overall Study||41
5120507|NCT01485172|12597486|P2|STARTED|Overall Study||13
5120508|NCT01485172|12597487|P1|STARTED|Overall Study||40
5120509|NCT01485120|12597561|P1|NOT COMPLETED|Overall Study||2
5120510|NCT01485120|12597561|P1|COMPLETED|Overall Study||32
5120511|NCT01485120|12597561|P1|STARTED|Overall Study||34
5120512|NCT01485094|12597569|P3|NOT COMPLETED|Overall Study||1
5120513|NCT01485094|12597570|P2|NOT COMPLETED|Overall Study||2
5120514|NCT01485094|12597571|P1|NOT COMPLETED|Overall Study||3
5120515|NCT01485094|12597569|P3|COMPLETED|Overall Study||18
5120516|NCT01485094|12597570|P2|COMPLETED|Overall Study||18
5120517|NCT01485094|12597571|P1|COMPLETED|Overall Study||17
5120518|NCT01485094|12597569|P3|STARTED|Overall Study||19
5120519|NCT01485094|12597570|P2|STARTED|Overall Study||20
5120520|NCT01485094|12597571|P1|STARTED|Overall Study||20
5120521|NCT01485055|12597612|P1|NOT COMPLETED|Overall Study||0
5120522|NCT01485055|12597612|P1|COMPLETED|Overall Study||11
5120523|NCT01485055|12597612|P1|STARTED|Overall Study||11
5120524|NCT01484977|12597616|P1|NOT COMPLETED|Overall Study||27
5120525|NCT01484977|12597616|P1|COMPLETED|Overall Study||93
5120526|NCT01484977|12597616|P1|STARTED|Overall Study||120
5120527|NCT01484951|12597620|P1|NOT COMPLETED|Overall Study||5
5120528|NCT01484951|12597620|P1|COMPLETED|Overall Study||69
5120529|NCT01484951|12597620|P1|STARTED|Overall Study||74
5120530|NCT01484938|12597625|P1|NOT COMPLETED|Overall Study||4
5120531|NCT01484938|12597625|P1|COMPLETED|Overall Study||171
5120532|NCT01484938|12597625|P1|STARTED|Overall Study||175
5120533|NCT01484912|12597632|P2|NOT COMPLETED|Overall Study||1
5120534|NCT01484912|12597633|P1|NOT COMPLETED|Overall Study||1
5120535|NCT01484912|12597632|P2|COMPLETED|Overall Study||39
5120536|NCT01484912|12597633|P1|COMPLETED|Overall Study||38
5120537|NCT01484912|12597632|P2|STARTED|Overall Study||40
5120538|NCT01484912|12597633|P1|STARTED|Overall Study||39
5120539|NCT01484873|12597643|P1|NOT COMPLETED|Overall Study||2
5120540|NCT01484873|12597643|P1|COMPLETED|Overall Study||8
5120541|NCT01484873|12597643|P1|STARTED|Overall Study||10
5120542|NCT01484834|12597655|P4|NOT COMPLETED|Overall Study||4
5120543|NCT01484834|12597656|P3|NOT COMPLETED|Overall Study||1
5120544|NCT01484834|12597657|P2|NOT COMPLETED|Overall Study||8
5120545|NCT01484834|12597658|P1|NOT COMPLETED|Overall Study||5
5120546|NCT01484834|12597655|P4|COMPLETED|Overall Study||20
5120547|NCT01484834|12597656|P3|COMPLETED|Overall Study||38
5120548|NCT01484834|12597657|P2|COMPLETED|Overall Study||54
5120549|NCT01484834|12597658|P1|COMPLETED|Overall Study||60
5120550|NCT01484834|12597655|P4|STARTED|Overall Study||24
5120551|NCT01484834|12597656|P3|STARTED|Overall Study||39
5120552|NCT01484834|12597657|P2|STARTED|Overall Study||62
5120553|NCT01484834|12597658|P1|STARTED|Overall Study||65
5120554|NCT01484652|12597686|P2|NOT COMPLETED|Overall Study||21
5120555|NCT01484652|12597687|P1|NOT COMPLETED|Overall Study||15
5120556|NCT01484652|12597686|P2|COMPLETED|Overall Study||142
5120557|NCT01484652|12597687|P1|COMPLETED|Overall Study||151
5120558|NCT01484652|12597686|P2|STARTED|Overall Study||163
5120559|NCT01484652|12597687|P1|STARTED|Overall Study||166
5120560|NCT01484626|12597693|P1|NOT COMPLETED|Overall Study||0
5120561|NCT01484626|12597693|P1|COMPLETED|Overall Study||3
5120562|NCT01484626|12597693|P1|STARTED|Overall Study||3
5120563|NCT01484561|12597699|P2|NOT COMPLETED|Overall Study||6
5120564|NCT01484561|12597700|P1|NOT COMPLETED|Overall Study||9
5120565|NCT01484561|12597699|P2|COMPLETED|Overall Study||45
5120566|NCT01484561|12597700|P1|COMPLETED|Overall Study||88
5120567|NCT01484561|12597699|P2|STARTED|Overall Study||51
5120568|NCT01484561|12597700|P1|STARTED|Overall Study||97
5120569|NCT01484496|12597790|P4|NOT COMPLETED|Period 2||22
5120570|NCT01484496|12597791|P3|NOT COMPLETED|Period 2||15
5120571|NCT01484496|12597792|P2|NOT COMPLETED|Period 2||0
5120572|NCT01484496|12597793|P1|NOT COMPLETED|Period 2||0
5120573|NCT01484496|12597790|P4|COMPLETED|Period 2||434
5120574|NCT01484496|12597791|P3|COMPLETED|Period 2||191
5120575|NCT01484496|12597792|P2|COMPLETED|Period 2||0
5120576|NCT01484496|12597793|P1|COMPLETED|Period 2||0
5120577|NCT01484496|12597790|P4|STARTED|Period 2||456
5120578|NCT01484496|12597791|P3|STARTED|Period 2||206
5120579|NCT01484496|12597792|P2|STARTED|Period 2||0
5120580|NCT01484496|12597793|P1|STARTED|Period 2||0
5120581|NCT01484496|12597790|P4|NOT COMPLETED|Period 1||0
5120582|NCT01484496|12597791|P3|NOT COMPLETED|Period 1||0
5120583|NCT01484496|12597792|P2|NOT COMPLETED|Period 1||93
5120584|NCT01484496|12597793|P1|NOT COMPLETED|Period 1||66
5120585|NCT01484496|12597790|P4|COMPLETED|Period 1||0
5120586|NCT01484496|12597791|P3|COMPLETED|Period 1||0
5120587|NCT01484496|12597792|P2|COMPLETED|Period 1||463
5120588|NCT01484496|12597793|P1|COMPLETED|Period 1||214
5120589|NCT01484496|12597790|P4|STARTED|Period 1||0
5120590|NCT01484496|12597791|P3|STARTED|Period 1||0
5120591|NCT01484496|12597792|P2|STARTED|Period 1||556
5120592|NCT01484496|12597793|P1|STARTED|Period 1||280
5120593|NCT01484431|12597808|P3|NOT COMPLETED|Period 2||2
5120594|NCT01484431|12597809|P2|NOT COMPLETED|Period 2||1
5120595|NCT01484431|12597810|P1|NOT COMPLETED|Period 2||1
5120596|NCT01484431|12597808|P3|COMPLETED|Period 2||4
5120597|NCT01484431|12597809|P2|COMPLETED|Period 2||5
5120598|NCT01484431|12597810|P1|COMPLETED|Period 2||5
5120599|NCT01484431|12597808|P3|Received 40 mg|Period 2||1
5120600|NCT01484431|12597809|P2|Received 40 mg|Period 2||0
5120601|NCT01484431|12597810|P1|Received 40 mg|Period 2||0
5120602|NCT01484431|12597808|P3|Received 20 mg|Period 2||4
5120603|NCT01484431|12597809|P2|Received 20 mg|Period 2||1
5120604|NCT01484431|12597810|P1|Received 20 mg|Period 2||3
5120605|NCT01484431|12597808|P3|Received 15 mg|Period 2||1
5120606|NCT01484431|12597809|P2|Received 15 mg|Period 2||2
5120607|NCT01484431|12597810|P1|Received 15 mg|Period 2||1
5120608|NCT01484431|12597808|P3|Received 10 mg|Period 2||0
5120609|NCT01484431|12597809|P2|Received 10 mg|Period 2||1
5120610|NCT01484431|12597810|P1|Received 10 mg|Period 2||0
5120611|NCT01484431|12597808|P3|Received 8 mg|Period 2||0
5120612|NCT01484431|12597809|P2|Received 8 mg|Period 2||0
5120613|NCT01484431|12597810|P1|Received 8 mg|Period 2||1
5120614|NCT01484431|12597808|P3|Received 7.5 mg|Period 2||0
5120615|NCT01484431|12597809|P2|Received 7.5 mg|Period 2||2
5120616|NCT01484431|12597810|P1|Received 7.5 mg|Period 2||0
5120617|NCT01484431|12597808|P3|Received 7 mg|Period 2||0
5120618|NCT01484431|12597809|P2|Received 7 mg|Period 2||0
5120619|NCT01484431|12597810|P1|Received 7 mg|Period 2||1
5120620|NCT01484431|12597808|P3|STARTED|Period 2||6
5120621|NCT01484431|12597809|P2|STARTED|Period 2||6
5120622|NCT01484431|12597810|P1|STARTED|Period 2||6
5120623|NCT01484431|12597808|P3|NOT COMPLETED|Period 1: High Dose||0
5120624|NCT01484431|12597809|P2|NOT COMPLETED|Period 1: High Dose||1
5120625|NCT01484431|12597810|P1|NOT COMPLETED|Period 1: High Dose||0
5120626|NCT01484431|12597808|P3|COMPLETED|Period 1: High Dose||6
5120627|NCT01484431|12597809|P2|COMPLETED|Period 1: High Dose||6
5120628|NCT01484431|12597810|P1|COMPLETED|Period 1: High Dose||6
5120629|NCT01484431|12597808|P3|Received 40 mg|Period 1: High Dose||5
5120630|NCT01484431|12597809|P2|Received 40 mg|Period 1: High Dose||0
5120631|NCT01484431|12597810|P1|Received 40 mg|Period 1: High Dose||0
5120632|NCT01484431|12597808|P3|Received 20 mg|Period 1: High Dose||1
5120633|NCT01484431|12597809|P2|Received 20 mg|Period 1: High Dose||5
5120634|NCT01484431|12597810|P1|Received 20 mg|Period 1: High Dose||3
5120635|NCT01484431|12597808|P3|Received 15 mg|Period 1: High Dose||0
5120636|NCT01484431|12597809|P2|Received 15 mg|Period 1: High Dose||1
5120637|NCT01484431|12597810|P1|Received 15 mg|Period 1: High Dose||1
5120638|NCT01484431|12597808|P3|Received 10 mg|Period 1: High Dose||0
5120639|NCT01484431|12597809|P2|Received 10 mg|Period 1: High Dose||1
5120640|NCT01484431|12597810|P1|Received 10 mg|Period 1: High Dose||1
5120641|NCT01484431|12597808|P3|Received 8 mg|Period 1: High Dose||0
5120642|NCT01484431|12597809|P2|Received 8 mg|Period 1: High Dose||0
5120643|NCT01484431|12597810|P1|Received 8 mg|Period 1: High Dose||1
5120644|NCT01484431|12597808|P3|STARTED|Period 1: High Dose||6
5120645|NCT01484431|12597809|P2|STARTED|Period 1: High Dose||7
5120646|NCT01484431|12597810|P1|STARTED|Period 1: High Dose||6
5120647|NCT01484431|12597808|P3|NOT COMPLETED|Period 1: Low Dose||0
5120648|NCT01484431|12597809|P2|NOT COMPLETED|Period 1: Low Dose||0
5120649|NCT01484431|12597810|P1|NOT COMPLETED|Period 1: Low Dose||0
5120650|NCT01484431|12597808|P3|COMPLETED|Period 1: Low Dose||6
5120651|NCT01484431|12597809|P2|COMPLETED|Period 1: Low Dose||7
5120652|NCT01484431|12597810|P1|COMPLETED|Period 1: Low Dose||6
5120653|NCT01484431|12597808|P3|Received 10 mg|Period 1: Low Dose||6
5120654|NCT01484431|12597809|P2|Received 10 mg|Period 1: Low Dose||0
5120655|NCT01484431|12597810|P1|Received 10 mg|Period 1: Low Dose||0
5120656|NCT01484431|12597808|P3|Received 5 mg|Period 1: Low Dose||0
5120657|NCT01484431|12597809|P2|Received 5 mg|Period 1: Low Dose||7
5120658|NCT01484431|12597810|P1|Received 5 mg|Period 1: Low Dose||0
5120659|NCT01484431|12597808|P3|Received 4 mg|Period 1: Low Dose||0
5120660|NCT01484431|12597809|P2|Received 4 mg|Period 1: Low Dose||0
5120661|NCT01484431|12597810|P1|Received 4 mg|Period 1: Low Dose||5
5120662|NCT01484431|12597808|P3|Received 2 mg|Period 1: Low Dose||0
5120663|NCT01484431|12597809|P2|Received 2 mg|Period 1: Low Dose||0
5120664|NCT01484431|12597810|P1|Received 2 mg|Period 1: Low Dose||1
5120665|NCT01484431|12597808|P3|STARTED|Period 1: Low Dose||6
5120666|NCT01484431|12597809|P2|STARTED|Period 1: Low Dose||7
5120667|NCT01484431|12597810|P1|STARTED|Period 1: Low Dose||6
5120668|NCT01484340|12597827|P2|NOT COMPLETED|Overall Study||0
5120669|NCT01484340|12597828|P1|NOT COMPLETED|Overall Study||0
5120670|NCT01484340|12597827|P2|COMPLETED|Overall Study||279
5120671|NCT01484340|12597828|P1|COMPLETED|Overall Study||281
5120672|NCT01484340|12597827|P2|STARTED|Overall Study||279
5120673|NCT01484340|12597828|P1|STARTED|Overall Study||281
5120674|NCT01484314|12597840|P1|NOT COMPLETED|Overall Study||0
5120675|NCT01484314|12597840|P1|COMPLETED|Overall Study||1
5120676|NCT01484314|12597840|P1|STARTED|Overall Study||1
5120677|NCT01484275|12597848|P2|NOT COMPLETED|Overall Study||42
5120678|NCT01484275|12597849|P1|NOT COMPLETED|Overall Study||43
5120679|NCT01484275|12597848|P2|COMPLETED|Overall Study||0
5120680|NCT01484275|12597849|P1|COMPLETED|Overall Study||0
5120681|NCT01484275|12597848|P2|STARTED|Overall Study||42
5120682|NCT01484275|12597849|P1|STARTED|Overall Study||43
5120683|NCT01484197|12597871|P4|NOT COMPLETED|Treatment Period 4||0
5120684|NCT01484197|12597872|P3|NOT COMPLETED|Treatment Period 4||0
5120685|NCT01484197|12597873|P2|NOT COMPLETED|Treatment Period 4||0
5120686|NCT01484197|12597874|P1|NOT COMPLETED|Treatment Period 4||0
5120687|NCT01484197|12597871|P4|COMPLETED|Treatment Period 4||6
5120688|NCT01484197|12597872|P3|COMPLETED|Treatment Period 4||9
5120689|NCT01484197|12597873|P2|COMPLETED|Treatment Period 4||8
5120690|NCT01484197|12597874|P1|COMPLETED|Treatment Period 4||7
5120691|NCT01484197|12597871|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
5120692|NCT01484197|12597872|P3|STARTED|Treatment Period 4||9
5120693|NCT01484197|12597873|P2|STARTED|Treatment Period 4||8
5120694|NCT01484197|12597874|P1|STARTED|Treatment Period 4||7
5120695|NCT01484197|12597871|P4|NOT COMPLETED|Treatment Period 3||0
5120696|NCT01484197|12597872|P3|NOT COMPLETED|Treatment Period 3||0
5120697|NCT01484197|12597873|P2|NOT COMPLETED|Treatment Period 3||0
5120698|NCT01484197|12597874|P1|NOT COMPLETED|Treatment Period 3||0
5120699|NCT01484197|12597871|P4|COMPLETED|Treatment Period 3||8
5120700|NCT01484197|12597872|P3|COMPLETED|Treatment Period 3||9
5120701|NCT01484197|12597873|P2|COMPLETED|Treatment Period 3||8
5120702|NCT01484197|12597874|P1|COMPLETED|Treatment Period 3||7
5120703|NCT01484197|12597871|P4|STARTED|Treatment Period 3||8
5120704|NCT01484197|12597872|P3|STARTED|Treatment Period 3||9
5120705|NCT01484197|12597873|P2|STARTED|Treatment Period 3||8
5120706|NCT01484197|12597874|P1|STARTED|Treatment Period 3||7
5120707|NCT01484197|12597871|P4|NOT COMPLETED|Treatment Period 2||1
5120708|NCT01484197|12597872|P3|NOT COMPLETED|Treatment Period 2||0
5120709|NCT01484197|12597873|P2|NOT COMPLETED|Treatment Period 2||0
5120710|NCT01484197|12597874|P1|NOT COMPLETED|Treatment Period 2||0
5120711|NCT01484197|12597871|P4|COMPLETED|Treatment Period 2||8
5120712|NCT01484197|12597872|P3|COMPLETED|Treatment Period 2||9
5120713|NCT01484197|12597873|P2|COMPLETED|Treatment Period 2||8
5120714|NCT01484197|12597874|P1|COMPLETED|Treatment Period 2||7
5120715|NCT01484197|12597871|P4|STARTED|Treatment Period 2||9
5120716|NCT01484197|12597872|P3|STARTED|Treatment Period 2||9
5120717|NCT01484197|12597873|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
5120718|NCT01484197|12597874|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
5120719|NCT01484197|12597871|P4|NOT COMPLETED|Treatment Period 1||0
5120720|NCT01484197|12597872|P3|NOT COMPLETED|Treatment Period 1||0
5120721|NCT01484197|12597873|P2|NOT COMPLETED|Treatment Period 1||0
5120722|NCT01484197|12597874|P1|NOT COMPLETED|Treatment Period 1||1
5120723|NCT01484197|12597871|P4|COMPLETED|Treatment Period 1||9
5120724|NCT01484197|12597872|P3|COMPLETED|Treatment Period 1||9
5120725|NCT01484197|12597873|P2|COMPLETED|Treatment Period 1||9
5120726|NCT01484197|12597874|P1|COMPLETED|Treatment Period 1||8
5120727|NCT01484197|12597871|P4|STARTED|Treatment Period 1||9
5120728|NCT01484197|12597872|P3|STARTED|Treatment Period 1||9
5120729|NCT01484197|12597873|P2|STARTED|Treatment Period 1||9
5120730|NCT01484197|12597874|P1|STARTED|Treatment Period 1||9
5120731|NCT01484132|12597957|P1|NOT COMPLETED|Overall Study||22
5120732|NCT01484132|12597957|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
5120733|NCT01484132|12597957|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
5120734|NCT01484132|12597957|P1|STARTED|Overall Study||113
5120735|NCT01484054|12597965|P2|NOT COMPLETED|Period 2||0
5120736|NCT01484054|12597966|P1|NOT COMPLETED|Period 2||0
5120737|NCT01484054|12597965|P2|COMPLETED|Period 2||49
5120738|NCT01484054|12597966|P1|COMPLETED|Period 2||50
5120739|NCT01484054|12597965|P2|STARTED|Period 2||49
5120740|NCT01484054|12597966|P1|STARTED|Period 2||50
5120741|NCT01484054|12597965|P2|NOT COMPLETED|Period 1||1
5120742|NCT01484054|12597966|P1|NOT COMPLETED|Period 1||0
5120743|NCT01484054|12597965|P2|COMPLETED|Period 1||49
5120744|NCT01484054|12597966|P1|COMPLETED|Period 1||50
5120745|NCT01484054|12597965|P2|STARTED|Period 1||50
5120746|NCT01484054|12597966|P1|STARTED|Period 1||50
5120747|NCT01484041|12597976|P1|NOT COMPLETED|Overall Study||0
5120748|NCT01484041|12597976|P1|COMPLETED|Overall Study||12
5120749|NCT01484041|12597976|P1|STARTED|Overall Study||12
5120750|NCT01484028|12597984|P4|NOT COMPLETED|Period 2||0
5120751|NCT01484028|12597985|P3|NOT COMPLETED|Period 2||0
5120752|NCT01484028|12597986|P2|NOT COMPLETED|Period 2||0
5120753|NCT01484028|12597987|P1|NOT COMPLETED|Period 2||0
5120754|NCT01484028|12597984|P4|COMPLETED|Period 2||66
5120755|NCT01484028|12597985|P3|COMPLETED|Period 2||64
5120756|NCT01484028|12597986|P2|COMPLETED|Period 2||67
5120757|NCT01484028|12597987|P1|COMPLETED|Period 2||66
5120758|NCT01484028|12597984|P4|STARTED|Period 2||66
5120759|NCT01484028|12597985|P3|STARTED|Period 2||64
5120760|NCT01484028|12597986|P2|STARTED|Period 2||67
5120761|NCT01484028|12597987|P1|STARTED|Period 2||66
5120762|NCT01484028|12597984|P4|NOT COMPLETED|Period 1||1
5120763|NCT01484028|12597985|P3|NOT COMPLETED|Period 1||0
5120764|NCT01484028|12597986|P2|NOT COMPLETED|Period 1||3
5120765|NCT01484028|12597987|P1|NOT COMPLETED|Period 1||0
5120766|NCT01484028|12597984|P4|COMPLETED|Period 1||66
5120767|NCT01484028|12597985|P3|COMPLETED|Period 1||64
5120768|NCT01484028|12597986|P2|COMPLETED|Period 1||67
5120769|NCT01484028|12597987|P1|COMPLETED|Period 1||66
5120770|NCT01484028|12597984|P4|STARTED|Period 1||67
5120771|NCT01484028|12597985|P3|STARTED|Period 1||64
5120772|NCT01484028|12597986|P2|STARTED|Period 1||70
5120773|NCT01484028|12597987|P1|STARTED|Period 1||66
5120774|NCT01483963|12598002|P5|NOT COMPLETED|Overall Study||0
5120775|NCT01483963|12598003|P4|NOT COMPLETED|Overall Study||0
5120776|NCT01483963|12598004|P3|NOT COMPLETED|Overall Study||0
5120777|NCT01483963|12598005|P2|NOT COMPLETED|Overall Study||0
5120778|NCT01483963|12598006|P1|NOT COMPLETED|Overall Study||0
5120779|NCT01483963|12598002|P5|COMPLETED|Overall Study||10
5120780|NCT01483963|12598003|P4|COMPLETED|Overall Study||10
5120781|NCT01483963|12598004|P3|COMPLETED|Overall Study||10
5120782|NCT01483963|12598005|P2|COMPLETED|Overall Study||10
5120783|NCT01483963|12598006|P1|COMPLETED|Overall Study||10
5120784|NCT01483963|12598002|P5|STARTED|Overall Study||10
5120785|NCT01483963|12598003|P4|STARTED|Overall Study||10
5120786|NCT01483963|12598004|P3|STARTED|Overall Study||10
5120787|NCT01483963|12598005|P2|STARTED|Overall Study||10
5120788|NCT01483963|12598006|P1|STARTED|Overall Study||10
5120789|NCT01483937|12598080|P2|NOT COMPLETED|Overall Study||3
5120790|NCT01483937|12598081|P1|NOT COMPLETED|Overall Study||4
5120791|NCT01483937|12598080|P2|COMPLETED|Overall Study||14
5120792|NCT01483937|12598081|P1|COMPLETED|Overall Study||11
5120793|NCT01483937|12598080|P2|STARTED|Overall Study||17
5120794|NCT01483937|12598081|P1|STARTED|Overall Study||15
5120795|NCT01483924|12598108|P5|NOT COMPLETED|Overall Study||2
5120796|NCT01483924|12598109|P4|NOT COMPLETED|Overall Study||4
5120797|NCT01483924|12598110|P3|NOT COMPLETED|Overall Study||1
5120798|NCT01483924|12598111|P2|NOT COMPLETED|Overall Study||0
5120799|NCT01483924|12598112|P1|NOT COMPLETED|Overall Study||2
5120800|NCT01483924|12598108|P5|COMPLETED|Overall Study||10
5120801|NCT01483924|12598109|P4|COMPLETED|Overall Study||8
5120802|NCT01483924|12598110|P3|COMPLETED|Overall Study||11
5120803|NCT01483924|12598111|P2|COMPLETED|Overall Study||12
5120804|NCT01483924|12598112|P1|COMPLETED|Overall Study||10
5120805|NCT01483924|12598108|P5|STARTED|Overall Study||12
5120806|NCT01483924|12598109|P4|STARTED|Overall Study||12
5120807|NCT01483924|12598110|P3|STARTED|Overall Study||12
5120808|NCT01483924|12598111|P2|STARTED|Overall Study||12
5120809|NCT01483924|12598112|P1|STARTED|Overall Study||12
5120810|NCT01483872|12598160|P2|NOT COMPLETED|Overall Study||0
5120811|NCT01483872|12598161|P1|NOT COMPLETED|Overall Study||0
5120812|NCT01483872|12598160|P2|COMPLETED|Overall Study||1
5120813|NCT01483872|12598161|P1|COMPLETED|Overall Study||0
5120814|NCT01483872|12598160|P2|STARTED|Overall Study||1
5120815|NCT01483872|12598161|P1|STARTED|Overall Study||0
5120816|NCT01483820|12598165|P1|NOT COMPLETED|Overall Study||8
5120817|NCT01483820|12598165|P1|COMPLETED|Overall Study||0
5120818|NCT01483820|12598165|P1|STARTED|Overall Study||8
5120819|NCT01483807|12598174|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
5120820|NCT01483807|12598175|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
5120821|NCT01483807|12598174|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
5120822|NCT01483807|12598175|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
5120823|NCT01483807|12598174|P2|STARTED|Second Treatment Phase (7 Weeks)||10
5120824|NCT01483807|12598175|P1|STARTED|Second Treatment Phase (7 Weeks)||10
5120825|NCT01483807|12598174|P2|NOT COMPLETED|Washout (2 Weeks)||0
5120826|NCT01483807|12598175|P1|NOT COMPLETED|Washout (2 Weeks)||0
5120827|NCT01483807|12598174|P2|COMPLETED|Washout (2 Weeks)||10
5120828|NCT01483807|12598175|P1|COMPLETED|Washout (2 Weeks)||10
5120829|NCT01483807|12598174|P2|STARTED|Washout (2 Weeks)||10
5120830|NCT01483807|12598175|P1|STARTED|Washout (2 Weeks)||10
5120831|NCT01483807|12598174|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
5120832|NCT01483807|12598175|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
5120833|NCT01483807|12598174|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
5120834|NCT01483807|12598175|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
5120835|NCT01483807|12598174|P2|STARTED|First Treatment Phase (7 Weeks)||10
5120836|NCT01483807|12598175|P1|STARTED|First Treatment Phase (7 Weeks)||10
5120837|NCT01483651|12598186|P6|NOT COMPLETED|Overall Study||1
5120838|NCT01483651|12598187|P5|NOT COMPLETED|Overall Study||0
5120839|NCT01483651|12598188|P4|NOT COMPLETED|Overall Study||0
5120840|NCT01483651|12598189|P3|NOT COMPLETED|Overall Study||1
5120841|NCT01483651|12598190|P2|NOT COMPLETED|Overall Study||1
5120842|NCT01483651|12598191|P1|NOT COMPLETED|Overall Study||0
5120843|NCT01483651|12598186|P6|COMPLETED|Overall Study||1
5120844|NCT01483651|12598187|P5|COMPLETED|Overall Study||2
5120845|NCT01483651|12598188|P4|COMPLETED|Overall Study||1
5120846|NCT01483651|12598189|P3|COMPLETED|Overall Study||1
5120847|NCT01483651|12598190|P2|COMPLETED|Overall Study||2
5120848|NCT01483651|12598191|P1|COMPLETED|Overall Study||1
5120849|NCT01483651|12598186|P6|STARTED|Overall Study||2
5120850|NCT01483651|12598187|P5|STARTED|Overall Study||2
5120851|NCT01483651|12598188|P4|STARTED|Overall Study||1
5120852|NCT01483651|12598189|P3|STARTED|Overall Study||2
5120853|NCT01483651|12598190|P2|STARTED|Overall Study||3
5120854|NCT01483651|12598191|P1|STARTED|Overall Study||1
5120855|NCT01483625|12598201|P2|NOT COMPLETED|Overall Study||2
5120856|NCT01483625|12598202|P1|NOT COMPLETED|Overall Study||4
5120857|NCT01483625|12598201|P2|COMPLETED|Overall Study||66
5120858|NCT01483625|12598202|P1|COMPLETED|Overall Study||68
5120859|NCT01483625|12598201|P2|STARTED|Overall Study||68
5120860|NCT01483625|12598202|P1|STARTED|Overall Study||72
5120861|NCT01483599|12598225|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
5120862|NCT01483599|12598226|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
5120863|NCT01483599|12598227|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
5120864|NCT01483599|12598228|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
5120865|NCT01483599|12598229|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
5120866|NCT01483599|12598230|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
5120867|NCT01483599|12598231|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
5120868|NCT01483599|12598232|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120869|NCT01483599|12598233|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120870|NCT01483599|12598234|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120871|NCT01483599|12598235|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120872|NCT01483599|12598236|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120873|NCT01483599|12598237|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120874|NCT01483599|12598238|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120875|NCT01483599|12598225|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
5120876|NCT01483599|12598226|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
5120877|NCT01483599|12598227|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
5120878|NCT01483599|12598228|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
5120879|NCT01483599|12598229|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
5120880|NCT01483599|12598230|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
5120881|NCT01483599|12598231|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
5120882|NCT01483599|12598232|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120883|NCT01483599|12598233|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120884|NCT01483599|12598234|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120885|NCT01483599|12598235|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120886|NCT01483599|12598236|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120887|NCT01483599|12598237|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120888|NCT01483599|12598238|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
5120889|NCT01483599|12598225|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
5120890|NCT01483599|12598226|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
5120891|NCT01483599|12598227|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
5120892|NCT01483599|12598228|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
5120893|NCT01483599|12598229|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
5120894|NCT01483599|12598230|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
5120895|NCT01483599|12598231|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
5120896|NCT01483599|12598232|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
5120897|NCT01483599|12598233|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
5120898|NCT01483599|12598234|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
5120899|NCT01483599|12598235|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
5120900|NCT01483599|12598236|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
5120901|NCT01483599|12598237|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
5120902|NCT01483599|12598238|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
5120903|NCT01483599|12598225|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120904|NCT01483599|12598226|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120905|NCT01483599|12598227|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120906|NCT01483599|12598228|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120907|NCT01483599|12598229|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120908|NCT01483599|12598230|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120909|NCT01483599|12598231|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120910|NCT01483599|12598232|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
5120911|NCT01483599|12598233|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
5120912|NCT01483599|12598234|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
5120913|NCT01483599|12598235|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
5120914|NCT01483599|12598236|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120915|NCT01483599|12598237|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
5120916|NCT01483599|12598238|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
5120917|NCT01483599|12598225|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120918|NCT01483599|12598226|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120919|NCT01483599|12598227|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120920|NCT01483599|12598228|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120921|NCT01483599|12598229|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120922|NCT01483599|12598230|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120923|NCT01483599|12598231|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
5120924|NCT01483599|12598232|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
5120925|NCT01483599|12598233|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
5120926|NCT01483599|12598234|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
5120927|NCT01483599|12598235|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
5120928|NCT01483599|12598236|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
5120929|NCT01483599|12598237|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
5120930|NCT01483599|12598238|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
5120931|NCT01483599|12598225|P14|Treated|Controlled Period (CP) (up to Week 16)||0
5120932|NCT01483599|12598226|P13|Treated|Controlled Period (CP) (up to Week 16)||0
5120933|NCT01483599|12598227|P12|Treated|Controlled Period (CP) (up to Week 16)||0
5120934|NCT01483599|12598228|P11|Treated|Controlled Period (CP) (up to Week 16)||0
5120935|NCT01483599|12598229|P10|Treated|Controlled Period (CP) (up to Week 16)||0
5120936|NCT01483599|12598230|P9|Treated|Controlled Period (CP) (up to Week 16)||0
5120937|NCT01483599|12598231|P8|Treated|Controlled Period (CP) (up to Week 16)||0
5120938|NCT01483599|12598232|P7|Treated|Controlled Period (CP) (up to Week 16)||43
5120939|NCT01483599|12598233|P6|Treated|Controlled Period (CP) (up to Week 16)||41
5120940|NCT01483599|12598234|P5|Treated|Controlled Period (CP) (up to Week 16)||42
5120941|NCT01483599|12598235|P4|Treated|Controlled Period (CP) (up to Week 16)||42
5120942|NCT01483599|12598236|P3|Treated|Controlled Period (CP) (up to Week 16)||41
5120943|NCT01483599|12598237|P2|Treated|Controlled Period (CP) (up to Week 16)||41
5120944|NCT01483599|12598238|P1|Treated|Controlled Period (CP) (up to Week 16)||42
5120945|NCT01483599|12598225|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
5120946|NCT01483599|12598226|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
5120947|NCT01483599|12598227|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
5120948|NCT01483599|12598228|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
5120949|NCT01483599|12598229|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
5120950|NCT01483599|12598230|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
5120951|NCT01483599|12598231|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
5120952|NCT01483599|12598232|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
5120953|NCT01483599|12598233|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
5120954|NCT01483599|12598234|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
5120955|NCT01483599|12598235|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
5120956|NCT01483599|12598236|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
5120957|NCT01483599|12598237|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
5120958|NCT01483599|12598238|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
5120959|NCT01483560|12598289|P2|NOT COMPLETED|Overall Study||15
5120960|NCT01483560|12598290|P1|NOT COMPLETED|Overall Study||26
5120961|NCT01483560|12598289|P2|COMPLETED|Overall Study||194
5120962|NCT01483560|12598290|P1|COMPLETED|Overall Study||193
5120963|NCT01483560|12598289|P2|STARTED|Overall Study||209
5120964|NCT01483560|12598290|P1|STARTED|Overall Study||219
5120965|NCT01483378|12598310|P2|NOT COMPLETED|Overall Study||0
5120966|NCT01483378|12598311|P1|NOT COMPLETED|Overall Study||0
5120967|NCT01483378|12598310|P2|COMPLETED|Overall Study||66
5120968|NCT01483378|12598311|P1|COMPLETED|Overall Study||100
5120969|NCT01483378|12598310|P2|STARTED|Overall Study||66
5120970|NCT01483378|12598311|P1|STARTED|Overall Study||100
5120971|NCT01483352|12598317|P1|NOT COMPLETED|Overall Study||0
5120972|NCT01483352|12598317|P1|COMPLETED|Overall Study||12
5120973|NCT01483352|12598317|P1|STARTED|Overall Study||12
5120974|NCT01483209|12598336|P1|NOT COMPLETED|Overall Study||1
5120975|NCT01483209|12598336|P1|COMPLETED|Overall Study||1
5120976|NCT01483209|12598336|P1|STARTED|Overall Study||2
5120977|NCT01483183|12598351|P10|NOT COMPLETED|Overall Study||1
5120978|NCT01483183|12598352|P9|NOT COMPLETED|Overall Study||0
5120979|NCT01483183|12598353|P8|NOT COMPLETED|Overall Study||0
5120980|NCT01483183|12598354|P7|NOT COMPLETED|Overall Study||2
5120981|NCT01483183|12598355|P6|NOT COMPLETED|Overall Study||0
5120982|NCT01483183|12598356|P5|NOT COMPLETED|Overall Study||0
5120983|NCT01483183|12598357|P4|NOT COMPLETED|Overall Study||0
5120984|NCT01483183|12598358|P3|NOT COMPLETED|Overall Study||0
5120985|NCT01483183|12598359|P2|NOT COMPLETED|Overall Study||0
5120986|NCT01483183|12598360|P1|NOT COMPLETED|Overall Study||0
5120987|NCT01483183|12598351|P10|COMPLETED|Overall Study||4
5120988|NCT01483183|12598352|P9|COMPLETED|Overall Study||4
5120989|NCT01483183|12598353|P8|COMPLETED|Overall Study||4
5120990|NCT01483183|12598354|P7|COMPLETED|Overall Study||4
5120991|NCT01483183|12598355|P6|COMPLETED|Overall Study||4
5120992|NCT01483183|12598356|P5|COMPLETED|Overall Study||4
5120993|NCT01483183|12598357|P4|COMPLETED|Overall Study||3
5120994|NCT01483183|12598358|P3|COMPLETED|Overall Study||5
5120995|NCT01483183|12598359|P2|COMPLETED|Overall Study||1
5120996|NCT01483183|12598360|P1|COMPLETED|Overall Study||4
5120997|NCT01483183|12598351|P10|STARTED|Overall Study||5
5120998|NCT01483183|12598352|P9|STARTED|Overall Study||4
5120999|NCT01483183|12598353|P8|STARTED|Overall Study||4
5121000|NCT01483183|12598354|P7|STARTED|Overall Study||6
5121001|NCT01483183|12598355|P6|STARTED|Overall Study||4
5121002|NCT01483183|12598356|P5|STARTED|Overall Study||4
5121003|NCT01483183|12598357|P4|STARTED|Overall Study||3
5121004|NCT01483183|12598358|P3|STARTED|Overall Study||5
5121005|NCT01483183|12598359|P2|STARTED|Overall Study||1
5121006|NCT01483183|12598360|P1|STARTED|Overall Study||4
5121007|NCT01483118|12598430|P2|NOT COMPLETED|Overall Study||16
5121008|NCT01483118|12598431|P1|NOT COMPLETED|Overall Study||12
5121009|NCT01483118|12598430|P2|COMPLETED|Overall Study||6
5121010|NCT01483118|12598431|P1|COMPLETED|Overall Study||11
5121011|NCT01483118|12598430|P2|Completed 3 Months|Overall Study||11
5121012|NCT01483118|12598431|P1|Completed 3 Months|Overall Study||15
5121013|NCT01483118|12598430|P2|STARTED|Overall Study||22
5121014|NCT01483118|12598431|P1|STARTED|Overall Study||23
5121015|NCT01482962|12598443|P2|NOT COMPLETED|Overall Study||133
5121016|NCT01482962|12598444|P1|NOT COMPLETED|Overall Study||138
5121017|NCT01482962|12598443|P2|COMPLETED|Overall Study||0
5121018|NCT01482962|12598444|P1|COMPLETED|Overall Study||0
5121019|NCT01482962|12598443|P2|Safety Population: Received Study Drug|Overall Study||127
5121020|NCT01482962|12598444|P1|Safety Population: Received Study Drug|Overall Study||137
5121021|NCT01482962|12598443|P2|STARTED|Overall Study||133
5121022|NCT01482962|12598444|P1|STARTED|Overall Study||138
5121023|NCT01482910|12598477|P2|NOT COMPLETED|Overall Study||9
5121024|NCT01482910|12598478|P1|NOT COMPLETED|Overall Study||15
5121025|NCT01482910|12598477|P2|COMPLETED|Overall Study||67
5121026|NCT01482910|12598478|P1|COMPLETED|Overall Study||213
5121027|NCT01482910|12598477|P2|Completed Week 28|Overall Study||71
5121028|NCT01482910|12598478|P1|Completed Week 28|Overall Study||216
5121029|NCT01482910|12598477|P2|STARTED|Overall Study||76
5121030|NCT01482910|12598478|P1|STARTED|Overall Study||228
5121031|NCT01482884|12598490|P2|NOT COMPLETED|Overall Study||18
5121032|NCT01482884|12598491|P1|NOT COMPLETED|Overall Study||13
5121033|NCT01482884|12598490|P2|COMPLETED|Overall Study||37
5121034|NCT01482884|12598491|P1|COMPLETED|Overall Study||43
5121035|NCT01482884|12598490|P2|STARTED|Overall Study||55
5121036|NCT01482884|12598491|P1|STARTED|Overall Study|One participant did not receive study treatment|56
5121037|NCT01482819|12598517|P1|NOT COMPLETED|Overall Study||2
5121038|NCT01482819|12598517|P1|COMPLETED|Overall Study||19
5121039|NCT01482819|12598517|P1|STARTED|Overall Study||21
5121040|NCT01482767|12598537|P2|NOT COMPLETED|Overall Study||49
5121041|NCT01482767|12598538|P1|NOT COMPLETED|Overall Study||54
5121042|NCT01482767|12598537|P2|COMPLETED|Overall Study||78
5121043|NCT01482767|12598538|P1|COMPLETED|Overall Study||81
5121044|NCT01482767|12598537|P2|STARTED|Overall Study||127
5121045|NCT01482767|12598538|P1|STARTED|Overall Study||135
5121046|NCT01482429|12598560|P2|NOT COMPLETED|Protocol||0
5121047|NCT01482429|12598561|P1|NOT COMPLETED|Protocol||275
5121048|NCT01482429|12598560|P2|COMPLETED|Protocol||0
5121049|NCT01482429|12598561|P1|COMPLETED|Protocol||139
5121050|NCT01482429|12598560|P2|STARTED|Protocol||0
5121051|NCT01482429|12598561|P1|STARTED|Protocol||414
5121052|NCT01482429|12598560|P2|NOT COMPLETED|Care Usual||173
5121053|NCT01482429|12598561|P1|NOT COMPLETED|Care Usual||0
5121054|NCT01482429|12598560|P2|COMPLETED|Care Usual||96
5121055|NCT01482429|12598561|P1|COMPLETED|Care Usual||0
5121056|NCT01482429|12598560|P2|STARTED|Care Usual||269
5121057|NCT01482429|12598561|P1|STARTED|Care Usual||0
5121058|NCT01482351|12598571|P1|NOT COMPLETED|Overall Study||14
5121059|NCT01482351|12598571|P1|COMPLETED|Overall Study||54
5121060|NCT01482351|12598571|P1|12 Months|Overall Study||54
5121061|NCT01482351|12598571|P1|6 Months|Overall Study|14 dropped out|54
5121062|NCT01482351|12598571|P1|STARTED|Overall Study||68
5121063|NCT01482325|12598593|P1|NOT COMPLETED|Overall Study||0
5121064|NCT01482325|12598593|P1|COMPLETED|Overall Study||31
5121065|NCT01482325|12598593|P1|STARTED|Overall Study||31
5121066|NCT01482312|12598597|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
5121067|NCT01482312|12598598|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
5121068|NCT01482312|12598599|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
5121069|NCT01482312|12598597|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
5121070|NCT01482312|12598598|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
5121071|NCT01482312|12598599|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
5121072|NCT01482312|12598597|P3|STARTED|Period 3, 90 Minutes of Wear||9
5121073|NCT01482312|12598598|P2|STARTED|Period 3, 90 Minutes of Wear||9
5121074|NCT01482312|12598599|P1|STARTED|Period 3, 90 Minutes of Wear||8
5121075|NCT01482312|12598597|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
5121076|NCT01482312|12598598|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
5121077|NCT01482312|12598599|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
5121078|NCT01482312|12598597|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
5121079|NCT01482312|12598598|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
5121080|NCT01482312|12598599|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
5121081|NCT01482312|12598597|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
5121082|NCT01482312|12598598|P2|STARTED|Period 2, 90 Minutes of Wear||9
5121083|NCT01482312|12598599|P1|STARTED|Period 2, 90 Minutes of Wear||9
5121084|NCT01482312|12598597|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
5121085|NCT01482312|12598598|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
5121086|NCT01482312|12598599|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
5121087|NCT01482312|12598597|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
5121088|NCT01482312|12598598|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
5121089|NCT01482312|12598599|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
5121090|NCT01482312|12598597|P3|STARTED|Period 1, 90 Minutes of Wear||10
5121091|NCT01482312|12598598|P2|STARTED|Period 1, 90 Minutes of Wear||9
5121092|NCT01482312|12598599|P1|STARTED|Period 1, 90 Minutes of Wear||10
5121093|NCT01482221|12598613|P3|NOT COMPLETED|Overall Study||23
5121094|NCT01482221|12598614|P2|NOT COMPLETED|Overall Study||20
5121095|NCT01482221|12598615|P1|NOT COMPLETED|Overall Study||21
5121096|NCT01482221|12598613|P3|COMPLETED|Overall Study||77
5121097|NCT01482221|12598614|P2|COMPLETED|Overall Study||81
5121098|NCT01482221|12598615|P1|COMPLETED|Overall Study||80
5121099|NCT01482221|12598613|P3|STARTED|Overall Study||100
5121100|NCT01482221|12598614|P2|STARTED|Overall Study||101
5121101|NCT01482221|12598615|P1|STARTED|Overall Study||101
5121102|NCT01482169|12598656|P1|NOT COMPLETED|Overall Study||2
5121103|NCT01482169|12598656|P1|COMPLETED|Overall Study||46
5121104|NCT01482169|12598656|P1|STARTED|Overall Study||48
5121105|NCT01482091|12598665|P2|NOT COMPLETED|Overall Study||0
5121106|NCT01482091|12598666|P1|NOT COMPLETED|Overall Study||0
5121107|NCT01482091|12598665|P2|COMPLETED|Overall Study||24
5121108|NCT01482091|12598666|P1|COMPLETED|Overall Study||25
5121109|NCT01482091|12598665|P2|STARTED|Overall Study||24
5121110|NCT01482091|12598666|P1|STARTED|Overall Study||25
5121111|NCT01482065|12598698|P2|NOT COMPLETED|Overall Study||1
5121112|NCT01482065|12598699|P1|NOT COMPLETED|Overall Study||0
5121113|NCT01482065|12598698|P2|COMPLETED|Overall Study||4
5121114|NCT01482065|12598699|P1|COMPLETED|Overall Study||4
5121115|NCT01482065|12598698|P2|STARTED|Overall Study||5
5121116|NCT01482065|12598699|P1|STARTED|Overall Study||4
5121117|NCT01481935|12598713|P2|NOT COMPLETED|Overall Study||0
5121118|NCT01481935|12598714|P1|NOT COMPLETED|Overall Study||0
5121119|NCT01481935|12598713|P2|COMPLETED|Overall Study||93
5121120|NCT01481935|12598714|P1|COMPLETED|Overall Study||97
5121121|NCT01481935|12598713|P2|STARTED|Overall Study||93
5121122|NCT01481935|12598714|P1|STARTED|Overall Study||97
5121123|NCT01481896|12598720|P1|NOT COMPLETED|Overall Study||12
5121124|NCT01481896|12598720|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
5121125|NCT01481896|12598720|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
5121126|NCT01481896|12598720|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
5121127|NCT01481779|12598736|P2|NOT COMPLETED|Overall Study||28
5121128|NCT01481779|12598737|P1|NOT COMPLETED|Overall Study||70
5121129|NCT01481779|12598736|P2|COMPLETED|Overall Study||132
5121130|NCT01481779|12598737|P1|COMPLETED|Overall Study||225
5121131|NCT01481779|12598736|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
5121132|NCT01481779|12598737|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
5121133|NCT01481779|12598736|P2|STARTED|Overall Study||160
5121134|NCT01481779|12598737|P1|STARTED|Overall Study||295
5121135|NCT01481740|12598785|P2|NOT COMPLETED|Overall Study||7
5121136|NCT01481740|12598786|P1|NOT COMPLETED|Overall Study||11
5121137|NCT01481740|12598785|P2|COMPLETED|Overall Study||81
5121138|NCT01481740|12598786|P1|COMPLETED|Overall Study||79
5121139|NCT01481740|12598785|P2|STARTED|Overall Study||88
5121140|NCT01481740|12598786|P1|STARTED|Overall Study||90
5121141|NCT01481558|12598804|P2|NOT COMPLETED|Overall Study||0
5121142|NCT01481558|12598805|P1|NOT COMPLETED|Overall Study||0
5121143|NCT01481558|12598804|P2|COMPLETED|Overall Study||20
5121144|NCT01481558|12598805|P1|COMPLETED|Overall Study||20
5121145|NCT01481558|12598804|P2|STARTED|Overall Study||20
5121146|NCT01481558|12598805|P1|STARTED|Overall Study||20
5121147|NCT01481376|12598811|P1|NOT COMPLETED|Overall Study||31
5121148|NCT01481376|12598811|P1|COMPLETED|Overall Study||169
5121149|NCT01481376|12598811|P1|STARTED|Overall Study||200
5121150|NCT01481324|12598822|P3|NOT COMPLETED|Overall Study||2
5121151|NCT01481324|12598823|P2|NOT COMPLETED|Overall Study||2
5121152|NCT01481324|12598824|P1|NOT COMPLETED|Overall Study||0
5121153|NCT01481324|12598822|P3|COMPLETED|Overall Study||20
5121154|NCT01481324|12598823|P2|COMPLETED|Overall Study||22
5121155|NCT01481324|12598824|P1|COMPLETED|Overall Study||21
5121156|NCT01481324|12598822|P3|Month 3-Wear Rate Data|Overall Study||6
5121157|NCT01481324|12598823|P2|Month 3-Wear Rate Data|Overall Study||11
5121158|NCT01481324|12598824|P1|Month 3-Wear Rate Data|Overall Study||7
5121159|NCT01481324|12598822|P3|Month 2-Wear Rate Data|Overall Study||7
5121160|NCT01481324|12598823|P2|Month 2-Wear Rate Data|Overall Study||13
5121161|NCT01481324|12598824|P1|Month 2-Wear Rate Data|Overall Study||9
5121162|NCT01481324|12598822|P3|Month 1-Wear Rate Data|Overall Study||8
5121163|NCT01481324|12598823|P2|Month 1-Wear Rate Data|Overall Study||16
5121164|NCT01481324|12598824|P1|Month 1-Wear Rate Data|Overall Study||15
5121165|NCT01481324|12598822|P3|STARTED|Overall Study||22
5121166|NCT01481324|12598823|P2|STARTED|Overall Study||24
5121167|NCT01481324|12598824|P1|STARTED|Overall Study||21
5121168|NCT01481129|12598832|P1|NOT COMPLETED|Overall Study||0
5121169|NCT01481129|12598832|P1|COMPLETED|Overall Study||22
5121170|NCT01481129|12598832|P1|STARTED|Overall Study||22
5121171|NCT01481116|12598843|P3|NOT COMPLETED|Overall Study||813
5121172|NCT01481116|12598844|P2|NOT COMPLETED|Overall Study||817
5121173|NCT01481116|12598845|P1|NOT COMPLETED|Overall Study||824
5121174|NCT01481116|12598843|P3|COMPLETED|Overall Study||0
5121175|NCT01481116|12598844|P2|COMPLETED|Overall Study||0
5121176|NCT01481116|12598845|P1|COMPLETED|Overall Study||0
5121177|NCT01481116|12598843|P3|Treated|Overall Study||813
5121178|NCT01481116|12598844|P2|Treated|Overall Study||816
5121179|NCT01481116|12598845|P1|Treated|Overall Study||822
5121180|NCT01481116|12598843|P3|STARTED|Overall Study||813
5121181|NCT01481116|12598844|P2|STARTED|Overall Study||817
5121182|NCT01481116|12598845|P1|STARTED|Overall Study||824
5121183|NCT01480843|12598871|P1|NOT COMPLETED|Overall Study||5
5121184|NCT01480843|12598871|P1|COMPLETED|Overall Study||60
5121185|NCT01480843|12598871|P1|STARTED|Overall Study||65
5121186|NCT01480674|12598876|P1|NOT COMPLETED|Overall Study||35
5121187|NCT01480674|12598876|P1|COMPLETED|Overall Study||125
5121188|NCT01480674|12598876|P1|Analysed Set|Overall Study||128
5121189|NCT01480674|12598876|P1|Safety Set|Overall Study||154
5121190|NCT01480674|12598876|P1|STARTED|Overall Study||160
5121191|NCT01480596|12598890|P2|NOT COMPLETED|Overall Study||2
5121192|NCT01480596|12598891|P1|NOT COMPLETED|Overall Study||5
5121193|NCT01480596|12598890|P2|COMPLETED|Overall Study||16
5121194|NCT01480596|12598891|P1|COMPLETED|Overall Study||17
5121195|NCT01480596|12598890|P2|STARTED|Overall Study||18
5121196|NCT01480596|12598891|P1|STARTED|Overall Study||22
5121197|NCT01480297|12598933|P1|NOT COMPLETED|Overall Study||0
5121198|NCT01480297|12598933|P1|COMPLETED|Overall Study||8
5121199|NCT01480297|12598933|P1|STARTED|Overall Study||8
5121200|NCT01480284|12598939|P2|NOT COMPLETED|Overall Study||0
5121201|NCT01480284|12598940|P1|NOT COMPLETED|Overall Study||8
5121202|NCT01480284|12598939|P2|COMPLETED|Overall Study||56
5121203|NCT01480284|12598940|P1|COMPLETED|Overall Study||102
5121204|NCT01480284|12598939|P2|STARTED|Overall Study||56
5121205|NCT01480284|12598940|P1|STARTED|Overall Study||110
5121206|NCT01480258|12598970|P2|NOT COMPLETED|Toddler Dose||0
5121207|NCT01480258|12598971|P1|NOT COMPLETED|Toddler Dose||0
5121208|NCT01480258|12598970|P2|COMPLETED|Toddler Dose||642
5121209|NCT01480258|12598971|P1|COMPLETED|Toddler Dose||639
5121210|NCT01480258|12598970|P2|STARTED|Toddler Dose||642
5121211|NCT01480258|12598971|P1|STARTED|Toddler Dose||639
5121212|NCT01480258|12598970|P2|NOT COMPLETED|Interim Period||9
5121213|NCT01480258|12598971|P1|NOT COMPLETED|Interim Period||10
5121214|NCT01480258|12598970|P2|COMPLETED|Interim Period||642
5121215|NCT01480258|12598971|P1|COMPLETED|Interim Period||639
5121216|NCT01480258|12598970|P2|STARTED|Interim Period||651
5121217|NCT01480258|12598971|P1|STARTED|Interim Period||649
5121218|NCT01480258|12598970|P2|NOT COMPLETED|Infant Series||8
5121219|NCT01480258|12598971|P1|NOT COMPLETED|Infant Series||7
5121220|NCT01480258|12598970|P2|COMPLETED|Infant Series||651
5121221|NCT01480258|12598971|P1|COMPLETED|Infant Series||649
5121222|NCT01480258|12598970|P2|Vaccinated|Infant Series||659
5121223|NCT01480258|12598971|P1|Vaccinated|Infant Series||653
5121224|NCT01480258|12598970|P2|STARTED|Infant Series||659
5121225|NCT01480258|12598971|P1|STARTED|Infant Series||656
5121226|NCT01480232|12598997|P4|NOT COMPLETED|Overall Study||19
5121227|NCT01480232|12598998|P3|NOT COMPLETED|Overall Study||17
5121228|NCT01480232|12598999|P2|NOT COMPLETED|Overall Study||22
5121229|NCT01480232|12599000|P1|NOT COMPLETED|Overall Study||18
5121230|NCT01480232|12598997|P4|COMPLETED|Overall Study||22
5121231|NCT01480232|12598998|P3|COMPLETED|Overall Study||21
5121232|NCT01480232|12598999|P2|COMPLETED|Overall Study||19
5121233|NCT01480232|12599000|P1|COMPLETED|Overall Study||22
5121234|NCT01480232|12598997|P4|STARTED|Overall Study||41
5121235|NCT01480232|12598998|P3|STARTED|Overall Study||38
5121236|NCT01480232|12598999|P2|STARTED|Overall Study||41
5121237|NCT01480232|12599000|P1|STARTED|Overall Study||40
5121238|NCT01480219|12599028|P2|NOT COMPLETED|Overall Study||0
5121239|NCT01480219|12599029|P1|NOT COMPLETED|Overall Study||0
5121240|NCT01480219|12599028|P2|COMPLETED|Overall Study||142
5121241|NCT01480219|12599029|P1|COMPLETED|Overall Study||325
5121242|NCT01480219|12599028|P2|STARTED|Overall Study||142
5121243|NCT01480219|12599029|P1|STARTED|Overall Study||325
5121244|NCT01480180|12599037|P6|NOT COMPLETED|Extension Phase, Part 2||0
5121245|NCT01480180|12599038|P5|NOT COMPLETED|Extension Phase, Part 2||2
5121246|NCT01480180|12599039|P4|NOT COMPLETED|Extension Phase, Part 2||7
5121247|NCT01480180|12599040|P3|NOT COMPLETED|Extension Phase, Part 2||17
5121248|NCT01480180|12599041|P2|NOT COMPLETED|Extension Phase, Part 2||0
5121249|NCT01480180|12599042|P1|NOT COMPLETED|Extension Phase, Part 2||0
5121250|NCT01480180|12599037|P6|COMPLETED|Extension Phase, Part 2||0
5121251|NCT01480180|12599038|P5|COMPLETED|Extension Phase, Part 2||3
5121252|NCT01480180|12599039|P4|COMPLETED|Extension Phase, Part 2||33
5121253|NCT01480180|12599040|P3|COMPLETED|Extension Phase, Part 2||77
5121254|NCT01480180|12599041|P2|COMPLETED|Extension Phase, Part 2||0
5121255|NCT01480180|12599042|P1|COMPLETED|Extension Phase, Part 2||0
5121256|NCT01480180|12599037|P6|STARTED|Extension Phase, Part 2||0
5121257|NCT01480180|12599038|P5|STARTED|Extension Phase, Part 2||5
5121258|NCT01480180|12599039|P4|STARTED|Extension Phase, Part 2||40
5121259|NCT01480180|12599040|P3|STARTED|Extension Phase, Part 2||94
5121260|NCT01480180|12599041|P2|STARTED|Extension Phase, Part 2||0
5121261|NCT01480180|12599042|P1|STARTED|Extension Phase, Part 2||0
5121262|NCT01480180|12599037|P6|NOT COMPLETED|Extension Phase, Part 1||0
5121263|NCT01480180|12599038|P5|NOT COMPLETED|Extension Phase, Part 1||0
5121264|NCT01480180|12599039|P4|NOT COMPLETED|Extension Phase, Part 1||10
5121265|NCT01480180|12599040|P3|NOT COMPLETED|Extension Phase, Part 1||10
5121266|NCT01480180|12599041|P2|NOT COMPLETED|Extension Phase, Part 1||0
5121267|NCT01480180|12599042|P1|NOT COMPLETED|Extension Phase, Part 1||0
5121268|NCT01480180|12599037|P6|COMPLETED|Extension Phase, Part 1||0
5121269|NCT01480180|12599038|P5|COMPLETED|Extension Phase, Part 1||7
5121270|NCT01480180|12599039|P4|COMPLETED|Extension Phase, Part 1||28
5121271|NCT01480180|12599040|P3|COMPLETED|Extension Phase, Part 1||95
5121272|NCT01480180|12599041|P2|COMPLETED|Extension Phase, Part 1||0
5121273|NCT01480180|12599042|P1|COMPLETED|Extension Phase, Part 1||0
5121274|NCT01480180|12599037|P6|STARTED|Extension Phase, Part 1||0
5121275|NCT01480180|12599038|P5|STARTED|Extension Phase, Part 1||7
5121276|NCT01480180|12599039|P4|STARTED|Extension Phase, Part 1||38
5121277|NCT01480180|12599040|P3|STARTED|Extension Phase, Part 1||105
5121278|NCT01480180|12599041|P2|STARTED|Extension Phase, Part 1||0
5121279|NCT01480180|12599042|P1|STARTED|Extension Phase, Part 1||0
5121280|NCT01480180|12599037|P6|NOT COMPLETED|Main Phase||0
5121281|NCT01480180|12599038|P5|NOT COMPLETED|Main Phase||0
5121282|NCT01480180|12599039|P4|NOT COMPLETED|Main Phase||0
5121283|NCT01480180|12599040|P3|NOT COMPLETED|Main Phase||0
5121284|NCT01480180|12599041|P2|NOT COMPLETED|Main Phase||1
5121285|NCT01480180|12599042|P1|NOT COMPLETED|Main Phase||19
5121286|NCT01480180|12599037|P6|COMPLETED|Main Phase|Not applicable for this phase|0
5121287|NCT01480180|12599038|P5|COMPLETED|Main Phase|Not applicable for this phase|0
5121288|NCT01480180|12599039|P4|COMPLETED|Main Phase|Not applicable for this phase|0
5121289|NCT01480180|12599040|P3|COMPLETED|Main Phase|Not applicable for this phase|0
5121290|NCT01480180|12599041|P2|COMPLETED|Main Phase||11
5121291|NCT01480180|12599042|P1|COMPLETED|Main Phase||155
5121292|NCT01480180|12599037|P6|Max. Participants After Switching|Main Phase||0
5121293|NCT01480180|12599038|P5|Max. Participants After Switching|Main Phase||0
5121294|NCT01480180|12599039|P4|Max. Participants After Switching|Main Phase||0
5121295|NCT01480180|12599040|P3|Max. Participants After Switching|Main Phase||0
5121296|NCT01480180|12599041|P2|Max. Participants After Switching|Main Phase||11
5121297|NCT01480180|12599042|P1|Max. Participants After Switching|Main Phase||175
5121298|NCT01480180|12599037|P6|STARTED|Main Phase|Not applicable for this phase|0
5121299|NCT01480180|12599038|P5|STARTED|Main Phase|Not applicable for this phase|0
5121300|NCT01480180|12599039|P4|STARTED|Main Phase|Not applicable for this phase|0
5121301|NCT01480180|12599040|P3|STARTED|Main Phase|Not applicable for this phase|0
5121302|NCT01480180|12599041|P2|STARTED|Main Phase||12
5121303|NCT01480180|12599042|P1|STARTED|Main Phase||174
5121304|NCT01480089|12599199|P2|NOT COMPLETED|Overall Study||0
5121305|NCT01480089|12599200|P1|NOT COMPLETED|Overall Study||0
5121306|NCT01480089|12599199|P2|COMPLETED|Overall Study||30
5121307|NCT01480089|12599200|P1|COMPLETED|Overall Study||25
5121308|NCT01480089|12599199|P2|STARTED|Overall Study||30
5121309|NCT01480089|12599200|P1|STARTED|Overall Study||25
5121310|NCT01480076|12599210|P1|NOT COMPLETED|Overall Study||290
5121311|NCT01480076|12599210|P1|COMPLETED|Overall Study||611
5121312|NCT01480076|12599210|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
5121313|NCT01480076|12599210|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
5121314|NCT01479985|12599331|P2|NOT COMPLETED|Overall Study||0
5121315|NCT01479985|12599332|P1|NOT COMPLETED|Overall Study||0
5121316|NCT01479985|12599331|P2|COMPLETED|Overall Study||80
5121317|NCT01479985|12599332|P1|COMPLETED|Overall Study||161
5121318|NCT01479985|12599331|P2|STARTED|Overall Study||80
5121319|NCT01479985|12599332|P1|STARTED|Overall Study||161
5121320|NCT01479868|12599340|P1|NOT COMPLETED|Overall Study||9
5121321|NCT01479868|12599340|P1|COMPLETED|Overall Study||97
5121322|NCT01479868|12599340|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
5121323|NCT01479777|12599355|P1|NOT COMPLETED|Overall Study||2
5121324|NCT01479777|12599355|P1|COMPLETED|Overall Study||10
5121325|NCT01479777|12599355|P1|STARTED|Overall Study||12
5121326|NCT01479764|12599367|P2|NOT COMPLETED|Treated||2
5121327|NCT01479764|12599368|P1|NOT COMPLETED|Treated||0
5121328|NCT01479764|12599367|P2|COMPLETED|Treated||75
5121329|NCT01479764|12599368|P1|COMPLETED|Treated||74
5121330|NCT01479764|12599367|P2|STARTED|Treated||77
5121331|NCT01479764|12599368|P1|STARTED|Treated||74
5121332|NCT01479764|12599367|P2|NOT COMPLETED|Randomized||1
5121333|NCT01479764|12599368|P1|NOT COMPLETED|Randomized||2
5121334|NCT01479764|12599367|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
5121335|NCT01479764|12599368|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
5121336|NCT01479764|12599367|P2|STARTED|Randomized||78
5121337|NCT01479764|12599368|P1|STARTED|Randomized||76
5121338|NCT01479725|12599378|P2|NOT COMPLETED|Overall Study||1
5121339|NCT01479725|12599379|P1|NOT COMPLETED|Overall Study||2
5121340|NCT01479725|12599378|P2|COMPLETED|Overall Study||1
5121341|NCT01479725|12599379|P1|COMPLETED|Overall Study||4
5121342|NCT01479725|12599378|P2|STARTED|Overall Study||2
5121343|NCT01479725|12599379|P1|STARTED|Overall Study||6
5121344|NCT01479621|12599391|P7|NOT COMPLETED|Treatment Period||20
5121345|NCT01479621|12599392|P6|NOT COMPLETED|Treatment Period||41
5121346|NCT01479621|12599393|P5|NOT COMPLETED|Treatment Period||21
5121347|NCT01479621|12599394|P4|NOT COMPLETED|Treatment Period||12
5121348|NCT01479621|12599395|P3|NOT COMPLETED|Treatment Period||21
5121349|NCT01479621|12599396|P2|NOT COMPLETED|Treatment Period||24
5121350|NCT01479621|12599397|P1|NOT COMPLETED|Treatment Period||0
5121351|NCT01479621|12599391|P7|COMPLETED|Treatment Period||84
5121352|NCT01479621|12599392|P6|COMPLETED|Treatment Period||63
5121353|NCT01479621|12599393|P5|COMPLETED|Treatment Period||82
5121354|NCT01479621|12599394|P4|COMPLETED|Treatment Period||92
5121355|NCT01479621|12599395|P3|COMPLETED|Treatment Period||83
5121356|NCT01479621|12599396|P2|COMPLETED|Treatment Period||79
5121357|NCT01479621|12599397|P1|COMPLETED|Treatment Period||0
5121358|NCT01479621|12599391|P7|Full Analysis Set|Treatment Period||102
5121359|NCT01479621|12599392|P6|Full Analysis Set|Treatment Period||102
5121360|NCT01479621|12599393|P5|Full Analysis Set|Treatment Period||102
5121361|NCT01479621|12599394|P4|Full Analysis Set|Treatment Period||102
5121362|NCT01479621|12599395|P3|Full Analysis Set|Treatment Period||101
5121363|NCT01479621|12599396|P2|Full Analysis Set|Treatment Period||102
5121364|NCT01479621|12599397|P1|Full Analysis Set|Treatment Period||0
5121365|NCT01479621|12599391|P7|Safety Population|Treatment Period||104
5121366|NCT01479621|12599392|P6|Safety Population|Treatment Period||104
5121367|NCT01479621|12599393|P5|Safety Population|Treatment Period||103
5121368|NCT01479621|12599394|P4|Safety Population|Treatment Period||104
5121369|NCT01479621|12599395|P3|Safety Population|Treatment Period||104
5121370|NCT01479621|12599396|P2|Safety Population|Treatment Period||103
5121371|NCT01479621|12599397|P1|Safety Population|Treatment Period||0
5121372|NCT01479621|12599391|P7|STARTED|Treatment Period||104
5121373|NCT01479621|12599392|P6|STARTED|Treatment Period||104
5121374|NCT01479621|12599393|P5|STARTED|Treatment Period||103
5121375|NCT01479621|12599394|P4|STARTED|Treatment Period||104
5121376|NCT01479621|12599395|P3|STARTED|Treatment Period||104
5121377|NCT01479621|12599396|P2|STARTED|Treatment Period||103
5121378|NCT01479621|12599397|P1|STARTED|Treatment Period||0
5121379|NCT01479621|12599391|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121380|NCT01479621|12599392|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121381|NCT01479621|12599393|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121382|NCT01479621|12599394|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121383|NCT01479621|12599395|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121384|NCT01479621|12599396|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121385|NCT01479621|12599397|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
5121386|NCT01479621|12599391|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121387|NCT01479621|12599392|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121388|NCT01479621|12599393|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121389|NCT01479621|12599394|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121390|NCT01479621|12599395|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121391|NCT01479621|12599396|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
5121392|NCT01479621|12599397|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
5121393|NCT01479621|12599391|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121394|NCT01479621|12599392|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121395|NCT01479621|12599393|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121396|NCT01479621|12599394|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121397|NCT01479621|12599395|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121398|NCT01479621|12599396|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
5121399|NCT01479621|12599397|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
5121400|NCT01479595|12599485|P2|NOT COMPLETED|Overall Study||2
5121401|NCT01479595|12599486|P1|NOT COMPLETED|Overall Study||2
5121402|NCT01479595|12599485|P2|COMPLETED|Overall Study||19
5121403|NCT01479595|12599486|P1|COMPLETED|Overall Study||42
5121404|NCT01479595|12599485|P2|Per Protocol Analysis Set|Overall Study||20
5121405|NCT01479595|12599486|P1|Per Protocol Analysis Set|Overall Study||41
5121406|NCT01479595|12599485|P2|PK Analysis Set|Overall Study||0
5121407|NCT01479595|12599486|P1|PK Analysis Set|Overall Study||42
5121408|NCT01479595|12599485|P2|STARTED|Overall Study||21
5121409|NCT01479595|12599486|P1|STARTED|Overall Study||44
5121410|NCT01479543|12599513|P5|NOT COMPLETED|Overall Study||1
5121411|NCT01479543|12599514|P4|NOT COMPLETED|Overall Study||0
5121412|NCT01479543|12599515|P3|NOT COMPLETED|Overall Study||1
5121413|NCT01479543|12599516|P2|NOT COMPLETED|Overall Study||0
5121414|NCT01479543|12599517|P1|NOT COMPLETED|Overall Study||1
5121415|NCT01479543|12599513|P5|COMPLETED|Overall Study||20
5121416|NCT01479543|12599514|P4|COMPLETED|Overall Study||20
5121417|NCT01479543|12599515|P3|COMPLETED|Overall Study||20
5121418|NCT01479543|12599516|P2|COMPLETED|Overall Study||20
5121419|NCT01479543|12599517|P1|COMPLETED|Overall Study||20
5121420|NCT01479543|12599513|P5|STARTED|Overall Study||21
5121421|NCT01479543|12599514|P4|STARTED|Overall Study||20
5121422|NCT01479543|12599515|P3|STARTED|Overall Study||21
5121423|NCT01479543|12599516|P2|STARTED|Overall Study||20
5121424|NCT01479543|12599517|P1|STARTED|Overall Study||21
5121425|NCT01479530|12599531|P2|NOT COMPLETED|Overall Study||12
5121426|NCT01479530|12599532|P1|NOT COMPLETED|Overall Study||10
5121427|NCT01479530|12599531|P2|COMPLETED|Overall Study||151
5121428|NCT01479530|12599532|P1|COMPLETED|Overall Study||148
5121429|NCT01479530|12599531|P2|STARTED|Overall Study||163
5121430|NCT01479530|12599532|P1|STARTED|Overall Study||158
5121431|NCT01479517|12599547|P3|NOT COMPLETED|Overall Study||0
5121432|NCT01479517|12599548|P2|NOT COMPLETED|Overall Study||0
5121433|NCT01479517|12599549|P1|NOT COMPLETED|Overall Study||0
5121434|NCT01479517|12599547|P3|COMPLETED|Overall Study||10
5121435|NCT01479517|12599548|P2|COMPLETED|Overall Study||10
5121436|NCT01479517|12599549|P1|COMPLETED|Overall Study||10
5121437|NCT01479517|12599547|P3|STARTED|Overall Study||10
5121438|NCT01479517|12599548|P2|STARTED|Overall Study||10
5121439|NCT01479517|12599549|P1|STARTED|Overall Study||10
5121440|NCT01479478|12599568|P2|NOT COMPLETED|Overall Study||0
5121441|NCT01479478|12599569|P1|NOT COMPLETED|Overall Study||0
5121442|NCT01479478|12599568|P2|COMPLETED|Overall Study||126
5121443|NCT01479478|12599569|P1|COMPLETED|Overall Study||125
5121444|NCT01479478|12599568|P2|STARTED|Overall Study||126
5121445|NCT01479478|12599569|P1|STARTED|Overall Study||125
5121446|NCT01479465|12599613|P4|NOT COMPLETED|Overall Study||85
5121447|NCT01479465|12599614|P3|NOT COMPLETED|Overall Study||86
5121448|NCT01479465|12599615|P2|NOT COMPLETED|Overall Study||84
5121449|NCT01479465|12599616|P1|NOT COMPLETED|Overall Study||11
5121450|NCT01479465|12599613|P4|COMPLETED|Overall Study||0
5121451|NCT01479465|12599614|P3|COMPLETED|Overall Study||0
5121452|NCT01479465|12599615|P2|COMPLETED|Overall Study||0
5121453|NCT01479465|12599616|P1|COMPLETED|Overall Study||0
5121454|NCT01479465|12599613|P4|STARTED|Overall Study||85
5121455|NCT01479465|12599614|P3|STARTED|Overall Study||86
5121456|NCT01479465|12599615|P2|STARTED|Overall Study||84
5121457|NCT01479465|12599616|P1|STARTED|Overall Study||11
5121458|NCT01479426|12599636|P2|NOT COMPLETED|Overall Study||3
5121459|NCT01479426|12599637|P1|NOT COMPLETED|Overall Study||4
5121460|NCT01479426|12599636|P2|COMPLETED|Overall Study||37
5121461|NCT01479426|12599637|P1|COMPLETED|Overall Study||36
5121462|NCT01479426|12599636|P2|STARTED|Overall Study||40
5121463|NCT01479426|12599637|P1|STARTED|Overall Study||40
5121464|NCT01479374|12599652|P3|NOT COMPLETED|Overall Study||5
5121465|NCT01479374|12599653|P2|NOT COMPLETED|Overall Study||8
5121466|NCT01479374|12599654|P1|NOT COMPLETED|Overall Study||3
5121467|NCT01479374|12599652|P3|COMPLETED|Overall Study||63
5121468|NCT01479374|12599653|P2|COMPLETED|Overall Study||60
5121469|NCT01479374|12599654|P1|COMPLETED|Overall Study||63
5121470|NCT01479374|12599652|P3|STARTED|Overall Study||68
5121471|NCT01479374|12599653|P2|STARTED|Overall Study||68
5121472|NCT01479374|12599654|P1|STARTED|Overall Study||66
5121473|NCT01479348|12599680|P2|NOT COMPLETED|Overall Study||0
5121474|NCT01479348|12599681|P1|NOT COMPLETED|Overall Study||0
5121475|NCT01479348|12599680|P2|COMPLETED|Overall Study||0
5121476|NCT01479348|12599681|P1|COMPLETED|Overall Study||5
5121477|NCT01479348|12599680|P2|STARTED|Overall Study||0
5121478|NCT01479348|12599681|P1|STARTED|Overall Study||5
5121479|NCT01479270|12599690|P2|NOT COMPLETED|Overall Study||0
5121480|NCT01479270|12599691|P1|NOT COMPLETED|Overall Study||0
5121481|NCT01479270|12599690|P2|COMPLETED|Overall Study||28
5121482|NCT01479270|12599691|P1|COMPLETED|Overall Study||28
5121483|NCT01479270|12599690|P2|STARTED|Overall Study||28
5121484|NCT01479270|12599691|P1|STARTED|Overall Study||28
5121485|NCT01479127|12599703|P1|NOT COMPLETED|Overall Study||3
5121486|NCT01479127|12599703|P1|COMPLETED|Overall Study||5
5121487|NCT01479127|12599703|P1|Started LCIG|Overall Study||6
5121488|NCT01479127|12599703|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
5121489|NCT01479010|12599737|P1|NOT COMPLETED|Overall Study||1
5121490|NCT01479010|12599737|P1|COMPLETED|Overall Study||1
5121491|NCT01479010|12599737|P1|STARTED|Overall Study||2
5121492|NCT01478971|12599748|P1|NOT COMPLETED|Peginesatide Treatment Period||14
5121493|NCT01478971|12599748|P1|COMPLETED|Peginesatide Treatment Period||143
5121494|NCT01478971|12599748|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
5121495|NCT01478971|12599748|P1|NOT COMPLETED|Standard of Care Period||25
5121496|NCT01478971|12599748|P1|COMPLETED|Standard of Care Period||159
5121497|NCT01478971|12599748|P1|Received Treatment|Standard of Care Period||178
5121498|NCT01478971|12599748|P1|STARTED|Standard of Care Period||184
5121499|NCT01478958|12599765|P3|NOT COMPLETED|Overall Study||3
5121500|NCT01478958|12599766|P2|NOT COMPLETED|Overall Study||2
5121501|NCT01478958|12599767|P1|NOT COMPLETED|Overall Study||2
5121502|NCT01478958|12599765|P3|COMPLETED|Overall Study||66
5121503|NCT01478958|12599766|P2|COMPLETED|Overall Study||64
5121504|NCT01478958|12599767|P1|COMPLETED|Overall Study||65
5121505|NCT01478958|12599765|P3|STARTED|Overall Study||69
5121506|NCT01478958|12599766|P2|STARTED|Overall Study||66
5121507|NCT01478958|12599767|P1|STARTED|Overall Study||67
5121508|NCT01478854|12599775|P1|NOT COMPLETED|Overall Study||0
5121509|NCT01478854|12599775|P1|COMPLETED|Overall Study||30
5121510|NCT01478854|12599775|P1|STARTED|Overall Study||30
5121511|NCT01478828|12599787|P1|NOT COMPLETED|Overall Study||1
5121512|NCT01478828|12599787|P1|COMPLETED|Overall Study||1
5121513|NCT01478828|12599787|P1|STARTED|Overall Study||2
5121514|NCT01478620|12599798|P1|NOT COMPLETED|Overall Study||6
5121515|NCT01478620|12599798|P1|COMPLETED|Overall Study||119
5121516|NCT01478620|12599798|P1|STARTED|Overall Study||125
5121517|NCT01478594|12599804|P2|NOT COMPLETED|Overall Study||28
5121518|NCT01478594|12599805|P1|NOT COMPLETED|Overall Study||65
5121519|NCT01478594|12599804|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
5121520|NCT01478594|12599805|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
5121521|NCT01478594|12599804|P2|Treated|Overall Study||87
5121522|NCT01478594|12599805|P1|Treated|Overall Study||177
5121523|NCT01478594|12599804|P2|STARTED|Overall Study||88
5121524|NCT01478594|12599805|P1|STARTED|Overall Study||177
5121525|NCT01478581|12599881|P4|NOT COMPLETED|Overall Study||0
5121526|NCT01478581|12599882|P3|NOT COMPLETED|Overall Study||0
5121527|NCT01478581|12599883|P2|NOT COMPLETED|Overall Study||0
5121528|NCT01478581|12599884|P1|NOT COMPLETED|Overall Study||0
5121529|NCT01478581|12599881|P4|COMPLETED|Overall Study||43
5121530|NCT01478581|12599882|P3|COMPLETED|Overall Study||18
5121531|NCT01478581|12599883|P2|COMPLETED|Overall Study||18
5121532|NCT01478581|12599884|P1|COMPLETED|Overall Study||13
5121533|NCT01478581|12599881|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
5121534|NCT01478581|12599882|P3|STARTED|Overall Study||18
5121535|NCT01478581|12599883|P2|STARTED|Overall Study||18
5121536|NCT01478581|12599884|P1|STARTED|Overall Study||13
5121537|NCT01478373|12599934|P1|NOT COMPLETED|Survival Phase||38
5121538|NCT01478373|12599934|P1|COMPLETED|Survival Phase||0
5121539|NCT01478373|12599934|P1|STARTED|Survival Phase||38
5121540|NCT01478373|12599934|P1|NOT COMPLETED|Treatment Phase||1
5121541|NCT01478373|12599934|P1|COMPLETED|Treatment Phase||38
5121542|NCT01478373|12599934|P1|STARTED|Treatment Phase||39
5121543|NCT01478360|12599947|P2|NOT COMPLETED|Overall Study||3
5121544|NCT01478360|12599948|P1|NOT COMPLETED|Overall Study||2
5121545|NCT01478360|12599947|P2|COMPLETED|Overall Study||12
5121546|NCT01478360|12599948|P1|COMPLETED|Overall Study||29
5121547|NCT01478360|12599947|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
5121548|NCT01478360|12599948|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
5121549|NCT01478360|12599947|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
5121550|NCT01478360|12599948|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
5121551|NCT01478360|12599947|P2|STARTED|Overall Study||15
5121552|NCT01478360|12599948|P1|STARTED|Overall Study||31
5121553|NCT01478347|12599954|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
5121554|NCT01478347|12599954|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
5121555|NCT01478347|12599954|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
5121556|NCT01478347|12599954|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
5121557|NCT01478347|12599954|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
5121558|NCT01478347|12599954|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
5121559|NCT01478321|12599959|P1|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
5121560|NCT01478321|12599959|P1|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
5121561|NCT01478321|12599959|P1|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
5121562|NCT01478321|12599959|P1|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
5121563|NCT01478321|12599959|P1|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
5121564|NCT01478321|12599959|P1|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
5121565|NCT01478321|12599959|P1|STARTED|Adjuvant Therapy Until PD or Toxicity||37
5121566|NCT01478321|12599959|P1|NOT COMPLETED|Started Adjuvant Therapy||1
5121567|NCT01478321|12599959|P1|COMPLETED|Started Adjuvant Therapy||37
5121568|NCT01478321|12599959|P1|Completed First Cycle|Started Adjuvant Therapy||37
5121569|NCT01478321|12599959|P1|STARTED|Started Adjuvant Therapy||38
5121570|NCT01478321|12599959|P1|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
5121571|NCT01478321|12599959|P1|COMPLETED|Concurrent Therapy (5 Weeks)||38
5121572|NCT01478321|12599959|P1|STARTED|Concurrent Therapy (5 Weeks)||54
5121573|NCT01478256|12599971|P2|NOT COMPLETED|Overall Study||0
5121574|NCT01478256|12599972|P1|NOT COMPLETED|Overall Study||0
5121575|NCT01478256|12599971|P2|COMPLETED|Overall Study||15
5121576|NCT01478256|12599972|P1|COMPLETED|Overall Study||15
5121577|NCT01478256|12599971|P2|STARTED|Overall Study||15
5121578|NCT01478256|12599972|P1|STARTED|Overall Study||15
5121579|NCT01478113|12599982|P2|NOT COMPLETED|Overall Study||1
5121580|NCT01478113|12599983|P1|NOT COMPLETED|Overall Study||1
5121581|NCT01478113|12599982|P2|COMPLETED|Overall Study||1
5121582|NCT01478113|12599983|P1|COMPLETED|Overall Study||1
5121583|NCT01478113|12599982|P2|STARTED|Overall Study||2
5121584|NCT01478113|12599983|P1|STARTED|Overall Study||2
5121585|NCT01478087|12600001|P1|NOT COMPLETED|Overall Study||1
5121586|NCT01478087|12600001|P1|COMPLETED|Overall Study||2
5121587|NCT01478087|12600001|P1|STARTED|Overall Study||3
5121588|NCT01478048|12600008|P2|NOT COMPLETED|Overall Study||75
5121589|NCT01478048|12600009|P1|NOT COMPLETED|Overall Study||77
5121590|NCT01478048|12600008|P2|COMPLETED|Overall Study||0
5121591|NCT01478048|12600009|P1|COMPLETED|Overall Study||0
5121592|NCT01478048|12600008|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
5121593|NCT01478048|12600009|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
5121594|NCT01478048|12600008|P2|STARTED|Overall Study||75
5121595|NCT01478048|12600009|P1|STARTED|Overall Study||77
5121596|NCT01478009|12600027|P2|NOT COMPLETED|Overall Study||1
5121597|NCT01478009|12600028|P1|NOT COMPLETED|Overall Study||1
5121598|NCT01478009|12600027|P2|COMPLETED|Overall Study||49
5121599|NCT01478009|12600028|P1|COMPLETED|Overall Study||49
5121600|NCT01478009|12600027|P2|STARTED|Overall Study||50
5121601|NCT01478009|12600028|P1|STARTED|Overall Study||50
5121602|NCT01477892|12600038|P2|NOT COMPLETED|Overall Study||2
5121603|NCT01477892|12600039|P1|NOT COMPLETED|Overall Study||0
5121604|NCT01477892|12600038|P2|COMPLETED|Overall Study||5
5121605|NCT01477892|12600039|P1|COMPLETED|Overall Study||7
5121606|NCT01477892|12600038|P2|STARTED|Overall Study||7
5121607|NCT01477892|12600039|P1|STARTED|Overall Study||7
5121608|NCT01477853|12600050|P3|NOT COMPLETED|Phase B||11
5121609|NCT01477853|12600051|P2|NOT COMPLETED|Phase B||11
5121610|NCT01477853|12600052|P1|NOT COMPLETED|Phase B||12
5121611|NCT01477853|12600050|P3|COMPLETED|Phase B||0
5121612|NCT01477853|12600051|P2|COMPLETED|Phase B||0
5121613|NCT01477853|12600052|P1|COMPLETED|Phase B||0
5121614|NCT01477853|12600050|P3|STARTED|Phase B||11
5121615|NCT01477853|12600051|P2|STARTED|Phase B||11
5121616|NCT01477853|12600052|P1|STARTED|Phase B||12
5121617|NCT01477853|12600050|P3|NOT COMPLETED|Phase A||44
5121618|NCT01477853|12600051|P2|NOT COMPLETED|Phase A||45
5121619|NCT01477853|12600052|P1|NOT COMPLETED|Phase A||43
5121620|NCT01477853|12600050|P3|COMPLETED|Phase A||11
5121621|NCT01477853|12600051|P2|COMPLETED|Phase A||11
5121622|NCT01477853|12600052|P1|COMPLETED|Phase A||12
5121623|NCT01477853|12600050|P3|STARTED|Phase A||55
5121624|NCT01477853|12600051|P2|STARTED|Phase A||56
5121625|NCT01477853|12600052|P1|STARTED|Phase A||55
5121626|NCT01477762|12600094|P4|NOT COMPLETED|Overall Study||2
5121627|NCT01477762|12600095|P3|NOT COMPLETED|Overall Study||4
5121628|NCT01477762|12600096|P2|NOT COMPLETED|Overall Study||13
5121629|NCT01477762|12600097|P1|NOT COMPLETED|Overall Study||9
5121630|NCT01477762|12600094|P4|COMPLETED|Overall Study||11
5121631|NCT01477762|12600095|P3|COMPLETED|Overall Study||16
5121632|NCT01477762|12600096|P2|COMPLETED|Overall Study||20
5121633|NCT01477762|12600097|P1|COMPLETED|Overall Study||16
5121634|NCT01477762|12600094|P4|STARTED|Overall Study||13
5121635|NCT01477762|12600095|P3|STARTED|Overall Study||20
5121636|NCT01477762|12600096|P2|STARTED|Overall Study||33
5121637|NCT01477762|12600097|P1|STARTED|Overall Study||25
5121638|NCT01477749|12600119|P1|NOT COMPLETED|Overall Study||4
5121639|NCT01477749|12600119|P1|COMPLETED|Overall Study||43
5121640|NCT01477749|12600119|P1|STARTED|Overall Study||47
5121641|NCT01477710|12600126|P1|NOT COMPLETED|Overall Study||0
5121642|NCT01477710|12600126|P1|COMPLETED|Overall Study||30
5121643|NCT01477710|12600126|P1|STARTED|Overall Study||30
5121644|NCT01477567|12600141|P7|NOT COMPLETED|Overall Study||0
5121645|NCT01477567|12600142|P6|NOT COMPLETED|Overall Study||0
5121646|NCT01477567|12600143|P5|NOT COMPLETED|Overall Study||0
5121647|NCT01477567|12600144|P4|NOT COMPLETED|Overall Study||0
5121648|NCT01477567|12600145|P3|NOT COMPLETED|Overall Study||0
5121649|NCT01477567|12600146|P2|NOT COMPLETED|Overall Study||0
5121650|NCT01477567|12600147|P1|NOT COMPLETED|Overall Study||0
5121651|NCT01477567|12600141|P7|COMPLETED|Overall Study||6
5121652|NCT01477567|12600142|P6|COMPLETED|Overall Study||5
5121653|NCT01477567|12600143|P5|COMPLETED|Overall Study||6
5121654|NCT01477567|12600144|P4|COMPLETED|Overall Study||6
5121655|NCT01477567|12600145|P3|COMPLETED|Overall Study||6
5121656|NCT01477567|12600146|P2|COMPLETED|Overall Study||6
5121657|NCT01477567|12600147|P1|COMPLETED|Overall Study||5
5121658|NCT01477567|12600141|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5121659|NCT01477567|12600142|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
5121660|NCT01477567|12600143|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5121661|NCT01477567|12600144|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5121662|NCT01477567|12600145|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5121663|NCT01477567|12600146|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5121664|NCT01477567|12600147|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
5121665|NCT01477567|12600141|P7|STARTED|Overall Study||6
5121666|NCT01477567|12600142|P6|STARTED|Overall Study||5
5121667|NCT01477567|12600143|P5|STARTED|Overall Study||6
5121668|NCT01477567|12600144|P4|STARTED|Overall Study||6
5121669|NCT01477567|12600145|P3|STARTED|Overall Study||6
5121670|NCT01477567|12600146|P2|STARTED|Overall Study||6
5121671|NCT01477567|12600147|P1|STARTED|Overall Study||5
5121672|NCT01477463|12600203|P2|NOT COMPLETED|Overall Study||0
5121673|NCT01477463|12600204|P1|NOT COMPLETED|Overall Study||0
5121674|NCT01477463|12600203|P2|COMPLETED|Overall Study||6
5121675|NCT01477463|12600204|P1|COMPLETED|Overall Study||18
5121676|NCT01477463|12600203|P2|STARTED|Overall Study||6
5121677|NCT01477463|12600204|P1|STARTED|Overall Study||18
5121678|NCT01477450|12600217|P3|NOT COMPLETED|Overall Study||0
5121679|NCT01477450|12600218|P2|NOT COMPLETED|Overall Study||0
5121680|NCT01477450|12600219|P1|NOT COMPLETED|Overall Study||0
5121681|NCT01477450|12600217|P3|COMPLETED|Overall Study||10
5121682|NCT01477450|12600218|P2|COMPLETED|Overall Study||10
5121683|NCT01477450|12600219|P1|COMPLETED|Overall Study||10
5121684|NCT01477450|12600217|P3|STARTED|Overall Study||10
5121685|NCT01477450|12600218|P2|STARTED|Overall Study||10
5121686|NCT01477450|12600219|P1|STARTED|Overall Study||10
5121687|NCT01477333|12600227|P1|NOT COMPLETED|Overall Study||3
5121688|NCT01477333|12600227|P1|COMPLETED|Overall Study||15
5121689|NCT01477333|12600227|P1|STARTED|Overall Study||18
5121690|NCT01477320|12600245|P2|NOT COMPLETED|Overall Study||15
5121691|NCT01477320|12600246|P1|NOT COMPLETED|Overall Study||7
5121692|NCT01477320|12600245|P2|COMPLETED|Overall Study||47
5121693|NCT01477320|12600246|P1|COMPLETED|Overall Study||55
5121694|NCT01477320|12600245|P2|STARTED|Overall Study||62
5121695|NCT01477320|12600246|P1|STARTED|Overall Study||62
5121696|NCT01477177|12600254|P1|NOT COMPLETED|Overall Study||0
5121697|NCT01477177|12600254|P1|COMPLETED|Overall Study||4
5121698|NCT01477177|12600254|P1|STARTED|Overall Study||4
5121699|NCT01476748|12600265|P3|NOT COMPLETED|Overall Study||0
5121700|NCT01476748|12600266|P2|NOT COMPLETED|Overall Study||0
5121701|NCT01476748|12600267|P1|NOT COMPLETED|Overall Study||0
5121702|NCT01476748|12600265|P3|COMPLETED|Overall Study||5
5121703|NCT01476748|12600266|P2|COMPLETED|Overall Study||5
5121704|NCT01476748|12600267|P1|COMPLETED|Overall Study||5
5121705|NCT01476748|12600265|P3|STARTED|Overall Study||5
5121706|NCT01476748|12600266|P2|STARTED|Overall Study||5
5121707|NCT01476748|12600267|P1|STARTED|Overall Study||5
5121708|NCT01476722|12600278|P1|NOT COMPLETED|Overall Study||1
5121709|NCT01476722|12600278|P1|COMPLETED|Overall Study||124
5121710|NCT01476722|12600278|P1|STARTED|Overall Study||125
5121711|NCT01476696|12600285|P3|NOT COMPLETED|Overall Study||0
5121712|NCT01476696|12600286|P2|NOT COMPLETED|Overall Study||1
5121713|NCT01476696|12600287|P1|NOT COMPLETED|Overall Study||3
5121714|NCT01476696|12600285|P3|COMPLETED|Overall Study||9
5121715|NCT01476696|12600286|P2|COMPLETED|Overall Study||8
5121716|NCT01476696|12600287|P1|COMPLETED|Overall Study||12
5121717|NCT01476696|12600285|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
5121813|NCT01475825|12600807|P4|COMPLETED|Overall Study||22
5121718|NCT01476696|12600286|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
5121719|NCT01476696|12600287|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
5121720|NCT01476696|12600285|P3|STARTED|Overall Study||9
5121721|NCT01476696|12600286|P2|STARTED|Overall Study||9
5121722|NCT01476696|12600287|P1|STARTED|Overall Study||15
5121723|NCT01476644|12600301|P1|NOT COMPLETED|Overall Study||39
5121724|NCT01476644|12600301|P1|COMPLETED|Overall Study||122
5121725|NCT01476644|12600301|P1|STARTED|Overall Study||161
5121726|NCT01476475|12600308|P2|NOT COMPLETED|Overall Study||3
5121727|NCT01476475|12600309|P1|NOT COMPLETED|Overall Study||11
5121728|NCT01476475|12600308|P2|COMPLETED|Overall Study||159
5121729|NCT01476475|12600309|P1|COMPLETED|Overall Study||150
5121730|NCT01476475|12600308|P2|STARTED|Overall Study||162
5121731|NCT01476475|12600309|P1|STARTED|Overall Study||161
5121732|NCT01476449|12600343|P2|NOT COMPLETED|Overall Study||2
5121733|NCT01476449|12600344|P1|NOT COMPLETED|Overall Study||2
5121734|NCT01476449|12600343|P2|COMPLETED|Overall Study||8
5121735|NCT01476449|12600344|P1|COMPLETED|Overall Study||8
5121736|NCT01476449|12600343|P2|STARTED|Overall Study||10
5121737|NCT01476449|12600344|P1|STARTED|Overall Study||10
5121738|NCT01476345|12600358|P2|NOT COMPLETED|Period 4||0
5121739|NCT01476345|12600359|P1|NOT COMPLETED|Period 4||0
5121740|NCT01476345|12600358|P2|COMPLETED|Period 4||39
5121741|NCT01476345|12600359|P1|COMPLETED|Period 4||39
5121742|NCT01476345|12600358|P2|STARTED|Period 4||39
5121743|NCT01476345|12600359|P1|STARTED|Period 4||39
5121744|NCT01476345|12600358|P2|NOT COMPLETED|Period 3||0
5121745|NCT01476345|12600359|P1|NOT COMPLETED|Period 3||0
5121746|NCT01476345|12600358|P2|COMPLETED|Period 3||39
5121747|NCT01476345|12600359|P1|COMPLETED|Period 3||39
5121748|NCT01476345|12600358|P2|STARTED|Period 3||39
5121749|NCT01476345|12600359|P1|STARTED|Period 3||39
5121750|NCT01476345|12600358|P2|NOT COMPLETED|Period 2||0
5121751|NCT01476345|12600359|P1|NOT COMPLETED|Period 2||0
5121752|NCT01476345|12600358|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
5121753|NCT01476345|12600359|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
5121754|NCT01476345|12600358|P2|STARTED|Period 2||40
5121755|NCT01476345|12600359|P1|STARTED|Period 2||40
5121756|NCT01476345|12600358|P2|NOT COMPLETED|Period 1||0
5121757|NCT01476345|12600359|P1|NOT COMPLETED|Period 1||0
5121758|NCT01476345|12600358|P2|COMPLETED|Period 1||40
5121759|NCT01476345|12600359|P1|COMPLETED|Period 1||40
5121760|NCT01476345|12600358|P2|Received at Least 1 Dose of Study Drug|Period 1||40
5121761|NCT01476345|12600359|P1|Received at Least 1 Dose of Study Drug|Period 1||40
5121762|NCT01476345|12600358|P2|STARTED|Period 1||40
5121763|NCT01476345|12600359|P1|STARTED|Period 1||40
5121764|NCT01476267|12600371|P1|NOT COMPLETED|Overall Study||0
5121765|NCT01476267|12600371|P1|COMPLETED|Overall Study||6
5121766|NCT01476267|12600371|P1|STARTED|Overall Study||6
5121767|NCT01476202|12600379|P3|NOT COMPLETED|Overall Study||0
5121768|NCT01476202|12600380|P2|NOT COMPLETED|Overall Study||0
5121769|NCT01476202|12600381|P1|NOT COMPLETED|Overall Study||0
5121770|NCT01476202|12600379|P3|COMPLETED|Overall Study||40
5121771|NCT01476202|12600380|P2|COMPLETED|Overall Study||40
5121772|NCT01476202|12600381|P1|COMPLETED|Overall Study||40
5121773|NCT01476202|12600379|P3|STARTED|Overall Study||40
5121774|NCT01476202|12600380|P2|STARTED|Overall Study||40
5121775|NCT01476202|12600381|P1|STARTED|Overall Study||40
5121776|NCT01475955|12600397|P5|NOT COMPLETED|Overall Study||0
5121777|NCT01475955|12600398|P4|NOT COMPLETED|Overall Study||0
5121778|NCT01475955|12600399|P3|NOT COMPLETED|Overall Study||3
5121779|NCT01475955|12600400|P2|NOT COMPLETED|Overall Study||0
5121780|NCT01475955|12600401|P1|NOT COMPLETED|Overall Study||1
5121781|NCT01475955|12600397|P5|COMPLETED|Overall Study||46
5121782|NCT01475955|12600398|P4|COMPLETED|Overall Study||46
5121783|NCT01475955|12600399|P3|COMPLETED|Overall Study||44
5121784|NCT01475955|12600400|P2|COMPLETED|Overall Study||48
5121785|NCT01475955|12600401|P1|COMPLETED|Overall Study||47
5121786|NCT01475955|12600397|P5|STARTED|Overall Study||46
5121787|NCT01475955|12600398|P4|STARTED|Overall Study||46
5121788|NCT01475955|12600399|P3|STARTED|Overall Study||47
5121789|NCT01475955|12600400|P2|STARTED|Overall Study||48
5121790|NCT01475955|12600401|P1|STARTED|Overall Study||48
5121791|NCT01475851|12600760|P2|NOT COMPLETED|Overall Study||0
5121792|NCT01475851|12600761|P1|NOT COMPLETED|Overall Study||1
5121793|NCT01475851|12600760|P2|COMPLETED|Overall Study||21
5121794|NCT01475851|12600761|P1|COMPLETED|Overall Study||12
5121795|NCT01475851|12600760|P2|STARTED|Overall Study||21
5121796|NCT01475851|12600761|P1|STARTED|Overall Study||13
5121797|NCT01475838|12600789|P2|NOT COMPLETED|Extension Phase||0
5121798|NCT01475838|12600790|P1|NOT COMPLETED|Extension Phase||1
5121799|NCT01475838|12600789|P2|COMPLETED|Extension Phase||20
5121800|NCT01475838|12600790|P1|COMPLETED|Extension Phase||41
5121801|NCT01475838|12600789|P2|STARTED|Extension Phase||20
5121802|NCT01475838|12600790|P1|STARTED|Extension Phase||42
5121803|NCT01475838|12600789|P2|NOT COMPLETED|Randomized Phase||36
5121804|NCT01475838|12600790|P1|NOT COMPLETED|Randomized Phase||30
5121805|NCT01475838|12600789|P2|COMPLETED|Randomized Phase||109
5121806|NCT01475838|12600790|P1|COMPLETED|Randomized Phase||263
5121807|NCT01475838|12600789|P2|STARTED|Randomized Phase||145
5121808|NCT01475838|12600790|P1|STARTED|Randomized Phase||293
5121809|NCT01475825|12600807|P4|NOT COMPLETED|Overall Study||30
5121810|NCT01475825|12600808|P3|NOT COMPLETED|Overall Study||64
5121811|NCT01475825|12600809|P2|NOT COMPLETED|Overall Study||32
5121812|NCT01475825|12600810|P1|NOT COMPLETED|Overall Study||67
5121814|NCT01475825|12600808|P3|COMPLETED|Overall Study||38
5121815|NCT01475825|12600809|P2|COMPLETED|Overall Study||19
5121816|NCT01475825|12600810|P1|COMPLETED|Overall Study||37
5121817|NCT01475825|12600807|P4|Completed Open-Label Continuation|Overall Study||22
5121818|NCT01475825|12600808|P3|Completed Open-Label Continuation|Overall Study||38
5121819|NCT01475825|12600809|P2|Completed Open-Label Continuation|Overall Study||19
5121820|NCT01475825|12600810|P1|Completed Open-Label Continuation|Overall Study||37
5121821|NCT01475825|12600807|P4|Entered Open-Label Continuation|Overall Study||29
5121822|NCT01475825|12600808|P3|Entered Open-Label Continuation|Overall Study||44
5121823|NCT01475825|12600809|P2|Entered Open-Label Continuation|Overall Study||31
5121824|NCT01475825|12600810|P1|Entered Open-Label Continuation|Overall Study||45
5121825|NCT01475825|12600807|P4|Completed Blinded Treatment Period|Overall Study||40
5121826|NCT01475825|12600808|P3|Completed Blinded Treatment Period|Overall Study||59
5121827|NCT01475825|12600809|P2|Completed Blinded Treatment Period|Overall Study||42
5121828|NCT01475825|12600810|P1|Completed Blinded Treatment Period|Overall Study||60
5121829|NCT01475825|12600807|P4|Randomized and Treated|Overall Study||52
5121830|NCT01475825|12600808|P3|Randomized and Treated|Overall Study||102
5121831|NCT01475825|12600809|P2|Randomized and Treated|Overall Study||51
5121832|NCT01475825|12600810|P1|Randomized and Treated|Overall Study||104
5121833|NCT01475825|12600807|P4|STARTED|Overall Study||52
5121834|NCT01475825|12600808|P3|STARTED|Overall Study||102
5121835|NCT01475825|12600809|P2|STARTED|Overall Study||51
5121836|NCT01475825|12600810|P1|STARTED|Overall Study||104
5121837|NCT01475734|12600842|P2|NOT COMPLETED|Overall Study||1
5121838|NCT01475734|12600843|P1|NOT COMPLETED|Overall Study||2
5121839|NCT01475734|12600842|P2|COMPLETED|Overall Study||21
5121840|NCT01475734|12600843|P1|COMPLETED|Overall Study||20
5121841|NCT01475734|12600842|P2|STARTED|Overall Study||22
5121842|NCT01475734|12600843|P1|STARTED|Overall Study||22
5121843|NCT01475721|12600871|P2|NOT COMPLETED|Overall Study||14
5121844|NCT01475721|12600872|P1|NOT COMPLETED|Overall Study||11
5121845|NCT01475721|12600871|P2|COMPLETED|Overall Study||5831
5121846|NCT01475721|12600872|P1|COMPLETED|Overall Study||5823
5121847|NCT01475721|12600871|P2|STARTED|Overall Study||5845
5121848|NCT01475721|12600872|P1|STARTED|Overall Study||5834
5121849|NCT01475643|12600888|P2|NOT COMPLETED|Overall Study||10
5121850|NCT01475643|12600889|P1|NOT COMPLETED|Overall Study||14
5121851|NCT01475643|12600888|P2|COMPLETED|Overall Study||43
5121852|NCT01475643|12600889|P1|COMPLETED|Overall Study||40
5121853|NCT01475643|12600888|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
5121854|NCT01475643|12600889|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
5121855|NCT01475513|12600899|P2|NOT COMPLETED|Overall Study||10
5121856|NCT01475513|12600900|P1|NOT COMPLETED|Overall Study||3
5121857|NCT01475513|12600899|P2|COMPLETED|Overall Study||16
5121858|NCT01475513|12600900|P1|COMPLETED|Overall Study||17
5121859|NCT01475513|12600899|P2|STARTED|Overall Study||26
5121860|NCT01475513|12600900|P1|STARTED|Overall Study||20
5121861|NCT01475487|12600938|P2|NOT COMPLETED|Overall Study||1
5121862|NCT01475487|12600939|P1|NOT COMPLETED|Overall Study||2
5121863|NCT01475487|12600938|P2|COMPLETED|Overall Study||24
5121864|NCT01475487|12600939|P1|COMPLETED|Overall Study||23
5121865|NCT01475487|12600938|P2|STARTED|Overall Study||25
5121866|NCT01475487|12600939|P1|STARTED|Overall Study||25
5121867|NCT01475474|12600951|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
5121868|NCT01475474|12600951|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
5121869|NCT01475474|12600951|P1|STARTED|Return to Baseline Period - 4 Weeks||73
5121870|NCT01475474|12600951|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
5121871|NCT01475474|12600951|P1|COMPLETED|Treatment Period - 12 Weeks||73
5121872|NCT01475474|12600951|P1|STARTED|Treatment Period - 12 Weeks||91
5121873|NCT01475474|12600951|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
5121874|NCT01475474|12600951|P1|COMPLETED|Baseline Period - 4 Weeks||91
5121875|NCT01475474|12600951|P1|STARTED|Baseline Period - 4 Weeks||97
5121876|NCT01475461|12600962|P7|NOT COMPLETED|Treatment Period||2
5121877|NCT01475461|12600963|P6|NOT COMPLETED|Treatment Period||5
5121878|NCT01475461|12600964|P5|NOT COMPLETED|Treatment Period||4
5121879|NCT01475461|12600965|P4|NOT COMPLETED|Treatment Period||8
5121880|NCT01475461|12600966|P3|NOT COMPLETED|Treatment Period||4
5121881|NCT01475461|12600967|P2|NOT COMPLETED|Treatment Period||9
5121882|NCT01475461|12600968|P1|NOT COMPLETED|Treatment Period||0
5121883|NCT01475461|12600962|P7|COMPLETED|Treatment Period||53
5121884|NCT01475461|12600963|P6|COMPLETED|Treatment Period||51
5121885|NCT01475461|12600964|P5|COMPLETED|Treatment Period||52
5121886|NCT01475461|12600965|P4|COMPLETED|Treatment Period||46
5121887|NCT01475461|12600966|P3|COMPLETED|Treatment Period||53
5121888|NCT01475461|12600967|P2|COMPLETED|Treatment Period||48
5121889|NCT01475461|12600968|P1|COMPLETED|Treatment Period||0
5121890|NCT01475461|12600962|P7|STARTED|Treatment Period||55
5121891|NCT01475461|12600963|P6|STARTED|Treatment Period||56
5121892|NCT01475461|12600964|P5|STARTED|Treatment Period||56
5121893|NCT01475461|12600965|P4|STARTED|Treatment Period||54
5121894|NCT01475461|12600966|P3|STARTED|Treatment Period||57
5121895|NCT01475461|12600967|P2|STARTED|Treatment Period||57
5121896|NCT01475461|12600968|P1|STARTED|Treatment Period||0
5121897|NCT01475461|12600962|P7|NOT COMPLETED|Run-in Period||0
5121898|NCT01475461|12600963|P6|NOT COMPLETED|Run-in Period||0
5121899|NCT01475461|12600964|P5|NOT COMPLETED|Run-in Period||0
5121900|NCT01475461|12600965|P4|NOT COMPLETED|Run-in Period||0
5121901|NCT01475461|12600966|P3|NOT COMPLETED|Run-in Period||0
5121902|NCT01475461|12600967|P2|NOT COMPLETED|Run-in Period||0
5121903|NCT01475461|12600968|P1|NOT COMPLETED|Run-in Period||41
5121904|NCT01475461|12600962|P7|COMPLETED|Run-in Period||0
5121905|NCT01475461|12600963|P6|COMPLETED|Run-in Period||0
5121906|NCT01475461|12600964|P5|COMPLETED|Run-in Period||0
5121907|NCT01475461|12600965|P4|COMPLETED|Run-in Period||0
5121908|NCT01475461|12600966|P3|COMPLETED|Run-in Period||0
5121909|NCT01475461|12600967|P2|COMPLETED|Run-in Period||0
5121910|NCT01475461|12600968|P1|COMPLETED|Run-in Period||335
5121911|NCT01475461|12600962|P7|STARTED|Run-in Period||0
5121912|NCT01475461|12600963|P6|STARTED|Run-in Period||0
5121913|NCT01475461|12600964|P5|STARTED|Run-in Period||0
5121914|NCT01475461|12600965|P4|STARTED|Run-in Period||0
5121915|NCT01475461|12600966|P3|STARTED|Run-in Period||0
5121916|NCT01475461|12600967|P2|STARTED|Run-in Period||0
5121917|NCT01475461|12600968|P1|STARTED|Run-in Period||376
5121918|NCT01475331|12601048|P2|NOT COMPLETED|Overall Study||2
5121919|NCT01475331|12601049|P1|NOT COMPLETED|Overall Study||5
5121920|NCT01475331|12601048|P2|COMPLETED|Overall Study||21
5121921|NCT01475331|12601049|P1|COMPLETED|Overall Study||18
5121922|NCT01475331|12601048|P2|STARTED|Overall Study||23
5121923|NCT01475331|12601049|P1|STARTED|Overall Study||23
5121924|NCT01475305|12601057|P2|NOT COMPLETED|Overall Study||0
5121925|NCT01475305|12601058|P1|NOT COMPLETED|Overall Study||0
5121926|NCT01475305|12601057|P2|COMPLETED|Overall Study||3
5121927|NCT01475305|12601058|P1|COMPLETED|Overall Study||4
5121928|NCT01475305|12601057|P2|End of Quarantine, Day 15|Overall Study||3
5121929|NCT01475305|12601058|P1|End of Quarantine, Day 15|Overall Study||4
5121930|NCT01475305|12601057|P2|STARTED|Overall Study||3
5121931|NCT01475305|12601058|P1|STARTED|Overall Study||4
5121932|NCT01475253|12601101|P4|NOT COMPLETED|Open Label Extension||0
5121933|NCT01475253|12601102|P3|NOT COMPLETED|Open Label Extension||0
5121934|NCT01475253|12601103|P2|NOT COMPLETED|Open Label Extension||0
5121935|NCT01475253|12601104|P1|NOT COMPLETED|Open Label Extension||0
5121936|NCT01475253|12601101|P4|COMPLETED|Open Label Extension||56
5121937|NCT01475253|12601102|P3|COMPLETED|Open Label Extension||0
5121938|NCT01475253|12601103|P2|COMPLETED|Open Label Extension||0
5121939|NCT01475253|12601104|P1|COMPLETED|Open Label Extension||0
5121940|NCT01475253|12601101|P4|STARTED|Open Label Extension||56
5121941|NCT01475253|12601102|P3|STARTED|Open Label Extension||0
5121942|NCT01475253|12601103|P2|STARTED|Open Label Extension||0
5121943|NCT01475253|12601104|P1|STARTED|Open Label Extension||0
5121944|NCT01475253|12601101|P4|NOT COMPLETED|Randomized, Blinded Study||0
5121945|NCT01475253|12601102|P3|NOT COMPLETED|Randomized, Blinded Study||0
5121946|NCT01475253|12601103|P2|NOT COMPLETED|Randomized, Blinded Study||1
5121947|NCT01475253|12601104|P1|NOT COMPLETED|Randomized, Blinded Study||2
5121948|NCT01475253|12601101|P4|COMPLETED|Randomized, Blinded Study||0
5121949|NCT01475253|12601102|P3|COMPLETED|Randomized, Blinded Study||11
5121950|NCT01475253|12601103|P2|COMPLETED|Randomized, Blinded Study||45
5121951|NCT01475253|12601104|P1|COMPLETED|Randomized, Blinded Study||45
5121952|NCT01475253|12601101|P4|STARTED|Randomized, Blinded Study||0
5121953|NCT01475253|12601102|P3|STARTED|Randomized, Blinded Study||11
5121954|NCT01475253|12601103|P2|STARTED|Randomized, Blinded Study||46
5121955|NCT01475253|12601104|P1|STARTED|Randomized, Blinded Study||47
5121956|NCT01475214|12601133|P3|NOT COMPLETED|Overall Study||2
5121957|NCT01475214|12601134|P2|NOT COMPLETED|Overall Study||4
5121958|NCT01475214|12601135|P1|NOT COMPLETED|Overall Study||5
5121959|NCT01475214|12601133|P3|COMPLETED|Overall Study||79
5121960|NCT01475214|12601134|P2|COMPLETED|Overall Study||75
5121961|NCT01475214|12601135|P1|COMPLETED|Overall Study||79
5121962|NCT01475214|12601133|P3|STARTED|Overall Study||81
5121963|NCT01475214|12601134|P2|STARTED|Overall Study||79
5121964|NCT01475214|12601135|P1|STARTED|Overall Study||84
5121965|NCT01475175|12601146|P1|NOT COMPLETED|Overall Study||0
5121966|NCT01475175|12601146|P1|COMPLETED|Overall Study||12
5121967|NCT01475175|12601146|P1|STARTED|Overall Study||12
5121968|NCT01475162|12601158|P1|NOT COMPLETED|Overall Study||14
5121969|NCT01475162|12601158|P1|COMPLETED|Overall Study||0
5121970|NCT01475162|12601158|P1|STARTED|Overall Study||14
5121971|NCT01475097|12601171|P2|NOT COMPLETED|Overall Study||1
5121972|NCT01475097|12601172|P1|NOT COMPLETED|Overall Study||1
5121973|NCT01475097|12601171|P2|COMPLETED|Overall Study||126
5121974|NCT01475097|12601172|P1|COMPLETED|Overall Study||127
5121975|NCT01475097|12601171|P2|STARTED|Overall Study||127
5121976|NCT01475097|12601172|P1|STARTED|Overall Study||128
5121977|NCT01475071|12601180|P1|NOT COMPLETED|Overall Study||8
5121978|NCT01475071|12601180|P1|COMPLETED|Overall Study||92
5121979|NCT01475071|12601180|P1|STARTED|Overall Study||100
5121980|NCT01474993|12601190|P2|NOT COMPLETED|Overall Study||3
5121981|NCT01474993|12601191|P1|NOT COMPLETED|Overall Study||1
5121982|NCT01474993|12601190|P2|COMPLETED|Overall Study||26
5121983|NCT01474993|12601191|P1|COMPLETED|Overall Study||14
5121984|NCT01474993|12601190|P2|STARTED|Overall Study||29
5121985|NCT01474993|12601191|P1|STARTED|Overall Study||15
5121986|NCT01474915|12601221|P2|NOT COMPLETED|Overall Study||10
5121987|NCT01474915|12601222|P1|NOT COMPLETED|Overall Study||10
5121988|NCT01474915|12601221|P2|COMPLETED|Overall Study||51
5121989|NCT01474915|12601222|P1|COMPLETED|Overall Study||50
5121990|NCT01474915|12601221|P2|STARTED|Overall Study||61
5121991|NCT01474915|12601222|P1|STARTED|Overall Study||60
5121992|NCT01474876|12601233|P3|NOT COMPLETED|Overall Study||0
5121993|NCT01474876|12601234|P2|NOT COMPLETED|Overall Study||23
5121994|NCT01474876|12601235|P1|NOT COMPLETED|Overall Study||66
5121995|NCT01474876|12601233|P3|COMPLETED|Overall Study||1
5121996|NCT01474876|12601234|P2|COMPLETED|Overall Study||128
5121997|NCT01474876|12601235|P1|COMPLETED|Overall Study||337
5121998|NCT01474876|12601233|P3|STARTED|Overall Study||1
5121999|NCT01474876|12601234|P2|STARTED|Overall Study||151
5122000|NCT01474876|12601235|P1|STARTED|Overall Study||403
5122001|NCT01474863|12601269|P3|NOT COMPLETED|Overall Study||0
5122002|NCT01474863|12601270|P2|NOT COMPLETED|Overall Study||0
5122003|NCT01474863|12601271|P1|NOT COMPLETED|Overall Study||0
5122004|NCT01474863|12601269|P3|COMPLETED|Overall Study||24
5122005|NCT01474863|12601270|P2|COMPLETED|Overall Study||22
5122006|NCT01474863|12601271|P1|COMPLETED|Overall Study||26
5122007|NCT01474863|12601269|P3|STARTED|Overall Study||24
5122008|NCT01474863|12601270|P2|STARTED|Overall Study||22
5122009|NCT01474863|12601271|P1|STARTED|Overall Study||26
5122010|NCT01474772|12601281|P2|NOT COMPLETED|Follow-up||1
5122011|NCT01474772|12601282|P1|NOT COMPLETED|Follow-up||0
5122012|NCT01474772|12601281|P2|COMPLETED|Follow-up||86
5122013|NCT01474772|12601282|P1|COMPLETED|Follow-up||77
5122014|NCT01474772|12601281|P2|STARTED|Follow-up||87
5122015|NCT01474772|12601282|P1|STARTED|Follow-up||77
5122016|NCT01474772|12601281|P2|NOT COMPLETED|Period 2||10
5122017|NCT01474772|12601282|P1|NOT COMPLETED|Period 2||9
5122018|NCT01474772|12601281|P2|COMPLETED|Period 2||87
5122019|NCT01474772|12601282|P1|COMPLETED|Period 2||77
5122020|NCT01474772|12601281|P2|STARTED|Period 2||97
5122021|NCT01474772|12601282|P1|STARTED|Period 2||86
5122022|NCT01474772|12601281|P2|NOT COMPLETED|Washout||2
5122023|NCT01474772|12601282|P1|NOT COMPLETED|Washout||3
5122024|NCT01474772|12601281|P2|COMPLETED|Washout||97
5122025|NCT01474772|12601282|P1|COMPLETED|Washout||86
5122026|NCT01474772|12601281|P2|STARTED|Washout||99
5122027|NCT01474772|12601282|P1|STARTED|Washout||89
5122028|NCT01474772|12601281|P2|NOT COMPLETED|Period 1||3
5122029|NCT01474772|12601282|P1|NOT COMPLETED|Period 1||12
5122030|NCT01474772|12601281|P2|COMPLETED|Period 1||99
5122031|NCT01474772|12601282|P1|COMPLETED|Period 1||89
5122032|NCT01474772|12601281|P2|STARTED|Period 1|STARTED=treated|102
5122033|NCT01474772|12601282|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
5122034|NCT01474746|12601332|P2|NOT COMPLETED|Overall Study||2
5122035|NCT01474746|12601333|P1|NOT COMPLETED|Overall Study||3
5122036|NCT01474746|12601332|P2|COMPLETED|Overall Study||25
5122037|NCT01474746|12601333|P1|COMPLETED|Overall Study||27
5122038|NCT01474746|12601332|P2|STARTED|Overall Study||27
5122039|NCT01474746|12601333|P1|STARTED|Overall Study||30
5122040|NCT01474681|12601397|P4|NOT COMPLETED|Overall Study||6
5122041|NCT01474681|12601398|P3|NOT COMPLETED|Overall Study||2
5122042|NCT01474681|12601399|P2|NOT COMPLETED|Overall Study||3
5122043|NCT01474681|12601400|P1|NOT COMPLETED|Overall Study||0
5122044|NCT01474681|12601397|P4|COMPLETED|Overall Study||9
5122045|NCT01474681|12601398|P3|COMPLETED|Overall Study||1
5122046|NCT01474681|12601399|P2|COMPLETED|Overall Study||5
5122047|NCT01474681|12601400|P1|COMPLETED|Overall Study||1
5122048|NCT01474681|12601397|P4|STARTED|Overall Study||15
5122049|NCT01474681|12601398|P3|STARTED|Overall Study||3
5122050|NCT01474681|12601399|P2|STARTED|Overall Study||8
5122051|NCT01474681|12601400|P1|STARTED|Overall Study||1
5122052|NCT01474590|12601444|P2|NOT COMPLETED|Overall Study||17
5122053|NCT01474590|12601445|P1|NOT COMPLETED|Overall Study||28
5122054|NCT01474590|12601444|P2|COMPLETED|Overall Study||116
5122055|NCT01474590|12601445|P1|COMPLETED|Overall Study||105
5122056|NCT01474590|12601444|P2|STARTED|Overall Study||133
5122057|NCT01474590|12601445|P1|STARTED|Overall Study||133
5122058|NCT01474551|12601451|P1|NOT COMPLETED|Overall Study||1
5122059|NCT01474551|12601451|P1|COMPLETED|Overall Study||1
5122060|NCT01474551|12601451|P1|STARTED|Overall Study||2
5122061|NCT01474538|12601457|P2|NOT COMPLETED|Treatment Period 2||2
5122062|NCT01474538|12601458|P1|NOT COMPLETED|Treatment Period 2||6
5122063|NCT01474538|12601457|P2|COMPLETED|Treatment Period 2||56
5122064|NCT01474538|12601458|P1|COMPLETED|Treatment Period 2||51
5122065|NCT01474538|12601457|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
5122066|NCT01474538|12601458|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
5122067|NCT01474538|12601457|P2|STARTED|Treatment Period 2||58
5122068|NCT01474538|12601458|P1|STARTED|Treatment Period 2||57
5122069|NCT01474538|12601457|P2|NOT COMPLETED|Treatment Period 1||4
5122070|NCT01474538|12601458|P1|NOT COMPLETED|Treatment Period 1||3
5122071|NCT01474538|12601457|P2|COMPLETED|Treatment Period 1||58
5122072|NCT01474538|12601458|P1|COMPLETED|Treatment Period 1||57
5122073|NCT01474538|12601457|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
5122074|NCT01474538|12601458|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
5122075|NCT01474538|12601457|P2|STARTED|Treatment Period 1||62
5122076|NCT01474538|12601458|P1|STARTED|Treatment Period 1||60
5122077|NCT01474512|12601475|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
5122078|NCT01474512|12601476|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
5122079|NCT01474512|12601477|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
5122080|NCT01474512|12601478|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
5122081|NCT01474512|12601479|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
5122082|NCT01474512|12601480|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
5122083|NCT01474512|12601481|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
5122084|NCT01474512|12601482|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
5122085|NCT01474512|12601483|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
5122086|NCT01474512|12601484|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
5122087|NCT01474512|12601485|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
5122088|NCT01474512|12601486|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
5122089|NCT01474512|12601487|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
5122090|NCT01474512|12601488|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
5122091|NCT01474512|12601489|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
5122092|NCT01474512|12601490|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
5122093|NCT01474512|12601491|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
5122094|NCT01474512|12601492|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
5122095|NCT01474512|12601475|P18|COMPLETED|Post-Treatment Follow-Up||239
5122096|NCT01474512|12601476|P17|COMPLETED|Post-Treatment Follow-Up||544
5122097|NCT01474512|12601477|P16|COMPLETED|Post-Treatment Follow-Up||17
5122098|NCT01474512|12601478|P15|COMPLETED|Post-Treatment Follow-Up||0
5122099|NCT01474512|12601479|P14|COMPLETED|Post-Treatment Follow-Up||0
5122100|NCT01474512|12601480|P13|COMPLETED|Post-Treatment Follow-Up||0
5122101|NCT01474512|12601481|P12|COMPLETED|Post-Treatment Follow-Up||0
5122102|NCT01474512|12601482|P11|COMPLETED|Post-Treatment Follow-Up||0
5122103|NCT01474512|12601483|P10|COMPLETED|Post-Treatment Follow-Up||0
5122104|NCT01474512|12601484|P9|COMPLETED|Post-Treatment Follow-Up||0
5122105|NCT01474512|12601485|P8|COMPLETED|Post-Treatment Follow-Up||0
5122106|NCT01474512|12601486|P7|COMPLETED|Post-Treatment Follow-Up||0
5122107|NCT01474512|12601487|P6|COMPLETED|Post-Treatment Follow-Up||0
5122108|NCT01474512|12601488|P5|COMPLETED|Post-Treatment Follow-Up||0
5122109|NCT01474512|12601489|P4|COMPLETED|Post-Treatment Follow-Up||0
5122110|NCT01474512|12601490|P3|COMPLETED|Post-Treatment Follow-Up||0
5122111|NCT01474512|12601491|P2|COMPLETED|Post-Treatment Follow-Up||0
5122112|NCT01474512|12601492|P1|COMPLETED|Post-Treatment Follow-Up||0
5122113|NCT01474512|12601475|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
5122114|NCT01474512|12601476|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
5122115|NCT01474512|12601477|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
5122116|NCT01474512|12601478|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
5122117|NCT01474512|12601479|P14|STARTED|Post-Treatment Follow-Up||0
5122118|NCT01474512|12601480|P13|STARTED|Post-Treatment Follow-Up||0
5122119|NCT01474512|12601481|P12|STARTED|Post-Treatment Follow-Up||0
5122120|NCT01474512|12601482|P11|STARTED|Post-Treatment Follow-Up||0
5122121|NCT01474512|12601483|P10|STARTED|Post-Treatment Follow-Up||0
5122122|NCT01474512|12601484|P9|STARTED|Post-Treatment Follow-Up||0
5122123|NCT01474512|12601485|P8|STARTED|Post-Treatment Follow-Up||0
5122124|NCT01474512|12601486|P7|STARTED|Post-Treatment Follow-Up||0
5122125|NCT01474512|12601487|P6|STARTED|Post-Treatment Follow-Up||0
5122126|NCT01474512|12601488|P5|STARTED|Post-Treatment Follow-Up||0
5122127|NCT01474512|12601489|P4|STARTED|Post-Treatment Follow-Up||0
5122128|NCT01474512|12601490|P3|STARTED|Post-Treatment Follow-Up||0
5122129|NCT01474512|12601491|P2|STARTED|Post-Treatment Follow-Up||0
5122130|NCT01474512|12601492|P1|STARTED|Post-Treatment Follow-Up||0
5122131|NCT01474512|12601475|P18|NOT COMPLETED|Long-Term Extension Period||0
5122132|NCT01474512|12601476|P17|NOT COMPLETED|Long-Term Extension Period||0
5122133|NCT01474512|12601477|P16|NOT COMPLETED|Long-Term Extension Period||0
5122134|NCT01474512|12601478|P15|NOT COMPLETED|Long-Term Extension Period||0
5122135|NCT01474512|12601479|P14|NOT COMPLETED|Long-Term Extension Period||220
5122136|NCT01474512|12601480|P13|NOT COMPLETED|Long-Term Extension Period||218
5122137|NCT01474512|12601481|P12|NOT COMPLETED|Long-Term Extension Period||26
5122138|NCT01474512|12601482|P11|NOT COMPLETED|Long-Term Extension Period||0
5122139|NCT01474512|12601483|P10|NOT COMPLETED|Long-Term Extension Period||0
5122140|NCT01474512|12601484|P9|NOT COMPLETED|Long-Term Extension Period||0
5122141|NCT01474512|12601485|P8|NOT COMPLETED|Long-Term Extension Period||0
5122142|NCT01474512|12601486|P7|NOT COMPLETED|Long-Term Extension Period||0
5122143|NCT01474512|12601487|P6|NOT COMPLETED|Long-Term Extension Period||0
5122144|NCT01474512|12601488|P5|NOT COMPLETED|Long-Term Extension Period||0
5122145|NCT01474512|12601489|P4|NOT COMPLETED|Long-Term Extension Period||0
5122146|NCT01474512|12601490|P3|NOT COMPLETED|Long-Term Extension Period||0
5122147|NCT01474512|12601491|P2|NOT COMPLETED|Long-Term Extension Period||0
5122148|NCT01474512|12601492|P1|NOT COMPLETED|Long-Term Extension Period||0
5122149|NCT01474512|12601475|P18|COMPLETED|Long-Term Extension Period||0
5122150|NCT01474512|12601476|P17|COMPLETED|Long-Term Extension Period||0
5122151|NCT01474512|12601477|P16|COMPLETED|Long-Term Extension Period||0
5122152|NCT01474512|12601478|P15|COMPLETED|Long-Term Extension Period||0
5122153|NCT01474512|12601479|P14|COMPLETED|Long-Term Extension Period||855
5122154|NCT01474512|12601480|P13|COMPLETED|Long-Term Extension Period||836
5122155|NCT01474512|12601481|P12|COMPLETED|Long-Term Extension Period||0
5122156|NCT01474512|12601482|P11|COMPLETED|Long-Term Extension Period||0
5122157|NCT01474512|12601483|P10|COMPLETED|Long-Term Extension Period||0
5122158|NCT01474512|12601484|P9|COMPLETED|Long-Term Extension Period||0
5122159|NCT01474512|12601485|P8|COMPLETED|Long-Term Extension Period||0
5122160|NCT01474512|12601486|P7|COMPLETED|Long-Term Extension Period||0
5122161|NCT01474512|12601487|P6|COMPLETED|Long-Term Extension Period||0
5122162|NCT01474512|12601488|P5|COMPLETED|Long-Term Extension Period||0
5122163|NCT01474512|12601489|P4|COMPLETED|Long-Term Extension Period||0
5122164|NCT01474512|12601490|P3|COMPLETED|Long-Term Extension Period||0
5122165|NCT01474512|12601491|P2|COMPLETED|Long-Term Extension Period||0
5122166|NCT01474512|12601492|P1|COMPLETED|Long-Term Extension Period||0
5122167|NCT01474512|12601475|P18|STARTED|Long-Term Extension Period||0
5122168|NCT01474512|12601476|P17|STARTED|Long-Term Extension Period||0
5122169|NCT01474512|12601477|P16|STARTED|Long-Term Extension Period||0
5122170|NCT01474512|12601478|P15|STARTED|Long-Term Extension Period||0
5122171|NCT01474512|12601479|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
5122172|NCT01474512|12601480|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
5122173|NCT01474512|12601481|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
5122174|NCT01474512|12601482|P11|STARTED|Long-Term Extension Period||0
5122175|NCT01474512|12601483|P10|STARTED|Long-Term Extension Period||0
5122176|NCT01474512|12601484|P9|STARTED|Long-Term Extension Period||0
5122177|NCT01474512|12601485|P8|STARTED|Long-Term Extension Period||0
5122178|NCT01474512|12601486|P7|STARTED|Long-Term Extension Period||0
5122179|NCT01474512|12601487|P6|STARTED|Long-Term Extension Period||0
5122180|NCT01474512|12601488|P5|STARTED|Long-Term Extension Period||0
5122181|NCT01474512|12601489|P4|STARTED|Long-Term Extension Period||0
5122182|NCT01474512|12601490|P3|STARTED|Long-Term Extension Period||0
5122183|NCT01474512|12601491|P2|STARTED|Long-Term Extension Period||0
5122184|NCT01474512|12601492|P1|STARTED|Long-Term Extension Period||0
5122185|NCT01474512|12601475|P18|NOT COMPLETED|Maintenance Period||0
5122186|NCT01474512|12601476|P17|NOT COMPLETED|Maintenance Period||0
5122187|NCT01474512|12601477|P16|NOT COMPLETED|Maintenance Period||0
5122188|NCT01474512|12601478|P15|NOT COMPLETED|Maintenance Period||0
5122189|NCT01474512|12601479|P14|NOT COMPLETED|Maintenance Period||0
5122190|NCT01474512|12601480|P13|NOT COMPLETED|Maintenance Period||0
5122191|NCT01474512|12601481|P12|NOT COMPLETED|Maintenance Period||0
5122192|NCT01474512|12601482|P11|NOT COMPLETED|Maintenance Period||0
5122193|NCT01474512|12601483|P10|NOT COMPLETED|Maintenance Period||18
5122194|NCT01474512|12601484|P9|NOT COMPLETED|Maintenance Period||16
5122195|NCT01474512|12601485|P8|NOT COMPLETED|Maintenance Period||41
5122196|NCT01474512|12601486|P7|NOT COMPLETED|Maintenance Period||10
5122197|NCT01474512|12601487|P6|NOT COMPLETED|Maintenance Period||52
5122198|NCT01474512|12601488|P5|NOT COMPLETED|Maintenance Period||119
5122199|NCT01474512|12601489|P4|NOT COMPLETED|Maintenance Period||202
5122200|NCT01474512|12601490|P3|NOT COMPLETED|Maintenance Period||0
5122201|NCT01474512|12601491|P2|NOT COMPLETED|Maintenance Period||0
5122202|NCT01474512|12601492|P1|NOT COMPLETED|Maintenance Period||0
5122203|NCT01474512|12601475|P18|COMPLETED|Maintenance Period||0
5122204|NCT01474512|12601476|P17|COMPLETED|Maintenance Period||0
5122205|NCT01474512|12601477|P16|COMPLETED|Maintenance Period||0
5122206|NCT01474512|12601478|P15|COMPLETED|Maintenance Period||0
5122207|NCT01474512|12601479|P14|COMPLETED|Maintenance Period||0
5122208|NCT01474512|12601480|P13|COMPLETED|Maintenance Period||0
5122209|NCT01474512|12601481|P12|COMPLETED|Maintenance Period||0
5122210|NCT01474512|12601482|P11|COMPLETED|Maintenance Period||0
5122211|NCT01474512|12601483|P10|COMPLETED|Maintenance Period||44
5122212|NCT01474512|12601484|P9|COMPLETED|Maintenance Period||62
5122213|NCT01474512|12601485|P8|COMPLETED|Maintenance Period||350
5122214|NCT01474512|12601486|P7|COMPLETED|Maintenance Period||6
5122215|NCT01474512|12601487|P6|COMPLETED|Maintenance Period||177
5122216|NCT01474512|12601488|P5|COMPLETED|Maintenance Period||108
5122217|NCT01474512|12601489|P4|COMPLETED|Maintenance Period||24
5122218|NCT01474512|12601490|P3|COMPLETED|Maintenance Period||0
5122219|NCT01474512|12601491|P2|COMPLETED|Maintenance Period||0
5122220|NCT01474512|12601492|P1|COMPLETED|Maintenance Period||0
5122221|NCT01474512|12601475|P18|Relapsed Population Completers|Maintenance Period||0
5122222|NCT01474512|12601476|P17|Relapsed Population Completers|Maintenance Period||0
5122223|NCT01474512|12601477|P16|Relapsed Population Completers|Maintenance Period||0
5122224|NCT01474512|12601478|P15|Relapsed Population Completers|Maintenance Period||0
5122225|NCT01474512|12601479|P14|Relapsed Population Completers|Maintenance Period||0
5122226|NCT01474512|12601480|P13|Relapsed Population Completers|Maintenance Period||0
5122227|NCT01474512|12601481|P12|Relapsed Population Completers|Maintenance Period||0
5122228|NCT01474512|12601482|P11|Relapsed Population Completers|Maintenance Period||321
5122229|NCT01474512|12601483|P10|Relapsed Population Completers|Maintenance Period||0
5122230|NCT01474512|12601484|P9|Relapsed Population Completers|Maintenance Period||0
5122231|NCT01474512|12601485|P8|Relapsed Population Completers|Maintenance Period||0
5122232|NCT01474512|12601486|P7|Relapsed Population Completers|Maintenance Period||0
5122233|NCT01474512|12601487|P6|Relapsed Population Completers|Maintenance Period||0
5122234|NCT01474512|12601488|P5|Relapsed Population Completers|Maintenance Period||0
5122235|NCT01474512|12601489|P4|Relapsed Population Completers|Maintenance Period||0
5122236|NCT01474512|12601490|P3|Relapsed Population Completers|Maintenance Period||0
5122237|NCT01474512|12601491|P2|Relapsed Population Completers|Maintenance Period||0
5122238|NCT01474512|12601492|P1|Relapsed Population Completers|Maintenance Period||0
5122239|NCT01474512|12601475|P18|Relapsed Population Received Drug|Maintenance Period||0
5122240|NCT01474512|12601476|P17|Relapsed Population Received Drug|Maintenance Period||0
5122241|NCT01474512|12601477|P16|Relapsed Population Received Drug|Maintenance Period||0
5122242|NCT01474512|12601478|P15|Relapsed Population Received Drug|Maintenance Period||0
5122243|NCT01474512|12601479|P14|Relapsed Population Received Drug|Maintenance Period||0
5122244|NCT01474512|12601480|P13|Relapsed Population Received Drug|Maintenance Period||0
5122245|NCT01474512|12601481|P12|Relapsed Population Received Drug|Maintenance Period||0
5122246|NCT01474512|12601482|P11|Relapsed Population Received Drug|Maintenance Period||348
5122247|NCT01474512|12601483|P10|Relapsed Population Received Drug|Maintenance Period||0
5122248|NCT01474512|12601484|P9|Relapsed Population Received Drug|Maintenance Period||0
5122249|NCT01474512|12601485|P8|Relapsed Population Received Drug|Maintenance Period||0
5122250|NCT01474512|12601486|P7|Relapsed Population Received Drug|Maintenance Period||0
5122251|NCT01474512|12601487|P6|Relapsed Population Received Drug|Maintenance Period||0
5122252|NCT01474512|12601488|P5|Relapsed Population Received Drug|Maintenance Period||0
5122253|NCT01474512|12601489|P4|Relapsed Population Received Drug|Maintenance Period||0
5122254|NCT01474512|12601490|P3|Relapsed Population Received Drug|Maintenance Period||0
5122255|NCT01474512|12601491|P2|Relapsed Population Received Drug|Maintenance Period||0
5122256|NCT01474512|12601492|P1|Relapsed Population Received Drug|Maintenance Period||0
5122257|NCT01474512|12601475|P18|Received Study Drug|Maintenance Period||0
5122258|NCT01474512|12601476|P17|Received Study Drug|Maintenance Period||0
5122259|NCT01474512|12601477|P16|Received Study Drug|Maintenance Period||0
5122260|NCT01474512|12601478|P15|Received Study Drug|Maintenance Period||0
5122261|NCT01474512|12601479|P14|Received Study Drug|Maintenance Period||0
5122262|NCT01474512|12601480|P13|Received Study Drug|Maintenance Period||0
5122263|NCT01474512|12601481|P12|Received Study Drug|Maintenance Period||0
5122264|NCT01474512|12601482|P11|Received Study Drug|Maintenance Period||0
5122265|NCT01474512|12601483|P10|Received Study Drug|Maintenance Period||62
5122266|NCT01474512|12601484|P9|Received Study Drug|Maintenance Period||78
5122267|NCT01474512|12601485|P8|Received Study Drug|Maintenance Period||391
5122268|NCT01474512|12601486|P7|Received Study Drug|Maintenance Period||16
5122269|NCT01474512|12601487|P6|Received Study Drug|Maintenance Period||229
5122270|NCT01474512|12601488|P5|Received Study Drug|Maintenance Period||227
5122271|NCT01474512|12601489|P4|Received Study Drug|Maintenance Period||226
5122272|NCT01474512|12601490|P3|Received Study Drug|Maintenance Period||0
5122273|NCT01474512|12601491|P2|Received Study Drug|Maintenance Period||0
5122274|NCT01474512|12601492|P1|Received Study Drug|Maintenance Period||0
5122275|NCT01474512|12601475|P18|STARTED|Maintenance Period||0
5122276|NCT01474512|12601476|P17|STARTED|Maintenance Period||0
5122277|NCT01474512|12601477|P16|STARTED|Maintenance Period||0
5122278|NCT01474512|12601478|P15|STARTED|Maintenance Period||0
5122279|NCT01474512|12601479|P14|STARTED|Maintenance Period||0
5122280|NCT01474512|12601480|P13|STARTED|Maintenance Period||0
5122281|NCT01474512|12601481|P12|STARTED|Maintenance Period||0
5122282|NCT01474512|12601482|P11|STARTED|Maintenance Period||0
5122283|NCT01474512|12601483|P10|STARTED|Maintenance Period||62
5122284|NCT01474512|12601484|P9|STARTED|Maintenance Period||78
5122285|NCT01474512|12601485|P8|STARTED|Maintenance Period||391
5122286|NCT01474512|12601486|P7|STARTED|Maintenance Period||16
5122287|NCT01474512|12601487|P6|STARTED|Maintenance Period||229
5122288|NCT01474512|12601488|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
5122289|NCT01474512|12601489|P4|STARTED|Maintenance Period||226
5122290|NCT01474512|12601490|P3|STARTED|Maintenance Period||0
5122291|NCT01474512|12601491|P2|STARTED|Maintenance Period||0
5122292|NCT01474512|12601492|P1|STARTED|Maintenance Period||0
5122293|NCT01474512|12601475|P18|NOT COMPLETED|Induction Period||0
5122294|NCT01474512|12601476|P17|NOT COMPLETED|Induction Period||0
5122295|NCT01474512|12601477|P16|NOT COMPLETED|Induction Period||0
5122296|NCT01474512|12601478|P15|NOT COMPLETED|Induction Period||0
5122297|NCT01474512|12601479|P14|NOT COMPLETED|Induction Period||0
5122298|NCT01474512|12601480|P13|NOT COMPLETED|Induction Period||0
5122299|NCT01474512|12601481|P12|NOT COMPLETED|Induction Period||0
5122300|NCT01474512|12601482|P11|NOT COMPLETED|Induction Period||0
5122301|NCT01474512|12601483|P10|NOT COMPLETED|Induction Period||0
5122302|NCT01474512|12601484|P9|NOT COMPLETED|Induction Period||0
5122303|NCT01474512|12601485|P8|NOT COMPLETED|Induction Period||0
5122304|NCT01474512|12601486|P7|NOT COMPLETED|Induction Period||0
5122305|NCT01474512|12601487|P6|NOT COMPLETED|Induction Period||0
5122306|NCT01474512|12601488|P5|NOT COMPLETED|Induction Period||0
5122307|NCT01474512|12601489|P4|NOT COMPLETED|Induction Period||0
5122308|NCT01474512|12601490|P3|NOT COMPLETED|Induction Period||18
5122309|NCT01474512|12601491|P2|NOT COMPLETED|Induction Period||24
5122310|NCT01474512|12601492|P1|NOT COMPLETED|Induction Period||24
5122311|NCT01474512|12601475|P18|COMPLETED|Induction Period||0
5122312|NCT01474512|12601476|P17|COMPLETED|Induction Period||0
5122313|NCT01474512|12601477|P16|COMPLETED|Induction Period||0
5122314|NCT01474512|12601478|P15|COMPLETED|Induction Period||0
5122315|NCT01474512|12601479|P14|COMPLETED|Induction Period||0
5122316|NCT01474512|12601480|P13|COMPLETED|Induction Period||0
5122317|NCT01474512|12601481|P12|COMPLETED|Induction Period||0
5122318|NCT01474512|12601482|P11|COMPLETED|Induction Period||0
5122319|NCT01474512|12601483|P10|COMPLETED|Induction Period||0
5122320|NCT01474512|12601484|P9|COMPLETED|Induction Period||0
5122321|NCT01474512|12601485|P8|COMPLETED|Induction Period||0
5122322|NCT01474512|12601486|P7|COMPLETED|Induction Period||0
5122323|NCT01474512|12601487|P6|COMPLETED|Induction Period||0
5122324|NCT01474512|12601488|P5|COMPLETED|Induction Period||0
5122325|NCT01474512|12601489|P4|COMPLETED|Induction Period||0
5122326|NCT01474512|12601490|P3|COMPLETED|Induction Period||415
5122327|NCT01474512|12601491|P2|COMPLETED|Induction Period||408
5122328|NCT01474512|12601492|P1|COMPLETED|Induction Period||407
5122329|NCT01474512|12601475|P18|Received Study Drug|Induction Period||0
5122330|NCT01474512|12601476|P17|Received Study Drug|Induction Period||0
5122331|NCT01474512|12601477|P16|Received Study Drug|Induction Period||0
5122332|NCT01474512|12601478|P15|Received Study Drug|Induction Period||0
5122333|NCT01474512|12601479|P14|Received Study Drug|Induction Period||0
5122334|NCT01474512|12601480|P13|Received Study Drug|Induction Period||0
5122335|NCT01474512|12601481|P12|Received Study Drug|Induction Period||0
5122336|NCT01474512|12601482|P11|Received Study Drug|Induction Period||0
5122337|NCT01474512|12601483|P10|Received Study Drug|Induction Period||0
5122338|NCT01474512|12601484|P9|Received Study Drug|Induction Period||0
5122339|NCT01474512|12601485|P8|Received Study Drug|Induction Period||0
5122340|NCT01474512|12601486|P7|Received Study Drug|Induction Period||0
5122341|NCT01474512|12601487|P6|Received Study Drug|Induction Period||0
5122342|NCT01474512|12601488|P5|Received Study Drug|Induction Period||0
5122343|NCT01474512|12601489|P4|Received Study Drug|Induction Period||0
5122344|NCT01474512|12601490|P3|Received Study Drug|Induction Period||433
5122345|NCT01474512|12601491|P2|Received Study Drug|Induction Period||432
5122346|NCT01474512|12601492|P1|Received Study Drug|Induction Period||431
5122347|NCT01474512|12601475|P18|STARTED|Induction Period||0
5122348|NCT01474512|12601476|P17|STARTED|Induction Period||0
5122349|NCT01474512|12601477|P16|STARTED|Induction Period||0
5122350|NCT01474512|12601478|P15|STARTED|Induction Period||0
5122351|NCT01474512|12601479|P14|STARTED|Induction Period||0
5122352|NCT01474512|12601480|P13|STARTED|Induction Period||0
5122353|NCT01474512|12601481|P12|STARTED|Induction Period||0
5122354|NCT01474512|12601482|P11|STARTED|Induction Period||0
5122355|NCT01474512|12601483|P10|STARTED|Induction Period||0
5122356|NCT01474512|12601484|P9|STARTED|Induction Period||0
5122357|NCT01474512|12601485|P8|STARTED|Induction Period||0
5122358|NCT01474512|12601486|P7|STARTED|Induction Period||0
5122359|NCT01474512|12601487|P6|STARTED|Induction Period||0
5122360|NCT01474512|12601488|P5|STARTED|Induction Period||0
5122361|NCT01474512|12601489|P4|STARTED|Induction Period||0
5122362|NCT01474512|12601490|P3|STARTED|Induction Period||433
5122363|NCT01474512|12601491|P2|STARTED|Induction Period||432
5122364|NCT01474512|12601492|P1|STARTED|Induction Period||431
5122365|NCT01474434|12601568|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
5122366|NCT01474434|12601569|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
5122367|NCT01474434|12601570|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
5122368|NCT01474434|12601571|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
5122369|NCT01474434|12601568|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
5122370|NCT01474434|12601569|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
5122371|NCT01474434|12601570|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
5122372|NCT01474434|12601571|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
5122373|NCT01474434|12601568|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
5122374|NCT01474434|12601569|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
5122375|NCT01474434|12601570|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
5122376|NCT01474434|12601571|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
5122377|NCT01474434|12601568|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
5122378|NCT01474434|12601569|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
5122379|NCT01474434|12601570|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
5122380|NCT01474434|12601571|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
5122381|NCT01474434|12601568|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
5122382|NCT01474434|12601569|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
5122383|NCT01474434|12601570|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
5122384|NCT01474434|12601571|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
5122385|NCT01474434|12601568|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
5122386|NCT01474434|12601569|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
5122387|NCT01474434|12601570|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
5122388|NCT01474434|12601571|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
5122389|NCT01474317|12601613|P1|NOT COMPLETED|Overall Study||2
5122390|NCT01474317|12601613|P1|COMPLETED|Overall Study||224
5122391|NCT01474317|12601613|P1|STARTED|Overall Study||226
5122392|NCT01474291|12601622|P1|NOT COMPLETED|Overall Study||220
5122393|NCT01474291|12601622|P1|COMPLETED|Overall Study||383
5122394|NCT01474291|12601622|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
5122395|NCT01474291|12601622|P1|STARTED|Overall Study||603
5122396|NCT01474239|12601666|P2|NOT COMPLETED|Overall Study||32
5122397|NCT01474239|12601667|P1|NOT COMPLETED|Overall Study||59
5122398|NCT01474239|12601666|P2|COMPLETED|Overall Study||0
5122399|NCT01474239|12601667|P1|COMPLETED|Overall Study||0
5122400|NCT01474239|12601666|P2|STARTED|Overall Study||32
5122401|NCT01474239|12601667|P1|STARTED|Overall Study||59
5122402|NCT01474213|12601705|P2|NOT COMPLETED|Overall Study||0
5122403|NCT01474213|12601706|P1|NOT COMPLETED|Overall Study||0
5122404|NCT01474213|12601705|P2|COMPLETED|Overall Study||20
5122405|NCT01474213|12601706|P1|COMPLETED|Overall Study||20
5122406|NCT01474213|12601705|P2|STARTED|Overall Study||20
5122407|NCT01474213|12601706|P1|STARTED|Overall Study||20
5122408|NCT01474200|12601730|P2|NOT COMPLETED|Overall Study||30
5122409|NCT01474200|12601731|P1|NOT COMPLETED|Overall Study||29
5122410|NCT01474200|12601730|P2|COMPLETED|Overall Study||84
5122411|NCT01474200|12601731|P1|COMPLETED|Overall Study||81
5122412|NCT01474200|12601730|P2|STARTED|Overall Study||114
5122413|NCT01474200|12601731|P1|STARTED|Overall Study||110
5122414|NCT01474122|12601784|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
5122415|NCT01474122|12601785|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
5122416|NCT01474122|12601786|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
5122417|NCT01474122|12601784|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
5122503|NCT01473940|12601925|P1|Went on to Start Maintenance Therapy|Maintenance Therapy||2
5122418|NCT01474122|12601785|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
5122419|NCT01474122|12601786|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
5122420|NCT01474122|12601784|P3|STARTED|Period 2: Week 16 to End of Study||88
5122421|NCT01474122|12601785|P2|STARTED|Period 2: Week 16 to End of Study||86
5122422|NCT01474122|12601786|P1|STARTED|Period 2: Week 16 to End of Study||87
5122423|NCT01474122|12601784|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
5122424|NCT01474122|12601785|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
5122425|NCT01474122|12601786|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
5122426|NCT01474122|12601784|P3|COMPLETED|Period 1: Baseline to Week 16||88
5122427|NCT01474122|12601785|P2|COMPLETED|Period 1: Baseline to Week 16||86
5122428|NCT01474122|12601786|P1|COMPLETED|Period 1: Baseline to Week 16||87
5122429|NCT01474122|12601784|P3|STARTED|Period 1: Baseline to Week 16||89
5122430|NCT01474122|12601785|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
5122431|NCT01474122|12601786|P1|STARTED|Period 1: Baseline to Week 16||88
5122432|NCT01474109|12601812|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
5122433|NCT01474109|12601813|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
5122434|NCT01474109|12601814|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
5122435|NCT01474109|12601812|P3|COMPLETED|Period 2: Week 16 to End of Study||83
5122436|NCT01474109|12601813|P2|COMPLETED|Period 2: Week 16 to End of Study||73
5122437|NCT01474109|12601814|P1|COMPLETED|Period 2: Week 16 to End of Study||70
5122438|NCT01474109|12601812|P3|STARTED|Period 2: Week 16 to End of Study||95
5122439|NCT01474109|12601813|P2|STARTED|Period 2: Week 16 to End of Study||91
5122440|NCT01474109|12601814|P1|STARTED|Period 2: Week 16 to End of Study||88
5122441|NCT01474109|12601812|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
5122442|NCT01474109|12601813|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
5122443|NCT01474109|12601814|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
5122444|NCT01474109|12601812|P3|COMPLETED|Period 1: Baseline to Week 16||95
5122445|NCT01474109|12601813|P2|COMPLETED|Period 1: Baseline to Week 16||91
5122446|NCT01474109|12601814|P1|COMPLETED|Period 1: Baseline to Week 16||88
5122447|NCT01474109|12601812|P3|STARTED|Period 1: Baseline to Week 16||97
5122448|NCT01474109|12601813|P2|STARTED|Period 1: Baseline to Week 16||97
5122449|NCT01474109|12601814|P1|STARTED|Period 1: Baseline to Week 16||95
5122450|NCT01474018|12601839|P2|NOT COMPLETED|Overall Study||3
5122451|NCT01474018|12601840|P1|NOT COMPLETED|Overall Study||0
5122452|NCT01474018|12601839|P2|COMPLETED|Overall Study||7
5122453|NCT01474018|12601840|P1|COMPLETED|Overall Study|Writing paper|5
5122454|NCT01474018|12601839|P2|STARTED|Overall Study||10
5122455|NCT01474018|12601840|P1|STARTED|Overall Study||5
5122456|NCT01473992|12601850|P3|NOT COMPLETED|Overall Study||0
5122457|NCT01473992|12601851|P2|NOT COMPLETED|Overall Study||0
5122458|NCT01473992|12601852|P1|NOT COMPLETED|Overall Study||0
5122459|NCT01473992|12601850|P3|COMPLETED|Overall Study||5
5122460|NCT01473992|12601851|P2|COMPLETED|Overall Study||10
5122461|NCT01473992|12601852|P1|COMPLETED|Overall Study||10
5122462|NCT01473992|12601850|P3|STARTED|Overall Study||5
5122463|NCT01473992|12601851|P2|STARTED|Overall Study||10
5122464|NCT01473992|12601852|P1|STARTED|Overall Study||10
5122465|NCT01473953|12601872|P5|NOT COMPLETED|Overall Study||0
5122466|NCT01473953|12601873|P4|NOT COMPLETED|Overall Study||0
5122467|NCT01473953|12601874|P3|NOT COMPLETED|Overall Study||0
5122468|NCT01473953|12601875|P2|NOT COMPLETED|Overall Study||0
5122469|NCT01473953|12601876|P1|NOT COMPLETED|Overall Study||1
5122470|NCT01473953|12601872|P5|COMPLETED|Overall Study||8
5122471|NCT01473953|12601873|P4|COMPLETED|Overall Study||5
5122472|NCT01473953|12601874|P3|COMPLETED|Overall Study||6
5122473|NCT01473953|12601875|P2|COMPLETED|Overall Study||6
5122474|NCT01473953|12601876|P1|COMPLETED|Overall Study||5
5122475|NCT01473953|12601872|P5|STARTED|Overall Study||8
5122476|NCT01473953|12601873|P4|STARTED|Overall Study||5
5122477|NCT01473953|12601874|P3|STARTED|Overall Study||6
5122478|NCT01473953|12601875|P2|STARTED|Overall Study||6
5122479|NCT01473953|12601876|P1|STARTED|Overall Study||6
5122480|NCT01473940|12601922|P4|NOT COMPLETED|Follow-up Until Death||0
5122481|NCT01473940|12601923|P3|NOT COMPLETED|Follow-up Until Death||0
5122482|NCT01473940|12601924|P2|NOT COMPLETED|Follow-up Until Death||0
5122483|NCT01473940|12601925|P1|NOT COMPLETED|Follow-up Until Death||0
5122484|NCT01473940|12601922|P4|COMPLETED|Follow-up Until Death||7
5122485|NCT01473940|12601923|P3|COMPLETED|Follow-up Until Death||5
5122486|NCT01473940|12601924|P2|COMPLETED|Follow-up Until Death||4
5122487|NCT01473940|12601925|P1|COMPLETED|Follow-up Until Death||3
5122488|NCT01473940|12601922|P4|STARTED|Follow-up Until Death||7
5122489|NCT01473940|12601923|P3|STARTED|Follow-up Until Death||5
5122490|NCT01473940|12601924|P2|STARTED|Follow-up Until Death||4
5122491|NCT01473940|12601925|P1|STARTED|Follow-up Until Death||3
5122492|NCT01473940|12601922|P4|NOT COMPLETED|Maintenance Therapy||4
5122493|NCT01473940|12601923|P3|NOT COMPLETED|Maintenance Therapy||1
5122494|NCT01473940|12601924|P2|NOT COMPLETED|Maintenance Therapy||2
5122495|NCT01473940|12601925|P1|NOT COMPLETED|Maintenance Therapy||1
5122496|NCT01473940|12601922|P4|COMPLETED|Maintenance Therapy||3
5122497|NCT01473940|12601923|P3|COMPLETED|Maintenance Therapy||3
5122498|NCT01473940|12601924|P2|COMPLETED|Maintenance Therapy||1
5122499|NCT01473940|12601925|P1|COMPLETED|Maintenance Therapy||2
5122500|NCT01473940|12601922|P4|Went on to Start Maintenance Therapy|Maintenance Therapy||3
5122501|NCT01473940|12601923|P3|Went on to Start Maintenance Therapy|Maintenance Therapy||3
5122502|NCT01473940|12601924|P2|Went on to Start Maintenance Therapy|Maintenance Therapy||1
5122504|NCT01473940|12601922|P4|Evaluated for Response|Maintenance Therapy||7
5122505|NCT01473940|12601923|P3|Evaluated for Response|Maintenance Therapy||4
5122506|NCT01473940|12601924|P2|Evaluated for Response|Maintenance Therapy||3
5122507|NCT01473940|12601925|P1|Evaluated for Response|Maintenance Therapy||3
5122508|NCT01473940|12601922|P4|STARTED|Maintenance Therapy||7
5122509|NCT01473940|12601923|P3|STARTED|Maintenance Therapy||4
5122510|NCT01473940|12601924|P2|STARTED|Maintenance Therapy||3
5122511|NCT01473940|12601925|P1|STARTED|Maintenance Therapy||3
5122512|NCT01473940|12601922|P4|NOT COMPLETED|Induction Therapy||1
5122513|NCT01473940|12601923|P3|NOT COMPLETED|Induction Therapy||2
5122514|NCT01473940|12601924|P2|NOT COMPLETED|Induction Therapy||1
5122515|NCT01473940|12601925|P1|NOT COMPLETED|Induction Therapy||0
5122516|NCT01473940|12601922|P4|COMPLETED|Induction Therapy||7
5122517|NCT01473940|12601923|P3|COMPLETED|Induction Therapy||4
5122518|NCT01473940|12601924|P2|COMPLETED|Induction Therapy||3
5122519|NCT01473940|12601925|P1|COMPLETED|Induction Therapy||3
5122520|NCT01473940|12601922|P4|Completed Induction- 12 Weeks|Induction Therapy||7
5122521|NCT01473940|12601923|P3|Completed Induction- 12 Weeks|Induction Therapy||4
5122522|NCT01473940|12601924|P2|Completed Induction- 12 Weeks|Induction Therapy||3
5122523|NCT01473940|12601925|P1|Completed Induction- 12 Weeks|Induction Therapy||3
5122524|NCT01473940|12601922|P4|Started Treatment|Induction Therapy||8
5122525|NCT01473940|12601923|P3|Started Treatment|Induction Therapy||6
5122526|NCT01473940|12601924|P2|Started Treatment|Induction Therapy||4
5122527|NCT01473940|12601925|P1|Started Treatment|Induction Therapy||3
5122528|NCT01473940|12601922|P4|STARTED|Induction Therapy||8
5122529|NCT01473940|12601923|P3|STARTED|Induction Therapy||6
5122530|NCT01473940|12601924|P2|STARTED|Induction Therapy||4
5122531|NCT01473940|12601925|P1|STARTED|Induction Therapy||3
5122532|NCT01473836|12601955|P1|NOT COMPLETED|Overall Study||6
5122533|NCT01473836|12601955|P1|COMPLETED|Overall Study||32
5122534|NCT01473836|12601955|P1|STARTED|Overall Study||38
5122535|NCT01473758|12601966|P4|NOT COMPLETED|Cycle 2||0
5122536|NCT01473758|12601967|P3|NOT COMPLETED|Cycle 2||5
5122537|NCT01473758|12601968|P2|NOT COMPLETED|Cycle 2||0
5122538|NCT01473758|12601969|P1|NOT COMPLETED|Cycle 2||0
5122539|NCT01473758|12601966|P4|COMPLETED|Cycle 2||4
5122540|NCT01473758|12601967|P3|COMPLETED|Cycle 2||5
5122541|NCT01473758|12601968|P2|COMPLETED|Cycle 2||0
5122542|NCT01473758|12601969|P1|COMPLETED|Cycle 2||0
5122543|NCT01473758|12601966|P4|STARTED|Cycle 2||4
5122544|NCT01473758|12601967|P3|STARTED|Cycle 2||10
5122545|NCT01473758|12601968|P2|STARTED|Cycle 2||0
5122546|NCT01473758|12601969|P1|STARTED|Cycle 2||0
5122547|NCT01473758|12601966|P4|NOT COMPLETED|Cycle 1||0
5122548|NCT01473758|12601967|P3|NOT COMPLETED|Cycle 1||0
5122549|NCT01473758|12601968|P2|NOT COMPLETED|Cycle 1||3
5122550|NCT01473758|12601969|P1|NOT COMPLETED|Cycle 1||11
5122551|NCT01473758|12601966|P4|COMPLETED|Cycle 1||0
5122552|NCT01473758|12601967|P3|COMPLETED|Cycle 1||0
5122553|NCT01473758|12601968|P2|COMPLETED|Cycle 1||40
5122554|NCT01473758|12601969|P1|COMPLETED|Cycle 1||27
5122555|NCT01473758|12601966|P4|STARTED|Cycle 1||0
5122556|NCT01473758|12601967|P3|STARTED|Cycle 1||0
5122557|NCT01473758|12601968|P2|STARTED|Cycle 1||43
5122558|NCT01473758|12601969|P1|STARTED|Cycle 1||38
5122559|NCT01473745|12602093|P2|NOT COMPLETED|Overall Study||0
5122560|NCT01473745|12602094|P1|NOT COMPLETED|Overall Study||0
5122561|NCT01473745|12602093|P2|COMPLETED|Overall Study||24
5122562|NCT01473745|12602094|P1|COMPLETED|Overall Study||24
5122563|NCT01473745|12602093|P2|STARTED|Overall Study||24
5122564|NCT01473745|12602094|P1|STARTED|Overall Study||24
5122565|NCT01473732|12602106|P2|NOT COMPLETED|Overall Study||0
5122566|NCT01473732|12602107|P1|NOT COMPLETED|Overall Study||2
5122567|NCT01473732|12602106|P2|COMPLETED|Overall Study||0
5122568|NCT01473732|12602107|P1|COMPLETED|Overall Study||0
5122569|NCT01473732|12602106|P2|STARTED|Overall Study||0
5122570|NCT01473732|12602107|P1|STARTED|Overall Study||2
5122571|NCT01473602|12602115|P2|NOT COMPLETED|Overall Study||8
5122572|NCT01473602|12602116|P1|NOT COMPLETED|Overall Study||8
5122573|NCT01473602|12602115|P2|COMPLETED|Overall Study||13
5122574|NCT01473602|12602116|P1|COMPLETED|Overall Study||10
5122575|NCT01473602|12602115|P2|Completed 12 Months|Overall Study||13
5122576|NCT01473602|12602116|P1|Completed 12 Months|Overall Study||10
5122577|NCT01473602|12602115|P2|Completed 6 Months|Overall Study||15
5122578|NCT01473602|12602116|P1|Completed 6 Months|Overall Study||12
5122579|NCT01473602|12602115|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
5122580|NCT01473602|12602116|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
5122581|NCT01473602|12602115|P2|STARTED|Overall Study||21
5122582|NCT01473602|12602116|P1|STARTED|Overall Study||18
5122583|NCT01473589|12602152|P2|NOT COMPLETED|Overall Study||16
5122584|NCT01473589|12602153|P1|NOT COMPLETED|Overall Study||11
5122585|NCT01473589|12602152|P2|COMPLETED|Overall Study||46
5122586|NCT01473589|12602153|P1|COMPLETED|Overall Study||49
5122587|NCT01473589|12602152|P2|Completed 12 Months|Overall Study||48
5122588|NCT01473589|12602153|P1|Completed 12 Months|Overall Study||49
5122589|NCT01473589|12602152|P2|Completed 6 Months|Overall Study||54
5122590|NCT01473589|12602153|P1|Completed 6 Months|Overall Study||51
5122591|NCT01473589|12602152|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
5122592|NCT01473589|12602153|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
5122593|NCT01473589|12602152|P2|STARTED|Overall Study||62
5122594|NCT01473589|12602153|P1|STARTED|Overall Study||60
5122595|NCT01473563|12602187|P1|NOT COMPLETED|Overall Study||1
5122596|NCT01473563|12602187|P1|COMPLETED|Overall Study||51
5122597|NCT01473563|12602187|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
5122598|NCT01473563|12602187|P1|STARTED|Overall Study||52
5122599|NCT01473524|12602209|P3|NOT COMPLETED|Overall Study||3
5122600|NCT01473524|12602210|P2|NOT COMPLETED|Overall Study||9
5122601|NCT01473524|12602211|P1|NOT COMPLETED|Overall Study||7
5122602|NCT01473524|12602209|P3|COMPLETED|Overall Study||70
5122603|NCT01473524|12602210|P2|COMPLETED|Overall Study||64
5122604|NCT01473524|12602211|P1|COMPLETED|Overall Study||64
5122605|NCT01473524|12602209|P3|STARTED|Overall Study||73
5122606|NCT01473524|12602210|P2|STARTED|Overall Study||73
5122607|NCT01473524|12602211|P1|STARTED|Overall Study||71
5122608|NCT01473420|12602244|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
5122609|NCT01473420|12602245|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
5122610|NCT01473420|12602244|P2|COMPLETED|Maintenance Period (16 Weeks)||105
5122611|NCT01473420|12602245|P1|COMPLETED|Maintenance Period (16 Weeks)||106
5122612|NCT01473420|12602244|P2|STARTED|Maintenance Period (16 Weeks)||122
5122613|NCT01473420|12602245|P1|STARTED|Maintenance Period (16 Weeks)||124
5122614|NCT01473420|12602244|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
5122615|NCT01473420|12602245|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
5122616|NCT01473420|12602244|P2|COMPLETED|Titration Period (18 Weeks)||122
5122617|NCT01473420|12602245|P1|COMPLETED|Titration Period (18 Weeks)||124
5122618|NCT01473420|12602244|P2|Treated|Titration Period (18 Weeks)||86
5122619|NCT01473420|12602245|P1|Treated|Titration Period (18 Weeks)||80
5122620|NCT01473420|12602244|P2|STARTED|Titration Period (18 Weeks)||160
5122621|NCT01473420|12602245|P1|STARTED|Titration Period (18 Weeks)||160
5122622|NCT01473407|12602329|P2|NOT COMPLETED|Overall Study||47
5122623|NCT01473407|12602330|P1|NOT COMPLETED|Overall Study||54
5122624|NCT01473407|12602329|P2|COMPLETED|Overall Study||259
5122625|NCT01473407|12602330|P1|COMPLETED|Overall Study||252
5122626|NCT01473407|12602329|P2|STARTED|Overall Study||306
5122627|NCT01473407|12602330|P1|STARTED|Overall Study||306
5122628|NCT01473394|12602384|P2|NOT COMPLETED|Overall Study||43
5122629|NCT01473394|12602385|P1|NOT COMPLETED|Overall Study||45
5122630|NCT01473394|12602384|P2|COMPLETED|Overall Study||212
5122631|NCT01473394|12602385|P1|COMPLETED|Overall Study||208
5122632|NCT01473394|12602384|P2|STARTED|Overall Study||255
5122633|NCT01473394|12602385|P1|STARTED|Overall Study||253
5122634|NCT01473381|12602399|P4|NOT COMPLETED|Overall Study||89
5122635|NCT01473381|12602400|P3|NOT COMPLETED|Overall Study||102
5122636|NCT01473381|12602401|P2|NOT COMPLETED|Overall Study||93
5122637|NCT01473381|12602402|P1|NOT COMPLETED|Overall Study||80
5122638|NCT01473381|12602399|P4|COMPLETED|Overall Study||200
5122639|NCT01473381|12602400|P3|COMPLETED|Overall Study||189
5122640|NCT01473381|12602401|P2|COMPLETED|Overall Study||199
5122641|NCT01473381|12602402|P1|COMPLETED|Overall Study||210
5122642|NCT01473381|12602399|P4|Safety Population|Overall Study||282
5122643|NCT01473381|12602400|P3|Safety Population|Overall Study||287
5122644|NCT01473381|12602401|P2|Safety Population|Overall Study||288
5122645|NCT01473381|12602402|P1|Safety Population|Overall Study||281
5122646|NCT01473381|12602399|P4|STARTED|Overall Study||289
5122647|NCT01473381|12602400|P3|STARTED|Overall Study||291
5122648|NCT01473381|12602401|P2|STARTED|Overall Study||292
5122649|NCT01473381|12602402|P1|STARTED|Overall Study||290
5122650|NCT01473368|12602424|P4|NOT COMPLETED|Overall Study||0
5122651|NCT01473368|12602425|P3|NOT COMPLETED|Overall Study||3
5122652|NCT01473368|12602426|P2|NOT COMPLETED|Overall Study||0
5122653|NCT01473368|12602427|P1|NOT COMPLETED|Overall Study||1
5122654|NCT01473368|12602424|P4|COMPLETED|Overall Study||12
5122655|NCT01473368|12602425|P3|COMPLETED|Overall Study||12
5122656|NCT01473368|12602426|P2|COMPLETED|Overall Study||12
5122657|NCT01473368|12602427|P1|COMPLETED|Overall Study||13
5122658|NCT01473368|12602424|P4|STARTED|Overall Study||12
5122659|NCT01473368|12602425|P3|STARTED|Overall Study||15
5122660|NCT01473368|12602426|P2|STARTED|Overall Study||12
5122661|NCT01473368|12602427|P1|STARTED|Overall Study||14
5122662|NCT01473355|12602464|P1|NOT COMPLETED|Overall Study||6
5122663|NCT01473355|12602464|P1|COMPLETED|Overall Study||39
5122664|NCT01473355|12602464|P1|STARTED|Overall Study||45
5122665|NCT01473160|12602473|P1|NOT COMPLETED|Overall Study||0
5122666|NCT01473160|12602473|P1|COMPLETED|Overall Study||9
5122667|NCT01473160|12602473|P1|STARTED|Overall Study||9
5122668|NCT01472965|12602493|P2|NOT COMPLETED|Overall Study||0
5122669|NCT01472965|12602494|P1|NOT COMPLETED|Overall Study||1
5122670|NCT01472965|12602493|P2|COMPLETED|Overall Study||46
5122671|NCT01472965|12602494|P1|COMPLETED|Overall Study||48
5122672|NCT01472965|12602493|P2|STARTED|Overall Study||46
5122673|NCT01472965|12602494|P1|STARTED|Overall Study||49
5122674|NCT01472939|12602514|P4|NOT COMPLETED|Overall Study||20
5122675|NCT01472939|12602515|P3|NOT COMPLETED|Overall Study||11
5122676|NCT01472939|12602516|P2|NOT COMPLETED|Overall Study||14
5122677|NCT01472939|12602517|P1|NOT COMPLETED|Overall Study||20
5122678|NCT01472939|12602514|P4|COMPLETED|Overall Study||99
5122679|NCT01472939|12602515|P3|COMPLETED|Overall Study||108
5122680|NCT01472939|12602516|P2|COMPLETED|Overall Study||105
5122681|NCT01472939|12602517|P1|COMPLETED|Overall Study||103
5122682|NCT01472939|12602514|P4|STARTED|Overall Study||119
5122683|NCT01472939|12602515|P3|STARTED|Overall Study||119
5122684|NCT01472939|12602516|P2|STARTED|Overall Study||119
5122685|NCT01472939|12602517|P1|STARTED|Overall Study||123
5122686|NCT01472874|12602544|P1|NOT COMPLETED|Overall Study||0
5122687|NCT01472874|12602544|P1|COMPLETED|Overall Study||8
5122688|NCT01472874|12602544|P1|STARTED|Overall Study||8
5122689|NCT01472835|12602561|P2|NOT COMPLETED|Overall Study||0
5122690|NCT01472835|12602562|P1|NOT COMPLETED|Overall Study||2
5122691|NCT01472835|12602561|P2|COMPLETED|Overall Study||36
5122692|NCT01472835|12602562|P1|COMPLETED|Overall Study||35
5122693|NCT01472835|12602561|P2|STARTED|Overall Study||36
5122694|NCT01472835|12602562|P1|STARTED|Overall Study||37
5122695|NCT01472822|12602578|P2|NOT COMPLETED|Overall Study||2
5122696|NCT01472822|12602579|P1|NOT COMPLETED|Overall Study||2
5122697|NCT01472822|12602578|P2|COMPLETED|Overall Study||28
5122698|NCT01472822|12602579|P1|COMPLETED|Overall Study||28
5122699|NCT01472822|12602578|P2|STARTED|Overall Study||30
5122700|NCT01472822|12602579|P1|STARTED|Overall Study||30
5122701|NCT01472757|12602597|P4|NOT COMPLETED|Overall Study||19
5122702|NCT01472757|12602598|P3|NOT COMPLETED|Overall Study||19
5122703|NCT01472757|12602599|P2|NOT COMPLETED|Overall Study||13
5122704|NCT01472757|12602600|P1|NOT COMPLETED|Overall Study||30
5122705|NCT01472757|12602597|P4|COMPLETED|Overall Study||75
5122706|NCT01472757|12602598|P3|COMPLETED|Overall Study||76
5122707|NCT01472757|12602599|P2|COMPLETED|Overall Study||80
5122708|NCT01472757|12602600|P1|COMPLETED|Overall Study||61
5122709|NCT01472757|12602597|P4|Full Analysis Set|Overall Study||92
5122710|NCT01472757|12602598|P3|Full Analysis Set|Overall Study||92
5122711|NCT01472757|12602599|P2|Full Analysis Set|Overall Study||93
5122712|NCT01472757|12602600|P1|Full Analysis Set|Overall Study||91
5122713|NCT01472757|12602597|P4|STARTED|Overall Study||94
5122714|NCT01472757|12602598|P3|STARTED|Overall Study||95
5122715|NCT01472757|12602599|P2|STARTED|Overall Study||93
5122716|NCT01472757|12602600|P1|STARTED|Overall Study||91
5122717|NCT01472718|12602624|P2|NOT COMPLETED|Overall Study||7
5122718|NCT01472718|12602625|P1|NOT COMPLETED|Overall Study||6
5122719|NCT01472718|12602624|P2|COMPLETED|Overall Study||97
5122720|NCT01472718|12602625|P1|COMPLETED|Overall Study||98
5122721|NCT01472718|12602624|P2|STARTED|Overall Study||104
5122722|NCT01472718|12602625|P1|STARTED|Overall Study||104
5122723|NCT01472692|12602635|P2|NOT COMPLETED|Overall Study||0
5122724|NCT01472692|12602636|P1|NOT COMPLETED|Overall Study||0
5122725|NCT01472692|12602635|P2|COMPLETED|Overall Study||0
5122726|NCT01472692|12602636|P1|COMPLETED|Overall Study||0
5122727|NCT01472692|12602635|P2|STARTED|Overall Study||0
5122728|NCT01472692|12602636|P1|STARTED|Overall Study||0
5122729|NCT01472562|12602644|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
5122730|NCT01472562|12602644|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
5122731|NCT01472562|12602644|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
5122732|NCT01472562|12602644|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
5122733|NCT01472562|12602644|P1|COMPLETED|Induction Phase (Week 1- 48)||27
5122734|NCT01472562|12602644|P1|STARTED|Induction Phase (Week 1- 48)||38
5122735|NCT01472549|12602650|P2|NOT COMPLETED|Overall Study||0
5122736|NCT01472549|12602651|P1|NOT COMPLETED|Overall Study||0
5122737|NCT01472549|12602650|P2|COMPLETED|Overall Study||575
5122738|NCT01472549|12602651|P1|COMPLETED|Overall Study||572
5122739|NCT01472549|12602650|P2|STARTED|Overall Study||575
5122740|NCT01472549|12602651|P1|STARTED|Overall Study||572
5122741|NCT01472445|12602673|P2|NOT COMPLETED|Overall Study||0
5122742|NCT01472445|12602674|P1|NOT COMPLETED|Overall Study||0
5122743|NCT01472445|12602673|P2|COMPLETED|Overall Study||16
5122744|NCT01472445|12602674|P1|COMPLETED|Overall Study||25
5122745|NCT01472445|12602673|P2|STARTED|Overall Study||16
5122746|NCT01472445|12602674|P1|STARTED|Overall Study||25
5122747|NCT01472432|12602698|P2|NOT COMPLETED|Overall Study||0
5122748|NCT01472432|12602699|P1|NOT COMPLETED|Overall Study||0
5122749|NCT01472432|12602698|P2|COMPLETED|Overall Study||53
5122750|NCT01472432|12602699|P1|COMPLETED|Overall Study||53
5122751|NCT01472432|12602698|P2|Ulcer Reduction|Overall Study||33
5122752|NCT01472432|12602699|P1|Ulcer Reduction|Overall Study||13
5122753|NCT01472432|12602698|P2|STARTED|Overall Study||53
5122754|NCT01472432|12602699|P1|STARTED|Overall Study||53
5122755|NCT01472380|12602715|P1|NOT COMPLETED|Efavirenz and FFA||0
5122756|NCT01472380|12602715|P1|COMPLETED|Efavirenz and FFA||28
5122757|NCT01472380|12602715|P1|STARTED|Efavirenz and FFA||28
5122758|NCT01472380|12602715|P1|NOT COMPLETED|1 Day Period Between Dosing||1
5122759|NCT01472380|12602715|P1|COMPLETED|1 Day Period Between Dosing||28
5122760|NCT01472380|12602715|P1|STARTED|1 Day Period Between Dosing||29
5122761|NCT01472380|12602715|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
5122762|NCT01472380|12602715|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
5122763|NCT01472380|12602715|P1|STARTED|Fenofibric Acid (FFA) Alone||29
5122764|NCT01472380|12602715|P1|NOT COMPLETED|Efavirenz Alone||1
5122765|NCT01472380|12602715|P1|COMPLETED|Efavirenz Alone||29
5122766|NCT01472380|12602715|P1|STARTED|Efavirenz Alone||30
5122767|NCT01472341|12602726|P1|NOT COMPLETED|Overall Study||272
5122768|NCT01472341|12602726|P1|COMPLETED|Overall Study||235
5122769|NCT01472341|12602726|P1|STARTED|Overall Study||507
5122770|NCT01472289|12602732|P1|NOT COMPLETED|Overall Study||2
5122771|NCT01472289|12602732|P1|COMPLETED|Overall Study||15
5122772|NCT01472289|12602732|P1|STARTED|Overall Study||17
5122773|NCT01472185|12602744|P2|NOT COMPLETED|Overall Study||34
5122774|NCT01472185|12602745|P1|NOT COMPLETED|Overall Study||34
5122775|NCT01472185|12602744|P2|COMPLETED|Overall Study||199
5122776|NCT01472185|12602745|P1|COMPLETED|Overall Study||198
5122777|NCT01472185|12602744|P2|STARTED|Overall Study||233
5122778|NCT01472185|12602745|P1|STARTED|Overall Study||232
5122779|NCT01472081|12602765|P6|NOT COMPLETED|Overall Study||6
5122780|NCT01472081|12602766|P5|NOT COMPLETED|Overall Study||47
5122781|NCT01472081|12602767|P4|NOT COMPLETED|Overall Study||46
5122782|NCT01472081|12602768|P3|NOT COMPLETED|Overall Study||20
5122783|NCT01472081|12602769|P2|NOT COMPLETED|Overall Study||26
5122784|NCT01472081|12602770|P1|NOT COMPLETED|Overall Study||7
5122785|NCT01472081|12602765|P6|COMPLETED|Overall Study||0
5122786|NCT01472081|12602766|P5|COMPLETED|Overall Study||0
5122787|NCT01472081|12602767|P4|COMPLETED|Overall Study||1
5122788|NCT01472081|12602768|P3|COMPLETED|Overall Study||0
5122789|NCT01472081|12602769|P2|COMPLETED|Overall Study||0
5122790|NCT01472081|12602770|P1|COMPLETED|Overall Study||0
5122791|NCT01472081|12602765|P6|STARTED|Overall Study||6
5122792|NCT01472081|12602766|P5|STARTED|Overall Study||47
5122793|NCT01472081|12602767|P4|STARTED|Overall Study||47
5122794|NCT01472081|12602768|P3|STARTED|Overall Study||20
5122795|NCT01472081|12602769|P2|STARTED|Overall Study||26
5122796|NCT01472081|12602770|P1|STARTED|Overall Study||7
5122797|NCT01471782|12602819|P6|NOT COMPLETED|Overall Study||41
5122798|NCT01471782|12602820|P5|NOT COMPLETED|Overall Study||26
5122799|NCT01471782|12602821|P4|NOT COMPLETED|Overall Study||5
5122800|NCT01471782|12602822|P3|NOT COMPLETED|Overall Study||5
5122801|NCT01471782|12602823|P2|NOT COMPLETED|Overall Study||6
5122802|NCT01471782|12602824|P1|NOT COMPLETED|Overall Study||5
5122803|NCT01471782|12602819|P6|COMPLETED|Overall Study|Completed 5 cycles|3
5122804|NCT01471782|12602820|P5|COMPLETED|Overall Study|Completed 5 cycles|0
5122805|NCT01471782|12602821|P4|COMPLETED|Overall Study|Completed 5 cycles|1
5122806|NCT01471782|12602822|P3|COMPLETED|Overall Study|Completed 5 cycles|0
5122807|NCT01471782|12602823|P2|COMPLETED|Overall Study|Completed 5 cycles|1
5122808|NCT01471782|12602824|P1|COMPLETED|Overall Study|Completed 5 cycles|0
5122809|NCT01471782|12602819|P6|STARTED|Overall Study||44
5122810|NCT01471782|12602820|P5|STARTED|Overall Study||26
5122811|NCT01471782|12602821|P4|STARTED|Overall Study||6
5122812|NCT01471782|12602822|P3|STARTED|Overall Study||5
5122813|NCT01471782|12602823|P2|STARTED|Overall Study||7
5122814|NCT01471782|12602824|P1|STARTED|Overall Study||5
5122815|NCT01471691|12602878|P2|NOT COMPLETED|Overall Study||1
5122816|NCT01471691|12602879|P1|NOT COMPLETED|Overall Study||0
5122817|NCT01471691|12602878|P2|COMPLETED|Overall Study||5
5122818|NCT01471691|12602879|P1|COMPLETED|Overall Study||8
5122819|NCT01471691|12602878|P2|STARTED|Overall Study||6
5122820|NCT01471691|12602879|P1|STARTED|Overall Study||8
5122821|NCT01471379|12602888|P3|NOT COMPLETED|Overall Study||0
5122822|NCT01471379|12602889|P2|NOT COMPLETED|Overall Study||1
5122823|NCT01471379|12602890|P1|NOT COMPLETED|Overall Study||1
5122824|NCT01471379|12602888|P3|COMPLETED|Overall Study||0
5122825|NCT01471379|12602889|P2|COMPLETED|Overall Study||0
5122826|NCT01471379|12602890|P1|COMPLETED|Overall Study||0
5122827|NCT01471379|12602888|P3|STARTED|Overall Study||0
5122828|NCT01471379|12602889|P2|STARTED|Overall Study||1
5122829|NCT01471379|12602890|P1|STARTED|Overall Study||1
5122830|NCT01471353|12602910|P1|NOT COMPLETED|Overall Study||3
5122831|NCT01471353|12602910|P1|COMPLETED|Overall Study||39
5122832|NCT01471353|12602910|P1|STARTED|Overall Study||42
5122833|NCT01471340|12602921|P2|NOT COMPLETED|Overall Study||6
5122834|NCT01471340|12602922|P1|NOT COMPLETED|Overall Study||6
5122835|NCT01471340|12602921|P2|COMPLETED|Overall Study||5855
5122836|NCT01471340|12602922|P1|COMPLETED|Overall Study||5862
5122837|NCT01471340|12602921|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
5122838|NCT01471340|12602922|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
5122839|NCT01471639|12602932|P1|NOT COMPLETED|Overall Study||0
5122840|NCT01471639|12602932|P1|COMPLETED|Overall Study||37
5122841|NCT01471639|12602932|P1|STARTED|Overall Study||37
5122842|NCT01471626|12602937|P1|NOT COMPLETED|Overall Study||0
5122843|NCT01471626|12602937|P1|COMPLETED|Overall Study||21
5122844|NCT01471626|12602937|P1|STARTED|Overall Study||21
5122845|NCT01471574|12602945|P4|NOT COMPLETED|Follow-up Period||3
5122846|NCT01471574|12602946|P3|NOT COMPLETED|Follow-up Period||7
5122847|NCT01471574|12602947|P2|NOT COMPLETED|Follow-up Period||2
5122848|NCT01471574|12602948|P1|NOT COMPLETED|Follow-up Period||7
5122849|NCT01471574|12602945|P4|COMPLETED|Follow-up Period||21
5122850|NCT01471574|12602946|P3|COMPLETED|Follow-up Period||95
5122851|NCT01471574|12602947|P2|COMPLETED|Follow-up Period||32
5122852|NCT01471574|12602948|P1|COMPLETED|Follow-up Period||114
5122853|NCT01471574|12602945|P4|STARTED|Follow-up Period||24
5122854|NCT01471574|12602946|P3|STARTED|Follow-up Period||102
5122855|NCT01471574|12602947|P2|STARTED|Follow-up Period||34
5122856|NCT01471574|12602948|P1|STARTED|Follow-up Period||121
5122857|NCT01471574|12602945|P4|NOT COMPLETED|Treatment Period||3
5122858|NCT01471574|12602946|P3|NOT COMPLETED|Treatment Period||24
5122859|NCT01471574|12602947|P2|NOT COMPLETED|Treatment Period||10
5122860|NCT01471574|12602948|P1|NOT COMPLETED|Treatment Period||31
5122861|NCT01471574|12602945|P4|COMPLETED|Treatment Period||21
5122862|NCT01471574|12602946|P3|COMPLETED|Treatment Period||82
5122863|NCT01471574|12602947|P2|COMPLETED|Treatment Period||29
5122864|NCT01471574|12602948|P1|COMPLETED|Treatment Period||101
5122865|NCT01471574|12602945|P4|STARTED|Treatment Period||24
5122866|NCT01471574|12602946|P3|STARTED|Treatment Period||106
5122867|NCT01471574|12602947|P2|STARTED|Treatment Period||39
5122868|NCT01471574|12602948|P1|STARTED|Treatment Period||132
5122869|NCT01471522|12602979|P2|NOT COMPLETED|Overall Study||48
5122870|NCT01471522|12602980|P1|NOT COMPLETED|Overall Study||64
5122871|NCT01471522|12602979|P2|COMPLETED|Overall Study||2543
5122872|NCT01471522|12602980|P1|COMPLETED|Overall Study||2524
5122873|NCT01471522|12602979|P2|STARTED|Overall Study||2591
5122874|NCT01471522|12602980|P1|STARTED|Overall Study||2588
5122875|NCT01471457|12603006|P2|NOT COMPLETED|Overall Study||18
5122876|NCT01471457|12603007|P1|NOT COMPLETED|Overall Study||19
5122877|NCT01471457|12603006|P2|COMPLETED|Overall Study||74
5122878|NCT01471457|12603007|P1|COMPLETED|Overall Study||73
5122879|NCT01471457|12603006|P2|STARTED|Overall Study||92
5122880|NCT01471457|12603007|P1|STARTED|Overall Study||92
5122881|NCT01471197|12603017|P2|NOT COMPLETED|Overall Study||2
5122882|NCT01471197|12603018|P1|NOT COMPLETED|Overall Study||6
5122883|NCT01471197|12603017|P2|COMPLETED|Overall Study||0
5122884|NCT01471197|12603018|P1|COMPLETED|Overall Study||0
5122885|NCT01471197|12603017|P2|STARTED|Overall Study||2
5122886|NCT01471197|12603018|P1|STARTED|Overall Study||6
5122887|NCT01471171|12603028|P2|NOT COMPLETED|Treatment Period 2||0
5122888|NCT01471171|12603029|P1|NOT COMPLETED|Treatment Period 2||1
5122889|NCT01471171|12603028|P2|COMPLETED|Treatment Period 2||54
5122890|NCT01471171|12603029|P1|COMPLETED|Treatment Period 2||52
5122891|NCT01471171|12603028|P2|STARTED|Treatment Period 2||54
5122892|NCT01471171|12603029|P1|STARTED|Treatment Period 2||53
5122893|NCT01471171|12603028|P2|NOT COMPLETED|Treatment Period 1||1
5122894|NCT01471171|12603029|P1|NOT COMPLETED|Treatment Period 1||4
5122895|NCT01471171|12603028|P2|COMPLETED|Treatment Period 1||54
5122896|NCT01471171|12603029|P1|COMPLETED|Treatment Period 1||53
5122897|NCT01471171|12603028|P2|STARTED|Treatment Period 1||55
5122898|NCT01471171|12603029|P1|STARTED|Treatment Period 1||57
5122899|NCT01471054|12603041|P2|NOT COMPLETED|Overall Study||0
5122900|NCT01471054|12603042|P1|NOT COMPLETED|Overall Study||4
5122901|NCT01471054|12603041|P2|COMPLETED|Overall Study||1
5122902|NCT01471054|12603042|P1|COMPLETED|Overall Study||1
5122903|NCT01471054|12603041|P2|STARTED|Overall Study||1
5122904|NCT01471054|12603042|P1|STARTED|Overall Study||5
5122905|NCT01471041|12603058|P1|NOT COMPLETED|Overall Study||7
5122906|NCT01471041|12603058|P1|COMPLETED|Overall Study||47
5122907|NCT01471041|12603058|P1|STARTED|Overall Study||54
5122908|NCT01471028|12603065|P2|NOT COMPLETED|VTI-208E||12
5122909|NCT01471028|12603066|P1|NOT COMPLETED|VTI-208E||8
5122910|NCT01471028|12603065|P2|COMPLETED|VTI-208E||51
5122911|NCT01471028|12603066|P1|COMPLETED|VTI-208E||48
5122912|NCT01471028|12603065|P2|Database Lock, 31 July 2015|VTI-208E||63
5122913|NCT01471028|12603066|P1|Database Lock, 31 July 2015|VTI-208E||56
5122914|NCT01471028|12603065|P2|STARTED|VTI-208E||63
5122915|NCT01471028|12603066|P1|STARTED|VTI-208E||56
5122916|NCT01471028|12603065|P2|NOT COMPLETED|VTI-208||44
5122917|NCT01471028|12603066|P1|NOT COMPLETED|VTI-208||40
5122918|NCT01471028|12603065|P2|COMPLETED|VTI-208||63
5122919|NCT01471028|12603066|P1|COMPLETED|VTI-208||56
5122920|NCT01471028|12603065|P2|STARTED|VTI-208||107
5122921|NCT01471028|12603066|P1|STARTED|VTI-208||96
5122922|NCT01471015|12603081|P3|NOT COMPLETED|Overall Study||1
5122923|NCT01471015|12603082|P2|NOT COMPLETED|Overall Study||1
5122924|NCT01471015|12603083|P1|NOT COMPLETED|Overall Study||0
5122925|NCT01471015|12603081|P3|COMPLETED|Overall Study||9
5122926|NCT01471015|12603082|P2|COMPLETED|Overall Study||9
5122927|NCT01471015|12603083|P1|COMPLETED|Overall Study||10
5122928|NCT01471015|12603081|P3|STARTED|Overall Study||10
5122929|NCT01471015|12603082|P2|STARTED|Overall Study||10
5122930|NCT01471015|12603083|P1|STARTED|Overall Study||10
5122931|NCT01470859|12603097|P2|NOT COMPLETED|Overall Study||0
5122932|NCT01470859|12603098|P1|NOT COMPLETED|Overall Study||1
5122933|NCT01470859|12603097|P2|COMPLETED|Overall Study||15
5122934|NCT01470859|12603098|P1|COMPLETED|Overall Study||14
5122935|NCT01470859|12603097|P2|STARTED|Overall Study||15
5122936|NCT01470859|12603098|P1|STARTED|Overall Study||15
5122937|NCT01470781|12603114|P2|NOT COMPLETED|Overall Study||12
5122938|NCT01470781|12603115|P1|NOT COMPLETED|Overall Study||18
5122939|NCT01470781|12603114|P2|COMPLETED|Overall Study||21
5122940|NCT01470781|12603115|P1|COMPLETED|Overall Study||21
5122941|NCT01470781|12603114|P2|Post-Treatment Assessment|Overall Study||23
5122942|NCT01470781|12603115|P1|Post-Treatment Assessment|Overall Study||22
5122943|NCT01470781|12603114|P2|Midpoint Assessment|Overall Study||30
5122944|NCT01470781|12603115|P1|Midpoint Assessment|Overall Study||30
5122945|NCT01470781|12603114|P2|STARTED|Overall Study||33
5122946|NCT01470781|12603115|P1|STARTED|Overall Study||39
5122947|NCT01470651|12603133|P2|NOT COMPLETED|Overall Study||3
5122948|NCT01470651|12603134|P1|NOT COMPLETED|Overall Study||7
5122949|NCT01470651|12603133|P2|COMPLETED|Overall Study||10
5122950|NCT01470651|12603134|P1|COMPLETED|Overall Study||6
5122951|NCT01470651|12603133|P2|STARTED|Overall Study||13
5122952|NCT01470651|12603134|P1|STARTED|Overall Study||13
5122953|NCT01470599|12603144|P2|NOT COMPLETED|Overall Study||43
5122954|NCT01470599|12603145|P1|NOT COMPLETED|Overall Study||19
5122955|NCT01470599|12603144|P2|COMPLETED|Overall Study||45
5122956|NCT01470599|12603145|P1|COMPLETED|Overall Study||43
5122957|NCT01470599|12603144|P2|STARTED|Overall Study||88
5122958|NCT01470599|12603145|P1|STARTED|Overall Study||62
5122959|NCT01470469|12603209|P2|NOT COMPLETED|Overall Study||24
5122960|NCT01470469|12603210|P1|NOT COMPLETED|Overall Study||10
5122961|NCT01470469|12603209|P2|COMPLETED|Overall Study||38
5122962|NCT01470469|12603210|P1|COMPLETED|Overall Study||11
5122963|NCT01470469|12603209|P2|STARTED|Overall Study||62
5122964|NCT01470469|12603210|P1|STARTED|Overall Study||21
5122965|NCT01470417|12603230|P2|NOT COMPLETED|Overall Study||2
5122966|NCT01470417|12603231|P1|NOT COMPLETED|Overall Study||0
5122967|NCT01470417|12603230|P2|COMPLETED|Overall Study||5
5122968|NCT01470417|12603231|P1|COMPLETED|Overall Study||3
5122969|NCT01470417|12603230|P2|STARTED|Overall Study||7
5122970|NCT01470417|12603231|P1|STARTED|Overall Study||3
5122971|NCT01470326|12603243|P1|NOT COMPLETED|Overall Study||153
5122972|NCT01470326|12603243|P1|COMPLETED|Overall Study||3034
5122973|NCT01470326|12603243|P1|STARTED|Overall Study||3187
5122974|NCT01470248|12603254|P1|NOT COMPLETED|Overall Study||1
5122975|NCT01470248|12603254|P1|COMPLETED|Overall Study||19
5122976|NCT01470248|12603254|P1|STARTED|Overall Study||20
5122977|NCT01470196|12603261|P1|NOT COMPLETED|Overall Study||0
5122978|NCT01470196|12603261|P1|COMPLETED|Overall Study||31
5122979|NCT01470196|12603261|P1|STARTED|Overall Study||31
5122980|NCT01470170|12603274|P5|NOT COMPLETED|Overall Study||0
5122981|NCT01470170|12603275|P4|NOT COMPLETED|Overall Study||0
5122982|NCT01470170|12603276|P3|NOT COMPLETED|Overall Study||0
5122983|NCT01470170|12603277|P2|NOT COMPLETED|Overall Study||0
5122984|NCT01470170|12603278|P1|NOT COMPLETED|Overall Study||0
5122985|NCT01470170|12603274|P5|COMPLETED|Overall Study||34
5122986|NCT01470170|12603275|P4|COMPLETED|Overall Study||36
5122987|NCT01470170|12603276|P3|COMPLETED|Overall Study||34
5122988|NCT01470170|12603277|P2|COMPLETED|Overall Study||35
5122989|NCT01470170|12603278|P1|COMPLETED|Overall Study||34
5122990|NCT01470170|12603274|P5|STARTED|Overall Study||34
5122991|NCT01470170|12603275|P4|STARTED|Overall Study||36
5122992|NCT01470170|12603276|P3|STARTED|Overall Study||34
5122993|NCT01470170|12603277|P2|STARTED|Overall Study||35
5122994|NCT01470170|12603278|P1|STARTED|Overall Study||34
5122995|NCT01470144|12603310|P1|NOT COMPLETED|Overall Study||10
5122996|NCT01470144|12603310|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
5122997|NCT01470144|12603310|P1|STARTED|Overall Study||41
5122998|NCT01470118|12603318|P3|NOT COMPLETED|Overall Study||2
5122999|NCT01470118|12603319|P2|NOT COMPLETED|Overall Study||5
5123000|NCT01470118|12603320|P1|NOT COMPLETED|Overall Study||5
5123001|NCT01470118|12603318|P3|COMPLETED|Overall Study||39
5123002|NCT01470118|12603319|P2|COMPLETED|Overall Study||38
5123003|NCT01470118|12603320|P1|COMPLETED|Overall Study||38
5123004|NCT01470118|12603318|P3|STARTED|Overall Study||41
5123005|NCT01470118|12603319|P2|STARTED|Overall Study||43
5123006|NCT01470118|12603320|P1|STARTED|Overall Study||43
5123007|NCT01470027|12603355|P3|NOT COMPLETED|Overall Study||1
5123008|NCT01470027|12603356|P2|NOT COMPLETED|Overall Study||1
5123009|NCT01470027|12603357|P1|NOT COMPLETED|Overall Study||1
5123010|NCT01470027|12603355|P3|COMPLETED|Overall Study||15
5123011|NCT01470027|12603356|P2|COMPLETED|Overall Study||14
5123012|NCT01470027|12603357|P1|COMPLETED|Overall Study||15
5123013|NCT01470027|12603355|P3|STARTED|Overall Study||16
5123014|NCT01470027|12603356|P2|STARTED|Overall Study||15
5123015|NCT01470027|12603357|P1|STARTED|Overall Study||16
5123016|NCT01470001|12603415|P2|NOT COMPLETED|Overall Study||2
5123017|NCT01470001|12603416|P1|NOT COMPLETED|Overall Study||5
5123018|NCT01470001|12603415|P2|COMPLETED|Overall Study||58
5123019|NCT01470001|12603416|P1|COMPLETED|Overall Study||53
5123020|NCT01470001|12603415|P2|STARTED|Overall Study||60
5123021|NCT01470001|12603416|P1|STARTED|Overall Study||58
5123022|NCT01469819|12603426|P1|NOT COMPLETED|Overall Study||8
5123023|NCT01469819|12603426|P1|COMPLETED|Overall Study||29
5123024|NCT01469819|12603426|P1|STARTED|Overall Study||37
5123025|NCT01469767|12603436|P1|NOT COMPLETED|Overall Study||0
5123026|NCT01469767|12603436|P1|COMPLETED|Overall Study||10
5123027|NCT01469767|12603436|P1|STARTED|Overall Study||10
5123028|NCT01469715|12603444|P1|NOT COMPLETED|Overall Study||0
5123029|NCT01469715|12603444|P1|COMPLETED|Overall Study||16
5123030|NCT01469715|12603444|P1|STARTED|Overall Study||16
5123031|NCT01469637|12603450|P2|NOT COMPLETED|Second Intervention||0
5123032|NCT01469637|12603451|P1|NOT COMPLETED|Second Intervention||1
5123033|NCT01469637|12603450|P2|COMPLETED|Second Intervention||21
5123034|NCT01469637|12603451|P1|COMPLETED|Second Intervention||21
5123035|NCT01469637|12603450|P2|STARTED|Second Intervention||21
5123036|NCT01469637|12603451|P1|STARTED|Second Intervention||22
5123037|NCT01469637|12603450|P2|NOT COMPLETED|First Intervention||1
5123038|NCT01469637|12603451|P1|NOT COMPLETED|First Intervention||0
5123039|NCT01469637|12603450|P2|COMPLETED|First Intervention||21
5123040|NCT01469637|12603451|P1|COMPLETED|First Intervention||22
5123041|NCT01469637|12603450|P2|STARTED|First Intervention||22
5123042|NCT01469637|12603451|P1|STARTED|First Intervention||22
5123043|NCT01469546|12603459|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
5123044|NCT01469546|12603459|P1|COMPLETED|Dose Escalation to 10 mg||19
5123045|NCT01469546|12603459|P1|STARTED|Dose Escalation to 10 mg||19
5123046|NCT01469546|12603459|P1|NOT COMPLETED|Received 5 mg Dose||23
5123047|NCT01469546|12603459|P1|COMPLETED|Received 5 mg Dose||19
5123048|NCT01469546|12603459|P1|Completed First Cycle|Received 5 mg Dose||30
5123049|NCT01469546|12603459|P1|STARTED|Received 5 mg Dose||42
5123050|NCT01469377|12603469|P3|NOT COMPLETED|Overall Study||66
5123051|NCT01469377|12603470|P2|NOT COMPLETED|Overall Study||48
5123052|NCT01469377|12603471|P1|NOT COMPLETED|Overall Study||35
5123053|NCT01469377|12603469|P3|COMPLETED|Overall Study||210
5123054|NCT01469377|12603470|P2|COMPLETED|Overall Study||226
5123055|NCT01469377|12603471|P1|COMPLETED|Overall Study||234
5123056|NCT01469377|12603469|P3|STARTED|Overall Study||276
5123057|NCT01469377|12603470|P2|STARTED|Overall Study||274
5123058|NCT01469377|12603471|P1|STARTED|Overall Study||269
5123059|NCT01469364|12603482|P1|NOT COMPLETED|Overall Study||2
5123060|NCT01469364|12603482|P1|COMPLETED|Overall Study||28
5123061|NCT01469364|12603482|P1|STARTED|Overall Study||30
5123062|NCT01469234|12603500|P3|NOT COMPLETED|Overall Study||0
5123063|NCT01469234|12603501|P2|NOT COMPLETED|Overall Study||0
5123064|NCT01469234|12603502|P1|NOT COMPLETED|Overall Study||0
5123065|NCT01469234|12603500|P3|COMPLETED|Overall Study||85
5123066|NCT01469234|12603501|P2|COMPLETED|Overall Study||85
5123067|NCT01469234|12603502|P1|COMPLETED|Overall Study||85
5123068|NCT01469234|12603500|P3|STARTED|Overall Study||85
5123069|NCT01469234|12603501|P2|STARTED|Overall Study||85
5123070|NCT01469234|12603502|P1|STARTED|Overall Study||85
5123071|NCT01469221|12603533|P3|NOT COMPLETED|Double Blind Phase||0
5123072|NCT01469221|12603534|P2|NOT COMPLETED|Double Blind Phase||17
5123073|NCT01469221|12603535|P1|NOT COMPLETED|Double Blind Phase||14
5123074|NCT01469221|12603533|P3|COMPLETED|Double Blind Phase||0
5123075|NCT01469221|12603534|P2|COMPLETED|Double Blind Phase||0
5123076|NCT01469221|12603535|P1|COMPLETED|Double Blind Phase||0
5123077|NCT01469221|12603533|P3|STARTED|Double Blind Phase||0
5123078|NCT01469221|12603534|P2|STARTED|Double Blind Phase||17
5123079|NCT01469221|12603535|P1|STARTED|Double Blind Phase||14
5123080|NCT01469221|12603533|P3|NOT COMPLETED|Open Label Phase||3
5123081|NCT01469221|12603534|P2|NOT COMPLETED|Open Label Phase||0
5123082|NCT01469221|12603535|P1|NOT COMPLETED|Open Label Phase||0
5123083|NCT01469221|12603533|P3|COMPLETED|Open Label Phase||44
5123084|NCT01469221|12603534|P2|COMPLETED|Open Label Phase||0
5123085|NCT01469221|12603535|P1|COMPLETED|Open Label Phase||0
5123086|NCT01469221|12603533|P3|STARTED|Open Label Phase||47
5123087|NCT01469221|12603534|P2|STARTED|Open Label Phase||0
5123088|NCT01469221|12603535|P1|STARTED|Open Label Phase||0
5123089|NCT01469182|12603546|P2|NOT COMPLETED|Overall Study||6
5123090|NCT01469182|12603547|P1|NOT COMPLETED|Overall Study||35
5123091|NCT01469182|12603546|P2|COMPLETED|Overall Study||298
5123092|NCT01469182|12603547|P1|COMPLETED|Overall Study||575
5123093|NCT01469182|12603546|P2|Treated|Overall Study||304
5123094|NCT01469182|12603547|P1|Treated|Overall Study||609
5123095|NCT01469182|12603546|P2|STARTED|Overall Study||304
5123096|NCT01469182|12603547|P1|STARTED|Overall Study||610
5123097|NCT01469065|12603574|P5|NOT COMPLETED|Overall Study||1
5123098|NCT01469065|12603575|P4|NOT COMPLETED|Overall Study||0
5123099|NCT01469065|12603576|P3|NOT COMPLETED|Overall Study||0
5123100|NCT01469065|12603577|P2|NOT COMPLETED|Overall Study||1
5123101|NCT01469065|12603578|P1|NOT COMPLETED|Overall Study||0
5123102|NCT01469065|12603574|P5|COMPLETED|Overall Study||16
5123103|NCT01469065|12603575|P4|COMPLETED|Overall Study||16
5123104|NCT01469065|12603576|P3|COMPLETED|Overall Study||16
5123105|NCT01469065|12603577|P2|COMPLETED|Overall Study||16
5123106|NCT01469065|12603578|P1|COMPLETED|Overall Study||16
5123107|NCT01469065|12603574|P5|STARTED|Overall Study||17
5123108|NCT01469065|12603575|P4|STARTED|Overall Study||16
5123109|NCT01469065|12603576|P3|STARTED|Overall Study||16
5123110|NCT01469065|12603577|P2|STARTED|Overall Study||17
5123111|NCT01469065|12603578|P1|STARTED|Overall Study||16
5123112|NCT01469052|12603674|P6|NOT COMPLETED|Overall Study||6
5123113|NCT01469052|12603675|P5|NOT COMPLETED|Overall Study||8
5123114|NCT01469052|12603676|P4|NOT COMPLETED|Overall Study||5
5123115|NCT01469052|12603677|P3|NOT COMPLETED|Overall Study||6
5123116|NCT01469052|12603678|P2|NOT COMPLETED|Overall Study||4
5123117|NCT01469052|12603679|P1|NOT COMPLETED|Overall Study||6
5123118|NCT01469052|12603674|P6|COMPLETED|Overall Study||0
5123119|NCT01469052|12603675|P5|COMPLETED|Overall Study||0
5123120|NCT01469052|12603676|P4|COMPLETED|Overall Study||1
5123121|NCT01469052|12603677|P3|COMPLETED|Overall Study||0
5123122|NCT01469052|12603678|P2|COMPLETED|Overall Study||0
5123123|NCT01469052|12603679|P1|COMPLETED|Overall Study||0
5123124|NCT01469052|12603674|P6|STARTED|Overall Study||6
5123125|NCT01469052|12603675|P5|STARTED|Overall Study||8
5123126|NCT01469052|12603676|P4|STARTED|Overall Study||6
5123127|NCT01469052|12603677|P3|STARTED|Overall Study||6
5123128|NCT01469052|12603678|P2|STARTED|Overall Study||4
5123129|NCT01469052|12603679|P1|STARTED|Overall Study||6
5123130|NCT01469039|12603726|P3|NOT COMPLETED|Overall Study||113
5123131|NCT01469039|12603727|P2|NOT COMPLETED|Overall Study||73
5123132|NCT01469039|12603728|P1|NOT COMPLETED|Overall Study||77
5123133|NCT01469039|12603726|P3|COMPLETED|Overall Study||95
5123134|NCT01469039|12603727|P2|COMPLETED|Overall Study||135
5123135|NCT01469039|12603728|P1|COMPLETED|Overall Study||130
5123136|NCT01469039|12603726|P3|STARTED|Overall Study||208
5123137|NCT01469039|12603727|P2|STARTED|Overall Study||208
5123138|NCT01469039|12603728|P1|STARTED|Overall Study||207
5123139|NCT01469013|12603744|P13|NOT COMPLETED|Part B (Extension Period)||6
5123140|NCT01469013|12603745|P12|NOT COMPLETED|Part B (Extension Period)||6
5123141|NCT01469013|12603746|P11|NOT COMPLETED|Part B (Extension Period)||2
5123142|NCT01469013|12603747|P10|NOT COMPLETED|Part B (Extension Period)||3
5123143|NCT01469013|12603748|P9|NOT COMPLETED|Part B (Extension Period)||4
5123144|NCT01469013|12603749|P8|NOT COMPLETED|Part B (Extension Period)||5
5123145|NCT01469013|12603750|P7|NOT COMPLETED|Part B (Extension Period)||5
5123146|NCT01469013|12603751|P6|NOT COMPLETED|Part B (Extension Period)||2
5123147|NCT01469013|12603752|P5|NOT COMPLETED|Part B (Extension Period)||0
5123148|NCT01469013|12603753|P4|NOT COMPLETED|Part B (Extension Period)||0
5123149|NCT01469013|12603754|P3|NOT COMPLETED|Part B (Extension Period)||0
5123150|NCT01469013|12603755|P2|NOT COMPLETED|Part B (Extension Period)||0
5123151|NCT01469013|12603756|P1|NOT COMPLETED|Part B (Extension Period)||0
5123152|NCT01469013|12603744|P13|COMPLETED|Part B (Extension Period)||18
5123153|NCT01469013|12603745|P12|COMPLETED|Part B (Extension Period)||18
5123154|NCT01469013|12603746|P11|COMPLETED|Part B (Extension Period)||10
5123155|NCT01469013|12603747|P10|COMPLETED|Part B (Extension Period)||8
5123156|NCT01469013|12603748|P9|COMPLETED|Part B (Extension Period)||20
5123157|NCT01469013|12603749|P8|COMPLETED|Part B (Extension Period)||18
5123158|NCT01469013|12603750|P7|COMPLETED|Part B (Extension Period)||7
5123159|NCT01469013|12603751|P6|COMPLETED|Part B (Extension Period)||10
5123160|NCT01469013|12603752|P5|COMPLETED|Part B (Extension Period)||0
5123161|NCT01469013|12603753|P4|COMPLETED|Part B (Extension Period)||0
5123162|NCT01469013|12603754|P3|COMPLETED|Part B (Extension Period)||0
5123163|NCT01469013|12603755|P2|COMPLETED|Part B (Extension Period)||0
5123164|NCT01469013|12603756|P1|COMPLETED|Part B (Extension Period)||0
5123165|NCT01469013|12603744|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
5123166|NCT01469013|12603745|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
5123167|NCT01469013|12603746|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
5123168|NCT01469013|12603747|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
5123169|NCT01469013|12603748|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
5123170|NCT01469013|12603749|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
5123171|NCT01469013|12603750|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
5123172|NCT01469013|12603751|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
5123173|NCT01469013|12603752|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
5123174|NCT01469013|12603753|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
5123175|NCT01469013|12603754|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
5123176|NCT01469013|12603755|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
5123177|NCT01469013|12603756|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
5123178|NCT01469013|12603744|P13|STARTED|Part B (Extension Period)||24
5123179|NCT01469013|12603745|P12|STARTED|Part B (Extension Period)||24
5123180|NCT01469013|12603746|P11|STARTED|Part B (Extension Period)||12
5123181|NCT01469013|12603747|P10|STARTED|Part B (Extension Period)||11
5123182|NCT01469013|12603748|P9|STARTED|Part B (Extension Period)||24
5123183|NCT01469013|12603749|P8|STARTED|Part B (Extension Period)||23
5123184|NCT01469013|12603750|P7|STARTED|Part B (Extension Period)||12
5123185|NCT01469013|12603751|P6|STARTED|Part B (Extension Period)||12
5123186|NCT01469013|12603752|P5|STARTED|Part B (Extension Period)||0
5123187|NCT01469013|12603753|P4|STARTED|Part B (Extension Period)||0
5123188|NCT01469013|12603754|P3|STARTED|Part B (Extension Period)||0
5123189|NCT01469013|12603755|P2|STARTED|Part B (Extension Period)||0
5123190|NCT01469013|12603756|P1|STARTED|Part B (Extension Period)||0
5123191|NCT01469013|12603744|P13|NOT COMPLETED|Part A (Treatment Period)||0
5123192|NCT01469013|12603745|P12|NOT COMPLETED|Part A (Treatment Period)||0
5123193|NCT01469013|12603746|P11|NOT COMPLETED|Part A (Treatment Period)||0
5123194|NCT01469013|12603747|P10|NOT COMPLETED|Part A (Treatment Period)||0
5123195|NCT01469013|12603748|P9|NOT COMPLETED|Part A (Treatment Period)||0
5123196|NCT01469013|12603749|P8|NOT COMPLETED|Part A (Treatment Period)||0
5123197|NCT01469013|12603750|P7|NOT COMPLETED|Part A (Treatment Period)||0
5123198|NCT01469013|12603751|P6|NOT COMPLETED|Part A (Treatment Period)||0
5123199|NCT01469013|12603752|P5|NOT COMPLETED|Part A (Treatment Period)||1
5123200|NCT01469013|12603753|P4|NOT COMPLETED|Part A (Treatment Period)||0
5123201|NCT01469013|12603754|P3|NOT COMPLETED|Part A (Treatment Period)||1
5123202|NCT01469013|12603755|P2|NOT COMPLETED|Part A (Treatment Period)||0
5123203|NCT01469013|12603756|P1|NOT COMPLETED|Part A (Treatment Period)||1
5123204|NCT01469013|12603744|P13|COMPLETED|Part A (Treatment Period)||0
5123205|NCT01469013|12603745|P12|COMPLETED|Part A (Treatment Period)||0
5123206|NCT01469013|12603746|P11|COMPLETED|Part A (Treatment Period)||0
5123207|NCT01469013|12603747|P10|COMPLETED|Part A (Treatment Period)||0
5123208|NCT01469013|12603748|P9|COMPLETED|Part A (Treatment Period)||0
5123209|NCT01469013|12603749|P8|COMPLETED|Part A (Treatment Period)||0
5123210|NCT01469013|12603750|P7|COMPLETED|Part A (Treatment Period)||0
5123211|NCT01469013|12603751|P6|COMPLETED|Part A (Treatment Period)||0
5123212|NCT01469013|12603752|P5|COMPLETED|Part A (Treatment Period)||48
5123213|NCT01469013|12603753|P4|COMPLETED|Part A (Treatment Period)||24
5123214|NCT01469013|12603754|P3|COMPLETED|Part A (Treatment Period)||23
5123215|NCT01469013|12603755|P2|COMPLETED|Part A (Treatment Period)||24
5123216|NCT01469013|12603756|P1|COMPLETED|Part A (Treatment Period)||23
5123217|NCT01469013|12603744|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123218|NCT01469013|12603745|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123219|NCT01469013|12603746|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123220|NCT01469013|12603747|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123221|NCT01469013|12603748|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123222|NCT01469013|12603749|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123223|NCT01469013|12603750|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123224|NCT01469013|12603751|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
5123225|NCT01469013|12603752|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
5123226|NCT01469013|12603753|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
5123227|NCT01469013|12603754|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
5123228|NCT01469013|12603755|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
5123229|NCT01469013|12603756|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
5123230|NCT01469013|12603744|P13|STARTED|Part A (Treatment Period)||0
5123231|NCT01469013|12603745|P12|STARTED|Part A (Treatment Period)||0
5123232|NCT01469013|12603746|P11|STARTED|Part A (Treatment Period)||0
5123233|NCT01469013|12603747|P10|STARTED|Part A (Treatment Period)||0
5123234|NCT01469013|12603748|P9|STARTED|Part A (Treatment Period)||0
5123235|NCT01469013|12603749|P8|STARTED|Part A (Treatment Period)||0
5123236|NCT01469013|12603750|P7|STARTED|Part A (Treatment Period)||0
5123237|NCT01469013|12603751|P6|STARTED|Part A (Treatment Period)||0
5123238|NCT01469013|12603752|P5|STARTED|Part A (Treatment Period)||49
5123239|NCT01469013|12603753|P4|STARTED|Part A (Treatment Period)||24
5123240|NCT01469013|12603754|P3|STARTED|Part A (Treatment Period)||24
5123241|NCT01469013|12603755|P2|STARTED|Part A (Treatment Period)||24
5123242|NCT01469013|12603756|P1|STARTED|Part A (Treatment Period)||24
5123243|NCT01469000|12603841|P2|NOT COMPLETED|Overall Study||4
5123244|NCT01469000|12603842|P1|NOT COMPLETED|Overall Study||20
5123245|NCT01469000|12603841|P2|COMPLETED|Overall Study||62
5123246|NCT01469000|12603842|P1|COMPLETED|Overall Study||109
5123247|NCT01469000|12603841|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
5123248|NCT01469000|12603842|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
5123249|NCT01469000|12603841|P2|STARTED|Overall Study||66
5123250|NCT01469000|12603842|P1|STARTED|Overall Study||129
5123251|NCT01468987|12603862|P2|NOT COMPLETED|Overall Study||60
5123252|NCT01468987|12603863|P1|NOT COMPLETED|Overall Study||71
5123253|NCT01468987|12603862|P2|COMPLETED|Overall Study||618
5123254|NCT01468987|12603863|P1|COMPLETED|Overall Study||620
5123255|NCT01468987|12603862|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
5123256|NCT01468987|12603863|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
5123257|NCT01468987|12603862|P2|STARTED|Overall Study||678
5123258|NCT01468987|12603863|P1|STARTED|Overall Study||691
5123259|NCT01468974|12603907|P1|NOT COMPLETED|3 Years Follow-up||6
5123260|NCT01468974|12603907|P1|COMPLETED|3 Years Follow-up||26
5123261|NCT01468974|12603907|P1|STARTED|3 Years Follow-up||32
5123262|NCT01468974|12603907|P1|NOT COMPLETED|2 Years Follow-up||2
5123263|NCT01468974|12603907|P1|COMPLETED|2 Years Follow-up||32
5123264|NCT01468974|12603907|P1|STARTED|2 Years Follow-up||34
5123265|NCT01468974|12603907|P1|NOT COMPLETED|1 Year Follow-up||0
5123266|NCT01468974|12603907|P1|COMPLETED|1 Year Follow-up||34
5123267|NCT01468974|12603907|P1|STARTED|1 Year Follow-up||34
5123268|NCT01468974|12603907|P1|NOT COMPLETED|6 Months Follow-up||0
5123269|NCT01468974|12603907|P1|COMPLETED|6 Months Follow-up||34
5123270|NCT01468974|12603907|P1|STARTED|6 Months Follow-up||34
5123271|NCT01468974|12603907|P1|NOT COMPLETED|1 Month Follow-up||1
5123272|NCT01468974|12603907|P1|COMPLETED|1 Month Follow-up||34
5123273|NCT01468974|12603907|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
5123274|NCT01468909|12604040|P2|NOT COMPLETED|Overall Study||2
5123275|NCT01468909|12604041|P1|NOT COMPLETED|Overall Study||2
5123276|NCT01468909|12604040|P2|COMPLETED|Overall Study||52
5123277|NCT01468909|12604041|P1|COMPLETED|Overall Study||50
5123278|NCT01468909|12604040|P2|STARTED|Overall Study||54
5123279|NCT01468909|12604041|P1|STARTED|Overall Study||52
5123280|NCT01468896|12604057|P2|NOT COMPLETED|Overall Study||0
5123281|NCT01468896|12604058|P1|NOT COMPLETED|Overall Study||0
5123282|NCT01468896|12604057|P2|COMPLETED|Overall Study||17
5123283|NCT01468896|12604058|P1|COMPLETED|Overall Study||6
5123284|NCT01468896|12604057|P2|STARTED|Overall Study||17
5123285|NCT01468896|12604058|P1|STARTED|Overall Study||6
5123286|NCT01468818|12604074|P1|NOT COMPLETED|Overall Study||2
5123287|NCT01468818|12604074|P1|COMPLETED|Overall Study||16
5123288|NCT01468818|12604074|P1|STARTED|Overall Study||18
5123289|NCT01468675|12604081|P2|NOT COMPLETED|Overall Study||1372
5123290|NCT01468675|12604082|P1|NOT COMPLETED|Overall Study||1000
5123291|NCT01468675|12604081|P2|COMPLETED|Overall Study||2004
5123292|NCT01468675|12604082|P1|COMPLETED|Overall Study||1699
5123293|NCT01468675|12604081|P2|STARTED|Overall Study||3376
5123294|NCT01468675|12604082|P1|STARTED|Overall Study||2699
5123295|NCT01468597|12604088|P1|NOT COMPLETED|Overall Study||35
5123296|NCT01468597|12604088|P1|COMPLETED|Overall Study||149
5123297|NCT01468597|12604088|P1|STARTED|Overall Study||184
5123298|NCT01468584|12604093|P1|NOT COMPLETED|Overall Study||0
5123299|NCT01468584|12604093|P1|COMPLETED|Overall Study||10
5123300|NCT01468584|12604093|P1|STARTED|Overall Study||10
5123301|NCT01468558|12604097|P1|NOT COMPLETED|Overall Study||2
5123302|NCT01468558|12604097|P1|COMPLETED|Overall Study||22
5123303|NCT01468558|12604097|P1|STARTED|Overall Study||24
5123304|NCT01468350|12604112|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
5123305|NCT01468350|12604113|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
5123306|NCT01468350|12604114|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
5123307|NCT01468350|12604115|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
5123308|NCT01468350|12604112|P4|COMPLETED|(PART B) Day 1, Day 15||12
5123309|NCT01468350|12604113|P3|COMPLETED|(PART B) Day 1, Day 15||12
5123310|NCT01468350|12604114|P2|COMPLETED|(PART B) Day 1, Day 15||0
5123311|NCT01468350|12604115|P1|COMPLETED|(PART B) Day 1, Day 15||0
5123312|NCT01468350|12604112|P4|STARTED|(PART B) Day 1, Day 15||12
5123313|NCT01468350|12604113|P3|STARTED|(PART B) Day 1, Day 15||12
5123314|NCT01468350|12604114|P2|STARTED|(PART B) Day 1, Day 15||0
5123315|NCT01468350|12604115|P1|STARTED|(PART B) Day 1, Day 15||0
5123316|NCT01468350|12604112|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
5123317|NCT01468350|12604113|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
5123318|NCT01468350|12604114|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
5123319|NCT01468350|12604115|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
5123320|NCT01468350|12604112|P4|COMPLETED|(PART A) Day 1, Day 3||0
5123321|NCT01468350|12604113|P3|COMPLETED|(PART A) Day 1, Day 3||0
5123322|NCT01468350|12604114|P2|COMPLETED|(PART A) Day 1, Day 3||5
5123323|NCT01468350|12604115|P1|COMPLETED|(PART A) Day 1, Day 3||6
5123324|NCT01468350|12604112|P4|STARTED|(PART A) Day 1, Day 3||0
5123325|NCT01468350|12604113|P3|STARTED|(PART A) Day 1, Day 3||0
5123326|NCT01468350|12604114|P2|STARTED|(PART A) Day 1, Day 3||5
5123327|NCT01468350|12604115|P1|STARTED|(PART A) Day 1, Day 3||6
5123328|NCT01468337|12604125|P1|NOT COMPLETED|Overall Study||0
5123329|NCT01468337|12604125|P1|COMPLETED|Overall Study||5
5123330|NCT01468337|12604125|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
5123331|NCT01468337|12604125|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
5123332|NCT01468337|12604125|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
5123333|NCT01468337|12604125|P1|Week 2|Overall Study||5
5123334|NCT01468337|12604125|P1|STARTED|Overall Study||5
5123335|NCT01468311|12604137|P1|NOT COMPLETED|Overall Study||2
5123336|NCT01468311|12604137|P1|COMPLETED|Overall Study||4
5123337|NCT01468311|12604137|P1|STARTED|Overall Study||6
5123338|NCT01468233|12604149|P6|NOT COMPLETED|Treatment Period 2||23
5123339|NCT01468233|12604150|P5|NOT COMPLETED|Treatment Period 2||28
5123340|NCT01468233|12604151|P4|NOT COMPLETED|Treatment Period 2||28
5123341|NCT01468233|12604152|P3|NOT COMPLETED|Treatment Period 2||111
5123342|NCT01468233|12604153|P2|NOT COMPLETED|Treatment Period 2||0
5123343|NCT01468233|12604154|P1|NOT COMPLETED|Treatment Period 2||0
5123344|NCT01468233|12604149|P6|COMPLETED|Treatment Period 2||28
5123345|NCT01468233|12604150|P5|COMPLETED|Treatment Period 2||25
5123346|NCT01468233|12604151|P4|COMPLETED|Treatment Period 2||23
5123347|NCT01468233|12604152|P3|COMPLETED|Treatment Period 2||40
5123348|NCT01468233|12604153|P2|COMPLETED|Treatment Period 2||0
5123349|NCT01468233|12604154|P1|COMPLETED|Treatment Period 2||0
5123350|NCT01468233|12604149|P6|STARTED|Treatment Period 2||51
5123351|NCT01468233|12604150|P5|STARTED|Treatment Period 2||53
5123352|NCT01468233|12604151|P4|STARTED|Treatment Period 2||51
5123353|NCT01468233|12604152|P3|STARTED|Treatment Period 2||151
5123354|NCT01468233|12604153|P2|STARTED|Treatment Period 2||0
5123355|NCT01468233|12604154|P1|STARTED|Treatment Period 2||0
5123356|NCT01468233|12604149|P6|NOT COMPLETED|Treatment Period 1||0
5123357|NCT01468233|12604150|P5|NOT COMPLETED|Treatment Period 1||0
5123358|NCT01468233|12604151|P4|NOT COMPLETED|Treatment Period 1||0
5123359|NCT01468233|12604152|P3|NOT COMPLETED|Treatment Period 1||0
5123360|NCT01468233|12604153|P2|NOT COMPLETED|Treatment Period 1||8
5123361|NCT01468233|12604154|P1|NOT COMPLETED|Treatment Period 1||12
5123362|NCT01468233|12604149|P6|COMPLETED|Treatment Period 1||0
5123363|NCT01468233|12604150|P5|COMPLETED|Treatment Period 1||0
5123364|NCT01468233|12604151|P4|COMPLETED|Treatment Period 1||0
5123365|NCT01468233|12604152|P3|COMPLETED|Treatment Period 1||0
5123366|NCT01468233|12604153|P2|COMPLETED|Treatment Period 1||155
5123367|NCT01468233|12604154|P1|COMPLETED|Treatment Period 1||151
5123368|NCT01468233|12604149|P6|STARTED|Treatment Period 1||0
5123369|NCT01468233|12604150|P5|STARTED|Treatment Period 1||0
5123370|NCT01468233|12604151|P4|STARTED|Treatment Period 1||0
5123371|NCT01468233|12604152|P3|STARTED|Treatment Period 1||0
5123372|NCT01468233|12604153|P2|STARTED|Treatment Period 1||163
5123373|NCT01468233|12604154|P1|STARTED|Treatment Period 1||163
5123374|NCT01468207|12604176|P6|NOT COMPLETED|Treatment Period 2||20
5123375|NCT01468207|12604177|P5|NOT COMPLETED|Treatment Period 2||21
5123376|NCT01468207|12604178|P4|NOT COMPLETED|Treatment Period 2||27
5123377|NCT01468207|12604179|P3|NOT COMPLETED|Treatment Period 2||52
5123378|NCT01468207|12604180|P2|NOT COMPLETED|Treatment Period 2||0
5123379|NCT01468207|12604181|P1|NOT COMPLETED|Treatment Period 2||0
5123380|NCT01468207|12604176|P6|COMPLETED|Treatment Period 2||28
5123381|NCT01468207|12604177|P5|COMPLETED|Treatment Period 2||27
5123382|NCT01468207|12604178|P4|COMPLETED|Treatment Period 2||22
5123383|NCT01468207|12604179|P3|COMPLETED|Treatment Period 2||93
5123384|NCT01468207|12604180|P2|COMPLETED|Treatment Period 2||0
5123385|NCT01468207|12604181|P1|COMPLETED|Treatment Period 2||0
5123386|NCT01468207|12604176|P6|STARTED|Treatment Period 2||48
5123387|NCT01468207|12604177|P5|STARTED|Treatment Period 2||48
5123388|NCT01468207|12604178|P4|STARTED|Treatment Period 2||49
5123389|NCT01468207|12604179|P3|STARTED|Treatment Period 2||145
5123390|NCT01468207|12604180|P2|STARTED|Treatment Period 2||0
5123391|NCT01468207|12604181|P1|STARTED|Treatment Period 2||0
5123392|NCT01468207|12604176|P6|NOT COMPLETED|Treatment Period 1||0
5123393|NCT01468207|12604177|P5|NOT COMPLETED|Treatment Period 1||0
5123394|NCT01468207|12604178|P4|NOT COMPLETED|Treatment Period 1||0
5123395|NCT01468207|12604179|P3|NOT COMPLETED|Treatment Period 1||0
5123396|NCT01468207|12604180|P2|NOT COMPLETED|Treatment Period 1||8
5123397|NCT01468207|12604181|P1|NOT COMPLETED|Treatment Period 1||9
5123398|NCT01468207|12604176|P6|COMPLETED|Treatment Period 1||0
5123399|NCT01468207|12604177|P5|COMPLETED|Treatment Period 1||0
5123400|NCT01468207|12604178|P4|COMPLETED|Treatment Period 1||0
5123401|NCT01468207|12604179|P3|COMPLETED|Treatment Period 1||0
5123402|NCT01468207|12604180|P2|COMPLETED|Treatment Period 1||145
5123403|NCT01468207|12604181|P1|COMPLETED|Treatment Period 1||145
5123404|NCT01468207|12604176|P6|Received Study Drug|Treatment Period 1||0
5123405|NCT01468207|12604177|P5|Received Study Drug|Treatment Period 1||0
5123406|NCT01468207|12604178|P4|Received Study Drug|Treatment Period 1||0
5123407|NCT01468207|12604179|P3|Received Study Drug|Treatment Period 1||0
5123408|NCT01468207|12604180|P2|Received Study Drug|Treatment Period 1||153
5123409|NCT01468207|12604181|P1|Received Study Drug|Treatment Period 1||152
5123410|NCT01468207|12604176|P6|STARTED|Treatment Period 1||0
5123411|NCT01468207|12604177|P5|STARTED|Treatment Period 1||0
5123412|NCT01468207|12604178|P4|STARTED|Treatment Period 1||0
5123413|NCT01468207|12604179|P3|STARTED|Treatment Period 1||0
5123414|NCT01468207|12604180|P2|STARTED|Treatment Period 1||153
5123415|NCT01468207|12604181|P1|STARTED|Treatment Period 1||154
5123416|NCT01468181|12604206|P5|NOT COMPLETED|Overall Study||5
5123417|NCT01468181|12604207|P4|NOT COMPLETED|Overall Study||3
5123418|NCT01468181|12604208|P3|NOT COMPLETED|Overall Study||8
5123419|NCT01468181|12604209|P2|NOT COMPLETED|Overall Study||2
5123420|NCT01468181|12604210|P1|NOT COMPLETED|Overall Study||10
5123421|NCT01468181|12604206|P5|COMPLETED|Overall Study||66
5123422|NCT01468181|12604207|P4|COMPLETED|Overall Study||63
5123423|NCT01468181|12604208|P3|COMPLETED|Overall Study||57
5123424|NCT01468181|12604209|P2|COMPLETED|Overall Study||59
5123425|NCT01468181|12604210|P1|COMPLETED|Overall Study||121
5123426|NCT01468181|12604206|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
5123427|NCT01468181|12604207|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
5123428|NCT01468181|12604208|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
5123429|NCT01468181|12604209|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
5123430|NCT01468181|12604210|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
5123431|NCT01468181|12604206|P5|STARTED|Overall Study||71
5123432|NCT01468181|12604207|P4|STARTED|Overall Study||66
5123433|NCT01468181|12604208|P3|STARTED|Overall Study||65
5123434|NCT01468181|12604209|P2|STARTED|Overall Study||61
5123435|NCT01468181|12604210|P1|STARTED|Overall Study||131
5123436|NCT01468077|12604259|P2|NOT COMPLETED|Overall Study||3
5123437|NCT01468077|12604260|P1|NOT COMPLETED|Overall Study||4
5123438|NCT01468077|12604259|P2|COMPLETED|Overall Study||22
5123439|NCT01468077|12604260|P1|COMPLETED|Overall Study||18
5123440|NCT01468077|12604259|P2|STARTED|Overall Study||25
5123441|NCT01468077|12604260|P1|STARTED|Overall Study||22
5123442|NCT01468012|12604299|P3|NOT COMPLETED|Overall Study||4
5123443|NCT01468012|12604300|P2|NOT COMPLETED|Overall Study||1
5123444|NCT01468012|12604301|P1|NOT COMPLETED|Overall Study||2
5123445|NCT01468012|12604299|P3|COMPLETED|Overall Study||0
5123446|NCT01468012|12604300|P2|COMPLETED|Overall Study||9
5123447|NCT01468012|12604301|P1|COMPLETED|Overall Study||7
5123448|NCT01468012|12604299|P3|STARTED|Overall Study||4
5123449|NCT01468012|12604300|P2|STARTED|Overall Study||10
5123450|NCT01468012|12604301|P1|STARTED|Overall Study||9
5123451|NCT01467999|12604312|P1|NOT COMPLETED|Overall Study||13
5123452|NCT01467999|12604312|P1|COMPLETED|Overall Study||9
5123453|NCT01467999|12604312|P1|STARTED|Overall Study||22
5123454|NCT01467960|12604322|P6|NOT COMPLETED|Overall Study||30
5123455|NCT01467960|12604323|P5|NOT COMPLETED|Overall Study||30
5123456|NCT01467960|12604324|P4|NOT COMPLETED|Overall Study||30
5123457|NCT01467960|12604325|P3|NOT COMPLETED|Overall Study||0
5123458|NCT01467960|12604326|P2|NOT COMPLETED|Overall Study||0
5123459|NCT01467960|12604327|P1|NOT COMPLETED|Overall Study||0
5123460|NCT01467960|12604322|P6|COMPLETED|Overall Study||0
5123461|NCT01467960|12604323|P5|COMPLETED|Overall Study||0
5123462|NCT01467960|12604324|P4|COMPLETED|Overall Study||0
5123463|NCT01467960|12604325|P3|COMPLETED|Overall Study||30
5123464|NCT01467960|12604326|P2|COMPLETED|Overall Study||30
5123465|NCT01467960|12604327|P1|COMPLETED|Overall Study||30
5123466|NCT01467960|12604322|P6|STARTED|Overall Study||30
5123467|NCT01467960|12604323|P5|STARTED|Overall Study||30
5123468|NCT01467960|12604324|P4|STARTED|Overall Study||30
5123469|NCT01467960|12604325|P3|STARTED|Overall Study||30
5123470|NCT01467960|12604326|P2|STARTED|Overall Study||30
5123471|NCT01467960|12604327|P1|STARTED|Overall Study||30
5123472|NCT01467947|12604341|P1|NOT COMPLETED|Overall Study||0
5123473|NCT01467947|12604341|P1|COMPLETED|Overall Study||46
5123474|NCT01467947|12604341|P1|STARTED|Overall Study||46
5123475|NCT01467934|12604349|P3|NOT COMPLETED|Overall Study||0
5123476|NCT01467934|12604350|P2|NOT COMPLETED|Overall Study||0
5123477|NCT01467934|12604351|P1|NOT COMPLETED|Overall Study||0
5123478|NCT01467934|12604349|P3|COMPLETED|Overall Study||110
5123479|NCT01467934|12604350|P2|COMPLETED|Overall Study||212
5123480|NCT01467934|12604351|P1|COMPLETED|Overall Study||208
5123481|NCT01467934|12604349|P3|STARTED|Overall Study||110
5123482|NCT01467934|12604350|P2|STARTED|Overall Study||212
5123483|NCT01467934|12604351|P1|STARTED|Overall Study||208
5123484|NCT01467882|12604359|P1|NOT COMPLETED|Overall Study||0
5123485|NCT01467882|12604359|P1|COMPLETED|Overall Study||44
5123486|NCT01467882|12604359|P1|STARTED|Overall Study||44
5123487|NCT01467713|12604386|P4|NOT COMPLETED|Overall Study||109
5123488|NCT01467713|12604387|P3|NOT COMPLETED|Overall Study||102
5123489|NCT01467713|12604388|P2|NOT COMPLETED|Overall Study||104
5123490|NCT01467713|12604389|P1|NOT COMPLETED|Overall Study||102
5123491|NCT01467713|12604386|P4|COMPLETED|Overall Study||45
5123492|NCT01467713|12604387|P3|COMPLETED|Overall Study||58
5123493|NCT01467713|12604388|P2|COMPLETED|Overall Study||60
5123494|NCT01467713|12604389|P1|COMPLETED|Overall Study||62
5123495|NCT01467713|12604386|P4|Safety Analysis Set: Received Treatment|Overall Study||154
5123496|NCT01467713|12604387|P3|Safety Analysis Set: Received Treatment|Overall Study||159
5123497|NCT01467713|12604388|P2|Safety Analysis Set: Received Treatment|Overall Study||164
5123498|NCT01467713|12604389|P1|Safety Analysis Set: Received Treatment|Overall Study||163
5123499|NCT01467713|12604386|P4|STARTED|Overall Study||154
5123500|NCT01467713|12604387|P3|STARTED|Overall Study||160
5123501|NCT01467713|12604388|P2|STARTED|Overall Study||164
5123502|NCT01467713|12604389|P1|STARTED|Overall Study||164
5123503|NCT01467700|12604443|P4|NOT COMPLETED|Overall Study||27
5123504|NCT01467700|12604444|P3|NOT COMPLETED|Overall Study||27
5123505|NCT01467700|12604445|P2|NOT COMPLETED|Overall Study||28
5123506|NCT01467700|12604446|P1|NOT COMPLETED|Overall Study||29
5123507|NCT01467700|12604443|P4|COMPLETED|Overall Study||96
5123508|NCT01467700|12604444|P3|COMPLETED|Overall Study||97
5123509|NCT01467700|12604445|P2|COMPLETED|Overall Study||100
5123510|NCT01467700|12604446|P1|COMPLETED|Overall Study||86
5123511|NCT01467700|12604443|P4|Safety Set - Received Treatment|Overall Study||123
5123512|NCT01467700|12604444|P3|Safety Set - Received Treatment|Overall Study||124
5123513|NCT01467700|12604445|P2|Safety Set - Received Treatment|Overall Study||127
5123514|NCT01467700|12604446|P1|Safety Set - Received Treatment|Overall Study||115
5123515|NCT01467700|12604443|P4|STARTED|Overall Study||123
5123516|NCT01467700|12604444|P3|STARTED|Overall Study||124
5123517|NCT01467700|12604445|P2|STARTED|Overall Study||128
5123518|NCT01467700|12604446|P1|STARTED|Overall Study||115
5123519|NCT01467661|12604488|P1|NOT COMPLETED|Overall Study||21
5123520|NCT01467661|12604488|P1|COMPLETED|Overall Study||32
5123521|NCT01467661|12604488|P1|Started Post Marketing Trial|Overall Study||33
5123522|NCT01467661|12604488|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
5123523|NCT01467661|12604488|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
5123524|NCT01467661|12604488|P1|STARTED|Overall Study||53
5123525|NCT01467583|12604508|P3|NOT COMPLETED|Overall Study||2
5123526|NCT01467583|12604509|P2|NOT COMPLETED|Overall Study||1
5123527|NCT01467583|12604510|P1|NOT COMPLETED|Overall Study||2
5123528|NCT01467583|12604508|P3|COMPLETED|Overall Study||10
5123529|NCT01467583|12604509|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
5123530|NCT01467583|12604510|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
5123531|NCT01467583|12604508|P3|STARTED|Overall Study||12
5123532|NCT01467583|12604509|P2|STARTED|Overall Study||4
5123533|NCT01467583|12604510|P1|STARTED|Overall Study||16
5123534|NCT01467570|12604523|P2|NOT COMPLETED|Overall Study||9
5123535|NCT01467570|12604524|P1|NOT COMPLETED|Overall Study||8
5123536|NCT01467570|12604523|P2|COMPLETED|Overall Study||63
5123537|NCT01467570|12604524|P1|COMPLETED|Overall Study||67
5123538|NCT01467570|12604523|P2|STARTED|Overall Study||72
5123539|NCT01467570|12604524|P1|STARTED|Overall Study||75
5123540|NCT01467557|12604550|P2|NOT COMPLETED|Overall Study||107
5123541|NCT01467557|12604551|P1|NOT COMPLETED|Overall Study||99
5123542|NCT01467557|12604550|P2|COMPLETED|Overall Study||463
5123543|NCT01467557|12604551|P1|COMPLETED|Overall Study||502
5123544|NCT01467557|12604550|P2|12 Month Survey Completed|Overall Study||463
5123545|NCT01467557|12604551|P1|12 Month Survey Completed|Overall Study||502
5123546|NCT01467557|12604550|P2|4 Month Survey Completed|Overall Study||493
5123547|NCT01467557|12604551|P1|4 Month Survey Completed|Overall Study||533
5123548|NCT01467557|12604550|P2|2 Week Survey Completed|Overall Study||522
5123549|NCT01467557|12604551|P1|2 Week Survey Completed|Overall Study||551
5123550|NCT01467557|12604550|P2|STARTED|Overall Study||570
5123551|NCT01467557|12604551|P1|STARTED|Overall Study||601
5123552|NCT01467505|12604561|P2|NOT COMPLETED|Overall Study||3
5123553|NCT01467505|12604562|P1|NOT COMPLETED|Overall Study||33
5123554|NCT01467505|12604561|P2|COMPLETED|Overall Study||7
5123555|NCT01467505|12604562|P1|COMPLETED|Overall Study||18
5123556|NCT01467505|12604561|P2|STARTED|Overall Study||10
5123557|NCT01467505|12604562|P1|STARTED|Overall Study||51
5123558|NCT01467492|12604594|P2|NOT COMPLETED|Overall Study||13
5123559|NCT01467492|12604595|P1|NOT COMPLETED|Overall Study||22
5123560|NCT01467492|12604594|P2|COMPLETED|Overall Study||25
5123561|NCT01467492|12604595|P1|COMPLETED|Overall Study||61
5123562|NCT01467492|12604594|P2|STARTED|Overall Study||38
5123563|NCT01467492|12604595|P1|STARTED|Overall Study||83
5123564|NCT01467479|12604619|P3|NOT COMPLETED|Overall Study||16
5123565|NCT01467479|12604620|P2|NOT COMPLETED|Overall Study||17
5123566|NCT01467479|12604621|P1|NOT COMPLETED|Overall Study||9
5123567|NCT01467479|12604619|P3|COMPLETED|Overall Study||45
5123568|NCT01467479|12604620|P2|COMPLETED|Overall Study||52
5123569|NCT01467479|12604621|P1|COMPLETED|Overall Study||46
5123570|NCT01467479|12604619|P3|Treated|Overall Study||59
5123571|NCT01467479|12604620|P2|Treated|Overall Study||69
5123572|NCT01467479|12604621|P1|Treated|Overall Study||54
5123573|NCT01467479|12604619|P3|STARTED|Overall Study||61
5123574|NCT01467479|12604620|P2|STARTED|Overall Study||69
5123575|NCT01467479|12604621|P1|STARTED|Overall Study||55
5123576|NCT01467466|12604652|P4|NOT COMPLETED|Overall Study||88
5123577|NCT01467466|12604653|P3|NOT COMPLETED|Overall Study||104
5123578|NCT01467466|12604654|P2|NOT COMPLETED|Overall Study||104
5123579|NCT01467466|12604655|P1|NOT COMPLETED|Overall Study||109
5123580|NCT01467466|12604652|P4|COMPLETED|Overall Study||1203
5123581|NCT01467466|12604653|P3|COMPLETED|Overall Study||1190
5123582|NCT01467466|12604654|P2|COMPLETED|Overall Study||1188
5123583|NCT01467466|12604655|P1|COMPLETED|Overall Study||1191
5123584|NCT01467466|12604652|P4|STARTED|Overall Study||1291
5123585|NCT01467466|12604653|P3|STARTED|Overall Study||1294
5123586|NCT01467466|12604654|P2|STARTED|Overall Study||1292
5123587|NCT01467466|12604655|P1|STARTED|Overall Study||1300
5123588|NCT01467427|12604667|P2|NOT COMPLETED|Overall Study||13
5123589|NCT01467427|12604668|P1|NOT COMPLETED|Overall Study||12
5123590|NCT01467427|12604667|P2|COMPLETED|Overall Study||0
5123591|NCT01467427|12604668|P1|COMPLETED|Overall Study||0
5123592|NCT01467427|12604667|P2|Completed Main Phase|Overall Study||13
5123593|NCT01467427|12604668|P1|Completed Main Phase|Overall Study||11
5123594|NCT01467427|12604667|P2|STARTED|Overall Study||13
5123595|NCT01467427|12604668|P1|STARTED|Overall Study||12
5123596|NCT01467271|12604686|P1|NOT COMPLETED|Overall Study||202
5123597|NCT01467271|12604686|P1|COMPLETED|Overall Study||338
5123598|NCT01467271|12604686|P1|STARTED|Overall Study||540
5123599|NCT01467076|12604693|P3|NOT COMPLETED|Overall Study||0
5123600|NCT01467076|12604694|P2|NOT COMPLETED|Overall Study||0
5123601|NCT01467076|12604695|P1|NOT COMPLETED|Overall Study||1
5123602|NCT01467076|12604693|P3|COMPLETED|Overall Study||2
5123603|NCT01467076|12604694|P2|COMPLETED|Overall Study||2
5123604|NCT01467076|12604695|P1|COMPLETED|Overall Study||2
5123605|NCT01467076|12604693|P3|STARTED|Overall Study||2
5123606|NCT01467076|12604694|P2|STARTED|Overall Study||2
5123607|NCT01467076|12604695|P1|STARTED|Overall Study||3
5123608|NCT01467037|12604732|P1|NOT COMPLETED|Overall Study||0
5123609|NCT01467037|12604732|P1|COMPLETED|Overall Study||374
5123610|NCT01467037|12604732|P1|STARTED|Overall Study||374
5123611|NCT01466985|12604742|P3|NOT COMPLETED|Overall Study||0
5123612|NCT01466985|12604743|P2|NOT COMPLETED|Overall Study||0
5123613|NCT01466985|12604744|P1|NOT COMPLETED|Overall Study||0
5123614|NCT01466985|12604742|P3|COMPLETED|Overall Study||6
5123615|NCT01466985|12604743|P2|COMPLETED|Overall Study||6
5123616|NCT01466985|12604744|P1|COMPLETED|Overall Study||6
5123617|NCT01466985|12604742|P3|STARTED|Overall Study||6
5123618|NCT01466985|12604743|P2|STARTED|Overall Study||6
5123619|NCT01466985|12604744|P1|STARTED|Overall Study||6
5123620|NCT01466972|12604761|P1|NOT COMPLETED|Overall Study||0
5123621|NCT01466972|12604761|P1|COMPLETED|Overall Study||30
5123622|NCT01466972|12604761|P1|STARTED|Overall Study||30
5123623|NCT01466881|12604767|P1|NOT COMPLETED|Overall Study||40
5123624|NCT01466881|12604767|P1|COMPLETED|Overall Study||2
5123625|NCT01466881|12604767|P1|Eligible and Treated|Overall Study||37
5123626|NCT01466881|12604767|P1|STARTED|Overall Study||42
5123627|NCT01466790|12604784|P8|NOT COMPLETED|Overall Study||1
5123628|NCT01466790|12604785|P7|NOT COMPLETED|Overall Study||1
5123629|NCT01466790|12604786|P6|NOT COMPLETED|Overall Study||0
5123630|NCT01466790|12604787|P5|NOT COMPLETED|Overall Study||3
5123631|NCT01466790|12604788|P4|NOT COMPLETED|Overall Study||0
5123632|NCT01466790|12604789|P3|NOT COMPLETED|Overall Study||0
5123633|NCT01466790|12604790|P2|NOT COMPLETED|Overall Study||1
5123634|NCT01466790|12604791|P1|NOT COMPLETED|Overall Study||4
5123635|NCT01466790|12604784|P8|COMPLETED|Overall Study||13
5123636|NCT01466790|12604785|P7|COMPLETED|Overall Study||26
5123637|NCT01466790|12604786|P6|COMPLETED|Overall Study||16
5123638|NCT01466790|12604787|P5|COMPLETED|Overall Study||27
5123639|NCT01466790|12604788|P4|COMPLETED|Overall Study||14
5123640|NCT01466790|12604789|P3|COMPLETED|Overall Study||27
5123641|NCT01466790|12604790|P2|COMPLETED|Overall Study||14
5123642|NCT01466790|12604791|P1|COMPLETED|Overall Study||20
5123643|NCT01466790|12604784|P8|STARTED|Overall Study||14
5123644|NCT01466790|12604785|P7|STARTED|Overall Study||27
5123645|NCT01466790|12604786|P6|STARTED|Overall Study||16
5123646|NCT01466790|12604787|P5|STARTED|Overall Study||30
5123647|NCT01466790|12604788|P4|STARTED|Overall Study||14
5123648|NCT01466790|12604789|P3|STARTED|Overall Study||27
5123649|NCT01466790|12604790|P2|STARTED|Overall Study||15
5123650|NCT01466790|12604791|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
5123651|NCT01466764|12604855|P2|NOT COMPLETED|Overall Study||0
5123652|NCT01466764|12604856|P1|NOT COMPLETED|Overall Study||0
5123653|NCT01466764|12604855|P2|COMPLETED|Overall Study||5
5123654|NCT01466764|12604856|P1|COMPLETED|Overall Study||5
5123655|NCT01466764|12604855|P2|STARTED|Overall Study||5
5123656|NCT01466764|12604856|P1|STARTED|Overall Study||5
5123657|NCT01466751|12604876|P2|NOT COMPLETED|Overall Study||0
5123658|NCT01466751|12604877|P1|NOT COMPLETED|Overall Study||1
5123659|NCT01466751|12604876|P2|COMPLETED|Overall Study||14
5123660|NCT01466751|12604877|P1|COMPLETED|Overall Study||13
5123661|NCT01466751|12604876|P2|STARTED|Overall Study||14
5123662|NCT01466751|12604877|P1|STARTED|Overall Study||14
5123663|NCT01466673|12604887|P2|NOT COMPLETED|Overall Study||6
5123664|NCT01466673|12604888|P1|NOT COMPLETED|Overall Study||7
5123665|NCT01466673|12604887|P2|COMPLETED|Overall Study||95
5123666|NCT01466673|12604888|P1|COMPLETED|Overall Study||93
5123667|NCT01466673|12604887|P2|STARTED|Overall Study||101
5123668|NCT01466673|12604888|P1|STARTED|Overall Study||100
5123669|NCT01466660|12604914|P2|NOT COMPLETED|Overall Study||159
5123670|NCT01466660|12604915|P1|NOT COMPLETED|Overall Study||160
5123671|NCT01466660|12604914|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
5123672|NCT01466660|12604915|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
5123673|NCT01466660|12604914|P2|STARTED|Overall Study||159
5123674|NCT01466660|12604915|P1|STARTED|Overall Study||160
5123675|NCT01466595|12604941|P2|NOT COMPLETED|Overall Study||1
5123676|NCT01466595|12604942|P1|NOT COMPLETED|Overall Study||0
5123677|NCT01466595|12604941|P2|COMPLETED|Overall Study||23
5123678|NCT01466595|12604942|P1|COMPLETED|Overall Study||49
5123679|NCT01466595|12604941|P2|STARTED|Overall Study||24
5123680|NCT01466595|12604942|P1|STARTED|Overall Study||49
5123681|NCT01466491|12605036|P4|NOT COMPLETED|Overall Study||0
5123682|NCT01466491|12605037|P3|NOT COMPLETED|Overall Study||3
5123683|NCT01466491|12605038|P2|NOT COMPLETED|Overall Study||3
5123684|NCT01466491|12605039|P1|NOT COMPLETED|Overall Study||0
5123685|NCT01466491|12605036|P4|COMPLETED|Overall Study||83
5123686|NCT01466491|12605037|P3|COMPLETED|Overall Study||80
5123687|NCT01466491|12605038|P2|COMPLETED|Overall Study||80
5123688|NCT01466491|12605039|P1|COMPLETED|Overall Study||83
5123689|NCT01466491|12605036|P4|STARTED|Overall Study||83
5123690|NCT01466491|12605037|P3|STARTED|Overall Study||83
5123691|NCT01466491|12605038|P2|STARTED|Overall Study||83
5123692|NCT01466491|12605039|P1|STARTED|Overall Study||83
5123693|NCT01466387|12605059|P6|NOT COMPLETED|Overall Study||1
5123694|NCT01466387|12605060|P5|NOT COMPLETED|Overall Study||0
5123695|NCT01466387|12605061|P4|NOT COMPLETED|Overall Study||2
5123696|NCT01466387|12605062|P3|NOT COMPLETED|Overall Study||1
5123697|NCT01466387|12605063|P2|NOT COMPLETED|Overall Study||0
5123698|NCT01466387|12605064|P1|NOT COMPLETED|Overall Study||1
5123699|NCT01466387|12605059|P6|COMPLETED|Overall Study||99
5123700|NCT01466387|12605060|P5|COMPLETED|Overall Study||51
5123701|NCT01466387|12605061|P4|COMPLETED|Overall Study||99
5123702|NCT01466387|12605062|P3|COMPLETED|Overall Study||98
5123703|NCT01466387|12605063|P2|COMPLETED|Overall Study||100
5123704|NCT01466387|12605064|P1|COMPLETED|Overall Study||100
5123705|NCT01466387|12605059|P6|STARTED|Overall Study||100
5123706|NCT01466387|12605060|P5|STARTED|Overall Study||51
5123707|NCT01466387|12605061|P4|STARTED|Overall Study||101
5123708|NCT01466387|12605062|P3|STARTED|Overall Study||99
5123709|NCT01466387|12605063|P2|STARTED|Overall Study||100
5123710|NCT01466387|12605064|P1|STARTED|Overall Study||101
5123711|NCT01466361|12605106|P4|NOT COMPLETED|Overall Study||0
5123712|NCT01466361|12605107|P3|NOT COMPLETED|Overall Study||0
5123713|NCT01466361|12605108|P2|NOT COMPLETED|Overall Study||0
5123714|NCT01466361|12605109|P1|NOT COMPLETED|Overall Study||0
5123715|NCT01466361|12605106|P4|COMPLETED|Overall Study||41
5123716|NCT01466361|12605107|P3|COMPLETED|Overall Study||60
5123717|NCT01466361|12605108|P2|COMPLETED|Overall Study||34
5123718|NCT01466361|12605109|P1|COMPLETED|Overall Study||52
5123719|NCT01466361|12605106|P4|STARTED|Overall Study||41
5123720|NCT01466361|12605107|P3|STARTED|Overall Study||60
5123721|NCT01466361|12605108|P2|STARTED|Overall Study||34
5123722|NCT01466361|12605109|P1|STARTED|Overall Study||52
5123723|NCT01466348|12605125|P2|NOT COMPLETED|Period II - Second Intervention||0
5123724|NCT01466348|12605126|P1|NOT COMPLETED|Period II - Second Intervention||0
5123725|NCT01466348|12605125|P2|COMPLETED|Period II - Second Intervention||36
5123726|NCT01466348|12605126|P1|COMPLETED|Period II - Second Intervention||35
5123727|NCT01466348|12605125|P2|STARTED|Period II - Second Intervention||36
5123728|NCT01466348|12605126|P1|STARTED|Period II - Second Intervention||35
5123729|NCT01466348|12605125|P2|NOT COMPLETED|Period I - First Intervention||1
5123730|NCT01466348|12605126|P1|NOT COMPLETED|Period I - First Intervention||0
5123731|NCT01466348|12605125|P2|COMPLETED|Period I - First Intervention||35
5123732|NCT01466348|12605126|P1|COMPLETED|Period I - First Intervention||36
5123733|NCT01466348|12605125|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
5123734|NCT01466348|12605126|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
5123735|NCT01466348|12605125|P2|STARTED|Period I - First Intervention||36
5123736|NCT01466348|12605126|P1|STARTED|Period I - First Intervention||36
5123737|NCT01466270|12605154|P2|NOT COMPLETED|Overall Study||6
5123738|NCT01466270|12605155|P1|NOT COMPLETED|Overall Study||12
5123739|NCT01466270|12605154|P2|COMPLETED|Overall Study||25
5123740|NCT01466270|12605155|P1|COMPLETED|Overall Study||19
5123741|NCT01466270|12605154|P2|STARTED|Overall Study||31
5123742|NCT01466270|12605155|P1|STARTED|Overall Study||31
5123743|NCT01466192|12605167|P1|NOT COMPLETED|Overall Study||4
5123744|NCT01466192|12605167|P1|COMPLETED|Overall Study||104
5123745|NCT01466192|12605167|P1|STARTED|Overall Study||108
5123746|NCT01466179|12605171|P1|NOT COMPLETED|Overall Study||179
5123747|NCT01466179|12605171|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
5123748|NCT01466179|12605171|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
5123749|NCT01466166|12605191|P1|NOT COMPLETED|Overall Study||163
5123750|NCT01466166|12605191|P1|COMPLETED|Overall Study||25
5123751|NCT01466166|12605191|P1|Completed 24 Weeks of Treatment|Overall Study||55
5123752|NCT01466166|12605191|P1|Received Treatment|Overall Study||188
5123753|NCT01466166|12605191|P1|STARTED|Overall Study||188
5123754|NCT01466153|12605205|P3|NOT COMPLETED|Overall Study||25
5123755|NCT01466153|12605206|P2|NOT COMPLETED|Overall Study||24
5123756|NCT01466153|12605207|P1|NOT COMPLETED|Overall Study||29
5123757|NCT01466153|12605205|P3|COMPLETED|Overall Study||36
5123758|NCT01466153|12605206|P2|COMPLETED|Overall Study||12
5123759|NCT01466153|12605207|P1|COMPLETED|Overall Study||33
5123760|NCT01466153|12605205|P3|STARTED|Overall Study||61
5123761|NCT01466153|12605206|P2|STARTED|Overall Study||36
5123762|NCT01466153|12605207|P1|STARTED|Overall Study||62
5123763|NCT01466127|12605248|P2|NOT COMPLETED|Overall Study||16
5123764|NCT01466127|12605249|P1|NOT COMPLETED|Overall Study||14
5123765|NCT01466127|12605248|P2|COMPLETED|Overall Study||14
5123766|NCT01466127|12605249|P1|COMPLETED|Overall Study||16
5123767|NCT01466127|12605248|P2|STARTED|Overall Study||30
5123768|NCT01466127|12605249|P1|STARTED|Overall Study||30
5123769|NCT01466075|12605255|P1|NOT COMPLETED|Overall Study||0
5123770|NCT01466075|12605255|P1|COMPLETED|Overall Study||207
5123771|NCT01466075|12605255|P1|STARTED|Overall Study||207
5123772|NCT01466062|12605262|P1|NOT COMPLETED|Overall Study||2
5123773|NCT01466062|12605262|P1|COMPLETED|Overall Study||26
5123774|NCT01466062|12605262|P1|STARTED|Overall Study||28
5123775|NCT01465997|12605285|P2|NOT COMPLETED|Overall Study||89
5123776|NCT01465997|12605286|P1|NOT COMPLETED|Overall Study||68
5123777|NCT01465997|12605285|P2|COMPLETED|Overall Study||180
5123778|NCT01465997|12605286|P1|COMPLETED|Overall Study||211
5123779|NCT01465997|12605285|P2|STARTED|Overall Study||269
5123780|NCT01465997|12605286|P1|STARTED|Overall Study||279
5123781|NCT01465958|12605296|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
5123782|NCT01465958|12605297|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
5123783|NCT01465958|12605296|P2|COMPLETED|Subcutaneous (SC) Phase||10
5123784|NCT01465958|12605297|P1|COMPLETED|Subcutaneous (SC) Phase||0
5123785|NCT01465958|12605296|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
5123786|NCT01465958|12605297|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
5123787|NCT01465958|12605296|P2|NOT COMPLETED|Intravenous (IV) Phase||0
5123788|NCT01465958|12605297|P1|NOT COMPLETED|Intravenous (IV) Phase||0
5123789|NCT01465958|12605296|P2|COMPLETED|Intravenous (IV) Phase||0
5123790|NCT01465958|12605297|P1|COMPLETED|Intravenous (IV) Phase||11
5123791|NCT01465958|12605296|P2|STARTED|Intravenous (IV) Phase||0
5123792|NCT01465958|12605297|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
5123793|NCT01465958|12605296|P2|NOT COMPLETED|Run-in Phase||0
5123794|NCT01465958|12605297|P1|NOT COMPLETED|Run-in Phase||1
5123795|NCT01465958|12605296|P2|COMPLETED|Run-in Phase||0
5123796|NCT01465958|12605297|P1|COMPLETED|Run-in Phase||10
5123797|NCT01465958|12605296|P2|STARTED|Run-in Phase||0
5123798|NCT01465958|12605297|P1|STARTED|Run-in Phase||11
5123799|NCT01465841|12605305|P1|NOT COMPLETED|Overall Study||68
5123800|NCT01465841|12605305|P1|COMPLETED|Overall Study||449
5123801|NCT01465841|12605305|P1|STARTED|Overall Study||517
5123802|NCT01465802|12605318|P5|NOT COMPLETED|Overall Study||12
5123803|NCT01465802|12605319|P4|NOT COMPLETED|Overall Study||29
5123804|NCT01465802|12605320|P3|NOT COMPLETED|Overall Study||0
5123805|NCT01465802|12605321|P2|NOT COMPLETED|Overall Study||24
5123806|NCT01465802|12605322|P1|NOT COMPLETED|Overall Study||33
5123807|NCT01465802|12605318|P5|COMPLETED|Overall Study||13
5123808|NCT01465802|12605319|P4|COMPLETED|Overall Study||38
5123809|NCT01465802|12605320|P3|COMPLETED|Overall Study||7
5123810|NCT01465802|12605321|P2|COMPLETED|Overall Study||42
5123811|NCT01465802|12605322|P1|COMPLETED|Overall Study||33
5123812|NCT01465802|12605318|P5|STARTED|Overall Study||25
5123813|NCT01465802|12605319|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
5123814|NCT01465802|12605320|P3|STARTED|Overall Study||7
5123815|NCT01465802|12605321|P2|STARTED|Overall Study||66
5123816|NCT01465802|12605322|P1|STARTED|Overall Study||66
5123817|NCT01465763|12605374|P3|NOT COMPLETED|Overall Study||4
5123818|NCT01465763|12605375|P2|NOT COMPLETED|Overall Study||1
5123819|NCT01465763|12605376|P1|NOT COMPLETED|Overall Study||31
5123820|NCT01465763|12605374|P3|COMPLETED|Overall Study||118
5123821|NCT01465763|12605375|P2|COMPLETED|Overall Study||15
5123822|NCT01465763|12605376|P1|COMPLETED|Overall Study||445
5123823|NCT01465763|12605374|P3|STARTED|Overall Study||122
5123824|NCT01465763|12605375|P2|STARTED|Overall Study||16
5123825|NCT01465763|12605376|P1|STARTED|Overall Study||476
5123826|NCT01465659|12605405|P4|NOT COMPLETED|Completed Follow for 1 Year||6
5123827|NCT01465659|12605406|P3|NOT COMPLETED|Completed Follow for 1 Year||2
5123828|NCT01465659|12605407|P2|NOT COMPLETED|Completed Follow for 1 Year||3
5123829|NCT01465659|12605408|P1|NOT COMPLETED|Completed Follow for 1 Year||6
5123830|NCT01465659|12605405|P4|COMPLETED|Completed Follow for 1 Year||5
5123831|NCT01465659|12605406|P3|COMPLETED|Completed Follow for 1 Year||4
5123832|NCT01465659|12605407|P2|COMPLETED|Completed Follow for 1 Year||1
5123833|NCT01465659|12605408|P1|COMPLETED|Completed Follow for 1 Year||1
5123834|NCT01465659|12605405|P4|STARTED|Completed Follow for 1 Year||11
5123835|NCT01465659|12605406|P3|STARTED|Completed Follow for 1 Year||6
5123836|NCT01465659|12605407|P2|STARTED|Completed Follow for 1 Year||4
5123837|NCT01465659|12605408|P1|STARTED|Completed Follow for 1 Year||7
5123838|NCT01465659|12605405|P4|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
5123839|NCT01465659|12605406|P3|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
5123840|NCT01465659|12605407|P2|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
5123841|NCT01465659|12605408|P1|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
5123842|NCT01465659|12605405|P4|COMPLETED|Went on to Cycle 3 and Beyond||9
5123843|NCT01465659|12605406|P3|COMPLETED|Went on to Cycle 3 and Beyond||4
5123844|NCT01465659|12605407|P2|COMPLETED|Went on to Cycle 3 and Beyond||4
5123845|NCT01465659|12605408|P1|COMPLETED|Went on to Cycle 3 and Beyond||5
5123846|NCT01465659|12605405|P4|STARTED|Went on to Cycle 3 and Beyond||9
5123847|NCT01465659|12605406|P3|STARTED|Went on to Cycle 3 and Beyond||4
5123848|NCT01465659|12605407|P2|STARTED|Went on to Cycle 3 and Beyond||4
5123849|NCT01465659|12605408|P1|STARTED|Went on to Cycle 3 and Beyond||5
5123850|NCT01465659|12605405|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
5123851|NCT01465659|12605406|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
5123852|NCT01465659|12605407|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
5123853|NCT01465659|12605408|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
5123854|NCT01465659|12605405|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
5123855|NCT01465659|12605406|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
5123856|NCT01465659|12605407|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
5123857|NCT01465659|12605408|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
5123858|NCT01465659|12605405|P4|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
5123859|NCT01465659|12605406|P3|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
5123860|NCT01465659|12605407|P2|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
5123861|NCT01465659|12605408|P1|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
5123862|NCT01465659|12605405|P4|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
5123863|NCT01465659|12605406|P3|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
5123864|NCT01465659|12605407|P2|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
5123865|NCT01465659|12605408|P1|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
5123866|NCT01465659|12605405|P4|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
5123867|NCT01465659|12605406|P3|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
5123868|NCT01465659|12605407|P2|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
5123869|NCT01465659|12605408|P1|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
5123870|NCT01465659|12605405|P4|STARTED|Completed 2 Cycles/Reached 1st Response||10
5123871|NCT01465659|12605406|P3|STARTED|Completed 2 Cycles/Reached 1st Response||6
5123872|NCT01465659|12605407|P2|STARTED|Completed 2 Cycles/Reached 1st Response||4
5123873|NCT01465659|12605408|P1|STARTED|Completed 2 Cycles/Reached 1st Response||7
5123874|NCT01465659|12605405|P4|NOT COMPLETED|Completed 1 Cycle of Treatment||1
5123875|NCT01465659|12605406|P3|NOT COMPLETED|Completed 1 Cycle of Treatment||0
5123876|NCT01465659|12605407|P2|NOT COMPLETED|Completed 1 Cycle of Treatment||1
5123877|NCT01465659|12605408|P1|NOT COMPLETED|Completed 1 Cycle of Treatment||0
5123878|NCT01465659|12605405|P4|COMPLETED|Completed 1 Cycle of Treatment||10
5123879|NCT01465659|12605406|P3|COMPLETED|Completed 1 Cycle of Treatment||6
5123880|NCT01465659|12605407|P2|COMPLETED|Completed 1 Cycle of Treatment||4
5123881|NCT01465659|12605408|P1|COMPLETED|Completed 1 Cycle of Treatment||7
5123882|NCT01465659|12605405|P4|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
5123883|NCT01465659|12605406|P3|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
5123884|NCT01465659|12605407|P2|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
5123885|NCT01465659|12605408|P1|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
5123886|NCT01465659|12605405|P4|STARTED|Completed 1 Cycle of Treatment||11
5123887|NCT01465659|12605406|P3|STARTED|Completed 1 Cycle of Treatment||6
5123888|NCT01465659|12605407|P2|STARTED|Completed 1 Cycle of Treatment||5
5123889|NCT01465659|12605408|P1|STARTED|Completed 1 Cycle of Treatment||7
5123890|NCT01465464|12605418|P2|NOT COMPLETED|Overall Study||444
5123891|NCT01465464|12605419|P1|NOT COMPLETED|Overall Study||444
5123892|NCT01465464|12605418|P2|COMPLETED|Overall Study||0
5123893|NCT01465464|12605419|P1|COMPLETED|Overall Study||0
5123894|NCT01465464|12605418|P2|STARTED|Overall Study||444
5123895|NCT01465464|12605419|P1|STARTED|Overall Study||444
5123896|NCT01465412|12605431|P4|NOT COMPLETED|Overall Study||0
5123897|NCT01465412|12605432|P3|NOT COMPLETED|Overall Study||0
5123898|NCT01465412|12605433|P2|NOT COMPLETED|Overall Study||0
5123899|NCT01465412|12605434|P1|NOT COMPLETED|Overall Study||0
5123900|NCT01465412|12605431|P4|COMPLETED|Overall Study||9
5123901|NCT01465412|12605432|P3|COMPLETED|Overall Study||9
5123902|NCT01465412|12605433|P2|COMPLETED|Overall Study||12
5123903|NCT01465412|12605434|P1|COMPLETED|Overall Study||12
5123904|NCT01465412|12605431|P4|STARTED|Overall Study||9
5123905|NCT01465412|12605432|P3|STARTED|Overall Study||9
5123906|NCT01465412|12605433|P2|STARTED|Overall Study||12
5123907|NCT01465412|12605434|P1|STARTED|Overall Study||12
5123908|NCT01465386|12605472|P1|NOT COMPLETED|Overall Study||4
5123909|NCT01465386|12605472|P1|COMPLETED|Overall Study||2
5123910|NCT01465386|12605472|P1|STARTED|Overall Study||6
5123911|NCT01465347|12605476|P2|NOT COMPLETED|Overall Study||3
5123912|NCT01465347|12605477|P1|NOT COMPLETED|Overall Study||1
5123913|NCT01465347|12605476|P2|COMPLETED|Overall Study||53
5123914|NCT01465347|12605477|P1|COMPLETED|Overall Study||2
5123915|NCT01465347|12605476|P2|STARTED|Overall Study||56
5123916|NCT01465347|12605477|P1|STARTED|Overall Study||3
5123917|NCT01465334|12605489|P2|NOT COMPLETED|Overall Study||6
5123918|NCT01465334|12605490|P1|NOT COMPLETED|Overall Study||2
5123919|NCT01465334|12605489|P2|COMPLETED|Overall Study||9
5123920|NCT01465334|12605490|P1|COMPLETED|Overall Study||13
5123921|NCT01465334|12605489|P2|Eligible for Allogeneic Transplant|Overall Study||9
5123922|NCT01465334|12605490|P1|Eligible for Allogeneic Transplant|Overall Study||9
5123923|NCT01465334|12605489|P2|Complete Part B Induction|Overall Study||15
5123924|NCT01465334|12605490|P1|Complete Part B Induction|Overall Study||7
5123925|NCT01465334|12605489|P2|Complete Part A Induction|Overall Study||15
5123926|NCT01465334|12605490|P1|Complete Part A Induction|Overall Study||12
5123927|NCT01465334|12605489|P2|STARTED|Overall Study||15
5123928|NCT01465334|12605490|P1|STARTED|Overall Study||15
5123929|NCT01465230|12605516|P1|NOT COMPLETED|Overall Study||2
5123930|NCT01465230|12605516|P1|COMPLETED|Overall Study||0
5123931|NCT01465230|12605516|P1|STARTED|Overall Study||2
5123932|NCT01465178|12605522|P2|NOT COMPLETED|Overall Study||0
5123933|NCT01465178|12605523|P1|NOT COMPLETED|Overall Study||1
5123934|NCT01465178|12605522|P2|COMPLETED|Overall Study||31
5123935|NCT01465178|12605523|P1|COMPLETED|Overall Study||30
5123936|NCT01465178|12605522|P2|STARTED|Overall Study||31
5123937|NCT01465178|12605523|P1|STARTED|Overall Study||31
5123938|NCT01465048|12605534|P3|NOT COMPLETED|Overall Study||0
5123939|NCT01465048|12605535|P2|NOT COMPLETED|Overall Study||0
5123940|NCT01465048|12605536|P1|NOT COMPLETED|Overall Study||0
5123941|NCT01465048|12605534|P3|COMPLETED|Overall Study||6
5123942|NCT01465048|12605535|P2|COMPLETED|Overall Study||6
5123943|NCT01465048|12605536|P1|COMPLETED|Overall Study||6
5123944|NCT01465048|12605534|P3|STARTED|Overall Study||6
5123945|NCT01465048|12605535|P2|STARTED|Overall Study||6
5123946|NCT01465048|12605536|P1|STARTED|Overall Study||6
5123947|NCT01465022|12605547|P3|NOT COMPLETED|Overall Study||70
5123948|NCT01465022|12605548|P2|NOT COMPLETED|Overall Study||23
5123949|NCT01465022|12605549|P1|NOT COMPLETED|Overall Study||23
5123950|NCT01465022|12605547|P3|COMPLETED|Overall Study||0
5123951|NCT01465022|12605548|P2|COMPLETED|Overall Study||40
5123952|NCT01465022|12605549|P1|COMPLETED|Overall Study||41
5123953|NCT01465022|12605547|P3|STARTED|Overall Study||70
5123954|NCT01465022|12605548|P2|STARTED|Overall Study||63
5123955|NCT01465022|12605549|P1|STARTED|Overall Study||64
5123956|NCT01464996|12605563|P1|NOT COMPLETED|Overall Study||0
5123957|NCT01464996|12605563|P1|COMPLETED|Overall Study||24
5123958|NCT01464996|12605563|P1|OptiBond FL|Overall Study||24
5123959|NCT01464996|12605563|P1|OptiBond XTR|Overall Study||23
5123960|NCT01464996|12605563|P1|STARTED|Overall Study||24
5123961|NCT01464931|12605583|P2|NOT COMPLETED|Overall Study||0
5123962|NCT01464931|12605584|P1|NOT COMPLETED|Overall Study||1
5123963|NCT01464931|12605583|P2|COMPLETED|Overall Study||16
5123964|NCT01464931|12605584|P1|COMPLETED|Overall Study||15
5123965|NCT01464931|12605583|P2|STARTED|Overall Study||16
5123966|NCT01464931|12605584|P1|STARTED|Overall Study||16
5123967|NCT01464879|12605621|P1|NOT COMPLETED|Overall Study||2
5123968|NCT01464879|12605621|P1|COMPLETED|Overall Study||18
5123969|NCT01464879|12605621|P1|Applicator Application (3.75 mL)|Overall Study||18
5123970|NCT01464879|12605621|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
5123971|NCT01464879|12605621|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
5123972|NCT01464879|12605621|P1|Washout Period|Overall Study||20
5123973|NCT01464879|12605621|P1|Hand Application (2.50 mL)|Overall Study||20
5123974|NCT01464879|12605621|P1|STARTED|Overall Study||20
5123975|NCT01464840|12605658|P3|NOT COMPLETED|Overall Study||0
5123976|NCT01464840|12605659|P2|NOT COMPLETED|Overall Study||0
5123977|NCT01464840|12605660|P1|NOT COMPLETED|Overall Study||0
5123978|NCT01464840|12605658|P3|COMPLETED|Overall Study||10
5123979|NCT01464840|12605659|P2|COMPLETED|Overall Study||10
5123980|NCT01464840|12605660|P1|COMPLETED|Overall Study||10
5123981|NCT01464840|12605658|P3|STARTED|Overall Study||10
5123982|NCT01464840|12605659|P2|STARTED|Overall Study||10
5123983|NCT01464840|12605660|P1|STARTED|Overall Study||10
5123984|NCT01464827|12605682|P14|NOT COMPLETED|Overall Study||3
5123985|NCT01464827|12605683|P13|NOT COMPLETED|Overall Study||2
5123986|NCT01464827|12605684|P12|NOT COMPLETED|Overall Study||2
5123987|NCT01464827|12605685|P11|NOT COMPLETED|Overall Study||2
5123988|NCT01464827|12605686|P10|NOT COMPLETED|Overall Study||3
5123989|NCT01464827|12605687|P9|NOT COMPLETED|Overall Study||3
5123990|NCT01464827|12605688|P8|NOT COMPLETED|Overall Study||3
5123991|NCT01464827|12605689|P7|NOT COMPLETED|Overall Study||4
5123992|NCT01464827|12605690|P6|NOT COMPLETED|Overall Study||1
5123993|NCT01464827|12605691|P5|NOT COMPLETED|Overall Study||8
5123994|NCT01464827|12605692|P4|NOT COMPLETED|Overall Study||4
5123995|NCT01464827|12605693|P3|NOT COMPLETED|Overall Study||0
5123996|NCT01464827|12605694|P2|NOT COMPLETED|Overall Study||7
5123997|NCT01464827|12605695|P1|NOT COMPLETED|Overall Study||3
5123998|NCT01464827|12605682|P14|COMPLETED|Overall Study||19
5123999|NCT01464827|12605683|P13|COMPLETED|Overall Study||21
5124000|NCT01464827|12605684|P12|COMPLETED|Overall Study||21
5124001|NCT01464827|12605685|P11|COMPLETED|Overall Study||21
5124002|NCT01464827|12605686|P10|COMPLETED|Overall Study||44
5124003|NCT01464827|12605687|P9|COMPLETED|Overall Study||37
5124004|NCT01464827|12605688|P8|COMPLETED|Overall Study||37
5124005|NCT01464827|12605689|P7|COMPLETED|Overall Study||37
5124006|NCT01464827|12605690|P6|COMPLETED|Overall Study||38
5124007|NCT01464827|12605691|P5|COMPLETED|Overall Study||72
5124008|NCT01464827|12605692|P4|COMPLETED|Overall Study||36
5124009|NCT01464827|12605693|P3|COMPLETED|Overall Study||39
5124010|NCT01464827|12605694|P2|COMPLETED|Overall Study||36
5124011|NCT01464827|12605695|P1|COMPLETED|Overall Study||77
5124012|NCT01464827|12605682|P14|Treated|Overall Study||20
5124013|NCT01464827|12605683|P13|Treated|Overall Study||23
5124014|NCT01464827|12605684|P12|Treated|Overall Study||22
5124015|NCT01464827|12605685|P11|Treated|Overall Study||23
5124016|NCT01464827|12605686|P10|Treated|Overall Study||45
5124017|NCT01464827|12605687|P9|Treated|Overall Study||40
5124018|NCT01464827|12605688|P8|Treated|Overall Study||40
5124019|NCT01464827|12605689|P7|Treated|Overall Study||40
5124020|NCT01464827|12605690|P6|Treated|Overall Study||39
5124021|NCT01464827|12605691|P5|Treated|Overall Study||79
5124022|NCT01464827|12605692|P4|Treated|Overall Study||40
5124023|NCT01464827|12605693|P3|Treated|Overall Study||39
5124024|NCT01464827|12605694|P2|Treated|Overall Study||41
5124025|NCT01464827|12605695|P1|Treated|Overall Study||80
5124026|NCT01464827|12605682|P14|STARTED|Overall Study||22
5124027|NCT01464827|12605683|P13|STARTED|Overall Study||23
5124028|NCT01464827|12605684|P12|STARTED|Overall Study||23
5124029|NCT01464827|12605685|P11|STARTED|Overall Study||23
5124030|NCT01464827|12605686|P10|STARTED|Overall Study||47
5124031|NCT01464827|12605687|P9|STARTED|Overall Study||40
5124032|NCT01464827|12605688|P8|STARTED|Overall Study||40
5124033|NCT01464827|12605689|P7|STARTED|Overall Study||41
5124034|NCT01464827|12605690|P6|STARTED|Overall Study||39
5124035|NCT01464827|12605691|P5|STARTED|Overall Study||80
5124036|NCT01464827|12605692|P4|STARTED|Overall Study||40
5124037|NCT01464827|12605693|P3|STARTED|Overall Study||39
5124038|NCT01464827|12605694|P2|STARTED|Overall Study||43
5124039|NCT01464827|12605695|P1|STARTED|Overall Study||80
5124040|NCT01464788|12605742|P3|NOT COMPLETED|Overall Study||0
5124041|NCT01464788|12605743|P2|NOT COMPLETED|Overall Study||2
5124042|NCT01464788|12605744|P1|NOT COMPLETED|Overall Study||0
5124043|NCT01464788|12605742|P3|COMPLETED|Overall Study||29
5124044|NCT01464788|12605743|P2|COMPLETED|Overall Study||29
5124045|NCT01464788|12605744|P1|COMPLETED|Overall Study||30
5124046|NCT01464788|12605742|P3|STARTED|Overall Study||29
5124047|NCT01464788|12605743|P2|STARTED|Overall Study||31
5124048|NCT01464788|12605744|P1|STARTED|Overall Study||30
5124049|NCT01464775|12605757|P2|NOT COMPLETED|Overall Study||6
5124050|NCT01464775|12605758|P1|NOT COMPLETED|Overall Study||11
5124051|NCT01464775|12605757|P2|COMPLETED|Overall Study||38
5124052|NCT01464775|12605758|P1|COMPLETED|Overall Study||112
5124053|NCT01464775|12605757|P2|STARTED|Overall Study||44
5124054|NCT01464775|12605758|P1|STARTED|Overall Study||123
5124055|NCT01464723|12605766|P1|NOT COMPLETED|Overall Study||0
5124056|NCT01464723|12605766|P1|COMPLETED|Overall Study||0
5124057|NCT01464723|12605766|P1|STARTED|Overall Study||0
5124058|NCT01464697|12605775|P2|NOT COMPLETED|Overall Study||10
5124059|NCT01464697|12605776|P1|NOT COMPLETED|Overall Study||3
5124060|NCT01464697|12605775|P2|COMPLETED|Overall Study||86
5124061|NCT01464697|12605776|P1|COMPLETED|Overall Study||90
5124062|NCT01464697|12605775|P2|STARTED|Overall Study||96
5124063|NCT01464697|12605776|P1|STARTED|Overall Study||93
5124064|NCT01464619|12605830|P2|NOT COMPLETED|Overall Study||4
5124065|NCT01464619|12605831|P1|NOT COMPLETED|Overall Study||3
5124066|NCT01464619|12605830|P2|COMPLETED|Overall Study||25
5124067|NCT01464619|12605831|P1|COMPLETED|Overall Study||29
5124068|NCT01464619|12605830|P2|STARTED|Overall Study||29
5124069|NCT01464619|12605831|P1|STARTED|Overall Study||32
5124070|NCT01464424|12605851|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
5124071|NCT01464424|12605852|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
5124072|NCT01464424|12605851|P2|COMPLETED|Period 2, Second 6 Weeks||41
5124073|NCT01464424|12605852|P1|COMPLETED|Period 2, Second 6 Weeks||42
5124074|NCT01464424|12605851|P2|STARTED|Period 2, Second 6 Weeks||41
5124075|NCT01464424|12605852|P1|STARTED|Period 2, Second 6 Weeks||42
5124076|NCT01464424|12605851|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
5124077|NCT01464424|12605852|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
5124078|NCT01464424|12605851|P2|COMPLETED|Period 1, First 6 Weeks||41
5124079|NCT01464424|12605852|P1|COMPLETED|Period 1, First 6 Weeks||42
5124080|NCT01464424|12605851|P2|STARTED|Period 1, First 6 Weeks||42
5124081|NCT01464424|12605852|P1|STARTED|Period 1, First 6 Weeks||42
5124082|NCT01464359|12605860|P1|NOT COMPLETED|Overall Study||0
5124083|NCT01464359|12605860|P1|COMPLETED|Overall Study||3
5124084|NCT01464359|12605860|P1|STARTED|Overall Study||3
5124085|NCT01464346|12605872|P3|NOT COMPLETED|Overall Study||1
5124086|NCT01464346|12605873|P2|NOT COMPLETED|Overall Study||0
5124087|NCT01464346|12605874|P1|NOT COMPLETED|Overall Study||0
5124088|NCT01464346|12605872|P3|COMPLETED|Overall Study||28
5124089|NCT01464346|12605873|P2|COMPLETED|Overall Study||32
5124090|NCT01464346|12605874|P1|COMPLETED|Overall Study||29
5124091|NCT01464346|12605872|P3|STARTED|Overall Study||29
5124092|NCT01464346|12605873|P2|STARTED|Overall Study||32
5124093|NCT01464346|12605874|P1|STARTED|Overall Study||29
5124094|NCT01464333|12605883|P1|NOT COMPLETED|Overall Study||163
5124095|NCT01464333|12605883|P1|COMPLETED|Overall Study||226
5124096|NCT01464333|12605883|P1|STARTED|Overall Study||389
5124097|NCT01464307|12605896|P2|NOT COMPLETED|Open-Label Extension Period||0
5124098|NCT01464307|12605897|P1|NOT COMPLETED|Open-Label Extension Period||51
5124099|NCT01464307|12605896|P2|COMPLETED|Open-Label Extension Period||0
5124100|NCT01464307|12605897|P1|COMPLETED|Open-Label Extension Period||218
5124101|NCT01464307|12605896|P2|Treated|Open-Label Extension Period||0
5124102|NCT01464307|12605897|P1|Treated|Open-Label Extension Period||269
5124103|NCT01464307|12605896|P2|STARTED|Open-Label Extension Period||0
5124104|NCT01464307|12605897|P1|STARTED|Open-Label Extension Period||269
5124105|NCT01464307|12605896|P2|NOT COMPLETED|Main Period||5
5124106|NCT01464307|12605897|P1|NOT COMPLETED|Main Period||15
5124107|NCT01464307|12605896|P2|COMPLETED|Main Period||140
5124108|NCT01464307|12605897|P1|COMPLETED|Main Period||129
5124109|NCT01464307|12605896|P2|Treated|Main Period||145
5124110|NCT01464307|12605897|P1|Treated|Main Period||144
5124111|NCT01464307|12605896|P2|STARTED|Main Period||145
5124112|NCT01464307|12605897|P1|STARTED|Main Period||144
5124113|NCT01464255|12605912|P2|NOT COMPLETED|Overall Study||1
5124114|NCT01464255|12605913|P1|NOT COMPLETED|Overall Study||0
5124115|NCT01464255|12605912|P2|COMPLETED|Overall Study||24
5124116|NCT01464255|12605913|P1|COMPLETED|Overall Study||25
5124117|NCT01464255|12605912|P2|STARTED|Overall Study||25
5124118|NCT01464255|12605913|P1|STARTED|Overall Study||25
5124119|NCT01464229|12605938|P2|NOT COMPLETED|Overall Study||2
5124120|NCT01464229|12605939|P1|NOT COMPLETED|Overall Study||5
5124121|NCT01464229|12605938|P2|COMPLETED|Overall Study||8
5124122|NCT01464229|12605939|P1|COMPLETED|Overall Study||5
5124123|NCT01464229|12605938|P2|STARTED|Overall Study||10
5124124|NCT01464229|12605939|P1|STARTED|Overall Study||10
5124125|NCT01464190|12605947|P2|NOT COMPLETED|Overall Study||41
5124126|NCT01464190|12605948|P1|NOT COMPLETED|Overall Study||69
5124127|NCT01464190|12605947|P2|COMPLETED|Overall Study||227
5124128|NCT01464190|12605948|P1|COMPLETED|Overall Study||322
5124129|NCT01464190|12605947|P2|STARTED|Overall Study||268
5124130|NCT01464190|12605948|P1|STARTED|Overall Study||391
5124131|NCT01464021|12605958|P1|NOT COMPLETED|Overall Study||26
5124132|NCT01464021|12605958|P1|COMPLETED|Overall Study||0
5124133|NCT01464021|12605958|P1|STARTED|Overall Study||26
5124134|NCT01463982|12605974|P4|NOT COMPLETED|Overall Study||0
5124135|NCT01463982|12605975|P3|NOT COMPLETED|Overall Study||2
5124136|NCT01463982|12605976|P2|NOT COMPLETED|Overall Study||1
5124137|NCT01463982|12605977|P1|NOT COMPLETED|Overall Study||0
5124138|NCT01463982|12605974|P4|COMPLETED|Overall Study||6
5124139|NCT01463982|12605975|P3|COMPLETED|Overall Study||2
5124140|NCT01463982|12605976|P2|COMPLETED|Overall Study||7
5124141|NCT01463982|12605977|P1|COMPLETED|Overall Study||3
5124142|NCT01463982|12605974|P4|STARTED|Overall Study||6
5124143|NCT01463982|12605975|P3|STARTED|Overall Study||4
5124144|NCT01463982|12605976|P2|STARTED|Overall Study||8
5124145|NCT01463982|12605977|P1|STARTED|Overall Study||3
5124146|NCT01463878|12605993|P2|NOT COMPLETED|Overall Study||2
5124147|NCT01463878|12605994|P1|NOT COMPLETED|Overall Study||2
5124148|NCT01463878|12605993|P2|COMPLETED|Overall Study||7
5124149|NCT01463878|12605994|P1|COMPLETED|Overall Study||7
5124150|NCT01463878|12605993|P2|STARTED|Overall Study||9
5124151|NCT01463878|12605994|P1|STARTED|Overall Study||9
5124152|NCT01463696|12606008|P8|NOT COMPLETED|Overall Study||4
5124153|NCT01463696|12606009|P7|NOT COMPLETED|Overall Study||10
5124154|NCT01463696|12606010|P6|NOT COMPLETED|Overall Study||3
5124155|NCT01463696|12606011|P5|NOT COMPLETED|Overall Study||1
5124156|NCT01463696|12606012|P4|NOT COMPLETED|Overall Study||4
5124157|NCT01463696|12606013|P3|NOT COMPLETED|Overall Study||1
5124158|NCT01463696|12606014|P2|NOT COMPLETED|Overall Study||2
5124159|NCT01463696|12606015|P1|NOT COMPLETED|Overall Study||0
5124160|NCT01463696|12606008|P8|COMPLETED|Overall Study||2
5124161|NCT01463696|12606009|P7|COMPLETED|Overall Study||6
5124162|NCT01463696|12606010|P6|COMPLETED|Overall Study||3
5124163|NCT01463696|12606011|P5|COMPLETED|Overall Study||2
5124164|NCT01463696|12606012|P4|COMPLETED|Overall Study||3
5124165|NCT01463696|12606013|P3|COMPLETED|Overall Study||2
5124166|NCT01463696|12606014|P2|COMPLETED|Overall Study||4
5124167|NCT01463696|12606015|P1|COMPLETED|Overall Study||1
5124168|NCT01463696|12606008|P8|Treated|Overall Study||6
5124169|NCT01463696|12606009|P7|Treated|Overall Study||15
5124170|NCT01463696|12606010|P6|Treated|Overall Study||6
5124171|NCT01463696|12606011|P5|Treated|Overall Study||3
5124172|NCT01463696|12606012|P4|Treated|Overall Study||7
5124173|NCT01463696|12606013|P3|Treated|Overall Study||3
5124174|NCT01463696|12606014|P2|Treated|Overall Study||6
5124175|NCT01463696|12606015|P1|Treated|Overall Study||1
5124176|NCT01463696|12606008|P8|STARTED|Overall Study||6
5124177|NCT01463696|12606009|P7|STARTED|Overall Study||16
5124178|NCT01463696|12606010|P6|STARTED|Overall Study||6
5124179|NCT01463696|12606011|P5|STARTED|Overall Study||3
5124180|NCT01463696|12606012|P4|STARTED|Overall Study||7
5124181|NCT01463696|12606013|P3|STARTED|Overall Study||3
5124182|NCT01463696|12606014|P2|STARTED|Overall Study||6
5124183|NCT01463696|12606015|P1|STARTED|Overall Study||1
5124184|NCT01463683|12606068|P3|NOT COMPLETED|Overall Study||11
5124185|NCT01463683|12606069|P2|NOT COMPLETED|Overall Study||31
5124186|NCT01463683|12606070|P1|NOT COMPLETED|Overall Study||19
5124187|NCT01463683|12606068|P3|COMPLETED|Overall Study||93
5124188|NCT01463683|12606069|P2|COMPLETED|Overall Study||278
5124189|NCT01463683|12606070|P1|COMPLETED|Overall Study||290
5124190|NCT01463683|12606068|P3|Received Vaccination 3 (Month 6)|Overall Study||93
5124191|NCT01463683|12606069|P2|Received Vaccination 3 (Month 6)|Overall Study||281
5124192|NCT01463683|12606070|P1|Received Vaccination 3 (Month 6)|Overall Study||290
5124193|NCT01463683|12606068|P3|Received Vaccination 2 (Month 1)|Overall Study||103
5124194|NCT01463683|12606069|P2|Received Vaccination 2 (Month 1)|Overall Study||300
5124195|NCT01463683|12606070|P1|Received Vaccination 2 (Month 1)|Overall Study||302
5124196|NCT01463683|12606068|P3|Received Vaccination 1 (Day 1)|Overall Study||104
5124197|NCT01463683|12606069|P2|Received Vaccination 1 (Day 1)|Overall Study||308
5124198|NCT01463683|12606070|P1|Received Vaccination 1 (Day 1)|Overall Study||309
5124199|NCT01463683|12606068|P3|STARTED|Overall Study||104
5124200|NCT01463683|12606069|P2|STARTED|Overall Study||309
5124201|NCT01463683|12606070|P1|STARTED|Overall Study||309
5124202|NCT01463631|12606087|P4|NOT COMPLETED|Overall Study||6
5124203|NCT01463631|12606088|P3|NOT COMPLETED|Overall Study||1
5124204|NCT01463631|12606089|P2|NOT COMPLETED|Overall Study||0
5124205|NCT01463631|12606090|P1|NOT COMPLETED|Overall Study||0
5124206|NCT01463631|12606087|P4|COMPLETED|Overall Study||9
5124207|NCT01463631|12606088|P3|COMPLETED|Overall Study||4
5124208|NCT01463631|12606089|P2|COMPLETED|Overall Study||4
5124209|NCT01463631|12606090|P1|COMPLETED|Overall Study||3
5124210|NCT01463631|12606087|P4|Received at Least One Dose of Study Drug|Overall Study||15
5124211|NCT01463631|12606088|P3|Received at Least One Dose of Study Drug|Overall Study||5
5124212|NCT01463631|12606089|P2|Received at Least One Dose of Study Drug|Overall Study||4
5124213|NCT01463631|12606090|P1|Received at Least One Dose of Study Drug|Overall Study||3
5124214|NCT01463631|12606087|P4|STARTED|Overall Study||15
5124215|NCT01463631|12606088|P3|STARTED|Overall Study||5
5124216|NCT01463631|12606089|P2|STARTED|Overall Study||4
5124217|NCT01463631|12606090|P1|STARTED|Overall Study||3
5124218|NCT01463527|12606112|P2|NOT COMPLETED|Overall Study||7
5124219|NCT01463527|12606113|P1|NOT COMPLETED|Overall Study||6
5124220|NCT01463527|12606112|P2|COMPLETED|Overall Study||77
5124221|NCT01463527|12606113|P1|COMPLETED|Overall Study||77
5124222|NCT01463527|12606112|P2|STARTED|Overall Study||84
5124223|NCT01463527|12606113|P1|STARTED|Overall Study||83
5124224|NCT01463384|12606121|P1|NOT COMPLETED|Overall Study||0
5124225|NCT01463384|12606121|P1|COMPLETED|Overall Study||13
5124226|NCT01463384|12606121|P1|STARTED|Overall Study||13
5124227|NCT01463306|12606136|P3|NOT COMPLETED|Overall Study||5
5124228|NCT01463306|12606137|P2|NOT COMPLETED|Overall Study||52
5124229|NCT01463306|12606138|P1|NOT COMPLETED|Overall Study||86
5124230|NCT01463306|12606136|P3|COMPLETED|Overall Study||6
5124231|NCT01463306|12606137|P2|COMPLETED|Overall Study||158
5124232|NCT01463306|12606138|P1|COMPLETED|Overall Study||298
5124233|NCT01463306|12606136|P3|STARTED|Overall Study||11
5124234|NCT01463306|12606137|P2|STARTED|Overall Study||210
5124235|NCT01463306|12606138|P1|STARTED|Overall Study||384
5124236|NCT01463293|12606209|P3|NOT COMPLETED|Overall Study||12
5124237|NCT01463293|12606210|P2|NOT COMPLETED|Overall Study||16
5124238|NCT01463293|12606211|P1|NOT COMPLETED|Overall Study||6
5124239|NCT01463293|12606209|P3|COMPLETED|Overall Study||59
5124240|NCT01463293|12606210|P2|COMPLETED|Overall Study||63
5124241|NCT01463293|12606211|P1|COMPLETED|Overall Study||68
5124242|NCT01463293|12606209|P3|STARTED|Overall Study||71
5124243|NCT01463293|12606210|P2|STARTED|Overall Study||79
5124244|NCT01463293|12606211|P1|STARTED|Overall Study||74
5124245|NCT01463202|12606221|P2|NOT COMPLETED|Overall Study||0
5124246|NCT01463202|12606222|P1|NOT COMPLETED|Overall Study||0
5124247|NCT01463202|12606221|P2|COMPLETED|Overall Study||78
5124248|NCT01463202|12606222|P1|COMPLETED|Overall Study||79
5124249|NCT01463202|12606221|P2|STARTED|Overall Study||78
5124250|NCT01463202|12606222|P1|STARTED|Overall Study||79
5124251|NCT01463111|12606234|P1|NOT COMPLETED|Overall Study||9
5124252|NCT01463111|12606234|P1|COMPLETED|Overall Study||17
5124253|NCT01463111|12606234|P1|STARTED|Overall Study||26
5124254|NCT01463098|12606256|P14|NOT COMPLETED|Part B (11 Days)||0
5124255|NCT01463098|12606257|P13|NOT COMPLETED|Part B (11 Days)||0
5124256|NCT01463098|12606258|P12|NOT COMPLETED|Part B (11 Days)||1
5124257|NCT01463098|12606259|P11|NOT COMPLETED|Part B (11 Days)||0
5124258|NCT01463098|12606260|P10|NOT COMPLETED|Part B (11 Days)||0
5124259|NCT01463098|12606261|P9|NOT COMPLETED|Part B (11 Days)||0
5124260|NCT01463098|12606262|P8|NOT COMPLETED|Part B (11 Days)||0
5124261|NCT01463098|12606263|P7|NOT COMPLETED|Part B (11 Days)||0
5124262|NCT01463098|12606264|P6|NOT COMPLETED|Part B (11 Days)||0
5124263|NCT01463098|12606265|P5|NOT COMPLETED|Part B (11 Days)||0
5124264|NCT01463098|12606266|P4|NOT COMPLETED|Part B (11 Days)||0
5124265|NCT01463098|12606267|P3|NOT COMPLETED|Part B (11 Days)||0
5124266|NCT01463098|12606268|P2|NOT COMPLETED|Part B (11 Days)||0
5124267|NCT01463098|12606269|P1|NOT COMPLETED|Part B (11 Days)||0
5124268|NCT01463098|12606256|P14|COMPLETED|Part B (11 Days)||12
5124269|NCT01463098|12606257|P13|COMPLETED|Part B (11 Days)||10
5124270|NCT01463098|12606258|P12|COMPLETED|Part B (11 Days)||12
5124271|NCT01463098|12606259|P11|COMPLETED|Part B (11 Days)||11
5124272|NCT01463098|12606260|P10|COMPLETED|Part B (11 Days)||12
5124273|NCT01463098|12606261|P9|COMPLETED|Part B (11 Days)||0
5124274|NCT01463098|12606262|P8|COMPLETED|Part B (11 Days)||0
5124275|NCT01463098|12606263|P7|COMPLETED|Part B (11 Days)||0
5124276|NCT01463098|12606264|P6|COMPLETED|Part B (11 Days)||0
5124277|NCT01463098|12606265|P5|COMPLETED|Part B (11 Days)||0
5124278|NCT01463098|12606266|P4|COMPLETED|Part B (11 Days)||0
5124279|NCT01463098|12606267|P3|COMPLETED|Part B (11 Days)||0
5124280|NCT01463098|12606268|P2|COMPLETED|Part B (11 Days)||0
5124281|NCT01463098|12606269|P1|COMPLETED|Part B (11 Days)||0
5124282|NCT01463098|12606256|P14|STARTED|Part B (11 Days)||12
5124283|NCT01463098|12606257|P13|STARTED|Part B (11 Days)||10
5124284|NCT01463098|12606258|P12|STARTED|Part B (11 Days)||13
5124285|NCT01463098|12606259|P11|STARTED|Part B (11 Days)||11
5124286|NCT01463098|12606260|P10|STARTED|Part B (11 Days)||12
5124287|NCT01463098|12606261|P9|STARTED|Part B (11 Days)||0
5124288|NCT01463098|12606262|P8|STARTED|Part B (11 Days)||0
5124289|NCT01463098|12606263|P7|STARTED|Part B (11 Days)||0
5124290|NCT01463098|12606264|P6|STARTED|Part B (11 Days)||0
5124291|NCT01463098|12606265|P5|STARTED|Part B (11 Days)||0
5124292|NCT01463098|12606266|P4|STARTED|Part B (11 Days)||0
5124293|NCT01463098|12606267|P3|STARTED|Part B (11 Days)||0
5124294|NCT01463098|12606268|P2|STARTED|Part B (11 Days)||0
5124295|NCT01463098|12606269|P1|STARTED|Part B (11 Days)||0
5124296|NCT01463098|12606256|P14|NOT COMPLETED|Part A (11 Days)||0
5124297|NCT01463098|12606257|P13|NOT COMPLETED|Part A (11 Days)||0
5124298|NCT01463098|12606258|P12|NOT COMPLETED|Part A (11 Days)||0
5124299|NCT01463098|12606259|P11|NOT COMPLETED|Part A (11 Days)||0
5124300|NCT01463098|12606260|P10|NOT COMPLETED|Part A (11 Days)||0
5124301|NCT01463098|12606261|P9|NOT COMPLETED|Part A (11 Days)||1
5124302|NCT01463098|12606262|P8|NOT COMPLETED|Part A (11 Days)||0
5124303|NCT01463098|12606263|P7|NOT COMPLETED|Part A (11 Days)||0
5124304|NCT01463098|12606264|P6|NOT COMPLETED|Part A (11 Days)||0
5124305|NCT01463098|12606265|P5|NOT COMPLETED|Part A (11 Days)||1
5124306|NCT01463098|12606266|P4|NOT COMPLETED|Part A (11 Days)||0
5124307|NCT01463098|12606267|P3|NOT COMPLETED|Part A (11 Days)||0
5124308|NCT01463098|12606268|P2|NOT COMPLETED|Part A (11 Days)||0
5124309|NCT01463098|12606269|P1|NOT COMPLETED|Part A (11 Days)||2
5124310|NCT01463098|12606256|P14|COMPLETED|Part A (11 Days)||0
5124311|NCT01463098|12606257|P13|COMPLETED|Part A (11 Days)||0
5124312|NCT01463098|12606258|P12|COMPLETED|Part A (11 Days)||0
5124313|NCT01463098|12606259|P11|COMPLETED|Part A (11 Days)||0
5124314|NCT01463098|12606260|P10|COMPLETED|Part A (11 Days)||0
5124315|NCT01463098|12606261|P9|COMPLETED|Part A (11 Days)||5
5124316|NCT01463098|12606262|P8|COMPLETED|Part A (11 Days)||6
5124317|NCT01463098|12606263|P7|COMPLETED|Part A (11 Days)||6
5124318|NCT01463098|12606264|P6|COMPLETED|Part A (11 Days)||6
5124319|NCT01463098|12606265|P5|COMPLETED|Part A (11 Days)||5
5124320|NCT01463098|12606266|P4|COMPLETED|Part A (11 Days)||6
5124321|NCT01463098|12606267|P3|COMPLETED|Part A (11 Days)||6
5124322|NCT01463098|12606268|P2|COMPLETED|Part A (11 Days)||6
5124323|NCT01463098|12606269|P1|COMPLETED|Part A (11 Days)||14
5124324|NCT01463098|12606256|P14|STARTED|Part A (11 Days)||0
5124325|NCT01463098|12606257|P13|STARTED|Part A (11 Days)||0
5124326|NCT01463098|12606258|P12|STARTED|Part A (11 Days)||0
5124327|NCT01463098|12606259|P11|STARTED|Part A (11 Days)||0
5124328|NCT01463098|12606260|P10|STARTED|Part A (11 Days)||0
5124329|NCT01463098|12606261|P9|STARTED|Part A (11 Days)||6
5124330|NCT01463098|12606262|P8|STARTED|Part A (11 Days)||6
5124331|NCT01463098|12606263|P7|STARTED|Part A (11 Days)||6
5124332|NCT01463098|12606264|P6|STARTED|Part A (11 Days)||6
5124333|NCT01463098|12606265|P5|STARTED|Part A (11 Days)||6
5124334|NCT01463098|12606266|P4|STARTED|Part A (11 Days)||6
5124335|NCT01463098|12606267|P3|STARTED|Part A (11 Days)||6
5124336|NCT01463098|12606268|P2|STARTED|Part A (11 Days)||6
5124337|NCT01463098|12606269|P1|STARTED|Part A (11 Days)||16
5124338|NCT01463033|12606592|P2|NOT COMPLETED|Overall Study||6
5124339|NCT01463033|12606593|P1|NOT COMPLETED|Overall Study||7
5124340|NCT01463033|12606592|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
5124341|NCT01463033|12606593|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
5124342|NCT01463033|12606592|P2|STARTED|Overall Study||60
5124343|NCT01463033|12606593|P1|STARTED|Overall Study||66
5124344|NCT01463007|12606600|P1|NOT COMPLETED|Overall Study||1
5124345|NCT01463007|12606600|P1|COMPLETED|Overall Study||40
5124346|NCT01463007|12606600|P1|STARTED|Overall Study||41
5124347|NCT01462942|12606611|P5|NOT COMPLETED|Overall Study||45
5124348|NCT01462942|12606612|P4|NOT COMPLETED|Overall Study||50
5124349|NCT01462942|12606613|P3|NOT COMPLETED|Overall Study||40
5124350|NCT01462942|12606614|P2|NOT COMPLETED|Overall Study||34
5124351|NCT01462942|12606615|P1|NOT COMPLETED|Overall Study||34
5124352|NCT01462942|12606611|P5|COMPLETED|Overall Study||339
5124353|NCT01462942|12606612|P4|COMPLETED|Overall Study||335
5124354|NCT01462942|12606613|P3|COMPLETED|Overall Study||341
5124355|NCT01462942|12606614|P2|COMPLETED|Overall Study||351
5124356|NCT01462942|12606615|P1|COMPLETED|Overall Study||160
5124357|NCT01462942|12606611|P5|STARTED|Overall Study||384
5124358|NCT01462942|12606612|P4|STARTED|Overall Study||385
5124359|NCT01462942|12606613|P3|STARTED|Overall Study||381
5124360|NCT01462942|12606614|P2|STARTED|Overall Study||385
5124361|NCT01462942|12606615|P1|STARTED|Overall Study||194
5124362|NCT01462929|12606645|P3|NOT COMPLETED|Overall Study||5
5124363|NCT01462929|12606646|P2|NOT COMPLETED|Overall Study||4
5124364|NCT01462929|12606647|P1|NOT COMPLETED|Overall Study||5
5124365|NCT01462929|12606645|P3|COMPLETED|Overall Study||80
5124366|NCT01462929|12606646|P2|COMPLETED|Overall Study||154
5124367|NCT01462929|12606647|P1|COMPLETED|Overall Study||166
5124368|NCT01462929|12606645|P3|STARTED|Overall Study||85
5124369|NCT01462929|12606646|P2|STARTED|Overall Study||158
5124370|NCT01462929|12606647|P1|STARTED|Overall Study||171
5124371|NCT01462877|12606658|P1|NOT COMPLETED|Overall Study||71
5124372|NCT01462877|12606658|P1|COMPLETED|Overall Study||435
5124373|NCT01462877|12606658|P1|Per-protocol Set|Overall Study||364
5124374|NCT01462877|12606658|P1|Full Analysis Set|Overall Study||468
5124375|NCT01462877|12606658|P1|Safety Set|Overall Study||492
5124376|NCT01462877|12606658|P1|STARTED|Overall Study||506
5124377|NCT01462812|12606674|P2|NOT COMPLETED|Overall Study||1
5124378|NCT01462812|12606675|P1|NOT COMPLETED|Overall Study||0
5124379|NCT01462812|12606674|P2|COMPLETED|Overall Study||111
5124380|NCT01462812|12606675|P1|COMPLETED|Overall Study||111
5124381|NCT01462812|12606674|P2|STARTED|Overall Study||112
5124382|NCT01462812|12606675|P1|STARTED|Overall Study||111
5124383|NCT01462773|12606681|P1|NOT COMPLETED|Overall Study||0
5124384|NCT01462773|12606681|P1|COMPLETED|Overall Study||16
5124385|NCT01462773|12606681|P1|STARTED|Overall Study||16
5124386|NCT01462695|12606688|P2|NOT COMPLETED|Overall Study||13
5124387|NCT01462695|12606689|P1|NOT COMPLETED|Overall Study||17
5124388|NCT01462695|12606688|P2|COMPLETED|Overall Study||0
5124389|NCT01462695|12606689|P1|COMPLETED|Overall Study||0
5124390|NCT01462695|12606688|P2|STARTED|Overall Study||13
5124391|NCT01462695|12606689|P1|STARTED|Overall Study||17
5124392|NCT01462565|12606695|P1|NOT COMPLETED|Overall Study||0
5124393|NCT01462565|12606695|P1|COMPLETED|Overall Study||16
5124394|NCT01462565|12606695|P1|STARTED|Overall Study||16
5124395|NCT01462435|12606717|P4|NOT COMPLETED|Overall Study||5
5124396|NCT01462435|12606718|P3|NOT COMPLETED|Overall Study||1
5124397|NCT01462435|12606719|P2|NOT COMPLETED|Overall Study||0
5124398|NCT01462435|12606720|P1|NOT COMPLETED|Overall Study||1
5124399|NCT01462435|12606717|P4|COMPLETED|Overall Study||101
5124400|NCT01462435|12606718|P3|COMPLETED|Overall Study||106
5124401|NCT01462435|12606719|P2|COMPLETED|Overall Study||109
5124402|NCT01462435|12606720|P1|COMPLETED|Overall Study||105
5124403|NCT01462435|12606717|P4|STARTED|Overall Study||106
5124404|NCT01462435|12606718|P3|STARTED|Overall Study||107
5124405|NCT01462435|12606719|P2|STARTED|Overall Study||109
5124406|NCT01462435|12606720|P1|STARTED|Overall Study||106
5124407|NCT01462370|12606758|P2|NOT COMPLETED|Overall Study||5
5124408|NCT01462370|12606759|P1|NOT COMPLETED|Overall Study||1
5124409|NCT01462370|12606758|P2|COMPLETED|Overall Study||65
5124410|NCT01462370|12606759|P1|COMPLETED|Overall Study||68
5124411|NCT01462370|12606758|P2|STARTED|Overall Study||70
5124412|NCT01462370|12606759|P1|STARTED|Overall Study||69
5124413|NCT01462357|12606794|P3|NOT COMPLETED|Overall Study||12
5124414|NCT01462357|12606795|P2|NOT COMPLETED|Overall Study||19
5124415|NCT01462357|12606796|P1|NOT COMPLETED|Overall Study||8
5124416|NCT01462357|12606794|P3|COMPLETED|Overall Study||346
5124417|NCT01462357|12606795|P2|COMPLETED|Overall Study||339
5124418|NCT01462357|12606796|P1|COMPLETED|Overall Study||351
5124419|NCT01462357|12606794|P3|STARTED|Overall Study||358
5124420|NCT01462357|12606795|P2|STARTED|Overall Study||358
5124421|NCT01462357|12606796|P1|STARTED|Overall Study||359
5124422|NCT01462344|12606869|P2|NOT COMPLETED|Overall Study||350
5124423|NCT01462344|12606870|P1|NOT COMPLETED|Overall Study||383
5124424|NCT01462344|12606869|P2|COMPLETED|Overall Study||2751
5124425|NCT01462344|12606870|P1|COMPLETED|Overall Study||2724
5124426|NCT01462344|12606869|P2|STARTED|Overall Study||3101
5124427|NCT01462344|12606870|P1|STARTED|Overall Study||3107
5124428|NCT01462318|12606892|P3|NOT COMPLETED|Extension Phase||45
5124429|NCT01462318|12606893|P2|NOT COMPLETED|Extension Phase||0
5124430|NCT01462318|12606894|P1|NOT COMPLETED|Extension Phase||0
5124431|NCT01462318|12606892|P3|COMPLETED|Extension Phase||70
5124432|NCT01462318|12606893|P2|COMPLETED|Extension Phase||0
5124433|NCT01462318|12606894|P1|COMPLETED|Extension Phase||0
5124434|NCT01462318|12606892|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
5124435|NCT01462318|12606893|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
5124436|NCT01462318|12606894|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
5124437|NCT01462318|12606892|P3|NOT COMPLETED|Main Study / TP-DI Study||0
5124438|NCT01462318|12606893|P2|NOT COMPLETED|Main Study / TP-DI Study||0
5124439|NCT01462318|12606894|P1|NOT COMPLETED|Main Study / TP-DI Study||8
5124440|NCT01462318|12606892|P3|COMPLETED|Main Study / TP-DI Study||0
5124441|NCT01462318|12606893|P2|COMPLETED|Main Study / TP-DI Study||20
5124442|NCT01462318|12606894|P1|COMPLETED|Main Study / TP-DI Study||105
5124443|NCT01462318|12606892|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
5124444|NCT01462318|12606893|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
5124445|NCT01462318|12606894|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
5124446|NCT01462318|12606892|P3|STARTED|Main Study / TP-DI Study||0
5124447|NCT01462318|12606893|P2|STARTED|Main Study / TP-DI Study||20
5124448|NCT01462318|12606894|P1|STARTED|Main Study / TP-DI Study||113
5124449|NCT01462305|12606913|P2|NOT COMPLETED|Overall Study||4
5124450|NCT01462305|12606914|P1|NOT COMPLETED|Overall Study||2
5124451|NCT01462305|12606913|P2|COMPLETED|Overall Study||13
5124452|NCT01462305|12606914|P1|COMPLETED|Overall Study||16
5124453|NCT01462305|12606913|P2|STARTED|Overall Study||17
5124454|NCT01462305|12606914|P1|STARTED|Overall Study||18
5124455|NCT01462292|12606927|P3|NOT COMPLETED|Overall Study||0
5124456|NCT01462292|12606928|P2|NOT COMPLETED|Overall Study||0
5124457|NCT01462292|12606929|P1|NOT COMPLETED|Overall Study||0
5124458|NCT01462292|12606927|P3|COMPLETED|Overall Study||18
5124459|NCT01462292|12606928|P2|COMPLETED|Overall Study||17
5124460|NCT01462292|12606929|P1|COMPLETED|Overall Study||16
5124461|NCT01462292|12606927|P3|STARTED|Overall Study||18
5124462|NCT01462292|12606928|P2|STARTED|Overall Study||17
5124463|NCT01462292|12606929|P1|STARTED|Overall Study||16
5124464|NCT01462279|12606988|P1|NOT COMPLETED|Overall Study||3
5124465|NCT01462279|12606988|P1|COMPLETED|Overall Study||17
5124466|NCT01462279|12606988|P1|STARTED|Overall Study||20
5124467|NCT01462266|12606995|P2|NOT COMPLETED|Overall Study||27
5124468|NCT01462266|12606996|P1|NOT COMPLETED|Overall Study||35
5124469|NCT01462266|12606995|P2|COMPLETED|Overall Study||303
5124470|NCT01462266|12606996|P1|COMPLETED|Overall Study||295
5124471|NCT01462266|12606995|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
5124472|NCT01462266|12606996|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
5124473|NCT01462266|12606995|P2|STARTED|Overall Study||330
5124474|NCT01462266|12606996|P1|STARTED|Overall Study||330
5124475|NCT01462253|12607010|P1|NOT COMPLETED|Overall Study||8
5124476|NCT01462253|12607010|P1|COMPLETED|Overall Study||27
5124477|NCT01462253|12607010|P1|STARTED|Overall Study||35
5124478|NCT01462227|12607021|P4|NOT COMPLETED|Second Assignment||0
5124479|NCT01462227|12607022|P3|NOT COMPLETED|Second Assignment||1
5124480|NCT01462227|12607023|P2|NOT COMPLETED|Second Assignment||1
5124481|NCT01462227|12607024|P1|NOT COMPLETED|Second Assignment||1
5124482|NCT01462227|12607021|P4|COMPLETED|Second Assignment||5
5124483|NCT01462227|12607022|P3|COMPLETED|Second Assignment||5
5124484|NCT01462227|12607023|P2|COMPLETED|Second Assignment||1
5124485|NCT01462227|12607024|P1|COMPLETED|Second Assignment||3
5124486|NCT01462227|12607021|P4|STARTED|Second Assignment||5
5124487|NCT01462227|12607022|P3|STARTED|Second Assignment||6
5124488|NCT01462227|12607023|P2|STARTED|Second Assignment||2
5124489|NCT01462227|12607024|P1|STARTED|Second Assignment||4
5124490|NCT01462227|12607021|P4|NOT COMPLETED|First Assignment||0
5124491|NCT01462227|12607022|P3|NOT COMPLETED|First Assignment||0
5124492|NCT01462227|12607023|P2|NOT COMPLETED|First Assignment||0
5124493|NCT01462227|12607024|P1|NOT COMPLETED|First Assignment||0
5124494|NCT01462227|12607021|P4|COMPLETED|First Assignment||5
5124495|NCT01462227|12607022|P3|COMPLETED|First Assignment||6
5124496|NCT01462227|12607023|P2|COMPLETED|First Assignment||2
5124497|NCT01462227|12607024|P1|COMPLETED|First Assignment||4
5124498|NCT01462227|12607021|P4|STARTED|First Assignment||5
5124499|NCT01462227|12607022|P3|STARTED|First Assignment||6
5124500|NCT01462227|12607023|P2|STARTED|First Assignment||2
5124501|NCT01462227|12607024|P1|STARTED|First Assignment||4
5124502|NCT01462162|12607042|P1|NOT COMPLETED|Overall Study||12
5124503|NCT01462162|12607042|P1|COMPLETED|Overall Study||108
5124504|NCT01462162|12607042|P1|STARTED|Overall Study||120
5124505|NCT01462110|12607069|P2|NOT COMPLETED|Overall Study||0
5124506|NCT01462110|12607070|P1|NOT COMPLETED|Overall Study||1
5124507|NCT01462110|12607069|P2|COMPLETED|Overall Study||43
5124508|NCT01462110|12607070|P1|COMPLETED|Overall Study||43
5124509|NCT01462110|12607069|P2|STARTED|Overall Study||43
5124510|NCT01462110|12607070|P1|STARTED|Overall Study||44
5124511|NCT01462084|12607090|P2|NOT COMPLETED|Overall Study||1
5124512|NCT01462084|12607091|P1|NOT COMPLETED|Overall Study||2
5124513|NCT01462084|12607090|P2|COMPLETED|Overall Study||9
5124514|NCT01462084|12607091|P1|COMPLETED|Overall Study||9
5124515|NCT01462084|12607090|P2|Included for Analysis|Overall Study||9
5124516|NCT01462084|12607091|P1|Included for Analysis|Overall Study||9
5124517|NCT01462084|12607090|P2|STARTED|Overall Study||10
5124518|NCT01462084|12607091|P1|STARTED|Overall Study||11
5124519|NCT01462045|12607102|P3|NOT COMPLETED|Overall Study||0
5124520|NCT01462045|12607103|P2|NOT COMPLETED|Overall Study||1
5124521|NCT01462045|12607104|P1|NOT COMPLETED|Overall Study||0
5124522|NCT01462045|12607102|P3|COMPLETED|Overall Study||7
5124523|NCT01462045|12607103|P2|COMPLETED|Overall Study||10
5124524|NCT01462045|12607104|P1|COMPLETED|Overall Study||11
5124525|NCT01462045|12607102|P3|STARTED|Overall Study||7
5124526|NCT01462045|12607103|P2|STARTED|Overall Study||11
5124527|NCT01462045|12607104|P1|STARTED|Overall Study||11
5124528|NCT01461993|12607118|P3|NOT COMPLETED|Overall Study||64
5124529|NCT01461993|12607119|P2|NOT COMPLETED|Overall Study||157
5124530|NCT01461993|12607120|P1|NOT COMPLETED|Overall Study||151
5124531|NCT01461993|12607118|P3|COMPLETED|Overall Study||438
5124532|NCT01461993|12607119|P2|COMPLETED|Overall Study||841
5124533|NCT01461993|12607120|P1|COMPLETED|Overall Study||848
5124534|NCT01461993|12607118|P3|STARTED|Overall Study||502
5124535|NCT01461993|12607119|P2|STARTED|Overall Study||998
5124536|NCT01461993|12607120|P1|STARTED|Overall Study||999
5124537|NCT01461980|12607145|P3|NOT COMPLETED|Overall Study||165
5124538|NCT01461980|12607146|P2|NOT COMPLETED|Overall Study||145
5124539|NCT01461980|12607147|P1|NOT COMPLETED|Overall Study||166
5124540|NCT01461980|12607145|P3|COMPLETED|Overall Study||717
5124541|NCT01461980|12607146|P2|COMPLETED|Overall Study||733
5124542|NCT01461980|12607147|P1|COMPLETED|Overall Study||722
5124543|NCT01461980|12607145|P3|Vaccination 3|Overall Study||748
5124544|NCT01461980|12607146|P2|Vaccination 3|Overall Study||777
5124545|NCT01461980|12607147|P1|Vaccination 3|Overall Study||757
5124546|NCT01461980|12607145|P3|Vaccination 2|Overall Study||799
5124547|NCT01461980|12607146|P2|Vaccination 2|Overall Study||819
5124548|NCT01461980|12607147|P1|Vaccination 2|Overall Study||802
5124549|NCT01461980|12607145|P3|Vaccination 1|Overall Study||875
5124550|NCT01461980|12607146|P2|Vaccination 1|Overall Study||870
5124551|NCT01461980|12607147|P1|Vaccination 1|Overall Study||884
5124552|NCT01461980|12607145|P3|STARTED|Overall Study||882
5124553|NCT01461980|12607146|P2|STARTED|Overall Study||878
5124554|NCT01461980|12607147|P1|STARTED|Overall Study||888
5124555|NCT01461928|12607177|P3|NOT COMPLETED|Maintenance II (15 Months)||27
5124556|NCT01461928|12607178|P2|NOT COMPLETED|Maintenance II (15 Months)||23
5124557|NCT01461928|12607179|P1|NOT COMPLETED|Maintenance II (15 Months)||0
5124558|NCT01461928|12607177|P3|COMPLETED|Maintenance II (15 Months)||111
5124559|NCT01461928|12607178|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
5124560|NCT01461928|12607179|P1|COMPLETED|Maintenance II (15 Months)||0
5124561|NCT01461928|12607177|P3|STARTED|Maintenance II (15 Months)||138
5124562|NCT01461928|12607178|P2|STARTED|Maintenance II (15 Months)||138
5124563|NCT01461928|12607179|P1|STARTED|Maintenance II (15 Months)||0
5124564|NCT01461928|12607177|P3|NOT COMPLETED|Maintenance I (24 Months)||0
5124565|NCT01461928|12607178|P2|NOT COMPLETED|Maintenance I (24 Months)||0
5124566|NCT01461928|12607179|P1|NOT COMPLETED|Maintenance I (24 Months)||218
5124567|NCT01461928|12607177|P3|COMPLETED|Maintenance I (24 Months)||0
5124568|NCT01461928|12607178|P2|COMPLETED|Maintenance I (24 Months)||0
5124569|NCT01461928|12607179|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
5124570|NCT01461928|12607177|P3|STARTED|Maintenance I (24 Months)||0
5124571|NCT01461928|12607178|P2|STARTED|Maintenance I (24 Months)||0
5124572|NCT01461928|12607179|P1|STARTED|Maintenance I (24 Months)||494
5124573|NCT01461928|12607177|P3|NOT COMPLETED|Induction (up to 8 Months)||0
5124574|NCT01461928|12607178|P2|NOT COMPLETED|Induction (up to 8 Months)||0
5124575|NCT01461928|12607179|P1|NOT COMPLETED|Induction (up to 8 Months)||198
5124576|NCT01461928|12607177|P3|COMPLETED|Induction (up to 8 Months)||0
5124577|NCT01461928|12607178|P2|COMPLETED|Induction (up to 8 Months)||0
5124578|NCT01461928|12607179|P1|COMPLETED|Induction (up to 8 Months)||494
5124579|NCT01461928|12607177|P3|STARTED|Induction (up to 8 Months)||0
5124580|NCT01461928|12607178|P2|STARTED|Induction (up to 8 Months)||0
5124581|NCT01461928|12607179|P1|STARTED|Induction (up to 8 Months)||692
5124582|NCT01461863|12607200|P2|NOT COMPLETED|Overall Study||0
5124583|NCT01461863|12607201|P1|NOT COMPLETED|Overall Study||0
5124584|NCT01461863|12607200|P2|COMPLETED|Overall Study||48
5124585|NCT01461863|12607201|P1|COMPLETED|Overall Study||48
5124586|NCT01461863|12607200|P2|STARTED|Overall Study||48
5124587|NCT01461863|12607201|P1|STARTED|Overall Study||48
5124588|NCT01461824|12607212|P3|NOT COMPLETED|Overall Study||3
5124589|NCT01461824|12607213|P2|NOT COMPLETED|Overall Study||4
5124590|NCT01461824|12607214|P1|NOT COMPLETED|Overall Study||2
5124591|NCT01461824|12607212|P3|COMPLETED|Overall Study||8
5124592|NCT01461824|12607213|P2|COMPLETED|Overall Study||7
5124593|NCT01461824|12607214|P1|COMPLETED|Overall Study||10
5124594|NCT01461824|12607212|P3|STARTED|Overall Study||11
5124595|NCT01461824|12607213|P2|STARTED|Overall Study||11
5124596|NCT01461824|12607214|P1|STARTED|Overall Study||12
5124597|NCT01461811|12607230|P2|NOT COMPLETED|Overall Study||3
5124598|NCT01461811|12607231|P1|NOT COMPLETED|Overall Study||4
5124599|NCT01461811|12607230|P2|COMPLETED|Overall Study||46
5124600|NCT01461811|12607231|P1|COMPLETED|Overall Study||91
5124601|NCT01461811|12607230|P2|STARTED|Overall Study||49
5124602|NCT01461811|12607231|P1|STARTED|Overall Study||95
5124603|NCT01461733|12607261|P2|NOT COMPLETED|Overall Study||4
5124604|NCT01461733|12607262|P1|NOT COMPLETED|Overall Study||4
5124605|NCT01461733|12607261|P2|COMPLETED|Overall Study||8
5124606|NCT01461733|12607262|P1|COMPLETED|Overall Study||8
5124607|NCT01461733|12607261|P2|STARTED|Overall Study||12
5124608|NCT01461733|12607262|P1|STARTED|Overall Study||12
5124609|NCT01461707|12607270|P2|NOT COMPLETED|Overall Study||0
5124610|NCT01461707|12607271|P1|NOT COMPLETED|Overall Study||1
5124611|NCT01461707|12607270|P2|COMPLETED|Overall Study||15
5124612|NCT01461707|12607271|P1|COMPLETED|Overall Study||14
5124613|NCT01461707|12607270|P2|STARTED|Overall Study||15
5124614|NCT01461707|12607271|P1|STARTED|Overall Study||15
5124615|NCT01461668|12607281|P2|NOT COMPLETED|Overall Study||1
5124616|NCT01461668|12607282|P1|NOT COMPLETED|Overall Study||2
5124617|NCT01461668|12607281|P2|COMPLETED|Overall Study||25
5124618|NCT01461668|12607282|P1|COMPLETED|Overall Study||25
5124619|NCT01461668|12607281|P2|STARTED|Overall Study||26
5124620|NCT01461668|12607282|P1|STARTED|Overall Study||27
5124621|NCT01461655|12607288|P1|NOT COMPLETED|Overall Study||0
5124622|NCT01461655|12607288|P1|COMPLETED|Overall Study||40
5124623|NCT01461655|12607288|P1|STARTED|Overall Study||40
5124624|NCT01461551|12607308|P3|NOT COMPLETED|Overall Study||2
5124625|NCT01461551|12607309|P2|NOT COMPLETED|Overall Study||1
5124626|NCT01461551|12607310|P1|NOT COMPLETED|Overall Study||2
5124627|NCT01461551|12607308|P3|COMPLETED|Overall Study||33
5124628|NCT01461551|12607309|P2|COMPLETED|Overall Study||34
5124629|NCT01461551|12607310|P1|COMPLETED|Overall Study||33
5124630|NCT01461551|12607308|P3|STARTED|Overall Study||35
5124631|NCT01461551|12607309|P2|STARTED|Overall Study||35
5124632|NCT01461551|12607310|P1|STARTED|Overall Study||35
5124633|NCT01461538|12607321|P3|NOT COMPLETED|Overall Study||2
5124634|NCT01461538|12607322|P2|NOT COMPLETED|Overall Study||8
5124635|NCT01461538|12607323|P1|NOT COMPLETED|Overall Study||18
5124636|NCT01461538|12607321|P3|COMPLETED|Overall Study||7
5124637|NCT01461538|12607322|P2|COMPLETED|Overall Study||20
5124638|NCT01461538|12607323|P1|COMPLETED|Overall Study||28
5124639|NCT01461538|12607321|P3|STARTED|Overall Study||9
5124640|NCT01461538|12607322|P2|STARTED|Overall Study||28
5124641|NCT01461538|12607323|P1|STARTED|Overall Study||46
5124642|NCT01461499|12607361|P2|NOT COMPLETED|Overall Study||4
5124643|NCT01461499|12607362|P1|NOT COMPLETED|Overall Study||8
5124644|NCT01461499|12607361|P2|COMPLETED|Overall Study||114
5124645|NCT01461499|12607362|P1|COMPLETED|Overall Study||111
5124646|NCT01461499|12607361|P2|STARTED|Overall Study||118
5124647|NCT01461499|12607362|P1|STARTED|Overall Study||119
5124648|NCT01461473|12607372|P2|NOT COMPLETED|Overall Study||4
5124649|NCT01461473|12607373|P1|NOT COMPLETED|Overall Study||5
5124650|NCT01461473|12607372|P2|COMPLETED|Overall Study||55
5124651|NCT01461473|12607373|P1|COMPLETED|Overall Study||67
5124652|NCT01461473|12607372|P2|STARTED|Overall Study||59
5124653|NCT01461473|12607373|P1|STARTED|Overall Study||72
5124654|NCT01461369|12607392|P3|NOT COMPLETED|Overall Study||17
5124655|NCT01461369|12607393|P2|NOT COMPLETED|Overall Study||17
5124656|NCT01461369|12607394|P1|NOT COMPLETED|Overall Study||13
5124657|NCT01461369|12607392|P3|COMPLETED|Overall Study||86
5124658|NCT01461369|12607393|P2|COMPLETED|Overall Study||81
5124659|NCT01461369|12607394|P1|COMPLETED|Overall Study||91
5124660|NCT01461369|12607392|P3|STARTED|Overall Study||103
5124661|NCT01461369|12607393|P2|STARTED|Overall Study||98
5124662|NCT01461369|12607394|P1|STARTED|Overall Study||104
5124663|NCT01461096|12607419|P2|NOT COMPLETED|Overall Study||61
5124664|NCT01461096|12607420|P1|NOT COMPLETED|Overall Study||62
5124665|NCT01461096|12607419|P2|COMPLETED|Overall Study||226
5124666|NCT01461096|12607420|P1|COMPLETED|Overall Study||226
5124667|NCT01461096|12607419|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
5124668|NCT01461096|12607420|P1|Did Not Start Treatment|Overall Study||0
5124669|NCT01461096|12607419|P2|STARTED|Overall Study||287
5124670|NCT01461096|12607420|P1|STARTED|Overall Study||288
5124671|NCT01461057|12607436|P2|NOT COMPLETED|Overall Study||15
5124672|NCT01461057|12607437|P1|NOT COMPLETED|Overall Study||15
5124673|NCT01461057|12607436|P2|COMPLETED|Overall Study||0
5124674|NCT01461057|12607437|P1|COMPLETED|Overall Study||0
5124675|NCT01461057|12607436|P2|STARTED|Overall Study||15
5124676|NCT01461057|12607437|P1|STARTED|Overall Study||15
5124677|NCT01461044|12607447|P2|NOT COMPLETED|Overall Study||40
5124678|NCT01461044|12607448|P1|NOT COMPLETED|Overall Study||70
5124679|NCT01461044|12607447|P2|COMPLETED|Overall Study||37
5124680|NCT01461044|12607448|P1|COMPLETED|Overall Study||80
5124681|NCT01461044|12607447|P2|Participants Alive at Inclusion|Overall Study||58
5124682|NCT01461044|12607448|P1|Participants Alive at Inclusion|Overall Study||127
5124683|NCT01461044|12607447|P2|STARTED|Overall Study||77
5124684|NCT01461044|12607448|P1|STARTED|Overall Study||150
5124685|NCT01461005|12607521|P1|NOT COMPLETED|Overall Study||1
5124686|NCT01461005|12607521|P1|COMPLETED|Overall Study||0
5124687|NCT01461005|12607521|P1|STARTED|Overall Study||1
5124688|NCT01460940|12607530|P1|NOT COMPLETED|Overall Study||0
5124689|NCT01460940|12607530|P1|COMPLETED|Overall Study||24
5124690|NCT01460940|12607530|P1|STARTED|Overall Study||24
5124691|NCT01460927|12607536|P1|NOT COMPLETED|Overall Study||0
5124692|NCT01460927|12607536|P1|COMPLETED|Overall Study||25
5124693|NCT01460927|12607536|P1|STARTED|Overall Study||25
5124694|NCT01460901|12607544|P1|NOT COMPLETED|Overall Study||2
5124695|NCT01460901|12607544|P1|COMPLETED|Overall Study|Follow-up completed|3
5124696|NCT01460901|12607544|P1|tV-CTL Infusion|Overall Study||3
5124697|NCT01460901|12607544|P1|STARTED|Overall Study|First enrollment|5
5124698|NCT01460875|12607552|P1|NOT COMPLETED|Overall Study||0
5124699|NCT01460875|12607552|P1|COMPLETED|Overall Study||34
5124700|NCT01460875|12607552|P1|STARTED|Overall Study||34
5124701|NCT01460732|12607563|P1|NOT COMPLETED|Overall Study||0
5124702|NCT01460732|12607563|P1|COMPLETED|Overall Study||81
5124703|NCT01460732|12607563|P1|STARTED|Overall Study||81
5124704|NCT01460719|12607576|P1|NOT COMPLETED|Overall Study||2
5124705|NCT01460719|12607576|P1|COMPLETED|Overall Study||78
5124706|NCT01460719|12607576|P1|Vaccination 4 (~Day 90)|Overall Study||78
5124707|NCT01460719|12607576|P1|Vaccination 3 (~Day 60)|Overall Study||78
5124708|NCT01460719|12607576|P1|Vaccination 2 (~Day 30)|Overall Study||78
5124709|NCT01460719|12607576|P1|Vaccination 1 (Day 1)|Overall Study||80
5124710|NCT01460719|12607576|P1|STARTED|Overall Study||80
5124711|NCT01460628|12607586|P1|NOT COMPLETED|Overall Study||5
5124712|NCT01460628|12607586|P1|COMPLETED|Overall Study||20
5124713|NCT01460628|12607586|P1|STARTED|Overall Study||25
5124714|NCT01460446|12607598|P2|NOT COMPLETED|Overall Study||20
5124715|NCT01460446|12607599|P1|NOT COMPLETED|Overall Study||5
5124716|NCT01460446|12607598|P2|COMPLETED|Overall Study||93
5124717|NCT01460446|12607599|P1|COMPLETED|Overall Study||100
5124718|NCT01460446|12607598|P2|STARTED|Overall Study||113
5124719|NCT01460446|12607599|P1|STARTED|Overall Study||105
5124720|NCT01460407|12607626|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
5124721|NCT01460407|12607627|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
5124722|NCT01460407|12607626|P2|COMPLETED|Period 2: Day 6 to Day 14||13
5124723|NCT01460407|12607627|P1|COMPLETED|Period 2: Day 6 to Day 14||0
5124724|NCT01460407|12607626|P2|STARTED|Period 2: Day 6 to Day 14||14
5124725|NCT01460407|12607627|P1|STARTED|Period 2: Day 6 to Day 14||0
5124726|NCT01460407|12607626|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
5124727|NCT01460407|12607627|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
5124728|NCT01460407|12607626|P2|COMPLETED|Period 1: Day 1 to Day 5||0
5124729|NCT01460407|12607627|P1|COMPLETED|Period 1: Day 1 to Day 5||14
5124730|NCT01460407|12607626|P2|STARTED|Period 1: Day 1 to Day 5||0
5124731|NCT01460407|12607627|P1|STARTED|Period 1: Day 1 to Day 5||14
5124732|NCT01460381|12607640|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
5124733|NCT01460381|12607641|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
5124734|NCT01460381|12607640|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
5124735|NCT01460381|12607641|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
5124736|NCT01460381|12607640|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
5124737|NCT01460381|12607641|P1|STARTED|Period 2 (Days 8-15)||7
5124738|NCT01460381|12607640|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
5124739|NCT01460381|12607641|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
5124740|NCT01460381|12607640|P2|COMPLETED|Period 1 (Days 1-7)||11
5124741|NCT01460381|12607641|P1|COMPLETED|Period 1 (Days 1-7)||7
5124742|NCT01460381|12607640|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
5124743|NCT01460381|12607641|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
5124744|NCT01460381|12607640|P2|STARTED|Period 1 (Days 1-7)||11
5124745|NCT01460381|12607641|P1|STARTED|Period 1 (Days 1-7)||7
5124746|NCT01460368|12607657|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
5124747|NCT01460368|12607658|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
5124748|NCT01460368|12607659|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
5124749|NCT01460368|12607660|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
5124750|NCT01460368|12607661|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
5124751|NCT01460368|12607662|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
5124752|NCT01460368|12607663|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
5124753|NCT01460368|12607657|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
5124754|NCT01460368|12607658|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
5124755|NCT01460368|12607659|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
5124756|NCT01460368|12607660|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
5124757|NCT01460368|12607661|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
5124758|NCT01460368|12607662|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
5124759|NCT01460368|12607663|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
5124760|NCT01460368|12607657|P7|STARTED|Part B: Third Interventions (Period 3)||9
5124761|NCT01460368|12607658|P6|STARTED|Part B: Third Interventions (Period 3)||10
5124762|NCT01460368|12607659|P5|STARTED|Part B: Third Interventions (Period 3)||9
5124763|NCT01460368|12607660|P4|STARTED|Part B: Third Interventions (Period 3)||10
5124764|NCT01460368|12607661|P3|STARTED|Part B: Third Interventions (Period 3)||9
5124765|NCT01460368|12607662|P2|STARTED|Part B: Third Interventions (Period 3)||8
5124766|NCT01460368|12607663|P1|STARTED|Part B: Third Interventions (Period 3)||0
5124767|NCT01460368|12607657|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124768|NCT01460368|12607658|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124769|NCT01460368|12607659|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124770|NCT01460368|12607660|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124771|NCT01460368|12607661|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
5124772|NCT01460368|12607662|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124773|NCT01460368|12607663|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124774|NCT01460368|12607657|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
5124775|NCT01460368|12607658|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
5124776|NCT01460368|12607659|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
5124777|NCT01460368|12607660|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
5124778|NCT01460368|12607661|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
5124779|NCT01460368|12607662|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
5124780|NCT01460368|12607663|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
5124781|NCT01460368|12607657|P7|STARTED|Part B: Washout (up to 15 Days)||9
5124782|NCT01460368|12607658|P6|STARTED|Part B: Washout (up to 15 Days)||10
5124783|NCT01460368|12607659|P5|STARTED|Part B: Washout (up to 15 Days)||9
5124784|NCT01460368|12607660|P4|STARTED|Part B: Washout (up to 15 Days)||10
5124785|NCT01460368|12607661|P3|STARTED|Part B: Washout (up to 15 Days)||10
5124786|NCT01460368|12607662|P2|STARTED|Part B: Washout (up to 15 Days)||8
5124787|NCT01460368|12607663|P1|STARTED|Part B: Washout (up to 15 Days)||0
5124788|NCT01460368|12607657|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
5124789|NCT01460368|12607658|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
5124790|NCT01460368|12607659|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
5124791|NCT01460368|12607660|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
5124792|NCT01460368|12607661|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
5124793|NCT01460368|12607662|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
5124794|NCT01460368|12607663|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
5124795|NCT01460368|12607657|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
5124796|NCT01460368|12607658|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
5124797|NCT01460368|12607659|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
5124798|NCT01460368|12607660|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
5124799|NCT01460368|12607661|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
5124800|NCT01460368|12607662|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
5124801|NCT01460368|12607663|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
5124802|NCT01460368|12607657|P7|STARTED|Part B: Second Intervention (Period 2)||10
5124803|NCT01460368|12607658|P6|STARTED|Part B: Second Intervention (Period 2)||10
5124804|NCT01460368|12607659|P5|STARTED|Part B: Second Intervention (Period 2)||9
5124805|NCT01460368|12607660|P4|STARTED|Part B: Second Intervention (Period 2)||10
5124806|NCT01460368|12607661|P3|STARTED|Part B: Second Intervention (Period 2)||10
5124807|NCT01460368|12607662|P2|STARTED|Part B: Second Intervention (Period 2)||10
5124808|NCT01460368|12607663|P1|STARTED|Part B: Second Intervention (Period 2)||0
5124809|NCT01460368|12607657|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124810|NCT01460368|12607658|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124811|NCT01460368|12607659|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124812|NCT01460368|12607660|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124813|NCT01460368|12607661|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124814|NCT01460368|12607662|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124815|NCT01460368|12607663|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
5124816|NCT01460368|12607657|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
5124817|NCT01460368|12607658|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
5124818|NCT01460368|12607659|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
5124819|NCT01460368|12607660|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
5124820|NCT01460368|12607661|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
5124821|NCT01460368|12607662|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
5124822|NCT01460368|12607663|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
5124823|NCT01460368|12607657|P7|STARTED|Part B: Washout (up to 15 Days)||10
5124824|NCT01460368|12607658|P6|STARTED|Part B: Washout (up to 15 Days)||10
5124825|NCT01460368|12607659|P5|STARTED|Part B: Washout (up to 15 Days)||9
5124826|NCT01460368|12607660|P4|STARTED|Part B: Washout (up to 15 Days)||10
5124827|NCT01460368|12607661|P3|STARTED|Part B: Washout (up to 15 Days)||10
5124828|NCT01460368|12607662|P2|STARTED|Part B: Washout (up to 15 Days)||10
5124829|NCT01460368|12607663|P1|STARTED|Part B: Washout (up to 15 Days)||0
5124830|NCT01460368|12607657|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124831|NCT01460368|12607658|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124832|NCT01460368|12607659|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
5124833|NCT01460368|12607660|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124834|NCT01460368|12607661|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124835|NCT01460368|12607662|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124836|NCT01460368|12607663|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
5124837|NCT01460368|12607657|P7|COMPLETED|Part B: First Intervention (Period 1)||10
5124838|NCT01460368|12607658|P6|COMPLETED|Part B: First Intervention (Period 1)||10
5124839|NCT01460368|12607659|P5|COMPLETED|Part B: First Intervention (Period 1)||9
5124840|NCT01460368|12607660|P4|COMPLETED|Part B: First Intervention (Period 1)||10
5124841|NCT01460368|12607661|P3|COMPLETED|Part B: First Intervention (Period 1)||10
5124842|NCT01460368|12607662|P2|COMPLETED|Part B: First Intervention (Period 1)||10
5124843|NCT01460368|12607663|P1|COMPLETED|Part B: First Intervention (Period 1)||0
5124844|NCT01460368|12607657|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124845|NCT01460368|12607658|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124846|NCT01460368|12607659|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124847|NCT01460368|12607660|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124848|NCT01460368|12607661|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124849|NCT01460368|12607662|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
5124850|NCT01460368|12607663|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
5124851|NCT01460368|12607657|P7|STARTED|Part B: First Intervention (Period 1)||10
5124852|NCT01460368|12607658|P6|STARTED|Part B: First Intervention (Period 1)||10
5124853|NCT01460368|12607659|P5|STARTED|Part B: First Intervention (Period 1)||10
5124854|NCT01460368|12607660|P4|STARTED|Part B: First Intervention (Period 1)||10
5124855|NCT01460368|12607661|P3|STARTED|Part B: First Intervention (Period 1)||10
5124856|NCT01460368|12607662|P2|STARTED|Part B: First Intervention (Period 1)||10
5124857|NCT01460368|12607663|P1|STARTED|Part B: First Intervention (Period 1)||0
5124858|NCT01460368|12607657|P7|NOT COMPLETED|Part A||0
5124859|NCT01460368|12607658|P6|NOT COMPLETED|Part A||0
5124860|NCT01460368|12607659|P5|NOT COMPLETED|Part A||0
5124861|NCT01460368|12607660|P4|NOT COMPLETED|Part A||0
5124862|NCT01460368|12607661|P3|NOT COMPLETED|Part A||0
5124863|NCT01460368|12607662|P2|NOT COMPLETED|Part A||0
5124864|NCT01460368|12607663|P1|NOT COMPLETED|Part A||0
5124865|NCT01460368|12607657|P7|COMPLETED|Part A||0
5124866|NCT01460368|12607658|P6|COMPLETED|Part A||0
5124867|NCT01460368|12607659|P5|COMPLETED|Part A||0
5124868|NCT01460368|12607660|P4|COMPLETED|Part A||0
5124869|NCT01460368|12607661|P3|COMPLETED|Part A||0
5124870|NCT01460368|12607662|P2|COMPLETED|Part A||0
5124871|NCT01460368|12607663|P1|COMPLETED|Part A||7
5124872|NCT01460368|12607657|P7|Received at Least One Dose of Study Drug|Part A||0
5124873|NCT01460368|12607658|P6|Received at Least One Dose of Study Drug|Part A||0
5124874|NCT01460368|12607659|P5|Received at Least One Dose of Study Drug|Part A||0
5124875|NCT01460368|12607660|P4|Received at Least One Dose of Study Drug|Part A||0
5124876|NCT01460368|12607661|P3|Received at Least One Dose of Study Drug|Part A||0
5124877|NCT01460368|12607662|P2|Received at Least One Dose of Study Drug|Part A||0
5124878|NCT01460368|12607663|P1|Received at Least One Dose of Study Drug|Part A||7
5124879|NCT01460368|12607657|P7|STARTED|Part A||0
5124880|NCT01460368|12607658|P6|STARTED|Part A||0
5124881|NCT01460368|12607659|P5|STARTED|Part A||0
5124882|NCT01460368|12607660|P4|STARTED|Part A||0
5124883|NCT01460368|12607661|P3|STARTED|Part A||0
5124884|NCT01460368|12607662|P2|STARTED|Part A||0
5124885|NCT01460368|12607663|P1|STARTED|Part A||7
5124886|NCT01460342|12607675|P2|NOT COMPLETED|Overall Study||14
5124887|NCT01460342|12607676|P1|NOT COMPLETED|Overall Study||11
5124888|NCT01460342|12607675|P2|COMPLETED|Overall Study||292
5124889|NCT01460342|12607676|P1|COMPLETED|Overall Study||293
5124890|NCT01460342|12607675|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
5124891|NCT01460342|12607676|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
5124892|NCT01460342|12607675|P2|STARTED|Overall Study||306
5124893|NCT01460342|12607676|P1|STARTED|Overall Study||304
5124894|NCT01460303|12607698|P2|NOT COMPLETED|Overall Study||0
5124895|NCT01460303|12607699|P1|NOT COMPLETED|Overall Study||0
5124896|NCT01460303|12607698|P2|COMPLETED|Overall Study||24
5124897|NCT01460303|12607699|P1|COMPLETED|Overall Study||25
5124898|NCT01460303|12607698|P2|STARTED|Overall Study||24
5124899|NCT01460303|12607699|P1|STARTED|Overall Study||25
5124900|NCT01460290|12607707|P1|NOT COMPLETED|Overall Study||4
5124901|NCT01460290|12607707|P1|COMPLETED|Overall Study||11
5124902|NCT01460290|12607707|P1|STARTED|Overall Study||15
5124903|NCT01460225|12607727|P1|NOT COMPLETED|Overall Study||0
5124904|NCT01460225|12607727|P1|COMPLETED|Overall Study|November 2010|19
5124905|NCT01460225|12607727|P1|STARTED|Overall Study|January 2009.|19
5124906|NCT01460160|12607734|P2|NOT COMPLETED|Follow-up||2
5124907|NCT01460160|12607735|P1|NOT COMPLETED|Follow-up||11
5124908|NCT01460160|12607734|P2|COMPLETED|Follow-up||20
5124909|NCT01460160|12607735|P1|COMPLETED|Follow-up||67
5124910|NCT01460160|12607734|P2|STARTED|Follow-up||22
5124911|NCT01460160|12607735|P1|STARTED|Follow-up||78
5124912|NCT01460160|12607734|P2|NOT COMPLETED|Treatment||5
5124913|NCT01460160|12607735|P1|NOT COMPLETED|Treatment||23
5124914|NCT01460160|12607734|P2|COMPLETED|Treatment||19
5124915|NCT01460160|12607735|P1|COMPLETED|Treatment||59
5124916|NCT01460160|12607734|P2|STARTED|Treatment||24
5124917|NCT01460160|12607735|P1|STARTED|Treatment||82
5124918|NCT01459913|12607776|P4|NOT COMPLETED|Overall Study||33
5124919|NCT01459913|12607777|P3|NOT COMPLETED|Overall Study||13
5124920|NCT01459913|12607778|P2|NOT COMPLETED|Overall Study||20
5124921|NCT01459913|12607779|P1|NOT COMPLETED|Overall Study||41
5124922|NCT01459913|12607776|P4|COMPLETED|Overall Study||29
5124923|NCT01459913|12607777|P3|COMPLETED|Overall Study||6
5124924|NCT01459913|12607778|P2|COMPLETED|Overall Study||32
5124925|NCT01459913|12607779|P1|COMPLETED|Overall Study||65
5124926|NCT01459913|12607776|P4|STARTED|Overall Study||62
5124927|NCT01459913|12607777|P3|STARTED|Overall Study||19
5124928|NCT01459913|12607778|P2|STARTED|Overall Study||52
5124929|NCT01459913|12607779|P1|STARTED|Overall Study||106
5124930|NCT01459796|12607810|P2|NOT COMPLETED|Overall Study||126
5124931|NCT01459796|12607811|P1|NOT COMPLETED|Overall Study||94
5124932|NCT01459796|12607810|P2|COMPLETED|Overall Study||0
5124933|NCT01459796|12607811|P1|COMPLETED|Overall Study||0
5124934|NCT01459796|12607810|P2|STARTED|Overall Study||126
5124935|NCT01459796|12607811|P1|STARTED|Overall Study||94
5124936|NCT01459783|12607829|P2|NOT COMPLETED|6 Months to 12 Months||30
5124937|NCT01459783|12607830|P1|NOT COMPLETED|6 Months to 12 Months||19
5124938|NCT01459783|12607829|P2|COMPLETED|6 Months to 12 Months||23
5124939|NCT01459783|12607830|P1|COMPLETED|6 Months to 12 Months||20
5124940|NCT01459783|12607829|P2|STARTED|6 Months to 12 Months||53
5124941|NCT01459783|12607830|P1|STARTED|6 Months to 12 Months||39
5124942|NCT01459783|12607829|P2|NOT COMPLETED|Baseline to 6 Months||20
5124943|NCT01459783|12607830|P1|NOT COMPLETED|Baseline to 6 Months||32
5124944|NCT01459783|12607829|P2|COMPLETED|Baseline to 6 Months||53
5124945|NCT01459783|12607830|P1|COMPLETED|Baseline to 6 Months||39
5124946|NCT01459783|12607829|P2|STARTED|Baseline to 6 Months||73
5124947|NCT01459783|12607830|P1|STARTED|Baseline to 6 Months||71
5124948|NCT01459718|12607838|P1|NOT COMPLETED|Overall Study||3
5124949|NCT01459718|12607838|P1|COMPLETED|Overall Study||10
5124950|NCT01459718|12607838|P1|Safety Analysis Set|Overall Study||13
5124951|NCT01459718|12607838|P1|STARTED|Overall Study||13
5124952|NCT01459705|12607852|P3|NOT COMPLETED|Overall Study||7
5124953|NCT01459705|12607853|P2|NOT COMPLETED|Overall Study||24
5124954|NCT01459705|12607854|P1|NOT COMPLETED|Overall Study||22
5124955|NCT01459705|12607852|P3|COMPLETED|Overall Study||47
5124956|NCT01459705|12607853|P2|COMPLETED|Overall Study||30
5124957|NCT01459705|12607854|P1|COMPLETED|Overall Study||32
5124958|NCT01459705|12607852|P3|STARTED|Overall Study||54
5124959|NCT01459705|12607853|P2|STARTED|Overall Study||54
5124960|NCT01459705|12607854|P1|STARTED|Overall Study||54
5124961|NCT01459653|12607872|P1|NOT COMPLETED|Overall Study||668
5124962|NCT01459653|12607872|P1|COMPLETED|Overall Study||828
5124963|NCT01459653|12607872|P1|STARTED|Overall Study||1496
5124964|NCT01459614|12608020|P2|NOT COMPLETED|Overall Study||0
5124965|NCT01459614|12608021|P1|NOT COMPLETED|Overall Study||1
5124966|NCT01459614|12608020|P2|COMPLETED|Overall Study||10
5124967|NCT01459614|12608021|P1|COMPLETED|Overall Study||28
5124968|NCT01459614|12608020|P2|STARTED|Overall Study||10
5124969|NCT01459614|12608021|P1|STARTED|Overall Study||29
5124970|NCT01459588|12608037|P4|NOT COMPLETED|Overall Study||1
5124971|NCT01459588|12608038|P3|NOT COMPLETED|Overall Study||1
5124972|NCT01459588|12608039|P2|NOT COMPLETED|Overall Study||2
5124973|NCT01459588|12608040|P1|NOT COMPLETED|Overall Study||1
5124974|NCT01459588|12608037|P4|COMPLETED|Overall Study||55
5124975|NCT01459588|12608038|P3|COMPLETED|Overall Study||102
5124976|NCT01459588|12608039|P2|COMPLETED|Overall Study||49
5124977|NCT01459588|12608040|P1|COMPLETED|Overall Study||104
5124978|NCT01459588|12608037|P4|STARTED|Overall Study||56
5124979|NCT01459588|12608038|P3|STARTED|Overall Study||103
5124980|NCT01459588|12608039|P2|STARTED|Overall Study||51
5124981|NCT01459588|12608040|P1|STARTED|Overall Study||105
5124982|NCT01459068|12608068|P2|NOT COMPLETED|Overall Study||34
5124983|NCT01459068|12608069|P1|NOT COMPLETED|Overall Study||39
5124984|NCT01459068|12608068|P2|COMPLETED|Overall Study||148
5124985|NCT01459068|12608069|P1|COMPLETED|Overall Study||126
5124986|NCT01459068|12608068|P2|STARTED|Overall Study||182
5124987|NCT01459068|12608069|P1|STARTED|Overall Study||165
5124988|NCT01459016|12608085|P1|NOT COMPLETED|Overall Study||15
5124989|NCT01459016|12608085|P1|COMPLETED|Overall Study||41
5124990|NCT01459016|12608085|P1|STARTED|Overall Study||56
5124991|NCT01458990|12608101|P2|NOT COMPLETED|Overall Study||0
5124992|NCT01458990|12608102|P1|NOT COMPLETED|Overall Study||0
5124993|NCT01458990|12608101|P2|COMPLETED|Overall Study||15
5124994|NCT01458990|12608102|P1|COMPLETED|Overall Study||45
5124995|NCT01458990|12608101|P2|STARTED|Overall Study||15
5124996|NCT01458990|12608102|P1|STARTED|Overall Study||45
5124997|NCT01458951|12608113|P3|NOT COMPLETED|Overall Study||15
5124998|NCT01458951|12608114|P2|NOT COMPLETED|Overall Study||1
5124999|NCT01458951|12608115|P1|NOT COMPLETED|Overall Study||32
5125000|NCT01458951|12608113|P3|COMPLETED|Overall Study||97
5125001|NCT01458951|12608114|P2|COMPLETED|Overall Study||5
5125002|NCT01458951|12608115|P1|COMPLETED|Overall Study||397
5125003|NCT01458951|12608113|P3|STARTED|Overall Study||112
5125004|NCT01458951|12608114|P2|STARTED|Overall Study||6
5125005|NCT01458951|12608115|P1|STARTED|Overall Study||429
5125006|NCT01458639|12608140|P1|NOT COMPLETED|Overall Study||6
5125007|NCT01458639|12608140|P1|COMPLETED|Overall Study||12
5125008|NCT01458639|12608140|P1|STARTED|Overall Study||18
5125009|NCT01458587|12608152|P2|NOT COMPLETED|Overall Study||0
5125010|NCT01458587|12608153|P1|NOT COMPLETED|Overall Study||1
5125011|NCT01458587|12608152|P2|COMPLETED|Overall Study||35
5125012|NCT01458587|12608153|P1|COMPLETED|Overall Study||34
5125013|NCT01458587|12608152|P2|STARTED|Overall Study||35
5125014|NCT01458587|12608153|P1|STARTED|Overall Study||35
5125015|NCT01458574|12608316|P3|NOT COMPLETED|Overall Study||145
5125016|NCT01458574|12608317|P2|NOT COMPLETED|Overall Study||71
5125017|NCT01458574|12608318|P1|NOT COMPLETED|Overall Study||87
5125018|NCT01458574|12608316|P3|COMPLETED|Overall Study||53
5125019|NCT01458574|12608317|P2|COMPLETED|Overall Study||126
5125020|NCT01458574|12608318|P1|COMPLETED|Overall Study||111
5125021|NCT01458574|12608316|P3|Treated|Overall Study||198
5125022|NCT01458574|12608317|P2|Treated|Overall Study||196
5125023|NCT01458574|12608318|P1|Treated|Overall Study||198
5125024|NCT01458574|12608316|P3|STARTED|Overall Study||198
5125025|NCT01458574|12608317|P2|STARTED|Overall Study||197
5125026|NCT01458574|12608318|P1|STARTED|Overall Study||198
5125027|NCT01458561|12608403|P2|NOT COMPLETED|Overall Study||0
5125028|NCT01458561|12608404|P1|NOT COMPLETED|Overall Study||0
5125029|NCT01458561|12608403|P2|COMPLETED|Overall Study||1
5125030|NCT01458561|12608404|P1|COMPLETED|Overall Study||0
5125031|NCT01458561|12608403|P2|STARTED|Overall Study||1
5125032|NCT01458561|12608404|P1|STARTED|Overall Study||0
5125033|NCT01458535|12608448|P6|NOT COMPLETED|Overall Study||4
5125034|NCT01458535|12608449|P5|NOT COMPLETED|Overall Study||4
5125035|NCT01458535|12608450|P4|NOT COMPLETED|Overall Study||4
5125036|NCT01458535|12608451|P3|NOT COMPLETED|Overall Study||2
5125037|NCT01458535|12608452|P2|NOT COMPLETED|Overall Study||2
5125038|NCT01458535|12608453|P1|NOT COMPLETED|Overall Study||0
5125039|NCT01458535|12608448|P6|COMPLETED|Overall Study||7
5125040|NCT01458535|12608449|P5|COMPLETED|Overall Study||6
5125041|NCT01458535|12608450|P4|COMPLETED|Overall Study||6
5125042|NCT01458535|12608451|P3|COMPLETED|Overall Study||8
5125043|NCT01458535|12608452|P2|COMPLETED|Overall Study||8
5125044|NCT01458535|12608453|P1|COMPLETED|Overall Study||10
5125045|NCT01458535|12608448|P6|STARTED|Overall Study||11
5125046|NCT01458535|12608449|P5|STARTED|Overall Study||10
5125047|NCT01458535|12608450|P4|STARTED|Overall Study||10
5125048|NCT01458535|12608451|P3|STARTED|Overall Study||10
5125049|NCT01458535|12608452|P2|STARTED|Overall Study||10
5125050|NCT01458535|12608453|P1|STARTED|Overall Study||10
5125051|NCT01458522|12608505|P2|NOT COMPLETED|Overall Study||11
5125052|NCT01458522|12608506|P1|NOT COMPLETED|Overall Study||3
5125053|NCT01458522|12608505|P2|COMPLETED|Overall Study||26
5125054|NCT01458522|12608506|P1|COMPLETED|Overall Study||34
5125055|NCT01458522|12608505|P2|Crossover to Second Drug|Overall Study||10
5125056|NCT01458522|12608506|P1|Crossover to Second Drug|Overall Study||15
5125057|NCT01458522|12608505|P2|Received First Drug|Overall Study||35
5125058|NCT01458522|12608506|P1|Received First Drug|Overall Study||35
5125059|NCT01458522|12608505|P2|STARTED|Overall Study||37
5125060|NCT01458522|12608506|P1|STARTED|Overall Study||37
5125061|NCT01458392|12608535|P3|NOT COMPLETED|Overall Study||31
5125062|NCT01458392|12608536|P2|NOT COMPLETED|Overall Study||13
5125063|NCT01458392|12608537|P1|NOT COMPLETED|Overall Study||2
5125064|NCT01458392|12608535|P3|COMPLETED|Overall Study||0
5125065|NCT01458392|12608536|P2|COMPLETED|Overall Study||0
5125066|NCT01458392|12608537|P1|COMPLETED|Overall Study||0
5125067|NCT01458392|12608535|P3|STARTED|Overall Study||31
5125068|NCT01458392|12608536|P2|STARTED|Overall Study||13
5125069|NCT01458392|12608537|P1|STARTED|Overall Study||2
5125070|NCT01458366|12608562|P5|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
5125071|NCT01458366|12608563|P4|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125072|NCT01458366|12608564|P3|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125073|NCT01458366|12608565|P2|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125074|NCT01458366|12608566|P1|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125075|NCT01458366|12608562|P5|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
5125076|NCT01458366|12608563|P4|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125077|NCT01458366|12608564|P3|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125078|NCT01458366|12608565|P2|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125079|NCT01458366|12608566|P1|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
5125080|NCT01458366|12608562|P5|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
5125081|NCT01458366|12608563|P4|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
5125082|NCT01458366|12608564|P3|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
5125083|NCT01458366|12608565|P2|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
5125084|NCT01458366|12608566|P1|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
5125085|NCT01458366|12608562|P5|NOT COMPLETED|Period 4: 120mg/m^2||0
5125086|NCT01458366|12608563|P4|NOT COMPLETED|Period 4: 120mg/m^2||0
5125087|NCT01458366|12608564|P3|NOT COMPLETED|Period 4: 120mg/m^2||0
5125088|NCT01458366|12608565|P2|NOT COMPLETED|Period 4: 120mg/m^2||0
5125089|NCT01458366|12608566|P1|NOT COMPLETED|Period 4: 120mg/m^2||0
5125090|NCT01458366|12608562|P5|COMPLETED|Period 4: 120mg/m^2||0
5125091|NCT01458366|12608563|P4|COMPLETED|Period 4: 120mg/m^2||3
5125092|NCT01458366|12608564|P3|COMPLETED|Period 4: 120mg/m^2||0
5125093|NCT01458366|12608565|P2|COMPLETED|Period 4: 120mg/m^2||0
5125094|NCT01458366|12608566|P1|COMPLETED|Period 4: 120mg/m^2||0
5125095|NCT01458366|12608562|P5|STARTED|Period 4: 120mg/m^2||0
5125096|NCT01458366|12608563|P4|STARTED|Period 4: 120mg/m^2||3
5125097|NCT01458366|12608564|P3|STARTED|Period 4: 120mg/m^2||0
5125098|NCT01458366|12608565|P2|STARTED|Period 4: 120mg/m^2||0
5125099|NCT01458366|12608566|P1|STARTED|Period 4: 120mg/m^2||0
5125100|NCT01458366|12608562|P5|NOT COMPLETED|Period 3: 90mg/m^2||0
5125101|NCT01458366|12608563|P4|NOT COMPLETED|Period 3: 90mg/m^2||0
5125102|NCT01458366|12608564|P3|NOT COMPLETED|Period 3: 90mg/m^2||0
5125103|NCT01458366|12608565|P2|NOT COMPLETED|Period 3: 90mg/m^2||0
5125104|NCT01458366|12608566|P1|NOT COMPLETED|Period 3: 90mg/m^2||0
5125105|NCT01458366|12608562|P5|COMPLETED|Period 3: 90mg/m^2||0
5125106|NCT01458366|12608563|P4|COMPLETED|Period 3: 90mg/m^2||0
5125107|NCT01458366|12608564|P3|COMPLETED|Period 3: 90mg/m^2||3
5125108|NCT01458366|12608565|P2|COMPLETED|Period 3: 90mg/m^2||0
5125109|NCT01458366|12608566|P1|COMPLETED|Period 3: 90mg/m^2||0
5125110|NCT01458366|12608562|P5|STARTED|Period 3: 90mg/m^2||0
5125111|NCT01458366|12608563|P4|STARTED|Period 3: 90mg/m^2||0
5125112|NCT01458366|12608564|P3|STARTED|Period 3: 90mg/m^2||3
5125113|NCT01458366|12608565|P2|STARTED|Period 3: 90mg/m^2||0
5125114|NCT01458366|12608566|P1|STARTED|Period 3: 90mg/m^2||0
5125115|NCT01458366|12608562|P5|NOT COMPLETED|Period 2: 50mg/m^2||0
5125116|NCT01458366|12608563|P4|NOT COMPLETED|Period 2: 50mg/m^2||0
5125117|NCT01458366|12608564|P3|NOT COMPLETED|Period 2: 50mg/m^2||0
5125118|NCT01458366|12608565|P2|NOT COMPLETED|Period 2: 50mg/m^2||0
5125119|NCT01458366|12608566|P1|NOT COMPLETED|Period 2: 50mg/m^2||0
5125120|NCT01458366|12608562|P5|COMPLETED|Period 2: 50mg/m^2||0
5125121|NCT01458366|12608563|P4|COMPLETED|Period 2: 50mg/m^2||0
5125122|NCT01458366|12608564|P3|COMPLETED|Period 2: 50mg/m^2||0
5125123|NCT01458366|12608565|P2|COMPLETED|Period 2: 50mg/m^2||0
5125124|NCT01458366|12608566|P1|COMPLETED|Period 2: 50mg/m^2||0
5125125|NCT01458366|12608562|P5|STARTED|Period 2: 50mg/m^2||0
5125126|NCT01458366|12608563|P4|STARTED|Period 2: 50mg/m^2||0
5125127|NCT01458366|12608564|P3|STARTED|Period 2: 50mg/m^2||0
5125128|NCT01458366|12608565|P2|STARTED|Period 2: 50mg/m^2||0
5125129|NCT01458366|12608566|P1|STARTED|Period 2: 50mg/m^2||0
5125130|NCT01458366|12608562|P5|NOT COMPLETED|Period 1: 70mg/m^2||0
5125131|NCT01458366|12608563|P4|NOT COMPLETED|Period 1: 70mg/m^2||0
5125132|NCT01458366|12608564|P3|NOT COMPLETED|Period 1: 70mg/m^2||0
5125133|NCT01458366|12608565|P2|NOT COMPLETED|Period 1: 70mg/m^2||0
5125134|NCT01458366|12608566|P1|NOT COMPLETED|Period 1: 70mg/m^2||2
5125135|NCT01458366|12608562|P5|COMPLETED|Period 1: 70mg/m^2||0
5125136|NCT01458366|12608563|P4|COMPLETED|Period 1: 70mg/m^2||0
5125137|NCT01458366|12608564|P3|COMPLETED|Period 1: 70mg/m^2||0
5125138|NCT01458366|12608565|P2|COMPLETED|Period 1: 70mg/m^2||0
5125139|NCT01458366|12608566|P1|COMPLETED|Period 1: 70mg/m^2||3
5125140|NCT01458366|12608562|P5|STARTED|Period 1: 70mg/m^2||0
5125141|NCT01458366|12608563|P4|STARTED|Period 1: 70mg/m^2||0
5125142|NCT01458366|12608564|P3|STARTED|Period 1: 70mg/m^2||0
5125143|NCT01458366|12608565|P2|STARTED|Period 1: 70mg/m^2||0
5125144|NCT01458366|12608566|P1|STARTED|Period 1: 70mg/m^2||5
5125145|NCT01458288|12608581|P1|NOT COMPLETED|Overall Study||0
5125146|NCT01458288|12608581|P1|COMPLETED|Overall Study||12
5125147|NCT01458288|12608581|P1|STARTED|Overall Study||12
5125148|NCT01458275|12608593|P3|NOT COMPLETED|Overall Study||9
5125149|NCT01458275|12608594|P2|NOT COMPLETED|Overall Study||13
5125150|NCT01458275|12608595|P1|NOT COMPLETED|Overall Study||14
5125151|NCT01458275|12608593|P3|COMPLETED|Overall Study||273
5125152|NCT01458275|12608594|P2|COMPLETED|Overall Study||269
5125153|NCT01458275|12608595|P1|COMPLETED|Overall Study||269
5125154|NCT01458275|12608593|P3|STARTED|Overall Study||282
5125155|NCT01458275|12608594|P2|STARTED|Overall Study||282
5125156|NCT01458275|12608595|P1|STARTED|Overall Study||283
5125157|NCT01458249|12608637|P1|NOT COMPLETED|Overall Study||8
5125158|NCT01458249|12608637|P1|COMPLETED|Overall Study||44
5125159|NCT01458249|12608637|P1|Participants Treated|Overall Study||51
5125160|NCT01458249|12608637|P1|STARTED|Overall Study||52
5125161|NCT01458210|12608656|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
5125162|NCT01458210|12608656|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
5125163|NCT01458210|12608656|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
5125164|NCT01458210|12608656|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
5125165|NCT01458210|12608656|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
5125166|NCT01458210|12608656|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
5125167|NCT01458210|12608656|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
5125168|NCT01458210|12608656|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
5125169|NCT01458210|12608656|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
5125170|NCT01458210|12608656|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
5125171|NCT01458171|12608673|P1|NOT COMPLETED|Overall Study||1
5125172|NCT01458171|12608673|P1|COMPLETED|Overall Study||22
5125173|NCT01458171|12608673|P1|STARTED|Overall Study||23
5125174|NCT01458132|12608696|P2|NOT COMPLETED|Overall Study||3
5125175|NCT01458132|12608697|P1|NOT COMPLETED|Overall Study||15
5125176|NCT01458132|12608696|P2|COMPLETED|Overall Study||1
5125177|NCT01458132|12608697|P1|COMPLETED|Overall Study||0
5125178|NCT01458132|12608696|P2|STARTED|Overall Study||4
5125179|NCT01458132|12608697|P1|STARTED|Overall Study||15
5125180|NCT01458119|12608705|P1|NOT COMPLETED|Overall Study||20
5125181|NCT01458119|12608705|P1|COMPLETED|Overall Study||65
5125182|NCT01458119|12608705|P1|ITT-Amenable Population|Overall Study||68
5125183|NCT01458119|12608705|P1|Intent to Treat (ITT) Population|Overall Study||85
5125184|NCT01458119|12608705|P1|Safety Population|Overall Study||85
5125185|NCT01458119|12608705|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
5125186|NCT01458119|12608705|P1|STARTED|Overall Study||85
5125187|NCT01458106|12608712|P2|NOT COMPLETED|Overall Study||1
5125188|NCT01458106|12608713|P1|NOT COMPLETED|Overall Study||3
5125189|NCT01458106|12608712|P2|COMPLETED|Overall Study||34
5125190|NCT01458106|12608713|P1|COMPLETED|Overall Study||33
5125191|NCT01458106|12608712|P2|Non-PK Subgroup|Overall Study||0
5125192|NCT01458106|12608713|P1|Non-PK Subgroup|Overall Study||11
5125193|NCT01458106|12608712|P2|PK Subgroup|Overall Study||35
5125194|NCT01458106|12608713|P1|PK Subgroup|Overall Study||25
5125195|NCT01458106|12608712|P2|STARTED|Overall Study||35
5125196|NCT01458106|12608713|P1|STARTED|Overall Study||36
5125197|NCT01457950|12608790|P4|NOT COMPLETED|Open-Label Phase||2
5125198|NCT01457950|12608791|P3|NOT COMPLETED|Open-Label Phase||2
5125199|NCT01457950|12608792|P2|NOT COMPLETED|Open-Label Phase||0
5125200|NCT01457950|12608793|P1|NOT COMPLETED|Open-Label Phase||0
5125201|NCT01457950|12608790|P4|COMPLETED|Open-Label Phase||61
5125202|NCT01457950|12608791|P3|COMPLETED|Open-Label Phase||58
5125203|NCT01457950|12608792|P2|COMPLETED|Open-Label Phase||0
5125204|NCT01457950|12608793|P1|COMPLETED|Open-Label Phase||0
5125205|NCT01457950|12608790|P4|STARTED|Open-Label Phase||63
5125206|NCT01457950|12608791|P3|STARTED|Open-Label Phase||60
5125207|NCT01457950|12608792|P2|STARTED|Open-Label Phase||0
5125208|NCT01457950|12608793|P1|STARTED|Open-Label Phase||0
5125209|NCT01457950|12608790|P4|NOT COMPLETED|Double-Blind Phase||0
5125210|NCT01457950|12608791|P3|NOT COMPLETED|Double-Blind Phase||0
5125211|NCT01457950|12608792|P2|NOT COMPLETED|Double-Blind Phase||3
5125212|NCT01457950|12608793|P1|NOT COMPLETED|Double-Blind Phase||9
5125213|NCT01457950|12608790|P4|COMPLETED|Double-Blind Phase||0
5125214|NCT01457950|12608791|P3|COMPLETED|Double-Blind Phase||0
5125215|NCT01457950|12608792|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
5125216|NCT01457950|12608793|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
5125217|NCT01457950|12608790|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
5125218|NCT01457950|12608791|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
5125219|NCT01457950|12608792|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
5125220|NCT01457950|12608793|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
5125221|NCT01457950|12608790|P4|STARTED|Double-Blind Phase||0
5125222|NCT01457950|12608791|P3|STARTED|Double-Blind Phase||0
5125223|NCT01457950|12608792|P2|STARTED|Double-Blind Phase||66
5125224|NCT01457950|12608793|P1|STARTED|Double-Blind Phase||69
5125225|NCT01457924|12608872|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
5125226|NCT01457924|12608873|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
5125227|NCT01457924|12608874|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
5125228|NCT01457924|12608875|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
5125229|NCT01457924|12608876|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
5125230|NCT01457924|12608872|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
5125231|NCT01457924|12608873|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
5125232|NCT01457924|12608874|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
5125233|NCT01457924|12608875|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
5125234|NCT01457924|12608876|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
5125235|NCT01457924|12608872|P5|STARTED|Individualized FUP (Weeks 48+)||42
5125236|NCT01457924|12608873|P4|STARTED|Individualized FUP (Weeks 48+)||20
5125237|NCT01457924|12608874|P3|STARTED|Individualized FUP (Weeks 48+)||16
5125238|NCT01457924|12608875|P2|STARTED|Individualized FUP (Weeks 48+)||18
5125239|NCT01457924|12608876|P1|STARTED|Individualized FUP (Weeks 48+)||16
5125240|NCT01457924|12608872|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
5125241|NCT01457924|12608873|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
5125242|NCT01457924|12608874|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
5125243|NCT01457924|12608875|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
5125244|NCT01457924|12608876|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
5125245|NCT01457924|12608872|P5|COMPLETED|FUP (Weeks 24-48)||57
5125246|NCT01457924|12608873|P4|COMPLETED|FUP (Weeks 24-48)||32
5125247|NCT01457924|12608874|P3|COMPLETED|FUP (Weeks 24-48)||30
5125248|NCT01457924|12608875|P2|COMPLETED|FUP (Weeks 24-48)||30
5125249|NCT01457924|12608876|P1|COMPLETED|FUP (Weeks 24-48)||63
5125250|NCT01457924|12608872|P5|STARTED|FUP (Weeks 24-48)||59
5125251|NCT01457924|12608873|P4|STARTED|FUP (Weeks 24-48)||33
5125252|NCT01457924|12608874|P3|STARTED|FUP (Weeks 24-48)||32
5125253|NCT01457924|12608875|P2|STARTED|FUP (Weeks 24-48)||31
5125254|NCT01457924|12608876|P1|STARTED|FUP (Weeks 24-48)||66
5125255|NCT01457924|12608872|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
5125256|NCT01457924|12608873|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
5125257|NCT01457924|12608874|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
5125258|NCT01457924|12608875|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
5125259|NCT01457924|12608876|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
5125260|NCT01457924|12608872|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
5125261|NCT01457924|12608873|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
5125262|NCT01457924|12608874|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
5125263|NCT01457924|12608875|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
5125264|NCT01457924|12608876|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
5125265|NCT01457924|12608872|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
5125266|NCT01457924|12608873|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
5125267|NCT01457924|12608874|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
5125268|NCT01457924|12608875|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
5125269|NCT01457924|12608876|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
5125270|NCT01457924|12608872|P5|STARTED|Treatment Phase (Weeks 0-24)||64
5125271|NCT01457924|12608873|P4|STARTED|Treatment Phase (Weeks 0-24)||34
5125272|NCT01457924|12608874|P3|STARTED|Treatment Phase (Weeks 0-24)||32
5125273|NCT01457924|12608875|P2|STARTED|Treatment Phase (Weeks 0-24)||34
5125274|NCT01457924|12608876|P1|STARTED|Treatment Phase (Weeks 0-24)||67
5125275|NCT01457885|12608938|P1|NOT COMPLETED|Overall Study||0
5125276|NCT01457885|12608938|P1|COMPLETED|Overall Study||74
5125277|NCT01457885|12608938|P1|STARTED|Overall Study||74
5125278|NCT01457846|12608946|P2|NOT COMPLETED|Overall Study||30
5125279|NCT01457846|12608947|P1|NOT COMPLETED|Overall Study||41
5125280|NCT01457846|12608946|P2|COMPLETED|Overall Study||0
5125281|NCT01457846|12608947|P1|COMPLETED|Overall Study||0
5125282|NCT01457846|12608946|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
5125283|NCT01457846|12608947|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
5125284|NCT01457846|12608946|P2|Did Not Receive Treatment|Overall Study||3
5125285|NCT01457846|12608947|P1|Did Not Receive Treatment|Overall Study||1
5125286|NCT01457846|12608946|P2|Received Treatment|Overall Study||27
5125287|NCT01457846|12608947|P1|Received Treatment|Overall Study||40
5125288|NCT01457846|12608946|P2|STARTED|Overall Study||30
5125289|NCT01457846|12608947|P1|STARTED|Overall Study||41
5125290|NCT01457703|12608963|P2|NOT COMPLETED|Overall Study||11
5125291|NCT01457703|12608964|P1|NOT COMPLETED|Overall Study||6
5125292|NCT01457703|12608963|P2|COMPLETED|Overall Study||22
5125293|NCT01457703|12608964|P1|COMPLETED|Overall Study||23
5125294|NCT01457703|12608963|P2|STARTED|Overall Study||33
5125295|NCT01457703|12608964|P1|STARTED|Overall Study||29
5125296|NCT01457573|12608978|P1|NOT COMPLETED|Overall Study||0
5125297|NCT01457573|12608978|P1|COMPLETED|Overall Study||10
5125298|NCT01457573|12608978|P1|STARTED|Overall Study||10
5125299|NCT01457521|12608994|P2|NOT COMPLETED|Overall Study||10
5125300|NCT01457521|12608995|P1|NOT COMPLETED|Overall Study||12
5125301|NCT01457521|12608994|P2|COMPLETED|Overall Study||117
5125302|NCT01457521|12608995|P1|COMPLETED|Overall Study||111
5125303|NCT01457521|12608994|P2|STARTED|Overall Study||127
5125304|NCT01457521|12608995|P1|STARTED|Overall Study||123
5125305|NCT01457430|12609001|P1|NOT COMPLETED|Overall Study||0
5125306|NCT01457430|12609001|P1|COMPLETED|Overall Study||19
5125307|NCT01457430|12609001|P1|STARTED|Overall Study||19
5125308|NCT01457417|12609013|P5|NOT COMPLETED|Overall Study||0
5125309|NCT01457417|12609014|P4|NOT COMPLETED|Overall Study||0
5125310|NCT01457417|12609015|P3|NOT COMPLETED|Overall Study||0
5125311|NCT01457417|12609016|P2|NOT COMPLETED|Overall Study||0
5125312|NCT01457417|12609017|P1|NOT COMPLETED|Overall Study||0
5125313|NCT01457417|12609013|P5|COMPLETED|Overall Study||19
5125314|NCT01457417|12609014|P4|COMPLETED|Overall Study||3
5125315|NCT01457417|12609015|P3|COMPLETED|Overall Study||4
5125316|NCT01457417|12609016|P2|COMPLETED|Overall Study||3
5125317|NCT01457417|12609017|P1|COMPLETED|Overall Study||3
5125318|NCT01457417|12609013|P5|STARTED|Overall Study||19
5125319|NCT01457417|12609014|P4|STARTED|Overall Study||3
5125320|NCT01457417|12609015|P3|STARTED|Overall Study||4
5125321|NCT01457417|12609016|P2|STARTED|Overall Study||3
5125322|NCT01457417|12609017|P1|STARTED|Overall Study||3
5125323|NCT01457352|12609075|P2|NOT COMPLETED|Period 3||5
5125324|NCT01457352|12609076|P1|NOT COMPLETED|Period 3||1
5125325|NCT01457352|12609075|P2|COMPLETED|Period 3||144
5125326|NCT01457352|12609076|P1|COMPLETED|Period 3||146
5125327|NCT01457352|12609075|P2|Randomization|Period 3||149
5125328|NCT01457352|12609076|P1|Randomization|Period 3||147
5125329|NCT01457352|12609075|P2|STARTED|Period 3||149
5125330|NCT01457352|12609076|P1|STARTED|Period 3||147
5125331|NCT01457352|12609075|P2|NOT COMPLETED|Period 2||0
5125332|NCT01457352|12609076|P1|NOT COMPLETED|Period 2||80
5125333|NCT01457352|12609075|P2|COMPLETED|Period 2||0
5125334|NCT01457352|12609076|P1|COMPLETED|Period 2||296
5125335|NCT01457352|12609075|P2|STARTED|Period 2||0
5125336|NCT01457352|12609076|P1|STARTED|Period 2||376
5125337|NCT01457352|12609075|P2|NOT COMPLETED|Period 1||0
5125338|NCT01457352|12609076|P1|NOT COMPLETED|Period 1||16
5125339|NCT01457352|12609075|P2|COMPLETED|Period 1||0
5125340|NCT01457352|12609076|P1|COMPLETED|Period 1||376
5125341|NCT01457352|12609075|P2|STARTED|Period 1||0
5125342|NCT01457352|12609076|P1|STARTED|Period 1||392
5125343|NCT01457339|12609088|P2|NOT COMPLETED|Period 6 (250 mg)||1
5125344|NCT01457339|12609089|P1|NOT COMPLETED|Period 6 (250 mg)||1
5125345|NCT01457339|12609088|P2|COMPLETED|Period 6 (250 mg)||21
5125346|NCT01457339|12609089|P1|COMPLETED|Period 6 (250 mg)||6
5125347|NCT01457339|12609088|P2|STARTED|Period 6 (250 mg)||22
5125348|NCT01457339|12609089|P1|STARTED|Period 6 (250 mg)||7
5125349|NCT01457339|12609088|P2|NOT COMPLETED|Period 5 (200 mg)||1
5125350|NCT01457339|12609089|P1|NOT COMPLETED|Period 5 (200 mg)||0
5125351|NCT01457339|12609088|P2|COMPLETED|Period 5 (200 mg)||22
5125352|NCT01457339|12609089|P1|COMPLETED|Period 5 (200 mg)||7
5125353|NCT01457339|12609088|P2|STARTED|Period 5 (200 mg)||23
5125354|NCT01457339|12609089|P1|STARTED|Period 5 (200 mg)||7
5125355|NCT01457339|12609088|P2|NOT COMPLETED|Period 4 (150 mg)||0
5125356|NCT01457339|12609089|P1|NOT COMPLETED|Period 4 (150 mg)||0
5125357|NCT01457339|12609088|P2|COMPLETED|Period 4 (150 mg)||23
5125358|NCT01457339|12609089|P1|COMPLETED|Period 4 (150 mg)||7
5125359|NCT01457339|12609088|P2|STARTED|Period 4 (150 mg)||23
5125360|NCT01457339|12609089|P1|STARTED|Period 4 (150 mg)||7
5125361|NCT01457339|12609088|P2|NOT COMPLETED|Period 3 (100 mg)||1
5125362|NCT01457339|12609089|P1|NOT COMPLETED|Period 3 (100 mg)||0
5125363|NCT01457339|12609088|P2|COMPLETED|Period 3 (100 mg)||23
5125364|NCT01457339|12609089|P1|COMPLETED|Period 3 (100 mg)||7
5125365|NCT01457339|12609088|P2|STARTED|Period 3 (100 mg)||24
5125366|NCT01457339|12609089|P1|STARTED|Period 3 (100 mg)||7
5125367|NCT01457339|12609088|P2|NOT COMPLETED|Period 2 (70 mg)||0
5125368|NCT01457339|12609089|P1|NOT COMPLETED|Period 2 (70 mg)||0
5125369|NCT01457339|12609088|P2|COMPLETED|Period 2 (70 mg)||24
5125370|NCT01457339|12609089|P1|COMPLETED|Period 2 (70 mg)||7
5125371|NCT01457339|12609088|P2|STARTED|Period 2 (70 mg)||24
5125372|NCT01457339|12609089|P1|STARTED|Period 2 (70 mg)||7
5125373|NCT01457339|12609088|P2|NOT COMPLETED|Period 1 (50 mg)||0
5125374|NCT01457339|12609089|P1|NOT COMPLETED|Period 1 (50 mg)||0
5125375|NCT01457339|12609088|P2|COMPLETED|Period 1 (50 mg)||24
5125376|NCT01457339|12609089|P1|COMPLETED|Period 1 (50 mg)||7
5125377|NCT01457339|12609088|P2|STARTED|Period 1 (50 mg)||24
5125378|NCT01457339|12609089|P1|STARTED|Period 1 (50 mg)||7
5125379|NCT01457196|12609255|P1|NOT COMPLETED|Overall Study||0
5125380|NCT01457196|12609255|P1|COMPLETED|Overall Study||2074
5125381|NCT01457196|12609255|P1|STARTED|Overall Study||2074
5125382|NCT01457053|12609261|P2|NOT COMPLETED|Overall Study||1
5125383|NCT01457053|12609262|P1|NOT COMPLETED|Overall Study||1
5125384|NCT01457053|12609261|P2|COMPLETED|Overall Study||1
5125385|NCT01457053|12609262|P1|COMPLETED|Overall Study||1
5125386|NCT01457053|12609261|P2|STARTED|Overall Study||2
5125387|NCT01457053|12609262|P1|STARTED|Overall Study||2
5125388|NCT01457014|12609268|P4|NOT COMPLETED|Fourth Night||0
5125389|NCT01457014|12609269|P3|NOT COMPLETED|Fourth Night||0
5125390|NCT01457014|12609270|P2|NOT COMPLETED|Fourth Night||0
5125391|NCT01457014|12609271|P1|NOT COMPLETED|Fourth Night||0
5125392|NCT01457014|12609268|P4|COMPLETED|Fourth Night||11
5125393|NCT01457014|12609269|P3|COMPLETED|Fourth Night||12
5125394|NCT01457014|12609270|P2|COMPLETED|Fourth Night||11
5125395|NCT01457014|12609271|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
5125471|NCT01456897|12609417|P2|NOT COMPLETED|Overall Study||57
5125396|NCT01457014|12609268|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125397|NCT01457014|12609269|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
5125398|NCT01457014|12609270|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125399|NCT01457014|12609271|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
5125400|NCT01457014|12609268|P4|NOT COMPLETED|Third Night||0
5125401|NCT01457014|12609269|P3|NOT COMPLETED|Third Night||0
5125402|NCT01457014|12609270|P2|NOT COMPLETED|Third Night||0
5125403|NCT01457014|12609271|P1|NOT COMPLETED|Third Night||0
5125404|NCT01457014|12609268|P4|COMPLETED|Third Night||12
5125405|NCT01457014|12609269|P3|COMPLETED|Third Night||11
5125406|NCT01457014|12609270|P2|COMPLETED|Third Night||11
5125407|NCT01457014|12609271|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
5125408|NCT01457014|12609268|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
5125409|NCT01457014|12609269|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125410|NCT01457014|12609270|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125411|NCT01457014|12609271|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
5125412|NCT01457014|12609268|P4|NOT COMPLETED|Second Night||0
5125413|NCT01457014|12609269|P3|NOT COMPLETED|Second Night||0
5125414|NCT01457014|12609270|P2|NOT COMPLETED|Second Night||0
5125415|NCT01457014|12609271|P1|NOT COMPLETED|Second Night||0
5125416|NCT01457014|12609268|P4|COMPLETED|Second Night||11
5125417|NCT01457014|12609269|P3|COMPLETED|Second Night||11
5125418|NCT01457014|12609270|P2|COMPLETED|Second Night||12
5125419|NCT01457014|12609271|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
5125420|NCT01457014|12609268|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125421|NCT01457014|12609269|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
5125422|NCT01457014|12609270|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
5125423|NCT01457014|12609271|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
5125424|NCT01457014|12609268|P4|NOT COMPLETED|First Night||0
5125425|NCT01457014|12609269|P3|NOT COMPLETED|First Night||0
5125426|NCT01457014|12609270|P2|NOT COMPLETED|First Night||0
5125427|NCT01457014|12609271|P1|NOT COMPLETED|First Night||40
5125428|NCT01457014|12609268|P4|COMPLETED|First Night||0
5125429|NCT01457014|12609269|P3|COMPLETED|First Night||0
5125430|NCT01457014|12609270|P2|COMPLETED|First Night||0
5125431|NCT01457014|12609271|P1|COMPLETED|First Night||34
5125432|NCT01457014|12609268|P4|STARTED|First Night||0
5125433|NCT01457014|12609269|P3|STARTED|First Night||0
5125434|NCT01457014|12609270|P2|STARTED|First Night||0
5125435|NCT01457014|12609271|P1|STARTED|First Night||74
5125436|NCT01456962|12609288|P2|NOT COMPLETED|Overall Study||1
5125437|NCT01456962|12609289|P1|NOT COMPLETED|Overall Study||2
5125438|NCT01456962|12609288|P2|COMPLETED|Overall Study||19
5125439|NCT01456962|12609289|P1|COMPLETED|Overall Study||14
5125440|NCT01456962|12609288|P2|STARTED|Overall Study||20
5125441|NCT01456962|12609289|P1|STARTED|Overall Study||16
5125442|NCT01456949|12609295|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
5125443|NCT01456949|12609295|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
5125444|NCT01456949|12609295|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
5125445|NCT01456949|12609295|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
5125446|NCT01456949|12609295|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
5125447|NCT01456949|12609295|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
5125448|NCT01456949|12609295|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
5125449|NCT01456949|12609295|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
5125450|NCT01456949|12609295|P1|NOT COMPLETED|Enrollment||37
5125451|NCT01456949|12609295|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
5125452|NCT01456949|12609295|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
5125453|NCT01456949|12609295|P1|Treated|Enrollment||359
5125454|NCT01456949|12609295|P1|STARTED|Enrollment||402
5125455|NCT01456936|12609306|P4|NOT COMPLETED|Overall Study||483
5125456|NCT01456936|12609307|P3|NOT COMPLETED|Overall Study||481
5125457|NCT01456936|12609308|P2|NOT COMPLETED|Overall Study||448
5125458|NCT01456936|12609309|P1|NOT COMPLETED|Overall Study||439
5125459|NCT01456936|12609306|P4|COMPLETED|Overall Study||1552
5125460|NCT01456936|12609307|P3|COMPLETED|Overall Study||1557
5125461|NCT01456936|12609308|P2|COMPLETED|Overall Study||1586
5125462|NCT01456936|12609309|P1|COMPLETED|Overall Study||1598
5125463|NCT01456936|12609306|P4|Randomized and Treated|Overall Study||2014
5125464|NCT01456936|12609307|P3|Randomized and Treated|Overall Study||2022
5125465|NCT01456936|12609308|P2|Randomized and Treated|Overall Study||2006
5125466|NCT01456936|12609309|P1|Randomized and Treated|Overall Study||2016
5125467|NCT01456936|12609306|P4|STARTED|Overall Study||2035
5125468|NCT01456936|12609307|P3|STARTED|Overall Study||2038
5125469|NCT01456936|12609308|P2|STARTED|Overall Study||2034
5125470|NCT01456936|12609309|P1|STARTED|Overall Study||2037
5125472|NCT01456897|12609418|P1|NOT COMPLETED|Overall Study||75
5125473|NCT01456897|12609417|P2|COMPLETED|Overall Study||41
5125474|NCT01456897|12609418|P1|COMPLETED|Overall Study||109
5125475|NCT01456897|12609417|P2|STARTED|Overall Study||98
5125476|NCT01456897|12609418|P1|STARTED|Overall Study||184
5125477|NCT01456780|12609437|P3|NOT COMPLETED|Overall Study||0
5125478|NCT01456780|12609438|P2|NOT COMPLETED|Overall Study||3
5125479|NCT01456780|12609439|P1|NOT COMPLETED|Overall Study||3
5125480|NCT01456780|12609437|P3|COMPLETED|Overall Study||20
5125481|NCT01456780|12609438|P2|COMPLETED|Overall Study||17
5125482|NCT01456780|12609439|P1|COMPLETED|Overall Study||17
5125483|NCT01456780|12609437|P3|STARTED|Overall Study||20
5125484|NCT01456780|12609438|P2|STARTED|Overall Study||20
5125485|NCT01456780|12609439|P1|STARTED|Overall Study||20
5125486|NCT01456494|12609458|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
5125487|NCT01456494|12609459|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
5125488|NCT01456494|12609458|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
5125489|NCT01456494|12609459|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
5125490|NCT01456494|12609458|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
5125491|NCT01456494|12609459|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
5125492|NCT01456494|12609458|P2|NOT COMPLETED|Initial Inpatient Visit||0
5125493|NCT01456494|12609459|P1|NOT COMPLETED|Initial Inpatient Visit||0
5125494|NCT01456494|12609458|P2|COMPLETED|Initial Inpatient Visit||26
5125495|NCT01456494|12609459|P1|COMPLETED|Initial Inpatient Visit||24
5125496|NCT01456494|12609458|P2|STARTED|Initial Inpatient Visit||26
5125497|NCT01456494|12609459|P1|STARTED|Initial Inpatient Visit||24
5125498|NCT01456299|12609476|P3|NOT COMPLETED|Overall Study||1
5125499|NCT01456299|12609477|P2|NOT COMPLETED|Overall Study||1
5125500|NCT01456299|12609478|P1|NOT COMPLETED|Overall Study||0
5125501|NCT01456299|12609476|P3|COMPLETED|Overall Study||33
5125502|NCT01456299|12609477|P2|COMPLETED|Overall Study||33
5125503|NCT01456299|12609478|P1|COMPLETED|Overall Study||34
5125504|NCT01456299|12609476|P3|STARTED|Overall Study||34
5125505|NCT01456299|12609477|P2|STARTED|Overall Study||34
5125506|NCT01456299|12609478|P1|STARTED|Overall Study||34
5125507|NCT01456221|12609488|P2|NOT COMPLETED|Overall Study||57
5125508|NCT01456221|12609489|P1|NOT COMPLETED|Overall Study||64
5125509|NCT01456221|12609488|P2|COMPLETED|Overall Study||126
5125510|NCT01456221|12609489|P1|COMPLETED|Overall Study||119
5125511|NCT01456221|12609488|P2|STARTED|Overall Study||183
5125512|NCT01456221|12609489|P1|STARTED|Overall Study||183
5125513|NCT01456195|12609504|P3|NOT COMPLETED|Overall Study||14
5125514|NCT01456195|12609505|P2|NOT COMPLETED|Overall Study||10
5125515|NCT01456195|12609506|P1|NOT COMPLETED|Overall Study||11
5125516|NCT01456195|12609504|P3|COMPLETED|Overall Study||127
5125517|NCT01456195|12609505|P2|COMPLETED|Overall Study||127
5125518|NCT01456195|12609506|P1|COMPLETED|Overall Study||132
5125519|NCT01456195|12609504|P3|STARTED|Overall Study||141
5125520|NCT01456195|12609505|P2|STARTED|Overall Study||137
5125521|NCT01456195|12609506|P1|STARTED|Overall Study||143
5125522|NCT01456169|12609526|P3|NOT COMPLETED|Overall Study||12
5125523|NCT01456169|12609527|P2|NOT COMPLETED|Overall Study||5
5125524|NCT01456169|12609528|P1|NOT COMPLETED|Overall Study||10
5125525|NCT01456169|12609526|P3|COMPLETED|Overall Study||123
5125526|NCT01456169|12609527|P2|COMPLETED|Overall Study||122
5125527|NCT01456169|12609528|P1|COMPLETED|Overall Study||123
5125528|NCT01456169|12609526|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
5125529|NCT01456169|12609527|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
5125530|NCT01456169|12609528|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
5125531|NCT01456143|12609579|P1|NOT COMPLETED|Overall Study||0
5125532|NCT01456143|12609579|P1|COMPLETED|Overall Study||33
5125533|NCT01456143|12609579|P1|STARTED|Overall Study||33
5125534|NCT01456130|12609588|P1|NOT COMPLETED|Overall Study||10
5125535|NCT01456130|12609588|P1|COMPLETED|Overall Study||57
5125536|NCT01456130|12609588|P1|STARTED|Overall Study||67
5125537|NCT01456052|12609598|P3|NOT COMPLETED|Overall Study||5
5125538|NCT01456052|12609599|P2|NOT COMPLETED|Overall Study||5
5125539|NCT01456052|12609600|P1|NOT COMPLETED|Overall Study||2
5125540|NCT01456052|12609598|P3|COMPLETED|Overall Study||19
5125541|NCT01456052|12609599|P2|COMPLETED|Overall Study||20
5125542|NCT01456052|12609600|P1|COMPLETED|Overall Study||8
5125543|NCT01456052|12609598|P3|STARTED|Overall Study||24
5125544|NCT01456052|12609599|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
5125545|NCT01456052|12609600|P1|STARTED|Overall Study||10
5125546|NCT01456039|12609620|P3|NOT COMPLETED|Phase 2 (Second Step)||33
5125547|NCT01456039|12609621|P2|NOT COMPLETED|Phase 2 (Second Step)||0
5125548|NCT01456039|12609622|P1|NOT COMPLETED|Phase 2 (Second Step)||0
5125549|NCT01456039|12609620|P3|COMPLETED|Phase 2 (Second Step)||7
5125550|NCT01456039|12609621|P2|COMPLETED|Phase 2 (Second Step)||0
5125551|NCT01456039|12609622|P1|COMPLETED|Phase 2 (Second Step)||0
5125552|NCT01456039|12609620|P3|STARTED|Phase 2 (Second Step)||40
5125553|NCT01456039|12609621|P2|STARTED|Phase 2 (Second Step)||0
5125554|NCT01456039|12609622|P1|STARTED|Phase 2 (Second Step)||0
5125555|NCT01456039|12609620|P3|NOT COMPLETED|Phase 1 (First Step)||0
5125556|NCT01456039|12609621|P2|NOT COMPLETED|Phase 1 (First Step)||7
5125557|NCT01456039|12609622|P1|NOT COMPLETED|Phase 1 (First Step)||2
5125558|NCT01456039|12609620|P3|COMPLETED|Phase 1 (First Step)||0
5125559|NCT01456039|12609621|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
5125560|NCT01456039|12609622|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
5125561|NCT01456039|12609620|P3|STARTED|Phase 1 (First Step)||0
5125562|NCT01456039|12609621|P2|STARTED|Phase 1 (First Step)||8
5125563|NCT01456039|12609622|P1|STARTED|Phase 1 (First Step)||3
5125564|NCT01456000|12609694|P2|NOT COMPLETED|Overall Study||3
5125565|NCT01456000|12609695|P1|NOT COMPLETED|Overall Study||8
5125566|NCT01456000|12609694|P2|COMPLETED|Overall Study||172
5125567|NCT01456000|12609695|P1|COMPLETED|Overall Study||170
5125568|NCT01456000|12609694|P2|STARTED|Overall Study||175
5125569|NCT01456000|12609695|P1|STARTED|Overall Study||178
5125570|NCT01455545|12609701|P2|NOT COMPLETED|Overall Study||0
5125571|NCT01455545|12609702|P1|NOT COMPLETED|Overall Study||0
5125572|NCT01455545|12609701|P2|COMPLETED|Overall Study||45
5125573|NCT01455545|12609702|P1|COMPLETED|Overall Study||55
5125574|NCT01455545|12609701|P2|STARTED|Overall Study||45
5125575|NCT01455545|12609702|P1|STARTED|Overall Study||55
5125576|NCT01455519|12609732|P2|NOT COMPLETED|Overall Study||5
5125577|NCT01455519|12609733|P1|NOT COMPLETED|Overall Study||4
5125578|NCT01455519|12609732|P2|COMPLETED|Overall Study||18
5125579|NCT01455519|12609733|P1|COMPLETED|Overall Study||8
5125580|NCT01455519|12609732|P2|STARTED|Overall Study||23
5125581|NCT01455519|12609733|P1|STARTED|Overall Study||12
5125582|NCT01455428|12609765|P2|NOT COMPLETED|Overall Study||18
5125583|NCT01455428|12609766|P1|NOT COMPLETED|Overall Study||14
5125584|NCT01455428|12609765|P2|COMPLETED|Overall Study||92
5125585|NCT01455428|12609766|P1|COMPLETED|Overall Study||98
5125586|NCT01455428|12609765|P2|Treated|Overall Study||109
5125587|NCT01455428|12609766|P1|Treated|Overall Study||111
5125588|NCT01455428|12609765|P2|STARTED|Overall Study||110
5125589|NCT01455428|12609766|P1|STARTED|Overall Study||112
5125590|NCT01455415|12609822|P2|NOT COMPLETED|Follow-up||2
5125591|NCT01455415|12609823|P1|NOT COMPLETED|Follow-up||3
5125592|NCT01455415|12609822|P2|COMPLETED|Follow-up||104
5125593|NCT01455415|12609823|P1|COMPLETED|Follow-up||111
5125594|NCT01455415|12609822|P2|STARTED|Follow-up||106
5125595|NCT01455415|12609823|P1|STARTED|Follow-up||114
5125596|NCT01455415|12609822|P2|NOT COMPLETED|Period 2||10
5125597|NCT01455415|12609823|P1|NOT COMPLETED|Period 2||13
5125598|NCT01455415|12609822|P2|COMPLETED|Period 2||106
5125599|NCT01455415|12609823|P1|COMPLETED|Period 2||114
5125600|NCT01455415|12609822|P2|STARTED|Period 2||116
5125601|NCT01455415|12609823|P1|STARTED|Period 2||127
5125602|NCT01455415|12609822|P2|NOT COMPLETED|Washout||7
5125603|NCT01455415|12609823|P1|NOT COMPLETED|Washout||8
5125604|NCT01455415|12609822|P2|COMPLETED|Washout||116
5125605|NCT01455415|12609823|P1|COMPLETED|Washout||127
5125606|NCT01455415|12609822|P2|STARTED|Washout||123
5125607|NCT01455415|12609823|P1|STARTED|Washout||135
5125608|NCT01455415|12609822|P2|NOT COMPLETED|Period 1||24
5125609|NCT01455415|12609823|P1|NOT COMPLETED|Period 1||19
5125610|NCT01455415|12609822|P2|COMPLETED|Period 1||123
5125611|NCT01455415|12609823|P1|COMPLETED|Period 1||135
5125612|NCT01455415|12609822|P2|STARTED|Period 1|Started=Treated|147
5125613|NCT01455415|12609823|P1|STARTED|Period 1|Started=Treated|154
5125614|NCT01455220|12609873|P1|NOT COMPLETED|Overall Study||30
5125615|NCT01455220|12609873|P1|COMPLETED|Overall Study||15
5125616|NCT01455220|12609873|P1|STARTED|Overall Study||45
5125617|NCT01455194|12609883|P4|NOT COMPLETED|Overall Study||28
5125618|NCT01455194|12609884|P3|NOT COMPLETED|Overall Study||30
5125619|NCT01455194|12609885|P2|NOT COMPLETED|Overall Study||31
5125620|NCT01455194|12609886|P1|NOT COMPLETED|Overall Study||153
5125621|NCT01455194|12609883|P4|COMPLETED|Overall Study||97
5125622|NCT01455194|12609884|P3|COMPLETED|Overall Study||92
5125623|NCT01455194|12609885|P2|COMPLETED|Overall Study||89
5125624|NCT01455194|12609886|P1|COMPLETED|Overall Study||0
5125625|NCT01455194|12609883|P4|STARTED|Overall Study||125
5125626|NCT01455194|12609884|P3|STARTED|Overall Study||122
5125627|NCT01455194|12609885|P2|STARTED|Overall Study||120
5125628|NCT01455194|12609886|P1|STARTED|Overall Study||153
5125629|NCT01455181|12609935|P1|NOT COMPLETED|Overall Study||0
5125630|NCT01455181|12609935|P1|COMPLETED|Overall Study||24
5125631|NCT01455181|12609935|P1|STARTED|Overall Study||24
5125632|NCT01455064|12609943|P1|NOT COMPLETED|Overall Study||1
5125633|NCT01455064|12609943|P1|COMPLETED|Overall Study||30
5125634|NCT01455064|12609943|P1|STARTED|Overall Study||31
5125635|NCT01455012|12609949|P2|NOT COMPLETED|Overall Study||4
5125636|NCT01455012|12609950|P1|NOT COMPLETED|Overall Study||11
5125637|NCT01455012|12609949|P2|COMPLETED|Overall Study||36
5125638|NCT01455012|12609950|P1|COMPLETED|Overall Study||30
5125639|NCT01455012|12609949|P2|STARTED|Overall Study||40
5125640|NCT01455012|12609950|P1|STARTED|Overall Study||41
5125641|NCT01454947|12609990|P8|NOT COMPLETED|Overall Study||5
5125642|NCT01454947|12609991|P7|NOT COMPLETED|Overall Study||1
5125643|NCT01454947|12609992|P6|NOT COMPLETED|Overall Study||3
5125644|NCT01454947|12609993|P5|NOT COMPLETED|Overall Study||1
5125645|NCT01454947|12609994|P4|NOT COMPLETED|Overall Study||1
5125646|NCT01454947|12609995|P3|NOT COMPLETED|Overall Study||3
5125647|NCT01454947|12609996|P2|NOT COMPLETED|Overall Study||4
5125648|NCT01454947|12609997|P1|NOT COMPLETED|Overall Study||3
5125649|NCT01454947|12609990|P8|COMPLETED|Overall Study||23
5125650|NCT01454947|12609991|P7|COMPLETED|Overall Study||26
5125651|NCT01454947|12609992|P6|COMPLETED|Overall Study||32
5125652|NCT01454947|12609993|P5|COMPLETED|Overall Study||33
5125653|NCT01454947|12609994|P4|COMPLETED|Overall Study||19
5125654|NCT01454947|12609995|P3|COMPLETED|Overall Study||32
5125655|NCT01454947|12609996|P2|COMPLETED|Overall Study||38
5125656|NCT01454947|12609997|P1|COMPLETED|Overall Study||24
5125657|NCT01454947|12609990|P8|STARTED|Overall Study||28
5125658|NCT01454947|12609991|P7|STARTED|Overall Study||27
5125659|NCT01454947|12609992|P6|STARTED|Overall Study||35
5125660|NCT01454947|12609993|P5|STARTED|Overall Study||34
5125661|NCT01454947|12609994|P4|STARTED|Overall Study||20
5125662|NCT01454947|12609995|P3|STARTED|Overall Study||35
5125663|NCT01454947|12609996|P2|STARTED|Overall Study||42
5125664|NCT01454947|12609997|P1|STARTED|Overall Study||27
5125665|NCT01454934|12610017|P2|NOT COMPLETED|Overall Study||270
5125666|NCT01454934|12610018|P1|NOT COMPLETED|Overall Study||270
5125667|NCT01454934|12610017|P2|COMPLETED|Overall Study||0
5125668|NCT01454934|12610018|P1|COMPLETED|Overall Study||0
5125669|NCT01454934|12610017|P2|STARTED|Overall Study||270
5125670|NCT01454934|12610018|P1|STARTED|Overall Study||270
5125671|NCT01454830|12610030|P2|NOT COMPLETED|Overall Study||27
5125672|NCT01454830|12610031|P1|NOT COMPLETED|Overall Study||31
5125673|NCT01454830|12610030|P2|COMPLETED|Overall Study||30
5125674|NCT01454830|12610031|P1|COMPLETED|Overall Study||30
5125675|NCT01454830|12610030|P2|STARTED|Overall Study||57
5125676|NCT01454830|12610031|P1|STARTED|Overall Study||61
5125677|NCT01454791|12610051|P2|NOT COMPLETED|Overall Study||0
5125678|NCT01454791|12610052|P1|NOT COMPLETED|Overall Study||0
5125679|NCT01454791|12610051|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
5125680|NCT01454791|12610052|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
5125681|NCT01454791|12610051|P2|STARTED|Overall Study||20
5125682|NCT01454791|12610052|P1|STARTED|Overall Study||20
5125683|NCT01454778|12610062|P1|NOT COMPLETED|Overall Study||3
5125684|NCT01454778|12610062|P1|COMPLETED|Overall Study||47
5125685|NCT01454778|12610062|P1|STARTED|Overall Study||50
5125686|NCT01454739|12610073|P2|NOT COMPLETED|Overall Study||21
5125687|NCT01454739|12610074|P1|NOT COMPLETED|Overall Study||7
5125688|NCT01454739|12610073|P2|COMPLETED|Overall Study||158
5125689|NCT01454739|12610074|P1|COMPLETED|Overall Study||54
5125690|NCT01454739|12610073|P2|Surgery Subgroup|Overall Study||26
5125691|NCT01454739|12610074|P1|Surgery Subgroup|Overall Study||2
5125692|NCT01454739|12610073|P2|Episodic|Overall Study||13
5125693|NCT01454739|12610074|P1|Episodic|Overall Study||0
5125694|NCT01454739|12610073|P2|Personalized Prophylaxis|Overall Study||23
5125695|NCT01454739|12610074|P1|Personalized Prophylaxis|Overall Study||3
5125696|NCT01454739|12610073|P2|Weekly Prophylaxis|Overall Study||34
5125697|NCT01454739|12610074|P1|Weekly Prophylaxis|Overall Study||0
5125698|NCT01454739|12610073|P2|Tailored Prophylaxis|Overall Study||131
5125699|NCT01454739|12610074|P1|Tailored Prophylaxis|Overall Study||59
5125700|NCT01454739|12610073|P2|STARTED|Overall Study||179
5125701|NCT01454739|12610074|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
5125702|NCT01454726|12610103|P2|NOT COMPLETED|Overall Study||1
5125703|NCT01454726|12610104|P1|NOT COMPLETED|Overall Study||0
5125704|NCT01454726|12610103|P2|COMPLETED|Overall Study||10
5125705|NCT01454726|12610104|P1|COMPLETED|Overall Study||16
5125706|NCT01454726|12610103|P2|STARTED|Overall Study||11
5125707|NCT01454726|12610104|P1|STARTED|Overall Study||16
5125708|NCT01454596|12610122|P12|NOT COMPLETED|Overall Study||0
5125709|NCT01454596|12610123|P11|NOT COMPLETED|Overall Study||1
5125710|NCT01454596|12610124|P10|NOT COMPLETED|Overall Study||1
5125711|NCT01454596|12610125|P9|NOT COMPLETED|Overall Study||0
5125712|NCT01454596|12610126|P8|NOT COMPLETED|Overall Study||0
5125713|NCT01454596|12610127|P7|NOT COMPLETED|Overall Study||0
5125714|NCT01454596|12610128|P6|NOT COMPLETED|Overall Study||0
5125715|NCT01454596|12610129|P5|NOT COMPLETED|Overall Study||0
5125716|NCT01454596|12610130|P4|NOT COMPLETED|Overall Study||0
5125717|NCT01454596|12610131|P3|NOT COMPLETED|Overall Study||0
5125718|NCT01454596|12610132|P2|NOT COMPLETED|Overall Study||0
5125719|NCT01454596|12610133|P1|NOT COMPLETED|Overall Study||0
5125720|NCT01454596|12610122|P12|COMPLETED|Overall Study||1
5125721|NCT01454596|12610123|P11|COMPLETED|Overall Study||0
5125722|NCT01454596|12610124|P10|COMPLETED|Overall Study||2
5125723|NCT01454596|12610125|P9|COMPLETED|Overall Study||3
5125724|NCT01454596|12610126|P8|COMPLETED|Overall Study||3
5125725|NCT01454596|12610127|P7|COMPLETED|Overall Study||1
5125726|NCT01454596|12610128|P6|COMPLETED|Overall Study||1
5125727|NCT01454596|12610129|P5|COMPLETED|Overall Study||1
5125728|NCT01454596|12610130|P4|COMPLETED|Overall Study||1
5125729|NCT01454596|12610131|P3|COMPLETED|Overall Study||1
5125730|NCT01454596|12610132|P2|COMPLETED|Overall Study||1
5125731|NCT01454596|12610133|P1|COMPLETED|Overall Study||1
5125732|NCT01454596|12610122|P12|STARTED|Overall Study||1
5125733|NCT01454596|12610123|P11|STARTED|Overall Study||1
5125734|NCT01454596|12610124|P10|STARTED|Overall Study||3
5125735|NCT01454596|12610125|P9|STARTED|Overall Study||3
5125736|NCT01454596|12610126|P8|STARTED|Overall Study||3
5125737|NCT01454596|12610127|P7|STARTED|Overall Study||1
5125738|NCT01454596|12610128|P6|STARTED|Overall Study||1
5125739|NCT01454596|12610129|P5|STARTED|Overall Study||1
5125740|NCT01454596|12610130|P4|STARTED|Overall Study||1
5125741|NCT01454596|12610131|P3|STARTED|Overall Study||1
5125742|NCT01454596|12610132|P2|STARTED|Overall Study||1
5125743|NCT01454596|12610133|P1|STARTED|Overall Study||1
5125744|NCT01454583|12610210|P3|NOT COMPLETED|3rd Year||297
5125745|NCT01454583|12610211|P2|NOT COMPLETED|3rd Year||512
5125746|NCT01454583|12610212|P1|NOT COMPLETED|3rd Year||1959
5125747|NCT01454583|12610210|P3|COMPLETED|3rd Year||285
5125748|NCT01454583|12610211|P2|COMPLETED|3rd Year||470
5125749|NCT01454583|12610212|P1|COMPLETED|3rd Year||1832
5125750|NCT01454583|12610210|P3|STARTED|3rd Year||582
5125751|NCT01454583|12610211|P2|STARTED|3rd Year||982
5125752|NCT01454583|12610212|P1|STARTED|3rd Year||3791
5125753|NCT01454583|12610210|P3|NOT COMPLETED|2nd Year||737
5125754|NCT01454583|12610211|P2|NOT COMPLETED|2nd Year||1049
5125755|NCT01454583|12610212|P1|NOT COMPLETED|2nd Year||3965
5125756|NCT01454583|12610210|P3|COMPLETED|2nd Year||1376
5125757|NCT01454583|12610211|P2|COMPLETED|2nd Year||1647
5125758|NCT01454583|12610212|P1|COMPLETED|2nd Year||6212
5125759|NCT01454583|12610210|P3|STARTED|2nd Year||2113
5125760|NCT01454583|12610211|P2|STARTED|2nd Year||2696
5125761|NCT01454583|12610212|P1|STARTED|2nd Year||10177
5125762|NCT01454583|12610210|P3|NOT COMPLETED|1st Year||180
5125763|NCT01454583|12610211|P2|NOT COMPLETED|1st Year||318
5125764|NCT01454583|12610212|P1|NOT COMPLETED|1st Year||1057
5125765|NCT01454583|12610210|P3|COMPLETED|1st Year||1933
5125766|NCT01454583|12610211|P2|COMPLETED|1st Year||2378
5125767|NCT01454583|12610212|P1|COMPLETED|1st Year||9120
5125768|NCT01454583|12610210|P3|STARTED|1st Year||2113
5125769|NCT01454583|12610211|P2|STARTED|1st Year||2696
5125770|NCT01454583|12610212|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
5125771|NCT01454531|12610280|P1|NOT COMPLETED|Overall Study||23
5125772|NCT01454531|12610280|P1|COMPLETED|Overall Study||173
5125773|NCT01454531|12610280|P1|Subjects Treated|Overall Study||192
5125774|NCT01454531|12610280|P1|STARTED|Overall Study||196
5125775|NCT01454505|12610292|P4|NOT COMPLETED|Overall Study||0
5125776|NCT01454505|12610293|P3|NOT COMPLETED|Overall Study||0
5125777|NCT01454505|12610294|P2|NOT COMPLETED|Overall Study||0
5125778|NCT01454505|12610295|P1|NOT COMPLETED|Overall Study||0
5125779|NCT01454505|12610292|P4|COMPLETED|Overall Study||20
5125780|NCT01454505|12610293|P3|COMPLETED|Overall Study||40
5125781|NCT01454505|12610294|P2|COMPLETED|Overall Study||15
5125782|NCT01454505|12610295|P1|COMPLETED|Overall Study||35
5125783|NCT01454505|12610292|P4|STARTED|Overall Study||20
5125784|NCT01454505|12610293|P3|STARTED|Overall Study||40
5125785|NCT01454505|12610294|P2|STARTED|Overall Study||15
5125786|NCT01454505|12610295|P1|STARTED|Overall Study||35
5125787|NCT01454414|12610309|P2|NOT COMPLETED|Overall Study||16
5125788|NCT01454414|12610310|P1|NOT COMPLETED|Overall Study||13
5125789|NCT01454414|12610309|P2|COMPLETED|Overall Study||64
5125790|NCT01454414|12610310|P1|COMPLETED|Overall Study||66
5125791|NCT01454414|12610309|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
5125792|NCT01454414|12610310|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
5125793|NCT01454414|12610309|P2|STARTED|Overall Study||80
5125794|NCT01454414|12610310|P1|STARTED|Overall Study||79
5125795|NCT01454401|12610316|P1|NOT COMPLETED|Overall Study||5
5125796|NCT01454401|12610316|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
5125797|NCT01454401|12610316|P1|STARTED|Overall Study|ITT|44
5125798|NCT01454362|12610323|P2|NOT COMPLETED|Overall Study||0
5125799|NCT01454362|12610324|P1|NOT COMPLETED|Overall Study||0
5125800|NCT01454362|12610323|P2|COMPLETED|Overall Study||23
5125801|NCT01454362|12610324|P1|COMPLETED|Overall Study||28
5125802|NCT01454362|12610323|P2|STARTED|Overall Study||23
5125803|NCT01454362|12610324|P1|STARTED|Overall Study||28
5125804|NCT01454284|12610340|P2|NOT COMPLETED|Overall Study||73
5125805|NCT01454284|12610341|P1|NOT COMPLETED|Overall Study||116
5125806|NCT01454284|12610340|P2|COMPLETED|Overall Study||377
5125807|NCT01454284|12610341|P1|COMPLETED|Overall Study||548
5125808|NCT01454284|12610340|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
5125809|NCT01454284|12610341|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
5125810|NCT01454284|12610340|P2|STARTED|Overall Study||450
5125811|NCT01454284|12610341|P1|STARTED|Overall Study||664
5125812|NCT01454258|12610389|P1|NOT COMPLETED|Overall Study||997
5125813|NCT01454258|12610389|P1|COMPLETED|Overall Study||9103
5125814|NCT01454258|12610389|P1|STARTED|Overall Study||10100
5125815|NCT01454102|12610411|P16|NOT COMPLETED|Overall Study||1
5125816|NCT01454102|12610412|P15|NOT COMPLETED|Overall Study||3
5125817|NCT01454102|12610413|P14|NOT COMPLETED|Overall Study||4
5125818|NCT01454102|12610414|P13|NOT COMPLETED|Overall Study||7
5125819|NCT01454102|12610415|P12|NOT COMPLETED|Overall Study||4
5125820|NCT01454102|12610416|P11|NOT COMPLETED|Overall Study||0
5125821|NCT01454102|12610417|P10|NOT COMPLETED|Overall Study||0
5125822|NCT01454102|12610418|P9|NOT COMPLETED|Overall Study||1
5125823|NCT01454102|12610419|P8|NOT COMPLETED|Overall Study||0
5125824|NCT01454102|12610420|P7|NOT COMPLETED|Overall Study||2
5125825|NCT01454102|12610421|P6|NOT COMPLETED|Overall Study||3
5125826|NCT01454102|12610422|P5|NOT COMPLETED|Overall Study||3
5125827|NCT01454102|12610423|P4|NOT COMPLETED|Overall Study||0
5125828|NCT01454102|12610424|P3|NOT COMPLETED|Overall Study||0
5125829|NCT01454102|12610425|P2|NOT COMPLETED|Overall Study||0
5125830|NCT01454102|12610426|P1|NOT COMPLETED|Overall Study||0
5125831|NCT01454102|12610411|P16|COMPLETED|Overall Study||13
5125832|NCT01454102|12610412|P15|COMPLETED|Overall Study||36
5125833|NCT01454102|12610413|P14|COMPLETED|Overall Study||34
5125834|NCT01454102|12610414|P13|COMPLETED|Overall Study||33
5125835|NCT01454102|12610415|P12|COMPLETED|Overall Study||27
5125836|NCT01454102|12610416|P11|COMPLETED|Overall Study||12
5125837|NCT01454102|12610417|P10|COMPLETED|Overall Study||13
5125838|NCT01454102|12610418|P9|COMPLETED|Overall Study||12
5125839|NCT01454102|12610419|P8|COMPLETED|Overall Study||25
5125840|NCT01454102|12610420|P7|COMPLETED|Overall Study||22
5125841|NCT01454102|12610421|P6|COMPLETED|Overall Study||49
5125842|NCT01454102|12610422|P5|COMPLETED|Overall Study||18
5125843|NCT01454102|12610423|P4|COMPLETED|Overall Study||12
5125844|NCT01454102|12610424|P3|COMPLETED|Overall Study||15
5125845|NCT01454102|12610425|P2|COMPLETED|Overall Study||15
5125846|NCT01454102|12610426|P1|COMPLETED|Overall Study||12
5125847|NCT01454102|12610411|P16|STARTED|Overall Study||14
5125848|NCT01454102|12610412|P15|STARTED|Overall Study||39
5125849|NCT01454102|12610413|P14|STARTED|Overall Study||38
5125850|NCT01454102|12610414|P13|STARTED|Overall Study||40
5125851|NCT01454102|12610415|P12|STARTED|Overall Study||31
5125852|NCT01454102|12610416|P11|STARTED|Overall Study||12
5125853|NCT01454102|12610417|P10|STARTED|Overall Study||13
5125854|NCT01454102|12610418|P9|STARTED|Overall Study||13
5125855|NCT01454102|12610419|P8|STARTED|Overall Study||25
5125856|NCT01454102|12610420|P7|STARTED|Overall Study||24
5125857|NCT01454102|12610421|P6|STARTED|Overall Study||52
5125858|NCT01454102|12610422|P5|STARTED|Overall Study||21
5125859|NCT01454102|12610423|P4|STARTED|Overall Study||12
5125860|NCT01454102|12610424|P3|STARTED|Overall Study||15
5125861|NCT01454102|12610425|P2|STARTED|Overall Study||15
5125862|NCT01454102|12610426|P1|STARTED|Overall Study||12
5125863|NCT01454076|12610546|P5|NOT COMPLETED|Overall Study||6
5125864|NCT01454076|12610547|P4|NOT COMPLETED|Overall Study||2
5125865|NCT01454076|12610548|P3|NOT COMPLETED|Overall Study||9
5125866|NCT01454076|12610549|P2|NOT COMPLETED|Overall Study||6
5125867|NCT01454076|12610550|P1|NOT COMPLETED|Overall Study||13
5125868|NCT01454076|12610546|P5|COMPLETED|Overall Study||15
5125869|NCT01454076|12610547|P4|COMPLETED|Overall Study||16
5125870|NCT01454076|12610548|P3|COMPLETED|Overall Study||15
5125871|NCT01454076|12610549|P2|COMPLETED|Overall Study||14
5125872|NCT01454076|12610550|P1|COMPLETED|Overall Study||16
5125873|NCT01454076|12610546|P5|STARTED|Overall Study||21
5125874|NCT01454076|12610547|P4|STARTED|Overall Study||18
5125875|NCT01454076|12610548|P3|STARTED|Overall Study||24
5125876|NCT01454076|12610549|P2|STARTED|Overall Study||20
5125877|NCT01454076|12610550|P1|STARTED|Overall Study||29
5125878|NCT01454063|12610603|P2|NOT COMPLETED|Treated||0
5125879|NCT01454063|12610604|P1|NOT COMPLETED|Treated||2
5125880|NCT01454063|12610603|P2|COMPLETED|Treated||201
5125881|NCT01454063|12610604|P1|COMPLETED|Treated||199
5125882|NCT01454063|12610603|P2|STARTED|Treated||201
5125883|NCT01454063|12610604|P1|STARTED|Treated||201
5125884|NCT01454063|12610603|P2|NOT COMPLETED|Randomized||2
5125885|NCT01454063|12610604|P1|NOT COMPLETED|Randomized||1
5125886|NCT01454063|12610603|P2|COMPLETED|Randomized||201
5125887|NCT01454063|12610604|P1|COMPLETED|Randomized||201
5125888|NCT01454063|12610603|P2|STARTED|Randomized||203
5125889|NCT01454063|12610604|P1|STARTED|Randomized||202
5125890|NCT01453998|12610625|P3|NOT COMPLETED|After Protocol Amendment 2.||0
5125891|NCT01453998|12610626|P2|NOT COMPLETED|After Protocol Amendment 2.||0
5125892|NCT01453998|12610627|P1|NOT COMPLETED|After Protocol Amendment 2.||1
5125893|NCT01453998|12610625|P3|COMPLETED|After Protocol Amendment 2.||124
5125894|NCT01453998|12610626|P2|COMPLETED|After Protocol Amendment 2.||130
5125895|NCT01453998|12610627|P1|COMPLETED|After Protocol Amendment 2.||130
5125896|NCT01453998|12610625|P3|STARTED|After Protocol Amendment 2.||124
5125897|NCT01453998|12610626|P2|STARTED|After Protocol Amendment 2.||130
5125898|NCT01453998|12610627|P1|STARTED|After Protocol Amendment 2.||131
5125899|NCT01453998|12610625|P3|NOT COMPLETED|Before Protocol Amendment 2||0
5125900|NCT01453998|12610626|P2|NOT COMPLETED|Before Protocol Amendment 2||0
5125901|NCT01453998|12610627|P1|NOT COMPLETED|Before Protocol Amendment 2||0
5125902|NCT01453998|12610625|P3|COMPLETED|Before Protocol Amendment 2||99
5125903|NCT01453998|12610626|P2|COMPLETED|Before Protocol Amendment 2||88
5125904|NCT01453998|12610627|P1|COMPLETED|Before Protocol Amendment 2||85
5125905|NCT01453998|12610625|P3|STARTED|Before Protocol Amendment 2||99
5125906|NCT01453998|12610626|P2|STARTED|Before Protocol Amendment 2||88
5125907|NCT01453998|12610627|P1|STARTED|Before Protocol Amendment 2||85
5125908|NCT01453946|12610791|P1|NOT COMPLETED|Overall Study||9
5125909|NCT01453946|12610791|P1|COMPLETED|Overall Study||41
5125910|NCT01453946|12610791|P1|STARTED|Overall Study||50
5125911|NCT01453894|12610799|P2|NOT COMPLETED|Overall Study||0
5125912|NCT01453894|12610800|P1|NOT COMPLETED|Overall Study||0
5125913|NCT01453894|12610799|P2|COMPLETED|Overall Study||225
5125914|NCT01453894|12610800|P1|COMPLETED|Overall Study||225
5125915|NCT01453894|12610799|P2|STARTED|Overall Study||225
5125916|NCT01453894|12610800|P1|STARTED|Overall Study||225
5125917|NCT01453855|12610808|P2|NOT COMPLETED|Overall Study||14
5125918|NCT01453855|12610809|P1|NOT COMPLETED|Overall Study||10
5125919|NCT01453855|12610808|P2|COMPLETED|Overall Study||408
5125920|NCT01453855|12610809|P1|COMPLETED|Overall Study||432
5125921|NCT01453855|12610808|P2|STARTED|Overall Study||422
5125922|NCT01453855|12610809|P1|STARTED|Overall Study||442
5125923|NCT01453725|12610817|P2|NOT COMPLETED|Overall Study||11
5125924|NCT01453725|12610818|P1|NOT COMPLETED|Overall Study||13
5125925|NCT01453725|12610817|P2|COMPLETED|Overall Study||89
5125926|NCT01453725|12610818|P1|COMPLETED|Overall Study||85
5125927|NCT01453725|12610817|P2|STARTED|Overall Study||100
5125928|NCT01453725|12610818|P1|STARTED|Overall Study||98
5125929|NCT01453595|12610841|P3|NOT COMPLETED|Overall Study||2
5125930|NCT01453595|12610842|P2|NOT COMPLETED|Overall Study||1
5125931|NCT01453595|12610843|P1|NOT COMPLETED|Overall Study||2
5125932|NCT01453595|12610841|P3|COMPLETED|Overall Study||0
5125933|NCT01453595|12610842|P2|COMPLETED|Overall Study||5
5125934|NCT01453595|12610843|P1|COMPLETED|Overall Study||0
5125935|NCT01453595|12610841|P3|STARTED|Overall Study||2
5125936|NCT01453595|12610842|P2|STARTED|Overall Study||6
5125937|NCT01453595|12610843|P1|STARTED|Overall Study||2
5125938|NCT01453569|12610852|P3|NOT COMPLETED|Overall Study||7
5125939|NCT01453569|12610853|P2|NOT COMPLETED|Overall Study||14
5125940|NCT01453569|12610854|P1|NOT COMPLETED|Overall Study||11
5125941|NCT01453569|12610852|P3|COMPLETED|Overall Study||78
5125942|NCT01453569|12610853|P2|COMPLETED|Overall Study||70
5125943|NCT01453569|12610854|P1|COMPLETED|Overall Study||75
5125944|NCT01453569|12610852|P3|STARTED|Overall Study||85
5125945|NCT01453569|12610853|P2|STARTED|Overall Study||84
5125946|NCT01453569|12610854|P1|STARTED|Overall Study||86
5125947|NCT01453439|12610873|P2|NOT COMPLETED|Follow-up||11
5125948|NCT01453439|12610874|P1|NOT COMPLETED|Follow-up||5
5125949|NCT01453439|12610873|P2|COMPLETED|Follow-up||37
5125950|NCT01453439|12610874|P1|COMPLETED|Follow-up||39
5125951|NCT01453439|12610873|P2|STARTED|Follow-up||48
5125952|NCT01453439|12610874|P1|STARTED|Follow-up||44
5125953|NCT01453439|12610873|P2|NOT COMPLETED|Treatment Phase||11
5125954|NCT01453439|12610874|P1|NOT COMPLETED|Treatment Phase||17
5125955|NCT01453439|12610873|P2|COMPLETED|Treatment Phase||48
5125956|NCT01453439|12610874|P1|COMPLETED|Treatment Phase||44
5125957|NCT01453439|12610873|P2|STARTED|Treatment Phase||59
5125958|NCT01453439|12610874|P1|STARTED|Treatment Phase||61
5125959|NCT01453413|12610894|P1|NOT COMPLETED|Overall Study||0
5125960|NCT01453413|12610894|P1|COMPLETED|Overall Study||297
5125961|NCT01453413|12610894|P1|STARTED|Overall Study||297
5125962|NCT01453387|12610901|P2|NOT COMPLETED|Overall Study||0
5125963|NCT01453387|12610902|P1|NOT COMPLETED|Overall Study||0
5125964|NCT01453387|12610901|P2|COMPLETED|Overall Study||7
5125965|NCT01453387|12610902|P1|COMPLETED|Overall Study||21
5125966|NCT01453387|12610901|P2|STARTED|Overall Study||7
5125967|NCT01453387|12610902|P1|STARTED|Overall Study||21
5125968|NCT01453374|12610985|P1|NOT COMPLETED|Overall Study||18
5125969|NCT01453374|12610985|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
5125970|NCT01453374|12610985|P1|STARTED|Overall Study||27
5125971|NCT01453361|12611001|P1|NOT COMPLETED|Overall Study||16
5125972|NCT01453361|12611001|P1|COMPLETED|Overall Study||2
5125973|NCT01453361|12611001|P1|STARTED|Overall Study||18
5125974|NCT01453348|12611009|P3|NOT COMPLETED|Overall Study||1
5125975|NCT01453348|12611010|P2|NOT COMPLETED|Overall Study||1
5125976|NCT01453348|12611011|P1|NOT COMPLETED|Overall Study||1
5125977|NCT01453348|12611009|P3|COMPLETED|Overall Study||83
5125978|NCT01453348|12611010|P2|COMPLETED|Overall Study||83
5125979|NCT01453348|12611011|P1|COMPLETED|Overall Study||83
5125980|NCT01453348|12611009|P3|STARTED|Overall Study||84
5125981|NCT01453348|12611010|P2|STARTED|Overall Study||84
5125982|NCT01453348|12611011|P1|STARTED|Overall Study||84
5125983|NCT01453296|12611027|P2|NOT COMPLETED|Treatment Period 2||0
5125984|NCT01453296|12611028|P1|NOT COMPLETED|Treatment Period 2||2
5125985|NCT01453296|12611027|P2|COMPLETED|Treatment Period 2||13
5125986|NCT01453296|12611028|P1|COMPLETED|Treatment Period 2||11
5125987|NCT01453296|12611027|P2|STARTED|Treatment Period 2||13
5125988|NCT01453296|12611028|P1|STARTED|Treatment Period 2||13
5125989|NCT01453296|12611027|P2|NOT COMPLETED|Washout Period||0
5125990|NCT01453296|12611028|P1|NOT COMPLETED|Washout Period||0
5125991|NCT01453296|12611027|P2|COMPLETED|Washout Period||13
5125992|NCT01453296|12611028|P1|COMPLETED|Washout Period||13
5125993|NCT01453296|12611027|P2|STARTED|Washout Period||13
5125994|NCT01453296|12611028|P1|STARTED|Washout Period||13
5125995|NCT01453296|12611027|P2|NOT COMPLETED|Treatment Period 1||1
5125996|NCT01453296|12611028|P1|NOT COMPLETED|Treatment Period 1||1
5125997|NCT01453296|12611027|P2|COMPLETED|Treatment Period 1||13
5125998|NCT01453296|12611028|P1|COMPLETED|Treatment Period 1||13
5125999|NCT01453296|12611027|P2|STARTED|Treatment Period 1||14
5126000|NCT01453296|12611028|P1|STARTED|Treatment Period 1||14
5126001|NCT01453205|12611095|P3|NOT COMPLETED|Overall Study||54
5126002|NCT01453205|12611096|P2|NOT COMPLETED|Overall Study||52
5126003|NCT01453205|12611097|P1|NOT COMPLETED|Overall Study||80
5126004|NCT01453205|12611095|P3|COMPLETED|Overall Study||1
5126005|NCT01453205|12611096|P2|COMPLETED|Overall Study||0
5126006|NCT01453205|12611097|P1|COMPLETED|Overall Study||0
5126007|NCT01453205|12611095|P3|STARTED|Overall Study||55
5126008|NCT01453205|12611096|P2|STARTED|Overall Study||52
5126009|NCT01453205|12611097|P1|STARTED|Overall Study||80
5126010|NCT01453166|12611148|P3|NOT COMPLETED|Overall Study||1
5126011|NCT01453166|12611149|P2|NOT COMPLETED|Overall Study||2
5126012|NCT01453166|12611150|P1|NOT COMPLETED|Overall Study||2
5126013|NCT01453166|12611148|P3|COMPLETED|Overall Study||38
5126014|NCT01453166|12611149|P2|COMPLETED|Overall Study||39
5126015|NCT01453166|12611150|P1|COMPLETED|Overall Study||40
5126016|NCT01453166|12611148|P3|STARTED|Overall Study||39
5126017|NCT01453166|12611149|P2|STARTED|Overall Study||41
5126018|NCT01453166|12611150|P1|STARTED|Overall Study||42
5126019|NCT01453153|12611173|P3|NOT COMPLETED|Overall Study||20
5126020|NCT01453153|12611174|P2|NOT COMPLETED|Overall Study||4
5126021|NCT01453153|12611175|P1|NOT COMPLETED|Overall Study||4
5126022|NCT01453153|12611173|P3|COMPLETED|Overall Study||0
5126023|NCT01453153|12611174|P2|COMPLETED|Overall Study||0
5126024|NCT01453153|12611175|P1|COMPLETED|Overall Study||0
5126025|NCT01453153|12611173|P3|STARTED|Overall Study||20
5126026|NCT01453153|12611174|P2|STARTED|Overall Study||4
5126027|NCT01453153|12611175|P1|STARTED|Overall Study||4
5126028|NCT01453075|12611248|P2|NOT COMPLETED|Overall Study||1
5126029|NCT01453075|12611249|P1|NOT COMPLETED|Overall Study||5
5126030|NCT01453075|12611248|P2|COMPLETED|Overall Study||14
5126031|NCT01453075|12611249|P1|COMPLETED|Overall Study||11
5126032|NCT01453075|12611248|P2|STARTED|Overall Study||15
5126033|NCT01453075|12611249|P1|STARTED|Overall Study||16
5126034|NCT01453049|12611257|P2|NOT COMPLETED|Overall Study||42
5126035|NCT01453049|12611258|P1|NOT COMPLETED|Overall Study||41
5126036|NCT01453049|12611257|P2|COMPLETED|Overall Study||2
5126037|NCT01453049|12611258|P1|COMPLETED|Overall Study||1
5126038|NCT01453049|12611257|P2|STARTED|Overall Study||44
5126039|NCT01453049|12611258|P1|STARTED|Overall Study||42
5126040|NCT01453036|12611331|P3|NOT COMPLETED|Overall Study||31
5126041|NCT01453036|12611332|P2|NOT COMPLETED|Overall Study||115
5126042|NCT01453036|12611333|P1|NOT COMPLETED|Overall Study||26
5126043|NCT01453036|12611331|P3|COMPLETED|Overall Study||277
5126044|NCT01453036|12611332|P2|COMPLETED|Overall Study||193
5126045|NCT01453036|12611333|P1|COMPLETED|Overall Study||282
5126046|NCT01453036|12611331|P3|STARTED|Overall Study||308
5126047|NCT01453036|12611332|P2|STARTED|Overall Study||308
5126048|NCT01453036|12611333|P1|STARTED|Overall Study||308
5126049|NCT01453023|12611341|P2|NOT COMPLETED|Treatment Period 2||1
5126050|NCT01453023|12611342|P1|NOT COMPLETED|Treatment Period 2||0
5126051|NCT01453023|12611341|P2|COMPLETED|Treatment Period 2||11
5126052|NCT01453023|12611342|P1|COMPLETED|Treatment Period 2||12
5126053|NCT01453023|12611341|P2|STARTED|Treatment Period 2||12
5126054|NCT01453023|12611342|P1|STARTED|Treatment Period 2||12
5126055|NCT01453023|12611341|P2|NOT COMPLETED|Washout Period||0
5126056|NCT01453023|12611342|P1|NOT COMPLETED|Washout Period||0
5126057|NCT01453023|12611341|P2|COMPLETED|Washout Period||12
5126058|NCT01453023|12611342|P1|COMPLETED|Washout Period||12
5126059|NCT01453023|12611341|P2|STARTED|Washout Period||12
5126060|NCT01453023|12611342|P1|STARTED|Washout Period||12
5126061|NCT01453023|12611341|P2|NOT COMPLETED|Treatment Period (TP) 1||1
5126062|NCT01453023|12611342|P1|NOT COMPLETED|Treatment Period (TP) 1||1
5126063|NCT01453023|12611341|P2|COMPLETED|Treatment Period (TP) 1||12
5126064|NCT01453023|12611342|P1|COMPLETED|Treatment Period (TP) 1||12
5126065|NCT01453023|12611341|P2|STARTED|Treatment Period (TP) 1||13
5126066|NCT01453023|12611342|P1|STARTED|Treatment Period (TP) 1||13
5126067|NCT01452854|12611410|P1|NOT COMPLETED|Overall Study||0
5126068|NCT01452854|12611410|P1|COMPLETED|Overall Study||2
5126069|NCT01452854|12611410|P1|STARTED|Overall Study||2
5126070|NCT01452789|12611416|P2|NOT COMPLETED|Overall Study||2
5126071|NCT01452789|12611417|P1|NOT COMPLETED|Overall Study||3
5126072|NCT01452789|12611416|P2|COMPLETED|Overall Study||28
5126073|NCT01452789|12611417|P1|COMPLETED|Overall Study||30
5126074|NCT01452789|12611416|P2|STARTED|Overall Study||30
5126075|NCT01452789|12611417|P1|STARTED|Overall Study||33
5126076|NCT01452529|12611431|P3|NOT COMPLETED|Double-blind (DB) Period||82
5126077|NCT01452529|12611432|P2|NOT COMPLETED|Double-blind (DB) Period||67
5126078|NCT01452529|12611433|P1|NOT COMPLETED|Double-blind (DB) Period||0
5126079|NCT01452529|12611431|P3|COMPLETED|Double-blind (DB) Period||210
5126080|NCT01452529|12611432|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
5126081|NCT01452529|12611433|P1|COMPLETED|Double-blind (DB) Period||0
5126082|NCT01452529|12611431|P3|STARTED|Double-blind (DB) Period||292
5126083|NCT01452529|12611432|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
5126084|NCT01452529|12611433|P1|STARTED|Double-blind (DB) Period||0
5126085|NCT01452529|12611431|P3|NOT COMPLETED|Run-in Period||0
5126086|NCT01452529|12611432|P2|NOT COMPLETED|Run-in Period||0
5126087|NCT01452529|12611433|P1|NOT COMPLETED|Run-in Period||313
5126088|NCT01452529|12611431|P3|COMPLETED|Run-in Period||0
5126089|NCT01452529|12611432|P2|COMPLETED|Run-in Period||0
5126090|NCT01452529|12611433|P1|COMPLETED|Run-in Period||592
5126091|NCT01452529|12611431|P3|STARTED|Run-in Period||0
5126092|NCT01452529|12611432|P2|STARTED|Run-in Period||0
5126093|NCT01452529|12611433|P1|STARTED|Run-in Period||905
5126094|NCT01452425|12611448|P1|NOT COMPLETED|Overall Study||0
5126095|NCT01452425|12611448|P1|COMPLETED|Overall Study||10
5126096|NCT01452425|12611448|P1|STARTED|Overall Study||10
5126097|NCT01452412|12611455|P2|NOT COMPLETED|Overall Study||17
5126098|NCT01452412|12611456|P1|NOT COMPLETED|Overall Study||28
5126099|NCT01452412|12611455|P2|COMPLETED|Overall Study||58
5126100|NCT01452412|12611456|P1|COMPLETED|Overall Study||46
5126101|NCT01452412|12611455|P2|STARTED|Overall Study||75
5126102|NCT01452412|12611456|P1|STARTED|Overall Study||74
5126103|NCT01452347|12611472|P2|NOT COMPLETED|Overall Study||7
5126104|NCT01452347|12611473|P1|NOT COMPLETED|Overall Study||17
5126105|NCT01452347|12611472|P2|COMPLETED|Overall Study||77
5126106|NCT01452347|12611473|P1|COMPLETED|Overall Study||151
5126107|NCT01452347|12611472|P2|STARTED|Overall Study||84
5126108|NCT01452347|12611473|P1|STARTED|Overall Study||168
5126109|NCT01452269|12611491|P2|NOT COMPLETED|Overall Study||5
5126110|NCT01452269|12611492|P1|NOT COMPLETED|Overall Study||1
5126111|NCT01452269|12611491|P2|COMPLETED|Overall Study||51
5126112|NCT01452269|12611492|P1|COMPLETED|Overall Study||47
5126113|NCT01452269|12611491|P2|STARTED|Overall Study||56
5126114|NCT01452269|12611492|P1|STARTED|Overall Study||48
5126115|NCT01452191|12611505|P3|NOT COMPLETED|Overall Study||112
5126116|NCT01452191|12611506|P2|NOT COMPLETED|Overall Study||117
5126117|NCT01452191|12611507|P1|NOT COMPLETED|Overall Study||132
5126118|NCT01452191|12611505|P3|COMPLETED|Overall Study||258
5126119|NCT01452191|12611506|P2|COMPLETED|Overall Study||252
5126120|NCT01452191|12611507|P1|COMPLETED|Overall Study||241
5126121|NCT01452191|12611505|P3|STARTED|Overall Study||370
5126122|NCT01452191|12611506|P2|STARTED|Overall Study||369
5126123|NCT01452191|12611507|P1|STARTED|Overall Study||373
5126124|NCT01452152|12611533|P3|NOT COMPLETED|Overall Study||4
5126125|NCT01452152|12611534|P2|NOT COMPLETED|Overall Study||0
5126126|NCT01452152|12611535|P1|NOT COMPLETED|Overall Study||5
5126127|NCT01452152|12611533|P3|COMPLETED|Overall Study||0
5126128|NCT01452152|12611534|P2|COMPLETED|Overall Study||0
5126129|NCT01452152|12611535|P1|COMPLETED|Overall Study||0
5126130|NCT01452152|12611533|P3|STARTED|Overall Study||4
5126131|NCT01452152|12611534|P2|STARTED|Overall Study||0
5126132|NCT01452152|12611535|P1|STARTED|Overall Study||5
5126133|NCT01452126|12611558|P1|NOT COMPLETED|Overall Study||0
5126134|NCT01452126|12611558|P1|COMPLETED|Overall Study||49
5126135|NCT01452126|12611558|P1|STARTED|Overall Study||49
5126136|NCT01451996|12611570|P4|NOT COMPLETED|Overall Study||0
5126137|NCT01451996|12611571|P3|NOT COMPLETED|Overall Study||0
5126138|NCT01451996|12611572|P2|NOT COMPLETED|Overall Study||0
5126139|NCT01451996|12611573|P1|NOT COMPLETED|Overall Study||0
5126140|NCT01451996|12611570|P4|COMPLETED|Overall Study||85
5126141|NCT01451996|12611571|P3|COMPLETED|Overall Study||85
5126142|NCT01451996|12611572|P2|COMPLETED|Overall Study||87
5126143|NCT01451996|12611573|P1|COMPLETED|Overall Study||83
5126144|NCT01451996|12611570|P4|STARTED|Overall Study||85
5126145|NCT01451996|12611571|P3|STARTED|Overall Study||85
5126146|NCT01451996|12611572|P2|STARTED|Overall Study||87
5126147|NCT01451996|12611573|P1|STARTED|Overall Study||83
5126148|NCT01451983|12611591|P4|NOT COMPLETED|Overall Study||0
5126149|NCT01451983|12611592|P3|NOT COMPLETED|Overall Study||0
5126150|NCT01451983|12611593|P2|NOT COMPLETED|Overall Study||0
5126151|NCT01451983|12611594|P1|NOT COMPLETED|Overall Study||0
5126152|NCT01451983|12611591|P4|COMPLETED|Overall Study||24
5126153|NCT01451983|12611592|P3|COMPLETED|Overall Study||61
5126154|NCT01451983|12611593|P2|COMPLETED|Overall Study||27
5126155|NCT01451983|12611594|P1|COMPLETED|Overall Study||26
5126156|NCT01451983|12611591|P4|STARTED|Overall Study||24
5126157|NCT01451983|12611592|P3|STARTED|Overall Study||61
5126158|NCT01451983|12611593|P2|STARTED|Overall Study||27
5126159|NCT01451983|12611594|P1|STARTED|Overall Study||26
5126160|NCT01451931|12611607|P3|NOT COMPLETED|Overall Study||43
5126161|NCT01451931|12611608|P2|NOT COMPLETED|Overall Study||58
5126162|NCT01451931|12611609|P1|NOT COMPLETED|Overall Study||33
5126163|NCT01451931|12611607|P3|COMPLETED|Overall Study||923
5126164|NCT01451931|12611608|P2|COMPLETED|Overall Study||843
5126165|NCT01451931|12611609|P1|COMPLETED|Overall Study||876
5126166|NCT01451931|12611607|P3|6-month Follow up|Overall Study||923
5126167|NCT01451931|12611608|P2|6-month Follow up|Overall Study||843
5126168|NCT01451931|12611609|P1|6-month Follow up|Overall Study||876
5126169|NCT01451931|12611607|P3|Baseline Data Collection|Overall Study||958
5126170|NCT01451931|12611608|P2|Baseline Data Collection|Overall Study||893
5126171|NCT01451931|12611609|P1|Baseline Data Collection|Overall Study||908
5126172|NCT01451931|12611607|P3|STARTED|Overall Study||966
5126173|NCT01451931|12611608|P2|STARTED|Overall Study||901
5126174|NCT01451931|12611609|P1|STARTED|Overall Study||909
5126175|NCT01451827|12611633|P4|NOT COMPLETED|Overall Study||4
5126176|NCT01451827|12611634|P3|NOT COMPLETED|Overall Study||2
5126177|NCT01451827|12611635|P2|NOT COMPLETED|Overall Study||5
5126178|NCT01451827|12611636|P1|NOT COMPLETED|Overall Study||3
5126179|NCT01451827|12611633|P4|COMPLETED|Overall Study||39
5126180|NCT01451827|12611634|P3|COMPLETED|Overall Study||42
5126181|NCT01451827|12611635|P2|COMPLETED|Overall Study||40
5126182|NCT01451827|12611636|P1|COMPLETED|Overall Study||42
5126183|NCT01451827|12611633|P4|STARTED|Overall Study||43
5126184|NCT01451827|12611634|P3|STARTED|Overall Study||44
5126185|NCT01451827|12611635|P2|STARTED|Overall Study||45
5126186|NCT01451827|12611636|P1|STARTED|Overall Study||45
5126187|NCT01451814|12611656|P2|NOT COMPLETED|Overall Study||5
5126188|NCT01451814|12611657|P1|NOT COMPLETED|Overall Study||6
5126189|NCT01451814|12611656|P2|COMPLETED|Overall Study||26
5126190|NCT01451814|12611657|P1|COMPLETED|Overall Study||29
5126191|NCT01451814|12611656|P2|Attended a Session|Overall Study||31
5126192|NCT01451814|12611657|P1|Attended a Session|Overall Study||35
5126193|NCT01451814|12611656|P2|STARTED|Overall Study||31
5126194|NCT01451814|12611657|P1|STARTED|Overall Study||35
5126195|NCT01451775|12611667|P6|NOT COMPLETED|Overall Study||0
5126196|NCT01451775|12611668|P5|NOT COMPLETED|Overall Study||0
5126197|NCT01451775|12611669|P4|NOT COMPLETED|Overall Study||0
5126198|NCT01451775|12611670|P3|NOT COMPLETED|Overall Study||0
5126199|NCT01451775|12611671|P2|NOT COMPLETED|Overall Study||0
5126200|NCT01451775|12611672|P1|NOT COMPLETED|Overall Study||0
5126201|NCT01451775|12611667|P6|COMPLETED|Overall Study||3
5126202|NCT01451775|12611668|P5|COMPLETED|Overall Study||3
5126203|NCT01451775|12611669|P4|COMPLETED|Overall Study||3
5126204|NCT01451775|12611670|P3|COMPLETED|Overall Study||3
5126205|NCT01451775|12611671|P2|COMPLETED|Overall Study||3
5126206|NCT01451775|12611672|P1|COMPLETED|Overall Study||3
5126207|NCT01451775|12611667|P6|STARTED|Overall Study||3
5126208|NCT01451775|12611668|P5|STARTED|Overall Study||3
5126209|NCT01451775|12611669|P4|STARTED|Overall Study||3
5126210|NCT01451775|12611670|P3|STARTED|Overall Study||3
5126211|NCT01451775|12611671|P2|STARTED|Overall Study||3
5126212|NCT01451775|12611672|P1|STARTED|Overall Study||3
5126213|NCT01451762|12611689|P3|NOT COMPLETED|Overall Study||6
5126214|NCT01451762|12611690|P2|NOT COMPLETED|Overall Study||6
5126215|NCT01451762|12611691|P1|NOT COMPLETED|Overall Study||3
5126216|NCT01451762|12611689|P3|COMPLETED|Overall Study||24
5126217|NCT01451762|12611690|P2|COMPLETED|Overall Study||24
5126218|NCT01451762|12611691|P1|COMPLETED|Overall Study||27
5126219|NCT01451762|12611689|P3|STARTED|Overall Study||30
5126220|NCT01451762|12611690|P2|STARTED|Overall Study||30
5126221|NCT01451762|12611691|P1|STARTED|Overall Study||30
5126222|NCT01451749|12611701|P2|NOT COMPLETED|Overall Study||14
5126223|NCT01451749|12611702|P1|NOT COMPLETED|Overall Study||32
5126224|NCT01451749|12611701|P2|COMPLETED|Overall Study||94
5126225|NCT01451749|12611702|P1|COMPLETED|Overall Study||184
5126226|NCT01451749|12611701|P2|STARTED|Overall Study||108
5126227|NCT01451749|12611702|P1|STARTED|Overall Study||216
5126228|NCT01451723|12611714|P2|NOT COMPLETED|Overall Study||5
5126229|NCT01451723|12611715|P1|NOT COMPLETED|Overall Study||6
5126230|NCT01451723|12611714|P2|COMPLETED|Overall Study||0
5126231|NCT01451723|12611715|P1|COMPLETED|Overall Study||0
5126232|NCT01451723|12611714|P2|STARTED|Overall Study||5
5126233|NCT01451723|12611715|P1|STARTED|Overall Study||6
5126234|NCT01451645|12611725|P2|NOT COMPLETED|Overall Study||8
5126235|NCT01451645|12611726|P1|NOT COMPLETED|Overall Study||9
5126236|NCT01451645|12611725|P2|COMPLETED|Overall Study||33
5126237|NCT01451645|12611726|P1|COMPLETED|Overall Study||32
5126238|NCT01451645|12611725|P2|STARTED|Overall Study||41
5126239|NCT01451645|12611726|P1|STARTED|Overall Study||41
5126240|NCT01451632|12611740|P10|NOT COMPLETED|Overall Study||0
5126241|NCT01451632|12611741|P9|NOT COMPLETED|Overall Study||0
5126242|NCT01451632|12611742|P8|NOT COMPLETED|Overall Study||0
5126243|NCT01451632|12611743|P7|NOT COMPLETED|Overall Study||0
5126244|NCT01451632|12611744|P6|NOT COMPLETED|Overall Study||0
5126245|NCT01451632|12611745|P5|NOT COMPLETED|Overall Study||0
5126246|NCT01451632|12611746|P4|NOT COMPLETED|Overall Study||0
5126247|NCT01451632|12611747|P3|NOT COMPLETED|Overall Study||0
5126248|NCT01451632|12611748|P2|NOT COMPLETED|Overall Study||0
5126249|NCT01451632|12611749|P1|NOT COMPLETED|Overall Study||0
5126250|NCT01451632|12611740|P10|COMPLETED|Overall Study||4
5126251|NCT01451632|12611741|P9|COMPLETED|Overall Study||4
5126252|NCT01451632|12611742|P8|COMPLETED|Overall Study||6
5126253|NCT01451632|12611743|P7|COMPLETED|Overall Study||8
5126254|NCT01451632|12611744|P6|COMPLETED|Overall Study||4
5126255|NCT01451632|12611745|P5|COMPLETED|Overall Study||4
5126256|NCT01451632|12611746|P4|COMPLETED|Overall Study||3
5126257|NCT01451632|12611747|P3|COMPLETED|Overall Study||3
5126258|NCT01451632|12611748|P2|COMPLETED|Overall Study||4
5126259|NCT01451632|12611749|P1|COMPLETED|Overall Study||8
5126260|NCT01451632|12611740|P10|STARTED|Overall Study||4
5126261|NCT01451632|12611741|P9|STARTED|Overall Study||4
5126262|NCT01451632|12611742|P8|STARTED|Overall Study||6
5126263|NCT01451632|12611743|P7|STARTED|Overall Study||8
5126264|NCT01451632|12611744|P6|STARTED|Overall Study||4
5126265|NCT01451632|12611745|P5|STARTED|Overall Study||4
5126266|NCT01451632|12611746|P4|STARTED|Overall Study||3
5126267|NCT01451632|12611747|P3|STARTED|Overall Study||3
5126268|NCT01451632|12611748|P2|STARTED|Overall Study||4
5126269|NCT01451632|12611749|P1|STARTED|Overall Study||8
5126270|NCT01451606|12611797|P2|NOT COMPLETED|Overall Study||3
5126271|NCT01451606|12611798|P1|NOT COMPLETED|Overall Study||4
5126272|NCT01451606|12611797|P2|COMPLETED|Overall Study||15
5126273|NCT01451606|12611798|P1|COMPLETED|Overall Study||12
5126274|NCT01451606|12611797|P2|STARTED|Overall Study||18
5126275|NCT01451606|12611798|P1|STARTED|Overall Study||16
5126276|NCT01451554|12611808|P2|NOT COMPLETED|Overall Study||9
5126277|NCT01451554|12611809|P1|NOT COMPLETED|Overall Study||14
5126278|NCT01451554|12611808|P2|COMPLETED|Overall Study||23
5126279|NCT01451554|12611809|P1|COMPLETED|Overall Study||19
5126280|NCT01451554|12611808|P2|STARTED|Overall Study||32
5126281|NCT01451554|12611809|P1|STARTED|Overall Study||33
5126282|NCT01451541|12611820|P3|NOT COMPLETED|Overall Study||27
5126283|NCT01451541|12611821|P2|NOT COMPLETED|Overall Study||25
5126284|NCT01451541|12611822|P1|NOT COMPLETED|Overall Study||36
5126285|NCT01451541|12611820|P3|COMPLETED|Overall Study||254
5126286|NCT01451541|12611821|P2|COMPLETED|Overall Study||257
5126287|NCT01451541|12611822|P1|COMPLETED|Overall Study||247
5126288|NCT01451541|12611820|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
5126289|NCT01451541|12611821|P2|STARTED|Overall Study||282
5126290|NCT01451541|12611822|P1|STARTED|Overall Study||283
5126291|NCT01451463|12611862|P1|NOT COMPLETED|Overall Study||0
5126292|NCT01451463|12611862|P1|COMPLETED|Overall Study||11
5126293|NCT01451463|12611862|P1|STARTED|Overall Study||11
5126294|NCT01451437|12611880|P9|NOT COMPLETED|Overall Study||4
5126295|NCT01451437|12611881|P8|NOT COMPLETED|Overall Study||3
5126296|NCT01451437|12611882|P7|NOT COMPLETED|Overall Study||6
5126297|NCT01451437|12611883|P6|NOT COMPLETED|Overall Study||3
5126298|NCT01451437|12611884|P5|NOT COMPLETED|Overall Study||4
5126299|NCT01451437|12611885|P4|NOT COMPLETED|Overall Study||1
5126300|NCT01451437|12611886|P3|NOT COMPLETED|Overall Study||3
5126301|NCT01451437|12611887|P2|NOT COMPLETED|Overall Study||1
5126302|NCT01451437|12611888|P1|NOT COMPLETED|Overall Study||1
5126303|NCT01451437|12611880|P9|COMPLETED|Overall Study||0
5126304|NCT01451437|12611881|P8|COMPLETED|Overall Study||0
5126305|NCT01451437|12611882|P7|COMPLETED|Overall Study||0
5126306|NCT01451437|12611883|P6|COMPLETED|Overall Study||0
5126307|NCT01451437|12611884|P5|COMPLETED|Overall Study||0
5126308|NCT01451437|12611885|P4|COMPLETED|Overall Study||0
5126309|NCT01451437|12611886|P3|COMPLETED|Overall Study||0
5126310|NCT01451437|12611887|P2|COMPLETED|Overall Study||0
5126311|NCT01451437|12611888|P1|COMPLETED|Overall Study||0
5126312|NCT01451437|12611880|P9|STARTED|Overall Study||4
5126313|NCT01451437|12611881|P8|STARTED|Overall Study||3
5126314|NCT01451437|12611882|P7|STARTED|Overall Study||6
5126315|NCT01451437|12611883|P6|STARTED|Overall Study||3
5126316|NCT01451437|12611884|P5|STARTED|Overall Study||4
5126317|NCT01451437|12611885|P4|STARTED|Overall Study||1
5126318|NCT01451437|12611886|P3|STARTED|Overall Study||3
5126319|NCT01451437|12611887|P2|STARTED|Overall Study||1
5126320|NCT01451437|12611888|P1|STARTED|Overall Study||1
5126321|NCT01451424|12612020|P4|NOT COMPLETED|Overall Study||5
5126322|NCT01451424|12612021|P3|NOT COMPLETED|Overall Study||1
5126323|NCT01451424|12612022|P2|NOT COMPLETED|Overall Study||2
5126324|NCT01451424|12612023|P1|NOT COMPLETED|Overall Study||1
5126325|NCT01451424|12612020|P4|COMPLETED|Overall Study||5
5126326|NCT01451424|12612021|P3|COMPLETED|Overall Study||11
5126327|NCT01451424|12612022|P2|COMPLETED|Overall Study||7
5126328|NCT01451424|12612023|P1|COMPLETED|Overall Study||8
5126329|NCT01451424|12612020|P4|STARTED|Overall Study||10
5126330|NCT01451424|12612021|P3|STARTED|Overall Study||12
5126331|NCT01451424|12612022|P2|STARTED|Overall Study||9
5126332|NCT01451424|12612023|P1|STARTED|Overall Study||9
5126333|NCT01451411|12612056|P2|NOT COMPLETED|Overall Study||0
5126334|NCT01451411|12612057|P1|NOT COMPLETED|Overall Study||0
5126335|NCT01451411|12612056|P2|COMPLETED|Overall Study||1
5126336|NCT01451411|12612057|P1|COMPLETED|Overall Study||3
5126337|NCT01451411|12612056|P2|STARTED|Overall Study||1
5126338|NCT01451411|12612057|P1|STARTED|Overall Study||3
5126339|NCT01451398|12612081|P2|NOT COMPLETED|Overall Study||37
5126340|NCT01451398|12612082|P1|NOT COMPLETED|Overall Study||27
5126341|NCT01451398|12612081|P2|COMPLETED|Overall Study||139
5126342|NCT01451398|12612082|P1|COMPLETED|Overall Study||150
5126343|NCT01451398|12612081|P2|STARTED|Overall Study||176
5126344|NCT01451398|12612082|P1|STARTED|Overall Study||177
5126345|NCT01451372|12612114|P1|NOT COMPLETED|Overall Study||0
5126346|NCT01451372|12612114|P1|COMPLETED|Overall Study||69
5126347|NCT01451372|12612114|P1|STARTED|Overall Study||69
5126348|NCT01451203|12612121|P2|NOT COMPLETED|Post-treatment Period||34
5126349|NCT01451203|12612122|P1|NOT COMPLETED|Post-treatment Period||14
5126350|NCT01451203|12612121|P2|COMPLETED|Post-treatment Period||74
5126351|NCT01451203|12612122|P1|COMPLETED|Post-treatment Period||57
5126352|NCT01451203|12612121|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
5126353|NCT01451203|12612122|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
5126354|NCT01451203|12612121|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
5126355|NCT01451203|12612122|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
5126356|NCT01451203|12612121|P2|NOT COMPLETED|Double-blind Treatment Period||50
5126357|NCT01451203|12612122|P1|NOT COMPLETED|Double-blind Treatment Period||85
5126358|NCT01451203|12612121|P2|COMPLETED|Double-blind Treatment Period||111
5126359|NCT01451203|12612122|P1|COMPLETED|Double-blind Treatment Period||73
5126360|NCT01451203|12612121|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
5126361|NCT01451203|12612122|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
5126362|NCT01451203|12612121|P2|Received Treatment|Double-blind Treatment Period||159
5126363|NCT01451203|12612122|P1|Received Treatment|Double-blind Treatment Period||157
5126364|NCT01451203|12612121|P2|STARTED|Double-blind Treatment Period||161
5126365|NCT01451203|12612122|P1|STARTED|Double-blind Treatment Period||158
5126366|NCT01451164|12612140|P4|NOT COMPLETED|Overall Study||46
5126367|NCT01451164|12612141|P3|NOT COMPLETED|Overall Study||45
5126368|NCT01451164|12612142|P2|NOT COMPLETED|Overall Study||34
5126369|NCT01451164|12612143|P1|NOT COMPLETED|Overall Study||43
5126370|NCT01451164|12612140|P4|COMPLETED|Overall Study||70
5126371|NCT01451164|12612141|P3|COMPLETED|Overall Study||68
5126372|NCT01451164|12612142|P2|COMPLETED|Overall Study||81
5126373|NCT01451164|12612143|P1|COMPLETED|Overall Study||72
5126374|NCT01451164|12612140|P4|STARTED|Overall Study||116
5126375|NCT01451164|12612141|P3|STARTED|Overall Study||113
5126376|NCT01451164|12612142|P2|STARTED|Overall Study||115
5126377|NCT01451164|12612143|P1|STARTED|Overall Study||115
5126378|NCT01450943|12612172|P3|NOT COMPLETED|Overall Study||6
5126379|NCT01450943|12612173|P2|NOT COMPLETED|Overall Study||7
5126380|NCT01450943|12612174|P1|NOT COMPLETED|Overall Study||2
5126381|NCT01450943|12612172|P3|COMPLETED|Overall Study||42
5126382|NCT01450943|12612173|P2|COMPLETED|Overall Study||35
5126383|NCT01450943|12612174|P1|COMPLETED|Overall Study||26
5126384|NCT01450943|12612172|P3|STARTED|Overall Study||48
5126385|NCT01450943|12612173|P2|STARTED|Overall Study||42
5126386|NCT01450943|12612174|P1|STARTED|Overall Study||28
5126387|NCT01450826|12612190|P2|NOT COMPLETED|Overall Study||0
5126388|NCT01450826|12612191|P1|NOT COMPLETED|Overall Study||0
5126389|NCT01450826|12612190|P2|COMPLETED|Overall Study||66
5126390|NCT01450826|12612191|P1|COMPLETED|Overall Study||70
5126391|NCT01450826|12612190|P2|STARTED|Overall Study||66
5126392|NCT01450826|12612191|P1|STARTED|Overall Study||70
5126393|NCT01450813|12612207|P4|NOT COMPLETED|Overall Study||3
5126394|NCT01450813|12612208|P3|NOT COMPLETED|Overall Study||0
5126395|NCT01450813|12612209|P2|NOT COMPLETED|Overall Study||1
5126396|NCT01450813|12612210|P1|NOT COMPLETED|Overall Study||1
5126397|NCT01450813|12612207|P4|COMPLETED|Overall Study||17
5126398|NCT01450813|12612208|P3|COMPLETED|Overall Study||20
5126399|NCT01450813|12612209|P2|COMPLETED|Overall Study||19
5126400|NCT01450813|12612210|P1|COMPLETED|Overall Study||19
5126401|NCT01450813|12612207|P4|STARTED|Overall Study||20
5126402|NCT01450813|12612208|P3|STARTED|Overall Study||20
5126403|NCT01450813|12612209|P2|STARTED|Overall Study||20
5126404|NCT01450813|12612210|P1|STARTED|Overall Study||20
5126405|NCT01450800|12612224|P2|NOT COMPLETED|Overall Study||3
5126406|NCT01450800|12612225|P1|NOT COMPLETED|Overall Study||1
5126407|NCT01450800|12612224|P2|COMPLETED|Overall Study||78
5126408|NCT01450800|12612225|P1|COMPLETED|Overall Study||81
5126409|NCT01450800|12612224|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
5126410|NCT01450800|12612225|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
5126411|NCT01450787|12612241|P2|NOT COMPLETED|Overall Study||0
5126412|NCT01450787|12612242|P1|NOT COMPLETED|Overall Study||0
5126413|NCT01450787|12612241|P2|COMPLETED|Overall Study||25
5126414|NCT01450787|12612242|P1|COMPLETED|Overall Study||38
5126415|NCT01450787|12612241|P2|STARTED|Overall Study||25
5126416|NCT01450787|12612242|P1|STARTED|Overall Study||38
5126417|NCT01450761|12612260|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
5126418|NCT01450761|12612261|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
5126419|NCT01450761|12612260|P2|COMPLETED|Treatment With Blinded Study Therapy||0
5126420|NCT01450761|12612261|P1|COMPLETED|Treatment With Blinded Study Therapy||0
5126421|NCT01450761|12612260|P2|STARTED|Treatment With Blinded Study Therapy||476
5126422|NCT01450761|12612261|P1|STARTED|Treatment With Blinded Study Therapy||478
5126423|NCT01450761|12612260|P2|NOT COMPLETED|Lead-in Chemotherapy||85
5126424|NCT01450761|12612261|P1|NOT COMPLETED|Lead-in Chemotherapy||84
5126425|NCT01450761|12612260|P2|COMPLETED|Lead-in Chemotherapy||476
5126426|NCT01450761|12612261|P1|COMPLETED|Lead-in Chemotherapy||478
5126427|NCT01450761|12612260|P2|STARTED|Lead-in Chemotherapy||561
5126428|NCT01450761|12612261|P1|STARTED|Lead-in Chemotherapy||562
5126429|NCT01450761|12612260|P2|NOT COMPLETED|Randomization||5
5126430|NCT01450761|12612261|P1|NOT COMPLETED|Randomization||4
5126431|NCT01450761|12612260|P2|COMPLETED|Randomization||561
5126432|NCT01450761|12612261|P1|COMPLETED|Randomization||562
5126433|NCT01450761|12612260|P2|STARTED|Randomization||566
5126434|NCT01450761|12612261|P1|STARTED|Randomization||566
5126435|NCT01450696|12612273|P2|NOT COMPLETED|Overall Study||148
5126436|NCT01450696|12612274|P1|NOT COMPLETED|Overall Study||148
5126437|NCT01450696|12612273|P2|COMPLETED|Overall Study||0
5126438|NCT01450696|12612274|P1|COMPLETED|Overall Study||0
5126439|NCT01450696|12612273|P2|Treated (Safety Population)|Overall Study||147
5126440|NCT01450696|12612274|P1|Treated (Safety Population)|Overall Study||147
5126441|NCT01450696|12612273|P2|STARTED|Overall Study||148
5126442|NCT01450696|12612274|P1|STARTED|Overall Study||148
5126443|NCT01450683|12612296|P1|NOT COMPLETED|Overall Study||2
5126444|NCT01450683|12612296|P1|COMPLETED|Overall Study||2
5126445|NCT01450683|12612296|P1|STARTED|Overall Study||4
5126446|NCT01450631|12612302|P2|NOT COMPLETED|Overall Study||4
5126447|NCT01450631|12612303|P1|NOT COMPLETED|Overall Study||3
5126448|NCT01450631|12612302|P2|COMPLETED|Overall Study||42
5126449|NCT01450631|12612303|P1|COMPLETED|Overall Study||43
5126450|NCT01450631|12612302|P2|STARTED|Overall Study||46
5126451|NCT01450631|12612303|P1|STARTED|Overall Study||46
5126452|NCT01450397|12612311|P1|NOT COMPLETED|Overall Study||0
5126453|NCT01450397|12612311|P1|COMPLETED|Overall Study||5
5126454|NCT01450397|12612311|P1|STARTED|Overall Study||5
5126455|NCT01450319|12612315|P1|NOT COMPLETED|Overall Study||0
5126456|NCT01450319|12612315|P1|COMPLETED|Overall Study||70
5126457|NCT01450319|12612315|P1|STARTED|Overall Study||70
5126458|NCT01450306|12612328|P2|NOT COMPLETED|Overall Study||0
5126459|NCT01450306|12612329|P1|NOT COMPLETED|Overall Study||0
5126460|NCT01450306|12612328|P2|COMPLETED|Overall Study||10
5126461|NCT01450306|12612329|P1|COMPLETED|Overall Study||10
5126462|NCT01450306|12612328|P2|STARTED|Overall Study||10
5126463|NCT01450306|12612329|P1|STARTED|Overall Study||10
5126464|NCT01450189|12612342|P3|NOT COMPLETED|Overall Study||0
5126465|NCT01450189|12612343|P2|NOT COMPLETED|Overall Study||0
5126466|NCT01450189|12612344|P1|NOT COMPLETED|Overall Study||0
5126467|NCT01450189|12612342|P3|COMPLETED|Overall Study||19
5126468|NCT01450189|12612343|P2|COMPLETED|Overall Study||18
5126469|NCT01450189|12612344|P1|COMPLETED|Overall Study||9
5126470|NCT01450189|12612342|P3|STARTED|Overall Study||19
5126471|NCT01450189|12612343|P2|STARTED|Overall Study||18
5126472|NCT01450189|12612344|P1|STARTED|Overall Study||9
5126473|NCT01450137|12612433|P2|NOT COMPLETED|Week 12 to Study End||2
5126474|NCT01450137|12612434|P1|NOT COMPLETED|Week 12 to Study End||0
5126475|NCT01450137|12612433|P2|COMPLETED|Week 12 to Study End||5
5126476|NCT01450137|12612434|P1|COMPLETED|Week 12 to Study End||18
5126477|NCT01450137|12612433|P2|STARTED|Week 12 to Study End||7
5126478|NCT01450137|12612434|P1|STARTED|Week 12 to Study End||18
5126479|NCT01450137|12612433|P2|NOT COMPLETED|Up to Week 12||3
5126480|NCT01450137|12612434|P1|NOT COMPLETED|Up to Week 12||2
5126481|NCT01450137|12612433|P2|COMPLETED|Up to Week 12||7
5126482|NCT01450137|12612434|P1|COMPLETED|Up to Week 12||18
5126483|NCT01450137|12612433|P2|STARTED|Up to Week 12||10
5126484|NCT01450137|12612434|P1|STARTED|Up to Week 12||20
5126485|NCT01450098|12612448|P2|NOT COMPLETED|Period 3||3
5126486|NCT01450098|12612449|P1|NOT COMPLETED|Period 3||0
5126487|NCT01450098|12612448|P2|COMPLETED|Period 3||28
5126488|NCT01450098|12612449|P1|COMPLETED|Period 3||8
5126489|NCT01450098|12612448|P2|Received at Least 1 Dose of Study Drug|Period 3||30
5126490|NCT01450098|12612449|P1|Received at Least 1 Dose of Study Drug|Period 3||8
5126491|NCT01450098|12612448|P2|STARTED|Period 3||31
5126492|NCT01450098|12612449|P1|STARTED|Period 3||8
5126493|NCT01450098|12612448|P2|NOT COMPLETED|Washout of at Least 14 Days||0
5126494|NCT01450098|12612449|P1|NOT COMPLETED|Washout of at Least 14 Days||0
5126495|NCT01450098|12612448|P2|COMPLETED|Washout of at Least 14 Days||31
5126496|NCT01450098|12612449|P1|COMPLETED|Washout of at Least 14 Days||8
5126497|NCT01450098|12612448|P2|STARTED|Washout of at Least 14 Days||31
5126498|NCT01450098|12612449|P1|STARTED|Washout of at Least 14 Days||8
5126499|NCT01450098|12612448|P2|NOT COMPLETED|Period 2||0
5126500|NCT01450098|12612449|P1|NOT COMPLETED|Period 2||0
5126501|NCT01450098|12612448|P2|COMPLETED|Period 2||31
5126502|NCT01450098|12612449|P1|COMPLETED|Period 2||8
5126503|NCT01450098|12612448|P2|Received at Least 1 Dose of Study Drug|Period 2||31
5126504|NCT01450098|12612449|P1|Received at Least 1 Dose of Study Drug|Period 2||8
5126505|NCT01450098|12612448|P2|STARTED|Period 2||31
5126506|NCT01450098|12612449|P1|STARTED|Period 2||8
5126507|NCT01450098|12612448|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
5126508|NCT01450098|12612449|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
5126509|NCT01450098|12612448|P2|COMPLETED|Washout Period of at Least 14 Days||31
5126510|NCT01450098|12612449|P1|COMPLETED|Washout Period of at Least 14 Days||8
5126511|NCT01450098|12612448|P2|STARTED|Washout Period of at Least 14 Days||31
5126512|NCT01450098|12612449|P1|STARTED|Washout Period of at Least 14 Days||8
5126513|NCT01450098|12612448|P2|NOT COMPLETED|Period 1||0
5126514|NCT01450098|12612449|P1|NOT COMPLETED|Period 1||0
5126515|NCT01450098|12612448|P2|COMPLETED|Period 1||31
5126516|NCT01450098|12612449|P1|COMPLETED|Period 1||8
5126517|NCT01450098|12612448|P2|Received at Least 1 Dose of Study Drug|Period 1||31
5126518|NCT01450098|12612449|P1|Received at Least 1 Dose of Study Drug|Period 1||8
5126519|NCT01450098|12612448|P2|STARTED|Period 1||31
5126520|NCT01450098|12612449|P1|STARTED|Period 1||8
5126521|NCT01450007|12612468|P3|NOT COMPLETED|Overall Study||3
5126522|NCT01450007|12612469|P2|NOT COMPLETED|Overall Study||5
5126523|NCT01450007|12612470|P1|NOT COMPLETED|Overall Study||2
5126524|NCT01450007|12612468|P3|COMPLETED|Overall Study||41
5126525|NCT01450007|12612469|P2|COMPLETED|Overall Study||37
5126526|NCT01450007|12612470|P1|COMPLETED|Overall Study||42
5126527|NCT01450007|12612468|P3|STARTED|Overall Study||44
5126528|NCT01450007|12612469|P2|STARTED|Overall Study||42
5126529|NCT01450007|12612470|P1|STARTED|Overall Study||44
5126530|NCT01449955|12612489|P2|NOT COMPLETED|Overall Study||2
5126531|NCT01449955|12612490|P1|NOT COMPLETED|Overall Study||1
5126532|NCT01449955|12612489|P2|COMPLETED|Overall Study||24
5126533|NCT01449955|12612490|P1|COMPLETED|Overall Study||27
5126534|NCT01449955|12612489|P2|STARTED|Overall Study||26
5126535|NCT01449955|12612490|P1|STARTED|Overall Study||28
5126536|NCT01449929|12612518|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
5126537|NCT01449929|12612519|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
5126538|NCT01449929|12612520|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
5126539|NCT01449929|12612518|P3|COMPLETED|Extension Phase Approximately 3 Years||115
5126540|NCT01449929|12612519|P2|COMPLETED|Extension Phase Approximately 3 Years||0
5126541|NCT01449929|12612520|P1|COMPLETED|Extension Phase Approximately 3 Years||0
5126542|NCT01449929|12612518|P3|STARTED|Extension Phase Approximately 3 Years||123
5126543|NCT01449929|12612519|P2|STARTED|Extension Phase Approximately 3 Years||0
5126544|NCT01449929|12612520|P1|STARTED|Extension Phase Approximately 3 Years||0
5126545|NCT01449929|12612518|P3|NOT COMPLETED|Randomization Phase 96 Week||0
5126546|NCT01449929|12612519|P2|NOT COMPLETED|Randomization Phase 96 Week||53
5126547|NCT01449929|12612520|P1|NOT COMPLETED|Randomization Phase 96 Week||33
5126548|NCT01449929|12612518|P3|COMPLETED|Randomization Phase 96 Week||0
5126549|NCT01449929|12612519|P2|COMPLETED|Randomization Phase 96 Week||189
5126550|NCT01449929|12612520|P1|COMPLETED|Randomization Phase 96 Week||209
5126551|NCT01449929|12612518|P3|STARTED|Randomization Phase 96 Week||0
5126552|NCT01449929|12612519|P2|STARTED|Randomization Phase 96 Week||242
5126553|NCT01449929|12612520|P1|STARTED|Randomization Phase 96 Week||242
5126554|NCT01449864|12612557|P1|NOT COMPLETED|Overall Study||5
5126555|NCT01449864|12612557|P1|COMPLETED|Overall Study||17
5126556|NCT01449864|12612557|P1|STARTED|Overall Study||22
5126557|NCT01449812|12612565|P3|NOT COMPLETED|Overall Study||1
5126558|NCT01449812|12612566|P2|NOT COMPLETED|Overall Study||0
5126559|NCT01449812|12612567|P1|NOT COMPLETED|Overall Study||2
5126560|NCT01449812|12612565|P3|COMPLETED|Overall Study||279
5126561|NCT01449812|12612566|P2|COMPLETED|Overall Study||273
5126562|NCT01449812|12612567|P1|COMPLETED|Overall Study||270
5126563|NCT01449812|12612565|P3|STARTED|Overall Study||280
5126564|NCT01449812|12612566|P2|STARTED|Overall Study||273
5126565|NCT01449812|12612567|P1|STARTED|Overall Study||272
5126566|NCT01449747|12612661|P2|NOT COMPLETED|Overall Study||0
5126567|NCT01449747|12612662|P1|NOT COMPLETED|Overall Study||0
5126568|NCT01449747|12612661|P2|COMPLETED|Overall Study||12
5126569|NCT01449747|12612662|P1|COMPLETED|Overall Study||12
5126570|NCT01449747|12612661|P2|STARTED|Overall Study||12
5126571|NCT01449747|12612662|P1|STARTED|Overall Study||12
5126572|NCT01449734|12612676|P1|NOT COMPLETED|Overall Study||0
5126573|NCT01449734|12612676|P1|COMPLETED|Overall Study||215
5126574|NCT01449734|12612676|P1|STARTED|Overall Study||215
5126575|NCT01449721|12612682|P2|NOT COMPLETED|Overall Study||2
5126576|NCT01449721|12612683|P1|NOT COMPLETED|Overall Study||0
5126577|NCT01449721|12612682|P2|COMPLETED|Overall Study||28
5126578|NCT01449721|12612683|P1|COMPLETED|Overall Study||112
5126579|NCT01449721|12612682|P2|STARTED|Overall Study||30
5126580|NCT01449721|12612683|P1|STARTED|Overall Study||112
5126581|NCT01449708|12612695|P2|NOT COMPLETED|Overall Study||3
5126582|NCT01449708|12612696|P1|NOT COMPLETED|Overall Study||2
5126583|NCT01449708|12612695|P2|COMPLETED|Overall Study||60
5126584|NCT01449708|12612696|P1|COMPLETED|Overall Study||59
5126585|NCT01449708|12612695|P2|STARTED|Overall Study||63
5126586|NCT01449708|12612696|P1|STARTED|Overall Study||61
5126587|NCT01449682|12612707|P2|NOT COMPLETED|Overall Study||1
5126588|NCT01449682|12612708|P1|NOT COMPLETED|Overall Study||1
5126589|NCT01449682|12612707|P2|COMPLETED|Overall Study||4
5126590|NCT01449682|12612708|P1|COMPLETED|Overall Study||4
5126591|NCT01449682|12612707|P2|STARTED|Overall Study||5
5126592|NCT01449682|12612708|P1|STARTED|Overall Study||5
5126593|NCT01449630|12612729|P9|NOT COMPLETED|Period 3||0
5126594|NCT01449630|12612730|P8|NOT COMPLETED|Period 3||0
5126595|NCT01449630|12612731|P7|NOT COMPLETED|Period 3||0
5126596|NCT01449630|12612732|P6|NOT COMPLETED|Period 3||0
5126597|NCT01449630|12612733|P5|NOT COMPLETED|Period 3||0
5126598|NCT01449630|12612734|P4|NOT COMPLETED|Period 3||0
5126599|NCT01449630|12612735|P3|NOT COMPLETED|Period 3||0
5126600|NCT01449630|12612736|P2|NOT COMPLETED|Period 3||0
5126601|NCT01449630|12612737|P1|NOT COMPLETED|Period 3||0
5126602|NCT01449630|12612729|P9|COMPLETED|Period 3||2
5126603|NCT01449630|12612730|P8|COMPLETED|Period 3||6
5126604|NCT01449630|12612731|P7|COMPLETED|Period 3||1
5126605|NCT01449630|12612732|P6|COMPLETED|Period 3||1
5126606|NCT01449630|12612733|P5|COMPLETED|Period 3||5
5126607|NCT01449630|12612734|P4|COMPLETED|Period 3||1
5126608|NCT01449630|12612735|P3|COMPLETED|Period 3||2
5126609|NCT01449630|12612736|P2|COMPLETED|Period 3||6
5126610|NCT01449630|12612737|P1|COMPLETED|Period 3||1
5126611|NCT01449630|12612729|P9|STARTED|Period 3||2
5126612|NCT01449630|12612730|P8|STARTED|Period 3||6
5126613|NCT01449630|12612731|P7|STARTED|Period 3||1
5126614|NCT01449630|12612732|P6|STARTED|Period 3||1
5126615|NCT01449630|12612733|P5|STARTED|Period 3||5
5126616|NCT01449630|12612734|P4|STARTED|Period 3||1
5126617|NCT01449630|12612735|P3|STARTED|Period 3||2
5126618|NCT01449630|12612736|P2|STARTED|Period 3||6
5126619|NCT01449630|12612737|P1|STARTED|Period 3||1
5126620|NCT01449630|12612729|P9|NOT COMPLETED|Period 2||0
5126621|NCT01449630|12612730|P8|NOT COMPLETED|Period 2||0
5126622|NCT01449630|12612731|P7|NOT COMPLETED|Period 2||1
5126623|NCT01449630|12612732|P6|NOT COMPLETED|Period 2||0
5126624|NCT01449630|12612733|P5|NOT COMPLETED|Period 2||0
5126625|NCT01449630|12612734|P4|NOT COMPLETED|Period 2||0
5126626|NCT01449630|12612735|P3|NOT COMPLETED|Period 2||0
5126627|NCT01449630|12612736|P2|NOT COMPLETED|Period 2||0
5126628|NCT01449630|12612737|P1|NOT COMPLETED|Period 2||0
5126629|NCT01449630|12612729|P9|COMPLETED|Period 2||2
5126630|NCT01449630|12612730|P8|COMPLETED|Period 2||6
5126631|NCT01449630|12612731|P7|COMPLETED|Period 2||1
5126632|NCT01449630|12612732|P6|COMPLETED|Period 2||1
5126633|NCT01449630|12612733|P5|COMPLETED|Period 2||5
5126634|NCT01449630|12612734|P4|COMPLETED|Period 2||1
5126635|NCT01449630|12612735|P3|COMPLETED|Period 2||2
5126636|NCT01449630|12612736|P2|COMPLETED|Period 2||6
5126637|NCT01449630|12612737|P1|COMPLETED|Period 2||1
5126638|NCT01449630|12612729|P9|STARTED|Period 2||2
5126639|NCT01449630|12612730|P8|STARTED|Period 2||6
5126640|NCT01449630|12612731|P7|STARTED|Period 2||2
5126641|NCT01449630|12612732|P6|STARTED|Period 2||1
5126642|NCT01449630|12612733|P5|STARTED|Period 2||5
5126643|NCT01449630|12612734|P4|STARTED|Period 2||1
5126644|NCT01449630|12612735|P3|STARTED|Period 2||2
5126645|NCT01449630|12612736|P2|STARTED|Period 2||6
5126646|NCT01449630|12612737|P1|STARTED|Period 2||1
5126647|NCT01449630|12612729|P9|NOT COMPLETED|Period 1||0
5126648|NCT01449630|12612730|P8|NOT COMPLETED|Period 1||0
5126649|NCT01449630|12612731|P7|NOT COMPLETED|Period 1||0
5126650|NCT01449630|12612732|P6|NOT COMPLETED|Period 1||1
5126651|NCT01449630|12612733|P5|NOT COMPLETED|Period 1||0
5126652|NCT01449630|12612734|P4|NOT COMPLETED|Period 1||1
5126653|NCT01449630|12612735|P3|NOT COMPLETED|Period 1||0
5126654|NCT01449630|12612736|P2|NOT COMPLETED|Period 1||0
5126655|NCT01449630|12612737|P1|NOT COMPLETED|Period 1||1
5126656|NCT01449630|12612729|P9|COMPLETED|Period 1||2
5126657|NCT01449630|12612730|P8|COMPLETED|Period 1||6
5126658|NCT01449630|12612731|P7|COMPLETED|Period 1||2
5126659|NCT01449630|12612732|P6|COMPLETED|Period 1||1
5126660|NCT01449630|12612733|P5|COMPLETED|Period 1||5
5126661|NCT01449630|12612734|P4|COMPLETED|Period 1||1
5126662|NCT01449630|12612735|P3|COMPLETED|Period 1||2
5126663|NCT01449630|12612736|P2|COMPLETED|Period 1||6
5126664|NCT01449630|12612737|P1|COMPLETED|Period 1||1
5126665|NCT01449630|12612729|P9|Received at Least 1 Dose|Period 1||2
5126666|NCT01449630|12612730|P8|Received at Least 1 Dose|Period 1||6
5126667|NCT01449630|12612731|P7|Received at Least 1 Dose|Period 1||2
5126668|NCT01449630|12612732|P6|Received at Least 1 Dose|Period 1||1
5126669|NCT01449630|12612733|P5|Received at Least 1 Dose|Period 1||5
5126670|NCT01449630|12612734|P4|Received at Least 1 Dose|Period 1||2
5126671|NCT01449630|12612735|P3|Received at Least 1 Dose|Period 1||2
5126672|NCT01449630|12612736|P2|Received at Least 1 Dose|Period 1||6
5126673|NCT01449630|12612737|P1|Received at Least 1 Dose|Period 1||2
5126674|NCT01449630|12612729|P9|STARTED|Period 1||2
5126675|NCT01449630|12612730|P8|STARTED|Period 1||6
5126676|NCT01449630|12612731|P7|STARTED|Period 1||2
5126677|NCT01449630|12612732|P6|STARTED|Period 1||2
5126678|NCT01449630|12612733|P5|STARTED|Period 1||5
5126679|NCT01449630|12612734|P4|STARTED|Period 1||2
5126680|NCT01449630|12612735|P3|STARTED|Period 1||2
5126681|NCT01449630|12612736|P2|STARTED|Period 1||6
5126682|NCT01449630|12612737|P1|STARTED|Period 1||2
5126683|NCT01449539|12612807|P1|NOT COMPLETED|Overall Study||4
5126684|NCT01449539|12612807|P1|COMPLETED|Overall Study||4
5126685|NCT01449539|12612807|P1|STARTED|Overall Study||8
5126686|NCT01449526|12612813|P2|NOT COMPLETED|Overall Study||6
5126687|NCT01449526|12612814|P1|NOT COMPLETED|Overall Study||2
5126688|NCT01449526|12612813|P2|COMPLETED|Overall Study||77
5126689|NCT01449526|12612814|P1|COMPLETED|Overall Study||81
5126690|NCT01449526|12612813|P2|STARTED|Overall Study||83
5126691|NCT01449526|12612814|P1|STARTED|Overall Study||83
5126692|NCT01449513|12612824|P2|NOT COMPLETED|Overall Study||0
5126693|NCT01449513|12612825|P1|NOT COMPLETED|Overall Study||0
5126694|NCT01449513|12612824|P2|COMPLETED|Overall Study||8
5126695|NCT01449513|12612825|P1|COMPLETED|Overall Study||16
5126696|NCT01449513|12612824|P2|STARTED|Overall Study||8
5126697|NCT01449513|12612825|P1|STARTED|Overall Study||16
5126698|NCT01449461|12612883|P6|NOT COMPLETED|Overall Study||15
5126699|NCT01449461|12612884|P5|NOT COMPLETED|Overall Study||48
5126700|NCT01449461|12612885|P4|NOT COMPLETED|Overall Study||32
5126701|NCT01449461|12612886|P3|NOT COMPLETED|Overall Study||18
5126702|NCT01449461|12612887|P2|NOT COMPLETED|Overall Study||18
5126703|NCT01449461|12612888|P1|NOT COMPLETED|Overall Study||6
5126704|NCT01449461|12612883|P6|COMPLETED|Overall Study||0
5126705|NCT01449461|12612884|P5|COMPLETED|Overall Study||0
5126706|NCT01449461|12612885|P4|COMPLETED|Overall Study||0
5126707|NCT01449461|12612886|P3|COMPLETED|Overall Study||0
5126708|NCT01449461|12612887|P2|COMPLETED|Overall Study||0
5126709|NCT01449461|12612888|P1|COMPLETED|Overall Study||0
5126710|NCT01449461|12612883|P6|STARTED|Overall Study||15
5126711|NCT01449461|12612884|P5|STARTED|Overall Study||48
5126712|NCT01449461|12612885|P4|STARTED|Overall Study||32
5126713|NCT01449461|12612886|P3|STARTED|Overall Study||18
5126714|NCT01449461|12612887|P2|STARTED|Overall Study||18
5126715|NCT01449461|12612888|P1|STARTED|Overall Study||6
5126716|NCT01449370|12613025|P25|NOT COMPLETED|Overall Study||8
5126717|NCT01449370|12613026|P24|NOT COMPLETED|Overall Study||10
5126718|NCT01449370|12613027|P23|NOT COMPLETED|Overall Study||4
5126719|NCT01449370|12613028|P22|NOT COMPLETED|Overall Study||4
5126720|NCT01449370|12613029|P21|NOT COMPLETED|Overall Study||6
5126721|NCT01449370|12613030|P20|NOT COMPLETED|Overall Study||3
5126722|NCT01449370|12613031|P19|NOT COMPLETED|Overall Study||3
5126723|NCT01449370|12613032|P18|NOT COMPLETED|Overall Study||3
5126724|NCT01449370|12613033|P17|NOT COMPLETED|Overall Study||7
5126725|NCT01449370|12613034|P16|NOT COMPLETED|Overall Study||3
5126726|NCT01449370|12613035|P15|NOT COMPLETED|Overall Study||3
5126727|NCT01449370|12613036|P14|NOT COMPLETED|Overall Study||11
5126728|NCT01449370|12613037|P13|NOT COMPLETED|Overall Study||3
5126729|NCT01449370|12613038|P12|NOT COMPLETED|Overall Study||3
5126730|NCT01449370|12613039|P11|NOT COMPLETED|Overall Study||3
5126731|NCT01449370|12613040|P10|NOT COMPLETED|Overall Study||3
5126732|NCT01449370|12613041|P9|NOT COMPLETED|Overall Study||12
5126733|NCT01449370|12613042|P8|NOT COMPLETED|Overall Study||3
5126734|NCT01449370|12613043|P7|NOT COMPLETED|Overall Study||3
5126735|NCT01449370|12613044|P6|NOT COMPLETED|Overall Study||3
5126736|NCT01449370|12613045|P5|NOT COMPLETED|Overall Study||3
5126737|NCT01449370|12613046|P4|NOT COMPLETED|Overall Study||4
5126738|NCT01449370|12613047|P3|NOT COMPLETED|Overall Study||8
5126739|NCT01449370|12613048|P2|NOT COMPLETED|Overall Study||6
5126740|NCT01449370|12613049|P1|NOT COMPLETED|Overall Study||6
5126741|NCT01449370|12613025|P25|COMPLETED|Overall Study||0
5126742|NCT01449370|12613026|P24|COMPLETED|Overall Study||0
5126743|NCT01449370|12613027|P23|COMPLETED|Overall Study||0
5126744|NCT01449370|12613028|P22|COMPLETED|Overall Study||0
5126745|NCT01449370|12613029|P21|COMPLETED|Overall Study||0
5126746|NCT01449370|12613030|P20|COMPLETED|Overall Study||0
5126747|NCT01449370|12613031|P19|COMPLETED|Overall Study||0
5126748|NCT01449370|12613032|P18|COMPLETED|Overall Study||0
5126749|NCT01449370|12613033|P17|COMPLETED|Overall Study||0
5126750|NCT01449370|12613034|P16|COMPLETED|Overall Study||0
5126751|NCT01449370|12613035|P15|COMPLETED|Overall Study||0
5126752|NCT01449370|12613036|P14|COMPLETED|Overall Study||0
5126753|NCT01449370|12613037|P13|COMPLETED|Overall Study||0
5126754|NCT01449370|12613038|P12|COMPLETED|Overall Study||0
5126755|NCT01449370|12613039|P11|COMPLETED|Overall Study||0
5126756|NCT01449370|12613040|P10|COMPLETED|Overall Study||0
5126757|NCT01449370|12613041|P9|COMPLETED|Overall Study||0
5126758|NCT01449370|12613042|P8|COMPLETED|Overall Study||0
5126759|NCT01449370|12613043|P7|COMPLETED|Overall Study||0
5126760|NCT01449370|12613044|P6|COMPLETED|Overall Study||0
5126761|NCT01449370|12613045|P5|COMPLETED|Overall Study||0
5126762|NCT01449370|12613046|P4|COMPLETED|Overall Study||0
5126763|NCT01449370|12613047|P3|COMPLETED|Overall Study||0
5126764|NCT01449370|12613048|P2|COMPLETED|Overall Study||0
5126765|NCT01449370|12613049|P1|COMPLETED|Overall Study||0
5126766|NCT01449370|12613025|P25|STARTED|Overall Study||8
5126767|NCT01449370|12613026|P24|STARTED|Overall Study||10
5126768|NCT01449370|12613027|P23|STARTED|Overall Study||4
5126769|NCT01449370|12613028|P22|STARTED|Overall Study||4
5126770|NCT01449370|12613029|P21|STARTED|Overall Study||6
5126771|NCT01449370|12613030|P20|STARTED|Overall Study||3
5126772|NCT01449370|12613031|P19|STARTED|Overall Study||3
5126773|NCT01449370|12613032|P18|STARTED|Overall Study||3
5126774|NCT01449370|12613033|P17|STARTED|Overall Study||7
5126775|NCT01449370|12613034|P16|STARTED|Overall Study||3
5126776|NCT01449370|12613035|P15|STARTED|Overall Study||3
5126777|NCT01449370|12613036|P14|STARTED|Overall Study||11
5126778|NCT01449370|12613037|P13|STARTED|Overall Study||3
5126779|NCT01449370|12613038|P12|STARTED|Overall Study||3
5126780|NCT01449370|12613039|P11|STARTED|Overall Study||3
5126781|NCT01449370|12613040|P10|STARTED|Overall Study||3
5126782|NCT01449370|12613041|P9|STARTED|Overall Study||12
5126783|NCT01449370|12613042|P8|STARTED|Overall Study||3
5126784|NCT01449370|12613043|P7|STARTED|Overall Study||3
5126785|NCT01449370|12613044|P6|STARTED|Overall Study||3
5126786|NCT01449370|12613045|P5|STARTED|Overall Study||3
5126787|NCT01449370|12613046|P4|STARTED|Overall Study||4
5126788|NCT01449370|12613047|P3|STARTED|Overall Study||8
5126789|NCT01449370|12613048|P2|STARTED|Overall Study||6
5126790|NCT01449370|12613049|P1|STARTED|Overall Study||6
5126791|NCT01449305|12613422|P1|NOT COMPLETED|Overall Study||2
5126792|NCT01449305|12613422|P1|COMPLETED|Overall Study||42
5126793|NCT01449305|12613422|P1|STARTED|Overall Study||44
5126794|NCT01449279|12613427|P1|NOT COMPLETED|Overall Study||7
5126795|NCT01449279|12613427|P1|COMPLETED|Overall Study||15
5126796|NCT01449279|12613427|P1|STARTED|Overall Study||22
5126797|NCT01449266|12613438|P1|NOT COMPLETED|Overall Study||0
5126798|NCT01449266|12613438|P1|COMPLETED|Overall Study||10
5126799|NCT01449266|12613438|P1|STARTED|Overall Study||10
5126800|NCT01449240|12613445|P1|NOT COMPLETED|Overall Study||0
5126801|NCT01449240|12613445|P1|COMPLETED|Overall Study||10
5126802|NCT01449240|12613445|P1|STARTED|Overall Study||10
5126803|NCT01449006|12613452|P2|NOT COMPLETED|Overall Study||0
5126804|NCT01449006|12613453|P1|NOT COMPLETED|Overall Study||3
5126805|NCT01449006|12613452|P2|COMPLETED|Overall Study||9
5126806|NCT01449006|12613453|P1|COMPLETED|Overall Study||5
5126807|NCT01449006|12613452|P2|STARTED|Overall Study||9
5126808|NCT01449006|12613453|P1|STARTED|Overall Study||8
5126809|NCT01448850|12613467|P2|NOT COMPLETED|Overall Study||40
5126810|NCT01448850|12613468|P1|NOT COMPLETED|Overall Study||34
5126811|NCT01448850|12613467|P2|COMPLETED|Overall Study||120
5126812|NCT01448850|12613468|P1|COMPLETED|Overall Study||130
5126813|NCT01448850|12613467|P2|STARTED|Overall Study||160
5126814|NCT01448850|12613468|P1|STARTED|Overall Study||164
5126815|NCT01448824|12613499|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
5126816|NCT01448824|12613500|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126817|NCT01448824|12613501|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126818|NCT01448824|12613502|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126819|NCT01448824|12613503|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126820|NCT01448824|12613504|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126821|NCT01448824|12613505|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126822|NCT01448824|12613506|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126823|NCT01448824|12613499|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
5126824|NCT01448824|12613500|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126825|NCT01448824|12613501|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126826|NCT01448824|12613502|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126827|NCT01448824|12613503|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126828|NCT01448824|12613504|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126829|NCT01448824|12613505|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126830|NCT01448824|12613506|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
5126831|NCT01448824|12613499|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
5126832|NCT01448824|12613500|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126833|NCT01448824|12613501|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126834|NCT01448824|12613502|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126835|NCT01448824|12613503|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126836|NCT01448824|12613504|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126837|NCT01448824|12613505|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126838|NCT01448824|12613506|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
5126839|NCT01448824|12613499|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
5126840|NCT01448824|12613500|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126841|NCT01448824|12613501|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126842|NCT01448824|12613502|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126843|NCT01448824|12613503|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126844|NCT01448824|12613504|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126845|NCT01448824|12613505|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126846|NCT01448824|12613506|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
5126847|NCT01448824|12613499|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
5126848|NCT01448824|12613500|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126849|NCT01448824|12613501|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126850|NCT01448824|12613502|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126851|NCT01448824|12613503|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126852|NCT01448824|12613504|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126853|NCT01448824|12613505|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126854|NCT01448824|12613506|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
5126855|NCT01448824|12613499|P8|NOT COMPLETED|Part 2: Washout Period||0
5126856|NCT01448824|12613500|P7|NOT COMPLETED|Part 2: Washout Period||0
5126857|NCT01448824|12613501|P6|NOT COMPLETED|Part 2: Washout Period||0
5126858|NCT01448824|12613502|P5|NOT COMPLETED|Part 2: Washout Period||0
5126859|NCT01448824|12613503|P4|NOT COMPLETED|Part 2: Washout Period||0
5126860|NCT01448824|12613504|P3|NOT COMPLETED|Part 2: Washout Period||0
5126861|NCT01448824|12613505|P2|NOT COMPLETED|Part 2: Washout Period||0
5126862|NCT01448824|12613506|P1|NOT COMPLETED|Part 2: Washout Period||0
5126863|NCT01448824|12613499|P8|COMPLETED|Part 2: Washout Period||11
5126864|NCT01448824|12613500|P7|COMPLETED|Part 2: Washout Period||0
5126865|NCT01448824|12613501|P6|COMPLETED|Part 2: Washout Period||0
5126866|NCT01448824|12613502|P5|COMPLETED|Part 2: Washout Period||0
5126867|NCT01448824|12613503|P4|COMPLETED|Part 2: Washout Period||0
5126868|NCT01448824|12613504|P3|COMPLETED|Part 2: Washout Period||0
5126869|NCT01448824|12613505|P2|COMPLETED|Part 2: Washout Period||0
5126870|NCT01448824|12613506|P1|COMPLETED|Part 2: Washout Period||0
5126871|NCT01448824|12613499|P8|STARTED|Part 2: Washout Period||11
5126872|NCT01448824|12613500|P7|STARTED|Part 2: Washout Period||0
5126873|NCT01448824|12613501|P6|STARTED|Part 2: Washout Period||0
5126874|NCT01448824|12613502|P5|STARTED|Part 2: Washout Period||0
5126875|NCT01448824|12613503|P4|STARTED|Part 2: Washout Period||0
5126876|NCT01448824|12613504|P3|STARTED|Part 2: Washout Period||0
5126877|NCT01448824|12613505|P2|STARTED|Part 2: Washout Period||0
5126878|NCT01448824|12613506|P1|STARTED|Part 2: Washout Period||0
5126879|NCT01448824|12613499|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
5126880|NCT01448824|12613500|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126881|NCT01448824|12613501|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126882|NCT01448824|12613502|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126883|NCT01448824|12613503|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126884|NCT01448824|12613504|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126885|NCT01448824|12613505|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126886|NCT01448824|12613506|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126887|NCT01448824|12613499|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
5126888|NCT01448824|12613500|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126889|NCT01448824|12613501|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126890|NCT01448824|12613502|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126891|NCT01448824|12613503|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126892|NCT01448824|12613504|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126893|NCT01448824|12613505|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126894|NCT01448824|12613506|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
5126895|NCT01448824|12613499|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
5126896|NCT01448824|12613500|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126897|NCT01448824|12613501|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126898|NCT01448824|12613502|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126899|NCT01448824|12613503|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126900|NCT01448824|12613504|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126901|NCT01448824|12613505|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126902|NCT01448824|12613506|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
5126903|NCT01448824|12613499|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
5126904|NCT01448824|12613500|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126905|NCT01448824|12613501|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126906|NCT01448824|12613502|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126907|NCT01448824|12613503|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126908|NCT01448824|12613504|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126909|NCT01448824|12613505|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126910|NCT01448824|12613506|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
5126911|NCT01448824|12613499|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126912|NCT01448824|12613500|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126913|NCT01448824|12613501|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126914|NCT01448824|12613502|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126915|NCT01448824|12613503|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126916|NCT01448824|12613504|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126917|NCT01448824|12613505|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126918|NCT01448824|12613506|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126919|NCT01448824|12613499|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126920|NCT01448824|12613500|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126921|NCT01448824|12613501|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126922|NCT01448824|12613502|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126923|NCT01448824|12613503|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
5126924|NCT01448824|12613504|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
5126925|NCT01448824|12613505|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
5126926|NCT01448824|12613506|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
5126927|NCT01448824|12613499|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
5126928|NCT01448824|12613500|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
5126929|NCT01448824|12613501|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
5126930|NCT01448824|12613502|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
5126931|NCT01448824|12613503|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
5126932|NCT01448824|12613504|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
5126933|NCT01448824|12613505|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
5126934|NCT01448824|12613506|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
5126935|NCT01448824|12613499|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
5126936|NCT01448824|12613500|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
5126937|NCT01448824|12613501|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
5126938|NCT01448824|12613502|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
5126939|NCT01448824|12613503|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
5126940|NCT01448824|12613504|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
5126941|NCT01448824|12613505|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
5126942|NCT01448824|12613506|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
5126943|NCT01448824|12613499|P8|NOT COMPLETED|Part 1: Washout Period||0
5126944|NCT01448824|12613500|P7|NOT COMPLETED|Part 1: Washout Period||0
5126945|NCT01448824|12613501|P6|NOT COMPLETED|Part 1: Washout Period||0
5126946|NCT01448824|12613502|P5|NOT COMPLETED|Part 1: Washout Period||0
5126947|NCT01448824|12613503|P4|NOT COMPLETED|Part 1: Washout Period||0
5126948|NCT01448824|12613504|P3|NOT COMPLETED|Part 1: Washout Period||0
5126949|NCT01448824|12613505|P2|NOT COMPLETED|Part 1: Washout Period||0
5126950|NCT01448824|12613506|P1|NOT COMPLETED|Part 1: Washout Period||1
5126951|NCT01448824|12613499|P8|COMPLETED|Part 1: Washout Period||0
5126952|NCT01448824|12613500|P7|COMPLETED|Part 1: Washout Period||0
5126953|NCT01448824|12613501|P6|COMPLETED|Part 1: Washout Period||0
5126954|NCT01448824|12613502|P5|COMPLETED|Part 1: Washout Period||0
5126955|NCT01448824|12613503|P4|COMPLETED|Part 1: Washout Period||0
5126956|NCT01448824|12613504|P3|COMPLETED|Part 1: Washout Period||4
5126957|NCT01448824|12613505|P2|COMPLETED|Part 1: Washout Period||4
5126958|NCT01448824|12613506|P1|COMPLETED|Part 1: Washout Period||11
5126959|NCT01448824|12613499|P8|STARTED|Part 1: Washout Period||0
5126960|NCT01448824|12613500|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
5126961|NCT01448824|12613501|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
5126962|NCT01448824|12613502|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
5126963|NCT01448824|12613503|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
5126964|NCT01448824|12613504|P3|STARTED|Part 1: Washout Period||4
5126965|NCT01448824|12613505|P2|STARTED|Part 1: Washout Period||4
5126966|NCT01448824|12613506|P1|STARTED|Part 1: Washout Period||12
5126967|NCT01448824|12613499|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
5126968|NCT01448824|12613500|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
5126969|NCT01448824|12613501|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
5126970|NCT01448824|12613502|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
5126971|NCT01448824|12613503|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
5126972|NCT01448824|12613504|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
5126973|NCT01448824|12613505|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
5126974|NCT01448824|12613506|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
5126975|NCT01448824|12613499|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
5126976|NCT01448824|12613500|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
5126977|NCT01448824|12613501|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
5126978|NCT01448824|12613502|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
5126979|NCT01448824|12613503|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
5126980|NCT01448824|12613504|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
5126981|NCT01448824|12613505|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
5126982|NCT01448824|12613506|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
5126983|NCT01448824|12613499|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
5126984|NCT01448824|12613500|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
5126985|NCT01448824|12613501|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
5126986|NCT01448824|12613502|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
5126987|NCT01448824|12613503|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
5126988|NCT01448824|12613504|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
5126989|NCT01448824|12613505|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
5126990|NCT01448824|12613506|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
5126991|NCT01448824|12613499|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
5126992|NCT01448824|12613500|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
5126993|NCT01448824|12613501|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
5126994|NCT01448824|12613502|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
5126995|NCT01448824|12613503|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
5126996|NCT01448824|12613504|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
5126997|NCT01448824|12613505|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
5126998|NCT01448824|12613506|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
5126999|NCT01448707|12613557|P2|NOT COMPLETED|Overall Study||18
5127000|NCT01448707|12613558|P1|NOT COMPLETED|Overall Study||18
5127001|NCT01448707|12613557|P2|COMPLETED|Overall Study||118
5127002|NCT01448707|12613558|P1|COMPLETED|Overall Study||119
5127003|NCT01448707|12613557|P2|STARTED|Overall Study||136
5127004|NCT01448707|12613558|P1|STARTED|Overall Study||137
5127005|NCT01448616|12613579|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
5127006|NCT01448616|12613580|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
5127007|NCT01448616|12613581|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
5127008|NCT01448616|12613582|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
5127009|NCT01448616|12613579|P4|COMPLETED|Study Drug (Treatment Phase)||9
5127010|NCT01448616|12613580|P3|COMPLETED|Study Drug (Treatment Phase)||23
5127011|NCT01448616|12613581|P2|COMPLETED|Study Drug (Treatment Phase)||22
5127012|NCT01448616|12613582|P1|COMPLETED|Study Drug (Treatment Phase)||0
5127013|NCT01448616|12613579|P4|STARTED|Study Drug (Treatment Phase)||13
5127014|NCT01448616|12613580|P3|STARTED|Study Drug (Treatment Phase)||27
5127015|NCT01448616|12613581|P2|STARTED|Study Drug (Treatment Phase)||24
5127016|NCT01448616|12613582|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
5127017|NCT01448616|12613579|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
5127018|NCT01448616|12613580|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
5127019|NCT01448616|12613581|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
5127020|NCT01448616|12613582|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
5127021|NCT01448616|12613579|P4|COMPLETED|Lead-In (Observational Phase)||0
5127022|NCT01448616|12613580|P3|COMPLETED|Lead-In (Observational Phase)||0
5127023|NCT01448616|12613581|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
5127024|NCT01448616|12613582|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
5127025|NCT01448616|12613579|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
5127026|NCT01448616|12613580|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
5127027|NCT01448616|12613581|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
5127028|NCT01448616|12613582|P1|STARTED|Lead-In (Observational Phase)||73
5127029|NCT01448525|12613602|P2|NOT COMPLETED|Overall Study||2
5127030|NCT01448525|12613603|P1|NOT COMPLETED|Overall Study||1
5127031|NCT01448525|12613602|P2|COMPLETED|Overall Study||42
5127032|NCT01448525|12613603|P1|COMPLETED|Overall Study||43
5127033|NCT01448525|12613602|P2|STARTED|Overall Study||44
5127034|NCT01448525|12613603|P1|STARTED|Overall Study||44
5127035|NCT01448486|12613613|P2|NOT COMPLETED|Overall Study||0
5127036|NCT01448486|12613614|P1|NOT COMPLETED|Overall Study||0
5127037|NCT01448486|12613613|P2|COMPLETED|Overall Study||3
5127038|NCT01448486|12613614|P1|COMPLETED|Overall Study||3
5127039|NCT01448486|12613613|P2|STARTED|Overall Study||3
5127040|NCT01448486|12613614|P1|STARTED|Overall Study||3
5127041|NCT01448356|12613622|P1|NOT COMPLETED|Overall Study||0
5127042|NCT01448356|12613622|P1|COMPLETED|Overall Study|cross-over|10
5127043|NCT01448356|12613622|P1|STARTED|Overall Study||10
5127044|NCT01448213|12613629|P2|NOT COMPLETED|Overall Study||22
5127045|NCT01448213|12613630|P1|NOT COMPLETED|Overall Study||17
5127046|NCT01448213|12613629|P2|COMPLETED|Overall Study||112
5127047|NCT01448213|12613630|P1|COMPLETED|Overall Study||113
5127048|NCT01448213|12613629|P2|STARTED|Overall Study||134
5127049|NCT01448213|12613630|P1|STARTED|Overall Study||130
5127050|NCT01448057|12613640|P2|NOT COMPLETED|Overall Study||4
5127051|NCT01448057|12613641|P1|NOT COMPLETED|Overall Study||8
5127052|NCT01448057|12613640|P2|COMPLETED|Overall Study||167
5127053|NCT01448057|12613641|P1|COMPLETED|Overall Study||162
5127054|NCT01448057|12613640|P2|STARTED|Overall Study||171
5127055|NCT01448057|12613641|P1|STARTED|Overall Study||170
5127056|NCT01448044|12613651|P2|NOT COMPLETED|Follow Up Period||14
5127057|NCT01448044|12613652|P1|NOT COMPLETED|Follow Up Period||12
5127058|NCT01448044|12613651|P2|COMPLETED|Follow Up Period||26
5127059|NCT01448044|12613652|P1|COMPLETED|Follow Up Period||65
5127060|NCT01448044|12613651|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
5127061|NCT01448044|12613652|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
5127062|NCT01448044|12613651|P2|NOT COMPLETED|Treatment Period||16
5127063|NCT01448044|12613652|P1|NOT COMPLETED|Treatment Period||23
5127064|NCT01448044|12613651|P2|COMPLETED|Treatment Period||26
5127065|NCT01448044|12613652|P1|COMPLETED|Treatment Period||59
5127066|NCT01448044|12613651|P2|STARTED|Treatment Period||42
5127067|NCT01448044|12613652|P1|STARTED|Treatment Period||82
5127068|NCT01447927|12613668|P2|NOT COMPLETED|Overall Study||3
5127069|NCT01447927|12613669|P1|NOT COMPLETED|Overall Study||5
5127070|NCT01447927|12613668|P2|COMPLETED|Overall Study||33
5127071|NCT01447927|12613669|P1|COMPLETED|Overall Study||33
5127072|NCT01447927|12613668|P2|STARTED|Overall Study||36
5127073|NCT01447927|12613669|P1|STARTED|Overall Study||38
5127074|NCT01447914|12613677|P1|NOT COMPLETED|Overall Study||0
5127075|NCT01447914|12613677|P1|COMPLETED|Overall Study||16
5127076|NCT01447914|12613677|P1|STARTED|Overall Study||16
5127077|NCT01447888|12613688|P2|NOT COMPLETED|Overall Study||0
5127078|NCT01447888|12613689|P1|NOT COMPLETED|Overall Study||0
5127079|NCT01447888|12613688|P2|COMPLETED|Overall Study||55
5127080|NCT01447888|12613689|P1|COMPLETED|Overall Study||45
5127081|NCT01447888|12613688|P2|STARTED|Overall Study||55
5127082|NCT01447888|12613689|P1|STARTED|Overall Study||45
5127083|NCT01447849|12613701|P4|NOT COMPLETED|Second Intervention||0
5127084|NCT01447849|12613702|P3|NOT COMPLETED|Second Intervention||0
5127085|NCT01447849|12613703|P2|NOT COMPLETED|Second Intervention||0
5127086|NCT01447849|12613704|P1|NOT COMPLETED|Second Intervention||0
5127087|NCT01447849|12613701|P4|COMPLETED|Second Intervention||10
5127088|NCT01447849|12613702|P3|COMPLETED|Second Intervention||10
5127089|NCT01447849|12613703|P2|COMPLETED|Second Intervention||10
5127090|NCT01447849|12613704|P1|COMPLETED|Second Intervention||10
5127091|NCT01447849|12613701|P4|STARTED|Second Intervention||10
5127092|NCT01447849|12613702|P3|STARTED|Second Intervention||10
5127093|NCT01447849|12613703|P2|STARTED|Second Intervention||10
5127094|NCT01447849|12613704|P1|STARTED|Second Intervention||10
5127095|NCT01447849|12613701|P4|NOT COMPLETED|Washout Period for 1 Week||0
5127096|NCT01447849|12613702|P3|NOT COMPLETED|Washout Period for 1 Week||0
5127097|NCT01447849|12613703|P2|NOT COMPLETED|Washout Period for 1 Week||0
5127098|NCT01447849|12613704|P1|NOT COMPLETED|Washout Period for 1 Week||0
5127099|NCT01447849|12613701|P4|COMPLETED|Washout Period for 1 Week||10
5127100|NCT01447849|12613702|P3|COMPLETED|Washout Period for 1 Week||10
5127101|NCT01447849|12613703|P2|COMPLETED|Washout Period for 1 Week||10
5127102|NCT01447849|12613704|P1|COMPLETED|Washout Period for 1 Week||10
5127103|NCT01447849|12613701|P4|STARTED|Washout Period for 1 Week||10
5127104|NCT01447849|12613702|P3|STARTED|Washout Period for 1 Week||10
5127105|NCT01447849|12613703|P2|STARTED|Washout Period for 1 Week||10
5127106|NCT01447849|12613704|P1|STARTED|Washout Period for 1 Week||10
5127107|NCT01447849|12613701|P4|NOT COMPLETED|First Intervention||0
5127108|NCT01447849|12613702|P3|NOT COMPLETED|First Intervention||0
5127109|NCT01447849|12613703|P2|NOT COMPLETED|First Intervention||0
5127110|NCT01447849|12613704|P1|NOT COMPLETED|First Intervention||0
5127111|NCT01447849|12613701|P4|COMPLETED|First Intervention||10
5127112|NCT01447849|12613702|P3|COMPLETED|First Intervention||10
5127113|NCT01447849|12613703|P2|COMPLETED|First Intervention||10
5127114|NCT01447849|12613704|P1|COMPLETED|First Intervention||10
5127115|NCT01447849|12613701|P4|STARTED|First Intervention||10
5127116|NCT01447849|12613702|P3|STARTED|First Intervention||10
5127117|NCT01447849|12613703|P2|STARTED|First Intervention||10
5127118|NCT01447849|12613704|P1|STARTED|First Intervention||10
5127119|NCT01447719|12613714|P1|NOT COMPLETED|Overall Study||93
5127120|NCT01447719|12613714|P1|COMPLETED|Overall Study||59
5127121|NCT01447719|12613714|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
5127122|NCT01447719|12613714|P1|Valid AV-45 Scan Acquired|Overall Study||147
5127123|NCT01447719|12613714|P1|STARTED|Overall Study||152
5127124|NCT01447706|12613727|P2|NOT COMPLETED|Overall Study||3
5127125|NCT01447706|12613728|P1|NOT COMPLETED|Overall Study||0
5127126|NCT01447706|12613727|P2|COMPLETED|Overall Study||80
5127127|NCT01447706|12613728|P1|COMPLETED|Overall Study||140
5127128|NCT01447706|12613727|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
5127129|NCT01447706|12613728|P1|STARTED|Overall Study||140
5127130|NCT01447576|12613740|P1|NOT COMPLETED|Overall Study||476
5127131|NCT01447576|12613740|P1|COMPLETED|Overall Study||560
5127132|NCT01447576|12613740|P1|STARTED|Overall Study||1036
5127133|NCT01447511|12613751|P5|NOT COMPLETED|Rifampin Period||0
5127134|NCT01447511|12613752|P4|NOT COMPLETED|Rifampin Period||1
5127135|NCT01447511|12613753|P3|NOT COMPLETED|Rifampin Period||0
5127136|NCT01447511|12613754|P2|NOT COMPLETED|Rifampin Period||0
5127137|NCT01447511|12613755|P1|NOT COMPLETED|Rifampin Period||0
5127138|NCT01447511|12613751|P5|COMPLETED|Rifampin Period||4
5127139|NCT01447511|12613752|P4|COMPLETED|Rifampin Period||2
5127140|NCT01447511|12613753|P3|COMPLETED|Rifampin Period||8
5127141|NCT01447511|12613754|P2|COMPLETED|Rifampin Period||5
5127142|NCT01447511|12613755|P1|COMPLETED|Rifampin Period||8
5127143|NCT01447511|12613751|P5|STARTED|Rifampin Period||4
5127144|NCT01447511|12613752|P4|STARTED|Rifampin Period||3
5127145|NCT01447511|12613753|P3|STARTED|Rifampin Period||8
5127146|NCT01447511|12613754|P2|STARTED|Rifampin Period||5
5127147|NCT01447511|12613755|P1|STARTED|Rifampin Period||8
5127148|NCT01447511|12613751|P5|NOT COMPLETED|Fluconazole Period||0
5127149|NCT01447511|12613752|P4|NOT COMPLETED|Fluconazole Period||0
5127150|NCT01447511|12613753|P3|NOT COMPLETED|Fluconazole Period||1
5127151|NCT01447511|12613754|P2|NOT COMPLETED|Fluconazole Period||0
5127152|NCT01447511|12613755|P1|NOT COMPLETED|Fluconazole Period||0
5127153|NCT01447511|12613751|P5|COMPLETED|Fluconazole Period||4
5127154|NCT01447511|12613752|P4|COMPLETED|Fluconazole Period||3
5127155|NCT01447511|12613753|P3|COMPLETED|Fluconazole Period||8
5127156|NCT01447511|12613754|P2|COMPLETED|Fluconazole Period||0
5127157|NCT01447511|12613755|P1|COMPLETED|Fluconazole Period||8
5127158|NCT01447511|12613751|P5|STARTED|Fluconazole Period||4
5127159|NCT01447511|12613752|P4|STARTED|Fluconazole Period||3
5127160|NCT01447511|12613753|P3|STARTED|Fluconazole Period||9
5127161|NCT01447511|12613754|P2|STARTED|Fluconazole Period||0
5127162|NCT01447511|12613755|P1|STARTED|Fluconazole Period||8
5127163|NCT01447511|12613751|P5|NOT COMPLETED|Control Period||0
5127164|NCT01447511|12613752|P4|NOT COMPLETED|Control Period||0
5127165|NCT01447511|12613753|P3|NOT COMPLETED|Control Period||0
5127166|NCT01447511|12613754|P2|NOT COMPLETED|Control Period||0
5127167|NCT01447511|12613755|P1|NOT COMPLETED|Control Period||0
5127168|NCT01447511|12613751|P5|COMPLETED|Control Period||4
5127169|NCT01447511|12613752|P4|COMPLETED|Control Period||3
5127170|NCT01447511|12613753|P3|COMPLETED|Control Period||9
5127171|NCT01447511|12613754|P2|COMPLETED|Control Period||5
5127172|NCT01447511|12613755|P1|COMPLETED|Control Period||8
5127173|NCT01447511|12613751|P5|STARTED|Control Period||4
5127174|NCT01447511|12613752|P4|STARTED|Control Period||3
5127175|NCT01447511|12613753|P3|STARTED|Control Period||9
5127176|NCT01447511|12613754|P2|STARTED|Control Period||5
5127177|NCT01447511|12613755|P1|STARTED|Control Period||8
5127178|NCT01447446|12613773|P6|NOT COMPLETED|Overall Study||32
5127179|NCT01447446|12613774|P5|NOT COMPLETED|Overall Study||211
5127180|NCT01447446|12613775|P4|NOT COMPLETED|Overall Study||33
5127181|NCT01447446|12613776|P3|NOT COMPLETED|Overall Study||100
5127182|NCT01447446|12613777|P2|NOT COMPLETED|Overall Study||165
5127183|NCT01447446|12613778|P1|NOT COMPLETED|Overall Study||722
5127184|NCT01447446|12613773|P6|COMPLETED|Overall Study||54
5127185|NCT01447446|12613774|P5|COMPLETED|Overall Study||610
5127186|NCT01447446|12613775|P4|COMPLETED|Overall Study||60
5127187|NCT01447446|12613776|P3|COMPLETED|Overall Study||192
5127188|NCT01447446|12613777|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
5127189|NCT01447446|12613778|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
5127190|NCT01447446|12613773|P6|STARTED|Overall Study||86
5127191|NCT01447446|12613774|P5|STARTED|Overall Study||821
5127192|NCT01447446|12613775|P4|STARTED|Overall Study||93
5127193|NCT01447446|12613776|P3|STARTED|Overall Study||292
5127194|NCT01447446|12613777|P2|STARTED|Overall Study||496
5127195|NCT01447446|12613778|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
5127196|NCT01447433|12613868|P2|NOT COMPLETED|Overall Study||6
5127197|NCT01447433|12613869|P1|NOT COMPLETED|Overall Study||4
5127198|NCT01447433|12613868|P2|COMPLETED|Overall Study||21
5127199|NCT01447433|12613869|P1|COMPLETED|Overall Study||22
5127200|NCT01447433|12613868|P2|STARTED|Overall Study||27
5127201|NCT01447433|12613869|P1|STARTED|Overall Study||26
5127202|NCT01447420|12613896|P3|NOT COMPLETED|Overall Study||10
5127203|NCT01447420|12613897|P2|NOT COMPLETED|Overall Study||27
5127204|NCT01447420|12613898|P1|NOT COMPLETED|Overall Study||10
5127205|NCT01447420|12613896|P3|COMPLETED|Overall Study||8
5127206|NCT01447420|12613897|P2|COMPLETED|Overall Study||45
5127207|NCT01447420|12613898|P1|COMPLETED|Overall Study||29
5127208|NCT01447420|12613896|P3|STARTED|Overall Study||18
5127209|NCT01447420|12613897|P2|STARTED|Overall Study||72
5127210|NCT01447420|12613898|P1|STARTED|Overall Study||39
5127211|NCT01447407|12613918|P4|NOT COMPLETED|Overall Study||2
5127212|NCT01447407|12613919|P3|NOT COMPLETED|Overall Study||1
5127213|NCT01447407|12613920|P2|NOT COMPLETED|Overall Study||0
5127214|NCT01447407|12613921|P1|NOT COMPLETED|Overall Study||2
5127215|NCT01447407|12613918|P4|COMPLETED|Overall Study||40
5127216|NCT01447407|12613919|P3|COMPLETED|Overall Study||40
5127217|NCT01447407|12613920|P2|COMPLETED|Overall Study||40
5127218|NCT01447407|12613921|P1|COMPLETED|Overall Study||39
5127219|NCT01447407|12613918|P4|STARTED|Overall Study||42
5127220|NCT01447407|12613919|P3|STARTED|Overall Study||41
5127221|NCT01447407|12613920|P2|STARTED|Overall Study||40
5127222|NCT01447407|12613921|P1|STARTED|Overall Study||41
5127223|NCT01447225|12613959|P10|NOT COMPLETED|Overall Study||0
5127224|NCT01447225|12613960|P9|NOT COMPLETED|Overall Study||0
5127225|NCT01447225|12613961|P8|NOT COMPLETED|Overall Study||0
5127226|NCT01447225|12613962|P7|NOT COMPLETED|Overall Study||0
5127227|NCT01447225|12613963|P6|NOT COMPLETED|Overall Study||0
5127228|NCT01447225|12613964|P5|NOT COMPLETED|Overall Study||0
5127229|NCT01447225|12613965|P4|NOT COMPLETED|Overall Study||0
5127230|NCT01447225|12613966|P3|NOT COMPLETED|Overall Study||0
5127231|NCT01447225|12613967|P2|NOT COMPLETED|Overall Study||0
5127232|NCT01447225|12613968|P1|NOT COMPLETED|Overall Study||0
5127233|NCT01447225|12613959|P10|COMPLETED|Overall Study||4
5127234|NCT01447225|12613960|P9|COMPLETED|Overall Study||3
5127235|NCT01447225|12613961|P8|COMPLETED|Overall Study||4
5127236|NCT01447225|12613962|P7|COMPLETED|Overall Study||7
5127237|NCT01447225|12613963|P6|COMPLETED|Overall Study||3
5127238|NCT01447225|12613964|P5|COMPLETED|Overall Study||3
5127239|NCT01447225|12613965|P4|COMPLETED|Overall Study||3
5127240|NCT01447225|12613966|P3|COMPLETED|Overall Study||5
5127241|NCT01447225|12613967|P2|COMPLETED|Overall Study||8
5127242|NCT01447225|12613968|P1|COMPLETED|Overall Study||3
5127243|NCT01447225|12613959|P10|STARTED|Overall Study||4
5127244|NCT01447225|12613960|P9|STARTED|Overall Study||3
5127245|NCT01447225|12613961|P8|STARTED|Overall Study||4
5127246|NCT01447225|12613962|P7|STARTED|Overall Study||7
5127247|NCT01447225|12613963|P6|STARTED|Overall Study||3
5127248|NCT01447225|12613964|P5|STARTED|Overall Study||3
5127249|NCT01447225|12613965|P4|STARTED|Overall Study||3
5127250|NCT01447225|12613966|P3|STARTED|Overall Study||5
5127251|NCT01447225|12613967|P2|STARTED|Overall Study||8
5127252|NCT01447225|12613968|P1|STARTED|Overall Study||3
5127253|NCT01447121|12614038|P1|NOT COMPLETED|Overall Study||0
5127254|NCT01447121|12614038|P1|COMPLETED|Overall Study||118
5127255|NCT01447121|12614038|P1|STARTED|Overall Study||118
5127256|NCT01447017|12614045|P2|NOT COMPLETED|Overall Study||10
5127257|NCT01447017|12614046|P1|NOT COMPLETED|Overall Study||10
5127258|NCT01447017|12614045|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
5127259|NCT01447017|12614046|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
5127260|NCT01447017|12614045|P2|Performed Visit 2|Overall Study||24
5127261|NCT01447017|12614046|P1|Performed Visit 2|Overall Study||43
5127262|NCT01447017|12614045|P2|STARTED|Overall Study||24
5127263|NCT01447017|12614046|P1|STARTED|Overall Study||45
5127264|NCT01446874|12614055|P3|NOT COMPLETED|Overall Study||18
5127265|NCT01446874|12614056|P2|NOT COMPLETED|Overall Study||4
5127266|NCT01446874|12614057|P1|NOT COMPLETED|Overall Study||2
5127267|NCT01446874|12614055|P3|COMPLETED|Overall Study||62
5127268|NCT01446874|12614056|P2|COMPLETED|Overall Study||46
5127269|NCT01446874|12614057|P1|COMPLETED|Overall Study||18
5127270|NCT01446874|12614055|P3|STARTED|Overall Study||80
5127271|NCT01446874|12614056|P2|STARTED|Overall Study||50
5127272|NCT01446874|12614057|P1|STARTED|Overall Study||20
5127273|NCT01446809|12614085|P3|NOT COMPLETED|Overall Study||2
5127274|NCT01446809|12614086|P2|NOT COMPLETED|Overall Study||0
5127275|NCT01446809|12614087|P1|NOT COMPLETED|Overall Study||0
5127276|NCT01446809|12614085|P3|COMPLETED|Overall Study||0
5127277|NCT01446809|12614086|P2|COMPLETED|Overall Study||7
5127278|NCT01446809|12614087|P1|COMPLETED|Overall Study||14
5127279|NCT01446809|12614085|P3|STARTED|Overall Study||2
5127280|NCT01446809|12614086|P2|STARTED|Overall Study||7
5127281|NCT01446809|12614087|P1|STARTED|Overall Study||14
5127282|NCT01446796|12614110|P2|NOT COMPLETED|Overall Study||0
5127283|NCT01446796|12614111|P1|NOT COMPLETED|Overall Study||1
5127284|NCT01446796|12614110|P2|COMPLETED|Overall Study|Study terminated early|0
5127285|NCT01446796|12614111|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
5127286|NCT01446796|12614110|P2|STARTED|Overall Study||0
5127287|NCT01446796|12614111|P1|STARTED|Overall Study||3
5127288|NCT01446705|12614125|P2|NOT COMPLETED|Overall Study||0
5127289|NCT01446705|12614126|P1|NOT COMPLETED|Overall Study||0
5127290|NCT01446705|12614125|P2|COMPLETED|Overall Study||6627
5127291|NCT01446705|12614126|P1|COMPLETED|Overall Study||50446
5127292|NCT01446705|12614125|P2|STARTED|Overall Study||6627
5127293|NCT01446705|12614126|P1|STARTED|Overall Study||50446
5127294|NCT01446666|12614142|P1|NOT COMPLETED|Overall Study||81
5127295|NCT01446666|12614142|P1|COMPLETED|Overall Study||326
5127296|NCT01446666|12614142|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
5127297|NCT01446419|12614157|P2|NOT COMPLETED|Overall Study||1
5127298|NCT01446419|12614158|P1|NOT COMPLETED|Overall Study||5
5127299|NCT01446419|12614157|P2|COMPLETED|Overall Study||77
5127300|NCT01446419|12614158|P1|COMPLETED|Overall Study||142
5127301|NCT01446419|12614157|P2|12 Month Follow-up|Overall Study||77
5127302|NCT01446419|12614158|P1|12 Month Follow-up|Overall Study||142
5127303|NCT01446419|12614157|P2|6 Month Follow-up|Overall Study||77
5127304|NCT01446419|12614158|P1|6 Month Follow-up|Overall Study||144
5127305|NCT01446419|12614157|P2|3 Month Follow-up|Overall Study||77
5127306|NCT01446419|12614158|P1|3 Month Follow-up|Overall Study||146
5127307|NCT01446419|12614157|P2|STARTED|Overall Study||78
5127308|NCT01446419|12614158|P1|STARTED|Overall Study||147
5127309|NCT01446289|12614172|P4|NOT COMPLETED|Overall Study||0
5127310|NCT01446289|12614173|P3|NOT COMPLETED|Overall Study||1
5127311|NCT01446289|12614174|P2|NOT COMPLETED|Overall Study||0
5127312|NCT01446289|12614175|P1|NOT COMPLETED|Overall Study||1
5127313|NCT01446289|12614172|P4|COMPLETED|Overall Study||35
5127314|NCT01446289|12614173|P3|COMPLETED|Overall Study||50
5127315|NCT01446289|12614174|P2|COMPLETED|Overall Study||35
5127316|NCT01446289|12614175|P1|COMPLETED|Overall Study||50
5127317|NCT01446289|12614172|P4|STARTED|Overall Study||35
5127318|NCT01446289|12614173|P3|STARTED|Overall Study||51
5127319|NCT01446289|12614174|P2|STARTED|Overall Study||35
5127320|NCT01446289|12614175|P1|STARTED|Overall Study||51
5127321|NCT01446250|12614203|P4|NOT COMPLETED|Follow-up||6
5127322|NCT01446250|12614204|P3|NOT COMPLETED|Follow-up||0
5127323|NCT01446250|12614205|P2|NOT COMPLETED|Follow-up||0
5127324|NCT01446250|12614206|P1|NOT COMPLETED|Follow-up||0
5127325|NCT01446250|12614203|P4|COMPLETED|Follow-up||0
5127326|NCT01446250|12614204|P3|COMPLETED|Follow-up||0
5127327|NCT01446250|12614205|P2|COMPLETED|Follow-up||0
5127328|NCT01446250|12614206|P1|COMPLETED|Follow-up||0
5127329|NCT01446250|12614203|P4|STARTED|Follow-up||6
5127330|NCT01446250|12614204|P3|STARTED|Follow-up||0
5127331|NCT01446250|12614205|P2|STARTED|Follow-up||0
5127332|NCT01446250|12614206|P1|STARTED|Follow-up||0
5127333|NCT01446250|12614203|P4|NOT COMPLETED|Treatment Period 2||0
5127334|NCT01446250|12614204|P3|NOT COMPLETED|Treatment Period 2||0
5127335|NCT01446250|12614205|P2|NOT COMPLETED|Treatment Period 2||1
5127336|NCT01446250|12614206|P1|NOT COMPLETED|Treatment Period 2||0
5127337|NCT01446250|12614203|P4|COMPLETED|Treatment Period 2||0
5127338|NCT01446250|12614204|P3|COMPLETED|Treatment Period 2||0
5127339|NCT01446250|12614205|P2|COMPLETED|Treatment Period 2||6
5127340|NCT01446250|12614206|P1|COMPLETED|Treatment Period 2||0
5127341|NCT01446250|12614203|P4|STARTED|Treatment Period 2||0
5127342|NCT01446250|12614204|P3|STARTED|Treatment Period 2||0
5127343|NCT01446250|12614205|P2|STARTED|Treatment Period 2||7
5127344|NCT01446250|12614206|P1|STARTED|Treatment Period 2||0
5127345|NCT01446250|12614203|P4|NOT COMPLETED|Clinical Hold||0
5127346|NCT01446250|12614204|P3|NOT COMPLETED|Clinical Hold||0
5127347|NCT01446250|12614205|P2|NOT COMPLETED|Clinical Hold||0
5127348|NCT01446250|12614206|P1|NOT COMPLETED|Clinical Hold||0
5127349|NCT01446250|12614203|P4|COMPLETED|Clinical Hold||0
5127350|NCT01446250|12614204|P3|COMPLETED|Clinical Hold||5
5127351|NCT01446250|12614205|P2|COMPLETED|Clinical Hold||2
5127352|NCT01446250|12614206|P1|COMPLETED|Clinical Hold||0
5127353|NCT01446250|12614203|P4|STARTED|Clinical Hold||0
5127354|NCT01446250|12614204|P3|STARTED|Clinical Hold||5
5127355|NCT01446250|12614205|P2|STARTED|Clinical Hold||2
5127356|NCT01446250|12614206|P1|STARTED|Clinical Hold||0
5127357|NCT01446250|12614203|P4|NOT COMPLETED|Treatment Period 1||0
5127358|NCT01446250|12614204|P3|NOT COMPLETED|Treatment Period 1||0
5127359|NCT01446250|12614205|P2|NOT COMPLETED|Treatment Period 1||1
5127360|NCT01446250|12614206|P1|NOT COMPLETED|Treatment Period 1||0
5127361|NCT01446250|12614203|P4|COMPLETED|Treatment Period 1||0
5127362|NCT01446250|12614204|P3|COMPLETED|Treatment Period 1||0
5127363|NCT01446250|12614205|P2|COMPLETED|Treatment Period 1||2
5127364|NCT01446250|12614206|P1|COMPLETED|Treatment Period 1||5
5127365|NCT01446250|12614203|P4|STARTED|Treatment Period 1||0
5127366|NCT01446250|12614204|P3|STARTED|Treatment Period 1||0
5127367|NCT01446250|12614205|P2|STARTED|Treatment Period 1||3
5127368|NCT01446250|12614206|P1|STARTED|Treatment Period 1||5
5127369|NCT01446237|12614218|P1|NOT COMPLETED|Overall Study||10
5127370|NCT01446237|12614218|P1|COMPLETED|Overall Study||115
5127371|NCT01446237|12614218|P1|STARTED|Overall Study||125
5127372|NCT01446159|12614230|P4|NOT COMPLETED|Overall Study||62
5127373|NCT01446159|12614231|P3|NOT COMPLETED|Overall Study||71
5127374|NCT01446159|12614232|P2|NOT COMPLETED|Overall Study||3
5127375|NCT01446159|12614233|P1|NOT COMPLETED|Overall Study||3
5127376|NCT01446159|12614230|P4|COMPLETED|Overall Study||23
5127377|NCT01446159|12614231|P3|COMPLETED|Overall Study||21
5127378|NCT01446159|12614232|P2|COMPLETED|Overall Study||0
5127379|NCT01446159|12614233|P1|COMPLETED|Overall Study||0
5127380|NCT01446159|12614230|P4|STARTED|Overall Study||85
5127381|NCT01446159|12614231|P3|STARTED|Overall Study||92
5127382|NCT01446159|12614232|P2|STARTED|Overall Study||3
5127383|NCT01446159|12614233|P1|STARTED|Overall Study||3
5127384|NCT01446042|12614308|P3|NOT COMPLETED|Overall Study||9
5127385|NCT01446042|12614309|P2|NOT COMPLETED|Overall Study||3
5127386|NCT01446042|12614310|P1|NOT COMPLETED|Overall Study||20
5127387|NCT01446042|12614308|P3|COMPLETED|Overall Study||69
5127388|NCT01446042|12614309|P2|COMPLETED|Overall Study||83
5127389|NCT01446042|12614310|P1|COMPLETED|Overall Study||122
5127390|NCT01446042|12614308|P3|STARTED|Overall Study||78
5127391|NCT01446042|12614309|P2|STARTED|Overall Study||86
5127392|NCT01446042|12614310|P1|STARTED|Overall Study||142
5127393|NCT01446003|12614321|P2|NOT COMPLETED|Period 2||0
5127394|NCT01446003|12614322|P1|NOT COMPLETED|Period 2||1
5127395|NCT01446003|12614321|P2|COMPLETED|Period 2||15
5127396|NCT01446003|12614322|P1|COMPLETED|Period 2||13
5127397|NCT01446003|12614321|P2|STARTED|Period 2||15
5127398|NCT01446003|12614322|P1|STARTED|Period 2||14
5127399|NCT01446003|12614321|P2|NOT COMPLETED|Period 1||0
5127400|NCT01446003|12614322|P1|NOT COMPLETED|Period 1||2
5127401|NCT01446003|12614321|P2|COMPLETED|Period 1||15
5127402|NCT01446003|12614322|P1|COMPLETED|Period 1||14
5127403|NCT01446003|12614321|P2|STARTED|Period 1||15
5127404|NCT01446003|12614322|P1|STARTED|Period 1||16
5127405|NCT01445951|12614343|P3|NOT COMPLETED|Overall Study||19
5127406|NCT01445951|12614344|P2|NOT COMPLETED|Overall Study||36
5127407|NCT01445951|12614345|P1|NOT COMPLETED|Overall Study||44
5127408|NCT01445951|12614343|P3|COMPLETED|Overall Study||151
5127409|NCT01445951|12614344|P2|COMPLETED|Overall Study||138
5127410|NCT01445951|12614345|P1|COMPLETED|Overall Study||130
5127411|NCT01445951|12614343|P3|STARTED|Overall Study||170
5127412|NCT01445951|12614344|P2|STARTED|Overall Study||174
5127413|NCT01445951|12614345|P1|STARTED|Overall Study||174
5127414|NCT01445886|12614383|P1|NOT COMPLETED|Overall Study||5
5127415|NCT01445886|12614383|P1|COMPLETED|Overall Study||28
5127416|NCT01445886|12614383|P1|STARTED|Overall Study||33
5127417|NCT01445873|12614393|P1|NOT COMPLETED|Overall Study||0
5127418|NCT01445873|12614393|P1|COMPLETED|Overall Study||36
5127419|NCT01445873|12614393|P1|STARTED|Overall Study||36
5127420|NCT01445847|12614423|P2|NOT COMPLETED|Overall Study||14
5127421|NCT01445847|12614424|P1|NOT COMPLETED|Overall Study||14
5127422|NCT01445847|12614423|P2|COMPLETED|Overall Study||36
5127423|NCT01445847|12614424|P1|COMPLETED|Overall Study||36
5127424|NCT01445847|12614423|P2|STARTED|Overall Study||50
5127425|NCT01445847|12614424|P1|STARTED|Overall Study||50
5127426|NCT01445821|12614432|P2|NOT COMPLETED|Overall Study||0
5127427|NCT01445821|12614433|P1|NOT COMPLETED|Overall Study||0
5127428|NCT01445821|12614432|P2|COMPLETED|Overall Study||22
5127429|NCT01445821|12614433|P1|COMPLETED|Overall Study||22
5127430|NCT01445821|12614432|P2|STARTED|Overall Study||22
5127431|NCT01445821|12614433|P1|STARTED|Overall Study||22
5127432|NCT01445769|12614441|P1|NOT COMPLETED|Overall Study||8
5127433|NCT01445769|12614441|P1|COMPLETED|Overall Study||37
5127434|NCT01445769|12614441|P1|STARTED|Overall Study||45
5127435|NCT01445678|12614461|P2|NOT COMPLETED|Overall Study||21
5127436|NCT01445678|12614462|P1|NOT COMPLETED|Overall Study||30
5127437|NCT01445678|12614461|P2|COMPLETED|Overall Study||476
5127438|NCT01445678|12614462|P1|COMPLETED|Overall Study||452
5127439|NCT01445678|12614461|P2|STARTED|Overall Study||497
5127440|NCT01445678|12614462|P1|STARTED|Overall Study||482
5127441|NCT01445652|12614480|P2|NOT COMPLETED|Overall Study||3
5127442|NCT01445652|12614481|P1|NOT COMPLETED|Overall Study||10
5127443|NCT01445652|12614480|P2|COMPLETED|Overall Study||50
5127444|NCT01445652|12614481|P1|COMPLETED|Overall Study||47
5127445|NCT01445652|12614480|P2|STARTED|Overall Study||53
5127446|NCT01445652|12614481|P1|STARTED|Overall Study||57
5127447|NCT01445626|12614489|P1|NOT COMPLETED|Overall Study||0
5127448|NCT01445626|12614489|P1|COMPLETED|Overall Study||87
5127449|NCT01445626|12614489|P1|STARTED|Overall Study||87
5127450|NCT01445613|12614499|P1|NOT COMPLETED|1-year Follow-up||77
5127451|NCT01445613|12614499|P1|COMPLETED|1-year Follow-up||1088
5127452|NCT01445613|12614499|P1|STARTED|1-year Follow-up||1165
5127453|NCT01445613|12614499|P1|NOT COMPLETED|30-day Follow-up||35
5127454|NCT01445613|12614499|P1|COMPLETED|30-day Follow-up||1165
5127455|NCT01445613|12614499|P1|STARTED|30-day Follow-up||1200
5127456|NCT01445548|12614517|P1|NOT COMPLETED|Overall Study||1
5127457|NCT01445548|12614517|P1|COMPLETED|Overall Study||5
5127458|NCT01445548|12614517|P1|STARTED|Overall Study||6
5127459|NCT01445301|12614542|P3|NOT COMPLETED|Overall Study||9
5127460|NCT01445301|12614543|P2|NOT COMPLETED|Overall Study||35
5127461|NCT01445301|12614544|P1|NOT COMPLETED|Overall Study||21
5127462|NCT01445301|12614542|P3|COMPLETED|Overall Study||290
5127463|NCT01445301|12614543|P2|COMPLETED|Overall Study||262
5127464|NCT01445301|12614544|P1|COMPLETED|Overall Study||183
5127465|NCT01445301|12614542|P3|STARTED|Overall Study||299
5127466|NCT01445301|12614543|P2|STARTED|Overall Study||297
5127467|NCT01445301|12614544|P1|STARTED|Overall Study||204
5127468|NCT01445171|12614579|P1|NOT COMPLETED|Overall Study||95
5127469|NCT01445171|12614579|P1|COMPLETED|Overall Study||200
5127470|NCT01445171|12614579|P1|Implanted With Study Device|Overall Study||287
5127471|NCT01445171|12614579|P1|STARTED|Overall Study||295
5127472|NCT01445028|12614602|P2|NOT COMPLETED|Overall Study||3
5127473|NCT01445028|12614603|P1|NOT COMPLETED|Overall Study||0
5127474|NCT01445028|12614602|P2|COMPLETED|Overall Study||51
5127475|NCT01445028|12614603|P1|COMPLETED|Overall Study||58
5127476|NCT01445028|12614602|P2|STARTED|Overall Study||54
5127477|NCT01445028|12614603|P1|STARTED|Overall Study||58
5127478|NCT01444924|12614611|P2|NOT COMPLETED|Overall Study||0
5127479|NCT01444924|12614612|P1|NOT COMPLETED|Overall Study||0
5127480|NCT01444924|12614611|P2|COMPLETED|Overall Study||33
5127481|NCT01444924|12614612|P1|COMPLETED|Overall Study||31
5127482|NCT01444924|12614611|P2|STARTED|Overall Study||33
5127483|NCT01444924|12614612|P1|STARTED|Overall Study||31
5127484|NCT01444911|12614622|P2|NOT COMPLETED|Overall Study||0
5127485|NCT01444911|12614623|P1|NOT COMPLETED|Overall Study||8
5127486|NCT01444911|12614622|P2|COMPLETED|Overall Study||13
5127487|NCT01444911|12614623|P1|COMPLETED|Overall Study||8
5127488|NCT01444911|12614622|P2|STARTED|Overall Study||13
5127489|NCT01444911|12614623|P1|STARTED|Overall Study||16
5127490|NCT01444898|12614635|P1|NOT COMPLETED|Overall Study||1
5127491|NCT01444898|12614635|P1|COMPLETED|Overall Study||9
5127492|NCT01444898|12614635|P1|STARTED|Overall Study||10
5127493|NCT01444781|12614650|P3|NOT COMPLETED|Overall Study||3
5127494|NCT01444781|12614651|P2|NOT COMPLETED|Overall Study||4
5127495|NCT01444781|12614652|P1|NOT COMPLETED|Overall Study||3
5127496|NCT01444781|12614650|P3|COMPLETED|Overall Study||272
5127497|NCT01444781|12614651|P2|COMPLETED|Overall Study||411
5127498|NCT01444781|12614652|P1|COMPLETED|Overall Study||413
5127499|NCT01444781|12614650|P3|STARTED|Overall Study||275
5127500|NCT01444781|12614651|P2|STARTED|Overall Study||415
5127501|NCT01444781|12614652|P1|STARTED|Overall Study||416
5127502|NCT01444742|12614690|P1|NOT COMPLETED|Overall Study||1
5127503|NCT01444742|12614690|P1|COMPLETED|Overall Study||80
5127504|NCT01444742|12614690|P1|STARTED|Overall Study||81
5127505|NCT01444651|12614697|P2|NOT COMPLETED|Overall Study||9
5127506|NCT01444651|12614698|P1|NOT COMPLETED|Overall Study||11
5127507|NCT01444651|12614697|P2|COMPLETED|Overall Study||28
5127508|NCT01444651|12614698|P1|COMPLETED|Overall Study||25
5127509|NCT01444651|12614697|P2|STARTED|Overall Study||37
5127510|NCT01444651|12614698|P1|STARTED|Overall Study||36
5127511|NCT01444456|12614714|P1|NOT COMPLETED|Overall Study||285
5127512|NCT01444456|12614714|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
5127513|NCT01444456|12614714|P1|Received Darbepoetin Alfa|Overall Study||1134
5127514|NCT01444456|12614714|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
5127515|NCT01444456|12614714|P1|STARTED|Overall Study||1262
5127516|NCT01444430|12614725|P2|NOT COMPLETED|Overall Study||81
5127517|NCT01444430|12614726|P1|NOT COMPLETED|Overall Study||61
5127518|NCT01444430|12614725|P2|COMPLETED|Overall Study||5766
5127519|NCT01444430|12614726|P1|COMPLETED|Overall Study||5785
5127520|NCT01444430|12614725|P2|STARTED|Overall Study||5847
5127521|NCT01444430|12614726|P1|STARTED|Overall Study||5846
5127522|NCT01444417|12614748|P2|NOT COMPLETED|Overall Study||1
5127523|NCT01444417|12614749|P1|NOT COMPLETED|Overall Study||2
5127524|NCT01444417|12614748|P2|COMPLETED|Overall Study||41
5127525|NCT01444417|12614749|P1|COMPLETED|Overall Study||18
5127526|NCT01444417|12614748|P2|Received Treatment|Overall Study||42
5127527|NCT01444417|12614749|P1|Received Treatment|Overall Study||19
5127528|NCT01444417|12614748|P2|STARTED|Overall Study||42
5127529|NCT01444417|12614749|P1|STARTED|Overall Study||20
5127530|NCT01444391|12614765|P1|NOT COMPLETED|Overall Study||1
5127531|NCT01444391|12614765|P1|COMPLETED|Overall Study||41
5127532|NCT01444391|12614765|P1|STARTED|Overall Study||42
5127533|NCT01444378|12614773|P1|NOT COMPLETED|Overall Study||17
5127534|NCT01444378|12614773|P1|COMPLETED|Overall Study||124
5127535|NCT01444378|12614773|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
5127536|NCT01444300|12614885|P2|NOT COMPLETED|Overall Study||0
5127537|NCT01444300|12614886|P1|NOT COMPLETED|Overall Study||4
5127538|NCT01444300|12614885|P2|COMPLETED|Overall Study||12
5127539|NCT01444300|12614886|P1|COMPLETED|Overall Study||8
5127540|NCT01444300|12614885|P2|STARTED|Overall Study||12
5127541|NCT01444300|12614886|P1|STARTED|Overall Study||12
5127542|NCT01444287|12614896|P1|NOT COMPLETED|Period 4||0
5127543|NCT01444287|12614896|P1|COMPLETED|Period 4||22
5127544|NCT01444287|12614896|P1|STARTED|Period 4||22
5127545|NCT01444287|12614896|P1|NOT COMPLETED|Period 3||0
5127546|NCT01444287|12614896|P1|COMPLETED|Period 3||22
5127547|NCT01444287|12614896|P1|STARTED|Period 3||22
5127548|NCT01444287|12614896|P1|NOT COMPLETED|Period 2||0
5127549|NCT01444287|12614896|P1|COMPLETED|Period 2||22
5127550|NCT01444287|12614896|P1|STARTED|Period 2||22
5127551|NCT01444287|12614896|P1|NOT COMPLETED|Period 1||0
5127552|NCT01444287|12614896|P1|COMPLETED|Period 1||22
5127553|NCT01444287|12614896|P1|STARTED|Period 1||22
5127554|NCT01444092|12614918|P1|NOT COMPLETED|Overall Study||17
5127555|NCT01444092|12614918|P1|COMPLETED|Overall Study||91
5127556|NCT01444092|12614918|P1|INFORMED CONSENT OBTAINED|Overall Study||108
5127557|NCT01444092|12614918|P1|STARTED|Overall Study||108
5127558|NCT01444027|12614927|P3|NOT COMPLETED|Overall Study||38
5127559|NCT01444027|12614928|P2|NOT COMPLETED|Overall Study||30
5127560|NCT01444027|12614929|P1|NOT COMPLETED|Overall Study||30
5127561|NCT01444027|12614927|P3|COMPLETED|Overall Study||133
5127562|NCT01444027|12614928|P2|COMPLETED|Overall Study||141
5127563|NCT01444027|12614929|P1|COMPLETED|Overall Study||142
5127564|NCT01444027|12614927|P3|3 Month Follow-up|Overall Study||133
5127565|NCT01444027|12614928|P2|3 Month Follow-up|Overall Study||141
5127566|NCT01444027|12614929|P1|3 Month Follow-up|Overall Study||142
5127567|NCT01444027|12614927|P3|1 Month Follow-up|Overall Study||141
5127568|NCT01444027|12614928|P2|1 Month Follow-up|Overall Study||159
5127569|NCT01444027|12614929|P1|1 Month Follow-up|Overall Study||160
5127570|NCT01444027|12614927|P3|Received Intervention as Assigned|Overall Study||147
5127571|NCT01444027|12614928|P2|Received Intervention as Assigned|Overall Study||161
5127572|NCT01444027|12614929|P1|Received Intervention as Assigned|Overall Study||168
5127573|NCT01444027|12614927|P3|STARTED|Overall Study||171
5127574|NCT01444027|12614928|P2|STARTED|Overall Study||171
5127575|NCT01444027|12614929|P1|STARTED|Overall Study||172
5127576|NCT01443923|12614951|P2|NOT COMPLETED|Overall Study||0
5127577|NCT01443923|12614952|P1|NOT COMPLETED|Overall Study||1
5127578|NCT01443923|12614951|P2|COMPLETED|Overall Study||1
5127579|NCT01443923|12614952|P1|COMPLETED|Overall Study||2
5127580|NCT01443923|12614951|P2|STARTED|Overall Study||1
5127581|NCT01443923|12614952|P1|STARTED|Overall Study||3
5127582|NCT01443858|12614969|P3|NOT COMPLETED|Overall Study||7
5127583|NCT01443858|12614970|P2|NOT COMPLETED|Overall Study||13
5127584|NCT01443858|12614971|P1|NOT COMPLETED|Overall Study||15
5127585|NCT01443858|12614969|P3|COMPLETED|Overall Study||18
5127586|NCT01443858|12614970|P2|COMPLETED|Overall Study||12
5127587|NCT01443858|12614971|P1|COMPLETED|Overall Study||10
5127588|NCT01443858|12614969|P3|STARTED|Overall Study||25
5127589|NCT01443858|12614970|P2|STARTED|Overall Study||25
5127590|NCT01443858|12614971|P1|STARTED|Overall Study||25
5127591|NCT01443845|12614993|P2|NOT COMPLETED|Overall Study||337
5127592|NCT01443845|12614994|P1|NOT COMPLETED|Overall Study||254
5127593|NCT01443845|12614993|P2|COMPLETED|Overall Study||841
5127594|NCT01443845|12614994|P1|COMPLETED|Overall Study||922
5127595|NCT01443845|12614993|P2|STARTED|Overall Study||1178
5127596|NCT01443845|12614994|P1|STARTED|Overall Study||1176
5127597|NCT01443546|12615009|P3|NOT COMPLETED|Overall Study||0
5127598|NCT01443546|12615010|P2|NOT COMPLETED|Overall Study||0
5127599|NCT01443546|12615011|P1|NOT COMPLETED|Overall Study||0
5127600|NCT01443546|12615009|P3|COMPLETED|Overall Study||8
5127601|NCT01443546|12615010|P2|COMPLETED|Overall Study||9
5127602|NCT01443546|12615011|P1|COMPLETED|Overall Study||9
5127603|NCT01443546|12615009|P3|STARTED|Overall Study||8
5127604|NCT01443546|12615010|P2|STARTED|Overall Study||9
5127605|NCT01443546|12615011|P1|STARTED|Overall Study||9
5127606|NCT01443494|12615031|P1|NOT COMPLETED|Overall Study||0
5127607|NCT01443494|12615031|P1|COMPLETED|Overall Study||19
5127608|NCT01443494|12615031|P1|STARTED|Overall Study||19
5127609|NCT01443442|12615038|P2|NOT COMPLETED|Overall Study||0
5127610|NCT01443442|12615039|P1|NOT COMPLETED|Overall Study||0
5127611|NCT01443442|12615038|P2|COMPLETED|Overall Study||11
5127612|NCT01443442|12615039|P1|COMPLETED|Overall Study||12
5127613|NCT01443442|12615038|P2|STARTED|Overall Study||11
5127614|NCT01443442|12615039|P1|STARTED|Overall Study||12
5127615|NCT01443403|12615049|P4|NOT COMPLETED|Overall Study||9
5127616|NCT01443403|12615050|P3|NOT COMPLETED|Overall Study||7
5127617|NCT01443403|12615051|P2|NOT COMPLETED|Overall Study||6
5127618|NCT01443403|12615052|P1|NOT COMPLETED|Overall Study||6
5127619|NCT01443403|12615049|P4|COMPLETED|Overall Study||52
5127620|NCT01443403|12615050|P3|COMPLETED|Overall Study||54
5127621|NCT01443403|12615051|P2|COMPLETED|Overall Study||55
5127622|NCT01443403|12615052|P1|COMPLETED|Overall Study||55
5127623|NCT01443403|12615049|P4|Received Treatment|Overall Study||61
5127624|NCT01443403|12615050|P3|Received Treatment|Overall Study||60
5127625|NCT01443403|12615051|P2|Received Treatment|Overall Study||61
5127626|NCT01443403|12615052|P1|Received Treatment|Overall Study||61
5127627|NCT01443403|12615049|P4|STARTED|Overall Study||61
5127628|NCT01443403|12615050|P3|STARTED|Overall Study||61
5127629|NCT01443403|12615051|P2|STARTED|Overall Study||61
5127630|NCT01443403|12615052|P1|STARTED|Overall Study||61
5127631|NCT01443364|12615199|P1|NOT COMPLETED|Overall Study||41
5127632|NCT01443364|12615199|P1|COMPLETED|Overall Study||91
5127633|NCT01443364|12615199|P1|STARTED|Overall Study||132
5127634|NCT01443130|12615328|P6|NOT COMPLETED|Overall Study||34
5127635|NCT01443130|12615329|P5|NOT COMPLETED|Overall Study||44
5127636|NCT01443130|12615330|P4|NOT COMPLETED|Overall Study||39
5127637|NCT01443130|12615331|P3|NOT COMPLETED|Overall Study||77
5127638|NCT01443130|12615332|P2|NOT COMPLETED|Overall Study||69
5127639|NCT01443130|12615333|P1|NOT COMPLETED|Overall Study||68
5127640|NCT01443130|12615328|P6|COMPLETED|Overall Study||225
5127641|NCT01443130|12615329|P5|COMPLETED|Overall Study||230
5127642|NCT01443130|12615330|P4|COMPLETED|Overall Study||231
5127643|NCT01443130|12615331|P3|COMPLETED|Overall Study||223
5127644|NCT01443130|12615332|P2|COMPLETED|Overall Study||231
5127645|NCT01443130|12615333|P1|COMPLETED|Overall Study||232
5127646|NCT01443130|12615328|P6|STARTED|Overall Study||259
5127647|NCT01443130|12615329|P5|STARTED|Overall Study||274
5127648|NCT01443130|12615330|P4|STARTED|Overall Study||270
5127649|NCT01443130|12615331|P3|STARTED|Overall Study||300
5127650|NCT01443130|12615332|P2|STARTED|Overall Study||300
5127651|NCT01443130|12615333|P1|STARTED|Overall Study||300
5127652|NCT01443078|12615383|P1|NOT COMPLETED|Overall Study||29
5127653|NCT01443078|12615383|P1|COMPLETED|Overall Study||13
5127654|NCT01443078|12615383|P1|STARTED|Overall Study||42
5127655|NCT01443026|12615390|P2|NOT COMPLETED|Overall Study||5
5127656|NCT01443026|12615391|P1|NOT COMPLETED|Overall Study||3
5127657|NCT01443026|12615390|P2|COMPLETED|Overall Study||32
5127658|NCT01443026|12615391|P1|COMPLETED|Overall Study||26
5127659|NCT01443026|12615390|P2|STARTED|Overall Study||37
5127660|NCT01443026|12615391|P1|STARTED|Overall Study||29
5127661|NCT01442844|12615399|P2|NOT COMPLETED|Overall Study||0
5127662|NCT01442844|12615400|P1|NOT COMPLETED|Overall Study||0
5127663|NCT01442844|12615399|P2|COMPLETED|Overall Study||2
5127664|NCT01442844|12615400|P1|COMPLETED|Overall Study||1
5127665|NCT01442844|12615399|P2|STARTED|Overall Study||2
5127666|NCT01442844|12615400|P1|STARTED|Overall Study||1
5127667|NCT01442779|12615406|P1|NOT COMPLETED|Overall Study||7
5127668|NCT01442779|12615406|P1|COMPLETED|Overall Study||11
5127669|NCT01442779|12615406|P1|STARTED|Overall Study||18
5127670|NCT01442714|12615412|P1|NOT COMPLETED|Overall Study||12
5127671|NCT01442714|12615412|P1|COMPLETED|Overall Study||21
5127672|NCT01442714|12615412|P1|STARTED|Overall Study||33
5127673|NCT01442688|12615420|P2|NOT COMPLETED|Second Intervention||0
5127674|NCT01442688|12615421|P1|NOT COMPLETED|Second Intervention||1
5127675|NCT01442688|12615420|P2|COMPLETED|Second Intervention||31
5127676|NCT01442688|12615421|P1|COMPLETED|Second Intervention||28
5127677|NCT01442688|12615420|P2|STARTED|Second Intervention||31
5127678|NCT01442688|12615421|P1|STARTED|Second Intervention||29
5127679|NCT01442688|12615420|P2|NOT COMPLETED|First Intervention||0
5127680|NCT01442688|12615421|P1|NOT COMPLETED|First Intervention||2
5127681|NCT01442688|12615420|P2|COMPLETED|First Intervention||31
5127682|NCT01442688|12615421|P1|COMPLETED|First Intervention||29
5127683|NCT01442688|12615420|P2|STARTED|First Intervention||31
5127684|NCT01442688|12615421|P1|STARTED|First Intervention||31
5127685|NCT01442675|12615429|P1|NOT COMPLETED|Overall Study||12
5127686|NCT01442675|12615429|P1|COMPLETED|Overall Study||822
5127687|NCT01442675|12615429|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
5127688|NCT01442675|12615429|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
5127689|NCT01442675|12615429|P1|STARTED|Overall Study||834
5127690|NCT01442493|12615441|P2|NOT COMPLETED|Overall Study||2
5127691|NCT01442493|12615442|P1|NOT COMPLETED|Overall Study||3
5127692|NCT01442493|12615441|P2|COMPLETED|Overall Study||149
5127693|NCT01442493|12615442|P1|COMPLETED|Overall Study||146
5127694|NCT01442493|12615441|P2|STARTED|Overall Study||151
5127695|NCT01442493|12615442|P1|STARTED|Overall Study||149
5127696|NCT01442376|12615463|P3|NOT COMPLETED|Overall Study||5
5127697|NCT01442376|12615464|P2|NOT COMPLETED|Overall Study||9
5127698|NCT01442376|12615465|P1|NOT COMPLETED|Overall Study||3
5127699|NCT01442376|12615463|P3|COMPLETED|Overall Study||159
5127700|NCT01442376|12615464|P2|COMPLETED|Overall Study||160
5127701|NCT01442376|12615465|P1|COMPLETED|Overall Study||166
5127702|NCT01442376|12615463|P3|STARTED|Overall Study|Randomized patients|164
5127703|NCT01442376|12615464|P2|STARTED|Overall Study|Randomized patients|169
5127704|NCT01442376|12615465|P1|STARTED|Overall Study|Randomized patients|169
5127705|NCT01442181|12615478|P2|NOT COMPLETED|Overall Study||3
5127706|NCT01442181|12615479|P1|NOT COMPLETED|Overall Study||4
5127707|NCT01442181|12615478|P2|COMPLETED|Overall Study||8
5127708|NCT01442181|12615479|P1|COMPLETED|Overall Study||10
5127709|NCT01442181|12615478|P2|STARTED|Overall Study||11
5127710|NCT01442181|12615479|P1|STARTED|Overall Study||14
5127711|NCT01442155|12615503|P1|NOT COMPLETED|Overall Study||65
5127712|NCT01442155|12615503|P1|COMPLETED|Overall Study||9
5127713|NCT01442155|12615503|P1|STARTED|Overall Study||74
5127714|NCT01442129|12615510|P2|NOT COMPLETED|Overall Study||0
5127715|NCT01442129|12615511|P1|NOT COMPLETED|Overall Study||0
5127716|NCT01442129|12615510|P2|COMPLETED|Overall Study||10
5127717|NCT01442129|12615511|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
5127718|NCT01442129|12615510|P2|STARTED|Overall Study||10
5127719|NCT01442129|12615511|P1|STARTED|Overall Study||20
5127720|NCT01442103|12615519|P1|NOT COMPLETED|Overall Study||2
5127721|NCT01442103|12615519|P1|COMPLETED|Overall Study||8
5127722|NCT01442103|12615519|P1|STARTED|Overall Study||10
5127723|NCT01442064|12615529|P6|NOT COMPLETED|Overall Study||99
5127724|NCT01442064|12615530|P5|NOT COMPLETED|Overall Study||106
5127725|NCT01442064|12615531|P4|NOT COMPLETED|Overall Study||98
5127726|NCT01442064|12615532|P3|NOT COMPLETED|Overall Study||104
5127727|NCT01442064|12615533|P2|NOT COMPLETED|Overall Study||101
5127728|NCT01442064|12615534|P1|NOT COMPLETED|Overall Study||97
5127729|NCT01442064|12615529|P6|COMPLETED|Overall Study||0
5127730|NCT01442064|12615530|P5|COMPLETED|Overall Study||1
5127731|NCT01442064|12615531|P4|COMPLETED|Overall Study||0
5127732|NCT01442064|12615532|P3|COMPLETED|Overall Study||0
5127733|NCT01442064|12615533|P2|COMPLETED|Overall Study||2
5127734|NCT01442064|12615534|P1|COMPLETED|Overall Study||0
5127735|NCT01442064|12615529|P6|Received Study Drug in Extension Study|Overall Study||81
5127736|NCT01442064|12615530|P5|Received Study Drug in Extension Study|Overall Study||89
5127737|NCT01442064|12615531|P4|Received Study Drug in Extension Study|Overall Study||70
5127738|NCT01442064|12615532|P3|Received Study Drug in Extension Study|Overall Study||60
5127739|NCT01442064|12615533|P2|Received Study Drug in Extension Study|Overall Study||70
5127740|NCT01442064|12615534|P1|Received Study Drug in Extension Study|Overall Study||61
5127741|NCT01442064|12615529|P6|Ranibizumab-Treated Subjects|Overall Study||99
5127742|NCT01442064|12615530|P5|Ranibizumab-Treated Subjects|Overall Study||107
5127743|NCT01442064|12615531|P4|Ranibizumab-Treated Subjects|Overall Study||96
5127744|NCT01442064|12615532|P3|Ranibizumab-Treated Subjects|Overall Study||104
5127745|NCT01442064|12615533|P2|Ranibizumab-Treated Subjects|Overall Study||103
5127746|NCT01442064|12615534|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
5127747|NCT01442064|12615529|P6|STARTED|Overall Study||99
5127748|NCT01442064|12615530|P5|STARTED|Overall Study||107
5127749|NCT01442064|12615531|P4|STARTED|Overall Study||98
5127750|NCT01442064|12615532|P3|STARTED|Overall Study||104
5127751|NCT01442064|12615533|P2|STARTED|Overall Study||103
5127752|NCT01442064|12615534|P1|STARTED|Overall Study||97
5127753|NCT01442038|12615571|P2|NOT COMPLETED|Overall Study||279
5127754|NCT01442038|12615572|P1|NOT COMPLETED|Overall Study||303
5127755|NCT01442038|12615571|P2|COMPLETED|Overall Study||1040
5127756|NCT01442038|12615572|P1|COMPLETED|Overall Study||1029
5127757|NCT01442038|12615571|P2|STARTED|Overall Study||1319
5127758|NCT01442038|12615572|P1|STARTED|Overall Study||1332
5127759|NCT01441973|12615586|P2|NOT COMPLETED|Overall Study||16
5127760|NCT01441973|12615587|P1|NOT COMPLETED|Overall Study||15
5127761|NCT01441973|12615586|P2|COMPLETED|Overall Study|Still receiving treatment|0
5127762|NCT01441973|12615587|P1|COMPLETED|Overall Study|Still receiving treatment|0
5127763|NCT01441973|12615586|P2|STARTED|Overall Study||16
5127764|NCT01441973|12615587|P1|STARTED|Overall Study||15
5127765|NCT01441960|12615609|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
5127766|NCT01441960|12615610|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
5127767|NCT01441960|12615609|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
5127768|NCT01441960|12615610|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
5127769|NCT01441960|12615609|P2|STARTED|Second Neuromuscular Blocking Agent||13
5127770|NCT01441960|12615610|P1|STARTED|Second Neuromuscular Blocking Agent||18
5127771|NCT01441960|12615609|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
5127772|NCT01441960|12615610|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
5127773|NCT01441960|12615609|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
5127774|NCT01441960|12615610|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
5127775|NCT01441960|12615609|P2|STARTED|First Neuromuscular Blocking Agent:||19
5127776|NCT01441960|12615610|P1|STARTED|First Neuromuscular Blocking Agent:||26
5127777|NCT01441882|12615620|P1|NOT COMPLETED|Overall Study||6
5127778|NCT01441882|12615620|P1|COMPLETED|Overall Study||13
5127779|NCT01441882|12615620|P1|STARTED|Overall Study||19
5127780|NCT01441843|12615626|P2|NOT COMPLETED|Overall Study||5
5127781|NCT01441843|12615627|P1|NOT COMPLETED|Overall Study||12
5127782|NCT01441843|12615626|P2|COMPLETED|Overall Study||195
5127783|NCT01441843|12615627|P1|COMPLETED|Overall Study||188
5127784|NCT01441843|12615626|P2|STARTED|Overall Study||200
5127785|NCT01441843|12615627|P1|STARTED|Overall Study||200
5127786|NCT01441765|12615635|P2|NOT COMPLETED|Overall Study||0
5127787|NCT01441765|12615636|P1|NOT COMPLETED|Overall Study||1
5127788|NCT01441765|12615635|P2|COMPLETED|Overall Study|not opened|0
5127789|NCT01441765|12615636|P1|COMPLETED|Overall Study||10
5127790|NCT01441765|12615635|P2|STARTED|Overall Study|not opened|0
5127791|NCT01441765|12615636|P1|STARTED|Overall Study||11
5127792|NCT01441635|12615660|P10|NOT COMPLETED|Overall Study||2
5127793|NCT01441635|12615661|P9|NOT COMPLETED|Overall Study||2
5127794|NCT01441635|12615662|P8|NOT COMPLETED|Overall Study||4
5127795|NCT01441635|12615663|P7|NOT COMPLETED|Overall Study||6
5127796|NCT01441635|12615664|P6|NOT COMPLETED|Overall Study||5
5127797|NCT01441635|12615665|P5|NOT COMPLETED|Overall Study||2
5127798|NCT01441635|12615666|P4|NOT COMPLETED|Overall Study||7
5127799|NCT01441635|12615667|P3|NOT COMPLETED|Overall Study||3
5127800|NCT01441635|12615668|P2|NOT COMPLETED|Overall Study||6
5127801|NCT01441635|12615669|P1|NOT COMPLETED|Overall Study||6
5127802|NCT01441635|12615660|P10|COMPLETED|Overall Study||25
5127803|NCT01441635|12615661|P9|COMPLETED|Overall Study||14
5127804|NCT01441635|12615662|P8|COMPLETED|Overall Study||26
5127805|NCT01441635|12615663|P7|COMPLETED|Overall Study||24
5127806|NCT01441635|12615664|P6|COMPLETED|Overall Study||29
5127807|NCT01441635|12615665|P5|COMPLETED|Overall Study||16
5127808|NCT01441635|12615666|P4|COMPLETED|Overall Study||28
5127809|NCT01441635|12615667|P3|COMPLETED|Overall Study||13
5127810|NCT01441635|12615668|P2|COMPLETED|Overall Study||27
5127811|NCT01441635|12615669|P1|COMPLETED|Overall Study||26
5127812|NCT01441635|12615660|P10|STARTED|Overall Study||27
5127813|NCT01441635|12615661|P9|STARTED|Overall Study||16
5127814|NCT01441635|12615662|P8|STARTED|Overall Study||30
5127815|NCT01441635|12615663|P7|STARTED|Overall Study||30
5127816|NCT01441635|12615664|P6|STARTED|Overall Study||34
5127817|NCT01441635|12615665|P5|STARTED|Overall Study||18
5127818|NCT01441635|12615666|P4|STARTED|Overall Study||35
5127819|NCT01441635|12615667|P3|STARTED|Overall Study||16
5127820|NCT01441635|12615668|P2|STARTED|Overall Study||33
5127821|NCT01441635|12615669|P1|STARTED|Overall Study||32
5127822|NCT01441596|12615884|P3|NOT COMPLETED|Overall Study||4
5127823|NCT01441596|12615885|P2|NOT COMPLETED|Overall Study||3
5127824|NCT01441596|12615886|P1|NOT COMPLETED|Overall Study||4
5127825|NCT01441596|12615884|P3|COMPLETED|Overall Study||39
5127826|NCT01441596|12615885|P2|COMPLETED|Overall Study||35
5127827|NCT01441596|12615886|P1|COMPLETED|Overall Study||36
5127828|NCT01441596|12615884|P3|STARTED|Overall Study||43
5127829|NCT01441596|12615885|P2|STARTED|Overall Study||38
5127830|NCT01441596|12615886|P1|STARTED|Overall Study||40
5127831|NCT01441570|12615902|P2|NOT COMPLETED|Overall Study||0
5127832|NCT01441570|12615903|P1|NOT COMPLETED|Overall Study||0
5127833|NCT01441570|12615902|P2|COMPLETED|Overall Study||5
5127834|NCT01441570|12615903|P1|COMPLETED|Overall Study||6
5127835|NCT01441570|12615902|P2|STARTED|Overall Study||5
5127836|NCT01441570|12615903|P1|STARTED|Overall Study||6
5127837|NCT01441466|12615913|P2|NOT COMPLETED|Overall Study||0
5127838|NCT01441466|12615914|P1|NOT COMPLETED|Overall Study||0
5127839|NCT01441466|12615913|P2|COMPLETED|Overall Study||11
5127840|NCT01441466|12615914|P1|COMPLETED|Overall Study||37
5127841|NCT01441466|12615913|P2|STARTED|Overall Study||11
5127842|NCT01441466|12615914|P1|STARTED|Overall Study||37
5127843|NCT01441440|12615933|P3|NOT COMPLETED|Overall Study||22
5127844|NCT01441440|12615934|P2|NOT COMPLETED|Overall Study||23
5127845|NCT01441440|12615935|P1|NOT COMPLETED|Overall Study||17
5127846|NCT01441440|12615933|P3|COMPLETED|Overall Study||158
5127847|NCT01441440|12615934|P2|COMPLETED|Overall Study||151
5127848|NCT01441440|12615935|P1|COMPLETED|Overall Study||166
5127849|NCT01441440|12615933|P3|STARTED|Overall Study|Safety analysis set|180
5127850|NCT01441440|12615934|P2|STARTED|Overall Study|Safety analysis set|174
5127851|NCT01441440|12615935|P1|STARTED|Overall Study|Safety analysis set|183
5127852|NCT01441414|12615958|P1|NOT COMPLETED|Overall Study||15
5127853|NCT01441414|12615958|P1|COMPLETED|Overall Study||3
5127854|NCT01441414|12615958|P1|STARTED|Overall Study||18
5127855|NCT01441401|12615983|P1|NOT COMPLETED|Overall Study||0
5127856|NCT01441401|12615983|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
5127857|NCT01441401|12615983|P1|STARTED|Overall Study||82
5127858|NCT01441245|12616011|P2|NOT COMPLETED|Overall Study||0
5127859|NCT01441245|12616012|P1|NOT COMPLETED|Overall Study||0
5127860|NCT01441245|12616011|P2|COMPLETED|Overall Study||27
5127861|NCT01441245|12616012|P1|COMPLETED|Overall Study||30
5127862|NCT01441245|12616011|P2|STARTED|Overall Study||27
5127863|NCT01441245|12616012|P1|STARTED|Overall Study||30
5127864|NCT01441180|12616037|P3|NOT COMPLETED|Overall Study||3
5127865|NCT01441180|12616038|P2|NOT COMPLETED|Overall Study||1
5127866|NCT01441180|12616039|P1|NOT COMPLETED|Overall Study||1
5127867|NCT01441180|12616037|P3|COMPLETED|Overall Study||22
5127868|NCT01441180|12616038|P2|COMPLETED|Overall Study||24
5127869|NCT01441180|12616039|P1|COMPLETED|Overall Study||9
5127870|NCT01441180|12616037|P3|STARTED|Overall Study||25
5127871|NCT01441180|12616038|P2|STARTED|Overall Study||25
5127872|NCT01441180|12616039|P1|STARTED|Overall Study||10
5127873|NCT01441102|12616050|P1|NOT COMPLETED|Overall Study||3
5127874|NCT01441102|12616050|P1|COMPLETED|Overall Study||4
5127875|NCT01441102|12616050|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
5127876|NCT01441076|12616070|P1|NOT COMPLETED|Overall Study||2
5127877|NCT01441076|12616070|P1|COMPLETED|Overall Study||4
5127878|NCT01441076|12616070|P1|STARTED|Overall Study||6
5127879|NCT01441063|12616088|P1|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
5127880|NCT01441063|12616088|P1|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
5127881|NCT01441063|12616088|P1|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
5127882|NCT01441063|12616088|P1|NOT COMPLETED|Tocilizumab Alone||3
5127883|NCT01441063|12616088|P1|COMPLETED|Tocilizumab Alone||5
5127884|NCT01441063|12616088|P1|STARTED|Tocilizumab Alone||8
5127885|NCT01441037|12616117|P1|NOT COMPLETED|Overall Study||0
5127886|NCT01441037|12616117|P1|COMPLETED|Overall Study||27
5127887|NCT01441037|12616117|P1|STARTED|Overall Study||27
5127888|NCT01440972|12616123|P2|NOT COMPLETED|Overall Study||2
5127889|NCT01440972|12616124|P1|NOT COMPLETED|Overall Study||3
5127890|NCT01440972|12616123|P2|COMPLETED|Overall Study||19
5127891|NCT01440972|12616124|P1|COMPLETED|Overall Study||21
5127892|NCT01440972|12616123|P2|STARTED|Overall Study||21
5127893|NCT01440972|12616124|P1|STARTED|Overall Study||24
5127894|NCT01440959|12616138|P1|NOT COMPLETED|Overall Study||0
5127895|NCT01440959|12616138|P1|COMPLETED|Overall Study||30
5127896|NCT01440959|12616138|P1|STARTED|Overall Study||30
5127897|NCT01440946|12616148|P2|NOT COMPLETED|Overall Study||1
5127898|NCT01440946|12616149|P1|NOT COMPLETED|Overall Study||2
5127899|NCT01440946|12616148|P2|COMPLETED|Overall Study||14
5127900|NCT01440946|12616149|P1|COMPLETED|Overall Study||13
5127901|NCT01440946|12616148|P2|STARTED|Overall Study||15
5127902|NCT01440946|12616149|P1|STARTED|Overall Study||15
5127903|NCT01440881|12616188|P2|NOT COMPLETED|Overall Study||1
5127904|NCT01440881|12616189|P1|NOT COMPLETED|Overall Study||0
5127905|NCT01440881|12616188|P2|COMPLETED|Overall Study||14
5127906|NCT01440881|12616189|P1|COMPLETED|Overall Study||14
5127907|NCT01440881|12616188|P2|STARTED|Overall Study||15
5127908|NCT01440881|12616189|P1|STARTED|Overall Study||14
5127909|NCT01440816|12616203|P2|NOT COMPLETED|Overall Study||11
5127910|NCT01440816|12616204|P1|NOT COMPLETED|Overall Study||1
5127911|NCT01440816|12616203|P2|COMPLETED|Overall Study||1
5127912|NCT01440816|12616204|P1|COMPLETED|Overall Study||2
5127913|NCT01440816|12616203|P2|STARTED|Overall Study||12
5127914|NCT01440816|12616204|P1|STARTED|Overall Study||3
5127915|NCT01440803|12616220|P2|NOT COMPLETED|Overall Study||4
5127916|NCT01440803|12616221|P1|NOT COMPLETED|Overall Study||2
5127917|NCT01440803|12616220|P2|COMPLETED|Overall Study||24
5127918|NCT01440803|12616221|P1|COMPLETED|Overall Study||11
5127919|NCT01440803|12616220|P2|Period 3 - Forteo Open Label|Overall Study||27
5127920|NCT01440803|12616221|P1|Period 3 - Forteo Open Label|Overall Study||13
5127921|NCT01440803|12616220|P2|Period 2 - Forteo/Forteo|Overall Study||28
5127922|NCT01440803|12616221|P1|Period 2 - Forteo/Forteo|Overall Study||13
5127923|NCT01440803|12616220|P2|Period 1 - Forteo/Placebo|Overall Study||28
5127924|NCT01440803|12616221|P1|Period 1 - Forteo/Placebo|Overall Study||13
5127925|NCT01440803|12616220|P2|STARTED|Overall Study||28
5127926|NCT01440803|12616221|P1|STARTED|Overall Study||13
5127927|NCT01440764|12616230|P7|NOT COMPLETED|Test Day 3||0
5127928|NCT01440764|12616231|P6|NOT COMPLETED|Test Day 3||0
5127929|NCT01440764|12616232|P5|NOT COMPLETED|Test Day 3||0
5127930|NCT01440764|12616233|P4|NOT COMPLETED|Test Day 3||0
5127931|NCT01440764|12616234|P3|NOT COMPLETED|Test Day 3||0
5127932|NCT01440764|12616235|P2|NOT COMPLETED|Test Day 3||0
5127933|NCT01440764|12616236|P1|NOT COMPLETED|Test Day 3||0
5127934|NCT01440764|12616230|P7|COMPLETED|Test Day 3||3
5127935|NCT01440764|12616231|P6|COMPLETED|Test Day 3||5
5127936|NCT01440764|12616232|P5|COMPLETED|Test Day 3||3
5127937|NCT01440764|12616233|P4|COMPLETED|Test Day 3||1
5127938|NCT01440764|12616234|P3|COMPLETED|Test Day 3||6
5127939|NCT01440764|12616235|P2|COMPLETED|Test Day 3||2
5127940|NCT01440764|12616236|P1|COMPLETED|Test Day 3||3
5127941|NCT01440764|12616230|P7|STARTED|Test Day 3||3
5127942|NCT01440764|12616231|P6|STARTED|Test Day 3||5
5127943|NCT01440764|12616232|P5|STARTED|Test Day 3||3
5127944|NCT01440764|12616233|P4|STARTED|Test Day 3||1
5127945|NCT01440764|12616234|P3|STARTED|Test Day 3||6
5127946|NCT01440764|12616235|P2|STARTED|Test Day 3||2
5127947|NCT01440764|12616236|P1|STARTED|Test Day 3||3
5127948|NCT01440764|12616230|P7|NOT COMPLETED|Test Day 2||0
5127949|NCT01440764|12616231|P6|NOT COMPLETED|Test Day 2||0
5127950|NCT01440764|12616232|P5|NOT COMPLETED|Test Day 2||0
5127951|NCT01440764|12616233|P4|NOT COMPLETED|Test Day 2||0
5127952|NCT01440764|12616234|P3|NOT COMPLETED|Test Day 2||0
5127953|NCT01440764|12616235|P2|NOT COMPLETED|Test Day 2||0
5127954|NCT01440764|12616236|P1|NOT COMPLETED|Test Day 2||0
5127955|NCT01440764|12616230|P7|COMPLETED|Test Day 2||3
5127956|NCT01440764|12616231|P6|COMPLETED|Test Day 2||5
5127957|NCT01440764|12616232|P5|COMPLETED|Test Day 2||3
5127958|NCT01440764|12616233|P4|COMPLETED|Test Day 2||1
5127959|NCT01440764|12616234|P3|COMPLETED|Test Day 2||6
5127960|NCT01440764|12616235|P2|COMPLETED|Test Day 2||2
5127961|NCT01440764|12616236|P1|COMPLETED|Test Day 2||3
5127962|NCT01440764|12616230|P7|STARTED|Test Day 2||3
5127963|NCT01440764|12616231|P6|STARTED|Test Day 2||5
5127964|NCT01440764|12616232|P5|STARTED|Test Day 2||3
5127965|NCT01440764|12616233|P4|STARTED|Test Day 2||1
5127966|NCT01440764|12616234|P3|STARTED|Test Day 2||6
5127967|NCT01440764|12616235|P2|STARTED|Test Day 2||2
5127968|NCT01440764|12616236|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
5127969|NCT01440764|12616230|P7|NOT COMPLETED|Test Day 1||0
5127970|NCT01440764|12616231|P6|NOT COMPLETED|Test Day 1||0
5127971|NCT01440764|12616232|P5|NOT COMPLETED|Test Day 1||0
5127972|NCT01440764|12616233|P4|NOT COMPLETED|Test Day 1||0
5127973|NCT01440764|12616234|P3|NOT COMPLETED|Test Day 1||0
5127974|NCT01440764|12616235|P2|NOT COMPLETED|Test Day 1||0
5127975|NCT01440764|12616236|P1|NOT COMPLETED|Test Day 1||0
5127976|NCT01440764|12616230|P7|COMPLETED|Test Day 1||3
5127977|NCT01440764|12616231|P6|COMPLETED|Test Day 1||5
5127978|NCT01440764|12616232|P5|COMPLETED|Test Day 1||3
5127979|NCT01440764|12616233|P4|COMPLETED|Test Day 1||1
5127980|NCT01440764|12616234|P3|COMPLETED|Test Day 1||6
5127981|NCT01440764|12616235|P2|COMPLETED|Test Day 1||2
5127982|NCT01440764|12616236|P1|COMPLETED|Test Day 1||4
5127983|NCT01440764|12616230|P7|STARTED|Test Day 1||3
5127984|NCT01440764|12616231|P6|STARTED|Test Day 1||5
5127985|NCT01440764|12616232|P5|STARTED|Test Day 1||3
5127986|NCT01440764|12616233|P4|STARTED|Test Day 1||1
5127987|NCT01440764|12616234|P3|STARTED|Test Day 1||6
5127988|NCT01440764|12616235|P2|STARTED|Test Day 1||2
5127989|NCT01440764|12616236|P1|STARTED|Test Day 1||4
5127990|NCT01440647|12616257|P2|NOT COMPLETED|Overall Study||3
5127991|NCT01440647|12616258|P1|NOT COMPLETED|Overall Study||2
5127992|NCT01440647|12616257|P2|COMPLETED|Overall Study||15
5127993|NCT01440647|12616258|P1|COMPLETED|Overall Study||14
5127994|NCT01440647|12616257|P2|STARTED|Overall Study||18
5127995|NCT01440647|12616258|P1|STARTED|Overall Study||16
5127996|NCT01440634|12616268|P2|NOT COMPLETED|Randomization Phase||10
5127997|NCT01440634|12616269|P1|NOT COMPLETED|Randomization Phase||6
5127998|NCT01440634|12616268|P2|COMPLETED|Randomization Phase||14
5127999|NCT01440634|12616269|P1|COMPLETED|Randomization Phase||24
5128000|NCT01440634|12616268|P2|STARTED|Randomization Phase||24
5128001|NCT01440634|12616269|P1|STARTED|Randomization Phase||30
5128002|NCT01440634|12616268|P2|NOT COMPLETED|Cross Sectional Phase||0
5128003|NCT01440634|12616269|P1|NOT COMPLETED|Cross Sectional Phase||0
5128004|NCT01440634|12616268|P2|COMPLETED|Cross Sectional Phase||347
5128005|NCT01440634|12616269|P1|COMPLETED|Cross Sectional Phase||0
5128006|NCT01440634|12616268|P2|STARTED|Cross Sectional Phase||347
5128007|NCT01440634|12616269|P1|STARTED|Cross Sectional Phase||0
5128008|NCT01440595|12616277|P3|NOT COMPLETED|Overall Study||1
5128009|NCT01440595|12616278|P2|NOT COMPLETED|Overall Study||3
5128010|NCT01440595|12616279|P1|NOT COMPLETED|Overall Study||1
5128011|NCT01440595|12616277|P3|COMPLETED|Overall Study||0
5128012|NCT01440595|12616278|P2|COMPLETED|Overall Study||0
5128013|NCT01440595|12616279|P1|COMPLETED|Overall Study||0
5128014|NCT01440595|12616277|P3|STARTED|Overall Study||1
5128015|NCT01440595|12616278|P2|STARTED|Overall Study||3
5128016|NCT01440595|12616279|P1|STARTED|Overall Study||1
5128017|NCT01440569|12616299|P2|NOT COMPLETED|Open-Label Rollover Phase||6
5128018|NCT01440569|12616300|P1|NOT COMPLETED|Open-Label Rollover Phase||47
5128019|NCT01440569|12616299|P2|COMPLETED|Open-Label Rollover Phase||7
5128020|NCT01440569|12616300|P1|COMPLETED|Open-Label Rollover Phase||204
5128112|NCT01440101|12616487|P3|COMPLETED|Overall Study||46
5128021|NCT01440569|12616299|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
5128022|NCT01440569|12616300|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
5128023|NCT01440569|12616299|P2|NOT COMPLETED|Main Study||4
5128024|NCT01440569|12616300|P1|NOT COMPLETED|Main Study||36
5128025|NCT01440569|12616299|P2|COMPLETED|Main Study||14
5128026|NCT01440569|12616300|P1|COMPLETED|Main Study||260
5128027|NCT01440569|12616299|P2|Enrolled and Treated|Main Study||18
5128028|NCT01440569|12616300|P1|Enrolled and Treated|Main Study||295
5128029|NCT01440569|12616299|P2|STARTED|Main Study||18
5128030|NCT01440569|12616300|P1|STARTED|Main Study||296
5128031|NCT01440543|12616322|P4|NOT COMPLETED|Overall Study||6
5128032|NCT01440543|12616323|P3|NOT COMPLETED|Overall Study||2
5128033|NCT01440543|12616324|P2|NOT COMPLETED|Overall Study||4
5128034|NCT01440543|12616325|P1|NOT COMPLETED|Overall Study||4
5128035|NCT01440543|12616322|P4|COMPLETED|Overall Study||101
5128036|NCT01440543|12616323|P3|COMPLETED|Overall Study||100
5128037|NCT01440543|12616324|P2|COMPLETED|Overall Study||101
5128038|NCT01440543|12616325|P1|COMPLETED|Overall Study||102
5128039|NCT01440543|12616322|P4|STARTED|Overall Study||107
5128040|NCT01440543|12616323|P3|STARTED|Overall Study||102
5128041|NCT01440543|12616324|P2|STARTED|Overall Study||105
5128042|NCT01440543|12616325|P1|STARTED|Overall Study||106
5128043|NCT01440517|12616335|P1|NOT COMPLETED|Overall Study||1
5128044|NCT01440517|12616335|P1|COMPLETED|Overall Study||4
5128045|NCT01440517|12616335|P1|STARTED|Overall Study||5
5128046|NCT01440452|12616344|P4|NOT COMPLETED|Overall Study||0
5128047|NCT01440452|12616345|P3|NOT COMPLETED|Overall Study||0
5128048|NCT01440452|12616346|P2|NOT COMPLETED|Overall Study||0
5128049|NCT01440452|12616347|P1|NOT COMPLETED|Overall Study||0
5128050|NCT01440452|12616344|P4|COMPLETED|Overall Study||4
5128051|NCT01440452|12616345|P3|COMPLETED|Overall Study||8
5128052|NCT01440452|12616346|P2|COMPLETED|Overall Study||7
5128053|NCT01440452|12616347|P1|COMPLETED|Overall Study||6
5128054|NCT01440452|12616344|P4|STARTED|Overall Study||4
5128055|NCT01440452|12616345|P3|STARTED|Overall Study||8
5128056|NCT01440452|12616346|P2|STARTED|Overall Study||7
5128057|NCT01440452|12616347|P1|STARTED|Overall Study||6
5128058|NCT01440387|12616387|P2|NOT COMPLETED|Overall Study||0
5128059|NCT01440387|12616388|P1|NOT COMPLETED|Overall Study||0
5128060|NCT01440387|12616387|P2|COMPLETED|Overall Study||56
5128061|NCT01440387|12616388|P1|COMPLETED|Overall Study||56
5128062|NCT01440387|12616387|P2|STARTED|Overall Study||56
5128063|NCT01440387|12616388|P1|STARTED|Overall Study||56
5128064|NCT01440374|12616411|P4|NOT COMPLETED|Part 3: Extension||32
5128065|NCT01440374|12616412|P3|NOT COMPLETED|Part 3: Extension||0
5128066|NCT01440374|12616413|P2|NOT COMPLETED|Part 3: Extension||0
5128067|NCT01440374|12616414|P1|NOT COMPLETED|Part 3: Extension||0
5128068|NCT01440374|12616411|P4|COMPLETED|Part 3: Extension||27
5128069|NCT01440374|12616412|P3|COMPLETED|Part 3: Extension||0
5128070|NCT01440374|12616413|P2|COMPLETED|Part 3: Extension||0
5128071|NCT01440374|12616414|P1|COMPLETED|Part 3: Extension||0
5128072|NCT01440374|12616411|P4|STARTED|Part 3: Extension||59
5128073|NCT01440374|12616412|P3|STARTED|Part 3: Extension||0
5128074|NCT01440374|12616413|P2|STARTED|Part 3: Extension||0
5128075|NCT01440374|12616414|P1|STARTED|Part 3: Extension||0
5128076|NCT01440374|12616411|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
5128077|NCT01440374|12616412|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
5128078|NCT01440374|12616413|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
5128079|NCT01440374|12616414|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
5128080|NCT01440374|12616411|P4|COMPLETED|Part 2; Double-blind Phase||0
5128081|NCT01440374|12616412|P3|COMPLETED|Part 2; Double-blind Phase||43
5128082|NCT01440374|12616413|P2|COMPLETED|Part 2; Double-blind Phase||27
5128083|NCT01440374|12616414|P1|COMPLETED|Part 2; Double-blind Phase||0
5128084|NCT01440374|12616411|P4|STARTED|Part 2; Double-blind Phase||0
5128085|NCT01440374|12616412|P3|STARTED|Part 2; Double-blind Phase||98
5128086|NCT01440374|12616413|P2|STARTED|Part 2; Double-blind Phase||47
5128087|NCT01440374|12616414|P1|STARTED|Part 2; Double-blind Phase||0
5128088|NCT01440374|12616411|P4|NOT COMPLETED|Part 1: Open-label Phase||0
5128089|NCT01440374|12616412|P3|NOT COMPLETED|Part 1: Open-label Phase||0
5128090|NCT01440374|12616413|P2|NOT COMPLETED|Part 1: Open-label Phase||0
5128091|NCT01440374|12616414|P1|NOT COMPLETED|Part 1: Open-label Phase||6
5128092|NCT01440374|12616411|P4|COMPLETED|Part 1: Open-label Phase||0
5128093|NCT01440374|12616412|P3|COMPLETED|Part 1: Open-label Phase||0
5128094|NCT01440374|12616413|P2|COMPLETED|Part 1: Open-label Phase||0
5128095|NCT01440374|12616414|P1|COMPLETED|Part 1: Open-label Phase||11
5128096|NCT01440374|12616411|P4|STARTED|Part 1: Open-label Phase||0
5128097|NCT01440374|12616412|P3|STARTED|Part 1: Open-label Phase||0
5128098|NCT01440374|12616413|P2|STARTED|Part 1: Open-label Phase||0
5128099|NCT01440374|12616414|P1|STARTED|Part 1: Open-label Phase||17
5128100|NCT01440322|12616449|P2|NOT COMPLETED|Overall Study||1
5128101|NCT01440322|12616450|P1|NOT COMPLETED|Overall Study||7
5128102|NCT01440322|12616449|P2|COMPLETED|Overall Study||49
5128103|NCT01440322|12616450|P1|COMPLETED|Overall Study||90
5128104|NCT01440322|12616449|P2|STARTED|Overall Study||50
5128105|NCT01440322|12616450|P1|STARTED|Overall Study||97
5128106|NCT01440283|12616472|P1|NOT COMPLETED|Overall Study||10
5128107|NCT01440283|12616472|P1|COMPLETED|Overall Study||4
5128108|NCT01440283|12616472|P1|STARTED|Overall Study||14
5128109|NCT01440101|12616487|P3|NOT COMPLETED|Overall Study||1
5128110|NCT01440101|12616488|P2|NOT COMPLETED|Overall Study||4
5128111|NCT01440101|12616489|P1|NOT COMPLETED|Overall Study||2
5128113|NCT01440101|12616488|P2|COMPLETED|Overall Study||43
5128114|NCT01440101|12616489|P1|COMPLETED|Overall Study||10
5128115|NCT01440101|12616487|P3|STARTED|Overall Study||47
5128116|NCT01440101|12616488|P2|STARTED|Overall Study||47
5128117|NCT01440101|12616489|P1|STARTED|Overall Study||12
5128118|NCT01440049|12616522|P1|NOT COMPLETED|Overall Study||5
5128119|NCT01440049|12616522|P1|COMPLETED|Overall Study||155
5128120|NCT01440049|12616522|P1|STARTED|Overall Study||160
5128121|NCT01439971|12616554|P5|NOT COMPLETED|Overall Study||1
5128122|NCT01439971|12616555|P4|NOT COMPLETED|Overall Study||0
5128123|NCT01439971|12616556|P3|NOT COMPLETED|Overall Study||2
5128124|NCT01439971|12616557|P2|NOT COMPLETED|Overall Study||1
5128125|NCT01439971|12616558|P1|NOT COMPLETED|Overall Study||0
5128126|NCT01439971|12616554|P5|COMPLETED|Overall Study||6
5128127|NCT01439971|12616555|P4|COMPLETED|Overall Study||6
5128128|NCT01439971|12616556|P3|COMPLETED|Overall Study||6
5128129|NCT01439971|12616557|P2|COMPLETED|Overall Study||6
5128130|NCT01439971|12616558|P1|COMPLETED|Overall Study||1
5128131|NCT01439971|12616554|P5|Received Treatment|Overall Study||6
5128132|NCT01439971|12616555|P4|Received Treatment|Overall Study||6
5128133|NCT01439971|12616556|P3|Received Treatment|Overall Study||6
5128134|NCT01439971|12616557|P2|Received Treatment|Overall Study||6
5128135|NCT01439971|12616558|P1|Received Treatment|Overall Study||1
5128136|NCT01439971|12616554|P5|STARTED|Overall Study||7
5128137|NCT01439971|12616555|P4|STARTED|Overall Study||6
5128138|NCT01439971|12616556|P3|STARTED|Overall Study||8
5128139|NCT01439971|12616557|P2|STARTED|Overall Study||7
5128140|NCT01439971|12616558|P1|STARTED|Overall Study||1
5128141|NCT01439945|12616738|P4|NOT COMPLETED|Optional Continuation Phase||0
5128142|NCT01439945|12616739|P3|NOT COMPLETED|Optional Continuation Phase||0
5128143|NCT01439945|12616740|P2|NOT COMPLETED|Optional Continuation Phase||0
5128144|NCT01439945|12616741|P1|NOT COMPLETED|Optional Continuation Phase||0
5128145|NCT01439945|12616738|P4|COMPLETED|Optional Continuation Phase||0
5128146|NCT01439945|12616739|P3|COMPLETED|Optional Continuation Phase||0
5128147|NCT01439945|12616740|P2|COMPLETED|Optional Continuation Phase||44
5128148|NCT01439945|12616741|P1|COMPLETED|Optional Continuation Phase||72
5128149|NCT01439945|12616738|P4|STARTED|Optional Continuation Phase||0
5128150|NCT01439945|12616739|P3|STARTED|Optional Continuation Phase||0
5128151|NCT01439945|12616740|P2|STARTED|Optional Continuation Phase||44
5128152|NCT01439945|12616741|P1|STARTED|Optional Continuation Phase||72
5128153|NCT01439945|12616738|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
5128154|NCT01439945|12616739|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
5128155|NCT01439945|12616740|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
5128156|NCT01439945|12616741|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
5128157|NCT01439945|12616738|P4|COMPLETED|Double-Blind Treatment Phase||46
5128158|NCT01439945|12616739|P3|COMPLETED|Double-Blind Treatment Phase||45
5128159|NCT01439945|12616740|P2|COMPLETED|Double-Blind Treatment Phase||91
5128160|NCT01439945|12616741|P1|COMPLETED|Double-Blind Treatment Phase||93
5128161|NCT01439945|12616738|P4|STARTED|Double-Blind Treatment Phase||48
5128162|NCT01439945|12616739|P3|STARTED|Double-Blind Treatment Phase||48
5128163|NCT01439945|12616740|P2|STARTED|Double-Blind Treatment Phase||96
5128164|NCT01439945|12616741|P1|STARTED|Double-Blind Treatment Phase||97
5128165|NCT01439880|12616766|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
5128166|NCT01439880|12616767|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
5128167|NCT01439880|12616766|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
5128168|NCT01439880|12616767|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
5128169|NCT01439880|12616766|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
5128170|NCT01439880|12616767|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
5128171|NCT01439880|12616766|P2|STARTED|All-IP Period (Years 2 to 5)||822
5128172|NCT01439880|12616767|P1|STARTED|All-IP Period (Years 2 to 5)||398
5128173|NCT01439880|12616766|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
5128174|NCT01439880|12616767|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
5128175|NCT01439880|12616766|P2|COMPLETED|SOC-controlled Period (Year 1)||822
5128176|NCT01439880|12616767|P1|COMPLETED|SOC-controlled Period (Year 1)||398
5128177|NCT01439880|12616766|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
5128178|NCT01439880|12616767|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
5128179|NCT01439880|12616766|P2|STARTED|SOC-controlled Period (Year 1)||882
5128180|NCT01439880|12616767|P1|STARTED|SOC-controlled Period (Year 1)||442
5128181|NCT01439867|12616810|P2|NOT COMPLETED|Overall Study||8
5128182|NCT01439867|12616811|P1|NOT COMPLETED|Overall Study||6
5128183|NCT01439867|12616810|P2|COMPLETED|Overall Study||2
5128184|NCT01439867|12616811|P1|COMPLETED|Overall Study||2
5128185|NCT01439867|12616810|P2|Received Treatment|Overall Study||10
5128186|NCT01439867|12616811|P1|Received Treatment|Overall Study||7
5128187|NCT01439867|12616810|P2|STARTED|Overall Study||10
5128188|NCT01439867|12616811|P1|STARTED|Overall Study||8
5128189|NCT01439854|12616852|P2|NOT COMPLETED|Overall Study||0
5128190|NCT01439854|12616853|P1|NOT COMPLETED|Overall Study||0
5128191|NCT01439854|12616852|P2|COMPLETED|Overall Study||10
5128192|NCT01439854|12616853|P1|COMPLETED|Overall Study||8
5128193|NCT01439854|12616852|P2|STARTED|Overall Study||10
5128194|NCT01439854|12616853|P1|STARTED|Overall Study||8
5128195|NCT01439724|12616863|P2|NOT COMPLETED|Overall Study||8
5128196|NCT01439724|12616864|P1|NOT COMPLETED|Overall Study||9
5128197|NCT01439724|12616863|P2|COMPLETED|Overall Study||39
5128198|NCT01439724|12616864|P1|COMPLETED|Overall Study||38
5128199|NCT01439724|12616863|P2|STARTED|Overall Study||47
5128200|NCT01439724|12616864|P1|STARTED|Overall Study||47
5128201|NCT01439711|12616870|P1|NOT COMPLETED|Overall Study||40
5128202|NCT01439711|12616870|P1|COMPLETED|Overall Study||68
5128203|NCT01439711|12616870|P1|STARTED|Overall Study||108
5128204|NCT01439672|12616881|P1|NOT COMPLETED|Overall Study||24
5128205|NCT01439672|12616881|P1|COMPLETED|Overall Study||11
5128206|NCT01439672|12616881|P1|STARTED|Overall Study||35
5128207|NCT01439633|12616885|P1|NOT COMPLETED|Overall Study||0
5128208|NCT01439633|12616885|P1|COMPLETED|Overall Study||22
5128209|NCT01439633|12616885|P1|STARTED|Overall Study||22
5128210|NCT01439620|12616889|P1|NOT COMPLETED|Overall Study||0
5128211|NCT01439620|12616889|P1|COMPLETED|Overall Study||7
5128212|NCT01439620|12616889|P1|STARTED|Overall Study||7
5128213|NCT01439594|12616893|P1|NOT COMPLETED|Overall Study||0
5128214|NCT01439594|12616893|P1|COMPLETED|Overall Study||17
5128215|NCT01439594|12616893|P1|STARTED|Overall Study||17
5128216|NCT01439581|12616899|P2|NOT COMPLETED|Overall Study||0
5128217|NCT01439581|12616900|P1|NOT COMPLETED|Overall Study||0
5128218|NCT01439581|12616899|P2|COMPLETED|Overall Study||212
5128219|NCT01439581|12616900|P1|COMPLETED|Overall Study||216
5128220|NCT01439581|12616899|P2|STARTED|Overall Study||212
5128221|NCT01439581|12616900|P1|STARTED|Overall Study||216
5128222|NCT01439568|12616908|P2|NOT COMPLETED|Overall Study||2
5128223|NCT01439568|12616909|P1|NOT COMPLETED|Overall Study||3
5128224|NCT01439568|12616908|P2|COMPLETED|Overall Study||41
5128225|NCT01439568|12616909|P1|COMPLETED|Overall Study||44
5128226|NCT01439568|12616908|P2|Received at Least One Dose of Study Drug|Overall Study||43
5128227|NCT01439568|12616909|P1|Received at Least One Dose of Study Drug|Overall Study||47
5128228|NCT01439568|12616908|P2|STARTED|Overall Study||43
5128229|NCT01439568|12616909|P1|STARTED|Overall Study||47
5128230|NCT01439555|12616921|P1|NOT COMPLETED|Overall Study||1
5128231|NCT01439555|12616921|P1|COMPLETED|Overall Study||10
5128232|NCT01439555|12616921|P1|STARTED|Overall Study||11
5128233|NCT01439373|12616933|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
5128234|NCT01439373|12616934|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
5128235|NCT01439373|12616933|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
5128236|NCT01439373|12616934|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
5128237|NCT01439373|12616933|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
5128238|NCT01439373|12616934|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
5128239|NCT01439373|12616933|P2|NOT COMPLETED|Monotherapy (Day 1)||1
5128240|NCT01439373|12616934|P1|NOT COMPLETED|Monotherapy (Day 1)||0
5128241|NCT01439373|12616933|P2|COMPLETED|Monotherapy (Day 1)||4
5128242|NCT01439373|12616934|P1|COMPLETED|Monotherapy (Day 1)||11
5128243|NCT01439373|12616933|P2|STARTED|Monotherapy (Day 1)||5
5128244|NCT01439373|12616934|P1|STARTED|Monotherapy (Day 1)||11
5128245|NCT01439360|12616977|P2|NOT COMPLETED|Overall Study||208
5128246|NCT01439360|12616978|P1|NOT COMPLETED|Overall Study||198
5128247|NCT01439360|12616977|P2|COMPLETED|Overall Study||5804
5128248|NCT01439360|12616978|P1|COMPLETED|Overall Study||5808
5128249|NCT01439360|12616977|P2|STARTED|Overall Study||6012
5128250|NCT01439360|12616978|P1|STARTED|Overall Study||6006
5128251|NCT01439282|12617028|P2|NOT COMPLETED|Overall Study||1
5128252|NCT01439282|12617029|P1|NOT COMPLETED|Overall Study||8
5128253|NCT01439282|12617028|P2|COMPLETED|Overall Study||9
5128254|NCT01439282|12617029|P1|COMPLETED|Overall Study||59
5128255|NCT01439282|12617028|P2|STARTED|Overall Study||10
5128256|NCT01439282|12617029|P1|STARTED|Overall Study||67
5128257|NCT01439204|12617041|P2|NOT COMPLETED|Overall Study||3
5128258|NCT01439204|12617042|P1|NOT COMPLETED|Overall Study||4
5128259|NCT01439204|12617041|P2|COMPLETED|Overall Study||33
5128260|NCT01439204|12617042|P1|COMPLETED|Overall Study||32
5128261|NCT01439204|12617041|P2|STARTED|Overall Study||36
5128262|NCT01439204|12617042|P1|STARTED|Overall Study||36
5128263|NCT01439165|12617076|P2|NOT COMPLETED|Overall Study||2
5128264|NCT01439165|12617077|P1|NOT COMPLETED|Overall Study||21
5128265|NCT01439165|12617076|P2|COMPLETED|Overall Study||326
5128266|NCT01439165|12617077|P1|COMPLETED|Overall Study||981
5128267|NCT01439165|12617076|P2|STARTED|Overall Study||328
5128268|NCT01439165|12617077|P1|STARTED|Overall Study||1002
5128269|NCT01439126|12617091|P2|NOT COMPLETED|Overall Study||42
5128270|NCT01439126|12617092|P1|NOT COMPLETED|Overall Study||31
5128271|NCT01439126|12617091|P2|COMPLETED|Overall Study||25
5128272|NCT01439126|12617092|P1|COMPLETED|Overall Study||37
5128273|NCT01439126|12617091|P2|STARTED|Overall Study||67
5128274|NCT01439126|12617092|P1|STARTED|Overall Study||68
5128275|NCT01439087|12617112|P1|NOT COMPLETED|Overall Study||0
5128276|NCT01439087|12617112|P1|COMPLETED|Overall Study||2
5128277|NCT01439087|12617112|P1|STARTED|Overall Study||2
5128278|NCT01439074|12617118|P2|NOT COMPLETED|Overall Study||13
5128279|NCT01439074|12617119|P1|NOT COMPLETED|Overall Study||9
5128280|NCT01439074|12617118|P2|COMPLETED|Overall Study||74
5128281|NCT01439074|12617119|P1|COMPLETED|Overall Study||66
5128282|NCT01439074|12617118|P2|STARTED|Overall Study||87
5128283|NCT01439074|12617119|P1|STARTED|Overall Study||75
5128284|NCT01439035|12617131|P1|NOT COMPLETED|Overall Study||0
5128285|NCT01439035|12617131|P1|COMPLETED|Overall Study||6
5128286|NCT01439035|12617131|P1|STARTED|Overall Study||6
5128287|NCT01439009|12617137|P2|NOT COMPLETED|Overall Study||3
5128288|NCT01439009|12617138|P1|NOT COMPLETED|Overall Study||8
5128289|NCT01439009|12617137|P2|COMPLETED|Overall Study||47
5128290|NCT01439009|12617138|P1|COMPLETED|Overall Study||42
5128291|NCT01439009|12617137|P2|STARTED|Overall Study||50
5128292|NCT01439009|12617138|P1|STARTED|Overall Study||50
5128293|NCT01438996|12617171|P3|NOT COMPLETED|Overall Study||0
5128294|NCT01438996|12617172|P2|NOT COMPLETED|Overall Study||1
5128295|NCT01438996|12617173|P1|NOT COMPLETED|Overall Study||4
5128296|NCT01438996|12617171|P3|COMPLETED|Overall Study||20
5128297|NCT01438996|12617172|P2|COMPLETED|Overall Study||12
5128298|NCT01438996|12617173|P1|COMPLETED|Overall Study||14
5128299|NCT01438996|12617171|P3|STARTED|Overall Study||20
5128300|NCT01438996|12617172|P2|STARTED|Overall Study||13
5128301|NCT01438996|12617173|P1|STARTED|Overall Study||18
5128302|NCT01438840|12617207|P3|NOT COMPLETED|Extension Phase||10
5128303|NCT01438840|12617208|P2|NOT COMPLETED|Extension Phase||0
5128304|NCT01438840|12617209|P1|NOT COMPLETED|Extension Phase||0
5128305|NCT01438840|12617207|P3|COMPLETED|Extension Phase||29
5128306|NCT01438840|12617208|P2|COMPLETED|Extension Phase||0
5128307|NCT01438840|12617209|P1|COMPLETED|Extension Phase||0
5128308|NCT01438840|12617207|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
5128309|NCT01438840|12617208|P2|STARTED|Extension Phase||0
5128310|NCT01438840|12617209|P1|STARTED|Extension Phase||0
5128311|NCT01438840|12617207|P3|NOT COMPLETED|Core Study||0
5128312|NCT01438840|12617208|P2|NOT COMPLETED|Core Study||10
5128313|NCT01438840|12617209|P1|NOT COMPLETED|Core Study||16
5128314|NCT01438840|12617207|P3|COMPLETED|Core Study||0
5128315|NCT01438840|12617208|P2|COMPLETED|Core Study||22
5128316|NCT01438840|12617209|P1|COMPLETED|Core Study||1
5128317|NCT01438840|12617207|P3|STARTED|Core Study||0
5128318|NCT01438840|12617208|P2|STARTED|Core Study||32
5128319|NCT01438840|12617209|P1|STARTED|Core Study||17
5128320|NCT01438814|12617222|P2|NOT COMPLETED|Overall Study||14
5128321|NCT01438814|12617223|P1|NOT COMPLETED|Overall Study||14
5128322|NCT01438814|12617222|P2|COMPLETED|Overall Study||331
5128323|NCT01438814|12617223|P1|COMPLETED|Overall Study||330
5128324|NCT01438814|12617222|P2|STARTED|Overall Study||345
5128325|NCT01438814|12617223|P1|STARTED|Overall Study||344
5128326|NCT01438710|12617253|P2|NOT COMPLETED|Second Week of Treatment||0
5128327|NCT01438710|12617254|P1|NOT COMPLETED|Second Week of Treatment||1
5128328|NCT01438710|12617253|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
5128329|NCT01438710|12617254|P1|COMPLETED|Second Week of Treatment||40
5128330|NCT01438710|12617253|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
5128331|NCT01438710|12617254|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
5128332|NCT01438710|12617253|P2|NOT COMPLETED|First Week of Treatment||3
5128333|NCT01438710|12617254|P1|NOT COMPLETED|First Week of Treatment||0
5128334|NCT01438710|12617253|P2|COMPLETED|First Week of Treatment||41
5128335|NCT01438710|12617254|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
5128336|NCT01438710|12617253|P2|STARTED|First Week of Treatment||44
5128337|NCT01438710|12617254|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
5128338|NCT01438541|12617259|P1|NOT COMPLETED|Overall Study||7
5128339|NCT01438541|12617259|P1|COMPLETED|Overall Study||22
5128340|NCT01438541|12617259|P1|STARTED|Overall Study||29
5128341|NCT01438489|12617268|P3|NOT COMPLETED|Overall Study||19
5128342|NCT01438489|12617269|P2|NOT COMPLETED|Overall Study||16
5128343|NCT01438489|12617270|P1|NOT COMPLETED|Overall Study||26
5128344|NCT01438489|12617268|P3|COMPLETED|Overall Study||85
5128345|NCT01438489|12617269|P2|COMPLETED|Overall Study||84
5128346|NCT01438489|12617270|P1|COMPLETED|Overall Study||77
5128347|NCT01438489|12617268|P3|STARTED|Overall Study||104
5128348|NCT01438489|12617269|P2|STARTED|Overall Study||100
5128349|NCT01438489|12617270|P1|STARTED|Overall Study||103
5128350|NCT01438476|12617315|P2|NOT COMPLETED|Overall Study||11
5128351|NCT01438476|12617316|P1|NOT COMPLETED|Overall Study||10
5128352|NCT01438476|12617315|P2|COMPLETED|Overall Study||34
5128353|NCT01438476|12617316|P1|COMPLETED|Overall Study||106
5128354|NCT01438476|12617315|P2|STARTED|Overall Study||45
5128355|NCT01438476|12617316|P1|STARTED|Overall Study||116
5128356|NCT01438424|12617322|P1|NOT COMPLETED|Overall Study||417
5128357|NCT01438424|12617322|P1|COMPLETED|Overall Study|Completed treatment|634
5128358|NCT01438424|12617322|P1|STARTED|Overall Study|Received treatment|1051
5128359|NCT01438307|12617360|P2|NOT COMPLETED|Overall Study||1
5128360|NCT01438307|12617361|P1|NOT COMPLETED|Overall Study||1
5128361|NCT01438307|12617360|P2|COMPLETED|Overall Study||13
5128362|NCT01438307|12617361|P1|COMPLETED|Overall Study||13
5128363|NCT01438307|12617360|P2|STARTED|Overall Study||14
5128364|NCT01438307|12617361|P1|STARTED|Overall Study||14
5128365|NCT01438294|12617375|P2|NOT COMPLETED|Overall Study||7
5128366|NCT01438294|12617376|P1|NOT COMPLETED|Overall Study||3
5128367|NCT01438294|12617375|P2|COMPLETED|Overall Study||13
5128368|NCT01438294|12617376|P1|COMPLETED|Overall Study||13
5128369|NCT01438294|12617375|P2|STARTED|Overall Study||20
5128370|NCT01438294|12617376|P1|STARTED|Overall Study||16
5128371|NCT01438229|12617386|P1|NOT COMPLETED|Overall Study||3
5128372|NCT01438229|12617386|P1|COMPLETED|Overall Study||44
5128373|NCT01438229|12617386|P1|Underwent Procedure|Overall Study||46
5128374|NCT01438229|12617386|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
5128375|NCT01438229|12617386|P1|STARTED|Overall Study||47
5128376|NCT01438177|12617419|P1|NOT COMPLETED|Overall Study||2
5128377|NCT01438177|12617419|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
5128378|NCT01438177|12617419|P1|STARTED|Overall Study||11
5128379|NCT01438151|12617426|P1|NOT COMPLETED|Overall Study||8
5128380|NCT01438151|12617426|P1|COMPLETED|Overall Study||3
5128381|NCT01438151|12617426|P1|STARTED|Overall Study||11
5128382|NCT01438060|12617432|P2|NOT COMPLETED|On Study Beyond Week 140||8
5128383|NCT01438060|12617433|P1|NOT COMPLETED|On Study Beyond Week 140||0
5128384|NCT01438060|12617432|P2|COMPLETED|On Study Beyond Week 140||1
5128385|NCT01438060|12617433|P1|COMPLETED|On Study Beyond Week 140||0
5128386|NCT01438060|12617432|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
5128387|NCT01438060|12617433|P1|STARTED|On Study Beyond Week 140||0
5128388|NCT01438060|12617432|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
5128389|NCT01438060|12617433|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
5128390|NCT01438060|12617432|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
5128391|NCT01438060|12617433|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
5128392|NCT01438060|12617432|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
5128393|NCT01438060|12617433|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
5128394|NCT01438060|12617432|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
5128395|NCT01438060|12617433|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
5128396|NCT01438060|12617432|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
5128397|NCT01438060|12617433|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
5128398|NCT01438060|12617432|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
5128399|NCT01438060|12617433|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
5128400|NCT01437995|12617514|P3|NOT COMPLETED|Overall Study||20
5128401|NCT01437995|12617515|P2|NOT COMPLETED|Overall Study||18
5128402|NCT01437995|12617516|P1|NOT COMPLETED|Overall Study||11
5128403|NCT01437995|12617514|P3|COMPLETED|Overall Study||135
5128404|NCT01437995|12617515|P2|COMPLETED|Overall Study||131
5128405|NCT01437995|12617516|P1|COMPLETED|Overall Study||140
5128406|NCT01437995|12617514|P3|Included in Treatment Failure Analysis|Overall Study||151
5128407|NCT01437995|12617515|P2|Included in Treatment Failure Analysis|Overall Study||146
5128408|NCT01437995|12617516|P1|Included in Treatment Failure Analysis|Overall Study||150
5128409|NCT01437995|12617514|P3|STARTED|Overall Study||155
5128410|NCT01437995|12617515|P2|STARTED|Overall Study||149
5128411|NCT01437995|12617516|P1|STARTED|Overall Study||151
5128412|NCT01437943|12617538|P2|NOT COMPLETED|Overall Study||2
5128413|NCT01437943|12617539|P1|NOT COMPLETED|Overall Study||7
5128414|NCT01437943|12617538|P2|COMPLETED|Overall Study||1
5128415|NCT01437943|12617539|P1|COMPLETED|Overall Study||0
5128416|NCT01437943|12617538|P2|STARTED|Overall Study||3
5128417|NCT01437943|12617539|P1|STARTED|Overall Study||7
5128418|NCT01437878|12617547|P2|NOT COMPLETED|Overall Study||0
5128419|NCT01437878|12617548|P1|NOT COMPLETED|Overall Study||1
5128420|NCT01437878|12617547|P2|COMPLETED|Overall Study||1
5128421|NCT01437878|12617548|P1|COMPLETED|Overall Study||0
5128422|NCT01437878|12617547|P2|STARTED|Overall Study||1
5128423|NCT01437878|12617548|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
5128424|NCT01437852|12617588|P1|NOT COMPLETED|Overall Study||0
5128425|NCT01437852|12617588|P1|COMPLETED|Overall Study||30
5128426|NCT01437852|12617588|P1|Received Autograft|Overall Study||30
5128427|NCT01437852|12617588|P1|Received StrataGraft Skin Tissue|Overall Study||30
5128428|NCT01437852|12617588|P1|STARTED|Overall Study||30
5128429|NCT01437605|12617596|P2|NOT COMPLETED|Overall Study||0
5128430|NCT01437605|12617597|P1|NOT COMPLETED|Overall Study||0
5128431|NCT01437605|12617596|P2|COMPLETED|Overall Study||5
5128432|NCT01437605|12617597|P1|COMPLETED|Overall Study||9
5128433|NCT01437605|12617596|P2|STARTED|Overall Study||5
5128434|NCT01437605|12617597|P1|STARTED|Overall Study||9
5128435|NCT01437540|12617615|P2|NOT COMPLETED|Overall Study||65
5128436|NCT01437540|12617616|P1|NOT COMPLETED|Overall Study||127
5128437|NCT01437540|12617615|P2|COMPLETED|Overall Study||133
5128438|NCT01437540|12617616|P1|COMPLETED|Overall Study||265
5128439|NCT01437540|12617615|P2|STARTED|Overall Study||198
5128440|NCT01437540|12617616|P1|STARTED|Overall Study||392
5128441|NCT01437501|12617630|P2|NOT COMPLETED|Overall Study||11
5128442|NCT01437501|12617631|P1|NOT COMPLETED|Overall Study||13
5128443|NCT01437501|12617630|P2|COMPLETED|Overall Study||132
5128444|NCT01437501|12617631|P1|COMPLETED|Overall Study||135
5128445|NCT01437501|12617630|P2|STARTED|Overall Study||143
5128446|NCT01437501|12617631|P1|STARTED|Overall Study||148
5128447|NCT01437488|12617639|P1|NOT COMPLETED|Overall Study||0
5128448|NCT01437488|12617639|P1|COMPLETED|Overall Study||14
5128449|NCT01437488|12617639|P1|STARTED|Overall Study||14
5128450|NCT01437449|12617646|P1|NOT COMPLETED|Overall Study||0
5128451|NCT01437449|12617646|P1|COMPLETED|Overall Study||27
5128452|NCT01437449|12617646|P1|STARTED|Overall Study||27
5128453|NCT01437423|12617653|P1|NOT COMPLETED|Overall Study||15
5128454|NCT01437423|12617653|P1|COMPLETED|Overall Study||647
5128455|NCT01437423|12617653|P1|STARTED|Overall Study||662
5128456|NCT01437397|12617665|P5|NOT COMPLETED|Overall Study||101
5128457|NCT01437397|12617666|P4|NOT COMPLETED|Overall Study||69
5128458|NCT01437397|12617667|P3|NOT COMPLETED|Overall Study||72
5128459|NCT01437397|12617668|P2|NOT COMPLETED|Overall Study||62
5128460|NCT01437397|12617669|P1|NOT COMPLETED|Overall Study||66
5128461|NCT01437397|12617665|P5|COMPLETED|Overall Study||236
5128462|NCT01437397|12617666|P4|COMPLETED|Overall Study||270
5128463|NCT01437397|12617667|P3|COMPLETED|Overall Study||268
5128464|NCT01437397|12617668|P2|COMPLETED|Overall Study||276
5128465|NCT01437397|12617669|P1|COMPLETED|Overall Study||272
5128466|NCT01437397|12617665|P5|STARTED|Overall Study||337
5128467|NCT01437397|12617666|P4|STARTED|Overall Study||339
5128468|NCT01437397|12617667|P3|STARTED|Overall Study||340
5128469|NCT01437397|12617668|P2|STARTED|Overall Study||338
5128470|NCT01437397|12617669|P1|STARTED|Overall Study||338
5128471|NCT01437319|12617696|P3|NOT COMPLETED|Phase II||37
5128472|NCT01437319|12617697|P2|NOT COMPLETED|Phase II||44
5128473|NCT01437319|12617698|P1|NOT COMPLETED|Phase II||0
5128474|NCT01437319|12617696|P3|COMPLETED|Phase II||75
5128475|NCT01437319|12617697|P2|COMPLETED|Phase II||71
5128476|NCT01437319|12617698|P1|COMPLETED|Phase II||0
5128477|NCT01437319|12617696|P3|STARTED|Phase II||112
5128478|NCT01437319|12617697|P2|STARTED|Phase II||115
5128479|NCT01437319|12617698|P1|STARTED|Phase II||0
5128480|NCT01437319|12617696|P3|NOT COMPLETED|Phase I||0
5128481|NCT01437319|12617697|P2|NOT COMPLETED|Phase I||0
5128482|NCT01437319|12617698|P1|NOT COMPLETED|Phase I||55
5128483|NCT01437319|12617696|P3|COMPLETED|Phase I||0
5128484|NCT01437319|12617697|P2|COMPLETED|Phase I||0
5128485|NCT01437319|12617698|P1|COMPLETED|Phase I||227
5128486|NCT01437319|12617696|P3|STARTED|Phase I||0
5128487|NCT01437319|12617697|P2|STARTED|Phase I||0
5128488|NCT01437319|12617698|P1|STARTED|Phase I||282
5128489|NCT01437267|12617713|P6|NOT COMPLETED|Overall Study||0
5128490|NCT01437267|12617714|P5|NOT COMPLETED|Overall Study||0
5128491|NCT01437267|12617715|P4|NOT COMPLETED|Overall Study||1
5128492|NCT01437267|12617716|P3|NOT COMPLETED|Overall Study||0
5128493|NCT01437267|12617717|P2|NOT COMPLETED|Overall Study||1
5128494|NCT01437267|12617718|P1|NOT COMPLETED|Overall Study||0
5128495|NCT01437267|12617713|P6|COMPLETED|Overall Study||20
5128496|NCT01437267|12617714|P5|COMPLETED|Overall Study||20
5128497|NCT01437267|12617715|P4|COMPLETED|Overall Study||19
5128498|NCT01437267|12617716|P3|COMPLETED|Overall Study||20
5128499|NCT01437267|12617717|P2|COMPLETED|Overall Study||19
5128500|NCT01437267|12617718|P1|COMPLETED|Overall Study||20
5128501|NCT01437267|12617713|P6|STARTED|Overall Study||20
5128502|NCT01437267|12617714|P5|STARTED|Overall Study||20
5128503|NCT01437267|12617715|P4|STARTED|Overall Study||20
5128504|NCT01437267|12617716|P3|STARTED|Overall Study||20
5128505|NCT01437267|12617717|P2|STARTED|Overall Study||20
5128506|NCT01437267|12617718|P1|STARTED|Overall Study||20
5128507|NCT01437124|12617756|P1|NOT COMPLETED|Overall Study||0
5128508|NCT01437124|12617756|P1|COMPLETED|Overall Study||83
5128509|NCT01437124|12617756|P1|STARTED|Overall Study||83
5128510|NCT01437111|12617761|P1|NOT COMPLETED|Overall Study||18
5128511|NCT01437111|12617761|P1|COMPLETED|Overall Study||182
5128512|NCT01437111|12617761|P1|Treated Participants|Overall Study||198
5128513|NCT01437111|12617761|P1|STARTED|Overall Study||200
5128514|NCT01437098|12617772|P1|NOT COMPLETED|Overall Study||13
5128515|NCT01437098|12617772|P1|COMPLETED|Overall Study||42
5128516|NCT01437098|12617772|P1|36 Months|Overall Study||36
5128517|NCT01437098|12617772|P1|24 Months|Overall Study||42
5128518|NCT01437098|12617772|P1|12 Months|Overall Study||45
5128519|NCT01437098|12617772|P1|6 Months|Overall Study||47
5128520|NCT01437098|12617772|P1|30 Days|Overall Study||51
5128521|NCT01437098|12617772|P1|STARTED|Overall Study||55
5128522|NCT01436799|12617829|P2|NOT COMPLETED|Overall Study||0
5128523|NCT01436799|12617830|P1|NOT COMPLETED|Overall Study||0
5128524|NCT01436799|12617829|P2|COMPLETED|Overall Study||20
5128525|NCT01436799|12617830|P1|COMPLETED|Overall Study||20
5128526|NCT01436799|12617829|P2|STARTED|Overall Study||20
5128527|NCT01436799|12617830|P1|STARTED|Overall Study||20
5128528|NCT01436643|12617839|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
5128529|NCT01436643|12617840|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
5128530|NCT01436643|12617841|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
5128531|NCT01436643|12617842|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
5128532|NCT01436643|12617839|P4|COMPLETED|Core Phase (16 Weeks)||0
5128533|NCT01436643|12617840|P3|COMPLETED|Core Phase (16 Weeks)||17
5128534|NCT01436643|12617841|P2|COMPLETED|Core Phase (16 Weeks)||11
5128535|NCT01436643|12617842|P1|COMPLETED|Core Phase (16 Weeks)||16
5128536|NCT01436643|12617839|P4|STARTED|Core Phase (16 Weeks)||0
5128537|NCT01436643|12617840|P3|STARTED|Core Phase (16 Weeks)||20
5128538|NCT01436643|12617841|P2|STARTED|Core Phase (16 Weeks)||15
5128539|NCT01436643|12617842|P1|STARTED|Core Phase (16 Weeks)||17
5128540|NCT01436643|12617839|P4|NOT COMPLETED|2-week Pre-treatment||10
5128541|NCT01436643|12617840|P3|NOT COMPLETED|2-week Pre-treatment||0
5128542|NCT01436643|12617841|P2|NOT COMPLETED|2-week Pre-treatment||0
5128543|NCT01436643|12617842|P1|NOT COMPLETED|2-week Pre-treatment||0
5128544|NCT01436643|12617839|P4|COMPLETED|2-week Pre-treatment||44
5128545|NCT01436643|12617840|P3|COMPLETED|2-week Pre-treatment||0
5128546|NCT01436643|12617841|P2|COMPLETED|2-week Pre-treatment||0
5128547|NCT01436643|12617842|P1|COMPLETED|2-week Pre-treatment||0
5128548|NCT01436643|12617839|P4|STARTED|2-week Pre-treatment||54
5128549|NCT01436643|12617840|P3|STARTED|2-week Pre-treatment||0
5128550|NCT01436643|12617841|P2|STARTED|2-week Pre-treatment||0
5128551|NCT01436643|12617842|P1|STARTED|2-week Pre-treatment||0
5128552|NCT01436526|12617854|P2|NOT COMPLETED|Period 2||0
5128553|NCT01436526|12617855|P1|NOT COMPLETED|Period 2||0
5128554|NCT01436526|12617854|P2|COMPLETED|Period 2||13
5128555|NCT01436526|12617855|P1|COMPLETED|Period 2||13
5128556|NCT01436526|12617854|P2|Participants Received Treatment|Period 2||13
5128557|NCT01436526|12617855|P1|Participants Received Treatment|Period 2||13
5128558|NCT01436526|12617854|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
5128559|NCT01436526|12617855|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
5128560|NCT01436526|12617854|P2|NOT COMPLETED|Period 1||0
5128561|NCT01436526|12617855|P1|NOT COMPLETED|Period 1||0
5128562|NCT01436526|12617854|P2|COMPLETED|Period 1||14
5128563|NCT01436526|12617855|P1|COMPLETED|Period 1||14
5128564|NCT01436526|12617854|P2|Participants Received Treatment|Period 1||14
5128565|NCT01436526|12617855|P1|Participants Received Treatment|Period 1||14
5128566|NCT01436526|12617854|P2|STARTED|Period 1||14
5128567|NCT01436526|12617855|P1|STARTED|Period 1||14
5128568|NCT01436500|12617877|P5|NOT COMPLETED|Overall Study||4
5128569|NCT01436500|12617878|P4|NOT COMPLETED|Overall Study||1
5128570|NCT01436500|12617879|P3|NOT COMPLETED|Overall Study||5
5128571|NCT01436500|12617880|P2|NOT COMPLETED|Overall Study||3
5128572|NCT01436500|12617881|P1|NOT COMPLETED|Overall Study||3
5128573|NCT01436500|12617877|P5|COMPLETED|Overall Study||9
5128574|NCT01436500|12617878|P4|COMPLETED|Overall Study||5
5128575|NCT01436500|12617879|P3|COMPLETED|Overall Study||7
5128576|NCT01436500|12617880|P2|COMPLETED|Overall Study||9
5128577|NCT01436500|12617881|P1|COMPLETED|Overall Study||9
5128578|NCT01436500|12617877|P5|STARTED|Overall Study||13
5128579|NCT01436500|12617878|P4|STARTED|Overall Study||6
5128580|NCT01436500|12617879|P3|STARTED|Overall Study||12
5128581|NCT01436500|12617880|P2|STARTED|Overall Study||12
5128582|NCT01436500|12617881|P1|STARTED|Overall Study||12
5128583|NCT01436435|12617914|P1|NOT COMPLETED|Overall Study||64
5128584|NCT01436435|12617914|P1|COMPLETED|Overall Study||177
5128585|NCT01436435|12617914|P1|STARTED|Overall Study||241
5128586|NCT01436396|12617925|P2|NOT COMPLETED|Overall Study||42
5128587|NCT01436396|12617926|P1|NOT COMPLETED|Overall Study||32
5128588|NCT01436396|12617925|P2|COMPLETED|Overall Study||354
5128589|NCT01436396|12617926|P1|COMPLETED|Overall Study||364
5128590|NCT01436396|12617925|P2|Vaccinated|Overall Study||393
5128591|NCT01436396|12617926|P1|Vaccinated|Overall Study||394
5128592|NCT01436396|12617925|P2|STARTED|Overall Study||396
5128593|NCT01436396|12617926|P1|STARTED|Overall Study||396
5128594|NCT01436370|12617966|P8|NOT COMPLETED|Overall Study||0
5128595|NCT01436370|12617967|P7|NOT COMPLETED|Overall Study||0
5128596|NCT01436370|12617968|P6|NOT COMPLETED|Overall Study||0
5128597|NCT01436370|12617969|P5|NOT COMPLETED|Overall Study||1
5128598|NCT01436370|12617970|P4|NOT COMPLETED|Overall Study||0
5128599|NCT01436370|12617971|P3|NOT COMPLETED|Overall Study||0
5128600|NCT01436370|12617972|P2|NOT COMPLETED|Overall Study||0
5128601|NCT01436370|12617973|P1|NOT COMPLETED|Overall Study||0
5128602|NCT01436370|12617966|P8|COMPLETED|Overall Study||16
5128603|NCT01436370|12617967|P7|COMPLETED|Overall Study||16
5128604|NCT01436370|12617968|P6|COMPLETED|Overall Study||19
5128605|NCT01436370|12617969|P5|COMPLETED|Overall Study||18
5128606|NCT01436370|12617970|P4|COMPLETED|Overall Study||10
5128607|NCT01436370|12617971|P3|COMPLETED|Overall Study||10
5128608|NCT01436370|12617972|P2|COMPLETED|Overall Study||6
5128609|NCT01436370|12617973|P1|COMPLETED|Overall Study||6
5128610|NCT01436370|12617966|P8|STARTED|Overall Study||16
5128611|NCT01436370|12617967|P7|STARTED|Overall Study||16
5128612|NCT01436370|12617968|P6|STARTED|Overall Study||19
5128613|NCT01436370|12617969|P5|STARTED|Overall Study||19
5128614|NCT01436370|12617970|P4|STARTED|Overall Study||10
5128615|NCT01436370|12617971|P3|STARTED|Overall Study||10
5128616|NCT01436370|12617972|P2|STARTED|Overall Study||6
5128617|NCT01436370|12617973|P1|STARTED|Overall Study||6
5128618|NCT01436357|12618053|P2|NOT COMPLETED|Overall Study||128
5128619|NCT01436357|12618054|P1|NOT COMPLETED|Overall Study||122
5128620|NCT01436357|12618053|P2|COMPLETED|Overall Study||146
5128621|NCT01436357|12618054|P1|COMPLETED|Overall Study||152
5128622|NCT01436357|12618053|P2|Stage 2|Overall Study||226
5128623|NCT01436357|12618054|P1|Stage 2|Overall Study||225
5128624|NCT01436357|12618053|P2|Stage 1|Overall Study||48
5128625|NCT01436357|12618054|P1|Stage 1|Overall Study||49
5128626|NCT01436357|12618053|P2|STARTED|Overall Study||274
5128627|NCT01436357|12618054|P1|STARTED|Overall Study||274
5128628|NCT01436305|12618075|P3|NOT COMPLETED|Overall Study||0
5128629|NCT01436305|12618076|P2|NOT COMPLETED|Overall Study||4
5128630|NCT01436305|12618077|P1|NOT COMPLETED|Overall Study||2
5128631|NCT01436305|12618075|P3|COMPLETED|Overall Study||7
5128632|NCT01436305|12618076|P2|COMPLETED|Overall Study||2
5128633|NCT01436305|12618077|P1|COMPLETED|Overall Study||4
5128634|NCT01436305|12618075|P3|STARTED|Overall Study||7
5128635|NCT01436305|12618076|P2|STARTED|Overall Study||6
5128636|NCT01436305|12618077|P1|STARTED|Overall Study||6
5128637|NCT01436279|12618174|P2|NOT COMPLETED|Overall Study||0
5128638|NCT01436279|12618175|P1|NOT COMPLETED|Overall Study||0
5128639|NCT01436279|12618174|P2|COMPLETED|Overall Study||20
5128640|NCT01436279|12618175|P1|COMPLETED|Overall Study||30
5128641|NCT01436279|12618174|P2|STARTED|Overall Study||20
5128642|NCT01436279|12618175|P1|STARTED|Overall Study||30
5128643|NCT01436266|12618197|P2|NOT COMPLETED|Overall Study||0
5128644|NCT01436266|12618198|P1|NOT COMPLETED|Overall Study||0
5128645|NCT01436266|12618197|P2|COMPLETED|Overall Study||1
5128646|NCT01436266|12618198|P1|COMPLETED|Overall Study||1
5128647|NCT01436266|12618197|P2|STARTED|Overall Study||1
5128648|NCT01436266|12618198|P1|STARTED|Overall Study||1
5128649|NCT01436253|12618204|P1|NOT COMPLETED|Overall Study||299
5128650|NCT01436253|12618204|P1|COMPLETED|Overall Study||1897
5128651|NCT01436253|12618204|P1|STARTED|Overall Study||2196
5128652|NCT01436201|12618209|P1|NOT COMPLETED|Overall Study||4
5128653|NCT01436201|12618209|P1|COMPLETED|Overall Study||20
5128654|NCT01436201|12618209|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
5128655|NCT01436201|12618209|P1|STARTED|Overall Study||24
5128656|NCT01436175|12618219|P1|NOT COMPLETED|Overall Study||1270
5128657|NCT01436175|12618219|P1|COMPLETED|Overall Study||300
5128658|NCT01436175|12618219|P1|STARTED|Overall Study||1570
5128659|NCT01436162|12618246|P3|NOT COMPLETED|Randomized Phase||25
5128660|NCT01436162|12618247|P2|NOT COMPLETED|Randomized Phase||31
5128661|NCT01436162|12618248|P1|NOT COMPLETED|Randomized Phase||44
5128662|NCT01436162|12618246|P3|COMPLETED|Randomized Phase||189
5128663|NCT01436162|12618247|P2|COMPLETED|Randomized Phase||181
5128664|NCT01436162|12618248|P1|COMPLETED|Randomized Phase||353
5128665|NCT01436162|12618246|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
5128666|NCT01436162|12618247|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
5128667|NCT01436162|12618248|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
5128668|NCT01436162|12618246|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
5128669|NCT01436162|12618247|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
5128670|NCT01436162|12618248|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
5128671|NCT01436162|12618246|P3|COMPLETED|Single-blind Lead-in Phase||0
5128672|NCT01436162|12618247|P2|COMPLETED|Single-blind Lead-in Phase||0
5128673|NCT01436162|12618248|P1|COMPLETED|Single-blind Lead-in Phase||823
5128674|NCT01436162|12618246|P3|STARTED|Single-blind Lead-in Phase||0
5128675|NCT01436162|12618247|P2|STARTED|Single-blind Lead-in Phase||0
5128676|NCT01436162|12618248|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
5128677|NCT01436149|12618282|P3|NOT COMPLETED|Randomized Phase||42
5128678|NCT01436149|12618283|P2|NOT COMPLETED|Randomized Phase||38
5128679|NCT01436149|12618284|P1|NOT COMPLETED|Randomized Phase||77
5128680|NCT01436149|12618282|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
5128681|NCT01436149|12618283|P2|COMPLETED|Randomized Phase||164
5128682|NCT01436149|12618284|P1|COMPLETED|Randomized Phase||415
5128683|NCT01436149|12618282|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
5128684|NCT01436149|12618283|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
5128685|NCT01436149|12618284|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
5128686|NCT01436149|12618282|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128687|NCT01436149|12618283|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128688|NCT01436149|12618284|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
5128689|NCT01436149|12618282|P3|COMPLETED|Antidepressant Lead-in Phase||0
5128690|NCT01436149|12618283|P2|COMPLETED|Antidepressant Lead-in Phase||0
5128691|NCT01436149|12618284|P1|COMPLETED|Antidepressant Lead-in Phase||896
5128692|NCT01436149|12618282|P3|STARTED|Antidepressant Lead-in Phase||0
5128693|NCT01436149|12618283|P2|STARTED|Antidepressant Lead-in Phase||0
5128694|NCT01436149|12618284|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
5128695|NCT01436110|12618315|P3|NOT COMPLETED|Overall Study||23
5128696|NCT01436110|12618316|P2|NOT COMPLETED|Overall Study||26
5128697|NCT01436110|12618317|P1|NOT COMPLETED|Overall Study||39
5128698|NCT01436110|12618315|P3|COMPLETED|Overall Study||95
5128699|NCT01436110|12618316|P2|COMPLETED|Overall Study||91
5128700|NCT01436110|12618317|P1|COMPLETED|Overall Study||77
5128701|NCT01436110|12618315|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
5128702|NCT01436110|12618316|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
5128703|NCT01436110|12618317|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
5128704|NCT01436110|12618315|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
5128705|NCT01436110|12618316|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
5128706|NCT01436110|12618317|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
5128707|NCT01436084|12618340|P1|NOT COMPLETED|Overall Study||4
5128708|NCT01436084|12618340|P1|COMPLETED|Overall Study||0
5128709|NCT01436084|12618340|P1|STARTED|Overall Study||4
5128710|NCT01436071|12618346|P2|NOT COMPLETED|Overall Study||14
5128711|NCT01436071|12618347|P1|NOT COMPLETED|Overall Study||26
5128712|NCT01436071|12618346|P2|COMPLETED|Overall Study||110
5128713|NCT01436071|12618347|P1|COMPLETED|Overall Study||98
5128714|NCT01436071|12618346|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
5128715|NCT01436071|12618347|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
5128716|NCT01436071|12618346|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
5128717|NCT01436071|12618347|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
5128718|NCT01436045|12618363|P2|NOT COMPLETED|Overall Study||0
5128719|NCT01436045|12618364|P1|NOT COMPLETED|Overall Study||0
5128720|NCT01436045|12618363|P2|COMPLETED|Overall Study||6
5128721|NCT01436045|12618364|P1|COMPLETED|Overall Study||6
5128722|NCT01436045|12618363|P2|STARTED|Overall Study||6
5128723|NCT01436045|12618364|P1|STARTED|Overall Study||6
5128724|NCT01436006|12618375|P1|NOT COMPLETED|Overall Study||37
5128725|NCT01436006|12618375|P1|COMPLETED|Overall Study||6663
5128726|NCT01436006|12618375|P1|STARTED|Overall Study||6700
5128727|NCT01435928|12618389|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
5128728|NCT01435928|12618390|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
5128729|NCT01435928|12618391|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
5128730|NCT01435928|12618389|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
5128731|NCT01435928|12618390|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
5128732|NCT01435928|12618391|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
5128733|NCT01435928|12618389|P3|STARTED|Double Blind Phase - 28 Weeks||141
5128734|NCT01435928|12618390|P2|STARTED|Double Blind Phase - 28 Weeks||144
5128735|NCT01435928|12618391|P1|STARTED|Double Blind Phase - 28 Weeks||0
5128736|NCT01435928|12618389|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
5128737|NCT01435928|12618390|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
5128738|NCT01435928|12618391|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
5128739|NCT01435928|12618389|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
5128740|NCT01435928|12618390|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
5128741|NCT01435928|12618391|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
5128742|NCT01435928|12618389|P3|STARTED|Open Label Phase - up to 24 Weeks||0
5128743|NCT01435928|12618390|P2|STARTED|Open Label Phase - up to 24 Weeks||0
5128744|NCT01435928|12618391|P1|STARTED|Open Label Phase - up to 24 Weeks||676
5128745|NCT01435824|12618418|P2|NOT COMPLETED|Second Intervention||0
5128746|NCT01435824|12618419|P1|NOT COMPLETED|Second Intervention||0
5128747|NCT01435824|12618418|P2|COMPLETED|Second Intervention||8
5128748|NCT01435824|12618419|P1|COMPLETED|Second Intervention||8
5128749|NCT01435824|12618418|P2|STARTED|Second Intervention||8
5128750|NCT01435824|12618419|P1|STARTED|Second Intervention||8
5128751|NCT01435824|12618418|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
5128752|NCT01435824|12618419|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
5128753|NCT01435824|12618418|P2|COMPLETED|Washout of 1-2 Weeks||8
5128754|NCT01435824|12618419|P1|COMPLETED|Washout of 1-2 Weeks||8
5128755|NCT01435824|12618418|P2|STARTED|Washout of 1-2 Weeks||8
5128756|NCT01435824|12618419|P1|STARTED|Washout of 1-2 Weeks||8
5128757|NCT01435824|12618418|P2|NOT COMPLETED|First Intervention||0
5128758|NCT01435824|12618419|P1|NOT COMPLETED|First Intervention||0
5128759|NCT01435824|12618418|P2|COMPLETED|First Intervention||8
5128760|NCT01435824|12618419|P1|COMPLETED|First Intervention||8
5128761|NCT01435824|12618418|P2|STARTED|First Intervention||8
5128762|NCT01435824|12618419|P1|STARTED|First Intervention||8
5128763|NCT01435798|12618437|P1|NOT COMPLETED|Overall Study||1
5128764|NCT01435798|12618437|P1|COMPLETED|Overall Study|Crossover design|25
5128765|NCT01435798|12618437|P1|100% MTD|Overall Study||25
5128766|NCT01435798|12618437|P1|50% MTD|Overall Study||25
5128767|NCT01435798|12618437|P1|25% MTD|Overall Study||26
5128768|NCT01435798|12618437|P1|0% MTD|Overall Study||25
5128769|NCT01435798|12618437|P1|STARTED|Overall Study|Crossover design|26
5128770|NCT01435772|12618454|P3|NOT COMPLETED|Overall Study||15
5128771|NCT01435772|12618455|P2|NOT COMPLETED|Overall Study||3
5128772|NCT01435772|12618456|P1|NOT COMPLETED|Overall Study||3
5128773|NCT01435772|12618454|P3|COMPLETED|Overall Study||0
5128774|NCT01435772|12618455|P2|COMPLETED|Overall Study||0
5128775|NCT01435772|12618456|P1|COMPLETED|Overall Study||0
5128776|NCT01435772|12618454|P3|STARTED|Overall Study||15
5128777|NCT01435772|12618455|P2|STARTED|Overall Study||3
5128778|NCT01435772|12618456|P1|STARTED|Overall Study||3
5128779|NCT01435759|12618506|P6|NOT COMPLETED|Double-blind Phase||9
5128780|NCT01435759|12618507|P5|NOT COMPLETED|Double-blind Phase||9
5128781|NCT01435759|12618508|P4|NOT COMPLETED|Double-blind Phase||9
5128782|NCT01435759|12618509|P3|NOT COMPLETED|Double-blind Phase||7
5128783|NCT01435759|12618510|P2|NOT COMPLETED|Double-blind Phase||7
5128784|NCT01435759|12618511|P1|NOT COMPLETED|Double-blind Phase||66
5128785|NCT01435759|12618506|P6|COMPLETED|Double-blind Phase||71
5128786|NCT01435759|12618507|P5|COMPLETED|Double-blind Phase||69
5128787|NCT01435759|12618508|P4|COMPLETED|Double-blind Phase||69
5128788|NCT01435759|12618509|P3|COMPLETED|Double-blind Phase||71
5128789|NCT01435759|12618510|P2|COMPLETED|Double-blind Phase||71
5128790|NCT01435759|12618511|P1|COMPLETED|Double-blind Phase||397
5128791|NCT01435759|12618506|P6|STARTED|Double-blind Phase||80
5128792|NCT01435759|12618507|P5|STARTED|Double-blind Phase||78
5128793|NCT01435759|12618508|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
5128794|NCT01435759|12618509|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
5128795|NCT01435759|12618510|P2|STARTED|Double-blind Phase||78
5128796|NCT01435759|12618511|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
5128797|NCT01435759|12618506|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128798|NCT01435759|12618507|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128799|NCT01435759|12618508|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128800|NCT01435759|12618509|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128801|NCT01435759|12618510|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
5128802|NCT01435759|12618511|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
5128803|NCT01435759|12618506|P6|COMPLETED|Antidepressant Lead-in Phase||0
5128804|NCT01435759|12618507|P5|COMPLETED|Antidepressant Lead-in Phase||0
5128805|NCT01435759|12618508|P4|COMPLETED|Antidepressant Lead-in Phase||0
5128806|NCT01435759|12618509|P3|COMPLETED|Antidepressant Lead-in Phase||0
5128807|NCT01435759|12618510|P2|COMPLETED|Antidepressant Lead-in Phase||0
5128808|NCT01435759|12618511|P1|COMPLETED|Antidepressant Lead-in Phase||855
5128809|NCT01435759|12618506|P6|STARTED|Antidepressant Lead-in Phase||0
5128810|NCT01435759|12618507|P5|STARTED|Antidepressant Lead-in Phase||0
5128811|NCT01435759|12618508|P4|STARTED|Antidepressant Lead-in Phase||0
5128812|NCT01435759|12618509|P3|STARTED|Antidepressant Lead-in Phase||0
5128813|NCT01435759|12618510|P2|STARTED|Antidepressant Lead-in Phase||0
5128814|NCT01435759|12618511|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
5128815|NCT01435655|12618538|P1|NOT COMPLETED|Overall Study||3
5128816|NCT01435655|12618538|P1|COMPLETED|Overall Study||7
5128817|NCT01435655|12618538|P1|STARTED|Overall Study||10
5128818|NCT01435616|12618552|P2|NOT COMPLETED|Overall Study||80
5128819|NCT01435616|12618553|P1|NOT COMPLETED|Overall Study||171
5128820|NCT01435616|12618552|P2|COMPLETED|Overall Study||455
5128821|NCT01435616|12618553|P1|COMPLETED|Overall Study||832
5128822|NCT01435616|12618552|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
5128823|NCT01435616|12618553|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
5128824|NCT01435616|12618552|P2|STARTED|Overall Study||535
5128825|NCT01435616|12618553|P1|STARTED|Overall Study||1003
5128826|NCT01435603|12618599|P2|NOT COMPLETED|Overall Study||35
5128827|NCT01435603|12618600|P1|NOT COMPLETED|Overall Study||39
5128828|NCT01435603|12618599|P2|COMPLETED|Overall Study||129
5128829|NCT01435603|12618600|P1|COMPLETED|Overall Study||128
5128830|NCT01435603|12618599|P2|STARTED|Overall Study||164
5128831|NCT01435603|12618600|P1|STARTED|Overall Study||167
5128832|NCT01435577|12618608|P2|NOT COMPLETED|Overall Study||52
5128833|NCT01435577|12618609|P1|NOT COMPLETED|Overall Study||17
5128834|NCT01435577|12618608|P2|COMPLETED|Overall Study||13
5128835|NCT01435577|12618609|P1|COMPLETED|Overall Study||47
5128836|NCT01435577|12618608|P2|STARTED|Overall Study||65
5128837|NCT01435577|12618609|P1|STARTED|Overall Study||64
5128838|NCT01435460|12618659|P2|NOT COMPLETED|Overall Study||6
5128839|NCT01435460|12618660|P1|NOT COMPLETED|Overall Study||11
5128840|NCT01435460|12618659|P2|COMPLETED|Overall Study||143
5128841|NCT01435460|12618660|P1|COMPLETED|Overall Study||140
5128842|NCT01435460|12618659|P2|STARTED|Overall Study||149
5128843|NCT01435460|12618660|P1|STARTED|Overall Study||151
5128844|NCT01435382|12618676|P4|NOT COMPLETED|Overall Study||1
5128845|NCT01435382|12618677|P3|NOT COMPLETED|Overall Study||1
5128846|NCT01435382|12618678|P2|NOT COMPLETED|Overall Study||2
5128847|NCT01435382|12618679|P1|NOT COMPLETED|Overall Study||1
5128848|NCT01435382|12618676|P4|COMPLETED|Overall Study||10
5128849|NCT01435382|12618677|P3|COMPLETED|Overall Study||12
5128850|NCT01435382|12618678|P2|COMPLETED|Overall Study||11
5128851|NCT01435382|12618679|P1|COMPLETED|Overall Study||11
5128852|NCT01435382|12618676|P4|STARTED|Overall Study||11
5128853|NCT01435382|12618677|P3|STARTED|Overall Study||13
5128854|NCT01435382|12618678|P2|STARTED|Overall Study||13
5128855|NCT01435382|12618679|P1|STARTED|Overall Study||12
5128856|NCT01435356|12618768|P2|NOT COMPLETED|Overall Study||24
5128857|NCT01435356|12618769|P1|NOT COMPLETED|Overall Study||32
5128858|NCT01435356|12618768|P2|COMPLETED|Overall Study||5
5128859|NCT01435356|12618769|P1|COMPLETED|Overall Study||16
5128860|NCT01435356|12618768|P2|STARTED|Overall Study||29
5128861|NCT01435356|12618769|P1|STARTED|Overall Study||48
5128862|NCT01435304|12618783|P2|NOT COMPLETED|Overall Study||0
5128863|NCT01435304|12618784|P1|NOT COMPLETED|Overall Study||0
5128864|NCT01435304|12618783|P2|COMPLETED|Overall Study||50
5128865|NCT01435304|12618784|P1|COMPLETED|Overall Study||50
5128866|NCT01435304|12618783|P2|STARTED|Overall Study||50
5128867|NCT01435304|12618784|P1|STARTED|Overall Study||50
5128868|NCT01435265|12618802|P2|NOT COMPLETED|Overall Study||1
5128869|NCT01435265|12618803|P1|NOT COMPLETED|Overall Study||0
5128870|NCT01435265|12618802|P2|COMPLETED|Overall Study||3
5128871|NCT01435265|12618803|P1|COMPLETED|Overall Study||3
5128872|NCT01435265|12618802|P2|STARTED|Overall Study||4
5128873|NCT01435265|12618803|P1|STARTED|Overall Study||3
5128874|NCT01435174|12618813|P1|NOT COMPLETED|Overall Study||9
5128875|NCT01435174|12618813|P1|COMPLETED|Overall Study||8
5128876|NCT01435174|12618813|P1|STARTED|Overall Study||17
5128877|NCT01435122|12618817|P1|NOT COMPLETED|Overall Study||8
5128878|NCT01435122|12618817|P1|COMPLETED|Overall Study||22
5128879|NCT01435122|12618817|P1|STARTED|Overall Study||30
5128880|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 4 Years||7
5128881|NCT01435031|12618826|P1|COMPLETED|ITT at 4 Years||171
5128882|NCT01435031|12618826|P1|STARTED|ITT at 4 Years||178
5128883|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 3 Years||11
5128884|NCT01435031|12618826|P1|COMPLETED|ITT at 3 Years||178
5128885|NCT01435031|12618826|P1|STARTED|ITT at 3 Years||189
5128886|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 2 Years||13
5128887|NCT01435031|12618826|P1|COMPLETED|ITT at 2 Years||189
5128888|NCT01435031|12618826|P1|STARTED|ITT at 2 Years||202
5128889|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 1 Year||9
5128890|NCT01435031|12618826|P1|COMPLETED|ITT at 1 Year||202
5128891|NCT01435031|12618826|P1|STARTED|ITT at 1 Year||211
5128892|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 6 Months||5
5128893|NCT01435031|12618826|P1|COMPLETED|ITT at 6 Months||211
5128894|NCT01435031|12618826|P1|STARTED|ITT at 6 Months||216
5128895|NCT01435031|12618826|P1|NOT COMPLETED|ITT at 1 Month||6
5128896|NCT01435031|12618826|P1|COMPLETED|ITT at 1 Month||216
5128897|NCT01435031|12618826|P1|STARTED|ITT at 1 Month|ITT population|222
5128898|NCT01435018|12618927|P3|NOT COMPLETED|Overall Study||108
5128899|NCT01435018|12618928|P2|NOT COMPLETED|Overall Study||50
5128900|NCT01435018|12618929|P1|NOT COMPLETED|Overall Study||110
5128901|NCT01435018|12618927|P3|COMPLETED|Overall Study||31
5128902|NCT01435018|12618928|P2|COMPLETED|Overall Study||10
5128903|NCT01435018|12618929|P1|COMPLETED|Overall Study||25
5128904|NCT01435018|12618927|P3|STARTED|Overall Study||139
5128905|NCT01435018|12618928|P2|STARTED|Overall Study||60
5128906|NCT01435018|12618929|P1|STARTED|Overall Study||135
5128907|NCT01434823|12619014|P2|NOT COMPLETED|Overall Study||7
5128908|NCT01434823|12619015|P1|NOT COMPLETED|Overall Study||4
5128909|NCT01434823|12619014|P2|COMPLETED|Overall Study||778
5128910|NCT01434823|12619015|P1|COMPLETED|Overall Study||820
5128911|NCT01434823|12619014|P2|STARTED|Overall Study||785
5128912|NCT01434823|12619015|P1|STARTED|Overall Study||824
5128913|NCT01434810|12619033|P2|NOT COMPLETED|Overall Study||10
5128914|NCT01434810|12619034|P1|NOT COMPLETED|Overall Study||23
5128915|NCT01434810|12619033|P2|COMPLETED|Overall Study||213
5128916|NCT01434810|12619034|P1|COMPLETED|Overall Study||201
5128917|NCT01434810|12619033|P2|STARTED|Overall Study||223
5128918|NCT01434810|12619034|P1|STARTED|Overall Study||224
5128919|NCT01434745|12619046|P2|NOT COMPLETED|Overall Study||0
5128920|NCT01434745|12619047|P1|NOT COMPLETED|Overall Study||0
5128921|NCT01434745|12619046|P2|COMPLETED|Overall Study||0
5128922|NCT01434745|12619047|P1|COMPLETED|Overall Study||0
5128923|NCT01434745|12619046|P2|STARTED|Overall Study||0
5128924|NCT01434745|12619047|P1|STARTED|Overall Study||0
5128925|NCT01434693|12619069|P4|NOT COMPLETED|Overall Study||1
5128926|NCT01434693|12619070|P3|NOT COMPLETED|Overall Study||1
5128927|NCT01434693|12619071|P2|NOT COMPLETED|Overall Study||0
5128928|NCT01434693|12619072|P1|NOT COMPLETED|Overall Study||3
5128929|NCT01434693|12619069|P4|COMPLETED|Overall Study||8
5128930|NCT01434693|12619070|P3|COMPLETED|Overall Study||8
5128931|NCT01434693|12619071|P2|COMPLETED|Overall Study||9
5128932|NCT01434693|12619072|P1|COMPLETED|Overall Study||6
5128933|NCT01434693|12619069|P4|STARTED|Overall Study||9
5128934|NCT01434693|12619070|P3|STARTED|Overall Study||9
5128935|NCT01434693|12619071|P2|STARTED|Overall Study||9
5128936|NCT01434693|12619072|P1|STARTED|Overall Study||9
5128937|NCT01434680|12619086|P4|NOT COMPLETED|Overall Study||0
5128938|NCT01434680|12619087|P3|NOT COMPLETED|Overall Study||2
5128939|NCT01434680|12619088|P2|NOT COMPLETED|Overall Study||2
5128940|NCT01434680|12619089|P1|NOT COMPLETED|Overall Study||3
5128941|NCT01434680|12619086|P4|COMPLETED|Overall Study||119
5128942|NCT01434680|12619087|P3|COMPLETED|Overall Study||304
5128943|NCT01434680|12619088|P2|COMPLETED|Overall Study||266
5128944|NCT01434680|12619089|P1|COMPLETED|Overall Study||296
5128945|NCT01434680|12619086|P4|STARTED|Overall Study||119
5128946|NCT01434680|12619087|P3|STARTED|Overall Study||306
5128947|NCT01434680|12619088|P2|STARTED|Overall Study||268
5128948|NCT01434680|12619089|P1|STARTED|Overall Study||299
5128949|NCT01434667|12619106|P2|NOT COMPLETED|Overall Study||10
5128950|NCT01434667|12619107|P1|NOT COMPLETED|Overall Study||5
5128951|NCT01434667|12619106|P2|COMPLETED|Overall Study||65
5128952|NCT01434667|12619107|P1|COMPLETED|Overall Study||34
5128953|NCT01434667|12619106|P2|STARTED|Overall Study||75
5128954|NCT01434667|12619107|P1|STARTED|Overall Study||39
5128955|NCT01434654|12619133|P2|NOT COMPLETED|Overall Study||0
5128956|NCT01434654|12619134|P1|NOT COMPLETED|Overall Study||2
5128957|NCT01434654|12619133|P2|COMPLETED|Overall Study||12
5128958|NCT01434654|12619134|P1|COMPLETED|Overall Study||5
5128959|NCT01434654|12619133|P2|STARTED|Overall Study||12
5128960|NCT01434654|12619134|P1|STARTED|Overall Study||7
5128961|NCT01434641|12619146|P1|NOT COMPLETED|Overall Study||0
5128962|NCT01434641|12619146|P1|COMPLETED|Overall Study||102
5128963|NCT01434641|12619146|P1|STARTED|Overall Study||102
5128964|NCT01434511|12619151|P1|NOT COMPLETED|Overall Study||0
5128965|NCT01434511|12619151|P1|COMPLETED|Overall Study||1
5128966|NCT01434511|12619151|P1|STARTED|Overall Study||1
5128967|NCT01434342|12619170|P2|NOT COMPLETED|Overall Study||17
5128968|NCT01434342|12619171|P1|NOT COMPLETED|Overall Study||48
5128969|NCT01434342|12619170|P2|COMPLETED|Overall Study||31
5128970|NCT01434342|12619171|P1|COMPLETED|Overall Study||50
5128971|NCT01434342|12619170|P2|STARTED|Overall Study||48
5128972|NCT01434342|12619171|P1|STARTED|Overall Study||98
5128973|NCT01434290|12619181|P2|NOT COMPLETED|Overall Study||7
5128974|NCT01434290|12619182|P1|NOT COMPLETED|Overall Study||8
5128975|NCT01434290|12619181|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
5128976|NCT01434290|12619182|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
5128977|NCT01434290|12619181|P2|STARTED|Overall Study||128
5128978|NCT01434290|12619182|P1|STARTED|Overall Study||127
5128979|NCT01434186|12619210|P2|NOT COMPLETED|Overall Study||0
5128980|NCT01434186|12619211|P1|NOT COMPLETED|Overall Study||0
5128981|NCT01434186|12619210|P2|COMPLETED|Overall Study||4
5128982|NCT01434186|12619211|P1|COMPLETED|Overall Study||2
5128983|NCT01434186|12619210|P2|STARTED|Overall Study||4
5128984|NCT01434186|12619211|P1|STARTED|Overall Study||2
5128985|NCT01434121|12619220|P3|NOT COMPLETED|Overall Study||0
5128986|NCT01434121|12619221|P2|NOT COMPLETED|Overall Study||0
5128987|NCT01434121|12619222|P1|NOT COMPLETED|Overall Study||0
5128988|NCT01434121|12619220|P3|COMPLETED|Overall Study||8
5128989|NCT01434121|12619221|P2|COMPLETED|Overall Study||8
5128990|NCT01434121|12619222|P1|COMPLETED|Overall Study||8
5128991|NCT01434121|12619220|P3|STARTED|Overall Study||8
5128992|NCT01434121|12619221|P2|STARTED|Overall Study||8
5128993|NCT01434121|12619222|P1|STARTED|Overall Study||8
5128994|NCT01434030|12619248|P1|NOT COMPLETED|Overall Study||1
5128995|NCT01434030|12619248|P1|COMPLETED|Overall Study||56
5128996|NCT01434030|12619248|P1|STARTED|Overall Study||57
5128997|NCT01433978|12619255|P3|NOT COMPLETED|Extension Phase||6
5128998|NCT01433978|12619256|P2|NOT COMPLETED|Extension Phase||0
5128999|NCT01433978|12619257|P1|NOT COMPLETED|Extension Phase||0
5129000|NCT01433978|12619255|P3|COMPLETED|Extension Phase||0
5129001|NCT01433978|12619256|P2|COMPLETED|Extension Phase||0
5129002|NCT01433978|12619257|P1|COMPLETED|Extension Phase||0
5129003|NCT01433978|12619255|P3|STARTED|Extension Phase||6
5129004|NCT01433978|12619256|P2|STARTED|Extension Phase||0
5129005|NCT01433978|12619257|P1|STARTED|Extension Phase||0
5129006|NCT01433978|12619255|P3|NOT COMPLETED|Core Study||0
5129007|NCT01433978|12619256|P2|NOT COMPLETED|Core Study||11
5129008|NCT01433978|12619257|P1|NOT COMPLETED|Core Study||11
5129009|NCT01433978|12619255|P3|COMPLETED|Core Study||0
5129010|NCT01433978|12619256|P2|COMPLETED|Core Study||1
5129011|NCT01433978|12619257|P1|COMPLETED|Core Study||0
5129012|NCT01433978|12619255|P3|STARTED|Core Study||0
5129013|NCT01433978|12619256|P2|STARTED|Core Study||12
5129014|NCT01433978|12619257|P1|STARTED|Core Study||11
5129015|NCT01433913|12619266|P2|NOT COMPLETED|Overall Study||0
5129016|NCT01433913|12619267|P1|NOT COMPLETED|Overall Study||1
5129017|NCT01433913|12619266|P2|COMPLETED|Overall Study||10
5129018|NCT01433913|12619267|P1|COMPLETED|Overall Study||9
5129019|NCT01433913|12619266|P2|STARTED|Overall Study||10
5129020|NCT01433913|12619267|P1|STARTED|Overall Study||10
5129021|NCT01433731|12619303|P4|NOT COMPLETED|Overall Study||0
5129022|NCT01433731|12619304|P3|NOT COMPLETED|Overall Study||0
5129023|NCT01433731|12619305|P2|NOT COMPLETED|Overall Study||0
5129024|NCT01433731|12619306|P1|NOT COMPLETED|Overall Study||0
5129025|NCT01433731|12619303|P4|COMPLETED|Overall Study||5
5129026|NCT01433731|12619304|P3|COMPLETED|Overall Study||5
5129027|NCT01433731|12619305|P2|COMPLETED|Overall Study||5
5129028|NCT01433731|12619306|P1|COMPLETED|Overall Study||3
5129029|NCT01433731|12619303|P4|STARTED|Overall Study||5
5129030|NCT01433731|12619304|P3|STARTED|Overall Study||5
5129031|NCT01433731|12619305|P2|STARTED|Overall Study||5
5129032|NCT01433731|12619306|P1|STARTED|Overall Study||3
5129033|NCT01433549|12619314|P2|NOT COMPLETED|Phase 2: Second Study Product||1
5129034|NCT01433549|12619315|P1|NOT COMPLETED|Phase 2: Second Study Product||0
5129035|NCT01433549|12619314|P2|COMPLETED|Phase 2: Second Study Product||12
5129036|NCT01433549|12619315|P1|COMPLETED|Phase 2: Second Study Product||12
5129037|NCT01433549|12619314|P2|STARTED|Phase 2: Second Study Product||13
5129038|NCT01433549|12619315|P1|STARTED|Phase 2: Second Study Product||12
5129039|NCT01433549|12619314|P2|NOT COMPLETED|Phase 1: First Study Product||0
5129040|NCT01433549|12619315|P1|NOT COMPLETED|Phase 1: First Study Product||0
5129041|NCT01433549|12619314|P2|COMPLETED|Phase 1: First Study Product||13
5129042|NCT01433549|12619315|P1|COMPLETED|Phase 1: First Study Product||12
5129043|NCT01433549|12619314|P2|STARTED|Phase 1: First Study Product||13
5129044|NCT01433549|12619315|P1|STARTED|Phase 1: First Study Product||12
5129045|NCT01433471|12619325|P2|NOT COMPLETED|Overall Study||1
5129046|NCT01433471|12619326|P1|NOT COMPLETED|Overall Study||0
5129047|NCT01433471|12619325|P2|COMPLETED|Overall Study||1
5129048|NCT01433471|12619326|P1|COMPLETED|Overall Study||2
5129049|NCT01433471|12619325|P2|STARTED|Overall Study||2
5129050|NCT01433471|12619326|P1|STARTED|Overall Study||2
5129051|NCT01433354|12619342|P1|NOT COMPLETED|Overall Study||119
5129052|NCT01433354|12619342|P1|COMPLETED|Overall Study||0
5129053|NCT01433354|12619342|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
5129054|NCT01433263|12619358|P2|NOT COMPLETED|Overall Study||12
5129055|NCT01433263|12619359|P1|NOT COMPLETED|Overall Study||19
5129056|NCT01433263|12619358|P2|COMPLETED|Overall Study||16
5129057|NCT01433263|12619359|P1|COMPLETED|Overall Study||10
5129058|NCT01433263|12619358|P2|STARTED|Overall Study||28
5129059|NCT01433263|12619359|P1|STARTED|Overall Study||29
5129060|NCT01433250|12619388|P2|NOT COMPLETED|Overall Study||3
5129061|NCT01433250|12619389|P1|NOT COMPLETED|Overall Study||3
5129062|NCT01433250|12619388|P2|COMPLETED|Overall Study||14
5129063|NCT01433250|12619389|P1|COMPLETED|Overall Study||19
5129064|NCT01433250|12619388|P2|STARTED|Overall Study||17
5129065|NCT01433250|12619389|P1|STARTED|Overall Study||22
5129066|NCT01433172|12619408|P3|NOT COMPLETED|Overall Study||1
5129067|NCT01433172|12619409|P2|NOT COMPLETED|Overall Study||3
5129068|NCT01433172|12619410|P1|NOT COMPLETED|Overall Study||0
5129069|NCT01433172|12619408|P3|COMPLETED|Overall Study||32
5129070|NCT01433172|12619409|P2|COMPLETED|Overall Study||34
5129071|NCT01433172|12619410|P1|COMPLETED|Overall Study||3
5129072|NCT01433172|12619408|P3|STARTED|Overall Study||33
5129073|NCT01433172|12619409|P2|STARTED|Overall Study||37
5129074|NCT01433172|12619410|P1|STARTED|Overall Study||3
5129075|NCT01433159|12619422|P2|NOT COMPLETED|Overall Study||1
5129076|NCT01433159|12619423|P1|NOT COMPLETED|Overall Study||2
5129077|NCT01433159|12619422|P2|COMPLETED|Overall Study||9
5129078|NCT01433159|12619423|P1|COMPLETED|Overall Study||7
5129079|NCT01433159|12619422|P2|STARTED|Overall Study||10
5129080|NCT01433159|12619423|P1|STARTED|Overall Study||9
5129081|NCT01433107|12619431|P2|NOT COMPLETED|Overall Study||17
5129082|NCT01433107|12619432|P1|NOT COMPLETED|Overall Study||27
5129083|NCT01433107|12619431|P2|COMPLETED|Overall Study||128
5129084|NCT01433107|12619432|P1|COMPLETED|Overall Study||118
5129085|NCT01433107|12619431|P2|STARTED|Overall Study||145
5129086|NCT01433107|12619432|P1|STARTED|Overall Study||145
5129087|NCT01433081|12619444|P2|NOT COMPLETED|Overall Study||2
5129088|NCT01433081|12619445|P1|NOT COMPLETED|Overall Study||2
5129089|NCT01433081|12619444|P2|COMPLETED|Overall Study||23
5129090|NCT01433081|12619445|P1|COMPLETED|Overall Study||23
5129091|NCT01433081|12619444|P2|STARTED|Overall Study||25
5129092|NCT01433081|12619445|P1|STARTED|Overall Study||25
5129093|NCT01433055|12619455|P2|NOT COMPLETED|Overall Study||0
5129094|NCT01433055|12619456|P1|NOT COMPLETED|Overall Study||2
5129095|NCT01433055|12619455|P2|COMPLETED|Overall Study||23
5129096|NCT01433055|12619456|P1|COMPLETED|Overall Study||27
5129097|NCT01433055|12619455|P2|STARTED|Overall Study||23
5129098|NCT01433055|12619456|P1|STARTED|Overall Study||29
5129099|NCT01433042|12619470|P1|NOT COMPLETED|Overall Study||1
5129100|NCT01433042|12619470|P1|COMPLETED|Overall Study||224
5129101|NCT01433042|12619470|P1|STARTED|Overall Study||225
5129102|NCT01433016|12619474|P1|NOT COMPLETED|Overall Study||0
5129103|NCT01433016|12619474|P1|COMPLETED|Overall Study||20
5129104|NCT01433016|12619474|P1|STARTED|Overall Study||20
5129105|NCT01432938|12619478|P2|NOT COMPLETED|Second Intervention||0
5129106|NCT01432938|12619479|P1|NOT COMPLETED|Second Intervention||1
5129107|NCT01432938|12619478|P2|COMPLETED|Second Intervention||14
5129108|NCT01432938|12619479|P1|COMPLETED|Second Intervention||11
5129109|NCT01432938|12619478|P2|STARTED|Second Intervention||14
5129110|NCT01432938|12619479|P1|STARTED|Second Intervention||12
5129111|NCT01432938|12619478|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
5129112|NCT01432938|12619479|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
5129113|NCT01432938|12619478|P2|COMPLETED|Washout Period of at Least 24 Days||14
5129114|NCT01432938|12619479|P1|COMPLETED|Washout Period of at Least 24 Days||12
5129115|NCT01432938|12619478|P2|STARTED|Washout Period of at Least 24 Days||14
5129116|NCT01432938|12619479|P1|STARTED|Washout Period of at Least 24 Days||12
5129117|NCT01432938|12619478|P2|NOT COMPLETED|First Intervention||0
5129118|NCT01432938|12619479|P1|NOT COMPLETED|First Intervention||2
5129119|NCT01432938|12619478|P2|COMPLETED|First Intervention||14
5129120|NCT01432938|12619479|P1|COMPLETED|First Intervention||12
5129121|NCT01432938|12619478|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
5129122|NCT01432938|12619479|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
5129123|NCT01432938|12619478|P2|STARTED|First Intervention||14
5129124|NCT01432938|12619479|P1|STARTED|First Intervention||14
5129125|NCT01432886|12619496|P2|NOT COMPLETED|Overall Study||0
5129126|NCT01432886|12619497|P1|NOT COMPLETED|Overall Study||0
5129127|NCT01432886|12619496|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
5129128|NCT01432886|12619497|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
5129129|NCT01432886|12619496|P2|STARTED|Overall Study||6
5129130|NCT01432886|12619497|P1|STARTED|Overall Study||6
5129131|NCT01432756|12619509|P4|NOT COMPLETED|Overall Study||1
5129132|NCT01432756|12619510|P3|NOT COMPLETED|Overall Study||2
5129133|NCT01432756|12619511|P2|NOT COMPLETED|Overall Study||0
5129134|NCT01432756|12619512|P1|NOT COMPLETED|Overall Study||1
5129135|NCT01432756|12619509|P4|COMPLETED|Overall Study||33
5129136|NCT01432756|12619510|P3|COMPLETED|Overall Study||30
5129137|NCT01432756|12619511|P2|COMPLETED|Overall Study||34
5129138|NCT01432756|12619512|P1|COMPLETED|Overall Study||31
5129139|NCT01432756|12619509|P4|STARTED|Overall Study||34
5129140|NCT01432756|12619510|P3|STARTED|Overall Study||32
5129141|NCT01432756|12619511|P2|STARTED|Overall Study||34
5129142|NCT01432756|12619512|P1|STARTED|Overall Study||32
5129143|NCT01432626|12619520|P1|NOT COMPLETED|Overall Study||7
5129144|NCT01432626|12619520|P1|COMPLETED|Overall Study|Completed both images|3
5129145|NCT01432626|12619520|P1|STARTED|Overall Study||10
5129146|NCT01432600|12619527|P3|NOT COMPLETED|Overall Study||1
5129147|NCT01432600|12619528|P2|NOT COMPLETED|Overall Study||1
5129148|NCT01432600|12619529|P1|NOT COMPLETED|Overall Study||0
5129149|NCT01432600|12619527|P3|COMPLETED|Overall Study||33
5129150|NCT01432600|12619528|P2|COMPLETED|Overall Study||35
5129151|NCT01432600|12619529|P1|COMPLETED|Overall Study||10
5129152|NCT01432600|12619527|P3|STARTED|Overall Study||34
5129153|NCT01432600|12619528|P2|STARTED|Overall Study||36
5129154|NCT01432600|12619529|P1|STARTED|Overall Study||10
5129155|NCT01432574|12619545|P1|NOT COMPLETED|Overall Study||3
5129156|NCT01432574|12619545|P1|COMPLETED|Overall Study||147
5129157|NCT01432574|12619545|P1|STARTED|Overall Study||150
5129158|NCT01432561|12619551|P1|NOT COMPLETED|Overall Study||0
5129159|NCT01432561|12619551|P1|COMPLETED|Overall Study||8
5129160|NCT01432561|12619551|P1|STARTED|Overall Study||8
5129161|NCT01432535|12619560|P3|NOT COMPLETED|Overall Study||0
5129162|NCT01432535|12619561|P2|NOT COMPLETED|Overall Study||0
5129163|NCT01432535|12619562|P1|NOT COMPLETED|Overall Study||0
5129164|NCT01432535|12619560|P3|COMPLETED|Overall Study||6
5129165|NCT01432535|12619561|P2|COMPLETED|Overall Study||7
5129166|NCT01432535|12619562|P1|COMPLETED|Overall Study||12
5129167|NCT01432535|12619560|P3|STARTED|Overall Study||6
5129168|NCT01432535|12619561|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
5129169|NCT01432535|12619562|P1|STARTED|Overall Study||12
5129170|NCT01432457|12619591|P3|NOT COMPLETED|Overall Study||59
5129171|NCT01432457|12619592|P2|NOT COMPLETED|Overall Study||48
5129172|NCT01432457|12619593|P1|NOT COMPLETED|Overall Study||37
5129173|NCT01432457|12619591|P3|COMPLETED|Overall Study||253
5129174|NCT01432457|12619592|P2|COMPLETED|Overall Study||258
5129175|NCT01432457|12619593|P1|COMPLETED|Overall Study||269
5129176|NCT01432457|12619591|P3|STARTED|Overall Study||312
5129177|NCT01432457|12619592|P2|STARTED|Overall Study||306
5129178|NCT01432457|12619593|P1|STARTED|Overall Study||306
5129179|NCT01432444|12619622|P3|NOT COMPLETED|Extension Phase||192
5129180|NCT01432444|12619623|P2|NOT COMPLETED|Extension Phase||0
5129181|NCT01432444|12619624|P1|NOT COMPLETED|Extension Phase||0
5129182|NCT01432444|12619622|P3|COMPLETED|Extension Phase||0
5129183|NCT01432444|12619623|P2|COMPLETED|Extension Phase||0
5129184|NCT01432444|12619624|P1|COMPLETED|Extension Phase||0
5129185|NCT01432444|12619622|P3|STARTED|Extension Phase||192
5129186|NCT01432444|12619623|P2|STARTED|Extension Phase||0
5129187|NCT01432444|12619624|P1|STARTED|Extension Phase||0
5129188|NCT01432444|12619622|P3|NOT COMPLETED|Treatment Phase||0
5129189|NCT01432444|12619623|P2|NOT COMPLETED|Treatment Phase||140
5129190|NCT01432444|12619624|P1|NOT COMPLETED|Treatment Phase||0
5129191|NCT01432444|12619622|P3|COMPLETED|Treatment Phase||0
5129192|NCT01432444|12619623|P2|COMPLETED|Treatment Phase||293
5129193|NCT01432444|12619624|P1|COMPLETED|Treatment Phase||0
5129194|NCT01432444|12619622|P3|STARTED|Treatment Phase||0
5129195|NCT01432444|12619623|P2|STARTED|Treatment Phase||433
5129196|NCT01432444|12619624|P1|STARTED|Treatment Phase||0
5129197|NCT01432444|12619622|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
5129198|NCT01432444|12619623|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
5129199|NCT01432444|12619624|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
5129200|NCT01432444|12619622|P3|COMPLETED|Tolerability/Cross-titration Phase||0
5129201|NCT01432444|12619623|P2|COMPLETED|Tolerability/Cross-titration Phase||0
5129202|NCT01432444|12619624|P1|COMPLETED|Tolerability/Cross-titration Phase||265
5129203|NCT01432444|12619622|P3|STARTED|Tolerability/Cross-titration Phase||0
5129204|NCT01432444|12619623|P2|STARTED|Tolerability/Cross-titration Phase||0
5129205|NCT01432444|12619624|P1|STARTED|Tolerability/Cross-titration Phase||325
5129206|NCT01432405|12619636|P2|NOT COMPLETED|Overall Study||2
5129207|NCT01432405|12619637|P1|NOT COMPLETED|Overall Study||1
5129208|NCT01432405|12619636|P2|COMPLETED|Overall Study||10
5129209|NCT01432405|12619637|P1|COMPLETED|Overall Study||11
5129210|NCT01432405|12619636|P2|STARTED|Overall Study||12
5129211|NCT01432405|12619637|P1|STARTED|Overall Study||12
5129212|NCT01432379|12619645|P1|NOT COMPLETED|Overall Study||385
5129213|NCT01432379|12619645|P1|COMPLETED|Overall Study||783
5129214|NCT01432379|12619645|P1|STARTED|Overall Study||1168
5129215|NCT01432366|12619650|P1|NOT COMPLETED|Overall Study||68
5129216|NCT01432366|12619650|P1|COMPLETED|Overall Study||392
5129217|NCT01432366|12619650|P1|STARTED|Overall Study||460
5129218|NCT01432327|12619672|P4|NOT COMPLETED|Posttest 1 Year||23
5129219|NCT01432327|12619673|P3|NOT COMPLETED|Posttest 1 Year||20
5129220|NCT01432327|12619674|P2|NOT COMPLETED|Posttest 1 Year||28
5129221|NCT01432327|12619675|P1|NOT COMPLETED|Posttest 1 Year||24
5129222|NCT01432327|12619672|P4|COMPLETED|Posttest 1 Year||31
5129223|NCT01432327|12619673|P3|COMPLETED|Posttest 1 Year||30
5129224|NCT01432327|12619674|P2|COMPLETED|Posttest 1 Year||27
5129225|NCT01432327|12619675|P1|COMPLETED|Posttest 1 Year||28
5129226|NCT01432327|12619672|P4|STARTED|Posttest 1 Year||54
5129227|NCT01432327|12619673|P3|STARTED|Posttest 1 Year||50
5129228|NCT01432327|12619674|P2|STARTED|Posttest 1 Year||55
5129229|NCT01432327|12619675|P1|STARTED|Posttest 1 Year||52
5129230|NCT01432327|12619672|P4|NOT COMPLETED|Posttest 6 Months||2
5129231|NCT01432327|12619673|P3|NOT COMPLETED|Posttest 6 Months||5
5129232|NCT01432327|12619674|P2|NOT COMPLETED|Posttest 6 Months||0
5129233|NCT01432327|12619675|P1|NOT COMPLETED|Posttest 6 Months||0
5129234|NCT01432327|12619672|P4|COMPLETED|Posttest 6 Months||54
5129235|NCT01432327|12619673|P3|COMPLETED|Posttest 6 Months||50
5129236|NCT01432327|12619674|P2|COMPLETED|Posttest 6 Months||55
5129237|NCT01432327|12619675|P1|COMPLETED|Posttest 6 Months||52
5129238|NCT01432327|12619672|P4|STARTED|Posttest 6 Months||56
5129239|NCT01432327|12619673|P3|STARTED|Posttest 6 Months||55
5129240|NCT01432327|12619674|P2|STARTED|Posttest 6 Months||55
5129241|NCT01432327|12619675|P1|STARTED|Posttest 6 Months||52
5129242|NCT01432327|12619672|P4|NOT COMPLETED|Posttest 3 Months||1
5129243|NCT01432327|12619673|P3|NOT COMPLETED|Posttest 3 Months||2
5129244|NCT01432327|12619674|P2|NOT COMPLETED|Posttest 3 Months||2
5129245|NCT01432327|12619675|P1|NOT COMPLETED|Posttest 3 Months||4
5129246|NCT01432327|12619672|P4|COMPLETED|Posttest 3 Months||56
5129247|NCT01432327|12619673|P3|COMPLETED|Posttest 3 Months||55
5129248|NCT01432327|12619674|P2|COMPLETED|Posttest 3 Months||55
5129249|NCT01432327|12619675|P1|COMPLETED|Posttest 3 Months||52
5129250|NCT01432327|12619672|P4|STARTED|Posttest 3 Months||57
5129251|NCT01432327|12619673|P3|STARTED|Posttest 3 Months||57
5129252|NCT01432327|12619674|P2|STARTED|Posttest 3 Months||57
5129253|NCT01432327|12619675|P1|STARTED|Posttest 3 Months||56
5129254|NCT01432327|12619672|P4|NOT COMPLETED|Baseline||0
5129255|NCT01432327|12619673|P3|NOT COMPLETED|Baseline||0
5129256|NCT01432327|12619674|P2|NOT COMPLETED|Baseline||0
5129257|NCT01432327|12619675|P1|NOT COMPLETED|Baseline||0
5129258|NCT01432327|12619672|P4|COMPLETED|Baseline||57
5129259|NCT01432327|12619673|P3|COMPLETED|Baseline||57
5129260|NCT01432327|12619674|P2|COMPLETED|Baseline||57
5129261|NCT01432327|12619675|P1|COMPLETED|Baseline||56
5129262|NCT01432327|12619672|P4|STARTED|Baseline||57
5129263|NCT01432327|12619673|P3|STARTED|Baseline||57
5129264|NCT01432327|12619674|P2|STARTED|Baseline||57
5129265|NCT01432327|12619675|P1|STARTED|Baseline||56
5129266|NCT01432275|12619685|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
5129267|NCT01432275|12619686|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
5129268|NCT01432275|12619685|P2|COMPLETED|ADC With Calculator (10 Days)||79
5129269|NCT01432275|12619686|P1|COMPLETED|ADC With Calculator (10 Days)||85
5129270|NCT01432275|12619685|P2|STARTED|ADC With Calculator (10 Days)||81
5129271|NCT01432275|12619686|P1|STARTED|ADC With Calculator (10 Days)||88
5129272|NCT01432275|12619685|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
5129273|NCT01432275|12619686|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
5129274|NCT01432275|12619685|P2|COMPLETED|Second BG Meter System (7 Days)||81
5129275|NCT01432275|12619686|P1|COMPLETED|Second BG Meter System (7 Days)||88
5129276|NCT01432275|12619685|P2|STARTED|Second BG Meter System (7 Days)||84
5129277|NCT01432275|12619686|P1|STARTED|Second BG Meter System (7 Days)||90
5129278|NCT01432275|12619685|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
5129279|NCT01432275|12619686|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
5129280|NCT01432275|12619685|P2|COMPLETED|First BG Meter System (7 Days)||84
5129281|NCT01432275|12619686|P1|COMPLETED|First BG Meter System (7 Days)||90
5129282|NCT01432275|12619685|P2|STARTED|First BG Meter System (7 Days)||87
5129283|NCT01432275|12619686|P1|STARTED|First BG Meter System (7 Days)||90
5129284|NCT01432262|12619695|P2|NOT COMPLETED|Overall Study||1
5129285|NCT01432262|12619696|P1|NOT COMPLETED|Overall Study||2
5129286|NCT01432262|12619695|P2|COMPLETED|Overall Study||161
5129287|NCT01432262|12619696|P1|COMPLETED|Overall Study||160
5129288|NCT01432262|12619695|P2|Vaccinated|Overall Study||161
5129289|NCT01432262|12619696|P1|Vaccinated|Overall Study||162
5129290|NCT01432262|12619695|P2|STARTED|Overall Study||162
5129291|NCT01432262|12619696|P1|STARTED|Overall Study||162
5129292|NCT01432236|12619714|P2|NOT COMPLETED|Overall Study||18
5129293|NCT01432236|12619715|P1|NOT COMPLETED|Overall Study||26
5129294|NCT01432236|12619714|P2|COMPLETED|Overall Study||79
5129295|NCT01432236|12619715|P1|COMPLETED|Overall Study||70
5129296|NCT01432236|12619714|P2|STARTED|Overall Study||97
5129297|NCT01432236|12619715|P1|STARTED|Overall Study||96
5129298|NCT01432171|12619762|P2|NOT COMPLETED|Overall Study||11
5129299|NCT01432171|12619763|P1|NOT COMPLETED|Overall Study||14
5129300|NCT01432171|12619762|P2|COMPLETED|Overall Study||8
5129301|NCT01432171|12619763|P1|COMPLETED|Overall Study||4
5129302|NCT01432171|12619762|P2|STARTED|Overall Study||19
5129303|NCT01432171|12619763|P1|STARTED|Overall Study||18
5129304|NCT01432145|12619769|P1|NOT COMPLETED|Overall Study||7
5129305|NCT01432145|12619769|P1|COMPLETED|Overall Study||67
5129306|NCT01432145|12619769|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
5129307|NCT01432015|12619776|P2|NOT COMPLETED|Overall Study||0
5129308|NCT01432015|12619777|P1|NOT COMPLETED|Overall Study||0
5129309|NCT01432015|12619776|P2|COMPLETED|Overall Study||10
5129310|NCT01432015|12619777|P1|COMPLETED|Overall Study||10
5129311|NCT01432015|12619776|P2|STARTED|Overall Study||10
5129312|NCT01432015|12619777|P1|STARTED|Overall Study||10
5129313|NCT01431989|12619785|P2|NOT COMPLETED|Period 2||0
5129314|NCT01431989|12619786|P1|NOT COMPLETED|Period 2||0
5129315|NCT01431989|12619785|P2|COMPLETED|Period 2||14
5129316|NCT01431989|12619786|P1|COMPLETED|Period 2||14
5129317|NCT01431989|12619785|P2|STARTED|Period 2||14
5129318|NCT01431989|12619786|P1|STARTED|Period 2||14
5129319|NCT01431989|12619785|P2|NOT COMPLETED|14-Day Washout Period||0
5129320|NCT01431989|12619786|P1|NOT COMPLETED|14-Day Washout Period||0
5129321|NCT01431989|12619785|P2|COMPLETED|14-Day Washout Period||14
5129322|NCT01431989|12619786|P1|COMPLETED|14-Day Washout Period||14
5129323|NCT01431989|12619785|P2|STARTED|14-Day Washout Period||14
5129324|NCT01431989|12619786|P1|STARTED|14-Day Washout Period||14
5129325|NCT01431989|12619785|P2|NOT COMPLETED|Period 1||0
5129326|NCT01431989|12619786|P1|NOT COMPLETED|Period 1||0
5129327|NCT01431989|12619785|P2|COMPLETED|Period 1||14
5129328|NCT01431989|12619786|P1|COMPLETED|Period 1||14
5129329|NCT01431989|12619785|P2|STARTED|Period 1||14
5129330|NCT01431989|12619786|P1|STARTED|Period 1||14
5129331|NCT01431976|12619804|P1|NOT COMPLETED|Overall Study||14
5129332|NCT01431976|12619804|P1|COMPLETED|Overall Study||6
5129333|NCT01431976|12619804|P1|STARTED|Overall Study||20
5129334|NCT01431963|12619815|P1|NOT COMPLETED|Overall Study||35
5129335|NCT01431963|12619815|P1|COMPLETED|Overall Study||32
5129336|NCT01431963|12619815|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
5129337|NCT01431963|12619815|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
5129338|NCT01431963|12619815|P1|Complete MP (24 Weeks)|Overall Study||42
5129339|NCT01431963|12619815|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
5129340|NCT01431963|12619815|P1|Complete EP (6 Weeks)|Overall Study||52
5129341|NCT01431963|12619815|P1|Received Treatment|Overall Study||65
5129342|NCT01431963|12619815|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
5129343|NCT01431963|12619815|P1|STARTED|Overall Study||67
5129344|NCT01431950|12619823|P2|NOT COMPLETED|Overall Study||15
5129345|NCT01431950|12619824|P1|NOT COMPLETED|Overall Study||19
5129346|NCT01431950|12619823|P2|COMPLETED|Overall Study||104
5129347|NCT01431950|12619824|P1|COMPLETED|Overall Study||100
5129348|NCT01431950|12619823|P2|STARTED|Overall Study||119
5129349|NCT01431950|12619824|P1|STARTED|Overall Study||119
5129350|NCT01431846|12619841|P3|NOT COMPLETED|Overall Study||0
5129351|NCT01431846|12619842|P2|NOT COMPLETED|Overall Study||0
5129352|NCT01431846|12619843|P1|NOT COMPLETED|Overall Study||0
5129353|NCT01431846|12619841|P3|COMPLETED|Overall Study||8
5129354|NCT01431846|12619842|P2|COMPLETED|Overall Study||3
5129355|NCT01431846|12619843|P1|COMPLETED|Overall Study||8
5129356|NCT01431846|12619841|P3|STARTED|Overall Study||8
5129357|NCT01431846|12619842|P2|STARTED|Overall Study||3
5129358|NCT01431846|12619843|P1|STARTED|Overall Study||8
5129359|NCT01431794|12619856|P5|NOT COMPLETED|Overall Study||0
5129360|NCT01431794|12619857|P4|NOT COMPLETED|Overall Study||0
5129361|NCT01431794|12619858|P3|NOT COMPLETED|Overall Study||0
5129362|NCT01431794|12619859|P2|NOT COMPLETED|Overall Study||0
5129363|NCT01431794|12619860|P1|NOT COMPLETED|Overall Study||0
5129364|NCT01431794|12619856|P5|COMPLETED|Overall Study|not started due to early study's termination|0
5129365|NCT01431794|12619857|P4|COMPLETED|Overall Study|not started due to early study's termination|0
5129366|NCT01431794|12619858|P3|COMPLETED|Overall Study|not started due to early study's termination|0
5129367|NCT01431794|12619859|P2|COMPLETED|Overall Study|not started due to early study's termination|0
5129368|NCT01431794|12619860|P1|COMPLETED|Overall Study||13
5129369|NCT01431794|12619856|P5|STARTED|Overall Study|not started due to early study's termination|0
5129370|NCT01431794|12619857|P4|STARTED|Overall Study|not started due to early study's termination|0
5129371|NCT01431794|12619858|P3|STARTED|Overall Study|not started due to early study's termination|0
5129372|NCT01431794|12619859|P2|STARTED|Overall Study|not started due to early study's termination|0
5129373|NCT01431794|12619860|P1|STARTED|Overall Study||13
5129374|NCT01431755|12619878|P1|NOT COMPLETED|Overall Study||5
5129375|NCT01431755|12619878|P1|COMPLETED|Overall Study||49
5129376|NCT01431755|12619878|P1|STARTED|Overall Study||54
5129377|NCT01431716|12619889|P1|NOT COMPLETED|Overall Study||1
5129378|NCT01431716|12619889|P1|COMPLETED|Overall Study||41
5129379|NCT01431716|12619889|P1|STARTED|Overall Study||42
5129380|NCT01431703|12619906|P1|NOT COMPLETED|Overall Study||0
5129381|NCT01431703|12619906|P1|COMPLETED|Overall Study||326
5129382|NCT01431703|12619906|P1|STARTED|Overall Study||326
5129383|NCT01431534|12619913|P3|NOT COMPLETED|Extension Phase||0
5129384|NCT01431534|12619914|P2|NOT COMPLETED|Extension Phase||0
5129385|NCT01431534|12619915|P1|NOT COMPLETED|Extension Phase||0
5129386|NCT01431534|12619913|P3|COMPLETED|Extension Phase||2
5129387|NCT01431534|12619914|P2|COMPLETED|Extension Phase||0
5129388|NCT01431534|12619915|P1|COMPLETED|Extension Phase||0
5129389|NCT01431534|12619913|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
5129390|NCT01431534|12619914|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
5129391|NCT01431534|12619915|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
5129392|NCT01431534|12619913|P3|NOT COMPLETED|Treatment Phase||11
5129393|NCT01431534|12619914|P2|NOT COMPLETED|Treatment Phase||3
5129394|NCT01431534|12619915|P1|NOT COMPLETED|Treatment Phase||4
5129395|NCT01431534|12619913|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
5129396|NCT01431534|12619914|P2|COMPLETED|Treatment Phase||0
5129397|NCT01431534|12619915|P1|COMPLETED|Treatment Phase||0
5129398|NCT01431534|12619913|P3|STARTED|Treatment Phase||13
5129399|NCT01431534|12619914|P2|STARTED|Treatment Phase||3
5129400|NCT01431534|12619915|P1|STARTED|Treatment Phase||4
5129401|NCT01431521|12619930|P4|NOT COMPLETED|Overall Study||0
5129402|NCT01431521|12619931|P3|NOT COMPLETED|Overall Study||1
5129403|NCT01431521|12619932|P2|NOT COMPLETED|Overall Study||0
5129404|NCT01431521|12619933|P1|NOT COMPLETED|Overall Study||0
5129405|NCT01431521|12619930|P4|COMPLETED|Overall Study||5
5129406|NCT01431521|12619931|P3|COMPLETED|Overall Study||10
5129407|NCT01431521|12619932|P2|COMPLETED|Overall Study||5
5129408|NCT01431521|12619933|P1|COMPLETED|Overall Study||10
5129409|NCT01431521|12619930|P4|Treated|Overall Study||5
5129410|NCT01431521|12619931|P3|Treated|Overall Study||10
5129411|NCT01431521|12619932|P2|Treated|Overall Study||5
5129412|NCT01431521|12619933|P1|Treated|Overall Study||10
5129413|NCT01431521|12619930|P4|STARTED|Overall Study||5
5129414|NCT01431521|12619931|P3|STARTED|Overall Study||11
5129415|NCT01431521|12619932|P2|STARTED|Overall Study||5
5129416|NCT01431521|12619933|P1|STARTED|Overall Study||10
5129417|NCT01431508|12619954|P1|NOT COMPLETED|Overall Study||2
5129418|NCT01431508|12619954|P1|COMPLETED|Overall Study||13
5129419|NCT01431508|12619954|P1|STARTED|Overall Study||15
5129420|NCT01431391|12619960|P2|NOT COMPLETED|Overall Study||4
5129421|NCT01431391|12619961|P1|NOT COMPLETED|Overall Study||8
5129422|NCT01431391|12619960|P2|COMPLETED|Overall Study||30
5129423|NCT01431391|12619961|P1|COMPLETED|Overall Study||26
5129424|NCT01431391|12619960|P2|Received ≥1 Leaukapheresis|Overall Study||34
5129425|NCT01431391|12619961|P1|Received ≥1 Leaukapheresis|Overall Study||34
5129426|NCT01431391|12619960|P2|STARTED|Overall Study||34
5129427|NCT01431391|12619961|P1|STARTED|Overall Study||34
5129428|NCT01431339|12619971|P2|NOT COMPLETED|Overall Study||35
5129429|NCT01431339|12619972|P1|NOT COMPLETED|Overall Study||39
5129430|NCT01431339|12619971|P2|COMPLETED|Overall Study||333
5129431|NCT01431339|12619972|P1|COMPLETED|Overall Study||332
5129432|NCT01431339|12619971|P2|Safety Population|Overall Study||367
5129433|NCT01431339|12619972|P1|Safety Population|Overall Study||368
5129434|NCT01431339|12619971|P2|STARTED|Overall Study||368
5129435|NCT01431339|12619972|P1|STARTED|Overall Study||371
5129436|NCT01431313|12619987|P3|NOT COMPLETED|Overall Study||0
5129437|NCT01431313|12619988|P2|NOT COMPLETED|Overall Study||0
5129438|NCT01431313|12619989|P1|NOT COMPLETED|Overall Study||0
5129439|NCT01431313|12619987|P3|COMPLETED|Overall Study||8
5129440|NCT01431313|12619988|P2|COMPLETED|Overall Study||20
5129441|NCT01431313|12619989|P1|COMPLETED|Overall Study||20
5129442|NCT01431313|12619987|P3|STARTED|Overall Study||8
5129443|NCT01431313|12619988|P2|STARTED|Overall Study||20
5129444|NCT01431313|12619989|P1|STARTED|Overall Study||20
5129445|NCT01431300|12620021|P3|NOT COMPLETED|Overall Study||0
5129446|NCT01431300|12620022|P2|NOT COMPLETED|Overall Study||0
5129447|NCT01431300|12620023|P1|NOT COMPLETED|Overall Study||1
5129448|NCT01431300|12620021|P3|COMPLETED|Overall Study||10
5129449|NCT01431300|12620022|P2|COMPLETED|Overall Study||10
5129450|NCT01431300|12620023|P1|COMPLETED|Overall Study||10
5129451|NCT01431300|12620021|P3|STARTED|Overall Study||10
5129452|NCT01431300|12620022|P2|STARTED|Overall Study||10
5129453|NCT01431300|12620023|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
5129454|NCT01431287|12620039|P5|NOT COMPLETED|Overall Study||77
5129455|NCT01431287|12620040|P4|NOT COMPLETED|Overall Study||63
5129456|NCT01431287|12620041|P3|NOT COMPLETED|Overall Study||97
5129457|NCT01431287|12620042|P2|NOT COMPLETED|Overall Study||98
5129458|NCT01431287|12620043|P1|NOT COMPLETED|Overall Study||98
5129459|NCT01431287|12620039|P5|COMPLETED|Overall Study||430
5129460|NCT01431287|12620040|P4|COMPLETED|Overall Study||445
5129461|NCT01431287|12620041|P3|COMPLETED|Overall Study||410
5129462|NCT01431287|12620042|P2|COMPLETED|Overall Study||409
5129463|NCT01431287|12620043|P1|COMPLETED|Overall Study||412
5129464|NCT01431287|12620039|P5|STARTED|Overall Study||507
5129465|NCT01431287|12620040|P4|STARTED|Overall Study||508
5129466|NCT01431287|12620041|P3|STARTED|Overall Study||507
5129467|NCT01431287|12620042|P2|STARTED|Overall Study||507
5129468|NCT01431287|12620043|P1|STARTED|Overall Study|started are actually the randomized|510
5129469|NCT01431274|12620205|P5|NOT COMPLETED|Overall Study||56
5129470|NCT01431274|12620206|P4|NOT COMPLETED|Overall Study||60
5129471|NCT01431274|12620207|P3|NOT COMPLETED|Overall Study||72
5129472|NCT01431274|12620208|P2|NOT COMPLETED|Overall Study||77
5129473|NCT01431274|12620209|P1|NOT COMPLETED|Overall Study||97
5129474|NCT01431274|12620205|P5|COMPLETED|Overall Study||466
5129475|NCT01431274|12620206|P4|COMPLETED|Overall Study||462
5129476|NCT01431274|12620207|P3|COMPLETED|Overall Study||455
5129477|NCT01431274|12620208|P2|COMPLETED|Overall Study||448
5129478|NCT01431274|12620209|P1|COMPLETED|Overall Study||431
5129479|NCT01431274|12620205|P5|STARTED|Overall Study||522
5129480|NCT01431274|12620206|P4|STARTED|Overall Study||522
5129481|NCT01431274|12620207|P3|STARTED|Overall Study||527
5129482|NCT01431274|12620208|P2|STARTED|Overall Study||525
5129483|NCT01431274|12620209|P1|STARTED|Overall Study||528
5129484|NCT01431170|12620368|P2|NOT COMPLETED|Overall Study||1
5129485|NCT01431170|12620369|P1|NOT COMPLETED|Overall Study||3
5129486|NCT01431170|12620368|P2|COMPLETED|Overall Study||11
5129487|NCT01431170|12620369|P1|COMPLETED|Overall Study||9
5129488|NCT01431170|12620368|P2|STARTED|Overall Study||12
5129489|NCT01431170|12620369|P1|STARTED|Overall Study||12
5129490|NCT01431144|12620387|P2|NOT COMPLETED|Overall Study||0
5129491|NCT01431144|12620388|P1|NOT COMPLETED|Overall Study||2
5129492|NCT01431144|12620387|P2|COMPLETED|Overall Study||14
5129493|NCT01431144|12620388|P1|COMPLETED|Overall Study||11
5129494|NCT01431144|12620387|P2|STARTED|Overall Study||14
5129495|NCT01431144|12620388|P1|STARTED|Overall Study||13
5129496|NCT01431131|12620396|P2|NOT COMPLETED|Overall Study||0
5129497|NCT01431131|12620397|P1|NOT COMPLETED|Overall Study||0
5129498|NCT01431131|12620396|P2|COMPLETED|Overall Study||12
5129499|NCT01431131|12620397|P1|COMPLETED|Overall Study||12
5129500|NCT01431131|12620396|P2|STARTED|Overall Study||12
5129501|NCT01431131|12620397|P1|STARTED|Overall Study||12
5129502|NCT01431105|12620405|P1|NOT COMPLETED|Overall Study||0
5129503|NCT01431105|12620405|P1|COMPLETED|Overall Study||34
5129504|NCT01431105|12620405|P1|STARTED|Overall Study||34
5129505|NCT01431079|12620411|P2|NOT COMPLETED|Overall Study||39
5129506|NCT01431079|12620412|P1|NOT COMPLETED|Overall Study||35
5129507|NCT01431079|12620411|P2|COMPLETED|Overall Study||6
5129508|NCT01431079|12620412|P1|COMPLETED|Overall Study||10
5129509|NCT01431079|12620411|P2|Post-test|Overall Study||45
5129510|NCT01431079|12620412|P1|Post-test|Overall Study||45
5129511|NCT01431079|12620411|P2|STARTED|Overall Study||45
5129512|NCT01431079|12620412|P1|STARTED|Overall Study||45
5129513|NCT01431014|12620466|P2|NOT COMPLETED|Overall Study||9
5129514|NCT01431014|12620467|P1|NOT COMPLETED|Overall Study||3
5129515|NCT01431014|12620466|P2|COMPLETED|Overall Study||25
5129516|NCT01431014|12620467|P1|COMPLETED|Overall Study||31
5129517|NCT01431014|12620466|P2|STARTED|Overall Study||34
5129518|NCT01431014|12620467|P1|STARTED|Overall Study||34
5129519|NCT01430819|12620475|P2|NOT COMPLETED|Overall Study||0
5129520|NCT01430819|12620476|P1|NOT COMPLETED|Overall Study||0
5129521|NCT01430819|12620475|P2|COMPLETED|Overall Study||150
5129522|NCT01430819|12620476|P1|COMPLETED|Overall Study||150
5129523|NCT01430819|12620475|P2|STARTED|Overall Study||150
5129524|NCT01430819|12620476|P1|STARTED|Overall Study||150
5129525|NCT01430754|12620491|P2|NOT COMPLETED|Randomized Phase||0
5129526|NCT01430754|12620492|P1|NOT COMPLETED|Randomized Phase||0
5129527|NCT01430754|12620491|P2|COMPLETED|Randomized Phase||10
5129528|NCT01430754|12620492|P1|COMPLETED|Randomized Phase||10
5129529|NCT01430754|12620491|P2|STARTED|Randomized Phase||10
5129530|NCT01430754|12620492|P1|STARTED|Randomized Phase||10
5129531|NCT01430754|12620491|P2|NOT COMPLETED|Run-In Phase||0
5129532|NCT01430754|12620492|P1|NOT COMPLETED|Run-In Phase||37
5129533|NCT01430754|12620491|P2|COMPLETED|Run-In Phase||0
5129534|NCT01430754|12620492|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
5129535|NCT01430754|12620491|P2|Entrained - After Run-In Phase|Run-In Phase||0
5129536|NCT01430754|12620492|P1|Entrained - After Run-In Phase|Run-In Phase||24
5129537|NCT01430754|12620491|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
5129538|NCT01430754|12620492|P1|STARTED|Run-In Phase||57
5129539|NCT01430741|12620514|P4|NOT COMPLETED|Overall Study||0
5129540|NCT01430741|12620515|P3|NOT COMPLETED|Overall Study||10
5129541|NCT01430741|12620516|P2|NOT COMPLETED|Overall Study||0
5129542|NCT01430741|12620517|P1|NOT COMPLETED|Overall Study||0
5129543|NCT01430741|12620514|P4|COMPLETED|Overall Study||81
5129544|NCT01430741|12620515|P3|COMPLETED|Overall Study||37
5129545|NCT01430741|12620516|P2|COMPLETED|Overall Study||87
5129546|NCT01430741|12620517|P1|COMPLETED|Overall Study||22
5129547|NCT01430741|12620514|P4|STARTED|Overall Study||81
5129548|NCT01430741|12620515|P3|STARTED|Overall Study||47
5129549|NCT01430741|12620516|P2|STARTED|Overall Study||87
5129550|NCT01430741|12620517|P1|STARTED|Overall Study||22
5129551|NCT01430624|12620550|P3|NOT COMPLETED|Overall Study||29
5129552|NCT01430624|12620551|P2|NOT COMPLETED|Overall Study||34
5129553|NCT01430624|12620552|P1|NOT COMPLETED|Overall Study||28
5129554|NCT01430624|12620550|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
5129555|NCT01430624|12620551|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
5129556|NCT01430624|12620552|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
5129557|NCT01430624|12620550|P3|Eligible Baseline Completes|Overall Study||79
5129558|NCT01430624|12620551|P2|Eligible Baseline Completes|Overall Study||77
5129559|NCT01430624|12620552|P1|Eligible Baseline Completes|Overall Study||77
5129560|NCT01430624|12620550|P3|STARTED|Overall Study||81
5129561|NCT01430624|12620551|P2|STARTED|Overall Study||82
5129562|NCT01430624|12620552|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
5129563|NCT01430611|12620583|P2|NOT COMPLETED|Overall Study||15
5129564|NCT01430611|12620584|P1|NOT COMPLETED|Overall Study||17
5129565|NCT01430611|12620583|P2|COMPLETED|Overall Study||318
5129566|NCT01430611|12620584|P1|COMPLETED|Overall Study||315
5129567|NCT01430611|12620583|P2|STARTED|Overall Study||333
5129568|NCT01430611|12620584|P1|STARTED|Overall Study||332
5129569|NCT01430585|12620602|P1|NOT COMPLETED|Overall Study||14
5129570|NCT01430585|12620602|P1|COMPLETED|Overall Study||0
5129571|NCT01430585|12620602|P1|STARTED|Overall Study||14
5129572|NCT01430468|12620637|P2|NOT COMPLETED|Overall Study||6
5129573|NCT01430468|12620638|P1|NOT COMPLETED|Overall Study||7
5129574|NCT01430468|12620637|P2|COMPLETED|Overall Study||16
5129575|NCT01430468|12620638|P1|COMPLETED|Overall Study||15
5129576|NCT01430468|12620637|P2|STARTED|Overall Study||22
5129577|NCT01430468|12620638|P1|STARTED|Overall Study||22
5129578|NCT01430455|12620646|P1|NOT COMPLETED|Overall Study||2
5129579|NCT01430455|12620646|P1|COMPLETED|Overall Study||5
5129580|NCT01430455|12620646|P1|STARTED|Overall Study||7
5129581|NCT01430403|12620653|P3|NOT COMPLETED|Overall Study||8
5129582|NCT01430403|12620654|P2|NOT COMPLETED|Overall Study||9
5129583|NCT01430403|12620655|P1|NOT COMPLETED|Overall Study||17
5129584|NCT01430403|12620653|P3|COMPLETED|Overall Study||81
5129585|NCT01430403|12620654|P2|COMPLETED|Overall Study||121
5129586|NCT01430403|12620655|P1|COMPLETED|Overall Study||242
5129587|NCT01430403|12620653|P3|STARTED|Overall Study|Intent-to-treat|89
5129588|NCT01430403|12620654|P2|STARTED|Overall Study|Intent-to-treat|130
5129589|NCT01430403|12620655|P1|STARTED|Overall Study|Intent-to-treat|259
5129590|NCT01430325|12620708|P4|NOT COMPLETED|Overall Study||0
5129591|NCT01430325|12620709|P3|NOT COMPLETED|Overall Study||0
5129592|NCT01430325|12620710|P2|NOT COMPLETED|Overall Study||0
5129593|NCT01430325|12620711|P1|NOT COMPLETED|Overall Study||0
5129594|NCT01430325|12620708|P4|COMPLETED|Overall Study||12
5129595|NCT01430325|12620709|P3|COMPLETED|Overall Study||8
5129596|NCT01430325|12620710|P2|COMPLETED|Overall Study||12
5129597|NCT01430325|12620711|P1|COMPLETED|Overall Study||10
5129598|NCT01430325|12620708|P4|STARTED|Overall Study||12
5129599|NCT01430325|12620709|P3|STARTED|Overall Study||8
5129600|NCT01430325|12620710|P2|STARTED|Overall Study||12
5129601|NCT01430325|12620711|P1|STARTED|Overall Study||10
5129602|NCT01430299|12620731|P2|NOT COMPLETED|Overall Study||2
5129603|NCT01430299|12620732|P1|NOT COMPLETED|Overall Study||4
5129604|NCT01430299|12620731|P2|COMPLETED|Overall Study||21
5129605|NCT01430299|12620732|P1|COMPLETED|Overall Study||16
5129606|NCT01430299|12620731|P2|STARTED|Overall Study||23
5129607|NCT01430299|12620732|P1|STARTED|Overall Study||20
5129608|NCT01430182|12620740|P2|NOT COMPLETED|Overall Study||0
5129609|NCT01430182|12620741|P1|NOT COMPLETED|Overall Study||0
5129610|NCT01430182|12620740|P2|COMPLETED|Overall Study||8
5129611|NCT01430182|12620741|P1|COMPLETED|Overall Study||9
5129612|NCT01430182|12620740|P2|STARTED|Overall Study||8
5129613|NCT01430182|12620741|P1|STARTED|Overall Study||9
5129614|NCT01430169|12620747|P1|NOT COMPLETED|Overall Study||0
5129615|NCT01430169|12620747|P1|COMPLETED|Overall Study||20
5129616|NCT01430169|12620747|P1|STARTED|Overall Study||20
5129617|NCT01430130|12620762|P1|NOT COMPLETED|Overall Study||2
5129618|NCT01430130|12620762|P1|COMPLETED|Overall Study||10
5129619|NCT01430130|12620762|P1|STARTED|Overall Study||12
5129620|NCT01430104|12620768|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
5129621|NCT01430104|12620768|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
5129622|NCT01430104|12620768|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
5129623|NCT01430104|12620768|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
5129624|NCT01430104|12620768|P1|NOT COMPLETED|14-Day Lead-In Period||0
5129625|NCT01430104|12620768|P1|COMPLETED|14-Day Lead-In Period||30
5129626|NCT01430104|12620768|P1|STARTED|14-Day Lead-In Period||30
5129627|NCT01430091|12620780|P1|NOT COMPLETED|Overall Study||0
5129628|NCT01430091|12620780|P1|COMPLETED|Overall Study||18
5129629|NCT01430091|12620780|P1|STARTED|Overall Study||18
5129630|NCT01429987|12620806|P4|NOT COMPLETED|Overall Study||66
5129631|NCT01429987|12620807|P3|NOT COMPLETED|Overall Study||36
5129632|NCT01429987|12620808|P2|NOT COMPLETED|Overall Study||62
5129633|NCT01429987|12620809|P1|NOT COMPLETED|Overall Study||49
5129634|NCT01429987|12620806|P4|COMPLETED|Overall Study||171
5129635|NCT01429987|12620807|P3|COMPLETED|Overall Study||202
5129636|NCT01429987|12620808|P2|COMPLETED|Overall Study||176
5129637|NCT01429987|12620809|P1|COMPLETED|Overall Study||189
5129638|NCT01429987|12620806|P4|STARTED|Overall Study||237
5129639|NCT01429987|12620807|P3|STARTED|Overall Study||238
5129640|NCT01429987|12620808|P2|STARTED|Overall Study||238
5129641|NCT01429987|12620809|P1|STARTED|Overall Study||238
5129642|NCT01429792|12620835|P1|NOT COMPLETED|Overall Study||406
5129643|NCT01429792|12620835|P1|COMPLETED|Overall Study||607
5129644|NCT01429792|12620835|P1|Genotype 4|Overall Study||5
5129645|NCT01429792|12620835|P1|Genotype 2 & 3|Overall Study||305
5129646|NCT01429792|12620835|P1|Genotype 1|Overall Study||687
5129647|NCT01429792|12620835|P1|STARTED|Overall Study||1013
5129648|NCT01429623|12620849|P2|NOT COMPLETED|Overall Study||59
5129649|NCT01429623|12620850|P1|NOT COMPLETED|Overall Study||51
5129650|NCT01429623|12620849|P2|COMPLETED|Overall Study||48
5129651|NCT01429623|12620850|P1|COMPLETED|Overall Study||51
5129652|NCT01429623|12620849|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
5129653|NCT01429623|12620850|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
5129654|NCT01429623|12620849|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
5129655|NCT01429623|12620850|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
5129656|NCT01429584|12620864|P2|NOT COMPLETED|Overall Study||1
5129657|NCT01429584|12620865|P1|NOT COMPLETED|Overall Study||1
5129658|NCT01429584|12620864|P2|COMPLETED|Overall Study||14
5129659|NCT01429584|12620865|P1|COMPLETED|Overall Study||14
5129660|NCT01429584|12620864|P2|STARTED|Overall Study||15
5129661|NCT01429584|12620865|P1|STARTED|Overall Study||15
5129662|NCT01429532|12620878|P3|NOT COMPLETED|Overall Study||0
5129663|NCT01429532|12620879|P2|NOT COMPLETED|Overall Study||0
5129664|NCT01429532|12620880|P1|NOT COMPLETED|Overall Study||0
5129665|NCT01429532|12620878|P3|COMPLETED|Overall Study||40
5129666|NCT01429532|12620879|P2|COMPLETED|Overall Study||40
5129667|NCT01429532|12620880|P1|COMPLETED|Overall Study||40
5129668|NCT01429532|12620878|P3|STARTED|Overall Study||40
5129669|NCT01429532|12620879|P2|STARTED|Overall Study||40
5129670|NCT01429532|12620880|P1|STARTED|Overall Study||40
5129671|NCT01429454|12620896|P2|NOT COMPLETED|Overall Study||30
5129672|NCT01429454|12620897|P1|NOT COMPLETED|Overall Study||27
5129673|NCT01429454|12620896|P2|COMPLETED|Overall Study||35
5129674|NCT01429454|12620897|P1|COMPLETED|Overall Study||35
5129675|NCT01429454|12620896|P2|STARTED|Overall Study||65
5129676|NCT01429454|12620897|P1|STARTED|Overall Study||62
5129677|NCT01429441|12620907|P2|NOT COMPLETED|Overall Study||23
5129678|NCT01429441|12620908|P1|NOT COMPLETED|Overall Study||38
5129679|NCT01429441|12620907|P2|COMPLETED|Overall Study||51
5129680|NCT01429441|12620908|P1|COMPLETED|Overall Study||108
5129681|NCT01429441|12620907|P2|STARTED|Overall Study||74
5129682|NCT01429441|12620908|P1|STARTED|Overall Study||146
5129683|NCT01429298|12620918|P2|NOT COMPLETED|Overall Study||6
5129684|NCT01429298|12620919|P1|NOT COMPLETED|Overall Study||4
5129685|NCT01429298|12620918|P2|COMPLETED|Overall Study||169
5129686|NCT01429298|12620919|P1|COMPLETED|Overall Study||171
5129687|NCT01429298|12620918|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
5129688|NCT01429298|12620919|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
5129689|NCT01429298|12620918|P2|STARTED|Overall Study||175
5129690|NCT01429298|12620919|P1|STARTED|Overall Study||175
5129691|NCT01429285|12620935|P2|NOT COMPLETED|Overall Study||9
5129692|NCT01429285|12620936|P1|NOT COMPLETED|Overall Study||22
5129693|NCT01429285|12620935|P2|COMPLETED|Overall Study||166
5129694|NCT01429285|12620936|P1|COMPLETED|Overall Study||153
5129695|NCT01429285|12620935|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
5129696|NCT01429285|12620936|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
5129697|NCT01429285|12620935|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
5129698|NCT01429285|12620936|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
5129699|NCT01429285|12620935|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
5129700|NCT01429285|12620936|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
5129701|NCT01429285|12620935|P2|STARTED|Overall Study||175
5129702|NCT01429285|12620936|P1|STARTED|Overall Study||175
5129703|NCT01429272|12620958|P4|NOT COMPLETED|Overall Study||5
5129704|NCT01429272|12620959|P3|NOT COMPLETED|Overall Study||4
5129705|NCT01429272|12620960|P2|NOT COMPLETED|Overall Study||9
5129706|NCT01429272|12620961|P1|NOT COMPLETED|Overall Study||6
5129707|NCT01429272|12620958|P4|COMPLETED|Overall Study||14
5129708|NCT01429272|12620959|P3|COMPLETED|Overall Study||15
5129709|NCT01429272|12620960|P2|COMPLETED|Overall Study||22
5129710|NCT01429272|12620961|P1|COMPLETED|Overall Study||24
5129711|NCT01429272|12620958|P4|STARTED|Overall Study||19
5129712|NCT01429272|12620959|P3|STARTED|Overall Study||19
5129713|NCT01429272|12620960|P2|STARTED|Overall Study||31
5129714|NCT01429272|12620961|P1|STARTED|Overall Study||30
5129715|NCT01429259|12620975|P1|NOT COMPLETED|Overall Study||0
5129716|NCT01429259|12620975|P1|COMPLETED|Overall Study||30
5129717|NCT01429259|12620975|P1|STARTED|Overall Study||30
5129718|NCT01429077|12620982|P2|NOT COMPLETED|Overall Study||3
5129719|NCT01429077|12620983|P1|NOT COMPLETED|Overall Study||0
5129720|NCT01429077|12620982|P2|COMPLETED|Overall Study||14
5129721|NCT01429077|12620983|P1|COMPLETED|Overall Study||19
5129722|NCT01429077|12620982|P2|Completed 6-week Intervention|Overall Study||17
5129723|NCT01429077|12620983|P1|Completed 6-week Intervention|Overall Study||19
5129724|NCT01429077|12620982|P2|STARTED|Overall Study||17
5129725|NCT01429077|12620983|P1|STARTED|Overall Study||19
5129726|NCT01429064|12620993|P4|NOT COMPLETED|Overall Study||0
5129727|NCT01429064|12620994|P3|NOT COMPLETED|Overall Study||0
5129728|NCT01429064|12620995|P2|NOT COMPLETED|Overall Study||0
5129729|NCT01429064|12620996|P1|NOT COMPLETED|Overall Study||0
5129730|NCT01429064|12620993|P4|COMPLETED|Overall Study||16
5129731|NCT01429064|12620994|P3|COMPLETED|Overall Study||19
5129732|NCT01429064|12620995|P2|COMPLETED|Overall Study||22
5129733|NCT01429064|12620996|P1|COMPLETED|Overall Study||19
5129734|NCT01429064|12620993|P4|STARTED|Overall Study||16
5129735|NCT01429064|12620994|P3|STARTED|Overall Study||19
5129736|NCT01429064|12620995|P2|STARTED|Overall Study||22
5129737|NCT01429064|12620996|P1|STARTED|Overall Study||19
5129738|NCT01429051|12621006|P1|NOT COMPLETED|Tolerability Phase||15
5129739|NCT01429051|12621006|P1|COMPLETED|Tolerability Phase||16
5129740|NCT01429051|12621006|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
5129741|NCT01429051|12621006|P1|NOT COMPLETED|Efficacy Phase||2
5129742|NCT01429051|12621006|P1|COMPLETED|Efficacy Phase||13
5129743|NCT01429051|12621006|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
5129744|NCT01429051|12621006|P1|NOT COMPLETED|Titration Phase||12
5129745|NCT01429051|12621006|P1|COMPLETED|Titration Phase||33
5129746|NCT01429051|12621006|P1|STARTED|Titration Phase||45
5129747|NCT01428882|12621029|P2|NOT COMPLETED|Overall Study||10
5129748|NCT01428882|12621030|P1|NOT COMPLETED|Overall Study||6
5129749|NCT01428882|12621029|P2|COMPLETED|Overall Study||58
5129750|NCT01428882|12621030|P1|COMPLETED|Overall Study||61
5129751|NCT01428882|12621029|P2|STARTED|Overall Study||68
5129752|NCT01428882|12621030|P1|STARTED|Overall Study||67
5129753|NCT01428765|12621042|P1|NOT COMPLETED|Overall Study||0
5129754|NCT01428765|12621042|P1|COMPLETED|Overall Study||1063
5129755|NCT01428765|12621042|P1|STARTED|Overall Study||1063
5129756|NCT01428713|12621053|P2|NOT COMPLETED|Overall Study||5
5129757|NCT01428713|12621054|P1|NOT COMPLETED|Overall Study||3
5129758|NCT01428713|12621053|P2|COMPLETED|Overall Study||3
5129759|NCT01428713|12621054|P1|COMPLETED|Overall Study||6
5129760|NCT01428713|12621053|P2|STARTED|Overall Study||8
5129761|NCT01428713|12621054|P1|STARTED|Overall Study||9
5129762|NCT01428661|12621063|P3|NOT COMPLETED|Open Label Extension||320
5129763|NCT01428661|12621064|P2|NOT COMPLETED|Open Label Extension||0
5129764|NCT01428661|12621065|P1|NOT COMPLETED|Open Label Extension||0
5129765|NCT01428661|12621063|P3|COMPLETED|Open Label Extension||19
5129766|NCT01428661|12621064|P2|COMPLETED|Open Label Extension|Does not apply.|0
5129767|NCT01428661|12621065|P1|COMPLETED|Open Label Extension|Does not apply.|0
5129768|NCT01428661|12621063|P3|STARTED|Open Label Extension||339
5129769|NCT01428661|12621064|P2|STARTED|Open Label Extension|Does not apply.|0
5129770|NCT01428661|12621065|P1|STARTED|Open Label Extension|Does not apply.|0
5129771|NCT01428661|12621063|P3|NOT COMPLETED|Double-Masked Phase||0
5129772|NCT01428661|12621064|P2|NOT COMPLETED|Double-Masked Phase||49
5129773|NCT01428661|12621065|P1|NOT COMPLETED|Double-Masked Phase||57
5129774|NCT01428661|12621063|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
5129775|NCT01428661|12621064|P2|COMPLETED|Double-Masked Phase||204
5129776|NCT01428661|12621065|P1|COMPLETED|Double-Masked Phase||197
5129777|NCT01428661|12621063|P3|STARTED|Double-Masked Phase|Does not apply.|0
5129778|NCT01428661|12621064|P2|STARTED|Double-Masked Phase||253
5129779|NCT01428661|12621065|P1|STARTED|Double-Masked Phase||254
5129780|NCT01428583|12621073|P1|NOT COMPLETED|Overall Study||237
5129781|NCT01428583|12621073|P1|COMPLETED|Overall Study||158
5129782|NCT01428583|12621073|P1|STARTED|Overall Study||395
5129783|NCT01428453|12621097|P2|NOT COMPLETED|Overall Study||9
5129784|NCT01428453|12621098|P1|NOT COMPLETED|Overall Study||6
5129785|NCT01428453|12621097|P2|COMPLETED|Overall Study||52
5129786|NCT01428453|12621098|P1|COMPLETED|Overall Study||56
5129787|NCT01428453|12621097|P2|STARTED|Overall Study||61
5129788|NCT01428453|12621098|P1|STARTED|Overall Study||62
5129789|NCT01428336|12621124|P2|NOT COMPLETED|Overall Study||0
5129790|NCT01428336|12621125|P1|NOT COMPLETED|Overall Study||0
5129791|NCT01428336|12621124|P2|COMPLETED|Overall Study||12
5129792|NCT01428336|12621125|P1|COMPLETED|Overall Study||10
5129793|NCT01428336|12621124|P2|STARTED|Overall Study||12
5129794|NCT01428336|12621125|P1|STARTED|Overall Study||10
5129795|NCT01428258|12621137|P2|NOT COMPLETED|Intervention 2||0
5129796|NCT01428258|12621138|P1|NOT COMPLETED|Intervention 2||0
5129797|NCT01428258|12621137|P2|COMPLETED|Intervention 2||15
5129798|NCT01428258|12621138|P1|COMPLETED|Intervention 2||15
5129799|NCT01428258|12621137|P2|STARTED|Intervention 2||15
5129800|NCT01428258|12621138|P1|STARTED|Intervention 2||15
5129801|NCT01428258|12621137|P2|NOT COMPLETED|Intervention 1||0
5129802|NCT01428258|12621138|P1|NOT COMPLETED|Intervention 1||2
5129803|NCT01428258|12621137|P2|COMPLETED|Intervention 1||15
5129804|NCT01428258|12621138|P1|COMPLETED|Intervention 1||15
5129805|NCT01428258|12621137|P2|STARTED|Intervention 1||15
5129806|NCT01428258|12621138|P1|STARTED|Intervention 1||17
5129807|NCT01428219|12621156|P1|NOT COMPLETED|Overall Study||3
5129808|NCT01428219|12621156|P1|COMPLETED|Overall Study||22
5129809|NCT01428219|12621156|P1|STARTED|Overall Study||25
5129810|NCT01428193|12621167|P1|NOT COMPLETED|Overall Study||2
5129811|NCT01428193|12621167|P1|COMPLETED|Overall Study||2
5129812|NCT01428193|12621167|P1|STARTED|Overall Study||4
5129813|NCT01428128|12621171|P1|NOT COMPLETED|Overall Study||17
5129814|NCT01428128|12621171|P1|COMPLETED|Overall Study||33
5129815|NCT01428128|12621171|P1|STARTED|Overall Study||50
5129816|NCT01428115|12621176|P1|NOT COMPLETED|Overall Study||21
5129817|NCT01428115|12621176|P1|COMPLETED|Overall Study||62
5129818|NCT01428115|12621176|P1|STARTED|Overall Study||83
5129819|NCT01428076|12621191|P2|NOT COMPLETED|Overall Study||1
5129820|NCT01428076|12621192|P1|NOT COMPLETED|Overall Study||0
5129821|NCT01428076|12621191|P2|COMPLETED|Overall Study||11
5129822|NCT01428076|12621192|P1|COMPLETED|Overall Study||9
5129823|NCT01428076|12621191|P2|STARTED|Overall Study||12
5129824|NCT01428076|12621192|P1|STARTED|Overall Study||9
5129825|NCT01428063|12621203|P3|NOT COMPLETED|Overall Study||1
5129826|NCT01428063|12621204|P2|NOT COMPLETED|Overall Study||10
5129827|NCT01428063|12621205|P1|NOT COMPLETED|Overall Study||10
5129828|NCT01428063|12621203|P3|COMPLETED|Overall Study||5
5129829|NCT01428063|12621204|P2|COMPLETED|Overall Study||112
5129830|NCT01428063|12621205|P1|COMPLETED|Overall Study||89
5129831|NCT01428063|12621203|P3|STARTED|Overall Study||6
5129832|NCT01428063|12621204|P2|STARTED|Overall Study||122
5129833|NCT01428063|12621205|P1|STARTED|Overall Study||99
5129834|NCT01428024|12621276|P2|NOT COMPLETED|Overall Study||1
5129835|NCT01428024|12621277|P1|NOT COMPLETED|Overall Study||1
5129836|NCT01428024|12621276|P2|COMPLETED|Overall Study||29
5129837|NCT01428024|12621277|P1|COMPLETED|Overall Study||29
5129838|NCT01428024|12621276|P2|STARTED|Overall Study||30
5129839|NCT01428024|12621277|P1|STARTED|Overall Study||30
5129840|NCT01427972|12621306|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129841|NCT01427972|12621307|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129842|NCT01427972|12621308|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129843|NCT01427972|12621309|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129844|NCT01427972|12621310|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129845|NCT01427972|12621311|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129846|NCT01427972|12621312|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129847|NCT01427972|12621313|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129848|NCT01427972|12621314|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129849|NCT01427972|12621315|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129850|NCT01427972|12621316|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
5129851|NCT01427972|12621317|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
5129852|NCT01427972|12621306|P12|COMPLETED|Treatment Period 2 (21 Days)||4
5129853|NCT01427972|12621307|P11|COMPLETED|Treatment Period 2 (21 Days)||3
5129854|NCT01427972|12621308|P10|COMPLETED|Treatment Period 2 (21 Days)||3
5129855|NCT01427972|12621309|P9|COMPLETED|Treatment Period 2 (21 Days)||3
5129856|NCT01427972|12621310|P8|COMPLETED|Treatment Period 2 (21 Days)||4
5129857|NCT01427972|12621311|P7|COMPLETED|Treatment Period 2 (21 Days)||3
5129858|NCT01427972|12621312|P6|COMPLETED|Treatment Period 2 (21 Days)||1
5129859|NCT01427972|12621313|P5|COMPLETED|Treatment Period 2 (21 Days)||4
5129860|NCT01427972|12621314|P4|COMPLETED|Treatment Period 2 (21 Days)||3
5129861|NCT01427972|12621315|P3|COMPLETED|Treatment Period 2 (21 Days)||4
5129862|NCT01427972|12621316|P2|COMPLETED|Treatment Period 2 (21 Days)||3
5129863|NCT01427972|12621317|P1|COMPLETED|Treatment Period 2 (21 Days)||3
5129864|NCT01427972|12621306|P12|STARTED|Treatment Period 2 (21 Days)||4
5129865|NCT01427972|12621307|P11|STARTED|Treatment Period 2 (21 Days)||3
5129866|NCT01427972|12621308|P10|STARTED|Treatment Period 2 (21 Days)||3
5129867|NCT01427972|12621309|P9|STARTED|Treatment Period 2 (21 Days)||3
5129868|NCT01427972|12621310|P8|STARTED|Treatment Period 2 (21 Days)||4
5129869|NCT01427972|12621311|P7|STARTED|Treatment Period 2 (21 Days)||3
5129870|NCT01427972|12621312|P6|STARTED|Treatment Period 2 (21 Days)||1
5129871|NCT01427972|12621313|P5|STARTED|Treatment Period 2 (21 Days)||4
5129872|NCT01427972|12621314|P4|STARTED|Treatment Period 2 (21 Days)||3
5129873|NCT01427972|12621315|P3|STARTED|Treatment Period 2 (21 Days)||4
5129874|NCT01427972|12621316|P2|STARTED|Treatment Period 2 (21 Days)||4
5129875|NCT01427972|12621317|P1|STARTED|Treatment Period 2 (21 Days)||3
5129876|NCT01427972|12621306|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
5129877|NCT01427972|12621307|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
5129878|NCT01427972|12621308|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
5129879|NCT01427972|12621309|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
5129880|NCT01427972|12621310|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
5129881|NCT01427972|12621311|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
5129882|NCT01427972|12621312|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
5129883|NCT01427972|12621313|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
5129884|NCT01427972|12621314|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
5129885|NCT01427972|12621315|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
5129886|NCT01427972|12621316|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
5129887|NCT01427972|12621317|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
5129888|NCT01427972|12621306|P12|COMPLETED|Washout (at Least 28 Days)||4
5129889|NCT01427972|12621307|P11|COMPLETED|Washout (at Least 28 Days)||3
5129890|NCT01427972|12621308|P10|COMPLETED|Washout (at Least 28 Days)||3
5129891|NCT01427972|12621309|P9|COMPLETED|Washout (at Least 28 Days)||3
5129892|NCT01427972|12621310|P8|COMPLETED|Washout (at Least 28 Days)||4
5129893|NCT01427972|12621311|P7|COMPLETED|Washout (at Least 28 Days)||3
5129894|NCT01427972|12621312|P6|COMPLETED|Washout (at Least 28 Days)||1
5129895|NCT01427972|12621313|P5|COMPLETED|Washout (at Least 28 Days)||4
5129896|NCT01427972|12621314|P4|COMPLETED|Washout (at Least 28 Days)||3
5129897|NCT01427972|12621315|P3|COMPLETED|Washout (at Least 28 Days)||4
5129898|NCT01427972|12621316|P2|COMPLETED|Washout (at Least 28 Days)||4
5129899|NCT01427972|12621317|P1|COMPLETED|Washout (at Least 28 Days)||3
5129900|NCT01427972|12621306|P12|STARTED|Washout (at Least 28 Days)||4
5129901|NCT01427972|12621307|P11|STARTED|Washout (at Least 28 Days)||3
5129902|NCT01427972|12621308|P10|STARTED|Washout (at Least 28 Days)||3
5129903|NCT01427972|12621309|P9|STARTED|Washout (at Least 28 Days)||3
5129904|NCT01427972|12621310|P8|STARTED|Washout (at Least 28 Days)||4
5129905|NCT01427972|12621311|P7|STARTED|Washout (at Least 28 Days)||3
5129906|NCT01427972|12621312|P6|STARTED|Washout (at Least 28 Days)||3
5129907|NCT01427972|12621313|P5|STARTED|Washout (at Least 28 Days)||4
5129908|NCT01427972|12621314|P4|STARTED|Washout (at Least 28 Days)||3
5129909|NCT01427972|12621315|P3|STARTED|Washout (at Least 28 Days)||4
5129910|NCT01427972|12621316|P2|STARTED|Washout (at Least 28 Days)||4
5129911|NCT01427972|12621317|P1|STARTED|Washout (at Least 28 Days)||3
5129912|NCT01427972|12621306|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129913|NCT01427972|12621307|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129914|NCT01427972|12621308|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129915|NCT01427972|12621309|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129916|NCT01427972|12621310|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
5129917|NCT01427972|12621311|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129918|NCT01427972|12621312|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129919|NCT01427972|12621313|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129920|NCT01427972|12621314|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129921|NCT01427972|12621315|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129922|NCT01427972|12621316|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129923|NCT01427972|12621317|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
5129924|NCT01427972|12621306|P12|COMPLETED|Treatment Period 1 (21 Days)||4
5129925|NCT01427972|12621307|P11|COMPLETED|Treatment Period 1 (21 Days)||3
5129926|NCT01427972|12621308|P10|COMPLETED|Treatment Period 1 (21 Days)||3
5129927|NCT01427972|12621309|P9|COMPLETED|Treatment Period 1 (21 Days)||3
5129928|NCT01427972|12621310|P8|COMPLETED|Treatment Period 1 (21 Days)||4
5129929|NCT01427972|12621311|P7|COMPLETED|Treatment Period 1 (21 Days)||3
5129930|NCT01427972|12621312|P6|COMPLETED|Treatment Period 1 (21 Days)||3
5129931|NCT01427972|12621313|P5|COMPLETED|Treatment Period 1 (21 Days)||4
5129932|NCT01427972|12621314|P4|COMPLETED|Treatment Period 1 (21 Days)||3
5129933|NCT01427972|12621315|P3|COMPLETED|Treatment Period 1 (21 Days)||4
5129934|NCT01427972|12621316|P2|COMPLETED|Treatment Period 1 (21 Days)||4
5129935|NCT01427972|12621317|P1|COMPLETED|Treatment Period 1 (21 Days)||3
5129936|NCT01427972|12621306|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
5129937|NCT01427972|12621307|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129938|NCT01427972|12621308|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129939|NCT01427972|12621309|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129940|NCT01427972|12621310|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
5129941|NCT01427972|12621311|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129942|NCT01427972|12621312|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129943|NCT01427972|12621313|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
5129944|NCT01427972|12621314|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129945|NCT01427972|12621315|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
5129946|NCT01427972|12621316|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
5129947|NCT01427972|12621317|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
5129948|NCT01427972|12621306|P12|STARTED|Treatment Period 1 (21 Days)||4
5129949|NCT01427972|12621307|P11|STARTED|Treatment Period 1 (21 Days)||3
5129950|NCT01427972|12621308|P10|STARTED|Treatment Period 1 (21 Days)||3
5129951|NCT01427972|12621309|P9|STARTED|Treatment Period 1 (21 Days)||3
5129952|NCT01427972|12621310|P8|STARTED|Treatment Period 1 (21 Days)||5
5129953|NCT01427972|12621311|P7|STARTED|Treatment Period 1 (21 Days)||3
5129954|NCT01427972|12621312|P6|STARTED|Treatment Period 1 (21 Days)||3
5129955|NCT01427972|12621313|P5|STARTED|Treatment Period 1 (21 Days)||4
5129956|NCT01427972|12621314|P4|STARTED|Treatment Period 1 (21 Days)||3
5129957|NCT01427972|12621315|P3|STARTED|Treatment Period 1 (21 Days)||4
5129958|NCT01427972|12621316|P2|STARTED|Treatment Period 1 (21 Days)||4
5129959|NCT01427972|12621317|P1|STARTED|Treatment Period 1 (21 Days)||3
5129960|NCT01427933|12621343|P2|NOT COMPLETED|Overall Study||13
5129961|NCT01427933|12621344|P1|NOT COMPLETED|Overall Study||8
5129962|NCT01427933|12621343|P2|COMPLETED|Overall Study||57
5129963|NCT01427933|12621344|P1|COMPLETED|Overall Study||63
5129964|NCT01427933|12621343|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
5129965|NCT01427933|12621344|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
5129966|NCT01427933|12621343|P2|STARTED|Overall Study||70
5129967|NCT01427933|12621344|P1|STARTED|Overall Study||71
5129968|NCT01427920|12621364|P2|NOT COMPLETED|Overall Study||17
5129969|NCT01427920|12621365|P1|NOT COMPLETED|Overall Study||9
5129970|NCT01427920|12621364|P2|COMPLETED|Overall Study||157
5129971|NCT01427920|12621365|P1|COMPLETED|Overall Study||165
5129972|NCT01427920|12621364|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
5129973|NCT01427920|12621365|P1|Exposed|Overall Study||174
5129974|NCT01427920|12621364|P2|STARTED|Overall Study||174
5129975|NCT01427920|12621365|P1|STARTED|Overall Study||174
5129976|NCT01427907|12621385|P2|NOT COMPLETED|Overall Study||4
5129977|NCT01427907|12621386|P1|NOT COMPLETED|Overall Study||3
5129978|NCT01427907|12621385|P2|COMPLETED|Overall Study|Completed study|14
5129979|NCT01427907|12621386|P1|COMPLETED|Overall Study|Completed study|17
5129980|NCT01427907|12621385|P2|STARTED|Overall Study|Randomized|18
5129981|NCT01427907|12621386|P1|STARTED|Overall Study|Randomized|20
5129982|NCT01427881|12621392|P1|NOT COMPLETED|Overall Study||0
5129983|NCT01427881|12621392|P1|COMPLETED|Overall Study||43
5129984|NCT01427881|12621392|P1|STARTED|Overall Study||43
5129985|NCT01427803|12621407|P2|NOT COMPLETED|Overall Study||26
5129986|NCT01427803|12621408|P1|NOT COMPLETED|Overall Study||63
5129987|NCT01427803|12621407|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
5129988|NCT01427803|12621408|P1|COMPLETED|Overall Study||463
5129989|NCT01427803|12621407|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
5129990|NCT01427803|12621408|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
5129991|NCT01427803|12621407|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
5129992|NCT01427803|12621408|P1|Baseline Assessment|Overall Study||516
5129993|NCT01427803|12621407|P2|Purchased Product|Overall Study||252
5129994|NCT01427803|12621408|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
5129995|NCT01427803|12621407|P2|STARTED|Overall Study||252
5129996|NCT01427803|12621408|P1|STARTED|Overall Study||526
5129997|NCT01427751|12621422|P2|NOT COMPLETED|Overall Study||14
5129998|NCT01427751|12621423|P1|NOT COMPLETED|Overall Study||42
5129999|NCT01427751|12621422|P2|COMPLETED|Overall Study||139
5130000|NCT01427751|12621423|P1|COMPLETED|Overall Study||112
5130001|NCT01427751|12621422|P2|STARTED|Overall Study||153
5130002|NCT01427751|12621423|P1|STARTED|Overall Study||154
5130003|NCT01427738|12621443|P2|NOT COMPLETED|Overall Study||21
5130004|NCT01427738|12621444|P1|NOT COMPLETED|Overall Study||19
5130005|NCT01427738|12621443|P2|COMPLETED|Overall Study||90
5130006|NCT01427738|12621444|P1|COMPLETED|Overall Study||91
5130007|NCT01427738|12621443|P2|STARTED|Overall Study||111
5130008|NCT01427738|12621444|P1|STARTED|Overall Study||110
5130009|NCT01427608|12621464|P2|NOT COMPLETED|Overall Study||38
5130010|NCT01427608|12621465|P1|NOT COMPLETED|Overall Study||21
5130011|NCT01427608|12621464|P2|COMPLETED|Overall Study||24
5130012|NCT01427608|12621465|P1|COMPLETED|Overall Study||43
5130013|NCT01427608|12621464|P2|STARTED|Overall Study||62
5130014|NCT01427608|12621465|P1|STARTED|Overall Study||64
5130015|NCT01427517|12621480|P3|NOT COMPLETED|Overall Study||0
5130016|NCT01427517|12621481|P2|NOT COMPLETED|Overall Study||0
5130017|NCT01427517|12621482|P1|NOT COMPLETED|Overall Study||0
5130018|NCT01427517|12621480|P3|COMPLETED|Overall Study||3
5130019|NCT01427517|12621481|P2|COMPLETED|Overall Study||3
5130020|NCT01427517|12621482|P1|COMPLETED|Overall Study||3
5130021|NCT01427517|12621480|P3|STARTED|Overall Study||3
5130022|NCT01427517|12621481|P2|STARTED|Overall Study||3
5130023|NCT01427517|12621482|P1|STARTED|Overall Study||3
5130024|NCT01427504|12621496|P6|NOT COMPLETED|Overall Study||2
5130025|NCT01427504|12621497|P5|NOT COMPLETED|Overall Study||1
5130026|NCT01427504|12621498|P4|NOT COMPLETED|Overall Study||1
5130027|NCT01427504|12621499|P3|NOT COMPLETED|Overall Study||1
5130028|NCT01427504|12621500|P2|NOT COMPLETED|Overall Study||1
5130029|NCT01427504|12621501|P1|NOT COMPLETED|Overall Study||0
5130030|NCT01427504|12621496|P6|COMPLETED|Overall Study||4
5130031|NCT01427504|12621497|P5|COMPLETED|Overall Study||2
5130032|NCT01427504|12621498|P4|COMPLETED|Overall Study||5
5130033|NCT01427504|12621499|P3|COMPLETED|Overall Study||3
5130034|NCT01427504|12621500|P2|COMPLETED|Overall Study||2
5130035|NCT01427504|12621501|P1|COMPLETED|Overall Study||4
5130036|NCT01427504|12621496|P6|Received Combination|Overall Study||6
5130037|NCT01427504|12621497|P5|Received Combination|Overall Study||3
5130038|NCT01427504|12621498|P4|Received Combination|Overall Study||6
5130039|NCT01427504|12621499|P3|Received Combination|Overall Study||3
5130040|NCT01427504|12621500|P2|Received Combination|Overall Study||3
5130041|NCT01427504|12621501|P1|Received Combination|Overall Study||4
5130042|NCT01427504|12621496|P6|Received Etravirine|Overall Study||4
5130043|NCT01427504|12621497|P5|Received Etravirine|Overall Study||2
5130044|NCT01427504|12621498|P4|Received Etravirine|Overall Study||6
5130045|NCT01427504|12621499|P3|Received Etravirine|Overall Study||4
5130046|NCT01427504|12621500|P2|Received Etravirine|Overall Study||2
5130047|NCT01427504|12621501|P1|Received Etravirine|Overall Study||4
5130048|NCT01427504|12621496|P6|Received Boceprevir|Overall Study||4
5130049|NCT01427504|12621497|P5|Received Boceprevir|Overall Study||2
5130050|NCT01427504|12621498|P4|Received Boceprevir|Overall Study||5
5130051|NCT01427504|12621499|P3|Received Boceprevir|Overall Study||3
5130052|NCT01427504|12621500|P2|Received Boceprevir|Overall Study||3
5130053|NCT01427504|12621501|P1|Received Boceprevir|Overall Study||4
5130054|NCT01427504|12621496|P6|STARTED|Overall Study||6
5130055|NCT01427504|12621497|P5|STARTED|Overall Study||3
5130056|NCT01427504|12621498|P4|STARTED|Overall Study||6
5130057|NCT01427504|12621499|P3|STARTED|Overall Study||4
5130058|NCT01427504|12621500|P2|STARTED|Overall Study||3
5130059|NCT01427504|12621501|P1|STARTED|Overall Study||4
5130060|NCT01427309|12621522|P4|NOT COMPLETED|Overall Study||376
5130061|NCT01427309|12621523|P3|NOT COMPLETED|Overall Study||361
5130062|NCT01427309|12621524|P2|NOT COMPLETED|Overall Study||407
5130063|NCT01427309|12621525|P1|NOT COMPLETED|Overall Study||372
5130064|NCT01427309|12621522|P4|COMPLETED|Overall Study||8373
5130065|NCT01427309|12621523|P3|COMPLETED|Overall Study||8376
5130066|NCT01427309|12621524|P2|COMPLETED|Overall Study||6837
5130067|NCT01427309|12621525|P1|COMPLETED|Overall Study||6881
5130068|NCT01427309|12621522|P4|STARTED|Overall Study||8749
5130069|NCT01427309|12621523|P3|STARTED|Overall Study||8737
5130070|NCT01427309|12621524|P2|STARTED|Overall Study||7244
5130071|NCT01427309|12621525|P1|STARTED|Overall Study||7253
5130072|NCT01427296|12621565|P2|NOT COMPLETED|Overall Study||0
5130073|NCT01427296|12621566|P1|NOT COMPLETED|Overall Study||0
5130074|NCT01427296|12621565|P2|COMPLETED|Overall Study||1051
5130075|NCT01427296|12621566|P1|COMPLETED|Overall Study||1041
5130076|NCT01427296|12621565|P2|STARTED|Overall Study||1051
5130077|NCT01427296|12621566|P1|STARTED|Overall Study||1041
5130078|NCT01426958|12621572|P1|NOT COMPLETED|Overall Study||2
5130079|NCT01426958|12621572|P1|COMPLETED|Overall Study||22
5130080|NCT01426958|12621572|P1|STARTED|Overall Study||24
5130081|NCT01426867|12621589|P3|NOT COMPLETED|Overall Study||0
5130082|NCT01426867|12621590|P2|NOT COMPLETED|Overall Study||0
5130083|NCT01426867|12621591|P1|NOT COMPLETED|Overall Study||0
5130084|NCT01426867|12621589|P3|COMPLETED|Overall Study||34
5130085|NCT01426867|12621590|P2|COMPLETED|Overall Study||34
5130086|NCT01426867|12621591|P1|COMPLETED|Overall Study||33
5130087|NCT01426867|12621589|P3|STARTED|Overall Study||34
5130088|NCT01426867|12621590|P2|STARTED|Overall Study||34
5130089|NCT01426867|12621591|P1|STARTED|Overall Study||33
5130090|NCT01426854|12621601|P2|NOT COMPLETED|Overall Study||31
5130091|NCT01426854|12621602|P1|NOT COMPLETED|Overall Study||12
5130092|NCT01426854|12621601|P2|COMPLETED|Overall Study||98
5130093|NCT01426854|12621602|P1|COMPLETED|Overall Study||119
5130094|NCT01426854|12621601|P2|STARTED|Overall Study||129
5130095|NCT01426854|12621602|P1|STARTED|Overall Study||131
5130096|NCT01426789|12621612|P6|NOT COMPLETED|Part 2||0
5130097|NCT01426789|12621613|P5|NOT COMPLETED|Part 2||8
5130098|NCT01426789|12621614|P4|NOT COMPLETED|Part 2||1
5130099|NCT01426789|12621615|P3|NOT COMPLETED|Part 2||15
5130100|NCT01426789|12621616|P2|NOT COMPLETED|Part 2||0
5130101|NCT01426789|12621617|P1|NOT COMPLETED|Part 2||0
5130102|NCT01426789|12621612|P6|COMPLETED|Part 2||1
5130103|NCT01426789|12621613|P5|COMPLETED|Part 2||19
5130104|NCT01426789|12621614|P4|COMPLETED|Part 2||12
5130105|NCT01426789|12621615|P3|COMPLETED|Part 2||34
5130106|NCT01426789|12621616|P2|COMPLETED|Part 2||0
5130107|NCT01426789|12621617|P1|COMPLETED|Part 2||0
5130108|NCT01426789|12621612|P6|STARTED|Part 2||1
5130109|NCT01426789|12621613|P5|STARTED|Part 2||27
5130110|NCT01426789|12621614|P4|STARTED|Part 2||13
5130111|NCT01426789|12621615|P3|STARTED|Part 2||49
5130112|NCT01426789|12621616|P2|STARTED|Part 2||0
5130113|NCT01426789|12621617|P1|STARTED|Part 2||0
5130114|NCT01426789|12621612|P6|NOT COMPLETED|Part 1||0
5130115|NCT01426789|12621613|P5|NOT COMPLETED|Part 1||0
5130116|NCT01426789|12621614|P4|NOT COMPLETED|Part 1||0
5130117|NCT01426789|12621615|P3|NOT COMPLETED|Part 1||0
5130118|NCT01426789|12621616|P2|NOT COMPLETED|Part 1||4
5130119|NCT01426789|12621617|P1|NOT COMPLETED|Part 1||6
5130120|NCT01426789|12621612|P6|COMPLETED|Part 1||0
5130121|NCT01426789|12621613|P5|COMPLETED|Part 1||0
5130122|NCT01426789|12621614|P4|COMPLETED|Part 1||0
5130123|NCT01426789|12621615|P3|COMPLETED|Part 1||0
5130124|NCT01426789|12621616|P2|COMPLETED|Part 1||28
5130125|NCT01426789|12621617|P1|COMPLETED|Part 1||62
5130126|NCT01426789|12621612|P6|STARTED|Part 1||0
5130127|NCT01426789|12621613|P5|STARTED|Part 1||0
5130128|NCT01426789|12621614|P4|STARTED|Part 1||0
5130129|NCT01426789|12621615|P3|STARTED|Part 1||0
5130130|NCT01426789|12621616|P2|STARTED|Part 1||32
5130131|NCT01426789|12621617|P1|STARTED|Part 1||68
5130132|NCT01426763|12621633|P2|NOT COMPLETED|Overall Study||0
5130133|NCT01426763|12621634|P1|NOT COMPLETED|Overall Study||0
5130134|NCT01426763|12621633|P2|COMPLETED|Overall Study||6
5130135|NCT01426763|12621634|P1|COMPLETED|Overall Study||6
5130136|NCT01426763|12621633|P2|STARTED|Overall Study||6
5130137|NCT01426763|12621634|P1|STARTED|Overall Study||6
5130138|NCT01426581|12621642|P2|NOT COMPLETED|Overall Study||0
5130139|NCT01426581|12621643|P1|NOT COMPLETED|Overall Study||0
5130140|NCT01426581|12621642|P2|COMPLETED|Overall Study||58
5130141|NCT01426581|12621643|P1|COMPLETED|Overall Study||62
5130142|NCT01426581|12621642|P2|STARTED|Overall Study||58
5130143|NCT01426581|12621643|P1|STARTED|Overall Study||62
5130144|NCT01426555|12621659|P2|NOT COMPLETED|Overall Study||15
5130145|NCT01426555|12621660|P1|NOT COMPLETED|Overall Study||18
5130146|NCT01426555|12621659|P2|COMPLETED|Overall Study||20
5130147|NCT01426555|12621660|P1|COMPLETED|Overall Study||17
5130148|NCT01426555|12621659|P2|STARTED|Overall Study||35
5130149|NCT01426555|12621660|P1|STARTED|Overall Study||35
5130150|NCT01426516|12621670|P2|NOT COMPLETED|Overall Study||0
5130151|NCT01426516|12621671|P1|NOT COMPLETED|Overall Study||0
5130152|NCT01426516|12621670|P2|COMPLETED|Overall Study||17
5130153|NCT01426516|12621671|P1|COMPLETED|Overall Study||12
5130154|NCT01426516|12621670|P2|STARTED|Overall Study||17
5130155|NCT01426516|12621671|P1|STARTED|Overall Study||12
5130156|NCT01426438|12621679|P2|NOT COMPLETED|Overall Study||10
5130157|NCT01426438|12621680|P1|NOT COMPLETED|Overall Study||15
5130158|NCT01426438|12621679|P2|COMPLETED|Overall Study||39
5130159|NCT01426438|12621680|P1|COMPLETED|Overall Study||35
5130160|NCT01426438|12621679|P2|STARTED|Overall Study||49
5130161|NCT01426438|12621680|P1|STARTED|Overall Study||50
5130162|NCT01426425|12621712|P1|NOT COMPLETED|Overall Study||175
5130163|NCT01426425|12621712|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
5130164|NCT01426425|12621712|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
5130165|NCT01426425|12621712|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
5130166|NCT01426425|12621712|P1|STARTED|Overall Study||572
5130167|NCT01426412|12621727|P9|NOT COMPLETED|Overall Study||1
5130168|NCT01426412|12621728|P8|NOT COMPLETED|Overall Study||3
5130169|NCT01426412|12621729|P7|NOT COMPLETED|Overall Study||0
5130170|NCT01426412|12621730|P6|NOT COMPLETED|Overall Study||0
5130171|NCT01426412|12621731|P5|NOT COMPLETED|Overall Study||1
5130172|NCT01426412|12621732|P4|NOT COMPLETED|Overall Study||0
5130173|NCT01426412|12621733|P3|NOT COMPLETED|Overall Study||0
5130174|NCT01426412|12621734|P2|NOT COMPLETED|Overall Study||0
5130175|NCT01426412|12621735|P1|NOT COMPLETED|Overall Study||1
5130176|NCT01426412|12621727|P9|COMPLETED|Overall Study||16
5130177|NCT01426412|12621728|P8|COMPLETED|Overall Study||7
5130178|NCT01426412|12621729|P7|COMPLETED|Overall Study||6
5130179|NCT01426412|12621730|P6|COMPLETED|Overall Study||6
5130180|NCT01426412|12621731|P5|COMPLETED|Overall Study||5
5130181|NCT01426412|12621732|P4|COMPLETED|Overall Study||6
5130182|NCT01426412|12621733|P3|COMPLETED|Overall Study||6
5130183|NCT01426412|12621734|P2|COMPLETED|Overall Study||6
5130184|NCT01426412|12621735|P1|COMPLETED|Overall Study||5
5130185|NCT01426412|12621727|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
5130186|NCT01426412|12621728|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
5130187|NCT01426412|12621729|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5130188|NCT01426412|12621730|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
5130189|NCT01426412|12621731|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5130190|NCT01426412|12621732|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5130191|NCT01426412|12621733|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5130192|NCT01426412|12621734|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5130193|NCT01426412|12621735|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5130194|NCT01426412|12621727|P9|STARTED|Overall Study||17
5130195|NCT01426412|12621728|P8|STARTED|Overall Study||10
5130196|NCT01426412|12621729|P7|STARTED|Overall Study||6
5130197|NCT01426412|12621730|P6|STARTED|Overall Study||6
5130198|NCT01426412|12621731|P5|STARTED|Overall Study||6
5130199|NCT01426412|12621732|P4|STARTED|Overall Study||6
5130200|NCT01426412|12621733|P3|STARTED|Overall Study||6
5130201|NCT01426412|12621734|P2|STARTED|Overall Study||6
5130202|NCT01426412|12621735|P1|STARTED|Overall Study||6
5130203|NCT01426386|12621798|P6|NOT COMPLETED|Overall Study||1
5130204|NCT01426386|12621799|P5|NOT COMPLETED|Overall Study||4
5130205|NCT01426386|12621800|P4|NOT COMPLETED|Overall Study||0
5130206|NCT01426386|12621801|P3|NOT COMPLETED|Overall Study||2
5130207|NCT01426386|12621802|P2|NOT COMPLETED|Overall Study||6
5130208|NCT01426386|12621803|P1|NOT COMPLETED|Overall Study||3
5130209|NCT01426386|12621798|P6|COMPLETED|Overall Study||42
5130210|NCT01426386|12621799|P5|COMPLETED|Overall Study||43
5130211|NCT01426386|12621800|P4|COMPLETED|Overall Study||44
5130212|NCT01426386|12621801|P3|COMPLETED|Overall Study||42
5130213|NCT01426386|12621802|P2|COMPLETED|Overall Study||39
5130214|NCT01426386|12621803|P1|COMPLETED|Overall Study||39
5130215|NCT01426386|12621798|P6|STARTED|Overall Study||43
5130216|NCT01426386|12621799|P5|STARTED|Overall Study||47
5130217|NCT01426386|12621800|P4|STARTED|Overall Study||44
5130218|NCT01426386|12621801|P3|STARTED|Overall Study||44
5130219|NCT01426386|12621802|P2|STARTED|Overall Study||45
5130220|NCT01426386|12621803|P1|STARTED|Overall Study||42
5130221|NCT01426373|12621859|P1|NOT COMPLETED|Overall Study||34
5130222|NCT01426373|12621859|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
5130223|NCT01426373|12621859|P1|STARTED|Overall Study||165
5130224|NCT01426360|12621877|P2|NOT COMPLETED|Overall Study||0
5130225|NCT01426360|12621878|P1|NOT COMPLETED|Overall Study||0
5130226|NCT01426360|12621877|P2|COMPLETED|Overall Study||41
5130227|NCT01426360|12621878|P1|COMPLETED|Overall Study||38
5130228|NCT01426360|12621877|P2|STARTED|Overall Study||41
5130229|NCT01426360|12621878|P1|STARTED|Overall Study||38
5130230|NCT01426347|12621892|P2|NOT COMPLETED|Overall Study||3
5130231|NCT01426347|12621893|P1|NOT COMPLETED|Overall Study||7
5130232|NCT01426347|12621892|P2|COMPLETED|Overall Study||39
5130233|NCT01426347|12621893|P1|COMPLETED|Overall Study||34
5130234|NCT01426347|12621892|P2|STARTED|Overall Study||42
5130235|NCT01426347|12621893|P1|STARTED|Overall Study||41
5130236|NCT01426269|12621901|P3|NOT COMPLETED|Period 2: 40 Weeks||47
5130237|NCT01426269|12621902|P2|NOT COMPLETED|Period 2: 40 Weeks||38
5130238|NCT01426269|12621903|P1|NOT COMPLETED|Period 2: 40 Weeks||0
5130239|NCT01426269|12621901|P3|COMPLETED|Period 2: 40 Weeks||18
5130240|NCT01426269|12621902|P2|COMPLETED|Period 2: 40 Weeks||27
5130241|NCT01426269|12621903|P1|COMPLETED|Period 2: 40 Weeks||0
5130242|NCT01426269|12621901|P3|STARTED|Period 2: 40 Weeks||65
5130243|NCT01426269|12621902|P2|STARTED|Period 2: 40 Weeks||65
5130244|NCT01426269|12621903|P1|STARTED|Period 2: 40 Weeks||0
5130245|NCT01426269|12621901|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
5130246|NCT01426269|12621902|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
5130247|NCT01426269|12621903|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
5130248|NCT01426269|12621901|P3|COMPLETED|Eligibility for Period 2, Randomization||0
5130249|NCT01426269|12621902|P2|COMPLETED|Eligibility for Period 2, Randomization||0
5130250|NCT01426269|12621903|P1|COMPLETED|Eligibility for Period 2, Randomization||130
5130251|NCT01426269|12621901|P3|STARTED|Eligibility for Period 2, Randomization||0
5130252|NCT01426269|12621902|P2|STARTED|Eligibility for Period 2, Randomization||0
5130253|NCT01426269|12621903|P1|STARTED|Eligibility for Period 2, Randomization||180
5130254|NCT01426269|12621901|P3|NOT COMPLETED|Period 1: 12 Weeks||0
5130255|NCT01426269|12621902|P2|NOT COMPLETED|Period 1: 12 Weeks||0
5130256|NCT01426269|12621903|P1|NOT COMPLETED|Period 1: 12 Weeks||55
5130257|NCT01426269|12621901|P3|COMPLETED|Period 1: 12 Weeks||0
5130258|NCT01426269|12621902|P2|COMPLETED|Period 1: 12 Weeks||0
5130259|NCT01426269|12621903|P1|COMPLETED|Period 1: 12 Weeks||180
5130260|NCT01426269|12621901|P3|STARTED|Period 1: 12 Weeks||0
5130261|NCT01426269|12621902|P2|STARTED|Period 1: 12 Weeks||0
5130262|NCT01426269|12621903|P1|STARTED|Period 1: 12 Weeks||235
5130263|NCT01426230|12621930|P2|NOT COMPLETED|Overall Study||27
5130264|NCT01426230|12621931|P1|NOT COMPLETED|Overall Study||31
5130265|NCT01426230|12621930|P2|COMPLETED|Overall Study||84
5130266|NCT01426230|12621931|P1|COMPLETED|Overall Study||55
5130267|NCT01426230|12621930|P2|STARTED|Overall Study||111
5130268|NCT01426230|12621931|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
5130269|NCT01426217|12621938|P2|NOT COMPLETED|Overall Study||14
5130270|NCT01426217|12621939|P1|NOT COMPLETED|Overall Study||8
5130271|NCT01426217|12621938|P2|COMPLETED|Overall Study||266
5130272|NCT01426217|12621939|P1|COMPLETED|Overall Study||306
5130273|NCT01426217|12621938|P2|STARTED|Overall Study||280
5130274|NCT01426217|12621939|P1|STARTED|Overall Study||314
5130275|NCT01426191|12621945|P1|NOT COMPLETED|Overall Study||0
5130276|NCT01426191|12621945|P1|COMPLETED|Overall Study||2032
5130277|NCT01426191|12621945|P1|STARTED|Overall Study||2032
5130278|NCT01426113|12621952|P2|NOT COMPLETED|Overall Study||2
5130279|NCT01426113|12621953|P1|NOT COMPLETED|Overall Study||1
5130280|NCT01426113|12621952|P2|COMPLETED|Overall Study||1
5130281|NCT01426113|12621953|P1|COMPLETED|Overall Study||2
5130282|NCT01426113|12621952|P2|STARTED|Overall Study||3
5130283|NCT01426113|12621953|P1|STARTED|Overall Study||3
5130284|NCT01426009|12621959|P1|NOT COMPLETED|Washout 4||1
5130285|NCT01426009|12621959|P1|COMPLETED|Washout 4||126
5130286|NCT01426009|12621959|P1|STARTED|Washout 4||127
5130287|NCT01426009|12621959|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
5130288|NCT01426009|12621959|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
5130289|NCT01426009|12621959|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
5130290|NCT01426009|12621959|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
5130291|NCT01426009|12621959|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
5130292|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
5130293|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
5130294|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
5130295|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
5130296|NCT01426009|12621959|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
5130297|NCT01426009|12621959|P1|NOT COMPLETED|Washout 3||1
5130298|NCT01426009|12621959|P1|COMPLETED|Washout 3||128
5130299|NCT01426009|12621959|P1|STARTED|Washout 3||129
5130300|NCT01426009|12621959|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
5130301|NCT01426009|12621959|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
5130302|NCT01426009|12621959|P1|Placebo|Period 3-Third Intervention (7 Days)||22
5130303|NCT01426009|12621959|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
5130304|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
5130305|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
5130306|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
5130307|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
5130308|NCT01426009|12621959|P1|STARTED|Period 3-Third Intervention (7 Days)||129
5130309|NCT01426009|12621959|P1|NOT COMPLETED|Washout 2||1
5130310|NCT01426009|12621959|P1|COMPLETED|Washout 2||129
5130311|NCT01426009|12621959|P1|STARTED|Washout 2||130
5130312|NCT01426009|12621959|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
5130313|NCT01426009|12621959|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
5130314|NCT01426009|12621959|P1|Placebo|Period 2-Second Intervention (7 Days)||21
5130315|NCT01426009|12621959|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
5130316|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
5130317|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
5130318|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
5130319|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
5130320|NCT01426009|12621959|P1|STARTED|Period 2-Second Intervention (7 Days)||135
5130321|NCT01426009|12621959|P1|NOT COMPLETED|Washout 1||2
5130322|NCT01426009|12621959|P1|COMPLETED|Washout 1||135
5130323|NCT01426009|12621959|P1|STARTED|Washout 1||137
5130324|NCT01426009|12621959|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
5130325|NCT01426009|12621959|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
5130326|NCT01426009|12621959|P1|Placebo|Period 1-First Intervention (7 Days)||24
5130327|NCT01426009|12621959|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
5130328|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
5130329|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
5130330|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
5130331|NCT01426009|12621959|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
5130332|NCT01426009|12621959|P1|STARTED|Period 1-First Intervention (7 Days)||139
5130333|NCT01425879|12622015|P1|NOT COMPLETED|Overall Study||0
5130334|NCT01425879|12622015|P1|COMPLETED|Overall Study||8
5130335|NCT01425879|12622015|P1|STARTED|Overall Study||8
5130336|NCT01425853|12622024|P2|NOT COMPLETED|Overall Study||77
5130337|NCT01425853|12622025|P1|NOT COMPLETED|Overall Study||64
5130338|NCT01425853|12622024|P2|COMPLETED|Overall Study||225
5130339|NCT01425853|12622025|P1|COMPLETED|Overall Study||240
5130340|NCT01425853|12622024|P2|Per Protocol (PP)|Overall Study||258
5130341|NCT01425853|12622025|P1|Per Protocol (PP)|Overall Study||264
5130342|NCT01425853|12622024|P2|Safety Population|Overall Study||299
5130343|NCT01425853|12622025|P1|Safety Population|Overall Study||304
5130344|NCT01425853|12622024|P2|STARTED|Overall Study||302
5130345|NCT01425853|12622025|P1|STARTED|Overall Study||304
5130346|NCT01425814|12622055|P6|NOT COMPLETED|Period 5||1
5130347|NCT01425814|12622056|P5|NOT COMPLETED|Period 5||0
5130348|NCT01425814|12622057|P4|NOT COMPLETED|Period 5||0
5130349|NCT01425814|12622058|P3|NOT COMPLETED|Period 5||1
5130350|NCT01425814|12622059|P2|NOT COMPLETED|Period 5||0
5130351|NCT01425814|12622060|P1|NOT COMPLETED|Period 5||0
5130352|NCT01425814|12622055|P6|COMPLETED|Period 5||11
5130353|NCT01425814|12622056|P5|COMPLETED|Period 5||12
5130354|NCT01425814|12622057|P4|COMPLETED|Period 5||10
5130355|NCT01425814|12622058|P3|COMPLETED|Period 5||10
5130356|NCT01425814|12622059|P2|COMPLETED|Period 5||9
5130357|NCT01425814|12622060|P1|COMPLETED|Period 5||11
5130358|NCT01425814|12622055|P6|STARTED|Period 5||12
5130359|NCT01425814|12622056|P5|STARTED|Period 5||12
5130360|NCT01425814|12622057|P4|STARTED|Period 5||10
5130361|NCT01425814|12622058|P3|STARTED|Period 5||11
5130362|NCT01425814|12622059|P2|STARTED|Period 5||9
5130363|NCT01425814|12622060|P1|STARTED|Period 5||11
5130364|NCT01425814|12622055|P6|NOT COMPLETED|Period 4||0
5130365|NCT01425814|12622056|P5|NOT COMPLETED|Period 4||0
5130366|NCT01425814|12622057|P4|NOT COMPLETED|Period 4||0
5130367|NCT01425814|12622058|P3|NOT COMPLETED|Period 4||1
5130368|NCT01425814|12622059|P2|NOT COMPLETED|Period 4||0
5130369|NCT01425814|12622060|P1|NOT COMPLETED|Period 4||1
5130370|NCT01425814|12622055|P6|COMPLETED|Period 4||12
5130371|NCT01425814|12622056|P5|COMPLETED|Period 4||12
5130372|NCT01425814|12622057|P4|COMPLETED|Period 4||10
5130373|NCT01425814|12622058|P3|COMPLETED|Period 4||11
5130374|NCT01425814|12622059|P2|COMPLETED|Period 4||9
5130375|NCT01425814|12622060|P1|COMPLETED|Period 4||11
5130376|NCT01425814|12622055|P6|STARTED|Period 4||12
5130377|NCT01425814|12622056|P5|STARTED|Period 4||12
5130378|NCT01425814|12622057|P4|STARTED|Period 4||10
5130379|NCT01425814|12622058|P3|STARTED|Period 4||12
5130380|NCT01425814|12622059|P2|STARTED|Period 4||9
5130381|NCT01425814|12622060|P1|STARTED|Period 4||12
5130382|NCT01425814|12622055|P6|NOT COMPLETED|Period 3||1
5130383|NCT01425814|12622056|P5|NOT COMPLETED|Period 3||0
5130384|NCT01425814|12622057|P4|NOT COMPLETED|Period 3||0
5130385|NCT01425814|12622058|P3|NOT COMPLETED|Period 3||0
5130386|NCT01425814|12622059|P2|NOT COMPLETED|Period 3||0
5130387|NCT01425814|12622060|P1|NOT COMPLETED|Period 3||0
5130388|NCT01425814|12622055|P6|COMPLETED|Period 3||12
5130389|NCT01425814|12622056|P5|COMPLETED|Period 3||12
5130390|NCT01425814|12622057|P4|COMPLETED|Period 3||10
5130391|NCT01425814|12622058|P3|COMPLETED|Period 3||12
5130392|NCT01425814|12622059|P2|COMPLETED|Period 3||9
5130393|NCT01425814|12622060|P1|COMPLETED|Period 3||12
5130394|NCT01425814|12622055|P6|STARTED|Period 3||13
5130395|NCT01425814|12622056|P5|STARTED|Period 3||12
5130396|NCT01425814|12622057|P4|STARTED|Period 3||10
5130397|NCT01425814|12622058|P3|STARTED|Period 3||12
5130398|NCT01425814|12622059|P2|STARTED|Period 3||9
5130399|NCT01425814|12622060|P1|STARTED|Period 3||12
5130400|NCT01425814|12622055|P6|NOT COMPLETED|Period 2||0
5130401|NCT01425814|12622056|P5|NOT COMPLETED|Period 2||0
5130402|NCT01425814|12622057|P4|NOT COMPLETED|Period 2||0
5130403|NCT01425814|12622058|P3|NOT COMPLETED|Period 2||0
5130404|NCT01425814|12622059|P2|NOT COMPLETED|Period 2||1
5130405|NCT01425814|12622060|P1|NOT COMPLETED|Period 2||0
5130406|NCT01425814|12622055|P6|COMPLETED|Period 2||13
5130407|NCT01425814|12622056|P5|COMPLETED|Period 2||12
5130408|NCT01425814|12622057|P4|COMPLETED|Period 2||10
5130409|NCT01425814|12622058|P3|COMPLETED|Period 2||12
5130410|NCT01425814|12622059|P2|COMPLETED|Period 2||9
5130411|NCT01425814|12622060|P1|COMPLETED|Period 2||12
5130412|NCT01425814|12622055|P6|STARTED|Period 2||13
5130413|NCT01425814|12622056|P5|STARTED|Period 2||12
5130414|NCT01425814|12622057|P4|STARTED|Period 2||10
5130415|NCT01425814|12622058|P3|STARTED|Period 2||12
5130416|NCT01425814|12622059|P2|STARTED|Period 2||10
5130417|NCT01425814|12622060|P1|STARTED|Period 2||12
5130418|NCT01425814|12622055|P6|NOT COMPLETED|Period 1||0
5130419|NCT01425814|12622056|P5|NOT COMPLETED|Period 1||0
5130420|NCT01425814|12622057|P4|NOT COMPLETED|Period 1||0
5130421|NCT01425814|12622058|P3|NOT COMPLETED|Period 1||0
5130422|NCT01425814|12622059|P2|NOT COMPLETED|Period 1||1
5130423|NCT01425814|12622060|P1|NOT COMPLETED|Period 1||0
5130424|NCT01425814|12622055|P6|COMPLETED|Period 1||13
5130425|NCT01425814|12622056|P5|COMPLETED|Period 1||12
5130426|NCT01425814|12622057|P4|COMPLETED|Period 1||10
5130427|NCT01425814|12622058|P3|COMPLETED|Period 1||12
5130428|NCT01425814|12622059|P2|COMPLETED|Period 1||10
5130429|NCT01425814|12622060|P1|COMPLETED|Period 1||12
5130430|NCT01425814|12622055|P6|STARTED|Period 1||13
5130431|NCT01425814|12622056|P5|STARTED|Period 1||12
5130432|NCT01425814|12622057|P4|STARTED|Period 1||10
5130433|NCT01425814|12622058|P3|STARTED|Period 1||12
5130434|NCT01425814|12622059|P2|STARTED|Period 1||11
5130435|NCT01425814|12622060|P1|STARTED|Period 1||12
5130436|NCT01425801|12622152|P6|NOT COMPLETED|Period 6||0
5130437|NCT01425801|12622153|P5|NOT COMPLETED|Period 6||0
5130438|NCT01425801|12622154|P4|NOT COMPLETED|Period 6||0
5130439|NCT01425801|12622155|P3|NOT COMPLETED|Period 6||0
5130440|NCT01425801|12622156|P2|NOT COMPLETED|Period 6||0
5130441|NCT01425801|12622157|P1|NOT COMPLETED|Period 6||0
5130442|NCT01425801|12622152|P6|COMPLETED|Period 6||10
5130443|NCT01425801|12622153|P5|COMPLETED|Period 6||11
5130444|NCT01425801|12622154|P4|COMPLETED|Period 6||12
5130445|NCT01425801|12622155|P3|COMPLETED|Period 6||7
5130446|NCT01425801|12622156|P2|COMPLETED|Period 6||9
5130447|NCT01425801|12622157|P1|COMPLETED|Period 6||9
5130448|NCT01425801|12622152|P6|STARTED|Period 6||10
5130449|NCT01425801|12622153|P5|STARTED|Period 6||11
5130450|NCT01425801|12622154|P4|STARTED|Period 6||12
5130451|NCT01425801|12622155|P3|STARTED|Period 6||7
5130452|NCT01425801|12622156|P2|STARTED|Period 6||9
5130453|NCT01425801|12622157|P1|STARTED|Period 6||9
5130454|NCT01425801|12622152|P6|NOT COMPLETED|Period 5||0
5130455|NCT01425801|12622153|P5|NOT COMPLETED|Period 5||0
5130456|NCT01425801|12622154|P4|NOT COMPLETED|Period 5||0
5130457|NCT01425801|12622155|P3|NOT COMPLETED|Period 5||0
5130458|NCT01425801|12622156|P2|NOT COMPLETED|Period 5||0
5130459|NCT01425801|12622157|P1|NOT COMPLETED|Period 5||0
5130460|NCT01425801|12622152|P6|COMPLETED|Period 5||10
5130461|NCT01425801|12622153|P5|COMPLETED|Period 5||11
5130462|NCT01425801|12622154|P4|COMPLETED|Period 5||12
5130463|NCT01425801|12622155|P3|COMPLETED|Period 5||7
5130464|NCT01425801|12622156|P2|COMPLETED|Period 5||9
5130465|NCT01425801|12622157|P1|COMPLETED|Period 5||9
5130466|NCT01425801|12622152|P6|STARTED|Period 5||10
5130467|NCT01425801|12622153|P5|STARTED|Period 5||11
5130468|NCT01425801|12622154|P4|STARTED|Period 5||12
5130469|NCT01425801|12622155|P3|STARTED|Period 5||7
5130470|NCT01425801|12622156|P2|STARTED|Period 5||9
5130471|NCT01425801|12622157|P1|STARTED|Period 5||9
5130472|NCT01425801|12622152|P6|NOT COMPLETED|Period 4||0
5130473|NCT01425801|12622153|P5|NOT COMPLETED|Period 4||0
5130474|NCT01425801|12622154|P4|NOT COMPLETED|Period 4||0
5130475|NCT01425801|12622155|P3|NOT COMPLETED|Period 4||1
5130476|NCT01425801|12622156|P2|NOT COMPLETED|Period 4||0
5130477|NCT01425801|12622157|P1|NOT COMPLETED|Period 4||0
5130478|NCT01425801|12622152|P6|COMPLETED|Period 4||10
5130479|NCT01425801|12622153|P5|COMPLETED|Period 4||11
5130480|NCT01425801|12622154|P4|COMPLETED|Period 4||12
5130481|NCT01425801|12622155|P3|COMPLETED|Period 4||7
5130482|NCT01425801|12622156|P2|COMPLETED|Period 4||9
5130483|NCT01425801|12622157|P1|COMPLETED|Period 4||9
5130484|NCT01425801|12622152|P6|STARTED|Period 4||10
5130485|NCT01425801|12622153|P5|STARTED|Period 4||11
5130486|NCT01425801|12622154|P4|STARTED|Period 4||12
5130487|NCT01425801|12622155|P3|STARTED|Period 4||8
5130488|NCT01425801|12622156|P2|STARTED|Period 4||9
5130489|NCT01425801|12622157|P1|STARTED|Period 4||9
5130490|NCT01425801|12622152|P6|NOT COMPLETED|Period 3||0
5130491|NCT01425801|12622153|P5|NOT COMPLETED|Period 3||0
5130492|NCT01425801|12622154|P4|NOT COMPLETED|Period 3||0
5130493|NCT01425801|12622155|P3|NOT COMPLETED|Period 3||1
5130494|NCT01425801|12622156|P2|NOT COMPLETED|Period 3||0
5130495|NCT01425801|12622157|P1|NOT COMPLETED|Period 3||0
5130496|NCT01425801|12622152|P6|COMPLETED|Period 3||10
5130497|NCT01425801|12622153|P5|COMPLETED|Period 3||11
5130498|NCT01425801|12622154|P4|COMPLETED|Period 3||12
5130499|NCT01425801|12622155|P3|COMPLETED|Period 3||8
5130500|NCT01425801|12622156|P2|COMPLETED|Period 3||9
5130501|NCT01425801|12622157|P1|COMPLETED|Period 3||9
5130502|NCT01425801|12622152|P6|STARTED|Period 3||10
5130503|NCT01425801|12622153|P5|STARTED|Period 3||11
5130504|NCT01425801|12622154|P4|STARTED|Period 3||12
5130505|NCT01425801|12622155|P3|STARTED|Period 3||9
5130506|NCT01425801|12622156|P2|STARTED|Period 3||9
5130507|NCT01425801|12622157|P1|STARTED|Period 3||9
5130508|NCT01425801|12622152|P6|NOT COMPLETED|Period 2||0
5130509|NCT01425801|12622153|P5|NOT COMPLETED|Period 2||1
5130510|NCT01425801|12622154|P4|NOT COMPLETED|Period 2||0
5130511|NCT01425801|12622155|P3|NOT COMPLETED|Period 2||0
5130512|NCT01425801|12622156|P2|NOT COMPLETED|Period 2||0
5130513|NCT01425801|12622157|P1|NOT COMPLETED|Period 2||0
5130514|NCT01425801|12622152|P6|COMPLETED|Period 2||10
5130515|NCT01425801|12622153|P5|COMPLETED|Period 2||11
5130516|NCT01425801|12622154|P4|COMPLETED|Period 2||12
5130517|NCT01425801|12622155|P3|COMPLETED|Period 2||9
5130518|NCT01425801|12622156|P2|COMPLETED|Period 2||9
5130519|NCT01425801|12622157|P1|COMPLETED|Period 2||9
5130520|NCT01425801|12622152|P6|STARTED|Period 2||10
5130521|NCT01425801|12622153|P5|STARTED|Period 2||12
5130522|NCT01425801|12622154|P4|STARTED|Period 2||12
5130523|NCT01425801|12622155|P3|STARTED|Period 2||9
5130524|NCT01425801|12622156|P2|STARTED|Period 2||9
5130525|NCT01425801|12622157|P1|STARTED|Period 2||9
5130526|NCT01425801|12622152|P6|NOT COMPLETED|Period 1||0
5130527|NCT01425801|12622153|P5|NOT COMPLETED|Period 1||1
5130528|NCT01425801|12622154|P4|NOT COMPLETED|Period 1||0
5130529|NCT01425801|12622155|P3|NOT COMPLETED|Period 1||0
5130530|NCT01425801|12622156|P2|NOT COMPLETED|Period 1||0
5130531|NCT01425801|12622157|P1|NOT COMPLETED|Period 1||0
5130532|NCT01425801|12622152|P6|COMPLETED|Period 1||10
5130533|NCT01425801|12622153|P5|COMPLETED|Period 1||12
5130534|NCT01425801|12622154|P4|COMPLETED|Period 1||12
5130535|NCT01425801|12622155|P3|COMPLETED|Period 1||9
5130536|NCT01425801|12622156|P2|COMPLETED|Period 1||9
5130537|NCT01425801|12622157|P1|COMPLETED|Period 1||9
5130538|NCT01425801|12622152|P6|STARTED|Period 1||10
5130539|NCT01425801|12622153|P5|STARTED|Period 1||13
5130540|NCT01425801|12622154|P4|STARTED|Period 1||12
5130541|NCT01425801|12622155|P3|STARTED|Period 1||9
5130542|NCT01425801|12622156|P2|STARTED|Period 1||9
5130543|NCT01425801|12622157|P1|STARTED|Period 1||9
5130544|NCT01425749|12622263|P2|NOT COMPLETED|Overall Study||1
5130545|NCT01425749|12622264|P1|NOT COMPLETED|Overall Study||0
5130546|NCT01425749|12622263|P2|COMPLETED|Overall Study||11
5130547|NCT01425749|12622264|P1|COMPLETED|Overall Study||13
5130548|NCT01425749|12622263|P2|STARTED|Overall Study||12
5130549|NCT01425749|12622264|P1|STARTED|Overall Study||13
5130550|NCT01425723|12622281|P2|NOT COMPLETED|Overall Study||18
5130551|NCT01425723|12622282|P1|NOT COMPLETED|Overall Study||4
5130552|NCT01425723|12622281|P2|COMPLETED|Overall Study||75
5130553|NCT01425723|12622282|P1|COMPLETED|Overall Study||23
5130554|NCT01425723|12622281|P2|Surgery Subgroup|Overall Study||15
5130555|NCT01425723|12622282|P1|Surgery Subgroup|Overall Study||1
5130556|NCT01425723|12622281|P2|Episodic|Overall Study||15
5130557|NCT01425723|12622282|P1|Episodic|Overall Study||0
5130558|NCT01425723|12622281|P2|Personalized Prophylaxis|Overall Study||17
5130559|NCT01425723|12622282|P1|Personalized Prophylaxis|Overall Study||2
5130560|NCT01425723|12622281|P2|Individualized Prophylaxis|Overall Study||31
5130561|NCT01425723|12622282|P1|Individualized Prophylaxis|Overall Study||5
5130562|NCT01425723|12622281|P2|Weekly Prophylaxis|Overall Study||51
5130563|NCT01425723|12622282|P1|Weekly Prophylaxis|Overall Study||23
5130564|NCT01425723|12622281|P2|STARTED|Overall Study||93
5130565|NCT01425723|12622282|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
5130566|NCT01425632|12622312|P3|NOT COMPLETED|Overall Study||4
5130567|NCT01425632|12622313|P2|NOT COMPLETED|Overall Study||1
5130568|NCT01425632|12622314|P1|NOT COMPLETED|Overall Study||1
5130569|NCT01425632|12622312|P3|COMPLETED|Overall Study||159
5130570|NCT01425632|12622313|P2|COMPLETED|Overall Study||165
5130571|NCT01425632|12622314|P1|COMPLETED|Overall Study||160
5130572|NCT01425632|12622312|P3|STARTED|Overall Study||163
5130573|NCT01425632|12622313|P2|STARTED|Overall Study||166
5130574|NCT01425632|12622314|P1|STARTED|Overall Study||161
5130575|NCT01425528|12622324|P2|NOT COMPLETED|Overall Study||1
5130576|NCT01425528|12622325|P1|NOT COMPLETED|Overall Study||1
5130577|NCT01425528|12622324|P2|COMPLETED|Overall Study||5
5130578|NCT01425528|12622325|P1|COMPLETED|Overall Study||5
5130579|NCT01425528|12622324|P2|STARTED|Overall Study||6
5130580|NCT01425528|12622325|P1|STARTED|Overall Study||6
5130581|NCT01425463|12622333|P2|NOT COMPLETED|Overall Study||24
5130582|NCT01425463|12622334|P1|NOT COMPLETED|Overall Study||24
5130583|NCT01425463|12622333|P2|COMPLETED|Overall Study||102
5130584|NCT01425463|12622334|P1|COMPLETED|Overall Study||106
5130585|NCT01425463|12622333|P2|Full Analysis Set|Overall Study||116
5130586|NCT01425463|12622334|P1|Full Analysis Set|Overall Study||122
5130587|NCT01425463|12622333|P2|Safety Set|Overall Study||122
5130588|NCT01425463|12622334|P1|Safety Set|Overall Study||126
5130589|NCT01425463|12622333|P2|STARTED|Overall Study||126
5130590|NCT01425463|12622334|P1|STARTED|Overall Study||130
5130591|NCT01425359|12622350|P2|NOT COMPLETED|Overall Study||22
5130592|NCT01425359|12622351|P1|NOT COMPLETED|Overall Study||19
5130593|NCT01425359|12622350|P2|COMPLETED|Overall Study||451
5130594|NCT01425359|12622351|P1|COMPLETED|Overall Study||457
5130595|NCT01425359|12622350|P2|STARTED|Overall Study||473
5130596|NCT01425359|12622351|P1|STARTED|Overall Study||476
5130597|NCT01425307|12622369|P2|NOT COMPLETED|Overall Study||19
5130598|NCT01425307|12622370|P1|NOT COMPLETED|Overall Study||19
5130599|NCT01425307|12622369|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
5130600|NCT01425307|12622370|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
5130601|NCT01425307|12622369|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
5130602|NCT01425307|12622370|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
5130603|NCT01425281|12622382|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
5130604|NCT01425281|12622383|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
5130605|NCT01425281|12622382|P2|COMPLETED|At 5-year Clinical Follow-up||125
5130606|NCT01425281|12622383|P1|COMPLETED|At 5-year Clinical Follow-up||256
5130607|NCT01425281|12622382|P2|STARTED|At 5-year Clinical Follow-up||136
5130608|NCT01425281|12622383|P1|STARTED|At 5-year Clinical Follow-up||288
5130609|NCT01425281|12622382|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
5130610|NCT01425281|12622383|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
5130611|NCT01425281|12622382|P2|COMPLETED|At 4-year Clinical Follow-up||136
5130612|NCT01425281|12622383|P1|COMPLETED|At 4-year Clinical Follow-up||288
5130613|NCT01425281|12622382|P2|STARTED|At 4-year Clinical Follow-up||157
5130614|NCT01425281|12622383|P1|STARTED|At 4-year Clinical Follow-up||318
5130615|NCT01425281|12622382|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
5130616|NCT01425281|12622383|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
5130617|NCT01425281|12622382|P2|COMPLETED|At 3-year Clinical Follow-up||157
5130618|NCT01425281|12622383|P1|COMPLETED|At 3-year Clinical Follow-up||318
5130619|NCT01425281|12622382|P2|STARTED|At 3-year Clinical Follow-up||163
5130620|NCT01425281|12622383|P1|STARTED|At 3-year Clinical Follow-up||323
5130621|NCT01425281|12622382|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
5130622|NCT01425281|12622383|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
5130623|NCT01425281|12622382|P2|COMPLETED|At 2-year Clinical Follow-up||163
5130624|NCT01425281|12622383|P1|COMPLETED|At 2-year Clinical Follow-up||323
5130625|NCT01425281|12622382|P2|STARTED|At 2-year Clinical Follow-up||164
5130626|NCT01425281|12622383|P1|STARTED|At 2-year Clinical Follow-up||329
5130627|NCT01425281|12622382|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
5130628|NCT01425281|12622383|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
5130629|NCT01425281|12622382|P2|COMPLETED|At 1-year Clinical Follow-up||164
5130630|NCT01425281|12622383|P1|COMPLETED|At 1-year Clinical Follow-up||329
5130631|NCT01425281|12622382|P2|STARTED|At 1-year Clinical Follow-up||165
5130632|NCT01425281|12622383|P1|STARTED|At 1-year Clinical Follow-up||331
5130633|NCT01425281|12622382|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
5130634|NCT01425281|12622383|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
5130635|NCT01425281|12622382|P2|COMPLETED|At 180-day Clinical Follow-up||165
5130636|NCT01425281|12622383|P1|COMPLETED|At 180-day Clinical Follow-up||331
5130637|NCT01425281|12622382|P2|STARTED|At 180-day Clinical Follow-up||166
5130638|NCT01425281|12622383|P1|STARTED|At 180-day Clinical Follow-up||334
5130639|NCT01425281|12622382|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
5130640|NCT01425281|12622383|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
5130641|NCT01425281|12622382|P2|COMPLETED|At 30-day Clinical Follow-up||166
5130642|NCT01425281|12622383|P1|COMPLETED|At 30-day Clinical Follow-up||334
5130643|NCT01425281|12622382|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
5130644|NCT01425281|12622383|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
5130645|NCT01425268|12622601|P2|NOT COMPLETED|Overall Study||0
5130646|NCT01425268|12622602|P1|NOT COMPLETED|Overall Study||8
5130647|NCT01425268|12622601|P2|COMPLETED|Overall Study||52
5130648|NCT01425268|12622602|P1|COMPLETED|Overall Study||98
5130649|NCT01425268|12622601|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
5130650|NCT01425268|12622602|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
5130651|NCT01425229|12622610|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
5130652|NCT01425229|12622610|P1|COMPLETED|Bosentan During Clarithromycin||16
5130653|NCT01425229|12622610|P1|STARTED|Bosentan During Clarithromycin||16
5130654|NCT01425229|12622610|P1|NOT COMPLETED|Bosentan Steady-state||0
5130655|NCT01425229|12622610|P1|COMPLETED|Bosentan Steady-state||16
5130656|NCT01425229|12622610|P1|STARTED|Bosentan Steady-state||16
5130657|NCT01425229|12622610|P1|NOT COMPLETED|Bosentan Single Dose||0
5130658|NCT01425229|12622610|P1|COMPLETED|Bosentan Single Dose||16
5130659|NCT01425229|12622610|P1|STARTED|Bosentan Single Dose||16
5130660|NCT01425203|12622623|P3|NOT COMPLETED|Follow-up Phase||0
5130661|NCT01425203|12622624|P2|NOT COMPLETED|Follow-up Phase||0
5130662|NCT01425203|12622625|P1|NOT COMPLETED|Follow-up Phase||0
5130663|NCT01425203|12622623|P3|COMPLETED|Follow-up Phase||27
5130664|NCT01425203|12622624|P2|COMPLETED|Follow-up Phase||49
5130665|NCT01425203|12622625|P1|COMPLETED|Follow-up Phase||153
5130666|NCT01425203|12622623|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
5130667|NCT01425203|12622624|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
5130668|NCT01425203|12622625|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
5130669|NCT01425203|12622623|P3|NOT COMPLETED|Crossover Phase||6
5130670|NCT01425203|12622624|P2|NOT COMPLETED|Crossover Phase||0
5130671|NCT01425203|12622625|P1|NOT COMPLETED|Crossover Phase||0
5130672|NCT01425203|12622623|P3|COMPLETED|Crossover Phase||21
5130673|NCT01425203|12622624|P2|COMPLETED|Crossover Phase||0
5130674|NCT01425203|12622625|P1|COMPLETED|Crossover Phase||0
5130675|NCT01425203|12622623|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
5130676|NCT01425203|12622624|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
5130677|NCT01425203|12622625|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
5130678|NCT01425203|12622623|P3|NOT COMPLETED|Treatment Phase||0
5130679|NCT01425203|12622624|P2|NOT COMPLETED|Treatment Phase||37
5130680|NCT01425203|12622625|P1|NOT COMPLETED|Treatment Phase||27
5130681|NCT01425203|12622623|P3|COMPLETED|Treatment Phase||0
5130682|NCT01425203|12622624|P2|COMPLETED|Treatment Phase||42
5130683|NCT01425203|12622625|P1|COMPLETED|Treatment Phase||132
5130684|NCT01425203|12622623|P3|Treated (FAS)|Treatment Phase||0
5130685|NCT01425203|12622624|P2|Treated (FAS)|Treatment Phase||78
5130686|NCT01425203|12622625|P1|Treated (FAS)|Treatment Phase||159
5130687|NCT01425203|12622623|P3|STARTED|Treatment Phase||0
5130688|NCT01425203|12622624|P2|STARTED|Treatment Phase||79
5130689|NCT01425203|12622625|P1|STARTED|Treatment Phase||159
5130690|NCT01425190|12622642|P3|NOT COMPLETED|Overall Study||0
5130691|NCT01425190|12622643|P2|NOT COMPLETED|Overall Study||0
5130692|NCT01425190|12622644|P1|NOT COMPLETED|Overall Study||1
5130693|NCT01425190|12622642|P3|COMPLETED|Overall Study||0
5130694|NCT01425190|12622643|P2|COMPLETED|Overall Study||0
5130695|NCT01425190|12622644|P1|COMPLETED|Overall Study||15
5130696|NCT01425190|12622642|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
5130697|NCT01425190|12622643|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
5130698|NCT01425190|12622644|P1|STARTED|Overall Study||16
5130699|NCT01424943|12622663|P2|NOT COMPLETED|Overall Study||1
5130700|NCT01424943|12622664|P1|NOT COMPLETED|Overall Study||13
5130701|NCT01424943|12622663|P2|COMPLETED|Overall Study||23
5130702|NCT01424943|12622664|P1|COMPLETED|Overall Study||12
5130703|NCT01424943|12622663|P2|STARTED|Overall Study||24
5130704|NCT01424943|12622664|P1|STARTED|Overall Study||25
5130705|NCT01424930|12622680|P2|NOT COMPLETED|Overall Study||14
5130706|NCT01424930|12622681|P1|NOT COMPLETED|Overall Study||4
5130707|NCT01424930|12622680|P2|COMPLETED|Overall Study||4
5130708|NCT01424930|12622681|P1|COMPLETED|Overall Study||3
5130709|NCT01424930|12622680|P2|Completed Food Safety Evaluation|Overall Study||18
5130710|NCT01424930|12622681|P1|Completed Food Safety Evaluation|Overall Study||6
5130711|NCT01424930|12622680|P2|STARTED|Overall Study||18
5130712|NCT01424930|12622681|P1|STARTED|Overall Study||7
5130713|NCT01424813|12622695|P2|NOT COMPLETED|Overall Study||2
5130714|NCT01424813|12622696|P1|NOT COMPLETED|Overall Study||5
5130715|NCT01424813|12622695|P2|COMPLETED|Overall Study||77
5130716|NCT01424813|12622696|P1|COMPLETED|Overall Study||74
5130717|NCT01424813|12622695|P2|Treated|Overall Study|Safety set and full analysis set|78
5130718|NCT01424813|12622696|P1|Treated|Overall Study|Safety set and full analysis set|79
5130719|NCT01424813|12622695|P2|STARTED|Overall Study||79
5130720|NCT01424813|12622696|P1|STARTED|Overall Study||79
5130721|NCT01424670|12622716|P2|NOT COMPLETED|Continuation Period||14
5130722|NCT01424670|12622717|P1|NOT COMPLETED|Continuation Period||34
5130723|NCT01424670|12622716|P2|COMPLETED|Continuation Period||142
5130724|NCT01424670|12622717|P1|COMPLETED|Continuation Period||288
5130725|NCT01424670|12622716|P2|STARTED|Continuation Period||156
5130726|NCT01424670|12622717|P1|STARTED|Continuation Period||322
5130727|NCT01424670|12622716|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
5130728|NCT01424670|12622717|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
5130729|NCT01424670|12622716|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
5130730|NCT01424670|12622717|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
5130731|NCT01424670|12622716|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
5130732|NCT01424670|12622717|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
5130733|NCT01424670|12622716|P2|STARTED|6-Month Intensive Period (182 Days)||170
5130734|NCT01424670|12622717|P1|STARTED|6-Month Intensive Period (182 Days)||341
5130735|NCT01424644|12622739|P2|NOT COMPLETED|Overall Study||27
5130736|NCT01424644|12622740|P1|NOT COMPLETED|Overall Study||33
5130737|NCT01424644|12622739|P2|COMPLETED|Overall Study||372
5130738|NCT01424644|12622740|P1|COMPLETED|Overall Study||369
5130739|NCT01424644|12622739|P2|STARTED|Overall Study||399
5130740|NCT01424644|12622740|P1|STARTED|Overall Study||402
5130741|NCT01424566|12622754|P3|NOT COMPLETED|Double-blind Treatment||15
5130742|NCT01424566|12622755|P2|NOT COMPLETED|Double-blind Treatment||25
5130743|NCT01424566|12622756|P1|NOT COMPLETED|Double-blind Treatment||0
5130744|NCT01424566|12622754|P3|COMPLETED|Double-blind Treatment||88
5130745|NCT01424566|12622755|P2|COMPLETED|Double-blind Treatment||78
5130746|NCT01424566|12622756|P1|COMPLETED|Double-blind Treatment||0
5130747|NCT01424566|12622754|P3|ITT Population|Double-blind Treatment||103
5130748|NCT01424566|12622755|P2|ITT Population|Double-blind Treatment||103
5130749|NCT01424566|12622756|P1|ITT Population|Double-blind Treatment||0
5130750|NCT01424566|12622754|P3|Randomized Safety Population|Double-blind Treatment||103
5130751|NCT01424566|12622755|P2|Randomized Safety Population|Double-blind Treatment||103
5130752|NCT01424566|12622756|P1|Randomized Safety Population|Double-blind Treatment||0
5130753|NCT01424566|12622754|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
5130754|NCT01424566|12622755|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
5130755|NCT01424566|12622756|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
5130756|NCT01424566|12622754|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
5130757|NCT01424566|12622755|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
5130758|NCT01424566|12622756|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
5130759|NCT01424566|12622754|P3|NOT COMPLETED|Single-blind Treatment||0
5130760|NCT01424566|12622755|P2|NOT COMPLETED|Single-blind Treatment||0
5130761|NCT01424566|12622756|P1|NOT COMPLETED|Single-blind Treatment||200
5130762|NCT01424566|12622754|P3|COMPLETED|Single-blind Treatment||0
5130763|NCT01424566|12622755|P2|COMPLETED|Single-blind Treatment||0
5130764|NCT01424566|12622756|P1|COMPLETED|Single-blind Treatment||206
5130765|NCT01424566|12622754|P3|Met Randomization Criteria|Single-blind Treatment||0
5130766|NCT01424566|12622755|P2|Met Randomization Criteria|Single-blind Treatment||0
5130767|NCT01424566|12622756|P1|Met Randomization Criteria|Single-blind Treatment||206
5130768|NCT01424566|12622754|P3|Single-blind Safety Population|Single-blind Treatment||0
5130769|NCT01424566|12622755|P2|Single-blind Safety Population|Single-blind Treatment||0
5130770|NCT01424566|12622756|P1|Single-blind Safety Population|Single-blind Treatment||404
5130771|NCT01424566|12622754|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
5130772|NCT01424566|12622755|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
5130773|NCT01424566|12622756|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
5130774|NCT01424566|12622754|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
5130775|NCT01424566|12622755|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
5130776|NCT01424566|12622756|P1|STARTED|Single-blind Treatment||406
5130777|NCT01424514|12622783|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
5130778|NCT01424514|12622784|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
5130779|NCT01424514|12622783|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
5130780|NCT01424514|12622784|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
5130781|NCT01424514|12622783|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
5130782|NCT01424514|12622784|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
5130783|NCT01424514|12622783|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
5130784|NCT01424514|12622784|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
5130785|NCT01424514|12622783|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
5130786|NCT01424514|12622784|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
5130787|NCT01424514|12622783|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
5130788|NCT01424514|12622784|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
5130789|NCT01424514|12622783|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
5130790|NCT01424514|12622784|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
5130791|NCT01424514|12622783|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
5130792|NCT01424514|12622784|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
5130793|NCT01424514|12622783|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
5130794|NCT01424514|12622784|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
5130795|NCT01424501|12622829|P6|NOT COMPLETED|Overall Study||0
5130796|NCT01424501|12622830|P5|NOT COMPLETED|Overall Study||0
5130797|NCT01424501|12622831|P4|NOT COMPLETED|Overall Study||0
5130798|NCT01424501|12622832|P3|NOT COMPLETED|Overall Study||2
5130799|NCT01424501|12622833|P2|NOT COMPLETED|Overall Study||1
5130800|NCT01424501|12622834|P1|NOT COMPLETED|Overall Study||1
5130801|NCT01424501|12622829|P6|COMPLETED|Overall Study||40
5130802|NCT01424501|12622830|P5|COMPLETED|Overall Study||40
5130803|NCT01424501|12622831|P4|COMPLETED|Overall Study||25
5130804|NCT01424501|12622832|P3|COMPLETED|Overall Study||22
5130805|NCT01424501|12622833|P2|COMPLETED|Overall Study||5
5130806|NCT01424501|12622834|P1|COMPLETED|Overall Study||6
5130807|NCT01424501|12622829|P6|STARTED|Overall Study||40
5130808|NCT01424501|12622830|P5|STARTED|Overall Study||40
5130809|NCT01424501|12622831|P4|STARTED|Overall Study||25
5130810|NCT01424501|12622832|P3|STARTED|Overall Study||24
5130811|NCT01424501|12622833|P2|STARTED|Overall Study||6
5130812|NCT01424501|12622834|P1|STARTED|Overall Study||7
5130813|NCT01424397|12623010|P12|NOT COMPLETED|Period-3 (8 Days)||0
5130814|NCT01424397|12623011|P11|NOT COMPLETED|Period-3 (8 Days)||0
5130815|NCT01424397|12623012|P10|NOT COMPLETED|Period-3 (8 Days)||0
5130816|NCT01424397|12623013|P9|NOT COMPLETED|Period-3 (8 Days)||0
5130817|NCT01424397|12623014|P8|NOT COMPLETED|Period-3 (8 Days)||0
5130818|NCT01424397|12623015|P7|NOT COMPLETED|Period-3 (8 Days)||0
5130819|NCT01424397|12623016|P6|NOT COMPLETED|Period-3 (8 Days)||0
5130820|NCT01424397|12623017|P5|NOT COMPLETED|Period-3 (8 Days)||0
5130821|NCT01424397|12623018|P4|NOT COMPLETED|Period-3 (8 Days)||0
5130822|NCT01424397|12623019|P3|NOT COMPLETED|Period-3 (8 Days)||0
5130823|NCT01424397|12623020|P2|NOT COMPLETED|Period-3 (8 Days)||0
5130824|NCT01424397|12623021|P1|NOT COMPLETED|Period-3 (8 Days)||0
5130825|NCT01424397|12623010|P12|COMPLETED|Period-3 (8 Days)||4
5130826|NCT01424397|12623011|P11|COMPLETED|Period-3 (8 Days)||4
5130827|NCT01424397|12623012|P10|COMPLETED|Period-3 (8 Days)||3
5130828|NCT01424397|12623013|P9|COMPLETED|Period-3 (8 Days)||4
5130829|NCT01424397|12623014|P8|COMPLETED|Period-3 (8 Days)||4
5130830|NCT01424397|12623015|P7|COMPLETED|Period-3 (8 Days)||4
5130831|NCT01424397|12623016|P6|COMPLETED|Period-3 (8 Days)||8
5130832|NCT01424397|12623017|P5|COMPLETED|Period-3 (8 Days)||8
5130833|NCT01424397|12623018|P4|COMPLETED|Period-3 (8 Days)||8
5130834|NCT01424397|12623019|P3|COMPLETED|Period-3 (8 Days)||7
5130835|NCT01424397|12623020|P2|COMPLETED|Period-3 (8 Days)||8
5130836|NCT01424397|12623021|P1|COMPLETED|Period-3 (8 Days)||7
5130837|NCT01424397|12623010|P12|STARTED|Period-3 (8 Days)||4
5130838|NCT01424397|12623011|P11|STARTED|Period-3 (8 Days)||4
5130839|NCT01424397|12623012|P10|STARTED|Period-3 (8 Days)||3
5130840|NCT01424397|12623013|P9|STARTED|Period-3 (8 Days)||4
5130841|NCT01424397|12623014|P8|STARTED|Period-3 (8 Days)||4
5130842|NCT01424397|12623015|P7|STARTED|Period-3 (8 Days)||4
5130843|NCT01424397|12623016|P6|STARTED|Period-3 (8 Days)||8
5130844|NCT01424397|12623017|P5|STARTED|Period-3 (8 Days)||8
5130845|NCT01424397|12623018|P4|STARTED|Period-3 (8 Days)||8
5130846|NCT01424397|12623019|P3|STARTED|Period-3 (8 Days)||7
5130847|NCT01424397|12623020|P2|STARTED|Period-3 (8 Days)||8
5130848|NCT01424397|12623021|P1|STARTED|Period-3 (8 Days)||7
5130849|NCT01424397|12623010|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130850|NCT01424397|12623011|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130851|NCT01424397|12623012|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130852|NCT01424397|12623013|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130853|NCT01424397|12623014|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130854|NCT01424397|12623015|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130855|NCT01424397|12623016|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130856|NCT01424397|12623017|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130857|NCT01424397|12623018|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130858|NCT01424397|12623019|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130859|NCT01424397|12623020|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130860|NCT01424397|12623021|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
5130861|NCT01424397|12623010|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
5130862|NCT01424397|12623011|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
5130863|NCT01424397|12623012|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
5130864|NCT01424397|12623013|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
5130865|NCT01424397|12623014|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
5130866|NCT01424397|12623015|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
5130867|NCT01424397|12623016|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
5130868|NCT01424397|12623017|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
5130869|NCT01424397|12623018|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
5130870|NCT01424397|12623019|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
5130871|NCT01424397|12623020|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
5130872|NCT01424397|12623021|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
5130873|NCT01424397|12623010|P12|STARTED|Washout Period-2 (14-20 Days)||4
5130874|NCT01424397|12623011|P11|STARTED|Washout Period-2 (14-20 Days)||4
5130875|NCT01424397|12623012|P10|STARTED|Washout Period-2 (14-20 Days)||3
5130876|NCT01424397|12623013|P9|STARTED|Washout Period-2 (14-20 Days)||4
5130877|NCT01424397|12623014|P8|STARTED|Washout Period-2 (14-20 Days)||4
5130878|NCT01424397|12623015|P7|STARTED|Washout Period-2 (14-20 Days)||4
5130879|NCT01424397|12623016|P6|STARTED|Washout Period-2 (14-20 Days)||8
5130880|NCT01424397|12623017|P5|STARTED|Washout Period-2 (14-20 Days)||8
5130881|NCT01424397|12623018|P4|STARTED|Washout Period-2 (14-20 Days)||8
5130882|NCT01424397|12623019|P3|STARTED|Washout Period-2 (14-20 Days)||7
5130883|NCT01424397|12623020|P2|STARTED|Washout Period-2 (14-20 Days)||8
5130884|NCT01424397|12623021|P1|STARTED|Washout Period-2 (14-20 Days)||7
5130885|NCT01424397|12623010|P12|NOT COMPLETED|Period-2 (8 Days)||0
5130886|NCT01424397|12623011|P11|NOT COMPLETED|Period-2 (8 Days)||0
5130887|NCT01424397|12623012|P10|NOT COMPLETED|Period-2 (8 Days)||0
5130888|NCT01424397|12623013|P9|NOT COMPLETED|Period-2 (8 Days)||0
5130889|NCT01424397|12623014|P8|NOT COMPLETED|Period-2 (8 Days)||0
5130890|NCT01424397|12623015|P7|NOT COMPLETED|Period-2 (8 Days)||0
5130891|NCT01424397|12623016|P6|NOT COMPLETED|Period-2 (8 Days)||0
5130892|NCT01424397|12623017|P5|NOT COMPLETED|Period-2 (8 Days)||0
5130893|NCT01424397|12623018|P4|NOT COMPLETED|Period-2 (8 Days)||0
5130894|NCT01424397|12623019|P3|NOT COMPLETED|Period-2 (8 Days)||1
5130895|NCT01424397|12623020|P2|NOT COMPLETED|Period-2 (8 Days)||0
5130896|NCT01424397|12623021|P1|NOT COMPLETED|Period-2 (8 Days)||0
5130897|NCT01424397|12623010|P12|COMPLETED|Period-2 (8 Days)||4
5130898|NCT01424397|12623011|P11|COMPLETED|Period-2 (8 Days)||4
5130899|NCT01424397|12623012|P10|COMPLETED|Period-2 (8 Days)||3
5130900|NCT01424397|12623013|P9|COMPLETED|Period-2 (8 Days)||4
5130901|NCT01424397|12623014|P8|COMPLETED|Period-2 (8 Days)||4
5130902|NCT01424397|12623015|P7|COMPLETED|Period-2 (8 Days)||4
5130903|NCT01424397|12623016|P6|COMPLETED|Period-2 (8 Days)||8
5130904|NCT01424397|12623017|P5|COMPLETED|Period-2 (8 Days)||8
5130905|NCT01424397|12623018|P4|COMPLETED|Period-2 (8 Days)||8
5130906|NCT01424397|12623019|P3|COMPLETED|Period-2 (8 Days)||7
5130907|NCT01424397|12623020|P2|COMPLETED|Period-2 (8 Days)||8
5130908|NCT01424397|12623021|P1|COMPLETED|Period-2 (8 Days)||7
5130909|NCT01424397|12623010|P12|STARTED|Period-2 (8 Days)||4
5130910|NCT01424397|12623011|P11|STARTED|Period-2 (8 Days)||4
5130911|NCT01424397|12623012|P10|STARTED|Period-2 (8 Days)||3
5130912|NCT01424397|12623013|P9|STARTED|Period-2 (8 Days)||4
5130913|NCT01424397|12623014|P8|STARTED|Period-2 (8 Days)||4
5130914|NCT01424397|12623015|P7|STARTED|Period-2 (8 Days)||4
5130915|NCT01424397|12623016|P6|STARTED|Period-2 (8 Days)||8
5130916|NCT01424397|12623017|P5|STARTED|Period-2 (8 Days)||8
5130917|NCT01424397|12623018|P4|STARTED|Period-2 (8 Days)||8
5130918|NCT01424397|12623019|P3|STARTED|Period-2 (8 Days)||8
5130919|NCT01424397|12623020|P2|STARTED|Period-2 (8 Days)||8
5130920|NCT01424397|12623021|P1|STARTED|Period-2 (8 Days)||7
5130921|NCT01424397|12623010|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130922|NCT01424397|12623011|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130923|NCT01424397|12623012|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130924|NCT01424397|12623013|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130925|NCT01424397|12623014|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130926|NCT01424397|12623015|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130927|NCT01424397|12623016|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130928|NCT01424397|12623017|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130929|NCT01424397|12623018|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130930|NCT01424397|12623019|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130931|NCT01424397|12623020|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130932|NCT01424397|12623021|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
5130933|NCT01424397|12623010|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
5130934|NCT01424397|12623011|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
5130935|NCT01424397|12623012|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
5130936|NCT01424397|12623013|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
5130937|NCT01424397|12623014|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
5130938|NCT01424397|12623015|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
5130939|NCT01424397|12623016|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
5130940|NCT01424397|12623017|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
5130941|NCT01424397|12623018|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
5130942|NCT01424397|12623019|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
5130943|NCT01424397|12623020|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
5130944|NCT01424397|12623021|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
5130945|NCT01424397|12623010|P12|STARTED|Washout Period-1 (14-20 Days)||4
5130946|NCT01424397|12623011|P11|STARTED|Washout Period-1 (14-20 Days)||4
5130947|NCT01424397|12623012|P10|STARTED|Washout Period-1 (14-20 Days)||3
5130948|NCT01424397|12623013|P9|STARTED|Washout Period-1 (14-20 Days)||4
5130949|NCT01424397|12623014|P8|STARTED|Washout Period-1 (14-20 Days)||4
5130950|NCT01424397|12623015|P7|STARTED|Washout Period-1 (14-20 Days)||4
5130951|NCT01424397|12623016|P6|STARTED|Washout Period-1 (14-20 Days)||8
5130952|NCT01424397|12623017|P5|STARTED|Washout Period-1 (14-20 Days)||8
5130953|NCT01424397|12623018|P4|STARTED|Washout Period-1 (14-20 Days)||8
5130954|NCT01424397|12623019|P3|STARTED|Washout Period-1 (14-20 Days)||8
5130955|NCT01424397|12623020|P2|STARTED|Washout Period-1 (14-20 Days)||8
5130956|NCT01424397|12623021|P1|STARTED|Washout Period-1 (14-20 Days)||7
5130957|NCT01424397|12623010|P12|NOT COMPLETED|Period-1 (8 Days)||0
5130958|NCT01424397|12623011|P11|NOT COMPLETED|Period-1 (8 Days)||0
5130959|NCT01424397|12623012|P10|NOT COMPLETED|Period-1 (8 Days)||0
5130960|NCT01424397|12623013|P9|NOT COMPLETED|Period-1 (8 Days)||0
5130961|NCT01424397|12623014|P8|NOT COMPLETED|Period-1 (8 Days)||0
5130962|NCT01424397|12623015|P7|NOT COMPLETED|Period-1 (8 Days)||0
5130963|NCT01424397|12623016|P6|NOT COMPLETED|Period-1 (8 Days)||0
5130964|NCT01424397|12623017|P5|NOT COMPLETED|Period-1 (8 Days)||0
5130965|NCT01424397|12623018|P4|NOT COMPLETED|Period-1 (8 Days)||0
5130966|NCT01424397|12623019|P3|NOT COMPLETED|Period-1 (8 Days)||0
5130967|NCT01424397|12623020|P2|NOT COMPLETED|Period-1 (8 Days)||0
5130968|NCT01424397|12623021|P1|NOT COMPLETED|Period-1 (8 Days)||0
5130969|NCT01424397|12623010|P12|COMPLETED|Period-1 (8 Days)||4
5130970|NCT01424397|12623011|P11|COMPLETED|Period-1 (8 Days)||4
5130971|NCT01424397|12623012|P10|COMPLETED|Period-1 (8 Days)||3
5130972|NCT01424397|12623013|P9|COMPLETED|Period-1 (8 Days)||4
5130973|NCT01424397|12623014|P8|COMPLETED|Period-1 (8 Days)||4
5130974|NCT01424397|12623015|P7|COMPLETED|Period-1 (8 Days)||4
5130975|NCT01424397|12623016|P6|COMPLETED|Period-1 (8 Days)||8
5130976|NCT01424397|12623017|P5|COMPLETED|Period-1 (8 Days)||8
5130977|NCT01424397|12623018|P4|COMPLETED|Period-1 (8 Days)||8
5130978|NCT01424397|12623019|P3|COMPLETED|Period-1 (8 Days)||8
5130979|NCT01424397|12623020|P2|COMPLETED|Period-1 (8 Days)||8
5130980|NCT01424397|12623021|P1|COMPLETED|Period-1 (8 Days)||7
5130981|NCT01424397|12623010|P12|STARTED|Period-1 (8 Days)||4
5130982|NCT01424397|12623011|P11|STARTED|Period-1 (8 Days)||4
5130983|NCT01424397|12623012|P10|STARTED|Period-1 (8 Days)||3
5130984|NCT01424397|12623013|P9|STARTED|Period-1 (8 Days)||4
5130985|NCT01424397|12623014|P8|STARTED|Period-1 (8 Days)||4
5130986|NCT01424397|12623015|P7|STARTED|Period-1 (8 Days)||4
5130987|NCT01424397|12623016|P6|STARTED|Period-1 (8 Days)||8
5130988|NCT01424397|12623017|P5|STARTED|Period-1 (8 Days)||8
5130989|NCT01424397|12623018|P4|STARTED|Period-1 (8 Days)||8
5130990|NCT01424397|12623019|P3|STARTED|Period-1 (8 Days)||8
5130991|NCT01424397|12623020|P2|STARTED|Period-1 (8 Days)||8
5130992|NCT01424397|12623021|P1|STARTED|Period-1 (8 Days)||7
5130993|NCT01424306|12623067|P6|NOT COMPLETED|Overall Study||0
5130994|NCT01424306|12623068|P5|NOT COMPLETED|Overall Study||1
5130995|NCT01424306|12623069|P4|NOT COMPLETED|Overall Study||0
5130996|NCT01424306|12623070|P3|NOT COMPLETED|Overall Study||0
5130997|NCT01424306|12623071|P2|NOT COMPLETED|Overall Study||0
5130998|NCT01424306|12623072|P1|NOT COMPLETED|Overall Study||0
5130999|NCT01424306|12623067|P6|COMPLETED|Overall Study||6
5131000|NCT01424306|12623068|P5|COMPLETED|Overall Study||4
5131001|NCT01424306|12623069|P4|COMPLETED|Overall Study||3
5131002|NCT01424306|12623070|P3|COMPLETED|Overall Study||3
5131003|NCT01424306|12623071|P2|COMPLETED|Overall Study||4
5131004|NCT01424306|12623072|P1|COMPLETED|Overall Study||4
5131005|NCT01424306|12623067|P6|STARTED|Overall Study||6
5131006|NCT01424306|12623068|P5|STARTED|Overall Study||5
5131007|NCT01424306|12623069|P4|STARTED|Overall Study||3
5131008|NCT01424306|12623070|P3|STARTED|Overall Study||3
5131009|NCT01424306|12623071|P2|STARTED|Overall Study||4
5131010|NCT01424306|12623072|P1|STARTED|Overall Study||4
5131011|NCT01424228|12623121|P2|NOT COMPLETED|Overall Study||47
5131012|NCT01424228|12623122|P1|NOT COMPLETED|Overall Study||56
5131013|NCT01424228|12623121|P2|COMPLETED|Overall Study||135
5131014|NCT01424228|12623122|P1|COMPLETED|Overall Study||126
5131015|NCT01424228|12623121|P2|STARTED|Overall Study||182
5131016|NCT01424228|12623122|P1|STARTED|Overall Study||182
5131017|NCT01424215|12623162|P2|NOT COMPLETED|Overall Study||0
5131018|NCT01424215|12623163|P1|NOT COMPLETED|Overall Study||0
5131019|NCT01424215|12623162|P2|COMPLETED|Overall Study||50
5131020|NCT01424215|12623163|P1|COMPLETED|Overall Study||50
5131021|NCT01424215|12623162|P2|STARTED|Overall Study||50
5131022|NCT01424215|12623163|P1|STARTED|Overall Study||50
5131023|NCT01424189|12623173|P2|NOT COMPLETED|Overall Study||6
5131024|NCT01424189|12623174|P1|NOT COMPLETED|Overall Study||13
5131025|NCT01424189|12623173|P2|COMPLETED|Overall Study||182
5131026|NCT01424189|12623174|P1|COMPLETED|Overall Study||373
5131027|NCT01424189|12623173|P2|STARTED|Overall Study||188
5131028|NCT01424189|12623174|P1|STARTED|Overall Study||386
5131029|NCT01424072|12623189|P3|NOT COMPLETED|Overall Study||0
5131030|NCT01424072|12623190|P2|NOT COMPLETED|Overall Study||0
5131031|NCT01424072|12623191|P1|NOT COMPLETED|Overall Study||0
5131032|NCT01424072|12623189|P3|COMPLETED|Overall Study||22
5131033|NCT01424072|12623190|P2|COMPLETED|Overall Study||26
5131034|NCT01424072|12623191|P1|COMPLETED|Overall Study||27
5131035|NCT01424072|12623189|P3|STARTED|Overall Study||22
5131036|NCT01424072|12623190|P2|STARTED|Overall Study||26
5131037|NCT01424072|12623191|P1|STARTED|Overall Study||27
5131038|NCT01424033|12623208|P1|NOT COMPLETED|Overall Study||5
5131039|NCT01424033|12623208|P1|COMPLETED|Overall Study||0
5131040|NCT01424033|12623208|P1|STARTED|Overall Study||5
5131041|NCT01423916|12623215|P3|NOT COMPLETED|Overall Study||7
5131042|NCT01423916|12623216|P2|NOT COMPLETED|Overall Study||20
5131043|NCT01423916|12623217|P1|NOT COMPLETED|Overall Study||11
5131044|NCT01423916|12623215|P3|COMPLETED|Overall Study||64
5131045|NCT01423916|12623216|P2|COMPLETED|Overall Study||53
5131046|NCT01423916|12623217|P1|COMPLETED|Overall Study||63
5131047|NCT01423916|12623215|P3|STARTED|Overall Study||71
5131048|NCT01423916|12623216|P2|STARTED|Overall Study||73
5131049|NCT01423916|12623217|P1|STARTED|Overall Study||74
5131050|NCT01423812|12623273|P2|NOT COMPLETED|Overall Study||4
5131051|NCT01423812|12623274|P1|NOT COMPLETED|Overall Study||3
5131052|NCT01423812|12623273|P2|COMPLETED|Overall Study||26
5131053|NCT01423812|12623274|P1|COMPLETED|Overall Study||27
5131054|NCT01423812|12623273|P2|STARTED|Overall Study||30
5131055|NCT01423812|12623274|P1|STARTED|Overall Study||30
5131056|NCT01423773|12623282|P2|NOT COMPLETED|Period 2, 2 Days||0
5131057|NCT01423773|12623283|P1|NOT COMPLETED|Period 2, 2 Days||0
5131058|NCT01423773|12623282|P2|COMPLETED|Period 2, 2 Days||10
5131059|NCT01423773|12623283|P1|COMPLETED|Period 2, 2 Days||10
5131060|NCT01423773|12623282|P2|STARTED|Period 2, 2 Days||10
5131061|NCT01423773|12623283|P1|STARTED|Period 2, 2 Days||10
5131062|NCT01423773|12623282|P2|NOT COMPLETED|Period One, 2 Days||0
5131063|NCT01423773|12623283|P1|NOT COMPLETED|Period One, 2 Days||0
5131064|NCT01423773|12623282|P2|COMPLETED|Period One, 2 Days||10
5131065|NCT01423773|12623283|P1|COMPLETED|Period One, 2 Days||10
5131066|NCT01423773|12623282|P2|STARTED|Period One, 2 Days||10
5131067|NCT01423773|12623283|P1|STARTED|Period One, 2 Days||10
5131068|NCT01423760|12623291|P2|NOT COMPLETED|Overall Study||0
5131069|NCT01423760|12623292|P1|NOT COMPLETED|Overall Study||0
5131070|NCT01423760|12623291|P2|COMPLETED|Overall Study||13
5131071|NCT01423760|12623292|P1|COMPLETED|Overall Study||14
5131072|NCT01423760|12623291|P2|Safety Analysis Set|Overall Study||8
5131073|NCT01423760|12623292|P1|Safety Analysis Set|Overall Study||12
5131074|NCT01423760|12623291|P2|Number of Non-treatment Subjects|Overall Study||5
5131075|NCT01423760|12623292|P1|Number of Non-treatment Subjects|Overall Study||2
5131076|NCT01423760|12623291|P2|Number of Tecemotide Subjects|Overall Study||8
5131077|NCT01423760|12623292|P1|Number of Tecemotide Subjects|Overall Study||12
5131078|NCT01423760|12623291|P2|STARTED|Overall Study||13
5131079|NCT01423760|12623292|P1|STARTED|Overall Study||14
5131080|NCT01423617|12623302|P2|NOT COMPLETED|Overall Study||1
5131081|NCT01423617|12623303|P1|NOT COMPLETED|Overall Study||0
5131082|NCT01423617|12623302|P2|COMPLETED|Overall Study||45
5131083|NCT01423617|12623303|P1|COMPLETED|Overall Study||46
5131084|NCT01423617|12623302|P2|STARTED|Overall Study||46
5131085|NCT01423617|12623303|P1|STARTED|Overall Study||46
5131086|NCT01423604|12623320|P2|NOT COMPLETED|Randomized||63
5131087|NCT01423604|12623321|P1|NOT COMPLETED|Randomized||63
5131088|NCT01423604|12623320|P2|COMPLETED|Randomized||0
5131089|NCT01423604|12623321|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
5131090|NCT01423604|12623320|P2|STARTED|Randomized||63
5131091|NCT01423604|12623321|P1|STARTED|Randomized||64
5131092|NCT01423604|12623320|P2|NOT COMPLETED|Safety Run-In||0
5131093|NCT01423604|12623321|P1|NOT COMPLETED|Safety Run-In||9
5131094|NCT01423604|12623320|P2|COMPLETED|Safety Run-In||0
5131095|NCT01423604|12623321|P1|COMPLETED|Safety Run-In||0
5131096|NCT01423604|12623320|P2|STARTED|Safety Run-In||0
5131097|NCT01423604|12623321|P1|STARTED|Safety Run-In||9
5131098|NCT01423253|12623336|P1|NOT COMPLETED|Overall Study||9
5131099|NCT01423253|12623336|P1|COMPLETED|Overall Study||39
5131100|NCT01423253|12623336|P1|STARTED|Overall Study||48
5131101|NCT01423162|12623349|P2|NOT COMPLETED|Overall Study||0
5131102|NCT01423162|12623350|P1|NOT COMPLETED|Overall Study||0
5131103|NCT01423162|12623349|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
5131104|NCT01423162|12623350|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
5131105|NCT01423162|12623349|P2|STARTED|Overall Study||9
5131106|NCT01423162|12623350|P1|STARTED|Overall Study||11
5131107|NCT01423084|12623358|P2|NOT COMPLETED|Overall Study||4
5131108|NCT01423084|12623359|P1|NOT COMPLETED|Overall Study||2
5131109|NCT01423084|12623358|P2|COMPLETED|Overall Study||170
5131110|NCT01423084|12623359|P1|COMPLETED|Overall Study||168
5131111|NCT01423084|12623358|P2|STARTED|Overall Study||174
5131112|NCT01423084|12623359|P1|STARTED|Overall Study||170
5131113|NCT01422915|12623389|P1|NOT COMPLETED|Overall Study||1
5131114|NCT01422915|12623389|P1|COMPLETED|Overall Study||3
5131115|NCT01422915|12623389|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
5131116|NCT01422889|12623394|P1|NOT COMPLETED|Overall Study||9
5131117|NCT01422889|12623394|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
5131118|NCT01422889|12623394|P1|STARTED|Overall Study||1120
5131119|NCT01422876|12623409|P10|NOT COMPLETED|Week 52||17
5131120|NCT01422876|12623410|P9|NOT COMPLETED|Week 52||21
5131121|NCT01422876|12623411|P8|NOT COMPLETED|Week 52||23
5131122|NCT01422876|12623412|P7|NOT COMPLETED|Week 52||16
5131123|NCT01422876|12623413|P6|NOT COMPLETED|Week 52||17
5131124|NCT01422876|12623414|P5|NOT COMPLETED|Week 52||15
5131125|NCT01422876|12623415|P4|NOT COMPLETED|Week 52||18
5131126|NCT01422876|12623416|P3|NOT COMPLETED|Week 52||13
5131127|NCT01422876|12623417|P2|NOT COMPLETED|Week 52||10
5131128|NCT01422876|12623418|P1|NOT COMPLETED|Week 52||12
5131129|NCT01422876|12623409|P10|COMPLETED|Week 52||118
5131130|NCT01422876|12623410|P9|COMPLETED|Week 52||113
5131131|NCT01422876|12623411|P8|COMPLETED|Week 52||112
5131132|NCT01422876|12623412|P7|COMPLETED|Week 52||120
5131133|NCT01422876|12623413|P6|COMPLETED|Week 52||120
5131134|NCT01422876|12623414|P5|COMPLETED|Week 52||117
5131135|NCT01422876|12623415|P4|COMPLETED|Week 52||122
5131136|NCT01422876|12623416|P3|COMPLETED|Week 52||128
5131137|NCT01422876|12623417|P2|COMPLETED|Week 52||126
5131138|NCT01422876|12623418|P1|COMPLETED|Week 52||125
5131139|NCT01422876|12623409|P10|STARTED|Week 52||135
5131140|NCT01422876|12623410|P9|STARTED|Week 52||134
5131141|NCT01422876|12623411|P8|STARTED|Week 52||135
5131142|NCT01422876|12623412|P7|STARTED|Week 52||136
5131143|NCT01422876|12623413|P6|STARTED|Week 52||137
5131144|NCT01422876|12623414|P5|STARTED|Week 52||132
5131145|NCT01422876|12623415|P4|STARTED|Week 52||140
5131146|NCT01422876|12623416|P3|STARTED|Week 52||141
5131147|NCT01422876|12623417|P2|STARTED|Week 52||136
5131148|NCT01422876|12623418|P1|STARTED|Week 52||137
5131149|NCT01422876|12623409|P10|NOT COMPLETED|Week 24||10
5131150|NCT01422876|12623410|P9|NOT COMPLETED|Week 24||6
5131151|NCT01422876|12623411|P8|NOT COMPLETED|Week 24||7
5131152|NCT01422876|12623412|P7|NOT COMPLETED|Week 24||6
5131153|NCT01422876|12623413|P6|NOT COMPLETED|Week 24||6
5131154|NCT01422876|12623414|P5|NOT COMPLETED|Week 24||7
5131155|NCT01422876|12623415|P4|NOT COMPLETED|Week 24||8
5131156|NCT01422876|12623416|P3|NOT COMPLETED|Week 24||5
5131157|NCT01422876|12623417|P2|NOT COMPLETED|Week 24||3
5131158|NCT01422876|12623418|P1|NOT COMPLETED|Week 24||6
5131159|NCT01422876|12623409|P10|COMPLETED|Week 24||125
5131160|NCT01422876|12623410|P9|COMPLETED|Week 24||128
5131161|NCT01422876|12623411|P8|COMPLETED|Week 24||128
5131162|NCT01422876|12623412|P7|COMPLETED|Week 24||130
5131163|NCT01422876|12623413|P6|COMPLETED|Week 24||131
5131164|NCT01422876|12623414|P5|COMPLETED|Week 24||125
5131165|NCT01422876|12623415|P4|COMPLETED|Week 24||132
5131166|NCT01422876|12623416|P3|COMPLETED|Week 24||136
5131167|NCT01422876|12623417|P2|COMPLETED|Week 24||133
5131168|NCT01422876|12623418|P1|COMPLETED|Week 24||131
5131169|NCT01422876|12623409|P10|STARTED|Week 24||135
5131170|NCT01422876|12623410|P9|STARTED|Week 24||134
5131171|NCT01422876|12623411|P8|STARTED|Week 24||135
5131172|NCT01422876|12623412|P7|STARTED|Week 24||136
5131173|NCT01422876|12623413|P6|STARTED|Week 24||137
5131174|NCT01422876|12623414|P5|STARTED|Week 24||132
5131175|NCT01422876|12623415|P4|STARTED|Week 24||140
5131176|NCT01422876|12623416|P3|STARTED|Week 24||141
5131177|NCT01422876|12623417|P2|STARTED|Week 24||136
5131178|NCT01422876|12623418|P1|STARTED|Week 24||137
5131179|NCT01422850|12623465|P1|NOT COMPLETED|Overall Study||3
5131180|NCT01422850|12623465|P1|COMPLETED|Overall Study||18
5131181|NCT01422850|12623465|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
5131182|NCT01422850|12623465|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
5131183|NCT01422850|12623465|P1|Week 9 - Second Treatment|Overall Study||20
5131184|NCT01422850|12623465|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
5131185|NCT01422850|12623465|P1|Week 4 - First Treatment|Overall Study||21
5131186|NCT01422850|12623465|P1|STARTED|Overall Study||21
5131187|NCT01422824|12623471|P1|NOT COMPLETED|Overall Study||38
5131188|NCT01422824|12623471|P1|COMPLETED|Overall Study||147
5131189|NCT01422824|12623471|P1|Treated|Overall Study||184
5131190|NCT01422824|12623471|P1|STARTED|Overall Study||185
5131191|NCT01422720|12623476|P1|NOT COMPLETED|Overall Study||22
5131192|NCT01422720|12623476|P1|COMPLETED|Overall Study||50
5131193|NCT01422720|12623476|P1|Per-Protocol Set (PPS)|Overall Study||55
5131194|NCT01422720|12623476|P1|Full Analysis Set (FAS)|Overall Study||71
5131195|NCT01422720|12623476|P1|Safety Set|Overall Study||72
5131196|NCT01422720|12623476|P1|STARTED|Overall Study||72
5131197|NCT01422538|12623487|P3|NOT COMPLETED|Overall Study||2
5131198|NCT01422538|12623488|P2|NOT COMPLETED|Overall Study||2
5131199|NCT01422538|12623489|P1|NOT COMPLETED|Overall Study||0
5131200|NCT01422538|12623487|P3|COMPLETED|Overall Study||8
5131201|NCT01422538|12623488|P2|COMPLETED|Overall Study||8
5131202|NCT01422538|12623489|P1|COMPLETED|Overall Study||10
5131203|NCT01422538|12623487|P3|STARTED|Overall Study||10
5131204|NCT01422538|12623488|P2|STARTED|Overall Study||10
5131205|NCT01422538|12623489|P1|STARTED|Overall Study||10
5131206|NCT01422434|12623514|P3|NOT COMPLETED|Overall Study||6
5131207|NCT01422434|12623515|P2|NOT COMPLETED|Overall Study||5
5131208|NCT01422434|12623516|P1|NOT COMPLETED|Overall Study||11
5131209|NCT01422434|12623514|P3|COMPLETED|Overall Study||217
5131210|NCT01422434|12623515|P2|COMPLETED|Overall Study||221
5131211|NCT01422434|12623516|P1|COMPLETED|Overall Study||216
5131212|NCT01422434|12623514|P3|STARTED|Overall Study||223
5131213|NCT01422434|12623515|P2|STARTED|Overall Study||226
5131214|NCT01422434|12623516|P1|STARTED|Overall Study||227
5131215|NCT01422408|12623533|P1|NOT COMPLETED|Overall Study||4
5131216|NCT01422408|12623533|P1|COMPLETED|Overall Study||30
5131217|NCT01422408|12623533|P1|STARTED|Overall Study||34
5131218|NCT01422382|12623562|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
5131219|NCT01422382|12623562|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
5131220|NCT01422382|12623562|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
5131221|NCT01422382|12623562|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
5131222|NCT01422382|12623562|P1|COMPLETED|Diltiazem 240 mg QD||28
5131223|NCT01422382|12623562|P1|STARTED|Diltiazem 240 mg QD||28
5131224|NCT01422382|12623562|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
5131225|NCT01422382|12623562|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
5131226|NCT01422382|12623562|P1|STARTED|NK-104 4mg Once Daily (QD)||28
5131227|NCT01422369|12623567|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
5131228|NCT01422369|12623567|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
5131229|NCT01422369|12623567|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
5131230|NCT01422369|12623567|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
5131231|NCT01422369|12623567|P1|COMPLETED|Prezista 800mg/100mg QD||28
5131232|NCT01422369|12623567|P1|STARTED|Prezista 800mg/100mg QD||28
5131233|NCT01422369|12623567|P1|NOT COMPLETED|NK-104 4mg QD||0
5131234|NCT01422369|12623567|P1|COMPLETED|NK-104 4mg QD||28
5131235|NCT01422369|12623567|P1|STARTED|NK-104 4mg QD||28
5131236|NCT01422356|12623572|P1|NOT COMPLETED|Overall Study||31
5131237|NCT01422356|12623572|P1|COMPLETED|Overall Study||169
5131238|NCT01422356|12623572|P1|STARTED|Overall Study||200
5131239|NCT01422304|12623578|P2|NOT COMPLETED|Overall Study||37
5131240|NCT01422304|12623579|P1|NOT COMPLETED|Overall Study||24
5131241|NCT01422304|12623578|P2|COMPLETED|Overall Study||563
5131242|NCT01422304|12623579|P1|COMPLETED|Overall Study||574
5131243|NCT01422304|12623578|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
5131244|NCT01422304|12623579|P1|Treated|Overall Study||595
5131245|NCT01422304|12623578|P2|STARTED|Overall Study|Randomized|600
5131246|NCT01422304|12623579|P1|STARTED|Overall Study|Randomized|598
5131247|NCT01422239|12623611|P2|NOT COMPLETED|Overall Study||3
5131248|NCT01422239|12623612|P1|NOT COMPLETED|Overall Study||4
5131249|NCT01422239|12623611|P2|COMPLETED|Overall Study||3
5131250|NCT01422239|12623612|P1|COMPLETED|Overall Study||10
5131251|NCT01422239|12623611|P2|STARTED|Overall Study||6
5131252|NCT01422239|12623612|P1|STARTED|Overall Study||14
5131253|NCT01422226|12623624|P2|NOT COMPLETED|Overall Study||0
5131254|NCT01422226|12623625|P1|NOT COMPLETED|Overall Study||0
5131255|NCT01422226|12623624|P2|COMPLETED|Overall Study||2
5131256|NCT01422226|12623625|P1|COMPLETED|Overall Study||1
5131257|NCT01422226|12623624|P2|STARTED|Overall Study||2
5131258|NCT01422226|12623625|P1|STARTED|Overall Study||1
5131259|NCT01422213|12623634|P3|NOT COMPLETED|Overall Study||29
5131260|NCT01422213|12623635|P2|NOT COMPLETED|Overall Study||22
5131261|NCT01422213|12623636|P1|NOT COMPLETED|Overall Study||33
5131262|NCT01422213|12623634|P3|COMPLETED|Overall Study||178
5131263|NCT01422213|12623635|P2|COMPLETED|Overall Study||173
5131264|NCT01422213|12623636|P1|COMPLETED|Overall Study||163
5131265|NCT01422213|12623634|P3|STARTED|Overall Study||207
5131266|NCT01422213|12623635|P2|STARTED|Overall Study||195
5131267|NCT01422213|12623636|P1|STARTED|Overall Study||196
5131268|NCT01422187|12623697|P3|NOT COMPLETED|Overall Study||0
5131269|NCT01422187|12623698|P2|NOT COMPLETED|Overall Study||1
5131270|NCT01422187|12623699|P1|NOT COMPLETED|Overall Study||1
5131271|NCT01422187|12623697|P3|COMPLETED|Overall Study||2
5131272|NCT01422187|12623698|P2|COMPLETED|Overall Study||8
5131273|NCT01422187|12623699|P1|COMPLETED|Overall Study||7
5131274|NCT01422187|12623697|P3|STARTED|Overall Study||2
5131275|NCT01422187|12623698|P2|STARTED|Overall Study||9
5131276|NCT01422187|12623699|P1|STARTED|Overall Study||8
5131277|NCT01422161|12623718|P2|NOT COMPLETED|Overall Study||0
5131278|NCT01422161|12623719|P1|NOT COMPLETED|Overall Study||0
5131279|NCT01422161|12623718|P2|COMPLETED|Overall Study||6
5131280|NCT01422161|12623719|P1|COMPLETED|Overall Study||10
5131281|NCT01422161|12623718|P2|STARTED|Overall Study||6
5131282|NCT01422161|12623719|P1|STARTED|Overall Study||10
5131283|NCT01422135|12623735|P6|NOT COMPLETED|Overall Study||1
5131284|NCT01422135|12623736|P5|NOT COMPLETED|Overall Study||0
5131285|NCT01422135|12623737|P4|NOT COMPLETED|Overall Study||0
5131286|NCT01422135|12623738|P3|NOT COMPLETED|Overall Study||1
5131287|NCT01422135|12623739|P2|NOT COMPLETED|Overall Study||0
5131288|NCT01422135|12623740|P1|NOT COMPLETED|Overall Study||0
5131289|NCT01422135|12623735|P6|COMPLETED|Overall Study||3
5131290|NCT01422135|12623736|P5|COMPLETED|Overall Study||4
5131291|NCT01422135|12623737|P4|COMPLETED|Overall Study||4
5131292|NCT01422135|12623738|P3|COMPLETED|Overall Study||3
5131293|NCT01422135|12623739|P2|COMPLETED|Overall Study||4
5131294|NCT01422135|12623740|P1|COMPLETED|Overall Study||4
5131295|NCT01422135|12623735|P6|STARTED|Overall Study||4
5131296|NCT01422135|12623736|P5|STARTED|Overall Study||4
5131297|NCT01422135|12623737|P4|STARTED|Overall Study||4
5131298|NCT01422135|12623738|P3|STARTED|Overall Study||4
5131299|NCT01422135|12623739|P2|STARTED|Overall Study||4
5131300|NCT01422135|12623740|P1|STARTED|Overall Study||4
5131301|NCT01422070|12623751|P2|NOT COMPLETED|Overall Study||0
5131302|NCT01422070|12623752|P1|NOT COMPLETED|Overall Study||0
5131303|NCT01422070|12623751|P2|COMPLETED|Overall Study||803
5131304|NCT01422070|12623752|P1|COMPLETED|Overall Study||5031
5131305|NCT01422070|12623751|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
5131306|NCT01422070|12623752|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
5131307|NCT01421719|12623763|P1|NOT COMPLETED|Overall Study||4
5131308|NCT01421719|12623763|P1|COMPLETED|Overall Study||16
5131309|NCT01421719|12623763|P1|STARTED|Overall Study||20
5131310|NCT01421667|12623772|P4|NOT COMPLETED|Overall Study||1
5131311|NCT01421667|12623773|P3|NOT COMPLETED|Overall Study||2
5131312|NCT01421667|12623774|P2|NOT COMPLETED|Overall Study||2
5131313|NCT01421667|12623775|P1|NOT COMPLETED|Overall Study||0
5131314|NCT01421667|12623772|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
5131315|NCT01421667|12623773|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
5131316|NCT01421667|12623774|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
5131317|NCT01421667|12623775|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
5131318|NCT01421667|12623772|P4|STARTED|Overall Study||16
5131319|NCT01421667|12623773|P3|STARTED|Overall Study||53
5131320|NCT01421667|12623774|P2|STARTED|Overall Study||68
5131321|NCT01421667|12623775|P1|STARTED|Overall Study||35
5131322|NCT01421654|12623827|P2|NOT COMPLETED|Overall Study||0
5131323|NCT01421654|12623828|P1|NOT COMPLETED|Overall Study||0
5131324|NCT01421654|12623827|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
5131325|NCT01421654|12623828|P1|COMPLETED|Overall Study||11
5131326|NCT01421654|12623827|P2|STARTED|Overall Study||9
5131327|NCT01421654|12623828|P1|STARTED|Overall Study||11
5131328|NCT01421641|12623836|P2|NOT COMPLETED|Overall Study||2
5131329|NCT01421641|12623837|P1|NOT COMPLETED|Overall Study||2
5131330|NCT01421641|12623836|P2|COMPLETED|Overall Study||35
5131331|NCT01421641|12623837|P1|COMPLETED|Overall Study||35
5131332|NCT01421641|12623836|P2|STARTED|Overall Study||37
5131333|NCT01421641|12623837|P1|STARTED|Overall Study||37
5131334|NCT01421589|12623847|P1|NOT COMPLETED|Overall Study||0
5131335|NCT01421589|12623847|P1|COMPLETED|Overall Study||15
5131336|NCT01421589|12623847|P1|STARTED|Overall Study||15
5131337|NCT01421511|12623859|P2|NOT COMPLETED|Overall Study||28
5131338|NCT01421511|12623860|P1|NOT COMPLETED|Overall Study||19
5131339|NCT01421511|12623859|P2|COMPLETED|Overall Study||306
5131340|NCT01421511|12623860|P1|COMPLETED|Overall Study||313
5131341|NCT01421511|12623859|P2|STARTED|Overall Study||334
5131342|NCT01421511|12623860|P1|STARTED|Overall Study||332
5131343|NCT01421498|12623882|P2|NOT COMPLETED|Overall Study||11
5131344|NCT01421498|12623883|P1|NOT COMPLETED|Overall Study||12
5131345|NCT01421498|12623882|P2|COMPLETED|Overall Study||284
5131346|NCT01421498|12623883|P1|COMPLETED|Overall Study||281
5131347|NCT01421498|12623882|P2|STARTED|Overall Study||295
5131348|NCT01421498|12623883|P1|STARTED|Overall Study||293
5131349|NCT01421472|12623895|P4|NOT COMPLETED|Overall Study||0
5131350|NCT01421472|12623896|P3|NOT COMPLETED|Overall Study||0
5131351|NCT01421472|12623897|P2|NOT COMPLETED|Overall Study||0
5131352|NCT01421472|12623898|P1|NOT COMPLETED|Overall Study||0
5131353|NCT01421472|12623895|P4|COMPLETED|Overall Study||32
5131354|NCT01421472|12623896|P3|COMPLETED|Overall Study||64
5131355|NCT01421472|12623897|P2|COMPLETED|Overall Study||33
5131356|NCT01421472|12623898|P1|COMPLETED|Overall Study||67
5131357|NCT01421472|12623895|P4|STARTED|Overall Study||32
5131358|NCT01421472|12623896|P3|STARTED|Overall Study||64
5131359|NCT01421472|12623897|P2|STARTED|Overall Study||33
5131360|NCT01421472|12623898|P1|STARTED|Overall Study||67
5131361|NCT01421459|12623910|P2|NOT COMPLETED|Overall Study||52
5131362|NCT01421459|12623911|P1|NOT COMPLETED|Overall Study||45
5131363|NCT01421459|12623910|P2|COMPLETED|Overall Study||328
5131364|NCT01421459|12623911|P1|COMPLETED|Overall Study||334
5131365|NCT01421459|12623910|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
5131366|NCT01421459|12623911|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
5131367|NCT01421459|12623910|P2|STARTED|Overall Study||380
5131368|NCT01421459|12623911|P1|STARTED|Overall Study||379
5131369|NCT01421355|12623945|P1|NOT COMPLETED|Overall Study||6
5131370|NCT01421355|12623945|P1|COMPLETED|Overall Study||15
5131371|NCT01421355|12623945|P1|STARTED|Overall Study||21
5131372|NCT01421342|12623952|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
5131373|NCT01421342|12623953|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
5131374|NCT01421342|12623954|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
5131375|NCT01421342|12623952|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
5131376|NCT01421342|12623953|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
5131377|NCT01421342|12623954|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
5131378|NCT01421342|12623952|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
5131379|NCT01421342|12623953|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
5131380|NCT01421342|12623954|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
5131381|NCT01421342|12623952|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
5131382|NCT01421342|12623953|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
5131383|NCT01421342|12623954|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
5131384|NCT01421342|12623952|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
5131385|NCT01421342|12623953|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
5131386|NCT01421342|12623954|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
5131387|NCT01421342|12623952|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
5131388|NCT01421342|12623953|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
5131389|NCT01421342|12623954|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
5131390|NCT01421342|12623952|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
5131391|NCT01421342|12623953|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
5131392|NCT01421342|12623954|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
5131393|NCT01421342|12623952|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
5131394|NCT01421342|12623953|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
5131395|NCT01421342|12623954|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
5131396|NCT01421342|12623952|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
5131397|NCT01421342|12623953|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
5131398|NCT01421342|12623954|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
5131399|NCT01421303|12623971|P1|NOT COMPLETED|Overall Study||22
5131400|NCT01421303|12623971|P1|COMPLETED|Overall Study||58
5131401|NCT01421303|12623971|P1|STARTED|Overall Study||80
5131402|NCT01421277|12623998|P2|NOT COMPLETED|Overall Study||92
5131403|NCT01421277|12623999|P1|NOT COMPLETED|Overall Study||0
5131404|NCT01421277|12623998|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
5131405|NCT01421277|12623999|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
5131406|NCT01421277|12623998|P2|STARTED|Overall Study||191
5131407|NCT01421277|12623999|P1|STARTED|Overall Study||25
5131408|NCT01421225|12624011|P2|NOT COMPLETED|Overall Study||1
5131409|NCT01421225|12624012|P1|NOT COMPLETED|Overall Study||0
5131410|NCT01421225|12624011|P2|COMPLETED|Overall Study||5
5131411|NCT01421225|12624012|P1|COMPLETED|Overall Study||4
5131412|NCT01421225|12624011|P2|STARTED|Overall Study||6
5131413|NCT01421225|12624012|P1|STARTED|Overall Study||4
5131414|NCT01421147|12624026|P2|NOT COMPLETED|Extension Period||11
5131415|NCT01421147|12624027|P1|NOT COMPLETED|Extension Period||8
5131416|NCT01421147|12624026|P2|COMPLETED|Extension Period||245
5131417|NCT01421147|12624027|P1|COMPLETED|Extension Period||245
5131418|NCT01421147|12624026|P2|STARTED|Extension Period||256
5131419|NCT01421147|12624027|P1|STARTED|Extension Period||253
5131420|NCT01421147|12624026|P2|NOT COMPLETED|Treatment Period||11
5131421|NCT01421147|12624027|P1|NOT COMPLETED|Treatment Period||16
5131422|NCT01421147|12624026|P2|COMPLETED|Treatment Period||256
5131423|NCT01421147|12624027|P1|COMPLETED|Treatment Period||253
5131424|NCT01421147|12624026|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
5131425|NCT01421147|12624027|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
5131426|NCT01421147|12624026|P2|STARTED|Treatment Period||267
5131427|NCT01421147|12624027|P1|STARTED|Treatment Period||269
5131428|NCT01421134|12624059|P2|NOT COMPLETED|Overall Study||15
5131429|NCT01421134|12624060|P1|NOT COMPLETED|Overall Study||7
5131430|NCT01421134|12624059|P2|COMPLETED|Overall Study||87
5131431|NCT01421134|12624060|P1|COMPLETED|Overall Study||102
5131432|NCT01421134|12624059|P2|STARTED|Overall Study||102
5131433|NCT01421134|12624060|P1|STARTED|Overall Study||109
5131434|NCT01420965|12624081|P3|NOT COMPLETED|Overall Study||0
5131435|NCT01420965|12624082|P2|NOT COMPLETED|Overall Study||1
5131436|NCT01420965|12624083|P1|NOT COMPLETED|Overall Study||1
5131437|NCT01420965|12624081|P3|COMPLETED|Overall Study||3
5131438|NCT01420965|12624082|P2|COMPLETED|Overall Study||1
5131439|NCT01420965|12624083|P1|COMPLETED|Overall Study||1
5131440|NCT01420965|12624081|P3|STARTED|Overall Study||3
5131441|NCT01420965|12624082|P2|STARTED|Overall Study||2
5131442|NCT01420965|12624083|P1|STARTED|Overall Study||2
5131443|NCT01420926|12624096|P2|NOT COMPLETED|Overall Study||65
5131444|NCT01420926|12624097|P1|NOT COMPLETED|Overall Study||60
5131445|NCT01420926|12624096|P2|COMPLETED|Overall Study||16
5131446|NCT01420926|12624097|P1|COMPLETED|Overall Study||22
5131447|NCT01420926|12624096|P2|STARTED|Overall Study||81
5131448|NCT01420926|12624097|P1|STARTED|Overall Study||82
5131449|NCT01420848|12624114|P3|NOT COMPLETED|Overall Study||0
5131450|NCT01420848|12624115|P2|NOT COMPLETED|Overall Study||0
5131451|NCT01420848|12624116|P1|NOT COMPLETED|Overall Study||0
5131452|NCT01420848|12624114|P3|COMPLETED|Overall Study||22
5131453|NCT01420848|12624115|P2|COMPLETED|Overall Study||25
5131454|NCT01420848|12624116|P1|COMPLETED|Overall Study||24
5131455|NCT01420848|12624114|P3|STARTED|Overall Study||22
5131456|NCT01420848|12624115|P2|STARTED|Overall Study||25
5131457|NCT01420848|12624116|P1|STARTED|Overall Study||24
5131458|NCT01420653|12624131|P4|NOT COMPLETED|Overall Study||7
5131459|NCT01420653|12624132|P3|NOT COMPLETED|Overall Study||4
5131460|NCT01420653|12624133|P2|NOT COMPLETED|Overall Study||3
5131461|NCT01420653|12624134|P1|NOT COMPLETED|Overall Study||3
5131462|NCT01420653|12624131|P4|COMPLETED|Overall Study||68
5131463|NCT01420653|12624132|P3|COMPLETED|Overall Study||108
5131464|NCT01420653|12624133|P2|COMPLETED|Overall Study||108
5131465|NCT01420653|12624134|P1|COMPLETED|Overall Study||107
5131466|NCT01420653|12624131|P4|STARTED|Overall Study||75
5131467|NCT01420653|12624132|P3|STARTED|Overall Study||112
5131468|NCT01420653|12624133|P2|STARTED|Overall Study||111
5131469|NCT01420653|12624134|P1|STARTED|Overall Study||110
5131470|NCT01420627|12624144|P1|NOT COMPLETED|EZN-2279 Maintenance Period||0
5131471|NCT01420627|12624144|P1|COMPLETED|EZN-2279 Maintenance Period||6
5131472|NCT01420627|12624144|P1|STARTED|EZN-2279 Maintenance Period||6
5131473|NCT01420627|12624144|P1|NOT COMPLETED|EZN-2279 Treatment Period||1
5131474|NCT01420627|12624144|P1|COMPLETED|EZN-2279 Treatment Period||6
5131475|NCT01420627|12624144|P1|STARTED|EZN-2279 Treatment Period||7
5131476|NCT01420627|12624144|P1|NOT COMPLETED|Adagen Lead-in Period||0
5131477|NCT01420627|12624144|P1|COMPLETED|Adagen Lead-in Period||7
5131478|NCT01420627|12624144|P1|STARTED|Adagen Lead-in Period||7
5131479|NCT01420549|12624160|P2|NOT COMPLETED|Overall Study||5
5131480|NCT01420549|12624161|P1|NOT COMPLETED|Overall Study||7
5131481|NCT01420549|12624160|P2|COMPLETED|Overall Study||58
5131482|NCT01420549|12624161|P1|COMPLETED|Overall Study||59
5131483|NCT01420549|12624160|P2|STARTED|Overall Study||63
5131484|NCT01420549|12624161|P1|STARTED|Overall Study||66
5131485|NCT01420289|12624169|P2|NOT COMPLETED|Overall Study||0
5131486|NCT01420289|12624170|P1|NOT COMPLETED|Overall Study||0
5131487|NCT01420289|12624169|P2|COMPLETED|Overall Study||16
5131488|NCT01420289|12624170|P1|COMPLETED|Overall Study||18
5131489|NCT01420289|12624169|P2|STARTED|Overall Study||16
5131490|NCT01420289|12624170|P1|STARTED|Overall Study||18
5131491|NCT01420146|12624182|P1|NOT COMPLETED|Overall Study||0
5131492|NCT01420146|12624182|P1|COMPLETED|Overall Study||20
5131493|NCT01420146|12624182|P1|STARTED|Overall Study||20
5131494|NCT01420081|12624195|P9|NOT COMPLETED|Overall Study||3
5131495|NCT01420081|12624196|P8|NOT COMPLETED|Overall Study||3
5131496|NCT01420081|12624197|P7|NOT COMPLETED|Overall Study||3
5131497|NCT01420081|12624198|P6|NOT COMPLETED|Overall Study||20
5131498|NCT01420081|12624199|P5|NOT COMPLETED|Overall Study||20
5131499|NCT01420081|12624200|P4|NOT COMPLETED|Overall Study||3
5131500|NCT01420081|12624201|P3|NOT COMPLETED|Overall Study||11
5131501|NCT01420081|12624202|P2|NOT COMPLETED|Overall Study||1
5131502|NCT01420081|12624203|P1|NOT COMPLETED|Overall Study||3
5131503|NCT01420081|12624195|P9|COMPLETED|Overall Study||0
5131504|NCT01420081|12624196|P8|COMPLETED|Overall Study||0
5131505|NCT01420081|12624197|P7|COMPLETED|Overall Study||0
5131506|NCT01420081|12624198|P6|COMPLETED|Overall Study||0
5131507|NCT01420081|12624199|P5|COMPLETED|Overall Study||0
5131508|NCT01420081|12624200|P4|COMPLETED|Overall Study||0
5131509|NCT01420081|12624201|P3|COMPLETED|Overall Study||0
5131510|NCT01420081|12624202|P2|COMPLETED|Overall Study||0
5131511|NCT01420081|12624203|P1|COMPLETED|Overall Study||0
5131512|NCT01420081|12624195|P9|STARTED|Overall Study||3
5131513|NCT01420081|12624196|P8|STARTED|Overall Study||3
5131514|NCT01420081|12624197|P7|STARTED|Overall Study||3
5131515|NCT01420081|12624198|P6|STARTED|Overall Study||20
5131516|NCT01420081|12624199|P5|STARTED|Overall Study||20
5131517|NCT01420081|12624200|P4|STARTED|Overall Study||3
5131518|NCT01420081|12624201|P3|STARTED|Overall Study||11
5131519|NCT01420081|12624202|P2|STARTED|Overall Study||1
5131520|NCT01420081|12624203|P1|STARTED|Overall Study||3
5131521|NCT01420068|12624284|P2|NOT COMPLETED|Overall Study||5
5131522|NCT01420068|12624285|P1|NOT COMPLETED|Overall Study||2
5131523|NCT01420068|12624284|P2|COMPLETED|Overall Study||50
5131524|NCT01420068|12624285|P1|COMPLETED|Overall Study||49
5131525|NCT01420068|12624284|P2|STARTED|Overall Study||55
5131526|NCT01420068|12624285|P1|STARTED|Overall Study||51
5131527|NCT01420016|12624307|P4|NOT COMPLETED|Safety Analysis||0
5131528|NCT01420016|12624308|P3|NOT COMPLETED|Safety Analysis||0
5131529|NCT01420016|12624309|P2|NOT COMPLETED|Safety Analysis||0
5131530|NCT01420016|12624310|P1|NOT COMPLETED|Safety Analysis||0
5131531|NCT01420016|12624307|P4|COMPLETED|Safety Analysis||5159
5131532|NCT01420016|12624308|P3|COMPLETED|Safety Analysis||6392
5131533|NCT01420016|12624309|P2|COMPLETED|Safety Analysis||0
5131534|NCT01420016|12624310|P1|COMPLETED|Safety Analysis||0
5131535|NCT01420016|12624307|P4|STARTED|Safety Analysis||5159
5131536|NCT01420016|12624308|P3|STARTED|Safety Analysis||6392
5131537|NCT01420016|12624309|P2|STARTED|Safety Analysis||0
5131538|NCT01420016|12624310|P1|STARTED|Safety Analysis||0
5131539|NCT01420016|12624307|P4|NOT COMPLETED|Primary Analysis||0
5131540|NCT01420016|12624308|P3|NOT COMPLETED|Primary Analysis||0
5131541|NCT01420016|12624309|P2|NOT COMPLETED|Primary Analysis||2540
5131542|NCT01420016|12624310|P1|NOT COMPLETED|Primary Analysis||2927
5131543|NCT01420016|12624307|P4|COMPLETED|Primary Analysis||0
5131544|NCT01420016|12624308|P3|COMPLETED|Primary Analysis||0
5131545|NCT01420016|12624309|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
5131546|NCT01420016|12624310|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
5131547|NCT01420016|12624307|P4|STARTED|Primary Analysis||0
5131548|NCT01420016|12624308|P3|STARTED|Primary Analysis||0
5131549|NCT01420016|12624309|P2|STARTED|Primary Analysis||6411
5131550|NCT01420016|12624310|P1|STARTED|Primary Analysis||6970
5131551|NCT01419977|12624318|P2|NOT COMPLETED|Overall Study||0
5131552|NCT01419977|12624319|P1|NOT COMPLETED|Overall Study||0
5131553|NCT01419977|12624318|P2|COMPLETED|Overall Study||13
5131554|NCT01419977|12624319|P1|COMPLETED|Overall Study||16
5131555|NCT01419977|12624318|P2|STARTED|Overall Study||13
5131556|NCT01419977|12624319|P1|STARTED|Overall Study||16
5131557|NCT01419795|12624333|P2|NOT COMPLETED|Overall Study||0
5131558|NCT01419795|12624334|P1|NOT COMPLETED|Overall Study||0
5131559|NCT01419795|12624333|P2|COMPLETED|Overall Study||0
5131560|NCT01419795|12624334|P1|COMPLETED|Overall Study||3
5131561|NCT01419795|12624333|P2|STARTED|Overall Study||0
5131562|NCT01419795|12624334|P1|STARTED|Overall Study||3
5131563|NCT01419769|12624356|P1|NOT COMPLETED|Overall Study||4
5131564|NCT01419769|12624356|P1|COMPLETED|Overall Study||29
5131565|NCT01419769|12624356|P1|STARTED|Overall Study||33
5131566|NCT01419717|12624369|P1|NOT COMPLETED|Overall Study||125
5131567|NCT01419717|12624369|P1|COMPLETED|Overall Study||4
5131568|NCT01419717|12624369|P1|Received Denosumab|Overall Study||128
5131569|NCT01419717|12624369|P1|STARTED|Overall Study||129
5131570|NCT01419639|12624374|P1|NOT COMPLETED|Overall Study||1
5131571|NCT01419639|12624374|P1|COMPLETED|Overall Study||9
5131572|NCT01419639|12624374|P1|STARTED|Overall Study||10
5131573|NCT01419626|12624383|P3|NOT COMPLETED|Overall Study||3
5131574|NCT01419626|12624384|P2|NOT COMPLETED|Overall Study||3
5131575|NCT01419626|12624385|P1|NOT COMPLETED|Overall Study||4
5131576|NCT01419626|12624383|P3|COMPLETED|Overall Study||44
5131577|NCT01419626|12624384|P2|COMPLETED|Overall Study||44
5131578|NCT01419626|12624385|P1|COMPLETED|Overall Study||42
5131579|NCT01419626|12624383|P3|STARTED|Overall Study||47
5131580|NCT01419626|12624384|P2|STARTED|Overall Study||47
5131581|NCT01419626|12624385|P1|STARTED|Overall Study||46
5131582|NCT01419314|12624416|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
5131583|NCT01419314|12624417|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
5131584|NCT01419314|12624416|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
5131585|NCT01419314|12624417|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
5131586|NCT01419314|12624416|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
5131587|NCT01419314|12624417|P1|STARTED|Follow-up at Week 6 of the Trial||17
5131588|NCT01419314|12624416|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
5131589|NCT01419314|12624417|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
5131590|NCT01419314|12624416|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
5131591|NCT01419314|12624417|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
5131592|NCT01419314|12624416|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
5131593|NCT01419314|12624417|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
5131594|NCT01419314|12624416|P2|NOT COMPLETED|Start of Study||0
5131595|NCT01419314|12624417|P1|NOT COMPLETED|Start of Study||0
5131596|NCT01419314|12624416|P2|COMPLETED|Start of Study||22
5131597|NCT01419314|12624417|P1|COMPLETED|Start of Study||23
5131598|NCT01419314|12624416|P2|STARTED|Start of Study|No comfort issues reported.|22
5131599|NCT01419314|12624417|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
5131600|NCT01419275|12624437|P1|NOT COMPLETED|Overall Study||0
5131601|NCT01419275|12624437|P1|COMPLETED|Overall Study||126
5131602|NCT01419275|12624437|P1|STARTED|Overall Study||126
5131603|NCT01419249|12624443|P2|NOT COMPLETED|Overall Study||0
5131604|NCT01419249|12624444|P1|NOT COMPLETED|Overall Study||0
5131605|NCT01419249|12624443|P2|COMPLETED|Overall Study||140
5131606|NCT01419249|12624444|P1|COMPLETED|Overall Study||318
5131607|NCT01419249|12624443|P2|STARTED|Overall Study||140
5131608|NCT01419249|12624444|P1|STARTED|Overall Study||318
5131609|NCT01419236|12624458|P2|NOT COMPLETED|Overall Study||5
5131610|NCT01419236|12624459|P1|NOT COMPLETED|Overall Study||5
5131611|NCT01419236|12624458|P2|COMPLETED|Overall Study||35
5131612|NCT01419236|12624459|P1|COMPLETED|Overall Study||31
5131613|NCT01419236|12624458|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
5131614|NCT01419236|12624459|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
5131615|NCT01419236|12624458|P2|STARTED|Overall Study||40
5131616|NCT01419236|12624459|P1|STARTED|Overall Study||36
5131617|NCT01419197|12624483|P2|NOT COMPLETED|Overall Study||198
5131618|NCT01419197|12624484|P1|NOT COMPLETED|Overall Study||404
5131619|NCT01419197|12624483|P2|COMPLETED|Overall Study||0
5131620|NCT01419197|12624484|P1|COMPLETED|Overall Study||0
5131621|NCT01419197|12624483|P2|Switched to Trastuzumab Emtansine|Overall Study||94
5131622|NCT01419197|12624484|P1|Switched to Trastuzumab Emtansine|Overall Study||0
5131623|NCT01419197|12624483|P2|STARTED|Overall Study||198
5131624|NCT01419197|12624484|P1|STARTED|Overall Study||404
5131625|NCT01419184|12624509|P2|NOT COMPLETED|Overall Study||15
5131626|NCT01419184|12624510|P1|NOT COMPLETED|Overall Study||10
5131627|NCT01419184|12624509|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
5131628|NCT01419184|12624510|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
5131629|NCT01419184|12624509|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
5131630|NCT01419184|12624510|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
5131631|NCT01419184|12624509|P2|STARTED|Overall Study||121
5131632|NCT01419184|12624510|P1|STARTED|Overall Study||128
5131633|NCT01419171|12624526|P1|NOT COMPLETED|Overall Study||0
5131634|NCT01419171|12624526|P1|COMPLETED|Overall Study||328
5131635|NCT01419171|12624526|P1|STARTED|Overall Study||328
5131636|NCT01419080|12624543|P1|NOT COMPLETED|Overall Study||131
5131637|NCT01419080|12624543|P1|COMPLETED|Overall Study||666
5131638|NCT01419080|12624543|P1|STARTED|Overall Study||797
5131639|NCT01419028|12624549|P1|NOT COMPLETED|Overall Study||0
5131640|NCT01419028|12624549|P1|COMPLETED|Overall Study||48
5131641|NCT01419028|12624549|P1|STARTED|Overall Study||48
5131642|NCT01418937|12624554|P1|NOT COMPLETED|Overall Study||8
5131643|NCT01418937|12624554|P1|COMPLETED|Overall Study||156
5131644|NCT01418937|12624554|P1|STARTED|Overall Study||164
5131645|NCT01418703|12624563|P4|NOT COMPLETED|Overall Study||0
5131646|NCT01418703|12624564|P3|NOT COMPLETED|Overall Study||0
5131647|NCT01418703|12624565|P2|NOT COMPLETED|Overall Study||0
5131648|NCT01418703|12624566|P1|NOT COMPLETED|Overall Study||0
5131649|NCT01418703|12624563|P4|COMPLETED|Overall Study||6
5131650|NCT01418703|12624564|P3|COMPLETED|Overall Study||6
5131651|NCT01418703|12624565|P2|COMPLETED|Overall Study||13
5131652|NCT01418703|12624566|P1|COMPLETED|Overall Study||13
5131653|NCT01418703|12624563|P4|STARTED|Overall Study||6
5131654|NCT01418703|12624564|P3|STARTED|Overall Study||6
5131655|NCT01418703|12624565|P2|STARTED|Overall Study||13
5131656|NCT01418703|12624566|P1|STARTED|Overall Study||13
5131657|NCT01418482|12624577|P1|NOT COMPLETED|Overall Study||0
5131658|NCT01418482|12624577|P1|COMPLETED|Overall Study||15
5131659|NCT01418482|12624577|P1|STARTED|Overall Study||15
5131660|NCT01418378|12624585|P2|NOT COMPLETED|Overall Study||5
5131661|NCT01418378|12624586|P1|NOT COMPLETED|Overall Study||1
5131662|NCT01418378|12624585|P2|COMPLETED|Overall Study||83
5131663|NCT01418378|12624586|P1|COMPLETED|Overall Study||89
5131664|NCT01418378|12624585|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
5131665|NCT01418378|12624586|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
5131666|NCT01418378|12624585|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
5131667|NCT01418378|12624586|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
5131668|NCT01418365|12624660|P2|NOT COMPLETED|Second Intervention||1
5131669|NCT01418365|12624661|P1|NOT COMPLETED|Second Intervention||0
5131670|NCT01418365|12624660|P2|COMPLETED|Second Intervention||13
5131671|NCT01418365|12624661|P1|COMPLETED|Second Intervention||14
5131672|NCT01418365|12624660|P2|STARTED|Second Intervention||14
5131673|NCT01418365|12624661|P1|STARTED|Second Intervention||14
5131674|NCT01418365|12624660|P2|NOT COMPLETED|First Intervention||1
5131675|NCT01418365|12624661|P1|NOT COMPLETED|First Intervention||1
5131676|NCT01418365|12624660|P2|COMPLETED|First Intervention||14
5131677|NCT01418365|12624661|P1|COMPLETED|First Intervention||14
5131678|NCT01418365|12624660|P2|STARTED|First Intervention||15
5131679|NCT01418365|12624661|P1|STARTED|First Intervention||15
5131680|NCT01418209|12624672|P3|NOT COMPLETED|Overall Study||4
5131681|NCT01418209|12624673|P2|NOT COMPLETED|Overall Study||3
5131682|NCT01418209|12624674|P1|NOT COMPLETED|Overall Study||2
5131683|NCT01418209|12624672|P3|COMPLETED|Overall Study||142
5131684|NCT01418209|12624673|P2|COMPLETED|Overall Study||93
5131685|NCT01418209|12624674|P1|COMPLETED|Overall Study||95
5131686|NCT01418209|12624672|P3|STARTED|Overall Study||146
5131687|NCT01418209|12624673|P2|STARTED|Overall Study||96
5131688|NCT01418209|12624674|P1|STARTED|Overall Study||97
5131689|NCT01418001|12624703|P1|NOT COMPLETED|Overall Study||0
5131690|NCT01418001|12624703|P1|COMPLETED|Overall Study||5
5131691|NCT01418001|12624703|P1|STARTED|Overall Study||5
5131692|NCT01417936|12624708|P1|NOT COMPLETED|Overall Study||0
5131693|NCT01417936|12624708|P1|COMPLETED|Overall Study||26
5131694|NCT01417936|12624708|P1|STARTED|Overall Study||26
5131695|NCT01417741|12624729|P2|NOT COMPLETED|Overall Study||0
5131696|NCT01417741|12624730|P1|NOT COMPLETED|Overall Study||0
5131697|NCT01417741|12624729|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
5131698|NCT01417741|12624730|P1|COMPLETED|Overall Study||75
5131699|NCT01417741|12624729|P2|STARTED|Overall Study||86
5131700|NCT01417741|12624730|P1|STARTED|Overall Study||75
5131701|NCT01417481|12624738|P2|NOT COMPLETED|Second Period (8 Weeks)||0
5131702|NCT01417481|12624739|P1|NOT COMPLETED|Second Period (8 Weeks)||0
5131703|NCT01417481|12624738|P2|COMPLETED|Second Period (8 Weeks)||5
5131704|NCT01417481|12624739|P1|COMPLETED|Second Period (8 Weeks)||8
5131705|NCT01417481|12624738|P2|STARTED|Second Period (8 Weeks)||5
5131706|NCT01417481|12624739|P1|STARTED|Second Period (8 Weeks)||8
5131707|NCT01417481|12624738|P2|NOT COMPLETED|Washout (2 Weeks)||0
5131708|NCT01417481|12624739|P1|NOT COMPLETED|Washout (2 Weeks)||0
5131709|NCT01417481|12624738|P2|COMPLETED|Washout (2 Weeks)||5
5131710|NCT01417481|12624739|P1|COMPLETED|Washout (2 Weeks)||8
5131711|NCT01417481|12624738|P2|STARTED|Washout (2 Weeks)||5
5131712|NCT01417481|12624739|P1|STARTED|Washout (2 Weeks)||8
5131713|NCT01417481|12624738|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
5131714|NCT01417481|12624739|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
5131715|NCT01417481|12624738|P2|COMPLETED|First Intervention (8 Weeks)||5
5131716|NCT01417481|12624739|P1|COMPLETED|First Intervention (8 Weeks)||8
5131717|NCT01417481|12624738|P2|STARTED|First Intervention (8 Weeks)||7
5131718|NCT01417481|12624739|P1|STARTED|First Intervention (8 Weeks)||8
5131719|NCT01417455|12624771|P8|NOT COMPLETED|Overall Study||0
5131720|NCT01417455|12624772|P7|NOT COMPLETED|Overall Study||0
5131721|NCT01417455|12624773|P6|NOT COMPLETED|Overall Study||0
5131722|NCT01417455|12624774|P5|NOT COMPLETED|Overall Study||0
5131723|NCT01417455|12624775|P4|NOT COMPLETED|Overall Study||0
5131724|NCT01417455|12624776|P3|NOT COMPLETED|Overall Study||0
5131725|NCT01417455|12624777|P2|NOT COMPLETED|Overall Study||0
5131726|NCT01417455|12624778|P1|NOT COMPLETED|Overall Study||0
5131727|NCT01417455|12624771|P8|COMPLETED|Overall Study||25
5131728|NCT01417455|12624772|P7|COMPLETED|Overall Study||13
5131729|NCT01417455|12624773|P6|COMPLETED|Overall Study||13
5131730|NCT01417455|12624774|P5|COMPLETED|Overall Study||30
5131731|NCT01417455|12624775|P4|COMPLETED|Overall Study||17
5131732|NCT01417455|12624776|P3|COMPLETED|Overall Study||17
5131733|NCT01417455|12624777|P2|COMPLETED|Overall Study||16
5131734|NCT01417455|12624778|P1|COMPLETED|Overall Study||16
5131735|NCT01417455|12624771|P8|STARTED|Overall Study||25
5131736|NCT01417455|12624772|P7|STARTED|Overall Study||13
5131737|NCT01417455|12624773|P6|STARTED|Overall Study||13
5131738|NCT01417455|12624774|P5|STARTED|Overall Study||30
5131739|NCT01417455|12624775|P4|STARTED|Overall Study||17
5131740|NCT01417455|12624776|P3|STARTED|Overall Study||17
5131741|NCT01417455|12624777|P2|STARTED|Overall Study||16
5131742|NCT01417455|12624778|P1|STARTED|Overall Study||16
5131743|NCT01417377|12624804|P1|NOT COMPLETED|Overall Study||13
5131744|NCT01417377|12624804|P1|COMPLETED|Overall Study||9
5131745|NCT01417377|12624804|P1|Treated|Overall Study||21
5131746|NCT01417377|12624804|P1|STARTED|Overall Study||22
5131747|NCT01417195|12624813|P2|NOT COMPLETED|Overall Study||1
5131748|NCT01417195|12624814|P1|NOT COMPLETED|Overall Study||3
5131749|NCT01417195|12624813|P2|COMPLETED|Overall Study||61
5131750|NCT01417195|12624814|P1|COMPLETED|Overall Study||57
5131751|NCT01417195|12624813|P2|STARTED|Overall Study||62
5131752|NCT01417195|12624814|P1|STARTED|Overall Study||60
5131753|NCT01417156|12624830|P1|NOT COMPLETED|Overall Study||14
5131754|NCT01417156|12624830|P1|COMPLETED|Overall Study||6
5131755|NCT01417156|12624830|P1|STARTED|Overall Study||20
5131756|NCT01417104|12624840|P2|NOT COMPLETED|Overall Study||2
5131757|NCT01417104|12624841|P1|NOT COMPLETED|Overall Study||6
5131758|NCT01417104|12624840|P2|COMPLETED|Overall Study||35
5131759|NCT01417104|12624841|P1|COMPLETED|Overall Study||28
5131760|NCT01417104|12624840|P2|STARTED|Overall Study||37
5131761|NCT01417104|12624841|P1|STARTED|Overall Study||34
5131762|NCT01417078|12624851|P1|NOT COMPLETED|Overall Study||1
5131763|NCT01417078|12624851|P1|COMPLETED|Overall Study||30
5131764|NCT01417078|12624851|P1|STARTED|Overall Study||31
5131765|NCT01417026|12624863|P2|NOT COMPLETED|Overall Study||0
5131766|NCT01417026|12624864|P1|NOT COMPLETED|Overall Study||2
5131767|NCT01417026|12624863|P2|COMPLETED|Overall Study||13
5131768|NCT01417026|12624864|P1|COMPLETED|Overall Study||14
5131769|NCT01417026|12624863|P2|STARTED|Overall Study||13
5131770|NCT01417026|12624864|P1|STARTED|Overall Study||16
5131771|NCT01417000|12624876|P2|NOT COMPLETED|Overall Study||29
5131772|NCT01417000|12624877|P1|NOT COMPLETED|Overall Study||61
5131773|NCT01417000|12624876|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
5131774|NCT01417000|12624877|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
5131775|NCT01417000|12624876|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
5131776|NCT01417000|12624877|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
5131777|NCT01416987|12624885|P1|NOT COMPLETED|Overall Study||0
5131778|NCT01416987|12624885|P1|COMPLETED|Overall Study||600
5131779|NCT01416987|12624885|P1|STARTED|Overall Study||600
5131780|NCT01416805|12624894|P2|NOT COMPLETED|Overall Study||4
5131781|NCT01416805|12624895|P1|NOT COMPLETED|Overall Study||4
5131782|NCT01416805|12624894|P2|COMPLETED|Overall Study||47
5131783|NCT01416805|12624895|P1|COMPLETED|Overall Study||45
5131784|NCT01416805|12624894|P2|STARTED|Overall Study||51
5131785|NCT01416805|12624895|P1|STARTED|Overall Study||49
5131786|NCT01416636|12624905|P2|NOT COMPLETED|Overall Study||6
5131787|NCT01416636|12624906|P1|NOT COMPLETED|Overall Study||8
5131788|NCT01416636|12624905|P2|COMPLETED|Overall Study||46
5131789|NCT01416636|12624906|P1|COMPLETED|Overall Study||45
5131790|NCT01416636|12624905|P2|STARTED|Overall Study||52
5131791|NCT01416636|12624906|P1|STARTED|Overall Study||53
5131792|NCT01416610|12624934|P1|NOT COMPLETED|Overall Study||43
5131793|NCT01416610|12624934|P1|COMPLETED|Overall Study||45
5131794|NCT01416610|12624934|P1|Completed Follow-up|Overall Study||45
5131795|NCT01416610|12624934|P1|Completed Treatment|Overall Study||47
5131796|NCT01416610|12624934|P1|Per Protocol|Overall Study||83
5131797|NCT01416610|12624934|P1|Safety Population|Overall Study||86
5131798|NCT01416610|12624934|P1|Intention to Treat|Overall Study||88
5131799|NCT01416610|12624934|P1|STARTED|Overall Study||88
5131800|NCT01416584|12624951|P3|NOT COMPLETED|Overall Study||1
5131801|NCT01416584|12624952|P2|NOT COMPLETED|Overall Study||2
5131802|NCT01416584|12624953|P1|NOT COMPLETED|Overall Study||3
5131803|NCT01416584|12624951|P3|COMPLETED|Overall Study||32
5131804|NCT01416584|12624952|P2|COMPLETED|Overall Study||33
5131805|NCT01416584|12624953|P1|COMPLETED|Overall Study||27
5131806|NCT01416584|12624951|P3|STARTED|Overall Study||33
5131807|NCT01416584|12624952|P2|STARTED|Overall Study||35
5131808|NCT01416584|12624953|P1|STARTED|Overall Study||30
5131809|NCT01416571|12624988|P1|NOT COMPLETED|Overall Study||2
5131810|NCT01416571|12624988|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
5131811|NCT01416571|12624988|P1|STARTED|Overall Study||78
5131812|NCT01416389|12625017|P2|NOT COMPLETED|Overall Study||0
5131813|NCT01416389|12625018|P1|NOT COMPLETED|Overall Study||3
5131814|NCT01416389|12625017|P2|COMPLETED|Overall Study||13
5131815|NCT01416389|12625018|P1|COMPLETED|Overall Study||23
5131816|NCT01416389|12625017|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
5131817|NCT01416389|12625018|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
5131818|NCT01416389|12625017|P2|STARTED|Overall Study||13
5131819|NCT01416389|12625018|P1|STARTED|Overall Study||26
5131820|NCT01416272|12625035|P1|NOT COMPLETED|Overall Study||4
5131821|NCT01416272|12625035|P1|COMPLETED|Overall Study||8
5131822|NCT01416272|12625035|P1|STARTED|Overall Study||12
5131823|NCT01416194|12625044|P3|NOT COMPLETED|Overall Study||0
5131824|NCT01416194|12625045|P2|NOT COMPLETED|Overall Study||0
5131825|NCT01416194|12625046|P1|NOT COMPLETED|Overall Study||0
5131826|NCT01416194|12625044|P3|COMPLETED|Overall Study||6666
5131827|NCT01416194|12625045|P2|COMPLETED|Overall Study||2720
5131828|NCT01416194|12625046|P1|COMPLETED|Overall Study||1111
5131829|NCT01416194|12625044|P3|STARTED|Overall Study||6666
5131830|NCT01416194|12625045|P2|STARTED|Overall Study||2720
5131831|NCT01416194|12625046|P1|STARTED|Overall Study||1111
5131832|NCT01416181|12625092|P2|NOT COMPLETED|Part 2||286
5131833|NCT01416181|12625093|P1|NOT COMPLETED|Part 2||271
5131834|NCT01416181|12625092|P2|COMPLETED|Part 2||6
5131835|NCT01416181|12625093|P1|COMPLETED|Part 2||3
5131836|NCT01416181|12625092|P2|Completed Treatment for > 96 Weeks|Part 2||0
5131837|NCT01416181|12625093|P1|Completed Treatment for > 96 Weeks|Part 2||1
5131838|NCT01416181|12625092|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
5131839|NCT01416181|12625093|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
5131840|NCT01416181|12625092|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
5131841|NCT01416181|12625093|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
5131842|NCT01416181|12625092|P2|STARTED|Part 2||292
5131843|NCT01416181|12625093|P1|STARTED|Part 2||274
5131844|NCT01416181|12625092|P2|NOT COMPLETED|Part 1||114
5131845|NCT01416181|12625093|P1|NOT COMPLETED|Part 1||137
5131846|NCT01416181|12625092|P2|COMPLETED|Part 1|Completed Study through Week 108|326
5131847|NCT01416181|12625093|P1|COMPLETED|Part 1|Completed Study through Week 108|312
5131848|NCT01416181|12625092|P2|Withdrew Prior to Dosing|Part 1||1
5131849|NCT01416181|12625093|P1|Withdrew Prior to Dosing|Part 1||0
5131850|NCT01416181|12625092|P2|STARTED|Part 1||440
5131851|NCT01416181|12625093|P1|STARTED|Part 1||449
5131852|NCT01416155|12625155|P1|NOT COMPLETED|Overall Study||58
5131853|NCT01416155|12625155|P1|COMPLETED|Overall Study||39
5131854|NCT01416155|12625155|P1|STARTED|Overall Study||97
5131855|NCT01416142|12625162|P3|NOT COMPLETED|PureVision2 HD||1
5131856|NCT01416142|12625163|P2|NOT COMPLETED|PureVision2 HD||0
5131857|NCT01416142|12625164|P1|NOT COMPLETED|PureVision2 HD||0
5131858|NCT01416142|12625162|P3|COMPLETED|PureVision2 HD||62
5131859|NCT01416142|12625163|P2|COMPLETED|PureVision2 HD||0
5131860|NCT01416142|12625164|P1|COMPLETED|PureVision2 HD||0
5131861|NCT01416142|12625162|P3|STARTED|PureVision2 HD||63
5131862|NCT01416142|12625163|P2|STARTED|PureVision2 HD||0
5131863|NCT01416142|12625164|P1|STARTED|PureVision2 HD||0
5131864|NCT01416142|12625162|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
5131865|NCT01416142|12625163|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
5131866|NCT01416142|12625164|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
5131867|NCT01416142|12625162|P3|COMPLETED|Cross Over at Movie Intermission||0
5131868|NCT01416142|12625163|P2|COMPLETED|Cross Over at Movie Intermission||31
5131869|NCT01416142|12625164|P1|COMPLETED|Cross Over at Movie Intermission||32
5131870|NCT01416142|12625162|P3|STARTED|Cross Over at Movie Intermission||0
5131871|NCT01416142|12625163|P2|STARTED|Cross Over at Movie Intermission||31
5131872|NCT01416142|12625164|P1|STARTED|Cross Over at Movie Intermission||32
5131873|NCT01416129|12625175|P2|NOT COMPLETED|Experimental Condition: Brimless||0
5131874|NCT01416129|12625176|P1|NOT COMPLETED|Experimental Condition: Brimless||0
5131875|NCT01416129|12625175|P2|COMPLETED|Experimental Condition: Brimless||5
5131876|NCT01416129|12625176|P1|COMPLETED|Experimental Condition: Brimless||5
5131877|NCT01416129|12625175|P2|STARTED|Experimental Condition: Brimless||5
5131878|NCT01416129|12625176|P1|STARTED|Experimental Condition: Brimless||5
5131879|NCT01416129|12625175|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
5131880|NCT01416129|12625176|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
5131881|NCT01416129|12625175|P2|COMPLETED|Control Condition: Ischial Containment||5
5131882|NCT01416129|12625176|P1|COMPLETED|Control Condition: Ischial Containment||5
5131975|NCT01415349|12625395|P2|COMPLETED|Treatment Period 1||19
5131883|NCT01416129|12625175|P2|STARTED|Control Condition: Ischial Containment||5
5131884|NCT01416129|12625176|P1|STARTED|Control Condition: Ischial Containment||5
5131885|NCT01416025|12625184|P2|NOT COMPLETED|Overall Study||0
5131886|NCT01416025|12625185|P1|NOT COMPLETED|Overall Study||0
5131887|NCT01416025|12625184|P2|COMPLETED|Overall Study||15
5131888|NCT01416025|12625185|P1|COMPLETED|Overall Study||14
5131889|NCT01416025|12625184|P2|STARTED|Overall Study||15
5131890|NCT01416025|12625185|P1|STARTED|Overall Study||14
5131891|NCT01415986|12625191|P1|NOT COMPLETED|Overall Study||1
5131892|NCT01415986|12625191|P1|COMPLETED|Overall Study|Study terminated|0
5131893|NCT01415986|12625191|P1|STARTED|Overall Study||1
5131894|NCT01415960|12625196|P1|NOT COMPLETED|Overall Study||12
5131895|NCT01415960|12625196|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
5131896|NCT01415960|12625196|P1|PK Subgroup|Overall Study||30
5131897|NCT01415960|12625196|P1|ITT|Overall Study||161
5131898|NCT01415960|12625196|P1|STARTED|Overall Study||163
5131899|NCT01415934|12625208|P2|NOT COMPLETED|Overall Study||7
5131900|NCT01415934|12625209|P1|NOT COMPLETED|Overall Study||3
5131901|NCT01415934|12625208|P2|COMPLETED|Overall Study||182
5131902|NCT01415934|12625209|P1|COMPLETED|Overall Study||189
5131903|NCT01415934|12625208|P2|STARTED|Overall Study||189
5131904|NCT01415934|12625209|P1|STARTED|Overall Study||192
5131905|NCT01415921|12625217|P2|NOT COMPLETED|Overall Study||3
5131906|NCT01415921|12625218|P1|NOT COMPLETED|Overall Study||3
5131907|NCT01415921|12625217|P2|COMPLETED|Overall Study||14
5131908|NCT01415921|12625218|P1|COMPLETED|Overall Study||13
5131909|NCT01415921|12625217|P2|STARTED|Overall Study||17
5131910|NCT01415921|12625218|P1|STARTED|Overall Study||16
5131911|NCT01415908|12625228|P2|NOT COMPLETED|Overall Study||0
5131912|NCT01415908|12625229|P1|NOT COMPLETED|Overall Study||1
5131913|NCT01415908|12625228|P2|COMPLETED|Overall Study||4
5131914|NCT01415908|12625229|P1|COMPLETED|Overall Study||10
5131915|NCT01415908|12625228|P2|STARTED|Overall Study||4
5131916|NCT01415908|12625229|P1|STARTED|Overall Study||11
5131917|NCT01415583|12625257|P2|NOT COMPLETED|Overall Study||0
5131918|NCT01415583|12625258|P1|NOT COMPLETED|Overall Study||0
5131919|NCT01415583|12625257|P2|COMPLETED|Overall Study||157
5131920|NCT01415583|12625258|P1|COMPLETED|Overall Study||157
5131921|NCT01415583|12625257|P2|STARTED|Overall Study||157
5131922|NCT01415583|12625258|P1|STARTED|Overall Study||157
5131923|NCT01415531|12625266|P2|NOT COMPLETED|Overall Study||37
5131924|NCT01415531|12625267|P1|NOT COMPLETED|Overall Study||25
5131925|NCT01415531|12625266|P2|COMPLETED|Overall Study||390
5131926|NCT01415531|12625267|P1|COMPLETED|Overall Study||189
5131927|NCT01415531|12625266|P2|STARTED|Overall Study||427
5131928|NCT01415531|12625267|P1|STARTED|Overall Study||214
5131929|NCT01415518|12625277|P2|NOT COMPLETED|Overall Study||31
5131930|NCT01415518|12625278|P1|NOT COMPLETED|Overall Study||16
5131931|NCT01415518|12625277|P2|COMPLETED|Overall Study||261
5131932|NCT01415518|12625278|P1|COMPLETED|Overall Study||276
5131933|NCT01415518|12625277|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
5131934|NCT01415518|12625278|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
5131935|NCT01415518|12625277|P2|Patients Who Received Study Treatment|Overall Study||292
5131936|NCT01415518|12625278|P1|Patients Who Received Study Treatment|Overall Study||290
5131937|NCT01415518|12625277|P2|STARTED|Overall Study||292
5131938|NCT01415518|12625278|P1|STARTED|Overall Study||292
5131939|NCT01415453|12625330|P1|NOT COMPLETED|Overall Study||0
5131940|NCT01415453|12625330|P1|COMPLETED|Overall Study||1
5131941|NCT01415453|12625330|P1|Imaging Study|Overall Study||1
5131942|NCT01415453|12625330|P1|STARTED|Overall Study||1
5131943|NCT01415440|12625337|P3|NOT COMPLETED|Overall Study||2
5131944|NCT01415440|12625338|P2|NOT COMPLETED|Overall Study||1
5131945|NCT01415440|12625339|P1|NOT COMPLETED|Overall Study||4
5131946|NCT01415440|12625337|P3|COMPLETED|Overall Study||27
5131947|NCT01415440|12625338|P2|COMPLETED|Overall Study||28
5131948|NCT01415440|12625339|P1|COMPLETED|Overall Study||37
5131949|NCT01415440|12625337|P3|STARTED|Overall Study||29
5131950|NCT01415440|12625338|P2|STARTED|Overall Study||29
5131951|NCT01415440|12625339|P1|STARTED|Overall Study||41
5131952|NCT01415427|12625350|P4|NOT COMPLETED|Overall Study||56
5131953|NCT01415427|12625351|P3|NOT COMPLETED|Overall Study||58
5131954|NCT01415427|12625352|P2|NOT COMPLETED|Overall Study||29
5131955|NCT01415427|12625353|P1|NOT COMPLETED|Overall Study||29
5131956|NCT01415427|12625350|P4|COMPLETED|Overall Study||0
5131957|NCT01415427|12625351|P3|COMPLETED|Overall Study||1
5131958|NCT01415427|12625352|P2|COMPLETED|Overall Study||0
5131959|NCT01415427|12625353|P1|COMPLETED|Overall Study||0
5131960|NCT01415427|12625350|P4|STARTED|Overall Study||56
5131961|NCT01415427|12625351|P3|STARTED|Overall Study||59
5131962|NCT01415427|12625352|P2|STARTED|Overall Study||29
5131963|NCT01415427|12625353|P1|STARTED|Overall Study||29
5131964|NCT01415401|12625390|P1|NOT COMPLETED|Overall Study||7
5131965|NCT01415401|12625390|P1|COMPLETED|Overall Study||47
5131966|NCT01415401|12625390|P1|STARTED|Overall Study||54
5131967|NCT01415349|12625395|P2|NOT COMPLETED|Treatment Period 2||0
5131968|NCT01415349|12625396|P1|NOT COMPLETED|Treatment Period 2||0
5131969|NCT01415349|12625395|P2|COMPLETED|Treatment Period 2||19
5131970|NCT01415349|12625396|P1|COMPLETED|Treatment Period 2||21
5131971|NCT01415349|12625395|P2|STARTED|Treatment Period 2||19
5131972|NCT01415349|12625396|P1|STARTED|Treatment Period 2||21
5131973|NCT01415349|12625395|P2|NOT COMPLETED|Treatment Period 1||2
5131974|NCT01415349|12625396|P1|NOT COMPLETED|Treatment Period 1||0
5131976|NCT01415349|12625396|P1|COMPLETED|Treatment Period 1||21
5131977|NCT01415349|12625395|P2|STARTED|Treatment Period 1||21
5131978|NCT01415349|12625396|P1|STARTED|Treatment Period 1||21
5131979|NCT01415232|12625404|P1|NOT COMPLETED|Overall Study||0
5131980|NCT01415232|12625404|P1|COMPLETED|Overall Study||160
5131981|NCT01415232|12625404|P1|STARTED|Overall Study||160
5131982|NCT01414855|12625408|P1|NOT COMPLETED|Overall Study||29
5131983|NCT01414855|12625408|P1|COMPLETED|Overall Study||71
5131984|NCT01414855|12625408|P1|STARTED|Overall Study||100
5131985|NCT01414634|12625424|P8|NOT COMPLETED|Overall Study||0
5131986|NCT01414634|12625425|P7|NOT COMPLETED|Overall Study||0
5131987|NCT01414634|12625426|P6|NOT COMPLETED|Overall Study||0
5131988|NCT01414634|12625427|P5|NOT COMPLETED|Overall Study||0
5131989|NCT01414634|12625428|P4|NOT COMPLETED|Overall Study||0
5131990|NCT01414634|12625429|P3|NOT COMPLETED|Overall Study||0
5131991|NCT01414634|12625430|P2|NOT COMPLETED|Overall Study||0
5131992|NCT01414634|12625431|P1|NOT COMPLETED|Overall Study||0
5131993|NCT01414634|12625424|P8|COMPLETED|Overall Study||1
5131994|NCT01414634|12625425|P7|COMPLETED|Overall Study||1
5131995|NCT01414634|12625426|P6|COMPLETED|Overall Study||2
5131996|NCT01414634|12625427|P5|COMPLETED|Overall Study||1
5131997|NCT01414634|12625428|P4|COMPLETED|Overall Study||1
5131998|NCT01414634|12625429|P3|COMPLETED|Overall Study||1
5131999|NCT01414634|12625430|P2|COMPLETED|Overall Study||1
5132000|NCT01414634|12625431|P1|COMPLETED|Overall Study||1
5132001|NCT01414634|12625424|P8|STARTED|Overall Study||1
5132002|NCT01414634|12625425|P7|STARTED|Overall Study||1
5132003|NCT01414634|12625426|P6|STARTED|Overall Study||2
5132004|NCT01414634|12625427|P5|STARTED|Overall Study||1
5132005|NCT01414634|12625428|P4|STARTED|Overall Study||1
5132006|NCT01414634|12625429|P3|STARTED|Overall Study||1
5132007|NCT01414634|12625430|P2|STARTED|Overall Study||1
5132008|NCT01414634|12625431|P1|STARTED|Overall Study||1
5132009|NCT01414413|12625444|P2|NOT COMPLETED|Overall Study||0
5132010|NCT01414413|12625445|P1|NOT COMPLETED|Overall Study||0
5132011|NCT01414413|12625444|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
5132012|NCT01414413|12625445|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
5132013|NCT01414413|12625444|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
5132014|NCT01414413|12625445|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
5132015|NCT01414257|12625457|P1|NOT COMPLETED|Overall Study||22
5132016|NCT01414257|12625457|P1|COMPLETED|Overall Study||2838
5132017|NCT01414257|12625457|P1|STARTED|Overall Study||2860
5132018|NCT01414244|12625470|P2|NOT COMPLETED|Overall Study||0
5132019|NCT01414244|12625471|P1|NOT COMPLETED|Overall Study||0
5132020|NCT01414244|12625470|P2|COMPLETED|Overall Study||52
5132021|NCT01414244|12625471|P1|COMPLETED|Overall Study||54
5132022|NCT01414244|12625470|P2|STARTED|Overall Study||52
5132023|NCT01414244|12625471|P1|STARTED|Overall Study||54
5132024|NCT01414205|12625485|P2|NOT COMPLETED|Overall Study||7
5132025|NCT01414205|12625486|P1|NOT COMPLETED|Overall Study||7
5132026|NCT01414205|12625485|P2|COMPLETED|Overall Study||32
5132027|NCT01414205|12625486|P1|COMPLETED|Overall Study||34
5132028|NCT01414205|12625485|P2|Received Study Drug|Overall Study||38
5132029|NCT01414205|12625486|P1|Received Study Drug|Overall Study||40
5132030|NCT01414205|12625485|P2|STARTED|Overall Study||39
5132031|NCT01414205|12625486|P1|STARTED|Overall Study||41
5132032|NCT01414192|12625522|P4|NOT COMPLETED|Overall Study||0
5132033|NCT01414192|12625523|P3|NOT COMPLETED|Overall Study||0
5132034|NCT01414192|12625524|P2|NOT COMPLETED|Overall Study||0
5132035|NCT01414192|12625525|P1|NOT COMPLETED|Overall Study||0
5132036|NCT01414192|12625522|P4|COMPLETED|Overall Study||1726
5132037|NCT01414192|12625523|P3|COMPLETED|Overall Study||424
5132038|NCT01414192|12625524|P2|COMPLETED|Overall Study||575
5132039|NCT01414192|12625525|P1|COMPLETED|Overall Study||490
5132040|NCT01414192|12625522|P4|STARTED|Overall Study||1726
5132041|NCT01414192|12625523|P3|STARTED|Overall Study||424
5132042|NCT01414192|12625524|P2|STARTED|Overall Study||575
5132043|NCT01414192|12625525|P1|STARTED|Overall Study||490
5132044|NCT01414166|12625555|P2|NOT COMPLETED|Overall Study||83
5132045|NCT01414166|12625556|P1|NOT COMPLETED|Overall Study||91
5132046|NCT01414166|12625555|P2|COMPLETED|Overall Study||39
5132047|NCT01414166|12625556|P1|COMPLETED|Overall Study||31
5132048|NCT01414166|12625555|P2|Treated|Overall Study||121
5132049|NCT01414166|12625556|P1|Treated|Overall Study||120
5132050|NCT01414166|12625555|P2|STARTED|Overall Study||122
5132051|NCT01414166|12625556|P1|STARTED|Overall Study||122
5132052|NCT01414153|12625582|P4|NOT COMPLETED|Overall Study||4
5132053|NCT01414153|12625583|P3|NOT COMPLETED|Overall Study||4
5132054|NCT01414153|12625584|P2|NOT COMPLETED|Overall Study||2
5132055|NCT01414153|12625585|P1|NOT COMPLETED|Overall Study||8
5132056|NCT01414153|12625582|P4|COMPLETED|Overall Study||37
5132057|NCT01414153|12625583|P3|COMPLETED|Overall Study||35
5132058|NCT01414153|12625584|P2|COMPLETED|Overall Study||38
5132059|NCT01414153|12625585|P1|COMPLETED|Overall Study||30
5132060|NCT01414153|12625582|P4|STARTED|Overall Study||41
5132061|NCT01414153|12625583|P3|STARTED|Overall Study||39
5132062|NCT01414153|12625584|P2|STARTED|Overall Study||40
5132063|NCT01414153|12625585|P1|STARTED|Overall Study||38
5132064|NCT01414114|12625619|P1|NOT COMPLETED|Overall Study||5
5132065|NCT01414114|12625619|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
5132066|NCT01414114|12625619|P1|STARTED|Overall Study||37
5132067|NCT01414036|12625639|P2|NOT COMPLETED|Completed 3 Month Survey||5
5132068|NCT01414036|12625640|P1|NOT COMPLETED|Completed 3 Month Survey||9
5132069|NCT01414036|12625639|P2|COMPLETED|Completed 3 Month Survey||19
5132070|NCT01414036|12625640|P1|COMPLETED|Completed 3 Month Survey||14
5132071|NCT01414036|12625639|P2|STARTED|Completed 3 Month Survey||24
5132072|NCT01414036|12625640|P1|STARTED|Completed 3 Month Survey||23
5132073|NCT01414036|12625639|P2|NOT COMPLETED|Received Allocated Intervention||13
5132074|NCT01414036|12625640|P1|NOT COMPLETED|Received Allocated Intervention||0
5132075|NCT01414036|12625639|P2|COMPLETED|Received Allocated Intervention||11
5132076|NCT01414036|12625640|P1|COMPLETED|Received Allocated Intervention||23
5132077|NCT01414036|12625639|P2|STARTED|Received Allocated Intervention||24
5132078|NCT01414036|12625640|P1|STARTED|Received Allocated Intervention||23
5132079|NCT01414010|12625654|P4|NOT COMPLETED|Overall Study||0
5132080|NCT01414010|12625655|P3|NOT COMPLETED|Overall Study||0
5132081|NCT01414010|12625656|P2|NOT COMPLETED|Overall Study||0
5132082|NCT01414010|12625657|P1|NOT COMPLETED|Overall Study||2
5132083|NCT01414010|12625654|P4|COMPLETED|Overall Study||8
5132084|NCT01414010|12625655|P3|COMPLETED|Overall Study||8
5132085|NCT01414010|12625656|P2|COMPLETED|Overall Study||8
5132086|NCT01414010|12625657|P1|COMPLETED|Overall Study||6
5132087|NCT01414010|12625654|P4|STARTED|Overall Study||8
5132088|NCT01414010|12625655|P3|STARTED|Overall Study||8
5132089|NCT01414010|12625656|P2|STARTED|Overall Study||8
5132090|NCT01414010|12625657|P1|STARTED|Overall Study||8
5132091|NCT01413958|12625675|P2|NOT COMPLETED|Overall Study||1
5132092|NCT01413958|12625676|P1|NOT COMPLETED|Overall Study||0
5132093|NCT01413958|12625675|P2|COMPLETED|Overall Study||286
5132094|NCT01413958|12625676|P1|COMPLETED|Overall Study||288
5132095|NCT01413958|12625675|P2|STARTED|Overall Study||287
5132096|NCT01413958|12625676|P1|STARTED|Overall Study||288
5132097|NCT01413750|12625711|P4|NOT COMPLETED|Overall Study||0
5132098|NCT01413750|12625712|P3|NOT COMPLETED|Overall Study||0
5132099|NCT01413750|12625713|P2|NOT COMPLETED|Overall Study||0
5132100|NCT01413750|12625714|P1|NOT COMPLETED|Overall Study||0
5132101|NCT01413750|12625711|P4|COMPLETED|Overall Study||7
5132102|NCT01413750|12625712|P3|COMPLETED|Overall Study||4
5132103|NCT01413750|12625713|P2|COMPLETED|Overall Study||6
5132104|NCT01413750|12625714|P1|COMPLETED|Overall Study||6
5132105|NCT01413750|12625711|P4|STARTED|Overall Study||7
5132106|NCT01413750|12625712|P3|STARTED|Overall Study||4
5132107|NCT01413750|12625713|P2|STARTED|Overall Study||6
5132108|NCT01413750|12625714|P1|STARTED|Overall Study||6
5132109|NCT01413542|12625727|P4|NOT COMPLETED|Overall Study||1
5132110|NCT01413542|12625728|P3|NOT COMPLETED|Overall Study||3
5132111|NCT01413542|12625729|P2|NOT COMPLETED|Overall Study||0
5132112|NCT01413542|12625730|P1|NOT COMPLETED|Overall Study||1
5132113|NCT01413542|12625727|P4|COMPLETED|Overall Study||7
5132114|NCT01413542|12625728|P3|COMPLETED|Overall Study||6
5132115|NCT01413542|12625729|P2|COMPLETED|Overall Study||6
5132116|NCT01413542|12625730|P1|COMPLETED|Overall Study||5
5132117|NCT01413542|12625727|P4|STARTED|Overall Study||8
5132118|NCT01413542|12625728|P3|STARTED|Overall Study||9
5132119|NCT01413542|12625729|P2|STARTED|Overall Study||6
5132120|NCT01413542|12625730|P1|STARTED|Overall Study||6
5132121|NCT01413516|12625745|P2|NOT COMPLETED|Overall Study||0
5132122|NCT01413516|12625746|P1|NOT COMPLETED|Overall Study||0
5132123|NCT01413516|12625745|P2|COMPLETED|Overall Study||9
5132124|NCT01413516|12625746|P1|COMPLETED|Overall Study||8
5132125|NCT01413516|12625745|P2|STARTED|Overall Study||9
5132126|NCT01413516|12625746|P1|STARTED|Overall Study||8
5132127|NCT01413503|12625752|P1|NOT COMPLETED|Overall Study||1
5132128|NCT01413503|12625752|P1|COMPLETED|Overall Study||49
5132129|NCT01413503|12625752|P1|STARTED|Overall Study||50
5132130|NCT01413360|12625756|P1|NOT COMPLETED|Overall Study||3
5132131|NCT01413360|12625756|P1|COMPLETED|Overall Study||7
5132132|NCT01413360|12625756|P1|STARTED|Overall Study||10
5132133|NCT01413204|12625764|P3|NOT COMPLETED|Overall Study||19
5132134|NCT01413204|12625765|P2|NOT COMPLETED|Overall Study||6
5132135|NCT01413204|12625766|P1|NOT COMPLETED|Overall Study||6
5132136|NCT01413204|12625764|P3|COMPLETED|Overall Study||74
5132137|NCT01413204|12625765|P2|COMPLETED|Overall Study||83
5132138|NCT01413204|12625766|P1|COMPLETED|Overall Study||84
5132139|NCT01413204|12625764|P3|STARTED|Overall Study||93
5132140|NCT01413204|12625765|P2|STARTED|Overall Study||89
5132141|NCT01413204|12625766|P1|STARTED|Overall Study||90
5132142|NCT01413191|12625774|P1|NOT COMPLETED|Overall Study||11
5132143|NCT01413191|12625774|P1|COMPLETED|Overall Study||7
5132144|NCT01413191|12625774|P1|STARTED|Overall Study||18
5132145|NCT01413178|12625786|P2|NOT COMPLETED|Overall Study||2
5132146|NCT01413178|12625787|P1|NOT COMPLETED|Overall Study||1
5132147|NCT01413178|12625786|P2|COMPLETED|Overall Study||98
5132148|NCT01413178|12625787|P1|COMPLETED|Overall Study||104
5132149|NCT01413178|12625786|P2|STARTED|Overall Study||100
5132150|NCT01413178|12625787|P1|STARTED|Overall Study||105
5132151|NCT01413087|12625803|P2|NOT COMPLETED|Overall Study||0
5132152|NCT01413087|12625804|P1|NOT COMPLETED|Overall Study||0
5132153|NCT01413087|12625803|P2|COMPLETED|Overall Study||6
5132154|NCT01413087|12625804|P1|COMPLETED|Overall Study||6
5132155|NCT01413087|12625803|P2|STARTED|Overall Study||6
5132156|NCT01413087|12625804|P1|STARTED|Overall Study||6
5132157|NCT01412983|12625830|P2|NOT COMPLETED|2nd Period||0
5132158|NCT01412983|12625831|P1|NOT COMPLETED|2nd Period||0
5132159|NCT01412983|12625830|P2|COMPLETED|2nd Period||46
5132160|NCT01412983|12625831|P1|COMPLETED|2nd Period||50
5132161|NCT01412983|12625830|P2|STARTED|2nd Period||46
5132162|NCT01412983|12625831|P1|STARTED|2nd Period||50
5132163|NCT01412983|12625830|P2|NOT COMPLETED|1st Period||4
5132164|NCT01412983|12625831|P1|NOT COMPLETED|1st Period||0
5132165|NCT01412983|12625830|P2|COMPLETED|1st Period||46
5132166|NCT01412983|12625831|P1|COMPLETED|1st Period||50
5132167|NCT01412983|12625830|P2|STARTED|1st Period||50
5132168|NCT01412983|12625831|P1|STARTED|1st Period||50
5132169|NCT01412957|12625841|P2|NOT COMPLETED|Overall Study||157
5132170|NCT01412957|12625842|P1|NOT COMPLETED|Overall Study||149
5132171|NCT01412957|12625841|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
5132172|NCT01412957|12625842|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
5132173|NCT01412957|12625841|P2|STARTED|Overall Study||188
5132174|NCT01412957|12625842|P1|STARTED|Overall Study||189
5132175|NCT01412944|12625864|P6|NOT COMPLETED|Follow-up||0
5132176|NCT01412944|12625865|P5|NOT COMPLETED|Follow-up||0
5132177|NCT01412944|12625866|P4|NOT COMPLETED|Follow-up||0
5132178|NCT01412944|12625867|P3|NOT COMPLETED|Follow-up||0
5132179|NCT01412944|12625868|P2|NOT COMPLETED|Follow-up||0
5132180|NCT01412944|12625869|P1|NOT COMPLETED|Follow-up||0
5132181|NCT01412944|12625864|P6|COMPLETED|Follow-up||0
5132182|NCT01412944|12625865|P5|COMPLETED|Follow-up||2
5132183|NCT01412944|12625866|P4|COMPLETED|Follow-up||1
5132184|NCT01412944|12625867|P3|COMPLETED|Follow-up||2
5132185|NCT01412944|12625868|P2|COMPLETED|Follow-up||0
5132186|NCT01412944|12625869|P1|COMPLETED|Follow-up||0
5132187|NCT01412944|12625864|P6|STARTED|Follow-up||0
5132188|NCT01412944|12625865|P5|STARTED|Follow-up||2
5132189|NCT01412944|12625866|P4|STARTED|Follow-up||1
5132190|NCT01412944|12625867|P3|STARTED|Follow-up||2
5132191|NCT01412944|12625868|P2|STARTED|Follow-up||0
5132192|NCT01412944|12625869|P1|STARTED|Follow-up||0
5132193|NCT01412944|12625864|P6|NOT COMPLETED|Entire: IV + Maintenance||0
5132194|NCT01412944|12625865|P5|NOT COMPLETED|Entire: IV + Maintenance||0
5132195|NCT01412944|12625866|P4|NOT COMPLETED|Entire: IV + Maintenance||0
5132196|NCT01412944|12625867|P3|NOT COMPLETED|Entire: IV + Maintenance||0
5132197|NCT01412944|12625868|P2|NOT COMPLETED|Entire: IV + Maintenance||5
5132198|NCT01412944|12625869|P1|NOT COMPLETED|Entire: IV + Maintenance||2
5132199|NCT01412944|12625864|P6|COMPLETED|Entire: IV + Maintenance||0
5132200|NCT01412944|12625865|P5|COMPLETED|Entire: IV + Maintenance||0
5132201|NCT01412944|12625866|P4|COMPLETED|Entire: IV + Maintenance||0
5132202|NCT01412944|12625867|P3|COMPLETED|Entire: IV + Maintenance||0
5132203|NCT01412944|12625868|P2|COMPLETED|Entire: IV + Maintenance||17
5132204|NCT01412944|12625869|P1|COMPLETED|Entire: IV + Maintenance||19
5132205|NCT01412944|12625864|P6|STARTED|Entire: IV + Maintenance||0
5132206|NCT01412944|12625865|P5|STARTED|Entire: IV + Maintenance||0
5132207|NCT01412944|12625866|P4|STARTED|Entire: IV + Maintenance||0
5132208|NCT01412944|12625867|P3|STARTED|Entire: IV + Maintenance||0
5132209|NCT01412944|12625868|P2|STARTED|Entire: IV + Maintenance||22
5132210|NCT01412944|12625869|P1|STARTED|Entire: IV + Maintenance||21
5132211|NCT01412944|12625864|P6|NOT COMPLETED|Entire: IV + Maintenance||2
5132212|NCT01412944|12625865|P5|NOT COMPLETED|Entire: IV + Maintenance||3
5132213|NCT01412944|12625866|P4|NOT COMPLETED|Entire: IV + Maintenance||1
5132214|NCT01412944|12625867|P3|NOT COMPLETED|Entire: IV + Maintenance||1
5132215|NCT01412944|12625868|P2|NOT COMPLETED|Entire: IV + Maintenance||0
5132216|NCT01412944|12625869|P1|NOT COMPLETED|Entire: IV + Maintenance||0
5132217|NCT01412944|12625864|P6|COMPLETED|Entire: IV + Maintenance||6
5132218|NCT01412944|12625865|P5|COMPLETED|Entire: IV + Maintenance||11
5132219|NCT01412944|12625866|P4|COMPLETED|Entire: IV + Maintenance||5
5132220|NCT01412944|12625867|P3|COMPLETED|Entire: IV + Maintenance||14
5132221|NCT01412944|12625868|P2|COMPLETED|Entire: IV + Maintenance||0
5132222|NCT01412944|12625869|P1|COMPLETED|Entire: IV + Maintenance||0
5132223|NCT01412944|12625864|P6|STARTED|Entire: IV + Maintenance||8
5132224|NCT01412944|12625865|P5|STARTED|Entire: IV + Maintenance||14
5132225|NCT01412944|12625866|P4|STARTED|Entire: IV + Maintenance||6
5132226|NCT01412944|12625867|P3|STARTED|Entire: IV + Maintenance||15
5132227|NCT01412944|12625868|P2|STARTED|Entire: IV + Maintenance||0
5132228|NCT01412944|12625869|P1|STARTED|Entire: IV + Maintenance||0
5132229|NCT01412944|12625864|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
5132230|NCT01412944|12625865|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
5132231|NCT01412944|12625866|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
5132232|NCT01412944|12625867|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
5132233|NCT01412944|12625868|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
5132234|NCT01412944|12625869|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
5132235|NCT01412944|12625864|P6|COMPLETED|IV: Per CAIN457A2307||0
5132236|NCT01412944|12625865|P5|COMPLETED|IV: Per CAIN457A2307||0
5132237|NCT01412944|12625866|P4|COMPLETED|IV: Per CAIN457A2307||0
5132238|NCT01412944|12625867|P3|COMPLETED|IV: Per CAIN457A2307||0
5132239|NCT01412944|12625868|P2|COMPLETED|IV: Per CAIN457A2307||20
5132240|NCT01412944|12625869|P1|COMPLETED|IV: Per CAIN457A2307||20
5132241|NCT01412944|12625864|P6|STARTED|IV: Per CAIN457A2307||0
5132242|NCT01412944|12625865|P5|STARTED|IV: Per CAIN457A2307||0
5132243|NCT01412944|12625866|P4|STARTED|IV: Per CAIN457A2307||0
5132244|NCT01412944|12625867|P3|STARTED|IV: Per CAIN457A2307||0
5132245|NCT01412944|12625868|P2|STARTED|IV: Per CAIN457A2307||22
5132246|NCT01412944|12625869|P1|STARTED|IV: Per CAIN457A2307||21
5132247|NCT01412944|12625864|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
5132248|NCT01412944|12625865|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132249|NCT01412944|12625866|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132250|NCT01412944|12625867|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
5132251|NCT01412944|12625868|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132252|NCT01412944|12625869|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132253|NCT01412944|12625864|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
5132254|NCT01412944|12625865|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
5132255|NCT01412944|12625866|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
5132256|NCT01412944|12625867|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
5132257|NCT01412944|12625868|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132258|NCT01412944|12625869|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
5132259|NCT01412944|12625864|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
5132260|NCT01412944|12625865|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
5132261|NCT01412944|12625866|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
5132262|NCT01412944|12625867|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
5132263|NCT01412944|12625868|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
5132264|NCT01412944|12625869|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
5132265|NCT01412918|12625905|P2|NOT COMPLETED|Overall Study||0
5132266|NCT01412918|12625906|P1|NOT COMPLETED|Overall Study||0
5132267|NCT01412918|12625905|P2|COMPLETED|Overall Study||1
5132268|NCT01412918|12625906|P1|COMPLETED|Overall Study||20
5132269|NCT01412918|12625905|P2|STARTED|Overall Study||1
5132270|NCT01412918|12625906|P1|STARTED|Overall Study||20
5132271|NCT01412879|12625915|P3|NOT COMPLETED|Consolidation Therapy||0
5132272|NCT01412879|12625916|P2|NOT COMPLETED|Consolidation Therapy||0
5132273|NCT01412879|12625917|P1|NOT COMPLETED|Consolidation Therapy||0
5132274|NCT01412879|12625915|P3|COMPLETED|Consolidation Therapy||26
5132275|NCT01412879|12625916|P2|COMPLETED|Consolidation Therapy||0
5132276|NCT01412879|12625917|P1|COMPLETED|Consolidation Therapy||0
5132277|NCT01412879|12625915|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
5132278|NCT01412879|12625916|P2|STARTED|Consolidation Therapy||0
5132279|NCT01412879|12625917|P1|STARTED|Consolidation Therapy||0
5132280|NCT01412879|12625915|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
5132281|NCT01412879|12625916|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
5132282|NCT01412879|12625917|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
5132283|NCT01412879|12625915|P3|COMPLETED|Initial Registration (Induction Therapy)||0
5132284|NCT01412879|12625916|P2|COMPLETED|Initial Registration (Induction Therapy)||27
5132285|NCT01412879|12625917|P1|COMPLETED|Initial Registration (Induction Therapy)||5
5132286|NCT01412879|12625915|P3|Treatment Started|Initial Registration (Induction Therapy)||0
5132287|NCT01412879|12625916|P2|Treatment Started|Initial Registration (Induction Therapy)||35
5132288|NCT01412879|12625917|P1|Treatment Started|Initial Registration (Induction Therapy)||17
5132289|NCT01412879|12625915|P3|STARTED|Initial Registration (Induction Therapy)||0
5132290|NCT01412879|12625916|P2|STARTED|Initial Registration (Induction Therapy)||35
5132291|NCT01412879|12625917|P1|STARTED|Initial Registration (Induction Therapy)||18
5132292|NCT01412866|12625933|P2|NOT COMPLETED|Overall Study||2
5132293|NCT01412866|12625934|P1|NOT COMPLETED|Overall Study||1
5132294|NCT01412866|12625933|P2|COMPLETED|Overall Study||64
5132295|NCT01412866|12625934|P1|COMPLETED|Overall Study||57
5132296|NCT01412866|12625933|P2|STARTED|Overall Study||66
5132297|NCT01412866|12625934|P1|STARTED|Overall Study||58
5132298|NCT01412801|12625946|P6|NOT COMPLETED|Overall Study||3
5132299|NCT01412801|12625947|P5|NOT COMPLETED|Overall Study||3
5132300|NCT01412801|12625948|P4|NOT COMPLETED|Overall Study||4
5132301|NCT01412801|12625949|P3|NOT COMPLETED|Overall Study||7
5132302|NCT01412801|12625950|P2|NOT COMPLETED|Overall Study||5
5132303|NCT01412801|12625951|P1|NOT COMPLETED|Overall Study||4
5132304|NCT01412801|12625946|P6|COMPLETED|Overall Study||84
5132305|NCT01412801|12625947|P5|COMPLETED|Overall Study||85
5132306|NCT01412801|12625948|P4|COMPLETED|Overall Study||87
5132307|NCT01412801|12625949|P3|COMPLETED|Overall Study||83
5132308|NCT01412801|12625950|P2|COMPLETED|Overall Study||84
5132309|NCT01412801|12625951|P1|COMPLETED|Overall Study||87
5132310|NCT01412801|12625946|P6|STARTED|Overall Study||87
5132311|NCT01412801|12625947|P5|STARTED|Overall Study||88
5132312|NCT01412801|12625948|P4|STARTED|Overall Study||91
5132313|NCT01412801|12625949|P3|STARTED|Overall Study||90
5132314|NCT01412801|12625950|P2|STARTED|Overall Study||89
5132315|NCT01412801|12625951|P1|STARTED|Overall Study||91
5132316|NCT01412710|12625990|P2|NOT COMPLETED|Overall Study||5
5132317|NCT01412710|12625991|P1|NOT COMPLETED|Overall Study||4
5132318|NCT01412710|12625990|P2|COMPLETED|Overall Study||22
5132319|NCT01412710|12625991|P1|COMPLETED|Overall Study||46
5132320|NCT01412710|12625990|P2|STARTED|Overall Study||27
5132321|NCT01412710|12625991|P1|STARTED|Overall Study||50
5132322|NCT01412554|12625999|P1|NOT COMPLETED|Overall Study||0
5132323|NCT01412554|12625999|P1|COMPLETED|Overall Study||103
5132324|NCT01412554|12625999|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
5132325|NCT01412541|12626005|P2|NOT COMPLETED|Overall Study||43
5132326|NCT01412541|12626006|P1|NOT COMPLETED|Overall Study||126
5132327|NCT01412541|12626005|P2|COMPLETED|Overall Study||117
5132328|NCT01412541|12626006|P1|COMPLETED|Overall Study||246
5132329|NCT01412541|12626005|P2|STARTED|Overall Study||160
5132330|NCT01412541|12626006|P1|STARTED|Overall Study||372
5132331|NCT01412424|12626046|P1|NOT COMPLETED|Extension Treatment Period||6
5132332|NCT01412424|12626046|P1|COMPLETED|Extension Treatment Period||82
5132333|NCT01412424|12626046|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
5132334|NCT01412424|12626046|P1|NOT COMPLETED|Core Treatment Period||53
5132335|NCT01412424|12626046|P1|COMPLETED|Core Treatment Period||102
5132336|NCT01412424|12626046|P1|STARTED|Core Treatment Period||155
5132337|NCT01412333|12626064|P2|NOT COMPLETED|Overall Study||57
5132338|NCT01412333|12626065|P1|NOT COMPLETED|Overall Study||98
5132339|NCT01412333|12626064|P2|COMPLETED|Overall Study||360
5132340|NCT01412333|12626065|P1|COMPLETED|Overall Study||320
5132341|NCT01412333|12626064|P2|STARTED|Overall Study||417
5132342|NCT01412333|12626065|P1|STARTED|Overall Study||418
5132343|NCT01412281|12626100|P4|NOT COMPLETED|Overall Study||0
5132344|NCT01412281|12626101|P3|NOT COMPLETED|Overall Study||0
5132345|NCT01412281|12626102|P2|NOT COMPLETED|Overall Study||0
5132346|NCT01412281|12626103|P1|NOT COMPLETED|Overall Study||0
5132347|NCT01412281|12626100|P4|COMPLETED|Overall Study||110
5132348|NCT01412281|12626101|P3|COMPLETED|Overall Study||110
5132349|NCT01412281|12626102|P2|COMPLETED|Overall Study||110
5132350|NCT01412281|12626103|P1|COMPLETED|Overall Study||110
5132351|NCT01412281|12626100|P4|STARTED|Overall Study||110
5132352|NCT01412281|12626101|P3|STARTED|Overall Study||110
5132353|NCT01412281|12626102|P2|STARTED|Overall Study||110
5132354|NCT01412281|12626103|P1|STARTED|Overall Study||110
5132355|NCT01412229|12626125|P1|NOT COMPLETED|Overall Study||1
5132356|NCT01412229|12626125|P1|COMPLETED|Overall Study||38
5132357|NCT01412229|12626125|P1|STARTED|Overall Study||39
5132358|NCT01412164|12626137|P1|NOT COMPLETED|Overall Study||47
5132359|NCT01412164|12626137|P1|COMPLETED|Overall Study||683
5132360|NCT01412164|12626137|P1|STARTED|Overall Study||730
5132361|NCT01412151|12626148|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
5132362|NCT01412151|12626148|P1|COMPLETED|Week 306 - 310 - Washout Period||3
5132363|NCT01412151|12626148|P1|STARTED|Week 306 - 310 - Washout Period||5
5132364|NCT01412151|12626148|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
5132365|NCT01412151|12626148|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
5132366|NCT01412151|12626148|P1|STARTED|Week 0 - 306 - Treatment Period||10
5132367|NCT01412086|12626154|P1|NOT COMPLETED|Overall Study||0
5132368|NCT01412086|12626154|P1|COMPLETED|Overall Study||112
5132369|NCT01412086|12626154|P1|STARTED|Overall Study||112
5132370|NCT01412060|12626159|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
5132371|NCT01412060|12626160|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
5132372|NCT01412060|12626161|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
5132373|NCT01412060|12626159|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
5132374|NCT01412060|12626160|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
5132375|NCT01412060|12626161|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
5132376|NCT01412060|12626159|P3|STARTED|Double-blind Treatment Phase (DBP)||101
5132377|NCT01412060|12626160|P2|STARTED|Double-blind Treatment Phase (DBP)||99
5132378|NCT01412060|12626161|P1|STARTED|Double-blind Treatment Phase (DBP)||0
5132379|NCT01412060|12626159|P3|NOT COMPLETED|Period Between SP and DBP||0
5132380|NCT01412060|12626160|P2|NOT COMPLETED|Period Between SP and DBP||0
5132381|NCT01412060|12626161|P1|NOT COMPLETED|Period Between SP and DBP||64
5132382|NCT01412060|12626159|P3|COMPLETED|Period Between SP and DBP||0
5132383|NCT01412060|12626160|P2|COMPLETED|Period Between SP and DBP||0
5132384|NCT01412060|12626161|P1|COMPLETED|Period Between SP and DBP||200
5132385|NCT01412060|12626159|P3|STARTED|Period Between SP and DBP||0
5132386|NCT01412060|12626160|P2|STARTED|Period Between SP and DBP||0
5132387|NCT01412060|12626161|P1|STARTED|Period Between SP and DBP||264
5132388|NCT01412060|12626159|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
5132389|NCT01412060|12626160|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
5132390|NCT01412060|12626161|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
5132391|NCT01412060|12626159|P3|COMPLETED|Open-label Stabilization Period (SP)||0
5132392|NCT01412060|12626160|P2|COMPLETED|Open-label Stabilization Period (SP)||0
5132393|NCT01412060|12626161|P1|COMPLETED|Open-label Stabilization Period (SP)||264
5132394|NCT01412060|12626159|P3|STARTED|Open-label Stabilization Period (SP)||0
5132395|NCT01412060|12626160|P2|STARTED|Open-label Stabilization Period (SP)||0
5132396|NCT01412060|12626161|P1|STARTED|Open-label Stabilization Period (SP)||364
5132397|NCT01412060|12626159|P3|NOT COMPLETED|Period Between RIP and SP||0
5132398|NCT01412060|12626160|P2|NOT COMPLETED|Period Between RIP and SP||0
5132399|NCT01412060|12626161|P1|NOT COMPLETED|Period Between RIP and SP||54
5132400|NCT01412060|12626159|P3|COMPLETED|Period Between RIP and SP||0
5132401|NCT01412060|12626160|P2|COMPLETED|Period Between RIP and SP||0
5132402|NCT01412060|12626161|P1|COMPLETED|Period Between RIP and SP||364
5132403|NCT01412060|12626159|P3|STARTED|Period Between RIP and SP||0
5132404|NCT01412060|12626160|P2|STARTED|Period Between RIP and SP||0
5132405|NCT01412060|12626161|P1|STARTED|Period Between RIP and SP||418
5132406|NCT01412060|12626159|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
5132407|NCT01412060|12626160|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
5132408|NCT01412060|12626161|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
5132409|NCT01412060|12626159|P3|COMPLETED|Open-label Run-in Period (RIP)||0
5132410|NCT01412060|12626160|P2|COMPLETED|Open-label Run-in Period (RIP)||0
5132411|NCT01412060|12626161|P1|COMPLETED|Open-label Run-in Period (RIP)||418
5132412|NCT01412060|12626159|P3|STARTED|Open-label Run-in Period (RIP)||0
5132413|NCT01412060|12626160|P2|STARTED|Open-label Run-in Period (RIP)||0
5132414|NCT01412060|12626161|P1|STARTED|Open-label Run-in Period (RIP)||765
5132415|NCT01412021|12626171|P1|NOT COMPLETED|Overall Study||19
5132416|NCT01412021|12626171|P1|COMPLETED|Overall Study||356
5132417|NCT01412021|12626171|P1|Case Report Forms Locked|Overall Study||368
5132418|NCT01412021|12626171|P1|STARTED|Overall Study||375
5132419|NCT01411995|12626208|P2|NOT COMPLETED|Overall Study||1
5132420|NCT01411995|12626209|P1|NOT COMPLETED|Overall Study||0
5132421|NCT01411995|12626208|P2|COMPLETED|Overall Study||99
5132422|NCT01411995|12626209|P1|COMPLETED|Overall Study||100
5132423|NCT01411995|12626208|P2|STARTED|Overall Study||100
5132424|NCT01411995|12626209|P1|STARTED|Overall Study||100
5132425|NCT01411917|12626217|P2|NOT COMPLETED|Overall Study||1
5132426|NCT01411917|12626218|P1|NOT COMPLETED|Overall Study||0
5132427|NCT01411917|12626217|P2|COMPLETED|Overall Study||36
5132428|NCT01411917|12626218|P1|COMPLETED|Overall Study||32
5132429|NCT01411917|12626217|P2|STARTED|Overall Study||37
5132430|NCT01411917|12626218|P1|STARTED|Overall Study||32
5132431|NCT01411891|12626240|P2|NOT COMPLETED|Overall Study||2
5132432|NCT01411891|12626241|P1|NOT COMPLETED|Overall Study||3
5132433|NCT01411891|12626240|P2|COMPLETED|Overall Study||48
5132434|NCT01411891|12626241|P1|COMPLETED|Overall Study||47
5132435|NCT01411891|12626240|P2|STARTED|Overall Study||50
5132436|NCT01411891|12626241|P1|STARTED|Overall Study||50
5132437|NCT01411852|12626251|P2|NOT COMPLETED|Hospital Intervention Phase||18
5132438|NCT01411852|12626252|P1|NOT COMPLETED|Hospital Intervention Phase||24
5132439|NCT01411852|12626251|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
5132440|NCT01411852|12626252|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
5132441|NCT01411852|12626251|P2|STARTED|Hospital Intervention Phase||89
5132442|NCT01411852|12626252|P1|STARTED|Hospital Intervention Phase||83
5132443|NCT01411852|12626251|P2|NOT COMPLETED|Prehospital Intervention Phase||7
5132444|NCT01411852|12626252|P1|NOT COMPLETED|Prehospital Intervention Phase||12
5132445|NCT01411852|12626251|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
5132446|NCT01411852|12626252|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
5132447|NCT01411852|12626251|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
5132448|NCT01411852|12626252|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
5132449|NCT01411839|12626297|P2|NOT COMPLETED|Overall Study||3
5132450|NCT01411839|12626298|P1|NOT COMPLETED|Overall Study||4
5132451|NCT01411839|12626297|P2|COMPLETED|Overall Study||17
5132452|NCT01411839|12626298|P1|COMPLETED|Overall Study||16
5132453|NCT01411839|12626297|P2|STARTED|Overall Study||20
5132454|NCT01411839|12626298|P1|STARTED|Overall Study||20
5132455|NCT01411774|12626310|P2|NOT COMPLETED|Overall Study||3
5132456|NCT01411774|12626311|P1|NOT COMPLETED|Overall Study||0
5132457|NCT01411774|12626310|P2|COMPLETED|Overall Study||67
5132458|NCT01411774|12626311|P1|COMPLETED|Overall Study||72
5132459|NCT01411774|12626310|P2|STARTED|Overall Study||70
5132460|NCT01411774|12626311|P1|STARTED|Overall Study||72
5132461|NCT01411696|12626319|P1|NOT COMPLETED|Overall Study||0
5132462|NCT01411696|12626319|P1|COMPLETED|Overall Study||289
5132463|NCT01411696|12626319|P1|STARTED|Overall Study||289
5132464|NCT01411592|12626328|P2|NOT COMPLETED|Overall Study||0
5132465|NCT01411592|12626329|P1|NOT COMPLETED|Overall Study||0
5132466|NCT01411592|12626328|P2|COMPLETED|Overall Study||16
5132467|NCT01411592|12626329|P1|COMPLETED|Overall Study||14
5132468|NCT01411592|12626328|P2|5-Year Time Frame|Overall Study||16
5132469|NCT01411592|12626329|P1|5-Year Time Frame|Overall Study||14
5132470|NCT01411592|12626328|P2|STARTED|Overall Study||16
5132471|NCT01411592|12626329|P1|STARTED|Overall Study||14
5132472|NCT01411527|12626339|P2|NOT COMPLETED|Overall Study||0
5132473|NCT01411527|12626340|P1|NOT COMPLETED|Overall Study||0
5132474|NCT01411527|12626339|P2|COMPLETED|Overall Study||93
5132475|NCT01411527|12626340|P1|COMPLETED|Overall Study||1864
5132476|NCT01411527|12626339|P2|STARTED|Overall Study||93
5132477|NCT01411527|12626340|P1|STARTED|Overall Study||1864
5132478|NCT01411501|12626349|P4|NOT COMPLETED|Overall Study||7
5132479|NCT01411501|12626350|P3|NOT COMPLETED|Overall Study||6
5132480|NCT01411501|12626351|P2|NOT COMPLETED|Overall Study||6
5132481|NCT01411501|12626352|P1|NOT COMPLETED|Overall Study||10
5132482|NCT01411501|12626349|P4|COMPLETED|Overall Study||163
5132483|NCT01411501|12626350|P3|COMPLETED|Overall Study||159
5132484|NCT01411501|12626351|P2|COMPLETED|Overall Study||166
5132485|NCT01411501|12626352|P1|COMPLETED|Overall Study||158
5132486|NCT01411501|12626349|P4|STARTED|Overall Study||170
5132487|NCT01411501|12626350|P3|STARTED|Overall Study||165
5132488|NCT01411501|12626351|P2|STARTED|Overall Study||172
5132489|NCT01411501|12626352|P1|STARTED|Overall Study||168
5132490|NCT01411488|12626384|P2|NOT COMPLETED|Overall Study||0
5132491|NCT01411488|12626385|P1|NOT COMPLETED|Overall Study||0
5132492|NCT01411488|12626384|P2|COMPLETED|Overall Study||38
5132493|NCT01411488|12626385|P1|COMPLETED|Overall Study||41
5132494|NCT01411488|12626384|P2|STARTED|Overall Study||38
5132495|NCT01411488|12626385|P1|STARTED|Overall Study||41
5132496|NCT01411267|12626397|P10|NOT COMPLETED|Overall Study||0
5132497|NCT01411267|12626398|P9|NOT COMPLETED|Overall Study||0
5132498|NCT01411267|12626399|P8|NOT COMPLETED|Overall Study||0
5132499|NCT01411267|12626400|P7|NOT COMPLETED|Overall Study||0
5132500|NCT01411267|12626401|P6|NOT COMPLETED|Overall Study||2
5132501|NCT01411267|12626402|P5|NOT COMPLETED|Overall Study||2
5132502|NCT01411267|12626403|P4|NOT COMPLETED|Overall Study||1
5132503|NCT01411267|12626404|P3|NOT COMPLETED|Overall Study||0
5132504|NCT01411267|12626405|P2|NOT COMPLETED|Overall Study||0
5132505|NCT01411267|12626406|P1|NOT COMPLETED|Overall Study||0
5132506|NCT01411267|12626397|P10|COMPLETED|Overall Study||0
5132507|NCT01411267|12626398|P9|COMPLETED|Overall Study||0
5132508|NCT01411267|12626399|P8|COMPLETED|Overall Study||0
5132509|NCT01411267|12626400|P7|COMPLETED|Overall Study||0
5132510|NCT01411267|12626401|P6|COMPLETED|Overall Study||10
5132511|NCT01411267|12626402|P5|COMPLETED|Overall Study||0
5132512|NCT01411267|12626403|P4|COMPLETED|Overall Study||4
5132513|NCT01411267|12626404|P3|COMPLETED|Overall Study||2
5132514|NCT01411267|12626405|P2|COMPLETED|Overall Study||3
5132515|NCT01411267|12626406|P1|COMPLETED|Overall Study||0
5132516|NCT01411267|12626397|P10|STARTED|Overall Study||0
5132517|NCT01411267|12626398|P9|STARTED|Overall Study||0
5132518|NCT01411267|12626399|P8|STARTED|Overall Study||0
5132519|NCT01411267|12626400|P7|STARTED|Overall Study||0
5132520|NCT01411267|12626401|P6|STARTED|Overall Study||12
5132521|NCT01411267|12626402|P5|STARTED|Overall Study||2
5132522|NCT01411267|12626403|P4|STARTED|Overall Study||5
5132523|NCT01411267|12626404|P3|STARTED|Overall Study||2
5132524|NCT01411267|12626405|P2|STARTED|Overall Study||3
5132525|NCT01411267|12626406|P1|STARTED|Overall Study||0
5132526|NCT01411241|12626426|P2|NOT COMPLETED|Overall Study||22
5132527|NCT01411241|12626427|P1|NOT COMPLETED|Overall Study||11
5132528|NCT01411241|12626426|P2|COMPLETED|Overall Study||293
5132529|NCT01411241|12626427|P1|COMPLETED|Overall Study||298
5132530|NCT01411241|12626426|P2|STARTED|Overall Study||315
5132531|NCT01411241|12626427|P1|STARTED|Overall Study||309
5132532|NCT01411228|12626452|P3|NOT COMPLETED|Overall Study||1
5132533|NCT01411228|12626453|P2|NOT COMPLETED|Overall Study||0
5132534|NCT01411228|12626454|P1|NOT COMPLETED|Overall Study||1
5132535|NCT01411228|12626452|P3|COMPLETED|Overall Study||4
5132536|NCT01411228|12626453|P2|COMPLETED|Overall Study||5
5132537|NCT01411228|12626454|P1|COMPLETED|Overall Study||4
5132538|NCT01411228|12626452|P3|STARTED|Overall Study||5
5132539|NCT01411228|12626453|P2|STARTED|Overall Study||5
5132540|NCT01411228|12626454|P1|STARTED|Overall Study||5
5132541|NCT01411215|12626476|P2|NOT COMPLETED|Overall Study||84
5132542|NCT01411215|12626477|P1|NOT COMPLETED|Overall Study||66
5132543|NCT01411215|12626476|P2|COMPLETED|Overall Study||7
5132544|NCT01411215|12626477|P1|COMPLETED|Overall Study||3
5132545|NCT01411215|12626476|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
5132546|NCT01411215|12626477|P1|Treated|Overall Study||69
5132547|NCT01411215|12626476|P2|STARTED|Overall Study||91
5132548|NCT01411215|12626477|P1|STARTED|Overall Study||69
5132549|NCT01411137|12626510|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
5132550|NCT01411137|12626510|P1|COMPLETED|Part 3: Open-Label Extension||12
5132551|NCT01411137|12626510|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
5132552|NCT01411137|12626510|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
5132553|NCT01411137|12626510|P1|COMPLETED|Part 2: Open-Label Extension||25
5132554|NCT01411137|12626510|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
5132555|NCT01411137|12626510|P1|NOT COMPLETED|Part 1: Dose Conversion||10
5132556|NCT01411137|12626510|P1|COMPLETED|Part 1: Dose Conversion||33
5132557|NCT01411137|12626510|P1|STARTED|Part 1: Dose Conversion||43
5132558|NCT01411085|12626529|P1|NOT COMPLETED|Overall Study||3
5132559|NCT01411085|12626529|P1|COMPLETED|Overall Study||7
5132560|NCT01411085|12626529|P1|STARTED|Overall Study||10
5132561|NCT01410812|12626536|P3|NOT COMPLETED|Overall Study||0
5132562|NCT01410812|12626537|P2|NOT COMPLETED|Overall Study||0
5132563|NCT01410812|12626538|P1|NOT COMPLETED|Overall Study||0
5132564|NCT01410812|12626536|P3|COMPLETED|Overall Study||76
5132565|NCT01410812|12626537|P2|COMPLETED|Overall Study||75
5132566|NCT01410812|12626538|P1|COMPLETED|Overall Study||75
5132567|NCT01410812|12626536|P3|STARTED|Overall Study||76
5132568|NCT01410812|12626537|P2|STARTED|Overall Study||75
5132569|NCT01410812|12626538|P1|STARTED|Overall Study||75
5132570|NCT01410799|12626549|P1|NOT COMPLETED|Overall Study||13
5132571|NCT01410799|12626549|P1|COMPLETED|Overall Study||0
5132572|NCT01410799|12626549|P1|STARTED|Overall Study||13
5132573|NCT01410773|12626558|P1|NOT COMPLETED|Overall Study||0
5132574|NCT01410773|12626558|P1|COMPLETED|Overall Study||110
5132575|NCT01410773|12626558|P1|STARTED|Overall Study||110
5132576|NCT01410604|12626565|P2|NOT COMPLETED|Overall Study||2
5132577|NCT01410604|12626566|P1|NOT COMPLETED|Overall Study||3
5132578|NCT01410604|12626565|P2|COMPLETED|Overall Study||14
5132579|NCT01410604|12626566|P1|COMPLETED|Overall Study||12
5132580|NCT01410604|12626565|P2|STARTED|Overall Study||16
5132581|NCT01410604|12626566|P1|STARTED|Overall Study||15
5132582|NCT01410565|12626588|P3|NOT COMPLETED|Double Blind Phase||0
5132583|NCT01410565|12626589|P2|NOT COMPLETED|Double Blind Phase||15
5132584|NCT01410565|12626590|P1|NOT COMPLETED|Double Blind Phase||13
5132585|NCT01410565|12626588|P3|COMPLETED|Double Blind Phase||0
5132586|NCT01410565|12626589|P2|COMPLETED|Double Blind Phase||0
5132587|NCT01410565|12626590|P1|COMPLETED|Double Blind Phase||0
5132588|NCT01410565|12626588|P3|STARTED|Double Blind Phase||0
5132589|NCT01410565|12626589|P2|STARTED|Double Blind Phase||15
5132590|NCT01410565|12626590|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
5132591|NCT01410565|12626588|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
5132592|NCT01410565|12626589|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
5132593|NCT01410565|12626590|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
5132594|NCT01410565|12626588|P3|COMPLETED|Open Label Phase Apaziquone||58
5132595|NCT01410565|12626589|P2|COMPLETED|Open Label Phase Apaziquone||0
5132596|NCT01410565|12626590|P1|COMPLETED|Open Label Phase Apaziquone||0
5132597|NCT01410565|12626588|P3|STARTED|Open Label Phase Apaziquone||66
5132598|NCT01410565|12626589|P2|STARTED|Open Label Phase Apaziquone||0
5132599|NCT01410565|12626590|P1|STARTED|Open Label Phase Apaziquone||0
5132600|NCT01410552|12626600|P1|NOT COMPLETED|Overall Study||136
5132601|NCT01410552|12626600|P1|COMPLETED|Overall Study||877
5132602|NCT01410552|12626600|P1|STARTED|Overall Study||1013
5132603|NCT01410474|12626607|P2|NOT COMPLETED|Overall Study||1
5132604|NCT01410474|12626608|P1|NOT COMPLETED|Overall Study||0
5132605|NCT01410474|12626607|P2|COMPLETED|Overall Study||167
5132606|NCT01410474|12626608|P1|COMPLETED|Overall Study||173
5132607|NCT01410474|12626607|P2|STARTED|Overall Study||168
5132608|NCT01410474|12626608|P1|STARTED|Overall Study||173
5132609|NCT01410448|12626631|P2|NOT COMPLETED|Overall Study||35
5132610|NCT01410448|12626632|P1|NOT COMPLETED|Overall Study||12
5132611|NCT01410448|12626631|P2|COMPLETED|Overall Study||155
5132612|NCT01410448|12626632|P1|COMPLETED|Overall Study||181
5132613|NCT01410448|12626631|P2|Modified ITT Analysis Set|Overall Study||149
5132614|NCT01410448|12626632|P1|Modified ITT Analysis Set|Overall Study||161
5132615|NCT01410448|12626631|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
5132616|NCT01410448|12626632|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
5132617|NCT01410448|12626631|P2|STARTED|Overall Study||190
5132618|NCT01410448|12626632|P1|STARTED|Overall Study||193
5132619|NCT01410409|12626672|P2|NOT COMPLETED|Overall Study||4
5132620|NCT01410409|12626673|P1|NOT COMPLETED|Overall Study||1
5132621|NCT01410409|12626672|P2|COMPLETED|Overall Study||46
5132622|NCT01410409|12626673|P1|COMPLETED|Overall Study||49
5132623|NCT01410409|12626672|P2|STARTED|Overall Study||50
5132624|NCT01410409|12626673|P1|STARTED|Overall Study||50
5132625|NCT01410357|12626697|P2|NOT COMPLETED|Overall Study||24
5132626|NCT01410357|12626698|P1|NOT COMPLETED|Overall Study||26
5132627|NCT01410357|12626697|P2|COMPLETED|Overall Study||76
5132628|NCT01410357|12626698|P1|COMPLETED|Overall Study||74
5132629|NCT01410357|12626697|P2|STARTED|Overall Study||100
5132630|NCT01410357|12626698|P1|STARTED|Overall Study||100
5132631|NCT01410344|12626752|P1|NOT COMPLETED|Overall Study||3
5132632|NCT01410344|12626752|P1|COMPLETED|Overall Study||17
5132633|NCT01410344|12626752|P1|STARTED|Overall Study||20
5132634|NCT01410240|12626769|P3|NOT COMPLETED|Overall Study||2
5132635|NCT01410240|12626770|P2|NOT COMPLETED|Overall Study||1
5132636|NCT01410240|12626771|P1|NOT COMPLETED|Overall Study||1
5132637|NCT01410240|12626769|P3|COMPLETED|Overall Study||10
5132638|NCT01410240|12626770|P2|COMPLETED|Overall Study||52
5132639|NCT01410240|12626771|P1|COMPLETED|Overall Study||52
5132640|NCT01410240|12626769|P3|STARTED|Overall Study||12
5132641|NCT01410240|12626770|P2|STARTED|Overall Study||53
5132642|NCT01410240|12626771|P1|STARTED|Overall Study||53
5132643|NCT01410227|12626842|P4|NOT COMPLETED|Overall Study||1
5132644|NCT01410227|12626843|P3|NOT COMPLETED|Overall Study||2
5132645|NCT01410227|12626844|P2|NOT COMPLETED|Overall Study||0
5132646|NCT01410227|12626845|P1|NOT COMPLETED|Overall Study||4
5132647|NCT01410227|12626842|P4|COMPLETED|Overall Study||5
5132648|NCT01410227|12626843|P3|COMPLETED|Overall Study||13
5132649|NCT01410227|12626844|P2|COMPLETED|Overall Study||8
5132650|NCT01410227|12626845|P1|COMPLETED|Overall Study||4
5132651|NCT01410227|12626842|P4|STARTED|Overall Study||6
5132652|NCT01410227|12626843|P3|STARTED|Overall Study||15
5132653|NCT01410227|12626844|P2|STARTED|Overall Study||8
5132654|NCT01410227|12626845|P1|STARTED|Overall Study||8
5132655|NCT01410110|12626917|P2|NOT COMPLETED|Overall Study||2
5132656|NCT01410110|12626918|P1|NOT COMPLETED|Overall Study||4
5132657|NCT01410110|12626917|P2|COMPLETED|Overall Study||22
5132658|NCT01410110|12626918|P1|COMPLETED|Overall Study||20
5132659|NCT01410110|12626917|P2|6 Month Follow-up|Overall Study||22
5132660|NCT01410110|12626918|P1|6 Month Follow-up|Overall Study||20
5132661|NCT01410110|12626917|P2|3 Months (End of Intervention)|Overall Study||22
5132662|NCT01410110|12626918|P1|3 Months (End of Intervention)|Overall Study||20
5132663|NCT01410110|12626917|P2|Randomization|Overall Study||24
5132664|NCT01410110|12626918|P1|Randomization|Overall Study||24
5132665|NCT01410110|12626917|P2|STARTED|Overall Study||24
5132666|NCT01410110|12626918|P1|STARTED|Overall Study||24
5132667|NCT01410097|12626942|P2|NOT COMPLETED|Overall Study||3
5132668|NCT01410097|12626943|P1|NOT COMPLETED|Overall Study||5
5132669|NCT01410097|12626942|P2|COMPLETED|Overall Study||530
5132670|NCT01410097|12626943|P1|COMPLETED|Overall Study||551
5132671|NCT01410097|12626942|P2|STARTED|Overall Study||533
5132672|NCT01410097|12626943|P1|STARTED|Overall Study||556
5132673|NCT01410084|12626967|P2|NOT COMPLETED|Overall Study||3
5132674|NCT01410084|12626968|P1|NOT COMPLETED|Overall Study||1
5132675|NCT01410084|12626967|P2|COMPLETED|Overall Study||27
5132676|NCT01410084|12626968|P1|COMPLETED|Overall Study||37
5132677|NCT01410084|12626967|P2|STARTED|Overall Study||30
5132678|NCT01410084|12626968|P1|STARTED|Overall Study||38
5132679|NCT01410058|12626980|P2|NOT COMPLETED|Day 35||0
5132680|NCT01410058|12626981|P1|NOT COMPLETED|Day 35||0
5132681|NCT01410058|12626980|P2|COMPLETED|Day 35||6
5132682|NCT01410058|12626981|P1|COMPLETED|Day 35||13
5132683|NCT01410058|12626980|P2|STARTED|Day 35||6
5132684|NCT01410058|12626981|P1|STARTED|Day 35||13
5132685|NCT01410058|12626980|P2|NOT COMPLETED|Baseline Day 22||0
5132686|NCT01410058|12626981|P1|NOT COMPLETED|Baseline Day 22||0
5132687|NCT01410058|12626980|P2|COMPLETED|Baseline Day 22||6
5132688|NCT01410058|12626981|P1|COMPLETED|Baseline Day 22||13
5132689|NCT01410058|12626980|P2|STARTED|Baseline Day 22||6
5132690|NCT01410058|12626981|P1|STARTED|Baseline Day 22||13
5132691|NCT01410058|12626980|P2|NOT COMPLETED|Washout Day 0||0
5132692|NCT01410058|12626981|P1|NOT COMPLETED|Washout Day 0||0
5132693|NCT01410058|12626980|P2|COMPLETED|Washout Day 0||6
5132694|NCT01410058|12626981|P1|COMPLETED|Washout Day 0||13
5132695|NCT01410058|12626980|P2|STARTED|Washout Day 0||6
5132696|NCT01410058|12626981|P1|STARTED|Washout Day 0||13
5132697|NCT01409993|12626993|P4|NOT COMPLETED|Overall Study||5
5132698|NCT01409993|12626994|P3|NOT COMPLETED|Overall Study||3
5132699|NCT01409993|12626995|P2|NOT COMPLETED|Overall Study||5
5132700|NCT01409993|12626996|P1|NOT COMPLETED|Overall Study||4
5132701|NCT01409993|12626993|P4|COMPLETED|Overall Study||8
5132702|NCT01409993|12626994|P3|COMPLETED|Overall Study||11
5132703|NCT01409993|12626995|P2|COMPLETED|Overall Study||21
5132704|NCT01409993|12626996|P1|COMPLETED|Overall Study||21
5132705|NCT01409993|12626993|P4|STARTED|Overall Study||13
5132706|NCT01409993|12626994|P3|STARTED|Overall Study||14
5132707|NCT01409993|12626995|P2|STARTED|Overall Study||26
5132708|NCT01409993|12626996|P1|STARTED|Overall Study||25
5132709|NCT01409928|12627014|P1|NOT COMPLETED|Overall Study||12
5132710|NCT01409928|12627014|P1|COMPLETED|Overall Study||4
5132711|NCT01409928|12627014|P1|STARTED|Overall Study||16
5132712|NCT01409837|12627020|P2|NOT COMPLETED|Overall Study||2
5132713|NCT01409837|12627021|P1|NOT COMPLETED|Overall Study||3
5132714|NCT01409837|12627020|P2|COMPLETED|Overall Study||14
5132715|NCT01409837|12627021|P1|COMPLETED|Overall Study||14
5132716|NCT01409837|12627020|P2|282nd Week|Overall Study||14
5132717|NCT01409837|12627021|P1|282nd Week|Overall Study||14
5132718|NCT01409837|12627020|P2|186th Week|Overall Study||14
5132719|NCT01409837|12627021|P1|186th Week|Overall Study|Moved away to another location|14
5132720|NCT01409837|12627020|P2|138th Week|Overall Study||14
5132721|NCT01409837|12627021|P1|138th Week|Overall Study||15
5132722|NCT01409837|12627020|P2|114th Week|Overall Study||14
5132723|NCT01409837|12627021|P1|114th Week|Overall Study||15
5132724|NCT01409837|12627020|P2|102nd Week|Overall Study|Married another wife|14
5132725|NCT01409837|12627021|P1|102nd Week|Overall Study||15
5132726|NCT01409837|12627020|P2|96th Week|Overall Study||15
5132727|NCT01409837|12627021|P1|96th Week|Overall Study||15
5132728|NCT01409837|12627020|P2|48th Week|Overall Study||15
5132729|NCT01409837|12627021|P1|48th Week|Overall Study|Lost to follow-up|15
5132730|NCT01409837|12627020|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
5132731|NCT01409837|12627021|P1|24th Week|Overall Study||16
5132732|NCT01409837|12627020|P2|12th Week|Overall Study||16
5132733|NCT01409837|12627021|P1|12th Week|Overall Study|Moved away to another location|16
5132734|NCT01409837|12627020|P2|6th Week|Overall Study||16
5132735|NCT01409837|12627021|P1|6th Week|Overall Study||17
5132736|NCT01409837|12627020|P2|STARTED|Overall Study||16
5132737|NCT01409837|12627021|P1|STARTED|Overall Study||17
5132738|NCT01409811|12627043|P1|NOT COMPLETED|Overall Study||1
5132739|NCT01409811|12627043|P1|COMPLETED|Overall Study||8
5132740|NCT01409811|12627043|P1|STARTED|Overall Study||9
5132741|NCT01409707|12627050|P3|NOT COMPLETED|Overall Study||16
5132742|NCT01409707|12627051|P2|NOT COMPLETED|Overall Study||17
5132743|NCT01409707|12627052|P1|NOT COMPLETED|Overall Study||5
5132744|NCT01409707|12627050|P3|COMPLETED|Overall Study||24
5132745|NCT01409707|12627051|P2|COMPLETED|Overall Study||28
5132746|NCT01409707|12627052|P1|COMPLETED|Overall Study||36
5132747|NCT01409707|12627050|P3|STARTED|Overall Study||40
5132748|NCT01409707|12627051|P2|STARTED|Overall Study||45
5132749|NCT01409707|12627052|P1|STARTED|Overall Study||41
5132750|NCT01409564|12627064|P2|NOT COMPLETED|Overall Study||5
5132751|NCT01409564|12627065|P1|NOT COMPLETED|Overall Study||5
5132752|NCT01409564|12627064|P2|COMPLETED|Overall Study||18
5132753|NCT01409564|12627065|P1|COMPLETED|Overall Study||18
5132754|NCT01409564|12627064|P2|STARTED|Overall Study||23
5132755|NCT01409564|12627065|P1|STARTED|Overall Study||23
5132756|NCT01409434|12627083|P1|NOT COMPLETED|Overall Study||4
5132757|NCT01409434|12627083|P1|COMPLETED|Overall Study||40
5132758|NCT01409434|12627083|P1|STARTED|Overall Study||44
5132759|NCT01409382|12627093|P2|NOT COMPLETED|Overall Study||80
5132760|NCT01409382|12627094|P1|NOT COMPLETED|Overall Study||81
5132761|NCT01409382|12627093|P2|COMPLETED|Overall Study||160
5132762|NCT01409382|12627094|P1|COMPLETED|Overall Study||159
5132763|NCT01409382|12627093|P2|STARTED|Overall Study||240
5132764|NCT01409382|12627094|P1|STARTED|Overall Study||240
5132765|NCT01409291|12627108|P2|NOT COMPLETED|Overall Study||9
5132766|NCT01409291|12627109|P1|NOT COMPLETED|Overall Study||7
5132767|NCT01409291|12627108|P2|COMPLETED|Overall Study||19
5132768|NCT01409291|12627109|P1|COMPLETED|Overall Study||29
5132769|NCT01409291|12627108|P2|STARTED|Overall Study||28
5132770|NCT01409291|12627109|P1|STARTED|Overall Study||36
5132771|NCT01409239|12627119|P2|NOT COMPLETED|Overall Study||0
5132772|NCT01409239|12627120|P1|NOT COMPLETED|Overall Study||0
5132773|NCT01409239|12627119|P2|COMPLETED|Overall Study||17
5132774|NCT01409239|12627120|P1|COMPLETED|Overall Study||16
5132775|NCT01409239|12627119|P2|STARTED|Overall Study||17
5132776|NCT01409239|12627120|P1|STARTED|Overall Study||16
5132777|NCT01409213|12627126|P1|NOT COMPLETED|Overall Study||0
5132778|NCT01409213|12627126|P1|COMPLETED|Overall Study||1523
5132779|NCT01409213|12627126|P1|STARTED|Overall Study||1523
5132780|NCT01409096|12627133|P2|NOT COMPLETED|Overall Study||5
5132781|NCT01409096|12627134|P1|NOT COMPLETED|Overall Study||2
5132782|NCT01409096|12627133|P2|COMPLETED|Overall Study||35
5132783|NCT01409096|12627134|P1|COMPLETED|Overall Study||38
5132784|NCT01409096|12627133|P2|STARTED|Overall Study||40
5132785|NCT01409096|12627134|P1|STARTED|Overall Study||40
5132786|NCT01409031|12627148|P2|NOT COMPLETED|Overall Study||0
5132787|NCT01409031|12627149|P1|NOT COMPLETED|Overall Study||1
5132788|NCT01409031|12627148|P2|COMPLETED|Overall Study||2
5132789|NCT01409031|12627149|P1|COMPLETED|Overall Study||0
5132790|NCT01409031|12627148|P2|STARTED|Overall Study||2
5132791|NCT01409031|12627149|P1|STARTED|Overall Study||1
5132792|NCT01408992|12627165|P1|NOT COMPLETED|Overall Study||0
5132793|NCT01408992|12627165|P1|COMPLETED|Overall Study||558
5132794|NCT01408992|12627165|P1|STARTED|Overall Study||558
5132795|NCT01408914|12627180|P3|NOT COMPLETED|Overall Study||13
5132796|NCT01408914|12627181|P2|NOT COMPLETED|Overall Study||12
5132797|NCT01408914|12627182|P1|NOT COMPLETED|Overall Study||12
5132798|NCT01408914|12627180|P3|COMPLETED|Overall Study||47
5132799|NCT01408914|12627181|P2|COMPLETED|Overall Study||48
5132800|NCT01408914|12627182|P1|COMPLETED|Overall Study||48
5132801|NCT01408914|12627180|P3|STARTED|Overall Study||60
5132802|NCT01408914|12627181|P2|STARTED|Overall Study||60
5132803|NCT01408914|12627182|P1|STARTED|Overall Study||60
5132804|NCT01408901|12627200|P4|NOT COMPLETED|26-Week Follow-Up||1
5132805|NCT01408901|12627201|P3|NOT COMPLETED|26-Week Follow-Up||0
5132806|NCT01408901|12627202|P2|NOT COMPLETED|26-Week Follow-Up||2
5132807|NCT01408901|12627203|P1|NOT COMPLETED|26-Week Follow-Up||1
5132808|NCT01408901|12627200|P4|COMPLETED|26-Week Follow-Up||46
5132809|NCT01408901|12627201|P3|COMPLETED|26-Week Follow-Up||50
5132810|NCT01408901|12627202|P2|COMPLETED|26-Week Follow-Up||50
5132811|NCT01408901|12627203|P1|COMPLETED|26-Week Follow-Up||48
5132812|NCT01408901|12627200|P4|STARTED|26-Week Follow-Up||47
5132813|NCT01408901|12627201|P3|STARTED|26-Week Follow-Up||50
5132814|NCT01408901|12627202|P2|STARTED|26-Week Follow-Up||52
5132815|NCT01408901|12627203|P1|STARTED|26-Week Follow-Up||49
5132816|NCT01408901|12627200|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
5132817|NCT01408901|12627201|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
5132818|NCT01408901|12627202|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
5132819|NCT01408901|12627203|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
5132820|NCT01408901|12627200|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
5132821|NCT01408901|12627201|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
5132822|NCT01408901|12627202|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
5132823|NCT01408901|12627203|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
5132824|NCT01408901|12627200|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
5132825|NCT01408901|12627201|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
5132826|NCT01408901|12627202|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
5132827|NCT01408901|12627203|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
5132828|NCT01408901|12627200|P4|NOT COMPLETED|6-Week Follow-Up||4
5132829|NCT01408901|12627201|P3|NOT COMPLETED|6-Week Follow-Up||3
5132830|NCT01408901|12627202|P2|NOT COMPLETED|6-Week Follow-Up||2
5132831|NCT01408901|12627203|P1|NOT COMPLETED|6-Week Follow-Up||3
5132832|NCT01408901|12627200|P4|COMPLETED|6-Week Follow-Up||47
5132833|NCT01408901|12627201|P3|COMPLETED|6-Week Follow-Up||50
5132834|NCT01408901|12627202|P2|COMPLETED|6-Week Follow-Up||51
5132835|NCT01408901|12627203|P1|COMPLETED|6-Week Follow-Up||50
5132836|NCT01408901|12627200|P4|STARTED|6-Week Follow-Up||51
5132837|NCT01408901|12627201|P3|STARTED|6-Week Follow-Up||53
5132838|NCT01408901|12627202|P2|STARTED|6-Week Follow-Up||53
5132839|NCT01408901|12627203|P1|STARTED|6-Week Follow-Up||53
5132840|NCT01408888|12627229|P2|NOT COMPLETED|Second Intervention||0
5132841|NCT01408888|12627230|P1|NOT COMPLETED|Second Intervention||2
5132842|NCT01408888|12627229|P2|COMPLETED|Second Intervention||8
5132843|NCT01408888|12627230|P1|COMPLETED|Second Intervention||16
5132844|NCT01408888|12627229|P2|STARTED|Second Intervention||8
5132845|NCT01408888|12627230|P1|STARTED|Second Intervention||18
5132846|NCT01408888|12627229|P2|NOT COMPLETED|Washout of at Least 21 Days||0
5132847|NCT01408888|12627230|P1|NOT COMPLETED|Washout of at Least 21 Days||0
5132848|NCT01408888|12627229|P2|COMPLETED|Washout of at Least 21 Days||8
5132849|NCT01408888|12627230|P1|COMPLETED|Washout of at Least 21 Days||18
5132850|NCT01408888|12627229|P2|STARTED|Washout of at Least 21 Days||8
5132851|NCT01408888|12627230|P1|STARTED|Washout of at Least 21 Days||18
5132852|NCT01408888|12627229|P2|NOT COMPLETED|First Intervention||3
5132853|NCT01408888|12627230|P1|NOT COMPLETED|First Intervention||0
5132854|NCT01408888|12627229|P2|COMPLETED|First Intervention||8
5132855|NCT01408888|12627230|P1|COMPLETED|First Intervention||18
5132856|NCT01408888|12627229|P2|Received at Least 1 Dose of Drug|First Intervention||11
5132857|NCT01408888|12627230|P1|Received at Least 1 Dose of Drug|First Intervention||18
5132858|NCT01408888|12627229|P2|STARTED|First Intervention||11
5132859|NCT01408888|12627230|P1|STARTED|First Intervention||18
5132860|NCT01408862|12627253|P1|NOT COMPLETED|Overall Study||0
5132861|NCT01408862|12627253|P1|COMPLETED|Overall Study||20
5132862|NCT01408862|12627253|P1|STARTED|Overall Study||20
5132863|NCT01408732|12627258|P2|NOT COMPLETED|Overall Study||2
5132864|NCT01408732|12627259|P1|NOT COMPLETED|Overall Study||2
5132865|NCT01408732|12627258|P2|COMPLETED|Overall Study||7
5132866|NCT01408732|12627259|P1|COMPLETED|Overall Study||7
5132867|NCT01408732|12627258|P2|STARTED|Overall Study||9
5132868|NCT01408732|12627259|P1|STARTED|Overall Study||9
5132869|NCT01408719|12627285|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132870|NCT01408719|12627286|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132871|NCT01408719|12627287|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132872|NCT01408719|12627288|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132873|NCT01408719|12627289|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132874|NCT01408719|12627290|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132875|NCT01408719|12627291|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132876|NCT01408719|12627292|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132877|NCT01408719|12627293|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132878|NCT01408719|12627294|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132879|NCT01408719|12627295|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132880|NCT01408719|12627296|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132881|NCT01408719|12627297|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132882|NCT01408719|12627298|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132883|NCT01408719|12627299|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132884|NCT01408719|12627300|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132885|NCT01408719|12627301|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132886|NCT01408719|12627302|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132887|NCT01408719|12627303|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132888|NCT01408719|12627304|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
5132889|NCT01408719|12627285|P20|COMPLETED|Fourth Intervention (35 Days)||1
5132890|NCT01408719|12627286|P19|COMPLETED|Fourth Intervention (35 Days)||0
5132891|NCT01408719|12627287|P18|COMPLETED|Fourth Intervention (35 Days)||2
5132892|NCT01408719|12627288|P17|COMPLETED|Fourth Intervention (35 Days)||2
5132893|NCT01408719|12627289|P16|COMPLETED|Fourth Intervention (35 Days)||1
5132894|NCT01408719|12627290|P15|COMPLETED|Fourth Intervention (35 Days)||1
5132895|NCT01408719|12627291|P14|COMPLETED|Fourth Intervention (35 Days)||3
5132896|NCT01408719|12627292|P13|COMPLETED|Fourth Intervention (35 Days)||1
5132897|NCT01408719|12627293|P12|COMPLETED|Fourth Intervention (35 Days)||2
5132898|NCT01408719|12627294|P11|COMPLETED|Fourth Intervention (35 Days)||2
5132899|NCT01408719|12627295|P10|COMPLETED|Fourth Intervention (35 Days)||1
5132900|NCT01408719|12627296|P9|COMPLETED|Fourth Intervention (35 Days)||1
5132901|NCT01408719|12627297|P8|COMPLETED|Fourth Intervention (35 Days)||2
5132902|NCT01408719|12627298|P7|COMPLETED|Fourth Intervention (35 Days)||2
5132903|NCT01408719|12627299|P6|COMPLETED|Fourth Intervention (35 Days)||3
5132904|NCT01408719|12627300|P5|COMPLETED|Fourth Intervention (35 Days)||3
5132905|NCT01408719|12627301|P4|COMPLETED|Fourth Intervention (35 Days)||2
5132906|NCT01408719|12627302|P3|COMPLETED|Fourth Intervention (35 Days)||1
5132907|NCT01408719|12627303|P2|COMPLETED|Fourth Intervention (35 Days)||3
5132908|NCT01408719|12627304|P1|COMPLETED|Fourth Intervention (35 Days)||2
5132909|NCT01408719|12627285|P20|STARTED|Fourth Intervention (35 Days)||1
5132910|NCT01408719|12627286|P19|STARTED|Fourth Intervention (35 Days)||0
5132911|NCT01408719|12627287|P18|STARTED|Fourth Intervention (35 Days)||2
5132912|NCT01408719|12627288|P17|STARTED|Fourth Intervention (35 Days)||2
5132913|NCT01408719|12627289|P16|STARTED|Fourth Intervention (35 Days)||1
5132914|NCT01408719|12627290|P15|STARTED|Fourth Intervention (35 Days)||1
5132915|NCT01408719|12627291|P14|STARTED|Fourth Intervention (35 Days)||3
5132916|NCT01408719|12627292|P13|STARTED|Fourth Intervention (35 Days)||1
5132917|NCT01408719|12627293|P12|STARTED|Fourth Intervention (35 Days)||2
5132918|NCT01408719|12627294|P11|STARTED|Fourth Intervention (35 Days)||2
5132919|NCT01408719|12627295|P10|STARTED|Fourth Intervention (35 Days)||1
5132920|NCT01408719|12627296|P9|STARTED|Fourth Intervention (35 Days)||1
5132921|NCT01408719|12627297|P8|STARTED|Fourth Intervention (35 Days)||2
5132922|NCT01408719|12627298|P7|STARTED|Fourth Intervention (35 Days)||2
5132923|NCT01408719|12627299|P6|STARTED|Fourth Intervention (35 Days)||3
5132924|NCT01408719|12627300|P5|STARTED|Fourth Intervention (35 Days)||3
5132925|NCT01408719|12627301|P4|STARTED|Fourth Intervention (35 Days)||2
5132926|NCT01408719|12627302|P3|STARTED|Fourth Intervention (35 Days)||1
5132927|NCT01408719|12627303|P2|STARTED|Fourth Intervention (35 Days)||3
5132928|NCT01408719|12627304|P1|STARTED|Fourth Intervention (35 Days)||2
5132929|NCT01408719|12627285|P20|NOT COMPLETED|Washout Period (28 Days)||0
5132930|NCT01408719|12627286|P19|NOT COMPLETED|Washout Period (28 Days)||0
5132931|NCT01408719|12627287|P18|NOT COMPLETED|Washout Period (28 Days)||0
5132932|NCT01408719|12627288|P17|NOT COMPLETED|Washout Period (28 Days)||0
5132933|NCT01408719|12627289|P16|NOT COMPLETED|Washout Period (28 Days)||0
5132934|NCT01408719|12627290|P15|NOT COMPLETED|Washout Period (28 Days)||0
5132935|NCT01408719|12627291|P14|NOT COMPLETED|Washout Period (28 Days)||0
5132936|NCT01408719|12627292|P13|NOT COMPLETED|Washout Period (28 Days)||0
5132937|NCT01408719|12627293|P12|NOT COMPLETED|Washout Period (28 Days)||0
5132938|NCT01408719|12627294|P11|NOT COMPLETED|Washout Period (28 Days)||0
5132939|NCT01408719|12627295|P10|NOT COMPLETED|Washout Period (28 Days)||0
5132940|NCT01408719|12627296|P9|NOT COMPLETED|Washout Period (28 Days)||0
5132941|NCT01408719|12627297|P8|NOT COMPLETED|Washout Period (28 Days)||0
5132942|NCT01408719|12627298|P7|NOT COMPLETED|Washout Period (28 Days)||0
5132943|NCT01408719|12627299|P6|NOT COMPLETED|Washout Period (28 Days)||0
5132944|NCT01408719|12627300|P5|NOT COMPLETED|Washout Period (28 Days)||0
5132945|NCT01408719|12627301|P4|NOT COMPLETED|Washout Period (28 Days)||0
5132946|NCT01408719|12627302|P3|NOT COMPLETED|Washout Period (28 Days)||0
5132947|NCT01408719|12627303|P2|NOT COMPLETED|Washout Period (28 Days)||0
5132948|NCT01408719|12627304|P1|NOT COMPLETED|Washout Period (28 Days)||0
5132949|NCT01408719|12627285|P20|COMPLETED|Washout Period (28 Days)||1
5132950|NCT01408719|12627286|P19|COMPLETED|Washout Period (28 Days)||0
5132951|NCT01408719|12627287|P18|COMPLETED|Washout Period (28 Days)||2
5132952|NCT01408719|12627288|P17|COMPLETED|Washout Period (28 Days)||2
5132953|NCT01408719|12627289|P16|COMPLETED|Washout Period (28 Days)||1
5132954|NCT01408719|12627290|P15|COMPLETED|Washout Period (28 Days)||1
5132955|NCT01408719|12627291|P14|COMPLETED|Washout Period (28 Days)||3
5132956|NCT01408719|12627292|P13|COMPLETED|Washout Period (28 Days)||1
5132957|NCT01408719|12627293|P12|COMPLETED|Washout Period (28 Days)||2
5132958|NCT01408719|12627294|P11|COMPLETED|Washout Period (28 Days)||2
5132959|NCT01408719|12627295|P10|COMPLETED|Washout Period (28 Days)||1
5132960|NCT01408719|12627296|P9|COMPLETED|Washout Period (28 Days)||1
5132961|NCT01408719|12627297|P8|COMPLETED|Washout Period (28 Days)||2
5132962|NCT01408719|12627298|P7|COMPLETED|Washout Period (28 Days)||2
5132963|NCT01408719|12627299|P6|COMPLETED|Washout Period (28 Days)||3
5132964|NCT01408719|12627300|P5|COMPLETED|Washout Period (28 Days)||3
5132965|NCT01408719|12627301|P4|COMPLETED|Washout Period (28 Days)||2
5132966|NCT01408719|12627302|P3|COMPLETED|Washout Period (28 Days)||1
5132967|NCT01408719|12627303|P2|COMPLETED|Washout Period (28 Days)||3
5132968|NCT01408719|12627304|P1|COMPLETED|Washout Period (28 Days)||2
5132969|NCT01408719|12627285|P20|STARTED|Washout Period (28 Days)||1
5132970|NCT01408719|12627286|P19|STARTED|Washout Period (28 Days)||0
5132971|NCT01408719|12627287|P18|STARTED|Washout Period (28 Days)||2
5132972|NCT01408719|12627288|P17|STARTED|Washout Period (28 Days)||2
5132973|NCT01408719|12627289|P16|STARTED|Washout Period (28 Days)||1
5132974|NCT01408719|12627290|P15|STARTED|Washout Period (28 Days)||1
5132975|NCT01408719|12627291|P14|STARTED|Washout Period (28 Days)||3
5132976|NCT01408719|12627292|P13|STARTED|Washout Period (28 Days)||1
5132977|NCT01408719|12627293|P12|STARTED|Washout Period (28 Days)||2
5132978|NCT01408719|12627294|P11|STARTED|Washout Period (28 Days)||2
5132979|NCT01408719|12627295|P10|STARTED|Washout Period (28 Days)||1
5132980|NCT01408719|12627296|P9|STARTED|Washout Period (28 Days)||1
5132981|NCT01408719|12627297|P8|STARTED|Washout Period (28 Days)||2
5132982|NCT01408719|12627298|P7|STARTED|Washout Period (28 Days)||2
5132983|NCT01408719|12627299|P6|STARTED|Washout Period (28 Days)||3
5132984|NCT01408719|12627300|P5|STARTED|Washout Period (28 Days)||3
5132985|NCT01408719|12627301|P4|STARTED|Washout Period (28 Days)||2
5132986|NCT01408719|12627302|P3|STARTED|Washout Period (28 Days)||1
5132987|NCT01408719|12627303|P2|STARTED|Washout Period (28 Days)||3
5132988|NCT01408719|12627304|P1|STARTED|Washout Period (28 Days)||2
5132989|NCT01408719|12627285|P20|NOT COMPLETED|Third Intervention (35 Days)||0
5132990|NCT01408719|12627286|P19|NOT COMPLETED|Third Intervention (35 Days)||0
5132991|NCT01408719|12627287|P18|NOT COMPLETED|Third Intervention (35 Days)||0
5132992|NCT01408719|12627288|P17|NOT COMPLETED|Third Intervention (35 Days)||0
5132993|NCT01408719|12627289|P16|NOT COMPLETED|Third Intervention (35 Days)||0
5132994|NCT01408719|12627290|P15|NOT COMPLETED|Third Intervention (35 Days)||0
5132995|NCT01408719|12627291|P14|NOT COMPLETED|Third Intervention (35 Days)||0
5132996|NCT01408719|12627292|P13|NOT COMPLETED|Third Intervention (35 Days)||0
5132997|NCT01408719|12627293|P12|NOT COMPLETED|Third Intervention (35 Days)||0
5132998|NCT01408719|12627294|P11|NOT COMPLETED|Third Intervention (35 Days)||0
5132999|NCT01408719|12627295|P10|NOT COMPLETED|Third Intervention (35 Days)||0
5133000|NCT01408719|12627296|P9|NOT COMPLETED|Third Intervention (35 Days)||0
5133001|NCT01408719|12627297|P8|NOT COMPLETED|Third Intervention (35 Days)||1
5133002|NCT01408719|12627298|P7|NOT COMPLETED|Third Intervention (35 Days)||0
5133003|NCT01408719|12627299|P6|NOT COMPLETED|Third Intervention (35 Days)||0
5133004|NCT01408719|12627300|P5|NOT COMPLETED|Third Intervention (35 Days)||0
5133005|NCT01408719|12627301|P4|NOT COMPLETED|Third Intervention (35 Days)||0
5133006|NCT01408719|12627302|P3|NOT COMPLETED|Third Intervention (35 Days)||0
5133007|NCT01408719|12627303|P2|NOT COMPLETED|Third Intervention (35 Days)||0
5133008|NCT01408719|12627304|P1|NOT COMPLETED|Third Intervention (35 Days)||0
5133009|NCT01408719|12627285|P20|COMPLETED|Third Intervention (35 Days)||1
5133010|NCT01408719|12627286|P19|COMPLETED|Third Intervention (35 Days)||0
5133011|NCT01408719|12627287|P18|COMPLETED|Third Intervention (35 Days)||2
5133012|NCT01408719|12627288|P17|COMPLETED|Third Intervention (35 Days)||2
5133013|NCT01408719|12627289|P16|COMPLETED|Third Intervention (35 Days)||1
5133014|NCT01408719|12627290|P15|COMPLETED|Third Intervention (35 Days)||1
5133015|NCT01408719|12627291|P14|COMPLETED|Third Intervention (35 Days)||3
5133016|NCT01408719|12627292|P13|COMPLETED|Third Intervention (35 Days)||2
5133017|NCT01408719|12627293|P12|COMPLETED|Third Intervention (35 Days)||2
5133018|NCT01408719|12627294|P11|COMPLETED|Third Intervention (35 Days)||2
5133019|NCT01408719|12627295|P10|COMPLETED|Third Intervention (35 Days)||1
5133020|NCT01408719|12627296|P9|COMPLETED|Third Intervention (35 Days)||1
5133021|NCT01408719|12627297|P8|COMPLETED|Third Intervention (35 Days)||2
5133022|NCT01408719|12627298|P7|COMPLETED|Third Intervention (35 Days)||2
5133023|NCT01408719|12627299|P6|COMPLETED|Third Intervention (35 Days)||3
5133024|NCT01408719|12627300|P5|COMPLETED|Third Intervention (35 Days)||3
5133025|NCT01408719|12627301|P4|COMPLETED|Third Intervention (35 Days)||2
5133026|NCT01408719|12627302|P3|COMPLETED|Third Intervention (35 Days)||1
5133027|NCT01408719|12627303|P2|COMPLETED|Third Intervention (35 Days)||3
5133028|NCT01408719|12627304|P1|COMPLETED|Third Intervention (35 Days)||2
5133029|NCT01408719|12627285|P20|STARTED|Third Intervention (35 Days)||1
5133030|NCT01408719|12627286|P19|STARTED|Third Intervention (35 Days)||0
5133031|NCT01408719|12627287|P18|STARTED|Third Intervention (35 Days)||2
5133032|NCT01408719|12627288|P17|STARTED|Third Intervention (35 Days)||2
5133033|NCT01408719|12627289|P16|STARTED|Third Intervention (35 Days)||1
5133034|NCT01408719|12627290|P15|STARTED|Third Intervention (35 Days)||1
5133035|NCT01408719|12627291|P14|STARTED|Third Intervention (35 Days)||3
5133036|NCT01408719|12627292|P13|STARTED|Third Intervention (35 Days)||2
5133037|NCT01408719|12627293|P12|STARTED|Third Intervention (35 Days)||2
5133038|NCT01408719|12627294|P11|STARTED|Third Intervention (35 Days)||2
5133039|NCT01408719|12627295|P10|STARTED|Third Intervention (35 Days)||1
5133040|NCT01408719|12627296|P9|STARTED|Third Intervention (35 Days)||1
5133041|NCT01408719|12627297|P8|STARTED|Third Intervention (35 Days)||3
5133042|NCT01408719|12627298|P7|STARTED|Third Intervention (35 Days)||2
5133043|NCT01408719|12627299|P6|STARTED|Third Intervention (35 Days)||3
5133044|NCT01408719|12627300|P5|STARTED|Third Intervention (35 Days)||3
5133045|NCT01408719|12627301|P4|STARTED|Third Intervention (35 Days)||2
5133046|NCT01408719|12627302|P3|STARTED|Third Intervention (35 Days)||1
5133047|NCT01408719|12627303|P2|STARTED|Third Intervention (35 Days)||3
5133048|NCT01408719|12627304|P1|STARTED|Third Intervention (35 Days)||2
5133049|NCT01408719|12627285|P20|NOT COMPLETED|Washout Period (28 Days)||0
5133050|NCT01408719|12627286|P19|NOT COMPLETED|Washout Period (28 Days)||0
5133051|NCT01408719|12627287|P18|NOT COMPLETED|Washout Period (28 Days)||0
5133052|NCT01408719|12627288|P17|NOT COMPLETED|Washout Period (28 Days)||0
5133053|NCT01408719|12627289|P16|NOT COMPLETED|Washout Period (28 Days)||0
5133054|NCT01408719|12627290|P15|NOT COMPLETED|Washout Period (28 Days)||0
5133055|NCT01408719|12627291|P14|NOT COMPLETED|Washout Period (28 Days)||0
5133056|NCT01408719|12627292|P13|NOT COMPLETED|Washout Period (28 Days)||0
5133057|NCT01408719|12627293|P12|NOT COMPLETED|Washout Period (28 Days)||0
5133058|NCT01408719|12627294|P11|NOT COMPLETED|Washout Period (28 Days)||0
5133059|NCT01408719|12627295|P10|NOT COMPLETED|Washout Period (28 Days)||0
5133060|NCT01408719|12627296|P9|NOT COMPLETED|Washout Period (28 Days)||0
5133061|NCT01408719|12627297|P8|NOT COMPLETED|Washout Period (28 Days)||0
5133062|NCT01408719|12627298|P7|NOT COMPLETED|Washout Period (28 Days)||0
5133063|NCT01408719|12627299|P6|NOT COMPLETED|Washout Period (28 Days)||0
5133064|NCT01408719|12627300|P5|NOT COMPLETED|Washout Period (28 Days)||0
5133065|NCT01408719|12627301|P4|NOT COMPLETED|Washout Period (28 Days)||0
5133066|NCT01408719|12627302|P3|NOT COMPLETED|Washout Period (28 Days)||0
5133067|NCT01408719|12627303|P2|NOT COMPLETED|Washout Period (28 Days)||0
5133068|NCT01408719|12627304|P1|NOT COMPLETED|Washout Period (28 Days)||0
5133069|NCT01408719|12627285|P20|COMPLETED|Washout Period (28 Days)||1
5133070|NCT01408719|12627286|P19|COMPLETED|Washout Period (28 Days)||0
5133071|NCT01408719|12627287|P18|COMPLETED|Washout Period (28 Days)||2
5133072|NCT01408719|12627288|P17|COMPLETED|Washout Period (28 Days)||2
5133073|NCT01408719|12627289|P16|COMPLETED|Washout Period (28 Days)||1
5133074|NCT01408719|12627290|P15|COMPLETED|Washout Period (28 Days)||1
5133075|NCT01408719|12627291|P14|COMPLETED|Washout Period (28 Days)||3
5133076|NCT01408719|12627292|P13|COMPLETED|Washout Period (28 Days)||2
5133077|NCT01408719|12627293|P12|COMPLETED|Washout Period (28 Days)||2
5133078|NCT01408719|12627294|P11|COMPLETED|Washout Period (28 Days)||2
5133079|NCT01408719|12627295|P10|COMPLETED|Washout Period (28 Days)||1
5133080|NCT01408719|12627296|P9|COMPLETED|Washout Period (28 Days)||1
5133081|NCT01408719|12627297|P8|COMPLETED|Washout Period (28 Days)||3
5133082|NCT01408719|12627298|P7|COMPLETED|Washout Period (28 Days)||2
5133083|NCT01408719|12627299|P6|COMPLETED|Washout Period (28 Days)||3
5133084|NCT01408719|12627300|P5|COMPLETED|Washout Period (28 Days)||3
5133085|NCT01408719|12627301|P4|COMPLETED|Washout Period (28 Days)||2
5133086|NCT01408719|12627302|P3|COMPLETED|Washout Period (28 Days)||1
5133087|NCT01408719|12627303|P2|COMPLETED|Washout Period (28 Days)||3
5133088|NCT01408719|12627304|P1|COMPLETED|Washout Period (28 Days)||2
5133089|NCT01408719|12627285|P20|STARTED|Washout Period (28 Days)||1
5133090|NCT01408719|12627286|P19|STARTED|Washout Period (28 Days)||0
5133091|NCT01408719|12627287|P18|STARTED|Washout Period (28 Days)||2
5133092|NCT01408719|12627288|P17|STARTED|Washout Period (28 Days)||2
5133093|NCT01408719|12627289|P16|STARTED|Washout Period (28 Days)||1
5133094|NCT01408719|12627290|P15|STARTED|Washout Period (28 Days)||1
5133095|NCT01408719|12627291|P14|STARTED|Washout Period (28 Days)||3
5133096|NCT01408719|12627292|P13|STARTED|Washout Period (28 Days)||2
5133097|NCT01408719|12627293|P12|STARTED|Washout Period (28 Days)||2
5133098|NCT01408719|12627294|P11|STARTED|Washout Period (28 Days)||2
5133099|NCT01408719|12627295|P10|STARTED|Washout Period (28 Days)||1
5133100|NCT01408719|12627296|P9|STARTED|Washout Period (28 Days)||1
5133101|NCT01408719|12627297|P8|STARTED|Washout Period (28 Days)||3
5133102|NCT01408719|12627298|P7|STARTED|Washout Period (28 Days)||2
5133103|NCT01408719|12627299|P6|STARTED|Washout Period (28 Days)||3
5133104|NCT01408719|12627300|P5|STARTED|Washout Period (28 Days)||3
5133105|NCT01408719|12627301|P4|STARTED|Washout Period (28 Days)||2
5133106|NCT01408719|12627302|P3|STARTED|Washout Period (28 Days)||1
5133107|NCT01408719|12627303|P2|STARTED|Washout Period (28 Days)||3
5133108|NCT01408719|12627304|P1|STARTED|Washout Period (28 Days)||2
5133109|NCT01408719|12627285|P20|NOT COMPLETED|Second Intervention (35 Days)||0
5133110|NCT01408719|12627286|P19|NOT COMPLETED|Second Intervention (35 Days)||0
5133111|NCT01408719|12627287|P18|NOT COMPLETED|Second Intervention (35 Days)||0
5133112|NCT01408719|12627288|P17|NOT COMPLETED|Second Intervention (35 Days)||0
5133113|NCT01408719|12627289|P16|NOT COMPLETED|Second Intervention (35 Days)||0
5133114|NCT01408719|12627290|P15|NOT COMPLETED|Second Intervention (35 Days)||0
5133115|NCT01408719|12627291|P14|NOT COMPLETED|Second Intervention (35 Days)||1
5133116|NCT01408719|12627292|P13|NOT COMPLETED|Second Intervention (35 Days)||0
5133117|NCT01408719|12627293|P12|NOT COMPLETED|Second Intervention (35 Days)||0
5133118|NCT01408719|12627294|P11|NOT COMPLETED|Second Intervention (35 Days)||0
5133119|NCT01408719|12627295|P10|NOT COMPLETED|Second Intervention (35 Days)||0
5133120|NCT01408719|12627296|P9|NOT COMPLETED|Second Intervention (35 Days)||0
5133121|NCT01408719|12627297|P8|NOT COMPLETED|Second Intervention (35 Days)||0
5133122|NCT01408719|12627298|P7|NOT COMPLETED|Second Intervention (35 Days)||0
5133123|NCT01408719|12627299|P6|NOT COMPLETED|Second Intervention (35 Days)||0
5133124|NCT01408719|12627300|P5|NOT COMPLETED|Second Intervention (35 Days)||0
5133125|NCT01408719|12627301|P4|NOT COMPLETED|Second Intervention (35 Days)||0
5133126|NCT01408719|12627302|P3|NOT COMPLETED|Second Intervention (35 Days)||0
5133127|NCT01408719|12627303|P2|NOT COMPLETED|Second Intervention (35 Days)||0
5133128|NCT01408719|12627304|P1|NOT COMPLETED|Second Intervention (35 Days)||0
5133129|NCT01408719|12627285|P20|COMPLETED|Second Intervention (35 Days)||1
5133130|NCT01408719|12627286|P19|COMPLETED|Second Intervention (35 Days)||0
5133131|NCT01408719|12627287|P18|COMPLETED|Second Intervention (35 Days)||2
5133132|NCT01408719|12627288|P17|COMPLETED|Second Intervention (35 Days)||2
5133133|NCT01408719|12627289|P16|COMPLETED|Second Intervention (35 Days)||2
5133134|NCT01408719|12627290|P15|COMPLETED|Second Intervention (35 Days)||1
5133135|NCT01408719|12627291|P14|COMPLETED|Second Intervention (35 Days)||3
5133136|NCT01408719|12627292|P13|COMPLETED|Second Intervention (35 Days)||2
5133137|NCT01408719|12627293|P12|COMPLETED|Second Intervention (35 Days)||2
5133138|NCT01408719|12627294|P11|COMPLETED|Second Intervention (35 Days)||2
5133139|NCT01408719|12627295|P10|COMPLETED|Second Intervention (35 Days)||1
5133140|NCT01408719|12627296|P9|COMPLETED|Second Intervention (35 Days)||1
5133141|NCT01408719|12627297|P8|COMPLETED|Second Intervention (35 Days)||3
5133142|NCT01408719|12627298|P7|COMPLETED|Second Intervention (35 Days)||2
5133143|NCT01408719|12627299|P6|COMPLETED|Second Intervention (35 Days)||3
5133144|NCT01408719|12627300|P5|COMPLETED|Second Intervention (35 Days)||3
5133145|NCT01408719|12627301|P4|COMPLETED|Second Intervention (35 Days)||2
5133146|NCT01408719|12627302|P3|COMPLETED|Second Intervention (35 Days)||1
5133147|NCT01408719|12627303|P2|COMPLETED|Second Intervention (35 Days)||3
5133148|NCT01408719|12627304|P1|COMPLETED|Second Intervention (35 Days)||2
5133149|NCT01408719|12627285|P20|STARTED|Second Intervention (35 Days)||1
5133150|NCT01408719|12627286|P19|STARTED|Second Intervention (35 Days)||0
5133151|NCT01408719|12627287|P18|STARTED|Second Intervention (35 Days)||2
5133152|NCT01408719|12627288|P17|STARTED|Second Intervention (35 Days)||2
5133153|NCT01408719|12627289|P16|STARTED|Second Intervention (35 Days)||2
5133154|NCT01408719|12627290|P15|STARTED|Second Intervention (35 Days)||1
5133155|NCT01408719|12627291|P14|STARTED|Second Intervention (35 Days)||4
5133156|NCT01408719|12627292|P13|STARTED|Second Intervention (35 Days)||2
5133157|NCT01408719|12627293|P12|STARTED|Second Intervention (35 Days)||2
5133158|NCT01408719|12627294|P11|STARTED|Second Intervention (35 Days)||2
5133159|NCT01408719|12627295|P10|STARTED|Second Intervention (35 Days)||1
5133160|NCT01408719|12627296|P9|STARTED|Second Intervention (35 Days)||1
5133161|NCT01408719|12627297|P8|STARTED|Second Intervention (35 Days)||3
5133162|NCT01408719|12627298|P7|STARTED|Second Intervention (35 Days)||2
5133163|NCT01408719|12627299|P6|STARTED|Second Intervention (35 Days)||3
5133164|NCT01408719|12627300|P5|STARTED|Second Intervention (35 Days)||3
5133165|NCT01408719|12627301|P4|STARTED|Second Intervention (35 Days)||2
5133166|NCT01408719|12627302|P3|STARTED|Second Intervention (35 Days)||1
5133167|NCT01408719|12627303|P2|STARTED|Second Intervention (35 Days)||3
5133168|NCT01408719|12627304|P1|STARTED|Second Intervention (35 Days)||2
5133169|NCT01408719|12627285|P20|NOT COMPLETED|Washout Period (28 Days)||0
5133170|NCT01408719|12627286|P19|NOT COMPLETED|Washout Period (28 Days)||0
5133171|NCT01408719|12627287|P18|NOT COMPLETED|Washout Period (28 Days)||0
5133172|NCT01408719|12627288|P17|NOT COMPLETED|Washout Period (28 Days)||0
5133173|NCT01408719|12627289|P16|NOT COMPLETED|Washout Period (28 Days)||0
5133174|NCT01408719|12627290|P15|NOT COMPLETED|Washout Period (28 Days)||0
5133175|NCT01408719|12627291|P14|NOT COMPLETED|Washout Period (28 Days)||0
5133176|NCT01408719|12627292|P13|NOT COMPLETED|Washout Period (28 Days)||0
5133177|NCT01408719|12627293|P12|NOT COMPLETED|Washout Period (28 Days)||0
5133178|NCT01408719|12627294|P11|NOT COMPLETED|Washout Period (28 Days)||0
5133179|NCT01408719|12627295|P10|NOT COMPLETED|Washout Period (28 Days)||0
5133180|NCT01408719|12627296|P9|NOT COMPLETED|Washout Period (28 Days)||0
5133181|NCT01408719|12627297|P8|NOT COMPLETED|Washout Period (28 Days)||0
5133182|NCT01408719|12627298|P7|NOT COMPLETED|Washout Period (28 Days)||0
5133183|NCT01408719|12627299|P6|NOT COMPLETED|Washout Period (28 Days)||0
5133184|NCT01408719|12627300|P5|NOT COMPLETED|Washout Period (28 Days)||0
5133185|NCT01408719|12627301|P4|NOT COMPLETED|Washout Period (28 Days)||0
5133186|NCT01408719|12627302|P3|NOT COMPLETED|Washout Period (28 Days)||0
5133187|NCT01408719|12627303|P2|NOT COMPLETED|Washout Period (28 Days)||0
5133188|NCT01408719|12627304|P1|NOT COMPLETED|Washout Period (28 Days)||0
5133189|NCT01408719|12627285|P20|COMPLETED|Washout Period (28 Days)||1
5133190|NCT01408719|12627286|P19|COMPLETED|Washout Period (28 Days)||0
5133191|NCT01408719|12627287|P18|COMPLETED|Washout Period (28 Days)||2
5133192|NCT01408719|12627288|P17|COMPLETED|Washout Period (28 Days)||2
5133193|NCT01408719|12627289|P16|COMPLETED|Washout Period (28 Days)||2
5133194|NCT01408719|12627290|P15|COMPLETED|Washout Period (28 Days)||1
5133195|NCT01408719|12627291|P14|COMPLETED|Washout Period (28 Days)||4
5133196|NCT01408719|12627292|P13|COMPLETED|Washout Period (28 Days)||2
5133197|NCT01408719|12627293|P12|COMPLETED|Washout Period (28 Days)||2
5133198|NCT01408719|12627294|P11|COMPLETED|Washout Period (28 Days)||2
5133199|NCT01408719|12627295|P10|COMPLETED|Washout Period (28 Days)||1
5133200|NCT01408719|12627296|P9|COMPLETED|Washout Period (28 Days)||1
5133201|NCT01408719|12627297|P8|COMPLETED|Washout Period (28 Days)||3
5133202|NCT01408719|12627298|P7|COMPLETED|Washout Period (28 Days)||2
5133203|NCT01408719|12627299|P6|COMPLETED|Washout Period (28 Days)||3
5133204|NCT01408719|12627300|P5|COMPLETED|Washout Period (28 Days)||3
5133205|NCT01408719|12627301|P4|COMPLETED|Washout Period (28 Days)||2
5133206|NCT01408719|12627302|P3|COMPLETED|Washout Period (28 Days)||1
5133207|NCT01408719|12627303|P2|COMPLETED|Washout Period (28 Days)||3
5133208|NCT01408719|12627304|P1|COMPLETED|Washout Period (28 Days)||2
5133209|NCT01408719|12627285|P20|STARTED|Washout Period (28 Days)||1
5133210|NCT01408719|12627286|P19|STARTED|Washout Period (28 Days)||0
5133211|NCT01408719|12627287|P18|STARTED|Washout Period (28 Days)||2
5133212|NCT01408719|12627288|P17|STARTED|Washout Period (28 Days)||2
5133213|NCT01408719|12627289|P16|STARTED|Washout Period (28 Days)||2
5133214|NCT01408719|12627290|P15|STARTED|Washout Period (28 Days)||1
5133215|NCT01408719|12627291|P14|STARTED|Washout Period (28 Days)||4
5133216|NCT01408719|12627292|P13|STARTED|Washout Period (28 Days)||2
5133217|NCT01408719|12627293|P12|STARTED|Washout Period (28 Days)||2
5133218|NCT01408719|12627294|P11|STARTED|Washout Period (28 Days)||2
5133219|NCT01408719|12627295|P10|STARTED|Washout Period (28 Days)||1
5133220|NCT01408719|12627296|P9|STARTED|Washout Period (28 Days)||1
5133221|NCT01408719|12627297|P8|STARTED|Washout Period (28 Days)||3
5133222|NCT01408719|12627298|P7|STARTED|Washout Period (28 Days)||2
5133223|NCT01408719|12627299|P6|STARTED|Washout Period (28 Days)||3
5133224|NCT01408719|12627300|P5|STARTED|Washout Period (28 Days)||3
5133225|NCT01408719|12627301|P4|STARTED|Washout Period (28 Days)||2
5133226|NCT01408719|12627302|P3|STARTED|Washout Period (28 Days)||1
5133227|NCT01408719|12627303|P2|STARTED|Washout Period (28 Days)||3
5133228|NCT01408719|12627304|P1|STARTED|Washout Period (28 Days)||2
5133229|NCT01408719|12627285|P20|NOT COMPLETED|First Intervention (35 Days)||0
5133230|NCT01408719|12627286|P19|NOT COMPLETED|First Intervention (35 Days)||1
5133231|NCT01408719|12627287|P18|NOT COMPLETED|First Intervention (35 Days)||0
5133232|NCT01408719|12627288|P17|NOT COMPLETED|First Intervention (35 Days)||1
5133233|NCT01408719|12627289|P16|NOT COMPLETED|First Intervention (35 Days)||0
5133234|NCT01408719|12627290|P15|NOT COMPLETED|First Intervention (35 Days)||0
5133235|NCT01408719|12627291|P14|NOT COMPLETED|First Intervention (35 Days)||1
5133236|NCT01408719|12627292|P13|NOT COMPLETED|First Intervention (35 Days)||0
5133237|NCT01408719|12627293|P12|NOT COMPLETED|First Intervention (35 Days)||0
5133238|NCT01408719|12627294|P11|NOT COMPLETED|First Intervention (35 Days)||0
5133239|NCT01408719|12627295|P10|NOT COMPLETED|First Intervention (35 Days)||0
5133240|NCT01408719|12627296|P9|NOT COMPLETED|First Intervention (35 Days)||1
5133241|NCT01408719|12627297|P8|NOT COMPLETED|First Intervention (35 Days)||0
5133242|NCT01408719|12627298|P7|NOT COMPLETED|First Intervention (35 Days)||0
5133243|NCT01408719|12627299|P6|NOT COMPLETED|First Intervention (35 Days)||0
5133244|NCT01408719|12627300|P5|NOT COMPLETED|First Intervention (35 Days)||1
5133245|NCT01408719|12627301|P4|NOT COMPLETED|First Intervention (35 Days)||0
5133246|NCT01408719|12627302|P3|NOT COMPLETED|First Intervention (35 Days)||1
5133247|NCT01408719|12627303|P2|NOT COMPLETED|First Intervention (35 Days)||0
5133248|NCT01408719|12627304|P1|NOT COMPLETED|First Intervention (35 Days)||0
5133249|NCT01408719|12627285|P20|COMPLETED|First Intervention (35 Days)||1
5133250|NCT01408719|12627286|P19|COMPLETED|First Intervention (35 Days)||0
5133251|NCT01408719|12627287|P18|COMPLETED|First Intervention (35 Days)||2
5133252|NCT01408719|12627288|P17|COMPLETED|First Intervention (35 Days)||2
5133253|NCT01408719|12627289|P16|COMPLETED|First Intervention (35 Days)||2
5133254|NCT01408719|12627290|P15|COMPLETED|First Intervention (35 Days)||1
5133255|NCT01408719|12627291|P14|COMPLETED|First Intervention (35 Days)||4
5133256|NCT01408719|12627292|P13|COMPLETED|First Intervention (35 Days)||2
5133257|NCT01408719|12627293|P12|COMPLETED|First Intervention (35 Days)||2
5133258|NCT01408719|12627294|P11|COMPLETED|First Intervention (35 Days)||2
5133259|NCT01408719|12627295|P10|COMPLETED|First Intervention (35 Days)||1
5133260|NCT01408719|12627296|P9|COMPLETED|First Intervention (35 Days)||1
5133261|NCT01408719|12627297|P8|COMPLETED|First Intervention (35 Days)||3
5133262|NCT01408719|12627298|P7|COMPLETED|First Intervention (35 Days)||2
5133263|NCT01408719|12627299|P6|COMPLETED|First Intervention (35 Days)||3
5133264|NCT01408719|12627300|P5|COMPLETED|First Intervention (35 Days)||3
5133265|NCT01408719|12627301|P4|COMPLETED|First Intervention (35 Days)||2
5133266|NCT01408719|12627302|P3|COMPLETED|First Intervention (35 Days)||1
5133267|NCT01408719|12627303|P2|COMPLETED|First Intervention (35 Days)||3
5133268|NCT01408719|12627304|P1|COMPLETED|First Intervention (35 Days)||2
5133269|NCT01408719|12627285|P20|STARTED|First Intervention (35 Days)||1
5133270|NCT01408719|12627286|P19|STARTED|First Intervention (35 Days)||1
5133271|NCT01408719|12627287|P18|STARTED|First Intervention (35 Days)||2
5133272|NCT01408719|12627288|P17|STARTED|First Intervention (35 Days)||3
5133273|NCT01408719|12627289|P16|STARTED|First Intervention (35 Days)||2
5133274|NCT01408719|12627290|P15|STARTED|First Intervention (35 Days)||1
5133275|NCT01408719|12627291|P14|STARTED|First Intervention (35 Days)||5
5133276|NCT01408719|12627292|P13|STARTED|First Intervention (35 Days)||2
5133277|NCT01408719|12627293|P12|STARTED|First Intervention (35 Days)||2
5133278|NCT01408719|12627294|P11|STARTED|First Intervention (35 Days)||2
5133279|NCT01408719|12627295|P10|STARTED|First Intervention (35 Days)||1
5133280|NCT01408719|12627296|P9|STARTED|First Intervention (35 Days)||2
5133281|NCT01408719|12627297|P8|STARTED|First Intervention (35 Days)||3
5133282|NCT01408719|12627298|P7|STARTED|First Intervention (35 Days)||2
5133283|NCT01408719|12627299|P6|STARTED|First Intervention (35 Days)||3
5133284|NCT01408719|12627300|P5|STARTED|First Intervention (35 Days)||4
5133285|NCT01408719|12627301|P4|STARTED|First Intervention (35 Days)||2
5133286|NCT01408719|12627302|P3|STARTED|First Intervention (35 Days)||2
5133287|NCT01408719|12627303|P2|STARTED|First Intervention (35 Days)||3
5133288|NCT01408719|12627304|P1|STARTED|First Intervention (35 Days)||2
5133289|NCT01408706|12627316|P2|NOT COMPLETED|Overall Study||0
5133290|NCT01408706|12627317|P1|NOT COMPLETED|Overall Study||1
5133291|NCT01408706|12627316|P2|COMPLETED|Overall Study||30
5133292|NCT01408706|12627317|P1|COMPLETED|Overall Study||29
5133293|NCT01408706|12627316|P2|STARTED|Overall Study||30
5133294|NCT01408706|12627317|P1|STARTED|Overall Study||30
5133295|NCT01408641|12627329|P2|NOT COMPLETED|Overall Study||0
5133296|NCT01408641|12627330|P1|NOT COMPLETED|Overall Study||1
5133297|NCT01408641|12627329|P2|COMPLETED|Overall Study||0
5133298|NCT01408641|12627330|P1|COMPLETED|Overall Study||0
5133299|NCT01408641|12627329|P2|STARTED|Overall Study||0
5133300|NCT01408641|12627330|P1|STARTED|Overall Study||1
5133301|NCT01408628|12627338|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
5133302|NCT01408628|12627338|P1|COMPLETED|Completed 6 Month Follow-Up||25
5133303|NCT01408628|12627338|P1|STARTED|Completed 6 Month Follow-Up||39
5133304|NCT01408628|12627338|P1|NOT COMPLETED|Started Classes/Intervention||0
5133305|NCT01408628|12627338|P1|COMPLETED|Started Classes/Intervention||39
5133306|NCT01408628|12627338|P1|STARTED|Started Classes/Intervention||39
5133307|NCT01408628|12627338|P1|NOT COMPLETED|Consented||12
5133308|NCT01408628|12627338|P1|COMPLETED|Consented||39
5133309|NCT01408628|12627338|P1|STARTED|Consented||51
5133310|NCT01408576|12627347|P3|NOT COMPLETED|Overall Study||508
5133311|NCT01408576|12627348|P2|NOT COMPLETED|Overall Study||498
5133312|NCT01408576|12627349|P1|NOT COMPLETED|Overall Study||188
5133313|NCT01408576|12627347|P3|COMPLETED|Overall Study||0
5133314|NCT01408576|12627348|P2|COMPLETED|Overall Study||0
5133315|NCT01408576|12627349|P1|COMPLETED|Overall Study||56
5133316|NCT01408576|12627347|P3|STARTED|Overall Study||508
5133317|NCT01408576|12627348|P2|STARTED|Overall Study||498
5133318|NCT01408576|12627349|P1|STARTED|Overall Study||244
5133319|NCT01408563|12627396|P1|NOT COMPLETED|Overall Study||2
5133320|NCT01408563|12627396|P1|COMPLETED|Overall Study||31
5133321|NCT01408563|12627396|P1|Received Transplant|Overall Study||31
5133322|NCT01408563|12627396|P1|STARTED|Overall Study||33
5133323|NCT01408537|12627412|P1|NOT COMPLETED|Overall Study||8
5133324|NCT01408537|12627412|P1|COMPLETED|Overall Study||144
5133325|NCT01408537|12627412|P1|STARTED|Overall Study||152
5133326|NCT01408485|12627428|P1|NOT COMPLETED|Overall Study||21
5133327|NCT01408485|12627428|P1|COMPLETED|Overall Study||179
5133328|NCT01408485|12627428|P1|STARTED|Overall Study||200
5133329|NCT01408329|12627436|P2|NOT COMPLETED|Overall Study||4
5133330|NCT01408329|12627437|P1|NOT COMPLETED|Overall Study||3
5133331|NCT01408329|12627436|P2|COMPLETED|Overall Study||11
5133332|NCT01408329|12627437|P1|COMPLETED|Overall Study||10
5133333|NCT01408329|12627436|P2|STARTED|Overall Study||15
5133334|NCT01408329|12627437|P1|STARTED|Overall Study||13
5133335|NCT01408303|12627446|P3|NOT COMPLETED|Overall Study||6
5133336|NCT01408303|12627447|P2|NOT COMPLETED|Overall Study||12
5133337|NCT01408303|12627448|P1|NOT COMPLETED|Overall Study||6
5133338|NCT01408303|12627446|P3|COMPLETED|Overall Study||210
5133339|NCT01408303|12627447|P2|COMPLETED|Overall Study||204
5133340|NCT01408303|12627448|P1|COMPLETED|Overall Study||209
5133341|NCT01408303|12627446|P3|STARTED|Overall Study||216
5133342|NCT01408303|12627447|P2|STARTED|Overall Study||216
5133343|NCT01408303|12627448|P1|STARTED|Overall Study||215
5133344|NCT01408277|12627458|P2|NOT COMPLETED|Overall Study||4
5133345|NCT01408277|12627459|P1|NOT COMPLETED|Overall Study||8
5133346|NCT01408277|12627458|P2|COMPLETED|Overall Study||23
5133347|NCT01408277|12627459|P1|COMPLETED|Overall Study||20
5133348|NCT01408277|12627458|P2|STARTED|Overall Study||27
5133349|NCT01408277|12627459|P1|STARTED|Overall Study||28
5133350|NCT01408043|12627465|P1|NOT COMPLETED|Overall Study||1
5133351|NCT01408043|12627465|P1|COMPLETED|Overall Study||24
5133352|NCT01408043|12627465|P1|STARTED|Overall Study||25
5133353|NCT01408030|12627484|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
5133354|NCT01408030|12627485|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
5133355|NCT01408030|12627486|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
5133356|NCT01408030|12627487|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
5133357|NCT01408030|12627484|P4|COMPLETED|Observation Phase (Off Drug)||21
5133358|NCT01408030|12627485|P3|COMPLETED|Observation Phase (Off Drug)||26
5133359|NCT01408030|12627486|P2|COMPLETED|Observation Phase (Off Drug)||18
5133360|NCT01408030|12627487|P1|COMPLETED|Observation Phase (Off Drug)||22
5133361|NCT01408030|12627484|P4|STARTED|Observation Phase (Off Drug)||25
5133362|NCT01408030|12627485|P3|STARTED|Observation Phase (Off Drug)||32
5133363|NCT01408030|12627486|P2|STARTED|Observation Phase (Off Drug)||24
5133364|NCT01408030|12627487|P1|STARTED|Observation Phase (Off Drug)||26
5133365|NCT01408030|12627484|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
5133366|NCT01408030|12627485|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
5133367|NCT01408030|12627486|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
5133368|NCT01408030|12627487|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
5133369|NCT01408030|12627484|P4|COMPLETED|Treatment Phase (on Drug)||25
5133370|NCT01408030|12627485|P3|COMPLETED|Treatment Phase (on Drug)||32
5133371|NCT01408030|12627486|P2|COMPLETED|Treatment Phase (on Drug)||24
5133372|NCT01408030|12627487|P1|COMPLETED|Treatment Phase (on Drug)||26
5133373|NCT01408030|12627484|P4|STARTED|Treatment Phase (on Drug)||28
5133374|NCT01408030|12627485|P3|STARTED|Treatment Phase (on Drug)||33
5133375|NCT01408030|12627486|P2|STARTED|Treatment Phase (on Drug)||31
5133376|NCT01408030|12627487|P1|STARTED|Treatment Phase (on Drug)||29
5133377|NCT01407952|12627519|P2|NOT COMPLETED|Overall Study||37
5133378|NCT01407952|12627520|P1|NOT COMPLETED|Overall Study||46
5133379|NCT01407952|12627519|P2|COMPLETED|Overall Study||266
5133380|NCT01407952|12627520|P1|COMPLETED|Overall Study||251
5133381|NCT01407952|12627519|P2|STARTED|Overall Study||303
5133382|NCT01407952|12627520|P1|STARTED|Overall Study||297
5133383|NCT01407926|12627546|P1|NOT COMPLETED|Overall Study||55
5133384|NCT01407926|12627546|P1|COMPLETED|Overall Study||87
5133385|NCT01407926|12627546|P1|STARTED|Overall Study||142
5133386|NCT01407575|12627563|P2|NOT COMPLETED|Overall Study||1
5133387|NCT01407575|12627564|P1|NOT COMPLETED|Overall Study||2
5133388|NCT01407575|12627563|P2|COMPLETED|Overall Study||5
5133389|NCT01407575|12627564|P1|COMPLETED|Overall Study||5
5133390|NCT01407575|12627563|P2|STARTED|Overall Study||6
5133391|NCT01407575|12627564|P1|STARTED|Overall Study||7
5133392|NCT01407523|12627582|P1|NOT COMPLETED|Overall Study||0
5133393|NCT01407523|12627582|P1|COMPLETED|Overall Study||16
5133394|NCT01407523|12627582|P1|STARTED|Overall Study||16
5133395|NCT01407367|12627594|P2|NOT COMPLETED|Overall Study||78
5133396|NCT01407367|12627595|P1|NOT COMPLETED|Overall Study||40
5133397|NCT01407367|12627594|P2|COMPLETED|Overall Study||164
5133398|NCT01407367|12627595|P1|COMPLETED|Overall Study||68
5133399|NCT01407367|12627594|P2|STARTED|Overall Study||242
5133400|NCT01407367|12627595|P1|STARTED|Overall Study||108
5133401|NCT01407354|12627609|P2|NOT COMPLETED|Second Intervention||2
5133402|NCT01407354|12627610|P1|NOT COMPLETED|Second Intervention||0
5133403|NCT01407354|12627609|P2|COMPLETED|Second Intervention||13
5133404|NCT01407354|12627610|P1|COMPLETED|Second Intervention||18
5133405|NCT01407354|12627609|P2|STARTED|Second Intervention||15
5133406|NCT01407354|12627610|P1|STARTED|Second Intervention||18
5133407|NCT01407354|12627609|P2|NOT COMPLETED|First Intervention||2
5133408|NCT01407354|12627610|P1|NOT COMPLETED|First Intervention||2
5133409|NCT01407354|12627609|P2|COMPLETED|First Intervention||15
5133410|NCT01407354|12627610|P1|COMPLETED|First Intervention||18
5133411|NCT01407354|12627609|P2|STARTED|First Intervention||17
5133412|NCT01407354|12627610|P1|STARTED|First Intervention||20
5133413|NCT01407276|12627626|P8|NOT COMPLETED|Overall Study||1
5133414|NCT01407276|12627627|P7|NOT COMPLETED|Overall Study||0
5133415|NCT01407276|12627628|P6|NOT COMPLETED|Overall Study||0
5133416|NCT01407276|12627629|P5|NOT COMPLETED|Overall Study||0
5133417|NCT01407276|12627630|P4|NOT COMPLETED|Overall Study||0
5133418|NCT01407276|12627631|P3|NOT COMPLETED|Overall Study||0
5133419|NCT01407276|12627632|P2|NOT COMPLETED|Overall Study||0
5133420|NCT01407276|12627633|P1|NOT COMPLETED|Overall Study||0
5133421|NCT01407276|12627626|P8|COMPLETED|Overall Study||6
5133422|NCT01407276|12627627|P7|COMPLETED|Overall Study||6
5133423|NCT01407276|12627628|P6|COMPLETED|Overall Study||6
5133424|NCT01407276|12627629|P5|COMPLETED|Overall Study||6
5133425|NCT01407276|12627630|P4|COMPLETED|Overall Study||6
5133426|NCT01407276|12627631|P3|COMPLETED|Overall Study||6
5133427|NCT01407276|12627632|P2|COMPLETED|Overall Study||6
5133428|NCT01407276|12627633|P1|COMPLETED|Overall Study||6
5133429|NCT01407276|12627626|P8|STARTED|Overall Study||7
5133430|NCT01407276|12627627|P7|STARTED|Overall Study||6
5133431|NCT01407276|12627628|P6|STARTED|Overall Study||6
5133432|NCT01407276|12627629|P5|STARTED|Overall Study||6
5133433|NCT01407276|12627630|P4|STARTED|Overall Study||6
5133434|NCT01407276|12627631|P3|STARTED|Overall Study||6
5133435|NCT01407276|12627632|P2|STARTED|Overall Study||6
5133436|NCT01407276|12627633|P1|STARTED|Overall Study||6
5133437|NCT01407094|12627760|P3|NOT COMPLETED|Stage 2||15
5133438|NCT01407094|12627761|P2|NOT COMPLETED|Stage 2||11
5133439|NCT01407094|12627762|P1|NOT COMPLETED|Stage 2||21
5133440|NCT01407094|12627760|P3|COMPLETED|Stage 2||38
5133441|NCT01407094|12627761|P2|COMPLETED|Stage 2||35
5133442|NCT01407094|12627762|P1|COMPLETED|Stage 2||113
5133443|NCT01407094|12627760|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
5133444|NCT01407094|12627761|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
5133445|NCT01407094|12627762|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
5133446|NCT01407094|12627760|P3|NOT COMPLETED|Stage 1||0
5133447|NCT01407094|12627761|P2|NOT COMPLETED|Stage 1||27
5133448|NCT01407094|12627762|P1|NOT COMPLETED|Stage 1||34
5133449|NCT01407094|12627760|P3|COMPLETED|Stage 1||0
5133450|NCT01407094|12627761|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
5133451|NCT01407094|12627762|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
5133452|NCT01407094|12627760|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
5133453|NCT01407094|12627761|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
5133454|NCT01407094|12627762|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
5133455|NCT01407068|12627770|P1|NOT COMPLETED|Overall Study||0
5133456|NCT01407068|12627770|P1|COMPLETED|Overall Study||60
5133457|NCT01407068|12627770|P1|STARTED|Overall Study||60
5133458|NCT01406990|12627779|P1|NOT COMPLETED|Overall Study||0
5133459|NCT01406990|12627779|P1|COMPLETED|Overall Study||15
5133460|NCT01406990|12627779|P1|STARTED|Overall Study||15
5133461|NCT01406938|12627785|P6|NOT COMPLETED|Follow up||3
5133462|NCT01406938|12627786|P5|NOT COMPLETED|Follow up||9
5133463|NCT01406938|12627787|P4|NOT COMPLETED|Follow up||3
5133464|NCT01406938|12627788|P3|NOT COMPLETED|Follow up||8
5133465|NCT01406938|12627789|P2|NOT COMPLETED|Follow up||5
5133466|NCT01406938|12627790|P1|NOT COMPLETED|Follow up||8
5133467|NCT01406938|12627785|P6|COMPLETED|Follow up||32
5133468|NCT01406938|12627786|P5|COMPLETED|Follow up||31
5133469|NCT01406938|12627787|P4|COMPLETED|Follow up||36
5133470|NCT01406938|12627788|P3|COMPLETED|Follow up||32
5133471|NCT01406938|12627789|P2|COMPLETED|Follow up||18
5133472|NCT01406938|12627790|P1|COMPLETED|Follow up||18
5133473|NCT01406938|12627785|P6|STARTED|Follow up||35
5133474|NCT01406938|12627786|P5|STARTED|Follow up||40
5133475|NCT01406938|12627787|P4|STARTED|Follow up||39
5133476|NCT01406938|12627788|P3|STARTED|Follow up||40
5133477|NCT01406938|12627789|P2|STARTED|Follow up||23
5133478|NCT01406938|12627790|P1|STARTED|Follow up||26
5133479|NCT01406938|12627785|P6|NOT COMPLETED|Maintenance Period||16
5133480|NCT01406938|12627786|P5|NOT COMPLETED|Maintenance Period||25
5133481|NCT01406938|12627787|P4|NOT COMPLETED|Maintenance Period||18
5133482|NCT01406938|12627788|P3|NOT COMPLETED|Maintenance Period||17
5133483|NCT01406938|12627789|P2|NOT COMPLETED|Maintenance Period||0
5133484|NCT01406938|12627790|P1|NOT COMPLETED|Maintenance Period||0
5133485|NCT01406938|12627785|P6|COMPLETED|Maintenance Period||201
5133486|NCT01406938|12627786|P5|COMPLETED|Maintenance Period||181
5133487|NCT01406938|12627787|P4|COMPLETED|Maintenance Period||199
5133488|NCT01406938|12627788|P3|COMPLETED|Maintenance Period||186
5133489|NCT01406938|12627789|P2|COMPLETED|Maintenance Period||0
5133490|NCT01406938|12627790|P1|COMPLETED|Maintenance Period||0
5133491|NCT01406938|12627785|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
5133492|NCT01406938|12627786|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
5133493|NCT01406938|12627787|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
5133494|NCT01406938|12627788|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
5133495|NCT01406938|12627789|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
5133496|NCT01406938|12627790|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
5133497|NCT01406938|12627785|P6|STARTED|Maintenance Period||217
5133498|NCT01406938|12627786|P5|STARTED|Maintenance Period||206
5133499|NCT01406938|12627787|P4|STARTED|Maintenance Period||217
5133500|NCT01406938|12627788|P3|STARTED|Maintenance Period||203
5133501|NCT01406938|12627789|P2|STARTED|Maintenance Period||0
5133502|NCT01406938|12627790|P1|STARTED|Maintenance Period||0
5133503|NCT01406938|12627785|P6|NOT COMPLETED|Induction Period||0
5133504|NCT01406938|12627786|P5|NOT COMPLETED|Induction Period||0
5133505|NCT01406938|12627787|P4|NOT COMPLETED|Induction Period||0
5133506|NCT01406938|12627788|P3|NOT COMPLETED|Induction Period||0
5133507|NCT01406938|12627789|P2|NOT COMPLETED|Induction Period||20
5133508|NCT01406938|12627790|P1|NOT COMPLETED|Induction Period||18
5133509|NCT01406938|12627785|P6|COMPLETED|Induction Period||0
5133510|NCT01406938|12627786|P5|COMPLETED|Induction Period||0
5133511|NCT01406938|12627787|P4|COMPLETED|Induction Period||0
5133512|NCT01406938|12627788|P3|COMPLETED|Induction Period||0
5133513|NCT01406938|12627789|P2|COMPLETED|Induction Period||464
5133514|NCT01406938|12627790|P1|COMPLETED|Induction Period||464
5133515|NCT01406938|12627785|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
5133516|NCT01406938|12627786|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
5133517|NCT01406938|12627787|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
5133518|NCT01406938|12627788|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
5133519|NCT01406938|12627789|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
5133520|NCT01406938|12627790|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
5133521|NCT01406938|12627785|P6|STARTED|Induction Period||0
5133522|NCT01406938|12627786|P5|STARTED|Induction Period||0
5133523|NCT01406938|12627787|P4|STARTED|Induction Period||0
5133524|NCT01406938|12627788|P3|STARTED|Induction Period||0
5133525|NCT01406938|12627789|P2|STARTED|Induction Period||484
5133526|NCT01406938|12627790|P1|STARTED|Induction Period||482
5133527|NCT01406873|12627908|P2|NOT COMPLETED|Overall Study||1
5133528|NCT01406873|12627909|P1|NOT COMPLETED|Overall Study||1
5133529|NCT01406873|12627908|P2|COMPLETED|Overall Study||20
5133530|NCT01406873|12627909|P1|COMPLETED|Overall Study||20
5133531|NCT01406873|12627908|P2|STARTED|Overall Study||21
5133532|NCT01406873|12627909|P1|STARTED|Overall Study||21
5133533|NCT01406860|12627927|P2|NOT COMPLETED|Overall Study||0
5133534|NCT01406860|12627928|P1|NOT COMPLETED|Overall Study||0
5133535|NCT01406860|12627927|P2|COMPLETED|Overall Study||8
5133536|NCT01406860|12627928|P1|COMPLETED|Overall Study||11
5133537|NCT01406860|12627927|P2|STARTED|Overall Study||8
5133538|NCT01406860|12627928|P1|STARTED|Overall Study||11
5133539|NCT01406795|12627940|P1|NOT COMPLETED|Overall Study||1
5133540|NCT01406795|12627940|P1|COMPLETED|Overall Study||0
5133541|NCT01406795|12627940|P1|STARTED|Overall Study||1
5133542|NCT01406717|12627956|P2|NOT COMPLETED|Overall Study||31
5133543|NCT01406717|12627957|P1|NOT COMPLETED|Overall Study||43
5133544|NCT01406717|12627956|P2|COMPLETED|Overall Study||149
5133545|NCT01406717|12627957|P1|COMPLETED|Overall Study||137
5133546|NCT01406717|12627956|P2|STARTED|Overall Study||180
5133547|NCT01406717|12627957|P1|STARTED|Overall Study||180
5133548|NCT01406652|12627987|P2|NOT COMPLETED|Overall Study||20
5133549|NCT01406652|12627988|P1|NOT COMPLETED|Overall Study||20
5133550|NCT01406652|12627987|P2|COMPLETED|Overall Study||95
5133551|NCT01406652|12627988|P1|COMPLETED|Overall Study||89
5133552|NCT01406652|12627987|P2|STARTED|Overall Study||115
5133553|NCT01406652|12627988|P1|STARTED|Overall Study||109
5133554|NCT01406574|12627996|P4|NOT COMPLETED|Overall Study||4
5133555|NCT01406574|12627997|P3|NOT COMPLETED|Overall Study||1
5133556|NCT01406574|12627998|P2|NOT COMPLETED|Overall Study||1
5133557|NCT01406574|12627999|P1|NOT COMPLETED|Overall Study||1
5133558|NCT01406574|12627996|P4|COMPLETED|Overall Study||1
5133559|NCT01406574|12627997|P3|COMPLETED|Overall Study||6
5133560|NCT01406574|12627998|P2|COMPLETED|Overall Study||3
5133561|NCT01406574|12627999|P1|COMPLETED|Overall Study||6
5133562|NCT01406574|12627996|P4|STARTED|Overall Study||5
5133563|NCT01406574|12627997|P3|STARTED|Overall Study||7
5133564|NCT01406574|12627998|P2|STARTED|Overall Study||4
5133565|NCT01406574|12627999|P1|STARTED|Overall Study||7
5133566|NCT01406444|12628014|P3|NOT COMPLETED|Overall Study||2
5133567|NCT01406444|12628015|P2|NOT COMPLETED|Overall Study||9
5133568|NCT01406444|12628016|P1|NOT COMPLETED|Overall Study||10
5133569|NCT01406444|12628014|P3|COMPLETED|Overall Study||14
5133570|NCT01406444|12628015|P2|COMPLETED|Overall Study||24
5133571|NCT01406444|12628016|P1|COMPLETED|Overall Study||23
5133572|NCT01406444|12628014|P3|STARTED|Overall Study||16
5133573|NCT01406444|12628015|P2|STARTED|Overall Study||33
5133574|NCT01406444|12628016|P1|STARTED|Overall Study||33
5133575|NCT01406223|12628031|P4|NOT COMPLETED|Overall Study||16
5133576|NCT01406223|12628032|P3|NOT COMPLETED|Overall Study||18
5133577|NCT01406223|12628033|P2|NOT COMPLETED|Overall Study||12
5133578|NCT01406223|12628034|P1|NOT COMPLETED|Overall Study||12
5133579|NCT01406223|12628031|P4|COMPLETED|Overall Study||3
5133580|NCT01406223|12628032|P3|COMPLETED|Overall Study||2
5133581|NCT01406223|12628033|P2|COMPLETED|Overall Study||7
5133582|NCT01406223|12628034|P1|COMPLETED|Overall Study||6
5133583|NCT01406223|12628031|P4|STARTED|Overall Study||19
5133584|NCT01406223|12628032|P3|STARTED|Overall Study||20
5133585|NCT01406223|12628033|P2|STARTED|Overall Study||19
5133586|NCT01406223|12628034|P1|STARTED|Overall Study||18
5133587|NCT01406015|12628050|P2|NOT COMPLETED|Overall Study||3
5133588|NCT01406015|12628051|P1|NOT COMPLETED|Overall Study||3
5133589|NCT01406015|12628050|P2|COMPLETED|Overall Study||16
5133590|NCT01406015|12628051|P1|COMPLETED|Overall Study||16
5133591|NCT01406015|12628050|P2|STARTED|Overall Study||19
5133592|NCT01406015|12628051|P1|STARTED|Overall Study||19
5133593|NCT01405950|12628067|P4|NOT COMPLETED|Overall Study||0
5133594|NCT01405950|12628068|P3|NOT COMPLETED|Overall Study||0
5133595|NCT01405950|12628069|P2|NOT COMPLETED|Overall Study||0
5133596|NCT01405950|12628070|P1|NOT COMPLETED|Overall Study||1
5133597|NCT01405950|12628067|P4|COMPLETED|Overall Study||0
5133598|NCT01405950|12628068|P3|COMPLETED|Overall Study||0
5133599|NCT01405950|12628069|P2|COMPLETED|Overall Study||2
5133600|NCT01405950|12628070|P1|COMPLETED|Overall Study||7
5133601|NCT01405950|12628067|P4|STARTED|Overall Study||0
5133602|NCT01405950|12628068|P3|STARTED|Overall Study||0
5133603|NCT01405950|12628069|P2|STARTED|Overall Study||2
5133604|NCT01405950|12628070|P1|STARTED|Overall Study||8
5133605|NCT01405937|12628084|P2|NOT COMPLETED|Overall Study||0
5133606|NCT01405937|12628085|P1|NOT COMPLETED|Overall Study||0
5133607|NCT01405937|12628084|P2|COMPLETED|Overall Study||26
5133608|NCT01405937|12628085|P1|COMPLETED|Overall Study||25
5133609|NCT01405937|12628084|P2|STARTED|Overall Study||26
5133610|NCT01405937|12628085|P1|STARTED|Overall Study||25
5133611|NCT01405924|12628105|P1|NOT COMPLETED|Overall Study||10
5133612|NCT01405924|12628105|P1|COMPLETED|Overall Study||101
5133613|NCT01405924|12628105|P1|STARTED|Overall Study||111
5133614|NCT01405911|12628118|P3|NOT COMPLETED|Overall Study||1
5133615|NCT01405911|12628119|P2|NOT COMPLETED|Overall Study||3
5133616|NCT01405911|12628120|P1|NOT COMPLETED|Overall Study||4
5133617|NCT01405911|12628118|P3|COMPLETED|Overall Study||76
5133618|NCT01405911|12628119|P2|COMPLETED|Overall Study||79
5133619|NCT01405911|12628120|P1|COMPLETED|Overall Study||79
5133620|NCT01405911|12628118|P3|Treated|Overall Study||77
5133621|NCT01405911|12628119|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
5133622|NCT01405911|12628120|P1|Treated|Overall Study||82
5133623|NCT01405911|12628118|P3|STARTED|Overall Study||77
5133624|NCT01405911|12628119|P2|STARTED|Overall Study||82
5133625|NCT01405911|12628120|P1|STARTED|Overall Study||83
5133626|NCT01405898|12628139|P2|NOT COMPLETED|Overall Study||2
5133627|NCT01405898|12628140|P1|NOT COMPLETED|Overall Study||2
5133628|NCT01405898|12628139|P2|COMPLETED|Overall Study||32
5133629|NCT01405898|12628140|P1|COMPLETED|Overall Study||32
5133630|NCT01405898|12628139|P2|STARTED|Overall Study||34
5133631|NCT01405898|12628140|P1|STARTED|Overall Study||34
5133632|NCT01405820|12628164|P6|NOT COMPLETED|Open-Label Treatment Period||2
5133633|NCT01405820|12628165|P5|NOT COMPLETED|Open-Label Treatment Period||2
5133634|NCT01405820|12628166|P4|NOT COMPLETED|Open-Label Treatment Period||5
5133635|NCT01405820|12628167|P3|NOT COMPLETED|Open-Label Treatment Period||3
5133636|NCT01405820|12628168|P2|NOT COMPLETED|Open-Label Treatment Period||2
5133637|NCT01405820|12628169|P1|NOT COMPLETED|Open-Label Treatment Period||4
5133638|NCT01405820|12628164|P6|COMPLETED|Open-Label Treatment Period||30
5133639|NCT01405820|12628165|P5|COMPLETED|Open-Label Treatment Period||40
5133640|NCT01405820|12628166|P4|COMPLETED|Open-Label Treatment Period||37
5133641|NCT01405820|12628167|P3|COMPLETED|Open-Label Treatment Period||39
5133642|NCT01405820|12628168|P2|COMPLETED|Open-Label Treatment Period||33
5133643|NCT01405820|12628169|P1|COMPLETED|Open-Label Treatment Period||40
5133644|NCT01405820|12628164|P6|STARTED|Open-Label Treatment Period||32
5133645|NCT01405820|12628165|P5|STARTED|Open-Label Treatment Period||42
5133646|NCT01405820|12628166|P4|STARTED|Open-Label Treatment Period||42
5133647|NCT01405820|12628167|P3|STARTED|Open-Label Treatment Period||42
5133648|NCT01405820|12628168|P2|STARTED|Open-Label Treatment Period||35
5133649|NCT01405820|12628169|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
5133650|NCT01405820|12628164|P6|NOT COMPLETED|Randomized Treatment Period||37
5133651|NCT01405820|12628165|P5|NOT COMPLETED|Randomized Treatment Period||45
5133652|NCT01405820|12628166|P4|NOT COMPLETED|Randomized Treatment Period||51
5133653|NCT01405820|12628167|P3|NOT COMPLETED|Randomized Treatment Period||43
5133654|NCT01405820|12628168|P2|NOT COMPLETED|Randomized Treatment Period||10
5133655|NCT01405820|12628169|P1|NOT COMPLETED|Randomized Treatment Period||11
5133656|NCT01405820|12628164|P6|COMPLETED|Randomized Treatment Period||1
5133657|NCT01405820|12628165|P5|COMPLETED|Randomized Treatment Period||2
5133658|NCT01405820|12628166|P4|COMPLETED|Randomized Treatment Period||3
5133659|NCT01405820|12628167|P3|COMPLETED|Randomized Treatment Period||9
5133660|NCT01405820|12628168|P2|COMPLETED|Randomized Treatment Period||35
5133661|NCT01405820|12628169|P1|COMPLETED|Randomized Treatment Period||43
5133662|NCT01405820|12628164|P6|Safety Population|Randomized Treatment Period||38
5133663|NCT01405820|12628165|P5|Safety Population|Randomized Treatment Period||47
5133664|NCT01405820|12628166|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
5133665|NCT01405820|12628167|P3|Safety Population|Randomized Treatment Period||52
5133666|NCT01405820|12628168|P2|Safety Population|Randomized Treatment Period||45
5133667|NCT01405820|12628169|P1|Safety Population|Randomized Treatment Period||54
5133668|NCT01405820|12628164|P6|STARTED|Randomized Treatment Period||38
5133669|NCT01405820|12628165|P5|STARTED|Randomized Treatment Period||47
5133670|NCT01405820|12628166|P4|STARTED|Randomized Treatment Period||54
5133671|NCT01405820|12628167|P3|STARTED|Randomized Treatment Period||52
5133672|NCT01405820|12628168|P2|STARTED|Randomized Treatment Period||45
5133673|NCT01405820|12628169|P1|STARTED|Randomized Treatment Period||54
5133674|NCT01405794|12628189|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
5133675|NCT01405794|12628189|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
5133676|NCT01405794|12628189|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
5133677|NCT01405794|12628189|P1|NOT COMPLETED|72 hr Washout||0
5133678|NCT01405794|12628189|P1|COMPLETED|72 hr Washout||12
5133679|NCT01405794|12628189|P1|STARTED|72 hr Washout||12
5133680|NCT01405794|12628189|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
5133681|NCT01405794|12628189|P1|COMPLETED|First Dose Placebo (14 Days)||12
5133682|NCT01405794|12628189|P1|STARTED|First Dose Placebo (14 Days)||12
5133683|NCT01405768|12628265|P2|NOT COMPLETED|Overall Study||0
5133684|NCT01405768|12628266|P1|NOT COMPLETED|Overall Study||4
5133685|NCT01405768|12628265|P2|COMPLETED|Overall Study||28
5133686|NCT01405768|12628266|P1|COMPLETED|Overall Study||24
5133687|NCT01405768|12628265|P2|STARTED|Overall Study||28
5133688|NCT01405768|12628266|P1|STARTED|Overall Study||28
5133689|NCT01405742|12628278|P2|NOT COMPLETED|Overall Study||0
5133690|NCT01405742|12628279|P1|NOT COMPLETED|Overall Study||1
5133691|NCT01405742|12628278|P2|COMPLETED|Overall Study||2
5133692|NCT01405742|12628279|P1|COMPLETED|Overall Study||1
5133693|NCT01405742|12628278|P2|STARTED|Overall Study||2
5133694|NCT01405742|12628279|P1|STARTED|Overall Study||2
5133695|NCT01405560|12628289|P1|NOT COMPLETED|Overall Study||1
5133696|NCT01405560|12628289|P1|COMPLETED|Overall Study||41
5133697|NCT01405560|12628289|P1|STARTED|Overall Study||42
5133698|NCT01405508|12628304|P4|NOT COMPLETED|Overall Study||0
5133699|NCT01405508|12628305|P3|NOT COMPLETED|Overall Study||0
5133700|NCT01405508|12628306|P2|NOT COMPLETED|Overall Study||1
5133701|NCT01405508|12628307|P1|NOT COMPLETED|Overall Study||1
5133702|NCT01405508|12628304|P4|COMPLETED|Overall Study||26
5133703|NCT01405508|12628305|P3|COMPLETED|Overall Study||27
5133704|NCT01405508|12628306|P2|COMPLETED|Overall Study||25
5133705|NCT01405508|12628307|P1|COMPLETED|Overall Study||25
5133706|NCT01405508|12628304|P4|STARTED|Overall Study||26
5133707|NCT01405508|12628305|P3|STARTED|Overall Study||27
5133708|NCT01405508|12628306|P2|STARTED|Overall Study||26
5133709|NCT01405508|12628307|P1|STARTED|Overall Study||26
5133710|NCT01405469|12628325|P1|NOT COMPLETED|Overall Study||0
5133711|NCT01405469|12628325|P1|COMPLETED|Overall Study||16
5133712|NCT01405469|12628325|P1|STARTED|Overall Study||16
5133713|NCT01405456|12628339|P2|NOT COMPLETED|Overall Study||1
5133714|NCT01405456|12628340|P1|NOT COMPLETED|Overall Study||3
5133715|NCT01405456|12628339|P2|COMPLETED|Overall Study||20
5133716|NCT01405456|12628340|P1|COMPLETED|Overall Study||22
5133717|NCT01405456|12628339|P2|STARTED|Overall Study||21
5133718|NCT01405456|12628340|P1|STARTED|Overall Study||25
5133719|NCT01405313|12628368|P1|NOT COMPLETED|Overall Study||0
5133720|NCT01405313|12628368|P1|COMPLETED|Overall Study||21
5133721|NCT01405313|12628368|P1|STARTED|Overall Study||21
5133722|NCT01405196|12628380|P4|NOT COMPLETED|Overall Study||9
5133723|NCT01405196|12628381|P3|NOT COMPLETED|Overall Study||23
5133724|NCT01405196|12628382|P2|NOT COMPLETED|Overall Study||12
5133725|NCT01405196|12628383|P1|NOT COMPLETED|Overall Study||11
5133726|NCT01405196|12628380|P4|COMPLETED|Overall Study||36
5133727|NCT01405196|12628381|P3|COMPLETED|Overall Study||23
5133728|NCT01405196|12628382|P2|COMPLETED|Overall Study||35
5133729|NCT01405196|12628383|P1|COMPLETED|Overall Study||34
5133730|NCT01405196|12628380|P4|STARTED|Overall Study||45
5133731|NCT01405196|12628381|P3|STARTED|Overall Study||46
5133732|NCT01405196|12628382|P2|STARTED|Overall Study||47
5133733|NCT01405196|12628383|P1|STARTED|Overall Study||45
5133734|NCT01405053|12628470|P2|NOT COMPLETED|Overall Study||8
5133735|NCT01405053|12628471|P1|NOT COMPLETED|Overall Study||10
5133736|NCT01405053|12628470|P2|COMPLETED|Overall Study||4
5133737|NCT01405053|12628471|P1|COMPLETED|Overall Study||15
5133738|NCT01405053|12628470|P2|STARTED|Overall Study||12
5133739|NCT01405053|12628471|P1|STARTED|Overall Study||25
5133740|NCT01405027|12628497|P2|NOT COMPLETED|Overall Study||51
5133741|NCT01405027|12628498|P1|NOT COMPLETED|Overall Study||32
5133742|NCT01405027|12628497|P2|COMPLETED|Overall Study||62
5133743|NCT01405027|12628498|P1|COMPLETED|Overall Study||52
5133744|NCT01405027|12628497|P2|STARTED|Overall Study||113
5133745|NCT01405027|12628498|P1|STARTED|Overall Study||84
5133746|NCT01404988|12628515|P3|NOT COMPLETED|Overall Study||3
5133747|NCT01404988|12628516|P2|NOT COMPLETED|Overall Study||4
5133748|NCT01404988|12628517|P1|NOT COMPLETED|Overall Study||6
5133749|NCT01404988|12628515|P3|COMPLETED|Overall Study||30
5133750|NCT01404988|12628516|P2|COMPLETED|Overall Study||29
5133751|NCT01404988|12628517|P1|COMPLETED|Overall Study||27
5133752|NCT01404988|12628515|P3|STARTED|Overall Study||33
5133753|NCT01404988|12628516|P2|STARTED|Overall Study||33
5133754|NCT01404988|12628517|P1|STARTED|Overall Study||33
5133755|NCT01404936|12628534|P1|NOT COMPLETED|Overall Study||0
5133756|NCT01404936|12628534|P1|COMPLETED|Overall Study||30
5133757|NCT01404936|12628534|P1|STARTED|Overall Study||30
5133758|NCT01404923|12628540|P2|NOT COMPLETED|Overall Study||17
5133759|NCT01404923|12628541|P1|NOT COMPLETED|Overall Study||23
5133760|NCT01404923|12628540|P2|COMPLETED|Overall Study||197
5133761|NCT01404923|12628541|P1|COMPLETED|Overall Study||199
5133762|NCT01404923|12628540|P2|STARTED|Overall Study||214
5133763|NCT01404923|12628541|P1|STARTED|Overall Study||222
5133764|NCT01404832|12628549|P1|NOT COMPLETED|Overall Study||0
5133765|NCT01404832|12628549|P1|COMPLETED|Overall Study||21
5133766|NCT01404832|12628549|P1|STARTED|Overall Study||21
5133767|NCT01404650|12628554|P1|NOT COMPLETED|Overall Study||0
5133768|NCT01404650|12628554|P1|COMPLETED|Overall Study||25
5133769|NCT01404650|12628554|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
5133770|NCT01404611|12628564|P3|NOT COMPLETED|Overall Study||5
5133771|NCT01404611|12628565|P2|NOT COMPLETED|Overall Study||19
5133772|NCT01404611|12628566|P1|NOT COMPLETED|Overall Study||8
5133773|NCT01404611|12628564|P3|COMPLETED|Overall Study||106
5133774|NCT01404611|12628565|P2|COMPLETED|Overall Study||89
5133775|NCT01404611|12628566|P1|COMPLETED|Overall Study||104
5133776|NCT01404611|12628564|P3|STARTED|Overall Study||111
5133777|NCT01404611|12628565|P2|STARTED|Overall Study||108
5133778|NCT01404611|12628566|P1|STARTED|Overall Study||112
5133779|NCT01404572|12628574|P3|NOT COMPLETED|Overall Study||0
5133780|NCT01404572|12628575|P2|NOT COMPLETED|Overall Study||0
5133781|NCT01404572|12628576|P1|NOT COMPLETED|Overall Study||0
5133782|NCT01404572|12628574|P3|COMPLETED|Overall Study||4
5133783|NCT01404572|12628575|P2|COMPLETED|Overall Study||4
5133784|NCT01404572|12628576|P1|COMPLETED|Overall Study||4
5133785|NCT01404572|12628574|P3|STARTED|Overall Study||4
5133786|NCT01404572|12628575|P2|STARTED|Overall Study||4
5133787|NCT01404572|12628576|P1|STARTED|Overall Study||4
5133788|NCT01404559|12628607|P4|NOT COMPLETED|Overall Study||0
5133789|NCT01404559|12628608|P3|NOT COMPLETED|Overall Study||0
5133790|NCT01404559|12628609|P2|NOT COMPLETED|Overall Study||0
5133791|NCT01404559|12628610|P1|NOT COMPLETED|Overall Study||0
5133792|NCT01404559|12628607|P4|COMPLETED|Overall Study||14
5133793|NCT01404559|12628608|P3|COMPLETED|Overall Study||4
5133794|NCT01404559|12628609|P2|COMPLETED|Overall Study||5
5133795|NCT01404559|12628610|P1|COMPLETED|Overall Study||5
5133796|NCT01404559|12628607|P4|STARTED|Overall Study||14
5133797|NCT01404559|12628608|P3|STARTED|Overall Study||4
5133798|NCT01404559|12628609|P2|STARTED|Overall Study||5
5133799|NCT01404559|12628610|P1|STARTED|Overall Study||5
5133800|NCT01404429|12628623|P2|NOT COMPLETED|Overall Study||7
5133801|NCT01404429|12628624|P1|NOT COMPLETED|Overall Study||9
5133802|NCT01404429|12628623|P2|COMPLETED|Overall Study||46
5133803|NCT01404429|12628624|P1|COMPLETED|Overall Study||38
5133804|NCT01404429|12628623|P2|STARTED|Overall Study||53
5133805|NCT01404429|12628624|P1|STARTED|Overall Study||47
5133806|NCT01404325|12628638|P2|NOT COMPLETED|Overall Study||2
5133807|NCT01404325|12628639|P1|NOT COMPLETED|Overall Study||4
5133808|NCT01404325|12628638|P2|COMPLETED|Overall Study||61
5133809|NCT01404325|12628639|P1|COMPLETED|Overall Study||63
5133810|NCT01404325|12628638|P2|STARTED|Overall Study||63
5133811|NCT01404325|12628639|P1|STARTED|Overall Study||67
5133812|NCT01404312|12628697|P2|NOT COMPLETED|Overall Study||311
5133813|NCT01404312|12628698|P1|NOT COMPLETED|Overall Study||298
5133814|NCT01404312|12628697|P2|COMPLETED|Overall Study||1193
5133815|NCT01404312|12628698|P1|COMPLETED|Overall Study||1198
5133816|NCT01404312|12628697|P2|STARTED|Overall Study||1504
5133817|NCT01404312|12628698|P1|STARTED|Overall Study||1496
5133818|NCT01404260|12628720|P2|NOT COMPLETED|Overall Study||9
5133819|NCT01404260|12628721|P1|NOT COMPLETED|Overall Study||3
5133820|NCT01404260|12628720|P2|COMPLETED|Overall Study||101
5133821|NCT01404260|12628721|P1|COMPLETED|Overall Study||106
5133822|NCT01404260|12628720|P2|STARTED|Overall Study||110
5133823|NCT01404260|12628721|P1|STARTED|Overall Study||109
5133824|NCT01404234|12628727|P1|NOT COMPLETED|Overall Study||2
5133825|NCT01404234|12628727|P1|COMPLETED|Overall Study||59
5133826|NCT01404234|12628727|P1|STARTED|Overall Study||61
5133827|NCT01404208|12628743|P2|NOT COMPLETED|Overall Study||0
5133828|NCT01404208|12628744|P1|NOT COMPLETED|Overall Study||3
5133829|NCT01404208|12628743|P2|COMPLETED|Overall Study||72
5133830|NCT01404208|12628744|P1|COMPLETED|Overall Study||67
5133831|NCT01404208|12628743|P2|STARTED|Overall Study||72
5133832|NCT01404208|12628744|P1|STARTED|Overall Study||70
5133833|NCT01404078|12628754|P2|NOT COMPLETED|Overall Study||20
5133834|NCT01404078|12628755|P1|NOT COMPLETED|Overall Study||18
5133835|NCT01404078|12628754|P2|COMPLETED|Overall Study||237
5133836|NCT01404078|12628755|P1|COMPLETED|Overall Study||243
5133837|NCT01404078|12628754|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
5133838|NCT01404078|12628755|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
5133839|NCT01404039|12628770|P13|NOT COMPLETED|Overall Study||0
5133840|NCT01404039|12628771|P12|NOT COMPLETED|Overall Study||0
5133841|NCT01404039|12628772|P11|NOT COMPLETED|Overall Study||1
5133842|NCT01404039|12628773|P10|NOT COMPLETED|Overall Study||1
5133843|NCT01404039|12628774|P9|NOT COMPLETED|Overall Study||0
5133844|NCT01404039|12628775|P8|NOT COMPLETED|Overall Study||0
5133845|NCT01404039|12628776|P7|NOT COMPLETED|Overall Study||0
5133846|NCT01404039|12628777|P6|NOT COMPLETED|Overall Study||0
5133847|NCT01404039|12628778|P5|NOT COMPLETED|Overall Study||0
5133848|NCT01404039|12628779|P4|NOT COMPLETED|Overall Study||0
5133849|NCT01404039|12628780|P3|NOT COMPLETED|Overall Study||0
5133850|NCT01404039|12628781|P2|NOT COMPLETED|Overall Study||0
5133851|NCT01404039|12628782|P1|NOT COMPLETED|Overall Study||1
5133852|NCT01404039|12628770|P13|COMPLETED|Overall Study||0
5133853|NCT01404039|12628771|P12|COMPLETED|Overall Study||0
5133854|NCT01404039|12628772|P11|COMPLETED|Overall Study||14
5133855|NCT01404039|12628773|P10|COMPLETED|Overall Study||14
5133856|NCT01404039|12628774|P9|COMPLETED|Overall Study||15
5133857|NCT01404039|12628775|P8|COMPLETED|Overall Study||15
5133858|NCT01404039|12628776|P7|COMPLETED|Overall Study||10
5133859|NCT01404039|12628777|P6|COMPLETED|Overall Study||10
5133860|NCT01404039|12628778|P5|COMPLETED|Overall Study||10
5133861|NCT01404039|12628779|P4|COMPLETED|Overall Study||10
5133862|NCT01404039|12628780|P3|COMPLETED|Overall Study||5
5133863|NCT01404039|12628781|P2|COMPLETED|Overall Study||5
5133864|NCT01404039|12628782|P1|COMPLETED|Overall Study||4
5133865|NCT01404039|12628770|P13|STARTED|Overall Study||0
5133866|NCT01404039|12628771|P12|STARTED|Overall Study||0
5133867|NCT01404039|12628772|P11|STARTED|Overall Study||15
5133868|NCT01404039|12628773|P10|STARTED|Overall Study||15
5133869|NCT01404039|12628774|P9|STARTED|Overall Study||15
5133870|NCT01404039|12628775|P8|STARTED|Overall Study||15
5133871|NCT01404039|12628776|P7|STARTED|Overall Study||10
5133872|NCT01404039|12628777|P6|STARTED|Overall Study||10
5133873|NCT01404039|12628778|P5|STARTED|Overall Study||10
5133874|NCT01404039|12628779|P4|STARTED|Overall Study||10
5133875|NCT01404039|12628780|P3|STARTED|Overall Study||5
5133876|NCT01404039|12628781|P2|STARTED|Overall Study||5
5133877|NCT01404039|12628782|P1|STARTED|Overall Study||5
5133878|NCT01403987|12628809|P3|NOT COMPLETED|Overall Study||18
5133879|NCT01403987|12628810|P2|NOT COMPLETED|Overall Study||17
5133880|NCT01403987|12628811|P1|NOT COMPLETED|Overall Study||18
5133881|NCT01403987|12628809|P3|COMPLETED|Overall Study||50
5133882|NCT01403987|12628810|P2|COMPLETED|Overall Study||17
5133883|NCT01403987|12628811|P1|COMPLETED|Overall Study||16
5133884|NCT01403987|12628809|P3|STARTED|Overall Study||68
5133885|NCT01403987|12628810|P2|STARTED|Overall Study||34
5133886|NCT01403987|12628811|P1|STARTED|Overall Study||34
5133887|NCT01403805|12628827|P2|NOT COMPLETED|Overall Study||7
5133888|NCT01403805|12628828|P1|NOT COMPLETED|Overall Study||0
5133889|NCT01403805|12628827|P2|COMPLETED|Overall Study||98
5133890|NCT01403805|12628828|P1|COMPLETED|Overall Study||94
5133891|NCT01403805|12628827|P2|Pneumonia Diagnosis|Overall Study||2
5133892|NCT01403805|12628828|P1|Pneumonia Diagnosis|Overall Study||21
5133893|NCT01403805|12628827|P2|STARTED|Overall Study||105
5133894|NCT01403805|12628828|P1|STARTED|Overall Study||94
5133895|NCT01403610|12628844|P4|NOT COMPLETED|Overall Study||0
5133896|NCT01403610|12628845|P3|NOT COMPLETED|Overall Study||0
5133897|NCT01403610|12628846|P2|NOT COMPLETED|Overall Study||3
5133898|NCT01403610|12628847|P1|NOT COMPLETED|Overall Study||2
5133899|NCT01403610|12628844|P4|COMPLETED|Overall Study||13
5133900|NCT01403610|12628845|P3|COMPLETED|Overall Study||4
5133901|NCT01403610|12628846|P2|COMPLETED|Overall Study||3
5133902|NCT01403610|12628847|P1|COMPLETED|Overall Study||3
5133903|NCT01403610|12628844|P4|STARTED|Overall Study||13
5133904|NCT01403610|12628845|P3|STARTED|Overall Study||4
5133905|NCT01403610|12628846|P2|STARTED|Overall Study||6
5133906|NCT01403610|12628847|P1|STARTED|Overall Study||5
5133907|NCT01403441|12628857|P1|NOT COMPLETED|Overall Study||0
5133908|NCT01403441|12628857|P1|COMPLETED|Overall Study||3
5133909|NCT01403441|12628857|P1|STARTED|Overall Study||3
5133910|NCT01403376|12628867|P3|NOT COMPLETED|Overall Study||0
5133911|NCT01403376|12628868|P2|NOT COMPLETED|Overall Study||0
5133912|NCT01403376|12628869|P1|NOT COMPLETED|Overall Study||0
5133913|NCT01403376|12628867|P3|COMPLETED|Overall Study||46
5133914|NCT01403376|12628868|P2|COMPLETED|Overall Study||41
5133915|NCT01403376|12628869|P1|COMPLETED|Overall Study||41
5133916|NCT01403376|12628867|P3|STARTED|Overall Study||46
5133917|NCT01403376|12628868|P2|STARTED|Overall Study||41
5133918|NCT01403376|12628869|P1|STARTED|Overall Study||41
5133919|NCT01403246|12628889|P1|NOT COMPLETED|Overall Study||0
5133920|NCT01403246|12628889|P1|COMPLETED|Overall Study||9
5133921|NCT01403246|12628889|P1|STARTED|Overall Study||9
5133922|NCT01403194|12628893|P1|NOT COMPLETED|Overall Study||10
5133923|NCT01403194|12628893|P1|COMPLETED|Overall Study||1
5133924|NCT01403194|12628893|P1|STARTED|Overall Study||11
5133925|NCT01403116|12628901|P2|NOT COMPLETED|Overall Study||27
5133926|NCT01403116|12628902|P1|NOT COMPLETED|Overall Study||32
5133927|NCT01403116|12628901|P2|COMPLETED|Overall Study||133
5133928|NCT01403116|12628902|P1|COMPLETED|Overall Study||129
5133929|NCT01403116|12628901|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
5133930|NCT01403116|12628902|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
5133931|NCT01403116|12628901|P2|Randomized|Overall Study||163
5133932|NCT01403116|12628902|P1|Randomized|Overall Study||162
5133933|NCT01403116|12628901|P2|STARTED|Overall Study||160
5133934|NCT01403116|12628902|P1|STARTED|Overall Study||161
5133935|NCT01403090|12628909|P1|NOT COMPLETED|Overall Study||0
5133936|NCT01403090|12628909|P1|COMPLETED|Overall Study||8
5133937|NCT01403090|12628909|P1|STARTED|Overall Study||8
5133938|NCT01403051|12628915|P2|NOT COMPLETED|Overall Study||6
5133939|NCT01403051|12628916|P1|NOT COMPLETED|Overall Study||10
5133940|NCT01403051|12628915|P2|COMPLETED|Overall Study||80
5133941|NCT01403051|12628916|P1|COMPLETED|Overall Study||71
5133942|NCT01403051|12628915|P2|Initiated Study Treatment|Overall Study||86
5133943|NCT01403051|12628916|P1|Initiated Study Treatment|Overall Study||81
5133944|NCT01403051|12628915|P2|STARTED|Overall Study||86
5133945|NCT01403051|12628916|P1|STARTED|Overall Study||81
5133946|NCT01402986|12628952|P4|NOT COMPLETED|Overall Study||22
5133947|NCT01402986|12628953|P3|NOT COMPLETED|Overall Study||8
5133948|NCT01402986|12628954|P2|NOT COMPLETED|Overall Study||15
5133949|NCT01402986|12628955|P1|NOT COMPLETED|Overall Study||9
5133950|NCT01402986|12628952|P4|COMPLETED|Overall Study||129
5133951|NCT01402986|12628953|P3|COMPLETED|Overall Study||67
5133952|NCT01402986|12628954|P2|COMPLETED|Overall Study||135
5133953|NCT01402986|12628955|P1|COMPLETED|Overall Study||67
5133954|NCT01402986|12628952|P4|STARTED|Overall Study||151
5133955|NCT01402986|12628953|P3|STARTED|Overall Study||75
5133956|NCT01402986|12628954|P2|STARTED|Overall Study||150
5133957|NCT01402986|12628955|P1|STARTED|Overall Study||76
5133958|NCT01402947|12629090|P2|NOT COMPLETED|Second Intervention||0
5133959|NCT01402947|12629091|P1|NOT COMPLETED|Second Intervention||0
5133960|NCT01402947|12629090|P2|COMPLETED|Second Intervention||14
5133961|NCT01402947|12629091|P1|COMPLETED|Second Intervention||15
5133962|NCT01402947|12629090|P2|STARTED|Second Intervention||14
5133963|NCT01402947|12629091|P1|STARTED|Second Intervention||15
5133964|NCT01402947|12629090|P2|NOT COMPLETED|First Intervention||1
5133965|NCT01402947|12629091|P1|NOT COMPLETED|First Intervention||0
5133966|NCT01402947|12629090|P2|COMPLETED|First Intervention||14
5133967|NCT01402947|12629091|P1|COMPLETED|First Intervention||15
5133968|NCT01402947|12629090|P2|STARTED|First Intervention||15
5133969|NCT01402947|12629091|P1|STARTED|First Intervention||15
5133970|NCT01402869|12629102|P3|NOT COMPLETED|Overall Study||1
5133971|NCT01402869|12629103|P2|NOT COMPLETED|Overall Study||0
5133972|NCT01402869|12629104|P1|NOT COMPLETED|Overall Study||0
5133973|NCT01402869|12629102|P3|COMPLETED|Overall Study||30
5133974|NCT01402869|12629103|P2|COMPLETED|Overall Study||30
5133975|NCT01402869|12629104|P1|COMPLETED|Overall Study||30
5133976|NCT01402869|12629102|P3|STARTED|Overall Study||31
5133977|NCT01402869|12629103|P2|STARTED|Overall Study||30
5133978|NCT01402869|12629104|P1|STARTED|Overall Study||30
5133979|NCT01402817|12629118|P1|NOT COMPLETED|Overall Study||11
5133980|NCT01402817|12629118|P1|COMPLETED|Overall Study||8
5133981|NCT01402817|12629118|P1|STARTED|Overall Study||19
5133982|NCT01402700|12629123|P1|NOT COMPLETED|Overall Study||7
5133983|NCT01402700|12629123|P1|COMPLETED|Overall Study||68
5133984|NCT01402700|12629123|P1|STARTED|Overall Study||75
5133985|NCT01402570|12629127|P1|NOT COMPLETED|Overall Study||1
5133986|NCT01402570|12629127|P1|COMPLETED|Overall Study||19
5133987|NCT01402570|12629127|P1|STARTED|Overall Study||20
5133988|NCT01402544|12629134|P1|NOT COMPLETED|Overall Study||6
5133989|NCT01402544|12629134|P1|COMPLETED|Overall Study||6
5133990|NCT01402544|12629134|P1|STARTED|Overall Study||12
5133991|NCT01402531|12629140|P1|NOT COMPLETED|Overall Study||0
5133992|NCT01402531|12629140|P1|COMPLETED|Overall Study||0
5133993|NCT01402531|12629140|P1|STARTED|Overall Study||0
5133994|NCT01402427|12629146|P2|NOT COMPLETED|Overall Study||0
5133995|NCT01402427|12629147|P1|NOT COMPLETED|Overall Study||0
5133996|NCT01402427|12629146|P2|COMPLETED|Overall Study||294
5133997|NCT01402427|12629147|P1|COMPLETED|Overall Study||297
5133998|NCT01402427|12629146|P2|STARTED|Overall Study||294
5133999|NCT01402427|12629147|P1|STARTED|Overall Study||297
5134000|NCT01402375|12629171|P6|NOT COMPLETED|Overall Study||0
5134001|NCT01402375|12629172|P5|NOT COMPLETED|Overall Study||0
5134002|NCT01402375|12629173|P4|NOT COMPLETED|Overall Study||0
5134003|NCT01402375|12629174|P3|NOT COMPLETED|Overall Study||0
5134004|NCT01402375|12629175|P2|NOT COMPLETED|Overall Study||0
5134005|NCT01402375|12629176|P1|NOT COMPLETED|Overall Study||0
5134006|NCT01402375|12629171|P6|COMPLETED|Overall Study||120
5134007|NCT01402375|12629172|P5|COMPLETED|Overall Study||120
5134008|NCT01402375|12629173|P4|COMPLETED|Overall Study||120
5134009|NCT01402375|12629174|P3|COMPLETED|Overall Study||120
5134010|NCT01402375|12629175|P2|COMPLETED|Overall Study||120
5134011|NCT01402375|12629176|P1|COMPLETED|Overall Study||120
5134012|NCT01402375|12629171|P6|STARTED|Overall Study||120
5134013|NCT01402375|12629172|P5|STARTED|Overall Study||120
5134014|NCT01402375|12629173|P4|STARTED|Overall Study||120
5134015|NCT01402375|12629174|P3|STARTED|Overall Study||120
5134016|NCT01402375|12629175|P2|STARTED|Overall Study||120
5134017|NCT01402375|12629176|P1|STARTED|Overall Study||120
5134018|NCT01402284|12629208|P1|NOT COMPLETED|Overall Study||14
5134019|NCT01402284|12629208|P1|COMPLETED|Overall Study||31
5134020|NCT01402284|12629208|P1|STARTED|Overall Study||45
5134021|NCT01402141|12629221|P2|NOT COMPLETED|Overall Study||2
5134022|NCT01402141|12629222|P1|NOT COMPLETED|Overall Study||1
5134023|NCT01402141|12629221|P2|COMPLETED|Overall Study||28
5134024|NCT01402141|12629222|P1|COMPLETED|Overall Study||29
5134025|NCT01402141|12629221|P2|STARTED|Overall Study||30
5134026|NCT01402141|12629222|P1|STARTED|Overall Study||30
5134027|NCT01402128|12629244|P2|NOT COMPLETED|Overall Study||0
5134028|NCT01402128|12629245|P1|NOT COMPLETED|Overall Study||1
5134029|NCT01402128|12629244|P2|COMPLETED|Overall Study||40
5134030|NCT01402128|12629245|P1|COMPLETED|Overall Study||39
5134031|NCT01402128|12629244|P2|STARTED|Overall Study||40
5134032|NCT01402128|12629245|P1|STARTED|Overall Study||40
5134033|NCT01402115|12629273|P2|NOT COMPLETED|Overall Study||1
5134034|NCT01402115|12629274|P1|NOT COMPLETED|Overall Study||1
5134035|NCT01402115|12629273|P2|COMPLETED|Overall Study||29
5134036|NCT01402115|12629274|P1|COMPLETED|Overall Study||29
5134037|NCT01402115|12629273|P2|STARTED|Overall Study||30
5134038|NCT01402115|12629274|P1|STARTED|Overall Study||30
5134039|NCT01402102|12629290|P2|NOT COMPLETED|Overall Study||3
5134040|NCT01402102|12629291|P1|NOT COMPLETED|Overall Study||2
5134041|NCT01402102|12629290|P2|COMPLETED|Overall Study||27
5134042|NCT01402102|12629291|P1|COMPLETED|Overall Study||28
5134043|NCT01402102|12629290|P2|STARTED|Overall Study||30
5134044|NCT01402102|12629291|P1|STARTED|Overall Study||30
5134045|NCT01402063|12629311|P2|NOT COMPLETED|Overall Study||3
5134046|NCT01402063|12629312|P1|NOT COMPLETED|Overall Study||3
5134047|NCT01402063|12629311|P2|COMPLETED|Overall Study||18
5134048|NCT01402063|12629312|P1|COMPLETED|Overall Study||39
5134049|NCT01402063|12629311|P2|STARTED|Overall Study||21
5134050|NCT01402063|12629312|P1|STARTED|Overall Study||42
5134051|NCT01402050|12629320|P2|NOT COMPLETED|Overall Study||0
5134052|NCT01402050|12629321|P1|NOT COMPLETED|Overall Study||0
5134053|NCT01402050|12629320|P2|COMPLETED|Overall Study||191
5134054|NCT01402050|12629321|P1|COMPLETED|Overall Study||185
5134055|NCT01402050|12629320|P2|STARTED|Overall Study||191
5134056|NCT01402050|12629321|P1|STARTED|Overall Study||185
5134057|NCT01402011|12629330|P3|NOT COMPLETED|Nine Month Follow-up||0
5134058|NCT01402011|12629331|P2|NOT COMPLETED|Nine Month Follow-up||1
5134059|NCT01402011|12629332|P1|NOT COMPLETED|Nine Month Follow-up||0
5134060|NCT01402011|12629330|P3|COMPLETED|Nine Month Follow-up||26
5134061|NCT01402011|12629331|P2|COMPLETED|Nine Month Follow-up||19
5134062|NCT01402011|12629332|P1|COMPLETED|Nine Month Follow-up||27
5134063|NCT01402011|12629330|P3|STARTED|Nine Month Follow-up||26
5134064|NCT01402011|12629331|P2|STARTED|Nine Month Follow-up||20
5134065|NCT01402011|12629332|P1|STARTED|Nine Month Follow-up||27
5134066|NCT01402011|12629330|P3|NOT COMPLETED|Active Treatment Period||0
5134067|NCT01402011|12629331|P2|NOT COMPLETED|Active Treatment Period||3
5134068|NCT01402011|12629332|P1|NOT COMPLETED|Active Treatment Period||1
5134069|NCT01402011|12629330|P3|COMPLETED|Active Treatment Period||26
5134070|NCT01402011|12629331|P2|COMPLETED|Active Treatment Period||20
5134071|NCT01402011|12629332|P1|COMPLETED|Active Treatment Period||27
5134072|NCT01402011|12629330|P3|STARTED|Active Treatment Period||26
5134073|NCT01402011|12629331|P2|STARTED|Active Treatment Period||23
5134074|NCT01402011|12629332|P1|STARTED|Active Treatment Period||28
5134075|NCT01402011|12629330|P3|NOT COMPLETED|Delayed Treatment Period||0
5134076|NCT01402011|12629331|P2|NOT COMPLETED|Delayed Treatment Period||0
5134077|NCT01402011|12629332|P1|NOT COMPLETED|Delayed Treatment Period||1
5134078|NCT01402011|12629330|P3|COMPLETED|Delayed Treatment Period||26
5134079|NCT01402011|12629331|P2|COMPLETED|Delayed Treatment Period||23
5134080|NCT01402011|12629332|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
5134081|NCT01402011|12629330|P3|STARTED|Delayed Treatment Period||26
5134082|NCT01402011|12629331|P2|STARTED|Delayed Treatment Period||23
5134083|NCT01402011|12629332|P1|STARTED|Delayed Treatment Period||29
5134084|NCT01401959|12629361|P3|NOT COMPLETED|Treated||5
5134085|NCT01401959|12629362|P2|NOT COMPLETED|Treated||8
5134086|NCT01401959|12629363|P1|NOT COMPLETED|Treated||7
5134087|NCT01401959|12629361|P3|COMPLETED|Treated||26
5134088|NCT01401959|12629362|P2|COMPLETED|Treated||34
5134089|NCT01401959|12629363|P1|COMPLETED|Treated||46
5134090|NCT01401959|12629361|P3|STARTED|Treated||31
5134091|NCT01401959|12629362|P2|STARTED|Treated||42
5134092|NCT01401959|12629363|P1|STARTED|Treated||53
5134093|NCT01401959|12629361|P3|NOT COMPLETED|Enrolled||0
5134094|NCT01401959|12629362|P2|NOT COMPLETED|Enrolled||0
5134095|NCT01401959|12629363|P1|NOT COMPLETED|Enrolled||1
5134096|NCT01401959|12629361|P3|COMPLETED|Enrolled||31
5134097|NCT01401959|12629362|P2|COMPLETED|Enrolled||42
5134098|NCT01401959|12629363|P1|COMPLETED|Enrolled||53
5134099|NCT01401959|12629361|P3|STARTED|Enrolled||31
5134100|NCT01401959|12629362|P2|STARTED|Enrolled||42
5134101|NCT01401959|12629363|P1|STARTED|Enrolled||54
5134102|NCT01401907|12629379|P2|NOT COMPLETED|Overall Study||51
5134103|NCT01401907|12629380|P1|NOT COMPLETED|Overall Study||57
5134104|NCT01401907|12629379|P2|COMPLETED|Overall Study||124
5134105|NCT01401907|12629380|P1|COMPLETED|Overall Study||118
5134106|NCT01401907|12629379|P2|12 Week Outcomes|Overall Study||153
5134107|NCT01401907|12629380|P1|12 Week Outcomes|Overall Study||148
5134108|NCT01401907|12629379|P2|STARTED|Overall Study||175
5134109|NCT01401907|12629380|P1|STARTED|Overall Study||175
5134110|NCT01401842|12629400|P2|NOT COMPLETED|Overall Study||67
5134111|NCT01401842|12629401|P1|NOT COMPLETED|Overall Study||68
5134112|NCT01401842|12629400|P2|COMPLETED|Overall Study||217
5134113|NCT01401842|12629401|P1|COMPLETED|Overall Study||230
5134114|NCT01401842|12629400|P2|STARTED|Overall Study||284
5134115|NCT01401842|12629401|P1|STARTED|Overall Study||298
5134116|NCT01401699|12629411|P1|NOT COMPLETED|Overall Study||0
5134117|NCT01401699|12629411|P1|COMPLETED|Overall Study||109
5134118|NCT01401699|12629411|P1|STARTED|Overall Study||109
5134119|NCT01401647|12629418|P3|NOT COMPLETED|Overall Study||3
5134120|NCT01401647|12629419|P2|NOT COMPLETED|Overall Study||8
5134121|NCT01401647|12629420|P1|NOT COMPLETED|Overall Study||4
5134122|NCT01401647|12629418|P3|COMPLETED|Overall Study||1056
5134123|NCT01401647|12629419|P2|COMPLETED|Overall Study||985
5134124|NCT01401647|12629420|P1|COMPLETED|Overall Study||968
5134125|NCT01401647|12629418|P3|STARTED|Overall Study||1059
5134126|NCT01401647|12629419|P2|STARTED|Overall Study||993
5134127|NCT01401647|12629420|P1|STARTED|Overall Study||972
5134128|NCT01401595|12629433|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
5134129|NCT01401595|12629434|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
5134130|NCT01401595|12629433|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
5134131|NCT01401595|12629434|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
5134132|NCT01401595|12629433|P2|STARTED|Imaging and Treatment (for NE Arm)||10
5134133|NCT01401595|12629434|P1|STARTED|Imaging and Treatment (for NE Arm)||32
5134134|NCT01401595|12629433|P2|NOT COMPLETED|Recruitment and Screening||2
5134135|NCT01401595|12629434|P1|NOT COMPLETED|Recruitment and Screening||43
5134136|NCT01401595|12629433|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
5134137|NCT01401595|12629434|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
5134138|NCT01401595|12629433|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
5134139|NCT01401595|12629434|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
5134140|NCT01401582|12629445|P2|NOT COMPLETED|Overall Study||117
5134141|NCT01401582|12629446|P1|NOT COMPLETED|Overall Study||110
5134142|NCT01401582|12629445|P2|COMPLETED|Overall Study||291
5134143|NCT01401582|12629446|P1|COMPLETED|Overall Study||116
5134144|NCT01401582|12629445|P2|Baseline Completed|Overall Study||348
5134145|NCT01401582|12629446|P1|Baseline Completed|Overall Study||168
5134146|NCT01401582|12629445|P2|STARTED|Overall Study||408
5134147|NCT01401582|12629446|P1|STARTED|Overall Study||226
5134148|NCT01401543|12629462|P4|NOT COMPLETED|Fourth Intervention||0
5134149|NCT01401543|12629463|P3|NOT COMPLETED|Fourth Intervention||0
5134150|NCT01401543|12629464|P2|NOT COMPLETED|Fourth Intervention||0
5134151|NCT01401543|12629465|P1|NOT COMPLETED|Fourth Intervention||0
5134152|NCT01401543|12629462|P4|COMPLETED|Fourth Intervention||6
5134153|NCT01401543|12629463|P3|COMPLETED|Fourth Intervention||6
5134154|NCT01401543|12629464|P2|COMPLETED|Fourth Intervention||6
5134155|NCT01401543|12629465|P1|COMPLETED|Fourth Intervention||6
5134156|NCT01401543|12629462|P4|STARTED|Fourth Intervention||6
5134157|NCT01401543|12629463|P3|STARTED|Fourth Intervention||6
5134158|NCT01401543|12629464|P2|STARTED|Fourth Intervention||6
5134159|NCT01401543|12629465|P1|STARTED|Fourth Intervention||6
5134160|NCT01401543|12629462|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
5134161|NCT01401543|12629463|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
5134162|NCT01401543|12629464|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
5134163|NCT01401543|12629465|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
5134164|NCT01401543|12629462|P4|COMPLETED|Third Washout Period of 1 Week||6
5134165|NCT01401543|12629463|P3|COMPLETED|Third Washout Period of 1 Week||6
5134166|NCT01401543|12629464|P2|COMPLETED|Third Washout Period of 1 Week||6
5134167|NCT01401543|12629465|P1|COMPLETED|Third Washout Period of 1 Week||6
5134168|NCT01401543|12629462|P4|STARTED|Third Washout Period of 1 Week||6
5134169|NCT01401543|12629463|P3|STARTED|Third Washout Period of 1 Week||6
5134170|NCT01401543|12629464|P2|STARTED|Third Washout Period of 1 Week||6
5134171|NCT01401543|12629465|P1|STARTED|Third Washout Period of 1 Week||6
5134172|NCT01401543|12629462|P4|NOT COMPLETED|Third Intervention||0
5134173|NCT01401543|12629463|P3|NOT COMPLETED|Third Intervention||0
5134174|NCT01401543|12629464|P2|NOT COMPLETED|Third Intervention||0
5134175|NCT01401543|12629465|P1|NOT COMPLETED|Third Intervention||0
5134176|NCT01401543|12629462|P4|COMPLETED|Third Intervention||6
5134177|NCT01401543|12629463|P3|COMPLETED|Third Intervention||6
5134178|NCT01401543|12629464|P2|COMPLETED|Third Intervention||6
5134179|NCT01401543|12629465|P1|COMPLETED|Third Intervention||6
5134180|NCT01401543|12629462|P4|STARTED|Third Intervention||6
5134181|NCT01401543|12629463|P3|STARTED|Third Intervention||6
5134182|NCT01401543|12629464|P2|STARTED|Third Intervention||6
5134183|NCT01401543|12629465|P1|STARTED|Third Intervention||6
5134184|NCT01401543|12629462|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
5134185|NCT01401543|12629463|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
5134186|NCT01401543|12629464|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
5134187|NCT01401543|12629465|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
5134188|NCT01401543|12629462|P4|COMPLETED|Second Washout Period of 1 Week||6
5134189|NCT01401543|12629463|P3|COMPLETED|Second Washout Period of 1 Week||6
5134190|NCT01401543|12629464|P2|COMPLETED|Second Washout Period of 1 Week||6
5134191|NCT01401543|12629465|P1|COMPLETED|Second Washout Period of 1 Week||6
5134192|NCT01401543|12629462|P4|STARTED|Second Washout Period of 1 Week||6
5134193|NCT01401543|12629463|P3|STARTED|Second Washout Period of 1 Week||6
5134194|NCT01401543|12629464|P2|STARTED|Second Washout Period of 1 Week||6
5134195|NCT01401543|12629465|P1|STARTED|Second Washout Period of 1 Week||6
5134196|NCT01401543|12629462|P4|NOT COMPLETED|Second Intervention||0
5134197|NCT01401543|12629463|P3|NOT COMPLETED|Second Intervention||0
5134198|NCT01401543|12629464|P2|NOT COMPLETED|Second Intervention||0
5134199|NCT01401543|12629465|P1|NOT COMPLETED|Second Intervention||0
5134200|NCT01401543|12629462|P4|COMPLETED|Second Intervention||6
5134201|NCT01401543|12629463|P3|COMPLETED|Second Intervention||6
5134202|NCT01401543|12629464|P2|COMPLETED|Second Intervention||6
5134203|NCT01401543|12629465|P1|COMPLETED|Second Intervention||6
5134204|NCT01401543|12629462|P4|STARTED|Second Intervention||6
5134205|NCT01401543|12629463|P3|STARTED|Second Intervention||6
5134206|NCT01401543|12629464|P2|STARTED|Second Intervention||6
5134207|NCT01401543|12629465|P1|STARTED|Second Intervention||6
5134208|NCT01401543|12629462|P4|NOT COMPLETED|First Washout Period of 1 Week||0
5134209|NCT01401543|12629463|P3|NOT COMPLETED|First Washout Period of 1 Week||0
5134210|NCT01401543|12629464|P2|NOT COMPLETED|First Washout Period of 1 Week||0
5134211|NCT01401543|12629465|P1|NOT COMPLETED|First Washout Period of 1 Week||0
5134212|NCT01401543|12629462|P4|COMPLETED|First Washout Period of 1 Week||6
5134213|NCT01401543|12629463|P3|COMPLETED|First Washout Period of 1 Week||6
5134214|NCT01401543|12629464|P2|COMPLETED|First Washout Period of 1 Week||6
5134215|NCT01401543|12629465|P1|COMPLETED|First Washout Period of 1 Week||6
5134216|NCT01401543|12629462|P4|STARTED|First Washout Period of 1 Week||6
5134217|NCT01401543|12629463|P3|STARTED|First Washout Period of 1 Week||6
5134218|NCT01401543|12629464|P2|STARTED|First Washout Period of 1 Week||6
5134219|NCT01401543|12629465|P1|STARTED|First Washout Period of 1 Week||6
5134220|NCT01401543|12629462|P4|NOT COMPLETED|First Intervention||0
5134221|NCT01401543|12629463|P3|NOT COMPLETED|First Intervention||0
5134222|NCT01401543|12629464|P2|NOT COMPLETED|First Intervention||0
5134223|NCT01401543|12629465|P1|NOT COMPLETED|First Intervention||0
5134224|NCT01401543|12629462|P4|COMPLETED|First Intervention||6
5134225|NCT01401543|12629463|P3|COMPLETED|First Intervention||6
5134226|NCT01401543|12629464|P2|COMPLETED|First Intervention||6
5134227|NCT01401543|12629465|P1|COMPLETED|First Intervention||6
5134228|NCT01401543|12629462|P4|STARTED|First Intervention||6
5134229|NCT01401543|12629463|P3|STARTED|First Intervention||6
5134230|NCT01401543|12629464|P2|STARTED|First Intervention||6
5134231|NCT01401543|12629465|P1|STARTED|First Intervention||6
5134232|NCT01401530|12629490|P3|NOT COMPLETED|Overall Study||3
5134233|NCT01401530|12629491|P2|NOT COMPLETED|Overall Study||6
5134234|NCT01401530|12629492|P1|NOT COMPLETED|Overall Study||3
5134235|NCT01401530|12629490|P3|COMPLETED|Overall Study||0
5134236|NCT01401530|12629491|P2|COMPLETED|Overall Study||1
5134237|NCT01401530|12629492|P1|COMPLETED|Overall Study||0
5134238|NCT01401530|12629490|P3|STARTED|Overall Study||3
5134239|NCT01401530|12629491|P2|STARTED|Overall Study||7
5134240|NCT01401530|12629492|P1|STARTED|Overall Study||3
5134241|NCT01401517|12629532|P3|NOT COMPLETED|Overall Study||3
5134242|NCT01401517|12629533|P2|NOT COMPLETED|Overall Study||2
5134243|NCT01401517|12629534|P1|NOT COMPLETED|Overall Study||3
5134244|NCT01401517|12629532|P3|COMPLETED|Overall Study||15
5134245|NCT01401517|12629533|P2|COMPLETED|Overall Study||17
5134246|NCT01401517|12629534|P1|COMPLETED|Overall Study||15
5134247|NCT01401517|12629532|P3|STARTED|Overall Study||18
5134248|NCT01401517|12629533|P2|STARTED|Overall Study||19
5134249|NCT01401517|12629534|P1|STARTED|Overall Study||18
5134250|NCT01401478|12629551|P1|NOT COMPLETED|Overall Study||31
5134251|NCT01401478|12629551|P1|COMPLETED|Overall Study||55
5134252|NCT01401478|12629551|P1|STARTED|Overall Study||86
5134253|NCT01401465|12629564|P2|NOT COMPLETED|Treatment Period 2||2
5134254|NCT01401465|12629565|P1|NOT COMPLETED|Treatment Period 2||0
5134255|NCT01401465|12629564|P2|COMPLETED|Treatment Period 2||144
5134256|NCT01401465|12629565|P1|COMPLETED|Treatment Period 2||150
5134257|NCT01401465|12629564|P2|STARTED|Treatment Period 2||146
5134258|NCT01401465|12629565|P1|STARTED|Treatment Period 2||150
5134259|NCT01401465|12629564|P2|NOT COMPLETED|Washout||0
5134260|NCT01401465|12629565|P1|NOT COMPLETED|Washout||0
5134261|NCT01401465|12629564|P2|COMPLETED|Washout||146
5134262|NCT01401465|12629565|P1|COMPLETED|Washout||150
5134263|NCT01401465|12629564|P2|STARTED|Washout||146
5134264|NCT01401465|12629565|P1|STARTED|Washout||150
5134265|NCT01401465|12629564|P2|NOT COMPLETED|Treatment Period 1||16
5134266|NCT01401465|12629565|P1|NOT COMPLETED|Treatment Period 1||15
5134267|NCT01401465|12629564|P2|COMPLETED|Treatment Period 1||146
5134268|NCT01401465|12629565|P1|COMPLETED|Treatment Period 1||150
5134269|NCT01401465|12629564|P2|STARTED|Treatment Period 1||162
5134270|NCT01401465|12629565|P1|STARTED|Treatment Period 1||165
5134271|NCT01401452|12629628|P1|NOT COMPLETED|Overall Study||72
5134272|NCT01401452|12629628|P1|COMPLETED|Overall Study||174
5134273|NCT01401452|12629628|P1|Visit 5 (9 Months)|Overall Study||175
5134274|NCT01401452|12629628|P1|Visit 4 (6 Months)|Overall Study||172
5134275|NCT01401452|12629628|P1|Visit 3 (3 Months)|Overall Study||217
5134276|NCT01401452|12629628|P1|Visit 2 (1 Month)|Overall Study||225
5134277|NCT01401452|12629628|P1|Visit 1 (Baseline)|Overall Study||246
5134278|NCT01401452|12629628|P1|STARTED|Overall Study||246
5134279|NCT01401361|12629640|P1|NOT COMPLETED|Overall Study||28
5134280|NCT01401361|12629640|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
5134281|NCT01401361|12629640|P1|STARTED|Overall Study||150
5134282|NCT01401322|12629646|P1|NOT COMPLETED|Overall Study||2
5134283|NCT01401322|12629646|P1|COMPLETED|Overall Study||3
5134284|NCT01401322|12629646|P1|STARTED|Overall Study||5
5134285|NCT01401283|12629652|P2|NOT COMPLETED|Overall Study||10
5134286|NCT01401283|12629653|P1|NOT COMPLETED|Overall Study||10
5134287|NCT01401283|12629652|P2|COMPLETED|Overall Study||81
5134288|NCT01401283|12629653|P1|COMPLETED|Overall Study||79
5134289|NCT01401283|12629652|P2|STARTED|Overall Study||91
5134290|NCT01401283|12629653|P1|STARTED|Overall Study||89
5134291|NCT01401257|12629665|P4|NOT COMPLETED|Overall Study||2
5134292|NCT01401257|12629666|P3|NOT COMPLETED|Overall Study||3
5134293|NCT01401257|12629667|P2|NOT COMPLETED|Overall Study||2
5134294|NCT01401257|12629668|P1|NOT COMPLETED|Overall Study||0
5134295|NCT01401257|12629665|P4|COMPLETED|Overall Study||17
5134296|NCT01401257|12629666|P3|COMPLETED|Overall Study||16
5134297|NCT01401257|12629667|P2|COMPLETED|Overall Study||19
5134298|NCT01401257|12629668|P1|COMPLETED|Overall Study||21
5134299|NCT01401257|12629665|P4|STARTED|Overall Study||19
5134300|NCT01401257|12629666|P3|STARTED|Overall Study||19
5134301|NCT01401257|12629667|P2|STARTED|Overall Study||21
5134302|NCT01401257|12629668|P1|STARTED|Overall Study||21
5134303|NCT01401166|12629680|P4|NOT COMPLETED|Safety Follow-Up Period||19
5134304|NCT01401166|12629681|P3|NOT COMPLETED|Safety Follow-Up Period||17
5134305|NCT01401166|12629682|P2|NOT COMPLETED|Safety Follow-Up Period||18
5134306|NCT01401166|12629683|P1|NOT COMPLETED|Safety Follow-Up Period||25
5134307|NCT01401166|12629680|P4|COMPLETED|Safety Follow-Up Period||100
5134308|NCT01401166|12629681|P3|COMPLETED|Safety Follow-Up Period||104
5134309|NCT01401166|12629682|P2|COMPLETED|Safety Follow-Up Period||106
5134310|NCT01401166|12629683|P1|COMPLETED|Safety Follow-Up Period||99
5134311|NCT01401166|12629680|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
5134312|NCT01401166|12629681|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
5134313|NCT01401166|12629682|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
5134314|NCT01401166|12629683|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
5134315|NCT01401166|12629680|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
5134316|NCT01401166|12629681|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
5134317|NCT01401166|12629682|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
5134318|NCT01401166|12629683|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
5134319|NCT01401166|12629680|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
5134320|NCT01401166|12629681|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
5134321|NCT01401166|12629682|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
5134322|NCT01401166|12629683|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
5134323|NCT01401166|12629680|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
5134324|NCT01401166|12629681|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
5134325|NCT01401166|12629682|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
5134326|NCT01401166|12629683|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
5134327|NCT01401166|12629680|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
5134328|NCT01401166|12629681|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
5134329|NCT01401166|12629682|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
5134330|NCT01401166|12629683|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
5134331|NCT01401166|12629680|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
5134332|NCT01401166|12629681|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
5134333|NCT01401166|12629682|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
5134334|NCT01401166|12629683|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
5134335|NCT01401166|12629680|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
5134336|NCT01401166|12629681|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
5134337|NCT01401166|12629682|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
5134338|NCT01401166|12629683|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
5134339|NCT01401166|12629680|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
5134340|NCT01401166|12629681|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
5134341|NCT01401166|12629682|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
5134342|NCT01401166|12629683|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
5134343|NCT01401166|12629680|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
5134344|NCT01401166|12629681|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
5134345|NCT01401166|12629682|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
5134346|NCT01401166|12629683|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
5134347|NCT01401166|12629680|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
5134348|NCT01401166|12629681|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
5134349|NCT01401166|12629682|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
5134350|NCT01401166|12629683|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
5134351|NCT01401153|12629719|P2|NOT COMPLETED|Second Test Day||5
5134352|NCT01401153|12629720|P1|NOT COMPLETED|Second Test Day||0
5134353|NCT01401153|12629719|P2|COMPLETED|Second Test Day||60
5134354|NCT01401153|12629720|P1|COMPLETED|Second Test Day||45
5134355|NCT01401153|12629719|P2|STARTED|Second Test Day||65
5134356|NCT01401153|12629720|P1|STARTED|Second Test Day||45
5134357|NCT01401153|12629719|P2|NOT COMPLETED|First Test Day||10
5134358|NCT01401153|12629720|P1|NOT COMPLETED|First Test Day||1
5134359|NCT01401153|12629719|P2|COMPLETED|First Test Day||45
5134360|NCT01401153|12629720|P1|COMPLETED|First Test Day||65
5134361|NCT01401153|12629719|P2|STARTED|First Test Day||55
5134362|NCT01401153|12629720|P1|STARTED|First Test Day||66
5134363|NCT01401101|12629754|P2|NOT COMPLETED|Overall Study||27
5134364|NCT01401101|12629755|P1|NOT COMPLETED|Overall Study||22
5134365|NCT01401101|12629754|P2|COMPLETED|Overall Study||171
5134366|NCT01401101|12629755|P1|COMPLETED|Overall Study||184
5134367|NCT01401101|12629754|P2|STARTED|Overall Study||198
5134368|NCT01401101|12629755|P1|STARTED|Overall Study||206
5134369|NCT01401062|12629767|P2|NOT COMPLETED|Overall Study||8
5134370|NCT01401062|12629768|P1|NOT COMPLETED|Overall Study||11
5134371|NCT01401062|12629767|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
5134372|NCT01401062|12629768|P1|COMPLETED|Overall Study||0
5134373|NCT01401062|12629767|P2|STARTED|Overall Study||12
5134374|NCT01401062|12629768|P1|STARTED|Overall Study||11
5134375|NCT01401049|12629776|P2|NOT COMPLETED|Overall Study||0
5134376|NCT01401049|12629777|P1|NOT COMPLETED|Overall Study||0
5134377|NCT01401049|12629776|P2|COMPLETED|Overall Study||0
5134378|NCT01401049|12629777|P1|COMPLETED|Overall Study||0
5134379|NCT01401049|12629776|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
5134380|NCT01401049|12629777|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
5134381|NCT01401023|12629785|P1|NOT COMPLETED|Overall Study||0
5134382|NCT01401023|12629785|P1|COMPLETED|Overall Study||10
5134383|NCT01401023|12629785|P1|STARTED|Overall Study||10
5134384|NCT01401010|12629795|P2|NOT COMPLETED|Overall Study||0
5134385|NCT01401010|12629796|P1|NOT COMPLETED|Overall Study||1
5134386|NCT01401010|12629795|P2|COMPLETED|Overall Study||6
5134387|NCT01401010|12629796|P1|COMPLETED|Overall Study||5
5134388|NCT01401010|12629795|P2|STARTED|Overall Study||6
5134389|NCT01401010|12629796|P1|STARTED|Overall Study||6
5134390|NCT01400971|12629819|P1|NOT COMPLETED|Overall Study||917
5134391|NCT01400971|12629819|P1|COMPLETED|Overall Study||3382
5134392|NCT01400971|12629819|P1|Complete Treatment Data|Overall Study||2528
5134393|NCT01400971|12629819|P1|STARTED|Overall Study||4299
5134394|NCT01400958|12629828|P2|NOT COMPLETED|Overall Study||2
5134395|NCT01400958|12629829|P1|NOT COMPLETED|Overall Study||1
5134396|NCT01400958|12629828|P2|COMPLETED|Overall Study||1
5134397|NCT01400958|12629829|P1|COMPLETED|Overall Study||2
5134398|NCT01400958|12629828|P2|STARTED|Overall Study||3
5134399|NCT01400958|12629829|P1|STARTED|Overall Study||3
5134400|NCT01400932|12629839|P2|NOT COMPLETED|Overall Study||15
5134401|NCT01400932|12629840|P1|NOT COMPLETED|Overall Study||14
5134402|NCT01400932|12629839|P2|COMPLETED|Overall Study||167
5134403|NCT01400932|12629840|P1|COMPLETED|Overall Study||164
5134404|NCT01400932|12629839|P2|STARTED|Overall Study||182
5134405|NCT01400932|12629840|P1|STARTED|Overall Study||178
5134406|NCT01400919|12629862|P1|NOT COMPLETED|Overall Study||8
5134407|NCT01400919|12629862|P1|COMPLETED|Overall Study||67
5134408|NCT01400919|12629862|P1|STARTED|Overall Study||75
5134409|NCT01400906|12629866|P6|NOT COMPLETED|Treatment Period 3||0
5134410|NCT01400906|12629867|P5|NOT COMPLETED|Treatment Period 3||0
5134411|NCT01400906|12629868|P4|NOT COMPLETED|Treatment Period 3||0
5134412|NCT01400906|12629869|P3|NOT COMPLETED|Treatment Period 3||0
5134413|NCT01400906|12629870|P2|NOT COMPLETED|Treatment Period 3||0
5134414|NCT01400906|12629871|P1|NOT COMPLETED|Treatment Period 3||0
5134415|NCT01400906|12629866|P6|COMPLETED|Treatment Period 3||5
5134416|NCT01400906|12629867|P5|COMPLETED|Treatment Period 3||6
5134417|NCT01400906|12629868|P4|COMPLETED|Treatment Period 3||6
5134418|NCT01400906|12629869|P3|COMPLETED|Treatment Period 3||6
5134419|NCT01400906|12629870|P2|COMPLETED|Treatment Period 3||6
5134420|NCT01400906|12629871|P1|COMPLETED|Treatment Period 3||6
5134421|NCT01400906|12629866|P6|STARTED|Treatment Period 3||5
5134422|NCT01400906|12629867|P5|STARTED|Treatment Period 3||6
5134423|NCT01400906|12629868|P4|STARTED|Treatment Period 3||6
5134424|NCT01400906|12629869|P3|STARTED|Treatment Period 3||6
5134425|NCT01400906|12629870|P2|STARTED|Treatment Period 3||6
5134426|NCT01400906|12629871|P1|STARTED|Treatment Period 3||6
5134427|NCT01400906|12629866|P6|NOT COMPLETED|Washout Period 2||0
5134428|NCT01400906|12629867|P5|NOT COMPLETED|Washout Period 2||0
5134429|NCT01400906|12629868|P4|NOT COMPLETED|Washout Period 2||0
5134430|NCT01400906|12629869|P3|NOT COMPLETED|Washout Period 2||0
5134431|NCT01400906|12629870|P2|NOT COMPLETED|Washout Period 2||0
5134432|NCT01400906|12629871|P1|NOT COMPLETED|Washout Period 2||0
5134433|NCT01400906|12629866|P6|COMPLETED|Washout Period 2||5
5134434|NCT01400906|12629867|P5|COMPLETED|Washout Period 2||6
5134435|NCT01400906|12629868|P4|COMPLETED|Washout Period 2||6
5134436|NCT01400906|12629869|P3|COMPLETED|Washout Period 2||6
5134437|NCT01400906|12629870|P2|COMPLETED|Washout Period 2||6
5134438|NCT01400906|12629871|P1|COMPLETED|Washout Period 2||6
5134439|NCT01400906|12629866|P6|STARTED|Washout Period 2||5
5134440|NCT01400906|12629867|P5|STARTED|Washout Period 2||6
5134441|NCT01400906|12629868|P4|STARTED|Washout Period 2||6
5134442|NCT01400906|12629869|P3|STARTED|Washout Period 2||6
5134443|NCT01400906|12629870|P2|STARTED|Washout Period 2||6
5134444|NCT01400906|12629871|P1|STARTED|Washout Period 2||6
5134445|NCT01400906|12629866|P6|NOT COMPLETED|Treatment Period 2||0
5134446|NCT01400906|12629867|P5|NOT COMPLETED|Treatment Period 2||0
5134447|NCT01400906|12629868|P4|NOT COMPLETED|Treatment Period 2||0
5134448|NCT01400906|12629869|P3|NOT COMPLETED|Treatment Period 2||0
5134449|NCT01400906|12629870|P2|NOT COMPLETED|Treatment Period 2||0
5134450|NCT01400906|12629871|P1|NOT COMPLETED|Treatment Period 2||0
5134451|NCT01400906|12629866|P6|COMPLETED|Treatment Period 2||5
5134452|NCT01400906|12629867|P5|COMPLETED|Treatment Period 2||6
5134453|NCT01400906|12629868|P4|COMPLETED|Treatment Period 2||6
5134454|NCT01400906|12629869|P3|COMPLETED|Treatment Period 2||6
5134455|NCT01400906|12629870|P2|COMPLETED|Treatment Period 2||6
5134456|NCT01400906|12629871|P1|COMPLETED|Treatment Period 2||6
5134457|NCT01400906|12629866|P6|STARTED|Treatment Period 2||5
5134458|NCT01400906|12629867|P5|STARTED|Treatment Period 2||6
5134459|NCT01400906|12629868|P4|STARTED|Treatment Period 2||6
5134460|NCT01400906|12629869|P3|STARTED|Treatment Period 2||6
5134461|NCT01400906|12629870|P2|STARTED|Treatment Period 2||6
5134462|NCT01400906|12629871|P1|STARTED|Treatment Period 2||6
5134463|NCT01400906|12629866|P6|NOT COMPLETED|Washout Period 1||0
5134464|NCT01400906|12629867|P5|NOT COMPLETED|Washout Period 1||0
5134465|NCT01400906|12629868|P4|NOT COMPLETED|Washout Period 1||0
5134466|NCT01400906|12629869|P3|NOT COMPLETED|Washout Period 1||0
5134467|NCT01400906|12629870|P2|NOT COMPLETED|Washout Period 1||0
5134468|NCT01400906|12629871|P1|NOT COMPLETED|Washout Period 1||0
5134469|NCT01400906|12629866|P6|COMPLETED|Washout Period 1||5
5134470|NCT01400906|12629867|P5|COMPLETED|Washout Period 1||6
5134471|NCT01400906|12629868|P4|COMPLETED|Washout Period 1||6
5134472|NCT01400906|12629869|P3|COMPLETED|Washout Period 1||6
5134473|NCT01400906|12629870|P2|COMPLETED|Washout Period 1||6
5134474|NCT01400906|12629871|P1|COMPLETED|Washout Period 1||6
5134475|NCT01400906|12629866|P6|STARTED|Washout Period 1||5
5134476|NCT01400906|12629867|P5|STARTED|Washout Period 1||6
5134477|NCT01400906|12629868|P4|STARTED|Washout Period 1||6
5134478|NCT01400906|12629869|P3|STARTED|Washout Period 1||6
5134479|NCT01400906|12629870|P2|STARTED|Washout Period 1||6
5134480|NCT01400906|12629871|P1|STARTED|Washout Period 1||6
5134481|NCT01400906|12629866|P6|NOT COMPLETED|Treatment Period 1||0
5134482|NCT01400906|12629867|P5|NOT COMPLETED|Treatment Period 1||0
5134483|NCT01400906|12629868|P4|NOT COMPLETED|Treatment Period 1||0
5134484|NCT01400906|12629869|P3|NOT COMPLETED|Treatment Period 1||0
5134485|NCT01400906|12629870|P2|NOT COMPLETED|Treatment Period 1||0
5134486|NCT01400906|12629871|P1|NOT COMPLETED|Treatment Period 1||0
5134487|NCT01400906|12629866|P6|COMPLETED|Treatment Period 1||5
5134488|NCT01400906|12629867|P5|COMPLETED|Treatment Period 1||6
5134489|NCT01400906|12629868|P4|COMPLETED|Treatment Period 1||6
5134490|NCT01400906|12629869|P3|COMPLETED|Treatment Period 1||6
5134491|NCT01400906|12629870|P2|COMPLETED|Treatment Period 1||6
5134492|NCT01400906|12629871|P1|COMPLETED|Treatment Period 1||6
5134493|NCT01400906|12629866|P6|STARTED|Treatment Period 1||5
5134494|NCT01400906|12629867|P5|STARTED|Treatment Period 1||6
5134495|NCT01400906|12629868|P4|STARTED|Treatment Period 1||6
5134496|NCT01400906|12629869|P3|STARTED|Treatment Period 1||6
5134497|NCT01400906|12629870|P2|STARTED|Treatment Period 1||6
5134498|NCT01400906|12629871|P1|STARTED|Treatment Period 1||6
5134499|NCT01400893|12629905|P2|NOT COMPLETED|Overall Study||27
5134500|NCT01400893|12629906|P1|NOT COMPLETED|Overall Study||27
5134501|NCT01400893|12629905|P2|COMPLETED|Overall Study||38
5134502|NCT01400893|12629906|P1|COMPLETED|Overall Study||42
5134503|NCT01400893|12629905|P2|STARTED|Overall Study||65
5134504|NCT01400893|12629906|P1|STARTED|Overall Study||69
5134505|NCT01400880|12629914|P1|NOT COMPLETED|Overall Study||2
5134506|NCT01400880|12629914|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
5134507|NCT01400880|12629914|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
5134508|NCT01400841|12629918|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
5134509|NCT01400841|12629918|P1|COMPLETED|Extended Study Phase (2 Years)||11
5134510|NCT01400841|12629918|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
5134511|NCT01400841|12629918|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
5134512|NCT01400841|12629918|P1|COMPLETED|Initial Study Phase (6 Months)||15
5134513|NCT01400841|12629918|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
5134514|NCT01400698|12629956|P6|NOT COMPLETED|Overall Study||6
5134515|NCT01400698|12629957|P5|NOT COMPLETED|Overall Study||7
5134516|NCT01400698|12629958|P4|NOT COMPLETED|Overall Study||8
5134517|NCT01400698|12629959|P3|NOT COMPLETED|Overall Study||2
5134518|NCT01400698|12629960|P2|NOT COMPLETED|Overall Study||11
5134519|NCT01400698|12629961|P1|NOT COMPLETED|Overall Study||15
5134520|NCT01400698|12629956|P6|COMPLETED|Overall Study||9
5134521|NCT01400698|12629957|P5|COMPLETED|Overall Study||7
5134522|NCT01400698|12629958|P4|COMPLETED|Overall Study||6
5134523|NCT01400698|12629959|P3|COMPLETED|Overall Study||0
5134524|NCT01400698|12629960|P2|COMPLETED|Overall Study||12
5134525|NCT01400698|12629961|P1|COMPLETED|Overall Study||8
5134526|NCT01400698|12629956|P6|STARTED|Overall Study||15
5134527|NCT01400698|12629957|P5|STARTED|Overall Study||14
5134528|NCT01400698|12629958|P4|STARTED|Overall Study||14
5134529|NCT01400698|12629959|P3|STARTED|Overall Study||2
5134530|NCT01400698|12629960|P2|STARTED|Overall Study||23
5134531|NCT01400698|12629961|P1|STARTED|Overall Study||23
5134532|NCT01400516|12629985|P2|NOT COMPLETED|Extension Trial||0
5134533|NCT01400516|12629986|P1|NOT COMPLETED|Extension Trial||0
5134534|NCT01400516|12629985|P2|COMPLETED|Extension Trial||7
5134535|NCT01400516|12629986|P1|COMPLETED|Extension Trial||6
5134536|NCT01400516|12629985|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
5134537|NCT01400516|12629986|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
5134538|NCT01400516|12629985|P2|NOT COMPLETED|Primary Trial||2
5134539|NCT01400516|12629986|P1|NOT COMPLETED|Primary Trial||0
5134540|NCT01400516|12629985|P2|COMPLETED|Primary Trial||12
5134541|NCT01400516|12629986|P1|COMPLETED|Primary Trial||12
5134542|NCT01400516|12629985|P2|STARTED|Primary Trial||14
5134543|NCT01400516|12629986|P1|STARTED|Primary Trial||12
5134544|NCT01400503|12629996|P1|NOT COMPLETED|Overall Study||60
5134545|NCT01400503|12629996|P1|COMPLETED|Overall Study||0
5134546|NCT01400503|12629996|P1|STARTED|Overall Study||60
5134547|NCT01400477|12630007|P2|NOT COMPLETED|Overall Study||0
5134548|NCT01400477|12630008|P1|NOT COMPLETED|Overall Study||2
5134549|NCT01400477|12630007|P2|COMPLETED|Overall Study||40
5134550|NCT01400477|12630008|P1|COMPLETED|Overall Study||38
5134551|NCT01400477|12630007|P2|STARTED|Overall Study||40
5134552|NCT01400477|12630008|P1|STARTED|Overall Study||40
5134553|NCT01400451|12630019|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
5134554|NCT01400451|12630020|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
5134555|NCT01400451|12630021|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
5134556|NCT01400451|12630019|P3|COMPLETED|Combination Treatment (or Intended)||0
5134557|NCT01400451|12630020|P2|COMPLETED|Combination Treatment (or Intended)||0
5134558|NCT01400451|12630021|P1|COMPLETED|Combination Treatment (or Intended)||0
5134559|NCT01400451|12630019|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
5134560|NCT01400451|12630020|P2|STARTED|Combination Treatment (or Intended)||4
5134561|NCT01400451|12630021|P1|STARTED|Combination Treatment (or Intended)||6
5134562|NCT01400451|12630019|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
5134563|NCT01400451|12630020|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
5134564|NCT01400451|12630021|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
5134565|NCT01400451|12630019|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
5134566|NCT01400451|12630020|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
5134567|NCT01400451|12630021|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
5134568|NCT01400451|12630019|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
5134569|NCT01400451|12630020|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
5134570|NCT01400451|12630021|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
5134571|NCT01400425|12630035|P1|NOT COMPLETED|Overall Study||10
5134572|NCT01400425|12630035|P1|COMPLETED|Overall Study||229
5134573|NCT01400425|12630035|P1|STARTED|Overall Study||239
5134574|NCT01400412|12630048|P2|NOT COMPLETED|Overall Study||17
5134575|NCT01400412|12630049|P1|NOT COMPLETED|Overall Study||10
5134576|NCT01400412|12630048|P2|COMPLETED|Overall Study||115
5134577|NCT01400412|12630049|P1|COMPLETED|Overall Study||120
5134578|NCT01400412|12630048|P2|STARTED|Overall Study||132
5134579|NCT01400412|12630049|P1|STARTED|Overall Study||130
5134580|NCT01400243|12630095|P2|NOT COMPLETED|Overall Study||11
5134581|NCT01400243|12630096|P1|NOT COMPLETED|Overall Study||8
5134582|NCT01400243|12630095|P2|COMPLETED|Overall Study||52
5134583|NCT01400243|12630096|P1|COMPLETED|Overall Study||56
5134584|NCT01400243|12630095|P2|STARTED|Overall Study||63
5134585|NCT01400243|12630096|P1|STARTED|Overall Study||64
5134586|NCT01400139|12630118|P1|NOT COMPLETED|HYD Extension Period||23
5134587|NCT01400139|12630118|P1|COMPLETED|HYD Extension Period||83
5134588|NCT01400139|12630118|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
5134589|NCT01400139|12630118|P1|NOT COMPLETED|HYD Core Study||512
5134590|NCT01400139|12630118|P1|COMPLETED|HYD Core Study||410
5134591|NCT01400139|12630118|P1|STARTED|HYD Core Study||922
5134592|NCT01400113|12630141|P2|NOT COMPLETED|Overall Study||1
5134593|NCT01400113|12630142|P1|NOT COMPLETED|Overall Study||1
5134594|NCT01400113|12630141|P2|COMPLETED|Overall Study||59
5134595|NCT01400113|12630142|P1|COMPLETED|Overall Study||59
5134596|NCT01400113|12630141|P2|STARTED|Overall Study||60
5134597|NCT01400113|12630142|P1|STARTED|Overall Study||60
5134598|NCT01399905|12630150|P2|NOT COMPLETED|Overall Study||1
5134599|NCT01399905|12630151|P1|NOT COMPLETED|Overall Study||1
5134600|NCT01399905|12630150|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
5134601|NCT01399905|12630151|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
5134602|NCT01399905|12630150|P2|STARTED|Overall Study||7
5134603|NCT01399905|12630151|P1|STARTED|Overall Study||7
5134604|NCT01399866|12630165|P2|NOT COMPLETED|Overall Study||2
5134605|NCT01399866|12630166|P1|NOT COMPLETED|Overall Study||4
5134606|NCT01399866|12630165|P2|COMPLETED|Overall Study||28
5134607|NCT01399866|12630166|P1|COMPLETED|Overall Study||28
5134608|NCT01399866|12630165|P2|STARTED|Overall Study||30
5134609|NCT01399866|12630166|P1|STARTED|Overall Study||32
5134610|NCT01399827|12630184|P2|NOT COMPLETED|Overall Study||0
5134611|NCT01399827|12630185|P1|NOT COMPLETED|Overall Study||0
5134612|NCT01399827|12630184|P2|COMPLETED|Overall Study||1
5134613|NCT01399827|12630185|P1|COMPLETED|Overall Study||1
5134614|NCT01399827|12630184|P2|STARTED|Overall Study||1
5134615|NCT01399827|12630185|P1|STARTED|Overall Study||1
5134616|NCT01399788|12630199|P2|NOT COMPLETED|Second Intervention Period||0
5134617|NCT01399788|12630200|P1|NOT COMPLETED|Second Intervention Period||0
5134618|NCT01399788|12630199|P2|COMPLETED|Second Intervention Period||18
5134619|NCT01399788|12630200|P1|COMPLETED|Second Intervention Period||17
5134620|NCT01399788|12630199|P2|STARTED|Second Intervention Period||18
5134621|NCT01399788|12630200|P1|STARTED|Second Intervention Period||17
5134622|NCT01399788|12630199|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
5134623|NCT01399788|12630200|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
5134624|NCT01399788|12630199|P2|COMPLETED|Washout Period (at Least 1 Week)||18
5134625|NCT01399788|12630200|P1|COMPLETED|Washout Period (at Least 1 Week)||17
5134626|NCT01399788|12630199|P2|STARTED|Washout Period (at Least 1 Week)||18
5134627|NCT01399788|12630200|P1|STARTED|Washout Period (at Least 1 Week)||17
5134628|NCT01399788|12630199|P2|NOT COMPLETED|First Intervention Period||0
5134629|NCT01399788|12630200|P1|NOT COMPLETED|First Intervention Period||1
5134630|NCT01399788|12630199|P2|COMPLETED|First Intervention Period||18
5134631|NCT01399788|12630200|P1|COMPLETED|First Intervention Period||17
5134632|NCT01399788|12630199|P2|STARTED|First Intervention Period||18
5134633|NCT01399788|12630200|P1|STARTED|First Intervention Period||18
5134634|NCT01399736|12630222|P2|NOT COMPLETED|Overall Study||4
5134635|NCT01399736|12630223|P1|NOT COMPLETED|Overall Study||4
5134636|NCT01399736|12630222|P2|COMPLETED|Overall Study||586
5134637|NCT01399736|12630223|P1|COMPLETED|Overall Study||291
5134638|NCT01399736|12630222|P2|STARTED|Overall Study||590
5134639|NCT01399736|12630223|P1|STARTED|Overall Study||295
5134640|NCT01399723|12630299|P2|NOT COMPLETED|Overall Study||1
5134641|NCT01399723|12630300|P1|NOT COMPLETED|Overall Study||0
5134642|NCT01399723|12630299|P2|COMPLETED|Overall Study||263
5134643|NCT01399723|12630300|P1|COMPLETED|Overall Study||263
5134644|NCT01399723|12630299|P2|STARTED|Overall Study||264
5134645|NCT01399723|12630300|P1|STARTED|Overall Study||263
5134646|NCT01399697|12630313|P3|NOT COMPLETED|Overall Study||4
5134647|NCT01399697|12630314|P2|NOT COMPLETED|Overall Study||3
5134648|NCT01399697|12630315|P1|NOT COMPLETED|Overall Study||41
5134649|NCT01399697|12630313|P3|COMPLETED|Overall Study||78
5134650|NCT01399697|12630314|P2|COMPLETED|Overall Study||80
5134651|NCT01399697|12630315|P1|COMPLETED|Overall Study||55
5134652|NCT01399697|12630313|P3|STARTED|Overall Study||82
5134653|NCT01399697|12630314|P2|STARTED|Overall Study||83
5134654|NCT01399697|12630315|P1|STARTED|Overall Study||96
5134655|NCT01399619|12630342|P4|NOT COMPLETED|Overall Study||17
5134656|NCT01399619|12630343|P3|NOT COMPLETED|Overall Study||12
5134657|NCT01399619|12630344|P2|NOT COMPLETED|Overall Study||0
5134658|NCT01399619|12630345|P1|NOT COMPLETED|Overall Study||25
5134659|NCT01399619|12630342|P4|COMPLETED|Overall Study||0
5134660|NCT01399619|12630343|P3|COMPLETED|Overall Study||74
5134661|NCT01399619|12630344|P2|COMPLETED|Overall Study||84
5134662|NCT01399619|12630345|P1|COMPLETED|Overall Study||98
5134663|NCT01399619|12630342|P4|STARTED|Overall Study||17
5134664|NCT01399619|12630343|P3|STARTED|Overall Study||86
5134665|NCT01399619|12630344|P2|STARTED|Overall Study||84
5134666|NCT01399619|12630345|P1|STARTED|Overall Study||123
5134667|NCT01399593|12630408|P2|NOT COMPLETED|Overall Study||2
5134668|NCT01399593|12630409|P1|NOT COMPLETED|Overall Study||3
5134669|NCT01399593|12630408|P2|COMPLETED|Overall Study||49
5134670|NCT01399593|12630409|P1|COMPLETED|Overall Study||48
5134671|NCT01399593|12630408|P2|STARTED|Overall Study||51
5134672|NCT01399593|12630409|P1|STARTED|Overall Study||51
5134673|NCT01399268|12630417|P2|NOT COMPLETED|Overall Study||0
5134674|NCT01399268|12630418|P1|NOT COMPLETED|Overall Study||0
5134675|NCT01399268|12630417|P2|COMPLETED|Overall Study||15
5134676|NCT01399268|12630418|P1|COMPLETED|Overall Study||15
5134677|NCT01399268|12630417|P2|STARTED|Overall Study||15
5134678|NCT01399268|12630418|P1|STARTED|Overall Study||15
5134679|NCT01399229|12630436|P3|NOT COMPLETED|Overall Study||0
5134680|NCT01399229|12630437|P2|NOT COMPLETED|Overall Study||0
5134681|NCT01399229|12630438|P1|NOT COMPLETED|Overall Study||0
5134682|NCT01399229|12630436|P3|COMPLETED|Overall Study||5
5134683|NCT01399229|12630437|P2|COMPLETED|Overall Study||5
5134684|NCT01399229|12630438|P1|COMPLETED|Overall Study||20
5134685|NCT01399229|12630436|P3|STARTED|Overall Study||5
5134686|NCT01399229|12630437|P2|STARTED|Overall Study||5
5134687|NCT01399229|12630438|P1|STARTED|Overall Study||20
5134688|NCT01399190|12630442|P1|NOT COMPLETED|Overall Study||20
5134689|NCT01399190|12630442|P1|COMPLETED|Overall Study||48
5134690|NCT01399190|12630442|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
5134691|NCT01399190|12630442|P1|Included in Final Analysis|Overall Study||63
5134692|NCT01399190|12630442|P1|STARTED|Overall Study||68
5134693|NCT01399125|12630450|P2|NOT COMPLETED|Overall Study||60
5134694|NCT01399125|12630451|P1|NOT COMPLETED|Overall Study||51
5134695|NCT01399125|12630450|P2|COMPLETED|Overall Study||193
5134696|NCT01399125|12630451|P1|COMPLETED|Overall Study||197
5134697|NCT01399125|12630450|P2|Per Protocol (PP) Population|Overall Study||188
5134698|NCT01399125|12630451|P1|Per Protocol (PP) Population|Overall Study||192
5134699|NCT01399125|12630450|P2|STARTED|Overall Study||253
5134700|NCT01399125|12630451|P1|STARTED|Overall Study||248
5134701|NCT01399099|12630465|P1|NOT COMPLETED|Overall Study||31
5134702|NCT01399099|12630465|P1|COMPLETED|Overall Study||36
5134703|NCT01399099|12630465|P1|6 Months|Overall Study||47
5134704|NCT01399099|12630465|P1|STARTED|Overall Study||67
5134705|NCT01399047|12630472|P2|NOT COMPLETED|Overall Study||1
5134706|NCT01399047|12630473|P1|NOT COMPLETED|Overall Study||0
5134707|NCT01399047|12630472|P2|COMPLETED|Overall Study||8
5134708|NCT01399047|12630473|P1|COMPLETED|Overall Study||10
5134709|NCT01399047|12630472|P2|STARTED|Overall Study||9
5134710|NCT01399047|12630473|P1|STARTED|Overall Study||10
5134711|NCT01399008|12630490|P3|NOT COMPLETED|Overall Study||2
5134712|NCT01399008|12630491|P2|NOT COMPLETED|Overall Study||5
5134713|NCT01399008|12630492|P1|NOT COMPLETED|Overall Study||3
5134714|NCT01399008|12630490|P3|COMPLETED|Overall Study||31
5134715|NCT01399008|12630491|P2|COMPLETED|Overall Study||27
5134716|NCT01399008|12630492|P1|COMPLETED|Overall Study||32
5134717|NCT01399008|12630490|P3|STARTED|Overall Study||33
5134718|NCT01399008|12630491|P2|STARTED|Overall Study||32
5134719|NCT01399008|12630492|P1|STARTED|Overall Study||35
5134720|NCT01398982|12630502|P2|NOT COMPLETED|Overall Study||2
5134721|NCT01398982|12630503|P1|NOT COMPLETED|Overall Study||6
5134722|NCT01398982|12630502|P2|COMPLETED|Overall Study||47
5134723|NCT01398982|12630503|P1|COMPLETED|Overall Study||38
5134724|NCT01398982|12630502|P2|STARTED|Overall Study||49
5134725|NCT01398982|12630503|P1|STARTED|Overall Study||44
5134726|NCT01398956|12630509|P1|NOT COMPLETED|Overall Study||10
5134727|NCT01398956|12630509|P1|COMPLETED|Overall Study||34
5134728|NCT01398956|12630509|P1|STARTED|Overall Study||44
5134729|NCT01398943|12630517|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5134730|NCT01398943|12630518|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5134731|NCT01398943|12630519|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5134732|NCT01398943|12630520|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5134733|NCT01398943|12630517|P4|COMPLETED|Second Intervention (1 Day)||15
5134734|NCT01398943|12630518|P3|COMPLETED|Second Intervention (1 Day)||15
5134735|NCT01398943|12630519|P2|COMPLETED|Second Intervention (1 Day)||15
5134736|NCT01398943|12630520|P1|COMPLETED|Second Intervention (1 Day)||15
5134737|NCT01398943|12630517|P4|STARTED|Second Intervention (1 Day)||15
5134738|NCT01398943|12630518|P3|STARTED|Second Intervention (1 Day)||15
5134739|NCT01398943|12630519|P2|STARTED|Second Intervention (1 Day)||15
5134740|NCT01398943|12630520|P1|STARTED|Second Intervention (1 Day)||15
5134741|NCT01398943|12630517|P4|NOT COMPLETED|Washout (2-7 Days)||0
5134742|NCT01398943|12630518|P3|NOT COMPLETED|Washout (2-7 Days)||0
5134743|NCT01398943|12630519|P2|NOT COMPLETED|Washout (2-7 Days)||0
5134744|NCT01398943|12630520|P1|NOT COMPLETED|Washout (2-7 Days)||0
5134745|NCT01398943|12630517|P4|COMPLETED|Washout (2-7 Days)||15
5134746|NCT01398943|12630518|P3|COMPLETED|Washout (2-7 Days)||15
5134747|NCT01398943|12630519|P2|COMPLETED|Washout (2-7 Days)||15
5134748|NCT01398943|12630520|P1|COMPLETED|Washout (2-7 Days)||15
5134749|NCT01398943|12630517|P4|STARTED|Washout (2-7 Days)||15
5134750|NCT01398943|12630518|P3|STARTED|Washout (2-7 Days)||15
5134751|NCT01398943|12630519|P2|STARTED|Washout (2-7 Days)||15
5134752|NCT01398943|12630520|P1|STARTED|Washout (2-7 Days)||15
5134753|NCT01398943|12630517|P4|NOT COMPLETED|First Intervention (1 Day)||0
5134754|NCT01398943|12630518|P3|NOT COMPLETED|First Intervention (1 Day)||0
5134755|NCT01398943|12630519|P2|NOT COMPLETED|First Intervention (1 Day)||0
5134756|NCT01398943|12630520|P1|NOT COMPLETED|First Intervention (1 Day)||0
5134757|NCT01398943|12630517|P4|COMPLETED|First Intervention (1 Day)||15
5134758|NCT01398943|12630518|P3|COMPLETED|First Intervention (1 Day)||15
5134759|NCT01398943|12630519|P2|COMPLETED|First Intervention (1 Day)||15
5134760|NCT01398943|12630520|P1|COMPLETED|First Intervention (1 Day)||15
5134761|NCT01398943|12630517|P4|STARTED|First Intervention (1 Day)||15
5134762|NCT01398943|12630518|P3|STARTED|First Intervention (1 Day)||15
5134763|NCT01398943|12630519|P2|STARTED|First Intervention (1 Day)||15
5134764|NCT01398943|12630520|P1|STARTED|First Intervention (1 Day)||15
5134765|NCT01398852|12630528|P1|NOT COMPLETED|Overall Study||372
5134766|NCT01398852|12630528|P1|COMPLETED|Overall Study||0
5134767|NCT01398852|12630528|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
5134768|NCT01398839|12630534|P2|NOT COMPLETED|Overall Study||0
5134769|NCT01398839|12630535|P1|NOT COMPLETED|Overall Study||0
5134770|NCT01398839|12630534|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
5134771|NCT01398839|12630535|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
5134772|NCT01398839|12630534|P2|STARTED|Overall Study||37
5134773|NCT01398839|12630535|P1|STARTED|Overall Study||35
5134774|NCT01398787|12630541|P1|NOT COMPLETED|Overall Study||1
5134775|NCT01398787|12630541|P1|COMPLETED|Overall Study||197
5134776|NCT01398787|12630541|P1|STARTED|Overall Study||198
5134777|NCT01398514|12630559|P2|NOT COMPLETED|Overall Study||6
5134778|NCT01398514|12630560|P1|NOT COMPLETED|Overall Study||8
5134779|NCT01398514|12630559|P2|COMPLETED|Overall Study||20
5134780|NCT01398514|12630560|P1|COMPLETED|Overall Study||18
5134781|NCT01398514|12630559|P2|STARTED|Overall Study||26
5134782|NCT01398514|12630560|P1|STARTED|Overall Study||26
5134783|NCT01398475|12630572|P4|NOT COMPLETED|Overall Study||0
5134784|NCT01398475|12630573|P3|NOT COMPLETED|Overall Study||0
5134785|NCT01398475|12630574|P2|NOT COMPLETED|Overall Study||0
5134786|NCT01398475|12630575|P1|NOT COMPLETED|Overall Study||0
5134787|NCT01398475|12630572|P4|COMPLETED|Overall Study||4
5134788|NCT01398475|12630573|P3|COMPLETED|Overall Study||4
5134789|NCT01398475|12630574|P2|COMPLETED|Overall Study||3
5134790|NCT01398475|12630575|P1|COMPLETED|Overall Study||4
5134791|NCT01398475|12630572|P4|Received Fourth Intervention|Overall Study||4
5134792|NCT01398475|12630573|P3|Received Fourth Intervention|Overall Study||4
5134793|NCT01398475|12630574|P2|Received Fourth Intervention|Overall Study||3
5134794|NCT01398475|12630575|P1|Received Fourth Intervention|Overall Study||4
5134795|NCT01398475|12630572|P4|Received Third Intervention|Overall Study||4
5134796|NCT01398475|12630573|P3|Received Third Intervention|Overall Study||4
5134797|NCT01398475|12630574|P2|Received Third Intervention|Overall Study||3
5134798|NCT01398475|12630575|P1|Received Third Intervention|Overall Study||4
5134799|NCT01398475|12630572|P4|Received Second Intervention|Overall Study||4
5134800|NCT01398475|12630573|P3|Received Second Intervention|Overall Study||4
5134801|NCT01398475|12630574|P2|Received Second Intervention|Overall Study||3
5134802|NCT01398475|12630575|P1|Received Second Intervention|Overall Study||4
5134803|NCT01398475|12630572|P4|Received First Intervention|Overall Study||4
5134804|NCT01398475|12630573|P3|Received First Intervention|Overall Study||4
5134805|NCT01398475|12630574|P2|Received First Intervention|Overall Study||3
5134806|NCT01398475|12630575|P1|Received First Intervention|Overall Study||4
5134807|NCT01398475|12630572|P4|STARTED|Overall Study||4
5134808|NCT01398475|12630573|P3|STARTED|Overall Study||4
5134809|NCT01398475|12630574|P2|STARTED|Overall Study||3
5134810|NCT01398475|12630575|P1|STARTED|Overall Study||4
5134811|NCT01398410|12630595|P2|NOT COMPLETED|Overall Study||56
5134812|NCT01398410|12630596|P1|NOT COMPLETED|Overall Study||58
5134813|NCT01398410|12630595|P2|COMPLETED|Overall Study||148
5134814|NCT01398410|12630596|P1|COMPLETED|Overall Study||143
5134815|NCT01398410|12630595|P2|STARTED|Overall Study||204
5134816|NCT01398410|12630596|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
5134817|NCT01398358|12630607|P3|NOT COMPLETED|Overall Study||21
5134818|NCT01398358|12630608|P2|NOT COMPLETED|Overall Study||23
5134819|NCT01398358|12630609|P1|NOT COMPLETED|Overall Study||15
5134820|NCT01398358|12630607|P3|COMPLETED|Overall Study||234
5134821|NCT01398358|12630608|P2|COMPLETED|Overall Study||201
5134822|NCT01398358|12630609|P1|COMPLETED|Overall Study||203
5134823|NCT01398358|12630607|P3|STARTED|Overall Study||255
5134824|NCT01398358|12630608|P2|STARTED|Overall Study||224
5134825|NCT01398358|12630609|P1|STARTED|Overall Study||218
5134826|NCT01398280|12630622|P2|NOT COMPLETED|Overall Study||0
5134827|NCT01398280|12630623|P1|NOT COMPLETED|Overall Study||4
5134828|NCT01398280|12630622|P2|COMPLETED|Overall Study||4
5134829|NCT01398280|12630623|P1|COMPLETED|Overall Study||7
5134830|NCT01398280|12630622|P2|STARTED|Overall Study||4
5134831|NCT01398280|12630623|P1|STARTED|Overall Study||11
5134832|NCT01398176|12630631|P2|NOT COMPLETED|Overall Study||6
5134833|NCT01398176|12630632|P1|NOT COMPLETED|Overall Study||3
5134834|NCT01398176|12630631|P2|COMPLETED|Overall Study||19
5134835|NCT01398176|12630632|P1|COMPLETED|Overall Study||23
5134836|NCT01398176|12630631|P2|STARTED|Overall Study||25
5134837|NCT01398176|12630632|P1|STARTED|Overall Study||26
5134838|NCT01398059|12630638|P6|NOT COMPLETED|Overall Study||0
5134839|NCT01398059|12630639|P5|NOT COMPLETED|Overall Study||0
5134840|NCT01398059|12630640|P4|NOT COMPLETED|Overall Study||0
5134841|NCT01398059|12630641|P3|NOT COMPLETED|Overall Study||0
5134842|NCT01398059|12630642|P2|NOT COMPLETED|Overall Study||0
5134843|NCT01398059|12630643|P1|NOT COMPLETED|Overall Study||0
5134844|NCT01398059|12630638|P6|COMPLETED|Overall Study||2
5134845|NCT01398059|12630639|P5|COMPLETED|Overall Study||4
5134846|NCT01398059|12630640|P4|COMPLETED|Overall Study||2
5134847|NCT01398059|12630641|P3|COMPLETED|Overall Study||4
5134848|NCT01398059|12630642|P2|COMPLETED|Overall Study||3
5134849|NCT01398059|12630643|P1|COMPLETED|Overall Study||4
5134850|NCT01398059|12630638|P6|STARTED|Overall Study||2
5134851|NCT01398059|12630639|P5|STARTED|Overall Study||4
5134852|NCT01398059|12630640|P4|STARTED|Overall Study||2
5134853|NCT01398059|12630641|P3|STARTED|Overall Study||4
5134854|NCT01398059|12630642|P2|STARTED|Overall Study||3
5134855|NCT01398059|12630643|P1|STARTED|Overall Study||4
5134856|NCT01397890|12630665|P2|NOT COMPLETED|Overall Study||31
5134857|NCT01397890|12630666|P1|NOT COMPLETED|Overall Study||23
5134858|NCT01397890|12630665|P2|COMPLETED|Overall Study||260
5134859|NCT01397890|12630666|P1|COMPLETED|Overall Study||264
5134860|NCT01397890|12630665|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
5134861|NCT01397890|12630666|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
5134862|NCT01397890|12630665|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
5134863|NCT01397890|12630666|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
5134864|NCT01397890|12630665|P2|STARTED|Overall Study||291
5134865|NCT01397890|12630666|P1|STARTED|Overall Study||287
5134866|NCT01397851|12630720|P2|NOT COMPLETED|Overall Study||46
5134867|NCT01397851|12630721|P1|NOT COMPLETED|Overall Study||79
5134868|NCT01397851|12630720|P2|COMPLETED|Overall Study||39917
5134869|NCT01397851|12630721|P1|COMPLETED|Overall Study||41555
5134870|NCT01397851|12630720|P2|STARTED|Overall Study||39963
5134871|NCT01397851|12630721|P1|STARTED|Overall Study||41634
5134872|NCT01397825|12630737|P5|NOT COMPLETED|Overall Study||0
5134873|NCT01397825|12630738|P4|NOT COMPLETED|Overall Study||3
5134874|NCT01397825|12630739|P3|NOT COMPLETED|Overall Study||25
5134875|NCT01397825|12630740|P2|NOT COMPLETED|Overall Study||4
5134876|NCT01397825|12630741|P1|NOT COMPLETED|Overall Study||13
5134877|NCT01397825|12630737|P5|COMPLETED|Overall Study||0
5134878|NCT01397825|12630738|P4|COMPLETED|Overall Study||0
5134879|NCT01397825|12630739|P3|COMPLETED|Overall Study||0
5134880|NCT01397825|12630740|P2|COMPLETED|Overall Study||0
5134881|NCT01397825|12630741|P1|COMPLETED|Overall Study||0
5134882|NCT01397825|12630737|P5|STARTED|Overall Study||0
5134883|NCT01397825|12630738|P4|STARTED|Overall Study||3
5134884|NCT01397825|12630739|P3|STARTED|Overall Study||25
5134885|NCT01397825|12630740|P2|STARTED|Overall Study||4
5134886|NCT01397825|12630741|P1|STARTED|Overall Study||13
5134887|NCT01397786|12630811|P3|NOT COMPLETED|Phase B||138
5134888|NCT01397786|12630812|P2|NOT COMPLETED|Phase B||95
5134889|NCT01397786|12630813|P1|NOT COMPLETED|Phase B||303
5134890|NCT01397786|12630811|P3|COMPLETED|Phase B||91
5134891|NCT01397786|12630812|P2|COMPLETED|Phase B||109
5134892|NCT01397786|12630813|P1|COMPLETED|Phase B||308
5134893|NCT01397786|12630811|P3|STARTED|Phase B||229
5134894|NCT01397786|12630812|P2|STARTED|Phase B||204
5134895|NCT01397786|12630813|P1|STARTED|Phase B||611
5134896|NCT01397786|12630811|P3|NOT COMPLETED|Phase A||28
5134897|NCT01397786|12630812|P2|NOT COMPLETED|Phase A||0
5134898|NCT01397786|12630813|P1|NOT COMPLETED|Phase A||0
5134899|NCT01397786|12630811|P3|COMPLETED|Phase A||199
5134900|NCT01397786|12630812|P2|COMPLETED|Phase A||0
5134901|NCT01397786|12630813|P1|COMPLETED|Phase A||12
5134902|NCT01397786|12630811|P3|STARTED|Phase A||227
5134903|NCT01397786|12630812|P2|STARTED|Phase A||0
5134904|NCT01397786|12630813|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
5134905|NCT01397747|12630879|P1|NOT COMPLETED|Overall Study||1027
5134906|NCT01397747|12630879|P1|COMPLETED|Overall Study||9989
5134907|NCT01397747|12630879|P1|STARTED|Overall Study||11016
5134908|NCT01397695|12630884|P1|NOT COMPLETED|Overall Study||0
5134909|NCT01397695|12630884|P1|COMPLETED|Overall Study||0
5134910|NCT01397695|12630884|P1|STARTED|Overall Study||0
5134911|NCT01397656|12630890|P2|NOT COMPLETED|Overall Study||0
5134912|NCT01397656|12630891|P1|NOT COMPLETED|Overall Study||0
5134913|NCT01397656|12630890|P2|COMPLETED|Overall Study||30
5134914|NCT01397656|12630891|P1|COMPLETED|Overall Study||33
5134915|NCT01397656|12630890|P2|STARTED|Overall Study||30
5134916|NCT01397656|12630891|P1|STARTED|Overall Study||33
5134917|NCT01397617|12630906|P3|NOT COMPLETED|Overall Study||29
5134918|NCT01397617|12630907|P2|NOT COMPLETED|Overall Study||23
5134919|NCT01397617|12630908|P1|NOT COMPLETED|Overall Study||31
5134920|NCT01397617|12630906|P3|COMPLETED|Overall Study||31
5134921|NCT01397617|12630907|P2|COMPLETED|Overall Study||30
5134922|NCT01397617|12630908|P1|COMPLETED|Overall Study||33
5134923|NCT01397617|12630906|P3|STARTED|Overall Study||60
5134924|NCT01397617|12630907|P2|STARTED|Overall Study||53
5134925|NCT01397617|12630908|P1|STARTED|Overall Study||64
5134926|NCT01397591|12630919|P1|NOT COMPLETED|Overall Study||0
5134927|NCT01397591|12630919|P1|COMPLETED|Overall Study||2
5134928|NCT01397591|12630919|P1|STARTED|Overall Study||2
5134929|NCT01397552|12630929|P2|NOT COMPLETED|Overall Study||1
5134930|NCT01397552|12630930|P1|NOT COMPLETED|Overall Study||3
5134931|NCT01397552|12630929|P2|COMPLETED|Overall Study||3
5134932|NCT01397552|12630930|P1|COMPLETED|Overall Study||1
5134933|NCT01397552|12630929|P2|STARTED|Overall Study||4
5134934|NCT01397552|12630930|P1|STARTED|Overall Study||4
5134935|NCT01397461|12630939|P3|NOT COMPLETED|Overall Study||2
5134936|NCT01397461|12630940|P2|NOT COMPLETED|Overall Study||6
5134937|NCT01397461|12630941|P1|NOT COMPLETED|Overall Study||2
5134938|NCT01397461|12630939|P3|COMPLETED|Overall Study||152
5134939|NCT01397461|12630940|P2|COMPLETED|Overall Study||150
5134940|NCT01397461|12630941|P1|COMPLETED|Overall Study||153
5134941|NCT01397461|12630939|P3|STARTED|Overall Study||154
5134942|NCT01397461|12630940|P2|STARTED|Overall Study||156
5134943|NCT01397461|12630941|P1|STARTED|Overall Study||155
5134944|NCT01397448|12630952|P3|NOT COMPLETED|Overall Study||18
5134945|NCT01397448|12630953|P2|NOT COMPLETED|Overall Study||15
5134946|NCT01397448|12630954|P1|NOT COMPLETED|Overall Study||18
5134947|NCT01397448|12630952|P3|COMPLETED|Overall Study||140
5134948|NCT01397448|12630953|P2|COMPLETED|Overall Study||142
5134949|NCT01397448|12630954|P1|COMPLETED|Overall Study||138
5134950|NCT01397448|12630952|P3|STARTED|Overall Study||158
5134951|NCT01397448|12630953|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
5134952|NCT01397448|12630954|P1|STARTED|Overall Study||156
5134953|NCT01397422|12630969|P4|NOT COMPLETED|Overall Study||8
5134954|NCT01397422|12630970|P3|NOT COMPLETED|Overall Study||3
5134955|NCT01397422|12630971|P2|NOT COMPLETED|Overall Study||3
5134956|NCT01397422|12630972|P1|NOT COMPLETED|Overall Study||2
5134957|NCT01397422|12630969|P4|COMPLETED|Overall Study||12
5134958|NCT01397422|12630970|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
5134959|NCT01397422|12630971|P2|COMPLETED|Overall Study||17
5134960|NCT01397422|12630972|P1|COMPLETED|Overall Study||20
5134961|NCT01397422|12630969|P4|STARTED|Overall Study||20
5134962|NCT01397422|12630970|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
5134963|NCT01397422|12630971|P2|STARTED|Overall Study||20
5134964|NCT01397422|12630972|P1|STARTED|Overall Study||22
5134965|NCT01397409|12631012|P10|NOT COMPLETED|Stage 3||0
5134966|NCT01397409|12631013|P9|NOT COMPLETED|Stage 3||0
5134967|NCT01397409|12631014|P8|NOT COMPLETED|Stage 3||2
5134968|NCT01397409|12631015|P7|NOT COMPLETED|Stage 3||0
5134969|NCT01397409|12631016|P6|NOT COMPLETED|Stage 3||0
5134970|NCT01397409|12631017|P5|NOT COMPLETED|Stage 3||0
5134971|NCT01397409|12631018|P4|NOT COMPLETED|Stage 3||0
5134972|NCT01397409|12631019|P3|NOT COMPLETED|Stage 3||0
5134973|NCT01397409|12631020|P2|NOT COMPLETED|Stage 3||0
5134974|NCT01397409|12631021|P1|NOT COMPLETED|Stage 3||0
5134975|NCT01397409|12631012|P10|COMPLETED|Stage 3||16
5134976|NCT01397409|12631013|P9|COMPLETED|Stage 3||25
5134977|NCT01397409|12631014|P8|COMPLETED|Stage 3||21
5134978|NCT01397409|12631015|P7|COMPLETED|Stage 3||0
5134979|NCT01397409|12631016|P6|COMPLETED|Stage 3||0
5134980|NCT01397409|12631017|P5|COMPLETED|Stage 3||0
5134981|NCT01397409|12631018|P4|COMPLETED|Stage 3||0
5134982|NCT01397409|12631019|P3|COMPLETED|Stage 3||0
5134983|NCT01397409|12631020|P2|COMPLETED|Stage 3||0
5134984|NCT01397409|12631021|P1|COMPLETED|Stage 3||0
5134985|NCT01397409|12631012|P10|STARTED|Stage 3||16
5134986|NCT01397409|12631013|P9|STARTED|Stage 3||25
5134987|NCT01397409|12631014|P8|STARTED|Stage 3||23
5134988|NCT01397409|12631015|P7|STARTED|Stage 3||0
5134989|NCT01397409|12631016|P6|STARTED|Stage 3||0
5134990|NCT01397409|12631017|P5|STARTED|Stage 3||0
5134991|NCT01397409|12631018|P4|STARTED|Stage 3||0
5134992|NCT01397409|12631019|P3|STARTED|Stage 3||0
5134993|NCT01397409|12631020|P2|STARTED|Stage 3||0
5134994|NCT01397409|12631021|P1|STARTED|Stage 3||0
5134995|NCT01397409|12631012|P10|NOT COMPLETED|Stage 2||0
5134996|NCT01397409|12631013|P9|NOT COMPLETED|Stage 2||0
5134997|NCT01397409|12631014|P8|NOT COMPLETED|Stage 2||0
5134998|NCT01397409|12631015|P7|NOT COMPLETED|Stage 2||0
5134999|NCT01397409|12631016|P6|NOT COMPLETED|Stage 2||4
5135000|NCT01397409|12631017|P5|NOT COMPLETED|Stage 2||8
5135001|NCT01397409|12631018|P4|NOT COMPLETED|Stage 2||0
5135002|NCT01397409|12631019|P3|NOT COMPLETED|Stage 2||0
5135003|NCT01397409|12631020|P2|NOT COMPLETED|Stage 2||0
5135004|NCT01397409|12631021|P1|NOT COMPLETED|Stage 2||0
5135005|NCT01397409|12631012|P10|COMPLETED|Stage 2||0
5135006|NCT01397409|12631013|P9|COMPLETED|Stage 2||0
5135007|NCT01397409|12631014|P8|COMPLETED|Stage 2||0
5135008|NCT01397409|12631015|P7|COMPLETED|Stage 2||58
5135009|NCT01397409|12631016|P6|COMPLETED|Stage 2||54
5135010|NCT01397409|12631017|P5|COMPLETED|Stage 2||59
5135011|NCT01397409|12631018|P4|COMPLETED|Stage 2||0
5135012|NCT01397409|12631019|P3|COMPLETED|Stage 2||0
5135013|NCT01397409|12631020|P2|COMPLETED|Stage 2||0
5135014|NCT01397409|12631021|P1|COMPLETED|Stage 2||0
5135015|NCT01397409|12631012|P10|STARTED|Stage 2||0
5135016|NCT01397409|12631013|P9|STARTED|Stage 2||0
5135017|NCT01397409|12631014|P8|STARTED|Stage 2||0
5135018|NCT01397409|12631015|P7|STARTED|Stage 2||58
5135019|NCT01397409|12631016|P6|STARTED|Stage 2||58
5135020|NCT01397409|12631017|P5|STARTED|Stage 2||67
5135021|NCT01397409|12631018|P4|STARTED|Stage 2||0
5135022|NCT01397409|12631019|P3|STARTED|Stage 2||0
5135023|NCT01397409|12631020|P2|STARTED|Stage 2||0
5135024|NCT01397409|12631021|P1|STARTED|Stage 2||0
5135025|NCT01397409|12631012|P10|NOT COMPLETED|Stage 1||0
5135026|NCT01397409|12631013|P9|NOT COMPLETED|Stage 1||0
5135027|NCT01397409|12631014|P8|NOT COMPLETED|Stage 1||0
5135028|NCT01397409|12631015|P7|NOT COMPLETED|Stage 1||0
5135029|NCT01397409|12631016|P6|NOT COMPLETED|Stage 1||0
5135030|NCT01397409|12631017|P5|NOT COMPLETED|Stage 1||0
5135031|NCT01397409|12631018|P4|NOT COMPLETED|Stage 1||0
5135032|NCT01397409|12631019|P3|NOT COMPLETED|Stage 1||0
5135033|NCT01397409|12631020|P2|NOT COMPLETED|Stage 1||0
5135034|NCT01397409|12631021|P1|NOT COMPLETED|Stage 1||0
5135035|NCT01397409|12631012|P10|COMPLETED|Stage 1||0
5135036|NCT01397409|12631013|P9|COMPLETED|Stage 1||0
5135037|NCT01397409|12631014|P8|COMPLETED|Stage 1||0
5135038|NCT01397409|12631015|P7|COMPLETED|Stage 1||0
5135039|NCT01397409|12631016|P6|COMPLETED|Stage 1||0
5135040|NCT01397409|12631017|P5|COMPLETED|Stage 1||0
5135041|NCT01397409|12631018|P4|COMPLETED|Stage 1||3
5135042|NCT01397409|12631019|P3|COMPLETED|Stage 1||6
5135043|NCT01397409|12631020|P2|COMPLETED|Stage 1||6
5135044|NCT01397409|12631021|P1|COMPLETED|Stage 1||9
5135045|NCT01397409|12631012|P10|STARTED|Stage 1||0
5135046|NCT01397409|12631013|P9|STARTED|Stage 1||0
5135047|NCT01397409|12631014|P8|STARTED|Stage 1||0
5135048|NCT01397409|12631015|P7|STARTED|Stage 1||0
5135049|NCT01397409|12631016|P6|STARTED|Stage 1||0
5135050|NCT01397409|12631017|P5|STARTED|Stage 1||0
5135051|NCT01397409|12631018|P4|STARTED|Stage 1||3
5135052|NCT01397409|12631019|P3|STARTED|Stage 1||6
5135053|NCT01397409|12631020|P2|STARTED|Stage 1||6
5135054|NCT01397409|12631021|P1|STARTED|Stage 1||9
5135055|NCT01397253|12631061|P2|NOT COMPLETED|Overall Study||149
5135056|NCT01397253|12631062|P1|NOT COMPLETED|Overall Study||126
5135057|NCT01397253|12631061|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
5135058|NCT01397253|12631062|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
5135059|NCT01397253|12631061|P2|STARTED|Overall Study||392
5135060|NCT01397253|12631062|P1|STARTED|Overall Study||443
5135061|NCT01397084|12631068|P1|NOT COMPLETED|Overall Study||8
5135062|NCT01397084|12631068|P1|COMPLETED|Overall Study||100
5135063|NCT01397084|12631068|P1|STARTED|Overall Study||108
5135064|NCT01397071|12631075|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
5135065|NCT01397071|12631075|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
5135066|NCT01397071|12631075|P1|STARTED|Consumption of Beef Patty With Avocado||11
5135067|NCT01397071|12631075|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
5135068|NCT01397071|12631075|P1|COMPLETED|Consumption of Beef Patty Alone||11
5135069|NCT01397071|12631075|P1|STARTED|Consumption of Beef Patty Alone||11
5135070|NCT01396551|12631083|P1|NOT COMPLETED|Overall Study||0
5135071|NCT01396551|12631083|P1|COMPLETED|Overall Study||69
5135072|NCT01396551|12631083|P1|STARTED|Overall Study||69
5135073|NCT01396525|12631087|P1|NOT COMPLETED|Overall Study||26
5135074|NCT01396525|12631087|P1|COMPLETED|Overall Study||127
5135075|NCT01396525|12631087|P1|STARTED|Overall Study||153
5135076|NCT01396512|12631187|P2|NOT COMPLETED|Overall Study||1
5135077|NCT01396512|12631188|P1|NOT COMPLETED|Overall Study||0
5135078|NCT01396512|12631187|P2|COMPLETED|Overall Study||136
5135079|NCT01396512|12631188|P1|COMPLETED|Overall Study||137
5135080|NCT01396512|12631187|P2|STARTED|Overall Study||137
5135081|NCT01396512|12631188|P1|STARTED|Overall Study||137
5135082|NCT01396486|12631203|P3|NOT COMPLETED|Overall Study||12
5135083|NCT01396486|12631204|P2|NOT COMPLETED|Overall Study||12
5135084|NCT01396486|12631205|P1|NOT COMPLETED|Overall Study||10
5135085|NCT01396486|12631203|P3|COMPLETED|Overall Study||10
5135086|NCT01396486|12631204|P2|COMPLETED|Overall Study||7
5135087|NCT01396486|12631205|P1|COMPLETED|Overall Study||10
5135088|NCT01396486|12631203|P3|Exposed|Overall Study||17
5135089|NCT01396486|12631204|P2|Exposed|Overall Study||16
5135090|NCT01396486|12631205|P1|Exposed|Overall Study||19
5135091|NCT01396486|12631203|P3|STARTED|Overall Study||22
5135092|NCT01396486|12631204|P2|STARTED|Overall Study||19
5135093|NCT01396486|12631205|P1|STARTED|Overall Study||20
5135094|NCT01396447|12631220|P4|NOT COMPLETED|Overall Study||52
5135095|NCT01396447|12631221|P3|NOT COMPLETED|Overall Study||30
5135096|NCT01396447|12631222|P2|NOT COMPLETED|Overall Study||40
5135097|NCT01396447|12631223|P1|NOT COMPLETED|Overall Study||43
5135098|NCT01396447|12631220|P4|COMPLETED|Overall Study||94
5135099|NCT01396447|12631221|P3|COMPLETED|Overall Study||117
5135100|NCT01396447|12631222|P2|COMPLETED|Overall Study||103
5135101|NCT01396447|12631223|P1|COMPLETED|Overall Study||105
5135102|NCT01396447|12631220|P4|Received Treatment|Overall Study||146
5135103|NCT01396447|12631221|P3|Received Treatment|Overall Study||146
5135104|NCT01396447|12631222|P2|Received Treatment|Overall Study||141
5135105|NCT01396447|12631223|P1|Received Treatment|Overall Study||145
5135106|NCT01396447|12631220|P4|STARTED|Overall Study||146
5135107|NCT01396447|12631221|P3|STARTED|Overall Study||147
5135108|NCT01396447|12631222|P2|STARTED|Overall Study||143
5135109|NCT01396447|12631223|P1|STARTED|Overall Study||148
5135110|NCT01396434|12631240|P3|NOT COMPLETED|Overall Study||0
5135111|NCT01396434|12631241|P2|NOT COMPLETED|Overall Study||0
5135112|NCT01396434|12631242|P1|NOT COMPLETED|Overall Study||11
5135113|NCT01396434|12631240|P3|COMPLETED|Overall Study||14
5135114|NCT01396434|12631241|P2|COMPLETED|Overall Study||175
5135115|NCT01396434|12631242|P1|COMPLETED|Overall Study||2806
5135116|NCT01396434|12631240|P3|STARTED|Overall Study||14
5135117|NCT01396434|12631241|P2|STARTED|Overall Study||175
5135118|NCT01396434|12631242|P1|STARTED|Overall Study||2817
5135119|NCT01396421|12631254|P4|NOT COMPLETED|Overall Study||75
5135120|NCT01396421|12631255|P3|NOT COMPLETED|Overall Study||34
5135121|NCT01396421|12631256|P2|NOT COMPLETED|Overall Study||58
5135122|NCT01396421|12631257|P1|NOT COMPLETED|Overall Study||59
5135123|NCT01396421|12631254|P4|COMPLETED|Overall Study||109
5135124|NCT01396421|12631255|P3|COMPLETED|Overall Study||56
5135125|NCT01396421|12631256|P2|COMPLETED|Overall Study||124
5135126|NCT01396421|12631257|P1|COMPLETED|Overall Study||121
5135127|NCT01396421|12631254|P4|STARTED|Overall Study||184
5135128|NCT01396421|12631255|P3|STARTED|Overall Study||90
5135129|NCT01396421|12631256|P2|STARTED|Overall Study||182
5135130|NCT01396421|12631257|P1|STARTED|Overall Study||180
5135131|NCT01396395|12631329|P2|NOT COMPLETED|Overall Study||27
5135132|NCT01396395|12631330|P1|NOT COMPLETED|Overall Study||40
5135133|NCT01396395|12631329|P2|COMPLETED|Overall Study||175
5135134|NCT01396395|12631330|P1|COMPLETED|Overall Study||160
5135135|NCT01396395|12631329|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
5135136|NCT01396395|12631330|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
5135137|NCT01396395|12631329|P2|STARTED|Overall Study||202
5135138|NCT01396395|12631330|P1|STARTED|Overall Study||200
5135139|NCT01396382|12631365|P1|NOT COMPLETED|Overall Study||0
5135140|NCT01396382|12631365|P1|COMPLETED|Overall Study||97
5135141|NCT01396382|12631365|P1|STARTED|Overall Study||97
5135142|NCT01396317|12631372|P2|NOT COMPLETED|Overall Study||0
5135143|NCT01396317|12631373|P1|NOT COMPLETED|Overall Study||1
5135144|NCT01396317|12631372|P2|COMPLETED|Overall Study||10
5135145|NCT01396317|12631373|P1|COMPLETED|Overall Study||9
5135146|NCT01396317|12631372|P2|STARTED|Overall Study||10
5135147|NCT01396317|12631373|P1|STARTED|Overall Study||10
5135148|NCT01396265|12631387|P1|NOT COMPLETED|Rifa+Afatinib||1
5135149|NCT01396265|12631387|P1|COMPLETED|Rifa+Afatinib||21
5135150|NCT01396265|12631387|P1|STARTED|Rifa+Afatinib||22
5135151|NCT01396265|12631387|P1|NOT COMPLETED|Washout||0
5135152|NCT01396265|12631387|P1|COMPLETED|Washout||22
5135153|NCT01396265|12631387|P1|STARTED|Washout||22
5135154|NCT01396265|12631387|P1|NOT COMPLETED|Afatinib||0
5135155|NCT01396265|12631387|P1|COMPLETED|Afatinib||22
5135156|NCT01396265|12631387|P1|STARTED|Afatinib||22
5135157|NCT01396239|12631414|P4|NOT COMPLETED|Overall Study||0
5135158|NCT01396239|12631415|P3|NOT COMPLETED|Overall Study||0
5135159|NCT01396239|12631416|P2|NOT COMPLETED|Overall Study||0
5135160|NCT01396239|12631417|P1|NOT COMPLETED|Overall Study||0
5135161|NCT01396239|12631414|P4|COMPLETED|Overall Study||2
5135162|NCT01396239|12631415|P3|COMPLETED|Overall Study||4
5135163|NCT01396239|12631416|P2|COMPLETED|Overall Study||2
5135164|NCT01396239|12631417|P1|COMPLETED|Overall Study||4
5135165|NCT01396239|12631414|P4|STARTED|Overall Study||2
5135166|NCT01396239|12631415|P3|STARTED|Overall Study||4
5135167|NCT01396239|12631416|P2|STARTED|Overall Study||2
5135168|NCT01396239|12631417|P1|STARTED|Overall Study||4
5135169|NCT01396226|12631440|P2|NOT COMPLETED|Overall Study||0
5135170|NCT01396226|12631441|P1|NOT COMPLETED|Overall Study||0
5135171|NCT01396226|12631440|P2|COMPLETED|Overall Study||6
5135172|NCT01396226|12631441|P1|COMPLETED|Overall Study||12
5135173|NCT01396226|12631440|P2|Patients Who Completed Treatment|Overall Study||6
5135174|NCT01396226|12631441|P1|Patients Who Completed Treatment|Overall Study||12
5135175|NCT01396226|12631440|P2|Patients Who Received Treatment|Overall Study||6
5135176|NCT01396226|12631441|P1|Patients Who Received Treatment|Overall Study||12
5135177|NCT01396226|12631440|P2|STARTED|Overall Study||6
5135178|NCT01396226|12631441|P1|STARTED|Overall Study||12
5135179|NCT01396187|12631476|P5|NOT COMPLETED|Overall Study||1
5135180|NCT01396187|12631477|P4|NOT COMPLETED|Overall Study||0
5135181|NCT01396187|12631478|P3|NOT COMPLETED|Overall Study||1
5135182|NCT01396187|12631479|P2|NOT COMPLETED|Overall Study||3
5135183|NCT01396187|12631480|P1|NOT COMPLETED|Overall Study||1
5135184|NCT01396187|12631476|P5|COMPLETED|Overall Study||9
5135185|NCT01396187|12631477|P4|COMPLETED|Overall Study||10
5135186|NCT01396187|12631478|P3|COMPLETED|Overall Study||9
5135187|NCT01396187|12631479|P2|COMPLETED|Overall Study||9
5135188|NCT01396187|12631480|P1|COMPLETED|Overall Study||7
5135189|NCT01396187|12631476|P5|STARTED|Overall Study||10
5135190|NCT01396187|12631477|P4|STARTED|Overall Study||10
5135191|NCT01396187|12631478|P3|STARTED|Overall Study||10
5135192|NCT01396187|12631479|P2|STARTED|Overall Study||12
5135193|NCT01396187|12631480|P1|STARTED|Overall Study||8
5135194|NCT01396161|12631580|P7|NOT COMPLETED|Overall Study||1
5135195|NCT01396161|12631581|P6|NOT COMPLETED|Overall Study||0
5135196|NCT01396161|12631582|P5|NOT COMPLETED|Overall Study||1
5135197|NCT01396161|12631583|P4|NOT COMPLETED|Overall Study||0
5135198|NCT01396161|12631584|P3|NOT COMPLETED|Overall Study||0
5135199|NCT01396161|12631585|P2|NOT COMPLETED|Overall Study||0
5135200|NCT01396161|12631586|P1|NOT COMPLETED|Overall Study||0
5135201|NCT01396161|12631580|P7|COMPLETED|Overall Study||10
5135202|NCT01396161|12631581|P6|COMPLETED|Overall Study||9
5135203|NCT01396161|12631582|P5|COMPLETED|Overall Study||8
5135204|NCT01396161|12631583|P4|COMPLETED|Overall Study||9
5135205|NCT01396161|12631584|P3|COMPLETED|Overall Study||9
5135206|NCT01396161|12631585|P2|COMPLETED|Overall Study||5
5135207|NCT01396161|12631586|P1|COMPLETED|Overall Study||12
5135208|NCT01396161|12631580|P7|STARTED|Overall Study||11
5135209|NCT01396161|12631581|P6|STARTED|Overall Study||9
5135210|NCT01396161|12631582|P5|STARTED|Overall Study||9
5135211|NCT01396161|12631583|P4|STARTED|Overall Study||9
5135212|NCT01396161|12631584|P3|STARTED|Overall Study||9
5135213|NCT01396161|12631585|P2|STARTED|Overall Study||5
5135214|NCT01396161|12631586|P1|STARTED|Overall Study||12
5135215|NCT01396148|12631639|P1|NOT COMPLETED|Overall Study||1
5135216|NCT01396148|12631639|P1|COMPLETED|Overall Study||5
5135217|NCT01396148|12631639|P1|STARTED|Overall Study||6
5135218|NCT01396083|12631669|P2|NOT COMPLETED|Overall Study||47
5135219|NCT01396083|12631670|P1|NOT COMPLETED|Overall Study||11
5135220|NCT01396083|12631669|P2|COMPLETED|Overall Study||72
5135221|NCT01396083|12631670|P1|COMPLETED|Overall Study||113
5135222|NCT01396083|12631669|P2|STARTED|Overall Study||119
5135223|NCT01396083|12631670|P1|STARTED|Overall Study||124
5135224|NCT01396070|12631694|P1|NOT COMPLETED|Overall Study||19
5135225|NCT01396070|12631694|P1|COMPLETED|Overall Study||17
5135226|NCT01396070|12631694|P1|STARTED|Overall Study||36
5135227|NCT01396057|12631703|P2|NOT COMPLETED|Overall Study||18
5135228|NCT01396057|12631704|P1|NOT COMPLETED|Overall Study||11
5135229|NCT01396057|12631703|P2|COMPLETED|Overall Study||100
5135230|NCT01396057|12631704|P1|COMPLETED|Overall Study||115
5135231|NCT01396057|12631703|P2|STARTED|Overall Study||118
5135232|NCT01396057|12631704|P1|STARTED|Overall Study||126
5135233|NCT01396044|12631730|P2|NOT COMPLETED|Overall Study||0
5135234|NCT01396044|12631731|P1|NOT COMPLETED|Overall Study||0
5135235|NCT01396044|12631730|P2|COMPLETED|Overall Study||171
5135236|NCT01396044|12631731|P1|COMPLETED|Overall Study||125
5135237|NCT01396044|12631730|P2|STARTED|Overall Study||171
5135238|NCT01396044|12631731|P1|STARTED|Overall Study||125
5135239|NCT01396005|12631753|P2|NOT COMPLETED|Overall Study||2
5135240|NCT01396005|12631754|P1|NOT COMPLETED|Overall Study||0
5135241|NCT01396005|12631753|P2|COMPLETED|Overall Study||9
5135242|NCT01396005|12631754|P1|COMPLETED|Overall Study||10
5135243|NCT01396005|12631753|P2|STARTED|Overall Study||11
5135244|NCT01396005|12631754|P1|STARTED|Overall Study||10
5135245|NCT01395966|12631773|P3|NOT COMPLETED|Overall Study||8
5135246|NCT01395966|12631774|P2|NOT COMPLETED|Overall Study||19
5135247|NCT01395966|12631775|P1|NOT COMPLETED|Overall Study||10
5135248|NCT01395966|12631773|P3|COMPLETED|Overall Study||104
5135249|NCT01395966|12631774|P2|COMPLETED|Overall Study||91
5135250|NCT01395966|12631775|P1|COMPLETED|Overall Study||99
5135251|NCT01395966|12631773|P3|STARTED|Overall Study||112
5135252|NCT01395966|12631774|P2|STARTED|Overall Study||110
5135253|NCT01395966|12631775|P1|STARTED|Overall Study||109
5135254|NCT01395914|12631785|P2|NOT COMPLETED|Overall Study||37
5135255|NCT01395914|12631786|P1|NOT COMPLETED|Overall Study||72
5135256|NCT01395914|12631785|P2|COMPLETED|Overall Study||131
5135257|NCT01395914|12631786|P1|COMPLETED|Overall Study||273
5135258|NCT01395914|12631785|P2|Safety Population|Overall Study||167
5135259|NCT01395914|12631786|P1|Safety Population|Overall Study||343
5135260|NCT01395914|12631785|P2|ITT Population|Overall Study||168
5135261|NCT01395914|12631786|P1|ITT Population|Overall Study||345
5135262|NCT01395914|12631785|P2|STARTED|Overall Study||168
5135263|NCT01395914|12631786|P1|STARTED|Overall Study||345
5135264|NCT01395901|12631800|P2|NOT COMPLETED|Overall Study||5
5135265|NCT01395901|12631801|P1|NOT COMPLETED|Overall Study||10
5135266|NCT01395901|12631800|P2|COMPLETED|Overall Study|Treated patients completing the study|329
5135267|NCT01395901|12631801|P1|COMPLETED|Overall Study|Treated patients completing the study|326
5135268|NCT01395901|12631800|P2|STARTED|Overall Study|Randomized Population|334
5135269|NCT01395901|12631801|P1|STARTED|Overall Study|Randomized Population|336
5135270|NCT01395888|12631817|P3|NOT COMPLETED|Treatment Period (TP)||17
5135271|NCT01395888|12631818|P2|NOT COMPLETED|Treatment Period (TP)||15
5135272|NCT01395888|12631819|P1|NOT COMPLETED|Treatment Period (TP)||0
5135273|NCT01395888|12631817|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
5135274|NCT01395888|12631818|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
5135275|NCT01395888|12631819|P1|COMPLETED|Treatment Period (TP)||0
5135276|NCT01395888|12631817|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
5135277|NCT01395888|12631818|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
5135278|NCT01395888|12631819|P1|Completed the Treatment Period|Treatment Period (TP)||0
5135279|NCT01395888|12631817|P3|STARTED|Treatment Period (TP)||130
5135280|NCT01395888|12631818|P2|STARTED|Treatment Period (TP)||127
5135281|NCT01395888|12631819|P1|STARTED|Treatment Period (TP)||0
5135282|NCT01395888|12631817|P3|NOT COMPLETED|2-week Run-in Period||0
5135283|NCT01395888|12631818|P2|NOT COMPLETED|2-week Run-in Period||0
5135284|NCT01395888|12631819|P1|NOT COMPLETED|2-week Run-in Period||22
5135285|NCT01395888|12631817|P3|COMPLETED|2-week Run-in Period||0
5135286|NCT01395888|12631818|P2|COMPLETED|2-week Run-in Period||0
5135287|NCT01395888|12631819|P1|COMPLETED|2-week Run-in Period||257
5135288|NCT01395888|12631817|P3|STARTED|2-week Run-in Period||0
5135289|NCT01395888|12631818|P2|STARTED|2-week Run-in Period||0
5135290|NCT01395888|12631819|P1|STARTED|2-week Run-in Period||279
5135291|NCT01395823|12631827|P2|NOT COMPLETED|Overall Study||9
5135292|NCT01395823|12631828|P1|NOT COMPLETED|Overall Study||15
5135293|NCT01395823|12631827|P2|COMPLETED|Overall Study||130
5135294|NCT01395823|12631828|P1|COMPLETED|Overall Study||122
5135295|NCT01395823|12631827|P2|STARTED|Overall Study||139
5135296|NCT01395823|12631828|P1|STARTED|Overall Study||137
5135297|NCT01395810|12631838|P4|NOT COMPLETED|Overall Study||0
5135298|NCT01395810|12631839|P3|NOT COMPLETED|Overall Study||0
5135299|NCT01395810|12631840|P2|NOT COMPLETED|Overall Study||4
5135300|NCT01395810|12631841|P1|NOT COMPLETED|Overall Study||2
5135301|NCT01395810|12631838|P4|COMPLETED|Overall Study||5
5135302|NCT01395810|12631839|P3|COMPLETED|Overall Study||0
5135303|NCT01395810|12631840|P2|COMPLETED|Overall Study||44
5135304|NCT01395810|12631841|P1|COMPLETED|Overall Study||16
5135305|NCT01395810|12631838|P4|After Switching the Arms|Overall Study||5
5135306|NCT01395810|12631839|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
5135307|NCT01395810|12631840|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
5135308|NCT01395810|12631841|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
5135309|NCT01395810|12631838|P4|STARTED|Overall Study||5
5135310|NCT01395810|12631839|P3|STARTED|Overall Study||0
5135311|NCT01395810|12631840|P2|STARTED|Overall Study||48
5135312|NCT01395810|12631841|P1|STARTED|Overall Study||18
5135313|NCT01395797|12631875|P6|NOT COMPLETED|Overall Study||3
5135314|NCT01395797|12631876|P5|NOT COMPLETED|Overall Study||2
5135315|NCT01395797|12631877|P4|NOT COMPLETED|Overall Study||2
5135316|NCT01395797|12631878|P3|NOT COMPLETED|Overall Study||4
5135317|NCT01395797|12631879|P2|NOT COMPLETED|Overall Study||1
5135318|NCT01395797|12631880|P1|NOT COMPLETED|Overall Study||3
5135319|NCT01395797|12631875|P6|COMPLETED|Overall Study||14
5135320|NCT01395797|12631876|P5|COMPLETED|Overall Study||7
5135321|NCT01395797|12631877|P4|COMPLETED|Overall Study||13
5135322|NCT01395797|12631878|P3|COMPLETED|Overall Study||14
5135323|NCT01395797|12631879|P2|COMPLETED|Overall Study||3
5135324|NCT01395797|12631880|P1|COMPLETED|Overall Study||16
5135325|NCT01395797|12631875|P6|STARTED|Overall Study||17
5135326|NCT01395797|12631876|P5|STARTED|Overall Study||9
5135327|NCT01395797|12631877|P4|STARTED|Overall Study||15
5135328|NCT01395797|12631878|P3|STARTED|Overall Study||18
5135329|NCT01395797|12631879|P2|STARTED|Overall Study||4
5135330|NCT01395797|12631880|P1|STARTED|Overall Study||19
5135331|NCT01395784|12631900|P1|NOT COMPLETED|Overall Study||15
5135332|NCT01395784|12631900|P1|COMPLETED|Overall Study||17
5135333|NCT01395784|12631900|P1|STARTED|Overall Study||32
5135334|NCT01395758|12631907|P3|NOT COMPLETED|Crossover Period||0
5135335|NCT01395758|12631908|P2|NOT COMPLETED|Crossover Period||0
5135336|NCT01395758|12631909|P1|NOT COMPLETED|Crossover Period||0
5135337|NCT01395758|12631907|P3|COMPLETED|Crossover Period||26
5135338|NCT01395758|12631908|P2|COMPLETED|Crossover Period||0
5135339|NCT01395758|12631909|P1|COMPLETED|Crossover Period||0
5135340|NCT01395758|12631907|P3|STARTED|Crossover Period||26
5135341|NCT01395758|12631908|P2|STARTED|Crossover Period||0
5135342|NCT01395758|12631909|P1|STARTED|Crossover Period||0
5135343|NCT01395758|12631907|P3|NOT COMPLETED|Open-label Treatment Period||0
5135344|NCT01395758|12631908|P2|NOT COMPLETED|Open-label Treatment Period||0
5135345|NCT01395758|12631909|P1|NOT COMPLETED|Open-label Treatment Period||4
5135346|NCT01395758|12631907|P3|COMPLETED|Open-label Treatment Period||0
5135347|NCT01395758|12631908|P2|COMPLETED|Open-label Treatment Period||45
5135348|NCT01395758|12631909|P1|COMPLETED|Open-label Treatment Period||47
5135349|NCT01395758|12631907|P3|STARTED|Open-label Treatment Period||0
5135350|NCT01395758|12631908|P2|STARTED|Open-label Treatment Period||45
5135351|NCT01395758|12631909|P1|STARTED|Open-label Treatment Period||51
5135352|NCT01395537|12631920|P1|NOT COMPLETED|Phase II||0
5135353|NCT01395537|12631920|P1|COMPLETED|Phase II||1
5135354|NCT01395537|12631920|P1|STARTED|Phase II||1
5135355|NCT01395537|12631920|P1|NOT COMPLETED|Phase I||0
5135356|NCT01395537|12631920|P1|COMPLETED|Phase I||13
5135357|NCT01395537|12631920|P1|STARTED|Phase I||13
5135358|NCT01395524|12631929|P3|NOT COMPLETED|Overall Study||17
5135359|NCT01395524|12631930|P2|NOT COMPLETED|Overall Study||16
5135360|NCT01395524|12631931|P1|NOT COMPLETED|Overall Study||18
5135361|NCT01395524|12631929|P3|COMPLETED|Overall Study||89
5135362|NCT01395524|12631930|P2|COMPLETED|Overall Study||83
5135363|NCT01395524|12631931|P1|COMPLETED|Overall Study||79
5135364|NCT01395524|12631929|P3|STARTED|Overall Study||106
5135365|NCT01395524|12631930|P2|STARTED|Overall Study||99
5135366|NCT01395524|12631931|P1|STARTED|Overall Study||97
5135367|NCT01395394|12631954|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
5135368|NCT01395394|12631955|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
5135369|NCT01395394|12631956|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
5135370|NCT01395394|12631954|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
5135371|NCT01395394|12631955|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
5135372|NCT01395394|12631956|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
5135373|NCT01395394|12631954|P3|STARTED|Study Visit 2 (Non-responders Only)||0
5135374|NCT01395394|12631955|P2|STARTED|Study Visit 2 (Non-responders Only)||0
5135375|NCT01395394|12631956|P1|STARTED|Study Visit 2 (Non-responders Only)||3
5135376|NCT01395394|12631954|P3|NOT COMPLETED|Baseline Study Visit||0
5135377|NCT01395394|12631955|P2|NOT COMPLETED|Baseline Study Visit||0
5135378|NCT01395394|12631956|P1|NOT COMPLETED|Baseline Study Visit||1
5135379|NCT01395394|12631954|P3|COMPLETED|Baseline Study Visit||5
5135380|NCT01395394|12631955|P2|COMPLETED|Baseline Study Visit||3
5135381|NCT01395394|12631956|P1|COMPLETED|Baseline Study Visit||3
5135382|NCT01395394|12631954|P3|STARTED|Baseline Study Visit||5
5135383|NCT01395394|12631955|P2|STARTED|Baseline Study Visit||3
5135384|NCT01395394|12631956|P1|STARTED|Baseline Study Visit||4
5135385|NCT01395368|12631967|P1|NOT COMPLETED|Overall Study||16
5135386|NCT01395368|12631967|P1|COMPLETED|Overall Study||92
5135387|NCT01395368|12631967|P1|STARTED|Overall Study||108
5135388|NCT01395329|12631974|P3|NOT COMPLETED|Overall Study||0
5135389|NCT01395329|12631975|P2|NOT COMPLETED|Overall Study||0
5135390|NCT01395329|12631976|P1|NOT COMPLETED|Overall Study||0
5135391|NCT01395329|12631974|P3|COMPLETED|Overall Study||14
5135392|NCT01395329|12631975|P2|COMPLETED|Overall Study||14
5135393|NCT01395329|12631976|P1|COMPLETED|Overall Study||14
5135394|NCT01395329|12631974|P3|STARTED|Overall Study||14
5135395|NCT01395329|12631975|P2|STARTED|Overall Study||14
5135396|NCT01395329|12631976|P1|STARTED|Overall Study||14
5135397|NCT01395316|12632023|P1|NOT COMPLETED|Overall Study||3
5135398|NCT01395316|12632023|P1|COMPLETED|Overall Study||5
5135399|NCT01395316|12632023|P1|STARTED|Overall Study||8
5135400|NCT01395277|12632029|P2|NOT COMPLETED|Overall Study||0
5135401|NCT01395277|12632030|P1|NOT COMPLETED|Overall Study||0
5135402|NCT01395277|12632029|P2|COMPLETED|Overall Study||15
5135403|NCT01395277|12632030|P1|COMPLETED|Overall Study||15
5135404|NCT01395277|12632029|P2|STARTED|Overall Study||15
5135405|NCT01395277|12632030|P1|STARTED|Overall Study||15
5135406|NCT01395043|12632038|P1|NOT COMPLETED|Overall Study||0
5135407|NCT01395043|12632038|P1|COMPLETED|Overall Study||15
5135408|NCT01395043|12632038|P1|STARTED|Overall Study||15
5135409|NCT01395030|12632043|P1|NOT COMPLETED|Overall Study||7
5135410|NCT01395030|12632043|P1|COMPLETED|Overall Study||57
5135411|NCT01395030|12632043|P1|Adequate Tissue for Analysis|Overall Study||50
5135412|NCT01395030|12632043|P1|Complete FCH PET/CT|Overall Study||57
5135413|NCT01395030|12632043|P1|STARTED|Overall Study||64
5135414|NCT01395017|12632053|P2|NOT COMPLETED|Overall Study||102
5135415|NCT01395017|12632054|P1|NOT COMPLETED|Overall Study||100
5135416|NCT01395017|12632053|P2|COMPLETED|Overall Study||0
5135417|NCT01395017|12632054|P1|COMPLETED|Overall Study||0
5135418|NCT01395017|12632053|P2|Treated|Overall Study||101
5135419|NCT01395017|12632054|P1|Treated|Overall Study||98
5135420|NCT01395017|12632053|P2|STARTED|Overall Study||102
5135421|NCT01395017|12632054|P1|STARTED|Overall Study||100
5135422|NCT01394991|12632064|P2|NOT COMPLETED|Overall Study||72
5135423|NCT01394991|12632065|P1|NOT COMPLETED|Overall Study||59
5135424|NCT01394991|12632064|P2|COMPLETED|Overall Study||190
5135425|NCT01394991|12632065|P1|COMPLETED|Overall Study||183
5135426|NCT01394991|12632064|P2|STARTED|Overall Study||262
5135427|NCT01394991|12632065|P1|STARTED|Overall Study||242
5135428|NCT01394978|12632087|P2|NOT COMPLETED|Overall Study||31
5135429|NCT01394978|12632088|P1|NOT COMPLETED|Overall Study||21
5135430|NCT01394978|12632087|P2|COMPLETED|Overall Study||245
5135431|NCT01394978|12632088|P1|COMPLETED|Overall Study||147
5135432|NCT01394978|12632087|P2|STARTED|Overall Study||276
5135433|NCT01394978|12632088|P1|STARTED|Overall Study||168
5135434|NCT01394952|12632096|P2|NOT COMPLETED|Overall Study||17
5135435|NCT01394952|12632097|P1|NOT COMPLETED|Overall Study||17
5135436|NCT01394952|12632096|P2|COMPLETED|Overall Study||4932
5135437|NCT01394952|12632097|P1|COMPLETED|Overall Study||4935
5135438|NCT01394952|12632096|P2|Received at Least One Dose of Study Drug|Overall Study||4943
5135439|NCT01394952|12632097|P1|Received at Least One Dose of Study Drug|Overall Study||4949
5135440|NCT01394952|12632096|P2|STARTED|Overall Study||4949
5135441|NCT01394952|12632097|P1|STARTED|Overall Study||4952
5135442|NCT01394926|12632113|P1|NOT COMPLETED|Overall Study||0
5135443|NCT01394926|12632113|P1|COMPLETED|Overall Study||21
5135444|NCT01394926|12632113|P1|STARTED|Overall Study||21
5135445|NCT01394718|12632124|P2|NOT COMPLETED|Overall Study||1
5135446|NCT01394718|12632125|P1|NOT COMPLETED|Overall Study||2
5135447|NCT01394718|12632124|P2|COMPLETED|Overall Study||29
5135448|NCT01394718|12632125|P1|COMPLETED|Overall Study||28
5135449|NCT01394718|12632124|P2|STARTED|Overall Study||30
5135450|NCT01394718|12632125|P1|STARTED|Overall Study||30
5135451|NCT01394705|12632139|P2|NOT COMPLETED|Overall Study||2
5135452|NCT01394705|12632140|P1|NOT COMPLETED|Overall Study||2
5135453|NCT01394705|12632139|P2|COMPLETED|Overall Study||19
5135454|NCT01394705|12632140|P1|COMPLETED|Overall Study||19
5135455|NCT01394705|12632139|P2|STARTED|Overall Study||21
5135456|NCT01394705|12632140|P1|STARTED|Overall Study||21
5135457|NCT01394692|12632150|P2|NOT COMPLETED|Overall Study||0
5135458|NCT01394692|12632151|P1|NOT COMPLETED|Overall Study||0
5135459|NCT01394692|12632150|P2|COMPLETED|Overall Study||29
5135460|NCT01394692|12632151|P1|COMPLETED|Overall Study||29
5135461|NCT01394692|12632150|P2|STARTED|Overall Study||29
5135462|NCT01394692|12632151|P1|STARTED|Overall Study||29
5135463|NCT01394627|12632157|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5135464|NCT01394627|12632158|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5135465|NCT01394627|12632157|P2|COMPLETED|Second Intervention (1 Day)||12
5135466|NCT01394627|12632158|P1|COMPLETED|Second Intervention (1 Day)||7
5135467|NCT01394627|12632157|P2|STARTED|Second Intervention (1 Day)||12
5135468|NCT01394627|12632158|P1|STARTED|Second Intervention (1 Day)||7
5135469|NCT01394627|12632157|P2|NOT COMPLETED|Washout (1-3 Months)||0
5135470|NCT01394627|12632158|P1|NOT COMPLETED|Washout (1-3 Months)||1
5135471|NCT01394627|12632157|P2|COMPLETED|Washout (1-3 Months)||12
5135472|NCT01394627|12632158|P1|COMPLETED|Washout (1-3 Months)||7
5135473|NCT01394627|12632157|P2|STARTED|Washout (1-3 Months)||12
5135474|NCT01394627|12632158|P1|STARTED|Washout (1-3 Months)||8
5135475|NCT01394627|12632157|P2|NOT COMPLETED|First Intervention (1 Day)||1
5135476|NCT01394627|12632158|P1|NOT COMPLETED|First Intervention (1 Day)||0
5135477|NCT01394627|12632157|P2|COMPLETED|First Intervention (1 Day)||12
5135478|NCT01394627|12632158|P1|COMPLETED|First Intervention (1 Day)||8
5135479|NCT01394627|12632157|P2|STARTED|First Intervention (1 Day)||13
5135480|NCT01394627|12632158|P1|STARTED|First Intervention (1 Day)||8
5135481|NCT01394614|12632168|P2|NOT COMPLETED|Overall Study||0
5135482|NCT01394614|12632169|P1|NOT COMPLETED|Overall Study||0
5135483|NCT01394614|12632168|P2|COMPLETED|Overall Study||16
5135484|NCT01394614|12632169|P1|COMPLETED|Overall Study||8
5135485|NCT01394614|12632168|P2|STARTED|Overall Study||16
5135486|NCT01394614|12632169|P1|STARTED|Overall Study||8
5135487|NCT01394523|12632178|P3|NOT COMPLETED|Overall Study||0
5135488|NCT01394523|12632179|P2|NOT COMPLETED|Overall Study||0
5135489|NCT01394523|12632180|P1|NOT COMPLETED|Overall Study||1
5135490|NCT01394523|12632178|P3|COMPLETED|Overall Study||13
5135491|NCT01394523|12632179|P2|COMPLETED|Overall Study||13
5135492|NCT01394523|12632180|P1|COMPLETED|Overall Study||12
5135493|NCT01394523|12632178|P3|STARTED|Overall Study||13
5135494|NCT01394523|12632179|P2|STARTED|Overall Study||13
5135495|NCT01394523|12632180|P1|STARTED|Overall Study||13
5135496|NCT01394510|12632188|P1|NOT COMPLETED|Overall Study||0
5135497|NCT01394510|12632188|P1|COMPLETED|Overall Study||13
5135498|NCT01394510|12632188|P1|STARTED|Overall Study||13
5135499|NCT01394276|12632194|P1|NOT COMPLETED|Overall Study||62
5135500|NCT01394276|12632194|P1|COMPLETED|Overall Study||260
5135501|NCT01394276|12632194|P1|STARTED|Overall Study||322
5135502|NCT01394250|12632218|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
5135503|NCT01394250|12632219|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
5135504|NCT01394250|12632218|P2|COMPLETED|Successful IV Placement & Follow-Up||110
5135505|NCT01394250|12632219|P1|COMPLETED|Successful IV Placement & Follow-Up||114
5135506|NCT01394250|12632218|P2|STARTED|Successful IV Placement & Follow-Up||121
5135507|NCT01394250|12632219|P1|STARTED|Successful IV Placement & Follow-Up||120
5135508|NCT01394250|12632218|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
5135509|NCT01394250|12632219|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
5135510|NCT01394250|12632218|P2|COMPLETED|Randomization and IV Placement Attempt||121
5135511|NCT01394250|12632219|P1|COMPLETED|Randomization and IV Placement Attempt||120
5135512|NCT01394250|12632218|P2|STARTED|Randomization and IV Placement Attempt||134
5135513|NCT01394250|12632219|P1|STARTED|Randomization and IV Placement Attempt||134
5135514|NCT01394211|12632227|P1|NOT COMPLETED|Overall Study||2
5135515|NCT01394211|12632227|P1|COMPLETED|Overall Study||0
5135516|NCT01394211|12632227|P1|STARTED|Overall Study||2
5135517|NCT01394185|12632233|P6|NOT COMPLETED|Overall Study||1
5135518|NCT01394185|12632234|P5|NOT COMPLETED|Overall Study||4
5135519|NCT01394185|12632235|P4|NOT COMPLETED|Overall Study||1
5135520|NCT01394185|12632236|P3|NOT COMPLETED|Overall Study||0
5135521|NCT01394185|12632237|P2|NOT COMPLETED|Overall Study||0
5135522|NCT01394185|12632238|P1|NOT COMPLETED|Overall Study||6
5135523|NCT01394185|12632233|P6|COMPLETED|Overall Study||2
5135524|NCT01394185|12632234|P5|COMPLETED|Overall Study||2
5135525|NCT01394185|12632235|P4|COMPLETED|Overall Study||3
5135526|NCT01394185|12632236|P3|COMPLETED|Overall Study||2
5135527|NCT01394185|12632237|P2|COMPLETED|Overall Study||2
5135528|NCT01394185|12632238|P1|COMPLETED|Overall Study||2
5135529|NCT01394185|12632233|P6|STARTED|Overall Study||3
5135530|NCT01394185|12632234|P5|STARTED|Overall Study||6
5135531|NCT01394185|12632235|P4|STARTED|Overall Study||4
5135532|NCT01394185|12632236|P3|STARTED|Overall Study||2
5135533|NCT01394185|12632237|P2|STARTED|Overall Study||2
5135534|NCT01394185|12632238|P1|STARTED|Overall Study||8
5135535|NCT01394159|12632251|P2|NOT COMPLETED|Overall Study||0
5135536|NCT01394159|12632252|P1|NOT COMPLETED|Overall Study||0
5135537|NCT01394159|12632251|P2|COMPLETED|Overall Study||28
5135538|NCT01394159|12632252|P1|COMPLETED|Overall Study||28
5135539|NCT01394159|12632251|P2|STARTED|Overall Study||28
5135540|NCT01394159|12632252|P1|STARTED|Overall Study||28
5135541|NCT01394081|12632264|P2|NOT COMPLETED|Overall Study||0
5135542|NCT01394081|12632265|P1|NOT COMPLETED|Overall Study||0
5135543|NCT01394081|12632264|P2|COMPLETED|Overall Study||102
5135544|NCT01394081|12632265|P1|COMPLETED|Overall Study||101
5135545|NCT01394081|12632264|P2|STARTED|Overall Study||102
5135546|NCT01394081|12632265|P1|STARTED|Overall Study||101
5135547|NCT01394003|12632281|P8|NOT COMPLETED|Overall Study||0
5135548|NCT01394003|12632282|P7|NOT COMPLETED|Overall Study||0
5135549|NCT01394003|12632283|P6|NOT COMPLETED|Overall Study||0
5135550|NCT01394003|12632284|P5|NOT COMPLETED|Overall Study||0
5135551|NCT01394003|12632285|P4|NOT COMPLETED|Overall Study||0
5135552|NCT01394003|12632286|P3|NOT COMPLETED|Overall Study||0
5135553|NCT01394003|12632287|P2|NOT COMPLETED|Overall Study||0
5135554|NCT01394003|12632288|P1|NOT COMPLETED|Overall Study||0
5135555|NCT01394003|12632281|P8|COMPLETED|Overall Study||2
5135556|NCT01394003|12632282|P7|COMPLETED|Overall Study||6
5135557|NCT01394003|12632283|P6|COMPLETED|Overall Study||3
5135558|NCT01394003|12632284|P5|COMPLETED|Overall Study||3
5135559|NCT01394003|12632285|P4|COMPLETED|Overall Study||6
5135560|NCT01394003|12632286|P3|COMPLETED|Overall Study||3
5135561|NCT01394003|12632287|P2|COMPLETED|Overall Study||8
5135562|NCT01394003|12632288|P1|COMPLETED|Overall Study||3
5135563|NCT01394003|12632281|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
5135650|NCT01393990|12632359|P1|STARTED|Overall Study||4
5135564|NCT01394003|12632282|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5135565|NCT01394003|12632283|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
5135566|NCT01394003|12632284|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5135567|NCT01394003|12632285|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5135568|NCT01394003|12632286|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5135569|NCT01394003|12632287|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
5135570|NCT01394003|12632288|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5135571|NCT01394003|12632281|P8|STARTED|Overall Study||2
5135572|NCT01394003|12632282|P7|STARTED|Overall Study||6
5135573|NCT01394003|12632283|P6|STARTED|Overall Study||3
5135574|NCT01394003|12632284|P5|STARTED|Overall Study||3
5135575|NCT01394003|12632285|P4|STARTED|Overall Study||6
5135576|NCT01394003|12632286|P3|STARTED|Overall Study||3
5135577|NCT01394003|12632287|P2|STARTED|Overall Study||8
5135578|NCT01394003|12632288|P1|STARTED|Overall Study||3
5135579|NCT01393990|12632342|P18|NOT COMPLETED|Overall Study||0
5135580|NCT01393990|12632343|P17|NOT COMPLETED|Overall Study||0
5135581|NCT01393990|12632344|P16|NOT COMPLETED|Overall Study||3
5135582|NCT01393990|12632345|P15|NOT COMPLETED|Overall Study||9
5135583|NCT01393990|12632346|P14|NOT COMPLETED|Overall Study||2
5135584|NCT01393990|12632347|P13|NOT COMPLETED|Overall Study||0
5135585|NCT01393990|12632348|P12|NOT COMPLETED|Overall Study||0
5135586|NCT01393990|12632349|P11|NOT COMPLETED|Overall Study||0
5135587|NCT01393990|12632350|P10|NOT COMPLETED|Overall Study||1
5135588|NCT01393990|12632351|P9|NOT COMPLETED|Overall Study||3
5135589|NCT01393990|12632352|P8|NOT COMPLETED|Overall Study||1
5135590|NCT01393990|12632353|P7|NOT COMPLETED|Overall Study||1
5135591|NCT01393990|12632354|P6|NOT COMPLETED|Overall Study||1
5135592|NCT01393990|12632355|P5|NOT COMPLETED|Overall Study||2
5135593|NCT01393990|12632356|P4|NOT COMPLETED|Overall Study||1
5135594|NCT01393990|12632357|P3|NOT COMPLETED|Overall Study||0
5135595|NCT01393990|12632358|P2|NOT COMPLETED|Overall Study||0
5135596|NCT01393990|12632359|P1|NOT COMPLETED|Overall Study||1
5135597|NCT01393990|12632342|P18|COMPLETED|Overall Study||6
5135598|NCT01393990|12632343|P17|COMPLETED|Overall Study||3
5135599|NCT01393990|12632344|P16|COMPLETED|Overall Study||5
5135600|NCT01393990|12632345|P15|COMPLETED|Overall Study||9
5135601|NCT01393990|12632346|P14|COMPLETED|Overall Study||3
5135602|NCT01393990|12632347|P13|COMPLETED|Overall Study||3
5135603|NCT01393990|12632348|P12|COMPLETED|Overall Study||3
5135604|NCT01393990|12632349|P11|COMPLETED|Overall Study||3
5135605|NCT01393990|12632350|P10|COMPLETED|Overall Study||2
5135606|NCT01393990|12632351|P9|COMPLETED|Overall Study||3
5135607|NCT01393990|12632352|P8|COMPLETED|Overall Study||6
5135608|NCT01393990|12632353|P7|COMPLETED|Overall Study||2
5135609|NCT01393990|12632354|P6|COMPLETED|Overall Study||2
5135610|NCT01393990|12632355|P5|COMPLETED|Overall Study||3
5135611|NCT01393990|12632356|P4|COMPLETED|Overall Study||2
5135612|NCT01393990|12632357|P3|COMPLETED|Overall Study||3
5135613|NCT01393990|12632358|P2|COMPLETED|Overall Study||3
5135614|NCT01393990|12632359|P1|COMPLETED|Overall Study||3
5135615|NCT01393990|12632342|P18|Received at Least 1 Dose of Study Drug|Overall Study||6
5135616|NCT01393990|12632343|P17|Received at Least 1 Dose of Study Drug|Overall Study||3
5135617|NCT01393990|12632344|P16|Received at Least 1 Dose of Study Drug|Overall Study||8
5135618|NCT01393990|12632345|P15|Received at Least 1 Dose of Study Drug|Overall Study||18
5135619|NCT01393990|12632346|P14|Received at Least 1 Dose of Study Drug|Overall Study||5
5135620|NCT01393990|12632347|P13|Received at Least 1 Dose of Study Drug|Overall Study||3
5135621|NCT01393990|12632348|P12|Received at Least 1 Dose of Study Drug|Overall Study||3
5135622|NCT01393990|12632349|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
5135623|NCT01393990|12632350|P10|Received at Least 1 Dose of Study Drug|Overall Study||3
5135624|NCT01393990|12632351|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
5135625|NCT01393990|12632352|P8|Received at Least 1 Dose of Study Drug|Overall Study||7
5135626|NCT01393990|12632353|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
5135627|NCT01393990|12632354|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
5135628|NCT01393990|12632355|P5|Received at Least 1 Dose of Study Drug|Overall Study||5
5135629|NCT01393990|12632356|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5135630|NCT01393990|12632357|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5135631|NCT01393990|12632358|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5135632|NCT01393990|12632359|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5135633|NCT01393990|12632342|P18|STARTED|Overall Study||6
5135634|NCT01393990|12632343|P17|STARTED|Overall Study||3
5135635|NCT01393990|12632344|P16|STARTED|Overall Study||8
5135636|NCT01393990|12632345|P15|STARTED|Overall Study||18
5135637|NCT01393990|12632346|P14|STARTED|Overall Study||5
5135638|NCT01393990|12632347|P13|STARTED|Overall Study||3
5135639|NCT01393990|12632348|P12|STARTED|Overall Study||3
5135640|NCT01393990|12632349|P11|STARTED|Overall Study||3
5135641|NCT01393990|12632350|P10|STARTED|Overall Study||3
5135642|NCT01393990|12632351|P9|STARTED|Overall Study||6
5135643|NCT01393990|12632352|P8|STARTED|Overall Study||7
5135644|NCT01393990|12632353|P7|STARTED|Overall Study||3
5135645|NCT01393990|12632354|P6|STARTED|Overall Study||3
5135646|NCT01393990|12632355|P5|STARTED|Overall Study||5
5135647|NCT01393990|12632356|P4|STARTED|Overall Study||3
5135648|NCT01393990|12632357|P3|STARTED|Overall Study||3
5135649|NCT01393990|12632358|P2|STARTED|Overall Study||3
5135651|NCT01393964|12632450|P3|NOT COMPLETED|Overall Study||9
5135652|NCT01393964|12632451|P2|NOT COMPLETED|Overall Study||9
5135653|NCT01393964|12632452|P1|NOT COMPLETED|Overall Study||8
5135654|NCT01393964|12632450|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
5135655|NCT01393964|12632451|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
5135656|NCT01393964|12632452|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
5135657|NCT01393964|12632450|P3|STARTED|Overall Study||9
5135658|NCT01393964|12632451|P2|STARTED|Overall Study||9
5135659|NCT01393964|12632452|P1|STARTED|Overall Study||8
5135660|NCT01393899|12632493|P3|NOT COMPLETED|Overall Study||23
5135661|NCT01393899|12632494|P2|NOT COMPLETED|Overall Study||28
5135662|NCT01393899|12632495|P1|NOT COMPLETED|Overall Study||32
5135663|NCT01393899|12632493|P3|COMPLETED|Overall Study||38
5135664|NCT01393899|12632494|P2|COMPLETED|Overall Study||32
5135665|NCT01393899|12632495|P1|COMPLETED|Overall Study||27
5135666|NCT01393899|12632493|P3|STARTED|Overall Study||61
5135667|NCT01393899|12632494|P2|STARTED|Overall Study||60
5135668|NCT01393899|12632495|P1|STARTED|Overall Study||59
5135669|NCT01393821|12632549|P2|NOT COMPLETED|Overall Study||3
5135670|NCT01393821|12632550|P1|NOT COMPLETED|Overall Study||5
5135671|NCT01393821|12632549|P2|COMPLETED|Overall Study||10
5135672|NCT01393821|12632550|P1|COMPLETED|Overall Study||9
5135673|NCT01393821|12632549|P2|STARTED|Overall Study||13
5135674|NCT01393821|12632550|P1|STARTED|Overall Study||14
5135675|NCT01393743|12632564|P3|NOT COMPLETED|Extension Phase||60
5135676|NCT01393743|12632565|P2|NOT COMPLETED|Extension Phase||0
5135677|NCT01393743|12632566|P1|NOT COMPLETED|Extension Phase||0
5135678|NCT01393743|12632564|P3|COMPLETED|Extension Phase||78
5135679|NCT01393743|12632565|P2|COMPLETED|Extension Phase||0
5135680|NCT01393743|12632566|P1|COMPLETED|Extension Phase||0
5135681|NCT01393743|12632564|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
5135682|NCT01393743|12632565|P2|STARTED|Extension Phase||0
5135683|NCT01393743|12632566|P1|STARTED|Extension Phase||0
5135684|NCT01393743|12632564|P3|NOT COMPLETED|Core Study||0
5135685|NCT01393743|12632565|P2|NOT COMPLETED|Core Study||13
5135686|NCT01393743|12632566|P1|NOT COMPLETED|Core Study||10
5135687|NCT01393743|12632564|P3|COMPLETED|Core Study||0
5135688|NCT01393743|12632565|P2|COMPLETED|Core Study||68
5135689|NCT01393743|12632566|P1|COMPLETED|Core Study||72
5135690|NCT01393743|12632564|P3|STARTED|Core Study||0
5135691|NCT01393743|12632565|P2|STARTED|Core Study|Treated|81
5135692|NCT01393743|12632566|P1|STARTED|Core Study|Treated|82
5135693|NCT01393730|12632589|P1|NOT COMPLETED|Overall Study||6
5135694|NCT01393730|12632589|P1|COMPLETED|Overall Study||34
5135695|NCT01393730|12632589|P1|Evaluable AR Mutation|Overall Study||14
5135696|NCT01393730|12632589|P1|Evaluable AR Amplification|Overall Study||21
5135697|NCT01393730|12632589|P1|Treated|Overall Study||38
5135698|NCT01393730|12632589|P1|STARTED|Overall Study||40
5135699|NCT01393717|12632601|P2|NOT COMPLETED|Overall Study||0
5135700|NCT01393717|12632602|P1|NOT COMPLETED|Overall Study||0
5135701|NCT01393717|12632601|P2|COMPLETED|Overall Study||20
5135702|NCT01393717|12632602|P1|COMPLETED|Overall Study||37
5135703|NCT01393717|12632601|P2|STARTED|Overall Study||20
5135704|NCT01393717|12632602|P1|STARTED|Overall Study||37
5135705|NCT01393704|12632616|P2|NOT COMPLETED|Overall Study||0
5135706|NCT01393704|12632617|P1|NOT COMPLETED|Overall Study||0
5135707|NCT01393704|12632616|P2|COMPLETED|Overall Study||76
5135708|NCT01393704|12632617|P1|COMPLETED|Overall Study||76
5135709|NCT01393704|12632616|P2|STARTED|Overall Study||76
5135710|NCT01393704|12632617|P1|STARTED|Overall Study||76
5135711|NCT01393626|12632635|P4|NOT COMPLETED|Overall Study||1
5135712|NCT01393626|12632636|P3|NOT COMPLETED|Overall Study||12
5135713|NCT01393626|12632637|P2|NOT COMPLETED|Overall Study||12
5135714|NCT01393626|12632638|P1|NOT COMPLETED|Overall Study||18
5135715|NCT01393626|12632635|P4|COMPLETED|Overall Study||15
5135716|NCT01393626|12632636|P3|COMPLETED|Overall Study||74
5135717|NCT01393626|12632637|P2|COMPLETED|Overall Study||74
5135718|NCT01393626|12632638|P1|COMPLETED|Overall Study||73
5135719|NCT01393626|12632635|P4|STARTED|Overall Study||16
5135720|NCT01393626|12632636|P3|STARTED|Overall Study||86
5135721|NCT01393626|12632637|P2|STARTED|Overall Study||86
5135722|NCT01393626|12632638|P1|STARTED|Overall Study||91
5135723|NCT01393613|12632718|P4|NOT COMPLETED|Overall Study||66
5135724|NCT01393613|12632719|P3|NOT COMPLETED|Overall Study||54
5135725|NCT01393613|12632720|P2|NOT COMPLETED|Overall Study||57
5135726|NCT01393613|12632721|P1|NOT COMPLETED|Overall Study||39
5135727|NCT01393613|12632718|P4|COMPLETED|Overall Study||118
5135728|NCT01393613|12632719|P3|COMPLETED|Overall Study||130
5135729|NCT01393613|12632720|P2|COMPLETED|Overall Study||129
5135730|NCT01393613|12632721|P1|COMPLETED|Overall Study||81
5135731|NCT01393613|12632718|P4|STARTED|Overall Study||184
5135732|NCT01393613|12632719|P3|STARTED|Overall Study||184
5135733|NCT01393613|12632720|P2|STARTED|Overall Study||186
5135734|NCT01393613|12632721|P1|STARTED|Overall Study||120
5135735|NCT01393600|12632783|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
5135736|NCT01393600|12632784|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
5135737|NCT01393600|12632785|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
5135738|NCT01393600|12632786|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
5135739|NCT01393600|12632783|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
5135740|NCT01393600|12632784|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
5135741|NCT01393600|12632785|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
5135742|NCT01393600|12632786|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
5135743|NCT01393600|12632783|P4|STARTED|Follow-up Period (Day 29 to 35)||8
5135744|NCT01393600|12632784|P3|STARTED|Follow-up Period (Day 29 to 35)||7
5135745|NCT01393600|12632785|P2|STARTED|Follow-up Period (Day 29 to 35)||7
5135746|NCT01393600|12632786|P1|STARTED|Follow-up Period (Day 29 to 35)||9
5135747|NCT01393600|12632783|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
5135748|NCT01393600|12632784|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
5135749|NCT01393600|12632785|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
5135750|NCT01393600|12632786|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
5135751|NCT01393600|12632783|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
5135752|NCT01393600|12632784|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
5135753|NCT01393600|12632785|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
5135754|NCT01393600|12632786|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
5135755|NCT01393600|12632783|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
5135756|NCT01393600|12632784|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
5135757|NCT01393600|12632785|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
5135758|NCT01393600|12632786|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
5135759|NCT01393600|12632783|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
5135760|NCT01393600|12632784|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
5135761|NCT01393600|12632785|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
5135762|NCT01393600|12632786|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
5135763|NCT01393600|12632783|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
5135764|NCT01393600|12632784|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
5135765|NCT01393600|12632785|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
5135766|NCT01393600|12632786|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
5135767|NCT01393600|12632783|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
5135768|NCT01393600|12632784|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
5135769|NCT01393600|12632785|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
5135770|NCT01393600|12632786|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
5135771|NCT01393457|12632805|P4|NOT COMPLETED|Overall Study||12
5135772|NCT01393457|12632806|P3|NOT COMPLETED|Overall Study||15
5135773|NCT01393457|12632807|P2|NOT COMPLETED|Overall Study||12
5135774|NCT01393457|12632808|P1|NOT COMPLETED|Overall Study||12
5135775|NCT01393457|12632805|P4|COMPLETED|Overall Study||15
5135776|NCT01393457|12632806|P3|COMPLETED|Overall Study||16
5135777|NCT01393457|12632807|P2|COMPLETED|Overall Study||14
5135778|NCT01393457|12632808|P1|COMPLETED|Overall Study||14
5135779|NCT01393457|12632805|P4|STARTED|Overall Study||27
5135780|NCT01393457|12632806|P3|STARTED|Overall Study||31
5135781|NCT01393457|12632807|P2|STARTED|Overall Study||26
5135782|NCT01393457|12632808|P1|STARTED|Overall Study||26
5135783|NCT01393444|12632822|P1|NOT COMPLETED|Overall Study||3
5135784|NCT01393444|12632822|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
5135785|NCT01393444|12632822|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
5135786|NCT01393444|12632822|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
5135787|NCT01393444|12632822|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
5135788|NCT01393444|12632822|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
5135789|NCT01393444|12632822|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
5135790|NCT01393444|12632822|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
5135791|NCT01393444|12632822|P1|STARTED|Overall Study||6
5135792|NCT01393405|12632827|P3|NOT COMPLETED|Maintenance Period Week||24
5135793|NCT01393405|12632828|P2|NOT COMPLETED|Maintenance Period Week||29
5135794|NCT01393405|12632829|P1|NOT COMPLETED|Maintenance Period Week||0
5135795|NCT01393405|12632827|P3|COMPLETED|Maintenance Period Week||16
5135796|NCT01393405|12632828|P2|COMPLETED|Maintenance Period Week||15
5135797|NCT01393405|12632829|P1|COMPLETED|Maintenance Period Week||0
5135798|NCT01393405|12632827|P3|STARTED|Maintenance Period Week||40
5135799|NCT01393405|12632828|P2|STARTED|Maintenance Period Week||44
5135800|NCT01393405|12632829|P1|STARTED|Maintenance Period Week||0
5135801|NCT01393405|12632827|P3|NOT COMPLETED|Induction Period (week1-16)||0
5135802|NCT01393405|12632828|P2|NOT COMPLETED|Induction Period (week1-16)||0
5135803|NCT01393405|12632829|P1|NOT COMPLETED|Induction Period (week1-16)||95
5135804|NCT01393405|12632827|P3|COMPLETED|Induction Period (week1-16)||0
5135805|NCT01393405|12632828|P2|COMPLETED|Induction Period (week1-16)||0
5135806|NCT01393405|12632829|P1|COMPLETED|Induction Period (week1-16)||84
5135807|NCT01393405|12632827|P3|STARTED|Induction Period (week1-16)||0
5135808|NCT01393405|12632828|P2|STARTED|Induction Period (week1-16)||0
5135809|NCT01393405|12632829|P1|STARTED|Induction Period (week1-16)||179
5135810|NCT01393392|12632848|P2|NOT COMPLETED|Overall Study||19
5135811|NCT01393392|12632849|P1|NOT COMPLETED|Overall Study||11
5135812|NCT01393392|12632848|P2|COMPLETED|Overall Study||24
5135813|NCT01393392|12632849|P1|COMPLETED|Overall Study||33
5135814|NCT01393392|12632848|P2|STARTED|Overall Study||43
5135815|NCT01393392|12632849|P1|STARTED|Overall Study||44
5135816|NCT01393301|12632867|P2|NOT COMPLETED|Overall Study||3
5135817|NCT01393301|12632868|P1|NOT COMPLETED|Overall Study||9
5135818|NCT01393301|12632867|P2|COMPLETED|Overall Study||24
5135819|NCT01393301|12632868|P1|COMPLETED|Overall Study||17
5135820|NCT01393301|12632867|P2|STARTED|Overall Study||27
5135821|NCT01393301|12632868|P1|STARTED|Overall Study||26
5135822|NCT01393158|12632881|P2|NOT COMPLETED|Overall Study||0
5135823|NCT01393158|12632882|P1|NOT COMPLETED|Overall Study||1
5135824|NCT01393158|12632881|P2|COMPLETED|Overall Study||10
5135825|NCT01393158|12632882|P1|COMPLETED|Overall Study||5
5135826|NCT01393158|12632881|P2|STARTED|Overall Study||10
5135827|NCT01393158|12632882|P1|STARTED|Overall Study||6
5135828|NCT01393132|12632896|P2|NOT COMPLETED|Overall Study||0
5135829|NCT01393132|12632897|P1|NOT COMPLETED|Overall Study||0
5135830|NCT01393132|12632896|P2|COMPLETED|Overall Study||3
5135831|NCT01393132|12632897|P1|COMPLETED|Overall Study||6
5135832|NCT01393132|12632896|P2|STARTED|Overall Study||3
5135833|NCT01393132|12632897|P1|STARTED|Overall Study||6
5135834|NCT01393106|12632909|P1|NOT COMPLETED|Overall Study||5
5135835|NCT01393106|12632909|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
5135836|NCT01393106|12632909|P1|STARTED|Overall Study||25
5135837|NCT01392989|12632926|P1|NOT COMPLETED|CIK Cell Infusion||0
5135838|NCT01392989|12632926|P1|COMPLETED|CIK Cell Infusion||31
5135839|NCT01392989|12632926|P1|STARTED|CIK Cell Infusion||31
5135840|NCT01392989|12632926|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
5135841|NCT01392989|12632926|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
5135842|NCT01392989|12632926|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
5135843|NCT01392963|12632936|P2|NOT COMPLETED|Week 24 Follow-up||0
5135844|NCT01392963|12632937|P1|NOT COMPLETED|Week 24 Follow-up||2
5135845|NCT01392963|12632936|P2|COMPLETED|Week 24 Follow-up||17
5135846|NCT01392963|12632937|P1|COMPLETED|Week 24 Follow-up||9
5135847|NCT01392963|12632936|P2|STARTED|Week 24 Follow-up||17
5135848|NCT01392963|12632937|P1|STARTED|Week 24 Follow-up||11
5135849|NCT01392963|12632936|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
5135850|NCT01392963|12632937|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
5135851|NCT01392963|12632936|P2|COMPLETED|Week 12 (Second Intervention)||17
5135852|NCT01392963|12632937|P1|COMPLETED|Week 12 (Second Intervention)||11
5135853|NCT01392963|12632936|P2|STARTED|Week 12 (Second Intervention)||17
5135854|NCT01392963|12632937|P1|STARTED|Week 12 (Second Intervention)||11
5135855|NCT01392963|12632936|P2|NOT COMPLETED|Week 0 (First Intervention)||2
5135856|NCT01392963|12632937|P1|NOT COMPLETED|Week 0 (First Intervention)||0
5135857|NCT01392963|12632936|P2|COMPLETED|Week 0 (First Intervention)||17
5135858|NCT01392963|12632937|P1|COMPLETED|Week 0 (First Intervention)||11
5135859|NCT01392963|12632936|P2|STARTED|Week 0 (First Intervention)||19
5135860|NCT01392963|12632937|P1|STARTED|Week 0 (First Intervention)||11
5135861|NCT01392742|12632945|P1|NOT COMPLETED|Overall Study||201
5135862|NCT01392742|12632945|P1|COMPLETED|Overall Study||242
5135863|NCT01392742|12632945|P1|STARTED|Overall Study||443
5135864|NCT01392703|12632960|P3|NOT COMPLETED|Day 9||0
5135865|NCT01392703|12632961|P2|NOT COMPLETED|Day 9||0
5135866|NCT01392703|12632962|P1|NOT COMPLETED|Day 9||0
5135867|NCT01392703|12632960|P3|COMPLETED|Day 9||25
5135868|NCT01392703|12632961|P2|COMPLETED|Day 9||26
5135869|NCT01392703|12632962|P1|COMPLETED|Day 9||26
5135870|NCT01392703|12632960|P3|STARTED|Day 9||25
5135871|NCT01392703|12632961|P2|STARTED|Day 9||26
5135872|NCT01392703|12632962|P1|STARTED|Day 9||26
5135873|NCT01392703|12632960|P3|NOT COMPLETED|Day 5||0
5135874|NCT01392703|12632961|P2|NOT COMPLETED|Day 5||0
5135875|NCT01392703|12632962|P1|NOT COMPLETED|Day 5||0
5135876|NCT01392703|12632960|P3|COMPLETED|Day 5||26
5135877|NCT01392703|12632961|P2|COMPLETED|Day 5||25
5135878|NCT01392703|12632962|P1|COMPLETED|Day 5||26
5135879|NCT01392703|12632960|P3|STARTED|Day 5||26
5135880|NCT01392703|12632961|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
5135881|NCT01392703|12632962|P1|STARTED|Day 5||26
5135882|NCT01392703|12632960|P3|NOT COMPLETED|Day 1||0
5135883|NCT01392703|12632961|P2|NOT COMPLETED|Day 1||0
5135884|NCT01392703|12632962|P1|NOT COMPLETED|Day 1||0
5135885|NCT01392703|12632960|P3|COMPLETED|Day 1||26
5135886|NCT01392703|12632961|P2|COMPLETED|Day 1||26
5135887|NCT01392703|12632962|P1|COMPLETED|Day 1||26
5135888|NCT01392703|12632960|P3|STARTED|Day 1||26
5135889|NCT01392703|12632961|P2|STARTED|Day 1||26
5135890|NCT01392703|12632962|P1|STARTED|Day 1||26
5135891|NCT01392677|12632991|P2|NOT COMPLETED|Overall Study||8
5135892|NCT01392677|12632992|P1|NOT COMPLETED|Overall Study||8
5135893|NCT01392677|12632991|P2|COMPLETED|Overall Study||101
5135894|NCT01392677|12632992|P1|COMPLETED|Overall Study||101
5135895|NCT01392677|12632991|P2|STARTED|Overall Study||109
5135896|NCT01392677|12632992|P1|STARTED|Overall Study||109
5135897|NCT01392625|12633008|P2|NOT COMPLETED|Overall Study||1
5135898|NCT01392625|12633009|P1|NOT COMPLETED|Overall Study||2
5135899|NCT01392625|12633008|P2|COMPLETED|Overall Study||18
5135900|NCT01392625|12633009|P1|COMPLETED|Overall Study||16
5135901|NCT01392625|12633008|P2|STARTED|Overall Study||19
5135902|NCT01392625|12633009|P1|STARTED|Overall Study||18
5135903|NCT01392573|12633027|P2|NOT COMPLETED|Overall Study||35
5135904|NCT01392573|12633028|P1|NOT COMPLETED|Overall Study||32
5135905|NCT01392573|12633027|P2|COMPLETED|Overall Study||171
5135906|NCT01392573|12633028|P1|COMPLETED|Overall Study||175
5135907|NCT01392573|12633027|P2|Exposed|Overall Study||206
5135908|NCT01392573|12633028|P1|Exposed|Overall Study||207
5135909|NCT01392573|12633027|P2|STARTED|Overall Study||206
5135910|NCT01392573|12633028|P1|STARTED|Overall Study||207
5135911|NCT01392560|12633036|P1|NOT COMPLETED|Overall Study||12
5135912|NCT01392560|12633036|P1|COMPLETED|Overall Study||40
5135913|NCT01392560|12633036|P1|STARTED|Overall Study||52
5135914|NCT01392547|12633042|P1|NOT COMPLETED|Overall Study||8
5135915|NCT01392547|12633042|P1|COMPLETED|Overall Study||64
5135916|NCT01392547|12633042|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
5135917|NCT01392495|12633056|P1|NOT COMPLETED|Overall Study||16
5135918|NCT01392495|12633056|P1|COMPLETED|Overall Study||1
5135919|NCT01392495|12633056|P1|Received 400 mg|Overall Study||13
5135920|NCT01392495|12633056|P1|Received 200 mg|Overall Study||4
5135921|NCT01392495|12633056|P1|STARTED|Overall Study||17
5135922|NCT01392443|12633068|P1|NOT COMPLETED|Overall Study||68
5135923|NCT01392443|12633068|P1|COMPLETED|Overall Study||52
5135924|NCT01392443|12633068|P1|STARTED|Overall Study||120
5135925|NCT01392378|12633081|P5|NOT COMPLETED|Toddler Dose||1
5135926|NCT01392378|12633082|P4|NOT COMPLETED|Toddler Dose||2
5135927|NCT01392378|12633083|P3|NOT COMPLETED|Toddler Dose||0
5135928|NCT01392378|12633084|P2|NOT COMPLETED|Toddler Dose||1
5135929|NCT01392378|12633085|P1|NOT COMPLETED|Toddler Dose||0
5135930|NCT01392378|12633081|P5|COMPLETED|Toddler Dose||208
5135931|NCT01392378|12633082|P4|COMPLETED|Toddler Dose||173
5135932|NCT01392378|12633083|P3|COMPLETED|Toddler Dose||170
5135933|NCT01392378|12633084|P2|COMPLETED|Toddler Dose||172
5135934|NCT01392378|12633085|P1|COMPLETED|Toddler Dose||169
5135935|NCT01392378|12633081|P5|STARTED|Toddler Dose||209
5135936|NCT01392378|12633082|P4|STARTED|Toddler Dose||175
5135937|NCT01392378|12633083|P3|STARTED|Toddler Dose||170
5135938|NCT01392378|12633084|P2|STARTED|Toddler Dose||173
5135939|NCT01392378|12633085|P1|STARTED|Toddler Dose||169
5135940|NCT01392378|12633081|P5|NOT COMPLETED|After Infant Series||1
5135941|NCT01392378|12633082|P4|NOT COMPLETED|After Infant Series||0
5135942|NCT01392378|12633083|P3|NOT COMPLETED|After Infant Series||2
5135943|NCT01392378|12633084|P2|NOT COMPLETED|After Infant Series||1
5135944|NCT01392378|12633085|P1|NOT COMPLETED|After Infant Series||0
5135945|NCT01392378|12633081|P5|COMPLETED|After Infant Series||209
5135946|NCT01392378|12633082|P4|COMPLETED|After Infant Series||175
5135947|NCT01392378|12633083|P3|COMPLETED|After Infant Series||170
5135948|NCT01392378|12633084|P2|COMPLETED|After Infant Series||173
5135949|NCT01392378|12633085|P1|COMPLETED|After Infant Series||169
5135950|NCT01392378|12633081|P5|STARTED|After Infant Series||210
5135951|NCT01392378|12633082|P4|STARTED|After Infant Series||175
5135952|NCT01392378|12633083|P3|STARTED|After Infant Series||172
5135953|NCT01392378|12633084|P2|STARTED|After Infant Series||174
5135954|NCT01392378|12633085|P1|STARTED|After Infant Series||169
5135955|NCT01392378|12633081|P5|NOT COMPLETED|Infant Series||0
5135956|NCT01392378|12633082|P4|NOT COMPLETED|Infant Series||2
5135957|NCT01392378|12633083|P3|NOT COMPLETED|Infant Series||0
5135958|NCT01392378|12633084|P2|NOT COMPLETED|Infant Series||2
5135959|NCT01392378|12633085|P1|NOT COMPLETED|Infant Series||4
5135960|NCT01392378|12633081|P5|COMPLETED|Infant Series||210
5135961|NCT01392378|12633082|P4|COMPLETED|Infant Series||175
5135962|NCT01392378|12633083|P3|COMPLETED|Infant Series||172
5135963|NCT01392378|12633084|P2|COMPLETED|Infant Series||174
5135964|NCT01392378|12633085|P1|COMPLETED|Infant Series||169
5135965|NCT01392378|12633081|P5|Vaccinated Dose 3|Infant Series||210
5135966|NCT01392378|12633082|P4|Vaccinated Dose 3|Infant Series||176
5135967|NCT01392378|12633083|P3|Vaccinated Dose 3|Infant Series||172
5135968|NCT01392378|12633084|P2|Vaccinated Dose 3|Infant Series||174
5135969|NCT01392378|12633085|P1|Vaccinated Dose 3|Infant Series||170
5135970|NCT01392378|12633081|P5|Vaccinated Dose 2|Infant Series||210
5135971|NCT01392378|12633082|P4|Vaccinated Dose 2|Infant Series||177
5135972|NCT01392378|12633083|P3|Vaccinated Dose 2|Infant Series||172
5135973|NCT01392378|12633084|P2|Vaccinated Dose 2|Infant Series||174
5135974|NCT01392378|12633085|P1|Vaccinated Dose 2|Infant Series||171
5135975|NCT01392378|12633081|P5|Vaccinated Dose 1|Infant Series||210
5135976|NCT01392378|12633082|P4|Vaccinated Dose 1|Infant Series||177
5135977|NCT01392378|12633083|P3|Vaccinated Dose 1|Infant Series||172
5135978|NCT01392378|12633084|P2|Vaccinated Dose 1|Infant Series||176
5135979|NCT01392378|12633085|P1|Vaccinated Dose 1|Infant Series||173
5135980|NCT01392378|12633081|P5|STARTED|Infant Series||210
5135981|NCT01392378|12633082|P4|STARTED|Infant Series||177
5135982|NCT01392378|12633083|P3|STARTED|Infant Series||172
5135983|NCT01392378|12633084|P2|STARTED|Infant Series||176
5135984|NCT01392378|12633085|P1|STARTED|Infant Series||173
5135985|NCT01392326|12633225|P3|NOT COMPLETED|Overall Study||48
5135986|NCT01392326|12633226|P2|NOT COMPLETED|Overall Study||35
5135987|NCT01392326|12633227|P1|NOT COMPLETED|Overall Study||47
5135988|NCT01392326|12633225|P3|COMPLETED|Overall Study||154
5135989|NCT01392326|12633226|P2|COMPLETED|Overall Study||167
5135990|NCT01392326|12633227|P1|COMPLETED|Overall Study||155
5135991|NCT01392326|12633225|P3|STARTED|Overall Study||202
5135992|NCT01392326|12633226|P2|STARTED|Overall Study||202
5135993|NCT01392326|12633227|P1|STARTED|Overall Study||202
5135994|NCT01392300|12633264|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
5135995|NCT01392300|12633265|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
5135996|NCT01392300|12633266|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
5135997|NCT01392300|12633264|P3|COMPLETED|Open Label Extension (OLEX) Period||248
5135998|NCT01392300|12633265|P2|COMPLETED|Open Label Extension (OLEX) Period||0
5135999|NCT01392300|12633266|P1|COMPLETED|Open Label Extension (OLEX) Period||0
5136000|NCT01392300|12633264|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
5136001|NCT01392300|12633265|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
5136002|NCT01392300|12633266|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
5136003|NCT01392300|12633264|P3|NOT COMPLETED|Main Period (MP)||0
5136004|NCT01392300|12633265|P2|NOT COMPLETED|Main Period (MP)||7
5136005|NCT01392300|12633266|P1|NOT COMPLETED|Main Period (MP)||11
5136006|NCT01392300|12633264|P3|COMPLETED|Main Period (MP)||0
5136007|NCT01392300|12633265|P2|COMPLETED|Main Period (MP)||100
5136008|NCT01392300|12633266|P1|COMPLETED|Main Period (MP)||199
5136009|NCT01392300|12633264|P3|STARTED|Main Period (MP)||0
5136010|NCT01392300|12633265|P2|STARTED|Main Period (MP)||107
5136011|NCT01392300|12633266|P1|STARTED|Main Period (MP)||210
5136012|NCT01392170|12633371|P1|NOT COMPLETED|Overall Study||2
5136013|NCT01392170|12633371|P1|COMPLETED|Overall Study||0
5136014|NCT01392170|12633371|P1|STARTED|Overall Study||2
5136015|NCT01392053|12633377|P2|NOT COMPLETED|Overall Study||0
5136016|NCT01392053|12633378|P1|NOT COMPLETED|Overall Study||0
5136017|NCT01392053|12633377|P2|COMPLETED|Overall Study||23
5136018|NCT01392053|12633378|P1|COMPLETED|Overall Study||23
5136019|NCT01392053|12633377|P2|STARTED|Overall Study||23
5136020|NCT01392053|12633378|P1|STARTED|Overall Study||23
5136021|NCT01391858|12633398|P2|NOT COMPLETED|Overall Study||0
5136022|NCT01391858|12633399|P1|NOT COMPLETED|Overall Study||2
5136023|NCT01391858|12633398|P2|COMPLETED|Overall Study||24
5136024|NCT01391858|12633399|P1|COMPLETED|Overall Study||23
5136025|NCT01391858|12633398|P2|STARTED|Overall Study||24
5136026|NCT01391858|12633399|P1|STARTED|Overall Study||25
5136027|NCT01391819|12633419|P1|NOT COMPLETED|Overall Study||402
5136028|NCT01391819|12633419|P1|COMPLETED|Overall Study||1714
5136029|NCT01391819|12633419|P1|STARTED|Overall Study||2116
5136030|NCT01391793|12633463|P2|NOT COMPLETED|Overall Study||144
5136031|NCT01391793|12633464|P1|NOT COMPLETED|Overall Study||147
5136032|NCT01391793|12633463|P2|COMPLETED|Overall Study||131
5136033|NCT01391793|12633464|P1|COMPLETED|Overall Study||124
5136034|NCT01391793|12633463|P2|Had a Positive Urine Culture|Overall Study||188
5136035|NCT01391793|12633464|P1|Had a Positive Urine Culture|Overall Study||197
5136036|NCT01391793|12633463|P2|STARTED|Overall Study||275
5136037|NCT01391793|12633464|P1|STARTED|Overall Study||271
5136038|NCT01391663|12633478|P4|NOT COMPLETED|Overall Study||0
5136039|NCT01391663|12633479|P3|NOT COMPLETED|Overall Study||1
5136040|NCT01391663|12633480|P2|NOT COMPLETED|Overall Study||0
5136041|NCT01391663|12633481|P1|NOT COMPLETED|Overall Study||0
5136042|NCT01391663|12633478|P4|COMPLETED|Overall Study||12
5136043|NCT01391663|12633479|P3|COMPLETED|Overall Study||11
5136044|NCT01391663|12633480|P2|COMPLETED|Overall Study||12
5136045|NCT01391663|12633481|P1|COMPLETED|Overall Study||12
5136046|NCT01391663|12633478|P4|STARTED|Overall Study||12
5136047|NCT01391663|12633479|P3|STARTED|Overall Study||12
5136048|NCT01391663|12633480|P2|STARTED|Overall Study||12
5136049|NCT01391663|12633481|P1|STARTED|Overall Study||12
5136050|NCT01391611|12633511|P1|NOT COMPLETED|Overall Study||22
5136051|NCT01391611|12633511|P1|COMPLETED|Overall Study||3
5136052|NCT01391611|12633511|P1|STARTED|Overall Study||25
5136053|NCT01391559|12633516|P2|NOT COMPLETED|Second Intervention||0
5136054|NCT01391559|12633517|P1|NOT COMPLETED|Second Intervention||0
5136055|NCT01391559|12633516|P2|COMPLETED|Second Intervention||10
5136056|NCT01391559|12633517|P1|COMPLETED|Second Intervention||10
5136057|NCT01391559|12633516|P2|STARTED|Second Intervention||10
5136058|NCT01391559|12633517|P1|STARTED|Second Intervention||10
5136059|NCT01391559|12633516|P2|NOT COMPLETED|First Intervention||0
5136060|NCT01391559|12633517|P1|NOT COMPLETED|First Intervention||0
5136061|NCT01391559|12633516|P2|COMPLETED|First Intervention||10
5136062|NCT01391559|12633517|P1|COMPLETED|First Intervention||10
5136063|NCT01391559|12633516|P2|STARTED|First Intervention||10
5136064|NCT01391559|12633517|P1|STARTED|First Intervention||10
5136065|NCT01391546|12633525|P2|NOT COMPLETED|Overall Study||0
5136066|NCT01391546|12633526|P1|NOT COMPLETED|Overall Study||1
5136067|NCT01391546|12633525|P2|COMPLETED|Overall Study||177
5136068|NCT01391546|12633526|P1|COMPLETED|Overall Study||176
5136069|NCT01391546|12633525|P2|Vaccinated|Overall Study||177
5136070|NCT01391546|12633526|P1|Vaccinated|Overall Study||176
5136071|NCT01391546|12633525|P2|STARTED|Overall Study||177
5136072|NCT01391546|12633526|P1|STARTED|Overall Study||177
5136073|NCT01391507|12633548|P4|NOT COMPLETED|Overall Study||7
5136074|NCT01391507|12633549|P3|NOT COMPLETED|Overall Study||4
5136075|NCT01391507|12633550|P2|NOT COMPLETED|Overall Study||4
5136076|NCT01391507|12633551|P1|NOT COMPLETED|Overall Study||4
5136077|NCT01391507|12633548|P4|COMPLETED|Overall Study||5
5136078|NCT01391507|12633549|P3|COMPLETED|Overall Study||2
5136079|NCT01391507|12633550|P2|COMPLETED|Overall Study||4
5136080|NCT01391507|12633551|P1|COMPLETED|Overall Study||6
5136081|NCT01391507|12633548|P4|STARTED|Overall Study||12
5136082|NCT01391507|12633549|P3|STARTED|Overall Study||6
5136083|NCT01391507|12633550|P2|STARTED|Overall Study||8
5136084|NCT01391507|12633551|P1|STARTED|Overall Study||10
5136085|NCT01391468|12633599|P2|NOT COMPLETED|Overall Study||2
5136086|NCT01391468|12633600|P1|NOT COMPLETED|Overall Study||6
5136087|NCT01391468|12633599|P2|COMPLETED|Overall Study||21
5136088|NCT01391468|12633600|P1|COMPLETED|Overall Study||18
5136089|NCT01391468|12633599|P2|STARTED|Overall Study||23
5136090|NCT01391468|12633600|P1|STARTED|Overall Study||24
5136091|NCT01391325|12633612|P1|NOT COMPLETED|Overall Study||494
5136092|NCT01391325|12633612|P1|COMPLETED|Overall Study||1238
5136093|NCT01391325|12633612|P1|STARTED|Overall Study||1732
5136094|NCT01391312|12633621|P2|NOT COMPLETED|Overall Study||1
5136095|NCT01391312|12633622|P1|NOT COMPLETED|Overall Study||2
5136096|NCT01391312|12633621|P2|COMPLETED|Overall Study||19
5136097|NCT01391312|12633622|P1|COMPLETED|Overall Study||18
5136098|NCT01391312|12633621|P2|STARTED|Overall Study||20
5136099|NCT01391312|12633622|P1|STARTED|Overall Study||20
5136100|NCT01391299|12633635|P3|NOT COMPLETED|Overall Study||2
5136101|NCT01391299|12633636|P2|NOT COMPLETED|Overall Study||1
5136102|NCT01391299|12633637|P1|NOT COMPLETED|Overall Study||0
5136103|NCT01391299|12633635|P3|COMPLETED|Overall Study||56
5136104|NCT01391299|12633636|P2|COMPLETED|Overall Study||59
5136105|NCT01391299|12633637|P1|COMPLETED|Overall Study||57
5136106|NCT01391299|12633635|P3|STARTED|Overall Study||58
5136107|NCT01391299|12633636|P2|STARTED|Overall Study||60
5136108|NCT01391299|12633637|P1|STARTED|Overall Study||57
5136109|NCT01391286|12633659|P2|NOT COMPLETED|Overall Study||0
5136110|NCT01391286|12633660|P1|NOT COMPLETED|Overall Study||0
5136111|NCT01391286|12633659|P2|COMPLETED|Overall Study||18
5136112|NCT01391286|12633660|P1|COMPLETED|Overall Study||18
5136113|NCT01391286|12633659|P2|STARTED|Overall Study||18
5136114|NCT01391286|12633660|P1|STARTED|Overall Study||18
5136115|NCT01391273|12633674|P2|NOT COMPLETED|Overall Study||2
5136116|NCT01391273|12633675|P1|NOT COMPLETED|Overall Study||4
5136117|NCT01391273|12633674|P2|COMPLETED|Overall Study||83
5136118|NCT01391273|12633675|P1|COMPLETED|Overall Study||84
5136119|NCT01391273|12633674|P2|STARTED|Overall Study||85
5136120|NCT01391273|12633675|P1|STARTED|Overall Study||88
5136121|NCT01391130|12633689|P2|NOT COMPLETED|Overall Study||6
5136122|NCT01391130|12633690|P1|NOT COMPLETED|Overall Study||6
5136123|NCT01391130|12633689|P2|COMPLETED|Overall Study||31
5136124|NCT01391130|12633690|P1|COMPLETED|Overall Study||67
5136125|NCT01391130|12633689|P2|Received At Least One Dose of Study Drug|Overall Study||36
5136126|NCT01391130|12633690|P1|Received At Least One Dose of Study Drug|Overall Study||72
5136127|NCT01391130|12633689|P2|STARTED|Overall Study||37
5136128|NCT01391130|12633690|P1|STARTED|Overall Study||73
5136129|NCT01391013|12633706|P2|NOT COMPLETED|Overall Study||0
5136130|NCT01391013|12633707|P1|NOT COMPLETED|Overall Study||0
5136131|NCT01391013|12633706|P2|COMPLETED|Overall Study||15
5136132|NCT01391013|12633707|P1|COMPLETED|Overall Study||15
5136133|NCT01391013|12633706|P2|STARTED|Overall Study||15
5136134|NCT01391013|12633707|P1|STARTED|Overall Study||15
5136135|NCT01391000|12633747|P2|NOT COMPLETED|Overall Study||0
5136136|NCT01391000|12633748|P1|NOT COMPLETED|Overall Study||2
5136137|NCT01391000|12633747|P2|COMPLETED|Overall Study||35
5136138|NCT01391000|12633748|P1|COMPLETED|Overall Study||33
5136139|NCT01391000|12633747|P2|STARTED|Overall Study||35
5136140|NCT01391000|12633748|P1|STARTED|Overall Study||35
5136141|NCT01390948|12633761|P3|NOT COMPLETED|Overall Study||3
5136142|NCT01390948|12633762|P2|NOT COMPLETED|Overall Study||62
5136143|NCT01390948|12633763|P1|NOT COMPLETED|Overall Study||59
5136144|NCT01390948|12633761|P3|COMPLETED|Overall Study||0
5136145|NCT01390948|12633762|P2|COMPLETED|Overall Study||0
5136146|NCT01390948|12633763|P1|COMPLETED|Overall Study||0
5136147|NCT01390948|12633761|P3|Treated|Overall Study||3
5136148|NCT01390948|12633762|P2|Treated|Overall Study||60
5136149|NCT01390948|12633763|P1|Treated|Overall Study||56
5136150|NCT01390948|12633761|P3|STARTED|Overall Study||3
5136151|NCT01390948|12633762|P2|STARTED|Overall Study||62
5136152|NCT01390948|12633763|P1|STARTED|Overall Study||59
5136153|NCT01390909|12633802|P6|NOT COMPLETED|Overall Study||0
5136154|NCT01390909|12633803|P5|NOT COMPLETED|Overall Study||0
5136155|NCT01390909|12633804|P4|NOT COMPLETED|Overall Study||0
5136156|NCT01390909|12633805|P3|NOT COMPLETED|Overall Study||0
5136157|NCT01390909|12633806|P2|NOT COMPLETED|Overall Study||0
5136158|NCT01390909|12633807|P1|NOT COMPLETED|Overall Study||0
5136159|NCT01390909|12633802|P6|COMPLETED|Overall Study||613
5136160|NCT01390909|12633803|P5|COMPLETED|Overall Study||613
5136161|NCT01390909|12633804|P4|COMPLETED|Overall Study||602
5136162|NCT01390909|12633805|P3|COMPLETED|Overall Study||3552
5136163|NCT01390909|12633806|P2|COMPLETED|Overall Study||3552
5136164|NCT01390909|12633807|P1|COMPLETED|Overall Study||3454
5136165|NCT01390909|12633802|P6|Participants in Subgroup|Overall Study||0
5136166|NCT01390909|12633803|P5|Participants in Subgroup|Overall Study||602
5136167|NCT01390909|12633804|P4|Participants in Subgroup|Overall Study||0
5136168|NCT01390909|12633805|P3|Participants in Subgroup|Overall Study||0
5136169|NCT01390909|12633806|P2|Participants in Subgroup|Overall Study||3454
5136170|NCT01390909|12633807|P1|Participants in Subgroup|Overall Study||0
5136171|NCT01390909|12633802|P6|STARTED|Overall Study||613
5136172|NCT01390909|12633803|P5|STARTED|Overall Study||613
5136173|NCT01390909|12633804|P4|STARTED|Overall Study||602
5136174|NCT01390909|12633805|P3|STARTED|Overall Study||3552
5136175|NCT01390909|12633806|P2|STARTED|Overall Study||3552
5136176|NCT01390909|12633807|P1|STARTED|Overall Study||3454
5136177|NCT01390870|12633825|P1|NOT COMPLETED|Overall Study||0
5136178|NCT01390870|12633825|P1|COMPLETED|Overall Study||400
5136179|NCT01390870|12633825|P1|STARTED|Overall Study||400
5136180|NCT01390857|12633829|P1|NOT COMPLETED|Overall Study||10
5136181|NCT01390857|12633829|P1|COMPLETED|Overall Study||369
5136182|NCT01390857|12633829|P1|STARTED|Overall Study||379
5136183|NCT01390844|12633840|P4|NOT COMPLETED|Follow-Up Phase||0
5136184|NCT01390844|12633841|P3|NOT COMPLETED|Follow-Up Phase||1
5136185|NCT01390844|12633842|P2|NOT COMPLETED|Follow-Up Phase||1
5136186|NCT01390844|12633843|P1|NOT COMPLETED|Follow-Up Phase||1
5136187|NCT01390844|12633840|P4|COMPLETED|Follow-Up Phase||8
5136188|NCT01390844|12633841|P3|COMPLETED|Follow-Up Phase||25
5136189|NCT01390844|12633842|P2|COMPLETED|Follow-Up Phase||36
5136190|NCT01390844|12633843|P1|COMPLETED|Follow-Up Phase||92
5136191|NCT01390844|12633840|P4|STARTED|Follow-Up Phase||8
5136192|NCT01390844|12633841|P3|STARTED|Follow-Up Phase||26
5136193|NCT01390844|12633842|P2|STARTED|Follow-Up Phase||37
5136194|NCT01390844|12633843|P1|STARTED|Follow-Up Phase||93
5136195|NCT01390844|12633840|P4|NOT COMPLETED|Treatment Phase||19
5136196|NCT01390844|12633841|P3|NOT COMPLETED|Treatment Phase||31
5136197|NCT01390844|12633842|P2|NOT COMPLETED|Treatment Phase||28
5136198|NCT01390844|12633843|P1|NOT COMPLETED|Treatment Phase||40
5136199|NCT01390844|12633840|P4|COMPLETED|Treatment Phase||8
5136200|NCT01390844|12633841|P3|COMPLETED|Treatment Phase||26
5136201|NCT01390844|12633842|P2|COMPLETED|Treatment Phase||37
5136202|NCT01390844|12633843|P1|COMPLETED|Treatment Phase||93
5136203|NCT01390844|12633840|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
5136204|NCT01390844|12633841|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
5136205|NCT01390844|12633842|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
5136206|NCT01390844|12633843|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
5136207|NCT01390844|12633840|P4|STARTED|Treatment Phase||27
5136208|NCT01390844|12633841|P3|STARTED|Treatment Phase||57
5136209|NCT01390844|12633842|P2|STARTED|Treatment Phase||65
5136210|NCT01390844|12633843|P1|STARTED|Treatment Phase||133
5136211|NCT01390818|12633884|P15|NOT COMPLETED|Overall Study||0
5136212|NCT01390818|12633885|P14|NOT COMPLETED|Overall Study||0
5136213|NCT01390818|12633886|P13|NOT COMPLETED|Overall Study||0
5136214|NCT01390818|12633887|P12|NOT COMPLETED|Overall Study||0
5136215|NCT01390818|12633888|P11|NOT COMPLETED|Overall Study||0
5136216|NCT01390818|12633889|P10|NOT COMPLETED|Overall Study||0
5136217|NCT01390818|12633890|P9|NOT COMPLETED|Overall Study||0
5136218|NCT01390818|12633891|P8|NOT COMPLETED|Overall Study||0
5136219|NCT01390818|12633892|P7|NOT COMPLETED|Overall Study||0
5136220|NCT01390818|12633893|P6|NOT COMPLETED|Overall Study||0
5136221|NCT01390818|12633894|P5|NOT COMPLETED|Overall Study||0
5136222|NCT01390818|12633895|P4|NOT COMPLETED|Overall Study||0
5136223|NCT01390818|12633896|P3|NOT COMPLETED|Overall Study||0
5136224|NCT01390818|12633897|P2|NOT COMPLETED|Overall Study||0
5136225|NCT01390818|12633898|P1|NOT COMPLETED|Overall Study||0
5136226|NCT01390818|12633884|P15|COMPLETED|Overall Study||15
5136227|NCT01390818|12633885|P14|COMPLETED|Overall Study||18
5136228|NCT01390818|12633886|P13|COMPLETED|Overall Study||24
5136229|NCT01390818|12633887|P12|COMPLETED|Overall Study||26
5136230|NCT01390818|12633888|P11|COMPLETED|Overall Study||4
5136231|NCT01390818|12633889|P10|COMPLETED|Overall Study||3
5136232|NCT01390818|12633890|P9|COMPLETED|Overall Study||3
5136233|NCT01390818|12633891|P8|COMPLETED|Overall Study||14
5136234|NCT01390818|12633892|P7|COMPLETED|Overall Study||19
5136235|NCT01390818|12633893|P6|COMPLETED|Overall Study||3
5136236|NCT01390818|12633894|P5|COMPLETED|Overall Study||4
5136237|NCT01390818|12633895|P4|COMPLETED|Overall Study||4
5136238|NCT01390818|12633896|P3|COMPLETED|Overall Study||3
5136239|NCT01390818|12633897|P2|COMPLETED|Overall Study||3
5136240|NCT01390818|12633898|P1|COMPLETED|Overall Study||3
5136241|NCT01390818|12633884|P15|STARTED|Overall Study||15
5136242|NCT01390818|12633885|P14|STARTED|Overall Study||18
5136243|NCT01390818|12633886|P13|STARTED|Overall Study||24
5136244|NCT01390818|12633887|P12|STARTED|Overall Study||26
5136245|NCT01390818|12633888|P11|STARTED|Overall Study||4
5136246|NCT01390818|12633889|P10|STARTED|Overall Study||3
5136247|NCT01390818|12633890|P9|STARTED|Overall Study||3
5136248|NCT01390818|12633891|P8|STARTED|Overall Study||14
5136249|NCT01390818|12633892|P7|STARTED|Overall Study||19
5136250|NCT01390818|12633893|P6|STARTED|Overall Study||3
5136251|NCT01390818|12633894|P5|STARTED|Overall Study||4
5136252|NCT01390818|12633895|P4|STARTED|Overall Study||4
5136253|NCT01390818|12633896|P3|STARTED|Overall Study||3
5136254|NCT01390818|12633897|P2|STARTED|Overall Study||3
5136255|NCT01390818|12633898|P1|STARTED|Overall Study||3
5136256|NCT01390779|12634170|P1|NOT COMPLETED|Overall Study||1
5136257|NCT01390779|12634170|P1|COMPLETED|Overall Study||32
5136258|NCT01390779|12634170|P1|STARTED|Overall Study||33
5136259|NCT01390649|12634175|P1|NOT COMPLETED|Overall Study||1
5136260|NCT01390649|12634175|P1|COMPLETED|Overall Study||56
5136261|NCT01390649|12634175|P1|STARTED|Overall Study|Subjects treated with Privigen|57
5136262|NCT01390441|12634185|P5|NOT COMPLETED|Extension Period||0
5136263|NCT01390441|12634186|P4|NOT COMPLETED|Extension Period||1
5136264|NCT01390441|12634187|P3|NOT COMPLETED|Extension Period||0
5136265|NCT01390441|12634188|P2|NOT COMPLETED|Extension Period||1
5136266|NCT01390441|12634189|P1|NOT COMPLETED|Extension Period||3
5136267|NCT01390441|12634185|P5|COMPLETED|Extension Period||3
5136268|NCT01390441|12634186|P4|COMPLETED|Extension Period||0
5136269|NCT01390441|12634187|P3|COMPLETED|Extension Period||1
5136270|NCT01390441|12634188|P2|COMPLETED|Extension Period||12
5136271|NCT01390441|12634189|P1|COMPLETED|Extension Period||12
5136272|NCT01390441|12634185|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
5136273|NCT01390441|12634186|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
5136274|NCT01390441|12634187|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
5136275|NCT01390441|12634188|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
5136276|NCT01390441|12634189|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
5136277|NCT01390441|12634185|P5|NOT COMPLETED|Treatment Period||11
5136278|NCT01390441|12634186|P4|NOT COMPLETED|Treatment Period||13
5136279|NCT01390441|12634187|P3|NOT COMPLETED|Treatment Period||10
5136280|NCT01390441|12634188|P2|NOT COMPLETED|Treatment Period||1
5136281|NCT01390441|12634189|P1|NOT COMPLETED|Treatment Period||1
5136282|NCT01390441|12634185|P5|COMPLETED|Treatment Period||7
5136283|NCT01390441|12634186|P4|COMPLETED|Treatment Period||6
5136284|NCT01390441|12634187|P3|COMPLETED|Treatment Period||8
5136285|NCT01390441|12634188|P2|COMPLETED|Treatment Period||21
5136286|NCT01390441|12634189|P1|COMPLETED|Treatment Period||22
5136287|NCT01390441|12634185|P5|STARTED|Treatment Period||18
5136288|NCT01390441|12634186|P4|STARTED|Treatment Period||19
5136289|NCT01390441|12634187|P3|STARTED|Treatment Period||18
5136290|NCT01390441|12634188|P2|STARTED|Treatment Period||22
5136291|NCT01390441|12634189|P1|STARTED|Treatment Period||23
5136292|NCT01390428|12634254|P6|NOT COMPLETED|Overall Study||0
5136293|NCT01390428|12634255|P5|NOT COMPLETED|Overall Study||1
5136294|NCT01390428|12634256|P4|NOT COMPLETED|Overall Study||0
5136295|NCT01390428|12634257|P3|NOT COMPLETED|Overall Study||1
5136296|NCT01390428|12634258|P2|NOT COMPLETED|Overall Study||0
5136297|NCT01390428|12634259|P1|NOT COMPLETED|Overall Study||0
5136298|NCT01390428|12634254|P6|COMPLETED|Overall Study||8
5136299|NCT01390428|12634255|P5|COMPLETED|Overall Study||7
5136300|NCT01390428|12634256|P4|COMPLETED|Overall Study||9
5136301|NCT01390428|12634257|P3|COMPLETED|Overall Study||8
5136302|NCT01390428|12634258|P2|COMPLETED|Overall Study||8
5136303|NCT01390428|12634259|P1|COMPLETED|Overall Study||8
5136304|NCT01390428|12634254|P6|STARTED|Overall Study||8
5136305|NCT01390428|12634255|P5|STARTED|Overall Study||8
5136306|NCT01390428|12634256|P4|STARTED|Overall Study||9
5136307|NCT01390428|12634257|P3|STARTED|Overall Study||9
5136308|NCT01390428|12634258|P2|STARTED|Overall Study||8
5136309|NCT01390428|12634259|P1|STARTED|Overall Study||8
5136310|NCT01390415|12634311|P2|NOT COMPLETED|Overall Study||0
5136311|NCT01390415|12634312|P1|NOT COMPLETED|Overall Study||0
5136312|NCT01390415|12634311|P2|COMPLETED|Overall Study||37
5136313|NCT01390415|12634312|P1|COMPLETED|Overall Study||99
5136314|NCT01390415|12634311|P2|STARTED|Overall Study||37
5136315|NCT01390415|12634312|P1|STARTED|Overall Study||99
5136316|NCT01390402|12634322|P1|NOT COMPLETED|Overall Study||5
5136317|NCT01390402|12634322|P1|COMPLETED|Overall Study||1
5136318|NCT01390402|12634322|P1|STARTED|Overall Study||6
5136319|NCT01390389|12634328|P2|NOT COMPLETED|Overall Study||1
5136320|NCT01390389|12634329|P1|NOT COMPLETED|Overall Study||4
5136321|NCT01390389|12634328|P2|COMPLETED|Overall Study||8
5136322|NCT01390389|12634329|P1|COMPLETED|Overall Study||6
5136323|NCT01390389|12634328|P2|STARTED|Overall Study||9
5136324|NCT01390389|12634329|P1|STARTED|Overall Study||10
5136325|NCT01390298|12634339|P1|NOT COMPLETED|Overall Study||24
5136326|NCT01390298|12634339|P1|COMPLETED|Overall Study||31
5136327|NCT01390298|12634339|P1|STARTED|Overall Study||55
5136328|NCT01390272|12634345|P2|NOT COMPLETED|Overall Study||15
5136329|NCT01390272|12634346|P1|NOT COMPLETED|Overall Study||17
5136330|NCT01390272|12634345|P2|COMPLETED|Overall Study||178
5136331|NCT01390272|12634346|P1|COMPLETED|Overall Study||175
5136332|NCT01390272|12634345|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
5136333|NCT01390272|12634346|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
5136334|NCT01390272|12634345|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
5136335|NCT01390272|12634346|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
5136336|NCT01390272|12634345|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
5136337|NCT01390272|12634346|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
5136338|NCT01390272|12634345|P2|STARTED|Overall Study||193
5136339|NCT01390272|12634346|P1|STARTED|Overall Study||192
5136340|NCT01390259|12634376|P2|NOT COMPLETED|Overall Study||0
5136341|NCT01390259|12634377|P1|NOT COMPLETED|Overall Study||0
5136342|NCT01390259|12634376|P2|COMPLETED|Overall Study||6
5136343|NCT01390259|12634377|P1|COMPLETED|Overall Study||5
5136344|NCT01390259|12634376|P2|STARTED|Overall Study||6
5136345|NCT01390259|12634377|P1|STARTED|Overall Study||5
5136346|NCT01390246|12634388|P2|NOT COMPLETED|Overall Study||25
5136347|NCT01390246|12634389|P1|NOT COMPLETED|Overall Study||20
5136348|NCT01390246|12634388|P2|COMPLETED|Overall Study||10
5136349|NCT01390246|12634389|P1|COMPLETED|Overall Study||10
5136350|NCT01390246|12634388|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
5136351|NCT01390246|12634389|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
5136352|NCT01390246|12634388|P2|Visit 6: End of Treatment|Overall Study||15
5136353|NCT01390246|12634389|P1|Visit 6: End of Treatment|Overall Study||15
5136354|NCT01390246|12634388|P2|Visit 2: Quit Day|Overall Study||24
5136355|NCT01390246|12634389|P1|Visit 2: Quit Day|Overall Study||24
5136356|NCT01390246|12634388|P2|STARTED|Overall Study||35
5136357|NCT01390246|12634389|P1|STARTED|Overall Study||30
5136358|NCT01390233|12634404|P3|NOT COMPLETED|Overall Study||6
5136359|NCT01390233|12634405|P2|NOT COMPLETED|Overall Study||2
5136360|NCT01390233|12634406|P1|NOT COMPLETED|Overall Study||5
5136361|NCT01390233|12634404|P3|COMPLETED|Overall Study||30
5136362|NCT01390233|12634405|P2|COMPLETED|Overall Study||29
5136363|NCT01390233|12634406|P1|COMPLETED|Overall Study||30
5136364|NCT01390233|12634404|P3|STARTED|Overall Study||36
5136365|NCT01390233|12634405|P2|STARTED|Overall Study||31
5136366|NCT01390233|12634406|P1|STARTED|Overall Study||35
5136367|NCT01390220|12634414|P3|NOT COMPLETED|Comparative Phase||0
5136368|NCT01390220|12634415|P2|NOT COMPLETED|Comparative Phase||1
5136369|NCT01390220|12634416|P1|NOT COMPLETED|Comparative Phase||0
5136370|NCT01390220|12634414|P3|COMPLETED|Comparative Phase||67
5136371|NCT01390220|12634415|P2|COMPLETED|Comparative Phase||133
5136372|NCT01390220|12634416|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
5136373|NCT01390220|12634414|P3|STARTED|Comparative Phase||67
5136374|NCT01390220|12634415|P2|STARTED|Comparative Phase||134
5136375|NCT01390220|12634416|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
5136376|NCT01390220|12634414|P3|NOT COMPLETED|Test Dose Phase||0
5136377|NCT01390220|12634415|P2|NOT COMPLETED|Test Dose Phase||0
5136378|NCT01390220|12634416|P1|NOT COMPLETED|Test Dose Phase||91
5136379|NCT01390220|12634414|P3|COMPLETED|Test Dose Phase||0
5136380|NCT01390220|12634415|P2|COMPLETED|Test Dose Phase||0
5136381|NCT01390220|12634416|P1|COMPLETED|Test Dose Phase||201
5136382|NCT01390220|12634414|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
5136383|NCT01390220|12634415|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
5136384|NCT01390220|12634416|P1|STARTED|Test Dose Phase||292
5136385|NCT01390181|12634431|P1|NOT COMPLETED|Overall Study||4
5136386|NCT01390181|12634431|P1|COMPLETED|Overall Study||0
5136387|NCT01390181|12634431|P1|STARTED|Overall Study||4
5136388|NCT01390064|12634437|P2|NOT COMPLETED|Overall Study||0
5136389|NCT01390064|12634438|P1|NOT COMPLETED|Overall Study||0
5136390|NCT01390064|12634437|P2|COMPLETED|Overall Study||3
5136391|NCT01390064|12634438|P1|COMPLETED|Overall Study||3
5136392|NCT01390064|12634437|P2|STARTED|Overall Study||3
5136393|NCT01390064|12634438|P1|STARTED|Overall Study||3
5136394|NCT01390038|12634444|P1|NOT COMPLETED|Overall Study||8
5136395|NCT01390038|12634444|P1|COMPLETED|Overall Study||149
5136396|NCT01390038|12634444|P1|STARTED|Overall Study||157
5136397|NCT01389973|12634454|P1|NOT COMPLETED|Overall Study||20
5136398|NCT01389973|12634454|P1|COMPLETED|Overall Study||0
5136399|NCT01389973|12634454|P1|STARTED|Overall Study||20
5136400|NCT01389882|12634464|P2|NOT COMPLETED|Overall Study||4
5136401|NCT01389882|12634465|P1|NOT COMPLETED|Overall Study||1
5136402|NCT01389882|12634464|P2|COMPLETED|Overall Study||7
5136403|NCT01389882|12634465|P1|COMPLETED|Overall Study||12
5136404|NCT01389882|12634464|P2|STARTED|Overall Study||11
5136405|NCT01389882|12634465|P1|STARTED|Overall Study||13
5136406|NCT01389856|12634495|P2|NOT COMPLETED|Overall Study||0
5136407|NCT01389856|12634496|P1|NOT COMPLETED|Overall Study||0
5136408|NCT01389856|12634495|P2|COMPLETED|Overall Study||8
5136409|NCT01389856|12634496|P1|COMPLETED|Overall Study||13
5136410|NCT01389856|12634495|P2|STARTED|Overall Study|Randomized and treated.|8
5136411|NCT01389856|12634496|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
5136412|NCT01389817|12634553|P2|NOT COMPLETED|Overall Study||0
5136413|NCT01389817|12634554|P1|NOT COMPLETED|Overall Study||4
5136414|NCT01389817|12634553|P2|COMPLETED|Overall Study||0
5136415|NCT01389817|12634554|P1|COMPLETED|Overall Study||0
5136416|NCT01389817|12634553|P2|STARTED|Overall Study||0
5136417|NCT01389817|12634554|P1|STARTED|Overall Study||4
5136418|NCT01389765|12634560|P2|NOT COMPLETED|Second Intervention (Day 1)||0
5136419|NCT01389765|12634561|P1|NOT COMPLETED|Second Intervention (Day 1)||0
5136420|NCT01389765|12634560|P2|COMPLETED|Second Intervention (Day 1)||12
5136421|NCT01389765|12634561|P1|COMPLETED|Second Intervention (Day 1)||12
5136422|NCT01389765|12634560|P2|STARTED|Second Intervention (Day 1)||12
5136423|NCT01389765|12634561|P1|STARTED|Second Intervention (Day 1)||12
5136424|NCT01389765|12634560|P2|NOT COMPLETED|Washout Period (7 Days)||0
5136425|NCT01389765|12634561|P1|NOT COMPLETED|Washout Period (7 Days)||0
5136426|NCT01389765|12634560|P2|COMPLETED|Washout Period (7 Days)||12
5136427|NCT01389765|12634561|P1|COMPLETED|Washout Period (7 Days)||12
5136428|NCT01389765|12634560|P2|STARTED|Washout Period (7 Days)||12
5136429|NCT01389765|12634561|P1|STARTED|Washout Period (7 Days)||12
5136430|NCT01389765|12634560|P2|NOT COMPLETED|First Intervention (Day 1)||0
5136431|NCT01389765|12634561|P1|NOT COMPLETED|First Intervention (Day 1)||0
5136432|NCT01389765|12634560|P2|COMPLETED|First Intervention (Day 1)||12
5136433|NCT01389765|12634561|P1|COMPLETED|First Intervention (Day 1)||12
5136434|NCT01389765|12634560|P2|STARTED|First Intervention (Day 1)||12
5136435|NCT01389765|12634561|P1|STARTED|First Intervention (Day 1)||12
5136436|NCT01389752|12634571|P2|NOT COMPLETED|Study Period 2||0
5136437|NCT01389752|12634572|P1|NOT COMPLETED|Study Period 2||1
5136438|NCT01389752|12634571|P2|COMPLETED|Study Period 2||9
5136439|NCT01389752|12634572|P1|COMPLETED|Study Period 2||10
5136440|NCT01389752|12634571|P2|STARTED|Study Period 2||9
5136441|NCT01389752|12634572|P1|STARTED|Study Period 2||11
5136442|NCT01389752|12634571|P2|NOT COMPLETED|Study Period 1||2
5136443|NCT01389752|12634572|P1|NOT COMPLETED|Study Period 1||0
5136444|NCT01389752|12634571|P2|COMPLETED|Study Period 1||9
5136445|NCT01389752|12634572|P1|COMPLETED|Study Period 1||11
5136446|NCT01389752|12634571|P2|STARTED|Study Period 1||11
5136447|NCT01389752|12634572|P1|STARTED|Study Period 1||11
5136448|NCT01389596|12634585|P3|NOT COMPLETED|Overall Study||10
5136449|NCT01389596|12634586|P2|NOT COMPLETED|Overall Study||16
5136450|NCT01389596|12634587|P1|NOT COMPLETED|Overall Study||10
5136451|NCT01389596|12634585|P3|COMPLETED|Overall Study||84
5136452|NCT01389596|12634586|P2|COMPLETED|Overall Study||81
5136453|NCT01389596|12634587|P1|COMPLETED|Overall Study||94
5136454|NCT01389596|12634585|P3|STARTED|Overall Study||94
5136455|NCT01389596|12634586|P2|STARTED|Overall Study||97
5136456|NCT01389596|12634587|P1|STARTED|Overall Study||104
5136457|NCT01389323|12634646|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
5136458|NCT01389323|12634646|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
5136459|NCT01389323|12634646|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
5136460|NCT01389323|12634646|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
5136461|NCT01389323|12634646|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
5136462|NCT01389323|12634646|P1|STARTED|Treatment Period (up to 48 Weeks)||246
5136463|NCT01389284|12634669|P3|NOT COMPLETED|Overall Study||0
5136464|NCT01389284|12634670|P2|NOT COMPLETED|Overall Study||0
5136465|NCT01389284|12634671|P1|NOT COMPLETED|Overall Study||0
5136466|NCT01389284|12634669|P3|COMPLETED|Overall Study||60
5136467|NCT01389284|12634670|P2|COMPLETED|Overall Study||120
5136468|NCT01389284|12634671|P1|COMPLETED|Overall Study||120
5136469|NCT01389284|12634669|P3|STARTED|Overall Study||60
5136470|NCT01389284|12634670|P2|STARTED|Overall Study||120
5136471|NCT01389284|12634671|P1|STARTED|Overall Study||120
5136472|NCT01389258|12634703|P1|NOT COMPLETED|Overall Study||5
5136473|NCT01389258|12634703|P1|COMPLETED|Overall Study||40
5136474|NCT01389258|12634703|P1|STARTED|Overall Study||45
5136475|NCT01389245|12634713|P1|NOT COMPLETED|Overall Study||15
5136476|NCT01389245|12634713|P1|COMPLETED|Overall Study||27
5136477|NCT01389245|12634713|P1|STARTED|Overall Study||42
5136478|NCT01389128|12634723|P2|NOT COMPLETED|Overall Study||6
5136479|NCT01389128|12634724|P1|NOT COMPLETED|Overall Study||5
5136480|NCT01389128|12634723|P2|COMPLETED|Overall Study||34
5136481|NCT01389128|12634724|P1|COMPLETED|Overall Study||35
5136482|NCT01389128|12634723|P2|STARTED|Overall Study||40
5136483|NCT01389128|12634724|P1|STARTED|Overall Study||40
5136484|NCT01389102|12634748|P6|NOT COMPLETED|Overall Study||8
5136485|NCT01389102|12634749|P5|NOT COMPLETED|Overall Study||13
5136486|NCT01389102|12634750|P4|NOT COMPLETED|Overall Study||7
5136487|NCT01389102|12634751|P3|NOT COMPLETED|Overall Study||19
5136488|NCT01389102|12634752|P2|NOT COMPLETED|Overall Study||12
5136489|NCT01389102|12634753|P1|NOT COMPLETED|Overall Study||18
5136490|NCT01389102|12634748|P6|COMPLETED|Overall Study||68
5136491|NCT01389102|12634749|P5|COMPLETED|Overall Study||61
5136492|NCT01389102|12634750|P4|COMPLETED|Overall Study||69
5136493|NCT01389102|12634751|P3|COMPLETED|Overall Study||58
5136494|NCT01389102|12634752|P2|COMPLETED|Overall Study||64
5136495|NCT01389102|12634753|P1|COMPLETED|Overall Study||57
5136496|NCT01389102|12634748|P6|STARTED|Overall Study||76
5136497|NCT01389102|12634749|P5|STARTED|Overall Study||74
5136498|NCT01389102|12634750|P4|STARTED|Overall Study||76
5136499|NCT01389102|12634751|P3|STARTED|Overall Study||77
5136500|NCT01389102|12634752|P2|STARTED|Overall Study||76
5136501|NCT01389102|12634753|P1|STARTED|Overall Study||75
5136502|NCT01389076|12634773|P1|NOT COMPLETED|Overall Study||0
5136503|NCT01389076|12634773|P1|COMPLETED|Overall Study||22
5136504|NCT01389076|12634773|P1|STARTED|Overall Study||22
5136505|NCT01388985|12634783|P2|NOT COMPLETED|Overall Study||38
5136506|NCT01388985|12634784|P1|NOT COMPLETED|Overall Study||49
5136507|NCT01388985|12634783|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
5136508|NCT01388985|12634784|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
5136509|NCT01388985|12634783|P2|Primary Vaccination Period|Overall Study||238
5136510|NCT01388985|12634784|P1|Primary Vaccination Period|Overall Study||231
5136511|NCT01388985|12634783|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
5136512|NCT01388985|12634784|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
5136513|NCT01388946|12634800|P2|NOT COMPLETED|Overall Study||3
5136514|NCT01388946|12634801|P1|NOT COMPLETED|Overall Study||6
5136515|NCT01388946|12634800|P2|COMPLETED|Overall Study||52
5136516|NCT01388946|12634801|P1|COMPLETED|Overall Study||49
5136517|NCT01388946|12634800|P2|STARTED|Overall Study||55
5136518|NCT01388946|12634801|P1|STARTED|Overall Study||55
5136519|NCT01388920|12634836|P3|NOT COMPLETED|Overall Study||0
5136520|NCT01388920|12634837|P2|NOT COMPLETED|Overall Study||0
5136521|NCT01388920|12634838|P1|NOT COMPLETED|Overall Study||0
5136522|NCT01388920|12634836|P3|COMPLETED|Overall Study||0
5136523|NCT01388920|12634837|P2|COMPLETED|Overall Study||1
5136524|NCT01388920|12634838|P1|COMPLETED|Overall Study||1
5136525|NCT01388920|12634836|P3|STARTED|Overall Study||0
5136526|NCT01388920|12634837|P2|STARTED|Overall Study||1
5136527|NCT01388920|12634838|P1|STARTED|Overall Study||1
5136528|NCT01388907|12634848|P2|NOT COMPLETED|Overall Study||0
5136529|NCT01388907|12634849|P1|NOT COMPLETED|Overall Study||2
5136530|NCT01388907|12634848|P2|COMPLETED|Overall Study||28
5136531|NCT01388907|12634849|P1|COMPLETED|Overall Study||31
5136532|NCT01388907|12634848|P2|STARTED|Overall Study||28
5136533|NCT01388907|12634849|P1|STARTED|Overall Study||33
5136534|NCT01388816|12634865|P4|NOT COMPLETED|Overall Study||0
5136535|NCT01388816|12634866|P3|NOT COMPLETED|Overall Study||3
5136536|NCT01388816|12634867|P2|NOT COMPLETED|Overall Study||4
5136537|NCT01388816|12634868|P1|NOT COMPLETED|Overall Study||2
5136538|NCT01388816|12634865|P4|COMPLETED|Overall Study||44
5136539|NCT01388816|12634866|P3|COMPLETED|Overall Study||41
5136540|NCT01388816|12634867|P2|COMPLETED|Overall Study||39
5136541|NCT01388816|12634868|P1|COMPLETED|Overall Study||43
5136542|NCT01388816|12634865|P4|STARTED|Overall Study||44
5136543|NCT01388816|12634866|P3|STARTED|Overall Study||44
5136544|NCT01388816|12634867|P2|STARTED|Overall Study||43
5136545|NCT01388816|12634868|P1|STARTED|Overall Study||45
5136546|NCT01388790|12634897|P1|NOT COMPLETED|Overall Study||8
5136547|NCT01388790|12634897|P1|COMPLETED|Overall Study||32
5136548|NCT01388790|12634897|P1|STARTED|Overall Study||40
5136549|NCT01388777|12634902|P1|NOT COMPLETED|Overall Study||0
5136550|NCT01388777|12634902|P1|COMPLETED|Overall Study||1
5136551|NCT01388777|12634902|P1|Cryoablation|Overall Study||1
5136552|NCT01388777|12634902|P1|STARTED|Overall Study||1
5136553|NCT01388647|12634908|P2|NOT COMPLETED|Overall Study||2
5136554|NCT01388647|12634909|P1|NOT COMPLETED|Overall Study||1
5136555|NCT01388647|12634908|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
5136556|NCT01388647|12634909|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
5136557|NCT01388647|12634908|P2|STARTED|Overall Study||6
5136558|NCT01388647|12634909|P1|STARTED|Overall Study||6
5136559|NCT01388543|12634922|P2|NOT COMPLETED|Day 14||4
5136560|NCT01388543|12634923|P1|NOT COMPLETED|Day 14||1
5136561|NCT01388543|12634922|P2|COMPLETED|Day 14||12
5136562|NCT01388543|12634923|P1|COMPLETED|Day 14||14
5136563|NCT01388543|12634922|P2|STARTED|Day 14||16
5136564|NCT01388543|12634923|P1|STARTED|Day 14||15
5136565|NCT01388543|12634922|P2|NOT COMPLETED|Day 7, Primary End Point||0
5136566|NCT01388543|12634923|P1|NOT COMPLETED|Day 7, Primary End Point||0
5136567|NCT01388543|12634922|P2|COMPLETED|Day 7, Primary End Point||16
5136568|NCT01388543|12634923|P1|COMPLETED|Day 7, Primary End Point||15
5136569|NCT01388543|12634922|P2|STARTED|Day 7, Primary End Point||16
5136570|NCT01388543|12634923|P1|STARTED|Day 7, Primary End Point||15
5136571|NCT01388530|12634929|P1|NOT COMPLETED|Overall Study||5
5136572|NCT01388530|12634929|P1|COMPLETED|Overall Study||20
5136573|NCT01388530|12634929|P1|STARTED|Overall Study||25
5136574|NCT01388491|12634938|P2|NOT COMPLETED|Overall Study||29
5136575|NCT01388491|12634939|P1|NOT COMPLETED|Overall Study||34
5136576|NCT01388491|12634938|P2|COMPLETED|Overall Study||114
5136577|NCT01388491|12634939|P1|COMPLETED|Overall Study||116
5136578|NCT01388491|12634938|P2|Per Protocol (PP) Population|Overall Study||121
5136579|NCT01388491|12634939|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
5136580|NCT01388491|12634938|P2|Intent-to-Treat (ITT) Population|Overall Study||136
5136581|NCT01388491|12634939|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
5136582|NCT01388491|12634938|P2|Safety Population|Overall Study||142
5136583|NCT01388491|12634939|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
5136584|NCT01388491|12634938|P2|STARTED|Overall Study||143
5136585|NCT01388491|12634939|P1|STARTED|Overall Study|number randomized|150
5136586|NCT01388361|12634974|P3|NOT COMPLETED|Overall Study||14
5136587|NCT01388361|12634975|P2|NOT COMPLETED|Overall Study||12
5136588|NCT01388361|12634976|P1|NOT COMPLETED|Overall Study||12
5136589|NCT01388361|12634974|P3|COMPLETED|Overall Study||75
5136590|NCT01388361|12634975|P2|COMPLETED|Overall Study||76
5136591|NCT01388361|12634976|P1|COMPLETED|Overall Study||224
5136592|NCT01388361|12634974|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
5136593|NCT01388361|12634975|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
5136594|NCT01388361|12634976|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
5136595|NCT01388361|12634974|P3|STARTED|Overall Study||89
5136596|NCT01388361|12634975|P2|STARTED|Overall Study||88
5136597|NCT01388361|12634976|P1|STARTED|Overall Study||236
5136598|NCT01388335|12634993|P1|NOT COMPLETED|Safety Extension||7
5136599|NCT01388335|12634993|P1|COMPLETED|Safety Extension||0
5136600|NCT01388335|12634993|P1|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
5136601|NCT01388335|12634993|P1|NOT COMPLETED|Period 2||3
5136602|NCT01388335|12634993|P1|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
5136603|NCT01388335|12634993|P1|Received at Least 1 Dose of Study Drug|Period 2||12
5136604|NCT01388335|12634993|P1|STARTED|Period 2||12
5136605|NCT01388335|12634993|P1|NOT COMPLETED|Period 1||1
5136606|NCT01388335|12634993|P1|COMPLETED|Period 1||12
5136607|NCT01388335|12634993|P1|Received at Least 1 Dose of Study Drug|Period 1||13
5136608|NCT01388335|12634993|P1|STARTED|Period 1||13
5136609|NCT01388166|12635020|P1|NOT COMPLETED|Overall Study||59
5136610|NCT01388166|12635020|P1|COMPLETED|Overall Study||1194
5136611|NCT01388166|12635020|P1|STARTED|Overall Study||1253
5136612|NCT01387815|12635028|P2|NOT COMPLETED|Overall Study||104
5136613|NCT01387815|12635029|P1|NOT COMPLETED|Overall Study||140
5136614|NCT01387815|12635028|P2|COMPLETED|Overall Study||189
5136615|NCT01387815|12635029|P1|COMPLETED|Overall Study||162
5136616|NCT01387815|12635028|P2|STARTED|Overall Study||293
5136617|NCT01387815|12635029|P1|STARTED|Overall Study||302
5136618|NCT01387789|12635323|P1|NOT COMPLETED|Overall Study||8
5136619|NCT01387789|12635323|P1|COMPLETED|Overall Study||63
5136620|NCT01387789|12635323|P1|STARTED|Overall Study||71
5136621|NCT01387737|12635337|P2|NOT COMPLETED|Overall Study||74
5136622|NCT01387737|12635338|P1|NOT COMPLETED|Overall Study||52
5136623|NCT01387737|12635337|P2|COMPLETED|Overall Study||641
5136624|NCT01387737|12635338|P1|COMPLETED|Overall Study||532
5136625|NCT01387737|12635337|P2|STARTED|Overall Study||715
5136626|NCT01387737|12635338|P1|STARTED|Overall Study||584
5136627|NCT01387672|12635350|P6|NOT COMPLETED|Overall Study||0
5136628|NCT01387672|12635351|P5|NOT COMPLETED|Overall Study||4
5136629|NCT01387672|12635352|P4|NOT COMPLETED|Overall Study||4
5136630|NCT01387672|12635353|P3|NOT COMPLETED|Overall Study||5
5136631|NCT01387672|12635354|P2|NOT COMPLETED|Overall Study||7
5136632|NCT01387672|12635355|P1|NOT COMPLETED|Overall Study||7
5136633|NCT01387672|12635350|P6|COMPLETED|Overall Study||37
5136634|NCT01387672|12635351|P5|COMPLETED|Overall Study||34
5136635|NCT01387672|12635352|P4|COMPLETED|Overall Study||35
5136636|NCT01387672|12635353|P3|COMPLETED|Overall Study||33
5136637|NCT01387672|12635354|P2|COMPLETED|Overall Study||31
5136638|NCT01387672|12635355|P1|COMPLETED|Overall Study||32
5136639|NCT01387672|12635350|P6|STARTED|Overall Study||37
5136640|NCT01387672|12635351|P5|STARTED|Overall Study||38
5136641|NCT01387672|12635352|P4|STARTED|Overall Study||39
5136642|NCT01387672|12635353|P3|STARTED|Overall Study||38
5136643|NCT01387672|12635354|P2|STARTED|Overall Study||38
5136644|NCT01387672|12635355|P1|STARTED|Overall Study||39
5136645|NCT01387607|12635372|P2|NOT COMPLETED|Overall Study||45
5136646|NCT01387607|12635373|P1|NOT COMPLETED|Overall Study||51
5136647|NCT01387607|12635372|P2|COMPLETED|Overall Study||125
5136648|NCT01387607|12635373|P1|COMPLETED|Overall Study||122
5136649|NCT01387607|12635372|P2|Received Treatment|Overall Study||164
5136650|NCT01387607|12635373|P1|Received Treatment|Overall Study||170
5136651|NCT01387607|12635372|P2|STARTED|Overall Study||170
5136652|NCT01387607|12635373|P1|STARTED|Overall Study||173
5136653|NCT01387594|12635427|P2|NOT COMPLETED|Overall Study||3
5136654|NCT01387594|12635428|P1|NOT COMPLETED|Overall Study||0
5136655|NCT01387594|12635427|P2|COMPLETED|Overall Study||36
5136656|NCT01387594|12635428|P1|COMPLETED|Overall Study||10
5136657|NCT01387594|12635427|P2|STARTED|Overall Study||39
5136658|NCT01387594|12635428|P1|STARTED|Overall Study||10
5136659|NCT01387581|12635443|P3|NOT COMPLETED|Overall Study||3
5136660|NCT01387581|12635444|P2|NOT COMPLETED|Overall Study||6
5136661|NCT01387581|12635445|P1|NOT COMPLETED|Overall Study||7
5136662|NCT01387581|12635443|P3|COMPLETED|Overall Study||9
5136663|NCT01387581|12635444|P2|COMPLETED|Overall Study||101
5136664|NCT01387581|12635445|P1|COMPLETED|Overall Study||101
5136665|NCT01387581|12635443|P3|STARTED|Overall Study||12
5136666|NCT01387581|12635444|P2|STARTED|Overall Study||107
5136667|NCT01387581|12635445|P1|STARTED|Overall Study||108
5136668|NCT01387542|12635456|P1|NOT COMPLETED|Overall Study||8
5136669|NCT01387542|12635456|P1|COMPLETED|Overall Study||32
5136670|NCT01387542|12635456|P1|Treated|Overall Study||38
5136671|NCT01387542|12635456|P1|STARTED|Overall Study||40
5136672|NCT01387516|12635467|P4|NOT COMPLETED|Overall Study||4
5136673|NCT01387516|12635468|P3|NOT COMPLETED|Overall Study||4
5136674|NCT01387516|12635469|P2|NOT COMPLETED|Overall Study||5
5136675|NCT01387516|12635470|P1|NOT COMPLETED|Overall Study||5
5136676|NCT01387516|12635467|P4|COMPLETED|Overall Study||65
5136677|NCT01387516|12635468|P3|COMPLETED|Overall Study||75
5136678|NCT01387516|12635469|P2|COMPLETED|Overall Study||63
5136679|NCT01387516|12635470|P1|COMPLETED|Overall Study||75
5136680|NCT01387516|12635467|P4|STARTED|Overall Study||69
5136681|NCT01387516|12635468|P3|STARTED|Overall Study||79
5136682|NCT01387516|12635469|P2|STARTED|Overall Study||68
5136683|NCT01387516|12635470|P1|STARTED|Overall Study||80
5136684|NCT01387464|12635494|P2|NOT COMPLETED|Overall Study||1
5136685|NCT01387464|12635495|P1|NOT COMPLETED|Overall Study||1
5136686|NCT01387464|12635494|P2|COMPLETED|Overall Study||29
5136687|NCT01387464|12635495|P1|COMPLETED|Overall Study||29
5136688|NCT01387464|12635494|P2|Per-Protocol Population|Overall Study||29
5136689|NCT01387464|12635495|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
5136690|NCT01387464|12635494|P2|Safety Population|Overall Study||29
5136691|NCT01387464|12635495|P1|Safety Population|Overall Study||30
5136692|NCT01387464|12635494|P2|STARTED|Overall Study||30
5136693|NCT01387464|12635495|P1|STARTED|Overall Study||30
5136694|NCT01387347|12635503|P2|NOT COMPLETED|Overall Study||1
5136695|NCT01387347|12635504|P1|NOT COMPLETED|Overall Study||2
5136696|NCT01387347|12635503|P2|COMPLETED|Overall Study||35
5136697|NCT01387347|12635504|P1|COMPLETED|Overall Study||34
5136698|NCT01387347|12635503|P2|STARTED|Overall Study||36
5136699|NCT01387347|12635504|P1|STARTED|Overall Study||36
5136700|NCT01387282|12635516|P2|NOT COMPLETED|Overall Study||47
5136701|NCT01387282|12635517|P1|NOT COMPLETED|Overall Study||97
5136702|NCT01387282|12635516|P2|COMPLETED|Overall Study||118
5136703|NCT01387282|12635517|P1|COMPLETED|Overall Study||233
5136704|NCT01387282|12635516|P2|Safety Population|Overall Study||161
5136705|NCT01387282|12635517|P1|Safety Population|Overall Study||330
5136706|NCT01387282|12635516|P2|MITT Population|Overall Study||136
5136707|NCT01387282|12635517|P1|MITT Population|Overall Study||268
5136708|NCT01387282|12635516|P2|ITT Population|Overall Study||165
5136709|NCT01387282|12635517|P1|ITT Population|Overall Study||330
5136710|NCT01387282|12635516|P2|STARTED|Overall Study||165
5136711|NCT01387282|12635517|P1|STARTED|Overall Study||330
5136712|NCT01387269|12635533|P2|NOT COMPLETED|Overall Study||40
5136713|NCT01387269|12635534|P1|NOT COMPLETED|Overall Study||92
5136714|NCT01387269|12635533|P2|COMPLETED|Overall Study||121
5136715|NCT01387269|12635534|P1|COMPLETED|Overall Study||231
5136716|NCT01387269|12635533|P2|Safety Population|Overall Study||161
5136717|NCT01387269|12635534|P1|Safety Population|Overall Study||320
5136718|NCT01387269|12635533|P2|MITT Population|Overall Study||141
5136719|NCT01387269|12635534|P1|MITT Population|Overall Study||284
5136720|NCT01387269|12635533|P2|ITT Population|Overall Study||161
5136721|NCT01387269|12635534|P1|ITT Population|Overall Study||323
5136722|NCT01387269|12635533|P2|STARTED|Overall Study||161
5136723|NCT01387269|12635534|P1|STARTED|Overall Study||323
5136724|NCT01387230|12635551|P3|NOT COMPLETED|Overall Study||13
5136725|NCT01387230|12635552|P2|NOT COMPLETED|Overall Study||7
5136726|NCT01387230|12635553|P1|NOT COMPLETED|Overall Study||18
5136727|NCT01387230|12635551|P3|COMPLETED|Overall Study||56
5136728|NCT01387230|12635552|P2|COMPLETED|Overall Study||62
5136729|NCT01387230|12635553|P1|COMPLETED|Overall Study||50
5136730|NCT01387230|12635551|P3|STARTED|Overall Study||69
5136731|NCT01387230|12635552|P2|STARTED|Overall Study||69
5136732|NCT01387230|12635553|P1|STARTED|Overall Study||68
5136733|NCT01387178|12635569|P2|NOT COMPLETED|Overall Study||0
5136734|NCT01387178|12635570|P1|NOT COMPLETED|Overall Study||0
5136735|NCT01387178|12635569|P2|COMPLETED|Overall Study||10641
5136736|NCT01387178|12635570|P1|COMPLETED|Overall Study||11582
5136737|NCT01387178|12635569|P2|STARTED|Overall Study||10641
5136738|NCT01387178|12635570|P1|STARTED|Overall Study||11582
5136739|NCT01387139|12635582|P2|NOT COMPLETED|Overall Study||0
5136740|NCT01387139|12635583|P1|NOT COMPLETED|Overall Study||0
5136741|NCT01387139|12635582|P2|COMPLETED|Overall Study||84
5136742|NCT01387139|12635583|P1|COMPLETED|Overall Study||99
5136743|NCT01387139|12635582|P2|STARTED|Overall Study||84
5136744|NCT01387139|12635583|P1|STARTED|Overall Study||99
5136745|NCT01387074|12635599|P1|NOT COMPLETED|Overall Study||8
5136746|NCT01387074|12635599|P1|COMPLETED|Overall Study||100
5136747|NCT01387074|12635599|P1|STARTED|Overall Study||108
5136748|NCT01387022|12635612|P2|NOT COMPLETED|Overall Study||4
5136749|NCT01387022|12635613|P1|NOT COMPLETED|Overall Study||1
5136750|NCT01387022|12635612|P2|COMPLETED|Overall Study||26
5136751|NCT01387022|12635613|P1|COMPLETED|Overall Study||28
5136752|NCT01387022|12635612|P2|STARTED|Overall Study||30
5136753|NCT01387022|12635613|P1|STARTED|Overall Study||29
5136754|NCT01386983|12635631|P2|NOT COMPLETED|Overall Study||0
5136755|NCT01386983|12635632|P1|NOT COMPLETED|Overall Study||0
5136756|NCT01386983|12635631|P2|COMPLETED|Overall Study||68
5136757|NCT01386983|12635632|P1|COMPLETED|Overall Study||264
5136758|NCT01386983|12635631|P2|STARTED|Overall Study||68
5136759|NCT01386983|12635632|P1|STARTED|Overall Study||264
5136760|NCT01386970|12635642|P2|NOT COMPLETED|Overall Study||2
5136761|NCT01386970|12635643|P1|NOT COMPLETED|Overall Study||4
5136762|NCT01386970|12635642|P2|COMPLETED|Overall Study||21
5136763|NCT01386970|12635643|P1|COMPLETED|Overall Study||16
5136764|NCT01386970|12635642|P2|STARTED|Overall Study||23
5136765|NCT01386970|12635643|P1|STARTED|Overall Study||20
5136766|NCT01386944|12635651|P1|NOT COMPLETED|Overall Study||56
5136767|NCT01386944|12635651|P1|COMPLETED|Overall Study||46
5136768|NCT01386944|12635651|P1|STARTED|Overall Study||102
5136769|NCT01386788|12635661|P1|NOT COMPLETED|Overall Study||2
5136770|NCT01386788|12635661|P1|COMPLETED|Overall Study||100
5136771|NCT01386788|12635661|P1|STARTED|Overall Study||102
5136772|NCT01386684|12635666|P1|NOT COMPLETED|Overall Study||293
5136773|NCT01386684|12635666|P1|COMPLETED|Overall Study||259
5136774|NCT01386684|12635666|P1|STARTED|Overall Study||552
5136775|NCT01386658|12635707|P2|NOT COMPLETED|Icatibant Exposure 3||0
5136776|NCT01386658|12635708|P1|NOT COMPLETED|Icatibant Exposure 3||0
5136777|NCT01386658|12635707|P2|COMPLETED|Icatibant Exposure 3||9
5136778|NCT01386658|12635708|P1|COMPLETED|Icatibant Exposure 3||0
5136779|NCT01386658|12635707|P2|STARTED|Icatibant Exposure 3||9
5136780|NCT01386658|12635708|P1|STARTED|Icatibant Exposure 3||0
5136781|NCT01386658|12635707|P2|NOT COMPLETED|Icatibant Exposure 2||0
5136782|NCT01386658|12635708|P1|NOT COMPLETED|Icatibant Exposure 2||0
5136783|NCT01386658|12635707|P2|COMPLETED|Icatibant Exposure 2||9
5136784|NCT01386658|12635708|P1|COMPLETED|Icatibant Exposure 2||0
5136785|NCT01386658|12635707|P2|STARTED|Icatibant Exposure 2||9
5136786|NCT01386658|12635708|P1|STARTED|Icatibant Exposure 2||0
5136787|NCT01386658|12635707|P2|NOT COMPLETED|Initial Icatibant Exposure||12
5136788|NCT01386658|12635708|P1|NOT COMPLETED|Initial Icatibant Exposure||0
5136789|NCT01386658|12635707|P2|COMPLETED|Initial Icatibant Exposure||9
5136790|NCT01386658|12635708|P1|COMPLETED|Initial Icatibant Exposure||11
5136791|NCT01386658|12635707|P2|STARTED|Initial Icatibant Exposure||21
5136792|NCT01386658|12635708|P1|STARTED|Initial Icatibant Exposure||11
5136793|NCT01386632|12635773|P2|NOT COMPLETED|Overall Study||4
5136794|NCT01386632|12635774|P1|NOT COMPLETED|Overall Study||5
5136795|NCT01386632|12635773|P2|COMPLETED|Overall Study||21
5136796|NCT01386632|12635774|P1|COMPLETED|Overall Study||20
5136797|NCT01386632|12635773|P2|STARTED|Overall Study||25
5136798|NCT01386632|12635774|P1|STARTED|Overall Study||25
5136799|NCT01386606|12635786|P4|NOT COMPLETED|Overall Study||1
5136800|NCT01386606|12635787|P3|NOT COMPLETED|Overall Study||3
5136801|NCT01386606|12635788|P2|NOT COMPLETED|Overall Study||4
5136802|NCT01386606|12635789|P1|NOT COMPLETED|Overall Study||4
5136803|NCT01386606|12635786|P4|COMPLETED|Overall Study||13
5136804|NCT01386606|12635787|P3|COMPLETED|Overall Study||13
5136805|NCT01386606|12635788|P2|COMPLETED|Overall Study||10
5136806|NCT01386606|12635789|P1|COMPLETED|Overall Study||12
5136807|NCT01386606|12635786|P4|STARTED|Overall Study||14
5136808|NCT01386606|12635787|P3|STARTED|Overall Study||16
5136809|NCT01386606|12635788|P2|STARTED|Overall Study||14
5136810|NCT01386606|12635789|P1|STARTED|Overall Study||16
5136811|NCT01386554|12635820|P3|NOT COMPLETED|Overall Study||6
5136812|NCT01386554|12635821|P2|NOT COMPLETED|Overall Study||9
5136813|NCT01386554|12635822|P1|NOT COMPLETED|Overall Study||3
5136814|NCT01386554|12635820|P3|COMPLETED|Overall Study||15
5136815|NCT01386554|12635821|P2|COMPLETED|Overall Study||26
5136816|NCT01386554|12635822|P1|COMPLETED|Overall Study||1
5136817|NCT01386554|12635820|P3|STARTED|Overall Study||21
5136818|NCT01386554|12635821|P2|STARTED|Overall Study||35
5136819|NCT01386554|12635822|P1|STARTED|Overall Study||4
5136820|NCT01386528|12635833|P1|NOT COMPLETED|Overall Study||0
5136821|NCT01386528|12635833|P1|COMPLETED|Overall Study||13
5136822|NCT01386528|12635833|P1|STARTED|Overall Study||13
5136823|NCT01386125|12635845|P2|NOT COMPLETED|Overall Study||37
5136824|NCT01386125|12635846|P1|NOT COMPLETED|Overall Study||25
5136825|NCT01386125|12635845|P2|COMPLETED|Overall Study||336
5136826|NCT01386125|12635846|P1|COMPLETED|Overall Study||350
5136827|NCT01386125|12635845|P2|STARTED|Overall Study||373
5136828|NCT01386125|12635846|P1|STARTED|Overall Study||375
5136829|NCT01386008|12635854|P1|NOT COMPLETED|Overall Study||20
5136830|NCT01386008|12635854|P1|COMPLETED|Overall Study||0
5136831|NCT01386008|12635854|P1|STARTED|Overall Study||20
5136832|NCT01385995|12635863|P2|NOT COMPLETED|Period 2, 2 Months||0
5136833|NCT01385995|12635864|P1|NOT COMPLETED|Period 2, 2 Months||0
5136834|NCT01385995|12635863|P2|COMPLETED|Period 2, 2 Months||25
5136835|NCT01385995|12635864|P1|COMPLETED|Period 2, 2 Months||24
5136836|NCT01385995|12635863|P2|STARTED|Period 2, 2 Months||25
5136837|NCT01385995|12635864|P1|STARTED|Period 2, 2 Months||24
5136838|NCT01385995|12635863|P2|NOT COMPLETED|Washout Period, 1 Month||0
5136839|NCT01385995|12635864|P1|NOT COMPLETED|Washout Period, 1 Month||0
5136840|NCT01385995|12635863|P2|COMPLETED|Washout Period, 1 Month||25
5136841|NCT01385995|12635864|P1|COMPLETED|Washout Period, 1 Month||24
5136842|NCT01385995|12635863|P2|STARTED|Washout Period, 1 Month||25
5136843|NCT01385995|12635864|P1|STARTED|Washout Period, 1 Month||24
5136844|NCT01385995|12635863|P2|NOT COMPLETED|Period 1, 2 Months||0
5136845|NCT01385995|12635864|P1|NOT COMPLETED|Period 1, 2 Months||1
5136846|NCT01385995|12635863|P2|COMPLETED|Period 1, 2 Months||25
5136847|NCT01385995|12635864|P1|COMPLETED|Period 1, 2 Months||24
5136848|NCT01385995|12635863|P2|STARTED|Period 1, 2 Months||25
5136849|NCT01385995|12635864|P1|STARTED|Period 1, 2 Months||25
5136850|NCT01385748|12635881|P3|NOT COMPLETED|Overall Study||13
5136851|NCT01385748|12635882|P2|NOT COMPLETED|Overall Study||14
5136852|NCT01385748|12635883|P1|NOT COMPLETED|Overall Study||15
5136853|NCT01385748|12635881|P3|COMPLETED|Overall Study||49
5136854|NCT01385748|12635882|P2|COMPLETED|Overall Study||51
5136855|NCT01385748|12635883|P1|COMPLETED|Overall Study||41
5136856|NCT01385748|12635881|P3|STARTED|Overall Study||62
5136857|NCT01385748|12635882|P2|STARTED|Overall Study||65
5136858|NCT01385748|12635883|P1|STARTED|Overall Study||56
5136859|NCT01385696|12635928|P2|NOT COMPLETED|Overall Study||0
5136860|NCT01385696|12635929|P1|NOT COMPLETED|Overall Study||0
5136861|NCT01385696|12635928|P2|COMPLETED|Overall Study||64
5136862|NCT01385696|12635929|P1|COMPLETED|Overall Study||66
5136863|NCT01385696|12635928|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
5136864|NCT01385696|12635929|P1|STARTED|Overall Study||66
5136865|NCT01385644|12635940|P2|NOT COMPLETED|Overall Study||0
5136866|NCT01385644|12635941|P1|NOT COMPLETED|Overall Study||0
5136867|NCT01385644|12635940|P2|COMPLETED|Overall Study||4
5136868|NCT01385644|12635941|P1|COMPLETED|Overall Study||4
5136869|NCT01385644|12635940|P2|STARTED|Overall Study||4
5136870|NCT01385644|12635941|P1|STARTED|Overall Study||4
5136871|NCT01385579|12635955|P2|NOT COMPLETED|Overall Study||0
5136872|NCT01385579|12635956|P1|NOT COMPLETED|Overall Study||0
5136873|NCT01385579|12635955|P2|COMPLETED|Overall Study||104
5136874|NCT01385579|12635956|P1|COMPLETED|Overall Study||98
5136875|NCT01385579|12635955|P2|STARTED|Overall Study||104
5136876|NCT01385579|12635956|P1|STARTED|Overall Study||98
5136877|NCT01385566|12635968|P6|NOT COMPLETED|Overall Study||0
5136878|NCT01385566|12635969|P5|NOT COMPLETED|Overall Study||0
5136879|NCT01385566|12635970|P4|NOT COMPLETED|Overall Study||1
5136880|NCT01385566|12635971|P3|NOT COMPLETED|Overall Study||0
5136881|NCT01385566|12635972|P2|NOT COMPLETED|Overall Study||0
5136882|NCT01385566|12635973|P1|NOT COMPLETED|Overall Study||1
5136883|NCT01385566|12635968|P6|COMPLETED|Overall Study||34
5136884|NCT01385566|12635969|P5|COMPLETED|Overall Study||34
5136885|NCT01385566|12635970|P4|COMPLETED|Overall Study||34
5136886|NCT01385566|12635971|P3|COMPLETED|Overall Study||34
5136887|NCT01385566|12635972|P2|COMPLETED|Overall Study||34
5136888|NCT01385566|12635973|P1|COMPLETED|Overall Study||51
5136889|NCT01385566|12635968|P6|STARTED|Overall Study||34
5136890|NCT01385566|12635969|P5|STARTED|Overall Study||34
5136891|NCT01385566|12635970|P4|STARTED|Overall Study||35
5136892|NCT01385566|12635971|P3|STARTED|Overall Study||34
5136893|NCT01385566|12635972|P2|STARTED|Overall Study||34
5136894|NCT01385566|12635973|P1|STARTED|Overall Study||52
5136895|NCT01385371|12636027|P2|NOT COMPLETED|Overall Study||97
5136896|NCT01385371|12636028|P1|NOT COMPLETED|Overall Study||149
5136897|NCT01385371|12636027|P2|COMPLETED|Overall Study||652
5136898|NCT01385371|12636028|P1|COMPLETED|Overall Study||603
5136899|NCT01385371|12636027|P2|STARTED|Overall Study||749
5136900|NCT01385371|12636028|P1|STARTED|Overall Study||752
5136901|NCT01385306|12636048|P1|NOT COMPLETED|Overall Study||0
5136902|NCT01385306|12636048|P1|COMPLETED|Overall Study||6
5136903|NCT01385306|12636048|P1|STARTED|Overall Study||6
5136904|NCT01385293|12636056|P1|NOT COMPLETED|Overall Study||0
5136905|NCT01385293|12636056|P1|COMPLETED|Overall Study||30
5136906|NCT01385293|12636056|P1|STARTED|Overall Study||30
5136907|NCT01385280|12636066|P1|NOT COMPLETED|Overall Study||0
5136908|NCT01385280|12636066|P1|COMPLETED|Overall Study||13
5136909|NCT01385280|12636066|P1|STARTED|Overall Study||13
5136910|NCT01385202|12636076|P1|NOT COMPLETED|Overall Study||18
5136911|NCT01385202|12636076|P1|COMPLETED|Overall Study||154
5136912|NCT01385202|12636076|P1|Undergoing Ablation|Overall Study||160
5136913|NCT01385202|12636076|P1|Study Catheter Inserted|Overall Study||161
5136914|NCT01385202|12636076|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
5136915|NCT01385189|12636088|P5|NOT COMPLETED|Overall Study||2
5136916|NCT01385189|12636089|P4|NOT COMPLETED|Overall Study||1
5136917|NCT01385189|12636090|P3|NOT COMPLETED|Overall Study||0
5136918|NCT01385189|12636091|P2|NOT COMPLETED|Overall Study||1
5136919|NCT01385189|12636092|P1|NOT COMPLETED|Overall Study||1
5136920|NCT01385189|12636088|P5|COMPLETED|Overall Study||6
5136921|NCT01385189|12636089|P4|COMPLETED|Overall Study||3
5136922|NCT01385189|12636090|P3|COMPLETED|Overall Study||4
5136923|NCT01385189|12636091|P2|COMPLETED|Overall Study||11
5136924|NCT01385189|12636092|P1|COMPLETED|Overall Study||11
5136925|NCT01385189|12636088|P5|STARTED|Overall Study||8
5136926|NCT01385189|12636089|P4|STARTED|Overall Study||4
5136927|NCT01385189|12636090|P3|STARTED|Overall Study||4
5136928|NCT01385189|12636091|P2|STARTED|Overall Study||12
5136929|NCT01385189|12636092|P1|STARTED|Overall Study||12
5136930|NCT01385176|12636113|P2|NOT COMPLETED|6-18 Month All VNS Active||3
5136931|NCT01385176|12636114|P1|NOT COMPLETED|6-18 Month All VNS Active||4
5136932|NCT01385176|12636113|P2|COMPLETED|6-18 Month All VNS Active||27
5136933|NCT01385176|12636114|P1|COMPLETED|6-18 Month All VNS Active||58
5136934|NCT01385176|12636113|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
5136935|NCT01385176|12636114|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
5136936|NCT01385176|12636113|P2|NOT COMPLETED|Randomization Phase||2
5136937|NCT01385176|12636114|P1|NOT COMPLETED|Randomization Phase||1
5136938|NCT01385176|12636113|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
5136939|NCT01385176|12636114|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
5136940|NCT01385176|12636113|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
5136941|NCT01385176|12636114|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
5136942|NCT01385137|12636130|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
5136943|NCT01385137|12636131|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
5136944|NCT01385137|12636130|P2|COMPLETED|Evaluable for Primary Endpoint||107
5136945|NCT01385137|12636131|P1|COMPLETED|Evaluable for Primary Endpoint||102
5136946|NCT01385137|12636130|P2|STARTED|Evaluable for Primary Endpoint||131
5136947|NCT01385137|12636131|P1|STARTED|Evaluable for Primary Endpoint||131
5136948|NCT01385137|12636130|P2|NOT COMPLETED|Evaluable at Baseline||4
5136949|NCT01385137|12636131|P1|NOT COMPLETED|Evaluable at Baseline||9
5136950|NCT01385137|12636130|P2|COMPLETED|Evaluable at Baseline||127
5136951|NCT01385137|12636131|P1|COMPLETED|Evaluable at Baseline||122
5136952|NCT01385137|12636130|P2|STARTED|Evaluable at Baseline||131
5136953|NCT01385137|12636131|P1|STARTED|Evaluable at Baseline||131
5136954|NCT01385098|12636145|P1|NOT COMPLETED|Overall Study||14
5136955|NCT01385098|12636145|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
5136956|NCT01385098|12636145|P1|STARTED|Overall Study||37
5136957|NCT01385033|12636153|P6|NOT COMPLETED|Part III||0
5136958|NCT01385033|12636154|P5|NOT COMPLETED|Part III||0
5136959|NCT01385033|12636155|P4|NOT COMPLETED|Part III||0
5136960|NCT01385033|12636156|P3|NOT COMPLETED|Part III||0
5136961|NCT01385033|12636157|P2|NOT COMPLETED|Part III||0
5136962|NCT01385033|12636158|P1|NOT COMPLETED|Part III||0
5136963|NCT01385033|12636153|P6|COMPLETED|Part III||0
5136964|NCT01385033|12636154|P5|COMPLETED|Part III||0
5136965|NCT01385033|12636155|P4|COMPLETED|Part III||0
5136966|NCT01385033|12636156|P3|COMPLETED|Part III||0
5136967|NCT01385033|12636157|P2|COMPLETED|Part III||0
5136968|NCT01385033|12636158|P1|COMPLETED|Part III||0
5136969|NCT01385033|12636153|P6|STARTED|Part III||0
5136970|NCT01385033|12636154|P5|STARTED|Part III||0
5136971|NCT01385033|12636155|P4|STARTED|Part III||0
5136972|NCT01385033|12636156|P3|STARTED|Part III||0
5136973|NCT01385033|12636157|P2|STARTED|Part III||0
5136974|NCT01385033|12636158|P1|STARTED|Part III||0
5136975|NCT01385033|12636153|P6|NOT COMPLETED|Part II||0
5136976|NCT01385033|12636154|P5|NOT COMPLETED|Part II||0
5136977|NCT01385033|12636155|P4|NOT COMPLETED|Part II||0
5136978|NCT01385033|12636156|P3|NOT COMPLETED|Part II||0
5136979|NCT01385033|12636157|P2|NOT COMPLETED|Part II||0
5136980|NCT01385033|12636158|P1|NOT COMPLETED|Part II||0
5136981|NCT01385033|12636153|P6|COMPLETED|Part II||0
5136982|NCT01385033|12636154|P5|COMPLETED|Part II||0
5136983|NCT01385033|12636155|P4|COMPLETED|Part II||0
5136984|NCT01385033|12636156|P3|COMPLETED|Part II||0
5136985|NCT01385033|12636157|P2|COMPLETED|Part II||0
5136986|NCT01385033|12636158|P1|COMPLETED|Part II||0
5136987|NCT01385033|12636153|P6|STARTED|Part II||0
5136988|NCT01385033|12636154|P5|STARTED|Part II||0
5136989|NCT01385033|12636155|P4|STARTED|Part II||0
5136990|NCT01385033|12636156|P3|STARTED|Part II||0
5136991|NCT01385033|12636157|P2|STARTED|Part II||0
5136992|NCT01385033|12636158|P1|STARTED|Part II||0
5136993|NCT01385033|12636153|P6|NOT COMPLETED|Part I||0
5136994|NCT01385033|12636154|P5|NOT COMPLETED|Part I||0
5136995|NCT01385033|12636155|P4|NOT COMPLETED|Part I||0
5136996|NCT01385033|12636156|P3|NOT COMPLETED|Part I||0
5136997|NCT01385033|12636157|P2|NOT COMPLETED|Part I||0
5136998|NCT01385033|12636158|P1|NOT COMPLETED|Part I||0
5136999|NCT01385033|12636153|P6|COMPLETED|Part I||0
5137000|NCT01385033|12636154|P5|COMPLETED|Part I||0
5137001|NCT01385033|12636155|P4|COMPLETED|Part I||0
5137002|NCT01385033|12636156|P3|COMPLETED|Part I||0
5137003|NCT01385033|12636157|P2|COMPLETED|Part I||14
5137004|NCT01385033|12636158|P1|COMPLETED|Part I||6
5137005|NCT01385033|12636153|P6|STARTED|Part I||0
5137006|NCT01385033|12636154|P5|STARTED|Part I||0
5137007|NCT01385033|12636155|P4|STARTED|Part I||0
5137008|NCT01385033|12636156|P3|STARTED|Part I||0
5137009|NCT01385033|12636157|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
5137010|NCT01385033|12636158|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
5137011|NCT01384877|12636167|P2|NOT COMPLETED|Treatment 2||2
5137012|NCT01384877|12636168|P1|NOT COMPLETED|Treatment 2||2
5137013|NCT01384877|12636167|P2|COMPLETED|Treatment 2||11
5137014|NCT01384877|12636168|P1|COMPLETED|Treatment 2||14
5137015|NCT01384877|12636167|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
5137016|NCT01384877|12636168|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
5137017|NCT01384877|12636167|P2|NOT COMPLETED|Treatment 1||0
5137018|NCT01384877|12636168|P1|NOT COMPLETED|Treatment 1||0
5137019|NCT01384877|12636167|P2|COMPLETED|Treatment 1||15
5137020|NCT01384877|12636168|P1|COMPLETED|Treatment 1||17
5137021|NCT01384877|12636167|P2|STARTED|Treatment 1||15
5137022|NCT01384877|12636168|P1|STARTED|Treatment 1||17
5137023|NCT01384760|12636194|P2|NOT COMPLETED|Overall Study||6
5137024|NCT01384760|12636195|P1|NOT COMPLETED|Overall Study||16
5137025|NCT01384760|12636194|P2|COMPLETED|Overall Study||37
5137026|NCT01384760|12636195|P1|COMPLETED|Overall Study||45
5137027|NCT01384760|12636194|P2|Randomized|Overall Study||43
5137028|NCT01384760|12636195|P1|Randomized|Overall Study||61
5137029|NCT01384760|12636194|P2|STARTED|Overall Study||43
5137030|NCT01384760|12636195|P1|STARTED|Overall Study||61
5137031|NCT01384734|12636208|P5|NOT COMPLETED|Overall Study||29
5137032|NCT01384734|12636209|P4|NOT COMPLETED|Overall Study||28
5137033|NCT01384734|12636210|P3|NOT COMPLETED|Overall Study||23
5137034|NCT01384734|12636211|P2|NOT COMPLETED|Overall Study||24
5137035|NCT01384734|12636212|P1|NOT COMPLETED|Overall Study||17
5137036|NCT01384734|12636208|P5|COMPLETED|Overall Study||22
5137037|NCT01384734|12636209|P4|COMPLETED|Overall Study||22
5137038|NCT01384734|12636210|P3|COMPLETED|Overall Study||28
5137039|NCT01384734|12636211|P2|COMPLETED|Overall Study||25
5137040|NCT01384734|12636212|P1|COMPLETED|Overall Study||33
5137041|NCT01384734|12636208|P5|STARTED|Overall Study||51
5137042|NCT01384734|12636209|P4|STARTED|Overall Study||50
5137043|NCT01384734|12636210|P3|STARTED|Overall Study||51
5137044|NCT01384734|12636211|P2|STARTED|Overall Study||49
5137045|NCT01384734|12636212|P1|STARTED|Overall Study||50
5137046|NCT01384591|12636295|P3|NOT COMPLETED|Overall Study||0
5137047|NCT01384591|12636296|P2|NOT COMPLETED|Overall Study||0
5137048|NCT01384591|12636297|P1|NOT COMPLETED|Overall Study||0
5137049|NCT01384591|12636295|P3|COMPLETED|Overall Study||2
5137050|NCT01384591|12636296|P2|COMPLETED|Overall Study||2
5137051|NCT01384591|12636297|P1|COMPLETED|Overall Study||2
5137052|NCT01384591|12636295|P3|STARTED|Overall Study||2
5137053|NCT01384591|12636296|P2|STARTED|Overall Study||2
5137054|NCT01384591|12636297|P1|STARTED|Overall Study||2
5137055|NCT01384539|12636427|P2|NOT COMPLETED|Overall Study||7
5137056|NCT01384539|12636428|P1|NOT COMPLETED|Overall Study||6
5137057|NCT01384539|12636427|P2|COMPLETED|Overall Study||57
5137058|NCT01384539|12636428|P1|COMPLETED|Overall Study||58
5137059|NCT01384539|12636427|P2|STARTED|Overall Study||64
5137060|NCT01384539|12636428|P1|STARTED|Overall Study||64
5137061|NCT01384292|12636441|P3|NOT COMPLETED|Part B||0
5137062|NCT01384292|12636442|P2|NOT COMPLETED|Part B||0
5137063|NCT01384292|12636443|P1|NOT COMPLETED|Part B||1
5137064|NCT01384292|12636441|P3|COMPLETED|Part B||0
5137065|NCT01384292|12636442|P2|COMPLETED|Part B||6
5137066|NCT01384292|12636443|P1|COMPLETED|Part B||2
5137067|NCT01384292|12636441|P3|STARTED|Part B||0
5137068|NCT01384292|12636442|P2|STARTED|Part B||6
5137069|NCT01384292|12636443|P1|STARTED|Part B||3
5137070|NCT01384292|12636441|P3|NOT COMPLETED|Part A||0
5137071|NCT01384292|12636442|P2|NOT COMPLETED|Part A||0
5137072|NCT01384292|12636443|P1|NOT COMPLETED|Part A||0
5137073|NCT01384292|12636441|P3|COMPLETED|Part A||4
5137074|NCT01384292|12636442|P2|COMPLETED|Part A||5
5137075|NCT01384292|12636443|P1|COMPLETED|Part A||5
5137076|NCT01384292|12636441|P3|STARTED|Part A||4
5137077|NCT01384292|12636442|P2|STARTED|Part A||5
5137078|NCT01384292|12636443|P1|STARTED|Part A||5
5137079|NCT01384019|12636455|P2|NOT COMPLETED|Overall Study||6
5137080|NCT01384019|12636456|P1|NOT COMPLETED|Overall Study||10
5137081|NCT01384019|12636455|P2|COMPLETED|Overall Study||55
5137082|NCT01384019|12636456|P1|COMPLETED|Overall Study||55
5137083|NCT01384019|12636455|P2|STARTED|Overall Study||61
5137084|NCT01384019|12636456|P1|STARTED|Overall Study||65
5137085|NCT01383993|12636465|P3|NOT COMPLETED|Overall Study||1
5137086|NCT01383993|12636466|P2|NOT COMPLETED|Overall Study||1
5137087|NCT01383993|12636467|P1|NOT COMPLETED|Overall Study||3
5137088|NCT01383993|12636465|P3|COMPLETED|Overall Study||1
5137089|NCT01383993|12636466|P2|COMPLETED|Overall Study||3
5137090|NCT01383993|12636467|P1|COMPLETED|Overall Study||12
5137091|NCT01383993|12636465|P3|STARTED|Overall Study||2
5137092|NCT01383993|12636466|P2|STARTED|Overall Study||4
5137093|NCT01383993|12636467|P1|STARTED|Overall Study||15
5137094|NCT01383954|12636514|P1|NOT COMPLETED|Overall Study||14
5137095|NCT01383954|12636514|P1|COMPLETED|Overall Study||38
5137096|NCT01383954|12636514|P1|Safety Population: Received Treatment|Overall Study||48
5137097|NCT01383954|12636514|P1|STARTED|Overall Study||52
5137098|NCT01383928|12636522|P3|NOT COMPLETED|Overall Study||40
5137099|NCT01383928|12636523|P2|NOT COMPLETED|Overall Study||7
5137100|NCT01383928|12636524|P1|NOT COMPLETED|Overall Study||5
5137101|NCT01383928|12636522|P3|COMPLETED|Overall Study||10
5137102|NCT01383928|12636523|P2|COMPLETED|Overall Study||0
5137103|NCT01383928|12636524|P1|COMPLETED|Overall Study||2
5137104|NCT01383928|12636522|P3|STARTED|Overall Study||50
5137105|NCT01383928|12636523|P2|STARTED|Overall Study||7
5137106|NCT01383928|12636524|P1|STARTED|Overall Study||7
5137107|NCT01383759|12636568|P2|NOT COMPLETED|Overall Study||0
5137108|NCT01383759|12636569|P1|NOT COMPLETED|Overall Study||0
5137109|NCT01383759|12636568|P2|COMPLETED|Overall Study||1
5137110|NCT01383759|12636569|P1|COMPLETED|Overall Study||19
5137111|NCT01383759|12636568|P2|STARTED|Overall Study||1
5137112|NCT01383759|12636569|P1|STARTED|Overall Study||19
5137113|NCT01383720|12636583|P1|NOT COMPLETED|Overall Study||0
5137114|NCT01383720|12636583|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
5137115|NCT01383720|12636583|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
5137116|NCT01383720|12636583|P1|STARTED|Overall Study||11
5137117|NCT01383707|12636605|P1|NOT COMPLETED|Overall Study||72
5137118|NCT01383707|12636605|P1|COMPLETED|Overall Study||5
5137119|NCT01383707|12636605|P1|STARTED|Overall Study||77
5137120|NCT01383681|12636614|P1|NOT COMPLETED|Overall Study||46
5137121|NCT01383681|12636614|P1|COMPLETED|Overall Study||189
5137122|NCT01383681|12636614|P1|STARTED|Overall Study||235
5137123|NCT01383616|12636621|P2|NOT COMPLETED|Overall Study||23
5137124|NCT01383616|12636622|P1|NOT COMPLETED|Overall Study||17
5137125|NCT01383616|12636621|P2|COMPLETED|Overall Study||21
5137126|NCT01383616|12636622|P1|COMPLETED|Overall Study||23
5137127|NCT01383616|12636621|P2|STARTED|Overall Study||44
5137128|NCT01383616|12636622|P1|STARTED|Overall Study||40
5137129|NCT01383499|12636645|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
5137130|NCT01383499|12636646|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
5137131|NCT01383499|12636647|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
5137132|NCT01383499|12636648|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
5137133|NCT01383499|12636645|P4|COMPLETED|Period 3 (4 Weeks)||25
5137134|NCT01383499|12636646|P3|COMPLETED|Period 3 (4 Weeks)||25
5137135|NCT01383499|12636647|P2|COMPLETED|Period 3 (4 Weeks)||24
5137136|NCT01383499|12636648|P1|COMPLETED|Period 3 (4 Weeks)||26
5137137|NCT01383499|12636645|P4|STARTED|Period 3 (4 Weeks)||25
5137138|NCT01383499|12636646|P3|STARTED|Period 3 (4 Weeks)||25
5137139|NCT01383499|12636647|P2|STARTED|Period 3 (4 Weeks)||24
5137140|NCT01383499|12636648|P1|STARTED|Period 3 (4 Weeks)||26
5137141|NCT01383499|12636645|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
5137142|NCT01383499|12636646|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
5137143|NCT01383499|12636647|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
5137144|NCT01383499|12636648|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
5137145|NCT01383499|12636645|P4|COMPLETED|Period 2 (4 Weeks)||25
5137146|NCT01383499|12636646|P3|COMPLETED|Period 2 (4 Weeks)||25
5137147|NCT01383499|12636647|P2|COMPLETED|Period 2 (4 Weeks)||24
5137148|NCT01383499|12636648|P1|COMPLETED|Period 2 (4 Weeks)||26
5137149|NCT01383499|12636645|P4|STARTED|Period 2 (4 Weeks)||25
5137150|NCT01383499|12636646|P3|STARTED|Period 2 (4 Weeks)||25
5137151|NCT01383499|12636647|P2|STARTED|Period 2 (4 Weeks)||24
5137152|NCT01383499|12636648|P1|STARTED|Period 2 (4 Weeks)||26
5137153|NCT01383499|12636645|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
5137154|NCT01383499|12636646|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
5137155|NCT01383499|12636647|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
5137156|NCT01383499|12636648|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
5137157|NCT01383499|12636645|P4|COMPLETED|Period 1 (4 Weeks)||25
5137158|NCT01383499|12636646|P3|COMPLETED|Period 1 (4 Weeks)||25
5137159|NCT01383499|12636647|P2|COMPLETED|Period 1 (4 Weeks)||24
5137160|NCT01383499|12636648|P1|COMPLETED|Period 1 (4 Weeks)||26
5137161|NCT01383499|12636645|P4|STARTED|Period 1 (4 Weeks)||25
5137162|NCT01383499|12636646|P3|STARTED|Period 1 (4 Weeks)||25
5137163|NCT01383499|12636647|P2|STARTED|Period 1 (4 Weeks)||24
5137164|NCT01383499|12636648|P1|STARTED|Period 1 (4 Weeks)||27
5137165|NCT01383486|12636698|P1|NOT COMPLETED|Overall Study||18
5137166|NCT01383486|12636698|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
5137167|NCT01383486|12636698|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
5137168|NCT01383486|12636698|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
5137169|NCT01383447|12636704|P1|NOT COMPLETED|Overall Study||2
5137170|NCT01383447|12636704|P1|COMPLETED|Overall Study||0
5137171|NCT01383447|12636704|P1|STARTED|Overall Study||2
5137172|NCT01383421|12636712|P1|NOT COMPLETED|Overall Study||346
5137173|NCT01383421|12636712|P1|COMPLETED|Overall Study||679
5137174|NCT01383421|12636712|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
5137175|NCT01383356|12636775|P2|NOT COMPLETED|Period 2||0
5137176|NCT01383356|12636776|P1|NOT COMPLETED|Period 2||0
5137177|NCT01383356|12636775|P2|COMPLETED|Period 2|Completed period 2.|23
5137178|NCT01383356|12636776|P1|COMPLETED|Period 2|Completed period 2.|21
5137179|NCT01383356|12636775|P2|STARTED|Period 2|Entered and treated.|23
5137180|NCT01383356|12636776|P1|STARTED|Period 2|Entered and treated.|21
5137181|NCT01383356|12636775|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
5137182|NCT01383356|12636776|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
5137183|NCT01383356|12636775|P2|COMPLETED|Washout Period (at Least 35 Days)||23
5137184|NCT01383356|12636776|P1|COMPLETED|Washout Period (at Least 35 Days)||21
5137185|NCT01383356|12636775|P2|STARTED|Washout Period (at Least 35 Days)||23
5137186|NCT01383356|12636776|P1|STARTED|Washout Period (at Least 35 Days)||21
5137187|NCT01383356|12636775|P2|NOT COMPLETED|Period 1||6
5137188|NCT01383356|12636776|P1|NOT COMPLETED|Period 1||8
5137189|NCT01383356|12636775|P2|COMPLETED|Period 1|Completed period 1.|23
5137190|NCT01383356|12636776|P1|COMPLETED|Period 1|Completed period 1.|21
5137191|NCT01383356|12636775|P2|STARTED|Period 1|Entered and treated.|29
5137192|NCT01383356|12636776|P1|STARTED|Period 1|Entered and treated.|29
5137193|NCT01383317|12636788|P2|NOT COMPLETED|Overall Study||2
5137194|NCT01383317|12636789|P1|NOT COMPLETED|Overall Study||3
5137195|NCT01383317|12636788|P2|COMPLETED|Overall Study||33
5137196|NCT01383317|12636789|P1|COMPLETED|Overall Study||26
5137197|NCT01383317|12636788|P2|STARTED|Overall Study||35
5137198|NCT01383317|12636789|P1|STARTED|Overall Study||29
5137199|NCT01383213|12636813|P2|NOT COMPLETED|Overall Study||0
5137200|NCT01383213|12636814|P1|NOT COMPLETED|Overall Study||0
5137201|NCT01383213|12636813|P2|COMPLETED|Overall Study||41
5137202|NCT01383213|12636814|P1|COMPLETED|Overall Study||40
5137203|NCT01383213|12636813|P2|STARTED|Overall Study||41
5137204|NCT01383213|12636814|P1|STARTED|Overall Study||40
5137205|NCT01383200|12636822|P2|NOT COMPLETED|Overall Study||0
5137206|NCT01383200|12636823|P1|NOT COMPLETED|Overall Study||0
5137207|NCT01383200|12636822|P2|COMPLETED|Overall Study||6
5137208|NCT01383200|12636823|P1|COMPLETED|Overall Study||5
5137209|NCT01383200|12636822|P2|STARTED|Overall Study||6
5137210|NCT01383200|12636823|P1|STARTED|Overall Study||5
5137211|NCT01383174|12636831|P2|NOT COMPLETED|6 Month Assessment||1
5137212|NCT01383174|12636832|P1|NOT COMPLETED|6 Month Assessment||5
5137213|NCT01383174|12636831|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
5137214|NCT01383174|12636832|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
5137215|NCT01383174|12636831|P2|STARTED|6 Month Assessment||74
5137216|NCT01383174|12636832|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
5137217|NCT01383174|12636831|P2|NOT COMPLETED|3 Month Assessment||1
5137218|NCT01383174|12636832|P1|NOT COMPLETED|3 Month Assessment||6
5137219|NCT01383174|12636831|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
5137220|NCT01383174|12636832|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
5137221|NCT01383174|12636831|P2|STARTED|3 Month Assessment||75
5137222|NCT01383174|12636832|P1|STARTED|3 Month Assessment||76
5137223|NCT01383174|12636831|P2|NOT COMPLETED|Baseline Assessment||0
5137224|NCT01383174|12636832|P1|NOT COMPLETED|Baseline Assessment||0
5137225|NCT01383174|12636831|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
5137226|NCT01383174|12636832|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
5137227|NCT01383174|12636831|P2|STARTED|Baseline Assessment||75
5137228|NCT01383174|12636832|P1|STARTED|Baseline Assessment||76
5137229|NCT01383161|12636858|P2|NOT COMPLETED|Overall Study||4
5137230|NCT01383161|12636859|P1|NOT COMPLETED|Overall Study||5
5137231|NCT01383161|12636858|P2|COMPLETED|Overall Study||17
5137232|NCT01383161|12636859|P1|COMPLETED|Overall Study||20
5137233|NCT01383161|12636858|P2|STARTED|Overall Study||21
5137234|NCT01383161|12636859|P1|STARTED|Overall Study||25
5137235|NCT01383096|12636878|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
5137236|NCT01383096|12636879|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
5137237|NCT01383096|12636880|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
5137238|NCT01383096|12636878|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137239|NCT01383096|12636879|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
5137240|NCT01383096|12636880|P1|COMPLETED|Fifth Intervention (8 Days)||11
5137241|NCT01383096|12636878|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137242|NCT01383096|12636879|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
5137243|NCT01383096|12636880|P1|STARTED|Fifth Intervention (8 Days)||13
5137244|NCT01383096|12636878|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
5137245|NCT01383096|12636879|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
5137246|NCT01383096|12636880|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
5137247|NCT01383096|12636878|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137248|NCT01383096|12636879|P2|COMPLETED|Fourth Intervention (8 Days)||12
5137249|NCT01383096|12636880|P1|COMPLETED|Fourth Intervention (8 Days)||13
5137250|NCT01383096|12636878|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137251|NCT01383096|12636879|P2|STARTED|Fourth Intervention (8 Days)||12
5137252|NCT01383096|12636880|P1|STARTED|Fourth Intervention (8 Days)||15
5137253|NCT01383096|12636878|P3|NOT COMPLETED|Third Intervention (8 Days)||0
5137254|NCT01383096|12636879|P2|NOT COMPLETED|Third Intervention (8 Days)||4
5137255|NCT01383096|12636880|P1|NOT COMPLETED|Third Intervention (8 Days)||4
5137256|NCT01383096|12636878|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137257|NCT01383096|12636879|P2|COMPLETED|Third Intervention (8 Days)||12
5137258|NCT01383096|12636880|P1|COMPLETED|Third Intervention (8 Days)||15
5137259|NCT01383096|12636878|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
5137260|NCT01383096|12636879|P2|STARTED|Third Intervention (8 Days)||16
5137261|NCT01383096|12636880|P1|STARTED|Third Intervention (8 Days)||19
5137262|NCT01383096|12636878|P3|NOT COMPLETED|Second Intervention (8 Days)||2
5137263|NCT01383096|12636879|P2|NOT COMPLETED|Second Intervention (8 Days)||1
5137264|NCT01383096|12636880|P1|NOT COMPLETED|Second Intervention (8 Days)||0
5137265|NCT01383096|12636878|P3|COMPLETED|Second Intervention (8 Days)||14
5137266|NCT01383096|12636879|P2|COMPLETED|Second Intervention (8 Days)||16
5137267|NCT01383096|12636880|P1|COMPLETED|Second Intervention (8 Days)||19
5137268|NCT01383096|12636878|P3|STARTED|Second Intervention (8 Days)||16
5137269|NCT01383096|12636879|P2|STARTED|Second Intervention (8 Days)||17
5137270|NCT01383096|12636880|P1|STARTED|Second Intervention (8 Days)||19
5137271|NCT01383096|12636878|P3|NOT COMPLETED|First Intervention (8 Days)||0
5137272|NCT01383096|12636879|P2|NOT COMPLETED|First Intervention (8 Days)||0
5137273|NCT01383096|12636880|P1|NOT COMPLETED|First Intervention (8 Days)||0
5137274|NCT01383096|12636878|P3|COMPLETED|First Intervention (8 Days)||16
5137275|NCT01383096|12636879|P2|COMPLETED|First Intervention (8 Days)||17
5137276|NCT01383096|12636880|P1|COMPLETED|First Intervention (8 Days)||19
5137277|NCT01383096|12636878|P3|STARTED|First Intervention (8 Days)||16
5137278|NCT01383096|12636879|P2|STARTED|First Intervention (8 Days)||17
5137279|NCT01383096|12636880|P1|STARTED|First Intervention (8 Days)||19
5137280|NCT01383018|12636926|P1|NOT COMPLETED|Overall Study||375
5137281|NCT01383018|12636926|P1|COMPLETED|Overall Study||1082
5137282|NCT01383018|12636926|P1|STARTED|Overall Study||1457
5137283|NCT01383005|12636968|P2|NOT COMPLETED|Overall Study||0
5137284|NCT01383005|12636969|P1|NOT COMPLETED|Overall Study||0
5137285|NCT01383005|12636968|P2|COMPLETED|Overall Study||60
5137286|NCT01383005|12636969|P1|COMPLETED|Overall Study||34
5137287|NCT01383005|12636968|P2|STARTED|Overall Study||60
5137288|NCT01383005|12636969|P1|STARTED|Overall Study||34
5137289|NCT01382940|12636988|P1|NOT COMPLETED|Overall Study||73
5137290|NCT01382940|12636988|P1|COMPLETED|Overall Study||278
5137291|NCT01382940|12636988|P1|Received Day 182 Infusion|Overall Study||278
5137292|NCT01382940|12636988|P1|Received Day 168 Infusion|Overall Study||290
5137293|NCT01382940|12636988|P1|Received Day 15 Infusions|Overall Study||341
5137294|NCT01382940|12636988|P1|Received Day 1 Infusion|Overall Study||351
5137295|NCT01382940|12636988|P1|STARTED|Overall Study||351
5137296|NCT01382901|12637000|P2|NOT COMPLETED|Overall Study||14
5137297|NCT01382901|12637001|P1|NOT COMPLETED|Overall Study||17
5137298|NCT01382901|12637000|P2|COMPLETED|Overall Study||7
5137299|NCT01382901|12637001|P1|COMPLETED|Overall Study||7
5137300|NCT01382901|12637000|P2|STARTED|Overall Study||21
5137301|NCT01382901|12637001|P1|STARTED|Overall Study||24
5137302|NCT01382719|12637011|P4|NOT COMPLETED|Overall Study||33
5137303|NCT01382719|12637012|P3|NOT COMPLETED|Overall Study||34
5137304|NCT01382719|12637013|P2|NOT COMPLETED|Overall Study||19
5137305|NCT01382719|12637014|P1|NOT COMPLETED|Overall Study||18
5137306|NCT01382719|12637011|P4|COMPLETED|Overall Study||66
5137307|NCT01382719|12637012|P3|COMPLETED|Overall Study||66
5137308|NCT01382719|12637013|P2|COMPLETED|Overall Study||81
5137309|NCT01382719|12637014|P1|COMPLETED|Overall Study||80
5137310|NCT01382719|12637011|P4|Subjects Not Dosed|Overall Study||1
5137311|NCT01382719|12637012|P3|Subjects Not Dosed|Overall Study||1
5137312|NCT01382719|12637013|P2|Subjects Not Dosed|Overall Study||0
5137313|NCT01382719|12637014|P1|Subjects Not Dosed|Overall Study||1
5137314|NCT01382719|12637011|P4|STARTED|Overall Study||99
5137315|NCT01382719|12637012|P3|STARTED|Overall Study||100
5137316|NCT01382719|12637013|P2|STARTED|Overall Study||100
5137317|NCT01382719|12637014|P1|STARTED|Overall Study||98
5137318|NCT01382602|12637050|P2|NOT COMPLETED|Overall Study||4
5137319|NCT01382602|12637051|P1|NOT COMPLETED|Overall Study||0
5137320|NCT01382602|12637050|P2|COMPLETED|Overall Study||46
5137321|NCT01382602|12637051|P1|COMPLETED|Overall Study||93
5137322|NCT01382602|12637050|P2|STARTED|Overall Study||50
5137323|NCT01382602|12637051|P1|STARTED|Overall Study||93
5137324|NCT01382446|12637059|P2|NOT COMPLETED|Overall Study||4
5137325|NCT01382446|12637060|P1|NOT COMPLETED|Overall Study||3
5137326|NCT01382446|12637059|P2|COMPLETED|Overall Study||29
5137327|NCT01382446|12637060|P1|COMPLETED|Overall Study||30
5137328|NCT01382446|12637059|P2|STARTED|Overall Study||33
5137329|NCT01382446|12637060|P1|STARTED|Overall Study||33
5137330|NCT01382303|12637068|P2|NOT COMPLETED|Overall Study||17
5137331|NCT01382303|12637069|P1|NOT COMPLETED|Overall Study||35
5137332|NCT01382303|12637068|P2|COMPLETED|Overall Study||70
5137333|NCT01382303|12637069|P1|COMPLETED|Overall Study||52
5137334|NCT01382303|12637068|P2|STARTED|Overall Study||87
5137335|NCT01382303|12637069|P1|STARTED|Overall Study||87
5137336|NCT01382251|12637087|P2|NOT COMPLETED|Overall Study||21
5137337|NCT01382251|12637088|P1|NOT COMPLETED|Overall Study||21
5137338|NCT01382251|12637087|P2|COMPLETED|Overall Study||102
5137339|NCT01382251|12637088|P1|COMPLETED|Overall Study||102
5137340|NCT01382251|12637087|P2|STARTED|Overall Study||123
5137341|NCT01382251|12637088|P1|STARTED|Overall Study||123
5137342|NCT01382225|12637101|P2|NOT COMPLETED|Overall Study||7
5137343|NCT01382225|12637102|P1|NOT COMPLETED|Overall Study||14
5137344|NCT01382225|12637101|P2|COMPLETED|Overall Study||722
5137345|NCT01382225|12637102|P1|COMPLETED|Overall Study||711
5137346|NCT01382225|12637101|P2|STARTED|Overall Study||729
5137347|NCT01382225|12637102|P1|STARTED|Overall Study||725
5137348|NCT01382212|12637124|P1|NOT COMPLETED|Overall Study||2
5137349|NCT01382212|12637124|P1|COMPLETED|Overall Study||11
5137350|NCT01382212|12637124|P1|STARTED|Overall Study||13
5137351|NCT01382186|12637150|P2|NOT COMPLETED|Overall Study||0
5137352|NCT01382186|12637151|P1|NOT COMPLETED|Overall Study||1
5137353|NCT01382186|12637150|P2|COMPLETED|Overall Study||819
5137354|NCT01382186|12637151|P1|COMPLETED|Overall Study||32
5137355|NCT01382186|12637150|P2|STARTED|Overall Study||819
5137356|NCT01382186|12637151|P1|STARTED|Overall Study||33
5137357|NCT01382108|12637167|P2|NOT COMPLETED|Overall Study||0
5137358|NCT01382108|12637168|P1|NOT COMPLETED|Overall Study||0
5137359|NCT01382108|12637167|P2|COMPLETED|Overall Study||19
5137360|NCT01382108|12637168|P1|COMPLETED|Overall Study||20
5137361|NCT01382108|12637167|P2|STARTED|Overall Study||19
5137362|NCT01382108|12637168|P1|STARTED|Overall Study||20
5137363|NCT01381952|12637178|P1|NOT COMPLETED|Overall Study||0
5137364|NCT01381952|12637178|P1|COMPLETED|Overall Study||20
5137365|NCT01381952|12637178|P1|Collected Dose and Image Information|Overall Study||20
5137366|NCT01381952|12637178|P1|STARTED|Overall Study||20
5137367|NCT01381926|12637187|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
5137368|NCT01381926|12637188|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
5137369|NCT01381926|12637187|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
5137370|NCT01381926|12637188|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
5137371|NCT01381926|12637187|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
5137372|NCT01381926|12637188|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
5137373|NCT01381926|12637187|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
5137374|NCT01381926|12637188|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
5137375|NCT01381926|12637187|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
5137376|NCT01381926|12637188|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
5137377|NCT01381926|12637187|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
5137378|NCT01381926|12637188|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
5137379|NCT01381900|12637201|P3|NOT COMPLETED|Overall Study||12
5137380|NCT01381900|12637202|P2|NOT COMPLETED|Overall Study||9
5137381|NCT01381900|12637203|P1|NOT COMPLETED|Overall Study||9
5137382|NCT01381900|12637201|P3|COMPLETED|Overall Study||215
5137383|NCT01381900|12637202|P2|COMPLETED|Overall Study||214
5137384|NCT01381900|12637203|P1|COMPLETED|Overall Study||217
5137385|NCT01381900|12637201|P3|STARTED|Overall Study||227
5137386|NCT01381900|12637202|P2|STARTED|Overall Study||223
5137387|NCT01381900|12637203|P1|STARTED|Overall Study||226
5137388|NCT01381874|12637226|P3|NOT COMPLETED|Overall Study||76
5137389|NCT01381874|12637227|P2|NOT COMPLETED|Overall Study||63
5137390|NCT01381874|12637228|P1|NOT COMPLETED|Overall Study||77
5137391|NCT01381874|12637226|P3|COMPLETED|Overall Study||30
5137392|NCT01381874|12637227|P2|COMPLETED|Overall Study||26
5137393|NCT01381874|12637228|P1|COMPLETED|Overall Study||25
5137394|NCT01381874|12637226|P3|Treated|Overall Study||104
5137395|NCT01381874|12637227|P2|Treated|Overall Study||87
5137396|NCT01381874|12637228|P1|Treated|Overall Study||102
5137397|NCT01381874|12637226|P3|STARTED|Overall Study||106
5137398|NCT01381874|12637227|P2|STARTED|Overall Study||89
5137399|NCT01381874|12637228|P1|STARTED|Overall Study||102
5137400|NCT01381861|12637254|P1|NOT COMPLETED|Overall Study||0
5137401|NCT01381861|12637254|P1|COMPLETED|Overall Study||23
5137402|NCT01381861|12637254|P1|STARTED|Overall Study||23
5137403|NCT01381679|12637265|P1|NOT COMPLETED|Overall Study||888
5137404|NCT01381679|12637265|P1|COMPLETED|Overall Study||794
5137405|NCT01381679|12637265|P1|STARTED|Overall Study||1682
5137406|NCT01381575|12637280|P3|NOT COMPLETED|Overall Study||20
5137407|NCT01381575|12637281|P2|NOT COMPLETED|Overall Study||39
5137408|NCT01381575|12637282|P1|NOT COMPLETED|Overall Study||26
5137409|NCT01381575|12637280|P3|COMPLETED|Overall Study||395
5137410|NCT01381575|12637281|P2|COMPLETED|Overall Study||443
5137411|NCT01381575|12637282|P1|COMPLETED|Overall Study||524
5137412|NCT01381575|12637280|P3|STARTED|Overall Study||415
5137413|NCT01381575|12637281|P2|STARTED|Overall Study||482
5137414|NCT01381575|12637282|P1|STARTED|Overall Study||550
5137415|NCT01381562|12637339|P3|NOT COMPLETED|Overall Study||0
5137416|NCT01381562|12637340|P2|NOT COMPLETED|Overall Study||1
5137417|NCT01381562|12637341|P1|NOT COMPLETED|Overall Study||0
5137418|NCT01381562|12637339|P3|COMPLETED|Overall Study||5
5137419|NCT01381562|12637340|P2|COMPLETED|Overall Study||3
5137420|NCT01381562|12637341|P1|COMPLETED|Overall Study||5
5137421|NCT01381562|12637339|P3|STARTED|Overall Study||5
5137422|NCT01381562|12637340|P2|STARTED|Overall Study||4
5137423|NCT01381562|12637341|P1|STARTED|Overall Study||5
5137424|NCT01381549|12637409|P3|NOT COMPLETED|Overall Study||1
5137425|NCT01381549|12637410|P2|NOT COMPLETED|Overall Study||0
5137426|NCT01381549|12637411|P1|NOT COMPLETED|Overall Study||0
5137427|NCT01381549|12637409|P3|COMPLETED|Overall Study||5
5137428|NCT01381549|12637410|P2|COMPLETED|Overall Study||8
5137429|NCT01381549|12637411|P1|COMPLETED|Overall Study||6
5137430|NCT01381549|12637409|P3|STARTED|Overall Study||6
5137431|NCT01381549|12637410|P2|STARTED|Overall Study||8
5137432|NCT01381549|12637411|P1|STARTED|Overall Study||6
5137433|NCT01381471|12637506|P1|NOT COMPLETED|Overall Study||0
5137434|NCT01381471|12637506|P1|COMPLETED|Overall Study||11060
5137435|NCT01381471|12637506|P1|STARTED|Overall Study||11060
5137436|NCT01381406|12637513|P2|NOT COMPLETED|Overall Study||0
5137437|NCT01381406|12637514|P1|NOT COMPLETED|Overall Study||0
5137438|NCT01381406|12637513|P2|COMPLETED|Overall Study||852
5137439|NCT01381406|12637514|P1|COMPLETED|Overall Study||2481
5137440|NCT01381406|12637513|P2|STARTED|Overall Study||852
5137441|NCT01381406|12637514|P1|STARTED|Overall Study||2481
5137442|NCT01381120|12637526|P2|NOT COMPLETED|Overall Study||9
5137443|NCT01381120|12637527|P1|NOT COMPLETED|Overall Study||11
5137444|NCT01381120|12637526|P2|COMPLETED|Overall Study||18
5137445|NCT01381120|12637527|P1|COMPLETED|Overall Study||39
5137446|NCT01381120|12637526|P2|STARTED|Overall Study||27
5137447|NCT01381120|12637527|P1|STARTED|Overall Study||50
5137448|NCT01381068|12637537|P2|NOT COMPLETED|Overall Study||0
5137449|NCT01381068|12637538|P1|NOT COMPLETED|Overall Study||1
5137450|NCT01381068|12637537|P2|COMPLETED|Overall Study||24
5137451|NCT01381068|12637538|P1|COMPLETED|Overall Study||24
5137452|NCT01381068|12637537|P2|STARTED|Overall Study||24
5137453|NCT01381068|12637538|P1|STARTED|Overall Study||25
5137454|NCT01381016|12637558|P2|NOT COMPLETED|Overall Study||6
5137455|NCT01381016|12637559|P1|NOT COMPLETED|Overall Study||3
5137456|NCT01381016|12637558|P2|COMPLETED|Overall Study||11
5137457|NCT01381016|12637559|P1|COMPLETED|Overall Study||10
5137458|NCT01381016|12637558|P2|STARTED|Overall Study||17
5137459|NCT01381016|12637559|P1|STARTED|Overall Study||13
5137460|NCT01380834|12637569|P2|NOT COMPLETED|Overall Study||0
5137461|NCT01380834|12637570|P1|NOT COMPLETED|Overall Study||1
5137462|NCT01380834|12637569|P2|COMPLETED|Overall Study||42
5137463|NCT01380834|12637570|P1|COMPLETED|Overall Study||41
5137464|NCT01380834|12637569|P2|STARTED|Overall Study||42
5137465|NCT01380834|12637570|P1|STARTED|Overall Study||42
5137466|NCT01380782|12637582|P4|NOT COMPLETED|Overall Study||4
5137467|NCT01380782|12637583|P3|NOT COMPLETED|Overall Study||11
5137468|NCT01380782|12637584|P2|NOT COMPLETED|Overall Study||10
5137469|NCT01380782|12637585|P1|NOT COMPLETED|Overall Study||12
5137470|NCT01380782|12637582|P4|COMPLETED|Overall Study||0
5137471|NCT01380782|12637583|P3|COMPLETED|Overall Study||0
5137472|NCT01380782|12637584|P2|COMPLETED|Overall Study||0
5137473|NCT01380782|12637585|P1|COMPLETED|Overall Study||0
5137474|NCT01380782|12637582|P4|STARTED|Overall Study||4
5137475|NCT01380782|12637583|P3|STARTED|Overall Study||11
5137476|NCT01380782|12637584|P2|STARTED|Overall Study||10
5137477|NCT01380782|12637585|P1|STARTED|Overall Study||12
5137478|NCT01380769|12637608|P2|NOT COMPLETED|Overall Study||14
5137479|NCT01380769|12637609|P1|NOT COMPLETED|Overall Study||9
5137480|NCT01380769|12637608|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
5137481|NCT01380769|12637609|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
5137482|NCT01380769|12637608|P2|STARTED|Overall Study||57
5137483|NCT01380769|12637609|P1|STARTED|Overall Study||100
5137484|NCT01380743|12637621|P4|NOT COMPLETED|Overall Study||0
5137485|NCT01380743|12637622|P3|NOT COMPLETED|Overall Study||0
5137486|NCT01380743|12637623|P2|NOT COMPLETED|Overall Study||0
5137487|NCT01380743|12637624|P1|NOT COMPLETED|Overall Study||0
5137488|NCT01380743|12637621|P4|COMPLETED|Overall Study||7
5137489|NCT01380743|12637622|P3|COMPLETED|Overall Study||6
5137490|NCT01380743|12637623|P2|COMPLETED|Overall Study||6
5137491|NCT01380743|12637624|P1|COMPLETED|Overall Study||6
5137492|NCT01380743|12637621|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
5137493|NCT01380743|12637622|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5137494|NCT01380743|12637623|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5137495|NCT01380743|12637624|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5137496|NCT01380743|12637621|P4|STARTED|Overall Study||7
5137497|NCT01380743|12637622|P3|STARTED|Overall Study||6
5137498|NCT01380743|12637623|P2|STARTED|Overall Study||6
5137499|NCT01380743|12637624|P1|STARTED|Overall Study||6
5137500|NCT01380730|12637670|P8|NOT COMPLETED|Overall Study||0
5137501|NCT01380730|12637671|P7|NOT COMPLETED|Overall Study||0
5137502|NCT01380730|12637672|P6|NOT COMPLETED|Overall Study||0
5137503|NCT01380730|12637673|P5|NOT COMPLETED|Overall Study||1
5137504|NCT01380730|12637674|P4|NOT COMPLETED|Overall Study||0
5137505|NCT01380730|12637675|P3|NOT COMPLETED|Overall Study||0
5137506|NCT01380730|12637676|P2|NOT COMPLETED|Overall Study||0
5137507|NCT01380730|12637677|P1|NOT COMPLETED|Overall Study||0
5137508|NCT01380730|12637670|P8|COMPLETED|Overall Study||80
5137509|NCT01380730|12637671|P7|COMPLETED|Overall Study||79
5137510|NCT01380730|12637672|P6|COMPLETED|Overall Study||79
5137511|NCT01380730|12637673|P5|COMPLETED|Overall Study||77
5137512|NCT01380730|12637674|P4|COMPLETED|Overall Study||79
5137513|NCT01380730|12637675|P3|COMPLETED|Overall Study||79
5137514|NCT01380730|12637676|P2|COMPLETED|Overall Study||79
5137515|NCT01380730|12637677|P1|COMPLETED|Overall Study||78
5137516|NCT01380730|12637670|P8|Received Treatment|Overall Study||80
5137517|NCT01380730|12637671|P7|Received Treatment|Overall Study||79
5137518|NCT01380730|12637672|P6|Received Treatment|Overall Study||79
5137519|NCT01380730|12637673|P5|Received Treatment|Overall Study||78
5137520|NCT01380730|12637674|P4|Received Treatment|Overall Study||79
5137521|NCT01380730|12637675|P3|Received Treatment|Overall Study||79
5137522|NCT01380730|12637676|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
5137523|NCT01380730|12637677|P1|Received Treatment|Overall Study||78
5137524|NCT01380730|12637670|P8|STARTED|Overall Study||80
5137525|NCT01380730|12637671|P7|STARTED|Overall Study||79
5137526|NCT01380730|12637672|P6|STARTED|Overall Study||79
5137527|NCT01380730|12637673|P5|STARTED|Overall Study||78
5137528|NCT01380730|12637674|P4|STARTED|Overall Study||79
5137529|NCT01380730|12637675|P3|STARTED|Overall Study||79
5137530|NCT01380730|12637676|P2|STARTED|Overall Study||79
5137531|NCT01380730|12637677|P1|STARTED|Overall Study||78
5137532|NCT01380691|12637735|P4|NOT COMPLETED|Period 2||0
5137533|NCT01380691|12637736|P3|NOT COMPLETED|Period 2||0
5137534|NCT01380691|12637737|P2|NOT COMPLETED|Period 2||0
5137535|NCT01380691|12637738|P1|NOT COMPLETED|Period 2||0
5137536|NCT01380691|12637735|P4|COMPLETED|Period 2||6
5137537|NCT01380691|12637736|P3|COMPLETED|Period 2||6
5137538|NCT01380691|12637737|P2|COMPLETED|Period 2||7
5137539|NCT01380691|12637738|P1|COMPLETED|Period 2||7
5137540|NCT01380691|12637735|P4|STARTED|Period 2||6
5137541|NCT01380691|12637736|P3|STARTED|Period 2||6
5137542|NCT01380691|12637737|P2|STARTED|Period 2||7
5137543|NCT01380691|12637738|P1|STARTED|Period 2||7
5137544|NCT01380691|12637735|P4|NOT COMPLETED|Washout (7 Days)||1
5137545|NCT01380691|12637736|P3|NOT COMPLETED|Washout (7 Days)||1
5137546|NCT01380691|12637737|P2|NOT COMPLETED|Washout (7 Days)||0
5137547|NCT01380691|12637738|P1|NOT COMPLETED|Washout (7 Days)||0
5137548|NCT01380691|12637735|P4|COMPLETED|Washout (7 Days)||6
5137549|NCT01380691|12637736|P3|COMPLETED|Washout (7 Days)||6
5137550|NCT01380691|12637737|P2|COMPLETED|Washout (7 Days)||7
5137551|NCT01380691|12637738|P1|COMPLETED|Washout (7 Days)||7
5137552|NCT01380691|12637735|P4|STARTED|Washout (7 Days)||7
5137553|NCT01380691|12637736|P3|STARTED|Washout (7 Days)||7
5137554|NCT01380691|12637737|P2|STARTED|Washout (7 Days)||7
5137555|NCT01380691|12637738|P1|STARTED|Washout (7 Days)||7
5137556|NCT01380691|12637735|P4|NOT COMPLETED|Period 1||0
5137557|NCT01380691|12637736|P3|NOT COMPLETED|Period 1||0
5137558|NCT01380691|12637737|P2|NOT COMPLETED|Period 1||0
5137559|NCT01380691|12637738|P1|NOT COMPLETED|Period 1||0
5137560|NCT01380691|12637735|P4|COMPLETED|Period 1||7
5137561|NCT01380691|12637736|P3|COMPLETED|Period 1||7
5137562|NCT01380691|12637737|P2|COMPLETED|Period 1||7
5137563|NCT01380691|12637738|P1|COMPLETED|Period 1||7
5137564|NCT01380691|12637735|P4|STARTED|Period 1||7
5137565|NCT01380691|12637736|P3|STARTED|Period 1||7
5137566|NCT01380691|12637737|P2|STARTED|Period 1||7
5137567|NCT01380691|12637738|P1|STARTED|Period 1||7
5137568|NCT01380639|12637790|P2|NOT COMPLETED|Overall Study||4
5137569|NCT01380639|12637791|P1|NOT COMPLETED|Overall Study||6
5137570|NCT01380639|12637790|P2|COMPLETED|Overall Study||36
5137571|NCT01380639|12637791|P1|COMPLETED|Overall Study||36
5137572|NCT01380639|12637790|P2|STARTED|Overall Study||40
5137573|NCT01380639|12637791|P1|STARTED|Overall Study||42
5137574|NCT01380535|12637799|P2|NOT COMPLETED|Overall Study||15
5137575|NCT01380535|12637800|P1|NOT COMPLETED|Overall Study||7
5137576|NCT01380535|12637799|P2|COMPLETED|Overall Study||16
5137577|NCT01380535|12637800|P1|COMPLETED|Overall Study||22
5137578|NCT01380535|12637799|P2|Intent-to-treat Population|Overall Study||24
5137579|NCT01380535|12637800|P1|Intent-to-treat Population|Overall Study||29
5137580|NCT01380535|12637799|P2|Safety Population|Overall Study||28
5137581|NCT01380535|12637800|P1|Safety Population|Overall Study||28
5137582|NCT01380535|12637799|P2|Baseline Population|Overall Study||31
5137583|NCT01380535|12637800|P1|Baseline Population|Overall Study||29
5137584|NCT01380535|12637799|P2|STARTED|Overall Study||31
5137585|NCT01380535|12637800|P1|STARTED|Overall Study||29
5137586|NCT01380379|12637806|P1|NOT COMPLETED|Overall Study||1
5137587|NCT01380379|12637806|P1|COMPLETED|Overall Study||8
5137588|NCT01380379|12637806|P1|STARTED|Overall Study||9
5137589|NCT01380366|12637811|P1|NOT COMPLETED|Overall Study||0
5137590|NCT01380366|12637811|P1|COMPLETED|Overall Study||15
5137591|NCT01380366|12637811|P1|STARTED|Overall Study||15
5137592|NCT01380327|12637819|P3|NOT COMPLETED|Overall Study||7
5137593|NCT01380327|12637820|P2|NOT COMPLETED|Overall Study||3
5137594|NCT01380327|12637821|P1|NOT COMPLETED|Overall Study||3
5137595|NCT01380327|12637819|P3|COMPLETED|Overall Study||21
5137596|NCT01380327|12637820|P2|COMPLETED|Overall Study||28
5137597|NCT01380327|12637821|P1|COMPLETED|Overall Study||27
5137598|NCT01380327|12637819|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
5137599|NCT01380327|12637820|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
5137600|NCT01380327|12637821|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
5137601|NCT01380197|12637843|P2|NOT COMPLETED|Overall Study||0
5137602|NCT01380197|12637844|P1|NOT COMPLETED|Overall Study||0
5137603|NCT01380197|12637843|P2|COMPLETED|Overall Study||20
5137604|NCT01380197|12637844|P1|COMPLETED|Overall Study||20
5137605|NCT01380197|12637843|P2|STARTED|Overall Study||20
5137606|NCT01380197|12637844|P1|STARTED|Overall Study||20
5137607|NCT01380184|12637852|P1|NOT COMPLETED|Part 2||14
5137608|NCT01380184|12637852|P1|COMPLETED|Part 2||0
5137609|NCT01380184|12637852|P1|STARTED|Part 2||14
5137610|NCT01380184|12637852|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
5137611|NCT01380184|12637852|P1|COMPLETED|Washout Period (≥2 Days)||14
5137612|NCT01380184|12637852|P1|STARTED|Washout Period (≥2 Days)||14
5137613|NCT01380184|12637852|P1|NOT COMPLETED|Part 1 (19 Days)||1
5137614|NCT01380184|12637852|P1|COMPLETED|Part 1 (19 Days)||14
5137615|NCT01380184|12637852|P1|STARTED|Part 1 (19 Days)||15
5137616|NCT01380145|12637863|P1|NOT COMPLETED|Overall Study||4
5137617|NCT01380145|12637863|P1|COMPLETED|Overall Study||9
5137618|NCT01380145|12637863|P1|STARTED|Overall Study||13
5137619|NCT01380093|12637871|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
5137620|NCT01380093|12637872|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137621|NCT01380093|12637873|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137622|NCT01380093|12637874|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137623|NCT01380093|12637875|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137624|NCT01380093|12637876|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137625|NCT01380093|12637877|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137626|NCT01380093|12637878|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137627|NCT01380093|12637879|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
5137628|NCT01380093|12637871|P9|COMPLETED|Treatment Phase: Third Intervention||4
5137629|NCT01380093|12637872|P8|COMPLETED|Treatment Phase: Third Intervention||6
5137630|NCT01380093|12637873|P7|COMPLETED|Treatment Phase: Third Intervention||6
5137631|NCT01380093|12637874|P6|COMPLETED|Treatment Phase: Third Intervention||6
5137632|NCT01380093|12637875|P5|COMPLETED|Treatment Phase: Third Intervention||6
5137633|NCT01380093|12637876|P4|COMPLETED|Treatment Phase: Third Intervention||5
5137634|NCT01380093|12637877|P3|COMPLETED|Treatment Phase: Third Intervention||0
5137635|NCT01380093|12637878|P2|COMPLETED|Treatment Phase: Third Intervention||0
5137636|NCT01380093|12637879|P1|COMPLETED|Treatment Phase: Third Intervention||0
5137637|NCT01380093|12637871|P9|STARTED|Treatment Phase: Third Intervention||6
5137638|NCT01380093|12637872|P8|STARTED|Treatment Phase: Third Intervention||6
5137639|NCT01380093|12637873|P7|STARTED|Treatment Phase: Third Intervention||6
5137640|NCT01380093|12637874|P6|STARTED|Treatment Phase: Third Intervention||6
5137641|NCT01380093|12637875|P5|STARTED|Treatment Phase: Third Intervention||6
5137642|NCT01380093|12637876|P4|STARTED|Treatment Phase: Third Intervention||5
5137643|NCT01380093|12637877|P3|STARTED|Treatment Phase: Third Intervention||0
5137644|NCT01380093|12637878|P2|STARTED|Treatment Phase: Third Intervention||0
5137645|NCT01380093|12637879|P1|STARTED|Treatment Phase: Third Intervention||0
5137646|NCT01380093|12637871|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
5137647|NCT01380093|12637872|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
5137648|NCT01380093|12637873|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
5137649|NCT01380093|12637874|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
5137650|NCT01380093|12637875|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
5137651|NCT01380093|12637876|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
5137652|NCT01380093|12637877|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
5137653|NCT01380093|12637878|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
5137654|NCT01380093|12637879|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
5137655|NCT01380093|12637871|P9|COMPLETED|Treatment Phase: Washout Period||6
5137656|NCT01380093|12637872|P8|COMPLETED|Treatment Phase: Washout Period||6
5137657|NCT01380093|12637873|P7|COMPLETED|Treatment Phase: Washout Period||6
5137658|NCT01380093|12637874|P6|COMPLETED|Treatment Phase: Washout Period||6
5137659|NCT01380093|12637875|P5|COMPLETED|Treatment Phase: Washout Period||6
5137660|NCT01380093|12637876|P4|COMPLETED|Treatment Phase: Washout Period||5
5137661|NCT01380093|12637877|P3|COMPLETED|Treatment Phase: Washout Period||0
5137662|NCT01380093|12637878|P2|COMPLETED|Treatment Phase: Washout Period||0
5137663|NCT01380093|12637879|P1|COMPLETED|Treatment Phase: Washout Period||0
5137664|NCT01380093|12637871|P9|STARTED|Treatment Phase: Washout Period||6
5137665|NCT01380093|12637872|P8|STARTED|Treatment Phase: Washout Period||6
5137666|NCT01380093|12637873|P7|STARTED|Treatment Phase: Washout Period||6
5137667|NCT01380093|12637874|P6|STARTED|Treatment Phase: Washout Period||6
5137668|NCT01380093|12637875|P5|STARTED|Treatment Phase: Washout Period||6
5137669|NCT01380093|12637876|P4|STARTED|Treatment Phase: Washout Period||5
5137670|NCT01380093|12637877|P3|STARTED|Treatment Phase: Washout Period||0
5137671|NCT01380093|12637878|P2|STARTED|Treatment Phase: Washout Period||0
5137672|NCT01380093|12637879|P1|STARTED|Treatment Phase: Washout Period||0
5137673|NCT01380093|12637871|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137674|NCT01380093|12637872|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137675|NCT01380093|12637873|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137676|NCT01380093|12637874|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137677|NCT01380093|12637875|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137678|NCT01380093|12637876|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
5137679|NCT01380093|12637877|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137680|NCT01380093|12637878|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137681|NCT01380093|12637879|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
5137682|NCT01380093|12637871|P9|COMPLETED|Treatment Phase: Second Intervention||6
5137683|NCT01380093|12637872|P8|COMPLETED|Treatment Phase: Second Intervention||6
5137684|NCT01380093|12637873|P7|COMPLETED|Treatment Phase: Second Intervention||6
5137685|NCT01380093|12637874|P6|COMPLETED|Treatment Phase: Second Intervention||6
5137686|NCT01380093|12637875|P5|COMPLETED|Treatment Phase: Second Intervention||6
5137687|NCT01380093|12637876|P4|COMPLETED|Treatment Phase: Second Intervention||5
5137688|NCT01380093|12637877|P3|COMPLETED|Treatment Phase: Second Intervention||0
5137689|NCT01380093|12637878|P2|COMPLETED|Treatment Phase: Second Intervention||0
5137690|NCT01380093|12637879|P1|COMPLETED|Treatment Phase: Second Intervention||0
5137691|NCT01380093|12637871|P9|STARTED|Treatment Phase: Second Intervention||6
5137692|NCT01380093|12637872|P8|STARTED|Treatment Phase: Second Intervention||6
5137693|NCT01380093|12637873|P7|STARTED|Treatment Phase: Second Intervention||6
5137694|NCT01380093|12637874|P6|STARTED|Treatment Phase: Second Intervention||6
5137695|NCT01380093|12637875|P5|STARTED|Treatment Phase: Second Intervention||6
5137696|NCT01380093|12637876|P4|STARTED|Treatment Phase: Second Intervention||6
5137697|NCT01380093|12637877|P3|STARTED|Treatment Phase: Second Intervention||0
5137698|NCT01380093|12637878|P2|STARTED|Treatment Phase: Second Intervention||0
5137699|NCT01380093|12637879|P1|STARTED|Treatment Phase: Second Intervention||0
5137700|NCT01380093|12637871|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
5137701|NCT01380093|12637872|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
5137702|NCT01380093|12637873|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
5137703|NCT01380093|12637874|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
5137704|NCT01380093|12637875|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
5137705|NCT01380093|12637876|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
5137706|NCT01380093|12637877|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
5137707|NCT01380093|12637878|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
5137708|NCT01380093|12637879|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
5137709|NCT01380093|12637871|P9|COMPLETED|Treatment Phase: Washout Period||6
5137710|NCT01380093|12637872|P8|COMPLETED|Treatment Phase: Washout Period||6
5137711|NCT01380093|12637873|P7|COMPLETED|Treatment Phase: Washout Period||6
5137712|NCT01380093|12637874|P6|COMPLETED|Treatment Phase: Washout Period||6
5137713|NCT01380093|12637875|P5|COMPLETED|Treatment Phase: Washout Period||6
5137714|NCT01380093|12637876|P4|COMPLETED|Treatment Phase: Washout Period||6
5137715|NCT01380093|12637877|P3|COMPLETED|Treatment Phase: Washout Period||0
5137716|NCT01380093|12637878|P2|COMPLETED|Treatment Phase: Washout Period||0
5137717|NCT01380093|12637879|P1|COMPLETED|Treatment Phase: Washout Period||0
5137718|NCT01380093|12637871|P9|STARTED|Treatment Phase: Washout Period||6
5137719|NCT01380093|12637872|P8|STARTED|Treatment Phase: Washout Period||6
5137720|NCT01380093|12637873|P7|STARTED|Treatment Phase: Washout Period||6
5137721|NCT01380093|12637874|P6|STARTED|Treatment Phase: Washout Period||6
5137722|NCT01380093|12637875|P5|STARTED|Treatment Phase: Washout Period||6
5137723|NCT01380093|12637876|P4|STARTED|Treatment Phase: Washout Period||6
5137724|NCT01380093|12637877|P3|STARTED|Treatment Phase: Washout Period||0
5137725|NCT01380093|12637878|P2|STARTED|Treatment Phase: Washout Period||0
5137726|NCT01380093|12637879|P1|STARTED|Treatment Phase: Washout Period||0
5137727|NCT01380093|12637871|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
5137728|NCT01380093|12637872|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
5137729|NCT01380093|12637873|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
5137730|NCT01380093|12637874|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
5137731|NCT01380093|12637875|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
5137732|NCT01380093|12637876|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
5137733|NCT01380093|12637877|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
5137734|NCT01380093|12637878|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
5137735|NCT01380093|12637879|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
5137736|NCT01380093|12637871|P9|COMPLETED|Treatment Phase: First Intervention||6
5137737|NCT01380093|12637872|P8|COMPLETED|Treatment Phase: First Intervention||6
5137738|NCT01380093|12637873|P7|COMPLETED|Treatment Phase: First Intervention||6
5137739|NCT01380093|12637874|P6|COMPLETED|Treatment Phase: First Intervention||6
5137740|NCT01380093|12637875|P5|COMPLETED|Treatment Phase: First Intervention||6
5137741|NCT01380093|12637876|P4|COMPLETED|Treatment Phase: First Intervention||6
5137742|NCT01380093|12637877|P3|COMPLETED|Treatment Phase: First Intervention||0
5137743|NCT01380093|12637878|P2|COMPLETED|Treatment Phase: First Intervention||0
5137744|NCT01380093|12637879|P1|COMPLETED|Treatment Phase: First Intervention||0
5137745|NCT01380093|12637871|P9|STARTED|Treatment Phase: First Intervention||6
5137746|NCT01380093|12637872|P8|STARTED|Treatment Phase: First Intervention||6
5137747|NCT01380093|12637873|P7|STARTED|Treatment Phase: First Intervention||6
5137748|NCT01380093|12637874|P6|STARTED|Treatment Phase: First Intervention||6
5137749|NCT01380093|12637875|P5|STARTED|Treatment Phase: First Intervention||6
5137750|NCT01380093|12637876|P4|STARTED|Treatment Phase: First Intervention||6
5137751|NCT01380093|12637877|P3|STARTED|Treatment Phase: First Intervention||0
5137752|NCT01380093|12637878|P2|STARTED|Treatment Phase: First Intervention||0
5137753|NCT01380093|12637879|P1|STARTED|Treatment Phase: First Intervention||0
5137754|NCT01380093|12637871|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137755|NCT01380093|12637872|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137756|NCT01380093|12637873|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137757|NCT01380093|12637874|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137758|NCT01380093|12637875|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137759|NCT01380093|12637876|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137760|NCT01380093|12637877|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
5137761|NCT01380093|12637878|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
5137762|NCT01380093|12637879|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
5137763|NCT01380093|12637871|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
5137764|NCT01380093|12637872|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
5137765|NCT01380093|12637873|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
5137766|NCT01380093|12637874|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
5137767|NCT01380093|12637875|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
5137768|NCT01380093|12637876|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
5137769|NCT01380093|12637877|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
5137770|NCT01380093|12637878|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
5137771|NCT01380093|12637879|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
5137772|NCT01380093|12637871|P9|STARTED|Drug Discrimination Phase: Day 2||0
5137773|NCT01380093|12637872|P8|STARTED|Drug Discrimination Phase: Day 2||0
5137774|NCT01380093|12637873|P7|STARTED|Drug Discrimination Phase: Day 2||0
5137775|NCT01380093|12637874|P6|STARTED|Drug Discrimination Phase: Day 2||0
5137776|NCT01380093|12637875|P5|STARTED|Drug Discrimination Phase: Day 2||0
5137777|NCT01380093|12637876|P4|STARTED|Drug Discrimination Phase: Day 2||0
5137778|NCT01380093|12637877|P3|STARTED|Drug Discrimination Phase: Day 2||29
5137779|NCT01380093|12637878|P2|STARTED|Drug Discrimination Phase: Day 2||29
5137780|NCT01380093|12637879|P1|STARTED|Drug Discrimination Phase: Day 2||0
5137781|NCT01380093|12637871|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137782|NCT01380093|12637872|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137783|NCT01380093|12637873|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137784|NCT01380093|12637874|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137785|NCT01380093|12637875|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137786|NCT01380093|12637876|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137787|NCT01380093|12637877|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137788|NCT01380093|12637878|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
5137789|NCT01380093|12637879|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
5137790|NCT01380093|12637871|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
5137791|NCT01380093|12637872|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
5137792|NCT01380093|12637873|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
5137793|NCT01380093|12637874|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
5137794|NCT01380093|12637875|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
5137795|NCT01380093|12637876|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
5137796|NCT01380093|12637877|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
5137797|NCT01380093|12637878|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
5137798|NCT01380093|12637879|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
5137799|NCT01380093|12637871|P9|STARTED|Drug Discrimination Phase: Day 1||0
5137800|NCT01380093|12637872|P8|STARTED|Drug Discrimination Phase: Day 1||0
5137801|NCT01380093|12637873|P7|STARTED|Drug Discrimination Phase: Day 1||0
5137802|NCT01380093|12637874|P6|STARTED|Drug Discrimination Phase: Day 1||0
5137803|NCT01380093|12637875|P5|STARTED|Drug Discrimination Phase: Day 1||0
5137804|NCT01380093|12637876|P4|STARTED|Drug Discrimination Phase: Day 1||0
5137805|NCT01380093|12637877|P3|STARTED|Drug Discrimination Phase: Day 1||29
5137806|NCT01380093|12637878|P2|STARTED|Drug Discrimination Phase: Day 1||30
5137807|NCT01380093|12637879|P1|STARTED|Drug Discrimination Phase: Day 1||0
5137808|NCT01380093|12637871|P9|NOT COMPLETED|Naloxone Challenge Phase||0
5137809|NCT01380093|12637872|P8|NOT COMPLETED|Naloxone Challenge Phase||0
5137810|NCT01380093|12637873|P7|NOT COMPLETED|Naloxone Challenge Phase||0
5137811|NCT01380093|12637874|P6|NOT COMPLETED|Naloxone Challenge Phase||0
5137812|NCT01380093|12637875|P5|NOT COMPLETED|Naloxone Challenge Phase||0
5137813|NCT01380093|12637876|P4|NOT COMPLETED|Naloxone Challenge Phase||0
5137814|NCT01380093|12637877|P3|NOT COMPLETED|Naloxone Challenge Phase||0
5137815|NCT01380093|12637878|P2|NOT COMPLETED|Naloxone Challenge Phase||0
5137816|NCT01380093|12637879|P1|NOT COMPLETED|Naloxone Challenge Phase||21
5137817|NCT01380093|12637871|P9|COMPLETED|Naloxone Challenge Phase||0
5137818|NCT01380093|12637872|P8|COMPLETED|Naloxone Challenge Phase||0
5137819|NCT01380093|12637873|P7|COMPLETED|Naloxone Challenge Phase||0
5137820|NCT01380093|12637874|P6|COMPLETED|Naloxone Challenge Phase||0
5137821|NCT01380093|12637875|P5|COMPLETED|Naloxone Challenge Phase||0
5137822|NCT01380093|12637876|P4|COMPLETED|Naloxone Challenge Phase||0
5137823|NCT01380093|12637877|P3|COMPLETED|Naloxone Challenge Phase||0
5137824|NCT01380093|12637878|P2|COMPLETED|Naloxone Challenge Phase||0
5137825|NCT01380093|12637879|P1|COMPLETED|Naloxone Challenge Phase||59
5137826|NCT01380093|12637871|P9|TREATED|Naloxone Challenge Phase||0
5137827|NCT01380093|12637872|P8|TREATED|Naloxone Challenge Phase||0
5137828|NCT01380093|12637873|P7|TREATED|Naloxone Challenge Phase||0
5137829|NCT01380093|12637874|P6|TREATED|Naloxone Challenge Phase||0
5137830|NCT01380093|12637875|P5|TREATED|Naloxone Challenge Phase||0
5137831|NCT01380093|12637876|P4|TREATED|Naloxone Challenge Phase||0
5137832|NCT01380093|12637877|P3|TREATED|Naloxone Challenge Phase||0
5137833|NCT01380093|12637878|P2|TREATED|Naloxone Challenge Phase||0
5137834|NCT01380093|12637879|P1|TREATED|Naloxone Challenge Phase||59
5137835|NCT01380093|12637871|P9|STARTED|Naloxone Challenge Phase||0
5137836|NCT01380093|12637872|P8|STARTED|Naloxone Challenge Phase||0
5137837|NCT01380093|12637873|P7|STARTED|Naloxone Challenge Phase||0
5137838|NCT01380093|12637874|P6|STARTED|Naloxone Challenge Phase||0
5137839|NCT01380093|12637875|P5|STARTED|Naloxone Challenge Phase||0
5137840|NCT01380093|12637876|P4|STARTED|Naloxone Challenge Phase||0
5137841|NCT01380093|12637877|P3|STARTED|Naloxone Challenge Phase||0
5137842|NCT01380093|12637878|P2|STARTED|Naloxone Challenge Phase||0
5137843|NCT01380093|12637879|P1|STARTED|Naloxone Challenge Phase||80
5137844|NCT01380080|12638171|P2|NOT COMPLETED|Overall Study||23
5137845|NCT01380080|12638172|P1|NOT COMPLETED|Overall Study||33
5137846|NCT01380080|12638171|P2|COMPLETED|Overall Study||403
5137847|NCT01380080|12638172|P1|COMPLETED|Overall Study||391
5137848|NCT01380080|12638171|P2|STARTED|Overall Study||426
5137849|NCT01380080|12638172|P1|STARTED|Overall Study||424
5137850|NCT01379963|12638188|P1|NOT COMPLETED|Overall Study||0
5137851|NCT01379963|12638188|P1|COMPLETED|Overall Study||780
5137852|NCT01379963|12638188|P1|STARTED|Overall Study||780
5137853|NCT01379937|12638197|P4|NOT COMPLETED|Overall Study||1
5137854|NCT01379937|12638198|P3|NOT COMPLETED|Overall Study||2
5137855|NCT01379937|12638199|P2|NOT COMPLETED|Overall Study||3
5137856|NCT01379937|12638200|P1|NOT COMPLETED|Overall Study||1
5137857|NCT01379937|12638197|P4|COMPLETED|Overall Study||103
5137858|NCT01379937|12638198|P3|COMPLETED|Overall Study||102
5137859|NCT01379937|12638199|P2|COMPLETED|Overall Study||153
5137860|NCT01379937|12638200|P1|COMPLETED|Overall Study||155
5137861|NCT01379937|12638197|P4|STARTED|Overall Study||104
5137862|NCT01379937|12638198|P3|STARTED|Overall Study||104
5137863|NCT01379937|12638199|P2|STARTED|Overall Study||156
5137864|NCT01379937|12638200|P1|STARTED|Overall Study||156
5137865|NCT01379781|12638282|P2|NOT COMPLETED|Overall Study||8
5137866|NCT01379781|12638283|P1|NOT COMPLETED|Overall Study||11
5137867|NCT01379781|12638282|P2|COMPLETED|Overall Study||19
5137868|NCT01379781|12638283|P1|COMPLETED|Overall Study||16
5137869|NCT01379781|12638282|P2|STARTED|Overall Study||27
5137870|NCT01379781|12638283|P1|STARTED|Overall Study||27
5137871|NCT01379768|12638292|P3|NOT COMPLETED|Overall Study||0
5137872|NCT01379768|12638293|P2|NOT COMPLETED|Overall Study||1
5137873|NCT01379768|12638294|P1|NOT COMPLETED|Overall Study||3
5137874|NCT01379768|12638292|P3|COMPLETED|Overall Study||20
5137875|NCT01379768|12638293|P2|COMPLETED|Overall Study||21
5137876|NCT01379768|12638294|P1|COMPLETED|Overall Study||20
5137877|NCT01379768|12638292|P3|STARTED|Overall Study||20
5137878|NCT01379768|12638293|P2|STARTED|Overall Study||22
5137879|NCT01379768|12638294|P1|STARTED|Overall Study||23
5137880|NCT01379703|12638317|P3|NOT COMPLETED|9 Months Through 18 Months||0
5137881|NCT01379703|12638318|P2|NOT COMPLETED|9 Months Through 18 Months||230
5137882|NCT01379703|12638319|P1|NOT COMPLETED|9 Months Through 18 Months||0
5137883|NCT01379703|12638317|P3|COMPLETED|9 Months Through 18 Months||0
5137884|NCT01379703|12638318|P2|COMPLETED|9 Months Through 18 Months||854
5137885|NCT01379703|12638319|P1|COMPLETED|9 Months Through 18 Months||0
5137886|NCT01379703|12638317|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
5137887|NCT01379703|12638318|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
5137888|NCT01379703|12638319|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
5137889|NCT01379703|12638317|P3|NOT COMPLETED|Study Start Through 9 Months||143
5137890|NCT01379703|12638318|P2|NOT COMPLETED|Study Start Through 9 Months||122
5137891|NCT01379703|12638319|P1|NOT COMPLETED|Study Start Through 9 Months||4
5137892|NCT01379703|12638317|P3|COMPLETED|Study Start Through 9 Months||873
5137893|NCT01379703|12638318|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
5137894|NCT01379703|12638319|P1|COMPLETED|Study Start Through 9 Months||62
5137895|NCT01379703|12638317|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
5137896|NCT01379703|12638318|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
5137897|NCT01379703|12638319|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
5137898|NCT01379664|12638382|P2|NOT COMPLETED|Overall Study||0
5137899|NCT01379664|12638383|P1|NOT COMPLETED|Overall Study||0
5137900|NCT01379664|12638382|P2|COMPLETED|Overall Study||870
5137901|NCT01379664|12638383|P1|COMPLETED|Overall Study||714
5137902|NCT01379664|12638382|P2|STARTED|Overall Study||870
5137903|NCT01379664|12638383|P1|STARTED|Overall Study||714
5137904|NCT01379651|12638395|P2|NOT COMPLETED|Overall Study||0
5137905|NCT01379651|12638396|P1|NOT COMPLETED|Overall Study||0
5137906|NCT01379651|12638395|P2|COMPLETED|Overall Study||10
5137907|NCT01379651|12638396|P1|COMPLETED|Overall Study||10
5137908|NCT01379651|12638395|P2|STARTED|Overall Study||10
5137909|NCT01379651|12638396|P1|STARTED|Overall Study||10
5137910|NCT01379625|12638406|P2|NOT COMPLETED|Overall Study||0
5137911|NCT01379625|12638407|P1|NOT COMPLETED|Overall Study||0
5137912|NCT01379625|12638406|P2|COMPLETED|Overall Study||16
5137913|NCT01379625|12638407|P1|COMPLETED|Overall Study||16
5137914|NCT01379625|12638406|P2|STARTED|Overall Study||16
5137915|NCT01379625|12638407|P1|STARTED|Overall Study||16
5137916|NCT01379573|12638417|P1|NOT COMPLETED|Overall Study||11
5137917|NCT01379573|12638417|P1|COMPLETED|Overall Study||63
5137918|NCT01379573|12638417|P1|STARTED|Overall Study||74
5137919|NCT01379534|12638431|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
5137920|NCT01379534|12638432|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
5137921|NCT01379534|12638431|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
5137922|NCT01379534|12638432|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
5137923|NCT01379534|12638431|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
5137924|NCT01379534|12638432|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
5137925|NCT01379534|12638431|P2|NOT COMPLETED|Treatment Phase||31
5137926|NCT01379534|12638432|P1|NOT COMPLETED|Treatment Phase||22
5137927|NCT01379534|12638431|P2|COMPLETED|Treatment Phase||0
5137928|NCT01379534|12638432|P1|COMPLETED|Treatment Phase||0
5137929|NCT01379534|12638431|P2|STARTED|Treatment Phase||31
5137930|NCT01379534|12638432|P1|STARTED|Treatment Phase||22
5137931|NCT01379521|12638452|P2|NOT COMPLETED|Post-Treatment Evaluations||21
5137932|NCT01379521|12638453|P1|NOT COMPLETED|Post-Treatment Evaluations||25
5137933|NCT01379521|12638452|P2|COMPLETED|Post-Treatment Evaluations||0
5137934|NCT01379521|12638453|P1|COMPLETED|Post-Treatment Evaluations||0
5137935|NCT01379521|12638452|P2|STARTED|Post-Treatment Evaluations||21
5137936|NCT01379521|12638453|P1|STARTED|Post-Treatment Evaluations||25
5137937|NCT01379521|12638452|P2|NOT COMPLETED|Overall Study -Treatment Period||26
5137938|NCT01379521|12638453|P1|NOT COMPLETED|Overall Study -Treatment Period||33
5137939|NCT01379521|12638452|P2|COMPLETED|Overall Study -Treatment Period||0
5137940|NCT01379521|12638453|P1|COMPLETED|Overall Study -Treatment Period||0
5137941|NCT01379521|12638452|P2|STARTED|Overall Study -Treatment Period||26
5137942|NCT01379521|12638453|P1|STARTED|Overall Study -Treatment Period||33
5137943|NCT01379508|12638475|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
5137944|NCT01379508|12638476|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
5137945|NCT01379508|12638477|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
5137946|NCT01379508|12638478|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
5137947|NCT01379508|12638475|P4|COMPLETED|Extension Period Weeks 109-156||10
5137948|NCT01379508|12638476|P3|COMPLETED|Extension Period Weeks 109-156||65
5137949|NCT01379508|12638477|P2|COMPLETED|Extension Period Weeks 109-156||14
5137950|NCT01379508|12638478|P1|COMPLETED|Extension Period Weeks 109-156||45
5137951|NCT01379508|12638475|P4|STARTED|Extension Period Weeks 109-156||10
5137952|NCT01379508|12638476|P3|STARTED|Extension Period Weeks 109-156||79
5137953|NCT01379508|12638477|P2|STARTED|Extension Period Weeks 109-156||17
5137954|NCT01379508|12638478|P1|STARTED|Extension Period Weeks 109-156||64
5137955|NCT01379508|12638475|P4|NOT COMPLETED|Treatment to Week 104||0
5137956|NCT01379508|12638476|P3|NOT COMPLETED|Treatment to Week 104||13
5137957|NCT01379508|12638477|P2|NOT COMPLETED|Treatment to Week 104||3
5137958|NCT01379508|12638478|P1|NOT COMPLETED|Treatment to Week 104||19
5137959|NCT01379508|12638475|P4|COMPLETED|Treatment to Week 104||11
5137960|NCT01379508|12638476|P3|COMPLETED|Treatment to Week 104||96
5137961|NCT01379508|12638477|P2|COMPLETED|Treatment to Week 104||19
5137962|NCT01379508|12638478|P1|COMPLETED|Treatment to Week 104||80
5137963|NCT01379508|12638475|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
5137964|NCT01379508|12638476|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
5137965|NCT01379508|12638477|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
5137966|NCT01379508|12638478|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
5137967|NCT01379508|12638475|P4|Completed Wk 24|Treatment to Week 104||11
5137968|NCT01379508|12638476|P3|Completed Wk 24|Treatment to Week 104||107
5137969|NCT01379508|12638477|P2|Completed Wk 24|Treatment to Week 104||22
5137970|NCT01379508|12638478|P1|Completed Wk 24|Treatment to Week 104||93
5137971|NCT01379508|12638475|P4|STARTED|Treatment to Week 104||11
5137972|NCT01379508|12638476|P3|STARTED|Treatment to Week 104||109
5137973|NCT01379508|12638477|P2|STARTED|Treatment to Week 104||22
5137974|NCT01379508|12638478|P1|STARTED|Treatment to Week 104||99
5137975|NCT01379222|12638504|P1|NOT COMPLETED|Overall Study||73
5137976|NCT01379222|12638504|P1|COMPLETED|Overall Study||105
5137977|NCT01379222|12638504|P1|STARTED|Overall Study||178
5137978|NCT01379183|12638510|P2|NOT COMPLETED|Overall Study||0
5137979|NCT01379183|12638511|P1|NOT COMPLETED|Overall Study||0
5137980|NCT01379183|12638510|P2|COMPLETED|Overall Study||21
5137981|NCT01379183|12638511|P1|COMPLETED|Overall Study||19
5137982|NCT01379183|12638510|P2|STARTED|Overall Study||21
5137983|NCT01379183|12638511|P1|STARTED|Overall Study||19
5137984|NCT01378988|12638529|P2|NOT COMPLETED|Overall Study||0
5137985|NCT01378988|12638530|P1|NOT COMPLETED|Overall Study||0
5137986|NCT01378988|12638529|P2|COMPLETED|Overall Study||3
5137987|NCT01378988|12638530|P1|COMPLETED|Overall Study||2
5137988|NCT01378988|12638529|P2|STARTED|Overall Study||3
5137989|NCT01378988|12638530|P1|STARTED|Overall Study||2
5137990|NCT01378975|12638560|P2|NOT COMPLETED|Overall Study||50
5137991|NCT01378975|12638561|P1|NOT COMPLETED|Overall Study||86
5137992|NCT01378975|12638560|P2|COMPLETED|Overall Study||6
5137993|NCT01378975|12638561|P1|COMPLETED|Overall Study||4
5137994|NCT01378975|12638560|P2|STARTED|Overall Study||56
5137995|NCT01378975|12638561|P1|STARTED|Overall Study||90
5137996|NCT01378962|12638587|P1|NOT COMPLETED|Overall Study||17
5137997|NCT01378962|12638587|P1|COMPLETED|Overall Study||33
5137998|NCT01378962|12638587|P1|STARTED|Overall Study||50
5137999|NCT01378520|12638600|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
5138000|NCT01378520|12638601|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
5138001|NCT01378520|12638600|P2|COMPLETED|Second Intervention (Day 4-6)||10
5138002|NCT01378520|12638601|P1|COMPLETED|Second Intervention (Day 4-6)||10
5138003|NCT01378520|12638600|P2|STARTED|Second Intervention (Day 4-6)||10
5138004|NCT01378520|12638601|P1|STARTED|Second Intervention (Day 4-6)||10
5138005|NCT01378520|12638600|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
5138006|NCT01378520|12638601|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
5138007|NCT01378520|12638600|P2|COMPLETED|First Intervention (Day 2-3)||10
5138008|NCT01378520|12638601|P1|COMPLETED|First Intervention (Day 2-3)||10
5138009|NCT01378520|12638600|P2|STARTED|First Intervention (Day 2-3)||10
5138010|NCT01378520|12638601|P1|STARTED|First Intervention (Day 2-3)||10
5138011|NCT01378429|12638613|P2|NOT COMPLETED|Overall Study||0
5138012|NCT01378429|12638614|P1|NOT COMPLETED|Overall Study||1
5138013|NCT01378429|12638613|P2|COMPLETED|Overall Study||47
5138014|NCT01378429|12638614|P1|COMPLETED|Overall Study||41
5138015|NCT01378429|12638613|P2|STARTED|Overall Study||47
5138016|NCT01378429|12638614|P1|STARTED|Overall Study||42
5138017|NCT01378416|12638646|P1|NOT COMPLETED|Overall Study||0
5138018|NCT01378416|12638646|P1|COMPLETED|Overall Study||16
5138019|NCT01378416|12638646|P1|STARTED|Overall Study||16
5138020|NCT01378377|12638657|P3|NOT COMPLETED|Overall Study||0
5138021|NCT01378377|12638658|P2|NOT COMPLETED|Overall Study||0
5138022|NCT01378377|12638659|P1|NOT COMPLETED|Overall Study||0
5138023|NCT01378377|12638657|P3|COMPLETED|Overall Study||6
5138024|NCT01378377|12638658|P2|COMPLETED|Overall Study||23
5138025|NCT01378377|12638659|P1|COMPLETED|Overall Study||4
5138026|NCT01378377|12638657|P3|STARTED|Overall Study||6
5138027|NCT01378377|12638658|P2|STARTED|Overall Study||23
5138028|NCT01378377|12638659|P1|STARTED|Overall Study||4
5138029|NCT01378325|12638727|P2|NOT COMPLETED|Overall Study||1
5138030|NCT01378325|12638728|P1|NOT COMPLETED|Overall Study||0
5138031|NCT01378325|12638727|P2|COMPLETED|Overall Study||39
5138032|NCT01378325|12638728|P1|COMPLETED|Overall Study||40
5138033|NCT01378325|12638727|P2|STARTED|Overall Study||40
5138034|NCT01378325|12638728|P1|STARTED|Overall Study||40
5138035|NCT01378299|12638734|P1|NOT COMPLETED|Overall Study||31
5138036|NCT01378299|12638734|P1|COMPLETED|Overall Study||74
5138037|NCT01378299|12638734|P1|BMI Group 3|Overall Study||27
5138038|NCT01378299|12638734|P1|BMI Group 2|Overall Study||40
5138039|NCT01378299|12638734|P1|BMI group1|Overall Study||38
5138040|NCT01378299|12638734|P1|STARTED|Overall Study||105
5138041|NCT01378221|12638773|P2|NOT COMPLETED|Overall Study||9
5138042|NCT01378221|12638774|P1|NOT COMPLETED|Overall Study||7
5138043|NCT01378221|12638773|P2|COMPLETED|Overall Study||30
5138044|NCT01378221|12638774|P1|COMPLETED|Overall Study||29
5138045|NCT01378221|12638773|P2|STARTED|Overall Study||39
5138046|NCT01378221|12638774|P1|STARTED|Overall Study||36
5138047|NCT01378195|12638782|P2|NOT COMPLETED|Overall Study||18
5138048|NCT01378195|12638783|P1|NOT COMPLETED|Overall Study||29
5138049|NCT01378195|12638782|P2|COMPLETED|Overall Study||57
5138050|NCT01378195|12638783|P1|COMPLETED|Overall Study||46
5138051|NCT01378195|12638782|P2|STARTED|Overall Study||75
5138052|NCT01378195|12638783|P1|STARTED|Overall Study||75
5138053|NCT01378117|12638796|P3|NOT COMPLETED|Overall Study||3
5138054|NCT01378117|12638797|P2|NOT COMPLETED|Overall Study||1
5138055|NCT01378117|12638798|P1|NOT COMPLETED|Overall Study||4
5138056|NCT01378117|12638796|P3|COMPLETED|Overall Study||26
5138057|NCT01378117|12638797|P2|COMPLETED|Overall Study||29
5138058|NCT01378117|12638798|P1|COMPLETED|Overall Study||27
5138059|NCT01378117|12638796|P3|STARTED|Overall Study||29
5138060|NCT01378117|12638797|P2|STARTED|Overall Study||30
5138061|NCT01378117|12638798|P1|STARTED|Overall Study||31
5138062|NCT01378104|12638832|P2|NOT COMPLETED|Overall Study||26
5138063|NCT01378104|12638833|P1|NOT COMPLETED|Overall Study||27
5138064|NCT01378104|12638832|P2|COMPLETED|Overall Study||60
5138065|NCT01378104|12638833|P1|COMPLETED|Overall Study||65
5138066|NCT01378104|12638832|P2|STARTED|Overall Study||86
5138067|NCT01378104|12638833|P1|STARTED|Overall Study||92
5138068|NCT01378065|12638841|P1|NOT COMPLETED|Overall Study||0
5138069|NCT01378065|12638841|P1|COMPLETED|Overall Study||30
5138070|NCT01378065|12638841|P1|12 Months|Overall Study||30
5138071|NCT01378065|12638841|P1|6 Months|Overall Study||30
5138072|NCT01378065|12638841|P1|3 Months|Overall Study||30
5138073|NCT01378065|12638841|P1|6 Week|Overall Study||30
5138074|NCT01378065|12638841|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
5138075|NCT01377987|12638878|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5138076|NCT01377987|12638879|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5138077|NCT01377987|12638878|P2|COMPLETED|Second Intervention (7 Days)||14
5138078|NCT01377987|12638879|P1|COMPLETED|Second Intervention (7 Days)||13
5138079|NCT01377987|12638878|P2|STARTED|Second Intervention (7 Days)||14
5138080|NCT01377987|12638879|P1|STARTED|Second Intervention (7 Days)||13
5138081|NCT01377987|12638878|P2|NOT COMPLETED|Washout (7 Days)||1
5138082|NCT01377987|12638879|P1|NOT COMPLETED|Washout (7 Days)||1
5138083|NCT01377987|12638878|P2|COMPLETED|Washout (7 Days)||14
5138084|NCT01377987|12638879|P1|COMPLETED|Washout (7 Days)||13
5138085|NCT01377987|12638878|P2|STARTED|Washout (7 Days)||15
5138086|NCT01377987|12638879|P1|STARTED|Washout (7 Days)||14
5138087|NCT01377987|12638878|P2|NOT COMPLETED|First Intervention (7 Days)||0
5138088|NCT01377987|12638879|P1|NOT COMPLETED|First Intervention (7 Days)||0
5138089|NCT01377987|12638878|P2|COMPLETED|First Intervention (7 Days)||15
5138090|NCT01377987|12638879|P1|COMPLETED|First Intervention (7 Days)||14
5138091|NCT01377987|12638878|P2|STARTED|First Intervention (7 Days)||15
5138092|NCT01377987|12638879|P1|STARTED|First Intervention (7 Days)||14
5138093|NCT01377922|12638897|P2|NOT COMPLETED|Overall Study||0
5138094|NCT01377922|12638898|P1|NOT COMPLETED|Overall Study||1
5138095|NCT01377922|12638897|P2|COMPLETED|Overall Study||16
5138096|NCT01377922|12638898|P1|COMPLETED|Overall Study||21
5138097|NCT01377922|12638897|P2|STARTED|Overall Study||16
5138098|NCT01377922|12638898|P1|STARTED|Overall Study||22
5138099|NCT01377636|12638910|P1|NOT COMPLETED|Overall Study||0
5138100|NCT01377636|12638910|P1|COMPLETED|Overall Study||20
5138101|NCT01377636|12638910|P1|STARTED|Overall Study||20
5138102|NCT01377623|12638924|P2|NOT COMPLETED|Overall Study||5
5138103|NCT01377623|12638925|P1|NOT COMPLETED|Overall Study||7
5138104|NCT01377623|12638924|P2|COMPLETED|Overall Study||28
5138105|NCT01377623|12638925|P1|COMPLETED|Overall Study||26
5138106|NCT01377623|12638924|P2|STARTED|Overall Study||33
5138107|NCT01377623|12638925|P1|STARTED|Overall Study||33
5138108|NCT01377584|12638945|P6|NOT COMPLETED|Overall Study||3
5138109|NCT01377584|12638946|P5|NOT COMPLETED|Overall Study||3
5138110|NCT01377584|12638947|P4|NOT COMPLETED|Overall Study||4
5138111|NCT01377584|12638948|P3|NOT COMPLETED|Overall Study||4
5138112|NCT01377584|12638949|P2|NOT COMPLETED|Overall Study||3
5138113|NCT01377584|12638950|P1|NOT COMPLETED|Overall Study||3
5138114|NCT01377584|12638945|P6|COMPLETED|Overall Study||9
5138115|NCT01377584|12638946|P5|COMPLETED|Overall Study||9
5138116|NCT01377584|12638947|P4|COMPLETED|Overall Study||6
5138117|NCT01377584|12638948|P3|COMPLETED|Overall Study||6
5138118|NCT01377584|12638949|P2|COMPLETED|Overall Study||5
5138119|NCT01377584|12638950|P1|COMPLETED|Overall Study||5
5138120|NCT01377584|12638945|P6|STARTED|Overall Study||12
5138121|NCT01377584|12638946|P5|STARTED|Overall Study||12
5138122|NCT01377584|12638947|P4|STARTED|Overall Study||10
5138123|NCT01377584|12638948|P3|STARTED|Overall Study||10
5138124|NCT01377584|12638949|P2|STARTED|Overall Study||8
5138125|NCT01377584|12638950|P1|STARTED|Overall Study||8
5138126|NCT01377480|12638983|P4|NOT COMPLETED|Overall Study||11
5138127|NCT01377480|12638984|P3|NOT COMPLETED|Overall Study||10
5138128|NCT01377480|12638985|P2|NOT COMPLETED|Overall Study||1
5138129|NCT01377480|12638986|P1|NOT COMPLETED|Overall Study||0
5138130|NCT01377480|12638983|P4|COMPLETED|Overall Study||19
5138131|NCT01377480|12638984|P3|COMPLETED|Overall Study||18
5138132|NCT01377480|12638985|P2|COMPLETED|Overall Study||29
5138133|NCT01377480|12638986|P1|COMPLETED|Overall Study||32
5138134|NCT01377480|12638983|P4|STARTED|Overall Study||30
5138135|NCT01377480|12638984|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
5138136|NCT01377480|12638985|P2|STARTED|Overall Study||30
5138137|NCT01377480|12638986|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
5138138|NCT01377467|12638998|P2|NOT COMPLETED|Overall Study||0
5138139|NCT01377467|12638999|P1|NOT COMPLETED|Overall Study||0
5138140|NCT01377467|12638998|P2|COMPLETED|Overall Study||44
5138141|NCT01377467|12638999|P1|COMPLETED|Overall Study||46
5138142|NCT01377467|12638998|P2|STARTED|Overall Study||44
5138143|NCT01377467|12638999|P1|STARTED|Overall Study||46
5138144|NCT01377441|12639047|P2|NOT COMPLETED|Overall Study||0
5138145|NCT01377441|12639048|P1|NOT COMPLETED|Overall Study||0
5138146|NCT01377441|12639047|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
5138147|NCT01377441|12639048|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
5138148|NCT01377441|12639047|P2|STARTED|Overall Study||0
5138149|NCT01377441|12639048|P1|STARTED|Overall Study||0
5138150|NCT01377402|12639056|P1|NOT COMPLETED|Overall Study||0
5138151|NCT01377402|12639056|P1|COMPLETED|Overall Study||982
5138152|NCT01377402|12639056|P1|STARTED|Overall Study||982
5138153|NCT01377389|12639062|P1|NOT COMPLETED|Overall Study||3
5138154|NCT01377389|12639062|P1|COMPLETED|Overall Study||27
5138155|NCT01377389|12639062|P1|STARTED|Overall Study||30
5138156|NCT01377233|12639076|P5|NOT COMPLETED|Double-blind||2
5138157|NCT01377233|12639077|P4|NOT COMPLETED|Double-blind||4
5138158|NCT01377233|12639078|P3|NOT COMPLETED|Double-blind||2
5138159|NCT01377233|12639079|P2|NOT COMPLETED|Double-blind||1
5138160|NCT01377233|12639080|P1|NOT COMPLETED|Double-blind||0
5138161|NCT01377233|12639076|P5|COMPLETED|Double-blind||8
5138162|NCT01377233|12639077|P4|COMPLETED|Double-blind||7
5138163|NCT01377233|12639078|P3|COMPLETED|Double-blind||8
5138164|NCT01377233|12639079|P2|COMPLETED|Double-blind||10
5138165|NCT01377233|12639080|P1|COMPLETED|Double-blind||0
5138166|NCT01377233|12639076|P5|STARTED|Double-blind||10
5138167|NCT01377233|12639077|P4|STARTED|Double-blind||11
5138168|NCT01377233|12639078|P3|STARTED|Double-blind||10
5138169|NCT01377233|12639079|P2|STARTED|Double-blind||11
5138170|NCT01377233|12639080|P1|STARTED|Double-blind||0
5138171|NCT01377233|12639076|P5|NOT COMPLETED|Open-label||0
5138172|NCT01377233|12639077|P4|NOT COMPLETED|Open-label||0
5138173|NCT01377233|12639078|P3|NOT COMPLETED|Open-label||0
5138174|NCT01377233|12639079|P2|NOT COMPLETED|Open-label||0
5138175|NCT01377233|12639080|P1|NOT COMPLETED|Open-label||4
5138176|NCT01377233|12639076|P5|COMPLETED|Open-label||0
5138177|NCT01377233|12639077|P4|COMPLETED|Open-label||0
5138178|NCT01377233|12639078|P3|COMPLETED|Open-label||0
5138179|NCT01377233|12639079|P2|COMPLETED|Open-label||0
5138180|NCT01377233|12639080|P1|COMPLETED|Open-label||42
5138181|NCT01377233|12639076|P5|STARTED|Open-label||0
5138182|NCT01377233|12639077|P4|STARTED|Open-label||0
5138183|NCT01377233|12639078|P3|STARTED|Open-label||0
5138184|NCT01377233|12639079|P2|STARTED|Open-label||0
5138185|NCT01377233|12639080|P1|STARTED|Open-label||46
5138186|NCT01377194|12639107|P3|NOT COMPLETED|Overall Study||46
5138187|NCT01377194|12639108|P2|NOT COMPLETED|Overall Study||43
5138188|NCT01377194|12639109|P1|NOT COMPLETED|Overall Study||32
5138189|NCT01377194|12639107|P3|COMPLETED|Overall Study||142
5138190|NCT01377194|12639108|P2|COMPLETED|Overall Study||145
5138191|NCT01377194|12639109|P1|COMPLETED|Overall Study||154
5138192|NCT01377194|12639107|P3|STARTED|Overall Study||188
5138193|NCT01377194|12639108|P2|STARTED|Overall Study||188
5138194|NCT01377194|12639109|P1|STARTED|Overall Study||186
5138195|NCT01377012|12639123|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
5138196|NCT01377012|12639124|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
5138197|NCT01377012|12639125|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
5138198|NCT01377012|12639123|P3|COMPLETED|Extension Study, Weeks 104-260||0
5138199|NCT01377012|12639124|P2|COMPLETED|Extension Study, Weeks 104-260||0
5138200|NCT01377012|12639125|P1|COMPLETED|Extension Study, Weeks 104-260||0
5138201|NCT01377012|12639123|P3|STARTED|Extension Study, Weeks 104-260||68
5138202|NCT01377012|12639124|P2|STARTED|Extension Study, Weeks 104-260||71
5138203|NCT01377012|12639125|P1|STARTED|Extension Study, Weeks 104-260||57
5138204|NCT01377012|12639123|P3|NOT COMPLETED|Core Study||134
5138205|NCT01377012|12639124|P2|NOT COMPLETED|Core Study||132
5138206|NCT01377012|12639125|P1|NOT COMPLETED|Core Study||134
5138207|NCT01377012|12639123|P3|COMPLETED|Core Study||80
5138208|NCT01377012|12639124|P2|COMPLETED|Core Study||81
5138209|NCT01377012|12639125|P1|COMPLETED|Core Study||76
5138210|NCT01377012|12639123|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
5138211|NCT01377012|12639124|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
5138212|NCT01377012|12639125|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
5138213|NCT01377012|12639123|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
5138214|NCT01377012|12639124|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
5138215|NCT01377012|12639125|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
5138216|NCT01377012|12639123|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
5138217|NCT01377012|12639124|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
5138218|NCT01377012|12639125|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
5138219|NCT01377012|12639123|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
5138220|NCT01377012|12639124|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
5138221|NCT01377012|12639125|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
5138222|NCT01377012|12639123|P3|STARTED|Core Study||214
5138223|NCT01377012|12639124|P2|STARTED|Core Study||213
5138224|NCT01377012|12639125|P1|STARTED|Core Study||210
5138225|NCT01376908|12639162|P2|NOT COMPLETED|Overall Study||3
5138226|NCT01376908|12639163|P1|NOT COMPLETED|Overall Study||2
5138227|NCT01376908|12639162|P2|COMPLETED|Overall Study||26
5138228|NCT01376908|12639163|P1|COMPLETED|Overall Study||25
5138229|NCT01376908|12639162|P2|STARTED|Overall Study||29
5138230|NCT01376908|12639163|P1|STARTED|Overall Study||27
5138231|NCT01376804|12639196|P1|NOT COMPLETED|Follow-up Period||0
5138232|NCT01376804|12639196|P1|COMPLETED|Follow-up Period||55
5138233|NCT01376804|12639196|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
5138234|NCT01376804|12639196|P1|NOT COMPLETED|Treatment Period||8
5138235|NCT01376804|12639196|P1|COMPLETED|Treatment Period||49
5138236|NCT01376804|12639196|P1|Received Study Drug|Treatment Period||56
5138237|NCT01376804|12639196|P1|STARTED|Treatment Period||57
5138238|NCT01376700|12639207|P1|NOT COMPLETED|Overall Study||16
5138239|NCT01376700|12639207|P1|COMPLETED|Overall Study||3
5138240|NCT01376700|12639207|P1|STARTED|Overall Study||19
5138241|NCT01376557|12639228|P5|NOT COMPLETED|Overall Study||7
5138242|NCT01376557|12639229|P4|NOT COMPLETED|Overall Study||6
5138243|NCT01376557|12639230|P3|NOT COMPLETED|Overall Study||5
5138244|NCT01376557|12639231|P2|NOT COMPLETED|Overall Study||6
5138245|NCT01376557|12639232|P1|NOT COMPLETED|Overall Study||8
5138246|NCT01376557|12639228|P5|COMPLETED|Overall Study||53
5138247|NCT01376557|12639229|P4|COMPLETED|Overall Study||54
5138248|NCT01376557|12639230|P3|COMPLETED|Overall Study||55
5138249|NCT01376557|12639231|P2|COMPLETED|Overall Study||54
5138250|NCT01376557|12639232|P1|COMPLETED|Overall Study||51
5138251|NCT01376557|12639228|P5|STARTED|Overall Study||60
5138252|NCT01376557|12639229|P4|STARTED|Overall Study||60
5138253|NCT01376557|12639230|P3|STARTED|Overall Study||60
5138254|NCT01376557|12639231|P2|STARTED|Overall Study||60
5138255|NCT01376557|12639232|P1|STARTED|Overall Study||59
5138256|NCT01376388|12639269|P1|NOT COMPLETED|Overall Study||18
5138257|NCT01376388|12639269|P1|COMPLETED|Overall Study||112
5138258|NCT01376388|12639269|P1|STARTED|Overall Study||130
5138259|NCT01376362|12639284|P1|NOT COMPLETED|Overall Study||0
5138260|NCT01376362|12639284|P1|COMPLETED|Overall Study||5
5138261|NCT01376362|12639284|P1|STARTED|Overall Study||5
5138262|NCT01376349|12639307|P3|NOT COMPLETED|Optional Continuation Phase||0
5138263|NCT01376349|12639308|P2|NOT COMPLETED|Optional Continuation Phase||0
5138264|NCT01376349|12639309|P1|NOT COMPLETED|Optional Continuation Phase||0
5138265|NCT01376349|12639307|P3|COMPLETED|Optional Continuation Phase||94
5138266|NCT01376349|12639308|P2|COMPLETED|Optional Continuation Phase||0
5138267|NCT01376349|12639309|P1|COMPLETED|Optional Continuation Phase||0
5138268|NCT01376349|12639307|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
5138269|NCT01376349|12639308|P2|STARTED|Optional Continuation Phase||0
5138270|NCT01376349|12639309|P1|STARTED|Optional Continuation Phase||0
5138271|NCT01376349|12639307|P3|NOT COMPLETED|Raondomized Treatment||29
5138272|NCT01376349|12639308|P2|NOT COMPLETED|Raondomized Treatment||35
5138273|NCT01376349|12639309|P1|NOT COMPLETED|Raondomized Treatment||24
5138274|NCT01376349|12639307|P3|COMPLETED|Raondomized Treatment||118
5138275|NCT01376349|12639308|P2|COMPLETED|Raondomized Treatment||114
5138276|NCT01376349|12639309|P1|COMPLETED|Raondomized Treatment||123
5138277|NCT01376349|12639307|P3|STARTED|Raondomized Treatment||147
5138278|NCT01376349|12639308|P2|STARTED|Raondomized Treatment||149
5138279|NCT01376349|12639309|P1|STARTED|Raondomized Treatment||147
5138280|NCT01376323|12639323|P5|NOT COMPLETED|Overall Study||1
5138281|NCT01376323|12639324|P4|NOT COMPLETED|Overall Study||5
5138282|NCT01376323|12639325|P3|NOT COMPLETED|Overall Study||3
5138283|NCT01376323|12639326|P2|NOT COMPLETED|Overall Study||1
5138284|NCT01376323|12639327|P1|NOT COMPLETED|Overall Study||2
5138285|NCT01376323|12639323|P5|COMPLETED|Overall Study||17
5138286|NCT01376323|12639324|P4|COMPLETED|Overall Study||14
5138287|NCT01376323|12639325|P3|COMPLETED|Overall Study||16
5138288|NCT01376323|12639326|P2|COMPLETED|Overall Study||17
5138289|NCT01376323|12639327|P1|COMPLETED|Overall Study||18
5138290|NCT01376323|12639323|P5|STARTED|Overall Study||18
5138291|NCT01376323|12639324|P4|STARTED|Overall Study||19
5138292|NCT01376323|12639325|P3|STARTED|Overall Study||19
5138293|NCT01376323|12639326|P2|STARTED|Overall Study||18
5138294|NCT01376323|12639327|P1|STARTED|Overall Study||20
5138295|NCT01376310|12639411|P2|NOT COMPLETED|Overall Study||11
5138296|NCT01376310|12639412|P1|NOT COMPLETED|Overall Study||36
5138297|NCT01376310|12639411|P2|COMPLETED|Overall Study||22
5138298|NCT01376310|12639412|P1|COMPLETED|Overall Study||90
5138299|NCT01376310|12639411|P2|STARTED|Overall Study||33
5138300|NCT01376310|12639412|P1|STARTED|Overall Study||126
5138301|NCT01376297|12639420|P2|NOT COMPLETED|Overall Study||49
5138302|NCT01376297|12639421|P1|NOT COMPLETED|Overall Study||128
5138303|NCT01376297|12639420|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
5138304|NCT01376297|12639421|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
5138305|NCT01376297|12639420|P2|STARTED|Overall Study|number of randomised patients|104
5138306|NCT01376297|12639421|P1|STARTED|Overall Study|number of randomised patients|309
5138307|NCT01376245|12639431|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
5138308|NCT01376245|12639432|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
5138309|NCT01376245|12639433|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
5138310|NCT01376245|12639434|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
5138311|NCT01376245|12639435|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
5138312|NCT01376245|12639431|P5|COMPLETED|24-week, Double-blind Treatment Period||134
5138313|NCT01376245|12639432|P4|COMPLETED|24-week, Double-blind Treatment Period||138
5138314|NCT01376245|12639433|P3|COMPLETED|24-week, Double-blind Treatment Period||135
5138315|NCT01376245|12639434|P2|COMPLETED|24-week, Double-blind Treatment Period||130
5138316|NCT01376245|12639435|P1|COMPLETED|24-week, Double-blind Treatment Period||0
5138317|NCT01376245|12639431|P5|STARTED|24-week, Double-blind Treatment Period||160
5138318|NCT01376245|12639432|P4|STARTED|24-week, Double-blind Treatment Period||161
5138319|NCT01376245|12639433|P3|STARTED|24-week, Double-blind Treatment Period||160
5138320|NCT01376245|12639434|P2|STARTED|24-week, Double-blind Treatment Period||162
5138321|NCT01376245|12639435|P1|STARTED|24-week, Double-blind Treatment Period||0
5138322|NCT01376245|12639431|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138323|NCT01376245|12639432|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138324|NCT01376245|12639433|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138325|NCT01376245|12639434|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138326|NCT01376245|12639435|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
5138327|NCT01376245|12639431|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138328|NCT01376245|12639432|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138329|NCT01376245|12639433|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138330|NCT01376245|12639434|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
5138331|NCT01376245|12639435|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
5138332|NCT01376245|12639431|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
5138333|NCT01376245|12639432|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
5138334|NCT01376245|12639433|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
5138335|NCT01376245|12639434|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
5138336|NCT01376245|12639435|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
5138337|NCT01376167|12639452|P3|NOT COMPLETED|Overall Study||6
5138338|NCT01376167|12639453|P2|NOT COMPLETED|Overall Study||10
5138339|NCT01376167|12639454|P1|NOT COMPLETED|Overall Study||4
5138340|NCT01376167|12639452|P3|COMPLETED|Overall Study||123
5138341|NCT01376167|12639453|P2|COMPLETED|Overall Study||250
5138342|NCT01376167|12639454|P1|COMPLETED|Overall Study||129
5138343|NCT01376167|12639452|P3|STARTED|Overall Study||129
5138344|NCT01376167|12639453|P2|STARTED|Overall Study||260
5138345|NCT01376167|12639454|P1|STARTED|Overall Study||133
5138346|NCT01376089|12639525|P2|NOT COMPLETED|Overall Study||4
5138347|NCT01376089|12639526|P1|NOT COMPLETED|Overall Study||3
5138348|NCT01376089|12639525|P2|COMPLETED|Overall Study||144
5138349|NCT01376089|12639526|P1|COMPLETED|Overall Study||148
5138350|NCT01376089|12639525|P2|STARTED|Overall Study||148
5138351|NCT01376089|12639526|P1|STARTED|Overall Study||151
5138352|NCT01376050|12639538|P2|NOT COMPLETED|Overall Study||0
5138353|NCT01376050|12639539|P1|NOT COMPLETED|Overall Study||0
5138354|NCT01376050|12639538|P2|COMPLETED|Overall Study||11
5138355|NCT01376050|12639539|P1|COMPLETED|Overall Study||13
5138356|NCT01376050|12639538|P2|STARTED|Overall Study||11
5138357|NCT01376050|12639539|P1|STARTED|Overall Study||13
5138358|NCT01376037|12639549|P2|NOT COMPLETED|Overall Study||2
5138359|NCT01376037|12639550|P1|NOT COMPLETED|Overall Study||0
5138360|NCT01376037|12639549|P2|COMPLETED|Overall Study||29
5138361|NCT01376037|12639550|P1|COMPLETED|Overall Study||31
5138362|NCT01376037|12639549|P2|STARTED|Overall Study||31
5138363|NCT01376037|12639550|P1|STARTED|Overall Study||31
5138364|NCT01375946|12639556|P6|NOT COMPLETED|Overall Study||0
5138365|NCT01375946|12639557|P5|NOT COMPLETED|Overall Study||0
5138366|NCT01375946|12639558|P4|NOT COMPLETED|Overall Study||0
5138367|NCT01375946|12639559|P3|NOT COMPLETED|Overall Study||0
5138368|NCT01375946|12639560|P2|NOT COMPLETED|Overall Study||0
5138369|NCT01375946|12639561|P1|NOT COMPLETED|Overall Study||0
5138370|NCT01375946|12639556|P6|COMPLETED|Overall Study||4
5138371|NCT01375946|12639557|P5|COMPLETED|Overall Study||4
5138372|NCT01375946|12639558|P4|COMPLETED|Overall Study||4
5138373|NCT01375946|12639559|P3|COMPLETED|Overall Study||4
5138374|NCT01375946|12639560|P2|COMPLETED|Overall Study||4
5138375|NCT01375946|12639561|P1|COMPLETED|Overall Study||4
5138376|NCT01375946|12639556|P6|STARTED|Overall Study||4
5138377|NCT01375946|12639557|P5|STARTED|Overall Study||4
5138378|NCT01375946|12639558|P4|STARTED|Overall Study||4
5138379|NCT01375946|12639559|P3|STARTED|Overall Study||4
5138380|NCT01375946|12639560|P2|STARTED|Overall Study||4
5138381|NCT01375946|12639561|P1|STARTED|Overall Study||4
5138382|NCT01375777|12639578|P9|NOT COMPLETED|Overall Study||2
5138383|NCT01375777|12639579|P8|NOT COMPLETED|Overall Study||2
5138384|NCT01375777|12639580|P7|NOT COMPLETED|Overall Study||2
5138385|NCT01375777|12639581|P6|NOT COMPLETED|Overall Study||1
5138386|NCT01375777|12639582|P5|NOT COMPLETED|Overall Study||1
5138387|NCT01375777|12639583|P4|NOT COMPLETED|Overall Study||0
5138388|NCT01375777|12639584|P3|NOT COMPLETED|Overall Study||1
5138389|NCT01375777|12639585|P2|NOT COMPLETED|Overall Study||3
5138390|NCT01375777|12639586|P1|NOT COMPLETED|Overall Study||2
5138391|NCT01375777|12639578|P9|COMPLETED|Overall Study||44
5138392|NCT01375777|12639579|P8|COMPLETED|Overall Study||44
5138393|NCT01375777|12639580|P7|COMPLETED|Overall Study||44
5138394|NCT01375777|12639581|P6|COMPLETED|Overall Study||44
5138395|NCT01375777|12639582|P5|COMPLETED|Overall Study||45
5138396|NCT01375777|12639583|P4|COMPLETED|Overall Study||45
5138397|NCT01375777|12639584|P3|COMPLETED|Overall Study||45
5138398|NCT01375777|12639585|P2|COMPLETED|Overall Study||42
5138399|NCT01375777|12639586|P1|COMPLETED|Overall Study||44
5138400|NCT01375777|12639578|P9|Received Treatment|Overall Study||45
5138401|NCT01375777|12639579|P8|Received Treatment|Overall Study||45
5138402|NCT01375777|12639580|P7|Received Treatment|Overall Study||45
5138403|NCT01375777|12639581|P6|Received Treatment|Overall Study||45
5138404|NCT01375777|12639582|P5|Received Treatment|Overall Study||46
5138405|NCT01375777|12639583|P4|Received Treatment|Overall Study||45
5138406|NCT01375777|12639584|P3|Received Treatment|Overall Study||45
5138407|NCT01375777|12639585|P2|Received Treatment|Overall Study||45
5138408|NCT01375777|12639586|P1|Received Treatment|Overall Study||45
5138409|NCT01375777|12639578|P9|STARTED|Overall Study||46
5138410|NCT01375777|12639579|P8|STARTED|Overall Study||46
5138411|NCT01375777|12639580|P7|STARTED|Overall Study||46
5138412|NCT01375777|12639581|P6|STARTED|Overall Study||45
5138413|NCT01375777|12639582|P5|STARTED|Overall Study||46
5138414|NCT01375777|12639583|P4|STARTED|Overall Study||45
5138415|NCT01375777|12639584|P3|STARTED|Overall Study||46
5138416|NCT01375777|12639585|P2|STARTED|Overall Study||45
5138417|NCT01375777|12639586|P1|STARTED|Overall Study||46
5138418|NCT01375764|12639656|P5|NOT COMPLETED|Overall Study||1
5138419|NCT01375764|12639657|P4|NOT COMPLETED|Overall Study||1
5138420|NCT01375764|12639658|P3|NOT COMPLETED|Overall Study||0
5138421|NCT01375764|12639659|P2|NOT COMPLETED|Overall Study||1
5138422|NCT01375764|12639660|P1|NOT COMPLETED|Overall Study||2
5138423|NCT01375764|12639656|P5|COMPLETED|Overall Study||31
5138424|NCT01375764|12639657|P4|COMPLETED|Overall Study||31
5138425|NCT01375764|12639658|P3|COMPLETED|Overall Study||32
5138426|NCT01375764|12639659|P2|COMPLETED|Overall Study||30
5138427|NCT01375764|12639660|P1|COMPLETED|Overall Study||31
5138428|NCT01375764|12639656|P5|Received Treatment|Overall Study||32
5138429|NCT01375764|12639657|P4|Received Treatment|Overall Study||31
5138430|NCT01375764|12639658|P3|Received Treatment|Overall Study||32
5138431|NCT01375764|12639659|P2|Received Treatment|Overall Study||30
5138432|NCT01375764|12639660|P1|Received Treatment|Overall Study||32
5138433|NCT01375764|12639656|P5|STARTED|Overall Study||32
5138434|NCT01375764|12639657|P4|STARTED|Overall Study||32
5138435|NCT01375764|12639658|P3|STARTED|Overall Study||32
5138436|NCT01375764|12639659|P2|STARTED|Overall Study||31
5138437|NCT01375764|12639660|P1|STARTED|Overall Study||33
5138438|NCT01375751|12639706|P3|NOT COMPLETED|Overall Study||0
5138439|NCT01375751|12639707|P2|NOT COMPLETED|Overall Study||1
5138440|NCT01375751|12639708|P1|NOT COMPLETED|Overall Study||0
5138441|NCT01375751|12639706|P3|COMPLETED|Overall Study||56
5138442|NCT01375751|12639707|P2|COMPLETED|Overall Study||55
5138443|NCT01375751|12639708|P1|COMPLETED|Overall Study||56
5138444|NCT01375751|12639706|P3|Received Treatment|Overall Study||56
5138445|NCT01375751|12639707|P2|Received Treatment|Overall Study||55
5138446|NCT01375751|12639708|P1|Received Treatment|Overall Study||56
5138447|NCT01375751|12639706|P3|STARTED|Overall Study||56
5138448|NCT01375751|12639707|P2|STARTED|Overall Study||56
5138449|NCT01375751|12639708|P1|STARTED|Overall Study||56
5138450|NCT01375673|12639733|P2|NOT COMPLETED|Overall Study||1
5138451|NCT01375673|12639734|P1|NOT COMPLETED|Overall Study||0
5138452|NCT01375673|12639733|P2|COMPLETED|Overall Study||6
5138453|NCT01375673|12639734|P1|COMPLETED|Overall Study||7
5138454|NCT01375673|12639733|P2|STARTED|Overall Study||7
5138455|NCT01375673|12639734|P1|STARTED|Overall Study||7
5138456|NCT01375660|12639746|P2|NOT COMPLETED|Overall Study||16
5138457|NCT01375660|12639747|P1|NOT COMPLETED|Overall Study||16
5138458|NCT01375660|12639746|P2|COMPLETED|Overall Study||87
5138459|NCT01375660|12639747|P1|COMPLETED|Overall Study||86
5138460|NCT01375660|12639746|P2|STARTED|Overall Study||103
5138461|NCT01375660|12639747|P1|STARTED|Overall Study||102
5138462|NCT01375608|12639765|P1|NOT COMPLETED|Overall Study||2
5138463|NCT01375608|12639765|P1|COMPLETED|Overall Study||8
5138464|NCT01375608|12639765|P1|STARTED|Overall Study||10
5138465|NCT01375569|12639769|P1|NOT COMPLETED|Overall Study||0
5138466|NCT01375569|12639769|P1|COMPLETED|Overall Study||11
5138467|NCT01375569|12639769|P1|STARTED|Overall Study||11
5138468|NCT01375491|12639777|P3|NOT COMPLETED|Overall Study||0
5138469|NCT01375491|12639778|P2|NOT COMPLETED|Overall Study||1
5138470|NCT01375491|12639779|P1|NOT COMPLETED|Overall Study||2
5138471|NCT01375491|12639777|P3|COMPLETED|Overall Study||15
5138472|NCT01375491|12639778|P2|COMPLETED|Overall Study||12
5138473|NCT01375491|12639779|P1|COMPLETED|Overall Study||9
5138474|NCT01375491|12639777|P3|STARTED|Overall Study||15
5138475|NCT01375491|12639778|P2|STARTED|Overall Study||13
5138476|NCT01375491|12639779|P1|STARTED|Overall Study||11
5138477|NCT01375374|12639793|P1|NOT COMPLETED|Overall Study||1
5138478|NCT01375374|12639793|P1|COMPLETED|Overall Study||10
5138479|NCT01375374|12639793|P1|STARTED|Overall Study||11
5138480|NCT01375205|12639802|P2|NOT COMPLETED|Overall Study||13
5138481|NCT01375205|12639803|P1|NOT COMPLETED|Overall Study||21
5138482|NCT01375205|12639802|P2|COMPLETED|Overall Study||33
5138483|NCT01375205|12639803|P1|COMPLETED|Overall Study||33
5138484|NCT01375205|12639802|P2|STARTED|Overall Study||46
5138485|NCT01375205|12639803|P1|STARTED|Overall Study||54
5138486|NCT01375140|12639823|P1|NOT COMPLETED|Overall Study||0
5138487|NCT01375140|12639823|P1|COMPLETED|Overall Study||31
5138488|NCT01375140|12639823|P1|STARTED|Overall Study||31
5138489|NCT01375127|12639833|P6|NOT COMPLETED|Overall Study||0
5138490|NCT01375127|12639834|P5|NOT COMPLETED|Overall Study||0
5138491|NCT01375127|12639835|P4|NOT COMPLETED|Overall Study||0
5138492|NCT01375127|12639836|P3|NOT COMPLETED|Overall Study||0
5138493|NCT01375127|12639837|P2|NOT COMPLETED|Overall Study||0
5138494|NCT01375127|12639838|P1|NOT COMPLETED|Overall Study||0
5138495|NCT01375127|12639833|P6|COMPLETED|Overall Study||3
5138496|NCT01375127|12639834|P5|COMPLETED|Overall Study||5
5138497|NCT01375127|12639835|P4|COMPLETED|Overall Study||33
5138498|NCT01375127|12639836|P3|COMPLETED|Overall Study||40
5138499|NCT01375127|12639837|P2|COMPLETED|Overall Study||1
5138500|NCT01375127|12639838|P1|COMPLETED|Overall Study||1
5138501|NCT01375127|12639833|P6|STARTED|Overall Study||3
5138502|NCT01375127|12639834|P5|STARTED|Overall Study||5
5138503|NCT01375127|12639835|P4|STARTED|Overall Study||33
5138504|NCT01375127|12639836|P3|STARTED|Overall Study||40
5138505|NCT01375127|12639837|P2|STARTED|Overall Study||1
5138506|NCT01375127|12639838|P1|STARTED|Overall Study||1
5138507|NCT01375075|12639876|P6|NOT COMPLETED|Overall Study||3
5138508|NCT01375075|12639877|P5|NOT COMPLETED|Overall Study||0
5138509|NCT01375075|12639878|P4|NOT COMPLETED|Overall Study||1
5138510|NCT01375075|12639879|P3|NOT COMPLETED|Overall Study||3
5138511|NCT01375075|12639880|P2|NOT COMPLETED|Overall Study||1
5138512|NCT01375075|12639881|P1|NOT COMPLETED|Overall Study||1
5138513|NCT01375075|12639876|P6|COMPLETED|Overall Study||25
5138514|NCT01375075|12639877|P5|COMPLETED|Overall Study||27
5138515|NCT01375075|12639878|P4|COMPLETED|Overall Study||27
5138516|NCT01375075|12639879|P3|COMPLETED|Overall Study||24
5138517|NCT01375075|12639880|P2|COMPLETED|Overall Study||27
5138518|NCT01375075|12639881|P1|COMPLETED|Overall Study||26
5138519|NCT01375075|12639876|P6|Received at Least One Dose of Study Drug|Overall Study||28
5138520|NCT01375075|12639877|P5|Received at Least One Dose of Study Drug|Overall Study||27
5138521|NCT01375075|12639878|P4|Received at Least One Dose of Study Drug|Overall Study||28
5138522|NCT01375075|12639879|P3|Received at Least One Dose of Study Drug|Overall Study||27
5138523|NCT01375075|12639880|P2|Received at Least One Dose of Study Drug|Overall Study||28
5138524|NCT01375075|12639881|P1|Received at Least One Dose of Study Drug|Overall Study||27
5138525|NCT01375075|12639876|P6|STARTED|Overall Study||28
5138526|NCT01375075|12639877|P5|STARTED|Overall Study||27
5138527|NCT01375075|12639878|P4|STARTED|Overall Study||28
5138528|NCT01375075|12639879|P3|STARTED|Overall Study||27
5138529|NCT01375075|12639880|P2|STARTED|Overall Study||28
5138530|NCT01375075|12639881|P1|STARTED|Overall Study||27
5138531|NCT01375049|12639965|P1|NOT COMPLETED|Overall Study||50
5138532|NCT01375049|12639965|P1|COMPLETED|Overall Study||55
5138533|NCT01375049|12639965|P1|STARTED|Overall Study||105
5138534|NCT01375010|12639982|P2|NOT COMPLETED|Overall Study||4
5138535|NCT01375010|12639983|P1|NOT COMPLETED|Overall Study||12
5138536|NCT01375010|12639982|P2|COMPLETED|Overall Study||38
5138537|NCT01375010|12639983|P1|COMPLETED|Overall Study||31
5138538|NCT01375010|12639982|P2|STARTED|Overall Study||42
5138539|NCT01375010|12639983|P1|STARTED|Overall Study||43
5138540|NCT01374971|12639997|P1|NOT COMPLETED|Overall Study||1
5138541|NCT01374971|12639997|P1|COMPLETED|Overall Study||11
5138542|NCT01374971|12639997|P1|STARTED|Overall Study||12
5138543|NCT01374919|12640002|P1|NOT COMPLETED|Overall Study||2
5138544|NCT01374919|12640002|P1|COMPLETED|Overall Study||58
5138545|NCT01374919|12640002|P1|STARTED|Overall Study||60
5138546|NCT01374906|12640009|P2|NOT COMPLETED|Overall Study||48
5138547|NCT01374906|12640010|P1|NOT COMPLETED|Overall Study||40
5138548|NCT01374906|12640009|P2|COMPLETED|Overall Study||28
5138549|NCT01374906|12640010|P1|COMPLETED|Overall Study||34
5138550|NCT01374906|12640009|P2|Completed Extension Phase|Overall Study||15
5138551|NCT01374906|12640010|P1|Completed Extension Phase|Overall Study||24
5138552|NCT01374906|12640009|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
5138553|NCT01374906|12640010|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
5138554|NCT01374906|12640009|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
5138555|NCT01374906|12640010|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
5138556|NCT01374906|12640009|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
5138557|NCT01374906|12640010|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
5138558|NCT01374906|12640009|P2|Completed Core Phase|Overall Study||54
5138559|NCT01374906|12640010|P1|Completed Core Phase|Overall Study||50
5138560|NCT01374906|12640009|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
5138561|NCT01374906|12640010|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
5138562|NCT01374906|12640009|P2|STARTED|Overall Study||76
5138563|NCT01374906|12640010|P1|STARTED|Overall Study||74
5138564|NCT01374802|12640077|P1|NOT COMPLETED|Overall Study||0
5138565|NCT01374802|12640077|P1|COMPLETED|Overall Study||14
5138566|NCT01374802|12640077|P1|STARTED|Overall Study||14
5138567|NCT01374568|12640091|P2|NOT COMPLETED|Overall Study||2
5138568|NCT01374568|12640092|P1|NOT COMPLETED|Overall Study||0
5138569|NCT01374568|12640091|P2|COMPLETED|Overall Study||1
5138570|NCT01374568|12640092|P1|COMPLETED|Overall Study||2
5138571|NCT01374568|12640091|P2|STARTED|Overall Study||3
5138572|NCT01374568|12640092|P1|STARTED|Overall Study||2
5138573|NCT01374516|12640102|P2|NOT COMPLETED|Surveillance Expansion Period||1253
5138574|NCT01374516|12640103|P1|NOT COMPLETED|Surveillance Expansion Period||2349
5138575|NCT01374516|12640102|P2|COMPLETED|Surveillance Expansion Period||5387
5138576|NCT01374516|12640103|P1|COMPLETED|Surveillance Expansion Period||10932
5138577|NCT01374516|12640102|P2|STARTED|Surveillance Expansion Period||6640
5138578|NCT01374516|12640103|P1|STARTED|Surveillance Expansion Period||13281
5138579|NCT01374516|12640102|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
5138580|NCT01374516|12640103|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
5138581|NCT01374516|12640102|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
5138582|NCT01374516|12640103|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
5138583|NCT01374516|12640102|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
5138584|NCT01374516|12640103|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
5138585|NCT01374451|12640137|P2|NOT COMPLETED|Overall Study||0
5138586|NCT01374451|12640138|P1|NOT COMPLETED|Overall Study||1
5138587|NCT01374451|12640137|P2|COMPLETED|Overall Study||81
5138588|NCT01374451|12640138|P1|COMPLETED|Overall Study||78
5138589|NCT01374451|12640137|P2|STARTED|Overall Study||81
5138590|NCT01374451|12640138|P1|STARTED|Overall Study||79
5138591|NCT01374438|12640167|P2|NOT COMPLETED|Overall Study||0
5138592|NCT01374438|12640168|P1|NOT COMPLETED|Overall Study||0
5138593|NCT01374438|12640167|P2|COMPLETED|Overall Study||13
5138594|NCT01374438|12640168|P1|COMPLETED|Overall Study||16
5138595|NCT01374438|12640167|P2|STARTED|Overall Study||13
5138596|NCT01374438|12640168|P1|STARTED|Overall Study||16
5138597|NCT01374425|12640184|P2|NOT COMPLETED|Overall Study||188
5138598|NCT01374425|12640185|P1|NOT COMPLETED|Overall Study||188
5138599|NCT01374425|12640184|P2|COMPLETED|Overall Study||0
5138600|NCT01374425|12640185|P1|COMPLETED|Overall Study||0
5138601|NCT01374425|12640184|P2|STARTED|Overall Study||188
5138602|NCT01374425|12640185|P1|STARTED|Overall Study||188
5138603|NCT01374269|12640265|P2|NOT COMPLETED|Overall Study||5
5138604|NCT01374269|12640266|P1|NOT COMPLETED|Overall Study||6
5138605|NCT01374269|12640265|P2|COMPLETED|Overall Study||39
5138606|NCT01374269|12640266|P1|COMPLETED|Overall Study||40
5138607|NCT01374269|12640265|P2|STARTED|Overall Study||44
5138608|NCT01374269|12640266|P1|STARTED|Overall Study||46
5138609|NCT01374217|12640394|P1|NOT COMPLETED|Overall Study||13
5138610|NCT01374217|12640394|P1|COMPLETED|Overall Study||0
5138611|NCT01374217|12640394|P1|STARTED|Overall Study||13
5138612|NCT01374178|12640402|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
5138613|NCT01374178|12640403|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
5138614|NCT01374178|12640402|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
5138615|NCT01374178|12640403|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
5138616|NCT01374178|12640402|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
5138617|NCT01374178|12640403|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
5138618|NCT01374178|12640402|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
5138619|NCT01374178|12640403|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
5138620|NCT01374178|12640402|P2|COMPLETED|Washout Period of at Least 7 Days||5
5138621|NCT01374178|12640403|P1|COMPLETED|Washout Period of at Least 7 Days||10
5138622|NCT01374178|12640402|P2|STARTED|Washout Period of at Least 7 Days||5
5138623|NCT01374178|12640403|P1|STARTED|Washout Period of at Least 7 Days||11
5138624|NCT01374178|12640402|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
5138625|NCT01374178|12640403|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
5138626|NCT01374178|12640402|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
5138627|NCT01374178|12640403|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
5138628|NCT01374178|12640402|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
5138629|NCT01374178|12640403|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
5138630|NCT01374178|12640402|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
5138631|NCT01374178|12640403|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
5138632|NCT01374087|12640421|P2|NOT COMPLETED|Overall Study||15
5138633|NCT01374087|12640422|P1|NOT COMPLETED|Overall Study||16
5138634|NCT01374087|12640421|P2|COMPLETED|Overall Study||0
5138635|NCT01374087|12640422|P1|COMPLETED|Overall Study||0
5138636|NCT01374087|12640421|P2|STARTED|Overall Study||15
5138637|NCT01374087|12640422|P1|STARTED|Overall Study||16
5138638|NCT01373931|12640442|P2|NOT COMPLETED|Period 2||0
5138639|NCT01373931|12640443|P1|NOT COMPLETED|Period 2||0
5138640|NCT01373931|12640442|P2|COMPLETED|Period 2||8
5138641|NCT01373931|12640443|P1|COMPLETED|Period 2||6
5138642|NCT01373931|12640442|P2|STARTED|Period 2||8
5138643|NCT01373931|12640443|P1|STARTED|Period 2||6
5138644|NCT01373931|12640442|P2|NOT COMPLETED|Period 1||2
5138645|NCT01373931|12640443|P1|NOT COMPLETED|Period 1||2
5138646|NCT01373931|12640442|P2|COMPLETED|Period 1||8
5138647|NCT01373931|12640443|P1|COMPLETED|Period 1||6
5138648|NCT01373931|12640442|P2|STARTED|Period 1||10
5138649|NCT01373931|12640443|P1|STARTED|Period 1||8
5138650|NCT01373931|12640442|P2|NOT COMPLETED|Lead-in Period||0
5138651|NCT01373931|12640443|P1|NOT COMPLETED|Lead-in Period||2
5138652|NCT01373931|12640442|P2|COMPLETED|Lead-in Period||10
5138653|NCT01373931|12640443|P1|COMPLETED|Lead-in Period||8
5138654|NCT01373931|12640442|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
5138655|NCT01373931|12640443|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
5138656|NCT01373931|12640442|P2|STARTED|Lead-in Period||10
5138657|NCT01373931|12640443|P1|STARTED|Lead-in Period||10
5138658|NCT01373918|12640456|P2|NOT COMPLETED|Overall Study||1
5138659|NCT01373918|12640457|P1|NOT COMPLETED|Overall Study||0
5138660|NCT01373918|12640456|P2|COMPLETED|Overall Study||15
5138661|NCT01373918|12640457|P1|COMPLETED|Overall Study||20
5138662|NCT01373918|12640456|P2|STARTED|Overall Study||16
5138663|NCT01373918|12640457|P1|STARTED|Overall Study||20
5138664|NCT01373671|12640469|P1|NOT COMPLETED|Overall Study||92
5138665|NCT01373671|12640469|P1|COMPLETED|Overall Study||672
5138666|NCT01373671|12640469|P1|STARTED|Overall Study||764
5138667|NCT01373580|12640474|P1|NOT COMPLETED|Overall Study||56
5138668|NCT01373580|12640474|P1|COMPLETED|Overall Study||317
5138669|NCT01373580|12640474|P1|STARTED|Overall Study||373
5138670|NCT01373489|12640482|P2|NOT COMPLETED|Overall Study||13
5138671|NCT01373489|12640483|P1|NOT COMPLETED|Overall Study||15
5138672|NCT01373489|12640482|P2|COMPLETED|Overall Study||41
5138673|NCT01373489|12640483|P1|COMPLETED|Overall Study||44
5138674|NCT01373489|12640482|P2|STARTED|Overall Study||54
5138675|NCT01373489|12640483|P1|STARTED|Overall Study||59
5138676|NCT01373450|12640489|P6|NOT COMPLETED|Crossover Period 4||0
5138677|NCT01373450|12640490|P5|NOT COMPLETED|Crossover Period 4||0
5138678|NCT01373450|12640491|P4|NOT COMPLETED|Crossover Period 4||0
5138679|NCT01373450|12640492|P3|NOT COMPLETED|Crossover Period 4||0
5138680|NCT01373450|12640493|P2|NOT COMPLETED|Crossover Period 4||0
5138681|NCT01373450|12640494|P1|NOT COMPLETED|Crossover Period 4||0
5138682|NCT01373450|12640489|P6|COMPLETED|Crossover Period 4||2
5138683|NCT01373450|12640490|P5|COMPLETED|Crossover Period 4||2
5138684|NCT01373450|12640491|P4|COMPLETED|Crossover Period 4||2
5138685|NCT01373450|12640492|P3|COMPLETED|Crossover Period 4||2
5138686|NCT01373450|12640493|P2|COMPLETED|Crossover Period 4||2
5138687|NCT01373450|12640494|P1|COMPLETED|Crossover Period 4||2
5138688|NCT01373450|12640489|P6|STARTED|Crossover Period 4||2
5138689|NCT01373450|12640490|P5|STARTED|Crossover Period 4||2
5138690|NCT01373450|12640491|P4|STARTED|Crossover Period 4||2
5138691|NCT01373450|12640492|P3|STARTED|Crossover Period 4||2
5138692|NCT01373450|12640493|P2|STARTED|Crossover Period 4||2
5138693|NCT01373450|12640494|P1|STARTED|Crossover Period 4||2
5138694|NCT01373450|12640489|P6|NOT COMPLETED|7 Day Wash-out||0
5138695|NCT01373450|12640490|P5|NOT COMPLETED|7 Day Wash-out||0
5138696|NCT01373450|12640491|P4|NOT COMPLETED|7 Day Wash-out||0
5138697|NCT01373450|12640492|P3|NOT COMPLETED|7 Day Wash-out||0
5138698|NCT01373450|12640493|P2|NOT COMPLETED|7 Day Wash-out||0
5138699|NCT01373450|12640494|P1|NOT COMPLETED|7 Day Wash-out||0
5138700|NCT01373450|12640489|P6|COMPLETED|7 Day Wash-out||2
5138701|NCT01373450|12640490|P5|COMPLETED|7 Day Wash-out||2
5138702|NCT01373450|12640491|P4|COMPLETED|7 Day Wash-out||2
5138703|NCT01373450|12640492|P3|COMPLETED|7 Day Wash-out||2
5138704|NCT01373450|12640493|P2|COMPLETED|7 Day Wash-out||2
5138705|NCT01373450|12640494|P1|COMPLETED|7 Day Wash-out||2
5138706|NCT01373450|12640489|P6|STARTED|7 Day Wash-out||2
5138707|NCT01373450|12640490|P5|STARTED|7 Day Wash-out||2
5138708|NCT01373450|12640491|P4|STARTED|7 Day Wash-out||2
5138709|NCT01373450|12640492|P3|STARTED|7 Day Wash-out||2
5138710|NCT01373450|12640493|P2|STARTED|7 Day Wash-out||2
5138711|NCT01373450|12640494|P1|STARTED|7 Day Wash-out||2
5138712|NCT01373450|12640489|P6|NOT COMPLETED|Crossover Period 3||0
5138713|NCT01373450|12640490|P5|NOT COMPLETED|Crossover Period 3||0
5138714|NCT01373450|12640491|P4|NOT COMPLETED|Crossover Period 3||0
5138715|NCT01373450|12640492|P3|NOT COMPLETED|Crossover Period 3||0
5138716|NCT01373450|12640493|P2|NOT COMPLETED|Crossover Period 3||0
5138717|NCT01373450|12640494|P1|NOT COMPLETED|Crossover Period 3||0
5138718|NCT01373450|12640489|P6|COMPLETED|Crossover Period 3||2
5138719|NCT01373450|12640490|P5|COMPLETED|Crossover Period 3||2
5138720|NCT01373450|12640491|P4|COMPLETED|Crossover Period 3||2
5138721|NCT01373450|12640492|P3|COMPLETED|Crossover Period 3||2
5138722|NCT01373450|12640493|P2|COMPLETED|Crossover Period 3||2
5138723|NCT01373450|12640494|P1|COMPLETED|Crossover Period 3||2
5138724|NCT01373450|12640489|P6|STARTED|Crossover Period 3||2
5138725|NCT01373450|12640490|P5|STARTED|Crossover Period 3||2
5138726|NCT01373450|12640491|P4|STARTED|Crossover Period 3||2
5138727|NCT01373450|12640492|P3|STARTED|Crossover Period 3||2
5138728|NCT01373450|12640493|P2|STARTED|Crossover Period 3||2
5138729|NCT01373450|12640494|P1|STARTED|Crossover Period 3||2
5138730|NCT01373450|12640489|P6|NOT COMPLETED|7 Day Wash-out||0
5138731|NCT01373450|12640490|P5|NOT COMPLETED|7 Day Wash-out||0
5138732|NCT01373450|12640491|P4|NOT COMPLETED|7 Day Wash-out||0
5138733|NCT01373450|12640492|P3|NOT COMPLETED|7 Day Wash-out||0
5138734|NCT01373450|12640493|P2|NOT COMPLETED|7 Day Wash-out||0
5138735|NCT01373450|12640494|P1|NOT COMPLETED|7 Day Wash-out||0
5138736|NCT01373450|12640489|P6|COMPLETED|7 Day Wash-out||2
5138737|NCT01373450|12640490|P5|COMPLETED|7 Day Wash-out||2
5138738|NCT01373450|12640491|P4|COMPLETED|7 Day Wash-out||2
5138739|NCT01373450|12640492|P3|COMPLETED|7 Day Wash-out||2
5138740|NCT01373450|12640493|P2|COMPLETED|7 Day Wash-out||2
5138741|NCT01373450|12640494|P1|COMPLETED|7 Day Wash-out||2
5138742|NCT01373450|12640489|P6|STARTED|7 Day Wash-out||2
5138743|NCT01373450|12640490|P5|STARTED|7 Day Wash-out||2
5138744|NCT01373450|12640491|P4|STARTED|7 Day Wash-out||2
5138745|NCT01373450|12640492|P3|STARTED|7 Day Wash-out||2
5138746|NCT01373450|12640493|P2|STARTED|7 Day Wash-out||2
5138747|NCT01373450|12640494|P1|STARTED|7 Day Wash-out||2
5138748|NCT01373450|12640489|P6|NOT COMPLETED|Crossover Period 2||0
5138749|NCT01373450|12640490|P5|NOT COMPLETED|Crossover Period 2||0
5138750|NCT01373450|12640491|P4|NOT COMPLETED|Crossover Period 2||0
5138751|NCT01373450|12640492|P3|NOT COMPLETED|Crossover Period 2||0
5138752|NCT01373450|12640493|P2|NOT COMPLETED|Crossover Period 2||0
5138753|NCT01373450|12640494|P1|NOT COMPLETED|Crossover Period 2||0
5138754|NCT01373450|12640489|P6|COMPLETED|Crossover Period 2||2
5138755|NCT01373450|12640490|P5|COMPLETED|Crossover Period 2||2
5138756|NCT01373450|12640491|P4|COMPLETED|Crossover Period 2||2
5138757|NCT01373450|12640492|P3|COMPLETED|Crossover Period 2||2
5138758|NCT01373450|12640493|P2|COMPLETED|Crossover Period 2||2
5138759|NCT01373450|12640494|P1|COMPLETED|Crossover Period 2||2
5138760|NCT01373450|12640489|P6|STARTED|Crossover Period 2||2
5138761|NCT01373450|12640490|P5|STARTED|Crossover Period 2||2
5138762|NCT01373450|12640491|P4|STARTED|Crossover Period 2||2
5138763|NCT01373450|12640492|P3|STARTED|Crossover Period 2||2
5138764|NCT01373450|12640493|P2|STARTED|Crossover Period 2||2
5138765|NCT01373450|12640494|P1|STARTED|Crossover Period 2||2
5138766|NCT01373450|12640489|P6|NOT COMPLETED|7 Day Wash-out||0
5138767|NCT01373450|12640490|P5|NOT COMPLETED|7 Day Wash-out||0
5138768|NCT01373450|12640491|P4|NOT COMPLETED|7 Day Wash-out||0
5138769|NCT01373450|12640492|P3|NOT COMPLETED|7 Day Wash-out||0
5138770|NCT01373450|12640493|P2|NOT COMPLETED|7 Day Wash-out||0
5138771|NCT01373450|12640494|P1|NOT COMPLETED|7 Day Wash-out||0
5138772|NCT01373450|12640489|P6|COMPLETED|7 Day Wash-out||2
5138773|NCT01373450|12640490|P5|COMPLETED|7 Day Wash-out||2
5138774|NCT01373450|12640491|P4|COMPLETED|7 Day Wash-out||2
5138775|NCT01373450|12640492|P3|COMPLETED|7 Day Wash-out||2
5138776|NCT01373450|12640493|P2|COMPLETED|7 Day Wash-out||2
5138777|NCT01373450|12640494|P1|COMPLETED|7 Day Wash-out||2
5138778|NCT01373450|12640489|P6|STARTED|7 Day Wash-out||2
5138779|NCT01373450|12640490|P5|STARTED|7 Day Wash-out||2
5138780|NCT01373450|12640491|P4|STARTED|7 Day Wash-out||2
5138781|NCT01373450|12640492|P3|STARTED|7 Day Wash-out||2
5138782|NCT01373450|12640493|P2|STARTED|7 Day Wash-out||2
5138783|NCT01373450|12640494|P1|STARTED|7 Day Wash-out||2
5138784|NCT01373450|12640489|P6|NOT COMPLETED|Crossover Period 1||0
5138785|NCT01373450|12640490|P5|NOT COMPLETED|Crossover Period 1||0
5138786|NCT01373450|12640491|P4|NOT COMPLETED|Crossover Period 1||0
5138787|NCT01373450|12640492|P3|NOT COMPLETED|Crossover Period 1||0
5138788|NCT01373450|12640493|P2|NOT COMPLETED|Crossover Period 1||0
5138789|NCT01373450|12640494|P1|NOT COMPLETED|Crossover Period 1||0
5138790|NCT01373450|12640489|P6|COMPLETED|Crossover Period 1||2
5138791|NCT01373450|12640490|P5|COMPLETED|Crossover Period 1||2
5138792|NCT01373450|12640491|P4|COMPLETED|Crossover Period 1||2
5138793|NCT01373450|12640492|P3|COMPLETED|Crossover Period 1||2
5138794|NCT01373450|12640493|P2|COMPLETED|Crossover Period 1||2
5138795|NCT01373450|12640494|P1|COMPLETED|Crossover Period 1||2
5138796|NCT01373450|12640489|P6|STARTED|Crossover Period 1||2
5138797|NCT01373450|12640490|P5|STARTED|Crossover Period 1||2
5138798|NCT01373450|12640491|P4|STARTED|Crossover Period 1||2
5138799|NCT01373450|12640492|P3|STARTED|Crossover Period 1||2
5138800|NCT01373450|12640493|P2|STARTED|Crossover Period 1||2
5138801|NCT01373450|12640494|P1|STARTED|Crossover Period 1||2
5138802|NCT01373346|12640516|P1|NOT COMPLETED|Overall Study||1
5138803|NCT01373346|12640516|P1|COMPLETED|Overall Study||14
5138804|NCT01373346|12640516|P1|STARTED|Overall Study||15
5138805|NCT01373294|12640539|P2|NOT COMPLETED|Overall Study||0
5138806|NCT01373294|12640540|P1|NOT COMPLETED|Overall Study||1
5138807|NCT01373294|12640539|P2|COMPLETED|Overall Study||2
5138808|NCT01373294|12640540|P1|COMPLETED|Overall Study||14
5138809|NCT01373294|12640539|P2|STARTED|Overall Study||2
5138810|NCT01373294|12640540|P1|STARTED|Overall Study||15
5138811|NCT01373281|12640549|P2|NOT COMPLETED|Surveillance Expansion Period||118
5138812|NCT01373281|12640550|P1|NOT COMPLETED|Surveillance Expansion Period||202
5138813|NCT01373281|12640549|P2|COMPLETED|Surveillance Expansion Period||3279
5138814|NCT01373281|12640550|P1|COMPLETED|Surveillance Expansion Period||6595
5138815|NCT01373281|12640549|P2|STARTED|Surveillance Expansion Period||3397
5138816|NCT01373281|12640550|P1|STARTED|Surveillance Expansion Period||6797
5138817|NCT01373281|12640549|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
5138818|NCT01373281|12640550|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
5138819|NCT01373281|12640549|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
5138820|NCT01373281|12640550|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
5138821|NCT01373281|12640549|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
5138822|NCT01373281|12640550|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
5138823|NCT01373242|12640582|P1|NOT COMPLETED|Overall Study||16
5138824|NCT01373242|12640582|P1|COMPLETED|Overall Study||38
5138825|NCT01373242|12640582|P1|STARTED|Overall Study||54
5138826|NCT01373229|12640598|P1|NOT COMPLETED|Overall Study||6
5138827|NCT01373229|12640598|P1|COMPLETED|Overall Study||9
5138828|NCT01373229|12640598|P1|STARTED|Overall Study||15
5138829|NCT01373164|12640612|P5|NOT COMPLETED|Overall Study||2
5138830|NCT01373164|12640613|P4|NOT COMPLETED|Overall Study||12
5138831|NCT01373164|12640614|P3|NOT COMPLETED|Overall Study||1
5138832|NCT01373164|12640615|P2|NOT COMPLETED|Overall Study||1
5138833|NCT01373164|12640616|P1|NOT COMPLETED|Overall Study||0
5138834|NCT01373164|12640612|P5|COMPLETED|Overall Study||50
5138835|NCT01373164|12640613|P4|COMPLETED|Overall Study||92
5138836|NCT01373164|12640614|P3|COMPLETED|Overall Study||4
5138837|NCT01373164|12640615|P2|COMPLETED|Overall Study||3
5138838|NCT01373164|12640616|P1|COMPLETED|Overall Study||5
5138839|NCT01373164|12640612|P5|Received at Least One Dose|Overall Study||52
5138840|NCT01373164|12640613|P4|Received at Least One Dose|Overall Study||103
5138841|NCT01373164|12640614|P3|Received at Least One Dose|Overall Study||5
5138842|NCT01373164|12640615|P2|Received at Least One Dose|Overall Study||4
5138843|NCT01373164|12640616|P1|Received at Least One Dose|Overall Study||5
5138844|NCT01373164|12640612|P5|STARTED|Overall Study||52
5138845|NCT01373164|12640613|P4|STARTED|Overall Study||104
5138846|NCT01373164|12640614|P3|STARTED|Overall Study||5
5138847|NCT01373164|12640615|P2|STARTED|Overall Study||4
5138848|NCT01373164|12640616|P1|STARTED|Overall Study||5
5138849|NCT01372995|12640650|P3|NOT COMPLETED|Overall Study||1
5138850|NCT01372995|12640651|P2|NOT COMPLETED|Overall Study||1
5138851|NCT01372995|12640652|P1|NOT COMPLETED|Overall Study||0
5138852|NCT01372995|12640650|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
5138853|NCT01372995|12640651|P2|COMPLETED|Overall Study||9
5138854|NCT01372995|12640652|P1|COMPLETED|Overall Study||10
5138855|NCT01372995|12640650|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
5138856|NCT01372995|12640651|P2|STARTED|Overall Study||10
5138857|NCT01372995|12640652|P1|STARTED|Overall Study||10
5138858|NCT01372878|12640699|P1|NOT COMPLETED|Overall Study||184
5138859|NCT01372878|12640699|P1|COMPLETED|Overall Study||700
5138860|NCT01372878|12640699|P1|STARTED|Overall Study||884
5138861|NCT01372813|12640704|P1|NOT COMPLETED|Overall Study||0
5138862|NCT01372813|12640704|P1|COMPLETED|Overall Study||3
5138863|NCT01372813|12640704|P1|STARTED|Overall Study||3
5138864|NCT01372774|12640719|P2|NOT COMPLETED|Overall Study||5
5138865|NCT01372774|12640720|P1|NOT COMPLETED|Overall Study||4
5138866|NCT01372774|12640719|P2|COMPLETED|Overall Study||93
5138867|NCT01372774|12640720|P1|COMPLETED|Overall Study||92
5138868|NCT01372774|12640719|P2|STARTED|Overall Study||98
5138869|NCT01372774|12640720|P1|STARTED|Overall Study||96
5138870|NCT01372748|12640736|P2|NOT COMPLETED|Overall Study||39
5138871|NCT01372748|12640737|P1|NOT COMPLETED|Overall Study||23
5138872|NCT01372748|12640736|P2|COMPLETED|Overall Study|defined as having vital status|12603
5138873|NCT01372748|12640737|P1|COMPLETED|Overall Study|defined as having vital status|11022
5138874|NCT01372748|12640736|P2|STARTED|Overall Study||12642
5138875|NCT01372748|12640737|P1|STARTED|Overall Study||11045
5138876|NCT01372618|12640745|P1|NOT COMPLETED|Overall Study||9
5138877|NCT01372618|12640745|P1|COMPLETED|Overall Study||0
5138878|NCT01372618|12640745|P1|STARTED|Overall Study||9
5138879|NCT01372605|12640753|P2|NOT COMPLETED|Overall Study||10
5138880|NCT01372605|12640754|P1|NOT COMPLETED|Overall Study||12
5138881|NCT01372605|12640753|P2|COMPLETED|Overall Study||145
5138882|NCT01372605|12640754|P1|COMPLETED|Overall Study||137
5138883|NCT01372605|12640753|P2|STARTED|Overall Study||155
5138884|NCT01372605|12640754|P1|STARTED|Overall Study||149
5138885|NCT01372501|12640780|P1|NOT COMPLETED|Overall Study||5
5138886|NCT01372501|12640780|P1|COMPLETED|Overall Study||14
5138887|NCT01372501|12640780|P1|STARTED|Overall Study||19
5138888|NCT01372462|12640785|P1|NOT COMPLETED|No Treatment Control||0
5138889|NCT01372462|12640785|P1|COMPLETED|No Treatment Control||15
5138890|NCT01372462|12640785|P1|STARTED|No Treatment Control||15
5138891|NCT01372462|12640785|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
5138892|NCT01372462|12640785|P1|COMPLETED|Oxygen Nasal Cannula||15
5138893|NCT01372462|12640785|P1|STARTED|Oxygen Nasal Cannula||15
5138894|NCT01372462|12640785|P1|NOT COMPLETED|NIOV - Oxygen||0
5138895|NCT01372462|12640785|P1|COMPLETED|NIOV - Oxygen||15
5138896|NCT01372462|12640785|P1|STARTED|NIOV - Oxygen||15
5138897|NCT01372462|12640785|P1|NOT COMPLETED|NIOV - Room Air||0
5138898|NCT01372462|12640785|P1|COMPLETED|NIOV - Room Air||15
5138899|NCT01372462|12640785|P1|STARTED|NIOV - Room Air||15
5138900|NCT01372410|12640803|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138901|NCT01372410|12640804|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138902|NCT01372410|12640805|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
5138903|NCT01372410|12640806|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138904|NCT01372410|12640807|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138905|NCT01372410|12640808|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
5138906|NCT01372410|12640809|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138907|NCT01372410|12640810|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
5138908|NCT01372410|12640803|P8|COMPLETED|Treatment Period 3 (7 Days)||18
5138909|NCT01372410|12640804|P7|COMPLETED|Treatment Period 3 (7 Days)||15
5138910|NCT01372410|12640805|P6|COMPLETED|Treatment Period 3 (7 Days)||18
5138911|NCT01372410|12640806|P5|COMPLETED|Treatment Period 3 (7 Days)||20
5138912|NCT01372410|12640807|P4|COMPLETED|Treatment Period 3 (7 Days)||22
5138913|NCT01372410|12640808|P3|COMPLETED|Treatment Period 3 (7 Days)||15
5138914|NCT01372410|12640809|P2|COMPLETED|Treatment Period 3 (7 Days)||18
5138915|NCT01372410|12640810|P1|COMPLETED|Treatment Period 3 (7 Days)||21
5138916|NCT01372410|12640803|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
5138917|NCT01372410|12640804|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
5138918|NCT01372410|12640805|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
5138919|NCT01372410|12640806|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
5138920|NCT01372410|12640807|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
5138921|NCT01372410|12640808|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
5138922|NCT01372410|12640809|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
5138923|NCT01372410|12640810|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
5138924|NCT01372410|12640803|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
5138925|NCT01372410|12640804|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
5138926|NCT01372410|12640805|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
5138927|NCT01372410|12640806|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
5138928|NCT01372410|12640807|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
5138929|NCT01372410|12640808|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
5138930|NCT01372410|12640809|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
5138931|NCT01372410|12640810|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
5138932|NCT01372410|12640803|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
5138933|NCT01372410|12640804|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
5138934|NCT01372410|12640805|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
5138935|NCT01372410|12640806|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
5138936|NCT01372410|12640807|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
5138937|NCT01372410|12640808|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
5138938|NCT01372410|12640809|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
5139006|NCT01372410|12640805|P6|COMPLETED|Treatment Period 1 (7 Days)||21
5138939|NCT01372410|12640810|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
5138940|NCT01372410|12640803|P8|STARTED|Washout Period 2 (10-14 Days)||19
5138941|NCT01372410|12640804|P7|STARTED|Washout Period 2 (10-14 Days)||21
5138942|NCT01372410|12640805|P6|STARTED|Washout Period 2 (10-14 Days)||16
5138943|NCT01372410|12640806|P5|STARTED|Washout Period 2 (10-14 Days)||19
5138944|NCT01372410|12640807|P4|STARTED|Washout Period 2 (10-14 Days)||17
5138945|NCT01372410|12640808|P3|STARTED|Washout Period 2 (10-14 Days)||22
5138946|NCT01372410|12640809|P2|STARTED|Washout Period 2 (10-14 Days)||21
5138947|NCT01372410|12640810|P1|STARTED|Washout Period 2 (10-14 Days)||19
5138948|NCT01372410|12640803|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138949|NCT01372410|12640804|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138950|NCT01372410|12640805|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138951|NCT01372410|12640806|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138952|NCT01372410|12640807|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138953|NCT01372410|12640808|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138954|NCT01372410|12640809|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138955|NCT01372410|12640810|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
5138956|NCT01372410|12640803|P8|COMPLETED|Treatment Period 2 (7 Days)||19
5138957|NCT01372410|12640804|P7|COMPLETED|Treatment Period 2 (7 Days)||21
5138958|NCT01372410|12640805|P6|COMPLETED|Treatment Period 2 (7 Days)||16
5138959|NCT01372410|12640806|P5|COMPLETED|Treatment Period 2 (7 Days)||19
5138960|NCT01372410|12640807|P4|COMPLETED|Treatment Period 2 (7 Days)||17
5138961|NCT01372410|12640808|P3|COMPLETED|Treatment Period 2 (7 Days)||22
5138962|NCT01372410|12640809|P2|COMPLETED|Treatment Period 2 (7 Days)||21
5138963|NCT01372410|12640810|P1|COMPLETED|Treatment Period 2 (7 Days)||19
5138964|NCT01372410|12640803|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
5138965|NCT01372410|12640804|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
5138966|NCT01372410|12640805|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
5138967|NCT01372410|12640806|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
5138968|NCT01372410|12640807|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
5138969|NCT01372410|12640808|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
5138970|NCT01372410|12640809|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
5138971|NCT01372410|12640810|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
5138972|NCT01372410|12640803|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
5138973|NCT01372410|12640804|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138974|NCT01372410|12640805|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138975|NCT01372410|12640806|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138976|NCT01372410|12640807|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138977|NCT01372410|12640808|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138978|NCT01372410|12640809|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
5138979|NCT01372410|12640810|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
5138980|NCT01372410|12640803|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
5138981|NCT01372410|12640804|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
5138982|NCT01372410|12640805|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
5138983|NCT01372410|12640806|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
5138984|NCT01372410|12640807|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
5138985|NCT01372410|12640808|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
5138986|NCT01372410|12640809|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
5138987|NCT01372410|12640810|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
5138988|NCT01372410|12640803|P8|STARTED|Washout Period 1 (10-14 Days)||19
5138989|NCT01372410|12640804|P7|STARTED|Washout Period 1 (10-14 Days)||20
5138990|NCT01372410|12640805|P6|STARTED|Washout Period 1 (10-14 Days)||21
5138991|NCT01372410|12640806|P5|STARTED|Washout Period 1 (10-14 Days)||19
5138992|NCT01372410|12640807|P4|STARTED|Washout Period 1 (10-14 Days)||20
5138993|NCT01372410|12640808|P3|STARTED|Washout Period 1 (10-14 Days)||19
5138994|NCT01372410|12640809|P2|STARTED|Washout Period 1 (10-14 Days)||19
5138995|NCT01372410|12640810|P1|STARTED|Washout Period 1 (10-14 Days)||19
5138996|NCT01372410|12640803|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5138997|NCT01372410|12640804|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
5138998|NCT01372410|12640805|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5138999|NCT01372410|12640806|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
5139000|NCT01372410|12640807|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5139001|NCT01372410|12640808|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
5139002|NCT01372410|12640809|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
5139003|NCT01372410|12640810|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
5139004|NCT01372410|12640803|P8|COMPLETED|Treatment Period 1 (7 Days)||19
5139005|NCT01372410|12640804|P7|COMPLETED|Treatment Period 1 (7 Days)||20
5139007|NCT01372410|12640806|P5|COMPLETED|Treatment Period 1 (7 Days)||19
5139008|NCT01372410|12640807|P4|COMPLETED|Treatment Period 1 (7 Days)||20
5139009|NCT01372410|12640808|P3|COMPLETED|Treatment Period 1 (7 Days)||19
5139010|NCT01372410|12640809|P2|COMPLETED|Treatment Period 1 (7 Days)||19
5139011|NCT01372410|12640810|P1|COMPLETED|Treatment Period 1 (7 Days)||19
5139012|NCT01372410|12640803|P8|STARTED|Treatment Period 1 (7 Days)||19
5139013|NCT01372410|12640804|P7|STARTED|Treatment Period 1 (7 Days)||22
5139014|NCT01372410|12640805|P6|STARTED|Treatment Period 1 (7 Days)||21
5139015|NCT01372410|12640806|P5|STARTED|Treatment Period 1 (7 Days)||21
5139016|NCT01372410|12640807|P4|STARTED|Treatment Period 1 (7 Days)||20
5139017|NCT01372410|12640808|P3|STARTED|Treatment Period 1 (7 Days)||19
5139018|NCT01372410|12640809|P2|STARTED|Treatment Period 1 (7 Days)||21
5139019|NCT01372410|12640810|P1|STARTED|Treatment Period 1 (7 Days)||20
5139020|NCT01372384|12640847|P1|NOT COMPLETED|Overall Study||3
5139021|NCT01372384|12640847|P1|COMPLETED|Overall Study||3
5139022|NCT01372384|12640847|P1|STARTED|Overall Study||6
5139023|NCT01372202|12640857|P3|NOT COMPLETED|Overall Study||0
5139024|NCT01372202|12640858|P2|NOT COMPLETED|Overall Study||0
5139025|NCT01372202|12640859|P1|NOT COMPLETED|Overall Study||0
5139026|NCT01372202|12640857|P3|COMPLETED|Overall Study||9
5139027|NCT01372202|12640858|P2|COMPLETED|Overall Study||9
5139028|NCT01372202|12640859|P1|COMPLETED|Overall Study||13
5139029|NCT01372202|12640857|P3|STARTED|Overall Study||9
5139030|NCT01372202|12640858|P2|STARTED|Overall Study||9
5139031|NCT01372202|12640859|P1|STARTED|Overall Study||13
5139032|NCT01372150|12640879|P3|NOT COMPLETED|Overall Study||16
5139033|NCT01372150|12640880|P2|NOT COMPLETED|Overall Study||14
5139034|NCT01372150|12640881|P1|NOT COMPLETED|Overall Study||13
5139035|NCT01372150|12640879|P3|COMPLETED|Overall Study||99
5139036|NCT01372150|12640880|P2|COMPLETED|Overall Study||99
5139037|NCT01372150|12640881|P1|COMPLETED|Overall Study||99
5139038|NCT01372150|12640879|P3|Treated|Overall Study||115
5139039|NCT01372150|12640880|P2|Treated|Overall Study||112
5139040|NCT01372150|12640881|P1|Treated|Overall Study||112
5139041|NCT01372150|12640879|P3|STARTED|Overall Study||115
5139042|NCT01372150|12640880|P2|STARTED|Overall Study||113
5139043|NCT01372150|12640881|P1|STARTED|Overall Study||112
5139044|NCT01372085|12640908|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139045|NCT01372085|12640909|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139046|NCT01372085|12640910|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139047|NCT01372085|12640911|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139048|NCT01372085|12640912|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139049|NCT01372085|12640913|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139050|NCT01372085|12640914|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139051|NCT01372085|12640915|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139052|NCT01372085|12640916|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139053|NCT01372085|12640917|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
5139054|NCT01372085|12640908|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
5139055|NCT01372085|12640909|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
5139056|NCT01372085|12640910|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
5139057|NCT01372085|12640911|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
5139058|NCT01372085|12640912|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
5139059|NCT01372085|12640913|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
5139060|NCT01372085|12640914|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
5139061|NCT01372085|12640915|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
5139062|NCT01372085|12640916|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
5139063|NCT01372085|12640917|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
5139064|NCT01372085|12640908|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
5139065|NCT01372085|12640909|P9|STARTED|Forth Intervention (Period 4a/4b)||1
5139066|NCT01372085|12640910|P8|STARTED|Forth Intervention (Period 4a/4b)||1
5139067|NCT01372085|12640911|P7|STARTED|Forth Intervention (Period 4a/4b)||3
5139068|NCT01372085|12640912|P6|STARTED|Forth Intervention (Period 4a/4b)||5
5139069|NCT01372085|12640913|P5|STARTED|Forth Intervention (Period 4a/4b)||2
5139070|NCT01372085|12640914|P4|STARTED|Forth Intervention (Period 4a/4b)||1
5139071|NCT01372085|12640915|P3|STARTED|Forth Intervention (Period 4a/4b)||2
5139072|NCT01372085|12640916|P2|STARTED|Forth Intervention (Period 4a/4b)||0
5139073|NCT01372085|12640917|P1|STARTED|Forth Intervention (Period 4a/4b)||0
5139074|NCT01372085|12640908|P10|NOT COMPLETED|Washout Period 3||0
5139075|NCT01372085|12640909|P9|NOT COMPLETED|Washout Period 3||0
5139076|NCT01372085|12640910|P8|NOT COMPLETED|Washout Period 3||0
5139077|NCT01372085|12640911|P7|NOT COMPLETED|Washout Period 3||0
5139078|NCT01372085|12640912|P6|NOT COMPLETED|Washout Period 3||2
5139079|NCT01372085|12640913|P5|NOT COMPLETED|Washout Period 3||0
5139080|NCT01372085|12640914|P4|NOT COMPLETED|Washout Period 3||0
5139081|NCT01372085|12640915|P3|NOT COMPLETED|Washout Period 3||0
5139082|NCT01372085|12640916|P2|NOT COMPLETED|Washout Period 3||0
5139083|NCT01372085|12640917|P1|NOT COMPLETED|Washout Period 3||0
5139084|NCT01372085|12640908|P10|COMPLETED|Washout Period 3||0
5139085|NCT01372085|12640909|P9|COMPLETED|Washout Period 3||1
5139086|NCT01372085|12640910|P8|COMPLETED|Washout Period 3||1
5139087|NCT01372085|12640911|P7|COMPLETED|Washout Period 3||3
5139088|NCT01372085|12640912|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
5139089|NCT01372085|12640913|P5|COMPLETED|Washout Period 3||2
5139090|NCT01372085|12640914|P4|COMPLETED|Washout Period 3||1
5139091|NCT01372085|12640915|P3|COMPLETED|Washout Period 3||2
5139092|NCT01372085|12640916|P2|COMPLETED|Washout Period 3||0
5139093|NCT01372085|12640917|P1|COMPLETED|Washout Period 3||0
5139094|NCT01372085|12640908|P10|STARTED|Washout Period 3||0
5139095|NCT01372085|12640909|P9|STARTED|Washout Period 3||1
5139096|NCT01372085|12640910|P8|STARTED|Washout Period 3||1
5139097|NCT01372085|12640911|P7|STARTED|Washout Period 3||3
5139098|NCT01372085|12640912|P6|STARTED|Washout Period 3||7
5139099|NCT01372085|12640913|P5|STARTED|Washout Period 3||2
5139100|NCT01372085|12640914|P4|STARTED|Washout Period 3||1
5139101|NCT01372085|12640915|P3|STARTED|Washout Period 3||2
5139102|NCT01372085|12640916|P2|STARTED|Washout Period 3||0
5139103|NCT01372085|12640917|P1|STARTED|Washout Period 3||0
5139104|NCT01372085|12640908|P10|NOT COMPLETED|Third Intervention (Period 3)||0
5139105|NCT01372085|12640909|P9|NOT COMPLETED|Third Intervention (Period 3)||0
5139106|NCT01372085|12640910|P8|NOT COMPLETED|Third Intervention (Period 3)||0
5139107|NCT01372085|12640911|P7|NOT COMPLETED|Third Intervention (Period 3)||0
5139108|NCT01372085|12640912|P6|NOT COMPLETED|Third Intervention (Period 3)||0
5139109|NCT01372085|12640913|P5|NOT COMPLETED|Third Intervention (Period 3)||0
5139110|NCT01372085|12640914|P4|NOT COMPLETED|Third Intervention (Period 3)||0
5139111|NCT01372085|12640915|P3|NOT COMPLETED|Third Intervention (Period 3)||0
5139112|NCT01372085|12640916|P2|NOT COMPLETED|Third Intervention (Period 3)||0
5139113|NCT01372085|12640917|P1|NOT COMPLETED|Third Intervention (Period 3)||0
5139114|NCT01372085|12640908|P10|COMPLETED|Third Intervention (Period 3)||0
5139115|NCT01372085|12640909|P9|COMPLETED|Third Intervention (Period 3)||1
5139116|NCT01372085|12640910|P8|COMPLETED|Third Intervention (Period 3)||1
5139117|NCT01372085|12640911|P7|COMPLETED|Third Intervention (Period 3)||3
5139118|NCT01372085|12640912|P6|COMPLETED|Third Intervention (Period 3)||7
5139119|NCT01372085|12640913|P5|COMPLETED|Third Intervention (Period 3)||2
5139120|NCT01372085|12640914|P4|COMPLETED|Third Intervention (Period 3)||1
5139121|NCT01372085|12640915|P3|COMPLETED|Third Intervention (Period 3)||2
5139122|NCT01372085|12640916|P2|COMPLETED|Third Intervention (Period 3)||0
5139123|NCT01372085|12640917|P1|COMPLETED|Third Intervention (Period 3)||0
5139124|NCT01372085|12640908|P10|STARTED|Third Intervention (Period 3)||0
5139125|NCT01372085|12640909|P9|STARTED|Third Intervention (Period 3)||1
5139126|NCT01372085|12640910|P8|STARTED|Third Intervention (Period 3)||1
5139127|NCT01372085|12640911|P7|STARTED|Third Intervention (Period 3)||3
5139128|NCT01372085|12640912|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
5139129|NCT01372085|12640913|P5|STARTED|Third Intervention (Period 3)||2
5139130|NCT01372085|12640914|P4|STARTED|Third Intervention (Period 3)||1
5139131|NCT01372085|12640915|P3|STARTED|Third Intervention (Period 3)||2
5139132|NCT01372085|12640916|P2|STARTED|Third Intervention (Period 3)||0
5139133|NCT01372085|12640917|P1|STARTED|Third Intervention (Period 3)||0
5139134|NCT01372085|12640908|P10|NOT COMPLETED|Washout Period 2||0
5139135|NCT01372085|12640909|P9|NOT COMPLETED|Washout Period 2||0
5139136|NCT01372085|12640910|P8|NOT COMPLETED|Washout Period 2||0
5139137|NCT01372085|12640911|P7|NOT COMPLETED|Washout Period 2||0
5139138|NCT01372085|12640912|P6|NOT COMPLETED|Washout Period 2||0
5139139|NCT01372085|12640913|P5|NOT COMPLETED|Washout Period 2||1
5139140|NCT01372085|12640914|P4|NOT COMPLETED|Washout Period 2||0
5139141|NCT01372085|12640915|P3|NOT COMPLETED|Washout Period 2||0
5139142|NCT01372085|12640916|P2|NOT COMPLETED|Washout Period 2||0
5139143|NCT01372085|12640917|P1|NOT COMPLETED|Washout Period 2||0
5139144|NCT01372085|12640908|P10|COMPLETED|Washout Period 2||0
5139145|NCT01372085|12640909|P9|COMPLETED|Washout Period 2||1
5139146|NCT01372085|12640910|P8|COMPLETED|Washout Period 2||1
5139147|NCT01372085|12640911|P7|COMPLETED|Washout Period 2||3
5139148|NCT01372085|12640912|P6|COMPLETED|Washout Period 2||5
5139149|NCT01372085|12640913|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
5139150|NCT01372085|12640914|P4|COMPLETED|Washout Period 2||1
5139151|NCT01372085|12640915|P3|COMPLETED|Washout Period 2||2
5139152|NCT01372085|12640916|P2|COMPLETED|Washout Period 2||0
5139153|NCT01372085|12640917|P1|COMPLETED|Washout Period 2||0
5139154|NCT01372085|12640908|P10|STARTED|Washout Period 2||0
5139155|NCT01372085|12640909|P9|STARTED|Washout Period 2||1
5139156|NCT01372085|12640910|P8|STARTED|Washout Period 2||1
5139157|NCT01372085|12640911|P7|STARTED|Washout Period 2||3
5139158|NCT01372085|12640912|P6|STARTED|Washout Period 2||5
5139159|NCT01372085|12640913|P5|STARTED|Washout Period 2||3
5139160|NCT01372085|12640914|P4|STARTED|Washout Period 2||1
5139161|NCT01372085|12640915|P3|STARTED|Washout Period 2||2
5139162|NCT01372085|12640916|P2|STARTED|Washout Period 2||0
5139163|NCT01372085|12640917|P1|STARTED|Washout Period 2||0
5139164|NCT01372085|12640908|P10|NOT COMPLETED|Second Intervention (Period 2)||0
5139165|NCT01372085|12640909|P9|NOT COMPLETED|Second Intervention (Period 2)||0
5139166|NCT01372085|12640910|P8|NOT COMPLETED|Second Intervention (Period 2)||0
5139167|NCT01372085|12640911|P7|NOT COMPLETED|Second Intervention (Period 2)||0
5139168|NCT01372085|12640912|P6|NOT COMPLETED|Second Intervention (Period 2)||0
5139169|NCT01372085|12640913|P5|NOT COMPLETED|Second Intervention (Period 2)||0
5139170|NCT01372085|12640914|P4|NOT COMPLETED|Second Intervention (Period 2)||0
5139171|NCT01372085|12640915|P3|NOT COMPLETED|Second Intervention (Period 2)||0
5139172|NCT01372085|12640916|P2|NOT COMPLETED|Second Intervention (Period 2)||0
5139173|NCT01372085|12640917|P1|NOT COMPLETED|Second Intervention (Period 2)||0
5139174|NCT01372085|12640908|P10|COMPLETED|Second Intervention (Period 2)||0
5139175|NCT01372085|12640909|P9|COMPLETED|Second Intervention (Period 2)||1
5139176|NCT01372085|12640910|P8|COMPLETED|Second Intervention (Period 2)||1
5139177|NCT01372085|12640911|P7|COMPLETED|Second Intervention (Period 2)||3
5139178|NCT01372085|12640912|P6|COMPLETED|Second Intervention (Period 2)||5
5139179|NCT01372085|12640913|P5|COMPLETED|Second Intervention (Period 2)||3
5139180|NCT01372085|12640914|P4|COMPLETED|Second Intervention (Period 2)||1
5139181|NCT01372085|12640915|P3|COMPLETED|Second Intervention (Period 2)||2
5139182|NCT01372085|12640916|P2|COMPLETED|Second Intervention (Period 2)||0
5139183|NCT01372085|12640917|P1|COMPLETED|Second Intervention (Period 2)||0
5139184|NCT01372085|12640908|P10|STARTED|Second Intervention (Period 2)||0
5139185|NCT01372085|12640909|P9|STARTED|Second Intervention (Period 2)||1
5139186|NCT01372085|12640910|P8|STARTED|Second Intervention (Period 2)||1
5139187|NCT01372085|12640911|P7|STARTED|Second Intervention (Period 2)||3
5139188|NCT01372085|12640912|P6|STARTED|Second Intervention (Period 2)||5
5139189|NCT01372085|12640913|P5|STARTED|Second Intervention (Period 2)||3
5139190|NCT01372085|12640914|P4|STARTED|Second Intervention (Period 2)||1
5139191|NCT01372085|12640915|P3|STARTED|Second Intervention (Period 2)||2
5139192|NCT01372085|12640916|P2|STARTED|Second Intervention (Period 2)||0
5139193|NCT01372085|12640917|P1|STARTED|Second Intervention (Period 2)||0
5139194|NCT01372085|12640908|P10|NOT COMPLETED|Washout Period 1||0
5139195|NCT01372085|12640909|P9|NOT COMPLETED|Washout Period 1||0
5139196|NCT01372085|12640910|P8|NOT COMPLETED|Washout Period 1||0
5139197|NCT01372085|12640911|P7|NOT COMPLETED|Washout Period 1||0
5139198|NCT01372085|12640912|P6|NOT COMPLETED|Washout Period 1||0
5139199|NCT01372085|12640913|P5|NOT COMPLETED|Washout Period 1||0
5139200|NCT01372085|12640914|P4|NOT COMPLETED|Washout Period 1||0
5139201|NCT01372085|12640915|P3|NOT COMPLETED|Washout Period 1||0
5139202|NCT01372085|12640916|P2|NOT COMPLETED|Washout Period 1||0
5139203|NCT01372085|12640917|P1|NOT COMPLETED|Washout Period 1||0
5139204|NCT01372085|12640908|P10|COMPLETED|Washout Period 1||0
5139205|NCT01372085|12640909|P9|COMPLETED|Washout Period 1||1
5139206|NCT01372085|12640910|P8|COMPLETED|Washout Period 1||1
5139207|NCT01372085|12640911|P7|COMPLETED|Washout Period 1||3
5139208|NCT01372085|12640912|P6|COMPLETED|Washout Period 1||5
5139209|NCT01372085|12640913|P5|COMPLETED|Washout Period 1||3
5139210|NCT01372085|12640914|P4|COMPLETED|Washout Period 1||1
5139211|NCT01372085|12640915|P3|COMPLETED|Washout Period 1||2
5139212|NCT01372085|12640916|P2|COMPLETED|Washout Period 1||0
5139213|NCT01372085|12640917|P1|COMPLETED|Washout Period 1||0
5139214|NCT01372085|12640908|P10|STARTED|Washout Period 1||0
5139215|NCT01372085|12640909|P9|STARTED|Washout Period 1||1
5139216|NCT01372085|12640910|P8|STARTED|Washout Period 1||1
5139217|NCT01372085|12640911|P7|STARTED|Washout Period 1||3
5139218|NCT01372085|12640912|P6|STARTED|Washout Period 1||5
5139219|NCT01372085|12640913|P5|STARTED|Washout Period 1||3
5139220|NCT01372085|12640914|P4|STARTED|Washout Period 1||1
5139221|NCT01372085|12640915|P3|STARTED|Washout Period 1||2
5139222|NCT01372085|12640916|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
5139223|NCT01372085|12640917|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
5139224|NCT01372085|12640908|P10|NOT COMPLETED|First Intervention (Period 1)||0
5139225|NCT01372085|12640909|P9|NOT COMPLETED|First Intervention (Period 1)||0
5139226|NCT01372085|12640910|P8|NOT COMPLETED|First Intervention (Period 1)||0
5139227|NCT01372085|12640911|P7|NOT COMPLETED|First Intervention (Period 1)||0
5139228|NCT01372085|12640912|P6|NOT COMPLETED|First Intervention (Period 1)||0
5139229|NCT01372085|12640913|P5|NOT COMPLETED|First Intervention (Period 1)||0
5139230|NCT01372085|12640914|P4|NOT COMPLETED|First Intervention (Period 1)||0
5139231|NCT01372085|12640915|P3|NOT COMPLETED|First Intervention (Period 1)||0
5139232|NCT01372085|12640916|P2|NOT COMPLETED|First Intervention (Period 1)||0
5139233|NCT01372085|12640917|P1|NOT COMPLETED|First Intervention (Period 1)||0
5139234|NCT01372085|12640908|P10|COMPLETED|First Intervention (Period 1)||0
5139235|NCT01372085|12640909|P9|COMPLETED|First Intervention (Period 1)||1
5139236|NCT01372085|12640910|P8|COMPLETED|First Intervention (Period 1)||1
5139237|NCT01372085|12640911|P7|COMPLETED|First Intervention (Period 1)||3
5139238|NCT01372085|12640912|P6|COMPLETED|First Intervention (Period 1)||5
5139239|NCT01372085|12640913|P5|COMPLETED|First Intervention (Period 1)||3
5139240|NCT01372085|12640914|P4|COMPLETED|First Intervention (Period 1)||1
5139241|NCT01372085|12640915|P3|COMPLETED|First Intervention (Period 1)||2
5139242|NCT01372085|12640916|P2|COMPLETED|First Intervention (Period 1)||2
5139243|NCT01372085|12640917|P1|COMPLETED|First Intervention (Period 1)||8
5139244|NCT01372085|12640908|P10|STARTED|First Intervention (Period 1)||0
5139245|NCT01372085|12640909|P9|STARTED|First Intervention (Period 1)||1
5139246|NCT01372085|12640910|P8|STARTED|First Intervention (Period 1)||1
5139247|NCT01372085|12640911|P7|STARTED|First Intervention (Period 1)||3
5139248|NCT01372085|12640912|P6|STARTED|First Intervention (Period 1)||5
5139249|NCT01372085|12640913|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
5139250|NCT01372085|12640914|P4|STARTED|First Intervention (Period 1)||1
5139251|NCT01372085|12640915|P3|STARTED|First Intervention (Period 1)||2
5139252|NCT01372085|12640916|P2|STARTED|First Intervention (Period 1)||2
5139253|NCT01372085|12640917|P1|STARTED|First Intervention (Period 1)||8
5139254|NCT01371994|12640949|P2|NOT COMPLETED|Overall Study||42
5139255|NCT01371994|12640950|P1|NOT COMPLETED|Overall Study||57
5139256|NCT01371994|12640949|P2|COMPLETED|Overall Study||278
5139257|NCT01371994|12640950|P1|COMPLETED|Overall Study||263
5139258|NCT01371994|12640949|P2|Received Treatment|Overall Study||313
5139259|NCT01371994|12640950|P1|Received Treatment|Overall Study||310
5139260|NCT01371994|12640949|P2|STARTED|Overall Study||320
5139261|NCT01371994|12640950|P1|STARTED|Overall Study||320
5139262|NCT01371981|12640998|P6|NOT COMPLETED|Overall Study||14
5139263|NCT01371981|12640999|P5|NOT COMPLETED|Overall Study||32
5139264|NCT01371981|12641000|P4|NOT COMPLETED|Overall Study||21
5139265|NCT01371981|12641001|P3|NOT COMPLETED|Overall Study||6
5139266|NCT01371981|12641002|P2|NOT COMPLETED|Overall Study||192
5139267|NCT01371981|12641003|P1|NOT COMPLETED|Overall Study||184
5139268|NCT01371981|12640998|P6|COMPLETED|Overall Study||368
5139269|NCT01371981|12640999|P5|COMPLETED|Overall Study||15
5139270|NCT01371981|12641000|P4|COMPLETED|Overall Study||12
5139271|NCT01371981|12641001|P3|COMPLETED|Overall Study||6
5139272|NCT01371981|12641002|P2|COMPLETED|Overall Study||399
5139273|NCT01371981|12641003|P1|COMPLETED|Overall Study||396
5139274|NCT01371981|12640998|P6|STARTED|Overall Study||382
5139275|NCT01371981|12640999|P5|STARTED|Overall Study||47
5139276|NCT01371981|12641000|P4|STARTED|Overall Study||33
5139277|NCT01371981|12641001|P3|STARTED|Overall Study||12
5139278|NCT01371981|12641002|P2|STARTED|Overall Study||591
5139279|NCT01371981|12641003|P1|STARTED|Overall Study||580
5139280|NCT01371877|12641062|P2|NOT COMPLETED|Overall Study||4
5139281|NCT01371877|12641063|P1|NOT COMPLETED|Overall Study||0
5139282|NCT01371877|12641062|P2|COMPLETED|Overall Study||17
5139283|NCT01371877|12641063|P1|COMPLETED|Overall Study||21
5139284|NCT01371877|12641062|P2|STARTED|Overall Study||21
5139285|NCT01371877|12641063|P1|STARTED|Overall Study||21
5139286|NCT01371851|12641075|P2|NOT COMPLETED|Overall Study||9
5139287|NCT01371851|12641076|P1|NOT COMPLETED|Overall Study||8
5139288|NCT01371851|12641075|P2|COMPLETED|Overall Study||2
5139289|NCT01371851|12641076|P1|COMPLETED|Overall Study||3
5139290|NCT01371851|12641075|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
5139291|NCT01371851|12641076|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
5139292|NCT01371838|12641084|P2|NOT COMPLETED|Overall Study||66
5139293|NCT01371838|12641085|P1|NOT COMPLETED|Overall Study||49
5139294|NCT01371838|12641084|P2|COMPLETED|Overall Study||317
5139295|NCT01371838|12641085|P1|COMPLETED|Overall Study||332
5139296|NCT01371838|12641084|P2|STARTED|Overall Study||383
5139297|NCT01371838|12641085|P1|STARTED|Overall Study||381
5139298|NCT01371825|12641121|P1|NOT COMPLETED|Overall Study||4
5139299|NCT01371825|12641121|P1|COMPLETED|Overall Study||5
5139300|NCT01371825|12641121|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
5139301|NCT01371825|12641121|P1|STARTED|Overall Study||9
5139302|NCT01371786|12641134|P2|NOT COMPLETED|Overall Study||0
5139303|NCT01371786|12641135|P1|NOT COMPLETED|Overall Study||0
5139304|NCT01371786|12641134|P2|COMPLETED|Overall Study||7
5139305|NCT01371786|12641135|P1|COMPLETED|Overall Study||7
5139306|NCT01371786|12641134|P2|STARTED|Overall Study||7
5139307|NCT01371786|12641135|P1|STARTED|Overall Study||7
5139308|NCT01371747|12641155|P6|NOT COMPLETED|Overall Study||14
5139309|NCT01371747|12641156|P5|NOT COMPLETED|Overall Study||7
5139310|NCT01371747|12641157|P4|NOT COMPLETED|Overall Study||9
5139311|NCT01371747|12641158|P3|NOT COMPLETED|Overall Study||24
5139312|NCT01371747|12641159|P2|NOT COMPLETED|Overall Study||23
5139313|NCT01371747|12641160|P1|NOT COMPLETED|Overall Study||18
5139314|NCT01371747|12641155|P6|COMPLETED|Overall Study||16
5139315|NCT01371747|12641156|P5|COMPLETED|Overall Study||21
5139316|NCT01371747|12641157|P4|COMPLETED|Overall Study||17
5139317|NCT01371747|12641158|P3|COMPLETED|Overall Study||50
5139318|NCT01371747|12641159|P2|COMPLETED|Overall Study||51
5139319|NCT01371747|12641160|P1|COMPLETED|Overall Study||56
5139320|NCT01371747|12641155|P6|STARTED|Overall Study||30
5139321|NCT01371747|12641156|P5|STARTED|Overall Study||28
5139322|NCT01371747|12641157|P4|STARTED|Overall Study||26
5139323|NCT01371747|12641158|P3|STARTED|Overall Study||74
5139324|NCT01371747|12641159|P2|STARTED|Overall Study||74
5139325|NCT01371747|12641160|P1|STARTED|Overall Study||74
5139326|NCT01371734|12641225|P3|NOT COMPLETED|Overall Study||17
5139327|NCT01371734|12641226|P2|NOT COMPLETED|Overall Study||19
5139328|NCT01371734|12641227|P1|NOT COMPLETED|Overall Study||23
5139329|NCT01371734|12641225|P3|COMPLETED|Overall Study||104
5139330|NCT01371734|12641226|P2|COMPLETED|Overall Study||103
5139331|NCT01371734|12641227|P1|COMPLETED|Overall Study||97
5139332|NCT01371734|12641225|P3|STARTED|Overall Study||121
5139333|NCT01371734|12641226|P2|STARTED|Overall Study||122
5139334|NCT01371734|12641227|P1|STARTED|Overall Study||120
5139335|NCT01371721|12641247|P3|NOT COMPLETED|Overall Study||30
5139336|NCT01371721|12641248|P2|NOT COMPLETED|Overall Study||24
5139337|NCT01371721|12641249|P1|NOT COMPLETED|Overall Study||29
5139338|NCT01371721|12641247|P3|COMPLETED|Overall Study||62
5139339|NCT01371721|12641248|P2|COMPLETED|Overall Study||65
5139340|NCT01371721|12641249|P1|COMPLETED|Overall Study||59
5139341|NCT01371721|12641247|P3|Treated|Overall Study||92
5139342|NCT01371721|12641248|P2|Treated|Overall Study||89
5139343|NCT01371721|12641249|P1|Treated|Overall Study||87
5139344|NCT01371721|12641247|P3|STARTED|Overall Study||92
5139345|NCT01371721|12641248|P2|STARTED|Overall Study||89
5139346|NCT01371721|12641249|P1|STARTED|Overall Study||88
5139347|NCT01371708|12641282|P3|NOT COMPLETED|Overall Study||39
5139348|NCT01371708|12641283|P2|NOT COMPLETED|Overall Study||30
5139349|NCT01371708|12641284|P1|NOT COMPLETED|Overall Study||26
5139350|NCT01371708|12641282|P3|COMPLETED|Overall Study||59
5139351|NCT01371708|12641283|P2|COMPLETED|Overall Study||63
5139352|NCT01371708|12641284|P1|COMPLETED|Overall Study||66
5139353|NCT01371708|12641282|P3|Received Treatment|Overall Study||97
5139354|NCT01371708|12641283|P2|Received Treatment|Overall Study||93
5139355|NCT01371708|12641284|P1|Received Treatment|Overall Study||91
5139356|NCT01371708|12641282|P3|STARTED|Overall Study||98
5139357|NCT01371708|12641283|P2|STARTED|Overall Study||93
5139358|NCT01371708|12641284|P1|STARTED|Overall Study||92
5139359|NCT01371656|12641316|P2|NOT COMPLETED|Overall Study||14
5139360|NCT01371656|12641317|P1|NOT COMPLETED|Overall Study||64
5139361|NCT01371656|12641316|P2|COMPLETED|Overall Study||296
5139362|NCT01371656|12641317|P1|COMPLETED|Overall Study||250
5139363|NCT01371656|12641316|P2|STARTED|Overall Study||310
5139364|NCT01371656|12641317|P1|STARTED|Overall Study||314
5139365|NCT01371643|12641337|P2|NOT COMPLETED|Overall Study||0
5139366|NCT01371643|12641338|P1|NOT COMPLETED|Overall Study||3
5139367|NCT01371643|12641337|P2|COMPLETED|Overall Study||26
5139368|NCT01371643|12641338|P1|COMPLETED|Overall Study||12
5139369|NCT01371643|12641337|P2|STARTED|Overall Study||26
5139370|NCT01371643|12641338|P1|STARTED|Overall Study||15
5139371|NCT01371565|12641348|P1|NOT COMPLETED|Overall Study||3
5139372|NCT01371565|12641348|P1|COMPLETED|Overall Study||1
5139373|NCT01371565|12641348|P1|STARTED|Overall Study||4
5139374|NCT01371552|12641352|P6|NOT COMPLETED|Part 2, One Week||0
5139375|NCT01371552|12641353|P5|NOT COMPLETED|Part 2, One Week||0
5139376|NCT01371552|12641354|P4|NOT COMPLETED|Part 2, One Week||0
5139377|NCT01371552|12641355|P3|NOT COMPLETED|Part 2, One Week||0
5139378|NCT01371552|12641356|P2|NOT COMPLETED|Part 2, One Week||0
5139379|NCT01371552|12641357|P1|NOT COMPLETED|Part 2, One Week||0
5139380|NCT01371552|12641352|P6|COMPLETED|Part 2, One Week||18
5139381|NCT01371552|12641353|P5|COMPLETED|Part 2, One Week||15
5139382|NCT01371552|12641354|P4|COMPLETED|Part 2, One Week||20
5139383|NCT01371552|12641355|P3|COMPLETED|Part 2, One Week||18
5139384|NCT01371552|12641356|P2|COMPLETED|Part 2, One Week||17
5139385|NCT01371552|12641357|P1|COMPLETED|Part 2, One Week||18
5139386|NCT01371552|12641352|P6|STARTED|Part 2, One Week||18
5139387|NCT01371552|12641353|P5|STARTED|Part 2, One Week||15
5139388|NCT01371552|12641354|P4|STARTED|Part 2, One Week||20
5139389|NCT01371552|12641355|P3|STARTED|Part 2, One Week||18
5139390|NCT01371552|12641356|P2|STARTED|Part 2, One Week||17
5139391|NCT01371552|12641357|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
5139392|NCT01371552|12641352|P6|NOT COMPLETED|Part 1, Third 3 Days||1
5139393|NCT01371552|12641353|P5|NOT COMPLETED|Part 1, Third 3 Days||1
5139394|NCT01371552|12641354|P4|NOT COMPLETED|Part 1, Third 3 Days||0
5139395|NCT01371552|12641355|P3|NOT COMPLETED|Part 1, Third 3 Days||0
5139396|NCT01371552|12641356|P2|NOT COMPLETED|Part 1, Third 3 Days||0
5139397|NCT01371552|12641357|P1|NOT COMPLETED|Part 1, Third 3 Days||0
5139398|NCT01371552|12641352|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
5139399|NCT01371552|12641353|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
5139400|NCT01371552|12641354|P4|COMPLETED|Part 1, Third 3 Days||20
5139401|NCT01371552|12641355|P3|COMPLETED|Part 1, Third 3 Days||18
5139402|NCT01371552|12641356|P2|COMPLETED|Part 1, Third 3 Days||17
5139403|NCT01371552|12641357|P1|COMPLETED|Part 1, Third 3 Days||19
5139404|NCT01371552|12641352|P6|STARTED|Part 1, Third 3 Days||18
5139405|NCT01371552|12641353|P5|STARTED|Part 1, Third 3 Days||15
5139406|NCT01371552|12641354|P4|STARTED|Part 1, Third 3 Days||20
5139407|NCT01371552|12641355|P3|STARTED|Part 1, Third 3 Days||18
5139408|NCT01371552|12641356|P2|STARTED|Part 1, Third 3 Days||17
5139409|NCT01371552|12641357|P1|STARTED|Part 1, Third 3 Days||19
5139410|NCT01371552|12641352|P6|NOT COMPLETED|Part 1, Second 3 Days||0
5139411|NCT01371552|12641353|P5|NOT COMPLETED|Part 1, Second 3 Days||0
5139412|NCT01371552|12641354|P4|NOT COMPLETED|Part 1, Second 3 Days||0
5139413|NCT01371552|12641355|P3|NOT COMPLETED|Part 1, Second 3 Days||0
5139414|NCT01371552|12641356|P2|NOT COMPLETED|Part 1, Second 3 Days||0
5139415|NCT01371552|12641357|P1|NOT COMPLETED|Part 1, Second 3 Days||1
5139416|NCT01371552|12641352|P6|COMPLETED|Part 1, Second 3 Days||18
5139417|NCT01371552|12641353|P5|COMPLETED|Part 1, Second 3 Days||15
5139418|NCT01371552|12641354|P4|COMPLETED|Part 1, Second 3 Days||20
5139419|NCT01371552|12641355|P3|COMPLETED|Part 1, Second 3 Days||18
5139420|NCT01371552|12641356|P2|COMPLETED|Part 1, Second 3 Days||17
5139421|NCT01371552|12641357|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
5139422|NCT01371552|12641352|P6|STARTED|Part 1, Second 3 Days||18
5139423|NCT01371552|12641353|P5|STARTED|Part 1, Second 3 Days||15
5139424|NCT01371552|12641354|P4|STARTED|Part 1, Second 3 Days||20
5139425|NCT01371552|12641355|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
5139426|NCT01371552|12641356|P2|STARTED|Part 1, Second 3 Days||17
5139427|NCT01371552|12641357|P1|STARTED|Part 1, Second 3 Days||19
5139428|NCT01371552|12641352|P6|NOT COMPLETED|Part 1, First 3 Days||0
5139429|NCT01371552|12641353|P5|NOT COMPLETED|Part 1, First 3 Days||0
5139430|NCT01371552|12641354|P4|NOT COMPLETED|Part 1, First 3 Days||0
5139431|NCT01371552|12641355|P3|NOT COMPLETED|Part 1, First 3 Days||1
5139432|NCT01371552|12641356|P2|NOT COMPLETED|Part 1, First 3 Days||0
5139433|NCT01371552|12641357|P1|NOT COMPLETED|Part 1, First 3 Days||0
5139434|NCT01371552|12641352|P6|COMPLETED|Part 1, First 3 Days||18
5139435|NCT01371552|12641353|P5|COMPLETED|Part 1, First 3 Days||15
5139436|NCT01371552|12641354|P4|COMPLETED|Part 1, First 3 Days||20
5139437|NCT01371552|12641355|P3|COMPLETED|Part 1, First 3 Days||19
5139438|NCT01371552|12641356|P2|COMPLETED|Part 1, First 3 Days||17
5139439|NCT01371552|12641357|P1|COMPLETED|Part 1, First 3 Days||19
5139440|NCT01371552|12641352|P6|STARTED|Part 1, First 3 Days||18
5139441|NCT01371552|12641353|P5|STARTED|Part 1, First 3 Days||15
5139442|NCT01371552|12641354|P4|STARTED|Part 1, First 3 Days||20
5139443|NCT01371552|12641355|P3|STARTED|Part 1, First 3 Days||20
5139444|NCT01371552|12641356|P2|STARTED|Part 1, First 3 Days||17
5139445|NCT01371552|12641357|P1|STARTED|Part 1, First 3 Days||19
5139446|NCT01371539|12641384|P2|NOT COMPLETED|Period Two: One Week||3
5139447|NCT01371539|12641385|P1|NOT COMPLETED|Period Two: One Week||0
5139448|NCT01371539|12641384|P2|COMPLETED|Period Two: One Week||47
5139449|NCT01371539|12641385|P1|COMPLETED|Period Two: One Week||53
5139450|NCT01371539|12641384|P2|STARTED|Period Two: One Week||50
5139451|NCT01371539|12641385|P1|STARTED|Period Two: One Week||53
5139452|NCT01371539|12641384|P2|NOT COMPLETED|Period One: One Week||1
5139453|NCT01371539|12641385|P1|NOT COMPLETED|Period One: One Week||0
5139454|NCT01371539|12641384|P2|COMPLETED|Period One: One Week||50
5139455|NCT01371539|12641385|P1|COMPLETED|Period One: One Week||53
5139456|NCT01371539|12641384|P2|STARTED|Period One: One Week||51
5139457|NCT01371539|12641385|P1|STARTED|Period One: One Week||53
5139458|NCT01371305|12641399|P6|NOT COMPLETED|Overall Study||2
5139459|NCT01371305|12641400|P5|NOT COMPLETED|Overall Study||4
5139460|NCT01371305|12641401|P4|NOT COMPLETED|Overall Study||2
5139461|NCT01371305|12641402|P3|NOT COMPLETED|Overall Study||0
5139462|NCT01371305|12641403|P2|NOT COMPLETED|Overall Study||0
5139463|NCT01371305|12641404|P1|NOT COMPLETED|Overall Study||0
5139464|NCT01371305|12641399|P6|COMPLETED|Overall Study||8
5139465|NCT01371305|12641400|P5|COMPLETED|Overall Study||2
5139466|NCT01371305|12641401|P4|COMPLETED|Overall Study||5
5139467|NCT01371305|12641402|P3|COMPLETED|Overall Study||6
5139468|NCT01371305|12641403|P2|COMPLETED|Overall Study||6
5139469|NCT01371305|12641404|P1|COMPLETED|Overall Study||6
5139470|NCT01371305|12641399|P6|STARTED|Overall Study||10
5139471|NCT01371305|12641400|P5|STARTED|Overall Study||6
5139472|NCT01371305|12641401|P4|STARTED|Overall Study||7
5139473|NCT01371305|12641402|P3|STARTED|Overall Study||6
5139474|NCT01371305|12641403|P2|STARTED|Overall Study||6
5139475|NCT01371305|12641404|P1|STARTED|Overall Study||6
5139476|NCT01371110|12641477|P2|NOT COMPLETED|Overall Study||0
5139477|NCT01371110|12641478|P1|NOT COMPLETED|Overall Study||0
5139478|NCT01371110|12641477|P2|COMPLETED|Overall Study||2
5139479|NCT01371110|12641478|P1|COMPLETED|Overall Study||1
5139480|NCT01371110|12641477|P2|STARTED|Overall Study||2
5139481|NCT01371110|12641478|P1|STARTED|Overall Study||1
5139482|NCT01371006|12641488|P2|NOT COMPLETED|Overall Study||0
5139483|NCT01371006|12641489|P1|NOT COMPLETED|Overall Study||1
5139484|NCT01371006|12641488|P2|COMPLETED|Overall Study||15
5139485|NCT01371006|12641489|P1|COMPLETED|Overall Study||13
5139486|NCT01371006|12641488|P2|STARTED|Overall Study||15
5139487|NCT01371006|12641489|P1|STARTED|Overall Study||14
5139488|NCT01370863|12641530|P2|NOT COMPLETED|Overall Study||3
5139489|NCT01370863|12641531|P1|NOT COMPLETED|Overall Study||2
5139490|NCT01370863|12641530|P2|COMPLETED|Overall Study||30
5139491|NCT01370863|12641531|P1|COMPLETED|Overall Study||32
5139492|NCT01370863|12641530|P2|STARTED|Overall Study||33
5139493|NCT01370863|12641531|P1|STARTED|Overall Study||34
5139494|NCT01370837|12641544|P3|NOT COMPLETED|Overall Study||0
5139495|NCT01370837|12641545|P2|NOT COMPLETED|Overall Study||0
5139496|NCT01370837|12641546|P1|NOT COMPLETED|Overall Study||0
5139497|NCT01370837|12641544|P3|COMPLETED|Overall Study||17
5139498|NCT01370837|12641545|P2|COMPLETED|Overall Study||12
5139499|NCT01370837|12641546|P1|COMPLETED|Overall Study||12
5139500|NCT01370837|12641544|P3|STARTED|Overall Study||17
5139501|NCT01370837|12641545|P2|STARTED|Overall Study||12
5139502|NCT01370837|12641546|P1|STARTED|Overall Study||12
5139503|NCT01370733|12641556|P2|NOT COMPLETED|Overall Study||22
5139504|NCT01370733|12641557|P1|NOT COMPLETED|Overall Study||17
5139505|NCT01370733|12641556|P2|COMPLETED|Overall Study||77
5139506|NCT01370733|12641557|P1|COMPLETED|Overall Study||86
5139507|NCT01370733|12641556|P2|STARTED|Overall Study||99
5139508|NCT01370733|12641557|P1|STARTED|Overall Study||103
5139509|NCT01370694|12641579|P1|NOT COMPLETED|Overall Study||6
5139510|NCT01370694|12641579|P1|COMPLETED|Overall Study||1
5139511|NCT01370694|12641579|P1|STARTED|Overall Study||7
5139512|NCT01370655|12641601|P12|NOT COMPLETED|Period 2||0
5139513|NCT01370655|12641602|P11|NOT COMPLETED|Period 2||1
5139514|NCT01370655|12641603|P10|NOT COMPLETED|Period 2||0
5139515|NCT01370655|12641604|P9|NOT COMPLETED|Period 2||2
5139516|NCT01370655|12641605|P8|NOT COMPLETED|Period 2||1
5139517|NCT01370655|12641606|P7|NOT COMPLETED|Period 2||1
5139518|NCT01370655|12641607|P6|NOT COMPLETED|Period 2||0
5139519|NCT01370655|12641608|P5|NOT COMPLETED|Period 2||1
5139520|NCT01370655|12641609|P4|NOT COMPLETED|Period 2||0
5139521|NCT01370655|12641610|P3|NOT COMPLETED|Period 2||2
5139522|NCT01370655|12641611|P2|NOT COMPLETED|Period 2||0
5139523|NCT01370655|12641612|P1|NOT COMPLETED|Period 2||0
5139524|NCT01370655|12641601|P12|COMPLETED|Period 2||3
5139525|NCT01370655|12641602|P11|COMPLETED|Period 2||2
5139526|NCT01370655|12641603|P10|COMPLETED|Period 2||2
5139527|NCT01370655|12641604|P9|COMPLETED|Period 2||1
5139528|NCT01370655|12641605|P8|COMPLETED|Period 2||3
5139529|NCT01370655|12641606|P7|COMPLETED|Period 2||2
5139530|NCT01370655|12641607|P6|COMPLETED|Period 2||4
5139531|NCT01370655|12641608|P5|COMPLETED|Period 2||2
5139532|NCT01370655|12641609|P4|COMPLETED|Period 2||3
5139533|NCT01370655|12641610|P3|COMPLETED|Period 2||1
5139534|NCT01370655|12641611|P2|COMPLETED|Period 2||7
5139535|NCT01370655|12641612|P1|COMPLETED|Period 2||5
5139536|NCT01370655|12641601|P12|STARTED|Period 2||3
5139537|NCT01370655|12641602|P11|STARTED|Period 2||3
5139538|NCT01370655|12641603|P10|STARTED|Period 2||2
5139539|NCT01370655|12641604|P9|STARTED|Period 2||3
5139540|NCT01370655|12641605|P8|STARTED|Period 2||4
5139541|NCT01370655|12641606|P7|STARTED|Period 2||3
5139542|NCT01370655|12641607|P6|STARTED|Period 2||4
5139543|NCT01370655|12641608|P5|STARTED|Period 2||3
5139544|NCT01370655|12641609|P4|STARTED|Period 2||3
5139545|NCT01370655|12641610|P3|STARTED|Period 2||3
5139546|NCT01370655|12641611|P2|STARTED|Period 2||7
5139547|NCT01370655|12641612|P1|STARTED|Period 2||5
5139548|NCT01370655|12641601|P12|NOT COMPLETED|Period 1||0
5139549|NCT01370655|12641602|P11|NOT COMPLETED|Period 1||0
5139550|NCT01370655|12641603|P10|NOT COMPLETED|Period 1||0
5139551|NCT01370655|12641604|P9|NOT COMPLETED|Period 1||0
5139552|NCT01370655|12641605|P8|NOT COMPLETED|Period 1||0
5139553|NCT01370655|12641606|P7|NOT COMPLETED|Period 1||1
5139554|NCT01370655|12641607|P6|NOT COMPLETED|Period 1||0
5139555|NCT01370655|12641608|P5|NOT COMPLETED|Period 1||0
5139556|NCT01370655|12641609|P4|NOT COMPLETED|Period 1||0
5139557|NCT01370655|12641610|P3|NOT COMPLETED|Period 1||0
5139558|NCT01370655|12641611|P2|NOT COMPLETED|Period 1||0
5139559|NCT01370655|12641612|P1|NOT COMPLETED|Period 1||2
5139560|NCT01370655|12641601|P12|COMPLETED|Period 1||3
5139561|NCT01370655|12641602|P11|COMPLETED|Period 1||3
5139562|NCT01370655|12641603|P10|COMPLETED|Period 1||2
5139563|NCT01370655|12641604|P9|COMPLETED|Period 1||3
5139564|NCT01370655|12641605|P8|COMPLETED|Period 1||4
5139565|NCT01370655|12641606|P7|COMPLETED|Period 1||3
5139566|NCT01370655|12641607|P6|COMPLETED|Period 1||4
5139567|NCT01370655|12641608|P5|COMPLETED|Period 1||3
5139568|NCT01370655|12641609|P4|COMPLETED|Period 1||3
5139569|NCT01370655|12641610|P3|COMPLETED|Period 1||3
5139570|NCT01370655|12641611|P2|COMPLETED|Period 1||7
5139571|NCT01370655|12641612|P1|COMPLETED|Period 1||5
5139572|NCT01370655|12641601|P12|STARTED|Period 1||3
5139573|NCT01370655|12641602|P11|STARTED|Period 1||3
5139574|NCT01370655|12641603|P10|STARTED|Period 1||2
5139575|NCT01370655|12641604|P9|STARTED|Period 1||3
5139576|NCT01370655|12641605|P8|STARTED|Period 1||4
5139577|NCT01370655|12641606|P7|STARTED|Period 1||4
5139578|NCT01370655|12641607|P6|STARTED|Period 1||4
5139579|NCT01370655|12641608|P5|STARTED|Period 1||3
5139580|NCT01370655|12641609|P4|STARTED|Period 1||3
5139581|NCT01370655|12641610|P3|STARTED|Period 1||3
5139582|NCT01370655|12641611|P2|STARTED|Period 1||7
5139583|NCT01370655|12641612|P1|STARTED|Period 1||7
5139584|NCT01370642|12641649|P3|NOT COMPLETED|Overall Study||29
5139585|NCT01370642|12641650|P2|NOT COMPLETED|Overall Study||6
5139586|NCT01370642|12641651|P1|NOT COMPLETED|Overall Study||8
5139587|NCT01370642|12641649|P3|COMPLETED|Overall Study||69
5139588|NCT01370642|12641650|P2|COMPLETED|Overall Study||92
5139589|NCT01370642|12641651|P1|COMPLETED|Overall Study||90
5139590|NCT01370642|12641649|P3|FAS Population|Overall Study||98
5139591|NCT01370642|12641650|P2|FAS Population|Overall Study||97
5139592|NCT01370642|12641651|P1|FAS Population|Overall Study||98
5139593|NCT01370642|12641649|P3|STARTED|Overall Study||98
5139594|NCT01370642|12641650|P2|STARTED|Overall Study||98
5139595|NCT01370642|12641651|P1|STARTED|Overall Study||98
5139596|NCT01370629|12641680|P1|NOT COMPLETED|Overall Study||6
5139597|NCT01370629|12641680|P1|COMPLETED|Overall Study||2009
5139598|NCT01370629|12641680|P1|STARTED|Overall Study||2015
5139599|NCT01370616|12641690|P2|NOT COMPLETED|Overall Study||67
5139600|NCT01370616|12641691|P1|NOT COMPLETED|Overall Study||62
5139601|NCT01370616|12641690|P2|COMPLETED|Overall Study||216
5139602|NCT01370616|12641691|P1|COMPLETED|Overall Study||220
5139603|NCT01370616|12641690|P2|Treated|Overall Study||275
5139604|NCT01370616|12641691|P1|Treated|Overall Study||275
5139605|NCT01370616|12641690|P2|STARTED|Overall Study|Participants randomized|283
5139606|NCT01370616|12641691|P1|STARTED|Overall Study|Participants randomized|282
5139607|NCT01370603|12641715|P2|NOT COMPLETED|Period 2||4
5139608|NCT01370603|12641716|P1|NOT COMPLETED|Period 2||3
5139609|NCT01370603|12641715|P2|COMPLETED|Period 2||146
5139610|NCT01370603|12641716|P1|COMPLETED|Period 2||138
5139611|NCT01370603|12641715|P2|STARTED|Period 2||150
5139612|NCT01370603|12641716|P1|STARTED|Period 2||141
5139613|NCT01370603|12641715|P2|NOT COMPLETED|Crossover Washout||4
5139614|NCT01370603|12641716|P1|NOT COMPLETED|Crossover Washout||9
5139615|NCT01370603|12641715|P2|COMPLETED|Crossover Washout||150
5139616|NCT01370603|12641716|P1|COMPLETED|Crossover Washout||141
5139617|NCT01370603|12641715|P2|STARTED|Crossover Washout||154
5139618|NCT01370603|12641716|P1|STARTED|Crossover Washout||150
5139619|NCT01370603|12641715|P2|NOT COMPLETED|Period 1||10
5139620|NCT01370603|12641716|P1|NOT COMPLETED|Period 1||14
5139621|NCT01370603|12641715|P2|COMPLETED|Period 1||154
5139622|NCT01370603|12641716|P1|COMPLETED|Period 1||150
5139623|NCT01370603|12641715|P2|STARTED|Period 1||164
5139624|NCT01370603|12641716|P1|STARTED|Period 1||164
5139625|NCT01370590|12641734|P2|NOT COMPLETED|Period 2||2
5139626|NCT01370590|12641735|P1|NOT COMPLETED|Period 2||1
5139627|NCT01370590|12641734|P2|COMPLETED|Period 2||184
5139628|NCT01370590|12641735|P1|COMPLETED|Period 2||180
5139629|NCT01370590|12641734|P2|STARTED|Period 2||186
5139630|NCT01370590|12641735|P1|STARTED|Period 2||181
5139631|NCT01370590|12641734|P2|NOT COMPLETED|Crossover Washout Period||6
5139632|NCT01370590|12641735|P1|NOT COMPLETED|Crossover Washout Period||6
5139633|NCT01370590|12641734|P2|COMPLETED|Crossover Washout Period||186
5139634|NCT01370590|12641735|P1|COMPLETED|Crossover Washout Period||181
5139635|NCT01370590|12641734|P2|STARTED|Crossover Washout Period||192
5139636|NCT01370590|12641735|P1|STARTED|Crossover Washout Period||187
5139637|NCT01370590|12641734|P2|NOT COMPLETED|Period 1||11
5139638|NCT01370590|12641735|P1|NOT COMPLETED|Period 1||16
5139639|NCT01370590|12641734|P2|COMPLETED|Period 1||192
5139640|NCT01370590|12641735|P1|COMPLETED|Period 1||187
5139641|NCT01370590|12641734|P2|STARTED|Period 1||203
5139642|NCT01370590|12641735|P1|STARTED|Period 1||203
5139643|NCT01370564|12641751|P1|NOT COMPLETED|Overall Study||0
5139644|NCT01370564|12641751|P1|COMPLETED|Overall Study||21
5139645|NCT01370564|12641751|P1|STARTED|Overall Study||21
5139646|NCT01370538|12641763|P2|NOT COMPLETED|Overall Study||19
5139647|NCT01370538|12641764|P1|NOT COMPLETED|Overall Study||19
5139648|NCT01370538|12641763|P2|COMPLETED|Overall Study||152
5139649|NCT01370538|12641764|P1|COMPLETED|Overall Study||151
5139650|NCT01370538|12641763|P2|Patients Who Completed Treatment|Overall Study||152
5139651|NCT01370538|12641764|P1|Patients Who Completed Treatment|Overall Study||151
5139652|NCT01370538|12641763|P2|Patients Who Received Treatment|Overall Study||161
5139653|NCT01370538|12641764|P1|Patients Who Received Treatment|Overall Study||165
5139654|NCT01370538|12641763|P2|STARTED|Overall Study||171
5139655|NCT01370538|12641764|P1|STARTED|Overall Study||170
5139656|NCT01370525|12641780|P2|NOT COMPLETED|Overall Study||11
5139657|NCT01370525|12641781|P1|NOT COMPLETED|Overall Study||8
5139658|NCT01370525|12641780|P2|COMPLETED|Overall Study||158
5139659|NCT01370525|12641781|P1|COMPLETED|Overall Study||163
5139660|NCT01370525|12641780|P2|Patients Who Completed Treatment|Overall Study||158
5139661|NCT01370525|12641781|P1|Patients Who Completed Treatment|Overall Study||163
5139662|NCT01370525|12641780|P2|Patients Who Received Treatment|Overall Study||163
5139663|NCT01370525|12641781|P1|Patients Who Received Treatment|Overall Study||168
5139664|NCT01370525|12641780|P2|STARTED|Overall Study||169
5139665|NCT01370525|12641781|P1|STARTED|Overall Study||171
5139666|NCT01370499|12641797|P2|NOT COMPLETED|Overall Study||44
5139667|NCT01370499|12641798|P1|NOT COMPLETED|Overall Study||111
5139668|NCT01370499|12641797|P2|COMPLETED|Overall Study||49
5139669|NCT01370499|12641798|P1|COMPLETED|Overall Study||84
5139670|NCT01370499|12641797|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
5139671|NCT01370499|12641798|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
5139672|NCT01370499|12641797|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
5139673|NCT01370499|12641798|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
5139674|NCT01370499|12641797|P2|STARTED|Overall Study||93
5139675|NCT01370499|12641798|P1|STARTED|Overall Study||195
5139676|NCT01370460|12641832|P2|NOT COMPLETED|Overall Study||0
5139677|NCT01370460|12641833|P1|NOT COMPLETED|Overall Study||0
5139678|NCT01370460|12641832|P2|COMPLETED|Overall Study||51
5139679|NCT01370460|12641833|P1|COMPLETED|Overall Study||50
5139680|NCT01370460|12641832|P2|STARTED|Overall Study||51
5139681|NCT01370460|12641833|P1|STARTED|Overall Study||50
5139682|NCT01370408|12641840|P1|NOT COMPLETED|Overall Study||9
5139683|NCT01370408|12641840|P1|COMPLETED|Overall Study||76
5139684|NCT01370408|12641840|P1|STARTED|Overall Study||85
5139685|NCT01370369|12641851|P1|NOT COMPLETED|Overall Study||0
5139686|NCT01370369|12641851|P1|COMPLETED|Overall Study||20
5139687|NCT01370369|12641851|P1|STARTED|Overall Study||20
5139688|NCT01370356|12641900|P2|NOT COMPLETED|Overall Study||227
5139689|NCT01370356|12641901|P1|NOT COMPLETED|Overall Study||192
5139690|NCT01370356|12641900|P2|COMPLETED|Overall Study||515
5139691|NCT01370356|12641901|P1|COMPLETED|Overall Study||559
5139692|NCT01370356|12641900|P2|STARTED|Overall Study||742
5139693|NCT01370356|12641901|P1|STARTED|Overall Study||751
5139694|NCT01370317|12641917|P2|NOT COMPLETED|Overall Study||1
5139695|NCT01370317|12641918|P1|NOT COMPLETED|Overall Study||1
5139696|NCT01370317|12641917|P2|COMPLETED|Overall Study||8
5139697|NCT01370317|12641918|P1|COMPLETED|Overall Study||17
5139698|NCT01370317|12641917|P2|STARTED|Overall Study||9
5139699|NCT01370317|12641918|P1|STARTED|Overall Study||18
5139700|NCT01370265|12641929|P2|NOT COMPLETED|Second Intervention||0
5139701|NCT01370265|12641930|P1|NOT COMPLETED|Second Intervention||0
5139702|NCT01370265|12641929|P2|COMPLETED|Second Intervention||5
5139703|NCT01370265|12641930|P1|COMPLETED|Second Intervention||5
5139704|NCT01370265|12641929|P2|STARTED|Second Intervention||5
5139705|NCT01370265|12641930|P1|STARTED|Second Intervention||5
5139706|NCT01370265|12641929|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
5139707|NCT01370265|12641930|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
5139708|NCT01370265|12641929|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
5139709|NCT01370265|12641930|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
5139710|NCT01370265|12641929|P2|STARTED|Washout Period (50-minute Period Decay)||5
5139711|NCT01370265|12641930|P1|STARTED|Washout Period (50-minute Period Decay)||5
5139712|NCT01370265|12641929|P2|NOT COMPLETED|First Intervention||1
5139713|NCT01370265|12641930|P1|NOT COMPLETED|First Intervention||1
5139714|NCT01370265|12641929|P2|COMPLETED|First Intervention||5
5139715|NCT01370265|12641930|P1|COMPLETED|First Intervention||5
5139716|NCT01370265|12641929|P2|STARTED|First Intervention||6
5139717|NCT01370265|12641930|P1|STARTED|First Intervention||6
5139718|NCT01370265|12641929|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
5139719|NCT01370265|12641930|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
5139720|NCT01370265|12641929|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
5139721|NCT01370265|12641930|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
5139722|NCT01370265|12641929|P2|STARTED|Washout Period (50-minute Period Decay)||6
5139723|NCT01370265|12641930|P1|STARTED|Washout Period (50-minute Period Decay)||6
5139724|NCT01370265|12641929|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
5139725|NCT01370265|12641930|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
5139726|NCT01370265|12641929|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
5139727|NCT01370265|12641930|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
5139728|NCT01370265|12641929|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
5139729|NCT01370265|12641930|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
5139730|NCT01370213|12641950|P3|NOT COMPLETED|Overall Study||0
5139731|NCT01370213|12641951|P2|NOT COMPLETED|Overall Study||2
5139732|NCT01370213|12641952|P1|NOT COMPLETED|Overall Study||1
5139733|NCT01370213|12641950|P3|COMPLETED|Overall Study||1
5139734|NCT01370213|12641951|P2|COMPLETED|Overall Study||15
5139735|NCT01370213|12641952|P1|COMPLETED|Overall Study||6
5139736|NCT01370213|12641950|P3|STARTED|Overall Study||1
5139737|NCT01370213|12641951|P2|STARTED|Overall Study||17
5139738|NCT01370213|12641952|P1|STARTED|Overall Study||7
5139739|NCT01370083|12641972|P2|NOT COMPLETED|Overall Study||1
5139740|NCT01370083|12641973|P1|NOT COMPLETED|Overall Study||2
5139741|NCT01370083|12641972|P2|COMPLETED|Overall Study||6
5139742|NCT01370083|12641973|P1|COMPLETED|Overall Study||5
5139743|NCT01370083|12641972|P2|STARTED|Overall Study||7
5139744|NCT01370083|12641973|P1|STARTED|Overall Study||7
5139745|NCT01370005|12641986|P3|NOT COMPLETED|Overall Study||11
5139746|NCT01370005|12641987|P2|NOT COMPLETED|Overall Study||11
5139747|NCT01370005|12641988|P1|NOT COMPLETED|Overall Study||16
5139748|NCT01370005|12641986|P3|COMPLETED|Overall Study||266
5139749|NCT01370005|12641987|P2|COMPLETED|Overall Study||265
5139750|NCT01370005|12641988|P1|COMPLETED|Overall Study||256
5139751|NCT01370005|12641986|P3|STARTED|Overall Study||277
5139752|NCT01370005|12641987|P2|STARTED|Overall Study||276
5139753|NCT01370005|12641988|P1|STARTED|Overall Study||272
5139754|NCT01369888|12642045|P4|NOT COMPLETED|Overall Study||0
5139755|NCT01369888|12642046|P3|NOT COMPLETED|Overall Study||0
5139756|NCT01369888|12642047|P2|NOT COMPLETED|Overall Study||0
5139757|NCT01369888|12642048|P1|NOT COMPLETED|Overall Study||0
5139758|NCT01369888|12642045|P4|COMPLETED|Overall Study||0
5139759|NCT01369888|12642046|P3|COMPLETED|Overall Study||0
5139760|NCT01369888|12642047|P2|COMPLETED|Overall Study||2
5139761|NCT01369888|12642048|P1|COMPLETED|Overall Study||1
5139762|NCT01369888|12642045|P4|STARTED|Overall Study||0
5139763|NCT01369888|12642046|P3|STARTED|Overall Study||0
5139764|NCT01369888|12642047|P2|STARTED|Overall Study||2
5139765|NCT01369888|12642048|P1|STARTED|Overall Study||1
5139766|NCT01369875|12642058|P2|NOT COMPLETED|Overall Study||0
5139767|NCT01369875|12642059|P1|NOT COMPLETED|Overall Study||0
5139768|NCT01369875|12642058|P2|COMPLETED|Overall Study||1
5139769|NCT01369875|12642059|P1|COMPLETED|Overall Study||1
5139770|NCT01369875|12642058|P2|STARTED|Overall Study||1
5139771|NCT01369875|12642059|P1|STARTED|Overall Study||1
5139772|NCT01369849|12642070|P3|NOT COMPLETED|Overall Study||1
5139773|NCT01369849|12642071|P2|NOT COMPLETED|Overall Study||1
5139774|NCT01369849|12642072|P1|NOT COMPLETED|Overall Study||0
5139775|NCT01369849|12642070|P3|COMPLETED|Overall Study||4
5139776|NCT01369849|12642071|P2|COMPLETED|Overall Study||3
5139777|NCT01369849|12642072|P1|COMPLETED|Overall Study||6
5139778|NCT01369849|12642070|P3|STARTED|Overall Study||5
5139779|NCT01369849|12642071|P2|STARTED|Overall Study||4
5139780|NCT01369849|12642072|P1|STARTED|Overall Study||6
5139781|NCT01369784|12642094|P1|NOT COMPLETED|Overall Study||12
5139782|NCT01369784|12642094|P1|COMPLETED|Overall Study||146
5139783|NCT01369784|12642094|P1|STARTED|Overall Study||158
5139784|NCT01369758|12642119|P1|NOT COMPLETED|Overall Study||0
5139785|NCT01369758|12642119|P1|COMPLETED|Overall Study||290
5139786|NCT01369758|12642119|P1|STARTED|Overall Study||290
5139787|NCT01369745|12642129|P5|NOT COMPLETED|Overall Study||18
5139788|NCT01369745|12642130|P4|NOT COMPLETED|Overall Study||20
5139789|NCT01369745|12642131|P3|NOT COMPLETED|Overall Study||2
5139790|NCT01369745|12642132|P2|NOT COMPLETED|Overall Study||13
5139791|NCT01369745|12642133|P1|NOT COMPLETED|Overall Study||7
5139792|NCT01369745|12642129|P5|COMPLETED|Overall Study||65
5139793|NCT01369745|12642130|P4|COMPLETED|Overall Study||64
5139794|NCT01369745|12642131|P3|COMPLETED|Overall Study||16
5139795|NCT01369745|12642132|P2|COMPLETED|Overall Study||28
5139796|NCT01369745|12642133|P1|COMPLETED|Overall Study||25
5139797|NCT01369745|12642129|P5|STARTED|Overall Study||83
5139798|NCT01369745|12642130|P4|STARTED|Overall Study||84
5139799|NCT01369745|12642131|P3|STARTED|Overall Study||18
5139800|NCT01369745|12642132|P2|STARTED|Overall Study||41
5139801|NCT01369745|12642133|P1|STARTED|Overall Study||32
5139802|NCT01369732|12642167|P2|NOT COMPLETED|Overall Study||2
5139803|NCT01369732|12642168|P1|NOT COMPLETED|Overall Study||4
5139804|NCT01369732|12642167|P2|COMPLETED|Overall Study||31
5139805|NCT01369732|12642168|P1|COMPLETED|Overall Study||29
5139806|NCT01369732|12642167|P2|STARTED|Overall Study||33
5139807|NCT01369732|12642168|P1|STARTED|Overall Study||33
5139808|NCT01369706|12642174|P1|NOT COMPLETED|Overall Study||0
5139809|NCT01369706|12642174|P1|COMPLETED|Overall Study||388
5139810|NCT01369706|12642174|P1|STARTED|Overall Study||388
5139811|NCT01369680|12642182|P4|NOT COMPLETED|Overall Study||2
5139812|NCT01369680|12642183|P3|NOT COMPLETED|Overall Study||1
5139813|NCT01369680|12642184|P2|NOT COMPLETED|Overall Study||0
5139814|NCT01369680|12642185|P1|NOT COMPLETED|Overall Study||0
5139815|NCT01369680|12642182|P4|COMPLETED|Overall Study||1
5139816|NCT01369680|12642183|P3|COMPLETED|Overall Study||2
5139817|NCT01369680|12642184|P2|COMPLETED|Overall Study||3
5139818|NCT01369680|12642185|P1|COMPLETED|Overall Study||3
5139819|NCT01369680|12642182|P4|STARTED|Overall Study||3
5139820|NCT01369680|12642183|P3|STARTED|Overall Study||3
5139821|NCT01369680|12642184|P2|STARTED|Overall Study||3
5139822|NCT01369680|12642185|P1|STARTED|Overall Study||3
5139823|NCT01369641|12642206|P1|NOT COMPLETED|Overall Study||1
5139824|NCT01369641|12642206|P1|COMPLETED|Overall Study||0
5139825|NCT01369641|12642206|P1|STARTED|Overall Study||1
5139826|NCT01369615|12642212|P2|NOT COMPLETED|Overall Study||2
5139827|NCT01369615|12642213|P1|NOT COMPLETED|Overall Study||0
5139828|NCT01369615|12642212|P2|COMPLETED|Overall Study||12
5139829|NCT01369615|12642213|P1|COMPLETED|Overall Study||9
5139830|NCT01369615|12642212|P2|STARTED|Overall Study||14
5139831|NCT01369615|12642213|P1|STARTED|Overall Study||9
5139832|NCT01369511|12642223|P4|NOT COMPLETED|Overall Study||11
5139833|NCT01369511|12642224|P3|NOT COMPLETED|Overall Study||11
5139834|NCT01369511|12642225|P2|NOT COMPLETED|Overall Study||13
5139835|NCT01369511|12642226|P1|NOT COMPLETED|Overall Study||13
5139836|NCT01369511|12642223|P4|COMPLETED|Overall Study||89
5139837|NCT01369511|12642224|P3|COMPLETED|Overall Study||87
5139838|NCT01369511|12642225|P2|COMPLETED|Overall Study||91
5139839|NCT01369511|12642226|P1|COMPLETED|Overall Study||85
5139840|NCT01369511|12642223|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
5139841|NCT01369511|12642224|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
5139842|NCT01369511|12642225|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
5139843|NCT01369511|12642226|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
5139844|NCT01369511|12642223|P4|STARTED|Overall Study||100
5139845|NCT01369511|12642224|P3|STARTED|Overall Study||98
5139846|NCT01369511|12642225|P2|STARTED|Overall Study||104
5139847|NCT01369511|12642226|P1|STARTED|Overall Study||98
5139848|NCT01369498|12642244|P4|NOT COMPLETED|Overall Study||15
5139849|NCT01369498|12642245|P3|NOT COMPLETED|Overall Study||15
5139850|NCT01369498|12642246|P2|NOT COMPLETED|Overall Study||12
5139851|NCT01369498|12642247|P1|NOT COMPLETED|Overall Study||12
5139852|NCT01369498|12642244|P4|COMPLETED|Overall Study||0
5139853|NCT01369498|12642245|P3|COMPLETED|Overall Study||0
5139854|NCT01369498|12642246|P2|COMPLETED|Overall Study||0
5139855|NCT01369498|12642247|P1|COMPLETED|Overall Study||0
5139856|NCT01369498|12642244|P4|STARTED|Overall Study||15
5139857|NCT01369498|12642245|P3|STARTED|Overall Study||15
5139858|NCT01369498|12642246|P2|STARTED|Overall Study||12
5139859|NCT01369498|12642247|P1|STARTED|Overall Study||12
5139860|NCT01369485|12642279|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
5139861|NCT01369485|12642280|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
5139862|NCT01369485|12642279|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
5139863|NCT01369485|12642280|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
5139864|NCT01369485|12642279|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
5139865|NCT01369485|12642280|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
5139866|NCT01369485|12642279|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
5139867|NCT01369485|12642280|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
5139868|NCT01369485|12642279|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
5139869|NCT01369485|12642280|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
5139870|NCT01369485|12642279|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
5139871|NCT01369485|12642280|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
5139872|NCT01369355|12642326|P6|NOT COMPLETED|Overall Study||272
5139873|NCT01369355|12642327|P5|NOT COMPLETED|Overall Study||154
5139874|NCT01369355|12642328|P4|NOT COMPLETED|Overall Study||30
5139875|NCT01369355|12642329|P3|NOT COMPLETED|Overall Study||31
5139876|NCT01369355|12642330|P2|NOT COMPLETED|Overall Study||29
5139877|NCT01369355|12642331|P1|NOT COMPLETED|Overall Study||31
5139878|NCT01369355|12642326|P6|COMPLETED|Overall Study||204
5139879|NCT01369355|12642327|P5|COMPLETED|Overall Study||131
5139880|NCT01369355|12642328|P4|COMPLETED|Overall Study||93
5139881|NCT01369355|12642329|P3|COMPLETED|Overall Study||101
5139882|NCT01369355|12642330|P2|COMPLETED|Overall Study||103
5139883|NCT01369355|12642331|P1|COMPLETED|Overall Study||102
5139884|NCT01369355|12642326|P6|Treated|Overall Study||476
5139885|NCT01369355|12642327|P5|Treated|Overall Study||285
5139886|NCT01369355|12642328|P4|Treated|Overall Study||123
5139887|NCT01369355|12642329|P3|Treated|Overall Study||131
5139888|NCT01369355|12642330|P2|Treated|Overall Study||132
5139889|NCT01369355|12642331|P1|Treated|Overall Study||133
5139890|NCT01369355|12642326|P6|STARTED|Overall Study||476
5139891|NCT01369355|12642327|P5|STARTED|Overall Study||285
5139892|NCT01369355|12642328|P4|STARTED|Overall Study||123
5139893|NCT01369355|12642329|P3|STARTED|Overall Study||132
5139894|NCT01369355|12642330|P2|STARTED|Overall Study||132
5139895|NCT01369355|12642331|P1|STARTED|Overall Study||133
5139896|NCT01369342|12642360|P3|NOT COMPLETED|Overall Study||3
5139897|NCT01369342|12642361|P2|NOT COMPLETED|Overall Study||9
5139898|NCT01369342|12642362|P1|NOT COMPLETED|Overall Study||13
5139899|NCT01369342|12642360|P3|COMPLETED|Overall Study||210
5139900|NCT01369342|12642361|P2|COMPLETED|Overall Study||204
5139901|NCT01369342|12642362|P1|COMPLETED|Overall Study||201
5139902|NCT01369342|12642360|P3|STARTED|Overall Study||213
5139903|NCT01369342|12642361|P2|STARTED|Overall Study||213
5139904|NCT01369342|12642362|P1|STARTED|Overall Study||214
5139905|NCT01369329|12642385|P3|NOT COMPLETED|Overall Study||14
5139906|NCT01369329|12642386|P2|NOT COMPLETED|Overall Study||11
5139907|NCT01369329|12642387|P1|NOT COMPLETED|Overall Study||12
5139908|NCT01369329|12642385|P3|COMPLETED|Overall Study||245
5139909|NCT01369329|12642386|P2|COMPLETED|Overall Study||243
5139910|NCT01369329|12642387|P1|COMPLETED|Overall Study||244
5139911|NCT01369329|12642385|P3|STARTED|Overall Study||259
5139912|NCT01369329|12642386|P2|STARTED|Overall Study||254
5139913|NCT01369329|12642387|P1|STARTED|Overall Study||256
5139914|NCT01369225|12642413|P6|NOT COMPLETED|Overall Study||0
5139915|NCT01369225|12642414|P5|NOT COMPLETED|Overall Study||2
5139916|NCT01369225|12642415|P4|NOT COMPLETED|Overall Study||2
5139917|NCT01369225|12642416|P3|NOT COMPLETED|Overall Study||3
5139918|NCT01369225|12642417|P2|NOT COMPLETED|Overall Study||0
5139919|NCT01369225|12642418|P1|NOT COMPLETED|Overall Study||2
5139920|NCT01369225|12642413|P6|COMPLETED|Overall Study||9
5139921|NCT01369225|12642414|P5|COMPLETED|Overall Study||10
5139922|NCT01369225|12642415|P4|COMPLETED|Overall Study||8
5139923|NCT01369225|12642416|P3|COMPLETED|Overall Study||9
5139924|NCT01369225|12642417|P2|COMPLETED|Overall Study||3
5139925|NCT01369225|12642418|P1|COMPLETED|Overall Study||4
5139926|NCT01369225|12642413|P6|STARTED|Overall Study||9
5139927|NCT01369225|12642414|P5|STARTED|Overall Study||12
5139928|NCT01369225|12642415|P4|STARTED|Overall Study||10
5139929|NCT01369225|12642416|P3|STARTED|Overall Study||12
5139930|NCT01369225|12642417|P2|STARTED|Overall Study||3
5139931|NCT01369225|12642418|P1|STARTED|Overall Study||6
5139932|NCT01369199|12642510|P1|NOT COMPLETED|Overall Study||3
5139933|NCT01369199|12642510|P1|COMPLETED|Overall Study||25
5139934|NCT01369199|12642510|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
5139935|NCT01369199|12642510|P1|STARTED|Overall Study||28
5139936|NCT01369108|12642532|P1|NOT COMPLETED|Overall Study||11
5139937|NCT01369108|12642532|P1|COMPLETED|Overall Study||49
5139938|NCT01369108|12642532|P1|STARTED|Overall Study|120 teeth|60
5139939|NCT01369069|12642541|P2|NOT COMPLETED|Overall Study||16
5139940|NCT01369069|12642542|P1|NOT COMPLETED|Overall Study||17
5139941|NCT01369069|12642541|P2|COMPLETED|Overall Study||554
5139942|NCT01369069|12642542|P1|COMPLETED|Overall Study||564
5139943|NCT01369069|12642541|P2|STARTED|Overall Study||570
5139944|NCT01369069|12642542|P1|STARTED|Overall Study||581
5139945|NCT01369030|12642558|P1|NOT COMPLETED|Overall Study||40
5139946|NCT01369030|12642558|P1|COMPLETED|Overall Study||554
5139947|NCT01369030|12642558|P1|STARTED|Overall Study||594
5139948|NCT01368965|12642564|P1|NOT COMPLETED|Overall Study||12
5139949|NCT01368965|12642564|P1|COMPLETED|Overall Study||40
5139950|NCT01368965|12642564|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
5139951|NCT01368965|12642564|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
5139952|NCT01368900|12642573|P1|NOT COMPLETED|Overall Study||7
5139953|NCT01368900|12642573|P1|COMPLETED|Overall Study||61
5139954|NCT01368900|12642573|P1|STARTED|Overall Study||68
5139955|NCT01368874|12642586|P3|NOT COMPLETED|Overall Study||1
5139956|NCT01368874|12642587|P2|NOT COMPLETED|Overall Study||0
5139957|NCT01368874|12642588|P1|NOT COMPLETED|Overall Study||3
5139958|NCT01368874|12642586|P3|COMPLETED|Overall Study||24
5139959|NCT01368874|12642587|P2|COMPLETED|Overall Study||5
5139960|NCT01368874|12642588|P1|COMPLETED|Overall Study||31
5139961|NCT01368874|12642586|P3|STARTED|Overall Study||25
5139962|NCT01368874|12642587|P2|STARTED|Overall Study||5
5139963|NCT01368874|12642588|P1|STARTED|Overall Study||34
5139964|NCT01368835|12642648|P1|NOT COMPLETED|Overall Study||33
5139965|NCT01368835|12642648|P1|COMPLETED|Overall Study||70
5139966|NCT01368835|12642648|P1|STARTED|Overall Study|103 Subjects Enrolled|103
5139967|NCT01368809|12642657|P2|NOT COMPLETED|Overall Study||0
5139968|NCT01368809|12642658|P1|NOT COMPLETED|Overall Study||0
5139969|NCT01368809|12642657|P2|COMPLETED|Overall Study||50
5139970|NCT01368809|12642658|P1|COMPLETED|Overall Study||50
5139971|NCT01368809|12642657|P2|STARTED|Overall Study||50
5139972|NCT01368809|12642658|P1|STARTED|Overall Study||50
5139973|NCT01368653|12642670|P2|NOT COMPLETED|Overall Study||9
5139974|NCT01368653|12642671|P1|NOT COMPLETED|Overall Study||6
5139975|NCT01368653|12642670|P2|COMPLETED|Overall Study||37
5139976|NCT01368653|12642671|P1|COMPLETED|Overall Study||41
5139977|NCT01368653|12642670|P2|Randomized to Advice Only in Phase 2|Overall Study||10
5139978|NCT01368653|12642671|P1|Randomized to Advice Only in Phase 2|Overall Study||10
5139979|NCT01368653|12642670|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
5139980|NCT01368653|12642671|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
5139981|NCT01368653|12642670|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
5139982|NCT01368653|12642671|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
5139983|NCT01368653|12642670|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
5139984|NCT01368653|12642671|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
5139985|NCT01368653|12642670|P2|Completed 4-week Follow-up|Overall Study||37
5139986|NCT01368653|12642671|P1|Completed 4-week Follow-up|Overall Study||44
5139987|NCT01368653|12642670|P2|STARTED|Overall Study||46
5139988|NCT01368653|12642671|P1|STARTED|Overall Study||47
5139989|NCT01368614|12642687|P4|NOT COMPLETED|Study Period||3
5139990|NCT01368614|12642688|P3|NOT COMPLETED|Study Period||2
5139991|NCT01368614|12642689|P2|NOT COMPLETED|Study Period||1
5139992|NCT01368614|12642690|P1|NOT COMPLETED|Study Period||0
5139993|NCT01368614|12642687|P4|COMPLETED|Study Period||8
5139994|NCT01368614|12642688|P3|COMPLETED|Study Period||8
5139995|NCT01368614|12642689|P2|COMPLETED|Study Period||10
5139996|NCT01368614|12642690|P1|COMPLETED|Study Period||0
5139997|NCT01368614|12642687|P4|STARTED|Study Period||11
5139998|NCT01368614|12642688|P3|STARTED|Study Period||10
5139999|NCT01368614|12642689|P2|STARTED|Study Period||11
5140000|NCT01368614|12642690|P1|STARTED|Study Period||0
5140001|NCT01368614|12642687|P4|NOT COMPLETED|Screening Period||0
5140002|NCT01368614|12642688|P3|NOT COMPLETED|Screening Period||0
5140003|NCT01368614|12642689|P2|NOT COMPLETED|Screening Period||0
5140004|NCT01368614|12642690|P1|NOT COMPLETED|Screening Period||58
5140005|NCT01368614|12642687|P4|COMPLETED|Screening Period||0
5140006|NCT01368614|12642688|P3|COMPLETED|Screening Period||0
5140007|NCT01368614|12642689|P2|COMPLETED|Screening Period||0
5140008|NCT01368614|12642690|P1|COMPLETED|Screening Period||32
5140009|NCT01368614|12642687|P4|STARTED|Screening Period||0
5140010|NCT01368614|12642688|P3|STARTED|Screening Period||0
5140011|NCT01368614|12642689|P2|STARTED|Screening Period||0
5140012|NCT01368614|12642690|P1|STARTED|Screening Period||90
5140013|NCT01368562|12642743|P1|NOT COMPLETED|Overall Study||19
5140014|NCT01368562|12642743|P1|COMPLETED|Overall Study||7
5140015|NCT01368562|12642743|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
5140016|NCT01368562|12642743|P1|STARTED|Overall Study||26
5140017|NCT01368536|12642750|P3|NOT COMPLETED|Overall Study||59
5140018|NCT01368536|12642751|P2|NOT COMPLETED|Overall Study||59
5140019|NCT01368536|12642752|P1|NOT COMPLETED|Overall Study||51
5140020|NCT01368536|12642750|P3|COMPLETED|Overall Study||83
5140021|NCT01368536|12642751|P2|COMPLETED|Overall Study||78
5140022|NCT01368536|12642752|P1|COMPLETED|Overall Study||87
5140023|NCT01368536|12642750|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
5140024|NCT01368536|12642751|P2|Full Analysis Set|Overall Study||137
5140025|NCT01368536|12642752|P1|Full Analysis Set|Overall Study||138
5140026|NCT01368536|12642750|P3|STARTED|Overall Study||142
5140027|NCT01368536|12642751|P2|STARTED|Overall Study||137
5140028|NCT01368536|12642752|P1|STARTED|Overall Study||138
5140029|NCT01368497|12642773|P1|NOT COMPLETED|Overall Study||2
5140030|NCT01368497|12642773|P1|COMPLETED|Overall Study||58
5140031|NCT01368497|12642773|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
5140032|NCT01368497|12642773|P1|STARTED|Overall Study||60
5140033|NCT01368432|12642801|P2|NOT COMPLETED|Overall Study||1
5140034|NCT01368432|12642802|P1|NOT COMPLETED|Overall Study||0
5140035|NCT01368432|12642801|P2|COMPLETED|Overall Study||7
5140036|NCT01368432|12642802|P1|COMPLETED|Overall Study||6
5140037|NCT01368432|12642801|P2|STARTED|Overall Study||8
5140038|NCT01368432|12642802|P1|STARTED|Overall Study||6
5140039|NCT01368406|12642836|P2|NOT COMPLETED|Overall Study||13
5140040|NCT01368406|12642837|P1|NOT COMPLETED|Overall Study||21
5140041|NCT01368406|12642836|P2|COMPLETED|Overall Study||66
5140042|NCT01368406|12642837|P1|COMPLETED|Overall Study||60
5140043|NCT01368406|12642836|P2|STARTED|Overall Study||79
5140044|NCT01368406|12642837|P1|STARTED|Overall Study||81
5140045|NCT01368276|12642845|P2|NOT COMPLETED|Overall Study||10
5140046|NCT01368276|12642846|P1|NOT COMPLETED|Overall Study||1
5140047|NCT01368276|12642845|P2|COMPLETED|Overall Study||18
5140048|NCT01368276|12642846|P1|COMPLETED|Overall Study||2
5140049|NCT01368276|12642845|P2|STARTED|Overall Study||28
5140050|NCT01368276|12642846|P1|STARTED|Overall Study||3
5140051|NCT01368263|12642859|P3|NOT COMPLETED|Overall Study||0
5140052|NCT01368263|12642860|P2|NOT COMPLETED|Overall Study||0
5140053|NCT01368263|12642861|P1|NOT COMPLETED|Overall Study||0
5140054|NCT01368263|12642859|P3|COMPLETED|Overall Study||1
5140055|NCT01368263|12642860|P2|COMPLETED|Overall Study||1
5140056|NCT01368263|12642861|P1|COMPLETED|Overall Study||6
5140057|NCT01368263|12642859|P3|STARTED|Overall Study||1
5140058|NCT01368263|12642860|P2|STARTED|Overall Study||1
5140059|NCT01368263|12642861|P1|STARTED|Overall Study||6
5140060|NCT01368211|12642883|P2|NOT COMPLETED|Second Platelets Transfusion||2
5140061|NCT01368211|12642884|P1|NOT COMPLETED|Second Platelets Transfusion||1
5140062|NCT01368211|12642883|P2|COMPLETED|Second Platelets Transfusion||5
5140063|NCT01368211|12642884|P1|COMPLETED|Second Platelets Transfusion||7
5140064|NCT01368211|12642883|P2|STARTED|Second Platelets Transfusion||7
5140065|NCT01368211|12642884|P1|STARTED|Second Platelets Transfusion||8
5140066|NCT01368211|12642883|P2|NOT COMPLETED|First Platelets Transfusion||0
5140067|NCT01368211|12642884|P1|NOT COMPLETED|First Platelets Transfusion||0
5140068|NCT01368211|12642883|P2|COMPLETED|First Platelets Transfusion||7
5140069|NCT01368211|12642884|P1|COMPLETED|First Platelets Transfusion||8
5140070|NCT01368211|12642883|P2|STARTED|First Platelets Transfusion||7
5140071|NCT01368211|12642884|P1|STARTED|First Platelets Transfusion||8
5140072|NCT01368185|12642892|P1|NOT COMPLETED|Overall Study||0
5140073|NCT01368185|12642892|P1|COMPLETED|Overall Study||1705
5140074|NCT01368185|12642892|P1|STARTED|Overall Study||1705
5140075|NCT01368081|12642912|P13|NOT COMPLETED|Overall Study||7
5140076|NCT01368081|12642913|P12|NOT COMPLETED|Overall Study||3
5140077|NCT01368081|12642914|P11|NOT COMPLETED|Overall Study||9
5140078|NCT01368081|12642915|P10|NOT COMPLETED|Overall Study||10
5140079|NCT01368081|12642916|P9|NOT COMPLETED|Overall Study||8
5140080|NCT01368081|12642917|P8|NOT COMPLETED|Overall Study||7
5140081|NCT01368081|12642918|P7|NOT COMPLETED|Overall Study||12
5140082|NCT01368081|12642919|P6|NOT COMPLETED|Overall Study||10
5140083|NCT01368081|12642920|P5|NOT COMPLETED|Overall Study||2
5140084|NCT01368081|12642921|P4|NOT COMPLETED|Overall Study||5
5140085|NCT01368081|12642922|P3|NOT COMPLETED|Overall Study||4
5140086|NCT01368081|12642923|P2|NOT COMPLETED|Overall Study||9
5140087|NCT01368081|12642924|P1|NOT COMPLETED|Overall Study||10
5140088|NCT01368081|12642912|P13|COMPLETED|Overall Study||63
5140089|NCT01368081|12642913|P12|COMPLETED|Overall Study||67
5140090|NCT01368081|12642914|P11|COMPLETED|Overall Study||62
5140091|NCT01368081|12642915|P10|COMPLETED|Overall Study||58
5140092|NCT01368081|12642916|P9|COMPLETED|Overall Study||62
5140093|NCT01368081|12642917|P8|COMPLETED|Overall Study||62
5140094|NCT01368081|12642918|P7|COMPLETED|Overall Study||124
5140095|NCT01368081|12642919|P6|COMPLETED|Overall Study||127
5140096|NCT01368081|12642920|P5|COMPLETED|Overall Study||63
5140097|NCT01368081|12642921|P4|COMPLETED|Overall Study||63
5140098|NCT01368081|12642922|P3|COMPLETED|Overall Study||59
5140099|NCT01368081|12642923|P2|COMPLETED|Overall Study||128
5140100|NCT01368081|12642924|P1|COMPLETED|Overall Study||126
5140101|NCT01368081|12642912|P13|STARTED|Overall Study||70
5140102|NCT01368081|12642913|P12|STARTED|Overall Study||70
5140103|NCT01368081|12642914|P11|STARTED|Overall Study||71
5140104|NCT01368081|12642915|P10|STARTED|Overall Study||68
5140105|NCT01368081|12642916|P9|STARTED|Overall Study||70
5140106|NCT01368081|12642917|P8|STARTED|Overall Study||69
5140107|NCT01368081|12642918|P7|STARTED|Overall Study||136
5140108|NCT01368081|12642919|P6|STARTED|Overall Study||137
5140109|NCT01368081|12642920|P5|STARTED|Overall Study||65
5140110|NCT01368081|12642921|P4|STARTED|Overall Study||68
5140111|NCT01368081|12642922|P3|STARTED|Overall Study||63
5140112|NCT01368081|12642923|P2|STARTED|Overall Study||137
5140113|NCT01368081|12642924|P1|STARTED|Overall Study||136
5140114|NCT01368042|12642978|P1|NOT COMPLETED|Overall Study||30
5140115|NCT01368042|12642978|P1|COMPLETED|Overall Study||235
5140116|NCT01368042|12642978|P1|STARTED|Overall Study||265
5140117|NCT01367886|12642998|P1|NOT COMPLETED|Overall Study||7
5140118|NCT01367886|12642998|P1|COMPLETED|Overall Study||14
5140119|NCT01367886|12642998|P1|STARTED|Overall Study||21
5140120|NCT01367860|12643007|P2|NOT COMPLETED|Overall Study||0
5140121|NCT01367860|12643008|P1|NOT COMPLETED|Overall Study||0
5140122|NCT01367860|12643007|P2|COMPLETED|Overall Study||20
5140123|NCT01367860|12643008|P1|COMPLETED|Overall Study||20
5140124|NCT01367860|12643007|P2|STARTED|Overall Study||20
5140125|NCT01367860|12643008|P1|STARTED|Overall Study||20
5140126|NCT01367847|12643048|P2|NOT COMPLETED|Overall Study||2
5140127|NCT01367847|12643049|P1|NOT COMPLETED|Overall Study||2
5140128|NCT01367847|12643048|P2|COMPLETED|Overall Study||7
5140129|NCT01367847|12643049|P1|COMPLETED|Overall Study||8
5140130|NCT01367847|12643048|P2|STARTED|Overall Study||9
5140131|NCT01367847|12643049|P1|STARTED|Overall Study||10
5140132|NCT01367834|12643065|P2|NOT COMPLETED|Overall Study||3
5140133|NCT01367834|12643066|P1|NOT COMPLETED|Overall Study||2
5140134|NCT01367834|12643065|P2|COMPLETED|Overall Study||3
5140135|NCT01367834|12643066|P1|COMPLETED|Overall Study||9
5140136|NCT01367834|12643065|P2|STARTED|Overall Study||6
5140137|NCT01367834|12643066|P1|STARTED|Overall Study||11
5140138|NCT01367704|12643090|P2|NOT COMPLETED|Overall Study||161
5140139|NCT01367704|12643091|P1|NOT COMPLETED|Overall Study||47
5140140|NCT01367704|12643090|P2|COMPLETED|Overall Study||847
5140141|NCT01367704|12643091|P1|COMPLETED|Overall Study||951
5140142|NCT01367704|12643090|P2|STARTED|Overall Study||1008
5140143|NCT01367704|12643091|P1|STARTED|Overall Study||998
5140144|NCT01367665|12643103|P2|NOT COMPLETED|Overall Study||55
5140145|NCT01367665|12643104|P1|NOT COMPLETED|Overall Study||442
5140146|NCT01367665|12643103|P2|COMPLETED|Overall Study||41
5140147|NCT01367665|12643104|P1|COMPLETED|Overall Study||677
5140148|NCT01367665|12643103|P2|STARTED|Overall Study||96
5140149|NCT01367665|12643104|P1|STARTED|Overall Study||1119
5140150|NCT01367457|12643135|P3|NOT COMPLETED|Overall Study||0
5140151|NCT01367457|12643136|P2|NOT COMPLETED|Overall Study||0
5140152|NCT01367457|12643137|P1|NOT COMPLETED|Overall Study||188
5140153|NCT01367457|12643135|P3|COMPLETED|Overall Study||26
5140154|NCT01367457|12643136|P2|COMPLETED|Overall Study||23
5140155|NCT01367457|12643137|P1|COMPLETED|Overall Study||5
5140156|NCT01367457|12643135|P3|STARTED|Overall Study||26
5140157|NCT01367457|12643136|P2|STARTED|Overall Study||23
5140158|NCT01367457|12643137|P1|STARTED|Overall Study||193
5140159|NCT01367444|12643164|P7|NOT COMPLETED|Overall Study||0
5140160|NCT01367444|12643165|P6|NOT COMPLETED|Overall Study||0
5140161|NCT01367444|12643166|P5|NOT COMPLETED|Overall Study||0
5140162|NCT01367444|12643167|P4|NOT COMPLETED|Overall Study||0
5140163|NCT01367444|12643168|P3|NOT COMPLETED|Overall Study||0
5140164|NCT01367444|12643169|P2|NOT COMPLETED|Overall Study||0
5140165|NCT01367444|12643170|P1|NOT COMPLETED|Overall Study||0
5140166|NCT01367444|12643164|P7|COMPLETED|Overall Study||1
5140167|NCT01367444|12643165|P6|COMPLETED|Overall Study||4
5140168|NCT01367444|12643166|P5|COMPLETED|Overall Study||6
5140169|NCT01367444|12643167|P4|COMPLETED|Overall Study||4
5140170|NCT01367444|12643168|P3|COMPLETED|Overall Study||4
5140171|NCT01367444|12643169|P2|COMPLETED|Overall Study||4
5140172|NCT01367444|12643170|P1|COMPLETED|Overall Study||4
5140173|NCT01367444|12643164|P7|STARTED|Overall Study||1
5140174|NCT01367444|12643165|P6|STARTED|Overall Study||4
5140175|NCT01367444|12643166|P5|STARTED|Overall Study||6
5140176|NCT01367444|12643167|P4|STARTED|Overall Study||4
5140177|NCT01367444|12643168|P3|STARTED|Overall Study||4
5140178|NCT01367444|12643169|P2|STARTED|Overall Study||4
5140179|NCT01367444|12643170|P1|STARTED|Overall Study||4
5140180|NCT01367262|12643193|P1|NOT COMPLETED|Overall Study||0
5140181|NCT01367262|12643193|P1|COMPLETED|Overall Study||6
5140182|NCT01367262|12643193|P1|STARTED|Overall Study||6
5140183|NCT01367249|12643206|P2|NOT COMPLETED|Overall Study||16
5140184|NCT01367249|12643207|P1|NOT COMPLETED|Overall Study||9
5140185|NCT01367249|12643206|P2|COMPLETED|Overall Study||202
5140186|NCT01367249|12643207|P1|COMPLETED|Overall Study||213
5140187|NCT01367249|12643206|P2|STARTED|Overall Study||218
5140188|NCT01367249|12643207|P1|STARTED|Overall Study||222
5140189|NCT01367236|12643217|P2|NOT COMPLETED|Overall Study||1
5140190|NCT01367236|12643218|P1|NOT COMPLETED|Overall Study||3
5140191|NCT01367236|12643217|P2|COMPLETED|Overall Study||29
5140192|NCT01367236|12643218|P1|COMPLETED|Overall Study||27
5140193|NCT01367236|12643217|P2|STARTED|Overall Study||30
5140194|NCT01367236|12643218|P1|STARTED|Overall Study||30
5140195|NCT01367158|12643237|P11|NOT COMPLETED|Overall Study||1
5140196|NCT01367158|12643238|P10|NOT COMPLETED|Overall Study||0
5140197|NCT01367158|12643239|P9|NOT COMPLETED|Overall Study||0
5140198|NCT01367158|12643240|P8|NOT COMPLETED|Overall Study||2
5140199|NCT01367158|12643241|P7|NOT COMPLETED|Overall Study||0
5140200|NCT01367158|12643242|P6|NOT COMPLETED|Overall Study||2
5140201|NCT01367158|12643243|P5|NOT COMPLETED|Overall Study||2
5140202|NCT01367158|12643244|P4|NOT COMPLETED|Overall Study||1
5140203|NCT01367158|12643245|P3|NOT COMPLETED|Overall Study||1
5140204|NCT01367158|12643246|P2|NOT COMPLETED|Overall Study||3
5140205|NCT01367158|12643247|P1|NOT COMPLETED|Overall Study||0
5140206|NCT01367158|12643237|P11|COMPLETED|Overall Study||72
5140207|NCT01367158|12643238|P10|COMPLETED|Overall Study||50
5140208|NCT01367158|12643239|P9|COMPLETED|Overall Study||23
5140209|NCT01367158|12643240|P8|COMPLETED|Overall Study||47
5140210|NCT01367158|12643241|P7|COMPLETED|Overall Study||25
5140211|NCT01367158|12643242|P6|COMPLETED|Overall Study||46
5140212|NCT01367158|12643243|P5|COMPLETED|Overall Study||23
5140213|NCT01367158|12643244|P4|COMPLETED|Overall Study||48
5140214|NCT01367158|12643245|P3|COMPLETED|Overall Study||23
5140215|NCT01367158|12643246|P2|COMPLETED|Overall Study||46
5140216|NCT01367158|12643247|P1|COMPLETED|Overall Study||25
5140217|NCT01367158|12643237|P11|STARTED|Overall Study||73
5140218|NCT01367158|12643238|P10|STARTED|Overall Study||50
5140219|NCT01367158|12643239|P9|STARTED|Overall Study||23
5140220|NCT01367158|12643240|P8|STARTED|Overall Study||49
5140221|NCT01367158|12643241|P7|STARTED|Overall Study||25
5140222|NCT01367158|12643242|P6|STARTED|Overall Study||48
5140223|NCT01367158|12643243|P5|STARTED|Overall Study||25
5140224|NCT01367158|12643244|P4|STARTED|Overall Study||49
5140225|NCT01367158|12643245|P3|STARTED|Overall Study||24
5140226|NCT01367158|12643246|P2|STARTED|Overall Study||49
5140227|NCT01367158|12643247|P1|STARTED|Overall Study||25
5140228|NCT01367119|12643391|P2|NOT COMPLETED|Overall Study||1
5140229|NCT01367119|12643392|P1|NOT COMPLETED|Overall Study||2
5140230|NCT01367119|12643391|P2|COMPLETED|Overall Study||16
5140231|NCT01367119|12643392|P1|COMPLETED|Overall Study||19
5140232|NCT01367119|12643391|P2|STARTED|Overall Study||17
5140233|NCT01367119|12643392|P1|STARTED|Overall Study||21
5140234|NCT01367080|12643404|P2|NOT COMPLETED|2nd Administration||0
5140235|NCT01367080|12643405|P1|NOT COMPLETED|2nd Administration||0
5140236|NCT01367080|12643404|P2|COMPLETED|2nd Administration||6
5140237|NCT01367080|12643405|P1|COMPLETED|2nd Administration||6
5140238|NCT01367080|12643404|P2|STARTED|2nd Administration||6
5140239|NCT01367080|12643405|P1|STARTED|2nd Administration||6
5140240|NCT01367080|12643404|P2|NOT COMPLETED|1st Administration||0
5140241|NCT01367080|12643405|P1|NOT COMPLETED|1st Administration||0
5140242|NCT01367080|12643404|P2|COMPLETED|1st Administration||6
5140243|NCT01367080|12643405|P1|COMPLETED|1st Administration||6
5140244|NCT01367080|12643404|P2|STARTED|1st Administration||6
5140245|NCT01367080|12643405|P1|STARTED|1st Administration||6
5140246|NCT01366976|12643419|P2|NOT COMPLETED|Overall Study||0
5140247|NCT01366976|12643420|P1|NOT COMPLETED|Overall Study||0
5140248|NCT01366976|12643419|P2|COMPLETED|Overall Study||30
5140249|NCT01366976|12643420|P1|COMPLETED|Overall Study||30
5140250|NCT01366976|12643419|P2|STARTED|Overall Study||30
5140251|NCT01366976|12643420|P1|STARTED|Overall Study||30
5140252|NCT01366885|12643432|P1|NOT COMPLETED|Overall Study||1
5140253|NCT01366885|12643432|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
5140254|NCT01366885|12643432|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
5140255|NCT01366872|12643437|P1|NOT COMPLETED|Overall Study||0
5140256|NCT01366872|12643437|P1|COMPLETED|Overall Study||50
5140257|NCT01366872|12643437|P1|STARTED|Overall Study||50
5140258|NCT01366846|12643447|P4|NOT COMPLETED|Overall Study||1
5140259|NCT01366846|12643448|P3|NOT COMPLETED|Overall Study||1
5140260|NCT01366846|12643449|P2|NOT COMPLETED|Overall Study||4
5140261|NCT01366846|12643450|P1|NOT COMPLETED|Overall Study||3
5140262|NCT01366846|12643447|P4|COMPLETED|Overall Study||45
5140263|NCT01366846|12643448|P3|COMPLETED|Overall Study||46
5140264|NCT01366846|12643449|P2|COMPLETED|Overall Study||224
5140265|NCT01366846|12643450|P1|COMPLETED|Overall Study||232
5140266|NCT01366846|12643447|P4|STARTED|Overall Study||46
5140267|NCT01366846|12643448|P3|STARTED|Overall Study||47
5140268|NCT01366846|12643449|P2|STARTED|Overall Study||228
5140269|NCT01366846|12643450|P1|STARTED|Overall Study||235
5140270|NCT01366638|12643473|P3|NOT COMPLETED|Overall Study||6
5140271|NCT01366638|12643474|P2|NOT COMPLETED|Overall Study||0
5140272|NCT01366638|12643475|P1|NOT COMPLETED|Overall Study||1
5140273|NCT01366638|12643473|P3|COMPLETED|Overall Study||20
5140274|NCT01366638|12643474|P2|COMPLETED|Overall Study||29
5140275|NCT01366638|12643475|P1|COMPLETED|Overall Study||23
5140276|NCT01366638|12643473|P3|STARTED|Overall Study||26
5140277|NCT01366638|12643474|P2|STARTED|Overall Study||29
5140278|NCT01366638|12643475|P1|STARTED|Overall Study||24
5140279|NCT01366534|12643512|P3|NOT COMPLETED|Overall Study||0
5140280|NCT01366534|12643513|P2|NOT COMPLETED|Overall Study||2
5140281|NCT01366534|12643514|P1|NOT COMPLETED|Overall Study||2
5140282|NCT01366534|12643512|P3|COMPLETED|Overall Study||12
5140283|NCT01366534|12643513|P2|COMPLETED|Overall Study||25
5140284|NCT01366534|12643514|P1|COMPLETED|Overall Study||26
5140285|NCT01366534|12643512|P3|STARTED|Overall Study||12
5140286|NCT01366534|12643513|P2|STARTED|Overall Study||27
5140287|NCT01366534|12643514|P1|STARTED|Overall Study||28
5140288|NCT01366521|12643564|P4|NOT COMPLETED|Overall Study||0
5140289|NCT01366521|12643565|P3|NOT COMPLETED|Overall Study||2
5140290|NCT01366521|12643566|P2|NOT COMPLETED|Overall Study||1
5140291|NCT01366521|12643567|P1|NOT COMPLETED|Overall Study||1
5140292|NCT01366521|12643564|P4|COMPLETED|Overall Study||11
5140293|NCT01366521|12643565|P3|COMPLETED|Overall Study||21
5140294|NCT01366521|12643566|P2|COMPLETED|Overall Study||14
5140295|NCT01366521|12643567|P1|COMPLETED|Overall Study||20
5140296|NCT01366521|12643564|P4|STARTED|Overall Study||11
5140297|NCT01366521|12643565|P3|STARTED|Overall Study||23
5140298|NCT01366521|12643566|P2|STARTED|Overall Study||15
5140299|NCT01366521|12643567|P1|STARTED|Overall Study||21
5140300|NCT01366495|12643646|P4|NOT COMPLETED|HIV Study||0
5140301|NCT01366495|12643647|P3|NOT COMPLETED|HIV Study||0
5140302|NCT01366495|12643648|P2|NOT COMPLETED|HIV Study||0
5140303|NCT01366495|12643649|P1|NOT COMPLETED|HIV Study||1
5140304|NCT01366495|12643646|P4|COMPLETED|HIV Study||0
5140305|NCT01366495|12643647|P3|COMPLETED|HIV Study||0
5140306|NCT01366495|12643648|P2|COMPLETED|HIV Study||50
5140307|NCT01366495|12643649|P1|COMPLETED|HIV Study||49
5140308|NCT01366495|12643646|P4|STARTED|HIV Study||0
5140309|NCT01366495|12643647|P3|STARTED|HIV Study||0
5140310|NCT01366495|12643648|P2|STARTED|HIV Study||50
5140311|NCT01366495|12643649|P1|STARTED|HIV Study||50
5140312|NCT01366495|12643646|P4|NOT COMPLETED|Testing Study||0
5140313|NCT01366495|12643647|P3|NOT COMPLETED|Testing Study||0
5140314|NCT01366495|12643648|P2|NOT COMPLETED|Testing Study||0
5140315|NCT01366495|12643649|P1|NOT COMPLETED|Testing Study||0
5140316|NCT01366495|12643646|P4|COMPLETED|Testing Study||348
5140317|NCT01366495|12643647|P3|COMPLETED|Testing Study||349
5140318|NCT01366495|12643648|P2|COMPLETED|Testing Study||0
5140319|NCT01366495|12643649|P1|COMPLETED|Testing Study||0
5140320|NCT01366495|12643646|P4|STARTED|Testing Study||348
5140321|NCT01366495|12643647|P3|STARTED|Testing Study||349
5140322|NCT01366495|12643648|P2|STARTED|Testing Study||0
5140323|NCT01366495|12643649|P1|STARTED|Testing Study||0
5140324|NCT01366443|12643663|P1|NOT COMPLETED|Overall Study||3
5140325|NCT01366443|12643663|P1|COMPLETED|Overall Study||285
5140326|NCT01366443|12643663|P1|STARTED|Overall Study||288
5140327|NCT01366417|12643668|P1|NOT COMPLETED|Overall Study||18
5140328|NCT01366417|12643668|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
5140329|NCT01366417|12643668|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
5140330|NCT01366417|12643668|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
5140331|NCT01366417|12643668|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
5140332|NCT01366417|12643668|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
5140333|NCT01366417|12643668|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
5140334|NCT01366417|12643668|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
5140335|NCT01366417|12643668|P1|STARTED|Overall Study||43
5140336|NCT01366209|12643677|P2|NOT COMPLETED|Overall Study||36
5140337|NCT01366209|12643678|P1|NOT COMPLETED|Overall Study||35
5140338|NCT01366209|12643677|P2|COMPLETED|Overall Study||241
5140339|NCT01366209|12643678|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
5140340|NCT01366209|12643677|P2|STARTED|Overall Study||277
5140341|NCT01366209|12643678|P1|STARTED|Overall Study||278
5140342|NCT01366196|12643686|P2|NOT COMPLETED|Overall Study||0
5140343|NCT01366196|12643687|P1|NOT COMPLETED|Overall Study||0
5140344|NCT01366196|12643686|P2|COMPLETED|Overall Study||43
5140345|NCT01366196|12643687|P1|COMPLETED|Overall Study||43
5140346|NCT01366196|12643686|P2|STARTED|Overall Study||43
5140347|NCT01366196|12643687|P1|STARTED|Overall Study||43
5140348|NCT01366092|12643701|P1|NOT COMPLETED|Overall Study||4
5140349|NCT01366092|12643701|P1|COMPLETED|Overall Study||31
5140350|NCT01366092|12643701|P1|STARTED|Overall Study||35
5140351|NCT01365910|12643710|P1|NOT COMPLETED|Overall Study||30
5140352|NCT01365910|12643710|P1|COMPLETED|Overall Study||0
5140353|NCT01365910|12643710|P1|STARTED|Overall Study||30
5140354|NCT01365845|12643717|P3|NOT COMPLETED|Treatment Phase||0
5140355|NCT01365845|12643718|P2|NOT COMPLETED|Treatment Phase||0
5140356|NCT01365845|12643719|P1|NOT COMPLETED|Treatment Phase||0
5140357|NCT01365845|12643717|P3|COMPLETED|Treatment Phase||18
5140358|NCT01365845|12643718|P2|COMPLETED|Treatment Phase||0
5140359|NCT01365845|12643719|P1|COMPLETED|Treatment Phase||0
5140360|NCT01365845|12643717|P3|STARTED|Treatment Phase||18
5140361|NCT01365845|12643718|P2|STARTED|Treatment Phase||0
5140362|NCT01365845|12643719|P1|STARTED|Treatment Phase||0
5140363|NCT01365845|12643717|P3|NOT COMPLETED|Induction Phase||0
5140364|NCT01365845|12643718|P2|NOT COMPLETED|Induction Phase||0
5140365|NCT01365845|12643719|P1|NOT COMPLETED|Induction Phase||0
5140366|NCT01365845|12643717|P3|COMPLETED|Induction Phase||0
5140367|NCT01365845|12643718|P2|COMPLETED|Induction Phase||0
5140368|NCT01365845|12643719|P1|COMPLETED|Induction Phase||18
5140369|NCT01365845|12643717|P3|STARTED|Induction Phase||0
5140370|NCT01365845|12643718|P2|STARTED|Induction Phase||0
5140371|NCT01365845|12643719|P1|STARTED|Induction Phase||18
5140372|NCT01365819|12643726|P2|NOT COMPLETED|Overall Study||13
5140373|NCT01365819|12643727|P1|NOT COMPLETED|Overall Study||13
5140374|NCT01365819|12643726|P2|COMPLETED|Overall Study||14
5140375|NCT01365819|12643727|P1|COMPLETED|Overall Study||12
5140376|NCT01365819|12643726|P2|STARTED|Overall Study||27
5140377|NCT01365819|12643727|P1|STARTED|Overall Study||25
5140378|NCT01365793|12643745|P4|NOT COMPLETED|Overall Study||2
5140379|NCT01365793|12643746|P3|NOT COMPLETED|Overall Study||7
5140380|NCT01365793|12643747|P2|NOT COMPLETED|Overall Study||7
5140381|NCT01365793|12643748|P1|NOT COMPLETED|Overall Study||2
5140382|NCT01365793|12643745|P4|COMPLETED|Overall Study||347
5140383|NCT01365793|12643746|P3|COMPLETED|Overall Study||338
5140384|NCT01365793|12643747|P2|COMPLETED|Overall Study||344
5140385|NCT01365793|12643748|P1|COMPLETED|Overall Study||342
5140386|NCT01365793|12643745|P4|STARTED|Overall Study||349
5140387|NCT01365793|12643746|P3|STARTED|Overall Study||345
5140388|NCT01365793|12643747|P2|STARTED|Overall Study||351
5140389|NCT01365793|12643748|P1|STARTED|Overall Study||344
5140390|NCT01365650|12643774|P1|NOT COMPLETED|Treatment C||0
5140391|NCT01365650|12643774|P1|COMPLETED|Treatment C||24
5140392|NCT01365650|12643774|P1|STARTED|Treatment C||24
5140393|NCT01365650|12643774|P1|NOT COMPLETED|Treatment B||0
5140394|NCT01365650|12643774|P1|COMPLETED|Treatment B||24
5140395|NCT01365650|12643774|P1|STARTED|Treatment B||24
5140396|NCT01365650|12643774|P1|NOT COMPLETED|Treatment A||0
5140397|NCT01365650|12643774|P1|COMPLETED|Treatment A||24
5140398|NCT01365650|12643774|P1|STARTED|Treatment A||24
5140399|NCT01365624|12643799|P2|NOT COMPLETED|Overall Study||0
5140400|NCT01365624|12643800|P1|NOT COMPLETED|Overall Study||0
5140401|NCT01365624|12643799|P2|COMPLETED|Overall Study||15
5140402|NCT01365624|12643800|P1|COMPLETED|Overall Study||15
5140403|NCT01365624|12643799|P2|STARTED|Overall Study||15
5140404|NCT01365624|12643800|P1|STARTED|Overall Study||15
5140405|NCT01365611|12643816|P1|NOT COMPLETED|Overall Study||0
5140406|NCT01365611|12643816|P1|COMPLETED|Overall Study||36
5140407|NCT01365611|12643816|P1|STARTED|Overall Study||36
5140408|NCT01365585|12643832|P1|NOT COMPLETED|Overall Study||0
5140409|NCT01365585|12643832|P1|COMPLETED|Overall Study||227
5140410|NCT01365585|12643832|P1|STARTED|Overall Study||227
5140411|NCT01365546|12643846|P1|NOT COMPLETED|Overall Study||11
5140412|NCT01365546|12643846|P1|COMPLETED|Overall Study||30
5140413|NCT01365546|12643846|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
5140414|NCT01365507|12643856|P2|NOT COMPLETED|Overall Study||9
5140415|NCT01365507|12643857|P1|NOT COMPLETED|Overall Study||9
5140416|NCT01365507|12643856|P2|COMPLETED|Overall Study||131
5140417|NCT01365507|12643857|P1|COMPLETED|Overall Study||127
5140418|NCT01365507|12643856|P2|Exposed|Overall Study||140
5140419|NCT01365507|12643857|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
5140420|NCT01365507|12643856|P2|STARTED|Overall Study||140
5140421|NCT01365507|12643857|P1|STARTED|Overall Study||136
5140422|NCT01365494|12643873|P2|NOT COMPLETED|Overall Study||3
5140423|NCT01365494|12643874|P1|NOT COMPLETED|Overall Study||2
5140424|NCT01365494|12643873|P2|COMPLETED|Overall Study||121
5140425|NCT01365494|12643874|P1|COMPLETED|Overall Study||124
5140426|NCT01365494|12643873|P2|STARTED|Overall Study||124
5140427|NCT01365494|12643874|P1|STARTED|Overall Study||126
5140428|NCT01365481|12643890|P4|NOT COMPLETED|Overall Study||7
5140429|NCT01365481|12643891|P3|NOT COMPLETED|Overall Study||4
5140430|NCT01365481|12643892|P2|NOT COMPLETED|Overall Study||15
5140431|NCT01365481|12643893|P1|NOT COMPLETED|Overall Study||7
5140432|NCT01365481|12643890|P4|COMPLETED|Overall Study||50
5140433|NCT01365481|12643891|P3|COMPLETED|Overall Study||14
5140434|NCT01365481|12643892|P2|COMPLETED|Overall Study||37
5140435|NCT01365481|12643893|P1|COMPLETED|Overall Study||16
5140436|NCT01365481|12643890|P4|STARTED|Overall Study||57
5140437|NCT01365481|12643891|P3|STARTED|Overall Study||18
5140438|NCT01365481|12643892|P2|STARTED|Overall Study||52
5140439|NCT01365481|12643893|P1|STARTED|Overall Study||23
5140440|NCT01365468|12643913|P2|NOT COMPLETED|Overall Study||0
5140441|NCT01365468|12643914|P1|NOT COMPLETED|Overall Study||4
5140442|NCT01365468|12643913|P2|COMPLETED|Overall Study||5
5140443|NCT01365468|12643914|P1|COMPLETED|Overall Study||0
5140444|NCT01365468|12643913|P2|STARTED|Overall Study||5
5140445|NCT01365468|12643914|P1|STARTED|Overall Study||4
5140446|NCT01365455|12643929|P5|NOT COMPLETED|Follow-up Period||0
5140447|NCT01365455|12643930|P4|NOT COMPLETED|Follow-up Period||0
5140448|NCT01365455|12643931|P3|NOT COMPLETED|Follow-up Period||0
5140449|NCT01365455|12643932|P2|NOT COMPLETED|Follow-up Period||0
5140450|NCT01365455|12643933|P1|NOT COMPLETED|Follow-up Period||0
5140451|NCT01365455|12643929|P5|COMPLETED|Follow-up Period||0
5140452|NCT01365455|12643930|P4|COMPLETED|Follow-up Period||0
5140453|NCT01365455|12643931|P3|COMPLETED|Follow-up Period||18
5140454|NCT01365455|12643932|P2|COMPLETED|Follow-up Period||47
5140455|NCT01365455|12643933|P1|COMPLETED|Follow-up Period||58
5140456|NCT01365455|12643929|P5|STARTED|Follow-up Period||0
5140457|NCT01365455|12643930|P4|STARTED|Follow-up Period||0
5140458|NCT01365455|12643931|P3|STARTED|Follow-up Period||18
5140459|NCT01365455|12643932|P2|STARTED|Follow-up Period||47
5140460|NCT01365455|12643933|P1|STARTED|Follow-up Period||58
5140461|NCT01365455|12643929|P5|NOT COMPLETED|Maintenance Period||13
5140462|NCT01365455|12643930|P4|NOT COMPLETED|Maintenance Period||9
5140463|NCT01365455|12643931|P3|NOT COMPLETED|Maintenance Period||3
5140464|NCT01365455|12643932|P2|NOT COMPLETED|Maintenance Period||23
5140465|NCT01365455|12643933|P1|NOT COMPLETED|Maintenance Period||29
5140466|NCT01365455|12643929|P5|COMPLETED|Maintenance Period||92
5140467|NCT01365455|12643930|P4|COMPLETED|Maintenance Period||100
5140468|NCT01365455|12643931|P3|COMPLETED|Maintenance Period||15
5140469|NCT01365455|12643932|P2|COMPLETED|Maintenance Period||215
5140470|NCT01365455|12643933|P1|COMPLETED|Maintenance Period||201
5140471|NCT01365455|12643929|P5|STARTED|Maintenance Period||105
5140472|NCT01365455|12643930|P4|STARTED|Maintenance Period||109
5140473|NCT01365455|12643931|P3|STARTED|Maintenance Period||18
5140474|NCT01365455|12643932|P2|STARTED|Maintenance Period||238
5140475|NCT01365455|12643933|P1|STARTED|Maintenance Period||230
5140476|NCT01365455|12643929|P5|NOT COMPLETED|Induction Period||0
5140477|NCT01365455|12643930|P4|NOT COMPLETED|Induction Period||0
5140478|NCT01365455|12643931|P3|NOT COMPLETED|Induction Period||16
5140479|NCT01365455|12643932|P2|NOT COMPLETED|Induction Period||7
5140480|NCT01365455|12643933|P1|NOT COMPLETED|Induction Period||15
5140481|NCT01365455|12643929|P5|COMPLETED|Induction Period||0
5140482|NCT01365455|12643930|P4|COMPLETED|Induction Period||0
5140483|NCT01365455|12643931|P3|COMPLETED|Induction Period||232
5140484|NCT01365455|12643932|P2|COMPLETED|Induction Period||238
5140485|NCT01365455|12643933|P1|COMPLETED|Induction Period||230
5140486|NCT01365455|12643929|P5|STARTED|Induction Period||0
5140487|NCT01365455|12643930|P4|STARTED|Induction Period||0
5140488|NCT01365455|12643931|P3|STARTED|Induction Period||248
5140489|NCT01365455|12643932|P2|STARTED|Induction Period||245
5140490|NCT01365455|12643933|P1|STARTED|Induction Period||245
5140491|NCT01365273|12644023|P2|NOT COMPLETED|Overall Study||1
5140492|NCT01365273|12644024|P1|NOT COMPLETED|Overall Study||2
5140493|NCT01365273|12644023|P2|COMPLETED|Overall Study||20
5140494|NCT01365273|12644024|P1|COMPLETED|Overall Study||20
5140495|NCT01365273|12644023|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
5140496|NCT01365273|12644024|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
5140497|NCT01365273|12644023|P2|STARTED|Overall Study||21
5140498|NCT01365273|12644024|P1|STARTED|Overall Study||22
5140499|NCT01365130|12644034|P1|NOT COMPLETED|Overall Study||2
5140500|NCT01365130|12644034|P1|COMPLETED|Overall Study||13
5140501|NCT01365130|12644034|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
5140502|NCT01365091|12644043|P4|NOT COMPLETED|Period 2||0
5140503|NCT01365091|12644044|P3|NOT COMPLETED|Period 2||1
5140504|NCT01365091|12644045|P2|NOT COMPLETED|Period 2||0
5140505|NCT01365091|12644046|P1|NOT COMPLETED|Period 2||1
5140506|NCT01365091|12644043|P4|COMPLETED|Period 2||25
5140507|NCT01365091|12644044|P3|COMPLETED|Period 2||24
5140508|NCT01365091|12644045|P2|COMPLETED|Period 2||26
5140509|NCT01365091|12644046|P1|COMPLETED|Period 2||25
5140510|NCT01365091|12644043|P4|STARTED|Period 2||25
5140511|NCT01365091|12644044|P3|STARTED|Period 2||25
5140512|NCT01365091|12644045|P2|STARTED|Period 2||26
5140513|NCT01365091|12644046|P1|STARTED|Period 2||26
5140514|NCT01365091|12644043|P4|NOT COMPLETED|Period 1||3
5140515|NCT01365091|12644044|P3|NOT COMPLETED|Period 1||3
5140516|NCT01365091|12644045|P2|NOT COMPLETED|Period 1||2
5140517|NCT01365091|12644046|P1|NOT COMPLETED|Period 1||2
5140518|NCT01365091|12644043|P4|COMPLETED|Period 1||25
5140519|NCT01365091|12644044|P3|COMPLETED|Period 1||25
5140520|NCT01365091|12644045|P2|COMPLETED|Period 1||26
5140521|NCT01365091|12644046|P1|COMPLETED|Period 1||26
5140522|NCT01365091|12644043|P4|STARTED|Period 1||28
5140523|NCT01365091|12644044|P3|STARTED|Period 1||28
5140524|NCT01365091|12644045|P2|STARTED|Period 1||28
5140525|NCT01365091|12644046|P1|STARTED|Period 1||28
5140526|NCT01365052|12644074|P2|NOT COMPLETED|Overall Study||4
5140527|NCT01365052|12644075|P1|NOT COMPLETED|Overall Study||4
5140528|NCT01365052|12644074|P2|COMPLETED|Overall Study||105
5140529|NCT01365052|12644075|P1|COMPLETED|Overall Study||213
5140530|NCT01365052|12644074|P2|STARTED|Overall Study||109
5140531|NCT01365052|12644075|P1|STARTED|Overall Study||217
5140532|NCT01365039|12644091|P2|NOT COMPLETED|Overall Study||0
5140533|NCT01365039|12644092|P1|NOT COMPLETED|Overall Study||1
5140534|NCT01365039|12644091|P2|COMPLETED|Overall Study||87
5140535|NCT01365039|12644092|P1|COMPLETED|Overall Study||85
5140536|NCT01365039|12644091|P2|STARTED|Overall Study||87
5140537|NCT01365039|12644092|P1|STARTED|Overall Study||86
5140538|NCT01364922|12644103|P3|NOT COMPLETED|Double-Blind (DB) Period||5
5140539|NCT01364922|12644104|P2|NOT COMPLETED|Double-Blind (DB) Period||5
5140540|NCT01364922|12644105|P1|NOT COMPLETED|Double-Blind (DB) Period||0
5140541|NCT01364922|12644103|P3|COMPLETED|Double-Blind (DB) Period||42
5140542|NCT01364922|12644104|P2|COMPLETED|Double-Blind (DB) Period||94
5140543|NCT01364922|12644105|P1|COMPLETED|Double-Blind (DB) Period||0
5140544|NCT01364922|12644103|P3|STARTED|Double-Blind (DB) Period||47
5140545|NCT01364922|12644104|P2|STARTED|Double-Blind (DB) Period||99
5140546|NCT01364922|12644105|P1|STARTED|Double-Blind (DB) Period||0
5140547|NCT01364922|12644103|P3|NOT COMPLETED|Open-label (OL) Period||0
5140548|NCT01364922|12644104|P2|NOT COMPLETED|Open-label (OL) Period||0
5140549|NCT01364922|12644105|P1|NOT COMPLETED|Open-label (OL) Period||22
5140550|NCT01364922|12644103|P3|COMPLETED|Open-label (OL) Period||0
5140551|NCT01364922|12644104|P2|COMPLETED|Open-label (OL) Period||0
5140552|NCT01364922|12644105|P1|COMPLETED|Open-label (OL) Period||146
5140553|NCT01364922|12644103|P3|STARTED|Open-label (OL) Period||0
5140554|NCT01364922|12644104|P2|STARTED|Open-label (OL) Period||0
5140555|NCT01364922|12644105|P1|STARTED|Open-label (OL) Period||168
5140556|NCT01364896|12644116|P1|NOT COMPLETED|Overall Study||0
5140557|NCT01364896|12644116|P1|COMPLETED|Overall Study||46
5140558|NCT01364896|12644116|P1|STARTED|Overall Study||46
5140559|NCT01364870|12644127|P3|NOT COMPLETED|Overall Study||14
5140560|NCT01364870|12644128|P2|NOT COMPLETED|Overall Study||30
5140561|NCT01364870|12644129|P1|NOT COMPLETED|Overall Study||22
5140562|NCT01364870|12644127|P3|COMPLETED|Overall Study||58
5140563|NCT01364870|12644128|P2|COMPLETED|Overall Study||93
5140564|NCT01364870|12644129|P1|COMPLETED|Overall Study||100
5140565|NCT01364870|12644127|P3|STARTED|Overall Study||72
5140566|NCT01364870|12644128|P2|STARTED|Overall Study||123
5140567|NCT01364870|12644129|P1|STARTED|Overall Study||122
5140568|NCT01364740|12644140|P1|NOT COMPLETED|Overall Study||0
5140569|NCT01364740|12644140|P1|COMPLETED|Overall Study||10
5140570|NCT01364740|12644140|P1|STARTED|Overall Study||10
5140571|NCT01364727|12644148|P1|NOT COMPLETED|Overall Study||2
5140572|NCT01364727|12644148|P1|COMPLETED|Overall Study||33
5140573|NCT01364727|12644148|P1|STARTED|Overall Study||35
5140574|NCT01364649|12644156|P2|NOT COMPLETED|Overall Study||43
5140575|NCT01364649|12644157|P1|NOT COMPLETED|Overall Study||56
5140576|NCT01364649|12644156|P2|COMPLETED|Overall Study||179
5140577|NCT01364649|12644157|P1|COMPLETED|Overall Study||169
5140578|NCT01364649|12644156|P2|STARTED|Overall Study||222
5140579|NCT01364649|12644157|P1|STARTED|Overall Study||225
5140580|NCT01364623|12644170|P4|NOT COMPLETED|Multiple Dose||0
5140581|NCT01364623|12644171|P3|NOT COMPLETED|Multiple Dose||0
5140582|NCT01364623|12644172|P2|NOT COMPLETED|Multiple Dose||0
5140583|NCT01364623|12644173|P1|NOT COMPLETED|Multiple Dose||0
5140584|NCT01364623|12644170|P4|COMPLETED|Multiple Dose||8
5140585|NCT01364623|12644171|P3|COMPLETED|Multiple Dose||0
5140586|NCT01364623|12644172|P2|COMPLETED|Multiple Dose||0
5140587|NCT01364623|12644173|P1|COMPLETED|Multiple Dose||0
5140588|NCT01364623|12644170|P4|STARTED|Multiple Dose||8
5140589|NCT01364623|12644171|P3|STARTED|Multiple Dose||0
5140590|NCT01364623|12644172|P2|STARTED|Multiple Dose||0
5140591|NCT01364623|12644173|P1|STARTED|Multiple Dose||0
5140592|NCT01364623|12644170|P4|NOT COMPLETED|Single Dose||0
5140593|NCT01364623|12644171|P3|NOT COMPLETED|Single Dose||0
5140594|NCT01364623|12644172|P2|NOT COMPLETED|Single Dose||0
5140595|NCT01364623|12644173|P1|NOT COMPLETED|Single Dose||0
5140596|NCT01364623|12644170|P4|COMPLETED|Single Dose||0
5140597|NCT01364623|12644171|P3|COMPLETED|Single Dose||8
5140598|NCT01364623|12644172|P2|COMPLETED|Single Dose||8
5140599|NCT01364623|12644173|P1|COMPLETED|Single Dose||8
5140600|NCT01364623|12644170|P4|STARTED|Single Dose||0
5140601|NCT01364623|12644171|P3|STARTED|Single Dose||8
5140602|NCT01364623|12644172|P2|STARTED|Single Dose||8
5140603|NCT01364623|12644173|P1|STARTED|Single Dose||8
5140604|NCT01364584|12644198|P2|NOT COMPLETED|Overall Study||0
5140605|NCT01364584|12644199|P1|NOT COMPLETED|Overall Study||0
5140606|NCT01364584|12644198|P2|COMPLETED|Overall Study||12
5140607|NCT01364584|12644199|P1|COMPLETED|Overall Study||11
5140608|NCT01364584|12644198|P2|STARTED|Overall Study||12
5140609|NCT01364584|12644199|P1|STARTED|Overall Study||11
5140610|NCT01364558|12644233|P3|NOT COMPLETED|Dose Three||0
5140611|NCT01364558|12644234|P2|NOT COMPLETED|Dose Three||0
5140612|NCT01364558|12644235|P1|NOT COMPLETED|Dose Three||0
5140613|NCT01364558|12644233|P3|COMPLETED|Dose Three||8
5140614|NCT01364558|12644234|P2|COMPLETED|Dose Three||8
5140615|NCT01364558|12644235|P1|COMPLETED|Dose Three||8
5140616|NCT01364558|12644233|P3|STARTED|Dose Three||8
5140617|NCT01364558|12644234|P2|STARTED|Dose Three||8
5140618|NCT01364558|12644235|P1|STARTED|Dose Three||8
5140619|NCT01364558|12644233|P3|NOT COMPLETED|Dose Two||0
5140620|NCT01364558|12644234|P2|NOT COMPLETED|Dose Two||0
5140621|NCT01364558|12644235|P1|NOT COMPLETED|Dose Two||0
5140622|NCT01364558|12644233|P3|COMPLETED|Dose Two||8
5140623|NCT01364558|12644234|P2|COMPLETED|Dose Two||8
5140624|NCT01364558|12644235|P1|COMPLETED|Dose Two||8
5140625|NCT01364558|12644233|P3|STARTED|Dose Two||8
5140626|NCT01364558|12644234|P2|STARTED|Dose Two||8
5140627|NCT01364558|12644235|P1|STARTED|Dose Two||8
5140628|NCT01364558|12644233|P3|NOT COMPLETED|Dose One||0
5140629|NCT01364558|12644234|P2|NOT COMPLETED|Dose One||0
5140630|NCT01364558|12644235|P1|NOT COMPLETED|Dose One||0
5140631|NCT01364558|12644233|P3|COMPLETED|Dose One||8
5140632|NCT01364558|12644234|P2|COMPLETED|Dose One||8
5140633|NCT01364558|12644235|P1|COMPLETED|Dose One||8
5140634|NCT01364558|12644233|P3|STARTED|Dose One||8
5140635|NCT01364558|12644234|P2|STARTED|Dose One||8
5140636|NCT01364558|12644235|P1|STARTED|Dose One||8
5140637|NCT01364467|12644245|P2|NOT COMPLETED|Overall Study||2
5140638|NCT01364467|12644246|P1|NOT COMPLETED|Overall Study||1
5140639|NCT01364467|12644245|P2|COMPLETED|Overall Study||18
5140640|NCT01364467|12644246|P1|COMPLETED|Overall Study||9
5140641|NCT01364467|12644245|P2|STARTED|Overall Study||20
5140642|NCT01364467|12644246|P1|STARTED|Overall Study||10
5140643|NCT01364428|12644258|P2|NOT COMPLETED|Overall Study||15
5140644|NCT01364428|12644259|P1|NOT COMPLETED|Overall Study||20
5140645|NCT01364428|12644258|P2|COMPLETED|Overall Study||172
5140646|NCT01364428|12644259|P1|COMPLETED|Overall Study||166
5140647|NCT01364428|12644258|P2|Exposed|Overall Study||187
5140648|NCT01364428|12644259|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
5140649|NCT01364428|12644258|P2|STARTED|Overall Study||187
5140650|NCT01364428|12644259|P1|STARTED|Overall Study||186
5140651|NCT01364389|12644276|P3|NOT COMPLETED|Overall Study||1
5140652|NCT01364389|12644277|P2|NOT COMPLETED|Overall Study||1
5140653|NCT01364389|12644278|P1|NOT COMPLETED|Overall Study||2
5140654|NCT01364389|12644276|P3|COMPLETED|Overall Study||4
5140655|NCT01364389|12644277|P2|COMPLETED|Overall Study||5
5140656|NCT01364389|12644278|P1|COMPLETED|Overall Study||3
5140657|NCT01364389|12644276|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
5140658|NCT01364389|12644277|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
5140659|NCT01364389|12644278|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
5140660|NCT01364389|12644276|P3|STARTED|Overall Study||5
5140661|NCT01364389|12644277|P2|STARTED|Overall Study||6
5140662|NCT01364389|12644278|P1|STARTED|Overall Study||5
5140663|NCT01364298|12644297|P2|NOT COMPLETED|Overall Study||23
5140664|NCT01364298|12644298|P1|NOT COMPLETED|Overall Study||14
5140665|NCT01364298|12644297|P2|COMPLETED|Overall Study||154
5140666|NCT01364298|12644298|P1|COMPLETED|Overall Study||162
5140667|NCT01364298|12644297|P2|Treated|Overall Study||174
5140668|NCT01364298|12644298|P1|Treated|Overall Study||174
5140669|NCT01364298|12644297|P2|STARTED|Overall Study||177
5140670|NCT01364298|12644298|P1|STARTED|Overall Study||176
5140671|NCT01364259|12644322|P2|NOT COMPLETED|Overall Study||0
5140672|NCT01364259|12644323|P1|NOT COMPLETED|Overall Study||0
5140673|NCT01364259|12644322|P2|COMPLETED|Overall Study||8
5140674|NCT01364259|12644323|P1|COMPLETED|Overall Study||9
5140675|NCT01364259|12644322|P2|STARTED|Overall Study||8
5140676|NCT01364259|12644323|P1|STARTED|Overall Study||9
5140677|NCT01364233|12644331|P1|NOT COMPLETED|Overall Study||1
5140678|NCT01364233|12644331|P1|COMPLETED|Overall Study||9
5140679|NCT01364233|12644331|P1|STARTED|Overall Study||10
5140680|NCT01364207|12644335|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
5140681|NCT01364207|12644336|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
5140682|NCT01364207|12644335|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
5140683|NCT01364207|12644336|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
5140684|NCT01364207|12644335|P2|STARTED|Second Visit (~1.5-2 Hours)||54
5140685|NCT01364207|12644336|P1|STARTED|Second Visit (~1.5-2 Hours)||52
5140686|NCT01364207|12644335|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
5140687|NCT01364207|12644336|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
5140688|NCT01364207|12644335|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
5140689|NCT01364207|12644336|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
5140690|NCT01364207|12644335|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
5140691|NCT01364207|12644336|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
5140692|NCT01364207|12644335|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
5140693|NCT01364207|12644336|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
5140694|NCT01364207|12644335|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
5140695|NCT01364207|12644336|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
5140696|NCT01364207|12644335|P2|STARTED|First Visit (~1.5-2 Hours)||58
5140697|NCT01364207|12644336|P1|STARTED|First Visit (~1.5-2 Hours)||54
5140698|NCT01364090|12644347|P3|NOT COMPLETED|Overall Study||6
5140699|NCT01364090|12644348|P2|NOT COMPLETED|Overall Study||14
5140700|NCT01364090|12644349|P1|NOT COMPLETED|Overall Study||3
5140701|NCT01364090|12644347|P3|COMPLETED|Overall Study||0
5140702|NCT01364090|12644348|P2|COMPLETED|Overall Study||12
5140703|NCT01364090|12644349|P1|COMPLETED|Overall Study||58
5140704|NCT01364090|12644347|P3|STARTED|Overall Study||6
5140705|NCT01364090|12644348|P2|STARTED|Overall Study||26
5140706|NCT01364090|12644349|P1|STARTED|Overall Study||61
5140707|NCT01363999|12644357|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
5140708|NCT01363999|12644357|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
5140709|NCT01363999|12644357|P1|STARTED|D: RO4607381/ F49 Tablet||24
5140710|NCT01363999|12644357|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
5140711|NCT01363999|12644357|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
5140712|NCT01363999|12644357|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
5140713|NCT01363999|12644357|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
5140714|NCT01363999|12644357|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
5140715|NCT01363999|12644357|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
5140716|NCT01363999|12644357|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
5140717|NCT01363999|12644357|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
5140718|NCT01363999|12644357|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
5140719|NCT01363986|12644376|P1|NOT COMPLETED|Overall Study||1
5140720|NCT01363986|12644376|P1|COMPLETED|Overall Study||2
5140721|NCT01363986|12644376|P1|STARTED|Overall Study||3
5140722|NCT01363908|12644386|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
5140723|NCT01363908|12644387|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
5140724|NCT01363908|12644386|P2|COMPLETED|Chronic Dosing (CD) Phase||10
5140725|NCT01363908|12644387|P1|COMPLETED|Chronic Dosing (CD) Phase||3
5140726|NCT01363908|12644386|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
5140727|NCT01363908|12644387|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
5140728|NCT01363908|12644386|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
5140729|NCT01363908|12644387|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
5140730|NCT01363908|12644386|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
5140731|NCT01363908|12644387|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
5140732|NCT01363908|12644386|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
5140733|NCT01363908|12644387|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
5140734|NCT01363908|12644386|P2|NOT COMPLETED|Screening/Enrollment||0
5140735|NCT01363908|12644387|P1|NOT COMPLETED|Screening/Enrollment||1
5140736|NCT01363908|12644386|P2|COMPLETED|Screening/Enrollment||16
5140737|NCT01363908|12644387|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
5140738|NCT01363908|12644386|P2|STARTED|Screening/Enrollment||16
5140739|NCT01363908|12644387|P1|STARTED|Screening/Enrollment||14
5140740|NCT01363843|12644417|P1|NOT COMPLETED|Overall Study||1
5140741|NCT01363843|12644417|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
5140742|NCT01363843|12644417|P1|STARTED|Overall Study||39
5140743|NCT01363765|12644424|P2|NOT COMPLETED|Overall Study||4731
5140744|NCT01363765|12644425|P1|NOT COMPLETED|Overall Study||5800
5140745|NCT01363765|12644424|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
5140746|NCT01363765|12644425|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
5140747|NCT01363765|12644424|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
5140748|NCT01363765|12644425|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
5140749|NCT01363713|12644437|P1|NOT COMPLETED|Overall Study||6
5140750|NCT01363713|12644437|P1|COMPLETED|Overall Study|Analysed (n=130)|124
5140751|NCT01363713|12644437|P1|ALLOCATED|Overall Study||130
5140752|NCT01363713|12644437|P1|STARTED|Overall Study|Assessed for eligibility|130
5140753|NCT01363700|12644446|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
5140754|NCT01363700|12644447|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
5140755|NCT01363700|12644448|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
5140756|NCT01363700|12644449|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
5140757|NCT01363700|12644450|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
5140758|NCT01363700|12644446|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
5140759|NCT01363700|12644447|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
5140760|NCT01363700|12644448|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
5140761|NCT01363700|12644449|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
5140762|NCT01363700|12644450|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
5140763|NCT01363700|12644446|P5|STARTED|Epinastine vs Olopatadine Period2||43
5140764|NCT01363700|12644447|P4|STARTED|Epinastine vs Olopatadine Period2||43
5140765|NCT01363700|12644448|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
5140766|NCT01363700|12644449|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
5140767|NCT01363700|12644450|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
5140768|NCT01363700|12644446|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
5140769|NCT01363700|12644447|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
5140770|NCT01363700|12644448|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
5140771|NCT01363700|12644449|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
5140772|NCT01363700|12644450|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
5140773|NCT01363700|12644446|P5|COMPLETED|Epinastine vs Placebo Period1||0
5140774|NCT01363700|12644447|P4|COMPLETED|Epinastine vs Placebo Period1||0
5140775|NCT01363700|12644448|P3|COMPLETED|Epinastine vs Placebo Period1||22
5140776|NCT01363700|12644449|P2|COMPLETED|Epinastine vs Placebo Period1||21
5140777|NCT01363700|12644450|P1|COMPLETED|Epinastine vs Placebo Period1||43
5140778|NCT01363700|12644446|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
5140779|NCT01363700|12644447|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
5140780|NCT01363700|12644448|P3|STARTED|Epinastine vs Placebo Period1||22
5140781|NCT01363700|12644449|P2|STARTED|Epinastine vs Placebo Period1||22
5140782|NCT01363700|12644450|P1|STARTED|Epinastine vs Placebo Period1||43
5140783|NCT01363661|12644469|P2|NOT COMPLETED|Overall Study||4
5140784|NCT01363661|12644470|P1|NOT COMPLETED|Overall Study||14
5140785|NCT01363661|12644469|P2|COMPLETED|Overall Study||28
5140786|NCT01363661|12644470|P1|COMPLETED|Overall Study||18
5140787|NCT01363661|12644469|P2|STARTED|Overall Study||32
5140788|NCT01363661|12644470|P1|STARTED|Overall Study||32
5140789|NCT01363492|12644486|P1|NOT COMPLETED|Overall Study||0
5140790|NCT01363492|12644486|P1|COMPLETED|Overall Study||14
5140791|NCT01363492|12644486|P1|STARTED|Overall Study||14
5140792|NCT01363479|12644501|P2|NOT COMPLETED|Overall Study||21
5140793|NCT01363479|12644502|P1|NOT COMPLETED|Overall Study||12
5140794|NCT01363479|12644501|P2|COMPLETED|Overall Study||351
5140795|NCT01363479|12644502|P1|COMPLETED|Overall Study||359
5140796|NCT01363479|12644501|P2|STARTED|Overall Study|number of randomised patients|372
5140797|NCT01363479|12644502|P1|STARTED|Overall Study|number of randomised patients|371
5140798|NCT01363440|12644511|P3|NOT COMPLETED|Overall Study||27
5140799|NCT01363440|12644512|P2|NOT COMPLETED|Overall Study||31
5140800|NCT01363440|12644513|P1|NOT COMPLETED|Overall Study||23
5140801|NCT01363440|12644511|P3|COMPLETED|Overall Study|Completed Week 100|127
5140802|NCT01363440|12644512|P2|COMPLETED|Overall Study|Completed Week 100|125
5140803|NCT01363440|12644513|P1|COMPLETED|Overall Study|Completed Week 100|133
5140804|NCT01363440|12644511|P3|Completed Week 100|Overall Study||127
5140805|NCT01363440|12644512|P2|Completed Week 100|Overall Study||125
5140806|NCT01363440|12644513|P1|Completed Week 100|Overall Study||133
5140807|NCT01363440|12644511|P3|Completed Week 52|Overall Study||144
5140808|NCT01363440|12644512|P2|Completed Week 52|Overall Study||146
5140809|NCT01363440|12644513|P1|Completed Week 52|Overall Study||145
5140810|NCT01363440|12644511|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
5140899|NCT01362907|12644816|P2|NOT COMPLETED|Period 2, One Week||0
5140811|NCT01363440|12644512|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
5140812|NCT01363440|12644513|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
5140813|NCT01363440|12644511|P3|STARTED|Overall Study|randomized|154
5140814|NCT01363440|12644512|P2|STARTED|Overall Study|randomized|156
5140815|NCT01363440|12644513|P1|STARTED|Overall Study|randomized|156
5140816|NCT01363401|12644544|P2|NOT COMPLETED|Overall Study||4
5140817|NCT01363401|12644545|P1|NOT COMPLETED|Overall Study||2
5140818|NCT01363401|12644544|P2|COMPLETED|Overall Study||27
5140819|NCT01363401|12644545|P1|COMPLETED|Overall Study||39
5140820|NCT01363401|12644544|P2|STARTED|Overall Study||31
5140821|NCT01363401|12644545|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
5140822|NCT01363388|12644560|P3|NOT COMPLETED|Overall Study||4
5140823|NCT01363388|12644561|P2|NOT COMPLETED|Overall Study||3
5140824|NCT01363388|12644562|P1|NOT COMPLETED|Overall Study||5
5140825|NCT01363388|12644560|P3|COMPLETED|Overall Study||18
5140826|NCT01363388|12644561|P2|COMPLETED|Overall Study||19
5140827|NCT01363388|12644562|P1|COMPLETED|Overall Study||18
5140828|NCT01363388|12644560|P3|STARTED|Overall Study||22
5140829|NCT01363388|12644561|P2|STARTED|Overall Study||22
5140830|NCT01363388|12644562|P1|STARTED|Overall Study||23
5140831|NCT01363349|12644572|P2|NOT COMPLETED|Overall Study||70
5140832|NCT01363349|12644573|P1|NOT COMPLETED|Overall Study||67
5140833|NCT01363349|12644572|P2|COMPLETED|Overall Study||66
5140834|NCT01363349|12644573|P1|COMPLETED|Overall Study||66
5140835|NCT01363349|12644572|P2|Randomized|Overall Study||136
5140836|NCT01363349|12644573|P1|Randomized|Overall Study||133
5140837|NCT01363349|12644572|P2|STARTED|Overall Study||136
5140838|NCT01363349|12644573|P1|STARTED|Overall Study||133
5140839|NCT01363297|12644584|P5|NOT COMPLETED|Overall Study||31
5140840|NCT01363297|12644585|P4|NOT COMPLETED|Overall Study||10
5140841|NCT01363297|12644586|P3|NOT COMPLETED|Overall Study||6
5140842|NCT01363297|12644587|P2|NOT COMPLETED|Overall Study||6
5140843|NCT01363297|12644588|P1|NOT COMPLETED|Overall Study||3
5140844|NCT01363297|12644584|P5|COMPLETED|Overall Study||4
5140845|NCT01363297|12644585|P4|COMPLETED|Overall Study||3
5140846|NCT01363297|12644586|P3|COMPLETED|Overall Study||3
5140847|NCT01363297|12644587|P2|COMPLETED|Overall Study||6
5140848|NCT01363297|12644588|P1|COMPLETED|Overall Study||0
5140849|NCT01363297|12644584|P5|STARTED|Overall Study||35
5140850|NCT01363297|12644585|P4|STARTED|Overall Study||13
5140851|NCT01363297|12644586|P3|STARTED|Overall Study||9
5140852|NCT01363297|12644587|P2|STARTED|Overall Study||12
5140853|NCT01363297|12644588|P1|STARTED|Overall Study||3
5140854|NCT01363258|12644680|P2|NOT COMPLETED|Overall Study||0
5140855|NCT01363258|12644681|P1|NOT COMPLETED|Overall Study||0
5140856|NCT01363258|12644680|P2|COMPLETED|Overall Study||46
5140857|NCT01363258|12644681|P1|COMPLETED|Overall Study||54
5140858|NCT01363258|12644680|P2|STARTED|Overall Study||46
5140859|NCT01363258|12644681|P1|STARTED|Overall Study||54
5140860|NCT01363076|12644691|P2|NOT COMPLETED|Overall Study||1
5140861|NCT01363076|12644692|P1|NOT COMPLETED|Overall Study||0
5140862|NCT01363076|12644691|P2|COMPLETED|Overall Study||12
5140863|NCT01363076|12644692|P1|COMPLETED|Overall Study||7
5140864|NCT01363076|12644691|P2|STARTED|Overall Study||13
5140865|NCT01363076|12644692|P1|STARTED|Overall Study||7
5140866|NCT01363050|12644710|P1|NOT COMPLETED|Overall Study||0
5140867|NCT01363050|12644710|P1|COMPLETED|Overall Study||15
5140868|NCT01363050|12644710|P1|STARTED|Overall Study||15
5140869|NCT01363011|12644724|P2|NOT COMPLETED|Extension Phase||8
5140870|NCT01363011|12644725|P1|NOT COMPLETED|Extension Phase||5
5140871|NCT01363011|12644724|P2|COMPLETED|Extension Phase||41
5140872|NCT01363011|12644725|P1|COMPLETED|Extension Phase||13
5140873|NCT01363011|12644724|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
5140874|NCT01363011|12644725|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
5140875|NCT01363011|12644724|P2|NOT COMPLETED|Main Study||9
5140876|NCT01363011|12644725|P1|NOT COMPLETED|Main Study||4
5140877|NCT01363011|12644724|P2|COMPLETED|Main Study||64
5140878|NCT01363011|12644725|P1|COMPLETED|Main Study||29
5140879|NCT01363011|12644724|P2|STARTED|Main Study||73
5140880|NCT01363011|12644725|P1|STARTED|Main Study||33
5140881|NCT01362959|12644767|P2|NOT COMPLETED|Overall Study||0
5140882|NCT01362959|12644768|P1|NOT COMPLETED|Overall Study||0
5140883|NCT01362959|12644767|P2|COMPLETED|Overall Study||26
5140884|NCT01362959|12644768|P1|COMPLETED|Overall Study||21
5140885|NCT01362959|12644767|P2|STARTED|Overall Study||26
5140886|NCT01362959|12644768|P1|STARTED|Overall Study||21
5140887|NCT01362946|12644782|P2|NOT COMPLETED|Second Behavior Modification Block||0
5140888|NCT01362946|12644783|P1|NOT COMPLETED|Second Behavior Modification Block||0
5140889|NCT01362946|12644782|P2|COMPLETED|Second Behavior Modification Block||24
5140890|NCT01362946|12644783|P1|COMPLETED|Second Behavior Modification Block||23
5140891|NCT01362946|12644782|P2|STARTED|Second Behavior Modification Block||24
5140892|NCT01362946|12644783|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
5140893|NCT01362946|12644782|P2|NOT COMPLETED|First Behavior Modification Block||0
5140894|NCT01362946|12644783|P1|NOT COMPLETED|First Behavior Modification Block||0
5140895|NCT01362946|12644782|P2|COMPLETED|First Behavior Modification Block||24
5140896|NCT01362946|12644783|P1|COMPLETED|First Behavior Modification Block||24
5140897|NCT01362946|12644782|P2|STARTED|First Behavior Modification Block||24
5140898|NCT01362946|12644783|P1|STARTED|First Behavior Modification Block||24
5140900|NCT01362907|12644817|P1|NOT COMPLETED|Period 2, One Week||0
5140901|NCT01362907|12644816|P2|COMPLETED|Period 2, One Week||20
5140902|NCT01362907|12644817|P1|COMPLETED|Period 2, One Week||20
5140903|NCT01362907|12644816|P2|STARTED|Period 2, One Week||20
5140904|NCT01362907|12644817|P1|STARTED|Period 2, One Week||20
5140905|NCT01362907|12644816|P2|NOT COMPLETED|Period 1, One Week||0
5140906|NCT01362907|12644817|P1|NOT COMPLETED|Period 1, One Week||0
5140907|NCT01362907|12644816|P2|COMPLETED|Period 1, One Week||20
5140908|NCT01362907|12644817|P1|COMPLETED|Period 1, One Week||20
5140909|NCT01362907|12644816|P2|STARTED|Period 1, One Week||20
5140910|NCT01362907|12644817|P1|STARTED|Period 1, One Week||20
5140911|NCT01362894|12644831|P2|NOT COMPLETED|Period Two, 1 Week||0
5140912|NCT01362894|12644832|P1|NOT COMPLETED|Period Two, 1 Week||0
5140913|NCT01362894|12644831|P2|COMPLETED|Period Two, 1 Week||115
5140914|NCT01362894|12644832|P1|COMPLETED|Period Two, 1 Week||118
5140915|NCT01362894|12644831|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
5140916|NCT01362894|12644832|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
5140917|NCT01362894|12644831|P2|NOT COMPLETED|Period One, 1 Week||0
5140918|NCT01362894|12644832|P1|NOT COMPLETED|Period One, 1 Week||0
5140919|NCT01362894|12644831|P2|COMPLETED|Period One, 1 Week||117
5140920|NCT01362894|12644832|P1|COMPLETED|Period One, 1 Week||119
5140921|NCT01362894|12644831|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
5140922|NCT01362894|12644832|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
5140923|NCT01362790|12644852|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140924|NCT01362790|12644853|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140925|NCT01362790|12644854|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
5140926|NCT01362790|12644855|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140927|NCT01362790|12644856|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140928|NCT01362790|12644857|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140929|NCT01362790|12644858|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
5140930|NCT01362790|12644852|P7|COMPLETED|Dose De-escalation of Regimen A||0
5140931|NCT01362790|12644853|P6|COMPLETED|Dose De-escalation of Regimen A||0
5140932|NCT01362790|12644854|P5|COMPLETED|Dose De-escalation of Regimen A||2
5140933|NCT01362790|12644855|P4|COMPLETED|Dose De-escalation of Regimen A||0
5140934|NCT01362790|12644856|P3|COMPLETED|Dose De-escalation of Regimen A||0
5140935|NCT01362790|12644857|P2|COMPLETED|Dose De-escalation of Regimen A||0
5140936|NCT01362790|12644858|P1|COMPLETED|Dose De-escalation of Regimen A||0
5140937|NCT01362790|12644852|P7|STARTED|Dose De-escalation of Regimen A||0
5140938|NCT01362790|12644853|P6|STARTED|Dose De-escalation of Regimen A||0
5140939|NCT01362790|12644854|P5|STARTED|Dose De-escalation of Regimen A||8
5140940|NCT01362790|12644855|P4|STARTED|Dose De-escalation of Regimen A||0
5140941|NCT01362790|12644856|P3|STARTED|Dose De-escalation of Regimen A||0
5140942|NCT01362790|12644857|P2|STARTED|Dose De-escalation of Regimen A||0
5140943|NCT01362790|12644858|P1|STARTED|Dose De-escalation of Regimen A||0
5140944|NCT01362790|12644852|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
5140945|NCT01362790|12644853|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
5140946|NCT01362790|12644854|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
5140947|NCT01362790|12644855|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
5140948|NCT01362790|12644856|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
5140949|NCT01362790|12644857|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
5140950|NCT01362790|12644858|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
5140951|NCT01362790|12644852|P7|COMPLETED|Pilot Phase & Phase 2||0
5140952|NCT01362790|12644853|P6|COMPLETED|Pilot Phase & Phase 2||0
5140953|NCT01362790|12644854|P5|COMPLETED|Pilot Phase & Phase 2||0
5140954|NCT01362790|12644855|P4|COMPLETED|Pilot Phase & Phase 2||1
5140955|NCT01362790|12644856|P3|COMPLETED|Pilot Phase & Phase 2||2
5140956|NCT01362790|12644857|P2|COMPLETED|Pilot Phase & Phase 2||0
5140957|NCT01362790|12644858|P1|COMPLETED|Pilot Phase & Phase 2||1
5140958|NCT01362790|12644852|P7|STARTED|Pilot Phase & Phase 2||0
5140959|NCT01362790|12644853|P6|STARTED|Pilot Phase & Phase 2||4
5140960|NCT01362790|12644854|P5|STARTED|Pilot Phase & Phase 2||0
5140961|NCT01362790|12644855|P4|STARTED|Pilot Phase & Phase 2||15
5140962|NCT01362790|12644856|P3|STARTED|Pilot Phase & Phase 2||7
5140963|NCT01362790|12644857|P2|STARTED|Pilot Phase & Phase 2||8
5140964|NCT01362790|12644858|P1|STARTED|Pilot Phase & Phase 2||11
5140965|NCT01362686|12644908|P3|NOT COMPLETED|Overall Study||10
5140966|NCT01362686|12644909|P2|NOT COMPLETED|Overall Study||12
5140967|NCT01362686|12644910|P1|NOT COMPLETED|Overall Study||8
5140968|NCT01362686|12644908|P3|COMPLETED|Overall Study||53
5140969|NCT01362686|12644909|P2|COMPLETED|Overall Study||54
5140970|NCT01362686|12644910|P1|COMPLETED|Overall Study||59
5140971|NCT01362686|12644908|P3|STARTED|Overall Study||63
5140972|NCT01362686|12644909|P2|STARTED|Overall Study||66
5140973|NCT01362686|12644910|P1|STARTED|Overall Study||67
5140974|NCT01362608|12644926|P2|NOT COMPLETED|Overall Study||8
5140975|NCT01362608|12644927|P1|NOT COMPLETED|Overall Study||4
5140976|NCT01362608|12644926|P2|COMPLETED|Overall Study||61
5140977|NCT01362608|12644927|P1|COMPLETED|Overall Study||63
5140978|NCT01362608|12644926|P2|STARTED|Overall Study||69
5140979|NCT01362608|12644927|P1|STARTED|Overall Study||67
5140980|NCT01362530|12644965|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
5140981|NCT01362530|12644966|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
5140982|NCT01362530|12644965|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
5140983|NCT01362530|12644966|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
5140984|NCT01362530|12644965|P2|STARTED|Optional Extension (Cycles 2-6)||0
5140985|NCT01362530|12644966|P1|STARTED|Optional Extension (Cycles 2-6)||171
5140986|NCT01362530|12644965|P2|NOT COMPLETED|Base Study (Cycle 1)||3
5140987|NCT01362530|12644966|P1|NOT COMPLETED|Base Study (Cycle 1)||5
5140988|NCT01362530|12644965|P2|COMPLETED|Base Study (Cycle 1)||149
5140989|NCT01362530|12644966|P1|COMPLETED|Base Study (Cycle 1)||150
5140990|NCT01362530|12644965|P2|Received Study Treatment|Base Study (Cycle 1)||150
5140991|NCT01362530|12644966|P1|Received Study Treatment|Base Study (Cycle 1)||152
5140992|NCT01362530|12644965|P2|STARTED|Base Study (Cycle 1)||152
5140993|NCT01362530|12644966|P1|STARTED|Base Study (Cycle 1)||155
5140994|NCT01362517|12644979|P1|NOT COMPLETED|Overall Study||2
5140995|NCT01362517|12644979|P1|COMPLETED|Overall Study||129
5140996|NCT01362517|12644979|P1|STARTED|Overall Study||131
5140997|NCT01362491|12644990|P3|NOT COMPLETED|Overall Study||0
5140998|NCT01362491|12644991|P2|NOT COMPLETED|Overall Study||0
5140999|NCT01362491|12644992|P1|NOT COMPLETED|Overall Study||1
5141000|NCT01362491|12644990|P3|COMPLETED|Overall Study||46
5141001|NCT01362491|12644991|P2|COMPLETED|Overall Study||89
5141002|NCT01362491|12644992|P1|COMPLETED|Overall Study||90
5141003|NCT01362491|12644990|P3|STARTED|Overall Study||46
5141004|NCT01362491|12644991|P2|STARTED|Overall Study||89
5141005|NCT01362491|12644992|P1|STARTED|Overall Study||91
5141006|NCT01362439|12645040|P1|NOT COMPLETED|Overall Study||15
5141007|NCT01362439|12645040|P1|COMPLETED|Overall Study||118
5141008|NCT01362439|12645040|P1|STARTED|Overall Study||133
5141009|NCT01362348|12645055|P1|NOT COMPLETED|Overall Study||14
5141010|NCT01362348|12645055|P1|COMPLETED|Overall Study||5
5141011|NCT01362348|12645055|P1|STARTED|Overall Study||19
5141012|NCT01362322|12645074|P2|NOT COMPLETED|Overall Study||7
5141013|NCT01362322|12645075|P1|NOT COMPLETED|Overall Study||5
5141014|NCT01362322|12645074|P2|COMPLETED|Overall Study||329
5141015|NCT01362322|12645075|P1|COMPLETED|Overall Study||330
5141016|NCT01362322|12645074|P2|STARTED|Overall Study||336
5141017|NCT01362322|12645075|P1|STARTED|Overall Study||335
5141018|NCT01362296|12645107|P4|NOT COMPLETED|Crossover Phase||2
5141019|NCT01362296|12645108|P3|NOT COMPLETED|Crossover Phase||23
5141020|NCT01362296|12645109|P2|NOT COMPLETED|Crossover Phase||0
5141021|NCT01362296|12645110|P1|NOT COMPLETED|Crossover Phase||0
5141022|NCT01362296|12645107|P4|COMPLETED|Crossover Phase||0
5141023|NCT01362296|12645108|P3|COMPLETED|Crossover Phase||0
5141024|NCT01362296|12645109|P2|COMPLETED|Crossover Phase||0
5141025|NCT01362296|12645110|P1|COMPLETED|Crossover Phase||0
5141026|NCT01362296|12645107|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
5141027|NCT01362296|12645108|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
5141028|NCT01362296|12645109|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
5141029|NCT01362296|12645110|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
5141030|NCT01362296|12645107|P4|NOT COMPLETED|Randomized Phase (RP)||0
5141031|NCT01362296|12645108|P3|NOT COMPLETED|Randomized Phase (RP)||0
5141032|NCT01362296|12645109|P2|NOT COMPLETED|Randomized Phase (RP)||43
5141033|NCT01362296|12645110|P1|NOT COMPLETED|Randomized Phase (RP)||87
5141034|NCT01362296|12645107|P4|COMPLETED|Randomized Phase (RP)||0
5141035|NCT01362296|12645108|P3|COMPLETED|Randomized Phase (RP)||0
5141036|NCT01362296|12645109|P2|COMPLETED|Randomized Phase (RP)||0
5141037|NCT01362296|12645110|P1|COMPLETED|Randomized Phase (RP)||0
5141038|NCT01362296|12645107|P4|STARTED|Randomized Phase (RP)||0
5141039|NCT01362296|12645108|P3|STARTED|Randomized Phase (RP)||0
5141040|NCT01362296|12645109|P2|STARTED|Randomized Phase (RP)||43
5141041|NCT01362296|12645110|P1|STARTED|Randomized Phase (RP)||87
5141042|NCT01362270|12645158|P2|NOT COMPLETED|Overall Study||2
5141043|NCT01362270|12645159|P1|NOT COMPLETED|Overall Study||2
5141044|NCT01362270|12645158|P2|COMPLETED|Overall Study||6
5141045|NCT01362270|12645159|P1|COMPLETED|Overall Study||5
5141046|NCT01362270|12645158|P2|STARTED|Overall Study||8
5141047|NCT01362270|12645159|P1|STARTED|Overall Study||7
5141048|NCT01362244|12645171|P2|NOT COMPLETED|Overall Study||32
5141049|NCT01362244|12645172|P1|NOT COMPLETED|Overall Study||32
5141050|NCT01362244|12645171|P2|COMPLETED|Overall Study||19
5141051|NCT01362244|12645172|P1|COMPLETED|Overall Study||22
5141052|NCT01362244|12645171|P2|STARTED|Overall Study||51
5141053|NCT01362244|12645172|P1|STARTED|Overall Study||54
5141054|NCT01362205|12645245|P2|NOT COMPLETED|Overall Study||0
5141055|NCT01362205|12645246|P1|NOT COMPLETED|Overall Study||0
5141056|NCT01362205|12645245|P2|COMPLETED|Overall Study||27
5141057|NCT01362205|12645246|P1|COMPLETED|Overall Study||22
5141058|NCT01362205|12645245|P2|STARTED|Overall Study||27
5141059|NCT01362205|12645246|P1|STARTED|Overall Study||22
5141060|NCT01362192|12645272|P1|NOT COMPLETED|Overall Study||4
5141061|NCT01362192|12645272|P1|COMPLETED|Overall Study||16
5141062|NCT01362192|12645272|P1|STARTED|Overall Study||20
5141063|NCT01362140|12645284|P2|NOT COMPLETED|Overall Study||11
5141064|NCT01362140|12645285|P1|NOT COMPLETED|Overall Study||10
5141065|NCT01362140|12645284|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
5141066|NCT01362140|12645285|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
5141067|NCT01362140|12645284|P2|Received Treatment|Overall Study||97
5141068|NCT01362140|12645285|P1|Received Treatment|Overall Study||49
5141069|NCT01362140|12645284|P2|STARTED|Overall Study||98
5141070|NCT01362140|12645285|P1|STARTED|Overall Study||49
5141071|NCT01362127|12645309|P2|NOT COMPLETED|Overall Study||0
5141072|NCT01362127|12645310|P1|NOT COMPLETED|Overall Study||0
5141073|NCT01362127|12645309|P2|COMPLETED|Overall Study||91
5141074|NCT01362127|12645310|P1|COMPLETED|Overall Study||90
5141075|NCT01362127|12645309|P2|STARTED|Overall Study||91
5141076|NCT01362127|12645310|P1|STARTED|Overall Study||90
5141077|NCT01362062|12645322|P2|NOT COMPLETED|Overall Study||0
5141078|NCT01362062|12645323|P1|NOT COMPLETED|Overall Study||26
5141079|NCT01362062|12645322|P2|COMPLETED|Overall Study||62
5141080|NCT01362062|12645323|P1|COMPLETED|Overall Study||22
5141081|NCT01362062|12645322|P2|STARTED|Overall Study||62
5141082|NCT01362062|12645323|P1|STARTED|Overall Study||48
5141083|NCT01362049|12645344|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
5141084|NCT01362049|12645345|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
5141085|NCT01362049|12645346|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
5141086|NCT01362049|12645347|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
5141087|NCT01362049|12645344|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
5141088|NCT01362049|12645345|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
5141089|NCT01362049|12645346|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
5141090|NCT01362049|12645347|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
5141091|NCT01362049|12645344|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
5141092|NCT01362049|12645345|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
5141093|NCT01362049|12645346|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
5141094|NCT01362049|12645347|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
5141095|NCT01362049|12645344|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
5141096|NCT01362049|12645345|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
5141097|NCT01362049|12645346|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
5141098|NCT01362049|12645347|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
5141099|NCT01362049|12645344|P4|COMPLETED|Follow-Up at 7 Weeks||24
5141100|NCT01362049|12645345|P3|COMPLETED|Follow-Up at 7 Weeks||30
5141101|NCT01362049|12645346|P2|COMPLETED|Follow-Up at 7 Weeks||16
5141102|NCT01362049|12645347|P1|COMPLETED|Follow-Up at 7 Weeks||23
5141103|NCT01362049|12645344|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
5141104|NCT01362049|12645345|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
5141105|NCT01362049|12645346|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
5141106|NCT01362049|12645347|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
5141107|NCT01362049|12645344|P4|STARTED|Follow-Up at 7 Weeks||25
5141108|NCT01362049|12645345|P3|STARTED|Follow-Up at 7 Weeks||32
5141109|NCT01362049|12645346|P2|STARTED|Follow-Up at 7 Weeks||19
5141110|NCT01362049|12645347|P1|STARTED|Follow-Up at 7 Weeks||26
5141111|NCT01361919|12645388|P3|NOT COMPLETED|Overall Study||10
5141112|NCT01361919|12645389|P2|NOT COMPLETED|Overall Study||12
5141113|NCT01361919|12645390|P1|NOT COMPLETED|Overall Study||10
5141114|NCT01361919|12645388|P3|COMPLETED|Overall Study||88
5141115|NCT01361919|12645389|P2|COMPLETED|Overall Study||88
5141116|NCT01361919|12645390|P1|COMPLETED|Overall Study||90
5141117|NCT01361919|12645388|P3|STARTED|Overall Study||98
5141118|NCT01361919|12645389|P2|STARTED|Overall Study||100
5141119|NCT01361919|12645390|P1|STARTED|Overall Study||100
5141120|NCT01361867|12645404|P1|NOT COMPLETED|Overall Study||0
5141121|NCT01361867|12645404|P1|COMPLETED|Overall Study||15
5141122|NCT01361867|12645404|P1|STARTED|Overall Study||15
5141123|NCT01361854|12645409|P2|NOT COMPLETED|Second Intervention||0
5141124|NCT01361854|12645410|P1|NOT COMPLETED|Second Intervention||0
5141125|NCT01361854|12645409|P2|COMPLETED|Second Intervention||48
5141126|NCT01361854|12645410|P1|COMPLETED|Second Intervention||47
5141127|NCT01361854|12645409|P2|STARTED|Second Intervention||48
5141128|NCT01361854|12645410|P1|STARTED|Second Intervention||47
5141129|NCT01361854|12645409|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
5141130|NCT01361854|12645410|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
5141131|NCT01361854|12645409|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
5141132|NCT01361854|12645410|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
5141133|NCT01361854|12645409|P2|STARTED|Wash-out, Maximum 2 Weeks||48
5141134|NCT01361854|12645410|P1|STARTED|Wash-out, Maximum 2 Weeks||47
5141135|NCT01361854|12645409|P2|NOT COMPLETED|Day 1||3
5141136|NCT01361854|12645410|P1|NOT COMPLETED|Day 1||4
5141137|NCT01361854|12645409|P2|COMPLETED|Day 1||48
5141138|NCT01361854|12645410|P1|COMPLETED|Day 1||47
5141139|NCT01361854|12645409|P2|STARTED|Day 1||51
5141140|NCT01361854|12645410|P1|STARTED|Day 1||51
5141141|NCT01361633|12645418|P2|NOT COMPLETED|Overall Study||3
5141142|NCT01361633|12645419|P1|NOT COMPLETED|Overall Study||6
5141143|NCT01361633|12645418|P2|COMPLETED|Overall Study||23
5141144|NCT01361633|12645419|P1|COMPLETED|Overall Study||19
5141145|NCT01361633|12645418|P2|STARTED|Overall Study||26
5141146|NCT01361633|12645419|P1|STARTED|Overall Study||25
5141147|NCT01361620|12645425|P1|NOT COMPLETED|Overall Study||0
5141148|NCT01361620|12645425|P1|COMPLETED|Overall Study||132
5141149|NCT01361620|12645425|P1|STARTED|Overall Study||132
5141150|NCT01361607|12645431|P2|NOT COMPLETED|Overall Study||41
5141151|NCT01361607|12645432|P1|NOT COMPLETED|Overall Study||64
5141152|NCT01361607|12645431|P2|COMPLETED|Overall Study||158
5141153|NCT01361607|12645432|P1|COMPLETED|Overall Study||136
5141154|NCT01361607|12645431|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
5141155|NCT01361607|12645432|P1|ITT Population|Overall Study||198
5141156|NCT01361607|12645431|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
5141157|NCT01361607|12645432|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
5141158|NCT01361607|12645431|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
5141159|NCT01361607|12645432|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
5141160|NCT01361607|12645431|P2|STARTED|Overall Study||199
5141161|NCT01361607|12645432|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
5141162|NCT01361594|12645460|P2|NOT COMPLETED|Overall Study||2
5141163|NCT01361594|12645461|P1|NOT COMPLETED|Overall Study||1
5141164|NCT01361594|12645460|P2|COMPLETED|Overall Study||151
5141165|NCT01361594|12645461|P1|COMPLETED|Overall Study||151
5141166|NCT01361594|12645460|P2|STARTED|Overall Study||153
5141167|NCT01361594|12645461|P1|STARTED|Overall Study||152
5141168|NCT01361568|12645475|P6|NOT COMPLETED|Overall Study||2
5141169|NCT01361568|12645476|P5|NOT COMPLETED|Overall Study||1
5141170|NCT01361568|12645477|P4|NOT COMPLETED|Overall Study||0
5141171|NCT01361568|12645478|P3|NOT COMPLETED|Overall Study||0
5141172|NCT01361568|12645479|P2|NOT COMPLETED|Overall Study||1
5141173|NCT01361568|12645480|P1|NOT COMPLETED|Overall Study||2
5141174|NCT01361568|12645475|P6|COMPLETED|Overall Study||11
5141175|NCT01361568|12645476|P5|COMPLETED|Overall Study||6
5141176|NCT01361568|12645477|P4|COMPLETED|Overall Study||21
5141177|NCT01361568|12645478|P3|COMPLETED|Overall Study||20
5141178|NCT01361568|12645479|P2|COMPLETED|Overall Study||70
5141179|NCT01361568|12645480|P1|COMPLETED|Overall Study||69
5141180|NCT01361568|12645475|P6|STARTED|Overall Study||13
5141181|NCT01361568|12645476|P5|STARTED|Overall Study||7
5141182|NCT01361568|12645477|P4|STARTED|Overall Study||21
5141183|NCT01361568|12645478|P3|STARTED|Overall Study||20
5141184|NCT01361568|12645479|P2|STARTED|Overall Study||71
5141185|NCT01361568|12645480|P1|STARTED|Overall Study||71
5141186|NCT01361464|12645510|P1|NOT COMPLETED|Overall Study||3
5141187|NCT01361464|12645510|P1|COMPLETED|Overall Study||18
5141188|NCT01361464|12645510|P1|STARTED|Overall Study||21
5141189|NCT01361308|12645519|P2|NOT COMPLETED|Overall Study||30
5141190|NCT01361308|12645520|P1|NOT COMPLETED|Overall Study||35
5141191|NCT01361308|12645519|P2|COMPLETED|Overall Study||278
5141192|NCT01361308|12645520|P1|COMPLETED|Overall Study||271
5141193|NCT01361308|12645519|P2|STARTED|Overall Study||308
5141194|NCT01361308|12645520|P1|STARTED|Overall Study||306
5141195|NCT01361217|12645560|P1|NOT COMPLETED|Overall Study||0
5141196|NCT01361217|12645560|P1|COMPLETED|Overall Study||10
5141197|NCT01361217|12645560|P1|STARTED|Overall Study||10
5141198|NCT01361178|12645568|P2|NOT COMPLETED|Overall Study||0
5141199|NCT01361178|12645569|P1|NOT COMPLETED|Overall Study||13
5141200|NCT01361178|12645568|P2|COMPLETED|Overall Study||11
5141201|NCT01361178|12645569|P1|COMPLETED|Overall Study||109
5141202|NCT01361178|12645568|P2|STARTED|Overall Study||11
5141203|NCT01361178|12645569|P1|STARTED|Overall Study||122
5141204|NCT01361126|12645577|P2|NOT COMPLETED|Overall Study||2
5141205|NCT01361126|12645578|P1|NOT COMPLETED|Overall Study||0
5141206|NCT01361126|12645577|P2|COMPLETED|Overall Study||2
5141207|NCT01361126|12645578|P1|COMPLETED|Overall Study||13
5141208|NCT01361126|12645577|P2|STARTED|Overall Study||4
5141209|NCT01361126|12645578|P1|STARTED|Overall Study||13
5141210|NCT01361113|12645593|P1|NOT COMPLETED|Overall Study||0
5141211|NCT01361113|12645593|P1|COMPLETED|Overall Study||21
5141212|NCT01361113|12645593|P1|STARTED|Overall Study||21
5141213|NCT01361048|12645604|P3|NOT COMPLETED|Overall Study||1
5141214|NCT01361048|12645605|P2|NOT COMPLETED|Overall Study||0
5141215|NCT01361048|12645606|P1|NOT COMPLETED|Overall Study||0
5141216|NCT01361048|12645604|P3|COMPLETED|Overall Study||9
5141217|NCT01361048|12645605|P2|COMPLETED|Overall Study||10
5141218|NCT01361048|12645606|P1|COMPLETED|Overall Study||20
5141219|NCT01361048|12645604|P3|STARTED|Overall Study||10
5141220|NCT01361048|12645605|P2|STARTED|Overall Study||10
5141221|NCT01361048|12645606|P1|STARTED|Overall Study||20
5141222|NCT01361009|12645617|P1|NOT COMPLETED|Overall Study||116
5141223|NCT01361009|12645617|P1|COMPLETED|Overall Study||1901
5141224|NCT01361009|12645617|P1|STARTED|Overall Study||2017
5141225|NCT01360996|12645627|P3|NOT COMPLETED|Overall Study||2
5141226|NCT01360996|12645628|P2|NOT COMPLETED|Overall Study||3
5141227|NCT01360996|12645629|P1|NOT COMPLETED|Overall Study||6
5141228|NCT01360996|12645627|P3|COMPLETED|Overall Study||21
5141229|NCT01360996|12645628|P2|COMPLETED|Overall Study||18
5141230|NCT01360996|12645629|P1|COMPLETED|Overall Study||14
5141231|NCT01360996|12645627|P3|STARTED|Overall Study||23
5141232|NCT01360996|12645628|P2|STARTED|Overall Study||21
5141233|NCT01360996|12645629|P1|STARTED|Overall Study||20
5141234|NCT01360866|12645652|P4|NOT COMPLETED|Overall Study||22
5141235|NCT01360866|12645653|P3|NOT COMPLETED|Overall Study||519
5141236|NCT01360866|12645654|P2|NOT COMPLETED|Overall Study||287
5141237|NCT01360866|12645655|P1|NOT COMPLETED|Overall Study||221
5141238|NCT01360866|12645652|P4|COMPLETED|Overall Study||54
5141239|NCT01360866|12645653|P3|COMPLETED|Overall Study||1126
5141240|NCT01360866|12645654|P2|COMPLETED|Overall Study||420
5141241|NCT01360866|12645655|P1|COMPLETED|Overall Study||295
5141242|NCT01360866|12645652|P4|STARTED|Overall Study||76
5141243|NCT01360866|12645653|P3|STARTED|Overall Study||1645
5141244|NCT01360866|12645654|P2|STARTED|Overall Study||707
5141245|NCT01360866|12645655|P1|STARTED|Overall Study||516
5141246|NCT01360840|12645684|P3|NOT COMPLETED|Overall Study||9
5141247|NCT01360840|12645685|P2|NOT COMPLETED|Overall Study||10
5141248|NCT01360840|12645686|P1|NOT COMPLETED|Overall Study||10
5141249|NCT01360840|12645684|P3|COMPLETED|Overall Study||51
5141250|NCT01360840|12645685|P2|COMPLETED|Overall Study||50
5141251|NCT01360840|12645686|P1|COMPLETED|Overall Study||50
5141252|NCT01360840|12645684|P3|STARTED|Overall Study||60
5141253|NCT01360840|12645685|P2|STARTED|Overall Study||60
5141254|NCT01360840|12645686|P1|STARTED|Overall Study||60
5141255|NCT01360762|12645736|P1|NOT COMPLETED|Whole Study Period||36
5141256|NCT01360762|12645736|P1|COMPLETED|Whole Study Period||38
5141257|NCT01360762|12645736|P1|STARTED|Whole Study Period||74
5141258|NCT01360762|12645736|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
5141259|NCT01360762|12645736|P1|COMPLETED|Main Study Period (12-month Treatment)||45
5141260|NCT01360762|12645736|P1|STARTED|Main Study Period (12-month Treatment)||74
5141261|NCT01360645|12645746|P4|NOT COMPLETED|Phase A+||24
5141262|NCT01360645|12645747|P3|NOT COMPLETED|Phase A+||0
5141263|NCT01360645|12645748|P2|NOT COMPLETED|Phase A+||0
5141264|NCT01360645|12645749|P1|NOT COMPLETED|Phase A+||0
5141265|NCT01360645|12645746|P4|COMPLETED|Phase A+||307
5141266|NCT01360645|12645747|P3|COMPLETED|Phase A+||0
5141267|NCT01360645|12645748|P2|COMPLETED|Phase A+||0
5141268|NCT01360645|12645749|P1|COMPLETED|Phase A+||0
5141269|NCT01360645|12645746|P4|STARTED|Phase A+||331
5141270|NCT01360645|12645747|P3|STARTED|Phase A+||0
5141271|NCT01360645|12645748|P2|STARTED|Phase A+||0
5141272|NCT01360645|12645749|P1|STARTED|Phase A+||0
5141273|NCT01360645|12645746|P4|NOT COMPLETED|Phase B (6 Weeks)||0
5141274|NCT01360645|12645747|P3|NOT COMPLETED|Phase B (6 Weeks)||13
5141275|NCT01360645|12645748|P2|NOT COMPLETED|Phase B (6 Weeks)||14
5141276|NCT01360645|12645749|P1|NOT COMPLETED|Phase B (6 Weeks)||0
5141277|NCT01360645|12645746|P4|COMPLETED|Phase B (6 Weeks)||0
5141278|NCT01360645|12645747|P3|COMPLETED|Phase B (6 Weeks)||178
5141279|NCT01360645|12645748|P2|COMPLETED|Phase B (6 Weeks)||174
5141280|NCT01360645|12645749|P1|COMPLETED|Phase B (6 Weeks)||0
5141281|NCT01360645|12645746|P4|STARTED|Phase B (6 Weeks)||0
5141282|NCT01360645|12645747|P3|STARTED|Phase B (6 Weeks)||191
5141283|NCT01360645|12645748|P2|STARTED|Phase B (6 Weeks)||188
5141284|NCT01360645|12645749|P1|STARTED|Phase B (6 Weeks)||0
5141285|NCT01360645|12645746|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141286|NCT01360645|12645747|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141287|NCT01360645|12645748|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141288|NCT01360645|12645749|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
5141289|NCT01360645|12645746|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141290|NCT01360645|12645747|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141291|NCT01360645|12645748|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141292|NCT01360645|12645749|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
5141293|NCT01360645|12645746|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141294|NCT01360645|12645747|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141295|NCT01360645|12645748|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
5141296|NCT01360645|12645749|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
5141297|NCT01360632|12645804|P5|NOT COMPLETED|Phase A+||25
5141298|NCT01360632|12645805|P4|NOT COMPLETED|Phase A+||0
5141299|NCT01360632|12645806|P3|NOT COMPLETED|Phase A+||0
5141300|NCT01360632|12645807|P2|NOT COMPLETED|Phase A+||0
5141301|NCT01360632|12645808|P1|NOT COMPLETED|Phase A+||0
5141302|NCT01360632|12645804|P5|COMPLETED|Phase A+||575
5141303|NCT01360632|12645805|P4|COMPLETED|Phase A+||0
5141304|NCT01360632|12645806|P3|COMPLETED|Phase A+||0
5141305|NCT01360632|12645807|P2|COMPLETED|Phase A+||0
5141306|NCT01360632|12645808|P1|COMPLETED|Phase A+||0
5141307|NCT01360632|12645804|P5|STARTED|Phase A+||600
5141308|NCT01360632|12645805|P4|STARTED|Phase A+||0
5141309|NCT01360632|12645806|P3|STARTED|Phase A+||0
5141310|NCT01360632|12645807|P2|STARTED|Phase A+||0
5141311|NCT01360632|12645808|P1|STARTED|Phase A+||0
5141312|NCT01360632|12645804|P5|NOT COMPLETED|Phase B (6 Weeks)||0
5141313|NCT01360632|12645805|P4|NOT COMPLETED|Phase B (6 Weeks)||13
5141314|NCT01360632|12645806|P3|NOT COMPLETED|Phase B (6 Weeks)||20
5141315|NCT01360632|12645807|P2|NOT COMPLETED|Phase B (6 Weeks)||10
5141316|NCT01360632|12645808|P1|NOT COMPLETED|Phase B (6 Weeks)||0
5141317|NCT01360632|12645804|P5|COMPLETED|Phase B (6 Weeks)||0
5141318|NCT01360632|12645805|P4|COMPLETED|Phase B (6 Weeks)||208
5141319|NCT01360632|12645806|P3|COMPLETED|Phase B (6 Weeks)||210
5141320|NCT01360632|12645807|P2|COMPLETED|Phase B (6 Weeks)||216
5141321|NCT01360632|12645808|P1|COMPLETED|Phase B (6 Weeks)||0
5141322|NCT01360632|12645804|P5|STARTED|Phase B (6 Weeks)||0
5141323|NCT01360632|12645805|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
5141324|NCT01360632|12645806|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
5141325|NCT01360632|12645807|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
5141326|NCT01360632|12645808|P1|STARTED|Phase B (6 Weeks)||0
5141327|NCT01360632|12645804|P5|NOT COMPLETED|Phase A (8 Weeks)||0
5141328|NCT01360632|12645805|P4|NOT COMPLETED|Phase A (8 Weeks)||0
5141329|NCT01360632|12645806|P3|NOT COMPLETED|Phase A (8 Weeks)||0
5141330|NCT01360632|12645807|P2|NOT COMPLETED|Phase A (8 Weeks)||0
5141331|NCT01360632|12645808|P1|NOT COMPLETED|Phase A (8 Weeks)||255
5141332|NCT01360632|12645804|P5|COMPLETED|Phase A (8 Weeks)||0
5141333|NCT01360632|12645805|P4|COMPLETED|Phase A (8 Weeks)||0
5141334|NCT01360632|12645806|P3|COMPLETED|Phase A (8 Weeks)||0
5141335|NCT01360632|12645807|P2|COMPLETED|Phase A (8 Weeks)||0
5141336|NCT01360632|12645808|P1|COMPLETED|Phase A (8 Weeks)||1277
5141337|NCT01360632|12645804|P5|STARTED|Phase A (8 Weeks)||0
5141338|NCT01360632|12645805|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
5141339|NCT01360632|12645806|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
5141340|NCT01360632|12645807|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
5141427|NCT01359644|12646104|P10|NOT COMPLETED|Follow-up Period||0
5141341|NCT01360632|12645808|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
5141342|NCT01360554|12645887|P2|NOT COMPLETED|Overall Study||439
5141343|NCT01360554|12645888|P1|NOT COMPLETED|Overall Study||439
5141344|NCT01360554|12645887|P2|COMPLETED|Overall Study||0
5141345|NCT01360554|12645888|P1|COMPLETED|Overall Study||0
5141346|NCT01360554|12645887|P2|Treated|Overall Study||436
5141347|NCT01360554|12645888|P1|Treated|Overall Study||436
5141348|NCT01360554|12645887|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
5141349|NCT01360554|12645888|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
5141350|NCT01360450|12645926|P2|NOT COMPLETED|Overall Study||0
5141351|NCT01360450|12645927|P1|NOT COMPLETED|Overall Study||0
5141352|NCT01360450|12645926|P2|COMPLETED|Overall Study||6
5141353|NCT01360450|12645927|P1|COMPLETED|Overall Study||6
5141354|NCT01360450|12645926|P2|Completed Treatment|Overall Study||6
5141355|NCT01360450|12645927|P1|Completed Treatment|Overall Study||6
5141356|NCT01360450|12645926|P2|STARTED|Overall Study||6
5141357|NCT01360450|12645927|P1|STARTED|Overall Study||6
5141358|NCT01360398|12645937|P1|NOT COMPLETED|Overall Study||22
5141359|NCT01360398|12645937|P1|COMPLETED|Overall Study||105
5141360|NCT01360398|12645937|P1|STARTED|Overall Study||127
5141361|NCT01360229|12645961|P2|NOT COMPLETED|Overall Study||2
5141362|NCT01360229|12645962|P1|NOT COMPLETED|Overall Study||3
5141363|NCT01360229|12645961|P2|COMPLETED|Overall Study||45
5141364|NCT01360229|12645962|P1|COMPLETED|Overall Study||44
5141365|NCT01360229|12645961|P2|STARTED|Overall Study||47
5141366|NCT01360229|12645962|P1|STARTED|Overall Study||47
5141367|NCT01360021|12645971|P3|NOT COMPLETED|Overall Study||7
5141368|NCT01360021|12645972|P2|NOT COMPLETED|Overall Study||4
5141369|NCT01360021|12645973|P1|NOT COMPLETED|Overall Study||8
5141370|NCT01360021|12645971|P3|COMPLETED|Overall Study|Patients who completed study|65
5141371|NCT01360021|12645972|P2|COMPLETED|Overall Study|Patients who completed study|67
5141372|NCT01360021|12645973|P1|COMPLETED|Overall Study|Patients who completed study|63
5141373|NCT01360021|12645971|P3|STARTED|Overall Study|Patients randomized|72
5141374|NCT01360021|12645972|P2|STARTED|Overall Study|Patients randomized|71
5141375|NCT01360021|12645973|P1|STARTED|Overall Study|Patients randomized|71
5141376|NCT01359943|12645999|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
5141377|NCT01359943|12646000|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
5141378|NCT01359943|12646001|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
5141379|NCT01359943|12645999|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
5141380|NCT01359943|12646000|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
5141381|NCT01359943|12646001|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
5141382|NCT01359943|12645999|P3|STARTED|Follow-up (Weeks 52 - 60)||44
5141383|NCT01359943|12646000|P2|STARTED|Follow-up (Weeks 52 - 60)||84
5141384|NCT01359943|12646001|P1|STARTED|Follow-up (Weeks 52 - 60)||86
5141385|NCT01359943|12645999|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
5141386|NCT01359943|12646000|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
5141387|NCT01359943|12646001|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
5141388|NCT01359943|12645999|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
5141389|NCT01359943|12646000|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
5141390|NCT01359943|12646001|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
5141391|NCT01359943|12645999|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
5141392|NCT01359943|12646000|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
5141393|NCT01359943|12646001|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
5141394|NCT01359943|12645999|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
5141395|NCT01359943|12646000|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
5141396|NCT01359943|12646001|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
5141397|NCT01359943|12645999|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
5141398|NCT01359943|12646000|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
5141399|NCT01359943|12646001|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
5141400|NCT01359943|12645999|P3|STARTED|Double-blind (Weeks 0 - 16)||44
5141401|NCT01359943|12646000|P2|STARTED|Double-blind (Weeks 0 - 16)||89
5141402|NCT01359943|12646001|P1|STARTED|Double-blind (Weeks 0 - 16)||88
5141403|NCT01359904|12646049|P2|NOT COMPLETED|Overall Study||0
5141404|NCT01359904|12646050|P1|NOT COMPLETED|Overall Study||1
5141405|NCT01359904|12646049|P2|COMPLETED|Overall Study||19
5141406|NCT01359904|12646050|P1|COMPLETED|Overall Study||14
5141407|NCT01359904|12646049|P2|STARTED|Overall Study||19
5141408|NCT01359904|12646050|P1|STARTED|Overall Study||15
5141409|NCT01359748|12646066|P4|NOT COMPLETED|Overall Study||0
5141410|NCT01359748|12646067|P3|NOT COMPLETED|Overall Study||0
5141411|NCT01359748|12646068|P2|NOT COMPLETED|Overall Study||0
5141412|NCT01359748|12646069|P1|NOT COMPLETED|Overall Study||0
5141413|NCT01359748|12646066|P4|COMPLETED|Overall Study||11
5141414|NCT01359748|12646067|P3|COMPLETED|Overall Study||10
5141415|NCT01359748|12646068|P2|COMPLETED|Overall Study||20
5141416|NCT01359748|12646069|P1|COMPLETED|Overall Study||48
5141417|NCT01359748|12646066|P4|STARTED|Overall Study||11
5141418|NCT01359748|12646067|P3|STARTED|Overall Study||10
5141419|NCT01359748|12646068|P2|STARTED|Overall Study||20
5141420|NCT01359748|12646069|P1|STARTED|Overall Study||48
5141421|NCT01359735|12646079|P2|NOT COMPLETED|Overall Study||0
5141422|NCT01359735|12646080|P1|NOT COMPLETED|Overall Study||0
5141423|NCT01359735|12646079|P2|COMPLETED|Overall Study||4
5141424|NCT01359735|12646080|P1|COMPLETED|Overall Study||4
5141425|NCT01359735|12646079|P2|STARTED|Overall Study||4
5141426|NCT01359735|12646080|P1|STARTED|Overall Study||4
5141428|NCT01359644|12646105|P9|NOT COMPLETED|Follow-up Period||0
5141429|NCT01359644|12646106|P8|NOT COMPLETED|Follow-up Period||2
5141430|NCT01359644|12646107|P7|NOT COMPLETED|Follow-up Period||1
5141431|NCT01359644|12646108|P6|NOT COMPLETED|Follow-up Period||1
5141432|NCT01359644|12646109|P5|NOT COMPLETED|Follow-up Period||0
5141433|NCT01359644|12646110|P4|NOT COMPLETED|Follow-up Period||0
5141434|NCT01359644|12646111|P3|NOT COMPLETED|Follow-up Period||0
5141435|NCT01359644|12646112|P2|NOT COMPLETED|Follow-up Period||0
5141436|NCT01359644|12646113|P1|NOT COMPLETED|Follow-up Period||0
5141437|NCT01359644|12646104|P10|COMPLETED|Follow-up Period||20
5141438|NCT01359644|12646105|P9|COMPLETED|Follow-up Period||21
5141439|NCT01359644|12646106|P8|COMPLETED|Follow-up Period||39
5141440|NCT01359644|12646107|P7|COMPLETED|Follow-up Period||40
5141441|NCT01359644|12646108|P6|COMPLETED|Follow-up Period||12
5141442|NCT01359644|12646109|P5|COMPLETED|Follow-up Period||15
5141443|NCT01359644|12646110|P4|COMPLETED|Follow-up Period||14
5141444|NCT01359644|12646111|P3|COMPLETED|Follow-up Period||14
5141445|NCT01359644|12646112|P2|COMPLETED|Follow-up Period||16
5141446|NCT01359644|12646113|P1|COMPLETED|Follow-up Period||15
5141447|NCT01359644|12646104|P10|STARTED|Follow-up Period||20
5141448|NCT01359644|12646105|P9|STARTED|Follow-up Period||21
5141449|NCT01359644|12646106|P8|STARTED|Follow-up Period||41
5141450|NCT01359644|12646107|P7|STARTED|Follow-up Period||41
5141451|NCT01359644|12646108|P6|STARTED|Follow-up Period||13
5141452|NCT01359644|12646109|P5|STARTED|Follow-up Period||15
5141453|NCT01359644|12646110|P4|STARTED|Follow-up Period||14
5141454|NCT01359644|12646111|P3|STARTED|Follow-up Period||14
5141455|NCT01359644|12646112|P2|STARTED|Follow-up Period||16
5141456|NCT01359644|12646113|P1|STARTED|Follow-up Period||15
5141457|NCT01359644|12646104|P10|NOT COMPLETED|Treatment Period||0
5141458|NCT01359644|12646105|P9|NOT COMPLETED|Treatment Period||0
5141459|NCT01359644|12646106|P8|NOT COMPLETED|Treatment Period||0
5141460|NCT01359644|12646107|P7|NOT COMPLETED|Treatment Period||0
5141461|NCT01359644|12646108|P6|NOT COMPLETED|Treatment Period||2
5141462|NCT01359644|12646109|P5|NOT COMPLETED|Treatment Period||0
5141463|NCT01359644|12646110|P4|NOT COMPLETED|Treatment Period||0
5141464|NCT01359644|12646111|P3|NOT COMPLETED|Treatment Period||1
5141465|NCT01359644|12646112|P2|NOT COMPLETED|Treatment Period||1
5141466|NCT01359644|12646113|P1|NOT COMPLETED|Treatment Period||0
5141467|NCT01359644|12646104|P10|COMPLETED|Treatment Period||20
5141468|NCT01359644|12646105|P9|COMPLETED|Treatment Period||21
5141469|NCT01359644|12646106|P8|COMPLETED|Treatment Period||41
5141470|NCT01359644|12646107|P7|COMPLETED|Treatment Period||41
5141471|NCT01359644|12646108|P6|COMPLETED|Treatment Period||12
5141472|NCT01359644|12646109|P5|COMPLETED|Treatment Period||15
5141473|NCT01359644|12646110|P4|COMPLETED|Treatment Period||14
5141474|NCT01359644|12646111|P3|COMPLETED|Treatment Period||13
5141475|NCT01359644|12646112|P2|COMPLETED|Treatment Period||15
5141476|NCT01359644|12646113|P1|COMPLETED|Treatment Period||15
5141477|NCT01359644|12646104|P10|STARTED|Treatment Period||20
5141478|NCT01359644|12646105|P9|STARTED|Treatment Period||21
5141479|NCT01359644|12646106|P8|STARTED|Treatment Period||41
5141480|NCT01359644|12646107|P7|STARTED|Treatment Period||41
5141481|NCT01359644|12646108|P6|STARTED|Treatment Period||14
5141482|NCT01359644|12646109|P5|STARTED|Treatment Period||15
5141483|NCT01359644|12646110|P4|STARTED|Treatment Period||14
5141484|NCT01359644|12646111|P3|STARTED|Treatment Period||14
5141485|NCT01359644|12646112|P2|STARTED|Treatment Period||16
5141486|NCT01359644|12646113|P1|STARTED|Treatment Period||15
5141487|NCT01359449|12646157|P2|NOT COMPLETED|Overall Study||4
5141488|NCT01359449|12646158|P1|NOT COMPLETED|Overall Study||4
5141489|NCT01359449|12646157|P2|COMPLETED|Overall Study||58
5141490|NCT01359449|12646158|P1|COMPLETED|Overall Study||57
5141491|NCT01359449|12646157|P2|STARTED|Overall Study||62
5141492|NCT01359449|12646158|P1|STARTED|Overall Study||61
5141493|NCT01359410|12646182|P2|NOT COMPLETED|Overall Study||0
5141494|NCT01359410|12646183|P1|NOT COMPLETED|Overall Study||0
5141495|NCT01359410|12646182|P2|COMPLETED|Overall Study||46
5141496|NCT01359410|12646183|P1|COMPLETED|Overall Study||54
5141497|NCT01359410|12646182|P2|STARTED|Overall Study||46
5141498|NCT01359410|12646183|P1|STARTED|Overall Study||54
5141499|NCT01359371|12646197|P1|NOT COMPLETED|Overall Study||0
5141500|NCT01359371|12646197|P1|COMPLETED|Overall Study||41
5141501|NCT01359371|12646197|P1|STARTED|Overall Study||41
5141502|NCT01359254|12646204|P2|NOT COMPLETED|Overall Study||0
5141503|NCT01359254|12646205|P1|NOT COMPLETED|Overall Study||1
5141504|NCT01359254|12646204|P2|COMPLETED|Overall Study||0
5141505|NCT01359254|12646205|P1|COMPLETED|Overall Study||0
5141506|NCT01359254|12646204|P2|STARTED|Overall Study||0
5141507|NCT01359254|12646205|P1|STARTED|Overall Study||1
5141508|NCT01359150|12646215|P2|NOT COMPLETED|Overall Study||5
5141509|NCT01359150|12646216|P1|NOT COMPLETED|Overall Study||7
5141510|NCT01359150|12646215|P2|COMPLETED|Overall Study||106
5141511|NCT01359150|12646216|P1|COMPLETED|Overall Study||105
5141512|NCT01359150|12646215|P2|STARTED|Overall Study||111
5141513|NCT01359150|12646216|P1|STARTED|Overall Study||112
5141514|NCT01359111|12646238|P1|NOT COMPLETED|Overall Study||0
5141515|NCT01359111|12646238|P1|COMPLETED|Overall Study||20
5141516|NCT01359111|12646238|P1|STARTED|Overall Study||20
5141517|NCT01359046|12646247|P2|NOT COMPLETED|Overall Study||17
5141518|NCT01359046|12646248|P1|NOT COMPLETED|Overall Study||7
5141519|NCT01359046|12646247|P2|COMPLETED|Overall Study||127
5141520|NCT01359046|12646248|P1|COMPLETED|Overall Study||137
5141521|NCT01359046|12646247|P2|STARTED|Overall Study||144
5141522|NCT01359046|12646248|P1|STARTED|Overall Study||144
5141523|NCT01359007|12646256|P1|NOT COMPLETED|Overall Study||2
5141524|NCT01359007|12646256|P1|COMPLETED|Overall Study||3
5141525|NCT01359007|12646256|P1|STARTED|Overall Study||5
5141526|NCT01358981|12646271|P7|NOT COMPLETED|Period 4||0
5141527|NCT01358981|12646272|P6|NOT COMPLETED|Period 4||0
5141528|NCT01358981|12646273|P5|NOT COMPLETED|Period 4||0
5141529|NCT01358981|12646274|P4|NOT COMPLETED|Period 4||0
5141530|NCT01358981|12646275|P3|NOT COMPLETED|Period 4||0
5141531|NCT01358981|12646276|P2|NOT COMPLETED|Period 4||0
5141532|NCT01358981|12646277|P1|NOT COMPLETED|Period 4||0
5141533|NCT01358981|12646271|P7|COMPLETED|Period 4||0
5141534|NCT01358981|12646272|P6|COMPLETED|Period 4||0
5141535|NCT01358981|12646273|P5|COMPLETED|Period 4||0
5141536|NCT01358981|12646274|P4|COMPLETED|Period 4||2
5141537|NCT01358981|12646275|P3|COMPLETED|Period 4||2
5141538|NCT01358981|12646276|P2|COMPLETED|Period 4||2
5141539|NCT01358981|12646277|P1|COMPLETED|Period 4||2
5141540|NCT01358981|12646271|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
5141541|NCT01358981|12646272|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
5141542|NCT01358981|12646273|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
5141543|NCT01358981|12646274|P4|STARTED|Period 4||2
5141544|NCT01358981|12646275|P3|STARTED|Period 4||2
5141545|NCT01358981|12646276|P2|STARTED|Period 4||2
5141546|NCT01358981|12646277|P1|STARTED|Period 4||2
5141547|NCT01358981|12646271|P7|NOT COMPLETED|Period 3||0
5141548|NCT01358981|12646272|P6|NOT COMPLETED|Period 3||0
5141549|NCT01358981|12646273|P5|NOT COMPLETED|Period 3||0
5141550|NCT01358981|12646274|P4|NOT COMPLETED|Period 3||0
5141551|NCT01358981|12646275|P3|NOT COMPLETED|Period 3||0
5141552|NCT01358981|12646276|P2|NOT COMPLETED|Period 3||0
5141553|NCT01358981|12646277|P1|NOT COMPLETED|Period 3||0
5141554|NCT01358981|12646271|P7|COMPLETED|Period 3||3
5141555|NCT01358981|12646272|P6|COMPLETED|Period 3||3
5141556|NCT01358981|12646273|P5|COMPLETED|Period 3||3
5141557|NCT01358981|12646274|P4|COMPLETED|Period 3||2
5141558|NCT01358981|12646275|P3|COMPLETED|Period 3||2
5141559|NCT01358981|12646276|P2|COMPLETED|Period 3||2
5141560|NCT01358981|12646277|P1|COMPLETED|Period 3||2
5141561|NCT01358981|12646271|P7|STARTED|Period 3||3
5141562|NCT01358981|12646272|P6|STARTED|Period 3||3
5141563|NCT01358981|12646273|P5|STARTED|Period 3||3
5141564|NCT01358981|12646274|P4|STARTED|Period 3||2
5141565|NCT01358981|12646275|P3|STARTED|Period 3||2
5141566|NCT01358981|12646276|P2|STARTED|Period 3||2
5141567|NCT01358981|12646277|P1|STARTED|Period 3||2
5141568|NCT01358981|12646271|P7|NOT COMPLETED|Period 2||0
5141569|NCT01358981|12646272|P6|NOT COMPLETED|Period 2||0
5141570|NCT01358981|12646273|P5|NOT COMPLETED|Period 2||0
5141571|NCT01358981|12646274|P4|NOT COMPLETED|Period 2||0
5141572|NCT01358981|12646275|P3|NOT COMPLETED|Period 2||0
5141573|NCT01358981|12646276|P2|NOT COMPLETED|Period 2||0
5141574|NCT01358981|12646277|P1|NOT COMPLETED|Period 2||0
5141575|NCT01358981|12646271|P7|COMPLETED|Period 2||3
5141576|NCT01358981|12646272|P6|COMPLETED|Period 2||3
5141577|NCT01358981|12646273|P5|COMPLETED|Period 2||3
5141578|NCT01358981|12646274|P4|COMPLETED|Period 2||2
5141579|NCT01358981|12646275|P3|COMPLETED|Period 2||2
5141580|NCT01358981|12646276|P2|COMPLETED|Period 2||2
5141581|NCT01358981|12646277|P1|COMPLETED|Period 2||2
5141582|NCT01358981|12646271|P7|STARTED|Period 2||3
5141583|NCT01358981|12646272|P6|STARTED|Period 2||3
5141584|NCT01358981|12646273|P5|STARTED|Period 2||3
5141585|NCT01358981|12646274|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
5141586|NCT01358981|12646275|P3|STARTED|Period 2||2
5141587|NCT01358981|12646276|P2|STARTED|Period 2||2
5141588|NCT01358981|12646277|P1|STARTED|Period 2||2
5141589|NCT01358981|12646271|P7|NOT COMPLETED|Period 1||0
5141590|NCT01358981|12646272|P6|NOT COMPLETED|Period 1||0
5141591|NCT01358981|12646273|P5|NOT COMPLETED|Period 1||0
5141592|NCT01358981|12646274|P4|NOT COMPLETED|Period 1||1
5141593|NCT01358981|12646275|P3|NOT COMPLETED|Period 1||0
5141594|NCT01358981|12646276|P2|NOT COMPLETED|Period 1||0
5141595|NCT01358981|12646277|P1|NOT COMPLETED|Period 1||0
5141596|NCT01358981|12646271|P7|COMPLETED|Period 1||3
5141597|NCT01358981|12646272|P6|COMPLETED|Period 1||3
5141598|NCT01358981|12646273|P5|COMPLETED|Period 1||3
5141599|NCT01358981|12646274|P4|COMPLETED|Period 1||1
5141600|NCT01358981|12646275|P3|COMPLETED|Period 1||2
5141601|NCT01358981|12646276|P2|COMPLETED|Period 1||2
5141602|NCT01358981|12646277|P1|COMPLETED|Period 1||2
5141603|NCT01358981|12646271|P7|Received at Least 1dose of Study Drug|Period 1||3
5141604|NCT01358981|12646272|P6|Received at Least 1dose of Study Drug|Period 1||3
5141605|NCT01358981|12646273|P5|Received at Least 1dose of Study Drug|Period 1||3
5141606|NCT01358981|12646274|P4|Received at Least 1dose of Study Drug|Period 1||2
5141607|NCT01358981|12646275|P3|Received at Least 1dose of Study Drug|Period 1||2
5141608|NCT01358981|12646276|P2|Received at Least 1dose of Study Drug|Period 1||2
5141609|NCT01358981|12646277|P1|Received at Least 1dose of Study Drug|Period 1||2
5141610|NCT01358981|12646271|P7|STARTED|Period 1||3
5141611|NCT01358981|12646272|P6|STARTED|Period 1||3
5141612|NCT01358981|12646273|P5|STARTED|Period 1||3
5141613|NCT01358981|12646274|P4|STARTED|Period 1||2
5141614|NCT01358981|12646275|P3|STARTED|Period 1||2
5141615|NCT01358981|12646276|P2|STARTED|Period 1||2
5141616|NCT01358981|12646277|P1|STARTED|Period 1||2
5141617|NCT01358968|12646338|P4|NOT COMPLETED|Continued Access Phase||7
5141618|NCT01358968|12646339|P3|NOT COMPLETED|Continued Access Phase||12
5141619|NCT01358968|12646340|P2|NOT COMPLETED|Continued Access Phase||0
5141620|NCT01358968|12646341|P1|NOT COMPLETED|Continued Access Phase||0
5141621|NCT01358968|12646338|P4|COMPLETED|Continued Access Phase||0
5141622|NCT01358968|12646339|P3|COMPLETED|Continued Access Phase||0
5141623|NCT01358968|12646340|P2|COMPLETED|Continued Access Phase||0
5141624|NCT01358968|12646341|P1|COMPLETED|Continued Access Phase||0
5141625|NCT01358968|12646338|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
5141626|NCT01358968|12646339|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
5141627|NCT01358968|12646340|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
5141628|NCT01358968|12646341|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
5141629|NCT01358968|12646338|P4|STARTED|Continued Access Phase||7
5141630|NCT01358968|12646339|P3|STARTED|Continued Access Phase||12
5141631|NCT01358968|12646340|P2|STARTED|Continued Access Phase||0
5141632|NCT01358968|12646341|P1|STARTED|Continued Access Phase||0
5141633|NCT01358968|12646338|P4|NOT COMPLETED|Period 2||0
5141634|NCT01358968|12646339|P3|NOT COMPLETED|Period 2||0
5141635|NCT01358968|12646340|P2|NOT COMPLETED|Period 2||1
5141636|NCT01358968|12646341|P1|NOT COMPLETED|Period 2||0
5141637|NCT01358968|12646338|P4|COMPLETED|Period 2||0
5141638|NCT01358968|12646339|P3|COMPLETED|Period 2||0
5141639|NCT01358968|12646340|P2|COMPLETED|Period 2||19
5141640|NCT01358968|12646341|P1|COMPLETED|Period 2||0
5141641|NCT01358968|12646338|P4|Received at Least 1 Dose of Study Drug|Period 2||0
5141642|NCT01358968|12646339|P3|Received at Least 1 Dose of Study Drug|Period 2||0
5141643|NCT01358968|12646340|P2|Received at Least 1 Dose of Study Drug|Period 2||19
5141644|NCT01358968|12646341|P1|Received at Least 1 Dose of Study Drug|Period 2||0
5141645|NCT01358968|12646338|P4|STARTED|Period 2||0
5141646|NCT01358968|12646339|P3|STARTED|Period 2||0
5141647|NCT01358968|12646340|P2|STARTED|Period 2||20
5141648|NCT01358968|12646341|P1|STARTED|Period 2||0
5141649|NCT01358968|12646338|P4|NOT COMPLETED|Period 1||0
5141650|NCT01358968|12646339|P3|NOT COMPLETED|Period 1||0
5141651|NCT01358968|12646340|P2|NOT COMPLETED|Period 1||0
5141652|NCT01358968|12646341|P1|NOT COMPLETED|Period 1||0
5141653|NCT01358968|12646338|P4|COMPLETED|Period 1||0
5141654|NCT01358968|12646339|P3|COMPLETED|Period 1||0
5141655|NCT01358968|12646340|P2|COMPLETED|Period 1||0
5141656|NCT01358968|12646341|P1|COMPLETED|Period 1||20
5141657|NCT01358968|12646338|P4|Received at Least 1 Dose of Study Drug|Period 1||0
5141658|NCT01358968|12646339|P3|Received at Least 1 Dose of Study Drug|Period 1||0
5141659|NCT01358968|12646340|P2|Received at Least 1 Dose of Study Drug|Period 1||0
5141660|NCT01358968|12646341|P1|Received at Least 1 Dose of Study Drug|Period 1||20
5141661|NCT01358968|12646338|P4|STARTED|Period 1||0
5141662|NCT01358968|12646339|P3|STARTED|Period 1||0
5141663|NCT01358968|12646340|P2|STARTED|Period 1||0
5141664|NCT01358968|12646341|P1|STARTED|Period 1||20
5141665|NCT01358877|12646357|P2|NOT COMPLETED|Overall Study||2404
5141666|NCT01358877|12646358|P1|NOT COMPLETED|Overall Study||2400
5141667|NCT01358877|12646357|P2|COMPLETED|Overall Study||0
5141668|NCT01358877|12646358|P1|COMPLETED|Overall Study||0
5141669|NCT01358877|12646357|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
5141670|NCT01358877|12646358|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
5141671|NCT01358877|12646357|P2|Did Not Receive Study Drug|Overall Study||13
5141672|NCT01358877|12646358|P1|Did Not Receive Study Drug|Overall Study||22
5141673|NCT01358877|12646357|P2|STARTED|Overall Study||2404
5141674|NCT01358877|12646358|P1|STARTED|Overall Study||2400
5141675|NCT01358864|12646428|P8|NOT COMPLETED|Overall Study||55
5141676|NCT01358864|12646429|P7|NOT COMPLETED|Overall Study||65
5141677|NCT01358864|12646430|P6|NOT COMPLETED|Overall Study||13
5141678|NCT01358864|12646431|P5|NOT COMPLETED|Overall Study||11
5141679|NCT01358864|12646432|P4|NOT COMPLETED|Overall Study||19
5141680|NCT01358864|12646433|P3|NOT COMPLETED|Overall Study||16
5141681|NCT01358864|12646434|P2|NOT COMPLETED|Overall Study||13
5141682|NCT01358864|12646435|P1|NOT COMPLETED|Overall Study||31
5141683|NCT01358864|12646428|P8|COMPLETED|Overall Study||85
5141684|NCT01358864|12646429|P7|COMPLETED|Overall Study||81
5141685|NCT01358864|12646430|P6|COMPLETED|Overall Study||42
5141686|NCT01358864|12646431|P5|COMPLETED|Overall Study||46
5141687|NCT01358864|12646432|P4|COMPLETED|Overall Study||10
5141688|NCT01358864|12646433|P3|COMPLETED|Overall Study||87
5141689|NCT01358864|12646434|P2|COMPLETED|Overall Study||86
5141690|NCT01358864|12646435|P1|COMPLETED|Overall Study||18
5141691|NCT01358864|12646428|P8|STARTED|Overall Study||140
5141692|NCT01358864|12646429|P7|STARTED|Overall Study||146
5141693|NCT01358864|12646430|P6|STARTED|Overall Study||55
5141694|NCT01358864|12646431|P5|STARTED|Overall Study||57
5141695|NCT01358864|12646432|P4|STARTED|Overall Study||29
5141696|NCT01358864|12646433|P3|STARTED|Overall Study||103
5141697|NCT01358864|12646434|P2|STARTED|Overall Study||99
5141698|NCT01358864|12646435|P1|STARTED|Overall Study||49
5141699|NCT01358825|12646526|P2|NOT COMPLETED|Overall Study||1
5141700|NCT01358825|12646527|P1|NOT COMPLETED|Overall Study||0
5141701|NCT01358825|12646526|P2|COMPLETED|Overall Study||45
5141702|NCT01358825|12646527|P1|COMPLETED|Overall Study||12
5141703|NCT01358825|12646526|P2|STARTED|Overall Study||46
5141704|NCT01358825|12646527|P1|STARTED|Overall Study||12
5141705|NCT01358760|12646551|P3|NOT COMPLETED|Overall Study||25
5141706|NCT01358760|12646552|P2|NOT COMPLETED|Overall Study||20
5141707|NCT01358760|12646553|P1|NOT COMPLETED|Overall Study||22
5141708|NCT01358760|12646551|P3|COMPLETED|Overall Study||125
5141709|NCT01358760|12646552|P2|COMPLETED|Overall Study||128
5141710|NCT01358760|12646553|P1|COMPLETED|Overall Study||130
5141711|NCT01358760|12646551|P3|ITT Population|Overall Study||134
5141712|NCT01358760|12646552|P2|ITT Population|Overall Study||134
5141713|NCT01358760|12646553|P1|ITT Population|Overall Study||139
5141714|NCT01358760|12646551|P3|Safety Population|Overall Study||148
5141715|NCT01358760|12646552|P2|Safety Population|Overall Study||143
5141716|NCT01358760|12646553|P1|Safety Population|Overall Study||150
5141717|NCT01358760|12646551|P3|STARTED|Overall Study||150
5141718|NCT01358760|12646552|P2|STARTED|Overall Study||148
5141719|NCT01358760|12646553|P1|STARTED|Overall Study||152
5141720|NCT01358734|12646588|P3|NOT COMPLETED|Overall Study||34
5141721|NCT01358734|12646589|P2|NOT COMPLETED|Overall Study||39
5141722|NCT01358734|12646590|P1|NOT COMPLETED|Overall Study||15
5141723|NCT01358734|12646588|P3|COMPLETED|Overall Study||0
5141724|NCT01358734|12646589|P2|COMPLETED|Overall Study||0
5141725|NCT01358734|12646590|P1|COMPLETED|Overall Study||0
5141726|NCT01358734|12646588|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
5141727|NCT01358734|12646589|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
5141728|NCT01358734|12646590|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
5141729|NCT01358734|12646588|P3|STARTED|Overall Study||34
5141730|NCT01358734|12646589|P2|STARTED|Overall Study||39
5141731|NCT01358734|12646590|P1|STARTED|Overall Study||15
5141732|NCT01358721|12646638|P4|NOT COMPLETED|Overall Study||24
5141733|NCT01358721|12646639|P3|NOT COMPLETED|Overall Study||22
5141734|NCT01358721|12646640|P2|NOT COMPLETED|Overall Study||22
5141735|NCT01358721|12646641|P1|NOT COMPLETED|Overall Study||21
5141736|NCT01358721|12646638|P4|COMPLETED|Overall Study||0
5141737|NCT01358721|12646639|P3|COMPLETED|Overall Study||1
5141738|NCT01358721|12646640|P2|COMPLETED|Overall Study||0
5141739|NCT01358721|12646641|P1|COMPLETED|Overall Study||1
5141740|NCT01358721|12646638|P4|STARTED|Overall Study||24
5141741|NCT01358721|12646639|P3|STARTED|Overall Study||23
5141742|NCT01358721|12646640|P2|STARTED|Overall Study||22
5141743|NCT01358721|12646641|P1|STARTED|Overall Study||22
5141744|NCT01358708|12646693|P2|NOT COMPLETED|Open-Label Treatment Phase||0
5141745|NCT01358708|12646694|P1|NOT COMPLETED|Open-Label Treatment Phase||0
5141746|NCT01358708|12646693|P2|COMPLETED|Open-Label Treatment Phase||12
5141747|NCT01358708|12646694|P1|COMPLETED|Open-Label Treatment Phase||5
5141748|NCT01358708|12646693|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
5141749|NCT01358708|12646694|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
5141750|NCT01358708|12646693|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
5141751|NCT01358708|12646694|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
5141752|NCT01358708|12646693|P2|COMPLETED|Double-Blind Treatment Phase||13
5141753|NCT01358708|12646694|P1|COMPLETED|Double-Blind Treatment Phase||10
5141754|NCT01358708|12646693|P2|Received Study Medication|Double-Blind Treatment Phase||13
5141755|NCT01358708|12646694|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
5141756|NCT01358708|12646693|P2|Randomized|Double-Blind Treatment Phase||13
5141757|NCT01358708|12646694|P1|Randomized|Double-Blind Treatment Phase||13
5141758|NCT01358708|12646693|P2|STARTED|Double-Blind Treatment Phase||13
5141759|NCT01358708|12646694|P1|STARTED|Double-Blind Treatment Phase||13
5141760|NCT01358578|12646717|P6|NOT COMPLETED|Follow-up Period||0
5141761|NCT01358578|12646718|P5|NOT COMPLETED|Follow-up Period||0
5141762|NCT01358578|12646719|P4|NOT COMPLETED|Follow-up Period||19
5141763|NCT01358578|12646720|P3|NOT COMPLETED|Follow-up Period||5
5141764|NCT01358578|12646721|P2|NOT COMPLETED|Follow-up Period||6
5141765|NCT01358578|12646722|P1|NOT COMPLETED|Follow-up Period||10
5141766|NCT01358578|12646717|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
5141767|NCT01358578|12646718|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
5141768|NCT01358578|12646719|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
5141769|NCT01358578|12646720|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
5141770|NCT01358578|12646721|P2|COMPLETED|Follow-up Period||119
5141771|NCT01358578|12646722|P1|COMPLETED|Follow-up Period||138
5141772|NCT01358578|12646717|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
5141773|NCT01358578|12646718|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
5141774|NCT01358578|12646719|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
5141775|NCT01358578|12646720|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
5141776|NCT01358578|12646721|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
5141777|NCT01358578|12646722|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
5141778|NCT01358578|12646717|P6|NOT COMPLETED|Maintenance Period||11
5141779|NCT01358578|12646718|P5|NOT COMPLETED|Maintenance Period||17
5141780|NCT01358578|12646719|P4|NOT COMPLETED|Maintenance Period||42
5141781|NCT01358578|12646720|P3|NOT COMPLETED|Maintenance Period||2
5141782|NCT01358578|12646721|P2|NOT COMPLETED|Maintenance Period||22
5141783|NCT01358578|12646722|P1|NOT COMPLETED|Maintenance Period||39
5141784|NCT01358578|12646717|P6|COMPLETED|Maintenance Period||131
5141785|NCT01358578|12646718|P5|COMPLETED|Maintenance Period||125
5141786|NCT01358578|12646719|P4|COMPLETED|Maintenance Period||263
5141787|NCT01358578|12646720|P3|COMPLETED|Maintenance Period||15
5141788|NCT01358578|12646721|P2|COMPLETED|Maintenance Period||290
5141789|NCT01358578|12646722|P1|COMPLETED|Maintenance Period||276
5141790|NCT01358578|12646717|P6|STARTED|Maintenance Period||142
5141791|NCT01358578|12646718|P5|STARTED|Maintenance Period||142
5141792|NCT01358578|12646719|P4|STARTED|Maintenance Period||305
5141793|NCT01358578|12646720|P3|STARTED|Maintenance Period||17
5141794|NCT01358578|12646721|P2|STARTED|Maintenance Period||312
5141795|NCT01358578|12646722|P1|STARTED|Maintenance Period||315
5141796|NCT01358578|12646717|P6|NOT COMPLETED|Induction Period||0
5141797|NCT01358578|12646718|P5|NOT COMPLETED|Induction Period||0
5141798|NCT01358578|12646719|P4|NOT COMPLETED|Induction Period||21
5141799|NCT01358578|12646720|P3|NOT COMPLETED|Induction Period||25
5141800|NCT01358578|12646721|P2|NOT COMPLETED|Induction Period||15
5141801|NCT01358578|12646722|P1|NOT COMPLETED|Induction Period||12
5141802|NCT01358578|12646717|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
5141803|NCT01358578|12646718|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
5141804|NCT01358578|12646719|P4|COMPLETED|Induction Period||305
5141805|NCT01358578|12646720|P3|COMPLETED|Induction Period||301
5141806|NCT01358578|12646721|P2|COMPLETED|Induction Period||312
5141807|NCT01358578|12646722|P1|COMPLETED|Induction Period||315
5141808|NCT01358578|12646717|P6|STARTED|Induction Period|These groups are populated after the induction period|0
5141809|NCT01358578|12646718|P5|STARTED|Induction Period|These groups are populated after the induction period|0
5141810|NCT01358578|12646719|P4|STARTED|Induction Period||326
5141811|NCT01358578|12646720|P3|STARTED|Induction Period||326
5141812|NCT01358578|12646721|P2|STARTED|Induction Period||327
5141813|NCT01358578|12646722|P1|STARTED|Induction Period||327
5141814|NCT01358526|12646774|P3|NOT COMPLETED|Double-blind Phase||121
5141815|NCT01358526|12646775|P2|NOT COMPLETED|Double-blind Phase||80
5141816|NCT01358526|12646776|P1|NOT COMPLETED|Double-blind Phase||0
5141817|NCT01358526|12646774|P3|COMPLETED|Double-blind Phase||181
5141818|NCT01358526|12646775|P2|COMPLETED|Double-blind Phase||218
5141819|NCT01358526|12646776|P1|COMPLETED|Double-blind Phase||0
5141820|NCT01358526|12646774|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
5141821|NCT01358526|12646775|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
5141822|NCT01358526|12646776|P1|STARTED|Double-blind Phase||0
5141823|NCT01358526|12646774|P3|NOT COMPLETED|Open-label Titration Period||0
5141824|NCT01358526|12646775|P2|NOT COMPLETED|Open-label Titration Period||0
5141825|NCT01358526|12646776|P1|NOT COMPLETED|Open-label Titration Period||494
5141826|NCT01358526|12646774|P3|COMPLETED|Open-label Titration Period||0
5141827|NCT01358526|12646775|P2|COMPLETED|Open-label Titration Period||0
5141828|NCT01358526|12646776|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
5141829|NCT01358526|12646774|P3|STARTED|Open-label Titration Period||0
5141830|NCT01358526|12646775|P2|STARTED|Open-label Titration Period||0
5141831|NCT01358526|12646776|P1|STARTED|Open-label Titration Period||1095
5141832|NCT01358357|12646793|P3|NOT COMPLETED|Double-Blind Phase||0
5141833|NCT01358357|12646794|P2|NOT COMPLETED|Double-Blind Phase||100
5141834|NCT01358357|12646795|P1|NOT COMPLETED|Double-Blind Phase||80
5141835|NCT01358357|12646793|P3|COMPLETED|Double-Blind Phase||0
5141836|NCT01358357|12646794|P2|COMPLETED|Double-Blind Phase||150
5141837|NCT01358357|12646795|P1|COMPLETED|Double-Blind Phase||166
5141838|NCT01358357|12646793|P3|STARTED|Double-Blind Phase||0
5141839|NCT01358357|12646794|P2|STARTED|Double-Blind Phase||250
5141840|NCT01358357|12646795|P1|STARTED|Double-Blind Phase||246
5141841|NCT01358357|12646793|P3|NOT COMPLETED|Open Label Phase||462
5141842|NCT01358357|12646794|P2|NOT COMPLETED|Open Label Phase||0
5141843|NCT01358357|12646795|P1|NOT COMPLETED|Open Label Phase||0
5141844|NCT01358357|12646793|P3|COMPLETED|Open Label Phase||503
5141845|NCT01358357|12646794|P2|COMPLETED|Open Label Phase||0
5141846|NCT01358357|12646795|P1|COMPLETED|Open Label Phase||0
5141847|NCT01358357|12646793|P3|STARTED|Open Label Phase||965
5141848|NCT01358357|12646794|P2|STARTED|Open Label Phase||0
5141849|NCT01358357|12646795|P1|STARTED|Open Label Phase||0
5141850|NCT01358331|12646834|P6|NOT COMPLETED|Overall Study||6
5141851|NCT01358331|12646835|P5|NOT COMPLETED|Overall Study||7
5141852|NCT01358331|12646836|P4|NOT COMPLETED|Overall Study||3
5141853|NCT01358331|12646837|P3|NOT COMPLETED|Overall Study||4
5141854|NCT01358331|12646838|P2|NOT COMPLETED|Overall Study||3
5141855|NCT01358331|12646839|P1|NOT COMPLETED|Overall Study||2
5141856|NCT01358331|12646834|P6|COMPLETED|Overall Study||0
5141857|NCT01358331|12646835|P5|COMPLETED|Overall Study||0
5141858|NCT01358331|12646836|P4|COMPLETED|Overall Study||0
5141859|NCT01358331|12646837|P3|COMPLETED|Overall Study||0
5141860|NCT01358331|12646838|P2|COMPLETED|Overall Study||0
5141861|NCT01358331|12646839|P1|COMPLETED|Overall Study||0
5141862|NCT01358331|12646834|P6|STARTED|Overall Study||6
5141863|NCT01358331|12646835|P5|STARTED|Overall Study||7
5141864|NCT01358331|12646836|P4|STARTED|Overall Study||3
5141865|NCT01358331|12646837|P3|STARTED|Overall Study||4
5141866|NCT01358331|12646838|P2|STARTED|Overall Study||3
5141867|NCT01358331|12646839|P1|STARTED|Overall Study||2
5141868|NCT01358266|12646862|P3|NOT COMPLETED|Open-Label Period||70
5141869|NCT01358266|12646863|P2|NOT COMPLETED|Open-Label Period||44
5141870|NCT01358266|12646864|P1|NOT COMPLETED|Open-Label Period||56
5141871|NCT01358266|12646862|P3|COMPLETED|Open-Label Period||44
5141872|NCT01358266|12646863|P2|COMPLETED|Open-Label Period||58
5141873|NCT01358266|12646864|P1|COMPLETED|Open-Label Period||63
5141874|NCT01358266|12646862|P3|STARTED|Open-Label Period||114
5141875|NCT01358266|12646863|P2|STARTED|Open-Label Period||102
5141876|NCT01358266|12646864|P1|STARTED|Open-Label Period||119
5141877|NCT01358266|12646862|P3|NOT COMPLETED|Double-Masked Period||39
5141878|NCT01358266|12646863|P2|NOT COMPLETED|Double-Masked Period||46
5141879|NCT01358266|12646864|P1|NOT COMPLETED|Double-Masked Period||33
5141880|NCT01358266|12646862|P3|COMPLETED|Double-Masked Period||137
5141881|NCT01358266|12646863|P2|COMPLETED|Double-Masked Period||162
5141882|NCT01358266|12646864|P1|COMPLETED|Double-Masked Period||175
5141883|NCT01358266|12646862|P3|STARTED|Double-Masked Period||176
5141884|NCT01358266|12646863|P2|STARTED|Double-Masked Period||208
5141885|NCT01358266|12646864|P1|STARTED|Double-Masked Period||208
5141886|NCT01358175|12646891|P3|NOT COMPLETED|Overall Study||32
5141887|NCT01358175|12646892|P2|NOT COMPLETED|Overall Study||28
5141888|NCT01358175|12646893|P1|NOT COMPLETED|Overall Study||21
5141889|NCT01358175|12646891|P3|COMPLETED|Overall Study||90
5141890|NCT01358175|12646892|P2|COMPLETED|Overall Study||97
5141891|NCT01358175|12646893|P1|COMPLETED|Overall Study||103
5141892|NCT01358175|12646891|P3|STARTED|Overall Study||122
5141893|NCT01358175|12646892|P2|STARTED|Overall Study||125
5141894|NCT01358175|12646893|P1|STARTED|Overall Study||124
5141895|NCT01357980|12646930|P4|NOT COMPLETED|Overall Study||0
5141896|NCT01357980|12646931|P3|NOT COMPLETED|Overall Study||1
5141897|NCT01357980|12646932|P2|NOT COMPLETED|Overall Study||1
5141898|NCT01357980|12646933|P1|NOT COMPLETED|Overall Study||0
5141899|NCT01357980|12646930|P4|COMPLETED|Overall Study||7
5141900|NCT01357980|12646931|P3|COMPLETED|Overall Study||16
5141901|NCT01357980|12646932|P2|COMPLETED|Overall Study||6
5141902|NCT01357980|12646933|P1|COMPLETED|Overall Study||16
5141903|NCT01357980|12646930|P4|STARTED|Overall Study||7
5141904|NCT01357980|12646931|P3|STARTED|Overall Study||17
5141905|NCT01357980|12646932|P2|STARTED|Overall Study||7
5141906|NCT01357980|12646933|P1|STARTED|Overall Study||16
5141907|NCT01357915|12646977|P2|NOT COMPLETED|Overall Study||0
5141908|NCT01357915|12646978|P1|NOT COMPLETED|Overall Study||3
5141909|NCT01357915|12646977|P2|COMPLETED|Overall Study||17
5141910|NCT01357915|12646978|P1|COMPLETED|Overall Study||27
5141911|NCT01357915|12646977|P2|STARTED|Overall Study||17
5141912|NCT01357915|12646978|P1|STARTED|Overall Study||30
5141913|NCT01357889|12646996|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
5141914|NCT01357889|12646997|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
5141915|NCT01357889|12646996|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
5141916|NCT01357889|12646997|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
5141917|NCT01357889|12646996|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
5141918|NCT01357889|12646997|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
5141919|NCT01357889|12646996|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
5141920|NCT01357889|12646997|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
5141921|NCT01357889|12646996|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
5141922|NCT01357889|12646997|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
5141923|NCT01357889|12646996|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
5141924|NCT01357889|12646997|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
5141925|NCT01357889|12646996|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
5141926|NCT01357889|12646997|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
5141927|NCT01357889|12646996|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
5141928|NCT01357889|12646997|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
5141929|NCT01357889|12646996|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
5141930|NCT01357889|12646997|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
5141931|NCT01357850|12647041|P4|NOT COMPLETED|Overall Study||0
5141932|NCT01357850|12647042|P3|NOT COMPLETED|Overall Study||0
5141933|NCT01357850|12647043|P2|NOT COMPLETED|Overall Study||0
5141934|NCT01357850|12647044|P1|NOT COMPLETED|Overall Study||1
5141935|NCT01357850|12647041|P4|COMPLETED|Overall Study||27
5141936|NCT01357850|12647042|P3|COMPLETED|Overall Study||13
5141937|NCT01357850|12647043|P2|COMPLETED|Overall Study||12
5141938|NCT01357850|12647044|P1|COMPLETED|Overall Study||29
5141939|NCT01357850|12647041|P4|STARTED|Overall Study||27
5141940|NCT01357850|12647042|P3|STARTED|Overall Study||13
5141941|NCT01357850|12647043|P2|STARTED|Overall Study||12
5141942|NCT01357850|12647044|P1|STARTED|Overall Study||30
5141943|NCT01357720|12647118|P2|NOT COMPLETED|Overall Study||5
5141944|NCT01357720|12647119|P1|NOT COMPLETED|Overall Study||2
5141945|NCT01357720|12647118|P2|COMPLETED|Overall Study||195
5141946|NCT01357720|12647119|P1|COMPLETED|Overall Study||198
5141947|NCT01357720|12647118|P2|STARTED|Overall Study||200
5141948|NCT01357720|12647119|P1|STARTED|Overall Study||200
5141949|NCT01357655|12647135|P2|NOT COMPLETED|Overall Study||0
5141950|NCT01357655|12647136|P1|NOT COMPLETED|Overall Study||66
5141951|NCT01357655|12647135|P2|COMPLETED|Overall Study||0
5141952|NCT01357655|12647136|P1|COMPLETED|Overall Study||0
5141953|NCT01357655|12647135|P2|STARTED|Overall Study||0
5141954|NCT01357655|12647136|P1|STARTED|Overall Study||66
5141955|NCT01357616|12647153|P2|NOT COMPLETED|Overall Study||9
5141956|NCT01357616|12647154|P1|NOT COMPLETED|Overall Study||10
5141957|NCT01357616|12647153|P2|COMPLETED|Overall Study||153
5141958|NCT01357616|12647154|P1|COMPLETED|Overall Study||156
5141959|NCT01357616|12647153|P2|STARTED|Overall Study||162
5141960|NCT01357616|12647154|P1|STARTED|Overall Study||166
5141961|NCT01357577|12647168|P2|NOT COMPLETED|Overall Study||26
5141962|NCT01357577|12647169|P1|NOT COMPLETED|Overall Study||37
5141963|NCT01357577|12647168|P2|COMPLETED|Overall Study||39
5141964|NCT01357577|12647169|P1|COMPLETED|Overall Study||27
5141965|NCT01357577|12647168|P2|Post-Treatment Assessment Completed|Overall Study||39
5141966|NCT01357577|12647169|P1|Post-Treatment Assessment Completed|Overall Study||24
5141967|NCT01357577|12647168|P2|STARTED|Overall Study||65
5141968|NCT01357577|12647169|P1|STARTED|Overall Study||64
5141969|NCT01357564|12647185|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
5141970|NCT01357564|12647186|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
5141971|NCT01357564|12647185|P2|COMPLETED|Long-term (8-month) Follow-up||102
5141972|NCT01357564|12647186|P1|COMPLETED|Long-term (8-month) Follow-up||104
5141973|NCT01357564|12647185|P2|STARTED|Long-term (8-month) Follow-up||118
5141974|NCT01357564|12647186|P1|STARTED|Long-term (8-month) Follow-up||106
5141975|NCT01357564|12647185|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
5141976|NCT01357564|12647186|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
5141977|NCT01357564|12647185|P2|COMPLETED|Short-term (4-month) Follow up||118
5141978|NCT01357564|12647186|P1|COMPLETED|Short-term (4-month) Follow up||106
5141979|NCT01357564|12647185|P2|STARTED|Short-term (4-month) Follow up||168
5141980|NCT01357564|12647186|P1|STARTED|Short-term (4-month) Follow up||154
5141981|NCT01357551|12647196|P2|NOT COMPLETED|Overall Study||11
5141982|NCT01357551|12647197|P1|NOT COMPLETED|Overall Study||22
5141983|NCT01357551|12647196|P2|COMPLETED|Overall Study||101
5141984|NCT01357551|12647197|P1|COMPLETED|Overall Study||88
5141985|NCT01357551|12647196|P2|STARTED|Overall Study||112
5141986|NCT01357551|12647197|P1|STARTED|Overall Study||110
5141987|NCT01357512|12647211|P2|NOT COMPLETED|Overall Study||5
5141988|NCT01357512|12647212|P1|NOT COMPLETED|Overall Study||12
5141989|NCT01357512|12647211|P2|COMPLETED|Overall Study||60
5141990|NCT01357512|12647212|P1|COMPLETED|Overall Study||53
5141991|NCT01357512|12647211|P2|STARTED|Overall Study||65
5141992|NCT01357512|12647212|P1|STARTED|Overall Study||65
5141993|NCT01357239|12647224|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
5141994|NCT01357239|12647225|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
5141995|NCT01357239|12647226|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
5141996|NCT01357239|12647227|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
5141997|NCT01357239|12647224|P4|COMPLETED|Stratum II: Partially-Methylated||18
5141998|NCT01357239|12647225|P3|COMPLETED|Stratum II: Partially-Methylated||21
5141999|NCT01357239|12647226|P2|COMPLETED|Stratum II: Partially-Methylated||21
5142000|NCT01357239|12647227|P1|COMPLETED|Stratum II: Partially-Methylated||23
5142001|NCT01357239|12647224|P4|STARTED|Stratum II: Partially-Methylated||20
5142002|NCT01357239|12647225|P3|STARTED|Stratum II: Partially-Methylated||22
5142003|NCT01357239|12647226|P2|STARTED|Stratum II: Partially-Methylated||21
5142004|NCT01357239|12647227|P1|STARTED|Stratum II: Partially-Methylated||23
5142005|NCT01357239|12647224|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
5142006|NCT01357239|12647225|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
5142007|NCT01357239|12647226|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
5142008|NCT01357239|12647227|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
5142009|NCT01357239|12647224|P4|COMPLETED|Stratum I: Fully-Methylated||22
5142010|NCT01357239|12647225|P3|COMPLETED|Stratum I: Fully-Methylated||16
5142011|NCT01357239|12647226|P2|COMPLETED|Stratum I: Fully-Methylated||6
5142012|NCT01357239|12647227|P1|COMPLETED|Stratum I: Fully-Methylated||8
5142013|NCT01357239|12647224|P4|STARTED|Stratum I: Fully-Methylated||22
5142014|NCT01357239|12647225|P3|STARTED|Stratum I: Fully-Methylated||17
5142015|NCT01357239|12647226|P2|STARTED|Stratum I: Fully-Methylated||6
5142016|NCT01357239|12647227|P1|STARTED|Stratum I: Fully-Methylated||8
5142017|NCT01357239|12647224|P4|NOT COMPLETED|Stratum: All Patients||2
5142018|NCT01357239|12647225|P3|NOT COMPLETED|Stratum: All Patients||2
5142019|NCT01357239|12647226|P2|NOT COMPLETED|Stratum: All Patients||0
5142020|NCT01357239|12647227|P1|NOT COMPLETED|Stratum: All Patients||0
5142021|NCT01357239|12647224|P4|COMPLETED|Stratum: All Patients||40
5142022|NCT01357239|12647225|P3|COMPLETED|Stratum: All Patients||37
5142023|NCT01357239|12647226|P2|COMPLETED|Stratum: All Patients||27
5142024|NCT01357239|12647227|P1|COMPLETED|Stratum: All Patients||31
5142025|NCT01357239|12647224|P4|STARTED|Stratum: All Patients||42
5142026|NCT01357239|12647225|P3|STARTED|Stratum: All Patients||39
5142027|NCT01357239|12647226|P2|STARTED|Stratum: All Patients||27
5142028|NCT01357239|12647227|P1|STARTED|Stratum: All Patients||31
5142029|NCT01357161|12647285|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
5142030|NCT01357161|12647286|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
5142031|NCT01357161|12647287|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
5142032|NCT01357161|12647285|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
5142033|NCT01357161|12647286|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
5142034|NCT01357161|12647287|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
5142035|NCT01357161|12647285|P3|Treated|Part 2 (Double-Blind Comparison)||60
5142036|NCT01357161|12647286|P2|Treated|Part 2 (Double-Blind Comparison)||59
5142037|NCT01357161|12647287|P1|Treated|Part 2 (Double-Blind Comparison)||0
5142038|NCT01357161|12647285|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
5142039|NCT01357161|12647286|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
5142040|NCT01357161|12647287|P1|STARTED|Part 2 (Double-Blind Comparison)||0
5142041|NCT01357161|12647285|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
5142042|NCT01357161|12647286|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
5142043|NCT01357161|12647287|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
5142044|NCT01357161|12647285|P3|COMPLETED|Part 1 (Open Label Run-in)||0
5142045|NCT01357161|12647286|P2|COMPLETED|Part 1 (Open Label Run-in)||0
5142046|NCT01357161|12647287|P1|COMPLETED|Part 1 (Open Label Run-in)||0
5142047|NCT01357161|12647285|P3|STARTED|Part 1 (Open Label Run-in)||0
5142048|NCT01357161|12647286|P2|STARTED|Part 1 (Open Label Run-in)||0
5142049|NCT01357161|12647287|P1|STARTED|Part 1 (Open Label Run-in)||15
5142050|NCT01357148|12647316|P1|NOT COMPLETED|Overall Study||0
5142051|NCT01357148|12647316|P1|COMPLETED|Overall Study||143
5142052|NCT01357148|12647316|P1|STARTED|Overall Study||143
5142053|NCT01357135|12647326|P3|NOT COMPLETED|Overall Study||263
5142054|NCT01357135|12647327|P2|NOT COMPLETED|Overall Study||223
5142055|NCT01357135|12647328|P1|NOT COMPLETED|Overall Study||598
5142056|NCT01357135|12647326|P3|COMPLETED|Overall Study||583
5142057|NCT01357135|12647327|P2|COMPLETED|Overall Study||510
5142058|NCT01357135|12647328|P1|COMPLETED|Overall Study||1276
5142059|NCT01357135|12647326|P3|STARTED|Overall Study||846
5142060|NCT01357135|12647327|P2|STARTED|Overall Study||733
5142061|NCT01357135|12647328|P1|STARTED|Overall Study||1874
5142062|NCT01356966|12647339|P2|NOT COMPLETED|Overall Study||2
5142063|NCT01356966|12647340|P1|NOT COMPLETED|Overall Study||2
5142064|NCT01356966|12647339|P2|COMPLETED|Overall Study||12
5142065|NCT01356966|12647340|P1|COMPLETED|Overall Study||16
5142066|NCT01356966|12647339|P2|STARTED|Overall Study||14
5142067|NCT01356966|12647340|P1|STARTED|Overall Study||18
5142068|NCT01356940|12647352|P2|NOT COMPLETED|Second Intervention (28 Days)||0
5142069|NCT01356940|12647353|P1|NOT COMPLETED|Second Intervention (28 Days)||1
5142070|NCT01356940|12647352|P2|COMPLETED|Second Intervention (28 Days)||21
5142071|NCT01356940|12647353|P1|COMPLETED|Second Intervention (28 Days)||20
5142072|NCT01356940|12647352|P2|STARTED|Second Intervention (28 Days)||21
5142073|NCT01356940|12647353|P1|STARTED|Second Intervention (28 Days)||21
5142074|NCT01356940|12647352|P2|NOT COMPLETED|Washout (14 Days)||0
5142075|NCT01356940|12647353|P1|NOT COMPLETED|Washout (14 Days)||0
5142076|NCT01356940|12647352|P2|COMPLETED|Washout (14 Days)||21
5142077|NCT01356940|12647353|P1|COMPLETED|Washout (14 Days)||21
5142078|NCT01356940|12647352|P2|STARTED|Washout (14 Days)||21
5142079|NCT01356940|12647353|P1|STARTED|Washout (14 Days)||21
5142080|NCT01356940|12647352|P2|NOT COMPLETED|First Intervention (28 Days)||0
5142081|NCT01356940|12647353|P1|NOT COMPLETED|First Intervention (28 Days)||1
5142082|NCT01356940|12647352|P2|COMPLETED|First Intervention (28 Days)||21
5142083|NCT01356940|12647353|P1|COMPLETED|First Intervention (28 Days)||21
5142084|NCT01356940|12647352|P2|STARTED|First Intervention (28 Days)||21
5142085|NCT01356940|12647353|P1|STARTED|First Intervention (28 Days)||22
5142086|NCT01356667|12647363|P2|NOT COMPLETED|Overall Study||6
5142087|NCT01356667|12647364|P1|NOT COMPLETED|Overall Study||4
5142088|NCT01356667|12647363|P2|COMPLETED|Overall Study||0
5142089|NCT01356667|12647364|P1|COMPLETED|Overall Study||0
5142090|NCT01356667|12647363|P2|STARTED|Overall Study||6
5142091|NCT01356667|12647364|P1|STARTED|Overall Study||4
5142092|NCT01356628|12647374|P1|NOT COMPLETED|Overall Study||0
5142093|NCT01356628|12647374|P1|COMPLETED|Overall Study||23
5142094|NCT01356628|12647374|P1|STARTED|Overall Study||23
5142095|NCT01356602|12647382|P3|NOT COMPLETED|Overall Study||24
5142096|NCT01356602|12647383|P2|NOT COMPLETED|Overall Study||15
5142097|NCT01356602|12647384|P1|NOT COMPLETED|Overall Study||9
5142098|NCT01356602|12647382|P3|COMPLETED|Overall Study||108
5142099|NCT01356602|12647383|P2|COMPLETED|Overall Study||117
5142100|NCT01356602|12647384|P1|COMPLETED|Overall Study||124
5142101|NCT01356602|12647382|P3|Full Analysis Set|Overall Study||129
5142102|NCT01356602|12647383|P2|Full Analysis Set|Overall Study||129
5142103|NCT01356602|12647384|P1|Full Analysis Set|Overall Study||131
5142104|NCT01356602|12647382|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
5142105|NCT01356602|12647383|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
5142106|NCT01356602|12647384|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
5142107|NCT01356602|12647382|P3|STARTED|Overall Study||132
5142108|NCT01356602|12647383|P2|STARTED|Overall Study||132
5142109|NCT01356602|12647384|P1|STARTED|Overall Study||133
5142110|NCT01356589|12647443|P1|NOT COMPLETED|Overall Study||5
5142111|NCT01356589|12647443|P1|COMPLETED|Overall Study||1283
5142112|NCT01356589|12647443|P1|Treated|Overall Study||1285
5142113|NCT01356589|12647443|P1|STARTED|Overall Study||1288
5142114|NCT01356498|12647455|P6|NOT COMPLETED|Overall Study||14
5142115|NCT01356498|12647456|P5|NOT COMPLETED|Overall Study||20
5142116|NCT01356498|12647457|P4|NOT COMPLETED|Overall Study||14
5142117|NCT01356498|12647458|P3|NOT COMPLETED|Overall Study||12
5142118|NCT01356498|12647459|P2|NOT COMPLETED|Overall Study||8
5142119|NCT01356498|12647460|P1|NOT COMPLETED|Overall Study||11
5142120|NCT01356498|12647455|P6|COMPLETED|Overall Study||2
5142121|NCT01356498|12647456|P5|COMPLETED|Overall Study||8
5142122|NCT01356498|12647457|P4|COMPLETED|Overall Study||8
5142123|NCT01356498|12647458|P3|COMPLETED|Overall Study||11
5142124|NCT01356498|12647459|P2|COMPLETED|Overall Study||17
5142125|NCT01356498|12647460|P1|COMPLETED|Overall Study||24
5142126|NCT01356498|12647455|P6|STARTED|Overall Study||16
5142127|NCT01356498|12647456|P5|STARTED|Overall Study||28
5142128|NCT01356498|12647457|P4|STARTED|Overall Study||22
5142129|NCT01356498|12647458|P3|STARTED|Overall Study||23
5142216|NCT01355588|12647596|P3|COMPLETED|Third Intervention (After Washout)||4
5142130|NCT01356498|12647459|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
5142131|NCT01356498|12647460|P1|STARTED|Overall Study||35
5142132|NCT01356407|12647500|P2|NOT COMPLETED|Overall Study||4
5142133|NCT01356407|12647501|P1|NOT COMPLETED|Overall Study||6
5142134|NCT01356407|12647500|P2|COMPLETED|Overall Study||146
5142135|NCT01356407|12647501|P1|COMPLETED|Overall Study||144
5142136|NCT01356407|12647500|P2|STARTED|Overall Study||150
5142137|NCT01356407|12647501|P1|STARTED|Overall Study||150
5142138|NCT01356277|12647519|P2|NOT COMPLETED|Intervention Interval||7
5142139|NCT01356277|12647520|P1|NOT COMPLETED|Intervention Interval||10
5142140|NCT01356277|12647519|P2|COMPLETED|Intervention Interval||81
5142141|NCT01356277|12647520|P1|COMPLETED|Intervention Interval||66
5142142|NCT01356277|12647519|P2|STARTED|Intervention Interval||88
5142143|NCT01356277|12647520|P1|STARTED|Intervention Interval||76
5142144|NCT01356277|12647519|P2|NOT COMPLETED|Run-in||0
5142145|NCT01356277|12647520|P1|NOT COMPLETED|Run-in||5
5142146|NCT01356277|12647519|P2|COMPLETED|Run-in||88
5142147|NCT01356277|12647520|P1|COMPLETED|Run-in||76
5142148|NCT01356277|12647519|P2|STARTED|Run-in||88
5142149|NCT01356277|12647520|P1|STARTED|Run-in||81
5142150|NCT01356147|12647540|P2|NOT COMPLETED|Overall Study||0
5142151|NCT01356147|12647541|P1|NOT COMPLETED|Overall Study||0
5142152|NCT01356147|12647540|P2|COMPLETED|Overall Study||6
5142153|NCT01356147|12647541|P1|COMPLETED|Overall Study||5
5142154|NCT01356147|12647540|P2|STARTED|Overall Study||6
5142155|NCT01356147|12647541|P1|STARTED|Overall Study||5
5142156|NCT01355978|12647551|P1|NOT COMPLETED|Overall Study||4
5142157|NCT01355978|12647551|P1|COMPLETED|Overall Study||18
5142158|NCT01355978|12647551|P1|STARTED|Overall Study||22
5142159|NCT01355796|12647557|P2|NOT COMPLETED|Overall Study||0
5142160|NCT01355796|12647558|P1|NOT COMPLETED|Overall Study||0
5142161|NCT01355796|12647557|P2|COMPLETED|Overall Study||15
5142162|NCT01355796|12647558|P1|COMPLETED|Overall Study||15
5142163|NCT01355796|12647557|P2|Second Intervention for 14 Days|Overall Study||15
5142164|NCT01355796|12647558|P1|Second Intervention for 14 Days|Overall Study||15
5142165|NCT01355796|12647557|P2|Washout Period for 7 Days|Overall Study||15
5142166|NCT01355796|12647558|P1|Washout Period for 7 Days|Overall Study||15
5142167|NCT01355796|12647557|P2|First Intervention for 14 Days|Overall Study||15
5142168|NCT01355796|12647558|P1|First Intervention for 14 Days|Overall Study||15
5142169|NCT01355796|12647557|P2|STARTED|Overall Study||15
5142170|NCT01355796|12647558|P1|STARTED|Overall Study||15
5142171|NCT01355705|12647566|P1|NOT COMPLETED|Overall Study||0
5142172|NCT01355705|12647566|P1|COMPLETED|Overall Study||14
5142173|NCT01355705|12647566|P1|STARTED|Overall Study||14
5142174|NCT01355679|12647573|P1|NOT COMPLETED|Overall Study||2
5142175|NCT01355679|12647573|P1|COMPLETED|Overall Study||14
5142176|NCT01355679|12647573|P1|STARTED|Overall Study||16
5142177|NCT01355627|12647582|P2|NOT COMPLETED|Overall Study||38
5142178|NCT01355627|12647583|P1|NOT COMPLETED|Overall Study||33
5142179|NCT01355627|12647582|P2|COMPLETED|Overall Study||326
5142180|NCT01355627|12647583|P1|COMPLETED|Overall Study||329
5142181|NCT01355627|12647582|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
5142182|NCT01355627|12647583|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
5142183|NCT01355627|12647582|P2|Safety Analysis Set|Overall Study||364
5142184|NCT01355627|12647583|P1|Safety Analysis Set|Overall Study||362
5142185|NCT01355627|12647582|P2|STARTED|Overall Study||364
5142186|NCT01355627|12647583|P1|STARTED|Overall Study||362
5142187|NCT01355588|12647595|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
5142188|NCT01355588|12647596|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
5142189|NCT01355588|12647597|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
5142190|NCT01355588|12647598|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
5142191|NCT01355588|12647595|P4|COMPLETED|Fourth Intervention (After Washout)||4
5142192|NCT01355588|12647596|P3|COMPLETED|Fourth Intervention (After Washout)||4
5142193|NCT01355588|12647597|P2|COMPLETED|Fourth Intervention (After Washout)||4
5142194|NCT01355588|12647598|P1|COMPLETED|Fourth Intervention (After Washout)||4
5142195|NCT01355588|12647595|P4|STARTED|Fourth Intervention (After Washout)||4
5142196|NCT01355588|12647596|P3|STARTED|Fourth Intervention (After Washout)||4
5142197|NCT01355588|12647597|P2|STARTED|Fourth Intervention (After Washout)||4
5142198|NCT01355588|12647598|P1|STARTED|Fourth Intervention (After Washout)||4
5142199|NCT01355588|12647595|P4|NOT COMPLETED|Washout (3-7 Days)||0
5142200|NCT01355588|12647596|P3|NOT COMPLETED|Washout (3-7 Days)||0
5142201|NCT01355588|12647597|P2|NOT COMPLETED|Washout (3-7 Days)||0
5142202|NCT01355588|12647598|P1|NOT COMPLETED|Washout (3-7 Days)||0
5142203|NCT01355588|12647595|P4|COMPLETED|Washout (3-7 Days)||4
5142204|NCT01355588|12647596|P3|COMPLETED|Washout (3-7 Days)||4
5142205|NCT01355588|12647597|P2|COMPLETED|Washout (3-7 Days)||4
5142206|NCT01355588|12647598|P1|COMPLETED|Washout (3-7 Days)||4
5142207|NCT01355588|12647595|P4|STARTED|Washout (3-7 Days)||4
5142208|NCT01355588|12647596|P3|STARTED|Washout (3-7 Days)||4
5142209|NCT01355588|12647597|P2|STARTED|Washout (3-7 Days)||4
5142210|NCT01355588|12647598|P1|STARTED|Washout (3-7 Days)||4
5142211|NCT01355588|12647595|P4|NOT COMPLETED|Third Intervention (After Washout)||0
5142212|NCT01355588|12647596|P3|NOT COMPLETED|Third Intervention (After Washout)||0
5142213|NCT01355588|12647597|P2|NOT COMPLETED|Third Intervention (After Washout)||0
5142214|NCT01355588|12647598|P1|NOT COMPLETED|Third Intervention (After Washout)||0
5142215|NCT01355588|12647595|P4|COMPLETED|Third Intervention (After Washout)||4
5142217|NCT01355588|12647597|P2|COMPLETED|Third Intervention (After Washout)||4
5142218|NCT01355588|12647598|P1|COMPLETED|Third Intervention (After Washout)||4
5142219|NCT01355588|12647595|P4|STARTED|Third Intervention (After Washout)||4
5142220|NCT01355588|12647596|P3|STARTED|Third Intervention (After Washout)||4
5142221|NCT01355588|12647597|P2|STARTED|Third Intervention (After Washout)||4
5142222|NCT01355588|12647598|P1|STARTED|Third Intervention (After Washout)||4
5142223|NCT01355588|12647595|P4|NOT COMPLETED|Washout (3-7 Days)||0
5142224|NCT01355588|12647596|P3|NOT COMPLETED|Washout (3-7 Days)||0
5142225|NCT01355588|12647597|P2|NOT COMPLETED|Washout (3-7 Days)||0
5142226|NCT01355588|12647598|P1|NOT COMPLETED|Washout (3-7 Days)||0
5142227|NCT01355588|12647595|P4|COMPLETED|Washout (3-7 Days)||4
5142228|NCT01355588|12647596|P3|COMPLETED|Washout (3-7 Days)||4
5142229|NCT01355588|12647597|P2|COMPLETED|Washout (3-7 Days)||4
5142230|NCT01355588|12647598|P1|COMPLETED|Washout (3-7 Days)||4
5142231|NCT01355588|12647595|P4|STARTED|Washout (3-7 Days)||4
5142232|NCT01355588|12647596|P3|STARTED|Washout (3-7 Days)||4
5142233|NCT01355588|12647597|P2|STARTED|Washout (3-7 Days)||4
5142234|NCT01355588|12647598|P1|STARTED|Washout (3-7 Days)||4
5142235|NCT01355588|12647595|P4|NOT COMPLETED|Second Intervention (After Washout)||0
5142236|NCT01355588|12647596|P3|NOT COMPLETED|Second Intervention (After Washout)||0
5142237|NCT01355588|12647597|P2|NOT COMPLETED|Second Intervention (After Washout)||0
5142238|NCT01355588|12647598|P1|NOT COMPLETED|Second Intervention (After Washout)||0
5142239|NCT01355588|12647595|P4|COMPLETED|Second Intervention (After Washout)||4
5142240|NCT01355588|12647596|P3|COMPLETED|Second Intervention (After Washout)||4
5142241|NCT01355588|12647597|P2|COMPLETED|Second Intervention (After Washout)||4
5142242|NCT01355588|12647598|P1|COMPLETED|Second Intervention (After Washout)||4
5142243|NCT01355588|12647595|P4|STARTED|Second Intervention (After Washout)||4
5142244|NCT01355588|12647596|P3|STARTED|Second Intervention (After Washout)||4
5142245|NCT01355588|12647597|P2|STARTED|Second Intervention (After Washout)||4
5142246|NCT01355588|12647598|P1|STARTED|Second Intervention (After Washout)||4
5142247|NCT01355588|12647595|P4|NOT COMPLETED|Washout (3-7 Days)||0
5142248|NCT01355588|12647596|P3|NOT COMPLETED|Washout (3-7 Days)||0
5142249|NCT01355588|12647597|P2|NOT COMPLETED|Washout (3-7 Days)||0
5142250|NCT01355588|12647598|P1|NOT COMPLETED|Washout (3-7 Days)||0
5142251|NCT01355588|12647595|P4|COMPLETED|Washout (3-7 Days)||4
5142252|NCT01355588|12647596|P3|COMPLETED|Washout (3-7 Days)||4
5142253|NCT01355588|12647597|P2|COMPLETED|Washout (3-7 Days)||4
5142254|NCT01355588|12647598|P1|COMPLETED|Washout (3-7 Days)||4
5142255|NCT01355588|12647595|P4|STARTED|Washout (3-7 Days)||4
5142256|NCT01355588|12647596|P3|STARTED|Washout (3-7 Days)||4
5142257|NCT01355588|12647597|P2|STARTED|Washout (3-7 Days)||4
5142258|NCT01355588|12647598|P1|STARTED|Washout (3-7 Days)||4
5142259|NCT01355588|12647595|P4|NOT COMPLETED|First Intervention (Day 1)||0
5142260|NCT01355588|12647596|P3|NOT COMPLETED|First Intervention (Day 1)||0
5142261|NCT01355588|12647597|P2|NOT COMPLETED|First Intervention (Day 1)||0
5142262|NCT01355588|12647598|P1|NOT COMPLETED|First Intervention (Day 1)||0
5142263|NCT01355588|12647595|P4|COMPLETED|First Intervention (Day 1)||4
5142264|NCT01355588|12647596|P3|COMPLETED|First Intervention (Day 1)||4
5142265|NCT01355588|12647597|P2|COMPLETED|First Intervention (Day 1)||4
5142266|NCT01355588|12647598|P1|COMPLETED|First Intervention (Day 1)||4
5142267|NCT01355588|12647595|P4|STARTED|First Intervention (Day 1)||4
5142268|NCT01355588|12647596|P3|STARTED|First Intervention (Day 1)||4
5142269|NCT01355588|12647597|P2|STARTED|First Intervention (Day 1)||4
5142270|NCT01355588|12647598|P1|STARTED|First Intervention (Day 1)||4
5142271|NCT01355523|12647622|P2|NOT COMPLETED|Overall Study||10
5142272|NCT01355523|12647623|P1|NOT COMPLETED|Overall Study||1
5142273|NCT01355523|12647622|P2|COMPLETED|Overall Study||16
5142274|NCT01355523|12647623|P1|COMPLETED|Overall Study||27
5142275|NCT01355523|12647622|P2|STARTED|Overall Study||26
5142276|NCT01355523|12647623|P1|STARTED|Overall Study||28
5142277|NCT01355484|12647667|P2|NOT COMPLETED|Overall Study||54
5142278|NCT01355484|12647668|P1|NOT COMPLETED|Overall Study||51
5142279|NCT01355484|12647667|P2|COMPLETED|Overall Study||107
5142280|NCT01355484|12647668|P1|COMPLETED|Overall Study||109
5142281|NCT01355484|12647667|P2|STARTED|Overall Study||161
5142282|NCT01355484|12647668|P1|STARTED|Overall Study||160
5142283|NCT01355471|12647678|P2|NOT COMPLETED|Overall Study||3
5142284|NCT01355471|12647679|P1|NOT COMPLETED|Overall Study||7
5142285|NCT01355471|12647678|P2|COMPLETED|Overall Study||142
5142286|NCT01355471|12647679|P1|COMPLETED|Overall Study||141
5142287|NCT01355471|12647678|P2|STARTED|Overall Study||145
5142288|NCT01355471|12647679|P1|STARTED|Overall Study||148
5142289|NCT01355458|12647687|P2|NOT COMPLETED|Overall Study||4
5142290|NCT01355458|12647688|P1|NOT COMPLETED|Overall Study||2
5142291|NCT01355458|12647687|P2|COMPLETED|Overall Study||127
5142292|NCT01355458|12647688|P1|COMPLETED|Overall Study||127
5142293|NCT01355458|12647687|P2|STARTED|Overall Study||131
5142294|NCT01355458|12647688|P1|STARTED|Overall Study||129
5142295|NCT01355419|12647694|P1|NOT COMPLETED|Overall Study||8
5142296|NCT01355419|12647694|P1|COMPLETED|Overall Study||142
5142297|NCT01355419|12647694|P1|STARTED|Overall Study||150
5142298|NCT01355302|12647699|P3|NOT COMPLETED|Phase 2||0
5142299|NCT01355302|12647700|P2|NOT COMPLETED|Phase 2||0
5142300|NCT01355302|12647701|P1|NOT COMPLETED|Phase 2||0
5142301|NCT01355302|12647699|P3|COMPLETED|Phase 2||0
5142302|NCT01355302|12647700|P2|COMPLETED|Phase 2||0
5142303|NCT01355302|12647701|P1|COMPLETED|Phase 2||0
5142304|NCT01355302|12647699|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
5142396|NCT01354990|12647872|P1|COMPLETED|Overall Study||2974
5142305|NCT01355302|12647700|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
5142306|NCT01355302|12647701|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
5142307|NCT01355302|12647699|P3|NOT COMPLETED|Phase 1b||0
5142308|NCT01355302|12647700|P2|NOT COMPLETED|Phase 1b||0
5142309|NCT01355302|12647701|P1|NOT COMPLETED|Phase 1b||6
5142310|NCT01355302|12647699|P3|COMPLETED|Phase 1b||0
5142311|NCT01355302|12647700|P2|COMPLETED|Phase 1b||0
5142312|NCT01355302|12647701|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
5142313|NCT01355302|12647699|P3|STARTED|Phase 1b||0
5142314|NCT01355302|12647700|P2|STARTED|Phase 1b||0
5142315|NCT01355302|12647701|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
5142316|NCT01355289|12647716|P5|NOT COMPLETED|Open Label Extension||34
5142317|NCT01355289|12647717|P4|NOT COMPLETED|Open Label Extension||0
5142318|NCT01355289|12647718|P3|NOT COMPLETED|Open Label Extension||0
5142319|NCT01355289|12647719|P2|NOT COMPLETED|Open Label Extension||0
5142320|NCT01355289|12647720|P1|NOT COMPLETED|Open Label Extension||0
5142321|NCT01355289|12647716|P5|COMPLETED|Open Label Extension||28
5142322|NCT01355289|12647717|P4|COMPLETED|Open Label Extension||0
5142323|NCT01355289|12647718|P3|COMPLETED|Open Label Extension||0
5142324|NCT01355289|12647719|P2|COMPLETED|Open Label Extension||0
5142325|NCT01355289|12647720|P1|COMPLETED|Open Label Extension||0
5142326|NCT01355289|12647716|P5|STARTED|Open Label Extension||62
5142327|NCT01355289|12647717|P4|STARTED|Open Label Extension||0
5142328|NCT01355289|12647718|P3|STARTED|Open Label Extension||0
5142329|NCT01355289|12647719|P2|STARTED|Open Label Extension||0
5142330|NCT01355289|12647720|P1|STARTED|Open Label Extension||0
5142331|NCT01355289|12647716|P5|NOT COMPLETED|Core Study||0
5142332|NCT01355289|12647717|P4|NOT COMPLETED|Core Study||2
5142333|NCT01355289|12647718|P3|NOT COMPLETED|Core Study||0
5142334|NCT01355289|12647719|P2|NOT COMPLETED|Core Study||0
5142335|NCT01355289|12647720|P1|NOT COMPLETED|Core Study||1
5142336|NCT01355289|12647716|P5|COMPLETED|Core Study||0
5142337|NCT01355289|12647717|P4|COMPLETED|Core Study||12
5142338|NCT01355289|12647718|P3|COMPLETED|Core Study||18
5142339|NCT01355289|12647719|P2|COMPLETED|Core Study||16
5142340|NCT01355289|12647720|P1|COMPLETED|Core Study||16
5142341|NCT01355289|12647716|P5|STARTED|Core Study||0
5142342|NCT01355289|12647717|P4|STARTED|Core Study||14
5142343|NCT01355289|12647718|P3|STARTED|Core Study||18
5142344|NCT01355289|12647719|P2|STARTED|Core Study||16
5142345|NCT01355289|12647720|P1|STARTED|Core Study||17
5142346|NCT01355224|12647747|P4|NOT COMPLETED|Overall Study||29
5142347|NCT01355224|12647748|P3|NOT COMPLETED|Overall Study||19
5142348|NCT01355224|12647749|P2|NOT COMPLETED|Overall Study||23
5142349|NCT01355224|12647750|P1|NOT COMPLETED|Overall Study||31
5142350|NCT01355224|12647747|P4|COMPLETED|Overall Study||172
5142351|NCT01355224|12647748|P3|COMPLETED|Overall Study||177
5142352|NCT01355224|12647749|P2|COMPLETED|Overall Study||180
5142353|NCT01355224|12647750|P1|COMPLETED|Overall Study||167
5142354|NCT01355224|12647747|P4|Competed Baseline|Overall Study||193
5142355|NCT01355224|12647748|P3|Competed Baseline|Overall Study||193
5142356|NCT01355224|12647749|P2|Competed Baseline|Overall Study||200
5142357|NCT01355224|12647750|P1|Competed Baseline|Overall Study||191
5142358|NCT01355224|12647747|P4|STARTED|Overall Study||201
5142359|NCT01355224|12647748|P3|STARTED|Overall Study||196
5142360|NCT01355224|12647749|P2|STARTED|Overall Study||203
5142361|NCT01355224|12647750|P1|STARTED|Overall Study||198
5142362|NCT01355159|12647772|P2|NOT COMPLETED|Overall Study||79
5142363|NCT01355159|12647773|P1|NOT COMPLETED|Overall Study||84
5142364|NCT01355159|12647772|P2|COMPLETED|Overall Study||1157
5142365|NCT01355159|12647773|P1|COMPLETED|Overall Study||1144
5142366|NCT01355159|12647772|P2|STARTED|Overall Study||1236
5142367|NCT01355159|12647773|P1|STARTED|Overall Study||1228
5142368|NCT01355081|12647830|P3|NOT COMPLETED|Overall Study||11
5142369|NCT01355081|12647831|P2|NOT COMPLETED|Overall Study||10
5142370|NCT01355081|12647832|P1|NOT COMPLETED|Overall Study||7
5142371|NCT01355081|12647830|P3|COMPLETED|Overall Study||113
5142372|NCT01355081|12647831|P2|COMPLETED|Overall Study||113
5142373|NCT01355081|12647832|P1|COMPLETED|Overall Study||112
5142374|NCT01355081|12647830|P3|STARTED|Overall Study||124
5142375|NCT01355081|12647831|P2|STARTED|Overall Study||123
5142376|NCT01355081|12647832|P1|STARTED|Overall Study||119
5142377|NCT01355068|12647855|P2|NOT COMPLETED|Second Intervention Period||0
5142378|NCT01355068|12647856|P1|NOT COMPLETED|Second Intervention Period||0
5142379|NCT01355068|12647855|P2|COMPLETED|Second Intervention Period||11
5142380|NCT01355068|12647856|P1|COMPLETED|Second Intervention Period||13
5142381|NCT01355068|12647855|P2|STARTED|Second Intervention Period||11
5142382|NCT01355068|12647856|P1|STARTED|Second Intervention Period||13
5142383|NCT01355068|12647855|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5142384|NCT01355068|12647856|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5142385|NCT01355068|12647855|P2|COMPLETED|Washout Period (at Least 7 Days)||11
5142386|NCT01355068|12647856|P1|COMPLETED|Washout Period (at Least 7 Days)||13
5142387|NCT01355068|12647855|P2|STARTED|Washout Period (at Least 7 Days)||11
5142388|NCT01355068|12647856|P1|STARTED|Washout Period (at Least 7 Days)||13
5142389|NCT01355068|12647855|P2|NOT COMPLETED|First Intervention Period||2
5142390|NCT01355068|12647856|P1|NOT COMPLETED|First Intervention Period||0
5142391|NCT01355068|12647855|P2|COMPLETED|First Intervention Period||11
5142392|NCT01355068|12647856|P1|COMPLETED|First Intervention Period||13
5142393|NCT01355068|12647855|P2|STARTED|First Intervention Period||13
5142394|NCT01355068|12647856|P1|STARTED|First Intervention Period||13
5142395|NCT01354990|12647872|P1|NOT COMPLETED|Overall Study||0
5142397|NCT01354990|12647872|P1|STARTED|Overall Study||2974
5142398|NCT01354964|12647881|P2|NOT COMPLETED|Overall Study||1
5142399|NCT01354964|12647882|P1|NOT COMPLETED|Overall Study||4
5142400|NCT01354964|12647881|P2|COMPLETED|Overall Study||7
5142401|NCT01354964|12647882|P1|COMPLETED|Overall Study||7
5142402|NCT01354964|12647881|P2|STARTED|Overall Study||8
5142403|NCT01354964|12647882|P1|STARTED|Overall Study||11
5142404|NCT01354951|12647898|P1|NOT COMPLETED|Overall Study||2
5142405|NCT01354951|12647898|P1|COMPLETED|Overall Study||1
5142406|NCT01354951|12647898|P1|STARTED|Overall Study||3
5142407|NCT01354938|12647905|P1|NOT COMPLETED|Overall Study||1
5142408|NCT01354938|12647905|P1|COMPLETED|Overall Study||219
5142409|NCT01354938|12647905|P1|STARTED|Overall Study||220
5142410|NCT01354899|12647911|P1|NOT COMPLETED|Overall Study||3
5142411|NCT01354899|12647911|P1|COMPLETED|Overall Study||21
5142412|NCT01354899|12647911|P1|STARTED|Overall Study||24
5142413|NCT01354691|12647918|P2|NOT COMPLETED|Overall Study||22
5142414|NCT01354691|12647919|P1|NOT COMPLETED|Overall Study||21
5142415|NCT01354691|12647918|P2|COMPLETED|Overall Study||77
5142416|NCT01354691|12647919|P1|COMPLETED|Overall Study||80
5142417|NCT01354691|12647918|P2|PP|Overall Study||75
5142418|NCT01354691|12647919|P1|PP|Overall Study||79
5142419|NCT01354691|12647918|P2|ITT|Overall Study||96
5142420|NCT01354691|12647919|P1|ITT|Overall Study||99
5142421|NCT01354691|12647918|P2|STARTED|Overall Study||99
5142422|NCT01354691|12647919|P1|STARTED|Overall Study||101
5142423|NCT01354652|12647936|P3|NOT COMPLETED|Overall Study||0
5142424|NCT01354652|12647937|P2|NOT COMPLETED|Overall Study||2
5142425|NCT01354652|12647938|P1|NOT COMPLETED|Overall Study||3
5142426|NCT01354652|12647936|P3|COMPLETED|Overall Study||0
5142427|NCT01354652|12647937|P2|COMPLETED|Overall Study||0
5142428|NCT01354652|12647938|P1|COMPLETED|Overall Study||0
5142429|NCT01354652|12647936|P3|STARTED|Overall Study||0
5142430|NCT01354652|12647937|P2|STARTED|Overall Study||2
5142431|NCT01354652|12647938|P1|STARTED|Overall Study||3
5142432|NCT01354496|12647963|P6|NOT COMPLETED|Period 3||0
5142433|NCT01354496|12647964|P5|NOT COMPLETED|Period 3||0
5142434|NCT01354496|12647965|P4|NOT COMPLETED|Period 3||0
5142435|NCT01354496|12647966|P3|NOT COMPLETED|Period 3||0
5142436|NCT01354496|12647967|P2|NOT COMPLETED|Period 3||0
5142437|NCT01354496|12647968|P1|NOT COMPLETED|Period 3||0
5142438|NCT01354496|12647963|P6|COMPLETED|Period 3||6
5142439|NCT01354496|12647964|P5|COMPLETED|Period 3||5
5142440|NCT01354496|12647965|P4|COMPLETED|Period 3||4
5142441|NCT01354496|12647966|P3|COMPLETED|Period 3||4
5142442|NCT01354496|12647967|P2|COMPLETED|Period 3||5
5142443|NCT01354496|12647968|P1|COMPLETED|Period 3||6
5142444|NCT01354496|12647963|P6|STARTED|Period 3||6
5142445|NCT01354496|12647964|P5|STARTED|Period 3||5
5142446|NCT01354496|12647965|P4|STARTED|Period 3||4
5142447|NCT01354496|12647966|P3|STARTED|Period 3||4
5142448|NCT01354496|12647967|P2|STARTED|Period 3||5
5142449|NCT01354496|12647968|P1|STARTED|Period 3||6
5142450|NCT01354496|12647963|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
5142451|NCT01354496|12647964|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
5142452|NCT01354496|12647965|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
5142453|NCT01354496|12647966|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
5142454|NCT01354496|12647967|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
5142455|NCT01354496|12647968|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
5142456|NCT01354496|12647963|P6|COMPLETED|Washout (at Least 14 Days)||6
5142457|NCT01354496|12647964|P5|COMPLETED|Washout (at Least 14 Days)||5
5142458|NCT01354496|12647965|P4|COMPLETED|Washout (at Least 14 Days)||4
5142459|NCT01354496|12647966|P3|COMPLETED|Washout (at Least 14 Days)||4
5142460|NCT01354496|12647967|P2|COMPLETED|Washout (at Least 14 Days)||5
5142461|NCT01354496|12647968|P1|COMPLETED|Washout (at Least 14 Days)||6
5142462|NCT01354496|12647963|P6|STARTED|Washout (at Least 14 Days)||6
5142463|NCT01354496|12647964|P5|STARTED|Washout (at Least 14 Days)||5
5142464|NCT01354496|12647965|P4|STARTED|Washout (at Least 14 Days)||5
5142465|NCT01354496|12647966|P3|STARTED|Washout (at Least 14 Days)||4
5142466|NCT01354496|12647967|P2|STARTED|Washout (at Least 14 Days)||6
5142467|NCT01354496|12647968|P1|STARTED|Washout (at Least 14 Days)||6
5142468|NCT01354496|12647963|P6|NOT COMPLETED|Period 2||0
5142469|NCT01354496|12647964|P5|NOT COMPLETED|Period 2||0
5142470|NCT01354496|12647965|P4|NOT COMPLETED|Period 2||1
5142471|NCT01354496|12647966|P3|NOT COMPLETED|Period 2||0
5142472|NCT01354496|12647967|P2|NOT COMPLETED|Period 2||0
5142473|NCT01354496|12647968|P1|NOT COMPLETED|Period 2||0
5142474|NCT01354496|12647963|P6|COMPLETED|Period 2||6
5142475|NCT01354496|12647964|P5|COMPLETED|Period 2||5
5142476|NCT01354496|12647965|P4|COMPLETED|Period 2||5
5142477|NCT01354496|12647966|P3|COMPLETED|Period 2||4
5142478|NCT01354496|12647967|P2|COMPLETED|Period 2||6
5142479|NCT01354496|12647968|P1|COMPLETED|Period 2||6
5142480|NCT01354496|12647963|P6|STARTED|Period 2||6
5142481|NCT01354496|12647964|P5|STARTED|Period 2||5
5142482|NCT01354496|12647965|P4|STARTED|Period 2||6
5142483|NCT01354496|12647966|P3|STARTED|Period 2||4
5142484|NCT01354496|12647967|P2|STARTED|Period 2||6
5142485|NCT01354496|12647968|P1|STARTED|Period 2||6
5142486|NCT01354496|12647963|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
5142487|NCT01354496|12647964|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
5142488|NCT01354496|12647965|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
5142489|NCT01354496|12647966|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
5142490|NCT01354496|12647967|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
5142491|NCT01354496|12647968|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
5142492|NCT01354496|12647963|P6|COMPLETED|Washout (at Least 14 Days)||6
5142493|NCT01354496|12647964|P5|COMPLETED|Washout (at Least 14 Days)||5
5142494|NCT01354496|12647965|P4|COMPLETED|Washout (at Least 14 Days)||6
5142495|NCT01354496|12647966|P3|COMPLETED|Washout (at Least 14 Days)||4
5142496|NCT01354496|12647967|P2|COMPLETED|Washout (at Least 14 Days)||6
5142497|NCT01354496|12647968|P1|COMPLETED|Washout (at Least 14 Days)||6
5142498|NCT01354496|12647963|P6|STARTED|Washout (at Least 14 Days)||6
5142499|NCT01354496|12647964|P5|STARTED|Washout (at Least 14 Days)||5
5142500|NCT01354496|12647965|P4|STARTED|Washout (at Least 14 Days)||6
5142501|NCT01354496|12647966|P3|STARTED|Washout (at Least 14 Days)||4
5142502|NCT01354496|12647967|P2|STARTED|Washout (at Least 14 Days)||6
5142503|NCT01354496|12647968|P1|STARTED|Washout (at Least 14 Days)||6
5142504|NCT01354496|12647963|P6|NOT COMPLETED|Period 1||0
5142505|NCT01354496|12647964|P5|NOT COMPLETED|Period 1||0
5142506|NCT01354496|12647965|P4|NOT COMPLETED|Period 1||0
5142507|NCT01354496|12647966|P3|NOT COMPLETED|Period 1||2
5142508|NCT01354496|12647967|P2|NOT COMPLETED|Period 1||0
5142509|NCT01354496|12647968|P1|NOT COMPLETED|Period 1||0
5142510|NCT01354496|12647963|P6|COMPLETED|Period 1||6
5142511|NCT01354496|12647964|P5|COMPLETED|Period 1||5
5142512|NCT01354496|12647965|P4|COMPLETED|Period 1||6
5142513|NCT01354496|12647966|P3|COMPLETED|Period 1||4
5142514|NCT01354496|12647967|P2|COMPLETED|Period 1||6
5142515|NCT01354496|12647968|P1|COMPLETED|Period 1||6
5142516|NCT01354496|12647963|P6|Received at Least 1 Dose of Study Drug|Period 1||6
5142517|NCT01354496|12647964|P5|Received at Least 1 Dose of Study Drug|Period 1||5
5142518|NCT01354496|12647965|P4|Received at Least 1 Dose of Study Drug|Period 1||6
5142519|NCT01354496|12647966|P3|Received at Least 1 Dose of Study Drug|Period 1||6
5142520|NCT01354496|12647967|P2|Received at Least 1 Dose of Study Drug|Period 1||6
5142521|NCT01354496|12647968|P1|Received at Least 1 Dose of Study Drug|Period 1||6
5142522|NCT01354496|12647963|P6|STARTED|Period 1||6
5142523|NCT01354496|12647964|P5|STARTED|Period 1||5
5142524|NCT01354496|12647965|P4|STARTED|Period 1||6
5142525|NCT01354496|12647966|P3|STARTED|Period 1||6
5142526|NCT01354496|12647967|P2|STARTED|Period 1||6
5142527|NCT01354496|12647968|P1|STARTED|Period 1||6
5142528|NCT01354444|12647997|P2|NOT COMPLETED|Overall Study||4
5142529|NCT01354444|12647998|P1|NOT COMPLETED|Overall Study||8
5142530|NCT01354444|12647997|P2|COMPLETED|Overall Study||11
5142531|NCT01354444|12647998|P1|COMPLETED|Overall Study||6
5142532|NCT01354444|12647997|P2|STARTED|Overall Study||15
5142533|NCT01354444|12647998|P1|STARTED|Overall Study||14
5142534|NCT01354431|12648011|P3|NOT COMPLETED|Participants Treated||54
5142535|NCT01354431|12648012|P2|NOT COMPLETED|Participants Treated||54
5142536|NCT01354431|12648013|P1|NOT COMPLETED|Participants Treated||59
5142537|NCT01354431|12648011|P3|COMPLETED|Participants Treated||0
5142538|NCT01354431|12648012|P2|COMPLETED|Participants Treated||0
5142539|NCT01354431|12648013|P1|COMPLETED|Participants Treated||0
5142540|NCT01354431|12648011|P3|STARTED|Participants Treated||54
5142541|NCT01354431|12648012|P2|STARTED|Participants Treated||54
5142542|NCT01354431|12648013|P1|STARTED|Participants Treated||59
5142543|NCT01354431|12648011|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
5142544|NCT01354431|12648012|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
5142545|NCT01354431|12648013|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
5142546|NCT01354431|12648011|P3|COMPLETED|Randomized to Enter Treatment Period||54
5142547|NCT01354431|12648012|P2|COMPLETED|Randomized to Enter Treatment Period||54
5142548|NCT01354431|12648013|P1|COMPLETED|Randomized to Enter Treatment Period||59
5142549|NCT01354431|12648011|P3|STARTED|Randomized to Enter Treatment Period||54
5142550|NCT01354431|12648012|P2|STARTED|Randomized to Enter Treatment Period||54
5142551|NCT01354431|12648013|P1|STARTED|Randomized to Enter Treatment Period||60
5142552|NCT01354314|12648037|P4|NOT COMPLETED|Overall Study||6
5142553|NCT01354314|12648038|P3|NOT COMPLETED|Overall Study||8
5142554|NCT01354314|12648039|P2|NOT COMPLETED|Overall Study||3
5142555|NCT01354314|12648040|P1|NOT COMPLETED|Overall Study||6
5142556|NCT01354314|12648037|P4|COMPLETED|Overall Study||5
5142557|NCT01354314|12648038|P3|COMPLETED|Overall Study||3
5142558|NCT01354314|12648039|P2|COMPLETED|Overall Study||8
5142559|NCT01354314|12648040|P1|COMPLETED|Overall Study||6
5142560|NCT01354314|12648037|P4|Completed (ITT)|Overall Study||10
5142561|NCT01354314|12648038|P3|Completed (ITT)|Overall Study||9
5142562|NCT01354314|12648039|P2|Completed (ITT)|Overall Study||11
5142563|NCT01354314|12648040|P1|Completed (ITT)|Overall Study||11
5142564|NCT01354314|12648037|P4|STARTED|Overall Study||11
5142565|NCT01354314|12648038|P3|STARTED|Overall Study||11
5142566|NCT01354314|12648039|P2|STARTED|Overall Study||11
5142567|NCT01354314|12648040|P1|STARTED|Overall Study||12
5142568|NCT01354223|12648176|P2|NOT COMPLETED|Overall Study||1
5142569|NCT01354223|12648177|P1|NOT COMPLETED|Overall Study||3
5142570|NCT01354223|12648176|P2|COMPLETED|Overall Study||29
5142571|NCT01354223|12648177|P1|COMPLETED|Overall Study||57
5142572|NCT01354223|12648176|P2|STARTED|Overall Study||30
5142573|NCT01354223|12648177|P1|STARTED|Overall Study||60
5142574|NCT01354197|12648193|P1|NOT COMPLETED|Overall Study||0
5142575|NCT01354197|12648193|P1|COMPLETED|Overall Study||4652
5142576|NCT01354197|12648193|P1|STARTED|Overall Study||4652
5142577|NCT01354145|12648201|P2|NOT COMPLETED|Overall Study||34
5142578|NCT01354145|12648202|P1|NOT COMPLETED|Overall Study||39
5142579|NCT01354145|12648201|P2|COMPLETED|Overall Study||63
5142580|NCT01354145|12648202|P1|COMPLETED|Overall Study||58
5142581|NCT01354145|12648201|P2|STARTED|Overall Study||97
5142582|NCT01354145|12648202|P1|STARTED|Overall Study||97
5142583|NCT01354132|12648236|P2|NOT COMPLETED|1 Month Post Study Medication||3
5142584|NCT01354132|12648237|P1|NOT COMPLETED|1 Month Post Study Medication||1
5142585|NCT01354132|12648236|P2|COMPLETED|1 Month Post Study Medication||16
5142586|NCT01354132|12648237|P1|COMPLETED|1 Month Post Study Medication||21
5142587|NCT01354132|12648236|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
5142588|NCT01354132|12648237|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
5142589|NCT01354132|12648236|P2|STARTED|1 Month Post Study Medication||19
5142590|NCT01354132|12648237|P1|STARTED|1 Month Post Study Medication||22
5142591|NCT01354132|12648236|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
5142592|NCT01354132|12648237|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
5142593|NCT01354132|12648236|P2|COMPLETED|Double Blind (Visits 1-7)||19
5142594|NCT01354132|12648237|P1|COMPLETED|Double Blind (Visits 1-7)||22
5142595|NCT01354132|12648236|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
5142596|NCT01354132|12648237|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
5142597|NCT01354132|12648236|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
5142598|NCT01354132|12648237|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
5142599|NCT01354132|12648236|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
5142600|NCT01354132|12648237|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
5142601|NCT01354132|12648236|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
5142602|NCT01354132|12648237|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
5142603|NCT01354132|12648236|P2|NOT COMPLETED|Randomization||1
5142604|NCT01354132|12648237|P1|NOT COMPLETED|Randomization||1
5142605|NCT01354132|12648236|P2|COMPLETED|Randomization||30
5142606|NCT01354132|12648237|P1|COMPLETED|Randomization||31
5142607|NCT01354132|12648236|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
5142608|NCT01354132|12648237|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
5142609|NCT01354106|12648275|P1|NOT COMPLETED|Overall Study||2
5142610|NCT01354106|12648275|P1|COMPLETED|Overall Study||24
5142611|NCT01354106|12648275|P1|STARTED|Overall Study||26
5142612|NCT01354028|12648281|P2|NOT COMPLETED|Overall Study||5
5142613|NCT01354028|12648282|P1|NOT COMPLETED|Overall Study||2
5142614|NCT01354028|12648281|P2|COMPLETED|Overall Study||10
5142615|NCT01354028|12648282|P1|COMPLETED|Overall Study||13
5142616|NCT01354028|12648281|P2|STARTED|Overall Study||15
5142617|NCT01354028|12648282|P1|STARTED|Overall Study||15
5142618|NCT01354015|12648296|P2|NOT COMPLETED|Overall Study||5
5142619|NCT01354015|12648297|P1|NOT COMPLETED|Overall Study||6
5142620|NCT01354015|12648296|P2|COMPLETED|Overall Study||43
5142621|NCT01354015|12648297|P1|COMPLETED|Overall Study||44
5142622|NCT01354015|12648296|P2|STARTED|Overall Study||48
5142623|NCT01354015|12648297|P1|STARTED|Overall Study||50
5142624|NCT01353976|12648307|P2|NOT COMPLETED|Overall Study||51
5142625|NCT01353976|12648308|P1|NOT COMPLETED|Overall Study||48
5142626|NCT01353976|12648307|P2|COMPLETED|Overall Study||83
5142627|NCT01353976|12648308|P1|COMPLETED|Overall Study||82
5142628|NCT01353976|12648307|P2|STARTED|Overall Study||134
5142629|NCT01353976|12648308|P1|STARTED|Overall Study||130
5142630|NCT01353963|12648318|P1|NOT COMPLETED|Overall Study||2
5142631|NCT01353963|12648318|P1|COMPLETED|Overall Study||11
5142632|NCT01353963|12648318|P1|STARTED|Overall Study||13
5142633|NCT01353911|12648336|P8|NOT COMPLETED|Overall Study||15
5142634|NCT01353911|12648337|P7|NOT COMPLETED|Overall Study||6
5142635|NCT01353911|12648338|P6|NOT COMPLETED|Overall Study||7
5142636|NCT01353911|12648339|P5|NOT COMPLETED|Overall Study||6
5142637|NCT01353911|12648340|P4|NOT COMPLETED|Overall Study||2
5142638|NCT01353911|12648341|P3|NOT COMPLETED|Overall Study||9
5142639|NCT01353911|12648342|P2|NOT COMPLETED|Overall Study||9
5142640|NCT01353911|12648343|P1|NOT COMPLETED|Overall Study||8
5142641|NCT01353911|12648336|P8|COMPLETED|Overall Study||51
5142642|NCT01353911|12648337|P7|COMPLETED|Overall Study||30
5142643|NCT01353911|12648338|P6|COMPLETED|Overall Study||36
5142644|NCT01353911|12648339|P5|COMPLETED|Overall Study||23
5142645|NCT01353911|12648340|P4|COMPLETED|Overall Study||22
5142646|NCT01353911|12648341|P3|COMPLETED|Overall Study||59
5142647|NCT01353911|12648342|P2|COMPLETED|Overall Study||57
5142648|NCT01353911|12648343|P1|COMPLETED|Overall Study||28
5142649|NCT01353911|12648336|P8|STARTED|Overall Study||66
5142650|NCT01353911|12648337|P7|STARTED|Overall Study||36
5142651|NCT01353911|12648338|P6|STARTED|Overall Study||43
5142652|NCT01353911|12648339|P5|STARTED|Overall Study||29
5142653|NCT01353911|12648340|P4|STARTED|Overall Study||24
5142654|NCT01353911|12648341|P3|STARTED|Overall Study||68
5142655|NCT01353911|12648342|P2|STARTED|Overall Study||66
5142656|NCT01353911|12648343|P1|STARTED|Overall Study||36
5142657|NCT01353898|12648423|P6|NOT COMPLETED|Overall Study||1
5142658|NCT01353898|12648424|P5|NOT COMPLETED|Overall Study||0
5142659|NCT01353898|12648425|P4|NOT COMPLETED|Overall Study||0
5142660|NCT01353898|12648426|P3|NOT COMPLETED|Overall Study||0
5142661|NCT01353898|12648427|P2|NOT COMPLETED|Overall Study||0
5142662|NCT01353898|12648428|P1|NOT COMPLETED|Overall Study||0
5142663|NCT01353898|12648423|P6|COMPLETED|Overall Study||1
5142664|NCT01353898|12648424|P5|COMPLETED|Overall Study||2
5142665|NCT01353898|12648425|P4|COMPLETED|Overall Study||2
5142666|NCT01353898|12648426|P3|COMPLETED|Overall Study||2
5142667|NCT01353898|12648427|P2|COMPLETED|Overall Study||2
5142668|NCT01353898|12648428|P1|COMPLETED|Overall Study||2
5142669|NCT01353898|12648423|P6|STARTED|Overall Study||2
5142670|NCT01353898|12648424|P5|STARTED|Overall Study||2
5142671|NCT01353898|12648425|P4|STARTED|Overall Study||2
5142672|NCT01353898|12648426|P3|STARTED|Overall Study||2
5142673|NCT01353898|12648427|P2|STARTED|Overall Study||2
5142674|NCT01353898|12648428|P1|STARTED|Overall Study||2
5142675|NCT01353859|12648454|P1|NOT COMPLETED|Overall Study||4
5142676|NCT01353859|12648454|P1|COMPLETED|Overall Study||35
5142677|NCT01353859|12648454|P1|STARTED|Overall Study||39
5142678|NCT01353703|12648469|P2|NOT COMPLETED|Overall Study||0
5142679|NCT01353703|12648470|P1|NOT COMPLETED|Overall Study||1
5142680|NCT01353703|12648469|P2|COMPLETED|Overall Study||112
5142681|NCT01353703|12648470|P1|COMPLETED|Overall Study||111
5142682|NCT01353703|12648469|P2|STARTED|Overall Study||112
5142683|NCT01353703|12648470|P1|STARTED|Overall Study||112
5142684|NCT01353664|12648516|P1|NOT COMPLETED|Overall Study||19
5142685|NCT01353664|12648516|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
5142686|NCT01353664|12648516|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
5142687|NCT01353586|12648522|P2|NOT COMPLETED|Overall Study||2
5142688|NCT01353586|12648523|P1|NOT COMPLETED|Overall Study||7
5142689|NCT01353586|12648522|P2|COMPLETED|Overall Study||17
5142690|NCT01353586|12648523|P1|COMPLETED|Overall Study||160
5142691|NCT01353586|12648522|P2|Participated in SNA Substudy|Overall Study||19
5142692|NCT01353586|12648523|P1|Participated in SNA Substudy|Overall Study||19
5142693|NCT01353586|12648522|P2|Participated in Roll-in Phase|Overall Study||0
5142694|NCT01353586|12648523|P1|Participated in Roll-in Phase|Overall Study||22
5142695|NCT01353586|12648522|P2|Participated in Workflow Phase|Overall Study||0
5142696|NCT01353586|12648523|P1|Participated in Workflow Phase|Overall Study||20
5142697|NCT01353586|12648522|P2|STARTED|Overall Study||19
5142698|NCT01353586|12648523|P1|STARTED|Overall Study||167
5142699|NCT01353508|12648541|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
5142700|NCT01353508|12648542|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
5142701|NCT01353508|12648543|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
5142702|NCT01353508|12648544|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
5142703|NCT01353508|12648541|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
5142704|NCT01353508|12648542|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
5142705|NCT01353508|12648543|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
5142706|NCT01353508|12648544|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
5142707|NCT01353508|12648541|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
5142708|NCT01353508|12648542|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
5142709|NCT01353508|12648543|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
5142710|NCT01353508|12648544|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
5142711|NCT01353508|12648541|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
5142712|NCT01353508|12648542|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
5142713|NCT01353508|12648543|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
5142714|NCT01353508|12648544|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
5142715|NCT01353508|12648541|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
5142716|NCT01353508|12648542|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
5142717|NCT01353508|12648543|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
5142718|NCT01353508|12648544|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
5142719|NCT01353508|12648541|P4|STARTED|Period 1 - First Intervention (7 Days)||8
5142720|NCT01353508|12648542|P3|STARTED|Period 1 - First Intervention (7 Days)||8
5142721|NCT01353508|12648543|P2|STARTED|Period 1 - First Intervention (7 Days)||8
5142722|NCT01353508|12648544|P1|STARTED|Period 1 - First Intervention (7 Days)||8
5142723|NCT01353274|12648622|P1|NOT COMPLETED|Overall Study||28
5142724|NCT01353274|12648622|P1|COMPLETED|Overall Study||1129
5142725|NCT01353274|12648622|P1|STARTED|Overall Study||1157
5142726|NCT01353222|12648632|P2|NOT COMPLETED|Overall Study||72
5142727|NCT01353222|12648633|P1|NOT COMPLETED|Overall Study||70
5142728|NCT01353222|12648632|P2|COMPLETED|Overall Study||0
5142729|NCT01353222|12648633|P1|COMPLETED|Overall Study||0
5142730|NCT01353222|12648632|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
5142731|NCT01353222|12648633|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
5142732|NCT01353222|12648632|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
5142733|NCT01353222|12648633|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
5142734|NCT01353222|12648632|P2|STARTED|Overall Study||72
5142735|NCT01353222|12648633|P1|STARTED|Overall Study||70
5142736|NCT01353196|12648641|P2|NOT COMPLETED|Overall Study||11
5142737|NCT01353196|12648642|P1|NOT COMPLETED|Overall Study||29
5142738|NCT01353196|12648641|P2|COMPLETED|Overall Study||59
5142739|NCT01353196|12648642|P1|COMPLETED|Overall Study||71
5142740|NCT01353196|12648641|P2|STARTED|Overall Study||70
5142741|NCT01353196|12648642|P1|STARTED|Overall Study||100
5142742|NCT01353144|12648650|P2|NOT COMPLETED|Overall Study||8
5142743|NCT01353144|12648651|P1|NOT COMPLETED|Overall Study||9
5142744|NCT01353144|12648650|P2|COMPLETED|Overall Study||81
5142745|NCT01353144|12648651|P1|COMPLETED|Overall Study||80
5142746|NCT01353144|12648650|P2|STARTED|Overall Study||89
5142747|NCT01353144|12648651|P1|STARTED|Overall Study||89
5142748|NCT01353079|12648661|P2|NOT COMPLETED|Overall Study||21
5142749|NCT01353079|12648662|P1|NOT COMPLETED|Overall Study||27
5142750|NCT01353079|12648661|P2|COMPLETED|Overall Study||190
5142751|NCT01353079|12648662|P1|COMPLETED|Overall Study||191
5142752|NCT01353079|12648661|P2|STARTED|Overall Study||211
5142753|NCT01353079|12648662|P1|STARTED|Overall Study||218
5142754|NCT01352845|12648676|P2|NOT COMPLETED|Overall Study||203
5142755|NCT01352845|12648677|P1|NOT COMPLETED|Overall Study||671
5142756|NCT01352845|12648676|P2|COMPLETED|Overall Study||619
5142757|NCT01352845|12648677|P1|COMPLETED|Overall Study||1800
5142758|NCT01352845|12648676|P2|STARTED|Overall Study||822
5142759|NCT01352845|12648677|P1|STARTED|Overall Study||2471
5142760|NCT01352793|12648766|P2|NOT COMPLETED|Overall Study||245
5142761|NCT01352793|12648767|P1|NOT COMPLETED|Overall Study||585
5142762|NCT01352793|12648766|P2|COMPLETED|Overall Study||1663
5142763|NCT01352793|12648767|P1|COMPLETED|Overall Study||3219
5142764|NCT01352793|12648766|P2|Vaccination 3|Overall Study||1710
5142765|NCT01352793|12648767|P1|Vaccination 3|Overall Study||3314
5142766|NCT01352793|12648766|P2|Vaccination 2|Overall Study||1806
5142767|NCT01352793|12648767|P1|Vaccination 2|Overall Study||3530
5142768|NCT01352793|12648766|P2|Vaccination 1|Overall Study||1908
5142769|NCT01352793|12648767|P1|Vaccination 1|Overall Study||3796
5142770|NCT01352793|12648766|P2|STARTED|Overall Study||1908
5142771|NCT01352793|12648767|P1|STARTED|Overall Study||3804
5142772|NCT01352741|12648791|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
5142773|NCT01352741|12648792|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
5142774|NCT01352741|12648791|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
5142775|NCT01352741|12648792|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
5142776|NCT01352741|12648791|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
5142777|NCT01352741|12648792|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
5142778|NCT01352741|12648791|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
5142779|NCT01352741|12648792|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
5142780|NCT01352741|12648791|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
5142781|NCT01352741|12648792|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
5142782|NCT01352741|12648791|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
5142783|NCT01352741|12648792|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
5142784|NCT01352741|12648791|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
5142785|NCT01352741|12648792|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
5142786|NCT01352741|12648791|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
5142787|NCT01352741|12648792|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
5142788|NCT01352741|12648791|P2|NOT COMPLETED|Double-blind Comparative Period||26
5142789|NCT01352741|12648792|P1|NOT COMPLETED|Double-blind Comparative Period||28
5142790|NCT01352741|12648791|P2|COMPLETED|Double-blind Comparative Period||133
5142791|NCT01352741|12648792|P1|COMPLETED|Double-blind Comparative Period||126
5142792|NCT01352741|12648791|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
5142793|NCT01352741|12648792|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
5142794|NCT01352741|12648791|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
5142795|NCT01352741|12648792|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
5142796|NCT01352741|12648791|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
5142797|NCT01352741|12648792|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
5142798|NCT01352741|12648791|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
5142799|NCT01352741|12648792|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
5142800|NCT01352741|12648791|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
5142801|NCT01352741|12648792|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
5142802|NCT01352741|12648791|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
5142803|NCT01352741|12648792|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
5142804|NCT01352741|12648791|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
5142805|NCT01352741|12648792|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
5142806|NCT01352741|12648791|P2|Per Protocol Set|Double-blind Comparative Period||149
5142807|NCT01352741|12648792|P1|Per Protocol Set|Double-blind Comparative Period||139
5142808|NCT01352741|12648791|P2|Major Protocol Deviations|Double-blind Comparative Period||8
5142809|NCT01352741|12648792|P1|Major Protocol Deviations|Double-blind Comparative Period||13
5142810|NCT01352741|12648791|P2|Full Analysis Set|Double-blind Comparative Period||157
5142811|NCT01352741|12648792|P1|Full Analysis Set|Double-blind Comparative Period||152
5142812|NCT01352741|12648791|P2|No Pain Assessments Available|Double-blind Comparative Period||2
5142813|NCT01352741|12648792|P1|No Pain Assessments Available|Double-blind Comparative Period||2
5142814|NCT01352741|12648791|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
5142815|NCT01352741|12648792|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
5142816|NCT01352741|12648791|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
5142817|NCT01352741|12648792|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
5142818|NCT01352741|12648791|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
5142819|NCT01352741|12648792|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
5142820|NCT01352741|12648791|P2|COMPLETED|Open-label Tapentadol Titration Period||0
5142821|NCT01352741|12648792|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
5142822|NCT01352741|12648791|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
5142823|NCT01352741|12648792|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
5142824|NCT01352741|12648791|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
5142825|NCT01352741|12648792|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
5142826|NCT01352741|12648791|P2|STARTED|Open-label Tapentadol Titration Period||0
5142827|NCT01352741|12648792|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
5142828|NCT01352715|12648886|P2|NOT COMPLETED|Overall Study||46
5142829|NCT01352715|12648887|P1|NOT COMPLETED|Overall Study||45
5142830|NCT01352715|12648886|P2|COMPLETED|Overall Study||209
5142831|NCT01352715|12648887|P1|COMPLETED|Overall Study||215
5142832|NCT01352715|12648886|P2|STARTED|Overall Study||255
5142833|NCT01352715|12648887|P1|STARTED|Overall Study||260
5142834|NCT01352637|12648913|P4|NOT COMPLETED|Drug||35
5142835|NCT01352637|12648914|P3|NOT COMPLETED|Drug||25
5142836|NCT01352637|12648915|P2|NOT COMPLETED|Drug||0
5142837|NCT01352637|12648916|P1|NOT COMPLETED|Drug||0
5142838|NCT01352637|12648913|P4|COMPLETED|Drug||62
5142839|NCT01352637|12648914|P3|COMPLETED|Drug||70
5142840|NCT01352637|12648915|P2|COMPLETED|Drug||0
5142841|NCT01352637|12648916|P1|COMPLETED|Drug||0
5142842|NCT01352637|12648913|P4|STARTED|Drug||97
5142843|NCT01352637|12648914|P3|STARTED|Drug||95
5142844|NCT01352637|12648915|P2|STARTED|Drug||0
5142845|NCT01352637|12648916|P1|STARTED|Drug||0
5142846|NCT01352637|12648913|P4|NOT COMPLETED|Exposure Therapy||0
5142847|NCT01352637|12648914|P3|NOT COMPLETED|Exposure Therapy||0
5142848|NCT01352637|12648915|P2|NOT COMPLETED|Exposure Therapy||33
5142849|NCT01352637|12648916|P1|NOT COMPLETED|Exposure Therapy||27
5142850|NCT01352637|12648913|P4|COMPLETED|Exposure Therapy||0
5142851|NCT01352637|12648914|P3|COMPLETED|Exposure Therapy||0
5142852|NCT01352637|12648915|P2|COMPLETED|Exposure Therapy||62
5142853|NCT01352637|12648916|P1|COMPLETED|Exposure Therapy||70
5142854|NCT01352637|12648913|P4|STARTED|Exposure Therapy||0
5142855|NCT01352637|12648914|P3|STARTED|Exposure Therapy||0
5142856|NCT01352637|12648915|P2|STARTED|Exposure Therapy||95
5142857|NCT01352637|12648916|P1|STARTED|Exposure Therapy||97
5142858|NCT01352585|12648926|P1|NOT COMPLETED|Overall Study||11
5142859|NCT01352585|12648926|P1|COMPLETED|Overall Study||36
5142860|NCT01352585|12648926|P1|STARTED|Overall Study||47
5142861|NCT01352546|12648937|P1|NOT COMPLETED|Overall Study||0
5142862|NCT01352546|12648937|P1|COMPLETED|Overall Study||31
5142863|NCT01352546|12648937|P1|STARTED|Overall Study||31
5142864|NCT01352507|12648943|P2|NOT COMPLETED|Extension Phase||0
5142865|NCT01352507|12648944|P1|NOT COMPLETED|Extension Phase||0
5142866|NCT01352507|12648943|P2|COMPLETED|Extension Phase||173
5142867|NCT01352507|12648944|P1|COMPLETED|Extension Phase||164
5142868|NCT01352507|12648943|P2|STARTED|Extension Phase||173
5142869|NCT01352507|12648944|P1|STARTED|Extension Phase||164
5142870|NCT01352507|12648943|P2|NOT COMPLETED|Treatment Period 2||3
5142871|NCT01352507|12648944|P1|NOT COMPLETED|Treatment Period 2||6
5142872|NCT01352507|12648943|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
5142873|NCT01352507|12648944|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
5142874|NCT01352507|12648943|P2|Received Treatment|Treatment Period 2||181
5142875|NCT01352507|12648944|P1|Received Treatment|Treatment Period 2||173
5142876|NCT01352507|12648943|P2|STARTED|Treatment Period 2||183
5142877|NCT01352507|12648944|P1|STARTED|Treatment Period 2||176
5142878|NCT01352507|12648943|P2|NOT COMPLETED|Washout Period||1
5142879|NCT01352507|12648944|P1|NOT COMPLETED|Washout Period||0
5142880|NCT01352507|12648943|P2|COMPLETED|Washout Period||183
5142881|NCT01352507|12648944|P1|COMPLETED|Washout Period||176
5142882|NCT01352507|12648943|P2|STARTED|Washout Period||184
5142883|NCT01352507|12648944|P1|STARTED|Washout Period||176
5142884|NCT01352507|12648943|P2|NOT COMPLETED|Treatment Period 1||9
5142885|NCT01352507|12648944|P1|NOT COMPLETED|Treatment Period 1||14
5142886|NCT01352507|12648943|P2|COMPLETED|Treatment Period 1||184
5142887|NCT01352507|12648944|P1|COMPLETED|Treatment Period 1||176
5142888|NCT01352507|12648943|P2|Received Treatment|Treatment Period 1||188
5142889|NCT01352507|12648944|P1|Received Treatment|Treatment Period 1||182
5142890|NCT01352507|12648943|P2|STARTED|Treatment Period 1||193
5142891|NCT01352507|12648944|P1|STARTED|Treatment Period 1||190
5142892|NCT01352468|12648977|P2|NOT COMPLETED|Overall Study||4
5142893|NCT01352468|12648978|P1|NOT COMPLETED|Overall Study||5
5142894|NCT01352468|12648977|P2|COMPLETED|Overall Study||18
5142895|NCT01352468|12648978|P1|COMPLETED|Overall Study||17
5142896|NCT01352468|12648977|P2|STARTED|Overall Study||22
5142897|NCT01352468|12648978|P1|STARTED|Overall Study||22
5142898|NCT01352442|12648988|P1|NOT COMPLETED|Overall Study||12
5142899|NCT01352442|12648988|P1|COMPLETED|Overall Study||139
5142900|NCT01352442|12648988|P1|STARTED|Overall Study||151
5142901|NCT01352416|12648997|P4|NOT COMPLETED|Overall Study||1
5142902|NCT01352416|12648998|P3|NOT COMPLETED|Overall Study||2
5142903|NCT01352416|12648999|P2|NOT COMPLETED|Overall Study||2
5142904|NCT01352416|12649000|P1|NOT COMPLETED|Overall Study||1
5142905|NCT01352416|12648997|P4|COMPLETED|Overall Study||1
5142906|NCT01352416|12648998|P3|COMPLETED|Overall Study||0
5142907|NCT01352416|12648999|P2|COMPLETED|Overall Study||5
5142908|NCT01352416|12649000|P1|COMPLETED|Overall Study||3
5142909|NCT01352416|12648997|P4|STARTED|Overall Study||2
5142910|NCT01352416|12648998|P3|STARTED|Overall Study||2
5142911|NCT01352416|12648999|P2|STARTED|Overall Study||7
5142912|NCT01352416|12649000|P1|STARTED|Overall Study||4
5142913|NCT01352286|12649010|P1|NOT COMPLETED|Overall Study||0
5142914|NCT01352286|12649010|P1|COMPLETED|Overall Study||25
5142915|NCT01352286|12649010|P1|Received T-cells|Overall Study||25
5142916|NCT01352286|12649010|P1|STARTED|Overall Study||25
5142917|NCT01352221|12649022|P4|NOT COMPLETED|Open-label Phase||11
5142918|NCT01352221|12649023|P3|NOT COMPLETED|Open-label Phase||13
5142919|NCT01352221|12649024|P2|NOT COMPLETED|Open-label Phase||0
5142920|NCT01352221|12649025|P1|NOT COMPLETED|Open-label Phase||0
5142921|NCT01352221|12649022|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
5142922|NCT01352221|12649023|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
5142923|NCT01352221|12649024|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
5142924|NCT01352221|12649025|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
5142925|NCT01352221|12649022|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
5142926|NCT01352221|12649023|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
5142927|NCT01352221|12649024|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
5142928|NCT01352221|12649025|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
5142929|NCT01352221|12649022|P4|NOT COMPLETED|Double-blind Phase||0
5142930|NCT01352221|12649023|P3|NOT COMPLETED|Double-blind Phase||0
5142931|NCT01352221|12649024|P2|NOT COMPLETED|Double-blind Phase||11
5142932|NCT01352221|12649025|P1|NOT COMPLETED|Double-blind Phase||9
5142933|NCT01352221|12649022|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
5142934|NCT01352221|12649023|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
5142935|NCT01352221|12649024|P2|COMPLETED|Double-blind Phase||53
5142936|NCT01352221|12649025|P1|COMPLETED|Double-blind Phase||55
5142937|NCT01352221|12649022|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
5142938|NCT01352221|12649023|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
5142939|NCT01352221|12649024|P2|STARTED|Double-blind Phase||64
5142940|NCT01352221|12649025|P1|STARTED|Double-blind Phase||64
5142941|NCT01352117|12649085|P2|NOT COMPLETED|Overall Study||24
5142942|NCT01352117|12649086|P1|NOT COMPLETED|Overall Study||21
5142943|NCT01352117|12649085|P2|COMPLETED|Overall Study||72
5142944|NCT01352117|12649086|P1|COMPLETED|Overall Study||75
5142945|NCT01352117|12649085|P2|Study Week 96 Data Potential|Overall Study||61
5142946|NCT01352117|12649086|P1|Study Week 96 Data Potential|Overall Study||58
5142947|NCT01352117|12649085|P2|Study Week 48 Data Potential|Overall Study||83
5142948|NCT01352117|12649086|P1|Study Week 48 Data Potential|Overall Study||80
5142949|NCT01352117|12649085|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
5142950|NCT01352117|12649086|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
5142951|NCT01352117|12649085|P2|STARTED|Overall Study||96
5142952|NCT01352117|12649086|P1|STARTED|Overall Study||96
5142953|NCT01351740|12649140|P2|NOT COMPLETED|Overall Study||6
5142954|NCT01351740|12649141|P1|NOT COMPLETED|Overall Study||2
5142955|NCT01351740|12649140|P2|COMPLETED|Overall Study||19
5142956|NCT01351740|12649141|P1|COMPLETED|Overall Study||23
5142957|NCT01351740|12649140|P2|STARTED|Overall Study||25
5142958|NCT01351740|12649141|P1|STARTED|Overall Study||25
5142959|NCT01351623|12649149|P1|NOT COMPLETED|Overall Study||9
5142960|NCT01351623|12649149|P1|COMPLETED|Overall Study||35
5142961|NCT01351623|12649149|P1|STARTED|Overall Study||44
5142962|NCT01351506|12649155|P1|NOT COMPLETED|Overall Study||137
5142963|NCT01351506|12649155|P1|COMPLETED|Overall Study||465
5142964|NCT01351506|12649155|P1|STARTED|Overall Study||602
5142965|NCT01351480|12649165|P1|NOT COMPLETED|Overall Study||8
5142966|NCT01351480|12649165|P1|COMPLETED|Overall Study||26
5142967|NCT01351480|12649165|P1|STARTED|Overall Study||34
5142968|NCT01351415|12649175|P2|NOT COMPLETED|Overall Study||240
5142969|NCT01351415|12649176|P1|NOT COMPLETED|Overall Study||245
5142970|NCT01351415|12649175|P2|COMPLETED|Overall Study||0
5142971|NCT01351415|12649176|P1|COMPLETED|Overall Study||0
5142972|NCT01351415|12649175|P2|Treated Participants|Overall Study||232
5142973|NCT01351415|12649176|P1|Treated Participants|Overall Study||243
5142974|NCT01351415|12649175|P2|STARTED|Overall Study||240
5142975|NCT01351415|12649176|P1|STARTED|Overall Study||245
5142976|NCT01351376|12649198|P2|NOT COMPLETED|Overall Study||0
5142977|NCT01351376|12649199|P1|NOT COMPLETED|Overall Study||0
5142978|NCT01351376|12649198|P2|COMPLETED|Overall Study||11
5142979|NCT01351376|12649199|P1|COMPLETED|Overall Study||10
5142980|NCT01351376|12649198|P2|STARTED|Overall Study||11
5142981|NCT01351376|12649199|P1|STARTED|Overall Study||10
5142982|NCT01351350|12649212|P5|NOT COMPLETED|Overall Study||7
5142983|NCT01351350|12649213|P4|NOT COMPLETED|Overall Study||13
5142984|NCT01351350|12649214|P3|NOT COMPLETED|Overall Study||11
5142985|NCT01351350|12649215|P2|NOT COMPLETED|Overall Study||29
5142986|NCT01351350|12649216|P1|NOT COMPLETED|Overall Study||8
5142987|NCT01351350|12649212|P5|COMPLETED|Overall Study||0
5142988|NCT01351350|12649213|P4|COMPLETED|Overall Study||0
5142989|NCT01351350|12649214|P3|COMPLETED|Overall Study||0
5142990|NCT01351350|12649215|P2|COMPLETED|Overall Study||0
5142991|NCT01351350|12649216|P1|COMPLETED|Overall Study||0
5142992|NCT01351350|12649212|P5|Dose-escalation Evaluable|Overall Study||0
5142993|NCT01351350|12649213|P4|Dose-escalation Evaluable|Overall Study||0
5142994|NCT01351350|12649214|P3|Dose-escalation Evaluable|Overall Study||10
5142995|NCT01351350|12649215|P2|Dose-escalation Evaluable|Overall Study||23
5142996|NCT01351350|12649216|P1|Dose-escalation Evaluable|Overall Study||7
5142997|NCT01351350|12649212|P5|Treated|Overall Study||7
5142998|NCT01351350|12649213|P4|Treated|Overall Study||13
5142999|NCT01351350|12649214|P3|Treated|Overall Study||10
5143000|NCT01351350|12649215|P2|Treated|Overall Study||29
5143001|NCT01351350|12649216|P1|Treated|Overall Study||8
5143002|NCT01351350|12649212|P5|STARTED|Overall Study||7
5143003|NCT01351350|12649213|P4|STARTED|Overall Study||13
5143004|NCT01351350|12649214|P3|STARTED|Overall Study||11
5143005|NCT01351350|12649215|P2|STARTED|Overall Study||29
5143006|NCT01351350|12649216|P1|STARTED|Overall Study||8
5143007|NCT01351337|12649329|P1|NOT COMPLETED|Overall Study||0
5143008|NCT01351337|12649329|P1|COMPLETED|Overall Study||58
5143009|NCT01351337|12649329|P1|STARTED|Overall Study||58
5143010|NCT01351090|12649338|P3|NOT COMPLETED|Overall Study||6
5143011|NCT01351090|12649339|P2|NOT COMPLETED|Overall Study||11
5143012|NCT01351090|12649340|P1|NOT COMPLETED|Overall Study||11
5143013|NCT01351090|12649338|P3|COMPLETED|Overall Study||36
5143014|NCT01351090|12649339|P2|COMPLETED|Overall Study||31
5143015|NCT01351090|12649340|P1|COMPLETED|Overall Study||32
5143016|NCT01351090|12649338|P3|STARTED|Overall Study||42
5143017|NCT01351090|12649339|P2|STARTED|Overall Study||42
5143018|NCT01351090|12649340|P1|STARTED|Overall Study||43
5143019|NCT01351077|12649359|P2|NOT COMPLETED|Overall Study||0
5143020|NCT01351077|12649360|P1|NOT COMPLETED|Overall Study||0
5143021|NCT01351077|12649359|P2|COMPLETED|Overall Study||180
5143022|NCT01351077|12649360|P1|COMPLETED|Overall Study||180
5143023|NCT01351077|12649359|P2|STARTED|Overall Study||180
5143024|NCT01351077|12649360|P1|STARTED|Overall Study||180
5143025|NCT01351064|12649376|P2|NOT COMPLETED|Overall Study||0
5143026|NCT01351064|12649377|P1|NOT COMPLETED|Overall Study||0
5143027|NCT01351064|12649376|P2|COMPLETED|Overall Study||42
5143028|NCT01351064|12649377|P1|COMPLETED|Overall Study||42
5143029|NCT01351064|12649376|P2|STARTED|Overall Study||42
5143030|NCT01351064|12649377|P1|STARTED|Overall Study||42
5143031|NCT01351025|12649387|P2|NOT COMPLETED|Week 44 - 48||0
5143032|NCT01351025|12649388|P1|NOT COMPLETED|Week 44 - 48||0
5143033|NCT01351025|12649387|P2|COMPLETED|Week 44 - 48||43
5143034|NCT01351025|12649388|P1|COMPLETED|Week 44 - 48||42
5143035|NCT01351025|12649387|P2|STARTED|Week 44 - 48||43
5143036|NCT01351025|12649388|P1|STARTED|Week 44 - 48||42
5143037|NCT01351025|12649387|P2|NOT COMPLETED|Week 24 - 44||4
5143038|NCT01351025|12649388|P1|NOT COMPLETED|Week 24 - 44||1
5143039|NCT01351025|12649387|P2|COMPLETED|Week 24 - 44||43
5143040|NCT01351025|12649388|P1|COMPLETED|Week 24 - 44||42
5143041|NCT01351025|12649387|P2|STARTED|Week 24 - 44||47
5143042|NCT01351025|12649388|P1|STARTED|Week 24 - 44||43
5143043|NCT01351025|12649387|P2|NOT COMPLETED|Week 20 - 24||0
5143044|NCT01351025|12649388|P1|NOT COMPLETED|Week 20 - 24||0
5143045|NCT01351025|12649387|P2|COMPLETED|Week 20 - 24||47
5143046|NCT01351025|12649388|P1|COMPLETED|Week 20 - 24||43
5143047|NCT01351025|12649387|P2|STARTED|Week 20 - 24||47
5143048|NCT01351025|12649388|P1|STARTED|Week 20 - 24||43
5143049|NCT01351025|12649387|P2|NOT COMPLETED|Week 0 - 20||1
5143050|NCT01351025|12649388|P1|NOT COMPLETED|Week 0 - 20||3
5143051|NCT01351025|12649387|P2|COMPLETED|Week 0 - 20||47
5143052|NCT01351025|12649388|P1|COMPLETED|Week 0 - 20||43
5143053|NCT01351025|12649387|P2|STARTED|Week 0 - 20||48
5143054|NCT01351025|12649388|P1|STARTED|Week 0 - 20||46
5143055|NCT01350999|12649421|P3|NOT COMPLETED|Overall Study||21
5143056|NCT01350999|12649422|P2|NOT COMPLETED|Overall Study||14
5143057|NCT01350999|12649423|P1|NOT COMPLETED|Overall Study||8
5143058|NCT01350999|12649421|P3|COMPLETED|Overall Study||146
5143059|NCT01350999|12649422|P2|COMPLETED|Overall Study||157
5143060|NCT01350999|12649423|P1|COMPLETED|Overall Study||157
5143061|NCT01350999|12649421|P3|Treated|Overall Study||167
5143062|NCT01350999|12649422|P2|Treated|Overall Study||171
5143063|NCT01350999|12649423|P1|Treated|Overall Study||165
5143064|NCT01350999|12649421|P3|STARTED|Overall Study||167
5143065|NCT01350999|12649422|P2|STARTED|Overall Study||171
5143066|NCT01350999|12649423|P1|STARTED|Overall Study||165
5143067|NCT01350973|12649461|P3|NOT COMPLETED|Overall Study||8
5143068|NCT01350973|12649462|P2|NOT COMPLETED|Overall Study||8
5143069|NCT01350973|12649463|P1|NOT COMPLETED|Overall Study||6
5143070|NCT01350973|12649461|P3|COMPLETED|Overall Study||187
5143071|NCT01350973|12649462|P2|COMPLETED|Overall Study||202
5143072|NCT01350973|12649463|P1|COMPLETED|Overall Study||200
5143073|NCT01350973|12649461|P3|Received Treatment|Overall Study||195
5143074|NCT01350973|12649462|P2|Received Treatment|Overall Study||210
5143075|NCT01350973|12649463|P1|Received Treatment|Overall Study||205
5143076|NCT01350973|12649461|P3|STARTED|Overall Study||195
5143077|NCT01350973|12649462|P2|STARTED|Overall Study||210
5143078|NCT01350973|12649463|P1|STARTED|Overall Study||206
5143079|NCT01350947|12649498|P1|NOT COMPLETED|Overall Study||0
5143080|NCT01350947|12649498|P1|COMPLETED|Overall Study||11
5143081|NCT01350947|12649498|P1|STARTED|Overall Study||11
5143082|NCT01350934|12649504|P2|NOT COMPLETED|Extension Study||4
5143083|NCT01350934|12649505|P1|NOT COMPLETED|Extension Study||5
5143084|NCT01350934|12649504|P2|COMPLETED|Extension Study||101
5143085|NCT01350934|12649505|P1|COMPLETED|Extension Study||95
5143086|NCT01350934|12649504|P2|STARTED|Extension Study||105
5143087|NCT01350934|12649505|P1|STARTED|Extension Study||100
5143088|NCT01350934|12649504|P2|NOT COMPLETED|Base Study||3
5143089|NCT01350934|12649505|P1|NOT COMPLETED|Base Study||11
5143090|NCT01350934|12649504|P2|COMPLETED|Base Study||105
5143091|NCT01350934|12649505|P1|COMPLETED|Base Study||100
5143092|NCT01350934|12649504|P2|STARTED|Base Study||108
5143093|NCT01350934|12649505|P1|STARTED|Base Study||111
5143094|NCT01350804|12649527|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
5143095|NCT01350804|12649528|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
5143096|NCT01350804|12649529|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
5143097|NCT01350804|12649530|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
5143098|NCT01350804|12649527|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
5143099|NCT01350804|12649528|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
5143100|NCT01350804|12649529|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
5143101|NCT01350804|12649530|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
5143102|NCT01350804|12649527|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
5143103|NCT01350804|12649528|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
5143104|NCT01350804|12649529|P2|STARTED|Extension Study, Weeks 52 - 260||79
5143105|NCT01350804|12649530|P1|STARTED|Extension Study, Weeks 52 - 260||80
5143106|NCT01350804|12649527|P4|NOT COMPLETED|Core Study||26
5143107|NCT01350804|12649528|P3|NOT COMPLETED|Core Study||47
5143108|NCT01350804|12649529|P2|NOT COMPLETED|Core Study||47
5143109|NCT01350804|12649530|P1|NOT COMPLETED|Core Study||41
5143110|NCT01350804|12649527|P4|COMPLETED|Core Study||112
5143111|NCT01350804|12649528|P3|COMPLETED|Core Study||91
5143112|NCT01350804|12649529|P2|COMPLETED|Core Study||90
5143113|NCT01350804|12649530|P1|COMPLETED|Core Study||97
5143114|NCT01350804|12649527|P4|Full Analysis Set|Core Study||138
5143115|NCT01350804|12649528|P3|Full Analysis Set|Core Study||138
5143116|NCT01350804|12649529|P2|Full Analysis Set|Core Study||137
5143117|NCT01350804|12649530|P1|Full Analysis Set|Core Study||138
5143118|NCT01350804|12649527|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
5143119|NCT01350804|12649528|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
5143120|NCT01350804|12649529|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
5143121|NCT01350804|12649530|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
5143122|NCT01350804|12649527|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
5143123|NCT01350804|12649528|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
5143124|NCT01350804|12649529|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
5143125|NCT01350804|12649530|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
5143126|NCT01350804|12649527|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
5143127|NCT01350804|12649528|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
5143128|NCT01350804|12649529|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
5143129|NCT01350804|12649530|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
5143130|NCT01350804|12649527|P4|STARTED|Core Study||138
5143131|NCT01350804|12649528|P3|STARTED|Core Study||138
5143132|NCT01350804|12649529|P2|STARTED|Core Study||137
5143133|NCT01350804|12649530|P1|STARTED|Core Study||138
5143134|NCT01350583|12649619|P1|NOT COMPLETED|Overall Study||0
5143135|NCT01350583|12649619|P1|COMPLETED|Overall Study||2
5143136|NCT01350583|12649619|P1|STARTED|Overall Study||2
5143137|NCT01350544|12649627|P2|NOT COMPLETED|Overall Study||22
5143138|NCT01350544|12649628|P1|NOT COMPLETED|Overall Study||23
5143139|NCT01350544|12649627|P2|COMPLETED|Overall Study||86
5143140|NCT01350544|12649628|P1|COMPLETED|Overall Study||85
5143141|NCT01350544|12649627|P2|STARTED|Overall Study||108
5143142|NCT01350544|12649628|P1|STARTED|Overall Study||108
5143143|NCT01350505|12649634|P1|NOT COMPLETED|Overall Study||4
5143144|NCT01350505|12649634|P1|COMPLETED|Overall Study||17
5143145|NCT01350505|12649634|P1|STARTED|Overall Study||21
5143146|NCT01350492|12649640|P2|NOT COMPLETED|Post Intervention Follow-Up||2
5143147|NCT01350492|12649641|P1|NOT COMPLETED|Post Intervention Follow-Up||6
5143148|NCT01350492|12649640|P2|COMPLETED|Post Intervention Follow-Up||18
5143149|NCT01350492|12649641|P1|COMPLETED|Post Intervention Follow-Up||17
5143150|NCT01350492|12649640|P2|6-month MRI Scan|Post Intervention Follow-Up||20
5143151|NCT01350492|12649641|P1|6-month MRI Scan|Post Intervention Follow-Up||20
5143152|NCT01350492|12649640|P2|STARTED|Post Intervention Follow-Up||20
5143153|NCT01350492|12649641|P1|STARTED|Post Intervention Follow-Up||23
5143154|NCT01350492|12649640|P2|NOT COMPLETED|Intervention||6
5143155|NCT01350492|12649641|P1|NOT COMPLETED|Intervention||5
5143156|NCT01350492|12649640|P2|COMPLETED|Intervention||20
5143157|NCT01350492|12649641|P1|COMPLETED|Intervention||23
5143158|NCT01350492|12649640|P2|11-week MRI Scan|Intervention||21
5143159|NCT01350492|12649641|P1|11-week MRI Scan|Intervention||23
5143160|NCT01350492|12649640|P2|6-week MRI Scan|Intervention||22
5143161|NCT01350492|12649641|P1|6-week MRI Scan|Intervention||24
5143162|NCT01350492|12649640|P2|STARTED|Intervention||26
5143163|NCT01350492|12649641|P1|STARTED|Intervention||28
5143164|NCT01350479|12649653|P2|NOT COMPLETED|Overall Study||0
5143165|NCT01350479|12649654|P1|NOT COMPLETED|Overall Study||0
5143166|NCT01350479|12649653|P2|COMPLETED|Overall Study||106
5143167|NCT01350479|12649654|P1|COMPLETED|Overall Study||94
5143168|NCT01350479|12649653|P2|STARTED|Overall Study||106
5143169|NCT01350479|12649654|P1|STARTED|Overall Study||94
5143170|NCT01350453|12649662|P2|NOT COMPLETED|Overall Study||1
5143171|NCT01350453|12649663|P1|NOT COMPLETED|Overall Study||2
5143172|NCT01350453|12649662|P2|COMPLETED|Overall Study||7
5143173|NCT01350453|12649663|P1|COMPLETED|Overall Study||9
5143174|NCT01350453|12649662|P2|STARTED|Overall Study||8
5143175|NCT01350453|12649663|P1|STARTED|Overall Study||11
5143176|NCT01350414|12649677|P1|NOT COMPLETED|Overall Study||19
5143177|NCT01350414|12649677|P1|COMPLETED|Overall Study||162
5143178|NCT01350414|12649677|P1|Year 5|Overall Study||162
5143179|NCT01350414|12649677|P1|Year 4|Overall Study||159
5143180|NCT01350414|12649677|P1|Year 3|Overall Study||162
5143181|NCT01350414|12649677|P1|Year 2|Overall Study||165
5143182|NCT01350414|12649677|P1|STARTED|Overall Study||181
5143183|NCT01350401|12649694|P1|NOT COMPLETED|Overall Study||0
5143184|NCT01350401|12649694|P1|COMPLETED|Overall Study||4
5143185|NCT01350401|12649694|P1|STARTED|Overall Study||4
5143186|NCT01350388|12649706|P2|NOT COMPLETED|Overall Study||1
5143187|NCT01350388|12649707|P1|NOT COMPLETED|Overall Study||3
5143188|NCT01350388|12649706|P2|COMPLETED|Overall Study||39
5143189|NCT01350388|12649707|P1|COMPLETED|Overall Study||37
5143190|NCT01350388|12649706|P2|STARTED|Overall Study||40
5143191|NCT01350388|12649707|P1|STARTED|Overall Study||40
5143192|NCT01350271|12649726|P3|NOT COMPLETED|Overall Study||26
5143193|NCT01350271|12649727|P2|NOT COMPLETED|Overall Study||17
5143194|NCT01350271|12649728|P1|NOT COMPLETED|Overall Study||21
5143195|NCT01350271|12649726|P3|COMPLETED|Overall Study||48
5143196|NCT01350271|12649727|P2|COMPLETED|Overall Study||53
5143197|NCT01350271|12649728|P1|COMPLETED|Overall Study||49
5143198|NCT01350271|12649726|P3|STARTED|Overall Study||74
5143199|NCT01350271|12649727|P2|STARTED|Overall Study||70
5143200|NCT01350271|12649728|P1|STARTED|Overall Study||70
5143201|NCT01350258|12649742|P1|NOT COMPLETED|Overall Study||0
5143202|NCT01350258|12649742|P1|COMPLETED|Overall Study||8
5143203|NCT01350258|12649742|P1|STARTED|Overall Study||8
5143204|NCT01350245|12649751|P1|NOT COMPLETED|Overall Study||0
5143205|NCT01350245|12649751|P1|COMPLETED|Overall Study||28
5143206|NCT01350245|12649751|P1|STARTED|Overall Study||28
5143207|NCT01350232|12649756|P1|NOT COMPLETED|Overall Study||0
5143208|NCT01350232|12649756|P1|COMPLETED|Overall Study||2
5143209|NCT01350232|12649756|P1|STARTED|Overall Study||2
5143210|NCT01350141|12649770|P3|NOT COMPLETED|Overall Study||1
5143211|NCT01350141|12649771|P2|NOT COMPLETED|Overall Study||0
5143212|NCT01350141|12649772|P1|NOT COMPLETED|Overall Study||3
5143213|NCT01350141|12649770|P3|COMPLETED|Overall Study||15
5143214|NCT01350141|12649771|P2|COMPLETED|Overall Study||15
5143215|NCT01350141|12649772|P1|COMPLETED|Overall Study||12
5143216|NCT01350141|12649770|P3|Treated|Overall Study||16
5143217|NCT01350141|12649771|P2|Treated|Overall Study||15
5143218|NCT01350141|12649772|P1|Treated|Overall Study||14
5143219|NCT01350141|12649770|P3|STARTED|Overall Study||16
5143220|NCT01350141|12649771|P2|STARTED|Overall Study||15
5143221|NCT01350141|12649772|P1|STARTED|Overall Study||15
5143222|NCT01350128|12649806|P1|NOT COMPLETED|Overall Study||14
5143223|NCT01350128|12649806|P1|COMPLETED|Overall Study||89
5143224|NCT01350128|12649806|P1|Atrovent HFA 34 µg BID|Overall Study||48
5143225|NCT01350128|12649806|P1|Placebo MDI BID|Overall Study||48
5143226|NCT01350128|12649806|P1|GP MDI 4.6 µg BID|Overall Study||45
5143227|NCT01350128|12649806|P1|GP MDI 9 µg BID|Overall Study||49
5143228|NCT01350128|12649806|P1|GP MDI 18 µg BID|Overall Study||49
5143229|NCT01350128|12649806|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
5143230|NCT01350128|12649806|P1|STARTED|Overall Study||103
5143231|NCT01350115|12649870|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
5143232|NCT01350115|12649871|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
5143233|NCT01350115|12649870|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
5143234|NCT01350115|12649871|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
5143235|NCT01350115|12649870|P2|STARTED|Long Term Follow-Up (All Patients)||2
5143236|NCT01350115|12649871|P1|STARTED|Long Term Follow-Up (All Patients)||8
5143237|NCT01350115|12649870|P2|NOT COMPLETED|Core Study (All Patients)||0
5143238|NCT01350115|12649871|P1|NOT COMPLETED|Core Study (All Patients)||0
5143239|NCT01350115|12649870|P2|COMPLETED|Core Study (All Patients)||2
5143240|NCT01350115|12649871|P1|COMPLETED|Core Study (All Patients)||8
5143241|NCT01350115|12649870|P2|Pharmacodynamic Set|Core Study (All Patients)||2
5143242|NCT01350115|12649871|P1|Pharmacodynamic Set|Core Study (All Patients)||7
5143243|NCT01350115|12649870|P2|Safety Anlysis Set|Core Study (All Patients)||2
5143244|NCT01350115|12649871|P1|Safety Anlysis Set|Core Study (All Patients)||8
5143245|NCT01350115|12649870|P2|STARTED|Core Study (All Patients)||2
5143246|NCT01350115|12649871|P1|STARTED|Core Study (All Patients)||8
5143247|NCT01350102|12649887|P4|NOT COMPLETED|Overall Study||0
5143248|NCT01350102|12649888|P3|NOT COMPLETED|Overall Study||1
5143249|NCT01350102|12649889|P2|NOT COMPLETED|Overall Study||0
5143250|NCT01350102|12649890|P1|NOT COMPLETED|Overall Study||0
5143251|NCT01350102|12649887|P4|COMPLETED|Overall Study||0
5143252|NCT01350102|12649888|P3|COMPLETED|Overall Study||0
5143253|NCT01350102|12649889|P2|COMPLETED|Overall Study||1
5143254|NCT01350102|12649890|P1|COMPLETED|Overall Study||0
5143255|NCT01350102|12649887|P4|STARTED|Overall Study||0
5143256|NCT01350102|12649888|P3|STARTED|Overall Study||1
5143257|NCT01350102|12649889|P2|STARTED|Overall Study||1
5143258|NCT01350102|12649890|P1|STARTED|Overall Study||0
5143259|NCT01349972|12649910|P2|NOT COMPLETED|Overall Study||2
5143260|NCT01349972|12649911|P1|NOT COMPLETED|Overall Study||5
5143261|NCT01349972|12649910|P2|COMPLETED|Overall Study||56
5143262|NCT01349972|12649911|P1|COMPLETED|Overall Study||109
5143263|NCT01349972|12649910|P2|STARTED|Overall Study||58
5143264|NCT01349972|12649911|P1|STARTED|Overall Study||114
5143265|NCT01349959|12649927|P1|NOT COMPLETED|Overall Study||7
5143266|NCT01349959|12649927|P1|COMPLETED|Overall Study||33
5143267|NCT01349959|12649927|P1|STARTED|Overall Study||40
5143268|NCT01349933|12649938|P1|NOT COMPLETED|Overall Study||0
5143269|NCT01349933|12649938|P1|COMPLETED|Overall Study||21
5143270|NCT01349933|12649938|P1|STARTED|Overall Study||21
5143271|NCT01349920|12649948|P1|NOT COMPLETED|Overall Study||0
5143272|NCT01349920|12649948|P1|COMPLETED|Overall Study||15
5143273|NCT01349920|12649948|P1|STARTED|Overall Study||15
5143274|NCT01349907|12649968|P2|NOT COMPLETED|Overall Study||43
5143275|NCT01349907|12649969|P1|NOT COMPLETED|Overall Study||139
5143276|NCT01349907|12649968|P2|COMPLETED|Overall Study||38
5143277|NCT01349907|12649969|P1|COMPLETED|Overall Study||102
5143278|NCT01349907|12649968|P2|STARTED|Overall Study|Enrolled and Treated|81
5143279|NCT01349907|12649969|P1|STARTED|Overall Study|Enrolled and Treated|241
5143280|NCT01349829|12650007|P2|NOT COMPLETED|Overall Study||23
5143281|NCT01349829|12650008|P1|NOT COMPLETED|Overall Study||9
5143282|NCT01349829|12650007|P2|COMPLETED|Overall Study||102
5143283|NCT01349829|12650008|P1|COMPLETED|Overall Study||117
5143284|NCT01349829|12650007|P2|STARTED|Overall Study||125
5143285|NCT01349829|12650008|P1|STARTED|Overall Study||126
5143286|NCT01349816|12650026|P1|NOT COMPLETED|Overall Study||30
5143287|NCT01349816|12650026|P1|COMPLETED|Overall Study||155
5143288|NCT01349816|12650026|P1|FF MDI 9.6 µg|Overall Study||61
5143289|NCT01349816|12650026|P1|GFF MDI 9/9.6 µg|Overall Study||57
5143290|NCT01349816|12650026|P1|GFF MDI 18/9.6 µg|Overall Study||57
5143291|NCT01349816|12650026|P1|GFF MDI 36/9.6 µg|Overall Study||56
5143292|NCT01349816|12650026|P1|GFF MDI 36/7.2 µg|Overall Study||58
5143293|NCT01349816|12650026|P1|GP MDI 36 µg|Overall Study||61
5143294|NCT01349816|12650026|P1|STARTED|Overall Study||185
5143295|NCT01349803|12650092|P4|NOT COMPLETED|Overall Study||2
5143296|NCT01349803|12650093|P3|NOT COMPLETED|Overall Study||3
5143297|NCT01349803|12650094|P2|NOT COMPLETED|Overall Study||1
5143298|NCT01349803|12650095|P1|NOT COMPLETED|Overall Study||1
5143299|NCT01349803|12650092|P4|COMPLETED|Overall Study||57
5143300|NCT01349803|12650093|P3|COMPLETED|Overall Study||57
5143301|NCT01349803|12650094|P2|COMPLETED|Overall Study||57
5143302|NCT01349803|12650095|P1|COMPLETED|Overall Study||59
5143303|NCT01349803|12650092|P4|STARTED|Overall Study||59
5143304|NCT01349803|12650093|P3|STARTED|Overall Study||60
5143305|NCT01349803|12650094|P2|STARTED|Overall Study||58
5143306|NCT01349803|12650095|P1|STARTED|Overall Study||60
5143307|NCT01349790|12650165|P1|NOT COMPLETED|Overall Study||9
5143308|NCT01349790|12650165|P1|COMPLETED|Overall Study||31
5143309|NCT01349790|12650165|P1|STARTED|Overall Study||40
5143310|NCT01349673|12650184|P1|NOT COMPLETED|Overall Study||114
5143311|NCT01349673|12650184|P1|COMPLETED|Overall Study||0
5143312|NCT01349673|12650184|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
5143313|NCT01349673|12650184|P1|Participants Entered Cycle 8|Overall Study||1
5143314|NCT01349673|12650184|P1|Participants Entered Cycle 7|Overall Study||3
5143315|NCT01349673|12650184|P1|Participants Entered Cycle 6|Overall Study||5
5143316|NCT01349673|12650184|P1|Participants Entered Cycle 5|Overall Study||12
5143317|NCT01349673|12650184|P1|Participants Entered Cycle 4|Overall Study||22
5143318|NCT01349673|12650184|P1|Participants Entered Cycle 3|Overall Study||41
5143319|NCT01349673|12650184|P1|Participants Entered Cycle 2|Overall Study||65
5143320|NCT01349673|12650184|P1|Participants Entered Cycle 1|Overall Study||114
5143321|NCT01349673|12650184|P1|STARTED|Overall Study||114
5143322|NCT01349660|12650194|P3|NOT COMPLETED|Overall Study||76
5143323|NCT01349660|12650195|P2|NOT COMPLETED|Overall Study||6
5143324|NCT01349660|12650196|P1|NOT COMPLETED|Overall Study||6
5143325|NCT01349660|12650194|P3|COMPLETED|Overall Study||0
5143326|NCT01349660|12650195|P2|COMPLETED|Overall Study||0
5143327|NCT01349660|12650196|P1|COMPLETED|Overall Study||0
5143328|NCT01349660|12650194|P3|STARTED|Overall Study||76
5143329|NCT01349660|12650195|P2|STARTED|Overall Study||6
5143330|NCT01349660|12650196|P1|STARTED|Overall Study||6
5143331|NCT01349595|12650214|P2|NOT COMPLETED|Overall Study||2
5143332|NCT01349595|12650215|P1|NOT COMPLETED|Overall Study||2
5143333|NCT01349595|12650214|P2|COMPLETED|Overall Study||0
5143334|NCT01349595|12650215|P1|COMPLETED|Overall Study||0
5143335|NCT01349595|12650214|P2|STARTED|Overall Study||2
5143336|NCT01349595|12650215|P1|STARTED|Overall Study||2
5143337|NCT01349569|12650221|P1|NOT COMPLETED|Overall Study||4
5143338|NCT01349569|12650221|P1|COMPLETED|Overall Study||12
5143339|NCT01349569|12650221|P1|STARTED|Overall Study||16
5143340|NCT01349491|12650233|P2|NOT COMPLETED|Overall Study||0
5143341|NCT01349491|12650234|P1|NOT COMPLETED|Overall Study||0
5143342|NCT01349491|12650233|P2|COMPLETED|Overall Study||5
5143343|NCT01349491|12650234|P1|COMPLETED|Overall Study||5
5143344|NCT01349491|12650233|P2|STARTED|Overall Study||5
5143345|NCT01349491|12650234|P1|STARTED|Overall Study||5
5143346|NCT01349465|12650242|P2|NOT COMPLETED|Overall Study||22
5143347|NCT01349465|12650243|P1|NOT COMPLETED|Overall Study||18
5143348|NCT01349465|12650242|P2|COMPLETED|Overall Study||27
5143349|NCT01349465|12650243|P1|COMPLETED|Overall Study||182
5143350|NCT01349465|12650242|P2|STARTED|Overall Study||49
5143351|NCT01349465|12650243|P1|STARTED|Overall Study||200
5143352|NCT01349231|12650255|P1|NOT COMPLETED|Overall Study||0
5143353|NCT01349231|12650255|P1|COMPLETED|Overall Study||10
5143354|NCT01349231|12650255|P1|STARTED|Overall Study||10
5143355|NCT01349192|12650264|P2|NOT COMPLETED|Overall Study||6
5143356|NCT01349192|12650265|P1|NOT COMPLETED|Overall Study||3
5143357|NCT01349192|12650264|P2|COMPLETED|Overall Study||17
5143358|NCT01349192|12650265|P1|COMPLETED|Overall Study||21
5143359|NCT01349192|12650264|P2|Withdrawals|Overall Study||6
5143360|NCT01349192|12650265|P1|Withdrawals|Overall Study||3
5143361|NCT01349192|12650264|P2|Evaluable for Primary Endpoint|Overall Study||19
5143362|NCT01349192|12650265|P1|Evaluable for Primary Endpoint|Overall Study||22
5143363|NCT01349192|12650264|P2|STARTED|Overall Study||23
5143364|NCT01349192|12650265|P1|STARTED|Overall Study||24
5143365|NCT01349114|12650279|P2|NOT COMPLETED|Overall Study||0
5143366|NCT01349114|12650280|P1|NOT COMPLETED|Overall Study||0
5143367|NCT01349114|12650279|P2|COMPLETED|Overall Study||11
5143368|NCT01349114|12650280|P1|COMPLETED|Overall Study||10
5143369|NCT01349114|12650279|P2|STARTED|Overall Study||11
5143370|NCT01349114|12650280|P1|STARTED|Overall Study||10
5143371|NCT01349049|12650297|P9|NOT COMPLETED|Overall Study||55
5143372|NCT01349049|12650298|P8|NOT COMPLETED|Overall Study||4
5143373|NCT01349049|12650299|P7|NOT COMPLETED|Overall Study||5
5143374|NCT01349049|12650300|P6|NOT COMPLETED|Overall Study||6
5143375|NCT01349049|12650301|P5|NOT COMPLETED|Overall Study||3
5143376|NCT01349049|12650302|P4|NOT COMPLETED|Overall Study||3
5143377|NCT01349049|12650303|P3|NOT COMPLETED|Overall Study||3
5143378|NCT01349049|12650304|P2|NOT COMPLETED|Overall Study||7
5143379|NCT01349049|12650305|P1|NOT COMPLETED|Overall Study||3
5143380|NCT01349049|12650297|P9|COMPLETED|Overall Study||1
5143381|NCT01349049|12650298|P8|COMPLETED|Overall Study||0
5143382|NCT01349049|12650299|P7|COMPLETED|Overall Study||0
5143383|NCT01349049|12650300|P6|COMPLETED|Overall Study||0
5143384|NCT01349049|12650301|P5|COMPLETED|Overall Study||0
5143385|NCT01349049|12650302|P4|COMPLETED|Overall Study||0
5143386|NCT01349049|12650303|P3|COMPLETED|Overall Study||0
5143387|NCT01349049|12650304|P2|COMPLETED|Overall Study||0
5143388|NCT01349049|12650305|P1|COMPLETED|Overall Study||0
5143389|NCT01349049|12650297|P9|STARTED|Overall Study||56
5143390|NCT01349049|12650298|P8|STARTED|Overall Study||4
5143391|NCT01349049|12650299|P7|STARTED|Overall Study||5
5143392|NCT01349049|12650300|P6|STARTED|Overall Study||6
5143393|NCT01349049|12650301|P5|STARTED|Overall Study||3
5143394|NCT01349049|12650302|P4|STARTED|Overall Study||3
5143395|NCT01349049|12650303|P3|STARTED|Overall Study||3
5143396|NCT01349049|12650304|P2|STARTED|Overall Study||7
5143397|NCT01349049|12650305|P1|STARTED|Overall Study||3
5143398|NCT01349036|12650359|P2|NOT COMPLETED|Overall Study||24
5143399|NCT01349036|12650360|P1|NOT COMPLETED|Overall Study||14
5143400|NCT01349036|12650359|P2|COMPLETED|Overall Study||0
5143401|NCT01349036|12650360|P1|COMPLETED|Overall Study||0
5143402|NCT01349036|12650359|P2|STARTED|Overall Study||24
5143403|NCT01349036|12650360|P1|STARTED|Overall Study||14
5143404|NCT01348854|12650378|P2|NOT COMPLETED|Overall Study||1
5143405|NCT01348854|12650379|P1|NOT COMPLETED|Overall Study||3
5143406|NCT01348854|12650378|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
5143407|NCT01348854|12650379|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
5143408|NCT01348854|12650378|P2|STARTED|Overall Study|10 eyes of 6 participants|6
5143409|NCT01348854|12650379|P1|STARTED|Overall Study|53 eyes of 34 participants|34
5143410|NCT01348789|12650387|P1|NOT COMPLETED|Overall Study||4
5143411|NCT01348789|12650387|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
5143412|NCT01348789|12650387|P1|STARTED|Overall Study||37
5143413|NCT01348776|12650398|P1|NOT COMPLETED|Overall Study||3
5143414|NCT01348776|12650398|P1|COMPLETED|Overall Study||84
5143415|NCT01348776|12650398|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
5143416|NCT01348763|12650411|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
5143417|NCT01348763|12650411|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
5143418|NCT01348763|12650411|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
5143419|NCT01348763|12650411|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
5143420|NCT01348763|12650411|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
5143421|NCT01348763|12650411|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
5143422|NCT01348698|12650416|P1|NOT COMPLETED|Overall Study||72
5143423|NCT01348698|12650416|P1|COMPLETED|Overall Study||2
5143424|NCT01348698|12650416|P1|STARTED|Overall Study||74
5143425|NCT01348607|12650426|P3|NOT COMPLETED|Overall Study||0
5143426|NCT01348607|12650427|P2|NOT COMPLETED|Overall Study||0
5143427|NCT01348607|12650428|P1|NOT COMPLETED|Overall Study||0
5143428|NCT01348607|12650426|P3|COMPLETED|Overall Study||0
5143429|NCT01348607|12650427|P2|COMPLETED|Overall Study||0
5143430|NCT01348607|12650428|P1|COMPLETED|Overall Study||1
5143431|NCT01348607|12650426|P3|STARTED|Overall Study||0
5143432|NCT01348607|12650427|P2|STARTED|Overall Study||0
5143433|NCT01348607|12650428|P1|STARTED|Overall Study||1
5143434|NCT01348542|12650441|P2|NOT COMPLETED|Overall Study||0
5143435|NCT01348542|12650442|P1|NOT COMPLETED|Overall Study||3
5143436|NCT01348542|12650441|P2|COMPLETED|Overall Study||11
5143437|NCT01348542|12650442|P1|COMPLETED|Overall Study||10
5143438|NCT01348542|12650441|P2|STARTED|Overall Study||11
5143439|NCT01348542|12650442|P1|STARTED|Overall Study||13
5143440|NCT01348490|12650458|P1|NOT COMPLETED|Overall Study||24
5143441|NCT01348490|12650458|P1|COMPLETED|Overall Study||42
5143442|NCT01348490|12650458|P1|STARTED|Overall Study||66
5143443|NCT01348425|12650516|P2|NOT COMPLETED|Overall Study||1
5143444|NCT01348425|12650517|P1|NOT COMPLETED|Overall Study||1
5143445|NCT01348425|12650516|P2|COMPLETED|Overall Study||13
5143446|NCT01348425|12650517|P1|COMPLETED|Overall Study||30
5143447|NCT01348425|12650516|P2|STARTED|Overall Study||14
5143448|NCT01348425|12650517|P1|STARTED|Overall Study||31
5143449|NCT01348347|12650525|P3|NOT COMPLETED|Overall Study||6
5143450|NCT01348347|12650526|P2|NOT COMPLETED|Overall Study||6
5143451|NCT01348347|12650527|P1|NOT COMPLETED|Overall Study||3
5143452|NCT01348347|12650525|P3|COMPLETED|Overall Study||0
5143453|NCT01348347|12650526|P2|COMPLETED|Overall Study||0
5143454|NCT01348347|12650527|P1|COMPLETED|Overall Study||0
5143455|NCT01348347|12650525|P3|STARTED|Overall Study||6
5143456|NCT01348347|12650526|P2|STARTED|Overall Study||6
5143457|NCT01348347|12650527|P1|STARTED|Overall Study||3
5143458|NCT01348165|12650558|P7|NOT COMPLETED|Overall Study||1
5143459|NCT01348165|12650559|P6|NOT COMPLETED|Overall Study||0
5143460|NCT01348165|12650560|P5|NOT COMPLETED|Overall Study||0
5143461|NCT01348165|12650561|P4|NOT COMPLETED|Overall Study||0
5143462|NCT01348165|12650562|P3|NOT COMPLETED|Overall Study||0
5143463|NCT01348165|12650563|P2|NOT COMPLETED|Overall Study||0
5143464|NCT01348165|12650564|P1|NOT COMPLETED|Overall Study||0
5143465|NCT01348165|12650558|P7|COMPLETED|Overall Study||5
5143466|NCT01348165|12650559|P6|COMPLETED|Overall Study||1
5143467|NCT01348165|12650560|P5|COMPLETED|Overall Study||6
5143468|NCT01348165|12650561|P4|COMPLETED|Overall Study||6
5143469|NCT01348165|12650562|P3|COMPLETED|Overall Study||6
5143470|NCT01348165|12650563|P2|COMPLETED|Overall Study||5
5143471|NCT01348165|12650564|P1|COMPLETED|Overall Study||10
5143472|NCT01348165|12650558|P7|STARTED|Overall Study||6
5143473|NCT01348165|12650559|P6|STARTED|Overall Study||1
5143474|NCT01348165|12650560|P5|STARTED|Overall Study||6
5143475|NCT01348165|12650561|P4|STARTED|Overall Study||6
5143476|NCT01348165|12650562|P3|STARTED|Overall Study||6
5143477|NCT01348165|12650563|P2|STARTED|Overall Study||5
5143478|NCT01348165|12650564|P1|STARTED|Overall Study||10
5143479|NCT01348139|12650693|P6|NOT COMPLETED|Period 6||0
5143480|NCT01348139|12650694|P5|NOT COMPLETED|Period 6||0
5143481|NCT01348139|12650695|P4|NOT COMPLETED|Period 6||0
5143482|NCT01348139|12650696|P3|NOT COMPLETED|Period 6||0
5143483|NCT01348139|12650697|P2|NOT COMPLETED|Period 6||0
5143484|NCT01348139|12650698|P1|NOT COMPLETED|Period 6||0
5143485|NCT01348139|12650693|P6|COMPLETED|Period 6||4
5143486|NCT01348139|12650694|P5|COMPLETED|Period 6||5
5143487|NCT01348139|12650695|P4|COMPLETED|Period 6||4
5143488|NCT01348139|12650696|P3|COMPLETED|Period 6||4
5143489|NCT01348139|12650697|P2|COMPLETED|Period 6||4
5143490|NCT01348139|12650698|P1|COMPLETED|Period 6||4
5143491|NCT01348139|12650693|P6|STARTED|Period 6||4
5143492|NCT01348139|12650694|P5|STARTED|Period 6||5
5143493|NCT01348139|12650695|P4|STARTED|Period 6||4
5143494|NCT01348139|12650696|P3|STARTED|Period 6||4
5143495|NCT01348139|12650697|P2|STARTED|Period 6||4
5143496|NCT01348139|12650698|P1|STARTED|Period 6||4
5143497|NCT01348139|12650693|P6|NOT COMPLETED|Period 5||0
5143498|NCT01348139|12650694|P5|NOT COMPLETED|Period 5||0
5143499|NCT01348139|12650695|P4|NOT COMPLETED|Period 5||0
5143500|NCT01348139|12650696|P3|NOT COMPLETED|Period 5||0
5143501|NCT01348139|12650697|P2|NOT COMPLETED|Period 5||0
5143502|NCT01348139|12650698|P1|NOT COMPLETED|Period 5||0
5143503|NCT01348139|12650693|P6|COMPLETED|Period 5||4
5143504|NCT01348139|12650694|P5|COMPLETED|Period 5||5
5143505|NCT01348139|12650695|P4|COMPLETED|Period 5||4
5143506|NCT01348139|12650696|P3|COMPLETED|Period 5||4
5143507|NCT01348139|12650697|P2|COMPLETED|Period 5||4
5143508|NCT01348139|12650698|P1|COMPLETED|Period 5||4
5143509|NCT01348139|12650693|P6|STARTED|Period 5||4
5143510|NCT01348139|12650694|P5|STARTED|Period 5||5
5143511|NCT01348139|12650695|P4|STARTED|Period 5||4
5143512|NCT01348139|12650696|P3|STARTED|Period 5||4
5143513|NCT01348139|12650697|P2|STARTED|Period 5||4
5143514|NCT01348139|12650698|P1|STARTED|Period 5||4
5143515|NCT01348139|12650693|P6|NOT COMPLETED|Period 4||0
5143516|NCT01348139|12650694|P5|NOT COMPLETED|Period 4||0
5143517|NCT01348139|12650695|P4|NOT COMPLETED|Period 4||0
5143518|NCT01348139|12650696|P3|NOT COMPLETED|Period 4||0
5143519|NCT01348139|12650697|P2|NOT COMPLETED|Period 4||0
5143520|NCT01348139|12650698|P1|NOT COMPLETED|Period 4||0
5143521|NCT01348139|12650693|P6|COMPLETED|Period 4||4
5143522|NCT01348139|12650694|P5|COMPLETED|Period 4||5
5143523|NCT01348139|12650695|P4|COMPLETED|Period 4||4
5143524|NCT01348139|12650696|P3|COMPLETED|Period 4||4
5143525|NCT01348139|12650697|P2|COMPLETED|Period 4||4
5143526|NCT01348139|12650698|P1|COMPLETED|Period 4||4
5143527|NCT01348139|12650693|P6|STARTED|Period 4||4
5143528|NCT01348139|12650694|P5|STARTED|Period 4||5
5143529|NCT01348139|12650695|P4|STARTED|Period 4||4
5143530|NCT01348139|12650696|P3|STARTED|Period 4||4
5143531|NCT01348139|12650697|P2|STARTED|Period 4||4
5143532|NCT01348139|12650698|P1|STARTED|Period 4||4
5143533|NCT01348139|12650693|P6|NOT COMPLETED|Period 3||0
5143534|NCT01348139|12650694|P5|NOT COMPLETED|Period 3||0
5143535|NCT01348139|12650695|P4|NOT COMPLETED|Period 3||0
5143536|NCT01348139|12650696|P3|NOT COMPLETED|Period 3||0
5143537|NCT01348139|12650697|P2|NOT COMPLETED|Period 3||0
5143538|NCT01348139|12650698|P1|NOT COMPLETED|Period 3||0
5143539|NCT01348139|12650693|P6|COMPLETED|Period 3||4
5143540|NCT01348139|12650694|P5|COMPLETED|Period 3||5
5143541|NCT01348139|12650695|P4|COMPLETED|Period 3||4
5143542|NCT01348139|12650696|P3|COMPLETED|Period 3||4
5143543|NCT01348139|12650697|P2|COMPLETED|Period 3||4
5143544|NCT01348139|12650698|P1|COMPLETED|Period 3||4
5143545|NCT01348139|12650693|P6|STARTED|Period 3||4
5143546|NCT01348139|12650694|P5|STARTED|Period 3||5
5143547|NCT01348139|12650695|P4|STARTED|Period 3||4
5143548|NCT01348139|12650696|P3|STARTED|Period 3||4
5143549|NCT01348139|12650697|P2|STARTED|Period 3||4
5143550|NCT01348139|12650698|P1|STARTED|Period 3||4
5143551|NCT01348139|12650693|P6|NOT COMPLETED|Period 2||0
5143552|NCT01348139|12650694|P5|NOT COMPLETED|Period 2||0
5143553|NCT01348139|12650695|P4|NOT COMPLETED|Period 2||0
5143554|NCT01348139|12650696|P3|NOT COMPLETED|Period 2||0
5143555|NCT01348139|12650697|P2|NOT COMPLETED|Period 2||0
5143556|NCT01348139|12650698|P1|NOT COMPLETED|Period 2||0
5143557|NCT01348139|12650693|P6|COMPLETED|Period 2||4
5143558|NCT01348139|12650694|P5|COMPLETED|Period 2||5
5143559|NCT01348139|12650695|P4|COMPLETED|Period 2||4
5143560|NCT01348139|12650696|P3|COMPLETED|Period 2||4
5143561|NCT01348139|12650697|P2|COMPLETED|Period 2||4
5143562|NCT01348139|12650698|P1|COMPLETED|Period 2||4
5143563|NCT01348139|12650693|P6|STARTED|Period 2||4
5143564|NCT01348139|12650694|P5|STARTED|Period 2||5
5143565|NCT01348139|12650695|P4|STARTED|Period 2||4
5143566|NCT01348139|12650696|P3|STARTED|Period 2||4
5143567|NCT01348139|12650697|P2|STARTED|Period 2||4
5143568|NCT01348139|12650698|P1|STARTED|Period 2||4
5143569|NCT01348139|12650693|P6|NOT COMPLETED|Period 1||0
5143570|NCT01348139|12650694|P5|NOT COMPLETED|Period 1||0
5143571|NCT01348139|12650695|P4|NOT COMPLETED|Period 1||0
5143572|NCT01348139|12650696|P3|NOT COMPLETED|Period 1||0
5143573|NCT01348139|12650697|P2|NOT COMPLETED|Period 1||0
5143574|NCT01348139|12650698|P1|NOT COMPLETED|Period 1||1
5143575|NCT01348139|12650693|P6|COMPLETED|Period 1||4
5143576|NCT01348139|12650694|P5|COMPLETED|Period 1||5
5143577|NCT01348139|12650695|P4|COMPLETED|Period 1||4
5143578|NCT01348139|12650696|P3|COMPLETED|Period 1||4
5143579|NCT01348139|12650697|P2|COMPLETED|Period 1||4
5143580|NCT01348139|12650698|P1|COMPLETED|Period 1||4
5143581|NCT01348139|12650693|P6|STARTED|Period 1||4
5143582|NCT01348139|12650694|P5|STARTED|Period 1||5
5143583|NCT01348139|12650695|P4|STARTED|Period 1||4
5143584|NCT01348139|12650696|P3|STARTED|Period 1||4
5143585|NCT01348139|12650697|P2|STARTED|Period 1||4
5143586|NCT01348139|12650698|P1|STARTED|Period 1||5
5143587|NCT01348100|12650779|P7|NOT COMPLETED|Overall Study||3
5143588|NCT01348100|12650780|P6|NOT COMPLETED|Overall Study||2
5143589|NCT01348100|12650781|P5|NOT COMPLETED|Overall Study||1
5143590|NCT01348100|12650782|P4|NOT COMPLETED|Overall Study||1
5143591|NCT01348100|12650783|P3|NOT COMPLETED|Overall Study||2
5143592|NCT01348100|12650784|P2|NOT COMPLETED|Overall Study||0
5143593|NCT01348100|12650785|P1|NOT COMPLETED|Overall Study||0
5143594|NCT01348100|12650779|P7|COMPLETED|Overall Study||13
5143595|NCT01348100|12650780|P6|COMPLETED|Overall Study||14
5143596|NCT01348100|12650781|P5|COMPLETED|Overall Study||14
5143597|NCT01348100|12650782|P4|COMPLETED|Overall Study||14
5143598|NCT01348100|12650783|P3|COMPLETED|Overall Study||13
5143599|NCT01348100|12650784|P2|COMPLETED|Overall Study||2
5143600|NCT01348100|12650785|P1|COMPLETED|Overall Study||2
5143601|NCT01348100|12650779|P7|STARTED|Overall Study||16
5143602|NCT01348100|12650780|P6|STARTED|Overall Study||16
5143603|NCT01348100|12650781|P5|STARTED|Overall Study||15
5143604|NCT01348100|12650782|P4|STARTED|Overall Study||15
5143605|NCT01348100|12650783|P3|STARTED|Overall Study||15
5143606|NCT01348100|12650784|P2|STARTED|Overall Study||2
5143607|NCT01348100|12650785|P1|STARTED|Overall Study||2
5143608|NCT01348087|12650830|P1|NOT COMPLETED|Overall Study||148
5143609|NCT01348087|12650830|P1|COMPLETED|Overall Study||0
5143610|NCT01348087|12650830|P1|STARTED|Overall Study||148
5143611|NCT01347931|12650844|P1|NOT COMPLETED|NIOV System||0
5143612|NCT01347931|12650844|P1|COMPLETED|NIOV System||29
5143613|NCT01347931|12650844|P1|STARTED|NIOV System||29
5143614|NCT01347931|12650844|P1|NOT COMPLETED|Standard Oxygen Therapy||1
5143615|NCT01347931|12650844|P1|COMPLETED|Standard Oxygen Therapy||29
5143616|NCT01347931|12650844|P1|STARTED|Standard Oxygen Therapy||30
5143617|NCT01347879|12650856|P2|NOT COMPLETED|Overall Study||17
5143618|NCT01347879|12650857|P1|NOT COMPLETED|Overall Study||7
5143619|NCT01347879|12650856|P2|COMPLETED|Overall Study||83
5143620|NCT01347879|12650857|P1|COMPLETED|Overall Study||46
5143621|NCT01347879|12650856|P2|STARTED|Overall Study||100
5143622|NCT01347879|12650857|P1|STARTED|Overall Study||53
5143623|NCT01347866|12650906|P17|NOT COMPLETED|Overall Study||2
5143624|NCT01347866|12650907|P16|NOT COMPLETED|Overall Study||4
5143625|NCT01347866|12650908|P15|NOT COMPLETED|Overall Study||3
5143626|NCT01347866|12650909|P14|NOT COMPLETED|Overall Study||7
5143627|NCT01347866|12650910|P13|NOT COMPLETED|Overall Study||7
5143628|NCT01347866|12650911|P12|NOT COMPLETED|Overall Study||4
5143629|NCT01347866|12650912|P11|NOT COMPLETED|Overall Study||3
5143630|NCT01347866|12650913|P10|NOT COMPLETED|Overall Study||7
5143631|NCT01347866|12650914|P9|NOT COMPLETED|Overall Study||31
5143632|NCT01347866|12650915|P8|NOT COMPLETED|Overall Study||4
5143633|NCT01347866|12650916|P7|NOT COMPLETED|Overall Study||6
5143634|NCT01347866|12650917|P6|NOT COMPLETED|Overall Study||3
5143635|NCT01347866|12650918|P5|NOT COMPLETED|Overall Study||7
5143636|NCT01347866|12650919|P4|NOT COMPLETED|Overall Study||7
5143637|NCT01347866|12650920|P3|NOT COMPLETED|Overall Study||1
5143638|NCT01347866|12650921|P2|NOT COMPLETED|Overall Study||1
5143639|NCT01347866|12650922|P1|NOT COMPLETED|Overall Study||5
5143640|NCT01347866|12650906|P17|COMPLETED|Overall Study||0
5143641|NCT01347866|12650907|P16|COMPLETED|Overall Study||0
5143642|NCT01347866|12650908|P15|COMPLETED|Overall Study||0
5143643|NCT01347866|12650909|P14|COMPLETED|Overall Study||0
5143644|NCT01347866|12650910|P13|COMPLETED|Overall Study||0
5143645|NCT01347866|12650911|P12|COMPLETED|Overall Study||0
5143646|NCT01347866|12650912|P11|COMPLETED|Overall Study||0
5143647|NCT01347866|12650913|P10|COMPLETED|Overall Study||0
5143648|NCT01347866|12650914|P9|COMPLETED|Overall Study||0
5143649|NCT01347866|12650915|P8|COMPLETED|Overall Study||0
5143650|NCT01347866|12650916|P7|COMPLETED|Overall Study||0
5143651|NCT01347866|12650917|P6|COMPLETED|Overall Study||0
5143652|NCT01347866|12650918|P5|COMPLETED|Overall Study||0
5143653|NCT01347866|12650919|P4|COMPLETED|Overall Study||0
5143654|NCT01347866|12650920|P3|COMPLETED|Overall Study||0
5143655|NCT01347866|12650921|P2|COMPLETED|Overall Study||0
5143656|NCT01347866|12650922|P1|COMPLETED|Overall Study||0
5143657|NCT01347866|12650906|P17|STARTED|Overall Study||2
5143658|NCT01347866|12650907|P16|STARTED|Overall Study||4
5143659|NCT01347866|12650908|P15|STARTED|Overall Study||3
5143660|NCT01347866|12650909|P14|STARTED|Overall Study||7
5143661|NCT01347866|12650910|P13|STARTED|Overall Study||7
5143662|NCT01347866|12650911|P12|STARTED|Overall Study||4
5143663|NCT01347866|12650912|P11|STARTED|Overall Study||3
5143664|NCT01347866|12650913|P10|STARTED|Overall Study||7
5143665|NCT01347866|12650914|P9|STARTED|Overall Study||31
5143666|NCT01347866|12650915|P8|STARTED|Overall Study||4
5143667|NCT01347866|12650916|P7|STARTED|Overall Study||6
5143668|NCT01347866|12650917|P6|STARTED|Overall Study||3
5143669|NCT01347866|12650918|P5|STARTED|Overall Study||7
5143670|NCT01347866|12650919|P4|STARTED|Overall Study||7
5143671|NCT01347866|12650920|P3|STARTED|Overall Study||1
5143672|NCT01347866|12650921|P2|STARTED|Overall Study||1
5143673|NCT01347866|12650922|P1|STARTED|Overall Study||5
5143674|NCT01347840|12651296|P1|NOT COMPLETED|Overall Study||1
5143675|NCT01347840|12651296|P1|COMPLETED|Overall Study||0
5143676|NCT01347840|12651296|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
5143677|NCT01347788|12651309|P3|NOT COMPLETED|Overall Study||0
5143678|NCT01347788|12651310|P2|NOT COMPLETED|Overall Study||0
5143679|NCT01347788|12651311|P1|NOT COMPLETED|Overall Study||0
5143680|NCT01347788|12651309|P3|COMPLETED|Overall Study||13
5143681|NCT01347788|12651310|P2|COMPLETED|Overall Study||10
5143682|NCT01347788|12651311|P1|COMPLETED|Overall Study||11
5143683|NCT01347788|12651309|P3|STARTED|Overall Study||13
5143684|NCT01347788|12651310|P2|STARTED|Overall Study||10
5143685|NCT01347788|12651311|P1|STARTED|Overall Study||11
5143686|NCT01347762|12651323|P4|NOT COMPLETED|Overall Study||8
5143687|NCT01347762|12651324|P3|NOT COMPLETED|Overall Study||9
5143688|NCT01347762|12651325|P2|NOT COMPLETED|Overall Study||2
5143689|NCT01347762|12651326|P1|NOT COMPLETED|Overall Study||4
5143690|NCT01347762|12651323|P4|COMPLETED|Overall Study||10
5143691|NCT01347762|12651324|P3|COMPLETED|Overall Study||7
5143692|NCT01347762|12651325|P2|COMPLETED|Overall Study||6
5143693|NCT01347762|12651326|P1|COMPLETED|Overall Study||6
5143694|NCT01347762|12651323|P4|STARTED|Overall Study||18
5143695|NCT01347762|12651324|P3|STARTED|Overall Study||16
5143696|NCT01347762|12651325|P2|STARTED|Overall Study||8
5143697|NCT01347762|12651326|P1|STARTED|Overall Study||10
5143698|NCT01347710|12651352|P1|NOT COMPLETED|Overall Study||31
5143699|NCT01347710|12651352|P1|COMPLETED|Overall Study||764
5143700|NCT01347710|12651352|P1|STARTED|Overall Study||795
5143701|NCT01347632|12651367|P1|NOT COMPLETED|Overall Study||2
5143702|NCT01347632|12651367|P1|COMPLETED|Overall Study||33
5143703|NCT01347632|12651367|P1|STARTED|Overall Study||35
5143704|NCT01347580|12651374|P2|NOT COMPLETED|Overall Study||56
5143705|NCT01347580|12651375|P1|NOT COMPLETED|Overall Study||65
5143706|NCT01347580|12651374|P2|COMPLETED|Overall Study|based on randomized treatment|897
5143707|NCT01347580|12651375|P1|COMPLETED|Overall Study|based on randomized treatment|844
5143708|NCT01347580|12651374|P2|Safety Population|Overall Study|based on actual treatment|950
5143709|NCT01347580|12651375|P1|Safety Population|Overall Study|based on actual treatment|908
5143710|NCT01347580|12651374|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
5143711|NCT01347580|12651375|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
5143712|NCT01347580|12651374|P2|STARTED|Overall Study|based on randomized treatment|953
5143713|NCT01347580|12651375|P1|STARTED|Overall Study|based on randomized treatment|909
5143714|NCT01347554|12651405|P2|NOT COMPLETED|Overall Study||11
5143715|NCT01347554|12651406|P1|NOT COMPLETED|Overall Study||7
5143716|NCT01347554|12651405|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
5143717|NCT01347554|12651406|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
5143718|NCT01347554|12651405|P2|STARTED|Overall Study||242
5143719|NCT01347554|12651406|P1|STARTED|Overall Study||237
5143720|NCT01347333|12651420|P2|NOT COMPLETED|Overall Study||0
5143721|NCT01347333|12651421|P1|NOT COMPLETED|Overall Study||0
5143722|NCT01347333|12651420|P2|COMPLETED|Overall Study||0
5143723|NCT01347333|12651421|P1|COMPLETED|Overall Study||23
5143724|NCT01347333|12651420|P2|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
5143725|NCT01347333|12651421|P1|STARTED|Overall Study||23
5143726|NCT01347307|12651431|P2|NOT COMPLETED|Overall Study||5
5143727|NCT01347307|12651432|P1|NOT COMPLETED|Overall Study||0
5143728|NCT01347307|12651431|P2|COMPLETED|Overall Study||28
5143729|NCT01347307|12651432|P1|COMPLETED|Overall Study||3
5143730|NCT01347307|12651431|P2|STARTED|Overall Study||33
5143731|NCT01347307|12651432|P1|STARTED|Overall Study||3
5143732|NCT01347255|12651442|P1|NOT COMPLETED|Overall Study||0
5143733|NCT01347255|12651442|P1|COMPLETED|Overall Study||24
5143734|NCT01347255|12651442|P1|STARTED|Overall Study||24
5143735|NCT01347112|12651467|P2|NOT COMPLETED|Overall Study||12
5143736|NCT01347112|12651468|P1|NOT COMPLETED|Overall Study||4
5143737|NCT01347112|12651467|P2|COMPLETED|Overall Study||5
5143738|NCT01347112|12651468|P1|COMPLETED|Overall Study||12
5143739|NCT01347112|12651467|P2|STARTED|Overall Study||17
5143740|NCT01347112|12651468|P1|STARTED|Overall Study||16
5143741|NCT01347086|12651488|P10|NOT COMPLETED|Overall Study||1
5143742|NCT01347086|12651489|P9|NOT COMPLETED|Overall Study||0
5143743|NCT01347086|12651490|P8|NOT COMPLETED|Overall Study||1
5143744|NCT01347086|12651491|P7|NOT COMPLETED|Overall Study||1
5143745|NCT01347086|12651492|P6|NOT COMPLETED|Overall Study||0
5143746|NCT01347086|12651493|P5|NOT COMPLETED|Overall Study||0
5143747|NCT01347086|12651494|P4|NOT COMPLETED|Overall Study||0
5143748|NCT01347086|12651495|P3|NOT COMPLETED|Overall Study||1
5143749|NCT01347086|12651496|P2|NOT COMPLETED|Overall Study||0
5143750|NCT01347086|12651497|P1|NOT COMPLETED|Overall Study||0
5143751|NCT01347086|12651488|P10|COMPLETED|Overall Study||6
5143752|NCT01347086|12651489|P9|COMPLETED|Overall Study||6
5143753|NCT01347086|12651490|P8|COMPLETED|Overall Study||6
5143754|NCT01347086|12651491|P7|COMPLETED|Overall Study||6
5143755|NCT01347086|12651492|P6|COMPLETED|Overall Study||6
5143756|NCT01347086|12651493|P5|COMPLETED|Overall Study||6
5143757|NCT01347086|12651494|P4|COMPLETED|Overall Study||6
5143758|NCT01347086|12651495|P3|COMPLETED|Overall Study||6
5143759|NCT01347086|12651496|P2|COMPLETED|Overall Study||6
5143760|NCT01347086|12651497|P1|COMPLETED|Overall Study||2
5143761|NCT01347086|12651488|P10|STARTED|Overall Study|One subject was not treated.|7
5143762|NCT01347086|12651489|P9|STARTED|Overall Study||6
5143763|NCT01347086|12651490|P8|STARTED|Overall Study|One subject was not treated.|7
5143764|NCT01347086|12651491|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
5143765|NCT01347086|12651492|P6|STARTED|Overall Study||6
5143766|NCT01347086|12651493|P5|STARTED|Overall Study||6
5143767|NCT01347086|12651494|P4|STARTED|Overall Study||6
5143768|NCT01347086|12651495|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
5143769|NCT01347086|12651496|P2|STARTED|Overall Study||6
5143770|NCT01347086|12651497|P1|STARTED|Overall Study||2
5143771|NCT01347073|12651596|P1|NOT COMPLETED|Overall Study||2
5143772|NCT01347073|12651596|P1|COMPLETED|Overall Study||21
5143773|NCT01347073|12651596|P1|STARTED|Overall Study||23
5143774|NCT01347060|12651610|P2|NOT COMPLETED|Overall Study||0
5143775|NCT01347060|12651611|P1|NOT COMPLETED|Overall Study||0
5143776|NCT01347060|12651610|P2|COMPLETED|Overall Study||7580
5143777|NCT01347060|12651611|P1|COMPLETED|Overall Study||9868
5143778|NCT01347060|12651610|P2|STARTED|Overall Study||7580
5143779|NCT01347060|12651611|P1|STARTED|Overall Study||9868
5143780|NCT01347034|12651623|P2|NOT COMPLETED|Overall Study||0
5143781|NCT01347034|12651624|P1|NOT COMPLETED|Overall Study||0
5143782|NCT01347034|12651623|P2|COMPLETED|Overall Study||14
5143783|NCT01347034|12651624|P1|COMPLETED|Overall Study||6
5143784|NCT01347034|12651623|P2|STARTED|Overall Study||14
5143785|NCT01347034|12651624|P1|STARTED|Overall Study||6
5143786|NCT01347008|12651634|P2|NOT COMPLETED|Overall Study||0
5143787|NCT01347008|12651635|P1|NOT COMPLETED|Overall Study||0
5143788|NCT01347008|12651634|P2|COMPLETED|Overall Study||20
5143789|NCT01347008|12651635|P1|COMPLETED|Overall Study||21
5143790|NCT01347008|12651634|P2|STARTED|Overall Study||20
5143791|NCT01347008|12651635|P1|STARTED|Overall Study||21
5143792|NCT01346852|12651647|P2|NOT COMPLETED|Overall Study||0
5143793|NCT01346852|12651648|P1|NOT COMPLETED|Overall Study||0
5143794|NCT01346852|12651647|P2|COMPLETED|Overall Study||59684
5143795|NCT01346852|12651648|P1|COMPLETED|Overall Study||41753
5143796|NCT01346852|12651647|P2|STARTED|Overall Study||59684
5143797|NCT01346852|12651648|P1|STARTED|Overall Study||41753
5143798|NCT01346839|12651658|P2|NOT COMPLETED|Overall Study||209
5143799|NCT01346839|12651659|P1|NOT COMPLETED|Overall Study||314
5143800|NCT01346839|12651658|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
5143801|NCT01346839|12651659|P1|COMPLETED|Overall Study||369
5143802|NCT01346839|12651658|P2|STARTED|Overall Study||573
5143803|NCT01346839|12651659|P1|STARTED|Overall Study||683
5143804|NCT01346774|12651675|P2|NOT COMPLETED|Overall Study||17
5143805|NCT01346774|12651676|P1|NOT COMPLETED|Overall Study||13
5143806|NCT01346774|12651675|P2|COMPLETED|Overall Study||63
5143807|NCT01346774|12651676|P1|COMPLETED|Overall Study||67
5143808|NCT01346774|12651675|P2|STARTED|Overall Study||80
5143809|NCT01346774|12651676|P1|STARTED|Overall Study||80
5143810|NCT01346696|12651682|P1|NOT COMPLETED|Overall Study||1
5143811|NCT01346696|12651682|P1|COMPLETED|Overall Study||44
5143812|NCT01346696|12651682|P1|STARTED|Overall Study||45
5143813|NCT01346683|12651693|P1|NOT COMPLETED|Overall Study||0
5143814|NCT01346683|12651693|P1|COMPLETED|Overall Study||45
5143815|NCT01346683|12651693|P1|STARTED|Overall Study||45
5143816|NCT01346592|12651704|P3|NOT COMPLETED|Overall Study||78
5143817|NCT01346592|12651705|P2|NOT COMPLETED|Overall Study||89
5143818|NCT01346592|12651706|P1|NOT COMPLETED|Overall Study||153
5143819|NCT01346592|12651704|P3|COMPLETED|Overall Study||1408
5143820|NCT01346592|12651705|P2|COMPLETED|Overall Study||1389
5143821|NCT01346592|12651706|P1|COMPLETED|Overall Study||2983
5143822|NCT01346592|12651704|P3|STARTED|Overall Study||1486
5143823|NCT01346592|12651705|P2|STARTED|Overall Study||1478
5143824|NCT01346592|12651706|P1|STARTED|Overall Study||3136
5143825|NCT01346540|12651798|P2|NOT COMPLETED|Overall Study||12
5143826|NCT01346540|12651799|P1|NOT COMPLETED|Overall Study||3
5143827|NCT01346540|12651798|P2|COMPLETED|Overall Study||0
5143828|NCT01346540|12651799|P1|COMPLETED|Overall Study||1
5143829|NCT01346540|12651798|P2|STARTED|Overall Study||12
5143830|NCT01346540|12651799|P1|STARTED|Overall Study||4
5143831|NCT01346514|12651810|P2|NOT COMPLETED|Overall Study||37
5143832|NCT01346514|12651811|P1|NOT COMPLETED|Overall Study||29
5143833|NCT01346514|12651810|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
5143834|NCT01346514|12651811|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
5143835|NCT01346514|12651810|P2|12 Month Assessment|Overall Study||53
5143836|NCT01346514|12651811|P1|12 Month Assessment|Overall Study||62
5143837|NCT01346514|12651810|P2|9 Month Assessment|Overall Study||59
5143838|NCT01346514|12651811|P1|9 Month Assessment|Overall Study||67
5143839|NCT01346514|12651810|P2|6 Month Assessment|Overall Study||61
5143840|NCT01346514|12651811|P1|6 Month Assessment|Overall Study||74
5143841|NCT01346514|12651810|P2|3 Month Assessment|Overall Study||68
5143842|NCT01346514|12651811|P1|3 Month Assessment|Overall Study||83
5143843|NCT01346514|12651810|P2|STARTED|Overall Study||90
5143844|NCT01346514|12651811|P1|STARTED|Overall Study||91
5143845|NCT01346501|12651831|P2|NOT COMPLETED|Overall Study||13
5143846|NCT01346501|12651832|P1|NOT COMPLETED|Overall Study||11
5143847|NCT01346501|12651831|P2|COMPLETED|Overall Study||80
5143848|NCT01346501|12651832|P1|COMPLETED|Overall Study||68
5143849|NCT01346501|12651831|P2|STARTED|Overall Study||93
5143850|NCT01346501|12651832|P1|STARTED|Overall Study||79
5143851|NCT01346488|12651845|P1|NOT COMPLETED|Overall Study||706
5143852|NCT01346488|12651845|P1|COMPLETED|Overall Study||1262
5143853|NCT01346488|12651845|P1|STARTED|Overall Study||1968
5143854|NCT01346475|12651865|P2|NOT COMPLETED|Second Intervention||0
5143855|NCT01346475|12651866|P1|NOT COMPLETED|Second Intervention||0
5143856|NCT01346475|12651865|P2|COMPLETED|Second Intervention||25
5143857|NCT01346475|12651866|P1|COMPLETED|Second Intervention||18
5143858|NCT01346475|12651865|P2|STARTED|Second Intervention||25
5143859|NCT01346475|12651866|P1|STARTED|Second Intervention||18
5143860|NCT01346475|12651865|P2|NOT COMPLETED|First Intervention||3
5143861|NCT01346475|12651866|P1|NOT COMPLETED|First Intervention||4
5143862|NCT01346475|12651865|P2|COMPLETED|First Intervention||25
5143863|NCT01346475|12651866|P1|COMPLETED|First Intervention||18
5143864|NCT01346475|12651865|P2|STARTED|First Intervention||28
5143865|NCT01346475|12651866|P1|STARTED|First Intervention||22
5143866|NCT01346410|12651878|P1|NOT COMPLETED|Overall Study||1
5143867|NCT01346410|12651878|P1|COMPLETED|Overall Study||0
5143868|NCT01346410|12651878|P1|STARTED|Overall Study||1
5143869|NCT01346397|12651885|P2|NOT COMPLETED|Overall Study||0
5143870|NCT01346397|12651886|P1|NOT COMPLETED|Overall Study||0
5143871|NCT01346397|12651885|P2|COMPLETED|Overall Study||85
5143872|NCT01346397|12651886|P1|COMPLETED|Overall Study||85
5143873|NCT01346397|12651885|P2|STARTED|Overall Study||85
5143874|NCT01346397|12651886|P1|STARTED|Overall Study||85
5143875|NCT01346371|12651896|P2|NOT COMPLETED|Overall Study||0
5143876|NCT01346371|12651897|P1|NOT COMPLETED|Overall Study||2
5143877|NCT01346371|12651896|P2|COMPLETED|Overall Study||20
5143878|NCT01346371|12651897|P1|COMPLETED|Overall Study||18
5143879|NCT01346371|12651896|P2|STARTED|Overall Study||20
5143880|NCT01346371|12651897|P1|STARTED|Overall Study||20
5143881|NCT01346293|12651905|P2|NOT COMPLETED|Overall Study||21
5143882|NCT01346293|12651906|P1|NOT COMPLETED|Overall Study||67
5143883|NCT01346293|12651905|P2|COMPLETED|Overall Study||608
5143884|NCT01346293|12651906|P1|COMPLETED|Overall Study||2676
5143885|NCT01346293|12651905|P2|STARTED|Overall Study||629
5143886|NCT01346293|12651906|P1|STARTED|Overall Study||2743
5143887|NCT01346189|12651936|P4|NOT COMPLETED|Overall Study||11
5143888|NCT01346189|12651937|P3|NOT COMPLETED|Overall Study||14
5143889|NCT01346189|12651938|P2|NOT COMPLETED|Overall Study||17
5143890|NCT01346189|12651939|P1|NOT COMPLETED|Overall Study||16
5143891|NCT01346189|12651936|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
5143892|NCT01346189|12651937|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
5143893|NCT01346189|12651938|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
5143894|NCT01346189|12651939|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
5143895|NCT01346189|12651936|P4|STARTED|Overall Study||366
5143896|NCT01346189|12651937|P3|STARTED|Overall Study||346
5143897|NCT01346189|12651938|P2|STARTED|Overall Study||358
5143898|NCT01346189|12651939|P1|STARTED|Overall Study||433
5143899|NCT01346176|12651956|P3|NOT COMPLETED|Completed Satisfaction Survey||6
5143900|NCT01346176|12651957|P2|NOT COMPLETED|Completed Satisfaction Survey||4
5143901|NCT01346176|12651958|P1|NOT COMPLETED|Completed Satisfaction Survey||6
5143902|NCT01346176|12651956|P3|COMPLETED|Completed Satisfaction Survey||27
5143903|NCT01346176|12651957|P2|COMPLETED|Completed Satisfaction Survey||22
5143904|NCT01346176|12651958|P1|COMPLETED|Completed Satisfaction Survey||29
5143905|NCT01346176|12651956|P3|STARTED|Completed Satisfaction Survey||33
5143906|NCT01346176|12651957|P2|STARTED|Completed Satisfaction Survey||26
5143907|NCT01346176|12651958|P1|STARTED|Completed Satisfaction Survey||35
5143908|NCT01346176|12651956|P3|NOT COMPLETED|Completed Advance Directive||10
5143909|NCT01346176|12651957|P2|NOT COMPLETED|Completed Advance Directive||14
5143910|NCT01346176|12651958|P1|NOT COMPLETED|Completed Advance Directive||13
5143911|NCT01346176|12651956|P3|COMPLETED|Completed Advance Directive||33
5143912|NCT01346176|12651957|P2|COMPLETED|Completed Advance Directive||26
5143913|NCT01346176|12651958|P1|COMPLETED|Completed Advance Directive||35
5143914|NCT01346176|12651956|P3|STARTED|Completed Advance Directive||43
5143915|NCT01346176|12651957|P2|STARTED|Completed Advance Directive||40
5143916|NCT01346176|12651958|P1|STARTED|Completed Advance Directive||48
5143917|NCT01346176|12651956|P3|NOT COMPLETED|Recruited||0
5143918|NCT01346176|12651957|P2|NOT COMPLETED|Recruited||0
5143919|NCT01346176|12651958|P1|NOT COMPLETED|Recruited||1
5143920|NCT01346176|12651956|P3|COMPLETED|Recruited||43
5143921|NCT01346176|12651957|P2|COMPLETED|Recruited||40
5143922|NCT01346176|12651958|P1|COMPLETED|Recruited||48
5143923|NCT01346176|12651956|P3|STARTED|Recruited||43
5143924|NCT01346176|12651957|P2|STARTED|Recruited||40
5143925|NCT01346176|12651958|P1|STARTED|Recruited||49
5143926|NCT01346085|12651969|P1|NOT COMPLETED|Overall Study||0
5143927|NCT01346085|12651969|P1|COMPLETED|Overall Study||10
5143928|NCT01346085|12651969|P1|STARTED|Overall Study||10
5143929|NCT01346072|12651976|P2|NOT COMPLETED|Overall Study||0
5143930|NCT01346072|12651977|P1|NOT COMPLETED|Overall Study||0
5143931|NCT01346072|12651976|P2|COMPLETED|Overall Study||10
5143932|NCT01346072|12651977|P1|COMPLETED|Overall Study||11
5143933|NCT01346072|12651976|P2|STARTED|Overall Study||10
5143934|NCT01346072|12651977|P1|STARTED|Overall Study||11
5143935|NCT01346059|12651987|P2|NOT COMPLETED|Overall Study||0
5143936|NCT01346059|12651988|P1|NOT COMPLETED|Overall Study||1
5143937|NCT01346059|12651987|P2|COMPLETED|Overall Study||1
5143938|NCT01346059|12651988|P1|COMPLETED|Overall Study||0
5143939|NCT01346059|12651987|P2|STARTED|Overall Study||1
5143940|NCT01346059|12651988|P1|STARTED|Overall Study||1
5143941|NCT01345929|12652000|P2|NOT COMPLETED|Overall Study||19
5143942|NCT01345929|12652001|P1|NOT COMPLETED|Overall Study||21
5143943|NCT01345929|12652000|P2|COMPLETED|Overall Study||516
5143944|NCT01345929|12652001|P1|COMPLETED|Overall Study||512
5143945|NCT01345929|12652000|P2|STARTED|Overall Study||535
5143946|NCT01345929|12652001|P1|STARTED|Overall Study||533
5143947|NCT01345786|12652013|P4|NOT COMPLETED|Overall Study||3
5143948|NCT01345786|12652014|P3|NOT COMPLETED|Overall Study||5
5143949|NCT01345786|12652015|P2|NOT COMPLETED|Overall Study||8
5143950|NCT01345786|12652016|P1|NOT COMPLETED|Overall Study||6
5143951|NCT01345786|12652013|P4|COMPLETED|Overall Study||35
5143952|NCT01345786|12652014|P3|COMPLETED|Overall Study||33
5143953|NCT01345786|12652015|P2|COMPLETED|Overall Study||33
5143954|NCT01345786|12652016|P1|COMPLETED|Overall Study||35
5143955|NCT01345786|12652013|P4|Treated|Overall Study||37
5143956|NCT01345786|12652014|P3|Treated|Overall Study||37
5143957|NCT01345786|12652015|P2|Treated|Overall Study||41
5143958|NCT01345786|12652016|P1|Treated|Overall Study||41
5143959|NCT01345786|12652013|P4|STARTED|Overall Study|Number randomized|38
5143960|NCT01345786|12652014|P3|STARTED|Overall Study|Number randomized|38
5143961|NCT01345786|12652015|P2|STARTED|Overall Study|Number randomized|41
5143962|NCT01345786|12652016|P1|STARTED|Overall Study|Number randomized|41
5143963|NCT01345721|12652065|P3|NOT COMPLETED|Overall Study||0
5143964|NCT01345721|12652066|P2|NOT COMPLETED|Overall Study||0
5143965|NCT01345721|12652067|P1|NOT COMPLETED|Overall Study||0
5143966|NCT01345721|12652065|P3|COMPLETED|Overall Study||65
5143967|NCT01345721|12652066|P2|COMPLETED|Overall Study||66
5143968|NCT01345721|12652067|P1|COMPLETED|Overall Study||74
5143969|NCT01345721|12652065|P3|STARTED|Overall Study||65
5143970|NCT01345721|12652066|P2|STARTED|Overall Study||66
5143971|NCT01345721|12652067|P1|STARTED|Overall Study||74
5143972|NCT01345682|12652096|P2|NOT COMPLETED|Overall Study||161
5143973|NCT01345682|12652097|P1|NOT COMPLETED|Overall Study||322
5143974|NCT01345682|12652096|P2|COMPLETED|Overall Study||0
5143975|NCT01345682|12652097|P1|COMPLETED|Overall Study||0
5143976|NCT01345682|12652096|P2|STARTED|Overall Study|Randomised|161
5143977|NCT01345682|12652097|P1|STARTED|Overall Study|Randomised|322
5143978|NCT01345669|12652131|P2|NOT COMPLETED|Overall Study||119
5143979|NCT01345669|12652132|P1|NOT COMPLETED|Overall Study||287
5143980|NCT01345669|12652131|P2|COMPLETED|Overall Study||87
5143981|NCT01345669|12652132|P1|COMPLETED|Overall Study||124
5143982|NCT01345669|12652131|P2|STARTED|Overall Study||206
5143983|NCT01345669|12652132|P1|STARTED|Overall Study||411
5143984|NCT01345630|12652150|P2|NOT COMPLETED|Overall Study||359
5143985|NCT01345630|12652151|P1|NOT COMPLETED|Overall Study||361
5143986|NCT01345630|12652150|P2|COMPLETED|Overall Study||42
5143987|NCT01345630|12652151|P1|COMPLETED|Overall Study||35
5143988|NCT01345630|12652150|P2|STARTED|Overall Study||401
5143989|NCT01345630|12652151|P1|STARTED|Overall Study||396
5143990|NCT01345591|12652207|P1|NOT COMPLETED|Overall Study||1
5143991|NCT01345591|12652207|P1|COMPLETED|Overall Study||19
5143992|NCT01345591|12652207|P1|STARTED|Overall Study||20
5143993|NCT01345513|12652216|P1|NOT COMPLETED|Overall Study||0
5143994|NCT01345513|12652216|P1|COMPLETED|Overall Study||50
5143995|NCT01345513|12652216|P1|STARTED|Overall Study||50
5143996|NCT01345318|12652223|P1|NOT COMPLETED|Overall Study||80
5143997|NCT01345318|12652223|P1|COMPLETED|Overall Study||111
5143998|NCT01345318|12652223|P1|STARTED|Overall Study||191
5143999|NCT01345292|12652231|P3|NOT COMPLETED|Overall Study||1
5144000|NCT01345292|12652232|P2|NOT COMPLETED|Overall Study||0
5144001|NCT01345292|12652233|P1|NOT COMPLETED|Overall Study||2
5144002|NCT01345292|12652231|P3|COMPLETED|Overall Study||74
5144003|NCT01345292|12652232|P2|COMPLETED|Overall Study||76
5144004|NCT01345292|12652233|P1|COMPLETED|Overall Study||73
5144005|NCT01345292|12652231|P3|STARTED|Overall Study||75
5144006|NCT01345292|12652232|P2|STARTED|Overall Study||76
5144007|NCT01345292|12652233|P1|STARTED|Overall Study||75
5144008|NCT01345253|12652264|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
5144009|NCT01345253|12652265|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
5144010|NCT01345253|12652264|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
5144011|NCT01345253|12652265|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
5144012|NCT01345253|12652264|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
5144013|NCT01345253|12652265|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
5144014|NCT01345253|12652264|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
5144015|NCT01345253|12652265|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
5144016|NCT01345253|12652264|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
5144017|NCT01345253|12652265|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
5144018|NCT01345253|12652264|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
5144019|NCT01345253|12652265|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
5144020|NCT01345240|12652286|P5|NOT COMPLETED|Overall Study||10
5144021|NCT01345240|12652287|P4|NOT COMPLETED|Overall Study||9
5144022|NCT01345240|12652288|P3|NOT COMPLETED|Overall Study||18
5144023|NCT01345240|12652289|P2|NOT COMPLETED|Overall Study||14
5144024|NCT01345240|12652290|P1|NOT COMPLETED|Overall Study||11
5144025|NCT01345240|12652286|P5|COMPLETED|Overall Study||129
5144026|NCT01345240|12652287|P4|COMPLETED|Overall Study||132
5144027|NCT01345240|12652288|P3|COMPLETED|Overall Study||123
5144028|NCT01345240|12652289|P2|COMPLETED|Overall Study||128
5144029|NCT01345240|12652290|P1|COMPLETED|Overall Study||131
5144030|NCT01345240|12652286|P5|STARTED|Overall Study||139
5144031|NCT01345240|12652287|P4|STARTED|Overall Study||141
5144032|NCT01345240|12652288|P3|STARTED|Overall Study||141
5144033|NCT01345240|12652289|P2|STARTED|Overall Study||142
5144034|NCT01345240|12652290|P1|STARTED|Overall Study||142
5144035|NCT01345188|12652410|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
5144036|NCT01345188|12652410|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
5144037|NCT01345188|12652410|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
5144038|NCT01345188|12652410|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
5144039|NCT01345188|12652410|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
5144040|NCT01345188|12652410|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
5144041|NCT01345162|12652422|P2|NOT COMPLETED|Overall Study||4
5144042|NCT01345162|12652423|P1|NOT COMPLETED|Overall Study||2
5144043|NCT01345162|12652422|P2|COMPLETED|Overall Study||96
5144044|NCT01345162|12652423|P1|COMPLETED|Overall Study||98
5144045|NCT01345162|12652422|P2|STARTED|Overall Study||100
5144046|NCT01345162|12652423|P1|STARTED|Overall Study||100
5144047|NCT01345123|12652432|P3|NOT COMPLETED|Overall Study||88
5144048|NCT01345123|12652433|P2|NOT COMPLETED|Overall Study||85
5144049|NCT01345123|12652434|P1|NOT COMPLETED|Overall Study||79
5144050|NCT01345123|12652432|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
5144051|NCT01345123|12652433|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
5144052|NCT01345123|12652434|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
5144053|NCT01345123|12652432|P3|STARTED|Overall Study||3291
5144054|NCT01345123|12652433|P2|STARTED|Overall Study||3311
5144055|NCT01345123|12652434|P1|STARTED|Overall Study||3323
5144056|NCT01345058|12652456|P2|NOT COMPLETED|Overall Study||0
5144057|NCT01345058|12652457|P1|NOT COMPLETED|Overall Study||5
5144058|NCT01345058|12652456|P2|COMPLETED|Overall Study||36
5144059|NCT01345058|12652457|P1|COMPLETED|Overall Study||15
5144060|NCT01345058|12652456|P2|Received Lacosamide|Overall Study||0
5144061|NCT01345058|12652457|P1|Received Lacosamide|Overall Study||19
5144062|NCT01345058|12652456|P2|STARTED|Overall Study||36
5144063|NCT01345058|12652457|P1|STARTED|Overall Study||20
5144064|NCT01345019|12652473|P2|NOT COMPLETED|Open Label Treatment Phase||193
5144065|NCT01345019|12652474|P1|NOT COMPLETED|Open Label Treatment Phase||191
5144066|NCT01345019|12652473|P2|COMPLETED|Open Label Treatment Phase||233
5144067|NCT01345019|12652474|P1|COMPLETED|Open Label Treatment Phase||227
5144068|NCT01345019|12652473|P2|STARTED|Open Label Treatment Phase||426
5144069|NCT01345019|12652474|P1|STARTED|Open Label Treatment Phase||418
5144070|NCT01345019|12652473|P2|NOT COMPLETED|Blinded Treatment Phase||304
5144071|NCT01345019|12652474|P1|NOT COMPLETED|Blinded Treatment Phase||318
5144072|NCT01345019|12652473|P2|COMPLETED|Blinded Treatment Phase||555
5144073|NCT01345019|12652474|P1|COMPLETED|Blinded Treatment Phase||541
5144074|NCT01345019|12652473|P2|Received Treatment|Blinded Treatment Phase||850
5144075|NCT01345019|12652474|P1|Received Treatment|Blinded Treatment Phase||852
5144076|NCT01345019|12652473|P2|STARTED|Blinded Treatment Phase||859
5144077|NCT01345019|12652474|P1|STARTED|Blinded Treatment Phase||859
5144078|NCT01344876|12652496|P5|NOT COMPLETED|Overall Study||1
5144079|NCT01344876|12652497|P4|NOT COMPLETED|Overall Study||3
5144080|NCT01344876|12652498|P3|NOT COMPLETED|Overall Study||1
5144081|NCT01344876|12652499|P2|NOT COMPLETED|Overall Study||0
5144082|NCT01344876|12652500|P1|NOT COMPLETED|Overall Study||1
5144083|NCT01344876|12652496|P5|COMPLETED|Overall Study||2
5144084|NCT01344876|12652497|P4|COMPLETED|Overall Study||3
5144085|NCT01344876|12652498|P3|COMPLETED|Overall Study||3
5144086|NCT01344876|12652499|P2|COMPLETED|Overall Study||3
5144087|NCT01344876|12652500|P1|COMPLETED|Overall Study||3
5144088|NCT01344876|12652496|P5|STARTED|Overall Study||3
5144089|NCT01344876|12652497|P4|STARTED|Overall Study||6
5144090|NCT01344876|12652498|P3|STARTED|Overall Study||4
5144091|NCT01344876|12652499|P2|STARTED|Overall Study||3
5144092|NCT01344876|12652500|P1|STARTED|Overall Study||4
5144093|NCT01344824|12652514|P1|NOT COMPLETED|Overall Study||37
5144094|NCT01344824|12652514|P1|COMPLETED|Overall Study||1
5144095|NCT01344824|12652514|P1|STARTED|Overall Study||38
5144096|NCT01344759|12652522|P2|NOT COMPLETED|Overall Study||2
5144097|NCT01344759|12652523|P1|NOT COMPLETED|Overall Study||0
5144098|NCT01344759|12652522|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
5144099|NCT01344759|12652523|P1|COMPLETED|Overall Study||30
5144100|NCT01344759|12652522|P2|STARTED|Overall Study||30
5144101|NCT01344759|12652523|P1|STARTED|Overall Study||30
5144102|NCT01344629|12652555|P2|NOT COMPLETED|Crossover Period 4||0
5144103|NCT01344629|12652556|P1|NOT COMPLETED|Crossover Period 4||0
5144104|NCT01344629|12652555|P2|COMPLETED|Crossover Period 4||31
5144105|NCT01344629|12652556|P1|COMPLETED|Crossover Period 4||32
5144106|NCT01344629|12652555|P2|STARTED|Crossover Period 4||31
5144107|NCT01344629|12652556|P1|STARTED|Crossover Period 4||32
5144108|NCT01344629|12652555|P2|NOT COMPLETED|Crossover Period 3||0
5144109|NCT01344629|12652556|P1|NOT COMPLETED|Crossover Period 3||0
5144110|NCT01344629|12652555|P2|COMPLETED|Crossover Period 3||31
5144111|NCT01344629|12652556|P1|COMPLETED|Crossover Period 3||32
5144112|NCT01344629|12652555|P2|STARTED|Crossover Period 3||31
5144113|NCT01344629|12652556|P1|STARTED|Crossover Period 3||32
5144114|NCT01344629|12652555|P2|NOT COMPLETED|Crossover Period 2||1
5144115|NCT01344629|12652556|P1|NOT COMPLETED|Crossover Period 2||0
5144116|NCT01344629|12652555|P2|COMPLETED|Crossover Period 2||31
5144117|NCT01344629|12652556|P1|COMPLETED|Crossover Period 2||32
5144118|NCT01344629|12652555|P2|STARTED|Crossover Period 2||32
5144119|NCT01344629|12652556|P1|STARTED|Crossover Period 2||32
5144120|NCT01344629|12652555|P2|NOT COMPLETED|Crossover Period 1||0
5144121|NCT01344629|12652556|P1|NOT COMPLETED|Crossover Period 1||0
5144122|NCT01344629|12652555|P2|COMPLETED|Crossover Period 1||32
5144123|NCT01344629|12652556|P1|COMPLETED|Crossover Period 1||32
5144124|NCT01344629|12652555|P2|STARTED|Crossover Period 1||32
5144125|NCT01344629|12652556|P1|STARTED|Crossover Period 1||32
5144126|NCT01344616|12652576|P2|NOT COMPLETED|Overall Study||44
5144127|NCT01344616|12652577|P1|NOT COMPLETED|Overall Study||35
5144128|NCT01344616|12652576|P2|COMPLETED|Overall Study||194
5144129|NCT01344616|12652577|P1|COMPLETED|Overall Study||209
5144130|NCT01344616|12652576|P2|STARTED|Overall Study||238
5144131|NCT01344616|12652577|P1|STARTED|Overall Study||244
5144132|NCT01344538|12652585|P2|NOT COMPLETED|Overall Study||1
5144133|NCT01344538|12652586|P1|NOT COMPLETED|Overall Study||2
5144134|NCT01344538|12652585|P2|COMPLETED|Overall Study||16
5144135|NCT01344538|12652586|P1|COMPLETED|Overall Study||14
5144136|NCT01344538|12652585|P2|STARTED|Overall Study||17
5144137|NCT01344538|12652586|P1|STARTED|Overall Study||16
5144138|NCT01344460|12652592|P1|NOT COMPLETED|Overall Study||3
5144139|NCT01344460|12652592|P1|COMPLETED|Overall Study||312
5144140|NCT01344460|12652592|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
5144141|NCT01344460|12652592|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
5144142|NCT01344447|12652637|P1|NOT COMPLETED|Overall Study||8
5144143|NCT01344447|12652637|P1|COMPLETED|Overall Study||471
5144144|NCT01344447|12652637|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
5144145|NCT01344447|12652637|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
5144146|NCT01344369|12652681|P2|NOT COMPLETED|Second Intervention||1
5144147|NCT01344369|12652682|P1|NOT COMPLETED|Second Intervention||0
5144148|NCT01344369|12652681|P2|COMPLETED|Second Intervention||16
5144149|NCT01344369|12652682|P1|COMPLETED|Second Intervention||17
5144150|NCT01344369|12652681|P2|STARTED|Second Intervention||17
5144151|NCT01344369|12652682|P1|STARTED|Second Intervention||17
5144152|NCT01344369|12652681|P2|NOT COMPLETED|Washout of 28 Days||1
5144153|NCT01344369|12652682|P1|NOT COMPLETED|Washout of 28 Days||1
5144154|NCT01344369|12652681|P2|COMPLETED|Washout of 28 Days||17
5144155|NCT01344369|12652682|P1|COMPLETED|Washout of 28 Days||17
5144156|NCT01344369|12652681|P2|STARTED|Washout of 28 Days||18
5144157|NCT01344369|12652682|P1|STARTED|Washout of 28 Days||18
5144158|NCT01344369|12652681|P2|NOT COMPLETED|First Intervention||0
5144159|NCT01344369|12652682|P1|NOT COMPLETED|First Intervention||0
5144160|NCT01344369|12652681|P2|COMPLETED|First Intervention||18
5144161|NCT01344369|12652682|P1|COMPLETED|First Intervention||18
5144162|NCT01344369|12652681|P2|STARTED|First Intervention||18
5144163|NCT01344369|12652682|P1|STARTED|First Intervention||18
5144164|NCT01344356|12652700|P2|NOT COMPLETED|Overall Study||9
5144165|NCT01344356|12652701|P1|NOT COMPLETED|Overall Study||0
5144166|NCT01344356|12652700|P2|COMPLETED|Overall Study||9
5144167|NCT01344356|12652701|P1|COMPLETED|Overall Study||1
5144168|NCT01344356|12652700|P2|STARTED|Overall Study||18
5144169|NCT01344356|12652701|P1|STARTED|Overall Study||1
5144170|NCT01344226|12652713|P1|NOT COMPLETED|Overall Study||8
5144171|NCT01344226|12652713|P1|COMPLETED|Overall Study||41
5144172|NCT01344226|12652713|P1|STARTED|Overall Study||49
5144173|NCT01344161|12652722|P2|NOT COMPLETED|Overall Study||3
5144174|NCT01344161|12652723|P1|NOT COMPLETED|Overall Study||5
5144175|NCT01344161|12652722|P2|COMPLETED|Overall Study||39
5144176|NCT01344161|12652723|P1|COMPLETED|Overall Study||38
5144177|NCT01344161|12652722|P2|STARTED|Overall Study||42
5144178|NCT01344161|12652723|P1|STARTED|Overall Study||43
5144179|NCT01344057|12652735|P1|NOT COMPLETED|Overall Study||1
5144180|NCT01344057|12652735|P1|COMPLETED|Overall Study||62
5144181|NCT01344057|12652735|P1|STARTED|Overall Study||63
5144182|NCT01343901|12652742|P1|NOT COMPLETED|Overall Study||113
5144183|NCT01343901|12652742|P1|COMPLETED|Overall Study||97
5144184|NCT01343901|12652742|P1|Efficacy Population|Overall Study||205
5144185|NCT01343901|12652742|P1|STARTED|Overall Study||210
5144186|NCT01343888|12652766|P3|NOT COMPLETED|Overall Study||22
5144187|NCT01343888|12652767|P2|NOT COMPLETED|Overall Study||39
5144188|NCT01343888|12652768|P1|NOT COMPLETED|Overall Study||25
5144189|NCT01343888|12652766|P3|COMPLETED|Overall Study||110
5144190|NCT01343888|12652767|P2|COMPLETED|Overall Study||222
5144191|NCT01343888|12652768|P1|COMPLETED|Overall Study||234
5144192|NCT01343888|12652766|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
5144193|NCT01343888|12652767|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
5144194|NCT01343888|12652768|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
5144195|NCT01343823|12652810|P4|NOT COMPLETED|Overall Study||1
5144196|NCT01343823|12652811|P3|NOT COMPLETED|Overall Study||0
5144197|NCT01343823|12652812|P2|NOT COMPLETED|Overall Study||0
5144198|NCT01343823|12652813|P1|NOT COMPLETED|Overall Study||2
5144199|NCT01343823|12652810|P4|COMPLETED|Overall Study||19
5144200|NCT01343823|12652811|P3|COMPLETED|Overall Study||19
5144201|NCT01343823|12652812|P2|COMPLETED|Overall Study||20
5144202|NCT01343823|12652813|P1|COMPLETED|Overall Study||18
5144203|NCT01343823|12652810|P4|STARTED|Overall Study||20
5144204|NCT01343823|12652811|P3|STARTED|Overall Study||19
5144205|NCT01343823|12652812|P2|STARTED|Overall Study||20
5144206|NCT01343823|12652813|P1|STARTED|Overall Study||20
5144207|NCT01343693|12652827|P1|NOT COMPLETED|Overall Study||9
5144208|NCT01343693|12652827|P1|COMPLETED|Overall Study||110
5144209|NCT01343693|12652827|P1|STARTED|Overall Study||119
5144210|NCT01343667|12652834|P2|NOT COMPLETED|Overall Study||56
5144211|NCT01343667|12652835|P1|NOT COMPLETED|Overall Study||12
5144212|NCT01343667|12652834|P2|COMPLETED|Overall Study||916
5144213|NCT01343667|12652835|P1|COMPLETED|Overall Study||413
5144214|NCT01343667|12652834|P2|STARTED|Overall Study||972
5144215|NCT01343667|12652835|P1|STARTED|Overall Study||425
5144216|NCT01343485|12652843|P2|NOT COMPLETED|Overall Study||134
5144217|NCT01343485|12652844|P1|NOT COMPLETED|Overall Study||149
5144218|NCT01343485|12652843|P2|COMPLETED|Overall Study||46
5144219|NCT01343485|12652844|P1|COMPLETED|Overall Study||36
5144220|NCT01343485|12652843|P2|STARTED|Overall Study||180
5144221|NCT01343485|12652844|P1|STARTED|Overall Study||185
5144222|NCT01343407|12652850|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144223|NCT01343407|12652851|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144224|NCT01343407|12652852|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144225|NCT01343407|12652853|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144226|NCT01343407|12652854|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144227|NCT01343407|12652855|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
5144228|NCT01343407|12652850|P6|COMPLETED|Third Treatment Period (Part 2)||3
5144229|NCT01343407|12652851|P5|COMPLETED|Third Treatment Period (Part 2)||3
5144230|NCT01343407|12652852|P4|COMPLETED|Third Treatment Period (Part 2)||3
5144231|NCT01343407|12652853|P3|COMPLETED|Third Treatment Period (Part 2)||1
5144232|NCT01343407|12652854|P2|COMPLETED|Third Treatment Period (Part 2)||2
5144233|NCT01343407|12652855|P1|COMPLETED|Third Treatment Period (Part 2)||2
5144234|NCT01343407|12652850|P6|STARTED|Third Treatment Period (Part 2)||3
5144235|NCT01343407|12652851|P5|STARTED|Third Treatment Period (Part 2)||3
5144236|NCT01343407|12652852|P4|STARTED|Third Treatment Period (Part 2)||3
5144237|NCT01343407|12652853|P3|STARTED|Third Treatment Period (Part 2)||1
5144238|NCT01343407|12652854|P2|STARTED|Third Treatment Period (Part 2)||2
5144239|NCT01343407|12652855|P1|STARTED|Third Treatment Period (Part 2)||2
5144240|NCT01343407|12652850|P6|NOT COMPLETED|Second Washout (Part 2)||0
5144241|NCT01343407|12652851|P5|NOT COMPLETED|Second Washout (Part 2)||0
5144242|NCT01343407|12652852|P4|NOT COMPLETED|Second Washout (Part 2)||0
5144243|NCT01343407|12652853|P3|NOT COMPLETED|Second Washout (Part 2)||1
5144244|NCT01343407|12652854|P2|NOT COMPLETED|Second Washout (Part 2)||0
5144245|NCT01343407|12652855|P1|NOT COMPLETED|Second Washout (Part 2)||0
5144246|NCT01343407|12652850|P6|COMPLETED|Second Washout (Part 2)||3
5144247|NCT01343407|12652851|P5|COMPLETED|Second Washout (Part 2)||3
5144248|NCT01343407|12652852|P4|COMPLETED|Second Washout (Part 2)||3
5144249|NCT01343407|12652853|P3|COMPLETED|Second Washout (Part 2)||1
5144250|NCT01343407|12652854|P2|COMPLETED|Second Washout (Part 2)||2
5144251|NCT01343407|12652855|P1|COMPLETED|Second Washout (Part 2)||2
5144252|NCT01343407|12652850|P6|STARTED|Second Washout (Part 2)||3
5144253|NCT01343407|12652851|P5|STARTED|Second Washout (Part 2)||3
5144254|NCT01343407|12652852|P4|STARTED|Second Washout (Part 2)||3
5144255|NCT01343407|12652853|P3|STARTED|Second Washout (Part 2)||2
5144256|NCT01343407|12652854|P2|STARTED|Second Washout (Part 2)||2
5144257|NCT01343407|12652855|P1|STARTED|Second Washout (Part 2)||2
5144258|NCT01343407|12652850|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
5144259|NCT01343407|12652851|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
5144260|NCT01343407|12652852|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
5144261|NCT01343407|12652853|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
5144262|NCT01343407|12652854|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
5144263|NCT01343407|12652855|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
5144264|NCT01343407|12652850|P6|COMPLETED|Second Treatment Period (Part 2)||3
5144265|NCT01343407|12652851|P5|COMPLETED|Second Treatment Period (Part 2)||3
5144266|NCT01343407|12652852|P4|COMPLETED|Second Treatment Period (Part 2)||3
5144267|NCT01343407|12652853|P3|COMPLETED|Second Treatment Period (Part 2)||2
5144268|NCT01343407|12652854|P2|COMPLETED|Second Treatment Period (Part 2)||2
5144269|NCT01343407|12652855|P1|COMPLETED|Second Treatment Period (Part 2)||2
5144270|NCT01343407|12652850|P6|STARTED|Second Treatment Period (Part 2)||3
5144271|NCT01343407|12652851|P5|STARTED|Second Treatment Period (Part 2)||3
5144272|NCT01343407|12652852|P4|STARTED|Second Treatment Period (Part 2)||3
5144273|NCT01343407|12652853|P3|STARTED|Second Treatment Period (Part 2)||3
5144274|NCT01343407|12652854|P2|STARTED|Second Treatment Period (Part 2)||2
5144275|NCT01343407|12652855|P1|STARTED|Second Treatment Period (Part 2)||2
5144276|NCT01343407|12652850|P6|NOT COMPLETED|First Washout (Part 2)||0
5144277|NCT01343407|12652851|P5|NOT COMPLETED|First Washout (Part 2)||0
5144278|NCT01343407|12652852|P4|NOT COMPLETED|First Washout (Part 2)||0
5144279|NCT01343407|12652853|P3|NOT COMPLETED|First Washout (Part 2)||0
5144280|NCT01343407|12652854|P2|NOT COMPLETED|First Washout (Part 2)||0
5144281|NCT01343407|12652855|P1|NOT COMPLETED|First Washout (Part 2)||0
5144282|NCT01343407|12652850|P6|COMPLETED|First Washout (Part 2)||3
5144283|NCT01343407|12652851|P5|COMPLETED|First Washout (Part 2)||3
5144284|NCT01343407|12652852|P4|COMPLETED|First Washout (Part 2)||3
5144285|NCT01343407|12652853|P3|COMPLETED|First Washout (Part 2)||3
5144286|NCT01343407|12652854|P2|COMPLETED|First Washout (Part 2)||2
5144287|NCT01343407|12652855|P1|COMPLETED|First Washout (Part 2)||2
5144288|NCT01343407|12652850|P6|STARTED|First Washout (Part 2)||3
5144289|NCT01343407|12652851|P5|STARTED|First Washout (Part 2)||3
5144290|NCT01343407|12652852|P4|STARTED|First Washout (Part 2)||3
5144291|NCT01343407|12652853|P3|STARTED|First Washout (Part 2)||3
5144292|NCT01343407|12652854|P2|STARTED|First Washout (Part 2)||2
5144293|NCT01343407|12652855|P1|STARTED|First Washout (Part 2)||2
5144294|NCT01343407|12652850|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
5144295|NCT01343407|12652851|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
5144296|NCT01343407|12652852|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
5144297|NCT01343407|12652853|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
5144298|NCT01343407|12652854|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
5144299|NCT01343407|12652855|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
5144300|NCT01343407|12652850|P6|COMPLETED|First Treatment Period (Part 2)||3
5144301|NCT01343407|12652851|P5|COMPLETED|First Treatment Period (Part 2)||3
5144302|NCT01343407|12652852|P4|COMPLETED|First Treatment Period (Part 2)||3
5144303|NCT01343407|12652853|P3|COMPLETED|First Treatment Period (Part 2)||3
5144304|NCT01343407|12652854|P2|COMPLETED|First Treatment Period (Part 2)||2
5144305|NCT01343407|12652855|P1|COMPLETED|First Treatment Period (Part 2)||2
5144306|NCT01343407|12652850|P6|STARTED|First Treatment Period (Part 2)||3
5144307|NCT01343407|12652851|P5|STARTED|First Treatment Period (Part 2)||3
5144308|NCT01343407|12652852|P4|STARTED|First Treatment Period (Part 2)||3
5144309|NCT01343407|12652853|P3|STARTED|First Treatment Period (Part 2)||3
5144310|NCT01343407|12652854|P2|STARTED|First Treatment Period (Part 2)||2
5144311|NCT01343407|12652855|P1|STARTED|First Treatment Period (Part 2)||2
5144312|NCT01343368|12652883|P2|NOT COMPLETED|Overall Study||0
5144313|NCT01343368|12652884|P1|NOT COMPLETED|Overall Study||2
5144314|NCT01343368|12652883|P2|COMPLETED|Overall Study||10
5144315|NCT01343368|12652884|P1|COMPLETED|Overall Study||7
5144316|NCT01343368|12652883|P2|STARTED|Overall Study||10
5144317|NCT01343368|12652884|P1|STARTED|Overall Study||9
5144318|NCT01343277|12652920|P2|NOT COMPLETED|Overall Study||193
5144319|NCT01343277|12652921|P1|NOT COMPLETED|Overall Study||384
5144320|NCT01343277|12652920|P2|COMPLETED|Overall Study||0
5144321|NCT01343277|12652921|P1|COMPLETED|Overall Study||0
5144322|NCT01343277|12652920|P2|Treated|Overall Study||172
5144323|NCT01343277|12652921|P1|Treated|Overall Study||378
5144324|NCT01343277|12652920|P2|STARTED|Overall Study||193
5144325|NCT01343277|12652921|P1|STARTED|Overall Study||384
5144326|NCT01343251|12652939|P2|NOT COMPLETED|Overall Study||0
5144327|NCT01343251|12652940|P1|NOT COMPLETED|Overall Study||0
5144328|NCT01343251|12652939|P2|COMPLETED|Overall Study||17
5144329|NCT01343251|12652940|P1|COMPLETED|Overall Study||16
5144330|NCT01343251|12652939|P2|STARTED|Overall Study||17
5144331|NCT01343251|12652940|P1|STARTED|Overall Study||16
5144332|NCT01343095|12652957|P3|NOT COMPLETED|Overall Study||0
5144333|NCT01343095|12652958|P2|NOT COMPLETED|Overall Study||0
5144334|NCT01343095|12652959|P1|NOT COMPLETED|Overall Study||0
5144335|NCT01343095|12652957|P3|COMPLETED|Overall Study||3
5144336|NCT01343095|12652958|P2|COMPLETED|Overall Study||3
5144337|NCT01343095|12652959|P1|COMPLETED|Overall Study||2
5144338|NCT01343095|12652957|P3|STARTED|Overall Study||3
5144339|NCT01343095|12652958|P2|STARTED|Overall Study||3
5144340|NCT01343095|12652959|P1|STARTED|Overall Study||2
5144341|NCT01343082|12652982|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
5144342|NCT01343082|12652983|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
5144343|NCT01343082|12652984|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
5144344|NCT01343082|12652982|P3|COMPLETED|Treatment Period , Switched to DE-111||31
5144345|NCT01343082|12652983|P2|COMPLETED|Treatment Period , Switched to DE-111||36
5144346|NCT01343082|12652984|P1|COMPLETED|Treatment Period , Switched to DE-111||43
5144347|NCT01343082|12652982|P3|STARTED|Treatment Period , Switched to DE-111||43
5144348|NCT01343082|12652983|P2|STARTED|Treatment Period , Switched to DE-111||45
5144349|NCT01343082|12652984|P1|STARTED|Treatment Period , Switched to DE-111||48
5144350|NCT01343082|12652982|P3|NOT COMPLETED|The run-in Period||5
5144351|NCT01343082|12652983|P2|NOT COMPLETED|The run-in Period||4
5144352|NCT01343082|12652984|P1|NOT COMPLETED|The run-in Period||3
5144353|NCT01343082|12652982|P3|COMPLETED|The run-in Period||43
5144354|NCT01343082|12652983|P2|COMPLETED|The run-in Period||45
5144355|NCT01343082|12652984|P1|COMPLETED|The run-in Period||48
5144356|NCT01343082|12652982|P3|STARTED|The run-in Period||48
5144357|NCT01343082|12652983|P2|STARTED|The run-in Period||49
5144358|NCT01343082|12652984|P1|STARTED|The run-in Period||51
5144359|NCT01343056|12652992|P4|NOT COMPLETED|Overall Study||9
5144360|NCT01343056|12652993|P3|NOT COMPLETED|Overall Study||3
5144361|NCT01343056|12652994|P2|NOT COMPLETED|Overall Study||5
5144362|NCT01343056|12652995|P1|NOT COMPLETED|Overall Study||7
5144363|NCT01343056|12652992|P4|COMPLETED|Overall Study||29
5144364|NCT01343056|12652993|P3|COMPLETED|Overall Study||29
5144365|NCT01343056|12652994|P2|COMPLETED|Overall Study||31
5144366|NCT01343056|12652995|P1|COMPLETED|Overall Study||28
5144367|NCT01343056|12652992|P4|STARTED|Overall Study||38
5144368|NCT01343056|12652993|P3|STARTED|Overall Study||32
5144369|NCT01343056|12652994|P2|STARTED|Overall Study||36
5144370|NCT01343056|12652995|P1|STARTED|Overall Study||35
5144371|NCT01343043|12653037|P4|NOT COMPLETED|Overall Study||1
5144372|NCT01343043|12653038|P3|NOT COMPLETED|Overall Study||0
5144373|NCT01343043|12653039|P2|NOT COMPLETED|Overall Study||1
5144374|NCT01343043|12653040|P1|NOT COMPLETED|Overall Study||3
5144375|NCT01343043|12653037|P4|COMPLETED|Overall Study||15
5144376|NCT01343043|12653038|P3|COMPLETED|Overall Study||5
5144377|NCT01343043|12653039|P2|COMPLETED|Overall Study||13
5144378|NCT01343043|12653040|P1|COMPLETED|Overall Study||12
5144379|NCT01343043|12653037|P4|Received T-cell Infusion|Overall Study||15
5144380|NCT01343043|12653038|P3|Received T-cell Infusion|Overall Study||5
5144381|NCT01343043|12653039|P2|Received T-cell Infusion|Overall Study||13
5144382|NCT01343043|12653040|P1|Received T-cell Infusion|Overall Study||12
5144383|NCT01343043|12653037|P4|STARTED|Overall Study||16
5144384|NCT01343043|12653038|P3|STARTED|Overall Study||5
5144385|NCT01343043|12653039|P2|STARTED|Overall Study||14
5144386|NCT01343043|12653040|P1|STARTED|Overall Study||15
5144387|NCT01343004|12653101|P3|NOT COMPLETED|Overall Study||160
5144388|NCT01343004|12653102|P2|NOT COMPLETED|Overall Study||218
5144389|NCT01343004|12653103|P1|NOT COMPLETED|Overall Study||184
5144390|NCT01343004|12653101|P3|COMPLETED|Overall Study||658
5144391|NCT01343004|12653102|P2|COMPLETED|Overall Study||606
5144392|NCT01343004|12653103|P1|COMPLETED|Overall Study||637
5144393|NCT01343004|12653101|P3|STARTED|Overall Study||818
5144394|NCT01343004|12653102|P2|STARTED|Overall Study||824
5144395|NCT01343004|12653103|P1|STARTED|Overall Study||821
5144396|NCT01342965|12653128|P2|NOT COMPLETED|Overall Study||107
5144397|NCT01342965|12653129|P1|NOT COMPLETED|Overall Study||109
5144398|NCT01342965|12653128|P2|COMPLETED|Overall Study||0
5144399|NCT01342965|12653129|P1|COMPLETED|Overall Study||1
5144400|NCT01342965|12653128|P2|Received Treatment|Overall Study||104
5144401|NCT01342965|12653129|P1|Received Treatment|Overall Study||110
5144402|NCT01342965|12653128|P2|STARTED|Overall Study||107
5144403|NCT01342965|12653129|P1|STARTED|Overall Study||110
5144404|NCT01342926|12653147|P4|NOT COMPLETED|Overall Study||12
5144405|NCT01342926|12653148|P3|NOT COMPLETED|Overall Study||14
5144406|NCT01342926|12653149|P2|NOT COMPLETED|Overall Study||15
5144407|NCT01342926|12653150|P1|NOT COMPLETED|Overall Study||9
5144408|NCT01342926|12653147|P4|COMPLETED|Overall Study||39
5144409|NCT01342926|12653148|P3|COMPLETED|Overall Study||34
5144410|NCT01342926|12653149|P2|COMPLETED|Overall Study||31
5144411|NCT01342926|12653150|P1|COMPLETED|Overall Study||37
5144412|NCT01342926|12653147|P4|STARTED|Overall Study||51
5144413|NCT01342926|12653148|P3|STARTED|Overall Study||48
5144414|NCT01342926|12653149|P2|STARTED|Overall Study||46
5144415|NCT01342926|12653150|P1|STARTED|Overall Study||46
5144416|NCT01342913|12653230|P3|NOT COMPLETED|Double-Blind Treatment Period||23
5144417|NCT01342913|12653231|P2|NOT COMPLETED|Double-Blind Treatment Period||16
5144418|NCT01342913|12653232|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5144419|NCT01342913|12653230|P3|COMPLETED|Double-Blind Treatment Period||243
5144420|NCT01342913|12653231|P2|COMPLETED|Double-Blind Treatment Period||246
5144421|NCT01342913|12653232|P1|COMPLETED|Double-Blind Treatment Period||0
5144422|NCT01342913|12653230|P3|STARTED|Double-Blind Treatment Period||266
5144423|NCT01342913|12653231|P2|STARTED|Double-Blind Treatment Period||262
5144424|NCT01342913|12653232|P1|STARTED|Double-Blind Treatment Period||0
5144425|NCT01342913|12653230|P3|NOT COMPLETED|2-week Run-in Period||0
5144426|NCT01342913|12653231|P2|NOT COMPLETED|2-week Run-in Period||0
5144427|NCT01342913|12653232|P1|NOT COMPLETED|2-week Run-in Period||174
5144428|NCT01342913|12653230|P3|COMPLETED|2-week Run-in Period||0
5144429|NCT01342913|12653231|P2|COMPLETED|2-week Run-in Period||0
5144430|NCT01342913|12653232|P1|COMPLETED|2-week Run-in Period||528
5144431|NCT01342913|12653230|P3|STARTED|2-week Run-in Period||0
5144432|NCT01342913|12653231|P2|STARTED|2-week Run-in Period||0
5144433|NCT01342913|12653232|P1|STARTED|2-week Run-in Period||702
5144434|NCT01342887|12653242|P1|NOT COMPLETED|Overall Study||2
5144435|NCT01342887|12653242|P1|COMPLETED|Overall Study||4
5144436|NCT01342887|12653242|P1|STARTED|Overall Study||6
5144437|NCT01342770|12653249|P1|NOT COMPLETED|Overall Study||0
5144438|NCT01342770|12653249|P1|COMPLETED|Overall Study||6
5144439|NCT01342770|12653249|P1|STARTED|Overall Study||6
5144440|NCT01342757|12653267|P1|NOT COMPLETED|Overall Study||0
5144441|NCT01342757|12653267|P1|COMPLETED|Overall Study||12
5144442|NCT01342757|12653267|P1|STARTED|Overall Study||12
5144443|NCT01342666|12653276|P2|NOT COMPLETED|Overall Study||0
5144444|NCT01342666|12653277|P1|NOT COMPLETED|Overall Study||0
5144445|NCT01342666|12653276|P2|COMPLETED|Overall Study||24
5144446|NCT01342666|12653277|P1|COMPLETED|Overall Study||26
5144447|NCT01342666|12653276|P2|STARTED|Overall Study||24
5144448|NCT01342666|12653277|P1|STARTED|Overall Study||26
5144449|NCT01342640|12653283|P1|NOT COMPLETED|Overall Study||41
5144450|NCT01342640|12653283|P1|COMPLETED|Overall Study||29
5144451|NCT01342640|12653283|P1|STARTED|Overall Study||70
5144452|NCT01342549|12653291|P2|NOT COMPLETED|Overall Study||0
5144453|NCT01342549|12653292|P1|NOT COMPLETED|Overall Study||0
5144454|NCT01342549|12653291|P2|COMPLETED|Overall Study||31
5144455|NCT01342549|12653292|P1|COMPLETED|Overall Study||31
5144456|NCT01342549|12653291|P2|STARTED|Overall Study||31
5144457|NCT01342549|12653292|P1|STARTED|Overall Study||31
5144458|NCT01342523|12653330|P32|NOT COMPLETED|Overall Study||1
5144459|NCT01342523|12653331|P31|NOT COMPLETED|Overall Study||1
5144460|NCT01342523|12653332|P30|NOT COMPLETED|Overall Study||1
5144461|NCT01342523|12653333|P29|NOT COMPLETED|Overall Study||1
5144462|NCT01342523|12653334|P28|NOT COMPLETED|Overall Study||1
5144463|NCT01342523|12653335|P27|NOT COMPLETED|Overall Study||1
5144464|NCT01342523|12653336|P26|NOT COMPLETED|Overall Study||2
5144465|NCT01342523|12653337|P25|NOT COMPLETED|Overall Study||1
5144466|NCT01342523|12653338|P24|NOT COMPLETED|Overall Study||1
5144467|NCT01342523|12653339|P23|NOT COMPLETED|Overall Study||0
5144468|NCT01342523|12653340|P22|NOT COMPLETED|Overall Study||0
5144469|NCT01342523|12653341|P21|NOT COMPLETED|Overall Study||0
5144470|NCT01342523|12653342|P20|NOT COMPLETED|Overall Study||0
5144471|NCT01342523|12653343|P19|NOT COMPLETED|Overall Study||0
5144472|NCT01342523|12653344|P18|NOT COMPLETED|Overall Study||0
5144473|NCT01342523|12653345|P17|NOT COMPLETED|Overall Study||1
5144474|NCT01342523|12653346|P16|NOT COMPLETED|Overall Study||0
5144475|NCT01342523|12653347|P15|NOT COMPLETED|Overall Study||1
5144476|NCT01342523|12653348|P14|NOT COMPLETED|Overall Study||2
5144477|NCT01342523|12653349|P13|NOT COMPLETED|Overall Study||0
5144478|NCT01342523|12653350|P12|NOT COMPLETED|Overall Study||2
5144479|NCT01342523|12653351|P11|NOT COMPLETED|Overall Study||0
5144480|NCT01342523|12653352|P10|NOT COMPLETED|Overall Study||0
5144481|NCT01342523|12653353|P9|NOT COMPLETED|Overall Study||0
5144482|NCT01342523|12653354|P8|NOT COMPLETED|Overall Study||0
5144483|NCT01342523|12653355|P7|NOT COMPLETED|Overall Study||0
5144484|NCT01342523|12653356|P6|NOT COMPLETED|Overall Study||0
5144485|NCT01342523|12653357|P5|NOT COMPLETED|Overall Study||0
5144486|NCT01342523|12653358|P4|NOT COMPLETED|Overall Study||1
5144487|NCT01342523|12653359|P3|NOT COMPLETED|Overall Study||0
5144488|NCT01342523|12653360|P2|NOT COMPLETED|Overall Study||0
5144489|NCT01342523|12653361|P1|NOT COMPLETED|Overall Study||1
5144490|NCT01342523|12653330|P32|COMPLETED|Overall Study||27
5144491|NCT01342523|12653331|P31|COMPLETED|Overall Study||30
5144492|NCT01342523|12653332|P30|COMPLETED|Overall Study||28
5144493|NCT01342523|12653333|P29|COMPLETED|Overall Study||34
5144494|NCT01342523|12653334|P28|COMPLETED|Overall Study||30
5144495|NCT01342523|12653335|P27|COMPLETED|Overall Study||33
5144496|NCT01342523|12653336|P26|COMPLETED|Overall Study||36
5144497|NCT01342523|12653337|P25|COMPLETED|Overall Study||36
5144498|NCT01342523|12653338|P24|COMPLETED|Overall Study||35
5144499|NCT01342523|12653339|P23|COMPLETED|Overall Study||36
5144500|NCT01342523|12653340|P22|COMPLETED|Overall Study||30
5144501|NCT01342523|12653341|P21|COMPLETED|Overall Study||29
5144502|NCT01342523|12653342|P20|COMPLETED|Overall Study||27
5144503|NCT01342523|12653343|P19|COMPLETED|Overall Study||21
5144504|NCT01342523|12653344|P18|COMPLETED|Overall Study||27
5144505|NCT01342523|12653345|P17|COMPLETED|Overall Study||28
5144506|NCT01342523|12653346|P16|COMPLETED|Overall Study||32
5144507|NCT01342523|12653347|P15|COMPLETED|Overall Study||37
5144508|NCT01342523|12653348|P14|COMPLETED|Overall Study||36
5144509|NCT01342523|12653349|P13|COMPLETED|Overall Study||39
5144510|NCT01342523|12653350|P12|COMPLETED|Overall Study||36
5144511|NCT01342523|12653351|P11|COMPLETED|Overall Study||38
5144512|NCT01342523|12653352|P10|COMPLETED|Overall Study||28
5144513|NCT01342523|12653353|P9|COMPLETED|Overall Study||28
5144514|NCT01342523|12653354|P8|COMPLETED|Overall Study||27
5144515|NCT01342523|12653355|P7|COMPLETED|Overall Study||22
5144516|NCT01342523|12653356|P6|COMPLETED|Overall Study||36
5144517|NCT01342523|12653357|P5|COMPLETED|Overall Study||36
5144518|NCT01342523|12653358|P4|COMPLETED|Overall Study||32
5144519|NCT01342523|12653359|P3|COMPLETED|Overall Study||36
5144520|NCT01342523|12653360|P2|COMPLETED|Overall Study||32
5144521|NCT01342523|12653361|P1|COMPLETED|Overall Study||34
5144522|NCT01342523|12653330|P32|STARTED|Overall Study||28
5144523|NCT01342523|12653331|P31|STARTED|Overall Study||31
5144524|NCT01342523|12653332|P30|STARTED|Overall Study||29
5144525|NCT01342523|12653333|P29|STARTED|Overall Study||35
5144526|NCT01342523|12653334|P28|STARTED|Overall Study||31
5144527|NCT01342523|12653335|P27|STARTED|Overall Study||34
5144528|NCT01342523|12653336|P26|STARTED|Overall Study||38
5144529|NCT01342523|12653337|P25|STARTED|Overall Study||37
5144530|NCT01342523|12653338|P24|STARTED|Overall Study||36
5144531|NCT01342523|12653339|P23|STARTED|Overall Study||36
5144532|NCT01342523|12653340|P22|STARTED|Overall Study||30
5144533|NCT01342523|12653341|P21|STARTED|Overall Study||29
5144534|NCT01342523|12653342|P20|STARTED|Overall Study||27
5144535|NCT01342523|12653343|P19|STARTED|Overall Study||21
5144536|NCT01342523|12653344|P18|STARTED|Overall Study||27
5144537|NCT01342523|12653345|P17|STARTED|Overall Study||29
5144538|NCT01342523|12653346|P16|STARTED|Overall Study||32
5144539|NCT01342523|12653347|P15|STARTED|Overall Study||38
5144540|NCT01342523|12653348|P14|STARTED|Overall Study||38
5144541|NCT01342523|12653349|P13|STARTED|Overall Study||39
5144542|NCT01342523|12653350|P12|STARTED|Overall Study||38
5144543|NCT01342523|12653351|P11|STARTED|Overall Study||38
5144544|NCT01342523|12653352|P10|STARTED|Overall Study||28
5144545|NCT01342523|12653353|P9|STARTED|Overall Study||28
5144546|NCT01342523|12653354|P8|STARTED|Overall Study||27
5144547|NCT01342523|12653355|P7|STARTED|Overall Study||22
5144548|NCT01342523|12653356|P6|STARTED|Overall Study||36
5144549|NCT01342523|12653357|P5|STARTED|Overall Study||36
5144550|NCT01342523|12653358|P4|STARTED|Overall Study||33
5144551|NCT01342523|12653359|P3|STARTED|Overall Study||36
5144552|NCT01342523|12653360|P2|STARTED|Overall Study||32
5144553|NCT01342523|12653361|P1|STARTED|Overall Study||35
5144554|NCT01342510|12653378|P4|NOT COMPLETED|Overall Study||11
5144555|NCT01342510|12653379|P3|NOT COMPLETED|Overall Study||13
5144556|NCT01342510|12653380|P2|NOT COMPLETED|Overall Study||6
5144557|NCT01342510|12653381|P1|NOT COMPLETED|Overall Study||12
5144558|NCT01342510|12653378|P4|COMPLETED|Overall Study||39
5144559|NCT01342510|12653379|P3|COMPLETED|Overall Study||37
5144560|NCT01342510|12653380|P2|COMPLETED|Overall Study||44
5144561|NCT01342510|12653381|P1|COMPLETED|Overall Study||38
5144562|NCT01342510|12653378|P4|STARTED|Overall Study||50
5144563|NCT01342510|12653379|P3|STARTED|Overall Study||50
5144564|NCT01342510|12653380|P2|STARTED|Overall Study||50
5144565|NCT01342510|12653381|P1|STARTED|Overall Study||50
5144566|NCT01342484|12653398|P3|NOT COMPLETED|Overall Study||1
5144567|NCT01342484|12653399|P2|NOT COMPLETED|Overall Study||0
5144568|NCT01342484|12653400|P1|NOT COMPLETED|Overall Study||2
5144569|NCT01342484|12653398|P3|COMPLETED|Overall Study||13
5144570|NCT01342484|12653399|P2|COMPLETED|Overall Study||10
5144571|NCT01342484|12653400|P1|COMPLETED|Overall Study||13
5144572|NCT01342484|12653398|P3|STARTED|Overall Study||14
5144573|NCT01342484|12653399|P2|STARTED|Overall Study||10
5144574|NCT01342484|12653400|P1|STARTED|Overall Study||15
5144575|NCT01342471|12653416|P2|NOT COMPLETED|Overall Study||6
5144576|NCT01342471|12653417|P1|NOT COMPLETED|Overall Study||5
5144577|NCT01342471|12653416|P2|COMPLETED|Overall Study||23
5144578|NCT01342471|12653417|P1|COMPLETED|Overall Study||24
5144579|NCT01342471|12653416|P2|STARTED|Overall Study||29
5144580|NCT01342471|12653417|P1|STARTED|Overall Study||29
5144581|NCT01342458|12653433|P2|NOT COMPLETED|Overall Study||4
5144582|NCT01342458|12653434|P1|NOT COMPLETED|Overall Study||2
5144583|NCT01342458|12653433|P2|COMPLETED|Overall Study||24
5144584|NCT01342458|12653434|P1|COMPLETED|Overall Study||26
5144585|NCT01342458|12653433|P2|STARTED|Overall Study||28
5144586|NCT01342458|12653434|P1|STARTED|Overall Study||28
5144587|NCT01342445|12653456|P2|NOT COMPLETED|Overall Study||2
5144588|NCT01342445|12653457|P1|NOT COMPLETED|Overall Study||0
5144589|NCT01342445|12653456|P2|COMPLETED|Overall Study||22
5144590|NCT01342445|12653457|P1|COMPLETED|Overall Study||26
5144591|NCT01342445|12653456|P2|STARTED|Overall Study||24
5144592|NCT01342445|12653457|P1|STARTED|Overall Study||26
5144593|NCT01342341|12653473|P2|NOT COMPLETED|Overall Study||4
5144594|NCT01342341|12653474|P1|NOT COMPLETED|Overall Study||4
5144595|NCT01342341|12653473|P2|COMPLETED|Overall Study||20
5144596|NCT01342341|12653474|P1|COMPLETED|Overall Study||20
5144597|NCT01342341|12653473|P2|STARTED|Overall Study||24
5144598|NCT01342341|12653474|P1|STARTED|Overall Study||24
5144599|NCT01342211|12653485|P5|NOT COMPLETED|Overall Study||2
5144600|NCT01342211|12653486|P4|NOT COMPLETED|Overall Study||2
5144601|NCT01342211|12653487|P3|NOT COMPLETED|Overall Study||0
5144602|NCT01342211|12653488|P2|NOT COMPLETED|Overall Study||2
5144603|NCT01342211|12653489|P1|NOT COMPLETED|Overall Study||0
5144604|NCT01342211|12653485|P5|COMPLETED|Overall Study||16
5144605|NCT01342211|12653486|P4|COMPLETED|Overall Study||17
5144606|NCT01342211|12653487|P3|COMPLETED|Overall Study||18
5144607|NCT01342211|12653488|P2|COMPLETED|Overall Study||17
5144608|NCT01342211|12653489|P1|COMPLETED|Overall Study||19
5144609|NCT01342211|12653485|P5|Treated|Overall Study||17
5144610|NCT01342211|12653486|P4|Treated|Overall Study||19
5144611|NCT01342211|12653487|P3|Treated|Overall Study||18
5144612|NCT01342211|12653488|P2|Treated|Overall Study||17
5144613|NCT01342211|12653489|P1|Treated|Overall Study||19
5144614|NCT01342211|12653485|P5|STARTED|Overall Study||18
5144615|NCT01342211|12653486|P4|STARTED|Overall Study||19
5144616|NCT01342211|12653487|P3|STARTED|Overall Study||18
5144617|NCT01342211|12653488|P2|STARTED|Overall Study||19
5144618|NCT01342211|12653489|P1|STARTED|Overall Study||19
5144619|NCT01342172|12653555|P1|NOT COMPLETED|Overall Study||0
5144620|NCT01342172|12653555|P1|COMPLETED|Overall Study||9
5144621|NCT01342172|12653555|P1|STARTED|Overall Study||9
5144622|NCT01342107|12653568|P2|NOT COMPLETED|Overall Study||0
5144623|NCT01342107|12653569|P1|NOT COMPLETED|Overall Study||0
5144624|NCT01342107|12653568|P2|COMPLETED|Overall Study||32
5144625|NCT01342107|12653569|P1|COMPLETED|Overall Study||34
5144626|NCT01342107|12653568|P2|STARTED|Overall Study||32
5144627|NCT01342107|12653569|P1|STARTED|Overall Study||34
5144628|NCT01342094|12653577|P2|NOT COMPLETED|Overall Study||3
5144629|NCT01342094|12653578|P1|NOT COMPLETED|Overall Study||5
5144630|NCT01342094|12653577|P2|COMPLETED|Overall Study||81
5144631|NCT01342094|12653578|P1|COMPLETED|Overall Study||77
5144632|NCT01342094|12653577|P2|STARTED|Overall Study||84
5144633|NCT01342094|12653578|P1|STARTED|Overall Study||82
5144634|NCT01342081|12653587|P3|NOT COMPLETED|Overall Study||1
5144635|NCT01342081|12653588|P2|NOT COMPLETED|Overall Study||2
5144636|NCT01342081|12653589|P1|NOT COMPLETED|Overall Study||2
5144637|NCT01342081|12653587|P3|COMPLETED|Overall Study||163
5144638|NCT01342081|12653588|P2|COMPLETED|Overall Study||162
5144639|NCT01342081|12653589|P1|COMPLETED|Overall Study||159
5144640|NCT01342081|12653587|P3|STARTED|Overall Study||164
5144641|NCT01342081|12653588|P2|STARTED|Overall Study||164
5144642|NCT01342081|12653589|P1|STARTED|Overall Study||161
5144643|NCT01342029|12653597|P2|NOT COMPLETED|Period 2||0
5144644|NCT01342029|12653598|P1|NOT COMPLETED|Period 2||2
5144645|NCT01342029|12653597|P2|COMPLETED|Period 2||67
5144646|NCT01342029|12653598|P1|COMPLETED|Period 2||65
5144647|NCT01342029|12653597|P2|Dropout|Period 2||0
5144648|NCT01342029|12653598|P1|Dropout|Period 2||2
5144649|NCT01342029|12653597|P2|STARTED|Period 2||67
5144650|NCT01342029|12653598|P1|STARTED|Period 2||67
5144651|NCT01342029|12653597|P2|NOT COMPLETED|Washout||4
5144652|NCT01342029|12653598|P1|NOT COMPLETED|Washout||0
5144653|NCT01342029|12653597|P2|COMPLETED|Washout||67
5144654|NCT01342029|12653598|P1|COMPLETED|Washout||67
5144655|NCT01342029|12653597|P2|STARTED|Washout||71
5144656|NCT01342029|12653598|P1|STARTED|Washout||67
5144657|NCT01342029|12653597|P2|NOT COMPLETED|Period 1||1
5144658|NCT01342029|12653598|P1|NOT COMPLETED|Period 1||3
5144659|NCT01342029|12653597|P2|COMPLETED|Period 1||71
5144660|NCT01342029|12653598|P1|COMPLETED|Period 1||67
5144661|NCT01342029|12653597|P2|Dropout|Period 1||1
5144662|NCT01342029|12653598|P1|Dropout|Period 1||3
5144663|NCT01342029|12653597|P2|STARTED|Period 1||72
5144664|NCT01342029|12653598|P1|STARTED|Period 1||70
5144665|NCT01341990|12653608|P2|NOT COMPLETED|Overall Study||1
5144666|NCT01341990|12653609|P1|NOT COMPLETED|Overall Study||3
5144667|NCT01341990|12653608|P2|COMPLETED|Overall Study||32
5144668|NCT01341990|12653609|P1|COMPLETED|Overall Study||32
5144669|NCT01341990|12653608|P2|STARTED|Overall Study||33
5144670|NCT01341990|12653609|P1|STARTED|Overall Study||35
5144671|NCT01341977|12653619|P2|NOT COMPLETED|Overall Study||15
5144672|NCT01341977|12653620|P1|NOT COMPLETED|Overall Study||14
5144673|NCT01341977|12653619|P2|COMPLETED|Overall Study||270
5144674|NCT01341977|12653620|P1|COMPLETED|Overall Study||274
5144675|NCT01341977|12653619|P2|STARTED|Overall Study||285
5144676|NCT01341977|12653620|P1|STARTED|Overall Study||288
5144677|NCT01341912|12653626|P1|NOT COMPLETED|Overall Study||0
5144678|NCT01341912|12653626|P1|COMPLETED|Overall Study||3
5144679|NCT01341912|12653626|P1|STARTED|Overall Study||3
5144680|NCT01341782|12653633|P2|NOT COMPLETED|Overall Study||14
5144681|NCT01341782|12653634|P1|NOT COMPLETED|Overall Study||15
5144682|NCT01341782|12653633|P2|COMPLETED|Overall Study||114
5144683|NCT01341782|12653634|P1|COMPLETED|Overall Study||112
5144684|NCT01341782|12653633|P2|STARTED|Overall Study||128
5144685|NCT01341782|12653634|P1|STARTED|Overall Study||127
5144686|NCT01341639|12653652|P2|NOT COMPLETED|Post-Treatment||3
5144687|NCT01341639|12653653|P1|NOT COMPLETED|Post-Treatment||0
5144688|NCT01341639|12653652|P2|COMPLETED|Post-Treatment||545
5144689|NCT01341639|12653653|P1|COMPLETED|Post-Treatment||539
5144690|NCT01341639|12653652|P2|STARTED|Post-Treatment||548
5144691|NCT01341639|12653653|P1|STARTED|Post-Treatment||539
5144692|NCT01341639|12653652|P2|NOT COMPLETED|Toddler Dose||34
5144693|NCT01341639|12653653|P1|NOT COMPLETED|Toddler Dose||51
5144694|NCT01341639|12653652|P2|COMPLETED|Toddler Dose||548
5144695|NCT01341639|12653653|P1|COMPLETED|Toddler Dose||539
5144696|NCT01341639|12653652|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
5144697|NCT01341639|12653653|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
5144698|NCT01341639|12653652|P2|NOT COMPLETED|Interim Period||9
5144699|NCT01341639|12653653|P1|NOT COMPLETED|Interim Period||8
5144700|NCT01341639|12653652|P2|COMPLETED|Interim Period||581
5144701|NCT01341639|12653653|P1|COMPLETED|Interim Period||591
5144702|NCT01341639|12653652|P2|STARTED|Interim Period||590
5144703|NCT01341639|12653653|P1|STARTED|Interim Period||599
5144704|NCT01341639|12653652|P2|NOT COMPLETED|Infant Series||32
5144705|NCT01341639|12653653|P1|NOT COMPLETED|Infant Series||29
5144706|NCT01341639|12653652|P2|COMPLETED|Infant Series||590
5144707|NCT01341639|12653653|P1|COMPLETED|Infant Series||599
5144708|NCT01341639|12653652|P2|Treated|Infant Series||605
5144709|NCT01341639|12653653|P1|Treated|Infant Series||610
5144710|NCT01341639|12653652|P2|Site 0048 Excluded|Infant Series||606
5144711|NCT01341639|12653653|P1|Site 0048 Excluded|Infant Series||611
5144712|NCT01341639|12653652|P2|STARTED|Infant Series||622
5144713|NCT01341639|12653653|P1|STARTED|Infant Series||628
5144714|NCT01341600|12653677|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
5144715|NCT01341600|12653678|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
5144716|NCT01341600|12653679|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
5144717|NCT01341600|12653677|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
5144718|NCT01341600|12653678|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
5144719|NCT01341600|12653679|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
5144720|NCT01341600|12653677|P3|STARTED|Clopidogrel Plus Omeprazole||4
5144721|NCT01341600|12653678|P2|STARTED|Clopidogrel Plus Omeprazole||5
5144722|NCT01341600|12653679|P1|STARTED|Clopidogrel Plus Omeprazole||5
5144723|NCT01341600|12653677|P3|NOT COMPLETED|Clopidogrel 225 mg||0
5144724|NCT01341600|12653678|P2|NOT COMPLETED|Clopidogrel 225 mg||0
5144725|NCT01341600|12653679|P1|NOT COMPLETED|Clopidogrel 225 mg||0
5144726|NCT01341600|12653677|P3|COMPLETED|Clopidogrel 225 mg||6
5144727|NCT01341600|12653678|P2|COMPLETED|Clopidogrel 225 mg||6
5144728|NCT01341600|12653679|P1|COMPLETED|Clopidogrel 225 mg||6
5144729|NCT01341600|12653677|P3|STARTED|Clopidogrel 225 mg||6
5144730|NCT01341600|12653678|P2|STARTED|Clopidogrel 225 mg||6
5144731|NCT01341600|12653679|P1|STARTED|Clopidogrel 225 mg||6
5144732|NCT01341600|12653677|P3|NOT COMPLETED|Clopidogrel 150 mg||0
5144733|NCT01341600|12653678|P2|NOT COMPLETED|Clopidogrel 150 mg||0
5144734|NCT01341600|12653679|P1|NOT COMPLETED|Clopidogrel 150 mg||0
5144735|NCT01341600|12653677|P3|COMPLETED|Clopidogrel 150 mg||6
5144736|NCT01341600|12653678|P2|COMPLETED|Clopidogrel 150 mg||6
5144737|NCT01341600|12653679|P1|COMPLETED|Clopidogrel 150 mg||6
5144738|NCT01341600|12653677|P3|STARTED|Clopidogrel 150 mg||6
5144739|NCT01341600|12653678|P2|STARTED|Clopidogrel 150 mg||6
5144740|NCT01341600|12653679|P1|STARTED|Clopidogrel 150 mg||6
5144741|NCT01341600|12653677|P3|NOT COMPLETED|Clopidogrel 75 mg||0
5144742|NCT01341600|12653678|P2|NOT COMPLETED|Clopidogrel 75 mg||0
5144743|NCT01341600|12653679|P1|NOT COMPLETED|Clopidogrel 75 mg||0
5144744|NCT01341600|12653677|P3|COMPLETED|Clopidogrel 75 mg||6
5144745|NCT01341600|12653678|P2|COMPLETED|Clopidogrel 75 mg||6
5144746|NCT01341600|12653679|P1|COMPLETED|Clopidogrel 75 mg||6
5144747|NCT01341600|12653677|P3|STARTED|Clopidogrel 75 mg||6
5144748|NCT01341600|12653678|P2|STARTED|Clopidogrel 75 mg||6
5144749|NCT01341600|12653679|P1|STARTED|Clopidogrel 75 mg||6
5144750|NCT01341587|12653698|P2|NOT COMPLETED|Overall Study||10
5144751|NCT01341587|12653699|P1|NOT COMPLETED|Overall Study||4
5144752|NCT01341587|12653698|P2|COMPLETED|Overall Study||0
5144753|NCT01341587|12653699|P1|COMPLETED|Overall Study||0
5144754|NCT01341587|12653698|P2|STARTED|Overall Study||10
5144755|NCT01341587|12653699|P1|STARTED|Overall Study||4
5144756|NCT01341470|12653711|P6|NOT COMPLETED|Overall Study||1
5144757|NCT01341470|12653712|P5|NOT COMPLETED|Overall Study||0
5144758|NCT01341470|12653713|P4|NOT COMPLETED|Overall Study||1
5144759|NCT01341470|12653714|P3|NOT COMPLETED|Overall Study||1
5144760|NCT01341470|12653715|P2|NOT COMPLETED|Overall Study||0
5144761|NCT01341470|12653716|P1|NOT COMPLETED|Overall Study||0
5144762|NCT01341470|12653711|P6|COMPLETED|Overall Study||9
5144763|NCT01341470|12653712|P5|COMPLETED|Overall Study||2
5144764|NCT01341470|12653713|P4|COMPLETED|Overall Study||9
5144765|NCT01341470|12653714|P3|COMPLETED|Overall Study||9
5144766|NCT01341470|12653715|P2|COMPLETED|Overall Study||9
5144767|NCT01341470|12653716|P1|COMPLETED|Overall Study||6
5144768|NCT01341470|12653711|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
5144769|NCT01341470|12653712|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
5144770|NCT01341470|12653713|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
5144771|NCT01341470|12653714|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
5144772|NCT01341470|12653715|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
5144773|NCT01341470|12653716|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5144774|NCT01341470|12653711|P6|STARTED|Overall Study||10
5144775|NCT01341470|12653712|P5|STARTED|Overall Study||2
5144776|NCT01341470|12653713|P4|STARTED|Overall Study||10
5144777|NCT01341470|12653714|P3|STARTED|Overall Study||10
5144778|NCT01341470|12653715|P2|STARTED|Overall Study||9
5144779|NCT01341470|12653716|P1|STARTED|Overall Study||6
5144780|NCT01341457|12653750|P2|NOT COMPLETED|Overall Study||0
5144781|NCT01341457|12653751|P1|NOT COMPLETED|Overall Study||2
5144782|NCT01341457|12653750|P2|COMPLETED|Overall Study||10
5144783|NCT01341457|12653751|P1|COMPLETED|Overall Study||5
5144784|NCT01341457|12653750|P2|Received at Least One Dose of Study Drug|Overall Study||10
5144785|NCT01341457|12653751|P1|Received at Least One Dose of Study Drug|Overall Study||7
5144786|NCT01341457|12653750|P2|STARTED|Overall Study||10
5144787|NCT01341457|12653751|P1|STARTED|Overall Study||7
5144788|NCT01341444|12653769|P2|NOT COMPLETED|Overall Study||3
5144789|NCT01341444|12653770|P1|NOT COMPLETED|Overall Study||5
5144790|NCT01341444|12653769|P2|COMPLETED|Overall Study||29
5144791|NCT01341444|12653770|P1|COMPLETED|Overall Study||26
5144792|NCT01341444|12653769|P2|STARTED|Overall Study||32
5144793|NCT01341444|12653770|P1|STARTED|Overall Study||31
5144794|NCT01341301|12653776|P1|NOT COMPLETED|Overall Study||0
5144795|NCT01341301|12653776|P1|COMPLETED|Overall Study||25
5144796|NCT01341301|12653776|P1|STARTED|Overall Study||25
5144797|NCT01341067|12653783|P1|NOT COMPLETED|Overall Study||4
5144798|NCT01341067|12653783|P1|COMPLETED|Overall Study||26
5144799|NCT01341067|12653783|P1|STARTED|Overall Study||30
5144800|NCT01340976|12653796|P6|NOT COMPLETED|Overall Study||1
5144801|NCT01340976|12653797|P5|NOT COMPLETED|Overall Study||2
5144802|NCT01340976|12653798|P4|NOT COMPLETED|Overall Study||3
5144803|NCT01340976|12653799|P3|NOT COMPLETED|Overall Study||3
5144804|NCT01340976|12653800|P2|NOT COMPLETED|Overall Study||2
5144805|NCT01340976|12653801|P1|NOT COMPLETED|Overall Study||4
5144806|NCT01340976|12653796|P6|COMPLETED|Overall Study||6
5144807|NCT01340976|12653797|P5|COMPLETED|Overall Study||5
5144808|NCT01340976|12653798|P4|COMPLETED|Overall Study||2
5144809|NCT01340976|12653799|P3|COMPLETED|Overall Study||4
5144810|NCT01340976|12653800|P2|COMPLETED|Overall Study||1
5144811|NCT01340976|12653801|P1|COMPLETED|Overall Study||0
5144812|NCT01340976|12653796|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
5144813|NCT01340976|12653797|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
5144814|NCT01340976|12653798|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
5144815|NCT01340976|12653799|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
5144816|NCT01340976|12653800|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5144817|NCT01340976|12653801|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5144818|NCT01340976|12653796|P6|STARTED|Overall Study||7
5144819|NCT01340976|12653797|P5|STARTED|Overall Study||7
5144820|NCT01340976|12653798|P4|STARTED|Overall Study||5
5144821|NCT01340976|12653799|P3|STARTED|Overall Study||7
5144822|NCT01340976|12653800|P2|STARTED|Overall Study||3
5144823|NCT01340976|12653801|P1|STARTED|Overall Study||4
5144824|NCT01340937|12653839|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
5144825|NCT01340937|12653840|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
5144826|NCT01340937|12653841|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
5144827|NCT01340937|12653842|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
5144828|NCT01340937|12653839|P4|COMPLETED|Period 3: Toddler Vaccinations||319
5144829|NCT01340937|12653840|P3|COMPLETED|Period 3: Toddler Vaccinations||660
5144830|NCT01340937|12653841|P2|COMPLETED|Period 3: Toddler Vaccinations||641
5144831|NCT01340937|12653842|P1|COMPLETED|Period 3: Toddler Vaccinations||666
5144832|NCT01340937|12653839|P4|STARTED|Period 3: Toddler Vaccinations||329
5144833|NCT01340937|12653840|P3|STARTED|Period 3: Toddler Vaccinations||669
5144834|NCT01340937|12653841|P2|STARTED|Period 3: Toddler Vaccinations||658
5144835|NCT01340937|12653842|P1|STARTED|Period 3: Toddler Vaccinations||675
5144836|NCT01340937|12653839|P4|NOT COMPLETED|Period 2: Interim Period||41
5144837|NCT01340937|12653840|P3|NOT COMPLETED|Period 2: Interim Period||84
5144838|NCT01340937|12653841|P2|NOT COMPLETED|Period 2: Interim Period||79
5144839|NCT01340937|12653842|P1|NOT COMPLETED|Period 2: Interim Period||67
5144840|NCT01340937|12653839|P4|COMPLETED|Period 2: Interim Period||329
5144841|NCT01340937|12653840|P3|COMPLETED|Period 2: Interim Period||669
5144842|NCT01340937|12653841|P2|COMPLETED|Period 2: Interim Period||658
5144843|NCT01340937|12653842|P1|COMPLETED|Period 2: Interim Period||675
5144844|NCT01340937|12653839|P4|STARTED|Period 2: Interim Period||370
5144845|NCT01340937|12653840|P3|STARTED|Period 2: Interim Period||753
5144846|NCT01340937|12653841|P2|STARTED|Period 2: Interim Period||737
5144847|NCT01340937|12653842|P1|STARTED|Period 2: Interim Period||742
5144848|NCT01340937|12653839|P4|NOT COMPLETED|Period 1: Infant Series||32
5144849|NCT01340937|12653840|P3|NOT COMPLETED|Period 1: Infant Series||56
5144850|NCT01340937|12653841|P2|NOT COMPLETED|Period 1: Infant Series||60
5144851|NCT01340937|12653842|P1|NOT COMPLETED|Period 1: Infant Series||58
5144852|NCT01340937|12653839|P4|COMPLETED|Period 1: Infant Series||370
5144853|NCT01340937|12653840|P3|COMPLETED|Period 1: Infant Series||753
5144854|NCT01340937|12653841|P2|COMPLETED|Period 1: Infant Series||737
5144855|NCT01340937|12653842|P1|COMPLETED|Period 1: Infant Series||742
5144856|NCT01340937|12653839|P4|STARTED|Period 1: Infant Series||402
5144857|NCT01340937|12653840|P3|STARTED|Period 1: Infant Series||809
5144858|NCT01340937|12653841|P2|STARTED|Period 1: Infant Series||797
5144859|NCT01340937|12653842|P1|STARTED|Period 1: Infant Series||800
5144860|NCT01340898|12654002|P3|NOT COMPLETED|Booster Phase||7
5144861|NCT01340898|12654003|P2|NOT COMPLETED|Booster Phase||2
5144862|NCT01340898|12654004|P1|NOT COMPLETED|Booster Phase||10
5144863|NCT01340898|12654002|P3|COMPLETED|Booster Phase||163
5144864|NCT01340898|12654003|P2|COMPLETED|Booster Phase||164
5144865|NCT01340898|12654004|P1|COMPLETED|Booster Phase||332
5144866|NCT01340898|12654002|P3|STARTED|Booster Phase||170
5144867|NCT01340898|12654003|P2|STARTED|Booster Phase||166
5144868|NCT01340898|12654004|P1|STARTED|Booster Phase||342
5144869|NCT01340898|12654002|P3|NOT COMPLETED|Primary Phase||6
5144870|NCT01340898|12654003|P2|NOT COMPLETED|Primary Phase||9
5144871|NCT01340898|12654004|P1|NOT COMPLETED|Primary Phase||16
5144872|NCT01340898|12654002|P3|COMPLETED|Primary Phase||181
5144873|NCT01340898|12654003|P2|COMPLETED|Primary Phase||178
5144874|NCT01340898|12654004|P1|COMPLETED|Primary Phase||360
5144875|NCT01340898|12654002|P3|STARTED|Primary Phase||187
5144876|NCT01340898|12654003|P2|STARTED|Primary Phase||187
5144877|NCT01340898|12654004|P1|STARTED|Primary Phase||376
5144878|NCT01340885|12654107|P3|NOT COMPLETED|Overall Study||0
5144879|NCT01340885|12654108|P2|NOT COMPLETED|Overall Study||0
5144880|NCT01340885|12654109|P1|NOT COMPLETED|Overall Study||0
5144881|NCT01340885|12654107|P3|COMPLETED|Overall Study||0
5144882|NCT01340885|12654108|P2|COMPLETED|Overall Study||0
5144883|NCT01340885|12654109|P1|COMPLETED|Overall Study||0
5144884|NCT01340885|12654107|P3|STARTED|Overall Study||0
5144885|NCT01340885|12654108|P2|STARTED|Overall Study||0
5144886|NCT01340885|12654109|P1|STARTED|Overall Study||0
5144887|NCT01340872|12654134|P4|NOT COMPLETED|Open-label Phase||11
5144888|NCT01340872|12654135|P3|NOT COMPLETED|Open-label Phase||13
5144889|NCT01340872|12654136|P2|NOT COMPLETED|Open-label Phase||0
5144890|NCT01340872|12654137|P1|NOT COMPLETED|Open-label Phase||0
5144891|NCT01340872|12654134|P4|COMPLETED|Open-label Phase||36
5144892|NCT01340872|12654135|P3|COMPLETED|Open-label Phase||37
5144893|NCT01340872|12654136|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
5144894|NCT01340872|12654137|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
5144895|NCT01340872|12654134|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
5144896|NCT01340872|12654135|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
5144897|NCT01340872|12654136|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
5144898|NCT01340872|12654137|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
5144899|NCT01340872|12654134|P4|NOT COMPLETED|Double-blind Phase||0
5144900|NCT01340872|12654135|P3|NOT COMPLETED|Double-blind Phase||0
5144901|NCT01340872|12654136|P2|NOT COMPLETED|Double-blind Phase||11
5144902|NCT01340872|12654137|P1|NOT COMPLETED|Double-blind Phase||9
5144903|NCT01340872|12654134|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
5144904|NCT01340872|12654135|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
5144905|NCT01340872|12654136|P2|COMPLETED|Double-blind Phase||53
5144906|NCT01340872|12654137|P1|COMPLETED|Double-blind Phase||55
5144907|NCT01340872|12654134|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
5144908|NCT01340872|12654135|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
5144909|NCT01340872|12654136|P2|STARTED|Double-blind Phase||64
5144910|NCT01340872|12654137|P1|STARTED|Double-blind Phase||64
5144911|NCT01340794|12654197|P2|NOT COMPLETED|Overall Study||1
5144912|NCT01340794|12654198|P1|NOT COMPLETED|Overall Study||0
5144913|NCT01340794|12654197|P2|COMPLETED|Overall Study||4
5144914|NCT01340794|12654198|P1|COMPLETED|Overall Study||2
5144915|NCT01340794|12654197|P2|STARTED|Overall Study||5
5144916|NCT01340794|12654198|P1|STARTED|Overall Study||2
5144917|NCT01340768|12654214|P2|NOT COMPLETED|Overall Study||5
5144918|NCT01340768|12654215|P1|NOT COMPLETED|Overall Study||17
5144919|NCT01340768|12654214|P2|COMPLETED|Overall Study||429
5144920|NCT01340768|12654215|P1|COMPLETED|Overall Study||419
5144921|NCT01340768|12654214|P2|STARTED|Overall Study||434
5144922|NCT01340768|12654215|P1|STARTED|Overall Study||436
5144923|NCT01340664|12654226|P3|NOT COMPLETED|Overall Study||13
5144924|NCT01340664|12654227|P2|NOT COMPLETED|Overall Study||8
5144925|NCT01340664|12654228|P1|NOT COMPLETED|Overall Study||7
5144926|NCT01340664|12654226|P3|COMPLETED|Overall Study||80
5144927|NCT01340664|12654227|P2|COMPLETED|Overall Study||85
5144928|NCT01340664|12654228|P1|COMPLETED|Overall Study||86
5144929|NCT01340664|12654226|P3|STARTED|Overall Study||93
5144930|NCT01340664|12654227|P2|STARTED|Overall Study||93
5144931|NCT01340664|12654228|P1|STARTED|Overall Study||93
5144932|NCT01340651|12654245|P1|NOT COMPLETED|Overall Study||17
5144933|NCT01340651|12654245|P1|COMPLETED|Overall Study||24
5144934|NCT01340651|12654245|P1|STARTED|Overall Study||41
5144935|NCT01340625|12654261|P2|NOT COMPLETED|Second Intervention||0
5144936|NCT01340625|12654262|P1|NOT COMPLETED|Second Intervention||0
5144937|NCT01340625|12654261|P2|COMPLETED|Second Intervention||18
5144938|NCT01340625|12654262|P1|COMPLETED|Second Intervention||16
5144939|NCT01340625|12654261|P2|STARTED|Second Intervention||18
5144940|NCT01340625|12654262|P1|STARTED|Second Intervention||16
5144941|NCT01340625|12654261|P2|NOT COMPLETED|Washout Period of 28 Days||0
5144942|NCT01340625|12654262|P1|NOT COMPLETED|Washout Period of 28 Days||1
5144943|NCT01340625|12654261|P2|COMPLETED|Washout Period of 28 Days||18
5144944|NCT01340625|12654262|P1|COMPLETED|Washout Period of 28 Days||16
5144945|NCT01340625|12654261|P2|STARTED|Washout Period of 28 Days||18
5144946|NCT01340625|12654262|P1|STARTED|Washout Period of 28 Days||17
5144947|NCT01340625|12654261|P2|NOT COMPLETED|First Intervention||0
5144948|NCT01340625|12654262|P1|NOT COMPLETED|First Intervention||1
5144949|NCT01340625|12654261|P2|COMPLETED|First Intervention||18
5144950|NCT01340625|12654262|P1|COMPLETED|First Intervention||17
5144951|NCT01340625|12654261|P2|STARTED|First Intervention||18
5144952|NCT01340625|12654262|P1|STARTED|First Intervention||18
5144953|NCT01340586|12654280|P2|NOT COMPLETED|Overall Study||0
5144954|NCT01340586|12654281|P1|NOT COMPLETED|Overall Study||0
5144955|NCT01340586|12654280|P2|COMPLETED|Overall Study||8
5144956|NCT01340586|12654281|P1|COMPLETED|Overall Study||8
5144957|NCT01340586|12654280|P2|STARTED|Overall Study||8
5144958|NCT01340586|12654281|P1|STARTED|Overall Study||8
5144959|NCT01340573|12654346|P1|NOT COMPLETED|Overall Study||3
5144960|NCT01340573|12654346|P1|COMPLETED|Overall Study||0
5144961|NCT01340573|12654346|P1|STARTED|Overall Study||3
5144962|NCT01340495|12654367|P1|NOT COMPLETED|Overall Study||1
5144963|NCT01340495|12654367|P1|COMPLETED|Overall Study||69
5144964|NCT01340495|12654367|P1|STARTED|Overall Study||70
5144965|NCT01340300|12654378|P4|NOT COMPLETED|Overall Study||14
5144966|NCT01340300|12654379|P3|NOT COMPLETED|Overall Study||15
5144967|NCT01340300|12654380|P2|NOT COMPLETED|Overall Study||9
5144968|NCT01340300|12654381|P1|NOT COMPLETED|Overall Study||9
5144969|NCT01340300|12654378|P4|COMPLETED|Overall Study||20
5144970|NCT01340300|12654379|P3|COMPLETED|Overall Study||20
5144971|NCT01340300|12654380|P2|COMPLETED|Overall Study||26
5144972|NCT01340300|12654381|P1|COMPLETED|Overall Study||26
5144973|NCT01340300|12654378|P4|Follow-up Blood Sample|Overall Study||18
5144974|NCT01340300|12654379|P3|Follow-up Blood Sample|Overall Study||19
5144975|NCT01340300|12654380|P2|Follow-up Blood Sample|Overall Study||26
5144976|NCT01340300|12654381|P1|Follow-up Blood Sample|Overall Study||25
5144977|NCT01340300|12654378|P4|Baseline Blood Sample|Overall Study||29
5144978|NCT01340300|12654379|P3|Baseline Blood Sample|Overall Study||32
5144979|NCT01340300|12654380|P2|Baseline Blood Sample|Overall Study||34
5144980|NCT01340300|12654381|P1|Baseline Blood Sample|Overall Study||33
5144981|NCT01340300|12654378|P4|STARTED|Overall Study||34
5144982|NCT01340300|12654379|P3|STARTED|Overall Study||35
5144983|NCT01340300|12654380|P2|STARTED|Overall Study||35
5144984|NCT01340300|12654381|P1|STARTED|Overall Study||35
5144985|NCT01340209|12654414|P3|NOT COMPLETED|Overall Study||8
5144986|NCT01340209|12654415|P2|NOT COMPLETED|Overall Study||8
5144987|NCT01340209|12654416|P1|NOT COMPLETED|Overall Study||5
5144988|NCT01340209|12654414|P3|COMPLETED|Overall Study||106
5144989|NCT01340209|12654415|P2|COMPLETED|Overall Study||106
5144990|NCT01340209|12654416|P1|COMPLETED|Overall Study||52
5144991|NCT01340209|12654414|P3|STARTED|Overall Study||114
5144992|NCT01340209|12654415|P2|STARTED|Overall Study||114
5144993|NCT01340209|12654416|P1|STARTED|Overall Study||57
5144994|NCT01340196|12654451|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
5144995|NCT01340196|12654451|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
5144996|NCT01340196|12654451|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
5144997|NCT01340196|12654451|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
5144998|NCT01340196|12654451|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
5144999|NCT01340196|12654451|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
5145000|NCT01340196|12654451|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
5145001|NCT01340196|12654451|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
5145002|NCT01340196|12654451|P1|STARTED|Treat. Period 1 (Tenofovir)||16
5145003|NCT01340144|12654482|P2|NOT COMPLETED|Overall Study||58
5145004|NCT01340144|12654483|P1|NOT COMPLETED|Overall Study||72
5145005|NCT01340144|12654482|P2|COMPLETED|Overall Study||567
5145006|NCT01340144|12654483|P1|COMPLETED|Overall Study||553
5145007|NCT01340144|12654482|P2|STARTED|Overall Study||625
5145008|NCT01340144|12654483|P1|STARTED|Overall Study||625
5145009|NCT01340066|12654491|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
5145010|NCT01340066|12654492|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
5145011|NCT01340066|12654493|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
5145012|NCT01340066|12654491|P3|COMPLETED|5 Week Double Blind Randomization Period||31
5145013|NCT01340066|12654492|P2|COMPLETED|5 Week Double Blind Randomization Period||28
5145014|NCT01340066|12654493|P1|COMPLETED|5 Week Double Blind Randomization Period||0
5145015|NCT01340066|12654491|P3|STARTED|5 Week Double Blind Randomization Period||34
5145016|NCT01340066|12654492|P2|STARTED|5 Week Double Blind Randomization Period||33
5145017|NCT01340066|12654493|P1|STARTED|5 Week Double Blind Randomization Period||0
5145018|NCT01340066|12654491|P3|NOT COMPLETED|Placebo Run in Period||0
5145019|NCT01340066|12654492|P2|NOT COMPLETED|Placebo Run in Period||0
5145020|NCT01340066|12654493|P1|NOT COMPLETED|Placebo Run in Period||27
5145021|NCT01340066|12654491|P3|COMPLETED|Placebo Run in Period||0
5145022|NCT01340066|12654492|P2|COMPLETED|Placebo Run in Period||0
5145023|NCT01340066|12654493|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
5145024|NCT01340066|12654491|P3|STARTED|Placebo Run in Period||0
5145025|NCT01340066|12654492|P2|STARTED|Placebo Run in Period||0
5145026|NCT01340066|12654493|P1|STARTED|Placebo Run in Period||94
5145027|NCT01340053|12654504|P4|NOT COMPLETED|Overall Study||3
5145028|NCT01340053|12654505|P3|NOT COMPLETED|Overall Study||4
5145029|NCT01340053|12654506|P2|NOT COMPLETED|Overall Study||2
5145030|NCT01340053|12654507|P1|NOT COMPLETED|Overall Study||4
5145031|NCT01340053|12654504|P4|COMPLETED|Overall Study||43
5145032|NCT01340053|12654505|P3|COMPLETED|Overall Study||43
5145033|NCT01340053|12654506|P2|COMPLETED|Overall Study||44
5145034|NCT01340053|12654507|P1|COMPLETED|Overall Study||43
5145035|NCT01340053|12654504|P4|STARTED|Overall Study||46
5145036|NCT01340053|12654505|P3|STARTED|Overall Study||47
5145037|NCT01340053|12654506|P2|STARTED|Overall Study||46
5145038|NCT01340053|12654507|P1|STARTED|Overall Study||47
5145039|NCT01340027|12654533|P12|NOT COMPLETED|Overall Study||4
5145040|NCT01340027|12654534|P11|NOT COMPLETED|Overall Study||2
5145041|NCT01340027|12654535|P10|NOT COMPLETED|Overall Study||6
5145042|NCT01340027|12654536|P9|NOT COMPLETED|Overall Study||8
5145043|NCT01340027|12654537|P8|NOT COMPLETED|Overall Study||7
5145044|NCT01340027|12654538|P7|NOT COMPLETED|Overall Study||7
5145045|NCT01340027|12654539|P6|NOT COMPLETED|Overall Study||4
5145046|NCT01340027|12654540|P5|NOT COMPLETED|Overall Study||10
5145047|NCT01340027|12654541|P4|NOT COMPLETED|Overall Study||4
5145048|NCT01340027|12654542|P3|NOT COMPLETED|Overall Study||4
5145049|NCT01340027|12654543|P2|NOT COMPLETED|Overall Study||7
5145050|NCT01340027|12654544|P1|NOT COMPLETED|Overall Study||5
5145051|NCT01340027|12654533|P12|COMPLETED|Overall Study||77
5145052|NCT01340027|12654534|P11|COMPLETED|Overall Study||79
5145053|NCT01340027|12654535|P10|COMPLETED|Overall Study||146
5145054|NCT01340027|12654536|P9|COMPLETED|Overall Study||136
5145055|NCT01340027|12654537|P8|COMPLETED|Overall Study||142
5145056|NCT01340027|12654538|P7|COMPLETED|Overall Study||142
5145057|NCT01340027|12654539|P6|COMPLETED|Overall Study||74
5145058|NCT01340027|12654540|P5|COMPLETED|Overall Study||146
5145059|NCT01340027|12654541|P4|COMPLETED|Overall Study||75
5145060|NCT01340027|12654542|P3|COMPLETED|Overall Study||75
5145061|NCT01340027|12654543|P2|COMPLETED|Overall Study||71
5145062|NCT01340027|12654544|P1|COMPLETED|Overall Study||76
5145063|NCT01340027|12654533|P12|Received Treatment|Overall Study||81
5145064|NCT01340027|12654534|P11|Received Treatment|Overall Study||81
5145065|NCT01340027|12654535|P10|Received Treatment|Overall Study||152
5145066|NCT01340027|12654536|P9|Received Treatment|Overall Study||144
5145067|NCT01340027|12654537|P8|Received Treatment|Overall Study||149
5145068|NCT01340027|12654538|P7|Received Treatment|Overall Study||149
5145069|NCT01340027|12654539|P6|Received Treatment|Overall Study||78
5145070|NCT01340027|12654540|P5|Received Treatment|Overall Study||156
5145071|NCT01340027|12654541|P4|Received Treatment|Overall Study||79
5145072|NCT01340027|12654542|P3|Received Treatment|Overall Study||78
5145073|NCT01340027|12654543|P2|Received Treatment|Overall Study||78
5145074|NCT01340027|12654544|P1|Received Treatment|Overall Study||81
5145075|NCT01340027|12654533|P12|STARTED|Overall Study||81
5145076|NCT01340027|12654534|P11|STARTED|Overall Study||81
5145077|NCT01340027|12654535|P10|STARTED|Overall Study||152
5145078|NCT01340027|12654536|P9|STARTED|Overall Study||144
5145079|NCT01340027|12654537|P8|STARTED|Overall Study||149
5145080|NCT01340027|12654538|P7|STARTED|Overall Study||149
5145081|NCT01340027|12654539|P6|STARTED|Overall Study||78
5145082|NCT01340027|12654540|P5|STARTED|Overall Study||156
5145083|NCT01340027|12654541|P4|STARTED|Overall Study||79
5145084|NCT01340027|12654542|P3|STARTED|Overall Study||79
5145085|NCT01340027|12654543|P2|STARTED|Overall Study||78
5145086|NCT01340027|12654544|P1|STARTED|Overall Study||81
5145087|NCT01340014|12654920|P2|NOT COMPLETED|Period 2, Second 7 Days||1
5145088|NCT01340014|12654921|P1|NOT COMPLETED|Period 2, Second 7 Days||0
5145089|NCT01340014|12654920|P2|COMPLETED|Period 2, Second 7 Days||56
5145090|NCT01340014|12654921|P1|COMPLETED|Period 2, Second 7 Days||53
5145091|NCT01340014|12654920|P2|STARTED|Period 2, Second 7 Days||57
5145092|NCT01340014|12654921|P1|STARTED|Period 2, Second 7 Days||53
5145093|NCT01340014|12654920|P2|NOT COMPLETED|Period 1, First 7 Days||0
5145094|NCT01340014|12654921|P1|NOT COMPLETED|Period 1, First 7 Days||2
5145095|NCT01340014|12654920|P2|COMPLETED|Period 1, First 7 Days||57
5145096|NCT01340014|12654921|P1|COMPLETED|Period 1, First 7 Days||53
5145097|NCT01340014|12654920|P2|STARTED|Period 1, First 7 Days||57
5145098|NCT01340014|12654921|P1|STARTED|Period 1, First 7 Days||55
5145099|NCT01339936|12654929|P1|NOT COMPLETED|Overall Study||2
5145100|NCT01339936|12654929|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
5145101|NCT01339936|12654929|P1|STARTED|Overall Study|plus 2 screen failures|38
5145102|NCT01339923|12654942|P7|NOT COMPLETED|Overall Study||14
5145103|NCT01339923|12654943|P6|NOT COMPLETED|Overall Study||9
5145104|NCT01339923|12654944|P5|NOT COMPLETED|Overall Study||5
5145105|NCT01339923|12654945|P4|NOT COMPLETED|Overall Study||4
5145106|NCT01339923|12654946|P3|NOT COMPLETED|Overall Study||8
5145107|NCT01339923|12654947|P2|NOT COMPLETED|Overall Study||16
5145108|NCT01339923|12654948|P1|NOT COMPLETED|Overall Study||14
5145109|NCT01339923|12654942|P7|COMPLETED|Overall Study||111
5145110|NCT01339923|12654943|P6|COMPLETED|Overall Study||117
5145111|NCT01339923|12654944|P5|COMPLETED|Overall Study||295
5145112|NCT01339923|12654945|P4|COMPLETED|Overall Study||100
5145113|NCT01339923|12654946|P3|COMPLETED|Overall Study||243
5145114|NCT01339923|12654947|P2|COMPLETED|Overall Study||234
5145115|NCT01339923|12654948|P1|COMPLETED|Overall Study||239
5145116|NCT01339923|12654942|P7|STARTED|Overall Study||125
5145117|NCT01339923|12654943|P6|STARTED|Overall Study||126
5145118|NCT01339923|12654944|P5|STARTED|Overall Study||300
5145119|NCT01339923|12654945|P4|STARTED|Overall Study||104
5145120|NCT01339923|12654946|P3|STARTED|Overall Study||251
5145121|NCT01339923|12654947|P2|STARTED|Overall Study||250
5145122|NCT01339923|12654948|P1|STARTED|Overall Study||253
5145123|NCT01339910|12655019|P2|NOT COMPLETED|Overall Study||4
5145124|NCT01339910|12655020|P1|NOT COMPLETED|Overall Study||3
5145125|NCT01339910|12655019|P2|COMPLETED|Overall Study||133
5145126|NCT01339910|12655020|P1|COMPLETED|Overall Study||132
5145127|NCT01339910|12655019|P2|STARTED|Overall Study||137
5145128|NCT01339910|12655020|P1|STARTED|Overall Study||135
5145129|NCT01339897|12655058|P4|NOT COMPLETED|Overall Study||1
5145130|NCT01339897|12655059|P3|NOT COMPLETED|Overall Study||0
5145131|NCT01339897|12655060|P2|NOT COMPLETED|Overall Study||0
5145132|NCT01339897|12655061|P1|NOT COMPLETED|Overall Study||1
5145133|NCT01339897|12655058|P4|COMPLETED|Overall Study||5
5145134|NCT01339897|12655059|P3|COMPLETED|Overall Study||6
5145135|NCT01339897|12655060|P2|COMPLETED|Overall Study||6
5145136|NCT01339897|12655061|P1|COMPLETED|Overall Study||6
5145137|NCT01339897|12655058|P4|STARTED|Overall Study||6
5145138|NCT01339897|12655059|P3|STARTED|Overall Study||6
5145139|NCT01339897|12655060|P2|STARTED|Overall Study||6
5145140|NCT01339897|12655061|P1|STARTED|Overall Study||7
5145141|NCT01339858|12655089|P2|NOT COMPLETED|Overall Study||12
5145142|NCT01339858|12655090|P1|NOT COMPLETED|Overall Study||16
5145143|NCT01339858|12655089|P2|COMPLETED|Overall Study||18
5145144|NCT01339858|12655090|P1|COMPLETED|Overall Study||14
5145145|NCT01339858|12655089|P2|STARTED|Overall Study||30
5145146|NCT01339858|12655090|P1|STARTED|Overall Study||30
5145147|NCT01339832|12655114|P1|NOT COMPLETED|Overall Study||14
5145148|NCT01339832|12655114|P1|COMPLETED|Overall Study||37
5145149|NCT01339832|12655114|P1|STARTED|Overall Study||51
5145150|NCT01339559|12655125|P1|NOT COMPLETED|Overall Study||398
5145151|NCT01339559|12655125|P1|COMPLETED|Overall Study||368
5145152|NCT01339559|12655125|P1|STARTED|Overall Study||766
5145153|NCT01339429|12655134|P1|NOT COMPLETED|Overall Study||4
5145154|NCT01339429|12655134|P1|COMPLETED|Overall Study||37
5145155|NCT01339429|12655134|P1|STARTED|Overall Study||41
5145156|NCT01339416|12655139|P1|NOT COMPLETED|Overall Study||0
5145157|NCT01339416|12655139|P1|COMPLETED|Overall Study||8202
5145158|NCT01339416|12655139|P1|STARTED|Overall Study||8202
5145159|NCT01339403|12655151|P2|NOT COMPLETED|Overall Study||0
5145160|NCT01339403|12655152|P1|NOT COMPLETED|Overall Study||0
5145161|NCT01339403|12655151|P2|COMPLETED|Overall Study||257600
5145162|NCT01339403|12655152|P1|COMPLETED|Overall Study||24768
5145163|NCT01339403|12655151|P2|STARTED|Overall Study||257600
5145164|NCT01339403|12655152|P1|STARTED|Overall Study||24768
5145165|NCT01339390|12655174|P2|NOT COMPLETED|Overall Study||156
5145166|NCT01339390|12655175|P1|NOT COMPLETED|Overall Study||157
5145167|NCT01339390|12655174|P2|COMPLETED|Overall Study||1442
5145168|NCT01339390|12655175|P1|COMPLETED|Overall Study||1414
5145169|NCT01339390|12655174|P2|STARTED|Overall Study||1598
5145170|NCT01339390|12655175|P1|STARTED|Overall Study||1571
5145171|NCT01339299|12655183|P2|NOT COMPLETED|Overall Study||0
5145172|NCT01339299|12655184|P1|NOT COMPLETED|Overall Study||0
5145173|NCT01339299|12655183|P2|COMPLETED|Overall Study||50
5145174|NCT01339299|12655184|P1|COMPLETED|Overall Study||50
5145175|NCT01339299|12655183|P2|STARTED|Overall Study||50
5145176|NCT01339299|12655184|P1|STARTED|Overall Study||50
5145177|NCT01339273|12655192|P2|NOT COMPLETED|Overall Study||8
5145178|NCT01339273|12655193|P1|NOT COMPLETED|Overall Study||8
5145179|NCT01339273|12655192|P2|COMPLETED|Overall Study||28
5145180|NCT01339273|12655193|P1|COMPLETED|Overall Study||28
5145181|NCT01339273|12655192|P2|STARTED|Overall Study||36
5145182|NCT01339273|12655193|P1|STARTED|Overall Study||36
5145183|NCT01339260|12655227|P2|NOT COMPLETED|Multi-cycle Extension||193
5145184|NCT01339260|12655228|P1|NOT COMPLETED|Multi-cycle Extension||186
5145185|NCT01339260|12655227|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
5145186|NCT01339260|12655228|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
5145187|NCT01339260|12655227|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
5145188|NCT01339260|12655228|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
5145189|NCT01339260|12655227|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
5145190|NCT01339260|12655228|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
5145191|NCT01339260|12655227|P2|NOT COMPLETED|Cycle 1||10
5145192|NCT01339260|12655228|P1|NOT COMPLETED|Cycle 1||7
5145193|NCT01339260|12655227|P2|COMPLETED|Cycle 1||719
5145194|NCT01339260|12655228|P1|COMPLETED|Cycle 1||719
5145195|NCT01339260|12655227|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
5145196|NCT01339260|12655228|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
5145197|NCT01339260|12655227|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
5145198|NCT01339260|12655228|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
5145199|NCT01339260|12655227|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
5145200|NCT01339260|12655228|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
5145201|NCT01339247|12655240|P2|NOT COMPLETED|Period 2||0
5145202|NCT01339247|12655241|P1|NOT COMPLETED|Period 2||0
5145203|NCT01339247|12655240|P2|COMPLETED|Period 2||30
5145204|NCT01339247|12655241|P1|COMPLETED|Period 2||30
5145205|NCT01339247|12655240|P2|STARTED|Period 2||30
5145206|NCT01339247|12655241|P1|STARTED|Period 2||30
5145207|NCT01339247|12655240|P2|NOT COMPLETED|Period 1||0
5145208|NCT01339247|12655241|P1|NOT COMPLETED|Period 1||0
5145209|NCT01339247|12655240|P2|COMPLETED|Period 1||30
5145210|NCT01339247|12655241|P1|COMPLETED|Period 1||30
5145211|NCT01339247|12655240|P2|STARTED|Period 1||30
5145212|NCT01339247|12655241|P1|STARTED|Period 1||30
5145213|NCT01339091|12655253|P2|NOT COMPLETED|Overall Study||28
5145214|NCT01339091|12655254|P1|NOT COMPLETED|Overall Study||27
5145215|NCT01339091|12655253|P2|COMPLETED|Overall Study||257
5145216|NCT01339091|12655254|P1|COMPLETED|Overall Study||261
5145217|NCT01339091|12655253|P2|Safety Population|Overall Study||284
5145218|NCT01339091|12655254|P1|Safety Population|Overall Study||284
5145219|NCT01339091|12655253|P2|STARTED|Overall Study||285
5145220|NCT01339091|12655254|P1|STARTED|Overall Study||288
5145221|NCT01339052|12655268|P2|NOT COMPLETED|Overall Study||50
5145222|NCT01339052|12655269|P1|NOT COMPLETED|Overall Study||15
5145223|NCT01339052|12655268|P2|COMPLETED|Overall Study||0
5145224|NCT01339052|12655269|P1|COMPLETED|Overall Study||0
5145225|NCT01339052|12655268|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
5145226|NCT01339052|12655269|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
5145227|NCT01339052|12655268|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
5145228|NCT01339052|12655269|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
5145229|NCT01339052|12655268|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
5145230|NCT01339052|12655269|P1|Measurable Disease|Overall Study||11
5145231|NCT01339052|12655268|P2|STARTED|Overall Study||50
5145232|NCT01339052|12655269|P1|STARTED|Overall Study||15
5145233|NCT01339013|12655289|P1|NOT COMPLETED|Overall Study||0
5145234|NCT01339013|12655289|P1|COMPLETED|Overall Study||6
5145235|NCT01339013|12655289|P1|STARTED|Overall Study||6
5145236|NCT01339000|12655295|P2|NOT COMPLETED|Overall Study||0
5145237|NCT01339000|12655296|P1|NOT COMPLETED|Overall Study||1
5145238|NCT01339000|12655295|P2|COMPLETED|Overall Study||0
5145239|NCT01339000|12655296|P1|COMPLETED|Overall Study||0
5145240|NCT01339000|12655295|P2|STARTED|Overall Study||0
5145241|NCT01339000|12655296|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
5145242|NCT01338987|12655315|P5|NOT COMPLETED|Overall Study||0
5145243|NCT01338987|12655316|P4|NOT COMPLETED|Overall Study||0
5145244|NCT01338987|12655317|P3|NOT COMPLETED|Overall Study||2
5145245|NCT01338987|12655318|P2|NOT COMPLETED|Overall Study||1
5145246|NCT01338987|12655319|P1|NOT COMPLETED|Overall Study||2
5145247|NCT01338987|12655315|P5|COMPLETED|Overall Study||2
5145248|NCT01338987|12655316|P4|COMPLETED|Overall Study||31
5145249|NCT01338987|12655317|P3|COMPLETED|Overall Study||20
5145250|NCT01338987|12655318|P2|COMPLETED|Overall Study||8
5145251|NCT01338987|12655319|P1|COMPLETED|Overall Study||10
5145252|NCT01338987|12655315|P5|STARTED|Overall Study||2
5145253|NCT01338987|12655316|P4|STARTED|Overall Study||31
5145254|NCT01338987|12655317|P3|STARTED|Overall Study||22
5145255|NCT01338987|12655318|P2|STARTED|Overall Study||9
5145256|NCT01338987|12655319|P1|STARTED|Overall Study||12
5145257|NCT01338870|12655340|P6|NOT COMPLETED|Overall Study||6
5145258|NCT01338870|12655341|P5|NOT COMPLETED|Overall Study||6
5145259|NCT01338870|12655342|P4|NOT COMPLETED|Overall Study||9
5145260|NCT01338870|12655343|P3|NOT COMPLETED|Overall Study||11
5145261|NCT01338870|12655344|P2|NOT COMPLETED|Overall Study||12
5145262|NCT01338870|12655345|P1|NOT COMPLETED|Overall Study||9
5145263|NCT01338870|12655340|P6|COMPLETED|Overall Study||44
5145264|NCT01338870|12655341|P5|COMPLETED|Overall Study||46
5145265|NCT01338870|12655342|P4|COMPLETED|Overall Study||41
5145266|NCT01338870|12655343|P3|COMPLETED|Overall Study||39
5145267|NCT01338870|12655344|P2|COMPLETED|Overall Study||37
5145268|NCT01338870|12655345|P1|COMPLETED|Overall Study||41
5145269|NCT01338870|12655340|P6|STARTED|Overall Study||50
5145270|NCT01338870|12655341|P5|STARTED|Overall Study||52
5145271|NCT01338870|12655342|P4|STARTED|Overall Study||50
5145272|NCT01338870|12655343|P3|STARTED|Overall Study||50
5145273|NCT01338870|12655344|P2|STARTED|Overall Study||49
5145274|NCT01338870|12655345|P1|STARTED|Overall Study||50
5145275|NCT01338857|12655395|P1|NOT COMPLETED|Overall Study||11
5145276|NCT01338857|12655395|P1|COMPLETED|Overall Study||1
5145277|NCT01338857|12655395|P1|STARTED|Overall Study||12
5145278|NCT01338818|12655400|P1|NOT COMPLETED|Overall Study||36
5145279|NCT01338818|12655400|P1|COMPLETED|Overall Study||262
5145280|NCT01338818|12655400|P1|STARTED|Overall Study||298
5145281|NCT01338792|12655406|P1|NOT COMPLETED|Overall Study||4
5145282|NCT01338792|12655406|P1|COMPLETED|Overall Study||43
5145283|NCT01338792|12655406|P1|STARTED|Overall Study||47
5145284|NCT01338649|12655414|P2|NOT COMPLETED|Overall Study||0
5145285|NCT01338649|12655415|P1|NOT COMPLETED|Overall Study||0
5145286|NCT01338649|12655414|P2|COMPLETED|Overall Study||14
5145287|NCT01338649|12655415|P1|COMPLETED|Overall Study||13
5145288|NCT01338649|12655414|P2|STARTED|Overall Study||14
5145289|NCT01338649|12655415|P1|STARTED|Overall Study||13
5145290|NCT01338636|12655421|P1|NOT COMPLETED|Overall Study||8
5145291|NCT01338636|12655421|P1|COMPLETED|Overall Study||22
5145292|NCT01338636|12655421|P1|STARTED|Overall Study||30
5145293|NCT01338610|12655435|P3|NOT COMPLETED|Overall Study||1
5145294|NCT01338610|12655436|P2|NOT COMPLETED|Overall Study||1
5145295|NCT01338610|12655437|P1|NOT COMPLETED|Overall Study||5
5145296|NCT01338610|12655435|P3|COMPLETED|Overall Study||28
5145297|NCT01338610|12655436|P2|COMPLETED|Overall Study||55
5145298|NCT01338610|12655437|P1|COMPLETED|Overall Study||34
5145299|NCT01338610|12655435|P3|STARTED|Overall Study||29
5145300|NCT01338610|12655436|P2|STARTED|Overall Study||56
5145301|NCT01338610|12655437|P1|STARTED|Overall Study||39
5145302|NCT01338506|12655446|P2|NOT COMPLETED|Overall Study||14
5145303|NCT01338506|12655447|P1|NOT COMPLETED|Overall Study||25
5145304|NCT01338506|12655446|P2|COMPLETED|Overall Study||13
5145305|NCT01338506|12655447|P1|COMPLETED|Overall Study||29
5145306|NCT01338506|12655446|P2|STARTED|Overall Study||27
5145307|NCT01338506|12655447|P1|STARTED|Overall Study||54
5145308|NCT01338493|12655463|P1|NOT COMPLETED|24 Months Follow up||0
5145309|NCT01338493|12655463|P1|COMPLETED|24 Months Follow up||104
5145310|NCT01338493|12655463|P1|STARTED|24 Months Follow up||104
5145311|NCT01338493|12655463|P1|NOT COMPLETED|12 Months Follow up||9
5145312|NCT01338493|12655463|P1|COMPLETED|12 Months Follow up||104
5145313|NCT01338493|12655463|P1|STARTED|12 Months Follow up||113
5145314|NCT01338493|12655463|P1|NOT COMPLETED|6 Months Follow up||19
5145315|NCT01338493|12655463|P1|COMPLETED|6 Months Follow up||113
5145316|NCT01338493|12655463|P1|STARTED|6 Months Follow up||132
5145317|NCT01338493|12655463|P1|NOT COMPLETED|Discharge||2
5145318|NCT01338493|12655463|P1|COMPLETED|Discharge||132
5145319|NCT01338493|12655463|P1|STARTED|Discharge||134
5145320|NCT01338493|12655463|P1|NOT COMPLETED|Implant||0
5145321|NCT01338493|12655463|P1|COMPLETED|Implant||134
5145322|NCT01338493|12655463|P1|STARTED|Implant||134
5145323|NCT01338493|12655463|P1|NOT COMPLETED|Enrolled||5
5145324|NCT01338493|12655463|P1|COMPLETED|Enrolled||134
5145325|NCT01338493|12655463|P1|STARTED|Enrolled||139
5145326|NCT01338415|12655470|P2|NOT COMPLETED|Overall Study||9
5145327|NCT01338415|12655471|P1|NOT COMPLETED|Overall Study||10
5145328|NCT01338415|12655470|P2|COMPLETED|Overall Study||22
5145329|NCT01338415|12655471|P1|COMPLETED|Overall Study||23
5145330|NCT01338415|12655470|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
5145331|NCT01338415|12655471|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
5145332|NCT01338415|12655470|P2|STARTED|Overall Study||31
5145333|NCT01338415|12655471|P1|STARTED|Overall Study||33
5145334|NCT01338298|12655493|P2|NOT COMPLETED|Overall Study||3
5145335|NCT01338298|12655494|P1|NOT COMPLETED|Overall Study||4
5145336|NCT01338298|12655493|P2|COMPLETED|Overall Study||15
5145337|NCT01338298|12655494|P1|COMPLETED|Overall Study||20
5145338|NCT01338298|12655493|P2|STARTED|Overall Study||18
5145339|NCT01338298|12655494|P1|STARTED|Overall Study||24
5145340|NCT01338025|12655504|P2|NOT COMPLETED|Overall Study||11
5145341|NCT01338025|12655505|P1|NOT COMPLETED|Overall Study||11
5145342|NCT01338025|12655504|P2|COMPLETED|Overall Study||6
5145343|NCT01338025|12655505|P1|COMPLETED|Overall Study||5
5145344|NCT01338025|12655504|P2|STARTED|Overall Study||17
5145345|NCT01338025|12655505|P1|STARTED|Overall Study||16
5145346|NCT01338012|12655517|P1|NOT COMPLETED|Overall Study||8
5145347|NCT01338012|12655517|P1|COMPLETED|Overall Study||0
5145348|NCT01338012|12655517|P1|STARTED|Overall Study||8
5145349|NCT01337986|12655523|P2|NOT COMPLETED|Overall Study||5
5145350|NCT01337986|12655524|P1|NOT COMPLETED|Overall Study||3
5145351|NCT01337986|12655523|P2|COMPLETED|Overall Study||18
5145352|NCT01337986|12655524|P1|COMPLETED|Overall Study||20
5145353|NCT01337986|12655523|P2|STARTED|Overall Study||23
5145354|NCT01337986|12655524|P1|STARTED|Overall Study||23
5145355|NCT01337973|12655561|P3|NOT COMPLETED|Overall Study||11
5145356|NCT01337973|12655562|P2|NOT COMPLETED|Overall Study||15
5145357|NCT01337973|12655563|P1|NOT COMPLETED|Overall Study||16
5145358|NCT01337973|12655561|P3|COMPLETED|Overall Study||49
5145359|NCT01337973|12655562|P2|COMPLETED|Overall Study||45
5145360|NCT01337973|12655563|P1|COMPLETED|Overall Study||44
5145361|NCT01337973|12655561|P3|STARTED|Overall Study||60
5145362|NCT01337973|12655562|P2|STARTED|Overall Study||60
5145363|NCT01337973|12655563|P1|STARTED|Overall Study||60
5145364|NCT01337960|12655577|P3|NOT COMPLETED|Overall Study||0
5145365|NCT01337960|12655578|P2|NOT COMPLETED|Overall Study||0
5145366|NCT01337960|12655579|P1|NOT COMPLETED|Overall Study||2
5145367|NCT01337960|12655577|P3|COMPLETED|Overall Study||6
5145368|NCT01337960|12655578|P2|COMPLETED|Overall Study||14
5145369|NCT01337960|12655579|P1|COMPLETED|Overall Study||12
5145370|NCT01337960|12655577|P3|STARTED|Overall Study||6
5145371|NCT01337960|12655578|P2|STARTED|Overall Study||14
5145372|NCT01337960|12655579|P1|STARTED|Overall Study||14
5145373|NCT01337739|12655601|P2|NOT COMPLETED|Overall Study||0
5145374|NCT01337739|12655602|P1|NOT COMPLETED|Overall Study||0
5145375|NCT01337739|12655601|P2|COMPLETED|Overall Study||4
5145376|NCT01337739|12655602|P1|COMPLETED|Overall Study||6
5145377|NCT01337739|12655601|P2|STARTED|Overall Study||4
5145378|NCT01337739|12655602|P1|STARTED|Overall Study||6
5145379|NCT01337700|12655612|P2|NOT COMPLETED|Overall Study||0
5145380|NCT01337700|12655613|P1|NOT COMPLETED|Overall Study||0
5145381|NCT01337700|12655612|P2|COMPLETED|Overall Study||5
5145382|NCT01337700|12655613|P1|COMPLETED|Overall Study||5
5145383|NCT01337700|12655612|P2|STARTED|Overall Study||5
5145384|NCT01337700|12655613|P1|STARTED|Overall Study||5
5145385|NCT01337687|12655629|P2|NOT COMPLETED|Overall Study||0
5145386|NCT01337687|12655630|P1|NOT COMPLETED|Overall Study||0
5145387|NCT01337687|12655629|P2|COMPLETED|Overall Study||9
5145388|NCT01337687|12655630|P1|COMPLETED|Overall Study||10
5145389|NCT01337687|12655629|P2|STARTED|Overall Study||9
5145390|NCT01337687|12655630|P1|STARTED|Overall Study||10
5145391|NCT01337674|12655644|P4|NOT COMPLETED|Treatment Period 2||0
5145392|NCT01337674|12655645|P3|NOT COMPLETED|Treatment Period 2||1
5145393|NCT01337674|12655646|P2|NOT COMPLETED|Treatment Period 2||0
5145394|NCT01337674|12655647|P1|NOT COMPLETED|Treatment Period 2||0
5145395|NCT01337674|12655644|P4|COMPLETED|Treatment Period 2||6
5145396|NCT01337674|12655645|P3|COMPLETED|Treatment Period 2||5
5145397|NCT01337674|12655646|P2|COMPLETED|Treatment Period 2||6
5145398|NCT01337674|12655647|P1|COMPLETED|Treatment Period 2||6
5145399|NCT01337674|12655644|P4|STARTED|Treatment Period 2||6
5145400|NCT01337674|12655645|P3|STARTED|Treatment Period 2||6
5145401|NCT01337674|12655646|P2|STARTED|Treatment Period 2||6
5145402|NCT01337674|12655647|P1|STARTED|Treatment Period 2||6
5145403|NCT01337674|12655644|P4|NOT COMPLETED|Two-week Washout Period||0
5145404|NCT01337674|12655645|P3|NOT COMPLETED|Two-week Washout Period||0
5145405|NCT01337674|12655646|P2|NOT COMPLETED|Two-week Washout Period||0
5145406|NCT01337674|12655647|P1|NOT COMPLETED|Two-week Washout Period||0
5145407|NCT01337674|12655644|P4|COMPLETED|Two-week Washout Period||6
5145408|NCT01337674|12655645|P3|COMPLETED|Two-week Washout Period||6
5145409|NCT01337674|12655646|P2|COMPLETED|Two-week Washout Period||6
5145410|NCT01337674|12655647|P1|COMPLETED|Two-week Washout Period||6
5145411|NCT01337674|12655644|P4|STARTED|Two-week Washout Period||6
5145412|NCT01337674|12655645|P3|STARTED|Two-week Washout Period||6
5145413|NCT01337674|12655646|P2|STARTED|Two-week Washout Period||6
5145414|NCT01337674|12655647|P1|STARTED|Two-week Washout Period||6
5145415|NCT01337674|12655644|P4|NOT COMPLETED|Treatment Period 1||1
5145416|NCT01337674|12655645|P3|NOT COMPLETED|Treatment Period 1||0
5145417|NCT01337674|12655646|P2|NOT COMPLETED|Treatment Period 1||1
5145418|NCT01337674|12655647|P1|NOT COMPLETED|Treatment Period 1||0
5145419|NCT01337674|12655644|P4|COMPLETED|Treatment Period 1||6
5145420|NCT01337674|12655645|P3|COMPLETED|Treatment Period 1||6
5145421|NCT01337674|12655646|P2|COMPLETED|Treatment Period 1||6
5145422|NCT01337674|12655647|P1|COMPLETED|Treatment Period 1||6
5145423|NCT01337674|12655644|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
5145424|NCT01337674|12655645|P3|STARTED|Treatment Period 1||6
5145425|NCT01337674|12655646|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
5145426|NCT01337674|12655647|P1|STARTED|Treatment Period 1||6
5145427|NCT01337635|12655665|P2|NOT COMPLETED|Overall Study||1
5145428|NCT01337635|12655666|P1|NOT COMPLETED|Overall Study||0
5145429|NCT01337635|12655665|P2|COMPLETED|Overall Study||3
5145430|NCT01337635|12655666|P1|COMPLETED|Overall Study||3
5145431|NCT01337635|12655665|P2|STARTED|Overall Study||4
5145432|NCT01337635|12655666|P1|STARTED|Overall Study||3
5145433|NCT01337609|12655677|P3|NOT COMPLETED|Overall Study||0
5145434|NCT01337609|12655678|P2|NOT COMPLETED|Overall Study||0
5145435|NCT01337609|12655679|P1|NOT COMPLETED|Overall Study||1
5145436|NCT01337609|12655677|P3|COMPLETED|Overall Study||2
5145437|NCT01337609|12655678|P2|COMPLETED|Overall Study||2
5145438|NCT01337609|12655679|P1|COMPLETED|Overall Study||0
5145439|NCT01337609|12655677|P3|STARTED|Overall Study||2
5145440|NCT01337609|12655678|P2|STARTED|Overall Study||2
5145441|NCT01337609|12655679|P1|STARTED|Overall Study||1
5145442|NCT01337596|12655708|P9|NOT COMPLETED|Overall Study||0
5145443|NCT01337596|12655709|P8|NOT COMPLETED|Overall Study||0
5145444|NCT01337596|12655710|P7|NOT COMPLETED|Overall Study||0
5145445|NCT01337596|12655711|P6|NOT COMPLETED|Overall Study||0
5145446|NCT01337596|12655712|P5|NOT COMPLETED|Overall Study||2
5145447|NCT01337596|12655713|P4|NOT COMPLETED|Overall Study||0
5145448|NCT01337596|12655714|P3|NOT COMPLETED|Overall Study||0
5145449|NCT01337596|12655715|P2|NOT COMPLETED|Overall Study||0
5145450|NCT01337596|12655716|P1|NOT COMPLETED|Overall Study||0
5145451|NCT01337596|12655708|P9|COMPLETED|Overall Study||7
5145452|NCT01337596|12655709|P8|COMPLETED|Overall Study||2
5145453|NCT01337596|12655710|P7|COMPLETED|Overall Study||12
5145454|NCT01337596|12655711|P6|COMPLETED|Overall Study||7
5145455|NCT01337596|12655712|P5|COMPLETED|Overall Study||5
5145456|NCT01337596|12655713|P4|COMPLETED|Overall Study||7
5145457|NCT01337596|12655714|P3|COMPLETED|Overall Study||7
5145458|NCT01337596|12655715|P2|COMPLETED|Overall Study||7
5145459|NCT01337596|12655716|P1|COMPLETED|Overall Study||7
5145460|NCT01337596|12655708|P9|Safety Population|Overall Study||7
5145461|NCT01337596|12655709|P8|Safety Population|Overall Study||2
5145462|NCT01337596|12655710|P7|Safety Population|Overall Study||12
5145463|NCT01337596|12655711|P6|Safety Population|Overall Study||7
5145464|NCT01337596|12655712|P5|Safety Population|Overall Study||7
5145465|NCT01337596|12655713|P4|Safety Population|Overall Study||7
5145466|NCT01337596|12655714|P3|Safety Population|Overall Study||7
5145467|NCT01337596|12655715|P2|Safety Population|Overall Study||7
5145468|NCT01337596|12655716|P1|Safety Population|Overall Study||7
5145469|NCT01337596|12655708|P9|STARTED|Overall Study||7
5145470|NCT01337596|12655709|P8|STARTED|Overall Study||2
5145471|NCT01337596|12655710|P7|STARTED|Overall Study||12
5145472|NCT01337596|12655711|P6|STARTED|Overall Study||7
5145473|NCT01337596|12655712|P5|STARTED|Overall Study||7
5145474|NCT01337596|12655713|P4|STARTED|Overall Study||7
5145475|NCT01337596|12655714|P3|STARTED|Overall Study||7
5145476|NCT01337596|12655715|P2|STARTED|Overall Study||7
5145477|NCT01337596|12655716|P1|STARTED|Overall Study||7
5145478|NCT01337336|12655752|P2|NOT COMPLETED|Overall Study||0
5145479|NCT01337336|12655753|P1|NOT COMPLETED|Overall Study||0
5145480|NCT01337336|12655752|P2|COMPLETED|Overall Study||2923
5145481|NCT01337336|12655753|P1|COMPLETED|Overall Study||1078
5145482|NCT01337336|12655752|P2|STARTED|Overall Study||2923
5145483|NCT01337336|12655753|P1|STARTED|Overall Study||1078
5145484|NCT01337297|12655767|P2|NOT COMPLETED|Overall Study||6
5145485|NCT01337297|12655768|P1|NOT COMPLETED|Overall Study||5
5145486|NCT01337297|12655767|P2|COMPLETED|Overall Study||3
5145487|NCT01337297|12655768|P1|COMPLETED|Overall Study||6
5145488|NCT01337297|12655767|P2|STARTED|Overall Study||9
5145489|NCT01337297|12655768|P1|STARTED|Overall Study||11
5145490|NCT01337167|12655776|P2|NOT COMPLETED|Toddler Vaccinations||13
5145491|NCT01337167|12655777|P1|NOT COMPLETED|Toddler Vaccinations||14
5145492|NCT01337167|12655776|P2|COMPLETED|Toddler Vaccinations||407
5145493|NCT01337167|12655777|P1|COMPLETED|Toddler Vaccinations||829
5145494|NCT01337167|12655776|P2|STARTED|Toddler Vaccinations||420
5145495|NCT01337167|12655777|P1|STARTED|Toddler Vaccinations||843
5145496|NCT01337167|12655776|P2|NOT COMPLETED|Interim Period||40
5145497|NCT01337167|12655777|P1|NOT COMPLETED|Interim Period||81
5145498|NCT01337167|12655776|P2|COMPLETED|Interim Period||420
5145499|NCT01337167|12655777|P1|COMPLETED|Interim Period||843
5145500|NCT01337167|12655776|P2|STARTED|Interim Period||460
5145501|NCT01337167|12655777|P1|STARTED|Interim Period||924
5145502|NCT01337167|12655776|P2|NOT COMPLETED|Infant Series||27
5145503|NCT01337167|12655777|P1|NOT COMPLETED|Infant Series||62
5145504|NCT01337167|12655776|P2|COMPLETED|Infant Series||460
5145505|NCT01337167|12655777|P1|COMPLETED|Infant Series||924
5145506|NCT01337167|12655776|P2|STARTED|Infant Series||487
5145507|NCT01337167|12655777|P1|STARTED|Infant Series||986
5145508|NCT01337115|12655845|P2|NOT COMPLETED|Overall Study||0
5145509|NCT01337115|12655846|P1|NOT COMPLETED|Overall Study||2
5145510|NCT01337115|12655845|P2|COMPLETED|Overall Study||25
5145511|NCT01337115|12655846|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
5145512|NCT01337115|12655845|P2|STARTED|Overall Study||25
5145513|NCT01337115|12655846|P1|STARTED|Overall Study||25
5145514|NCT01337089|12655858|P1|NOT COMPLETED|Overall Study||404
5145515|NCT01337089|12655858|P1|COMPLETED|Overall Study||256
5145516|NCT01337089|12655858|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
5145517|NCT01337089|12655858|P1|Safety Population|Overall Study||660
5145518|NCT01337089|12655858|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
5145519|NCT01337089|12655858|P1|STARTED|Overall Study||660
5145520|NCT01337076|12655866|P1|NOT COMPLETED|Overall Study||2
5145521|NCT01337076|12655866|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
5145522|NCT01337076|12655866|P1|STARTED|Overall Study|subjects implanted|21
5145523|NCT01337050|12655873|P3|NOT COMPLETED|Overall Study||19
5145524|NCT01337050|12655874|P2|NOT COMPLETED|Overall Study||13
5145525|NCT01337050|12655875|P1|NOT COMPLETED|Overall Study||4
5145526|NCT01337050|12655873|P3|COMPLETED|Overall Study||0
5145527|NCT01337050|12655874|P2|COMPLETED|Overall Study||0
5145528|NCT01337050|12655875|P1|COMPLETED|Overall Study||0
5145529|NCT01337050|12655873|P3|STARTED|Overall Study||19
5145530|NCT01337050|12655874|P2|STARTED|Overall Study||13
5145531|NCT01337050|12655875|P1|STARTED|Overall Study||4
5145532|NCT01336972|12655936|P3|NOT COMPLETED|Overall Study||0
5145533|NCT01336972|12655937|P2|NOT COMPLETED|Overall Study||1
5145534|NCT01336972|12655938|P1|NOT COMPLETED|Overall Study||1
5145535|NCT01336972|12655936|P3|COMPLETED|Overall Study||9
5145536|NCT01336972|12655937|P2|COMPLETED|Overall Study||9
5145537|NCT01336972|12655938|P1|COMPLETED|Overall Study||9
5145538|NCT01336972|12655936|P3|STARTED|Overall Study||9
5145539|NCT01336972|12655937|P2|STARTED|Overall Study||10
5145540|NCT01336972|12655938|P1|STARTED|Overall Study||10
5145541|NCT01336959|12655976|P3|NOT COMPLETED|Overall Study||1
5145542|NCT01336959|12655977|P2|NOT COMPLETED|Overall Study||5
5145543|NCT01336959|12655978|P1|NOT COMPLETED|Overall Study||0
5145544|NCT01336959|12655976|P3|COMPLETED|Overall Study||40
5145545|NCT01336959|12655977|P2|COMPLETED|Overall Study||37
5145546|NCT01336959|12655978|P1|COMPLETED|Overall Study||8
5145547|NCT01336959|12655976|P3|STARTED|Overall Study||41
5145548|NCT01336959|12655977|P2|STARTED|Overall Study||42
5145549|NCT01336959|12655978|P1|STARTED|Overall Study||8
5145550|NCT01336933|12655989|P1|NOT COMPLETED|Overall Study||1
5145551|NCT01336933|12655989|P1|COMPLETED|Overall Study||33
5145552|NCT01336933|12655989|P1|STARTED|Overall Study||34
5145553|NCT01336894|12656000|P2|NOT COMPLETED|Follow-up||7
5145554|NCT01336894|12656001|P1|NOT COMPLETED|Follow-up||2
5145555|NCT01336894|12656000|P2|COMPLETED|Follow-up||0
5145556|NCT01336894|12656001|P1|COMPLETED|Follow-up||2
5145557|NCT01336894|12656000|P2|STARTED|Follow-up||7
5145558|NCT01336894|12656001|P1|STARTED|Follow-up||4
5145559|NCT01336894|12656000|P2|NOT COMPLETED|Protocol Interventions||0
5145560|NCT01336894|12656001|P1|NOT COMPLETED|Protocol Interventions||0
5145561|NCT01336894|12656000|P2|COMPLETED|Protocol Interventions||7
5145562|NCT01336894|12656001|P1|COMPLETED|Protocol Interventions||4
5145563|NCT01336894|12656000|P2|STARTED|Protocol Interventions||7
5145564|NCT01336894|12656001|P1|STARTED|Protocol Interventions||4
5145565|NCT01336803|12656019|P1|NOT COMPLETED|Overall Study||0
5145566|NCT01336803|12656019|P1|COMPLETED|Overall Study||21
5145567|NCT01336803|12656019|P1|Lymphoma|Overall Study||7
5145568|NCT01336803|12656019|P1|Osteomyelitis|Overall Study||4
5145569|NCT01336803|12656019|P1|Bone Sarcoma|Overall Study||10
5145570|NCT01336803|12656019|P1|STARTED|Overall Study||21
5145571|NCT01336764|12656033|P2|NOT COMPLETED|Overall Study||5
5145572|NCT01336764|12656034|P1|NOT COMPLETED|Overall Study||5
5145573|NCT01336764|12656033|P2|COMPLETED|Overall Study||5
5145574|NCT01336764|12656034|P1|COMPLETED|Overall Study||7
5145575|NCT01336764|12656033|P2|STARTED|Overall Study||10
5145576|NCT01336764|12656034|P1|STARTED|Overall Study||12
5145577|NCT01336738|12656045|P5|NOT COMPLETED|Overall Study||10
5145578|NCT01336738|12656046|P4|NOT COMPLETED|Overall Study||7
5145579|NCT01336738|12656047|P3|NOT COMPLETED|Overall Study||8
5145580|NCT01336738|12656048|P2|NOT COMPLETED|Overall Study||9
5145581|NCT01336738|12656049|P1|NOT COMPLETED|Overall Study||7
5145582|NCT01336738|12656045|P5|COMPLETED|Overall Study||43
5145583|NCT01336738|12656046|P4|COMPLETED|Overall Study||47
5145584|NCT01336738|12656047|P3|COMPLETED|Overall Study||45
5145585|NCT01336738|12656048|P2|COMPLETED|Overall Study||45
5145586|NCT01336738|12656049|P1|COMPLETED|Overall Study||45
5145587|NCT01336738|12656045|P5|STARTED|Overall Study||53
5145588|NCT01336738|12656046|P4|STARTED|Overall Study||54
5145589|NCT01336738|12656047|P3|STARTED|Overall Study||53
5145590|NCT01336738|12656048|P2|STARTED|Overall Study||54
5145591|NCT01336738|12656049|P1|STARTED|Overall Study||52
5145592|NCT01336712|12656091|P1|NOT COMPLETED|Overall Study||3
5145593|NCT01336712|12656091|P1|COMPLETED|Overall Study||27
5145594|NCT01336712|12656091|P1|STARTED|Overall Study||30
5145595|NCT01336647|12656104|P3|NOT COMPLETED|Overall Study||3
5145596|NCT01336647|12656105|P2|NOT COMPLETED|Overall Study||1
5145597|NCT01336647|12656106|P1|NOT COMPLETED|Overall Study||4
5145598|NCT01336647|12656104|P3|COMPLETED|Overall Study||44
5145599|NCT01336647|12656105|P2|COMPLETED|Overall Study||48
5145600|NCT01336647|12656106|P1|COMPLETED|Overall Study||42
5145601|NCT01336647|12656104|P3|STARTED|Overall Study||47
5145602|NCT01336647|12656105|P2|STARTED|Overall Study||49
5145603|NCT01336647|12656106|P1|STARTED|Overall Study||46
5145604|NCT01336634|12656120|P3|NOT COMPLETED|Overall Study||36
5145605|NCT01336634|12656121|P2|NOT COMPLETED|Overall Study||57
5145606|NCT01336634|12656122|P1|NOT COMPLETED|Overall Study||84
5145607|NCT01336634|12656120|P3|COMPLETED|Overall Study||0
5145608|NCT01336634|12656121|P2|COMPLETED|Overall Study||0
5145609|NCT01336634|12656122|P1|COMPLETED|Overall Study||0
5145610|NCT01336634|12656120|P3|STARTED|Overall Study||36
5145611|NCT01336634|12656121|P2|STARTED|Overall Study||57
5145612|NCT01336634|12656122|P1|STARTED|Overall Study||84
5145613|NCT01336621|12656163|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
5145614|NCT01336621|12656163|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
5145615|NCT01336621|12656163|P1|STARTED|SFUCP (up to 2.6 Years)||9
5145616|NCT01336621|12656163|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
5145617|NCT01336621|12656163|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
5145618|NCT01336621|12656163|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
5145619|NCT01336608|12656213|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
5145620|NCT01336608|12656214|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
5145621|NCT01336608|12656215|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
5145622|NCT01336608|12656216|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
5145623|NCT01336608|12656213|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
5145624|NCT01336608|12656214|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
5145625|NCT01336608|12656215|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
5145626|NCT01336608|12656216|P1|COMPLETED|24-week, Double-blind Treatment Period||0
5145627|NCT01336608|12656213|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
5145628|NCT01336608|12656214|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
5145629|NCT01336608|12656215|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
5145630|NCT01336608|12656216|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
5145631|NCT01336608|12656213|P4|STARTED|24-week, Double-blind Treatment Period||135
5145632|NCT01336608|12656214|P3|STARTED|24-week, Double-blind Treatment Period||154
5145633|NCT01336608|12656215|P2|STARTED|24-week, Double-blind Treatment Period||141
5145634|NCT01336608|12656216|P1|STARTED|24-week, Double-blind Treatment Period||0
5145635|NCT01336608|12656213|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5145636|NCT01336608|12656214|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5145637|NCT01336608|12656215|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5145638|NCT01336608|12656216|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
5145639|NCT01336608|12656213|P4|COMPLETED|2-week, Single-blind Run-In Period||0
5145640|NCT01336608|12656214|P3|COMPLETED|2-week, Single-blind Run-In Period||0
5145641|NCT01336608|12656215|P2|COMPLETED|2-week, Single-blind Run-In Period||0
5145642|NCT01336608|12656216|P1|COMPLETED|2-week, Single-blind Run-In Period||444
5145643|NCT01336608|12656213|P4|STARTED|2-week, Single-blind Run-In Period||0
5145644|NCT01336608|12656214|P3|STARTED|2-week, Single-blind Run-In Period||0
5145645|NCT01336608|12656215|P2|STARTED|2-week, Single-blind Run-In Period||0
5145646|NCT01336608|12656216|P1|STARTED|2-week, Single-blind Run-In Period||559
5145647|NCT01336569|12656230|P1|NOT COMPLETED|Overall Study||4
5145648|NCT01336569|12656230|P1|COMPLETED|Overall Study||45
5145649|NCT01336569|12656230|P1|STARTED|Overall Study||49
5145650|NCT01336413|12656236|P2|NOT COMPLETED|Overall Study||8
5145651|NCT01336413|12656237|P1|NOT COMPLETED|Overall Study||1
5145652|NCT01336413|12656236|P2|COMPLETED|Overall Study||18
5145653|NCT01336413|12656237|P1|COMPLETED|Overall Study||26
5145654|NCT01336413|12656236|P2|STARTED|Overall Study||26
5145655|NCT01336413|12656237|P1|STARTED|Overall Study||27
5145656|NCT01336296|12656261|P2|NOT COMPLETED|Overall Study||4
5145657|NCT01336296|12656262|P1|NOT COMPLETED|Overall Study||5
5145658|NCT01336296|12656261|P2|COMPLETED|Overall Study||17
5145659|NCT01336296|12656262|P1|COMPLETED|Overall Study||35
5145660|NCT01336296|12656261|P2|STARTED|Overall Study||21
5145661|NCT01336296|12656262|P1|STARTED|Overall Study||40
5145662|NCT01336205|12656278|P2|NOT COMPLETED|Overall Study||89
5145663|NCT01336205|12656279|P1|NOT COMPLETED|Overall Study||233
5145664|NCT01336205|12656278|P2|COMPLETED|Overall Study||192
5145665|NCT01336205|12656279|P1|COMPLETED|Overall Study||330
5145666|NCT01336205|12656278|P2|STARTED|Overall Study||281
5145667|NCT01336205|12656279|P1|STARTED|Overall Study||563
5145668|NCT01336140|12656291|P2|NOT COMPLETED|Overall Study||0
5145669|NCT01336140|12656292|P1|NOT COMPLETED|Overall Study||0
5145670|NCT01336140|12656291|P2|COMPLETED|Overall Study||150
5145671|NCT01336140|12656292|P1|COMPLETED|Overall Study||150
5145672|NCT01336140|12656291|P2|STARTED|Overall Study||150
5145673|NCT01336140|12656292|P1|STARTED|Overall Study||150
5145674|NCT01336023|12656307|P3|NOT COMPLETED|Week 27 to 52||28
5145675|NCT01336023|12656308|P2|NOT COMPLETED|Week 27 to 52||44
5145676|NCT01336023|12656309|P1|NOT COMPLETED|Week 27 to 52||28
5145677|NCT01336023|12656307|P3|COMPLETED|Week 27 to 52||285
5145678|NCT01336023|12656308|P2|COMPLETED|Week 27 to 52||621
5145679|NCT01336023|12656309|P1|COMPLETED|Week 27 to 52||305
5145680|NCT01336023|12656307|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
5145681|NCT01336023|12656308|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
5145682|NCT01336023|12656309|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
5145683|NCT01336023|12656307|P3|NOT COMPLETED|Week 0 to Week 26||73
5145684|NCT01336023|12656308|P2|NOT COMPLETED|Week 0 to Week 26||98
5145685|NCT01336023|12656309|P1|NOT COMPLETED|Week 0 to Week 26||48
5145686|NCT01336023|12656307|P3|COMPLETED|Week 0 to Week 26||342
5145687|NCT01336023|12656308|P2|COMPLETED|Week 0 to Week 26||736
5145688|NCT01336023|12656309|P1|COMPLETED|Week 0 to Week 26||366
5145689|NCT01336023|12656307|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
5145690|NCT01336023|12656308|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
5145691|NCT01336023|12656309|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
5145692|NCT01336023|12656307|P3|STARTED|Week 0 to Week 26||415
5145693|NCT01336023|12656308|P2|STARTED|Week 0 to Week 26||834
5145694|NCT01336023|12656309|P1|STARTED|Week 0 to Week 26||414
5145695|NCT01335997|12656330|P2|NOT COMPLETED|Period III||79
5145696|NCT01335997|12656331|P1|NOT COMPLETED|Period III||78
5145697|NCT01335997|12656330|P2|COMPLETED|Period III||4
5145698|NCT01335997|12656331|P1|COMPLETED|Period III||6
5145699|NCT01335997|12656330|P2|STARTED|Period III||83
5145700|NCT01335997|12656331|P1|STARTED|Period III||84
5145701|NCT01335997|12656330|P2|NOT COMPLETED|Period I and II||479
5145702|NCT01335997|12656331|P1|NOT COMPLETED|Period I and II||493
5145703|NCT01335997|12656330|P2|COMPLETED|Period I and II||83
5145704|NCT01335997|12656331|P1|COMPLETED|Period I and II||84
5145705|NCT01335997|12656330|P2|STARTED|Period I and II||562
5145706|NCT01335997|12656331|P1|STARTED|Period I and II||577
5145707|NCT01335971|12656344|P3|NOT COMPLETED|Overall Study||1
5145708|NCT01335971|12656345|P2|NOT COMPLETED|Overall Study||1
5145709|NCT01335971|12656346|P1|NOT COMPLETED|Overall Study||2
5145710|NCT01335971|12656344|P3|COMPLETED|Overall Study||28
5145711|NCT01335971|12656345|P2|COMPLETED|Overall Study||28
5145712|NCT01335971|12656346|P1|COMPLETED|Overall Study||29
5145713|NCT01335971|12656344|P3|STARTED|Overall Study||29
5145714|NCT01335971|12656345|P2|STARTED|Overall Study||29
5145715|NCT01335971|12656346|P1|STARTED|Overall Study||31
5145716|NCT01335932|12656383|P2|NOT COMPLETED|Overall Study||4
5145717|NCT01335932|12656384|P1|NOT COMPLETED|Overall Study||0
5145718|NCT01335932|12656383|P2|COMPLETED|Overall Study||72
5145719|NCT01335932|12656384|P1|COMPLETED|Overall Study||84
5145720|NCT01335932|12656383|P2|STARTED|Overall Study||76
5145721|NCT01335932|12656384|P1|STARTED|Overall Study||84
5145722|NCT01335867|12656524|P2|NOT COMPLETED|Overall Study||4
5145723|NCT01335867|12656525|P1|NOT COMPLETED|Overall Study||7
5145724|NCT01335867|12656524|P2|COMPLETED|Overall Study||12
5145725|NCT01335867|12656525|P1|COMPLETED|Overall Study||9
5145726|NCT01335867|12656524|P2|STARTED|Overall Study||16
5145727|NCT01335867|12656525|P1|STARTED|Overall Study||16
5145728|NCT01335789|12656541|P2|NOT COMPLETED|Overall Study||0
5145729|NCT01335789|12656542|P1|NOT COMPLETED|Overall Study||0
5145730|NCT01335789|12656541|P2|COMPLETED|Overall Study||8
5145731|NCT01335789|12656542|P1|COMPLETED|Overall Study||8
5145732|NCT01335789|12656541|P2|STARTED|Overall Study||8
5145733|NCT01335789|12656542|P1|STARTED|Overall Study||8
5145734|NCT01335750|12656552|P1|NOT COMPLETED|Overall Study||0
5145735|NCT01335750|12656552|P1|COMPLETED|Overall Study||32
5145736|NCT01335750|12656552|P1|STARTED|Overall Study||32
5145737|NCT01335724|12656573|P2|NOT COMPLETED|Overall Study||0
5145738|NCT01335724|12656574|P1|NOT COMPLETED|Overall Study||0
5145739|NCT01335724|12656573|P2|COMPLETED|Overall Study||36
5145740|NCT01335724|12656574|P1|COMPLETED|Overall Study||36
5145741|NCT01335724|12656573|P2|STARTED|Overall Study||36
5145742|NCT01335724|12656574|P1|STARTED|Overall Study||36
5145743|NCT01335698|12656589|P5|NOT COMPLETED|Treatment Stage 2||1
5145744|NCT01335698|12656590|P4|NOT COMPLETED|Treatment Stage 2||8
5145745|NCT01335698|12656591|P3|NOT COMPLETED|Treatment Stage 2||5
5145746|NCT01335698|12656592|P2|NOT COMPLETED|Treatment Stage 2||3
5145747|NCT01335698|12656593|P1|NOT COMPLETED|Treatment Stage 2||11
5145748|NCT01335698|12656589|P5|COMPLETED|Treatment Stage 2||5
5145749|NCT01335698|12656590|P4|COMPLETED|Treatment Stage 2||18
5145750|NCT01335698|12656591|P3|COMPLETED|Treatment Stage 2||11
5145751|NCT01335698|12656592|P2|COMPLETED|Treatment Stage 2||1
5145752|NCT01335698|12656593|P1|COMPLETED|Treatment Stage 2||4
5145753|NCT01335698|12656589|P5|STARTED|Treatment Stage 2||6
5145754|NCT01335698|12656590|P4|STARTED|Treatment Stage 2||26
5145755|NCT01335698|12656591|P3|STARTED|Treatment Stage 2||16
5145756|NCT01335698|12656592|P2|STARTED|Treatment Stage 2||4
5145757|NCT01335698|12656593|P1|STARTED|Treatment Stage 2||15
5145758|NCT01335698|12656589|P5|NOT COMPLETED|Treatment Stage 1||2
5145759|NCT01335698|12656590|P4|NOT COMPLETED|Treatment Stage 1||9
5145760|NCT01335698|12656591|P3|NOT COMPLETED|Treatment Stage 1||5
5145761|NCT01335698|12656592|P2|NOT COMPLETED|Treatment Stage 1||8
5145762|NCT01335698|12656593|P1|NOT COMPLETED|Treatment Stage 1||8
5145763|NCT01335698|12656589|P5|COMPLETED|Treatment Stage 1||6
5145764|NCT01335698|12656590|P4|COMPLETED|Treatment Stage 1||26
5145765|NCT01335698|12656591|P3|COMPLETED|Treatment Stage 1||16
5145766|NCT01335698|12656592|P2|COMPLETED|Treatment Stage 1||4
5145767|NCT01335698|12656593|P1|COMPLETED|Treatment Stage 1||15
5145768|NCT01335698|12656589|P5|STARTED|Treatment Stage 1||8
5145769|NCT01335698|12656590|P4|STARTED|Treatment Stage 1||35
5145770|NCT01335698|12656591|P3|STARTED|Treatment Stage 1||21
5145771|NCT01335698|12656592|P2|STARTED|Treatment Stage 1||12
5145772|NCT01335698|12656593|P1|STARTED|Treatment Stage 1||23
5145773|NCT01335685|12656658|P8|NOT COMPLETED|Overall Study||3
5145774|NCT01335685|12656659|P7|NOT COMPLETED|Overall Study||2
5145775|NCT01335685|12656660|P6|NOT COMPLETED|Overall Study||5
5145776|NCT01335685|12656661|P5|NOT COMPLETED|Overall Study||0
5145777|NCT01335685|12656662|P4|NOT COMPLETED|Overall Study||11
5145778|NCT01335685|12656663|P3|NOT COMPLETED|Overall Study||2
5145779|NCT01335685|12656664|P2|NOT COMPLETED|Overall Study||1
5145780|NCT01335685|12656665|P1|NOT COMPLETED|Overall Study||3
5145781|NCT01335685|12656658|P8|COMPLETED|Overall Study||3
5145782|NCT01335685|12656659|P7|COMPLETED|Overall Study||2
5145783|NCT01335685|12656660|P6|COMPLETED|Overall Study||1
5145784|NCT01335685|12656661|P5|COMPLETED|Overall Study||5
5145785|NCT01335685|12656662|P4|COMPLETED|Overall Study||15
5145786|NCT01335685|12656663|P3|COMPLETED|Overall Study||1
5145787|NCT01335685|12656664|P2|COMPLETED|Overall Study||3
5145788|NCT01335685|12656665|P1|COMPLETED|Overall Study||4
5145789|NCT01335685|12656658|P8|STARTED|Overall Study||6
5145790|NCT01335685|12656659|P7|STARTED|Overall Study||4
5145791|NCT01335685|12656660|P6|STARTED|Overall Study||6
5145792|NCT01335685|12656661|P5|STARTED|Overall Study||5
5145793|NCT01335685|12656662|P4|STARTED|Overall Study||26
5145794|NCT01335685|12656663|P3|STARTED|Overall Study||3
5145795|NCT01335685|12656664|P2|STARTED|Overall Study||4
5145796|NCT01335685|12656665|P1|STARTED|Overall Study||7
5145797|NCT01335620|12656767|P1|NOT COMPLETED|Overall Study||0
5145798|NCT01335620|12656767|P1|COMPLETED|Overall Study||19
5145799|NCT01335620|12656767|P1|STARTED|Overall Study||19
5145800|NCT01335542|12656776|P2|NOT COMPLETED|Overall Study||0
5145801|NCT01335542|12656777|P1|NOT COMPLETED|Overall Study||0
5145802|NCT01335542|12656776|P2|COMPLETED|Overall Study||45
5145803|NCT01335542|12656777|P1|COMPLETED|Overall Study||45
5145804|NCT01335542|12656776|P2|STARTED|Overall Study||45
5145805|NCT01335542|12656777|P1|STARTED|Overall Study||45
5145806|NCT01335477|12656785|P2|NOT COMPLETED|Overall Study||59
5145807|NCT01335477|12656786|P1|NOT COMPLETED|Overall Study||41
5145808|NCT01335477|12656785|P2|COMPLETED|Overall Study||272
5145809|NCT01335477|12656786|P1|COMPLETED|Overall Study||179
5145810|NCT01335477|12656785|P2|STARTED|Overall Study||331
5145811|NCT01335477|12656786|P1|STARTED|Overall Study||220
5145812|NCT01335464|12656850|P2|NOT COMPLETED|Overall Study||49
5145813|NCT01335464|12656851|P1|NOT COMPLETED|Overall Study||32
5145814|NCT01335464|12656850|P2|COMPLETED|Overall Study||260
5145815|NCT01335464|12656851|P1|COMPLETED|Overall Study||174
5145816|NCT01335464|12656850|P2|STARTED|Overall Study||309
5145817|NCT01335464|12656851|P1|STARTED|Overall Study||206
5145818|NCT01335308|12656916|P3|NOT COMPLETED|Overall Study||81
5145819|NCT01335308|12656917|P2|NOT COMPLETED|Overall Study||67
5145820|NCT01335308|12656918|P1|NOT COMPLETED|Overall Study||40
5145821|NCT01335308|12656916|P3|COMPLETED|Overall Study||154
5145822|NCT01335308|12656917|P2|COMPLETED|Overall Study||145
5145823|NCT01335308|12656918|P1|COMPLETED|Overall Study||158
5145824|NCT01335308|12656916|P3|STARTED|Overall Study||235
5145825|NCT01335308|12656917|P2|STARTED|Overall Study||212
5145826|NCT01335308|12656918|P1|STARTED|Overall Study||198
5145827|NCT01335230|12656939|P4|NOT COMPLETED|Overall Study||0
5145828|NCT01335230|12656940|P3|NOT COMPLETED|Overall Study||0
5145829|NCT01335230|12656941|P2|NOT COMPLETED|Overall Study||0
5145830|NCT01335230|12656942|P1|NOT COMPLETED|Overall Study||0
5145831|NCT01335230|12656939|P4|COMPLETED|Overall Study|subjects|10
5145832|NCT01335230|12656940|P3|COMPLETED|Overall Study|subjects|10
5145833|NCT01335230|12656941|P2|COMPLETED|Overall Study|subjects|10
5145834|NCT01335230|12656942|P1|COMPLETED|Overall Study|subjects|10
5145835|NCT01335230|12656939|P4|STARTED|Overall Study|subjects|10
5145836|NCT01335230|12656940|P3|STARTED|Overall Study|subjects|10
5145837|NCT01335230|12656941|P2|STARTED|Overall Study|subjects|10
5145838|NCT01335230|12656942|P1|STARTED|Overall Study|subjects|10
5145839|NCT01335204|12656952|P1|NOT COMPLETED|Overall Study||0
5145840|NCT01335204|12656952|P1|COMPLETED|Overall Study||4
5145841|NCT01335204|12656952|P1|STARTED|Overall Study||4
5145842|NCT01335191|12656963|P2|NOT COMPLETED|Overall Study||0
5145843|NCT01335191|12656964|P1|NOT COMPLETED|Overall Study||0
5145844|NCT01335191|12656963|P2|COMPLETED|Overall Study||11
5145845|NCT01335191|12656964|P1|COMPLETED|Overall Study||16
5145846|NCT01335191|12656963|P2|STARTED|Overall Study||11
5145847|NCT01335191|12656964|P1|STARTED|Overall Study||16
5145848|NCT01335061|12656970|P1|NOT COMPLETED|Overall Study||0
5145849|NCT01335061|12656970|P1|COMPLETED|Overall Study||25
5145850|NCT01335061|12656970|P1|STARTED|Overall Study||25
5145851|NCT01334957|12656985|P1|NOT COMPLETED|Overall Study||0
5145852|NCT01334957|12656985|P1|COMPLETED|Overall Study||300
5145853|NCT01334957|12656985|P1|Received Multiple Doses|Overall Study||48
5145854|NCT01334957|12656985|P1|Received Single Dose|Overall Study||252
5145855|NCT01334957|12656985|P1|STARTED|Overall Study||300
5145856|NCT01334944|12656993|P2|NOT COMPLETED|Overall Study||0
5145857|NCT01334944|12656994|P1|NOT COMPLETED|Overall Study||0
5145858|NCT01334944|12656993|P2|COMPLETED|Overall Study||139
5145859|NCT01334944|12656994|P1|COMPLETED|Overall Study||11
5145860|NCT01334944|12656993|P2|Received Multiple Doses|Overall Study||43
5145861|NCT01334944|12656994|P1|Received Multiple Doses|Overall Study||10
5145862|NCT01334944|12656993|P2|Received Singel Dose|Overall Study||96
5145863|NCT01334944|12656994|P1|Received Singel Dose|Overall Study||1
5145864|NCT01334944|12656993|P2|STARTED|Overall Study||139
5145865|NCT01334944|12656994|P1|STARTED|Overall Study||11
5145866|NCT01334918|12657020|P2|NOT COMPLETED|Overall Study||1
5145867|NCT01334918|12657021|P1|NOT COMPLETED|Overall Study||8
5145868|NCT01334918|12657020|P2|COMPLETED|Overall Study||60
5145869|NCT01334918|12657021|P1|COMPLETED|Overall Study||55
5145870|NCT01334918|12657020|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
5145871|NCT01334918|12657021|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
5145872|NCT01334918|12657020|P2|STARTED|Overall Study||61
5145873|NCT01334918|12657021|P1|STARTED|Overall Study||63
5145874|NCT01334866|12657047|P1|NOT COMPLETED|Overall Study||19
5145875|NCT01334866|12657047|P1|COMPLETED|Overall Study||72
5145876|NCT01334866|12657047|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
5145877|NCT01334723|12657057|P2|NOT COMPLETED|Overall Study||0
5145878|NCT01334723|12657058|P1|NOT COMPLETED|Overall Study||0
5145879|NCT01334723|12657057|P2|COMPLETED|Overall Study||17739
5145880|NCT01334723|12657058|P1|COMPLETED|Overall Study||17293
5145881|NCT01334723|12657057|P2|STARTED|Overall Study||17739
5145882|NCT01334723|12657058|P1|STARTED|Overall Study||17293
5145883|NCT01334710|12657084|P1|NOT COMPLETED|Overall Study||3
5145884|NCT01334710|12657084|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
5145885|NCT01334710|12657084|P1|STARTED|Overall Study||3
5145886|NCT01334606|12657089|P1|NOT COMPLETED|Overall Study||18
5145887|NCT01334606|12657089|P1|COMPLETED|Overall Study||3
5145888|NCT01334606|12657089|P1|STARTED|Overall Study||21
5145889|NCT01334554|12657097|P2|NOT COMPLETED|Overall Study||2
5145890|NCT01334554|12657098|P1|NOT COMPLETED|Overall Study||4
5145891|NCT01334554|12657097|P2|COMPLETED|Overall Study||21
5145892|NCT01334554|12657098|P1|COMPLETED|Overall Study||19
5145893|NCT01334554|12657097|P2|STARTED|Overall Study||23
5145894|NCT01334554|12657098|P1|STARTED|Overall Study||23
5145895|NCT01334515|12657108|P2|NOT COMPLETED|Overall Study||29
5145896|NCT01334515|12657109|P1|NOT COMPLETED|Overall Study||12
5145897|NCT01334515|12657108|P2|COMPLETED|Overall Study||7
5145898|NCT01334515|12657109|P1|COMPLETED|Overall Study||4
5145899|NCT01334515|12657108|P2|STARTED|Overall Study||36
5145900|NCT01334515|12657109|P1|STARTED|Overall Study||16
5145901|NCT01334229|12657119|P2|NOT COMPLETED|Overall Study||0
5145902|NCT01334229|12657120|P1|NOT COMPLETED|Overall Study||0
5145903|NCT01334229|12657119|P2|COMPLETED|Overall Study||11
5145904|NCT01334229|12657120|P1|COMPLETED|Overall Study||11
5145905|NCT01334229|12657119|P2|STARTED|Overall Study||11
5145906|NCT01334229|12657120|P1|STARTED|Overall Study||11
5145907|NCT01334216|12657138|P2|NOT COMPLETED|Overall Study||0
5145908|NCT01334216|12657139|P1|NOT COMPLETED|Overall Study||0
5145909|NCT01334216|12657138|P2|COMPLETED|Overall Study||194
5145910|NCT01334216|12657139|P1|COMPLETED|Overall Study||168
5145911|NCT01334216|12657138|P2|STARTED|Overall Study||194
5145912|NCT01334216|12657139|P1|STARTED|Overall Study||168
5145913|NCT01334125|12657147|P2|NOT COMPLETED|Overall Study||3
5145914|NCT01334125|12657148|P1|NOT COMPLETED|Overall Study||3
5145915|NCT01334125|12657147|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
5145916|NCT01334125|12657148|P1|COMPLETED|Overall Study|3 subjects move to another city|12
5145917|NCT01334125|12657147|P2|STARTED|Overall Study||13
5145918|NCT01334125|12657148|P1|STARTED|Overall Study||15
5145919|NCT01333956|12657164|P4|NOT COMPLETED|Overall Study||2
5145920|NCT01333956|12657165|P3|NOT COMPLETED|Overall Study||1
5145921|NCT01333956|12657166|P2|NOT COMPLETED|Overall Study||4
5145922|NCT01333956|12657167|P1|NOT COMPLETED|Overall Study||2
5145923|NCT01333956|12657164|P4|COMPLETED|Overall Study||28
5145924|NCT01333956|12657165|P3|COMPLETED|Overall Study||29
5145925|NCT01333956|12657166|P2|COMPLETED|Overall Study||26
5145926|NCT01333956|12657167|P1|COMPLETED|Overall Study||28
5145927|NCT01333956|12657164|P4|STARTED|Overall Study||30
5145928|NCT01333956|12657165|P3|STARTED|Overall Study||30
5145929|NCT01333956|12657166|P2|STARTED|Overall Study||30
5145930|NCT01333956|12657167|P1|STARTED|Overall Study||30
5145931|NCT01333943|12657203|P2|NOT COMPLETED|Overall Study||0
5145932|NCT01333943|12657204|P1|NOT COMPLETED|Overall Study||1
5145933|NCT01333943|12657203|P2|COMPLETED|Overall Study||47
5145934|NCT01333943|12657204|P1|COMPLETED|Overall Study||46
5145935|NCT01333943|12657203|P2|STARTED|Overall Study||47
5145936|NCT01333943|12657204|P1|STARTED|Overall Study||47
5145937|NCT01333865|12657220|P1|NOT COMPLETED|Overall Study||2
5145938|NCT01333865|12657220|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
5145939|NCT01333865|12657220|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
5145940|NCT01333813|12657225|P1|NOT COMPLETED|Overall Study||0
5145941|NCT01333813|12657225|P1|COMPLETED|Overall Study||297
5145942|NCT01333813|12657225|P1|STARTED|Overall Study||297
5145943|NCT01333722|12657240|P2|NOT COMPLETED|Overall Study||3
5145944|NCT01333722|12657241|P1|NOT COMPLETED|Overall Study||0
5145945|NCT01333722|12657240|P2|COMPLETED|Overall Study||46
5145946|NCT01333722|12657241|P1|COMPLETED|Overall Study||51
5145947|NCT01333722|12657240|P2|STARTED|Overall Study||49
5145948|NCT01333722|12657241|P1|STARTED|Overall Study||51
5145949|NCT01333592|12657255|P2|NOT COMPLETED|Overall Study||17
5145950|NCT01333592|12657256|P1|NOT COMPLETED|Overall Study||9
5145951|NCT01333592|12657255|P2|COMPLETED|Overall Study||52
5145952|NCT01333592|12657256|P1|COMPLETED|Overall Study||58
5145953|NCT01333592|12657255|P2|STARTED|Overall Study||69
5145954|NCT01333592|12657256|P1|STARTED|Overall Study||67
5145955|NCT01333501|12657266|P2|NOT COMPLETED|Overall Study||21
5145956|NCT01333501|12657267|P1|NOT COMPLETED|Overall Study||9
5145957|NCT01333501|12657266|P2|COMPLETED|Overall Study||30
5145958|NCT01333501|12657267|P1|COMPLETED|Overall Study||97
5145959|NCT01333501|12657266|P2|Safety Population|Overall Study||47
5145960|NCT01333501|12657267|P1|Safety Population|Overall Study||104
5145961|NCT01333501|12657266|P2|Full Analysis Set (FAS)|Overall Study||28
5145962|NCT01333501|12657267|P1|Full Analysis Set (FAS)|Overall Study||80
5145963|NCT01333501|12657266|P2|STARTED|Overall Study||51
5145964|NCT01333501|12657267|P1|STARTED|Overall Study||106
5145965|NCT01333488|12657316|P3|NOT COMPLETED|Overall Study||0
5145966|NCT01333488|12657317|P2|NOT COMPLETED|Overall Study||0
5145967|NCT01333488|12657318|P1|NOT COMPLETED|Overall Study||0
5145968|NCT01333488|12657316|P3|COMPLETED|Overall Study||3
5145969|NCT01333488|12657317|P2|COMPLETED|Overall Study||1
5145970|NCT01333488|12657318|P1|COMPLETED|Overall Study||2
5145971|NCT01333488|12657316|P3|STARTED|Overall Study||3
5145972|NCT01333488|12657317|P2|STARTED|Overall Study||1
5145973|NCT01333488|12657318|P1|STARTED|Overall Study||2
5145974|NCT01333475|12657334|P2|NOT COMPLETED|Overall Study||3
5145975|NCT01333475|12657335|P1|NOT COMPLETED|Overall Study||2
5145976|NCT01333475|12657334|P2|COMPLETED|Overall Study||6
5145977|NCT01333475|12657335|P1|COMPLETED|Overall Study||10
5145978|NCT01333475|12657334|P2|STARTED|Overall Study||9
5145979|NCT01333475|12657335|P1|STARTED|Overall Study||12
5145980|NCT01333436|12657345|P2|NOT COMPLETED|Overall Study||0
5145981|NCT01333436|12657346|P1|NOT COMPLETED|Overall Study||0
5145982|NCT01333436|12657345|P2|COMPLETED|Overall Study||50
5145983|NCT01333436|12657346|P1|COMPLETED|Overall Study||43
5145984|NCT01333436|12657345|P2|STARTED|Overall Study||50
5145985|NCT01333436|12657346|P1|STARTED|Overall Study||43
5145986|NCT01333397|12657361|P5|NOT COMPLETED|Overall Study||0
5145987|NCT01333397|12657362|P4|NOT COMPLETED|Overall Study||1
5145988|NCT01333397|12657363|P3|NOT COMPLETED|Overall Study||0
5145989|NCT01333397|12657364|P2|NOT COMPLETED|Overall Study||0
5145990|NCT01333397|12657365|P1|NOT COMPLETED|Overall Study||1
5145991|NCT01333397|12657361|P5|COMPLETED|Overall Study||35
5145992|NCT01333397|12657362|P4|COMPLETED|Overall Study||34
5145993|NCT01333397|12657363|P3|COMPLETED|Overall Study||35
5145994|NCT01333397|12657364|P2|COMPLETED|Overall Study||36
5145995|NCT01333397|12657365|P1|COMPLETED|Overall Study||34
5145996|NCT01333397|12657361|P5|STARTED|Overall Study||35
5145997|NCT01333397|12657362|P4|STARTED|Overall Study||35
5145998|NCT01333397|12657363|P3|STARTED|Overall Study||35
5145999|NCT01333397|12657364|P2|STARTED|Overall Study||36
5146000|NCT01333397|12657365|P1|STARTED|Overall Study||35
5146001|NCT01333189|12657439|P2|NOT COMPLETED|Overall Study||2
5146002|NCT01333189|12657440|P1|NOT COMPLETED|Overall Study||2
5146003|NCT01333189|12657439|P2|COMPLETED|Overall Study||11
5146004|NCT01333189|12657440|P1|COMPLETED|Overall Study||11
5146005|NCT01333189|12657439|P2|STARTED|Overall Study||13
5146006|NCT01333189|12657440|P1|STARTED|Overall Study||13
5146007|NCT01333111|12657471|P3|NOT COMPLETED|Overall Study||2
5146008|NCT01333111|12657472|P2|NOT COMPLETED|Overall Study||3
5146009|NCT01333111|12657473|P1|NOT COMPLETED|Overall Study||2
5146010|NCT01333111|12657471|P3|COMPLETED|Overall Study||13
5146011|NCT01333111|12657472|P2|COMPLETED|Overall Study||26
5146012|NCT01333111|12657473|P1|COMPLETED|Overall Study||28
5146013|NCT01333111|12657471|P3|STARTED|Overall Study||15
5146014|NCT01333111|12657472|P2|STARTED|Overall Study||29
5146015|NCT01333111|12657473|P1|STARTED|Overall Study||30
5146016|NCT01333098|12657497|P1|NOT COMPLETED|Overall Study||3
5146017|NCT01333098|12657497|P1|COMPLETED|Overall Study||12
5146018|NCT01333098|12657497|P1|STARTED|Overall Study||15
5146019|NCT01333072|12657508|P2|NOT COMPLETED|Overall Study||4
5146020|NCT01333072|12657509|P1|NOT COMPLETED|Overall Study||6
5146021|NCT01333072|12657508|P2|COMPLETED|Overall Study||27
5146022|NCT01333072|12657509|P1|COMPLETED|Overall Study||24
5146023|NCT01333072|12657508|P2|STARTED|Overall Study||31
5146024|NCT01333072|12657509|P1|STARTED|Overall Study||30
5146025|NCT01333059|12657517|P2|NOT COMPLETED|Overall Study||3
5146026|NCT01333059|12657518|P1|NOT COMPLETED|Overall Study||6
5146027|NCT01333059|12657517|P2|COMPLETED|Overall Study||8
5146028|NCT01333059|12657518|P1|COMPLETED|Overall Study||8
5146029|NCT01333059|12657517|P2|STARTED|Overall Study||11
5146030|NCT01333059|12657518|P1|STARTED|Overall Study||14
5146031|NCT01332994|12657528|P1|NOT COMPLETED|Overall Study||71
5146032|NCT01332994|12657528|P1|COMPLETED|Overall Study||448
5146033|NCT01332994|12657528|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
5146034|NCT01332994|12657528|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
5146035|NCT01332994|12657528|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
5146036|NCT01332994|12657528|P1|Completed Week 16|Overall Study||463
5146037|NCT01332994|12657528|P1|STARTED|Overall Study||519
5146038|NCT01332981|12657584|P1|NOT COMPLETED|Overall Study||0
5146039|NCT01332981|12657584|P1|COMPLETED|Overall Study||220
5146040|NCT01332981|12657584|P1|STARTED|Overall Study||220
5146041|NCT01332968|12657597|P8|NOT COMPLETED|Follow-Up Period||531
5146042|NCT01332968|12657598|P7|NOT COMPLETED|Follow-Up Period||542
5146043|NCT01332968|12657599|P6|NOT COMPLETED|Follow-Up Period||0
5146044|NCT01332968|12657600|P5|NOT COMPLETED|Follow-Up Period||0
5146045|NCT01332968|12657601|P4|NOT COMPLETED|Follow-Up Period||0
5146046|NCT01332968|12657602|P3|NOT COMPLETED|Follow-Up Period||0
5146047|NCT01332968|12657603|P2|NOT COMPLETED|Follow-Up Period||0
5146048|NCT01332968|12657604|P1|NOT COMPLETED|Follow-Up Period||0
5146049|NCT01332968|12657597|P8|COMPLETED|Follow-Up Period||0
5146050|NCT01332968|12657598|P7|COMPLETED|Follow-Up Period||0
5146051|NCT01332968|12657599|P6|COMPLETED|Follow-Up Period||0
5146052|NCT01332968|12657600|P5|COMPLETED|Follow-Up Period||0
5146053|NCT01332968|12657601|P4|COMPLETED|Follow-Up Period||0
5146054|NCT01332968|12657602|P3|COMPLETED|Follow-Up Period||0
5146055|NCT01332968|12657603|P2|COMPLETED|Follow-Up Period||0
5146056|NCT01332968|12657604|P1|COMPLETED|Follow-Up Period||0
5146057|NCT01332968|12657597|P8|STARTED|Follow-Up Period||531
5146058|NCT01332968|12657598|P7|STARTED|Follow-Up Period||542
5146059|NCT01332968|12657599|P6|STARTED|Follow-Up Period||0
5146060|NCT01332968|12657600|P5|STARTED|Follow-Up Period||0
5146061|NCT01332968|12657601|P4|STARTED|Follow-Up Period||0
5146062|NCT01332968|12657602|P3|STARTED|Follow-Up Period||0
5146063|NCT01332968|12657603|P2|STARTED|Follow-Up Period||0
5146064|NCT01332968|12657604|P1|STARTED|Follow-Up Period||0
5146065|NCT01332968|12657597|P8|NOT COMPLETED|Maintenance/Observation Period||0
5146066|NCT01332968|12657598|P7|NOT COMPLETED|Maintenance/Observation Period||0
5146067|NCT01332968|12657599|P6|NOT COMPLETED|Maintenance/Observation Period||9
5146068|NCT01332968|12657600|P5|NOT COMPLETED|Maintenance/Observation Period||10
5146069|NCT01332968|12657601|P4|NOT COMPLETED|Maintenance/Observation Period||207
5146070|NCT01332968|12657602|P3|NOT COMPLETED|Maintenance/Observation Period||213
5146071|NCT01332968|12657603|P2|NOT COMPLETED|Maintenance/Observation Period||0
5146072|NCT01332968|12657604|P1|NOT COMPLETED|Maintenance/Observation Period||0
5146073|NCT01332968|12657597|P8|COMPLETED|Maintenance/Observation Period||0
5146074|NCT01332968|12657598|P7|COMPLETED|Maintenance/Observation Period||0
5146075|NCT01332968|12657599|P6|COMPLETED|Maintenance/Observation Period||2
5146076|NCT01332968|12657600|P5|COMPLETED|Maintenance/Observation Period||2
5146077|NCT01332968|12657601|P4|COMPLETED|Maintenance/Observation Period||417
5146078|NCT01332968|12657602|P3|COMPLETED|Maintenance/Observation Period||399
5146079|NCT01332968|12657603|P2|COMPLETED|Maintenance/Observation Period||0
5146080|NCT01332968|12657604|P1|COMPLETED|Maintenance/Observation Period||0
5146081|NCT01332968|12657597|P8|STARTED|Maintenance/Observation Period||0
5146082|NCT01332968|12657598|P7|STARTED|Maintenance/Observation Period||0
5146083|NCT01332968|12657599|P6|STARTED|Maintenance/Observation Period||11
5146084|NCT01332968|12657600|P5|STARTED|Maintenance/Observation Period||12
5146085|NCT01332968|12657601|P4|STARTED|Maintenance/Observation Period||624
5146086|NCT01332968|12657602|P3|STARTED|Maintenance/Observation Period||612
5146087|NCT01332968|12657603|P2|STARTED|Maintenance/Observation Period||0
5146088|NCT01332968|12657604|P1|STARTED|Maintenance/Observation Period||0
5146089|NCT01332968|12657597|P8|NOT COMPLETED|Induction Period||0
5146090|NCT01332968|12657598|P7|NOT COMPLETED|Induction Period||0
5146091|NCT01332968|12657599|P6|NOT COMPLETED|Induction Period||0
5146092|NCT01332968|12657600|P5|NOT COMPLETED|Induction Period||0
5146093|NCT01332968|12657601|P4|NOT COMPLETED|Induction Period||0
5146094|NCT01332968|12657602|P3|NOT COMPLETED|Induction Period||0
5146095|NCT01332968|12657603|P2|NOT COMPLETED|Induction Period||56
5146096|NCT01332968|12657604|P1|NOT COMPLETED|Induction Period||58
5146097|NCT01332968|12657597|P8|COMPLETED|Induction Period||0
5146098|NCT01332968|12657598|P7|COMPLETED|Induction Period||0
5146099|NCT01332968|12657599|P6|COMPLETED|Induction Period||0
5146100|NCT01332968|12657600|P5|COMPLETED|Induction Period||0
5146101|NCT01332968|12657601|P4|COMPLETED|Induction Period||0
5146102|NCT01332968|12657602|P3|COMPLETED|Induction Period||0
5146103|NCT01332968|12657603|P2|COMPLETED|Induction Period||646
5146104|NCT01332968|12657604|P1|COMPLETED|Induction Period||641
5146105|NCT01332968|12657597|P8|STARTED|Induction Period||0
5146106|NCT01332968|12657598|P7|STARTED|Induction Period||0
5146107|NCT01332968|12657599|P6|STARTED|Induction Period||0
5146108|NCT01332968|12657600|P5|STARTED|Induction Period||0
5146109|NCT01332968|12657601|P4|STARTED|Induction Period||0
5146110|NCT01332968|12657602|P3|STARTED|Induction Period||0
5146111|NCT01332968|12657603|P2|STARTED|Induction Period||702
5146112|NCT01332968|12657604|P1|STARTED|Induction Period||699
5146113|NCT01332851|12657670|P2|NOT COMPLETED|Overall Study||13
5146114|NCT01332851|12657671|P1|NOT COMPLETED|Overall Study||11
5146115|NCT01332851|12657670|P2|COMPLETED|Overall Study||110
5146116|NCT01332851|12657671|P1|COMPLETED|Overall Study||113
5146117|NCT01332851|12657670|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
5146118|NCT01332851|12657671|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
5146119|NCT01332851|12657670|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
5146120|NCT01332851|12657671|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
5146121|NCT01332851|12657670|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
5146122|NCT01332851|12657671|P1|Completed Follow up 1|Overall Study||116
5146123|NCT01332851|12657670|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
5146124|NCT01332851|12657671|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
5146125|NCT01332851|12657670|P2|STARTED|Overall Study||123
5146126|NCT01332851|12657671|P1|STARTED|Overall Study||124
5146127|NCT01332799|12657705|P2|NOT COMPLETED|Overall Study||10
5146128|NCT01332799|12657706|P1|NOT COMPLETED|Overall Study||10
5146129|NCT01332799|12657705|P2|COMPLETED|Overall Study||0
5146130|NCT01332799|12657706|P1|COMPLETED|Overall Study||0
5146131|NCT01332799|12657705|P2|STARTED|Overall Study||10
5146132|NCT01332799|12657706|P1|STARTED|Overall Study||10
5146133|NCT01332721|12657716|P1|NOT COMPLETED|Overall Study||0
5146134|NCT01332721|12657716|P1|COMPLETED|Overall Study||38
5146135|NCT01332721|12657716|P1|STARTED|Overall Study||38
5146136|NCT01332630|12657722|P1|NOT COMPLETED|Overall Study||3
5146137|NCT01332630|12657722|P1|COMPLETED|Overall Study||21
5146138|NCT01332630|12657722|P1|STARTED|Overall Study||24
5146139|NCT01332578|12657726|P2|NOT COMPLETED|Period II||0
5146140|NCT01332578|12657727|P1|NOT COMPLETED|Period II||0
5146141|NCT01332578|12657726|P2|COMPLETED|Period II||13
5146142|NCT01332578|12657727|P1|COMPLETED|Period II||12
5146143|NCT01332578|12657726|P2|STARTED|Period II||13
5146144|NCT01332578|12657727|P1|STARTED|Period II||12
5146145|NCT01332578|12657726|P2|NOT COMPLETED|Washout Period||0
5146146|NCT01332578|12657727|P1|NOT COMPLETED|Washout Period||0
5146147|NCT01332578|12657726|P2|COMPLETED|Washout Period||13
5146148|NCT01332578|12657727|P1|COMPLETED|Washout Period||12
5146149|NCT01332578|12657726|P2|STARTED|Washout Period||13
5146150|NCT01332578|12657727|P1|STARTED|Washout Period||12
5146151|NCT01332578|12657726|P2|NOT COMPLETED|Period I||0
5146152|NCT01332578|12657727|P1|NOT COMPLETED|Period I||0
5146153|NCT01332578|12657726|P2|COMPLETED|Period I||13
5146154|NCT01332578|12657727|P1|COMPLETED|Period I||12
5146155|NCT01332578|12657726|P2|STARTED|Period I||13
5146156|NCT01332578|12657727|P1|STARTED|Period I||12
5146157|NCT01332500|12657750|P4|NOT COMPLETED|Overall Study||0
5146158|NCT01332500|12657751|P3|NOT COMPLETED|Overall Study||0
5146159|NCT01332500|12657752|P2|NOT COMPLETED|Overall Study||0
5146160|NCT01332500|12657753|P1|NOT COMPLETED|Overall Study||0
5146161|NCT01332500|12657750|P4|COMPLETED|Overall Study||5806
5146162|NCT01332500|12657751|P3|COMPLETED|Overall Study||2903
5146163|NCT01332500|12657752|P2|COMPLETED|Overall Study||39771
5146164|NCT01332500|12657753|P1|COMPLETED|Overall Study||13257
5146165|NCT01332500|12657750|P4|STARTED|Overall Study||5806
5146166|NCT01332500|12657751|P3|STARTED|Overall Study||2903
5146167|NCT01332500|12657752|P2|STARTED|Overall Study||39771
5146168|NCT01332500|12657753|P1|STARTED|Overall Study||13257
5146169|NCT01332487|12657773|P2|NOT COMPLETED|Overall Study||0
5146170|NCT01332487|12657774|P1|NOT COMPLETED|Overall Study||0
5146171|NCT01332487|12657773|P2|COMPLETED|Overall Study||3063
5146172|NCT01332487|12657774|P1|COMPLETED|Overall Study||5554
5146173|NCT01332487|12657773|P2|STARTED|Overall Study||3063
5146174|NCT01332487|12657774|P1|STARTED|Overall Study||5554
5146175|NCT01332461|12657784|P2|NOT COMPLETED|Overall Study||0
5146176|NCT01332461|12657785|P1|NOT COMPLETED|Overall Study||0
5146177|NCT01332461|12657784|P2|COMPLETED|Overall Study||4386
5146178|NCT01332461|12657785|P1|COMPLETED|Overall Study||1291
5146179|NCT01332461|12657784|P2|STARTED|Overall Study||4386
5146180|NCT01332461|12657785|P1|STARTED|Overall Study||1291
5146181|NCT01332435|12657799|P4|NOT COMPLETED|Overall Study||0
5146182|NCT01332435|12657800|P3|NOT COMPLETED|Overall Study||0
5146183|NCT01332435|12657801|P2|NOT COMPLETED|Overall Study||0
5146184|NCT01332435|12657802|P1|NOT COMPLETED|Overall Study||0
5146185|NCT01332435|12657799|P4|COMPLETED|Overall Study||1656
5146186|NCT01332435|12657800|P3|COMPLETED|Overall Study||2604
5146187|NCT01332435|12657801|P2|COMPLETED|Overall Study||1064
5146188|NCT01332435|12657802|P1|COMPLETED|Overall Study||1572
5146189|NCT01332435|12657799|P4|STARTED|Overall Study||1656
5146190|NCT01332435|12657800|P3|STARTED|Overall Study||2604
5146191|NCT01332435|12657801|P2|STARTED|Overall Study||1064
5146192|NCT01332435|12657802|P1|STARTED|Overall Study||1572
5146193|NCT01332357|12657832|P1|NOT COMPLETED|Overall Study||0
5146194|NCT01332357|12657832|P1|COMPLETED|Overall Study||6139
5146195|NCT01332357|12657832|P1|STARTED|Overall Study||6139
5146196|NCT01332331|12657838|P2|NOT COMPLETED|Overall Study||2
5146197|NCT01332331|12657839|P1|NOT COMPLETED|Overall Study||2
5146198|NCT01332331|12657838|P2|COMPLETED|Overall Study||18
5146199|NCT01332331|12657839|P1|COMPLETED|Overall Study||19
5146200|NCT01332331|12657838|P2|STARTED|Overall Study||20
5146201|NCT01332331|12657839|P1|STARTED|Overall Study||21
5146202|NCT01332318|12657891|P4|NOT COMPLETED|Overall Study||2
5146203|NCT01332318|12657892|P3|NOT COMPLETED|Overall Study||1
5146204|NCT01332318|12657893|P2|NOT COMPLETED|Overall Study||4
5146205|NCT01332318|12657894|P1|NOT COMPLETED|Overall Study||2
5146206|NCT01332318|12657891|P4|COMPLETED|Overall Study||28
5146207|NCT01332318|12657892|P3|COMPLETED|Overall Study||33
5146208|NCT01332318|12657893|P2|COMPLETED|Overall Study||28
5146209|NCT01332318|12657894|P1|COMPLETED|Overall Study||32
5146210|NCT01332318|12657891|P4|STARTED|Overall Study||30
5146211|NCT01332318|12657892|P3|STARTED|Overall Study||34
5146212|NCT01332318|12657893|P2|STARTED|Overall Study||32
5146213|NCT01332318|12657894|P1|STARTED|Overall Study||34
5146214|NCT01332305|12658005|P5|NOT COMPLETED|Overall Study||12
5146215|NCT01332305|12658006|P4|NOT COMPLETED|Overall Study||8
5146216|NCT01332305|12658007|P3|NOT COMPLETED|Overall Study||14
5146217|NCT01332305|12658008|P2|NOT COMPLETED|Overall Study||14
5146218|NCT01332305|12658009|P1|NOT COMPLETED|Overall Study||10
5146219|NCT01332305|12658005|P5|COMPLETED|Overall Study||33
5146220|NCT01332305|12658006|P4|COMPLETED|Overall Study||30
5146221|NCT01332305|12658007|P3|COMPLETED|Overall Study||31
5146222|NCT01332305|12658008|P2|COMPLETED|Overall Study||34
5146223|NCT01332305|12658009|P1|COMPLETED|Overall Study||31
5146224|NCT01332305|12658005|P5|STARTED|Overall Study||45
5146225|NCT01332305|12658006|P4|STARTED|Overall Study||38
5146226|NCT01332305|12658007|P3|STARTED|Overall Study||45
5146227|NCT01332305|12658008|P2|STARTED|Overall Study||48
5146228|NCT01332305|12658009|P1|STARTED|Overall Study||41
5146229|NCT01332292|12658031|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5146230|NCT01332292|12658032|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5146231|NCT01332292|12658031|P2|COMPLETED|Treatment Period 2 (14 Days)||11
5146232|NCT01332292|12658032|P1|COMPLETED|Treatment Period 2 (14 Days)||11
5146233|NCT01332292|12658031|P2|STARTED|Treatment Period 2 (14 Days)||12
5146234|NCT01332292|12658032|P1|STARTED|Treatment Period 2 (14 Days)||12
5146235|NCT01332292|12658031|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
5146236|NCT01332292|12658032|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
5146237|NCT01332292|12658031|P2|COMPLETED|Washout Period (>=7 Days)||12
5146238|NCT01332292|12658032|P1|COMPLETED|Washout Period (>=7 Days)||12
5146239|NCT01332292|12658031|P2|STARTED|Washout Period (>=7 Days)||12
5146240|NCT01332292|12658032|P1|STARTED|Washout Period (>=7 Days)||12
5146241|NCT01332292|12658031|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5146242|NCT01332292|12658032|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5146243|NCT01332292|12658031|P2|COMPLETED|Treatment Period 1 (14 Days)||12
5146244|NCT01332292|12658032|P1|COMPLETED|Treatment Period 1 (14 Days)||12
5146245|NCT01332292|12658031|P2|STARTED|Treatment Period 1 (14 Days)||13
5146246|NCT01332292|12658032|P1|STARTED|Treatment Period 1 (14 Days)||14
5146247|NCT01332253|12658094|P2|NOT COMPLETED|Overall Study||0
5146248|NCT01332253|12658095|P1|NOT COMPLETED|Overall Study||0
5146249|NCT01332253|12658094|P2|COMPLETED|Overall Study||79
5146250|NCT01332253|12658095|P1|COMPLETED|Overall Study||82
5146251|NCT01332253|12658094|P2|STARTED|Overall Study||79
5146252|NCT01332253|12658095|P1|STARTED|Overall Study||82
5146253|NCT01332227|12658123|P2|NOT COMPLETED|Overall Study||5
5146254|NCT01332227|12658124|P1|NOT COMPLETED|Overall Study||16
5146255|NCT01332227|12658123|P2|COMPLETED|Overall Study||32
5146256|NCT01332227|12658124|P1|COMPLETED|Overall Study||56
5146257|NCT01332227|12658123|P2|STARTED|Overall Study|Participants who received treatment|37
5146258|NCT01332227|12658124|P1|STARTED|Overall Study|Participants who received treatment|72
5146259|NCT01332188|12658146|P4|NOT COMPLETED|Overall Study||0
5146260|NCT01332188|12658147|P3|NOT COMPLETED|Overall Study||4
5146261|NCT01332188|12658148|P2|NOT COMPLETED|Overall Study||1
5146262|NCT01332188|12658149|P1|NOT COMPLETED|Overall Study||2
5146263|NCT01332188|12658146|P4|COMPLETED|Overall Study||25
5146264|NCT01332188|12658147|P3|COMPLETED|Overall Study||21
5146265|NCT01332188|12658148|P2|COMPLETED|Overall Study||25
5146266|NCT01332188|12658149|P1|COMPLETED|Overall Study||23
5146267|NCT01332188|12658146|P4|STARTED|Overall Study||25
5146268|NCT01332188|12658147|P3|STARTED|Overall Study||25
5146269|NCT01332188|12658148|P2|STARTED|Overall Study||26
5146270|NCT01332188|12658149|P1|STARTED|Overall Study||25
5146271|NCT01332149|12658305|P2|NOT COMPLETED|Overall Study||38
5146272|NCT01332149|12658306|P1|NOT COMPLETED|Overall Study||30
5146273|NCT01332149|12658305|P2|COMPLETED|Overall Study||271
5146274|NCT01332149|12658306|P1|COMPLETED|Overall Study||284
5146275|NCT01332149|12658305|P2|Treated|Overall Study||307
5146276|NCT01332149|12658306|P1|Treated|Overall Study||313
5146277|NCT01332149|12658305|P2|STARTED|Overall Study|Assigned to study treatment.|309
5146278|NCT01332149|12658306|P1|STARTED|Overall Study|Assigned to study treatment.|314
5146279|NCT01332123|12658360|P1|NOT COMPLETED|Overall Study||0
5146280|NCT01332123|12658360|P1|COMPLETED|Overall Study||10
5146281|NCT01332123|12658360|P1|STARTED|Overall Study||10
5146282|NCT01332071|12658365|P2|NOT COMPLETED|Period 2||0
5146283|NCT01332071|12658366|P1|NOT COMPLETED|Period 2||0
5146284|NCT01332071|12658365|P2|COMPLETED|Period 2||13
5146285|NCT01332071|12658366|P1|COMPLETED|Period 2||13
5146286|NCT01332071|12658365|P2|STARTED|Period 2||13
5146287|NCT01332071|12658366|P1|STARTED|Period 2||13
5146288|NCT01332071|12658365|P2|NOT COMPLETED|7-Day Washout Period||0
5146289|NCT01332071|12658366|P1|NOT COMPLETED|7-Day Washout Period||0
5146290|NCT01332071|12658365|P2|COMPLETED|7-Day Washout Period||13
5146291|NCT01332071|12658366|P1|COMPLETED|7-Day Washout Period||13
5146292|NCT01332071|12658365|P2|STARTED|7-Day Washout Period||13
5146293|NCT01332071|12658366|P1|STARTED|7-Day Washout Period||13
5146294|NCT01332071|12658365|P2|NOT COMPLETED|Period 1||0
5146295|NCT01332071|12658366|P1|NOT COMPLETED|Period 1||0
5146296|NCT01332071|12658365|P2|COMPLETED|Period 1||13
5146297|NCT01332071|12658366|P1|COMPLETED|Period 1||13
5146298|NCT01332071|12658365|P2|STARTED|Period 1||13
5146299|NCT01332071|12658366|P1|STARTED|Period 1||13
5146300|NCT01332019|12658384|P2|NOT COMPLETED|Overall Study||122
5146301|NCT01332019|12658385|P1|NOT COMPLETED|Overall Study||113
5146302|NCT01332019|12658384|P2|COMPLETED|Overall Study||425
5146303|NCT01332019|12658385|P1|COMPLETED|Overall Study||417
5146304|NCT01332019|12658384|P2|STARTED|Overall Study||547
5146305|NCT01332019|12658385|P1|STARTED|Overall Study||530
5146306|NCT01331837|12658469|P2|NOT COMPLETED|Overall Study||67
5146307|NCT01331837|12658470|P1|NOT COMPLETED|Overall Study||56
5146308|NCT01331837|12658469|P2|COMPLETED|Overall Study||1475
5146309|NCT01331837|12658470|P1|COMPLETED|Overall Study||1482
5146310|NCT01331837|12658469|P2|STARTED|Overall Study||1542
5146311|NCT01331837|12658470|P1|STARTED|Overall Study||1538
5146312|NCT01331824|12658510|P1|NOT COMPLETED|Overall Study||13
5146313|NCT01331824|12658510|P1|COMPLETED|Overall Study||9
5146314|NCT01331824|12658510|P1|STARTED|Overall Study||22
5146315|NCT01331694|12658523|P6|NOT COMPLETED|Overall Study||0
5146316|NCT01331694|12658524|P5|NOT COMPLETED|Overall Study||0
5146317|NCT01331694|12658525|P4|NOT COMPLETED|Overall Study||0
5146318|NCT01331694|12658526|P3|NOT COMPLETED|Overall Study||0
5146319|NCT01331694|12658527|P2|NOT COMPLETED|Overall Study||0
5146320|NCT01331694|12658528|P1|NOT COMPLETED|Overall Study||0
5146321|NCT01331694|12658523|P6|COMPLETED|Overall Study||9126
5146322|NCT01331694|12658524|P5|COMPLETED|Overall Study||10617
5146323|NCT01331694|12658525|P4|COMPLETED|Overall Study||12595
5146324|NCT01331694|12658526|P3|COMPLETED|Overall Study||12659
5146325|NCT01331694|12658527|P2|COMPLETED|Overall Study||14449
5146326|NCT01331694|12658528|P1|COMPLETED|Overall Study||16684
5146327|NCT01331694|12658523|P6|STARTED|Overall Study||9126
5146328|NCT01331694|12658524|P5|STARTED|Overall Study||10617
5146329|NCT01331694|12658525|P4|STARTED|Overall Study||12595
5146330|NCT01331694|12658526|P3|STARTED|Overall Study||12659
5146331|NCT01331694|12658527|P2|STARTED|Overall Study||14449
5146332|NCT01331694|12658528|P1|STARTED|Overall Study||16684
5146333|NCT01331681|12658545|P3|NOT COMPLETED|Overall Study||35
5146334|NCT01331681|12658546|P2|NOT COMPLETED|Overall Study||34
5146335|NCT01331681|12658547|P1|NOT COMPLETED|Overall Study||35
5146336|NCT01331681|12658545|P3|COMPLETED|Overall Study|Completed Week 148|100
5146337|NCT01331681|12658546|P2|COMPLETED|Overall Study|Completed Week 148|101
5146338|NCT01331681|12658547|P1|COMPLETED|Overall Study|Completed Week 148|101
5146339|NCT01331681|12658545|P3|Completed Week 148|Overall Study||100
5146340|NCT01331681|12658546|P2|Completed Week 148|Overall Study||101
5146341|NCT01331681|12658547|P1|Completed Week 148|Overall Study||101
5146342|NCT01331681|12658545|P3|Completed Week 100|Overall Study||105
5146343|NCT01331681|12658546|P2|Completed Week 100|Overall Study||110
5146344|NCT01331681|12658547|P1|Completed Week 100|Overall Study||115
5146345|NCT01331681|12658545|P3|Completed Week 52|Overall Study||115
5146346|NCT01331681|12658546|P2|Completed Week 52|Overall Study||121
5146347|NCT01331681|12658547|P1|Completed Week 52|Overall Study||125
5146348|NCT01331681|12658545|P3|Participants Received Treatment|Overall Study|safety population|133
5146349|NCT01331681|12658546|P2|Participants Received Treatment|Overall Study|safety population|135
5146350|NCT01331681|12658547|P1|Participants Received Treatment|Overall Study|safety population|136
5146351|NCT01331681|12658545|P3|STARTED|Overall Study|randomized|135
5146352|NCT01331681|12658546|P2|STARTED|Overall Study|randomized|135
5146353|NCT01331681|12658547|P1|STARTED|Overall Study|randomized|136
5146354|NCT01331408|12658573|P1|NOT COMPLETED|Overall Study||11
5146355|NCT01331408|12658573|P1|COMPLETED|Overall Study||50
5146356|NCT01331408|12658573|P1|STARTED|Overall Study||61
5146357|NCT01331304|12658581|P2|NOT COMPLETED|Overall Study||60
5146358|NCT01331304|12658582|P1|NOT COMPLETED|Overall Study||58
5146359|NCT01331304|12658581|P2|COMPLETED|Overall Study||182
5146360|NCT01331304|12658582|P1|COMPLETED|Overall Study||182
5146361|NCT01331304|12658581|P2|STARTED|Overall Study||242
5146362|NCT01331304|12658582|P1|STARTED|Overall Study||240
5146363|NCT01331291|12658596|P2|NOT COMPLETED|Overall Study||9
5146364|NCT01331291|12658597|P1|NOT COMPLETED|Overall Study||2
5146365|NCT01331291|12658596|P2|COMPLETED|Overall Study||0
5146366|NCT01331291|12658597|P1|COMPLETED|Overall Study||0
5146367|NCT01331291|12658596|P2|STARTED|Overall Study||9
5146368|NCT01331291|12658597|P1|STARTED|Overall Study||2
5146369|NCT01331213|12658610|P2|NOT COMPLETED|Overall Study||0
5146370|NCT01331213|12658611|P1|NOT COMPLETED|Overall Study||0
5146371|NCT01331213|12658610|P2|COMPLETED|Overall Study||10
5146372|NCT01331213|12658611|P1|COMPLETED|Overall Study||8
5146373|NCT01331213|12658610|P2|STARTED|Overall Study||10
5146374|NCT01331213|12658611|P1|STARTED|Overall Study||8
5146375|NCT01331161|12658631|P2|NOT COMPLETED|Overall Study||2
5146376|NCT01331161|12658632|P1|NOT COMPLETED|Overall Study||1
5146377|NCT01331161|12658631|P2|COMPLETED|Overall Study||31
5146378|NCT01331161|12658632|P1|COMPLETED|Overall Study||43
5146379|NCT01331161|12658631|P2|STARTED|Overall Study||33
5146380|NCT01331161|12658632|P1|STARTED|Overall Study||44
5146381|NCT01331109|12658640|P1|NOT COMPLETED|Overall Study||57
5146382|NCT01331109|12658640|P1|COMPLETED|Overall Study||0
5146383|NCT01331109|12658640|P1|STARTED|Overall Study||57
5146384|NCT01331083|12658652|P2|NOT COMPLETED|Overall Study||0
5146385|NCT01331083|12658653|P1|NOT COMPLETED|Overall Study||0
5146386|NCT01331083|12658652|P2|COMPLETED|Overall Study||25
5146387|NCT01331083|12658653|P1|COMPLETED|Overall Study||43
5146388|NCT01331083|12658652|P2|STARTED|Overall Study||25
5146389|NCT01331083|12658653|P1|STARTED|Overall Study||43
5146390|NCT01331005|12658667|P2|NOT COMPLETED|Overall Study||4
5146391|NCT01331005|12658668|P1|NOT COMPLETED|Overall Study||4
5146392|NCT01331005|12658667|P2|COMPLETED|Overall Study||57
5146393|NCT01331005|12658668|P1|COMPLETED|Overall Study||60
5146394|NCT01331005|12658667|P2|STARTED|Overall Study||61
5146395|NCT01331005|12658668|P1|STARTED|Overall Study||64
5146396|NCT01330966|12658678|P1|NOT COMPLETED|Overall Study||5
5146397|NCT01330966|12658678|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
5146398|NCT01330966|12658678|P1|STARTED|Overall Study||47
5146399|NCT01330953|12658689|P5|NOT COMPLETED|Overall Study||0
5146400|NCT01330953|12658690|P4|NOT COMPLETED|Overall Study||0
5146401|NCT01330953|12658691|P3|NOT COMPLETED|Overall Study||0
5146402|NCT01330953|12658692|P2|NOT COMPLETED|Overall Study||0
5146403|NCT01330953|12658693|P1|NOT COMPLETED|Overall Study||0
5146404|NCT01330953|12658689|P5|COMPLETED|Overall Study||6
5146405|NCT01330953|12658690|P4|COMPLETED|Overall Study||6
5146406|NCT01330953|12658691|P3|COMPLETED|Overall Study||6
5146407|NCT01330953|12658692|P2|COMPLETED|Overall Study||6
5146408|NCT01330953|12658693|P1|COMPLETED|Overall Study||8
5146409|NCT01330953|12658689|P5|STARTED|Overall Study||6
5146410|NCT01330953|12658690|P4|STARTED|Overall Study||6
5146411|NCT01330953|12658691|P3|STARTED|Overall Study||6
5146412|NCT01330953|12658692|P2|STARTED|Overall Study||6
5146413|NCT01330953|12658693|P1|STARTED|Overall Study||8
5146414|NCT01330914|12658739|P1|NOT COMPLETED|Overall Study||7
5146415|NCT01330914|12658739|P1|COMPLETED|Overall Study||48
5146416|NCT01330914|12658739|P1|STARTED|Overall Study||55
5146417|NCT01330628|12658747|P2|NOT COMPLETED|Overall Study||40
5146418|NCT01330628|12658748|P1|NOT COMPLETED|Overall Study||70
5146419|NCT01330628|12658747|P2|COMPLETED|Overall Study||42
5146420|NCT01330628|12658748|P1|COMPLETED|Overall Study||100
5146421|NCT01330628|12658747|P2|6 Month Follow-up|Overall Study||60
5146422|NCT01330628|12658748|P1|6 Month Follow-up|Overall Study||135
5146423|NCT01330628|12658747|P2|30 Day Follow-up|Overall Study||73
5146424|NCT01330628|12658748|P1|30 Day Follow-up|Overall Study||165
5146425|NCT01330628|12658747|P2|STARTED|Overall Study||82
5146426|NCT01330628|12658748|P1|STARTED|Overall Study||170
5146427|NCT01330459|12658758|P2|NOT COMPLETED|Overall Study||2
5146428|NCT01330459|12658759|P1|NOT COMPLETED|Overall Study||0
5146429|NCT01330459|12658758|P2|COMPLETED|Overall Study||58
5146430|NCT01330459|12658759|P1|COMPLETED|Overall Study||61
5146431|NCT01330459|12658758|P2|STARTED|Overall Study||60
5146432|NCT01330459|12658759|P1|STARTED|Overall Study||61
5146433|NCT01330433|12658775|P2|NOT COMPLETED|Overall Study||3
5146434|NCT01330433|12658776|P1|NOT COMPLETED|Overall Study||2
5146435|NCT01330433|12658775|P2|COMPLETED|Overall Study||16
5146436|NCT01330433|12658776|P1|COMPLETED|Overall Study||14
5146437|NCT01330433|12658775|P2|STARTED|Overall Study||19
5146438|NCT01330433|12658776|P1|STARTED|Overall Study||16
5146439|NCT01330420|12658796|P1|NOT COMPLETED|Overall Study||4
5146440|NCT01330420|12658796|P1|COMPLETED|Overall Study||24
5146441|NCT01330420|12658796|P1|STARTED|Overall Study||28
5146442|NCT01330394|12658806|P2|NOT COMPLETED|Overall Study||0
5146443|NCT01330394|12658807|P1|NOT COMPLETED|Overall Study||0
5146444|NCT01330394|12658806|P2|COMPLETED|Overall Study||16
5146445|NCT01330394|12658807|P1|COMPLETED|Overall Study||17
5146446|NCT01330394|12658806|P2|STARTED|Overall Study||16
5146447|NCT01330394|12658807|P1|STARTED|Overall Study||17
5146448|NCT01330381|12658815|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
5146449|NCT01330381|12658816|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
5146450|NCT01330381|12658817|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
5146451|NCT01330381|12658815|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
5146452|NCT01330381|12658816|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
5146453|NCT01330381|12658817|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
5146454|NCT01330381|12658815|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
5146455|NCT01330381|12658816|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
5146456|NCT01330381|12658817|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
5146457|NCT01330381|12658815|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
5146458|NCT01330381|12658816|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
5146459|NCT01330381|12658817|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
5146460|NCT01330381|12658815|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
5146461|NCT01330381|12658816|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
5146462|NCT01330381|12658817|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
5146463|NCT01330381|12658815|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
5146464|NCT01330381|12658816|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
5146465|NCT01330381|12658817|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
5146466|NCT01330381|12658815|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
5146467|NCT01330381|12658816|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
5146468|NCT01330381|12658817|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
5146469|NCT01330355|12658863|P2|NOT COMPLETED|Overall Study||0
5146470|NCT01330355|12658864|P1|NOT COMPLETED|Overall Study||0
5146471|NCT01330355|12658863|P2|COMPLETED|Overall Study||17
5146472|NCT01330355|12658864|P1|COMPLETED|Overall Study||16
5146473|NCT01330355|12658863|P2|STARTED|Overall Study||17
5146474|NCT01330355|12658864|P1|STARTED|Overall Study||16
5146475|NCT01330316|12658878|P2|NOT COMPLETED|Overall Study||15
5146476|NCT01330316|12658879|P1|NOT COMPLETED|Overall Study||2
5146477|NCT01330316|12658878|P2|COMPLETED|Overall Study||60
5146478|NCT01330316|12658879|P1|COMPLETED|Overall Study||41
5146479|NCT01330316|12658878|P2|STARTED|Overall Study||75
5146480|NCT01330316|12658879|P1|STARTED|Overall Study||43
5146481|NCT01330303|12658915|P2|NOT COMPLETED|Period 2||0
5146482|NCT01330303|12658916|P1|NOT COMPLETED|Period 2||0
5146483|NCT01330303|12658915|P2|COMPLETED|Period 2||18
5146484|NCT01330303|12658916|P1|COMPLETED|Period 2||19
5146485|NCT01330303|12658915|P2|STARTED|Period 2||18
5146486|NCT01330303|12658916|P1|STARTED|Period 2||19
5146487|NCT01330303|12658915|P2|NOT COMPLETED|7-Day Washout Period||0
5146488|NCT01330303|12658916|P1|NOT COMPLETED|7-Day Washout Period||0
5146489|NCT01330303|12658915|P2|COMPLETED|7-Day Washout Period||18
5146490|NCT01330303|12658916|P1|COMPLETED|7-Day Washout Period||19
5146491|NCT01330303|12658915|P2|STARTED|7-Day Washout Period||18
5146492|NCT01330303|12658916|P1|STARTED|7-Day Washout Period||19
5146493|NCT01330303|12658915|P2|NOT COMPLETED|Period 1||2
5146494|NCT01330303|12658916|P1|NOT COMPLETED|Period 1||1
5146495|NCT01330303|12658915|P2|COMPLETED|Period 1||18
5146496|NCT01330303|12658916|P1|COMPLETED|Period 1||19
5146497|NCT01330303|12658915|P2|STARTED|Period 1||20
5146498|NCT01330303|12658916|P1|STARTED|Period 1||20
5146499|NCT01330290|12658926|P1|NOT COMPLETED|Overall Study||0
5146500|NCT01330290|12658926|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
5146501|NCT01330290|12658926|P1|STARTED|Overall Study||148
5146502|NCT01330134|12658952|P2|NOT COMPLETED|Overall Study||0
5146503|NCT01330134|12658953|P1|NOT COMPLETED|Overall Study||0
5146504|NCT01330134|12658952|P2|COMPLETED|Overall Study||237
5146505|NCT01330134|12658953|P1|COMPLETED|Overall Study||244
5146506|NCT01330134|12658952|P2|STARTED|Overall Study||237
5146507|NCT01330134|12658953|P1|STARTED|Overall Study||244
5146508|NCT01330108|12658963|P1|NOT COMPLETED|Overall Study||4
5146509|NCT01330108|12658963|P1|COMPLETED|Overall Study||28
5146510|NCT01330108|12658963|P1|STARTED|Overall Study||32
5146511|NCT01330043|12658970|P2|NOT COMPLETED|Overall Study||4
5146512|NCT01330043|12658971|P1|NOT COMPLETED|Overall Study||0
5146513|NCT01330043|12658970|P2|COMPLETED|Overall Study||108
5146514|NCT01330043|12658971|P1|COMPLETED|Overall Study||111
5146515|NCT01330043|12658970|P2|STARTED|Overall Study||112
5146516|NCT01330043|12658971|P1|STARTED|Overall Study||111
5146517|NCT01330030|12658981|P2|NOT COMPLETED|Overall Study||17
5146518|NCT01330030|12658982|P1|NOT COMPLETED|Overall Study||16
5146519|NCT01330030|12658981|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
5146520|NCT01330030|12658982|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
5146521|NCT01330030|12658981|P2|STARTED|Overall Study||122
5146522|NCT01330030|12658982|P1|STARTED|Overall Study||121
5146523|NCT01330017|12658993|P5|NOT COMPLETED|Overall Study||3
5146524|NCT01330017|12658994|P4|NOT COMPLETED|Overall Study||12
5146525|NCT01330017|12658995|P3|NOT COMPLETED|Overall Study||8
5146526|NCT01330017|12658996|P2|NOT COMPLETED|Overall Study||4
5146527|NCT01330017|12658997|P1|NOT COMPLETED|Overall Study||5
5146528|NCT01330017|12658993|P5|COMPLETED|Overall Study||100
5146529|NCT01330017|12658994|P4|COMPLETED|Overall Study||100
5146530|NCT01330017|12658995|P3|COMPLETED|Overall Study||99
5146531|NCT01330017|12658996|P2|COMPLETED|Overall Study||104
5146532|NCT01330017|12658997|P1|COMPLETED|Overall Study||104
5146533|NCT01330017|12658993|P5|STARTED|Overall Study||103
5146534|NCT01330017|12658994|P4|STARTED|Overall Study||112
5146535|NCT01330017|12658995|P3|STARTED|Overall Study||107
5146536|NCT01330017|12658996|P2|STARTED|Overall Study||108
5146537|NCT01330017|12658997|P1|STARTED|Overall Study||109
5146538|NCT01329978|12659046|P5|NOT COMPLETED|Rerandomization Treatment Period||4
5146539|NCT01329978|12659047|P4|NOT COMPLETED|Rerandomization Treatment Period||5
5146540|NCT01329978|12659048|P3|NOT COMPLETED|Rerandomization Treatment Period||0
5146541|NCT01329978|12659049|P2|NOT COMPLETED|Rerandomization Treatment Period||0
5146542|NCT01329978|12659050|P1|NOT COMPLETED|Rerandomization Treatment Period||0
5146543|NCT01329978|12659046|P5|COMPLETED|Rerandomization Treatment Period||71
5146544|NCT01329978|12659047|P4|COMPLETED|Rerandomization Treatment Period||70
5146545|NCT01329978|12659048|P3|COMPLETED|Rerandomization Treatment Period||0
5146546|NCT01329978|12659049|P2|COMPLETED|Rerandomization Treatment Period||0
5146547|NCT01329978|12659050|P1|COMPLETED|Rerandomization Treatment Period||0
5146548|NCT01329978|12659046|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
5146549|NCT01329978|12659047|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
5146550|NCT01329978|12659048|P3|STARTED|Rerandomization Treatment Period||0
5146551|NCT01329978|12659049|P2|STARTED|Rerandomization Treatment Period||0
5146552|NCT01329978|12659050|P1|STARTED|Rerandomization Treatment Period||0
5146553|NCT01329978|12659046|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
5146554|NCT01329978|12659047|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
5146555|NCT01329978|12659048|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
5146556|NCT01329978|12659049|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
5146557|NCT01329978|12659050|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
5146558|NCT01329978|12659046|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
5146559|NCT01329978|12659047|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
5146560|NCT01329978|12659048|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
5146561|NCT01329978|12659049|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
5146562|NCT01329978|12659050|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
5146563|NCT01329978|12659046|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
5146564|NCT01329978|12659047|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
5146565|NCT01329978|12659048|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
5146566|NCT01329978|12659049|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
5146567|NCT01329978|12659050|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
5146568|NCT01329939|12659124|P4|NOT COMPLETED|Overall Study||5
5146569|NCT01329939|12659125|P3|NOT COMPLETED|Overall Study||1
5146570|NCT01329939|12659126|P2|NOT COMPLETED|Overall Study||1
5146571|NCT01329939|12659127|P1|NOT COMPLETED|Overall Study||3
5146572|NCT01329939|12659124|P4|COMPLETED|Overall Study||4
5146573|NCT01329939|12659125|P3|COMPLETED|Overall Study||4
5146574|NCT01329939|12659126|P2|COMPLETED|Overall Study||4
5146575|NCT01329939|12659127|P1|COMPLETED|Overall Study||4
5146576|NCT01329939|12659124|P4|STARTED|Overall Study||9
5146577|NCT01329939|12659125|P3|STARTED|Overall Study||5
5146578|NCT01329939|12659126|P2|STARTED|Overall Study||5
5146579|NCT01329939|12659127|P1|STARTED|Overall Study||7
5146580|NCT01329900|12659165|P1|NOT COMPLETED|Overall Study||1
5146581|NCT01329900|12659165|P1|COMPLETED|Overall Study||49
5146582|NCT01329900|12659165|P1|STARTED|Overall Study||50
5146583|NCT01329848|12659169|P1|NOT COMPLETED|Overall Study||29
5146584|NCT01329848|12659169|P1|COMPLETED|Overall Study||54
5146585|NCT01329848|12659169|P1|STARTED|Overall Study||83
5146586|NCT01329679|12659174|P2|NOT COMPLETED|Overall Study||0
5146587|NCT01329679|12659175|P1|NOT COMPLETED|Overall Study||0
5146588|NCT01329679|12659174|P2|COMPLETED|Overall Study||13
5146589|NCT01329679|12659175|P1|COMPLETED|Overall Study||13
5146590|NCT01329679|12659174|P2|STARTED|Overall Study||13
5146591|NCT01329679|12659175|P1|STARTED|Overall Study||13
5146592|NCT01329562|12659195|P2|NOT COMPLETED|Overall Study||7
5146593|NCT01329562|12659196|P1|NOT COMPLETED|Overall Study||9
5146594|NCT01329562|12659195|P2|COMPLETED|Overall Study||14
5146595|NCT01329562|12659196|P1|COMPLETED|Overall Study||11
5146596|NCT01329562|12659195|P2|STARTED|Overall Study||21
5146597|NCT01329562|12659196|P1|STARTED|Overall Study||20
5146598|NCT01329549|12659245|P1|NOT COMPLETED|Overall Study||2
5146599|NCT01329549|12659245|P1|COMPLETED|Overall Study||0
5146600|NCT01329549|12659245|P1|STARTED|Overall Study||2
5146601|NCT01329419|12659256|P1|NOT COMPLETED|Overall Study||235
5146602|NCT01329419|12659256|P1|COMPLETED|Overall Study||4158
5146603|NCT01329419|12659256|P1|STARTED|Overall Study||4393
5146604|NCT01329380|12659262|P1|NOT COMPLETED|Overall Study||29
5146605|NCT01329380|12659262|P1|COMPLETED|Overall Study||374
5146606|NCT01329380|12659262|P1|Safety Population|Overall Study||396
5146607|NCT01329380|12659262|P1|STARTED|Overall Study||403
5146608|NCT01329263|12659274|P2|NOT COMPLETED|Overall Study||23
5146609|NCT01329263|12659275|P1|NOT COMPLETED|Overall Study||5
5146610|NCT01329263|12659274|P2|COMPLETED|Overall Study||22
5146611|NCT01329263|12659275|P1|COMPLETED|Overall Study||10
5146612|NCT01329263|12659274|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
5146613|NCT01329263|12659275|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
5146614|NCT01329263|12659274|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
5146615|NCT01329263|12659275|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
5146616|NCT01329263|12659274|P2|Completed Period 1 Own Menthol|Overall Study||45
5146617|NCT01329263|12659275|P1|Completed Period 1 Own Menthol|Overall Study||15
5146618|NCT01329263|12659274|P2|STARTED|Overall Study||45
5146619|NCT01329263|12659275|P1|STARTED|Overall Study||15
5146620|NCT01329198|12659289|P2|NOT COMPLETED|Overall Study||0
5146621|NCT01329198|12659290|P1|NOT COMPLETED|Overall Study||0
5146622|NCT01329198|12659289|P2|COMPLETED|Overall Study||2
5146623|NCT01329198|12659290|P1|COMPLETED|Overall Study||3
5146624|NCT01329198|12659289|P2|STARTED|Overall Study||2
5146625|NCT01329198|12659290|P1|STARTED|Overall Study||3
5146626|NCT01329185|12659303|P2|NOT COMPLETED|Overall Study||0
5146627|NCT01329185|12659304|P1|NOT COMPLETED|Overall Study||0
5146628|NCT01329185|12659303|P2|COMPLETED|Overall Study||7
5146629|NCT01329185|12659304|P1|COMPLETED|Overall Study||10
5146630|NCT01329185|12659303|P2|PTLD|Overall Study||0
5146631|NCT01329185|12659304|P1|PTLD|Overall Study||1
5146632|NCT01329185|12659303|P2|CMV Disease|Overall Study||0
5146633|NCT01329185|12659304|P1|CMV Disease|Overall Study||1
5146634|NCT01329185|12659303|P2|STARTED|Overall Study||7
5146635|NCT01329185|12659304|P1|STARTED|Overall Study||10
5146636|NCT01329029|12659312|P2|NOT COMPLETED|Overall Study||192
5146637|NCT01329029|12659313|P1|NOT COMPLETED|Overall Study||269
5146638|NCT01329029|12659312|P2|COMPLETED|Overall Study||780
5146639|NCT01329029|12659313|P1|COMPLETED|Overall Study||704
5146640|NCT01329029|12659312|P2|Safety Population|Overall Study||967
5146641|NCT01329029|12659313|P1|Safety Population|Overall Study||968
5146642|NCT01329029|12659312|P2|Full Analysis Set (FAS)|Overall Study||966
5146643|NCT01329029|12659313|P1|Full Analysis Set (FAS)|Overall Study||969
5146644|NCT01329029|12659312|P2|STARTED|Overall Study||972
5146645|NCT01329029|12659313|P1|STARTED|Overall Study||973
5146646|NCT01328964|12659386|P3|NOT COMPLETED|Overall Study||0
5146647|NCT01328964|12659387|P2|NOT COMPLETED|Overall Study||0
5146648|NCT01328964|12659388|P1|NOT COMPLETED|Overall Study||0
5146649|NCT01328964|12659386|P3|COMPLETED|Overall Study||4424
5146650|NCT01328964|12659387|P2|COMPLETED|Overall Study||3270
5146651|NCT01328964|12659388|P1|COMPLETED|Overall Study||2212
5146652|NCT01328964|12659386|P3|STARTED|Overall Study||4424
5146653|NCT01328964|12659387|P2|STARTED|Overall Study||3270
5146654|NCT01328964|12659388|P1|STARTED|Overall Study||2212
5146655|NCT01328951|12659403|P2|NOT COMPLETED|Overall Study||322
5146656|NCT01328951|12659404|P1|NOT COMPLETED|Overall Study||321
5146657|NCT01328951|12659403|P2|COMPLETED|Overall Study||0
5146658|NCT01328951|12659404|P1|COMPLETED|Overall Study||0
5146659|NCT01328951|12659403|P2|STARTED|Overall Study||322
5146660|NCT01328951|12659404|P1|STARTED|Overall Study||321
5146661|NCT01328873|12659428|P1|NOT COMPLETED|Overall Study||0
5146662|NCT01328873|12659428|P1|COMPLETED|Overall Study||49
5146663|NCT01328873|12659428|P1|STARTED|Overall Study||49
5146664|NCT01328782|12659440|P3|NOT COMPLETED|Overall Study||0
5146665|NCT01328782|12659441|P2|NOT COMPLETED|Overall Study||0
5146666|NCT01328782|12659442|P1|NOT COMPLETED|Overall Study||0
5146667|NCT01328782|12659440|P3|COMPLETED|Overall Study||39
5146668|NCT01328782|12659441|P2|COMPLETED|Overall Study||42
5146669|NCT01328782|12659442|P1|COMPLETED|Overall Study||43
5146670|NCT01328782|12659440|P3|STARTED|Overall Study||39
5146671|NCT01328782|12659441|P2|STARTED|Overall Study||42
5146672|NCT01328782|12659442|P1|STARTED|Overall Study||43
5146673|NCT01328769|12659464|P2|NOT COMPLETED|Overall Study||1
5146674|NCT01328769|12659465|P1|NOT COMPLETED|Overall Study||0
5146675|NCT01328769|12659464|P2|COMPLETED|Overall Study||23
5146676|NCT01328769|12659465|P1|COMPLETED|Overall Study||25
5146677|NCT01328769|12659464|P2|STARTED|Overall Study||24
5146678|NCT01328769|12659465|P1|STARTED|Overall Study||25
5146679|NCT01328756|12659473|P1|NOT COMPLETED|Overall Study||123
5146680|NCT01328756|12659473|P1|COMPLETED|Overall Study||191
5146681|NCT01328756|12659473|P1|STARTED|Overall Study||314
5146682|NCT01328743|12659492|P2|NOT COMPLETED|Overall Study||10
5146683|NCT01328743|12659493|P1|NOT COMPLETED|Overall Study||9
5146684|NCT01328743|12659492|P2|COMPLETED|Overall Study||79
5146685|NCT01328743|12659493|P1|COMPLETED|Overall Study||82
5146686|NCT01328743|12659492|P2|STARTED|Overall Study||89
5146687|NCT01328743|12659493|P1|STARTED|Overall Study||91
5146688|NCT01328717|12659509|P1|NOT COMPLETED|Overall Study||1
5146689|NCT01328717|12659509|P1|COMPLETED|Overall Study||77
5146690|NCT01328717|12659509|P1|STARTED|Overall Study||78
5146691|NCT01328587|12659514|P1|NOT COMPLETED|Overall Study||0
5146692|NCT01328587|12659514|P1|COMPLETED|Overall Study||34
5146693|NCT01328587|12659514|P1|STARTED|Overall Study||34
5146694|NCT01328574|12659518|P1|NOT COMPLETED|Overall Study||1
5146695|NCT01328574|12659518|P1|COMPLETED|Overall Study||12
5146696|NCT01328574|12659518|P1|STARTED|Overall Study||13
5146697|NCT01328548|12659532|P2|NOT COMPLETED|Overall Study||0
5146698|NCT01328548|12659533|P1|NOT COMPLETED|Overall Study||4
5146699|NCT01328548|12659532|P2|COMPLETED|Overall Study||50
5146700|NCT01328548|12659533|P1|COMPLETED|Overall Study||187
5146701|NCT01328548|12659532|P2|STARTED|Overall Study||50
5146702|NCT01328548|12659533|P1|STARTED|Overall Study||191
5146703|NCT01328535|12659551|P1|NOT COMPLETED|Overall Study||1
5146704|NCT01328535|12659551|P1|COMPLETED|Overall Study||24
5146705|NCT01328535|12659551|P1|STARTED|Overall Study||25
5146706|NCT01328496|12659562|P2|NOT COMPLETED|Overall Study||0
5146707|NCT01328496|12659563|P1|NOT COMPLETED|Overall Study||1
5146708|NCT01328496|12659562|P2|COMPLETED|Overall Study||4
5146709|NCT01328496|12659563|P1|COMPLETED|Overall Study||9
5146710|NCT01328496|12659562|P2|STARTED|Overall Study||4
5146711|NCT01328496|12659563|P1|STARTED|Overall Study||10
5146712|NCT01328444|12659581|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
5146713|NCT01328444|12659582|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
5146714|NCT01328444|12659583|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
5146715|NCT01328444|12659584|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
5146716|NCT01328444|12659585|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
5146717|NCT01328444|12659586|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
5146718|NCT01328444|12659581|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
5146719|NCT01328444|12659582|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
5146720|NCT01328444|12659583|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
5146721|NCT01328444|12659584|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
5146722|NCT01328444|12659585|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
5146723|NCT01328444|12659586|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
5146724|NCT01328444|12659581|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
5146725|NCT01328444|12659582|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
5146726|NCT01328444|12659583|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
5146727|NCT01328444|12659584|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
5146728|NCT01328444|12659585|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
5146729|NCT01328444|12659586|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
5146730|NCT01328444|12659581|P6|NOT COMPLETED|Washout Period (14 Days)||4
5146731|NCT01328444|12659582|P5|NOT COMPLETED|Washout Period (14 Days)||1
5146732|NCT01328444|12659583|P4|NOT COMPLETED|Washout Period (14 Days)||1
5146733|NCT01328444|12659584|P3|NOT COMPLETED|Washout Period (14 Days)||0
5146734|NCT01328444|12659585|P2|NOT COMPLETED|Washout Period (14 Days)||1
5146735|NCT01328444|12659586|P1|NOT COMPLETED|Washout Period (14 Days)||1
5146736|NCT01328444|12659581|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
5146737|NCT01328444|12659582|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
5146738|NCT01328444|12659583|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
5146739|NCT01328444|12659584|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
5146740|NCT01328444|12659585|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
5146741|NCT01328444|12659586|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
5146742|NCT01328444|12659581|P6|STARTED|Washout Period (14 Days)||72
5146743|NCT01328444|12659582|P5|STARTED|Washout Period (14 Days)||67
5146744|NCT01328444|12659583|P4|STARTED|Washout Period (14 Days)||33
5146745|NCT01328444|12659584|P3|STARTED|Washout Period (14 Days)||25
5146746|NCT01328444|12659585|P2|STARTED|Washout Period (14 Days)||21
5146747|NCT01328444|12659586|P1|STARTED|Washout Period (14 Days)||83
5146748|NCT01328444|12659581|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
5146749|NCT01328444|12659582|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
5146750|NCT01328444|12659583|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
5146751|NCT01328444|12659584|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
5146752|NCT01328444|12659585|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
5146753|NCT01328444|12659586|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
5146754|NCT01328444|12659581|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
5146755|NCT01328444|12659582|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
5146756|NCT01328444|12659583|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
5146757|NCT01328444|12659584|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
5146758|NCT01328444|12659585|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
5146759|NCT01328444|12659586|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
5146760|NCT01328444|12659581|P6|STARTED|Treatment Period 1 (12 Weeks)||78
5146761|NCT01328444|12659582|P5|STARTED|Treatment Period 1 (12 Weeks)||81
5146762|NCT01328444|12659583|P4|STARTED|Treatment Period 1 (12 Weeks)||41
5146763|NCT01328444|12659584|P3|STARTED|Treatment Period 1 (12 Weeks)||28
5146764|NCT01328444|12659585|P2|STARTED|Treatment Period 1 (12 Weeks)||26
5146765|NCT01328444|12659586|P1|STARTED|Treatment Period 1 (12 Weeks)||94
5146766|NCT01328431|12659632|P2|NOT COMPLETED|12 Month (12M)||97
5146767|NCT01328431|12659633|P1|NOT COMPLETED|12 Month (12M)||84
5146768|NCT01328431|12659632|P2|COMPLETED|12 Month (12M)||289
5146769|NCT01328431|12659633|P1|COMPLETED|12 Month (12M)||304
5146770|NCT01328431|12659632|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
5146771|NCT01328431|12659633|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
5146772|NCT01328431|12659632|P2|NOT COMPLETED|3 Month (3M)||72
5146773|NCT01328431|12659633|P1|NOT COMPLETED|3 Month (3M)||77
5146774|NCT01328431|12659632|P2|COMPLETED|3 Month (3M)||316
5146775|NCT01328431|12659633|P1|COMPLETED|3 Month (3M)||313
5146776|NCT01328431|12659632|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
5146777|NCT01328431|12659633|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
5146778|NCT01328431|12659632|P2|NOT COMPLETED|1 Month (1M)||58
5146779|NCT01328431|12659633|P1|NOT COMPLETED|1 Month (1M)||55
5146780|NCT01328431|12659632|P2|COMPLETED|1 Month (1M)||330
5146781|NCT01328431|12659633|P1|COMPLETED|1 Month (1M)||335
5146782|NCT01328431|12659632|P2|STARTED|1 Month (1M)||388
5146783|NCT01328431|12659633|P1|STARTED|1 Month (1M)||390
5146784|NCT01328431|12659632|P2|NOT COMPLETED|Baseline||2
5146785|NCT01328431|12659633|P1|NOT COMPLETED|Baseline||0
5146786|NCT01328431|12659632|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
5146787|NCT01328431|12659633|P1|COMPLETED|Baseline||390
5146788|NCT01328431|12659632|P2|STARTED|Baseline||390
5146789|NCT01328431|12659633|P1|STARTED|Baseline||390
5146790|NCT01328405|12659643|P2|NOT COMPLETED|Overall Study||0
5146791|NCT01328405|12659644|P1|NOT COMPLETED|Overall Study||0
5146792|NCT01328405|12659643|P2|COMPLETED|Overall Study||48
5146793|NCT01328405|12659644|P1|COMPLETED|Overall Study||52
5146794|NCT01328405|12659643|P2|STARTED|Overall Study||48
5146795|NCT01328405|12659644|P1|STARTED|Overall Study||52
5146796|NCT01328379|12659661|P3|NOT COMPLETED|Overall Study||0
5146797|NCT01328379|12659662|P2|NOT COMPLETED|Overall Study||0
5146798|NCT01328379|12659663|P1|NOT COMPLETED|Overall Study||1
5146799|NCT01328379|12659661|P3|COMPLETED|Overall Study||143
5146800|NCT01328379|12659662|P2|COMPLETED|Overall Study||144
5146801|NCT01328379|12659663|P1|COMPLETED|Overall Study||142
5146802|NCT01328379|12659661|P3|STARTED|Overall Study||143
5146803|NCT01328379|12659662|P2|STARTED|Overall Study||144
5146804|NCT01328379|12659663|P1|STARTED|Overall Study||143
5146805|NCT01328366|12659689|P1|NOT COMPLETED|Overall Study||10
5146806|NCT01328366|12659689|P1|COMPLETED|Overall Study||143
5146807|NCT01328366|12659689|P1|STARTED|Overall Study||153
5146808|NCT01328249|12659709|P2|NOT COMPLETED|Overall Study||3
5146809|NCT01328249|12659710|P1|NOT COMPLETED|Overall Study||7
5146810|NCT01328249|12659709|P2|COMPLETED|Overall Study||23
5146811|NCT01328249|12659710|P1|COMPLETED|Overall Study||48
5146812|NCT01328249|12659709|P2|STARTED|Overall Study||26
5146813|NCT01328249|12659710|P1|STARTED|Overall Study||55
5146814|NCT01328184|12659718|P1|NOT COMPLETED|Overall Study||0
5146815|NCT01328184|12659718|P1|COMPLETED|Overall Study||18
5146816|NCT01328184|12659718|P1|STARTED|Overall Study||18
5146817|NCT01328158|12659758|P1|NOT COMPLETED|Overall Study||0
5146818|NCT01328158|12659758|P1|COMPLETED|Overall Study||220
5146819|NCT01328158|12659758|P1|STARTED|Overall Study||220
5146820|NCT01328080|12659796|P1|NOT COMPLETED|Overall Study||5
5146821|NCT01328080|12659796|P1|COMPLETED|Overall Study||6
5146822|NCT01328080|12659796|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
5146823|NCT01328054|12659800|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
5146824|NCT01328054|12659801|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
5146825|NCT01328054|12659800|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
5146826|NCT01328054|12659801|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
5146827|NCT01328054|12659800|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
5146828|NCT01328054|12659801|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
5146829|NCT01328054|12659800|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
5146830|NCT01328054|12659801|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
5146831|NCT01328054|12659800|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
5146832|NCT01328054|12659801|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
5146833|NCT01328054|12659800|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
5146834|NCT01328054|12659801|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
5146835|NCT01328041|12659826|P1|NOT COMPLETED|Overall Study||57
5146836|NCT01328041|12659826|P1|COMPLETED|Overall Study||126
5146837|NCT01328041|12659826|P1|STARTED|Overall Study||183
5146838|NCT01328002|12659848|P2|NOT COMPLETED|Double-Blind Period||0
5146839|NCT01328002|12659849|P1|NOT COMPLETED|Double-Blind Period||2
5146840|NCT01328002|12659848|P2|COMPLETED|Double-Blind Period||6
5146841|NCT01328002|12659849|P1|COMPLETED|Double-Blind Period||12
5146842|NCT01328002|12659848|P2|STARTED|Double-Blind Period||6
5146843|NCT01328002|12659849|P1|STARTED|Double-Blind Period||14
5146844|NCT01328002|12659848|P2|NOT COMPLETED|Open-Label Period||0
5146845|NCT01328002|12659849|P1|NOT COMPLETED|Open-Label Period||96
5146846|NCT01328002|12659848|P2|COMPLETED|Open-Label Period||0
5146847|NCT01328002|12659849|P1|COMPLETED|Open-Label Period||20
5146848|NCT01328002|12659848|P2|STARTED|Open-Label Period||0
5146849|NCT01328002|12659849|P1|STARTED|Open-Label Period||116
5146850|NCT01327989|12659858|P1|NOT COMPLETED|Overall Study||14
5146851|NCT01327989|12659858|P1|COMPLETED|Overall Study||188
5146852|NCT01327989|12659858|P1|STARTED|Overall Study||202
5146853|NCT01327976|12659872|P2|NOT COMPLETED|Overall Study||7
5146854|NCT01327976|12659873|P1|NOT COMPLETED|Overall Study||8
5146855|NCT01327976|12659872|P2|COMPLETED|Overall Study||70
5146856|NCT01327976|12659873|P1|COMPLETED|Overall Study||154
5146857|NCT01327976|12659872|P2|STARTED|Overall Study||77
5146858|NCT01327976|12659873|P1|STARTED|Overall Study||162
5146859|NCT01327885|12659885|P2|NOT COMPLETED|Overall Study||224
5146860|NCT01327885|12659886|P1|NOT COMPLETED|Overall Study||228
5146861|NCT01327885|12659885|P2|COMPLETED|Overall Study||0
5146862|NCT01327885|12659886|P1|COMPLETED|Overall Study||0
5146863|NCT01327885|12659885|P2|STARTED|Overall Study||224
5146864|NCT01327885|12659886|P1|STARTED|Overall Study||228
5146865|NCT01327846|12659902|P4|NOT COMPLETED|Extension Phase||1706
5146866|NCT01327846|12659903|P3|NOT COMPLETED|Extension Phase||1092
5146867|NCT01327846|12659904|P2|NOT COMPLETED|Extension Phase||1144
5146868|NCT01327846|12659905|P1|NOT COMPLETED|Extension Phase||1099
5146869|NCT01327846|12659902|P4|COMPLETED|Extension Phase||238
5146870|NCT01327846|12659903|P3|COMPLETED|Extension Phase||187
5146871|NCT01327846|12659904|P2|COMPLETED|Extension Phase||143
5146872|NCT01327846|12659905|P1|COMPLETED|Extension Phase||168
5146873|NCT01327846|12659902|P4|Details Missing|Extension Phase||0
5146874|NCT01327846|12659903|P3|Details Missing|Extension Phase||1
5146875|NCT01327846|12659904|P2|Details Missing|Extension Phase||1
5146876|NCT01327846|12659905|P1|Details Missing|Extension Phase||0
5146877|NCT01327846|12659902|P4|Completed Treatment Period|Extension Phase||60
5146878|NCT01327846|12659903|P3|Completed Treatment Period|Extension Phase||49
5146879|NCT01327846|12659904|P2|Completed Treatment Period|Extension Phase||45
5146880|NCT01327846|12659905|P1|Completed Treatment Period|Extension Phase||41
5146881|NCT01327846|12659902|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
5146882|NCT01327846|12659903|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
5146883|NCT01327846|12659904|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
5146884|NCT01327846|12659905|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
5146885|NCT01327846|12659902|P4|STARTED|Extension Phase||1944
5146886|NCT01327846|12659903|P3|STARTED|Extension Phase||1279
5146887|NCT01327846|12659904|P2|STARTED|Extension Phase||1287
5146888|NCT01327846|12659905|P1|STARTED|Extension Phase||1267
5146889|NCT01327846|12659902|P4|NOT COMPLETED|Core Phase||33
5146890|NCT01327846|12659903|P3|NOT COMPLETED|Core Phase||26
5146891|NCT01327846|12659904|P2|NOT COMPLETED|Core Phase||32
5146892|NCT01327846|12659905|P1|NOT COMPLETED|Core Phase||28
5146893|NCT01327846|12659902|P4|COMPLETED|Core Phase||3311
5146894|NCT01327846|12659903|P3|COMPLETED|Core Phase||2144
5146895|NCT01327846|12659904|P2|COMPLETED|Core Phase||2252
5146896|NCT01327846|12659905|P1|COMPLETED|Core Phase||2235
5146897|NCT01327846|12659902|P4|STARTED|Core Phase||3344
5146898|NCT01327846|12659903|P3|STARTED|Core Phase||2170
5146899|NCT01327846|12659904|P2|STARTED|Core Phase||2284
5146900|NCT01327846|12659905|P1|STARTED|Core Phase||2263
5146901|NCT01327703|12659980|P2|NOT COMPLETED|Second Treatment Period||2
5146902|NCT01327703|12659981|P1|NOT COMPLETED|Second Treatment Period||1
5146903|NCT01327703|12659980|P2|COMPLETED|Second Treatment Period||42
5146904|NCT01327703|12659981|P1|COMPLETED|Second Treatment Period||39
5146905|NCT01327703|12659980|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
5146906|NCT01327703|12659981|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
5146907|NCT01327703|12659980|P2|NOT COMPLETED|First Treatment Period||0
5146908|NCT01327703|12659981|P1|NOT COMPLETED|First Treatment Period||0
5146909|NCT01327703|12659980|P2|COMPLETED|First Treatment Period||45
5146910|NCT01327703|12659981|P1|COMPLETED|First Treatment Period||42
5146911|NCT01327703|12659980|P2|STARTED|First Treatment Period||45
5146912|NCT01327703|12659981|P1|STARTED|First Treatment Period||42
5146913|NCT01327677|12660015|P2|NOT COMPLETED|Overall Study||13
5146914|NCT01327677|12660016|P1|NOT COMPLETED|Overall Study||20
5146915|NCT01327677|12660015|P2|COMPLETED|Overall Study||56
5146916|NCT01327677|12660016|P1|COMPLETED|Overall Study||48
5146917|NCT01327677|12660015|P2|STARTED|Overall Study||69
5146918|NCT01327677|12660016|P1|STARTED|Overall Study||68
5146919|NCT01327651|12660037|P9|NOT COMPLETED|Post Study Follow-up||2
5146920|NCT01327651|12660038|P8|NOT COMPLETED|Post Study Follow-up||1
5146921|NCT01327651|12660039|P7|NOT COMPLETED|Post Study Follow-up||4
5146922|NCT01327651|12660040|P6|NOT COMPLETED|Post Study Follow-up||0
5146923|NCT01327651|12660041|P5|NOT COMPLETED|Post Study Follow-up||0
5146924|NCT01327651|12660042|P4|NOT COMPLETED|Post Study Follow-up||0
5146925|NCT01327651|12660043|P3|NOT COMPLETED|Post Study Follow-up||1
5146926|NCT01327651|12660044|P2|NOT COMPLETED|Post Study Follow-up||1
5146927|NCT01327651|12660045|P1|NOT COMPLETED|Post Study Follow-up||0
5146928|NCT01327651|12660037|P9|COMPLETED|Post Study Follow-up||47
5146929|NCT01327651|12660038|P8|COMPLETED|Post Study Follow-up||49
5146930|NCT01327651|12660039|P7|COMPLETED|Post Study Follow-up||45
5146931|NCT01327651|12660040|P6|COMPLETED|Post Study Follow-up||59
5146932|NCT01327651|12660041|P5|COMPLETED|Post Study Follow-up||56
5146933|NCT01327651|12660042|P4|COMPLETED|Post Study Follow-up||57
5146934|NCT01327651|12660043|P3|COMPLETED|Post Study Follow-up||55
5146935|NCT01327651|12660044|P2|COMPLETED|Post Study Follow-up||55
5146936|NCT01327651|12660045|P1|COMPLETED|Post Study Follow-up||56
5146937|NCT01327651|12660037|P9|STARTED|Post Study Follow-up||49
5146938|NCT01327651|12660038|P8|STARTED|Post Study Follow-up||50
5146939|NCT01327651|12660039|P7|STARTED|Post Study Follow-up||49
5146940|NCT01327651|12660040|P6|STARTED|Post Study Follow-up||59
5146941|NCT01327651|12660041|P5|STARTED|Post Study Follow-up||56
5146942|NCT01327651|12660042|P4|STARTED|Post Study Follow-up||57
5146943|NCT01327651|12660043|P3|STARTED|Post Study Follow-up||56
5146944|NCT01327651|12660044|P2|STARTED|Post Study Follow-up||56
5146945|NCT01327651|12660045|P1|STARTED|Post Study Follow-up||56
5146946|NCT01327651|12660037|P9|NOT COMPLETED|Self-administered Dosing Period||11
5146947|NCT01327651|12660038|P8|NOT COMPLETED|Self-administered Dosing Period||10
5146948|NCT01327651|12660039|P7|NOT COMPLETED|Self-administered Dosing Period||10
5146949|NCT01327651|12660040|P6|NOT COMPLETED|Self-administered Dosing Period||0
5146950|NCT01327651|12660041|P5|NOT COMPLETED|Self-administered Dosing Period||3
5146951|NCT01327651|12660042|P4|NOT COMPLETED|Self-administered Dosing Period||3
5146952|NCT01327651|12660043|P3|NOT COMPLETED|Self-administered Dosing Period||4
5146953|NCT01327651|12660044|P2|NOT COMPLETED|Self-administered Dosing Period||3
5146954|NCT01327651|12660045|P1|NOT COMPLETED|Self-administered Dosing Period||4
5146955|NCT01327651|12660037|P9|COMPLETED|Self-administered Dosing Period||49
5146956|NCT01327651|12660038|P8|COMPLETED|Self-administered Dosing Period||50
5146957|NCT01327651|12660039|P7|COMPLETED|Self-administered Dosing Period||49
5146958|NCT01327651|12660040|P6|COMPLETED|Self-administered Dosing Period||59
5146959|NCT01327651|12660041|P5|COMPLETED|Self-administered Dosing Period||56
5146960|NCT01327651|12660042|P4|COMPLETED|Self-administered Dosing Period||57
5146961|NCT01327651|12660043|P3|COMPLETED|Self-administered Dosing Period||56
5146962|NCT01327651|12660044|P2|COMPLETED|Self-administered Dosing Period||56
5146963|NCT01327651|12660045|P1|COMPLETED|Self-administered Dosing Period||56
5146964|NCT01327651|12660037|P9|Week 26|Self-administered Dosing Period||49
5146965|NCT01327651|12660038|P8|Week 26|Self-administered Dosing Period||51
5146966|NCT01327651|12660039|P7|Week 26|Self-administered Dosing Period||50
5146967|NCT01327651|12660040|P6|Week 26|Self-administered Dosing Period||58
5146968|NCT01327651|12660041|P5|Week 26|Self-administered Dosing Period||56
5146969|NCT01327651|12660042|P4|Week 26|Self-administered Dosing Period||57
5146970|NCT01327651|12660043|P3|Week 26|Self-administered Dosing Period||53
5146971|NCT01327651|12660044|P2|Week 26|Self-administered Dosing Period||56
5146972|NCT01327651|12660045|P1|Week 26|Self-administered Dosing Period||58
5146973|NCT01327651|12660037|P9|Week 22|Self-administered Dosing Period||51
5146974|NCT01327651|12660038|P8|Week 22|Self-administered Dosing Period||50
5146975|NCT01327651|12660039|P7|Week 22|Self-administered Dosing Period||50
5146976|NCT01327651|12660040|P6|Week 22|Self-administered Dosing Period||59
5146977|NCT01327651|12660041|P5|Week 22|Self-administered Dosing Period||56
5146978|NCT01327651|12660042|P4|Week 22|Self-administered Dosing Period||58
5146979|NCT01327651|12660043|P3|Week 22|Self-administered Dosing Period||55
5146980|NCT01327651|12660044|P2|Week 22|Self-administered Dosing Period||56
5146981|NCT01327651|12660045|P1|Week 22|Self-administered Dosing Period||59
5146982|NCT01327651|12660037|P9|Week 18|Self-administered Dosing Period||53
5146983|NCT01327651|12660038|P8|Week 18|Self-administered Dosing Period||49
5146984|NCT01327651|12660039|P7|Week 18|Self-administered Dosing Period||53
5146985|NCT01327651|12660040|P6|Week 18|Self-administered Dosing Period||59
5146986|NCT01327651|12660041|P5|Week 18|Self-administered Dosing Period||57
5146987|NCT01327651|12660042|P4|Week 18|Self-administered Dosing Period||60
5146988|NCT01327651|12660043|P3|Week 18|Self-administered Dosing Period||56
5146989|NCT01327651|12660044|P2|Week 18|Self-administered Dosing Period||56
5146990|NCT01327651|12660045|P1|Week 18|Self-administered Dosing Period||57
5146991|NCT01327651|12660037|P9|Week 14|Self-administered Dosing Period||54
5146992|NCT01327651|12660038|P8|Week 14|Self-administered Dosing Period||51
5146993|NCT01327651|12660039|P7|Week 14|Self-administered Dosing Period||54
5146994|NCT01327651|12660040|P6|Week 14|Self-administered Dosing Period||59
5146995|NCT01327651|12660041|P5|Week 14|Self-administered Dosing Period||58
5146996|NCT01327651|12660042|P4|Week 14|Self-administered Dosing Period||60
5146997|NCT01327651|12660043|P3|Week 14|Self-administered Dosing Period||57
5146998|NCT01327651|12660044|P2|Week 14|Self-administered Dosing Period||55
5146999|NCT01327651|12660045|P1|Week 14|Self-administered Dosing Period||59
5147000|NCT01327651|12660037|P9|Week 10|Self-administered Dosing Period||56
5147001|NCT01327651|12660038|P8|Week 10|Self-administered Dosing Period||57
5147002|NCT01327651|12660039|P7|Week 10|Self-administered Dosing Period||57
5147003|NCT01327651|12660040|P6|Week 10|Self-administered Dosing Period||59
5147004|NCT01327651|12660041|P5|Week 10|Self-administered Dosing Period||59
5147005|NCT01327651|12660042|P4|Week 10|Self-administered Dosing Period||60
5147006|NCT01327651|12660043|P3|Week 10|Self-administered Dosing Period||60
5147007|NCT01327651|12660044|P2|Week 10|Self-administered Dosing Period||58
5147008|NCT01327651|12660045|P1|Week 10|Self-administered Dosing Period||59
5147009|NCT01327651|12660037|P9|STARTED|Self-administered Dosing Period||60
5147010|NCT01327651|12660038|P8|STARTED|Self-administered Dosing Period||60
5147011|NCT01327651|12660039|P7|STARTED|Self-administered Dosing Period||59
5147012|NCT01327651|12660040|P6|STARTED|Self-administered Dosing Period||59
5147013|NCT01327651|12660041|P5|STARTED|Self-administered Dosing Period||59
5147014|NCT01327651|12660042|P4|STARTED|Self-administered Dosing Period||60
5147015|NCT01327651|12660043|P3|STARTED|Self-administered Dosing Period||60
5147016|NCT01327651|12660044|P2|STARTED|Self-administered Dosing Period||59
5147017|NCT01327651|12660045|P1|STARTED|Self-administered Dosing Period||60
5147018|NCT01327599|12660164|P1|NOT COMPLETED|Overall Study||3
5147019|NCT01327599|12660164|P1|COMPLETED|Overall Study||57
5147020|NCT01327599|12660164|P1|STARTED|Overall Study||60
5147021|NCT01327573|12660174|P2|NOT COMPLETED|Overall Study||1
5147022|NCT01327573|12660175|P1|NOT COMPLETED|Overall Study||3
5147023|NCT01327573|12660174|P2|COMPLETED|Overall Study||4
5147024|NCT01327573|12660175|P1|COMPLETED|Overall Study||8
5147025|NCT01327573|12660174|P2|Received Treatment/Control as Allocated|Overall Study||5
5147026|NCT01327573|12660175|P1|Received Treatment/Control as Allocated|Overall Study||10
5147027|NCT01327573|12660174|P2|STARTED|Overall Study||5
5147028|NCT01327573|12660175|P1|STARTED|Overall Study||11
5147029|NCT01327547|12660186|P2|NOT COMPLETED|Overall Study||22
5147030|NCT01327547|12660187|P1|NOT COMPLETED|Overall Study||20
5147031|NCT01327547|12660186|P2|COMPLETED|Overall Study||45
5147032|NCT01327547|12660187|P1|COMPLETED|Overall Study||50
5147033|NCT01327547|12660186|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
5147034|NCT01327547|12660187|P1|Randomized and Not Treated|Overall Study||0
5147035|NCT01327547|12660186|P2|STARTED|Overall Study||67
5147036|NCT01327547|12660187|P1|STARTED|Overall Study||70
5147037|NCT01327508|12660240|P2|NOT COMPLETED|Overall Study||0
5147038|NCT01327508|12660241|P1|NOT COMPLETED|Overall Study||0
5147039|NCT01327508|12660240|P2|COMPLETED|Overall Study||30
5147040|NCT01327508|12660241|P1|COMPLETED|Overall Study||30
5147041|NCT01327508|12660240|P2|STARTED|Overall Study||30
5147042|NCT01327508|12660241|P1|STARTED|Overall Study||30
5147043|NCT01327495|12660255|P6|NOT COMPLETED|Overall Study||2
5147044|NCT01327495|12660256|P5|NOT COMPLETED|Overall Study||3
5147045|NCT01327495|12660257|P4|NOT COMPLETED|Overall Study||0
5147046|NCT01327495|12660258|P3|NOT COMPLETED|Overall Study||2
5147047|NCT01327495|12660259|P2|NOT COMPLETED|Overall Study||2
5147048|NCT01327495|12660260|P1|NOT COMPLETED|Overall Study||2
5147049|NCT01327495|12660255|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
5147050|NCT01327495|12660256|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
5147051|NCT01327495|12660257|P4|COMPLETED|Overall Study||9
5147052|NCT01327495|12660258|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
5147053|NCT01327495|12660259|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
5147054|NCT01327495|12660260|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
5147055|NCT01327495|12660255|P6|STARTED|Overall Study||11
5147056|NCT01327495|12660256|P5|STARTED|Overall Study||11
5147057|NCT01327495|12660257|P4|STARTED|Overall Study||9
5147058|NCT01327495|12660258|P3|STARTED|Overall Study||10
5147059|NCT01327495|12660259|P2|STARTED|Overall Study||11
5147060|NCT01327495|12660260|P1|STARTED|Overall Study||10
5147061|NCT01327482|12660352|P1|NOT COMPLETED|Overall Study||1
5147062|NCT01327482|12660352|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
5147063|NCT01327482|12660352|P1|STARTED|Overall Study||10
5147064|NCT01327339|12660357|P1|NOT COMPLETED|Overall Study||8
5147065|NCT01327339|12660357|P1|COMPLETED|Overall Study||747
5147066|NCT01327339|12660357|P1|STARTED|Overall Study||755
5147067|NCT01327313|12660367|P4|NOT COMPLETED|Overall Study||0
5147068|NCT01327313|12660368|P3|NOT COMPLETED|Overall Study||0
5147069|NCT01327313|12660369|P2|NOT COMPLETED|Overall Study||0
5147070|NCT01327313|12660370|P1|NOT COMPLETED|Overall Study||0
5147071|NCT01327313|12660367|P4|COMPLETED|Overall Study||7
5147072|NCT01327313|12660368|P3|COMPLETED|Overall Study||6
5147073|NCT01327313|12660369|P2|COMPLETED|Overall Study||6
5147074|NCT01327313|12660370|P1|COMPLETED|Overall Study||8
5147075|NCT01327313|12660367|P4|STARTED|Overall Study||7
5147076|NCT01327313|12660368|P3|STARTED|Overall Study||6
5147077|NCT01327313|12660369|P2|STARTED|Overall Study||6
5147078|NCT01327313|12660370|P1|STARTED|Overall Study||8
5147079|NCT01327300|12660492|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
5147080|NCT01327300|12660493|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
5147081|NCT01327300|12660492|P2|COMPLETED|Second Intervention (12 Weeks)||2
5147082|NCT01327300|12660493|P1|COMPLETED|Second Intervention (12 Weeks)||4
5147083|NCT01327300|12660492|P2|STARTED|Second Intervention (12 Weeks)||2
5147084|NCT01327300|12660493|P1|STARTED|Second Intervention (12 Weeks)||4
5147085|NCT01327300|12660492|P2|NOT COMPLETED|Washout (3 Weeks)||0
5147086|NCT01327300|12660493|P1|NOT COMPLETED|Washout (3 Weeks)||1
5147087|NCT01327300|12660492|P2|COMPLETED|Washout (3 Weeks)||2
5147088|NCT01327300|12660493|P1|COMPLETED|Washout (3 Weeks)||4
5147089|NCT01327300|12660492|P2|STARTED|Washout (3 Weeks)||2
5147090|NCT01327300|12660493|P1|STARTED|Washout (3 Weeks)||5
5147091|NCT01327300|12660492|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
5147092|NCT01327300|12660493|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
5147093|NCT01327300|12660492|P2|COMPLETED|First Intervention (12 Weeks)||2
5147094|NCT01327300|12660493|P1|COMPLETED|First Intervention (12 Weeks)||5
5147095|NCT01327300|12660492|P2|STARTED|First Intervention (12 Weeks)||2
5147096|NCT01327300|12660493|P1|STARTED|First Intervention (12 Weeks)||5
5147097|NCT01327274|12660509|P1|NOT COMPLETED|Overall Study||0
5147098|NCT01327274|12660509|P1|COMPLETED|Overall Study||15
5147099|NCT01327274|12660509|P1|STARTED|Overall Study||15
5147100|NCT01327157|12660518|P2|NOT COMPLETED|91-180||0
5147101|NCT01327157|12660519|P1|NOT COMPLETED|91-180||0
5147102|NCT01327157|12660518|P2|COMPLETED|91-180||0
5147103|NCT01327157|12660519|P1|COMPLETED|91-180||7
5147104|NCT01327157|12660518|P2|STARTED|91-180||0
5147105|NCT01327157|12660519|P1|STARTED|91-180||7
5147106|NCT01327157|12660518|P2|NOT COMPLETED|01-90||0
5147107|NCT01327157|12660519|P1|NOT COMPLETED|01-90||0
5147108|NCT01327157|12660518|P2|COMPLETED|01-90||7
5147109|NCT01327157|12660519|P1|COMPLETED|01-90||7
5147110|NCT01327157|12660518|P2|STARTED|01-90||7
5147111|NCT01327157|12660519|P1|STARTED|01-90||7
5147112|NCT01327053|12660533|P2|NOT COMPLETED|Overall Study||151
5147113|NCT01327053|12660534|P1|NOT COMPLETED|Overall Study||79
5147114|NCT01327053|12660533|P2|COMPLETED|Overall Study||0
5147115|NCT01327053|12660534|P1|COMPLETED|Overall Study||0
5147116|NCT01327053|12660533|P2|Post-treatment Follow-up|Overall Study||40
5147117|NCT01327053|12660534|P1|Post-treatment Follow-up|Overall Study||19
5147118|NCT01327053|12660533|P2|Survival Follow-up|Overall Study||49
5147119|NCT01327053|12660534|P1|Survival Follow-up|Overall Study||33
5147120|NCT01327053|12660533|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
5147121|NCT01327053|12660534|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
5147122|NCT01327053|12660533|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
5147123|NCT01327053|12660534|P1|Untreated|Overall Study||0
5147124|NCT01327053|12660533|P2|STARTED|Overall Study||151
5147125|NCT01327053|12660534|P1|STARTED|Overall Study||79
5147126|NCT01326962|12660608|P1|NOT COMPLETED|Overall Study||7
5147127|NCT01326962|12660608|P1|COMPLETED|Overall Study||21
5147128|NCT01326962|12660608|P1|STARTED|Overall Study||28
5147129|NCT01326910|12660626|P2|NOT COMPLETED|Overall Study||3
5147130|NCT01326910|12660627|P1|NOT COMPLETED|Overall Study||4
5147131|NCT01326910|12660626|P2|COMPLETED|Overall Study||42
5147132|NCT01326910|12660627|P1|COMPLETED|Overall Study||41
5147133|NCT01326910|12660626|P2|STARTED|Overall Study||45
5147134|NCT01326910|12660627|P1|STARTED|Overall Study||45
5147135|NCT01326845|12660641|P2|NOT COMPLETED|Overall Study||5
5147136|NCT01326845|12660642|P1|NOT COMPLETED|Overall Study||7
5147137|NCT01326845|12660641|P2|COMPLETED|Overall Study|Study terminated early|0
5147138|NCT01326845|12660642|P1|COMPLETED|Overall Study|Study terminated early|0
5147139|NCT01326845|12660641|P2|STARTED|Overall Study||5
5147140|NCT01326845|12660642|P1|STARTED|Overall Study||7
5147141|NCT01326780|12660668|P4|NOT COMPLETED|Overall Study||13
5147142|NCT01326780|12660669|P3|NOT COMPLETED|Overall Study||6
5147143|NCT01326780|12660670|P2|NOT COMPLETED|Overall Study||9
5147144|NCT01326780|12660671|P1|NOT COMPLETED|Overall Study||13
5147145|NCT01326780|12660668|P4|COMPLETED|Overall Study||94
5147146|NCT01326780|12660669|P3|COMPLETED|Overall Study||103
5147147|NCT01326780|12660670|P2|COMPLETED|Overall Study||100
5147148|NCT01326780|12660671|P1|COMPLETED|Overall Study||93
5147149|NCT01326780|12660668|P4|STARTED|Overall Study||107
5147150|NCT01326780|12660669|P3|STARTED|Overall Study||109
5147151|NCT01326780|12660670|P2|STARTED|Overall Study||109
5147152|NCT01326780|12660671|P1|STARTED|Overall Study||106
5147153|NCT01326728|12660703|P2|NOT COMPLETED|Overall Study||9
5147154|NCT01326728|12660704|P1|NOT COMPLETED|Overall Study||47
5147155|NCT01326728|12660703|P2|COMPLETED|Overall Study||0
5147156|NCT01326728|12660704|P1|COMPLETED|Overall Study||0
5147157|NCT01326728|12660703|P2|STARTED|Overall Study||9
5147158|NCT01326728|12660704|P1|STARTED|Overall Study||47
5147159|NCT01326702|12660728|P7|NOT COMPLETED|Overall Study||7
5147160|NCT01326702|12660729|P6|NOT COMPLETED|Overall Study||8
5147161|NCT01326702|12660730|P5|NOT COMPLETED|Overall Study||4
5147162|NCT01326702|12660731|P4|NOT COMPLETED|Overall Study||3
5147163|NCT01326702|12660732|P3|NOT COMPLETED|Overall Study||5
5147164|NCT01326702|12660733|P2|NOT COMPLETED|Overall Study||2
5147165|NCT01326702|12660734|P1|NOT COMPLETED|Overall Study||2
5147166|NCT01326702|12660728|P7|COMPLETED|Overall Study||0
5147167|NCT01326702|12660729|P6|COMPLETED|Overall Study||7
5147168|NCT01326702|12660730|P5|COMPLETED|Overall Study||1
5147169|NCT01326702|12660731|P4|COMPLETED|Overall Study||1
5147170|NCT01326702|12660732|P3|COMPLETED|Overall Study||1
5147171|NCT01326702|12660733|P2|COMPLETED|Overall Study||1
5147172|NCT01326702|12660734|P1|COMPLETED|Overall Study||1
5147173|NCT01326702|12660728|P7|STARTED|Overall Study||7
5147174|NCT01326702|12660729|P6|STARTED|Overall Study||15
5147175|NCT01326702|12660730|P5|STARTED|Overall Study||5
5147176|NCT01326702|12660731|P4|STARTED|Overall Study||4
5147177|NCT01326702|12660732|P3|STARTED|Overall Study||6
5147178|NCT01326702|12660733|P2|STARTED|Overall Study||3
5147179|NCT01326702|12660734|P1|STARTED|Overall Study||3
5147180|NCT01326546|12660790|P2|NOT COMPLETED|Overall Study||13
5147181|NCT01326546|12660791|P1|NOT COMPLETED|Overall Study||17
5147182|NCT01326546|12660790|P2|COMPLETED|Overall Study||176
5147183|NCT01326546|12660791|P1|COMPLETED|Overall Study||172
5147184|NCT01326546|12660790|P2|STARTED|Overall Study||189
5147185|NCT01326546|12660791|P1|STARTED|Overall Study||189
5147186|NCT01326533|12660799|P2|NOT COMPLETED|Overall Study||0
5147187|NCT01326533|12660800|P1|NOT COMPLETED|Overall Study||4
5147188|NCT01326533|12660799|P2|COMPLETED|Overall Study||15
5147189|NCT01326533|12660800|P1|COMPLETED|Overall Study||13
5147190|NCT01326533|12660799|P2|STARTED|Overall Study||15
5147191|NCT01326533|12660800|P1|STARTED|Overall Study||17
5147192|NCT01326481|12660808|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
5147193|NCT01326481|12660808|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
5147194|NCT01326481|12660808|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
5147195|NCT01326481|12660808|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
5147196|NCT01326481|12660808|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
5147197|NCT01326481|12660808|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
5147198|NCT01326026|12660817|P2|NOT COMPLETED|Overall Study||13
5147199|NCT01326026|12660818|P1|NOT COMPLETED|Overall Study||12
5147200|NCT01326026|12660817|P2|COMPLETED|Overall Study||98
5147201|NCT01326026|12660818|P1|COMPLETED|Overall Study||99
5147202|NCT01326026|12660817|P2|Exposed|Overall Study||111
5147203|NCT01326026|12660818|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
5147204|NCT01326026|12660817|P2|STARTED|Overall Study||111
5147205|NCT01326026|12660818|P1|STARTED|Overall Study||111
5147206|NCT01325870|12660835|P3|NOT COMPLETED|Overall Study||8
5147207|NCT01325870|12660836|P2|NOT COMPLETED|Overall Study||13
5147208|NCT01325870|12660837|P1|NOT COMPLETED|Overall Study||11
5147209|NCT01325870|12660835|P3|COMPLETED|Overall Study||6
5147210|NCT01325870|12660836|P2|COMPLETED|Overall Study||3
5147211|NCT01325870|12660837|P1|COMPLETED|Overall Study||7
5147212|NCT01325870|12660835|P3|STARTED|Overall Study||14
5147213|NCT01325870|12660836|P2|STARTED|Overall Study||16
5147214|NCT01325870|12660837|P1|STARTED|Overall Study||18
5147215|NCT01325792|12660851|P1|NOT COMPLETED|Overall Study||17
5147216|NCT01325792|12660851|P1|COMPLETED|Overall Study||87
5147217|NCT01325792|12660851|P1|STARTED|Overall Study||104
5147218|NCT01325714|12660858|P2|NOT COMPLETED|Overall Study||31
5147219|NCT01325714|12660859|P1|NOT COMPLETED|Overall Study||34
5147220|NCT01325714|12660858|P2|COMPLETED|Overall Study||71
5147221|NCT01325714|12660859|P1|COMPLETED|Overall Study||67
5147222|NCT01325714|12660858|P2|12 Month Assessment|Overall Study||71
5147223|NCT01325714|12660859|P1|12 Month Assessment|Overall Study||67
5147224|NCT01325714|12660858|P2|6 Month Asessment|Overall Study||82
5147225|NCT01325714|12660859|P1|6 Month Asessment|Overall Study||75
5147226|NCT01325714|12660858|P2|3 Month Assessment|Overall Study||86
5147227|NCT01325714|12660859|P1|3 Month Assessment|Overall Study||82
5147228|NCT01325714|12660858|P2|STARTED|Overall Study||102
5147229|NCT01325714|12660859|P1|STARTED|Overall Study||101
5147230|NCT01325701|12660883|P2|NOT COMPLETED|Overall Study||3
5147231|NCT01325701|12660884|P1|NOT COMPLETED|Overall Study||21
5147232|NCT01325701|12660883|P2|COMPLETED|Overall Study||5
5147233|NCT01325701|12660884|P1|COMPLETED|Overall Study||49
5147234|NCT01325701|12660883|P2|STARTED|Overall Study||8
5147235|NCT01325701|12660884|P1|STARTED|Overall Study||70
5147236|NCT01325623|12660894|P1|NOT COMPLETED|Overall Study||3
5147237|NCT01325623|12660894|P1|COMPLETED|Overall Study||28
5147238|NCT01325623|12660894|P1|STARTED|Overall Study||31
5147239|NCT01325584|12660936|P1|NOT COMPLETED|Overall Study||1
5147240|NCT01325584|12660936|P1|COMPLETED|Overall Study||11
5147241|NCT01325584|12660936|P1|STARTED|Overall Study||12
5147242|NCT01325532|12660946|P2|NOT COMPLETED|Overall Study||0
5147243|NCT01325532|12660947|P1|NOT COMPLETED|Overall Study||2
5147244|NCT01325532|12660946|P2|COMPLETED|Overall Study||13
5147245|NCT01325532|12660947|P1|COMPLETED|Overall Study||15
5147246|NCT01325532|12660946|P2|STARTED|Overall Study||13
5147247|NCT01325532|12660947|P1|STARTED|Overall Study||17
5147248|NCT01325493|12660959|P2|NOT COMPLETED|Overall Study||3
5147249|NCT01325493|12660960|P1|NOT COMPLETED|Overall Study||1
5147250|NCT01325493|12660959|P2|COMPLETED|Overall Study||21
5147251|NCT01325493|12660960|P1|COMPLETED|Overall Study||29
5147252|NCT01325493|12660959|P2|STARTED|Overall Study||24
5147253|NCT01325493|12660960|P1|STARTED|Overall Study||30
5147254|NCT01325428|12660972|P1|NOT COMPLETED|Part B||3
5147255|NCT01325428|12660972|P1|COMPLETED|Part B||7
5147256|NCT01325428|12660972|P1|STARTED|Part B||10
5147257|NCT01325428|12660972|P1|NOT COMPLETED|Part A||16
5147258|NCT01325428|12660972|P1|COMPLETED|Part A||10
5147259|NCT01325428|12660972|P1|STARTED|Part A||26
5147260|NCT01325350|12660992|P5|NOT COMPLETED|Overall Study||12
5147261|NCT01325350|12660993|P4|NOT COMPLETED|Overall Study||9
5147262|NCT01325350|12660994|P3|NOT COMPLETED|Overall Study||17
5147263|NCT01325350|12660995|P2|NOT COMPLETED|Overall Study||5
5147264|NCT01325350|12660996|P1|NOT COMPLETED|Overall Study||6
5147265|NCT01325350|12660992|P5|COMPLETED|Overall Study||50
5147266|NCT01325350|12660993|P4|COMPLETED|Overall Study||52
5147267|NCT01325350|12660994|P3|COMPLETED|Overall Study||44
5147268|NCT01325350|12660995|P2|COMPLETED|Overall Study||56
5147269|NCT01325350|12660996|P1|COMPLETED|Overall Study||55
5147270|NCT01325350|12660992|P5|STARTED|Overall Study||62
5147271|NCT01325350|12660993|P4|STARTED|Overall Study||61
5147272|NCT01325350|12660994|P3|STARTED|Overall Study||61
5147273|NCT01325350|12660995|P2|STARTED|Overall Study||61
5147274|NCT01325350|12660996|P1|STARTED|Overall Study||61
5147275|NCT01325337|12661038|P5|NOT COMPLETED|Overall Study||8
5147276|NCT01325337|12661039|P4|NOT COMPLETED|Overall Study||10
5147277|NCT01325337|12661040|P3|NOT COMPLETED|Overall Study||9
5147278|NCT01325337|12661041|P2|NOT COMPLETED|Overall Study||9
5147279|NCT01325337|12661042|P1|NOT COMPLETED|Overall Study||5
5147280|NCT01325337|12661038|P5|COMPLETED|Overall Study||53
5147281|NCT01325337|12661039|P4|COMPLETED|Overall Study||52
5147282|NCT01325337|12661040|P3|COMPLETED|Overall Study||53
5147283|NCT01325337|12661041|P2|COMPLETED|Overall Study||52
5147284|NCT01325337|12661042|P1|COMPLETED|Overall Study||56
5147285|NCT01325337|12661038|P5|STARTED|Overall Study||61
5147286|NCT01325337|12661039|P4|STARTED|Overall Study||62
5147287|NCT01325337|12661040|P3|STARTED|Overall Study||62
5147288|NCT01325337|12661041|P2|STARTED|Overall Study||61
5147289|NCT01325337|12661042|P1|STARTED|Overall Study||61
5147290|NCT01325311|12661081|P2|NOT COMPLETED|Overall Study||0
5147291|NCT01325311|12661082|P1|NOT COMPLETED|Overall Study||0
5147292|NCT01325311|12661081|P2|COMPLETED|Overall Study||7
5147293|NCT01325311|12661082|P1|COMPLETED|Overall Study||8
5147294|NCT01325311|12661081|P2|STARTED|Overall Study||7
5147295|NCT01325311|12661082|P1|STARTED|Overall Study||8
5147296|NCT01325207|12661122|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
5147297|NCT01325207|12661123|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
5147298|NCT01325207|12661124|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
5147299|NCT01325207|12661125|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
5147300|NCT01325207|12661126|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
5147301|NCT01325207|12661127|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
5147302|NCT01325207|12661122|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
5147303|NCT01325207|12661123|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
5147304|NCT01325207|12661124|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
5147305|NCT01325207|12661125|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
5147306|NCT01325207|12661126|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
5147307|NCT01325207|12661127|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
5147308|NCT01325207|12661122|P6|STARTED|Follow-up Every 3 Months Until Death||19
5147309|NCT01325207|12661123|P5|STARTED|Follow-up Every 3 Months Until Death||7
5147310|NCT01325207|12661124|P4|STARTED|Follow-up Every 3 Months Until Death||1
5147311|NCT01325207|12661125|P3|STARTED|Follow-up Every 3 Months Until Death||1
5147312|NCT01325207|12661126|P2|STARTED|Follow-up Every 3 Months Until Death||3
5147313|NCT01325207|12661127|P1|STARTED|Follow-up Every 3 Months Until Death||3
5147314|NCT01325207|12661122|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
5147315|NCT01325207|12661123|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
5147316|NCT01325207|12661124|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
5147317|NCT01325207|12661125|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
5147318|NCT01325207|12661126|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
5147319|NCT01325207|12661127|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
5147320|NCT01325207|12661122|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
5147321|NCT01325207|12661123|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
5147322|NCT01325207|12661124|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
5147323|NCT01325207|12661125|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
5147324|NCT01325207|12661126|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
5147325|NCT01325207|12661127|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
5147326|NCT01325207|12661122|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
5147327|NCT01325207|12661123|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
5147328|NCT01325207|12661124|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
5147329|NCT01325207|12661125|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
5147330|NCT01325207|12661126|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
5147331|NCT01325207|12661127|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
5147332|NCT01325207|12661122|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
5147333|NCT01325207|12661123|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
5147334|NCT01325207|12661124|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
5147335|NCT01325207|12661125|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
5147336|NCT01325207|12661126|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
5147337|NCT01325207|12661127|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
5147338|NCT01325207|12661122|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
5147339|NCT01325207|12661123|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
5147340|NCT01325207|12661124|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
5147341|NCT01325207|12661125|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
5147342|NCT01325207|12661126|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
5147343|NCT01325207|12661127|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
5147344|NCT01325207|12661122|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
5147345|NCT01325207|12661123|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
5147346|NCT01325207|12661124|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
5147347|NCT01325207|12661125|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
5147348|NCT01325207|12661126|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
5147349|NCT01325207|12661127|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
5147350|NCT01325207|12661122|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
5147351|NCT01325207|12661123|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
5147352|NCT01325207|12661124|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
5147353|NCT01325207|12661125|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
5147354|NCT01325207|12661126|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
5147355|NCT01325207|12661127|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
5147356|NCT01325207|12661122|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
5147357|NCT01325207|12661123|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
5147358|NCT01325207|12661124|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
5147359|NCT01325207|12661125|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
5147360|NCT01325207|12661126|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
5147361|NCT01325207|12661127|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
5147362|NCT01325207|12661122|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
5147363|NCT01325207|12661123|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
5147364|NCT01325207|12661124|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
5147365|NCT01325207|12661125|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
5147366|NCT01325207|12661126|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
5147367|NCT01325207|12661127|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
5147368|NCT01325181|12661152|P2|NOT COMPLETED|Overall Study||2
5147369|NCT01325181|12661153|P1|NOT COMPLETED|Overall Study||0
5147370|NCT01325181|12661152|P2|COMPLETED|Overall Study||14
5147371|NCT01325181|12661153|P1|COMPLETED|Overall Study||18
5147372|NCT01325181|12661152|P2|STARTED|Overall Study||16
5147373|NCT01325181|12661153|P1|STARTED|Overall Study||18
5147374|NCT01324999|12661159|P1|NOT COMPLETED|Overall Study||5
5147375|NCT01324999|12661159|P1|COMPLETED|Overall Study||7
5147376|NCT01324999|12661159|P1|STARTED|Overall Study||12
5147377|NCT01324947|12661170|P1|NOT COMPLETED|Overall Study||74
5147378|NCT01324947|12661170|P1|COMPLETED|Overall Study||0
5147379|NCT01324947|12661170|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
5147380|NCT01324947|12661170|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
5147381|NCT01324947|12661170|P1|STARTED|Overall Study||74
5147382|NCT01324882|12661183|P2|NOT COMPLETED|Overall Study||0
5147383|NCT01324882|12661184|P1|NOT COMPLETED|Overall Study||0
5147384|NCT01324882|12661183|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
5147385|NCT01324882|12661184|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
5147386|NCT01324882|12661183|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
5147387|NCT01324882|12661184|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
5147388|NCT01324830|12661211|P19|NOT COMPLETED|Overall Study||6
5147389|NCT01324830|12661212|P18|NOT COMPLETED|Overall Study||6
5147390|NCT01324830|12661213|P17|NOT COMPLETED|Overall Study||3
5147391|NCT01324830|12661214|P16|NOT COMPLETED|Overall Study||3
5147392|NCT01324830|12661215|P15|NOT COMPLETED|Overall Study||1
5147393|NCT01324830|12661216|P14|NOT COMPLETED|Overall Study||1
5147394|NCT01324830|12661217|P13|NOT COMPLETED|Overall Study||1
5147395|NCT01324830|12661218|P12|NOT COMPLETED|Overall Study||1
5147396|NCT01324830|12661219|P11|NOT COMPLETED|Overall Study||4
5147397|NCT01324830|12661220|P10|NOT COMPLETED|Overall Study||6
5147398|NCT01324830|12661221|P9|NOT COMPLETED|Overall Study||5
5147399|NCT01324830|12661222|P8|NOT COMPLETED|Overall Study||3
5147400|NCT01324830|12661223|P7|NOT COMPLETED|Overall Study||3
5147401|NCT01324830|12661224|P6|NOT COMPLETED|Overall Study||7
5147402|NCT01324830|12661225|P5|NOT COMPLETED|Overall Study||7
5147403|NCT01324830|12661226|P4|NOT COMPLETED|Overall Study||3
5147404|NCT01324830|12661227|P3|NOT COMPLETED|Overall Study||3
5147405|NCT01324830|12661228|P2|NOT COMPLETED|Overall Study||3
5147406|NCT01324830|12661229|P1|NOT COMPLETED|Overall Study||3
5147407|NCT01324830|12661211|P19|COMPLETED|Overall Study||0
5147408|NCT01324830|12661212|P18|COMPLETED|Overall Study||0
5147409|NCT01324830|12661213|P17|COMPLETED|Overall Study||0
5147410|NCT01324830|12661214|P16|COMPLETED|Overall Study||0
5147411|NCT01324830|12661215|P15|COMPLETED|Overall Study||0
5147412|NCT01324830|12661216|P14|COMPLETED|Overall Study||0
5147413|NCT01324830|12661217|P13|COMPLETED|Overall Study||0
5147414|NCT01324830|12661218|P12|COMPLETED|Overall Study||0
5147415|NCT01324830|12661219|P11|COMPLETED|Overall Study||0
5147416|NCT01324830|12661220|P10|COMPLETED|Overall Study||0
5147417|NCT01324830|12661221|P9|COMPLETED|Overall Study||0
5147418|NCT01324830|12661222|P8|COMPLETED|Overall Study||0
5147419|NCT01324830|12661223|P7|COMPLETED|Overall Study||0
5147420|NCT01324830|12661224|P6|COMPLETED|Overall Study||0
5147421|NCT01324830|12661225|P5|COMPLETED|Overall Study||0
5147422|NCT01324830|12661226|P4|COMPLETED|Overall Study||0
5147423|NCT01324830|12661227|P3|COMPLETED|Overall Study||0
5147424|NCT01324830|12661228|P2|COMPLETED|Overall Study||0
5147425|NCT01324830|12661229|P1|COMPLETED|Overall Study||0
5147426|NCT01324830|12661211|P19|STARTED|Overall Study||6
5147427|NCT01324830|12661212|P18|STARTED|Overall Study||6
5147428|NCT01324830|12661213|P17|STARTED|Overall Study||3
5147429|NCT01324830|12661214|P16|STARTED|Overall Study||3
5147430|NCT01324830|12661215|P15|STARTED|Overall Study||1
5147431|NCT01324830|12661216|P14|STARTED|Overall Study||1
5147432|NCT01324830|12661217|P13|STARTED|Overall Study||1
5147433|NCT01324830|12661218|P12|STARTED|Overall Study||1
5147434|NCT01324830|12661219|P11|STARTED|Overall Study||4
5147435|NCT01324830|12661220|P10|STARTED|Overall Study||6
5147436|NCT01324830|12661221|P9|STARTED|Overall Study||5
5147437|NCT01324830|12661222|P8|STARTED|Overall Study||3
5147438|NCT01324830|12661223|P7|STARTED|Overall Study||3
5147439|NCT01324830|12661224|P6|STARTED|Overall Study||7
5147440|NCT01324830|12661225|P5|STARTED|Overall Study||7
5147441|NCT01324830|12661226|P4|STARTED|Overall Study||3
5147442|NCT01324830|12661227|P3|STARTED|Overall Study||3
5147443|NCT01324830|12661228|P2|STARTED|Overall Study||3
5147444|NCT01324830|12661229|P1|STARTED|Overall Study||3
5147445|NCT01324700|12661345|P4|NOT COMPLETED|Overall Study||11
5147446|NCT01324700|12661346|P3|NOT COMPLETED|Overall Study||16
5147447|NCT01324700|12661347|P2|NOT COMPLETED|Overall Study||4
5147448|NCT01324700|12661348|P1|NOT COMPLETED|Overall Study||9
5147449|NCT01324700|12661345|P4|COMPLETED|Overall Study||37
5147450|NCT01324700|12661346|P3|COMPLETED|Overall Study||33
5147451|NCT01324700|12661347|P2|COMPLETED|Overall Study||16
5147452|NCT01324700|12661348|P1|COMPLETED|Overall Study||13
5147453|NCT01324700|12661345|P4|STARTED|Overall Study||48
5147454|NCT01324700|12661346|P3|STARTED|Overall Study||49
5147455|NCT01324700|12661347|P2|STARTED|Overall Study||20
5147456|NCT01324700|12661348|P1|STARTED|Overall Study||22
5147457|NCT01324687|12661364|P2|NOT COMPLETED|Overall Study||15
5147458|NCT01324687|12661365|P1|NOT COMPLETED|Overall Study||0
5147459|NCT01324687|12661364|P2|COMPLETED|Overall Study||479
5147460|NCT01324687|12661365|P1|COMPLETED|Overall Study||1058
5147461|NCT01324687|12661364|P2|STARTED|Overall Study||494
5147462|NCT01324687|12661365|P1|STARTED|Overall Study||1058
5147463|NCT01324622|12661375|P2|NOT COMPLETED|Overall Study||7
5147464|NCT01324622|12661376|P1|NOT COMPLETED|Overall Study||9
5147465|NCT01324622|12661375|P2|COMPLETED|Overall Study||4
5147466|NCT01324622|12661376|P1|COMPLETED|Overall Study||4
5147467|NCT01324622|12661375|P2|STARTED|Overall Study||11
5147468|NCT01324622|12661376|P1|STARTED|Overall Study||13
5147469|NCT01324570|12661406|P2|NOT COMPLETED|Overall Study||14
5147470|NCT01324570|12661407|P1|NOT COMPLETED|Overall Study||4
5147471|NCT01324570|12661406|P2|COMPLETED|Overall Study||21
5147472|NCT01324570|12661407|P1|COMPLETED|Overall Study||2
5147473|NCT01324570|12661406|P2|STARTED|Overall Study||35
5147474|NCT01324570|12661407|P1|STARTED|Overall Study||6
5147475|NCT01324453|12661421|P2|NOT COMPLETED|Overall Study||0
5147476|NCT01324453|12661422|P1|NOT COMPLETED|Overall Study||0
5147477|NCT01324453|12661421|P2|COMPLETED|Overall Study||49
5147478|NCT01324453|12661422|P1|COMPLETED|Overall Study||54
5147479|NCT01324453|12661421|P2|STARTED|Overall Study||49
5147480|NCT01324453|12661422|P1|STARTED|Overall Study||54
5147481|NCT01324440|12661444|P2|NOT COMPLETED|Overall Study||1
5147482|NCT01324440|12661445|P1|NOT COMPLETED|Overall Study||0
5147483|NCT01324440|12661444|P2|COMPLETED|Overall Study||31
5147484|NCT01324440|12661445|P1|COMPLETED|Overall Study||32
5147485|NCT01324440|12661444|P2|STARTED|Overall Study||32
5147486|NCT01324440|12661445|P1|STARTED|Overall Study||32
5147487|NCT01324401|12661459|P2|NOT COMPLETED|Overall Study||6
5147488|NCT01324401|12661460|P1|NOT COMPLETED|Overall Study||1
5147489|NCT01324401|12661459|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
5147490|NCT01324401|12661460|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
5147491|NCT01324401|12661459|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
5147492|NCT01324401|12661460|P1|STARTED|Overall Study||4
5147493|NCT01324388|12661471|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
5147494|NCT01324388|12661472|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
5147495|NCT01324388|12661473|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
5147496|NCT01324388|12661474|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
5147497|NCT01324388|12661471|P4|COMPLETED|Part 2 of Study: Second Intervention||9
5147498|NCT01324388|12661472|P3|COMPLETED|Part 2 of Study: Second Intervention||9
5147499|NCT01324388|12661473|P2|COMPLETED|Part 2 of Study: Second Intervention||0
5147500|NCT01324388|12661474|P1|COMPLETED|Part 2 of Study: Second Intervention||0
5147501|NCT01324388|12661471|P4|STARTED|Part 2 of Study: Second Intervention||9
5147502|NCT01324388|12661472|P3|STARTED|Part 2 of Study: Second Intervention||10
5147503|NCT01324388|12661473|P2|STARTED|Part 2 of Study: Second Intervention||0
5147504|NCT01324388|12661474|P1|STARTED|Part 2 of Study: Second Intervention||0
5147505|NCT01324388|12661471|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
5147506|NCT01324388|12661472|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
5147507|NCT01324388|12661473|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
5147508|NCT01324388|12661474|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
5147509|NCT01324388|12661471|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
5147510|NCT01324388|12661472|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
5147511|NCT01324388|12661473|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
5147512|NCT01324388|12661474|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
5147513|NCT01324388|12661471|P4|STARTED|Part 2: Washout of at Least 21 Days||9
5147514|NCT01324388|12661472|P3|STARTED|Part 2: Washout of at Least 21 Days||10
5147515|NCT01324388|12661473|P2|STARTED|Part 2: Washout of at Least 21 Days||0
5147516|NCT01324388|12661474|P1|STARTED|Part 2: Washout of at Least 21 Days||0
5147517|NCT01324388|12661471|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
5147518|NCT01324388|12661472|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
5147519|NCT01324388|12661473|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
5147520|NCT01324388|12661474|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
5147521|NCT01324388|12661471|P4|COMPLETED|Part 2 of Study: First Intervention||9
5147522|NCT01324388|12661472|P3|COMPLETED|Part 2 of Study: First Intervention||10
5147523|NCT01324388|12661473|P2|COMPLETED|Part 2 of Study: First Intervention||0
5147524|NCT01324388|12661474|P1|COMPLETED|Part 2 of Study: First Intervention||0
5147525|NCT01324388|12661471|P4|STARTED|Part 2 of Study: First Intervention||10
5147526|NCT01324388|12661472|P3|STARTED|Part 2 of Study: First Intervention||10
5147527|NCT01324388|12661473|P2|STARTED|Part 2 of Study: First Intervention||0
5147528|NCT01324388|12661474|P1|STARTED|Part 2 of Study: First Intervention||0
5147529|NCT01324388|12661471|P4|NOT COMPLETED|Part 1 of Study||0
5147530|NCT01324388|12661472|P3|NOT COMPLETED|Part 1 of Study||0
5147531|NCT01324388|12661473|P2|NOT COMPLETED|Part 1 of Study||2
5147532|NCT01324388|12661474|P1|NOT COMPLETED|Part 1 of Study||4
5147533|NCT01324388|12661471|P4|COMPLETED|Part 1 of Study||0
5147534|NCT01324388|12661472|P3|COMPLETED|Part 1 of Study||0
5147535|NCT01324388|12661473|P2|COMPLETED|Part 1 of Study||6
5147536|NCT01324388|12661474|P1|COMPLETED|Part 1 of Study||19
5147537|NCT01324388|12661471|P4|Received at Least 1 Dose|Part 1 of Study||0
5147538|NCT01324388|12661472|P3|Received at Least 1 Dose|Part 1 of Study||0
5147539|NCT01324388|12661473|P2|Received at Least 1 Dose|Part 1 of Study||8
5147540|NCT01324388|12661474|P1|Received at Least 1 Dose|Part 1 of Study||23
5147541|NCT01324388|12661471|P4|STARTED|Part 1 of Study||0
5147542|NCT01324388|12661472|P3|STARTED|Part 1 of Study||0
5147543|NCT01324388|12661473|P2|STARTED|Part 1 of Study||8
5147544|NCT01324388|12661474|P1|STARTED|Part 1 of Study||23
5147545|NCT01324349|12661495|P2|NOT COMPLETED|Overall Study||2
5147546|NCT01324349|12661496|P1|NOT COMPLETED|Overall Study||1
5147547|NCT01324349|12661495|P2|COMPLETED|Overall Study||16
5147548|NCT01324349|12661496|P1|COMPLETED|Overall Study||31
5147549|NCT01324349|12661495|P2|STARTED|Overall Study||18
5147550|NCT01324349|12661496|P1|STARTED|Overall Study||32
5147551|NCT01324323|12661506|P1|NOT COMPLETED|Overall Study||1
5147552|NCT01324323|12661506|P1|COMPLETED|Overall Study||13
5147553|NCT01324323|12661506|P1|STARTED|Overall Study||14
5147554|NCT01324310|12661526|P1|NOT COMPLETED|Overall Study||2
5147555|NCT01324310|12661526|P1|COMPLETED|Overall Study||13
5147556|NCT01324310|12661526|P1|STARTED|Overall Study||15
5147557|NCT01324271|12661546|P2|NOT COMPLETED|Overall Study||0
5147558|NCT01324271|12661547|P1|NOT COMPLETED|Overall Study||4
5147559|NCT01324271|12661546|P2|COMPLETED|Overall Study||28
5147560|NCT01324271|12661547|P1|COMPLETED|Overall Study||53
5147561|NCT01324271|12661546|P2|STARTED|Overall Study||28
5147562|NCT01324271|12661547|P1|STARTED|Overall Study||57
5147563|NCT01324128|12661555|P4|NOT COMPLETED|Stage 2||3
5147564|NCT01324128|12661556|P3|NOT COMPLETED|Stage 2||8
5147565|NCT01324128|12661557|P2|NOT COMPLETED|Stage 2||0
5147566|NCT01324128|12661558|P1|NOT COMPLETED|Stage 2||0
5147567|NCT01324128|12661555|P4|COMPLETED|Stage 2||46
5147568|NCT01324128|12661556|P3|COMPLETED|Stage 2||42
5147569|NCT01324128|12661557|P2|COMPLETED|Stage 2||0
5147570|NCT01324128|12661558|P1|COMPLETED|Stage 2||0
5147571|NCT01324128|12661555|P4|STARTED|Stage 2||49
5147572|NCT01324128|12661556|P3|STARTED|Stage 2||50
5147573|NCT01324128|12661557|P2|STARTED|Stage 2||0
5147574|NCT01324128|12661558|P1|STARTED|Stage 2||0
5147575|NCT01324128|12661555|P4|NOT COMPLETED|Stage 1||0
5147576|NCT01324128|12661556|P3|NOT COMPLETED|Stage 1||0
5147577|NCT01324128|12661557|P2|NOT COMPLETED|Stage 1||56
5147578|NCT01324128|12661558|P1|NOT COMPLETED|Stage 1||195
5147579|NCT01324128|12661555|P4|COMPLETED|Stage 1||0
5147580|NCT01324128|12661556|P3|COMPLETED|Stage 1||0
5147581|NCT01324128|12661557|P2|COMPLETED|Stage 1||293
5147582|NCT01324128|12661558|P1|COMPLETED|Stage 1||515
5147583|NCT01324128|12661555|P4|STARTED|Stage 1||0
5147584|NCT01324128|12661556|P3|STARTED|Stage 1||0
5147585|NCT01324128|12661557|P2|STARTED|Stage 1||349
5147586|NCT01324128|12661558|P1|STARTED|Stage 1||710
5147587|NCT01324102|12661570|P2|NOT COMPLETED|Overall Study||6
5147588|NCT01324102|12661571|P1|NOT COMPLETED|Overall Study||1
5147589|NCT01324102|12661570|P2|COMPLETED|Overall Study||6
5147590|NCT01324102|12661571|P1|COMPLETED|Overall Study||10
5147591|NCT01324102|12661570|P2|STARTED|Overall Study|Yoga group 4 and 6|12
5147592|NCT01324102|12661571|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
5147593|NCT01324024|12661578|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
5147594|NCT01324024|12661579|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
5147595|NCT01324024|12661578|P2|COMPLETED|Second Intervention (4 Weeks)||16
5147596|NCT01324024|12661579|P1|COMPLETED|Second Intervention (4 Weeks)||16
5147597|NCT01324024|12661578|P2|STARTED|Second Intervention (4 Weeks)||17
5147598|NCT01324024|12661579|P1|STARTED|Second Intervention (4 Weeks)||18
5147599|NCT01324024|12661578|P2|NOT COMPLETED|Washout (2 Weeks)||0
5147600|NCT01324024|12661579|P1|NOT COMPLETED|Washout (2 Weeks)||0
5147601|NCT01324024|12661578|P2|COMPLETED|Washout (2 Weeks)||17
5147602|NCT01324024|12661579|P1|COMPLETED|Washout (2 Weeks)||18
5147603|NCT01324024|12661578|P2|STARTED|Washout (2 Weeks)||17
5147604|NCT01324024|12661579|P1|STARTED|Washout (2 Weeks)||18
5147605|NCT01324024|12661578|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
5147606|NCT01324024|12661579|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5147607|NCT01324024|12661578|P2|COMPLETED|First Intervention (4 Weeks)||17
5147608|NCT01324024|12661579|P1|COMPLETED|First Intervention (4 Weeks)||18
5147609|NCT01324024|12661578|P2|STARTED|First Intervention (4 Weeks)||17
5147610|NCT01324024|12661579|P1|STARTED|First Intervention (4 Weeks)||18
5147611|NCT01323998|12661597|P5|NOT COMPLETED|Overall Study||0
5147612|NCT01323998|12661598|P4|NOT COMPLETED|Overall Study||0
5147613|NCT01323998|12661599|P3|NOT COMPLETED|Overall Study||0
5147614|NCT01323998|12661600|P2|NOT COMPLETED|Overall Study||0
5147615|NCT01323998|12661601|P1|NOT COMPLETED|Overall Study||0
5147616|NCT01323998|12661597|P5|COMPLETED|Overall Study||6735
5147617|NCT01323998|12661598|P4|COMPLETED|Overall Study||12052
5147618|NCT01323998|12661599|P3|COMPLETED|Overall Study||10294
5147619|NCT01323998|12661600|P2|COMPLETED|Overall Study||18681
5147620|NCT01323998|12661601|P1|COMPLETED|Overall Study||200631
5147621|NCT01323998|12661597|P5|STARTED|Overall Study||6735
5147622|NCT01323998|12661598|P4|STARTED|Overall Study||12052
5147623|NCT01323998|12661599|P3|STARTED|Overall Study||10294
5147624|NCT01323998|12661600|P2|STARTED|Overall Study||18681
5147625|NCT01323998|12661601|P1|STARTED|Overall Study||200631
5147626|NCT01323972|12661617|P4|NOT COMPLETED|Overall Study||1
5147627|NCT01323972|12661618|P3|NOT COMPLETED|Overall Study||2
5147628|NCT01323972|12661619|P2|NOT COMPLETED|Overall Study||3
5147629|NCT01323972|12661620|P1|NOT COMPLETED|Overall Study||2
5147630|NCT01323972|12661617|P4|COMPLETED|Overall Study||79
5147631|NCT01323972|12661618|P3|COMPLETED|Overall Study||78
5147632|NCT01323972|12661619|P2|COMPLETED|Overall Study||76
5147633|NCT01323972|12661620|P1|COMPLETED|Overall Study||79
5147634|NCT01323972|12661617|P4|STARTED|Overall Study||80
5147635|NCT01323972|12661618|P3|STARTED|Overall Study||80
5147636|NCT01323972|12661619|P2|STARTED|Overall Study||79
5147637|NCT01323972|12661620|P1|STARTED|Overall Study||81
5147638|NCT01323959|12661655|P3|NOT COMPLETED|Overall Study||0
5147639|NCT01323959|12661656|P2|NOT COMPLETED|Overall Study||0
5147640|NCT01323959|12661657|P1|NOT COMPLETED|Overall Study||0
5147641|NCT01323959|12661655|P3|COMPLETED|Overall Study||72
5147642|NCT01323959|12661656|P2|COMPLETED|Overall Study||72
5147643|NCT01323959|12661657|P1|COMPLETED|Overall Study||67
5147644|NCT01323959|12661655|P3|STARTED|Overall Study||72
5147645|NCT01323959|12661656|P2|STARTED|Overall Study||72
5147646|NCT01323959|12661657|P1|STARTED|Overall Study||67
5147647|NCT01323946|12661716|P3|NOT COMPLETED|Overall Study||0
5147648|NCT01323946|12661717|P2|NOT COMPLETED|Overall Study||3
5147649|NCT01323946|12661718|P1|NOT COMPLETED|Overall Study||3
5147650|NCT01323946|12661716|P3|COMPLETED|Overall Study||33
5147651|NCT01323946|12661717|P2|COMPLETED|Overall Study||31
5147652|NCT01323946|12661718|P1|COMPLETED|Overall Study||43
5147653|NCT01323946|12661716|P3|STARTED|Overall Study||33
5147654|NCT01323946|12661717|P2|STARTED|Overall Study||34
5147655|NCT01323946|12661718|P1|STARTED|Overall Study||46
5147656|NCT01323920|12661839|P1|NOT COMPLETED|Overall Study||6
5147657|NCT01323920|12661839|P1|COMPLETED|Overall Study||29
5147658|NCT01323920|12661839|P1|STARTED|Overall Study||35
5147659|NCT01323855|12661851|P5|NOT COMPLETED|Overall Study||0
5147660|NCT01323855|12661852|P4|NOT COMPLETED|Overall Study||0
5147661|NCT01323855|12661853|P3|NOT COMPLETED|Overall Study||0
5147662|NCT01323855|12661854|P2|NOT COMPLETED|Overall Study||0
5147663|NCT01323855|12661855|P1|NOT COMPLETED|Overall Study||0
5147664|NCT01323855|12661851|P5|COMPLETED|Overall Study||11
5147665|NCT01323855|12661852|P4|COMPLETED|Overall Study||9
5147666|NCT01323855|12661853|P3|COMPLETED|Overall Study||8
5147667|NCT01323855|12661854|P2|COMPLETED|Overall Study||9
5147668|NCT01323855|12661855|P1|COMPLETED|Overall Study||9
5147669|NCT01323855|12661851|P5|STARTED|Overall Study||11
5147670|NCT01323855|12661852|P4|STARTED|Overall Study||9
5147671|NCT01323855|12661853|P3|STARTED|Overall Study||8
5147672|NCT01323855|12661854|P2|STARTED|Overall Study||9
5147673|NCT01323855|12661855|P1|STARTED|Overall Study||9
5147674|NCT01323790|12661880|P3|NOT COMPLETED|Overall Study||45
5147675|NCT01323790|12661881|P2|NOT COMPLETED|Overall Study||60
5147676|NCT01323790|12661882|P1|NOT COMPLETED|Overall Study||55
5147677|NCT01323790|12661880|P3|COMPLETED|Overall Study||188
5147678|NCT01323790|12661881|P2|COMPLETED|Overall Study||174
5147679|NCT01323790|12661882|P1|COMPLETED|Overall Study||178
5147680|NCT01323790|12661880|P3|STARTED|Overall Study||233
5147681|NCT01323790|12661881|P2|STARTED|Overall Study||234
5147682|NCT01323790|12661882|P1|STARTED|Overall Study||233
5147683|NCT01323777|12661920|P1|NOT COMPLETED|Overall Study||0
5147684|NCT01323777|12661920|P1|COMPLETED|Overall Study||65
5147685|NCT01323777|12661920|P1|STARTED|Overall Study||65
5147686|NCT01323673|12661933|P2|NOT COMPLETED|Overall Study||5
5147687|NCT01323673|12661934|P1|NOT COMPLETED|Overall Study||3
5147688|NCT01323673|12661933|P2|COMPLETED|Overall Study||58
5147689|NCT01323673|12661934|P1|COMPLETED|Overall Study||59
5147690|NCT01323673|12661933|P2|STARTED|Overall Study||63
5147691|NCT01323673|12661934|P1|STARTED|Overall Study||62
5147692|NCT01323660|12661954|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
5147693|NCT01323660|12661955|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
5147694|NCT01323660|12661956|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
5147695|NCT01323660|12661957|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
5147696|NCT01323660|12661958|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
5147697|NCT01323660|12661959|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
5147698|NCT01323660|12661954|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
5147699|NCT01323660|12661955|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
5147700|NCT01323660|12661956|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
5147701|NCT01323660|12661957|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
5147702|NCT01323660|12661958|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
5147703|NCT01323660|12661959|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
5147704|NCT01323660|12661954|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
5147705|NCT01323660|12661955|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
5147706|NCT01323660|12661956|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
5147707|NCT01323660|12661957|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
5147708|NCT01323660|12661958|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
5147709|NCT01323660|12661959|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
5147710|NCT01323660|12661954|P6|NOT COMPLETED|Washout Period (14 Days)||2
5147711|NCT01323660|12661955|P5|NOT COMPLETED|Washout Period (14 Days)||3
5147712|NCT01323660|12661956|P4|NOT COMPLETED|Washout Period (14 Days)||3
5147713|NCT01323660|12661957|P3|NOT COMPLETED|Washout Period (14 Days)||1
5147714|NCT01323660|12661958|P2|NOT COMPLETED|Washout Period (14 Days)||0
5147715|NCT01323660|12661959|P1|NOT COMPLETED|Washout Period (14 Days)||0
5147716|NCT01323660|12661954|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
5147717|NCT01323660|12661955|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
5147718|NCT01323660|12661956|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
5147719|NCT01323660|12661957|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
5147720|NCT01323660|12661958|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
5147721|NCT01323660|12661959|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
5147722|NCT01323660|12661954|P6|STARTED|Washout Period (14 Days)||61
5147723|NCT01323660|12661955|P5|STARTED|Washout Period (14 Days)||61
5147724|NCT01323660|12661956|P4|STARTED|Washout Period (14 Days)||31
5147725|NCT01323660|12661957|P3|STARTED|Washout Period (14 Days)||19
5147726|NCT01323660|12661958|P2|STARTED|Washout Period (14 Days)||21
5147727|NCT01323660|12661959|P1|STARTED|Washout Period (14 Days)||65
5147728|NCT01323660|12661954|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
5147729|NCT01323660|12661955|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
5147730|NCT01323660|12661956|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
5147731|NCT01323660|12661957|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
5147732|NCT01323660|12661958|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
5147733|NCT01323660|12661959|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
5147734|NCT01323660|12661954|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
5147735|NCT01323660|12661955|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
5147736|NCT01323660|12661956|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
5147737|NCT01323660|12661957|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
5147738|NCT01323660|12661958|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
5147739|NCT01323660|12661959|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
5147740|NCT01323660|12661954|P6|STARTED|Treatment Period 1 (12 Weeks)||70
5147741|NCT01323660|12661955|P5|STARTED|Treatment Period 1 (12 Weeks)||71
5147742|NCT01323660|12661956|P4|STARTED|Treatment Period 1 (12 Weeks)||36
5147743|NCT01323660|12661957|P3|STARTED|Treatment Period 1 (12 Weeks)||24
5147744|NCT01323660|12661958|P2|STARTED|Treatment Period 1 (12 Weeks)||22
5147745|NCT01323660|12661959|P1|STARTED|Treatment Period 1 (12 Weeks)||84
5147746|NCT01323647|12662005|P2|NOT COMPLETED|Overall Study||0
5147747|NCT01323647|12662006|P1|NOT COMPLETED|Overall Study||9
5147748|NCT01323647|12662005|P2|COMPLETED|Overall Study||487
5147749|NCT01323647|12662006|P1|COMPLETED|Overall Study||461
5147750|NCT01323647|12662005|P2|STARTED|Overall Study||487
5147751|NCT01323647|12662006|P1|STARTED|Overall Study||470
5147752|NCT01323634|12662023|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
5147753|NCT01323634|12662024|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
5147754|NCT01323634|12662025|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
5147755|NCT01323634|12662023|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
5147756|NCT01323634|12662024|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
5147757|NCT01323634|12662025|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
5147758|NCT01323634|12662023|P3|STARTED|Double-Blind (DB) Treatment Period||261
5147759|NCT01323634|12662024|P2|STARTED|Double-Blind (DB) Treatment Period||260
5147760|NCT01323634|12662025|P1|STARTED|Double-Blind (DB) Treatment Period||0
5147761|NCT01323634|12662023|P3|NOT COMPLETED|2-week Run-in Period||0
5147762|NCT01323634|12662024|P2|NOT COMPLETED|2-week Run-in Period||0
5147763|NCT01323634|12662025|P1|NOT COMPLETED|2-week Run-in Period||212
5147764|NCT01323634|12662023|P3|COMPLETED|2-week Run-in Period||0
5147765|NCT01323634|12662024|P2|COMPLETED|2-week Run-in Period||0
5147766|NCT01323634|12662025|P1|COMPLETED|2-week Run-in Period||521
5147767|NCT01323634|12662023|P3|STARTED|2-week Run-in Period||0
5147768|NCT01323634|12662024|P2|STARTED|2-week Run-in Period||0
5147769|NCT01323634|12662025|P1|STARTED|2-week Run-in Period||733
5147770|NCT01323621|12662035|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
5147771|NCT01323621|12662036|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
5147772|NCT01323621|12662037|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
5147773|NCT01323621|12662035|P3|COMPLETED|12-week, Double-blind Treatment Period||239
5147774|NCT01323621|12662036|P2|COMPLETED|12-week, Double-blind Treatment Period||237
5147775|NCT01323621|12662037|P1|COMPLETED|12-week, Double-blind Treatment Period||0
5147776|NCT01323621|12662035|P3|STARTED|12-week, Double-blind Treatment Period||259
5147777|NCT01323621|12662036|P2|STARTED|12-week, Double-blind Treatment Period||252
5147778|NCT01323621|12662037|P1|STARTED|12-week, Double-blind Treatment Period||0
5147779|NCT01323621|12662035|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
5147780|NCT01323621|12662036|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
5147781|NCT01323621|12662037|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
5147782|NCT01323621|12662035|P3|COMPLETED|2-week, Single-blind Run In Period||0
5147783|NCT01323621|12662036|P2|COMPLETED|2-week, Single-blind Run In Period||0
5147784|NCT01323621|12662037|P1|COMPLETED|2-week, Single-blind Run In Period||511
5147785|NCT01323621|12662035|P3|STARTED|2-week, Single-blind Run In Period||0
5147786|NCT01323621|12662036|P2|STARTED|2-week, Single-blind Run In Period||0
5147787|NCT01323621|12662037|P1|STARTED|2-week, Single-blind Run In Period||739
5147788|NCT01323595|12662047|P2|NOT COMPLETED|Overall Study||21
5147789|NCT01323595|12662048|P1|NOT COMPLETED|Overall Study||23
5147790|NCT01323595|12662047|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
5147791|NCT01323595|12662048|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
5147792|NCT01323595|12662047|P2|STARTED|Overall Study||39
5147793|NCT01323595|12662048|P1|STARTED|Overall Study||39
5147794|NCT01323582|12662058|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
5147795|NCT01323582|12662059|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
5147796|NCT01323582|12662058|P2|COMPLETED|Weeks 8-11 (Period 2)||10
5147797|NCT01323582|12662059|P1|COMPLETED|Weeks 8-11 (Period 2)||10
5147798|NCT01323582|12662058|P2|STARTED|Weeks 8-11 (Period 2)||11
5147799|NCT01323582|12662059|P1|STARTED|Weeks 8-11 (Period 2)||10
5147800|NCT01323582|12662058|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
5147801|NCT01323582|12662059|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
5147802|NCT01323582|12662058|P2|COMPLETED|Weeks 5-7 (Washout)||11
5147803|NCT01323582|12662059|P1|COMPLETED|Weeks 5-7 (Washout)||10
5147804|NCT01323582|12662058|P2|STARTED|Weeks 5-7 (Washout)||12
5147805|NCT01323582|12662059|P1|STARTED|Weeks 5-7 (Washout)||10
5147806|NCT01323582|12662058|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
5147807|NCT01323582|12662059|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
5147808|NCT01323582|12662058|P2|COMPLETED|Weeks 1-4 (First Period)||12
5147809|NCT01323582|12662059|P1|COMPLETED|Weeks 1-4 (First Period)||10
5147810|NCT01323582|12662058|P2|STARTED|Weeks 1-4 (First Period)||14
5147811|NCT01323582|12662059|P1|STARTED|Weeks 1-4 (First Period)||12
5147812|NCT01323517|12662075|P1|NOT COMPLETED|Overall Study||0
5147813|NCT01323517|12662075|P1|COMPLETED|Overall Study||26
5147814|NCT01323517|12662075|P1|STARTED|Overall Study||26
5147815|NCT01323478|12662082|P1|NOT COMPLETED|Overall Study||24
5147816|NCT01323478|12662082|P1|COMPLETED|Overall Study||47
5147817|NCT01323478|12662082|P1|STARTED|Overall Study||71
5147818|NCT01323387|12662095|P1|NOT COMPLETED|Overall Study||84
5147819|NCT01323387|12662095|P1|COMPLETED|Overall Study||94
5147820|NCT01323387|12662095|P1|STARTED|Overall Study||178
5147821|NCT01323270|12662108|P2|NOT COMPLETED|Overall Study||29
5147822|NCT01323270|12662109|P1|NOT COMPLETED|Overall Study||43
5147823|NCT01323270|12662108|P2|COMPLETED|Overall Study||347
5147824|NCT01323270|12662109|P1|COMPLETED|Overall Study||330
5147825|NCT01323270|12662108|P2|STARTED|Overall Study||376
5147826|NCT01323270|12662109|P1|STARTED|Overall Study||373
5147827|NCT01323192|12662131|P2|NOT COMPLETED|Overall Study||6
5147828|NCT01323192|12662132|P1|NOT COMPLETED|Overall Study||9
5147829|NCT01323192|12662131|P2|COMPLETED|Overall Study||135
5147830|NCT01323192|12662132|P1|COMPLETED|Overall Study||134
5147831|NCT01323192|12662131|P2|STARTED|Overall Study||141
5147832|NCT01323192|12662132|P1|STARTED|Overall Study||143
5147833|NCT01323153|12662150|P2|NOT COMPLETED|Overall Study||8
5147834|NCT01323153|12662151|P1|NOT COMPLETED|Overall Study||17
5147835|NCT01323153|12662150|P2|COMPLETED|Overall Study||142
5147836|NCT01323153|12662151|P1|COMPLETED|Overall Study||133
5147837|NCT01323153|12662150|P2|STARTED|Overall Study||150
5147838|NCT01323153|12662151|P1|STARTED|Overall Study||150
5147839|NCT01323140|12662157|P1|NOT COMPLETED|Overall Study||2
5147840|NCT01323140|12662157|P1|COMPLETED|Overall Study||38
5147841|NCT01323140|12662157|P1|STARTED|Overall Study||40
5147842|NCT01323010|12662163|P2|NOT COMPLETED|Overall Study||0
5147843|NCT01323010|12662164|P1|NOT COMPLETED|Overall Study||0
5147844|NCT01323010|12662163|P2|COMPLETED|Overall Study||59
5147845|NCT01323010|12662164|P1|COMPLETED|Overall Study||60
5147846|NCT01323010|12662163|P2|STARTED|Overall Study||59
5147847|NCT01323010|12662164|P1|STARTED|Overall Study||60
5147848|NCT01322971|12662215|P2|NOT COMPLETED|Overall Study||1
5147849|NCT01322971|12662216|P1|NOT COMPLETED|Overall Study||1
5147850|NCT01322971|12662215|P2|COMPLETED|Overall Study||0
5147851|NCT01322971|12662216|P1|COMPLETED|Overall Study||0
5147852|NCT01322971|12662215|P2|STARTED|Overall Study||1
5147853|NCT01322971|12662216|P1|STARTED|Overall Study||1
5147854|NCT01322945|12662230|P2|NOT COMPLETED|Overall Study||0
5147855|NCT01322945|12662231|P1|NOT COMPLETED|Overall Study||0
5147856|NCT01322945|12662230|P2|COMPLETED|Overall Study||42
5147857|NCT01322945|12662231|P1|COMPLETED|Overall Study||52
5147858|NCT01322945|12662230|P2|STARTED|Overall Study||42
5147859|NCT01322945|12662231|P1|STARTED|Overall Study||52
5147860|NCT01322841|12662241|P2|NOT COMPLETED|Overall Study||0
5147861|NCT01322841|12662242|P1|NOT COMPLETED|Overall Study||0
5147862|NCT01322841|12662241|P2|COMPLETED|Overall Study||1123
5147863|NCT01322841|12662242|P1|COMPLETED|Overall Study||1116
5147864|NCT01322841|12662241|P2|STARTED|Overall Study||1123
5147865|NCT01322841|12662242|P1|STARTED|Overall Study||1116
5147866|NCT01322815|12662252|P2|NOT COMPLETED|Overall Study||0
5147867|NCT01322815|12662253|P1|NOT COMPLETED|Overall Study||0
5147868|NCT01322815|12662252|P2|COMPLETED|Overall Study||4
5147869|NCT01322815|12662253|P1|COMPLETED|Overall Study||7
5147870|NCT01322815|12662252|P2|STARTED|Overall Study||4
5147871|NCT01322815|12662253|P1|STARTED|Overall Study||7
5147872|NCT01322633|12662261|P2|NOT COMPLETED|Overall Study||0
5147873|NCT01322633|12662262|P1|NOT COMPLETED|Overall Study||0
5147874|NCT01322633|12662261|P2|COMPLETED|Overall Study||27686
5147875|NCT01322633|12662262|P1|COMPLETED|Overall Study||34178
5147876|NCT01322633|12662261|P2|STARTED|Overall Study||27686
5147877|NCT01322633|12662262|P1|STARTED|Overall Study||34178
5147878|NCT01322607|12662274|P2|NOT COMPLETED|Overall Study||0
5147879|NCT01322607|12662275|P1|NOT COMPLETED|Overall Study||1
5147880|NCT01322607|12662274|P2|COMPLETED|Overall Study||9
5147881|NCT01322607|12662275|P1|COMPLETED|Overall Study||10
5147882|NCT01322607|12662274|P2|STARTED|Overall Study||9
5147883|NCT01322607|12662275|P1|STARTED|Overall Study||11
5147884|NCT01322594|12662293|P6|NOT COMPLETED|Overall Study||0
5147885|NCT01322594|12662294|P5|NOT COMPLETED|Overall Study||0
5147886|NCT01322594|12662295|P4|NOT COMPLETED|Overall Study||0
5147887|NCT01322594|12662296|P3|NOT COMPLETED|Overall Study||0
5147888|NCT01322594|12662297|P2|NOT COMPLETED|Overall Study||0
5147889|NCT01322594|12662298|P1|NOT COMPLETED|Overall Study||0
5147890|NCT01322594|12662293|P6|COMPLETED|Overall Study||6
5147891|NCT01322594|12662294|P5|COMPLETED|Overall Study||7
5147892|NCT01322594|12662295|P4|COMPLETED|Overall Study||6
5147893|NCT01322594|12662296|P3|COMPLETED|Overall Study||3
5147894|NCT01322594|12662297|P2|COMPLETED|Overall Study||3
5147895|NCT01322594|12662298|P1|COMPLETED|Overall Study||6
5147896|NCT01322594|12662293|P6|STARTED|Overall Study||6
5147897|NCT01322594|12662294|P5|STARTED|Overall Study||7
5147898|NCT01322594|12662295|P4|STARTED|Overall Study||6
5147899|NCT01322594|12662296|P3|STARTED|Overall Study||3
5147900|NCT01322594|12662297|P2|STARTED|Overall Study||3
5147901|NCT01322594|12662298|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
5147902|NCT01322490|12662381|P3|NOT COMPLETED|Long Term Follow-up Period||413
5147903|NCT01322490|12662382|P2|NOT COMPLETED|Long Term Follow-up Period||408
5147904|NCT01322490|12662383|P1|NOT COMPLETED|Long Term Follow-up Period||409
5147905|NCT01322490|12662381|P3|COMPLETED|Long Term Follow-up Period||0
5147906|NCT01322490|12662382|P2|COMPLETED|Long Term Follow-up Period||0
5147907|NCT01322490|12662383|P1|COMPLETED|Long Term Follow-up Period||0
5147908|NCT01322490|12662381|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
5147909|NCT01322490|12662382|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
5147910|NCT01322490|12662383|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
5147911|NCT01322490|12662381|P3|NOT COMPLETED|Treatment Period||153
5147912|NCT01322490|12662382|P2|NOT COMPLETED|Treatment Period||153
5147913|NCT01322490|12662383|P1|NOT COMPLETED|Treatment Period||132
5147914|NCT01322490|12662381|P3|COMPLETED|Treatment Period||280
5147915|NCT01322490|12662382|P2|COMPLETED|Treatment Period||279
5147916|NCT01322490|12662383|P1|COMPLETED|Treatment Period||300
5147917|NCT01322490|12662381|P3|Treated|Treatment Period||428
5147918|NCT01322490|12662382|P2|Treated|Treatment Period||429
5147919|NCT01322490|12662383|P1|Treated|Treatment Period||429
5147920|NCT01322490|12662381|P3|STARTED|Treatment Period||433
5147921|NCT01322490|12662382|P2|STARTED|Treatment Period||432
5147922|NCT01322490|12662383|P1|STARTED|Treatment Period||432
5147923|NCT01322386|12662396|P2|NOT COMPLETED|Overall Study||2
5147924|NCT01322386|12662397|P1|NOT COMPLETED|Overall Study||0
5147925|NCT01322386|12662396|P2|COMPLETED|Overall Study||9
5147926|NCT01322386|12662397|P1|COMPLETED|Overall Study||10
5147927|NCT01322386|12662396|P2|STARTED|Overall Study||11
5147928|NCT01322386|12662397|P1|STARTED|Overall Study||10
5147929|NCT01322360|12662405|P1|NOT COMPLETED|Overall Study||0
5147930|NCT01322360|12662405|P1|COMPLETED|Overall Study||50
5147931|NCT01322360|12662405|P1|STARTED|Overall Study||50
5147932|NCT01322347|12662412|P2|NOT COMPLETED|Overall Study||35
5147933|NCT01322347|12662413|P1|NOT COMPLETED|Overall Study||51
5147934|NCT01322347|12662412|P2|COMPLETED|Overall Study||112
5147935|NCT01322347|12662413|P1|COMPLETED|Overall Study||96
5147936|NCT01322347|12662412|P2|Completed St 3|Overall Study||86
5147937|NCT01322347|12662413|P1|Completed St 3|Overall Study||82
5147938|NCT01322347|12662412|P2|Enrolled in St 3|Overall Study||113
5147939|NCT01322347|12662413|P1|Enrolled in St 3|Overall Study||101
5147940|NCT01322347|12662412|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
5147941|NCT01322347|12662413|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
5147942|NCT01322347|12662412|P2|Completed 48 Wks in St 2|Overall Study||22
5147943|NCT01322347|12662413|P1|Completed 48 Wks in St 2|Overall Study||28
5147944|NCT01322347|12662412|P2|STARTED|Overall Study||147
5147945|NCT01322347|12662413|P1|STARTED|Overall Study||147
5147946|NCT01322048|12662450|P2|NOT COMPLETED|Overall Study||0
5147947|NCT01322048|12662451|P1|NOT COMPLETED|Overall Study||0
5147948|NCT01322048|12662450|P2|COMPLETED|Overall Study||26
5147949|NCT01322048|12662451|P1|COMPLETED|Overall Study||21
5147950|NCT01322048|12662450|P2|STARTED|Overall Study||26
5147951|NCT01322048|12662451|P1|STARTED|Overall Study||21
5147952|NCT01322022|12662461|P2|NOT COMPLETED|Overall Study||2
5147953|NCT01322022|12662462|P1|NOT COMPLETED|Overall Study||5
5147954|NCT01322022|12662461|P2|COMPLETED|Overall Study||18
5147955|NCT01322022|12662462|P1|COMPLETED|Overall Study||15
5147956|NCT01322022|12662461|P2|Week 4|Overall Study||18
5147957|NCT01322022|12662462|P1|Week 4|Overall Study||15
5147958|NCT01322022|12662461|P2|STARTED|Overall Study||20
5147959|NCT01322022|12662462|P1|STARTED|Overall Study||20
5147960|NCT01322009|12662476|P2|NOT COMPLETED|Overall Study||3
5147961|NCT01322009|12662477|P1|NOT COMPLETED|Overall Study||0
5147962|NCT01322009|12662476|P2|COMPLETED|Overall Study||4
5147963|NCT01322009|12662477|P1|COMPLETED|Overall Study||7
5147964|NCT01322009|12662476|P2|STARTED|Overall Study||7
5147965|NCT01322009|12662477|P1|STARTED|Overall Study||7
5147966|NCT01321879|12662485|P1|NOT COMPLETED|Overall Study||14
5147967|NCT01321879|12662485|P1|COMPLETED|Overall Study||25
5147968|NCT01321879|12662485|P1|STARTED|Overall Study||39
5147969|NCT01321749|12662491|P2|NOT COMPLETED|Overall Study||22
5147970|NCT01321749|12662492|P1|NOT COMPLETED|Overall Study||13
5147971|NCT01321749|12662491|P2|COMPLETED|Overall Study||30
5147972|NCT01321749|12662492|P1|COMPLETED|Overall Study||38
5147973|NCT01321749|12662491|P2|STARTED|Overall Study||52
5147974|NCT01321749|12662492|P1|STARTED|Overall Study||51
5147975|NCT01321723|12662501|P3|NOT COMPLETED|Overall Study||4
5147976|NCT01321723|12662502|P2|NOT COMPLETED|Overall Study||5
5147977|NCT01321723|12662503|P1|NOT COMPLETED|Overall Study||5
5147978|NCT01321723|12662501|P3|COMPLETED|Overall Study||28
5147979|NCT01321723|12662502|P2|COMPLETED|Overall Study||28
5147980|NCT01321723|12662503|P1|COMPLETED|Overall Study||27
5147981|NCT01321723|12662501|P3|STARTED|Overall Study||32
5147982|NCT01321723|12662502|P2|STARTED|Overall Study||33
5147983|NCT01321723|12662503|P1|STARTED|Overall Study||32
5147984|NCT01321710|12662525|P3|NOT COMPLETED|Overall Study||0
5147985|NCT01321710|12662526|P2|NOT COMPLETED|Overall Study||5
5147986|NCT01321710|12662527|P1|NOT COMPLETED|Overall Study||4
5147987|NCT01321710|12662525|P3|COMPLETED|Overall Study||44
5147988|NCT01321710|12662526|P2|COMPLETED|Overall Study||53
5147989|NCT01321710|12662527|P1|COMPLETED|Overall Study||46
5147990|NCT01321710|12662525|P3|STARTED|Overall Study||44
5147991|NCT01321710|12662526|P2|STARTED|Overall Study||58
5147992|NCT01321710|12662527|P1|STARTED|Overall Study||50
5147993|NCT01321697|12662542|P1|NOT COMPLETED|Overall Study||7
5147994|NCT01321697|12662542|P1|COMPLETED|Overall Study||0
5147995|NCT01321697|12662542|P1|STARTED|Overall Study||7
5147996|NCT01321606|12662548|P4|NOT COMPLETED|Overall Study||1
5147997|NCT01321606|12662549|P3|NOT COMPLETED|Overall Study||0
5147998|NCT01321606|12662550|P2|NOT COMPLETED|Overall Study||0
5147999|NCT01321606|12662551|P1|NOT COMPLETED|Overall Study||0
5148000|NCT01321606|12662548|P4|COMPLETED|Overall Study||28
5148001|NCT01321606|12662549|P3|COMPLETED|Overall Study||34
5148002|NCT01321606|12662550|P2|COMPLETED|Overall Study||32
5148003|NCT01321606|12662551|P1|COMPLETED|Overall Study||18
5148004|NCT01321606|12662548|P4|STARTED|Overall Study||29
5148005|NCT01321606|12662549|P3|STARTED|Overall Study||34
5148006|NCT01321606|12662550|P2|STARTED|Overall Study||32
5148007|NCT01321606|12662551|P1|STARTED|Overall Study||18
5148008|NCT01321554|12662571|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
5148009|NCT01321554|12662572|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
5148010|NCT01321554|12662573|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
5148011|NCT01321554|12662574|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
5148012|NCT01321554|12662571|P4|COMPLETED|OOL Lenvatinib Treatment Period||30
5148013|NCT01321554|12662572|P3|COMPLETED|OOL Lenvatinib Treatment Period||85
5148014|NCT01321554|12662573|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
5148015|NCT01321554|12662574|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
5148016|NCT01321554|12662571|P4|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
5148017|NCT01321554|12662572|P3|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
5148018|NCT01321554|12662573|P2|STARTED|OOL Lenvatinib Treatment Period||0
5148019|NCT01321554|12662574|P1|STARTED|OOL Lenvatinib Treatment Period||0
5148020|NCT01321554|12662571|P4|NOT COMPLETED|Randomization Phase||0
5148021|NCT01321554|12662572|P3|NOT COMPLETED|Randomization Phase||0
5148022|NCT01321554|12662573|P2|NOT COMPLETED|Randomization Phase||0
5148023|NCT01321554|12662574|P1|NOT COMPLETED|Randomization Phase||0
5148024|NCT01321554|12662571|P4|COMPLETED|Randomization Phase||0
5148025|NCT01321554|12662572|P3|COMPLETED|Randomization Phase||0
5148026|NCT01321554|12662573|P2|COMPLETED|Randomization Phase||131
5148027|NCT01321554|12662574|P1|COMPLETED|Randomization Phase||261
5148028|NCT01321554|12662571|P4|STARTED|Randomization Phase||0
5148029|NCT01321554|12662572|P3|STARTED|Randomization Phase||0
5148030|NCT01321554|12662573|P2|STARTED|Randomization Phase||131
5148031|NCT01321554|12662574|P1|STARTED|Randomization Phase||261
5148032|NCT01321073|12662587|P1|NOT COMPLETED|Overall Study||7
5148033|NCT01321073|12662587|P1|COMPLETED|Overall Study||57
5148034|NCT01321073|12662587|P1|STARTED|Overall Study||64
5148035|NCT01321008|12662591|P1|NOT COMPLETED|Overall Study||1
5148036|NCT01321008|12662591|P1|COMPLETED|Overall Study||0
5148037|NCT01321008|12662591|P1|STARTED|Overall Study||1
5148038|NCT01320943|12662597|P2|NOT COMPLETED|Overall Study||2
5148039|NCT01320943|12662598|P1|NOT COMPLETED|Overall Study||1
5148040|NCT01320943|12662597|P2|COMPLETED|Overall Study||20
5148041|NCT01320943|12662598|P1|COMPLETED|Overall Study||20
5148042|NCT01320943|12662597|P2|STARTED|Overall Study||22
5148043|NCT01320943|12662598|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
5148044|NCT01320826|12662617|P1|NOT COMPLETED|Overall Study||0
5148045|NCT01320826|12662617|P1|COMPLETED|Overall Study||577
5148046|NCT01320826|12662617|P1|STARTED|Overall Study||577
5148047|NCT01320735|12662632|P1|NOT COMPLETED|Overall Study||106
5148048|NCT01320735|12662632|P1|COMPLETED|Overall Study||194
5148049|NCT01320735|12662632|P1|STARTED|Overall Study||300
5148050|NCT01320722|12662654|P5|NOT COMPLETED|Overall Study||8
5148051|NCT01320722|12662655|P4|NOT COMPLETED|Overall Study||14
5148052|NCT01320722|12662656|P3|NOT COMPLETED|Overall Study||7
5148053|NCT01320722|12662657|P2|NOT COMPLETED|Overall Study||6
5148054|NCT01320722|12662658|P1|NOT COMPLETED|Overall Study||3
5148055|NCT01320722|12662654|P5|COMPLETED|Overall Study||45
5148056|NCT01320722|12662655|P4|COMPLETED|Overall Study||35
5148057|NCT01320722|12662656|P3|COMPLETED|Overall Study||40
5148058|NCT01320722|12662657|P2|COMPLETED|Overall Study||41
5148059|NCT01320722|12662658|P1|COMPLETED|Overall Study||43
5148060|NCT01320722|12662654|P5|Received Intervention|Overall Study||51
5148061|NCT01320722|12662655|P4|Received Intervention|Overall Study||48
5148062|NCT01320722|12662656|P3|Received Intervention|Overall Study||46
5148063|NCT01320722|12662657|P2|Received Intervention|Overall Study||45
5148064|NCT01320722|12662658|P1|Received Intervention|Overall Study||43
5148065|NCT01320722|12662654|P5|STARTED|Overall Study||53
5148066|NCT01320722|12662655|P4|STARTED|Overall Study||49
5148067|NCT01320722|12662656|P3|STARTED|Overall Study||47
5148068|NCT01320722|12662657|P2|STARTED|Overall Study||47
5148069|NCT01320722|12662658|P1|STARTED|Overall Study||46
5148070|NCT01320683|12662695|P1|NOT COMPLETED|Overall Study||1
5148071|NCT01320683|12662695|P1|COMPLETED|Overall Study||0
5148072|NCT01320683|12662695|P1|STARTED|Overall Study||1
5148073|NCT01320553|12662704|P4|NOT COMPLETED|Overall Study||1
5148074|NCT01320553|12662705|P3|NOT COMPLETED|Overall Study||2
5148075|NCT01320553|12662706|P2|NOT COMPLETED|Overall Study||4
5148076|NCT01320553|12662707|P1|NOT COMPLETED|Overall Study||1
5148077|NCT01320553|12662704|P4|COMPLETED|Overall Study||29
5148078|NCT01320553|12662705|P3|COMPLETED|Overall Study||29
5148079|NCT01320553|12662706|P2|COMPLETED|Overall Study||26
5148080|NCT01320553|12662707|P1|COMPLETED|Overall Study||30
5148081|NCT01320553|12662704|P4|STARTED|Overall Study||30
5148082|NCT01320553|12662705|P3|STARTED|Overall Study||31
5148083|NCT01320553|12662706|P2|STARTED|Overall Study||30
5148084|NCT01320553|12662707|P1|STARTED|Overall Study||31
5148085|NCT01320293|12662721|P1|NOT COMPLETED|Overall Study||2
5148086|NCT01320293|12662721|P1|COMPLETED|Overall Study||16
5148087|NCT01320293|12662721|P1|STARTED|Overall Study||18
5148088|NCT01320202|12662729|P2|NOT COMPLETED|Overall Study||44
5148089|NCT01320202|12662730|P1|NOT COMPLETED|Overall Study||56
5148090|NCT01320202|12662729|P2|COMPLETED|Overall Study||109
5148091|NCT01320202|12662730|P1|COMPLETED|Overall Study||96
5148092|NCT01320202|12662729|P2|Completed St 3|Overall Study||82
5148093|NCT01320202|12662730|P1|Completed St 3|Overall Study||79
5148094|NCT01320202|12662729|P2|Enrolled in St 3|Overall Study||109
5148095|NCT01320202|12662730|P1|Enrolled in St 3|Overall Study||98
5148096|NCT01320202|12662729|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
5148097|NCT01320202|12662730|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
5148098|NCT01320202|12662729|P2|Comp 48 Wks in St 2|Overall Study||27
5148099|NCT01320202|12662730|P1|Comp 48 Wks in St 2|Overall Study||27
5148100|NCT01320202|12662729|P2|STARTED|Overall Study||153
5148101|NCT01320202|12662730|P1|STARTED|Overall Study||152
5148102|NCT01320150|12662767|P1|NOT COMPLETED|Overall Study||66
5148103|NCT01320150|12662767|P1|COMPLETED|Overall Study||245
5148104|NCT01320150|12662767|P1|Non-PPP|Overall Study||211
5148105|NCT01320150|12662767|P1|PPP|Overall Study||34
5148106|NCT01320150|12662767|P1|STARTED|Overall Study||311
5148107|NCT01320137|12662773|P2|NOT COMPLETED|Overall Study||0
5148108|NCT01320137|12662774|P1|NOT COMPLETED|Overall Study||0
5148109|NCT01320137|12662773|P2|COMPLETED|Overall Study||40
5148110|NCT01320137|12662774|P1|COMPLETED|Overall Study||40
5148111|NCT01320137|12662773|P2|STARTED|Overall Study||40
5148112|NCT01320137|12662774|P1|STARTED|Overall Study||40
5148113|NCT01320072|12662788|P2|NOT COMPLETED|Overall Study||0
5148114|NCT01320072|12662789|P1|NOT COMPLETED|Overall Study||0
5148115|NCT01320072|12662788|P2|COMPLETED|Overall Study||13
5148116|NCT01320072|12662789|P1|COMPLETED|Overall Study||16
5148117|NCT01320072|12662788|P2|STARTED|Overall Study||13
5148118|NCT01320072|12662789|P1|STARTED|Overall Study||16
5148119|NCT01320033|12662801|P3|NOT COMPLETED|Overall Study||53
5148120|NCT01320033|12662802|P2|NOT COMPLETED|Overall Study||64
5148121|NCT01320033|12662803|P1|NOT COMPLETED|Overall Study||58
5148122|NCT01320033|12662801|P3|COMPLETED|Overall Study||169
5148123|NCT01320033|12662802|P2|COMPLETED|Overall Study||160
5148124|NCT01320033|12662803|P1|COMPLETED|Overall Study||158
5148125|NCT01320033|12662801|P3|STARTED|Overall Study||222
5148126|NCT01320033|12662802|P2|STARTED|Overall Study||224
5148127|NCT01320033|12662803|P1|STARTED|Overall Study||216
5148128|NCT01319994|12662831|P2|NOT COMPLETED|Overall Study||6
5148129|NCT01319994|12662832|P1|NOT COMPLETED|Overall Study||7
5148130|NCT01319994|12662831|P2|COMPLETED|Overall Study||21
5148131|NCT01319994|12662832|P1|COMPLETED|Overall Study||19
5148132|NCT01319994|12662831|P2|Did Not Develop Overt Diabetes|Overall Study||21
5148133|NCT01319994|12662832|P1|Did Not Develop Overt Diabetes|Overall Study||19
5148134|NCT01319994|12662831|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
5148135|NCT01319994|12662832|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
5148136|NCT01319994|12662831|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
5148137|NCT01319994|12662832|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
5148138|NCT01319994|12662831|P2|Abto Keep Appoinment Shedule|Overall Study||24
5148139|NCT01319994|12662832|P1|Abto Keep Appoinment Shedule|Overall Study||23
5148140|NCT01319994|12662831|P2|STARTED|Overall Study||27
5148141|NCT01319994|12662832|P1|STARTED|Overall Study||26
5148142|NCT01319929|12662842|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
5148143|NCT01319929|12662843|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
5148144|NCT01319929|12662842|P2|COMPLETED|Second Treatment Period (4 Weeks)||16
5148145|NCT01319929|12662843|P1|COMPLETED|Second Treatment Period (4 Weeks)||16
5148146|NCT01319929|12662842|P2|STARTED|Second Treatment Period (4 Weeks)||17
5148147|NCT01319929|12662843|P1|STARTED|Second Treatment Period (4 Weeks)||17
5148148|NCT01319929|12662842|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
5148149|NCT01319929|12662843|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
5148150|NCT01319929|12662842|P2|COMPLETED|Washout Period (3 Weeks)||17
5148151|NCT01319929|12662843|P1|COMPLETED|Washout Period (3 Weeks)||17
5148152|NCT01319929|12662842|P2|STARTED|Washout Period (3 Weeks)||17
5148153|NCT01319929|12662843|P1|STARTED|Washout Period (3 Weeks)||17
5148154|NCT01319929|12662842|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||2
5148155|NCT01319929|12662843|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||3
5148156|NCT01319929|12662842|P2|COMPLETED|First Treatment Period (4 Weeks)||17
5148157|NCT01319929|12662843|P1|COMPLETED|First Treatment Period (4 Weeks)||17
5148158|NCT01319929|12662842|P2|STARTED|First Treatment Period (4 Weeks)||19
5148159|NCT01319929|12662843|P1|STARTED|First Treatment Period (4 Weeks)||20
5148160|NCT01319877|12662875|P2|NOT COMPLETED|Overall Study||45
5148161|NCT01319877|12662876|P1|NOT COMPLETED|Overall Study||108
5148162|NCT01319877|12662875|P2|COMPLETED|Overall Study||108
5148163|NCT01319877|12662876|P1|COMPLETED|Overall Study||345
5148164|NCT01319877|12662875|P2|STARTED|Overall Study||153
5148165|NCT01319877|12662876|P1|STARTED|Overall Study||453
5148166|NCT01319851|12662911|P1|NOT COMPLETED|Overall Study||0
5148167|NCT01319851|12662911|P1|COMPLETED|Overall Study||3
5148168|NCT01319851|12662911|P1|STARTED|Overall Study||3
5148169|NCT01319812|12662923|P2|NOT COMPLETED|Overall Study||22
5148170|NCT01319812|12662924|P1|NOT COMPLETED|Overall Study||16
5148171|NCT01319812|12662923|P2|COMPLETED|Overall Study||280
5148172|NCT01319812|12662924|P1|COMPLETED|Overall Study||145
5148173|NCT01319812|12662923|P2|STARTED|Overall Study||302
5148174|NCT01319812|12662924|P1|STARTED|Overall Study||161
5148175|NCT01319799|12663005|P1|NOT COMPLETED|Overall Study||0
5148176|NCT01319799|12663005|P1|COMPLETED|Overall Study||10
5148177|NCT01319799|12663005|P1|STARTED|Overall Study||10
5148178|NCT01319773|12663015|P5|NOT COMPLETED|Overall Study||0
5148179|NCT01319773|12663016|P4|NOT COMPLETED|Overall Study||0
5148180|NCT01319773|12663017|P3|NOT COMPLETED|Overall Study||0
5148181|NCT01319773|12663018|P2|NOT COMPLETED|Overall Study||0
5148182|NCT01319773|12663019|P1|NOT COMPLETED|Overall Study||0
5148183|NCT01319773|12663015|P5|COMPLETED|Overall Study||8
5148184|NCT01319773|12663016|P4|COMPLETED|Overall Study||8
5148185|NCT01319773|12663017|P3|COMPLETED|Overall Study||8
5148186|NCT01319773|12663018|P2|COMPLETED|Overall Study||10
5148187|NCT01319773|12663019|P1|COMPLETED|Overall Study||10
5148188|NCT01319773|12663015|P5|STARTED|Overall Study||8
5148189|NCT01319773|12663016|P4|STARTED|Overall Study||8
5148190|NCT01319773|12663017|P3|STARTED|Overall Study||8
5148191|NCT01319773|12663018|P2|STARTED|Overall Study||10
5148192|NCT01319773|12663019|P1|STARTED|Overall Study||10
5148193|NCT01319760|12663035|P2|NOT COMPLETED|Overall Study||0
5148194|NCT01319760|12663036|P1|NOT COMPLETED|Overall Study||0
5148195|NCT01319760|12663035|P2|COMPLETED|Overall Study||5
5148196|NCT01319760|12663036|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
5148197|NCT01319760|12663035|P2|STARTED|Overall Study||5
5148198|NCT01319760|12663036|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
5148199|NCT01319721|12663044|P2|NOT COMPLETED|Overall Study||6
5148200|NCT01319721|12663045|P1|NOT COMPLETED|Overall Study||1
5148201|NCT01319721|12663044|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
5148202|NCT01319721|12663045|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
5148203|NCT01319721|12663044|P2|STARTED|Overall Study|The unit of measure is eyes.|48
5148204|NCT01319721|12663045|P1|STARTED|Overall Study|The unit of measure is eyes.|48
5148205|NCT01319617|12663059|P1|NOT COMPLETED|Overall Study||1
5148206|NCT01319617|12663059|P1|COMPLETED|Overall Study||40
5148207|NCT01319617|12663059|P1|STARTED|Overall Study||41
5148208|NCT01319552|12663063|P1|NOT COMPLETED|Overall Study||0
5148209|NCT01319552|12663063|P1|COMPLETED|Overall Study||14
5148210|NCT01319552|12663063|P1|STARTED|Overall Study||14
5148211|NCT01319539|12663068|P1|NOT COMPLETED|Overall Study||0
5148212|NCT01319539|12663068|P1|COMPLETED|Overall Study||12
5148213|NCT01319539|12663068|P1|STARTED|Overall Study||12
5148214|NCT01319500|12663078|P2|NOT COMPLETED|Overall Study||0
5148215|NCT01319500|12663079|P1|NOT COMPLETED|Overall Study||0
5148216|NCT01319500|12663078|P2|COMPLETED|Overall Study||2589
5148217|NCT01319500|12663079|P1|COMPLETED|Overall Study||1187
5148218|NCT01319500|12663078|P2|STARTED|Overall Study||2589
5148219|NCT01319500|12663079|P1|STARTED|Overall Study||1187
5148220|NCT01319422|12663098|P2|NOT COMPLETED|Overall Study||0
5148221|NCT01319422|12663099|P1|NOT COMPLETED|Overall Study||1
5148222|NCT01319422|12663098|P2|COMPLETED|Overall Study||20
5148223|NCT01319422|12663099|P1|COMPLETED|Overall Study||19
5148224|NCT01319422|12663098|P2|STARTED|Overall Study||20
5148225|NCT01319422|12663099|P1|STARTED|Overall Study||20
5148226|NCT01319396|12663113|P1|NOT COMPLETED|Overall Study||0
5148227|NCT01319396|12663113|P1|COMPLETED|Overall Study||24
5148228|NCT01319396|12663113|P1|STARTED|Overall Study||24
5148229|NCT01319383|12663117|P2|NOT COMPLETED|Overall Study||10
5148230|NCT01319383|12663118|P1|NOT COMPLETED|Overall Study||12
5148231|NCT01319383|12663117|P2|COMPLETED|Overall Study||3
5148232|NCT01319383|12663118|P1|COMPLETED|Overall Study||0
5148233|NCT01319383|12663117|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
5148234|NCT01319383|12663118|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
5148235|NCT01319383|12663117|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
5148236|NCT01319383|12663118|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
5148237|NCT01319383|12663117|P2|Step 2|Overall Study||0
5148238|NCT01319383|12663118|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
5148239|NCT01319383|12663117|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
5148240|NCT01319383|12663118|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
5148241|NCT01319383|12663117|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
5148242|NCT01319383|12663118|P1|Step 1|Overall Study||8
5148243|NCT01319383|12663117|P2|STARTED|Overall Study||13
5148244|NCT01319383|12663118|P1|STARTED|Overall Study||12
5148245|NCT01319318|12663135|P1|NOT COMPLETED|Overall Study||0
5148246|NCT01319318|12663135|P1|COMPLETED|Overall Study||25
5148247|NCT01319318|12663135|P1|STARTED|Overall Study||25
5148248|NCT01319110|12663141|P2|NOT COMPLETED|Overall Study||0
5148249|NCT01319110|12663142|P1|NOT COMPLETED|Overall Study||0
5148250|NCT01319110|12663141|P2|COMPLETED|Overall Study||5
5148251|NCT01319110|12663142|P1|COMPLETED|Overall Study||5
5148252|NCT01319110|12663141|P2|STARTED|Overall Study||5
5148253|NCT01319110|12663142|P1|STARTED|Overall Study||5
5148254|NCT01319045|12663150|P1|NOT COMPLETED|Overall Study||2
5148255|NCT01319045|12663150|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
5148256|NCT01319045|12663150|P1|STARTED|Overall Study||5
5148257|NCT01318993|12663157|P1|NOT COMPLETED|Overall Study||398
5148258|NCT01318993|12663157|P1|COMPLETED|Overall Study||0
5148259|NCT01318993|12663157|P1|STARTED|Overall Study||398
5148260|NCT01318967|12663173|P1|NOT COMPLETED|Overall Study||0
5148261|NCT01318967|12663173|P1|COMPLETED|Overall Study||10
5148262|NCT01318967|12663173|P1|STARTED|Overall Study||10
5148263|NCT01318915|12663178|P1|NOT COMPLETED|Overall Study||1
5148264|NCT01318915|12663178|P1|COMPLETED|Overall Study||9
5148265|NCT01318915|12663178|P1|STARTED|Overall Study||10
5148266|NCT01318902|12663207|P4|NOT COMPLETED|Overall Study||6
5148267|NCT01318902|12663208|P3|NOT COMPLETED|Overall Study||2
5148268|NCT01318902|12663209|P2|NOT COMPLETED|Overall Study||3
5148269|NCT01318902|12663210|P1|NOT COMPLETED|Overall Study||1
5148270|NCT01318902|12663207|P4|COMPLETED|Overall Study||5
5148271|NCT01318902|12663208|P3|COMPLETED|Overall Study||3
5148272|NCT01318902|12663209|P2|COMPLETED|Overall Study||2
5148273|NCT01318902|12663210|P1|COMPLETED|Overall Study||5
5148274|NCT01318902|12663207|P4|STARTED|Overall Study||11
5148275|NCT01318902|12663208|P3|STARTED|Overall Study||5
5148276|NCT01318902|12663209|P2|STARTED|Overall Study||5
5148277|NCT01318902|12663210|P1|STARTED|Overall Study||6
5148278|NCT01318876|12663287|P1|NOT COMPLETED|Day 29 Survey||1825
5148279|NCT01318876|12663287|P1|COMPLETED|Day 29 Survey||5724
5148280|NCT01318876|12663287|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
5148281|NCT01318876|12663287|P1|NOT COMPLETED|Day 8 Survey||1820
5148282|NCT01318876|12663287|P1|COMPLETED|Day 8 Survey||5825
5148283|NCT01318876|12663287|P1|STARTED|Day 8 Survey||7645
5148284|NCT01318811|12663294|P2|NOT COMPLETED|Overall Study||4
5148285|NCT01318811|12663295|P1|NOT COMPLETED|Overall Study||1
5148286|NCT01318811|12663294|P2|COMPLETED|Overall Study||4
5148287|NCT01318811|12663295|P1|COMPLETED|Overall Study||3
5148288|NCT01318811|12663294|P2|STARTED|Overall Study||8
5148289|NCT01318811|12663295|P1|STARTED|Overall Study||4
5148290|NCT01318733|12663303|P1|NOT COMPLETED|Overall Study||170
5148291|NCT01318733|12663303|P1|COMPLETED|Overall Study||279
5148292|NCT01318733|12663303|P1|STARTED|Overall Study||449
5148293|NCT01318694|12663311|P4|NOT COMPLETED|Overall Study||68
5148294|NCT01318694|12663312|P3|NOT COMPLETED|Overall Study||43
5148295|NCT01318694|12663313|P2|NOT COMPLETED|Overall Study||58
5148296|NCT01318694|12663314|P1|NOT COMPLETED|Overall Study||52
5148297|NCT01318694|12663311|P4|COMPLETED|Overall Study||200
5148298|NCT01318694|12663312|P3|COMPLETED|Overall Study||225
5148299|NCT01318694|12663313|P2|COMPLETED|Overall Study||212
5148300|NCT01318694|12663314|P1|COMPLETED|Overall Study||223
5148301|NCT01318694|12663311|P4|Safety Set|Overall Study||265
5148302|NCT01318694|12663312|P3|Safety Set|Overall Study||265
5148303|NCT01318694|12663313|P2|Safety Set|Overall Study||268
5148304|NCT01318694|12663314|P1|Safety Set|Overall Study||273
5148305|NCT01318694|12663311|P4|Full Analysis Set|Overall Study||268
5148306|NCT01318694|12663312|P3|Full Analysis Set|Overall Study||265
5148307|NCT01318694|12663313|P2|Full Analysis Set|Overall Study||270
5148308|NCT01318694|12663314|P1|Full Analysis Set|Overall Study||274
5148309|NCT01318694|12663311|P4|STARTED|Overall Study||268
5148310|NCT01318694|12663312|P3|STARTED|Overall Study||268
5148311|NCT01318694|12663313|P2|STARTED|Overall Study||270
5148312|NCT01318694|12663314|P1|STARTED|Overall Study||275
5148313|NCT01318538|12663370|P3|NOT COMPLETED|Overall Study||0
5148314|NCT01318538|12663371|P2|NOT COMPLETED|Overall Study||0
5148315|NCT01318538|12663372|P1|NOT COMPLETED|Overall Study||0
5148316|NCT01318538|12663370|P3|COMPLETED|Overall Study||8
5148317|NCT01318538|12663371|P2|COMPLETED|Overall Study||106
5148318|NCT01318538|12663372|P1|COMPLETED|Overall Study||52
5148319|NCT01318538|12663370|P3|STARTED|Overall Study||8
5148320|NCT01318538|12663371|P2|STARTED|Overall Study||106
5148321|NCT01318538|12663372|P1|STARTED|Overall Study||52
5148322|NCT01318512|12663396|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
5148323|NCT01318512|12663396|P1|COMPLETED|Maintenance Period (6 Months)||329
5148324|NCT01318512|12663396|P1|STARTED|Maintenance Period (6 Months)||340
5148325|NCT01318512|12663396|P1|NOT COMPLETED|Titration Period (4 Months)||0
5148326|NCT01318512|12663396|P1|COMPLETED|Titration Period (4 Months)||340
5148327|NCT01318512|12663396|P1|STARTED|Titration Period (4 Months)||340
5148328|NCT01318499|12663415|P3|NOT COMPLETED|Overall Study||147
5148329|NCT01318499|12663416|P2|NOT COMPLETED|Overall Study||76
5148330|NCT01318499|12663417|P1|NOT COMPLETED|Overall Study||65
5148331|NCT01318499|12663415|P3|COMPLETED|Overall Study||121
5148332|NCT01318499|12663416|P2|COMPLETED|Overall Study||458
5148333|NCT01318499|12663417|P1|COMPLETED|Overall Study||475
5148334|NCT01318499|12663415|P3|STARTED|Overall Study||268
5148335|NCT01318499|12663416|P2|STARTED|Overall Study||534
5148336|NCT01318499|12663417|P1|STARTED|Overall Study||540
5148337|NCT01318408|12663435|P1|NOT COMPLETED|Overall Study||8
5148338|NCT01318408|12663435|P1|COMPLETED|Overall Study||16
5148339|NCT01318408|12663435|P1|STARTED|Overall Study||24
5148340|NCT01318382|12663440|P1|NOT COMPLETED|Overall Study||13
5148341|NCT01318382|12663440|P1|COMPLETED|Overall Study||289
5148342|NCT01318382|12663440|P1|STARTED|Overall Study||302
5148343|NCT01318278|12663450|P3|NOT COMPLETED|Overall Study||0
5148344|NCT01318278|12663451|P2|NOT COMPLETED|Overall Study||0
5148345|NCT01318278|12663452|P1|NOT COMPLETED|Overall Study||0
5148346|NCT01318278|12663450|P3|COMPLETED|Overall Study||50
5148347|NCT01318278|12663451|P2|COMPLETED|Overall Study||10
5148348|NCT01318278|12663452|P1|COMPLETED|Overall Study||10
5148349|NCT01318278|12663450|P3|STARTED|Overall Study||50
5148350|NCT01318278|12663451|P2|STARTED|Overall Study||10
5148351|NCT01318278|12663452|P1|STARTED|Overall Study||10
5148352|NCT01318135|12663498|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
5148353|NCT01318135|12663499|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
5148354|NCT01318135|12663500|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
5148355|NCT01318135|12663501|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
5148356|NCT01318135|12663502|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
5148357|NCT01318135|12663503|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
5148358|NCT01318135|12663504|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
5148359|NCT01318135|12663505|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
5148360|NCT01318135|12663498|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
5148361|NCT01318135|12663499|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
5148362|NCT01318135|12663500|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
5148363|NCT01318135|12663501|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
5148364|NCT01318135|12663502|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
5148365|NCT01318135|12663503|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
5148366|NCT01318135|12663504|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
5148367|NCT01318135|12663505|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
5148368|NCT01318135|12663498|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
5148369|NCT01318135|12663499|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
5148370|NCT01318135|12663500|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
5148371|NCT01318135|12663501|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
5148372|NCT01318135|12663502|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
5148373|NCT01318135|12663503|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
5148374|NCT01318135|12663504|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
5148375|NCT01318135|12663505|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
5148376|NCT01318135|12663498|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148377|NCT01318135|12663499|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148378|NCT01318135|12663500|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148379|NCT01318135|12663501|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148380|NCT01318135|12663502|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148381|NCT01318135|12663503|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148382|NCT01318135|12663504|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148383|NCT01318135|12663505|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
5148384|NCT01318135|12663498|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
5148385|NCT01318135|12663499|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
5148386|NCT01318135|12663500|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
5148387|NCT01318135|12663501|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
5148388|NCT01318135|12663502|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
5148389|NCT01318135|12663503|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
5148390|NCT01318135|12663504|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
5148391|NCT01318135|12663505|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
5148392|NCT01318135|12663498|P8|STARTED|Enrolled - Long-Term Extension Study||49
5148393|NCT01318135|12663499|P7|STARTED|Enrolled - Long-Term Extension Study||50
5148394|NCT01318135|12663500|P6|STARTED|Enrolled - Long-Term Extension Study||90
5148395|NCT01318135|12663501|P5|STARTED|Enrolled - Long-Term Extension Study||91
5148396|NCT01318135|12663502|P4|STARTED|Enrolled - Long-Term Extension Study||49
5148397|NCT01318135|12663503|P3|STARTED|Enrolled - Long-Term Extension Study||46
5148398|NCT01318135|12663504|P2|STARTED|Enrolled - Long-Term Extension Study||102
5148399|NCT01318135|12663505|P1|STARTED|Enrolled - Long-Term Extension Study||99
5148400|NCT01318122|12663637|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
5148401|NCT01318122|12663638|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
5148402|NCT01318122|12663639|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
5148403|NCT01318122|12663640|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
5148404|NCT01318122|12663637|P4|COMPLETED|Entered - Long-Term Extension Study||48
5148405|NCT01318122|12663638|P3|COMPLETED|Entered - Long-Term Extension Study||49
5148406|NCT01318122|12663639|P2|COMPLETED|Entered - Long-Term Extension Study||99
5148407|NCT01318122|12663640|P1|COMPLETED|Entered - Long-Term Extension Study||96
5148408|NCT01318122|12663637|P4|STARTED|Entered - Long-Term Extension Study||52
5148409|NCT01318122|12663638|P3|STARTED|Entered - Long-Term Extension Study||55
5148410|NCT01318122|12663639|P2|STARTED|Entered - Long-Term Extension Study||110
5148411|NCT01318122|12663640|P1|STARTED|Entered - Long-Term Extension Study||105
5148412|NCT01318122|12663637|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
5148413|NCT01318122|12663638|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
5148414|NCT01318122|12663639|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5148415|NCT01318122|12663640|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
5148416|NCT01318122|12663637|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
5148417|NCT01318122|12663638|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
5148418|NCT01318122|12663639|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
5148419|NCT01318122|12663640|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
5148420|NCT01318122|12663637|P4|STARTED|Enrolled - Long-Term Extension Study||53
5148421|NCT01318122|12663638|P3|STARTED|Enrolled - Long-Term Extension Study||57
5148422|NCT01318122|12663639|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
5148423|NCT01318122|12663640|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
5148424|NCT01318109|12663709|P3|NOT COMPLETED|Overall Study||0
5148425|NCT01318109|12663710|P2|NOT COMPLETED|Overall Study||3
5148426|NCT01318109|12663711|P1|NOT COMPLETED|Overall Study||1
5148427|NCT01318109|12663709|P3|COMPLETED|Overall Study||100
5148428|NCT01318109|12663710|P2|COMPLETED|Overall Study||93
5148429|NCT01318109|12663711|P1|COMPLETED|Overall Study||91
5148430|NCT01318109|12663709|P3|STARTED|Overall Study||100
5148431|NCT01318109|12663710|P2|STARTED|Overall Study||96
5148432|NCT01318109|12663711|P1|STARTED|Overall Study||92
5148433|NCT01318083|12663746|P3|NOT COMPLETED|Overall Study||5
5148434|NCT01318083|12663747|P2|NOT COMPLETED|Overall Study||2
5148435|NCT01318083|12663748|P1|NOT COMPLETED|Overall Study||6
5148436|NCT01318083|12663746|P3|COMPLETED|Overall Study||98
5148437|NCT01318083|12663747|P2|COMPLETED|Overall Study||102
5148438|NCT01318083|12663748|P1|COMPLETED|Overall Study||99
5148439|NCT01318083|12663746|P3|STARTED|Overall Study||103
5148440|NCT01318083|12663747|P2|STARTED|Overall Study||104
5148441|NCT01318083|12663748|P1|STARTED|Overall Study||105
5148442|NCT01318070|12663783|P3|NOT COMPLETED|Overall Study||7
5148443|NCT01318070|12663784|P2|NOT COMPLETED|Overall Study||2
5148444|NCT01318070|12663785|P1|NOT COMPLETED|Overall Study||2
5148445|NCT01318070|12663783|P3|COMPLETED|Overall Study||108
5148446|NCT01318070|12663784|P2|COMPLETED|Overall Study||111
5148447|NCT01318070|12663785|P1|COMPLETED|Overall Study||109
5148448|NCT01318070|12663783|P3|STARTED|Overall Study||115
5148449|NCT01318070|12663784|P2|STARTED|Overall Study||113
5148450|NCT01318070|12663785|P1|STARTED|Overall Study||111
5148451|NCT01318018|12663819|P2|NOT COMPLETED|Overall Study||0
5148452|NCT01318018|12663820|P1|NOT COMPLETED|Overall Study||0
5148453|NCT01318018|12663819|P2|COMPLETED|Overall Study||10
5148454|NCT01318018|12663820|P1|COMPLETED|Overall Study||10
5148455|NCT01318018|12663819|P2|STARTED|Overall Study||10
5148456|NCT01318018|12663820|P1|STARTED|Overall Study||10
5148457|NCT01317940|12663832|P6|NOT COMPLETED|Overall Study||0
5148458|NCT01317940|12663833|P5|NOT COMPLETED|Overall Study||1
5148459|NCT01317940|12663834|P4|NOT COMPLETED|Overall Study||1
5148460|NCT01317940|12663835|P3|NOT COMPLETED|Overall Study||5
5148461|NCT01317940|12663836|P2|NOT COMPLETED|Overall Study||0
5148462|NCT01317940|12663837|P1|NOT COMPLETED|Overall Study||1
5148463|NCT01317940|12663832|P6|COMPLETED|Overall Study||4
5148464|NCT01317940|12663833|P5|COMPLETED|Overall Study||12
5148465|NCT01317940|12663834|P4|COMPLETED|Overall Study||5
5148466|NCT01317940|12663835|P3|COMPLETED|Overall Study||15
5148467|NCT01317940|12663836|P2|COMPLETED|Overall Study||10
5148468|NCT01317940|12663837|P1|COMPLETED|Overall Study||18
5148469|NCT01317940|12663832|P6|STARTED|Overall Study||4
5148470|NCT01317940|12663833|P5|STARTED|Overall Study||13
5148471|NCT01317940|12663834|P4|STARTED|Overall Study||6
5148472|NCT01317940|12663835|P3|STARTED|Overall Study||20
5148473|NCT01317940|12663836|P2|STARTED|Overall Study||10
5148474|NCT01317940|12663837|P1|STARTED|Overall Study||19
5148475|NCT01317901|12663858|P2|NOT COMPLETED|Overall Study||0
5148476|NCT01317901|12663859|P1|NOT COMPLETED|Overall Study||0
5148477|NCT01317901|12663858|P2|COMPLETED|Overall Study||6
5148478|NCT01317901|12663859|P1|COMPLETED|Overall Study||6
5148479|NCT01317901|12663858|P2|STARTED|Overall Study||6
5148480|NCT01317901|12663859|P1|STARTED|Overall Study||6
5148481|NCT01317797|12663868|P3|NOT COMPLETED|Overall Study||1
5148482|NCT01317797|12663869|P2|NOT COMPLETED|Overall Study||1
5148483|NCT01317797|12663870|P1|NOT COMPLETED|Overall Study||0
5148484|NCT01317797|12663868|P3|COMPLETED|Overall Study||8
5148485|NCT01317797|12663869|P2|COMPLETED|Overall Study||6
5148486|NCT01317797|12663870|P1|COMPLETED|Overall Study||8
5148487|NCT01317797|12663868|P3|STARTED|Overall Study||9
5148488|NCT01317797|12663869|P2|STARTED|Overall Study||7
5148489|NCT01317797|12663870|P1|STARTED|Overall Study||8
5148490|NCT01317667|12663925|P3|NOT COMPLETED|Overall Study||0
5148491|NCT01317667|12663926|P2|NOT COMPLETED|Overall Study||0
5148492|NCT01317667|12663927|P1|NOT COMPLETED|Overall Study||0
5148493|NCT01317667|12663925|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
5148494|NCT01317667|12663926|P2|COMPLETED|Overall Study||10
5148495|NCT01317667|12663927|P1|COMPLETED|Overall Study||10
5148496|NCT01317667|12663925|P3|STARTED|Overall Study||10
5148497|NCT01317667|12663926|P2|STARTED|Overall Study||10
5148498|NCT01317667|12663927|P1|STARTED|Overall Study||10
5148499|NCT01317641|12663947|P9|NOT COMPLETED|Overall Study||5
5148500|NCT01317641|12663948|P8|NOT COMPLETED|Overall Study||5
5148501|NCT01317641|12663949|P7|NOT COMPLETED|Overall Study||3
5148502|NCT01317641|12663950|P6|NOT COMPLETED|Overall Study||0
5148503|NCT01317641|12663951|P5|NOT COMPLETED|Overall Study||0
5148504|NCT01317641|12663952|P4|NOT COMPLETED|Overall Study||1
5148505|NCT01317641|12663953|P3|NOT COMPLETED|Overall Study||0
5148506|NCT01317641|12663954|P2|NOT COMPLETED|Overall Study||1
5148507|NCT01317641|12663955|P1|NOT COMPLETED|Overall Study||1
5148508|NCT01317641|12663947|P9|COMPLETED|Overall Study||31
5148509|NCT01317641|12663948|P8|COMPLETED|Overall Study||33
5148510|NCT01317641|12663949|P7|COMPLETED|Overall Study||35
5148511|NCT01317641|12663950|P6|COMPLETED|Overall Study||3
5148512|NCT01317641|12663951|P5|COMPLETED|Overall Study||3
5148513|NCT01317641|12663952|P4|COMPLETED|Overall Study||3
5148514|NCT01317641|12663953|P3|COMPLETED|Overall Study||3
5148515|NCT01317641|12663954|P2|COMPLETED|Overall Study||6
5148516|NCT01317641|12663955|P1|COMPLETED|Overall Study||3
5148517|NCT01317641|12663947|P9|STARTED|Overall Study||36
5148518|NCT01317641|12663948|P8|STARTED|Overall Study||38
5148519|NCT01317641|12663949|P7|STARTED|Overall Study||38
5148520|NCT01317641|12663950|P6|STARTED|Overall Study||3
5148521|NCT01317641|12663951|P5|STARTED|Overall Study||3
5148522|NCT01317641|12663952|P4|STARTED|Overall Study||4
5148523|NCT01317641|12663953|P3|STARTED|Overall Study||3
5148524|NCT01317641|12663954|P2|STARTED|Overall Study||7
5148525|NCT01317641|12663955|P1|STARTED|Overall Study||4
5148526|NCT01317615|12664057|P1|NOT COMPLETED|Overall Study||49
5148527|NCT01317615|12664057|P1|COMPLETED|Overall Study||0
5148528|NCT01317615|12664057|P1|STARTED|Overall Study||49
5148529|NCT01317550|12664070|P4|NOT COMPLETED|Overall Study||0
5148530|NCT01317550|12664071|P3|NOT COMPLETED|Overall Study||0
5148531|NCT01317550|12664072|P2|NOT COMPLETED|Overall Study||0
5148532|NCT01317550|12664073|P1|NOT COMPLETED|Overall Study||2
5148533|NCT01317550|12664070|P4|COMPLETED|Overall Study||3
5148534|NCT01317550|12664071|P3|COMPLETED|Overall Study||3
5148535|NCT01317550|12664072|P2|COMPLETED|Overall Study||3
5148536|NCT01317550|12664073|P1|COMPLETED|Overall Study||3
5148537|NCT01317550|12664070|P4|STARTED|Overall Study||3
5148538|NCT01317550|12664071|P3|STARTED|Overall Study||3
5148539|NCT01317550|12664072|P2|STARTED|Overall Study||3
5148540|NCT01317550|12664073|P1|STARTED|Overall Study||5
5148541|NCT01317472|12664085|P2|NOT COMPLETED|Overall Study||0
5148542|NCT01317472|12664086|P1|NOT COMPLETED|Overall Study||2
5148543|NCT01317472|12664085|P2|COMPLETED|Overall Study||2
5148544|NCT01317472|12664086|P1|COMPLETED|Overall Study||7
5148545|NCT01317472|12664085|P2|STARTED|Overall Study||2
5148546|NCT01317472|12664086|P1|STARTED|Overall Study||9
5148547|NCT01317199|12664096|P4|NOT COMPLETED|Randomized Phase 2||17
5148548|NCT01317199|12664097|P3|NOT COMPLETED|Randomized Phase 2||21
5148549|NCT01317199|12664098|P2|NOT COMPLETED|Randomized Phase 2||11
5148550|NCT01317199|12664099|P1|NOT COMPLETED|Randomized Phase 2||0
5148551|NCT01317199|12664096|P4|COMPLETED|Randomized Phase 2||32
5148552|NCT01317199|12664097|P3|COMPLETED|Randomized Phase 2||35
5148553|NCT01317199|12664098|P2|COMPLETED|Randomized Phase 2||13
5148554|NCT01317199|12664099|P1|COMPLETED|Randomized Phase 2||0
5148555|NCT01317199|12664096|P4|STARTED|Randomized Phase 2||49
5148556|NCT01317199|12664097|P3|STARTED|Randomized Phase 2||56
5148557|NCT01317199|12664098|P2|STARTED|Randomized Phase 2||24
5148558|NCT01317199|12664099|P1|STARTED|Randomized Phase 2||0
5148559|NCT01317199|12664096|P4|NOT COMPLETED|Dose-escalation Phase 1||0
5148560|NCT01317199|12664097|P3|NOT COMPLETED|Dose-escalation Phase 1||0
5148561|NCT01317199|12664098|P2|NOT COMPLETED|Dose-escalation Phase 1||0
5148562|NCT01317199|12664099|P1|NOT COMPLETED|Dose-escalation Phase 1||7
5148563|NCT01317199|12664096|P4|COMPLETED|Dose-escalation Phase 1||0
5148564|NCT01317199|12664097|P3|COMPLETED|Dose-escalation Phase 1||0
5148565|NCT01317199|12664098|P2|COMPLETED|Dose-escalation Phase 1||0
5148566|NCT01317199|12664099|P1|COMPLETED|Dose-escalation Phase 1||7
5148567|NCT01317199|12664096|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148568|NCT01317199|12664097|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148569|NCT01317199|12664098|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148570|NCT01317199|12664099|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
5148571|NCT01317199|12664096|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148572|NCT01317199|12664097|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148573|NCT01317199|12664098|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148574|NCT01317199|12664099|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
5148575|NCT01317199|12664096|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148576|NCT01317199|12664097|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148577|NCT01317199|12664098|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148578|NCT01317199|12664099|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
5148579|NCT01317199|12664096|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148580|NCT01317199|12664097|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148581|NCT01317199|12664098|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
5148582|NCT01317199|12664099|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
5148583|NCT01317199|12664096|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
5148584|NCT01317199|12664097|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
5148585|NCT01317199|12664098|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
5148586|NCT01317199|12664099|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
5148587|NCT01317199|12664096|P4|STARTED|Dose-escalation Phase 1||0
5148588|NCT01317199|12664097|P3|STARTED|Dose-escalation Phase 1||0
5148589|NCT01317199|12664098|P2|STARTED|Dose-escalation Phase 1||0
5148590|NCT01317199|12664099|P1|STARTED|Dose-escalation Phase 1||14
5148591|NCT01317160|12664128|P2|NOT COMPLETED|Overall Study||6
5148592|NCT01317160|12664129|P1|NOT COMPLETED|Overall Study||4
5148593|NCT01317160|12664128|P2|COMPLETED|Overall Study||69
5148594|NCT01317160|12664129|P1|COMPLETED|Overall Study||71
5148595|NCT01317160|12664128|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
5148596|NCT01317160|12664129|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
5148597|NCT01317160|12664128|P2|STARTED|Overall Study||75
5148598|NCT01317160|12664129|P1|STARTED|Overall Study||75
5148599|NCT01317095|12664139|P2|NOT COMPLETED|Overall Study||0
5148600|NCT01317095|12664140|P1|NOT COMPLETED|Overall Study||0
5148601|NCT01317095|12664139|P2|COMPLETED|Overall Study||41
5148602|NCT01317095|12664140|P1|COMPLETED|Overall Study||39
5148603|NCT01317095|12664139|P2|STARTED|Overall Study||41
5148604|NCT01317095|12664140|P1|STARTED|Overall Study||39
5148605|NCT01317030|12664154|P2|NOT COMPLETED|Overall Study||0
5148606|NCT01317030|12664155|P1|NOT COMPLETED|Overall Study||0
5148607|NCT01317030|12664154|P2|COMPLETED|Overall Study||13
5148608|NCT01317030|12664155|P1|COMPLETED|Overall Study||12
5148609|NCT01317030|12664154|P2|STARTED|Overall Study||13
5148610|NCT01317030|12664155|P1|STARTED|Overall Study||12
5148611|NCT01317004|12664163|P2|NOT COMPLETED|Overall Study||9
5148612|NCT01317004|12664164|P1|NOT COMPLETED|Overall Study||4
5148613|NCT01317004|12664163|P2|COMPLETED|Overall Study||5
5148614|NCT01317004|12664164|P1|COMPLETED|Overall Study||47
5148615|NCT01317004|12664163|P2|Safety Set|Overall Study||11
5148616|NCT01317004|12664164|P1|Safety Set|Overall Study||50
5148617|NCT01317004|12664163|P2|STARTED|Overall Study||14
5148618|NCT01317004|12664164|P1|STARTED|Overall Study||51
5148619|NCT01316939|12664185|P3|NOT COMPLETED|Overall Study||69
5148620|NCT01316939|12664186|P2|NOT COMPLETED|Overall Study||68
5148621|NCT01316939|12664187|P1|NOT COMPLETED|Overall Study||63
5148622|NCT01316939|12664185|P3|COMPLETED|Overall Study||7
5148623|NCT01316939|12664186|P2|COMPLETED|Overall Study||9
5148624|NCT01316939|12664187|P1|COMPLETED|Overall Study||13
5148625|NCT01316939|12664185|P3|STARTED|Overall Study||76
5148626|NCT01316939|12664186|P2|STARTED|Overall Study||77
5148627|NCT01316939|12664187|P1|STARTED|Overall Study||76
5148628|NCT01316926|12664267|P2|NOT COMPLETED|Period 2||0
5148629|NCT01316926|12664268|P1|NOT COMPLETED|Period 2||0
5148630|NCT01316926|12664267|P2|COMPLETED|Period 2||30
5148631|NCT01316926|12664268|P1|COMPLETED|Period 2||29
5148632|NCT01316926|12664267|P2|STARTED|Period 2||30
5148633|NCT01316926|12664268|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
5148634|NCT01316926|12664267|P2|NOT COMPLETED|Period 1||0
5148635|NCT01316926|12664268|P1|NOT COMPLETED|Period 1||0
5148636|NCT01316926|12664267|P2|COMPLETED|Period 1||30
5148637|NCT01316926|12664268|P1|COMPLETED|Period 1||30
5148638|NCT01316926|12664267|P2|STARTED|Period 1||30
5148639|NCT01316926|12664268|P1|STARTED|Period 1||30
5148640|NCT01316913|12664282|P4|NOT COMPLETED|Overall Study||39
5148641|NCT01316913|12664283|P3|NOT COMPLETED|Overall Study||49
5148642|NCT01316913|12664284|P2|NOT COMPLETED|Overall Study||54
5148643|NCT01316913|12664285|P1|NOT COMPLETED|Overall Study||57
5148644|NCT01316913|12664282|P4|COMPLETED|Overall Study||176
5148645|NCT01316913|12664283|P3|COMPLETED|Overall Study||166
5148646|NCT01316913|12664284|P2|COMPLETED|Overall Study||163
5148647|NCT01316913|12664285|P1|COMPLETED|Overall Study||165
5148648|NCT01316913|12664282|P4|STARTED|Overall Study||215
5148649|NCT01316913|12664283|P3|STARTED|Overall Study||215
5148650|NCT01316913|12664284|P2|STARTED|Overall Study||217
5148651|NCT01316913|12664285|P1|STARTED|Overall Study||222
5148652|NCT01316900|12664307|P4|NOT COMPLETED|Overall Study||31
5148653|NCT01316900|12664308|P3|NOT COMPLETED|Overall Study||41
5148654|NCT01316900|12664309|P2|NOT COMPLETED|Overall Study||31
5148655|NCT01316900|12664310|P1|NOT COMPLETED|Overall Study||44
5148656|NCT01316900|12664307|P4|COMPLETED|Overall Study||177
5148657|NCT01316900|12664308|P3|COMPLETED|Overall Study||173
5148658|NCT01316900|12664309|P2|COMPLETED|Overall Study||181
5148659|NCT01316900|12664310|P1|COMPLETED|Overall Study||165
5148660|NCT01316900|12664307|P4|STARTED|Overall Study||208
5148661|NCT01316900|12664308|P3|STARTED|Overall Study||214
5148662|NCT01316900|12664309|P2|STARTED|Overall Study||212
5148663|NCT01316900|12664310|P1|STARTED|Overall Study||209
5148664|NCT01316887|12664331|P3|NOT COMPLETED|Overall Study||83
5148665|NCT01316887|12664332|P2|NOT COMPLETED|Overall Study||94
5148666|NCT01316887|12664333|P1|NOT COMPLETED|Overall Study||43
5148667|NCT01316887|12664331|P3|COMPLETED|Overall Study||143
5148668|NCT01316887|12664332|P2|COMPLETED|Overall Study||133
5148669|NCT01316887|12664333|P1|COMPLETED|Overall Study||66
5148670|NCT01316887|12664331|P3|STARTED|Overall Study||226
5148671|NCT01316887|12664332|P2|STARTED|Overall Study||227
5148672|NCT01316887|12664333|P1|STARTED|Overall Study||109
5148673|NCT01316770|12664395|P2|NOT COMPLETED|Overall Study||0
5148674|NCT01316770|12664396|P1|NOT COMPLETED|Overall Study||0
5148675|NCT01316770|12664395|P2|COMPLETED|Overall Study||9
5148676|NCT01316770|12664396|P1|COMPLETED|Overall Study||9
5148677|NCT01316770|12664395|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
5148678|NCT01316770|12664396|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
5148679|NCT01316692|12664458|P1|NOT COMPLETED|Overall Study||12
5148680|NCT01316692|12664458|P1|COMPLETED|Overall Study||0
5148681|NCT01316692|12664458|P1|STARTED|Overall Study||12
5148682|NCT01316614|12664467|P1|NOT COMPLETED|Overall Study||37
5148683|NCT01316614|12664467|P1|COMPLETED|Overall Study||100
5148684|NCT01316614|12664467|P1|STARTED|Overall Study||137
5148685|NCT01316575|12664484|P2|NOT COMPLETED|Overall Study||1
5148686|NCT01316575|12664485|P1|NOT COMPLETED|Overall Study||2
5148687|NCT01316575|12664484|P2|COMPLETED|Overall Study||19
5148688|NCT01316575|12664485|P1|COMPLETED|Overall Study||18
5148689|NCT01316575|12664484|P2|STARTED|Overall Study||20
5148690|NCT01316575|12664485|P1|STARTED|Overall Study||20
5148691|NCT01316510|12664499|P2|NOT COMPLETED|Overall Study||0
5148692|NCT01316510|12664500|P1|NOT COMPLETED|Overall Study||0
5148693|NCT01316510|12664499|P2|COMPLETED|Overall Study||12
5148694|NCT01316510|12664500|P1|COMPLETED|Overall Study||12
5148695|NCT01316510|12664499|P2|STARTED|Overall Study||12
5148696|NCT01316510|12664500|P1|STARTED|Overall Study||12
5148697|NCT01316419|12664508|P1|NOT COMPLETED|Overall Study||265
5148698|NCT01316419|12664508|P1|COMPLETED|Overall Study||1824
5148699|NCT01316419|12664508|P1|STARTED|Overall Study||2089
5148700|NCT01316380|12664534|P3|NOT COMPLETED|Overall Study||3
5148701|NCT01316380|12664535|P2|NOT COMPLETED|Overall Study||5
5148702|NCT01316380|12664536|P1|NOT COMPLETED|Overall Study||2
5148703|NCT01316380|12664534|P3|COMPLETED|Overall Study||152
5148704|NCT01316380|12664535|P2|COMPLETED|Overall Study||149
5148705|NCT01316380|12664536|P1|COMPLETED|Overall Study||154
5148706|NCT01316380|12664534|P3|STARTED|Overall Study||155
5148707|NCT01316380|12664535|P2|STARTED|Overall Study||154
5148708|NCT01316380|12664536|P1|STARTED|Overall Study||156
5148709|NCT01316341|12664577|P3|NOT COMPLETED|Overall Study||0
5148710|NCT01316341|12664578|P2|NOT COMPLETED|Overall Study||0
5148711|NCT01316341|12664579|P1|NOT COMPLETED|Overall Study||0
5148712|NCT01316341|12664577|P3|COMPLETED|Overall Study||9
5148713|NCT01316341|12664578|P2|COMPLETED|Overall Study||9
5148714|NCT01316341|12664579|P1|COMPLETED|Overall Study||6
5148715|NCT01316341|12664577|P3|STARTED|Overall Study||9
5148716|NCT01316341|12664578|P2|STARTED|Overall Study||9
5148717|NCT01316341|12664579|P1|STARTED|Overall Study||6
5148718|NCT01316315|12664647|P2|NOT COMPLETED|Sequence 2||0
5148719|NCT01316315|12664648|P1|NOT COMPLETED|Sequence 2||0
5148720|NCT01316315|12664647|P2|COMPLETED|Sequence 2||7
5148721|NCT01316315|12664648|P1|COMPLETED|Sequence 2||7
5148722|NCT01316315|12664647|P2|STARTED|Sequence 2||7
5148723|NCT01316315|12664648|P1|STARTED|Sequence 2||7
5148724|NCT01316315|12664647|P2|NOT COMPLETED|Sequence 1||0
5148725|NCT01316315|12664648|P1|NOT COMPLETED|Sequence 1||0
5148726|NCT01316315|12664647|P2|COMPLETED|Sequence 1||7
5148727|NCT01316315|12664648|P1|COMPLETED|Sequence 1||7
5148728|NCT01316315|12664647|P2|STARTED|Sequence 1||7
5148729|NCT01316315|12664648|P1|STARTED|Sequence 1||7
5148730|NCT01316302|12664662|P2|NOT COMPLETED|Overall Study||11
5148731|NCT01316302|12664663|P1|NOT COMPLETED|Overall Study||10
5148732|NCT01316302|12664662|P2|COMPLETED|Overall Study||22
5148733|NCT01316302|12664663|P1|COMPLETED|Overall Study||20
5148734|NCT01316302|12664662|P2|STARTED|Overall Study||33
5148735|NCT01316302|12664663|P1|STARTED|Overall Study||30
5148736|NCT01316276|12664673|P1|NOT COMPLETED|Overall Study||67
5148737|NCT01316276|12664673|P1|COMPLETED|Overall Study||139
5148738|NCT01316276|12664673|P1|STARTED|Overall Study||206
5148739|NCT01316263|12664694|P2|NOT COMPLETED|Overall Study||0
5148740|NCT01316263|12664695|P1|NOT COMPLETED|Overall Study||0
5148741|NCT01316263|12664694|P2|COMPLETED|Overall Study||14
5148742|NCT01316263|12664695|P1|COMPLETED|Overall Study||7
5148743|NCT01316263|12664694|P2|Received Any Study Drug|Overall Study||14
5148744|NCT01316263|12664695|P1|Received Any Study Drug|Overall Study||7
5148745|NCT01316263|12664694|P2|STARTED|Overall Study||14
5148746|NCT01316263|12664695|P1|STARTED|Overall Study||7
5148747|NCT01316224|12664721|P1|NOT COMPLETED|Overall Study||10
5148748|NCT01316224|12664721|P1|COMPLETED|Overall Study||42
5148749|NCT01316224|12664721|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
5148750|NCT01316224|12664721|P1|Completed Visit 4 to Dermatologist|Overall Study||42
5148751|NCT01316224|12664721|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
5148752|NCT01316224|12664721|P1|Completed Visit 3 to Dermatologist|Overall Study||48
5148753|NCT01316224|12664721|P1|Completed Visit 2 to Dermatologist|Overall Study||51
5148754|NCT01316224|12664721|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
5148755|NCT01316224|12664721|P1|Completed Visit 1 to Dermatologist|Overall Study||52
5148756|NCT01316224|12664721|P1|STARTED|Overall Study||52
5148757|NCT01316211|12664737|P2|NOT COMPLETED|Overall Study||12
5148758|NCT01316211|12664738|P1|NOT COMPLETED|Overall Study||11
5148759|NCT01316211|12664737|P2|COMPLETED|Overall Study||111
5148760|NCT01316211|12664738|P1|COMPLETED|Overall Study||105
5148761|NCT01316211|12664737|P2|STARTED|Overall Study||123
5148762|NCT01316211|12664738|P1|STARTED|Overall Study||116
5148763|NCT01316055|12664774|P3|NOT COMPLETED|Overall Study||0
5148764|NCT01316055|12664775|P2|NOT COMPLETED|Overall Study||0
5148765|NCT01316055|12664776|P1|NOT COMPLETED|Overall Study||1
5148766|NCT01316055|12664774|P3|COMPLETED|Overall Study||12
5148767|NCT01316055|12664775|P2|COMPLETED|Overall Study||17
5148768|NCT01316055|12664776|P1|COMPLETED|Overall Study||12
5148769|NCT01316055|12664774|P3|STARTED|Overall Study||12
5148770|NCT01316055|12664775|P2|STARTED|Overall Study||17
5148771|NCT01316055|12664776|P1|STARTED|Overall Study||13
5148772|NCT01316042|12664792|P2|NOT COMPLETED|Overall Study||1
5148773|NCT01316042|12664793|P1|NOT COMPLETED|Overall Study||0
5148774|NCT01316042|12664792|P2|COMPLETED|Overall Study||1
5148775|NCT01316042|12664793|P1|COMPLETED|Overall Study||2
5148776|NCT01316042|12664792|P2|STARTED|Overall Study||2
5148777|NCT01316042|12664793|P1|STARTED|Overall Study||2
5148778|NCT01315873|12664799|P1|NOT COMPLETED|Overall Study||0
5148779|NCT01315873|12664799|P1|COMPLETED|Overall Study||24
5148780|NCT01315873|12664799|P1|STARTED|Overall Study||24
5148781|NCT01315847|12664807|P2|NOT COMPLETED|Part III, Period 2||0
5148782|NCT01315847|12664808|P1|NOT COMPLETED|Part III, Period 2||0
5148783|NCT01315847|12664807|P2|COMPLETED|Part III, Period 2||3
5148784|NCT01315847|12664808|P1|COMPLETED|Part III, Period 2||0
5148785|NCT01315847|12664807|P2|Received [11C]MK-4232|Part III, Period 2||3
5148786|NCT01315847|12664808|P1|Received [11C]MK-4232|Part III, Period 2||0
5148787|NCT01315847|12664807|P2|Received Telcagepant|Part III, Period 2||3
5148788|NCT01315847|12664808|P1|Received Telcagepant|Part III, Period 2||0
5148789|NCT01315847|12664807|P2|STARTED|Part III, Period 2||3
5148790|NCT01315847|12664808|P1|STARTED|Part III, Period 2||0
5148791|NCT01315847|12664807|P2|NOT COMPLETED|Part III, Period 1||1
5148792|NCT01315847|12664808|P1|NOT COMPLETED|Part III, Period 1||0
5148793|NCT01315847|12664807|P2|COMPLETED|Part III, Period 1||3
5148794|NCT01315847|12664808|P1|COMPLETED|Part III, Period 1||0
5148795|NCT01315847|12664807|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
5148796|NCT01315847|12664808|P1|Received [11C]MK-4232|Part III, Period 1||0
5148797|NCT01315847|12664807|P2|Received Telcagepant|Part III, Period 1||4
5148798|NCT01315847|12664808|P1|Received Telcagepant|Part III, Period 1||0
5148799|NCT01315847|12664807|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
5148800|NCT01315847|12664808|P1|STARTED|Part III, Period 1||0
5148801|NCT01315847|12664807|P2|NOT COMPLETED|Part I, Period 2||0
5148802|NCT01315847|12664808|P1|NOT COMPLETED|Part I, Period 2||0
5148803|NCT01315847|12664807|P2|COMPLETED|Part I, Period 2||0
5148804|NCT01315847|12664808|P1|COMPLETED|Part I, Period 2||3
5148805|NCT01315847|12664807|P2|Received [11C]MK-4232|Part I, Period 2||0
5148806|NCT01315847|12664808|P1|Received [11C]MK-4232|Part I, Period 2||3
5148807|NCT01315847|12664807|P2|Received Telcagepant|Part I, Period 2||0
5148808|NCT01315847|12664808|P1|Received Telcagepant|Part I, Period 2||3
5148809|NCT01315847|12664807|P2|STARTED|Part I, Period 2||0
5148810|NCT01315847|12664808|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
5148811|NCT01315847|12664807|P2|NOT COMPLETED|Part I, Period 1||0
5148812|NCT01315847|12664808|P1|NOT COMPLETED|Part I, Period 1||3
5148813|NCT01315847|12664807|P2|COMPLETED|Part I, Period 1||0
5148814|NCT01315847|12664808|P1|COMPLETED|Part I, Period 1||2
5148815|NCT01315847|12664807|P2|Received [11C]MK-4232|Part I, Period 1||0
5148816|NCT01315847|12664808|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
5148817|NCT01315847|12664807|P2|Received Telcagepant|Part I, Period 1||0
5148818|NCT01315847|12664808|P1|Received Telcagepant|Part I, Period 1||5
5148819|NCT01315847|12664807|P2|STARTED|Part I, Period 1||0
5148820|NCT01315847|12664808|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
5148821|NCT01315678|12664822|P2|NOT COMPLETED|Overall Study||6
5148822|NCT01315678|12664823|P1|NOT COMPLETED|Overall Study||14
5148823|NCT01315678|12664822|P2|COMPLETED|Overall Study||140
5148824|NCT01315678|12664823|P1|COMPLETED|Overall Study||134
5148825|NCT01315678|12664822|P2|STARTED|Overall Study||146
5148826|NCT01315678|12664823|P1|STARTED|Overall Study||148
5148827|NCT01315665|12664843|P2|NOT COMPLETED|Overall Study||0
5148828|NCT01315665|12664844|P1|NOT COMPLETED|Overall Study||0
5148829|NCT01315665|12664843|P2|COMPLETED|Overall Study||5
5148830|NCT01315665|12664844|P1|COMPLETED|Overall Study||10
5148831|NCT01315665|12664843|P2|STARTED|Overall Study||5
5148832|NCT01315665|12664844|P1|STARTED|Overall Study||10
5148833|NCT01315574|12664860|P2|NOT COMPLETED|Overall Study||0
5148834|NCT01315574|12664861|P1|NOT COMPLETED|Overall Study||0
5148835|NCT01315574|12664860|P2|COMPLETED|Overall Study||7
5148836|NCT01315574|12664861|P1|COMPLETED|Overall Study||7
5148837|NCT01315574|12664860|P2|STARTED|Overall Study||7
5148838|NCT01315574|12664861|P1|STARTED|Overall Study||7
5148839|NCT01315353|12664874|P3|NOT COMPLETED|Overall Study||13
5148840|NCT01315353|12664875|P2|NOT COMPLETED|Overall Study||23
5148841|NCT01315353|12664876|P1|NOT COMPLETED|Overall Study||29
5148842|NCT01315353|12664874|P3|COMPLETED|Overall Study||166
5148843|NCT01315353|12664875|P2|COMPLETED|Overall Study||120
5148844|NCT01315353|12664876|P1|COMPLETED|Overall Study||116
5148845|NCT01315353|12664874|P3|STARTED|Overall Study||179
5148846|NCT01315353|12664875|P2|STARTED|Overall Study||143
5148847|NCT01315353|12664876|P1|STARTED|Overall Study||145
5148848|NCT01315249|12664903|P2|NOT COMPLETED|Overall Study||47
5148849|NCT01315249|12664904|P1|NOT COMPLETED|Overall Study||44
5148850|NCT01315249|12664903|P2|COMPLETED|Overall Study||217
5148851|NCT01315249|12664904|P1|COMPLETED|Overall Study||215
5148852|NCT01315249|12664903|P2|STARTED|Overall Study||264
5148853|NCT01315249|12664904|P1|STARTED|Overall Study||259
5148854|NCT01315236|12664932|P2|NOT COMPLETED|12-Month Follow-up Period||1
5148855|NCT01315236|12664933|P1|NOT COMPLETED|12-Month Follow-up Period||1
5148856|NCT01315236|12664932|P2|COMPLETED|12-Month Follow-up Period||31
5148857|NCT01315236|12664933|P1|COMPLETED|12-Month Follow-up Period||26
5148858|NCT01315236|12664932|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
5148859|NCT01315236|12664933|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
5148860|NCT01315236|12664932|P2|NOT COMPLETED|Open-label Phase||2
5148861|NCT01315236|12664933|P1|NOT COMPLETED|Open-label Phase||1
5148862|NCT01315236|12664932|P2|COMPLETED|Open-label Phase||41
5148863|NCT01315236|12664933|P1|COMPLETED|Open-label Phase||34
5148864|NCT01315236|12664932|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
5148865|NCT01315236|12664933|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
5148866|NCT01315236|12664932|P2|NOT COMPLETED|Double-blind Phase||0
5148867|NCT01315236|12664933|P1|NOT COMPLETED|Double-blind Phase||4
5148868|NCT01315236|12664932|P2|COMPLETED|Double-blind Phase||45
5148869|NCT01315236|12664933|P1|COMPLETED|Double-blind Phase||40
5148870|NCT01315236|12664932|P2|STARTED|Double-blind Phase||45
5148871|NCT01315236|12664933|P1|STARTED|Double-blind Phase||44
5148872|NCT01315158|12664957|P2|NOT COMPLETED|Overall Study||0
5148873|NCT01315158|12664958|P1|NOT COMPLETED|Overall Study||0
5148874|NCT01315158|12664957|P2|COMPLETED|Overall Study||19
5148875|NCT01315158|12664958|P1|COMPLETED|Overall Study||17
5148876|NCT01315158|12664957|P2|STARTED|Overall Study||19
5148877|NCT01315158|12664958|P1|STARTED|Overall Study||17
5148878|NCT01315145|12664982|P2|NOT COMPLETED|Overall Study||5
5148879|NCT01315145|12664983|P1|NOT COMPLETED|Overall Study||17
5148880|NCT01315145|12664982|P2|COMPLETED|Overall Study||11
5148881|NCT01315145|12664983|P1|COMPLETED|Overall Study||105
5148882|NCT01315145|12664982|P2|STARTED|Overall Study||16
5148883|NCT01315145|12664983|P1|STARTED|Overall Study||122
5148884|NCT01315132|12664989|P1|NOT COMPLETED|Overall Study||1
5148885|NCT01315132|12664989|P1|COMPLETED|Overall Study||46
5148886|NCT01315132|12664989|P1|STARTED|Overall Study||47
5148887|NCT01315028|12664996|P2|NOT COMPLETED|Overall Study||1
5148888|NCT01315028|12664997|P1|NOT COMPLETED|Overall Study||1
5148889|NCT01315028|12664996|P2|COMPLETED|Overall Study||9
5148890|NCT01315028|12664997|P1|COMPLETED|Overall Study||9
5148891|NCT01315028|12664996|P2|STARTED|Overall Study||10
5148892|NCT01315028|12664997|P1|STARTED|Overall Study||10
5148893|NCT01315002|12665009|P2|NOT COMPLETED|Overall Study||5
5148894|NCT01315002|12665010|P1|NOT COMPLETED|Overall Study||5
5148895|NCT01315002|12665009|P2|COMPLETED|Overall Study||55
5148896|NCT01315002|12665010|P1|COMPLETED|Overall Study||56
5148897|NCT01315002|12665009|P2|STARTED|Overall Study||60
5148898|NCT01315002|12665010|P1|STARTED|Overall Study||61
5148899|NCT01314963|12665016|P1|NOT COMPLETED|Overall Study||0
5148900|NCT01314963|12665016|P1|COMPLETED|Overall Study||50
5148901|NCT01314963|12665016|P1|STARTED|Overall Study||50
5148902|NCT01314911|12665024|P2|NOT COMPLETED|Overall Study||6
5148903|NCT01314911|12665025|P1|NOT COMPLETED|Overall Study||5
5148904|NCT01314911|12665024|P2|COMPLETED|Overall Study||274
5148905|NCT01314911|12665025|P1|COMPLETED|Overall Study||273
5148906|NCT01314911|12665024|P2|STARTED|Overall Study||280
5148907|NCT01314911|12665025|P1|STARTED|Overall Study||278
5148908|NCT01314872|12665076|P15|NOT COMPLETED|Period 2||24
5148909|NCT01314872|12665077|P14|NOT COMPLETED|Period 2||53
5148910|NCT01314872|12665078|P13|NOT COMPLETED|Period 2||60
5148911|NCT01314872|12665079|P12|NOT COMPLETED|Period 2||48
5148912|NCT01314872|12665080|P11|NOT COMPLETED|Period 2||0
5148913|NCT01314872|12665081|P10|NOT COMPLETED|Period 2||0
5148914|NCT01314872|12665082|P9|NOT COMPLETED|Period 2||0
5148915|NCT01314872|12665083|P8|NOT COMPLETED|Period 2||0
5148916|NCT01314872|12665084|P7|NOT COMPLETED|Period 2||0
5148917|NCT01314872|12665085|P6|NOT COMPLETED|Period 2||0
5148918|NCT01314872|12665086|P5|NOT COMPLETED|Period 2||0
5148919|NCT01314872|12665087|P4|NOT COMPLETED|Period 2||0
5148920|NCT01314872|12665088|P3|NOT COMPLETED|Period 2||0
5148921|NCT01314872|12665089|P2|NOT COMPLETED|Period 2||0
5148922|NCT01314872|12665090|P1|NOT COMPLETED|Period 2||0
5148923|NCT01314872|12665076|P15|COMPLETED|Period 2||110
5148924|NCT01314872|12665077|P14|COMPLETED|Period 2||187
5148925|NCT01314872|12665078|P13|COMPLETED|Period 2||188
5148926|NCT01314872|12665079|P12|COMPLETED|Period 2||175
5148927|NCT01314872|12665080|P11|COMPLETED|Period 2||0
5148928|NCT01314872|12665081|P10|COMPLETED|Period 2||0
5148929|NCT01314872|12665082|P9|COMPLETED|Period 2||0
5148930|NCT01314872|12665083|P8|COMPLETED|Period 2||0
5148931|NCT01314872|12665084|P7|COMPLETED|Period 2||0
5148932|NCT01314872|12665085|P6|COMPLETED|Period 2||0
5148933|NCT01314872|12665086|P5|COMPLETED|Period 2||0
5148934|NCT01314872|12665087|P4|COMPLETED|Period 2||0
5148935|NCT01314872|12665088|P3|COMPLETED|Period 2||0
5148936|NCT01314872|12665089|P2|COMPLETED|Period 2||0
5148937|NCT01314872|12665090|P1|COMPLETED|Period 2||0
5148938|NCT01314872|12665076|P15|STARTED|Period 2||134
5148939|NCT01314872|12665077|P14|STARTED|Period 2||240
5148940|NCT01314872|12665078|P13|STARTED|Period 2||248
5148941|NCT01314872|12665079|P12|STARTED|Period 2||223
5148942|NCT01314872|12665080|P11|STARTED|Period 2||0
5148943|NCT01314872|12665081|P10|STARTED|Period 2||0
5148944|NCT01314872|12665082|P9|STARTED|Period 2||0
5148945|NCT01314872|12665083|P8|STARTED|Period 2||0
5148946|NCT01314872|12665084|P7|STARTED|Period 2||0
5148947|NCT01314872|12665085|P6|STARTED|Period 2||0
5148948|NCT01314872|12665086|P5|STARTED|Period 2||0
5148949|NCT01314872|12665087|P4|STARTED|Period 2||0
5148950|NCT01314872|12665088|P3|STARTED|Period 2||0
5148951|NCT01314872|12665089|P2|STARTED|Period 2||0
5148952|NCT01314872|12665090|P1|STARTED|Period 2||0
5148953|NCT01314872|12665076|P15|NOT COMPLETED|Treatment Period 1||0
5148954|NCT01314872|12665077|P14|NOT COMPLETED|Treatment Period 1||0
5148955|NCT01314872|12665078|P13|NOT COMPLETED|Treatment Period 1||0
5148956|NCT01314872|12665079|P12|NOT COMPLETED|Treatment Period 1||0
5148957|NCT01314872|12665080|P11|NOT COMPLETED|Treatment Period 1||3
5148958|NCT01314872|12665081|P10|NOT COMPLETED|Treatment Period 1||4
5148959|NCT01314872|12665082|P9|NOT COMPLETED|Treatment Period 1||6
5148960|NCT01314872|12665083|P8|NOT COMPLETED|Treatment Period 1||7
5148961|NCT01314872|12665084|P7|NOT COMPLETED|Treatment Period 1||8
5148962|NCT01314872|12665085|P6|NOT COMPLETED|Treatment Period 1||7
5148963|NCT01314872|12665086|P5|NOT COMPLETED|Treatment Period 1||7
5148964|NCT01314872|12665087|P4|NOT COMPLETED|Treatment Period 1||7
5148965|NCT01314872|12665088|P3|NOT COMPLETED|Treatment Period 1||6
5148966|NCT01314872|12665089|P2|NOT COMPLETED|Treatment Period 1||6
5148967|NCT01314872|12665090|P1|NOT COMPLETED|Treatment Period 1||10
5148968|NCT01314872|12665076|P15|COMPLETED|Treatment Period 1||0
5148969|NCT01314872|12665077|P14|COMPLETED|Treatment Period 1||0
5148970|NCT01314872|12665078|P13|COMPLETED|Treatment Period 1||0
5148971|NCT01314872|12665079|P12|COMPLETED|Treatment Period 1||0
5148972|NCT01314872|12665080|P11|COMPLETED|Treatment Period 1||107
5148973|NCT01314872|12665081|P10|COMPLETED|Treatment Period 1||118
5148974|NCT01314872|12665082|P9|COMPLETED|Treatment Period 1||106
5148975|NCT01314872|12665083|P8|COMPLETED|Treatment Period 1||57
5148976|NCT01314872|12665084|P7|COMPLETED|Treatment Period 1||126
5148977|NCT01314872|12665085|P6|COMPLETED|Treatment Period 1||128
5148978|NCT01314872|12665086|P5|COMPLETED|Treatment Period 1||142
5148979|NCT01314872|12665087|P4|COMPLETED|Treatment Period 1||143
5148980|NCT01314872|12665088|P3|COMPLETED|Treatment Period 1||128
5148981|NCT01314872|12665089|P2|COMPLETED|Treatment Period 1||138
5148982|NCT01314872|12665090|P1|COMPLETED|Treatment Period 1||131
5148983|NCT01314872|12665076|P15|STARTED|Treatment Period 1||0
5148984|NCT01314872|12665077|P14|STARTED|Treatment Period 1||0
5148985|NCT01314872|12665078|P13|STARTED|Treatment Period 1||0
5148986|NCT01314872|12665079|P12|STARTED|Treatment Period 1||0
5148987|NCT01314872|12665080|P11|STARTED|Treatment Period 1||110
5148988|NCT01314872|12665081|P10|STARTED|Treatment Period 1||122
5148989|NCT01314872|12665082|P9|STARTED|Treatment Period 1||112
5148990|NCT01314872|12665083|P8|STARTED|Treatment Period 1||64
5148991|NCT01314872|12665084|P7|STARTED|Treatment Period 1||134
5148992|NCT01314872|12665085|P6|STARTED|Treatment Period 1||135
5148993|NCT01314872|12665086|P5|STARTED|Treatment Period 1||149
5148994|NCT01314872|12665087|P4|STARTED|Treatment Period 1||150
5148995|NCT01314872|12665088|P3|STARTED|Treatment Period 1||134
5148996|NCT01314872|12665089|P2|STARTED|Treatment Period 1||144
5148997|NCT01314872|12665090|P1|STARTED|Treatment Period 1||141
5148998|NCT01314742|12665183|P2|NOT COMPLETED|Overall Study||0
5148999|NCT01314742|12665184|P1|NOT COMPLETED|Overall Study||0
5149000|NCT01314742|12665183|P2|COMPLETED|Overall Study||21
5149001|NCT01314742|12665184|P1|COMPLETED|Overall Study||20
5149002|NCT01314742|12665183|P2|STARTED|Overall Study||21
5149003|NCT01314742|12665184|P1|STARTED|Overall Study||20
5149004|NCT01314716|12665194|P2|NOT COMPLETED|Open-Label Phase||12
5149005|NCT01314716|12665195|P1|NOT COMPLETED|Open-Label Phase||10
5149006|NCT01314716|12665194|P2|COMPLETED|Open-Label Phase||98
5149007|NCT01314716|12665195|P1|COMPLETED|Open-Label Phase||102
5149008|NCT01314716|12665194|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
5149009|NCT01314716|12665195|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
5149010|NCT01314716|12665194|P2|NOT COMPLETED|Double-Blind Phase||15
5149011|NCT01314716|12665195|P1|NOT COMPLETED|Double-Blind Phase||17
5149012|NCT01314716|12665194|P2|COMPLETED|Double-Blind Phase||123
5149013|NCT01314716|12665195|P1|COMPLETED|Double-Blind Phase||119
5149014|NCT01314716|12665194|P2|Randomized and Treated|Double-Blind Phase||137
5149015|NCT01314716|12665195|P1|Randomized and Treated|Double-Blind Phase||135
5149016|NCT01314716|12665194|P2|STARTED|Double-Blind Phase||138
5149017|NCT01314716|12665195|P1|STARTED|Double-Blind Phase||136
5149018|NCT01314703|12665207|P1|NOT COMPLETED|Overall Study||8
5149019|NCT01314703|12665207|P1|COMPLETED|Overall Study||27
5149020|NCT01314703|12665207|P1|Discontinued When Enrollment Completed|Overall Study||3
5149021|NCT01314703|12665207|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
5149022|NCT01314703|12665207|P1|Excluded Prior to Screening Baseline|Overall Study||2
5149023|NCT01314703|12665207|P1|Completed Study|Overall Study||27
5149024|NCT01314703|12665207|P1|Completed Treatment Visit|Overall Study||27
5149025|NCT01314703|12665207|P1|Completed Screen Visit|Overall Study||33
5149026|NCT01314703|12665207|P1|Signed Informed Consent|Overall Study||35
5149027|NCT01314703|12665207|P1|STARTED|Overall Study||35
5149028|NCT01314443|12665216|P4|NOT COMPLETED|Overall Study||2
5149029|NCT01314443|12665217|P3|NOT COMPLETED|Overall Study||2
5149030|NCT01314443|12665218|P2|NOT COMPLETED|Overall Study||3
5149031|NCT01314443|12665219|P1|NOT COMPLETED|Overall Study||4
5149032|NCT01314443|12665216|P4|COMPLETED|Overall Study||13
5149033|NCT01314443|12665217|P3|COMPLETED|Overall Study||13
5149034|NCT01314443|12665218|P2|COMPLETED|Overall Study||16
5149035|NCT01314443|12665219|P1|COMPLETED|Overall Study||14
5149036|NCT01314443|12665216|P4|STARTED|Overall Study||15
5149037|NCT01314443|12665217|P3|STARTED|Overall Study||15
5149038|NCT01314443|12665218|P2|STARTED|Overall Study||19
5149039|NCT01314443|12665219|P1|STARTED|Overall Study||18
5149040|NCT01314417|12665237|P1|NOT COMPLETED|Overall Study||0
5149041|NCT01314417|12665237|P1|COMPLETED|Overall Study||2
5149042|NCT01314417|12665237|P1|STARTED|Overall Study||2
5149043|NCT01314313|12665268|P2|NOT COMPLETED|Overall Study||311
5149044|NCT01314313|12665269|P1|NOT COMPLETED|Overall Study||227
5149045|NCT01314313|12665268|P2|COMPLETED|Overall Study||710
5149046|NCT01314313|12665269|P1|COMPLETED|Overall Study||784
5149047|NCT01314313|12665268|P2|Valve Implanted|Overall Study||936
5149048|NCT01314313|12665269|P1|Valve Implanted|Overall Study||974
5149049|NCT01314313|12665268|P2|As Treated|Overall Study||944
5149050|NCT01314313|12665269|P1|As Treated|Overall Study||994
5149051|NCT01314313|12665268|P2|STARTED|Overall Study||1021
5149052|NCT01314313|12665269|P1|STARTED|Overall Study||1011
5149053|NCT01314261|12665289|P4|NOT COMPLETED|Overall Study||3
5149054|NCT01314261|12665290|P3|NOT COMPLETED|Overall Study||3
5149055|NCT01314261|12665291|P2|NOT COMPLETED|Overall Study||4
5149056|NCT01314261|12665292|P1|NOT COMPLETED|Overall Study||2
5149057|NCT01314261|12665289|P4|COMPLETED|Overall Study||6
5149058|NCT01314261|12665290|P3|COMPLETED|Overall Study||7
5149059|NCT01314261|12665291|P2|COMPLETED|Overall Study||5
5149060|NCT01314261|12665292|P1|COMPLETED|Overall Study||7
5149061|NCT01314261|12665289|P4|Discontinued pegIFN/RBV|Overall Study||1
5149062|NCT01314261|12665290|P3|Discontinued pegIFN/RBV|Overall Study||5
5149063|NCT01314261|12665291|P2|Discontinued pegIFN/RBV|Overall Study||4
5149064|NCT01314261|12665292|P1|Discontinued pegIFN/RBV|Overall Study||1
5149065|NCT01314261|12665289|P4|Discontinued ABT-267 or Placebo|Overall Study||0
5149066|NCT01314261|12665290|P3|Discontinued ABT-267 or Placebo|Overall Study||1
5149067|NCT01314261|12665291|P2|Discontinued ABT-267 or Placebo|Overall Study||0
5149068|NCT01314261|12665292|P1|Discontinued ABT-267 or Placebo|Overall Study||1
5149069|NCT01314261|12665289|P4|STARTED|Overall Study||9
5149070|NCT01314261|12665290|P3|STARTED|Overall Study||10
5149071|NCT01314261|12665291|P2|STARTED|Overall Study||9
5149072|NCT01314261|12665292|P1|STARTED|Overall Study||9
5149073|NCT01314118|12665343|P1|NOT COMPLETED|Overall Study||131
5149074|NCT01314118|12665343|P1|COMPLETED|Overall Study||0
5149075|NCT01314118|12665343|P1|STARTED|Overall Study||131
5149076|NCT01314105|12665352|P2|NOT COMPLETED|Overall Study||12
5149077|NCT01314105|12665353|P1|NOT COMPLETED|Overall Study||7
5149078|NCT01314105|12665352|P2|COMPLETED|Overall Study||0
5149079|NCT01314105|12665353|P1|COMPLETED|Overall Study||0
5149080|NCT01314105|12665352|P2|STARTED|Overall Study||12
5149081|NCT01314105|12665353|P1|STARTED|Overall Study||7
5149082|NCT01314014|12665395|P1|NOT COMPLETED|Overall Study||0
5149083|NCT01314014|12665395|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
5149084|NCT01314014|12665395|P1|STARTED|Overall Study||22
5149085|NCT01314001|12665406|P6|NOT COMPLETED|Overall Study||71
5149086|NCT01314001|12665407|P5|NOT COMPLETED|Overall Study||72
5149087|NCT01314001|12665408|P4|NOT COMPLETED|Overall Study||69
5149088|NCT01314001|12665409|P3|NOT COMPLETED|Overall Study||69
5149089|NCT01314001|12665410|P2|NOT COMPLETED|Overall Study||69
5149090|NCT01314001|12665411|P1|NOT COMPLETED|Overall Study||75
5149091|NCT01314001|12665406|P6|COMPLETED|Overall Study||129
5149092|NCT01314001|12665407|P5|COMPLETED|Overall Study||148
5149093|NCT01314001|12665408|P4|COMPLETED|Overall Study||122
5149094|NCT01314001|12665409|P3|COMPLETED|Overall Study||158
5149095|NCT01314001|12665410|P2|COMPLETED|Overall Study||124
5149096|NCT01314001|12665411|P1|COMPLETED|Overall Study||140
5149097|NCT01314001|12665406|P6|6-Month Follow Up Survey|Overall Study||139
5149098|NCT01314001|12665407|P5|6-Month Follow Up Survey|Overall Study||157
5149099|NCT01314001|12665408|P4|6-Month Follow Up Survey|Overall Study||135
5149100|NCT01314001|12665409|P3|6-Month Follow Up Survey|Overall Study||165
5149101|NCT01314001|12665410|P2|6-Month Follow Up Survey|Overall Study||137
5149102|NCT01314001|12665411|P1|6-Month Follow Up Survey|Overall Study||146
5149103|NCT01314001|12665406|P6|End-of-Treatment Visit|Overall Study||160
5149104|NCT01314001|12665407|P5|End-of-Treatment Visit|Overall Study||174
5149105|NCT01314001|12665408|P4|End-of-Treatment Visit|Overall Study||146
5149106|NCT01314001|12665409|P3|End-of-Treatment Visit|Overall Study||179
5149107|NCT01314001|12665410|P2|End-of-Treatment Visit|Overall Study||141
5149108|NCT01314001|12665411|P1|End-of-Treatment Visit|Overall Study||156
5149109|NCT01314001|12665406|P6|STARTED|Overall Study||200
5149110|NCT01314001|12665407|P5|STARTED|Overall Study||220
5149111|NCT01314001|12665408|P4|STARTED|Overall Study||191
5149112|NCT01314001|12665409|P3|STARTED|Overall Study||227
5149113|NCT01314001|12665410|P2|STARTED|Overall Study||193
5149114|NCT01314001|12665411|P1|STARTED|Overall Study||215
5149115|NCT01313936|12665457|P2|NOT COMPLETED|Overall Study||0
5149116|NCT01313936|12665458|P1|NOT COMPLETED|Overall Study||0
5149117|NCT01313936|12665457|P2|COMPLETED|Overall Study||26
5149118|NCT01313936|12665458|P1|COMPLETED|Overall Study||6
5149119|NCT01313936|12665457|P2|STARTED|Overall Study||26
5149120|NCT01313936|12665458|P1|STARTED|Overall Study||6
5149121|NCT01313923|12665471|P1|NOT COMPLETED|Overall Study||3
5149122|NCT01313923|12665471|P1|COMPLETED|Overall Study||0
5149123|NCT01313923|12665471|P1|STARTED|Overall Study||3
5149124|NCT01313910|12665475|P1|NOT COMPLETED|Overall Study||0
5149125|NCT01313910|12665475|P1|COMPLETED|Overall Study||8
5149126|NCT01313910|12665475|P1|STARTED|Overall Study||8
5149127|NCT01313897|12665483|P1|NOT COMPLETED|Overall Study||2
5149128|NCT01313897|12665483|P1|COMPLETED|Overall Study||8
5149129|NCT01313897|12665483|P1|STARTED|Overall Study||10
5149130|NCT01313884|12665487|P1|NOT COMPLETED|Overall Study||1
5149131|NCT01313884|12665487|P1|COMPLETED|Overall Study||2
5149132|NCT01313884|12665487|P1|STARTED|Overall Study||3
5149133|NCT01313858|12665495|P3|NOT COMPLETED|Overall Study||238
5149134|NCT01313858|12665496|P2|NOT COMPLETED|Overall Study||270
5149135|NCT01313858|12665497|P1|NOT COMPLETED|Overall Study||286
5149136|NCT01313858|12665495|P3|COMPLETED|Overall Study||305
5149137|NCT01313858|12665496|P2|COMPLETED|Overall Study||276
5149138|NCT01313858|12665497|P1|COMPLETED|Overall Study||238
5149139|NCT01313858|12665495|P3|STARTED|Overall Study||543
5149140|NCT01313858|12665496|P2|STARTED|Overall Study||546
5149141|NCT01313858|12665497|P1|STARTED|Overall Study||524
5149142|NCT01313780|12665520|P2|NOT COMPLETED|Overall Study||28
5149143|NCT01313780|12665521|P1|NOT COMPLETED|Overall Study||25
5149144|NCT01313780|12665520|P2|COMPLETED|Overall Study|PPS|31
5149145|NCT01313780|12665521|P1|COMPLETED|Overall Study|PPS|33
5149146|NCT01313780|12665520|P2|STARTED|Overall Study|FAS|59
5149147|NCT01313780|12665521|P1|STARTED|Overall Study|FAS|58
5149148|NCT01313767|12665531|P2|NOT COMPLETED|Overall Study||2
5149149|NCT01313767|12665532|P1|NOT COMPLETED|Overall Study||7
5149150|NCT01313767|12665531|P2|COMPLETED|Overall Study||96
5149151|NCT01313767|12665532|P1|COMPLETED|Overall Study||91
5149152|NCT01313767|12665531|P2|STARTED|Overall Study||98
5149153|NCT01313767|12665532|P1|STARTED|Overall Study||98
5149154|NCT01313728|12665574|P1|NOT COMPLETED|Baseline to Completion||0
5149155|NCT01313728|12665574|P1|COMPLETED|Baseline to Completion||25
5149156|NCT01313728|12665574|P1|STARTED|Baseline to Completion||25
5149157|NCT01313728|12665574|P1|NOT COMPLETED|Informed Consent to Baseline||1
5149158|NCT01313728|12665574|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
5149159|NCT01313728|12665574|P1|STARTED|Informed Consent to Baseline||26
5149160|NCT01313689|12665594|P5|NOT COMPLETED|24-Week Randomization 2||15
5149161|NCT01313689|12665595|P4|NOT COMPLETED|24-Week Randomization 2||1
5149162|NCT01313689|12665596|P3|NOT COMPLETED|24-Week Randomization 2||3
5149163|NCT01313689|12665597|P2|NOT COMPLETED|24-Week Randomization 2||0
5149164|NCT01313689|12665598|P1|NOT COMPLETED|24-Week Randomization 2||0
5149165|NCT01313689|12665594|P5|COMPLETED|24-Week Randomization 2||27
5149166|NCT01313689|12665595|P4|COMPLETED|24-Week Randomization 2||12
5149167|NCT01313689|12665596|P3|COMPLETED|24-Week Randomization 2||21
5149168|NCT01313689|12665597|P2|COMPLETED|24-Week Randomization 2||0
5149169|NCT01313689|12665598|P1|COMPLETED|24-Week Randomization 2||0
5149170|NCT01313689|12665594|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
5149171|NCT01313689|12665595|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
5149172|NCT01313689|12665596|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
5149173|NCT01313689|12665597|P2|STARTED|24-Week Randomization 2||0
5149174|NCT01313689|12665598|P1|STARTED|24-Week Randomization 2||0
5149175|NCT01313689|12665594|P5|NOT COMPLETED|24-Week Randomization 1||0
5149176|NCT01313689|12665595|P4|NOT COMPLETED|24-Week Randomization 1||0
5149177|NCT01313689|12665596|P3|NOT COMPLETED|24-Week Randomization 1||0
5149178|NCT01313689|12665597|P2|NOT COMPLETED|24-Week Randomization 1||10
5149179|NCT01313689|12665598|P1|NOT COMPLETED|24-Week Randomization 1||19
5149180|NCT01313689|12665594|P5|COMPLETED|24-Week Randomization 1||0
5149181|NCT01313689|12665595|P4|COMPLETED|24-Week Randomization 1||0
5149182|NCT01313689|12665596|P3|COMPLETED|24-Week Randomization 1||0
5149183|NCT01313689|12665597|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
5149184|NCT01313689|12665598|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
5149185|NCT01313689|12665594|P5|STARTED|24-Week Randomization 1||0
5149186|NCT01313689|12665595|P4|STARTED|24-Week Randomization 1||0
5149187|NCT01313689|12665596|P3|STARTED|24-Week Randomization 1||0
5149188|NCT01313689|12665597|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
5149189|NCT01313689|12665598|P1|STARTED|24-Week Randomization 1||79
5149190|NCT01313676|12665677|P4|NOT COMPLETED|Overall Study||994
5149191|NCT01313676|12665678|P3|NOT COMPLETED|Overall Study||1088
5149192|NCT01313676|12665679|P2|NOT COMPLETED|Overall Study||1113
5149193|NCT01313676|12665680|P1|NOT COMPLETED|Overall Study||1250
5149194|NCT01313676|12665677|P4|COMPLETED|Overall Study||3146
5149195|NCT01313676|12665678|P3|COMPLETED|Overall Study||3052
5149196|NCT01313676|12665679|P2|COMPLETED|Overall Study||3044
5149197|NCT01313676|12665680|P1|COMPLETED|Overall Study||2881
5149198|NCT01313676|12665677|P4|STARTED|Overall Study||4140
5149199|NCT01313676|12665678|P3|STARTED|Overall Study||4140
5149200|NCT01313676|12665679|P2|STARTED|Overall Study||4157
5149201|NCT01313676|12665680|P1|STARTED|Overall Study||4131
5149202|NCT01313663|12665700|P2|NOT COMPLETED|Overall Study||8
5149203|NCT01313663|12665701|P1|NOT COMPLETED|Overall Study||4
5149204|NCT01313663|12665700|P2|COMPLETED|Overall Study||3
5149205|NCT01313663|12665701|P1|COMPLETED|Overall Study||5
5149206|NCT01313663|12665700|P2|STARTED|Overall Study||11
5149207|NCT01313663|12665701|P1|STARTED|Overall Study||9
5149208|NCT01313650|12665739|P4|NOT COMPLETED|Overall Study||81
5149209|NCT01313650|12665740|P3|NOT COMPLETED|Overall Study||103
5149210|NCT01313650|12665741|P2|NOT COMPLETED|Overall Study||94
5149211|NCT01313650|12665742|P1|NOT COMPLETED|Overall Study||76
5149212|NCT01313650|12665739|P4|COMPLETED|Overall Study||332
5149213|NCT01313650|12665740|P3|COMPLETED|Overall Study||318
5149214|NCT01313650|12665741|P2|COMPLETED|Overall Study||324
5149215|NCT01313650|12665742|P1|COMPLETED|Overall Study||204
5149216|NCT01313650|12665739|P4|STARTED|Overall Study||413
5149217|NCT01313650|12665740|P3|STARTED|Overall Study||421
5149218|NCT01313650|12665741|P2|STARTED|Overall Study||418
5149219|NCT01313650|12665742|P1|STARTED|Overall Study||280
5149220|NCT01313637|12665768|P4|NOT COMPLETED|Overall Study||78
5149221|NCT01313637|12665769|P3|NOT COMPLETED|Overall Study||106
5149222|NCT01313637|12665770|P2|NOT COMPLETED|Overall Study||95
5149223|NCT01313637|12665771|P1|NOT COMPLETED|Overall Study||92
5149224|NCT01313637|12665768|P4|COMPLETED|Overall Study||325
5149225|NCT01313637|12665769|P3|COMPLETED|Overall Study||298
5149226|NCT01313637|12665770|P2|COMPLETED|Overall Study||312
5149227|NCT01313637|12665771|P1|COMPLETED|Overall Study||183
5149228|NCT01313637|12665768|P4|STARTED|Overall Study||403
5149229|NCT01313637|12665769|P3|STARTED|Overall Study||404
5149230|NCT01313637|12665770|P2|STARTED|Overall Study||407
5149231|NCT01313637|12665771|P1|STARTED|Overall Study||275
5149232|NCT01313624|12665795|P2|NOT COMPLETED|Open-Label Phase||13
5149233|NCT01313624|12665796|P1|NOT COMPLETED|Open-Label Phase||4
5149234|NCT01313624|12665795|P2|COMPLETED|Open-Label Phase||109
5149235|NCT01313624|12665796|P1|COMPLETED|Open-Label Phase||92
5149236|NCT01313624|12665795|P2|STARTED|Open-Label Phase||122
5149237|NCT01313624|12665796|P1|STARTED|Open-Label Phase||96
5149238|NCT01313624|12665795|P2|NOT COMPLETED|Double-Blind Phase||10
5149239|NCT01313624|12665796|P1|NOT COMPLETED|Double-Blind Phase||38
5149240|NCT01313624|12665795|P2|COMPLETED|Double-Blind Phase||122
5149241|NCT01313624|12665796|P1|COMPLETED|Double-Blind Phase||96
5149242|NCT01313624|12665795|P2|STARTED|Double-Blind Phase||132
5149243|NCT01313624|12665796|P1|STARTED|Double-Blind Phase||134
5149244|NCT01313559|12665810|P2|NOT COMPLETED|Overall Study||2
5149245|NCT01313559|12665811|P1|NOT COMPLETED|Overall Study||4
5149246|NCT01313559|12665810|P2|COMPLETED|Overall Study||0
5149247|NCT01313559|12665811|P1|COMPLETED|Overall Study||0
5149248|NCT01313559|12665810|P2|STARTED|Overall Study||2
5149249|NCT01313559|12665811|P1|STARTED|Overall Study||4
5149250|NCT01313520|12665825|P2|NOT COMPLETED|Overall Study||0
5149251|NCT01313520|12665826|P1|NOT COMPLETED|Overall Study||0
5149252|NCT01313520|12665825|P2|COMPLETED|Overall Study||31
5149253|NCT01313520|12665826|P1|COMPLETED|Overall Study||30
5149254|NCT01313520|12665825|P2|STARTED|Overall Study||31
5149255|NCT01313520|12665826|P1|STARTED|Overall Study||30
5149256|NCT01313507|12665846|P1|NOT COMPLETED|Overall Study||0
5149257|NCT01313507|12665846|P1|COMPLETED|Overall Study||21
5149258|NCT01313507|12665846|P1|STARTED|Overall Study||21
5149259|NCT01313494|12665854|P2|NOT COMPLETED|Overall Study||50
5149260|NCT01313494|12665855|P1|NOT COMPLETED|Overall Study||67
5149261|NCT01313494|12665854|P2|COMPLETED|Overall Study||263
5149262|NCT01313494|12665855|P1|COMPLETED|Overall Study||246
5149263|NCT01313494|12665854|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
5149264|NCT01313494|12665855|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
5149265|NCT01313494|12665854|P2|STARTED|Overall Study||313
5149266|NCT01313494|12665855|P1|STARTED|Overall Study||313
5149267|NCT01313416|12665907|P1|NOT COMPLETED|Overall Study||0
5149268|NCT01313416|12665907|P1|COMPLETED|Overall Study||2
5149269|NCT01313416|12665907|P1|STARTED|Overall Study||2
5149270|NCT01313312|12665912|P1|NOT COMPLETED|Overall Study||36
5149271|NCT01313312|12665912|P1|COMPLETED|Overall Study||222
5149272|NCT01313312|12665912|P1|Cycle 5|Overall Study||11
5149273|NCT01313312|12665912|P1|Cycle 4|Overall Study||81
5149274|NCT01313312|12665912|P1|Cycle 3|Overall Study||175
5149275|NCT01313312|12665912|P1|Cycle 2|Overall Study||229
5149276|NCT01313312|12665912|P1|Cycle 1|Overall Study||254
5149277|NCT01313312|12665912|P1|STARTED|Overall Study||258
5149278|NCT01313299|12665959|P3|NOT COMPLETED|Overall Study||4
5149279|NCT01313299|12665960|P2|NOT COMPLETED|Overall Study||3
5149280|NCT01313299|12665961|P1|NOT COMPLETED|Overall Study||7
5149281|NCT01313299|12665959|P3|COMPLETED|Overall Study||77
5149282|NCT01313299|12665960|P2|COMPLETED|Overall Study||78
5149283|NCT01313299|12665961|P1|COMPLETED|Overall Study||74
5149284|NCT01313299|12665959|P3|STARTED|Overall Study||81
5149285|NCT01313299|12665960|P2|STARTED|Overall Study||81
5149286|NCT01313299|12665961|P1|STARTED|Overall Study||81
5149287|NCT01313286|12665975|P2|NOT COMPLETED|Period 2||0
5149288|NCT01313286|12665976|P1|NOT COMPLETED|Period 2||0
5149289|NCT01313286|12665975|P2|COMPLETED|Period 2||8
5149290|NCT01313286|12665976|P1|COMPLETED|Period 2||6
5149291|NCT01313286|12665975|P2|STARTED|Period 2||8
5149292|NCT01313286|12665976|P1|STARTED|Period 2||6
5149293|NCT01313286|12665975|P2|NOT COMPLETED|Period 1||0
5149294|NCT01313286|12665976|P1|NOT COMPLETED|Period 1||2
5149295|NCT01313286|12665975|P2|COMPLETED|Period 1||8
5149296|NCT01313286|12665976|P1|COMPLETED|Period 1||6
5149297|NCT01313286|12665975|P2|STARTED|Period 1||8
5149298|NCT01313286|12665976|P1|STARTED|Period 1||8
5149299|NCT01313273|12665986|P2|NOT COMPLETED|Overall Study||1
5149300|NCT01313273|12665987|P1|NOT COMPLETED|Overall Study||2
5149301|NCT01313273|12665986|P2|COMPLETED|Overall Study||0
5149302|NCT01313273|12665987|P1|COMPLETED|Overall Study||0
5149303|NCT01313273|12665986|P2|STARTED|Overall Study||1
5149304|NCT01313273|12665987|P1|STARTED|Overall Study||2
5149305|NCT01313221|12666002|P3|NOT COMPLETED|Overall Study||23
5149306|NCT01313221|12666003|P2|NOT COMPLETED|Overall Study||8
5149307|NCT01313221|12666004|P1|NOT COMPLETED|Overall Study||12
5149308|NCT01313221|12666002|P3|COMPLETED|Overall Study||0
5149309|NCT01313221|12666003|P2|COMPLETED|Overall Study||135
5149310|NCT01313221|12666004|P1|COMPLETED|Overall Study||132
5149311|NCT01313221|12666002|P3|Randomized|Overall Study||0
5149312|NCT01313221|12666003|P2|Randomized|Overall Study||143
5149313|NCT01313221|12666004|P1|Randomized|Overall Study||144
5149314|NCT01313221|12666002|P3|STARTED|Overall Study||23
5149315|NCT01313221|12666003|P2|STARTED|Overall Study||143
5149316|NCT01313221|12666004|P1|STARTED|Overall Study||144
5149317|NCT01313208|12666056|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
5149318|NCT01313208|12666057|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
5149319|NCT01313208|12666056|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
5149320|NCT01313208|12666057|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
5149321|NCT01313208|12666056|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
5149322|NCT01313208|12666057|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
5149323|NCT01313208|12666056|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
5149324|NCT01313208|12666057|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
5149325|NCT01313208|12666056|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
5149326|NCT01313208|12666057|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
5149327|NCT01313208|12666056|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
5149328|NCT01313208|12666057|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
5149329|NCT01313182|12666147|P2|NOT COMPLETED|Overall Study||92
5149330|NCT01313182|12666148|P1|NOT COMPLETED|Overall Study||66
5149331|NCT01313182|12666147|P2|COMPLETED|Overall Study||763
5149332|NCT01313182|12666148|P1|COMPLETED|Overall Study||776
5149333|NCT01313182|12666147|P2|STARTED|Overall Study||855
5149334|NCT01313182|12666148|P1|STARTED|Overall Study||842
5149335|NCT01313117|12666160|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
5149336|NCT01313117|12666160|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
5149337|NCT01313117|12666160|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
5149338|NCT01313117|12666160|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
5149339|NCT01313117|12666160|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
5149340|NCT01313117|12666160|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
5149341|NCT01313117|12666160|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
5149342|NCT01313117|12666160|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
5149343|NCT01313117|12666160|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
5149344|NCT01313117|12666160|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
5149345|NCT01313117|12666160|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
5149346|NCT01313117|12666160|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
5149347|NCT01313117|12666160|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
5149348|NCT01313117|12666160|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
5149349|NCT01313117|12666160|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
5149350|NCT01313078|12666167|P1|NOT COMPLETED|Overall Study||3
5149351|NCT01313078|12666167|P1|COMPLETED|Overall Study||1
5149352|NCT01313078|12666167|P1|STARTED|Overall Study||4
5149353|NCT01313039|12666172|P1|NOT COMPLETED|Overall Study||2
5149354|NCT01313039|12666172|P1|COMPLETED|Overall Study||2
5149355|NCT01313039|12666172|P1|STARTED|Overall Study||4
5149356|NCT01312961|12666178|P2|NOT COMPLETED|Overall Study||7
5149357|NCT01312961|12666179|P1|NOT COMPLETED|Overall Study||17
5149358|NCT01312961|12666178|P2|COMPLETED|Overall Study||45
5149359|NCT01312961|12666179|P1|COMPLETED|Overall Study||35
5149360|NCT01312961|12666178|P2|Treated|Overall Study||52
5149361|NCT01312961|12666179|P1|Treated|Overall Study||52
5149362|NCT01312961|12666178|P2|STARTED|Overall Study||52
5149363|NCT01312961|12666179|P1|STARTED|Overall Study||52
5149364|NCT01312948|12666205|P1|NOT COMPLETED|Overall Study||0
5149365|NCT01312948|12666205|P1|COMPLETED|Overall Study||6
5149366|NCT01312948|12666205|P1|STARTED|Overall Study||6
5149367|NCT01312909|12666215|P3|NOT COMPLETED|Overall Study||47
5149368|NCT01312909|12666216|P2|NOT COMPLETED|Overall Study||36
5149369|NCT01312909|12666217|P1|NOT COMPLETED|Overall Study||42
5149370|NCT01312909|12666215|P3|COMPLETED|Overall Study||53
5149371|NCT01312909|12666216|P2|COMPLETED|Overall Study||67
5149372|NCT01312909|12666217|P1|COMPLETED|Overall Study||67
5149373|NCT01312909|12666215|P3|Treated|Overall Study||99
5149374|NCT01312909|12666216|P2|Treated|Overall Study||100
5149375|NCT01312909|12666217|P1|Treated|Overall Study||108
5149376|NCT01312909|12666215|P3|STARTED|Overall Study||100
5149377|NCT01312909|12666216|P2|STARTED|Overall Study||103
5149378|NCT01312909|12666217|P1|STARTED|Overall Study||109
5149379|NCT01312844|12666266|P2|NOT COMPLETED|Overall Study||0
5149380|NCT01312844|12666267|P1|NOT COMPLETED|Overall Study||0
5149381|NCT01312844|12666266|P2|COMPLETED|Overall Study||3
5149382|NCT01312844|12666267|P1|COMPLETED|Overall Study||4
5149383|NCT01312844|12666266|P2|STARTED|Overall Study||3
5149384|NCT01312844|12666267|P1|STARTED|Overall Study||4
5149385|NCT01312818|12666289|P1|NOT COMPLETED|Overall Study||0
5149386|NCT01312818|12666289|P1|COMPLETED|Overall Study||2
5149387|NCT01312818|12666289|P1|STARTED|Overall Study||2
5149388|NCT01312805|12666297|P2|NOT COMPLETED|Overall Study||0
5149389|NCT01312805|12666298|P1|NOT COMPLETED|Overall Study||0
5149390|NCT01312805|12666297|P2|COMPLETED|Overall Study||1082
5149391|NCT01312805|12666298|P1|COMPLETED|Overall Study||1016
5149392|NCT01312805|12666297|P2|STARTED|Overall Study||1082
5149393|NCT01312805|12666298|P1|STARTED|Overall Study||1016
5149394|NCT01312779|12666304|P1|NOT COMPLETED|Overall Study||32
5149395|NCT01312779|12666304|P1|COMPLETED|Overall Study||7
5149396|NCT01312779|12666304|P1|Implanted With Device|Overall Study||12
5149397|NCT01312779|12666304|P1|STARTED|Overall Study||39
5149398|NCT01312766|12666336|P2|NOT COMPLETED|Overall Study||5
5149399|NCT01312766|12666337|P1|NOT COMPLETED|Overall Study||6
5149400|NCT01312766|12666336|P2|COMPLETED|Overall Study||130
5149401|NCT01312766|12666337|P1|COMPLETED|Overall Study||129
5149402|NCT01312766|12666336|P2|STARTED|Overall Study||135
5149403|NCT01312766|12666337|P1|STARTED|Overall Study||135
5149404|NCT01312675|12666369|P2|NOT COMPLETED|Overall Study||0
5149405|NCT01312675|12666370|P1|NOT COMPLETED|Overall Study||0
5149406|NCT01312675|12666369|P2|COMPLETED|Overall Study||7
5149407|NCT01312675|12666370|P1|COMPLETED|Overall Study||9
5149408|NCT01312675|12666369|P2|STARTED|Overall Study||7
5149409|NCT01312675|12666370|P1|STARTED|Overall Study||9
5149410|NCT01312519|12666378|P2|NOT COMPLETED|Overall Study||0
5149411|NCT01312519|12666379|P1|NOT COMPLETED|Overall Study||0
5149412|NCT01312519|12666378|P2|COMPLETED|Overall Study||24
5149413|NCT01312519|12666379|P1|COMPLETED|Overall Study||26
5149414|NCT01312519|12666378|P2|STARTED|Overall Study||24
5149415|NCT01312519|12666379|P1|STARTED|Overall Study||26
5149416|NCT01312467|12666387|P1|NOT COMPLETED|Overall Study||13
5149417|NCT01312467|12666387|P1|COMPLETED|Overall Study||32
5149418|NCT01312467|12666387|P1|STARTED|Overall Study||45
5149419|NCT01312428|12666396|P2|NOT COMPLETED|Overall Study||4
5149420|NCT01312428|12666397|P1|NOT COMPLETED|Overall Study||3
5149421|NCT01312428|12666396|P2|COMPLETED|Overall Study||0
5149422|NCT01312428|12666397|P1|COMPLETED|Overall Study||0
5149423|NCT01312428|12666396|P2|STARTED|Overall Study||4
5149424|NCT01312428|12666397|P1|STARTED|Overall Study||3
5149425|NCT01312272|12666407|P2|NOT COMPLETED|Overall Study||1
5149426|NCT01312272|12666408|P1|NOT COMPLETED|Overall Study||0
5149427|NCT01312272|12666407|P2|COMPLETED|Overall Study||11
5149428|NCT01312272|12666408|P1|COMPLETED|Overall Study||12
5149429|NCT01312272|12666407|P2|STARTED|Overall Study||12
5149430|NCT01312272|12666408|P1|STARTED|Overall Study||12
5149431|NCT01312233|12666427|P3|NOT COMPLETED|Overall Study||7
5149432|NCT01312233|12666428|P2|NOT COMPLETED|Overall Study||0
5149433|NCT01312233|12666429|P1|NOT COMPLETED|Overall Study||2
5149434|NCT01312233|12666427|P3|COMPLETED|Overall Study||36
5149435|NCT01312233|12666428|P2|COMPLETED|Overall Study||44
5149436|NCT01312233|12666429|P1|COMPLETED|Overall Study||42
5149437|NCT01312233|12666427|P3|STARTED|Overall Study||43
5149438|NCT01312233|12666428|P2|STARTED|Overall Study||44
5149439|NCT01312233|12666429|P1|STARTED|Overall Study||44
5149440|NCT01312181|12666452|P3|NOT COMPLETED|Overall Study||8
5149441|NCT01312181|12666453|P2|NOT COMPLETED|Overall Study||6
5149442|NCT01312181|12666454|P1|NOT COMPLETED|Overall Study||2
5149443|NCT01312181|12666452|P3|COMPLETED|Overall Study||75
5149444|NCT01312181|12666453|P2|COMPLETED|Overall Study||71
5149445|NCT01312181|12666454|P1|COMPLETED|Overall Study||78
5149446|NCT01312181|12666452|P3|STARTED|Overall Study||83
5149447|NCT01312181|12666453|P2|STARTED|Overall Study||77
5149448|NCT01312181|12666454|P1|STARTED|Overall Study||80
5149449|NCT01312129|12666467|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
5149450|NCT01312129|12666468|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
5149451|NCT01312129|12666467|P2|COMPLETED|Second Intervention (24 Hours)||6
5149452|NCT01312129|12666468|P1|COMPLETED|Second Intervention (24 Hours)||6
5149453|NCT01312129|12666467|P2|Alcohol Cue|Second Intervention (24 Hours)||6
5149454|NCT01312129|12666468|P1|Alcohol Cue|Second Intervention (24 Hours)||6
5149455|NCT01312129|12666467|P2|Control Cue|Second Intervention (24 Hours)||6
5149456|NCT01312129|12666468|P1|Control Cue|Second Intervention (24 Hours)||6
5149457|NCT01312129|12666467|P2|STARTED|Second Intervention (24 Hours)||7
5149458|NCT01312129|12666468|P1|STARTED|Second Intervention (24 Hours)||6
5149459|NCT01312129|12666467|P2|NOT COMPLETED|Washout (1 Week)||0
5149460|NCT01312129|12666468|P1|NOT COMPLETED|Washout (1 Week)||0
5149461|NCT01312129|12666467|P2|COMPLETED|Washout (1 Week)||7
5149462|NCT01312129|12666468|P1|COMPLETED|Washout (1 Week)||6
5149463|NCT01312129|12666467|P2|STARTED|Washout (1 Week)||7
5149464|NCT01312129|12666468|P1|STARTED|Washout (1 Week)||6
5149465|NCT01312129|12666467|P2|NOT COMPLETED|First Intervention (24 Hours)||0
5149466|NCT01312129|12666468|P1|NOT COMPLETED|First Intervention (24 Hours)||0
5149467|NCT01312129|12666467|P2|COMPLETED|First Intervention (24 Hours)||7
5149468|NCT01312129|12666468|P1|COMPLETED|First Intervention (24 Hours)||6
5149469|NCT01312129|12666467|P2|Alcohol Cue|First Intervention (24 Hours)||7
5149470|NCT01312129|12666468|P1|Alcohol Cue|First Intervention (24 Hours)||6
5149471|NCT01312129|12666467|P2|Control Cue|First Intervention (24 Hours)||7
5149472|NCT01312129|12666468|P1|Control Cue|First Intervention (24 Hours)||6
5149473|NCT01312129|12666467|P2|STARTED|First Intervention (24 Hours)||7
5149474|NCT01312129|12666468|P1|STARTED|First Intervention (24 Hours)||6
5149475|NCT01312038|12666476|P2|NOT COMPLETED|Overall Study||0
5149476|NCT01312038|12666477|P1|NOT COMPLETED|Overall Study||0
5149477|NCT01312038|12666476|P2|COMPLETED|Overall Study||12
5149478|NCT01312038|12666477|P1|COMPLETED|Overall Study||13
5149479|NCT01312038|12666476|P2|STARTED|Overall Study||12
5149480|NCT01312038|12666477|P1|STARTED|Overall Study||13
5149481|NCT01311895|12666485|P2|NOT COMPLETED|Overall Study||0
5149482|NCT01311895|12666486|P1|NOT COMPLETED|Overall Study||0
5149483|NCT01311895|12666485|P2|COMPLETED|Overall Study||175
5149484|NCT01311895|12666486|P1|COMPLETED|Overall Study||175
5149485|NCT01311895|12666485|P2|STARTED|Overall Study||175
5149486|NCT01311895|12666486|P1|STARTED|Overall Study||175
5149487|NCT01311687|12666498|P2|NOT COMPLETED|PFS Follow-up Phase||0
5149488|NCT01311687|12666499|P1|NOT COMPLETED|PFS Follow-up Phase||0
5149489|NCT01311687|12666498|P2|COMPLETED|PFS Follow-up Phase||8
5149490|NCT01311687|12666499|P1|COMPLETED|PFS Follow-up Phase||11
5149491|NCT01311687|12666498|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
5149492|NCT01311687|12666499|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
5149493|NCT01311687|12666498|P2|STARTED|PFS Follow-up Phase||8
5149494|NCT01311687|12666499|P1|STARTED|PFS Follow-up Phase||11
5149495|NCT01311687|12666498|P2|NOT COMPLETED|Treatment Phase||0
5149496|NCT01311687|12666499|P1|NOT COMPLETED|Treatment Phase||0
5149497|NCT01311687|12666498|P2|COMPLETED|Treatment Phase||153
5149498|NCT01311687|12666499|P1|COMPLETED|Treatment Phase||302
5149499|NCT01311687|12666498|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
5149500|NCT01311687|12666499|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
5149501|NCT01311687|12666498|P2|Received Study Drug|Treatment Phase||150
5149502|NCT01311687|12666499|P1|Received Study Drug|Treatment Phase||300
5149503|NCT01311687|12666498|P2|STARTED|Treatment Phase||153
5149504|NCT01311687|12666499|P1|STARTED|Treatment Phase||302
5149505|NCT01311661|12666553|P1|NOT COMPLETED|Overall Study||7
5149506|NCT01311661|12666553|P1|COMPLETED|Overall Study||199
5149507|NCT01311661|12666553|P1|Received Olo 10 mcg qd|Overall Study||102
5149508|NCT01311661|12666553|P1|Received Olo 5 mcg Bid|Overall Study||101
5149509|NCT01311661|12666553|P1|Received Olo 5 mcg qd|Overall Study||101
5149510|NCT01311661|12666553|P1|Received Olo 2.5 mcg Bid|Overall Study||101
5149511|NCT01311661|12666553|P1|Received Placebo|Overall Study||201
5149512|NCT01311661|12666553|P1|STARTED|Overall Study|Entered and treated|206
5149513|NCT01311557|12666697|P2|NOT COMPLETED|Overall Study||6
5149514|NCT01311557|12666698|P1|NOT COMPLETED|Overall Study||5
5149515|NCT01311557|12666697|P2|COMPLETED|Overall Study||645
5149516|NCT01311557|12666698|P1|COMPLETED|Overall Study||646
5149517|NCT01311557|12666697|P2|STARTED|Overall Study||651
5149518|NCT01311557|12666698|P1|STARTED|Overall Study||651
5149519|NCT01311505|12666714|P2|NOT COMPLETED|Second Intervention Period||0
5149520|NCT01311505|12666715|P1|NOT COMPLETED|Second Intervention Period||0
5149521|NCT01311505|12666714|P2|COMPLETED|Second Intervention Period||10
5149522|NCT01311505|12666715|P1|COMPLETED|Second Intervention Period||10
5149523|NCT01311505|12666714|P2|STARTED|Second Intervention Period||10
5149524|NCT01311505|12666715|P1|STARTED|Second Intervention Period||10
5149525|NCT01311505|12666714|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5149526|NCT01311505|12666715|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5149527|NCT01311505|12666714|P2|COMPLETED|Washout Period (at Least 7 Days)||10
5149528|NCT01311505|12666715|P1|COMPLETED|Washout Period (at Least 7 Days)||10
5149529|NCT01311505|12666714|P2|STARTED|Washout Period (at Least 7 Days)||10
5149530|NCT01311505|12666715|P1|STARTED|Washout Period (at Least 7 Days)||10
5149531|NCT01311505|12666714|P2|NOT COMPLETED|First Intervention Period||1
5149532|NCT01311505|12666715|P1|NOT COMPLETED|First Intervention Period||0
5149533|NCT01311505|12666714|P2|COMPLETED|First Intervention Period||10
5149534|NCT01311505|12666715|P1|COMPLETED|First Intervention Period||10
5149535|NCT01311505|12666714|P2|STARTED|First Intervention Period||11
5149536|NCT01311505|12666715|P1|STARTED|First Intervention Period||10
5149537|NCT01311362|12666743|P1|NOT COMPLETED|Ambrisentan and SJW||0
5149538|NCT01311362|12666743|P1|COMPLETED|Ambrisentan and SJW||20
5149539|NCT01311362|12666743|P1|STARTED|Ambrisentan and SJW||20
5149540|NCT01311362|12666743|P1|NOT COMPLETED|Ambrisentan Steady-state||0
5149541|NCT01311362|12666743|P1|COMPLETED|Ambrisentan Steady-state||20
5149542|NCT01311362|12666743|P1|STARTED|Ambrisentan Steady-state||20
5149543|NCT01311362|12666743|P1|NOT COMPLETED|Ambrisentan Single Dose||0
5149544|NCT01311362|12666743|P1|COMPLETED|Ambrisentan Single Dose||20
5149545|NCT01311362|12666743|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
5149546|NCT01311102|12666756|P2|NOT COMPLETED|Overall Study||0
5149547|NCT01311102|12666757|P1|NOT COMPLETED|Overall Study||0
5149548|NCT01311102|12666756|P2|COMPLETED|Overall Study||20
5149549|NCT01311102|12666757|P1|COMPLETED|Overall Study||20
5149550|NCT01311102|12666756|P2|STARTED|Overall Study||20
5149551|NCT01311102|12666757|P1|STARTED|Overall Study||20
5149552|NCT01311024|12666771|P2|NOT COMPLETED|Overall Study||22
5149553|NCT01311024|12666772|P1|NOT COMPLETED|Overall Study||35
5149554|NCT01311024|12666771|P2|COMPLETED|Overall Study||789
5149555|NCT01311024|12666772|P1|COMPLETED|Overall Study||1495
5149556|NCT01311024|12666771|P2|STARTED|Overall Study||811
5149557|NCT01311024|12666772|P1|STARTED|Overall Study||1530
5149558|NCT01310868|12666778|P1|NOT COMPLETED|Overall Study||13
5149559|NCT01310868|12666778|P1|COMPLETED|Overall Study||59
5149560|NCT01310868|12666778|P1|STARTED|Overall Study||72
5149561|NCT01310855|12666786|P2|NOT COMPLETED|Overall Study||0
5149562|NCT01310855|12666787|P1|NOT COMPLETED|Overall Study||0
5149563|NCT01310855|12666786|P2|COMPLETED|Overall Study||19
5149564|NCT01310855|12666787|P1|COMPLETED|Overall Study||19
5149565|NCT01310855|12666786|P2|STARTED|Overall Study||19
5149566|NCT01310855|12666787|P1|STARTED|Overall Study||19
5149567|NCT01310803|12666795|P2|NOT COMPLETED|Overall Study||0
5149568|NCT01310803|12666796|P1|NOT COMPLETED|Overall Study||1
5149569|NCT01310803|12666795|P2|COMPLETED|Overall Study||0
5149570|NCT01310803|12666796|P1|COMPLETED|Overall Study||0
5149571|NCT01310803|12666795|P2|STARTED|Overall Study||0
5149572|NCT01310803|12666796|P1|STARTED|Overall Study||1
5149573|NCT01310777|12666807|P3|NOT COMPLETED|Overall Study||30
5149574|NCT01310777|12666808|P2|NOT COMPLETED|Overall Study||14
5149575|NCT01310777|12666809|P1|NOT COMPLETED|Overall Study||33
5149576|NCT01310777|12666807|P3|COMPLETED|Overall Study||145
5149577|NCT01310777|12666808|P2|COMPLETED|Overall Study||178
5149578|NCT01310777|12666809|P1|COMPLETED|Overall Study||160
5149579|NCT01310777|12666807|P3|STARTED|Overall Study||175
5149580|NCT01310777|12666808|P2|STARTED|Overall Study||192
5149581|NCT01310777|12666809|P1|STARTED|Overall Study||193
5149582|NCT01310699|12666819|P2|NOT COMPLETED|Overall Study||6
5149583|NCT01310699|12666820|P1|NOT COMPLETED|Overall Study||4
5149584|NCT01310699|12666819|P2|COMPLETED|Overall Study||143
5149585|NCT01310699|12666820|P1|COMPLETED|Overall Study||128
5149586|NCT01310699|12666819|P2|STARTED|Overall Study||149
5149587|NCT01310699|12666820|P1|STARTED|Overall Study||132
5149588|NCT01310582|12666832|P2|NOT COMPLETED|Overall Study||0
5149589|NCT01310582|12666833|P1|NOT COMPLETED|Overall Study||0
5149590|NCT01310582|12666832|P2|COMPLETED|Overall Study||26
5149591|NCT01310582|12666833|P1|COMPLETED|Overall Study||31
5149592|NCT01310582|12666832|P2|STARTED|Overall Study||26
5149593|NCT01310582|12666833|P1|STARTED|Overall Study||31
5149594|NCT01310413|12666847|P7|NOT COMPLETED|From Day U0 to Day U385||3
5149595|NCT01310413|12666848|P6|NOT COMPLETED|From Day U0 to Day U385||0
5149596|NCT01310413|12666849|P5|NOT COMPLETED|From Day U0 to Day U385||0
5149597|NCT01310413|12666850|P4|NOT COMPLETED|From Day U0 to Day U385||0
5149598|NCT01310413|12666851|P3|NOT COMPLETED|From Day U0 to Day U385||0
5149599|NCT01310413|12666852|P2|NOT COMPLETED|From Day U0 to Day U385||0
5149600|NCT01310413|12666853|P1|NOT COMPLETED|From Day U0 to Day U385||0
5149601|NCT01310413|12666847|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
5149602|NCT01310413|12666848|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149603|NCT01310413|12666849|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149604|NCT01310413|12666850|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149605|NCT01310413|12666851|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149606|NCT01310413|12666852|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149607|NCT01310413|12666853|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149608|NCT01310413|12666847|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
5149609|NCT01310413|12666848|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149610|NCT01310413|12666849|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149611|NCT01310413|12666850|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
5149612|NCT01310413|12666851|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149613|NCT01310413|12666852|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149614|NCT01310413|12666853|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
5149615|NCT01310413|12666847|P7|NOT COMPLETED|Day 0 to Day 385||0
5149616|NCT01310413|12666848|P6|NOT COMPLETED|Day 0 to Day 385||3
5149617|NCT01310413|12666849|P5|NOT COMPLETED|Day 0 to Day 385||3
5149618|NCT01310413|12666850|P4|NOT COMPLETED|Day 0 to Day 385||8
5149619|NCT01310413|12666851|P3|NOT COMPLETED|Day 0 to Day 385||7
5149620|NCT01310413|12666852|P2|NOT COMPLETED|Day 0 to Day 385||8
5149621|NCT01310413|12666853|P1|NOT COMPLETED|Day 0 to Day 385||27
5149622|NCT01310413|12666847|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
5149623|NCT01310413|12666848|P6|COMPLETED|Day 0 to Day 385||77
5149624|NCT01310413|12666849|P5|COMPLETED|Day 0 to Day 385||73
5149625|NCT01310413|12666850|P4|COMPLETED|Day 0 to Day 385||67
5149626|NCT01310413|12666851|P3|COMPLETED|Day 0 to Day 385||203
5149627|NCT01310413|12666852|P2|COMPLETED|Day 0 to Day 385||190
5149628|NCT01310413|12666853|P1|COMPLETED|Day 0 to Day 385||172
5149629|NCT01310413|12666847|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
5149630|NCT01310413|12666848|P6|STARTED|Day 0 to Day 385||80
5149631|NCT01310413|12666849|P5|STARTED|Day 0 to Day 385||76
5149632|NCT01310413|12666850|P4|STARTED|Day 0 to Day 385||75
5149633|NCT01310413|12666851|P3|STARTED|Day 0 to Day 385||210
5149634|NCT01310413|12666852|P2|STARTED|Day 0 to Day 385||198
5149635|NCT01310413|12666853|P1|STARTED|Day 0 to Day 385||199
5149636|NCT01310400|12667009|P3|NOT COMPLETED|Overall Study||30
5149637|NCT01310400|12667010|P2|NOT COMPLETED|Overall Study||32
5149638|NCT01310400|12667011|P1|NOT COMPLETED|Overall Study||28
5149639|NCT01310400|12667009|P3|COMPLETED|Overall Study||422
5149640|NCT01310400|12667010|P2|COMPLETED|Overall Study||420
5149641|NCT01310400|12667011|P1|COMPLETED|Overall Study||424
5149642|NCT01310400|12667009|P3|STARTED|Overall Study||452
5149643|NCT01310400|12667010|P2|STARTED|Overall Study||452
5149644|NCT01310400|12667011|P1|STARTED|Overall Study||452
5149645|NCT01310179|12667028|P1|NOT COMPLETED|Overall Study||0
5149646|NCT01310179|12667028|P1|COMPLETED|Overall Study||12
5149647|NCT01310179|12667028|P1|STARTED|Overall Study||12
5149648|NCT01310127|12667035|P2|NOT COMPLETED|Overall Study||1
5149649|NCT01310127|12667036|P1|NOT COMPLETED|Overall Study||2
5149650|NCT01310127|12667035|P2|COMPLETED|Overall Study||10
5149651|NCT01310127|12667036|P1|COMPLETED|Overall Study||10
5149652|NCT01310127|12667035|P2|STARTED|Overall Study||11
5149653|NCT01310127|12667036|P1|STARTED|Overall Study||12
5149654|NCT01310075|12667050|P2|NOT COMPLETED|Overall Study||10
5149655|NCT01310075|12667051|P1|NOT COMPLETED|Overall Study||14
5149656|NCT01310075|12667050|P2|COMPLETED|Overall Study||35
5149657|NCT01310075|12667051|P1|COMPLETED|Overall Study||31
5149658|NCT01310075|12667050|P2|STARTED|Overall Study||45
5149659|NCT01310075|12667051|P1|STARTED|Overall Study||45
5149660|NCT01310036|12667057|P1|NOT COMPLETED|Overall Study||202
5149661|NCT01310036|12667057|P1|COMPLETED|Overall Study||6
5149662|NCT01310036|12667057|P1|STARTED|Overall Study||208
5149663|NCT01309997|12667070|P2|NOT COMPLETED|Overall Study||6
5149664|NCT01309997|12667071|P1|NOT COMPLETED|Overall Study||5
5149665|NCT01309997|12667070|P2|COMPLETED|Overall Study||31
5149666|NCT01309997|12667071|P1|COMPLETED|Overall Study||30
5149667|NCT01309997|12667070|P2|Crossed Over to Second Arm|Overall Study||23
5149668|NCT01309997|12667071|P1|Crossed Over to Second Arm|Overall Study||19
5149669|NCT01309997|12667070|P2|Remained on First Arm Only|Overall Study||14
5149670|NCT01309997|12667071|P1|Remained on First Arm Only|Overall Study||16
5149671|NCT01309997|12667070|P2|STARTED|Overall Study||37
5149672|NCT01309997|12667071|P1|STARTED|Overall Study||35
5149673|NCT01309919|12667095|P2|NOT COMPLETED|Overall Study||48
5149674|NCT01309919|12667096|P1|NOT COMPLETED|Overall Study||17
5149675|NCT01309919|12667095|P2|COMPLETED|Overall Study||27
5149676|NCT01309919|12667096|P1|COMPLETED|Overall Study||58
5149677|NCT01309919|12667095|P2|STARTED|Overall Study||75
5149678|NCT01309919|12667096|P1|STARTED|Overall Study||75
5149679|NCT01309893|12667108|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
5149680|NCT01309893|12667109|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
5149681|NCT01309893|12667108|P2|COMPLETED|Week 2 - Crossover Intervention||32
5149682|NCT01309893|12667109|P1|COMPLETED|Week 2 - Crossover Intervention||32
5149683|NCT01309893|12667108|P2|STARTED|Week 2 - Crossover Intervention||33
5149684|NCT01309893|12667109|P1|STARTED|Week 2 - Crossover Intervention||33
5149685|NCT01309893|12667108|P2|NOT COMPLETED|Week 1 - First Intervention||0
5149686|NCT01309893|12667109|P1|NOT COMPLETED|Week 1 - First Intervention||0
5149687|NCT01309893|12667108|P2|COMPLETED|Week 1 - First Intervention||33
5149688|NCT01309893|12667109|P1|COMPLETED|Week 1 - First Intervention||33
5149689|NCT01309893|12667108|P2|STARTED|Week 1 - First Intervention||33
5149690|NCT01309893|12667109|P1|STARTED|Week 1 - First Intervention||33
5149691|NCT01309880|12667119|P2|NOT COMPLETED|Overall Study||0
5149692|NCT01309880|12667120|P1|NOT COMPLETED|Overall Study||0
5149693|NCT01309880|12667119|P2|COMPLETED|Overall Study||33
5149694|NCT01309880|12667120|P1|COMPLETED|Overall Study||33
5149695|NCT01309880|12667119|P2|STARTED|Overall Study||33
5149696|NCT01309880|12667120|P1|STARTED|Overall Study||33
5149697|NCT01309841|12667133|P3|NOT COMPLETED|Overall Study||37
5149698|NCT01309841|12667134|P2|NOT COMPLETED|Overall Study||41
5149699|NCT01309841|12667135|P1|NOT COMPLETED|Overall Study||39
5149700|NCT01309841|12667133|P3|COMPLETED|Overall Study||180
5149701|NCT01309841|12667134|P2|COMPLETED|Overall Study||177
5149702|NCT01309841|12667135|P1|COMPLETED|Overall Study||178
5149703|NCT01309841|12667133|P3|STARTED|Overall Study||217
5149704|NCT01309841|12667134|P2|STARTED|Overall Study||218
5149705|NCT01309841|12667135|P1|STARTED|Overall Study||217
5149706|NCT01309828|12667175|P2|NOT COMPLETED|Overall Study||16
5149707|NCT01309828|12667176|P1|NOT COMPLETED|Overall Study||16
5149708|NCT01309828|12667175|P2|COMPLETED|Overall Study||60
5149709|NCT01309828|12667176|P1|COMPLETED|Overall Study||61
5149710|NCT01309828|12667175|P2|STARTED|Overall Study||76
5149711|NCT01309828|12667176|P1|STARTED|Overall Study||77
5149712|NCT01309802|12667190|P2|NOT COMPLETED|Overall Study||9
5149713|NCT01309802|12667191|P1|NOT COMPLETED|Overall Study||12
5149714|NCT01309802|12667190|P2|COMPLETED|Overall Study||14
5149715|NCT01309802|12667191|P1|COMPLETED|Overall Study||13
5149716|NCT01309802|12667190|P2|STARTED|Overall Study||23
5149717|NCT01309802|12667191|P1|STARTED|Overall Study||25
5149718|NCT01309737|12667210|P5|NOT COMPLETED|Week 16 to 52||33
5149719|NCT01309737|12667211|P4|NOT COMPLETED|Week 16 to 52||34
5149720|NCT01309737|12667212|P3|NOT COMPLETED|Week 16 to 52||0
5149721|NCT01309737|12667213|P2|NOT COMPLETED|Week 16 to 52||103
5149722|NCT01309737|12667214|P1|NOT COMPLETED|Week 16 to 52||133
5149723|NCT01309737|12667210|P5|COMPLETED|Week 16 to 52||44
5149724|NCT01309737|12667211|P4|COMPLETED|Week 16 to 52||41
5149725|NCT01309737|12667212|P3|COMPLETED|Week 16 to 52||0
5149726|NCT01309737|12667213|P2|COMPLETED|Week 16 to 52||238
5149727|NCT01309737|12667214|P1|COMPLETED|Week 16 to 52||198
5149728|NCT01309737|12667210|P5|STARTED|Week 16 to 52||77
5149729|NCT01309737|12667211|P4|STARTED|Week 16 to 52||75
5149730|NCT01309737|12667212|P3|STARTED|Week 16 to 52||0
5149731|NCT01309737|12667213|P2|STARTED|Week 16 to 52||341
5149732|NCT01309737|12667214|P1|STARTED|Week 16 to 52||331
5149733|NCT01309737|12667210|P5|NOT COMPLETED|Week 0 to 16||0
5149734|NCT01309737|12667211|P4|NOT COMPLETED|Week 0 to 16||0
5149735|NCT01309737|12667212|P3|NOT COMPLETED|Week 0 to 16||44
5149736|NCT01309737|12667213|P2|NOT COMPLETED|Week 0 to 16||40
5149737|NCT01309737|12667214|P1|NOT COMPLETED|Week 0 to 16||52
5149738|NCT01309737|12667210|P5|COMPLETED|Week 0 to 16||0
5149739|NCT01309737|12667211|P4|COMPLETED|Week 0 to 16||0
5149740|NCT01309737|12667212|P3|COMPLETED|Week 0 to 16||152
5149741|NCT01309737|12667213|P2|COMPLETED|Week 0 to 16||341
5149742|NCT01309737|12667214|P1|COMPLETED|Week 0 to 16||331
5149743|NCT01309737|12667210|P5|Treated|Week 0 to 16||0
5149744|NCT01309737|12667211|P4|Treated|Week 0 to 16||0
5149745|NCT01309737|12667212|P3|Treated|Week 0 to 16||196
5149746|NCT01309737|12667213|P2|Treated|Week 0 to 16||381
5149747|NCT01309737|12667214|P1|Treated|Week 0 to 16||382
5149748|NCT01309737|12667210|P5|STARTED|Week 0 to 16||0
5149749|NCT01309737|12667211|P4|STARTED|Week 0 to 16||0
5149750|NCT01309737|12667212|P3|STARTED|Week 0 to 16||196
5149751|NCT01309737|12667213|P2|STARTED|Week 0 to 16||381
5149752|NCT01309737|12667214|P1|STARTED|Week 0 to 16||383
5149753|NCT01309672|12667409|P1|NOT COMPLETED|Overall Study||37
5149754|NCT01309672|12667409|P1|COMPLETED|Overall Study||4
5149755|NCT01309672|12667409|P1|Received Protocol Treatment|Overall Study||40
5149756|NCT01309672|12667409|P1|STARTED|Overall Study||41
5149757|NCT01309659|12667419|P2|NOT COMPLETED|Overall Study||1
5149758|NCT01309659|12667420|P1|NOT COMPLETED|Overall Study||0
5149759|NCT01309659|12667419|P2|COMPLETED|Overall Study||9
5149760|NCT01309659|12667420|P1|COMPLETED|Overall Study||9
5149761|NCT01309659|12667419|P2|STARTED|Overall Study||10
5149762|NCT01309659|12667420|P1|STARTED|Overall Study||9
5149763|NCT01309646|12667462|P2|NOT COMPLETED|Overall Study||0
5149764|NCT01309646|12667463|P1|NOT COMPLETED|Overall Study||0
5149765|NCT01309646|12667462|P2|COMPLETED|Overall Study||227
5149766|NCT01309646|12667463|P1|COMPLETED|Overall Study||224
5149767|NCT01309646|12667462|P2|STARTED|Overall Study||227
5149768|NCT01309646|12667463|P1|STARTED|Overall Study||224
5149769|NCT01309581|12667503|P2|NOT COMPLETED|Overall Study||0
5149770|NCT01309581|12667504|P1|NOT COMPLETED|Overall Study||0
5149771|NCT01309581|12667503|P2|COMPLETED|Overall Study||1
5149772|NCT01309581|12667504|P1|COMPLETED|Overall Study||2
5149773|NCT01309581|12667503|P2|STARTED|Overall Study||1
5149774|NCT01309581|12667504|P1|STARTED|Overall Study||2
5149775|NCT01309451|12667514|P2|NOT COMPLETED|Overall Study||3
5149776|NCT01309451|12667515|P1|NOT COMPLETED|Overall Study||2
5149777|NCT01309451|12667514|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
5149778|NCT01309451|12667515|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
5149779|NCT01309451|12667514|P2|STARTED|Overall Study|unit of measure is number of eyes|21
5149780|NCT01309451|12667515|P1|STARTED|Overall Study|unit of measure is number of eyes|19
5149781|NCT01309386|12667525|P2|NOT COMPLETED|Overall Study||21
5149782|NCT01309386|12667526|P1|NOT COMPLETED|Overall Study||22
5149783|NCT01309386|12667525|P2|COMPLETED|Overall Study||29
5149784|NCT01309386|12667526|P1|COMPLETED|Overall Study||28
5149785|NCT01309386|12667525|P2|STARTED|Overall Study||50
5149786|NCT01309386|12667526|P1|STARTED|Overall Study||50
5149787|NCT01309360|12667547|P3|NOT COMPLETED|Overall Study||0
5149788|NCT01309360|12667548|P2|NOT COMPLETED|Overall Study||0
5149789|NCT01309360|12667549|P1|NOT COMPLETED|Overall Study||0
5149790|NCT01309360|12667547|P3|COMPLETED|Overall Study||40
5149791|NCT01309360|12667548|P2|COMPLETED|Overall Study||40
5149792|NCT01309360|12667549|P1|COMPLETED|Overall Study||40
5149793|NCT01309360|12667547|P3|STARTED|Overall Study||40
5149794|NCT01309360|12667548|P2|STARTED|Overall Study||40
5149795|NCT01309360|12667549|P1|STARTED|Overall Study||40
5149796|NCT01309308|12667574|P2|NOT COMPLETED|Overall Study||4
5149797|NCT01309308|12667575|P1|NOT COMPLETED|Overall Study||6
5149798|NCT01309308|12667574|P2|COMPLETED|Overall Study||71
5149799|NCT01309308|12667575|P1|COMPLETED|Overall Study||69
5149800|NCT01309308|12667574|P2|STARTED|Overall Study||75
5149801|NCT01309308|12667575|P1|STARTED|Overall Study||75
5149802|NCT01309282|12667583|P1|NOT COMPLETED|Overall Study||1
5149803|NCT01309282|12667583|P1|COMPLETED|Overall Study||8
5149804|NCT01309282|12667583|P1|STARTED|Overall Study||9
5149805|NCT01309269|12667600|P1|NOT COMPLETED|Overall Study||840
5149806|NCT01309269|12667600|P1|COMPLETED|Overall Study||245
5149807|NCT01309269|12667600|P1|Treated|Overall Study||978
5149808|NCT01309269|12667600|P1|STARTED|Overall Study||1085
5149809|NCT01309243|12667608|P2|NOT COMPLETED|Extension Phase||0
5149810|NCT01309243|12667609|P1|NOT COMPLETED|Extension Phase||6
5149811|NCT01309243|12667608|P2|COMPLETED|Extension Phase||117
5149812|NCT01309243|12667609|P1|COMPLETED|Extension Phase||34
5149813|NCT01309243|12667608|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
5149814|NCT01309243|12667609|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
5149815|NCT01309243|12667608|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
5149816|NCT01309243|12667609|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
5149817|NCT01309243|12667608|P2|COMPLETED|Randomized Phase Through Week 96||290
5149818|NCT01309243|12667609|P1|COMPLETED|Randomized Phase Through Week 96||316
5149819|NCT01309243|12667608|P2|Randomized and Treated|Randomized Phase Through Week 96||392
5149820|NCT01309243|12667609|P1|Randomized and Treated|Randomized Phase Through Week 96||394
5149821|NCT01309243|12667608|P2|STARTED|Randomized Phase Through Week 96||399
5149822|NCT01309243|12667609|P1|STARTED|Randomized Phase Through Week 96||400
5149823|NCT01309204|12667635|P2|NOT COMPLETED|Overall Study||75
5149824|NCT01309204|12667636|P1|NOT COMPLETED|Overall Study||67
5149825|NCT01309204|12667635|P2|COMPLETED|Overall Study||361
5149826|NCT01309204|12667636|P1|COMPLETED|Overall Study||385
5149827|NCT01309204|12667635|P2|STARTED|Overall Study||436
5149828|NCT01309204|12667636|P1|STARTED|Overall Study||452
5149829|NCT01309165|12667644|P2|NOT COMPLETED|Overall Study||7
5149830|NCT01309165|12667645|P1|NOT COMPLETED|Overall Study||6
5149831|NCT01309165|12667644|P2|COMPLETED|Overall Study||9
5149832|NCT01309165|12667645|P1|COMPLETED|Overall Study||13
5149833|NCT01309165|12667644|P2|Included in Primary Analysis|Overall Study||12
5149834|NCT01309165|12667645|P1|Included in Primary Analysis|Overall Study||14
5149835|NCT01309165|12667644|P2|Received Allocated Intervention|Overall Study||14
5149836|NCT01309165|12667645|P1|Received Allocated Intervention|Overall Study||16
5149837|NCT01309165|12667644|P2|STARTED|Overall Study||16
5149838|NCT01309165|12667645|P1|STARTED|Overall Study||19
5149839|NCT01309100|12667657|P1|NOT COMPLETED|Overall Study||2
5149840|NCT01309100|12667657|P1|COMPLETED|Overall Study||142
5149841|NCT01309100|12667657|P1|STARTED|Overall Study||144
5149842|NCT01308918|12667668|P1|NOT COMPLETED|Overall Study||0
5149843|NCT01308918|12667668|P1|COMPLETED|Overall Study||50
5149844|NCT01308918|12667668|P1|STARTED|Overall Study||50
5149845|NCT01308853|12667675|P1|NOT COMPLETED|Overall Study||4
5149846|NCT01308853|12667675|P1|COMPLETED|Overall Study||20
5149847|NCT01308853|12667675|P1|STARTED|Overall Study||24
5149848|NCT01308840|12667680|P1|NOT COMPLETED|Overall Study||0
5149849|NCT01308840|12667680|P1|COMPLETED|Overall Study||31
5149850|NCT01308840|12667680|P1|STARTED|Overall Study||31
5149851|NCT01308814|12667689|P2|NOT COMPLETED|Overall Study||23
5149852|NCT01308814|12667690|P1|NOT COMPLETED|Overall Study||17
5149853|NCT01308814|12667689|P2|COMPLETED|Overall Study||63
5149854|NCT01308814|12667690|P1|COMPLETED|Overall Study||69
5149855|NCT01308814|12667689|P2|STARTED|Overall Study||86
5149856|NCT01308814|12667690|P1|STARTED|Overall Study||86
5149857|NCT01308788|12667710|P2|NOT COMPLETED|2-year Treatment||11
5149858|NCT01308788|12667711|P1|NOT COMPLETED|2-year Treatment||4
5149859|NCT01308788|12667710|P2|COMPLETED|2-year Treatment||10
5149860|NCT01308788|12667711|P1|COMPLETED|2-year Treatment||10
5149861|NCT01308788|12667710|P2|STARTED|2-year Treatment||21
5149862|NCT01308788|12667711|P1|STARTED|2-year Treatment||14
5149863|NCT01308788|12667710|P2|NOT COMPLETED|6-month Treatment||0
5149864|NCT01308788|12667711|P1|NOT COMPLETED|6-month Treatment||0
5149865|NCT01308788|12667710|P2|COMPLETED|6-month Treatment||21
5149866|NCT01308788|12667711|P1|COMPLETED|6-month Treatment||14
5149867|NCT01308788|12667710|P2|STARTED|6-month Treatment||21
5149868|NCT01308788|12667711|P1|STARTED|6-month Treatment||14
5149869|NCT01308762|12667746|P3|NOT COMPLETED|Overall Study||0
5149870|NCT01308762|12667747|P2|NOT COMPLETED|Overall Study||1
5149871|NCT01308762|12667748|P1|NOT COMPLETED|Overall Study||0
5149872|NCT01308762|12667746|P3|COMPLETED|Overall Study||6
5149873|NCT01308762|12667747|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
5149874|NCT01308762|12667748|P1|COMPLETED|Overall Study||6
5149875|NCT01308762|12667746|P3|STARTED|Overall Study||6
5149876|NCT01308762|12667747|P2|STARTED|Overall Study||7
5149877|NCT01308762|12667748|P1|STARTED|Overall Study||6
5149878|NCT01308749|12667761|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
5149879|NCT01308749|12667762|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
5149880|NCT01308749|12667761|P2|COMPLETED|Period 2: Open Label Treatment||11
5149881|NCT01308749|12667762|P1|COMPLETED|Period 2: Open Label Treatment||11
5149882|NCT01308749|12667761|P2|STARTED|Period 2: Open Label Treatment||13
5149883|NCT01308749|12667762|P1|STARTED|Period 2: Open Label Treatment||11
5149884|NCT01308749|12667761|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
5149885|NCT01308749|12667762|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
5149886|NCT01308749|12667761|P2|COMPLETED|Period 1: Double Blind Treatment||13
5149887|NCT01308749|12667762|P1|COMPLETED|Period 1: Double Blind Treatment||11
5149888|NCT01308749|12667761|P2|STARTED|Period 1: Double Blind Treatment||13
5149889|NCT01308749|12667762|P1|STARTED|Period 1: Double Blind Treatment||12
5149890|NCT01308736|12667792|P2|NOT COMPLETED|Overall Study||5
5149891|NCT01308736|12667793|P1|NOT COMPLETED|Overall Study||6
5149892|NCT01308736|12667792|P2|COMPLETED|Overall Study||27
5149893|NCT01308736|12667793|P1|COMPLETED|Overall Study||25
5149894|NCT01308736|12667792|P2|STARTED|Overall Study||32
5149895|NCT01308736|12667793|P1|STARTED|Overall Study||31
5149896|NCT01308619|12667801|P2|NOT COMPLETED|Overall Study||3
5149897|NCT01308619|12667802|P1|NOT COMPLETED|Overall Study||7
5149898|NCT01308619|12667801|P2|COMPLETED|Overall Study||83
5149899|NCT01308619|12667802|P1|COMPLETED|Overall Study||77
5149900|NCT01308619|12667801|P2|STARTED|Overall Study||86
5149901|NCT01308619|12667802|P1|STARTED|Overall Study||84
5149902|NCT01308580|12667816|P2|NOT COMPLETED|Overall Study||7
5149903|NCT01308580|12667817|P1|NOT COMPLETED|Overall Study||12
5149904|NCT01308580|12667816|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
5149905|NCT01308580|12667817|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
5149906|NCT01308580|12667816|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
5149907|NCT01308580|12667817|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
5149908|NCT01308580|12667816|P2|STARTED|Overall Study||602
5149909|NCT01308580|12667817|P1|STARTED|Overall Study||598
5149910|NCT01308567|12667860|P3|NOT COMPLETED|Overall Study||4
5149911|NCT01308567|12667861|P2|NOT COMPLETED|Overall Study||4
5149912|NCT01308567|12667862|P1|NOT COMPLETED|Overall Study||2
5149913|NCT01308567|12667860|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
5149914|NCT01308567|12667861|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
5149915|NCT01308567|12667862|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
5149916|NCT01308567|12667860|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
5149917|NCT01308567|12667861|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
5149918|NCT01308567|12667862|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
5149919|NCT01308567|12667860|P3|STARTED|Overall Study|Randomized|388
5149920|NCT01308567|12667861|P2|STARTED|Overall Study|Randomized|389
5149921|NCT01308567|12667862|P1|STARTED|Overall Study|Randomized|391
5149922|NCT01308476|12667902|P2|NOT COMPLETED|Overall Study||2
5149923|NCT01308476|12667903|P1|NOT COMPLETED|Overall Study||3
5149924|NCT01308476|12667902|P2|COMPLETED|Overall Study||45
5149925|NCT01308476|12667903|P1|COMPLETED|Overall Study||45
5149926|NCT01308476|12667902|P2|STARTED|Overall Study|Entered and treated.|47
5149927|NCT01308476|12667903|P1|STARTED|Overall Study|Entered and treated.|48
5149928|NCT01308463|12667923|P1|NOT COMPLETED|Overall Study||29
5149929|NCT01308463|12667923|P1|COMPLETED|Overall Study||0
5149930|NCT01308463|12667923|P1|12 Years|Overall Study||2
5149931|NCT01308463|12667923|P1|11 Years|Overall Study||8
5149932|NCT01308463|12667923|P1|10 Years|Overall Study||8
5149933|NCT01308463|12667923|P1|9 Years|Overall Study||11
5149934|NCT01308463|12667923|P1|8 Years|Overall Study||14
5149935|NCT01308463|12667923|P1|7 Years|Overall Study||12
5149936|NCT01308463|12667923|P1|6 Years|Overall Study||11
5149937|NCT01308463|12667923|P1|5 Years|Overall Study||20
5149938|NCT01308463|12667923|P1|4 Years|Overall Study||20
5149939|NCT01308463|12667923|P1|3 Years|Overall Study||17
5149940|NCT01308463|12667923|P1|2 Years|Overall Study||18
5149941|NCT01308463|12667923|P1|1 Year|Overall Study||21
5149942|NCT01308463|12667923|P1|6 Months|Overall Study||23
5149943|NCT01308463|12667923|P1|STARTED|Overall Study||29
5149944|NCT01308450|12667930|P1|NOT COMPLETED|Overall Study||2
5149945|NCT01308450|12667930|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
5149946|NCT01308450|12667930|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
5149947|NCT01308424|12667936|P3|NOT COMPLETED|Randomization||2
5149948|NCT01308424|12667937|P2|NOT COMPLETED|Randomization||3
5149949|NCT01308424|12667938|P1|NOT COMPLETED|Randomization||0
5149950|NCT01308424|12667936|P3|COMPLETED|Randomization||82
5149951|NCT01308424|12667937|P2|COMPLETED|Randomization||84
5149952|NCT01308424|12667938|P1|COMPLETED|Randomization||0
5149953|NCT01308424|12667936|P3|STARTED|Randomization||84
5149954|NCT01308424|12667937|P2|STARTED|Randomization||87
5149955|NCT01308424|12667938|P1|STARTED|Randomization||0
5149956|NCT01308424|12667936|P3|NOT COMPLETED|Baseline Eligibility||0
5149957|NCT01308424|12667937|P2|NOT COMPLETED|Baseline Eligibility||0
5149958|NCT01308424|12667938|P1|NOT COMPLETED|Baseline Eligibility||71
5149959|NCT01308424|12667936|P3|COMPLETED|Baseline Eligibility||0
5149960|NCT01308424|12667937|P2|COMPLETED|Baseline Eligibility||0
5149961|NCT01308424|12667938|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
5149962|NCT01308424|12667936|P3|STARTED|Baseline Eligibility||0
5149963|NCT01308424|12667937|P2|STARTED|Baseline Eligibility||0
5149964|NCT01308424|12667938|P1|STARTED|Baseline Eligibility||242
5149965|NCT01308294|12667948|P3|NOT COMPLETED|Cycle 3||0
5149966|NCT01308294|12667949|P2|NOT COMPLETED|Cycle 3||1
5149967|NCT01308294|12667950|P1|NOT COMPLETED|Cycle 3||0
5149968|NCT01308294|12667948|P3|COMPLETED|Cycle 3||0
5149969|NCT01308294|12667949|P2|COMPLETED|Cycle 3||4
5149970|NCT01308294|12667950|P1|COMPLETED|Cycle 3||10
5149971|NCT01308294|12667948|P3|STARTED|Cycle 3||0
5149972|NCT01308294|12667949|P2|STARTED|Cycle 3||5
5149973|NCT01308294|12667950|P1|STARTED|Cycle 3||10
5149974|NCT01308294|12667948|P3|NOT COMPLETED|Cycle 2||0
5149975|NCT01308294|12667949|P2|NOT COMPLETED|Cycle 2||1
5149976|NCT01308294|12667950|P1|NOT COMPLETED|Cycle 2||0
5149977|NCT01308294|12667948|P3|COMPLETED|Cycle 2||0
5149978|NCT01308294|12667949|P2|COMPLETED|Cycle 2||5
5149979|NCT01308294|12667950|P1|COMPLETED|Cycle 2||10
5149980|NCT01308294|12667948|P3|STARTED|Cycle 2||0
5149981|NCT01308294|12667949|P2|STARTED|Cycle 2||6
5149982|NCT01308294|12667950|P1|STARTED|Cycle 2||10
5149983|NCT01308294|12667948|P3|NOT COMPLETED|Cycle 1||0
5149984|NCT01308294|12667949|P2|NOT COMPLETED|Cycle 1||0
5149985|NCT01308294|12667950|P1|NOT COMPLETED|Cycle 1||0
5149986|NCT01308294|12667948|P3|COMPLETED|Cycle 1||0
5149987|NCT01308294|12667949|P2|COMPLETED|Cycle 1||6
5149988|NCT01308294|12667950|P1|COMPLETED|Cycle 1||10
5149989|NCT01308294|12667948|P3|STARTED|Cycle 1||0
5149990|NCT01308294|12667949|P2|STARTED|Cycle 1||6
5149991|NCT01308294|12667950|P1|STARTED|Cycle 1||10
5149992|NCT01308060|12667978|P2|NOT COMPLETED|Part B||8
5149993|NCT01308060|12667979|P1|NOT COMPLETED|Part B||19
5149994|NCT01308060|12667978|P2|COMPLETED|Part B||69
5149995|NCT01308060|12667979|P1|COMPLETED|Part B||219
5149996|NCT01308060|12667978|P2|STARTED|Part B||77
5149997|NCT01308060|12667979|P1|STARTED|Part B||238
5149998|NCT01308060|12667978|P2|NOT COMPLETED|Part A||6
5149999|NCT01308060|12667979|P1|NOT COMPLETED|Part A||14
5150000|NCT01308060|12667978|P2|COMPLETED|Part A||77
5150001|NCT01308060|12667979|P1|COMPLETED|Part A||238
5150002|NCT01308060|12667978|P2|STARTED|Part A||83
5150003|NCT01308060|12667979|P1|STARTED|Part A||252
5150004|NCT01308008|12667990|P2|NOT COMPLETED|12 Months||4
5150005|NCT01308008|12667991|P1|NOT COMPLETED|12 Months||8
5150006|NCT01308008|12667990|P2|COMPLETED|12 Months||58
5150007|NCT01308008|12667991|P1|COMPLETED|12 Months||46
5150008|NCT01308008|12667990|P2|STARTED|12 Months||62
5150009|NCT01308008|12667991|P1|STARTED|12 Months||54
5150010|NCT01308008|12667990|P2|NOT COMPLETED|6 Months||9
5150011|NCT01308008|12667991|P1|NOT COMPLETED|6 Months||8
5150012|NCT01308008|12667990|P2|COMPLETED|6 Months||62
5150013|NCT01308008|12667991|P1|COMPLETED|6 Months||54
5150014|NCT01308008|12667990|P2|STARTED|6 Months||71
5150015|NCT01308008|12667991|P1|STARTED|6 Months||62
5150016|NCT01308008|12667990|P2|NOT COMPLETED|4 Weeks||2
5150017|NCT01308008|12667991|P1|NOT COMPLETED|4 Weeks||9
5150018|NCT01308008|12667990|P2|COMPLETED|4 Weeks||71
5150019|NCT01308008|12667991|P1|COMPLETED|4 Weeks||62
5150020|NCT01308008|12667990|P2|STARTED|4 Weeks||73
5150021|NCT01308008|12667991|P1|STARTED|4 Weeks||71
5150022|NCT01307956|12668001|P1|NOT COMPLETED|Overall Study||0
5150023|NCT01307956|12668001|P1|COMPLETED|Overall Study||11
5150024|NCT01307956|12668001|P1|STARTED|Overall Study||11
5150025|NCT01307930|12668008|P1|NOT COMPLETED|Overall Study||2
5150026|NCT01307930|12668008|P1|COMPLETED|Overall Study||18
5150027|NCT01307930|12668008|P1|STARTED|Overall Study||20
5150028|NCT01307891|12668014|P2|NOT COMPLETED|Overall Study||1
5150029|NCT01307891|12668015|P1|NOT COMPLETED|Overall Study||3
5150030|NCT01307891|12668014|P2|COMPLETED|Overall Study||21
5150031|NCT01307891|12668015|P1|COMPLETED|Overall Study||39
5150032|NCT01307891|12668014|P2|STARTED|Overall Study||22
5150033|NCT01307891|12668015|P1|STARTED|Overall Study||42
5150034|NCT01307787|12668027|P2|NOT COMPLETED|Overall Study||0
5150035|NCT01307787|12668028|P1|NOT COMPLETED|Overall Study||2
5150036|NCT01307787|12668027|P2|COMPLETED|Overall Study||15
5150037|NCT01307787|12668028|P1|COMPLETED|Overall Study||17
5150038|NCT01307787|12668027|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
5150039|NCT01307787|12668028|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
5150040|NCT01307787|12668027|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
5150041|NCT01307787|12668028|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
5150042|NCT01307787|12668027|P2|STARTED|Overall Study||15
5150043|NCT01307787|12668028|P1|STARTED|Overall Study||19
5150044|NCT01307748|12668051|P3|NOT COMPLETED|Overall Study||0
5150045|NCT01307748|12668052|P2|NOT COMPLETED|Overall Study||0
5150046|NCT01307748|12668053|P1|NOT COMPLETED|Overall Study||0
5150047|NCT01307748|12668051|P3|COMPLETED|Overall Study||30
5150048|NCT01307748|12668052|P2|COMPLETED|Overall Study||31
5150049|NCT01307748|12668053|P1|COMPLETED|Overall Study||31
5150050|NCT01307748|12668051|P3|STARTED|Overall Study||30
5150051|NCT01307748|12668052|P2|STARTED|Overall Study||31
5150052|NCT01307748|12668053|P1|STARTED|Overall Study||31
5150053|NCT01307631|12668067|P2|NOT COMPLETED|Overall Study||0
5150054|NCT01307631|12668068|P1|NOT COMPLETED|Overall Study||0
5150055|NCT01307631|12668067|P2|COMPLETED|Overall Study||28
5150056|NCT01307631|12668068|P1|COMPLETED|Overall Study||9
5150057|NCT01307631|12668067|P2|STARTED|Overall Study||28
5150058|NCT01307631|12668068|P1|STARTED|Overall Study||9
5150059|NCT01307618|12668078|P2|NOT COMPLETED|Overall Study||0
5150060|NCT01307618|12668079|P1|NOT COMPLETED|Overall Study||0
5150061|NCT01307618|12668078|P2|COMPLETED|Overall Study||5
5150062|NCT01307618|12668079|P1|COMPLETED|Overall Study||5
5150063|NCT01307618|12668078|P2|STARTED|Overall Study||5
5150064|NCT01307618|12668079|P1|STARTED|Overall Study||5
5150065|NCT01307579|12668097|P2|NOT COMPLETED|Overall Study||145
5150066|NCT01307579|12668098|P1|NOT COMPLETED|Overall Study||140
5150067|NCT01307579|12668097|P2|COMPLETED|Overall Study||115
5150068|NCT01307579|12668098|P1|COMPLETED|Overall Study||117
5150069|NCT01307579|12668097|P2|STARTED|Overall Study||260
5150070|NCT01307579|12668098|P1|STARTED|Overall Study||257
5150071|NCT01307501|12668110|P1|NOT COMPLETED|Overall Study||23
5150072|NCT01307501|12668110|P1|COMPLETED|Overall Study||17
5150073|NCT01307501|12668110|P1|Intent-to-Treat (ITT) Population|Overall Study||40
5150074|NCT01307501|12668110|P1|STARTED|Overall Study||40
5150075|NCT01307462|12668123|P1|NOT COMPLETED|Overall Study||1
5150076|NCT01307462|12668123|P1|COMPLETED|Overall Study||35
5150077|NCT01307462|12668123|P1|STARTED|Overall Study||36
5150078|NCT01307449|12668140|P4|NOT COMPLETED|Overall Study||0
5150079|NCT01307449|12668141|P3|NOT COMPLETED|Overall Study||0
5150080|NCT01307449|12668142|P2|NOT COMPLETED|Overall Study||0
5150081|NCT01307449|12668143|P1|NOT COMPLETED|Overall Study||1
5150082|NCT01307449|12668140|P4|COMPLETED|Overall Study||11
5150083|NCT01307449|12668141|P3|COMPLETED|Overall Study||11
5150084|NCT01307449|12668142|P2|COMPLETED|Overall Study||33
5150085|NCT01307449|12668143|P1|COMPLETED|Overall Study||32
5150086|NCT01307449|12668140|P4|STARTED|Overall Study||11
5150087|NCT01307449|12668141|P3|STARTED|Overall Study||11
5150088|NCT01307449|12668142|P2|STARTED|Overall Study||33
5150089|NCT01307449|12668143|P1|STARTED|Overall Study||33
5150090|NCT01307423|12668176|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
5150091|NCT01307423|12668177|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
5150092|NCT01307423|12668178|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5150093|NCT01307423|12668179|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5150094|NCT01307423|12668180|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5150095|NCT01307423|12668181|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5150096|NCT01307423|12668182|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
5150097|NCT01307423|12668183|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
5150098|NCT01307423|12668184|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5150099|NCT01307423|12668176|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
5150100|NCT01307423|12668177|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
5150101|NCT01307423|12668178|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
5150102|NCT01307423|12668179|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
5150103|NCT01307423|12668180|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
5150104|NCT01307423|12668181|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
5150105|NCT01307423|12668182|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
5150106|NCT01307423|12668183|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
5150107|NCT01307423|12668184|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
5150108|NCT01307423|12668176|P9|STARTED|Long-term Safety Phase (Year 5)||44
5150109|NCT01307423|12668177|P8|STARTED|Long-term Safety Phase (Year 5)||38
5150110|NCT01307423|12668178|P7|STARTED|Long-term Safety Phase (Year 5)||0
5150111|NCT01307423|12668179|P6|STARTED|Long-term Safety Phase (Year 5)||0
5150112|NCT01307423|12668180|P5|STARTED|Long-term Safety Phase (Year 5)||0
5150113|NCT01307423|12668181|P4|STARTED|Long-term Safety Phase (Year 5)||0
5150114|NCT01307423|12668182|P3|STARTED|Long-term Safety Phase (Year 5)||86
5150115|NCT01307423|12668183|P2|STARTED|Long-term Safety Phase (Year 5)||81
5150116|NCT01307423|12668184|P1|STARTED|Long-term Safety Phase (Year 5)||0
5150117|NCT01307423|12668176|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
5150118|NCT01307423|12668177|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
5150119|NCT01307423|12668178|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5150120|NCT01307423|12668179|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5150121|NCT01307423|12668180|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5150122|NCT01307423|12668181|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5150123|NCT01307423|12668182|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
5150124|NCT01307423|12668183|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
5150125|NCT01307423|12668184|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5150126|NCT01307423|12668176|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
5150127|NCT01307423|12668177|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
5150128|NCT01307423|12668178|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
5150129|NCT01307423|12668179|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
5150130|NCT01307423|12668180|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
5150131|NCT01307423|12668181|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
5150132|NCT01307423|12668182|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
5150133|NCT01307423|12668183|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
5150134|NCT01307423|12668184|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
5150135|NCT01307423|12668176|P9|STARTED|Long-term Safety Phase (Year 4)||49
5150136|NCT01307423|12668177|P8|STARTED|Long-term Safety Phase (Year 4)||40
5150137|NCT01307423|12668178|P7|STARTED|Long-term Safety Phase (Year 4)||0
5150138|NCT01307423|12668179|P6|STARTED|Long-term Safety Phase (Year 4)||0
5150139|NCT01307423|12668180|P5|STARTED|Long-term Safety Phase (Year 4)||0
5150140|NCT01307423|12668181|P4|STARTED|Long-term Safety Phase (Year 4)||0
5150141|NCT01307423|12668182|P3|STARTED|Long-term Safety Phase (Year 4)||91
5150142|NCT01307423|12668183|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
5150143|NCT01307423|12668184|P1|STARTED|Long-term Safety Phase (Year 4)||0
5150144|NCT01307423|12668176|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
5150145|NCT01307423|12668177|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
5150146|NCT01307423|12668178|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5150147|NCT01307423|12668179|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5150148|NCT01307423|12668180|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5150149|NCT01307423|12668181|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5150150|NCT01307423|12668182|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
5150151|NCT01307423|12668183|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
5150152|NCT01307423|12668184|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5150153|NCT01307423|12668176|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
5150154|NCT01307423|12668177|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
5150155|NCT01307423|12668178|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
5150156|NCT01307423|12668179|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
5150157|NCT01307423|12668180|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
5150158|NCT01307423|12668181|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
5150159|NCT01307423|12668182|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
5150160|NCT01307423|12668183|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
5150161|NCT01307423|12668184|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
5150162|NCT01307423|12668176|P9|STARTED|Long-term Safety Phase (Year 3)||60
5150163|NCT01307423|12668177|P8|STARTED|Long-term Safety Phase (Year 3)||48
5150164|NCT01307423|12668178|P7|STARTED|Long-term Safety Phase (Year 3)||0
5150165|NCT01307423|12668179|P6|STARTED|Long-term Safety Phase (Year 3)||0
5150166|NCT01307423|12668180|P5|STARTED|Long-term Safety Phase (Year 3)||0
5150167|NCT01307423|12668181|P4|STARTED|Long-term Safety Phase (Year 3)||0
5150168|NCT01307423|12668182|P3|STARTED|Long-term Safety Phase (Year 3)||109
5150169|NCT01307423|12668183|P2|STARTED|Long-term Safety Phase (Year 3)||99
5150170|NCT01307423|12668184|P1|STARTED|Long-term Safety Phase (Year 3)||0
5150171|NCT01307423|12668176|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
5150172|NCT01307423|12668177|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
5150173|NCT01307423|12668178|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5150174|NCT01307423|12668179|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5150175|NCT01307423|12668180|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5150176|NCT01307423|12668181|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5150177|NCT01307423|12668182|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
5150178|NCT01307423|12668183|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
5150179|NCT01307423|12668184|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5150180|NCT01307423|12668176|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
5150181|NCT01307423|12668177|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
5150182|NCT01307423|12668178|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
5150183|NCT01307423|12668179|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
5150184|NCT01307423|12668180|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
5150185|NCT01307423|12668181|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
5150186|NCT01307423|12668182|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
5150187|NCT01307423|12668183|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
5150188|NCT01307423|12668184|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
5150189|NCT01307423|12668176|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
5150190|NCT01307423|12668177|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
5150191|NCT01307423|12668178|P7|STARTED|Long-term Safety Phase (Year 2)||0
5150192|NCT01307423|12668179|P6|STARTED|Long-term Safety Phase (Year 2)||0
5150193|NCT01307423|12668180|P5|STARTED|Long-term Safety Phase (Year 2)||0
5150194|NCT01307423|12668181|P4|STARTED|Long-term Safety Phase (Year 2)||0
5150195|NCT01307423|12668182|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
5150196|NCT01307423|12668183|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
5150197|NCT01307423|12668184|P1|STARTED|Long-term Safety Phase (Year 2)||0
5150198|NCT01307423|12668176|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
5150199|NCT01307423|12668177|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
5150200|NCT01307423|12668178|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
5150201|NCT01307423|12668179|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
5150202|NCT01307423|12668180|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
5150203|NCT01307423|12668181|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
5150204|NCT01307423|12668182|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
5150205|NCT01307423|12668183|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
5150206|NCT01307423|12668184|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
5150207|NCT01307423|12668176|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
5150208|NCT01307423|12668177|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
5150209|NCT01307423|12668178|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
5150210|NCT01307423|12668179|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
5150211|NCT01307423|12668180|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
5150212|NCT01307423|12668181|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
5150213|NCT01307423|12668182|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
5150214|NCT01307423|12668183|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
5150215|NCT01307423|12668184|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
5150216|NCT01307423|12668176|P9|STARTED|Active Treatment Phase (Week 25-52)||0
5150217|NCT01307423|12668177|P8|STARTED|Active Treatment Phase (Week 25-52)||0
5150218|NCT01307423|12668178|P7|STARTED|Active Treatment Phase (Week 25-52)||26
5150219|NCT01307423|12668179|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
5150220|NCT01307423|12668180|P5|STARTED|Active Treatment Phase (Week 25-52)||26
5150221|NCT01307423|12668181|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
5150222|NCT01307423|12668182|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
5150223|NCT01307423|12668183|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
5150224|NCT01307423|12668184|P1|STARTED|Active Treatment Phase (Week 25-52)||0
5150225|NCT01307423|12668176|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150226|NCT01307423|12668177|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150227|NCT01307423|12668178|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150228|NCT01307423|12668179|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150229|NCT01307423|12668180|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150230|NCT01307423|12668181|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150231|NCT01307423|12668182|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
5150232|NCT01307423|12668183|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
5150233|NCT01307423|12668184|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
5150234|NCT01307423|12668176|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150235|NCT01307423|12668177|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150236|NCT01307423|12668178|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150237|NCT01307423|12668179|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150238|NCT01307423|12668180|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150239|NCT01307423|12668181|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5150240|NCT01307423|12668182|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
5150241|NCT01307423|12668183|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
5150242|NCT01307423|12668184|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
5150243|NCT01307423|12668176|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150244|NCT01307423|12668177|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150245|NCT01307423|12668178|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150246|NCT01307423|12668179|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150247|NCT01307423|12668180|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150248|NCT01307423|12668181|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150249|NCT01307423|12668182|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
5150250|NCT01307423|12668183|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
5150251|NCT01307423|12668184|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
5150252|NCT01307423|12668176|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150253|NCT01307423|12668177|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150254|NCT01307423|12668178|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150255|NCT01307423|12668179|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150256|NCT01307423|12668180|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150257|NCT01307423|12668181|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5150258|NCT01307423|12668182|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
5150259|NCT01307423|12668183|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
5150260|NCT01307423|12668184|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
5150261|NCT01307423|12668176|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150262|NCT01307423|12668177|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150263|NCT01307423|12668178|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150264|NCT01307423|12668179|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150265|NCT01307423|12668180|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150266|NCT01307423|12668181|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5150267|NCT01307423|12668182|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
5150268|NCT01307423|12668183|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
5150269|NCT01307423|12668184|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
5150270|NCT01307423|12668176|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150271|NCT01307423|12668177|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150272|NCT01307423|12668178|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150273|NCT01307423|12668179|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150274|NCT01307423|12668180|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150275|NCT01307423|12668181|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5150276|NCT01307423|12668182|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
5150277|NCT01307423|12668183|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
5150278|NCT01307423|12668184|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
5150279|NCT01307397|12668368|P1|NOT COMPLETED|Overall Study||0
5150280|NCT01307397|12668368|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
5150281|NCT01307397|12668368|P1|STARTED|Overall Study||3219
5150282|NCT01307319|12668390|P3|NOT COMPLETED|Overall Study||7
5150283|NCT01307319|12668391|P2|NOT COMPLETED|Overall Study||8
5150284|NCT01307319|12668392|P1|NOT COMPLETED|Overall Study||4
5150285|NCT01307319|12668390|P3|COMPLETED|Overall Study||227
5150286|NCT01307319|12668391|P2|COMPLETED|Overall Study||234
5150287|NCT01307319|12668392|P1|COMPLETED|Overall Study||235
5150288|NCT01307319|12668390|P3|ITT Population|Overall Study||234
5150289|NCT01307319|12668391|P2|ITT Population|Overall Study||241
5150290|NCT01307319|12668392|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
5150291|NCT01307319|12668390|P3|Safety Population|Overall Study||234
5150292|NCT01307319|12668391|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
5150293|NCT01307319|12668392|P1|Safety Population|Overall Study||239
5150294|NCT01307319|12668390|P3|STARTED|Overall Study|Randomized|234
5150295|NCT01307319|12668391|P2|STARTED|Overall Study|Randomized|242
5150296|NCT01307319|12668392|P1|STARTED|Overall Study|Randomized|239
5150297|NCT01307267|12668426|P23|NOT COMPLETED|Overall Study||4
5150298|NCT01307267|12668427|P22|NOT COMPLETED|Overall Study||5
5150299|NCT01307267|12668428|P21|NOT COMPLETED|Overall Study||3
5150300|NCT01307267|12668429|P20|NOT COMPLETED|Overall Study||32
5150301|NCT01307267|12668430|P19|NOT COMPLETED|Overall Study||2
5150302|NCT01307267|12668431|P18|NOT COMPLETED|Overall Study||1
5150303|NCT01307267|12668432|P17|NOT COMPLETED|Overall Study||1
5150304|NCT01307267|12668433|P16|NOT COMPLETED|Overall Study||1
5150305|NCT01307267|12668434|P15|NOT COMPLETED|Overall Study||2
5150306|NCT01307267|12668435|P14|NOT COMPLETED|Overall Study||0
5150307|NCT01307267|12668436|P13|NOT COMPLETED|Overall Study||1
5150308|NCT01307267|12668437|P12|NOT COMPLETED|Overall Study||11
5150309|NCT01307267|12668438|P11|NOT COMPLETED|Overall Study||6
5150310|NCT01307267|12668439|P10|NOT COMPLETED|Overall Study||5
5150311|NCT01307267|12668440|P9|NOT COMPLETED|Overall Study||30
5150312|NCT01307267|12668441|P8|NOT COMPLETED|Overall Study||4
5150313|NCT01307267|12668442|P7|NOT COMPLETED|Overall Study||2
5150314|NCT01307267|12668443|P6|NOT COMPLETED|Overall Study||41
5150315|NCT01307267|12668444|P5|NOT COMPLETED|Overall Study||1
5150316|NCT01307267|12668445|P4|NOT COMPLETED|Overall Study||3
5150317|NCT01307267|12668446|P3|NOT COMPLETED|Overall Study||5
5150318|NCT01307267|12668447|P2|NOT COMPLETED|Overall Study||3
5150319|NCT01307267|12668448|P1|NOT COMPLETED|Overall Study||4
5150320|NCT01307267|12668426|P23|COMPLETED|Overall Study||0
5150321|NCT01307267|12668427|P22|COMPLETED|Overall Study||0
5150322|NCT01307267|12668428|P21|COMPLETED|Overall Study||0
5150323|NCT01307267|12668429|P20|COMPLETED|Overall Study||0
5150324|NCT01307267|12668430|P19|COMPLETED|Overall Study||2
5150325|NCT01307267|12668431|P18|COMPLETED|Overall Study||2
5150326|NCT01307267|12668432|P17|COMPLETED|Overall Study||2
5150327|NCT01307267|12668433|P16|COMPLETED|Overall Study||2
5150328|NCT01307267|12668434|P15|COMPLETED|Overall Study||2
5150329|NCT01307267|12668435|P14|COMPLETED|Overall Study||3
5150330|NCT01307267|12668436|P13|COMPLETED|Overall Study||2
5150331|NCT01307267|12668437|P12|COMPLETED|Overall Study||0
5150332|NCT01307267|12668438|P11|COMPLETED|Overall Study||0
5150333|NCT01307267|12668439|P10|COMPLETED|Overall Study||0
5150334|NCT01307267|12668440|P9|COMPLETED|Overall Study||1
5150335|NCT01307267|12668441|P8|COMPLETED|Overall Study||0
5150336|NCT01307267|12668442|P7|COMPLETED|Overall Study||1
5150337|NCT01307267|12668443|P6|COMPLETED|Overall Study||1
5150338|NCT01307267|12668444|P5|COMPLETED|Overall Study||2
5150339|NCT01307267|12668445|P4|COMPLETED|Overall Study||1
5150340|NCT01307267|12668446|P3|COMPLETED|Overall Study||1
5150341|NCT01307267|12668447|P2|COMPLETED|Overall Study||0
5150342|NCT01307267|12668448|P1|COMPLETED|Overall Study||0
5150343|NCT01307267|12668426|P23|STARTED|Overall Study||4
5150344|NCT01307267|12668427|P22|STARTED|Overall Study||5
5150345|NCT01307267|12668428|P21|STARTED|Overall Study||3
5150346|NCT01307267|12668429|P20|STARTED|Overall Study||32
5150347|NCT01307267|12668430|P19|STARTED|Overall Study||4
5150348|NCT01307267|12668431|P18|STARTED|Overall Study||3
5150349|NCT01307267|12668432|P17|STARTED|Overall Study||3
5150350|NCT01307267|12668433|P16|STARTED|Overall Study||3
5150351|NCT01307267|12668434|P15|STARTED|Overall Study||4
5150352|NCT01307267|12668435|P14|STARTED|Overall Study||3
5150353|NCT01307267|12668436|P13|STARTED|Overall Study||3
5150354|NCT01307267|12668437|P12|STARTED|Overall Study||11
5150355|NCT01307267|12668438|P11|STARTED|Overall Study||6
5150356|NCT01307267|12668439|P10|STARTED|Overall Study||5
5150357|NCT01307267|12668440|P9|STARTED|Overall Study||31
5150358|NCT01307267|12668441|P8|STARTED|Overall Study||4
5150359|NCT01307267|12668442|P7|STARTED|Overall Study||3
5150360|NCT01307267|12668443|P6|STARTED|Overall Study||42
5150361|NCT01307267|12668444|P5|STARTED|Overall Study||3
5150362|NCT01307267|12668445|P4|STARTED|Overall Study||4
5150363|NCT01307267|12668446|P3|STARTED|Overall Study||6
5150364|NCT01307267|12668447|P2|STARTED|Overall Study||3
5150365|NCT01307267|12668448|P1|STARTED|Overall Study||4
5150366|NCT01307111|12669039|P2|NOT COMPLETED|1-2 Week IUD Check up||2
5150367|NCT01307111|12669040|P1|NOT COMPLETED|1-2 Week IUD Check up||2
5150368|NCT01307111|12669039|P2|COMPLETED|1-2 Week IUD Check up||38
5150369|NCT01307111|12669040|P1|COMPLETED|1-2 Week IUD Check up||38
5150370|NCT01307111|12669039|P2|STARTED|1-2 Week IUD Check up||40
5150371|NCT01307111|12669040|P1|STARTED|1-2 Week IUD Check up||40
5150372|NCT01307111|12669039|P2|NOT COMPLETED|IUD Insertion||0
5150373|NCT01307111|12669040|P1|NOT COMPLETED|IUD Insertion||2
5150374|NCT01307111|12669039|P2|COMPLETED|IUD Insertion||40
5150375|NCT01307111|12669040|P1|COMPLETED|IUD Insertion||40
5150376|NCT01307111|12669039|P2|STARTED|IUD Insertion||40
5150377|NCT01307111|12669040|P1|STARTED|IUD Insertion||42
5150378|NCT01307098|12669051|P3|NOT COMPLETED|Overall Study||0
5150379|NCT01307098|12669052|P2|NOT COMPLETED|Overall Study||0
5150380|NCT01307098|12669053|P1|NOT COMPLETED|Overall Study||0
5150381|NCT01307098|12669051|P3|COMPLETED|Overall Study||3
5150382|NCT01307098|12669052|P2|COMPLETED|Overall Study||3
5150383|NCT01307098|12669053|P1|COMPLETED|Overall Study||3
5150384|NCT01307098|12669051|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5150385|NCT01307098|12669052|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5150386|NCT01307098|12669053|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5150387|NCT01307098|12669051|P3|STARTED|Overall Study||3
5150388|NCT01307098|12669052|P2|STARTED|Overall Study||3
5150389|NCT01307098|12669053|P1|STARTED|Overall Study||3
5150390|NCT01307046|12669063|P2|NOT COMPLETED|Overall Study||11
5150391|NCT01307046|12669064|P1|NOT COMPLETED|Overall Study||12
5150392|NCT01307046|12669063|P2|COMPLETED|Overall Study||159
5150393|NCT01307046|12669064|P1|COMPLETED|Overall Study||154
5150394|NCT01307046|12669063|P2|STARTED|Overall Study||170
5150395|NCT01307046|12669064|P1|STARTED|Overall Study||166
5150396|NCT01307033|12669076|P4|NOT COMPLETED|44-week Open-label Extension||12
5150397|NCT01307033|12669077|P3|NOT COMPLETED|44-week Open-label Extension||11
5150398|NCT01307033|12669078|P2|NOT COMPLETED|44-week Open-label Extension||0
5150399|NCT01307033|12669079|P1|NOT COMPLETED|44-week Open-label Extension||0
5150400|NCT01307033|12669076|P4|COMPLETED|44-week Open-label Extension||115
5150401|NCT01307033|12669077|P3|COMPLETED|44-week Open-label Extension||120
5150402|NCT01307033|12669078|P2|COMPLETED|44-week Open-label Extension||0
5150403|NCT01307033|12669079|P1|COMPLETED|44-week Open-label Extension||0
5150404|NCT01307033|12669076|P4|STARTED|44-week Open-label Extension||127
5150405|NCT01307033|12669077|P3|STARTED|44-week Open-label Extension||131
5150406|NCT01307033|12669078|P2|STARTED|44-week Open-label Extension||0
5150407|NCT01307033|12669079|P1|STARTED|44-week Open-label Extension||0
5150408|NCT01307033|12669076|P4|NOT COMPLETED|8-week Double-blind Period||0
5150409|NCT01307033|12669077|P3|NOT COMPLETED|8-week Double-blind Period||0
5150410|NCT01307033|12669078|P2|NOT COMPLETED|8-week Double-blind Period||7
5150411|NCT01307033|12669079|P1|NOT COMPLETED|8-week Double-blind Period||13
5150412|NCT01307033|12669076|P4|COMPLETED|8-week Double-blind Period||0
5150413|NCT01307033|12669077|P3|COMPLETED|8-week Double-blind Period||0
5150414|NCT01307033|12669078|P2|COMPLETED|8-week Double-blind Period||127
5150415|NCT01307033|12669079|P1|COMPLETED|8-week Double-blind Period||131
5150416|NCT01307033|12669076|P4|STARTED|8-week Double-blind Period||0
5150417|NCT01307033|12669077|P3|STARTED|8-week Double-blind Period||0
5150418|NCT01307033|12669078|P2|STARTED|8-week Double-blind Period||134
5150419|NCT01307033|12669079|P1|STARTED|8-week Double-blind Period||144
5150420|NCT01307020|12669101|P10|NOT COMPLETED|Overall Study||0
5150421|NCT01307020|12669102|P9|NOT COMPLETED|Overall Study||0
5150422|NCT01307020|12669103|P8|NOT COMPLETED|Overall Study||0
5150423|NCT01307020|12669104|P7|NOT COMPLETED|Overall Study||1
5150424|NCT01307020|12669105|P6|NOT COMPLETED|Overall Study||0
5150425|NCT01307020|12669106|P5|NOT COMPLETED|Overall Study||0
5150426|NCT01307020|12669107|P4|NOT COMPLETED|Overall Study||1
5150427|NCT01307020|12669108|P3|NOT COMPLETED|Overall Study||1
5150428|NCT01307020|12669109|P2|NOT COMPLETED|Overall Study||1
5150429|NCT01307020|12669110|P1|NOT COMPLETED|Overall Study||0
5150430|NCT01307020|12669101|P10|COMPLETED|Overall Study||62
5150431|NCT01307020|12669102|P9|COMPLETED|Overall Study||61
5150432|NCT01307020|12669103|P8|COMPLETED|Overall Study||60
5150433|NCT01307020|12669104|P7|COMPLETED|Overall Study||58
5150434|NCT01307020|12669105|P6|COMPLETED|Overall Study||61
5150435|NCT01307020|12669106|P5|COMPLETED|Overall Study||60
5150436|NCT01307020|12669107|P4|COMPLETED|Overall Study||60
5150437|NCT01307020|12669108|P3|COMPLETED|Overall Study||62
5150438|NCT01307020|12669109|P2|COMPLETED|Overall Study||62
5150439|NCT01307020|12669110|P1|COMPLETED|Overall Study||61
5150440|NCT01307020|12669101|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
5150441|NCT01307020|12669102|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
5150442|NCT01307020|12669103|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
5150443|NCT01307020|12669104|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
5150444|NCT01307020|12669105|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
5150445|NCT01307020|12669106|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
5150446|NCT01307020|12669107|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
5150447|NCT01307020|12669108|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
5150448|NCT01307020|12669109|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
5150449|NCT01307020|12669110|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
5150450|NCT01307020|12669101|P10|Safety Population|Overall Study||62
5150451|NCT01307020|12669102|P9|Safety Population|Overall Study||61
5150452|NCT01307020|12669103|P8|Safety Population|Overall Study||60
5150453|NCT01307020|12669104|P7|Safety Population|Overall Study||59
5150454|NCT01307020|12669105|P6|Safety Population|Overall Study||61
5150455|NCT01307020|12669106|P5|Safety Population|Overall Study||60
5150456|NCT01307020|12669107|P4|Safety Population|Overall Study||61
5150457|NCT01307020|12669108|P3|Safety Population|Overall Study||63
5150458|NCT01307020|12669109|P2|Safety Population|Overall Study||63
5150459|NCT01307020|12669110|P1|Safety Population|Overall Study||61
5150460|NCT01307020|12669101|P10|STARTED|Overall Study||62
5150461|NCT01307020|12669102|P9|STARTED|Overall Study||61
5150462|NCT01307020|12669103|P8|STARTED|Overall Study||60
5150463|NCT01307020|12669104|P7|STARTED|Overall Study||59
5150464|NCT01307020|12669105|P6|STARTED|Overall Study||61
5150465|NCT01307020|12669106|P5|STARTED|Overall Study||60
5150466|NCT01307020|12669107|P4|STARTED|Overall Study||61
5150467|NCT01307020|12669108|P3|STARTED|Overall Study||63
5150468|NCT01307020|12669109|P2|STARTED|Overall Study||63
5150469|NCT01307020|12669110|P1|STARTED|Overall Study||61
5150470|NCT01307007|12669154|P2|NOT COMPLETED|Overall Study||0
5150471|NCT01307007|12669155|P1|NOT COMPLETED|Overall Study||0
5150472|NCT01307007|12669154|P2|COMPLETED|Overall Study||30
5150473|NCT01307007|12669155|P1|COMPLETED|Overall Study||25
5150474|NCT01307007|12669154|P2|STARTED|Overall Study||30
5150475|NCT01307007|12669155|P1|STARTED|Overall Study||25
5150476|NCT01306968|12669165|P4|NOT COMPLETED|Overall Study||4
5150477|NCT01306968|12669166|P3|NOT COMPLETED|Overall Study||1
5150478|NCT01306968|12669167|P2|NOT COMPLETED|Overall Study||3
5150479|NCT01306968|12669168|P1|NOT COMPLETED|Overall Study||1
5150480|NCT01306968|12669165|P4|COMPLETED|Overall Study||21
5150481|NCT01306968|12669166|P3|COMPLETED|Overall Study||23
5150482|NCT01306968|12669167|P2|COMPLETED|Overall Study||20
5150483|NCT01306968|12669168|P1|COMPLETED|Overall Study||6
5150484|NCT01306968|12669165|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
5150485|NCT01306968|12669166|P3|STARTED|Overall Study||24
5150486|NCT01306968|12669167|P2|STARTED|Overall Study||23
5150487|NCT01306968|12669168|P1|STARTED|Overall Study||7
5150488|NCT01306942|12669193|P4|NOT COMPLETED|Phase II||16
5150489|NCT01306942|12669194|P3|NOT COMPLETED|Phase II||0
5150490|NCT01306942|12669195|P2|NOT COMPLETED|Phase II||0
5150491|NCT01306942|12669196|P1|NOT COMPLETED|Phase II||2
5150492|NCT01306942|12669193|P4|COMPLETED|Phase II||11
5150493|NCT01306942|12669194|P3|COMPLETED|Phase II||0
5150494|NCT01306942|12669195|P2|COMPLETED|Phase II||0
5150495|NCT01306942|12669196|P1|COMPLETED|Phase II||0
5150496|NCT01306942|12669193|P4|STARTED|Phase II||27
5150497|NCT01306942|12669194|P3|STARTED|Phase II||0
5150498|NCT01306942|12669195|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
5150499|NCT01306942|12669196|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
5150500|NCT01306942|12669193|P4|NOT COMPLETED|Phase I||0
5150501|NCT01306942|12669194|P3|NOT COMPLETED|Phase I||0
5150502|NCT01306942|12669195|P2|NOT COMPLETED|Phase I||3
5150503|NCT01306942|12669196|P1|NOT COMPLETED|Phase I||5
5150504|NCT01306942|12669193|P4|COMPLETED|Phase I||0
5150505|NCT01306942|12669194|P3|COMPLETED|Phase I||0
5150506|NCT01306942|12669195|P2|COMPLETED|Phase I||1
5150507|NCT01306942|12669196|P1|COMPLETED|Phase I||1
5150508|NCT01306942|12669193|P4|STARTED|Phase I||0
5150509|NCT01306942|12669194|P3|STARTED|Phase I||0
5150510|NCT01306942|12669195|P2|STARTED|Phase I||4
5150511|NCT01306942|12669196|P1|STARTED|Phase I||6
5150512|NCT01306890|12669228|P1|NOT COMPLETED|Overall Study||1519
5150513|NCT01306890|12669228|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
5150514|NCT01306890|12669228|P1|STARTED|Overall Study||1976
5150515|NCT01306877|12669235|P2|NOT COMPLETED|Overall Study||4
5150516|NCT01306877|12669236|P1|NOT COMPLETED|Overall Study||3
5150517|NCT01306877|12669235|P2|COMPLETED|Overall Study||67
5150518|NCT01306877|12669236|P1|COMPLETED|Overall Study||75
5150519|NCT01306877|12669235|P2|STARTED|Overall Study||71
5150520|NCT01306877|12669236|P1|STARTED|Overall Study||78
5150521|NCT01306656|12669256|P2|NOT COMPLETED|Overall Study||0
5150522|NCT01306656|12669257|P1|NOT COMPLETED|Overall Study||1
5150523|NCT01306656|12669256|P2|COMPLETED|Overall Study||2
5150524|NCT01306656|12669257|P1|COMPLETED|Overall Study||6
5150525|NCT01306656|12669256|P2|STARTED|Overall Study||2
5150526|NCT01306656|12669257|P1|STARTED|Overall Study||7
5150527|NCT01306643|12669269|P1|NOT COMPLETED|Overall Study||13
5150528|NCT01306643|12669269|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
5150529|NCT01306643|12669269|P1|STARTED|Overall Study||18
5150530|NCT01306617|12669281|P3|NOT COMPLETED|Overall Study||5
5150531|NCT01306617|12669282|P2|NOT COMPLETED|Overall Study||1
5150532|NCT01306617|12669283|P1|NOT COMPLETED|Overall Study||1
5150533|NCT01306617|12669281|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
5150534|NCT01306617|12669282|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
5150535|NCT01306617|12669283|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
5150536|NCT01306617|12669281|P3|STARTED|Overall Study||17
5150537|NCT01306617|12669282|P2|STARTED|Overall Study||14
5150538|NCT01306617|12669283|P1|STARTED|Overall Study||19
5150539|NCT01306331|12669326|P2|NOT COMPLETED|Overall Study||877
5150540|NCT01306331|12669327|P1|NOT COMPLETED|Overall Study||901
5150541|NCT01306331|12669326|P2|COMPLETED|Overall Study||788
5150542|NCT01306331|12669327|P1|COMPLETED|Overall Study||758
5150543|NCT01306331|12669326|P2|STARTED|Overall Study||1665
5150544|NCT01306331|12669327|P1|STARTED|Overall Study||1659
5150545|NCT01306305|12669337|P2|NOT COMPLETED|Overall Study||0
5150546|NCT01306305|12669338|P1|NOT COMPLETED|Overall Study||2
5150547|NCT01306305|12669337|P2|COMPLETED|Overall Study||55
5150548|NCT01306305|12669338|P1|COMPLETED|Overall Study||53
5150549|NCT01306305|12669337|P2|STARTED|Overall Study||55
5150550|NCT01306305|12669338|P1|STARTED|Overall Study||55
5150551|NCT01306292|12669354|P4|NOT COMPLETED|Second Injection||0
5150552|NCT01306292|12669355|P3|NOT COMPLETED|Second Injection||1
5150553|NCT01306292|12669356|P2|NOT COMPLETED|Second Injection||0
5150554|NCT01306292|12669357|P1|NOT COMPLETED|Second Injection||0
5150555|NCT01306292|12669354|P4|COMPLETED|Second Injection||10
5150556|NCT01306292|12669355|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
5150557|NCT01306292|12669356|P2|COMPLETED|Second Injection||8
5150558|NCT01306292|12669357|P1|COMPLETED|Second Injection||10
5150559|NCT01306292|12669354|P4|STARTED|Second Injection||10
5150560|NCT01306292|12669355|P3|STARTED|Second Injection||8
5150561|NCT01306292|12669356|P2|STARTED|Second Injection||8
5150562|NCT01306292|12669357|P1|STARTED|Second Injection||10
5150563|NCT01306292|12669354|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
5150564|NCT01306292|12669355|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
5150565|NCT01306292|12669356|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
5150566|NCT01306292|12669357|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
5150567|NCT01306292|12669354|P4|COMPLETED|Washout (at Least 10 Minutes)||10
5150568|NCT01306292|12669355|P3|COMPLETED|Washout (at Least 10 Minutes)||8
5150569|NCT01306292|12669356|P2|COMPLETED|Washout (at Least 10 Minutes)||8
5150570|NCT01306292|12669357|P1|COMPLETED|Washout (at Least 10 Minutes)||10
5150571|NCT01306292|12669354|P4|STARTED|Washout (at Least 10 Minutes)||10
5150572|NCT01306292|12669355|P3|STARTED|Washout (at Least 10 Minutes)||8
5150573|NCT01306292|12669356|P2|STARTED|Washout (at Least 10 Minutes)||8
5150574|NCT01306292|12669357|P1|STARTED|Washout (at Least 10 Minutes)||10
5150575|NCT01306292|12669354|P4|NOT COMPLETED|First Injection||0
5150576|NCT01306292|12669355|P3|NOT COMPLETED|First Injection||0
5150577|NCT01306292|12669356|P2|NOT COMPLETED|First Injection||0
5150578|NCT01306292|12669357|P1|NOT COMPLETED|First Injection||0
5150579|NCT01306292|12669354|P4|COMPLETED|First Injection||10
5150580|NCT01306292|12669355|P3|COMPLETED|First Injection||8
5150581|NCT01306292|12669356|P2|COMPLETED|First Injection||8
5150582|NCT01306292|12669357|P1|COMPLETED|First Injection||10
5150583|NCT01306292|12669354|P4|STARTED|First Injection||10
5150584|NCT01306292|12669355|P3|STARTED|First Injection||8
5150585|NCT01306292|12669356|P2|STARTED|First Injection||8
5150586|NCT01306292|12669357|P1|STARTED|First Injection||10
5150587|NCT01306253|12669375|P2|NOT COMPLETED|Overall Study||1
5150588|NCT01306253|12669376|P1|NOT COMPLETED|Overall Study||1
5150589|NCT01306253|12669375|P2|COMPLETED|Overall Study||56
5150590|NCT01306253|12669376|P1|COMPLETED|Overall Study||56
5150591|NCT01306253|12669375|P2|STARTED|Overall Study||57
5150592|NCT01306253|12669376|P1|STARTED|Overall Study||57
5150593|NCT01306214|12669393|P3|NOT COMPLETED|Overall Study||22
5150594|NCT01306214|12669394|P2|NOT COMPLETED|Overall Study||28
5150595|NCT01306214|12669395|P1|NOT COMPLETED|Overall Study||28
5150596|NCT01306214|12669393|P3|COMPLETED|Overall Study||168
5150597|NCT01306214|12669394|P2|COMPLETED|Overall Study||159
5150598|NCT01306214|12669395|P1|COMPLETED|Overall Study||161
5150599|NCT01306214|12669393|P3|STARTED|Overall Study||190
5150600|NCT01306214|12669394|P2|STARTED|Overall Study||187
5150601|NCT01306214|12669395|P1|STARTED|Overall Study||189
5150602|NCT01306201|12669412|P1|NOT COMPLETED|Overall Study||10
5150603|NCT01306201|12669412|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
5150604|NCT01306201|12669412|P1|STARTED|Overall Study||63
5150605|NCT01306175|12669420|P1|NOT COMPLETED|Second Intervention||0
5150606|NCT01306175|12669420|P1|COMPLETED|Second Intervention||20
5150607|NCT01306175|12669420|P1|STARTED|Second Intervention||20
5150608|NCT01306175|12669420|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
5150609|NCT01306175|12669420|P1|COMPLETED|Washout Period of at Least 14 Days||20
5150610|NCT01306175|12669420|P1|STARTED|Washout Period of at Least 14 Days||20
5150611|NCT01306175|12669420|P1|NOT COMPLETED|First Intervention||0
5150612|NCT01306175|12669420|P1|COMPLETED|First Intervention||20
5150613|NCT01306175|12669420|P1|STARTED|First Intervention||20
5150614|NCT01306162|12669434|P4|NOT COMPLETED|Period 4||0
5150615|NCT01306162|12669435|P3|NOT COMPLETED|Period 4||0
5150616|NCT01306162|12669436|P2|NOT COMPLETED|Period 4||0
5150617|NCT01306162|12669437|P1|NOT COMPLETED|Period 4||0
5150618|NCT01306162|12669434|P4|COMPLETED|Period 4||8
5150619|NCT01306162|12669435|P3|COMPLETED|Period 4||9
5150620|NCT01306162|12669436|P2|COMPLETED|Period 4||8
5150621|NCT01306162|12669437|P1|COMPLETED|Period 4||9
5150622|NCT01306162|12669434|P4|STARTED|Period 4||8
5150623|NCT01306162|12669435|P3|STARTED|Period 4||9
5150624|NCT01306162|12669436|P2|STARTED|Period 4||8
5150625|NCT01306162|12669437|P1|STARTED|Period 4||9
5150626|NCT01306162|12669434|P4|NOT COMPLETED|Washout 2||0
5150627|NCT01306162|12669435|P3|NOT COMPLETED|Washout 2||0
5150628|NCT01306162|12669436|P2|NOT COMPLETED|Washout 2||0
5150629|NCT01306162|12669437|P1|NOT COMPLETED|Washout 2||0
5150630|NCT01306162|12669434|P4|COMPLETED|Washout 2||8
5150631|NCT01306162|12669435|P3|COMPLETED|Washout 2||9
5150632|NCT01306162|12669436|P2|COMPLETED|Washout 2||8
5150633|NCT01306162|12669437|P1|COMPLETED|Washout 2||9
5150634|NCT01306162|12669434|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
5150635|NCT01306162|12669435|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
5150636|NCT01306162|12669436|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
5150637|NCT01306162|12669437|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
5150638|NCT01306162|12669434|P4|NOT COMPLETED|Period 3||0
5150639|NCT01306162|12669435|P3|NOT COMPLETED|Period 3||0
5150640|NCT01306162|12669436|P2|NOT COMPLETED|Period 3||0
5150641|NCT01306162|12669437|P1|NOT COMPLETED|Period 3||0
5150642|NCT01306162|12669434|P4|COMPLETED|Period 3||8
5150643|NCT01306162|12669435|P3|COMPLETED|Period 3||9
5150644|NCT01306162|12669436|P2|COMPLETED|Period 3||8
5150645|NCT01306162|12669437|P1|COMPLETED|Period 3||9
5150646|NCT01306162|12669434|P4|STARTED|Period 3||8
5150647|NCT01306162|12669435|P3|STARTED|Period 3||9
5150648|NCT01306162|12669436|P2|STARTED|Period 3||8
5150649|NCT01306162|12669437|P1|STARTED|Period 3||9
5150650|NCT01306162|12669434|P4|NOT COMPLETED|Period 2||0
5150651|NCT01306162|12669435|P3|NOT COMPLETED|Period 2||0
5150652|NCT01306162|12669436|P2|NOT COMPLETED|Period 2||0
5150653|NCT01306162|12669437|P1|NOT COMPLETED|Period 2||0
5150654|NCT01306162|12669434|P4|COMPLETED|Period 2||8
5150655|NCT01306162|12669435|P3|COMPLETED|Period 2||9
5150656|NCT01306162|12669436|P2|COMPLETED|Period 2||8
5150657|NCT01306162|12669437|P1|COMPLETED|Period 2||9
5150658|NCT01306162|12669434|P4|STARTED|Period 2|No washout phase after Period 2.|8
5150659|NCT01306162|12669435|P3|STARTED|Period 2|No washout phase after Period 2.|9
5150660|NCT01306162|12669436|P2|STARTED|Period 2|No washout phase after Period 2.|8
5150661|NCT01306162|12669437|P1|STARTED|Period 2|No washout phase after Period 2.|9
5150662|NCT01306162|12669434|P4|NOT COMPLETED|Washout 1||0
5150663|NCT01306162|12669435|P3|NOT COMPLETED|Washout 1||0
5150664|NCT01306162|12669436|P2|NOT COMPLETED|Washout 1||1
5150665|NCT01306162|12669437|P1|NOT COMPLETED|Washout 1||0
5150666|NCT01306162|12669434|P4|COMPLETED|Washout 1||8
5150667|NCT01306162|12669435|P3|COMPLETED|Washout 1||9
5150668|NCT01306162|12669436|P2|COMPLETED|Washout 1||8
5150669|NCT01306162|12669437|P1|COMPLETED|Washout 1||9
5150670|NCT01306162|12669434|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
5150671|NCT01306162|12669435|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
5150672|NCT01306162|12669436|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
5150673|NCT01306162|12669437|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
5150674|NCT01306162|12669434|P4|NOT COMPLETED|Period 1||1
5150675|NCT01306162|12669435|P3|NOT COMPLETED|Period 1||0
5150676|NCT01306162|12669436|P2|NOT COMPLETED|Period 1||0
5150677|NCT01306162|12669437|P1|NOT COMPLETED|Period 1||0
5150678|NCT01306162|12669434|P4|COMPLETED|Period 1||8
5150679|NCT01306162|12669435|P3|COMPLETED|Period 1||9
5150680|NCT01306162|12669436|P2|COMPLETED|Period 1||9
5150681|NCT01306162|12669437|P1|COMPLETED|Period 1||9
5150682|NCT01306162|12669434|P4|STARTED|Period 1||9
5150683|NCT01306162|12669435|P3|STARTED|Period 1||9
5150684|NCT01306162|12669436|P2|STARTED|Period 1||9
5150685|NCT01306162|12669437|P1|STARTED|Period 1||9
5150686|NCT01306058|12669465|P1|NOT COMPLETED|Overall Study||2
5150687|NCT01306058|12669465|P1|COMPLETED|Overall Study||25
5150688|NCT01306058|12669465|P1|STARTED|Overall Study||27
5150689|NCT01306032|12669492|P6|NOT COMPLETED|Disease Progression/Crossover||0
5150690|NCT01306032|12669493|P5|NOT COMPLETED|Disease Progression/Crossover||0
5150691|NCT01306032|12669494|P4|NOT COMPLETED|Disease Progression/Crossover||3
5150692|NCT01306032|12669495|P3|NOT COMPLETED|Disease Progression/Crossover||0
5150693|NCT01306032|12669496|P2|NOT COMPLETED|Disease Progression/Crossover||2
5150694|NCT01306032|12669497|P1|NOT COMPLETED|Disease Progression/Crossover||0
5150695|NCT01306032|12669492|P6|COMPLETED|Disease Progression/Crossover||0
5150696|NCT01306032|12669493|P5|COMPLETED|Disease Progression/Crossover||0
5150697|NCT01306032|12669494|P4|COMPLETED|Disease Progression/Crossover||26
5150698|NCT01306032|12669495|P3|COMPLETED|Disease Progression/Crossover||0
5150699|NCT01306032|12669496|P2|COMPLETED|Disease Progression/Crossover||14
5150700|NCT01306032|12669497|P1|COMPLETED|Disease Progression/Crossover||0
5150701|NCT01306032|12669492|P6|STARTED|Disease Progression/Crossover||0
5150702|NCT01306032|12669493|P5|STARTED|Disease Progression/Crossover||0
5150703|NCT01306032|12669494|P4|STARTED|Disease Progression/Crossover||29
5150704|NCT01306032|12669495|P3|STARTED|Disease Progression/Crossover||0
5150705|NCT01306032|12669496|P2|STARTED|Disease Progression/Crossover||16
5150706|NCT01306032|12669497|P1|STARTED|Disease Progression/Crossover||0
5150707|NCT01306032|12669492|P6|NOT COMPLETED|First Intervention||2
5150708|NCT01306032|12669493|P5|NOT COMPLETED|First Intervention||2
5150709|NCT01306032|12669494|P4|NOT COMPLETED|First Intervention||1
5150710|NCT01306032|12669495|P3|NOT COMPLETED|First Intervention||2
5150711|NCT01306032|12669496|P2|NOT COMPLETED|First Intervention||2
5150712|NCT01306032|12669497|P1|NOT COMPLETED|First Intervention||1
5150713|NCT01306032|12669492|P6|COMPLETED|First Intervention||0
5150714|NCT01306032|12669493|P5|COMPLETED|First Intervention||0
5150715|NCT01306032|12669494|P4|COMPLETED|First Intervention||37
5150716|NCT01306032|12669495|P3|COMPLETED|First Intervention||35
5150717|NCT01306032|12669496|P2|COMPLETED|First Intervention||18
5150718|NCT01306032|12669497|P1|COMPLETED|First Intervention||21
5150719|NCT01306032|12669492|P6|STARTED|First Intervention||2
5150720|NCT01306032|12669493|P5|STARTED|First Intervention||2
5150721|NCT01306032|12669494|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
5150722|NCT01306032|12669495|P3|STARTED|First Intervention||37
5150723|NCT01306032|12669496|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
5150724|NCT01306032|12669497|P1|STARTED|First Intervention||22
5150725|NCT01305941|12669549|P1|NOT COMPLETED|Overall Study||10
5150726|NCT01305941|12669549|P1|COMPLETED|Overall Study||22
5150727|NCT01305941|12669549|P1|STARTED|Overall Study||32
5150728|NCT01305811|12669563|P2|NOT COMPLETED|Overall Study||11
5150729|NCT01305811|12669564|P1|NOT COMPLETED|Overall Study||8
5150730|NCT01305811|12669563|P2|COMPLETED|Overall Study||41
5150731|NCT01305811|12669564|P1|COMPLETED|Overall Study||44
5150732|NCT01305811|12669563|P2|STARTED|Overall Study||52
5150733|NCT01305811|12669564|P1|STARTED|Overall Study||52
5150734|NCT01305772|12669574|P2|NOT COMPLETED|Overall Study||0
5150735|NCT01305772|12669575|P1|NOT COMPLETED|Overall Study||0
5150736|NCT01305772|12669574|P2|COMPLETED|Overall Study||1
5150737|NCT01305772|12669575|P1|COMPLETED|Overall Study||5
5150738|NCT01305772|12669574|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
5150739|NCT01305772|12669575|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
5150740|NCT01305772|12669574|P2|Surgery/Biopsy #2|Overall Study||1
5150741|NCT01305772|12669575|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
5150742|NCT01305772|12669574|P2|Research PET/CT #2|Overall Study||1
5150743|NCT01305772|12669575|P1|Research PET/CT #2|Overall Study||5
5150744|NCT01305772|12669574|P2|Panitumumab Dose #1|Overall Study||1
5150745|NCT01305772|12669575|P1|Panitumumab Dose #1|Overall Study||5
5150746|NCT01305772|12669574|P2|Research PET/CT #1|Overall Study||1
5150747|NCT01305772|12669575|P1|Research PET/CT #1|Overall Study||5
5150748|NCT01305772|12669574|P2|Genomic Screening + Biopsy #1|Overall Study||1
5150749|NCT01305772|12669575|P1|Genomic Screening + Biopsy #1|Overall Study||5
5150750|NCT01305772|12669574|P2|STARTED|Overall Study||1
5150751|NCT01305772|12669575|P1|STARTED|Overall Study||5
5150752|NCT01305655|12669582|P1|NOT COMPLETED|Overall Study||0
5150753|NCT01305655|12669582|P1|COMPLETED|Overall Study|December 31, 2014|47
5150754|NCT01305655|12669582|P1|STARTED|Overall Study|July 2008|47
5150755|NCT01305577|12669589|P3|NOT COMPLETED|Overall Study||10
5150756|NCT01305577|12669590|P2|NOT COMPLETED|Overall Study||11
5150757|NCT01305577|12669591|P1|NOT COMPLETED|Overall Study||13
5150758|NCT01305577|12669589|P3|COMPLETED|Overall Study||112
5150759|NCT01305577|12669590|P2|COMPLETED|Overall Study||110
5150760|NCT01305577|12669591|P1|COMPLETED|Overall Study||107
5150761|NCT01305577|12669589|P3|Received Treatment|Overall Study||122
5150762|NCT01305577|12669590|P2|Received Treatment|Overall Study||121
5150763|NCT01305577|12669591|P1|Received Treatment|Overall Study||119
5150764|NCT01305577|12669589|P3|STARTED|Overall Study||122
5150765|NCT01305577|12669590|P2|STARTED|Overall Study||121
5150766|NCT01305577|12669591|P1|STARTED|Overall Study||120
5150767|NCT01305564|12669620|P1|NOT COMPLETED|Overall Study||37
5150768|NCT01305564|12669620|P1|COMPLETED|Overall Study||163
5150769|NCT01305564|12669620|P1|STARTED|Overall Study||200
5150770|NCT01305473|12669635|P1|NOT COMPLETED|Overall Study||0
5150771|NCT01305473|12669635|P1|COMPLETED|Overall Study||90
5150772|NCT01305473|12669635|P1|STARTED|Overall Study||90
5150773|NCT01305408|12669647|P2|NOT COMPLETED|Overall Study||31
5150774|NCT01305408|12669648|P1|NOT COMPLETED|Overall Study||32
5150775|NCT01305408|12669647|P2|COMPLETED|Overall Study||169
5150776|NCT01305408|12669648|P1|COMPLETED|Overall Study||167
5150777|NCT01305408|12669647|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
5150778|NCT01305408|12669648|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
5150779|NCT01305408|12669647|P2|Safety Population|Overall Study|Treated participants.|200
5150780|NCT01305408|12669648|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
5150781|NCT01305408|12669647|P2|STARTED|Overall Study||200
5150782|NCT01305408|12669648|P1|STARTED|Overall Study||199
5150783|NCT01305356|12669700|P2|NOT COMPLETED|Overall Study||0
5150784|NCT01305356|12669701|P1|NOT COMPLETED|Overall Study||0
5150785|NCT01305356|12669700|P2|COMPLETED|Overall Study||167
5150786|NCT01305356|12669701|P1|COMPLETED|Overall Study||132
5150787|NCT01305356|12669700|P2|STARTED|Overall Study||167
5150788|NCT01305356|12669701|P1|STARTED|Overall Study||132
5150789|NCT01305265|12669717|P2|NOT COMPLETED|Overall Study||6
5150790|NCT01305265|12669718|P1|NOT COMPLETED|Overall Study||2
5150791|NCT01305265|12669717|P2|COMPLETED|Overall Study||64
5150792|NCT01305265|12669718|P1|COMPLETED|Overall Study||69
5150793|NCT01305265|12669717|P2|STARTED|Overall Study||70
5150794|NCT01305265|12669718|P1|STARTED|Overall Study||71
5150795|NCT01305252|12669726|P2|NOT COMPLETED|Overall Study||0
5150796|NCT01305252|12669727|P1|NOT COMPLETED|Overall Study||1
5150797|NCT01305252|12669726|P2|COMPLETED|Overall Study||11
5150798|NCT01305252|12669727|P1|COMPLETED|Overall Study||9
5150799|NCT01305252|12669726|P2|STARTED|Overall Study||11
5150800|NCT01305252|12669727|P1|STARTED|Overall Study||10
5150801|NCT01305239|12669741|P1|NOT COMPLETED|Overall Study||23
5150802|NCT01305239|12669741|P1|COMPLETED|Overall Study||375
5150803|NCT01305239|12669741|P1|Intent to Treat Population|Overall Study||287
5150804|NCT01305239|12669741|P1|Safety Set|Overall Study||397
5150805|NCT01305239|12669741|P1|STARTED|Overall Study||398
5150806|NCT01305213|12669751|P2|NOT COMPLETED|Overall Study||0
5150807|NCT01305213|12669752|P1|NOT COMPLETED|Overall Study||0
5150808|NCT01305213|12669751|P2|COMPLETED|Overall Study||54
5150809|NCT01305213|12669752|P1|COMPLETED|Overall Study||53
5150810|NCT01305213|12669751|P2|STARTED|Overall Study||54
5150811|NCT01305213|12669752|P1|STARTED|Overall Study||53
5150812|NCT01305200|12669771|P3|NOT COMPLETED|Overall Study||3
5150813|NCT01305200|12669772|P2|NOT COMPLETED|Overall Study||31
5150814|NCT01305200|12669773|P1|NOT COMPLETED|Overall Study||29
5150815|NCT01305200|12669771|P3|COMPLETED|Overall Study||0
5150816|NCT01305200|12669772|P2|COMPLETED|Overall Study||81
5150817|NCT01305200|12669773|P1|COMPLETED|Overall Study||82
5150818|NCT01305200|12669771|P3|STARTED|Overall Study||3
5150819|NCT01305200|12669772|P2|STARTED|Overall Study||112
5150820|NCT01305200|12669773|P1|STARTED|Overall Study||111
5150821|NCT01305044|12669803|P2|NOT COMPLETED|Overall Study||6
5150822|NCT01305044|12669804|P1|NOT COMPLETED|Overall Study||3
5150823|NCT01305044|12669803|P2|COMPLETED|Overall Study||25
5150824|NCT01305044|12669804|P1|COMPLETED|Overall Study||29
5150825|NCT01305044|12669803|P2|STARTED|Overall Study||31
5150826|NCT01305044|12669804|P1|STARTED|Overall Study||32
5150827|NCT01304966|12669828|P1|NOT COMPLETED|Overall Study||0
5150828|NCT01304966|12669828|P1|COMPLETED|Overall Study||15
5150829|NCT01304966|12669828|P1|STARTED|Overall Study||15
5150830|NCT01304940|12669836|P2|NOT COMPLETED|Overall Study||0
5150831|NCT01304940|12669837|P1|NOT COMPLETED|Overall Study||3
5150832|NCT01304940|12669836|P2|COMPLETED|Overall Study||25
5150833|NCT01304940|12669837|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
5150834|NCT01304940|12669836|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
5150835|NCT01304940|12669837|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
5150836|NCT01304940|12669836|P2|STARTED|Overall Study||25
5150837|NCT01304940|12669837|P1|STARTED|Overall Study||25
5150838|NCT01304706|12669843|P1|NOT COMPLETED|Overall Study||17
5150839|NCT01304706|12669843|P1|COMPLETED|Overall Study||104
5150840|NCT01304706|12669843|P1|STARTED|Overall Study||121
5150841|NCT01304693|12669852|P5|NOT COMPLETED|Overall Study||1
5150842|NCT01304693|12669853|P4|NOT COMPLETED|Overall Study||1
5150843|NCT01304693|12669854|P3|NOT COMPLETED|Overall Study||1
5150844|NCT01304693|12669855|P2|NOT COMPLETED|Overall Study||0
5150845|NCT01304693|12669856|P1|NOT COMPLETED|Overall Study||0
5150846|NCT01304693|12669852|P5|COMPLETED|Overall Study||60
5150847|NCT01304693|12669853|P4|COMPLETED|Overall Study||39
5150848|NCT01304693|12669854|P3|COMPLETED|Overall Study||47
5150849|NCT01304693|12669855|P2|COMPLETED|Overall Study||35
5150850|NCT01304693|12669856|P1|COMPLETED|Overall Study||10
5150851|NCT01304693|12669852|P5|STARTED|Overall Study||61
5150852|NCT01304693|12669853|P4|STARTED|Overall Study||40
5150853|NCT01304693|12669854|P3|STARTED|Overall Study||48
5150854|NCT01304693|12669855|P2|STARTED|Overall Study||35
5150855|NCT01304693|12669856|P1|STARTED|Overall Study||10
5150856|NCT01304641|12669875|P2|NOT COMPLETED|Overall Study||0
5150857|NCT01304641|12669876|P1|NOT COMPLETED|Overall Study||0
5150858|NCT01304641|12669875|P2|COMPLETED|Overall Study||20132
5150859|NCT01304641|12669876|P1|COMPLETED|Overall Study||11470
5150860|NCT01304641|12669875|P2|STARTED|Overall Study||20132
5150861|NCT01304641|12669876|P1|STARTED|Overall Study||11470
5150862|NCT01304589|12669894|P1|NOT COMPLETED|Overall Study||13
5150863|NCT01304589|12669894|P1|COMPLETED|Overall Study||18
5150864|NCT01304589|12669894|P1|STARTED|Overall Study||31
5150865|NCT01304498|12669903|P2|NOT COMPLETED|Overall Study||5
5150866|NCT01304498|12669904|P1|NOT COMPLETED|Overall Study||6
5150867|NCT01304498|12669903|P2|COMPLETED|Overall Study||295
5150868|NCT01304498|12669904|P1|COMPLETED|Overall Study||294
5150869|NCT01304498|12669903|P2|Received ≥1 Dose|Overall Study||300
5150870|NCT01304498|12669904|P1|Received ≥1 Dose|Overall Study||300
5150871|NCT01304498|12669903|P2|STARTED|Overall Study||300
5150872|NCT01304498|12669904|P1|STARTED|Overall Study||300
5150873|NCT01304407|12669924|P1|NOT COMPLETED|Overall Study||0
5150874|NCT01304407|12669924|P1|COMPLETED|Overall Study||29
5150875|NCT01304407|12669924|P1|STARTED|Overall Study||29
5150876|NCT01304329|12669928|P6|NOT COMPLETED|Third Intervention (3 Days)||0
5150877|NCT01304329|12669929|P5|NOT COMPLETED|Third Intervention (3 Days)||0
5150878|NCT01304329|12669930|P4|NOT COMPLETED|Third Intervention (3 Days)||0
5150879|NCT01304329|12669931|P3|NOT COMPLETED|Third Intervention (3 Days)||0
5150880|NCT01304329|12669932|P2|NOT COMPLETED|Third Intervention (3 Days)||1
5150881|NCT01304329|12669933|P1|NOT COMPLETED|Third Intervention (3 Days)||0
5150882|NCT01304329|12669928|P6|COMPLETED|Third Intervention (3 Days)||3
5150883|NCT01304329|12669929|P5|COMPLETED|Third Intervention (3 Days)||3
5150884|NCT01304329|12669930|P4|COMPLETED|Third Intervention (3 Days)||3
5150885|NCT01304329|12669931|P3|COMPLETED|Third Intervention (3 Days)||3
5150886|NCT01304329|12669932|P2|COMPLETED|Third Intervention (3 Days)||2
5150887|NCT01304329|12669933|P1|COMPLETED|Third Intervention (3 Days)||3
5150888|NCT01304329|12669928|P6|STARTED|Third Intervention (3 Days)||3
5150889|NCT01304329|12669929|P5|STARTED|Third Intervention (3 Days)||3
5150890|NCT01304329|12669930|P4|STARTED|Third Intervention (3 Days)||3
5150891|NCT01304329|12669931|P3|STARTED|Third Intervention (3 Days)||3
5150892|NCT01304329|12669932|P2|STARTED|Third Intervention (3 Days)||3
5150893|NCT01304329|12669933|P1|STARTED|Third Intervention (3 Days)||3
5150894|NCT01304329|12669928|P6|NOT COMPLETED|Second Intervention (3 Days)||0
5150895|NCT01304329|12669929|P5|NOT COMPLETED|Second Intervention (3 Days)||0
5150896|NCT01304329|12669930|P4|NOT COMPLETED|Second Intervention (3 Days)||0
5150897|NCT01304329|12669931|P3|NOT COMPLETED|Second Intervention (3 Days)||0
5150898|NCT01304329|12669932|P2|NOT COMPLETED|Second Intervention (3 Days)||0
5150899|NCT01304329|12669933|P1|NOT COMPLETED|Second Intervention (3 Days)||0
5150900|NCT01304329|12669928|P6|COMPLETED|Second Intervention (3 Days)||3
5150901|NCT01304329|12669929|P5|COMPLETED|Second Intervention (3 Days)||3
5150902|NCT01304329|12669930|P4|COMPLETED|Second Intervention (3 Days)||3
5150903|NCT01304329|12669931|P3|COMPLETED|Second Intervention (3 Days)||3
5150904|NCT01304329|12669932|P2|COMPLETED|Second Intervention (3 Days)||3
5150905|NCT01304329|12669933|P1|COMPLETED|Second Intervention (3 Days)||3
5150906|NCT01304329|12669928|P6|STARTED|Second Intervention (3 Days)||3
5150907|NCT01304329|12669929|P5|STARTED|Second Intervention (3 Days)||3
5150908|NCT01304329|12669930|P4|STARTED|Second Intervention (3 Days)||3
5150909|NCT01304329|12669931|P3|STARTED|Second Intervention (3 Days)||3
5150910|NCT01304329|12669932|P2|STARTED|Second Intervention (3 Days)||3
5150911|NCT01304329|12669933|P1|STARTED|Second Intervention (3 Days)||3
5150912|NCT01304329|12669928|P6|NOT COMPLETED|First Intervention (3 Days)||0
5150913|NCT01304329|12669929|P5|NOT COMPLETED|First Intervention (3 Days)||0
5150914|NCT01304329|12669930|P4|NOT COMPLETED|First Intervention (3 Days)||0
5150915|NCT01304329|12669931|P3|NOT COMPLETED|First Intervention (3 Days)||0
5150916|NCT01304329|12669932|P2|NOT COMPLETED|First Intervention (3 Days)||0
5150917|NCT01304329|12669933|P1|NOT COMPLETED|First Intervention (3 Days)||0
5150918|NCT01304329|12669928|P6|COMPLETED|First Intervention (3 Days)||3
5150919|NCT01304329|12669929|P5|COMPLETED|First Intervention (3 Days)||3
5150920|NCT01304329|12669930|P4|COMPLETED|First Intervention (3 Days)||3
5150921|NCT01304329|12669931|P3|COMPLETED|First Intervention (3 Days)||3
5150922|NCT01304329|12669932|P2|COMPLETED|First Intervention (3 Days)||3
5150923|NCT01304329|12669933|P1|COMPLETED|First Intervention (3 Days)||3
5150924|NCT01304329|12669928|P6|STARTED|First Intervention (3 Days)||3
5150925|NCT01304329|12669929|P5|STARTED|First Intervention (3 Days)||3
5150926|NCT01304329|12669930|P4|STARTED|First Intervention (3 Days)||3
5150927|NCT01304329|12669931|P3|STARTED|First Intervention (3 Days)||3
5150928|NCT01304329|12669932|P2|STARTED|First Intervention (3 Days)||3
5150929|NCT01304329|12669933|P1|STARTED|First Intervention (3 Days)||3
5150930|NCT01304316|12669950|P1|NOT COMPLETED|Overall Study||0
5150931|NCT01304316|12669950|P1|COMPLETED|Overall Study||12
5150932|NCT01304316|12669950|P1|STARTED|Overall Study||12
5150933|NCT01304277|12669964|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
5150934|NCT01304277|12669964|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
5150935|NCT01304277|12669964|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
5150936|NCT01304277|12669964|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
5150937|NCT01304277|12669964|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
5150938|NCT01304277|12669964|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
5150939|NCT01304238|12669986|P10|NOT COMPLETED|Overall Study||0
5150940|NCT01304238|12669987|P9|NOT COMPLETED|Overall Study||0
5150941|NCT01304238|12669988|P8|NOT COMPLETED|Overall Study||0
5150942|NCT01304238|12669989|P7|NOT COMPLETED|Overall Study||0
5150943|NCT01304238|12669990|P6|NOT COMPLETED|Overall Study||0
5150944|NCT01304238|12669991|P5|NOT COMPLETED|Overall Study||0
5150945|NCT01304238|12669992|P4|NOT COMPLETED|Overall Study||0
5150946|NCT01304238|12669993|P3|NOT COMPLETED|Overall Study||0
5150947|NCT01304238|12669994|P2|NOT COMPLETED|Overall Study||0
5150948|NCT01304238|12669995|P1|NOT COMPLETED|Overall Study||0
5150949|NCT01304238|12669986|P10|COMPLETED|Overall Study||3
5150950|NCT01304238|12669987|P9|COMPLETED|Overall Study||1
5150951|NCT01304238|12669988|P8|COMPLETED|Overall Study||4
5150952|NCT01304238|12669989|P7|COMPLETED|Overall Study||5
5150953|NCT01304238|12669990|P6|COMPLETED|Overall Study||11
5150954|NCT01304238|12669991|P5|COMPLETED|Overall Study||11
5150955|NCT01304238|12669992|P4|COMPLETED|Overall Study||78
5150956|NCT01304238|12669993|P3|COMPLETED|Overall Study||46
5150957|NCT01304238|12669994|P2|COMPLETED|Overall Study||4
5150958|NCT01304238|12669995|P1|COMPLETED|Overall Study||32
5150959|NCT01304238|12669986|P10|STARTED|Overall Study||3
5150960|NCT01304238|12669987|P9|STARTED|Overall Study||1
5150961|NCT01304238|12669988|P8|STARTED|Overall Study||4
5150962|NCT01304238|12669989|P7|STARTED|Overall Study||5
5150963|NCT01304238|12669990|P6|STARTED|Overall Study||11
5150964|NCT01304238|12669991|P5|STARTED|Overall Study||11
5150965|NCT01304238|12669992|P4|STARTED|Overall Study||78
5150966|NCT01304238|12669993|P3|STARTED|Overall Study||46
5150967|NCT01304238|12669994|P2|STARTED|Overall Study||4
5150968|NCT01304238|12669995|P1|STARTED|Overall Study||32
5150969|NCT01304147|12670067|P2|NOT COMPLETED|Second Intervention (7days)||1
5150970|NCT01304147|12670068|P1|NOT COMPLETED|Second Intervention (7days)||1
5150971|NCT01304147|12670067|P2|COMPLETED|Second Intervention (7days)||9
5150972|NCT01304147|12670068|P1|COMPLETED|Second Intervention (7days)||9
5150973|NCT01304147|12670067|P2|STARTED|Second Intervention (7days)||10
5150974|NCT01304147|12670068|P1|STARTED|Second Intervention (7days)||10
5150975|NCT01304147|12670067|P2|NOT COMPLETED|Washout (1 Day)||0
5150976|NCT01304147|12670068|P1|NOT COMPLETED|Washout (1 Day)||0
5150977|NCT01304147|12670067|P2|COMPLETED|Washout (1 Day)||10
5150978|NCT01304147|12670068|P1|COMPLETED|Washout (1 Day)||10
5150979|NCT01304147|12670067|P2|STARTED|Washout (1 Day)||10
5150980|NCT01304147|12670068|P1|STARTED|Washout (1 Day)||10
5150981|NCT01304147|12670067|P2|NOT COMPLETED|First Intervention (7days)||0
5150982|NCT01304147|12670068|P1|NOT COMPLETED|First Intervention (7days)||0
5150983|NCT01304147|12670067|P2|COMPLETED|First Intervention (7days)||10
5150984|NCT01304147|12670068|P1|COMPLETED|First Intervention (7days)||10
5150985|NCT01304147|12670067|P2|STARTED|First Intervention (7days)||10
5150986|NCT01304147|12670068|P1|STARTED|First Intervention (7days)||10
5150987|NCT01304082|12670076|P5|NOT COMPLETED|Overall Study||0
5150988|NCT01304082|12670077|P4|NOT COMPLETED|Overall Study||0
5150989|NCT01304082|12670078|P3|NOT COMPLETED|Overall Study||0
5150990|NCT01304082|12670079|P2|NOT COMPLETED|Overall Study||0
5150991|NCT01304082|12670080|P1|NOT COMPLETED|Overall Study||0
5150992|NCT01304082|12670076|P5|COMPLETED|Overall Study||5
5150993|NCT01304082|12670077|P4|COMPLETED|Overall Study||8
5150994|NCT01304082|12670078|P3|COMPLETED|Overall Study||11
5150995|NCT01304082|12670079|P2|COMPLETED|Overall Study||2
5150996|NCT01304082|12670080|P1|COMPLETED|Overall Study||3
5150997|NCT01304082|12670076|P5|Third Intervention|Overall Study||5
5150998|NCT01304082|12670077|P4|Third Intervention|Overall Study||8
5150999|NCT01304082|12670078|P3|Third Intervention|Overall Study||11
5151000|NCT01304082|12670079|P2|Third Intervention|Overall Study||2
5151001|NCT01304082|12670080|P1|Third Intervention|Overall Study||3
5151002|NCT01304082|12670076|P5|Second Intervention|Overall Study||5
5151003|NCT01304082|12670077|P4|Second Intervention|Overall Study||8
5151004|NCT01304082|12670078|P3|Second Intervention|Overall Study||11
5151005|NCT01304082|12670079|P2|Second Intervention|Overall Study||2
5151006|NCT01304082|12670080|P1|Second Intervention|Overall Study||3
5151007|NCT01304082|12670076|P5|First Intervention|Overall Study||5
5151008|NCT01304082|12670077|P4|First Intervention|Overall Study||8
5151009|NCT01304082|12670078|P3|First Intervention|Overall Study||11
5151010|NCT01304082|12670079|P2|First Intervention|Overall Study||2
5151011|NCT01304082|12670080|P1|First Intervention|Overall Study||3
5151012|NCT01304082|12670076|P5|STARTED|Overall Study||5
5151013|NCT01304082|12670077|P4|STARTED|Overall Study||8
5151014|NCT01304082|12670078|P3|STARTED|Overall Study||11
5151015|NCT01304082|12670079|P2|STARTED|Overall Study||2
5151016|NCT01304082|12670080|P1|STARTED|Overall Study||3
5151017|NCT01303965|12670099|P2|NOT COMPLETED|Overall Study||10
5151018|NCT01303965|12670100|P1|NOT COMPLETED|Overall Study||3
5151019|NCT01303965|12670099|P2|COMPLETED|Overall Study||1
5151020|NCT01303965|12670100|P1|COMPLETED|Overall Study||0
5151021|NCT01303965|12670099|P2|STARTED|Overall Study||11
5151022|NCT01303965|12670100|P1|STARTED|Overall Study||3
5151023|NCT01303939|12670114|P2|NOT COMPLETED|Overall Study||0
5151024|NCT01303939|12670115|P1|NOT COMPLETED|Overall Study||7
5151025|NCT01303939|12670114|P2|COMPLETED|Overall Study||15
5151026|NCT01303939|12670115|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
5151027|NCT01303939|12670114|P2|STARTED|Overall Study||15
5151028|NCT01303939|12670115|P1|STARTED|Overall Study||22
5151029|NCT01303861|12670128|P4|NOT COMPLETED|Overall Study||59
5151030|NCT01303861|12670129|P3|NOT COMPLETED|Overall Study||36
5151031|NCT01303861|12670130|P2|NOT COMPLETED|Overall Study||25
5151032|NCT01303861|12670131|P1|NOT COMPLETED|Overall Study||58
5151033|NCT01303861|12670128|P4|COMPLETED|Overall Study||54
5151034|NCT01303861|12670129|P3|COMPLETED|Overall Study||19
5151035|NCT01303861|12670130|P2|COMPLETED|Overall Study||25
5151036|NCT01303861|12670131|P1|COMPLETED|Overall Study||51
5151037|NCT01303861|12670128|P4|Finished Treatment Phase|Overall Study||72
5151038|NCT01303861|12670129|P3|Finished Treatment Phase|Overall Study||39
5151039|NCT01303861|12670130|P2|Finished Treatment Phase|Overall Study||34
5151040|NCT01303861|12670131|P1|Finished Treatment Phase|Overall Study||71
5151041|NCT01303861|12670128|P4|STARTED|Overall Study||113
5151042|NCT01303861|12670129|P3|STARTED|Overall Study||55
5151043|NCT01303861|12670130|P2|STARTED|Overall Study||50
5151044|NCT01303861|12670131|P1|STARTED|Overall Study||109
5151045|NCT01303835|12670152|P2|NOT COMPLETED|Overall Study||25
5151046|NCT01303835|12670153|P1|NOT COMPLETED|Overall Study||19
5151047|NCT01303835|12670152|P2|COMPLETED|Overall Study||31
5151048|NCT01303835|12670153|P1|COMPLETED|Overall Study||35
5151049|NCT01303835|12670152|P2|STARTED|Overall Study||56
5151050|NCT01303835|12670153|P1|STARTED|Overall Study||54
5151051|NCT01303744|12670167|P4|NOT COMPLETED|Overall Study||0
5151052|NCT01303744|12670168|P3|NOT COMPLETED|Overall Study||0
5151053|NCT01303744|12670169|P2|NOT COMPLETED|Overall Study||0
5151054|NCT01303744|12670170|P1|NOT COMPLETED|Overall Study||0
5151055|NCT01303744|12670167|P4|COMPLETED|Overall Study||24
5151056|NCT01303744|12670168|P3|COMPLETED|Overall Study||24
5151057|NCT01303744|12670169|P2|COMPLETED|Overall Study||24
5151058|NCT01303744|12670170|P1|COMPLETED|Overall Study||24
5151059|NCT01303744|12670167|P4|STARTED|Overall Study||24
5151060|NCT01303744|12670168|P3|STARTED|Overall Study||24
5151061|NCT01303744|12670169|P2|STARTED|Overall Study||24
5151062|NCT01303744|12670170|P1|STARTED|Overall Study||24
5151063|NCT01303627|12670190|P2|NOT COMPLETED|Overall Study||1
5151064|NCT01303627|12670191|P1|NOT COMPLETED|Overall Study||0
5151065|NCT01303627|12670190|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
5151066|NCT01303627|12670191|P1|COMPLETED|Overall Study||21
5151067|NCT01303627|12670190|P2|STARTED|Overall Study||21
5151068|NCT01303627|12670191|P1|STARTED|Overall Study||21
5151069|NCT01303510|12670199|P2|NOT COMPLETED|Overall Study||0
5151070|NCT01303510|12670200|P1|NOT COMPLETED|Overall Study||1
5151071|NCT01303510|12670199|P2|COMPLETED|Overall Study||56
5151072|NCT01303510|12670200|P1|COMPLETED|Overall Study||54
5151073|NCT01303510|12670199|P2|STARTED|Overall Study||56
5151074|NCT01303510|12670200|P1|STARTED|Overall Study||55
5151075|NCT01303445|12670214|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
5151076|NCT01303445|12670215|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
5151077|NCT01303445|12670214|P2|COMPLETED|Follow-up Period (14 Days)||25
5151078|NCT01303445|12670215|P1|COMPLETED|Follow-up Period (14 Days)||26
5151079|NCT01303445|12670214|P2|STARTED|Follow-up Period (14 Days)||26
5151080|NCT01303445|12670215|P1|STARTED|Follow-up Period (14 Days)||26
5151081|NCT01303445|12670214|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
5151082|NCT01303445|12670215|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
5151083|NCT01303445|12670214|P2|COMPLETED|Fourth Intervention (7 Days)||26
5151084|NCT01303445|12670215|P1|COMPLETED|Fourth Intervention (7 Days)||26
5151085|NCT01303445|12670214|P2|STARTED|Fourth Intervention (7 Days)||26
5151086|NCT01303445|12670215|P1|STARTED|Fourth Intervention (7 Days)||27
5151087|NCT01303445|12670214|P2|NOT COMPLETED|Third Intervention (7 Days)||0
5151088|NCT01303445|12670215|P1|NOT COMPLETED|Third Intervention (7 Days)||0
5151089|NCT01303445|12670214|P2|COMPLETED|Third Intervention (7 Days)||26
5151090|NCT01303445|12670215|P1|COMPLETED|Third Intervention (7 Days)||27
5151091|NCT01303445|12670214|P2|STARTED|Third Intervention (7 Days)||26
5151092|NCT01303445|12670215|P1|STARTED|Third Intervention (7 Days)||27
5151093|NCT01303445|12670214|P2|NOT COMPLETED|Washout (14 Days)||2
5151094|NCT01303445|12670215|P1|NOT COMPLETED|Washout (14 Days)||1
5151095|NCT01303445|12670214|P2|COMPLETED|Washout (14 Days)||26
5151096|NCT01303445|12670215|P1|COMPLETED|Washout (14 Days)||27
5151097|NCT01303445|12670214|P2|STARTED|Washout (14 Days)||28
5151098|NCT01303445|12670215|P1|STARTED|Washout (14 Days)||28
5151099|NCT01303445|12670214|P2|NOT COMPLETED|Second Intervention (7 Days)||2
5151100|NCT01303445|12670215|P1|NOT COMPLETED|Second Intervention (7 Days)||1
5151101|NCT01303445|12670214|P2|COMPLETED|Second Intervention (7 Days)||28
5151102|NCT01303445|12670215|P1|COMPLETED|Second Intervention (7 Days)||28
5151103|NCT01303445|12670214|P2|STARTED|Second Intervention (7 Days)||30
5151104|NCT01303445|12670215|P1|STARTED|Second Intervention (7 Days)||29
5151105|NCT01303445|12670214|P2|NOT COMPLETED|First Intervention (7 Days)||0
5151106|NCT01303445|12670215|P1|NOT COMPLETED|First Intervention (7 Days)||1
5151107|NCT01303445|12670214|P2|COMPLETED|First Intervention (7 Days)||30
5151108|NCT01303445|12670215|P1|COMPLETED|First Intervention (7 Days)||29
5151109|NCT01303445|12670214|P2|STARTED|First Intervention (7 Days)||30
5151110|NCT01303445|12670215|P1|STARTED|First Intervention (7 Days)||30
5151111|NCT01303419|12670245|P1|NOT COMPLETED|Overall Study||96
5151112|NCT01303419|12670245|P1|COMPLETED|Overall Study||128
5151113|NCT01303419|12670245|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
5151114|NCT01303406|12670255|P2|NOT COMPLETED|Overall Study||1
5151115|NCT01303406|12670256|P1|NOT COMPLETED|Overall Study||0
5151116|NCT01303406|12670255|P2|COMPLETED|Overall Study||15
5151117|NCT01303406|12670256|P1|COMPLETED|Overall Study||13
5151118|NCT01303406|12670255|P2|STARTED|Overall Study||16
5151119|NCT01303406|12670256|P1|STARTED|Overall Study||13
5151120|NCT01303380|12670264|P1|NOT COMPLETED|Overall Study||1
5151121|NCT01303380|12670264|P1|COMPLETED|Overall Study||8
5151122|NCT01303380|12670264|P1|STARTED|Overall Study||9
5151123|NCT01303224|12670294|P4|NOT COMPLETED|Overall Study||10
5151124|NCT01303224|12670295|P3|NOT COMPLETED|Overall Study||6
5151125|NCT01303224|12670296|P2|NOT COMPLETED|Overall Study||11
5151126|NCT01303224|12670297|P1|NOT COMPLETED|Overall Study||11
5151127|NCT01303224|12670294|P4|COMPLETED|Overall Study||133
5151128|NCT01303224|12670295|P3|COMPLETED|Overall Study||133
5151129|NCT01303224|12670296|P2|COMPLETED|Overall Study||131
5151130|NCT01303224|12670297|P1|COMPLETED|Overall Study||130
5151131|NCT01303224|12670294|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
5151132|NCT01303224|12670295|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
5151133|NCT01303224|12670296|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
5151134|NCT01303224|12670297|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
5151135|NCT01303224|12670294|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
5151136|NCT01303224|12670295|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
5151137|NCT01303224|12670296|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
5151138|NCT01303224|12670297|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
5151139|NCT01303159|12670323|P1|NOT COMPLETED|Overall Study||23
5151140|NCT01303159|12670323|P1|COMPLETED|Overall Study||6
5151141|NCT01303159|12670323|P1|STARTED|Overall Study||29
5151142|NCT01303003|12670330|P2|NOT COMPLETED|Overall Study||0
5151143|NCT01303003|12670331|P1|NOT COMPLETED|Overall Study||0
5151144|NCT01303003|12670330|P2|COMPLETED|Overall Study||0
5151145|NCT01303003|12670331|P1|COMPLETED|Overall Study||0
5151146|NCT01303003|12670330|P2|STARTED|Overall Study||0
5151147|NCT01303003|12670331|P1|STARTED|Overall Study||0
5151148|NCT01302964|12670341|P2|NOT COMPLETED|Overall Study||0
5151149|NCT01302964|12670342|P1|NOT COMPLETED|Overall Study||1
5151150|NCT01302964|12670341|P2|COMPLETED|Overall Study||10
5151151|NCT01302964|12670342|P1|COMPLETED|Overall Study||19
5151152|NCT01302964|12670341|P2|STARTED|Overall Study||10
5151153|NCT01302964|12670342|P1|STARTED|Overall Study||20
5151154|NCT01302938|12670352|P2|NOT COMPLETED|Overall Study||0
5151155|NCT01302938|12670353|P1|NOT COMPLETED|Overall Study||2
5151156|NCT01302938|12670352|P2|COMPLETED|Overall Study||6
5151157|NCT01302938|12670353|P1|COMPLETED|Overall Study||10
5151158|NCT01302938|12670352|P2|STARTED|Overall Study||6
5151159|NCT01302938|12670353|P1|STARTED|Overall Study||12
5151160|NCT01302899|12670398|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
5151161|NCT01302899|12670399|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
5151162|NCT01302899|12670398|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
5151163|NCT01302899|12670399|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
5151164|NCT01302899|12670398|P2|STARTED|Period 4 (Weeks 19 to 26)||3
5151165|NCT01302899|12670399|P1|STARTED|Period 4 (Weeks 19 to 26)||3
5151166|NCT01302899|12670398|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
5151167|NCT01302899|12670399|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
5151168|NCT01302899|12670398|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
5151169|NCT01302899|12670399|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
5151170|NCT01302899|12670398|P2|STARTED|Period 3 (Weeks 13 to 18)||3
5151171|NCT01302899|12670399|P1|STARTED|Period 3 (Weeks 13 to 18)||3
5151172|NCT01302899|12670398|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
5151173|NCT01302899|12670399|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
5151174|NCT01302899|12670398|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
5151175|NCT01302899|12670399|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
5151176|NCT01302899|12670398|P2|STARTED|Period 2 (Weeks 7 to 12)||4
5151177|NCT01302899|12670399|P1|STARTED|Period 2 (Weeks 7 to 12)||4
5151178|NCT01302899|12670398|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
5151179|NCT01302899|12670399|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
5151180|NCT01302899|12670398|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
5151181|NCT01302899|12670399|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
5151182|NCT01302899|12670398|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
5151183|NCT01302899|12670399|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
5151184|NCT01302860|12670449|P1|NOT COMPLETED|Overall Study||0
5151185|NCT01302860|12670449|P1|COMPLETED|Overall Study||17
5151186|NCT01302860|12670449|P1|STARTED|Overall Study||17
5151187|NCT01302834|12670463|P2|NOT COMPLETED|Overall Study||26
5151188|NCT01302834|12670464|P1|NOT COMPLETED|Overall Study||18
5151189|NCT01302834|12670463|P2|COMPLETED|Overall Study||399
5151190|NCT01302834|12670464|P1|COMPLETED|Overall Study||406
5151191|NCT01302834|12670463|P2|Progressed|Overall Study||122
5151192|NCT01302834|12670464|P1|Progressed|Overall Study||76
5151193|NCT01302834|12670463|P2|Feeding Tube Assessed|Overall Study||356
5151194|NCT01302834|12670464|P1|Feeding Tube Assessed|Overall Study||368
5151195|NCT01302834|12670463|P2|Dental Health Assessed 5 Years PT|Overall Study||43
5151196|NCT01302834|12670464|P1|Dental Health Assessed 5 Years PT|Overall Study||44
5151197|NCT01302834|12670463|P2|Dental Health Assessed 2 Years PT|Overall Study||201
5151198|NCT01302834|12670464|P1|Dental Health Assessed 2 Years PT|Overall Study||208
5151199|NCT01302834|12670463|P2|Dental Health Assessed 1 Year PT|Overall Study||267
5151200|NCT01302834|12670464|P1|Dental Health Assessed 1 Year PT|Overall Study||267
5151201|NCT01302834|12670463|P2|AE Assessed 5 Years PT|Overall Study||86
5151202|NCT01302834|12670464|P1|AE Assessed 5 Years PT|Overall Study||92
5151203|NCT01302834|12670463|P2|AE Assessed 2 Years PT|Overall Study||303
5151204|NCT01302834|12670464|P1|AE Assessed 2 Years PT|Overall Study||311
5151205|NCT01302834|12670463|P2|AE Assessment 1 Year PT|Overall Study||351
5151206|NCT01302834|12670464|P1|AE Assessment 1 Year PT|Overall Study||360
5151207|NCT01302834|12670463|P2|AE Assessed 6 Months PT|Overall Study||352
5151208|NCT01302834|12670464|P1|AE Assessed 6 Months PT|Overall Study||361
5151209|NCT01302834|12670463|P2|AE Assessed 3 Months PT|Overall Study||367
5151210|NCT01302834|12670464|P1|AE Assessed 3 Months PT|Overall Study||359
5151211|NCT01302834|12670463|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
5151212|NCT01302834|12670464|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
5151213|NCT01302834|12670463|P2|Started Treatment|Overall Study||394
5151214|NCT01302834|12670464|P1|Started Treatment|Overall Study||398
5151215|NCT01302834|12670463|P2|Eligible|Overall Study||399
5151216|NCT01302834|12670464|P1|Eligible|Overall Study||406
5151217|NCT01302834|12670463|P2|STARTED|Overall Study||425
5151218|NCT01302834|12670464|P1|STARTED|Overall Study||424
5151219|NCT01302743|12670509|P3|NOT COMPLETED|Overall Study||2
5151220|NCT01302743|12670510|P2|NOT COMPLETED|Overall Study||1
5151221|NCT01302743|12670511|P1|NOT COMPLETED|Overall Study||1
5151222|NCT01302743|12670509|P3|COMPLETED|Overall Study||8
5151223|NCT01302743|12670510|P2|COMPLETED|Overall Study||7
5151224|NCT01302743|12670511|P1|COMPLETED|Overall Study||6
5151225|NCT01302743|12670509|P3|STARTED|Overall Study||10
5151226|NCT01302743|12670510|P2|STARTED|Overall Study||8
5151227|NCT01302743|12670511|P1|STARTED|Overall Study||7
5151228|NCT01302691|12670524|P2|NOT COMPLETED|Overall Study||6
5151229|NCT01302691|12670525|P1|NOT COMPLETED|Overall Study||10
5151230|NCT01302691|12670524|P2|COMPLETED|Overall Study||157
5151231|NCT01302691|12670525|P1|COMPLETED|Overall Study||154
5151232|NCT01302691|12670524|P2|STARTED|Overall Study||163
5151233|NCT01302691|12670525|P1|STARTED|Overall Study||164
5151234|NCT01302548|12670545|P2|NOT COMPLETED|Overall Study||1
5151235|NCT01302548|12670546|P1|NOT COMPLETED|Overall Study||2
5151236|NCT01302548|12670545|P2|COMPLETED|Overall Study||18
5151237|NCT01302548|12670546|P1|COMPLETED|Overall Study||12
5151238|NCT01302548|12670545|P2|STARTED|Overall Study||19
5151239|NCT01302548|12670546|P1|STARTED|Overall Study||14
5151240|NCT01302483|12670558|P2|NOT COMPLETED|Overall Study||0
5151241|NCT01302483|12670559|P1|NOT COMPLETED|Overall Study||0
5151242|NCT01302483|12670558|P2|COMPLETED|Overall Study||15
5151243|NCT01302483|12670559|P1|COMPLETED|Overall Study||30
5151244|NCT01302483|12670558|P2|STARTED|Overall Study||15
5151245|NCT01302483|12670559|P1|STARTED|Overall Study||30
5151246|NCT01302444|12670575|P2|NOT COMPLETED|Overall Study||0
5151247|NCT01302444|12670576|P1|NOT COMPLETED|Overall Study||0
5151248|NCT01302444|12670575|P2|COMPLETED|Overall Study||0
5151249|NCT01302444|12670576|P1|COMPLETED|Overall Study||1
5151250|NCT01302444|12670575|P2|STARTED|Overall Study||0
5151251|NCT01302444|12670576|P1|STARTED|Overall Study||1
5151252|NCT01302418|12670596|P1|NOT COMPLETED|Overall Study||18
5151253|NCT01302418|12670596|P1|COMPLETED|Overall Study||254
5151254|NCT01302418|12670596|P1|STARTED|Overall Study||272
5151255|NCT01302392|12670602|P2|NOT COMPLETED|Overall Study||1
5151256|NCT01302392|12670603|P1|NOT COMPLETED|Overall Study||7
5151257|NCT01302392|12670602|P2|COMPLETED|Overall Study||156
5151258|NCT01302392|12670603|P1|COMPLETED|Overall Study||151
5151259|NCT01302392|12670602|P2|Treated|Overall Study||157
5151260|NCT01302392|12670603|P1|Treated|Overall Study||153
5151261|NCT01302392|12670602|P2|STARTED|Overall Study||157
5151262|NCT01302392|12670603|P1|STARTED|Overall Study||158
5151263|NCT01302379|12670627|P4|NOT COMPLETED|Overall Study||4
5151264|NCT01302379|12670628|P3|NOT COMPLETED|Overall Study||4
5151265|NCT01302379|12670629|P2|NOT COMPLETED|Overall Study||5
5151266|NCT01302379|12670630|P1|NOT COMPLETED|Overall Study||7
5151267|NCT01302379|12670627|P4|COMPLETED|Overall Study||79
5151268|NCT01302379|12670628|P3|COMPLETED|Overall Study||80
5151269|NCT01302379|12670629|P2|COMPLETED|Overall Study||78
5151270|NCT01302379|12670630|P1|COMPLETED|Overall Study||76
5151271|NCT01302379|12670627|P4|STARTED|Overall Study||83
5151272|NCT01302379|12670628|P3|STARTED|Overall Study||84
5151273|NCT01302379|12670629|P2|STARTED|Overall Study||83
5151274|NCT01302379|12670630|P1|STARTED|Overall Study||83
5151275|NCT01302366|12670654|P1|NOT COMPLETED|Overall Study||5
5151276|NCT01302366|12670654|P1|COMPLETED|Overall Study||15
5151277|NCT01302366|12670654|P1|STARTED|Overall Study||20
5151278|NCT01302119|12670662|P2|NOT COMPLETED|Overall Study||28
5151279|NCT01302119|12670663|P1|NOT COMPLETED|Overall Study||50
5151280|NCT01302119|12670662|P2|COMPLETED|Overall Study||177
5151281|NCT01302119|12670663|P1|COMPLETED|Overall Study||349
5151282|NCT01302119|12670662|P2|STARTED|Overall Study||205
5151283|NCT01302119|12670663|P1|STARTED|Overall Study||399
5151284|NCT01302067|12670678|P3|NOT COMPLETED|Overall Study||98
5151285|NCT01302067|12670679|P2|NOT COMPLETED|Overall Study||34
5151286|NCT01302067|12670680|P1|NOT COMPLETED|Overall Study||78
5151287|NCT01302067|12670678|P3|COMPLETED|Overall Study||681
5151288|NCT01302067|12670679|P2|COMPLETED|Overall Study||352
5151289|NCT01302067|12670680|P1|COMPLETED|Overall Study||712
5151290|NCT01302067|12670678|P3|STARTED|Overall Study||779
5151291|NCT01302067|12670679|P2|STARTED|Overall Study||386
5151292|NCT01302067|12670680|P1|STARTED|Overall Study||790
5151293|NCT01302054|12670751|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
5151294|NCT01302054|12670752|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
5151295|NCT01302054|12670753|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
5151296|NCT01302054|12670751|P3|COMPLETED|Double-Blind Treatment Phase||255
5151297|NCT01302054|12670752|P2|COMPLETED|Double-Blind Treatment Phase||281
5151298|NCT01302054|12670753|P1|COMPLETED|Double-Blind Treatment Phase||0
5151299|NCT01302054|12670751|P3|STARTED|Double-Blind Treatment Phase||301
5151300|NCT01302054|12670752|P2|STARTED|Double-Blind Treatment Phase||308
5151301|NCT01302054|12670753|P1|STARTED|Double-Blind Treatment Phase||0
5151302|NCT01302054|12670751|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
5151303|NCT01302054|12670752|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
5151304|NCT01302054|12670753|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
5151305|NCT01302054|12670751|P3|COMPLETED|Between Open-Label and Double Blind||0
5151306|NCT01302054|12670752|P2|COMPLETED|Between Open-Label and Double Blind||0
5151307|NCT01302054|12670753|P1|COMPLETED|Between Open-Label and Double Blind||609
5151308|NCT01302054|12670751|P3|STARTED|Between Open-Label and Double Blind||0
5151309|NCT01302054|12670752|P2|STARTED|Between Open-Label and Double Blind||0
5151310|NCT01302054|12670753|P1|STARTED|Between Open-Label and Double Blind||611
5151311|NCT01302054|12670751|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
5151312|NCT01302054|12670752|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
5151313|NCT01302054|12670753|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
5151314|NCT01302054|12670751|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
5151315|NCT01302054|12670752|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
5151316|NCT01302054|12670753|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
5151317|NCT01302054|12670751|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
5151318|NCT01302054|12670752|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
5151319|NCT01302054|12670753|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
5151320|NCT01302041|12670780|P1|NOT COMPLETED|Overall Study||40
5151321|NCT01302041|12670780|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
5151322|NCT01302041|12670780|P1|Treatment Received|Overall Study||67
5151323|NCT01302041|12670780|P1|STARTED|Overall Study||67
5151324|NCT01301963|12670811|P2|NOT COMPLETED|Overall Study||0
5151325|NCT01301963|12670812|P1|NOT COMPLETED|Overall Study||0
5151326|NCT01301963|12670811|P2|COMPLETED|Overall Study||4
5151327|NCT01301963|12670812|P1|COMPLETED|Overall Study||5
5151328|NCT01301963|12670811|P2|STARTED|Overall Study||4
5151329|NCT01301963|12670812|P1|STARTED|Overall Study||5
5151330|NCT01301950|12670822|P2|NOT COMPLETED|Overall Study||1
5151331|NCT01301950|12670823|P1|NOT COMPLETED|Overall Study||0
5151332|NCT01301950|12670822|P2|COMPLETED|Overall Study||14
5151333|NCT01301950|12670823|P1|COMPLETED|Overall Study||15
5151334|NCT01301950|12670822|P2|STARTED|Overall Study||15
5151335|NCT01301950|12670823|P1|STARTED|Overall Study||15
5151336|NCT01301833|12670841|P4|NOT COMPLETED|Overall Study||7
5151337|NCT01301833|12670842|P3|NOT COMPLETED|Overall Study||7
5151338|NCT01301833|12670843|P2|NOT COMPLETED|Overall Study||8
5151339|NCT01301833|12670844|P1|NOT COMPLETED|Overall Study||15
5151340|NCT01301833|12670841|P4|COMPLETED|Overall Study||68
5151341|NCT01301833|12670842|P3|COMPLETED|Overall Study||88
5151342|NCT01301833|12670843|P2|COMPLETED|Overall Study||72
5151343|NCT01301833|12670844|P1|COMPLETED|Overall Study||197
5151344|NCT01301833|12670841|P4|STARTED|Overall Study||75
5151345|NCT01301833|12670842|P3|STARTED|Overall Study||95
5151346|NCT01301833|12670843|P2|STARTED|Overall Study||80
5151347|NCT01301833|12670844|P1|STARTED|Overall Study||212
5151348|NCT01301742|12670870|P2|NOT COMPLETED|Second Intervention||0
5151349|NCT01301742|12670871|P1|NOT COMPLETED|Second Intervention||0
5151350|NCT01301742|12670870|P2|COMPLETED|Second Intervention||9
5151351|NCT01301742|12670871|P1|COMPLETED|Second Intervention||9
5151352|NCT01301742|12670870|P2|STARTED|Second Intervention||9
5151353|NCT01301742|12670871|P1|STARTED|Second Intervention||9
5151354|NCT01301742|12670870|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
5151355|NCT01301742|12670871|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
5151356|NCT01301742|12670870|P2|COMPLETED|Washout Period of at Least 7 Days||9
5151357|NCT01301742|12670871|P1|COMPLETED|Washout Period of at Least 7 Days||9
5151358|NCT01301742|12670870|P2|STARTED|Washout Period of at Least 7 Days||9
5151359|NCT01301742|12670871|P1|STARTED|Washout Period of at Least 7 Days||9
5151360|NCT01301742|12670870|P2|NOT COMPLETED|First Intervention||0
5151361|NCT01301742|12670871|P1|NOT COMPLETED|First Intervention||0
5151362|NCT01301742|12670870|P2|COMPLETED|First Intervention||9
5151363|NCT01301742|12670871|P1|COMPLETED|First Intervention||9
5151364|NCT01301742|12670870|P2|STARTED|First Intervention||9
5151365|NCT01301742|12670871|P1|STARTED|First Intervention||9
5151366|NCT01301729|12670882|P1|NOT COMPLETED|Overall Study||4
5151367|NCT01301729|12670882|P1|COMPLETED|Overall Study||28
5151368|NCT01301729|12670882|P1|STARTED|Overall Study||32
5151369|NCT01301625|12670893|P1|NOT COMPLETED|Overall Study||35
5151370|NCT01301625|12670893|P1|COMPLETED|Overall Study||43
5151371|NCT01301625|12670893|P1|STARTED|Overall Study||78
5151372|NCT01301508|12670965|P2|NOT COMPLETED|Overall Study||3
5151373|NCT01301508|12670966|P1|NOT COMPLETED|Overall Study||1
5151374|NCT01301508|12670965|P2|COMPLETED|Overall Study||22
5151375|NCT01301508|12670966|P1|COMPLETED|Overall Study||20
5151376|NCT01301508|12670965|P2|STARTED|Overall Study||25
5151377|NCT01301508|12670966|P1|STARTED|Overall Study||21
5151378|NCT01301456|12670996|P12|NOT COMPLETED|Stage 2||0
5151379|NCT01301456|12670997|P11|NOT COMPLETED|Stage 2||1
5151380|NCT01301456|12670998|P10|NOT COMPLETED|Stage 2||0
5151381|NCT01301456|12670999|P9|NOT COMPLETED|Stage 2||0
5151382|NCT01301456|12671000|P8|NOT COMPLETED|Stage 2||0
5151383|NCT01301456|12671001|P7|NOT COMPLETED|Stage 2||0
5151384|NCT01301456|12671002|P6|NOT COMPLETED|Stage 2||0
5151385|NCT01301456|12671003|P5|NOT COMPLETED|Stage 2||0
5151386|NCT01301456|12671004|P4|NOT COMPLETED|Stage 2||0
5151387|NCT01301456|12671005|P3|NOT COMPLETED|Stage 2||0
5151388|NCT01301456|12671006|P2|NOT COMPLETED|Stage 2||0
5151389|NCT01301456|12671007|P1|NOT COMPLETED|Stage 2||0
5151390|NCT01301456|12670996|P12|COMPLETED|Stage 2||6
5151391|NCT01301456|12670997|P11|COMPLETED|Stage 2||6
5151392|NCT01301456|12670998|P10|COMPLETED|Stage 2||7
5151393|NCT01301456|12670999|P9|COMPLETED|Stage 2||5
5151394|NCT01301456|12671000|P8|COMPLETED|Stage 2||7
5151395|NCT01301456|12671001|P7|COMPLETED|Stage 2||0
5151396|NCT01301456|12671002|P6|COMPLETED|Stage 2||0
5151397|NCT01301456|12671003|P5|COMPLETED|Stage 2||0
5151398|NCT01301456|12671004|P4|COMPLETED|Stage 2||0
5151399|NCT01301456|12671005|P3|COMPLETED|Stage 2||0
5151400|NCT01301456|12671006|P2|COMPLETED|Stage 2||0
5151401|NCT01301456|12671007|P1|COMPLETED|Stage 2||0
5151402|NCT01301456|12670996|P12|Received Treatment|Stage 2||6
5151403|NCT01301456|12670997|P11|Received Treatment|Stage 2||7
5151404|NCT01301456|12670998|P10|Received Treatment|Stage 2||7
5151405|NCT01301456|12670999|P9|Received Treatment|Stage 2||5
5151406|NCT01301456|12671000|P8|Received Treatment|Stage 2||7
5151407|NCT01301456|12671001|P7|Received Treatment|Stage 2||0
5151408|NCT01301456|12671002|P6|Received Treatment|Stage 2||0
5151409|NCT01301456|12671003|P5|Received Treatment|Stage 2||0
5151410|NCT01301456|12671004|P4|Received Treatment|Stage 2||0
5151411|NCT01301456|12671005|P3|Received Treatment|Stage 2||0
5151412|NCT01301456|12671006|P2|Received Treatment|Stage 2||0
5151413|NCT01301456|12671007|P1|Received Treatment|Stage 2||0
5151414|NCT01301456|12670996|P12|STARTED|Stage 2||6
5151415|NCT01301456|12670997|P11|STARTED|Stage 2||7
5151416|NCT01301456|12670998|P10|STARTED|Stage 2||7
5151417|NCT01301456|12670999|P9|STARTED|Stage 2||5
5151418|NCT01301456|12671000|P8|STARTED|Stage 2||7
5151419|NCT01301456|12671001|P7|STARTED|Stage 2||0
5151420|NCT01301456|12671002|P6|STARTED|Stage 2||0
5151421|NCT01301456|12671003|P5|STARTED|Stage 2||0
5151422|NCT01301456|12671004|P4|STARTED|Stage 2||0
5151423|NCT01301456|12671005|P3|STARTED|Stage 2||0
5151424|NCT01301456|12671006|P2|STARTED|Stage 2||0
5151425|NCT01301456|12671007|P1|STARTED|Stage 2||0
5151426|NCT01301456|12670996|P12|NOT COMPLETED|Stage 1||0
5151427|NCT01301456|12670997|P11|NOT COMPLETED|Stage 1||0
5151428|NCT01301456|12670998|P10|NOT COMPLETED|Stage 1||0
5151429|NCT01301456|12670999|P9|NOT COMPLETED|Stage 1||0
5151430|NCT01301456|12671000|P8|NOT COMPLETED|Stage 1||0
5151431|NCT01301456|12671001|P7|NOT COMPLETED|Stage 1||1
5151432|NCT01301456|12671002|P6|NOT COMPLETED|Stage 1||0
5151433|NCT01301456|12671003|P5|NOT COMPLETED|Stage 1||1
5151434|NCT01301456|12671004|P4|NOT COMPLETED|Stage 1||0
5151435|NCT01301456|12671005|P3|NOT COMPLETED|Stage 1||1
5151436|NCT01301456|12671006|P2|NOT COMPLETED|Stage 1||0
5151437|NCT01301456|12671007|P1|NOT COMPLETED|Stage 1||0
5151438|NCT01301456|12670996|P12|COMPLETED|Stage 1||0
5151439|NCT01301456|12670997|P11|COMPLETED|Stage 1||0
5151440|NCT01301456|12670998|P10|COMPLETED|Stage 1||0
5151441|NCT01301456|12670999|P9|COMPLETED|Stage 1||0
5151442|NCT01301456|12671000|P8|COMPLETED|Stage 1||0
5151443|NCT01301456|12671001|P7|COMPLETED|Stage 1||7
5151444|NCT01301456|12671002|P6|COMPLETED|Stage 1||5
5151445|NCT01301456|12671003|P5|COMPLETED|Stage 1||6
5151446|NCT01301456|12671004|P4|COMPLETED|Stage 1||6
5151447|NCT01301456|12671005|P3|COMPLETED|Stage 1||5
5151448|NCT01301456|12671006|P2|COMPLETED|Stage 1||5
5151449|NCT01301456|12671007|P1|COMPLETED|Stage 1||15
5151450|NCT01301456|12670996|P12|Received Treatment|Stage 1||0
5151451|NCT01301456|12670997|P11|Received Treatment|Stage 1||0
5151452|NCT01301456|12670998|P10|Received Treatment|Stage 1||0
5151453|NCT01301456|12670999|P9|Received Treatment|Stage 1||0
5151454|NCT01301456|12671000|P8|Received Treatment|Stage 1||0
5151455|NCT01301456|12671001|P7|Received Treatment|Stage 1||7
5151456|NCT01301456|12671002|P6|Received Treatment|Stage 1||5
5151457|NCT01301456|12671003|P5|Received Treatment|Stage 1||7
5151458|NCT01301456|12671004|P4|Received Treatment|Stage 1||6
5151459|NCT01301456|12671005|P3|Received Treatment|Stage 1||6
5151460|NCT01301456|12671006|P2|Received Treatment|Stage 1||5
5151461|NCT01301456|12671007|P1|Received Treatment|Stage 1||15
5151462|NCT01301456|12670996|P12|STARTED|Stage 1||0
5151463|NCT01301456|12670997|P11|STARTED|Stage 1||0
5151464|NCT01301456|12670998|P10|STARTED|Stage 1||0
5151465|NCT01301456|12670999|P9|STARTED|Stage 1||0
5151466|NCT01301456|12671000|P8|STARTED|Stage 1||0
5151467|NCT01301456|12671001|P7|STARTED|Stage 1||8
5151468|NCT01301456|12671002|P6|STARTED|Stage 1||5
5151469|NCT01301456|12671003|P5|STARTED|Stage 1||7
5151470|NCT01301456|12671004|P4|STARTED|Stage 1||6
5151471|NCT01301456|12671005|P3|STARTED|Stage 1||6
5151472|NCT01301456|12671006|P2|STARTED|Stage 1||5
5151473|NCT01301456|12671007|P1|STARTED|Stage 1||15
5151474|NCT01301391|12671233|P1|NOT COMPLETED|Overall Study||26
5151475|NCT01301391|12671233|P1|COMPLETED|Overall Study||4
5151476|NCT01301391|12671233|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
5151477|NCT01301274|12671245|P2|NOT COMPLETED|Overall Study||1
5151478|NCT01301274|12671246|P1|NOT COMPLETED|Overall Study||2
5151479|NCT01301274|12671245|P2|COMPLETED|Overall Study||31
5151480|NCT01301274|12671246|P1|COMPLETED|Overall Study||32
5151481|NCT01301274|12671245|P2|STARTED|Overall Study||32
5151482|NCT01301274|12671246|P1|STARTED|Overall Study||34
5151483|NCT01301092|12671261|P3|NOT COMPLETED|Overall Study||1
5151484|NCT01301092|12671262|P2|NOT COMPLETED|Overall Study||0
5151485|NCT01301092|12671263|P1|NOT COMPLETED|Overall Study||0
5151486|NCT01301092|12671261|P3|COMPLETED|Overall Study||7
5151487|NCT01301092|12671262|P2|COMPLETED|Overall Study||16
5151488|NCT01301092|12671263|P1|COMPLETED|Overall Study||6
5151489|NCT01301092|12671261|P3|STARTED|Overall Study||8
5151490|NCT01301092|12671262|P2|STARTED|Overall Study||16
5151491|NCT01301092|12671263|P1|STARTED|Overall Study||6
5151492|NCT01301079|12671280|P2|NOT COMPLETED|Overall Study||2
5151493|NCT01301079|12671281|P1|NOT COMPLETED|Overall Study||2
5151494|NCT01301079|12671280|P2|COMPLETED|Overall Study||28
5151495|NCT01301079|12671281|P1|COMPLETED|Overall Study||28
5151496|NCT01301079|12671280|P2|STARTED|Overall Study||30
5151497|NCT01301079|12671281|P1|STARTED|Overall Study||30
5151498|NCT01301066|12671359|P2|NOT COMPLETED|Overall Study||35
5151499|NCT01301066|12671360|P1|NOT COMPLETED|Overall Study||27
5151500|NCT01301066|12671359|P2|COMPLETED|Overall Study||91
5151501|NCT01301066|12671360|P1|COMPLETED|Overall Study||99
5151502|NCT01301066|12671359|P2|STARTED|Overall Study||126
5151503|NCT01301066|12671360|P1|STARTED|Overall Study||126
5151504|NCT01301027|12671368|P2|NOT COMPLETED|Overall Study||10
5151505|NCT01301027|12671369|P1|NOT COMPLETED|Overall Study||8
5151506|NCT01301027|12671368|P2|COMPLETED|Overall Study||37
5151507|NCT01301027|12671369|P1|COMPLETED|Overall Study||40
5151508|NCT01301027|12671368|P2|STARTED|Overall Study||47
5151509|NCT01301027|12671369|P1|STARTED|Overall Study||48
5151510|NCT01301001|12671381|P2|NOT COMPLETED|Second Intervention||0
5151511|NCT01301001|12671382|P1|NOT COMPLETED|Second Intervention||4
5151512|NCT01301001|12671381|P2|COMPLETED|Second Intervention||36
5151513|NCT01301001|12671382|P1|COMPLETED|Second Intervention||30
5151514|NCT01301001|12671381|P2|STARTED|Second Intervention||36
5151515|NCT01301001|12671382|P1|STARTED|Second Intervention||34
5151516|NCT01301001|12671381|P2|NOT COMPLETED|Washout (2 Weeks)||0
5151517|NCT01301001|12671382|P1|NOT COMPLETED|Washout (2 Weeks)||0
5151518|NCT01301001|12671381|P2|COMPLETED|Washout (2 Weeks)||36
5151519|NCT01301001|12671382|P1|COMPLETED|Washout (2 Weeks)||34
5151520|NCT01301001|12671381|P2|STARTED|Washout (2 Weeks)||36
5151521|NCT01301001|12671382|P1|STARTED|Washout (2 Weeks)||34
5151522|NCT01301001|12671381|P2|NOT COMPLETED|First Intervention||9
5151523|NCT01301001|12671382|P1|NOT COMPLETED|First Intervention||10
5151524|NCT01301001|12671381|P2|COMPLETED|First Intervention||36
5151525|NCT01301001|12671382|P1|COMPLETED|First Intervention||34
5151526|NCT01301001|12671381|P2|STARTED|First Intervention||45
5151527|NCT01301001|12671382|P1|STARTED|First Intervention||44
5151528|NCT01300949|12671395|P3|NOT COMPLETED|Overall Study||0
5151529|NCT01300949|12671396|P2|NOT COMPLETED|Overall Study||0
5151530|NCT01300949|12671397|P1|NOT COMPLETED|Overall Study||0
5151531|NCT01300949|12671395|P3|COMPLETED|Overall Study||35
5151532|NCT01300949|12671396|P2|COMPLETED|Overall Study||125
5151533|NCT01300949|12671397|P1|COMPLETED|Overall Study||154
5151534|NCT01300949|12671395|P3|STARTED|Overall Study||35
5151535|NCT01300949|12671396|P2|STARTED|Overall Study||125
5151536|NCT01300949|12671397|P1|STARTED|Overall Study||154
5151537|NCT01300923|12671405|P2|NOT COMPLETED|Overall Study||2
5151538|NCT01300923|12671406|P1|NOT COMPLETED|Overall Study||0
5151539|NCT01300923|12671405|P2|COMPLETED|Overall Study||0
5151540|NCT01300923|12671406|P1|COMPLETED|Overall Study||12
5151541|NCT01300923|12671405|P2|STARTED|Overall Study||2
5151542|NCT01300923|12671406|P1|STARTED|Overall Study||12
5151543|NCT01300819|12671419|P2|NOT COMPLETED|Overall Study||44
5151544|NCT01300819|12671420|P1|NOT COMPLETED|Overall Study||22
5151545|NCT01300819|12671419|P2|COMPLETED|Overall Study||180
5151546|NCT01300819|12671420|P1|COMPLETED|Overall Study||103
5151547|NCT01300819|12671419|P2|STARTED|Overall Study||224
5151548|NCT01300819|12671420|P1|STARTED|Overall Study||125
5151549|NCT01300767|12671448|P1|NOT COMPLETED|Overall Study||4
5151550|NCT01300767|12671448|P1|COMPLETED|Overall Study||70
5151551|NCT01300767|12671448|P1|STARTED|Overall Study||74
5151552|NCT01300741|12671476|P1|NOT COMPLETED|Overall Study||3
5151553|NCT01300741|12671476|P1|COMPLETED|Overall Study||72
5151554|NCT01300741|12671476|P1|STARTED|Overall Study||75
5151555|NCT01300728|12671506|P2|NOT COMPLETED|Overall Study||1
5151556|NCT01300728|12671507|P1|NOT COMPLETED|Overall Study||2
5151557|NCT01300728|12671506|P2|COMPLETED|Overall Study||25
5151558|NCT01300728|12671507|P1|COMPLETED|Overall Study||24
5151559|NCT01300728|12671506|P2|STARTED|Overall Study||26
5151560|NCT01300728|12671507|P1|STARTED|Overall Study||26
5151561|NCT01300650|12671521|P1|NOT COMPLETED|Overall Study||1
5151562|NCT01300650|12671521|P1|COMPLETED|Overall Study||7
5151563|NCT01300650|12671521|P1|STARTED|Overall Study||8
5151564|NCT01300624|12671527|P1|NOT COMPLETED|Overall Study||0
5151565|NCT01300624|12671527|P1|COMPLETED|Overall Study||11
5151566|NCT01300624|12671527|P1|STARTED|Overall Study||11
5151567|NCT01300572|12671537|P1|NOT COMPLETED|Overall Study||1
5151568|NCT01300572|12671537|P1|COMPLETED|Overall Study||15
5151569|NCT01300572|12671537|P1|STARTED|Overall Study||16
5151570|NCT01300559|12671552|P2|NOT COMPLETED|Overall Study||0
5151571|NCT01300559|12671553|P1|NOT COMPLETED|Overall Study||0
5151572|NCT01300559|12671552|P2|COMPLETED|Overall Study||30
5151573|NCT01300559|12671553|P1|COMPLETED|Overall Study||30
5151574|NCT01300559|12671552|P2|STARTED|Overall Study||30
5151575|NCT01300559|12671553|P1|STARTED|Overall Study||30
5151576|NCT01300546|12671561|P2|NOT COMPLETED|Overall Study||6
5151577|NCT01300546|12671562|P1|NOT COMPLETED|Overall Study||1
5151578|NCT01300546|12671561|P2|COMPLETED|Overall Study||14
5151579|NCT01300546|12671562|P1|COMPLETED|Overall Study||18
5151580|NCT01300546|12671561|P2|STARTED|Overall Study||20
5151581|NCT01300546|12671562|P1|STARTED|Overall Study||19
5151582|NCT01300455|12671592|P2|NOT COMPLETED|Period 2||0
5151583|NCT01300455|12671593|P1|NOT COMPLETED|Period 2||0
5151584|NCT01300455|12671592|P2|COMPLETED|Period 2||13
5151585|NCT01300455|12671593|P1|COMPLETED|Period 2||12
5151586|NCT01300455|12671592|P2|STARTED|Period 2||13
5151587|NCT01300455|12671593|P1|STARTED|Period 2||12
5151588|NCT01300455|12671592|P2|NOT COMPLETED|Washout||0
5151589|NCT01300455|12671593|P1|NOT COMPLETED|Washout||1
5151590|NCT01300455|12671592|P2|COMPLETED|Washout||13
5151591|NCT01300455|12671593|P1|COMPLETED|Washout||12
5151592|NCT01300455|12671592|P2|STARTED|Washout||13
5151593|NCT01300455|12671593|P1|STARTED|Washout||13
5151594|NCT01300455|12671592|P2|NOT COMPLETED|Period 1||0
5151595|NCT01300455|12671593|P1|NOT COMPLETED|Period 1||0
5151596|NCT01300455|12671592|P2|COMPLETED|Period 1||13
5151597|NCT01300455|12671593|P1|COMPLETED|Period 1||13
5151598|NCT01300455|12671592|P2|STARTED|Period 1||13
5151599|NCT01300455|12671593|P1|STARTED|Period 1||13
5151600|NCT01300351|12671613|P2|NOT COMPLETED|Overall Study||38
5151601|NCT01300351|12671614|P1|NOT COMPLETED|Overall Study||36
5151602|NCT01300351|12671613|P2|COMPLETED|Overall Study||72
5151603|NCT01300351|12671614|P1|COMPLETED|Overall Study||75
5151604|NCT01300351|12671613|P2|Received Study Treatment|Overall Study||110
5151605|NCT01300351|12671614|P1|Received Study Treatment|Overall Study||109
5151606|NCT01300351|12671613|P2|STARTED|Overall Study||110
5151607|NCT01300351|12671614|P1|STARTED|Overall Study||111
5151608|NCT01300338|12671630|P2|NOT COMPLETED|Overall Study||0
5151609|NCT01300338|12671631|P1|NOT COMPLETED|Overall Study||5
5151610|NCT01300338|12671630|P2|COMPLETED|Overall Study||25
5151611|NCT01300338|12671631|P1|COMPLETED|Overall Study||20
5151612|NCT01300338|12671630|P2|STARTED|Overall Study||25
5151613|NCT01300338|12671631|P1|STARTED|Overall Study||25
5151614|NCT01300286|12671639|P1|NOT COMPLETED|Overall Study||1
5151615|NCT01300286|12671639|P1|COMPLETED|Overall Study||22
5151616|NCT01300286|12671639|P1|STARTED|Overall Study||23
5151617|NCT01300260|12671649|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
5151618|NCT01300260|12671650|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
5151619|NCT01300260|12671649|P2|COMPLETED|Period 2 of Study: Second Intervention||15
5151620|NCT01300260|12671650|P1|COMPLETED|Period 2 of Study: Second Intervention||14
5151621|NCT01300260|12671649|P2|STARTED|Period 2 of Study: Second Intervention||16
5151622|NCT01300260|12671650|P1|STARTED|Period 2 of Study: Second Intervention||14
5151623|NCT01300260|12671649|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
5151624|NCT01300260|12671650|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
5151625|NCT01300260|12671649|P2|COMPLETED|Washout Period of at Least 28 Days||16
5151626|NCT01300260|12671650|P1|COMPLETED|Washout Period of at Least 28 Days||14
5151627|NCT01300260|12671649|P2|STARTED|Washout Period of at Least 28 Days||16
5151628|NCT01300260|12671650|P1|STARTED|Washout Period of at Least 28 Days||14
5151629|NCT01300260|12671649|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
5151630|NCT01300260|12671650|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
5151631|NCT01300260|12671649|P2|COMPLETED|Period 1 of Study: First Intervention||16
5151632|NCT01300260|12671650|P1|COMPLETED|Period 1 of Study: First Intervention||14
5151633|NCT01300260|12671649|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
5151634|NCT01300260|12671650|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
5151635|NCT01300260|12671649|P2|STARTED|Period 1 of Study: First Intervention||17
5151636|NCT01300260|12671650|P1|STARTED|Period 1 of Study: First Intervention||15
5151637|NCT01300247|12671682|P2|NOT COMPLETED|Overall Study||2
5151638|NCT01300247|12671683|P1|NOT COMPLETED|Overall Study||4
5151639|NCT01300247|12671682|P2|COMPLETED|Overall Study||18
5151640|NCT01300247|12671683|P1|COMPLETED|Overall Study||17
5151641|NCT01300247|12671682|P2|STARTED|Overall Study||20
5151642|NCT01300247|12671683|P1|STARTED|Overall Study||21
5151643|NCT01300234|12671715|P2|NOT COMPLETED|Overall Study||27
5151644|NCT01300234|12671716|P1|NOT COMPLETED|Overall Study||28
5151645|NCT01300234|12671715|P2|COMPLETED|Overall Study||228
5151646|NCT01300234|12671716|P1|COMPLETED|Overall Study||229
5151647|NCT01300234|12671715|P2|STARTED|Overall Study||255
5151648|NCT01300234|12671716|P1|STARTED|Overall Study||257
5151649|NCT01300052|12671752|P2|NOT COMPLETED|Overall Study||3
5151650|NCT01300052|12671753|P1|NOT COMPLETED|Overall Study||6
5151651|NCT01300052|12671752|P2|COMPLETED|Overall Study||19
5151652|NCT01300052|12671753|P1|COMPLETED|Overall Study||40
5151653|NCT01300052|12671752|P2|STARTED|Overall Study||22
5151654|NCT01300052|12671753|P1|STARTED|Overall Study||46
5151655|NCT01299961|12671771|P1|NOT COMPLETED|Overall Study||6
5151656|NCT01299961|12671771|P1|COMPLETED|Overall Study||19
5151657|NCT01299961|12671771|P1|STARTED|Overall Study||25
5151658|NCT01299909|12671780|P3|NOT COMPLETED|Overall Study||17
5151659|NCT01299909|12671781|P2|NOT COMPLETED|Overall Study||18
5151660|NCT01299909|12671782|P1|NOT COMPLETED|Overall Study||22
5151661|NCT01299909|12671780|P3|COMPLETED|Overall Study||23
5151662|NCT01299909|12671781|P2|COMPLETED|Overall Study||49
5151663|NCT01299909|12671782|P1|COMPLETED|Overall Study||46
5151664|NCT01299909|12671780|P3|STARTED|Overall Study||40
5151665|NCT01299909|12671781|P2|STARTED|Overall Study||67
5151666|NCT01299909|12671782|P1|STARTED|Overall Study||68
5151667|NCT01299896|12671797|P2|NOT COMPLETED|Overall Study||18
5151668|NCT01299896|12671798|P1|NOT COMPLETED|Overall Study||1
5151669|NCT01299896|12671797|P2|COMPLETED|Overall Study||296
5151670|NCT01299896|12671798|P1|COMPLETED|Overall Study||318
5151671|NCT01299896|12671797|P2|STARTED|Overall Study||314
5151672|NCT01299896|12671798|P1|STARTED|Overall Study||319
5151673|NCT01299805|12671806|P2|NOT COMPLETED|Overall Study||0
5151674|NCT01299805|12671807|P1|NOT COMPLETED|Overall Study||2
5151675|NCT01299805|12671806|P2|COMPLETED|Overall Study||5
5151676|NCT01299805|12671807|P1|COMPLETED|Overall Study||10
5151677|NCT01299805|12671806|P2|STARTED|Overall Study||5
5151678|NCT01299805|12671807|P1|STARTED|Overall Study||12
5151679|NCT01299766|12671837|P2|NOT COMPLETED|Overall Study||23
5151680|NCT01299766|12671838|P1|NOT COMPLETED|Overall Study||34
5151681|NCT01299766|12671837|P2|COMPLETED|Overall Study||87
5151682|NCT01299766|12671838|P1|COMPLETED|Overall Study||77
5151683|NCT01299766|12671837|P2|STARTED|Overall Study||110
5151684|NCT01299766|12671838|P1|STARTED|Overall Study||111
5151685|NCT01299727|12671849|P3|NOT COMPLETED|Overall Study||4
5151686|NCT01299727|12671850|P2|NOT COMPLETED|Overall Study||4
5151687|NCT01299727|12671851|P1|NOT COMPLETED|Overall Study||4
5151688|NCT01299727|12671849|P3|COMPLETED|Overall Study||0
5151689|NCT01299727|12671850|P2|COMPLETED|Overall Study||0
5151690|NCT01299727|12671851|P1|COMPLETED|Overall Study||0
5151691|NCT01299727|12671849|P3|STARTED|Overall Study||4
5151692|NCT01299727|12671850|P2|STARTED|Overall Study||4
5151693|NCT01299727|12671851|P1|STARTED|Overall Study||4
5151694|NCT01299610|12671898|P3|NOT COMPLETED|Overall Study||0
5151695|NCT01299610|12671899|P2|NOT COMPLETED|Overall Study||0
5151696|NCT01299610|12671900|P1|NOT COMPLETED|Overall Study||0
5151697|NCT01299610|12671898|P3|COMPLETED|Overall Study||10
5151698|NCT01299610|12671899|P2|COMPLETED|Overall Study||5
5151699|NCT01299610|12671900|P1|COMPLETED|Overall Study||10
5151700|NCT01299610|12671898|P3|STARTED|Overall Study||10
5151701|NCT01299610|12671899|P2|STARTED|Overall Study||5
5151702|NCT01299610|12671900|P1|STARTED|Overall Study||10
5151703|NCT01299584|12671945|P1|NOT COMPLETED|Overall Study||9
5151704|NCT01299584|12671945|P1|COMPLETED|Overall Study||766
5151705|NCT01299584|12671945|P1|STARTED|Overall Study||775
5151706|NCT01299571|12671952|P1|NOT COMPLETED|Overall Study||107
5151707|NCT01299571|12671952|P1|COMPLETED|Overall Study||3870
5151708|NCT01299571|12671952|P1|STARTED|Overall Study||3977
5151709|NCT01299480|12671963|P5|NOT COMPLETED|Overall Study||20
5151710|NCT01299480|12671964|P4|NOT COMPLETED|Overall Study||25
5151711|NCT01299480|12671965|P3|NOT COMPLETED|Overall Study||41
5151712|NCT01299480|12671966|P2|NOT COMPLETED|Overall Study||35
5151713|NCT01299480|12671967|P1|NOT COMPLETED|Overall Study||42
5151714|NCT01299480|12671963|P5|COMPLETED|Overall Study||123
5151715|NCT01299480|12671964|P4|COMPLETED|Overall Study||261
5151716|NCT01299480|12671965|P3|COMPLETED|Overall Study||386
5151717|NCT01299480|12671966|P2|COMPLETED|Overall Study||395
5151718|NCT01299480|12671967|P1|COMPLETED|Overall Study||385
5151719|NCT01299480|12671963|P5|STARTED|Overall Study||143
5151720|NCT01299480|12671964|P4|STARTED|Overall Study||286
5151721|NCT01299480|12671965|P3|STARTED|Overall Study||427
5151722|NCT01299480|12671966|P2|STARTED|Overall Study||430
5151723|NCT01299480|12671967|P1|STARTED|Overall Study||427
5151724|NCT01299454|12672006|P4|NOT COMPLETED|Overall Study||0
5151725|NCT01299454|12672007|P3|NOT COMPLETED|Overall Study||0
5151726|NCT01299454|12672008|P2|NOT COMPLETED|Overall Study||0
5151727|NCT01299454|12672009|P1|NOT COMPLETED|Overall Study||0
5151728|NCT01299454|12672006|P4|COMPLETED|Overall Study||23
5151729|NCT01299454|12672007|P3|COMPLETED|Overall Study||6
5151730|NCT01299454|12672008|P2|COMPLETED|Overall Study||8
5151731|NCT01299454|12672009|P1|COMPLETED|Overall Study||8
5151732|NCT01299454|12672006|P4|STARTED|Overall Study||23
5151733|NCT01299454|12672007|P3|STARTED|Overall Study||6
5151734|NCT01299454|12672008|P2|STARTED|Overall Study||8
5151735|NCT01299454|12672009|P1|STARTED|Overall Study||8
5151736|NCT01299389|12672169|P4|NOT COMPLETED|Post-observational||6
5151737|NCT01299389|12672170|P3|NOT COMPLETED|Post-observational||12
5151738|NCT01299389|12672171|P2|NOT COMPLETED|Post-observational||0
5151739|NCT01299389|12672172|P1|NOT COMPLETED|Post-observational||0
5151740|NCT01299389|12672169|P4|COMPLETED|Post-observational||149
5151741|NCT01299389|12672170|P3|COMPLETED|Post-observational||144
5151742|NCT01299389|12672171|P2|COMPLETED|Post-observational||0
5151743|NCT01299389|12672172|P1|COMPLETED|Post-observational||0
5151744|NCT01299389|12672169|P4|STARTED|Post-observational||155
5151745|NCT01299389|12672170|P3|STARTED|Post-observational||156
5151746|NCT01299389|12672171|P2|STARTED|Post-observational||0
5151747|NCT01299389|12672172|P1|STARTED|Post-observational||0
5151748|NCT01299389|12672169|P4|NOT COMPLETED|Double-blind||0
5151749|NCT01299389|12672170|P3|NOT COMPLETED|Double-blind||0
5151750|NCT01299389|12672171|P2|NOT COMPLETED|Double-blind||64
5151751|NCT01299389|12672172|P1|NOT COMPLETED|Double-blind||109
5151752|NCT01299389|12672169|P4|COMPLETED|Double-blind||0
5151753|NCT01299389|12672170|P3|COMPLETED|Double-blind||0
5151754|NCT01299389|12672171|P2|COMPLETED|Double-blind||95
5151755|NCT01299389|12672172|P1|COMPLETED|Double-blind||55
5151756|NCT01299389|12672169|P4|STARTED|Double-blind||0
5151757|NCT01299389|12672170|P3|STARTED|Double-blind||0
5151758|NCT01299389|12672171|P2|STARTED|Double-blind||159
5151759|NCT01299389|12672172|P1|STARTED|Double-blind||164
5151760|NCT01299376|12672194|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
5151761|NCT01299376|12672195|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
5151762|NCT01299376|12672194|P2|COMPLETED|Extension (Weeks 9 to 52)||118
5151763|NCT01299376|12672195|P1|COMPLETED|Extension (Weeks 9 to 52)||124
5151764|NCT01299376|12672194|P2|STARTED|Extension (Weeks 9 to 52)||133
5151765|NCT01299376|12672195|P1|STARTED|Extension (Weeks 9 to 52)||134
5151766|NCT01299376|12672194|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
5151767|NCT01299376|12672195|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
5151768|NCT01299376|12672194|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
5151769|NCT01299376|12672195|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
5151770|NCT01299376|12672194|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
5151771|NCT01299376|12672195|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
5151772|NCT01299285|12672225|P1|NOT COMPLETED|Overall Study||0
5151773|NCT01299285|12672225|P1|COMPLETED|Overall Study||6
5151774|NCT01299285|12672225|P1|STARTED|Overall Study||6
5151775|NCT01299272|12672238|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
5151776|NCT01299272|12672239|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
5151777|NCT01299272|12672240|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
5151778|NCT01299272|12672241|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
5151779|NCT01299272|12672238|P4|COMPLETED|Double-blind (DB) Randomized Period||234
5151780|NCT01299272|12672239|P3|COMPLETED|Double-blind (DB) Randomized Period||224
5151781|NCT01299272|12672240|P2|COMPLETED|Double-blind (DB) Randomized Period||0
5151782|NCT01299272|12672241|P1|COMPLETED|Double-blind (DB) Randomized Period||0
5151783|NCT01299272|12672238|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
5151784|NCT01299272|12672239|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
5151785|NCT01299272|12672240|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
5151786|NCT01299272|12672241|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
5151787|NCT01299272|12672238|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
5151788|NCT01299272|12672239|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
5151789|NCT01299272|12672240|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
5151790|NCT01299272|12672241|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
5151791|NCT01299272|12672238|P4|STARTED|Double-blind (DB) Randomized Period||292
5151792|NCT01299272|12672239|P3|STARTED|Double-blind (DB) Randomized Period||294
5151793|NCT01299272|12672240|P2|STARTED|Double-blind (DB) Randomized Period||0
5151794|NCT01299272|12672241|P1|STARTED|Double-blind (DB) Randomized Period||0
5151795|NCT01299272|12672238|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
5151796|NCT01299272|12672239|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
5151797|NCT01299272|12672240|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
5151798|NCT01299272|12672241|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
5151799|NCT01299272|12672238|P4|COMPLETED|Stabilization Open-label (OL) Period||0
5151800|NCT01299272|12672239|P3|COMPLETED|Stabilization Open-label (OL) Period||0
5151801|NCT01299272|12672240|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
5151802|NCT01299272|12672241|P1|COMPLETED|Stabilization Open-label (OL) Period||0
5151803|NCT01299272|12672238|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
5151804|NCT01299272|12672239|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
5151805|NCT01299272|12672240|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
5151806|NCT01299272|12672241|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
5151807|NCT01299272|12672238|P4|STARTED|Stabilization Open-label (OL) Period||0
5151808|NCT01299272|12672239|P3|STARTED|Stabilization Open-label (OL) Period||0
5151809|NCT01299272|12672240|P2|STARTED|Stabilization Open-label (OL) Period||835
5151810|NCT01299272|12672241|P1|STARTED|Stabilization Open-label (OL) Period||0
5151811|NCT01299272|12672238|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
5151812|NCT01299272|12672239|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
5151813|NCT01299272|12672240|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
5151814|NCT01299272|12672241|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
5151815|NCT01299272|12672238|P4|COMPLETED|Acute Open-label (OL) Period||0
5151816|NCT01299272|12672239|P3|COMPLETED|Acute Open-label (OL) Period||0
5151817|NCT01299272|12672240|P2|COMPLETED|Acute Open-label (OL) Period||0
5151818|NCT01299272|12672241|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
5151819|NCT01299272|12672238|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
5151820|NCT01299272|12672239|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
5151821|NCT01299272|12672240|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
5151822|NCT01299272|12672241|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
5151823|NCT01299272|12672238|P4|STARTED|Acute Open-label (OL) Period||0
5151824|NCT01299272|12672239|P3|STARTED|Acute Open-label (OL) Period||0
5151825|NCT01299272|12672240|P2|STARTED|Acute Open-label (OL) Period||0
5151826|NCT01299272|12672241|P1|STARTED|Acute Open-label (OL) Period||1249
5151827|NCT01299116|12672296|P3|NOT COMPLETED|Overall Study||11
5151828|NCT01299116|12672297|P2|NOT COMPLETED|Overall Study||9
5151829|NCT01299116|12672298|P1|NOT COMPLETED|Overall Study||65
5151830|NCT01299116|12672296|P3|COMPLETED|Overall Study||184
5151831|NCT01299116|12672297|P2|COMPLETED|Overall Study||168
5151832|NCT01299116|12672298|P1|COMPLETED|Overall Study||457
5151833|NCT01299116|12672296|P3|STARTED|Overall Study||195
5151834|NCT01299116|12672297|P2|STARTED|Overall Study||177
5151835|NCT01299116|12672298|P1|STARTED|Overall Study||522
5151836|NCT01299103|12672315|P3|NOT COMPLETED|Overall Study||2
5151837|NCT01299103|12672316|P2|NOT COMPLETED|Overall Study||2
5151838|NCT01299103|12672317|P1|NOT COMPLETED|Overall Study||0
5151839|NCT01299103|12672315|P3|COMPLETED|Overall Study||8
5151840|NCT01299103|12672316|P2|COMPLETED|Overall Study||13
5151841|NCT01299103|12672317|P1|COMPLETED|Overall Study||15
5151842|NCT01299103|12672315|P3|STARTED|Overall Study||10
5151843|NCT01299103|12672316|P2|STARTED|Overall Study||15
5151844|NCT01299103|12672317|P1|STARTED|Overall Study||15
5151845|NCT01299090|12672328|P1|NOT COMPLETED|Overall Study||0
5151846|NCT01299090|12672328|P1|COMPLETED|Overall Study||49
5151847|NCT01299090|12672328|P1|STARTED|Overall Study||49
5151848|NCT01299077|12672333|P1|NOT COMPLETED|Overall Study||0
5151849|NCT01299077|12672333|P1|COMPLETED|Overall Study||478
5151850|NCT01299077|12672333|P1|STARTED|Overall Study||478
5151851|NCT01299038|12672343|P2|NOT COMPLETED|Overall Study||0
5151852|NCT01299038|12672344|P1|NOT COMPLETED|Overall Study||1
5151853|NCT01299038|12672343|P2|COMPLETED|Overall Study|Evaluable|10
5151854|NCT01299038|12672344|P1|COMPLETED|Overall Study|Evaluable|9
5151855|NCT01299038|12672343|P2|STARTED|Overall Study|Consented|10
5151856|NCT01299038|12672344|P1|STARTED|Overall Study|Consented|10
5151857|NCT01299025|12672352|P2|NOT COMPLETED|Overall Study||1
5151858|NCT01299025|12672353|P1|NOT COMPLETED|Overall Study||3
5151859|NCT01299025|12672352|P2|COMPLETED|Overall Study||41
5151860|NCT01299025|12672353|P1|COMPLETED|Overall Study||39
5151861|NCT01299025|12672352|P2|STARTED|Overall Study||42
5151862|NCT01299025|12672353|P1|STARTED|Overall Study||42
5151863|NCT01298921|12672367|P2|NOT COMPLETED|Overall Study||0
5151864|NCT01298921|12672368|P1|NOT COMPLETED|Overall Study||0
5151865|NCT01298921|12672367|P2|COMPLETED|Overall Study||0
5151866|NCT01298921|12672368|P1|COMPLETED|Overall Study||0
5151867|NCT01298921|12672367|P2|STARTED|Overall Study||0
5151868|NCT01298921|12672368|P1|STARTED|Overall Study||0
5151869|NCT01298778|12672378|P2|NOT COMPLETED|Overall Study||6
5151870|NCT01298778|12672379|P1|NOT COMPLETED|Overall Study||3
5151871|NCT01298778|12672378|P2|COMPLETED|Overall Study||30
5151872|NCT01298778|12672379|P1|COMPLETED|Overall Study||30
5151873|NCT01298778|12672378|P2|STARTED|Overall Study||36
5151874|NCT01298778|12672379|P1|STARTED|Overall Study||33
5151875|NCT01298765|12672399|P1|NOT COMPLETED|Long-Term Treatment Period||99
5151876|NCT01298765|12672399|P1|COMPLETED|Long-Term Treatment Period||127
5151877|NCT01298765|12672399|P1|STARTED|Long-Term Treatment Period||226
5151878|NCT01298765|12672399|P1|NOT COMPLETED|Titration Period||76
5151879|NCT01298765|12672399|P1|COMPLETED|Titration Period||226
5151880|NCT01298765|12672399|P1|STARTED|Titration Period||302
5151881|NCT01298700|12672409|P2|NOT COMPLETED|Overall Study||100
5151882|NCT01298700|12672410|P1|NOT COMPLETED|Overall Study||101
5151883|NCT01298700|12672409|P2|COMPLETED|Overall Study||303
5151884|NCT01298700|12672410|P1|COMPLETED|Overall Study||302
5151885|NCT01298700|12672409|P2|Safety Population: Received Study Drug|Overall Study||398
5151886|NCT01298700|12672410|P1|Safety Population: Received Study Drug|Overall Study||400
5151887|NCT01298700|12672409|P2|STARTED|Overall Study||403
5151888|NCT01298700|12672410|P1|STARTED|Overall Study||403
5151889|NCT01298661|12672421|P3|NOT COMPLETED|Overall Study||2
5151890|NCT01298661|12672422|P2|NOT COMPLETED|Overall Study||0
5151891|NCT01298661|12672423|P1|NOT COMPLETED|Overall Study||2
5151892|NCT01298661|12672421|P3|COMPLETED|Overall Study||32
5151893|NCT01298661|12672422|P2|COMPLETED|Overall Study||24
5151894|NCT01298661|12672423|P1|COMPLETED|Overall Study||31
5151895|NCT01298661|12672421|P3|STARTED|Overall Study||34
5151896|NCT01298661|12672422|P2|STARTED|Overall Study||24
5151897|NCT01298661|12672423|P1|STARTED|Overall Study||33
5151898|NCT01298648|12672501|P1|NOT COMPLETED|Overall Study||23
5151899|NCT01298648|12672501|P1|COMPLETED|Overall Study||1693
5151900|NCT01298648|12672501|P1|STARTED|Overall Study||1716
5151901|NCT01298596|12672512|P2|NOT COMPLETED|Overall Study||33
5151902|NCT01298596|12672513|P1|NOT COMPLETED|Overall Study||28
5151903|NCT01298596|12672512|P2|COMPLETED|Overall Study||167
5151904|NCT01298596|12672513|P1|COMPLETED|Overall Study||172
5151905|NCT01298596|12672512|P2|STARTED|Overall Study||200
5151906|NCT01298596|12672513|P1|STARTED|Overall Study||200
5151907|NCT01298570|12672523|P2|NOT COMPLETED|Overall Study||61
5151908|NCT01298570|12672524|P1|NOT COMPLETED|Overall Study||120
5151909|NCT01298570|12672523|P2|COMPLETED|Overall Study||0
5151910|NCT01298570|12672524|P1|COMPLETED|Overall Study||0
5151911|NCT01298570|12672523|P2|STARTED|Overall Study||61
5151912|NCT01298570|12672524|P1|STARTED|Overall Study||120
5151913|NCT01298544|12672540|P1|NOT COMPLETED|Overall Study||0
5151914|NCT01298544|12672540|P1|COMPLETED|Overall Study||335
5151915|NCT01298544|12672540|P1|STARTED|Overall Study||335
5151916|NCT01298531|12672551|P2|NOT COMPLETED|Overall Study||7
5151917|NCT01298531|12672552|P1|NOT COMPLETED|Overall Study||9
5151918|NCT01298531|12672551|P2|COMPLETED|Overall Study||41
5151919|NCT01298531|12672552|P1|COMPLETED|Overall Study||33
5151920|NCT01298531|12672551|P2|STARTED|Overall Study||48
5151921|NCT01298531|12672552|P1|STARTED|Overall Study||42
5151922|NCT01298518|12672681|P3|NOT COMPLETED|Overall Study||1
5151923|NCT01298518|12672682|P2|NOT COMPLETED|Overall Study||0
5151924|NCT01298518|12672683|P1|NOT COMPLETED|Overall Study||0
5151925|NCT01298518|12672681|P3|COMPLETED|Overall Study||15
5151926|NCT01298518|12672682|P2|COMPLETED|Overall Study||16
5151927|NCT01298518|12672683|P1|COMPLETED|Overall Study||16
5151928|NCT01298518|12672681|P3|STARTED|Overall Study||16
5151929|NCT01298518|12672682|P2|STARTED|Overall Study||16
5151930|NCT01298518|12672683|P1|STARTED|Overall Study||16
5151931|NCT01298492|12672735|P1|NOT COMPLETED|Overall Study||119
5151932|NCT01298492|12672735|P1|COMPLETED|Overall Study||149
5151933|NCT01298492|12672735|P1|STARTED|Overall Study||268
5151934|NCT01298362|12672743|P2|NOT COMPLETED|Overall Study||43
5151935|NCT01298362|12672744|P1|NOT COMPLETED|Overall Study||38
5151936|NCT01298362|12672743|P2|COMPLETED|Overall Study||123
5151937|NCT01298362|12672744|P1|COMPLETED|Overall Study||86
5151938|NCT01298362|12672743|P2|STARTED|Overall Study||166
5151939|NCT01298362|12672744|P1|STARTED|Overall Study||124
5151940|NCT01298323|12672764|P2|NOT COMPLETED|Overall Study||88
5151941|NCT01298323|12672765|P1|NOT COMPLETED|Overall Study||86
5151942|NCT01298323|12672764|P2|COMPLETED|Overall Study||15
5151943|NCT01298323|12672765|P1|COMPLETED|Overall Study||16
5151944|NCT01298323|12672764|P2|Ongoing|Overall Study||55
5151945|NCT01298323|12672765|P1|Ongoing|Overall Study||55
5151946|NCT01298323|12672764|P2|STARTED|Overall Study||103
5151947|NCT01298323|12672765|P1|STARTED|Overall Study||102
5151948|NCT01298219|12672773|P2|NOT COMPLETED|Overall Study||36
5151949|NCT01298219|12672774|P1|NOT COMPLETED|Overall Study||50
5151950|NCT01298219|12672773|P2|COMPLETED|Overall Study||184
5151951|NCT01298219|12672774|P1|COMPLETED|Overall Study||169
5151952|NCT01298219|12672773|P2|Safety Analysis Set|Overall Study||220
5151953|NCT01298219|12672774|P1|Safety Analysis Set|Overall Study||219
5151954|NCT01298219|12672773|P2|Intention to Treat (ITT)|Overall Study||220
5151955|NCT01298219|12672774|P1|Intention to Treat (ITT)|Overall Study||219
5151956|NCT01298219|12672773|P2|STARTED|Overall Study||220
5151957|NCT01298219|12672774|P1|STARTED|Overall Study||219
5151958|NCT01298193|12672788|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
5151959|NCT01298193|12672788|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
5151960|NCT01298193|12672788|P1|STARTED|Efficacy Phase (Second Cycle)||24
5151961|NCT01298193|12672788|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
5151962|NCT01298193|12672788|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
5151963|NCT01298193|12672788|P1|STARTED|Observational Phase (First Cycle)||212
5151964|NCT01298167|12672803|P2|NOT COMPLETED|Overall Study||0
5151965|NCT01298167|12672804|P1|NOT COMPLETED|Overall Study||1
5151966|NCT01298167|12672803|P2|COMPLETED|Overall Study||8
5151967|NCT01298167|12672804|P1|COMPLETED|Overall Study||5
5151968|NCT01298167|12672803|P2|STARTED|Overall Study||8
5151969|NCT01298167|12672804|P1|STARTED|Overall Study||6
5151970|NCT01298141|12672810|P1|NOT COMPLETED|Overall Study||31
5151971|NCT01298141|12672810|P1|COMPLETED|Overall Study||140
5151972|NCT01298141|12672810|P1|Treated|Overall Study||167
5151973|NCT01298141|12672810|P1|STARTED|Overall Study||171
5151974|NCT01298128|12672822|P2|NOT COMPLETED|Overall Study||8
5151975|NCT01298128|12672823|P1|NOT COMPLETED|Overall Study||9
5151976|NCT01298128|12672822|P2|COMPLETED|Overall Study||27
5151977|NCT01298128|12672823|P1|COMPLETED|Overall Study||26
5151978|NCT01298128|12672822|P2|STARTED|Overall Study||35
5151979|NCT01298128|12672823|P1|STARTED|Overall Study||35
5151980|NCT01298063|12672834|P5|NOT COMPLETED|Overall Study||0
5151981|NCT01298063|12672835|P4|NOT COMPLETED|Overall Study||0
5151982|NCT01298063|12672836|P3|NOT COMPLETED|Overall Study||0
5151983|NCT01298063|12672837|P2|NOT COMPLETED|Overall Study||0
5151984|NCT01298063|12672838|P1|NOT COMPLETED|Overall Study||0
5151985|NCT01298063|12672834|P5|COMPLETED|Overall Study||8
5151986|NCT01298063|12672835|P4|COMPLETED|Overall Study||8
5151987|NCT01298063|12672836|P3|COMPLETED|Overall Study||8
5151988|NCT01298063|12672837|P2|COMPLETED|Overall Study||3
5151989|NCT01298063|12672838|P1|COMPLETED|Overall Study||8
5151990|NCT01298063|12672834|P5|STARTED|Overall Study||8
5151991|NCT01298063|12672835|P4|STARTED|Overall Study||8
5151992|NCT01298063|12672836|P3|STARTED|Overall Study||8
5151993|NCT01298063|12672837|P2|STARTED|Overall Study||3
5151994|NCT01298063|12672838|P1|STARTED|Overall Study||8
5151995|NCT01297985|12672867|P2|NOT COMPLETED|Overall Study||53
5151996|NCT01297985|12672868|P1|NOT COMPLETED|Overall Study||55
5151997|NCT01297985|12672867|P2|COMPLETED|Overall Study||163
5151998|NCT01297985|12672868|P1|COMPLETED|Overall Study||157
5151999|NCT01297985|12672867|P2|STARTED|Overall Study||216
5152000|NCT01297985|12672868|P1|STARTED|Overall Study||212
5152001|NCT01297920|12672885|P3|NOT COMPLETED|Overall Study||57
5152002|NCT01297920|12672886|P2|NOT COMPLETED|Overall Study||27
5152003|NCT01297920|12672887|P1|NOT COMPLETED|Overall Study||58
5152004|NCT01297920|12672885|P3|COMPLETED|Overall Study||178
5152005|NCT01297920|12672886|P2|COMPLETED|Overall Study||207
5152006|NCT01297920|12672887|P1|COMPLETED|Overall Study||163
5152007|NCT01297920|12672885|P3|STARTED|Overall Study||235
5152008|NCT01297920|12672886|P2|STARTED|Overall Study||234
5152009|NCT01297920|12672887|P1|STARTED|Overall Study||221
5152010|NCT01297595|12672895|P2|NOT COMPLETED|Second Intervention Period||0
5152011|NCT01297595|12672896|P1|NOT COMPLETED|Second Intervention Period||0
5152012|NCT01297595|12672895|P2|COMPLETED|Second Intervention Period||11
5152013|NCT01297595|12672896|P1|COMPLETED|Second Intervention Period||11
5152014|NCT01297595|12672895|P2|STARTED|Second Intervention Period||11
5152015|NCT01297595|12672896|P1|STARTED|Second Intervention Period||11
5152016|NCT01297595|12672895|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
5152017|NCT01297595|12672896|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
5152018|NCT01297595|12672895|P2|COMPLETED|Washout Period (At Least 14 Days)||11
5152019|NCT01297595|12672896|P1|COMPLETED|Washout Period (At Least 14 Days)||11
5152020|NCT01297595|12672895|P2|STARTED|Washout Period (At Least 14 Days)||11
5152021|NCT01297595|12672896|P1|STARTED|Washout Period (At Least 14 Days)||11
5152022|NCT01297595|12672895|P2|NOT COMPLETED|First Intervention Period||0
5152023|NCT01297595|12672896|P1|NOT COMPLETED|First Intervention Period||0
5152024|NCT01297595|12672895|P2|COMPLETED|First Intervention Period||11
5152025|NCT01297595|12672896|P1|COMPLETED|First Intervention Period||11
5152026|NCT01297595|12672895|P2|STARTED|First Intervention Period||11
5152027|NCT01297595|12672896|P1|STARTED|First Intervention Period||11
5152028|NCT01297517|12672931|P3|NOT COMPLETED|Overall Study||27
5152029|NCT01297517|12672932|P2|NOT COMPLETED|Overall Study||12
5152030|NCT01297517|12672933|P1|NOT COMPLETED|Overall Study||27
5152031|NCT01297517|12672931|P3|COMPLETED|Overall Study||193
5152032|NCT01297517|12672932|P2|COMPLETED|Overall Study||214
5152033|NCT01297517|12672933|P1|COMPLETED|Overall Study||187
5152034|NCT01297517|12672931|P3|STARTED|Overall Study||220
5152035|NCT01297517|12672932|P2|STARTED|Overall Study||226
5152036|NCT01297517|12672933|P1|STARTED|Overall Study||214
5152037|NCT01297504|12672941|P1|NOT COMPLETED|Overall Study||67
5152038|NCT01297504|12672941|P1|COMPLETED|Overall Study||397
5152039|NCT01297504|12672941|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
5152040|NCT01297504|12672941|P1|STARTED|Overall Study||464
5152041|NCT01297491|12672955|P2|NOT COMPLETED|Overall Study||33
5152042|NCT01297491|12672956|P1|NOT COMPLETED|Overall Study||30
5152043|NCT01297491|12672955|P2|COMPLETED|Overall Study||0
5152044|NCT01297491|12672956|P1|COMPLETED|Overall Study||0
5152045|NCT01297491|12672955|P2|STARTED|Overall Study||33
5152046|NCT01297491|12672956|P1|STARTED|Overall Study||30
5152047|NCT01297465|12672974|P2|NOT COMPLETED|Overall Study||10
5152048|NCT01297465|12672975|P1|NOT COMPLETED|Overall Study||8
5152049|NCT01297465|12672974|P2|COMPLETED|Overall Study||93
5152050|NCT01297465|12672975|P1|COMPLETED|Overall Study||91
5152051|NCT01297465|12672974|P2|STARTED|Overall Study||103
5152052|NCT01297465|12672975|P1|STARTED|Overall Study||99
5152053|NCT01297348|12673009|P2|NOT COMPLETED|Overall Study||0
5152054|NCT01297348|12673010|P1|NOT COMPLETED|Overall Study||0
5152055|NCT01297348|12673009|P2|COMPLETED|Overall Study||586401
5152056|NCT01297348|12673010|P1|COMPLETED|Overall Study||12281
5152057|NCT01297348|12673009|P2|STARTED|Overall Study||586401
5152058|NCT01297348|12673010|P1|STARTED|Overall Study||12281
5152059|NCT01297335|12673020|P1|NOT COMPLETED|Overall Study||0
5152060|NCT01297335|12673020|P1|COMPLETED|Overall Study||10
5152061|NCT01297335|12673020|P1|STARTED|Overall Study||10
5152062|NCT01297322|12673028|P2|NOT COMPLETED|Overall Study||4
5152063|NCT01297322|12673029|P1|NOT COMPLETED|Overall Study||1
5152064|NCT01297322|12673028|P2|COMPLETED|Overall Study||274
5152065|NCT01297322|12673029|P1|COMPLETED|Overall Study||141
5152066|NCT01297322|12673028|P2|STARTED|Overall Study||278
5152067|NCT01297322|12673029|P1|STARTED|Overall Study||142
5152068|NCT01297309|12673048|P1|NOT COMPLETED|Overall Study||14
5152069|NCT01297309|12673048|P1|COMPLETED|Overall Study||37
5152070|NCT01297309|12673048|P1|Started Extension Period|Overall Study||46
5152071|NCT01297309|12673048|P1|Treated|Overall Study||49
5152072|NCT01297309|12673048|P1|STARTED|Overall Study||51
5152073|NCT01297283|12673065|P1|NOT COMPLETED|Overall Study||19
5152074|NCT01297283|12673065|P1|COMPLETED|Overall Study||176
5152075|NCT01297283|12673065|P1|STARTED|Overall Study||195
5152076|NCT01297270|12673073|P3|NOT COMPLETED|Overall Study||29
5152077|NCT01297270|12673074|P2|NOT COMPLETED|Overall Study||72
5152078|NCT01297270|12673075|P1|NOT COMPLETED|Overall Study||45
5152079|NCT01297270|12673073|P3|COMPLETED|Overall Study||103
5152080|NCT01297270|12673074|P2|COMPLETED|Overall Study||192
5152081|NCT01297270|12673075|P1|COMPLETED|Overall Study||217
5152082|NCT01297270|12673073|P3|STARTED|Overall Study||132
5152083|NCT01297270|12673074|P2|STARTED|Overall Study||264
5152084|NCT01297270|12673075|P1|STARTED|Overall Study||262
5152085|NCT01297257|12673113|P1|NOT COMPLETED|Overall Study||0
5152086|NCT01297257|12673113|P1|COMPLETED|Overall Study||7740
5152087|NCT01297257|12673113|P1|STARTED|Overall Study||7740
5152088|NCT01297062|12673124|P7|NOT COMPLETED|Overall Study||8
5152089|NCT01297062|12673125|P6|NOT COMPLETED|Overall Study||1
5152090|NCT01297062|12673126|P5|NOT COMPLETED|Overall Study||2
5152091|NCT01297062|12673127|P4|NOT COMPLETED|Overall Study||1
5152092|NCT01297062|12673128|P3|NOT COMPLETED|Overall Study||2
5152093|NCT01297062|12673129|P2|NOT COMPLETED|Overall Study||1
5152094|NCT01297062|12673130|P1|NOT COMPLETED|Overall Study||4
5152095|NCT01297062|12673124|P7|COMPLETED|Overall Study||0
5152096|NCT01297062|12673125|P6|COMPLETED|Overall Study||13
5152097|NCT01297062|12673126|P5|COMPLETED|Overall Study||13
5152098|NCT01297062|12673127|P4|COMPLETED|Overall Study||13
5152099|NCT01297062|12673128|P3|COMPLETED|Overall Study||12
5152100|NCT01297062|12673129|P2|COMPLETED|Overall Study||13
5152101|NCT01297062|12673130|P1|COMPLETED|Overall Study||11
5152102|NCT01297062|12673124|P7|Evaluable Population|Overall Study||0
5152103|NCT01297062|12673125|P6|Evaluable Population|Overall Study||13
5152104|NCT01297062|12673126|P5|Evaluable Population|Overall Study||13
5152105|NCT01297062|12673127|P4|Evaluable Population|Overall Study||13
5152106|NCT01297062|12673128|P3|Evaluable Population|Overall Study||12
5152107|NCT01297062|12673129|P2|Evaluable Population|Overall Study||12
5152108|NCT01297062|12673130|P1|Evaluable Population|Overall Study||11
5152109|NCT01297062|12673124|P7|Intent to Treat (ITT)|Overall Study||0
5152110|NCT01297062|12673125|P6|Intent to Treat (ITT)|Overall Study||14
5152111|NCT01297062|12673126|P5|Intent to Treat (ITT)|Overall Study||15
5152112|NCT01297062|12673127|P4|Intent to Treat (ITT)|Overall Study||14
5152113|NCT01297062|12673128|P3|Intent to Treat (ITT)|Overall Study||14
5152114|NCT01297062|12673129|P2|Intent to Treat (ITT)|Overall Study||14
5152115|NCT01297062|12673130|P1|Intent to Treat (ITT)|Overall Study||15
5152116|NCT01297062|12673124|P7|STARTED|Overall Study||8
5152117|NCT01297062|12673125|P6|STARTED|Overall Study||14
5152118|NCT01297062|12673126|P5|STARTED|Overall Study||15
5152119|NCT01297062|12673127|P4|STARTED|Overall Study||14
5152120|NCT01297062|12673128|P3|STARTED|Overall Study||14
5152121|NCT01297062|12673129|P2|STARTED|Overall Study||14
5152122|NCT01297062|12673130|P1|STARTED|Overall Study||15
5152123|NCT01296841|12673154|P2|NOT COMPLETED|Overall Study||0
5152124|NCT01296841|12673155|P1|NOT COMPLETED|Overall Study||0
5152125|NCT01296841|12673154|P2|COMPLETED|Overall Study||15
5152126|NCT01296841|12673155|P1|COMPLETED|Overall Study||19
5152127|NCT01296841|12673154|P2|STARTED|Overall Study||15
5152128|NCT01296841|12673155|P1|STARTED|Overall Study||19
5152129|NCT01296815|12673167|P2|NOT COMPLETED|Overall Study||0
5152130|NCT01296815|12673168|P1|NOT COMPLETED|Overall Study||0
5152131|NCT01296815|12673167|P2|COMPLETED|Overall Study||7
5152132|NCT01296815|12673168|P1|COMPLETED|Overall Study||7
5152133|NCT01296815|12673167|P2|STARTED|Overall Study||7
5152134|NCT01296815|12673168|P1|STARTED|Overall Study||7
5152135|NCT01296763|12673177|P3|NOT COMPLETED|Overall Study||0
5152136|NCT01296763|12673178|P2|NOT COMPLETED|Overall Study||0
5152137|NCT01296763|12673179|P1|NOT COMPLETED|Overall Study||0
5152138|NCT01296763|12673177|P3|COMPLETED|Overall Study||6
5152139|NCT01296763|12673178|P2|COMPLETED|Overall Study||5
5152140|NCT01296763|12673179|P1|COMPLETED|Overall Study||7
5152141|NCT01296763|12673177|P3|STARTED|Overall Study||6
5152142|NCT01296763|12673178|P2|STARTED|Overall Study||5
5152143|NCT01296763|12673179|P1|STARTED|Overall Study||7
5152144|NCT01296698|12673192|P2|NOT COMPLETED|Overall Study||13
5152145|NCT01296698|12673193|P1|NOT COMPLETED|Overall Study||244
5152146|NCT01296698|12673192|P2|COMPLETED|Overall Study||0
5152147|NCT01296698|12673193|P1|COMPLETED|Overall Study||0
5152148|NCT01296698|12673192|P2|STARTED|Overall Study||13
5152149|NCT01296698|12673193|P1|STARTED|Overall Study||244
5152150|NCT01296672|12673247|P2|NOT COMPLETED|Overall Study||18
5152151|NCT01296672|12673248|P1|NOT COMPLETED|Overall Study||73
5152152|NCT01296672|12673247|P2|COMPLETED|Overall Study||59
5152153|NCT01296672|12673248|P1|COMPLETED|Overall Study||233
5152154|NCT01296672|12673247|P2|STARTED|Overall Study||77
5152155|NCT01296672|12673248|P1|STARTED|Overall Study||306
5152156|NCT01296646|12673260|P2|NOT COMPLETED|Overall Study||11
5152157|NCT01296646|12673261|P1|NOT COMPLETED|Overall Study||11
5152158|NCT01296646|12673260|P2|COMPLETED|Overall Study||29
5152159|NCT01296646|12673261|P1|COMPLETED|Overall Study||29
5152160|NCT01296646|12673260|P2|STARTED|Overall Study||40
5152161|NCT01296646|12673261|P1|STARTED|Overall Study||40
5152162|NCT01296568|12673269|P1|NOT COMPLETED|Continued Access Phase||3
5152163|NCT01296568|12673269|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
5152164|NCT01296568|12673269|P1|STARTED|Continued Access Phase||3
5152165|NCT01296568|12673269|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
5152166|NCT01296568|12673269|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
5152167|NCT01296568|12673269|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
5152168|NCT01296412|12673285|P2|NOT COMPLETED|Overall Study||70
5152169|NCT01296412|12673286|P1|NOT COMPLETED|Overall Study||51
5152170|NCT01296412|12673285|P2|COMPLETED|Overall Study||257
5152171|NCT01296412|12673286|P1|COMPLETED|Overall Study||275
5152172|NCT01296412|12673285|P2|STARTED|Overall Study||327
5152173|NCT01296412|12673286|P1|STARTED|Overall Study||326
5152174|NCT01296360|12673300|P2|NOT COMPLETED|Overall Study||8
5152175|NCT01296360|12673301|P1|NOT COMPLETED|Overall Study||6
5152176|NCT01296360|12673300|P2|COMPLETED|Overall Study||142
5152177|NCT01296360|12673301|P1|COMPLETED|Overall Study||144
5152178|NCT01296360|12673300|P2|Visit 2a (Month 13)|Overall Study||0
5152179|NCT01296360|12673301|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
5152180|NCT01296360|12673300|P2|Visit 2 (Month 12)|Overall Study||149
5152181|NCT01296360|12673301|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
5152182|NCT01296360|12673300|P2|STARTED|Overall Study||150
5152183|NCT01296360|12673301|P1|STARTED|Overall Study||150
5152184|NCT01296347|12673309|P2|NOT COMPLETED|12 Month Follow up||3
5152185|NCT01296347|12673310|P1|NOT COMPLETED|12 Month Follow up||4
5152186|NCT01296347|12673309|P2|COMPLETED|12 Month Follow up||28
5152187|NCT01296347|12673310|P1|COMPLETED|12 Month Follow up||28
5152188|NCT01296347|12673309|P2|STARTED|12 Month Follow up||31
5152189|NCT01296347|12673310|P1|STARTED|12 Month Follow up||32
5152190|NCT01296347|12673309|P2|NOT COMPLETED|6 Month Follow up||2
5152191|NCT01296347|12673310|P1|NOT COMPLETED|6 Month Follow up||2
5152192|NCT01296347|12673309|P2|COMPLETED|6 Month Follow up||31
5152193|NCT01296347|12673310|P1|COMPLETED|6 Month Follow up||32
5152194|NCT01296347|12673309|P2|STARTED|6 Month Follow up||33
5152195|NCT01296347|12673310|P1|STARTED|6 Month Follow up||34
5152196|NCT01296347|12673309|P2|NOT COMPLETED|3 Month Follow up||1
5152197|NCT01296347|12673310|P1|NOT COMPLETED|3 Month Follow up||1
5152198|NCT01296347|12673309|P2|COMPLETED|3 Month Follow up||33
5152199|NCT01296347|12673310|P1|COMPLETED|3 Month Follow up||34
5152200|NCT01296347|12673309|P2|STARTED|3 Month Follow up||34
5152201|NCT01296347|12673310|P1|STARTED|3 Month Follow up||35
5152202|NCT01296347|12673309|P2|NOT COMPLETED|6 Week Follow up||1
5152203|NCT01296347|12673310|P1|NOT COMPLETED|6 Week Follow up||0
5152204|NCT01296347|12673309|P2|COMPLETED|6 Week Follow up||34
5152205|NCT01296347|12673310|P1|COMPLETED|6 Week Follow up||35
5152206|NCT01296347|12673309|P2|STARTED|6 Week Follow up||35
5152207|NCT01296347|12673310|P1|STARTED|6 Week Follow up||35
5152208|NCT01296347|12673309|P2|NOT COMPLETED|Allocation||4
5152209|NCT01296347|12673310|P1|NOT COMPLETED|Allocation||3
5152210|NCT01296347|12673309|P2|COMPLETED|Allocation||35
5152211|NCT01296347|12673310|P1|COMPLETED|Allocation||35
5152212|NCT01296347|12673309|P2|STARTED|Allocation||39
5152213|NCT01296347|12673310|P1|STARTED|Allocation||38
5152214|NCT01296191|12673328|P2|NOT COMPLETED|Overall Study||1
5152215|NCT01296191|12673329|P1|NOT COMPLETED|Overall Study||3
5152216|NCT01296191|12673328|P2|COMPLETED|Overall Study||59
5152217|NCT01296191|12673329|P1|COMPLETED|Overall Study||57
5152218|NCT01296191|12673328|P2|STARTED|Overall Study||60
5152219|NCT01296191|12673329|P1|STARTED|Overall Study||60
5152220|NCT01296152|12673335|P1|NOT COMPLETED|Overall Study||1
5152221|NCT01296152|12673335|P1|COMPLETED|Overall Study||24
5152222|NCT01296152|12673335|P1|STARTED|Overall Study||25
5152223|NCT01296035|12673362|P1|NOT COMPLETED|Overall Study||1
5152224|NCT01296035|12673362|P1|COMPLETED|Overall Study||7
5152225|NCT01296035|12673362|P1|STARTED|Overall Study||8
5152226|NCT01295905|12673369|P2|NOT COMPLETED|Overall Study||0
5152227|NCT01295905|12673370|P1|NOT COMPLETED|Overall Study||2
5152228|NCT01295905|12673369|P2|COMPLETED|Overall Study||30
5152229|NCT01295905|12673370|P1|COMPLETED|Overall Study||58
5152230|NCT01295905|12673369|P2|STARTED|Overall Study||30
5152231|NCT01295905|12673370|P1|STARTED|Overall Study||60
5152232|NCT01295879|12673382|P1|NOT COMPLETED|Overall Study||0
5152233|NCT01295879|12673382|P1|COMPLETED|Overall Study||29
5152234|NCT01295879|12673382|P1|STARTED|Overall Study||29
5152235|NCT01295840|12673388|P1|NOT COMPLETED|Overall Study||1
5152236|NCT01295840|12673388|P1|COMPLETED|Overall Study||50
5152237|NCT01295840|12673388|P1|STARTED|Overall Study||51
5152238|NCT01295827|12673414|P15|NOT COMPLETED|Overall Study||0
5152239|NCT01295827|12673415|P14|NOT COMPLETED|Overall Study||0
5152240|NCT01295827|12673416|P13|NOT COMPLETED|Overall Study||0
5152241|NCT01295827|12673417|P12|NOT COMPLETED|Overall Study||186
5152242|NCT01295827|12673418|P11|NOT COMPLETED|Overall Study||276
5152243|NCT01295827|12673419|P10|NOT COMPLETED|Overall Study||55
5152244|NCT01295827|12673420|P9|NOT COMPLETED|Overall Study||169
5152245|NCT01295827|12673421|P8|NOT COMPLETED|Overall Study||297
5152246|NCT01295827|12673422|P7|NOT COMPLETED|Overall Study||146
5152247|NCT01295827|12673423|P6|NOT COMPLETED|Overall Study||6
5152248|NCT01295827|12673424|P5|NOT COMPLETED|Overall Study||2
5152249|NCT01295827|12673425|P4|NOT COMPLETED|Overall Study||4
5152250|NCT01295827|12673426|P3|NOT COMPLETED|Overall Study||12
5152251|NCT01295827|12673427|P2|NOT COMPLETED|Overall Study||3
5152252|NCT01295827|12673428|P1|NOT COMPLETED|Overall Study||4
5152253|NCT01295827|12673414|P15|COMPLETED|Overall Study||0
5152254|NCT01295827|12673415|P14|COMPLETED|Overall Study||0
5152255|NCT01295827|12673416|P13|COMPLETED|Overall Study||0
5152256|NCT01295827|12673417|P12|COMPLETED|Overall Study||17
5152257|NCT01295827|12673418|P11|COMPLETED|Overall Study||20
5152258|NCT01295827|12673419|P10|COMPLETED|Overall Study||6
5152259|NCT01295827|12673420|P9|COMPLETED|Overall Study||14
5152260|NCT01295827|12673421|P8|COMPLETED|Overall Study||24
5152261|NCT01295827|12673422|P7|COMPLETED|Overall Study||18
5152262|NCT01295827|12673423|P6|COMPLETED|Overall Study||0
5152263|NCT01295827|12673424|P5|COMPLETED|Overall Study||1
5152264|NCT01295827|12673425|P4|COMPLETED|Overall Study||0
5152265|NCT01295827|12673426|P3|COMPLETED|Overall Study||0
5152266|NCT01295827|12673427|P2|COMPLETED|Overall Study||0
5152267|NCT01295827|12673428|P1|COMPLETED|Overall Study||0
5152268|NCT01295827|12673414|P15|Treated (All Treated Population)|Overall Study||0
5152269|NCT01295827|12673415|P14|Treated (All Treated Population)|Overall Study||0
5152270|NCT01295827|12673416|P13|Treated (All Treated Population)|Overall Study||0
5152271|NCT01295827|12673417|P12|Treated (All Treated Population)|Overall Study||202
5152272|NCT01295827|12673418|P11|Treated (All Treated Population)|Overall Study||287
5152273|NCT01295827|12673419|P10|Treated (All Treated Population)|Overall Study||61
5152274|NCT01295827|12673420|P9|Treated (All Treated Population)|Overall Study||180
5152275|NCT01295827|12673421|P8|Treated (All Treated Population)|Overall Study||313
5152276|NCT01295827|12673422|P7|Treated (All Treated Population)|Overall Study||162
5152277|NCT01295827|12673423|P6|Treated (All Treated Population)|Overall Study||6
5152278|NCT01295827|12673424|P5|Treated (All Treated Population)|Overall Study||3
5152279|NCT01295827|12673425|P4|Treated (All Treated Population)|Overall Study||4
5152280|NCT01295827|12673426|P3|Treated (All Treated Population)|Overall Study||10
5152281|NCT01295827|12673427|P2|Treated (All Treated Population)|Overall Study||3
5152282|NCT01295827|12673428|P1|Treated (All Treated Population)|Overall Study||4
5152283|NCT01295827|12673414|P15|STARTED|Overall Study||0
5152284|NCT01295827|12673415|P14|STARTED|Overall Study||0
5152285|NCT01295827|12673416|P13|STARTED|Overall Study||0
5152286|NCT01295827|12673417|P12|STARTED|Overall Study||203
5152287|NCT01295827|12673418|P11|STARTED|Overall Study||296
5152288|NCT01295827|12673419|P10|STARTED|Overall Study||61
5152289|NCT01295827|12673420|P9|STARTED|Overall Study||183
5152290|NCT01295827|12673421|P8|STARTED|Overall Study||321
5152291|NCT01295827|12673422|P7|STARTED|Overall Study||164
5152292|NCT01295827|12673423|P6|STARTED|Overall Study||6
5152293|NCT01295827|12673424|P5|STARTED|Overall Study||3
5152294|NCT01295827|12673425|P4|STARTED|Overall Study||4
5152295|NCT01295827|12673426|P3|STARTED|Overall Study||12
5152296|NCT01295827|12673427|P2|STARTED|Overall Study||3
5152297|NCT01295827|12673428|P1|STARTED|Overall Study||4
5152298|NCT01295814|12673801|P2|NOT COMPLETED|Overall Study||2
5152299|NCT01295814|12673802|P1|NOT COMPLETED|Overall Study||2
5152300|NCT01295814|12673801|P2|COMPLETED|Overall Study||19
5152301|NCT01295814|12673802|P1|COMPLETED|Overall Study||20
5152302|NCT01295814|12673801|P2|STARTED|Overall Study||21
5152303|NCT01295814|12673802|P1|STARTED|Overall Study||22
5152304|NCT01295710|12673818|P2|NOT COMPLETED|Overall Study||50
5152305|NCT01295710|12673819|P1|NOT COMPLETED|Overall Study||78
5152306|NCT01295710|12673818|P2|COMPLETED|Overall Study||78
5152307|NCT01295710|12673819|P1|COMPLETED|Overall Study||48
5152308|NCT01295710|12673818|P2|STARTED|Overall Study|Randomized and treated|128
5152309|NCT01295710|12673819|P1|STARTED|Overall Study|Randomized and treated|126
5152310|NCT01295671|12673882|P3|NOT COMPLETED|Overall Study||3
5152311|NCT01295671|12673883|P2|NOT COMPLETED|Overall Study||7
5152312|NCT01295671|12673884|P1|NOT COMPLETED|Overall Study||7
5152313|NCT01295671|12673882|P3|COMPLETED|Overall Study||66
5152314|NCT01295671|12673883|P2|COMPLETED|Overall Study||60
5152315|NCT01295671|12673884|P1|COMPLETED|Overall Study||60
5152316|NCT01295671|12673882|P3|STARTED|Overall Study||69
5152317|NCT01295671|12673883|P2|STARTED|Overall Study||67
5152318|NCT01295671|12673884|P1|STARTED|Overall Study||67
5152319|NCT01295515|12673922|P1|NOT COMPLETED|Overall Study||0
5152320|NCT01295515|12673922|P1|COMPLETED|Overall Study||7
5152321|NCT01295515|12673922|P1|STARTED|Overall Study||7
5152322|NCT01295320|12673930|P1|NOT COMPLETED|Overall Study||10
5152323|NCT01295320|12673930|P1|COMPLETED|Overall Study||119
5152324|NCT01295320|12673930|P1|STARTED|Overall Study||129
5152325|NCT01295281|12673947|P2|NOT COMPLETED|Second Intervention (7days)||0
5152326|NCT01295281|12673948|P1|NOT COMPLETED|Second Intervention (7days)||0
5152327|NCT01295281|12673947|P2|COMPLETED|Second Intervention (7days)||51
5152328|NCT01295281|12673948|P1|COMPLETED|Second Intervention (7days)||53
5152329|NCT01295281|12673947|P2|STARTED|Second Intervention (7days)||51
5152330|NCT01295281|12673948|P1|STARTED|Second Intervention (7days)||53
5152331|NCT01295281|12673947|P2|NOT COMPLETED|First Intervention (7 Days)||1
5152332|NCT01295281|12673948|P1|NOT COMPLETED|First Intervention (7 Days)||0
5152333|NCT01295281|12673947|P2|COMPLETED|First Intervention (7 Days)||51
5152334|NCT01295281|12673948|P1|COMPLETED|First Intervention (7 Days)||53
5152335|NCT01295281|12673947|P2|STARTED|First Intervention (7 Days)||52
5152336|NCT01295281|12673948|P1|STARTED|First Intervention (7 Days)||53
5152337|NCT01295216|12673956|P2|NOT COMPLETED|Overall Study||34
5152338|NCT01295216|12673957|P1|NOT COMPLETED|Overall Study||50
5152339|NCT01295216|12673956|P2|COMPLETED|Overall Study||287
5152340|NCT01295216|12673957|P1|COMPLETED|Overall Study||266
5152341|NCT01295216|12673956|P2|STARTED|Overall Study||321
5152342|NCT01295216|12673957|P1|STARTED|Overall Study||316
5152343|NCT01295112|12673975|P2|NOT COMPLETED|Overall Study||0
5152344|NCT01295112|12673976|P1|NOT COMPLETED|Overall Study||0
5152345|NCT01295112|12673975|P2|COMPLETED|Overall Study||33
5152346|NCT01295112|12673976|P1|COMPLETED|Overall Study||35
5152347|NCT01295112|12673975|P2|STARTED|Overall Study||33
5152348|NCT01295112|12673976|P1|STARTED|Overall Study||35
5152349|NCT01295034|12673986|P2|NOT COMPLETED|Overall Study||5
5152350|NCT01295034|12673987|P1|NOT COMPLETED|Overall Study||5
5152351|NCT01295034|12673986|P2|COMPLETED|Overall Study||25
5152352|NCT01295034|12673987|P1|COMPLETED|Overall Study||27
5152353|NCT01295034|12673986|P2|STARTED|Overall Study||30
5152354|NCT01295034|12673987|P1|STARTED|Overall Study||32
5152355|NCT01294917|12673995|P1|NOT COMPLETED|Overall Study||6
5152356|NCT01294917|12673995|P1|COMPLETED|Overall Study||36
5152357|NCT01294917|12673995|P1|Received OptiFree RepleniSH MPS|Overall Study||36
5152358|NCT01294917|12673995|P1|Received Clear Care|Overall Study||36
5152359|NCT01294917|12673995|P1|Received Investigational MPS|Overall Study||36
5152360|NCT01294917|12673995|P1|STARTED|Overall Study||42
5152361|NCT01294800|12674005|P4|NOT COMPLETED|Overall Study||16
5152362|NCT01294800|12674006|P3|NOT COMPLETED|Overall Study||17
5152363|NCT01294800|12674007|P2|NOT COMPLETED|Overall Study||10
5152364|NCT01294800|12674008|P1|NOT COMPLETED|Overall Study||11
5152365|NCT01294800|12674005|P4|COMPLETED|Overall Study||97
5152366|NCT01294800|12674006|P3|COMPLETED|Overall Study||96
5152367|NCT01294800|12674007|P2|COMPLETED|Overall Study||103
5152368|NCT01294800|12674008|P1|COMPLETED|Overall Study||100
5152369|NCT01294800|12674005|P4|STARTED|Overall Study||113
5152370|NCT01294800|12674006|P3|STARTED|Overall Study||113
5152371|NCT01294800|12674007|P2|STARTED|Overall Study||113
5152372|NCT01294800|12674008|P1|STARTED|Overall Study||111
5152373|NCT01294787|12674034|P6|NOT COMPLETED|Period 3||0
5152374|NCT01294787|12674035|P5|NOT COMPLETED|Period 3||1
5152375|NCT01294787|12674036|P4|NOT COMPLETED|Period 3||0
5152376|NCT01294787|12674037|P3|NOT COMPLETED|Period 3||0
5152377|NCT01294787|12674038|P2|NOT COMPLETED|Period 3||0
5152378|NCT01294787|12674039|P1|NOT COMPLETED|Period 3||0
5152379|NCT01294787|12674034|P6|COMPLETED|Period 3||13
5152380|NCT01294787|12674035|P5|COMPLETED|Period 3||13
5152381|NCT01294787|12674036|P4|COMPLETED|Period 3||9
5152382|NCT01294787|12674037|P3|COMPLETED|Period 3||13
5152383|NCT01294787|12674038|P2|COMPLETED|Period 3||13
5152384|NCT01294787|12674039|P1|COMPLETED|Period 3||12
5152385|NCT01294787|12674034|P6|STARTED|Period 3||13
5152386|NCT01294787|12674035|P5|STARTED|Period 3||14
5152387|NCT01294787|12674036|P4|STARTED|Period 3||9
5152388|NCT01294787|12674037|P3|STARTED|Period 3||13
5152389|NCT01294787|12674038|P2|STARTED|Period 3||13
5152390|NCT01294787|12674039|P1|STARTED|Period 3||12
5152391|NCT01294787|12674034|P6|NOT COMPLETED|Period 2||0
5152392|NCT01294787|12674035|P5|NOT COMPLETED|Period 2||0
5152393|NCT01294787|12674036|P4|NOT COMPLETED|Period 2||2
5152394|NCT01294787|12674037|P3|NOT COMPLETED|Period 2||0
5152395|NCT01294787|12674038|P2|NOT COMPLETED|Period 2||3
5152396|NCT01294787|12674039|P1|NOT COMPLETED|Period 2||0
5152397|NCT01294787|12674034|P6|COMPLETED|Period 2||13
5152398|NCT01294787|12674035|P5|COMPLETED|Period 2||14
5152399|NCT01294787|12674036|P4|COMPLETED|Period 2||9
5152400|NCT01294787|12674037|P3|COMPLETED|Period 2||13
5152401|NCT01294787|12674038|P2|COMPLETED|Period 2||13
5152402|NCT01294787|12674039|P1|COMPLETED|Period 2||12
5152403|NCT01294787|12674034|P6|STARTED|Period 2||13
5152404|NCT01294787|12674035|P5|STARTED|Period 2||14
5152405|NCT01294787|12674036|P4|STARTED|Period 2||11
5152406|NCT01294787|12674037|P3|STARTED|Period 2||13
5152407|NCT01294787|12674038|P2|STARTED|Period 2||16
5152408|NCT01294787|12674039|P1|STARTED|Period 2||12
5152409|NCT01294787|12674034|P6|NOT COMPLETED|Period 1||2
5152410|NCT01294787|12674035|P5|NOT COMPLETED|Period 1||2
5152411|NCT01294787|12674036|P4|NOT COMPLETED|Period 1||1
5152412|NCT01294787|12674037|P3|NOT COMPLETED|Period 1||1
5152413|NCT01294787|12674038|P2|NOT COMPLETED|Period 1||0
5152414|NCT01294787|12674039|P1|NOT COMPLETED|Period 1||0
5152415|NCT01294787|12674034|P6|COMPLETED|Period 1||13
5152416|NCT01294787|12674035|P5|COMPLETED|Period 1||14
5152417|NCT01294787|12674036|P4|COMPLETED|Period 1||11
5152418|NCT01294787|12674037|P3|COMPLETED|Period 1||13
5152419|NCT01294787|12674038|P2|COMPLETED|Period 1||16
5152420|NCT01294787|12674039|P1|COMPLETED|Period 1||12
5152421|NCT01294787|12674034|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
5152422|NCT01294787|12674035|P5|STARTED|Period 1||16
5152423|NCT01294787|12674036|P4|STARTED|Period 1||12
5152424|NCT01294787|12674037|P3|STARTED|Period 1||14
5152425|NCT01294787|12674038|P2|STARTED|Period 1||16
5152426|NCT01294787|12674039|P1|STARTED|Period 1||12
5152427|NCT01294748|12674083|P2|NOT COMPLETED|Overall Study||2
5152428|NCT01294748|12674084|P1|NOT COMPLETED|Overall Study||5
5152429|NCT01294748|12674083|P2|COMPLETED|Overall Study|At 270 days|59
5152430|NCT01294748|12674084|P1|COMPLETED|Overall Study|At 270 days|118
5152431|NCT01294748|12674083|P2|STARTED|Overall Study||61
5152432|NCT01294748|12674084|P1|STARTED|Overall Study||123
5152433|NCT01294709|12674110|P2|NOT COMPLETED|Period 2||0
5152434|NCT01294709|12674111|P1|NOT COMPLETED|Period 2||1
5152435|NCT01294709|12674110|P2|COMPLETED|Period 2||31
5152436|NCT01294709|12674111|P1|COMPLETED|Period 2||28
5152437|NCT01294709|12674110|P2|STARTED|Period 2||31
5152438|NCT01294709|12674111|P1|STARTED|Period 2||29
5152439|NCT01294709|12674110|P2|NOT COMPLETED|Washout Period||1
5152440|NCT01294709|12674111|P1|NOT COMPLETED|Washout Period||1
5152441|NCT01294709|12674110|P2|COMPLETED|Washout Period||31
5152442|NCT01294709|12674111|P1|COMPLETED|Washout Period||29
5152443|NCT01294709|12674110|P2|STARTED|Washout Period||32
5152444|NCT01294709|12674111|P1|STARTED|Washout Period||30
5152445|NCT01294709|12674110|P2|NOT COMPLETED|Period 1||1
5152446|NCT01294709|12674111|P1|NOT COMPLETED|Period 1||1
5152447|NCT01294709|12674110|P2|COMPLETED|Period 1||32
5152448|NCT01294709|12674111|P1|COMPLETED|Period 1||30
5152449|NCT01294709|12674110|P2|STARTED|Period 1||33
5152450|NCT01294709|12674111|P1|STARTED|Period 1||31
5152451|NCT01294696|12674130|P1|NOT COMPLETED|Overall Study||74
5152452|NCT01294696|12674130|P1|COMPLETED|Overall Study||1187
5152453|NCT01294696|12674130|P1|STARTED|Overall Study||1261
5152454|NCT01294683|12674144|P2|NOT COMPLETED|Post Crossover (Period III)||32
5152455|NCT01294683|12674145|P1|NOT COMPLETED|Post Crossover (Period III)||33
5152456|NCT01294683|12674144|P2|COMPLETED|Post Crossover (Period III)||190
5152457|NCT01294683|12674145|P1|COMPLETED|Post Crossover (Period III)||199
5152458|NCT01294683|12674144|P2|STARTED|Post Crossover (Period III)||222
5152459|NCT01294683|12674145|P1|STARTED|Post Crossover (Period III)||232
5152460|NCT01294683|12674144|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
5152461|NCT01294683|12674145|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
5152462|NCT01294683|12674144|P2|COMPLETED|Precrossover (Periods I/II)||222
5152463|NCT01294683|12674145|P1|COMPLETED|Precrossover (Periods I/II)||232
5152464|NCT01294683|12674144|P2|Treated|Precrossover (Periods I/II)||486
5152465|NCT01294683|12674145|P1|Treated|Precrossover (Periods I/II)||486
5152466|NCT01294683|12674144|P2|STARTED|Precrossover (Periods I/II)||488
5152467|NCT01294683|12674145|P1|STARTED|Precrossover (Periods I/II)||489
5152468|NCT01294644|12674198|P3|NOT COMPLETED|Overall Study||14
5152469|NCT01294644|12674199|P2|NOT COMPLETED|Overall Study||10
5152470|NCT01294644|12674200|P1|NOT COMPLETED|Overall Study||10
5152471|NCT01294644|12674198|P3|COMPLETED|Overall Study||103
5152472|NCT01294644|12674199|P2|COMPLETED|Overall Study||112
5152473|NCT01294644|12674200|P1|COMPLETED|Overall Study||111
5152474|NCT01294644|12674198|P3|Received Treatment|Overall Study||114
5152475|NCT01294644|12674199|P2|Received Treatment|Overall Study||122
5152476|NCT01294644|12674200|P1|Received Treatment|Overall Study||118
5152477|NCT01294644|12674198|P3|STARTED|Overall Study||117
5152478|NCT01294644|12674199|P2|STARTED|Overall Study||122
5152479|NCT01294644|12674200|P1|STARTED|Overall Study||121
5152480|NCT01294592|12674231|P2|NOT COMPLETED|Overall Study||73
5152481|NCT01294592|12674232|P1|NOT COMPLETED|Overall Study||77
5152482|NCT01294592|12674231|P2|COMPLETED|Overall Study||300
5152483|NCT01294592|12674232|P1|COMPLETED|Overall Study||292
5152484|NCT01294592|12674231|P2|STARTED|Overall Study||373
5152485|NCT01294592|12674232|P1|STARTED|Overall Study||369
5152486|NCT01294579|12674260|P1|NOT COMPLETED|Overall Study||35
5152487|NCT01294579|12674260|P1|COMPLETED|Overall Study||14
5152488|NCT01294579|12674260|P1|STARTED|Overall Study||49
5152489|NCT01294553|12674270|P1|NOT COMPLETED|Overall Study||269
5152490|NCT01294553|12674270|P1|COMPLETED|Overall Study||713
5152491|NCT01294553|12674270|P1|STARTED|Overall Study||982
5152492|NCT01294514|12674276|P1|NOT COMPLETED|Overall Study||1
5152493|NCT01294514|12674276|P1|COMPLETED|Overall Study||26
5152494|NCT01294514|12674276|P1|STARTED|Overall Study||27
5152495|NCT01294462|12674286|P2|NOT COMPLETED|Overall Study||63
5152496|NCT01294462|12674287|P1|NOT COMPLETED|Overall Study||66
5152497|NCT01294462|12674286|P2|COMPLETED|Overall Study||337
5152498|NCT01294462|12674287|P1|COMPLETED|Overall Study||335
5152499|NCT01294462|12674286|P2|Received Randomized Treatment|Overall Study||380
5152500|NCT01294462|12674287|P1|Received Randomized Treatment|Overall Study||387
5152501|NCT01294462|12674286|P2|STARTED|Overall Study||400
5152502|NCT01294462|12674287|P1|STARTED|Overall Study||401
5152503|NCT01294449|12674301|P2|NOT COMPLETED|Overall Study||15
5152504|NCT01294449|12674302|P1|NOT COMPLETED|Overall Study||12
5152505|NCT01294449|12674301|P2|COMPLETED|Overall Study||237
5152506|NCT01294449|12674302|P1|COMPLETED|Overall Study||144
5152507|NCT01294449|12674301|P2|Consent to Registry|Overall Study||245
5152508|NCT01294449|12674302|P1|Consent to Registry|Overall Study||149
5152509|NCT01294449|12674301|P2|STARTED|Overall Study||252
5152510|NCT01294449|12674302|P1|STARTED|Overall Study||156
5152511|NCT01294436|12674310|P2|NOT COMPLETED|Overall Study||70
5152512|NCT01294436|12674311|P1|NOT COMPLETED|Overall Study||28
5152513|NCT01294436|12674310|P2|COMPLETED|Overall Study||409
5152514|NCT01294436|12674311|P1|COMPLETED|Overall Study||221
5152515|NCT01294436|12674310|P2|STARTED|Overall Study||479
5152516|NCT01294436|12674311|P1|STARTED|Overall Study||249
5152517|NCT01294423|12674346|P3|NOT COMPLETED|Overall Study||8
5152518|NCT01294423|12674347|P2|NOT COMPLETED|Overall Study||9
5152519|NCT01294423|12674348|P1|NOT COMPLETED|Overall Study||5
5152520|NCT01294423|12674346|P3|COMPLETED|Overall Study||79
5152521|NCT01294423|12674347|P2|COMPLETED|Overall Study||79
5152522|NCT01294423|12674348|P1|COMPLETED|Overall Study||81
5152523|NCT01294423|12674346|P3|STARTED|Overall Study||87
5152524|NCT01294423|12674347|P2|STARTED|Overall Study||88
5152525|NCT01294423|12674348|P1|STARTED|Overall Study||86
5152526|NCT01294397|12674362|P1|NOT COMPLETED|Overall Study||2
5152527|NCT01294397|12674362|P1|COMPLETED|Overall Study||17
5152528|NCT01294397|12674362|P1|STARTED|Overall Study||19
5152529|NCT01294384|12674375|P3|NOT COMPLETED|Overall Study||9
5152530|NCT01294384|12674376|P2|NOT COMPLETED|Overall Study||6
5152531|NCT01294384|12674377|P1|NOT COMPLETED|Overall Study||4
5152532|NCT01294384|12674375|P3|COMPLETED|Overall Study||95
5152533|NCT01294384|12674376|P2|COMPLETED|Overall Study||94
5152534|NCT01294384|12674377|P1|COMPLETED|Overall Study||97
5152535|NCT01294384|12674375|P3|STARTED|Overall Study||104
5152536|NCT01294384|12674376|P2|STARTED|Overall Study||100
5152537|NCT01294384|12674377|P1|STARTED|Overall Study||101
5152538|NCT01294371|12674406|P1|NOT COMPLETED|Overall Study||34
5152539|NCT01294371|12674406|P1|COMPLETED|Overall Study||357
5152540|NCT01294371|12674406|P1|Treated|Overall Study||390
5152541|NCT01294371|12674406|P1|STARTED|Overall Study||391
5152542|NCT01294358|12674414|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
5152543|NCT01294358|12674415|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152544|NCT01294358|12674416|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152545|NCT01294358|12674417|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152546|NCT01294358|12674418|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152547|NCT01294358|12674414|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152548|NCT01294358|12674415|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152549|NCT01294358|12674416|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152550|NCT01294358|12674417|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152551|NCT01294358|12674418|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
5152552|NCT01294358|12674414|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
5152553|NCT01294358|12674415|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
5152554|NCT01294358|12674416|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
5152555|NCT01294358|12674417|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
5152556|NCT01294358|12674418|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
5152557|NCT01294358|12674414|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152558|NCT01294358|12674415|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
5152559|NCT01294358|12674416|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152560|NCT01294358|12674417|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152561|NCT01294358|12674418|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152562|NCT01294358|12674414|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152563|NCT01294358|12674415|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
5152564|NCT01294358|12674416|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152565|NCT01294358|12674417|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152566|NCT01294358|12674418|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
5152567|NCT01294358|12674414|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
5152568|NCT01294358|12674415|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
5152569|NCT01294358|12674416|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
5152570|NCT01294358|12674417|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
5152571|NCT01294358|12674418|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
5152572|NCT01294358|12674414|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152573|NCT01294358|12674415|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152574|NCT01294358|12674416|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
5152575|NCT01294358|12674417|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152576|NCT01294358|12674418|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152577|NCT01294358|12674414|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152578|NCT01294358|12674415|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152579|NCT01294358|12674416|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
5152580|NCT01294358|12674417|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152581|NCT01294358|12674418|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
5152582|NCT01294358|12674414|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
5152583|NCT01294358|12674415|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
5152584|NCT01294358|12674416|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
5152585|NCT01294358|12674417|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
5152586|NCT01294358|12674418|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
5152587|NCT01294358|12674414|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152588|NCT01294358|12674415|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152589|NCT01294358|12674416|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152590|NCT01294358|12674417|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
5152591|NCT01294358|12674418|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152592|NCT01294358|12674414|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152593|NCT01294358|12674415|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152594|NCT01294358|12674416|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152595|NCT01294358|12674417|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
5152596|NCT01294358|12674418|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
5152597|NCT01294358|12674414|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
5152598|NCT01294358|12674415|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
5152599|NCT01294358|12674416|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
5152600|NCT01294358|12674417|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
5152601|NCT01294358|12674418|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
5152602|NCT01294358|12674414|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152603|NCT01294358|12674415|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152604|NCT01294358|12674416|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152605|NCT01294358|12674417|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152606|NCT01294358|12674418|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152607|NCT01294358|12674414|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152608|NCT01294358|12674415|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152609|NCT01294358|12674416|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152610|NCT01294358|12674417|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
5152611|NCT01294358|12674418|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
5152612|NCT01294358|12674414|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
5152613|NCT01294358|12674415|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
5152614|NCT01294358|12674416|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
5152615|NCT01294358|12674417|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
5152616|NCT01294358|12674418|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
5152617|NCT01294319|12674480|P8|NOT COMPLETED|Overall Study||0
5152618|NCT01294319|12674481|P7|NOT COMPLETED|Overall Study||0
5152619|NCT01294319|12674482|P6|NOT COMPLETED|Overall Study||0
5152620|NCT01294319|12674483|P5|NOT COMPLETED|Overall Study||0
5152621|NCT01294319|12674484|P4|NOT COMPLETED|Overall Study||0
5152622|NCT01294319|12674485|P3|NOT COMPLETED|Overall Study||0
5152623|NCT01294319|12674486|P2|NOT COMPLETED|Overall Study||0
5152624|NCT01294319|12674487|P1|NOT COMPLETED|Overall Study||0
5152625|NCT01294319|12674480|P8|COMPLETED|Overall Study||5
5152626|NCT01294319|12674481|P7|COMPLETED|Overall Study||5
5152627|NCT01294319|12674482|P6|COMPLETED|Overall Study||4
5152628|NCT01294319|12674483|P5|COMPLETED|Overall Study||5
5152629|NCT01294319|12674484|P4|COMPLETED|Overall Study||5
5152630|NCT01294319|12674485|P3|COMPLETED|Overall Study||5
5152631|NCT01294319|12674486|P2|COMPLETED|Overall Study||6
5152632|NCT01294319|12674487|P1|COMPLETED|Overall Study||4
5152633|NCT01294319|12674480|P8|STARTED|Overall Study||5
5152634|NCT01294319|12674481|P7|STARTED|Overall Study||5
5152635|NCT01294319|12674482|P6|STARTED|Overall Study||4
5152636|NCT01294319|12674483|P5|STARTED|Overall Study||5
5152637|NCT01294319|12674484|P4|STARTED|Overall Study||5
5152638|NCT01294319|12674485|P3|STARTED|Overall Study||5
5152639|NCT01294319|12674486|P2|STARTED|Overall Study||6
5152640|NCT01294319|12674487|P1|STARTED|Overall Study||4
5152641|NCT01294306|12674497|P2|NOT COMPLETED|Overall Study||0
5152642|NCT01294306|12674498|P1|NOT COMPLETED|Overall Study||0
5152643|NCT01294306|12674497|P2|COMPLETED|Overall Study||35
5152644|NCT01294306|12674498|P1|COMPLETED|Overall Study||45
5152645|NCT01294306|12674497|P2|STARTED|Overall Study||35
5152646|NCT01294306|12674498|P1|STARTED|Overall Study||45
5152647|NCT01294267|12674512|P1|NOT COMPLETED|Overall Study||0
5152648|NCT01294267|12674512|P1|COMPLETED|Overall Study||20
5152649|NCT01294267|12674512|P1|STARTED|Overall Study||20
5152650|NCT01294241|12674518|P1|NOT COMPLETED|Overall Study||0
5152651|NCT01294241|12674518|P1|COMPLETED|Overall Study||10
5152652|NCT01294241|12674518|P1|STARTED|Overall Study||10
5152653|NCT01294228|12674526|P1|NOT COMPLETED|Overall Study||0
5152654|NCT01294228|12674526|P1|COMPLETED|Overall Study||1001
5152655|NCT01294228|12674526|P1|STARTED|Overall Study||1001
5152656|NCT01294163|12674533|P3|NOT COMPLETED|Overall Study||3
5152657|NCT01294163|12674534|P2|NOT COMPLETED|Overall Study||0
5152658|NCT01294163|12674535|P1|NOT COMPLETED|Overall Study||1
5152659|NCT01294163|12674533|P3|COMPLETED|Overall Study||163
5152660|NCT01294163|12674534|P2|COMPLETED|Overall Study||165
5152661|NCT01294163|12674535|P1|COMPLETED|Overall Study||177
5152662|NCT01294163|12674533|P3|STARTED|Overall Study||166
5152663|NCT01294163|12674534|P2|STARTED|Overall Study||165
5152664|NCT01294163|12674535|P1|STARTED|Overall Study||178
5152665|NCT01294150|12674546|P2|NOT COMPLETED|Overall Study||2
5152666|NCT01294150|12674547|P1|NOT COMPLETED|Overall Study||2
5152667|NCT01294150|12674546|P2|COMPLETED|Overall Study||64
5152668|NCT01294150|12674547|P1|COMPLETED|Overall Study||138
5152669|NCT01294150|12674546|P2|STARTED|Overall Study||66
5152670|NCT01294150|12674547|P1|STARTED|Overall Study||140
5152671|NCT01294098|12674560|P3|NOT COMPLETED|Overall Study||1
5152672|NCT01294098|12674561|P2|NOT COMPLETED|Overall Study||1
5152673|NCT01294098|12674562|P1|NOT COMPLETED|Overall Study||0
5152674|NCT01294098|12674560|P3|COMPLETED|Overall Study||0
5152675|NCT01294098|12674561|P2|COMPLETED|Overall Study||0
5152676|NCT01294098|12674562|P1|COMPLETED|Overall Study||0
5152677|NCT01294098|12674560|P3|STARTED|Overall Study||1
5152678|NCT01294098|12674561|P2|STARTED|Overall Study||1
5152679|NCT01294098|12674562|P1|STARTED|Overall Study||0
5152680|NCT01294046|12674576|P1|NOT COMPLETED|Overall Study||3
5152681|NCT01294046|12674576|P1|COMPLETED|Overall Study||0
5152682|NCT01294046|12674576|P1|STARTED|Overall Study||3
5152683|NCT01293968|12674591|P2|NOT COMPLETED|Overall Study||3
5152684|NCT01293968|12674592|P1|NOT COMPLETED|Overall Study||3
5152685|NCT01293968|12674591|P2|COMPLETED|Overall Study||14
5152686|NCT01293968|12674592|P1|COMPLETED|Overall Study||17
5152687|NCT01293968|12674591|P2|STARTED|Overall Study||17
5152688|NCT01293968|12674592|P1|STARTED|Overall Study||20
5152689|NCT01293825|12674598|P1|NOT COMPLETED|Overall Study||10
5152690|NCT01293825|12674598|P1|COMPLETED|Overall Study||20
5152691|NCT01293825|12674598|P1|STARTED|Overall Study||30
5152692|NCT01293695|12674612|P2|NOT COMPLETED|Overall Study||7
5152693|NCT01293695|12674613|P1|NOT COMPLETED|Overall Study||15
5152694|NCT01293695|12674612|P2|COMPLETED|Overall Study||87
5152695|NCT01293695|12674613|P1|COMPLETED|Overall Study||78
5152696|NCT01293695|12674612|P2|STARTED|Overall Study||94
5152697|NCT01293695|12674613|P1|STARTED|Overall Study||93
5152698|NCT01293682|12674627|P1|NOT COMPLETED|Overall Study||0
5152699|NCT01293682|12674627|P1|COMPLETED|Overall Study||12
5152700|NCT01293682|12674627|P1|STARTED|Overall Study||12
5152701|NCT01293539|12674632|P1|NOT COMPLETED|Overall Study||1
5152702|NCT01293539|12674632|P1|COMPLETED|Overall Study||9
5152703|NCT01293539|12674632|P1|STARTED|Overall Study||10
5152704|NCT01293240|12674636|P1|NOT COMPLETED|Overall Study||2
5152705|NCT01293240|12674636|P1|COMPLETED|Overall Study||115
5152706|NCT01293240|12674636|P1|STARTED|Overall Study||117
5152707|NCT01293123|12674653|P2|NOT COMPLETED|Overall Study||1
5152708|NCT01293123|12674654|P1|NOT COMPLETED|Overall Study||0
5152709|NCT01293123|12674653|P2|COMPLETED|Overall Study||0
5152710|NCT01293123|12674654|P1|COMPLETED|Overall Study||1
5152711|NCT01293123|12674653|P2|STARTED|Overall Study||1
5152712|NCT01293123|12674654|P1|STARTED|Overall Study||1
5152713|NCT01293084|12674668|P1|NOT COMPLETED|Overall Study||5
5152714|NCT01293084|12674668|P1|COMPLETED|Overall Study||12
5152715|NCT01293084|12674668|P1|STARTED|Overall Study||17
5152716|NCT01293032|12674680|P4|NOT COMPLETED|Treatment||1
5152717|NCT01293032|12674681|P3|NOT COMPLETED|Treatment||1
5152718|NCT01293032|12674682|P2|NOT COMPLETED|Treatment||5
5152719|NCT01293032|12674683|P1|NOT COMPLETED|Treatment||2
5152720|NCT01293032|12674680|P4|COMPLETED|Treatment||13
5152721|NCT01293032|12674681|P3|COMPLETED|Treatment||10
5152722|NCT01293032|12674682|P2|COMPLETED|Treatment||14
5152723|NCT01293032|12674683|P1|COMPLETED|Treatment||10
5152724|NCT01293032|12674680|P4|STARTED|Treatment||14
5152725|NCT01293032|12674681|P3|STARTED|Treatment||11
5152726|NCT01293032|12674682|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
5152727|NCT01293032|12674683|P1|STARTED|Treatment||12
5152728|NCT01293032|12674680|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
5152729|NCT01293032|12674681|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
5152730|NCT01293032|12674682|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
5152731|NCT01293032|12674683|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
5152732|NCT01293032|12674680|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
5152733|NCT01293032|12674681|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
5152734|NCT01293032|12674682|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
5152735|NCT01293032|12674683|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
5152736|NCT01293032|12674680|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
5152737|NCT01293032|12674681|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
5152738|NCT01293032|12674682|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
5152739|NCT01293032|12674683|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
5152740|NCT01293032|12674680|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
5152741|NCT01293032|12674681|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
5152742|NCT01293032|12674682|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
5152743|NCT01293032|12674683|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
5152744|NCT01293006|12674694|P4|NOT COMPLETED|Period 2||0
5152745|NCT01293006|12674695|P3|NOT COMPLETED|Period 2||0
5152746|NCT01293006|12674696|P2|NOT COMPLETED|Period 2||0
5152747|NCT01293006|12674697|P1|NOT COMPLETED|Period 2||1
5152748|NCT01293006|12674694|P4|COMPLETED|Period 2||3
5152749|NCT01293006|12674695|P3|COMPLETED|Period 2||9
5152750|NCT01293006|12674696|P2|COMPLETED|Period 2||2
5152751|NCT01293006|12674697|P1|COMPLETED|Period 2||10
5152752|NCT01293006|12674694|P4|STARTED|Period 2||3
5152753|NCT01293006|12674695|P3|STARTED|Period 2||9
5152754|NCT01293006|12674696|P2|STARTED|Period 2||2
5152755|NCT01293006|12674697|P1|STARTED|Period 2||11
5152756|NCT01293006|12674694|P4|NOT COMPLETED|Washout||0
5152757|NCT01293006|12674695|P3|NOT COMPLETED|Washout||0
5152758|NCT01293006|12674696|P2|NOT COMPLETED|Washout||0
5152759|NCT01293006|12674697|P1|NOT COMPLETED|Washout||0
5152760|NCT01293006|12674694|P4|COMPLETED|Washout||3
5152761|NCT01293006|12674695|P3|COMPLETED|Washout||9
5152762|NCT01293006|12674696|P2|COMPLETED|Washout||2
5152763|NCT01293006|12674697|P1|COMPLETED|Washout||11
5152764|NCT01293006|12674694|P4|STARTED|Washout||3
5152765|NCT01293006|12674695|P3|STARTED|Washout||9
5152766|NCT01293006|12674696|P2|STARTED|Washout||2
5152767|NCT01293006|12674697|P1|STARTED|Washout||11
5152768|NCT01293006|12674694|P4|NOT COMPLETED|Period 1||0
5152769|NCT01293006|12674695|P3|NOT COMPLETED|Period 1||0
5152770|NCT01293006|12674696|P2|NOT COMPLETED|Period 1||0
5152771|NCT01293006|12674697|P1|NOT COMPLETED|Period 1||0
5152772|NCT01293006|12674694|P4|COMPLETED|Period 1||3
5152773|NCT01293006|12674695|P3|COMPLETED|Period 1||9
5152774|NCT01293006|12674696|P2|COMPLETED|Period 1||2
5152775|NCT01293006|12674697|P1|COMPLETED|Period 1||11
5152776|NCT01293006|12674694|P4|STARTED|Period 1||3
5152777|NCT01293006|12674695|P3|STARTED|Period 1||9
5152778|NCT01293006|12674696|P2|STARTED|Period 1||2
5152779|NCT01293006|12674697|P1|STARTED|Period 1||11
5152780|NCT01292928|12674718|P1|NOT COMPLETED|Overall Study||24
5152781|NCT01292928|12674718|P1|COMPLETED|Overall Study||275
5152782|NCT01292928|12674718|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
5152783|NCT01292928|12674718|P1|STARTED|Overall Study||299
5152784|NCT01292876|12674735|P1|NOT COMPLETED|Overall Study||4
5152785|NCT01292876|12674735|P1|COMPLETED|Overall Study||13
5152786|NCT01292876|12674735|P1|STARTED|Overall Study||17
5152787|NCT01292837|12674741|P1|NOT COMPLETED|Overall Study||2
5152788|NCT01292837|12674741|P1|COMPLETED|Overall Study||11
5152789|NCT01292837|12674741|P1|STARTED|Overall Study||13
5152790|NCT01292798|12674750|P1|NOT COMPLETED|Overall Study||0
5152791|NCT01292798|12674750|P1|COMPLETED|Overall Study||43
5152792|NCT01292798|12674750|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
5152793|NCT01292798|12674750|P1|STARTED|Overall Study||43
5152794|NCT01292746|12674756|P1|NOT COMPLETED|Overall Study||0
5152795|NCT01292746|12674756|P1|COMPLETED|Overall Study||14
5152796|NCT01292746|12674756|P1|STARTED|Overall Study||14
5152797|NCT01292642|12674760|P1|NOT COMPLETED|Overall Study||5
5152798|NCT01292642|12674760|P1|COMPLETED|Overall Study||7
5152799|NCT01292642|12674760|P1|STARTED|Overall Study||12
5152800|NCT01292629|12674768|P1|NOT COMPLETED|Overall Study||0
5152801|NCT01292629|12674768|P1|COMPLETED|Overall Study||125
5152802|NCT01292629|12674768|P1|STARTED|Overall Study||125
5152803|NCT01292603|12674778|P6|NOT COMPLETED|Overall Survival Status||10
5152804|NCT01292603|12674779|P5|NOT COMPLETED|Overall Survival Status||16
5152805|NCT01292603|12674780|P4|NOT COMPLETED|Overall Survival Status||1
5152806|NCT01292603|12674781|P3|NOT COMPLETED|Overall Survival Status||3
5152807|NCT01292603|12674782|P2|NOT COMPLETED|Overall Survival Status||1
5152808|NCT01292603|12674783|P1|NOT COMPLETED|Overall Survival Status||3
5152809|NCT01292603|12674778|P6|COMPLETED|Overall Survival Status||78
5152810|NCT01292603|12674779|P5|COMPLETED|Overall Survival Status||72
5152811|NCT01292603|12674780|P4|COMPLETED|Overall Survival Status||7
5152812|NCT01292603|12674781|P3|COMPLETED|Overall Survival Status||20
5152813|NCT01292603|12674782|P2|COMPLETED|Overall Survival Status||16
5152814|NCT01292603|12674783|P1|COMPLETED|Overall Survival Status||13
5152815|NCT01292603|12674778|P6|STARTED|Overall Survival Status||88
5152816|NCT01292603|12674779|P5|STARTED|Overall Survival Status||88
5152817|NCT01292603|12674780|P4|STARTED|Overall Survival Status||8
5152818|NCT01292603|12674781|P3|STARTED|Overall Survival Status||23
5152819|NCT01292603|12674782|P2|STARTED|Overall Survival Status||17
5152820|NCT01292603|12674783|P1|STARTED|Overall Survival Status||16
5152821|NCT01292603|12674778|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
5152822|NCT01292603|12674779|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
5152823|NCT01292603|12674780|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
5152824|NCT01292603|12674781|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
5152825|NCT01292603|12674782|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
5152826|NCT01292603|12674783|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
5152827|NCT01292603|12674778|P6|COMPLETED|Part 2: Regular Follow-Up||75
5152828|NCT01292603|12674779|P5|COMPLETED|Part 2: Regular Follow-Up||68
5152829|NCT01292603|12674780|P4|COMPLETED|Part 2: Regular Follow-Up||0
5152830|NCT01292603|12674781|P3|COMPLETED|Part 2: Regular Follow-Up||0
5152831|NCT01292603|12674782|P2|COMPLETED|Part 2: Regular Follow-Up||0
5152832|NCT01292603|12674783|P1|COMPLETED|Part 2: Regular Follow-Up||0
5152833|NCT01292603|12674778|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
5152834|NCT01292603|12674779|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
5152835|NCT01292603|12674780|P4|STARTED|Part 2: Regular Follow-Up||0
5152836|NCT01292603|12674781|P3|STARTED|Part 2: Regular Follow-Up||0
5152837|NCT01292603|12674782|P2|STARTED|Part 2: Regular Follow-Up||0
5152838|NCT01292603|12674783|P1|STARTED|Part 2: Regular Follow-Up||0
5152839|NCT01292603|12674778|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
5152840|NCT01292603|12674779|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
5152841|NCT01292603|12674780|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
5152842|NCT01292603|12674781|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
5152843|NCT01292603|12674782|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
5152844|NCT01292603|12674783|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
5152845|NCT01292603|12674778|P6|COMPLETED|Part 2: Dose Confirmation Period||73
5152846|NCT01292603|12674779|P5|COMPLETED|Part 2: Dose Confirmation Period||72
5152847|NCT01292603|12674780|P4|COMPLETED|Part 2: Dose Confirmation Period||0
5152848|NCT01292603|12674781|P3|COMPLETED|Part 2: Dose Confirmation Period||0
5152849|NCT01292603|12674782|P2|COMPLETED|Part 2: Dose Confirmation Period||0
5152850|NCT01292603|12674783|P1|COMPLETED|Part 2: Dose Confirmation Period||0
5152851|NCT01292603|12674778|P6|STARTED|Part 2: Dose Confirmation Period||88
5152852|NCT01292603|12674779|P5|STARTED|Part 2: Dose Confirmation Period||88
5152853|NCT01292603|12674780|P4|STARTED|Part 2: Dose Confirmation Period||0
5152854|NCT01292603|12674781|P3|STARTED|Part 2: Dose Confirmation Period||0
5152855|NCT01292603|12674782|P2|STARTED|Part 2: Dose Confirmation Period||0
5152856|NCT01292603|12674783|P1|STARTED|Part 2: Dose Confirmation Period||0
5152857|NCT01292603|12674778|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
5152858|NCT01292603|12674779|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
5152859|NCT01292603|12674780|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
5152860|NCT01292603|12674781|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
5152861|NCT01292603|12674782|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
5152862|NCT01292603|12674783|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
5152863|NCT01292603|12674778|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
5152864|NCT01292603|12674779|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
5152865|NCT01292603|12674780|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
5152866|NCT01292603|12674781|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
5152867|NCT01292603|12674782|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
5152868|NCT01292603|12674783|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
5152869|NCT01292603|12674778|P6|STARTED|Part 1: Regular Follow-Up Period||0
5152870|NCT01292603|12674779|P5|STARTED|Part 1: Regular Follow-Up Period||0
5152871|NCT01292603|12674780|P4|STARTED|Part 1: Regular Follow-Up Period||8
5152872|NCT01292603|12674781|P3|STARTED|Part 1: Regular Follow-Up Period||23
5152873|NCT01292603|12674782|P2|STARTED|Part 1: Regular Follow-Up Period||17
5152874|NCT01292603|12674783|P1|STARTED|Part 1: Regular Follow-Up Period||16
5152875|NCT01292603|12674778|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
5152876|NCT01292603|12674779|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
5152877|NCT01292603|12674780|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
5152878|NCT01292603|12674781|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
5152879|NCT01292603|12674782|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
5152880|NCT01292603|12674783|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
5152881|NCT01292603|12674778|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
5152882|NCT01292603|12674779|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
5152883|NCT01292603|12674780|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
5152884|NCT01292603|12674781|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
5152885|NCT01292603|12674782|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
5152886|NCT01292603|12674783|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
5152887|NCT01292603|12674778|P6|STARTED|Part 1: Pilot Dose Selection Period||0
5152888|NCT01292603|12674779|P5|STARTED|Part 1: Pilot Dose Selection Period||0
5152889|NCT01292603|12674780|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
5152890|NCT01292603|12674781|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
5152891|NCT01292603|12674782|P2|STARTED|Part 1: Pilot Dose Selection Period||17
5152892|NCT01292603|12674783|P1|STARTED|Part 1: Pilot Dose Selection Period||16
5152893|NCT01292538|12674829|P2|NOT COMPLETED|Overall Study||0
5152894|NCT01292538|12674830|P1|NOT COMPLETED|Overall Study||0
5152895|NCT01292538|12674829|P2|COMPLETED|Overall Study||32
5152896|NCT01292538|12674830|P1|COMPLETED|Overall Study||35
5152897|NCT01292538|12674829|P2|STARTED|Overall Study||32
5152898|NCT01292538|12674830|P1|STARTED|Overall Study||35
5152899|NCT01292486|12674836|P1|NOT COMPLETED|Overall Study||6
5152900|NCT01292486|12674836|P1|COMPLETED|Overall Study||26
5152901|NCT01292486|12674836|P1|STARTED|Overall Study||32
5152902|NCT01292473|12674850|P4|NOT COMPLETED|Overall Study||12
5152903|NCT01292473|12674851|P3|NOT COMPLETED|Overall Study||9
5152904|NCT01292473|12674852|P2|NOT COMPLETED|Overall Study||7
5152905|NCT01292473|12674853|P1|NOT COMPLETED|Overall Study||5
5152906|NCT01292473|12674850|P4|COMPLETED|Overall Study||67
5152907|NCT01292473|12674851|P3|COMPLETED|Overall Study||74
5152908|NCT01292473|12674852|P2|COMPLETED|Overall Study||75
5152909|NCT01292473|12674853|P1|COMPLETED|Overall Study||74
5152910|NCT01292473|12674850|P4|STARTED|Overall Study||79
5152911|NCT01292473|12674851|P3|STARTED|Overall Study||83
5152912|NCT01292473|12674852|P2|STARTED|Overall Study||82
5152913|NCT01292473|12674853|P1|STARTED|Overall Study||79
5152914|NCT01292304|12674895|P1|NOT COMPLETED|Overall Study||0
5152915|NCT01292304|12674895|P1|COMPLETED|Overall Study||10
5152916|NCT01292304|12674895|P1|STARTED|Overall Study||10
5152917|NCT01292265|12674903|P1|NOT COMPLETED|Overall Study||0
5152918|NCT01292265|12674903|P1|COMPLETED|Overall Study||3
5152919|NCT01292265|12674903|P1|STARTED|Overall Study||3
5152920|NCT01292239|12674912|P2|NOT COMPLETED|Overall Study||7
5152921|NCT01292239|12674913|P1|NOT COMPLETED|Overall Study||4
5152922|NCT01292239|12674912|P2|COMPLETED|Overall Study||53
5152923|NCT01292239|12674913|P1|COMPLETED|Overall Study||119
5152924|NCT01292239|12674912|P2|STARTED|Overall Study||60
5152925|NCT01292239|12674913|P1|STARTED|Overall Study||123
5152926|NCT01292226|12674934|P1|NOT COMPLETED|Overall Study||13
5152927|NCT01292226|12674934|P1|COMPLETED|Overall Study||32
5152928|NCT01292226|12674934|P1|STARTED|Overall Study||45
5152929|NCT01292187|12674967|P2|NOT COMPLETED|Overall Study||13
5152930|NCT01292187|12674968|P1|NOT COMPLETED|Overall Study||17
5152931|NCT01292187|12674967|P2|COMPLETED|Overall Study||30
5152932|NCT01292187|12674968|P1|COMPLETED|Overall Study||69
5152933|NCT01292187|12674967|P2|STARTED|Overall Study||43
5152934|NCT01292187|12674968|P1|STARTED|Overall Study||86
5152935|NCT01292135|12674978|P2|NOT COMPLETED|Overall Study||9
5152936|NCT01292135|12674979|P1|NOT COMPLETED|Overall Study||0
5152937|NCT01292135|12674978|P2|COMPLETED|Overall Study||21
5152938|NCT01292135|12674979|P1|COMPLETED|Overall Study||3
5152939|NCT01292135|12674978|P2|STARTED|Overall Study||30
5152940|NCT01292135|12674979|P1|STARTED|Overall Study||3
5152941|NCT01292070|12674997|P1|NOT COMPLETED|Overall Study||0
5152942|NCT01292070|12674997|P1|COMPLETED|Overall Study||4
5152943|NCT01292070|12674997|P1|STARTED|Overall Study||4
5152944|NCT01292057|12675003|P2|NOT COMPLETED|Overall Study||2
5152945|NCT01292057|12675004|P1|NOT COMPLETED|Overall Study||2
5152946|NCT01292057|12675003|P2|COMPLETED|Overall Study||48
5152947|NCT01292057|12675004|P1|COMPLETED|Overall Study||47
5152948|NCT01292057|12675003|P2|STARTED|Overall Study||50
5152949|NCT01292057|12675004|P1|STARTED|Overall Study||49
5152950|NCT01292005|12675014|P2|NOT COMPLETED|Overall Study||0
5152951|NCT01292005|12675015|P1|NOT COMPLETED|Overall Study||0
5152952|NCT01292005|12675014|P2|COMPLETED|Overall Study||14
5152953|NCT01292005|12675015|P1|COMPLETED|Overall Study||14
5152954|NCT01292005|12675014|P2|STARTED|Overall Study||14
5152955|NCT01292005|12675015|P1|STARTED|Overall Study||14
5152956|NCT01291836|12675039|P2|NOT COMPLETED|Overall Study||0
5152957|NCT01291836|12675040|P1|NOT COMPLETED|Overall Study||0
5152958|NCT01291836|12675039|P2|COMPLETED|Overall Study||71
5152959|NCT01291836|12675040|P1|COMPLETED|Overall Study||930
5152960|NCT01291836|12675039|P2|STARTED|Overall Study||71
5152961|NCT01291836|12675040|P1|STARTED|Overall Study||930
5152962|NCT01291784|12675046|P3|NOT COMPLETED|Overall Study||0
5152963|NCT01291784|12675047|P2|NOT COMPLETED|Overall Study||1
5152964|NCT01291784|12675048|P1|NOT COMPLETED|Overall Study||0
5152965|NCT01291784|12675046|P3|COMPLETED|Overall Study||1
5152966|NCT01291784|12675047|P2|COMPLETED|Overall Study||0
5152967|NCT01291784|12675048|P1|COMPLETED|Overall Study||1
5152968|NCT01291784|12675046|P3|STARTED|Overall Study||1
5152969|NCT01291784|12675047|P2|STARTED|Overall Study||1
5152970|NCT01291784|12675048|P1|STARTED|Overall Study||1
5152971|NCT01291498|12675068|P1|NOT COMPLETED|Overall Study||1
5152972|NCT01291498|12675068|P1|COMPLETED|Overall Study||0
5152973|NCT01291498|12675068|P1|STARTED|Overall Study||1
5152974|NCT01291277|12675076|P2|NOT COMPLETED|Overall Study||3
5152975|NCT01291277|12675077|P1|NOT COMPLETED|Overall Study||5
5152976|NCT01291277|12675076|P2|COMPLETED|Overall Study||42
5152977|NCT01291277|12675077|P1|COMPLETED|Overall Study||40
5152978|NCT01291277|12675076|P2|STARTED|Overall Study||45
5152979|NCT01291277|12675077|P1|STARTED|Overall Study||45
5152980|NCT01291264|12675083|P1|NOT COMPLETED|Overall Study||0
5152981|NCT01291264|12675083|P1|COMPLETED|Overall Study||260
5152982|NCT01291264|12675083|P1|STARTED|Overall Study||260
5152983|NCT01291225|12675089|P2|NOT COMPLETED|Overall Study||39
5152984|NCT01291225|12675090|P1|NOT COMPLETED|Overall Study||85
5152985|NCT01291225|12675089|P2|COMPLETED|Overall Study||121
5152986|NCT01291225|12675090|P1|COMPLETED|Overall Study||66
5152987|NCT01291225|12675089|P2|STARTED|Overall Study||160
5152988|NCT01291225|12675090|P1|STARTED|Overall Study||151
5152989|NCT01291173|12675104|P4|NOT COMPLETED|Overall Study||13
5152990|NCT01291173|12675105|P3|NOT COMPLETED|Overall Study||13
5152991|NCT01291173|12675106|P2|NOT COMPLETED|Overall Study||15
5152992|NCT01291173|12675107|P1|NOT COMPLETED|Overall Study||17
5152993|NCT01291173|12675104|P4|COMPLETED|Overall Study||52
5152994|NCT01291173|12675105|P3|COMPLETED|Overall Study||52
5152995|NCT01291173|12675106|P2|COMPLETED|Overall Study||51
5152996|NCT01291173|12675107|P1|COMPLETED|Overall Study||47
5152997|NCT01291173|12675104|P4|STARTED|Overall Study||65
5152998|NCT01291173|12675105|P3|STARTED|Overall Study||65
5152999|NCT01291173|12675106|P2|STARTED|Overall Study||66
5153000|NCT01291173|12675107|P1|STARTED|Overall Study||64
5153001|NCT01291160|12675171|P2|NOT COMPLETED|Overall Study||16
5153002|NCT01291160|12675172|P1|NOT COMPLETED|Overall Study||18
5153003|NCT01291160|12675171|P2|COMPLETED|Overall Study||48
5153004|NCT01291160|12675172|P1|COMPLETED|Overall Study||48
5153005|NCT01291160|12675171|P2|STARTED|Overall Study||64
5153006|NCT01291160|12675172|P1|STARTED|Overall Study||66
5153007|NCT01291108|12675182|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
5153008|NCT01291108|12675183|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
5153009|NCT01291108|12675184|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
5153010|NCT01291108|12675185|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
5153011|NCT01291108|12675186|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
5153012|NCT01291108|12675187|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
5153013|NCT01291108|12675182|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
5153014|NCT01291108|12675183|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
5153015|NCT01291108|12675184|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
5153016|NCT01291108|12675185|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
5153017|NCT01291108|12675186|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
5153018|NCT01291108|12675187|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
5153019|NCT01291108|12675182|P6|STARTED|Month 2 (Adjunctive Therapy)||26
5153020|NCT01291108|12675183|P5|STARTED|Month 2 (Adjunctive Therapy)||34
5153021|NCT01291108|12675184|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
5153022|NCT01291108|12675185|P3|STARTED|Month 2 (Adjunctive Therapy)||24
5153023|NCT01291108|12675186|P2|STARTED|Month 2 (Adjunctive Therapy)||40
5153024|NCT01291108|12675187|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
5153025|NCT01291108|12675182|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
5153026|NCT01291108|12675183|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
5153027|NCT01291108|12675184|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
5153028|NCT01291108|12675185|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
5153029|NCT01291108|12675186|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
5153030|NCT01291108|12675187|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
5153031|NCT01291108|12675182|P6|COMPLETED|Month 1 (Monotherapy)||0
5153032|NCT01291108|12675183|P5|COMPLETED|Month 1 (Monotherapy)||0
5153033|NCT01291108|12675184|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
5153034|NCT01291108|12675185|P3|COMPLETED|Month 1 (Monotherapy)||0
5153035|NCT01291108|12675186|P2|COMPLETED|Month 1 (Monotherapy)||0
5153036|NCT01291108|12675187|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
5153037|NCT01291108|12675182|P6|STARTED|Month 1 (Monotherapy)||0
5153038|NCT01291108|12675183|P5|STARTED|Month 1 (Monotherapy)||0
5153039|NCT01291108|12675184|P4|STARTED|Month 1 (Monotherapy)||60
5153040|NCT01291108|12675185|P3|STARTED|Month 1 (Monotherapy)||0
5153041|NCT01291108|12675186|P2|STARTED|Month 1 (Monotherapy)||0
5153042|NCT01291108|12675187|P1|STARTED|Month 1 (Monotherapy)||65
5153043|NCT01291056|12675203|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
5153044|NCT01291056|12675204|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
5153045|NCT01291056|12675203|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
5153046|NCT01291056|12675204|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
5153047|NCT01291056|12675203|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
5153048|NCT01291056|12675204|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
5153049|NCT01291056|12675203|P2|NOT COMPLETED|Washout||0
5153050|NCT01291056|12675204|P1|NOT COMPLETED|Washout||0
5153051|NCT01291056|12675203|P2|COMPLETED|Washout||10
5153052|NCT01291056|12675204|P1|COMPLETED|Washout||10
5153053|NCT01291056|12675203|P2|STARTED|Washout||10
5153054|NCT01291056|12675204|P1|STARTED|Washout||10
5153055|NCT01291056|12675203|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
5153056|NCT01291056|12675204|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
5153057|NCT01291056|12675203|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
5153058|NCT01291056|12675204|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
5153059|NCT01291056|12675203|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
5153060|NCT01291056|12675204|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
5153061|NCT01291017|12675216|P1|NOT COMPLETED|Overall Study||5
5153062|NCT01291017|12675216|P1|COMPLETED|Overall Study||14
5153063|NCT01291017|12675216|P1|STARTED|Overall Study||19
5153064|NCT01290978|12675224|P1|NOT COMPLETED|Overall Study||0
5153065|NCT01290978|12675224|P1|COMPLETED|Overall Study||22
5153066|NCT01290978|12675224|P1|STARTED|Overall Study||22
5153067|NCT01290952|12675233|P2|NOT COMPLETED|Overall Study||14
5153068|NCT01290952|12675234|P1|NOT COMPLETED|Overall Study||12
5153069|NCT01290952|12675233|P2|COMPLETED|Overall Study||193
5153070|NCT01290952|12675234|P1|COMPLETED|Overall Study||192
5153071|NCT01290952|12675233|P2|STARTED|Overall Study||207
5153072|NCT01290952|12675234|P1|STARTED|Overall Study||204
5153073|NCT01290913|12675242|P1|NOT COMPLETED|Overall Study||1
5153074|NCT01290913|12675242|P1|COMPLETED|Overall Study||12
5153075|NCT01290913|12675242|P1|STARTED|Overall Study||13
5153076|NCT01290887|12675249|P2|NOT COMPLETED|Overall Study||536
5153077|NCT01290887|12675250|P1|NOT COMPLETED|Overall Study||466
5153078|NCT01290887|12675249|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
5153079|NCT01290887|12675250|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
5153080|NCT01290887|12675249|P2|Safety Analysis Set|Overall Study||571
5153081|NCT01290887|12675250|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
5153082|NCT01290887|12675249|P2|STARTED|Overall Study||571
5153083|NCT01290887|12675250|P1|STARTED|Overall Study||481
5153084|NCT01290874|12675290|P2|NOT COMPLETED|Overall Study||404
5153085|NCT01290874|12675291|P1|NOT COMPLETED|Overall Study||410
5153086|NCT01290874|12675290|P2|COMPLETED|Overall Study||134
5153087|NCT01290874|12675291|P1|COMPLETED|Overall Study||122
5153088|NCT01290874|12675290|P2|STARTED|Overall Study||538
5153089|NCT01290874|12675291|P1|STARTED|Overall Study||532
5153090|NCT01290822|12675311|P1|NOT COMPLETED|Overall Study||11
5153091|NCT01290822|12675311|P1|COMPLETED|Overall Study||1
5153092|NCT01290822|12675311|P1|STARTED|Overall Study||12
5153093|NCT01290796|12675320|P1|NOT COMPLETED|Overall Study||30
5153094|NCT01290796|12675320|P1|COMPLETED|Overall Study||123
5153095|NCT01290796|12675320|P1|STARTED|Overall Study||153
5153096|NCT01290757|12675336|P2|NOT COMPLETED|Overall Study||2
5153097|NCT01290757|12675337|P1|NOT COMPLETED|Overall Study||2
5153098|NCT01290757|12675336|P2|COMPLETED|Overall Study||88
5153099|NCT01290757|12675337|P1|COMPLETED|Overall Study||88
5153100|NCT01290757|12675336|P2|STARTED|Overall Study||90
5153101|NCT01290757|12675337|P1|STARTED|Overall Study||90
5153102|NCT01290731|12675353|P1|NOT COMPLETED|Overall Study||1
5153103|NCT01290731|12675353|P1|COMPLETED|Overall Study||48
5153104|NCT01290731|12675353|P1|STARTED|Overall Study||49
5153105|NCT01290718|12675365|P1|NOT COMPLETED|Overall Study||4
5153106|NCT01290718|12675365|P1|COMPLETED|Overall Study||0
5153107|NCT01290718|12675365|P1|STARTED|Overall Study||4
5153108|NCT01290679|12675374|P2|NOT COMPLETED|Overall Study||21
5153109|NCT01290679|12675375|P1|NOT COMPLETED|Overall Study||16
5153110|NCT01290679|12675374|P2|COMPLETED|Overall Study||113
5153111|NCT01290679|12675375|P1|COMPLETED|Overall Study||241
5153112|NCT01290679|12675374|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
5153113|NCT01290679|12675375|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
5153114|NCT01290666|12675444|P1|NOT COMPLETED|Overall Study||38
5153115|NCT01290666|12675444|P1|COMPLETED|Overall Study||55
5153116|NCT01290666|12675444|P1|STARTED|Overall Study||93
5153117|NCT01290640|12675450|P2|NOT COMPLETED|Overall Study||0
5153118|NCT01290640|12675451|P1|NOT COMPLETED|Overall Study||0
5153119|NCT01290640|12675450|P2|COMPLETED|Overall Study||10
5153120|NCT01290640|12675451|P1|COMPLETED|Overall Study||12
5153121|NCT01290640|12675450|P2|STARTED|Overall Study||10
5153122|NCT01290640|12675451|P1|STARTED|Overall Study||12
5153123|NCT01290627|12675462|P3|NOT COMPLETED|Overall Study||0
5153124|NCT01290627|12675463|P2|NOT COMPLETED|Overall Study||0
5153125|NCT01290627|12675464|P1|NOT COMPLETED|Overall Study||0
5153126|NCT01290627|12675462|P3|COMPLETED|Overall Study||10
5153127|NCT01290627|12675463|P2|COMPLETED|Overall Study||10
5153128|NCT01290627|12675464|P1|COMPLETED|Overall Study||10
5153129|NCT01290627|12675462|P3|STARTED|Overall Study||10
5153130|NCT01290627|12675463|P2|STARTED|Overall Study||10
5153131|NCT01290627|12675464|P1|STARTED|Overall Study||10
5153132|NCT01290614|12675486|P2|NOT COMPLETED|Overall Study||0
5153133|NCT01290614|12675487|P1|NOT COMPLETED|Overall Study||552
5153134|NCT01290614|12675486|P2|COMPLETED|Overall Study||1129
5153135|NCT01290614|12675487|P1|COMPLETED|Overall Study||518
5153136|NCT01290614|12675486|P2|STARTED|Overall Study||1129
5153137|NCT01290614|12675487|P1|STARTED|Overall Study||1070
5153138|NCT01290601|12675497|P4|NOT COMPLETED|Overall Study||0
5153139|NCT01290601|12675498|P3|NOT COMPLETED|Overall Study||0
5153140|NCT01290601|12675499|P2|NOT COMPLETED|Overall Study||5
5153141|NCT01290601|12675500|P1|NOT COMPLETED|Overall Study||11
5153142|NCT01290601|12675497|P4|COMPLETED|Overall Study||0
5153143|NCT01290601|12675498|P3|COMPLETED|Overall Study||0
5153144|NCT01290601|12675499|P2|COMPLETED|Overall Study||19
5153145|NCT01290601|12675500|P1|COMPLETED|Overall Study||35
5153146|NCT01290601|12675497|P4|STARTED|Overall Study||0
5153147|NCT01290601|12675498|P3|STARTED|Overall Study||0
5153148|NCT01290601|12675499|P2|STARTED|Overall Study||24
5153149|NCT01290601|12675500|P1|STARTED|Overall Study||46
5153150|NCT01290536|12675514|P1|NOT COMPLETED|Overall Study||0
5153151|NCT01290536|12675514|P1|COMPLETED|Overall Study||42
5153152|NCT01290536|12675514|P1|STARTED|Overall Study||42
5153153|NCT01290523|12675521|P1|NOT COMPLETED|Overall Study||3
5153154|NCT01290523|12675521|P1|COMPLETED|Overall Study||11
5153155|NCT01290523|12675521|P1|STARTED|Overall Study||14
5153156|NCT01290484|12675526|P1|NOT COMPLETED|Overall Study||0
5153157|NCT01290484|12675526|P1|COMPLETED|Overall Study||7
5153158|NCT01290484|12675526|P1|STARTED|Overall Study||7
5153159|NCT01290445|12675533|P3|NOT COMPLETED|Overall Study||0
5153160|NCT01290445|12675534|P2|NOT COMPLETED|Overall Study||0
5153161|NCT01290445|12675535|P1|NOT COMPLETED|Overall Study||0
5153162|NCT01290445|12675533|P3|COMPLETED|Overall Study||806438
5153163|NCT01290445|12675534|P2|COMPLETED|Overall Study||78412
5153164|NCT01290445|12675535|P1|COMPLETED|Overall Study||335
5153165|NCT01290445|12675533|P3|STARTED|Overall Study||806438
5153166|NCT01290445|12675534|P2|STARTED|Overall Study||78412
5153167|NCT01290445|12675535|P1|STARTED|Overall Study||335
5153168|NCT01290341|12675560|P2|NOT COMPLETED|Overall Study||29
5153169|NCT01290341|12675561|P1|NOT COMPLETED|Overall Study||92
5153170|NCT01290341|12675560|P2|COMPLETED|Overall Study||258
5153171|NCT01290341|12675561|P1|COMPLETED|Overall Study||481
5153172|NCT01290341|12675560|P2|STARTED|Overall Study||287
5153173|NCT01290341|12675561|P1|STARTED|Overall Study||573
5153174|NCT01290315|12675573|P4|NOT COMPLETED|Overall Study||5
5153175|NCT01290315|12675574|P3|NOT COMPLETED|Overall Study||0
5153176|NCT01290315|12675575|P2|NOT COMPLETED|Overall Study||3
5153177|NCT01290315|12675576|P1|NOT COMPLETED|Overall Study||3
5153178|NCT01290315|12675573|P4|COMPLETED|Overall Study||8
5153179|NCT01290315|12675574|P3|COMPLETED|Overall Study||10
5153180|NCT01290315|12675575|P2|COMPLETED|Overall Study||9
5153181|NCT01290315|12675576|P1|COMPLETED|Overall Study||11
5153182|NCT01290315|12675573|P4|STARTED|Overall Study||13
5153183|NCT01290315|12675574|P3|STARTED|Overall Study||10
5153184|NCT01290315|12675575|P2|STARTED|Overall Study||12
5153185|NCT01290315|12675576|P1|STARTED|Overall Study||14
5153186|NCT01290263|12675598|P5|NOT COMPLETED|Overall Study||37
5153187|NCT01290263|12675599|P4|NOT COMPLETED|Overall Study||27
5153188|NCT01290263|12675600|P3|NOT COMPLETED|Overall Study||7
5153189|NCT01290263|12675601|P2|NOT COMPLETED|Overall Study||3
5153190|NCT01290263|12675602|P1|NOT COMPLETED|Overall Study||11
5153191|NCT01290263|12675598|P5|COMPLETED|Overall Study||0
5153192|NCT01290263|12675599|P4|COMPLETED|Overall Study||0
5153193|NCT01290263|12675600|P3|COMPLETED|Overall Study||0
5153194|NCT01290263|12675601|P2|COMPLETED|Overall Study||0
5153195|NCT01290263|12675602|P1|COMPLETED|Overall Study||0
5153196|NCT01290263|12675598|P5|STARTED|Overall Study||37
5153197|NCT01290263|12675599|P4|STARTED|Overall Study||27
5153198|NCT01290263|12675600|P3|STARTED|Overall Study||7
5153199|NCT01290263|12675601|P2|STARTED|Overall Study||3
5153200|NCT01290263|12675602|P1|STARTED|Overall Study||11
5153201|NCT01290237|12675620|P2|NOT COMPLETED|Overall Study||2
5153202|NCT01290237|12675621|P1|NOT COMPLETED|Overall Study||11
5153203|NCT01290237|12675620|P2|COMPLETED|Overall Study||27
5153204|NCT01290237|12675621|P1|COMPLETED|Overall Study||19
5153205|NCT01290237|12675620|P2|STARTED|Overall Study||29
5153206|NCT01290237|12675621|P1|STARTED|Overall Study||30
5153207|NCT01290224|12675629|P1|NOT COMPLETED|Overall Study||5
5153208|NCT01290224|12675629|P1|COMPLETED|Overall Study||5
5153209|NCT01290224|12675629|P1|STARTED|Overall Study||10
5153210|NCT01290094|12675640|P1|NOT COMPLETED|Overall Study||6
5153211|NCT01290094|12675640|P1|COMPLETED|Overall Study||35
5153212|NCT01290094|12675640|P1|STARTED|Overall Study||41
5153213|NCT01290068|12675653|P2|NOT COMPLETED|Overall Study||6
5153214|NCT01290068|12675654|P1|NOT COMPLETED|Overall Study||7
5153215|NCT01290068|12675653|P2|COMPLETED|Overall Study||94
5153216|NCT01290068|12675654|P1|COMPLETED|Overall Study||101
5153217|NCT01290068|12675653|P2|Implanted|Overall Study||98
5153218|NCT01290068|12675654|P1|Implanted|Overall Study||108
5153219|NCT01290068|12675653|P2|STARTED|Overall Study||100
5153220|NCT01290068|12675654|P1|STARTED|Overall Study||108
5153221|NCT01290029|12675666|P1|NOT COMPLETED|Overall Study||2
5153222|NCT01290029|12675666|P1|COMPLETED|Overall Study||12
5153223|NCT01290029|12675666|P1|Received Study Treatment|Overall Study||12
5153224|NCT01290029|12675666|P1|STARTED|Overall Study||14
5153225|NCT01289990|12675692|P13|NOT COMPLETED|Overall Study||98
5153226|NCT01289990|12675693|P12|NOT COMPLETED|Overall Study||68
5153227|NCT01289990|12675694|P11|NOT COMPLETED|Overall Study||76
5153228|NCT01289990|12675695|P10|NOT COMPLETED|Overall Study||86
5153229|NCT01289990|12675696|P9|NOT COMPLETED|Overall Study||75
5153230|NCT01289990|12675697|P8|NOT COMPLETED|Overall Study||55
5153231|NCT01289990|12675698|P7|NOT COMPLETED|Overall Study||88
5153232|NCT01289990|12675699|P6|NOT COMPLETED|Overall Study||74
5153233|NCT01289990|12675700|P5|NOT COMPLETED|Overall Study||72
5153234|NCT01289990|12675701|P4|NOT COMPLETED|Overall Study||87
5153235|NCT01289990|12675702|P3|NOT COMPLETED|Overall Study||109
5153236|NCT01289990|12675703|P2|NOT COMPLETED|Overall Study||81
5153237|NCT01289990|12675704|P1|NOT COMPLETED|Overall Study||77
5153238|NCT01289990|12675692|P13|COMPLETED|Overall Study||127
5153239|NCT01289990|12675693|P12|COMPLETED|Overall Study||150
5153240|NCT01289990|12675694|P11|COMPLETED|Overall Study||150
5153241|NCT01289990|12675695|P10|COMPLETED|Overall Study||121
5153242|NCT01289990|12675696|P9|COMPLETED|Overall Study||139
5153243|NCT01289990|12675697|P8|COMPLETED|Overall Study||162
5153244|NCT01289990|12675698|P7|COMPLETED|Overall Study||78
5153245|NCT01289990|12675699|P6|COMPLETED|Overall Study||94
5153246|NCT01289990|12675700|P5|COMPLETED|Overall Study||93
5153247|NCT01289990|12675701|P4|COMPLETED|Overall Study||136
5153248|NCT01289990|12675702|P3|COMPLETED|Overall Study||119
5153249|NCT01289990|12675703|P2|COMPLETED|Overall Study||143
5153250|NCT01289990|12675704|P1|COMPLETED|Overall Study||147
5153251|NCT01289990|12675692|P13|STARTED|Overall Study||225
5153252|NCT01289990|12675693|P12|STARTED|Overall Study||218
5153253|NCT01289990|12675694|P11|STARTED|Overall Study||226
5153254|NCT01289990|12675695|P10|STARTED|Overall Study||207
5153255|NCT01289990|12675696|P9|STARTED|Overall Study||214
5153256|NCT01289990|12675697|P8|STARTED|Overall Study||217
5153257|NCT01289990|12675698|P7|STARTED|Overall Study||166
5153258|NCT01289990|12675699|P6|STARTED|Overall Study||168
5153259|NCT01289990|12675700|P5|STARTED|Overall Study||165
5153260|NCT01289990|12675701|P4|STARTED|Overall Study||223
5153261|NCT01289990|12675702|P3|STARTED|Overall Study||228
5153262|NCT01289990|12675703|P2|STARTED|Overall Study||224
5153263|NCT01289990|12675704|P1|STARTED|Overall Study||224
5153264|NCT01289912|12675890|P2|NOT COMPLETED|Overall Study||2
5153265|NCT01289912|12675891|P1|NOT COMPLETED|Overall Study||3
5153266|NCT01289912|12675890|P2|COMPLETED|Overall Study||13
5153267|NCT01289912|12675891|P1|COMPLETED|Overall Study||29
5153268|NCT01289912|12675890|P2|STARTED|Overall Study||15
5153269|NCT01289912|12675891|P1|STARTED|Overall Study||32
5153270|NCT01289847|12675921|P1|NOT COMPLETED|Overall Study||1
5153271|NCT01289847|12675921|P1|COMPLETED|Overall Study||24
5153272|NCT01289847|12675921|P1|STARTED|Overall Study||25
5153273|NCT01289821|12675930|P1|NOT COMPLETED|Survival Follow-up Period||18
5153274|NCT01289821|12675930|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
5153275|NCT01289821|12675930|P1|STARTED|Survival Follow-up Period||52
5153276|NCT01289821|12675930|P1|NOT COMPLETED|Safety Follow-up Period||5
5153277|NCT01289821|12675930|P1|COMPLETED|Safety Follow-up Period||49
5153278|NCT01289821|12675930|P1|STARTED|Safety Follow-up Period||54
5153279|NCT01289821|12675930|P1|NOT COMPLETED|Treatment Period||54
5153280|NCT01289821|12675930|P1|COMPLETED|Treatment Period||0
5153281|NCT01289821|12675930|P1|Participants Received Regorafenib|Treatment Period||54
5153282|NCT01289821|12675930|P1|STARTED|Treatment Period||54
5153283|NCT01289782|12675941|P2|NOT COMPLETED|Overall Study||12
5153284|NCT01289782|12675942|P1|NOT COMPLETED|Overall Study||25
5153285|NCT01289782|12675941|P2|COMPLETED|Overall Study||118
5153286|NCT01289782|12675942|P1|COMPLETED|Overall Study||239
5153287|NCT01289782|12675941|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
5153288|NCT01289782|12675942|P1|STARTED|Overall Study||264
5153289|NCT01289678|12676011|P1|NOT COMPLETED|Overall Study||6
5153290|NCT01289678|12676011|P1|COMPLETED|Overall Study||12
5153291|NCT01289678|12676011|P1|STARTED|Overall Study||18
5153292|NCT01289639|12676018|P3|NOT COMPLETED|Overall Study||0
5153293|NCT01289639|12676019|P2|NOT COMPLETED|Overall Study||0
5153294|NCT01289639|12676020|P1|NOT COMPLETED|Overall Study||1
5153295|NCT01289639|12676018|P3|COMPLETED|Overall Study||0
5153296|NCT01289639|12676019|P2|COMPLETED|Overall Study||6
5153297|NCT01289639|12676020|P1|COMPLETED|Overall Study||4
5153298|NCT01289639|12676018|P3|STARTED|Overall Study||0
5153299|NCT01289639|12676019|P2|STARTED|Overall Study||6
5153300|NCT01289639|12676020|P1|STARTED|Overall Study||5
5153301|NCT01289574|12676046|P3|NOT COMPLETED|Overall Study||3
5153302|NCT01289574|12676047|P2|NOT COMPLETED|Overall Study||3
5153303|NCT01289574|12676048|P1|NOT COMPLETED|Overall Study||7
5153304|NCT01289574|12676046|P3|COMPLETED|Overall Study||60
5153305|NCT01289574|12676047|P2|COMPLETED|Overall Study||57
5153306|NCT01289574|12676048|P1|COMPLETED|Overall Study||51
5153307|NCT01289574|12676046|P3|STARTED|Overall Study||63
5153308|NCT01289574|12676047|P2|STARTED|Overall Study||60
5153309|NCT01289574|12676048|P1|STARTED|Overall Study||58
5153310|NCT01289548|12676065|P3|NOT COMPLETED|Overall Study||0
5153311|NCT01289548|12676066|P2|NOT COMPLETED|Overall Study||0
5153312|NCT01289548|12676067|P1|NOT COMPLETED|Overall Study||0
5153313|NCT01289548|12676065|P3|COMPLETED|Overall Study||40
5153314|NCT01289548|12676066|P2|COMPLETED|Overall Study||40
5153315|NCT01289548|12676067|P1|COMPLETED|Overall Study||40
5153316|NCT01289548|12676065|P3|Recipients|Overall Study||20
5153317|NCT01289548|12676066|P2|Recipients|Overall Study||20
5153318|NCT01289548|12676067|P1|Recipients|Overall Study||20
5153319|NCT01289548|12676065|P3|Donors|Overall Study||20
5153320|NCT01289548|12676066|P2|Donors|Overall Study||20
5153321|NCT01289548|12676067|P1|Donors|Overall Study||20
5153322|NCT01289548|12676065|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
5153323|NCT01289548|12676066|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
5153324|NCT01289548|12676067|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
5153325|NCT01289522|12676111|P1|NOT COMPLETED|Overall Study||11
5153326|NCT01289522|12676111|P1|COMPLETED|Overall Study||43
5153327|NCT01289522|12676111|P1|STARTED|Overall Study||54
5153328|NCT01289457|12676120|P3|NOT COMPLETED|Overall Study||0
5153329|NCT01289457|12676121|P2|NOT COMPLETED|Overall Study||0
5153330|NCT01289457|12676122|P1|NOT COMPLETED|Overall Study||0
5153331|NCT01289457|12676120|P3|COMPLETED|Overall Study||113
5153332|NCT01289457|12676121|P2|COMPLETED|Overall Study||157
5153333|NCT01289457|12676122|P1|COMPLETED|Overall Study||12
5153334|NCT01289457|12676120|P3|STARTED|Overall Study||113
5153335|NCT01289457|12676121|P2|STARTED|Overall Study||157
5153336|NCT01289457|12676122|P1|STARTED|Overall Study||12
5153337|NCT01289418|12676142|P1|NOT COMPLETED|Day 29 Survey||2468
5153338|NCT01289418|12676142|P1|COMPLETED|Day 29 Survey||4057
5153339|NCT01289418|12676142|P1|STARTED|Day 29 Survey||6525
5153340|NCT01289418|12676142|P1|NOT COMPLETED|Day 8 Survey||2218
5153341|NCT01289418|12676142|P1|COMPLETED|Day 8 Survey||4307
5153342|NCT01289418|12676142|P1|STARTED|Day 8 Survey||6525
5153343|NCT01289392|12676151|P3|NOT COMPLETED|Overall Study||0
5153344|NCT01289392|12676152|P2|NOT COMPLETED|Overall Study||0
5153345|NCT01289392|12676153|P1|NOT COMPLETED|Overall Study||0
5153346|NCT01289392|12676151|P3|COMPLETED|Overall Study||7
5153347|NCT01289392|12676152|P2|COMPLETED|Overall Study||9
5153348|NCT01289392|12676153|P1|COMPLETED|Overall Study||9
5153349|NCT01289392|12676151|P3|STARTED|Overall Study||7
5153350|NCT01289392|12676152|P2|STARTED|Overall Study||9
5153351|NCT01289392|12676153|P1|STARTED|Overall Study||9
5153352|NCT01289275|12676165|P4|NOT COMPLETED|Overall Study||0
5153353|NCT01289275|12676166|P3|NOT COMPLETED|Overall Study||0
5153354|NCT01289275|12676167|P2|NOT COMPLETED|Overall Study||0
5153355|NCT01289275|12676168|P1|NOT COMPLETED|Overall Study||0
5153356|NCT01289275|12676165|P4|COMPLETED|Overall Study||316
5153357|NCT01289275|12676166|P3|COMPLETED|Overall Study||317
5153358|NCT01289275|12676167|P2|COMPLETED|Overall Study||320
5153359|NCT01289275|12676168|P1|COMPLETED|Overall Study||317
5153360|NCT01289275|12676165|P4|STARTED|Overall Study||316
5153361|NCT01289275|12676166|P3|STARTED|Overall Study||317
5153362|NCT01289275|12676167|P2|STARTED|Overall Study||320
5153363|NCT01289275|12676168|P1|STARTED|Overall Study||317
5153364|NCT01289210|12676190|P1|NOT COMPLETED|Overall Study||1
5153365|NCT01289210|12676190|P1|COMPLETED|Overall Study||1
5153366|NCT01289210|12676190|P1|STARTED|Overall Study||2
5153367|NCT01289119|12676200|P6|NOT COMPLETED|Overall Study||4
5153368|NCT01289119|12676201|P5|NOT COMPLETED|Overall Study||5
5153369|NCT01289119|12676202|P4|NOT COMPLETED|Overall Study||6
5153370|NCT01289119|12676203|P3|NOT COMPLETED|Overall Study||9
5153371|NCT01289119|12676204|P2|NOT COMPLETED|Overall Study||9
5153372|NCT01289119|12676205|P1|NOT COMPLETED|Overall Study||9
5153373|NCT01289119|12676200|P6|COMPLETED|Overall Study||57
5153374|NCT01289119|12676201|P5|COMPLETED|Overall Study||58
5153375|NCT01289119|12676202|P4|COMPLETED|Overall Study||93
5153376|NCT01289119|12676203|P3|COMPLETED|Overall Study||89
5153377|NCT01289119|12676204|P2|COMPLETED|Overall Study||83
5153378|NCT01289119|12676205|P1|COMPLETED|Overall Study||84
5153379|NCT01289119|12676200|P6|Treated|Overall Study||61
5153380|NCT01289119|12676201|P5|Treated|Overall Study||63
5153381|NCT01289119|12676202|P4|Treated|Overall Study||99
5153382|NCT01289119|12676203|P3|Treated|Overall Study||98
5153383|NCT01289119|12676204|P2|Treated|Overall Study||92
5153384|NCT01289119|12676205|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
5153385|NCT01289119|12676200|P6|STARTED|Overall Study||61
5153386|NCT01289119|12676201|P5|STARTED|Overall Study||63
5153387|NCT01289119|12676202|P4|STARTED|Overall Study||99
5153388|NCT01289119|12676203|P3|STARTED|Overall Study||98
5153389|NCT01289119|12676204|P2|STARTED|Overall Study||92
5153390|NCT01289119|12676205|P1|STARTED|Overall Study||93
5153391|NCT01289080|12676287|P2|NOT COMPLETED|Overall Study||0
5153392|NCT01289080|12676288|P1|NOT COMPLETED|Overall Study||0
5153393|NCT01289080|12676287|P2|COMPLETED|Overall Study||10
5153394|NCT01289080|12676288|P1|COMPLETED|Overall Study||9
5153395|NCT01289080|12676287|P2|STARTED|Overall Study||10
5153396|NCT01289080|12676288|P1|STARTED|Overall Study||9
5153397|NCT01289067|12676319|P1|NOT COMPLETED|Overall Study||0
5153398|NCT01289067|12676319|P1|COMPLETED|Overall Study||13
5153399|NCT01289067|12676319|P1|STARTED|Overall Study||13
5153400|NCT01289041|12676326|P1|NOT COMPLETED|Overall Study||70
5153401|NCT01289041|12676326|P1|COMPLETED|Overall Study||0
5153402|NCT01289041|12676326|P1|STARTED|Overall Study||70
5153403|NCT01289028|12676338|P1|NOT COMPLETED|Overall Study||83
5153404|NCT01289028|12676338|P1|COMPLETED|Overall Study||42
5153405|NCT01289028|12676338|P1|STARTED|Overall Study||125
5153406|NCT01289015|12676352|P2|NOT COMPLETED|Overall Study||54
5153407|NCT01289015|12676353|P1|NOT COMPLETED|Overall Study||99
5153408|NCT01289015|12676352|P2|COMPLETED|Overall Study||230
5153409|NCT01289015|12676353|P1|COMPLETED|Overall Study||472
5153410|NCT01289015|12676352|P2|STARTED|Overall Study||284
5153411|NCT01289015|12676353|P1|STARTED|Overall Study||571
5153412|NCT01288989|12676366|P5|NOT COMPLETED|Overall Study||6
5153413|NCT01288989|12676367|P4|NOT COMPLETED|Overall Study||1
5153414|NCT01288989|12676368|P3|NOT COMPLETED|Overall Study||0
5153415|NCT01288989|12676369|P2|NOT COMPLETED|Overall Study||0
5153416|NCT01288989|12676370|P1|NOT COMPLETED|Overall Study||1
5153417|NCT01288989|12676366|P5|COMPLETED|Overall Study||15
5153418|NCT01288989|12676367|P4|COMPLETED|Overall Study||10
5153419|NCT01288989|12676368|P3|COMPLETED|Overall Study||3
5153420|NCT01288989|12676369|P2|COMPLETED|Overall Study||3
5153421|NCT01288989|12676370|P1|COMPLETED|Overall Study||5
5153422|NCT01288989|12676366|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
5153423|NCT01288989|12676367|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
5153424|NCT01288989|12676368|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5153425|NCT01288989|12676369|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5153426|NCT01288989|12676370|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5153427|NCT01288989|12676366|P5|STARTED|Overall Study||21
5153428|NCT01288989|12676367|P4|STARTED|Overall Study||11
5153429|NCT01288989|12676368|P3|STARTED|Overall Study||3
5153430|NCT01288989|12676369|P2|STARTED|Overall Study||3
5153431|NCT01288989|12676370|P1|STARTED|Overall Study||6
5153432|NCT01288976|12676431|P3|NOT COMPLETED|Overall Study||20
5153433|NCT01288976|12676432|P2|NOT COMPLETED|Overall Study||27
5153434|NCT01288976|12676433|P1|NOT COMPLETED|Overall Study||178
5153435|NCT01288976|12676431|P3|COMPLETED|Overall Study||85
5153436|NCT01288976|12676432|P2|COMPLETED|Overall Study||22
5153437|NCT01288976|12676433|P1|COMPLETED|Overall Study||389
5153438|NCT01288976|12676431|P3|STARTED|Overall Study||105
5153439|NCT01288976|12676432|P2|STARTED|Overall Study||49
5153440|NCT01288976|12676433|P1|STARTED|Overall Study||567
5153441|NCT01288911|12676462|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
5153442|NCT01288911|12676463|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
5153443|NCT01288911|12676462|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
5153444|NCT01288911|12676463|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
5153445|NCT01288911|12676462|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
5153446|NCT01288911|12676463|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
5153447|NCT01288911|12676462|P2|STARTED|Open-label Period (All Enzalutamide)||9
5153448|NCT01288911|12676463|P1|STARTED|Open-label Period (All Enzalutamide)||42
5153449|NCT01288911|12676462|P2|NOT COMPLETED|Double-blind Period||182
5153450|NCT01288911|12676463|P1|NOT COMPLETED|Double-blind Period||142
5153451|NCT01288911|12676462|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
5153452|NCT01288911|12676463|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
5153453|NCT01288911|12676462|P2|Received Treatment|Double-blind Period||189
5153454|NCT01288911|12676463|P1|Received Treatment|Double-blind Period||183
5153455|NCT01288911|12676462|P2|STARTED|Double-blind Period||191
5153456|NCT01288911|12676463|P1|STARTED|Double-blind Period||184
5153457|NCT01288859|12676494|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153458|NCT01288859|12676495|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153459|NCT01288859|12676496|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153460|NCT01288859|12676497|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153461|NCT01288859|12676498|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153462|NCT01288859|12676499|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153463|NCT01288859|12676494|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153464|NCT01288859|12676495|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
5153465|NCT01288859|12676496|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
5153466|NCT01288859|12676497|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153467|NCT01288859|12676498|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153468|NCT01288859|12676499|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
5153469|NCT01288859|12676494|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
5153470|NCT01288859|12676495|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
5153471|NCT01288859|12676496|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
5153472|NCT01288859|12676497|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
5153473|NCT01288859|12676498|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
5153474|NCT01288859|12676499|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
5153475|NCT01288859|12676494|P6|NOT COMPLETED|Washout Period of 1 Week||0
5153476|NCT01288859|12676495|P5|NOT COMPLETED|Washout Period of 1 Week||0
5153477|NCT01288859|12676496|P4|NOT COMPLETED|Washout Period of 1 Week||0
5153478|NCT01288859|12676497|P3|NOT COMPLETED|Washout Period of 1 Week||0
5153479|NCT01288859|12676498|P2|NOT COMPLETED|Washout Period of 1 Week||0
5153480|NCT01288859|12676499|P1|NOT COMPLETED|Washout Period of 1 Week||0
5153481|NCT01288859|12676494|P6|COMPLETED|Washout Period of 1 Week||0
5153482|NCT01288859|12676495|P5|COMPLETED|Washout Period of 1 Week||5
5153483|NCT01288859|12676496|P4|COMPLETED|Washout Period of 1 Week||5
5153484|NCT01288859|12676497|P3|COMPLETED|Washout Period of 1 Week||0
5153485|NCT01288859|12676498|P2|COMPLETED|Washout Period of 1 Week||0
5153486|NCT01288859|12676499|P1|COMPLETED|Washout Period of 1 Week||0
5153487|NCT01288859|12676494|P6|STARTED|Washout Period of 1 Week||0
5153488|NCT01288859|12676495|P5|STARTED|Washout Period of 1 Week||5
5153489|NCT01288859|12676496|P4|STARTED|Washout Period of 1 Week||5
5153490|NCT01288859|12676497|P3|STARTED|Washout Period of 1 Week||0
5153491|NCT01288859|12676498|P2|STARTED|Washout Period of 1 Week||0
5153492|NCT01288859|12676499|P1|STARTED|Washout Period of 1 Week||0
5153493|NCT01288859|12676494|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153494|NCT01288859|12676495|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153495|NCT01288859|12676496|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153496|NCT01288859|12676497|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153497|NCT01288859|12676498|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153498|NCT01288859|12676499|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153499|NCT01288859|12676494|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153500|NCT01288859|12676495|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
5153501|NCT01288859|12676496|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
5153502|NCT01288859|12676497|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153503|NCT01288859|12676498|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153504|NCT01288859|12676499|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
5153505|NCT01288859|12676494|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
5153506|NCT01288859|12676495|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
5153507|NCT01288859|12676496|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
5153508|NCT01288859|12676497|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
5153509|NCT01288859|12676498|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
5153510|NCT01288859|12676499|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
5153511|NCT01288859|12676494|P6|NOT COMPLETED|Washout Period of 1 Week||0
5153512|NCT01288859|12676495|P5|NOT COMPLETED|Washout Period of 1 Week||0
5153513|NCT01288859|12676496|P4|NOT COMPLETED|Washout Period of 1 Week||0
5153514|NCT01288859|12676497|P3|NOT COMPLETED|Washout Period of 1 Week||0
5153515|NCT01288859|12676498|P2|NOT COMPLETED|Washout Period of 1 Week||0
5153516|NCT01288859|12676499|P1|NOT COMPLETED|Washout Period of 1 Week||0
5153517|NCT01288859|12676494|P6|COMPLETED|Washout Period of 1 Week||0
5153518|NCT01288859|12676495|P5|COMPLETED|Washout Period of 1 Week||5
5153519|NCT01288859|12676496|P4|COMPLETED|Washout Period of 1 Week||5
5153520|NCT01288859|12676497|P3|COMPLETED|Washout Period of 1 Week||0
5153521|NCT01288859|12676498|P2|COMPLETED|Washout Period of 1 Week||0
5153522|NCT01288859|12676499|P1|COMPLETED|Washout Period of 1 Week||0
5153523|NCT01288859|12676494|P6|STARTED|Washout Period of 1 Week||0
5153524|NCT01288859|12676495|P5|STARTED|Washout Period of 1 Week||5
5153525|NCT01288859|12676496|P4|STARTED|Washout Period of 1 Week||5
5153526|NCT01288859|12676497|P3|STARTED|Washout Period of 1 Week||0
5153527|NCT01288859|12676498|P2|STARTED|Washout Period of 1 Week||0
5153528|NCT01288859|12676499|P1|STARTED|Washout Period of 1 Week||0
5153529|NCT01288859|12676494|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153530|NCT01288859|12676495|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153531|NCT01288859|12676496|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153532|NCT01288859|12676497|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153533|NCT01288859|12676498|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153534|NCT01288859|12676499|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153535|NCT01288859|12676494|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153536|NCT01288859|12676495|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153537|NCT01288859|12676496|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153538|NCT01288859|12676497|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
5153539|NCT01288859|12676498|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
5153540|NCT01288859|12676499|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153541|NCT01288859|12676494|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153542|NCT01288859|12676495|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153543|NCT01288859|12676496|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153544|NCT01288859|12676497|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
5153545|NCT01288859|12676498|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
5153546|NCT01288859|12676499|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
5153547|NCT01288859|12676494|P6|NOT COMPLETED|Washout Period of 1 Week||0
5153548|NCT01288859|12676495|P5|NOT COMPLETED|Washout Period of 1 Week||0
5153549|NCT01288859|12676496|P4|NOT COMPLETED|Washout Period of 1 Week||0
5153550|NCT01288859|12676497|P3|NOT COMPLETED|Washout Period of 1 Week||0
5153551|NCT01288859|12676498|P2|NOT COMPLETED|Washout Period of 1 Week||0
5153552|NCT01288859|12676499|P1|NOT COMPLETED|Washout Period of 1 Week||0
5153553|NCT01288859|12676494|P6|COMPLETED|Washout Period of 1 Week||0
5153554|NCT01288859|12676495|P5|COMPLETED|Washout Period of 1 Week||0
5153555|NCT01288859|12676496|P4|COMPLETED|Washout Period of 1 Week||0
5153556|NCT01288859|12676497|P3|COMPLETED|Washout Period of 1 Week||5
5153557|NCT01288859|12676498|P2|COMPLETED|Washout Period of 1 Week||5
5153558|NCT01288859|12676499|P1|COMPLETED|Washout Period of 1 Week||0
5153559|NCT01288859|12676494|P6|STARTED|Washout Period of 1 Week||0
5153560|NCT01288859|12676495|P5|STARTED|Washout Period of 1 Week||0
5153561|NCT01288859|12676496|P4|STARTED|Washout Period of 1 Week||0
5153562|NCT01288859|12676497|P3|STARTED|Washout Period of 1 Week||5
5153563|NCT01288859|12676498|P2|STARTED|Washout Period of 1 Week||5
5153564|NCT01288859|12676499|P1|STARTED|Washout Period of 1 Week||0
5153565|NCT01288859|12676494|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153566|NCT01288859|12676495|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153567|NCT01288859|12676496|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153568|NCT01288859|12676497|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153569|NCT01288859|12676498|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153570|NCT01288859|12676499|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153571|NCT01288859|12676494|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153572|NCT01288859|12676495|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153573|NCT01288859|12676496|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153574|NCT01288859|12676497|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
5153575|NCT01288859|12676498|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
5153576|NCT01288859|12676499|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153577|NCT01288859|12676494|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153578|NCT01288859|12676495|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153579|NCT01288859|12676496|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153580|NCT01288859|12676497|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
5153581|NCT01288859|12676498|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
5153582|NCT01288859|12676499|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
5153583|NCT01288859|12676494|P6|NOT COMPLETED|Washout Period of 1 Week||0
5153584|NCT01288859|12676495|P5|NOT COMPLETED|Washout Period of 1 Week||0
5153585|NCT01288859|12676496|P4|NOT COMPLETED|Washout Period of 1 Week||0
5153586|NCT01288859|12676497|P3|NOT COMPLETED|Washout Period of 1 Week||0
5153587|NCT01288859|12676498|P2|NOT COMPLETED|Washout Period of 1 Week||0
5153588|NCT01288859|12676499|P1|NOT COMPLETED|Washout Period of 1 Week||0
5153589|NCT01288859|12676494|P6|COMPLETED|Washout Period of 1 Week||5
5153590|NCT01288859|12676495|P5|COMPLETED|Washout Period of 1 Week||0
5153591|NCT01288859|12676496|P4|COMPLETED|Washout Period of 1 Week||0
5153592|NCT01288859|12676497|P3|COMPLETED|Washout Period of 1 Week||0
5153593|NCT01288859|12676498|P2|COMPLETED|Washout Period of 1 Week||0
5153594|NCT01288859|12676499|P1|COMPLETED|Washout Period of 1 Week||5
5153595|NCT01288859|12676494|P6|STARTED|Washout Period of 1 Week||5
5153596|NCT01288859|12676495|P5|STARTED|Washout Period of 1 Week||0
5153597|NCT01288859|12676496|P4|STARTED|Washout Period of 1 Week||0
5153598|NCT01288859|12676497|P3|STARTED|Washout Period of 1 Week||0
5153599|NCT01288859|12676498|P2|STARTED|Washout Period of 1 Week||0
5153600|NCT01288859|12676499|P1|STARTED|Washout Period of 1 Week||5
5153601|NCT01288859|12676494|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153602|NCT01288859|12676495|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153603|NCT01288859|12676496|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153604|NCT01288859|12676497|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153605|NCT01288859|12676498|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153606|NCT01288859|12676499|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153607|NCT01288859|12676494|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
5153608|NCT01288859|12676495|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153609|NCT01288859|12676496|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153610|NCT01288859|12676497|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153611|NCT01288859|12676498|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
5153612|NCT01288859|12676499|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
5153613|NCT01288859|12676494|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
5153614|NCT01288859|12676495|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
5153615|NCT01288859|12676496|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
5153616|NCT01288859|12676497|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
5153617|NCT01288859|12676498|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
5153618|NCT01288859|12676499|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
5153619|NCT01288859|12676494|P6|NOT COMPLETED|Washout Period of 1 Week||0
5153620|NCT01288859|12676495|P5|NOT COMPLETED|Washout Period of 1 Week||0
5153621|NCT01288859|12676496|P4|NOT COMPLETED|Washout Period of 1 Week||0
5153622|NCT01288859|12676497|P3|NOT COMPLETED|Washout Period of 1 Week||0
5153623|NCT01288859|12676498|P2|NOT COMPLETED|Washout Period of 1 Week||0
5153624|NCT01288859|12676499|P1|NOT COMPLETED|Washout Period of 1 Week||0
5153625|NCT01288859|12676494|P6|COMPLETED|Washout Period of 1 Week||5
5153626|NCT01288859|12676495|P5|COMPLETED|Washout Period of 1 Week||0
5153627|NCT01288859|12676496|P4|COMPLETED|Washout Period of 1 Week||0
5153628|NCT01288859|12676497|P3|COMPLETED|Washout Period of 1 Week||0
5153629|NCT01288859|12676498|P2|COMPLETED|Washout Period of 1 Week||0
5153630|NCT01288859|12676499|P1|COMPLETED|Washout Period of 1 Week||5
5153631|NCT01288859|12676494|P6|STARTED|Washout Period of 1 Week||5
5153632|NCT01288859|12676495|P5|STARTED|Washout Period of 1 Week||0
5153633|NCT01288859|12676496|P4|STARTED|Washout Period of 1 Week||0
5153634|NCT01288859|12676497|P3|STARTED|Washout Period of 1 Week||0
5153635|NCT01288859|12676498|P2|STARTED|Washout Period of 1 Week||0
5153636|NCT01288859|12676499|P1|STARTED|Washout Period of 1 Week||5
5153637|NCT01288859|12676494|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153638|NCT01288859|12676495|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153639|NCT01288859|12676496|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153640|NCT01288859|12676497|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153641|NCT01288859|12676498|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153642|NCT01288859|12676499|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153643|NCT01288859|12676494|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
5153644|NCT01288859|12676495|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153645|NCT01288859|12676496|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153646|NCT01288859|12676497|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153647|NCT01288859|12676498|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
5153648|NCT01288859|12676499|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
5153649|NCT01288859|12676494|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
5153650|NCT01288859|12676495|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
5153651|NCT01288859|12676496|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
5153652|NCT01288859|12676497|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
5153653|NCT01288859|12676498|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
5153654|NCT01288859|12676499|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
5153655|NCT01288833|12676527|P2|NOT COMPLETED|Overall Study||0
5153656|NCT01288833|12676528|P1|NOT COMPLETED|Overall Study||0
5153657|NCT01288833|12676527|P2|COMPLETED|Overall Study||281
5153658|NCT01288833|12676528|P1|COMPLETED|Overall Study||277
5153659|NCT01288833|12676527|P2|STARTED|Overall Study||281
5153660|NCT01288833|12676528|P1|STARTED|Overall Study||277
5153661|NCT01288807|12676542|P1|NOT COMPLETED|Overall Study||0
5153662|NCT01288807|12676542|P1|COMPLETED|Overall Study||8
5153663|NCT01288807|12676542|P1|STARTED|Overall Study||8
5153664|NCT01288781|12676552|P2|NOT COMPLETED|Overall Study||0
5153665|NCT01288781|12676553|P1|NOT COMPLETED|Overall Study||0
5153666|NCT01288781|12676552|P2|COMPLETED|Overall Study||12
5153667|NCT01288781|12676553|P1|COMPLETED|Overall Study||11
5153668|NCT01288781|12676552|P2|STARTED|Overall Study||12
5153669|NCT01288781|12676553|P1|STARTED|Overall Study||11
5153670|NCT01288729|12676573|P2|NOT COMPLETED|Overall Study||0
5153671|NCT01288729|12676574|P1|NOT COMPLETED|Overall Study||1
5153672|NCT01288729|12676573|P2|COMPLETED|Overall Study||10
5153673|NCT01288729|12676574|P1|COMPLETED|Overall Study||9
5153674|NCT01288729|12676573|P2|STARTED|Overall Study||10
5153675|NCT01288729|12676574|P1|STARTED|Overall Study||10
5153676|NCT01288612|12676583|P3|NOT COMPLETED|Overall Study||82
5153677|NCT01288612|12676584|P2|NOT COMPLETED|Overall Study||82
5153678|NCT01288612|12676585|P1|NOT COMPLETED|Overall Study||89
5153679|NCT01288612|12676583|P3|COMPLETED|Overall Study||76
5153680|NCT01288612|12676584|P2|COMPLETED|Overall Study||69
5153681|NCT01288612|12676585|P1|COMPLETED|Overall Study||61
5153682|NCT01288612|12676583|P3|Agreed to Take Part|Overall Study||76
5153683|NCT01288612|12676584|P2|Agreed to Take Part|Overall Study||72
5153684|NCT01288612|12676585|P1|Agreed to Take Part|Overall Study||61
5153685|NCT01288612|12676583|P3|Contacted|Overall Study||138
5153686|NCT01288612|12676584|P2|Contacted|Overall Study||135
5153687|NCT01288612|12676585|P1|Contacted|Overall Study||139
5153688|NCT01288612|12676583|P3|STARTED|Overall Study||158
5153689|NCT01288612|12676584|P2|STARTED|Overall Study||151
5153690|NCT01288612|12676585|P1|STARTED|Overall Study||150
5153691|NCT01288534|12676614|P1|NOT COMPLETED|Overall Study||0
5153692|NCT01288534|12676614|P1|COMPLETED|Overall Study||68
5153693|NCT01288534|12676614|P1|STARTED|Overall Study||68
5153694|NCT01288521|12676624|P2|NOT COMPLETED|Overall Study||0
5153695|NCT01288521|12676625|P1|NOT COMPLETED|Overall Study||0
5153696|NCT01288521|12676624|P2|COMPLETED|Overall Study||5
5153697|NCT01288521|12676625|P1|COMPLETED|Overall Study||3
5153698|NCT01288521|12676624|P2|STARTED|Overall Study||5
5153699|NCT01288521|12676625|P1|STARTED|Overall Study||3
5153700|NCT01288469|12676634|P3|NOT COMPLETED|Overall Study||2
5153701|NCT01288469|12676635|P2|NOT COMPLETED|Overall Study||3
5153702|NCT01288469|12676636|P1|NOT COMPLETED|Overall Study||7
5153703|NCT01288469|12676634|P3|COMPLETED|Overall Study||28
5153704|NCT01288469|12676635|P2|COMPLETED|Overall Study||28
5153705|NCT01288469|12676636|P1|COMPLETED|Overall Study||24
5153706|NCT01288469|12676634|P3|Treated|Overall Study||30
5153707|NCT01288469|12676635|P2|Treated|Overall Study||31
5153708|NCT01288469|12676636|P1|Treated|Overall Study||31
5153709|NCT01288469|12676634|P3|STARTED|Overall Study|Randomized|30
5153710|NCT01288469|12676635|P2|STARTED|Overall Study|Randomized|31
5153711|NCT01288469|12676636|P1|STARTED|Overall Study|Randomized|31
5153712|NCT01288443|12676668|P6|NOT COMPLETED|Overall Study||5
5153713|NCT01288443|12676669|P5|NOT COMPLETED|Overall Study||7
5153714|NCT01288443|12676670|P4|NOT COMPLETED|Overall Study||4
5153715|NCT01288443|12676671|P3|NOT COMPLETED|Overall Study||1
5153716|NCT01288443|12676672|P2|NOT COMPLETED|Overall Study||1
5153717|NCT01288443|12676673|P1|NOT COMPLETED|Overall Study||0
5153718|NCT01288443|12676668|P6|COMPLETED|Overall Study||25
5153719|NCT01288443|12676669|P5|COMPLETED|Overall Study||23
5153720|NCT01288443|12676670|P4|COMPLETED|Overall Study||27
5153721|NCT01288443|12676671|P3|COMPLETED|Overall Study||30
5153722|NCT01288443|12676672|P2|COMPLETED|Overall Study||29
5153723|NCT01288443|12676673|P1|COMPLETED|Overall Study||31
5153724|NCT01288443|12676668|P6|Treated|Overall Study||30
5153725|NCT01288443|12676669|P5|Treated|Overall Study||29
5153726|NCT01288443|12676670|P4|Treated|Overall Study||31
5153727|NCT01288443|12676671|P3|Treated|Overall Study||31
5153728|NCT01288443|12676672|P2|Treated|Overall Study||30
5153729|NCT01288443|12676673|P1|Treated|Overall Study||31
5153730|NCT01288443|12676668|P6|STARTED|Overall Study|Randomized|30
5153731|NCT01288443|12676669|P5|STARTED|Overall Study|Randomized|30
5153732|NCT01288443|12676670|P4|STARTED|Overall Study|Randomized|31
5153733|NCT01288443|12676671|P3|STARTED|Overall Study|Randomized|31
5153734|NCT01288443|12676672|P2|STARTED|Overall Study|Randomized|30
5153735|NCT01288443|12676673|P1|STARTED|Overall Study|Randomized|31
5153736|NCT01288430|12676733|P10|NOT COMPLETED|Part 2||3
5153737|NCT01288430|12676734|P9|NOT COMPLETED|Part 2||12
5153738|NCT01288430|12676735|P8|NOT COMPLETED|Part 2||12
5153739|NCT01288430|12676736|P7|NOT COMPLETED|Part 2||0
5153740|NCT01288430|12676737|P6|NOT COMPLETED|Part 2||0
5153741|NCT01288430|12676738|P5|NOT COMPLETED|Part 2||0
5153742|NCT01288430|12676739|P4|NOT COMPLETED|Part 2||0
5153743|NCT01288430|12676740|P3|NOT COMPLETED|Part 2||0
5153744|NCT01288430|12676741|P2|NOT COMPLETED|Part 2||0
5153745|NCT01288430|12676742|P1|NOT COMPLETED|Part 2||0
5153746|NCT01288430|12676733|P10|COMPLETED|Part 2||0
5153747|NCT01288430|12676734|P9|COMPLETED|Part 2||0
5153748|NCT01288430|12676735|P8|COMPLETED|Part 2||0
5153749|NCT01288430|12676736|P7|COMPLETED|Part 2||0
5153750|NCT01288430|12676737|P6|COMPLETED|Part 2||0
5153751|NCT01288430|12676738|P5|COMPLETED|Part 2||0
5153752|NCT01288430|12676739|P4|COMPLETED|Part 2||0
5153753|NCT01288430|12676740|P3|COMPLETED|Part 2||0
5153754|NCT01288430|12676741|P2|COMPLETED|Part 2||0
5153755|NCT01288430|12676742|P1|COMPLETED|Part 2||0
5153756|NCT01288430|12676733|P10|STARTED|Part 2||3
5153757|NCT01288430|12676734|P9|STARTED|Part 2||12
5153758|NCT01288430|12676735|P8|STARTED|Part 2||12
5153759|NCT01288430|12676736|P7|STARTED|Part 2||0
5153760|NCT01288430|12676737|P6|STARTED|Part 2||0
5153761|NCT01288430|12676738|P5|STARTED|Part 2||0
5153762|NCT01288430|12676739|P4|STARTED|Part 2||0
5153763|NCT01288430|12676740|P3|STARTED|Part 2||0
5153764|NCT01288430|12676741|P2|STARTED|Part 2||0
5153765|NCT01288430|12676742|P1|STARTED|Part 2||0
5153766|NCT01288430|12676733|P10|NOT COMPLETED|Part 1||0
5153767|NCT01288430|12676734|P9|NOT COMPLETED|Part 1||0
5153768|NCT01288430|12676735|P8|NOT COMPLETED|Part 1||0
5153769|NCT01288430|12676736|P7|NOT COMPLETED|Part 1||7
5153770|NCT01288430|12676737|P6|NOT COMPLETED|Part 1||6
5153771|NCT01288430|12676738|P5|NOT COMPLETED|Part 1||3
5153772|NCT01288430|12676739|P4|NOT COMPLETED|Part 1||7
5153773|NCT01288430|12676740|P3|NOT COMPLETED|Part 1||5
5153774|NCT01288430|12676741|P2|NOT COMPLETED|Part 1||3
5153775|NCT01288430|12676742|P1|NOT COMPLETED|Part 1||2
5153776|NCT01288430|12676733|P10|COMPLETED|Part 1||0
5153777|NCT01288430|12676734|P9|COMPLETED|Part 1||0
5153778|NCT01288430|12676735|P8|COMPLETED|Part 1||0
5153779|NCT01288430|12676736|P7|COMPLETED|Part 1||0
5153780|NCT01288430|12676737|P6|COMPLETED|Part 1||0
5153781|NCT01288430|12676738|P5|COMPLETED|Part 1||0
5153782|NCT01288430|12676739|P4|COMPLETED|Part 1||0
5153783|NCT01288430|12676740|P3|COMPLETED|Part 1||0
5153784|NCT01288430|12676741|P2|COMPLETED|Part 1||0
5153785|NCT01288430|12676742|P1|COMPLETED|Part 1||0
5153786|NCT01288430|12676733|P10|STARTED|Part 1||0
5153787|NCT01288430|12676734|P9|STARTED|Part 1||0
5153788|NCT01288430|12676735|P8|STARTED|Part 1||0
5153789|NCT01288430|12676736|P7|STARTED|Part 1||7
5153790|NCT01288430|12676737|P6|STARTED|Part 1||6
5153791|NCT01288430|12676738|P5|STARTED|Part 1||3
5153792|NCT01288430|12676739|P4|STARTED|Part 1||7
5153793|NCT01288430|12676740|P3|STARTED|Part 1||5
5153794|NCT01288430|12676741|P2|STARTED|Part 1||3
5153795|NCT01288430|12676742|P1|STARTED|Part 1||2
5153796|NCT01288287|12676866|P1|NOT COMPLETED|Overall Study||46
5153797|NCT01288287|12676866|P1|COMPLETED|Overall Study||103
5153798|NCT01288287|12676866|P1|Full Analysis Set|Overall Study||111
5153799|NCT01288287|12676866|P1|Safety Set|Overall Study||147
5153800|NCT01288287|12676866|P1|STARTED|Overall Study||149
5153801|NCT01288209|12676881|P2|NOT COMPLETED|Overall Study||3
5153802|NCT01288209|12676882|P1|NOT COMPLETED|Overall Study||2
5153803|NCT01288209|12676881|P2|COMPLETED|Overall Study||50
5153804|NCT01288209|12676882|P1|COMPLETED|Overall Study||51
5153805|NCT01288209|12676881|P2|STARTED|Overall Study||53
5153806|NCT01288209|12676882|P1|STARTED|Overall Study||53
5153807|NCT01288079|12676912|P4|NOT COMPLETED|Overall Study||17
5153808|NCT01288079|12676913|P3|NOT COMPLETED|Overall Study||19
5153809|NCT01288079|12676914|P2|NOT COMPLETED|Overall Study||27
5153810|NCT01288079|12676915|P1|NOT COMPLETED|Overall Study||20
5153811|NCT01288079|12676912|P4|COMPLETED|Overall Study||18
5153812|NCT01288079|12676913|P3|COMPLETED|Overall Study||18
5153813|NCT01288079|12676914|P2|COMPLETED|Overall Study||9
5153814|NCT01288079|12676915|P1|COMPLETED|Overall Study||17
5153815|NCT01288079|12676912|P4|STARTED|Overall Study||35
5153816|NCT01288079|12676913|P3|STARTED|Overall Study||37
5153817|NCT01288079|12676914|P2|STARTED|Overall Study||36
5153818|NCT01288079|12676915|P1|STARTED|Overall Study||37
5153819|NCT01288053|12676925|P1|NOT COMPLETED|Overall Study||1
5153820|NCT01288053|12676925|P1|COMPLETED|Overall Study||8
5153821|NCT01288053|12676925|P1|STARTED|Overall Study||9
5153822|NCT01288027|12676929|P1|NOT COMPLETED|Overall Study||0
5153823|NCT01288027|12676929|P1|COMPLETED|Overall Study||16
5153824|NCT01288027|12676929|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
5153825|NCT01288027|12676929|P1|STARTED|Overall Study||16
5153826|NCT01287897|12676943|P4|NOT COMPLETED|Overall Study||7
5153827|NCT01287897|12676944|P3|NOT COMPLETED|Overall Study||12
5153828|NCT01287897|12676945|P2|NOT COMPLETED|Overall Study||11
5153829|NCT01287897|12676946|P1|NOT COMPLETED|Overall Study||11
5153830|NCT01287897|12676943|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
5153831|NCT01287897|12676944|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
5153832|NCT01287897|12676945|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
5153833|NCT01287897|12676946|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
5153834|NCT01287897|12676943|P4|Enrolled in NCT01345318|Overall Study||29
5153835|NCT01287897|12676944|P3|Enrolled in NCT01345318|Overall Study||56
5153836|NCT01287897|12676945|P2|Enrolled in NCT01345318|Overall Study||50
5153837|NCT01287897|12676946|P1|Enrolled in NCT01345318|Overall Study||56
5153838|NCT01287897|12676943|P4|Completed Follow-up Period|Overall Study||4
5153839|NCT01287897|12676944|P3|Completed Follow-up Period|Overall Study||3
5153840|NCT01287897|12676945|P2|Completed Follow-up Period|Overall Study||8
5153841|NCT01287897|12676946|P1|Completed Follow-up Period|Overall Study||3
5153842|NCT01287897|12676943|P4|Completed Treatment Period|Overall Study||29
5153843|NCT01287897|12676944|P3|Completed Treatment Period|Overall Study||58
5153844|NCT01287897|12676945|P2|Completed Treatment Period|Overall Study||52
5153845|NCT01287897|12676946|P1|Completed Treatment Period|Overall Study||58
5153846|NCT01287897|12676943|P4|Treated|Overall Study||40
5153847|NCT01287897|12676944|P3|Treated|Overall Study||71
5153848|NCT01287897|12676945|P2|Treated|Overall Study||67
5153849|NCT01287897|12676946|P1|Treated|Overall Study||69
5153850|NCT01287897|12676943|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
5153851|NCT01287897|12676944|P3|STARTED|Overall Study||71
5153852|NCT01287897|12676945|P2|STARTED|Overall Study||69
5153853|NCT01287897|12676946|P1|STARTED|Overall Study||70
5153854|NCT01287832|12676997|P2|NOT COMPLETED|Overall Study||1
5153855|NCT01287832|12676998|P1|NOT COMPLETED|Overall Study||1
5153856|NCT01287832|12676997|P2|COMPLETED|Overall Study||4
5153857|NCT01287832|12676998|P1|COMPLETED|Overall Study||5
5153858|NCT01287832|12676997|P2|STARTED|Overall Study||5
5153859|NCT01287832|12676998|P1|STARTED|Overall Study||6
5153860|NCT01287754|12677006|P2|NOT COMPLETED|Overall Study||21
5153861|NCT01287754|12677007|P1|NOT COMPLETED|Overall Study||3
5153862|NCT01287754|12677006|P2|COMPLETED|Overall Study||0
5153863|NCT01287754|12677007|P1|COMPLETED|Overall Study||0
5153864|NCT01287754|12677006|P2|STARTED|Overall Study||21
5153865|NCT01287754|12677007|P1|STARTED|Overall Study||3
5153866|NCT01287741|12677019|P2|NOT COMPLETED|Overall Study||615
5153867|NCT01287741|12677020|P1|NOT COMPLETED|Overall Study||626
5153868|NCT01287741|12677019|P2|COMPLETED|Overall Study||91
5153869|NCT01287741|12677020|P1|COMPLETED|Overall Study||86
5153870|NCT01287741|12677019|P2|STARTED|Overall Study||706
5153871|NCT01287741|12677020|P1|STARTED|Overall Study||712
5153872|NCT01287611|12677056|P2|NOT COMPLETED|Overall Study||19
5153873|NCT01287611|12677057|P1|NOT COMPLETED|Overall Study||33
5153874|NCT01287611|12677056|P2|COMPLETED|Overall Study||65
5153875|NCT01287611|12677057|P1|COMPLETED|Overall Study||51
5153876|NCT01287611|12677056|P2|The Number of Patients Who Underwent C/S|Overall Study||84
5153877|NCT01287611|12677057|P1|The Number of Patients Who Underwent C/S|Overall Study||84
5153878|NCT01287611|12677056|P2|STARTED|Overall Study||84
5153879|NCT01287611|12677057|P1|STARTED|Overall Study||84
5153880|NCT01287520|12677074|P9|NOT COMPLETED|Overall Study||5
5153881|NCT01287520|12677075|P8|NOT COMPLETED|Overall Study||5
5153882|NCT01287520|12677076|P7|NOT COMPLETED|Overall Study||2
5153883|NCT01287520|12677077|P6|NOT COMPLETED|Overall Study||4
5153884|NCT01287520|12677078|P5|NOT COMPLETED|Overall Study||3
5153885|NCT01287520|12677079|P4|NOT COMPLETED|Overall Study||7
5153886|NCT01287520|12677080|P3|NOT COMPLETED|Overall Study||5
5153887|NCT01287520|12677081|P2|NOT COMPLETED|Overall Study||7
5153888|NCT01287520|12677082|P1|NOT COMPLETED|Overall Study||3
5153889|NCT01287520|12677074|P9|COMPLETED|Overall Study||0
5153890|NCT01287520|12677075|P8|COMPLETED|Overall Study||0
5153891|NCT01287520|12677076|P7|COMPLETED|Overall Study||0
5153892|NCT01287520|12677077|P6|COMPLETED|Overall Study||0
5153893|NCT01287520|12677078|P5|COMPLETED|Overall Study||0
5153894|NCT01287520|12677079|P4|COMPLETED|Overall Study||0
5153895|NCT01287520|12677080|P3|COMPLETED|Overall Study||0
5153896|NCT01287520|12677081|P2|COMPLETED|Overall Study||0
5153897|NCT01287520|12677082|P1|COMPLETED|Overall Study||0
5153898|NCT01287520|12677074|P9|STARTED|Overall Study||5
5153899|NCT01287520|12677075|P8|STARTED|Overall Study||5
5153900|NCT01287520|12677076|P7|STARTED|Overall Study||2
5153901|NCT01287520|12677077|P6|STARTED|Overall Study||4
5153902|NCT01287520|12677078|P5|STARTED|Overall Study||3
5153903|NCT01287520|12677079|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
5153904|NCT01287520|12677080|P3|STARTED|Overall Study||5
5153905|NCT01287520|12677081|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
5153906|NCT01287520|12677082|P1|STARTED|Overall Study||3
5153907|NCT01287416|12677146|P2|NOT COMPLETED|6 Month Follow-up||2
5153908|NCT01287416|12677147|P1|NOT COMPLETED|6 Month Follow-up||3
5153909|NCT01287416|12677146|P2|COMPLETED|6 Month Follow-up||22
5153910|NCT01287416|12677147|P1|COMPLETED|6 Month Follow-up||28
5153911|NCT01287416|12677146|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
5153912|NCT01287416|12677147|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
5153913|NCT01287416|12677146|P2|NOT COMPLETED|Pre-post Training||25
5153914|NCT01287416|12677147|P1|NOT COMPLETED|Pre-post Training||22
5153915|NCT01287416|12677146|P2|COMPLETED|Pre-post Training||23
5153916|NCT01287416|12677147|P1|COMPLETED|Pre-post Training||26
5153917|NCT01287416|12677146|P2|Post Training Questionnaire|Pre-post Training||23
5153918|NCT01287416|12677147|P1|Post Training Questionnaire|Pre-post Training||26
5153919|NCT01287416|12677146|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
5153920|NCT01287416|12677147|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
5153921|NCT01287416|12677146|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
5153922|NCT01287416|12677147|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
5153923|NCT01287403|12677183|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
5153924|NCT01287403|12677183|P1|COMPLETED|6th and Last Intervention (1 Day)||13
5153925|NCT01287403|12677183|P1|STARTED|6th and Last Intervention (1 Day)||13
5153926|NCT01287403|12677183|P1|NOT COMPLETED|Washout (7 Days)||0
5153927|NCT01287403|12677183|P1|COMPLETED|Washout (7 Days)||13
5153928|NCT01287403|12677183|P1|STARTED|Washout (7 Days)||13
5153929|NCT01287403|12677183|P1|NOT COMPLETED|5th Intervention (1 Day)||0
5153930|NCT01287403|12677183|P1|COMPLETED|5th Intervention (1 Day)||13
5153931|NCT01287403|12677183|P1|STARTED|5th Intervention (1 Day)||13
5153932|NCT01287403|12677183|P1|NOT COMPLETED|Washout (7 Days)||0
5153933|NCT01287403|12677183|P1|COMPLETED|Washout (7 Days)||13
5153934|NCT01287403|12677183|P1|STARTED|Washout (7 Days)||13
5153935|NCT01287403|12677183|P1|NOT COMPLETED|4th Intervention (1 Day)||0
5153936|NCT01287403|12677183|P1|COMPLETED|4th Intervention (1 Day)||13
5153937|NCT01287403|12677183|P1|STARTED|4th Intervention (1 Day)||13
5153938|NCT01287403|12677183|P1|NOT COMPLETED|Washout (7 Days)||0
5153939|NCT01287403|12677183|P1|COMPLETED|Washout (7 Days)||13
5153940|NCT01287403|12677183|P1|STARTED|Washout (7 Days)||13
5153941|NCT01287403|12677183|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
5153942|NCT01287403|12677183|P1|COMPLETED|3rd Intervention (1 Day)||13
5153943|NCT01287403|12677183|P1|STARTED|3rd Intervention (1 Day)||13
5153944|NCT01287403|12677183|P1|NOT COMPLETED|Washout (7 Days)||0
5153945|NCT01287403|12677183|P1|COMPLETED|Washout (7 Days)||13
5153946|NCT01287403|12677183|P1|STARTED|Washout (7 Days)||13
5153947|NCT01287403|12677183|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
5153948|NCT01287403|12677183|P1|COMPLETED|2nd Intervention (1 Day)||13
5153949|NCT01287403|12677183|P1|STARTED|2nd Intervention (1 Day)||13
5153950|NCT01287403|12677183|P1|NOT COMPLETED|Washout 7 Days||0
5153951|NCT01287403|12677183|P1|COMPLETED|Washout 7 Days||13
5153952|NCT01287403|12677183|P1|STARTED|Washout 7 Days||13
5153953|NCT01287403|12677183|P1|NOT COMPLETED|1st Intervention (1 Day)||1
5153954|NCT01287403|12677183|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
5153955|NCT01287403|12677183|P1|STARTED|1st Intervention (1 Day)||14
5153956|NCT01287403|12677183|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
5153957|NCT01287403|12677183|P1|COMPLETED|Diet Restriction (7 Days)||14
5153958|NCT01287403|12677183|P1|STARTED|Diet Restriction (7 Days)||14
5153959|NCT01287377|12677200|P3|NOT COMPLETED|Overall Study||0
5153960|NCT01287377|12677201|P2|NOT COMPLETED|Overall Study||0
5153961|NCT01287377|12677202|P1|NOT COMPLETED|Overall Study||0
5153962|NCT01287377|12677200|P3|COMPLETED|Overall Study|Study Complete|82
5153963|NCT01287377|12677201|P2|COMPLETED|Overall Study|Study Complete|81
5153964|NCT01287377|12677202|P1|COMPLETED|Overall Study|Study Complete|80
5153965|NCT01287377|12677200|P3|STARTED|Overall Study||82
5153966|NCT01287377|12677201|P2|STARTED|Overall Study||81
5153967|NCT01287377|12677202|P1|STARTED|Overall Study||80
5153968|NCT01287364|12677215|P2|NOT COMPLETED|Overall Study||10
5153969|NCT01287364|12677216|P1|NOT COMPLETED|Overall Study||9
5153970|NCT01287364|12677215|P2|COMPLETED|Overall Study||81
5153971|NCT01287364|12677216|P1|COMPLETED|Overall Study||85
5153972|NCT01287364|12677215|P2|STARTED|Overall Study||91
5153973|NCT01287364|12677216|P1|STARTED|Overall Study||94
5153974|NCT01287221|12677238|P2|NOT COMPLETED|Overall Study||5
5153975|NCT01287221|12677239|P1|NOT COMPLETED|Overall Study||4
5153976|NCT01287221|12677238|P2|COMPLETED|Overall Study||45
5153977|NCT01287221|12677239|P1|COMPLETED|Overall Study||46
5153978|NCT01287221|12677238|P2|Completed 12 Months Follow-up|Overall Study||39
5153979|NCT01287221|12677239|P1|Completed 12 Months Follow-up|Overall Study||40
5153980|NCT01287221|12677238|P2|Completed 9 Months Follow-up|Overall Study||40
5153981|NCT01287221|12677239|P1|Completed 9 Months Follow-up|Overall Study||42
5153982|NCT01287221|12677238|P2|Completed 6 Months Follow-up|Overall Study||43
5153983|NCT01287221|12677239|P1|Completed 6 Months Follow-up|Overall Study||47
5153984|NCT01287221|12677238|P2|Completed 3 Months Follow-up|Overall Study||50
5153985|NCT01287221|12677239|P1|Completed 3 Months Follow-up|Overall Study||49
5153986|NCT01287221|12677238|P2|STARTED|Overall Study||50
5153987|NCT01287221|12677239|P1|STARTED|Overall Study||50
5153988|NCT01287208|12677259|P2|NOT COMPLETED|Phase 2: Team Competition||0
5153989|NCT01287208|12677260|P1|NOT COMPLETED|Phase 2: Team Competition||0
5153990|NCT01287208|12677259|P2|COMPLETED|Phase 2: Team Competition||49
5153991|NCT01287208|12677260|P1|COMPLETED|Phase 2: Team Competition||50
5153992|NCT01287208|12677259|P2|STARTED|Phase 2: Team Competition||49
5153993|NCT01287208|12677260|P1|STARTED|Phase 2: Team Competition||50
5153994|NCT01287208|12677259|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
5153995|NCT01287208|12677260|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
5153996|NCT01287208|12677259|P2|COMPLETED|Phase 1: Randomized Phase||49
5153997|NCT01287208|12677260|P1|COMPLETED|Phase 1: Randomized Phase||50
5153998|NCT01287208|12677259|P2|STARTED|Phase 1: Randomized Phase||52
5153999|NCT01287208|12677260|P1|STARTED|Phase 1: Randomized Phase||52
5154000|NCT01287195|12677274|P1|NOT COMPLETED|Overall Study||2
5154001|NCT01287195|12677274|P1|COMPLETED|Overall Study||4
5154002|NCT01287195|12677274|P1|STARTED|Overall Study||6
5154003|NCT01287117|12677289|P4|NOT COMPLETED|Overall Study||12
5154004|NCT01287117|12677290|P3|NOT COMPLETED|Overall Study||16
5154005|NCT01287117|12677291|P2|NOT COMPLETED|Overall Study||14
5154006|NCT01287117|12677292|P1|NOT COMPLETED|Overall Study||15
5154007|NCT01287117|12677289|P4|COMPLETED|Overall Study||69
5154008|NCT01287117|12677290|P3|COMPLETED|Overall Study||64
5154009|NCT01287117|12677291|P2|COMPLETED|Overall Study||64
5154010|NCT01287117|12677292|P1|COMPLETED|Overall Study||65
5154011|NCT01287117|12677289|P4|Received Treatment|Overall Study||81
5154012|NCT01287117|12677290|P3|Received Treatment|Overall Study||80
5154013|NCT01287117|12677291|P2|Received Treatment|Overall Study||77
5154014|NCT01287117|12677292|P1|Received Treatment|Overall Study||80
5154015|NCT01287117|12677289|P4|STARTED|Overall Study||81
5154016|NCT01287117|12677290|P3|STARTED|Overall Study||80
5154017|NCT01287117|12677291|P2|STARTED|Overall Study||78
5154018|NCT01287117|12677292|P1|STARTED|Overall Study||80
5154019|NCT01287104|12677342|P4|NOT COMPLETED|Overall Study||3
5154020|NCT01287104|12677343|P3|NOT COMPLETED|Overall Study||7
5154021|NCT01287104|12677344|P2|NOT COMPLETED|Overall Study||5
5154022|NCT01287104|12677345|P1|NOT COMPLETED|Overall Study||1
5154023|NCT01287104|12677342|P4|COMPLETED|Overall Study||8
5154024|NCT01287104|12677343|P3|COMPLETED|Overall Study||5
5154025|NCT01287104|12677344|P2|COMPLETED|Overall Study||2
5154026|NCT01287104|12677345|P1|COMPLETED|Overall Study||3
5154027|NCT01287104|12677342|P4|STARTED|Overall Study||11
5154028|NCT01287104|12677343|P3|STARTED|Overall Study||12
5154029|NCT01287104|12677344|P2|STARTED|Overall Study||7
5154030|NCT01287104|12677345|P1|STARTED|Overall Study||4
5154031|NCT01287065|12677378|P6|NOT COMPLETED|Treatment Period 3||0
5154032|NCT01287065|12677379|P5|NOT COMPLETED|Treatment Period 3||0
5154033|NCT01287065|12677380|P4|NOT COMPLETED|Treatment Period 3||0
5154034|NCT01287065|12677381|P3|NOT COMPLETED|Treatment Period 3||0
5154035|NCT01287065|12677382|P2|NOT COMPLETED|Treatment Period 3||0
5154036|NCT01287065|12677383|P1|NOT COMPLETED|Treatment Period 3||0
5154037|NCT01287065|12677378|P6|COMPLETED|Treatment Period 3||4
5154038|NCT01287065|12677379|P5|COMPLETED|Treatment Period 3||4
5154039|NCT01287065|12677380|P4|COMPLETED|Treatment Period 3||4
5154040|NCT01287065|12677381|P3|COMPLETED|Treatment Period 3||4
5154041|NCT01287065|12677382|P2|COMPLETED|Treatment Period 3||4
5154042|NCT01287065|12677383|P1|COMPLETED|Treatment Period 3||4
5154043|NCT01287065|12677378|P6|STARTED|Treatment Period 3||4
5154044|NCT01287065|12677379|P5|STARTED|Treatment Period 3||4
5154045|NCT01287065|12677380|P4|STARTED|Treatment Period 3||4
5154046|NCT01287065|12677381|P3|STARTED|Treatment Period 3||4
5154047|NCT01287065|12677382|P2|STARTED|Treatment Period 3||4
5154048|NCT01287065|12677383|P1|STARTED|Treatment Period 3||4
5154049|NCT01287065|12677378|P6|NOT COMPLETED|Washout Period 2||0
5154050|NCT01287065|12677379|P5|NOT COMPLETED|Washout Period 2||0
5154051|NCT01287065|12677380|P4|NOT COMPLETED|Washout Period 2||0
5154052|NCT01287065|12677381|P3|NOT COMPLETED|Washout Period 2||0
5154053|NCT01287065|12677382|P2|NOT COMPLETED|Washout Period 2||0
5154054|NCT01287065|12677383|P1|NOT COMPLETED|Washout Period 2||0
5154055|NCT01287065|12677378|P6|COMPLETED|Washout Period 2||4
5154056|NCT01287065|12677379|P5|COMPLETED|Washout Period 2||4
5154057|NCT01287065|12677380|P4|COMPLETED|Washout Period 2||4
5154058|NCT01287065|12677381|P3|COMPLETED|Washout Period 2||4
5154059|NCT01287065|12677382|P2|COMPLETED|Washout Period 2||4
5154060|NCT01287065|12677383|P1|COMPLETED|Washout Period 2||4
5154061|NCT01287065|12677378|P6|STARTED|Washout Period 2||4
5154062|NCT01287065|12677379|P5|STARTED|Washout Period 2||4
5154063|NCT01287065|12677380|P4|STARTED|Washout Period 2||4
5154064|NCT01287065|12677381|P3|STARTED|Washout Period 2||4
5154065|NCT01287065|12677382|P2|STARTED|Washout Period 2||4
5154066|NCT01287065|12677383|P1|STARTED|Washout Period 2||4
5154067|NCT01287065|12677378|P6|NOT COMPLETED|Treatment Period 2||0
5154068|NCT01287065|12677379|P5|NOT COMPLETED|Treatment Period 2||0
5154069|NCT01287065|12677380|P4|NOT COMPLETED|Treatment Period 2||0
5154070|NCT01287065|12677381|P3|NOT COMPLETED|Treatment Period 2||0
5154071|NCT01287065|12677382|P2|NOT COMPLETED|Treatment Period 2||0
5154072|NCT01287065|12677383|P1|NOT COMPLETED|Treatment Period 2||0
5154073|NCT01287065|12677378|P6|COMPLETED|Treatment Period 2||4
5154074|NCT01287065|12677379|P5|COMPLETED|Treatment Period 2||4
5154075|NCT01287065|12677380|P4|COMPLETED|Treatment Period 2||4
5154076|NCT01287065|12677381|P3|COMPLETED|Treatment Period 2||4
5154077|NCT01287065|12677382|P2|COMPLETED|Treatment Period 2||4
5154078|NCT01287065|12677383|P1|COMPLETED|Treatment Period 2||4
5154079|NCT01287065|12677378|P6|STARTED|Treatment Period 2||4
5154080|NCT01287065|12677379|P5|STARTED|Treatment Period 2||4
5154081|NCT01287065|12677380|P4|STARTED|Treatment Period 2||4
5154082|NCT01287065|12677381|P3|STARTED|Treatment Period 2||4
5154083|NCT01287065|12677382|P2|STARTED|Treatment Period 2||4
5154084|NCT01287065|12677383|P1|STARTED|Treatment Period 2||4
5154085|NCT01287065|12677378|P6|NOT COMPLETED|Washout Period 1||0
5154086|NCT01287065|12677379|P5|NOT COMPLETED|Washout Period 1||0
5154087|NCT01287065|12677380|P4|NOT COMPLETED|Washout Period 1||0
5154088|NCT01287065|12677381|P3|NOT COMPLETED|Washout Period 1||0
5154089|NCT01287065|12677382|P2|NOT COMPLETED|Washout Period 1||0
5154090|NCT01287065|12677383|P1|NOT COMPLETED|Washout Period 1||0
5154091|NCT01287065|12677378|P6|COMPLETED|Washout Period 1||4
5154092|NCT01287065|12677379|P5|COMPLETED|Washout Period 1||4
5154093|NCT01287065|12677380|P4|COMPLETED|Washout Period 1||4
5154094|NCT01287065|12677381|P3|COMPLETED|Washout Period 1||4
5154095|NCT01287065|12677382|P2|COMPLETED|Washout Period 1||4
5154096|NCT01287065|12677383|P1|COMPLETED|Washout Period 1||4
5154097|NCT01287065|12677378|P6|STARTED|Washout Period 1||4
5154098|NCT01287065|12677379|P5|STARTED|Washout Period 1||4
5154099|NCT01287065|12677380|P4|STARTED|Washout Period 1||4
5154100|NCT01287065|12677381|P3|STARTED|Washout Period 1||4
5154101|NCT01287065|12677382|P2|STARTED|Washout Period 1||4
5154102|NCT01287065|12677383|P1|STARTED|Washout Period 1||4
5154103|NCT01287065|12677378|P6|NOT COMPLETED|Treatment Period 1||1
5154104|NCT01287065|12677379|P5|NOT COMPLETED|Treatment Period 1||1
5154105|NCT01287065|12677380|P4|NOT COMPLETED|Treatment Period 1||0
5154106|NCT01287065|12677381|P3|NOT COMPLETED|Treatment Period 1||0
5154107|NCT01287065|12677382|P2|NOT COMPLETED|Treatment Period 1||0
5154108|NCT01287065|12677383|P1|NOT COMPLETED|Treatment Period 1||0
5154109|NCT01287065|12677378|P6|COMPLETED|Treatment Period 1||4
5154110|NCT01287065|12677379|P5|COMPLETED|Treatment Period 1||4
5154111|NCT01287065|12677380|P4|COMPLETED|Treatment Period 1||4
5154112|NCT01287065|12677381|P3|COMPLETED|Treatment Period 1||4
5154113|NCT01287065|12677382|P2|COMPLETED|Treatment Period 1||4
5154114|NCT01287065|12677383|P1|COMPLETED|Treatment Period 1||4
5154115|NCT01287065|12677378|P6|STARTED|Treatment Period 1||5
5154116|NCT01287065|12677379|P5|STARTED|Treatment Period 1||5
5154117|NCT01287065|12677380|P4|STARTED|Treatment Period 1||4
5154118|NCT01287065|12677381|P3|STARTED|Treatment Period 1||4
5154119|NCT01287065|12677382|P2|STARTED|Treatment Period 1||4
5154120|NCT01287065|12677383|P1|STARTED|Treatment Period 1||4
5154121|NCT01287039|12677402|P2|NOT COMPLETED|Overall Study||27
5154122|NCT01287039|12677403|P1|NOT COMPLETED|Overall Study||29
5154123|NCT01287039|12677402|P2|COMPLETED|Overall Study||218
5154124|NCT01287039|12677403|P1|COMPLETED|Overall Study||215
5154125|NCT01287039|12677402|P2|STARTED|Overall Study||245
5154126|NCT01287039|12677403|P1|STARTED|Overall Study||244
5154127|NCT01287013|12677436|P3|NOT COMPLETED|Overall Study||21
5154128|NCT01287013|12677437|P2|NOT COMPLETED|Overall Study||5
5154129|NCT01287013|12677438|P1|NOT COMPLETED|Overall Study||3
5154130|NCT01287013|12677436|P3|COMPLETED|Overall Study||0
5154131|NCT01287013|12677437|P2|COMPLETED|Overall Study||29
5154132|NCT01287013|12677438|P1|COMPLETED|Overall Study||29
5154133|NCT01287013|12677436|P3|STARTED|Overall Study||21
5154134|NCT01287013|12677437|P2|STARTED|Overall Study||34
5154135|NCT01287013|12677438|P1|STARTED|Overall Study||32
5154136|NCT01286987|12677468|P15|NOT COMPLETED|Part 2: Dose Expansion||2
5154137|NCT01286987|12677469|P14|NOT COMPLETED|Part 2: Dose Expansion||24
5154138|NCT01286987|12677470|P13|NOT COMPLETED|Part 2: Dose Expansion||12
5154139|NCT01286987|12677471|P12|NOT COMPLETED|Part 2: Dose Expansion||10
5154140|NCT01286987|12677472|P11|NOT COMPLETED|Part 2: Dose Expansion||10
5154141|NCT01286987|12677473|P10|NOT COMPLETED|Part 2: Dose Expansion||11
5154142|NCT01286987|12677474|P9|NOT COMPLETED|Part 2: Dose Expansion||0
5154143|NCT01286987|12677475|P8|NOT COMPLETED|Part 2: Dose Expansion||0
5154144|NCT01286987|12677476|P7|NOT COMPLETED|Part 2: Dose Expansion||0
5154145|NCT01286987|12677477|P6|NOT COMPLETED|Part 2: Dose Expansion||0
5154146|NCT01286987|12677478|P5|NOT COMPLETED|Part 2: Dose Expansion||0
5154147|NCT01286987|12677479|P4|NOT COMPLETED|Part 2: Dose Expansion||0
5154148|NCT01286987|12677480|P3|NOT COMPLETED|Part 2: Dose Expansion||0
5154149|NCT01286987|12677481|P2|NOT COMPLETED|Part 2: Dose Expansion||0
5154150|NCT01286987|12677482|P1|NOT COMPLETED|Part 2: Dose Expansion||0
5154151|NCT01286987|12677468|P15|COMPLETED|Part 2: Dose Expansion||1
5154152|NCT01286987|12677469|P14|COMPLETED|Part 2: Dose Expansion||0
5154153|NCT01286987|12677470|P13|COMPLETED|Part 2: Dose Expansion||0
5154154|NCT01286987|12677471|P12|COMPLETED|Part 2: Dose Expansion||1
5154155|NCT01286987|12677472|P11|COMPLETED|Part 2: Dose Expansion||2
5154156|NCT01286987|12677473|P10|COMPLETED|Part 2: Dose Expansion||1
5154157|NCT01286987|12677474|P9|COMPLETED|Part 2: Dose Expansion||0
5154158|NCT01286987|12677475|P8|COMPLETED|Part 2: Dose Expansion||0
5154159|NCT01286987|12677476|P7|COMPLETED|Part 2: Dose Expansion||0
5154160|NCT01286987|12677477|P6|COMPLETED|Part 2: Dose Expansion||0
5154161|NCT01286987|12677478|P5|COMPLETED|Part 2: Dose Expansion||0
5154162|NCT01286987|12677479|P4|COMPLETED|Part 2: Dose Expansion||0
5154163|NCT01286987|12677480|P3|COMPLETED|Part 2: Dose Expansion||0
5154164|NCT01286987|12677481|P2|COMPLETED|Part 2: Dose Expansion||0
5154165|NCT01286987|12677482|P1|COMPLETED|Part 2: Dose Expansion||0
5154166|NCT01286987|12677468|P15|Treated|Part 2: Dose Expansion||3
5154167|NCT01286987|12677469|P14|Treated|Part 2: Dose Expansion||23
5154168|NCT01286987|12677470|P13|Treated|Part 2: Dose Expansion||12
5154169|NCT01286987|12677471|P12|Treated|Part 2: Dose Expansion||10
5154170|NCT01286987|12677472|P11|Treated|Part 2: Dose Expansion||11
5154171|NCT01286987|12677473|P10|Treated|Part 2: Dose Expansion||12
5154172|NCT01286987|12677474|P9|Treated|Part 2: Dose Expansion||0
5154173|NCT01286987|12677475|P8|Treated|Part 2: Dose Expansion||0
5154174|NCT01286987|12677476|P7|Treated|Part 2: Dose Expansion||0
5154175|NCT01286987|12677477|P6|Treated|Part 2: Dose Expansion||0
5154176|NCT01286987|12677478|P5|Treated|Part 2: Dose Expansion||0
5154177|NCT01286987|12677479|P4|Treated|Part 2: Dose Expansion||0
5154178|NCT01286987|12677480|P3|Treated|Part 2: Dose Expansion||0
5154179|NCT01286987|12677481|P2|Treated|Part 2: Dose Expansion||0
5154180|NCT01286987|12677482|P1|Treated|Part 2: Dose Expansion||0
5154181|NCT01286987|12677468|P15|STARTED|Part 2: Dose Expansion||3
5154182|NCT01286987|12677469|P14|STARTED|Part 2: Dose Expansion||24
5154183|NCT01286987|12677470|P13|STARTED|Part 2: Dose Expansion||12
5154184|NCT01286987|12677471|P12|STARTED|Part 2: Dose Expansion||11
5154185|NCT01286987|12677472|P11|STARTED|Part 2: Dose Expansion||12
5154186|NCT01286987|12677473|P10|STARTED|Part 2: Dose Expansion||12
5154187|NCT01286987|12677474|P9|STARTED|Part 2: Dose Expansion||0
5154188|NCT01286987|12677475|P8|STARTED|Part 2: Dose Expansion||0
5154189|NCT01286987|12677476|P7|STARTED|Part 2: Dose Expansion||0
5154190|NCT01286987|12677477|P6|STARTED|Part 2: Dose Expansion||0
5154191|NCT01286987|12677478|P5|STARTED|Part 2: Dose Expansion||0
5154192|NCT01286987|12677479|P4|STARTED|Part 2: Dose Expansion||0
5154193|NCT01286987|12677480|P3|STARTED|Part 2: Dose Expansion||0
5154194|NCT01286987|12677481|P2|STARTED|Part 2: Dose Expansion||0
5154195|NCT01286987|12677482|P1|STARTED|Part 2: Dose Expansion||0
5154196|NCT01286987|12677468|P15|NOT COMPLETED|Part 1: Dose Escalation||0
5154197|NCT01286987|12677469|P14|NOT COMPLETED|Part 1: Dose Escalation||0
5154198|NCT01286987|12677470|P13|NOT COMPLETED|Part 1: Dose Escalation||0
5154199|NCT01286987|12677471|P12|NOT COMPLETED|Part 1: Dose Escalation||0
5154200|NCT01286987|12677472|P11|NOT COMPLETED|Part 1: Dose Escalation||0
5154201|NCT01286987|12677473|P10|NOT COMPLETED|Part 1: Dose Escalation||0
5154202|NCT01286987|12677474|P9|NOT COMPLETED|Part 1: Dose Escalation||6
5154203|NCT01286987|12677475|P8|NOT COMPLETED|Part 1: Dose Escalation||5
5154204|NCT01286987|12677476|P7|NOT COMPLETED|Part 1: Dose Escalation||5
5154205|NCT01286987|12677477|P6|NOT COMPLETED|Part 1: Dose Escalation||6
5154206|NCT01286987|12677478|P5|NOT COMPLETED|Part 1: Dose Escalation||3
5154207|NCT01286987|12677479|P4|NOT COMPLETED|Part 1: Dose Escalation||3
5154208|NCT01286987|12677480|P3|NOT COMPLETED|Part 1: Dose Escalation||3
5154209|NCT01286987|12677481|P2|NOT COMPLETED|Part 1: Dose Escalation||3
5154210|NCT01286987|12677482|P1|NOT COMPLETED|Part 1: Dose Escalation||3
5154211|NCT01286987|12677468|P15|COMPLETED|Part 1: Dose Escalation||0
5154212|NCT01286987|12677469|P14|COMPLETED|Part 1: Dose Escalation||0
5154213|NCT01286987|12677470|P13|COMPLETED|Part 1: Dose Escalation||0
5154214|NCT01286987|12677471|P12|COMPLETED|Part 1: Dose Escalation||0
5154215|NCT01286987|12677472|P11|COMPLETED|Part 1: Dose Escalation||0
5154216|NCT01286987|12677473|P10|COMPLETED|Part 1: Dose Escalation||0
5154217|NCT01286987|12677474|P9|COMPLETED|Part 1: Dose Escalation||0
5154218|NCT01286987|12677475|P8|COMPLETED|Part 1: Dose Escalation||1
5154219|NCT01286987|12677476|P7|COMPLETED|Part 1: Dose Escalation||1
5154220|NCT01286987|12677477|P6|COMPLETED|Part 1: Dose Escalation||0
5154221|NCT01286987|12677478|P5|COMPLETED|Part 1: Dose Escalation||0
5154222|NCT01286987|12677479|P4|COMPLETED|Part 1: Dose Escalation||0
5154223|NCT01286987|12677480|P3|COMPLETED|Part 1: Dose Escalation||0
5154224|NCT01286987|12677481|P2|COMPLETED|Part 1: Dose Escalation||0
5154225|NCT01286987|12677482|P1|COMPLETED|Part 1: Dose Escalation||0
5154226|NCT01286987|12677468|P15|Breast Cancer|Part 1: Dose Escalation||0
5154227|NCT01286987|12677469|P14|Breast Cancer|Part 1: Dose Escalation||0
5154228|NCT01286987|12677470|P13|Breast Cancer|Part 1: Dose Escalation||0
5154229|NCT01286987|12677471|P12|Breast Cancer|Part 1: Dose Escalation||0
5154230|NCT01286987|12677472|P11|Breast Cancer|Part 1: Dose Escalation||0
5154231|NCT01286987|12677473|P10|Breast Cancer|Part 1: Dose Escalation||0
5154232|NCT01286987|12677474|P9|Breast Cancer|Part 1: Dose Escalation||3
5154233|NCT01286987|12677475|P8|Breast Cancer|Part 1: Dose Escalation||2
5154234|NCT01286987|12677476|P7|Breast Cancer|Part 1: Dose Escalation||2
5154235|NCT01286987|12677477|P6|Breast Cancer|Part 1: Dose Escalation||1
5154236|NCT01286987|12677478|P5|Breast Cancer|Part 1: Dose Escalation||0
5154237|NCT01286987|12677479|P4|Breast Cancer|Part 1: Dose Escalation||0
5154238|NCT01286987|12677480|P3|Breast Cancer|Part 1: Dose Escalation||0
5154239|NCT01286987|12677481|P2|Breast Cancer|Part 1: Dose Escalation||0
5154240|NCT01286987|12677482|P1|Breast Cancer|Part 1: Dose Escalation||0
5154241|NCT01286987|12677468|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154242|NCT01286987|12677469|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154243|NCT01286987|12677470|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154244|NCT01286987|12677471|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154245|NCT01286987|12677472|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154246|NCT01286987|12677473|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
5154247|NCT01286987|12677474|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
5154248|NCT01286987|12677475|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
5154249|NCT01286987|12677476|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
5154250|NCT01286987|12677477|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
5154251|NCT01286987|12677478|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
5154252|NCT01286987|12677479|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
5154253|NCT01286987|12677480|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
5154254|NCT01286987|12677481|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
5154255|NCT01286987|12677482|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
5154256|NCT01286987|12677468|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
5154257|NCT01286987|12677469|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
5154258|NCT01286987|12677470|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
5154259|NCT01286987|12677471|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
5154260|NCT01286987|12677472|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
5154261|NCT01286987|12677473|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
5154262|NCT01286987|12677474|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
5154263|NCT01286987|12677475|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
5154264|NCT01286987|12677476|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
5154265|NCT01286987|12677477|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
5154266|NCT01286987|12677478|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
5154267|NCT01286987|12677479|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
5154268|NCT01286987|12677480|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
5154269|NCT01286987|12677481|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
5154270|NCT01286987|12677482|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
5154271|NCT01286987|12677468|P15|Ewing Cancer|Part 1: Dose Escalation||0
5154272|NCT01286987|12677469|P14|Ewing Cancer|Part 1: Dose Escalation||0
5154273|NCT01286987|12677470|P13|Ewing Cancer|Part 1: Dose Escalation||0
5154274|NCT01286987|12677471|P12|Ewing Cancer|Part 1: Dose Escalation||0
5154275|NCT01286987|12677472|P11|Ewing Cancer|Part 1: Dose Escalation||0
5154276|NCT01286987|12677473|P10|Ewing Cancer|Part 1: Dose Escalation||0
5154277|NCT01286987|12677474|P9|Ewing Cancer|Part 1: Dose Escalation||1
5154278|NCT01286987|12677475|P8|Ewing Cancer|Part 1: Dose Escalation||1
5154279|NCT01286987|12677476|P7|Ewing Cancer|Part 1: Dose Escalation||0
5154280|NCT01286987|12677477|P6|Ewing Cancer|Part 1: Dose Escalation||0
5154281|NCT01286987|12677478|P5|Ewing Cancer|Part 1: Dose Escalation||0
5154282|NCT01286987|12677479|P4|Ewing Cancer|Part 1: Dose Escalation||0
5154283|NCT01286987|12677480|P3|Ewing Cancer|Part 1: Dose Escalation||0
5154284|NCT01286987|12677481|P2|Ewing Cancer|Part 1: Dose Escalation||0
5154285|NCT01286987|12677482|P1|Ewing Cancer|Part 1: Dose Escalation||0
5154286|NCT01286987|12677468|P15|Prostate Cancer|Part 1: Dose Escalation||0
5154287|NCT01286987|12677469|P14|Prostate Cancer|Part 1: Dose Escalation||0
5154288|NCT01286987|12677470|P13|Prostate Cancer|Part 1: Dose Escalation||0
5154289|NCT01286987|12677471|P12|Prostate Cancer|Part 1: Dose Escalation||0
5154290|NCT01286987|12677472|P11|Prostate Cancer|Part 1: Dose Escalation||0
5154291|NCT01286987|12677473|P10|Prostate Cancer|Part 1: Dose Escalation||0
5154292|NCT01286987|12677474|P9|Prostate Cancer|Part 1: Dose Escalation||0
5154293|NCT01286987|12677475|P8|Prostate Cancer|Part 1: Dose Escalation||0
5154294|NCT01286987|12677476|P7|Prostate Cancer|Part 1: Dose Escalation||0
5154295|NCT01286987|12677477|P6|Prostate Cancer|Part 1: Dose Escalation||1
5154296|NCT01286987|12677478|P5|Prostate Cancer|Part 1: Dose Escalation||0
5154297|NCT01286987|12677479|P4|Prostate Cancer|Part 1: Dose Escalation||0
5154298|NCT01286987|12677480|P3|Prostate Cancer|Part 1: Dose Escalation||0
5154299|NCT01286987|12677481|P2|Prostate Cancer|Part 1: Dose Escalation||0
5154300|NCT01286987|12677482|P1|Prostate Cancer|Part 1: Dose Escalation||0
5154301|NCT01286987|12677468|P15|Colorectal Cancer|Part 1: Dose Escalation||0
5154302|NCT01286987|12677469|P14|Colorectal Cancer|Part 1: Dose Escalation||0
5154303|NCT01286987|12677470|P13|Colorectal Cancer|Part 1: Dose Escalation||0
5154304|NCT01286987|12677471|P12|Colorectal Cancer|Part 1: Dose Escalation||0
5154305|NCT01286987|12677472|P11|Colorectal Cancer|Part 1: Dose Escalation||0
5154306|NCT01286987|12677473|P10|Colorectal Cancer|Part 1: Dose Escalation||0
5154307|NCT01286987|12677474|P9|Colorectal Cancer|Part 1: Dose Escalation||0
5154308|NCT01286987|12677475|P8|Colorectal Cancer|Part 1: Dose Escalation||0
5154309|NCT01286987|12677476|P7|Colorectal Cancer|Part 1: Dose Escalation||0
5154310|NCT01286987|12677477|P6|Colorectal Cancer|Part 1: Dose Escalation||0
5154311|NCT01286987|12677478|P5|Colorectal Cancer|Part 1: Dose Escalation||0
5154312|NCT01286987|12677479|P4|Colorectal Cancer|Part 1: Dose Escalation||0
5154313|NCT01286987|12677480|P3|Colorectal Cancer|Part 1: Dose Escalation||1
5154314|NCT01286987|12677481|P2|Colorectal Cancer|Part 1: Dose Escalation||0
5154315|NCT01286987|12677482|P1|Colorectal Cancer|Part 1: Dose Escalation||1
5154316|NCT01286987|12677468|P15|STARTED|Part 1: Dose Escalation||0
5154317|NCT01286987|12677469|P14|STARTED|Part 1: Dose Escalation||0
5154318|NCT01286987|12677470|P13|STARTED|Part 1: Dose Escalation||0
5154319|NCT01286987|12677471|P12|STARTED|Part 1: Dose Escalation||0
5154320|NCT01286987|12677472|P11|STARTED|Part 1: Dose Escalation||0
5154321|NCT01286987|12677473|P10|STARTED|Part 1: Dose Escalation||0
5154322|NCT01286987|12677474|P9|STARTED|Part 1: Dose Escalation||6
5154323|NCT01286987|12677475|P8|STARTED|Part 1: Dose Escalation||6
5154324|NCT01286987|12677476|P7|STARTED|Part 1: Dose Escalation||6
5154325|NCT01286987|12677477|P6|STARTED|Part 1: Dose Escalation||6
5154326|NCT01286987|12677478|P5|STARTED|Part 1: Dose Escalation||3
5154327|NCT01286987|12677479|P4|STARTED|Part 1: Dose Escalation||3
5154328|NCT01286987|12677480|P3|STARTED|Part 1: Dose Escalation||3
5154329|NCT01286987|12677481|P2|STARTED|Part 1: Dose Escalation||3
5154330|NCT01286987|12677482|P1|STARTED|Part 1: Dose Escalation||3
5154331|NCT01286870|12677623|P1|NOT COMPLETED|Overall Study||0
5154332|NCT01286870|12677623|P1|COMPLETED|Overall Study||11
5154333|NCT01286870|12677623|P1|STARTED|Overall Study||11
5154334|NCT01286818|12677628|P1|NOT COMPLETED|Overall Study||0
5154335|NCT01286818|12677628|P1|COMPLETED|Overall Study||6
5154336|NCT01286818|12677628|P1|Completed DLT Assessment Period|Overall Study||5
5154337|NCT01286818|12677628|P1|STARTED|Overall Study||6
5154338|NCT01286805|12677642|P2|NOT COMPLETED|Overall Study||1
5154339|NCT01286805|12677643|P1|NOT COMPLETED|Overall Study||0
5154340|NCT01286805|12677642|P2|COMPLETED|Overall Study||41
5154341|NCT01286805|12677643|P1|COMPLETED|Overall Study||41
5154342|NCT01286805|12677642|P2|STARTED|Overall Study||42
5154343|NCT01286805|12677643|P1|STARTED|Overall Study||41
5154344|NCT01286779|12677663|P1|NOT COMPLETED|Overall Study||19
5154345|NCT01286779|12677663|P1|COMPLETED|Overall Study||96
5154346|NCT01286779|12677663|P1|STARTED|Overall Study||115
5154347|NCT01286753|12677715|P2|NOT COMPLETED|Overall Study||25
5154348|NCT01286753|12677716|P1|NOT COMPLETED|Overall Study||26
5154349|NCT01286753|12677715|P2|COMPLETED|Overall Study||0
5154350|NCT01286753|12677716|P1|COMPLETED|Overall Study||0
5154351|NCT01286753|12677715|P2|STARTED|Overall Study||25
5154352|NCT01286753|12677716|P1|STARTED|Overall Study||26
5154353|NCT01286740|12677734|P1|NOT COMPLETED|Overall Study||2
5154354|NCT01286740|12677734|P1|COMPLETED|Overall Study||48
5154355|NCT01286740|12677734|P1|Week 12 (Primary Endpoint)|Overall Study||49
5154356|NCT01286740|12677734|P1|Enrolled and Treated|Overall Study||49
5154357|NCT01286740|12677734|P1|STARTED|Overall Study||50
5154358|NCT01286558|12677752|P2|NOT COMPLETED|Overall Study||2
5154359|NCT01286558|12677753|P1|NOT COMPLETED|Overall Study||1
5154360|NCT01286558|12677752|P2|COMPLETED|Overall Study||111
5154361|NCT01286558|12677753|P1|COMPLETED|Overall Study||111
5154362|NCT01286558|12677752|P2|STARTED|Overall Study||113
5154363|NCT01286558|12677753|P1|STARTED|Overall Study||112
5154364|NCT01286493|12677783|P1|NOT COMPLETED|Overall Study||3
5154365|NCT01286493|12677783|P1|COMPLETED|Overall Study||30
5154366|NCT01286493|12677783|P1|STARTED|Overall Study||33
5154367|NCT01286480|12677789|P2|NOT COMPLETED|Overall Study||3
5154368|NCT01286480|12677790|P1|NOT COMPLETED|Overall Study||5
5154369|NCT01286480|12677789|P2|COMPLETED|Overall Study||31
5154370|NCT01286480|12677790|P1|COMPLETED|Overall Study||27
5154371|NCT01286480|12677789|P2|STARTED|Overall Study||34
5154372|NCT01286480|12677790|P1|STARTED|Overall Study||32
5154373|NCT01286454|12677798|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154374|NCT01286454|12677799|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154375|NCT01286454|12677800|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154376|NCT01286454|12677801|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154377|NCT01286454|12677802|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154378|NCT01286454|12677803|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154379|NCT01286454|12677804|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154380|NCT01286454|12677805|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154381|NCT01286454|12677806|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154382|NCT01286454|12677807|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154383|NCT01286454|12677808|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
5154384|NCT01286454|12677798|P11|COMPLETED|Part II- Sixth Intervention Period||20
5154385|NCT01286454|12677799|P10|COMPLETED|Part II- Sixth Intervention Period||0
5154386|NCT01286454|12677800|P9|COMPLETED|Part II- Sixth Intervention Period||0
5154387|NCT01286454|12677801|P8|COMPLETED|Part II- Sixth Intervention Period||0
5154388|NCT01286454|12677802|P7|COMPLETED|Part II- Sixth Intervention Period||0
5154389|NCT01286454|12677803|P6|COMPLETED|Part II- Sixth Intervention Period||0
5154390|NCT01286454|12677804|P5|COMPLETED|Part II- Sixth Intervention Period||0
5154391|NCT01286454|12677805|P4|COMPLETED|Part II- Sixth Intervention Period||0
5154392|NCT01286454|12677806|P3|COMPLETED|Part II- Sixth Intervention Period||0
5154393|NCT01286454|12677807|P2|COMPLETED|Part II- Sixth Intervention Period||0
5154394|NCT01286454|12677808|P1|COMPLETED|Part II- Sixth Intervention Period||0
5154395|NCT01286454|12677798|P11|STARTED|Part II- Sixth Intervention Period||20
5154396|NCT01286454|12677799|P10|STARTED|Part II- Sixth Intervention Period||0
5154397|NCT01286454|12677800|P9|STARTED|Part II- Sixth Intervention Period||0
5154398|NCT01286454|12677801|P8|STARTED|Part II- Sixth Intervention Period||0
5154399|NCT01286454|12677802|P7|STARTED|Part II- Sixth Intervention Period||0
5154400|NCT01286454|12677803|P6|STARTED|Part II- Sixth Intervention Period||0
5154401|NCT01286454|12677804|P5|STARTED|Part II- Sixth Intervention Period||0
5154402|NCT01286454|12677805|P4|STARTED|Part II- Sixth Intervention Period||0
5154403|NCT01286454|12677806|P3|STARTED|Part II- Sixth Intervention Period||0
5154404|NCT01286454|12677807|P2|STARTED|Part II- Sixth Intervention Period||0
5154405|NCT01286454|12677808|P1|STARTED|Part II- Sixth Intervention Period||0
5154406|NCT01286454|12677798|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154407|NCT01286454|12677799|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154408|NCT01286454|12677800|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154409|NCT01286454|12677801|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154489|NCT01286454|12677804|P5|COMPLETED|Washout Period (At Least 3 Days)||2
5154410|NCT01286454|12677802|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154411|NCT01286454|12677803|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154412|NCT01286454|12677804|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154413|NCT01286454|12677805|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154414|NCT01286454|12677806|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154415|NCT01286454|12677807|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154416|NCT01286454|12677808|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154417|NCT01286454|12677798|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
5154418|NCT01286454|12677799|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154419|NCT01286454|12677800|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154420|NCT01286454|12677801|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154421|NCT01286454|12677802|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154422|NCT01286454|12677803|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154423|NCT01286454|12677804|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154424|NCT01286454|12677805|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154425|NCT01286454|12677806|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154426|NCT01286454|12677807|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154427|NCT01286454|12677808|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
5154428|NCT01286454|12677798|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
5154429|NCT01286454|12677799|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
5154430|NCT01286454|12677800|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
5154431|NCT01286454|12677801|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
5154432|NCT01286454|12677802|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
5154433|NCT01286454|12677803|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
5154434|NCT01286454|12677804|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
5154435|NCT01286454|12677805|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
5154436|NCT01286454|12677806|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
5154437|NCT01286454|12677807|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
5154438|NCT01286454|12677808|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
5154439|NCT01286454|12677798|P11|NOT COMPLETED|Fifth Intervention Period||0
5154440|NCT01286454|12677799|P10|NOT COMPLETED|Fifth Intervention Period||0
5154441|NCT01286454|12677800|P9|NOT COMPLETED|Fifth Intervention Period||0
5154442|NCT01286454|12677801|P8|NOT COMPLETED|Fifth Intervention Period||0
5154443|NCT01286454|12677802|P7|NOT COMPLETED|Fifth Intervention Period||0
5154444|NCT01286454|12677803|P6|NOT COMPLETED|Fifth Intervention Period||0
5154445|NCT01286454|12677804|P5|NOT COMPLETED|Fifth Intervention Period||0
5154446|NCT01286454|12677805|P4|NOT COMPLETED|Fifth Intervention Period||0
5154447|NCT01286454|12677806|P3|NOT COMPLETED|Fifth Intervention Period||0
5154448|NCT01286454|12677807|P2|NOT COMPLETED|Fifth Intervention Period||0
5154449|NCT01286454|12677808|P1|NOT COMPLETED|Fifth Intervention Period||0
5154450|NCT01286454|12677798|P11|COMPLETED|Fifth Intervention Period||0
5154451|NCT01286454|12677799|P10|COMPLETED|Fifth Intervention Period||2
5154452|NCT01286454|12677800|P9|COMPLETED|Fifth Intervention Period||2
5154453|NCT01286454|12677801|P8|COMPLETED|Fifth Intervention Period||2
5154454|NCT01286454|12677802|P7|COMPLETED|Fifth Intervention Period||2
5154455|NCT01286454|12677803|P6|COMPLETED|Fifth Intervention Period||2
5154456|NCT01286454|12677804|P5|COMPLETED|Fifth Intervention Period||2
5154457|NCT01286454|12677805|P4|COMPLETED|Fifth Intervention Period||2
5154458|NCT01286454|12677806|P3|COMPLETED|Fifth Intervention Period||2
5154459|NCT01286454|12677807|P2|COMPLETED|Fifth Intervention Period||2
5154460|NCT01286454|12677808|P1|COMPLETED|Fifth Intervention Period||2
5154461|NCT01286454|12677798|P11|STARTED|Fifth Intervention Period||0
5154462|NCT01286454|12677799|P10|STARTED|Fifth Intervention Period||2
5154463|NCT01286454|12677800|P9|STARTED|Fifth Intervention Period||2
5154464|NCT01286454|12677801|P8|STARTED|Fifth Intervention Period||2
5154465|NCT01286454|12677802|P7|STARTED|Fifth Intervention Period||2
5154466|NCT01286454|12677803|P6|STARTED|Fifth Intervention Period||2
5154467|NCT01286454|12677804|P5|STARTED|Fifth Intervention Period||2
5154468|NCT01286454|12677805|P4|STARTED|Fifth Intervention Period||2
5154469|NCT01286454|12677806|P3|STARTED|Fifth Intervention Period||2
5154470|NCT01286454|12677807|P2|STARTED|Fifth Intervention Period||2
5154471|NCT01286454|12677808|P1|STARTED|Fifth Intervention Period||2
5154472|NCT01286454|12677798|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154473|NCT01286454|12677799|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154474|NCT01286454|12677800|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154475|NCT01286454|12677801|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154476|NCT01286454|12677802|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154477|NCT01286454|12677803|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154478|NCT01286454|12677804|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154479|NCT01286454|12677805|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154480|NCT01286454|12677806|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154481|NCT01286454|12677807|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154482|NCT01286454|12677808|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154483|NCT01286454|12677798|P11|COMPLETED|Washout Period (At Least 3 Days)||0
5154484|NCT01286454|12677799|P10|COMPLETED|Washout Period (At Least 3 Days)||2
5154485|NCT01286454|12677800|P9|COMPLETED|Washout Period (At Least 3 Days)||2
5154486|NCT01286454|12677801|P8|COMPLETED|Washout Period (At Least 3 Days)||2
5154487|NCT01286454|12677802|P7|COMPLETED|Washout Period (At Least 3 Days)||2
5154488|NCT01286454|12677803|P6|COMPLETED|Washout Period (At Least 3 Days)||2
5154490|NCT01286454|12677805|P4|COMPLETED|Washout Period (At Least 3 Days)||2
5154491|NCT01286454|12677806|P3|COMPLETED|Washout Period (At Least 3 Days)||2
5154492|NCT01286454|12677807|P2|COMPLETED|Washout Period (At Least 3 Days)||2
5154493|NCT01286454|12677808|P1|COMPLETED|Washout Period (At Least 3 Days)||2
5154494|NCT01286454|12677798|P11|STARTED|Washout Period (At Least 3 Days)||0
5154495|NCT01286454|12677799|P10|STARTED|Washout Period (At Least 3 Days)||2
5154496|NCT01286454|12677800|P9|STARTED|Washout Period (At Least 3 Days)||2
5154497|NCT01286454|12677801|P8|STARTED|Washout Period (At Least 3 Days)||2
5154498|NCT01286454|12677802|P7|STARTED|Washout Period (At Least 3 Days)||2
5154499|NCT01286454|12677803|P6|STARTED|Washout Period (At Least 3 Days)||2
5154500|NCT01286454|12677804|P5|STARTED|Washout Period (At Least 3 Days)||2
5154501|NCT01286454|12677805|P4|STARTED|Washout Period (At Least 3 Days)||2
5154502|NCT01286454|12677806|P3|STARTED|Washout Period (At Least 3 Days)||2
5154503|NCT01286454|12677807|P2|STARTED|Washout Period (At Least 3 Days)||2
5154504|NCT01286454|12677808|P1|STARTED|Washout Period (At Least 3 Days)||2
5154505|NCT01286454|12677798|P11|NOT COMPLETED|Fourth Intervention Period||0
5154506|NCT01286454|12677799|P10|NOT COMPLETED|Fourth Intervention Period||0
5154507|NCT01286454|12677800|P9|NOT COMPLETED|Fourth Intervention Period||0
5154508|NCT01286454|12677801|P8|NOT COMPLETED|Fourth Intervention Period||0
5154509|NCT01286454|12677802|P7|NOT COMPLETED|Fourth Intervention Period||0
5154510|NCT01286454|12677803|P6|NOT COMPLETED|Fourth Intervention Period||0
5154511|NCT01286454|12677804|P5|NOT COMPLETED|Fourth Intervention Period||0
5154512|NCT01286454|12677805|P4|NOT COMPLETED|Fourth Intervention Period||0
5154513|NCT01286454|12677806|P3|NOT COMPLETED|Fourth Intervention Period||0
5154514|NCT01286454|12677807|P2|NOT COMPLETED|Fourth Intervention Period||0
5154515|NCT01286454|12677808|P1|NOT COMPLETED|Fourth Intervention Period||0
5154516|NCT01286454|12677798|P11|COMPLETED|Fourth Intervention Period||0
5154517|NCT01286454|12677799|P10|COMPLETED|Fourth Intervention Period||2
5154518|NCT01286454|12677800|P9|COMPLETED|Fourth Intervention Period||2
5154519|NCT01286454|12677801|P8|COMPLETED|Fourth Intervention Period||2
5154520|NCT01286454|12677802|P7|COMPLETED|Fourth Intervention Period||2
5154521|NCT01286454|12677803|P6|COMPLETED|Fourth Intervention Period||2
5154522|NCT01286454|12677804|P5|COMPLETED|Fourth Intervention Period||2
5154523|NCT01286454|12677805|P4|COMPLETED|Fourth Intervention Period||2
5154524|NCT01286454|12677806|P3|COMPLETED|Fourth Intervention Period||2
5154525|NCT01286454|12677807|P2|COMPLETED|Fourth Intervention Period||2
5154526|NCT01286454|12677808|P1|COMPLETED|Fourth Intervention Period||2
5154527|NCT01286454|12677798|P11|STARTED|Fourth Intervention Period||0
5154528|NCT01286454|12677799|P10|STARTED|Fourth Intervention Period||2
5154529|NCT01286454|12677800|P9|STARTED|Fourth Intervention Period||2
5154530|NCT01286454|12677801|P8|STARTED|Fourth Intervention Period||2
5154531|NCT01286454|12677802|P7|STARTED|Fourth Intervention Period||2
5154532|NCT01286454|12677803|P6|STARTED|Fourth Intervention Period||2
5154533|NCT01286454|12677804|P5|STARTED|Fourth Intervention Period||2
5154534|NCT01286454|12677805|P4|STARTED|Fourth Intervention Period||2
5154535|NCT01286454|12677806|P3|STARTED|Fourth Intervention Period||2
5154536|NCT01286454|12677807|P2|STARTED|Fourth Intervention Period||2
5154537|NCT01286454|12677808|P1|STARTED|Fourth Intervention Period||2
5154538|NCT01286454|12677798|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154539|NCT01286454|12677799|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154540|NCT01286454|12677800|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154541|NCT01286454|12677801|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154542|NCT01286454|12677802|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154543|NCT01286454|12677803|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154544|NCT01286454|12677804|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154545|NCT01286454|12677805|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154546|NCT01286454|12677806|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154547|NCT01286454|12677807|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154548|NCT01286454|12677808|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154549|NCT01286454|12677798|P11|COMPLETED|Washout Period (At Least 3 Days)||0
5154550|NCT01286454|12677799|P10|COMPLETED|Washout Period (At Least 3 Days)||2
5154551|NCT01286454|12677800|P9|COMPLETED|Washout Period (At Least 3 Days)||2
5154552|NCT01286454|12677801|P8|COMPLETED|Washout Period (At Least 3 Days)||2
5154553|NCT01286454|12677802|P7|COMPLETED|Washout Period (At Least 3 Days)||2
5154554|NCT01286454|12677803|P6|COMPLETED|Washout Period (At Least 3 Days)||2
5154555|NCT01286454|12677804|P5|COMPLETED|Washout Period (At Least 3 Days)||2
5154556|NCT01286454|12677805|P4|COMPLETED|Washout Period (At Least 3 Days)||2
5154557|NCT01286454|12677806|P3|COMPLETED|Washout Period (At Least 3 Days)||2
5154558|NCT01286454|12677807|P2|COMPLETED|Washout Period (At Least 3 Days)||2
5154559|NCT01286454|12677808|P1|COMPLETED|Washout Period (At Least 3 Days)||2
5154560|NCT01286454|12677798|P11|STARTED|Washout Period (At Least 3 Days)||0
5154561|NCT01286454|12677799|P10|STARTED|Washout Period (At Least 3 Days)||2
5154562|NCT01286454|12677800|P9|STARTED|Washout Period (At Least 3 Days)||2
5154563|NCT01286454|12677801|P8|STARTED|Washout Period (At Least 3 Days)||2
5154564|NCT01286454|12677802|P7|STARTED|Washout Period (At Least 3 Days)||2
5154565|NCT01286454|12677803|P6|STARTED|Washout Period (At Least 3 Days)||2
5154566|NCT01286454|12677804|P5|STARTED|Washout Period (At Least 3 Days)||2
5154567|NCT01286454|12677805|P4|STARTED|Washout Period (At Least 3 Days)||2
5154568|NCT01286454|12677806|P3|STARTED|Washout Period (At Least 3 Days)||2
5154569|NCT01286454|12677807|P2|STARTED|Washout Period (At Least 3 Days)||2
5154570|NCT01286454|12677808|P1|STARTED|Washout Period (At Least 3 Days)||2
5154571|NCT01286454|12677798|P11|NOT COMPLETED|Third Intervention Period||0
5154572|NCT01286454|12677799|P10|NOT COMPLETED|Third Intervention Period||0
5154573|NCT01286454|12677800|P9|NOT COMPLETED|Third Intervention Period||0
5154574|NCT01286454|12677801|P8|NOT COMPLETED|Third Intervention Period||0
5154575|NCT01286454|12677802|P7|NOT COMPLETED|Third Intervention Period||0
5154576|NCT01286454|12677803|P6|NOT COMPLETED|Third Intervention Period||0
5154577|NCT01286454|12677804|P5|NOT COMPLETED|Third Intervention Period||0
5154578|NCT01286454|12677805|P4|NOT COMPLETED|Third Intervention Period||0
5154579|NCT01286454|12677806|P3|NOT COMPLETED|Third Intervention Period||0
5154580|NCT01286454|12677807|P2|NOT COMPLETED|Third Intervention Period||0
5154581|NCT01286454|12677808|P1|NOT COMPLETED|Third Intervention Period||0
5154582|NCT01286454|12677798|P11|COMPLETED|Third Intervention Period||0
5154583|NCT01286454|12677799|P10|COMPLETED|Third Intervention Period||2
5154584|NCT01286454|12677800|P9|COMPLETED|Third Intervention Period||2
5154585|NCT01286454|12677801|P8|COMPLETED|Third Intervention Period||2
5154586|NCT01286454|12677802|P7|COMPLETED|Third Intervention Period||2
5154587|NCT01286454|12677803|P6|COMPLETED|Third Intervention Period||2
5154588|NCT01286454|12677804|P5|COMPLETED|Third Intervention Period||2
5154589|NCT01286454|12677805|P4|COMPLETED|Third Intervention Period||2
5154590|NCT01286454|12677806|P3|COMPLETED|Third Intervention Period||2
5154591|NCT01286454|12677807|P2|COMPLETED|Third Intervention Period||2
5154592|NCT01286454|12677808|P1|COMPLETED|Third Intervention Period||2
5154593|NCT01286454|12677798|P11|STARTED|Third Intervention Period||0
5154594|NCT01286454|12677799|P10|STARTED|Third Intervention Period||2
5154595|NCT01286454|12677800|P9|STARTED|Third Intervention Period||2
5154596|NCT01286454|12677801|P8|STARTED|Third Intervention Period||2
5154597|NCT01286454|12677802|P7|STARTED|Third Intervention Period||2
5154598|NCT01286454|12677803|P6|STARTED|Third Intervention Period||2
5154599|NCT01286454|12677804|P5|STARTED|Third Intervention Period||2
5154600|NCT01286454|12677805|P4|STARTED|Third Intervention Period||2
5154601|NCT01286454|12677806|P3|STARTED|Third Intervention Period||2
5154602|NCT01286454|12677807|P2|STARTED|Third Intervention Period||2
5154603|NCT01286454|12677808|P1|STARTED|Third Intervention Period||2
5154604|NCT01286454|12677798|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154605|NCT01286454|12677799|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154606|NCT01286454|12677800|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154607|NCT01286454|12677801|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154608|NCT01286454|12677802|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154609|NCT01286454|12677803|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154610|NCT01286454|12677804|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154611|NCT01286454|12677805|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154612|NCT01286454|12677806|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154613|NCT01286454|12677807|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154614|NCT01286454|12677808|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154615|NCT01286454|12677798|P11|COMPLETED|Washout Period (At Least 3 Days)||0
5154616|NCT01286454|12677799|P10|COMPLETED|Washout Period (At Least 3 Days)||2
5154617|NCT01286454|12677800|P9|COMPLETED|Washout Period (At Least 3 Days)||2
5154618|NCT01286454|12677801|P8|COMPLETED|Washout Period (At Least 3 Days)||2
5154619|NCT01286454|12677802|P7|COMPLETED|Washout Period (At Least 3 Days)||2
5154620|NCT01286454|12677803|P6|COMPLETED|Washout Period (At Least 3 Days)||2
5154621|NCT01286454|12677804|P5|COMPLETED|Washout Period (At Least 3 Days)||2
5154622|NCT01286454|12677805|P4|COMPLETED|Washout Period (At Least 3 Days)||2
5154623|NCT01286454|12677806|P3|COMPLETED|Washout Period (At Least 3 Days)||2
5154624|NCT01286454|12677807|P2|COMPLETED|Washout Period (At Least 3 Days)||2
5154625|NCT01286454|12677808|P1|COMPLETED|Washout Period (At Least 3 Days)||2
5154626|NCT01286454|12677798|P11|STARTED|Washout Period (At Least 3 Days)||0
5154627|NCT01286454|12677799|P10|STARTED|Washout Period (At Least 3 Days)||2
5154628|NCT01286454|12677800|P9|STARTED|Washout Period (At Least 3 Days)||2
5154629|NCT01286454|12677801|P8|STARTED|Washout Period (At Least 3 Days)||2
5154630|NCT01286454|12677802|P7|STARTED|Washout Period (At Least 3 Days)||2
5154631|NCT01286454|12677803|P6|STARTED|Washout Period (At Least 3 Days)||2
5154632|NCT01286454|12677804|P5|STARTED|Washout Period (At Least 3 Days)||2
5154633|NCT01286454|12677805|P4|STARTED|Washout Period (At Least 3 Days)||2
5154634|NCT01286454|12677806|P3|STARTED|Washout Period (At Least 3 Days)||2
5154635|NCT01286454|12677807|P2|STARTED|Washout Period (At Least 3 Days)||2
5154636|NCT01286454|12677808|P1|STARTED|Washout Period (At Least 3 Days)||2
5154637|NCT01286454|12677798|P11|NOT COMPLETED|Second Intervention Period||0
5154638|NCT01286454|12677799|P10|NOT COMPLETED|Second Intervention Period||0
5154639|NCT01286454|12677800|P9|NOT COMPLETED|Second Intervention Period||0
5154640|NCT01286454|12677801|P8|NOT COMPLETED|Second Intervention Period||0
5154641|NCT01286454|12677802|P7|NOT COMPLETED|Second Intervention Period||0
5154642|NCT01286454|12677803|P6|NOT COMPLETED|Second Intervention Period||0
5154643|NCT01286454|12677804|P5|NOT COMPLETED|Second Intervention Period||0
5154644|NCT01286454|12677805|P4|NOT COMPLETED|Second Intervention Period||0
5154645|NCT01286454|12677806|P3|NOT COMPLETED|Second Intervention Period||0
5154646|NCT01286454|12677807|P2|NOT COMPLETED|Second Intervention Period||0
5154647|NCT01286454|12677808|P1|NOT COMPLETED|Second Intervention Period||0
5154648|NCT01286454|12677798|P11|COMPLETED|Second Intervention Period||0
5154649|NCT01286454|12677799|P10|COMPLETED|Second Intervention Period||2
5154650|NCT01286454|12677800|P9|COMPLETED|Second Intervention Period||2
5154651|NCT01286454|12677801|P8|COMPLETED|Second Intervention Period||2
5154652|NCT01286454|12677802|P7|COMPLETED|Second Intervention Period||2
5154653|NCT01286454|12677803|P6|COMPLETED|Second Intervention Period||2
5154654|NCT01286454|12677804|P5|COMPLETED|Second Intervention Period||2
5154655|NCT01286454|12677805|P4|COMPLETED|Second Intervention Period||2
5154656|NCT01286454|12677806|P3|COMPLETED|Second Intervention Period||2
5154657|NCT01286454|12677807|P2|COMPLETED|Second Intervention Period||2
5154658|NCT01286454|12677808|P1|COMPLETED|Second Intervention Period||2
5154659|NCT01286454|12677798|P11|STARTED|Second Intervention Period||0
5154660|NCT01286454|12677799|P10|STARTED|Second Intervention Period||2
5154661|NCT01286454|12677800|P9|STARTED|Second Intervention Period||2
5154662|NCT01286454|12677801|P8|STARTED|Second Intervention Period||2
5154663|NCT01286454|12677802|P7|STARTED|Second Intervention Period||2
5154664|NCT01286454|12677803|P6|STARTED|Second Intervention Period||2
5154665|NCT01286454|12677804|P5|STARTED|Second Intervention Period||2
5154666|NCT01286454|12677805|P4|STARTED|Second Intervention Period||2
5154667|NCT01286454|12677806|P3|STARTED|Second Intervention Period||2
5154668|NCT01286454|12677807|P2|STARTED|Second Intervention Period||2
5154669|NCT01286454|12677808|P1|STARTED|Second Intervention Period||2
5154670|NCT01286454|12677798|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154671|NCT01286454|12677799|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154672|NCT01286454|12677800|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154673|NCT01286454|12677801|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154674|NCT01286454|12677802|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154675|NCT01286454|12677803|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154676|NCT01286454|12677804|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154677|NCT01286454|12677805|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154678|NCT01286454|12677806|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154679|NCT01286454|12677807|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154680|NCT01286454|12677808|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
5154681|NCT01286454|12677798|P11|COMPLETED|Washout Period (At Least 3 Days)||0
5154682|NCT01286454|12677799|P10|COMPLETED|Washout Period (At Least 3 Days)||2
5154683|NCT01286454|12677800|P9|COMPLETED|Washout Period (At Least 3 Days)||2
5154684|NCT01286454|12677801|P8|COMPLETED|Washout Period (At Least 3 Days)||2
5154685|NCT01286454|12677802|P7|COMPLETED|Washout Period (At Least 3 Days)||2
5154686|NCT01286454|12677803|P6|COMPLETED|Washout Period (At Least 3 Days)||2
5154687|NCT01286454|12677804|P5|COMPLETED|Washout Period (At Least 3 Days)||2
5154688|NCT01286454|12677805|P4|COMPLETED|Washout Period (At Least 3 Days)||2
5154689|NCT01286454|12677806|P3|COMPLETED|Washout Period (At Least 3 Days)||2
5154690|NCT01286454|12677807|P2|COMPLETED|Washout Period (At Least 3 Days)||2
5154691|NCT01286454|12677808|P1|COMPLETED|Washout Period (At Least 3 Days)||2
5154692|NCT01286454|12677798|P11|STARTED|Washout Period (At Least 3 Days)||0
5154693|NCT01286454|12677799|P10|STARTED|Washout Period (At Least 3 Days)||2
5154694|NCT01286454|12677800|P9|STARTED|Washout Period (At Least 3 Days)||2
5154695|NCT01286454|12677801|P8|STARTED|Washout Period (At Least 3 Days)||2
5154696|NCT01286454|12677802|P7|STARTED|Washout Period (At Least 3 Days)||2
5154697|NCT01286454|12677803|P6|STARTED|Washout Period (At Least 3 Days)||2
5154698|NCT01286454|12677804|P5|STARTED|Washout Period (At Least 3 Days)||2
5154699|NCT01286454|12677805|P4|STARTED|Washout Period (At Least 3 Days)||2
5154700|NCT01286454|12677806|P3|STARTED|Washout Period (At Least 3 Days)||2
5154701|NCT01286454|12677807|P2|STARTED|Washout Period (At Least 3 Days)||2
5154702|NCT01286454|12677808|P1|STARTED|Washout Period (At Least 3 Days)||2
5154703|NCT01286454|12677798|P11|NOT COMPLETED|Part I- First Intervention Period||0
5154704|NCT01286454|12677799|P10|NOT COMPLETED|Part I- First Intervention Period||0
5154705|NCT01286454|12677800|P9|NOT COMPLETED|Part I- First Intervention Period||0
5154706|NCT01286454|12677801|P8|NOT COMPLETED|Part I- First Intervention Period||0
5154707|NCT01286454|12677802|P7|NOT COMPLETED|Part I- First Intervention Period||0
5154708|NCT01286454|12677803|P6|NOT COMPLETED|Part I- First Intervention Period||0
5154709|NCT01286454|12677804|P5|NOT COMPLETED|Part I- First Intervention Period||0
5154710|NCT01286454|12677805|P4|NOT COMPLETED|Part I- First Intervention Period||0
5154711|NCT01286454|12677806|P3|NOT COMPLETED|Part I- First Intervention Period||0
5154712|NCT01286454|12677807|P2|NOT COMPLETED|Part I- First Intervention Period||0
5154713|NCT01286454|12677808|P1|NOT COMPLETED|Part I- First Intervention Period||0
5154714|NCT01286454|12677798|P11|COMPLETED|Part I- First Intervention Period||0
5154715|NCT01286454|12677799|P10|COMPLETED|Part I- First Intervention Period||2
5154716|NCT01286454|12677800|P9|COMPLETED|Part I- First Intervention Period||2
5154717|NCT01286454|12677801|P8|COMPLETED|Part I- First Intervention Period||2
5154718|NCT01286454|12677802|P7|COMPLETED|Part I- First Intervention Period||2
5154719|NCT01286454|12677803|P6|COMPLETED|Part I- First Intervention Period||2
5154720|NCT01286454|12677804|P5|COMPLETED|Part I- First Intervention Period||2
5154721|NCT01286454|12677805|P4|COMPLETED|Part I- First Intervention Period||2
5154722|NCT01286454|12677806|P3|COMPLETED|Part I- First Intervention Period||2
5154723|NCT01286454|12677807|P2|COMPLETED|Part I- First Intervention Period||2
5154724|NCT01286454|12677808|P1|COMPLETED|Part I- First Intervention Period||2
5154725|NCT01286454|12677798|P11|STARTED|Part I- First Intervention Period||0
5154726|NCT01286454|12677799|P10|STARTED|Part I- First Intervention Period||2
5154727|NCT01286454|12677800|P9|STARTED|Part I- First Intervention Period||2
5154728|NCT01286454|12677801|P8|STARTED|Part I- First Intervention Period||2
5154729|NCT01286454|12677802|P7|STARTED|Part I- First Intervention Period||2
5154730|NCT01286454|12677803|P6|STARTED|Part I- First Intervention Period||2
5154731|NCT01286454|12677804|P5|STARTED|Part I- First Intervention Period||2
5154732|NCT01286454|12677805|P4|STARTED|Part I- First Intervention Period||2
5154733|NCT01286454|12677806|P3|STARTED|Part I- First Intervention Period||2
5154734|NCT01286454|12677807|P2|STARTED|Part I- First Intervention Period||2
5154735|NCT01286454|12677808|P1|STARTED|Part I- First Intervention Period||2
5154736|NCT01286441|12677850|P4|NOT COMPLETED|Overall Study||11
5154737|NCT01286441|12677851|P3|NOT COMPLETED|Overall Study||7
5154738|NCT01286441|12677852|P2|NOT COMPLETED|Overall Study||7
5154739|NCT01286441|12677853|P1|NOT COMPLETED|Overall Study||7
5154740|NCT01286441|12677850|P4|COMPLETED|Overall Study||37
5154741|NCT01286441|12677851|P3|COMPLETED|Overall Study||39
5154742|NCT01286441|12677852|P2|COMPLETED|Overall Study||37
5154743|NCT01286441|12677853|P1|COMPLETED|Overall Study||38
5154744|NCT01286441|12677850|P4|STARTED|Overall Study||48
5154745|NCT01286441|12677851|P3|STARTED|Overall Study||46
5154746|NCT01286441|12677852|P2|STARTED|Overall Study||44
5154747|NCT01286441|12677853|P1|STARTED|Overall Study||45
5154748|NCT01286402|12677869|P2|NOT COMPLETED|Overall Study||0
5154749|NCT01286402|12677870|P1|NOT COMPLETED|Overall Study||0
5154750|NCT01286402|12677869|P2|COMPLETED|Overall Study||6
5154751|NCT01286402|12677870|P1|COMPLETED|Overall Study||5
5154752|NCT01286402|12677869|P2|STARTED|Overall Study||6
5154753|NCT01286402|12677870|P1|STARTED|Overall Study||5
5154754|NCT01286324|12677878|P2|NOT COMPLETED|Overall Study||0
5154755|NCT01286324|12677879|P1|NOT COMPLETED|Overall Study||0
5154756|NCT01286324|12677878|P2|COMPLETED|Overall Study||17
5154757|NCT01286324|12677879|P1|COMPLETED|Overall Study||17
5154758|NCT01286324|12677878|P2|STARTED|Overall Study||17
5154759|NCT01286324|12677879|P1|STARTED|Overall Study||17
5154760|NCT01286311|12677897|P2|NOT COMPLETED|Overall Study||0
5154761|NCT01286311|12677898|P1|NOT COMPLETED|Overall Study||14
5154762|NCT01286311|12677897|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
5154763|NCT01286311|12677898|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
5154764|NCT01286311|12677897|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
5154765|NCT01286311|12677898|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
5154766|NCT01286272|12677914|P2|NOT COMPLETED|Overall Study||3
5154767|NCT01286272|12677915|P1|NOT COMPLETED|Overall Study||1
5154768|NCT01286272|12677914|P2|COMPLETED|Overall Study||62
5154769|NCT01286272|12677915|P1|COMPLETED|Overall Study||66
5154770|NCT01286272|12677914|P2|STARTED|Overall Study||65
5154771|NCT01286272|12677915|P1|STARTED|Overall Study||67
5154772|NCT01286259|12677925|P1|NOT COMPLETED|Overall Study||0
5154773|NCT01286259|12677925|P1|COMPLETED|Overall Study||16
5154774|NCT01286259|12677925|P1|STARTED|Overall Study||16
5154775|NCT01286207|12677935|P3|NOT COMPLETED|Overall Study||90
5154776|NCT01286207|12677936|P2|NOT COMPLETED|Overall Study||248
5154777|NCT01286207|12677937|P1|NOT COMPLETED|Overall Study||298
5154778|NCT01286207|12677935|P3|COMPLETED|Overall Study||261
5154779|NCT01286207|12677936|P2|COMPLETED|Overall Study||609
5154780|NCT01286207|12677937|P1|COMPLETED|Overall Study||453
5154781|NCT01286207|12677935|P3|STARTED|Overall Study||351
5154782|NCT01286207|12677936|P2|STARTED|Overall Study||857
5154783|NCT01286207|12677937|P1|STARTED|Overall Study||751
5154784|NCT01286168|12677957|P1|NOT COMPLETED|Overall Study||3
5154785|NCT01286168|12677957|P1|COMPLETED|Overall Study||101
5154786|NCT01286168|12677957|P1|STARTED|Overall Study||104
5154787|NCT01286129|12677971|P2|NOT COMPLETED|Overall Study||5
5154788|NCT01286129|12677972|P1|NOT COMPLETED|Overall Study||8
5154789|NCT01286129|12677971|P2|COMPLETED|Overall Study||13
5154790|NCT01286129|12677972|P1|COMPLETED|Overall Study||19
5154791|NCT01286129|12677971|P2|STARTED|Overall Study||18
5154792|NCT01286129|12677972|P1|STARTED|Overall Study||27
5154793|NCT01286077|12677982|P2|NOT COMPLETED|Overall Study||7
5154794|NCT01286077|12677983|P1|NOT COMPLETED|Overall Study||10
5154795|NCT01286077|12677982|P2|COMPLETED|Overall Study||46
5154796|NCT01286077|12677983|P1|COMPLETED|Overall Study||41
5154797|NCT01286077|12677982|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
5154798|NCT01286077|12677983|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
5154799|NCT01286012|12678019|P2|NOT COMPLETED|Overall Study||14
5154800|NCT01286012|12678020|P1|NOT COMPLETED|Overall Study||13
5154801|NCT01286012|12678019|P2|COMPLETED|Overall Study||40
5154802|NCT01286012|12678020|P1|COMPLETED|Overall Study||41
5154803|NCT01286012|12678019|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
5154804|NCT01286012|12678020|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
5154805|NCT01285960|12678034|P1|NOT COMPLETED|Overall Study||6
5154806|NCT01285960|12678034|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
5154807|NCT01285960|12678034|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
5154808|NCT01285947|12678040|P2|NOT COMPLETED|Overall Study||0
5154809|NCT01285947|12678041|P1|NOT COMPLETED|Overall Study||0
5154810|NCT01285947|12678040|P2|COMPLETED|Overall Study||10
5154811|NCT01285947|12678041|P1|COMPLETED|Overall Study||10
5154812|NCT01285947|12678040|P2|STARTED|Overall Study||10
5154813|NCT01285947|12678041|P1|STARTED|Overall Study||10
5154814|NCT01285908|12678047|P3|NOT COMPLETED|Treatment Crossover||0
5154815|NCT01285908|12678048|P2|NOT COMPLETED|Treatment Crossover||0
5154816|NCT01285908|12678049|P1|NOT COMPLETED|Treatment Crossover||0
5154817|NCT01285908|12678047|P3|COMPLETED|Treatment Crossover||2
5154818|NCT01285908|12678048|P2|COMPLETED|Treatment Crossover||2
5154819|NCT01285908|12678049|P1|COMPLETED|Treatment Crossover||0
5154820|NCT01285908|12678047|P3|STARTED|Treatment Crossover||2
5154821|NCT01285908|12678048|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
5154822|NCT01285908|12678049|P1|STARTED|Treatment Crossover||0
5154823|NCT01285908|12678047|P3|NOT COMPLETED|Baseline Measurement||0
5154824|NCT01285908|12678048|P2|NOT COMPLETED|Baseline Measurement||0
5154825|NCT01285908|12678049|P1|NOT COMPLETED|Baseline Measurement||3
5154826|NCT01285908|12678047|P3|COMPLETED|Baseline Measurement||0
5154827|NCT01285908|12678048|P2|COMPLETED|Baseline Measurement||0
5154828|NCT01285908|12678049|P1|COMPLETED|Baseline Measurement||3
5154829|NCT01285908|12678047|P3|STARTED|Baseline Measurement||0
5154830|NCT01285908|12678048|P2|STARTED|Baseline Measurement||0
5154831|NCT01285908|12678049|P1|STARTED|Baseline Measurement||6
5154832|NCT01285843|12678083|P2|NOT COMPLETED|Overall Study||2
5154833|NCT01285843|12678084|P1|NOT COMPLETED|Overall Study||2
5154834|NCT01285843|12678083|P2|COMPLETED|Overall Study||18
5154835|NCT01285843|12678084|P1|COMPLETED|Overall Study||18
5154836|NCT01285843|12678083|P2|STARTED|Overall Study||20
5154837|NCT01285843|12678084|P1|STARTED|Overall Study||20
5154838|NCT01285791|12678099|P3|NOT COMPLETED|Overall Study||0
5154839|NCT01285791|12678100|P2|NOT COMPLETED|Overall Study||0
5154840|NCT01285791|12678101|P1|NOT COMPLETED|Overall Study||0
5154841|NCT01285791|12678099|P3|COMPLETED|Overall Study||13
5154842|NCT01285791|12678100|P2|COMPLETED|Overall Study||15
5154843|NCT01285791|12678101|P1|COMPLETED|Overall Study||11
5154844|NCT01285791|12678099|P3|STARTED|Overall Study||13
5154845|NCT01285791|12678100|P2|STARTED|Overall Study||15
5154846|NCT01285791|12678101|P1|STARTED|Overall Study||11
5154847|NCT01285713|12678111|P2|NOT COMPLETED|Overall Study||0
5154848|NCT01285713|12678112|P1|NOT COMPLETED|Overall Study||0
5154849|NCT01285713|12678111|P2|COMPLETED|Overall Study||41
5154850|NCT01285713|12678112|P1|COMPLETED|Overall Study||42
5154851|NCT01285713|12678111|P2|STARTED|Overall Study||41
5154852|NCT01285713|12678112|P1|STARTED|Overall Study||42
5154853|NCT01285635|12678121|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
5154854|NCT01285635|12678122|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
5154855|NCT01285635|12678123|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
5154856|NCT01285635|12678121|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
5154857|NCT01285635|12678122|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
5154858|NCT01285635|12678123|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
5154859|NCT01285635|12678121|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
5154860|NCT01285635|12678122|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
5154861|NCT01285635|12678123|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
5154862|NCT01285635|12678121|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
5154863|NCT01285635|12678122|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
5154864|NCT01285635|12678123|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
5154865|NCT01285635|12678121|P3|COMPLETED|First Intervention (2 Weeks)||11
5154866|NCT01285635|12678122|P2|COMPLETED|First Intervention (2 Weeks)||11
5154867|NCT01285635|12678123|P1|COMPLETED|First Intervention (2 Weeks)||13
5154868|NCT01285635|12678121|P3|STARTED|First Intervention (2 Weeks)||11
5154869|NCT01285635|12678122|P2|STARTED|First Intervention (2 Weeks)||11
5154870|NCT01285635|12678123|P1|STARTED|First Intervention (2 Weeks)||13
5154871|NCT01285609|12678143|P2|NOT COMPLETED|Treated With Blinded Therapy||359
5154872|NCT01285609|12678144|P1|NOT COMPLETED|Treated With Blinded Therapy||387
5154873|NCT01285609|12678143|P2|COMPLETED|Treated With Blinded Therapy||2
5154874|NCT01285609|12678144|P1|COMPLETED|Treated With Blinded Therapy||1
5154875|NCT01285609|12678143|P2|STARTED|Treated With Blinded Therapy||361
5154876|NCT01285609|12678144|P1|STARTED|Treated With Blinded Therapy||388
5154877|NCT01285609|12678143|P2|NOT COMPLETED|Randomized||116
5154878|NCT01285609|12678144|P1|NOT COMPLETED|Randomized||91
5154879|NCT01285609|12678143|P2|COMPLETED|Randomized||361
5154880|NCT01285609|12678144|P1|COMPLETED|Randomized||388
5154881|NCT01285609|12678143|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
5154882|NCT01285609|12678144|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
5154883|NCT01285609|12678143|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
5154884|NCT01285609|12678144|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
5154885|NCT01285518|12678162|P8|NOT COMPLETED|Overall Study||0
5154886|NCT01285518|12678163|P7|NOT COMPLETED|Overall Study||0
5154887|NCT01285518|12678164|P6|NOT COMPLETED|Overall Study||1
5154888|NCT01285518|12678165|P5|NOT COMPLETED|Overall Study||0
5154889|NCT01285518|12678166|P4|NOT COMPLETED|Overall Study||0
5154890|NCT01285518|12678167|P3|NOT COMPLETED|Overall Study||0
5154891|NCT01285518|12678168|P2|NOT COMPLETED|Overall Study||0
5154892|NCT01285518|12678169|P1|NOT COMPLETED|Overall Study||0
5154893|NCT01285518|12678162|P8|COMPLETED|Overall Study||14
5154894|NCT01285518|12678163|P7|COMPLETED|Overall Study||10
5154895|NCT01285518|12678164|P6|COMPLETED|Overall Study||9
5154896|NCT01285518|12678165|P5|COMPLETED|Overall Study||10
5154897|NCT01285518|12678166|P4|COMPLETED|Overall Study||10
5154898|NCT01285518|12678167|P3|COMPLETED|Overall Study||10
5154899|NCT01285518|12678168|P2|COMPLETED|Overall Study||10
5154900|NCT01285518|12678169|P1|COMPLETED|Overall Study||10
5154901|NCT01285518|12678162|P8|STARTED|Overall Study||14
5154902|NCT01285518|12678163|P7|STARTED|Overall Study||10
5154903|NCT01285518|12678164|P6|STARTED|Overall Study||10
5154904|NCT01285518|12678165|P5|STARTED|Overall Study||10
5154905|NCT01285518|12678166|P4|STARTED|Overall Study||10
5154906|NCT01285518|12678167|P3|STARTED|Overall Study||10
5154907|NCT01285518|12678168|P2|STARTED|Overall Study||10
5154908|NCT01285518|12678169|P1|STARTED|Overall Study||10
5154909|NCT01285492|12678429|P2|NOT COMPLETED|Overall Study||1
5154910|NCT01285492|12678430|P1|NOT COMPLETED|Overall Study||17
5154911|NCT01285492|12678429|P2|COMPLETED|Overall Study||38
5154912|NCT01285492|12678430|P1|COMPLETED|Overall Study||104
5154913|NCT01285492|12678429|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
5154914|NCT01285492|12678430|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
5154915|NCT01285492|12678429|P2|STARTED|Overall Study|All patients randomized to this group|39
5154916|NCT01285492|12678430|P1|STARTED|Overall Study|All patients randomized to this group|121
5154917|NCT01285427|12678448|P1|NOT COMPLETED|Overall Study||1
5154918|NCT01285427|12678448|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
5154919|NCT01285427|12678448|P1|STARTED|Overall Study||300
5154920|NCT01285401|12678462|P2|NOT COMPLETED|Overall Study||29
5154921|NCT01285401|12678463|P1|NOT COMPLETED|Overall Study||17
5154922|NCT01285401|12678462|P2|COMPLETED|Overall Study||88
5154923|NCT01285401|12678463|P1|COMPLETED|Overall Study||98
5154924|NCT01285401|12678462|P2|Treated|Overall Study||116
5154925|NCT01285401|12678463|P1|Treated|Overall Study||113
5154926|NCT01285401|12678462|P2|STARTED|Overall Study||117
5154927|NCT01285401|12678463|P1|STARTED|Overall Study||115
5154928|NCT01285349|12678504|P3|NOT COMPLETED|Overall Study||27
5154929|NCT01285349|12678505|P2|NOT COMPLETED|Overall Study||20
5154930|NCT01285349|12678506|P1|NOT COMPLETED|Overall Study||27
5154931|NCT01285349|12678504|P3|COMPLETED|Overall Study||157
5154932|NCT01285349|12678505|P2|COMPLETED|Overall Study||170
5154933|NCT01285349|12678506|P1|COMPLETED|Overall Study||163
5154934|NCT01285349|12678504|P3|STARTED|Overall Study||184
5154935|NCT01285349|12678505|P2|STARTED|Overall Study||190
5154936|NCT01285349|12678506|P1|STARTED|Overall Study||190
5154937|NCT01285323|12678519|P2|NOT COMPLETED|Overall Study||30
5154938|NCT01285323|12678520|P1|NOT COMPLETED|Overall Study||33
5154939|NCT01285323|12678519|P2|COMPLETED|Overall Study||202
5154940|NCT01285323|12678520|P1|COMPLETED|Overall Study||199
5154941|NCT01285323|12678519|P2|Safety Analysis Set|Overall Study||232
5154942|NCT01285323|12678520|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
5154943|NCT01285323|12678519|P2|Full Analysis Set|Overall Study||232
5154944|NCT01285323|12678520|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
5154945|NCT01285323|12678519|P2|STARTED|Overall Study||232
5154946|NCT01285323|12678520|P1|STARTED|Overall Study||232
5154947|NCT01285310|12678555|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
5154948|NCT01285310|12678556|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
5154949|NCT01285310|12678557|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
5154950|NCT01285310|12678558|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
5154951|NCT01285310|12678559|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
5154952|NCT01285310|12678555|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
5154953|NCT01285310|12678556|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
5154954|NCT01285310|12678557|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
5154955|NCT01285310|12678558|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
5154956|NCT01285310|12678559|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
5154957|NCT01285310|12678555|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
5154958|NCT01285310|12678556|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
5154959|NCT01285310|12678557|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
5154960|NCT01285310|12678558|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
5154961|NCT01285310|12678559|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
5154962|NCT01285310|12678555|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
5154963|NCT01285310|12678556|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
5154964|NCT01285310|12678557|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
5154965|NCT01285310|12678558|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
5154966|NCT01285310|12678559|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
5154967|NCT01285310|12678555|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
5154968|NCT01285310|12678556|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
5154969|NCT01285310|12678557|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
5154970|NCT01285310|12678558|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
5154971|NCT01285310|12678559|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
5154972|NCT01285310|12678555|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
5154973|NCT01285310|12678556|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
5154974|NCT01285310|12678557|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
5154975|NCT01285310|12678558|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
5154976|NCT01285310|12678559|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
5154977|NCT01285076|12678792|P1|NOT COMPLETED|Overall Study||0
5154978|NCT01285076|12678792|P1|COMPLETED|Overall Study||834
5154979|NCT01285076|12678792|P1|STARTED|Overall Study||834
5154980|NCT01285050|12678805|P1|NOT COMPLETED|Overall Study||1
5154981|NCT01285050|12678805|P1|COMPLETED|Overall Study||19
5154982|NCT01285050|12678805|P1|STARTED|Overall Study||20
5154983|NCT01285024|12678812|P2|NOT COMPLETED|Overall Study||0
5154984|NCT01285024|12678813|P1|NOT COMPLETED|Overall Study||0
5154985|NCT01285024|12678812|P2|COMPLETED|Overall Study||60
5154986|NCT01285024|12678813|P1|COMPLETED|Overall Study||49
5154987|NCT01285024|12678812|P2|STARTED|Overall Study||60
5154988|NCT01285024|12678813|P1|STARTED|Overall Study||49
5154989|NCT01284959|12678824|P3|NOT COMPLETED|Overall Study||1
5154990|NCT01284959|12678825|P2|NOT COMPLETED|Overall Study||0
5154991|NCT01284959|12678826|P1|NOT COMPLETED|Overall Study||1
5154992|NCT01284959|12678824|P3|COMPLETED|Overall Study||10
5154993|NCT01284959|12678825|P2|COMPLETED|Overall Study||12
5154994|NCT01284959|12678826|P1|COMPLETED|Overall Study||10
5154995|NCT01284959|12678824|P3|STARTED|Overall Study||11
5154996|NCT01284959|12678825|P2|STARTED|Overall Study||12
5154997|NCT01284959|12678826|P1|STARTED|Overall Study||11
5154998|NCT01284634|12678856|P4|NOT COMPLETED|Overall Study||1
5154999|NCT01284634|12678857|P3|NOT COMPLETED|Overall Study||2
5155000|NCT01284634|12678858|P2|NOT COMPLETED|Overall Study||0
5155001|NCT01284634|12678859|P1|NOT COMPLETED|Overall Study||1
5155002|NCT01284634|12678856|P4|COMPLETED|Overall Study||4
5155003|NCT01284634|12678857|P3|COMPLETED|Overall Study||5
5155004|NCT01284634|12678858|P2|COMPLETED|Overall Study||6
5155005|NCT01284634|12678859|P1|COMPLETED|Overall Study||6
5155006|NCT01284634|12678856|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
5155007|NCT01284634|12678857|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
5155008|NCT01284634|12678858|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
5155009|NCT01284634|12678859|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
5155010|NCT01284634|12678856|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
5155011|NCT01284634|12678857|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
5155012|NCT01284634|12678858|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5155013|NCT01284634|12678859|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
5155014|NCT01284634|12678856|P4|STARTED|Overall Study||5
5155015|NCT01284634|12678857|P3|STARTED|Overall Study||7
5155016|NCT01284634|12678858|P2|STARTED|Overall Study||6
5155017|NCT01284634|12678859|P1|STARTED|Overall Study||7
5155018|NCT01284621|12678889|P6|NOT COMPLETED|Third Intervention (8 Days)||0
5155019|NCT01284621|12678890|P5|NOT COMPLETED|Third Intervention (8 Days)||0
5155020|NCT01284621|12678891|P4|NOT COMPLETED|Third Intervention (8 Days)||0
5155021|NCT01284621|12678892|P3|NOT COMPLETED|Third Intervention (8 Days)||0
5155022|NCT01284621|12678893|P2|NOT COMPLETED|Third Intervention (8 Days)||0
5155023|NCT01284621|12678894|P1|NOT COMPLETED|Third Intervention (8 Days)||0
5155024|NCT01284621|12678889|P6|COMPLETED|Third Intervention (8 Days)||4
5155025|NCT01284621|12678890|P5|COMPLETED|Third Intervention (8 Days)||3
5155026|NCT01284621|12678891|P4|COMPLETED|Third Intervention (8 Days)||4
5155027|NCT01284621|12678892|P3|COMPLETED|Third Intervention (8 Days)||4
5155028|NCT01284621|12678893|P2|COMPLETED|Third Intervention (8 Days)||4
5155029|NCT01284621|12678894|P1|COMPLETED|Third Intervention (8 Days)||3
5155030|NCT01284621|12678889|P6|STARTED|Third Intervention (8 Days)||4
5155031|NCT01284621|12678890|P5|STARTED|Third Intervention (8 Days)||3
5155032|NCT01284621|12678891|P4|STARTED|Third Intervention (8 Days)||4
5155033|NCT01284621|12678892|P3|STARTED|Third Intervention (8 Days)||4
5155034|NCT01284621|12678893|P2|STARTED|Third Intervention (8 Days)||4
5155035|NCT01284621|12678894|P1|STARTED|Third Intervention (8 Days)||3
5155036|NCT01284621|12678889|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155037|NCT01284621|12678890|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155038|NCT01284621|12678891|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155039|NCT01284621|12678892|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155040|NCT01284621|12678893|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155041|NCT01284621|12678894|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5155042|NCT01284621|12678889|P6|COMPLETED|Washout Period 2 (7 Days)||4
5155043|NCT01284621|12678890|P5|COMPLETED|Washout Period 2 (7 Days)||3
5155044|NCT01284621|12678891|P4|COMPLETED|Washout Period 2 (7 Days)||4
5155045|NCT01284621|12678892|P3|COMPLETED|Washout Period 2 (7 Days)||4
5155046|NCT01284621|12678893|P2|COMPLETED|Washout Period 2 (7 Days)||4
5155047|NCT01284621|12678894|P1|COMPLETED|Washout Period 2 (7 Days)||3
5155048|NCT01284621|12678889|P6|STARTED|Washout Period 2 (7 Days)||4
5155049|NCT01284621|12678890|P5|STARTED|Washout Period 2 (7 Days)||3
5155050|NCT01284621|12678891|P4|STARTED|Washout Period 2 (7 Days)||4
5155051|NCT01284621|12678892|P3|STARTED|Washout Period 2 (7 Days)||4
5155052|NCT01284621|12678893|P2|STARTED|Washout Period 2 (7 Days)||4
5155053|NCT01284621|12678894|P1|STARTED|Washout Period 2 (7 Days)||3
5155054|NCT01284621|12678889|P6|NOT COMPLETED|Second Intervention (8 Days)||0
5155055|NCT01284621|12678890|P5|NOT COMPLETED|Second Intervention (8 Days)||0
5155056|NCT01284621|12678891|P4|NOT COMPLETED|Second Intervention (8 Days)||0
5155057|NCT01284621|12678892|P3|NOT COMPLETED|Second Intervention (8 Days)||0
5155058|NCT01284621|12678893|P2|NOT COMPLETED|Second Intervention (8 Days)||0
5155059|NCT01284621|12678894|P1|NOT COMPLETED|Second Intervention (8 Days)||0
5155060|NCT01284621|12678889|P6|COMPLETED|Second Intervention (8 Days)||4
5155061|NCT01284621|12678890|P5|COMPLETED|Second Intervention (8 Days)||3
5155062|NCT01284621|12678891|P4|COMPLETED|Second Intervention (8 Days)||4
5155063|NCT01284621|12678892|P3|COMPLETED|Second Intervention (8 Days)||4
5155064|NCT01284621|12678893|P2|COMPLETED|Second Intervention (8 Days)||4
5155065|NCT01284621|12678894|P1|COMPLETED|Second Intervention (8 Days)||3
5155066|NCT01284621|12678889|P6|STARTED|Second Intervention (8 Days)||4
5155067|NCT01284621|12678890|P5|STARTED|Second Intervention (8 Days)||3
5155068|NCT01284621|12678891|P4|STARTED|Second Intervention (8 Days)||4
5155069|NCT01284621|12678892|P3|STARTED|Second Intervention (8 Days)||4
5155070|NCT01284621|12678893|P2|STARTED|Second Intervention (8 Days)||4
5155071|NCT01284621|12678894|P1|STARTED|Second Intervention (8 Days)||3
5155072|NCT01284621|12678889|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
5155073|NCT01284621|12678890|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
5155074|NCT01284621|12678891|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5155075|NCT01284621|12678892|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
5155076|NCT01284621|12678893|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5155077|NCT01284621|12678894|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5155078|NCT01284621|12678889|P6|COMPLETED|Washout Period 1 (7 Days)||4
5155079|NCT01284621|12678890|P5|COMPLETED|Washout Period 1 (7 Days)||3
5155080|NCT01284621|12678891|P4|COMPLETED|Washout Period 1 (7 Days)||4
5155081|NCT01284621|12678892|P3|COMPLETED|Washout Period 1 (7 Days)||4
5155082|NCT01284621|12678893|P2|COMPLETED|Washout Period 1 (7 Days)||4
5155083|NCT01284621|12678894|P1|COMPLETED|Washout Period 1 (7 Days)||3
5155084|NCT01284621|12678889|P6|STARTED|Washout Period 1 (7 Days)||4
5155085|NCT01284621|12678890|P5|STARTED|Washout Period 1 (7 Days)||4
5155086|NCT01284621|12678891|P4|STARTED|Washout Period 1 (7 Days)||4
5155087|NCT01284621|12678892|P3|STARTED|Washout Period 1 (7 Days)||4
5155088|NCT01284621|12678893|P2|STARTED|Washout Period 1 (7 Days)||4
5155089|NCT01284621|12678894|P1|STARTED|Washout Period 1 (7 Days)||3
5155090|NCT01284621|12678889|P6|NOT COMPLETED|First Intervention (8 Days)||0
5155091|NCT01284621|12678890|P5|NOT COMPLETED|First Intervention (8 Days)||0
5155092|NCT01284621|12678891|P4|NOT COMPLETED|First Intervention (8 Days)||0
5155093|NCT01284621|12678892|P3|NOT COMPLETED|First Intervention (8 Days)||0
5155094|NCT01284621|12678893|P2|NOT COMPLETED|First Intervention (8 Days)||0
5155095|NCT01284621|12678894|P1|NOT COMPLETED|First Intervention (8 Days)||0
5155096|NCT01284621|12678889|P6|COMPLETED|First Intervention (8 Days)||4
5155097|NCT01284621|12678890|P5|COMPLETED|First Intervention (8 Days)||4
5155098|NCT01284621|12678891|P4|COMPLETED|First Intervention (8 Days)||4
5155099|NCT01284621|12678892|P3|COMPLETED|First Intervention (8 Days)||4
5155100|NCT01284621|12678893|P2|COMPLETED|First Intervention (8 Days)||4
5155101|NCT01284621|12678894|P1|COMPLETED|First Intervention (8 Days)||3
5155102|NCT01284621|12678889|P6|STARTED|First Intervention (8 Days)||4
5155103|NCT01284621|12678890|P5|STARTED|First Intervention (8 Days)||4
5155104|NCT01284621|12678891|P4|STARTED|First Intervention (8 Days)||4
5155105|NCT01284621|12678892|P3|STARTED|First Intervention (8 Days)||4
5155106|NCT01284621|12678893|P2|STARTED|First Intervention (8 Days)||4
5155107|NCT01284621|12678894|P1|STARTED|First Intervention (8 Days)||3
5155108|NCT01284517|12678938|P2|NOT COMPLETED|Overall Study||36
5155109|NCT01284517|12678939|P1|NOT COMPLETED|Overall Study||32
5155110|NCT01284517|12678938|P2|COMPLETED|Overall Study||140
5155111|NCT01284517|12678939|P1|COMPLETED|Overall Study||148
5155112|NCT01284517|12678938|P2|STARTED|Overall Study||176
5155113|NCT01284517|12678939|P1|STARTED|Overall Study||180
5155114|NCT01284504|12678951|P2|NOT COMPLETED|Overall Study||0
5155115|NCT01284504|12678952|P1|NOT COMPLETED|Overall Study||0
5155116|NCT01284504|12678951|P2|COMPLETED|Overall Study||0
5155117|NCT01284504|12678952|P1|COMPLETED|Overall Study||0
5155118|NCT01284504|12678951|P2|STARTED|Overall Study||0
5155119|NCT01284504|12678952|P1|STARTED|Overall Study||0
5155120|NCT01284491|12678962|P1|NOT COMPLETED|Overall Study||13
5155121|NCT01284491|12678962|P1|COMPLETED|Overall Study||0
5155122|NCT01284491|12678962|P1|STARTED|Overall Study||13
5155123|NCT01284426|12678968|P1|NOT COMPLETED|Overall Study||2
5155124|NCT01284426|12678968|P1|COMPLETED|Overall Study||92
5155125|NCT01284426|12678968|P1|STARTED|Overall Study||94
5155126|NCT01284361|12678972|P1|NOT COMPLETED|Overall Study||9
5155127|NCT01284361|12678972|P1|COMPLETED|Overall Study||82
5155128|NCT01284361|12678972|P1|STARTED|Overall Study||91
5155129|NCT01284335|12678992|P13|NOT COMPLETED|Overall Study||0
5155130|NCT01284335|12678993|P12|NOT COMPLETED|Overall Study||0
5155131|NCT01284335|12678994|P11|NOT COMPLETED|Overall Study||0
5155132|NCT01284335|12678995|P10|NOT COMPLETED|Overall Study||0
5155133|NCT01284335|12678996|P9|NOT COMPLETED|Overall Study||0
5155134|NCT01284335|12678997|P8|NOT COMPLETED|Overall Study||0
5155135|NCT01284335|12678998|P7|NOT COMPLETED|Overall Study||0
5155136|NCT01284335|12678999|P6|NOT COMPLETED|Overall Study||0
5155137|NCT01284335|12679000|P5|NOT COMPLETED|Overall Study||0
5155138|NCT01284335|12679001|P4|NOT COMPLETED|Overall Study||0
5155139|NCT01284335|12679002|P3|NOT COMPLETED|Overall Study||0
5155140|NCT01284335|12679003|P2|NOT COMPLETED|Overall Study||0
5155141|NCT01284335|12679004|P1|NOT COMPLETED|Overall Study||0
5155142|NCT01284335|12678992|P13|COMPLETED|Overall Study||12
5155143|NCT01284335|12678993|P12|COMPLETED|Overall Study||16
5155144|NCT01284335|12678994|P11|COMPLETED|Overall Study||45
5155145|NCT01284335|12678995|P10|COMPLETED|Overall Study||14
5155146|NCT01284335|12678996|P9|COMPLETED|Overall Study||4
5155147|NCT01284335|12678997|P8|COMPLETED|Overall Study||6
5155148|NCT01284335|12678998|P7|COMPLETED|Overall Study||19
5155149|NCT01284335|12678999|P6|COMPLETED|Overall Study||26
5155150|NCT01284335|12679000|P5|COMPLETED|Overall Study||24
5155151|NCT01284335|12679001|P4|COMPLETED|Overall Study||5
5155152|NCT01284335|12679002|P3|COMPLETED|Overall Study||5
5155153|NCT01284335|12679003|P2|COMPLETED|Overall Study||33
5155154|NCT01284335|12679004|P1|COMPLETED|Overall Study||25
5155155|NCT01284335|12678992|P13|Received at Least One Dose of Study Drug|Overall Study||12
5155156|NCT01284335|12678993|P12|Received at Least One Dose of Study Drug|Overall Study||16
5155157|NCT01284335|12678994|P11|Received at Least One Dose of Study Drug|Overall Study||45
5155158|NCT01284335|12678995|P10|Received at Least One Dose of Study Drug|Overall Study||14
5155159|NCT01284335|12678996|P9|Received at Least One Dose of Study Drug|Overall Study||4
5155160|NCT01284335|12678997|P8|Received at Least One Dose of Study Drug|Overall Study||6
5155161|NCT01284335|12678998|P7|Received at Least One Dose of Study Drug|Overall Study||19
5155162|NCT01284335|12678999|P6|Received at Least One Dose of Study Drug|Overall Study||26
5155163|NCT01284335|12679000|P5|Received at Least One Dose of Study Drug|Overall Study||24
5155164|NCT01284335|12679001|P4|Received at Least One Dose of Study Drug|Overall Study||5
5155165|NCT01284335|12679002|P3|Received at Least One Dose of Study Drug|Overall Study||5
5155166|NCT01284335|12679003|P2|Received at Least One Dose of Study Drug|Overall Study||33
5155167|NCT01284335|12679004|P1|Received at Least One Dose of Study Drug|Overall Study||25
5155168|NCT01284335|12678992|P13|STARTED|Overall Study||12
5155169|NCT01284335|12678993|P12|STARTED|Overall Study||16
5155170|NCT01284335|12678994|P11|STARTED|Overall Study||45
5155171|NCT01284335|12678995|P10|STARTED|Overall Study||14
5155172|NCT01284335|12678996|P9|STARTED|Overall Study||4
5155173|NCT01284335|12678997|P8|STARTED|Overall Study||6
5155174|NCT01284335|12678998|P7|STARTED|Overall Study||19
5155175|NCT01284335|12678999|P6|STARTED|Overall Study||26
5155176|NCT01284335|12679000|P5|STARTED|Overall Study||24
5155177|NCT01284335|12679001|P4|STARTED|Overall Study||5
5155178|NCT01284335|12679002|P3|STARTED|Overall Study||5
5155179|NCT01284335|12679003|P2|STARTED|Overall Study||33
5155180|NCT01284335|12679004|P1|STARTED|Overall Study||25
5155181|NCT01284296|12679052|P1|NOT COMPLETED|Overall Study||0
5155182|NCT01284296|12679052|P1|COMPLETED|Overall Study||20
5155183|NCT01284296|12679052|P1|STARTED|Overall Study||20
5155184|NCT01284244|12679059|P2|NOT COMPLETED|Overall Study||0
5155185|NCT01284244|12679060|P1|NOT COMPLETED|Overall Study||0
5155186|NCT01284244|12679059|P2|COMPLETED|Overall Study||18
5155187|NCT01284244|12679060|P1|COMPLETED|Overall Study||18
5155188|NCT01284244|12679059|P2|STARTED|Overall Study||18
5155189|NCT01284244|12679060|P1|STARTED|Overall Study||18
5155190|NCT01284140|12679068|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
5155191|NCT01284140|12679069|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
5155192|NCT01284140|12679068|P2|COMPLETED|Subjects With Paired 24hr Collections||5
5155193|NCT01284140|12679069|P1|COMPLETED|Subjects With Paired 24hr Collections||6
5155194|NCT01284140|12679068|P2|STARTED|Subjects With Paired 24hr Collections||11
5155195|NCT01284140|12679069|P1|STARTED|Subjects With Paired 24hr Collections||11
5155196|NCT01284140|12679068|P2|NOT COMPLETED|Randomization and Intervention||0
5155197|NCT01284140|12679069|P1|NOT COMPLETED|Randomization and Intervention||0
5155198|NCT01284140|12679068|P2|COMPLETED|Randomization and Intervention||11
5155199|NCT01284140|12679069|P1|COMPLETED|Randomization and Intervention||11
5155200|NCT01284140|12679068|P2|STARTED|Randomization and Intervention||11
5155201|NCT01284140|12679069|P1|STARTED|Randomization and Intervention||11
5155202|NCT01284127|12679083|P1|NOT COMPLETED|Overall Study||7
5155203|NCT01284127|12679083|P1|COMPLETED|Overall Study||31
5155204|NCT01284127|12679083|P1|STARTED|Overall Study||38
5155205|NCT01284114|12679092|P1|NOT COMPLETED|Overall Study||4
5155206|NCT01284114|12679092|P1|COMPLETED|Overall Study||19
5155207|NCT01284114|12679092|P1|STARTED|Overall Study||23
5155208|NCT01284062|12679104|P4|NOT COMPLETED|Overall Study||14
5155209|NCT01284062|12679105|P3|NOT COMPLETED|Overall Study||6
5155210|NCT01284062|12679106|P2|NOT COMPLETED|Overall Study||8
5155211|NCT01284062|12679107|P1|NOT COMPLETED|Overall Study||11
5155212|NCT01284062|12679104|P4|COMPLETED|Overall Study||7
5155213|NCT01284062|12679105|P3|COMPLETED|Overall Study||15
5155214|NCT01284062|12679106|P2|COMPLETED|Overall Study||13
5155215|NCT01284062|12679107|P1|COMPLETED|Overall Study||10
5155216|NCT01284062|12679104|P4|STARTED|Overall Study||21
5155217|NCT01284062|12679105|P3|STARTED|Overall Study||21
5155218|NCT01284062|12679106|P2|STARTED|Overall Study||21
5155219|NCT01284062|12679107|P1|STARTED|Overall Study||21
5155220|NCT01283971|12679181|P2|NOT COMPLETED|Overall Study||12
5155221|NCT01283971|12679182|P1|NOT COMPLETED|Overall Study||15
5155222|NCT01283971|12679181|P2|COMPLETED|Overall Study||36
5155223|NCT01283971|12679182|P1|COMPLETED|Overall Study||33
5155224|NCT01283971|12679181|P2|Intent to Treat Population|Overall Study||48
5155225|NCT01283971|12679182|P1|Intent to Treat Population|Overall Study||46
5155226|NCT01283971|12679181|P2|STARTED|Overall Study||48
5155227|NCT01283971|12679182|P1|STARTED|Overall Study||48
5155228|NCT01283581|12679229|P3|NOT COMPLETED|Overall Study||20
5155229|NCT01283581|12679230|P2|NOT COMPLETED|Overall Study||14
5155230|NCT01283581|12679231|P1|NOT COMPLETED|Overall Study||12
5155231|NCT01283581|12679229|P3|COMPLETED|Overall Study||78
5155232|NCT01283581|12679230|P2|COMPLETED|Overall Study||63
5155233|NCT01283581|12679231|P1|COMPLETED|Overall Study||69
5155234|NCT01283581|12679229|P3|STARTED|Overall Study||98
5155235|NCT01283581|12679230|P2|STARTED|Overall Study||77
5155236|NCT01283581|12679231|P1|STARTED|Overall Study||81
5155237|NCT01283555|12679257|P2|NOT COMPLETED|Second Intervention||0
5155238|NCT01283555|12679258|P1|NOT COMPLETED|Second Intervention||0
5155239|NCT01283555|12679257|P2|COMPLETED|Second Intervention||12
5155240|NCT01283555|12679258|P1|COMPLETED|Second Intervention||13
5155241|NCT01283555|12679257|P2|STARTED|Second Intervention||12
5155242|NCT01283555|12679258|P1|STARTED|Second Intervention||13
5155243|NCT01283555|12679257|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
5155244|NCT01283555|12679258|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
5155245|NCT01283555|12679257|P2|COMPLETED|Washout Period of at Least 21 Days||12
5155246|NCT01283555|12679258|P1|COMPLETED|Washout Period of at Least 21 Days||13
5155247|NCT01283555|12679257|P2|STARTED|Washout Period of at Least 21 Days||12
5155248|NCT01283555|12679258|P1|STARTED|Washout Period of at Least 21 Days||13
5155249|NCT01283555|12679257|P2|NOT COMPLETED|First Intervention||0
5155250|NCT01283555|12679258|P1|NOT COMPLETED|First Intervention||0
5155251|NCT01283555|12679257|P2|COMPLETED|First Intervention||12
5155252|NCT01283555|12679258|P1|COMPLETED|First Intervention||13
5155253|NCT01283555|12679257|P2|STARTED|First Intervention||12
5155254|NCT01283555|12679258|P1|STARTED|First Intervention||13
5155255|NCT01283542|12679301|P1|NOT COMPLETED|Extension Phase||3
5155256|NCT01283542|12679301|P1|COMPLETED|Extension Phase||10
5155257|NCT01283542|12679301|P1|Safety Analysis Set|Extension Phase||13
5155258|NCT01283542|12679301|P1|Full Analysis Set (FAS)|Extension Phase||13
5155259|NCT01283542|12679301|P1|STARTED|Extension Phase||13
5155260|NCT01283542|12679301|P1|NOT COMPLETED|Main Phase||7
5155261|NCT01283542|12679301|P1|COMPLETED|Main Phase||13
5155262|NCT01283542|12679301|P1|Safety Analysis Set|Main Phase||20
5155263|NCT01283542|12679301|P1|Full Analysis Set (FAS)|Main Phase||20
5155264|NCT01283542|12679301|P1|STARTED|Main Phase||20
5155265|NCT01283516|12679366|P9|NOT COMPLETED|Overall Study||255
5155266|NCT01283516|12679367|P8|NOT COMPLETED|Overall Study||5
5155267|NCT01283516|12679368|P7|NOT COMPLETED|Overall Study||10
5155268|NCT01283516|12679369|P6|NOT COMPLETED|Overall Study||10
5155269|NCT01283516|12679370|P5|NOT COMPLETED|Overall Study||14
5155270|NCT01283516|12679371|P4|NOT COMPLETED|Overall Study||3
5155271|NCT01283516|12679372|P3|NOT COMPLETED|Overall Study||3
5155272|NCT01283516|12679373|P2|NOT COMPLETED|Overall Study||2
5155273|NCT01283516|12679374|P1|NOT COMPLETED|Overall Study||2
5155274|NCT01283516|12679366|P9|COMPLETED|Overall Study||0
5155275|NCT01283516|12679367|P8|COMPLETED|Overall Study||0
5155276|NCT01283516|12679368|P7|COMPLETED|Overall Study||0
5155277|NCT01283516|12679369|P6|COMPLETED|Overall Study||0
5155278|NCT01283516|12679370|P5|COMPLETED|Overall Study||0
5155279|NCT01283516|12679371|P4|COMPLETED|Overall Study||0
5155280|NCT01283516|12679372|P3|COMPLETED|Overall Study||0
5155281|NCT01283516|12679373|P2|COMPLETED|Overall Study||0
5155282|NCT01283516|12679374|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
5155283|NCT01283516|12679366|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
5155284|NCT01283516|12679367|P8|Non-NSCLC|Overall Study||0
5155285|NCT01283516|12679368|P7|Non-NSCLC|Overall Study||1
5155286|NCT01283516|12679369|P6|Non-NSCLC|Overall Study||0
5155287|NCT01283516|12679370|P5|Non-NSCLC|Overall Study||2
5155288|NCT01283516|12679371|P4|Non-NSCLC|Overall Study||0
5155289|NCT01283516|12679372|P3|Non-NSCLC|Overall Study||1
5155290|NCT01283516|12679373|P2|Non-NSCLC|Overall Study||1
5155291|NCT01283516|12679374|P1|Non-NSCLC|Overall Study||0
5155292|NCT01283516|12679366|P9|Dose-Determining Set (DDS)|Overall Study||8
5155293|NCT01283516|12679367|P8|Dose-Determining Set (DDS)|Overall Study||5
5155294|NCT01283516|12679368|P7|Dose-Determining Set (DDS)|Overall Study||10
5155295|NCT01283516|12679369|P6|Dose-Determining Set (DDS)|Overall Study||8
5155296|NCT01283516|12679370|P5|Dose-Determining Set (DDS)|Overall Study||14
5155297|NCT01283516|12679371|P4|Dose-Determining Set (DDS)|Overall Study||3
5155298|NCT01283516|12679372|P3|Dose-Determining Set (DDS)|Overall Study||3
5155299|NCT01283516|12679373|P2|Dose-Determining Set (DDS)|Overall Study||1
5155300|NCT01283516|12679374|P1|Dose-Determining Set (DDS)|Overall Study||2
5155301|NCT01283516|12679366|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
5155302|NCT01283516|12679367|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
5155303|NCT01283516|12679368|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
5155304|NCT01283516|12679369|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
5155305|NCT01283516|12679370|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
5155306|NCT01283516|12679371|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
5155307|NCT01283516|12679372|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
5155308|NCT01283516|12679373|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
5155309|NCT01283516|12679374|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
5155310|NCT01283516|12679366|P9|STARTED|Overall Study||255
5155311|NCT01283516|12679367|P8|STARTED|Overall Study||5
5155312|NCT01283516|12679368|P7|STARTED|Overall Study||10
5155313|NCT01283516|12679369|P6|STARTED|Overall Study||10
5155314|NCT01283516|12679370|P5|STARTED|Overall Study||14
5155315|NCT01283516|12679371|P4|STARTED|Overall Study||3
5155316|NCT01283516|12679372|P3|STARTED|Overall Study||3
5155317|NCT01283516|12679373|P2|STARTED|Overall Study||2
5155318|NCT01283516|12679374|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
5155319|NCT01283464|12679496|P2|NOT COMPLETED|Overall Study||1
5155320|NCT01283464|12679497|P1|NOT COMPLETED|Overall Study||2
5155321|NCT01283464|12679496|P2|COMPLETED|Overall Study||11
5155322|NCT01283464|12679497|P1|COMPLETED|Overall Study||10
5155323|NCT01283464|12679496|P2|STARTED|Overall Study||12
5155324|NCT01283464|12679497|P1|STARTED|Overall Study||12
5155325|NCT01283386|12679505|P2|NOT COMPLETED|Overall Study||12
5155326|NCT01283386|12679506|P1|NOT COMPLETED|Overall Study||8
5155327|NCT01283386|12679505|P2|COMPLETED|Overall Study||4
5155328|NCT01283386|12679506|P1|COMPLETED|Overall Study||2
5155329|NCT01283386|12679505|P2|STARTED|Overall Study||16
5155330|NCT01283386|12679506|P1|STARTED|Overall Study||10
5155331|NCT01283334|12679530|P1|NOT COMPLETED|Overall Study||7
5155332|NCT01283334|12679530|P1|COMPLETED|Overall Study||13
5155333|NCT01283334|12679530|P1|STARTED|Overall Study||20
5155334|NCT01283321|12679538|P2|NOT COMPLETED|Overall Study||0
5155335|NCT01283321|12679539|P1|NOT COMPLETED|Overall Study||0
5155336|NCT01283321|12679538|P2|COMPLETED|Overall Study||10
5155337|NCT01283321|12679539|P1|COMPLETED|Overall Study||10
5155338|NCT01283321|12679538|P2|STARTED|Overall Study||10
5155339|NCT01283321|12679539|P1|STARTED|Overall Study||10
5155340|NCT01283282|12679553|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5155341|NCT01283282|12679554|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5155342|NCT01283282|12679553|P2|COMPLETED|Second Intervention (6 Weeks)||19
5155343|NCT01283282|12679554|P1|COMPLETED|Second Intervention (6 Weeks)||22
5155344|NCT01283282|12679553|P2|STARTED|Second Intervention (6 Weeks)||19
5155345|NCT01283282|12679554|P1|STARTED|Second Intervention (6 Weeks)||22
5155346|NCT01283282|12679553|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
5155347|NCT01283282|12679554|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
5155348|NCT01283282|12679553|P2|COMPLETED|First Intervention (6 Weeks)||19
5155349|NCT01283282|12679554|P1|COMPLETED|First Intervention (6 Weeks)||22
5155350|NCT01283282|12679553|P2|STARTED|First Intervention (6 Weeks)||23
5155351|NCT01283282|12679554|P1|STARTED|First Intervention (6 Weeks)||25
5155352|NCT01283152|12679574|P2|NOT COMPLETED|Overall Study||0
5155353|NCT01283152|12679575|P1|NOT COMPLETED|Overall Study||2
5155354|NCT01283152|12679574|P2|COMPLETED|Overall Study||25
5155355|NCT01283152|12679575|P1|COMPLETED|Overall Study||23
5155356|NCT01283152|12679574|P2|24-hr HESA Attempted|Overall Study||25
5155357|NCT01283152|12679575|P1|24-hr HESA Attempted|Overall Study||25
5155358|NCT01283152|12679574|P2|Study Treatment Received|Overall Study||25
5155359|NCT01283152|12679575|P1|Study Treatment Received|Overall Study||25
5155360|NCT01283152|12679574|P2|ITT Population|Overall Study||25
5155361|NCT01283152|12679575|P1|ITT Population|Overall Study||25
5155362|NCT01283152|12679574|P2|STARTED|Overall Study||25
5155363|NCT01283152|12679575|P1|STARTED|Overall Study||25
5155364|NCT01283139|12679589|P4|NOT COMPLETED|Overall Study||15
5155365|NCT01283139|12679590|P3|NOT COMPLETED|Overall Study||18
5155366|NCT01283139|12679591|P2|NOT COMPLETED|Overall Study||18
5155367|NCT01283139|12679592|P1|NOT COMPLETED|Overall Study||17
5155368|NCT01283139|12679589|P4|COMPLETED|Overall Study||92
5155369|NCT01283139|12679590|P3|COMPLETED|Overall Study||91
5155370|NCT01283139|12679591|P2|COMPLETED|Overall Study||90
5155371|NCT01283139|12679592|P1|COMPLETED|Overall Study||91
5155372|NCT01283139|12679589|P4|STARTED|Overall Study||107
5155373|NCT01283139|12679590|P3|STARTED|Overall Study||109
5155374|NCT01283139|12679591|P2|STARTED|Overall Study||108
5155375|NCT01283139|12679592|P1|STARTED|Overall Study||108
5155376|NCT01283035|12679634|P1|NOT COMPLETED|Overall Study||1
5155377|NCT01283035|12679634|P1|COMPLETED|Overall Study||5
5155378|NCT01283035|12679634|P1|STARTED|Overall Study||6
5155379|NCT01283022|12679643|P1|NOT COMPLETED|Overall Study||0
5155380|NCT01283022|12679643|P1|COMPLETED|Overall Study||24
5155381|NCT01283022|12679643|P1|STARTED|Overall Study||24
5155382|NCT01282866|12679649|P1|NOT COMPLETED|Overall Study||1
5155383|NCT01282866|12679649|P1|COMPLETED|Overall Study||34
5155384|NCT01282866|12679649|P1|STARTED|Overall Study||35
5155385|NCT01282814|12679657|P2|NOT COMPLETED|Second Intervention||0
5155386|NCT01282814|12679658|P1|NOT COMPLETED|Second Intervention||0
5155387|NCT01282814|12679657|P2|COMPLETED|Second Intervention||9
5155388|NCT01282814|12679658|P1|COMPLETED|Second Intervention||10
5155389|NCT01282814|12679657|P2|STARTED|Second Intervention||9
5155390|NCT01282814|12679658|P1|STARTED|Second Intervention||10
5155391|NCT01282814|12679657|P2|NOT COMPLETED|Washout of 7 Days||0
5155392|NCT01282814|12679658|P1|NOT COMPLETED|Washout of 7 Days||2
5155393|NCT01282814|12679657|P2|COMPLETED|Washout of 7 Days||9
5155394|NCT01282814|12679658|P1|COMPLETED|Washout of 7 Days||10
5155395|NCT01282814|12679657|P2|STARTED|Washout of 7 Days||9
5155396|NCT01282814|12679658|P1|STARTED|Washout of 7 Days||12
5155397|NCT01282814|12679657|P2|NOT COMPLETED|First Intervention||3
5155398|NCT01282814|12679658|P1|NOT COMPLETED|First Intervention||0
5155399|NCT01282814|12679657|P2|COMPLETED|First Intervention||9
5155400|NCT01282814|12679658|P1|COMPLETED|First Intervention||12
5155401|NCT01282814|12679657|P2|STARTED|First Intervention||12
5155402|NCT01282814|12679658|P1|STARTED|First Intervention||12
5155403|NCT01282801|12679670|P2|NOT COMPLETED|Second Intervention||1
5155404|NCT01282801|12679671|P1|NOT COMPLETED|Second Intervention||0
5155405|NCT01282801|12679670|P2|COMPLETED|Second Intervention||8
5155406|NCT01282801|12679671|P1|COMPLETED|Second Intervention||9
5155407|NCT01282801|12679670|P2|STARTED|Second Intervention||9
5155408|NCT01282801|12679671|P1|STARTED|Second Intervention||9
5155409|NCT01282801|12679670|P2|NOT COMPLETED|Washout of 7 Days||0
5155410|NCT01282801|12679671|P1|NOT COMPLETED|Washout of 7 Days||0
5155411|NCT01282801|12679670|P2|COMPLETED|Washout of 7 Days||9
5155412|NCT01282801|12679671|P1|COMPLETED|Washout of 7 Days||9
5155413|NCT01282801|12679670|P2|STARTED|Washout of 7 Days||9
5155414|NCT01282801|12679671|P1|STARTED|Washout of 7 Days||9
5155415|NCT01282801|12679670|P2|NOT COMPLETED|First Intervention||0
5155416|NCT01282801|12679671|P1|NOT COMPLETED|First Intervention||0
5155417|NCT01282801|12679670|P2|COMPLETED|First Intervention||9
5155418|NCT01282801|12679671|P1|COMPLETED|First Intervention||9
5155419|NCT01282801|12679670|P2|STARTED|First Intervention||9
5155420|NCT01282801|12679671|P1|STARTED|First Intervention||9
5155421|NCT01282723|12679687|P1|NOT COMPLETED|Overall Study||0
5155422|NCT01282723|12679687|P1|COMPLETED|Overall Study||20
5155423|NCT01282723|12679687|P1|STARTED|Overall Study||20
5155424|NCT01282710|12679691|P1|NOT COMPLETED|Overall Study||0
5155425|NCT01282710|12679691|P1|COMPLETED|Overall Study||20
5155426|NCT01282710|12679691|P1|STARTED|Overall Study||20
5155427|NCT01282476|12679695|P1|NOT COMPLETED|Overall Study||11
5155428|NCT01282476|12679695|P1|COMPLETED|Overall Study||7
5155429|NCT01282476|12679695|P1|STARTED|Overall Study||18
5155430|NCT01282463|12679704|P3|NOT COMPLETED|Overall Study||4
5155431|NCT01282463|12679705|P2|NOT COMPLETED|Overall Study||4
5155432|NCT01282463|12679706|P1|NOT COMPLETED|Overall Study||8
5155433|NCT01282463|12679704|P3|COMPLETED|Overall Study||46
5155434|NCT01282463|12679705|P2|COMPLETED|Overall Study||45
5155435|NCT01282463|12679706|P1|COMPLETED|Overall Study||41
5155436|NCT01282463|12679704|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
5155437|NCT01282463|12679705|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
5155438|NCT01282463|12679706|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
5155439|NCT01282463|12679704|P3|STARTED|Overall Study||50
5155440|NCT01282463|12679705|P2|STARTED|Overall Study||49
5155441|NCT01282463|12679706|P1|STARTED|Overall Study||49
5155442|NCT01282424|12679744|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
5155443|NCT01282424|12679744|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
5155444|NCT01282424|12679744|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
5155445|NCT01282424|12679744|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
5155446|NCT01282424|12679744|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
5155447|NCT01282424|12679744|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
5155448|NCT01282424|12679744|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
5155449|NCT01282424|12679744|P1|STARTED|Treatment Period (TP) (81 Months)||125
5155450|NCT01282372|12679761|P1|NOT COMPLETED|Overall Study||79
5155451|NCT01282372|12679761|P1|COMPLETED|Overall Study||421
5155452|NCT01282372|12679761|P1|STARTED|Overall Study||500
5155453|NCT01282294|12679789|P1|NOT COMPLETED|Overall Study||19
5155454|NCT01282294|12679789|P1|COMPLETED|Overall Study||81
5155455|NCT01282294|12679789|P1|12 Months|Overall Study||86
5155456|NCT01282294|12679789|P1|6 Months|Overall Study||94
5155457|NCT01282294|12679789|P1|3 Months|Overall Study||95
5155458|NCT01282294|12679789|P1|6 Weeks|Overall Study||95
5155459|NCT01282294|12679789|P1|Post-operative|Overall Study||99
5155460|NCT01282294|12679789|P1|Intra-operative|Overall Study||99
5155461|NCT01282294|12679789|P1|STARTED|Overall Study||100
5155462|NCT01282242|12679809|P2|NOT COMPLETED|Overall Study||0
5155463|NCT01282242|12679810|P1|NOT COMPLETED|Overall Study||0
5155464|NCT01282242|12679809|P2|COMPLETED|Overall Study||8
5155465|NCT01282242|12679810|P1|COMPLETED|Overall Study||80
5155466|NCT01282242|12679809|P2|STARTED|Overall Study||8
5155467|NCT01282242|12679810|P1|STARTED|Overall Study||80
5155468|NCT01282229|12679818|P1|NOT COMPLETED|Overall Study||2
5155469|NCT01282229|12679818|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
5155470|NCT01282229|12679818|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
5155471|NCT01282216|12679850|P4|NOT COMPLETED|Overall Study||8
5155472|NCT01282216|12679851|P3|NOT COMPLETED|Overall Study||33
5155473|NCT01282216|12679852|P2|NOT COMPLETED|Overall Study||0
5155474|NCT01282216|12679853|P1|NOT COMPLETED|Overall Study||0
5155475|NCT01282216|12679850|P4|COMPLETED|Overall Study||0
5155476|NCT01282216|12679851|P3|COMPLETED|Overall Study||19
5155477|NCT01282216|12679852|P2|COMPLETED|Overall Study||26
5155478|NCT01282216|12679853|P1|COMPLETED|Overall Study||18
5155479|NCT01282216|12679850|P4|STARTED|Overall Study||8
5155480|NCT01282216|12679851|P3|STARTED|Overall Study||52
5155481|NCT01282216|12679852|P2|STARTED|Overall Study||26
5155482|NCT01282216|12679853|P1|STARTED|Overall Study||18
5155483|NCT01282203|12679863|P1|NOT COMPLETED|Overall Study||1
5155484|NCT01282203|12679863|P1|COMPLETED|Overall Study||1121
5155485|NCT01282203|12679863|P1|STARTED|Overall Study||1122
5155486|NCT01282164|12679885|P2|NOT COMPLETED|Overall Study||0
5155487|NCT01282164|12679886|P1|NOT COMPLETED|Overall Study||1
5155488|NCT01282164|12679885|P2|COMPLETED|Overall Study||14
5155489|NCT01282164|12679886|P1|COMPLETED|Overall Study||28
5155490|NCT01282164|12679885|P2|STARTED|Overall Study||14
5155491|NCT01282164|12679886|P1|STARTED|Overall Study||29
5155492|NCT01282138|12679911|P2|NOT COMPLETED|CAPT||0
5155493|NCT01282138|12679912|P1|NOT COMPLETED|CAPT||0
5155494|NCT01282138|12679911|P2|COMPLETED|CAPT||7
5155495|NCT01282138|12679912|P1|COMPLETED|CAPT||6
5155496|NCT01282138|12679911|P2|STARTED|CAPT||7
5155497|NCT01282138|12679912|P1|STARTED|CAPT||6
5155498|NCT01282138|12679911|P2|NOT COMPLETED|EEC||0
5155499|NCT01282138|12679912|P1|NOT COMPLETED|EEC||0
5155500|NCT01282138|12679911|P2|COMPLETED|EEC||7
5155501|NCT01282138|12679912|P1|COMPLETED|EEC||6
5155502|NCT01282138|12679911|P2|STARTED|EEC||7
5155503|NCT01282138|12679912|P1|STARTED|EEC||6
5155504|NCT01282086|12679920|P1|NOT COMPLETED|Overall Study||0
5155505|NCT01282086|12679920|P1|COMPLETED|Overall Study||1365
5155506|NCT01282086|12679920|P1|STARTED|Overall Study||1365
5155507|NCT01281969|12679939|P3|NOT COMPLETED|Overall Study||12
5155508|NCT01281969|12679940|P2|NOT COMPLETED|Overall Study||0
5155509|NCT01281969|12679941|P1|NOT COMPLETED|Overall Study||1
5155510|NCT01281969|12679939|P3|COMPLETED|Overall Study||0
5155511|NCT01281969|12679940|P2|COMPLETED|Overall Study||18
5155512|NCT01281969|12679941|P1|COMPLETED|Overall Study||17
5155513|NCT01281969|12679939|P3|STARTED|Overall Study||12
5155514|NCT01281969|12679940|P2|STARTED|Overall Study||18
5155515|NCT01281969|12679941|P1|STARTED|Overall Study||18
5155516|NCT01281956|12679953|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
5155517|NCT01281956|12679954|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
5155518|NCT01281956|12679953|P2|COMPLETED|2nd Intervention (3 Months)||5
5155519|NCT01281956|12679954|P1|COMPLETED|2nd Intervention (3 Months)||4
5155520|NCT01281956|12679953|P2|STARTED|2nd Intervention (3 Months)||5
5155521|NCT01281956|12679954|P1|STARTED|2nd Intervention (3 Months)||5
5155522|NCT01281956|12679953|P2|NOT COMPLETED|1st Intervention (3 Months)||0
5155523|NCT01281956|12679954|P1|NOT COMPLETED|1st Intervention (3 Months)||0
5155524|NCT01281956|12679953|P2|COMPLETED|1st Intervention (3 Months)||5
5155525|NCT01281956|12679954|P1|COMPLETED|1st Intervention (3 Months)||5
5155526|NCT01281956|12679953|P2|STARTED|1st Intervention (3 Months)||5
5155527|NCT01281956|12679954|P1|STARTED|1st Intervention (3 Months)||5
5155528|NCT01281917|12679985|P1|NOT COMPLETED|Overall Study||1
5155529|NCT01281917|12679985|P1|COMPLETED|Overall Study||39
5155530|NCT01281917|12679985|P1|STARTED|Overall Study||40
5155531|NCT01281865|12679997|P2|NOT COMPLETED|Overall Study||1
5155532|NCT01281865|12679998|P1|NOT COMPLETED|Overall Study||3
5155533|NCT01281865|12679997|P2|COMPLETED|Overall Study||1
5155534|NCT01281865|12679998|P1|COMPLETED|Overall Study||9
5155535|NCT01281865|12679997|P2|STARTED|Overall Study||2
5155536|NCT01281865|12679998|P1|STARTED|Overall Study||12
5155537|NCT01281839|12680006|P2|NOT COMPLETED|Overall Study||14
5155538|NCT01281839|12680007|P1|NOT COMPLETED|Overall Study||10
5155539|NCT01281839|12680006|P2|COMPLETED|Overall Study||119
5155540|NCT01281839|12680007|P1|COMPLETED|Overall Study||250
5155541|NCT01281839|12680006|P2|STARTED|Overall Study||133
5155542|NCT01281839|12680007|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
5155543|NCT01281644|12680068|P1|NOT COMPLETED|Overall Study||5
5155544|NCT01281644|12680068|P1|COMPLETED|Overall Study||18
5155545|NCT01281644|12680068|P1|STARTED|Overall Study||23
5155546|NCT01281501|12680078|P2|NOT COMPLETED|Overall Study||0
5155547|NCT01281501|12680079|P1|NOT COMPLETED|Overall Study||0
5155548|NCT01281501|12680078|P2|COMPLETED|Overall Study||43
5155549|NCT01281501|12680079|P1|COMPLETED|Overall Study||44
5155550|NCT01281501|12680078|P2|STARTED|Overall Study||43
5155551|NCT01281501|12680079|P1|STARTED|Overall Study||44
5155552|NCT01281475|12680093|P2|NOT COMPLETED|Overall Study||8
5155553|NCT01281475|12680094|P1|NOT COMPLETED|Overall Study||4
5155554|NCT01281475|12680093|P2|COMPLETED|Overall Study||26
5155555|NCT01281475|12680094|P1|COMPLETED|Overall Study||29
5155556|NCT01281475|12680093|P2|STARTED|Overall Study||34
5155557|NCT01281475|12680094|P1|STARTED|Overall Study||33
5155558|NCT01281306|12680109|P7|NOT COMPLETED|Overall Study||7
5155559|NCT01281306|12680110|P6|NOT COMPLETED|Overall Study||7
5155560|NCT01281306|12680111|P5|NOT COMPLETED|Overall Study||9
5155561|NCT01281306|12680112|P4|NOT COMPLETED|Overall Study||11
5155562|NCT01281306|12680113|P3|NOT COMPLETED|Overall Study||8
5155563|NCT01281306|12680114|P2|NOT COMPLETED|Overall Study||4
5155564|NCT01281306|12680115|P1|NOT COMPLETED|Overall Study||8
5155565|NCT01281306|12680109|P7|COMPLETED|Overall Study||51
5155566|NCT01281306|12680110|P6|COMPLETED|Overall Study||135
5155567|NCT01281306|12680111|P5|COMPLETED|Overall Study||134
5155568|NCT01281306|12680112|P4|COMPLETED|Overall Study||123
5155569|NCT01281306|12680113|P3|COMPLETED|Overall Study||133
5155570|NCT01281306|12680114|P2|COMPLETED|Overall Study||141
5155571|NCT01281306|12680115|P1|COMPLETED|Overall Study||136
5155572|NCT01281306|12680109|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
5155573|NCT01281306|12680110|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
5155574|NCT01281306|12680111|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
5155575|NCT01281306|12680112|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
5155576|NCT01281306|12680113|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
5155577|NCT01281306|12680114|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
5155578|NCT01281306|12680115|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
5155579|NCT01281306|12680109|P7|Safety Set|Overall Study||58
5155580|NCT01281306|12680110|P6|Safety Set|Overall Study||142
5155581|NCT01281306|12680111|P5|Safety Set|Overall Study||143
5155582|NCT01281306|12680112|P4|Safety Set|Overall Study||133
5155583|NCT01281306|12680113|P3|Safety Set|Overall Study||141
5155584|NCT01281306|12680114|P2|Safety Set|Overall Study||145
5155585|NCT01281306|12680115|P1|Safety Set|Overall Study||143
5155586|NCT01281306|12680109|P7|Full Analysis Set|Overall Study||58
5155587|NCT01281306|12680110|P6|Full Analysis Set|Overall Study||142
5155588|NCT01281306|12680111|P5|Full Analysis Set|Overall Study||143
5155589|NCT01281306|12680112|P4|Full Analysis Set|Overall Study||133
5155590|NCT01281306|12680113|P3|Full Analysis Set|Overall Study||141
5155591|NCT01281306|12680114|P2|Full Analysis Set|Overall Study||145
5155592|NCT01281306|12680115|P1|Full Analysis Set|Overall Study||143
5155593|NCT01281306|12680109|P7|STARTED|Overall Study||58
5155594|NCT01281306|12680110|P6|STARTED|Overall Study||142
5155595|NCT01281306|12680111|P5|STARTED|Overall Study||143
5155596|NCT01281306|12680112|P4|STARTED|Overall Study||134
5155597|NCT01281306|12680113|P3|STARTED|Overall Study||141
5155598|NCT01281306|12680114|P2|STARTED|Overall Study||145
5155599|NCT01281306|12680115|P1|STARTED|Overall Study||144
5155600|NCT01281202|12680231|P2|NOT COMPLETED|Overall Study||36
5155601|NCT01281202|12680232|P1|NOT COMPLETED|Overall Study||28
5155602|NCT01281202|12680231|P2|COMPLETED|Overall Study||68
5155603|NCT01281202|12680232|P1|COMPLETED|Overall Study||75
5155604|NCT01281202|12680231|P2|STARTED|Overall Study||104
5155605|NCT01281202|12680232|P1|STARTED|Overall Study||103
5155606|NCT01281124|12680240|P1|NOT COMPLETED|Overall Study||1
5155607|NCT01281124|12680240|P1|COMPLETED|Overall Study||0
5155608|NCT01281124|12680240|P1|STARTED|Overall Study||1
5155609|NCT01281007|12680248|P2|NOT COMPLETED|Overall Study||8
5155610|NCT01281007|12680249|P1|NOT COMPLETED|Overall Study||4
5155611|NCT01281007|12680248|P2|COMPLETED|Overall Study||67
5155612|NCT01281007|12680249|P1|COMPLETED|Overall Study||71
5155613|NCT01281007|12680248|P2|STARTED|Overall Study||75
5155614|NCT01281007|12680249|P1|STARTED|Overall Study||75
5155615|NCT01280981|12680255|P1|NOT COMPLETED|Overall Study||92
5155616|NCT01280981|12680255|P1|COMPLETED|Overall Study||196
5155617|NCT01280981|12680255|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
5155618|NCT01280981|12680255|P1|STARTED|Overall Study||288
5155619|NCT01280968|12680266|P2|NOT COMPLETED|Overall Study||3
5155620|NCT01280968|12680267|P1|NOT COMPLETED|Overall Study||18
5155621|NCT01280968|12680266|P2|COMPLETED|Overall Study||4
5155622|NCT01280968|12680267|P1|COMPLETED|Overall Study||27
5155623|NCT01280968|12680266|P2|STARTED|Overall Study||7
5155624|NCT01280968|12680267|P1|STARTED|Overall Study||45
5155625|NCT01280955|12680283|P1|NOT COMPLETED|Overall Study||3
5155626|NCT01280955|12680283|P1|COMPLETED|Overall Study||27
5155627|NCT01280955|12680283|P1|STARTED|Overall Study||30
5155628|NCT01280942|12680316|P2|NOT COMPLETED|Overall Study||0
5155629|NCT01280942|12680317|P1|NOT COMPLETED|Overall Study||0
5155630|NCT01280942|12680316|P2|COMPLETED|Overall Study||9911
5155631|NCT01280942|12680317|P1|COMPLETED|Overall Study||10120
5155632|NCT01280942|12680316|P2|STARTED|Overall Study||9911
5155633|NCT01280942|12680317|P1|STARTED|Overall Study||10120
5155634|NCT01280903|12680327|P2|NOT COMPLETED|Overall Study||16
5155635|NCT01280903|12680328|P1|NOT COMPLETED|Overall Study||23
5155636|NCT01280903|12680327|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
5155637|NCT01280903|12680328|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
5155638|NCT01280903|12680327|P2|STARTED|Overall Study||91
5155639|NCT01280903|12680328|P1|STARTED|Overall Study||91
5155640|NCT01280721|12680392|P1|NOT COMPLETED|Overall Study||22
5155641|NCT01280721|12680392|P1|COMPLETED|Overall Study||113
5155642|NCT01280721|12680392|P1|STARTED|Overall Study||135
5155643|NCT01280695|12680412|P5|NOT COMPLETED|Overall Study||2
5155644|NCT01280695|12680413|P4|NOT COMPLETED|Overall Study||4
5155645|NCT01280695|12680414|P3|NOT COMPLETED|Overall Study||5
5155646|NCT01280695|12680415|P2|NOT COMPLETED|Overall Study||1
5155647|NCT01280695|12680416|P1|NOT COMPLETED|Overall Study||0
5155648|NCT01280695|12680412|P5|COMPLETED|Overall Study||24
5155649|NCT01280695|12680413|P4|COMPLETED|Overall Study||22
5155650|NCT01280695|12680414|P3|COMPLETED|Overall Study||21
5155651|NCT01280695|12680415|P2|COMPLETED|Overall Study||24
5155652|NCT01280695|12680416|P1|COMPLETED|Overall Study||26
5155653|NCT01280695|12680412|P5|STARTED|Overall Study||26
5155654|NCT01280695|12680413|P4|STARTED|Overall Study||26
5155655|NCT01280695|12680414|P3|STARTED|Overall Study||26
5155656|NCT01280695|12680415|P2|STARTED|Overall Study||25
5155657|NCT01280695|12680416|P1|STARTED|Overall Study||26
5155658|NCT01280656|12680456|P3|NOT COMPLETED|Overall Study||63
5155659|NCT01280656|12680457|P2|NOT COMPLETED|Overall Study||47
5155660|NCT01280656|12680458|P1|NOT COMPLETED|Overall Study||3
5155661|NCT01280656|12680456|P3|COMPLETED|Overall Study||223
5155662|NCT01280656|12680457|P2|COMPLETED|Overall Study||265
5155663|NCT01280656|12680458|P1|COMPLETED|Overall Study||59
5155664|NCT01280656|12680456|P3|STARTED|Overall Study||286
5155665|NCT01280656|12680457|P2|STARTED|Overall Study||312
5155666|NCT01280656|12680458|P1|STARTED|Overall Study||62
5155667|NCT01280604|12680504|P2|NOT COMPLETED|Overall Study||5
5155668|NCT01280604|12680505|P1|NOT COMPLETED|Overall Study||9
5155669|NCT01280604|12680504|P2|COMPLETED|Overall Study||28
5155670|NCT01280604|12680505|P1|COMPLETED|Overall Study||24
5155671|NCT01280604|12680504|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
5155672|NCT01280604|12680505|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
5155673|NCT01280604|12680504|P2|STARTED|Overall Study||33
5155674|NCT01280604|12680505|P1|STARTED|Overall Study||33
5155675|NCT01280591|12680525|P4|NOT COMPLETED|Overall Study||3
5155676|NCT01280591|12680526|P3|NOT COMPLETED|Overall Study||0
5155677|NCT01280591|12680527|P2|NOT COMPLETED|Overall Study||0
5155678|NCT01280591|12680528|P1|NOT COMPLETED|Overall Study||0
5155679|NCT01280591|12680525|P4|COMPLETED|Overall Study||99
5155680|NCT01280591|12680526|P3|COMPLETED|Overall Study||203
5155681|NCT01280591|12680527|P2|COMPLETED|Overall Study||204
5155682|NCT01280591|12680528|P1|COMPLETED|Overall Study||203
5155683|NCT01280591|12680525|P4|STARTED|Overall Study||102
5155684|NCT01280591|12680526|P3|STARTED|Overall Study||203
5155685|NCT01280591|12680527|P2|STARTED|Overall Study||204
5155686|NCT01280591|12680528|P1|STARTED|Overall Study||203
5155687|NCT01280552|12680620|P2|NOT COMPLETED|Overall Study||1
5155688|NCT01280552|12680621|P1|NOT COMPLETED|Overall Study||6
5155689|NCT01280552|12680620|P2|COMPLETED|Overall Study||42
5155690|NCT01280552|12680621|P1|COMPLETED|Overall Study|Survival is still being assessed|75
5155691|NCT01280552|12680620|P2|STARTED|Overall Study||43
5155692|NCT01280552|12680621|P1|STARTED|Overall Study||81
5155693|NCT01280409|12680635|P2|NOT COMPLETED|Overall Study||19
5155694|NCT01280409|12680636|P1|NOT COMPLETED|Overall Study||16
5155695|NCT01280409|12680635|P2|COMPLETED|Overall Study||36
5155696|NCT01280409|12680636|P1|COMPLETED|Overall Study||43
5155697|NCT01280409|12680635|P2|STARTED|Overall Study||55
5155698|NCT01280409|12680636|P1|STARTED|Overall Study||59
5155699|NCT01280357|12680666|P1|NOT COMPLETED|Overall Study||26
5155700|NCT01280357|12680666|P1|COMPLETED|Overall Study||34
5155701|NCT01280357|12680666|P1|STARTED|Overall Study||60
5155702|NCT01280266|12680675|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
5155703|NCT01280266|12680676|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
5155704|NCT01280266|12680675|P2|COMPLETED|Second Intervention (Week 5-9)||12
5155705|NCT01280266|12680676|P1|COMPLETED|Second Intervention (Week 5-9)||14
5155706|NCT01280266|12680675|P2|STARTED|Second Intervention (Week 5-9)||12
5155707|NCT01280266|12680676|P1|STARTED|Second Intervention (Week 5-9)||14
5155708|NCT01280266|12680675|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
5155709|NCT01280266|12680676|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
5155710|NCT01280266|12680675|P2|COMPLETED|Washout Period (Week 4-5)||12
5155711|NCT01280266|12680676|P1|COMPLETED|Washout Period (Week 4-5)||14
5155712|NCT01280266|12680675|P2|STARTED|Washout Period (Week 4-5)||12
5155713|NCT01280266|12680676|P1|STARTED|Washout Period (Week 4-5)||14
5155714|NCT01280266|12680675|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
5155715|NCT01280266|12680676|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
5155716|NCT01280266|12680675|P2|COMPLETED|First Intervention (Week 1-4)||12
5155717|NCT01280266|12680676|P1|COMPLETED|First Intervention (Week 1-4)||14
5155718|NCT01280266|12680675|P2|STARTED|First Intervention (Week 1-4)||14
5155719|NCT01280266|12680676|P1|STARTED|First Intervention (Week 1-4)||15
5155720|NCT01280201|12680698|P1|NOT COMPLETED|Overall Study||0
5155721|NCT01280201|12680698|P1|COMPLETED|Overall Study||44
5155722|NCT01280201|12680698|P1|STARTED|Overall Study||44
5155723|NCT01280123|12680710|P3|NOT COMPLETED|Overall Study||1
5155724|NCT01280123|12680711|P2|NOT COMPLETED|Overall Study||4
5155725|NCT01280123|12680712|P1|NOT COMPLETED|Overall Study||1
5155726|NCT01280123|12680710|P3|COMPLETED|Overall Study||70
5155727|NCT01280123|12680711|P2|COMPLETED|Overall Study||63
5155728|NCT01280123|12680712|P1|COMPLETED|Overall Study||71
5155729|NCT01280123|12680710|P3|STARTED|Overall Study||71
5155730|NCT01280123|12680711|P2|STARTED|Overall Study||67
5155731|NCT01280123|12680712|P1|STARTED|Overall Study||72
5155732|NCT01280110|12680737|P2|NOT COMPLETED|Overall Study||0
5155733|NCT01280110|12680738|P1|NOT COMPLETED|Overall Study||0
5155734|NCT01280110|12680737|P2|COMPLETED|Overall Study||22
5155735|NCT01280110|12680738|P1|COMPLETED|Overall Study||22
5155736|NCT01280110|12680737|P2|STARTED|Overall Study||22
5155737|NCT01280110|12680738|P1|STARTED|Overall Study||22
5155738|NCT01280058|12680748|P2|NOT COMPLETED|Overall Study||0
5155739|NCT01280058|12680749|P1|NOT COMPLETED|Overall Study||0
5155740|NCT01280058|12680748|P2|COMPLETED|Overall Study||37
5155741|NCT01280058|12680749|P1|COMPLETED|Overall Study||36
5155742|NCT01280058|12680748|P2|STARTED|Overall Study||37
5155743|NCT01280058|12680749|P1|STARTED|Overall Study||36
5155744|NCT01279954|12680767|P2|NOT COMPLETED|Overall Study||4
5155745|NCT01279954|12680768|P1|NOT COMPLETED|Overall Study||3
5155746|NCT01279954|12680767|P2|COMPLETED|Overall Study||1
5155747|NCT01279954|12680768|P1|COMPLETED|Overall Study||2
5155748|NCT01279954|12680767|P2|STARTED|Overall Study||5
5155749|NCT01279954|12680768|P1|STARTED|Overall Study||5
5155750|NCT01279850|12680779|P1|NOT COMPLETED|Overall Study||91
5155751|NCT01279850|12680779|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
5155752|NCT01279850|12680779|P1|STARTED|Overall Study||891
5155753|NCT01279681|12680795|P2|NOT COMPLETED|Overall Study||17
5155754|NCT01279681|12680796|P1|NOT COMPLETED|Overall Study||15
5155755|NCT01279681|12680795|P2|COMPLETED|Overall Study||0
5155756|NCT01279681|12680796|P1|COMPLETED|Overall Study||0
5155757|NCT01279681|12680795|P2|STARTED|Overall Study||17
5155758|NCT01279681|12680796|P1|STARTED|Overall Study||15
5155759|NCT01279616|12680808|P1|NOT COMPLETED|Overall Study||7
5155760|NCT01279616|12680808|P1|COMPLETED|Overall Study||1
5155761|NCT01279616|12680808|P1|STARTED|Overall Study||8
5155762|NCT01279564|12680814|P2|NOT COMPLETED|Overall Study||0
5155763|NCT01279564|12680815|P1|NOT COMPLETED|Overall Study||0
5155764|NCT01279564|12680814|P2|COMPLETED|Overall Study||32
5155765|NCT01279564|12680815|P1|COMPLETED|Overall Study||40
5155766|NCT01279564|12680814|P2|STARTED|Overall Study||32
5155767|NCT01279564|12680815|P1|STARTED|Overall Study||40
5155768|NCT01279486|12680821|P1|NOT COMPLETED|Overall Study||1
5155769|NCT01279486|12680821|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
5155770|NCT01279486|12680821|P1|STARTED|Overall Study||120
5155771|NCT01279447|12680827|P2|NOT COMPLETED|Overall Study||1
5155772|NCT01279447|12680828|P1|NOT COMPLETED|Overall Study||3
5155773|NCT01279447|12680827|P2|COMPLETED|Overall Study||33
5155774|NCT01279447|12680828|P1|COMPLETED|Overall Study||31
5155775|NCT01279447|12680827|P2|STARTED|Overall Study||34
5155776|NCT01279447|12680828|P1|STARTED|Overall Study||34
5155777|NCT01279343|12680836|P2|NOT COMPLETED|Overall Study||6
5155778|NCT01279343|12680837|P1|NOT COMPLETED|Overall Study||2
5155779|NCT01279343|12680836|P2|COMPLETED|Overall Study||58
5155780|NCT01279343|12680837|P1|COMPLETED|Overall Study||57
5155781|NCT01279343|12680836|P2|STARTED|Overall Study||64
5155782|NCT01279343|12680837|P1|STARTED|Overall Study||59
5155783|NCT01279317|12680861|P2|NOT COMPLETED|Period 2||0
5155784|NCT01279317|12680862|P1|NOT COMPLETED|Period 2||0
5155785|NCT01279317|12680861|P2|COMPLETED|Period 2||6
5155786|NCT01279317|12680862|P1|COMPLETED|Period 2||6
5155787|NCT01279317|12680861|P2|STARTED|Period 2||6
5155788|NCT01279317|12680862|P1|STARTED|Period 2||6
5155789|NCT01279317|12680861|P2|NOT COMPLETED|Washout||0
5155790|NCT01279317|12680862|P1|NOT COMPLETED|Washout||0
5155791|NCT01279317|12680861|P2|COMPLETED|Washout||6
5155792|NCT01279317|12680862|P1|COMPLETED|Washout||6
5155793|NCT01279317|12680861|P2|STARTED|Washout||6
5155794|NCT01279317|12680862|P1|STARTED|Washout||6
5155795|NCT01279317|12680861|P2|NOT COMPLETED|Period 1||0
5155796|NCT01279317|12680862|P1|NOT COMPLETED|Period 1||0
5155797|NCT01279317|12680861|P2|COMPLETED|Period 1||6
5155798|NCT01279317|12680862|P1|COMPLETED|Period 1||6
5155799|NCT01279317|12680861|P2|STARTED|Period 1||6
5155800|NCT01279317|12680862|P1|STARTED|Period 1||6
5155801|NCT01279265|12680869|P2|NOT COMPLETED|Overall Study||6
5155802|NCT01279265|12680870|P1|NOT COMPLETED|Overall Study||4
5155803|NCT01279265|12680869|P2|COMPLETED|Overall Study||11
5155804|NCT01279265|12680870|P1|COMPLETED|Overall Study||9
5155805|NCT01279265|12680869|P2|STARTED|Overall Study||17
5155806|NCT01279265|12680870|P1|STARTED|Overall Study||13
5155807|NCT01279200|12680882|P2|NOT COMPLETED|Overall Study||7
5155808|NCT01279200|12680883|P1|NOT COMPLETED|Overall Study||2
5155809|NCT01279200|12680882|P2|COMPLETED|Overall Study||4
5155810|NCT01279200|12680883|P1|COMPLETED|Overall Study||8
5155811|NCT01279200|12680882|P2|STARTED|Overall Study||11
5155812|NCT01279200|12680883|P1|STARTED|Overall Study||10
5155813|NCT01279187|12680893|P2|NOT COMPLETED|Overall Study||0
5155814|NCT01279187|12680894|P1|NOT COMPLETED|Overall Study||0
5155815|NCT01279187|12680893|P2|COMPLETED|Overall Study||13
5155816|NCT01279187|12680894|P1|COMPLETED|Overall Study||14
5155817|NCT01279187|12680893|P2|STARTED|Overall Study||13
5155818|NCT01279187|12680894|P1|STARTED|Overall Study||14
5155819|NCT01279109|12680910|P2|NOT COMPLETED|Overall Study||12
5155820|NCT01279109|12680911|P1|NOT COMPLETED|Overall Study||13
5155821|NCT01279109|12680910|P2|COMPLETED|Overall Study||55
5155822|NCT01279109|12680911|P1|COMPLETED|Overall Study||55
5155823|NCT01279109|12680910|P2|STARTED|Overall Study||67
5155824|NCT01279109|12680911|P1|STARTED|Overall Study||68
5155825|NCT01279070|12680921|P2|NOT COMPLETED|Overall Study||4
5155826|NCT01279070|12680922|P1|NOT COMPLETED|Overall Study||5
5155827|NCT01279070|12680921|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
5155828|NCT01279070|12680922|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
5155829|NCT01279070|12680921|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
5155830|NCT01279070|12680922|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
5155831|NCT01279044|12680941|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
5155832|NCT01279044|12680942|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
5155833|NCT01279044|12680943|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
5155834|NCT01279044|12680941|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
5155835|NCT01279044|12680942|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
5155836|NCT01279044|12680943|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
5155837|NCT01279044|12680941|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
5155838|NCT01279044|12680942|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
5155839|NCT01279044|12680943|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
5155840|NCT01279044|12680941|P3|NOT COMPLETED|PHASE 1 - Formative||0
5155841|NCT01279044|12680942|P2|NOT COMPLETED|PHASE 1 - Formative||0
5155842|NCT01279044|12680943|P1|NOT COMPLETED|PHASE 1 - Formative||0
5155843|NCT01279044|12680941|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
5155844|NCT01279044|12680942|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
5155845|NCT01279044|12680943|P1|COMPLETED|PHASE 1 - Formative||59
5155846|NCT01279044|12680941|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
5155847|NCT01279044|12680942|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
5155848|NCT01279044|12680943|P1|STARTED|PHASE 1 - Formative||59
5155849|NCT01278953|12680963|P2|NOT COMPLETED|Overall Study||11
5155850|NCT01278953|12680964|P1|NOT COMPLETED|Overall Study||9
5155851|NCT01278953|12680963|P2|COMPLETED|Overall Study||134
5155852|NCT01278953|12680964|P1|COMPLETED|Overall Study||146
5155853|NCT01278953|12680963|P2|STARTED|Overall Study||145
5155854|NCT01278953|12680964|P1|STARTED|Overall Study||155
5155855|NCT01278927|12680976|P4|NOT COMPLETED|Overall Study||0
5155856|NCT01278927|12680977|P3|NOT COMPLETED|Overall Study||0
5155857|NCT01278927|12680978|P2|NOT COMPLETED|Overall Study||0
5155858|NCT01278927|12680979|P1|NOT COMPLETED|Overall Study||0
5155859|NCT01278927|12680976|P4|COMPLETED|Overall Study||175
5155860|NCT01278927|12680977|P3|COMPLETED|Overall Study||178
5155861|NCT01278927|12680978|P2|COMPLETED|Overall Study||178
5155862|NCT01278927|12680979|P1|COMPLETED|Overall Study||180
5155863|NCT01278927|12680976|P4|STARTED|Overall Study||175
5155864|NCT01278927|12680977|P3|STARTED|Overall Study||178
5155865|NCT01278927|12680978|P2|STARTED|Overall Study||178
5155866|NCT01278927|12680979|P1|STARTED|Overall Study||180
5155867|NCT01278862|12681019|P2|NOT COMPLETED|Overall Study||1
5155868|NCT01278862|12681020|P1|NOT COMPLETED|Overall Study||1
5155869|NCT01278862|12681019|P2|COMPLETED|Overall Study||42
5155870|NCT01278862|12681020|P1|COMPLETED|Overall Study||44
5155871|NCT01278862|12681019|P2|STARTED|Overall Study||43
5155872|NCT01278862|12681020|P1|STARTED|Overall Study||45
5155873|NCT01278797|12681028|P2|NOT COMPLETED|Period 2||0
5155874|NCT01278797|12681029|P1|NOT COMPLETED|Period 2||0
5155875|NCT01278797|12681028|P2|COMPLETED|Period 2||13
5155876|NCT01278797|12681029|P1|COMPLETED|Period 2||13
5155877|NCT01278797|12681028|P2|STARTED|Period 2||13
5155878|NCT01278797|12681029|P1|STARTED|Period 2||13
5155879|NCT01278797|12681028|P2|NOT COMPLETED|Washout Period of 21 Days||0
5155880|NCT01278797|12681029|P1|NOT COMPLETED|Washout Period of 21 Days||0
5155881|NCT01278797|12681028|P2|COMPLETED|Washout Period of 21 Days||13
5155882|NCT01278797|12681029|P1|COMPLETED|Washout Period of 21 Days||13
5155883|NCT01278797|12681028|P2|STARTED|Washout Period of 21 Days||13
5155884|NCT01278797|12681029|P1|STARTED|Washout Period of 21 Days||13
5155885|NCT01278797|12681028|P2|NOT COMPLETED|Period 1||1
5155886|NCT01278797|12681029|P1|NOT COMPLETED|Period 1||1
5155887|NCT01278797|12681028|P2|COMPLETED|Period 1||13
5155888|NCT01278797|12681029|P1|COMPLETED|Period 1||13
5155889|NCT01278797|12681028|P2|STARTED|Period 1||14
5155890|NCT01278797|12681029|P1|STARTED|Period 1||14
5155891|NCT01278745|12681041|P4|NOT COMPLETED|Overall Study||78
5155892|NCT01278745|12681042|P3|NOT COMPLETED|Overall Study||121
5155893|NCT01278745|12681043|P2|NOT COMPLETED|Overall Study||6
5155894|NCT01278745|12681044|P1|NOT COMPLETED|Overall Study||5
5155895|NCT01278745|12681041|P4|COMPLETED|Overall Study||0
5155896|NCT01278745|12681042|P3|COMPLETED|Overall Study||0
5155897|NCT01278745|12681043|P2|COMPLETED|Overall Study||68
5155898|NCT01278745|12681044|P1|COMPLETED|Overall Study||84
5155899|NCT01278745|12681041|P4|STARTED|Overall Study||78
5155900|NCT01278745|12681042|P3|STARTED|Overall Study||121
5155901|NCT01278745|12681043|P2|STARTED|Overall Study||74
5155902|NCT01278745|12681044|P1|STARTED|Overall Study||89
5155903|NCT01278615|12681076|P1|NOT COMPLETED|Overall Study||2
5155904|NCT01278615|12681076|P1|COMPLETED|Overall Study||14
5155905|NCT01278615|12681076|P1|STARTED|Overall Study||16
5155906|NCT01278485|12681086|P1|NOT COMPLETED|Overall Study||0
5155907|NCT01278485|12681086|P1|COMPLETED|Overall Study||719
5155908|NCT01278485|12681086|P1|STARTED|Overall Study||719
5155909|NCT01278407|12681102|P5|NOT COMPLETED|Extension Phase||30
5155910|NCT01278407|12681103|P4|NOT COMPLETED|Extension Phase||12
5155911|NCT01278407|12681104|P3|NOT COMPLETED|Extension Phase||0
5155912|NCT01278407|12681105|P2|NOT COMPLETED|Extension Phase||0
5155913|NCT01278407|12681106|P1|NOT COMPLETED|Extension Phase||0
5155914|NCT01278407|12681102|P5|COMPLETED|Extension Phase||66
5155915|NCT01278407|12681103|P4|COMPLETED|Extension Phase||34
5155916|NCT01278407|12681104|P3|COMPLETED|Extension Phase||0
5155917|NCT01278407|12681105|P2|COMPLETED|Extension Phase||0
5155918|NCT01278407|12681106|P1|COMPLETED|Extension Phase||0
5155919|NCT01278407|12681102|P5|STARTED|Extension Phase||96
5155920|NCT01278407|12681103|P4|STARTED|Extension Phase||46
5155921|NCT01278407|12681104|P3|STARTED|Extension Phase||0
5155922|NCT01278407|12681105|P2|STARTED|Extension Phase||0
5155923|NCT01278407|12681106|P1|STARTED|Extension Phase||0
5155924|NCT01278407|12681102|P5|NOT COMPLETED|Confirmatory Phase||0
5155925|NCT01278407|12681103|P4|NOT COMPLETED|Confirmatory Phase||0
5155926|NCT01278407|12681104|P3|NOT COMPLETED|Confirmatory Phase||6
5155927|NCT01278407|12681105|P2|NOT COMPLETED|Confirmatory Phase||16
5155928|NCT01278407|12681106|P1|NOT COMPLETED|Confirmatory Phase||9
5155929|NCT01278407|12681102|P5|COMPLETED|Confirmatory Phase||0
5155930|NCT01278407|12681103|P4|COMPLETED|Confirmatory Phase||0
5155931|NCT01278407|12681104|P3|COMPLETED|Confirmatory Phase||43
5155932|NCT01278407|12681105|P2|COMPLETED|Confirmatory Phase||31
5155933|NCT01278407|12681106|P1|COMPLETED|Confirmatory Phase||37
5155934|NCT01278407|12681102|P5|STARTED|Confirmatory Phase||0
5155935|NCT01278407|12681103|P4|STARTED|Confirmatory Phase||0
5155936|NCT01278407|12681104|P3|STARTED|Confirmatory Phase||49
5155937|NCT01278407|12681105|P2|STARTED|Confirmatory Phase||47
5155938|NCT01278407|12681106|P1|STARTED|Confirmatory Phase||46
5155939|NCT01278394|12681119|P1|NOT COMPLETED|Overall Study||1
5155940|NCT01278394|12681119|P1|COMPLETED|Overall Study||28
5155941|NCT01278394|12681119|P1|STARTED|Overall Study||29
5155942|NCT01278342|12681132|P3|NOT COMPLETED|Overall Study||0
5155943|NCT01278342|12681133|P2|NOT COMPLETED|Overall Study||1
5155944|NCT01278342|12681134|P1|NOT COMPLETED|Overall Study||4
5155945|NCT01278342|12681132|P3|COMPLETED|Overall Study||32
5155946|NCT01278342|12681133|P2|COMPLETED|Overall Study||30
5155947|NCT01278342|12681134|P1|COMPLETED|Overall Study||3
5155948|NCT01278342|12681132|P3|STARTED|Overall Study||32
5155949|NCT01278342|12681133|P2|STARTED|Overall Study||31
5155950|NCT01278342|12681134|P1|STARTED|Overall Study||7
5155951|NCT01278303|12681148|P1|NOT COMPLETED|Overall Study||0
5155952|NCT01278303|12681148|P1|COMPLETED|Overall Study||82
5155953|NCT01278303|12681148|P1|STARTED|Overall Study||82
5155954|NCT01278173|12681154|P1|NOT COMPLETED|Overall Study||27
5155955|NCT01278173|12681154|P1|COMPLETED|Overall Study||38
5155956|NCT01278173|12681154|P1|STARTED|Overall Study||65
5155957|NCT01278160|12681161|P2|NOT COMPLETED|Overall Study||6
5155958|NCT01278160|12681162|P1|NOT COMPLETED|Overall Study||5
5155959|NCT01278160|12681161|P2|COMPLETED|Overall Study||84
5155960|NCT01278160|12681162|P1|COMPLETED|Overall Study||84
5155961|NCT01278160|12681161|P2|STARTED|Overall Study||90
5155962|NCT01278160|12681162|P1|STARTED|Overall Study||89
5155963|NCT01278030|12681178|P2|NOT COMPLETED|Overall Study||4
5155964|NCT01278030|12681179|P1|NOT COMPLETED|Overall Study||8
5155965|NCT01278030|12681178|P2|COMPLETED|Overall Study||31
5155966|NCT01278030|12681179|P1|COMPLETED|Overall Study||35
5155967|NCT01278030|12681178|P2|STARTED|Overall Study||35
5155968|NCT01278030|12681179|P1|STARTED|Overall Study||43
5155969|NCT01277887|12681187|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
5155970|NCT01277887|12681188|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
5155971|NCT01277887|12681187|P2|COMPLETED|Post-Quit Treatment Phase||5
5155972|NCT01277887|12681188|P1|COMPLETED|Post-Quit Treatment Phase||3
5155973|NCT01277887|12681187|P2|STARTED|Post-Quit Treatment Phase||10
5155974|NCT01277887|12681188|P1|STARTED|Post-Quit Treatment Phase||6
5155975|NCT01277887|12681187|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
5155976|NCT01277887|12681188|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
5155977|NCT01277887|12681187|P2|COMPLETED|Pre-Quit Treatment Phase||10
5155978|NCT01277887|12681188|P1|COMPLETED|Pre-Quit Treatment Phase||6
5155979|NCT01277887|12681187|P2|Entered Study|Pre-Quit Treatment Phase||10
5155980|NCT01277887|12681188|P1|Entered Study|Pre-Quit Treatment Phase||7
5155981|NCT01277887|12681187|P2|STARTED|Pre-Quit Treatment Phase||10
5155982|NCT01277887|12681188|P1|STARTED|Pre-Quit Treatment Phase||9
5155983|NCT01277861|12681200|P2|NOT COMPLETED|Overall Study||2
5155984|NCT01277861|12681201|P1|NOT COMPLETED|Overall Study||2
5155985|NCT01277861|12681200|P2|COMPLETED|Overall Study||47
5155986|NCT01277861|12681201|P1|COMPLETED|Overall Study||49
5155987|NCT01277861|12681200|P2|STARTED|Overall Study||49
5155988|NCT01277861|12681201|P1|STARTED|Overall Study||51
5155989|NCT01277822|12681213|P2|NOT COMPLETED|Overall Study||11
5155990|NCT01277822|12681214|P1|NOT COMPLETED|Overall Study||15
5155991|NCT01277822|12681213|P2|COMPLETED|Overall Study||155
5155992|NCT01277822|12681214|P1|COMPLETED|Overall Study||153
5155993|NCT01277822|12681213|P2|STARTED|Overall Study||166
5155994|NCT01277822|12681214|P1|STARTED|Overall Study||168
5155995|NCT01277783|12681234|P1|NOT COMPLETED|Overall Study||0
5155996|NCT01277783|12681234|P1|COMPLETED|Overall Study||138
5155997|NCT01277783|12681234|P1|STARTED|Overall Study||138
5155998|NCT01277757|12681250|P1|NOT COMPLETED|Overall Study||2
5155999|NCT01277757|12681250|P1|COMPLETED|Overall Study||28
5156000|NCT01277757|12681250|P1|STARTED|Overall Study||30
5156001|NCT01277744|12681257|P1|NOT COMPLETED|Overall Study||2
5156002|NCT01277744|12681257|P1|COMPLETED|Overall Study||20
5156003|NCT01277744|12681257|P1|STARTED|Overall Study||22
5156004|NCT01277718|12681262|P2|NOT COMPLETED|Period 3 - Third Intervention||0
5156005|NCT01277718|12681263|P1|NOT COMPLETED|Period 3 - Third Intervention||0
5156006|NCT01277718|12681262|P2|COMPLETED|Period 3 - Third Intervention||7
5156007|NCT01277718|12681263|P1|COMPLETED|Period 3 - Third Intervention||10
5156008|NCT01277718|12681262|P2|STARTED|Period 3 - Third Intervention||7
5156009|NCT01277718|12681263|P1|STARTED|Period 3 - Third Intervention||10
5156010|NCT01277718|12681262|P2|NOT COMPLETED|Washout Period of 13 Days||0
5156011|NCT01277718|12681263|P1|NOT COMPLETED|Washout Period of 13 Days||0
5156012|NCT01277718|12681262|P2|COMPLETED|Washout Period of 13 Days||7
5156013|NCT01277718|12681263|P1|COMPLETED|Washout Period of 13 Days||10
5156014|NCT01277718|12681262|P2|STARTED|Washout Period of 13 Days||7
5156015|NCT01277718|12681263|P1|STARTED|Washout Period of 13 Days||10
5156016|NCT01277718|12681262|P2|NOT COMPLETED|Period 2 - Second Intervention||3
5156017|NCT01277718|12681263|P1|NOT COMPLETED|Period 2 - Second Intervention||0
5156018|NCT01277718|12681262|P2|COMPLETED|Period 2 - Second Intervention||7
5156019|NCT01277718|12681263|P1|COMPLETED|Period 2 - Second Intervention||10
5156020|NCT01277718|12681262|P2|STARTED|Period 2 - Second Intervention||10
5156021|NCT01277718|12681263|P1|STARTED|Period 2 - Second Intervention||10
5156022|NCT01277718|12681262|P2|NOT COMPLETED|Washout Period of 13 Days||0
5156023|NCT01277718|12681263|P1|NOT COMPLETED|Washout Period of 13 Days||0
5156024|NCT01277718|12681262|P2|COMPLETED|Washout Period of 13 Days||10
5156025|NCT01277718|12681263|P1|COMPLETED|Washout Period of 13 Days||10
5156026|NCT01277718|12681262|P2|STARTED|Washout Period of 13 Days||10
5156027|NCT01277718|12681263|P1|STARTED|Washout Period of 13 Days||10
5156028|NCT01277718|12681262|P2|NOT COMPLETED|Period 1 - First Intervention||0
5156029|NCT01277718|12681263|P1|NOT COMPLETED|Period 1 - First Intervention||0
5156030|NCT01277718|12681262|P2|COMPLETED|Period 1 - First Intervention||10
5156031|NCT01277718|12681263|P1|COMPLETED|Period 1 - First Intervention||10
5156032|NCT01277718|12681262|P2|STARTED|Period 1 - First Intervention||10
5156033|NCT01277718|12681263|P1|STARTED|Period 1 - First Intervention||10
5156034|NCT01277666|12681277|P3|NOT COMPLETED|Overall Study||49
5156035|NCT01277666|12681278|P2|NOT COMPLETED|Overall Study||59
5156036|NCT01277666|12681279|P1|NOT COMPLETED|Overall Study||45
5156037|NCT01277666|12681277|P3|COMPLETED|Overall Study||153
5156038|NCT01277666|12681278|P2|COMPLETED|Overall Study||144
5156039|NCT01277666|12681279|P1|COMPLETED|Overall Study||158
5156040|NCT01277666|12681277|P3|STARTED|Overall Study||202
5156041|NCT01277666|12681278|P2|STARTED|Overall Study||203
5156042|NCT01277666|12681279|P1|STARTED|Overall Study||203
5156043|NCT01277601|12681312|P4|NOT COMPLETED|Overall Study||36
5156044|NCT01277601|12681313|P3|NOT COMPLETED|Overall Study||27
5156045|NCT01277601|12681314|P2|NOT COMPLETED|Overall Study||48
5156046|NCT01277601|12681315|P1|NOT COMPLETED|Overall Study||37
5156047|NCT01277601|12681312|P4|COMPLETED|Overall Study||150
5156048|NCT01277601|12681313|P3|COMPLETED|Overall Study||163
5156049|NCT01277601|12681314|P2|COMPLETED|Overall Study||139
5156050|NCT01277601|12681315|P1|COMPLETED|Overall Study||151
5156051|NCT01277601|12681312|P4|STARTED|Overall Study||186
5156052|NCT01277601|12681313|P3|STARTED|Overall Study||190
5156053|NCT01277601|12681314|P2|STARTED|Overall Study||187
5156054|NCT01277601|12681315|P1|STARTED|Overall Study||188
5156055|NCT01277549|12681406|P2|NOT COMPLETED|Overall Study||14
5156056|NCT01277549|12681407|P1|NOT COMPLETED|Overall Study||26
5156057|NCT01277549|12681406|P2|COMPLETED|Overall Study||15
5156058|NCT01277549|12681407|P1|COMPLETED|Overall Study||15
5156059|NCT01277549|12681406|P2|STARTED|Overall Study||29
5156060|NCT01277549|12681407|P1|STARTED|Overall Study||41
5156061|NCT01277523|12681424|P3|NOT COMPLETED|Overall Study||0
5156062|NCT01277523|12681425|P2|NOT COMPLETED|Overall Study||1
5156063|NCT01277523|12681426|P1|NOT COMPLETED|Overall Study||3
5156064|NCT01277523|12681424|P3|COMPLETED|Overall Study||130
5156065|NCT01277523|12681425|P2|COMPLETED|Overall Study||126
5156066|NCT01277523|12681426|P1|COMPLETED|Overall Study||132
5156067|NCT01277523|12681424|P3|STARTED|Overall Study||130
5156068|NCT01277523|12681425|P2|STARTED|Overall Study||127
5156069|NCT01277523|12681426|P1|STARTED|Overall Study||135
5156070|NCT01277510|12681478|P2|NOT COMPLETED|Open-label Phase||3
5156071|NCT01277510|12681479|P1|NOT COMPLETED|Open-label Phase||7
5156072|NCT01277510|12681478|P2|COMPLETED|Open-label Phase|Completed investigational product|1
5156073|NCT01277510|12681479|P1|COMPLETED|Open-label Phase|Completed investigational product|1
5156074|NCT01277510|12681478|P2|Received Investigational Product|Open-label Phase||4
5156075|NCT01277510|12681479|P1|Received Investigational Product|Open-label Phase||6
5156076|NCT01277510|12681478|P2|STARTED|Open-label Phase||4
5156077|NCT01277510|12681479|P1|STARTED|Open-label Phase||8
5156078|NCT01277510|12681478|P2|NOT COMPLETED|Double-blind Phase||18
5156079|NCT01277510|12681479|P1|NOT COMPLETED|Double-blind Phase||13
5156080|NCT01277510|12681478|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
5156081|NCT01277510|12681479|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
5156082|NCT01277510|12681478|P2|Received Investigational Product|Double-blind Phase||22
5156083|NCT01277510|12681479|P1|Received Investigational Product|Double-blind Phase||21
5156084|NCT01277510|12681478|P2|STARTED|Double-blind Phase||22
5156085|NCT01277510|12681479|P1|STARTED|Double-blind Phase||21
5156086|NCT01277354|12681503|P2|NOT COMPLETED|Overall Study||0
5156087|NCT01277354|12681504|P1|NOT COMPLETED|Overall Study||0
5156088|NCT01277354|12681503|P2|COMPLETED|Overall Study||1
5156089|NCT01277354|12681504|P1|COMPLETED|Overall Study||1
5156090|NCT01277354|12681503|P2|STARTED|Overall Study||1
5156091|NCT01277354|12681504|P1|STARTED|Overall Study||1
5156092|NCT01277302|12681513|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
5156093|NCT01277302|12681514|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
5156094|NCT01277302|12681515|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
5156095|NCT01277302|12681513|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
5156096|NCT01277302|12681514|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
5156097|NCT01277302|12681515|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
5156098|NCT01277302|12681513|P3|STARTED|8-Month Alternate Dose Regimen Period||19
5156099|NCT01277302|12681514|P2|STARTED|8-Month Alternate Dose Regimen Period||86
5156100|NCT01277302|12681515|P1|STARTED|8-Month Alternate Dose Regimen Period||85
5156101|NCT01277302|12681513|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
5156102|NCT01277302|12681514|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
5156103|NCT01277302|12681515|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
5156104|NCT01277302|12681513|P3|COMPLETED|7-Month Fixed Treatment Period||19
5156105|NCT01277302|12681514|P2|COMPLETED|7-Month Fixed Treatment Period||86
5156106|NCT01277302|12681515|P1|COMPLETED|7-Month Fixed Treatment Period||85
5156107|NCT01277302|12681513|P3|STARTED|7-Month Fixed Treatment Period||31
5156108|NCT01277302|12681514|P2|STARTED|7-Month Fixed Treatment Period||86
5156109|NCT01277302|12681515|P1|STARTED|7-Month Fixed Treatment Period||85
5156110|NCT01277211|12681547|P2|NOT COMPLETED|Overall Study||63
5156111|NCT01277211|12681548|P1|NOT COMPLETED|Overall Study||150
5156112|NCT01277211|12681547|P2|COMPLETED|Overall Study||182
5156113|NCT01277211|12681548|P1|COMPLETED|Overall Study||588
5156114|NCT01277211|12681547|P2|Treated|Overall Study||232
5156115|NCT01277211|12681548|P1|Treated|Overall Study||714
5156116|NCT01277211|12681547|P2|STARTED|Overall Study||245
5156117|NCT01277211|12681548|P1|STARTED|Overall Study||738
5156118|NCT01277159|12681563|P5|NOT COMPLETED|Overall Study||5
5156119|NCT01277159|12681564|P4|NOT COMPLETED|Overall Study||3
5156120|NCT01277159|12681565|P3|NOT COMPLETED|Overall Study||3
5156121|NCT01277159|12681566|P2|NOT COMPLETED|Overall Study||1
5156122|NCT01277159|12681567|P1|NOT COMPLETED|Overall Study||4
5156123|NCT01277159|12681563|P5|COMPLETED|Overall Study||16
5156124|NCT01277159|12681564|P4|COMPLETED|Overall Study||19
5156125|NCT01277159|12681565|P3|COMPLETED|Overall Study||19
5156126|NCT01277159|12681566|P2|COMPLETED|Overall Study||21
5156127|NCT01277159|12681567|P1|COMPLETED|Overall Study||17
5156128|NCT01277159|12681563|P5|STARTED|Overall Study||21
5156129|NCT01277159|12681564|P4|STARTED|Overall Study||22
5156130|NCT01277159|12681565|P3|STARTED|Overall Study||22
5156131|NCT01277159|12681566|P2|STARTED|Overall Study||22
5156132|NCT01277159|12681567|P1|STARTED|Overall Study||21
5156133|NCT01277081|12681581|P2|NOT COMPLETED|Overall Study||0
5156134|NCT01277081|12681582|P1|NOT COMPLETED|Overall Study||0
5156135|NCT01277081|12681581|P2|COMPLETED|Overall Study||100
5156136|NCT01277081|12681582|P1|COMPLETED|Overall Study||100
5156137|NCT01277081|12681581|P2|STARTED|Overall Study||100
5156138|NCT01277081|12681582|P1|STARTED|Overall Study||100
5156139|NCT01277042|12681600|P2|NOT COMPLETED|Overall Study||5
5156140|NCT01277042|12681601|P1|NOT COMPLETED|Overall Study||8
5156141|NCT01277042|12681600|P2|COMPLETED|Overall Study||601
5156142|NCT01277042|12681601|P1|COMPLETED|Overall Study||598
5156143|NCT01277042|12681600|P2|STARTED|Overall Study||606
5156144|NCT01277042|12681601|P1|STARTED|Overall Study||606
5156145|NCT01276860|12681625|P2|NOT COMPLETED|Overall Study||0
5156146|NCT01276860|12681626|P1|NOT COMPLETED|Overall Study||0
5156147|NCT01276860|12681625|P2|COMPLETED|Overall Study||2
5156148|NCT01276860|12681626|P1|COMPLETED|Overall Study||5
5156149|NCT01276860|12681625|P2|STARTED|Overall Study||2
5156150|NCT01276860|12681626|P1|STARTED|Overall Study||5
5156151|NCT01276847|12681637|P3|NOT COMPLETED|Overall Study||0
5156152|NCT01276847|12681638|P2|NOT COMPLETED|Overall Study||0
5156153|NCT01276847|12681639|P1|NOT COMPLETED|Overall Study||1
5156154|NCT01276847|12681637|P3|COMPLETED|Overall Study||20
5156155|NCT01276847|12681638|P2|COMPLETED|Overall Study||10
5156156|NCT01276847|12681639|P1|COMPLETED|Overall Study||9
5156157|NCT01276847|12681637|P3|STARTED|Overall Study||20
5156158|NCT01276847|12681638|P2|STARTED|Overall Study||10
5156159|NCT01276847|12681639|P1|STARTED|Overall Study||10
5156160|NCT01276821|12681649|P2|NOT COMPLETED|Overall Study||1
5156161|NCT01276821|12681650|P1|NOT COMPLETED|Overall Study||0
5156162|NCT01276821|12681649|P2|COMPLETED|Overall Study||49
5156163|NCT01276821|12681650|P1|COMPLETED|Overall Study||50
5156164|NCT01276821|12681649|P2|STARTED|Overall Study||50
5156165|NCT01276821|12681650|P1|STARTED|Overall Study||50
5156166|NCT01276756|12681670|P2|NOT COMPLETED|Overall Study||2
5156167|NCT01276756|12681671|P1|NOT COMPLETED|Overall Study||5
5156168|NCT01276756|12681670|P2|COMPLETED|Overall Study||48
5156169|NCT01276756|12681671|P1|COMPLETED|Overall Study||45
5156170|NCT01276756|12681670|P2|STARTED|Overall Study||50
5156171|NCT01276756|12681671|P1|STARTED|Overall Study||50
5156172|NCT01276652|12681688|P3|NOT COMPLETED|Period 2: Observational||0
5156173|NCT01276652|12681689|P2|NOT COMPLETED|Period 2: Observational||0
5156174|NCT01276652|12681690|P1|NOT COMPLETED|Period 2: Observational||0
5156175|NCT01276652|12681688|P3|COMPLETED|Period 2: Observational||5
5156176|NCT01276652|12681689|P2|COMPLETED|Period 2: Observational||8
5156177|NCT01276652|12681690|P1|COMPLETED|Period 2: Observational||9
5156178|NCT01276652|12681688|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
5156179|NCT01276652|12681689|P2|STARTED|Period 2: Observational||8
5156180|NCT01276652|12681690|P1|STARTED|Period 2: Observational||9
5156181|NCT01276652|12681688|P3|NOT COMPLETED|Period 1: Randomization||0
5156182|NCT01276652|12681689|P2|NOT COMPLETED|Period 1: Randomization||0
5156183|NCT01276652|12681690|P1|NOT COMPLETED|Period 1: Randomization||0
5156184|NCT01276652|12681688|P3|COMPLETED|Period 1: Randomization||0
5156185|NCT01276652|12681689|P2|COMPLETED|Period 1: Randomization||8
5156186|NCT01276652|12681690|P1|COMPLETED|Period 1: Randomization||9
5156187|NCT01276652|12681688|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
5156188|NCT01276652|12681689|P2|STARTED|Period 1: Randomization||8
5156189|NCT01276652|12681690|P1|STARTED|Period 1: Randomization||9
5156190|NCT01276639|12681716|P5|NOT COMPLETED|Week 16 to 52||21
5156191|NCT01276639|12681717|P4|NOT COMPLETED|Week 16 to 52||16
5156192|NCT01276639|12681718|P3|NOT COMPLETED|Week 16 to 52||0
5156193|NCT01276639|12681719|P2|NOT COMPLETED|Week 16 to 52||101
5156194|NCT01276639|12681720|P1|NOT COMPLETED|Week 16 to 52||127
5156195|NCT01276639|12681716|P5|COMPLETED|Week 16 to 52||45
5156196|NCT01276639|12681717|P4|COMPLETED|Week 16 to 52||50
5156197|NCT01276639|12681718|P3|COMPLETED|Week 16 to 52||0
5156198|NCT01276639|12681719|P2|COMPLETED|Week 16 to 52||219
5156199|NCT01276639|12681720|P1|COMPLETED|Week 16 to 52||186
5156200|NCT01276639|12681716|P5|STARTED|Week 16 to 52||66
5156201|NCT01276639|12681717|P4|STARTED|Week 16 to 52||66
5156202|NCT01276639|12681718|P3|STARTED|Week 16 to 52||0
5156203|NCT01276639|12681719|P2|STARTED|Week 16 to 52||320
5156204|NCT01276639|12681720|P1|STARTED|Week 16 to 52||313
5156205|NCT01276639|12681716|P5|NOT COMPLETED|Week 0 to 16||0
5156206|NCT01276639|12681717|P4|NOT COMPLETED|Week 0 to 16||0
5156207|NCT01276639|12681718|P3|NOT COMPLETED|Week 0 to 16||45
5156208|NCT01276639|12681719|P2|NOT COMPLETED|Week 0 to 16||41
5156209|NCT01276639|12681720|P1|NOT COMPLETED|Week 0 to 16||50
5156210|NCT01276639|12681716|P5|COMPLETED|Week 0 to 16||0
5156211|NCT01276639|12681717|P4|COMPLETED|Week 0 to 16||0
5156212|NCT01276639|12681718|P3|COMPLETED|Week 0 to 16||132
5156213|NCT01276639|12681719|P2|COMPLETED|Week 0 to 16||320
5156214|NCT01276639|12681720|P1|COMPLETED|Week 0 to 16||313
5156215|NCT01276639|12681716|P5|Treated|Week 0 to 16||0
5156216|NCT01276639|12681717|P4|Treated|Week 0 to 16||0
5156217|NCT01276639|12681718|P3|Treated|Week 0 to 16||177
5156218|NCT01276639|12681719|P2|Treated|Week 0 to 16||360
5156219|NCT01276639|12681720|P1|Treated|Week 0 to 16||363
5156220|NCT01276639|12681716|P5|STARTED|Week 0 to 16||0
5156221|NCT01276639|12681717|P4|STARTED|Week 0 to 16||0
5156222|NCT01276639|12681718|P3|STARTED|Week 0 to 16||177
5156223|NCT01276639|12681719|P2|STARTED|Week 0 to 16||361
5156224|NCT01276639|12681720|P1|STARTED|Week 0 to 16||363
5156225|NCT01276535|12681915|P1|NOT COMPLETED|Overall Study||0
5156226|NCT01276535|12681915|P1|COMPLETED|Overall Study||12
5156227|NCT01276535|12681915|P1|STARTED|Overall Study||12
5156228|NCT01276509|12681925|P4|NOT COMPLETED|Overall Study||5
5156229|NCT01276509|12681926|P3|NOT COMPLETED|Overall Study||5
5156230|NCT01276509|12681927|P2|NOT COMPLETED|Overall Study||12
5156231|NCT01276509|12681928|P1|NOT COMPLETED|Overall Study||13
5156232|NCT01276509|12681925|P4|COMPLETED|Overall Study||58
5156233|NCT01276509|12681926|P3|COMPLETED|Overall Study||63
5156234|NCT01276509|12681927|P2|COMPLETED|Overall Study||53
5156235|NCT01276509|12681928|P1|COMPLETED|Overall Study||53
5156236|NCT01276509|12681925|P4|STARTED|Overall Study||63
5156237|NCT01276509|12681926|P3|STARTED|Overall Study||68
5156238|NCT01276509|12681927|P2|STARTED|Overall Study||65
5156239|NCT01276509|12681928|P1|STARTED|Overall Study||66
5156240|NCT01276457|12681981|P2|NOT COMPLETED|Extension Study||2
5156241|NCT01276457|12681982|P1|NOT COMPLETED|Extension Study||6
5156242|NCT01276457|12681981|P2|COMPLETED|Extension Study||110
5156243|NCT01276457|12681982|P1|COMPLETED|Extension Study||105
5156244|NCT01276457|12681981|P2|STARTED|Extension Study||112
5156245|NCT01276457|12681982|P1|STARTED|Extension Study||111
5156246|NCT01276457|12681981|P2|NOT COMPLETED|Core Study||20
5156247|NCT01276457|12681982|P1|NOT COMPLETED|Core Study||13
5156248|NCT01276457|12681981|P2|COMPLETED|Core Study||123
5156249|NCT01276457|12681982|P1|COMPLETED|Core Study||129
5156250|NCT01276457|12681981|P2|STARTED|Core Study||143
5156251|NCT01276457|12681982|P1|STARTED|Core Study||142
5156252|NCT01276353|12681996|P2|NOT COMPLETED|Extension||9
5156253|NCT01276353|12681997|P1|NOT COMPLETED|Extension||7
5156254|NCT01276353|12681996|P2|COMPLETED|Extension||14
5156255|NCT01276353|12681997|P1|COMPLETED|Extension||12
5156256|NCT01276353|12681996|P2|STARTED|Extension||23
5156257|NCT01276353|12681997|P1|STARTED|Extension||19
5156258|NCT01276353|12681996|P2|NOT COMPLETED|Double-blind||0
5156259|NCT01276353|12681997|P1|NOT COMPLETED|Double-blind||3
5156260|NCT01276353|12681996|P2|COMPLETED|Double-blind||23
5156261|NCT01276353|12681997|P1|COMPLETED|Double-blind||19
5156262|NCT01276353|12681996|P2|STARTED|Double-blind||23
5156263|NCT01276353|12681997|P1|STARTED|Double-blind||22
5156264|NCT01276327|12682009|P2|NOT COMPLETED|Overall Study||3
5156265|NCT01276327|12682010|P1|NOT COMPLETED|Overall Study||2
5156266|NCT01276327|12682009|P2|COMPLETED|Overall Study||29
5156267|NCT01276327|12682010|P1|COMPLETED|Overall Study||30
5156268|NCT01276327|12682009|P2|STARTED|Overall Study||32
5156269|NCT01276327|12682010|P1|STARTED|Overall Study||32
5156270|NCT01276314|12682036|P4|NOT COMPLETED|Overall Study||5
5156271|NCT01276314|12682037|P3|NOT COMPLETED|Overall Study||4
5156272|NCT01276314|12682038|P2|NOT COMPLETED|Overall Study||10
5156273|NCT01276314|12682039|P1|NOT COMPLETED|Overall Study||10
5156274|NCT01276314|12682036|P4|COMPLETED|Overall Study||17
5156275|NCT01276314|12682037|P3|COMPLETED|Overall Study||18
5156276|NCT01276314|12682038|P2|COMPLETED|Overall Study||33
5156277|NCT01276314|12682039|P1|COMPLETED|Overall Study||38
5156278|NCT01276314|12682036|P4|STARTED|Overall Study||22
5156279|NCT01276314|12682037|P3|STARTED|Overall Study||22
5156280|NCT01276314|12682038|P2|STARTED|Overall Study||43
5156281|NCT01276314|12682039|P1|STARTED|Overall Study||48
5156282|NCT01276301|12682049|P2|NOT COMPLETED|Second Intervention||0
5156283|NCT01276301|12682050|P1|NOT COMPLETED|Second Intervention||0
5156284|NCT01276301|12682049|P2|COMPLETED|Second Intervention||8
5156285|NCT01276301|12682050|P1|COMPLETED|Second Intervention||8
5156286|NCT01276301|12682049|P2|STARTED|Second Intervention||8
5156287|NCT01276301|12682050|P1|STARTED|Second Intervention||8
5156288|NCT01276301|12682049|P2|NOT COMPLETED|Washout Period of 7 Days||0
5156289|NCT01276301|12682050|P1|NOT COMPLETED|Washout Period of 7 Days||0
5156290|NCT01276301|12682049|P2|COMPLETED|Washout Period of 7 Days||8
5156291|NCT01276301|12682050|P1|COMPLETED|Washout Period of 7 Days||8
5156292|NCT01276301|12682049|P2|STARTED|Washout Period of 7 Days||8
5156293|NCT01276301|12682050|P1|STARTED|Washout Period of 7 Days||8
5156294|NCT01276301|12682049|P2|NOT COMPLETED|First Intervention||0
5156295|NCT01276301|12682050|P1|NOT COMPLETED|First Intervention||0
5156296|NCT01276301|12682049|P2|COMPLETED|First Intervention||8
5156297|NCT01276301|12682050|P1|COMPLETED|First Intervention||8
5156298|NCT01276301|12682049|P2|STARTED|First Intervention||8
5156299|NCT01276301|12682050|P1|STARTED|First Intervention||8
5156300|NCT01276288|12682077|P4|NOT COMPLETED|Overall Study||0
5156301|NCT01276288|12682078|P3|NOT COMPLETED|Overall Study||0
5156302|NCT01276288|12682079|P2|NOT COMPLETED|Overall Study||1
5156303|NCT01276288|12682080|P1|NOT COMPLETED|Overall Study||2
5156304|NCT01276288|12682077|P4|COMPLETED|Overall Study||5
5156305|NCT01276288|12682078|P3|COMPLETED|Overall Study||5
5156306|NCT01276288|12682079|P2|COMPLETED|Overall Study||5
5156307|NCT01276288|12682080|P1|COMPLETED|Overall Study||5
5156308|NCT01276288|12682077|P4|Received EMPA+TOR|Overall Study||5
5156309|NCT01276288|12682078|P3|Received EMPA+TOR|Overall Study||5
5156310|NCT01276288|12682079|P2|Received EMPA+TOR|Overall Study||0
5156311|NCT01276288|12682080|P1|Received EMPA+TOR|Overall Study||0
5156312|NCT01276288|12682077|P4|Received EMPA+HCT|Overall Study||0
5156313|NCT01276288|12682078|P3|Received EMPA+HCT|Overall Study||0
5156314|NCT01276288|12682079|P2|Received EMPA+HCT|Overall Study||5
5156315|NCT01276288|12682080|P1|Received EMPA+HCT|Overall Study||5
5156316|NCT01276288|12682077|P4|Received EMPA|Overall Study||5
5156317|NCT01276288|12682078|P3|Received EMPA|Overall Study||5
5156318|NCT01276288|12682079|P2|Received EMPA|Overall Study||5
5156319|NCT01276288|12682080|P1|Received EMPA|Overall Study||6
5156320|NCT01276288|12682077|P4|STARTED|Overall Study||5
5156321|NCT01276288|12682078|P3|STARTED|Overall Study||5
5156322|NCT01276288|12682079|P2|STARTED|Overall Study||6
5156323|NCT01276288|12682080|P1|STARTED|Overall Study||7
5156324|NCT01276223|12682207|P3|NOT COMPLETED|Overall Study||3
5156325|NCT01276223|12682208|P2|NOT COMPLETED|Overall Study||4
5156326|NCT01276223|12682209|P1|NOT COMPLETED|Overall Study||11
5156327|NCT01276223|12682207|P3|COMPLETED|Overall Study||101
5156328|NCT01276223|12682208|P2|COMPLETED|Overall Study||103
5156329|NCT01276223|12682209|P1|COMPLETED|Overall Study||67
5156330|NCT01276223|12682207|P3|STARTED|Overall Study||104
5156331|NCT01276223|12682208|P2|STARTED|Overall Study||107
5156332|NCT01276223|12682209|P1|STARTED|Overall Study||78
5156333|NCT01276197|12682218|P2|NOT COMPLETED|Overall Study||110
5156334|NCT01276197|12682219|P1|NOT COMPLETED|Overall Study||108
5156335|NCT01276197|12682218|P2|COMPLETED|Overall Study||200
5156336|NCT01276197|12682219|P1|COMPLETED|Overall Study||200
5156337|NCT01276197|12682218|P2|STARTED|Overall Study||310
5156338|NCT01276197|12682219|P1|STARTED|Overall Study||308
5156339|NCT01276171|12682230|P3|NOT COMPLETED|Overall Study||0
5156340|NCT01276171|12682231|P2|NOT COMPLETED|Overall Study||0
5156341|NCT01276171|12682232|P1|NOT COMPLETED|Overall Study||0
5156342|NCT01276171|12682230|P3|COMPLETED|Overall Study||256
5156343|NCT01276171|12682231|P2|COMPLETED|Overall Study||244
5156344|NCT01276171|12682232|P1|COMPLETED|Overall Study||249
5156345|NCT01276171|12682230|P3|STARTED|Overall Study||256
5156346|NCT01276171|12682231|P2|STARTED|Overall Study||244
5156347|NCT01276171|12682232|P1|STARTED|Overall Study||249
5156348|NCT01276106|12682250|P4|NOT COMPLETED|Overall Study||13
5156349|NCT01276106|12682251|P3|NOT COMPLETED|Overall Study||16
5156350|NCT01276106|12682252|P2|NOT COMPLETED|Overall Study||9
5156351|NCT01276106|12682253|P1|NOT COMPLETED|Overall Study||12
5156352|NCT01276106|12682250|P4|COMPLETED|Overall Study||52
5156353|NCT01276106|12682251|P3|COMPLETED|Overall Study||49
5156354|NCT01276106|12682252|P2|COMPLETED|Overall Study||55
5156355|NCT01276106|12682253|P1|COMPLETED|Overall Study||53
5156356|NCT01276106|12682250|P4|STARTED|Overall Study||65
5156357|NCT01276106|12682251|P3|STARTED|Overall Study||65
5156358|NCT01276106|12682252|P2|STARTED|Overall Study||64
5156359|NCT01276106|12682253|P1|STARTED|Overall Study||65
5156360|NCT01276054|12682265|P2|NOT COMPLETED|Overall Study||2
5156361|NCT01276054|12682266|P1|NOT COMPLETED|Overall Study||2
5156362|NCT01276054|12682265|P2|COMPLETED|Overall Study||0
5156363|NCT01276054|12682266|P1|COMPLETED|Overall Study||0
5156364|NCT01276054|12682265|P2|STARTED|Overall Study||2
5156365|NCT01276054|12682266|P1|STARTED|Overall Study||2
5156366|NCT01275833|12682274|P2|NOT COMPLETED|Overall Study||1
5156367|NCT01275833|12682275|P1|NOT COMPLETED|Overall Study||1
5156368|NCT01275833|12682274|P2|COMPLETED|Overall Study||0
5156369|NCT01275833|12682275|P1|COMPLETED|Overall Study||0
5156370|NCT01275833|12682274|P2|STARTED|Overall Study||1
5156371|NCT01275833|12682275|P1|STARTED|Overall Study||1
5156372|NCT01275755|12682283|P2|NOT COMPLETED|Run-out Placebo Period||0
5156373|NCT01275755|12682284|P1|NOT COMPLETED|Run-out Placebo Period||1
5156374|NCT01275755|12682283|P2|COMPLETED|Run-out Placebo Period||37
5156375|NCT01275755|12682284|P1|COMPLETED|Run-out Placebo Period||38
5156376|NCT01275755|12682283|P2|STARTED|Run-out Placebo Period||37
5156377|NCT01275755|12682284|P1|STARTED|Run-out Placebo Period||39
5156378|NCT01275755|12682283|P2|NOT COMPLETED|Double-blind Treatment Period||3
5156379|NCT01275755|12682284|P1|NOT COMPLETED|Double-blind Treatment Period||2
5156380|NCT01275755|12682283|P2|COMPLETED|Double-blind Treatment Period||37
5156381|NCT01275755|12682284|P1|COMPLETED|Double-blind Treatment Period||39
5156382|NCT01275755|12682283|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
5156383|NCT01275755|12682284|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
5156384|NCT01275755|12682283|P2|STARTED|Double-blind Treatment Period||40
5156385|NCT01275755|12682284|P1|STARTED|Double-blind Treatment Period||41
5156386|NCT01275755|12682283|P2|NOT COMPLETED|Run-in Placebo Period||0
5156387|NCT01275755|12682284|P1|NOT COMPLETED|Run-in Placebo Period||0
5156388|NCT01275755|12682283|P2|COMPLETED|Run-in Placebo Period||40
5156389|NCT01275755|12682284|P1|COMPLETED|Run-in Placebo Period||41
5156390|NCT01275755|12682283|P2|STARTED|Run-in Placebo Period||40
5156391|NCT01275755|12682284|P1|STARTED|Run-in Placebo Period||41
5156392|NCT01275664|12682290|P1|NOT COMPLETED|Overall Study||0
5156393|NCT01275664|12682290|P1|COMPLETED|Overall Study||4
5156394|NCT01275664|12682290|P1|STARTED|Overall Study||4
5156395|NCT01275625|12682298|P1|NOT COMPLETED|Overall Study||13
5156396|NCT01275625|12682298|P1|COMPLETED|Overall Study||64
5156397|NCT01275625|12682298|P1|Treated|Overall Study||77
5156398|NCT01275625|12682298|P1|STARTED|Overall Study||77
5156399|NCT01275586|12682312|P1|NOT COMPLETED|Overall Study||3
5156400|NCT01275586|12682312|P1|COMPLETED|Overall Study||3
5156401|NCT01275586|12682312|P1|STARTED|Overall Study||6
5156402|NCT01275430|12682316|P1|NOT COMPLETED|Overall Study||9
5156403|NCT01275430|12682316|P1|COMPLETED|Overall Study||18
5156404|NCT01275430|12682316|P1|STARTED|Overall Study||27
5156405|NCT01275365|12682328|P4|NOT COMPLETED|Overall Study||3
5156406|NCT01275365|12682329|P3|NOT COMPLETED|Overall Study||5
5156407|NCT01275365|12682330|P2|NOT COMPLETED|Overall Study||3
5156408|NCT01275365|12682331|P1|NOT COMPLETED|Overall Study||3
5156409|NCT01275365|12682328|P4|COMPLETED|Overall Study||19
5156410|NCT01275365|12682329|P3|COMPLETED|Overall Study||17
5156411|NCT01275365|12682330|P2|COMPLETED|Overall Study||21
5156412|NCT01275365|12682331|P1|COMPLETED|Overall Study||21
5156413|NCT01275365|12682328|P4|STARTED|Overall Study||22
5156414|NCT01275365|12682329|P3|STARTED|Overall Study||22
5156415|NCT01275365|12682330|P2|STARTED|Overall Study||24
5156416|NCT01275365|12682331|P1|STARTED|Overall Study||24
5156417|NCT01275339|12682381|P4|NOT COMPLETED|Overall Study||0
5156418|NCT01275339|12682382|P3|NOT COMPLETED|Overall Study||1
5156419|NCT01275339|12682383|P2|NOT COMPLETED|Overall Study||0
5156420|NCT01275339|12682384|P1|NOT COMPLETED|Overall Study||1
5156421|NCT01275339|12682381|P4|COMPLETED|Overall Study||4
5156422|NCT01275339|12682382|P3|COMPLETED|Overall Study||3
5156423|NCT01275339|12682383|P2|COMPLETED|Overall Study||0
5156424|NCT01275339|12682384|P1|COMPLETED|Overall Study||1
5156425|NCT01275339|12682381|P4|STARTED|Overall Study||4
5156426|NCT01275339|12682382|P3|STARTED|Overall Study||4
5156427|NCT01275339|12682383|P2|STARTED|Overall Study||0
5156428|NCT01275339|12682384|P1|STARTED|Overall Study||2
5156429|NCT01275313|12682396|P2|NOT COMPLETED|Overall Study||52
5156430|NCT01275313|12682397|P1|NOT COMPLETED|Overall Study||25
5156431|NCT01275313|12682396|P2|COMPLETED|Overall Study||79
5156432|NCT01275313|12682397|P1|COMPLETED|Overall Study||102
5156433|NCT01275313|12682396|P2|STARTED|Overall Study||131
5156434|NCT01275313|12682397|P1|STARTED|Overall Study||127
5156435|NCT01275300|12682403|P2|NOT COMPLETED|Phase 2: Open-label 6days)||0
5156436|NCT01275300|12682404|P1|NOT COMPLETED|Phase 2: Open-label 6days)||0
5156437|NCT01275300|12682403|P2|COMPLETED|Phase 2: Open-label 6days)||4
5156438|NCT01275300|12682404|P1|COMPLETED|Phase 2: Open-label 6days)||5
5156439|NCT01275300|12682403|P2|STARTED|Phase 2: Open-label 6days)||4
5156440|NCT01275300|12682404|P1|STARTED|Phase 2: Open-label 6days)||5
5156441|NCT01275300|12682403|P2|NOT COMPLETED|Washout (14 Days)||0
5156442|NCT01275300|12682404|P1|NOT COMPLETED|Washout (14 Days)||0
5156443|NCT01275300|12682403|P2|COMPLETED|Washout (14 Days)||4
5156444|NCT01275300|12682404|P1|COMPLETED|Washout (14 Days)||5
5156445|NCT01275300|12682403|P2|STARTED|Washout (14 Days)||4
5156446|NCT01275300|12682404|P1|STARTED|Washout (14 Days)||5
5156447|NCT01275300|12682403|P2|NOT COMPLETED|2nd Intervention(5 Days)||0
5156448|NCT01275300|12682404|P1|NOT COMPLETED|2nd Intervention(5 Days)||0
5156449|NCT01275300|12682403|P2|COMPLETED|2nd Intervention(5 Days)||4
5156450|NCT01275300|12682404|P1|COMPLETED|2nd Intervention(5 Days)||5
5156451|NCT01275300|12682403|P2|STARTED|2nd Intervention(5 Days)||4
5156452|NCT01275300|12682404|P1|STARTED|2nd Intervention(5 Days)||5
5156453|NCT01275300|12682403|P2|NOT COMPLETED|Washout (14 Days)||0
5156454|NCT01275300|12682404|P1|NOT COMPLETED|Washout (14 Days)||0
5156455|NCT01275300|12682403|P2|COMPLETED|Washout (14 Days)||4
5156456|NCT01275300|12682404|P1|COMPLETED|Washout (14 Days)||5
5156457|NCT01275300|12682403|P2|STARTED|Washout (14 Days)||4
5156458|NCT01275300|12682404|P1|STARTED|Washout (14 Days)||5
5156459|NCT01275300|12682403|P2|NOT COMPLETED|1st Intervention (5 Days)||0
5156460|NCT01275300|12682404|P1|NOT COMPLETED|1st Intervention (5 Days)||0
5156461|NCT01275300|12682403|P2|COMPLETED|1st Intervention (5 Days)||4
5156462|NCT01275300|12682404|P1|COMPLETED|1st Intervention (5 Days)||5
5156463|NCT01275300|12682403|P2|STARTED|1st Intervention (5 Days)||4
5156464|NCT01275300|12682404|P1|STARTED|1st Intervention (5 Days)||5
5156465|NCT01275196|12682412|P2|NOT COMPLETED|Overall Study||21
5156466|NCT01275196|12682413|P1|NOT COMPLETED|Overall Study||20
5156467|NCT01275196|12682412|P2|COMPLETED|Overall Study||113
5156468|NCT01275196|12682413|P1|COMPLETED|Overall Study||113
5156469|NCT01275196|12682412|P2|Intended to Continue Into Extension|Overall Study||113
5156470|NCT01275196|12682413|P1|Intended to Continue Into Extension|Overall Study||112
5156471|NCT01275196|12682412|P2|STARTED|Overall Study||134
5156472|NCT01275196|12682413|P1|STARTED|Overall Study||133
5156473|NCT01275170|12682460|P8|NOT COMPLETED|Part 2: Period 2||0
5156474|NCT01275170|12682461|P7|NOT COMPLETED|Part 2: Period 2||0
5156475|NCT01275170|12682462|P6|NOT COMPLETED|Part 2: Period 2||0
5156476|NCT01275170|12682463|P5|NOT COMPLETED|Part 2: Period 2||0
5156477|NCT01275170|12682464|P4|NOT COMPLETED|Part 2: Period 2||0
5156478|NCT01275170|12682465|P3|NOT COMPLETED|Part 2: Period 2||0
5156479|NCT01275170|12682466|P2|NOT COMPLETED|Part 2: Period 2||0
5156480|NCT01275170|12682467|P1|NOT COMPLETED|Part 2: Period 2||0
5156481|NCT01275170|12682460|P8|COMPLETED|Part 2: Period 2||6
5156482|NCT01275170|12682461|P7|COMPLETED|Part 2: Period 2||6
5156483|NCT01275170|12682462|P6|COMPLETED|Part 2: Period 2||0
5156484|NCT01275170|12682463|P5|COMPLETED|Part 2: Period 2||0
5156485|NCT01275170|12682464|P4|COMPLETED|Part 2: Period 2||0
5156486|NCT01275170|12682465|P3|COMPLETED|Part 2: Period 2||0
5156487|NCT01275170|12682466|P2|COMPLETED|Part 2: Period 2||0
5156488|NCT01275170|12682467|P1|COMPLETED|Part 2: Period 2||0
5156489|NCT01275170|12682460|P8|STARTED|Part 2: Period 2||6
5156490|NCT01275170|12682461|P7|STARTED|Part 2: Period 2||6
5156491|NCT01275170|12682462|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
5156492|NCT01275170|12682463|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
5156493|NCT01275170|12682464|P4|STARTED|Part 2: Period 2||0
5156494|NCT01275170|12682465|P3|STARTED|Part 2: Period 2||0
5156495|NCT01275170|12682466|P2|STARTED|Part 2: Period 2||0
5156496|NCT01275170|12682467|P1|STARTED|Part 2: Period 2||0
5156497|NCT01275170|12682460|P8|NOT COMPLETED|Part 2: Period 1||0
5156498|NCT01275170|12682461|P7|NOT COMPLETED|Part 2: Period 1||0
5156499|NCT01275170|12682462|P6|NOT COMPLETED|Part 2: Period 1||0
5156500|NCT01275170|12682463|P5|NOT COMPLETED|Part 2: Period 1||0
5156501|NCT01275170|12682464|P4|NOT COMPLETED|Part 2: Period 1||0
5156502|NCT01275170|12682465|P3|NOT COMPLETED|Part 2: Period 1||0
5156503|NCT01275170|12682466|P2|NOT COMPLETED|Part 2: Period 1||0
5156504|NCT01275170|12682467|P1|NOT COMPLETED|Part 2: Period 1||0
5156505|NCT01275170|12682460|P8|COMPLETED|Part 2: Period 1||6
5156506|NCT01275170|12682461|P7|COMPLETED|Part 2: Period 1||6
5156507|NCT01275170|12682462|P6|COMPLETED|Part 2: Period 1||6
5156508|NCT01275170|12682463|P5|COMPLETED|Part 2: Period 1||6
5156509|NCT01275170|12682464|P4|COMPLETED|Part 2: Period 1||0
5156510|NCT01275170|12682465|P3|COMPLETED|Part 2: Period 1||0
5156511|NCT01275170|12682466|P2|COMPLETED|Part 2: Period 1||0
5156512|NCT01275170|12682467|P1|COMPLETED|Part 2: Period 1||0
5156513|NCT01275170|12682460|P8|STARTED|Part 2: Period 1||6
5156514|NCT01275170|12682461|P7|STARTED|Part 2: Period 1||6
5156515|NCT01275170|12682462|P6|STARTED|Part 2: Period 1||6
5156516|NCT01275170|12682463|P5|STARTED|Part 2: Period 1||6
5156517|NCT01275170|12682464|P4|STARTED|Part 2: Period 1||0
5156518|NCT01275170|12682465|P3|STARTED|Part 2: Period 1||0
5156519|NCT01275170|12682466|P2|STARTED|Part 2: Period 1||0
5156520|NCT01275170|12682467|P1|STARTED|Part 2: Period 1||0
5156521|NCT01275170|12682460|P8|NOT COMPLETED|Part 1: Period 2||0
5156522|NCT01275170|12682461|P7|NOT COMPLETED|Part 1: Period 2||0
5156523|NCT01275170|12682462|P6|NOT COMPLETED|Part 1: Period 2||0
5156524|NCT01275170|12682463|P5|NOT COMPLETED|Part 1: Period 2||0
5156525|NCT01275170|12682464|P4|NOT COMPLETED|Part 1: Period 2||0
5156526|NCT01275170|12682465|P3|NOT COMPLETED|Part 1: Period 2||0
5156527|NCT01275170|12682466|P2|NOT COMPLETED|Part 1: Period 2||0
5156528|NCT01275170|12682467|P1|NOT COMPLETED|Part 1: Period 2||0
5156529|NCT01275170|12682460|P8|COMPLETED|Part 1: Period 2||6
5156530|NCT01275170|12682461|P7|COMPLETED|Part 1: Period 2||6
5156531|NCT01275170|12682462|P6|COMPLETED|Part 1: Period 2||0
5156532|NCT01275170|12682463|P5|COMPLETED|Part 1: Period 2||0
5156533|NCT01275170|12682464|P4|COMPLETED|Part 1: Period 2||0
5156534|NCT01275170|12682465|P3|COMPLETED|Part 1: Period 2||0
5156535|NCT01275170|12682466|P2|COMPLETED|Part 1: Period 2||0
5156536|NCT01275170|12682467|P1|COMPLETED|Part 1: Period 2||0
5156537|NCT01275170|12682460|P8|STARTED|Part 1: Period 2||6
5156538|NCT01275170|12682461|P7|STARTED|Part 1: Period 2||6
5156539|NCT01275170|12682462|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
5156540|NCT01275170|12682463|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
5156541|NCT01275170|12682464|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
5156542|NCT01275170|12682465|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
5156543|NCT01275170|12682466|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
5156544|NCT01275170|12682467|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
5156545|NCT01275170|12682460|P8|NOT COMPLETED|Part 1: Period 1||0
5156546|NCT01275170|12682461|P7|NOT COMPLETED|Part 1: Period 1||0
5156547|NCT01275170|12682462|P6|NOT COMPLETED|Part 1: Period 1||0
5156548|NCT01275170|12682463|P5|NOT COMPLETED|Part 1: Period 1||0
5156549|NCT01275170|12682464|P4|NOT COMPLETED|Part 1: Period 1||0
5156550|NCT01275170|12682465|P3|NOT COMPLETED|Part 1: Period 1||0
5156551|NCT01275170|12682466|P2|NOT COMPLETED|Part 1: Period 1||0
5156552|NCT01275170|12682467|P1|NOT COMPLETED|Part 1: Period 1||1
5156553|NCT01275170|12682460|P8|COMPLETED|Part 1: Period 1||6
5156554|NCT01275170|12682461|P7|COMPLETED|Part 1: Period 1||6
5156555|NCT01275170|12682462|P6|COMPLETED|Part 1: Period 1||6
5156556|NCT01275170|12682463|P5|COMPLETED|Part 1: Period 1||6
5156557|NCT01275170|12682464|P4|COMPLETED|Part 1: Period 1||6
5156558|NCT01275170|12682465|P3|COMPLETED|Part 1: Period 1||6
5156559|NCT01275170|12682466|P2|COMPLETED|Part 1: Period 1||6
5156560|NCT01275170|12682467|P1|COMPLETED|Part 1: Period 1||6
5156561|NCT01275170|12682460|P8|Treated|Part 1: Period 1||6
5156562|NCT01275170|12682461|P7|Treated|Part 1: Period 1||6
5156563|NCT01275170|12682462|P6|Treated|Part 1: Period 1||6
5156564|NCT01275170|12682463|P5|Treated|Part 1: Period 1||6
5156565|NCT01275170|12682464|P4|Treated|Part 1: Period 1||6
5156566|NCT01275170|12682465|P3|Treated|Part 1: Period 1||6
5156567|NCT01275170|12682466|P2|Treated|Part 1: Period 1||6
5156568|NCT01275170|12682467|P1|Treated|Part 1: Period 1||6
5156569|NCT01275170|12682460|P8|STARTED|Part 1: Period 1||6
5156570|NCT01275170|12682461|P7|STARTED|Part 1: Period 1||6
5156571|NCT01275170|12682462|P6|STARTED|Part 1: Period 1||6
5156572|NCT01275170|12682463|P5|STARTED|Part 1: Period 1||6
5156573|NCT01275170|12682464|P4|STARTED|Part 1: Period 1||6
5156574|NCT01275170|12682465|P3|STARTED|Part 1: Period 1||6
5156575|NCT01275170|12682466|P2|STARTED|Part 1: Period 1||6
5156576|NCT01275170|12682467|P1|STARTED|Part 1: Period 1||7
5156577|NCT01275144|12682685|P2|NOT COMPLETED|Second Intervention (6 Days)||0
5156578|NCT01275144|12682686|P1|NOT COMPLETED|Second Intervention (6 Days)||1
5156579|NCT01275144|12682685|P2|COMPLETED|Second Intervention (6 Days)||14
5156580|NCT01275144|12682686|P1|COMPLETED|Second Intervention (6 Days)||13
5156581|NCT01275144|12682685|P2|STARTED|Second Intervention (6 Days)||14
5156582|NCT01275144|12682686|P1|STARTED|Second Intervention (6 Days)||14
5156583|NCT01275144|12682685|P2|NOT COMPLETED|Washout (7 Days)||0
5156584|NCT01275144|12682686|P1|NOT COMPLETED|Washout (7 Days)||0
5156585|NCT01275144|12682685|P2|COMPLETED|Washout (7 Days)||14
5156586|NCT01275144|12682686|P1|COMPLETED|Washout (7 Days)||14
5156587|NCT01275144|12682685|P2|STARTED|Washout (7 Days)||14
5156588|NCT01275144|12682686|P1|STARTED|Washout (7 Days)||14
5156589|NCT01275144|12682685|P2|NOT COMPLETED|First Intervention (6 Days)||0
5156590|NCT01275144|12682686|P1|NOT COMPLETED|First Intervention (6 Days)||0
5156591|NCT01275144|12682685|P2|COMPLETED|First Intervention (6 Days)||14
5156592|NCT01275144|12682686|P1|COMPLETED|First Intervention (6 Days)||14
5156593|NCT01275144|12682685|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
5156594|NCT01275144|12682686|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
5156595|NCT01275144|12682685|P2|STARTED|First Intervention (6 Days)||14
5156596|NCT01275144|12682686|P1|STARTED|First Intervention (6 Days)||14
5156597|NCT01275131|12682744|P4|NOT COMPLETED|Period 2 (Crossover)||2
5156598|NCT01275131|12682745|P3|NOT COMPLETED|Period 2 (Crossover)||1
5156599|NCT01275131|12682746|P2|NOT COMPLETED|Period 2 (Crossover)||1
5156600|NCT01275131|12682747|P1|NOT COMPLETED|Period 2 (Crossover)||1
5156601|NCT01275131|12682744|P4|COMPLETED|Period 2 (Crossover)||8
5156602|NCT01275131|12682745|P3|COMPLETED|Period 2 (Crossover)||9
5156603|NCT01275131|12682746|P2|COMPLETED|Period 2 (Crossover)||8
5156604|NCT01275131|12682747|P1|COMPLETED|Period 2 (Crossover)||8
5156605|NCT01275131|12682744|P4|STARTED|Period 2 (Crossover)||10
5156606|NCT01275131|12682745|P3|STARTED|Period 2 (Crossover)||10
5156607|NCT01275131|12682746|P2|STARTED|Period 2 (Crossover)||9
5156608|NCT01275131|12682747|P1|STARTED|Period 2 (Crossover)||9
5156609|NCT01275131|12682744|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
5156610|NCT01275131|12682745|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
5156611|NCT01275131|12682746|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
5156612|NCT01275131|12682747|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
5156613|NCT01275131|12682744|P4|COMPLETED|5- to 14-Day Washout Period||10
5156614|NCT01275131|12682745|P3|COMPLETED|5- to 14-Day Washout Period||10
5156615|NCT01275131|12682746|P2|COMPLETED|5- to 14-Day Washout Period||9
5156616|NCT01275131|12682747|P1|COMPLETED|5- to 14-Day Washout Period||9
5156617|NCT01275131|12682744|P4|STARTED|5- to 14-Day Washout Period||10
5156618|NCT01275131|12682745|P3|STARTED|5- to 14-Day Washout Period||10
5156619|NCT01275131|12682746|P2|STARTED|5- to 14-Day Washout Period||9
5156620|NCT01275131|12682747|P1|STARTED|5- to 14-Day Washout Period||9
5156621|NCT01275131|12682744|P4|NOT COMPLETED|Period 1||2
5156622|NCT01275131|12682745|P3|NOT COMPLETED|Period 1||3
5156623|NCT01275131|12682746|P2|NOT COMPLETED|Period 1||0
5156624|NCT01275131|12682747|P1|NOT COMPLETED|Period 1||2
5156625|NCT01275131|12682744|P4|COMPLETED|Period 1||10
5156626|NCT01275131|12682745|P3|COMPLETED|Period 1||10
5156627|NCT01275131|12682746|P2|COMPLETED|Period 1||9
5156628|NCT01275131|12682747|P1|COMPLETED|Period 1||9
5156629|NCT01275131|12682744|P4|Received at Least One Dose of Study Drug|Period 1||12
5156630|NCT01275131|12682745|P3|Received at Least One Dose of Study Drug|Period 1||13
5156631|NCT01275131|12682746|P2|Received at Least One Dose of Study Drug|Period 1||9
5156632|NCT01275131|12682747|P1|Received at Least One Dose of Study Drug|Period 1||11
5156633|NCT01275131|12682744|P4|STARTED|Period 1||12
5156634|NCT01275131|12682745|P3|STARTED|Period 1||13
5156635|NCT01275131|12682746|P2|STARTED|Period 1||9
5156636|NCT01275131|12682747|P1|STARTED|Period 1||11
5156637|NCT01275092|12682781|P1|NOT COMPLETED|Overall Study||0
5156638|NCT01275092|12682781|P1|COMPLETED|Overall Study||164
5156639|NCT01275092|12682781|P1|STARTED|Overall Study||164
5156640|NCT01275066|12682790|P3|NOT COMPLETED|Overall Study||1
5156641|NCT01275066|12682791|P2|NOT COMPLETED|Overall Study||0
5156642|NCT01275066|12682792|P1|NOT COMPLETED|Overall Study||1
5156643|NCT01275066|12682790|P3|COMPLETED|Overall Study||57
5156644|NCT01275066|12682791|P2|COMPLETED|Overall Study||59
5156645|NCT01275066|12682792|P1|COMPLETED|Overall Study||59
5156646|NCT01275066|12682790|P3|Treated|Overall Study||58
5156647|NCT01275066|12682791|P2|Treated|Overall Study||59
5156648|NCT01275066|12682792|P1|Treated|Overall Study||59
5156649|NCT01275066|12682790|P3|STARTED|Overall Study||58
5156650|NCT01275066|12682791|P2|STARTED|Overall Study||59
5156651|NCT01275066|12682792|P1|STARTED|Overall Study||60
5156652|NCT01275053|12682806|P1|NOT COMPLETED|Overall Study||0
5156653|NCT01275053|12682806|P1|COMPLETED|Overall Study||12
5156654|NCT01275053|12682806|P1|STARTED|Overall Study||12
5156655|NCT01274897|12682812|P2|NOT COMPLETED|Overall Study||0
5156656|NCT01274897|12682813|P1|NOT COMPLETED|Overall Study||0
5156657|NCT01274897|12682812|P2|COMPLETED|Overall Study||153
5156658|NCT01274897|12682813|P1|COMPLETED|Overall Study||297
5156659|NCT01274897|12682812|P2|STARTED|Overall Study||153
5156660|NCT01274897|12682813|P1|STARTED|Overall Study||297
5156661|NCT01274715|12682825|P1|NOT COMPLETED|Overall Study||4
5156662|NCT01274715|12682825|P1|COMPLETED|Overall Study||8
5156663|NCT01274715|12682825|P1|Screened Out at Baseline|Overall Study||3
5156664|NCT01274715|12682825|P1|STARTED|Overall Study||12
5156665|NCT01274637|12682832|P2|NOT COMPLETED|Overall Study||2
5156666|NCT01274637|12682833|P1|NOT COMPLETED|Overall Study||0
5156667|NCT01274637|12682832|P2|COMPLETED|Overall Study||30
5156668|NCT01274637|12682833|P1|COMPLETED|Overall Study||30
5156669|NCT01274637|12682832|P2|STARTED|Overall Study||32
5156670|NCT01274637|12682833|P1|STARTED|Overall Study||30
5156671|NCT01274611|12682849|P1|NOT COMPLETED|Overall Study||0
5156672|NCT01274611|12682849|P1|COMPLETED|Overall Study||20
5156673|NCT01274611|12682849|P1|STARTED|Overall Study||20
5156674|NCT01274585|12682859|P2|NOT COMPLETED|Overall Study||0
5156675|NCT01274585|12682860|P1|NOT COMPLETED|Overall Study||0
5156676|NCT01274585|12682859|P2|COMPLETED|Overall Study||3
5156677|NCT01274585|12682860|P1|COMPLETED|Overall Study||2
5156678|NCT01274585|12682859|P2|STARTED|Overall Study||3
5156679|NCT01274585|12682860|P1|STARTED|Overall Study||2
5156680|NCT01274559|12682872|P2|NOT COMPLETED|Overall Study||145
5156681|NCT01274559|12682873|P1|NOT COMPLETED|Overall Study||197
5156682|NCT01274559|12682872|P2|COMPLETED|Overall Study||441
5156683|NCT01274559|12682873|P1|COMPLETED|Overall Study||390
5156684|NCT01274559|12682872|P2|Treated|Overall Study||572
5156685|NCT01274559|12682873|P1|Treated|Overall Study||572
5156686|NCT01274559|12682872|P2|STARTED|Overall Study||586
5156687|NCT01274559|12682873|P1|STARTED|Overall Study||587
5156688|NCT01274533|12682923|P1|NOT COMPLETED|Overall Study||4
5156689|NCT01274533|12682923|P1|COMPLETED|Overall Study||0
5156690|NCT01274533|12682923|P1|STARTED|Overall Study||4
5156691|NCT01274520|12682930|P2|NOT COMPLETED|Overall Study||0
5156692|NCT01274520|12682931|P1|NOT COMPLETED|Overall Study||0
5156693|NCT01274520|12682930|P2|COMPLETED|Overall Study||24
5156694|NCT01274520|12682931|P1|COMPLETED|Overall Study||25
5156695|NCT01274520|12682930|P2|STARTED|Overall Study||24
5156696|NCT01274520|12682931|P1|STARTED|Overall Study||25
5156697|NCT01274429|12682959|P1|NOT COMPLETED|Overall Study||5
5156698|NCT01274429|12682959|P1|COMPLETED|Overall Study||0
5156699|NCT01274429|12682959|P1|STARTED|Overall Study||5
5156700|NCT01274182|12682967|P3|NOT COMPLETED|Overall Study||12
5156701|NCT01274182|12682968|P2|NOT COMPLETED|Overall Study||18
5156702|NCT01274182|12682969|P1|NOT COMPLETED|Overall Study||21
5156703|NCT01274182|12682967|P3|COMPLETED|Overall Study||80
5156704|NCT01274182|12682968|P2|COMPLETED|Overall Study||69
5156705|NCT01274182|12682969|P1|COMPLETED|Overall Study||112
5156706|NCT01274182|12682967|P3|24 Weeks|Overall Study||84
5156707|NCT01274182|12682968|P2|24 Weeks|Overall Study||83
5156708|NCT01274182|12682969|P1|24 Weeks|Overall Study||123
5156709|NCT01274182|12682967|P3|STARTED|Overall Study||92
5156710|NCT01274182|12682968|P2|STARTED|Overall Study||87
5156711|NCT01274182|12682969|P1|STARTED|Overall Study||133
5156712|NCT01273896|12683006|P1|NOT COMPLETED|Overall Study||0
5156713|NCT01273896|12683006|P1|COMPLETED|Overall Study||22
5156714|NCT01273896|12683006|P1|STARTED|Overall Study||22
5156715|NCT01273883|12683010|P2|NOT COMPLETED|Second Intervention||1
5156716|NCT01273883|12683011|P1|NOT COMPLETED|Second Intervention||2
5156717|NCT01273883|12683010|P2|COMPLETED|Second Intervention||17
5156718|NCT01273883|12683011|P1|COMPLETED|Second Intervention||15
5156719|NCT01273883|12683010|P2|STARTED|Second Intervention||18
5156720|NCT01273883|12683011|P1|STARTED|Second Intervention||17
5156721|NCT01273883|12683010|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5156722|NCT01273883|12683011|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5156723|NCT01273883|12683010|P2|COMPLETED|Washout Period of 2 Weeks||18
5156724|NCT01273883|12683011|P1|COMPLETED|Washout Period of 2 Weeks||17
5156725|NCT01273883|12683010|P2|STARTED|Washout Period of 2 Weeks||18
5156726|NCT01273883|12683011|P1|STARTED|Washout Period of 2 Weeks||17
5156727|NCT01273883|12683010|P2|NOT COMPLETED|First Intervention||1
5156728|NCT01273883|12683011|P1|NOT COMPLETED|First Intervention||2
5156729|NCT01273883|12683010|P2|COMPLETED|First Intervention||18
5156730|NCT01273883|12683011|P1|COMPLETED|First Intervention||17
5156731|NCT01273883|12683010|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
5156732|NCT01273883|12683011|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
5156733|NCT01273857|12683025|P2|NOT COMPLETED|Overall Study||0
5156734|NCT01273857|12683026|P1|NOT COMPLETED|Overall Study||0
5156735|NCT01273857|12683025|P2|COMPLETED|Overall Study||7
5156736|NCT01273857|12683026|P1|COMPLETED|Overall Study||7
5156737|NCT01273857|12683025|P2|STARTED|Overall Study||7
5156738|NCT01273857|12683026|P1|STARTED|Overall Study||7
5156739|NCT01273818|12683037|P3|NOT COMPLETED|Overall Study||9
5156740|NCT01273818|12683038|P2|NOT COMPLETED|Overall Study||2
5156741|NCT01273818|12683039|P1|NOT COMPLETED|Overall Study||13
5156742|NCT01273818|12683037|P3|COMPLETED|Overall Study||91
5156743|NCT01273818|12683038|P2|COMPLETED|Overall Study||98
5156744|NCT01273818|12683039|P1|COMPLETED|Overall Study||87
5156745|NCT01273818|12683037|P3|STARTED|Overall Study||100
5156746|NCT01273818|12683038|P2|STARTED|Overall Study||100
5156747|NCT01273818|12683039|P1|STARTED|Overall Study||100
5156748|NCT01273805|12683049|P2|NOT COMPLETED|Overall Study||10
5156749|NCT01273805|12683050|P1|NOT COMPLETED|Overall Study||10
5156750|NCT01273805|12683049|P2|COMPLETED|Overall Study||0
5156751|NCT01273805|12683050|P1|COMPLETED|Overall Study||0
5156752|NCT01273805|12683049|P2|STARTED|Overall Study||10
5156753|NCT01273805|12683050|P1|STARTED|Overall Study||10
5156754|NCT01273766|12683069|P3|NOT COMPLETED|Overall Study||0
5156755|NCT01273766|12683070|P2|NOT COMPLETED|Overall Study||0
5156756|NCT01273766|12683071|P1|NOT COMPLETED|Overall Study||0
5156757|NCT01273766|12683069|P3|COMPLETED|Overall Study||5
5156758|NCT01273766|12683070|P2|COMPLETED|Overall Study||7
5156759|NCT01273766|12683071|P1|COMPLETED|Overall Study||4
5156760|NCT01273766|12683069|P3|STARTED|Overall Study||5
5156761|NCT01273766|12683070|P2|STARTED|Overall Study||7
5156762|NCT01273766|12683071|P1|STARTED|Overall Study||4
5156763|NCT01273623|12683081|P1|NOT COMPLETED|Overall Study||29
5156764|NCT01273623|12683081|P1|COMPLETED|Overall Study|met IVUS criteria|26
5156765|NCT01273623|12683081|P1|STARTED|Overall Study|met angiographic criteria|55
5156766|NCT01273597|12683088|P1|NOT COMPLETED|Overall Study||8
5156767|NCT01273597|12683088|P1|COMPLETED|Overall Study||52
5156768|NCT01273597|12683088|P1|STARTED|Overall Study||60
5156769|NCT01273519|12683103|P3|NOT COMPLETED|Overall Study||8
5156770|NCT01273519|12683104|P2|NOT COMPLETED|Overall Study||5
5156771|NCT01273519|12683105|P1|NOT COMPLETED|Overall Study||19
5156772|NCT01273519|12683103|P3|COMPLETED|Overall Study||39
5156773|NCT01273519|12683104|P2|COMPLETED|Overall Study||25
5156774|NCT01273519|12683105|P1|COMPLETED|Overall Study||59
5156775|NCT01273519|12683103|P3|STARTED|Overall Study||47
5156776|NCT01273519|12683104|P2|STARTED|Overall Study||30
5156777|NCT01273519|12683105|P1|STARTED|Overall Study||78
5156778|NCT01273181|12683142|P4|NOT COMPLETED|Phase 2, Dose 2||1
5156779|NCT01273181|12683143|P3|NOT COMPLETED|Phase 2, Dose 2||0
5156780|NCT01273181|12683144|P2|NOT COMPLETED|Phase 2, Dose 2||0
5156781|NCT01273181|12683145|P1|NOT COMPLETED|Phase 2, Dose 2||0
5156782|NCT01273181|12683142|P4|COMPLETED|Phase 2, Dose 2||0
5156783|NCT01273181|12683143|P3|COMPLETED|Phase 2, Dose 2||0
5156784|NCT01273181|12683144|P2|COMPLETED|Phase 2, Dose 2||0
5156785|NCT01273181|12683145|P1|COMPLETED|Phase 2, Dose 2||0
5156786|NCT01273181|12683142|P4|STARTED|Phase 2, Dose 2||1
5156787|NCT01273181|12683143|P3|STARTED|Phase 2, Dose 2||0
5156788|NCT01273181|12683144|P2|STARTED|Phase 2, Dose 2||0
5156789|NCT01273181|12683145|P1|STARTED|Phase 2, Dose 2||0
5156790|NCT01273181|12683142|P4|NOT COMPLETED|Phase 2, Dose 1||0
5156791|NCT01273181|12683143|P3|NOT COMPLETED|Phase 2, Dose 1||1
5156792|NCT01273181|12683144|P2|NOT COMPLETED|Phase 2, Dose 1||0
5156793|NCT01273181|12683145|P1|NOT COMPLETED|Phase 2, Dose 1||0
5156794|NCT01273181|12683142|P4|COMPLETED|Phase 2, Dose 1||0
5156795|NCT01273181|12683143|P3|COMPLETED|Phase 2, Dose 1||1
5156796|NCT01273181|12683144|P2|COMPLETED|Phase 2, Dose 1||0
5156797|NCT01273181|12683145|P1|COMPLETED|Phase 2, Dose 1||0
5156798|NCT01273181|12683142|P4|STARTED|Phase 2, Dose 1||0
5156799|NCT01273181|12683143|P3|STARTED|Phase 2, Dose 1||2
5156800|NCT01273181|12683144|P2|STARTED|Phase 2, Dose 1||0
5156801|NCT01273181|12683145|P1|STARTED|Phase 2, Dose 1||0
5156802|NCT01273181|12683142|P4|NOT COMPLETED|Phase I, Dose 2||0
5156803|NCT01273181|12683143|P3|NOT COMPLETED|Phase I, Dose 2||0
5156804|NCT01273181|12683144|P2|NOT COMPLETED|Phase I, Dose 2||1
5156805|NCT01273181|12683145|P1|NOT COMPLETED|Phase I, Dose 2||0
5156806|NCT01273181|12683142|P4|COMPLETED|Phase I, Dose 2||0
5156807|NCT01273181|12683143|P3|COMPLETED|Phase I, Dose 2||0
5156808|NCT01273181|12683144|P2|COMPLETED|Phase I, Dose 2||2
5156809|NCT01273181|12683145|P1|COMPLETED|Phase I, Dose 2||0
5156810|NCT01273181|12683142|P4|STARTED|Phase I, Dose 2||0
5156811|NCT01273181|12683143|P3|STARTED|Phase I, Dose 2||0
5156812|NCT01273181|12683144|P2|STARTED|Phase I, Dose 2||3
5156813|NCT01273181|12683145|P1|STARTED|Phase I, Dose 2||0
5156814|NCT01273181|12683142|P4|NOT COMPLETED|Phase I, Dose 1||0
5156815|NCT01273181|12683143|P3|NOT COMPLETED|Phase I, Dose 1||0
5156816|NCT01273181|12683144|P2|NOT COMPLETED|Phase I, Dose 1||0
5156817|NCT01273181|12683145|P1|NOT COMPLETED|Phase I, Dose 1||1
5156818|NCT01273181|12683142|P4|COMPLETED|Phase I, Dose 1||0
5156819|NCT01273181|12683143|P3|COMPLETED|Phase I, Dose 1||0
5156820|NCT01273181|12683144|P2|COMPLETED|Phase I, Dose 1||0
5156821|NCT01273181|12683145|P1|COMPLETED|Phase I, Dose 1||2
5156822|NCT01273181|12683142|P4|STARTED|Phase I, Dose 1||0
5156823|NCT01273181|12683143|P3|STARTED|Phase I, Dose 1||0
5156824|NCT01273181|12683144|P2|STARTED|Phase I, Dose 1||0
5156825|NCT01273181|12683145|P1|STARTED|Phase I, Dose 1||3
5156826|NCT01273155|12683163|P7|NOT COMPLETED|Overall Study||6
5156827|NCT01273155|12683164|P6|NOT COMPLETED|Overall Study||5
5156828|NCT01273155|12683165|P5|NOT COMPLETED|Overall Study||2
5156829|NCT01273155|12683166|P4|NOT COMPLETED|Overall Study||1
5156830|NCT01273155|12683167|P3|NOT COMPLETED|Overall Study||12
5156831|NCT01273155|12683168|P2|NOT COMPLETED|Overall Study||4
5156832|NCT01273155|12683169|P1|NOT COMPLETED|Overall Study||2
5156833|NCT01273155|12683163|P7|COMPLETED|Overall Study||2
5156834|NCT01273155|12683164|P6|COMPLETED|Overall Study||5
5156835|NCT01273155|12683165|P5|COMPLETED|Overall Study||3
5156836|NCT01273155|12683166|P4|COMPLETED|Overall Study||4
5156837|NCT01273155|12683167|P3|COMPLETED|Overall Study||6
5156838|NCT01273155|12683168|P2|COMPLETED|Overall Study||8
5156839|NCT01273155|12683169|P1|COMPLETED|Overall Study||12
5156840|NCT01273155|12683163|P7|STARTED|Overall Study||8
5156841|NCT01273155|12683164|P6|STARTED|Overall Study||10
5156842|NCT01273155|12683165|P5|STARTED|Overall Study||5
5156843|NCT01273155|12683166|P4|STARTED|Overall Study||5
5156844|NCT01273155|12683167|P3|STARTED|Overall Study||18
5156845|NCT01273155|12683168|P2|STARTED|Overall Study||12
5156846|NCT01273155|12683169|P1|STARTED|Overall Study||14
5156847|NCT01273064|12683246|P5|NOT COMPLETED|Overall Study||10
5156848|NCT01273064|12683247|P4|NOT COMPLETED|Overall Study||20
5156849|NCT01273064|12683248|P3|NOT COMPLETED|Overall Study||31
5156850|NCT01273064|12683249|P2|NOT COMPLETED|Overall Study||30
5156851|NCT01273064|12683250|P1|NOT COMPLETED|Overall Study||23
5156852|NCT01273064|12683246|P5|COMPLETED|Overall Study||0
5156853|NCT01273064|12683247|P4|COMPLETED|Overall Study||0
5156854|NCT01273064|12683248|P3|COMPLETED|Overall Study||0
5156855|NCT01273064|12683249|P2|COMPLETED|Overall Study||0
5156856|NCT01273064|12683250|P1|COMPLETED|Overall Study||0
5156857|NCT01273064|12683246|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
5156858|NCT01273064|12683247|P4|STARTED|Overall Study||20
5156859|NCT01273064|12683248|P3|STARTED|Overall Study||31
5156860|NCT01273064|12683249|P2|STARTED|Overall Study||30
5156861|NCT01273064|12683250|P1|STARTED|Overall Study||23
5156862|NCT01273038|12683269|P2|NOT COMPLETED|Second Intervention (14 Days)||2
5156863|NCT01273038|12683270|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5156864|NCT01273038|12683269|P2|COMPLETED|Second Intervention (14 Days)||8
5156865|NCT01273038|12683270|P1|COMPLETED|Second Intervention (14 Days)||10
5156866|NCT01273038|12683269|P2|STARTED|Second Intervention (14 Days)||10
5156867|NCT01273038|12683270|P1|STARTED|Second Intervention (14 Days)||10
5156868|NCT01273038|12683269|P2|NOT COMPLETED|First Intervention (14 Days)||0
5156869|NCT01273038|12683270|P1|NOT COMPLETED|First Intervention (14 Days)||0
5156870|NCT01273038|12683269|P2|COMPLETED|First Intervention (14 Days)||10
5156871|NCT01273038|12683270|P1|COMPLETED|First Intervention (14 Days)||10
5156872|NCT01273038|12683269|P2|STARTED|First Intervention (14 Days)||10
5156873|NCT01273038|12683270|P1|STARTED|First Intervention (14 Days)||10
5156874|NCT01272960|12683278|P2|NOT COMPLETED|Overall Study||0
5156875|NCT01272960|12683279|P1|NOT COMPLETED|Overall Study||0
5156876|NCT01272960|12683278|P2|COMPLETED|Overall Study||15
5156877|NCT01272960|12683279|P1|COMPLETED|Overall Study||14
5156878|NCT01272960|12683278|P2|STARTED|Overall Study||15
5156879|NCT01272960|12683279|P1|STARTED|Overall Study||14
5156880|NCT01272947|12683293|P2|NOT COMPLETED|Overall Study||2
5156881|NCT01272947|12683294|P1|NOT COMPLETED|Overall Study||2
5156882|NCT01272947|12683293|P2|COMPLETED|Overall Study||98
5156883|NCT01272947|12683294|P1|COMPLETED|Overall Study||102
5156884|NCT01272947|12683293|P2|STARTED|Overall Study||100
5156885|NCT01272947|12683294|P1|STARTED|Overall Study||104
5156886|NCT01272934|12683304|P2|NOT COMPLETED|Overall Study||2
5156887|NCT01272934|12683305|P1|NOT COMPLETED|Overall Study||0
5156888|NCT01272934|12683304|P2|COMPLETED|Overall Study||101
5156889|NCT01272934|12683305|P1|COMPLETED|Overall Study||102
5156890|NCT01272934|12683304|P2|STARTED|Overall Study||103
5156891|NCT01272934|12683305|P1|STARTED|Overall Study||102
5156892|NCT01272921|12683315|P2|NOT COMPLETED|Overall Study||1
5156893|NCT01272921|12683316|P1|NOT COMPLETED|Overall Study||2
5156894|NCT01272921|12683315|P2|COMPLETED|Overall Study||70
5156895|NCT01272921|12683316|P1|COMPLETED|Overall Study||69
5156896|NCT01272921|12683315|P2|STARTED|Overall Study||71
5156897|NCT01272921|12683316|P1|STARTED|Overall Study||71
5156898|NCT01272908|12683324|P1|NOT COMPLETED|Re-Treatment Period||6
5156899|NCT01272908|12683324|P1|COMPLETED|Re-Treatment Period||71
5156900|NCT01272908|12683324|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
5156901|NCT01272908|12683324|P1|NOT COMPLETED|Initial Treatment Period||8
5156902|NCT01272908|12683324|P1|COMPLETED|Initial Treatment Period||112
5156903|NCT01272908|12683324|P1|STARTED|Initial Treatment Period||120
5156904|NCT01272882|12683358|P1|NOT COMPLETED|Overall Study||0
5156905|NCT01272882|12683358|P1|COMPLETED|Overall Study||13
5156906|NCT01272882|12683358|P1|STARTED|Overall Study||13
5156907|NCT01272869|12683364|P2|NOT COMPLETED|Period 2 (14 Days)||0
5156908|NCT01272869|12683365|P1|NOT COMPLETED|Period 2 (14 Days)||1
5156909|NCT01272869|12683364|P2|COMPLETED|Period 2 (14 Days)||10
5156910|NCT01272869|12683365|P1|COMPLETED|Period 2 (14 Days)||9
5156911|NCT01272869|12683364|P2|STARTED|Period 2 (14 Days)||10
5156912|NCT01272869|12683365|P1|STARTED|Period 2 (14 Days)||10
5156913|NCT01272869|12683364|P2|NOT COMPLETED|Period 1 (14 Days)||0
5156914|NCT01272869|12683365|P1|NOT COMPLETED|Period 1 (14 Days)||0
5156915|NCT01272869|12683364|P2|COMPLETED|Period 1 (14 Days)||10
5156916|NCT01272869|12683365|P1|COMPLETED|Period 1 (14 Days)||10
5156917|NCT01272869|12683364|P2|STARTED|Period 1 (14 Days)||10
5156918|NCT01272869|12683365|P1|STARTED|Period 1 (14 Days)||10
5156919|NCT01272830|12683373|P2|NOT COMPLETED|Overall Study||5
5156920|NCT01272830|12683374|P1|NOT COMPLETED|Overall Study||8
5156921|NCT01272830|12683373|P2|COMPLETED|Overall Study||21
5156922|NCT01272830|12683374|P1|COMPLETED|Overall Study||17
5156923|NCT01272830|12683373|P2|STARTED|Overall Study||26
5156924|NCT01272830|12683374|P1|STARTED|Overall Study||25
5156925|NCT01272804|12683392|P6|NOT COMPLETED|Overall Study||1
5156926|NCT01272804|12683393|P5|NOT COMPLETED|Overall Study||2
5156927|NCT01272804|12683394|P4|NOT COMPLETED|Overall Study||0
5156928|NCT01272804|12683395|P3|NOT COMPLETED|Overall Study||0
5156929|NCT01272804|12683396|P2|NOT COMPLETED|Overall Study||0
5156930|NCT01272804|12683397|P1|NOT COMPLETED|Overall Study||1
5156931|NCT01272804|12683392|P6|COMPLETED|Overall Study||15
5156932|NCT01272804|12683393|P5|COMPLETED|Overall Study||7
5156933|NCT01272804|12683394|P4|COMPLETED|Overall Study||9
5156934|NCT01272804|12683395|P3|COMPLETED|Overall Study||9
5156935|NCT01272804|12683396|P2|COMPLETED|Overall Study||9
5156936|NCT01272804|12683397|P1|COMPLETED|Overall Study||8
5156937|NCT01272804|12683392|P6|STARTED|Overall Study||16
5156938|NCT01272804|12683393|P5|STARTED|Overall Study||9
5156939|NCT01272804|12683394|P4|STARTED|Overall Study||9
5156940|NCT01272804|12683395|P3|STARTED|Overall Study||9
5156941|NCT01272804|12683396|P2|STARTED|Overall Study||9
5156942|NCT01272804|12683397|P1|STARTED|Overall Study||9
5156943|NCT01272661|12683555|P3|NOT COMPLETED|Overall Study||72
5156944|NCT01272661|12683556|P2|NOT COMPLETED|Overall Study||209
5156945|NCT01272661|12683557|P1|NOT COMPLETED|Overall Study||126
5156946|NCT01272661|12683555|P3|COMPLETED|Overall Study||314
5156947|NCT01272661|12683556|P2|COMPLETED|Overall Study||288
5156948|NCT01272661|12683557|P1|COMPLETED|Overall Study||287
5156949|NCT01272661|12683555|P3|STARTED|Overall Study||386
5156950|NCT01272661|12683556|P2|STARTED|Overall Study||497
5156951|NCT01272661|12683557|P1|STARTED|Overall Study||413
5156952|NCT01272635|12683582|P4|NOT COMPLETED|Overall Study||23
5156953|NCT01272635|12683583|P3|NOT COMPLETED|Overall Study||31
5156954|NCT01272635|12683584|P2|NOT COMPLETED|Overall Study||20
5156955|NCT01272635|12683585|P1|NOT COMPLETED|Overall Study||31
5156956|NCT01272635|12683582|P4|COMPLETED|Overall Study||129
5156957|NCT01272635|12683583|P3|COMPLETED|Overall Study||117
5156958|NCT01272635|12683584|P2|COMPLETED|Overall Study||134
5156959|NCT01272635|12683585|P1|COMPLETED|Overall Study||122
5156960|NCT01272635|12683582|P4|STARTED|Overall Study||152
5156961|NCT01272635|12683583|P3|STARTED|Overall Study||148
5156962|NCT01272635|12683584|P2|STARTED|Overall Study||154
5156963|NCT01272635|12683585|P1|STARTED|Overall Study||153
5156964|NCT01272583|12683603|P2|NOT COMPLETED|Overall Study||0
5156965|NCT01272583|12683604|P1|NOT COMPLETED|Overall Study||0
5156966|NCT01272583|12683603|P2|COMPLETED|Overall Study||8
5156967|NCT01272583|12683604|P1|COMPLETED|Overall Study||8
5156968|NCT01272583|12683603|P2|STARTED|Overall Study||8
5156969|NCT01272583|12683604|P1|STARTED|Overall Study||8
5156970|NCT01272388|12683635|P2|NOT COMPLETED|Overall Study||0
5156971|NCT01272388|12683636|P1|NOT COMPLETED|Overall Study||0
5156972|NCT01272388|12683635|P2|COMPLETED|Overall Study||0
5156973|NCT01272388|12683636|P1|COMPLETED|Overall Study||1
5156974|NCT01272388|12683635|P2|STARTED|Overall Study||0
5156975|NCT01272388|12683636|P1|STARTED|Overall Study||1
5156976|NCT01272284|12683644|P1|NOT COMPLETED|12-month Follow-up Visit||4
5156977|NCT01272284|12683644|P1|COMPLETED|12-month Follow-up Visit||105
5156978|NCT01272284|12683644|P1|STARTED|12-month Follow-up Visit||109
5156979|NCT01272284|12683644|P1|NOT COMPLETED|6-month Follow-up Visit||3
5156980|NCT01272284|12683644|P1|COMPLETED|6-month Follow-up Visit||109
5156981|NCT01272284|12683644|P1|STARTED|6-month Follow-up Visit||112
5156982|NCT01272284|12683644|P1|NOT COMPLETED|3-month Follow-up Visit||1
5156983|NCT01272284|12683644|P1|COMPLETED|3-month Follow-up Visit||112
5156984|NCT01272284|12683644|P1|STARTED|3-month Follow-up Visit||113
5156985|NCT01272245|12683658|P1|NOT COMPLETED|Overall Study||0
5156986|NCT01272245|12683658|P1|COMPLETED|Overall Study||36
5156987|NCT01272245|12683658|P1|STARTED|Overall Study||36
5156988|NCT01272232|12683669|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
5156989|NCT01272232|12683670|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
5156990|NCT01272232|12683671|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
5156991|NCT01272232|12683669|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
5156992|NCT01272232|12683670|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
5156993|NCT01272232|12683671|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
5156994|NCT01272232|12683669|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
5156995|NCT01272232|12683670|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
5156996|NCT01272232|12683671|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
5156997|NCT01272232|12683669|P3|NOT COMPLETED|Weeks 0-56||72
5156998|NCT01272232|12683670|P2|NOT COMPLETED|Weeks 0-56||47
5156999|NCT01272232|12683671|P1|NOT COMPLETED|Weeks 0-56||99
5157000|NCT01272232|12683669|P3|COMPLETED|Weeks 0-56||140
5157001|NCT01272232|12683670|P2|COMPLETED|Weeks 0-56||164
5157002|NCT01272232|12683671|P1|COMPLETED|Weeks 0-56||324
5157003|NCT01272232|12683669|P3|Exposed|Weeks 0-56||212
5157004|NCT01272232|12683670|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
5157005|NCT01272232|12683671|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
5157006|NCT01272232|12683669|P3|STARTED|Weeks 0-56||212
5157007|NCT01272232|12683670|P2|STARTED|Weeks 0-56||211
5157008|NCT01272232|12683671|P1|STARTED|Weeks 0-56||423
5157009|NCT01272219|12683716|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
5157010|NCT01272219|12683717|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
5157011|NCT01272219|12683718|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
5157012|NCT01272219|12683719|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
5157013|NCT01272219|12683720|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
5157014|NCT01272219|12683721|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
5157015|NCT01272219|12683716|P6|COMPLETED|Main + Extension Period: Week 0-172||327
5157016|NCT01272219|12683717|P5|COMPLETED|Main + Extension Period: Week 0-172||783
5157017|NCT01272219|12683718|P4|COMPLETED|Main + Extension Period: Week 0-172||0
5157018|NCT01272219|12683719|P3|COMPLETED|Main + Extension Period: Week 0-172||0
5157019|NCT01272219|12683720|P2|COMPLETED|Main + Extension Period: Week 0-172||0
5157020|NCT01272219|12683721|P1|COMPLETED|Main + Extension Period: Week 0-172||0
5157021|NCT01272219|12683716|P6|Exposed|Main + Extension Period: Week 0-172||747
5157022|NCT01272219|12683717|P5|Exposed|Main + Extension Period: Week 0-172||1501
5157023|NCT01272219|12683718|P4|Exposed|Main + Extension Period: Week 0-172||0
5157024|NCT01272219|12683719|P3|Exposed|Main + Extension Period: Week 0-172||0
5157025|NCT01272219|12683720|P2|Exposed|Main + Extension Period: Week 0-172||0
5157026|NCT01272219|12683721|P1|Exposed|Main + Extension Period: Week 0-172||0
5157027|NCT01272219|12683716|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
5157028|NCT01272219|12683717|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
5157029|NCT01272219|12683718|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
5157030|NCT01272219|12683719|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
5157031|NCT01272219|12683720|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
5157032|NCT01272219|12683721|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
5157033|NCT01272219|12683716|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157034|NCT01272219|12683717|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157035|NCT01272219|12683718|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
5157036|NCT01272219|12683719|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
5157037|NCT01272219|12683720|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
5157038|NCT01272219|12683721|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157039|NCT01272219|12683716|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157040|NCT01272219|12683717|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157041|NCT01272219|12683718|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
5157042|NCT01272219|12683719|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
5157043|NCT01272219|12683720|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
5157044|NCT01272219|12683721|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
5157045|NCT01272219|12683716|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
5157046|NCT01272219|12683717|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
5157047|NCT01272219|12683718|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
5157048|NCT01272219|12683719|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
5157049|NCT01272219|12683720|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
5157050|NCT01272219|12683721|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
5157051|NCT01272219|12683716|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
5157052|NCT01272219|12683717|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
5157053|NCT01272219|12683718|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
5157054|NCT01272219|12683719|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
5157144|NCT01271868|12683987|P1|NOT COMPLETED|Treatment Study||0
5157055|NCT01272219|12683720|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
5157056|NCT01272219|12683721|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
5157057|NCT01272219|12683716|P6|COMPLETED|Main Period: Week 0 to Week 56||505
5157058|NCT01272219|12683717|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
5157059|NCT01272219|12683718|P4|COMPLETED|Main Period: Week 0 to Week 56||296
5157060|NCT01272219|12683719|P3|COMPLETED|Main Period: Week 0 to Week 56||0
5157061|NCT01272219|12683720|P2|COMPLETED|Main Period: Week 0 to Week 56||0
5157062|NCT01272219|12683721|P1|COMPLETED|Main Period: Week 0 to Week 56||679
5157063|NCT01272219|12683716|P6|Exposed|Main Period: Week 0 to Week 56||755
5157064|NCT01272219|12683717|P5|Exposed|Main Period: Week 0 to Week 56||1524
5157065|NCT01272219|12683718|P4|Exposed|Main Period: Week 0 to Week 56||487
5157066|NCT01272219|12683719|P3|Exposed|Main Period: Week 0 to Week 56||0
5157067|NCT01272219|12683720|P2|Exposed|Main Period: Week 0 to Week 56||0
5157068|NCT01272219|12683721|P1|Exposed|Main Period: Week 0 to Week 56||957
5157069|NCT01272219|12683716|P6|STARTED|Main Period: Week 0 to Week 56||757
5157070|NCT01272219|12683717|P5|STARTED|Main Period: Week 0 to Week 56||1528
5157071|NCT01272219|12683718|P4|STARTED|Main Period: Week 0 to Week 56||487
5157072|NCT01272219|12683719|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
5157073|NCT01272219|12683720|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
5157074|NCT01272219|12683721|P1|STARTED|Main Period: Week 0 to Week 56||959
5157075|NCT01272193|12683755|P2|NOT COMPLETED|Overall Study||12
5157076|NCT01272193|12683756|P1|NOT COMPLETED|Overall Study||10
5157077|NCT01272193|12683755|P2|COMPLETED|Overall Study||137
5157078|NCT01272193|12683756|P1|COMPLETED|Overall Study||137
5157079|NCT01272193|12683755|P2|STARTED|Overall Study||149
5157080|NCT01272193|12683756|P1|STARTED|Overall Study||147
5157081|NCT01272180|12683776|P4|NOT COMPLETED|Overall Study||14
5157082|NCT01272180|12683777|P3|NOT COMPLETED|Overall Study||13
5157083|NCT01272180|12683778|P2|NOT COMPLETED|Overall Study||21
5157084|NCT01272180|12683779|P1|NOT COMPLETED|Overall Study||17
5157085|NCT01272180|12683776|P4|COMPLETED|Overall Study||107
5157086|NCT01272180|12683777|P3|COMPLETED|Overall Study||109
5157087|NCT01272180|12683778|P2|COMPLETED|Overall Study||100
5157088|NCT01272180|12683779|P1|COMPLETED|Overall Study||103
5157089|NCT01272180|12683776|P4|STARTED|Overall Study||121
5157090|NCT01272180|12683777|P3|STARTED|Overall Study||122
5157091|NCT01272180|12683778|P2|STARTED|Overall Study||121
5157092|NCT01272180|12683779|P1|STARTED|Overall Study||120
5157093|NCT01272141|12683819|P1|NOT COMPLETED|Overall Study||0
5157094|NCT01272141|12683819|P1|COMPLETED|Overall Study||5
5157095|NCT01272141|12683819|P1|STARTED|Overall Study||5
5157096|NCT01272076|12683824|P1|NOT COMPLETED|Overall Study||0
5157097|NCT01272076|12683824|P1|COMPLETED|Overall Study||52
5157098|NCT01272076|12683824|P1|STARTED|Overall Study||52
5157099|NCT01272011|12683831|P3|NOT COMPLETED|Overall Study||0
5157100|NCT01272011|12683832|P2|NOT COMPLETED|Overall Study||2
5157101|NCT01272011|12683833|P1|NOT COMPLETED|Overall Study||0
5157102|NCT01272011|12683831|P3|COMPLETED|Overall Study||3
5157103|NCT01272011|12683832|P2|COMPLETED|Overall Study||8
5157104|NCT01272011|12683833|P1|COMPLETED|Overall Study||3
5157105|NCT01272011|12683831|P3|STARTED|Overall Study||3
5157106|NCT01272011|12683832|P2|STARTED|Overall Study||10
5157107|NCT01272011|12683833|P1|STARTED|Overall Study||3
5157108|NCT01271946|12683846|P2|NOT COMPLETED|Overall Study||0
5157109|NCT01271946|12683847|P1|NOT COMPLETED|Overall Study||0
5157110|NCT01271946|12683846|P2|COMPLETED|Overall Study||5
5157111|NCT01271946|12683847|P1|COMPLETED|Overall Study||346
5157112|NCT01271946|12683846|P2|STARTED|Overall Study||5
5157113|NCT01271946|12683847|P1|STARTED|Overall Study||346
5157114|NCT01271933|12683869|P3|NOT COMPLETED|Double-Blind Phase||12
5157115|NCT01271933|12683870|P2|NOT COMPLETED|Double-Blind Phase||17
5157116|NCT01271933|12683871|P1|NOT COMPLETED|Double-Blind Phase||0
5157117|NCT01271933|12683869|P3|COMPLETED|Double-Blind Phase||47
5157118|NCT01271933|12683870|P2|COMPLETED|Double-Blind Phase||46
5157119|NCT01271933|12683871|P1|COMPLETED|Double-Blind Phase||0
5157120|NCT01271933|12683869|P3|Treated|Double-Blind Phase||58
5157121|NCT01271933|12683870|P2|Treated|Double-Blind Phase||63
5157122|NCT01271933|12683871|P1|Treated|Double-Blind Phase||0
5157123|NCT01271933|12683869|P3|STARTED|Double-Blind Phase||59
5157124|NCT01271933|12683870|P2|STARTED|Double-Blind Phase||63
5157125|NCT01271933|12683871|P1|STARTED|Double-Blind Phase||0
5157126|NCT01271933|12683869|P3|NOT COMPLETED|Single-Blind Phase||0
5157127|NCT01271933|12683870|P2|NOT COMPLETED|Single-Blind Phase||0
5157128|NCT01271933|12683871|P1|NOT COMPLETED|Single-Blind Phase||121
5157129|NCT01271933|12683869|P3|COMPLETED|Single-Blind Phase||0
5157130|NCT01271933|12683870|P2|COMPLETED|Single-Blind Phase||0
5157131|NCT01271933|12683871|P1|COMPLETED|Single-Blind Phase||320
5157132|NCT01271933|12683869|P3|STARTED|Single-Blind Phase||0
5157133|NCT01271933|12683870|P2|STARTED|Single-Blind Phase||0
5157134|NCT01271933|12683871|P1|STARTED|Single-Blind Phase||441
5157135|NCT01271907|12683971|P3|NOT COMPLETED|Overall Study||0
5157136|NCT01271907|12683972|P2|NOT COMPLETED|Overall Study||0
5157137|NCT01271907|12683973|P1|NOT COMPLETED|Overall Study||0
5157138|NCT01271907|12683971|P3|COMPLETED|Overall Study||0
5157139|NCT01271907|12683972|P2|COMPLETED|Overall Study||0
5157140|NCT01271907|12683973|P1|COMPLETED|Overall Study||3
5157141|NCT01271907|12683971|P3|STARTED|Overall Study||0
5157142|NCT01271907|12683972|P2|STARTED|Overall Study||0
5157143|NCT01271907|12683973|P1|STARTED|Overall Study||3
5157145|NCT01271868|12683987|P1|COMPLETED|Treatment Study||9
5157146|NCT01271868|12683987|P1|STARTED|Treatment Study||9
5157147|NCT01271868|12683987|P1|NOT COMPLETED|Pharmacokinetic Study||0
5157148|NCT01271868|12683987|P1|COMPLETED|Pharmacokinetic Study||9
5157149|NCT01271868|12683987|P1|STARTED|Pharmacokinetic Study||9
5157150|NCT01271855|12684000|P2|NOT COMPLETED|Overall Study||0
5157151|NCT01271855|12684001|P1|NOT COMPLETED|Overall Study||0
5157152|NCT01271855|12684000|P2|COMPLETED|Overall Study||52
5157153|NCT01271855|12684001|P1|COMPLETED|Overall Study||48
5157154|NCT01271855|12684000|P2|STARTED|Overall Study||52
5157155|NCT01271855|12684001|P1|STARTED|Overall Study||48
5157156|NCT01271803|12684014|P3|NOT COMPLETED|Overall Study||2
5157157|NCT01271803|12684015|P2|NOT COMPLETED|Overall Study||39
5157158|NCT01271803|12684016|P1|NOT COMPLETED|Overall Study||55
5157159|NCT01271803|12684014|P3|COMPLETED|Overall Study||0
5157160|NCT01271803|12684015|P2|COMPLETED|Overall Study||24
5157161|NCT01271803|12684016|P1|COMPLETED|Overall Study||11
5157162|NCT01271803|12684014|P3|STARTED|Overall Study||2
5157163|NCT01271803|12684015|P2|STARTED|Overall Study||63
5157164|NCT01271803|12684016|P1|STARTED|Overall Study||66
5157165|NCT01271725|12684178|P2|NOT COMPLETED|Part B||12
5157166|NCT01271725|12684179|P1|NOT COMPLETED|Part B||0
5157167|NCT01271725|12684178|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
5157168|NCT01271725|12684179|P1|COMPLETED|Part B||0
5157169|NCT01271725|12684178|P2|STARTED|Part B||39
5157170|NCT01271725|12684179|P1|STARTED|Part B||0
5157171|NCT01271725|12684178|P2|NOT COMPLETED|Part A||0
5157172|NCT01271725|12684179|P1|NOT COMPLETED|Part A||35
5157173|NCT01271725|12684178|P2|COMPLETED|Part A||0
5157174|NCT01271725|12684179|P1|COMPLETED|Part A||39
5157175|NCT01271725|12684178|P2|STARTED|Part A||0
5157176|NCT01271725|12684179|P1|STARTED|Part A|Started are the treated patients|74
5157177|NCT01271712|12684208|P2|NOT COMPLETED|Survival Follow-up||6
5157178|NCT01271712|12684209|P1|NOT COMPLETED|Survival Follow-up||15
5157179|NCT01271712|12684208|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
5157180|NCT01271712|12684209|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
5157181|NCT01271712|12684208|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
5157182|NCT01271712|12684209|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
5157183|NCT01271712|12684208|P2|NOT COMPLETED|Safety Follow-up||15
5157184|NCT01271712|12684209|P1|NOT COMPLETED|Safety Follow-up||21
5157185|NCT01271712|12684208|P2|COMPLETED|Safety Follow-up||37
5157186|NCT01271712|12684209|P1|COMPLETED|Safety Follow-up||97
5157187|NCT01271712|12684208|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
5157188|NCT01271712|12684209|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
5157189|NCT01271712|12684208|P2|NOT COMPLETED|Open Label Treatment||58
5157190|NCT01271712|12684209|P1|NOT COMPLETED|Open Label Treatment||91
5157191|NCT01271712|12684208|P2|COMPLETED|Open Label Treatment||0
5157192|NCT01271712|12684209|P1|COMPLETED|Open Label Treatment||0
5157193|NCT01271712|12684208|P2|STARTED|Open Label Treatment||58
5157194|NCT01271712|12684209|P1|STARTED|Open Label Treatment||91
5157195|NCT01271712|12684208|P2|NOT COMPLETED|Double Blind Treatment||8
5157196|NCT01271712|12684209|P1|NOT COMPLETED|Double Blind Treatment||42
5157197|NCT01271712|12684208|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
5157198|NCT01271712|12684209|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
5157199|NCT01271712|12684208|P2|Participants Received Treatment|Double Blind Treatment||66
5157200|NCT01271712|12684209|P1|Participants Received Treatment|Double Blind Treatment||132
5157201|NCT01271712|12684208|P2|STARTED|Double Blind Treatment||66
5157202|NCT01271712|12684209|P1|STARTED|Double Blind Treatment||133
5157203|NCT01271686|12684230|P1|NOT COMPLETED|Overall Study||0
5157204|NCT01271686|12684230|P1|COMPLETED|Overall Study||16
5157205|NCT01271686|12684230|P1|STARTED|Overall Study||16
5157206|NCT01271543|12684236|P2|NOT COMPLETED|Overall Study||1
5157207|NCT01271543|12684237|P1|NOT COMPLETED|Overall Study||1
5157208|NCT01271543|12684236|P2|COMPLETED|Overall Study||29
5157209|NCT01271543|12684237|P1|COMPLETED|Overall Study||29
5157210|NCT01271543|12684236|P2|STARTED|Overall Study||30
5157211|NCT01271543|12684237|P1|STARTED|Overall Study||30
5157212|NCT01271452|12684247|P2|NOT COMPLETED|Overall Study||8
5157213|NCT01271452|12684248|P1|NOT COMPLETED|Overall Study||7
5157214|NCT01271452|12684247|P2|COMPLETED|Overall Study||104
5157215|NCT01271452|12684248|P1|COMPLETED|Overall Study||105
5157216|NCT01271452|12684247|P2|STARTED|Overall Study||112
5157217|NCT01271452|12684248|P1|STARTED|Overall Study||112
5157218|NCT01271413|12684270|P2|NOT COMPLETED|Overall Study||8
5157219|NCT01271413|12684271|P1|NOT COMPLETED|Overall Study||9
5157220|NCT01271413|12684270|P2|COMPLETED|Overall Study||28
5157221|NCT01271413|12684271|P1|COMPLETED|Overall Study||28
5157222|NCT01271413|12684270|P2|STARTED|Overall Study||36
5157223|NCT01271413|12684271|P1|STARTED|Overall Study||37
5157224|NCT01271244|12684279|P2|NOT COMPLETED|Overall Study||3
5157225|NCT01271244|12684280|P1|NOT COMPLETED|Overall Study||7
5157226|NCT01271244|12684279|P2|COMPLETED|Overall Study||5
5157227|NCT01271244|12684280|P1|COMPLETED|Overall Study||11
5157228|NCT01271244|12684279|P2|STARTED|Overall Study||8
5157229|NCT01271244|12684280|P1|STARTED|Overall Study||18
5157230|NCT01271036|12684290|P2|NOT COMPLETED|Overall Study||0
5157231|NCT01271036|12684291|P1|NOT COMPLETED|Overall Study||0
5157232|NCT01271036|12684290|P2|COMPLETED|Overall Study||62
5157233|NCT01271036|12684291|P1|COMPLETED|Overall Study||62
5157234|NCT01271036|12684290|P2|STARTED|Overall Study||62
5157235|NCT01271036|12684291|P1|STARTED|Overall Study||62
5157236|NCT01271010|12684305|P1|NOT COMPLETED|Overall Study||61
5157237|NCT01271010|12684305|P1|COMPLETED|Overall Study||28
5157238|NCT01271010|12684305|P1|STARTED|Overall Study||89
5157239|NCT01270971|12684320|P2|NOT COMPLETED|Overall Study||23
5157240|NCT01270971|12684321|P1|NOT COMPLETED|Overall Study||52
5157241|NCT01270971|12684320|P2|COMPLETED|Overall Study||171
5157242|NCT01270971|12684321|P1|COMPLETED|Overall Study||348
5157243|NCT01270971|12684320|P2|STARTED|Overall Study||194
5157244|NCT01270971|12684321|P1|STARTED|Overall Study||400
5157245|NCT01270958|12684333|P1|NOT COMPLETED|Overall Study||4
5157246|NCT01270958|12684333|P1|COMPLETED|Overall Study||56
5157247|NCT01270958|12684333|P1|STARTED|Overall Study||60
5157248|NCT01270919|12684357|P1|NOT COMPLETED|Overall Study||0
5157249|NCT01270919|12684357|P1|COMPLETED|Overall Study||0
5157250|NCT01270919|12684357|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
5157251|NCT01270880|12684362|P1|NOT COMPLETED|Overall Study||1
5157252|NCT01270880|12684362|P1|COMPLETED|Overall Study||17
5157253|NCT01270880|12684362|P1|STARTED|Overall Study||18
5157254|NCT01270867|12684373|P2|NOT COMPLETED|Overall Study||0
5157255|NCT01270867|12684374|P1|NOT COMPLETED|Overall Study||1
5157256|NCT01270867|12684373|P2|COMPLETED|Overall Study||88
5157257|NCT01270867|12684374|P1|COMPLETED|Overall Study||89
5157258|NCT01270867|12684373|P2|STARTED|Overall Study||88
5157259|NCT01270867|12684374|P1|STARTED|Overall Study||90
5157260|NCT01270841|12684392|P4|NOT COMPLETED|Overall Study||13
5157261|NCT01270841|12684393|P3|NOT COMPLETED|Overall Study||11
5157262|NCT01270841|12684394|P2|NOT COMPLETED|Overall Study||14
5157263|NCT01270841|12684395|P1|NOT COMPLETED|Overall Study||13
5157264|NCT01270841|12684392|P4|COMPLETED|Overall Study||20
5157265|NCT01270841|12684393|P3|COMPLETED|Overall Study||18
5157266|NCT01270841|12684394|P2|COMPLETED|Overall Study||19
5157267|NCT01270841|12684395|P1|COMPLETED|Overall Study||16
5157268|NCT01270841|12684392|P4|STARTED|Overall Study||33
5157269|NCT01270841|12684393|P3|STARTED|Overall Study||29
5157270|NCT01270841|12684394|P2|STARTED|Overall Study||33
5157271|NCT01270841|12684395|P1|STARTED|Overall Study||29
5157272|NCT01270828|12684419|P3|NOT COMPLETED|Double Blind Phase||0
5157273|NCT01270828|12684420|P2|NOT COMPLETED|Double Blind Phase||45
5157274|NCT01270828|12684421|P1|NOT COMPLETED|Double Blind Phase||26
5157275|NCT01270828|12684419|P3|COMPLETED|Double Blind Phase||0
5157276|NCT01270828|12684420|P2|COMPLETED|Double Blind Phase||160
5157277|NCT01270828|12684421|P1|COMPLETED|Double Blind Phase||182
5157278|NCT01270828|12684419|P3|STARTED|Double Blind Phase||0
5157279|NCT01270828|12684420|P2|STARTED|Double Blind Phase||205
5157280|NCT01270828|12684421|P1|STARTED|Double Blind Phase||208
5157281|NCT01270828|12684419|P3|NOT COMPLETED|Pregabalin CR SB||146
5157282|NCT01270828|12684420|P2|NOT COMPLETED|Pregabalin CR SB||0
5157283|NCT01270828|12684421|P1|NOT COMPLETED|Pregabalin CR SB||0
5157284|NCT01270828|12684419|P3|COMPLETED|Pregabalin CR SB||660
5157285|NCT01270828|12684420|P2|COMPLETED|Pregabalin CR SB||0
5157286|NCT01270828|12684421|P1|COMPLETED|Pregabalin CR SB||0
5157287|NCT01270828|12684419|P3|STARTED|Pregabalin CR SB||806
5157288|NCT01270828|12684420|P2|STARTED|Pregabalin CR SB||0
5157289|NCT01270828|12684421|P1|STARTED|Pregabalin CR SB||0
5157290|NCT01270802|12684463|P2|NOT COMPLETED|Overall Study||1
5157291|NCT01270802|12684464|P1|NOT COMPLETED|Overall Study||2
5157292|NCT01270802|12684463|P2|COMPLETED|Overall Study||14
5157293|NCT01270802|12684464|P1|COMPLETED|Overall Study||13
5157294|NCT01270802|12684463|P2|STARTED|Overall Study||15
5157295|NCT01270802|12684464|P1|STARTED|Overall Study||15
5157296|NCT01270711|12684480|P8|NOT COMPLETED|Part 2: Effectiveness||0
5157297|NCT01270711|12684481|P7|NOT COMPLETED|Part 2: Effectiveness||0
5157298|NCT01270711|12684482|P6|NOT COMPLETED|Part 2: Effectiveness||0
5157299|NCT01270711|12684483|P5|NOT COMPLETED|Part 2: Effectiveness||0
5157300|NCT01270711|12684484|P4|NOT COMPLETED|Part 2: Effectiveness||0
5157301|NCT01270711|12684485|P3|NOT COMPLETED|Part 2: Effectiveness||0
5157302|NCT01270711|12684486|P2|NOT COMPLETED|Part 2: Effectiveness||0
5157303|NCT01270711|12684487|P1|NOT COMPLETED|Part 2: Effectiveness||0
5157304|NCT01270711|12684480|P8|COMPLETED|Part 2: Effectiveness||48
5157305|NCT01270711|12684481|P7|COMPLETED|Part 2: Effectiveness||2
5157306|NCT01270711|12684482|P6|COMPLETED|Part 2: Effectiveness||11
5157307|NCT01270711|12684483|P5|COMPLETED|Part 2: Effectiveness||0
5157308|NCT01270711|12684484|P4|COMPLETED|Part 2: Effectiveness||0
5157309|NCT01270711|12684485|P3|COMPLETED|Part 2: Effectiveness||0
5157310|NCT01270711|12684486|P2|COMPLETED|Part 2: Effectiveness||0
5157311|NCT01270711|12684487|P1|COMPLETED|Part 2: Effectiveness||0
5157312|NCT01270711|12684480|P8|STARTED|Part 2: Effectiveness||48
5157313|NCT01270711|12684481|P7|STARTED|Part 2: Effectiveness||2
5157314|NCT01270711|12684482|P6|STARTED|Part 2: Effectiveness||11
5157315|NCT01270711|12684483|P5|STARTED|Part 2: Effectiveness||0
5157316|NCT01270711|12684484|P4|STARTED|Part 2: Effectiveness||0
5157317|NCT01270711|12684485|P3|STARTED|Part 2: Effectiveness||0
5157318|NCT01270711|12684486|P2|STARTED|Part 2: Effectiveness||0
5157319|NCT01270711|12684487|P1|STARTED|Part 2: Effectiveness||0
5157320|NCT01270711|12684480|P8|NOT COMPLETED|Part 1: Compliance||0
5157321|NCT01270711|12684481|P7|NOT COMPLETED|Part 1: Compliance||0
5157322|NCT01270711|12684482|P6|NOT COMPLETED|Part 1: Compliance||0
5157323|NCT01270711|12684483|P5|NOT COMPLETED|Part 1: Compliance||0
5157324|NCT01270711|12684484|P4|NOT COMPLETED|Part 1: Compliance||0
5157325|NCT01270711|12684485|P3|NOT COMPLETED|Part 1: Compliance||0
5157326|NCT01270711|12684486|P2|NOT COMPLETED|Part 1: Compliance||0
5157327|NCT01270711|12684487|P1|NOT COMPLETED|Part 1: Compliance||0
5157328|NCT01270711|12684480|P8|COMPLETED|Part 1: Compliance||0
5157329|NCT01270711|12684481|P7|COMPLETED|Part 1: Compliance||0
5157330|NCT01270711|12684482|P6|COMPLETED|Part 1: Compliance||0
5157331|NCT01270711|12684483|P5|COMPLETED|Part 1: Compliance||2024
5157332|NCT01270711|12684484|P4|COMPLETED|Part 1: Compliance||5486
5157333|NCT01270711|12684485|P3|COMPLETED|Part 1: Compliance||326
5157334|NCT01270711|12684486|P2|COMPLETED|Part 1: Compliance||6580
5157335|NCT01270711|12684487|P1|COMPLETED|Part 1: Compliance||7537
5157336|NCT01270711|12684480|P8|STARTED|Part 1: Compliance||0
5157337|NCT01270711|12684481|P7|STARTED|Part 1: Compliance||0
5157338|NCT01270711|12684482|P6|STARTED|Part 1: Compliance||0
5157339|NCT01270711|12684483|P5|STARTED|Part 1: Compliance||2024
5157340|NCT01270711|12684484|P4|STARTED|Part 1: Compliance||5486
5157341|NCT01270711|12684485|P3|STARTED|Part 1: Compliance||326
5157342|NCT01270711|12684486|P2|STARTED|Part 1: Compliance||6580
5157343|NCT01270711|12684487|P1|STARTED|Part 1: Compliance||7537
5157344|NCT01270659|12684588|P4|NOT COMPLETED|Overall Study||0
5157345|NCT01270659|12684589|P3|NOT COMPLETED|Overall Study||0
5157346|NCT01270659|12684590|P2|NOT COMPLETED|Overall Study||0
5157347|NCT01270659|12684591|P1|NOT COMPLETED|Overall Study||0
5157348|NCT01270659|12684588|P4|COMPLETED|Overall Study||25
5157349|NCT01270659|12684589|P3|COMPLETED|Overall Study||4
5157350|NCT01270659|12684590|P2|COMPLETED|Overall Study||25
5157351|NCT01270659|12684591|P1|COMPLETED|Overall Study||6
5157352|NCT01270659|12684588|P4|STARTED|Overall Study||25
5157353|NCT01270659|12684589|P3|STARTED|Overall Study||4
5157354|NCT01270659|12684590|P2|STARTED|Overall Study||25
5157355|NCT01270659|12684591|P1|STARTED|Overall Study||6
5157356|NCT01270620|12684611|P2|NOT COMPLETED|Overall Study||3
5157357|NCT01270620|12684612|P1|NOT COMPLETED|Overall Study||1
5157358|NCT01270620|12684611|P2|COMPLETED|Overall Study||47
5157359|NCT01270620|12684612|P1|COMPLETED|Overall Study||49
5157360|NCT01270620|12684611|P2|STARTED|Overall Study||50
5157361|NCT01270620|12684612|P1|STARTED|Overall Study||50
5157362|NCT01270581|12684664|P2|NOT COMPLETED|Overall Study||0
5157363|NCT01270581|12684665|P1|NOT COMPLETED|Overall Study||1
5157364|NCT01270581|12684664|P2|COMPLETED|Overall Study||3
5157365|NCT01270581|12684665|P1|COMPLETED|Overall Study||3
5157366|NCT01270581|12684664|P2|STARTED|Overall Study||3
5157367|NCT01270581|12684665|P1|STARTED|Overall Study||4
5157368|NCT01270555|12684671|P1|NOT COMPLETED|Overall Study||13
5157369|NCT01270555|12684671|P1|COMPLETED|Overall Study||19
5157370|NCT01270555|12684671|P1|STARTED|Overall Study||32
5157371|NCT01270542|12684683|P2|NOT COMPLETED|Overall Study||1
5157372|NCT01270542|12684684|P1|NOT COMPLETED|Overall Study||1
5157373|NCT01270542|12684683|P2|COMPLETED|Overall Study||8
5157374|NCT01270542|12684684|P1|COMPLETED|Overall Study||9
5157375|NCT01270542|12684683|P2|STARTED|Overall Study||9
5157376|NCT01270542|12684684|P1|STARTED|Overall Study||10
5157377|NCT01270529|12684697|P3|NOT COMPLETED|Overall Study||0
5157378|NCT01270529|12684698|P2|NOT COMPLETED|Overall Study||0
5157379|NCT01270529|12684699|P1|NOT COMPLETED|Overall Study||0
5157380|NCT01270529|12684697|P3|COMPLETED|Overall Study||25
5157381|NCT01270529|12684698|P2|COMPLETED|Overall Study||7
5157382|NCT01270529|12684699|P1|COMPLETED|Overall Study||12
5157383|NCT01270529|12684697|P3|STARTED|Overall Study||25
5157384|NCT01270529|12684698|P2|STARTED|Overall Study||7
5157385|NCT01270529|12684699|P1|STARTED|Overall Study||12
5157386|NCT01270503|12684707|P1|NOT COMPLETED|Overall Study||1
5157387|NCT01270503|12684707|P1|COMPLETED|Overall Study||537
5157388|NCT01270503|12684707|P1|STARTED|Overall Study||538
5157389|NCT01270464|12684715|P3|NOT COMPLETED|Overall Study||18
5157390|NCT01270464|12684716|P2|NOT COMPLETED|Overall Study||12
5157391|NCT01270464|12684717|P1|NOT COMPLETED|Overall Study||20
5157392|NCT01270464|12684715|P3|COMPLETED|Overall Study||88
5157393|NCT01270464|12684716|P2|COMPLETED|Overall Study||92
5157394|NCT01270464|12684717|P1|COMPLETED|Overall Study||85
5157395|NCT01270464|12684715|P3|Pharmacokinetic Analysis Set|Overall Study||103
5157396|NCT01270464|12684716|P2|Pharmacokinetic Analysis Set|Overall Study||103
5157397|NCT01270464|12684717|P1|Pharmacokinetic Analysis Set|Overall Study||105
5157398|NCT01270464|12684715|P3|Full Analysis Set|Overall Study||103
5157399|NCT01270464|12684716|P2|Full Analysis Set|Overall Study||103
5157400|NCT01270464|12684717|P1|Full Analysis Set|Overall Study||105
5157401|NCT01270464|12684715|P3|Safety Analysis Set|Overall Study||103
5157402|NCT01270464|12684716|P2|Safety Analysis Set|Overall Study||103
5157403|NCT01270464|12684717|P1|Safety Analysis Set|Overall Study||105
5157404|NCT01270464|12684715|P3|STARTED|Overall Study||106
5157405|NCT01270464|12684716|P2|STARTED|Overall Study||104
5157406|NCT01270464|12684717|P1|STARTED|Overall Study||105
5157407|NCT01270256|12684766|P2|NOT COMPLETED|Overall Study||0
5157408|NCT01270256|12684767|P1|NOT COMPLETED|Overall Study||1
5157409|NCT01270256|12684766|P2|COMPLETED|Overall Study||20
5157410|NCT01270256|12684767|P1|COMPLETED|Overall Study||20
5157411|NCT01270256|12684766|P2|STARTED|Overall Study||20
5157412|NCT01270256|12684767|P1|STARTED|Overall Study||21
5157413|NCT01270139|12684776|P3|NOT COMPLETED|Overall Study||20
5157414|NCT01270139|12684777|P2|NOT COMPLETED|Overall Study||26
5157415|NCT01270139|12684778|P1|NOT COMPLETED|Overall Study||18
5157416|NCT01270139|12684776|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
5157417|NCT01270139|12684777|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
5157482|NCT01269710|12684915|P1|NOT COMPLETED|Overall Study||3
5157418|NCT01270139|12684778|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
5157419|NCT01270139|12684776|P3|STARTED|Overall Study|Intention-to-treat population|60
5157420|NCT01270139|12684777|P2|STARTED|Overall Study|Intention-to-treat population|60
5157421|NCT01270139|12684778|P1|STARTED|Overall Study|Intention-to-treat population|60
5157422|NCT01270126|12684838|P2|NOT COMPLETED|Overall Study||0
5157423|NCT01270126|12684839|P1|NOT COMPLETED|Overall Study||0
5157424|NCT01270126|12684838|P2|COMPLETED|Overall Study||10
5157425|NCT01270126|12684839|P1|COMPLETED|Overall Study||12
5157426|NCT01270126|12684838|P2|STARTED|Overall Study||10
5157427|NCT01270126|12684839|P1|STARTED|Overall Study||12
5157428|NCT01269918|12684847|P2|NOT COMPLETED|Overall Study||3
5157429|NCT01269918|12684848|P1|NOT COMPLETED|Overall Study||0
5157430|NCT01269918|12684847|P2|COMPLETED|Overall Study||68
5157431|NCT01269918|12684848|P1|COMPLETED|Overall Study||71
5157432|NCT01269918|12684847|P2|STARTED|Overall Study||71
5157433|NCT01269918|12684848|P1|STARTED|Overall Study||71
5157434|NCT01269801|12684882|P2|NOT COMPLETED|Overall Study||3
5157435|NCT01269801|12684883|P1|NOT COMPLETED|Overall Study||0
5157436|NCT01269801|12684882|P2|COMPLETED|Overall Study||77
5157437|NCT01269801|12684883|P1|COMPLETED|Overall Study||74
5157438|NCT01269801|12684882|P2|STARTED|Overall Study||80
5157439|NCT01269801|12684883|P1|STARTED|Overall Study||74
5157440|NCT01269749|12684891|P2|NOT COMPLETED|Overall Study||0
5157441|NCT01269749|12684892|P1|NOT COMPLETED|Overall Study||0
5157442|NCT01269749|12684891|P2|COMPLETED|Overall Study||3
5157443|NCT01269749|12684892|P1|COMPLETED|Overall Study||16
5157444|NCT01269749|12684891|P2|STARTED|Overall Study||3
5157445|NCT01269749|12684892|P1|STARTED|Overall Study||16
5157446|NCT01269736|12684902|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
5157447|NCT01269736|12684903|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
5157448|NCT01269736|12684902|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
5157449|NCT01269736|12684903|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
5157450|NCT01269736|12684902|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
5157451|NCT01269736|12684903|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
5157452|NCT01269736|12684902|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
5157453|NCT01269736|12684903|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
5157454|NCT01269736|12684902|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
5157455|NCT01269736|12684903|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
5157456|NCT01269736|12684902|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
5157457|NCT01269736|12684903|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
5157458|NCT01269736|12684902|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
5157459|NCT01269736|12684903|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
5157460|NCT01269736|12684902|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
5157461|NCT01269736|12684903|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
5157462|NCT01269736|12684902|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
5157463|NCT01269736|12684903|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
5157464|NCT01269736|12684902|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
5157465|NCT01269736|12684903|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
5157466|NCT01269736|12684902|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
5157467|NCT01269736|12684903|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
5157468|NCT01269736|12684902|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
5157469|NCT01269736|12684903|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
5157470|NCT01269736|12684902|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
5157471|NCT01269736|12684903|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
5157472|NCT01269736|12684902|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
5157473|NCT01269736|12684903|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
5157474|NCT01269736|12684902|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
5157475|NCT01269736|12684903|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
5157476|NCT01269736|12684902|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
5157477|NCT01269736|12684903|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
5157478|NCT01269736|12684902|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
5157479|NCT01269736|12684903|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
5157480|NCT01269736|12684902|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
5157481|NCT01269736|12684903|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
5157483|NCT01269710|12684915|P1|COMPLETED|Overall Study|This refers to Week 52.|1
5157484|NCT01269710|12684915|P1|Week 36|Overall Study||2
5157485|NCT01269710|12684915|P1|Week 12|Overall Study||3
5157486|NCT01269710|12684915|P1|STARTED|Overall Study||4
5157487|NCT01269385|12684923|P4|NOT COMPLETED|Overall Study||0
5157488|NCT01269385|12684924|P3|NOT COMPLETED|Overall Study||0
5157489|NCT01269385|12684925|P2|NOT COMPLETED|Overall Study||1
5157490|NCT01269385|12684926|P1|NOT COMPLETED|Overall Study||1
5157491|NCT01269385|12684923|P4|COMPLETED|Overall Study||8
5157492|NCT01269385|12684924|P3|COMPLETED|Overall Study||6
5157493|NCT01269385|12684925|P2|COMPLETED|Overall Study||3
5157494|NCT01269385|12684926|P1|COMPLETED|Overall Study||3
5157495|NCT01269385|12684923|P4|STARTED|Overall Study||8
5157496|NCT01269385|12684924|P3|STARTED|Overall Study||6
5157497|NCT01269385|12684925|P2|STARTED|Overall Study||4
5157498|NCT01269385|12684926|P1|STARTED|Overall Study||4
5157499|NCT01269346|12684940|P1|NOT COMPLETED|Extension Phase||43
5157500|NCT01269346|12684940|P1|COMPLETED|Extension Phase||0
5157501|NCT01269346|12684940|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
5157502|NCT01269346|12684940|P1|NOT COMPLETED|Treatment Phase||9
5157503|NCT01269346|12684940|P1|COMPLETED|Treatment Phase||43
5157504|NCT01269346|12684940|P1|Completed 6 Cycles|Treatment Phase||45
5157505|NCT01269346|12684940|P1|STARTED|Treatment Phase||52
5157506|NCT01269125|12684951|P3|NOT COMPLETED|Overall Study||0
5157507|NCT01269125|12684952|P2|NOT COMPLETED|Overall Study||5
5157508|NCT01269125|12684953|P1|NOT COMPLETED|Overall Study||7
5157509|NCT01269125|12684951|P3|COMPLETED|Overall Study||60
5157510|NCT01269125|12684952|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
5157511|NCT01269125|12684953|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
5157512|NCT01269125|12684951|P3|STARTED|Overall Study||60
5157513|NCT01269125|12684952|P2|STARTED|Overall Study||60
5157514|NCT01269125|12684953|P1|STARTED|Overall Study||60
5157515|NCT01269047|12684976|P3|NOT COMPLETED|Overall Study||1
5157516|NCT01269047|12684977|P2|NOT COMPLETED|Overall Study||2
5157517|NCT01269047|12684978|P1|NOT COMPLETED|Overall Study||1
5157518|NCT01269047|12684976|P3|COMPLETED|Overall Study||10
5157519|NCT01269047|12684977|P2|COMPLETED|Overall Study||11
5157520|NCT01269047|12684978|P1|COMPLETED|Overall Study||12
5157521|NCT01269047|12684976|P3|STARTED|Overall Study||11
5157522|NCT01269047|12684977|P2|STARTED|Overall Study||13
5157523|NCT01269047|12684978|P1|STARTED|Overall Study||13
5157524|NCT01268943|12684997|P4|NOT COMPLETED|Overall Study||0
5157525|NCT01268943|12684998|P3|NOT COMPLETED|Overall Study||0
5157526|NCT01268943|12684999|P2|NOT COMPLETED|Overall Study||0
5157527|NCT01268943|12685000|P1|NOT COMPLETED|Overall Study||0
5157528|NCT01268943|12684997|P4|COMPLETED|Overall Study||6
5157529|NCT01268943|12684998|P3|COMPLETED|Overall Study||3
5157530|NCT01268943|12684999|P2|COMPLETED|Overall Study||3
5157531|NCT01268943|12685000|P1|COMPLETED|Overall Study||6
5157532|NCT01268943|12684997|P4|STARTED|Overall Study||6
5157533|NCT01268943|12684998|P3|STARTED|Overall Study||3
5157534|NCT01268943|12684999|P2|STARTED|Overall Study||3
5157535|NCT01268943|12685000|P1|STARTED|Overall Study||6
5157536|NCT01268891|12685012|P2|NOT COMPLETED|Overall Study||8
5157537|NCT01268891|12685013|P1|NOT COMPLETED|Overall Study||8
5157538|NCT01268891|12685012|P2|COMPLETED|Overall Study||58
5157539|NCT01268891|12685013|P1|COMPLETED|Overall Study||58
5157540|NCT01268891|12685012|P2|STARTED|Overall Study||66
5157541|NCT01268891|12685013|P1|STARTED|Overall Study||66
5157542|NCT01268683|12685025|P1|NOT COMPLETED|Overall Study||0
5157543|NCT01268683|12685025|P1|COMPLETED|Overall Study||10
5157544|NCT01268683|12685025|P1|STARTED|Overall Study||10
5157545|NCT01268644|12685032|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
5157546|NCT01268644|12685032|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
5157547|NCT01268644|12685032|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
5157548|NCT01268644|12685032|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
5157549|NCT01268644|12685032|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
5157550|NCT01268644|12685032|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
5157551|NCT01268644|12685032|P1|NOT COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||0
5157552|NCT01268644|12685032|P1|COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||8
5157553|NCT01268644|12685032|P1|STARTED|Phase A (Weeks 0–12) Leptin Therapy||8
5157554|NCT01268644|12685032|P1|NOT COMPLETED|Baseline Period (Week 0)||0
5157555|NCT01268644|12685032|P1|COMPLETED|Baseline Period (Week 0)||8
5157556|NCT01268644|12685032|P1|STARTED|Baseline Period (Week 0)||8
5157557|NCT01268566|12685039|P1|NOT COMPLETED|Overall Study||43
5157558|NCT01268566|12685039|P1|COMPLETED|Overall Study||13
5157559|NCT01268566|12685039|P1|STARTED|Overall Study||56
5157560|NCT01268553|12685057|P1|NOT COMPLETED|Overall Study||0
5157561|NCT01268553|12685057|P1|COMPLETED|Overall Study||6
5157562|NCT01268553|12685057|P1|STARTED|Overall Study||6
5157563|NCT01268514|12685066|P1|NOT COMPLETED|Overall Study||41
5157564|NCT01268514|12685066|P1|COMPLETED|Overall Study||74
5157565|NCT01268514|12685066|P1|Participants Who Received the Device|Overall Study||114
5157566|NCT01268514|12685066|P1|STARTED|Overall Study||115
5157567|NCT01268501|12685075|P1|NOT COMPLETED|Overall Study||9
5157568|NCT01268501|12685075|P1|COMPLETED|Overall Study||87
5157569|NCT01268501|12685075|P1|STARTED|Overall Study||96
5157570|NCT01268488|12685079|P1|NOT COMPLETED|Overall Study||5
5157571|NCT01268488|12685079|P1|COMPLETED|Overall Study||93
5157572|NCT01268488|12685079|P1|STARTED|Overall Study||98
5157573|NCT01268306|12685086|P1|NOT COMPLETED|Overall Study||1
5157574|NCT01268306|12685086|P1|COMPLETED|Overall Study||7
5157575|NCT01268306|12685086|P1|STARTED|Overall Study||8
5157576|NCT01268293|12685090|P1|NOT COMPLETED|Overall Study||9
5157577|NCT01268293|12685090|P1|COMPLETED|Overall Study||0
5157578|NCT01268293|12685090|P1|Completed Cycle 1|Overall Study||9
5157579|NCT01268293|12685090|P1|STARTED|Overall Study||9
5157580|NCT01268267|12685095|P1|NOT COMPLETED|Overall Study||1
5157581|NCT01268267|12685095|P1|COMPLETED|Overall Study||93
5157582|NCT01268267|12685095|P1|STARTED|Overall Study||94
5157583|NCT01268189|12685102|P1|NOT COMPLETED|Overall Study||3
5157584|NCT01268189|12685102|P1|COMPLETED|Overall Study||17
5157585|NCT01268189|12685102|P1|STARTED|Overall Study||20
5157586|NCT01268150|12685116|P1|NOT COMPLETED|Extension Phase||27
5157587|NCT01268150|12685116|P1|COMPLETED|Extension Phase||1
5157588|NCT01268150|12685116|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
5157589|NCT01268150|12685116|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
5157590|NCT01268150|12685116|P1|NOT COMPLETED|Treatment Phase||28
5157591|NCT01268150|12685116|P1|COMPLETED|Treatment Phase||28
5157592|NCT01268150|12685116|P1|STARTED|Treatment Phase||56
5157593|NCT01268111|12685126|P2|NOT COMPLETED|Overall Study||0
5157594|NCT01268111|12685127|P1|NOT COMPLETED|Overall Study||0
5157595|NCT01268111|12685126|P2|COMPLETED|Overall Study||6
5157596|NCT01268111|12685127|P1|COMPLETED|Overall Study||6
5157597|NCT01268111|12685126|P2|STARTED|Overall Study||6
5157598|NCT01268111|12685127|P1|STARTED|Overall Study||6
5157599|NCT01268098|12685135|P2|NOT COMPLETED|Overall Study||0
5157600|NCT01268098|12685136|P1|NOT COMPLETED|Overall Study||1
5157601|NCT01268098|12685135|P2|COMPLETED|Overall Study||23
5157602|NCT01268098|12685136|P1|COMPLETED|Overall Study||18
5157603|NCT01268098|12685135|P2|STARTED|Overall Study||23
5157604|NCT01268098|12685136|P1|STARTED|Overall Study||19
5157605|NCT01268046|12685148|P4|NOT COMPLETED|Overall Study||1
5157606|NCT01268046|12685149|P3|NOT COMPLETED|Overall Study||1
5157607|NCT01268046|12685150|P2|NOT COMPLETED|Overall Study||0
5157608|NCT01268046|12685151|P1|NOT COMPLETED|Overall Study||1
5157609|NCT01268046|12685148|P4|COMPLETED|Overall Study||7
5157610|NCT01268046|12685149|P3|COMPLETED|Overall Study||7
5157611|NCT01268046|12685150|P2|COMPLETED|Overall Study||9
5157612|NCT01268046|12685151|P1|COMPLETED|Overall Study||12
5157613|NCT01268046|12685148|P4|STARTED|Overall Study||8
5157614|NCT01268046|12685149|P3|STARTED|Overall Study||8
5157615|NCT01268046|12685150|P2|STARTED|Overall Study||9
5157616|NCT01268046|12685151|P1|STARTED|Overall Study||13
5157617|NCT01267994|12685161|P1|NOT COMPLETED|Overall Study||2
5157618|NCT01267994|12685161|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
5157619|NCT01267994|12685161|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
5157620|NCT01267955|12685166|P1|NOT COMPLETED|Stage 2 (6 Months)||6
5157621|NCT01267955|12685166|P1|COMPLETED|Stage 2 (6 Months)||39
5157622|NCT01267955|12685166|P1|STARTED|Stage 2 (6 Months)||45
5157623|NCT01267955|12685166|P1|NOT COMPLETED|Stage 1 (6 Months)||3
5157624|NCT01267955|12685166|P1|COMPLETED|Stage 1 (6 Months)||17
5157625|NCT01267955|12685166|P1|STARTED|Stage 1 (6 Months)||20
5157626|NCT01267929|12685172|P2|NOT COMPLETED|Overall Study||0
5157627|NCT01267929|12685173|P1|NOT COMPLETED|Overall Study||0
5157628|NCT01267929|12685172|P2|COMPLETED|Overall Study||15
5157629|NCT01267929|12685173|P1|COMPLETED|Overall Study||15
5157630|NCT01267929|12685172|P2|STARTED|Overall Study||15
5157631|NCT01267929|12685173|P1|STARTED|Overall Study||15
5157632|NCT01267864|12685182|P3|NOT COMPLETED|Overall Study||0
5157633|NCT01267864|12685183|P2|NOT COMPLETED|Overall Study||0
5157634|NCT01267864|12685184|P1|NOT COMPLETED|Overall Study||0
5157635|NCT01267864|12685182|P3|COMPLETED|Overall Study||110
5157636|NCT01267864|12685183|P2|COMPLETED|Overall Study||110
5157637|NCT01267864|12685184|P1|COMPLETED|Overall Study||110
5157638|NCT01267864|12685182|P3|STARTED|Overall Study||110
5157639|NCT01267864|12685183|P2|STARTED|Overall Study||110
5157640|NCT01267864|12685184|P1|STARTED|Overall Study||110
5157641|NCT01267825|12685203|P2|NOT COMPLETED|Overall Study||0
5157642|NCT01267825|12685204|P1|NOT COMPLETED|Overall Study||1
5157643|NCT01267825|12685203|P2|COMPLETED|Overall Study||0
5157644|NCT01267825|12685204|P1|COMPLETED|Overall Study||0
5157645|NCT01267825|12685203|P2|STARTED|Overall Study||0
5157646|NCT01267825|12685204|P1|STARTED|Overall Study||1
5157647|NCT01267422|12685214|P2|NOT COMPLETED|Safety and Efficacy Study||0
5157648|NCT01267422|12685215|P1|NOT COMPLETED|Safety and Efficacy Study||0
5157649|NCT01267422|12685214|P2|COMPLETED|Safety and Efficacy Study||4
5157650|NCT01267422|12685215|P1|COMPLETED|Safety and Efficacy Study||5
5157651|NCT01267422|12685214|P2|STARTED|Safety and Efficacy Study||4
5157652|NCT01267422|12685215|P1|STARTED|Safety and Efficacy Study||5
5157653|NCT01267422|12685214|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
5157654|NCT01267422|12685215|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
5157655|NCT01267422|12685214|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
5157656|NCT01267422|12685215|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
5157657|NCT01267422|12685214|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
5157658|NCT01267422|12685215|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
5157659|NCT01267292|12685235|P2|NOT COMPLETED|Overall Study||6
5157660|NCT01267292|12685236|P1|NOT COMPLETED|Overall Study||4
5157661|NCT01267292|12685235|P2|COMPLETED|Overall Study||20
5157662|NCT01267292|12685236|P1|COMPLETED|Overall Study||20
5157663|NCT01267292|12685235|P2|STARTED|Overall Study||26
5157664|NCT01267292|12685236|P1|STARTED|Overall Study||24
5157665|NCT01267279|12685272|P2|NOT COMPLETED|Overall Study||6
5157666|NCT01267279|12685273|P1|NOT COMPLETED|Overall Study||2
5157667|NCT01267279|12685272|P2|COMPLETED|Overall Study||21
5157668|NCT01267279|12685273|P1|COMPLETED|Overall Study||22
5157669|NCT01267279|12685272|P2|STARTED|Overall Study||27
5157670|NCT01267279|12685273|P1|STARTED|Overall Study||24
5157671|NCT01267266|12685279|P2|NOT COMPLETED|Randomized Phase||0
5157672|NCT01267266|12685280|P1|NOT COMPLETED|Randomized Phase||0
5157673|NCT01267266|12685279|P2|COMPLETED|Randomized Phase||5
5157674|NCT01267266|12685280|P1|COMPLETED|Randomized Phase||3
5157675|NCT01267266|12685279|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
5157676|NCT01267266|12685280|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
5157677|NCT01267266|12685279|P2|NOT COMPLETED|Lead-in Phase||0
5157678|NCT01267266|12685280|P1|NOT COMPLETED|Lead-in Phase||23
5157679|NCT01267266|12685279|P2|COMPLETED|Lead-in Phase||0
5157680|NCT01267266|12685280|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
5157681|NCT01267266|12685279|P2|STARTED|Lead-in Phase||0
5157682|NCT01267266|12685280|P1|STARTED|Lead-in Phase||31
5157683|NCT01267266|12685279|P2|NOT COMPLETED|Enrollment Phase||0
5157684|NCT01267266|12685280|P1|NOT COMPLETED|Enrollment Phase||2
5157685|NCT01267266|12685279|P2|COMPLETED|Enrollment Phase||0
5157686|NCT01267266|12685280|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
5157687|NCT01267266|12685279|P2|STARTED|Enrollment Phase||0
5157688|NCT01267266|12685280|P1|STARTED|Enrollment Phase||33
5157689|NCT01267253|12685293|P1|NOT COMPLETED|Overall Study||3
5157690|NCT01267253|12685293|P1|COMPLETED|Overall Study|Eligible and treated patients|28
5157691|NCT01267253|12685293|P1|STARTED|Overall Study||31
5157692|NCT01267240|12685301|P1|NOT COMPLETED|Overall Study||0
5157693|NCT01267240|12685301|P1|COMPLETED|Overall Study||25
5157694|NCT01267240|12685301|P1|STARTED|Overall Study||25
5157695|NCT01267227|12685311|P4|NOT COMPLETED|Overall Study||3
5157696|NCT01267227|12685312|P3|NOT COMPLETED|Overall Study||2
5157697|NCT01267227|12685313|P2|NOT COMPLETED|Overall Study||1
5157698|NCT01267227|12685314|P1|NOT COMPLETED|Overall Study||1
5157699|NCT01267227|12685311|P4|COMPLETED|Overall Study||17
5157700|NCT01267227|12685312|P3|COMPLETED|Overall Study||18
5157701|NCT01267227|12685313|P2|COMPLETED|Overall Study||19
5157702|NCT01267227|12685314|P1|COMPLETED|Overall Study||19
5157703|NCT01267227|12685311|P4|STARTED|Overall Study||20
5157704|NCT01267227|12685312|P3|STARTED|Overall Study||20
5157705|NCT01267227|12685313|P2|STARTED|Overall Study||20
5157706|NCT01267227|12685314|P1|STARTED|Overall Study||20
5157707|NCT01267201|12685332|P6|NOT COMPLETED|Third Intervention Period||0
5157708|NCT01267201|12685333|P5|NOT COMPLETED|Third Intervention Period||0
5157709|NCT01267201|12685334|P4|NOT COMPLETED|Third Intervention Period||0
5157710|NCT01267201|12685335|P3|NOT COMPLETED|Third Intervention Period||0
5157711|NCT01267201|12685336|P2|NOT COMPLETED|Third Intervention Period||0
5157712|NCT01267201|12685337|P1|NOT COMPLETED|Third Intervention Period||0
5157713|NCT01267201|12685332|P6|COMPLETED|Third Intervention Period||4
5157714|NCT01267201|12685333|P5|COMPLETED|Third Intervention Period||4
5157715|NCT01267201|12685334|P4|COMPLETED|Third Intervention Period||4
5157716|NCT01267201|12685335|P3|COMPLETED|Third Intervention Period||4
5157717|NCT01267201|12685336|P2|COMPLETED|Third Intervention Period||3
5157718|NCT01267201|12685337|P1|COMPLETED|Third Intervention Period||3
5157719|NCT01267201|12685332|P6|STARTED|Third Intervention Period||4
5157720|NCT01267201|12685333|P5|STARTED|Third Intervention Period||4
5157721|NCT01267201|12685334|P4|STARTED|Third Intervention Period||4
5157722|NCT01267201|12685335|P3|STARTED|Third Intervention Period||4
5157723|NCT01267201|12685336|P2|STARTED|Third Intervention Period||3
5157724|NCT01267201|12685337|P1|STARTED|Third Intervention Period||3
5157725|NCT01267201|12685332|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157726|NCT01267201|12685333|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157727|NCT01267201|12685334|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157728|NCT01267201|12685335|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157729|NCT01267201|12685336|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157730|NCT01267201|12685337|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157731|NCT01267201|12685332|P6|COMPLETED|Washout Period (At Least 2 Days)||4
5157732|NCT01267201|12685333|P5|COMPLETED|Washout Period (At Least 2 Days)||4
5157733|NCT01267201|12685334|P4|COMPLETED|Washout Period (At Least 2 Days)||4
5157734|NCT01267201|12685335|P3|COMPLETED|Washout Period (At Least 2 Days)||4
5157735|NCT01267201|12685336|P2|COMPLETED|Washout Period (At Least 2 Days)||3
5157736|NCT01267201|12685337|P1|COMPLETED|Washout Period (At Least 2 Days)||3
5157737|NCT01267201|12685332|P6|STARTED|Washout Period (At Least 2 Days)||4
5157738|NCT01267201|12685333|P5|STARTED|Washout Period (At Least 2 Days)||4
5157739|NCT01267201|12685334|P4|STARTED|Washout Period (At Least 2 Days)||4
5157740|NCT01267201|12685335|P3|STARTED|Washout Period (At Least 2 Days)||4
5157741|NCT01267201|12685336|P2|STARTED|Washout Period (At Least 2 Days)||3
5157742|NCT01267201|12685337|P1|STARTED|Washout Period (At Least 2 Days)||3
5157743|NCT01267201|12685332|P6|NOT COMPLETED|Second Intervention Period||0
5157744|NCT01267201|12685333|P5|NOT COMPLETED|Second Intervention Period||0
5157745|NCT01267201|12685334|P4|NOT COMPLETED|Second Intervention Period||0
5157746|NCT01267201|12685335|P3|NOT COMPLETED|Second Intervention Period||0
5157747|NCT01267201|12685336|P2|NOT COMPLETED|Second Intervention Period||1
5157748|NCT01267201|12685337|P1|NOT COMPLETED|Second Intervention Period||0
5157749|NCT01267201|12685332|P6|COMPLETED|Second Intervention Period||4
5157750|NCT01267201|12685333|P5|COMPLETED|Second Intervention Period||4
5157751|NCT01267201|12685334|P4|COMPLETED|Second Intervention Period||4
5157752|NCT01267201|12685335|P3|COMPLETED|Second Intervention Period||4
5157753|NCT01267201|12685336|P2|COMPLETED|Second Intervention Period||3
5157754|NCT01267201|12685337|P1|COMPLETED|Second Intervention Period||3
5157755|NCT01267201|12685332|P6|STARTED|Second Intervention Period||4
5157756|NCT01267201|12685333|P5|STARTED|Second Intervention Period||4
5157757|NCT01267201|12685334|P4|STARTED|Second Intervention Period||4
5157758|NCT01267201|12685335|P3|STARTED|Second Intervention Period||4
5157759|NCT01267201|12685336|P2|STARTED|Second Intervention Period||4
5157760|NCT01267201|12685337|P1|STARTED|Second Intervention Period||3
5157761|NCT01267201|12685332|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157762|NCT01267201|12685333|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157763|NCT01267201|12685334|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157764|NCT01267201|12685335|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157765|NCT01267201|12685336|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157766|NCT01267201|12685337|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
5157767|NCT01267201|12685332|P6|COMPLETED|Washout Period (At Least 2 Days)||4
5157768|NCT01267201|12685333|P5|COMPLETED|Washout Period (At Least 2 Days)||4
5157769|NCT01267201|12685334|P4|COMPLETED|Washout Period (At Least 2 Days)||4
5157770|NCT01267201|12685335|P3|COMPLETED|Washout Period (At Least 2 Days)||4
5157771|NCT01267201|12685336|P2|COMPLETED|Washout Period (At Least 2 Days)||4
5157772|NCT01267201|12685337|P1|COMPLETED|Washout Period (At Least 2 Days)||3
5157773|NCT01267201|12685332|P6|STARTED|Washout Period (At Least 2 Days)||4
5157774|NCT01267201|12685333|P5|STARTED|Washout Period (At Least 2 Days)||4
5157775|NCT01267201|12685334|P4|STARTED|Washout Period (At Least 2 Days)||4
5157776|NCT01267201|12685335|P3|STARTED|Washout Period (At Least 2 Days)||4
5157777|NCT01267201|12685336|P2|STARTED|Washout Period (At Least 2 Days)||4
5157778|NCT01267201|12685337|P1|STARTED|Washout Period (At Least 2 Days)||3
5157779|NCT01267201|12685332|P6|NOT COMPLETED|First Intervention Period||0
5157780|NCT01267201|12685333|P5|NOT COMPLETED|First Intervention Period||0
5157781|NCT01267201|12685334|P4|NOT COMPLETED|First Intervention Period||0
5157782|NCT01267201|12685335|P3|NOT COMPLETED|First Intervention Period||0
5157783|NCT01267201|12685336|P2|NOT COMPLETED|First Intervention Period||0
5157784|NCT01267201|12685337|P1|NOT COMPLETED|First Intervention Period||1
5157785|NCT01267201|12685332|P6|COMPLETED|First Intervention Period||4
5157786|NCT01267201|12685333|P5|COMPLETED|First Intervention Period||4
5157787|NCT01267201|12685334|P4|COMPLETED|First Intervention Period||4
5157788|NCT01267201|12685335|P3|COMPLETED|First Intervention Period||4
5157789|NCT01267201|12685336|P2|COMPLETED|First Intervention Period||4
5157790|NCT01267201|12685337|P1|COMPLETED|First Intervention Period||3
5157791|NCT01267201|12685332|P6|STARTED|First Intervention Period||4
5157792|NCT01267201|12685333|P5|STARTED|First Intervention Period||4
5157793|NCT01267201|12685334|P4|STARTED|First Intervention Period||4
5157794|NCT01267201|12685335|P3|STARTED|First Intervention Period||4
5157795|NCT01267201|12685336|P2|STARTED|First Intervention Period||4
5157796|NCT01267201|12685337|P1|STARTED|First Intervention Period||4
5157797|NCT01267175|12685354|P1|NOT COMPLETED|Overall Study||2
5157798|NCT01267175|12685354|P1|COMPLETED|Overall Study||29
5157799|NCT01267175|12685354|P1|STARTED|Overall Study||31
5157800|NCT01267136|12685361|P2|NOT COMPLETED|Overall Study||6
5157801|NCT01267136|12685362|P1|NOT COMPLETED|Overall Study||4
5157802|NCT01267136|12685361|P2|COMPLETED|Overall Study||36
5157803|NCT01267136|12685362|P1|COMPLETED|Overall Study||38
5157804|NCT01267136|12685361|P2|STARTED|Overall Study||42
5157805|NCT01267136|12685362|P1|STARTED|Overall Study||42
5157806|NCT01267045|12685372|P2|NOT COMPLETED|6-month Outcome||3
5157807|NCT01267045|12685373|P1|NOT COMPLETED|6-month Outcome||0
5157808|NCT01267045|12685372|P2|COMPLETED|6-month Outcome||23
5157809|NCT01267045|12685373|P1|COMPLETED|6-month Outcome||22
5157810|NCT01267045|12685372|P2|STARTED|6-month Outcome||26
5157811|NCT01267045|12685373|P1|STARTED|6-month Outcome||22
5157812|NCT01267045|12685372|P2|NOT COMPLETED|2-month Outcomes||3
5157813|NCT01267045|12685373|P1|NOT COMPLETED|2-month Outcomes||4
5157814|NCT01267045|12685372|P2|COMPLETED|2-month Outcomes||26
5157815|NCT01267045|12685373|P1|COMPLETED|2-month Outcomes||22
5157816|NCT01267045|12685372|P2|STARTED|2-month Outcomes||29
5157817|NCT01267045|12685373|P1|STARTED|2-month Outcomes||26
5157818|NCT01267019|12685408|P3|NOT COMPLETED|Overall Study||6
5157819|NCT01267019|12685409|P2|NOT COMPLETED|Overall Study||6
5157820|NCT01267019|12685410|P1|NOT COMPLETED|Overall Study||6
5157821|NCT01267019|12685408|P3|COMPLETED|Overall Study||47
5157822|NCT01267019|12685409|P2|COMPLETED|Overall Study||47
5157823|NCT01267019|12685410|P1|COMPLETED|Overall Study||41
5157824|NCT01267019|12685408|P3|STARTED|Overall Study||53
5157825|NCT01267019|12685409|P2|STARTED|Overall Study||53
5157826|NCT01267019|12685410|P1|STARTED|Overall Study||47
5157827|NCT01266993|12685426|P2|NOT COMPLETED|Booster Phase (Month 69)||2
5157828|NCT01266993|12685427|P1|NOT COMPLETED|Booster Phase (Month 69)||5
5157829|NCT01266993|12685426|P2|COMPLETED|Booster Phase (Month 69)||60
5157830|NCT01266993|12685427|P1|COMPLETED|Booster Phase (Month 69)||174
5157831|NCT01266993|12685426|P2|STARTED|Booster Phase (Month 69)||62
5157832|NCT01266993|12685427|P1|STARTED|Booster Phase (Month 69)||179
5157833|NCT01266993|12685426|P2|NOT COMPLETED|Persistence Phase (Month 68)||0
5157834|NCT01266993|12685427|P1|NOT COMPLETED|Persistence Phase (Month 68)||0
5157835|NCT01266993|12685426|P2|COMPLETED|Persistence Phase (Month 68)||62
5157836|NCT01266993|12685427|P1|COMPLETED|Persistence Phase (Month 68)||179
5157837|NCT01266993|12685426|P2|STARTED|Persistence Phase (Month 68)||62
5157838|NCT01266993|12685427|P1|STARTED|Persistence Phase (Month 68)||179
5157839|NCT01266993|12685426|P2|NOT COMPLETED|Persistence Phase (Month 56)||0
5157840|NCT01266993|12685427|P1|NOT COMPLETED|Persistence Phase (Month 56)||0
5157841|NCT01266993|12685426|P2|COMPLETED|Persistence Phase (Month 56)||67
5157842|NCT01266993|12685427|P1|COMPLETED|Persistence Phase (Month 56)||193
5157843|NCT01266993|12685426|P2|STARTED|Persistence Phase (Month 56)||67
5157844|NCT01266993|12685427|P1|STARTED|Persistence Phase (Month 56)||193
5157845|NCT01266993|12685426|P2|NOT COMPLETED|Persistence Phase (Month 44)||0
5157846|NCT01266993|12685427|P1|NOT COMPLETED|Persistence Phase (Month 44)||0
5157847|NCT01266993|12685426|P2|COMPLETED|Persistence Phase (Month 44)||68
5157848|NCT01266993|12685427|P1|COMPLETED|Persistence Phase (Month 44)||193
5157849|NCT01266993|12685426|P2|STARTED|Persistence Phase (Month 44)||68
5157850|NCT01266993|12685427|P1|STARTED|Persistence Phase (Month 44)||193
5157851|NCT01266993|12685426|P2|NOT COMPLETED|Persistence Phase (Month 32)||0
5157852|NCT01266993|12685427|P1|NOT COMPLETED|Persistence Phase (Month 32)||0
5157853|NCT01266993|12685426|P2|COMPLETED|Persistence Phase (Month 32)||72
5157854|NCT01266993|12685427|P1|COMPLETED|Persistence Phase (Month 32)||199
5157855|NCT01266993|12685426|P2|STARTED|Persistence Phase (Month 32)||72
5157856|NCT01266993|12685427|P1|STARTED|Persistence Phase (Month 32)||199
5157857|NCT01266967|12685497|P2|NOT COMPLETED|Overall Study||83
5157858|NCT01266967|12685498|P1|NOT COMPLETED|Overall Study||89
5157859|NCT01266967|12685497|P2|COMPLETED|Overall Study||0
5157860|NCT01266967|12685498|P1|COMPLETED|Overall Study||0
5157861|NCT01266967|12685497|P2|STARTED|Overall Study||83
5157862|NCT01266967|12685498|P1|STARTED|Overall Study||89
5157863|NCT01266876|12685550|P5|NOT COMPLETED|Overall Study||0
5157864|NCT01266876|12685551|P4|NOT COMPLETED|Overall Study||1
5157865|NCT01266876|12685552|P3|NOT COMPLETED|Overall Study||0
5157866|NCT01266876|12685553|P2|NOT COMPLETED|Overall Study||0
5157867|NCT01266876|12685554|P1|NOT COMPLETED|Overall Study||0
5157868|NCT01266876|12685550|P5|COMPLETED|Overall Study||16
5157869|NCT01266876|12685551|P4|COMPLETED|Overall Study||14
5157870|NCT01266876|12685552|P3|COMPLETED|Overall Study||16
5157871|NCT01266876|12685553|P2|COMPLETED|Overall Study||15
5157872|NCT01266876|12685554|P1|COMPLETED|Overall Study||15
5157873|NCT01266876|12685550|P5|STARTED|Overall Study||16
5157874|NCT01266876|12685551|P4|STARTED|Overall Study||15
5157875|NCT01266876|12685552|P3|STARTED|Overall Study||16
5157876|NCT01266876|12685553|P2|STARTED|Overall Study||15
5157877|NCT01266876|12685554|P1|STARTED|Overall Study||15
5157878|NCT01266850|12685661|P5|NOT COMPLETED|Overall Study||30
5157879|NCT01266850|12685662|P4|NOT COMPLETED|Overall Study||28
5157880|NCT01266850|12685663|P3|NOT COMPLETED|Overall Study||24
5157881|NCT01266850|12685664|P2|NOT COMPLETED|Overall Study||36
5157882|NCT01266850|12685665|P1|NOT COMPLETED|Overall Study||30
5157883|NCT01266850|12685661|P5|COMPLETED|Overall Study||297
5157884|NCT01266850|12685662|P4|COMPLETED|Overall Study||301
5157885|NCT01266850|12685663|P3|COMPLETED|Overall Study||214
5157886|NCT01266850|12685664|P2|COMPLETED|Overall Study||212
5157887|NCT01266850|12685665|P1|COMPLETED|Overall Study||212
5157888|NCT01266850|12685661|P5|Received Third Vaccine|Overall Study||299
5157889|NCT01266850|12685662|P4|Received Third Vaccine|Overall Study||0
5157890|NCT01266850|12685663|P3|Received Third Vaccine|Overall Study||217
5157891|NCT01266850|12685664|P2|Received Third Vaccine|Overall Study||221
5157892|NCT01266850|12685665|P1|Received Third Vaccine|Overall Study||221
5157893|NCT01266850|12685661|P5|Received Second Vaccine|Overall Study||307
5157894|NCT01266850|12685662|P4|Received Second Vaccine|Overall Study||311
5157895|NCT01266850|12685663|P3|Received Second Vaccine|Overall Study||227
5157896|NCT01266850|12685664|P2|Received Second Vaccine|Overall Study||233
5157897|NCT01266850|12685665|P1|Received Second Vaccine|Overall Study||231
5157898|NCT01266850|12685661|P5|STARTED|Overall Study||327
5157899|NCT01266850|12685662|P4|STARTED|Overall Study||329
5157900|NCT01266850|12685663|P3|STARTED|Overall Study||238
5157901|NCT01266850|12685664|P2|STARTED|Overall Study||248
5157902|NCT01266850|12685665|P1|STARTED|Overall Study||242
5157903|NCT01266824|12685719|P2|NOT COMPLETED|Overall Study||3
5157904|NCT01266824|12685720|P1|NOT COMPLETED|Overall Study||2
5157905|NCT01266824|12685719|P2|COMPLETED|Overall Study||0
5157906|NCT01266824|12685720|P1|COMPLETED|Overall Study||0
5157907|NCT01266824|12685719|P2|STARTED|Overall Study||3
5157908|NCT01266824|12685720|P1|STARTED|Overall Study||2
5157909|NCT01266603|12685732|P1|NOT COMPLETED|Overall Study||42
5157910|NCT01266603|12685732|P1|COMPLETED|Overall Study||2
5157911|NCT01266603|12685732|P1|Maintenance Completion|Overall Study||2
5157912|NCT01266603|12685732|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
5157913|NCT01266603|12685732|P1|Patients Evaluable for Response|Overall Study||16
5157914|NCT01266603|12685732|P1|Patients Evaluable for Safety|Overall Study||17
5157915|NCT01266603|12685732|P1|MAGE-A3 Positive Tumor|Overall Study||18
5157916|NCT01266603|12685732|P1|STARTED|Overall Study||44
5157917|NCT01266590|12685738|P1|NOT COMPLETED|Overall Study||6
5157918|NCT01266590|12685738|P1|COMPLETED|Overall Study||24
5157919|NCT01266590|12685738|P1|STARTED|Overall Study||30
5157920|NCT01266447|12685749|P1|NOT COMPLETED|Overall Study||0
5157921|NCT01266447|12685749|P1|COMPLETED|Overall Study|Eligible and treated patients|27
5157922|NCT01266447|12685749|P1|STARTED|Overall Study||27
5157923|NCT01266317|12685758|P1|NOT COMPLETED|Overall Study||2
5157924|NCT01266317|12685758|P1|COMPLETED|Overall Study||7
5157925|NCT01266317|12685758|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
5157926|NCT01266291|12685763|P1|NOT COMPLETED|Overall Study||1
5157927|NCT01266291|12685763|P1|COMPLETED|Overall Study||0
5157928|NCT01266291|12685763|P1|STARTED|Overall Study||1
5157929|NCT01266265|12685770|P2|NOT COMPLETED|Overall Study||190
5157930|NCT01266265|12685771|P1|NOT COMPLETED|Overall Study||205
5157931|NCT01266265|12685770|P2|COMPLETED|Overall Study||477
5157932|NCT01266265|12685771|P1|COMPLETED|Overall Study||461
5157933|NCT01266265|12685770|P2|STARTED|Overall Study||667
5157934|NCT01266265|12685771|P1|STARTED|Overall Study||666
5157935|NCT01266161|12685779|P2|NOT COMPLETED|Overall Study||1
5157936|NCT01266161|12685780|P1|NOT COMPLETED|Overall Study||4
5157937|NCT01266161|12685779|P2|COMPLETED|Overall Study||53
5157938|NCT01266161|12685780|P1|COMPLETED|Overall Study||48
5157939|NCT01266161|12685779|P2|STARTED|Overall Study||54
5157940|NCT01266161|12685780|P1|STARTED|Overall Study||52
5157941|NCT01266148|12685812|P2|NOT COMPLETED|Overall Study||3
5157942|NCT01266148|12685813|P1|NOT COMPLETED|Overall Study||7
5157943|NCT01266148|12685812|P2|COMPLETED|Overall Study||56
5157944|NCT01266148|12685813|P1|COMPLETED|Overall Study||49
5157945|NCT01266148|12685812|P2|STARTED|Overall Study||59
5157946|NCT01266148|12685813|P1|STARTED|Overall Study||56
5157947|NCT01266122|12685841|P2|NOT COMPLETED|Overall Study||6
5157948|NCT01266122|12685842|P1|NOT COMPLETED|Overall Study||6
5157949|NCT01266122|12685841|P2|COMPLETED|Overall Study||42
5157950|NCT01266122|12685842|P1|COMPLETED|Overall Study||42
5157951|NCT01266122|12685841|P2|STARTED|Overall Study||48
5157952|NCT01266122|12685842|P1|STARTED|Overall Study||48
5157953|NCT01266070|12685850|P1|NOT COMPLETED|Overall Study||4
5157954|NCT01266070|12685850|P1|COMPLETED|Overall Study||2
5157955|NCT01266070|12685850|P1|STARTED|Overall Study||6
5157956|NCT01266031|12685858|P3|NOT COMPLETED|Overall Study||2
5157957|NCT01266031|12685859|P2|NOT COMPLETED|Overall Study||3
5157958|NCT01266031|12685860|P1|NOT COMPLETED|Overall Study||0
5157959|NCT01266031|12685858|P3|COMPLETED|Overall Study||47
5157960|NCT01266031|12685859|P2|COMPLETED|Overall Study||38
5157961|NCT01266031|12685860|P1|COMPLETED|Overall Study||6
5157962|NCT01266031|12685858|P3|STARTED|Overall Study||49
5157963|NCT01266031|12685859|P2|STARTED|Overall Study||41
5157964|NCT01266031|12685860|P1|STARTED|Overall Study||6
5157965|NCT01266018|12685887|P2|NOT COMPLETED|Overall Study||1
5157966|NCT01266018|12685888|P1|NOT COMPLETED|Overall Study||1
5157967|NCT01266018|12685887|P2|COMPLETED|Overall Study||12
5157968|NCT01266018|12685888|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
5157969|NCT01266018|12685887|P2|STARTED|Overall Study||13
5157970|NCT01266018|12685888|P1|STARTED|Overall Study||9
5157971|NCT01265992|12685899|P1|NOT COMPLETED|Overall Study||9
5157972|NCT01265992|12685899|P1|COMPLETED|Overall Study||41
5157973|NCT01265992|12685899|P1|Received Treatment|Overall Study||49
5157974|NCT01265992|12685899|P1|STARTED|Overall Study||50
5157975|NCT01265966|12685915|P3|NOT COMPLETED|Overall Study||2
5157976|NCT01265966|12685916|P2|NOT COMPLETED|Overall Study||2
5157977|NCT01265966|12685917|P1|NOT COMPLETED|Overall Study||3
5157978|NCT01265966|12685915|P3|COMPLETED|Overall Study||27
5157979|NCT01265966|12685916|P2|COMPLETED|Overall Study||39
5157980|NCT01265966|12685917|P1|COMPLETED|Overall Study||44
5157981|NCT01265966|12685915|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
5157982|NCT01265966|12685916|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
5157983|NCT01265966|12685917|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
5157984|NCT01265966|12685915|P3|STARTED|Overall Study||29
5157985|NCT01265966|12685916|P2|STARTED|Overall Study||41
5157986|NCT01265966|12685917|P1|STARTED|Overall Study||47
5157987|NCT01265953|12685927|P2|NOT COMPLETED|Overall Study||3
5157988|NCT01265953|12685928|P1|NOT COMPLETED|Overall Study||5
5157989|NCT01265953|12685927|P2|COMPLETED|Overall Study||45
5157990|NCT01265953|12685928|P1|COMPLETED|Overall Study||45
5157991|NCT01265953|12685927|P2|STARTED|Overall Study||48
5157992|NCT01265953|12685928|P1|STARTED|Overall Study||50
5157993|NCT01265875|12685940|P1|NOT COMPLETED|Overall Study||1
5157994|NCT01265875|12685940|P1|COMPLETED|Overall Study||11
5157995|NCT01265875|12685940|P1|STARTED|Overall Study||12
5157996|NCT01265823|12685948|P1|NOT COMPLETED|Overall Study||7
5157997|NCT01265823|12685948|P1|COMPLETED|Overall Study||143
5157998|NCT01265823|12685948|P1|STARTED|Overall Study||150
5157999|NCT01265797|12685977|P2|NOT COMPLETED|Open Label Month||1
5158000|NCT01265797|12685978|P1|NOT COMPLETED|Open Label Month||0
5158001|NCT01265797|12685977|P2|COMPLETED|Open Label Month||26
5158002|NCT01265797|12685978|P1|COMPLETED|Open Label Month||24
5158003|NCT01265797|12685977|P2|STARTED|Open Label Month||27
5158004|NCT01265797|12685978|P1|STARTED|Open Label Month||24
5158005|NCT01265797|12685977|P2|NOT COMPLETED|Blinded Month||2
5158006|NCT01265797|12685978|P1|NOT COMPLETED|Blinded Month||10
5158007|NCT01265797|12685977|P2|COMPLETED|Blinded Month||27
5158008|NCT01265797|12685978|P1|COMPLETED|Blinded Month||24
5158009|NCT01265797|12685977|P2|STARTED|Blinded Month||29
5158010|NCT01265797|12685978|P1|STARTED|Blinded Month||34
5158011|NCT01265797|12685977|P2|NOT COMPLETED|Run-in Month||5
5158012|NCT01265797|12685978|P1|NOT COMPLETED|Run-in Month||0
5158013|NCT01265797|12685977|P2|COMPLETED|Run-in Month||29
5158014|NCT01265797|12685978|P1|COMPLETED|Run-in Month||34
5158015|NCT01265797|12685977|P2|STARTED|Run-in Month||34
5158016|NCT01265797|12685978|P1|STARTED|Run-in Month||34
5158017|NCT01265784|12686009|P3|NOT COMPLETED|Overall Study||4
5158018|NCT01265784|12686010|P2|NOT COMPLETED|Overall Study||8
5158019|NCT01265784|12686011|P1|NOT COMPLETED|Overall Study||12
5158020|NCT01265784|12686009|P3|COMPLETED|Overall Study||26
5158021|NCT01265784|12686010|P2|COMPLETED|Overall Study||49
5158022|NCT01265784|12686011|P1|COMPLETED|Overall Study||44
5158023|NCT01265784|12686009|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
5158024|NCT01265784|12686010|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
5158025|NCT01265784|12686011|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
5158026|NCT01265784|12686009|P3|STARTED|Overall Study||30
5158027|NCT01265784|12686010|P2|STARTED|Overall Study||57
5158028|NCT01265784|12686011|P1|STARTED|Overall Study||56
5158029|NCT01265719|12686079|P2|NOT COMPLETED|Overall Study||13
5158030|NCT01265719|12686080|P1|NOT COMPLETED|Overall Study||14
5158031|NCT01265719|12686079|P2|COMPLETED|Overall Study||60
5158032|NCT01265719|12686080|P1|COMPLETED|Overall Study||88
5158033|NCT01265719|12686079|P2|STARTED|Overall Study||73
5158034|NCT01265719|12686080|P1|STARTED|Overall Study||102
5158035|NCT01265667|12686114|P2|NOT COMPLETED|Overall Study||13
5158036|NCT01265667|12686115|P1|NOT COMPLETED|Overall Study||20
5158037|NCT01265667|12686114|P2|COMPLETED|Overall Study||135
5158038|NCT01265667|12686115|P1|COMPLETED|Overall Study||125
5158039|NCT01265667|12686114|P2|STARTED|Overall Study||148
5158040|NCT01265667|12686115|P1|STARTED|Overall Study||145
5158041|NCT01265615|12686131|P4|NOT COMPLETED|Overall Study||3
5158042|NCT01265615|12686132|P3|NOT COMPLETED|Overall Study||4
5158043|NCT01265615|12686133|P2|NOT COMPLETED|Overall Study||2
5158044|NCT01265615|12686134|P1|NOT COMPLETED|Overall Study||2
5158045|NCT01265615|12686131|P4|COMPLETED|Overall Study||27
5158046|NCT01265615|12686132|P3|COMPLETED|Overall Study||26
5158047|NCT01265615|12686133|P2|COMPLETED|Overall Study||28
5158048|NCT01265615|12686134|P1|COMPLETED|Overall Study||28
5158049|NCT01265615|12686131|P4|STARTED|Overall Study||30
5158050|NCT01265615|12686132|P3|STARTED|Overall Study||30
5158051|NCT01265615|12686133|P2|STARTED|Overall Study||30
5158052|NCT01265615|12686134|P1|STARTED|Overall Study||30
5158053|NCT01265563|12686185|P5|NOT COMPLETED|Overall Study||2
5158054|NCT01265563|12686186|P4|NOT COMPLETED|Overall Study||0
5158055|NCT01265563|12686187|P3|NOT COMPLETED|Overall Study||1
5158056|NCT01265563|12686188|P2|NOT COMPLETED|Overall Study||1
5158057|NCT01265563|12686189|P1|NOT COMPLETED|Overall Study||0
5158058|NCT01265563|12686185|P5|COMPLETED|Overall Study||14
5158059|NCT01265563|12686186|P4|COMPLETED|Overall Study||16
5158060|NCT01265563|12686187|P3|COMPLETED|Overall Study||16
5158061|NCT01265563|12686188|P2|COMPLETED|Overall Study||12
5158062|NCT01265563|12686189|P1|COMPLETED|Overall Study||16
5158063|NCT01265563|12686185|P5|STARTED|Overall Study||16
5158064|NCT01265563|12686186|P4|STARTED|Overall Study||16
5158065|NCT01265563|12686187|P3|STARTED|Overall Study||17
5158066|NCT01265563|12686188|P2|STARTED|Overall Study||13
5158067|NCT01265563|12686189|P1|STARTED|Overall Study||16
5158068|NCT01265550|12686215|P4|NOT COMPLETED|Post Randomization||0
5158069|NCT01265550|12686216|P3|NOT COMPLETED|Post Randomization||20
5158070|NCT01265550|12686217|P2|NOT COMPLETED|Post Randomization||8
5158071|NCT01265550|12686218|P1|NOT COMPLETED|Post Randomization||15
5158072|NCT01265550|12686215|P4|COMPLETED|Post Randomization||0
5158073|NCT01265550|12686216|P3|COMPLETED|Post Randomization||6
5158074|NCT01265550|12686217|P2|COMPLETED|Post Randomization||19
5158075|NCT01265550|12686218|P1|COMPLETED|Post Randomization||10
5158076|NCT01265550|12686215|P4|STARTED|Post Randomization||0
5158077|NCT01265550|12686216|P3|STARTED|Post Randomization||26
5158078|NCT01265550|12686217|P2|STARTED|Post Randomization||27
5158079|NCT01265550|12686218|P1|STARTED|Post Randomization||25
5158080|NCT01265550|12686215|P4|NOT COMPLETED|Pre Randomization||288
5158081|NCT01265550|12686216|P3|NOT COMPLETED|Pre Randomization||0
5158082|NCT01265550|12686217|P2|NOT COMPLETED|Pre Randomization||0
5158083|NCT01265550|12686218|P1|NOT COMPLETED|Pre Randomization||0
5158084|NCT01265550|12686215|P4|COMPLETED|Pre Randomization||78
5158085|NCT01265550|12686216|P3|COMPLETED|Pre Randomization||0
5158086|NCT01265550|12686217|P2|COMPLETED|Pre Randomization||0
5158087|NCT01265550|12686218|P1|COMPLETED|Pre Randomization||0
5158088|NCT01265550|12686215|P4|STARTED|Pre Randomization||366
5158089|NCT01265550|12686216|P3|STARTED|Pre Randomization||0
5158090|NCT01265550|12686217|P2|STARTED|Pre Randomization||0
5158091|NCT01265550|12686218|P1|STARTED|Pre Randomization||0
5158092|NCT01265537|12686310|P2|NOT COMPLETED|Overall Study||2
5158093|NCT01265537|12686311|P1|NOT COMPLETED|Overall Study||2
5158094|NCT01265537|12686310|P2|COMPLETED|Overall Study||13
5158095|NCT01265537|12686311|P1|COMPLETED|Overall Study||13
5158096|NCT01265537|12686310|P2|STARTED|Overall Study||15
5158097|NCT01265537|12686311|P1|STARTED|Overall Study||15
5158098|NCT01265524|12686341|P2|NOT COMPLETED|Overall Study||6
5158099|NCT01265524|12686342|P1|NOT COMPLETED|Overall Study||18
5158100|NCT01265524|12686341|P2|COMPLETED|Overall Study||46
5158101|NCT01265524|12686342|P1|COMPLETED|Overall Study||41
5158102|NCT01265524|12686341|P2|STARTED|Overall Study||52
5158103|NCT01265524|12686342|P1|STARTED|Overall Study||59
5158104|NCT01265511|12686362|P2|NOT COMPLETED|Overall Study||3
5158105|NCT01265511|12686363|P1|NOT COMPLETED|Overall Study||2
5158106|NCT01265511|12686362|P2|COMPLETED|Overall Study||5
5158107|NCT01265511|12686363|P1|COMPLETED|Overall Study||0
5158108|NCT01265511|12686362|P2|STARTED|Overall Study||8
5158109|NCT01265511|12686363|P1|STARTED|Overall Study||2
5158110|NCT01265498|12686377|P2|NOT COMPLETED|Overall Study||33
5158111|NCT01265498|12686378|P1|NOT COMPLETED|Overall Study||31
5158112|NCT01265498|12686377|P2|COMPLETED|Overall Study||109
5158113|NCT01265498|12686378|P1|COMPLETED|Overall Study||110
5158114|NCT01265498|12686377|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
5158115|NCT01265498|12686378|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
5158116|NCT01265498|12686377|P2|STARTED|Overall Study||142
5158117|NCT01265498|12686378|P1|STARTED|Overall Study||141
5158118|NCT01265459|12686481|P3|NOT COMPLETED|Overall Study||2
5158119|NCT01265459|12686482|P2|NOT COMPLETED|Overall Study||0
5158120|NCT01265459|12686483|P1|NOT COMPLETED|Overall Study||0
5158121|NCT01265459|12686481|P3|COMPLETED|Overall Study||20
5158122|NCT01265459|12686482|P2|COMPLETED|Overall Study||23
5158123|NCT01265459|12686483|P1|COMPLETED|Overall Study||23
5158124|NCT01265459|12686481|P3|STARTED|Overall Study||22
5158125|NCT01265459|12686482|P2|STARTED|Overall Study||23
5158126|NCT01265459|12686483|P1|STARTED|Overall Study||23
5158127|NCT01265446|12686505|P2|NOT COMPLETED|Overall Study||0
5158128|NCT01265446|12686506|P1|NOT COMPLETED|Overall Study||1
5158129|NCT01265446|12686505|P2|COMPLETED|Overall Study||125
5158130|NCT01265446|12686506|P1|COMPLETED|Overall Study||124
5158131|NCT01265446|12686505|P2|STARTED|Overall Study||125
5158132|NCT01265446|12686506|P1|STARTED|Overall Study||125
5158133|NCT01265420|12686514|P1|NOT COMPLETED|Overall Study||1
5158134|NCT01265420|12686514|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
5158135|NCT01265420|12686514|P1|STARTED|Overall Study||7
5158136|NCT01265394|12686518|P1|NOT COMPLETED|Overall Study||37
5158137|NCT01265394|12686518|P1|COMPLETED|Overall Study||181
5158138|NCT01265394|12686518|P1|STARTED|Overall Study||218
5158139|NCT01265056|12686525|P2|NOT COMPLETED|Follow up||3
5158140|NCT01265056|12686526|P1|NOT COMPLETED|Follow up||7
5158141|NCT01265056|12686525|P2|COMPLETED|Follow up||24
5158142|NCT01265056|12686526|P1|COMPLETED|Follow up||19
5158143|NCT01265056|12686525|P2|STARTED|Follow up||27
5158144|NCT01265056|12686526|P1|STARTED|Follow up||26
5158145|NCT01265056|12686525|P2|NOT COMPLETED|Initial Study Period||2
5158146|NCT01265056|12686526|P1|NOT COMPLETED|Initial Study Period||2
5158147|NCT01265056|12686525|P2|COMPLETED|Initial Study Period||25
5158148|NCT01265056|12686526|P1|COMPLETED|Initial Study Period||24
5158149|NCT01265056|12686525|P2|STARTED|Initial Study Period||27
5158150|NCT01265056|12686526|P1|STARTED|Initial Study Period||26
5158151|NCT01264952|12686539|P3|NOT COMPLETED|Overall Study||0
5158152|NCT01264952|12686540|P2|NOT COMPLETED|Overall Study||0
5158153|NCT01264952|12686541|P1|NOT COMPLETED|Overall Study||0
5158154|NCT01264952|12686539|P3|COMPLETED|Overall Study||8
5158155|NCT01264952|12686540|P2|COMPLETED|Overall Study||2
5158156|NCT01264952|12686541|P1|COMPLETED|Overall Study||6
5158157|NCT01264952|12686539|P3|STARTED|Overall Study||8
5158158|NCT01264952|12686540|P2|STARTED|Overall Study||2
5158159|NCT01264952|12686541|P1|STARTED|Overall Study||6
5158160|NCT01264939|12686557|P2|NOT COMPLETED|Overall Study||28
5158161|NCT01264939|12686558|P1|NOT COMPLETED|Overall Study||18
5158162|NCT01264939|12686557|P2|COMPLETED|Overall Study||224
5158163|NCT01264939|12686558|P1|COMPLETED|Overall Study||66
5158164|NCT01264939|12686557|P2|STARTED|Overall Study||252
5158165|NCT01264939|12686558|P1|STARTED|Overall Study||84
5158166|NCT01264887|12686584|P1|NOT COMPLETED|Overall Study||31
5158167|NCT01264887|12686584|P1|COMPLETED|Overall Study||0
5158168|NCT01264887|12686584|P1|STARTED|Overall Study||31
5158169|NCT01264835|12686595|P1|NOT COMPLETED|Overall Study||1
5158170|NCT01264835|12686595|P1|COMPLETED|Overall Study||1
5158171|NCT01264835|12686595|P1|STARTED|Overall Study||2
5158172|NCT01264770|12686605|P6|NOT COMPLETED|Overall Study||6
5158173|NCT01264770|12686606|P5|NOT COMPLETED|Overall Study||8
5158174|NCT01264770|12686607|P4|NOT COMPLETED|Overall Study||6
5158175|NCT01264770|12686608|P3|NOT COMPLETED|Overall Study||16
5158176|NCT01264770|12686609|P2|NOT COMPLETED|Overall Study||10
5158177|NCT01264770|12686610|P1|NOT COMPLETED|Overall Study||18
5158178|NCT01264770|12686605|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
5158179|NCT01264770|12686606|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
5158180|NCT01264770|12686607|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
5158181|NCT01264770|12686608|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
5158182|NCT01264770|12686609|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
5158183|NCT01264770|12686610|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
5158184|NCT01264770|12686605|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
5158185|NCT01264770|12686606|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
5158186|NCT01264770|12686607|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
5158187|NCT01264770|12686608|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
5158188|NCT01264770|12686609|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
5158189|NCT01264770|12686610|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
5158190|NCT01264770|12686605|P6|STARTED|Overall Study|Patients who received treatment|25
5158191|NCT01264770|12686606|P5|STARTED|Overall Study|Patients who received treatment|27
5158192|NCT01264770|12686607|P4|STARTED|Overall Study|Patients who received treatment|54
5158193|NCT01264770|12686608|P3|STARTED|Overall Study|Patients who received treatment|57
5158194|NCT01264770|12686609|P2|STARTED|Overall Study|Patients who received treatment|48
5158195|NCT01264770|12686610|P1|STARTED|Overall Study|Patients who received treatment|54
5158196|NCT01264718|12686696|P2|NOT COMPLETED|Overall Study||43
5158197|NCT01264718|12686697|P1|NOT COMPLETED|Overall Study||49
5158198|NCT01264718|12686696|P2|COMPLETED|Overall Study||114
5158199|NCT01264718|12686697|P1|COMPLETED|Overall Study||123
5158200|NCT01264718|12686696|P2|STARTED|Overall Study||157
5158201|NCT01264718|12686697|P1|STARTED|Overall Study||172
5158202|NCT01264679|12686709|P1|NOT COMPLETED|Overall Study||5
5158203|NCT01264679|12686709|P1|COMPLETED|Overall Study||3
5158204|NCT01264679|12686709|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
5158205|NCT01264679|12686709|P1|STARTED|Overall Study||8
5158206|NCT01264614|12686717|P2|NOT COMPLETED|Overall Study||2
5158207|NCT01264614|12686718|P1|NOT COMPLETED|Overall Study||1
5158208|NCT01264614|12686717|P2|COMPLETED|Overall Study||7
5158209|NCT01264614|12686718|P1|COMPLETED|Overall Study||12
5158210|NCT01264614|12686717|P2|STARTED|Overall Study||9
5158211|NCT01264614|12686718|P1|STARTED|Overall Study||13
5158212|NCT01264601|12686734|P2|NOT COMPLETED|Overall Study||0
5158213|NCT01264601|12686735|P1|NOT COMPLETED|Overall Study||0
5158214|NCT01264601|12686734|P2|COMPLETED|Overall Study||14
5158215|NCT01264601|12686735|P1|COMPLETED|Overall Study||17
5158216|NCT01264601|12686734|P2|STARTED|Overall Study||14
5158217|NCT01264601|12686735|P1|STARTED|Overall Study||17
5158218|NCT01264419|12686743|P1|NOT COMPLETED|Overall Study||3
5158219|NCT01264419|12686743|P1|COMPLETED|Overall Study||72
5158220|NCT01264419|12686743|P1|STARTED|Overall Study||75
5158221|NCT01264380|12686748|P3|NOT COMPLETED|Period C||14
5158222|NCT01264380|12686749|P2|NOT COMPLETED|Period C||0
5158223|NCT01264380|12686750|P1|NOT COMPLETED|Period C||0
5158224|NCT01264380|12686748|P3|COMPLETED|Period C||2
5158225|NCT01264380|12686749|P2|COMPLETED|Period C||0
5158226|NCT01264380|12686750|P1|COMPLETED|Period C||0
5158227|NCT01264380|12686748|P3|STARTED|Period C||16
5158228|NCT01264380|12686749|P2|STARTED|Period C||0
5158229|NCT01264380|12686750|P1|STARTED|Period C||0
5158230|NCT01264380|12686748|P3|NOT COMPLETED|Period B||0
5158231|NCT01264380|12686749|P2|NOT COMPLETED|Period B||0
5158232|NCT01264380|12686750|P1|NOT COMPLETED|Period B||0
5158233|NCT01264380|12686748|P3|COMPLETED|Period B||0
5158234|NCT01264380|12686749|P2|COMPLETED|Period B||8
5158235|NCT01264380|12686750|P1|COMPLETED|Period B||8
5158236|NCT01264380|12686748|P3|STARTED|Period B||0
5158237|NCT01264380|12686749|P2|STARTED|Period B||8
5158238|NCT01264380|12686750|P1|STARTED|Period B||8
5158239|NCT01264380|12686748|P3|NOT COMPLETED|Period A||0
5158240|NCT01264380|12686749|P2|NOT COMPLETED|Period A||0
5158241|NCT01264380|12686750|P1|NOT COMPLETED|Period A||0
5158242|NCT01264380|12686748|P3|COMPLETED|Period A||0
5158243|NCT01264380|12686749|P2|COMPLETED|Period A||8
5158244|NCT01264380|12686750|P1|COMPLETED|Period A||8
5158245|NCT01264380|12686748|P3|STARTED|Period A||0
5158246|NCT01264380|12686749|P2|STARTED|Period A||8
5158247|NCT01264380|12686750|P1|STARTED|Period A||8
5158248|NCT01264081|12686771|P1|NOT COMPLETED|Analysis||0
5158249|NCT01264081|12686771|P1|COMPLETED|Analysis||2
5158250|NCT01264081|12686771|P1|STARTED|Analysis||2
5158251|NCT01264081|12686771|P1|NOT COMPLETED|Started Treatment||2
5158252|NCT01264081|12686771|P1|COMPLETED|Started Treatment||2
5158253|NCT01264081|12686771|P1|STARTED|Started Treatment||4
5158254|NCT01264081|12686771|P1|NOT COMPLETED|Participants Screened||30
5158255|NCT01264081|12686771|P1|COMPLETED|Participants Screened||4
5158256|NCT01264081|12686771|P1|STARTED|Participants Screened||34
5158257|NCT01264016|12686776|P1|NOT COMPLETED|Overall Study||2
5158258|NCT01264016|12686776|P1|COMPLETED|Overall Study||94
5158259|NCT01264016|12686776|P1|STARTED|Overall Study||96
5158260|NCT01263938|12686782|P1|NOT COMPLETED|Overall Study||0
5158261|NCT01263938|12686782|P1|COMPLETED|Overall Study||5
5158262|NCT01263938|12686782|P1|STARTED|Overall Study||5
5158263|NCT01263925|12686791|P2|NOT COMPLETED|Overall Study||52
5158264|NCT01263925|12686792|P1|NOT COMPLETED|Overall Study||51
5158265|NCT01263925|12686791|P2|COMPLETED|Overall Study||233
5158266|NCT01263925|12686792|P1|COMPLETED|Overall Study||225
5158267|NCT01263925|12686791|P2|Full Analysis Set|Overall Study||272
5158268|NCT01263925|12686792|P1|Full Analysis Set|Overall Study||269
5158269|NCT01263925|12686791|P2|STARTED|Overall Study||285
5158270|NCT01263925|12686792|P1|STARTED|Overall Study||276
5158271|NCT01263873|12686826|P2|NOT COMPLETED|Overall Study||1
5158272|NCT01263873|12686827|P1|NOT COMPLETED|Overall Study||1
5158273|NCT01263873|12686826|P2|COMPLETED|Overall Study||29
5158274|NCT01263873|12686827|P1|COMPLETED|Overall Study||29
5158275|NCT01263873|12686826|P2|STARTED|Overall Study||30
5158276|NCT01263873|12686827|P1|STARTED|Overall Study||30
5158277|NCT01263782|12686841|P4|NOT COMPLETED|Overall Study||1
5158278|NCT01263782|12686842|P3|NOT COMPLETED|Overall Study||3
5158279|NCT01263782|12686843|P2|NOT COMPLETED|Overall Study||0
5158280|NCT01263782|12686844|P1|NOT COMPLETED|Overall Study||0
5158281|NCT01263782|12686841|P4|COMPLETED|Overall Study||5
5158282|NCT01263782|12686842|P3|COMPLETED|Overall Study||3
5158283|NCT01263782|12686843|P2|COMPLETED|Overall Study||6
5158284|NCT01263782|12686844|P1|COMPLETED|Overall Study||6
5158285|NCT01263782|12686841|P4|STARTED|Overall Study||6
5158286|NCT01263782|12686842|P3|STARTED|Overall Study||6
5158287|NCT01263782|12686843|P2|STARTED|Overall Study||6
5158288|NCT01263782|12686844|P1|STARTED|Overall Study||6
5158289|NCT01263717|12686860|P2|NOT COMPLETED|Overall Study||6
5158290|NCT01263717|12686861|P1|NOT COMPLETED|Overall Study||5
5158291|NCT01263717|12686860|P2|COMPLETED|Overall Study||20
5158292|NCT01263717|12686861|P1|COMPLETED|Overall Study||23
5158293|NCT01263717|12686860|P2|Baseline Visit|Overall Study||22
5158294|NCT01263717|12686861|P1|Baseline Visit|Overall Study||28
5158295|NCT01263717|12686860|P2|STARTED|Overall Study||26
5158296|NCT01263717|12686861|P1|STARTED|Overall Study||28
5158297|NCT01263704|12686889|P1|NOT COMPLETED|Overall Study||29
5158298|NCT01263704|12686889|P1|COMPLETED|Overall Study||13
5158299|NCT01263704|12686889|P1|STARTED|Overall Study||42
5158300|NCT01263691|12686904|P6|NOT COMPLETED|Overall Study||0
5158301|NCT01263691|12686905|P5|NOT COMPLETED|Overall Study||0
5158302|NCT01263691|12686906|P4|NOT COMPLETED|Overall Study||1
5158303|NCT01263691|12686907|P3|NOT COMPLETED|Overall Study||1
5158304|NCT01263691|12686908|P2|NOT COMPLETED|Overall Study||0
5158305|NCT01263691|12686909|P1|NOT COMPLETED|Overall Study||3
5158306|NCT01263691|12686904|P6|COMPLETED|Overall Study||15
5158307|NCT01263691|12686905|P5|COMPLETED|Overall Study||18
5158308|NCT01263691|12686906|P4|COMPLETED|Overall Study||18
5158309|NCT01263691|12686907|P3|COMPLETED|Overall Study||16
5158310|NCT01263691|12686908|P2|COMPLETED|Overall Study||18
5158311|NCT01263691|12686909|P1|COMPLETED|Overall Study||15
5158312|NCT01263691|12686904|P6|STARTED|Overall Study||15
5158313|NCT01263691|12686905|P5|STARTED|Overall Study||18
5158314|NCT01263691|12686906|P4|STARTED|Overall Study||19
5158315|NCT01263691|12686907|P3|STARTED|Overall Study||17
5158316|NCT01263691|12686908|P2|STARTED|Overall Study||18
5158317|NCT01263691|12686909|P1|STARTED|Overall Study||18
5158318|NCT01263665|12687019|P1|NOT COMPLETED|Overall Study||9
5158319|NCT01263665|12687019|P1|COMPLETED|Overall Study||62
5158320|NCT01263665|12687019|P1|STARTED|Overall Study||71
5158321|NCT01263639|12687026|P2|NOT COMPLETED|Overall Study||79
5158322|NCT01263639|12687027|P1|NOT COMPLETED|Overall Study||73
5158323|NCT01263639|12687026|P2|COMPLETED|Overall Study||42
5158324|NCT01263639|12687027|P1|COMPLETED|Overall Study||34
5158325|NCT01263639|12687026|P2|STARTED|Overall Study||121
5158326|NCT01263639|12687027|P1|STARTED|Overall Study||107
5158327|NCT01263561|12687035|P2|NOT COMPLETED|Overall Study||2
5158328|NCT01263561|12687036|P1|NOT COMPLETED|Overall Study||1
5158329|NCT01263561|12687035|P2|COMPLETED|Overall Study||31
5158330|NCT01263561|12687036|P1|COMPLETED|Overall Study||30
5158331|NCT01263561|12687035|P2|STARTED|Overall Study||33
5158332|NCT01263561|12687036|P1|STARTED|Overall Study||31
5158333|NCT01263509|12687048|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
5158334|NCT01263509|12687049|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
5158335|NCT01263509|12687050|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
5158336|NCT01263509|12687051|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
5158337|NCT01263509|12687048|P4|COMPLETED|Entered - Long-Term Extension Study||24
5158338|NCT01263509|12687049|P3|COMPLETED|Entered - Long-Term Extension Study||27
5158339|NCT01263509|12687050|P2|COMPLETED|Entered - Long-Term Extension Study||48
5158340|NCT01263509|12687051|P1|COMPLETED|Entered - Long-Term Extension Study||53
5158341|NCT01263509|12687048|P4|STARTED|Entered - Long-Term Extension Study||26
5158342|NCT01263509|12687049|P3|STARTED|Entered - Long-Term Extension Study||32
5158343|NCT01263509|12687050|P2|STARTED|Entered - Long-Term Extension Study||60
5158344|NCT01263509|12687051|P1|STARTED|Entered - Long-Term Extension Study||61
5158345|NCT01263509|12687048|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158346|NCT01263509|12687049|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158347|NCT01263509|12687050|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158348|NCT01263509|12687051|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158349|NCT01263509|12687048|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
5158350|NCT01263509|12687049|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
5158351|NCT01263509|12687050|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
5158352|NCT01263509|12687051|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
5158353|NCT01263509|12687048|P4|STARTED|Enrolled - Long-Term Extension Study||26
5158354|NCT01263509|12687049|P3|STARTED|Enrolled - Long-Term Extension Study||32
5158355|NCT01263509|12687050|P2|STARTED|Enrolled - Long-Term Extension Study||60
5158356|NCT01263509|12687051|P1|STARTED|Enrolled - Long-Term Extension Study||61
5158357|NCT01263496|12687180|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
5158358|NCT01263496|12687181|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
5158359|NCT01263496|12687182|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
5158360|NCT01263496|12687183|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
5158361|NCT01263496|12687184|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
5158362|NCT01263496|12687185|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
5158363|NCT01263496|12687186|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
5158364|NCT01263496|12687187|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
5158365|NCT01263496|12687188|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
5158366|NCT01263496|12687180|P9|COMPLETED|Entered - Long-Term Extension Study||15
5158367|NCT01263496|12687181|P8|COMPLETED|Entered - Long-Term Extension Study||16
5158368|NCT01263496|12687182|P7|COMPLETED|Entered - Long-Term Extension Study||16
5158369|NCT01263496|12687183|P6|COMPLETED|Entered - Long-Term Extension Study||16
5158370|NCT01263496|12687184|P5|COMPLETED|Entered - Long-Term Extension Study||61
5158371|NCT01263496|12687185|P4|COMPLETED|Entered - Long-Term Extension Study||68
5158372|NCT01263496|12687186|P3|COMPLETED|Entered - Long-Term Extension Study||62
5158373|NCT01263496|12687187|P2|COMPLETED|Entered - Long-Term Extension Study||59
5158374|NCT01263496|12687188|P1|COMPLETED|Entered - Long-Term Extension Study||62
5158375|NCT01263496|12687180|P9|STARTED|Entered - Long-Term Extension Study||18
5158376|NCT01263496|12687181|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
5158377|NCT01263496|12687182|P7|STARTED|Entered - Long-Term Extension Study||17
5158378|NCT01263496|12687183|P6|STARTED|Entered - Long-Term Extension Study||17
5158379|NCT01263496|12687184|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
5158380|NCT01263496|12687185|P4|STARTED|Entered - Long-Term Extension Study||74
5158381|NCT01263496|12687186|P3|STARTED|Entered - Long-Term Extension Study||72
5158382|NCT01263496|12687187|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
5158383|NCT01263496|12687188|P1|STARTED|Entered - Long-Term Extension Study||71
5158384|NCT01263496|12687180|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158385|NCT01263496|12687181|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158386|NCT01263496|12687182|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158387|NCT01263496|12687183|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158388|NCT01263496|12687184|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
5158389|NCT01263496|12687185|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
5158390|NCT01263496|12687186|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158391|NCT01263496|12687187|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
5158392|NCT01263496|12687188|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
5158393|NCT01263496|12687180|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
5158394|NCT01263496|12687181|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
5158395|NCT01263496|12687182|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
5158396|NCT01263496|12687183|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
5158397|NCT01263496|12687184|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
5158398|NCT01263496|12687185|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
5158399|NCT01263496|12687186|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
5158400|NCT01263496|12687187|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
5158401|NCT01263496|12687188|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
5158402|NCT01263496|12687180|P9|STARTED|Enrolled - Long-Term Extension Study||18
5158403|NCT01263496|12687181|P8|STARTED|Enrolled - Long-Term Extension Study||18
5158404|NCT01263496|12687182|P7|STARTED|Enrolled - Long-Term Extension Study||17
5158405|NCT01263496|12687183|P6|STARTED|Enrolled - Long-Term Extension Study||17
5158406|NCT01263496|12687184|P5|STARTED|Enrolled - Long-Term Extension Study||74
5158407|NCT01263496|12687185|P4|STARTED|Enrolled - Long-Term Extension Study||75
5158408|NCT01263496|12687186|P3|STARTED|Enrolled - Long-Term Extension Study||72
5158409|NCT01263496|12687187|P2|STARTED|Enrolled - Long-Term Extension Study||75
5158410|NCT01263496|12687188|P1|STARTED|Enrolled - Long-Term Extension Study||72
5158411|NCT01263483|12687483|P3|NOT COMPLETED|Overall Study||5
5158412|NCT01263483|12687484|P2|NOT COMPLETED|Overall Study||2
5158413|NCT01263483|12687485|P1|NOT COMPLETED|Overall Study||7
5158414|NCT01263483|12687483|P3|COMPLETED|Overall Study||74
5158415|NCT01263483|12687484|P2|COMPLETED|Overall Study||74
5158416|NCT01263483|12687485|P1|COMPLETED|Overall Study||68
5158417|NCT01263483|12687483|P3|STARTED|Overall Study||79
5158418|NCT01263483|12687484|P2|STARTED|Overall Study||76
5158419|NCT01263483|12687485|P1|STARTED|Overall Study||75
5158420|NCT01263470|12687547|P6|NOT COMPLETED|Overall Study||5
5158421|NCT01263470|12687548|P5|NOT COMPLETED|Overall Study||3
5158422|NCT01263470|12687549|P4|NOT COMPLETED|Overall Study||3
5158423|NCT01263470|12687550|P3|NOT COMPLETED|Overall Study||4
5158424|NCT01263470|12687551|P2|NOT COMPLETED|Overall Study||5
5158425|NCT01263470|12687552|P1|NOT COMPLETED|Overall Study||2
5158426|NCT01263470|12687547|P6|COMPLETED|Overall Study||78
5158427|NCT01263470|12687548|P5|COMPLETED|Overall Study||76
5158428|NCT01263470|12687549|P4|COMPLETED|Overall Study||77
5158429|NCT01263470|12687550|P3|COMPLETED|Overall Study||80
5158430|NCT01263470|12687551|P2|COMPLETED|Overall Study||74
5158431|NCT01263470|12687552|P1|COMPLETED|Overall Study||73
5158432|NCT01263470|12687547|P6|STARTED|Overall Study||83
5158433|NCT01263470|12687548|P5|STARTED|Overall Study||79
5158434|NCT01263470|12687549|P4|STARTED|Overall Study||80
5158435|NCT01263470|12687550|P3|STARTED|Overall Study||84
5158436|NCT01263470|12687551|P2|STARTED|Overall Study||79
5158437|NCT01263470|12687552|P1|STARTED|Overall Study||75
5158438|NCT01263444|12687662|P1|NOT COMPLETED|Overall Study||10
5158439|NCT01263444|12687662|P1|COMPLETED|Overall Study||37
5158440|NCT01263444|12687662|P1|STARTED|Overall Study||47
5158441|NCT01263314|12687671|P8|NOT COMPLETED|Period 3||0
5158442|NCT01263314|12687672|P7|NOT COMPLETED|Period 3||0
5158443|NCT01263314|12687673|P6|NOT COMPLETED|Period 3||0
5158444|NCT01263314|12687674|P5|NOT COMPLETED|Period 3||0
5158445|NCT01263314|12687675|P4|NOT COMPLETED|Period 3||0
5158446|NCT01263314|12687676|P3|NOT COMPLETED|Period 3||0
5158447|NCT01263314|12687677|P2|NOT COMPLETED|Period 3||0
5158448|NCT01263314|12687678|P1|NOT COMPLETED|Period 3||0
5158449|NCT01263314|12687671|P8|COMPLETED|Period 3||2
5158450|NCT01263314|12687672|P7|COMPLETED|Period 3||2
5158451|NCT01263314|12687673|P6|COMPLETED|Period 3||2
5158452|NCT01263314|12687674|P5|COMPLETED|Period 3||2
5158453|NCT01263314|12687675|P4|COMPLETED|Period 3||2
5158454|NCT01263314|12687676|P3|COMPLETED|Period 3||2
5158455|NCT01263314|12687677|P2|COMPLETED|Period 3||2
5158456|NCT01263314|12687678|P1|COMPLETED|Period 3||2
5158457|NCT01263314|12687671|P8|STARTED|Period 3||2
5158458|NCT01263314|12687672|P7|STARTED|Period 3||2
5158459|NCT01263314|12687673|P6|STARTED|Period 3||2
5158460|NCT01263314|12687674|P5|STARTED|Period 3||2
5158461|NCT01263314|12687675|P4|STARTED|Period 3||2
5158462|NCT01263314|12687676|P3|STARTED|Period 3||2
5158463|NCT01263314|12687677|P2|STARTED|Period 3||2
5158464|NCT01263314|12687678|P1|STARTED|Period 3||2
5158465|NCT01263314|12687671|P8|NOT COMPLETED|Period 2||0
5158466|NCT01263314|12687672|P7|NOT COMPLETED|Period 2||0
5158467|NCT01263314|12687673|P6|NOT COMPLETED|Period 2||0
5158468|NCT01263314|12687674|P5|NOT COMPLETED|Period 2||0
5158469|NCT01263314|12687675|P4|NOT COMPLETED|Period 2||0
5158470|NCT01263314|12687676|P3|NOT COMPLETED|Period 2||0
5158471|NCT01263314|12687677|P2|NOT COMPLETED|Period 2||0
5158472|NCT01263314|12687678|P1|NOT COMPLETED|Period 2||0
5158473|NCT01263314|12687671|P8|COMPLETED|Period 2||2
5158474|NCT01263314|12687672|P7|COMPLETED|Period 2||2
5158475|NCT01263314|12687673|P6|COMPLETED|Period 2||2
5158476|NCT01263314|12687674|P5|COMPLETED|Period 2||2
5158477|NCT01263314|12687675|P4|COMPLETED|Period 2||2
5158478|NCT01263314|12687676|P3|COMPLETED|Period 2||2
5158479|NCT01263314|12687677|P2|COMPLETED|Period 2||2
5158480|NCT01263314|12687678|P1|COMPLETED|Period 2||2
5158481|NCT01263314|12687671|P8|STARTED|Period 2||2
5158482|NCT01263314|12687672|P7|STARTED|Period 2||2
5158483|NCT01263314|12687673|P6|STARTED|Period 2||2
5158484|NCT01263314|12687674|P5|STARTED|Period 2||2
5158485|NCT01263314|12687675|P4|STARTED|Period 2||2
5158486|NCT01263314|12687676|P3|STARTED|Period 2||2
5158487|NCT01263314|12687677|P2|STARTED|Period 2||2
5158488|NCT01263314|12687678|P1|STARTED|Period 2||2
5158489|NCT01263314|12687671|P8|NOT COMPLETED|Period 1||0
5158490|NCT01263314|12687672|P7|NOT COMPLETED|Period 1||0
5158491|NCT01263314|12687673|P6|NOT COMPLETED|Period 1||0
5158492|NCT01263314|12687674|P5|NOT COMPLETED|Period 1||0
5158493|NCT01263314|12687675|P4|NOT COMPLETED|Period 1||0
5158494|NCT01263314|12687676|P3|NOT COMPLETED|Period 1||0
5158495|NCT01263314|12687677|P2|NOT COMPLETED|Period 1||0
5158496|NCT01263314|12687678|P1|NOT COMPLETED|Period 1||0
5158497|NCT01263314|12687671|P8|COMPLETED|Period 1||2
5158498|NCT01263314|12687672|P7|COMPLETED|Period 1||2
5158499|NCT01263314|12687673|P6|COMPLETED|Period 1||2
5158500|NCT01263314|12687674|P5|COMPLETED|Period 1||2
5158501|NCT01263314|12687675|P4|COMPLETED|Period 1||2
5158502|NCT01263314|12687676|P3|COMPLETED|Period 1||2
5158503|NCT01263314|12687677|P2|COMPLETED|Period 1||2
5158504|NCT01263314|12687678|P1|COMPLETED|Period 1||2
5158505|NCT01263314|12687671|P8|STARTED|Period 1||2
5158506|NCT01263314|12687672|P7|STARTED|Period 1||2
5158507|NCT01263314|12687673|P6|STARTED|Period 1||2
5158508|NCT01263314|12687674|P5|STARTED|Period 1||2
5158509|NCT01263314|12687675|P4|STARTED|Period 1||2
5158510|NCT01263314|12687676|P3|STARTED|Period 1||2
5158511|NCT01263314|12687677|P2|STARTED|Period 1||2
5158512|NCT01263314|12687678|P1|STARTED|Period 1||2
5158513|NCT01263301|12687786|P2|NOT COMPLETED|Overall Study||0
5158514|NCT01263301|12687787|P1|NOT COMPLETED|Overall Study||0
5158515|NCT01263301|12687786|P2|COMPLETED|Overall Study||11
5158516|NCT01263301|12687787|P1|COMPLETED|Overall Study||5
5158517|NCT01263301|12687786|P2|STARTED|Overall Study||11
5158518|NCT01263301|12687787|P1|STARTED|Overall Study||5
5158519|NCT01263223|12687799|P2|NOT COMPLETED|7-day Follow-up||1
5158520|NCT01263223|12687800|P1|NOT COMPLETED|7-day Follow-up||1
5158521|NCT01263223|12687799|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
5158522|NCT01263223|12687800|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
5158523|NCT01263223|12687799|P2|STARTED|7-day Follow-up||11
5158524|NCT01263223|12687800|P1|STARTED|7-day Follow-up||12
5158525|NCT01263223|12687799|P2|NOT COMPLETED|Period 3||0
5158526|NCT01263223|12687800|P1|NOT COMPLETED|Period 3||0
5158527|NCT01263223|12687799|P2|COMPLETED|Period 3||11
5158528|NCT01263223|12687800|P1|COMPLETED|Period 3||12
5158529|NCT01263223|12687799|P2|STARTED|Period 3||11
5158530|NCT01263223|12687800|P1|STARTED|Period 3||12
5158531|NCT01263223|12687799|P2|NOT COMPLETED|Period 2||1
5158532|NCT01263223|12687800|P1|NOT COMPLETED|Period 2||0
5158533|NCT01263223|12687799|P2|COMPLETED|Period 2||11
5158534|NCT01263223|12687800|P1|COMPLETED|Period 2||12
5158535|NCT01263223|12687799|P2|STARTED|Period 2||12
5158536|NCT01263223|12687800|P1|STARTED|Period 2||12
5158537|NCT01263223|12687799|P2|NOT COMPLETED|3-Day Washout||0
5158538|NCT01263223|12687800|P1|NOT COMPLETED|3-Day Washout||0
5158539|NCT01263223|12687799|P2|COMPLETED|3-Day Washout||12
5158540|NCT01263223|12687800|P1|COMPLETED|3-Day Washout||12
5158541|NCT01263223|12687799|P2|STARTED|3-Day Washout||12
5158542|NCT01263223|12687800|P1|STARTED|3-Day Washout||12
5158543|NCT01263223|12687799|P2|NOT COMPLETED|Period 1||0
5158544|NCT01263223|12687800|P1|NOT COMPLETED|Period 1||0
5158545|NCT01263223|12687799|P2|COMPLETED|Period 1||12
5158546|NCT01263223|12687800|P1|COMPLETED|Period 1||12
5158547|NCT01263223|12687799|P2|STARTED|Period 1||12
5158548|NCT01263223|12687800|P1|STARTED|Period 1||12
5158549|NCT01263197|12687823|P6|NOT COMPLETED|Third Intervention (Period 3)||0
5158550|NCT01263197|12687824|P5|NOT COMPLETED|Third Intervention (Period 3)||0
5158551|NCT01263197|12687825|P4|NOT COMPLETED|Third Intervention (Period 3)||0
5158552|NCT01263197|12687826|P3|NOT COMPLETED|Third Intervention (Period 3)||0
5158553|NCT01263197|12687827|P2|NOT COMPLETED|Third Intervention (Period 3)||1
5158554|NCT01263197|12687828|P1|NOT COMPLETED|Third Intervention (Period 3)||0
5158555|NCT01263197|12687823|P6|COMPLETED|Third Intervention (Period 3)||6
5158556|NCT01263197|12687824|P5|COMPLETED|Third Intervention (Period 3)||7
5158557|NCT01263197|12687825|P4|COMPLETED|Third Intervention (Period 3)||7
5158558|NCT01263197|12687826|P3|COMPLETED|Third Intervention (Period 3)||8
5158559|NCT01263197|12687827|P2|COMPLETED|Third Intervention (Period 3)||7
5158560|NCT01263197|12687828|P1|COMPLETED|Third Intervention (Period 3)||8
5158561|NCT01263197|12687823|P6|STARTED|Third Intervention (Period 3)||6
5158562|NCT01263197|12687824|P5|STARTED|Third Intervention (Period 3)||7
5158563|NCT01263197|12687825|P4|STARTED|Third Intervention (Period 3)||7
5158564|NCT01263197|12687826|P3|STARTED|Third Intervention (Period 3)||8
5158565|NCT01263197|12687827|P2|STARTED|Third Intervention (Period 3)||8
5158566|NCT01263197|12687828|P1|STARTED|Third Intervention (Period 3)||8
5158567|NCT01263197|12687823|P6|NOT COMPLETED|Washout Period 2||1
5158568|NCT01263197|12687824|P5|NOT COMPLETED|Washout Period 2||0
5158569|NCT01263197|12687825|P4|NOT COMPLETED|Washout Period 2||1
5158570|NCT01263197|12687826|P3|NOT COMPLETED|Washout Period 2||0
5158571|NCT01263197|12687827|P2|NOT COMPLETED|Washout Period 2||0
5158572|NCT01263197|12687828|P1|NOT COMPLETED|Washout Period 2||0
5158573|NCT01263197|12687823|P6|COMPLETED|Washout Period 2||6
5158574|NCT01263197|12687824|P5|COMPLETED|Washout Period 2||7
5158575|NCT01263197|12687825|P4|COMPLETED|Washout Period 2||7
5158576|NCT01263197|12687826|P3|COMPLETED|Washout Period 2||8
5158577|NCT01263197|12687827|P2|COMPLETED|Washout Period 2||8
5158578|NCT01263197|12687828|P1|COMPLETED|Washout Period 2||8
5158579|NCT01263197|12687823|P6|STARTED|Washout Period 2||7
5158580|NCT01263197|12687824|P5|STARTED|Washout Period 2||7
5158581|NCT01263197|12687825|P4|STARTED|Washout Period 2||8
5158582|NCT01263197|12687826|P3|STARTED|Washout Period 2||8
5158583|NCT01263197|12687827|P2|STARTED|Washout Period 2||8
5158584|NCT01263197|12687828|P1|STARTED|Washout Period 2||8
5158585|NCT01263197|12687823|P6|NOT COMPLETED|Second Intervention (Period 2)||0
5158586|NCT01263197|12687824|P5|NOT COMPLETED|Second Intervention (Period 2)||0
5158587|NCT01263197|12687825|P4|NOT COMPLETED|Second Intervention (Period 2)||0
5158588|NCT01263197|12687826|P3|NOT COMPLETED|Second Intervention (Period 2)||0
5158589|NCT01263197|12687827|P2|NOT COMPLETED|Second Intervention (Period 2)||0
5158590|NCT01263197|12687828|P1|NOT COMPLETED|Second Intervention (Period 2)||0
5158591|NCT01263197|12687823|P6|COMPLETED|Second Intervention (Period 2)||7
5158592|NCT01263197|12687824|P5|COMPLETED|Second Intervention (Period 2)||7
5158593|NCT01263197|12687825|P4|COMPLETED|Second Intervention (Period 2)||8
5158594|NCT01263197|12687826|P3|COMPLETED|Second Intervention (Period 2)||8
5158595|NCT01263197|12687827|P2|COMPLETED|Second Intervention (Period 2)||8
5158596|NCT01263197|12687828|P1|COMPLETED|Second Intervention (Period 2)||8
5158597|NCT01263197|12687823|P6|STARTED|Second Intervention (Period 2)||7
5158598|NCT01263197|12687824|P5|STARTED|Second Intervention (Period 2)||7
5158599|NCT01263197|12687825|P4|STARTED|Second Intervention (Period 2)||8
5158600|NCT01263197|12687826|P3|STARTED|Second Intervention (Period 2)||8
5158601|NCT01263197|12687827|P2|STARTED|Second Intervention (Period 2)||8
5158602|NCT01263197|12687828|P1|STARTED|Second Intervention (Period 2)||8
5158603|NCT01263197|12687823|P6|NOT COMPLETED|Washout Period 1||0
5158604|NCT01263197|12687824|P5|NOT COMPLETED|Washout Period 1||1
5158605|NCT01263197|12687825|P4|NOT COMPLETED|Washout Period 1||0
5158606|NCT01263197|12687826|P3|NOT COMPLETED|Washout Period 1||0
5158607|NCT01263197|12687827|P2|NOT COMPLETED|Washout Period 1||0
5158608|NCT01263197|12687828|P1|NOT COMPLETED|Washout Period 1||0
5158609|NCT01263197|12687823|P6|COMPLETED|Washout Period 1||7
5158610|NCT01263197|12687824|P5|COMPLETED|Washout Period 1||7
5158611|NCT01263197|12687825|P4|COMPLETED|Washout Period 1||8
5158612|NCT01263197|12687826|P3|COMPLETED|Washout Period 1||8
5158613|NCT01263197|12687827|P2|COMPLETED|Washout Period 1||8
5158614|NCT01263197|12687828|P1|COMPLETED|Washout Period 1||8
5158615|NCT01263197|12687823|P6|STARTED|Washout Period 1||7
5158616|NCT01263197|12687824|P5|STARTED|Washout Period 1||8
5158617|NCT01263197|12687825|P4|STARTED|Washout Period 1||8
5158618|NCT01263197|12687826|P3|STARTED|Washout Period 1||8
5158619|NCT01263197|12687827|P2|STARTED|Washout Period 1||8
5158620|NCT01263197|12687828|P1|STARTED|Washout Period 1||8
5158621|NCT01263197|12687823|P6|NOT COMPLETED|First Intervention (Period 1)||1
5158622|NCT01263197|12687824|P5|NOT COMPLETED|First Intervention (Period 1)||0
5158623|NCT01263197|12687825|P4|NOT COMPLETED|First Intervention (Period 1)||0
5158624|NCT01263197|12687826|P3|NOT COMPLETED|First Intervention (Period 1)||0
5158625|NCT01263197|12687827|P2|NOT COMPLETED|First Intervention (Period 1)||0
5158626|NCT01263197|12687828|P1|NOT COMPLETED|First Intervention (Period 1)||0
5158627|NCT01263197|12687823|P6|COMPLETED|First Intervention (Period 1)||7
5158628|NCT01263197|12687824|P5|COMPLETED|First Intervention (Period 1)||8
5158629|NCT01263197|12687825|P4|COMPLETED|First Intervention (Period 1)||8
5158630|NCT01263197|12687826|P3|COMPLETED|First Intervention (Period 1)||8
5158631|NCT01263197|12687827|P2|COMPLETED|First Intervention (Period 1)||8
5158632|NCT01263197|12687828|P1|COMPLETED|First Intervention (Period 1)||8
5158633|NCT01263197|12687823|P6|STARTED|First Intervention (Period 1)||8
5158634|NCT01263197|12687824|P5|STARTED|First Intervention (Period 1)||8
5158635|NCT01263197|12687825|P4|STARTED|First Intervention (Period 1)||8
5158636|NCT01263197|12687826|P3|STARTED|First Intervention (Period 1)||8
5158637|NCT01263197|12687827|P2|STARTED|First Intervention (Period 1)||8
5158638|NCT01263197|12687828|P1|STARTED|First Intervention (Period 1)||8
5158639|NCT01263132|12687856|P2|NOT COMPLETED|Overall Study||0
5158640|NCT01263132|12687857|P1|NOT COMPLETED|Overall Study||0
5158641|NCT01263132|12687856|P2|COMPLETED|Overall Study||37
5158642|NCT01263132|12687857|P1|COMPLETED|Overall Study||38
5158643|NCT01263132|12687856|P2|STARTED|Overall Study||37
5158644|NCT01263132|12687857|P1|STARTED|Overall Study||38
5158645|NCT01263119|12687871|P1|NOT COMPLETED|Period 2||2
5158646|NCT01263119|12687871|P1|COMPLETED|Period 2||14
5158647|NCT01263119|12687871|P1|STARTED|Period 2||16
5158648|NCT01263119|12687871|P1|NOT COMPLETED|Period 1||2
5158649|NCT01263119|12687871|P1|COMPLETED|Period 1||16
5158650|NCT01263119|12687871|P1|STARTED|Period 1||18
5158651|NCT01263106|12687892|P2|NOT COMPLETED|Period 2 (7 Days)||0
5158652|NCT01263106|12687893|P1|NOT COMPLETED|Period 2 (7 Days)||0
5158653|NCT01263106|12687892|P2|COMPLETED|Period 2 (7 Days)||9
5158654|NCT01263106|12687893|P1|COMPLETED|Period 2 (7 Days)||10
5158655|NCT01263106|12687892|P2|STARTED|Period 2 (7 Days)||9
5158656|NCT01263106|12687893|P1|STARTED|Period 2 (7 Days)||10
5158657|NCT01263106|12687892|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
5158658|NCT01263106|12687893|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
5158659|NCT01263106|12687892|P2|COMPLETED|Washout (at Least 7 Days)||9
5158660|NCT01263106|12687893|P1|COMPLETED|Washout (at Least 7 Days)||10
5158661|NCT01263106|12687892|P2|STARTED|Washout (at Least 7 Days)||10
5158662|NCT01263106|12687893|P1|STARTED|Washout (at Least 7 Days)||11
5158663|NCT01263106|12687892|P2|NOT COMPLETED|Period 1 (7 Days)||0
5158664|NCT01263106|12687893|P1|NOT COMPLETED|Period 1 (7 Days)||0
5158665|NCT01263106|12687892|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
5158666|NCT01263106|12687893|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
5158667|NCT01263106|12687892|P2|STARTED|Period 1 (7 Days)||10
5158668|NCT01263106|12687893|P1|STARTED|Period 1 (7 Days)||11
5158669|NCT01263093|12687908|P2|NOT COMPLETED|Period 2||0
5158670|NCT01263093|12687909|P1|NOT COMPLETED|Period 2||1
5158671|NCT01263093|12687908|P2|COMPLETED|Period 2||23
5158672|NCT01263093|12687909|P1|COMPLETED|Period 2||22
5158673|NCT01263093|12687908|P2|STARTED|Period 2||23
5158674|NCT01263093|12687909|P1|STARTED|Period 2||23
5158675|NCT01263093|12687908|P2|NOT COMPLETED|Washout||0
5158676|NCT01263093|12687909|P1|NOT COMPLETED|Washout||1
5158677|NCT01263093|12687908|P2|COMPLETED|Washout||23
5158678|NCT01263093|12687909|P1|COMPLETED|Washout||23
5158679|NCT01263093|12687908|P2|STARTED|Washout||23
5158680|NCT01263093|12687909|P1|STARTED|Washout||24
5158681|NCT01263093|12687908|P2|NOT COMPLETED|Period 1||0
5158682|NCT01263093|12687909|P1|NOT COMPLETED|Period 1||0
5158683|NCT01263093|12687908|P2|COMPLETED|Period 1||23
5158684|NCT01263093|12687909|P1|COMPLETED|Period 1||24
5158685|NCT01263093|12687908|P2|STARTED|Period 1||23
5158686|NCT01263093|12687909|P1|STARTED|Period 1||24
5158687|NCT01263054|12687926|P2|NOT COMPLETED|Overall Study||6
5158688|NCT01263054|12687927|P1|NOT COMPLETED|Overall Study||5
5158689|NCT01263054|12687926|P2|COMPLETED|Overall Study||28
5158690|NCT01263054|12687927|P1|COMPLETED|Overall Study||24
5158691|NCT01263054|12687926|P2|STARTED|Overall Study||34
5158692|NCT01263054|12687927|P1|STARTED|Overall Study||29
5158693|NCT01263028|12687945|P1|NOT COMPLETED|Overall Study||6
5158694|NCT01263028|12687945|P1|COMPLETED|Overall Study||0
5158695|NCT01263028|12687945|P1|STARTED|Overall Study||6
5158696|NCT01263015|12687955|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
5158697|NCT01263015|12687956|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
5158698|NCT01263015|12687955|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
5158699|NCT01263015|12687956|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
5158700|NCT01263015|12687955|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
5158701|NCT01263015|12687956|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
5158702|NCT01263015|12687955|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
5158703|NCT01263015|12687956|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
5158704|NCT01263015|12687955|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
5158705|NCT01263015|12687956|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
5158706|NCT01263015|12687955|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
5158707|NCT01263015|12687956|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
5158708|NCT01262989|12687982|P2|NOT COMPLETED|Period 2||1
5158709|NCT01262989|12687983|P1|NOT COMPLETED|Period 2||0
5158710|NCT01262989|12687982|P2|COMPLETED|Period 2||16
5158711|NCT01262989|12687983|P1|COMPLETED|Period 2||19
5158712|NCT01262989|12687982|P2|STARTED|Period 2||17
5158713|NCT01262989|12687983|P1|STARTED|Period 2||19
5158714|NCT01262989|12687982|P2|NOT COMPLETED|7-Day Washout Period||0
5158715|NCT01262989|12687983|P1|NOT COMPLETED|7-Day Washout Period||0
5158716|NCT01262989|12687982|P2|COMPLETED|7-Day Washout Period||17
5158717|NCT01262989|12687983|P1|COMPLETED|7-Day Washout Period||19
5158718|NCT01262989|12687982|P2|STARTED|7-Day Washout Period||17
5158719|NCT01262989|12687983|P1|STARTED|7-Day Washout Period||19
5158720|NCT01262989|12687982|P2|NOT COMPLETED|Period 1||3
5158721|NCT01262989|12687983|P1|NOT COMPLETED|Period 1||1
5158722|NCT01262989|12687982|P2|COMPLETED|Period 1||17
5158723|NCT01262989|12687983|P1|COMPLETED|Period 1||19
5158724|NCT01262989|12687982|P2|STARTED|Period 1||20
5158725|NCT01262989|12687983|P1|STARTED|Period 1||20
5158726|NCT01262976|12687999|P6|NOT COMPLETED|Up to Year 3||4
5158727|NCT01262976|12688000|P5|NOT COMPLETED|Up to Year 3||2
5158728|NCT01262976|12688001|P4|NOT COMPLETED|Up to Year 3||5
5158729|NCT01262976|12688002|P3|NOT COMPLETED|Up to Year 3||7
5158730|NCT01262976|12688003|P2|NOT COMPLETED|Up to Year 3||2
5158731|NCT01262976|12688004|P1|NOT COMPLETED|Up to Year 3||6
5158732|NCT01262976|12687999|P6|COMPLETED|Up to Year 3||36
5158733|NCT01262976|12688000|P5|COMPLETED|Up to Year 3||38
5158734|NCT01262976|12688001|P4|COMPLETED|Up to Year 3||35
5158735|NCT01262976|12688002|P3|COMPLETED|Up to Year 3||33
5158736|NCT01262976|12688003|P2|COMPLETED|Up to Year 3||38
5158737|NCT01262976|12688004|P1|COMPLETED|Up to Year 3||34
5158738|NCT01262976|12687999|P6|STARTED|Up to Year 3||40
5158739|NCT01262976|12688000|P5|STARTED|Up to Year 3||40
5158740|NCT01262976|12688001|P4|STARTED|Up to Year 3||40
5158741|NCT01262976|12688002|P3|STARTED|Up to Year 3||40
5158742|NCT01262976|12688003|P2|STARTED|Up to Year 3||40
5158743|NCT01262976|12688004|P1|STARTED|Up to Year 3||40
5158744|NCT01262976|12687999|P6|NOT COMPLETED|Up to Year 2||5
5158745|NCT01262976|12688000|P5|NOT COMPLETED|Up to Year 2||4
5158746|NCT01262976|12688001|P4|NOT COMPLETED|Up to Year 2||4
5158747|NCT01262976|12688002|P3|NOT COMPLETED|Up to Year 2||5
5158748|NCT01262976|12688003|P2|NOT COMPLETED|Up to Year 2||1
5158749|NCT01262976|12688004|P1|NOT COMPLETED|Up to Year 2||5
5158750|NCT01262976|12687999|P6|COMPLETED|Up to Year 2||35
5158751|NCT01262976|12688000|P5|COMPLETED|Up to Year 2||36
5158752|NCT01262976|12688001|P4|COMPLETED|Up to Year 2||36
5158753|NCT01262976|12688002|P3|COMPLETED|Up to Year 2||35
5158754|NCT01262976|12688003|P2|COMPLETED|Up to Year 2||39
5158755|NCT01262976|12688004|P1|COMPLETED|Up to Year 2||35
5158756|NCT01262976|12687999|P6|STARTED|Up to Year 2||40
5158757|NCT01262976|12688000|P5|STARTED|Up to Year 2||40
5158758|NCT01262976|12688001|P4|STARTED|Up to Year 2||40
5158759|NCT01262976|12688002|P3|STARTED|Up to Year 2||40
5158760|NCT01262976|12688003|P2|STARTED|Up to Year 2||40
5158761|NCT01262976|12688004|P1|STARTED|Up to Year 2||40
5158762|NCT01262976|12687999|P6|NOT COMPLETED|Up to Year 1||9
5158763|NCT01262976|12688000|P5|NOT COMPLETED|Up to Year 1||11
5158764|NCT01262976|12688001|P4|NOT COMPLETED|Up to Year 1||4
5158765|NCT01262976|12688002|P3|NOT COMPLETED|Up to Year 1||3
5158766|NCT01262976|12688003|P2|NOT COMPLETED|Up to Year 1||1
5158767|NCT01262976|12688004|P1|NOT COMPLETED|Up to Year 1||9
5158768|NCT01262976|12687999|P6|COMPLETED|Up to Year 1||31
5158769|NCT01262976|12688000|P5|COMPLETED|Up to Year 1||29
5158770|NCT01262976|12688001|P4|COMPLETED|Up to Year 1||36
5158771|NCT01262976|12688002|P3|COMPLETED|Up to Year 1||37
5158772|NCT01262976|12688003|P2|COMPLETED|Up to Year 1||39
5158773|NCT01262976|12688004|P1|COMPLETED|Up to Year 1||31
5158774|NCT01262976|12687999|P6|STARTED|Up to Year 1||40
5158775|NCT01262976|12688000|P5|STARTED|Up to Year 1||40
5158776|NCT01262976|12688001|P4|STARTED|Up to Year 1||40
5158777|NCT01262976|12688002|P3|STARTED|Up to Year 1||40
5158778|NCT01262976|12688003|P2|STARTED|Up to Year 1||40
5158779|NCT01262976|12688004|P1|STARTED|Up to Year 1||40
5158780|NCT01262976|12687999|P6|NOT COMPLETED|Up to Month 7||4
5158781|NCT01262976|12688000|P5|NOT COMPLETED|Up to Month 7||2
5158782|NCT01262976|12688001|P4|NOT COMPLETED|Up to Month 7||6
5158783|NCT01262976|12688002|P3|NOT COMPLETED|Up to Month 7||6
5158784|NCT01262976|12688003|P2|NOT COMPLETED|Up to Month 7||0
5158785|NCT01262976|12688004|P1|NOT COMPLETED|Up to Month 7||5
5158786|NCT01262976|12687999|P6|COMPLETED|Up to Month 7||36
5158787|NCT01262976|12688000|P5|COMPLETED|Up to Month 7||38
5158788|NCT01262976|12688001|P4|COMPLETED|Up to Month 7||34
5158789|NCT01262976|12688002|P3|COMPLETED|Up to Month 7||34
5158790|NCT01262976|12688003|P2|COMPLETED|Up to Month 7||40
5158791|NCT01262976|12688004|P1|COMPLETED|Up to Month 7||35
5158792|NCT01262976|12687999|P6|STARTED|Up to Month 7||40
5158793|NCT01262976|12688000|P5|STARTED|Up to Month 7||40
5158794|NCT01262976|12688001|P4|STARTED|Up to Month 7||40
5158795|NCT01262976|12688002|P3|STARTED|Up to Month 7||40
5158796|NCT01262976|12688003|P2|STARTED|Up to Month 7||40
5158797|NCT01262976|12688004|P1|STARTED|Up to Month 7||40
5158798|NCT01262976|12687999|P6|NOT COMPLETED|Up to Month 2||4
5158799|NCT01262976|12688000|P5|NOT COMPLETED|Up to Month 2||2
5158800|NCT01262976|12688001|P4|NOT COMPLETED|Up to Month 2||2
5158801|NCT01262976|12688002|P3|NOT COMPLETED|Up to Month 2||1
5158802|NCT01262976|12688003|P2|NOT COMPLETED|Up to Month 2||1
5158803|NCT01262976|12688004|P1|NOT COMPLETED|Up to Month 2||3
5158804|NCT01262976|12687999|P6|COMPLETED|Up to Month 2||36
5158805|NCT01262976|12688000|P5|COMPLETED|Up to Month 2||38
5158806|NCT01262976|12688001|P4|COMPLETED|Up to Month 2||38
5158807|NCT01262976|12688002|P3|COMPLETED|Up to Month 2||39
5158808|NCT01262976|12688003|P2|COMPLETED|Up to Month 2||39
5158809|NCT01262976|12688004|P1|COMPLETED|Up to Month 2||37
5158810|NCT01262976|12687999|P6|STARTED|Up to Month 2||40
5158811|NCT01262976|12688000|P5|STARTED|Up to Month 2||40
5158812|NCT01262976|12688001|P4|STARTED|Up to Month 2||40
5158813|NCT01262976|12688002|P3|STARTED|Up to Month 2||40
5158814|NCT01262976|12688003|P2|STARTED|Up to Month 2||40
5158815|NCT01262976|12688004|P1|STARTED|Up to Month 2||40
5158816|NCT01262898|12688160|P4|NOT COMPLETED|Overall Study||0
5158817|NCT01262898|12688161|P3|NOT COMPLETED|Overall Study||0
5158818|NCT01262898|12688162|P2|NOT COMPLETED|Overall Study||2
5158819|NCT01262898|12688163|P1|NOT COMPLETED|Overall Study||3
5158820|NCT01262898|12688160|P4|COMPLETED|Overall Study||22
5158821|NCT01262898|12688161|P3|COMPLETED|Overall Study||18
5158822|NCT01262898|12688162|P2|COMPLETED|Overall Study||16
5158823|NCT01262898|12688163|P1|COMPLETED|Overall Study||18
5158824|NCT01262898|12688160|P4|STARTED|Overall Study||22
5158825|NCT01262898|12688161|P3|STARTED|Overall Study||18
5158826|NCT01262898|12688162|P2|STARTED|Overall Study||18
5158827|NCT01262898|12688163|P1|STARTED|Overall Study||21
5158828|NCT01262872|12688291|P8|NOT COMPLETED|Step 2||6
5158829|NCT01262872|12688292|P7|NOT COMPLETED|Step 2||9
5158830|NCT01262872|12688293|P6|NOT COMPLETED|Step 2||9
5158831|NCT01262872|12688294|P5|NOT COMPLETED|Step 2||5
5158832|NCT01262872|12688295|P4|NOT COMPLETED|Step 2||10
5158833|NCT01262872|12688296|P3|NOT COMPLETED|Step 2||9
5158834|NCT01262872|12688297|P2|NOT COMPLETED|Step 2||0
5158835|NCT01262872|12688298|P1|NOT COMPLETED|Step 2||0
5158836|NCT01262872|12688291|P8|COMPLETED|Step 2||194
5158837|NCT01262872|12688292|P7|COMPLETED|Step 2||191
5158838|NCT01262872|12688293|P6|COMPLETED|Step 2||191
5158839|NCT01262872|12688294|P5|COMPLETED|Step 2||195
5158840|NCT01262872|12688295|P4|COMPLETED|Step 2||190
5158841|NCT01262872|12688296|P3|COMPLETED|Step 2||191
5158842|NCT01262872|12688297|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158843|NCT01262872|12688298|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158844|NCT01262872|12688291|P8|STARTED|Step 2||200
5158845|NCT01262872|12688292|P7|STARTED|Step 2||200
5158846|NCT01262872|12688293|P6|STARTED|Step 2||200
5158847|NCT01262872|12688294|P5|STARTED|Step 2||200
5158848|NCT01262872|12688295|P4|STARTED|Step 2||200
5158849|NCT01262872|12688296|P3|STARTED|Step 2||200
5158850|NCT01262872|12688297|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158851|NCT01262872|12688298|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158852|NCT01262872|12688291|P8|NOT COMPLETED|Step 1||0
5158853|NCT01262872|12688292|P7|NOT COMPLETED|Step 1||0
5158854|NCT01262872|12688293|P6|NOT COMPLETED|Step 1||0
5158855|NCT01262872|12688294|P5|NOT COMPLETED|Step 1||0
5158856|NCT01262872|12688295|P4|NOT COMPLETED|Step 1||0
5158857|NCT01262872|12688296|P3|NOT COMPLETED|Step 1||0
5158858|NCT01262872|12688297|P2|NOT COMPLETED|Step 1||0
5158859|NCT01262872|12688298|P1|NOT COMPLETED|Step 1||0
5158860|NCT01262872|12688291|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158861|NCT01262872|12688292|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158862|NCT01262872|12688293|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158863|NCT01262872|12688294|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158864|NCT01262872|12688295|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
5158865|NCT01262872|12688296|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158866|NCT01262872|12688297|P2|COMPLETED|Step 1||60
5158867|NCT01262872|12688298|P1|COMPLETED|Step 1||60
5158868|NCT01262872|12688291|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158869|NCT01262872|12688292|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158870|NCT01262872|12688293|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158871|NCT01262872|12688294|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158872|NCT01262872|12688295|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158873|NCT01262872|12688296|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
5158874|NCT01262872|12688297|P2|STARTED|Step 1||60
5158875|NCT01262872|12688298|P1|STARTED|Step 1||60
5158876|NCT01262846|12688565|P2|NOT COMPLETED|Overall Study||3
5158877|NCT01262846|12688566|P1|NOT COMPLETED|Overall Study||2
5158878|NCT01262846|12688565|P2|COMPLETED|Overall Study||97
5158879|NCT01262846|12688566|P1|COMPLETED|Overall Study||93
5158880|NCT01262846|12688565|P2|STARTED|Overall Study||100
5158881|NCT01262846|12688566|P1|STARTED|Overall Study||95
5158882|NCT01262820|12688572|P1|NOT COMPLETED|Overall Study||15
5158883|NCT01262820|12688572|P1|COMPLETED|Overall Study||0
5158884|NCT01262820|12688572|P1|STARTED|Overall Study||15
5158885|NCT01262755|12688579|P1|NOT COMPLETED|Overall Study||0
5158886|NCT01262755|12688579|P1|COMPLETED|Overall Study||450
5158887|NCT01262755|12688579|P1|STARTED|Overall Study||450
5158888|NCT01262677|12688586|P3|NOT COMPLETED|Overall Study||12
5158889|NCT01262677|12688587|P2|NOT COMPLETED|Overall Study||15
5158890|NCT01262677|12688588|P1|NOT COMPLETED|Overall Study||9
5158891|NCT01262677|12688586|P3|COMPLETED|Overall Study||98
5158892|NCT01262677|12688587|P2|COMPLETED|Overall Study||98
5158893|NCT01262677|12688588|P1|COMPLETED|Overall Study||91
5158894|NCT01262677|12688586|P3|STARTED|Overall Study||110
5158895|NCT01262677|12688587|P2|STARTED|Overall Study||113
5158896|NCT01262677|12688588|P1|STARTED|Overall Study||100
5158897|NCT01262651|12688679|P2|NOT COMPLETED|Overall Study||48
5158898|NCT01262651|12688680|P1|NOT COMPLETED|Overall Study||58
5158899|NCT01262651|12688679|P2|COMPLETED|Overall Study||150
5158900|NCT01262651|12688680|P1|COMPLETED|Overall Study||141
5158901|NCT01262651|12688679|P2|ITT Population|Overall Study||198
5158902|NCT01262651|12688680|P1|ITT Population|Overall Study||199
5158903|NCT01262651|12688679|P2|Safety Population|Overall Study||198
5158904|NCT01262651|12688680|P1|Safety Population|Overall Study||199
5158905|NCT01262651|12688679|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
5158906|NCT01262651|12688680|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
5158907|NCT01262651|12688679|P2|STARTED|Overall Study||198
5158908|NCT01262651|12688680|P1|STARTED|Overall Study||199
5158909|NCT01262599|12688708|P2|NOT COMPLETED|Overall Study||0
5158910|NCT01262599|12688709|P1|NOT COMPLETED|Overall Study||0
5158911|NCT01262599|12688708|P2|COMPLETED|Overall Study||16
5158912|NCT01262599|12688709|P1|COMPLETED|Overall Study||16
5158913|NCT01262599|12688708|P2|STARTED|Overall Study||16
5158914|NCT01262599|12688709|P1|STARTED|Overall Study||16
5158915|NCT01262573|12688721|P2|NOT COMPLETED|Overall Study||1
5158916|NCT01262573|12688722|P1|NOT COMPLETED|Overall Study||0
5158917|NCT01262573|12688721|P2|COMPLETED|Overall Study||31
5158918|NCT01262573|12688722|P1|COMPLETED|Overall Study||32
5158919|NCT01262573|12688721|P2|STARTED|Overall Study||32
5158920|NCT01262573|12688722|P1|STARTED|Overall Study||32
5158921|NCT01262560|12688733|P3|NOT COMPLETED|Overall Study||2
5158922|NCT01262560|12688734|P2|NOT COMPLETED|Overall Study||1
5158923|NCT01262560|12688735|P1|NOT COMPLETED|Overall Study||0
5158924|NCT01262560|12688733|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
5158925|NCT01262560|12688734|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
5158926|NCT01262560|12688735|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
5158927|NCT01262560|12688733|P3|STARTED|Overall Study||56
5158928|NCT01262560|12688734|P2|STARTED|Overall Study||54
5158929|NCT01262560|12688735|P1|STARTED|Overall Study||53
5158930|NCT01262547|12688770|P1|NOT COMPLETED|Overall Study||0
5158931|NCT01262547|12688770|P1|COMPLETED|Overall Study||3
5158932|NCT01262547|12688770|P1|STARTED|Overall Study||3
5158933|NCT01262456|12688784|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
5158934|NCT01262456|12688785|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
5158935|NCT01262456|12688786|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
5158936|NCT01262456|12688784|P3|COMPLETED|1-Month Open-Label Extension Period||98
5158937|NCT01262456|12688785|P2|COMPLETED|1-Month Open-Label Extension Period||97
5158938|NCT01262456|12688786|P1|COMPLETED|1-Month Open-Label Extension Period||120
5158939|NCT01262456|12688784|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
5158940|NCT01262456|12688785|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
5158941|NCT01262456|12688786|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
5158942|NCT01262456|12688784|P3|STARTED|1-Month Open-Label Extension Period||103
5158943|NCT01262456|12688785|P2|STARTED|1-Month Open-Label Extension Period||100
5158944|NCT01262456|12688786|P1|STARTED|1-Month Open-Label Extension Period||124
5158945|NCT01262456|12688784|P3|NOT COMPLETED|3-Month Double-Blind Period||26
5158946|NCT01262456|12688785|P2|NOT COMPLETED|3-Month Double-Blind Period||23
5158947|NCT01262456|12688786|P1|NOT COMPLETED|3-Month Double-Blind Period||19
5158948|NCT01262456|12688784|P3|COMPLETED|3-Month Double-Blind Period||103
5158949|NCT01262456|12688785|P2|COMPLETED|3-Month Double-Blind Period||100
5158950|NCT01262456|12688786|P1|COMPLETED|3-Month Double-Blind Period||124
5158951|NCT01262456|12688784|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
5158952|NCT01262456|12688785|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
5158953|NCT01262456|12688786|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
5158954|NCT01262456|12688784|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
5158955|NCT01262456|12688785|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
5158956|NCT01262456|12688786|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
5158957|NCT01262456|12688784|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
5158958|NCT01262456|12688785|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
5158959|NCT01262456|12688786|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
5158960|NCT01262365|12688830|P3|NOT COMPLETED|Overall Study||94
5158961|NCT01262365|12688831|P2|NOT COMPLETED|Overall Study||81
5158962|NCT01262365|12688832|P1|NOT COMPLETED|Overall Study||90
5158963|NCT01262365|12688830|P3|COMPLETED|Overall Study||171
5158964|NCT01262365|12688831|P2|COMPLETED|Overall Study||181
5158965|NCT01262365|12688832|P1|COMPLETED|Overall Study||176
5158966|NCT01262365|12688830|P3|STARTED|Overall Study||265
5158967|NCT01262365|12688831|P2|STARTED|Overall Study||262
5158968|NCT01262365|12688832|P1|STARTED|Overall Study||266
5158969|NCT01262352|12688857|P2|NOT COMPLETED|Period 2||0
5158970|NCT01262352|12688858|P1|NOT COMPLETED|Period 2||0
5158971|NCT01262352|12688857|P2|COMPLETED|Period 2||8
5158972|NCT01262352|12688858|P1|COMPLETED|Period 2||9
5158973|NCT01262352|12688857|P2|Dosed|Period 2||8
5158974|NCT01262352|12688858|P1|Dosed|Period 2||9
5158975|NCT01262352|12688857|P2|STARTED|Period 2||8
5158976|NCT01262352|12688858|P1|STARTED|Period 2||9
5158977|NCT01262352|12688857|P2|NOT COMPLETED|Washout||2
5158978|NCT01262352|12688858|P1|NOT COMPLETED|Washout||1
5158979|NCT01262352|12688857|P2|COMPLETED|Washout||8
5158980|NCT01262352|12688858|P1|COMPLETED|Washout||9
5158981|NCT01262352|12688857|P2|STARTED|Washout||10
5158982|NCT01262352|12688858|P1|STARTED|Washout||10
5158983|NCT01262352|12688857|P2|NOT COMPLETED|Period 1||0
5158984|NCT01262352|12688858|P1|NOT COMPLETED|Period 1||1
5158985|NCT01262352|12688857|P2|COMPLETED|Period 1||10
5158986|NCT01262352|12688858|P1|COMPLETED|Period 1||10
5158987|NCT01262352|12688857|P2|Dosed|Period 1||10
5158988|NCT01262352|12688858|P1|Dosed|Period 1||10
5158989|NCT01262352|12688857|P2|STARTED|Period 1||10
5158990|NCT01262352|12688858|P1|STARTED|Period 1||11
5158991|NCT01262339|12688870|P1|NOT COMPLETED|Overall Study||0
5158992|NCT01262339|12688870|P1|COMPLETED|Overall Study||2
5158993|NCT01262339|12688870|P1|STARTED|Overall Study||2
5158994|NCT01262287|12688876|P2|NOT COMPLETED|Overall Study||1
5158995|NCT01262287|12688877|P1|NOT COMPLETED|Overall Study||2
5158996|NCT01262287|12688876|P2|COMPLETED|Overall Study||18
5158997|NCT01262287|12688877|P1|COMPLETED|Overall Study||18
5158998|NCT01262287|12688876|P2|STARTED|Overall Study||19
5158999|NCT01262287|12688877|P1|STARTED|Overall Study||20
5159000|NCT01262131|12688890|P3|NOT COMPLETED|Overall Study||0
5159001|NCT01262131|12688891|P2|NOT COMPLETED|Overall Study||0
5159002|NCT01262131|12688892|P1|NOT COMPLETED|Overall Study||0
5159003|NCT01262131|12688890|P3|COMPLETED|Overall Study||4
5159004|NCT01262131|12688891|P2|COMPLETED|Overall Study||4
5159005|NCT01262131|12688892|P1|COMPLETED|Overall Study||5
5159006|NCT01262131|12688890|P3|STARTED|Overall Study||4
5159007|NCT01262131|12688891|P2|STARTED|Overall Study||4
5159008|NCT01262131|12688892|P1|STARTED|Overall Study||5
5159009|NCT01262118|12688902|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
5159010|NCT01262118|12688903|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
5159011|NCT01262118|12688902|P2|COMPLETED|Treatment Period (6 Weeks)||0
5159012|NCT01262118|12688903|P1|COMPLETED|Treatment Period (6 Weeks)||36
5159013|NCT01262118|12688902|P2|STARTED|Treatment Period (6 Weeks)||0
5159014|NCT01262118|12688903|P1|STARTED|Treatment Period (6 Weeks)||36
5159015|NCT01262118|12688902|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
5159016|NCT01262118|12688903|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
5159017|NCT01262118|12688902|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
5159018|NCT01262118|12688903|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
5159019|NCT01262118|12688902|P2|STARTED|Baseline Assessment Period (3 Days)||33
5159020|NCT01262118|12688903|P1|STARTED|Baseline Assessment Period (3 Days)||36
5159021|NCT01262105|12688929|P2|NOT COMPLETED|Overall Study||0
5159022|NCT01262105|12688930|P1|NOT COMPLETED|Overall Study||0
5159023|NCT01262105|12688929|P2|COMPLETED|Overall Study||10
5159024|NCT01262105|12688930|P1|COMPLETED|Overall Study||13
5159025|NCT01262105|12688929|P2|STARTED|Overall Study||10
5159026|NCT01262105|12688930|P1|STARTED|Overall Study||13
5159027|NCT01262092|12688938|P2|NOT COMPLETED|Gabapentin Taper||0
5159028|NCT01262092|12688939|P1|NOT COMPLETED|Gabapentin Taper||1
5159029|NCT01262092|12688938|P2|COMPLETED|Gabapentin Taper||11
5159030|NCT01262092|12688939|P1|COMPLETED|Gabapentin Taper||9
5159031|NCT01262092|12688938|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
5159032|NCT01262092|12688939|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
5159033|NCT01262092|12688938|P2|NOT COMPLETED|Buprenorphine Taper||1
5159034|NCT01262092|12688939|P1|NOT COMPLETED|Buprenorphine Taper||1
5159035|NCT01262092|12688938|P2|COMPLETED|Buprenorphine Taper||12
5159036|NCT01262092|12688939|P1|COMPLETED|Buprenorphine Taper||11
5159037|NCT01262092|12688938|P2|STARTED|Buprenorphine Taper||13
5159038|NCT01262092|12688939|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
5159039|NCT01262092|12688938|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
5159040|NCT01262092|12688939|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
5159041|NCT01262092|12688938|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
5159042|NCT01262092|12688939|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
5159043|NCT01262092|12688938|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
5159044|NCT01262092|12688939|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
5159045|NCT01262027|12688945|P1|NOT COMPLETED|Overall Study||5
5159046|NCT01262027|12688945|P1|COMPLETED|Overall Study||17
5159047|NCT01262027|12688945|P1|STARTED|Overall Study||22
5159048|NCT01261975|12688950|P1|NOT COMPLETED|Overall Study||1
5159049|NCT01261975|12688950|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
5159050|NCT01261975|12688950|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
5159051|NCT01261793|12688972|P3|NOT COMPLETED|Overall Study||82
5159052|NCT01261793|12688973|P2|NOT COMPLETED|Overall Study||91
5159053|NCT01261793|12688974|P1|NOT COMPLETED|Overall Study||85
5159054|NCT01261793|12688972|P3|COMPLETED|Overall Study||184
5159055|NCT01261793|12688973|P2|COMPLETED|Overall Study||171
5159056|NCT01261793|12688974|P1|COMPLETED|Overall Study||178
5159057|NCT01261793|12688972|P3|STARTED|Overall Study||266
5159058|NCT01261793|12688973|P2|STARTED|Overall Study||262
5159059|NCT01261793|12688974|P1|STARTED|Overall Study||263
5159060|NCT01261780|12688999|P2|NOT COMPLETED|Overall Study||2
5159061|NCT01261780|12689000|P1|NOT COMPLETED|Overall Study||2
5159062|NCT01261780|12688999|P2|COMPLETED|Overall Study||5
5159063|NCT01261780|12689000|P1|COMPLETED|Overall Study||5
5159064|NCT01261780|12688999|P2|STARTED|Overall Study||7
5159065|NCT01261780|12689000|P1|STARTED|Overall Study||7
5159066|NCT01261624|12689010|P2|NOT COMPLETED|Week 13 to Week 24||1
5159067|NCT01261624|12689011|P1|NOT COMPLETED|Week 13 to Week 24||0
5159068|NCT01261624|12689010|P2|COMPLETED|Week 13 to Week 24||10
5159069|NCT01261624|12689011|P1|COMPLETED|Week 13 to Week 24||1
5159070|NCT01261624|12689010|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
5159071|NCT01261624|12689011|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
5159072|NCT01261624|12689010|P2|NOT COMPLETED|Week 0 to Week 12||3
5159073|NCT01261624|12689011|P1|NOT COMPLETED|Week 0 to Week 12||1
5159074|NCT01261624|12689010|P2|COMPLETED|Week 0 to Week 12||3
5159075|NCT01261624|12689011|P1|COMPLETED|Week 0 to Week 12||9
5159076|NCT01261624|12689010|P2|STARTED|Week 0 to Week 12||6
5159077|NCT01261624|12689011|P1|STARTED|Week 0 to Week 12||10
5159078|NCT01261611|12689031|P3|NOT COMPLETED|Treatment Cycle 5||0
5159079|NCT01261611|12689032|P2|NOT COMPLETED|Treatment Cycle 5||0
5159080|NCT01261611|12689033|P1|NOT COMPLETED|Treatment Cycle 5||3
5159081|NCT01261611|12689031|P3|COMPLETED|Treatment Cycle 5||0
5159082|NCT01261611|12689032|P2|COMPLETED|Treatment Cycle 5||0
5159083|NCT01261611|12689033|P1|COMPLETED|Treatment Cycle 5||217
5159084|NCT01261611|12689031|P3|STARTED|Treatment Cycle 5||0
5159085|NCT01261611|12689032|P2|STARTED|Treatment Cycle 5||0
5159086|NCT01261611|12689033|P1|STARTED|Treatment Cycle 5||220
5159087|NCT01261611|12689031|P3|NOT COMPLETED|Treatment Cycle 4||0
5159088|NCT01261611|12689032|P2|NOT COMPLETED|Treatment Cycle 4||0
5159089|NCT01261611|12689033|P1|NOT COMPLETED|Treatment Cycle 4||96
5159090|NCT01261611|12689031|P3|COMPLETED|Treatment Cycle 4||0
5159091|NCT01261611|12689032|P2|COMPLETED|Treatment Cycle 4||0
5159092|NCT01261611|12689033|P1|COMPLETED|Treatment Cycle 4||220
5159093|NCT01261611|12689031|P3|STARTED|Treatment Cycle 4||0
5159094|NCT01261611|12689032|P2|STARTED|Treatment Cycle 4||0
5159095|NCT01261611|12689033|P1|STARTED|Treatment Cycle 4||316
5159096|NCT01261611|12689031|P3|NOT COMPLETED|Treatment Cycle 3||0
5159097|NCT01261611|12689032|P2|NOT COMPLETED|Treatment Cycle 3||0
5159098|NCT01261611|12689033|P1|NOT COMPLETED|Treatment Cycle 3||30
5159099|NCT01261611|12689031|P3|COMPLETED|Treatment Cycle 3||0
5159100|NCT01261611|12689032|P2|COMPLETED|Treatment Cycle 3||0
5159101|NCT01261611|12689033|P1|COMPLETED|Treatment Cycle 3||316
5159102|NCT01261611|12689031|P3|STARTED|Treatment Cycle 3||0
5159103|NCT01261611|12689032|P2|STARTED|Treatment Cycle 3||0
5159104|NCT01261611|12689033|P1|STARTED|Treatment Cycle 3||346
5159105|NCT01261611|12689031|P3|NOT COMPLETED|Treatment Cycle 2||0
5159106|NCT01261611|12689032|P2|NOT COMPLETED|Treatment Cycle 2||0
5159107|NCT01261611|12689033|P1|NOT COMPLETED|Treatment Cycle 2||13
5159108|NCT01261611|12689031|P3|COMPLETED|Treatment Cycle 2||0
5159109|NCT01261611|12689032|P2|COMPLETED|Treatment Cycle 2||0
5159110|NCT01261611|12689033|P1|COMPLETED|Treatment Cycle 2||346
5159111|NCT01261611|12689031|P3|STARTED|Treatment Cycle 2||0
5159112|NCT01261611|12689032|P2|STARTED|Treatment Cycle 2||0
5159113|NCT01261611|12689033|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
5159114|NCT01261611|12689031|P3|NOT COMPLETED|Treatment Cycle 1||2
5159115|NCT01261611|12689032|P2|NOT COMPLETED|Treatment Cycle 1||3
5159116|NCT01261611|12689033|P1|NOT COMPLETED|Treatment Cycle 1||4
5159117|NCT01261611|12689031|P3|COMPLETED|Treatment Cycle 1||52
5159118|NCT01261611|12689032|P2|COMPLETED|Treatment Cycle 1||156
5159119|NCT01261611|12689033|P1|COMPLETED|Treatment Cycle 1||152
5159120|NCT01261611|12689031|P3|STARTED|Treatment Cycle 1||54
5159121|NCT01261611|12689032|P2|STARTED|Treatment Cycle 1||159
5159122|NCT01261611|12689033|P1|STARTED|Treatment Cycle 1||156
5159123|NCT01261559|12689071|P2|NOT COMPLETED|Overall Study||0
5159124|NCT01261559|12689072|P1|NOT COMPLETED|Overall Study||0
5159125|NCT01261559|12689071|P2|COMPLETED|Overall Study||36
5159126|NCT01261559|12689072|P1|COMPLETED|Overall Study||36
5159127|NCT01261559|12689071|P2|STARTED|Overall Study||36
5159128|NCT01261559|12689072|P1|STARTED|Overall Study||36
5159129|NCT01261507|12689084|P1|NOT COMPLETED|Overall Study||0
5159130|NCT01261507|12689084|P1|COMPLETED|Overall Study||15
5159131|NCT01261507|12689084|P1|STARTED|Overall Study||15
5159132|NCT01261390|12689097|P4|NOT COMPLETED|Overall Study||8
5159133|NCT01261390|12689098|P3|NOT COMPLETED|Overall Study||7
5159134|NCT01261390|12689099|P2|NOT COMPLETED|Overall Study||9
5159135|NCT01261390|12689100|P1|NOT COMPLETED|Overall Study||7
5159136|NCT01261390|12689097|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
5159137|NCT01261390|12689098|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
5159138|NCT01261390|12689099|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
5159139|NCT01261390|12689100|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
5159140|NCT01261390|12689097|P4|12-Month Visit|Overall Study||19
5159141|NCT01261390|12689098|P3|12-Month Visit|Overall Study||19
5159142|NCT01261390|12689099|P2|12-Month Visit|Overall Study||21
5159143|NCT01261390|12689100|P1|12-Month Visit|Overall Study||23
5159144|NCT01261390|12689097|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
5159145|NCT01261390|12689098|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
5159146|NCT01261390|12689099|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
5159147|NCT01261390|12689100|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
5159148|NCT01261390|12689097|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
5159149|NCT01261390|12689098|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
5159150|NCT01261390|12689099|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
5159151|NCT01261390|12689100|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
5159152|NCT01261325|12689265|P3|NOT COMPLETED|Overall Study||26
5159153|NCT01261325|12689266|P2|NOT COMPLETED|Overall Study||29
5159154|NCT01261325|12689267|P1|NOT COMPLETED|Overall Study||17
5159155|NCT01261325|12689265|P3|COMPLETED|Overall Study||225
5159156|NCT01261325|12689266|P2|COMPLETED|Overall Study||225
5159157|NCT01261325|12689267|P1|COMPLETED|Overall Study||246
5159158|NCT01261325|12689265|P3|STARTED|Overall Study||251
5159159|NCT01261325|12689266|P2|STARTED|Overall Study||254
5159160|NCT01261325|12689267|P1|STARTED|Overall Study||263
5159161|NCT01261247|12689299|P1|NOT COMPLETED|Overall Study||2
5159162|NCT01261247|12689299|P1|COMPLETED|Overall Study||39
5159163|NCT01261247|12689299|P1|STARTED|Overall Study||41
5159164|NCT01261052|12689306|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
5159165|NCT01261052|12689306|P1|COMPLETED|APD Only Intervention (33 Hours)||14
5159166|NCT01261052|12689306|P1|STARTED|APD Only Intervention (33 Hours)||14
5159167|NCT01261052|12689306|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
5159168|NCT01261052|12689306|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
5159169|NCT01261052|12689306|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
5159170|NCT01261000|12689312|P1|NOT COMPLETED|Overall Study||1
5159171|NCT01261000|12689312|P1|COMPLETED|Overall Study||7
5159172|NCT01261000|12689312|P1|STARTED|Overall Study||8
5159173|NCT01260948|12689318|P2|NOT COMPLETED|Second Intervention||1
5159174|NCT01260948|12689319|P1|NOT COMPLETED|Second Intervention||0
5159175|NCT01260948|12689318|P2|COMPLETED|Second Intervention||9
5159176|NCT01260948|12689319|P1|COMPLETED|Second Intervention||12
5159177|NCT01260948|12689318|P2|STARTED|Second Intervention||10
5159178|NCT01260948|12689319|P1|STARTED|Second Intervention||12
5159179|NCT01260948|12689318|P2|NOT COMPLETED|Washout of 28 Days||3
5159180|NCT01260948|12689319|P1|NOT COMPLETED|Washout of 28 Days||1
5159181|NCT01260948|12689318|P2|COMPLETED|Washout of 28 Days||10
5159182|NCT01260948|12689319|P1|COMPLETED|Washout of 28 Days||12
5159183|NCT01260948|12689318|P2|STARTED|Washout of 28 Days||13
5159184|NCT01260948|12689319|P1|STARTED|Washout of 28 Days||13
5159185|NCT01260948|12689318|P2|NOT COMPLETED|First Intervention||0
5159186|NCT01260948|12689319|P1|NOT COMPLETED|First Intervention||0
5159187|NCT01260948|12689318|P2|COMPLETED|First Intervention||13
5159188|NCT01260948|12689319|P1|COMPLETED|First Intervention||13
5159189|NCT01260948|12689318|P2|STARTED|First Intervention||13
5159190|NCT01260948|12689319|P1|STARTED|First Intervention||13
5159191|NCT01260922|12689329|P2|NOT COMPLETED|Second Intervention||2
5159192|NCT01260922|12689330|P1|NOT COMPLETED|Second Intervention||0
5159193|NCT01260922|12689329|P2|COMPLETED|Second Intervention||8
5159194|NCT01260922|12689330|P1|COMPLETED|Second Intervention||9
5159195|NCT01260922|12689329|P2|STARTED|Second Intervention||10
5159196|NCT01260922|12689330|P1|STARTED|Second Intervention||9
5159197|NCT01260922|12689329|P2|NOT COMPLETED|Washout of 28 Days||2
5159198|NCT01260922|12689330|P1|NOT COMPLETED|Washout of 28 Days||4
5159199|NCT01260922|12689329|P2|COMPLETED|Washout of 28 Days||10
5159200|NCT01260922|12689330|P1|COMPLETED|Washout of 28 Days||9
5159201|NCT01260922|12689329|P2|STARTED|Washout of 28 Days||12
5159202|NCT01260922|12689330|P1|STARTED|Washout of 28 Days||13
5159203|NCT01260922|12689329|P2|NOT COMPLETED|First Intervention||1
5159204|NCT01260922|12689330|P1|NOT COMPLETED|First Intervention||0
5159205|NCT01260922|12689329|P2|COMPLETED|First Intervention||12
5159206|NCT01260922|12689330|P1|COMPLETED|First Intervention||13
5159207|NCT01260922|12689329|P2|STARTED|First Intervention||13
5159208|NCT01260922|12689330|P1|STARTED|First Intervention||13
5159209|NCT01260896|12689340|P2|NOT COMPLETED|Second Intervention||0
5159210|NCT01260896|12689341|P1|NOT COMPLETED|Second Intervention||0
5159211|NCT01260896|12689340|P2|COMPLETED|Second Intervention||12
5159212|NCT01260896|12689341|P1|COMPLETED|Second Intervention||10
5159213|NCT01260896|12689340|P2|STARTED|Second Intervention||12
5159214|NCT01260896|12689341|P1|STARTED|Second Intervention||10
5159215|NCT01260896|12689340|P2|NOT COMPLETED|Washout of 7 Days||0
5159216|NCT01260896|12689341|P1|NOT COMPLETED|Washout of 7 Days||0
5159217|NCT01260896|12689340|P2|COMPLETED|Washout of 7 Days||12
5159218|NCT01260896|12689341|P1|COMPLETED|Washout of 7 Days||10
5159219|NCT01260896|12689340|P2|STARTED|Washout of 7 Days||12
5159220|NCT01260896|12689341|P1|STARTED|Washout of 7 Days||10
5159221|NCT01260896|12689340|P2|NOT COMPLETED|First Intervention||0
5159222|NCT01260896|12689341|P1|NOT COMPLETED|First Intervention||2
5159223|NCT01260896|12689340|P2|COMPLETED|First Intervention||12
5159224|NCT01260896|12689341|P1|COMPLETED|First Intervention||10
5159225|NCT01260896|12689340|P2|STARTED|First Intervention||12
5159226|NCT01260896|12689341|P1|STARTED|First Intervention||12
5159227|NCT01260883|12689360|P3|NOT COMPLETED|Overall Study||0
5159228|NCT01260883|12689361|P2|NOT COMPLETED|Overall Study||0
5159229|NCT01260883|12689362|P1|NOT COMPLETED|Overall Study||0
5159230|NCT01260883|12689360|P3|COMPLETED|Overall Study||18
5159231|NCT01260883|12689361|P2|COMPLETED|Overall Study||11
5159232|NCT01260883|12689362|P1|COMPLETED|Overall Study||22
5159233|NCT01260883|12689360|P3|STARTED|Overall Study||18
5159234|NCT01260883|12689361|P2|STARTED|Overall Study||11
5159235|NCT01260883|12689362|P1|STARTED|Overall Study||22
5159236|NCT01260701|12689399|P1|NOT COMPLETED|Overall Study||75
5159237|NCT01260701|12689399|P1|COMPLETED|Overall Study||0
5159238|NCT01260701|12689399|P1|Eligible and Began Protocol Therapy|Overall Study||70
5159239|NCT01260701|12689399|P1|Eligible|Overall Study||71
5159240|NCT01260701|12689399|P1|STARTED|Overall Study||75
5159241|NCT01260688|12689408|P2|NOT COMPLETED|Overall Study||0
5159242|NCT01260688|12689409|P1|NOT COMPLETED|Overall Study||0
5159243|NCT01260688|12689408|P2|COMPLETED|Overall Study||11
5159244|NCT01260688|12689409|P1|COMPLETED|Overall Study||11
5159245|NCT01260688|12689408|P2|STARTED|Overall Study||11
5159246|NCT01260688|12689409|P1|STARTED|Overall Study||11
5159247|NCT01260662|12689446|P3|NOT COMPLETED|Overall Study||0
5159248|NCT01260662|12689447|P2|NOT COMPLETED|Overall Study||0
5159249|NCT01260662|12689448|P1|NOT COMPLETED|Overall Study||0
5159250|NCT01260662|12689446|P3|COMPLETED|Overall Study||96
5159251|NCT01260662|12689447|P2|COMPLETED|Overall Study||85
5159252|NCT01260662|12689448|P1|COMPLETED|Overall Study||90
5159253|NCT01260662|12689446|P3|STARTED|Overall Study||96
5159254|NCT01260662|12689447|P2|STARTED|Overall Study||85
5159255|NCT01260662|12689448|P1|STARTED|Overall Study||90
5159256|NCT01260649|12689467|P2|NOT COMPLETED|Overall Study||1
5159257|NCT01260649|12689468|P1|NOT COMPLETED|Overall Study||2
5159258|NCT01260649|12689467|P2|COMPLETED|Overall Study||8
5159259|NCT01260649|12689468|P1|COMPLETED|Overall Study||6
5159260|NCT01260649|12689467|P2|STARTED|Overall Study||9
5159261|NCT01260649|12689468|P1|STARTED|Overall Study||8
5159262|NCT01260584|12689480|P4|NOT COMPLETED|Period 2||1
5159263|NCT01260584|12689481|P3|NOT COMPLETED|Period 2||5
5159264|NCT01260584|12689482|P2|NOT COMPLETED|Period 2||3
5159265|NCT01260584|12689483|P1|NOT COMPLETED|Period 2||1
5159266|NCT01260584|12689480|P4|COMPLETED|Period 2||26
5159267|NCT01260584|12689481|P3|COMPLETED|Period 2||20
5159268|NCT01260584|12689482|P2|COMPLETED|Period 2||25
5159269|NCT01260584|12689483|P1|COMPLETED|Period 2||26
5159270|NCT01260584|12689480|P4|STARTED|Period 2||27
5159271|NCT01260584|12689481|P3|STARTED|Period 2||25
5159272|NCT01260584|12689482|P2|STARTED|Period 2||28
5159273|NCT01260584|12689483|P1|STARTED|Period 2||27
5159274|NCT01260584|12689480|P4|NOT COMPLETED|Period 1||1
5159275|NCT01260584|12689481|P3|NOT COMPLETED|Period 1||2
5159276|NCT01260584|12689482|P2|NOT COMPLETED|Period 1||0
5159277|NCT01260584|12689483|P1|NOT COMPLETED|Period 1||0
5159278|NCT01260584|12689480|P4|COMPLETED|Period 1||27
5159279|NCT01260584|12689481|P3|COMPLETED|Period 1||25
5159280|NCT01260584|12689482|P2|COMPLETED|Period 1||28
5159281|NCT01260584|12689483|P1|COMPLETED|Period 1||27
5159282|NCT01260584|12689480|P4|STARTED|Period 1||28
5159283|NCT01260584|12689481|P3|STARTED|Period 1||27
5159284|NCT01260584|12689482|P2|STARTED|Period 1||28
5159285|NCT01260584|12689483|P1|STARTED|Period 1||27
5159286|NCT01260493|12689519|P2|NOT COMPLETED|Overall Study||4
5159287|NCT01260493|12689520|P1|NOT COMPLETED|Overall Study||16
5159288|NCT01260493|12689519|P2|COMPLETED|Overall Study||85
5159289|NCT01260493|12689520|P1|COMPLETED|Overall Study||76
5159290|NCT01260493|12689519|P2|STARTED|Overall Study||89
5159291|NCT01260493|12689520|P1|STARTED|Overall Study||92
5159292|NCT01260467|12689526|P1|NOT COMPLETED|Overall Study||2
5159293|NCT01260467|12689526|P1|COMPLETED|Overall Study||2
5159294|NCT01260467|12689526|P1|STARTED|Overall Study||4
5159295|NCT01260454|12689532|P1|NOT COMPLETED|Overall Study||0
5159296|NCT01260454|12689532|P1|COMPLETED|Overall Study||6
5159297|NCT01260454|12689532|P1|STARTED|Overall Study||6
5159298|NCT01260350|12689558|P22|NOT COMPLETED|Overall Study||0
5159299|NCT01260350|12689559|P21|NOT COMPLETED|Overall Study||3
5159300|NCT01260350|12689560|P20|NOT COMPLETED|Overall Study||0
5159301|NCT01260350|12689561|P19|NOT COMPLETED|Overall Study||0
5159302|NCT01260350|12689562|P18|NOT COMPLETED|Overall Study||1
5159303|NCT01260350|12689563|P17|NOT COMPLETED|Overall Study||0
5159304|NCT01260350|12689564|P16|NOT COMPLETED|Overall Study||0
5159305|NCT01260350|12689565|P15|NOT COMPLETED|Overall Study||0
5159306|NCT01260350|12689566|P14|NOT COMPLETED|Overall Study||0
5159307|NCT01260350|12689567|P13|NOT COMPLETED|Overall Study||0
5159308|NCT01260350|12689568|P12|NOT COMPLETED|Overall Study||0
5159309|NCT01260350|12689569|P11|NOT COMPLETED|Overall Study||0
5159310|NCT01260350|12689570|P10|NOT COMPLETED|Overall Study||0
5159311|NCT01260350|12689571|P9|NOT COMPLETED|Overall Study||1
5159312|NCT01260350|12689572|P8|NOT COMPLETED|Overall Study||0
5159313|NCT01260350|12689573|P7|NOT COMPLETED|Overall Study||0
5159314|NCT01260350|12689574|P6|NOT COMPLETED|Overall Study||0
5159315|NCT01260350|12689575|P5|NOT COMPLETED|Overall Study||0
5159316|NCT01260350|12689576|P4|NOT COMPLETED|Overall Study||0
5159317|NCT01260350|12689577|P3|NOT COMPLETED|Overall Study||0
5159318|NCT01260350|12689578|P2|NOT COMPLETED|Overall Study||0
5159319|NCT01260350|12689579|P1|NOT COMPLETED|Overall Study||0
5159320|NCT01260350|12689558|P22|COMPLETED|Overall Study||0
5159321|NCT01260350|12689559|P21|COMPLETED|Overall Study||22
5159322|NCT01260350|12689560|P20|COMPLETED|Overall Study||14
5159323|NCT01260350|12689561|P19|COMPLETED|Overall Study||0
5159324|NCT01260350|12689562|P18|COMPLETED|Overall Study||9
5159325|NCT01260350|12689563|P17|COMPLETED|Overall Study||9
5159326|NCT01260350|12689564|P16|COMPLETED|Overall Study||10
5159327|NCT01260350|12689565|P15|COMPLETED|Overall Study||25
5159328|NCT01260350|12689566|P14|COMPLETED|Overall Study||10
5159329|NCT01260350|12689567|P13|COMPLETED|Overall Study||25
5159330|NCT01260350|12689568|P12|COMPLETED|Overall Study||9
5159331|NCT01260350|12689569|P11|COMPLETED|Overall Study||10
5159332|NCT01260350|12689570|P10|COMPLETED|Overall Study||25
5159333|NCT01260350|12689571|P9|COMPLETED|Overall Study||24
5159334|NCT01260350|12689572|P8|COMPLETED|Overall Study||25
5159335|NCT01260350|12689573|P7|COMPLETED|Overall Study||10
5159336|NCT01260350|12689574|P6|COMPLETED|Overall Study||10
5159337|NCT01260350|12689575|P5|COMPLETED|Overall Study||10
5159338|NCT01260350|12689576|P4|COMPLETED|Overall Study||11
5159339|NCT01260350|12689577|P3|COMPLETED|Overall Study||10
5159340|NCT01260350|12689578|P2|COMPLETED|Overall Study||9
5159341|NCT01260350|12689579|P1|COMPLETED|Overall Study||10
5159342|NCT01260350|12689558|P22|STARTED|Overall Study||0
5159343|NCT01260350|12689559|P21|STARTED|Overall Study||25
5159344|NCT01260350|12689560|P20|STARTED|Overall Study||14
5159345|NCT01260350|12689561|P19|STARTED|Overall Study||0
5159346|NCT01260350|12689562|P18|STARTED|Overall Study||10
5159347|NCT01260350|12689563|P17|STARTED|Overall Study||9
5159348|NCT01260350|12689564|P16|STARTED|Overall Study||10
5159349|NCT01260350|12689565|P15|STARTED|Overall Study||25
5159350|NCT01260350|12689566|P14|STARTED|Overall Study||10
5159351|NCT01260350|12689567|P13|STARTED|Overall Study||25
5159352|NCT01260350|12689568|P12|STARTED|Overall Study||9
5159353|NCT01260350|12689569|P11|STARTED|Overall Study||10
5159354|NCT01260350|12689570|P10|STARTED|Overall Study||25
5159355|NCT01260350|12689571|P9|STARTED|Overall Study||25
5159356|NCT01260350|12689572|P8|STARTED|Overall Study||25
5159357|NCT01260350|12689573|P7|STARTED|Overall Study||10
5159358|NCT01260350|12689574|P6|STARTED|Overall Study||10
5159359|NCT01260350|12689575|P5|STARTED|Overall Study||10
5159360|NCT01260350|12689576|P4|STARTED|Overall Study||11
5159361|NCT01260350|12689577|P3|STARTED|Overall Study||10
5159362|NCT01260350|12689578|P2|STARTED|Overall Study||9
5159363|NCT01260350|12689579|P1|STARTED|Overall Study||10
5159364|NCT01260324|12689771|P2|NOT COMPLETED|Overall Study||0
5159365|NCT01260324|12689772|P1|NOT COMPLETED|Overall Study||0
5159366|NCT01260324|12689771|P2|COMPLETED|Overall Study||20000
5159367|NCT01260324|12689772|P1|COMPLETED|Overall Study||1283
5159368|NCT01260324|12689771|P2|STARTED|Overall Study||20000
5159369|NCT01260324|12689772|P1|STARTED|Overall Study||1283
5159370|NCT01260311|12689786|P1|NOT COMPLETED|Overall Study||127
5159371|NCT01260311|12689786|P1|COMPLETED|Overall Study||381
5159372|NCT01260311|12689786|P1|STARTED|Overall Study||508
5159373|NCT01260272|12689796|P2|NOT COMPLETED|Overall Study||2
5159374|NCT01260272|12689797|P1|NOT COMPLETED|Overall Study||2
5159375|NCT01260272|12689796|P2|COMPLETED|Overall Study||30
5159376|NCT01260272|12689797|P1|COMPLETED|Overall Study||15
5159377|NCT01260272|12689796|P2|STARTED|Overall Study||32
5159378|NCT01260272|12689797|P1|STARTED|Overall Study||17
5159379|NCT01260194|12689817|P1|NOT COMPLETED|Overall Study||1
5159380|NCT01260194|12689817|P1|COMPLETED|Overall Study||3
5159381|NCT01260194|12689817|P1|STARTED|Overall Study||4
5159382|NCT01260181|12689829|P1|NOT COMPLETED|Overall Study||1
5159383|NCT01260181|12689829|P1|COMPLETED|Overall Study||29
5159384|NCT01260181|12689829|P1|STARTED|Overall Study||30
5159385|NCT01260142|12689844|P6|NOT COMPLETED|Treatment Period 2||0
5159386|NCT01260142|12689845|P5|NOT COMPLETED|Treatment Period 2||0
5159387|NCT01260142|12689846|P4|NOT COMPLETED|Treatment Period 2||0
5159388|NCT01260142|12689847|P3|NOT COMPLETED|Treatment Period 2||0
5159389|NCT01260142|12689848|P2|NOT COMPLETED|Treatment Period 2||0
5159390|NCT01260142|12689849|P1|NOT COMPLETED|Treatment Period 2||0
5159391|NCT01260142|12689844|P6|COMPLETED|Treatment Period 2||3
5159392|NCT01260142|12689845|P5|COMPLETED|Treatment Period 2||4
5159393|NCT01260142|12689846|P4|COMPLETED|Treatment Period 2||6
5159394|NCT01260142|12689847|P3|COMPLETED|Treatment Period 2||6
5159395|NCT01260142|12689848|P2|COMPLETED|Treatment Period 2||5
5159396|NCT01260142|12689849|P1|COMPLETED|Treatment Period 2||5
5159397|NCT01260142|12689844|P6|STARTED|Treatment Period 2||3
5159398|NCT01260142|12689845|P5|STARTED|Treatment Period 2||4
5159399|NCT01260142|12689846|P4|STARTED|Treatment Period 2||6
5159400|NCT01260142|12689847|P3|STARTED|Treatment Period 2||6
5159401|NCT01260142|12689848|P2|STARTED|Treatment Period 2||5
5159402|NCT01260142|12689849|P1|STARTED|Treatment Period 2||5
5159403|NCT01260142|12689844|P6|NOT COMPLETED|Treatment Period 1||3
5159404|NCT01260142|12689845|P5|NOT COMPLETED|Treatment Period 1||2
5159405|NCT01260142|12689846|P4|NOT COMPLETED|Treatment Period 1||0
5159406|NCT01260142|12689847|P3|NOT COMPLETED|Treatment Period 1||0
5159407|NCT01260142|12689848|P2|NOT COMPLETED|Treatment Period 1||1
5159408|NCT01260142|12689849|P1|NOT COMPLETED|Treatment Period 1||1
5159409|NCT01260142|12689844|P6|COMPLETED|Treatment Period 1||3
5159410|NCT01260142|12689845|P5|COMPLETED|Treatment Period 1||4
5159411|NCT01260142|12689846|P4|COMPLETED|Treatment Period 1||6
5159412|NCT01260142|12689847|P3|COMPLETED|Treatment Period 1||6
5159413|NCT01260142|12689848|P2|COMPLETED|Treatment Period 1||5
5159414|NCT01260142|12689849|P1|COMPLETED|Treatment Period 1||5
5159415|NCT01260142|12689844|P6|STARTED|Treatment Period 1||6
5159416|NCT01260142|12689845|P5|STARTED|Treatment Period 1||6
5159417|NCT01260142|12689846|P4|STARTED|Treatment Period 1||6
5159418|NCT01260142|12689847|P3|STARTED|Treatment Period 1||6
5159419|NCT01260142|12689848|P2|STARTED|Treatment Period 1||6
5159420|NCT01260142|12689849|P1|STARTED|Treatment Period 1||6
5159421|NCT01259869|12689899|P1|NOT COMPLETED|Overall Study||1
5159422|NCT01259869|12689899|P1|COMPLETED|Overall Study||33
5159423|NCT01259869|12689899|P1|STARTED|Overall Study||34
5159424|NCT01259856|12689905|P2|NOT COMPLETED|Overall Study||74
5159425|NCT01259856|12689906|P1|NOT COMPLETED|Overall Study||69
5159426|NCT01259856|12689905|P2|COMPLETED|Overall Study||12
5159427|NCT01259856|12689906|P1|COMPLETED|Overall Study||13
5159428|NCT01259856|12689905|P2|STARTED|Overall Study||86
5159429|NCT01259856|12689906|P1|STARTED|Overall Study||82
5159430|NCT01259726|12689930|P4|NOT COMPLETED|Overall Study||5
5159431|NCT01259726|12689931|P3|NOT COMPLETED|Overall Study||4
5159432|NCT01259726|12689932|P2|NOT COMPLETED|Overall Study||4
5159433|NCT01259726|12689933|P1|NOT COMPLETED|Overall Study||5
5159434|NCT01259726|12689930|P4|COMPLETED|Overall Study||36
5159435|NCT01259726|12689931|P3|COMPLETED|Overall Study||39
5159436|NCT01259726|12689932|P2|COMPLETED|Overall Study||37
5159437|NCT01259726|12689933|P1|COMPLETED|Overall Study||38
5159438|NCT01259726|12689930|P4|Treated|Overall Study||39
5159439|NCT01259726|12689931|P3|Treated|Overall Study||41
5159440|NCT01259726|12689932|P2|Treated|Overall Study||37
5159441|NCT01259726|12689933|P1|Treated|Overall Study||40
5159442|NCT01259726|12689930|P4|STARTED|Overall Study||41
5159443|NCT01259726|12689931|P3|STARTED|Overall Study||43
5159444|NCT01259726|12689932|P2|STARTED|Overall Study||41
5159445|NCT01259726|12689933|P1|STARTED|Overall Study||43
5159446|NCT01259713|12689965|P2|NOT COMPLETED|Overall Study||41
5159447|NCT01259713|12689966|P1|NOT COMPLETED|Overall Study||95
5159448|NCT01259713|12689965|P2|COMPLETED|Overall Study||77
5159449|NCT01259713|12689966|P1|COMPLETED|Overall Study||142
5159450|NCT01259713|12689965|P2|STARTED|Overall Study||118
5159451|NCT01259713|12689966|P1|STARTED|Overall Study||237
5159452|NCT01259596|12689990|P2|NOT COMPLETED|Overall Study||6
5159453|NCT01259596|12689991|P1|NOT COMPLETED|Overall Study||4
5159454|NCT01259596|12689990|P2|COMPLETED|Overall Study||65
5159455|NCT01259596|12689991|P1|COMPLETED|Overall Study||66
5159456|NCT01259596|12689990|P2|STARTED|Overall Study||71
5159457|NCT01259596|12689991|P1|STARTED|Overall Study||70
5159458|NCT01259492|12690013|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
5159459|NCT01259492|12690014|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
5159460|NCT01259492|12690015|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
5159461|NCT01259492|12690016|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
5159462|NCT01259492|12690013|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
5159463|NCT01259492|12690014|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
5159464|NCT01259492|12690015|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
5159465|NCT01259492|12690016|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
5159466|NCT01259492|12690013|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
5159467|NCT01259492|12690014|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
5159468|NCT01259492|12690015|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
5159469|NCT01259492|12690016|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
5159470|NCT01259492|12690013|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
5159471|NCT01259492|12690014|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
5159472|NCT01259492|12690015|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
5159473|NCT01259492|12690016|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
5159474|NCT01259492|12690013|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
5159475|NCT01259492|12690014|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
5159476|NCT01259492|12690015|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
5159477|NCT01259492|12690016|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
5159478|NCT01259492|12690013|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
5159479|NCT01259492|12690014|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
5159480|NCT01259492|12690015|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
5159481|NCT01259492|12690016|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
5159482|NCT01259492|12690013|P4|STARTED|Period 2 (Week 10 to Week 14)||153
5159483|NCT01259492|12690014|P3|STARTED|Period 2 (Week 10 to Week 14)||138
5159484|NCT01259492|12690015|P2|STARTED|Period 2 (Week 10 to Week 14)||141
5159485|NCT01259492|12690016|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
5159486|NCT01259492|12690013|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
5159487|NCT01259492|12690014|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
5159488|NCT01259492|12690015|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
5159489|NCT01259492|12690016|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
5159490|NCT01259492|12690013|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
5159491|NCT01259492|12690014|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
5159492|NCT01259492|12690015|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
5159493|NCT01259492|12690016|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
5159494|NCT01259492|12690013|P4|Full Analysis Set|Period 1 (9 Weeks)||172
5159495|NCT01259492|12690014|P3|Full Analysis Set|Period 1 (9 Weeks)||179
5159496|NCT01259492|12690015|P2|Full Analysis Set|Period 1 (9 Weeks)||175
5159497|NCT01259492|12690016|P1|Full Analysis Set|Period 1 (9 Weeks)||174
5159498|NCT01259492|12690013|P4|STARTED|Period 1 (9 Weeks)||181
5159499|NCT01259492|12690014|P3|STARTED|Period 1 (9 Weeks)||181
5159500|NCT01259492|12690015|P2|STARTED|Period 1 (9 Weeks)||182
5159501|NCT01259492|12690016|P1|STARTED|Period 1 (9 Weeks)||181
5159502|NCT01259466|12690065|P2|NOT COMPLETED|Overall Study||9
5159503|NCT01259466|12690066|P1|NOT COMPLETED|Overall Study||1
5159504|NCT01259466|12690065|P2|COMPLETED|Overall Study||18
5159505|NCT01259466|12690066|P1|COMPLETED|Overall Study||26
5159506|NCT01259466|12690065|P2|STARTED|Overall Study||27
5159507|NCT01259466|12690066|P1|STARTED|Overall Study||27
5159508|NCT01259440|12690076|P2|NOT COMPLETED|Overall Study||0
5159509|NCT01259440|12690077|P1|NOT COMPLETED|Overall Study||0
5159510|NCT01259440|12690076|P2|COMPLETED|Overall Study||10
5159511|NCT01259440|12690077|P1|COMPLETED|Overall Study||13
5159512|NCT01259440|12690076|P2|STARTED|Overall Study||10
5159513|NCT01259440|12690077|P1|STARTED|Overall Study||13
5159514|NCT01259427|12690085|P2|NOT COMPLETED|Overall Study||14
5159515|NCT01259427|12690086|P1|NOT COMPLETED|Overall Study||18
5159516|NCT01259427|12690085|P2|COMPLETED|Overall Study||110
5159517|NCT01259427|12690086|P1|COMPLETED|Overall Study||106
5159518|NCT01259427|12690085|P2|STARTED|Overall Study||124
5159519|NCT01259427|12690086|P1|STARTED|Overall Study||124
5159520|NCT01259401|12690104|P2|NOT COMPLETED|4-month Follow-up||2
5159521|NCT01259401|12690105|P1|NOT COMPLETED|4-month Follow-up||0
5159522|NCT01259401|12690104|P2|COMPLETED|4-month Follow-up||19
5159523|NCT01259401|12690105|P1|COMPLETED|4-month Follow-up||21
5159524|NCT01259401|12690104|P2|STARTED|4-month Follow-up||21
5159525|NCT01259401|12690105|P1|STARTED|4-month Follow-up||21
5159526|NCT01259401|12690104|P2|NOT COMPLETED|End of 4-week Intervention||0
5159527|NCT01259401|12690105|P1|NOT COMPLETED|End of 4-week Intervention||0
5159528|NCT01259401|12690104|P2|COMPLETED|End of 4-week Intervention||21
5159529|NCT01259401|12690105|P1|COMPLETED|End of 4-week Intervention||21
5159530|NCT01259401|12690104|P2|STARTED|End of 4-week Intervention||21
5159531|NCT01259401|12690105|P1|STARTED|End of 4-week Intervention||21
5159532|NCT01259388|12690115|P2|NOT COMPLETED|Overall Study||1
5159533|NCT01259388|12690116|P1|NOT COMPLETED|Overall Study||5
5159534|NCT01259388|12690115|P2|COMPLETED|Overall Study||11
5159535|NCT01259388|12690116|P1|COMPLETED|Overall Study||6
5159536|NCT01259388|12690115|P2|STARTED|Overall Study||12
5159537|NCT01259388|12690116|P1|STARTED|Overall Study||11
5159538|NCT01259375|12690126|P1|NOT COMPLETED|Overall Study||1
5159539|NCT01259375|12690126|P1|COMPLETED|Overall Study||23
5159540|NCT01259375|12690126|P1|STARTED|Overall Study||24
5159541|NCT01259297|12690143|P8|NOT COMPLETED|Double Blind Randomized Period||3
5159542|NCT01259297|12690144|P7|NOT COMPLETED|Double Blind Randomized Period||6
5159543|NCT01259297|12690145|P6|NOT COMPLETED|Double Blind Randomized Period||8
5159544|NCT01259297|12690146|P5|NOT COMPLETED|Double Blind Randomized Period||4
5159545|NCT01259297|12690147|P4|NOT COMPLETED|Double Blind Randomized Period||4
5159546|NCT01259297|12690148|P3|NOT COMPLETED|Double Blind Randomized Period||1
5159547|NCT01259297|12690149|P2|NOT COMPLETED|Double Blind Randomized Period||3
5159548|NCT01259297|12690150|P1|NOT COMPLETED|Double Blind Randomized Period||2
5159549|NCT01259297|12690143|P8|COMPLETED|Double Blind Randomized Period||196
5159550|NCT01259297|12690144|P7|COMPLETED|Double Blind Randomized Period||190
5159551|NCT01259297|12690145|P6|COMPLETED|Double Blind Randomized Period||245
5159552|NCT01259297|12690146|P5|COMPLETED|Double Blind Randomized Period||247
5159553|NCT01259297|12690147|P4|COMPLETED|Double Blind Randomized Period||191
5159554|NCT01259297|12690148|P3|COMPLETED|Double Blind Randomized Period||188
5159555|NCT01259297|12690149|P2|COMPLETED|Double Blind Randomized Period||229
5159556|NCT01259297|12690150|P1|COMPLETED|Double Blind Randomized Period||242
5159557|NCT01259297|12690143|P8|STARTED|Double Blind Randomized Period||199
5159558|NCT01259297|12690144|P7|STARTED|Double Blind Randomized Period||196
5159559|NCT01259297|12690145|P6|STARTED|Double Blind Randomized Period||253
5159560|NCT01259297|12690146|P5|STARTED|Double Blind Randomized Period||251
5159561|NCT01259297|12690147|P4|STARTED|Double Blind Randomized Period||195
5159562|NCT01259297|12690148|P3|STARTED|Double Blind Randomized Period||189
5159563|NCT01259297|12690149|P2|STARTED|Double Blind Randomized Period||232
5159564|NCT01259297|12690150|P1|STARTED|Double Blind Randomized Period||244
5159565|NCT01259297|12690143|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159566|NCT01259297|12690144|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159567|NCT01259297|12690145|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159568|NCT01259297|12690146|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159569|NCT01259297|12690147|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159570|NCT01259297|12690148|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
5159571|NCT01259297|12690149|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159572|NCT01259297|12690150|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
5159573|NCT01259297|12690143|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159574|NCT01259297|12690144|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159575|NCT01259297|12690145|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159576|NCT01259297|12690146|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159577|NCT01259297|12690147|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159578|NCT01259297|12690148|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
5159579|NCT01259297|12690149|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
5159580|NCT01259297|12690150|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
5159581|NCT01259297|12690143|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159582|NCT01259297|12690144|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159583|NCT01259297|12690145|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159584|NCT01259297|12690146|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159585|NCT01259297|12690147|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159586|NCT01259297|12690148|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
5159587|NCT01259297|12690149|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
5159588|NCT01259297|12690150|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
5159589|NCT01259284|12690181|P3|NOT COMPLETED|Overall Study||0
5159590|NCT01259284|12690182|P2|NOT COMPLETED|Overall Study||0
5159591|NCT01259284|12690183|P1|NOT COMPLETED|Overall Study||2
5159592|NCT01259284|12690181|P3|COMPLETED|Overall Study||0
5159593|NCT01259284|12690182|P2|COMPLETED|Overall Study||0
5159594|NCT01259284|12690183|P1|COMPLETED|Overall Study||0
5159595|NCT01259284|12690181|P3|STARTED|Overall Study||0
5159596|NCT01259284|12690182|P2|STARTED|Overall Study||0
5159597|NCT01259284|12690183|P1|STARTED|Overall Study||2
5159598|NCT01259245|12690193|P2|NOT COMPLETED|Overall Study||26
5159599|NCT01259245|12690194|P1|NOT COMPLETED|Overall Study||28
5159600|NCT01259245|12690193|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
5159601|NCT01259245|12690194|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
5159602|NCT01259245|12690193|P2|STARTED|Overall Study||94
5159603|NCT01259245|12690194|P1|STARTED|Overall Study||98
5159604|NCT01259115|12690218|P2|NOT COMPLETED|Period 2||0
5159605|NCT01259115|12690219|P1|NOT COMPLETED|Period 2||1
5159606|NCT01259115|12690218|P2|COMPLETED|Period 2||9
5159607|NCT01259115|12690219|P1|COMPLETED|Period 2||6
5159608|NCT01259115|12690218|P2|STARTED|Period 2||9
5159609|NCT01259115|12690219|P1|STARTED|Period 2||7
5159610|NCT01259115|12690218|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
5159611|NCT01259115|12690219|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
5159612|NCT01259115|12690218|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
5159613|NCT01259115|12690219|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
5159614|NCT01259115|12690218|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
5159615|NCT01259115|12690219|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
5159616|NCT01259115|12690218|P2|NOT COMPLETED|Period 1||1
5159617|NCT01259115|12690219|P1|NOT COMPLETED|Period 1||3
5159618|NCT01259115|12690218|P2|COMPLETED|Period 1||9
5159619|NCT01259115|12690219|P1|COMPLETED|Period 1||7
5159620|NCT01259115|12690218|P2|STARTED|Period 1||10
5159621|NCT01259115|12690219|P1|STARTED|Period 1||10
5159622|NCT01259102|12690255|P5|NOT COMPLETED|Overall Study||1
5159623|NCT01259102|12690256|P4|NOT COMPLETED|Overall Study||2
5159624|NCT01259102|12690257|P3|NOT COMPLETED|Overall Study||2
5159625|NCT01259102|12690258|P2|NOT COMPLETED|Overall Study||0
5159626|NCT01259102|12690259|P1|NOT COMPLETED|Overall Study||1
5159627|NCT01259102|12690255|P5|COMPLETED|Overall Study||13
5159628|NCT01259102|12690256|P4|COMPLETED|Overall Study||12
5159629|NCT01259102|12690257|P3|COMPLETED|Overall Study||13
5159630|NCT01259102|12690258|P2|COMPLETED|Overall Study||14
5159631|NCT01259102|12690259|P1|COMPLETED|Overall Study||12
5159632|NCT01259102|12690255|P5|STARTED|Overall Study||14
5159633|NCT01259102|12690256|P4|STARTED|Overall Study||14
5159634|NCT01259102|12690257|P3|STARTED|Overall Study||15
5159635|NCT01259102|12690258|P2|STARTED|Overall Study||14
5159636|NCT01259102|12690259|P1|STARTED|Overall Study||13
5159637|NCT01259089|12690316|P6|NOT COMPLETED|Survival Follow up for Two Years||19
5159638|NCT01259089|12690317|P5|NOT COMPLETED|Survival Follow up for Two Years||6
5159639|NCT01259089|12690318|P4|NOT COMPLETED|Survival Follow up for Two Years||3
5159640|NCT01259089|12690319|P3|NOT COMPLETED|Survival Follow up for Two Years||2
5159641|NCT01259089|12690320|P2|NOT COMPLETED|Survival Follow up for Two Years||2
5159642|NCT01259089|12690321|P1|NOT COMPLETED|Survival Follow up for Two Years||3
5159643|NCT01259089|12690316|P6|COMPLETED|Survival Follow up for Two Years||0
5159644|NCT01259089|12690317|P5|COMPLETED|Survival Follow up for Two Years||0
5159645|NCT01259089|12690318|P4|COMPLETED|Survival Follow up for Two Years||0
5159646|NCT01259089|12690319|P3|COMPLETED|Survival Follow up for Two Years||1
5159647|NCT01259089|12690320|P2|COMPLETED|Survival Follow up for Two Years||1
5159648|NCT01259089|12690321|P1|COMPLETED|Survival Follow up for Two Years||0
5159649|NCT01259089|12690316|P6|STARTED|Survival Follow up for Two Years||19
5159650|NCT01259089|12690317|P5|STARTED|Survival Follow up for Two Years||6
5159651|NCT01259089|12690318|P4|STARTED|Survival Follow up for Two Years||3
5159652|NCT01259089|12690319|P3|STARTED|Survival Follow up for Two Years||3
5159653|NCT01259089|12690320|P2|STARTED|Survival Follow up for Two Years||3
5159654|NCT01259089|12690321|P1|STARTED|Survival Follow up for Two Years||3
5159655|NCT01259089|12690316|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
5159656|NCT01259089|12690317|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
5159657|NCT01259089|12690318|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
5159658|NCT01259089|12690319|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
5159659|NCT01259089|12690320|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
5159660|NCT01259089|12690321|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
5159661|NCT01259089|12690316|P6|COMPLETED|Continued Treatment After 8 Weeks||7
5159662|NCT01259089|12690317|P5|COMPLETED|Continued Treatment After 8 Weeks||0
5159663|NCT01259089|12690318|P4|COMPLETED|Continued Treatment After 8 Weeks||1
5159664|NCT01259089|12690319|P3|COMPLETED|Continued Treatment After 8 Weeks||1
5159665|NCT01259089|12690320|P2|COMPLETED|Continued Treatment After 8 Weeks||2
5159666|NCT01259089|12690321|P1|COMPLETED|Continued Treatment After 8 Weeks||1
5159667|NCT01259089|12690316|P6|STARTED|Continued Treatment After 8 Weeks||8
5159668|NCT01259089|12690317|P5|STARTED|Continued Treatment After 8 Weeks||2
5159669|NCT01259089|12690318|P4|STARTED|Continued Treatment After 8 Weeks||2
5159670|NCT01259089|12690319|P3|STARTED|Continued Treatment After 8 Weeks||2
5159671|NCT01259089|12690320|P2|STARTED|Continued Treatment After 8 Weeks||3
5159672|NCT01259089|12690321|P1|STARTED|Continued Treatment After 8 Weeks||3
5159673|NCT01259089|12690316|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
5159674|NCT01259089|12690317|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
5159675|NCT01259089|12690318|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
5159676|NCT01259089|12690319|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
5159677|NCT01259089|12690320|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
5159678|NCT01259089|12690321|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
5159679|NCT01259089|12690316|P6|COMPLETED|Confirmed Response at 8 Weeks||8
5159680|NCT01259089|12690317|P5|COMPLETED|Confirmed Response at 8 Weeks||2
5159681|NCT01259089|12690318|P4|COMPLETED|Confirmed Response at 8 Weeks||2
5159682|NCT01259089|12690319|P3|COMPLETED|Confirmed Response at 8 Weeks||2
5159683|NCT01259089|12690320|P2|COMPLETED|Confirmed Response at 8 Weeks||3
5159684|NCT01259089|12690321|P1|COMPLETED|Confirmed Response at 8 Weeks||3
5159685|NCT01259089|12690316|P6|STARTED|Confirmed Response at 8 Weeks||18
5159686|NCT01259089|12690317|P5|STARTED|Confirmed Response at 8 Weeks||6
5159687|NCT01259089|12690318|P4|STARTED|Confirmed Response at 8 Weeks||3
5159688|NCT01259089|12690319|P3|STARTED|Confirmed Response at 8 Weeks||3
5159689|NCT01259089|12690320|P2|STARTED|Confirmed Response at 8 Weeks||3
5159690|NCT01259089|12690321|P1|STARTED|Confirmed Response at 8 Weeks||3
5159691|NCT01259089|12690316|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
5159692|NCT01259089|12690317|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
5159693|NCT01259089|12690318|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
5159694|NCT01259089|12690319|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
5159695|NCT01259089|12690320|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
5159696|NCT01259089|12690321|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
5159697|NCT01259089|12690316|P6|COMPLETED|Reached First Response at 4 Weeks||18
5159698|NCT01259089|12690317|P5|COMPLETED|Reached First Response at 4 Weeks||6
5159699|NCT01259089|12690318|P4|COMPLETED|Reached First Response at 4 Weeks||3
5159700|NCT01259089|12690319|P3|COMPLETED|Reached First Response at 4 Weeks||3
5159701|NCT01259089|12690320|P2|COMPLETED|Reached First Response at 4 Weeks||3
5159702|NCT01259089|12690321|P1|COMPLETED|Reached First Response at 4 Weeks||3
5159703|NCT01259089|12690316|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
5159704|NCT01259089|12690317|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
5159705|NCT01259089|12690318|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
5159706|NCT01259089|12690319|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
5159707|NCT01259089|12690320|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
5159708|NCT01259089|12690321|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
5159709|NCT01259089|12690316|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
5159710|NCT01259089|12690317|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
5159711|NCT01259089|12690318|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
5159712|NCT01259089|12690319|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
5159713|NCT01259089|12690320|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
5159714|NCT01259089|12690321|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
5159715|NCT01259089|12690316|P6|STARTED|Reached First Response at 4 Weeks||20
5159716|NCT01259089|12690317|P5|STARTED|Reached First Response at 4 Weeks||6
5159717|NCT01259089|12690318|P4|STARTED|Reached First Response at 4 Weeks||3
5159718|NCT01259089|12690319|P3|STARTED|Reached First Response at 4 Weeks||3
5159719|NCT01259089|12690320|P2|STARTED|Reached First Response at 4 Weeks||3
5159720|NCT01259089|12690321|P1|STARTED|Reached First Response at 4 Weeks||3
5159721|NCT01259063|12690340|P1|NOT COMPLETED|Overall Study||0
5159722|NCT01259063|12690340|P1|COMPLETED|Overall Study||33
5159723|NCT01259063|12690340|P1|STARTED|Overall Study||33
5159724|NCT01259024|12690349|P1|NOT COMPLETED|Overall Study||1
5159725|NCT01259024|12690349|P1|COMPLETED|Overall Study||0
5159726|NCT01259024|12690349|P1|STARTED|Overall Study||1
5159727|NCT01259011|12690358|P2|NOT COMPLETED|After Patient Death||0
5159728|NCT01259011|12690359|P1|NOT COMPLETED|After Patient Death||0
5159729|NCT01259011|12690358|P2|COMPLETED|After Patient Death||28
5159730|NCT01259011|12690359|P1|COMPLETED|After Patient Death||17
5159731|NCT01259011|12690358|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
5159732|NCT01259011|12690359|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
5159733|NCT01259011|12690358|P2|NOT COMPLETED|Main Study Period||0
5159734|NCT01259011|12690359|P1|NOT COMPLETED|Main Study Period||0
5159735|NCT01259011|12690358|P2|COMPLETED|Main Study Period||109
5159736|NCT01259011|12690359|P1|COMPLETED|Main Study Period||101
5159737|NCT01259011|12690358|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
5159738|NCT01259011|12690359|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
5159739|NCT01258998|12690369|P1|NOT COMPLETED|Overall Study||1
5159740|NCT01258998|12690369|P1|COMPLETED|Overall Study||59
5159741|NCT01258998|12690369|P1|STARTED|Overall Study||60
5159742|NCT01258985|12690375|P2|NOT COMPLETED|Overall Study||0
5159743|NCT01258985|12690376|P1|NOT COMPLETED|Overall Study||0
5159744|NCT01258985|12690375|P2|COMPLETED|Overall Study||98
5159745|NCT01258985|12690376|P1|COMPLETED|Overall Study||106
5159746|NCT01258985|12690375|P2|STARTED|Overall Study||98
5159747|NCT01258985|12690376|P1|STARTED|Overall Study||106
5159748|NCT01258855|12690404|P2|NOT COMPLETED|Overall Study||0
5159749|NCT01258855|12690405|P1|NOT COMPLETED|Overall Study||0
5159750|NCT01258855|12690404|P2|COMPLETED|Overall Study||29
5159751|NCT01258855|12690405|P1|COMPLETED|Overall Study||55
5159752|NCT01258855|12690404|P2|STARTED|Overall Study||29
5159753|NCT01258855|12690405|P1|STARTED|Overall Study||55
5159754|NCT01258803|12690423|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159755|NCT01258803|12690424|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159756|NCT01258803|12690425|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159757|NCT01258803|12690426|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159758|NCT01258803|12690427|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159759|NCT01258803|12690428|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
5159760|NCT01258803|12690423|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
5159761|NCT01258803|12690424|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
5159762|NCT01258803|12690425|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
5159763|NCT01258803|12690426|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
5159764|NCT01258803|12690427|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
5159765|NCT01258803|12690428|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
5159766|NCT01258803|12690423|P6|STARTED|Treatment Period 4 (1 Dose)||15
5159767|NCT01258803|12690424|P5|STARTED|Treatment Period 4 (1 Dose)||15
5159768|NCT01258803|12690425|P4|STARTED|Treatment Period 4 (1 Dose)||15
5159769|NCT01258803|12690426|P3|STARTED|Treatment Period 4 (1 Dose)||14
5159770|NCT01258803|12690427|P2|STARTED|Treatment Period 4 (1 Dose)||14
5159771|NCT01258803|12690428|P1|STARTED|Treatment Period 4 (1 Dose)||14
5159772|NCT01258803|12690423|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
5159773|NCT01258803|12690424|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
5159774|NCT01258803|12690425|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
5159775|NCT01258803|12690426|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
5159776|NCT01258803|12690427|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
5159777|NCT01258803|12690428|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
5159778|NCT01258803|12690423|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
5159779|NCT01258803|12690424|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
5159780|NCT01258803|12690425|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
5159781|NCT01258803|12690426|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
5159782|NCT01258803|12690427|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
5159783|NCT01258803|12690428|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
5159784|NCT01258803|12690423|P6|STARTED|Treatment Period 3 (1 Dose)||15
5159785|NCT01258803|12690424|P5|STARTED|Treatment Period 3 (1 Dose)||15
5159786|NCT01258803|12690425|P4|STARTED|Treatment Period 3 (1 Dose)||15
5159787|NCT01258803|12690426|P3|STARTED|Treatment Period 3 (1 Dose)||15
5159788|NCT01258803|12690427|P2|STARTED|Treatment Period 3 (1 Dose)||14
5159789|NCT01258803|12690428|P1|STARTED|Treatment Period 3 (1 Dose)||14
5159790|NCT01258803|12690423|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
5159791|NCT01258803|12690424|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
5159792|NCT01258803|12690425|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
5159793|NCT01258803|12690426|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
5159794|NCT01258803|12690427|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
5159795|NCT01258803|12690428|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
5159796|NCT01258803|12690423|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
5159797|NCT01258803|12690424|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
5159798|NCT01258803|12690425|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
5159799|NCT01258803|12690426|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
5159800|NCT01258803|12690427|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
5159801|NCT01258803|12690428|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
5159802|NCT01258803|12690423|P6|STARTED|Treatment Period 2 (1 Dose)||16
5159803|NCT01258803|12690424|P5|STARTED|Treatment Period 2 (1 Dose)||15
5159804|NCT01258803|12690425|P4|STARTED|Treatment Period 2 (1 Dose)||15
5159805|NCT01258803|12690426|P3|STARTED|Treatment Period 2 (1 Dose)||15
5159806|NCT01258803|12690427|P2|STARTED|Treatment Period 2 (1 Dose)||16
5159807|NCT01258803|12690428|P1|STARTED|Treatment Period 2 (1 Dose)||15
5159808|NCT01258803|12690423|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159809|NCT01258803|12690424|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159810|NCT01258803|12690425|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159811|NCT01258803|12690426|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159812|NCT01258803|12690427|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159813|NCT01258803|12690428|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
5159814|NCT01258803|12690423|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
5159815|NCT01258803|12690424|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
5159816|NCT01258803|12690425|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
5159817|NCT01258803|12690426|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
5159818|NCT01258803|12690427|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
5159819|NCT01258803|12690428|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
5159820|NCT01258803|12690423|P6|STARTED|Treatment Period 1 (1 Dose)||16
5159821|NCT01258803|12690424|P5|STARTED|Treatment Period 1 (1 Dose)||15
5159822|NCT01258803|12690425|P4|STARTED|Treatment Period 1 (1 Dose)||15
5159823|NCT01258803|12690426|P3|STARTED|Treatment Period 1 (1 Dose)||15
5159824|NCT01258803|12690427|P2|STARTED|Treatment Period 1 (1 Dose)||16
5159825|NCT01258803|12690428|P1|STARTED|Treatment Period 1 (1 Dose)||15
5159826|NCT01258790|12690456|P2|NOT COMPLETED|Overall Study||0
5159827|NCT01258790|12690457|P1|NOT COMPLETED|Overall Study||0
5159828|NCT01258790|12690456|P2|COMPLETED|Overall Study||6
5159829|NCT01258790|12690457|P1|COMPLETED|Overall Study||6
5159830|NCT01258790|12690456|P2|STARTED|Overall Study||6
5159831|NCT01258790|12690457|P1|STARTED|Overall Study||6
5159832|NCT01258738|12690465|P2|NOT COMPLETED|Open-label Period||21
5159833|NCT01258738|12690466|P1|NOT COMPLETED|Open-label Period||17
5159834|NCT01258738|12690465|P2|COMPLETED|Open-label Period||85
5159835|NCT01258738|12690466|P1|COMPLETED|Open-label Period||85
5159836|NCT01258738|12690465|P2|STARTED|Open-label Period||106
5159837|NCT01258738|12690466|P1|STARTED|Open-label Period||102
5159838|NCT01258738|12690465|P2|NOT COMPLETED|Double-blind Period||7
5159839|NCT01258738|12690466|P1|NOT COMPLETED|Double-blind Period||9
5159840|NCT01258738|12690465|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
5159841|NCT01258738|12690466|P1|COMPLETED|Double-blind Period||102
5159842|NCT01258738|12690465|P2|Treated|Double-blind Period||113
5159843|NCT01258738|12690466|P1|Treated|Double-blind Period||111
5159844|NCT01258738|12690465|P2|STARTED|Double-blind Period||114
5159845|NCT01258738|12690466|P1|STARTED|Double-blind Period||111
5159846|NCT01258660|12690604|P2|NOT COMPLETED|Overall Study||11
5159847|NCT01258660|12690605|P1|NOT COMPLETED|Overall Study||11
5159848|NCT01258660|12690604|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
5159849|NCT01258660|12690605|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
5159850|NCT01258660|12690604|P2|Completed Treatment|Overall Study||81
5159851|NCT01258660|12690605|P1|Completed Treatment|Overall Study||79
5159852|NCT01258660|12690604|P2|Received Treatment|Overall Study||82
5159853|NCT01258660|12690605|P1|Received Treatment|Overall Study||79
5159854|NCT01258660|12690604|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
5159855|NCT01258660|12690605|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
5159856|NCT01258608|12690624|P2|NOT COMPLETED|Overall Study||19
5159857|NCT01258608|12690625|P1|NOT COMPLETED|Overall Study||21
5159858|NCT01258608|12690624|P2|COMPLETED|Overall Study||31
5159859|NCT01258608|12690625|P1|COMPLETED|Overall Study||30
5159860|NCT01258608|12690624|P2|STARTED|Overall Study||50
5159861|NCT01258608|12690625|P1|STARTED|Overall Study||51
5159862|NCT01258595|12690673|P2|NOT COMPLETED|Overall Study||1
5159863|NCT01258595|12690674|P1|NOT COMPLETED|Overall Study||1
5159864|NCT01258595|12690673|P2|COMPLETED|Overall Study||151
5159865|NCT01258595|12690674|P1|COMPLETED|Overall Study||147
5159866|NCT01258595|12690673|P2|STARTED|Overall Study||152
5159867|NCT01258595|12690674|P1|STARTED|Overall Study||148
5159868|NCT01258582|12690690|P2|NOT COMPLETED|Overall Study||258
5159869|NCT01258582|12690691|P1|NOT COMPLETED|Overall Study||282
5159870|NCT01258582|12690690|P2|COMPLETED|Overall Study||563
5159871|NCT01258582|12690691|P1|COMPLETED|Overall Study||548
5159872|NCT01258582|12690690|P2|STARTED|Overall Study||821
5159873|NCT01258582|12690691|P1|STARTED|Overall Study||830
5159874|NCT01258504|12690697|P1|NOT COMPLETED|Bosentan and SJW||0
5159875|NCT01258504|12690697|P1|COMPLETED|Bosentan and SJW||13
5159876|NCT01258504|12690697|P1|STARTED|Bosentan and SJW||13
5159877|NCT01258504|12690697|P1|NOT COMPLETED|Bosentan Steady-state||0
5159878|NCT01258504|12690697|P1|COMPLETED|Bosentan Steady-state||13
5159879|NCT01258504|12690697|P1|STARTED|Bosentan Steady-state||13
5159880|NCT01258504|12690697|P1|NOT COMPLETED|Bosentan Single Dose||0
5159881|NCT01258504|12690697|P1|COMPLETED|Bosentan Single Dose||13
5159882|NCT01258504|12690697|P1|STARTED|Bosentan Single Dose||13
5159883|NCT01258387|12690716|P7|NOT COMPLETED|Overall Study||0
5159884|NCT01258387|12690717|P6|NOT COMPLETED|Overall Study||0
5159885|NCT01258387|12690718|P5|NOT COMPLETED|Overall Study||0
5159886|NCT01258387|12690719|P4|NOT COMPLETED|Overall Study||0
5159887|NCT01258387|12690720|P3|NOT COMPLETED|Overall Study||0
5159888|NCT01258387|12690721|P2|NOT COMPLETED|Overall Study||0
5159889|NCT01258387|12690722|P1|NOT COMPLETED|Overall Study||0
5159890|NCT01258387|12690716|P7|COMPLETED|Overall Study||4
5159891|NCT01258387|12690717|P6|COMPLETED|Overall Study||6
5159892|NCT01258387|12690718|P5|COMPLETED|Overall Study||6
5159893|NCT01258387|12690719|P4|COMPLETED|Overall Study||6
5159894|NCT01258387|12690720|P3|COMPLETED|Overall Study||6
5159895|NCT01258387|12690721|P2|COMPLETED|Overall Study||6
5159896|NCT01258387|12690722|P1|COMPLETED|Overall Study||6
5159897|NCT01258387|12690716|P7|Patients Randomized to Placebo|Overall Study||1
5159898|NCT01258387|12690717|P6|Patients Randomized to Placebo|Overall Study||2
5159899|NCT01258387|12690718|P5|Patients Randomized to Placebo|Overall Study||2
5159900|NCT01258387|12690719|P4|Patients Randomized to Placebo|Overall Study||2
5159901|NCT01258387|12690720|P3|Patients Randomized to Placebo|Overall Study||2
5159902|NCT01258387|12690721|P2|Patients Randomized to Placebo|Overall Study||2
5159903|NCT01258387|12690722|P1|Patients Randomized to Placebo|Overall Study||2
5159904|NCT01258387|12690716|P7|Patients Randomized to GGF2|Overall Study||3
5159905|NCT01258387|12690717|P6|Patients Randomized to GGF2|Overall Study||4
5159906|NCT01258387|12690718|P5|Patients Randomized to GGF2|Overall Study||4
5159907|NCT01258387|12690719|P4|Patients Randomized to GGF2|Overall Study||4
5159908|NCT01258387|12690720|P3|Patients Randomized to GGF2|Overall Study||4
5159909|NCT01258387|12690721|P2|Patients Randomized to GGF2|Overall Study||4
5159910|NCT01258387|12690722|P1|Patients Randomized to GGF2|Overall Study||4
5159911|NCT01258387|12690716|P7|STARTED|Overall Study||4
5159912|NCT01258387|12690717|P6|STARTED|Overall Study||6
5159913|NCT01258387|12690718|P5|STARTED|Overall Study||6
5159914|NCT01258387|12690719|P4|STARTED|Overall Study||6
5159915|NCT01258387|12690720|P3|STARTED|Overall Study||6
5159916|NCT01258387|12690721|P2|STARTED|Overall Study||6
5159917|NCT01258387|12690722|P1|STARTED|Overall Study||6
5159918|NCT01258374|12690764|P1|NOT COMPLETED|Overall Study||0
5159919|NCT01258374|12690764|P1|COMPLETED|Overall Study||15
5159920|NCT01258374|12690764|P1|STARTED|Overall Study||15
5159921|NCT01258348|12690771|P5|NOT COMPLETED|Overall Study||6
5159922|NCT01258348|12690772|P4|NOT COMPLETED|Overall Study||6
5159923|NCT01258348|12690773|P3|NOT COMPLETED|Overall Study||3
5159924|NCT01258348|12690774|P2|NOT COMPLETED|Overall Study||5
5159925|NCT01258348|12690775|P1|NOT COMPLETED|Overall Study||1
5159926|NCT01258348|12690771|P5|COMPLETED|Overall Study||0
5159927|NCT01258348|12690772|P4|COMPLETED|Overall Study||0
5159928|NCT01258348|12690773|P3|COMPLETED|Overall Study||0
5159929|NCT01258348|12690774|P2|COMPLETED|Overall Study||0
5159930|NCT01258348|12690775|P1|COMPLETED|Overall Study||0
5159931|NCT01258348|12690771|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5159932|NCT01258348|12690772|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5159933|NCT01258348|12690773|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5159934|NCT01258348|12690774|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
5159935|NCT01258348|12690775|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
5159936|NCT01258348|12690771|P5|STARTED|Overall Study||6
5159937|NCT01258348|12690772|P4|STARTED|Overall Study||6
5159938|NCT01258348|12690773|P3|STARTED|Overall Study||3
5159939|NCT01258348|12690774|P2|STARTED|Overall Study||5
5159940|NCT01258348|12690775|P1|STARTED|Overall Study||1
5159941|NCT01258153|12690803|P3|NOT COMPLETED|Overall Study||1
5159942|NCT01258153|12690804|P2|NOT COMPLETED|Overall Study||1
5159943|NCT01258153|12690805|P1|NOT COMPLETED|Overall Study||1
5159944|NCT01258153|12690803|P3|COMPLETED|Overall Study||36
5159945|NCT01258153|12690804|P2|COMPLETED|Overall Study||37
5159946|NCT01258153|12690805|P1|COMPLETED|Overall Study||39
5159947|NCT01258153|12690803|P3|STARTED|Overall Study||37
5159948|NCT01258153|12690804|P2|STARTED|Overall Study||38
5159949|NCT01258153|12690805|P1|STARTED|Overall Study||40
5159950|NCT01258101|12690832|P4|NOT COMPLETED|Overall Study||25
5159951|NCT01258101|12690833|P3|NOT COMPLETED|Overall Study||11
5159952|NCT01258101|12690834|P2|NOT COMPLETED|Overall Study||34
5159953|NCT01258101|12690835|P1|NOT COMPLETED|Overall Study||33
5159954|NCT01258101|12690832|P4|COMPLETED|Overall Study||27
5159955|NCT01258101|12690833|P3|COMPLETED|Overall Study||22
5159956|NCT01258101|12690834|P2|COMPLETED|Overall Study||110
5159957|NCT01258101|12690835|P1|COMPLETED|Overall Study||118
5159958|NCT01258101|12690832|P4|Standard Analysis Population|Overall Study||26
5159959|NCT01258101|12690833|P3|Standard Analysis Population|Overall Study||21
5159960|NCT01258101|12690834|P2|Standard Analysis Population|Overall Study||110
5159961|NCT01258101|12690835|P1|Standard Analysis Population|Overall Study||115
5159962|NCT01258101|12690832|P4|Safety Analysis Population|Overall Study||48
5159963|NCT01258101|12690833|P3|Safety Analysis Population|Overall Study||30
5159964|NCT01258101|12690834|P2|Safety Analysis Population|Overall Study||141
5159965|NCT01258101|12690835|P1|Safety Analysis Population|Overall Study||144
5159966|NCT01258101|12690832|P4|STARTED|Overall Study||52
5159967|NCT01258101|12690833|P3|STARTED|Overall Study||33
5159968|NCT01258101|12690834|P2|STARTED|Overall Study||144
5159969|NCT01258101|12690835|P1|STARTED|Overall Study||151
5159970|NCT01258049|12690887|P2|NOT COMPLETED|Overall Study||2
5159971|NCT01258049|12690888|P1|NOT COMPLETED|Overall Study||2
5159972|NCT01258049|12690887|P2|COMPLETED|Overall Study||72
5159973|NCT01258049|12690888|P1|COMPLETED|Overall Study||75
5159974|NCT01258049|12690887|P2|STARTED|Overall Study||74
5159975|NCT01258049|12690888|P1|STARTED|Overall Study||77
5159976|NCT01257880|12690926|P2|NOT COMPLETED|Overall Study||0
5159977|NCT01257880|12690927|P1|NOT COMPLETED|Overall Study||0
5159978|NCT01257880|12690926|P2|COMPLETED|Overall Study||19
5159979|NCT01257880|12690927|P1|COMPLETED|Overall Study||12
5159980|NCT01257880|12690926|P2|STARTED|Overall Study||19
5159981|NCT01257880|12690927|P1|STARTED|Overall Study||12
5159982|NCT01257802|12690937|P2|NOT COMPLETED|Overall Study||6
5159983|NCT01257802|12690938|P1|NOT COMPLETED|Overall Study||1
5159984|NCT01257802|12690937|P2|COMPLETED|Overall Study||2
5159985|NCT01257802|12690938|P1|COMPLETED|Overall Study||5
5159986|NCT01257802|12690937|P2|6 Month / 24 Week Visit|Overall Study||2
5159987|NCT01257802|12690938|P1|6 Month / 24 Week Visit|Overall Study||5
5159988|NCT01257802|12690937|P2|STARTED|Overall Study||8
5159989|NCT01257802|12690938|P1|STARTED|Overall Study||6
5159990|NCT01257750|12690952|P1|NOT COMPLETED|Overall Study||0
5159991|NCT01257750|12690952|P1|COMPLETED|Overall Study||20
5159992|NCT01257750|12690952|P1|STARTED|Overall Study||20
5159993|NCT01257737|12690965|P2|NOT COMPLETED|Overall Study||4
5159994|NCT01257737|12690966|P1|NOT COMPLETED|Overall Study||2
5159995|NCT01257737|12690965|P2|COMPLETED|Overall Study||39
5159996|NCT01257737|12690966|P1|COMPLETED|Overall Study||43
5159997|NCT01257737|12690965|P2|STARTED|Overall Study||43
5159998|NCT01257737|12690966|P1|STARTED|Overall Study||45
5159999|NCT01257698|12690986|P2|NOT COMPLETED|Overall Study||0
5160000|NCT01257698|12690987|P1|NOT COMPLETED|Overall Study||4
5160001|NCT01257698|12690986|P2|COMPLETED|Overall Study||9
5160002|NCT01257698|12690987|P1|COMPLETED|Overall Study||8
5160003|NCT01257698|12690986|P2|STARTED|Overall Study||9
5160004|NCT01257698|12690987|P1|STARTED|Overall Study||12
5160005|NCT01257581|12690996|P3|NOT COMPLETED|Overall Study||6
5160006|NCT01257581|12690997|P2|NOT COMPLETED|Overall Study||3
5160007|NCT01257581|12690998|P1|NOT COMPLETED|Overall Study||5
5160008|NCT01257581|12690996|P3|COMPLETED|Overall Study||11
5160009|NCT01257581|12690997|P2|COMPLETED|Overall Study||18
5160010|NCT01257581|12690998|P1|COMPLETED|Overall Study||17
5160011|NCT01257581|12690996|P3|STARTED|Overall Study||17
5160012|NCT01257581|12690997|P2|STARTED|Overall Study||21
5160013|NCT01257581|12690998|P1|STARTED|Overall Study||22
5160014|NCT01257568|12691036|P1|NOT COMPLETED|Overall Study||33
5160015|NCT01257568|12691036|P1|COMPLETED|Overall Study||7
5160016|NCT01257568|12691036|P1|STARTED|Overall Study||40
5160017|NCT01257542|12691050|P2|NOT COMPLETED|Overall Study||7
5160018|NCT01257542|12691051|P1|NOT COMPLETED|Overall Study||3
5160019|NCT01257542|12691050|P2|COMPLETED|Overall Study||45
5160020|NCT01257542|12691051|P1|COMPLETED|Overall Study||52
5160021|NCT01257542|12691050|P2|STARTED|Overall Study||52
5160022|NCT01257542|12691051|P1|STARTED|Overall Study||55
5160023|NCT01257503|12691071|P2|NOT COMPLETED|Overall Study||11
5160024|NCT01257503|12691072|P1|NOT COMPLETED|Overall Study||8
5160025|NCT01257503|12691071|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
5160026|NCT01257503|12691072|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
5160027|NCT01257503|12691071|P2|Returned Dosage Logbooks|Overall Study||80
5160028|NCT01257503|12691072|P1|Returned Dosage Logbooks|Overall Study||75
5160029|NCT01257503|12691071|P2|Returned Symptom Diaries|Overall Study||83
5160030|NCT01257503|12691072|P1|Returned Symptom Diaries|Overall Study||80
5160031|NCT01257503|12691071|P2|STARTED|Overall Study||130
5160032|NCT01257503|12691072|P1|STARTED|Overall Study||133
5160033|NCT01257438|12691088|P2|NOT COMPLETED|Overall Study||46
5160034|NCT01257438|12691089|P1|NOT COMPLETED|Overall Study||30
5160035|NCT01257438|12691088|P2|COMPLETED|Overall Study||97
5160036|NCT01257438|12691089|P1|COMPLETED|Overall Study||102
5160037|NCT01257438|12691088|P2|STARTED|Overall Study||143
5160038|NCT01257438|12691089|P1|STARTED|Overall Study||132
5160039|NCT01257425|12691101|P2|NOT COMPLETED|Overall Study||6
5160040|NCT01257425|12691102|P1|NOT COMPLETED|Overall Study||6
5160041|NCT01257425|12691101|P2|COMPLETED|Overall Study||45
5160042|NCT01257425|12691102|P1|COMPLETED|Overall Study||46
5160043|NCT01257425|12691101|P2|STARTED|Overall Study||51
5160044|NCT01257425|12691102|P1|STARTED|Overall Study||52
5160045|NCT01257347|12691124|P4|NOT COMPLETED|Overall Study||0
5160046|NCT01257347|12691125|P3|NOT COMPLETED|Overall Study||0
5160047|NCT01257347|12691126|P2|NOT COMPLETED|Overall Study||0
5160048|NCT01257347|12691127|P1|NOT COMPLETED|Overall Study||0
5160049|NCT01257347|12691124|P4|COMPLETED|Overall Study||65
5160050|NCT01257347|12691125|P3|COMPLETED|Overall Study||35
5160051|NCT01257347|12691126|P2|COMPLETED|Overall Study||12
5160052|NCT01257347|12691127|P1|COMPLETED|Overall Study||12
5160053|NCT01257347|12691124|P4|STARTED|Overall Study||65
5160054|NCT01257347|12691125|P3|STARTED|Overall Study||35
5160055|NCT01257347|12691126|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
5160056|NCT01257347|12691127|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
5160057|NCT01257230|12691144|P3|NOT COMPLETED|Overall Study||6
5160058|NCT01257230|12691145|P2|NOT COMPLETED|Overall Study||10
5160059|NCT01257230|12691146|P1|NOT COMPLETED|Overall Study||6
5160060|NCT01257230|12691144|P3|COMPLETED|Overall Study||129
5160061|NCT01257230|12691145|P2|COMPLETED|Overall Study||115
5160062|NCT01257230|12691146|P1|COMPLETED|Overall Study||132
5160063|NCT01257230|12691144|P3|STARTED|Overall Study||135
5160064|NCT01257230|12691145|P2|STARTED|Overall Study||125
5160065|NCT01257230|12691146|P1|STARTED|Overall Study||138
5160066|NCT01257217|12691201|P2|NOT COMPLETED|Overall Study||0
5160067|NCT01257217|12691202|P1|NOT COMPLETED|Overall Study||2
5160068|NCT01257217|12691201|P2|COMPLETED|Overall Study||10
5160069|NCT01257217|12691202|P1|COMPLETED|Overall Study||13
5160070|NCT01257217|12691201|P2|STARTED|Overall Study||10
5160071|NCT01257217|12691202|P1|STARTED|Overall Study||15
5160072|NCT01257204|12691223|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
5160073|NCT01257204|12691224|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
5160074|NCT01257204|12691225|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
5160075|NCT01257204|12691223|P3|COMPLETED|Follow-up Period (up to Week 48)||39
5160076|NCT01257204|12691224|P2|COMPLETED|Follow-up Period (up to Week 48)||41
5160077|NCT01257204|12691225|P1|COMPLETED|Follow-up Period (up to Week 48)||48
5160078|NCT01257204|12691223|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
5160079|NCT01257204|12691224|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
5160080|NCT01257204|12691225|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
5160081|NCT01257204|12691223|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
5160082|NCT01257204|12691224|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
5160083|NCT01257204|12691225|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
5160084|NCT01257204|12691223|P3|COMPLETED|Treatment Period (up to Week 24)||42
5160085|NCT01257204|12691224|P2|COMPLETED|Treatment Period (up to Week 24)||44
5160086|NCT01257204|12691225|P1|COMPLETED|Treatment Period (up to Week 24)||45
5160087|NCT01257204|12691223|P3|STARTED|Treatment Period (up to Week 24)||51
5160088|NCT01257204|12691224|P2|STARTED|Treatment Period (up to Week 24)||50
5160089|NCT01257204|12691225|P1|STARTED|Treatment Period (up to Week 24)||50
5160090|NCT01256983|12691271|P2|NOT COMPLETED|Overall Study||3
5160091|NCT01256983|12691272|P1|NOT COMPLETED|Overall Study||1
5160092|NCT01256983|12691271|P2|COMPLETED|Overall Study||12
5160093|NCT01256983|12691272|P1|COMPLETED|Overall Study||14
5160094|NCT01256983|12691271|P2|STARTED|Overall Study||15
5160095|NCT01256983|12691272|P1|STARTED|Overall Study||15
5160096|NCT01256944|12691280|P2|NOT COMPLETED|Overall Study||0
5160097|NCT01256944|12691281|P1|NOT COMPLETED|Overall Study||0
5160098|NCT01256944|12691280|P2|COMPLETED|Overall Study||220
5160099|NCT01256944|12691281|P1|COMPLETED|Overall Study||70
5160100|NCT01256944|12691280|P2|STARTED|Overall Study||220
5160101|NCT01256944|12691281|P1|STARTED|Overall Study||70
5160102|NCT01256918|12691309|P1|NOT COMPLETED|Overall Study||0
5160103|NCT01256918|12691309|P1|COMPLETED|Overall Study||200
5160104|NCT01256918|12691309|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
5160105|NCT01256918|12691309|P1|STARTED|Overall Study||200
5160106|NCT01256879|12691320|P1|NOT COMPLETED|Overall Study||1
5160107|NCT01256879|12691320|P1|COMPLETED|Overall Study||24
5160108|NCT01256879|12691320|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
5160109|NCT01256879|12691320|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
5160110|NCT01256879|12691320|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
5160111|NCT01256879|12691320|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
5160112|NCT01256879|12691320|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
5160113|NCT01256840|12691333|P3|NOT COMPLETED|Overall Study||0
5160114|NCT01256840|12691334|P2|NOT COMPLETED|Overall Study||0
5160115|NCT01256840|12691335|P1|NOT COMPLETED|Overall Study||0
5160116|NCT01256840|12691333|P3|COMPLETED|Overall Study||25
5160117|NCT01256840|12691334|P2|COMPLETED|Overall Study||16
5160118|NCT01256840|12691335|P1|COMPLETED|Overall Study||30
5160119|NCT01256840|12691333|P3|STARTED|Overall Study||25
5160120|NCT01256840|12691334|P2|STARTED|Overall Study||16
5160121|NCT01256840|12691335|P1|STARTED|Overall Study||30
5160122|NCT01256788|12691346|P3|NOT COMPLETED|Overall Study||3
5160123|NCT01256788|12691347|P2|NOT COMPLETED|Overall Study||8
5160124|NCT01256788|12691348|P1|NOT COMPLETED|Overall Study||5
5160125|NCT01256788|12691346|P3|COMPLETED|Overall Study||5
5160126|NCT01256788|12691347|P2|COMPLETED|Overall Study||6
5160127|NCT01256788|12691348|P1|COMPLETED|Overall Study||7
5160128|NCT01256788|12691346|P3|STARTED|Overall Study||8
5160129|NCT01256788|12691347|P2|STARTED|Overall Study||14
5160130|NCT01256788|12691348|P1|STARTED|Overall Study||12
5160131|NCT01256684|12691359|P3|NOT COMPLETED|Overall Study||11
5160132|NCT01256684|12691360|P2|NOT COMPLETED|Overall Study||13
5160133|NCT01256684|12691361|P1|NOT COMPLETED|Overall Study||9
5160134|NCT01256684|12691359|P3|COMPLETED|Overall Study||76
5160135|NCT01256684|12691360|P2|COMPLETED|Overall Study||74
5160136|NCT01256684|12691361|P1|COMPLETED|Overall Study||72
5160137|NCT01256684|12691359|P3|ITT Population|Overall Study||81
5160138|NCT01256684|12691360|P2|ITT Population|Overall Study||79
5160139|NCT01256684|12691361|P1|ITT Population|Overall Study||77
5160140|NCT01256684|12691359|P3|Safety Population|Overall Study||87
5160141|NCT01256684|12691360|P2|Safety Population|Overall Study||86
5160142|NCT01256684|12691361|P1|Safety Population|Overall Study||80
5160143|NCT01256684|12691359|P3|STARTED|Overall Study||87
5160144|NCT01256684|12691360|P2|STARTED|Overall Study||87
5160145|NCT01256684|12691361|P1|STARTED|Overall Study||81
5160146|NCT01256671|12691393|P1|NOT COMPLETED|Overall Study||95
5160147|NCT01256671|12691393|P1|COMPLETED|Overall Study||435
5160148|NCT01256671|12691393|P1|Safety Population|Overall Study||521
5160149|NCT01256671|12691393|P1|STARTED|Overall Study||530
5160150|NCT01256658|12691406|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
5160151|NCT01256658|12691407|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
5160152|NCT01256658|12691406|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
5160153|NCT01256658|12691407|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
5160154|NCT01256658|12691406|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
5160155|NCT01256658|12691407|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
5160156|NCT01256658|12691406|P2|Death|Period 2 - Follow up Only - No Treatment||8
5160157|NCT01256658|12691407|P1|Death|Period 2 - Follow up Only - No Treatment||6
5160158|NCT01256658|12691406|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
5160159|NCT01256658|12691407|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
5160160|NCT01256658|12691406|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
5160161|NCT01256658|12691407|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
5160162|NCT01256658|12691406|P2|NOT COMPLETED|Period 1||748
5160163|NCT01256658|12691407|P1|NOT COMPLETED|Period 1||920
5160164|NCT01256658|12691406|P2|COMPLETED|Period 1||6510
5160165|NCT01256658|12691407|P1|COMPLETED|Period 1||5897
5160166|NCT01256658|12691406|P2|STARTED|Period 1||7258
5160167|NCT01256658|12691407|P1|STARTED|Period 1||6817
5160168|NCT01256593|12691457|P1|NOT COMPLETED|Overall Study||214
5160169|NCT01256593|12691457|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
5160170|NCT01256593|12691457|P1|STARTED|Overall Study||3827
5160171|NCT01256567|12691471|P1|NOT COMPLETED|Overall Study||1
5160172|NCT01256567|12691471|P1|COMPLETED|Overall Study||6
5160173|NCT01256567|12691471|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
5160174|NCT01256567|12691471|P1|STARTED|Overall Study||7
5160175|NCT01256502|12691481|P1|NOT COMPLETED|Overall Study||10
5160176|NCT01256502|12691481|P1|COMPLETED|Overall Study||129
5160177|NCT01256502|12691481|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
5160178|NCT01256476|12691493|P2|NOT COMPLETED|Overall Study||7
5160179|NCT01256476|12691494|P1|NOT COMPLETED|Overall Study||6
5160180|NCT01256476|12691493|P2|COMPLETED|Overall Study||157
5160181|NCT01256476|12691494|P1|COMPLETED|Overall Study||158
5160182|NCT01256476|12691493|P2|STARTED|Overall Study||164
5160183|NCT01256476|12691494|P1|STARTED|Overall Study||164
5160184|NCT01256450|12691502|P3|NOT COMPLETED|Double-blind Treatment||37
5160185|NCT01256450|12691503|P2|NOT COMPLETED|Double-blind Treatment||28
5160186|NCT01256450|12691504|P1|NOT COMPLETED|Double-blind Treatment||0
5160187|NCT01256450|12691502|P3|COMPLETED|Double-blind Treatment||81
5160188|NCT01256450|12691503|P2|COMPLETED|Double-blind Treatment||89
5160189|NCT01256450|12691504|P1|COMPLETED|Double-blind Treatment||0
5160190|NCT01256450|12691502|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
5160191|NCT01256450|12691503|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
5160192|NCT01256450|12691504|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
5160193|NCT01256450|12691502|P3|NOT COMPLETED|Open-label Titration||0
5160194|NCT01256450|12691503|P2|NOT COMPLETED|Open-label Titration||0
5160195|NCT01256450|12691504|P1|NOT COMPLETED|Open-label Titration||99
5160196|NCT01256450|12691502|P3|COMPLETED|Open-label Titration||0
5160197|NCT01256450|12691503|P2|COMPLETED|Open-label Titration||0
5160198|NCT01256450|12691504|P1|COMPLETED|Open-label Titration||235
5160199|NCT01256450|12691502|P3|STARTED|Open-label Titration||0
5160200|NCT01256450|12691503|P2|STARTED|Open-label Titration||0
5160201|NCT01256450|12691504|P1|STARTED|Open-label Titration||334
5160202|NCT01256424|12691533|P4|NOT COMPLETED|Overall Study||7
5160203|NCT01256424|12691534|P3|NOT COMPLETED|Overall Study||7
5160204|NCT01256424|12691535|P2|NOT COMPLETED|Overall Study||8
5160205|NCT01256424|12691536|P1|NOT COMPLETED|Overall Study||9
5160206|NCT01256424|12691533|P4|COMPLETED|Overall Study||61
5160207|NCT01256424|12691534|P3|COMPLETED|Overall Study||55
5160208|NCT01256424|12691535|P2|COMPLETED|Overall Study||59
5160209|NCT01256424|12691536|P1|COMPLETED|Overall Study||56
5160210|NCT01256424|12691533|P4|STARTED|Overall Study||68
5160211|NCT01256424|12691534|P3|STARTED|Overall Study||62
5160212|NCT01256424|12691535|P2|STARTED|Overall Study||67
5160213|NCT01256424|12691536|P1|STARTED|Overall Study||65
5160214|NCT01256411|12691562|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
5160215|NCT01256411|12691563|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
5160216|NCT01256411|12691564|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
5160217|NCT01256411|12691565|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
5160218|NCT01256411|12691566|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
5160219|NCT01256411|12691567|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
5160220|NCT01256411|12691562|P6|COMPLETED|Extension by Mono or Combination Therapy||109
5160221|NCT01256411|12691563|P5|COMPLETED|Extension by Mono or Combination Therapy||211
5160222|NCT01256411|12691564|P4|COMPLETED|Extension by Mono or Combination Therapy||0
5160223|NCT01256411|12691565|P3|COMPLETED|Extension by Mono or Combination Therapy||0
5160224|NCT01256411|12691566|P2|COMPLETED|Extension by Mono or Combination Therapy||0
5160225|NCT01256411|12691567|P1|COMPLETED|Extension by Mono or Combination Therapy||0
5160226|NCT01256411|12691562|P6|STARTED|Extension by Mono or Combination Therapy||113
5160227|NCT01256411|12691563|P5|STARTED|Extension by Mono or Combination Therapy||228
5160228|NCT01256411|12691564|P4|STARTED|Extension by Mono or Combination Therapy||0
5160229|NCT01256411|12691565|P3|STARTED|Extension by Mono or Combination Therapy||0
5160230|NCT01256411|12691566|P2|STARTED|Extension by Mono or Combination Therapy||0
5160231|NCT01256411|12691567|P1|STARTED|Extension by Mono or Combination Therapy||0
5160232|NCT01256411|12691562|P6|NOT COMPLETED|Extension by Maximum Treatment||0
5160233|NCT01256411|12691563|P5|NOT COMPLETED|Extension by Maximum Treatment||0
5160234|NCT01256411|12691564|P4|NOT COMPLETED|Extension by Maximum Treatment||0
5160235|NCT01256411|12691565|P3|NOT COMPLETED|Extension by Maximum Treatment||4
5160236|NCT01256411|12691566|P2|NOT COMPLETED|Extension by Maximum Treatment||10
5160237|NCT01256411|12691567|P1|NOT COMPLETED|Extension by Maximum Treatment||7
5160238|NCT01256411|12691562|P6|COMPLETED|Extension by Maximum Treatment||0
5160239|NCT01256411|12691563|P5|COMPLETED|Extension by Maximum Treatment||0
5160240|NCT01256411|12691564|P4|COMPLETED|Extension by Maximum Treatment||4
5160241|NCT01256411|12691565|P3|COMPLETED|Extension by Maximum Treatment||105
5160242|NCT01256411|12691566|P2|COMPLETED|Extension by Maximum Treatment||79
5160243|NCT01256411|12691567|P1|COMPLETED|Extension by Maximum Treatment||132
5160244|NCT01256411|12691562|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
5160245|NCT01256411|12691563|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
5160246|NCT01256411|12691564|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
5160247|NCT01256411|12691565|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
5160248|NCT01256411|12691566|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
5160249|NCT01256411|12691567|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
5160250|NCT01256411|12691562|P6|STARTED|Extension by Maximum Treatment||0
5160251|NCT01256411|12691563|P5|STARTED|Extension by Maximum Treatment||0
5160252|NCT01256411|12691564|P4|STARTED|Extension by Maximum Treatment||4
5160253|NCT01256411|12691565|P3|STARTED|Extension by Maximum Treatment||109
5160254|NCT01256411|12691566|P2|STARTED|Extension by Maximum Treatment||89
5160255|NCT01256411|12691567|P1|STARTED|Extension by Maximum Treatment||139
5160256|NCT01256398|12691591|P1|NOT COMPLETED|Overall Study||1
5160257|NCT01256398|12691591|P1|COMPLETED|Overall Study||65
5160258|NCT01256398|12691591|P1|STARTED|Overall Study||66
5160259|NCT01256385|12691597|P2|NOT COMPLETED|Overall Study||3
5160260|NCT01256385|12691598|P1|NOT COMPLETED|Overall Study||3
5160261|NCT01256385|12691597|P2|COMPLETED|Overall Study||40
5160262|NCT01256385|12691598|P1|COMPLETED|Overall Study||40
5160263|NCT01256385|12691597|P2|Crossover From Arm B to Arm A|Overall Study||15
5160264|NCT01256385|12691598|P1|Crossover From Arm B to Arm A|Overall Study||0
5160265|NCT01256385|12691597|P2|STARTED|Overall Study||43
5160266|NCT01256385|12691598|P1|STARTED|Overall Study||43
5160267|NCT01256294|12691618|P2|NOT COMPLETED|Overall Study||2
5160268|NCT01256294|12691619|P1|NOT COMPLETED|Overall Study||4
5160269|NCT01256294|12691618|P2|COMPLETED|Overall Study||33
5160270|NCT01256294|12691619|P1|COMPLETED|Overall Study||32
5160271|NCT01256294|12691618|P2|STARTED|Overall Study||35
5160272|NCT01256294|12691619|P1|STARTED|Overall Study||36
5160273|NCT01256281|12691635|P1|NOT COMPLETED|Overall Study||0
5160274|NCT01256281|12691635|P1|COMPLETED|Overall Study||2
5160275|NCT01256281|12691635|P1|STARTED|Overall Study||2
5160276|NCT01256190|12691641|P2|NOT COMPLETED|Overall Study||0
5160277|NCT01256190|12691642|P1|NOT COMPLETED|Overall Study||2
5160278|NCT01256190|12691641|P2|COMPLETED|Overall Study||17
5160279|NCT01256190|12691642|P1|COMPLETED|Overall Study||37
5160280|NCT01256190|12691641|P2|STARTED|Overall Study||17
5160281|NCT01256190|12691642|P1|STARTED|Overall Study||39
5160282|NCT01256177|12691658|P2|NOT COMPLETED|Overall Study||37
5160283|NCT01256177|12691659|P1|NOT COMPLETED|Overall Study||50
5160284|NCT01256177|12691658|P2|COMPLETED|Overall Study||111
5160285|NCT01256177|12691659|P1|COMPLETED|Overall Study||98
5160286|NCT01256177|12691658|P2|STARTED|Overall Study||148
5160287|NCT01256177|12691659|P1|STARTED|Overall Study||148
5160288|NCT01256164|12691683|P2|NOT COMPLETED|Overall Study||0
5160289|NCT01256164|12691684|P1|NOT COMPLETED|Overall Study||0
5160290|NCT01256164|12691683|P2|COMPLETED|Overall Study||23
5160291|NCT01256164|12691684|P1|COMPLETED|Overall Study||47
5160292|NCT01256164|12691683|P2|STARTED|Overall Study||23
5160293|NCT01256164|12691684|P1|STARTED|Overall Study||47
5160294|NCT01256086|12691702|P4|NOT COMPLETED|Treatment Day 4||0
5160295|NCT01256086|12691703|P3|NOT COMPLETED|Treatment Day 4||0
5160296|NCT01256086|12691704|P2|NOT COMPLETED|Treatment Day 4||0
5160297|NCT01256086|12691705|P1|NOT COMPLETED|Treatment Day 4||0
5160298|NCT01256086|12691702|P4|COMPLETED|Treatment Day 4||11
5160299|NCT01256086|12691703|P3|COMPLETED|Treatment Day 4||9
5160300|NCT01256086|12691704|P2|COMPLETED|Treatment Day 4||10
5160301|NCT01256086|12691705|P1|COMPLETED|Treatment Day 4||11
5160302|NCT01256086|12691702|P4|STARTED|Treatment Day 4||11
5160303|NCT01256086|12691703|P3|STARTED|Treatment Day 4||9
5160304|NCT01256086|12691704|P2|STARTED|Treatment Day 4||10
5160305|NCT01256086|12691705|P1|STARTED|Treatment Day 4||11
5160306|NCT01256086|12691702|P4|NOT COMPLETED|Treatment Day 3||0
5160307|NCT01256086|12691703|P3|NOT COMPLETED|Treatment Day 3||0
5160308|NCT01256086|12691704|P2|NOT COMPLETED|Treatment Day 3||0
5160309|NCT01256086|12691705|P1|NOT COMPLETED|Treatment Day 3||0
5160310|NCT01256086|12691702|P4|COMPLETED|Treatment Day 3||11
5160311|NCT01256086|12691703|P3|COMPLETED|Treatment Day 3||9
5160312|NCT01256086|12691704|P2|COMPLETED|Treatment Day 3||10
5160313|NCT01256086|12691705|P1|COMPLETED|Treatment Day 3||11
5160314|NCT01256086|12691702|P4|STARTED|Treatment Day 3||11
5160315|NCT01256086|12691703|P3|STARTED|Treatment Day 3||9
5160316|NCT01256086|12691704|P2|STARTED|Treatment Day 3||10
5160317|NCT01256086|12691705|P1|STARTED|Treatment Day 3||11
5160318|NCT01256086|12691702|P4|NOT COMPLETED|Treatment Day 2||0
5160319|NCT01256086|12691703|P3|NOT COMPLETED|Treatment Day 2||0
5160320|NCT01256086|12691704|P2|NOT COMPLETED|Treatment Day 2||0
5160321|NCT01256086|12691705|P1|NOT COMPLETED|Treatment Day 2||0
5160322|NCT01256086|12691702|P4|COMPLETED|Treatment Day 2||11
5160323|NCT01256086|12691703|P3|COMPLETED|Treatment Day 2||9
5160324|NCT01256086|12691704|P2|COMPLETED|Treatment Day 2||10
5160325|NCT01256086|12691705|P1|COMPLETED|Treatment Day 2||11
5160326|NCT01256086|12691702|P4|STARTED|Treatment Day 2||11
5160327|NCT01256086|12691703|P3|STARTED|Treatment Day 2||9
5160328|NCT01256086|12691704|P2|STARTED|Treatment Day 2||10
5160329|NCT01256086|12691705|P1|STARTED|Treatment Day 2||11
5160330|NCT01256086|12691702|P4|NOT COMPLETED|Treatment Day 1||0
5160331|NCT01256086|12691703|P3|NOT COMPLETED|Treatment Day 1||0
5160332|NCT01256086|12691704|P2|NOT COMPLETED|Treatment Day 1||0
5160333|NCT01256086|12691705|P1|NOT COMPLETED|Treatment Day 1||0
5160334|NCT01256086|12691702|P4|COMPLETED|Treatment Day 1||11
5160335|NCT01256086|12691703|P3|COMPLETED|Treatment Day 1||11
5160336|NCT01256086|12691704|P2|COMPLETED|Treatment Day 1||11
5160337|NCT01256086|12691705|P1|COMPLETED|Treatment Day 1||11
5160338|NCT01256086|12691702|P4|STARTED|Treatment Day 1||11
5160339|NCT01256086|12691703|P3|STARTED|Treatment Day 1||11
5160340|NCT01256086|12691704|P2|STARTED|Treatment Day 1||11
5160341|NCT01256086|12691705|P1|STARTED|Treatment Day 1||11
5160342|NCT01256060|12691715|P4|NOT COMPLETED|Overall Study||0
5160343|NCT01256060|12691716|P3|NOT COMPLETED|Overall Study||0
5160344|NCT01256060|12691717|P2|NOT COMPLETED|Overall Study||1
5160345|NCT01256060|12691718|P1|NOT COMPLETED|Overall Study||0
5160346|NCT01256060|12691715|P4|COMPLETED|Overall Study||6
5160347|NCT01256060|12691716|P3|COMPLETED|Overall Study||3
5160348|NCT01256060|12691717|P2|COMPLETED|Overall Study||2
5160349|NCT01256060|12691718|P1|COMPLETED|Overall Study||3
5160350|NCT01256060|12691715|P4|STARTED|Overall Study||6
5160351|NCT01256060|12691716|P3|STARTED|Overall Study||3
5160352|NCT01256060|12691717|P2|STARTED|Overall Study||3
5160353|NCT01256060|12691718|P1|STARTED|Overall Study||3
5160354|NCT01256034|12691727|P2|NOT COMPLETED|Overall Study||25
5160355|NCT01256034|12691728|P1|NOT COMPLETED|Overall Study||25
5160356|NCT01256034|12691727|P2|COMPLETED|Overall Study||0
5160357|NCT01256034|12691728|P1|COMPLETED|Overall Study||0
5160358|NCT01256034|12691727|P2|STARTED|Overall Study||25
5160359|NCT01256034|12691728|P1|STARTED|Overall Study||25
5160360|NCT01256008|12691737|P3|NOT COMPLETED|Overall Study||21
5160361|NCT01256008|12691738|P2|NOT COMPLETED|Overall Study||7
5160362|NCT01256008|12691739|P1|NOT COMPLETED|Overall Study||8
5160363|NCT01256008|12691737|P3|COMPLETED|Overall Study||175
5160364|NCT01256008|12691738|P2|COMPLETED|Overall Study||91
5160365|NCT01256008|12691739|P1|COMPLETED|Overall Study||90
5160366|NCT01256008|12691737|P3|STARTED|Overall Study||196
5160367|NCT01256008|12691738|P2|STARTED|Overall Study||98
5160368|NCT01256008|12691739|P1|STARTED|Overall Study||98
5160369|NCT01255904|12691761|P2|NOT COMPLETED|Overall Study||4
5160370|NCT01255904|12691762|P1|NOT COMPLETED|Overall Study||1
5160371|NCT01255904|12691761|P2|COMPLETED|Overall Study||41
5160372|NCT01255904|12691762|P1|COMPLETED|Overall Study||44
5160373|NCT01255904|12691761|P2|STARTED|Overall Study||45
5160374|NCT01255904|12691762|P1|STARTED|Overall Study||45
5160375|NCT01255787|12691772|P4|NOT COMPLETED|Overall Study||22
5160376|NCT01255787|12691773|P3|NOT COMPLETED|Overall Study||18
5160377|NCT01255787|12691774|P2|NOT COMPLETED|Overall Study||17
5160378|NCT01255787|12691775|P1|NOT COMPLETED|Overall Study||16
5160379|NCT01255787|12691772|P4|COMPLETED|Overall Study||132
5160380|NCT01255787|12691773|P3|COMPLETED|Overall Study||132
5160381|NCT01255787|12691774|P2|COMPLETED|Overall Study||127
5160382|NCT01255787|12691775|P1|COMPLETED|Overall Study||136
5160383|NCT01255787|12691772|P4|Treated|Overall Study||150
5160384|NCT01255787|12691773|P3|Treated|Overall Study||148
5160385|NCT01255787|12691774|P2|Treated|Overall Study||144
5160386|NCT01255787|12691775|P1|Treated|Overall Study||152
5160387|NCT01255787|12691772|P4|STARTED|Overall Study||154
5160388|NCT01255787|12691773|P3|STARTED|Overall Study||150
5160389|NCT01255787|12691774|P2|STARTED|Overall Study||144
5160390|NCT01255787|12691775|P1|STARTED|Overall Study||152
5160391|NCT01255761|12691803|P2|NOT COMPLETED|Overall Study||175
5160392|NCT01255761|12691804|P1|NOT COMPLETED|Overall Study||182
5160393|NCT01255761|12691803|P2|COMPLETED|Overall Study||192
5160394|NCT01255761|12691804|P1|COMPLETED|Overall Study||187
5160395|NCT01255761|12691803|P2|STARTED|Overall Study||367
5160396|NCT01255761|12691804|P1|STARTED|Overall Study||369
5160397|NCT01255722|12691889|P3|NOT COMPLETED|Overall Study||1
5160398|NCT01255722|12691890|P2|NOT COMPLETED|Overall Study||1
5160399|NCT01255722|12691891|P1|NOT COMPLETED|Overall Study||3
5160400|NCT01255722|12691889|P3|COMPLETED|Overall Study||152
5160401|NCT01255722|12691890|P2|COMPLETED|Overall Study||159
5160402|NCT01255722|12691891|P1|COMPLETED|Overall Study||152
5160403|NCT01255722|12691889|P3|STARTED|Overall Study||153
5160404|NCT01255722|12691890|P2|STARTED|Overall Study||160
5160405|NCT01255722|12691891|P1|STARTED|Overall Study||155
5160406|NCT01255631|12691916|P2|NOT COMPLETED|Overall Study||6
5160407|NCT01255631|12691917|P1|NOT COMPLETED|Overall Study||9
5160408|NCT01255631|12691916|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
5160409|NCT01255631|12691917|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
5160410|NCT01255631|12691916|P2|STARTED|Overall Study||9
5160411|NCT01255631|12691917|P1|STARTED|Overall Study||13
5160412|NCT01255592|12691935|P2|NOT COMPLETED|Overall Study||1
5160413|NCT01255592|12691936|P1|NOT COMPLETED|Overall Study||6
5160414|NCT01255592|12691935|P2|COMPLETED|Overall Study||25
5160415|NCT01255592|12691936|P1|COMPLETED|Overall Study||20
5160416|NCT01255592|12691935|P2|STARTED|Overall Study||26
5160417|NCT01255592|12691936|P1|STARTED|Overall Study||26
5160418|NCT01255449|12691992|P1|NOT COMPLETED|Overall Study||0
5160419|NCT01255449|12691992|P1|COMPLETED|Overall Study||26
5160420|NCT01255449|12691992|P1|STARTED|Overall Study||26
5160421|NCT01255436|12691999|P2|NOT COMPLETED|Overall Study||194
5160422|NCT01255436|12692000|P1|NOT COMPLETED|Overall Study||182
5160423|NCT01255436|12691999|P2|COMPLETED|Overall Study||135
5160424|NCT01255436|12692000|P1|COMPLETED|Overall Study||151
5160425|NCT01255436|12691999|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
5160426|NCT01255436|12692000|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
5160427|NCT01255423|12692014|P2|NOT COMPLETED|Overall Study||3
5160428|NCT01255423|12692015|P1|NOT COMPLETED|Overall Study||3
5160429|NCT01255423|12692014|P2|COMPLETED|Overall Study||99
5160430|NCT01255423|12692015|P1|COMPLETED|Overall Study||101
5160431|NCT01255423|12692014|P2|STARTED|Overall Study||102
5160432|NCT01255423|12692015|P1|STARTED|Overall Study||104
5160433|NCT01255306|12692031|P2|NOT COMPLETED|Overall Study||1
5160434|NCT01255306|12692032|P1|NOT COMPLETED|Overall Study||1
5160435|NCT01255306|12692031|P2|COMPLETED|Overall Study||32
5160436|NCT01255306|12692032|P1|COMPLETED|Overall Study||25
5160437|NCT01255306|12692031|P2|STARTED|Overall Study||33
5160438|NCT01255306|12692032|P1|STARTED|Overall Study||26
5160439|NCT01255163|12692043|P2|NOT COMPLETED|Overall Study||5
5160440|NCT01255163|12692044|P1|NOT COMPLETED|Overall Study||4
5160441|NCT01255163|12692043|P2|COMPLETED|Overall Study||9
5160442|NCT01255163|12692044|P1|COMPLETED|Overall Study||9
5160443|NCT01255163|12692043|P2|STARTED|Overall Study||14
5160444|NCT01255163|12692044|P1|STARTED|Overall Study||13
5160445|NCT01255137|12692066|P1|NOT COMPLETED|Overall Study||0
5160446|NCT01255137|12692066|P1|COMPLETED|Overall Study||13
5160447|NCT01255137|12692066|P1|STARTED|Overall Study||13
5160448|NCT01254890|12692073|P2|NOT COMPLETED|Overall Study||10
5160449|NCT01254890|12692074|P1|NOT COMPLETED|Overall Study||1
5160450|NCT01254890|12692073|P2|COMPLETED|Overall Study||47
5160451|NCT01254890|12692074|P1|COMPLETED|Overall Study||2
5160452|NCT01254890|12692073|P2|STARTED|Overall Study||57
5160453|NCT01254890|12692074|P1|STARTED|Overall Study||3
5160454|NCT01254877|12692083|P3|NOT COMPLETED|Overall Study||5
5160455|NCT01254877|12692084|P2|NOT COMPLETED|Overall Study||11
5160456|NCT01254877|12692085|P1|NOT COMPLETED|Overall Study||10
5160457|NCT01254877|12692083|P3|COMPLETED|Overall Study||64
5160458|NCT01254877|12692084|P2|COMPLETED|Overall Study||58
5160459|NCT01254877|12692085|P1|COMPLETED|Overall Study||57
5160460|NCT01254877|12692083|P3|STARTED|Overall Study||69
5160461|NCT01254877|12692084|P2|STARTED|Overall Study||69
5160462|NCT01254877|12692085|P1|STARTED|Overall Study||67
5160463|NCT01254851|12692110|P2|NOT COMPLETED|Overall Study||9
5160464|NCT01254851|12692111|P1|NOT COMPLETED|Overall Study||8
5160465|NCT01254851|12692110|P2|COMPLETED|Overall Study||68
5160466|NCT01254851|12692111|P1|COMPLETED|Overall Study||61
5160467|NCT01254851|12692110|P2|STARTED|Overall Study||77
5160468|NCT01254851|12692111|P1|STARTED|Overall Study||69
5160469|NCT01254760|12692117|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
5160470|NCT01254760|12692118|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
5160471|NCT01254760|12692117|P2|COMPLETED|Second Period, 5 Days of Wear||38
5160472|NCT01254760|12692118|P1|COMPLETED|Second Period, 5 Days of Wear||34
5160473|NCT01254760|12692117|P2|STARTED|Second Period, 5 Days of Wear||38
5160474|NCT01254760|12692118|P1|STARTED|Second Period, 5 Days of Wear||34
5160475|NCT01254760|12692117|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
5160476|NCT01254760|12692118|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
5160477|NCT01254760|12692117|P2|COMPLETED|First Period, 5 Days of Wear||38
5160478|NCT01254760|12692118|P1|COMPLETED|First Period, 5 Days of Wear||34
5160479|NCT01254760|12692117|P2|STARTED|First Period, 5 Days of Wear||38
5160480|NCT01254760|12692118|P1|STARTED|First Period, 5 Days of Wear||34
5160481|NCT01254747|12692136|P4|NOT COMPLETED|Overall Study||2
5160482|NCT01254747|12692137|P3|NOT COMPLETED|Overall Study||4
5160483|NCT01254747|12692138|P2|NOT COMPLETED|Overall Study||6
5160484|NCT01254747|12692139|P1|NOT COMPLETED|Overall Study||0
5160485|NCT01254747|12692136|P4|COMPLETED|Overall Study||28
5160486|NCT01254747|12692137|P3|COMPLETED|Overall Study||26
5160487|NCT01254747|12692138|P2|COMPLETED|Overall Study||23
5160488|NCT01254747|12692139|P1|COMPLETED|Overall Study||40
5160489|NCT01254747|12692136|P4|STARTED|Overall Study||30
5160490|NCT01254747|12692137|P3|STARTED|Overall Study||30
5160491|NCT01254747|12692138|P2|STARTED|Overall Study||29
5160492|NCT01254747|12692139|P1|STARTED|Overall Study||40
5160493|NCT01254721|12692179|P2|NOT COMPLETED|Overall Study||22
5160494|NCT01254721|12692180|P1|NOT COMPLETED|Overall Study||15
5160495|NCT01254721|12692179|P2|COMPLETED|Overall Study||42
5160496|NCT01254721|12692180|P1|COMPLETED|Overall Study||52
5160497|NCT01254721|12692179|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
5160498|NCT01254721|12692180|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
5160499|NCT01254669|12692190|P2|NOT COMPLETED|Overall Study||4
5160500|NCT01254669|12692191|P1|NOT COMPLETED|Overall Study||3
5160501|NCT01254669|12692190|P2|COMPLETED|Overall Study||96
5160502|NCT01254669|12692191|P1|COMPLETED|Overall Study||97
5160503|NCT01254669|12692190|P2|STARTED|Overall Study||100
5160504|NCT01254669|12692191|P1|STARTED|Overall Study||100
5160505|NCT01254656|12692202|P3|NOT COMPLETED|Overall Study||18
5160506|NCT01254656|12692203|P2|NOT COMPLETED|Overall Study||43
5160507|NCT01254656|12692204|P1|NOT COMPLETED|Overall Study||47
5160508|NCT01254656|12692202|P3|COMPLETED|Overall Study||0
5160509|NCT01254656|12692203|P2|COMPLETED|Overall Study||0
5160510|NCT01254656|12692204|P1|COMPLETED|Overall Study||0
5160511|NCT01254656|12692202|P3|Treated|Overall Study||18
5160512|NCT01254656|12692203|P2|Treated|Overall Study||43
5160513|NCT01254656|12692204|P1|Treated|Overall Study||47
5160514|NCT01254656|12692202|P3|STARTED|Overall Study||18
5160515|NCT01254656|12692203|P2|STARTED|Overall Study||43
5160516|NCT01254656|12692204|P1|STARTED|Overall Study||47
5160517|NCT01254643|12692230|P1|NOT COMPLETED|Overall Study||1
5160518|NCT01254643|12692230|P1|COMPLETED|Overall Study||99
5160519|NCT01254643|12692230|P1|Vaccination 3|Overall Study||99
5160520|NCT01254643|12692230|P1|Vaccination 2|Overall Study||99
5160521|NCT01254643|12692230|P1|Vaccination 1|Overall Study||100
5160522|NCT01254643|12692230|P1|STARTED|Overall Study||100
5160523|NCT01254630|12692242|P4|NOT COMPLETED|Overall Study||1285
5160524|NCT01254630|12692243|P3|NOT COMPLETED|Overall Study||812
5160525|NCT01254630|12692244|P2|NOT COMPLETED|Overall Study||1288
5160526|NCT01254630|12692245|P1|NOT COMPLETED|Overall Study||802
5160527|NCT01254630|12692242|P4|COMPLETED|Overall Study||0
5160528|NCT01254630|12692243|P3|COMPLETED|Overall Study||552
5160529|NCT01254630|12692244|P2|COMPLETED|Overall Study||0
5160530|NCT01254630|12692245|P1|COMPLETED|Overall Study||546
5160531|NCT01254630|12692242|P4|Received Vaccination 4|Overall Study||1160
5160532|NCT01254630|12692243|P3|Received Vaccination 4|Overall Study||1212
5160533|NCT01254630|12692244|P2|Received Vaccination 4|Overall Study||1145
5160534|NCT01254630|12692245|P1|Received Vaccination 4|Overall Study||1155
5160535|NCT01254630|12692242|P4|Received Vaccination 3|Overall Study||1194
5160536|NCT01254630|12692243|P3|Received Vaccination 3|Overall Study||1247
5160537|NCT01254630|12692244|P2|Received Vaccination 3|Overall Study||1178
5160538|NCT01254630|12692245|P1|Received Vaccination 3|Overall Study||1198
5160539|NCT01254630|12692242|P4|Received Vaccination 2|Overall Study||1226
5160540|NCT01254630|12692243|P3|Received Vaccination 2|Overall Study||1286
5160541|NCT01254630|12692244|P2|Received Vaccination 2|Overall Study||1217
5160542|NCT01254630|12692245|P1|Received Vaccination 2|Overall Study||1255
5160543|NCT01254630|12692242|P4|Received Vaccination 1|Overall Study||1275
5160544|NCT01254630|12692243|P3|Received Vaccination 1|Overall Study||1350
5160545|NCT01254630|12692244|P2|Received Vaccination 1|Overall Study||1277
5160546|NCT01254630|12692245|P1|Received Vaccination 1|Overall Study||1328
5160547|NCT01254630|12692242|P4|STARTED|Overall Study||1285
5160548|NCT01254630|12692243|P3|STARTED|Overall Study||1364
5160549|NCT01254630|12692244|P2|STARTED|Overall Study||1288
5160550|NCT01254630|12692245|P1|STARTED|Overall Study||1348
5160551|NCT01254604|12692265|P2|NOT COMPLETED|Overall Study||9
5160552|NCT01254604|12692266|P1|NOT COMPLETED|Overall Study||8
5160553|NCT01254604|12692265|P2|COMPLETED|Overall Study||86
5160554|NCT01254604|12692266|P1|COMPLETED|Overall Study||87
5160555|NCT01254604|12692265|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
5160556|NCT01254604|12692266|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
5160557|NCT01254604|12692265|P2|STARTED|Overall Study||95
5160558|NCT01254604|12692266|P1|STARTED|Overall Study||95
5160559|NCT01254565|12692284|P6|NOT COMPLETED|Overall Study||4
5160560|NCT01254565|12692285|P5|NOT COMPLETED|Overall Study||4
5160561|NCT01254565|12692286|P4|NOT COMPLETED|Overall Study||1
5160562|NCT01254565|12692287|P3|NOT COMPLETED|Overall Study||0
5160563|NCT01254565|12692288|P2|NOT COMPLETED|Overall Study||1
5160564|NCT01254565|12692289|P1|NOT COMPLETED|Overall Study||1
5160565|NCT01254565|12692284|P6|COMPLETED|Overall Study||13
5160566|NCT01254565|12692285|P5|COMPLETED|Overall Study||12
5160567|NCT01254565|12692286|P4|COMPLETED|Overall Study||20
5160568|NCT01254565|12692287|P3|COMPLETED|Overall Study||21
5160569|NCT01254565|12692288|P2|COMPLETED|Overall Study||6
5160570|NCT01254565|12692289|P1|COMPLETED|Overall Study||4
5160571|NCT01254565|12692284|P6|Received Treatment|Overall Study||13
5160572|NCT01254565|12692285|P5|Received Treatment|Overall Study||13
5160573|NCT01254565|12692286|P4|Received Treatment|Overall Study||21
5160574|NCT01254565|12692287|P3|Received Treatment|Overall Study||21
5160575|NCT01254565|12692288|P2|Received Treatment|Overall Study||6
5160576|NCT01254565|12692289|P1|Received Treatment|Overall Study||4
5160577|NCT01254565|12692284|P6|STARTED|Overall Study||17
5160578|NCT01254565|12692285|P5|STARTED|Overall Study||16
5160579|NCT01254565|12692286|P4|STARTED|Overall Study||21
5160580|NCT01254565|12692287|P3|STARTED|Overall Study||21
5160581|NCT01254565|12692288|P2|STARTED|Overall Study||7
5160582|NCT01254565|12692289|P1|STARTED|Overall Study||5
5160583|NCT01254552|12692339|P1|NOT COMPLETED|CCTA With Xenetix 350||6
5160584|NCT01254552|12692339|P1|COMPLETED|CCTA With Xenetix 350||322
5160585|NCT01254552|12692339|P1|STARTED|CCTA With Xenetix 350||328
5160586|NCT01254552|12692339|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
5160587|NCT01254552|12692339|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
5160588|NCT01254552|12692339|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
5160589|NCT01254552|12692339|P1|NOT COMPLETED|Screening Visit||3
5160590|NCT01254552|12692339|P1|COMPLETED|Screening Visit||348
5160591|NCT01254552|12692339|P1|STARTED|Screening Visit||351
5160592|NCT01254422|12692349|P2|NOT COMPLETED|Overall Study||1
5160593|NCT01254422|12692350|P1|NOT COMPLETED|Overall Study||3
5160594|NCT01254422|12692349|P2|COMPLETED|Overall Study||50
5160595|NCT01254422|12692350|P1|COMPLETED|Overall Study||196
5160596|NCT01254422|12692349|P2|STARTED|Overall Study||51
5160597|NCT01254422|12692350|P1|STARTED|Overall Study||199
5160598|NCT01254409|12692378|P4|NOT COMPLETED|Overall Study||0
5160599|NCT01254409|12692379|P3|NOT COMPLETED|Overall Study||0
5160600|NCT01254409|12692380|P2|NOT COMPLETED|Overall Study||1
5160601|NCT01254409|12692381|P1|NOT COMPLETED|Overall Study||0
5160602|NCT01254409|12692378|P4|COMPLETED|Overall Study||4
5160603|NCT01254409|12692379|P3|COMPLETED|Overall Study||5
5160604|NCT01254409|12692380|P2|COMPLETED|Overall Study||5
5160605|NCT01254409|12692381|P1|COMPLETED|Overall Study||6
5160606|NCT01254409|12692378|P4|STARTED|Overall Study||4
5160607|NCT01254409|12692379|P3|STARTED|Overall Study||5
5160608|NCT01254409|12692380|P2|STARTED|Overall Study||6
5160609|NCT01254409|12692381|P1|STARTED|Overall Study||6
5160610|NCT01254396|12692433|P2|NOT COMPLETED|Second Intervention Period||0
5160611|NCT01254396|12692434|P1|NOT COMPLETED|Second Intervention Period||0
5160612|NCT01254396|12692433|P2|COMPLETED|Second Intervention Period||6
5160613|NCT01254396|12692434|P1|COMPLETED|Second Intervention Period||6
5160614|NCT01254396|12692433|P2|STARTED|Second Intervention Period||6
5160615|NCT01254396|12692434|P1|STARTED|Second Intervention Period||6
5160616|NCT01254396|12692433|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
5160617|NCT01254396|12692434|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
5160618|NCT01254396|12692433|P2|COMPLETED|Washout Period (at Least 1 Day)||6
5160619|NCT01254396|12692434|P1|COMPLETED|Washout Period (at Least 1 Day)||6
5160620|NCT01254396|12692433|P2|STARTED|Washout Period (at Least 1 Day)||6
5160621|NCT01254396|12692434|P1|STARTED|Washout Period (at Least 1 Day)||6
5160622|NCT01254396|12692433|P2|NOT COMPLETED|First Intervention Period||0
5160623|NCT01254396|12692434|P1|NOT COMPLETED|First Intervention Period||0
5160624|NCT01254396|12692433|P2|COMPLETED|First Intervention Period||6
5160625|NCT01254396|12692434|P1|COMPLETED|First Intervention Period||6
5160626|NCT01254396|12692433|P2|STARTED|First Intervention Period||6
5160627|NCT01254396|12692434|P1|STARTED|First Intervention Period||6
5160628|NCT01254344|12692450|P2|NOT COMPLETED|Overall Study||19
5160629|NCT01254344|12692451|P1|NOT COMPLETED|Overall Study||13
5160630|NCT01254344|12692450|P2|COMPLETED|Overall Study||281
5160631|NCT01254344|12692451|P1|COMPLETED|Overall Study||286
5160632|NCT01254344|12692450|P2|Treated|Overall Study||297
5160633|NCT01254344|12692451|P1|Treated|Overall Study||290
5160634|NCT01254344|12692450|P2|STARTED|Overall Study||300
5160635|NCT01254344|12692451|P1|STARTED|Overall Study||299
5160636|NCT01254331|12692459|P1|NOT COMPLETED|Extension Phase||4
5160637|NCT01254331|12692459|P1|COMPLETED|Extension Phase||41
5160638|NCT01254331|12692459|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
5160639|NCT01254331|12692459|P1|NOT COMPLETED|Initial Phase||5
5160640|NCT01254331|12692459|P1|COMPLETED|Initial Phase||46
5160641|NCT01254331|12692459|P1|STARTED|Initial Phase||51
5160642|NCT01254318|12692477|P1|NOT COMPLETED|Overall Study||52
5160643|NCT01254318|12692477|P1|COMPLETED|Overall Study|Alive at end of study|78
5160644|NCT01254318|12692477|P1|STARTED|Overall Study|Alive at start of study|130
5160645|NCT01254305|12692486|P3|NOT COMPLETED|Overall Study||17
5160646|NCT01254305|12692487|P2|NOT COMPLETED|Overall Study||18
5160647|NCT01254305|12692488|P1|NOT COMPLETED|Overall Study||22
5160648|NCT01254305|12692486|P3|COMPLETED|Overall Study||62
5160649|NCT01254305|12692487|P2|COMPLETED|Overall Study||72
5160650|NCT01254305|12692488|P1|COMPLETED|Overall Study||71
5160651|NCT01254305|12692486|P3|Safety Population|Overall Study||77
5160652|NCT01254305|12692487|P2|Safety Population|Overall Study||85
5160653|NCT01254305|12692488|P1|Safety Population|Overall Study||89
5160654|NCT01254305|12692486|P3|STARTED|Overall Study||79
5160655|NCT01254305|12692487|P2|STARTED|Overall Study||90
5160656|NCT01254305|12692488|P1|STARTED|Overall Study||93
5160657|NCT01254292|12692504|P2|NOT COMPLETED|LCS12 Extension Phase||0
5160658|NCT01254292|12692505|P1|NOT COMPLETED|LCS12 Extension Phase||37
5160659|NCT01254292|12692504|P2|COMPLETED|LCS12 Extension Phase||0
5160660|NCT01254292|12692505|P1|COMPLETED|LCS12 Extension Phase||163
5160661|NCT01254292|12692504|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
5160662|NCT01254292|12692505|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
5160663|NCT01254292|12692504|P2|NOT COMPLETED|Comparative Phase||81
5160664|NCT01254292|12692505|P1|NOT COMPLETED|Comparative Phase||55
5160665|NCT01254292|12692504|P2|COMPLETED|Comparative Phase||204
5160666|NCT01254292|12692505|P1|COMPLETED|Comparative Phase||227
5160667|NCT01254292|12692504|P2|Participants Received Treatment|Comparative Phase|safety population|281
5160668|NCT01254292|12692505|P1|Participants Received Treatment|Comparative Phase|safety population|279
5160669|NCT01254292|12692504|P2|STARTED|Comparative Phase||285
5160670|NCT01254292|12692505|P1|STARTED|Comparative Phase||282
5160671|NCT01254214|12692567|P2|NOT COMPLETED|Overall Study||1
5160672|NCT01254214|12692568|P1|NOT COMPLETED|Overall Study||3
5160673|NCT01254214|12692567|P2|COMPLETED|Overall Study||27
5160674|NCT01254214|12692568|P1|COMPLETED|Overall Study||24
5160675|NCT01254214|12692567|P2|STARTED|Overall Study||28
5160676|NCT01254214|12692568|P1|STARTED|Overall Study||27
5160677|NCT01254188|12692582|P1|NOT COMPLETED|Overall Study||93
5160678|NCT01254188|12692582|P1|COMPLETED|Overall Study||328
5160679|NCT01254188|12692582|P1|STARTED|Overall Study||421
5160680|NCT01254045|12692593|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160681|NCT01254045|12692594|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160682|NCT01254045|12692595|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160683|NCT01254045|12692596|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160684|NCT01254045|12692597|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160685|NCT01254045|12692598|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
5160686|NCT01254045|12692593|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
5160687|NCT01254045|12692594|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
5160688|NCT01254045|12692595|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
5160689|NCT01254045|12692596|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
5160690|NCT01254045|12692597|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
5160691|NCT01254045|12692598|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
5160692|NCT01254045|12692593|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
5160693|NCT01254045|12692594|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
5160694|NCT01254045|12692595|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
5160695|NCT01254045|12692596|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
5160696|NCT01254045|12692597|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
5160697|NCT01254045|12692598|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
5160698|NCT01254045|12692593|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160699|NCT01254045|12692594|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160700|NCT01254045|12692595|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160701|NCT01254045|12692596|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160702|NCT01254045|12692597|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160703|NCT01254045|12692598|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
5160704|NCT01254045|12692593|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
5160705|NCT01254045|12692594|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
5160706|NCT01254045|12692595|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
5160707|NCT01254045|12692596|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
5160708|NCT01254045|12692597|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
5160709|NCT01254045|12692598|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
5160710|NCT01254045|12692593|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
5160711|NCT01254045|12692594|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
5160712|NCT01254045|12692595|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
5160713|NCT01254045|12692596|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
5160714|NCT01254045|12692597|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
5160715|NCT01254045|12692598|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
5160716|NCT01254045|12692593|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
5160717|NCT01254045|12692594|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
5160718|NCT01254045|12692595|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
5160719|NCT01254045|12692596|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
5160720|NCT01254045|12692597|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
5160721|NCT01254045|12692598|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
5160722|NCT01254045|12692593|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
5160723|NCT01254045|12692594|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
5160724|NCT01254045|12692595|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
5160725|NCT01254045|12692596|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
5160726|NCT01254045|12692597|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
5160727|NCT01254045|12692598|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
5160728|NCT01254045|12692593|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
5160729|NCT01254045|12692594|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
5160730|NCT01254045|12692595|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
5160731|NCT01254045|12692596|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
5160732|NCT01254045|12692597|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
5160733|NCT01254045|12692598|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
5160734|NCT01254019|12692611|P2|NOT COMPLETED|Overall Study||4
5160735|NCT01254019|12692612|P1|NOT COMPLETED|Overall Study||1
5160736|NCT01254019|12692611|P2|COMPLETED|Overall Study||121
5160737|NCT01254019|12692612|P1|COMPLETED|Overall Study||60
5160738|NCT01254019|12692611|P2|STARTED|Overall Study||125
5160739|NCT01254019|12692612|P1|STARTED|Overall Study||61
5160740|NCT01253980|12692665|P2|NOT COMPLETED|Overall Study||0
5160741|NCT01253980|12692666|P1|NOT COMPLETED|Overall Study||0
5160742|NCT01253980|12692665|P2|COMPLETED|Overall Study||39
5160743|NCT01253980|12692666|P1|COMPLETED|Overall Study||35
5160744|NCT01253980|12692665|P2|STARTED|Overall Study||39
5160745|NCT01253980|12692666|P1|STARTED|Overall Study||35
5160746|NCT01253902|12692675|P3|NOT COMPLETED|Overall Study||4
5160747|NCT01253902|12692676|P2|NOT COMPLETED|Overall Study||2
5160748|NCT01253902|12692677|P1|NOT COMPLETED|Overall Study||5
5160749|NCT01253902|12692675|P3|COMPLETED|Overall Study||51
5160750|NCT01253902|12692676|P2|COMPLETED|Overall Study||51
5160751|NCT01253902|12692677|P1|COMPLETED|Overall Study||51
5160752|NCT01253902|12692675|P3|STARTED|Overall Study||55
5160753|NCT01253902|12692676|P2|STARTED|Overall Study||53
5160754|NCT01253902|12692677|P1|STARTED|Overall Study||56
5160755|NCT01253824|12692693|P2|NOT COMPLETED|Overall Study||0
5160756|NCT01253824|12692694|P1|NOT COMPLETED|Overall Study||0
5160757|NCT01253824|12692693|P2|COMPLETED|Overall Study||7
5160758|NCT01253824|12692694|P1|COMPLETED|Overall Study||7
5160759|NCT01253824|12692693|P2|STARTED|Overall Study||7
5160760|NCT01253824|12692694|P1|STARTED|Overall Study||7
5160761|NCT01253811|12692706|P1|NOT COMPLETED|Overall Study||1
5160762|NCT01253811|12692706|P1|COMPLETED|Overall Study||5
5160763|NCT01253811|12692706|P1|Exposed|Overall Study||6
5160764|NCT01253811|12692706|P1|STARTED|Overall Study||6
5160765|NCT01253642|12692725|P1|NOT COMPLETED|Overall Study||5
5160766|NCT01253642|12692725|P1|COMPLETED|Overall Study||6
5160767|NCT01253642|12692725|P1|STARTED|Overall Study||11
5160768|NCT01253577|12692737|P1|NOT COMPLETED|Overall Study||3
5160769|NCT01253577|12692737|P1|COMPLETED|Overall Study||102
5160770|NCT01253577|12692737|P1|STARTED|Overall Study||105
5160771|NCT01253564|12692745|P1|NOT COMPLETED|Overall Study||24
5160772|NCT01253564|12692745|P1|COMPLETED|Overall Study||0
5160773|NCT01253564|12692745|P1|STARTED|Overall Study||24
5160774|NCT01253525|12692762|P1|NOT COMPLETED|Overall Study||0
5160775|NCT01253525|12692762|P1|COMPLETED|Overall Study||6
5160776|NCT01253525|12692762|P1|Received Any Quantity of Study Drug|Overall Study||6
5160777|NCT01253525|12692762|P1|STARTED|Overall Study||6
5160778|NCT01253460|12692789|P1|NOT COMPLETED|Overall Study||0
5160779|NCT01253460|12692789|P1|COMPLETED|Overall Study||18
5160780|NCT01253460|12692789|P1|STARTED|Overall Study||18
5160781|NCT01253447|12692794|P1|NOT COMPLETED|Overall Study||2
5160782|NCT01253447|12692794|P1|COMPLETED|Overall Study||17
5160783|NCT01253447|12692794|P1|STARTED|Overall Study||19
5160784|NCT01253421|12692804|P5|NOT COMPLETED|Drug+Scanning Visit||1
5160785|NCT01253421|12692805|P4|NOT COMPLETED|Drug+Scanning Visit||0
5160786|NCT01253421|12692806|P3|NOT COMPLETED|Drug+Scanning Visit||0
5160787|NCT01253421|12692807|P2|NOT COMPLETED|Drug+Scanning Visit||0
5160788|NCT01253421|12692808|P1|NOT COMPLETED|Drug+Scanning Visit||0
5160789|NCT01253421|12692804|P5|COMPLETED|Drug+Scanning Visit||14
5160790|NCT01253421|12692805|P4|COMPLETED|Drug+Scanning Visit||16
5160791|NCT01253421|12692806|P3|COMPLETED|Drug+Scanning Visit||14
5160792|NCT01253421|12692807|P2|COMPLETED|Drug+Scanning Visit||15
5160793|NCT01253421|12692808|P1|COMPLETED|Drug+Scanning Visit||0
5160794|NCT01253421|12692804|P5|Received Drug Challenge|Drug+Scanning Visit||15
5160795|NCT01253421|12692805|P4|Received Drug Challenge|Drug+Scanning Visit||16
5160796|NCT01253421|12692806|P3|Received Drug Challenge|Drug+Scanning Visit||14
5160797|NCT01253421|12692807|P2|Received Drug Challenge|Drug+Scanning Visit||15
5160798|NCT01253421|12692808|P1|Received Drug Challenge|Drug+Scanning Visit||0
5160799|NCT01253421|12692804|P5|STARTED|Drug+Scanning Visit||15
5160800|NCT01253421|12692805|P4|STARTED|Drug+Scanning Visit||16
5160801|NCT01253421|12692806|P3|STARTED|Drug+Scanning Visit||14
5160802|NCT01253421|12692807|P2|STARTED|Drug+Scanning Visit||15
5160803|NCT01253421|12692808|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
5160804|NCT01253421|12692804|P5|NOT COMPLETED|Assessment and Scheduling||0
5160805|NCT01253421|12692805|P4|NOT COMPLETED|Assessment and Scheduling||0
5160806|NCT01253421|12692806|P3|NOT COMPLETED|Assessment and Scheduling||0
5160807|NCT01253421|12692807|P2|NOT COMPLETED|Assessment and Scheduling||0
5160808|NCT01253421|12692808|P1|NOT COMPLETED|Assessment and Scheduling||99
5160809|NCT01253421|12692804|P5|COMPLETED|Assessment and Scheduling||0
5160810|NCT01253421|12692805|P4|COMPLETED|Assessment and Scheduling||0
5160811|NCT01253421|12692806|P3|COMPLETED|Assessment and Scheduling||0
5160812|NCT01253421|12692807|P2|COMPLETED|Assessment and Scheduling||0
5160813|NCT01253421|12692808|P1|COMPLETED|Assessment and Scheduling||60
5160814|NCT01253421|12692804|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
5160815|NCT01253421|12692805|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
5160816|NCT01253421|12692806|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
5160817|NCT01253421|12692807|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
5160818|NCT01253421|12692808|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
5160819|NCT01253421|12692804|P5|Eligible After Screening Visit|Assessment and Scheduling||0
5160820|NCT01253421|12692805|P4|Eligible After Screening Visit|Assessment and Scheduling||0
5160821|NCT01253421|12692806|P3|Eligible After Screening Visit|Assessment and Scheduling||0
5160822|NCT01253421|12692807|P2|Eligible After Screening Visit|Assessment and Scheduling||0
5160823|NCT01253421|12692808|P1|Eligible After Screening Visit|Assessment and Scheduling||85
5160824|NCT01253421|12692804|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
5160825|NCT01253421|12692805|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
5160826|NCT01253421|12692806|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
5160827|NCT01253421|12692807|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
5160828|NCT01253421|12692808|P1|STARTED|Assessment and Scheduling||159
5160829|NCT01253408|12692857|P3|NOT COMPLETED|Overall Study||0
5160830|NCT01253408|12692858|P2|NOT COMPLETED|Overall Study||1
5160831|NCT01253408|12692859|P1|NOT COMPLETED|Overall Study||0
5160832|NCT01253408|12692857|P3|COMPLETED|Overall Study||13
5160833|NCT01253408|12692858|P2|COMPLETED|Overall Study||12
5160834|NCT01253408|12692859|P1|COMPLETED|Overall Study||10
5160835|NCT01253408|12692857|P3|STARTED|Overall Study||13
5160836|NCT01253408|12692858|P2|STARTED|Overall Study||13
5160837|NCT01253408|12692859|P1|STARTED|Overall Study||10
5160838|NCT01253369|12692882|P1|NOT COMPLETED|Overall Study||33
5160839|NCT01253369|12692882|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
5160840|NCT01253369|12692882|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
5160841|NCT01253369|12692882|P1|STARTED|Overall Study||33
5160842|NCT01253343|12692889|P2|NOT COMPLETED|Overall Study||0
5160843|NCT01253343|12692890|P1|NOT COMPLETED|Overall Study||0
5160844|NCT01253343|12692889|P2|COMPLETED|Overall Study||8
5160845|NCT01253343|12692890|P1|COMPLETED|Overall Study||9
5160846|NCT01253343|12692889|P2|STARTED|Overall Study||8
5160847|NCT01253343|12692890|P1|STARTED|Overall Study||9
5160848|NCT01253317|12692912|P1|NOT COMPLETED|Overall Study||2
5160849|NCT01253317|12692912|P1|COMPLETED|Overall Study||10
5160850|NCT01253317|12692912|P1|STARTED|Overall Study||12
5160851|NCT01253304|12692924|P4|NOT COMPLETED|Overall Study||1
5160852|NCT01253304|12692925|P3|NOT COMPLETED|Overall Study||0
5160853|NCT01253304|12692926|P2|NOT COMPLETED|Overall Study||0
5160854|NCT01253304|12692927|P1|NOT COMPLETED|Overall Study||0
5160855|NCT01253304|12692924|P4|COMPLETED|Overall Study||2
5160856|NCT01253304|12692925|P3|COMPLETED|Overall Study||6
5160857|NCT01253304|12692926|P2|COMPLETED|Overall Study||6
5160858|NCT01253304|12692927|P1|COMPLETED|Overall Study||11
5160859|NCT01253304|12692924|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5160860|NCT01253304|12692925|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5160861|NCT01253304|12692926|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5160862|NCT01253304|12692927|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
5160863|NCT01253304|12692924|P4|STARTED|Overall Study||3
5160864|NCT01253304|12692925|P3|STARTED|Overall Study||6
5160865|NCT01253304|12692926|P2|STARTED|Overall Study||6
5160866|NCT01253304|12692927|P1|STARTED|Overall Study||11
5160867|NCT01253291|12692966|P5|NOT COMPLETED|Overall Study||2
5160868|NCT01253291|12692967|P4|NOT COMPLETED|Overall Study||0
5160869|NCT01253291|12692968|P3|NOT COMPLETED|Overall Study||0
5160870|NCT01253291|12692969|P2|NOT COMPLETED|Overall Study||2
5160871|NCT01253291|12692970|P1|NOT COMPLETED|Overall Study||4
5160872|NCT01253291|12692966|P5|COMPLETED|Overall Study||3
5160873|NCT01253291|12692967|P4|COMPLETED|Overall Study||5
5160874|NCT01253291|12692968|P3|COMPLETED|Overall Study||4
5160875|NCT01253291|12692969|P2|COMPLETED|Overall Study||4
5160876|NCT01253291|12692970|P1|COMPLETED|Overall Study||2
5160877|NCT01253291|12692966|P5|Received Study Drug During BCDL|Overall Study||5
5160878|NCT01253291|12692967|P4|Received Study Drug During BCDL|Overall Study||5
5160879|NCT01253291|12692968|P3|Received Study Drug During BCDL|Overall Study||4
5160880|NCT01253291|12692969|P2|Received Study Drug During BCDL|Overall Study||6
5160881|NCT01253291|12692970|P1|Received Study Drug During BCDL|Overall Study||6
5160882|NCT01253291|12692966|P5|STARTED|Overall Study||5
5160883|NCT01253291|12692967|P4|STARTED|Overall Study||5
5160884|NCT01253291|12692968|P3|STARTED|Overall Study||4
5160885|NCT01253291|12692969|P2|STARTED|Overall Study||6
5160886|NCT01253291|12692970|P1|STARTED|Overall Study||6
5160887|NCT01253265|12692994|P5|NOT COMPLETED|Overall Study||1
5160888|NCT01253265|12692995|P4|NOT COMPLETED|Overall Study||0
5160889|NCT01253265|12692996|P3|NOT COMPLETED|Overall Study||0
5160890|NCT01253265|12692997|P2|NOT COMPLETED|Overall Study||0
5160891|NCT01253265|12692998|P1|NOT COMPLETED|Overall Study||1
5160892|NCT01253265|12692994|P5|COMPLETED|Overall Study||7
5160893|NCT01253265|12692995|P4|COMPLETED|Overall Study||6
5160894|NCT01253265|12692996|P3|COMPLETED|Overall Study||6
5160895|NCT01253265|12692997|P2|COMPLETED|Overall Study||6
5160896|NCT01253265|12692998|P1|COMPLETED|Overall Study||5
5160897|NCT01253265|12692994|P5|STARTED|Overall Study||8
5160898|NCT01253265|12692995|P4|STARTED|Overall Study||6
5160899|NCT01253265|12692996|P3|STARTED|Overall Study||6
5160900|NCT01253265|12692997|P2|STARTED|Overall Study||6
5160901|NCT01253265|12692998|P1|STARTED|Overall Study||6
5160902|NCT01253226|12693047|P5|NOT COMPLETED|Overall Study||2
5160903|NCT01253226|12693048|P4|NOT COMPLETED|Overall Study||1
5160904|NCT01253226|12693049|P3|NOT COMPLETED|Overall Study||1
5160905|NCT01253226|12693050|P2|NOT COMPLETED|Overall Study||1
5160906|NCT01253226|12693051|P1|NOT COMPLETED|Overall Study||0
5160907|NCT01253226|12693047|P5|COMPLETED|Overall Study||6
5160908|NCT01253226|12693048|P4|COMPLETED|Overall Study||5
5160909|NCT01253226|12693049|P3|COMPLETED|Overall Study||5
5160910|NCT01253226|12693050|P2|COMPLETED|Overall Study||5
5160911|NCT01253226|12693051|P1|COMPLETED|Overall Study||6
5160912|NCT01253226|12693047|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
5160913|NCT01253226|12693048|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5160914|NCT01253226|12693049|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5160915|NCT01253226|12693050|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5160916|NCT01253226|12693051|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5160917|NCT01253226|12693047|P5|STARTED|Overall Study||8
5160918|NCT01253226|12693048|P4|STARTED|Overall Study||6
5160919|NCT01253226|12693049|P3|STARTED|Overall Study||6
5160920|NCT01253226|12693050|P2|STARTED|Overall Study||6
5160921|NCT01253226|12693051|P1|STARTED|Overall Study||6
5160922|NCT01253200|12693111|P5|NOT COMPLETED|Overall Study||5
5160923|NCT01253200|12693112|P4|NOT COMPLETED|Overall Study||5
5160924|NCT01253200|12693113|P3|NOT COMPLETED|Overall Study||2
5160925|NCT01253200|12693114|P2|NOT COMPLETED|Overall Study||19
5160926|NCT01253200|12693115|P1|NOT COMPLETED|Overall Study||21
5160927|NCT01253200|12693111|P5|COMPLETED|Overall Study||0
5160928|NCT01253200|12693112|P4|COMPLETED|Overall Study||12
5160929|NCT01253200|12693113|P3|COMPLETED|Overall Study||28
5160930|NCT01253200|12693114|P2|COMPLETED|Overall Study||106
5160931|NCT01253200|12693115|P1|COMPLETED|Overall Study||104
5160932|NCT01253200|12693111|P5|3 Month Follow-up|Overall Study||0
5160933|NCT01253200|12693112|P4|3 Month Follow-up|Overall Study||12
5160934|NCT01253200|12693113|P3|3 Month Follow-up|Overall Study||28
5160935|NCT01253200|12693114|P2|3 Month Follow-up|Overall Study||106
5160936|NCT01253200|12693115|P1|3 Month Follow-up|Overall Study||104
5160937|NCT01253200|12693111|P5|10 Day Follow-up|Overall Study||0
5160938|NCT01253200|12693112|P4|10 Day Follow-up|Overall Study||12
5160939|NCT01253200|12693113|P3|10 Day Follow-up|Overall Study||28
5160940|NCT01253200|12693114|P2|10 Day Follow-up|Overall Study||111
5160941|NCT01253200|12693115|P1|10 Day Follow-up|Overall Study||106
5160942|NCT01253200|12693111|P5|Procedure|Overall Study||0
5160943|NCT01253200|12693112|P4|Procedure|Overall Study||12
5160944|NCT01253200|12693113|P3|Procedure|Overall Study||28
5160945|NCT01253200|12693114|P2|Procedure|Overall Study||111
5160946|NCT01253200|12693115|P1|Procedure|Overall Study||109
5160947|NCT01253200|12693111|P5|STARTED|Overall Study||5
5160948|NCT01253200|12693112|P4|STARTED|Overall Study||17
5160949|NCT01253200|12693113|P3|STARTED|Overall Study||30
5160950|NCT01253200|12693114|P2|STARTED|Overall Study||125
5160951|NCT01253200|12693115|P1|STARTED|Overall Study||125
5160952|NCT01253187|12693130|P6|NOT COMPLETED|Period 3||0
5160953|NCT01253187|12693131|P5|NOT COMPLETED|Period 3||1
5160954|NCT01253187|12693132|P4|NOT COMPLETED|Period 3||0
5160955|NCT01253187|12693133|P3|NOT COMPLETED|Period 3||0
5160956|NCT01253187|12693134|P2|NOT COMPLETED|Period 3||1
5160957|NCT01253187|12693135|P1|NOT COMPLETED|Period 3||1
5160958|NCT01253187|12693130|P6|COMPLETED|Period 3||6
5160959|NCT01253187|12693131|P5|COMPLETED|Period 3||7
5160960|NCT01253187|12693132|P4|COMPLETED|Period 3||7
5160961|NCT01253187|12693133|P3|COMPLETED|Period 3||7
5160962|NCT01253187|12693134|P2|COMPLETED|Period 3||7
5160963|NCT01253187|12693135|P1|COMPLETED|Period 3||6
5160964|NCT01253187|12693130|P6|STARTED|Period 3||6
5160965|NCT01253187|12693131|P5|STARTED|Period 3||8
5160966|NCT01253187|12693132|P4|STARTED|Period 3||7
5160967|NCT01253187|12693133|P3|STARTED|Period 3||7
5160968|NCT01253187|12693134|P2|STARTED|Period 3||8
5160969|NCT01253187|12693135|P1|STARTED|Period 3||7
5160970|NCT01253187|12693130|P6|NOT COMPLETED|Period 2||0
5160971|NCT01253187|12693131|P5|NOT COMPLETED|Period 2||1
5160972|NCT01253187|12693132|P4|NOT COMPLETED|Period 2||0
5160973|NCT01253187|12693133|P3|NOT COMPLETED|Period 2||0
5160974|NCT01253187|12693134|P2|NOT COMPLETED|Period 2||0
5160975|NCT01253187|12693135|P1|NOT COMPLETED|Period 2||0
5160976|NCT01253187|12693130|P6|COMPLETED|Period 2||6
5160977|NCT01253187|12693131|P5|COMPLETED|Period 2||8
5160978|NCT01253187|12693132|P4|COMPLETED|Period 2||7
5160979|NCT01253187|12693133|P3|COMPLETED|Period 2||7
5160980|NCT01253187|12693134|P2|COMPLETED|Period 2||8
5160981|NCT01253187|12693135|P1|COMPLETED|Period 2||7
5160982|NCT01253187|12693130|P6|STARTED|Period 2||6
5160983|NCT01253187|12693131|P5|STARTED|Period 2||9
5160984|NCT01253187|12693132|P4|STARTED|Period 2||7
5160985|NCT01253187|12693133|P3|STARTED|Period 2||7
5160986|NCT01253187|12693134|P2|STARTED|Period 2||8
5160987|NCT01253187|12693135|P1|STARTED|Period 2||7
5160988|NCT01253187|12693130|P6|NOT COMPLETED|Period 1||0
5160989|NCT01253187|12693131|P5|NOT COMPLETED|Period 1||0
5160990|NCT01253187|12693132|P4|NOT COMPLETED|Period 1||0
5160991|NCT01253187|12693133|P3|NOT COMPLETED|Period 1||0
5160992|NCT01253187|12693134|P2|NOT COMPLETED|Period 1||0
5160993|NCT01253187|12693135|P1|NOT COMPLETED|Period 1||0
5160994|NCT01253187|12693130|P6|COMPLETED|Period 1||6
5160995|NCT01253187|12693131|P5|COMPLETED|Period 1||9
5160996|NCT01253187|12693132|P4|COMPLETED|Period 1||7
5160997|NCT01253187|12693133|P3|COMPLETED|Period 1||7
5160998|NCT01253187|12693134|P2|COMPLETED|Period 1||8
5160999|NCT01253187|12693135|P1|COMPLETED|Period 1||7
5161000|NCT01253187|12693130|P6|STARTED|Period 1||6
5161001|NCT01253187|12693131|P5|STARTED|Period 1||9
5161002|NCT01253187|12693132|P4|STARTED|Period 1||7
5161003|NCT01253187|12693133|P3|STARTED|Period 1||7
5161004|NCT01253187|12693134|P2|STARTED|Period 1||8
5161005|NCT01253187|12693135|P1|STARTED|Period 1||7
5161006|NCT01253174|12693164|P6|NOT COMPLETED|Period 3||0
5161007|NCT01253174|12693165|P5|NOT COMPLETED|Period 3||1
5161008|NCT01253174|12693166|P4|NOT COMPLETED|Period 3||0
5161009|NCT01253174|12693167|P3|NOT COMPLETED|Period 3||1
5161010|NCT01253174|12693168|P2|NOT COMPLETED|Period 3||1
5161011|NCT01253174|12693169|P1|NOT COMPLETED|Period 3||0
5161012|NCT01253174|12693164|P6|COMPLETED|Period 3||7
5161013|NCT01253174|12693165|P5|COMPLETED|Period 3||7
5161014|NCT01253174|12693166|P4|COMPLETED|Period 3||7
5161015|NCT01253174|12693167|P3|COMPLETED|Period 3||6
5161016|NCT01253174|12693168|P2|COMPLETED|Period 3||8
5161017|NCT01253174|12693169|P1|COMPLETED|Period 3||6
5161018|NCT01253174|12693164|P6|STARTED|Period 3||7
5161019|NCT01253174|12693165|P5|STARTED|Period 3||8
5161020|NCT01253174|12693166|P4|STARTED|Period 3||7
5161021|NCT01253174|12693167|P3|STARTED|Period 3||7
5161022|NCT01253174|12693168|P2|STARTED|Period 3||9
5161023|NCT01253174|12693169|P1|STARTED|Period 3||6
5161024|NCT01253174|12693164|P6|NOT COMPLETED|Period 2||0
5161025|NCT01253174|12693165|P5|NOT COMPLETED|Period 2||0
5161026|NCT01253174|12693166|P4|NOT COMPLETED|Period 2||0
5161027|NCT01253174|12693167|P3|NOT COMPLETED|Period 2||1
5161028|NCT01253174|12693168|P2|NOT COMPLETED|Period 2||0
5161029|NCT01253174|12693169|P1|NOT COMPLETED|Period 2||0
5161030|NCT01253174|12693164|P6|COMPLETED|Period 2||7
5161031|NCT01253174|12693165|P5|COMPLETED|Period 2||8
5161032|NCT01253174|12693166|P4|COMPLETED|Period 2||7
5161033|NCT01253174|12693167|P3|COMPLETED|Period 2||7
5161034|NCT01253174|12693168|P2|COMPLETED|Period 2||9
5161035|NCT01253174|12693169|P1|COMPLETED|Period 2||6
5161036|NCT01253174|12693164|P6|STARTED|Period 2||7
5161037|NCT01253174|12693165|P5|STARTED|Period 2||8
5161038|NCT01253174|12693166|P4|STARTED|Period 2||7
5161039|NCT01253174|12693167|P3|STARTED|Period 2||8
5161040|NCT01253174|12693168|P2|STARTED|Period 2||9
5161041|NCT01253174|12693169|P1|STARTED|Period 2||6
5161042|NCT01253174|12693164|P6|NOT COMPLETED|Period 1||0
5161043|NCT01253174|12693165|P5|NOT COMPLETED|Period 1||1
5161044|NCT01253174|12693166|P4|NOT COMPLETED|Period 1||0
5161045|NCT01253174|12693167|P3|NOT COMPLETED|Period 1||1
5161046|NCT01253174|12693168|P2|NOT COMPLETED|Period 1||1
5161047|NCT01253174|12693169|P1|NOT COMPLETED|Period 1||0
5161048|NCT01253174|12693164|P6|COMPLETED|Period 1||7
5161049|NCT01253174|12693165|P5|COMPLETED|Period 1||8
5161050|NCT01253174|12693166|P4|COMPLETED|Period 1||7
5161051|NCT01253174|12693167|P3|COMPLETED|Period 1||8
5161052|NCT01253174|12693168|P2|COMPLETED|Period 1||9
5161053|NCT01253174|12693169|P1|COMPLETED|Period 1||6
5161054|NCT01253174|12693164|P6|STARTED|Period 1||7
5161055|NCT01253174|12693165|P5|STARTED|Period 1||9
5161056|NCT01253174|12693166|P4|STARTED|Period 1||7
5161057|NCT01253174|12693167|P3|STARTED|Period 1||9
5161058|NCT01253174|12693168|P2|STARTED|Period 1||10
5161059|NCT01253174|12693169|P1|STARTED|Period 1||6
5161060|NCT01253148|12693198|P1|NOT COMPLETED|Overall Study||0
5161061|NCT01253148|12693198|P1|COMPLETED|Overall Study||25
5161062|NCT01253148|12693198|P1|STARTED|Overall Study||25
5161063|NCT01253135|12693204|P1|NOT COMPLETED|Amended Protocol||1
5161064|NCT01253135|12693204|P1|COMPLETED|Amended Protocol||24
5161065|NCT01253135|12693204|P1|STARTED|Amended Protocol||25
5161066|NCT01253135|12693204|P1|NOT COMPLETED|Original Protocol||15
5161067|NCT01253135|12693204|P1|COMPLETED|Original Protocol||0
5161068|NCT01253135|12693204|P1|STARTED|Original Protocol||15
5161069|NCT01253070|12693212|P1|NOT COMPLETED|Overall Study||0
5161070|NCT01253070|12693212|P1|COMPLETED|Overall Study||54
5161071|NCT01253070|12693212|P1|STARTED|Overall Study||54
5161072|NCT01253044|12693223|P2|NOT COMPLETED|Overall Study||29
5161073|NCT01253044|12693224|P1|NOT COMPLETED|Overall Study||38
5161074|NCT01253044|12693223|P2|COMPLETED|Overall Study||51
5161075|NCT01253044|12693224|P1|COMPLETED|Overall Study||42
5161076|NCT01253044|12693223|P2|STARTED|Overall Study||80
5161077|NCT01253044|12693224|P1|STARTED|Overall Study||80
5161078|NCT01253018|12693234|P2|NOT COMPLETED|Overall Study||2
5161079|NCT01253018|12693235|P1|NOT COMPLETED|Overall Study||4
5161080|NCT01253018|12693234|P2|COMPLETED|Overall Study||21
5161081|NCT01253018|12693235|P1|COMPLETED|Overall Study||18
5161082|NCT01253018|12693234|P2|STARTED|Overall Study||23
5161083|NCT01253018|12693235|P1|STARTED|Overall Study||22
5161084|NCT01252966|12693249|P2|NOT COMPLETED|Overall Study||13
5161085|NCT01252966|12693250|P1|NOT COMPLETED|Overall Study||23
5161086|NCT01252966|12693249|P2|COMPLETED|Overall Study||92
5161087|NCT01252966|12693250|P1|COMPLETED|Overall Study||85
5161088|NCT01252966|12693249|P2|STARTED|Overall Study||105
5161089|NCT01252966|12693250|P1|STARTED|Overall Study||108
5161090|NCT01252953|12693266|P2|NOT COMPLETED|Overall Study||38
5161091|NCT01252953|12693267|P1|NOT COMPLETED|Overall Study||38
5161092|NCT01252953|12693266|P2|COMPLETED|Overall Study||15186
5161093|NCT01252953|12693267|P1|COMPLETED|Overall Study||15187
5161094|NCT01252953|12693266|P2|STARTED|Overall Study||15224
5161095|NCT01252953|12693267|P1|STARTED|Overall Study||15225
5161096|NCT01252940|12693281|P2|NOT COMPLETED|Extension Phase||3
5161097|NCT01252940|12693282|P1|NOT COMPLETED|Extension Phase||10
5161098|NCT01252940|12693281|P2|COMPLETED|Extension Phase||46
5161099|NCT01252940|12693282|P1|COMPLETED|Extension Phase||100
5161100|NCT01252940|12693281|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
5161101|NCT01252940|12693282|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
5161102|NCT01252940|12693281|P2|NOT COMPLETED|Main Study Phase||12
5161103|NCT01252940|12693282|P1|NOT COMPLETED|Main Study Phase||26
5161196|NCT01252134|12693623|P1|NOT COMPLETED|Period 3, 8 Hours||0
5161104|NCT01252940|12693281|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
5161105|NCT01252940|12693282|P1|COMPLETED|Main Study Phase||295
5161106|NCT01252940|12693281|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
5161107|NCT01252940|12693282|P1|Completed 24 Weeks|Main Study Phase||0
5161108|NCT01252940|12693281|P2|STARTED|Main Study Phase||161
5161109|NCT01252940|12693282|P1|STARTED|Main Study Phase||321
5161110|NCT01252810|12693313|P2|NOT COMPLETED|Overall Study||3
5161111|NCT01252810|12693314|P1|NOT COMPLETED|Overall Study||14
5161112|NCT01252810|12693313|P2|COMPLETED|Overall Study||139
5161113|NCT01252810|12693314|P1|COMPLETED|Overall Study||128
5161114|NCT01252810|12693313|P2|STARTED|Overall Study||142
5161115|NCT01252810|12693314|P1|STARTED|Overall Study||142
5161116|NCT01252745|12693327|P3|NOT COMPLETED|Overall Study||0
5161117|NCT01252745|12693328|P2|NOT COMPLETED|Overall Study||0
5161118|NCT01252745|12693329|P1|NOT COMPLETED|Overall Study||0
5161119|NCT01252745|12693327|P3|COMPLETED|Overall Study||7
5161120|NCT01252745|12693328|P2|COMPLETED|Overall Study||7
5161121|NCT01252745|12693329|P1|COMPLETED|Overall Study||8
5161122|NCT01252745|12693327|P3|STARTED|Overall Study||7
5161123|NCT01252745|12693328|P2|STARTED|Overall Study||7
5161124|NCT01252745|12693329|P1|STARTED|Overall Study||8
5161125|NCT01252667|12693349|P6|NOT COMPLETED|Overall Study||1
5161126|NCT01252667|12693350|P5|NOT COMPLETED|Overall Study||0
5161127|NCT01252667|12693351|P4|NOT COMPLETED|Overall Study||0
5161128|NCT01252667|12693352|P3|NOT COMPLETED|Overall Study||0
5161129|NCT01252667|12693353|P2|NOT COMPLETED|Overall Study||0
5161130|NCT01252667|12693354|P1|NOT COMPLETED|Overall Study||0
5161131|NCT01252667|12693349|P6|COMPLETED|Overall Study||34
5161132|NCT01252667|12693350|P5|COMPLETED|Overall Study||0
5161133|NCT01252667|12693351|P4|COMPLETED|Overall Study||0
5161134|NCT01252667|12693352|P3|COMPLETED|Overall Study||3
5161135|NCT01252667|12693353|P2|COMPLETED|Overall Study||3
5161136|NCT01252667|12693354|P1|COMPLETED|Overall Study||3
5161137|NCT01252667|12693349|P6|STARTED|Overall Study||35
5161138|NCT01252667|12693350|P5|STARTED|Overall Study||0
5161139|NCT01252667|12693351|P4|STARTED|Overall Study||0
5161140|NCT01252667|12693352|P3|STARTED|Overall Study||3
5161141|NCT01252667|12693353|P2|STARTED|Overall Study||3
5161142|NCT01252667|12693354|P1|STARTED|Overall Study||3
5161143|NCT01252563|12693416|P1|NOT COMPLETED|Overall Study||432
5161144|NCT01252563|12693416|P1|COMPLETED|Overall Study||13343
5161145|NCT01252563|12693416|P1|STARTED|Overall Study||13775
5161146|NCT01252355|12693456|P3|NOT COMPLETED|Overall Study||179
5161147|NCT01252355|12693457|P2|NOT COMPLETED|Overall Study||178
5161148|NCT01252355|12693458|P1|NOT COMPLETED|Overall Study||177
5161149|NCT01252355|12693456|P3|COMPLETED|Overall Study||0
5161150|NCT01252355|12693457|P2|COMPLETED|Overall Study||0
5161151|NCT01252355|12693458|P1|COMPLETED|Overall Study||0
5161152|NCT01252355|12693456|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
5161153|NCT01252355|12693457|P2|Treated|Overall Study||178
5161154|NCT01252355|12693458|P1|Treated|Overall Study||175
5161155|NCT01252355|12693456|P3|STARTED|Overall Study|Randomized.|179
5161156|NCT01252355|12693457|P2|STARTED|Overall Study|Randomized.|178
5161157|NCT01252355|12693458|P1|STARTED|Overall Study|Randomized.|177
5161158|NCT01252290|12693496|P1|NOT COMPLETED|Overall Study||1
5161159|NCT01252290|12693496|P1|COMPLETED|Overall Study||34
5161160|NCT01252290|12693496|P1|STARTED|Overall Study||35
5161161|NCT01252277|12693504|P1|NOT COMPLETED|Overall Study||2
5161162|NCT01252277|12693504|P1|COMPLETED|Overall Study||34
5161163|NCT01252277|12693504|P1|STARTED|Overall Study||36
5161164|NCT01252251|12693512|P1|NOT COMPLETED|Overall Study||1
5161165|NCT01252251|12693512|P1|COMPLETED|Overall Study||13
5161166|NCT01252251|12693512|P1|STARTED|Overall Study||14
5161167|NCT01252238|12693524|P3|NOT COMPLETED|Overall Study||4
5161168|NCT01252238|12693525|P2|NOT COMPLETED|Overall Study||4
5161169|NCT01252238|12693526|P1|NOT COMPLETED|Overall Study||4
5161170|NCT01252238|12693524|P3|COMPLETED|Overall Study|sponsor terminated study|4
5161171|NCT01252238|12693525|P2|COMPLETED|Overall Study|sponsor terminated study|4
5161172|NCT01252238|12693526|P1|COMPLETED|Overall Study|sponsor terminated study|4
5161173|NCT01252238|12693524|P3|STARTED|Overall Study||8
5161174|NCT01252238|12693525|P2|STARTED|Overall Study||8
5161175|NCT01252238|12693526|P1|STARTED|Overall Study||8
5161176|NCT01252186|12693543|P3|NOT COMPLETED|Overall Study||34
5161177|NCT01252186|12693544|P2|NOT COMPLETED|Overall Study||32
5161178|NCT01252186|12693545|P1|NOT COMPLETED|Overall Study||30
5161179|NCT01252186|12693543|P3|COMPLETED|Overall Study||53
5161180|NCT01252186|12693544|P2|COMPLETED|Overall Study||59
5161181|NCT01252186|12693545|P1|COMPLETED|Overall Study||57
5161182|NCT01252186|12693543|P3|Received Study Drug|Overall Study||80
5161183|NCT01252186|12693544|P2|Received Study Drug|Overall Study||89
5161184|NCT01252186|12693545|P1|Received Study Drug|Overall Study||83
5161185|NCT01252186|12693543|P3|STARTED|Overall Study||87
5161186|NCT01252186|12693544|P2|STARTED|Overall Study||91
5161187|NCT01252186|12693545|P1|STARTED|Overall Study||87
5161188|NCT01252147|12693613|P1|NOT COMPLETED|Overall Study||0
5161189|NCT01252147|12693613|P1|COMPLETED|Overall Study||68
5161190|NCT01252147|12693613|P1|STARTED|Overall Study||68
5161191|NCT01252134|12693618|P6|NOT COMPLETED|Period 3, 8 Hours||0
5161192|NCT01252134|12693619|P5|NOT COMPLETED|Period 3, 8 Hours||0
5161193|NCT01252134|12693620|P4|NOT COMPLETED|Period 3, 8 Hours||0
5161194|NCT01252134|12693621|P3|NOT COMPLETED|Period 3, 8 Hours||0
5161195|NCT01252134|12693622|P2|NOT COMPLETED|Period 3, 8 Hours||0
5161197|NCT01252134|12693618|P6|COMPLETED|Period 3, 8 Hours||4
5161198|NCT01252134|12693619|P5|COMPLETED|Period 3, 8 Hours||3
5161199|NCT01252134|12693620|P4|COMPLETED|Period 3, 8 Hours||5
5161200|NCT01252134|12693621|P3|COMPLETED|Period 3, 8 Hours||2
5161201|NCT01252134|12693622|P2|COMPLETED|Period 3, 8 Hours||3
5161202|NCT01252134|12693623|P1|COMPLETED|Period 3, 8 Hours||3
5161203|NCT01252134|12693618|P6|STARTED|Period 3, 8 Hours||4
5161204|NCT01252134|12693619|P5|STARTED|Period 3, 8 Hours||3
5161205|NCT01252134|12693620|P4|STARTED|Period 3, 8 Hours||5
5161206|NCT01252134|12693621|P3|STARTED|Period 3, 8 Hours||2
5161207|NCT01252134|12693622|P2|STARTED|Period 3, 8 Hours||3
5161208|NCT01252134|12693623|P1|STARTED|Period 3, 8 Hours||3
5161209|NCT01252134|12693618|P6|NOT COMPLETED|Period 2, 8 Hours||0
5161210|NCT01252134|12693619|P5|NOT COMPLETED|Period 2, 8 Hours||0
5161211|NCT01252134|12693620|P4|NOT COMPLETED|Period 2, 8 Hours||0
5161212|NCT01252134|12693621|P3|NOT COMPLETED|Period 2, 8 Hours||0
5161213|NCT01252134|12693622|P2|NOT COMPLETED|Period 2, 8 Hours||0
5161214|NCT01252134|12693623|P1|NOT COMPLETED|Period 2, 8 Hours||0
5161215|NCT01252134|12693618|P6|COMPLETED|Period 2, 8 Hours||4
5161216|NCT01252134|12693619|P5|COMPLETED|Period 2, 8 Hours||3
5161217|NCT01252134|12693620|P4|COMPLETED|Period 2, 8 Hours||5
5161218|NCT01252134|12693621|P3|COMPLETED|Period 2, 8 Hours||2
5161219|NCT01252134|12693622|P2|COMPLETED|Period 2, 8 Hours||3
5161220|NCT01252134|12693623|P1|COMPLETED|Period 2, 8 Hours||3
5161221|NCT01252134|12693618|P6|STARTED|Period 2, 8 Hours||4
5161222|NCT01252134|12693619|P5|STARTED|Period 2, 8 Hours||3
5161223|NCT01252134|12693620|P4|STARTED|Period 2, 8 Hours||5
5161224|NCT01252134|12693621|P3|STARTED|Period 2, 8 Hours||2
5161225|NCT01252134|12693622|P2|STARTED|Period 2, 8 Hours||3
5161226|NCT01252134|12693623|P1|STARTED|Period 2, 8 Hours||3
5161227|NCT01252134|12693618|P6|NOT COMPLETED|Period 1, 8 Hours||0
5161228|NCT01252134|12693619|P5|NOT COMPLETED|Period 1, 8 Hours||0
5161229|NCT01252134|12693620|P4|NOT COMPLETED|Period 1, 8 Hours||0
5161230|NCT01252134|12693621|P3|NOT COMPLETED|Period 1, 8 Hours||1
5161231|NCT01252134|12693622|P2|NOT COMPLETED|Period 1, 8 Hours||1
5161232|NCT01252134|12693623|P1|NOT COMPLETED|Period 1, 8 Hours||0
5161233|NCT01252134|12693618|P6|COMPLETED|Period 1, 8 Hours||4
5161234|NCT01252134|12693619|P5|COMPLETED|Period 1, 8 Hours||3
5161235|NCT01252134|12693620|P4|COMPLETED|Period 1, 8 Hours||5
5161236|NCT01252134|12693621|P3|COMPLETED|Period 1, 8 Hours||2
5161237|NCT01252134|12693622|P2|COMPLETED|Period 1, 8 Hours||3
5161238|NCT01252134|12693623|P1|COMPLETED|Period 1, 8 Hours||3
5161239|NCT01252134|12693618|P6|STARTED|Period 1, 8 Hours||4
5161240|NCT01252134|12693619|P5|STARTED|Period 1, 8 Hours||3
5161241|NCT01252134|12693620|P4|STARTED|Period 1, 8 Hours||5
5161242|NCT01252134|12693621|P3|STARTED|Period 1, 8 Hours||3
5161243|NCT01252134|12693622|P2|STARTED|Period 1, 8 Hours||4
5161244|NCT01252134|12693623|P1|STARTED|Period 1, 8 Hours||3
5161245|NCT01252095|12693642|P2|NOT COMPLETED|Overall Study||0
5161246|NCT01252095|12693643|P1|NOT COMPLETED|Overall Study||1
5161247|NCT01252095|12693642|P2|COMPLETED|Overall Study||1
5161248|NCT01252095|12693643|P1|COMPLETED|Overall Study||2
5161249|NCT01252095|12693642|P2|STARTED|Overall Study||1
5161250|NCT01252095|12693643|P1|STARTED|Overall Study||3
5161251|NCT01251978|12693651|P2|NOT COMPLETED|Overall Study||0
5161252|NCT01251978|12693652|P1|NOT COMPLETED|Overall Study||0
5161253|NCT01251978|12693651|P2|COMPLETED|Overall Study||3
5161254|NCT01251978|12693652|P1|COMPLETED|Overall Study||5
5161255|NCT01251978|12693651|P2|STARTED|Overall Study||3
5161256|NCT01251978|12693652|P1|STARTED|Overall Study||5
5161257|NCT01251965|12693664|P3|NOT COMPLETED|Overall Study||11
5161258|NCT01251965|12693665|P2|NOT COMPLETED|Overall Study||2
5161259|NCT01251965|12693666|P1|NOT COMPLETED|Overall Study||1
5161260|NCT01251965|12693664|P3|COMPLETED|Overall Study||7
5161261|NCT01251965|12693665|P2|COMPLETED|Overall Study||3
5161262|NCT01251965|12693666|P1|COMPLETED|Overall Study||3
5161263|NCT01251965|12693664|P3|STARTED|Overall Study||18
5161264|NCT01251965|12693665|P2|STARTED|Overall Study||5
5161265|NCT01251965|12693666|P1|STARTED|Overall Study||4
5161266|NCT01251952|12693678|P1|NOT COMPLETED|Overall Study||1
5161267|NCT01251952|12693678|P1|COMPLETED|Overall Study||1
5161268|NCT01251952|12693678|P1|STARTED|Overall Study||2
5161269|NCT01251861|12693684|P2|NOT COMPLETED|Overall Study||28
5161270|NCT01251861|12693685|P1|NOT COMPLETED|Overall Study||18
5161271|NCT01251861|12693684|P2|COMPLETED|Overall Study||26
5161272|NCT01251861|12693685|P1|COMPLETED|Overall Study||36
5161273|NCT01251861|12693684|P2|Pts With PSA Response|Overall Study||36
5161274|NCT01251861|12693685|P1|Pts With PSA Response|Overall Study||44
5161275|NCT01251861|12693684|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
5161276|NCT01251861|12693685|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
5161277|NCT01251861|12693684|P2|Pts Who Received Protocol Therapy|Overall Study||53
5161278|NCT01251861|12693685|P1|Pts Who Received Protocol Therapy|Overall Study||50
5161279|NCT01251861|12693684|P2|STARTED|Overall Study||54
5161280|NCT01251861|12693685|P1|STARTED|Overall Study||54
5161281|NCT01251770|12693713|P2|NOT COMPLETED|Overall Study||7
5161282|NCT01251770|12693714|P1|NOT COMPLETED|Overall Study||13
5161283|NCT01251770|12693713|P2|COMPLETED|Overall Study||29
5161284|NCT01251770|12693714|P1|COMPLETED|Overall Study||29
5161285|NCT01251770|12693713|P2|STARTED|Overall Study||36
5161286|NCT01251770|12693714|P1|STARTED|Overall Study||42
5161287|NCT01251757|12693725|P3|NOT COMPLETED|Overall Study||0
5161288|NCT01251757|12693726|P2|NOT COMPLETED|Overall Study||0
5161289|NCT01251757|12693727|P1|NOT COMPLETED|Overall Study||0
5161371|NCT01251380|12694153|P1|NOT COMPLETED|Overall Study||22
5161290|NCT01251757|12693725|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
5161291|NCT01251757|12693726|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
5161292|NCT01251757|12693727|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
5161293|NCT01251757|12693725|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
5161294|NCT01251757|12693726|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
5161295|NCT01251757|12693727|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
5161296|NCT01251744|12693758|P2|NOT COMPLETED|Overall Study||0
5161297|NCT01251744|12693759|P1|NOT COMPLETED|Overall Study||1
5161298|NCT01251744|12693758|P2|COMPLETED|Overall Study||78
5161299|NCT01251744|12693759|P1|COMPLETED|Overall Study||76
5161300|NCT01251744|12693758|P2|STARTED|Overall Study||78
5161301|NCT01251744|12693759|P1|STARTED|Overall Study||77
5161302|NCT01251653|12693817|P9|NOT COMPLETED|Overall Study||6
5161303|NCT01251653|12693818|P8|NOT COMPLETED|Overall Study||12
5161304|NCT01251653|12693819|P7|NOT COMPLETED|Overall Study||18
5161305|NCT01251653|12693820|P6|NOT COMPLETED|Overall Study||18
5161306|NCT01251653|12693821|P5|NOT COMPLETED|Overall Study||2
5161307|NCT01251653|12693822|P4|NOT COMPLETED|Overall Study||6
5161308|NCT01251653|12693823|P3|NOT COMPLETED|Overall Study||20
5161309|NCT01251653|12693824|P2|NOT COMPLETED|Overall Study||8
5161310|NCT01251653|12693825|P1|NOT COMPLETED|Overall Study||3
5161311|NCT01251653|12693817|P9|COMPLETED|Overall Study||0
5161312|NCT01251653|12693818|P8|COMPLETED|Overall Study||0
5161313|NCT01251653|12693819|P7|COMPLETED|Overall Study||0
5161314|NCT01251653|12693820|P6|COMPLETED|Overall Study||0
5161315|NCT01251653|12693821|P5|COMPLETED|Overall Study||0
5161316|NCT01251653|12693822|P4|COMPLETED|Overall Study||0
5161317|NCT01251653|12693823|P3|COMPLETED|Overall Study||0
5161318|NCT01251653|12693824|P2|COMPLETED|Overall Study||0
5161319|NCT01251653|12693825|P1|COMPLETED|Overall Study||0
5161320|NCT01251653|12693817|P9|STARTED|Overall Study||6
5161321|NCT01251653|12693818|P8|STARTED|Overall Study||12
5161322|NCT01251653|12693819|P7|STARTED|Overall Study||18
5161323|NCT01251653|12693820|P6|STARTED|Overall Study||18
5161324|NCT01251653|12693821|P5|STARTED|Overall Study||2
5161325|NCT01251653|12693822|P4|STARTED|Overall Study||6
5161326|NCT01251653|12693823|P3|STARTED|Overall Study||20
5161327|NCT01251653|12693824|P2|STARTED|Overall Study||8
5161328|NCT01251653|12693825|P1|STARTED|Overall Study||3
5161329|NCT01251614|12693953|P3|NOT COMPLETED|Overall Study||8
5161330|NCT01251614|12693954|P2|NOT COMPLETED|Overall Study||13
5161331|NCT01251614|12693955|P1|NOT COMPLETED|Overall Study||3
5161332|NCT01251614|12693953|P3|COMPLETED|Overall Study||30
5161333|NCT01251614|12693954|P2|COMPLETED|Overall Study||26
5161334|NCT01251614|12693955|P1|COMPLETED|Overall Study||34
5161335|NCT01251614|12693953|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
5161336|NCT01251614|12693954|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
5161337|NCT01251614|12693955|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
5161338|NCT01251614|12693953|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
5161339|NCT01251614|12693954|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
5161340|NCT01251614|12693955|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
5161341|NCT01251614|12693953|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
5161342|NCT01251614|12693954|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
5161343|NCT01251614|12693955|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
5161344|NCT01251614|12693953|P3|STARTED|Overall Study||38
5161345|NCT01251614|12693954|P2|STARTED|Overall Study||39
5161346|NCT01251614|12693955|P1|STARTED|Overall Study||37
5161347|NCT01251588|12694029|P2|NOT COMPLETED|Overall Study||4
5161348|NCT01251588|12694030|P1|NOT COMPLETED|Overall Study||0
5161349|NCT01251588|12694029|P2|COMPLETED|Overall Study||59
5161350|NCT01251588|12694030|P1|COMPLETED|Overall Study||65
5161351|NCT01251588|12694029|P2|STARTED|Overall Study||63
5161352|NCT01251588|12694030|P1|STARTED|Overall Study||65
5161353|NCT01251575|12694062|P1|NOT COMPLETED|Overall Study||1
5161354|NCT01251575|12694062|P1|COMPLETED|Overall Study||76
5161355|NCT01251575|12694062|P1|STARTED|Overall Study||77
5161356|NCT01251536|12694072|P3|NOT COMPLETED|Overall Study||0
5161357|NCT01251536|12694073|P2|NOT COMPLETED|Overall Study||0
5161358|NCT01251536|12694074|P1|NOT COMPLETED|Overall Study||0
5161359|NCT01251536|12694072|P3|COMPLETED|Overall Study||7
5161360|NCT01251536|12694073|P2|COMPLETED|Overall Study||93
5161361|NCT01251536|12694074|P1|COMPLETED|Overall Study||8
5161362|NCT01251536|12694072|P3|STARTED|Overall Study||7
5161363|NCT01251536|12694073|P2|STARTED|Overall Study||93
5161364|NCT01251536|12694074|P1|STARTED|Overall Study||8
5161365|NCT01251393|12694146|P2|NOT COMPLETED|Overall Study||44
5161366|NCT01251393|12694147|P1|NOT COMPLETED|Overall Study||32
5161367|NCT01251393|12694146|P2|COMPLETED|Overall Study||11
5161368|NCT01251393|12694147|P1|COMPLETED|Overall Study||24
5161369|NCT01251393|12694146|P2|STARTED|Overall Study||55
5161370|NCT01251393|12694147|P1|STARTED|Overall Study||56
5161372|NCT01251380|12694153|P1|COMPLETED|Overall Study||194
5161373|NCT01251380|12694153|P1|Cycle 4|Overall Study||11
5161374|NCT01251380|12694153|P1|Cycle 3|Overall Study||86
5161375|NCT01251380|12694153|P1|Cycle 2|Overall Study||175
5161376|NCT01251380|12694153|P1|Cycle 1|Overall Study||207
5161377|NCT01251380|12694153|P1|STARTED|Overall Study|Safety population.|216
5161378|NCT01251367|12694177|P1|NOT COMPLETED|Overall Study||76
5161379|NCT01251367|12694177|P1|COMPLETED|Overall Study||269
5161380|NCT01251367|12694177|P1|Cycle 4|Overall Study||139
5161381|NCT01251367|12694177|P1|Cycle 3|Overall Study||224
5161382|NCT01251367|12694177|P1|Cycle 2|Overall Study||297
5161383|NCT01251367|12694177|P1|Cycle 1|Overall Study||345
5161384|NCT01251367|12694177|P1|STARTED|Overall Study||345
5161385|NCT01251354|12694212|P1|NOT COMPLETED|Overall Study||6
5161386|NCT01251354|12694212|P1|COMPLETED|Overall Study||0
5161387|NCT01251354|12694212|P1|STARTED|Overall Study||6
5161388|NCT01251315|12694228|P6|NOT COMPLETED|Overall Study||0
5161389|NCT01251315|12694229|P5|NOT COMPLETED|Overall Study||0
5161390|NCT01251315|12694230|P4|NOT COMPLETED|Overall Study||0
5161391|NCT01251315|12694231|P3|NOT COMPLETED|Overall Study||0
5161392|NCT01251315|12694232|P2|NOT COMPLETED|Overall Study||0
5161393|NCT01251315|12694233|P1|NOT COMPLETED|Overall Study||0
5161394|NCT01251315|12694228|P6|COMPLETED|Overall Study||4
5161395|NCT01251315|12694229|P5|COMPLETED|Overall Study||4
5161396|NCT01251315|12694230|P4|COMPLETED|Overall Study||4
5161397|NCT01251315|12694231|P3|COMPLETED|Overall Study||4
5161398|NCT01251315|12694232|P2|COMPLETED|Overall Study||4
5161399|NCT01251315|12694233|P1|COMPLETED|Overall Study||4
5161400|NCT01251315|12694228|P6|STARTED|Overall Study||4
5161401|NCT01251315|12694229|P5|STARTED|Overall Study||4
5161402|NCT01251315|12694230|P4|STARTED|Overall Study||4
5161403|NCT01251315|12694231|P3|STARTED|Overall Study||4
5161404|NCT01251315|12694232|P2|STARTED|Overall Study||4
5161405|NCT01251315|12694233|P1|STARTED|Overall Study||4
5161406|NCT01251276|12694255|P2|NOT COMPLETED|Overall Study||1
5161407|NCT01251276|12694256|P1|NOT COMPLETED|Overall Study||1
5161408|NCT01251276|12694255|P2|COMPLETED|Overall Study||107
5161409|NCT01251276|12694256|P1|COMPLETED|Overall Study||95
5161410|NCT01251276|12694255|P2|Vaccinated|Overall Study||108
5161411|NCT01251276|12694256|P1|Vaccinated|Overall Study||96
5161412|NCT01251276|12694255|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
5161413|NCT01251276|12694256|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
5161414|NCT01251146|12694274|P2|NOT COMPLETED|Overall Study||10
5161415|NCT01251146|12694275|P1|NOT COMPLETED|Overall Study||3
5161416|NCT01251146|12694274|P2|COMPLETED|Overall Study||81
5161417|NCT01251146|12694275|P1|COMPLETED|Overall Study||83
5161418|NCT01251146|12694274|P2|STARTED|Overall Study||91
5161419|NCT01251146|12694275|P1|STARTED|Overall Study||86
5161420|NCT01251120|12694297|P2|NOT COMPLETED|Overall Study||1
5161421|NCT01251120|12694298|P1|NOT COMPLETED|Overall Study||0
5161422|NCT01251120|12694297|P2|COMPLETED|Overall Study||0
5161423|NCT01251120|12694298|P1|COMPLETED|Overall Study||1
5161424|NCT01251120|12694297|P2|STARTED|Overall Study||1
5161425|NCT01251120|12694298|P1|STARTED|Overall Study||1
5161426|NCT01251042|12694320|P2|NOT COMPLETED|Overall Study||0
5161427|NCT01251042|12694321|P1|NOT COMPLETED|Overall Study||0
5161428|NCT01251042|12694320|P2|COMPLETED|Overall Study||23
5161429|NCT01251042|12694321|P1|COMPLETED|Overall Study||26
5161430|NCT01251042|12694320|P2|STARTED|Overall Study||23
5161431|NCT01251042|12694321|P1|STARTED|Overall Study||26
5161432|NCT01250990|12694353|P2|NOT COMPLETED|Overall Study||2
5161433|NCT01250990|12694354|P1|NOT COMPLETED|Overall Study||4
5161434|NCT01250990|12694353|P2|COMPLETED|Overall Study||9
5161435|NCT01250990|12694354|P1|COMPLETED|Overall Study||7
5161436|NCT01250990|12694353|P2|STARTED|Overall Study||11
5161437|NCT01250990|12694354|P1|STARTED|Overall Study||11
5161438|NCT01250977|12694362|P2|NOT COMPLETED|Overall Study||2
5161439|NCT01250977|12694363|P1|NOT COMPLETED|Overall Study||0
5161440|NCT01250977|12694362|P2|COMPLETED|Overall Study||12
5161441|NCT01250977|12694363|P1|COMPLETED|Overall Study||6
5161442|NCT01250977|12694362|P2|STARTED|Overall Study||14
5161443|NCT01250977|12694363|P1|STARTED|Overall Study||6
5161444|NCT01250925|12694378|P3|NOT COMPLETED|Overall Study||2
5161445|NCT01250925|12694379|P2|NOT COMPLETED|Overall Study||3
5161446|NCT01250925|12694380|P1|NOT COMPLETED|Overall Study||5
5161447|NCT01250925|12694378|P3|COMPLETED|Overall Study||30
5161448|NCT01250925|12694379|P2|COMPLETED|Overall Study||28
5161449|NCT01250925|12694380|P1|COMPLETED|Overall Study||26
5161450|NCT01250925|12694378|P3|STARTED|Overall Study||32
5161451|NCT01250925|12694379|P2|STARTED|Overall Study||31
5161452|NCT01250925|12694380|P1|STARTED|Overall Study||31
5161453|NCT01250899|12694420|P2|NOT COMPLETED|Overall Study||0
5161454|NCT01250899|12694421|P1|NOT COMPLETED|Overall Study||0
5161455|NCT01250899|12694420|P2|COMPLETED|Overall Study||82
5161456|NCT01250899|12694421|P1|COMPLETED|Overall Study||40
5161457|NCT01250899|12694420|P2|STARTED|Overall Study||82
5161458|NCT01250899|12694421|P1|STARTED|Overall Study||40
5161459|NCT01250873|12694425|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
5161460|NCT01250873|12694425|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
5161461|NCT01250873|12694425|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
5161462|NCT01250873|12694425|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
5161463|NCT01250873|12694425|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
5161464|NCT01250873|12694425|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
5161465|NCT01250873|12694425|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
5161466|NCT01250873|12694425|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
5161467|NCT01250873|12694425|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
5161468|NCT01250834|12694436|P1|NOT COMPLETED|Overall Study||0
5161469|NCT01250834|12694436|P1|COMPLETED|Overall Study||27
5161470|NCT01250834|12694436|P1|STARTED|Overall Study||27
5161471|NCT01250769|12694457|P4|NOT COMPLETED|Overall Study||0
5161472|NCT01250769|12694458|P3|NOT COMPLETED|Overall Study||2
5161473|NCT01250769|12694459|P2|NOT COMPLETED|Overall Study||1
5161474|NCT01250769|12694460|P1|NOT COMPLETED|Overall Study||0
5161475|NCT01250769|12694457|P4|COMPLETED|Overall Study||11
5161476|NCT01250769|12694458|P3|COMPLETED|Overall Study||73
5161477|NCT01250769|12694459|P2|COMPLETED|Overall Study||72
5161478|NCT01250769|12694460|P1|COMPLETED|Overall Study||11
5161479|NCT01250769|12694457|P4|Day 14|Overall Study||11
5161480|NCT01250769|12694458|P3|Day 14|Overall Study||74
5161481|NCT01250769|12694459|P2|Day 14|Overall Study||72
5161482|NCT01250769|12694460|P1|Day 14|Overall Study||11
5161483|NCT01250769|12694457|P4|STARTED|Overall Study||11
5161484|NCT01250769|12694458|P3|STARTED|Overall Study||75
5161485|NCT01250769|12694459|P2|STARTED|Overall Study||73
5161486|NCT01250769|12694460|P1|STARTED|Overall Study||11
5161487|NCT01250756|12694492|P2|NOT COMPLETED|After Toddler Dose||1
5161488|NCT01250756|12694493|P1|NOT COMPLETED|After Toddler Dose||0
5161489|NCT01250756|12694492|P2|COMPLETED|After Toddler Dose||147
5161490|NCT01250756|12694493|P1|COMPLETED|After Toddler Dose||0
5161491|NCT01250756|12694492|P2|STARTED|After Toddler Dose||148
5161492|NCT01250756|12694493|P1|STARTED|After Toddler Dose||0
5161493|NCT01250756|12694492|P2|NOT COMPLETED|Toddler Dose||1
5161494|NCT01250756|12694493|P1|NOT COMPLETED|Toddler Dose||0
5161495|NCT01250756|12694492|P2|COMPLETED|Toddler Dose||148
5161496|NCT01250756|12694493|P1|COMPLETED|Toddler Dose||122
5161497|NCT01250756|12694492|P2|STARTED|Toddler Dose||149
5161498|NCT01250756|12694493|P1|STARTED|Toddler Dose||122
5161499|NCT01250756|12694492|P2|NOT COMPLETED|After Infant Series||4
5161500|NCT01250756|12694493|P1|NOT COMPLETED|After Infant Series||11
5161501|NCT01250756|12694492|P2|COMPLETED|After Infant Series||149
5161502|NCT01250756|12694493|P1|COMPLETED|After Infant Series||122
5161503|NCT01250756|12694492|P2|STARTED|After Infant Series||153
5161504|NCT01250756|12694493|P1|STARTED|After Infant Series||133
5161505|NCT01250756|12694492|P2|NOT COMPLETED|Infant Series||7
5161506|NCT01250756|12694493|P1|NOT COMPLETED|Infant Series||28
5161507|NCT01250756|12694492|P2|COMPLETED|Infant Series||153
5161508|NCT01250756|12694493|P1|COMPLETED|Infant Series||133
5161509|NCT01250756|12694492|P2|Vaccinated Dose 3|Infant Series||155
5161510|NCT01250756|12694493|P1|Vaccinated Dose 3|Infant Series||133
5161511|NCT01250756|12694492|P2|Vaccinated Dose 2|Infant Series||157
5161512|NCT01250756|12694493|P1|Vaccinated Dose 2|Infant Series||147
5161513|NCT01250756|12694492|P2|Vaccinated Dose 1|Infant Series||158
5161514|NCT01250756|12694493|P1|Vaccinated Dose 1|Infant Series||159
5161515|NCT01250756|12694492|P2|STARTED|Infant Series||160
5161516|NCT01250756|12694493|P1|STARTED|Infant Series||161
5161517|NCT01250730|12694546|P3|NOT COMPLETED|Overall Study||0
5161518|NCT01250730|12694547|P2|NOT COMPLETED|Overall Study||0
5161519|NCT01250730|12694548|P1|NOT COMPLETED|Overall Study||0
5161520|NCT01250730|12694546|P3|COMPLETED|Overall Study||6
5161521|NCT01250730|12694547|P2|COMPLETED|Overall Study||6
5161522|NCT01250730|12694548|P1|COMPLETED|Overall Study||6
5161523|NCT01250730|12694546|P3|STARTED|Overall Study||6
5161524|NCT01250730|12694547|P2|STARTED|Overall Study||6
5161525|NCT01250730|12694548|P1|STARTED|Overall Study||6
5161526|NCT01250717|12694604|P1|NOT COMPLETED|Overall Study||0
5161527|NCT01250717|12694604|P1|COMPLETED|Overall Study||28
5161528|NCT01250717|12694604|P1|STARTED|Overall Study||28
5161529|NCT01250509|12694610|P2|NOT COMPLETED|Overall Study||2
5161530|NCT01250509|12694611|P1|NOT COMPLETED|Overall Study||5
5161531|NCT01250509|12694610|P2|COMPLETED|Overall Study||21
5161532|NCT01250509|12694611|P1|COMPLETED|Overall Study||19
5161533|NCT01250509|12694610|P2|STARTED|Overall Study||23
5161534|NCT01250509|12694611|P1|STARTED|Overall Study||24
5161535|NCT01250418|12694625|P2|NOT COMPLETED|Overall Study||1
5161536|NCT01250418|12694626|P1|NOT COMPLETED|Overall Study||1
5161537|NCT01250418|12694625|P2|COMPLETED|Overall Study||15
5161538|NCT01250418|12694626|P1|COMPLETED|Overall Study||8
5161539|NCT01250418|12694625|P2|STARTED|Overall Study||16
5161540|NCT01250418|12694626|P1|STARTED|Overall Study||9
5161541|NCT01250379|12694634|P2|NOT COMPLETED|Overall Study||193
5161542|NCT01250379|12694635|P1|NOT COMPLETED|Overall Study||202
5161543|NCT01250379|12694634|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
5161544|NCT01250379|12694635|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
5161545|NCT01250379|12694634|P2|STARTED|Overall Study||247
5161546|NCT01250379|12694635|P1|STARTED|Overall Study||247
5161547|NCT01250210|12694696|P3|NOT COMPLETED|Overall Study||8
5161548|NCT01250210|12694697|P2|NOT COMPLETED|Overall Study||4
5161549|NCT01250210|12694698|P1|NOT COMPLETED|Overall Study||4
5161550|NCT01250210|12694696|P3|COMPLETED|Overall Study||25
5161551|NCT01250210|12694697|P2|COMPLETED|Overall Study||41
5161552|NCT01250210|12694698|P1|COMPLETED|Overall Study||41
5161553|NCT01250210|12694696|P3|STARTED|Overall Study||33
5161554|NCT01250210|12694697|P2|STARTED|Overall Study||45
5161555|NCT01250210|12694698|P1|STARTED|Overall Study||45
5161556|NCT01250184|12694712|P3|NOT COMPLETED|Overall Study||0
5161557|NCT01250184|12694713|P2|NOT COMPLETED|Overall Study||0
5161558|NCT01250184|12694714|P1|NOT COMPLETED|Overall Study||0
5161559|NCT01250184|12694712|P3|COMPLETED|Overall Study||43
5161560|NCT01250184|12694713|P2|COMPLETED|Overall Study||41
5161561|NCT01250184|12694714|P1|COMPLETED|Overall Study||43
5161562|NCT01250184|12694712|P3|STARTED|Overall Study||43
5161563|NCT01250184|12694713|P2|STARTED|Overall Study||41
5161564|NCT01250184|12694714|P1|STARTED|Overall Study||43
5161565|NCT01250171|12694740|P3|NOT COMPLETED|Overall Study||0
5161566|NCT01250171|12694741|P2|NOT COMPLETED|Overall Study||0
5161567|NCT01250171|12694742|P1|NOT COMPLETED|Overall Study||1
5161568|NCT01250171|12694740|P3|COMPLETED|Overall Study||24
5161569|NCT01250171|12694741|P2|COMPLETED|Overall Study||22
5161570|NCT01250171|12694742|P1|COMPLETED|Overall Study||25
5161571|NCT01250171|12694740|P3|STARTED|Overall Study||24
5161572|NCT01250171|12694741|P2|STARTED|Overall Study||22
5161573|NCT01250171|12694742|P1|STARTED|Overall Study||26
5161574|NCT01250145|12694773|P2|NOT COMPLETED|Overall Study||5
5161575|NCT01250145|12694774|P1|NOT COMPLETED|Overall Study||2
5161576|NCT01250145|12694773|P2|COMPLETED|Overall Study||205
5161577|NCT01250145|12694774|P1|COMPLETED|Overall Study||39
5161578|NCT01250145|12694773|P2|STARTED|Overall Study||210
5161579|NCT01250145|12694774|P1|STARTED|Overall Study||41
5161580|NCT01250119|12694794|P2|NOT COMPLETED|Treatment Phase||41
5161581|NCT01250119|12694795|P1|NOT COMPLETED|Treatment Phase||0
5161582|NCT01250119|12694794|P2|COMPLETED|Treatment Phase||0
5161583|NCT01250119|12694795|P1|COMPLETED|Treatment Phase||0
5161584|NCT01250119|12694794|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
5161585|NCT01250119|12694795|P1|STARTED|Treatment Phase||0
5161586|NCT01250119|12694794|P2|NOT COMPLETED|Diagnostic Phase||0
5161587|NCT01250119|12694795|P1|NOT COMPLETED|Diagnostic Phase||113
5161588|NCT01250119|12694794|P2|COMPLETED|Diagnostic Phase||0
5161589|NCT01250119|12694795|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
5161590|NCT01250119|12694794|P2|STARTED|Diagnostic Phase||0
5161591|NCT01250119|12694795|P1|STARTED|Diagnostic Phase||688
5161592|NCT01250054|12694810|P2|NOT COMPLETED|Period 2, One Week of Wear||0
5161593|NCT01250054|12694811|P1|NOT COMPLETED|Period 2, One Week of Wear||1
5161594|NCT01250054|12694810|P2|COMPLETED|Period 2, One Week of Wear||8
5161595|NCT01250054|12694811|P1|COMPLETED|Period 2, One Week of Wear||6
5161596|NCT01250054|12694810|P2|STARTED|Period 2, One Week of Wear||8
5161597|NCT01250054|12694811|P1|STARTED|Period 2, One Week of Wear||7
5161598|NCT01250054|12694810|P2|NOT COMPLETED|Period 1, One Week of Wear||0
5161599|NCT01250054|12694811|P1|NOT COMPLETED|Period 1, One Week of Wear||0
5161600|NCT01250054|12694810|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
5161601|NCT01250054|12694811|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
5161602|NCT01250054|12694810|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
5161603|NCT01250054|12694811|P1|STARTED|Period 1, One Week of Wear||8
5161604|NCT01250002|12694819|P2|NOT COMPLETED|Overall Study||3
5161605|NCT01250002|12694820|P1|NOT COMPLETED|Overall Study||4
5161606|NCT01250002|12694819|P2|COMPLETED|Overall Study||32
5161607|NCT01250002|12694820|P1|COMPLETED|Overall Study||31
5161608|NCT01250002|12694819|P2|STARTED|Overall Study||35
5161609|NCT01250002|12694820|P1|STARTED|Overall Study||35
5161610|NCT01249872|12694834|P6|NOT COMPLETED|Overall Study||0
5161611|NCT01249872|12694835|P5|NOT COMPLETED|Overall Study||0
5161612|NCT01249872|12694836|P4|NOT COMPLETED|Overall Study||0
5161613|NCT01249872|12694837|P3|NOT COMPLETED|Overall Study||0
5161614|NCT01249872|12694838|P2|NOT COMPLETED|Overall Study||0
5161615|NCT01249872|12694839|P1|NOT COMPLETED|Overall Study||0
5161616|NCT01249872|12694834|P6|COMPLETED|Overall Study||16
5161617|NCT01249872|12694835|P5|COMPLETED|Overall Study||16
5161618|NCT01249872|12694836|P4|COMPLETED|Overall Study||16
5161619|NCT01249872|12694837|P3|COMPLETED|Overall Study||16
5161620|NCT01249872|12694838|P2|COMPLETED|Overall Study||16
5161621|NCT01249872|12694839|P1|COMPLETED|Overall Study||16
5161622|NCT01249872|12694834|P6|STARTED|Overall Study||16
5161623|NCT01249872|12694835|P5|STARTED|Overall Study||16
5161624|NCT01249872|12694836|P4|STARTED|Overall Study||16
5161625|NCT01249872|12694837|P3|STARTED|Overall Study||16
5161626|NCT01249872|12694838|P2|STARTED|Overall Study||16
5161627|NCT01249872|12694839|P1|STARTED|Overall Study||16
5161628|NCT01249833|12694885|P2|NOT COMPLETED|Overall Study||1
5161629|NCT01249833|12694886|P1|NOT COMPLETED|Overall Study||0
5161630|NCT01249833|12694885|P2|COMPLETED|Overall Study||62
5161631|NCT01249833|12694886|P1|COMPLETED|Overall Study||59
5161632|NCT01249833|12694885|P2|STARTED|Overall Study||63
5161633|NCT01249833|12694886|P1|STARTED|Overall Study||59
5161634|NCT01249664|12694900|P2|NOT COMPLETED|Overall Study||0
5161635|NCT01249664|12694901|P1|NOT COMPLETED|Overall Study||6
5161636|NCT01249664|12694900|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
5161637|NCT01249664|12694901|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
5161638|NCT01249664|12694900|P2|Completed 48 Weeks Treatment|Overall Study||24
5161639|NCT01249664|12694901|P1|Completed 48 Weeks Treatment|Overall Study||78
5161640|NCT01249664|12694900|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
5161641|NCT01249664|12694901|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
5161727|NCT01249131|12695150|P2|STARTED|Third Intervention||3
5161642|NCT01249664|12694900|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
5161643|NCT01249664|12694901|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
5161644|NCT01249664|12694900|P2|Participants Received Treatment|Overall Study|Safety population|31
5161645|NCT01249664|12694901|P1|Participants Received Treatment|Overall Study|Safety population|91
5161646|NCT01249664|12694900|P2|STARTED|Overall Study||31
5161647|NCT01249664|12694901|P1|STARTED|Overall Study||91
5161648|NCT01249651|12694951|P1|NOT COMPLETED|Overall Study||7
5161649|NCT01249651|12694951|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
5161650|NCT01249651|12694951|P1|STARTED|Overall Study|Enrolled|101
5161651|NCT01249625|12694960|P2|NOT COMPLETED|Overall Study||0
5161652|NCT01249625|12694961|P1|NOT COMPLETED|Overall Study||0
5161653|NCT01249625|12694960|P2|COMPLETED|Overall Study||1488
5161654|NCT01249625|12694961|P1|COMPLETED|Overall Study||1374
5161655|NCT01249625|12694960|P2|STARTED|Overall Study||1488
5161656|NCT01249625|12694961|P1|STARTED|Overall Study||1374
5161657|NCT01249417|12694980|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
5161658|NCT01249417|12694981|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
5161659|NCT01249417|12694982|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
5161660|NCT01249417|12694980|P3|COMPLETED|Treatment Phase - ITT Population||73
5161661|NCT01249417|12694981|P2|COMPLETED|Treatment Phase - ITT Population||75
5161662|NCT01249417|12694982|P1|COMPLETED|Treatment Phase - ITT Population||78
5161663|NCT01249417|12694980|P3|STARTED|Treatment Phase - ITT Population||77
5161664|NCT01249417|12694981|P2|STARTED|Treatment Phase - ITT Population||79
5161665|NCT01249417|12694982|P1|STARTED|Treatment Phase - ITT Population||79
5161666|NCT01249417|12694980|P3|NOT COMPLETED|Randomised Population||4
5161667|NCT01249417|12694981|P2|NOT COMPLETED|Randomised Population||1
5161668|NCT01249417|12694982|P1|NOT COMPLETED|Randomised Population||1
5161669|NCT01249417|12694980|P3|COMPLETED|Randomised Population||77
5161670|NCT01249417|12694981|P2|COMPLETED|Randomised Population||79
5161671|NCT01249417|12694982|P1|COMPLETED|Randomised Population||79
5161672|NCT01249417|12694980|P3|Treated|Randomised Population||79
5161673|NCT01249417|12694981|P2|Treated|Randomised Population||80
5161674|NCT01249417|12694982|P1|Treated|Randomised Population||80
5161675|NCT01249417|12694980|P3|STARTED|Randomised Population||81
5161676|NCT01249417|12694981|P2|STARTED|Randomised Population||80
5161677|NCT01249417|12694982|P1|STARTED|Randomised Population||80
5161678|NCT01249404|12694999|P3|NOT COMPLETED|Overall Study||7
5161679|NCT01249404|12695000|P2|NOT COMPLETED|Overall Study||8
5161680|NCT01249404|12695001|P1|NOT COMPLETED|Overall Study||7
5161681|NCT01249404|12694999|P3|COMPLETED|Overall Study||125
5161682|NCT01249404|12695000|P2|COMPLETED|Overall Study||121
5161683|NCT01249404|12695001|P1|COMPLETED|Overall Study||120
5161684|NCT01249404|12694999|P3|STARTED|Overall Study||132
5161685|NCT01249404|12695000|P2|STARTED|Overall Study||129
5161686|NCT01249404|12695001|P1|STARTED|Overall Study||127
5161687|NCT01249365|12695078|P1|NOT COMPLETED|Overall Study||1
5161688|NCT01249365|12695078|P1|COMPLETED|Overall Study||198
5161689|NCT01249365|12695078|P1|STARTED|Overall Study||199
5161690|NCT01249274|12695086|P2|NOT COMPLETED|Overall Study||6
5161691|NCT01249274|12695087|P1|NOT COMPLETED|Overall Study||4
5161692|NCT01249274|12695086|P2|COMPLETED|Overall Study||19
5161693|NCT01249274|12695087|P1|COMPLETED|Overall Study||21
5161694|NCT01249274|12695086|P2|Completed Post Trial Visit But Not tx|Overall Study||2
5161695|NCT01249274|12695087|P1|Completed Post Trial Visit But Not tx|Overall Study||1
5161696|NCT01249274|12695086|P2|Completed Treatment & Post Trial Visit|Overall Study||17
5161697|NCT01249274|12695087|P1|Completed Treatment & Post Trial Visit|Overall Study||20
5161698|NCT01249274|12695086|P2|Completed Treatment|Overall Study||19
5161699|NCT01249274|12695087|P1|Completed Treatment|Overall Study||21
5161700|NCT01249274|12695086|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
5161701|NCT01249274|12695087|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
5161702|NCT01249261|12695113|P2|NOT COMPLETED|Overall Study||0
5161703|NCT01249261|12695114|P1|NOT COMPLETED|Overall Study||1
5161704|NCT01249261|12695113|P2|COMPLETED|Overall Study||31
5161705|NCT01249261|12695114|P1|COMPLETED|Overall Study||29
5161706|NCT01249261|12695113|P2|STARTED|Overall Study||31
5161707|NCT01249261|12695114|P1|STARTED|Overall Study||30
5161708|NCT01249157|12695142|P1|NOT COMPLETED|Overall Study||1
5161709|NCT01249157|12695142|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
5161710|NCT01249157|12695142|P1|STARTED|Overall Study||1
5161711|NCT01249131|12695146|P6|NOT COMPLETED|Third Intervention||0
5161712|NCT01249131|12695147|P5|NOT COMPLETED|Third Intervention||0
5161713|NCT01249131|12695148|P4|NOT COMPLETED|Third Intervention||0
5161714|NCT01249131|12695149|P3|NOT COMPLETED|Third Intervention||0
5161715|NCT01249131|12695150|P2|NOT COMPLETED|Third Intervention||0
5161716|NCT01249131|12695151|P1|NOT COMPLETED|Third Intervention||0
5161717|NCT01249131|12695146|P6|COMPLETED|Third Intervention||4
5161718|NCT01249131|12695147|P5|COMPLETED|Third Intervention||2
5161719|NCT01249131|12695148|P4|COMPLETED|Third Intervention||3
5161720|NCT01249131|12695149|P3|COMPLETED|Third Intervention||4
5161721|NCT01249131|12695150|P2|COMPLETED|Third Intervention||3
5161722|NCT01249131|12695151|P1|COMPLETED|Third Intervention||3
5161723|NCT01249131|12695146|P6|STARTED|Third Intervention||4
5161724|NCT01249131|12695147|P5|STARTED|Third Intervention||2
5161725|NCT01249131|12695148|P4|STARTED|Third Intervention||3
5161726|NCT01249131|12695149|P3|STARTED|Third Intervention||4
5161728|NCT01249131|12695151|P1|STARTED|Third Intervention||3
5161729|NCT01249131|12695146|P6|NOT COMPLETED|Washout Period of 10 Days||0
5161730|NCT01249131|12695147|P5|NOT COMPLETED|Washout Period of 10 Days||0
5161731|NCT01249131|12695148|P4|NOT COMPLETED|Washout Period of 10 Days||0
5161732|NCT01249131|12695149|P3|NOT COMPLETED|Washout Period of 10 Days||0
5161733|NCT01249131|12695150|P2|NOT COMPLETED|Washout Period of 10 Days||0
5161734|NCT01249131|12695151|P1|NOT COMPLETED|Washout Period of 10 Days||0
5161735|NCT01249131|12695146|P6|COMPLETED|Washout Period of 10 Days||4
5161736|NCT01249131|12695147|P5|COMPLETED|Washout Period of 10 Days||2
5161737|NCT01249131|12695148|P4|COMPLETED|Washout Period of 10 Days||3
5161738|NCT01249131|12695149|P3|COMPLETED|Washout Period of 10 Days||4
5161739|NCT01249131|12695150|P2|COMPLETED|Washout Period of 10 Days||3
5161740|NCT01249131|12695151|P1|COMPLETED|Washout Period of 10 Days||3
5161741|NCT01249131|12695146|P6|STARTED|Washout Period of 10 Days||4
5161742|NCT01249131|12695147|P5|STARTED|Washout Period of 10 Days||2
5161743|NCT01249131|12695148|P4|STARTED|Washout Period of 10 Days||3
5161744|NCT01249131|12695149|P3|STARTED|Washout Period of 10 Days||4
5161745|NCT01249131|12695150|P2|STARTED|Washout Period of 10 Days||3
5161746|NCT01249131|12695151|P1|STARTED|Washout Period of 10 Days||3
5161747|NCT01249131|12695146|P6|NOT COMPLETED|Second Intervention||0
5161748|NCT01249131|12695147|P5|NOT COMPLETED|Second Intervention||0
5161749|NCT01249131|12695148|P4|NOT COMPLETED|Second Intervention||0
5161750|NCT01249131|12695149|P3|NOT COMPLETED|Second Intervention||0
5161751|NCT01249131|12695150|P2|NOT COMPLETED|Second Intervention||0
5161752|NCT01249131|12695151|P1|NOT COMPLETED|Second Intervention||0
5161753|NCT01249131|12695146|P6|COMPLETED|Second Intervention||4
5161754|NCT01249131|12695147|P5|COMPLETED|Second Intervention||2
5161755|NCT01249131|12695148|P4|COMPLETED|Second Intervention||3
5161756|NCT01249131|12695149|P3|COMPLETED|Second Intervention||4
5161757|NCT01249131|12695150|P2|COMPLETED|Second Intervention||3
5161758|NCT01249131|12695151|P1|COMPLETED|Second Intervention||3
5161759|NCT01249131|12695146|P6|STARTED|Second Intervention||4
5161760|NCT01249131|12695147|P5|STARTED|Second Intervention||2
5161761|NCT01249131|12695148|P4|STARTED|Second Intervention||3
5161762|NCT01249131|12695149|P3|STARTED|Second Intervention||4
5161763|NCT01249131|12695150|P2|STARTED|Second Intervention||3
5161764|NCT01249131|12695151|P1|STARTED|Second Intervention||3
5161765|NCT01249131|12695146|P6|NOT COMPLETED|Washout Period of 10 Days||0
5161766|NCT01249131|12695147|P5|NOT COMPLETED|Washout Period of 10 Days||1
5161767|NCT01249131|12695148|P4|NOT COMPLETED|Washout Period of 10 Days||0
5161768|NCT01249131|12695149|P3|NOT COMPLETED|Washout Period of 10 Days||0
5161769|NCT01249131|12695150|P2|NOT COMPLETED|Washout Period of 10 Days||0
5161770|NCT01249131|12695151|P1|NOT COMPLETED|Washout Period of 10 Days||0
5161771|NCT01249131|12695146|P6|COMPLETED|Washout Period of 10 Days||4
5161772|NCT01249131|12695147|P5|COMPLETED|Washout Period of 10 Days||2
5161773|NCT01249131|12695148|P4|COMPLETED|Washout Period of 10 Days||3
5161774|NCT01249131|12695149|P3|COMPLETED|Washout Period of 10 Days||4
5161775|NCT01249131|12695150|P2|COMPLETED|Washout Period of 10 Days||3
5161776|NCT01249131|12695151|P1|COMPLETED|Washout Period of 10 Days||3
5161777|NCT01249131|12695146|P6|STARTED|Washout Period of 10 Days||4
5161778|NCT01249131|12695147|P5|STARTED|Washout Period of 10 Days||3
5161779|NCT01249131|12695148|P4|STARTED|Washout Period of 10 Days||3
5161780|NCT01249131|12695149|P3|STARTED|Washout Period of 10 Days||4
5161781|NCT01249131|12695150|P2|STARTED|Washout Period of 10 Days||3
5161782|NCT01249131|12695151|P1|STARTED|Washout Period of 10 Days||3
5161783|NCT01249131|12695146|P6|NOT COMPLETED|First Intervention||0
5161784|NCT01249131|12695147|P5|NOT COMPLETED|First Intervention||0
5161785|NCT01249131|12695148|P4|NOT COMPLETED|First Intervention||0
5161786|NCT01249131|12695149|P3|NOT COMPLETED|First Intervention||0
5161787|NCT01249131|12695150|P2|NOT COMPLETED|First Intervention||0
5161788|NCT01249131|12695151|P1|NOT COMPLETED|First Intervention||0
5161789|NCT01249131|12695146|P6|COMPLETED|First Intervention||4
5161790|NCT01249131|12695147|P5|COMPLETED|First Intervention||3
5161791|NCT01249131|12695148|P4|COMPLETED|First Intervention||3
5161792|NCT01249131|12695149|P3|COMPLETED|First Intervention||4
5161793|NCT01249131|12695150|P2|COMPLETED|First Intervention||3
5161794|NCT01249131|12695151|P1|COMPLETED|First Intervention||3
5161795|NCT01249131|12695146|P6|STARTED|First Intervention||4
5161796|NCT01249131|12695147|P5|STARTED|First Intervention||3
5161797|NCT01249131|12695148|P4|STARTED|First Intervention||3
5161798|NCT01249131|12695149|P3|STARTED|First Intervention||4
5161799|NCT01249131|12695150|P2|STARTED|First Intervention||3
5161800|NCT01249131|12695151|P1|STARTED|First Intervention||3
5161801|NCT01249118|12695171|P3|NOT COMPLETED|Second Washout Period||0
5161802|NCT01249118|12695172|P2|NOT COMPLETED|Second Washout Period||0
5161803|NCT01249118|12695173|P1|NOT COMPLETED|Second Washout Period||0
5161804|NCT01249118|12695171|P3|COMPLETED|Second Washout Period||5
5161805|NCT01249118|12695172|P2|COMPLETED|Second Washout Period||5
5161806|NCT01249118|12695173|P1|COMPLETED|Second Washout Period||2
5161807|NCT01249118|12695171|P3|STARTED|Second Washout Period||5
5161808|NCT01249118|12695172|P2|STARTED|Second Washout Period||5
5161809|NCT01249118|12695173|P1|STARTED|Second Washout Period||2
5161810|NCT01249118|12695171|P3|NOT COMPLETED|Second Intervention Period||0
5161811|NCT01249118|12695172|P2|NOT COMPLETED|Second Intervention Period||0
5161812|NCT01249118|12695173|P1|NOT COMPLETED|Second Intervention Period||0
5161813|NCT01249118|12695171|P3|COMPLETED|Second Intervention Period||5
5161814|NCT01249118|12695172|P2|COMPLETED|Second Intervention Period||5
5161815|NCT01249118|12695173|P1|COMPLETED|Second Intervention Period||2
5161816|NCT01249118|12695171|P3|STARTED|Second Intervention Period||5
5161817|NCT01249118|12695172|P2|STARTED|Second Intervention Period||5
5161818|NCT01249118|12695173|P1|STARTED|Second Intervention Period||2
5161819|NCT01249118|12695171|P3|NOT COMPLETED|First Washout Period||0
5161820|NCT01249118|12695172|P2|NOT COMPLETED|First Washout Period||1
5161821|NCT01249118|12695173|P1|NOT COMPLETED|First Washout Period||0
5161822|NCT01249118|12695171|P3|COMPLETED|First Washout Period||5
5161823|NCT01249118|12695172|P2|COMPLETED|First Washout Period||5
5161824|NCT01249118|12695173|P1|COMPLETED|First Washout Period||2
5161825|NCT01249118|12695171|P3|STARTED|First Washout Period||5
5161826|NCT01249118|12695172|P2|STARTED|First Washout Period||6
5161827|NCT01249118|12695173|P1|STARTED|First Washout Period||2
5161828|NCT01249118|12695171|P3|NOT COMPLETED|First Intervention Period||0
5161829|NCT01249118|12695172|P2|NOT COMPLETED|First Intervention Period||0
5161830|NCT01249118|12695173|P1|NOT COMPLETED|First Intervention Period||0
5161831|NCT01249118|12695171|P3|COMPLETED|First Intervention Period||5
5161832|NCT01249118|12695172|P2|COMPLETED|First Intervention Period||6
5161833|NCT01249118|12695173|P1|COMPLETED|First Intervention Period||2
5161834|NCT01249118|12695171|P3|STARTED|First Intervention Period||5
5161835|NCT01249118|12695172|P2|STARTED|First Intervention Period||6
5161836|NCT01249118|12695173|P1|STARTED|First Intervention Period||2
5161837|NCT01249092|12695207|P1|NOT COMPLETED|Overall Study||2
5161838|NCT01249092|12695207|P1|COMPLETED|Overall Study||18
5161839|NCT01249092|12695207|P1|STARTED|Overall Study||20
5161840|NCT01249027|12695213|P1|NOT COMPLETED|5 Years Clinical Follow up||68
5161841|NCT01249027|12695213|P1|COMPLETED|5 Years Clinical Follow up||2142
5161842|NCT01249027|12695213|P1|STARTED|5 Years Clinical Follow up||2210
5161843|NCT01249027|12695213|P1|NOT COMPLETED|4 Years Clinical Follow up||13
5161844|NCT01249027|12695213|P1|COMPLETED|4 Years Clinical Follow up||2210
5161845|NCT01249027|12695213|P1|STARTED|4 Years Clinical Follow up||2223
5161846|NCT01249027|12695213|P1|NOT COMPLETED|3 Years Clinical Follow up||31
5161847|NCT01249027|12695213|P1|COMPLETED|3 Years Clinical Follow up||2223
5161848|NCT01249027|12695213|P1|STARTED|3 Years Clinical Follow up||2254
5161849|NCT01249027|12695213|P1|NOT COMPLETED|2 Years Clinical Follow up||137
5161850|NCT01249027|12695213|P1|COMPLETED|2 Years Clinical Follow up||2254
5161851|NCT01249027|12695213|P1|STARTED|2 Years Clinical Follow up||2391
5161852|NCT01249027|12695213|P1|NOT COMPLETED|1 Year Clinical Follow up||91
5161853|NCT01249027|12695213|P1|COMPLETED|1 Year Clinical Follow up||2391
5161854|NCT01249027|12695213|P1|STARTED|1 Year Clinical Follow up||2482
5161855|NCT01248962|12695284|P2|NOT COMPLETED|Overall Study||16
5161856|NCT01248962|12695285|P1|NOT COMPLETED|Overall Study||16
5161857|NCT01248962|12695284|P2|COMPLETED|Overall Study||56
5161858|NCT01248962|12695285|P1|COMPLETED|Overall Study||58
5161859|NCT01248962|12695284|P2|STARTED|Overall Study||72
5161860|NCT01248962|12695285|P1|STARTED|Overall Study||74
5161861|NCT01248949|12695301|P5|NOT COMPLETED|Overall Study||4
5161862|NCT01248949|12695302|P4|NOT COMPLETED|Overall Study||10
5161863|NCT01248949|12695303|P3|NOT COMPLETED|Overall Study||37
5161864|NCT01248949|12695304|P2|NOT COMPLETED|Overall Study||13
5161865|NCT01248949|12695305|P1|NOT COMPLETED|Overall Study||33
5161866|NCT01248949|12695301|P5|COMPLETED|Overall Study||3
5161867|NCT01248949|12695302|P4|COMPLETED|Overall Study||3
5161868|NCT01248949|12695303|P3|COMPLETED|Overall Study||1
5161869|NCT01248949|12695304|P2|COMPLETED|Overall Study||3
5161870|NCT01248949|12695305|P1|COMPLETED|Overall Study||9
5161871|NCT01248949|12695301|P5|STARTED|Overall Study||7
5161872|NCT01248949|12695302|P4|STARTED|Overall Study||13
5161873|NCT01248949|12695303|P3|STARTED|Overall Study||38
5161874|NCT01248949|12695304|P2|STARTED|Overall Study||16
5161875|NCT01248949|12695305|P1|STARTED|Overall Study||42
5161876|NCT01248936|12695417|P1|NOT COMPLETED|Overall Study||374
5161877|NCT01248936|12695417|P1|COMPLETED|Overall Study||0
5161878|NCT01248936|12695417|P1|STARTED|Overall Study||374
5161879|NCT01248884|12695430|P3|NOT COMPLETED|Overall Study||1
5161880|NCT01248884|12695431|P2|NOT COMPLETED|Overall Study||3
5161881|NCT01248884|12695432|P1|NOT COMPLETED|Overall Study||2
5161882|NCT01248884|12695430|P3|COMPLETED|Overall Study||238
5161883|NCT01248884|12695431|P2|COMPLETED|Overall Study||239
5161884|NCT01248884|12695432|P1|COMPLETED|Overall Study||238
5161885|NCT01248884|12695430|P3|STARTED|Overall Study||239
5161886|NCT01248884|12695431|P2|STARTED|Overall Study||242
5161887|NCT01248884|12695432|P1|STARTED|Overall Study||240
5161888|NCT01248793|12695490|P2|NOT COMPLETED|Overall Study||6
5161889|NCT01248793|12695491|P1|NOT COMPLETED|Overall Study||4
5161890|NCT01248793|12695490|P2|COMPLETED|Overall Study||102
5161891|NCT01248793|12695491|P1|COMPLETED|Overall Study||101
5161892|NCT01248793|12695490|P2|STARTED|Overall Study||108
5161893|NCT01248793|12695491|P1|STARTED|Overall Study||105
5161894|NCT01248780|12695505|P2|NOT COMPLETED|Overall Study||15
5161895|NCT01248780|12695506|P1|NOT COMPLETED|Overall Study||9
5161896|NCT01248780|12695505|P2|COMPLETED|Overall Study||117
5161897|NCT01248780|12695506|P1|COMPLETED|Overall Study||123
5161898|NCT01248780|12695505|P2|STARTED|Overall Study||132
5161899|NCT01248780|12695506|P1|STARTED|Overall Study||132
5161900|NCT01248728|12695520|P2|NOT COMPLETED|Overall Study||2
5161901|NCT01248728|12695521|P1|NOT COMPLETED|Overall Study||4
5161902|NCT01248728|12695520|P2|COMPLETED|Overall Study||17
5161903|NCT01248728|12695521|P1|COMPLETED|Overall Study||15
5161904|NCT01248728|12695520|P2|STARTED|Overall Study||19
5161905|NCT01248728|12695521|P1|STARTED|Overall Study||19
5161906|NCT01248715|12695537|P2|NOT COMPLETED|Overall Study||510
5161907|NCT01248715|12695538|P1|NOT COMPLETED|Overall Study||501
5161908|NCT01248715|12695537|P2|COMPLETED|Overall Study||41
5161909|NCT01248715|12695538|P1|COMPLETED|Overall Study||55
5161910|NCT01248715|12695537|P2|STARTED|Overall Study||551
5161911|NCT01248715|12695538|P1|STARTED|Overall Study||556
5161912|NCT01248468|12695559|P3|NOT COMPLETED|Overall Study||4
5161913|NCT01248468|12695560|P2|NOT COMPLETED|Overall Study||14
5161914|NCT01248468|12695561|P1|NOT COMPLETED|Overall Study||15
5161915|NCT01248468|12695559|P3|COMPLETED|Overall Study||145
5161916|NCT01248468|12695560|P2|COMPLETED|Overall Study||290
5161917|NCT01248468|12695561|P1|COMPLETED|Overall Study||284
5161918|NCT01248468|12695559|P3|ITT Population|Overall Study||125
5161919|NCT01248468|12695560|P2|ITT Population|Overall Study||261
5161920|NCT01248468|12695561|P1|ITT Population|Overall Study||256
5161921|NCT01248468|12695559|P3|Safety Population|Overall Study||133
5161922|NCT01248468|12695560|P2|Safety Population|Overall Study||271
5161923|NCT01248468|12695561|P1|Safety Population|Overall Study||266
5161924|NCT01248468|12695559|P3|STARTED|Overall Study||149
5161925|NCT01248468|12695560|P2|STARTED|Overall Study||304
5161926|NCT01248468|12695561|P1|STARTED|Overall Study||299
5161927|NCT01248455|12695578|P1|NOT COMPLETED|Overall Study||1
5161928|NCT01248455|12695578|P1|COMPLETED|Overall Study||8
5161929|NCT01248455|12695578|P1|STARTED|Overall Study||9
5161930|NCT01248416|12695586|P3|NOT COMPLETED|Overall Study||1
5161931|NCT01248416|12695587|P2|NOT COMPLETED|Overall Study||0
5161932|NCT01248416|12695588|P1|NOT COMPLETED|Overall Study||4
5161933|NCT01248416|12695586|P3|COMPLETED|Overall Study||25
5161934|NCT01248416|12695587|P2|COMPLETED|Overall Study||25
5161935|NCT01248416|12695588|P1|COMPLETED|Overall Study||21
5161936|NCT01248416|12695586|P3|STARTED|Overall Study||26
5161937|NCT01248416|12695587|P2|STARTED|Overall Study||25
5161938|NCT01248416|12695588|P1|STARTED|Overall Study||25
5161939|NCT01248364|12695623|P4|NOT COMPLETED|Overall Study||0
5161940|NCT01248364|12695624|P3|NOT COMPLETED|Overall Study||0
5161941|NCT01248364|12695625|P2|NOT COMPLETED|Overall Study||1
5161942|NCT01248364|12695626|P1|NOT COMPLETED|Overall Study||0
5161943|NCT01248364|12695623|P4|COMPLETED|Overall Study||12
5161944|NCT01248364|12695624|P3|COMPLETED|Overall Study||13
5161945|NCT01248364|12695625|P2|COMPLETED|Overall Study||33
5161946|NCT01248364|12695626|P1|COMPLETED|Overall Study||32
5161947|NCT01248364|12695623|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
5161948|NCT01248364|12695624|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
5161949|NCT01248364|12695625|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
5161950|NCT01248364|12695626|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
5161951|NCT01248364|12695623|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
5161952|NCT01248364|12695624|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
5161953|NCT01248364|12695625|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
5161954|NCT01248364|12695626|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
5161955|NCT01248364|12695623|P4|STARTED|Overall Study||12
5161956|NCT01248364|12695624|P3|STARTED|Overall Study||13
5161957|NCT01248364|12695625|P2|STARTED|Overall Study||34
5161958|NCT01248364|12695626|P1|STARTED|Overall Study||32
5161959|NCT01248221|12695674|P2|NOT COMPLETED|Overall Study||0
5161960|NCT01248221|12695675|P1|NOT COMPLETED|Overall Study||0
5161961|NCT01248221|12695674|P2|COMPLETED|Overall Study||15
5161962|NCT01248221|12695675|P1|COMPLETED|Overall Study||15
5161963|NCT01248221|12695674|P2|STARTED|Overall Study||15
5161964|NCT01248221|12695675|P1|STARTED|Overall Study||15
5161965|NCT01248130|12695689|P2|NOT COMPLETED|Overall Study||0
5161966|NCT01248130|12695690|P1|NOT COMPLETED|Overall Study||2
5161967|NCT01248130|12695689|P2|COMPLETED|Overall Study||4
5161968|NCT01248130|12695690|P1|COMPLETED|Overall Study||1
5161969|NCT01248130|12695689|P2|STARTED|Overall Study||4
5161970|NCT01248130|12695690|P1|STARTED|Overall Study||3
5161971|NCT01248065|12695700|P2|NOT COMPLETED|Overall Study||22
5161972|NCT01248065|12695701|P1|NOT COMPLETED|Overall Study||26
5161973|NCT01248065|12695700|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
5161974|NCT01248065|12695701|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
5161975|NCT01248065|12695700|P2|STARTED|Overall Study||201
5161976|NCT01248065|12695701|P1|STARTED|Overall Study||207
5161977|NCT01248013|12695711|P1|NOT COMPLETED|Overall Study||14
5161978|NCT01248013|12695711|P1|COMPLETED|Overall Study||75
5161979|NCT01248013|12695711|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
5161980|NCT01248013|12695711|P1|STARTED|Overall Study||89
5161981|NCT01247974|12695717|P2|NOT COMPLETED|Overall Study||19
5161982|NCT01247974|12695718|P1|NOT COMPLETED|Overall Study||26
5161983|NCT01247974|12695717|P2|COMPLETED|Overall Study||203
5161984|NCT01247974|12695718|P1|COMPLETED|Overall Study||191
5161985|NCT01247974|12695717|P2|STARTED|Overall Study||222
5161986|NCT01247974|12695718|P1|STARTED|Overall Study||217
5161987|NCT01247922|12695726|P1|NOT COMPLETED|Overall Study||4
5161988|NCT01247922|12695726|P1|COMPLETED|Overall Study||0
5161989|NCT01247922|12695726|P1|Treated|Overall Study||4
5161990|NCT01247922|12695726|P1|STARTED|Overall Study||4
5161991|NCT01247675|12695736|P4|NOT COMPLETED|Overall Study||0
5161992|NCT01247675|12695737|P3|NOT COMPLETED|Overall Study||0
5161993|NCT01247675|12695738|P2|NOT COMPLETED|Overall Study||2
5161994|NCT01247675|12695739|P1|NOT COMPLETED|Overall Study||2
5161995|NCT01247675|12695736|P4|COMPLETED|Overall Study||8
5161996|NCT01247675|12695737|P3|COMPLETED|Overall Study||9
5161997|NCT01247675|12695738|P2|COMPLETED|Overall Study||8
5161998|NCT01247675|12695739|P1|COMPLETED|Overall Study||8
5161999|NCT01247675|12695736|P4|STARTED|Overall Study||8
5162000|NCT01247675|12695737|P3|STARTED|Overall Study||9
5162001|NCT01247675|12695738|P2|STARTED|Overall Study||10
5162002|NCT01247675|12695739|P1|STARTED|Overall Study||10
5162003|NCT01247571|12695761|P1|NOT COMPLETED|Overall Study||3
5162004|NCT01247571|12695761|P1|COMPLETED|Overall Study||19
5162005|NCT01247571|12695761|P1|STARTED|Overall Study||22
5162006|NCT01247428|12695769|P1|NOT COMPLETED|Overall Study||0
5162007|NCT01247428|12695769|P1|COMPLETED|Overall Study||30
5162008|NCT01247428|12695769|P1|STARTED|Overall Study||30
5162009|NCT01247363|12695790|P1|NOT COMPLETED|Overall Study||0
5162010|NCT01247363|12695790|P1|COMPLETED|Overall Study||20
5162011|NCT01247363|12695790|P1|STARTED|Overall Study||20
5162012|NCT01247350|12695824|P5|NOT COMPLETED|Overall Study||1
5162013|NCT01247350|12695825|P4|NOT COMPLETED|Overall Study||1
5162014|NCT01247350|12695826|P3|NOT COMPLETED|Overall Study||1
5162015|NCT01247350|12695827|P2|NOT COMPLETED|Overall Study||0
5162016|NCT01247350|12695828|P1|NOT COMPLETED|Overall Study||0
5162017|NCT01247350|12695824|P5|COMPLETED|Overall Study||8
5162018|NCT01247350|12695825|P4|COMPLETED|Overall Study||6
5162019|NCT01247350|12695826|P3|COMPLETED|Overall Study||5
5162020|NCT01247350|12695827|P2|COMPLETED|Overall Study||6
5162021|NCT01247350|12695828|P1|COMPLETED|Overall Study||6
5162022|NCT01247350|12695824|P5|Received Multiple Doses of Study Drug|Overall Study||5
5162023|NCT01247350|12695825|P4|Received Multiple Doses of Study Drug|Overall Study||6
5162024|NCT01247350|12695826|P3|Received Multiple Doses of Study Drug|Overall Study||6
5162025|NCT01247350|12695827|P2|Received Multiple Doses of Study Drug|Overall Study||0
5162026|NCT01247350|12695828|P1|Received Multiple Doses of Study Drug|Overall Study||0
5162027|NCT01247350|12695824|P5|STARTED|Overall Study||9
5162028|NCT01247350|12695825|P4|STARTED|Overall Study||7
5162029|NCT01247350|12695826|P3|STARTED|Overall Study||6
5162030|NCT01247350|12695827|P2|STARTED|Overall Study||6
5162031|NCT01247350|12695828|P1|STARTED|Overall Study||6
5162032|NCT01247324|12695886|P2|NOT COMPLETED|Overall Study||44
5162033|NCT01247324|12695887|P1|NOT COMPLETED|Overall Study||71
5162034|NCT01247324|12695886|P2|COMPLETED|Overall Study||366
5162035|NCT01247324|12695887|P1|COMPLETED|Overall Study||340
5162036|NCT01247324|12695886|P2|STARTED|Overall Study||410
5162037|NCT01247324|12695887|P1|STARTED|Overall Study||411
5162038|NCT01247298|12695918|P1|NOT COMPLETED|Overall Study||0
5162039|NCT01247298|12695918|P1|COMPLETED|Overall Study||17
5162040|NCT01247298|12695918|P1|STARTED|Overall Study||17
5162041|NCT01247285|12695928|P2|NOT COMPLETED|Second Intervention||0
5162042|NCT01247285|12695929|P1|NOT COMPLETED|Second Intervention||0
5162043|NCT01247285|12695928|P2|COMPLETED|Second Intervention||13
5162044|NCT01247285|12695929|P1|COMPLETED|Second Intervention||13
5162045|NCT01247285|12695928|P2|STARTED|Second Intervention||13
5162046|NCT01247285|12695929|P1|STARTED|Second Intervention||13
5162047|NCT01247285|12695928|P2|NOT COMPLETED|Washout of 28 Days||0
5162048|NCT01247285|12695929|P1|NOT COMPLETED|Washout of 28 Days||0
5162049|NCT01247285|12695928|P2|COMPLETED|Washout of 28 Days||13
5162050|NCT01247285|12695929|P1|COMPLETED|Washout of 28 Days||13
5162051|NCT01247285|12695928|P2|STARTED|Washout of 28 Days||13
5162052|NCT01247285|12695929|P1|STARTED|Washout of 28 Days||13
5162053|NCT01247285|12695928|P2|NOT COMPLETED|First Intervention||0
5162054|NCT01247285|12695929|P1|NOT COMPLETED|First Intervention||0
5162055|NCT01247285|12695928|P2|COMPLETED|First Intervention||13
5162056|NCT01247285|12695929|P1|COMPLETED|First Intervention||13
5162057|NCT01247285|12695928|P2|STARTED|First Intervention||13
5162058|NCT01247285|12695929|P1|STARTED|First Intervention||13
5162059|NCT01247272|12695947|P2|NOT COMPLETED|Second Intervention||0
5162060|NCT01247272|12695948|P1|NOT COMPLETED|Second Intervention||0
5162061|NCT01247272|12695947|P2|COMPLETED|Second Intervention||13
5162062|NCT01247272|12695948|P1|COMPLETED|Second Intervention||13
5162063|NCT01247272|12695947|P2|STARTED|Second Intervention||13
5162064|NCT01247272|12695948|P1|STARTED|Second Intervention||13
5162065|NCT01247272|12695947|P2|NOT COMPLETED|Washout of 28 Days||0
5162066|NCT01247272|12695948|P1|NOT COMPLETED|Washout of 28 Days||0
5162067|NCT01247272|12695947|P2|COMPLETED|Washout of 28 Days||13
5162068|NCT01247272|12695948|P1|COMPLETED|Washout of 28 Days||13
5162069|NCT01247272|12695947|P2|STARTED|Washout of 28 Days||13
5162070|NCT01247272|12695948|P1|STARTED|Washout of 28 Days||13
5162071|NCT01247272|12695947|P2|NOT COMPLETED|First Intervention||0
5162072|NCT01247272|12695948|P1|NOT COMPLETED|First Intervention||0
5162073|NCT01247272|12695947|P2|COMPLETED|First Intervention||13
5162074|NCT01247272|12695948|P1|COMPLETED|First Intervention||13
5162075|NCT01247272|12695947|P2|STARTED|First Intervention||13
5162076|NCT01247272|12695948|P1|STARTED|First Intervention||13
5162077|NCT01247220|12695966|P2|NOT COMPLETED|Overall Study||0
5162078|NCT01247220|12695967|P1|NOT COMPLETED|Overall Study||0
5162079|NCT01247220|12695966|P2|COMPLETED|Overall Study||6
5162080|NCT01247220|12695967|P1|COMPLETED|Overall Study||6
5162081|NCT01247220|12695966|P2|STARTED|Overall Study||6
5162082|NCT01247220|12695967|P1|STARTED|Overall Study||6
5162083|NCT01247090|12695980|P3|NOT COMPLETED|Overall Study||0
5162084|NCT01247090|12695981|P2|NOT COMPLETED|Overall Study||1
5162085|NCT01247090|12695982|P1|NOT COMPLETED|Overall Study||1
5162086|NCT01247090|12695980|P3|COMPLETED|Overall Study||4
5162087|NCT01247090|12695981|P2|COMPLETED|Overall Study||3
5162088|NCT01247090|12695982|P1|COMPLETED|Overall Study||3
5162089|NCT01247090|12695980|P3|STARTED|Overall Study||4
5162090|NCT01247090|12695981|P2|STARTED|Overall Study||4
5162091|NCT01247090|12695982|P1|STARTED|Overall Study||4
5162092|NCT01247064|12695992|P2|NOT COMPLETED|Overall Study||0
5162093|NCT01247064|12695993|P1|NOT COMPLETED|Overall Study||0
5162094|NCT01247064|12695992|P2|COMPLETED|Overall Study||31
5162095|NCT01247064|12695993|P1|COMPLETED|Overall Study||31
5162096|NCT01247064|12695992|P2|STARTED|Overall Study||31
5162097|NCT01247064|12695993|P1|STARTED|Overall Study||31
5162098|NCT01246999|12696011|P4|NOT COMPLETED|Overall Study||2
5162099|NCT01246999|12696012|P3|NOT COMPLETED|Overall Study||0
5162100|NCT01246999|12696013|P2|NOT COMPLETED|Overall Study||1
5162101|NCT01246999|12696014|P1|NOT COMPLETED|Overall Study||0
5162102|NCT01246999|12696011|P4|COMPLETED|Overall Study||15
5162103|NCT01246999|12696012|P3|COMPLETED|Overall Study||2
5162104|NCT01246999|12696013|P2|COMPLETED|Overall Study||3
5162105|NCT01246999|12696014|P1|COMPLETED|Overall Study||11
5162106|NCT01246999|12696011|P4|STARTED|Overall Study||17
5162107|NCT01246999|12696012|P3|STARTED|Overall Study||2
5162108|NCT01246999|12696013|P2|STARTED|Overall Study||4
5162109|NCT01246999|12696014|P1|STARTED|Overall Study||11
5162110|NCT01246973|12696049|P2|NOT COMPLETED|Overall Study||47
5162111|NCT01246973|12696050|P1|NOT COMPLETED|Overall Study||61
5162112|NCT01246973|12696049|P2|COMPLETED|Overall Study||295
5162113|NCT01246973|12696050|P1|COMPLETED|Overall Study||283
5162114|NCT01246973|12696049|P2|STARTED|Overall Study||342
5162115|NCT01246973|12696050|P1|STARTED|Overall Study||344
5162116|NCT01246960|12696060|P2|NOT COMPLETED|Overall Study||4
5162117|NCT01246960|12696061|P1|NOT COMPLETED|Overall Study||6
5162118|NCT01246960|12696060|P2|COMPLETED|Overall Study||80
5162119|NCT01246960|12696061|P1|COMPLETED|Overall Study||78
5162120|NCT01246960|12696060|P2|Received Any Quantity of Study Drug|Overall Study||80
5162121|NCT01246960|12696061|P1|Received Any Quantity of Study Drug|Overall Study||82
5162122|NCT01246960|12696060|P2|STARTED|Overall Study||84
5162123|NCT01246960|12696061|P1|STARTED|Overall Study||84
5162124|NCT01246895|12696081|P2|NOT COMPLETED|Overall Study||4
5162125|NCT01246895|12696082|P1|NOT COMPLETED|Overall Study||3
5162126|NCT01246895|12696081|P2|COMPLETED|Overall Study||26
5162127|NCT01246895|12696082|P1|COMPLETED|Overall Study||34
5162128|NCT01246895|12696081|P2|STARTED|Overall Study||30
5162129|NCT01246895|12696082|P1|STARTED|Overall Study||37
5162130|NCT01246791|12696096|P1|NOT COMPLETED|Overall Study||0
5162131|NCT01246791|12696096|P1|COMPLETED|Overall Study||12
5162132|NCT01246791|12696096|P1|STARTED|Overall Study||12
5162133|NCT01246713|12696111|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
5162134|NCT01246713|12696112|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
5162135|NCT01246713|12696111|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
5162136|NCT01246713|12696112|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
5162137|NCT01246713|12696111|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
5162138|NCT01246713|12696112|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
5162139|NCT01246713|12696111|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
5162140|NCT01246713|12696112|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
5162141|NCT01246713|12696111|P2|COMPLETED|Washout (at Least 14 Days)||9
5162142|NCT01246713|12696112|P1|COMPLETED|Washout (at Least 14 Days)||6
5162143|NCT01246713|12696111|P2|STARTED|Washout (at Least 14 Days)||9
5162144|NCT01246713|12696112|P1|STARTED|Washout (at Least 14 Days)||6
5162145|NCT01246713|12696111|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
5162146|NCT01246713|12696112|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
5162147|NCT01246713|12696111|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
5162148|NCT01246713|12696112|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
5162149|NCT01246713|12696111|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
5162150|NCT01246713|12696112|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
5162151|NCT01246479|12696118|P1|NOT COMPLETED|Overall Study||5
5162152|NCT01246479|12696118|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
5162153|NCT01246479|12696118|P1|STARTED|Overall Study||23
5162154|NCT01246401|12696128|P2|NOT COMPLETED|Overall Study||0
5162155|NCT01246401|12696129|P1|NOT COMPLETED|Overall Study||0
5162156|NCT01246401|12696128|P2|COMPLETED|Overall Study||27
5162157|NCT01246401|12696129|P1|COMPLETED|Overall Study||66
5162158|NCT01246401|12696128|P2|STARTED|Overall Study||27
5162159|NCT01246401|12696129|P1|STARTED|Overall Study||66
5162160|NCT01246349|12696155|P2|NOT COMPLETED|Overall Study||0
5162161|NCT01246349|12696156|P1|NOT COMPLETED|Overall Study||0
5162162|NCT01246349|12696155|P2|COMPLETED|Overall Study||20
5162163|NCT01246349|12696156|P1|COMPLETED|Overall Study||20
5162164|NCT01246349|12696155|P2|STARTED|Overall Study||20
5162165|NCT01246349|12696156|P1|STARTED|Overall Study||20
5162166|NCT01246258|12696168|P1|NOT COMPLETED|Overall Study||0
5162167|NCT01246258|12696168|P1|COMPLETED|Overall Study||5
5162168|NCT01246258|12696168|P1|STARTED|Overall Study||5
5162169|NCT01246206|12696173|P1|NOT COMPLETED|Overall Study||1
5162170|NCT01246206|12696173|P1|COMPLETED|Overall Study||20
5162171|NCT01246206|12696173|P1|STARTED|Overall Study||21
5162172|NCT01246076|12696184|P1|NOT COMPLETED|Overall Study||0
5162173|NCT01246076|12696184|P1|COMPLETED|Overall Study||24
5162174|NCT01246076|12696184|P1|STARTED|Overall Study||24
5162175|NCT01246063|12696199|P6|NOT COMPLETED|Overall Study||0
5162176|NCT01246063|12696200|P5|NOT COMPLETED|Overall Study||0
5162177|NCT01246063|12696201|P4|NOT COMPLETED|Overall Study||0
5162178|NCT01246063|12696202|P3|NOT COMPLETED|Overall Study||0
5162179|NCT01246063|12696203|P2|NOT COMPLETED|Overall Study||0
5162180|NCT01246063|12696204|P1|NOT COMPLETED|Overall Study||0
5162181|NCT01246063|12696199|P6|COMPLETED|Overall Study||17
5162182|NCT01246063|12696200|P5|COMPLETED|Overall Study||7
5162183|NCT01246063|12696201|P4|COMPLETED|Overall Study||5
5162184|NCT01246063|12696202|P3|COMPLETED|Overall Study||4
5162185|NCT01246063|12696203|P2|COMPLETED|Overall Study||4
5162186|NCT01246063|12696204|P1|COMPLETED|Overall Study||3
5162187|NCT01246063|12696199|P6|STARTED|Overall Study||17
5162188|NCT01246063|12696200|P5|STARTED|Overall Study||7
5162189|NCT01246063|12696201|P4|STARTED|Overall Study||5
5162190|NCT01246063|12696202|P3|STARTED|Overall Study||4
5162191|NCT01246063|12696203|P2|STARTED|Overall Study||4
5162192|NCT01246063|12696204|P1|STARTED|Overall Study||3
5162193|NCT01246050|12696241|P2|NOT COMPLETED|Overall Study||0
5162194|NCT01246050|12696242|P1|NOT COMPLETED|Overall Study||0
5162195|NCT01246050|12696241|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
5162196|NCT01246050|12696242|P1|COMPLETED|Overall Study||6
5162197|NCT01246050|12696241|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
5162198|NCT01246050|12696242|P1|STARTED|Overall Study||6
5162199|NCT01246011|12696251|P3|NOT COMPLETED|Overall Study||4
5162200|NCT01246011|12696252|P2|NOT COMPLETED|Overall Study||0
5162201|NCT01246011|12696253|P1|NOT COMPLETED|Overall Study||0
5162202|NCT01246011|12696251|P3|COMPLETED|Overall Study||5
5162203|NCT01246011|12696252|P2|COMPLETED|Overall Study||0
5162204|NCT01246011|12696253|P1|COMPLETED|Overall Study||0
5162205|NCT01246011|12696251|P3|STARTED|Overall Study||9
5162206|NCT01246011|12696252|P2|STARTED|Overall Study||0
5162207|NCT01246011|12696253|P1|STARTED|Overall Study||0
5162208|NCT01245972|12696267|P3|NOT COMPLETED|Overall Study||0
5162209|NCT01245972|12696268|P2|NOT COMPLETED|Overall Study||0
5162210|NCT01245972|12696269|P1|NOT COMPLETED|Overall Study||0
5162211|NCT01245972|12696267|P3|COMPLETED|Overall Study||8
5162212|NCT01245972|12696268|P2|COMPLETED|Overall Study||8
5162213|NCT01245972|12696269|P1|COMPLETED|Overall Study||7
5162214|NCT01245972|12696267|P3|STARTED|Overall Study||8
5162215|NCT01245972|12696268|P2|STARTED|Overall Study||8
5162216|NCT01245972|12696269|P1|STARTED|Overall Study||7
5162217|NCT01245764|12696281|P4|NOT COMPLETED|Study Phase B||0
5162218|NCT01245764|12696282|P3|NOT COMPLETED|Study Phase B||0
5162219|NCT01245764|12696283|P2|NOT COMPLETED|Study Phase B||0
5162220|NCT01245764|12696284|P1|NOT COMPLETED|Study Phase B||0
5162221|NCT01245764|12696281|P4|COMPLETED|Study Phase B||17
5162222|NCT01245764|12696282|P3|COMPLETED|Study Phase B||0
5162223|NCT01245764|12696283|P2|COMPLETED|Study Phase B||0
5162224|NCT01245764|12696284|P1|COMPLETED|Study Phase B||0
5162225|NCT01245764|12696281|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
5162226|NCT01245764|12696282|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
5162227|NCT01245764|12696283|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
5162228|NCT01245764|12696284|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
5162229|NCT01245764|12696281|P4|STARTED|Study Phase B||17
5162230|NCT01245764|12696282|P3|STARTED|Study Phase B||0
5162231|NCT01245764|12696283|P2|STARTED|Study Phase B||0
5162232|NCT01245764|12696284|P1|STARTED|Study Phase B||0
5162233|NCT01245764|12696281|P4|NOT COMPLETED|Study Phase A||3
5162234|NCT01245764|12696282|P3|NOT COMPLETED|Study Phase A||10
5162235|NCT01245764|12696283|P2|NOT COMPLETED|Study Phase A||5
5162236|NCT01245764|12696284|P1|NOT COMPLETED|Study Phase A||9
5162237|NCT01245764|12696281|P4|COMPLETED|Study Phase A||17
5162238|NCT01245764|12696282|P3|COMPLETED|Study Phase A||110
5162239|NCT01245764|12696283|P2|COMPLETED|Study Phase A||25
5162240|NCT01245764|12696284|P1|COMPLETED|Study Phase A||71
5162241|NCT01245764|12696281|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
5162242|NCT01245764|12696282|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
5162243|NCT01245764|12696283|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
5162244|NCT01245764|12696284|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
5162245|NCT01245764|12696281|P4|STARTED|Study Phase A||20
5162246|NCT01245764|12696282|P3|STARTED|Study Phase A||120
5162247|NCT01245764|12696283|P2|STARTED|Study Phase A||30
5162248|NCT01245764|12696284|P1|STARTED|Study Phase A||80
5162249|NCT01245751|12696322|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162250|NCT01245751|12696323|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162251|NCT01245751|12696324|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162252|NCT01245751|12696325|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162253|NCT01245751|12696322|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162254|NCT01245751|12696323|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
5162255|NCT01245751|12696324|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
5162256|NCT01245751|12696325|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
5162257|NCT01245751|12696322|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
5162258|NCT01245751|12696323|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
5162259|NCT01245751|12696324|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
5162260|NCT01245751|12696325|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
5162261|NCT01245751|12696322|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
5162262|NCT01245751|12696323|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
5162263|NCT01245751|12696324|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
5162264|NCT01245751|12696325|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
5162265|NCT01245751|12696322|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
5162266|NCT01245751|12696323|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
5162267|NCT01245751|12696324|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
5162268|NCT01245751|12696325|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
5162269|NCT01245751|12696322|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
5162270|NCT01245751|12696323|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
5162271|NCT01245751|12696324|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
5162272|NCT01245751|12696325|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
5162273|NCT01245751|12696322|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
5162274|NCT01245751|12696323|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
5162275|NCT01245751|12696324|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
5162276|NCT01245751|12696325|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
5162277|NCT01245738|12696338|P1|NOT COMPLETED|Overall Study||40
5162278|NCT01245738|12696338|P1|COMPLETED|Overall Study||474
5162279|NCT01245738|12696338|P1|STARTED|Overall Study||514
5162280|NCT01245699|12696357|P2|NOT COMPLETED|Overall Study||5
5162281|NCT01245699|12696358|P1|NOT COMPLETED|Overall Study||9
5162282|NCT01245699|12696357|P2|COMPLETED|Overall Study||49
5162283|NCT01245699|12696358|P1|COMPLETED|Overall Study||52
5162284|NCT01245699|12696357|P2|STARTED|Overall Study||54
5162285|NCT01245699|12696358|P1|STARTED|Overall Study||61
5162286|NCT01245673|12696374|P1|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
5162287|NCT01245673|12696374|P1|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
5162288|NCT01245673|12696374|P1|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
5162289|NCT01245673|12696374|P1|NOT COMPLETED|Start Lenalidomide||0
5162290|NCT01245673|12696374|P1|COMPLETED|Start Lenalidomide||26
5162291|NCT01245673|12696374|P1|STARTED|Start Lenalidomide||26
5162292|NCT01245673|12696374|P1|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
5162293|NCT01245673|12696374|P1|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
5162294|NCT01245673|12696374|P1|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
5162295|NCT01245673|12696374|P1|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
5162296|NCT01245673|12696374|P1|COMPLETED|Activated/Costimulated Autologous T Cell||27
5162297|NCT01245673|12696374|P1|STARTED|Activated/Costimulated Autologous T Cell||27
5162298|NCT01245673|12696374|P1|NOT COMPLETED|Pre Transplant Vaccinations||0
5162299|NCT01245673|12696374|P1|COMPLETED|Pre Transplant Vaccinations||27
5162300|NCT01245673|12696374|P1|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
5162301|NCT01245673|12696374|P1|STARTED|Pre Transplant Vaccinations||27
5162302|NCT01245673|12696374|P1|NOT COMPLETED|Enrollment||1
5162303|NCT01245673|12696374|P1|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
5162304|NCT01245673|12696374|P1|STARTED|Enrollment||28
5162305|NCT01245647|12696380|P2|NOT COMPLETED|Overall Study||4
5162306|NCT01245647|12696381|P1|NOT COMPLETED|Overall Study||0
5162307|NCT01245647|12696380|P2|COMPLETED|Overall Study||8
5162308|NCT01245647|12696381|P1|COMPLETED|Overall Study||7
5162309|NCT01245647|12696380|P2|STARTED|Overall Study||12
5162310|NCT01245647|12696381|P1|STARTED|Overall Study||7
5162311|NCT01245595|12696397|P2|NOT COMPLETED|Overall Study||0
5162312|NCT01245595|12696398|P1|NOT COMPLETED|Overall Study||0
5162313|NCT01245595|12696397|P2|COMPLETED|Overall Study||72
5162314|NCT01245595|12696398|P1|COMPLETED|Overall Study||72
5162315|NCT01245595|12696397|P2|Completed Full Course of Study Drug|Overall Study||61
5162316|NCT01245595|12696398|P1|Completed Full Course of Study Drug|Overall Study||57
5162317|NCT01245595|12696397|P2|STARTED|Overall Study||72
5162318|NCT01245595|12696398|P1|STARTED|Overall Study||72
5162319|NCT01245439|12696404|P1|NOT COMPLETED|Overall Study||0
5162320|NCT01245439|12696404|P1|COMPLETED|Overall Study||65
5162321|NCT01245439|12696404|P1|STARTED|Overall Study||65
5162322|NCT01245413|12696435|P2|NOT COMPLETED|Athena First,||0
5162323|NCT01245413|12696436|P1|NOT COMPLETED|Athena First,||0
5162324|NCT01245413|12696435|P2|COMPLETED|Athena First,||16
5162325|NCT01245413|12696436|P1|COMPLETED|Athena First,||16
5162326|NCT01245413|12696435|P2|STARTED|Athena First,||16
5162327|NCT01245413|12696436|P1|STARTED|Athena First,||16
5162328|NCT01245413|12696435|P2|NOT COMPLETED|Sensura First,||0
5162329|NCT01245413|12696436|P1|NOT COMPLETED|Sensura First,||0
5162330|NCT01245413|12696435|P2|COMPLETED|Sensura First,||16
5162331|NCT01245413|12696436|P1|COMPLETED|Sensura First,||16
5162332|NCT01245413|12696435|P2|STARTED|Sensura First,||16
5162333|NCT01245413|12696436|P1|STARTED|Sensura First,||16
5162334|NCT01245387|12696442|P1|NOT COMPLETED|Overall Study||813
5162335|NCT01245387|12696442|P1|COMPLETED|Overall Study||188
5162336|NCT01245387|12696442|P1|STARTED|Overall Study||1001
5162337|NCT01245374|12696491|P1|NOT COMPLETED|Overall Study||4
5162338|NCT01245374|12696491|P1|COMPLETED|Overall Study||99
5162339|NCT01245374|12696491|P1|STARTED|Overall Study||103
5162340|NCT01245283|12696514|P3|NOT COMPLETED|Overall Study||11
5162341|NCT01245283|12696515|P2|NOT COMPLETED|Overall Study||11
5162342|NCT01245283|12696516|P1|NOT COMPLETED|Overall Study||14
5162343|NCT01245283|12696514|P3|COMPLETED|Overall Study||19
5162344|NCT01245283|12696515|P2|COMPLETED|Overall Study||17
5162345|NCT01245283|12696516|P1|COMPLETED|Overall Study||18
5162346|NCT01245283|12696514|P3|STARTED|Overall Study||30
5162347|NCT01245283|12696515|P2|STARTED|Overall Study||28
5162348|NCT01245283|12696516|P1|STARTED|Overall Study||32
5162349|NCT01245270|12696550|P2|NOT COMPLETED|Overall Study||0
5162350|NCT01245270|12696551|P1|NOT COMPLETED|Overall Study||0
5162351|NCT01245270|12696550|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
5162352|NCT01245270|12696551|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
5162353|NCT01245270|12696550|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
5162354|NCT01245270|12696551|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
5162355|NCT01245140|12696561|P2|NOT COMPLETED|Overall Study||10
5162356|NCT01245140|12696562|P1|NOT COMPLETED|Overall Study||3
5162357|NCT01245140|12696561|P2|COMPLETED|Overall Study||14
5162358|NCT01245140|12696562|P1|COMPLETED|Overall Study||6
5162359|NCT01245140|12696561|P2|STARTED|Overall Study||24
5162360|NCT01245140|12696562|P1|STARTED|Overall Study||9
5162361|NCT01245101|12696618|P2|NOT COMPLETED|Period 3 (Treatment)||0
5162362|NCT01245101|12696619|P1|NOT COMPLETED|Period 3 (Treatment)||1
5162363|NCT01245101|12696618|P2|COMPLETED|Period 3 (Treatment)||0
5162364|NCT01245101|12696619|P1|COMPLETED|Period 3 (Treatment)||11
5162365|NCT01245101|12696618|P2|STARTED|Period 3 (Treatment)||0
5162366|NCT01245101|12696619|P1|STARTED|Period 3 (Treatment)||12
5162367|NCT01245101|12696618|P2|NOT COMPLETED|Period 2 (Washout)||0
5162368|NCT01245101|12696619|P1|NOT COMPLETED|Period 2 (Washout)||1
5162369|NCT01245101|12696618|P2|COMPLETED|Period 2 (Washout)||0
5162370|NCT01245101|12696619|P1|COMPLETED|Period 2 (Washout)||12
5162371|NCT01245101|12696618|P2|STARTED|Period 2 (Washout)||0
5162372|NCT01245101|12696619|P1|STARTED|Period 2 (Washout)||13
5162373|NCT01245101|12696618|P2|NOT COMPLETED|Period 1 (Treatment)||0
5162374|NCT01245101|12696619|P1|NOT COMPLETED|Period 1 (Treatment)||2
5162375|NCT01245101|12696618|P2|COMPLETED|Period 1 (Treatment)||0
5162376|NCT01245101|12696619|P1|COMPLETED|Period 1 (Treatment)||13
5162377|NCT01245101|12696618|P2|STARTED|Period 1 (Treatment)||0
5162378|NCT01245101|12696619|P1|STARTED|Period 1 (Treatment)||15
5162379|NCT01245062|12696629|P3|NOT COMPLETED|Cross-over Phase||17
5162380|NCT01245062|12696630|P2|NOT COMPLETED|Cross-over Phase||0
5162381|NCT01245062|12696631|P1|NOT COMPLETED|Cross-over Phase||0
5162382|NCT01245062|12696629|P3|COMPLETED|Cross-over Phase||53
5162383|NCT01245062|12696630|P2|COMPLETED|Cross-over Phase||0
5162384|NCT01245062|12696631|P1|COMPLETED|Cross-over Phase||0
5162385|NCT01245062|12696629|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
5162386|NCT01245062|12696630|P2|STARTED|Cross-over Phase||0
5162387|NCT01245062|12696631|P1|STARTED|Cross-over Phase||0
5162388|NCT01245062|12696629|P3|NOT COMPLETED|Randomization and Crossover Phase||0
5162389|NCT01245062|12696630|P2|NOT COMPLETED|Randomization and Crossover Phase||31
5162390|NCT01245062|12696631|P1|NOT COMPLETED|Randomization and Crossover Phase||41
5162391|NCT01245062|12696629|P3|COMPLETED|Randomization and Crossover Phase||0
5162392|NCT01245062|12696630|P2|COMPLETED|Randomization and Crossover Phase||77
5162393|NCT01245062|12696631|P1|COMPLETED|Randomization and Crossover Phase||173
5162394|NCT01245062|12696629|P3|STARTED|Randomization and Crossover Phase||0
5162395|NCT01245062|12696630|P2|STARTED|Randomization and Crossover Phase||108
5162396|NCT01245062|12696631|P1|STARTED|Randomization and Crossover Phase||214
5162397|NCT01245049|12696669|P2|NOT COMPLETED|Overall Study||4
5162398|NCT01245049|12696670|P1|NOT COMPLETED|Overall Study||1
5162399|NCT01245049|12696669|P2|COMPLETED|Overall Study||126
5162400|NCT01245049|12696670|P1|COMPLETED|Overall Study||254
5162401|NCT01245049|12696669|P2|STARTED|Overall Study||130
5162402|NCT01245049|12696670|P1|STARTED|Overall Study||255
5162403|NCT01244984|12696723|P3|NOT COMPLETED|Overall Study||4
5162404|NCT01244984|12696724|P2|NOT COMPLETED|Overall Study||14
5162405|NCT01244984|12696725|P1|NOT COMPLETED|Overall Study||5
5162406|NCT01244984|12696723|P3|COMPLETED|Overall Study||86
5162407|NCT01244984|12696724|P2|COMPLETED|Overall Study||79
5162408|NCT01244984|12696725|P1|COMPLETED|Overall Study||55
5162409|NCT01244984|12696723|P3|STARTED|Overall Study||90
5162410|NCT01244984|12696724|P2|STARTED|Overall Study||93
5162411|NCT01244984|12696725|P1|STARTED|Overall Study||60
5162412|NCT01244906|12696799|P1|NOT COMPLETED|Overall Study||8
5162413|NCT01244906|12696799|P1|COMPLETED|Overall Study||18
5162414|NCT01244906|12696799|P1|STARTED|Overall Study||26
5162415|NCT01244893|12696808|P2|NOT COMPLETED|Final Visit||0
5162416|NCT01244893|12696809|P1|NOT COMPLETED|Final Visit||0
5162417|NCT01244893|12696808|P2|COMPLETED|Final Visit||21
5162418|NCT01244893|12696809|P1|COMPLETED|Final Visit||21
5162419|NCT01244893|12696808|P2|STARTED|Final Visit||21
5162420|NCT01244893|12696809|P1|STARTED|Final Visit||21
5162421|NCT01244893|12696808|P2|NOT COMPLETED|1-Week Follow Up||0
5162422|NCT01244893|12696809|P1|NOT COMPLETED|1-Week Follow Up||1
5162423|NCT01244893|12696808|P2|COMPLETED|1-Week Follow Up||21
5162424|NCT01244893|12696809|P1|COMPLETED|1-Week Follow Up||21
5162425|NCT01244893|12696808|P2|STARTED|1-Week Follow Up||21
5162426|NCT01244893|12696809|P1|STARTED|1-Week Follow Up||22
5162427|NCT01244893|12696808|P2|NOT COMPLETED|Baseline||1
5162428|NCT01244893|12696809|P1|NOT COMPLETED|Baseline||0
5162429|NCT01244893|12696808|P2|COMPLETED|Baseline||21
5162430|NCT01244893|12696809|P1|COMPLETED|Baseline||22
5162431|NCT01244893|12696808|P2|STARTED|Baseline||22
5162432|NCT01244893|12696809|P1|STARTED|Baseline||22
5162433|NCT01244828|12696821|P1|NOT COMPLETED|Overall Study||78
5162434|NCT01244828|12696821|P1|COMPLETED|Overall Study||79
5162435|NCT01244828|12696821|P1|STARTED|Overall Study|Received study drug|157
5162436|NCT01244815|12696837|P4|NOT COMPLETED|Overall Study||12
5162437|NCT01244815|12696838|P3|NOT COMPLETED|Overall Study||11
5162438|NCT01244815|12696839|P2|NOT COMPLETED|Overall Study||17
5162439|NCT01244815|12696840|P1|NOT COMPLETED|Overall Study||14
5162440|NCT01244815|12696837|P4|COMPLETED|Overall Study||87
5162441|NCT01244815|12696838|P3|COMPLETED|Overall Study||88
5162442|NCT01244815|12696839|P2|COMPLETED|Overall Study||88
5162443|NCT01244815|12696840|P1|COMPLETED|Overall Study||87
5162444|NCT01244815|12696837|P4|Treated|Overall Study||99
5162445|NCT01244815|12696838|P3|Treated|Overall Study||99
5162446|NCT01244815|12696839|P2|Treated|Overall Study||104
5162447|NCT01244815|12696840|P1|Treated|Overall Study||101
5162448|NCT01244815|12696837|P4|STARTED|Overall Study|Randomized|99
5162449|NCT01244815|12696838|P3|STARTED|Overall Study|Randomized|99
5162450|NCT01244815|12696839|P2|STARTED|Overall Study|Randomized|105
5162451|NCT01244815|12696840|P1|STARTED|Overall Study|Randomized|101
5162452|NCT01244724|12696914|P1|NOT COMPLETED|Overall Study||8
5162453|NCT01244724|12696914|P1|COMPLETED|Overall Study||9
5162454|NCT01244724|12696914|P1|Week 2 Visit|Overall Study||15
5162455|NCT01244724|12696914|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
5162456|NCT01244711|12696919|P1|NOT COMPLETED|Overall Study||0
5162457|NCT01244711|12696919|P1|COMPLETED|Overall Study||1
5162458|NCT01244711|12696919|P1|STARTED|Overall Study||1
5162459|NCT01244633|12696923|P1|NOT COMPLETED|Overall Study||3
5162460|NCT01244633|12696923|P1|COMPLETED|Overall Study||15
5162461|NCT01244633|12696923|P1|STARTED|Overall Study||18
5162462|NCT01244620|12696927|P4|NOT COMPLETED|Overall Study||4
5162463|NCT01244620|12696928|P3|NOT COMPLETED|Overall Study||4
5162464|NCT01244620|12696929|P2|NOT COMPLETED|Overall Study||4
5162465|NCT01244620|12696930|P1|NOT COMPLETED|Overall Study||4
5162466|NCT01244620|12696927|P4|COMPLETED|Overall Study||0
5162467|NCT01244620|12696928|P3|COMPLETED|Overall Study||0
5162468|NCT01244620|12696929|P2|COMPLETED|Overall Study||0
5162469|NCT01244620|12696930|P1|COMPLETED|Overall Study||0
5162470|NCT01244620|12696927|P4|STARTED|Overall Study||4
5162471|NCT01244620|12696928|P3|STARTED|Overall Study||4
5162472|NCT01244620|12696929|P2|STARTED|Overall Study||4
5162473|NCT01244620|12696930|P1|STARTED|Overall Study||4
5162474|NCT01244529|12696964|P1|NOT COMPLETED|Overall Study||0
5162475|NCT01244529|12696964|P1|COMPLETED|Overall Study||41
5162476|NCT01244529|12696964|P1|STARTED|Overall Study||41
5162477|NCT01244516|12696989|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
5162478|NCT01244516|12696990|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
5162479|NCT01244516|12696991|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
5162480|NCT01244516|12696989|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
5162481|NCT01244516|12696990|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
5162482|NCT01244516|12696991|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
5162483|NCT01244516|12696989|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
5162484|NCT01244516|12696990|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
5162485|NCT01244516|12696991|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
5162486|NCT01244516|12696989|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
5162487|NCT01244516|12696990|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
5162488|NCT01244516|12696991|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
5162489|NCT01244516|12696989|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
5162490|NCT01244516|12696990|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
5162491|NCT01244516|12696991|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
5162492|NCT01244516|12696989|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
5162493|NCT01244516|12696990|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
5162494|NCT01244516|12696991|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
5162495|NCT01244503|12697004|P1|NOT COMPLETED|Overall Study||0
5162496|NCT01244503|12697004|P1|COMPLETED|Overall Study||61
5162497|NCT01244503|12697004|P1|STARTED|Overall Study||61
5162498|NCT01244490|12697012|P3|NOT COMPLETED|Overall Study||23
5162499|NCT01244490|12697013|P2|NOT COMPLETED|Overall Study||24
5162500|NCT01244490|12697014|P1|NOT COMPLETED|Overall Study||19
5162501|NCT01244490|12697012|P3|COMPLETED|Overall Study||89
5162502|NCT01244490|12697013|P2|COMPLETED|Overall Study||91
5162503|NCT01244490|12697014|P1|COMPLETED|Overall Study||92
5162504|NCT01244490|12697012|P3|STARTED|Overall Study||112
5162505|NCT01244490|12697013|P2|STARTED|Overall Study||115
5162506|NCT01244490|12697014|P1|STARTED|Overall Study||111
5162507|NCT01244477|12697069|P2|NOT COMPLETED|Overall Study||3
5162508|NCT01244477|12697070|P1|NOT COMPLETED|Overall Study||20
5162509|NCT01244477|12697069|P2|COMPLETED|Overall Study||20
5162510|NCT01244477|12697070|P1|COMPLETED|Overall Study||18
5162511|NCT01244477|12697069|P2|STARTED|Overall Study||23
5162512|NCT01244477|12697070|P1|STARTED|Overall Study||38
5162513|NCT01244451|12697082|P1|NOT COMPLETED|Overall Study||13
5162514|NCT01244451|12697082|P1|COMPLETED|Overall Study||36
5162515|NCT01244451|12697082|P1|STARTED|Overall Study||49
5162516|NCT01244425|12697091|P2|NOT COMPLETED|Overall Study||3
5162517|NCT01244425|12697092|P1|NOT COMPLETED|Overall Study||3
5162518|NCT01244425|12697091|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
5162519|NCT01244425|12697092|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
5162520|NCT01244425|12697091|P2|STARTED|Overall Study||35
5162521|NCT01244425|12697092|P1|STARTED|Overall Study||35
5162522|NCT01244412|12697112|P1|NOT COMPLETED|Overall Study||0
5162523|NCT01244412|12697112|P1|COMPLETED|Overall Study||1
5162524|NCT01244412|12697112|P1|STARTED|Overall Study||1
5162525|NCT01244243|12697116|P1|NOT COMPLETED|Overall Study||0
5162526|NCT01244243|12697116|P1|COMPLETED|Overall Study||41
5162527|NCT01244243|12697116|P1|STARTED|Overall Study||41
5162528|NCT01244126|12697124|P3|NOT COMPLETED|Overall Study||9
5162529|NCT01244126|12697125|P2|NOT COMPLETED|Overall Study||3
5162530|NCT01244126|12697126|P1|NOT COMPLETED|Overall Study||3
5162531|NCT01244126|12697124|P3|COMPLETED|Overall Study||48
5162532|NCT01244126|12697125|P2|COMPLETED|Overall Study||52
5162533|NCT01244126|12697126|P1|COMPLETED|Overall Study||56
5162534|NCT01244126|12697124|P3|STARTED|Overall Study||57
5162535|NCT01244126|12697125|P2|STARTED|Overall Study||55
5162536|NCT01244126|12697126|P1|STARTED|Overall Study||59
5162537|NCT01244061|12697139|P2|NOT COMPLETED|Overall Study||103
5162538|NCT01244061|12697140|P1|NOT COMPLETED|Overall Study||82
5162539|NCT01244061|12697139|P2|COMPLETED|Overall Study||144
5162540|NCT01244061|12697140|P1|COMPLETED|Overall Study||169
5162541|NCT01244061|12697139|P2|STARTED|Overall Study||247
5162542|NCT01244061|12697140|P1|STARTED|Overall Study||251
5162543|NCT01244035|12697152|P6|NOT COMPLETED|Part 1: Period 3||1
5162544|NCT01244035|12697153|P5|NOT COMPLETED|Part 1: Period 3||1
5162545|NCT01244035|12697154|P4|NOT COMPLETED|Part 1: Period 3||0
5162546|NCT01244035|12697155|P3|NOT COMPLETED|Part 1: Period 3||0
5162547|NCT01244035|12697156|P2|NOT COMPLETED|Part 1: Period 3||1
5162548|NCT01244035|12697157|P1|NOT COMPLETED|Part 1: Period 3||0
5162549|NCT01244035|12697152|P6|COMPLETED|Part 1: Period 3||2
5162550|NCT01244035|12697153|P5|COMPLETED|Part 1: Period 3||3
5162551|NCT01244035|12697154|P4|COMPLETED|Part 1: Period 3||5
5162552|NCT01244035|12697155|P3|COMPLETED|Part 1: Period 3||3
5162553|NCT01244035|12697156|P2|COMPLETED|Part 1: Period 3||2
5162554|NCT01244035|12697157|P1|COMPLETED|Part 1: Period 3||4
5162555|NCT01244035|12697152|P6|STARTED|Part 1: Period 3||3
5162556|NCT01244035|12697153|P5|STARTED|Part 1: Period 3||4
5162557|NCT01244035|12697154|P4|STARTED|Part 1: Period 3||5
5162558|NCT01244035|12697155|P3|STARTED|Part 1: Period 3||3
5162559|NCT01244035|12697156|P2|STARTED|Part 1: Period 3||3
5162560|NCT01244035|12697157|P1|STARTED|Part 1: Period 3||4
5162561|NCT01244035|12697152|P6|NOT COMPLETED|Part 1: Period 2||0
5162562|NCT01244035|12697153|P5|NOT COMPLETED|Part 1: Period 2||0
5162563|NCT01244035|12697154|P4|NOT COMPLETED|Part 1: Period 2||0
5162564|NCT01244035|12697155|P3|NOT COMPLETED|Part 1: Period 2||1
5162565|NCT01244035|12697156|P2|NOT COMPLETED|Part 1: Period 2||0
5162566|NCT01244035|12697157|P1|NOT COMPLETED|Part 1: Period 2||0
5162567|NCT01244035|12697152|P6|COMPLETED|Part 1: Period 2||3
5162568|NCT01244035|12697153|P5|COMPLETED|Part 1: Period 2||4
5162569|NCT01244035|12697154|P4|COMPLETED|Part 1: Period 2||5
5162570|NCT01244035|12697155|P3|COMPLETED|Part 1: Period 2||3
5162571|NCT01244035|12697156|P2|COMPLETED|Part 1: Period 2||3
5162572|NCT01244035|12697157|P1|COMPLETED|Part 1: Period 2||4
5162573|NCT01244035|12697152|P6|STARTED|Part 1: Period 2||3
5162574|NCT01244035|12697153|P5|STARTED|Part 1: Period 2||4
5162575|NCT01244035|12697154|P4|STARTED|Part 1: Period 2||5
5162576|NCT01244035|12697155|P3|STARTED|Part 1: Period 2||4
5162577|NCT01244035|12697156|P2|STARTED|Part 1: Period 2||3
5162578|NCT01244035|12697157|P1|STARTED|Part 1: Period 2||4
5162579|NCT01244035|12697152|P6|NOT COMPLETED|Part 1: Period 1||2
5162580|NCT01244035|12697153|P5|NOT COMPLETED|Part 1: Period 1||1
5162581|NCT01244035|12697154|P4|NOT COMPLETED|Part 1: Period 1||0
5162582|NCT01244035|12697155|P3|NOT COMPLETED|Part 1: Period 1||2
5162583|NCT01244035|12697156|P2|NOT COMPLETED|Part 1: Period 1||2
5162584|NCT01244035|12697157|P1|NOT COMPLETED|Part 1: Period 1||1
5162585|NCT01244035|12697152|P6|COMPLETED|Part 1: Period 1||3
5162586|NCT01244035|12697153|P5|COMPLETED|Part 1: Period 1||4
5162587|NCT01244035|12697154|P4|COMPLETED|Part 1: Period 1||5
5162588|NCT01244035|12697155|P3|COMPLETED|Part 1: Period 1||4
5162589|NCT01244035|12697156|P2|COMPLETED|Part 1: Period 1||3
5162590|NCT01244035|12697157|P1|COMPLETED|Part 1: Period 1||4
5162591|NCT01244035|12697152|P6|STARTED|Part 1: Period 1||5
5162592|NCT01244035|12697153|P5|STARTED|Part 1: Period 1||5
5162593|NCT01244035|12697154|P4|STARTED|Part 1: Period 1||5
5162594|NCT01244035|12697155|P3|STARTED|Part 1: Period 1||6
5162595|NCT01244035|12697156|P2|STARTED|Part 1: Period 1||5
5162596|NCT01244035|12697157|P1|STARTED|Part 1: Period 1||5
5162597|NCT01243957|12697185|P1|NOT COMPLETED|Overall Study||0
5162598|NCT01243957|12697185|P1|COMPLETED|Overall Study||20
5162599|NCT01243957|12697185|P1|STARTED|Overall Study||20
5162600|NCT01243944|12697198|P2|NOT COMPLETED|Overall Study||51
5162601|NCT01243944|12697199|P1|NOT COMPLETED|Overall Study||45
5162602|NCT01243944|12697198|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
5162603|NCT01243944|12697199|P1|COMPLETED|Overall Study||65
5162604|NCT01243944|12697198|P2|Followed for Survival|Overall Study||21
5162605|NCT01243944|12697199|P1|Followed for Survival|Overall Study||22
5162606|NCT01243944|12697198|P2|Treated|Overall Study||111
5162607|NCT01243944|12697199|P1|Treated|Overall Study||110
5162608|NCT01243944|12697198|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
5162609|NCT01243944|12697199|P1|STARTED|Overall Study||110
5162610|NCT01243892|12697227|P2|NOT COMPLETED|Overall Study||0
5162611|NCT01243892|12697228|P1|NOT COMPLETED|Overall Study||2
5162612|NCT01243892|12697227|P2|COMPLETED|Overall Study||3
5162613|NCT01243892|12697228|P1|COMPLETED|Overall Study||13
5162614|NCT01243892|12697227|P2|STARTED|Overall Study||3
5162615|NCT01243892|12697228|P1|STARTED|Overall Study||15
5162616|NCT01243775|12697238|P1|NOT COMPLETED|Overall Study||2
5162617|NCT01243775|12697238|P1|COMPLETED|Overall Study||31
5162618|NCT01243775|12697238|P1|STARTED|Overall Study||33
5162619|NCT01243762|12697252|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
5162620|NCT01243762|12697253|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162621|NCT01243762|12697254|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
5162622|NCT01243762|12697255|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
5162623|NCT01243762|12697256|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162624|NCT01243762|12697257|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
5162625|NCT01243762|12697258|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
5162626|NCT01243762|12697252|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162627|NCT01243762|12697253|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162628|NCT01243762|12697254|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162629|NCT01243762|12697255|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162630|NCT01243762|12697256|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162631|NCT01243762|12697257|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162632|NCT01243762|12697258|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
5162633|NCT01243762|12697252|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
5162634|NCT01243762|12697253|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
5162635|NCT01243762|12697254|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
5162636|NCT01243762|12697255|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
5162637|NCT01243762|12697256|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
5162638|NCT01243762|12697257|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
5162639|NCT01243762|12697258|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
5162640|NCT01243762|12697252|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
5162641|NCT01243762|12697253|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
5162642|NCT01243762|12697254|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
5162643|NCT01243762|12697255|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
5162644|NCT01243762|12697256|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
5162645|NCT01243762|12697257|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
5162646|NCT01243762|12697258|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
5162647|NCT01243762|12697252|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
5162648|NCT01243762|12697253|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
5162649|NCT01243762|12697254|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
5162650|NCT01243762|12697255|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
5162651|NCT01243762|12697256|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
5162652|NCT01243762|12697257|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
5162653|NCT01243762|12697258|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
5162654|NCT01243762|12697252|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
5162655|NCT01243762|12697253|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
5162656|NCT01243762|12697254|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
5162657|NCT01243762|12697255|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
5162658|NCT01243762|12697256|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
5162659|NCT01243762|12697257|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
5162660|NCT01243762|12697258|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
5162661|NCT01243671|12697277|P1|NOT COMPLETED|Overall Study||5
5162662|NCT01243671|12697277|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
5162663|NCT01243671|12697277|P1|Completed 52 Weeks of Treatment|Overall Study||17
5162664|NCT01243671|12697277|P1|Completed 24 Weeks of Treatment|Overall Study||18
5162665|NCT01243671|12697277|P1|STARTED|Overall Study||20
5162666|NCT01243619|12697290|P1|NOT COMPLETED|Overall Study||0
5162667|NCT01243619|12697290|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
5162668|NCT01243619|12697290|P1|STARTED|Overall Study||5
5162669|NCT01243580|12697296|P2|NOT COMPLETED|Overall Study||2
5162670|NCT01243580|12697297|P1|NOT COMPLETED|Overall Study||0
5162671|NCT01243580|12697296|P2|COMPLETED|Overall Study||16
5162672|NCT01243580|12697297|P1|COMPLETED|Overall Study||18
5162673|NCT01243580|12697296|P2|STARTED|Overall Study||18
5162674|NCT01243580|12697297|P1|STARTED|Overall Study||18
5162675|NCT01243567|12697326|P2|NOT COMPLETED|Overall Study||0
5162676|NCT01243567|12697327|P1|NOT COMPLETED|Overall Study||1
5162677|NCT01243567|12697326|P2|COMPLETED|Overall Study||38
5162678|NCT01243567|12697327|P1|COMPLETED|Overall Study||42
5162679|NCT01243567|12697326|P2|STARTED|Overall Study||38
5162680|NCT01243567|12697327|P1|STARTED|Overall Study||43
5162681|NCT01243450|12697344|P3|NOT COMPLETED|Overall Study||67
5162682|NCT01243450|12697345|P2|NOT COMPLETED|Overall Study||25
5162683|NCT01243450|12697346|P1|NOT COMPLETED|Overall Study||83
5162684|NCT01243450|12697344|P3|COMPLETED|Overall Study||337
5162685|NCT01243450|12697345|P2|COMPLETED|Overall Study||110
5162686|NCT01243450|12697346|P1|COMPLETED|Overall Study||318
5162687|NCT01243450|12697344|P3|STARTED|Overall Study||404
5162688|NCT01243450|12697345|P2|STARTED|Overall Study||135
5162689|NCT01243450|12697346|P1|STARTED|Overall Study||401
5162690|NCT01243424|12697356|P2|NOT COMPLETED|Discontinuation From Treatment||1182
5162691|NCT01243424|12697357|P1|NOT COMPLETED|Discontinuation From Treatment||1132
5162692|NCT01243424|12697356|P2|COMPLETED|Discontinuation From Treatment||1832
5162693|NCT01243424|12697357|P1|COMPLETED|Discontinuation From Treatment||1896
5162694|NCT01243424|12697356|P2|Treated|Discontinuation From Treatment||3010
5162695|NCT01243424|12697357|P1|Treated|Discontinuation From Treatment||3023
5162696|NCT01243424|12697356|P2|STARTED|Discontinuation From Treatment||3014
5162697|NCT01243424|12697357|P1|STARTED|Discontinuation From Treatment||3028
5162698|NCT01243424|12697356|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
5162699|NCT01243424|12697357|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
5162700|NCT01243424|12697356|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
5162701|NCT01243424|12697357|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
5162702|NCT01243424|12697356|P2|Treated|Discontinuation From Study (Treated Set)||3010
5162703|NCT01243424|12697357|P1|Treated|Discontinuation From Study (Treated Set)||3023
5162704|NCT01243424|12697356|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
5162705|NCT01243424|12697357|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
5162706|NCT01243424|12697356|P2|STARTED|Discontinuation From Study (Treated Set)||3014
5162707|NCT01243424|12697357|P1|STARTED|Discontinuation From Study (Treated Set)||3028
5162708|NCT01243411|12697399|P1|NOT COMPLETED|Overall Study||41
5162709|NCT01243411|12697399|P1|COMPLETED|Overall Study||306
5162710|NCT01243411|12697399|P1|STARTED|Overall Study||347
5162711|NCT01243333|12697411|P1|NOT COMPLETED|Overall Study||8
5162712|NCT01243333|12697411|P1|COMPLETED|Overall Study||18
5162713|NCT01243333|12697411|P1|STARTED|Overall Study||26
5162714|NCT01243320|12697417|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
5162715|NCT01243320|12697417|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
5162716|NCT01243320|12697417|P1|STARTED|32ppm Oral Silver (14 Days)||24
5162717|NCT01243320|12697417|P1|NOT COMPLETED|Washout (3 Days)||0
5162718|NCT01243320|12697417|P1|COMPLETED|Washout (3 Days)||36
5162719|NCT01243320|12697417|P1|STARTED|Washout (3 Days)||36
5162720|NCT01243320|12697417|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
5162721|NCT01243320|12697417|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
5162722|NCT01243320|12697417|P1|STARTED|10ppm Oral Silver (14 Days)||36
5162723|NCT01243320|12697417|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
5162724|NCT01243320|12697417|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
5162725|NCT01243320|12697417|P1|STARTED|10ppm Oral Silver (7 Days)||36
5162726|NCT01243320|12697417|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
5162727|NCT01243320|12697417|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
5162728|NCT01243320|12697417|P1|STARTED|10ppm Oral Silver (3 Days)||36
5162729|NCT01243294|12697493|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
5162730|NCT01243294|12697494|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
5162731|NCT01243294|12697493|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
5162732|NCT01243294|12697494|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
5162733|NCT01243294|12697493|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
5162734|NCT01243294|12697494|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
5162735|NCT01243294|12697493|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
5162736|NCT01243294|12697494|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
5162737|NCT01243294|12697493|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
5162738|NCT01243294|12697494|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
5162739|NCT01243294|12697493|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
5162740|NCT01243294|12697494|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
5162741|NCT01243268|12697510|P1|NOT COMPLETED|Overall Study||64
5162742|NCT01243268|12697510|P1|COMPLETED|Overall Study||610
5162743|NCT01243268|12697510|P1|STARTED|Overall Study||674
5162744|NCT01243242|12697520|P2|NOT COMPLETED|Overall Study||4
5162745|NCT01243242|12697521|P1|NOT COMPLETED|Overall Study||3
5162746|NCT01243242|12697520|P2|COMPLETED|Overall Study||56
5162747|NCT01243242|12697521|P1|COMPLETED|Overall Study||57
5162748|NCT01243242|12697520|P2|STARTED|Overall Study||60
5162749|NCT01243242|12697521|P1|STARTED|Overall Study||60
5162750|NCT01243177|12697535|P2|NOT COMPLETED|Overall Study||178
5162751|NCT01243177|12697536|P1|NOT COMPLETED|Overall Study||178
5162752|NCT01243177|12697535|P2|COMPLETED|Overall Study||264
5162753|NCT01243177|12697536|P1|COMPLETED|Overall Study||266
5162754|NCT01243177|12697535|P2|STARTED|Overall Study||442
5162755|NCT01243177|12697536|P1|STARTED|Overall Study||444
5162756|NCT01243151|12697557|P5|NOT COMPLETED|Overall Study||0
5162757|NCT01243151|12697558|P4|NOT COMPLETED|Overall Study||2
5162758|NCT01243151|12697559|P3|NOT COMPLETED|Overall Study||1
5162759|NCT01243151|12697560|P2|NOT COMPLETED|Overall Study||1
5162760|NCT01243151|12697561|P1|NOT COMPLETED|Overall Study||0
5162761|NCT01243151|12697557|P5|COMPLETED|Overall Study||14
5162762|NCT01243151|12697558|P4|COMPLETED|Overall Study||12
5162763|NCT01243151|12697559|P3|COMPLETED|Overall Study||13
5162764|NCT01243151|12697560|P2|COMPLETED|Overall Study||13
5162765|NCT01243151|12697561|P1|COMPLETED|Overall Study||12
5162766|NCT01243151|12697557|P5|Treated|Overall Study||14
5162767|NCT01243151|12697558|P4|Treated|Overall Study||13
5162768|NCT01243151|12697559|P3|Treated|Overall Study||14
5162769|NCT01243151|12697560|P2|Treated|Overall Study||14
5162770|NCT01243151|12697561|P1|Treated|Overall Study||12
5162771|NCT01243151|12697557|P5|STARTED|Overall Study||14
5162772|NCT01243151|12697558|P4|STARTED|Overall Study||14
5162773|NCT01243151|12697559|P3|STARTED|Overall Study||14
5162774|NCT01243151|12697560|P2|STARTED|Overall Study||14
5162775|NCT01243151|12697561|P1|STARTED|Overall Study||12
5162776|NCT01243112|12697800|P1|NOT COMPLETED|Overall Study||0
5162777|NCT01243112|12697800|P1|COMPLETED|Overall Study||25
5162778|NCT01243112|12697800|P1|STARTED|Overall Study||25
5162779|NCT01242813|12697805|P1|NOT COMPLETED|Overall Study||2
5162780|NCT01242813|12697805|P1|COMPLETED|Overall Study||18
5162781|NCT01242813|12697805|P1|STARTED|Overall Study||20
5162782|NCT01242748|12697827|P2|NOT COMPLETED|Overall Study||14
5162783|NCT01242748|12697828|P1|NOT COMPLETED|Overall Study||38
5162784|NCT01242748|12697827|P2|COMPLETED|Overall Study||80
5162785|NCT01242748|12697828|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
5162786|NCT01242748|12697827|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
5162787|NCT01242748|12697828|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
5162788|NCT01242748|12697827|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
5162789|NCT01242748|12697828|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
5162790|NCT01242748|12697827|P2|STARTED|Overall Study||94
5162791|NCT01242748|12697828|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
5162792|NCT01242527|12697852|P4|NOT COMPLETED|Overall Study||9
5162793|NCT01242527|12697853|P3|NOT COMPLETED|Overall Study||14
5162794|NCT01242527|12697854|P2|NOT COMPLETED|Overall Study||7
5162795|NCT01242527|12697855|P1|NOT COMPLETED|Overall Study||5
5162796|NCT01242527|12697852|P4|COMPLETED|Overall Study||90
5162797|NCT01242527|12697853|P3|COMPLETED|Overall Study||87
5162798|NCT01242527|12697854|P2|COMPLETED|Overall Study||93
5162799|NCT01242527|12697855|P1|COMPLETED|Overall Study||94
5162800|NCT01242527|12697852|P4|STARTED|Overall Study||99
5162801|NCT01242527|12697853|P3|STARTED|Overall Study||101
5162802|NCT01242527|12697854|P2|STARTED|Overall Study||100
5162803|NCT01242527|12697855|P1|STARTED|Overall Study||99
5162804|NCT01242514|12697868|P3|NOT COMPLETED|Overall Study||212
5162805|NCT01242514|12697869|P2|NOT COMPLETED|Overall Study||357
5162806|NCT01242514|12697870|P1|NOT COMPLETED|Overall Study||1343
5162807|NCT01242514|12697868|P3|COMPLETED|Overall Study|Due to project closure.|0
5162808|NCT01242514|12697869|P2|COMPLETED|Overall Study|Due to project closure.|0
5162809|NCT01242514|12697870|P1|COMPLETED|Overall Study|Due to project closure.|0
5162810|NCT01242514|12697868|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
5162811|NCT01242514|12697869|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
5162812|NCT01242514|12697870|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
5162813|NCT01242514|12697868|P3|STARTED|Overall Study|Patients who received treatment|212
5162814|NCT01242514|12697869|P2|STARTED|Overall Study|Patients who received treatment|357
5162815|NCT01242514|12697870|P1|STARTED|Overall Study|Patients who received treatment|1343
5162816|NCT01242371|12697889|P2|NOT COMPLETED|Overall Study||5
5162817|NCT01242371|12697890|P1|NOT COMPLETED|Overall Study||2
5162818|NCT01242371|12697889|P2|COMPLETED|Overall Study||27
5162819|NCT01242371|12697890|P1|COMPLETED|Overall Study||31
5162820|NCT01242371|12697889|P2|STARTED|Overall Study||32
5162821|NCT01242371|12697890|P1|STARTED|Overall Study||33
5162822|NCT01242176|12697896|P2|NOT COMPLETED|Second Intervention||0
5162823|NCT01242176|12697897|P1|NOT COMPLETED|Second Intervention||0
5162824|NCT01242176|12697896|P2|COMPLETED|Second Intervention||10
5162825|NCT01242176|12697897|P1|COMPLETED|Second Intervention||11
5162826|NCT01242176|12697896|P2|STARTED|Second Intervention||10
5162827|NCT01242176|12697897|P1|STARTED|Second Intervention||11
5162828|NCT01242176|12697896|P2|NOT COMPLETED|Washout Period of 7 Days||2
5162829|NCT01242176|12697897|P1|NOT COMPLETED|Washout Period of 7 Days||1
5162830|NCT01242176|12697896|P2|COMPLETED|Washout Period of 7 Days||10
5162831|NCT01242176|12697897|P1|COMPLETED|Washout Period of 7 Days||11
5162832|NCT01242176|12697896|P2|STARTED|Washout Period of 7 Days||12
5162833|NCT01242176|12697897|P1|STARTED|Washout Period of 7 Days||12
5162834|NCT01242176|12697896|P2|NOT COMPLETED|First Intervention||0
5162835|NCT01242176|12697897|P1|NOT COMPLETED|First Intervention||0
5162836|NCT01242176|12697896|P2|COMPLETED|First Intervention||12
5162837|NCT01242176|12697897|P1|COMPLETED|First Intervention||12
5162838|NCT01242176|12697896|P2|STARTED|First Intervention||12
5162839|NCT01242176|12697897|P1|STARTED|First Intervention||12
5162840|NCT01242111|12697907|P1|NOT COMPLETED|Overall Study||3
5162841|NCT01242111|12697907|P1|COMPLETED|Overall Study||17
5162842|NCT01242111|12697907|P1|STARTED|Overall Study||20
5162843|NCT01242085|12697919|P3|NOT COMPLETED|Overall Study||0
5162844|NCT01242085|12697920|P2|NOT COMPLETED|Overall Study||7
5162845|NCT01242085|12697921|P1|NOT COMPLETED|Overall Study||8
5162846|NCT01242085|12697919|P3|COMPLETED|Overall Study||1
5162847|NCT01242085|12697920|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
5162848|NCT01242085|12697921|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
5162849|NCT01242085|12697919|P3|STARTED|Overall Study||1
5162850|NCT01242085|12697920|P2|STARTED|Overall Study||33
5162851|NCT01242085|12697921|P1|STARTED|Overall Study||30
5162852|NCT01242020|12697931|P2|NOT COMPLETED|Overall Study||0
5162853|NCT01242020|12697932|P1|NOT COMPLETED|Overall Study||3
5162854|NCT01242020|12697931|P2|COMPLETED|Overall Study||0
5162855|NCT01242020|12697932|P1|COMPLETED|Overall Study||3
5162856|NCT01242020|12697931|P2|STARTED|Overall Study||0
5162857|NCT01242020|12697932|P1|STARTED|Overall Study||6
5162858|NCT01241916|12697942|P2|NOT COMPLETED|Overall Study||10
5162859|NCT01241916|12697943|P1|NOT COMPLETED|Overall Study||7
5162860|NCT01241916|12697942|P2|COMPLETED|Overall Study||21
5162861|NCT01241916|12697943|P1|COMPLETED|Overall Study||28
5162862|NCT01241916|12697942|P2|STARTED|Overall Study||31
5162863|NCT01241916|12697943|P1|STARTED|Overall Study||35
5162864|NCT01241903|12697953|P2|NOT COMPLETED|Overall Study||0
5162865|NCT01241903|12697954|P1|NOT COMPLETED|Overall Study||1
5162866|NCT01241903|12697953|P2|COMPLETED|Overall Study||27
5162867|NCT01241903|12697954|P1|COMPLETED|Overall Study||26
5162868|NCT01241903|12697953|P2|STARTED|Overall Study||27
5162869|NCT01241903|12697954|P1|STARTED|Overall Study||27
5162870|NCT01241760|12697962|P2|NOT COMPLETED|Overall Study||40
5162871|NCT01241760|12697963|P1|NOT COMPLETED|Overall Study||34
5162872|NCT01241760|12697962|P2|COMPLETED|Overall Study||329
5162873|NCT01241760|12697963|P1|COMPLETED|Overall Study||337
5162874|NCT01241760|12697962|P2|STARTED|Overall Study||369
5162875|NCT01241760|12697963|P1|STARTED|Overall Study||371
5162876|NCT01241604|12697982|P3|NOT COMPLETED|Study Period||0
5162877|NCT01241604|12697983|P2|NOT COMPLETED|Study Period||0
5162878|NCT01241604|12697984|P1|NOT COMPLETED|Study Period||0
5162879|NCT01241604|12697982|P3|COMPLETED|Study Period||3
5162880|NCT01241604|12697983|P2|COMPLETED|Study Period||5
5162881|NCT01241604|12697984|P1|COMPLETED|Study Period||0
5162882|NCT01241604|12697982|P3|STARTED|Study Period||3
5162883|NCT01241604|12697983|P2|STARTED|Study Period||5
5162884|NCT01241604|12697984|P1|STARTED|Study Period||0
5162885|NCT01241604|12697982|P3|NOT COMPLETED|Screening Period||0
5162886|NCT01241604|12697983|P2|NOT COMPLETED|Screening Period||0
5162887|NCT01241604|12697984|P1|NOT COMPLETED|Screening Period||3
5162888|NCT01241604|12697982|P3|COMPLETED|Screening Period||0
5162889|NCT01241604|12697983|P2|COMPLETED|Screening Period||0
5162890|NCT01241604|12697984|P1|COMPLETED|Screening Period||8
5162891|NCT01241604|12697982|P3|STARTED|Screening Period||0
5162892|NCT01241604|12697983|P2|STARTED|Screening Period||0
5162893|NCT01241604|12697984|P1|STARTED|Screening Period||11
5162894|NCT01241591|12698029|P4|NOT COMPLETED|Overall Study||12
5162895|NCT01241591|12698030|P3|NOT COMPLETED|Overall Study||22
5162896|NCT01241591|12698031|P2|NOT COMPLETED|Overall Study||24
5162897|NCT01241591|12698032|P1|NOT COMPLETED|Overall Study||23
5162898|NCT01241591|12698029|P4|COMPLETED|Overall Study||95
5162899|NCT01241591|12698030|P3|COMPLETED|Overall Study||313
5162900|NCT01241591|12698031|P2|COMPLETED|Overall Study||306
5162901|NCT01241591|12698032|P1|COMPLETED|Overall Study||306
5162902|NCT01241591|12698029|P4|STARTED|Overall Study||107
5162903|NCT01241591|12698030|P3|STARTED|Overall Study||335
5162904|NCT01241591|12698031|P2|STARTED|Overall Study||330
5162905|NCT01241591|12698032|P1|STARTED|Overall Study||329
5162906|NCT01241565|12698222|P1|NOT COMPLETED|Overall Study||0
5162907|NCT01241565|12698222|P1|COMPLETED|Overall Study||50
5162908|NCT01241565|12698222|P1|STARTED|Overall Study||50
5162909|NCT01241552|12698235|P4|NOT COMPLETED|Overall Study||64
5162910|NCT01241552|12698236|P3|NOT COMPLETED|Overall Study||60
5162911|NCT01241552|12698237|P2|NOT COMPLETED|Overall Study||63
5162912|NCT01241552|12698238|P1|NOT COMPLETED|Overall Study||41
5162913|NCT01241552|12698235|P4|COMPLETED|Overall Study||340
5162914|NCT01241552|12698236|P3|COMPLETED|Overall Study||343
5162915|NCT01241552|12698237|P2|COMPLETED|Overall Study||340
5162916|NCT01241552|12698238|P1|COMPLETED|Overall Study||201
5162917|NCT01241552|12698235|P4|Treated|Overall Study||397
5162918|NCT01241552|12698236|P3|Treated|Overall Study||388
5162919|NCT01241552|12698237|P2|Treated|Overall Study||392
5162920|NCT01241552|12698238|P1|Treated|Overall Study||235
5162921|NCT01241552|12698235|P4|STARTED|Overall Study||404
5162922|NCT01241552|12698236|P3|STARTED|Overall Study||403
5162923|NCT01241552|12698237|P2|STARTED|Overall Study||403
5162924|NCT01241552|12698238|P1|STARTED|Overall Study||242
5162925|NCT01241539|12698304|P1|NOT COMPLETED|Period 2||0
5162926|NCT01241539|12698304|P1|COMPLETED|Period 2||7
5162927|NCT01241539|12698304|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
5162928|NCT01241539|12698304|P1|NOT COMPLETED|Period 1||0
5162929|NCT01241539|12698304|P1|COMPLETED|Period 1||7
5162930|NCT01241539|12698304|P1|STARTED|Period 1||7
5162931|NCT01241513|12698325|P2|NOT COMPLETED|Overall Study||0
5162932|NCT01241513|12698326|P1|NOT COMPLETED|Overall Study||0
5162933|NCT01241513|12698325|P2|COMPLETED|Overall Study||9
5162934|NCT01241513|12698326|P1|COMPLETED|Overall Study|Study has been completed|10
5162935|NCT01241513|12698325|P2|STARTED|Overall Study||9
5162936|NCT01241513|12698326|P1|STARTED|Overall Study||10
5162937|NCT01241461|12698333|P2|NOT COMPLETED|Overall Study||6
5162938|NCT01241461|12698334|P1|NOT COMPLETED|Overall Study||3
5162939|NCT01241461|12698333|P2|COMPLETED|Overall Study||0
5162940|NCT01241461|12698334|P1|COMPLETED|Overall Study||0
5162941|NCT01241461|12698333|P2|STARTED|Overall Study||6
5162942|NCT01241461|12698334|P1|STARTED|Overall Study||3
5162943|NCT01241448|12698354|P4|NOT COMPLETED|Overall Study||23
5162944|NCT01241448|12698355|P3|NOT COMPLETED|Overall Study||23
5162945|NCT01241448|12698356|P2|NOT COMPLETED|Overall Study||29
5162946|NCT01241448|12698357|P1|NOT COMPLETED|Overall Study||37
5162947|NCT01241448|12698354|P4|COMPLETED|Overall Study||43
5162948|NCT01241448|12698355|P3|COMPLETED|Overall Study||43
5162949|NCT01241448|12698356|P2|COMPLETED|Overall Study||36
5162950|NCT01241448|12698357|P1|COMPLETED|Overall Study||29
5162951|NCT01241448|12698354|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
5162952|NCT01241448|12698355|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
5162953|NCT01241448|12698356|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
5162954|NCT01241448|12698357|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
5162955|NCT01241448|12698354|P4|Intent-to-Treat Population (ITT)|Overall Study||64
5162956|NCT01241448|12698355|P3|Intent-to-Treat Population (ITT)|Overall Study||64
5162957|NCT01241448|12698356|P2|Intent-to-Treat Population (ITT)|Overall Study||63
5162958|NCT01241448|12698357|P1|Intent-to-Treat Population (ITT)|Overall Study||63
5162959|NCT01241448|12698354|P4|STARTED|Overall Study||66
5162960|NCT01241448|12698355|P3|STARTED|Overall Study||66
5162961|NCT01241448|12698356|P2|STARTED|Overall Study||65
5162962|NCT01241448|12698357|P1|STARTED|Overall Study||66
5162963|NCT01241435|12698425|P4|NOT COMPLETED|Overall Study||0
5162964|NCT01241435|12698426|P3|NOT COMPLETED|Overall Study||0
5162965|NCT01241435|12698427|P2|NOT COMPLETED|Overall Study||0
5162966|NCT01241435|12698428|P1|NOT COMPLETED|Overall Study||0
5162967|NCT01241435|12698425|P4|COMPLETED|Overall Study||8
5162968|NCT01241435|12698426|P3|COMPLETED|Overall Study||8
5162969|NCT01241435|12698427|P2|COMPLETED|Overall Study||8
5162970|NCT01241435|12698428|P1|COMPLETED|Overall Study||12
5162971|NCT01241435|12698425|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
5162972|NCT01241435|12698426|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
5162973|NCT01241435|12698427|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
5162974|NCT01241435|12698428|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
5162975|NCT01241435|12698425|P4|STARTED|Overall Study||8
5162976|NCT01241435|12698426|P3|STARTED|Overall Study||8
5162977|NCT01241435|12698427|P2|STARTED|Overall Study||8
5162978|NCT01241435|12698428|P1|STARTED|Overall Study||12
5162979|NCT01241318|12698448|P2|NOT COMPLETED|Overall Study||742
5162980|NCT01241318|12698449|P1|NOT COMPLETED|Overall Study||1179
5162981|NCT01241318|12698448|P2|COMPLETED|Overall Study|Infants|19308
5162982|NCT01241318|12698449|P1|COMPLETED|Overall Study|Infants|18450
5162983|NCT01241318|12698448|P2|Liveborn Infant|Overall Study|Infants|19346
5162984|NCT01241318|12698449|P1|Liveborn Infant|Overall Study|Infants|18510
5162985|NCT01241318|12698448|P2|STARTED|Overall Study|Women enrolled|20050
5162986|NCT01241318|12698449|P1|STARTED|Overall Study|Women enrolled|19629
5162987|NCT01241292|12698462|P2|NOT COMPLETED|Overall Study||3
5162988|NCT01241292|12698463|P1|NOT COMPLETED|Overall Study||3
5162989|NCT01241292|12698462|P2|COMPLETED|Overall Study|completed=treatment on-going|0
5162990|NCT01241292|12698463|P1|COMPLETED|Overall Study|completed=treatment on-going|0
5162991|NCT01241292|12698462|P2|Entered Treatment Period|Overall Study||3
5162992|NCT01241292|12698463|P1|Entered Treatment Period|Overall Study||3
5162993|NCT01241292|12698462|P2|STARTED|Overall Study||3
5162994|NCT01241292|12698463|P1|STARTED|Overall Study||3
5162995|NCT01241279|12698487|P2|NOT COMPLETED|Overall Study||1
5162996|NCT01241279|12698488|P1|NOT COMPLETED|Overall Study||0
5162997|NCT01241279|12698487|P2|COMPLETED|Overall Study||1
5162998|NCT01241279|12698488|P1|COMPLETED|Overall Study||4
5162999|NCT01241279|12698487|P2|STARTED|Overall Study||2
5163000|NCT01241279|12698488|P1|STARTED|Overall Study||4
5163001|NCT01241240|12698498|P2|NOT COMPLETED|Overall Study||9
5163002|NCT01241240|12698499|P1|NOT COMPLETED|Overall Study||8
5163003|NCT01241240|12698498|P2|COMPLETED|Overall Study||89
5163004|NCT01241240|12698499|P1|COMPLETED|Overall Study||86
5163005|NCT01241240|12698498|P2|STARTED|Overall Study||98
5163006|NCT01241240|12698499|P1|STARTED|Overall Study||94
5163007|NCT01240915|12698517|P9|NOT COMPLETED|Overall Study||8
5163008|NCT01240915|12698518|P8|NOT COMPLETED|Overall Study||4
5163009|NCT01240915|12698519|P7|NOT COMPLETED|Overall Study||8
5163010|NCT01240915|12698520|P6|NOT COMPLETED|Overall Study||10
5163011|NCT01240915|12698521|P5|NOT COMPLETED|Overall Study||4
5163012|NCT01240915|12698522|P4|NOT COMPLETED|Overall Study||3
5163013|NCT01240915|12698523|P3|NOT COMPLETED|Overall Study||0
5163014|NCT01240915|12698524|P2|NOT COMPLETED|Overall Study||1
5163015|NCT01240915|12698525|P1|NOT COMPLETED|Overall Study||2
5163016|NCT01240915|12698517|P9|COMPLETED|Overall Study||13
5163017|NCT01240915|12698518|P8|COMPLETED|Overall Study||15
5163018|NCT01240915|12698519|P7|COMPLETED|Overall Study||17
5163019|NCT01240915|12698520|P6|COMPLETED|Overall Study||13
5163020|NCT01240915|12698521|P5|COMPLETED|Overall Study||2
5163021|NCT01240915|12698522|P4|COMPLETED|Overall Study||1
5163022|NCT01240915|12698523|P3|COMPLETED|Overall Study||2
5163023|NCT01240915|12698524|P2|COMPLETED|Overall Study||2
5163024|NCT01240915|12698525|P1|COMPLETED|Overall Study||0
5163025|NCT01240915|12698517|P9|STARTED|Overall Study||21
5163026|NCT01240915|12698518|P8|STARTED|Overall Study||19
5163027|NCT01240915|12698519|P7|STARTED|Overall Study||25
5163028|NCT01240915|12698520|P6|STARTED|Overall Study||23
5163029|NCT01240915|12698521|P5|STARTED|Overall Study||6
5163030|NCT01240915|12698522|P4|STARTED|Overall Study||4
5163031|NCT01240915|12698523|P3|STARTED|Overall Study||2
5163032|NCT01240915|12698524|P2|STARTED|Overall Study||3
5163033|NCT01240915|12698525|P1|STARTED|Overall Study||2
5163034|NCT01240902|12698708|P4|NOT COMPLETED|Overall Study||165
5163035|NCT01240902|12698709|P3|NOT COMPLETED|Overall Study||100
5163036|NCT01240902|12698710|P2|NOT COMPLETED|Overall Study||79
5163037|NCT01240902|12698711|P1|NOT COMPLETED|Overall Study||211
5163038|NCT01240902|12698708|P4|COMPLETED|Overall Study||237
5163039|NCT01240902|12698709|P3|COMPLETED|Overall Study||295
5163040|NCT01240902|12698710|P2|COMPLETED|Overall Study||77
5163041|NCT01240902|12698711|P1|COMPLETED|Overall Study||289
5163042|NCT01240902|12698708|P4|STARTED|Overall Study||402
5163043|NCT01240902|12698709|P3|STARTED|Overall Study||395
5163044|NCT01240902|12698710|P2|STARTED|Overall Study||156
5163045|NCT01240902|12698711|P1|STARTED|Overall Study||500
5163046|NCT01240863|12698799|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
5163047|NCT01240863|12698800|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
5163048|NCT01240863|12698801|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
5163049|NCT01240863|12698799|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
5163050|NCT01240863|12698800|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
5163051|NCT01240863|12698801|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
5163052|NCT01240863|12698799|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
5163053|NCT01240863|12698800|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
5163054|NCT01240863|12698801|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
5163055|NCT01240863|12698799|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
5163056|NCT01240863|12698800|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
5163057|NCT01240863|12698801|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
5163058|NCT01240863|12698799|P3|NOT COMPLETED|Open-label Titration Period||0
5163059|NCT01240863|12698800|P2|NOT COMPLETED|Open-label Titration Period||0
5163060|NCT01240863|12698801|P1|NOT COMPLETED|Open-label Titration Period||97
5163061|NCT01240863|12698799|P3|COMPLETED|Open-label Titration Period||0
5163062|NCT01240863|12698800|P2|COMPLETED|Open-label Titration Period||0
5163063|NCT01240863|12698801|P1|COMPLETED|Open-label Titration Period||294
5163064|NCT01240863|12698799|P3|Safety Analysis Set|Open-label Titration Period||0
5163065|NCT01240863|12698800|P2|Safety Analysis Set|Open-label Titration Period||0
5163066|NCT01240863|12698801|P1|Safety Analysis Set|Open-label Titration Period||389
5163067|NCT01240863|12698799|P3|STARTED|Open-label Titration Period||0
5163068|NCT01240863|12698800|P2|STARTED|Open-label Titration Period||0
5163069|NCT01240863|12698801|P1|STARTED|Open-label Titration Period||391
5163070|NCT01240811|12698863|P3|NOT COMPLETED|Overall Study||1
5163071|NCT01240811|12698864|P2|NOT COMPLETED|Overall Study||1
5163072|NCT01240811|12698865|P1|NOT COMPLETED|Overall Study||0
5163073|NCT01240811|12698863|P3|COMPLETED|Overall Study||16
5163074|NCT01240811|12698864|P2|COMPLETED|Overall Study||16
5163075|NCT01240811|12698865|P1|COMPLETED|Overall Study||8
5163076|NCT01240811|12698863|P3|STARTED|Overall Study||17
5163077|NCT01240811|12698864|P2|STARTED|Overall Study||17
5163078|NCT01240811|12698865|P1|STARTED|Overall Study||8
5163079|NCT01240785|12698881|P2|NOT COMPLETED|Overall Study||3
5163080|NCT01240785|12698882|P1|NOT COMPLETED|Overall Study||1
5163081|NCT01240785|12698881|P2|COMPLETED|Overall Study||107
5163082|NCT01240785|12698882|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
5163083|NCT01240785|12698881|P2|STARTED|Overall Study||110
5163084|NCT01240785|12698882|P1|STARTED|Overall Study||111
5163085|NCT01240746|12698913|P3|NOT COMPLETED|Overall Study||243
5163086|NCT01240746|12698914|P2|NOT COMPLETED|Overall Study||48
5163087|NCT01240746|12698915|P1|NOT COMPLETED|Overall Study||59
5163088|NCT01240746|12698913|P3|COMPLETED|Overall Study||2659
5163089|NCT01240746|12698914|P2|COMPLETED|Overall Study||677
5163090|NCT01240746|12698915|P1|COMPLETED|Overall Study||677
5163091|NCT01240746|12698913|P3|STARTED|Overall Study||2902
5163092|NCT01240746|12698914|P2|STARTED|Overall Study||725
5163093|NCT01240746|12698915|P1|STARTED|Overall Study||736
5163094|NCT01240590|12698970|P5|NOT COMPLETED|Phase II||1
5163095|NCT01240590|12698971|P4|NOT COMPLETED|Phase II||2
5163096|NCT01240590|12698972|P3|NOT COMPLETED|Phase II||0
5163097|NCT01240590|12698973|P2|NOT COMPLETED|Phase II||0
5163098|NCT01240590|12698974|P1|NOT COMPLETED|Phase II||0
5163099|NCT01240590|12698970|P5|COMPLETED|Phase II||0
5163100|NCT01240590|12698971|P4|COMPLETED|Phase II||15
5163101|NCT01240590|12698972|P3|COMPLETED|Phase II||0
5163102|NCT01240590|12698973|P2|COMPLETED|Phase II||0
5163103|NCT01240590|12698974|P1|COMPLETED|Phase II||0
5163104|NCT01240590|12698970|P5|STARTED|Phase II||1
5163105|NCT01240590|12698971|P4|STARTED|Phase II||17
5163106|NCT01240590|12698972|P3|STARTED|Phase II||0
5163107|NCT01240590|12698973|P2|STARTED|Phase II||0
5163108|NCT01240590|12698974|P1|STARTED|Phase II||0
5163109|NCT01240590|12698970|P5|NOT COMPLETED|Phase I||0
5163110|NCT01240590|12698971|P4|NOT COMPLETED|Phase I||0
5163111|NCT01240590|12698972|P3|NOT COMPLETED|Phase I||3
5163112|NCT01240590|12698973|P2|NOT COMPLETED|Phase I||0
5163113|NCT01240590|12698974|P1|NOT COMPLETED|Phase I||0
5163114|NCT01240590|12698970|P5|COMPLETED|Phase I||0
5163115|NCT01240590|12698971|P4|COMPLETED|Phase I||0
5163116|NCT01240590|12698972|P3|COMPLETED|Phase I||0
5163117|NCT01240590|12698973|P2|COMPLETED|Phase I||6
5163118|NCT01240590|12698974|P1|COMPLETED|Phase I||0
5163119|NCT01240590|12698970|P5|STARTED|Phase I||0
5163120|NCT01240590|12698971|P4|STARTED|Phase I||0
5163121|NCT01240590|12698972|P3|STARTED|Phase I||3
5163122|NCT01240590|12698973|P2|STARTED|Phase I||6
5163123|NCT01240590|12698974|P1|STARTED|Phase I||0
5163124|NCT01240551|12699002|P2|NOT COMPLETED|Overall Study||3
5163125|NCT01240551|12699003|P1|NOT COMPLETED|Overall Study||4
5163126|NCT01240551|12699002|P2|COMPLETED|Overall Study||27
5163127|NCT01240551|12699003|P1|COMPLETED|Overall Study||26
5163128|NCT01240551|12699002|P2|STARTED|Overall Study||30
5163129|NCT01240551|12699003|P1|STARTED|Overall Study||30
5163130|NCT01240382|12699013|P2|NOT COMPLETED|Overall Study||4
5163131|NCT01240382|12699014|P1|NOT COMPLETED|Overall Study||2
5163132|NCT01240382|12699013|P2|COMPLETED|Overall Study||139
5163133|NCT01240382|12699014|P1|COMPLETED|Overall Study||142
5163134|NCT01240382|12699013|P2|STARTED|Overall Study||143
5163135|NCT01240382|12699014|P1|STARTED|Overall Study||144
5163136|NCT01240356|12699024|P2|NOT COMPLETED|Overall Study||0
5163137|NCT01240356|12699025|P1|NOT COMPLETED|Overall Study||3
5163138|NCT01240356|12699024|P2|COMPLETED|Overall Study||20
5163139|NCT01240356|12699025|P1|COMPLETED|Overall Study||15
5163140|NCT01240356|12699024|P2|STARTED|Overall Study||20
5163141|NCT01240356|12699025|P1|STARTED|Overall Study||18
5163142|NCT01240330|12699036|P1|NOT COMPLETED|Overall Study||0
5163143|NCT01240330|12699036|P1|COMPLETED|Overall Study||33
5163144|NCT01240330|12699036|P1|STARTED|Overall Study||33
5163145|NCT01240304|12699042|P1|NOT COMPLETED|Overall Study||10
5163146|NCT01240304|12699042|P1|COMPLETED|Overall Study||0
5163147|NCT01240304|12699042|P1|STARTED|Overall Study||10
5163148|NCT01240200|12699048|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
5163149|NCT01240200|12699049|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
5163150|NCT01240200|12699048|P2|COMPLETED|12-week Crossover Phase - Period 2||23
5163151|NCT01240200|12699049|P1|COMPLETED|12-week Crossover Phase - Period 2||23
5163152|NCT01240200|12699048|P2|STARTED|12-week Crossover Phase - Period 2||23
5163153|NCT01240200|12699049|P1|STARTED|12-week Crossover Phase - Period 2||23
5163154|NCT01240200|12699048|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
5163155|NCT01240200|12699049|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
5163156|NCT01240200|12699048|P2|COMPLETED|12-week Crossover Phase - Period 1||23
5163157|NCT01240200|12699049|P1|COMPLETED|12-week Crossover Phase - Period 1||23
5163158|NCT01240200|12699048|P2|STARTED|12-week Crossover Phase - Period 1||24
5163159|NCT01240200|12699049|P1|STARTED|12-week Crossover Phase - Period 1||25
5163160|NCT01240135|12699067|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
5163161|NCT01240135|12699068|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
5163162|NCT01240135|12699067|P2|COMPLETED|Period Two, 14 Days of Wear||43
5163163|NCT01240135|12699068|P1|COMPLETED|Period Two, 14 Days of Wear||43
5163164|NCT01240135|12699067|P2|STARTED|Period Two, 14 Days of Wear||45
5163165|NCT01240135|12699068|P1|STARTED|Period Two, 14 Days of Wear||44
5163166|NCT01240135|12699067|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
5163167|NCT01240135|12699068|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
5163168|NCT01240135|12699067|P2|COMPLETED|Period One, 14 Days of Wear||45
5163169|NCT01240135|12699068|P1|COMPLETED|Period One, 14 Days of Wear||44
5163170|NCT01240135|12699067|P2|STARTED|Period One, 14 Days of Wear||45
5163171|NCT01240135|12699068|P1|STARTED|Period One, 14 Days of Wear||44
5163172|NCT01240122|12699076|P1|NOT COMPLETED|Overall Study||0
5163173|NCT01240122|12699076|P1|COMPLETED|Overall Study||29
5163174|NCT01240122|12699076|P1|STARTED|Overall Study||29
5163175|NCT01239992|12699085|P1|NOT COMPLETED|Overall Study||2
5163176|NCT01239992|12699085|P1|COMPLETED|Overall Study||10
5163177|NCT01239992|12699085|P1|STARTED|Overall Study||12
5163178|NCT01239797|12699094|P2|NOT COMPLETED|Treated Participants||274
5163179|NCT01239797|12699095|P1|NOT COMPLETED|Treated Participants||235
5163180|NCT01239797|12699094|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
5163181|NCT01239797|12699095|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
5163182|NCT01239797|12699094|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
5163183|NCT01239797|12699095|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
5163184|NCT01239797|12699094|P2|NOT COMPLETED|Randomized Participants||9
5163185|NCT01239797|12699095|P1|NOT COMPLETED|Randomized Participants||2
5163186|NCT01239797|12699094|P2|COMPLETED|Randomized Participants||316
5163187|NCT01239797|12699095|P1|COMPLETED|Randomized Participants||319
5163188|NCT01239797|12699094|P2|STARTED|Randomized Participants||325
5163189|NCT01239797|12699095|P1|STARTED|Randomized Participants||321
5163190|NCT01239745|12699103|P1|NOT COMPLETED|Overall Study||46
5163191|NCT01239745|12699103|P1|COMPLETED|Overall Study||0
5163192|NCT01239745|12699103|P1|STARTED|Overall Study||46
5163193|NCT01239732|12699114|P1|NOT COMPLETED|Overall Study||1021
5163194|NCT01239732|12699114|P1|COMPLETED|Overall Study||0
5163195|NCT01239732|12699114|P1|STARTED|Overall Study||1021
5163196|NCT01239680|12699127|P2|NOT COMPLETED|Overall Study||0
5163197|NCT01239680|12699128|P1|NOT COMPLETED|Overall Study||2
5163198|NCT01239680|12699127|P2|COMPLETED|Overall Study||2
5163199|NCT01239680|12699128|P1|COMPLETED|Overall Study||1
5163200|NCT01239680|12699127|P2|STARTED|Overall Study||2
5163201|NCT01239680|12699128|P1|STARTED|Overall Study||3
5163202|NCT01239511|12699138|P4|NOT COMPLETED|Overall Study||9
5163203|NCT01239511|12699139|P3|NOT COMPLETED|Overall Study||4
5163204|NCT01239511|12699140|P2|NOT COMPLETED|Overall Study||5
5163205|NCT01239511|12699141|P1|NOT COMPLETED|Overall Study||1
5163206|NCT01239511|12699138|P4|COMPLETED|Overall Study||38
5163207|NCT01239511|12699139|P3|COMPLETED|Overall Study||43
5163208|NCT01239511|12699140|P2|COMPLETED|Overall Study||40
5163209|NCT01239511|12699141|P1|COMPLETED|Overall Study||46
5163210|NCT01239511|12699138|P4|STARTED|Overall Study||47
5163211|NCT01239511|12699139|P3|STARTED|Overall Study||47
5163212|NCT01239511|12699140|P2|STARTED|Overall Study||45
5163213|NCT01239511|12699141|P1|STARTED|Overall Study||47
5163214|NCT01239472|12699153|P2|NOT COMPLETED|Overall Study||3
5163215|NCT01239472|12699154|P1|NOT COMPLETED|Overall Study||5
5163216|NCT01239472|12699153|P2|COMPLETED|Overall Study||12
5163217|NCT01239472|12699154|P1|COMPLETED|Overall Study||10
5163218|NCT01239472|12699153|P2|STARTED|Overall Study||15
5163219|NCT01239472|12699154|P1|STARTED|Overall Study||15
5163220|NCT01239394|12699162|P1|NOT COMPLETED|Overall Study||1
5163221|NCT01239394|12699162|P1|COMPLETED|Overall Study||41
5163222|NCT01239394|12699162|P1|STARTED|Overall Study||42
5163223|NCT01239381|12699169|P1|NOT COMPLETED|Overall Study||2
5163224|NCT01239381|12699169|P1|COMPLETED|Overall Study||90
5163225|NCT01239381|12699169|P1|STARTED|Overall Study||92
5163226|NCT01239368|12699189|P10|NOT COMPLETED|Overall Study||4
5163227|NCT01239368|12699190|P9|NOT COMPLETED|Overall Study||0
5163228|NCT01239368|12699191|P8|NOT COMPLETED|Overall Study||0
5163229|NCT01239368|12699192|P7|NOT COMPLETED|Overall Study||6
5163230|NCT01239368|12699193|P6|NOT COMPLETED|Overall Study||4
5163231|NCT01239368|12699194|P5|NOT COMPLETED|Overall Study||5
5163232|NCT01239368|12699195|P4|NOT COMPLETED|Overall Study||1
5163233|NCT01239368|12699196|P3|NOT COMPLETED|Overall Study||1
5163234|NCT01239368|12699197|P2|NOT COMPLETED|Overall Study||1
5163235|NCT01239368|12699198|P1|NOT COMPLETED|Overall Study||2
5163236|NCT01239368|12699189|P10|COMPLETED|Overall Study||1
5163237|NCT01239368|12699190|P9|COMPLETED|Overall Study||1
5163238|NCT01239368|12699191|P8|COMPLETED|Overall Study||0
5163239|NCT01239368|12699192|P7|COMPLETED|Overall Study||1
5163240|NCT01239368|12699193|P6|COMPLETED|Overall Study||1
5163241|NCT01239368|12699194|P5|COMPLETED|Overall Study||2
5163242|NCT01239368|12699195|P4|COMPLETED|Overall Study||1
5163243|NCT01239368|12699196|P3|COMPLETED|Overall Study||0
5163244|NCT01239368|12699197|P2|COMPLETED|Overall Study||0
5163245|NCT01239368|12699198|P1|COMPLETED|Overall Study||0
5163246|NCT01239368|12699189|P10|STARTED|Overall Study||5
5163247|NCT01239368|12699190|P9|STARTED|Overall Study||1
5163248|NCT01239368|12699191|P8|STARTED|Overall Study||0
5163249|NCT01239368|12699192|P7|STARTED|Overall Study||7
5163250|NCT01239368|12699193|P6|STARTED|Overall Study||5
5163251|NCT01239368|12699194|P5|STARTED|Overall Study||7
5163252|NCT01239368|12699195|P4|STARTED|Overall Study||2
5163253|NCT01239368|12699196|P3|STARTED|Overall Study||1
5163254|NCT01239368|12699197|P2|STARTED|Overall Study||1
5163255|NCT01239368|12699198|P1|STARTED|Overall Study||2
5163256|NCT01239355|12699242|P1|NOT COMPLETED|Overall Study||0
5163257|NCT01239355|12699242|P1|COMPLETED|Overall Study||15
5163258|NCT01239355|12699242|P1|STARTED|Overall Study||15
5163259|NCT01239342|12699250|P2|NOT COMPLETED|Overall Study||6
5163260|NCT01239342|12699251|P1|NOT COMPLETED|Overall Study||3
5163261|NCT01239342|12699250|P2|COMPLETED|Overall Study||8
5163262|NCT01239342|12699251|P1|COMPLETED|Overall Study||26
5163263|NCT01239342|12699250|P2|STARTED|Overall Study||14
5163264|NCT01239342|12699251|P1|STARTED|Overall Study||29
5163265|NCT01239316|12699267|P1|NOT COMPLETED|Overall Study||12
5163266|NCT01239316|12699267|P1|COMPLETED|Overall Study||0
5163267|NCT01239316|12699267|P1|STARTED|Overall Study||12
5163268|NCT01239212|12699275|P1|NOT COMPLETED|Overall Study||0
5163269|NCT01239212|12699275|P1|COMPLETED|Overall Study||7
5163270|NCT01239212|12699275|P1|STARTED|Overall Study||7
5163271|NCT01239121|12699282|P3|NOT COMPLETED|Overall Study||0
5163272|NCT01239121|12699283|P2|NOT COMPLETED|Overall Study||4
5163273|NCT01239121|12699284|P1|NOT COMPLETED|Overall Study||2
5163274|NCT01239121|12699282|P3|COMPLETED|Overall Study||15
5163275|NCT01239121|12699283|P2|COMPLETED|Overall Study||195
5163276|NCT01239121|12699284|P1|COMPLETED|Overall Study||186
5163277|NCT01239121|12699282|P3|STARTED|Overall Study||15
5163278|NCT01239121|12699283|P2|STARTED|Overall Study||199
5163279|NCT01239121|12699284|P1|STARTED|Overall Study||188
5163280|NCT01239056|12699298|P1|NOT COMPLETED|Overall Study||0
5163281|NCT01239056|12699298|P1|COMPLETED|Overall Study||20
5163282|NCT01239056|12699298|P1|STARTED|Overall Study||20
5163283|NCT01239043|12699306|P2|NOT COMPLETED|Overall Study||1
5163284|NCT01239043|12699307|P1|NOT COMPLETED|Overall Study||2
5163285|NCT01239043|12699306|P2|COMPLETED|Overall Study||102
5163286|NCT01239043|12699307|P1|COMPLETED|Overall Study||34
5163287|NCT01239043|12699306|P2|STARTED|Overall Study||103
5163288|NCT01239043|12699307|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
5163289|NCT01238991|12699335|P10|NOT COMPLETED|Overall Study||2
5163290|NCT01238991|12699336|P9|NOT COMPLETED|Overall Study||4
5163291|NCT01238991|12699337|P8|NOT COMPLETED|Overall Study||5
5163292|NCT01238991|12699338|P7|NOT COMPLETED|Overall Study||8
5163293|NCT01238991|12699339|P6|NOT COMPLETED|Overall Study||0
5163294|NCT01238991|12699340|P5|NOT COMPLETED|Overall Study||2
5163295|NCT01238991|12699341|P4|NOT COMPLETED|Overall Study||2
5163296|NCT01238991|12699342|P3|NOT COMPLETED|Overall Study||6
5163297|NCT01238991|12699343|P2|NOT COMPLETED|Overall Study||0
5163298|NCT01238991|12699344|P1|NOT COMPLETED|Overall Study||2
5163299|NCT01238991|12699335|P10|COMPLETED|Overall Study||0
5163300|NCT01238991|12699336|P9|COMPLETED|Overall Study||0
5163301|NCT01238991|12699337|P8|COMPLETED|Overall Study||0
5163302|NCT01238991|12699338|P7|COMPLETED|Overall Study||0
5163303|NCT01238991|12699339|P6|COMPLETED|Overall Study||2
5163304|NCT01238991|12699340|P5|COMPLETED|Overall Study||3
5163305|NCT01238991|12699341|P4|COMPLETED|Overall Study||4
5163306|NCT01238991|12699342|P3|COMPLETED|Overall Study||5
5163307|NCT01238991|12699343|P2|COMPLETED|Overall Study||3
5163308|NCT01238991|12699344|P1|COMPLETED|Overall Study||5
5163309|NCT01238991|12699335|P10|Received Treatment|Overall Study||2
5163310|NCT01238991|12699336|P9|Received Treatment|Overall Study||4
5163311|NCT01238991|12699337|P8|Received Treatment|Overall Study||5
5163312|NCT01238991|12699338|P7|Received Treatment|Overall Study||8
5163313|NCT01238991|12699339|P6|Received Treatment|Overall Study||2
5163314|NCT01238991|12699340|P5|Received Treatment|Overall Study||5
5163315|NCT01238991|12699341|P4|Received Treatment|Overall Study||6
5163316|NCT01238991|12699342|P3|Received Treatment|Overall Study||11
5163317|NCT01238991|12699343|P2|Received Treatment|Overall Study||3
5163318|NCT01238991|12699344|P1|Received Treatment|Overall Study||7
5163319|NCT01238991|12699335|P10|STARTED|Overall Study||2
5163320|NCT01238991|12699336|P9|STARTED|Overall Study||4
5163321|NCT01238991|12699337|P8|STARTED|Overall Study||5
5163322|NCT01238991|12699338|P7|STARTED|Overall Study||8
5163323|NCT01238991|12699339|P6|STARTED|Overall Study||2
5163324|NCT01238991|12699340|P5|STARTED|Overall Study||5
5163325|NCT01238991|12699341|P4|STARTED|Overall Study||6
5163326|NCT01238991|12699342|P3|STARTED|Overall Study||11
5163327|NCT01238991|12699343|P2|STARTED|Overall Study||3
5163328|NCT01238991|12699344|P1|STARTED|Overall Study||7
5163329|NCT01238900|12699431|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
5163330|NCT01238900|12699431|P1|COMPLETED|<12 Months Post Stent Removal||18
5163331|NCT01238900|12699431|P1|STARTED|<12 Months Post Stent Removal||23
5163332|NCT01238900|12699431|P1|NOT COMPLETED|6 Months Post Stent Placement||0
5163333|NCT01238900|12699431|P1|COMPLETED|6 Months Post Stent Placement||23
5163334|NCT01238900|12699431|P1|STARTED|6 Months Post Stent Placement||23
5163335|NCT01238861|12699445|P6|NOT COMPLETED|Overall Study||15
5163336|NCT01238861|12699446|P5|NOT COMPLETED|Overall Study||13
5163337|NCT01238861|12699447|P4|NOT COMPLETED|Overall Study||13
5163338|NCT01238861|12699448|P3|NOT COMPLETED|Overall Study||11
5163339|NCT01238861|12699449|P2|NOT COMPLETED|Overall Study||8
5163340|NCT01238861|12699450|P1|NOT COMPLETED|Overall Study||11
5163341|NCT01238861|12699445|P6|COMPLETED|Overall Study||125
5163342|NCT01238861|12699446|P5|COMPLETED|Overall Study||129
5163343|NCT01238861|12699447|P4|COMPLETED|Overall Study||69
5163344|NCT01238861|12699448|P3|COMPLETED|Overall Study||70
5163345|NCT01238861|12699449|P2|COMPLETED|Overall Study||73
5163346|NCT01238861|12699450|P1|COMPLETED|Overall Study||69
5163347|NCT01238861|12699445|P6|STARTED|Overall Study||140
5163348|NCT01238861|12699446|P5|STARTED|Overall Study||142
5163349|NCT01238861|12699447|P4|STARTED|Overall Study||82
5163350|NCT01238861|12699448|P3|STARTED|Overall Study||81
5163351|NCT01238861|12699449|P2|STARTED|Overall Study||81
5163352|NCT01238861|12699450|P1|STARTED|Overall Study||80
5163353|NCT01238848|12699530|P2|NOT COMPLETED|Overall Study||5
5163354|NCT01238848|12699531|P1|NOT COMPLETED|Overall Study||13
5163355|NCT01238848|12699530|P2|COMPLETED|Overall Study||45
5163356|NCT01238848|12699531|P1|COMPLETED|Overall Study||37
5163357|NCT01238848|12699530|P2|STARTED|Overall Study||50
5163358|NCT01238848|12699531|P1|STARTED|Overall Study||50
5163359|NCT01238822|12699539|P1|NOT COMPLETED|Overall Study||3
5163360|NCT01238822|12699539|P1|COMPLETED|Overall Study||93
5163361|NCT01238822|12699539|P1|Received High Dosage|Overall Study||93
5163362|NCT01238822|12699539|P1|Received Medium Dosage|Overall Study||93
5163363|NCT01238822|12699539|P1|Received Low Dosage|Overall Study||93
5163364|NCT01238822|12699539|P1|Received Placebo|Overall Study||93
5163365|NCT01238822|12699539|P1|STARTED|Overall Study||96
5163366|NCT01238640|12699549|P1|NOT COMPLETED|Overall Study||0
5163367|NCT01238640|12699549|P1|COMPLETED|Overall Study||84
5163368|NCT01238640|12699549|P1|STARTED|Overall Study||84
5163369|NCT01238588|12699566|P1|NOT COMPLETED|Overall Study||3
5163370|NCT01238588|12699566|P1|COMPLETED|Overall Study||9
5163371|NCT01238588|12699566|P1|STARTED|Overall Study||12
5163372|NCT01238575|12699579|P2|NOT COMPLETED|Overall Study||4
5163373|NCT01238575|12699580|P1|NOT COMPLETED|Overall Study||4
5163374|NCT01238575|12699579|P2|COMPLETED|Overall Study||28
5163375|NCT01238575|12699580|P1|COMPLETED|Overall Study||26
5163376|NCT01238575|12699579|P2|STARTED|Overall Study||32
5163377|NCT01238575|12699580|P1|STARTED|Overall Study||30
5163378|NCT01238549|12699616|P1|NOT COMPLETED|Overall Study||36
5163379|NCT01238549|12699616|P1|COMPLETED|Overall Study||248
5163380|NCT01238549|12699616|P1|STARTED|Overall Study||284
5163381|NCT01238536|12699635|P2|NOT COMPLETED|Overall Study||50
5163382|NCT01238536|12699636|P1|NOT COMPLETED|Overall Study||47
5163383|NCT01238536|12699635|P2|COMPLETED|Overall Study||150
5163384|NCT01238536|12699636|P1|COMPLETED|Overall Study||153
5163385|NCT01238536|12699635|P2|STARTED|Overall Study||200
5163386|NCT01238536|12699636|P1|STARTED|Overall Study||200
5163387|NCT01238471|12699650|P2|NOT COMPLETED|Overall Study||0
5163388|NCT01238471|12699651|P1|NOT COMPLETED|Overall Study||0
5163389|NCT01238471|12699650|P2|COMPLETED|Overall Study||10
5163390|NCT01238471|12699651|P1|COMPLETED|Overall Study||10
5163391|NCT01238471|12699650|P2|STARTED|Overall Study||10
5163392|NCT01238471|12699651|P1|STARTED|Overall Study||10
5163393|NCT01238341|12699657|P1|NOT COMPLETED|Overall Study||0
5163394|NCT01238341|12699657|P1|COMPLETED|Overall Study||7
5163395|NCT01238341|12699657|P1|STARTED|Overall Study||7
5163396|NCT01238211|12699664|P1|NOT COMPLETED|Overall Study||58
5163397|NCT01238211|12699664|P1|COMPLETED|Overall Study||3
5163398|NCT01238211|12699664|P1|STARTED|Overall Study||61
5163399|NCT01238172|12699670|P2|NOT COMPLETED|Overall Study||24
5163400|NCT01238172|12699671|P1|NOT COMPLETED|Overall Study||11
5163401|NCT01238172|12699670|P2|COMPLETED|Overall Study||217
5163402|NCT01238172|12699671|P1|COMPLETED|Overall Study||226
5163403|NCT01238172|12699670|P2|STARTED|Overall Study||241
5163404|NCT01238172|12699671|P1|STARTED|Overall Study||237
5163405|NCT01237951|12699683|P1|NOT COMPLETED|Overall Study||1
5163406|NCT01237951|12699683|P1|COMPLETED|Overall Study||74
5163407|NCT01237951|12699683|P1|STARTED|Overall Study||75
5163408|NCT01237899|12699701|P11|NOT COMPLETED|Second Dosing Period||0
5163409|NCT01237899|12699702|P10|NOT COMPLETED|Second Dosing Period||0
5163410|NCT01237899|12699703|P9|NOT COMPLETED|Second Dosing Period||0
5163411|NCT01237899|12699704|P8|NOT COMPLETED|Second Dosing Period||0
5163412|NCT01237899|12699705|P7|NOT COMPLETED|Second Dosing Period||0
5163413|NCT01237899|12699706|P6|NOT COMPLETED|Second Dosing Period||0
5163414|NCT01237899|12699707|P5|NOT COMPLETED|Second Dosing Period||0
5163415|NCT01237899|12699708|P4|NOT COMPLETED|Second Dosing Period||0
5163416|NCT01237899|12699709|P3|NOT COMPLETED|Second Dosing Period||0
5163417|NCT01237899|12699710|P2|NOT COMPLETED|Second Dosing Period||0
5163418|NCT01237899|12699711|P1|NOT COMPLETED|Second Dosing Period||0
5163419|NCT01237899|12699701|P11|COMPLETED|Second Dosing Period||4
5163420|NCT01237899|12699702|P10|COMPLETED|Second Dosing Period||3
5163421|NCT01237899|12699703|P9|COMPLETED|Second Dosing Period||4
5163422|NCT01237899|12699704|P8|COMPLETED|Second Dosing Period||3
5163423|NCT01237899|12699705|P7|COMPLETED|Second Dosing Period||1
5163424|NCT01237899|12699706|P6|COMPLETED|Second Dosing Period||4
5163425|NCT01237899|12699707|P5|COMPLETED|Second Dosing Period||2
5163426|NCT01237899|12699708|P4|COMPLETED|Second Dosing Period||3
5163427|NCT01237899|12699709|P3|COMPLETED|Second Dosing Period||3
5163428|NCT01237899|12699710|P2|COMPLETED|Second Dosing Period||3
5163429|NCT01237899|12699711|P1|COMPLETED|Second Dosing Period||1
5163430|NCT01237899|12699701|P11|STARTED|Second Dosing Period||4
5163431|NCT01237899|12699702|P10|STARTED|Second Dosing Period||3
5163432|NCT01237899|12699703|P9|STARTED|Second Dosing Period||4
5163433|NCT01237899|12699704|P8|STARTED|Second Dosing Period||3
5163434|NCT01237899|12699705|P7|STARTED|Second Dosing Period||1
5163435|NCT01237899|12699706|P6|STARTED|Second Dosing Period||4
5163436|NCT01237899|12699707|P5|STARTED|Second Dosing Period||2
5163437|NCT01237899|12699708|P4|STARTED|Second Dosing Period||3
5163438|NCT01237899|12699709|P3|STARTED|Second Dosing Period||3
5163439|NCT01237899|12699710|P2|STARTED|Second Dosing Period||3
5163440|NCT01237899|12699711|P1|STARTED|Second Dosing Period||1
5163441|NCT01237899|12699701|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163442|NCT01237899|12699702|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163443|NCT01237899|12699703|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163444|NCT01237899|12699704|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163445|NCT01237899|12699705|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163446|NCT01237899|12699706|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163447|NCT01237899|12699707|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163448|NCT01237899|12699708|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163449|NCT01237899|12699709|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
5163450|NCT01237899|12699710|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163451|NCT01237899|12699711|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
5163452|NCT01237899|12699701|P11|COMPLETED|Washout Period of at Least 7 Days||4
5163453|NCT01237899|12699702|P10|COMPLETED|Washout Period of at Least 7 Days||3
5163454|NCT01237899|12699703|P9|COMPLETED|Washout Period of at Least 7 Days||4
5163455|NCT01237899|12699704|P8|COMPLETED|Washout Period of at Least 7 Days||3
5163456|NCT01237899|12699705|P7|COMPLETED|Washout Period of at Least 7 Days||1
5163457|NCT01237899|12699706|P6|COMPLETED|Washout Period of at Least 7 Days||4
5163458|NCT01237899|12699707|P5|COMPLETED|Washout Period of at Least 7 Days||2
5163459|NCT01237899|12699708|P4|COMPLETED|Washout Period of at Least 7 Days||3
5163460|NCT01237899|12699709|P3|COMPLETED|Washout Period of at Least 7 Days||3
5163461|NCT01237899|12699710|P2|COMPLETED|Washout Period of at Least 7 Days||3
5163462|NCT01237899|12699711|P1|COMPLETED|Washout Period of at Least 7 Days||1
5163463|NCT01237899|12699701|P11|STARTED|Washout Period of at Least 7 Days||4
5163464|NCT01237899|12699702|P10|STARTED|Washout Period of at Least 7 Days||3
5163465|NCT01237899|12699703|P9|STARTED|Washout Period of at Least 7 Days||4
5163466|NCT01237899|12699704|P8|STARTED|Washout Period of at Least 7 Days||3
5163467|NCT01237899|12699705|P7|STARTED|Washout Period of at Least 7 Days||1
5163468|NCT01237899|12699706|P6|STARTED|Washout Period of at Least 7 Days||4
5163469|NCT01237899|12699707|P5|STARTED|Washout Period of at Least 7 Days||2
5163470|NCT01237899|12699708|P4|STARTED|Washout Period of at Least 7 Days||3
5163471|NCT01237899|12699709|P3|STARTED|Washout Period of at Least 7 Days||4
5163472|NCT01237899|12699710|P2|STARTED|Washout Period of at Least 7 Days||3
5163473|NCT01237899|12699711|P1|STARTED|Washout Period of at Least 7 Days||1
5163474|NCT01237899|12699701|P11|NOT COMPLETED|First Dosing Period||0
5163475|NCT01237899|12699702|P10|NOT COMPLETED|First Dosing Period||0
5163476|NCT01237899|12699703|P9|NOT COMPLETED|First Dosing Period||0
5163477|NCT01237899|12699704|P8|NOT COMPLETED|First Dosing Period||0
5163478|NCT01237899|12699705|P7|NOT COMPLETED|First Dosing Period||0
5163479|NCT01237899|12699706|P6|NOT COMPLETED|First Dosing Period||0
5163480|NCT01237899|12699707|P5|NOT COMPLETED|First Dosing Period||0
5163481|NCT01237899|12699708|P4|NOT COMPLETED|First Dosing Period||0
5163482|NCT01237899|12699709|P3|NOT COMPLETED|First Dosing Period||0
5163483|NCT01237899|12699710|P2|NOT COMPLETED|First Dosing Period||0
5163484|NCT01237899|12699711|P1|NOT COMPLETED|First Dosing Period||0
5163485|NCT01237899|12699701|P11|COMPLETED|First Dosing Period||4
5163486|NCT01237899|12699702|P10|COMPLETED|First Dosing Period||3
5163487|NCT01237899|12699703|P9|COMPLETED|First Dosing Period||4
5163488|NCT01237899|12699704|P8|COMPLETED|First Dosing Period||3
5163489|NCT01237899|12699705|P7|COMPLETED|First Dosing Period||1
5163490|NCT01237899|12699706|P6|COMPLETED|First Dosing Period||4
5163491|NCT01237899|12699707|P5|COMPLETED|First Dosing Period||2
5163492|NCT01237899|12699708|P4|COMPLETED|First Dosing Period||3
5163493|NCT01237899|12699709|P3|COMPLETED|First Dosing Period||4
5163494|NCT01237899|12699710|P2|COMPLETED|First Dosing Period||3
5163495|NCT01237899|12699711|P1|COMPLETED|First Dosing Period||1
5163496|NCT01237899|12699701|P11|STARTED|First Dosing Period||4
5163497|NCT01237899|12699702|P10|STARTED|First Dosing Period||3
5163498|NCT01237899|12699703|P9|STARTED|First Dosing Period||4
5163499|NCT01237899|12699704|P8|STARTED|First Dosing Period||3
5163500|NCT01237899|12699705|P7|STARTED|First Dosing Period||1
5163501|NCT01237899|12699706|P6|STARTED|First Dosing Period||4
5163502|NCT01237899|12699707|P5|STARTED|First Dosing Period||2
5163503|NCT01237899|12699708|P4|STARTED|First Dosing Period||3
5163504|NCT01237899|12699709|P3|STARTED|First Dosing Period||4
5163505|NCT01237899|12699710|P2|STARTED|First Dosing Period||3
5163506|NCT01237899|12699711|P1|STARTED|First Dosing Period||1
5163507|NCT01237821|12699741|P2|NOT COMPLETED|Overall Study||0
5163508|NCT01237821|12699742|P1|NOT COMPLETED|Overall Study||6
5163509|NCT01237821|12699741|P2|COMPLETED|Overall Study||34
5163510|NCT01237821|12699742|P1|COMPLETED|Overall Study||26
5163511|NCT01237821|12699741|P2|STARTED|Overall Study||34
5163512|NCT01237821|12699742|P1|STARTED|Overall Study||32
5163513|NCT01237678|12699791|P3|NOT COMPLETED|Phase II||50
5163514|NCT01237678|12699792|P2|NOT COMPLETED|Phase II||98
5163515|NCT01237678|12699793|P1|NOT COMPLETED|Phase II||0
5163516|NCT01237678|12699791|P3|COMPLETED|Phase II||0
5163517|NCT01237678|12699792|P2|COMPLETED|Phase II||0
5163518|NCT01237678|12699793|P1|COMPLETED|Phase II||0
5163519|NCT01237678|12699791|P3|Received Intervention|Phase II||47
5163520|NCT01237678|12699792|P2|Received Intervention|Phase II||94
5163521|NCT01237678|12699793|P1|Received Intervention|Phase II||0
5163522|NCT01237678|12699791|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
5163523|NCT01237678|12699792|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
5163524|NCT01237678|12699793|P1|STARTED|Phase II||0
5163525|NCT01237678|12699791|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163526|NCT01237678|12699792|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163527|NCT01237678|12699793|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
5163528|NCT01237678|12699791|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163529|NCT01237678|12699792|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163530|NCT01237678|12699793|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163531|NCT01237678|12699791|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
5163532|NCT01237678|12699792|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
5163533|NCT01237678|12699793|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
5163534|NCT01237678|12699791|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163535|NCT01237678|12699792|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
5163536|NCT01237678|12699793|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
5163537|NCT01237613|12699812|P1|NOT COMPLETED|Overall Study||0
5163538|NCT01237613|12699812|P1|COMPLETED|Overall Study||4
5163539|NCT01237613|12699812|P1|STARTED|Overall Study||4
5163540|NCT01237587|12699838|P2|NOT COMPLETED|Taper Phase||10
5163541|NCT01237587|12699839|P1|NOT COMPLETED|Taper Phase||5
5163542|NCT01237587|12699838|P2|COMPLETED|Taper Phase||34
5163543|NCT01237587|12699839|P1|COMPLETED|Taper Phase||31
5163544|NCT01237587|12699838|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
5163545|NCT01237587|12699839|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
5163546|NCT01237587|12699838|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
5163547|NCT01237587|12699839|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
5163548|NCT01237587|12699838|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
5163549|NCT01237587|12699839|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
5163550|NCT01237587|12699838|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
5163551|NCT01237587|12699839|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
5163552|NCT01237587|12699838|P2|STARTED|Open Label Treatment (Extension Phase)||75
5163553|NCT01237587|12699839|P1|STARTED|Open Label Treatment (Extension Phase)||74
5163554|NCT01237587|12699838|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
5163555|NCT01237587|12699839|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
5163556|NCT01237587|12699838|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
5163557|NCT01237587|12699839|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
5163558|NCT01237587|12699838|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
5163559|NCT01237587|12699839|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
5163560|NCT01237587|12699838|P2|STARTED|Double Blind Treatment (Acute Phase)||93
5163561|NCT01237587|12699839|P1|STARTED|Double Blind Treatment (Acute Phase)||91
5163562|NCT01237353|12699886|P1|NOT COMPLETED|Overall Study||0
5163563|NCT01237353|12699886|P1|COMPLETED|Overall Study||6
5163564|NCT01237353|12699886|P1|STARTED|Overall Study||6
5163565|NCT01237340|12699891|P1|NOT COMPLETED|Overall Study||40
5163566|NCT01237340|12699891|P1|COMPLETED|Overall Study||19
5163567|NCT01237340|12699891|P1|STARTED|Overall Study||59
5163568|NCT01237327|12699905|P2|NOT COMPLETED|Overall Study||40
5163569|NCT01237327|12699906|P1|NOT COMPLETED|Overall Study||42
5163570|NCT01237327|12699905|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
5163571|NCT01237327|12699906|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
5163572|NCT01237327|12699905|P2|Continued Treatment in Extension Study|Overall Study||17
5163573|NCT01237327|12699906|P1|Continued Treatment in Extension Study|Overall Study||21
5163574|NCT01237327|12699905|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
5163575|NCT01237327|12699906|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
5163576|NCT01237327|12699905|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
5163577|NCT01237327|12699906|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
5163578|NCT01237327|12699905|P2|STARTED|Overall Study||41
5163579|NCT01237327|12699906|P1|STARTED|Overall Study||43
5163580|NCT01237301|12699922|P2|NOT COMPLETED|Overall Study||4
5163581|NCT01237301|12699923|P1|NOT COMPLETED|Overall Study||5
5163582|NCT01237301|12699922|P2|COMPLETED|Overall Study||55
5163583|NCT01237301|12699923|P1|COMPLETED|Overall Study||60
5163584|NCT01237301|12699922|P2|STARTED|Overall Study||59
5163585|NCT01237301|12699923|P1|STARTED|Overall Study||65
5163586|NCT01237223|12699941|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
5163587|NCT01237223|12699942|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
5163588|NCT01237223|12699943|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
5163589|NCT01237223|12699944|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
5163590|NCT01237223|12699945|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
5163591|NCT01237223|12699946|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
5163592|NCT01237223|12699941|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
5163593|NCT01237223|12699942|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
5163594|NCT01237223|12699943|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
5163595|NCT01237223|12699944|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
5163596|NCT01237223|12699945|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
5163597|NCT01237223|12699946|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
5163598|NCT01237223|12699941|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
5163599|NCT01237223|12699942|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
5163600|NCT01237223|12699943|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
5163601|NCT01237223|12699944|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
5163602|NCT01237223|12699945|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
5163603|NCT01237223|12699946|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
5163604|NCT01237223|12699941|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163605|NCT01237223|12699942|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163606|NCT01237223|12699943|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163607|NCT01237223|12699944|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163608|NCT01237223|12699945|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163609|NCT01237223|12699946|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
5163610|NCT01237223|12699941|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163611|NCT01237223|12699942|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163612|NCT01237223|12699943|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163613|NCT01237223|12699944|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163614|NCT01237223|12699945|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
5163615|NCT01237223|12699946|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
5163616|NCT01237223|12699941|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
5163617|NCT01237223|12699942|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
5163618|NCT01237223|12699943|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
5163619|NCT01237223|12699944|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
5163620|NCT01237223|12699945|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
5163621|NCT01237223|12699946|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
5163622|NCT01237197|12699987|P2|NOT COMPLETED|Open Label Period||0
5163623|NCT01237197|12699988|P1|NOT COMPLETED|Open Label Period||0
5163624|NCT01237197|12699987|P2|COMPLETED|Open Label Period||10
5163625|NCT01237197|12699988|P1|COMPLETED|Open Label Period||12
5163626|NCT01237197|12699987|P2|STARTED|Open Label Period||10
5163627|NCT01237197|12699988|P1|STARTED|Open Label Period||12
5163628|NCT01237197|12699987|P2|NOT COMPLETED|Randomization Period||3
5163629|NCT01237197|12699988|P1|NOT COMPLETED|Randomization Period||1
5163630|NCT01237197|12699987|P2|COMPLETED|Randomization Period||10
5163631|NCT01237197|12699988|P1|COMPLETED|Randomization Period||12
5163632|NCT01237197|12699987|P2|STARTED|Randomization Period||13
5163633|NCT01237197|12699988|P1|STARTED|Randomization Period||13
5163634|NCT01237080|12699996|P2|NOT COMPLETED|Overall Study||0
5163635|NCT01237080|12699997|P1|NOT COMPLETED|Overall Study||0
5163636|NCT01237080|12699996|P2|COMPLETED|Overall Study||50
5163637|NCT01237080|12699997|P1|COMPLETED|Overall Study||50
5163638|NCT01237080|12699996|P2|STARTED|Overall Study||50
5163639|NCT01237080|12699997|P1|STARTED|Overall Study||50
5163640|NCT01237054|12700005|P1|NOT COMPLETED|Overall Study||1
5163641|NCT01237054|12700005|P1|COMPLETED|Overall Study||30
5163642|NCT01237054|12700005|P1|STARTED|Overall Study||31
5163643|NCT01237041|12700031|P5|NOT COMPLETED|Overall Study||0
5163644|NCT01237041|12700032|P4|NOT COMPLETED|Overall Study||0
5163645|NCT01237041|12700033|P3|NOT COMPLETED|Overall Study||0
5163646|NCT01237041|12700034|P2|NOT COMPLETED|Overall Study||0
5163647|NCT01237041|12700035|P1|NOT COMPLETED|Overall Study||0
5163648|NCT01237041|12700031|P5|COMPLETED|Overall Study||5
5163649|NCT01237041|12700032|P4|COMPLETED|Overall Study||5
5163650|NCT01237041|12700033|P3|COMPLETED|Overall Study||2
5163651|NCT01237041|12700034|P2|COMPLETED|Overall Study||3
5163652|NCT01237041|12700035|P1|COMPLETED|Overall Study||2
5163653|NCT01237041|12700031|P5|STARTED|Overall Study||5
5163654|NCT01237041|12700032|P4|STARTED|Overall Study||5
5163655|NCT01237041|12700033|P3|STARTED|Overall Study||2
5163656|NCT01237041|12700034|P2|STARTED|Overall Study||3
5163657|NCT01237041|12700035|P1|STARTED|Overall Study||2
5163658|NCT01236768|12700059|P2|NOT COMPLETED|Overall Study||61
5163659|NCT01236768|12700060|P1|NOT COMPLETED|Overall Study||89
5163660|NCT01236768|12700059|P2|COMPLETED|Overall Study||145
5163661|NCT01236768|12700060|P1|COMPLETED|Overall Study||112
5163662|NCT01236768|12700059|P2|STARTED|Overall Study||206
5163663|NCT01236768|12700060|P1|STARTED|Overall Study||201
5163664|NCT01236755|12700074|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
5163665|NCT01236755|12700074|P1|COMPLETED|Orthokeratology Wearing Phase||66
5163666|NCT01236755|12700074|P1|STARTED|Orthokeratology Wearing Phase||74
5163667|NCT01236755|12700074|P1|NOT COMPLETED|Spectacles Wearing Phase||17
5163668|NCT01236755|12700074|P1|COMPLETED|Spectacles Wearing Phase||74
5163669|NCT01236755|12700074|P1|STARTED|Spectacles Wearing Phase||91
5163670|NCT01236742|12700082|P3|NOT COMPLETED|Overall Study||3
5163671|NCT01236742|12700083|P2|NOT COMPLETED|Overall Study||3
5163672|NCT01236742|12700084|P1|NOT COMPLETED|Overall Study||3
5163673|NCT01236742|12700082|P3|COMPLETED|Overall Study||13
5163674|NCT01236742|12700083|P2|COMPLETED|Overall Study||16
5163675|NCT01236742|12700084|P1|COMPLETED|Overall Study||15
5163676|NCT01236742|12700082|P3|STARTED|Overall Study||16
5163677|NCT01236742|12700083|P2|STARTED|Overall Study||19
5163678|NCT01236742|12700084|P1|STARTED|Overall Study||18
5163679|NCT01236534|12700097|P2|NOT COMPLETED|Overall Study||0
5163680|NCT01236534|12700098|P1|NOT COMPLETED|Overall Study||3
5163681|NCT01236534|12700097|P2|COMPLETED|Overall Study||10
5163682|NCT01236534|12700098|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
5163683|NCT01236534|12700097|P2|STARTED|Overall Study||10
5163684|NCT01236534|12700098|P1|STARTED|Overall Study||11
5163685|NCT01236391|12700106|P1|NOT COMPLETED|Overall Study||16
5163686|NCT01236391|12700106|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
5163687|NCT01236391|12700106|P1|STARTED|Overall Study|Participants who received study treatment|111
5163688|NCT01236365|12700116|P2|NOT COMPLETED|Overall Study||2
5163689|NCT01236365|12700117|P1|NOT COMPLETED|Overall Study||2
5163690|NCT01236365|12700116|P2|COMPLETED|Overall Study||19
5163691|NCT01236365|12700117|P1|COMPLETED|Overall Study||19
5163692|NCT01236365|12700116|P2|STARTED|Overall Study||21
5163693|NCT01236365|12700117|P1|STARTED|Overall Study||21
5163694|NCT01236339|12700141|P2|NOT COMPLETED|Overall Study||13
5163695|NCT01236339|12700142|P1|NOT COMPLETED|Overall Study||11
5163696|NCT01236339|12700141|P2|COMPLETED|Overall Study||0
5163697|NCT01236339|12700142|P1|COMPLETED|Overall Study||2
5163698|NCT01236339|12700141|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
5163699|NCT01236339|12700142|P1|LVP Crossover to TIPS|Overall Study||0
5163700|NCT01236339|12700141|P2|STARTED|Overall Study||13
5163701|NCT01236339|12700142|P1|STARTED|Overall Study||13
5163702|NCT01235923|12700162|P2|NOT COMPLETED|Overall Study||0
5163703|NCT01235923|12700163|P1|NOT COMPLETED|Overall Study||0
5163704|NCT01235923|12700162|P2|COMPLETED|Overall Study||10
5163705|NCT01235923|12700163|P1|COMPLETED|Overall Study||10
5163706|NCT01235923|12700162|P2|STARTED|Overall Study||10
5163707|NCT01235923|12700163|P1|STARTED|Overall Study||10
5163708|NCT01235793|12700171|P1|NOT COMPLETED|Overall Study||6
5163709|NCT01235793|12700171|P1|COMPLETED|Overall Study||5
5163710|NCT01235793|12700171|P1|STARTED|Overall Study||11
5163711|NCT01236573|12700187|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
5163712|NCT01236573|12700188|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163713|NCT01236573|12700189|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163714|NCT01236573|12700190|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163715|NCT01236573|12700191|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163716|NCT01236573|12700192|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163717|NCT01236573|12700193|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163718|NCT01236573|12700194|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163719|NCT01236573|12700195|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163720|NCT01236573|12700196|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163721|NCT01236573|12700197|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163722|NCT01236573|12700187|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
5163723|NCT01236573|12700188|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163724|NCT01236573|12700189|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163725|NCT01236573|12700190|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163726|NCT01236573|12700191|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163727|NCT01236573|12700192|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163728|NCT01236573|12700193|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163729|NCT01236573|12700194|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163730|NCT01236573|12700195|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163731|NCT01236573|12700196|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163732|NCT01236573|12700197|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163733|NCT01236573|12700187|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
5163734|NCT01236573|12700188|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163735|NCT01236573|12700189|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163736|NCT01236573|12700190|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163737|NCT01236573|12700191|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163738|NCT01236573|12700192|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163739|NCT01236573|12700193|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163740|NCT01236573|12700194|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163741|NCT01236573|12700195|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163742|NCT01236573|12700196|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163743|NCT01236573|12700197|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
5163744|NCT01236573|12700187|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163745|NCT01236573|12700188|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
5163746|NCT01236573|12700189|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
5163747|NCT01236573|12700190|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163748|NCT01236573|12700191|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
5163749|NCT01236573|12700192|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163750|NCT01236573|12700193|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163751|NCT01236573|12700194|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163752|NCT01236573|12700195|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163753|NCT01236573|12700196|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163754|NCT01236573|12700197|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163755|NCT01236573|12700187|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163756|NCT01236573|12700188|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
5163839|NCT01236521|12700266|P1|3-month Completed|Overall Study||122
5163757|NCT01236573|12700189|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
5163758|NCT01236573|12700190|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
5163759|NCT01236573|12700191|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
5163760|NCT01236573|12700192|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
5163761|NCT01236573|12700193|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
5163762|NCT01236573|12700194|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163763|NCT01236573|12700195|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163764|NCT01236573|12700196|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163765|NCT01236573|12700197|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163766|NCT01236573|12700187|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163767|NCT01236573|12700188|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
5163768|NCT01236573|12700189|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
5163769|NCT01236573|12700190|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
5163770|NCT01236573|12700191|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
5163771|NCT01236573|12700192|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
5163772|NCT01236573|12700193|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
5163773|NCT01236573|12700194|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163774|NCT01236573|12700195|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163775|NCT01236573|12700196|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163776|NCT01236573|12700197|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
5163777|NCT01236573|12700187|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163778|NCT01236573|12700188|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163779|NCT01236573|12700189|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163780|NCT01236573|12700190|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163781|NCT01236573|12700191|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163782|NCT01236573|12700192|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163783|NCT01236573|12700193|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163784|NCT01236573|12700194|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163785|NCT01236573|12700195|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163786|NCT01236573|12700196|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163787|NCT01236573|12700197|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163788|NCT01236573|12700187|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163789|NCT01236573|12700188|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163790|NCT01236573|12700189|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163791|NCT01236573|12700190|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163792|NCT01236573|12700191|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163793|NCT01236573|12700192|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163794|NCT01236573|12700193|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163795|NCT01236573|12700194|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163796|NCT01236573|12700195|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
5163797|NCT01236573|12700196|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163798|NCT01236573|12700197|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163799|NCT01236573|12700187|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163800|NCT01236573|12700188|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163801|NCT01236573|12700189|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163802|NCT01236573|12700190|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163803|NCT01236573|12700191|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163804|NCT01236573|12700192|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163805|NCT01236573|12700193|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
5163806|NCT01236573|12700194|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163807|NCT01236573|12700195|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
5163808|NCT01236573|12700196|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163809|NCT01236573|12700197|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
5163810|NCT01236560|12700239|P6|NOT COMPLETED|Overall Study||0
5163811|NCT01236560|12700240|P5|NOT COMPLETED|Overall Study||0
5163812|NCT01236560|12700241|P4|NOT COMPLETED|Overall Study||22
5163813|NCT01236560|12700242|P3|NOT COMPLETED|Overall Study||20
5163814|NCT01236560|12700243|P2|NOT COMPLETED|Overall Study||24
5163815|NCT01236560|12700244|P1|NOT COMPLETED|Overall Study||5
5163816|NCT01236560|12700239|P6|COMPLETED|Overall Study||0
5163817|NCT01236560|12700240|P5|COMPLETED|Overall Study||0
5163818|NCT01236560|12700241|P4|COMPLETED|Overall Study||10
5163819|NCT01236560|12700242|P3|COMPLETED|Overall Study||11
5163820|NCT01236560|12700243|P2|COMPLETED|Overall Study||8
5163821|NCT01236560|12700244|P1|COMPLETED|Overall Study||1
5163822|NCT01236560|12700239|P6|STARTED|Overall Study||0
5163823|NCT01236560|12700240|P5|STARTED|Overall Study||0
5163824|NCT01236560|12700241|P4|STARTED|Overall Study||32
5163825|NCT01236560|12700242|P3|STARTED|Overall Study||31
5163826|NCT01236560|12700243|P2|STARTED|Overall Study||32
5163827|NCT01236560|12700244|P1|STARTED|Overall Study||6
5163828|NCT01236521|12700265|P2|NOT COMPLETED|Overall Study||25
5163829|NCT01236521|12700266|P1|NOT COMPLETED|Overall Study||21
5163830|NCT01236521|12700265|P2|COMPLETED|Overall Study||105
5163831|NCT01236521|12700266|P1|COMPLETED|Overall Study||110
5163832|NCT01236521|12700265|P2|12-moth Completed|Overall Study||105
5163833|NCT01236521|12700266|P1|12-moth Completed|Overall Study||110
5163834|NCT01236521|12700265|P2|9-month Completed|Overall Study||101
5163835|NCT01236521|12700266|P1|9-month Completed|Overall Study||115
5163836|NCT01236521|12700265|P2|6-month Completed|Overall Study||116
5163837|NCT01236521|12700266|P1|6-month Completed|Overall Study||122
5163838|NCT01236521|12700265|P2|3-month Completed|Overall Study||119
5163840|NCT01236521|12700265|P2|STARTED|Overall Study||130
5163841|NCT01236521|12700266|P1|STARTED|Overall Study||131
5163842|NCT01236378|12700294|P1|NOT COMPLETED|Overall Study||0
5163843|NCT01236378|12700294|P1|COMPLETED|Overall Study||24
5163844|NCT01236378|12700294|P1|STARTED|Overall Study||24
5163845|NCT01236352|12700317|P11|NOT COMPLETED|Overall Study||20
5163846|NCT01236352|12700318|P10|NOT COMPLETED|Overall Study||22
5163847|NCT01236352|12700319|P9|NOT COMPLETED|Overall Study||3
5163848|NCT01236352|12700320|P8|NOT COMPLETED|Overall Study||7
5163849|NCT01236352|12700321|P7|NOT COMPLETED|Overall Study||8
5163850|NCT01236352|12700322|P6|NOT COMPLETED|Overall Study||4
5163851|NCT01236352|12700323|P5|NOT COMPLETED|Overall Study||4
5163852|NCT01236352|12700324|P4|NOT COMPLETED|Overall Study||3
5163853|NCT01236352|12700325|P3|NOT COMPLETED|Overall Study||4
5163854|NCT01236352|12700326|P2|NOT COMPLETED|Overall Study||4
5163855|NCT01236352|12700327|P1|NOT COMPLETED|Overall Study||4
5163856|NCT01236352|12700317|P11|COMPLETED|Overall Study||0
5163857|NCT01236352|12700318|P10|COMPLETED|Overall Study||0
5163858|NCT01236352|12700319|P9|COMPLETED|Overall Study||0
5163859|NCT01236352|12700320|P8|COMPLETED|Overall Study||0
5163860|NCT01236352|12700321|P7|COMPLETED|Overall Study||0
5163861|NCT01236352|12700322|P6|COMPLETED|Overall Study||0
5163862|NCT01236352|12700323|P5|COMPLETED|Overall Study||0
5163863|NCT01236352|12700324|P4|COMPLETED|Overall Study||1
5163864|NCT01236352|12700325|P3|COMPLETED|Overall Study||0
5163865|NCT01236352|12700326|P2|COMPLETED|Overall Study||0
5163866|NCT01236352|12700327|P1|COMPLETED|Overall Study||0
5163867|NCT01236352|12700317|P11|STARTED|Overall Study||20
5163868|NCT01236352|12700318|P10|STARTED|Overall Study||22
5163869|NCT01236352|12700319|P9|STARTED|Overall Study||3
5163870|NCT01236352|12700320|P8|STARTED|Overall Study||7
5163871|NCT01236352|12700321|P7|STARTED|Overall Study||8
5163872|NCT01236352|12700322|P6|STARTED|Overall Study||4
5163873|NCT01236352|12700323|P5|STARTED|Overall Study||4
5163874|NCT01236352|12700324|P4|STARTED|Overall Study||4
5163875|NCT01236352|12700325|P3|STARTED|Overall Study||4
5163876|NCT01236352|12700326|P2|STARTED|Overall Study||4
5163877|NCT01236352|12700327|P1|STARTED|Overall Study||4
5163878|NCT01236326|12700496|P2|NOT COMPLETED|Overall Study||4
5163879|NCT01236326|12700497|P1|NOT COMPLETED|Overall Study||1
5163880|NCT01236326|12700496|P2|COMPLETED|Overall Study||51
5163881|NCT01236326|12700497|P1|COMPLETED|Overall Study||49
5163882|NCT01236326|12700496|P2|STARTED|Overall Study||55
5163883|NCT01236326|12700497|P1|STARTED|Overall Study||50
5163884|NCT01236300|12700511|P1|NOT COMPLETED|Overall Study||0
5163885|NCT01236300|12700511|P1|COMPLETED|Overall Study||66
5163886|NCT01236300|12700511|P1|STARTED|Overall Study||66
5163887|NCT01236196|12700521|P2|NOT COMPLETED|Overall Study||8
5163888|NCT01236196|12700522|P1|NOT COMPLETED|Overall Study||1
5163889|NCT01236196|12700521|P2|COMPLETED|Overall Study||13
5163890|NCT01236196|12700522|P1|COMPLETED|Overall Study||17
5163891|NCT01236196|12700521|P2|STARTED|Overall Study||21
5163892|NCT01236196|12700522|P1|STARTED|Overall Study||18
5163893|NCT01236170|12700534|P1|NOT COMPLETED|Overall Study||15
5163894|NCT01236170|12700534|P1|COMPLETED|Overall Study||482
5163895|NCT01236170|12700534|P1|STARTED|Overall Study||497
5163896|NCT01236118|12700545|P3|NOT COMPLETED|Overall Study||3
5163897|NCT01236118|12700546|P2|NOT COMPLETED|Overall Study||1
5163898|NCT01236118|12700547|P1|NOT COMPLETED|Overall Study||2
5163899|NCT01236118|12700545|P3|COMPLETED|Overall Study||14
5163900|NCT01236118|12700546|P2|COMPLETED|Overall Study||4
5163901|NCT01236118|12700547|P1|COMPLETED|Overall Study||4
5163902|NCT01236118|12700545|P3|STARTED|Overall Study||17
5163903|NCT01236118|12700546|P2|STARTED|Overall Study||5
5163904|NCT01236118|12700547|P1|STARTED|Overall Study||6
5163905|NCT01236105|12700555|P1|NOT COMPLETED|Overall Study||0
5163906|NCT01236105|12700555|P1|COMPLETED|Overall Study||21
5163907|NCT01236105|12700555|P1|STARTED|Overall Study||21
5163908|NCT01236053|12700591|P22|NOT COMPLETED|Overall Study||0
5163909|NCT01236053|12700592|P21|NOT COMPLETED|Overall Study||0
5163910|NCT01236053|12700593|P20|NOT COMPLETED|Overall Study||0
5163911|NCT01236053|12700594|P19|NOT COMPLETED|Overall Study||0
5163912|NCT01236053|12700595|P18|NOT COMPLETED|Overall Study||0
5163913|NCT01236053|12700596|P17|NOT COMPLETED|Overall Study||0
5163914|NCT01236053|12700597|P16|NOT COMPLETED|Overall Study||0
5163915|NCT01236053|12700598|P15|NOT COMPLETED|Overall Study||0
5163916|NCT01236053|12700599|P14|NOT COMPLETED|Overall Study||0
5163917|NCT01236053|12700600|P13|NOT COMPLETED|Overall Study||0
5163918|NCT01236053|12700601|P12|NOT COMPLETED|Overall Study||0
5163919|NCT01236053|12700602|P11|NOT COMPLETED|Overall Study||0
5163920|NCT01236053|12700603|P10|NOT COMPLETED|Overall Study||0
5163921|NCT01236053|12700604|P9|NOT COMPLETED|Overall Study||0
5163922|NCT01236053|12700605|P8|NOT COMPLETED|Overall Study||0
5163923|NCT01236053|12700606|P7|NOT COMPLETED|Overall Study||0
5163924|NCT01236053|12700607|P6|NOT COMPLETED|Overall Study||0
5163925|NCT01236053|12700608|P5|NOT COMPLETED|Overall Study||0
5163926|NCT01236053|12700609|P4|NOT COMPLETED|Overall Study||0
5163927|NCT01236053|12700610|P3|NOT COMPLETED|Overall Study||0
5163928|NCT01236053|12700611|P2|NOT COMPLETED|Overall Study||0
5163929|NCT01236053|12700612|P1|NOT COMPLETED|Overall Study||0
5163930|NCT01236053|12700591|P22|COMPLETED|Overall Study||12167
5163931|NCT01236053|12700592|P21|COMPLETED|Overall Study||1272
5163932|NCT01236053|12700593|P20|COMPLETED|Overall Study||20382
5163933|NCT01236053|12700594|P19|COMPLETED|Overall Study||2155
5163934|NCT01236053|12700595|P18|COMPLETED|Overall Study||380
5163935|NCT01236053|12700596|P17|COMPLETED|Overall Study||38
5163936|NCT01236053|12700597|P16|COMPLETED|Overall Study||43559
5163937|NCT01236053|12700598|P15|COMPLETED|Overall Study||4600
5163938|NCT01236053|12700599|P14|COMPLETED|Overall Study||1396
5163939|NCT01236053|12700600|P13|COMPLETED|Overall Study||148
5163940|NCT01236053|12700601|P12|COMPLETED|Overall Study||188924
5163941|NCT01236053|12700602|P11|COMPLETED|Overall Study||19564
5163942|NCT01236053|12700603|P10|COMPLETED|Overall Study||2935
5163943|NCT01236053|12700604|P9|COMPLETED|Overall Study||300
5163944|NCT01236053|12700605|P8|COMPLETED|Overall Study||102836
5163945|NCT01236053|12700606|P7|COMPLETED|Overall Study||10855
5163946|NCT01236053|12700607|P6|COMPLETED|Overall Study||2067
5163947|NCT01236053|12700608|P5|COMPLETED|Overall Study||212
5163948|NCT01236053|12700609|P4|COMPLETED|Overall Study||17853
5163949|NCT01236053|12700610|P3|COMPLETED|Overall Study||1877
5163950|NCT01236053|12700611|P2|COMPLETED|Overall Study||1710950
5163951|NCT01236053|12700612|P1|COMPLETED|Overall Study||179138
5163952|NCT01236053|12700591|P22|STARTED|Overall Study||12167
5163953|NCT01236053|12700592|P21|STARTED|Overall Study||1272
5163954|NCT01236053|12700593|P20|STARTED|Overall Study||20382
5163955|NCT01236053|12700594|P19|STARTED|Overall Study||2155
5163956|NCT01236053|12700595|P18|STARTED|Overall Study||380
5163957|NCT01236053|12700596|P17|STARTED|Overall Study||38
5163958|NCT01236053|12700597|P16|STARTED|Overall Study||43559
5163959|NCT01236053|12700598|P15|STARTED|Overall Study||4600
5163960|NCT01236053|12700599|P14|STARTED|Overall Study||1396
5163961|NCT01236053|12700600|P13|STARTED|Overall Study||148
5163962|NCT01236053|12700601|P12|STARTED|Overall Study||188924
5163963|NCT01236053|12700602|P11|STARTED|Overall Study||19564
5163964|NCT01236053|12700603|P10|STARTED|Overall Study||2935
5163965|NCT01236053|12700604|P9|STARTED|Overall Study||300
5163966|NCT01236053|12700605|P8|STARTED|Overall Study||102836
5163967|NCT01236053|12700606|P7|STARTED|Overall Study||10855
5163968|NCT01236053|12700607|P6|STARTED|Overall Study||2067
5163969|NCT01236053|12700608|P5|STARTED|Overall Study||212
5163970|NCT01236053|12700609|P4|STARTED|Overall Study||17853
5163971|NCT01236053|12700610|P3|STARTED|Overall Study||1877
5163972|NCT01236053|12700611|P2|STARTED|Overall Study||1710950
5163973|NCT01236053|12700612|P1|STARTED|Overall Study||179138
5163974|NCT01236001|12700748|P2|NOT COMPLETED|Overall Study||22
5163975|NCT01236001|12700749|P1|NOT COMPLETED|Overall Study||18
5163976|NCT01236001|12700748|P2|COMPLETED|Overall Study||65
5163977|NCT01236001|12700749|P1|COMPLETED|Overall Study||87
5163978|NCT01236001|12700748|P2|STARTED|Overall Study||87
5163979|NCT01236001|12700749|P1|STARTED|Overall Study||105
5163980|NCT01235975|12700781|P2|NOT COMPLETED|Overall Study||7
5163981|NCT01235975|12700782|P1|NOT COMPLETED|Overall Study||17
5163982|NCT01235975|12700781|P2|COMPLETED|Overall Study||88
5163983|NCT01235975|12700782|P1|COMPLETED|Overall Study||257
5163984|NCT01235975|12700781|P2|STARTED|Overall Study||95
5163985|NCT01235975|12700782|P1|STARTED|Overall Study||274
5163986|NCT01235949|12700832|P18|NOT COMPLETED|Booster Phase||2
5163987|NCT01235949|12700833|P17|NOT COMPLETED|Booster Phase||0
5163988|NCT01235949|12700834|P16|NOT COMPLETED|Booster Phase||1
5163989|NCT01235949|12700835|P15|NOT COMPLETED|Booster Phase||2
5163990|NCT01235949|12700836|P14|NOT COMPLETED|Booster Phase||0
5163991|NCT01235949|12700837|P13|NOT COMPLETED|Booster Phase||3
5163992|NCT01235949|12700838|P12|NOT COMPLETED|Booster Phase||3
5163993|NCT01235949|12700839|P11|NOT COMPLETED|Booster Phase||2
5163994|NCT01235949|12700840|P10|NOT COMPLETED|Booster Phase||1
5163995|NCT01235949|12700841|P9|NOT COMPLETED|Booster Phase||2
5163996|NCT01235949|12700842|P8|NOT COMPLETED|Booster Phase||1
5163997|NCT01235949|12700843|P7|NOT COMPLETED|Booster Phase||0
5163998|NCT01235949|12700844|P6|NOT COMPLETED|Booster Phase||0
5163999|NCT01235949|12700845|P5|NOT COMPLETED|Booster Phase||0
5164000|NCT01235949|12700846|P4|NOT COMPLETED|Booster Phase||0
5164001|NCT01235949|12700847|P3|NOT COMPLETED|Booster Phase||0
5164002|NCT01235949|12700848|P2|NOT COMPLETED|Booster Phase||0
5164003|NCT01235949|12700849|P1|NOT COMPLETED|Booster Phase||0
5164004|NCT01235949|12700832|P18|COMPLETED|Booster Phase||65
5164005|NCT01235949|12700833|P17|COMPLETED|Booster Phase||68
5164006|NCT01235949|12700834|P16|COMPLETED|Booster Phase||66
5164007|NCT01235949|12700835|P15|COMPLETED|Booster Phase||60
5164008|NCT01235949|12700836|P14|COMPLETED|Booster Phase||65
5164009|NCT01235949|12700837|P13|COMPLETED|Booster Phase||60
5164010|NCT01235949|12700838|P12|COMPLETED|Booster Phase||60
5164011|NCT01235949|12700839|P11|COMPLETED|Booster Phase||61
5164012|NCT01235949|12700840|P10|COMPLETED|Booster Phase||62
5164013|NCT01235949|12700841|P9|COMPLETED|Booster Phase||61
5164014|NCT01235949|12700842|P8|COMPLETED|Booster Phase||59
5164015|NCT01235949|12700843|P7|COMPLETED|Booster Phase||64
5164016|NCT01235949|12700844|P6|COMPLETED|Booster Phase||0
5164017|NCT01235949|12700845|P5|COMPLETED|Booster Phase||0
5164018|NCT01235949|12700846|P4|COMPLETED|Booster Phase||0
5164019|NCT01235949|12700847|P3|COMPLETED|Booster Phase||0
5164020|NCT01235949|12700848|P2|COMPLETED|Booster Phase||0
5164021|NCT01235949|12700849|P1|COMPLETED|Booster Phase||0
5164022|NCT01235949|12700832|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
5164023|NCT01235949|12700833|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
5164024|NCT01235949|12700834|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
5164025|NCT01235949|12700835|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
5164026|NCT01235949|12700836|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
5164027|NCT01235949|12700837|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
5164028|NCT01235949|12700838|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
5164029|NCT01235949|12700839|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
5164030|NCT01235949|12700840|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
5164031|NCT01235949|12700841|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
5164032|NCT01235949|12700842|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
5164033|NCT01235949|12700843|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
5164034|NCT01235949|12700844|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
5164035|NCT01235949|12700845|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
5164036|NCT01235949|12700846|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
5164037|NCT01235949|12700847|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
5164038|NCT01235949|12700848|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
5164039|NCT01235949|12700849|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
5164040|NCT01235949|12700832|P18|NOT COMPLETED|Primary Phase||0
5164041|NCT01235949|12700833|P17|NOT COMPLETED|Primary Phase||0
5164042|NCT01235949|12700834|P16|NOT COMPLETED|Primary Phase||0
5164043|NCT01235949|12700835|P15|NOT COMPLETED|Primary Phase||0
5164044|NCT01235949|12700836|P14|NOT COMPLETED|Primary Phase||0
5164045|NCT01235949|12700837|P13|NOT COMPLETED|Primary Phase||0
5164046|NCT01235949|12700838|P12|NOT COMPLETED|Primary Phase||0
5164047|NCT01235949|12700839|P11|NOT COMPLETED|Primary Phase||0
5164048|NCT01235949|12700840|P10|NOT COMPLETED|Primary Phase||0
5164049|NCT01235949|12700841|P9|NOT COMPLETED|Primary Phase||0
5164050|NCT01235949|12700842|P8|NOT COMPLETED|Primary Phase||0
5164051|NCT01235949|12700843|P7|NOT COMPLETED|Primary Phase||0
5164052|NCT01235949|12700844|P6|NOT COMPLETED|Primary Phase||7
5164053|NCT01235949|12700845|P5|NOT COMPLETED|Primary Phase||1
5164054|NCT01235949|12700846|P4|NOT COMPLETED|Primary Phase||2
5164055|NCT01235949|12700847|P3|NOT COMPLETED|Primary Phase||3
5164056|NCT01235949|12700848|P2|NOT COMPLETED|Primary Phase||3
5164057|NCT01235949|12700849|P1|NOT COMPLETED|Primary Phase||4
5164058|NCT01235949|12700832|P18|COMPLETED|Primary Phase||0
5164059|NCT01235949|12700833|P17|COMPLETED|Primary Phase||0
5164060|NCT01235949|12700834|P16|COMPLETED|Primary Phase||0
5164061|NCT01235949|12700835|P15|COMPLETED|Primary Phase||0
5164062|NCT01235949|12700836|P14|COMPLETED|Primary Phase||0
5164063|NCT01235949|12700837|P13|COMPLETED|Primary Phase||0
5164064|NCT01235949|12700838|P12|COMPLETED|Primary Phase||0
5164065|NCT01235949|12700839|P11|COMPLETED|Primary Phase||0
5164066|NCT01235949|12700840|P10|COMPLETED|Primary Phase||0
5164067|NCT01235949|12700841|P9|COMPLETED|Primary Phase||0
5164068|NCT01235949|12700842|P8|COMPLETED|Primary Phase||0
5164069|NCT01235949|12700843|P7|COMPLETED|Primary Phase||0
5164070|NCT01235949|12700844|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
5164071|NCT01235949|12700845|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
5164072|NCT01235949|12700846|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
5164073|NCT01235949|12700847|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
5164074|NCT01235949|12700848|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
5164075|NCT01235949|12700849|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
5164076|NCT01235949|12700832|P18|STARTED|Primary Phase||0
5164077|NCT01235949|12700833|P17|STARTED|Primary Phase||0
5164078|NCT01235949|12700834|P16|STARTED|Primary Phase||0
5164079|NCT01235949|12700835|P15|STARTED|Primary Phase||0
5164080|NCT01235949|12700836|P14|STARTED|Primary Phase||0
5164081|NCT01235949|12700837|P13|STARTED|Primary Phase||0
5164082|NCT01235949|12700838|P12|STARTED|Primary Phase||0
5164083|NCT01235949|12700839|P11|STARTED|Primary Phase||0
5164084|NCT01235949|12700840|P10|STARTED|Primary Phase||0
5164085|NCT01235949|12700841|P9|STARTED|Primary Phase||0
5164086|NCT01235949|12700842|P8|STARTED|Primary Phase||0
5164087|NCT01235949|12700843|P7|STARTED|Primary Phase||0
5164088|NCT01235949|12700844|P6|STARTED|Primary Phase||74
5164089|NCT01235949|12700845|P5|STARTED|Primary Phase||72
5164090|NCT01235949|12700846|P4|STARTED|Primary Phase||71
5164091|NCT01235949|12700847|P3|STARTED|Primary Phase||199
5164092|NCT01235949|12700848|P2|STARTED|Primary Phase||198
5164093|NCT01235949|12700849|P1|STARTED|Primary Phase||198
5164094|NCT01235910|12701085|P1|NOT COMPLETED|Overall Study||0
5164095|NCT01235910|12701085|P1|COMPLETED|Overall Study||1
5164096|NCT01235910|12701085|P1|STARTED|Overall Study||1
5164097|NCT01235897|12701091|P1|NOT COMPLETED|Overall Study||0
5164098|NCT01235897|12701091|P1|COMPLETED|Overall Study||16
5164099|NCT01235897|12701091|P1|STARTED|Overall Study||16
5164100|NCT01235741|12701099|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
5164101|NCT01235741|12701100|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
5164102|NCT01235741|12701101|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
5164103|NCT01235741|12701099|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
5164104|NCT01235741|12701100|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
5164105|NCT01235741|12701101|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
5164106|NCT01235741|12701099|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
5164107|NCT01235741|12701100|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
5164108|NCT01235741|12701101|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
5164109|NCT01235741|12701099|P3|NOT COMPLETED|Randomized to Treatment||36
5164110|NCT01235741|12701100|P2|NOT COMPLETED|Randomized to Treatment||36
5164111|NCT01235741|12701101|P1|NOT COMPLETED|Randomized to Treatment||0
5164112|NCT01235741|12701099|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
5164113|NCT01235741|12701100|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
5164114|NCT01235741|12701101|P1|COMPLETED|Randomized to Treatment||0
5164115|NCT01235741|12701099|P3|STARTED|Randomized to Treatment||36
5164116|NCT01235741|12701100|P2|STARTED|Randomized to Treatment||36
5164117|NCT01235741|12701101|P1|STARTED|Randomized to Treatment||0
5164118|NCT01235741|12701099|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
5164119|NCT01235741|12701100|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
5164120|NCT01235741|12701101|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
5164121|NCT01235741|12701099|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
5164122|NCT01235741|12701100|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
5164123|NCT01235741|12701101|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
5164124|NCT01235741|12701099|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
5164125|NCT01235741|12701100|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
5164126|NCT01235741|12701101|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
5164127|NCT01235728|12701128|P8|NOT COMPLETED|Overall Study||0
5164128|NCT01235728|12701129|P7|NOT COMPLETED|Overall Study||0
5164129|NCT01235728|12701130|P6|NOT COMPLETED|Overall Study||0
5164130|NCT01235728|12701131|P5|NOT COMPLETED|Overall Study||0
5164131|NCT01235728|12701132|P4|NOT COMPLETED|Overall Study||1
5164132|NCT01235728|12701133|P3|NOT COMPLETED|Overall Study||0
5164133|NCT01235728|12701134|P2|NOT COMPLETED|Overall Study||0
5164134|NCT01235728|12701135|P1|NOT COMPLETED|Overall Study||0
5164135|NCT01235728|12701128|P8|COMPLETED|Overall Study||3
5164136|NCT01235728|12701129|P7|COMPLETED|Overall Study||3
5164137|NCT01235728|12701130|P6|COMPLETED|Overall Study||3
5164138|NCT01235728|12701131|P5|COMPLETED|Overall Study||3
5164139|NCT01235728|12701132|P4|COMPLETED|Overall Study||2
5164140|NCT01235728|12701133|P3|COMPLETED|Overall Study||3
5164141|NCT01235728|12701134|P2|COMPLETED|Overall Study||3
5164142|NCT01235728|12701135|P1|COMPLETED|Overall Study||3
5164143|NCT01235728|12701128|P8|STARTED|Overall Study||3
5164144|NCT01235728|12701129|P7|STARTED|Overall Study||3
5164145|NCT01235728|12701130|P6|STARTED|Overall Study||3
5164146|NCT01235728|12701131|P5|STARTED|Overall Study||3
5164147|NCT01235728|12701132|P4|STARTED|Overall Study||3
5164148|NCT01235728|12701133|P3|STARTED|Overall Study||3
5164149|NCT01235728|12701134|P2|STARTED|Overall Study||3
5164150|NCT01235728|12701135|P1|STARTED|Overall Study||3
5164151|NCT01235715|12701145|P2|NOT COMPLETED|Overall Study||2
5164152|NCT01235715|12701146|P1|NOT COMPLETED|Overall Study||0
5164153|NCT01235715|12701145|P2|COMPLETED|Overall Study||100
5164154|NCT01235715|12701146|P1|COMPLETED|Overall Study||98
5164155|NCT01235715|12701145|P2|STARTED|Overall Study||102
5164156|NCT01235715|12701146|P1|STARTED|Overall Study||98
5164157|NCT01235689|12701186|P2|NOT COMPLETED|Overall Study||32
5164158|NCT01235689|12701187|P1|NOT COMPLETED|Overall Study||29
5164159|NCT01235689|12701186|P2|COMPLETED|Overall Study||90
5164160|NCT01235689|12701187|P1|COMPLETED|Overall Study||93
5164161|NCT01235689|12701186|P2|Randomized at Week 9|Overall Study||53
5164162|NCT01235689|12701187|P1|Randomized at Week 9|Overall Study||59
5164163|NCT01235689|12701186|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
5164164|NCT01235689|12701187|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
5164165|NCT01235689|12701186|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
5164166|NCT01235689|12701187|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
5164167|NCT01235598|12701259|P2|NOT COMPLETED|Overall Study||4
5164168|NCT01235598|12701260|P1|NOT COMPLETED|Overall Study||1
5164169|NCT01235598|12701259|P2|COMPLETED|Overall Study||24
5164170|NCT01235598|12701260|P1|COMPLETED|Overall Study||12
5164171|NCT01235598|12701259|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
5164172|NCT01235598|12701260|P1|STARTED|Overall Study||13
5164173|NCT01235546|12701305|P2|NOT COMPLETED|Overall Study||1
5164174|NCT01235546|12701306|P1|NOT COMPLETED|Overall Study||2
5164175|NCT01235546|12701305|P2|COMPLETED|Overall Study||1018
5164176|NCT01235546|12701306|P1|COMPLETED|Overall Study||992
5164177|NCT01235546|12701305|P2|STARTED|Overall Study||1019
5164178|NCT01235546|12701306|P1|STARTED|Overall Study||994
5164179|NCT01235507|12701330|P1|NOT COMPLETED|Overall Study||2
5164180|NCT01235507|12701330|P1|COMPLETED|Overall Study||69
5164181|NCT01235507|12701330|P1|STARTED|Overall Study||71
5164182|NCT01235442|12701344|P2|NOT COMPLETED|Overall Study||44
5164183|NCT01235442|12701345|P1|NOT COMPLETED|Overall Study||44
5164184|NCT01235442|12701344|P2|COMPLETED|Overall Study||251
5164185|NCT01235442|12701345|P1|COMPLETED|Overall Study||253
5164186|NCT01235442|12701344|P2|STARTED|Overall Study||295
5164187|NCT01235442|12701345|P1|STARTED|Overall Study||297
5164188|NCT01235403|12701363|P1|NOT COMPLETED|Overall Study||26
5164189|NCT01235403|12701363|P1|COMPLETED|Overall Study||74
5164190|NCT01235403|12701363|P1|STARTED|Overall Study||100
5164191|NCT01235377|12701371|P2|NOT COMPLETED|Overall Study||1
5164192|NCT01235377|12701372|P1|NOT COMPLETED|Overall Study||1
5164193|NCT01235377|12701371|P2|COMPLETED|Overall Study||8
5164194|NCT01235377|12701372|P1|COMPLETED|Overall Study||10
5164195|NCT01235377|12701371|P2|STARTED|Overall Study||9
5164196|NCT01235377|12701372|P1|STARTED|Overall Study||11
5164197|NCT01235351|12701380|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
5164198|NCT01235351|12701381|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
5164199|NCT01235351|12701380|P2|COMPLETED|Treatment With Different Dose Sequences||82
5164200|NCT01235351|12701381|P1|COMPLETED|Treatment With Different Dose Sequences||233
5164201|NCT01235351|12701380|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
5164202|NCT01235351|12701381|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
5164203|NCT01235351|12701380|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
5164204|NCT01235351|12701381|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
5164205|NCT01235351|12701380|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
5164206|NCT01235351|12701381|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
5164207|NCT01235351|12701380|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
5164208|NCT01235351|12701381|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
5164209|NCT01235351|12701380|P2|STARTED|Treatment With Different Dose Sequences||82
5164210|NCT01235351|12701381|P1|STARTED|Treatment With Different Dose Sequences||233
5164211|NCT01235351|12701380|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
5164212|NCT01235351|12701381|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
5164213|NCT01235351|12701380|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
5164214|NCT01235351|12701381|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
5164215|NCT01235351|12701380|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
5164216|NCT01235351|12701381|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
5164217|NCT01235338|12701393|P2|NOT COMPLETED|Overall Study||5
5164218|NCT01235338|12701394|P1|NOT COMPLETED|Overall Study||11
5164219|NCT01235338|12701393|P2|COMPLETED|Overall Study||33
5164220|NCT01235338|12701394|P1|COMPLETED|Overall Study||31
5164221|NCT01235338|12701393|P2|STARTED|Overall Study||38
5164222|NCT01235338|12701394|P1|STARTED|Overall Study||42
5164223|NCT01235234|12701439|P3|NOT COMPLETED|Overall Study||1
5164224|NCT01235234|12701440|P2|NOT COMPLETED|Overall Study||2
5164225|NCT01235234|12701441|P1|NOT COMPLETED|Overall Study||2
5164226|NCT01235234|12701439|P3|COMPLETED|Overall Study||80
5164227|NCT01235234|12701440|P2|COMPLETED|Overall Study||76
5164228|NCT01235234|12701441|P1|COMPLETED|Overall Study||75
5164229|NCT01235234|12701439|P3|STARTED|Overall Study||81
5164230|NCT01235234|12701440|P2|STARTED|Overall Study||78
5164231|NCT01235234|12701441|P1|STARTED|Overall Study||77
5164232|NCT01235195|12701449|P2|NOT COMPLETED|Second Intervention||0
5164233|NCT01235195|12701450|P1|NOT COMPLETED|Second Intervention||0
5164234|NCT01235195|12701449|P2|COMPLETED|Second Intervention||15
5164235|NCT01235195|12701450|P1|COMPLETED|Second Intervention||15
5164236|NCT01235195|12701449|P2|STARTED|Second Intervention||15
5164237|NCT01235195|12701450|P1|STARTED|Second Intervention||15
5164238|NCT01235195|12701449|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
5164239|NCT01235195|12701450|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
5164240|NCT01235195|12701449|P2|COMPLETED|Washout Period of At Least 8 Days||15
5164241|NCT01235195|12701450|P1|COMPLETED|Washout Period of At Least 8 Days||15
5164242|NCT01235195|12701449|P2|STARTED|Washout Period of At Least 8 Days||15
5164243|NCT01235195|12701450|P1|STARTED|Washout Period of At Least 8 Days||15
5164244|NCT01235195|12701449|P2|NOT COMPLETED|First Intervention||0
5164245|NCT01235195|12701450|P1|NOT COMPLETED|First Intervention||0
5164246|NCT01235195|12701449|P2|COMPLETED|First Intervention||15
5164247|NCT01235195|12701450|P1|COMPLETED|First Intervention||15
5164248|NCT01235195|12701449|P2|STARTED|First Intervention||15
5164249|NCT01235195|12701450|P1|STARTED|First Intervention||15
5164250|NCT01234922|12701470|P4|NOT COMPLETED|Overall Study||0
5164251|NCT01234922|12701471|P3|NOT COMPLETED|Overall Study||0
5164252|NCT01234922|12701472|P2|NOT COMPLETED|Overall Study||0
5164253|NCT01234922|12701473|P1|NOT COMPLETED|Overall Study||0
5164254|NCT01234922|12701470|P4|COMPLETED|Overall Study||2
5164255|NCT01234922|12701471|P3|COMPLETED|Overall Study||2
5164256|NCT01234922|12701472|P2|COMPLETED|Overall Study||1
5164257|NCT01234922|12701473|P1|COMPLETED|Overall Study||1
5164258|NCT01234922|12701470|P4|STARTED|Overall Study||2
5164259|NCT01234922|12701471|P3|STARTED|Overall Study||2
5164260|NCT01234922|12701472|P2|STARTED|Overall Study||1
5164261|NCT01234922|12701473|P1|STARTED|Overall Study||1
5164262|NCT01234883|12701489|P2|NOT COMPLETED|Overall Study||13
5164263|NCT01234883|12701490|P1|NOT COMPLETED|Overall Study||10
5164264|NCT01234883|12701489|P2|COMPLETED|Overall Study||36
5164265|NCT01234883|12701490|P1|COMPLETED|Overall Study||41
5164266|NCT01234883|12701489|P2|STARTED|Overall Study||49
5164267|NCT01234883|12701490|P1|STARTED|Overall Study||51
5164268|NCT01234870|12701496|P1|NOT COMPLETED|Overall Study||0
5164269|NCT01234870|12701496|P1|COMPLETED|Overall Study||40
5164270|NCT01234870|12701496|P1|STARTED|Overall Study||40
5164271|NCT01234831|12701503|P2|NOT COMPLETED|Overall Study||4
5164272|NCT01234831|12701504|P1|NOT COMPLETED|Overall Study||2
5164273|NCT01234831|12701503|P2|COMPLETED|Overall Study||198
5164274|NCT01234831|12701504|P1|COMPLETED|Overall Study||259
5164275|NCT01234831|12701503|P2|STARTED|Overall Study||202
5164276|NCT01234831|12701504|P1|STARTED|Overall Study||261
5164277|NCT01234766|12701516|P1|NOT COMPLETED|Overall Study||4
5164278|NCT01234766|12701516|P1|COMPLETED|Overall Study||35
5164279|NCT01234766|12701516|P1|STARTED|Overall Study||39
5164280|NCT01234714|12701520|P1|NOT COMPLETED|Overall Study||0
5164281|NCT01234714|12701520|P1|COMPLETED|Overall Study||84
5164282|NCT01234714|12701520|P1|STARTED|Overall Study||84
5164283|NCT01234675|12701537|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5164284|NCT01234675|12701538|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
5164285|NCT01234675|12701537|P2|COMPLETED|Second Intervention (6 Weeks)||8
5164286|NCT01234675|12701538|P1|COMPLETED|Second Intervention (6 Weeks)||7
5164287|NCT01234675|12701537|P2|STARTED|Second Intervention (6 Weeks)||8
5164288|NCT01234675|12701538|P1|STARTED|Second Intervention (6 Weeks)||9
5164289|NCT01234675|12701537|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
5164290|NCT01234675|12701538|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
5164291|NCT01234675|12701537|P2|COMPLETED|First Intervention (6 Weeks)||8
5164292|NCT01234675|12701538|P1|COMPLETED|First Intervention (6 Weeks)||9
5164293|NCT01234675|12701537|P2|STARTED|First Intervention (6 Weeks)||9
5164294|NCT01234675|12701538|P1|STARTED|First Intervention (6 Weeks)||10
5164295|NCT01234649|12701570|P2|NOT COMPLETED|Overall Study||38
5164296|NCT01234649|12701571|P1|NOT COMPLETED|Overall Study||43
5164297|NCT01234649|12701570|P2|COMPLETED|Overall Study||37
5164298|NCT01234649|12701571|P1|COMPLETED|Overall Study||35
5164299|NCT01234649|12701570|P2|STARTED|Overall Study||75
5164300|NCT01234649|12701571|P1|STARTED|Overall Study||78
5164301|NCT01234467|12701619|P1|NOT COMPLETED|Overall Study||12
5164302|NCT01234467|12701619|P1|COMPLETED|Overall Study||11
5164303|NCT01234467|12701619|P1|STARTED|Overall Study||23
5164304|NCT01234402|12701631|P3|NOT COMPLETED|Overall Study||8
5164305|NCT01234402|12701632|P2|NOT COMPLETED|Overall Study||6
5164306|NCT01234402|12701633|P1|NOT COMPLETED|Overall Study||1
5164307|NCT01234402|12701631|P3|COMPLETED|Overall Study||42
5164308|NCT01234402|12701632|P2|COMPLETED|Overall Study||45
5164309|NCT01234402|12701633|P1|COMPLETED|Overall Study||51
5164310|NCT01234402|12701631|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
5164311|NCT01234402|12701632|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
5164312|NCT01234402|12701633|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
5164313|NCT01234402|12701631|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
5164314|NCT01234402|12701632|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
5164315|NCT01234402|12701633|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
5164316|NCT01234402|12701631|P3|Received at Least One Dose of Study Drug|Overall Study||49
5164317|NCT01234402|12701632|P2|Received at Least One Dose of Study Drug|Overall Study||49
5164318|NCT01234402|12701633|P1|Received at Least One Dose of Study Drug|Overall Study||52
5164319|NCT01234402|12701631|P3|STARTED|Overall Study||50
5164320|NCT01234402|12701632|P2|STARTED|Overall Study||51
5164321|NCT01234402|12701633|P1|STARTED|Overall Study||52
5164322|NCT01234350|12701674|P2|NOT COMPLETED|Overall Study||267
5164323|NCT01234350|12701675|P1|NOT COMPLETED|Overall Study||687
5164324|NCT01234350|12701674|P2|COMPLETED|Overall Study||226
5164325|NCT01234350|12701675|P1|COMPLETED|Overall Study||313
5164326|NCT01234350|12701674|P2|STARTED|Overall Study||493
5164327|NCT01234350|12701675|P1|STARTED|Overall Study||1000
5164328|NCT01234337|12701701|P2|NOT COMPLETED|Overall Study||271
5164329|NCT01234337|12701702|P1|NOT COMPLETED|Overall Study||266
5164330|NCT01234337|12701701|P2|COMPLETED|Overall Study||0
5164331|NCT01234337|12701702|P1|COMPLETED|Overall Study||0
5164332|NCT01234337|12701701|P2|Participants Received Treatment|Overall Study||267
5164333|NCT01234337|12701702|P1|Participants Received Treatment|Overall Study||260
5164334|NCT01234337|12701701|P2|STARTED|Overall Study||271
5164335|NCT01234337|12701702|P1|STARTED|Overall Study||266
5164336|NCT01234207|12701730|P2|NOT COMPLETED|Second Intervention||0
5164337|NCT01234207|12701731|P1|NOT COMPLETED|Second Intervention||0
5164338|NCT01234207|12701730|P2|COMPLETED|Second Intervention||48
5164339|NCT01234207|12701731|P1|COMPLETED|Second Intervention||47
5164340|NCT01234207|12701730|P2|STARTED|Second Intervention||48
5164341|NCT01234207|12701731|P1|STARTED|Second Intervention||47
5164342|NCT01234207|12701730|P2|NOT COMPLETED|1-Week Washout Period||0
5164343|NCT01234207|12701731|P1|NOT COMPLETED|1-Week Washout Period||0
5164344|NCT01234207|12701730|P2|COMPLETED|1-Week Washout Period||48
5164345|NCT01234207|12701731|P1|COMPLETED|1-Week Washout Period||47
5164346|NCT01234207|12701730|P2|STARTED|1-Week Washout Period||48
5164347|NCT01234207|12701731|P1|STARTED|1-Week Washout Period||47
5164348|NCT01234207|12701730|P2|NOT COMPLETED|First Intervention||0
5164349|NCT01234207|12701731|P1|NOT COMPLETED|First Intervention||0
5164350|NCT01234207|12701730|P2|COMPLETED|First Intervention||48
5164351|NCT01234207|12701731|P1|COMPLETED|First Intervention||47
5164352|NCT01234207|12701730|P2|STARTED|First Intervention||48
5164353|NCT01234207|12701731|P1|STARTED|First Intervention||47
5164354|NCT01234103|12701753|P2|NOT COMPLETED|Overall Study||0
5164355|NCT01234103|12701754|P1|NOT COMPLETED|Overall Study||0
5164356|NCT01234103|12701753|P2|COMPLETED|Overall Study||391
5164357|NCT01234103|12701754|P1|COMPLETED|Overall Study||542
5164358|NCT01234103|12701753|P2|STARTED|Overall Study||391
5164359|NCT01234103|12701754|P1|STARTED|Overall Study||542
5164360|NCT01233999|12701762|P1|NOT COMPLETED|Overall Study||2
5164361|NCT01233999|12701762|P1|COMPLETED|Overall Study||8
5164362|NCT01233999|12701762|P1|STARTED|Overall Study||10
5164363|NCT01233921|12701768|P2|NOT COMPLETED|Overall Study||0
5164364|NCT01233921|12701769|P1|NOT COMPLETED|Overall Study||0
5164365|NCT01233921|12701768|P2|COMPLETED|Overall Study||3
5164366|NCT01233921|12701769|P1|COMPLETED|Overall Study||3
5164367|NCT01233921|12701768|P2|STARTED|Overall Study||3
5164368|NCT01233921|12701769|P1|STARTED|Overall Study||3
5164369|NCT01233869|12701781|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
5164370|NCT01233869|12701782|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
5164371|NCT01233869|12701783|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
5164372|NCT01233869|12701784|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
5164373|NCT01233869|12701781|P4|COMPLETED|Extended Treatment Period (46 Months)||18
5164374|NCT01233869|12701782|P3|COMPLETED|Extended Treatment Period (46 Months)||17
5164375|NCT01233869|12701783|P2|COMPLETED|Extended Treatment Period (46 Months)||0
5164376|NCT01233869|12701784|P1|COMPLETED|Extended Treatment Period (46 Months)||20
5164377|NCT01233869|12701781|P4|STARTED|Extended Treatment Period (46 Months)||34
5164378|NCT01233869|12701782|P3|STARTED|Extended Treatment Period (46 Months)||22
5164379|NCT01233869|12701783|P2|STARTED|Extended Treatment Period (46 Months)||3
5164380|NCT01233869|12701784|P1|STARTED|Extended Treatment Period (46 Months)||34
5164381|NCT01233869|12701781|P4|NOT COMPLETED|Washout Period 30 Days||0
5164382|NCT01233869|12701782|P3|NOT COMPLETED|Washout Period 30 Days||0
5164383|NCT01233869|12701783|P2|NOT COMPLETED|Washout Period 30 Days||0
5164384|NCT01233869|12701784|P1|NOT COMPLETED|Washout Period 30 Days||0
5164385|NCT01233869|12701781|P4|COMPLETED|Washout Period 30 Days||34
5164386|NCT01233869|12701782|P3|COMPLETED|Washout Period 30 Days||22
5164387|NCT01233869|12701783|P2|COMPLETED|Washout Period 30 Days||3
5164388|NCT01233869|12701784|P1|COMPLETED|Washout Period 30 Days||34
5164389|NCT01233869|12701781|P4|STARTED|Washout Period 30 Days||34
5164390|NCT01233869|12701782|P3|STARTED|Washout Period 30 Days||22
5164391|NCT01233869|12701783|P2|STARTED|Washout Period 30 Days||3
5164392|NCT01233869|12701784|P1|STARTED|Washout Period 30 Days||34
5164393|NCT01233869|12701781|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
5164394|NCT01233869|12701782|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
5164395|NCT01233869|12701783|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
5164396|NCT01233869|12701784|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
5164397|NCT01233869|12701781|P4|COMPLETED|Initial Treatment Period (24 Months)||34
5164398|NCT01233869|12701782|P3|COMPLETED|Initial Treatment Period (24 Months)||22
5164399|NCT01233869|12701783|P2|COMPLETED|Initial Treatment Period (24 Months)||3
5164400|NCT01233869|12701784|P1|COMPLETED|Initial Treatment Period (24 Months)||34
5164401|NCT01233869|12701781|P4|STARTED|Initial Treatment Period (24 Months)||56
5164402|NCT01233869|12701782|P3|STARTED|Initial Treatment Period (24 Months)||24
5164403|NCT01233869|12701783|P2|STARTED|Initial Treatment Period (24 Months)||31
5164404|NCT01233869|12701784|P1|STARTED|Initial Treatment Period (24 Months)||58
5164405|NCT01233817|12701870|P1|NOT COMPLETED|Overall Study||3
5164406|NCT01233817|12701870|P1|COMPLETED|Overall Study||9
5164407|NCT01233817|12701870|P1|STARTED|Overall Study||12
5164408|NCT01233726|12701877|P3|NOT COMPLETED|Overall Study||1
5164409|NCT01233726|12701878|P2|NOT COMPLETED|Overall Study||0
5164410|NCT01233726|12701879|P1|NOT COMPLETED|Overall Study||1
5164411|NCT01233726|12701877|P3|COMPLETED|Overall Study||52
5164412|NCT01233726|12701878|P2|COMPLETED|Overall Study||53
5164413|NCT01233726|12701879|P1|COMPLETED|Overall Study||52
5164414|NCT01233726|12701877|P3|STARTED|Overall Study||53
5164415|NCT01233726|12701878|P2|STARTED|Overall Study||53
5164416|NCT01233726|12701879|P1|STARTED|Overall Study||53
5164417|NCT01233687|12701917|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
5164418|NCT01233687|12701917|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
5164419|NCT01233687|12701917|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
5164420|NCT01233687|12701917|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
5164421|NCT01233687|12701917|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
5164422|NCT01233687|12701917|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
5164423|NCT01233687|12701917|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
5164424|NCT01233609|12701927|P2|NOT COMPLETED|Overall Study||2
5164425|NCT01233609|12701928|P1|NOT COMPLETED|Overall Study||9
5164426|NCT01233609|12701927|P2|COMPLETED|Overall Study||42
5164427|NCT01233609|12701928|P1|COMPLETED|Overall Study||37
5164428|NCT01233609|12701927|P2|STARTED|Overall Study||44
5164429|NCT01233609|12701928|P1|STARTED|Overall Study||46
5164430|NCT01233284|12701952|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
5164431|NCT01233284|12701953|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
5164432|NCT01233284|12701954|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
5164433|NCT01233284|12701955|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
5164434|NCT01233284|12701956|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
5164435|NCT01233284|12701952|P5|COMPLETED|Period 4 (4 Weeks)||1
5164436|NCT01233284|12701953|P4|COMPLETED|Period 4 (4 Weeks)||33
5164437|NCT01233284|12701954|P3|COMPLETED|Period 4 (4 Weeks)||35
5164438|NCT01233284|12701955|P2|COMPLETED|Period 4 (4 Weeks)||36
5164439|NCT01233284|12701956|P1|COMPLETED|Period 4 (4 Weeks)||36
5164440|NCT01233284|12701952|P5|STARTED|Period 4 (4 Weeks)||1
5164441|NCT01233284|12701953|P4|STARTED|Period 4 (4 Weeks)||34
5164442|NCT01233284|12701954|P3|STARTED|Period 4 (4 Weeks)||35
5164443|NCT01233284|12701955|P2|STARTED|Period 4 (4 Weeks)||37
5164444|NCT01233284|12701956|P1|STARTED|Period 4 (4 Weeks)||36
5164445|NCT01233284|12701952|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
5164446|NCT01233284|12701953|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
5164447|NCT01233284|12701954|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
5164448|NCT01233284|12701955|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
5164449|NCT01233284|12701956|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
5164450|NCT01233284|12701952|P5|COMPLETED|Period 3 (4 Weeks)||1
5164451|NCT01233284|12701953|P4|COMPLETED|Period 3 (4 Weeks)||34
5164452|NCT01233284|12701954|P3|COMPLETED|Period 3 (4 Weeks)||35
5164453|NCT01233284|12701955|P2|COMPLETED|Period 3 (4 Weeks)||37
5164454|NCT01233284|12701956|P1|COMPLETED|Period 3 (4 Weeks)||36
5164455|NCT01233284|12701952|P5|STARTED|Period 3 (4 Weeks)||1
5164456|NCT01233284|12701953|P4|STARTED|Period 3 (4 Weeks)||35
5164457|NCT01233284|12701954|P3|STARTED|Period 3 (4 Weeks)||36
5164458|NCT01233284|12701955|P2|STARTED|Period 3 (4 Weeks)||37
5164459|NCT01233284|12701956|P1|STARTED|Period 3 (4 Weeks)||36
5164460|NCT01233284|12701952|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
5164461|NCT01233284|12701953|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
5164462|NCT01233284|12701954|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
5164463|NCT01233284|12701955|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
5164464|NCT01233284|12701956|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
5164465|NCT01233284|12701952|P5|COMPLETED|Period 2 (4 Weeks)||1
5164466|NCT01233284|12701953|P4|COMPLETED|Period 2 (4 Weeks)||35
5164467|NCT01233284|12701954|P3|COMPLETED|Period 2 (4 Weeks)||36
5164468|NCT01233284|12701955|P2|COMPLETED|Period 2 (4 Weeks)||37
5164469|NCT01233284|12701956|P1|COMPLETED|Period 2 (4 Weeks)||36
5164470|NCT01233284|12701952|P5|STARTED|Period 2 (4 Weeks)||1
5164471|NCT01233284|12701953|P4|STARTED|Period 2 (4 Weeks)||35
5164472|NCT01233284|12701954|P3|STARTED|Period 2 (4 Weeks)||37
5164473|NCT01233284|12701955|P2|STARTED|Period 2 (4 Weeks)||37
5164474|NCT01233284|12701956|P1|STARTED|Period 2 (4 Weeks)||36
5164475|NCT01233284|12701952|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
5164476|NCT01233284|12701953|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
5164477|NCT01233284|12701954|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
5164478|NCT01233284|12701955|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
5164479|NCT01233284|12701956|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
5164480|NCT01233284|12701952|P5|COMPLETED|Period 1 (4 Weeks)||1
5164481|NCT01233284|12701953|P4|COMPLETED|Period 1 (4 Weeks)||35
5164482|NCT01233284|12701954|P3|COMPLETED|Period 1 (4 Weeks)||37
5164483|NCT01233284|12701955|P2|COMPLETED|Period 1 (4 Weeks)||37
5164484|NCT01233284|12701956|P1|COMPLETED|Period 1 (4 Weeks)||36
5164485|NCT01233284|12701952|P5|STARTED|Period 1 (4 Weeks)||1
5164486|NCT01233284|12701953|P4|STARTED|Period 1 (4 Weeks)||35
5164487|NCT01233284|12701954|P3|STARTED|Period 1 (4 Weeks)||38
5164488|NCT01233284|12701955|P2|STARTED|Period 1 (4 Weeks)||38
5164489|NCT01233284|12701956|P1|STARTED|Period 1 (4 Weeks)||37
5164490|NCT01233258|12702037|P6|NOT COMPLETED|Second Intervention (6 Months)||0
5164491|NCT01233258|12702038|P5|NOT COMPLETED|Second Intervention (6 Months)||0
5164492|NCT01233258|12702039|P4|NOT COMPLETED|Second Intervention (6 Months)||0
5164493|NCT01233258|12702040|P3|NOT COMPLETED|Second Intervention (6 Months)||0
5164494|NCT01233258|12702041|P2|NOT COMPLETED|Second Intervention (6 Months)||0
5164495|NCT01233258|12702042|P1|NOT COMPLETED|Second Intervention (6 Months)||0
5164496|NCT01233258|12702037|P6|COMPLETED|Second Intervention (6 Months)||15
5164497|NCT01233258|12702038|P5|COMPLETED|Second Intervention (6 Months)||16
5164498|NCT01233258|12702039|P4|COMPLETED|Second Intervention (6 Months)||15
5164499|NCT01233258|12702040|P3|COMPLETED|Second Intervention (6 Months)||13
5164500|NCT01233258|12702041|P2|COMPLETED|Second Intervention (6 Months)||10
5164501|NCT01233258|12702042|P1|COMPLETED|Second Intervention (6 Months)||10
5164502|NCT01233258|12702037|P6|STARTED|Second Intervention (6 Months)||15
5164503|NCT01233258|12702038|P5|STARTED|Second Intervention (6 Months)||16
5164504|NCT01233258|12702039|P4|STARTED|Second Intervention (6 Months)||15
5164505|NCT01233258|12702040|P3|STARTED|Second Intervention (6 Months)||13
5164506|NCT01233258|12702041|P2|STARTED|Second Intervention (6 Months)||10
5164507|NCT01233258|12702042|P1|STARTED|Second Intervention (6 Months)||10
5164508|NCT01233258|12702037|P6|NOT COMPLETED|Washout (2-3 Days)||0
5164509|NCT01233258|12702038|P5|NOT COMPLETED|Washout (2-3 Days)||0
5164510|NCT01233258|12702039|P4|NOT COMPLETED|Washout (2-3 Days)||0
5164511|NCT01233258|12702040|P3|NOT COMPLETED|Washout (2-3 Days)||0
5164512|NCT01233258|12702041|P2|NOT COMPLETED|Washout (2-3 Days)||0
5164513|NCT01233258|12702042|P1|NOT COMPLETED|Washout (2-3 Days)||0
5164514|NCT01233258|12702037|P6|COMPLETED|Washout (2-3 Days)||15
5164515|NCT01233258|12702038|P5|COMPLETED|Washout (2-3 Days)||16
5164516|NCT01233258|12702039|P4|COMPLETED|Washout (2-3 Days)||15
5164517|NCT01233258|12702040|P3|COMPLETED|Washout (2-3 Days)||13
5164518|NCT01233258|12702041|P2|COMPLETED|Washout (2-3 Days)||10
5164519|NCT01233258|12702042|P1|COMPLETED|Washout (2-3 Days)||10
5164520|NCT01233258|12702037|P6|STARTED|Washout (2-3 Days)||15
5164521|NCT01233258|12702038|P5|STARTED|Washout (2-3 Days)||16
5164522|NCT01233258|12702039|P4|STARTED|Washout (2-3 Days)||15
5164523|NCT01233258|12702040|P3|STARTED|Washout (2-3 Days)||13
5164524|NCT01233258|12702041|P2|STARTED|Washout (2-3 Days)||10
5164525|NCT01233258|12702042|P1|STARTED|Washout (2-3 Days)||10
5164526|NCT01233258|12702037|P6|NOT COMPLETED|First Intervention (6 Months)||1
5164527|NCT01233258|12702038|P5|NOT COMPLETED|First Intervention (6 Months)||0
5164528|NCT01233258|12702039|P4|NOT COMPLETED|First Intervention (6 Months)||1
5164529|NCT01233258|12702040|P3|NOT COMPLETED|First Intervention (6 Months)||1
5164530|NCT01233258|12702041|P2|NOT COMPLETED|First Intervention (6 Months)||0
5164531|NCT01233258|12702042|P1|NOT COMPLETED|First Intervention (6 Months)||1
5164532|NCT01233258|12702037|P6|COMPLETED|First Intervention (6 Months)||15
5164533|NCT01233258|12702038|P5|COMPLETED|First Intervention (6 Months)||16
5164534|NCT01233258|12702039|P4|COMPLETED|First Intervention (6 Months)||15
5164535|NCT01233258|12702040|P3|COMPLETED|First Intervention (6 Months)||13
5164536|NCT01233258|12702041|P2|COMPLETED|First Intervention (6 Months)||10
5164537|NCT01233258|12702042|P1|COMPLETED|First Intervention (6 Months)||10
5164538|NCT01233258|12702037|P6|Participants Received Treatment|First Intervention (6 Months)||15
5164539|NCT01233258|12702038|P5|Participants Received Treatment|First Intervention (6 Months)||16
5164540|NCT01233258|12702039|P4|Participants Received Treatment|First Intervention (6 Months)||15
5164541|NCT01233258|12702040|P3|Participants Received Treatment|First Intervention (6 Months)||13
5164542|NCT01233258|12702041|P2|Participants Received Treatment|First Intervention (6 Months)||10
5164543|NCT01233258|12702042|P1|Participants Received Treatment|First Intervention (6 Months)||11
5164544|NCT01233258|12702037|P6|STARTED|First Intervention (6 Months)||16
5164545|NCT01233258|12702038|P5|STARTED|First Intervention (6 Months)||16
5164546|NCT01233258|12702039|P4|STARTED|First Intervention (6 Months)||16
5164547|NCT01233258|12702040|P3|STARTED|First Intervention (6 Months)||14
5164548|NCT01233258|12702041|P2|STARTED|First Intervention (6 Months)||10
5164549|NCT01233258|12702042|P1|STARTED|First Intervention (6 Months)||11
5164550|NCT01233232|12702062|P3|NOT COMPLETED|Overall Study||0
5164551|NCT01233232|12702063|P2|NOT COMPLETED|Overall Study||0
5164552|NCT01233232|12702064|P1|NOT COMPLETED|Overall Study||1
5164553|NCT01233232|12702062|P3|COMPLETED|Overall Study||28
5164554|NCT01233232|12702063|P2|COMPLETED|Overall Study||30
5164555|NCT01233232|12702064|P1|COMPLETED|Overall Study||28
5164556|NCT01233232|12702062|P3|STARTED|Overall Study||28
5164557|NCT01233232|12702063|P2|STARTED|Overall Study||30
5164558|NCT01233232|12702064|P1|STARTED|Overall Study||29
5164559|NCT01233076|12702117|P2|NOT COMPLETED|Period 2, One Week||0
5164560|NCT01233076|12702118|P1|NOT COMPLETED|Period 2, One Week||1
5164561|NCT01233076|12702117|P2|COMPLETED|Period 2, One Week||30
5164562|NCT01233076|12702118|P1|COMPLETED|Period 2, One Week||29
5164563|NCT01233076|12702117|P2|STARTED|Period 2, One Week||30
5164564|NCT01233076|12702118|P1|STARTED|Period 2, One Week||30
5164565|NCT01233076|12702117|P2|NOT COMPLETED|Period 1, One Week||0
5164566|NCT01233076|12702118|P1|NOT COMPLETED|Period 1, One Week||0
5164567|NCT01233076|12702117|P2|COMPLETED|Period 1, One Week||30
5164568|NCT01233076|12702118|P1|COMPLETED|Period 1, One Week||30
5164569|NCT01233076|12702117|P2|STARTED|Period 1, One Week||30
5164570|NCT01233076|12702118|P1|STARTED|Period 1, One Week||30
5164571|NCT01233050|12702126|P2|NOT COMPLETED|Overall Study||6
5164572|NCT01233050|12702127|P1|NOT COMPLETED|Overall Study||8
5164573|NCT01233050|12702126|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
5164574|NCT01233050|12702127|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
5164575|NCT01233050|12702126|P2|STARTED|Overall Study||402
5164576|NCT01233050|12702127|P1|STARTED|Overall Study||400
5164577|NCT01232946|12702146|P3|NOT COMPLETED|Overall Study||2
5164578|NCT01232946|12702147|P2|NOT COMPLETED|Overall Study||1
5164579|NCT01232946|12702148|P1|NOT COMPLETED|Overall Study||0
5164580|NCT01232946|12702146|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
5164581|NCT01232946|12702147|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
5164582|NCT01232946|12702148|P1|COMPLETED|Overall Study||9
5164583|NCT01232946|12702146|P3|STARTED|Overall Study||11
5164584|NCT01232946|12702147|P2|STARTED|Overall Study||10
5164585|NCT01232946|12702148|P1|STARTED|Overall Study||9
5164586|NCT01232920|12702164|P2|NOT COMPLETED|Overall Study||7
5164587|NCT01232920|12702165|P1|NOT COMPLETED|Overall Study||6
5164588|NCT01232920|12702164|P2|COMPLETED|Overall Study||32
5164589|NCT01232920|12702165|P1|COMPLETED|Overall Study||35
5164590|NCT01232920|12702164|P2|STARTED|Overall Study||39
5164591|NCT01232920|12702165|P1|STARTED|Overall Study||41
5164592|NCT01232894|12702179|P2|NOT COMPLETED|Overall Study||8
5164593|NCT01232894|12702180|P1|NOT COMPLETED|Overall Study||12
5164594|NCT01232894|12702179|P2|COMPLETED|Overall Study||22
5164595|NCT01232894|12702180|P1|COMPLETED|Overall Study||48
5164596|NCT01232894|12702179|P2|Received Study Drug|Overall Study||28
5164597|NCT01232894|12702180|P1|Received Study Drug|Overall Study||59
5164598|NCT01232894|12702179|P2|STARTED|Overall Study||30
5164599|NCT01232894|12702180|P1|STARTED|Overall Study||60
5164600|NCT01232868|12702188|P2|NOT COMPLETED|Overall Study||4
5164601|NCT01232868|12702189|P1|NOT COMPLETED|Overall Study||2
5164602|NCT01232868|12702188|P2|COMPLETED|Overall Study||40
5164603|NCT01232868|12702189|P1|COMPLETED|Overall Study||20
5164604|NCT01232868|12702188|P2|STARTED|Overall Study||44
5164605|NCT01232868|12702189|P1|STARTED|Overall Study||22
5164606|NCT01232829|12702197|P1|NOT COMPLETED|Overall Study||0
5164607|NCT01232829|12702197|P1|COMPLETED|Overall Study||18
5164608|NCT01232829|12702197|P1|STARTED|Overall Study||18
5164609|NCT01232790|12702203|P2|NOT COMPLETED|Second Crossover||2
5164610|NCT01232790|12702204|P1|NOT COMPLETED|Second Crossover||1
5164611|NCT01232790|12702203|P2|COMPLETED|Second Crossover||9
5164612|NCT01232790|12702204|P1|COMPLETED|Second Crossover||10
5164613|NCT01232790|12702203|P2|STARTED|Second Crossover||11
5164614|NCT01232790|12702204|P1|STARTED|Second Crossover||11
5164615|NCT01232790|12702203|P2|NOT COMPLETED|First Crossover||0
5164616|NCT01232790|12702204|P1|NOT COMPLETED|First Crossover||1
5164617|NCT01232790|12702203|P2|COMPLETED|First Crossover||11
5164618|NCT01232790|12702204|P1|COMPLETED|First Crossover||11
5164619|NCT01232790|12702203|P2|STARTED|First Crossover||11
5164620|NCT01232790|12702204|P1|STARTED|First Crossover||12
5164621|NCT01232790|12702203|P2|NOT COMPLETED|Initial Assessment||1
5164622|NCT01232790|12702204|P1|NOT COMPLETED|Initial Assessment||0
5164623|NCT01232790|12702203|P2|COMPLETED|Initial Assessment||11
5164624|NCT01232790|12702204|P1|COMPLETED|Initial Assessment||12
5164625|NCT01232790|12702203|P2|STARTED|Initial Assessment||12
5164626|NCT01232790|12702204|P1|STARTED|Initial Assessment||12
5164627|NCT01232790|12702203|P2|NOT COMPLETED|Randomization||2
5164628|NCT01232790|12702204|P1|NOT COMPLETED|Randomization||2
5164629|NCT01232790|12702203|P2|COMPLETED|Randomization||12
5164630|NCT01232790|12702204|P1|COMPLETED|Randomization||12
5164631|NCT01232790|12702203|P2|STARTED|Randomization||14
5164632|NCT01232790|12702204|P1|STARTED|Randomization||14
5164633|NCT01232738|12702258|P1|NOT COMPLETED|Overall Study||13
5164634|NCT01232738|12702258|P1|COMPLETED|Overall Study||23
5164635|NCT01232738|12702258|P1|STARTED|Overall Study||36
5164636|NCT01232569|12702274|P4|NOT COMPLETED|Open-label Extension Period||27
5164637|NCT01232569|12702275|P3|NOT COMPLETED|Open-label Extension Period||27
5164638|NCT01232569|12702276|P2|NOT COMPLETED|Open-label Extension Period||0
5164639|NCT01232569|12702277|P1|NOT COMPLETED|Open-label Extension Period||0
5164640|NCT01232569|12702274|P4|COMPLETED|Open-label Extension Period||200
5164641|NCT01232569|12702275|P3|COMPLETED|Open-label Extension Period||203
5164642|NCT01232569|12702276|P2|COMPLETED|Open-label Extension Period||0
5164643|NCT01232569|12702277|P1|COMPLETED|Open-label Extension Period||0
5164644|NCT01232569|12702274|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
5164645|NCT01232569|12702275|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
5164646|NCT01232569|12702276|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
5164647|NCT01232569|12702277|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
5164648|NCT01232569|12702274|P4|NOT COMPLETED|Double-blind Treatment Period||0
5164649|NCT01232569|12702275|P3|NOT COMPLETED|Double-blind Treatment Period||0
5164650|NCT01232569|12702276|P2|NOT COMPLETED|Double-blind Treatment Period||9
5164651|NCT01232569|12702277|P1|NOT COMPLETED|Double-blind Treatment Period||28
5164652|NCT01232569|12702274|P4|COMPLETED|Double-blind Treatment Period||0
5164653|NCT01232569|12702275|P3|COMPLETED|Double-blind Treatment Period||0
5164654|NCT01232569|12702276|P2|COMPLETED|Double-blind Treatment Period||209
5164655|NCT01232569|12702277|P1|COMPLETED|Double-blind Treatment Period||410
5164656|NCT01232569|12702274|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
5164657|NCT01232569|12702275|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
5164658|NCT01232569|12702276|P2|STARTED|Double-blind Treatment Period||218
5164659|NCT01232569|12702277|P1|STARTED|Double-blind Treatment Period||438
5164660|NCT01232556|12702320|P2|NOT COMPLETED|Overall Study||171
5164661|NCT01232556|12702321|P1|NOT COMPLETED|Overall Study||159
5164662|NCT01232556|12702320|P2|COMPLETED|Overall Study||1
5164663|NCT01232556|12702321|P1|COMPLETED|Overall Study||7
5164664|NCT01232556|12702320|P2|Treated|Overall Study||167
5164665|NCT01232556|12702321|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
5164666|NCT01232556|12702320|P2|STARTED|Overall Study||172
5164667|NCT01232556|12702321|P1|STARTED|Overall Study||166
5164668|NCT01232504|12702344|P3|NOT COMPLETED|Overall Study||8
5164669|NCT01232504|12702345|P2|NOT COMPLETED|Overall Study||2
5164670|NCT01232504|12702346|P1|NOT COMPLETED|Overall Study||9
5164671|NCT01232504|12702344|P3|COMPLETED|Overall Study||61
5164672|NCT01232504|12702345|P2|COMPLETED|Overall Study||67
5164673|NCT01232504|12702346|P1|COMPLETED|Overall Study||59
5164674|NCT01232504|12702344|P3|STARTED|Overall Study||69
5164675|NCT01232504|12702345|P2|STARTED|Overall Study||69
5164676|NCT01232504|12702346|P1|STARTED|Overall Study||68
5164677|NCT01232491|12702380|P2|NOT COMPLETED|Overall Study||63
5164678|NCT01232491|12702381|P1|NOT COMPLETED|Overall Study||60
5164679|NCT01232491|12702380|P2|COMPLETED|Overall Study||242
5164680|NCT01232491|12702381|P1|COMPLETED|Overall Study||246
5164681|NCT01232491|12702380|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
5164682|NCT01232491|12702381|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
5164683|NCT01232491|12702380|P2|STARTED|Overall Study||305
5164684|NCT01232491|12702381|P1|STARTED|Overall Study||306
5164685|NCT01232465|12702401|P2|NOT COMPLETED|Overall Study||0
5164686|NCT01232465|12702402|P1|NOT COMPLETED|Overall Study||0
5164687|NCT01232465|12702401|P2|COMPLETED|Overall Study||402
5164688|NCT01232465|12702402|P1|COMPLETED|Overall Study||337
5164689|NCT01232465|12702401|P2|STARTED|Overall Study||402
5164690|NCT01232465|12702402|P1|STARTED|Overall Study||337
5164691|NCT01232452|12702410|P2|NOT COMPLETED|Overall Study||39
5164692|NCT01232452|12702411|P1|NOT COMPLETED|Overall Study||39
5164693|NCT01232452|12702410|P2|COMPLETED|Overall Study||46
5164694|NCT01232452|12702411|P1|COMPLETED|Overall Study||48
5164695|NCT01232452|12702410|P2|Received at Least One Dose of Study Drug|Overall Study||81
5164696|NCT01232452|12702411|P1|Received at Least One Dose of Study Drug|Overall Study||85
5164697|NCT01232452|12702410|P2|STARTED|Overall Study||85
5164698|NCT01232452|12702411|P1|STARTED|Overall Study||87
5164699|NCT01232296|12702437|P2|NOT COMPLETED|Overall Study||83
5164700|NCT01232296|12702438|P1|NOT COMPLETED|Overall Study||82
5164701|NCT01232296|12702437|P2|COMPLETED|Overall Study||0
5164702|NCT01232296|12702438|P1|COMPLETED|Overall Study||0
5164703|NCT01232296|12702437|P2|Safety Set|Overall Study||83
5164704|NCT01232296|12702438|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
5164705|NCT01232296|12702437|P2|Full Analysis Set|Overall Study||83
5164706|NCT01232296|12702438|P1|Full Analysis Set|Overall Study||82
5164707|NCT01232296|12702437|P2|STARTED|Overall Study||83
5164708|NCT01232296|12702438|P1|STARTED|Overall Study||82
5164709|NCT01232283|12702455|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
5164710|NCT01232283|12702456|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
5164711|NCT01232283|12702457|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164712|NCT01232283|12702458|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164713|NCT01232283|12702459|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164714|NCT01232283|12702460|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164715|NCT01232283|12702461|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164716|NCT01232283|12702462|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164717|NCT01232283|12702463|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164718|NCT01232283|12702464|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164719|NCT01232283|12702455|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
5164720|NCT01232283|12702456|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
5164721|NCT01232283|12702457|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164722|NCT01232283|12702458|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164723|NCT01232283|12702459|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164724|NCT01232283|12702460|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164725|NCT01232283|12702461|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164726|NCT01232283|12702462|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164727|NCT01232283|12702463|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164728|NCT01232283|12702464|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
5164729|NCT01232283|12702455|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
5164730|NCT01232283|12702456|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
5164731|NCT01232283|12702457|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164732|NCT01232283|12702458|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164733|NCT01232283|12702459|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164734|NCT01232283|12702460|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164735|NCT01232283|12702461|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164736|NCT01232283|12702462|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164737|NCT01232283|12702463|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164738|NCT01232283|12702464|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
5164739|NCT01232283|12702455|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164740|NCT01232283|12702456|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164741|NCT01232283|12702457|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
5164742|NCT01232283|12702458|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
5164743|NCT01232283|12702459|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
5164744|NCT01232283|12702460|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
5164745|NCT01232283|12702461|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164746|NCT01232283|12702462|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164747|NCT01232283|12702463|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164748|NCT01232283|12702464|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164749|NCT01232283|12702455|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164750|NCT01232283|12702456|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164751|NCT01232283|12702457|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
5164752|NCT01232283|12702458|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
5164753|NCT01232283|12702459|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
5164754|NCT01232283|12702460|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
5164755|NCT01232283|12702461|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164756|NCT01232283|12702462|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164757|NCT01232283|12702463|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164758|NCT01232283|12702464|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164759|NCT01232283|12702455|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164760|NCT01232283|12702456|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164761|NCT01232283|12702457|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
5164762|NCT01232283|12702458|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
5164763|NCT01232283|12702459|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164764|NCT01232283|12702460|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164765|NCT01232283|12702461|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164766|NCT01232283|12702462|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164767|NCT01232283|12702463|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164768|NCT01232283|12702464|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
5164769|NCT01232283|12702455|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164770|NCT01232283|12702456|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164771|NCT01232283|12702457|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
5164772|NCT01232283|12702458|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
5164773|NCT01232283|12702459|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
5164774|NCT01232283|12702460|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
5164775|NCT01232283|12702461|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164776|NCT01232283|12702462|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164777|NCT01232283|12702463|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164778|NCT01232283|12702464|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
5164779|NCT01232283|12702455|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164780|NCT01232283|12702456|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164781|NCT01232283|12702457|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164782|NCT01232283|12702458|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164783|NCT01232283|12702459|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164784|NCT01232283|12702460|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164785|NCT01232283|12702461|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
5164786|NCT01232283|12702462|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
5164787|NCT01232283|12702463|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164788|NCT01232283|12702464|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
5164789|NCT01232283|12702455|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164790|NCT01232283|12702456|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164791|NCT01232283|12702457|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164792|NCT01232283|12702458|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164793|NCT01232283|12702459|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164794|NCT01232283|12702460|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164795|NCT01232283|12702461|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
5164796|NCT01232283|12702462|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
5164797|NCT01232283|12702463|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164798|NCT01232283|12702464|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
5164799|NCT01232283|12702455|P10|STARTED|Maintenance Phase (Weeks16-32)||0
5164800|NCT01232283|12702456|P9|STARTED|Maintenance Phase (Weeks16-32)||0
5164801|NCT01232283|12702457|P8|STARTED|Maintenance Phase (Weeks16-32)||0
5164802|NCT01232283|12702458|P7|STARTED|Maintenance Phase (Weeks16-32)||0
5164803|NCT01232283|12702459|P6|STARTED|Maintenance Phase (Weeks16-32)||0
5164804|NCT01232283|12702460|P5|STARTED|Maintenance Phase (Weeks16-32)||0
5164805|NCT01232283|12702461|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
5164806|NCT01232283|12702462|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
5164807|NCT01232283|12702463|P2|STARTED|Maintenance Phase (Weeks16-32)||0
5164808|NCT01232283|12702464|P1|STARTED|Maintenance Phase (Weeks16-32)||0
5164809|NCT01232283|12702455|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164810|NCT01232283|12702456|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164811|NCT01232283|12702457|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164812|NCT01232283|12702458|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164813|NCT01232283|12702459|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164814|NCT01232283|12702460|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164815|NCT01232283|12702461|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164816|NCT01232283|12702462|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164817|NCT01232283|12702463|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
5164818|NCT01232283|12702464|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
5164819|NCT01232283|12702455|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164820|NCT01232283|12702456|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164821|NCT01232283|12702457|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164822|NCT01232283|12702458|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164823|NCT01232283|12702459|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164824|NCT01232283|12702460|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164825|NCT01232283|12702461|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164826|NCT01232283|12702462|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
5164827|NCT01232283|12702463|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
5164828|NCT01232283|12702464|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
5164829|NCT01232283|12702455|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164830|NCT01232283|12702456|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164831|NCT01232283|12702457|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164832|NCT01232283|12702458|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164833|NCT01232283|12702459|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164834|NCT01232283|12702460|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164835|NCT01232283|12702461|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164836|NCT01232283|12702462|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
5164837|NCT01232283|12702463|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
5164838|NCT01232283|12702464|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
5164839|NCT01232283|12702455|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164840|NCT01232283|12702456|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164841|NCT01232283|12702457|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164842|NCT01232283|12702458|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164843|NCT01232283|12702459|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164844|NCT01232283|12702460|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164845|NCT01232283|12702461|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164846|NCT01232283|12702462|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
5164847|NCT01232283|12702463|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
5164848|NCT01232283|12702464|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
5164849|NCT01232205|12702498|P2|NOT COMPLETED|Overall Study||3
5164850|NCT01232205|12702499|P1|NOT COMPLETED|Overall Study||3
5164851|NCT01232205|12702498|P2|COMPLETED|Overall Study||55
5164852|NCT01232205|12702499|P1|COMPLETED|Overall Study||49
5164853|NCT01232205|12702498|P2|STARTED|Overall Study||58
5164854|NCT01232205|12702499|P1|STARTED|Overall Study||52
5164855|NCT01232127|12702505|P3|NOT COMPLETED|Period 3: Days 18-24||0
5164856|NCT01232127|12702506|P2|NOT COMPLETED|Period 3: Days 18-24||0
5164857|NCT01232127|12702507|P1|NOT COMPLETED|Period 3: Days 18-24||0
5164858|NCT01232127|12702505|P3|COMPLETED|Period 3: Days 18-24||24
5164859|NCT01232127|12702506|P2|COMPLETED|Period 3: Days 18-24||0
5164860|NCT01232127|12702507|P1|COMPLETED|Period 3: Days 18-24||0
5164861|NCT01232127|12702505|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
5164862|NCT01232127|12702506|P2|STARTED|Period 3: Days 18-24||0
5164863|NCT01232127|12702507|P1|STARTED|Period 3: Days 18-24||0
5164864|NCT01232127|12702505|P3|NOT COMPLETED|Period 2: Days 11-17||0
5164865|NCT01232127|12702506|P2|NOT COMPLETED|Period 2: Days 11-17||0
5164866|NCT01232127|12702507|P1|NOT COMPLETED|Period 2: Days 11-17||0
5164867|NCT01232127|12702505|P3|COMPLETED|Period 2: Days 11-17||0
5164868|NCT01232127|12702506|P2|COMPLETED|Period 2: Days 11-17||24
5164869|NCT01232127|12702507|P1|COMPLETED|Period 2: Days 11-17||0
5164870|NCT01232127|12702505|P3|STARTED|Period 2: Days 11-17||0
5164871|NCT01232127|12702506|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
5164872|NCT01232127|12702507|P1|STARTED|Period 2: Days 11-17||0
5164873|NCT01232127|12702505|P3|NOT COMPLETED|Period 1: Days 1-10||0
5164874|NCT01232127|12702506|P2|NOT COMPLETED|Period 1: Days 1-10||0
5164875|NCT01232127|12702507|P1|NOT COMPLETED|Period 1: Days 1-10||1
5164876|NCT01232127|12702505|P3|COMPLETED|Period 1: Days 1-10||0
5164877|NCT01232127|12702506|P2|COMPLETED|Period 1: Days 1-10||0
5164878|NCT01232127|12702507|P1|COMPLETED|Period 1: Days 1-10||24
5164879|NCT01232127|12702505|P3|STARTED|Period 1: Days 1-10||0
5164880|NCT01232127|12702506|P2|STARTED|Period 1: Days 1-10||0
5164881|NCT01232127|12702507|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
5164882|NCT01231984|12702531|P4|NOT COMPLETED|Study Period 2||4
5164883|NCT01231984|12702532|P3|NOT COMPLETED|Study Period 2||0
5164884|NCT01231984|12702533|P2|NOT COMPLETED|Study Period 2||2
5164885|NCT01231984|12702534|P1|NOT COMPLETED|Study Period 2||3
5164886|NCT01231984|12702531|P4|COMPLETED|Study Period 2||56
5164887|NCT01231984|12702532|P3|COMPLETED|Study Period 2||59
5164888|NCT01231984|12702533|P2|COMPLETED|Study Period 2||61
5164889|NCT01231984|12702534|P1|COMPLETED|Study Period 2||54
5164890|NCT01231984|12702531|P4|STARTED|Study Period 2||60
5164891|NCT01231984|12702532|P3|STARTED|Study Period 2||59
5164892|NCT01231984|12702533|P2|STARTED|Study Period 2||63
5164893|NCT01231984|12702534|P1|STARTED|Study Period 2||57
5164894|NCT01231984|12702531|P4|NOT COMPLETED|Study Period 1||9
5164895|NCT01231984|12702532|P3|NOT COMPLETED|Study Period 1||7
5164896|NCT01231984|12702533|P2|NOT COMPLETED|Study Period 1||7
5164897|NCT01231984|12702534|P1|NOT COMPLETED|Study Period 1||12
5164898|NCT01231984|12702531|P4|COMPLETED|Study Period 1||60
5164899|NCT01231984|12702532|P3|COMPLETED|Study Period 1||59
5164900|NCT01231984|12702533|P2|COMPLETED|Study Period 1||63
5164901|NCT01231984|12702534|P1|COMPLETED|Study Period 1||57
5164902|NCT01231984|12702531|P4|STARTED|Study Period 1||69
5164903|NCT01231984|12702532|P3|STARTED|Study Period 1||66
5164904|NCT01231984|12702533|P2|STARTED|Study Period 1||70
5164905|NCT01231984|12702534|P1|STARTED|Study Period 1||69
5164906|NCT01231841|12702555|P1|NOT COMPLETED|Overall Study||0
5164907|NCT01231841|12702555|P1|COMPLETED|Overall Study||20
5164908|NCT01231841|12702555|P1|STARTED|Overall Study||20
5164909|NCT01231750|12702561|P2|NOT COMPLETED|Overall Study||0
5164910|NCT01231750|12702562|P1|NOT COMPLETED|Overall Study||0
5164911|NCT01231750|12702561|P2|COMPLETED|Overall Study||4
5164912|NCT01231750|12702562|P1|COMPLETED|Overall Study||3
5164913|NCT01231750|12702561|P2|STARTED|Overall Study||4
5164914|NCT01231750|12702562|P1|STARTED|Overall Study||3
5164915|NCT01231646|12702580|P2|NOT COMPLETED|Overall Study||0
5164916|NCT01231646|12702581|P1|NOT COMPLETED|Overall Study||0
5164917|NCT01231646|12702580|P2|COMPLETED|Overall Study||10
5164918|NCT01231646|12702581|P1|COMPLETED|Overall Study||28
5164919|NCT01231646|12702580|P2|STARTED|Overall Study||10
5164920|NCT01231646|12702581|P1|STARTED|Overall Study||28
5164921|NCT01231633|12702589|P2|NOT COMPLETED|Overall Study||0
5164922|NCT01231633|12702590|P1|NOT COMPLETED|Overall Study||0
5164923|NCT01231633|12702589|P2|COMPLETED|Overall Study||13
5164924|NCT01231633|12702590|P1|COMPLETED|Overall Study||14
5164925|NCT01231633|12702589|P2|STARTED|Overall Study||13
5164926|NCT01231633|12702590|P1|STARTED|Overall Study||14
5164927|NCT01231620|12702603|P3|NOT COMPLETED|Overall Study||39
5164928|NCT01231620|12702604|P2|NOT COMPLETED|Overall Study||31
5164929|NCT01231620|12702605|P1|NOT COMPLETED|Overall Study||26
5164930|NCT01231620|12702603|P3|COMPLETED|Overall Study||166
5164931|NCT01231620|12702604|P2|COMPLETED|Overall Study||178
5164932|NCT01231620|12702605|P1|COMPLETED|Overall Study||175
5164933|NCT01231620|12702603|P3|STARTED|Overall Study||205
5164934|NCT01231620|12702604|P2|STARTED|Overall Study||209
5164935|NCT01231620|12702605|P1|STARTED|Overall Study||201
5164936|NCT01231607|12702711|P5|NOT COMPLETED|Overall Study||24
5164937|NCT01231607|12702712|P4|NOT COMPLETED|Overall Study||38
5164938|NCT01231607|12702713|P3|NOT COMPLETED|Overall Study||31
5164939|NCT01231607|12702714|P2|NOT COMPLETED|Overall Study||34
5164940|NCT01231607|12702715|P1|NOT COMPLETED|Overall Study||29
5164941|NCT01231607|12702711|P5|COMPLETED|Overall Study||157
5164942|NCT01231607|12702712|P4|COMPLETED|Overall Study||141
5164943|NCT01231607|12702713|P3|COMPLETED|Overall Study||153
5164944|NCT01231607|12702714|P2|COMPLETED|Overall Study||154
5164945|NCT01231607|12702715|P1|COMPLETED|Overall Study||156
5164946|NCT01231607|12702711|P5|STARTED|Overall Study||181
5164947|NCT01231607|12702712|P4|STARTED|Overall Study||179
5164948|NCT01231607|12702713|P3|STARTED|Overall Study||184
5164949|NCT01231607|12702714|P2|STARTED|Overall Study||188
5164950|NCT01231607|12702715|P1|STARTED|Overall Study||185
5164951|NCT01231581|12702807|P2|NOT COMPLETED|Overall Study||80
5164952|NCT01231581|12702808|P1|NOT COMPLETED|Overall Study||80
5164953|NCT01231581|12702807|P2|COMPLETED|Overall Study||0
5164954|NCT01231581|12702808|P1|COMPLETED|Overall Study||0
5164955|NCT01231581|12702807|P2|Ongoing|Overall Study||0
5164956|NCT01231581|12702808|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
5164957|NCT01231581|12702807|P2|STARTED|Overall Study||80
5164958|NCT01231581|12702808|P1|STARTED|Overall Study||80
5164959|NCT01231555|12702829|P3|NOT COMPLETED|Overall Study||8
5164960|NCT01231555|12702830|P2|NOT COMPLETED|Overall Study||7
5164961|NCT01231555|12702831|P1|NOT COMPLETED|Overall Study||8
5164962|NCT01231555|12702829|P3|COMPLETED|Overall Study||0
5164963|NCT01231555|12702830|P2|COMPLETED|Overall Study||0
5164964|NCT01231555|12702831|P1|COMPLETED|Overall Study||0
5164965|NCT01231555|12702829|P3|STARTED|Overall Study||8
5164966|NCT01231555|12702830|P2|STARTED|Overall Study||7
5164967|NCT01231555|12702831|P1|STARTED|Overall Study||8
5164968|NCT01231516|12702862|P2|NOT COMPLETED|Open-label Phase||26
5164969|NCT01231516|12702863|P1|NOT COMPLETED|Open-label Phase||295
5164970|NCT01231516|12702862|P2|COMPLETED|Open-label Phase||1
5164971|NCT01231516|12702863|P1|COMPLETED|Open-label Phase||0
5164972|NCT01231516|12702862|P2|Ongoing at the Time of Analysis|Open-label Phase||23
5164973|NCT01231516|12702863|P1|Ongoing at the Time of Analysis|Open-label Phase||282
5164974|NCT01231516|12702862|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
5164975|NCT01231516|12702863|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
5164976|NCT01231516|12702862|P2|NOT COMPLETED|48 Week Double-blind Phase||79
5164977|NCT01231516|12702863|P1|NOT COMPLETED|48 Week Double-blind Phase||58
5164978|NCT01231516|12702862|P2|COMPLETED|48 Week Double-blind Phase||283
5164979|NCT01231516|12702863|P1|COMPLETED|48 Week Double-blind Phase||299
5164980|NCT01231516|12702862|P2|STARTED|48 Week Double-blind Phase||362
5164981|NCT01231516|12702863|P1|STARTED|48 Week Double-blind Phase||357
5164982|NCT01231503|12702893|P8|NOT COMPLETED|Overall Study||8
5164983|NCT01231503|12702894|P7|NOT COMPLETED|Overall Study||7
5164984|NCT01231503|12702895|P6|NOT COMPLETED|Overall Study||16
5164985|NCT01231503|12702896|P5|NOT COMPLETED|Overall Study||10
5164986|NCT01231503|12702897|P4|NOT COMPLETED|Overall Study||8
5164987|NCT01231503|12702898|P3|NOT COMPLETED|Overall Study||12
5164988|NCT01231503|12702899|P2|NOT COMPLETED|Overall Study||13
5164989|NCT01231503|12702900|P1|NOT COMPLETED|Overall Study||14
5164990|NCT01231503|12702893|P8|COMPLETED|Overall Study||52
5164991|NCT01231503|12702894|P7|COMPLETED|Overall Study||53
5164992|NCT01231503|12702895|P6|COMPLETED|Overall Study||44
5164993|NCT01231503|12702896|P5|COMPLETED|Overall Study||50
5164994|NCT01231503|12702897|P4|COMPLETED|Overall Study||52
5164995|NCT01231503|12702898|P3|COMPLETED|Overall Study||48
5164996|NCT01231503|12702899|P2|COMPLETED|Overall Study||46
5164997|NCT01231503|12702900|P1|COMPLETED|Overall Study||46
5164998|NCT01231503|12702893|P8|STARTED|Overall Study||60
5164999|NCT01231503|12702894|P7|STARTED|Overall Study||60
5165000|NCT01231503|12702895|P6|STARTED|Overall Study||60
5165001|NCT01231503|12702896|P5|STARTED|Overall Study||60
5165002|NCT01231503|12702897|P4|STARTED|Overall Study||60
5165003|NCT01231503|12702898|P3|STARTED|Overall Study||60
5165004|NCT01231503|12702899|P2|STARTED|Overall Study||59
5165005|NCT01231503|12702900|P1|STARTED|Overall Study||60
5165006|NCT01231464|12703140|P2|NOT COMPLETED|Overall Study||7
5165007|NCT01231464|12703141|P1|NOT COMPLETED|Overall Study||5
5165008|NCT01231464|12703140|P2|COMPLETED|Overall Study||176
5165009|NCT01231464|12703141|P1|COMPLETED|Overall Study||177
5165010|NCT01231464|12703140|P2|STARTED|Overall Study||183
5165011|NCT01231464|12703141|P1|STARTED|Overall Study||182
5165012|NCT01231412|12703154|P3|NOT COMPLETED|Overall Study||0
5165013|NCT01231412|12703155|P2|NOT COMPLETED|Overall Study||1
5165014|NCT01231412|12703156|P1|NOT COMPLETED|Overall Study||0
5165015|NCT01231412|12703154|P3|COMPLETED|Overall Study||6
5165016|NCT01231412|12703155|P2|COMPLETED|Overall Study||90
5165017|NCT01231412|12703156|P1|COMPLETED|Overall Study||77
5165018|NCT01231412|12703154|P3|STARTED|Overall Study||6
5165019|NCT01231412|12703155|P2|STARTED|Overall Study||91
5165020|NCT01231412|12703156|P1|STARTED|Overall Study||77
5165021|NCT01231399|12703179|P1|NOT COMPLETED|Overall Study||0
5165022|NCT01231399|12703179|P1|COMPLETED|Overall Study||6
5165023|NCT01231399|12703179|P1|STARTED|Overall Study||6
5165024|NCT01231373|12703190|P4|NOT COMPLETED|Overall Study||1
5165025|NCT01231373|12703191|P3|NOT COMPLETED|Overall Study||0
5165026|NCT01231373|12703192|P2|NOT COMPLETED|Overall Study||1
5165027|NCT01231373|12703193|P1|NOT COMPLETED|Overall Study||3
5165028|NCT01231373|12703190|P4|COMPLETED|Overall Study||57
5165029|NCT01231373|12703191|P3|COMPLETED|Overall Study||60
5165030|NCT01231373|12703192|P2|COMPLETED|Overall Study||57
5165031|NCT01231373|12703193|P1|COMPLETED|Overall Study||56
5165032|NCT01231373|12703190|P4|Patients Receiving Blinded Treatment|Overall Study||58
5165033|NCT01231373|12703191|P3|Patients Receiving Blinded Treatment|Overall Study||60
5165034|NCT01231373|12703192|P2|Patients Receiving Blinded Treatment|Overall Study||57
5165035|NCT01231373|12703193|P1|Patients Receiving Blinded Treatment|Overall Study||57
5165036|NCT01231373|12703190|P4|STARTED|Overall Study||58
5165037|NCT01231373|12703191|P3|STARTED|Overall Study||60
5165038|NCT01231373|12703192|P2|STARTED|Overall Study||58
5165039|NCT01231373|12703193|P1|STARTED|Overall Study||59
5165040|NCT01231334|12703213|P2|NOT COMPLETED|Overall Study||21
5165041|NCT01231334|12703214|P1|NOT COMPLETED|Overall Study||19
5165042|NCT01231334|12703213|P2|COMPLETED|Overall Study||120
5165043|NCT01231334|12703214|P1|COMPLETED|Overall Study||126
5165044|NCT01231334|12703213|P2|STARTED|Overall Study||141
5165045|NCT01231334|12703214|P1|STARTED|Overall Study||145
5165046|NCT01231321|12703232|P1|NOT COMPLETED|Overall Study||5
5165047|NCT01231321|12703232|P1|COMPLETED|Overall Study||95
5165048|NCT01231321|12703232|P1|STARTED|Overall Study||100
5165049|NCT01231230|12703243|P1|NOT COMPLETED|Overall Study||0
5165050|NCT01231230|12703243|P1|COMPLETED|Overall Study||14
5165051|NCT01231230|12703243|P1|Placebo|Overall Study||14
5165052|NCT01231230|12703243|P1|Fluticasone/Salmeterol|Overall Study||14
5165053|NCT01231230|12703243|P1|Salmeterol|Overall Study||14
5165054|NCT01231230|12703243|P1|Fluticasone|Overall Study||14
5165055|NCT01231230|12703243|P1|STARTED|Overall Study||14
5165056|NCT01230931|12703255|P2|NOT COMPLETED|Overall Study||0
5165057|NCT01230931|12703256|P1|NOT COMPLETED|Overall Study||0
5165058|NCT01230931|12703255|P2|COMPLETED|Overall Study||10
5165059|NCT01230931|12703256|P1|COMPLETED|Overall Study||10
5165060|NCT01230931|12703255|P2|STARTED|Overall Study||10
5165061|NCT01230931|12703256|P1|STARTED|Overall Study||10
5165062|NCT01230892|12703280|P2|NOT COMPLETED|Overall Study||1
5165063|NCT01230892|12703281|P1|NOT COMPLETED|Overall Study||3
5165064|NCT01230892|12703280|P2|COMPLETED|Overall Study||13
5165065|NCT01230892|12703281|P1|COMPLETED|Overall Study||12
5165066|NCT01230892|12703280|P2|STARTED|Overall Study||14
5165067|NCT01230892|12703281|P1|STARTED|Overall Study||15
5165068|NCT01230827|12703291|P4|NOT COMPLETED|Overall Study||78
5165069|NCT01230827|12703292|P3|NOT COMPLETED|Overall Study||65
5165070|NCT01230827|12703293|P2|NOT COMPLETED|Overall Study||11
5165071|NCT01230827|12703294|P1|NOT COMPLETED|Overall Study||19
5165072|NCT01230827|12703291|P4|COMPLETED|Overall Study||0
5165073|NCT01230827|12703292|P3|COMPLETED|Overall Study||0
5165074|NCT01230827|12703293|P2|COMPLETED|Overall Study||0
5165075|NCT01230827|12703294|P1|COMPLETED|Overall Study||0
5165076|NCT01230827|12703291|P4|STARTED|Overall Study||78
5165077|NCT01230827|12703292|P3|STARTED|Overall Study||65
5165078|NCT01230827|12703293|P2|STARTED|Overall Study||11
5165079|NCT01230827|12703294|P1|STARTED|Overall Study||19
5165080|NCT01230814|12703310|P2|NOT COMPLETED|Overall Study||4
5165081|NCT01230814|12703311|P1|NOT COMPLETED|Overall Study||13
5165082|NCT01230814|12703310|P2|COMPLETED|Overall Study||112
5165083|NCT01230814|12703311|P1|COMPLETED|Overall Study||105
5165084|NCT01230814|12703310|P2|STARTED|Overall Study||116
5165085|NCT01230814|12703311|P1|STARTED|Overall Study||118
5165086|NCT01230801|12703326|P3|NOT COMPLETED|Overall Study||1
5165087|NCT01230801|12703327|P2|NOT COMPLETED|Overall Study||0
5165088|NCT01230801|12703328|P1|NOT COMPLETED|Overall Study||0
5165089|NCT01230801|12703326|P3|COMPLETED|Overall Study||15
5165090|NCT01230801|12703327|P2|COMPLETED|Overall Study||3
5165091|NCT01230801|12703328|P1|COMPLETED|Overall Study||3
5165092|NCT01230801|12703326|P3|STARTED|Overall Study||16
5165093|NCT01230801|12703327|P2|STARTED|Overall Study||3
5165094|NCT01230801|12703328|P1|STARTED|Overall Study||3
5165095|NCT01230788|12703361|P1|NOT COMPLETED|Overall Study||1
5165096|NCT01230788|12703361|P1|COMPLETED|Overall Study||0
5165097|NCT01230788|12703361|P1|STARTED|Overall Study||1
5165098|NCT01230749|12703373|P4|NOT COMPLETED|Overall Study||2
5165099|NCT01230749|12703374|P3|NOT COMPLETED|Overall Study||2
5165100|NCT01230749|12703375|P2|NOT COMPLETED|Overall Study||2
5165101|NCT01230749|12703376|P1|NOT COMPLETED|Overall Study||0
5165102|NCT01230749|12703373|P4|COMPLETED|Overall Study||20
5165103|NCT01230749|12703374|P3|COMPLETED|Overall Study||21
5165104|NCT01230749|12703375|P2|COMPLETED|Overall Study||20
5165105|NCT01230749|12703376|P1|COMPLETED|Overall Study||22
5165106|NCT01230749|12703373|P4|STARTED|Overall Study||22
5165107|NCT01230749|12703374|P3|STARTED|Overall Study||23
5165108|NCT01230749|12703375|P2|STARTED|Overall Study||22
5165109|NCT01230749|12703376|P1|STARTED|Overall Study||22
5165110|NCT01230710|12703411|P1|NOT COMPLETED|Overall Study||49
5165111|NCT01230710|12703411|P1|COMPLETED|Overall Study||2
5165112|NCT01230710|12703411|P1|STARTED|Overall Study||51
5165113|NCT01230593|12703422|P3|NOT COMPLETED|Overall Study||12
5165114|NCT01230593|12703423|P2|NOT COMPLETED|Overall Study||18
5165115|NCT01230593|12703424|P1|NOT COMPLETED|Overall Study||15
5165116|NCT01230593|12703422|P3|COMPLETED|Overall Study||38
5165117|NCT01230593|12703423|P2|COMPLETED|Overall Study||32
5165118|NCT01230593|12703424|P1|COMPLETED|Overall Study||35
5165119|NCT01230593|12703422|P3|STARTED|Overall Study||50
5165120|NCT01230593|12703423|P2|STARTED|Overall Study||50
5165121|NCT01230593|12703424|P1|STARTED|Overall Study||50
5165122|NCT01230554|12703435|P1|NOT COMPLETED|Overall Study||3
5165123|NCT01230554|12703435|P1|COMPLETED|Overall Study||209
5165124|NCT01230554|12703435|P1|STARTED|Overall Study||212
5165125|NCT01230502|12703445|P3|NOT COMPLETED|Overall Study||0
5165126|NCT01230502|12703446|P2|NOT COMPLETED|Overall Study||0
5165127|NCT01230502|12703447|P1|NOT COMPLETED|Overall Study||0
5165128|NCT01230502|12703445|P3|COMPLETED|Overall Study||0
5165129|NCT01230502|12703446|P2|COMPLETED|Overall Study||0
5165130|NCT01230502|12703447|P1|COMPLETED|Overall Study||9
5165131|NCT01230502|12703445|P3|STARTED|Overall Study||0
5165132|NCT01230502|12703446|P2|STARTED|Overall Study||0
5165133|NCT01230502|12703447|P1|STARTED|Overall Study||9
5165134|NCT01230489|12703458|P1|NOT COMPLETED|Overall Study||5
5165135|NCT01230489|12703458|P1|COMPLETED|Overall Study||8
5165136|NCT01230489|12703458|P1|STARTED|Overall Study||13
5165137|NCT01230424|12703464|P2|NOT COMPLETED|Overall Study||0
5165138|NCT01230424|12703465|P1|NOT COMPLETED|Overall Study||0
5165139|NCT01230424|12703464|P2|COMPLETED|Overall Study||70
5165140|NCT01230424|12703465|P1|COMPLETED|Overall Study||70
5165141|NCT01230424|12703464|P2|STARTED|Overall Study||70
5165142|NCT01230424|12703465|P1|STARTED|Overall Study||70
5165143|NCT01230307|12703493|P2|NOT COMPLETED|Overall Study||2
5165144|NCT01230307|12703494|P1|NOT COMPLETED|Overall Study||0
5165145|NCT01230307|12703493|P2|COMPLETED|Overall Study||4
5165146|NCT01230307|12703494|P1|COMPLETED|Overall Study||6
5165147|NCT01230307|12703493|P2|STARTED|Overall Study||6
5165148|NCT01230307|12703494|P1|STARTED|Overall Study||6
5165149|NCT01230177|12703506|P1|NOT COMPLETED|Overall Study||0
5165150|NCT01230177|12703506|P1|COMPLETED|Overall Study||3
5165151|NCT01230177|12703506|P1|STARTED|Overall Study||3
5165152|NCT01230060|12703514|P1|NOT COMPLETED|Overall Study||1
5165153|NCT01230060|12703514|P1|COMPLETED|Overall Study||121
5165154|NCT01230060|12703514|P1|STARTED|Overall Study||122
5165155|NCT01230021|12703518|P1|NOT COMPLETED|Overall Study||0
5165156|NCT01230021|12703518|P1|COMPLETED|Overall Study||6
5165157|NCT01230021|12703518|P1|STARTED|Overall Study||6
5165158|NCT01229943|12703540|P2|NOT COMPLETED|Overall Study||17
5165159|NCT01229943|12703541|P1|NOT COMPLETED|Overall Study||18
5165160|NCT01229943|12703540|P2|COMPLETED|Overall Study||58
5165161|NCT01229943|12703541|P1|COMPLETED|Overall Study||57
5165162|NCT01229943|12703540|P2|STARTED|Overall Study||75
5165163|NCT01229943|12703541|P1|STARTED|Overall Study||75
5165164|NCT01229891|12703554|P3|NOT COMPLETED|Overall Study||0
5165165|NCT01229891|12703555|P2|NOT COMPLETED|Overall Study||0
5165166|NCT01229891|12703556|P1|NOT COMPLETED|Overall Study||0
5165167|NCT01229891|12703554|P3|COMPLETED|Overall Study||30
5165168|NCT01229891|12703555|P2|COMPLETED|Overall Study||30
5165169|NCT01229891|12703556|P1|COMPLETED|Overall Study||30
5165170|NCT01229891|12703554|P3|STARTED|Overall Study||30
5165171|NCT01229891|12703555|P2|STARTED|Overall Study||30
5165172|NCT01229891|12703556|P1|STARTED|Overall Study||30
5165173|NCT01229735|12703587|P2|NOT COMPLETED|Overall Study||66
5165174|NCT01229735|12703588|P1|NOT COMPLETED|Overall Study||66
5165175|NCT01229735|12703587|P2|COMPLETED|Overall Study||100
5165176|NCT01229735|12703588|P1|COMPLETED|Overall Study||111
5165177|NCT01229735|12703587|P2|STARTED|Overall Study||166
5165178|NCT01229735|12703588|P1|STARTED|Overall Study||177
5165179|NCT01229722|12703604|P2|NOT COMPLETED|Overall Study||4
5165180|NCT01229722|12703605|P1|NOT COMPLETED|Overall Study||0
5165181|NCT01229722|12703604|P2|COMPLETED|Overall Study||30
5165182|NCT01229722|12703605|P1|COMPLETED|Overall Study||36
5165183|NCT01229722|12703604|P2|STARTED|Overall Study||34
5165184|NCT01229722|12703605|P1|STARTED|Overall Study||36
5165185|NCT01229527|12703618|P3|NOT COMPLETED|Overall Study||0
5165186|NCT01229527|12703619|P2|NOT COMPLETED|Overall Study||0
5165187|NCT01229527|12703620|P1|NOT COMPLETED|Overall Study||0
5165188|NCT01229527|12703618|P3|COMPLETED|Overall Study||30
5165189|NCT01229527|12703619|P2|COMPLETED|Overall Study||30
5165190|NCT01229527|12703620|P1|COMPLETED|Overall Study||30
5165191|NCT01229527|12703618|P3|STARTED|Overall Study||30
5165192|NCT01229527|12703619|P2|STARTED|Overall Study||30
5165193|NCT01229527|12703620|P1|STARTED|Overall Study||30
5165194|NCT01229462|12703633|P2|NOT COMPLETED|Overall Study||9
5165195|NCT01229462|12703634|P1|NOT COMPLETED|Overall Study||5
5165196|NCT01229462|12703633|P2|COMPLETED|Overall Study||109
5165197|NCT01229462|12703634|P1|COMPLETED|Overall Study||115
5165198|NCT01229462|12703633|P2|STARTED|Overall Study||118
5165199|NCT01229462|12703634|P1|STARTED|Overall Study||120
5165200|NCT01229449|12703645|P5|NOT COMPLETED|Overall Study||1
5165201|NCT01229449|12703646|P4|NOT COMPLETED|Overall Study||1
5165202|NCT01229449|12703647|P3|NOT COMPLETED|Overall Study||2
5165203|NCT01229449|12703648|P2|NOT COMPLETED|Overall Study||4
5165204|NCT01229449|12703649|P1|NOT COMPLETED|Overall Study||1
5165205|NCT01229449|12703645|P5|COMPLETED|Overall Study||54
5165206|NCT01229449|12703646|P4|COMPLETED|Overall Study||112
5165207|NCT01229449|12703647|P3|COMPLETED|Overall Study||167
5165208|NCT01229449|12703648|P2|COMPLETED|Overall Study||164
5165209|NCT01229449|12703649|P1|COMPLETED|Overall Study||172
5165210|NCT01229449|12703645|P5|STARTED|Overall Study||55
5165211|NCT01229449|12703646|P4|STARTED|Overall Study||113
5165212|NCT01229449|12703647|P3|STARTED|Overall Study||169
5165213|NCT01229449|12703648|P2|STARTED|Overall Study||168
5165214|NCT01229449|12703649|P1|STARTED|Overall Study||173
5165215|NCT01229436|12703706|P1|NOT COMPLETED|Overall Study||5
5165216|NCT01229436|12703706|P1|COMPLETED|Overall Study||249
5165217|NCT01229436|12703706|P1|STARTED|Overall Study||254
5165218|NCT01229423|12703744|P1|NOT COMPLETED|Overall Study||15
5165219|NCT01229423|12703744|P1|COMPLETED|Overall Study||47
5165220|NCT01229423|12703744|P1|STARTED|Overall Study||62
5165221|NCT01229410|12703755|P2|NOT COMPLETED|Overall Study||3
5165222|NCT01229410|12703756|P1|NOT COMPLETED|Overall Study||5
5165223|NCT01229410|12703755|P2|COMPLETED|Overall Study||9
5165224|NCT01229410|12703756|P1|COMPLETED|Overall Study||7
5165225|NCT01229410|12703755|P2|STARTED|Overall Study||12
5165226|NCT01229410|12703756|P1|STARTED|Overall Study||12
5165227|NCT01229397|12703768|P2|NOT COMPLETED|Overall Study||9
5165228|NCT01229397|12703769|P1|NOT COMPLETED|Overall Study||11
5165229|NCT01229397|12703768|P2|COMPLETED|Overall Study||93
5165230|NCT01229397|12703769|P1|COMPLETED|Overall Study||92
5165231|NCT01229397|12703768|P2|STARTED|Overall Study||102
5165232|NCT01229397|12703769|P1|STARTED|Overall Study||103
5165233|NCT01229371|12703787|P4|NOT COMPLETED|Overall Study||0
5165234|NCT01229371|12703788|P3|NOT COMPLETED|Overall Study||0
5165235|NCT01229371|12703789|P2|NOT COMPLETED|Overall Study||1
5165236|NCT01229371|12703790|P1|NOT COMPLETED|Overall Study||0
5165237|NCT01229371|12703787|P4|COMPLETED|Overall Study||110
5165238|NCT01229371|12703788|P3|COMPLETED|Overall Study||110
5165239|NCT01229371|12703789|P2|COMPLETED|Overall Study||110
5165240|NCT01229371|12703790|P1|COMPLETED|Overall Study||109
5165241|NCT01229371|12703787|P4|STARTED|Overall Study||110
5165242|NCT01229371|12703788|P3|STARTED|Overall Study||110
5165243|NCT01229371|12703789|P2|STARTED|Overall Study||111
5165244|NCT01229371|12703790|P1|STARTED|Overall Study||109
5165245|NCT01229267|12703817|P5|NOT COMPLETED|Overall Study||220
5165246|NCT01229267|12703818|P4|NOT COMPLETED|Overall Study||35
5165247|NCT01229267|12703819|P3|NOT COMPLETED|Overall Study||86
5165248|NCT01229267|12703820|P2|NOT COMPLETED|Overall Study||82
5165249|NCT01229267|12703821|P1|NOT COMPLETED|Overall Study||81
5165250|NCT01229267|12703817|P5|COMPLETED|Overall Study||344
5165251|NCT01229267|12703818|P4|COMPLETED|Overall Study||71
5165252|NCT01229267|12703819|P3|COMPLETED|Overall Study||101
5165253|NCT01229267|12703820|P2|COMPLETED|Overall Study||102
5165254|NCT01229267|12703821|P1|COMPLETED|Overall Study||108
5165255|NCT01229267|12703817|P5|Received Vaccination 4|Overall Study||477
5165256|NCT01229267|12703818|P4|Received Vaccination 4|Overall Study||87
5165257|NCT01229267|12703819|P3|Received Vaccination 4|Overall Study||149
5165258|NCT01229267|12703820|P2|Received Vaccination 4|Overall Study||149
5165259|NCT01229267|12703821|P1|Received Vaccination 4|Overall Study||155
5165260|NCT01229267|12703817|P5|Received Vaccination 3|Overall Study||491
5165261|NCT01229267|12703818|P4|Received Vaccination 3|Overall Study||89
5165262|NCT01229267|12703819|P3|Received Vaccination 3|Overall Study||160
5165263|NCT01229267|12703820|P2|Received Vaccination 3|Overall Study||155
5165264|NCT01229267|12703821|P1|Received Vaccination 3|Overall Study||163
5165265|NCT01229267|12703817|P5|Received Vaccination 2|Overall Study||511
5165266|NCT01229267|12703818|P4|Received Vaccination 2|Overall Study||94
5165267|NCT01229267|12703819|P3|Received Vaccination 2|Overall Study||168
5165268|NCT01229267|12703820|P2|Received Vaccination 2|Overall Study||163
5165269|NCT01229267|12703821|P1|Received Vaccination 2|Overall Study||171
5165270|NCT01229267|12703817|P5|Received Vaccination 1|Overall Study||556
5165271|NCT01229267|12703818|P4|Received Vaccination 1|Overall Study||104
5165272|NCT01229267|12703819|P3|Received Vaccination 1|Overall Study||186
5165273|NCT01229267|12703820|P2|Received Vaccination 1|Overall Study||180
5165274|NCT01229267|12703821|P1|Received Vaccination 1|Overall Study||188
5165275|NCT01229267|12703817|P5|STARTED|Overall Study||564
5165276|NCT01229267|12703818|P4|STARTED|Overall Study||106
5165277|NCT01229267|12703819|P3|STARTED|Overall Study||187
5165278|NCT01229267|12703820|P2|STARTED|Overall Study||184
5165279|NCT01229267|12703821|P1|STARTED|Overall Study||189
5165280|NCT01229254|12703840|P3|NOT COMPLETED|Overall Study||12
5165281|NCT01229254|12703841|P2|NOT COMPLETED|Overall Study||16
5165282|NCT01229254|12703842|P1|NOT COMPLETED|Overall Study||15
5165283|NCT01229254|12703840|P3|COMPLETED|Overall Study||61
5165284|NCT01229254|12703841|P2|COMPLETED|Overall Study||58
5165285|NCT01229254|12703842|P1|COMPLETED|Overall Study||27
5165286|NCT01229254|12703840|P3|STARTED|Overall Study||73
5165287|NCT01229254|12703841|P2|STARTED|Overall Study||74
5165288|NCT01229254|12703842|P1|STARTED|Overall Study||42
5165289|NCT01229228|12703856|P5|NOT COMPLETED|Overall Study||1
5165290|NCT01229228|12703857|P4|NOT COMPLETED|Overall Study||0
5165291|NCT01229228|12703858|P3|NOT COMPLETED|Overall Study||1
5165292|NCT01229228|12703859|P2|NOT COMPLETED|Overall Study||0
5165293|NCT01229228|12703860|P1|NOT COMPLETED|Overall Study||1
5165294|NCT01229228|12703856|P5|COMPLETED|Overall Study||50
5165295|NCT01229228|12703857|P4|COMPLETED|Overall Study||51
5165296|NCT01229228|12703858|P3|COMPLETED|Overall Study||49
5165297|NCT01229228|12703859|P2|COMPLETED|Overall Study||51
5165298|NCT01229228|12703860|P1|COMPLETED|Overall Study||50
5165299|NCT01229228|12703856|P5|STARTED|Overall Study||51
5165300|NCT01229228|12703857|P4|STARTED|Overall Study||51
5165301|NCT01229228|12703858|P3|STARTED|Overall Study||50
5165302|NCT01229228|12703859|P2|STARTED|Overall Study||51
5165303|NCT01229228|12703860|P1|STARTED|Overall Study||51
5165304|NCT01229176|12703880|P8|NOT COMPLETED|Overall Study||3
5165305|NCT01229176|12703881|P7|NOT COMPLETED|Overall Study||0
5165306|NCT01229176|12703882|P6|NOT COMPLETED|Overall Study||2
5165307|NCT01229176|12703883|P5|NOT COMPLETED|Overall Study||2
5165308|NCT01229176|12703884|P4|NOT COMPLETED|Overall Study||1
5165309|NCT01229176|12703885|P3|NOT COMPLETED|Overall Study||0
5165310|NCT01229176|12703886|P2|NOT COMPLETED|Overall Study||3
5165311|NCT01229176|12703887|P1|NOT COMPLETED|Overall Study||0
5165312|NCT01229176|12703880|P8|COMPLETED|Overall Study||17
5165313|NCT01229176|12703881|P7|COMPLETED|Overall Study||20
5165314|NCT01229176|12703882|P6|COMPLETED|Overall Study||18
5165315|NCT01229176|12703883|P5|COMPLETED|Overall Study||18
5165316|NCT01229176|12703884|P4|COMPLETED|Overall Study||19
5165317|NCT01229176|12703885|P3|COMPLETED|Overall Study||20
5165318|NCT01229176|12703886|P2|COMPLETED|Overall Study||37
5165319|NCT01229176|12703887|P1|COMPLETED|Overall Study||40
5165320|NCT01229176|12703880|P8|STARTED|Overall Study||20
5165321|NCT01229176|12703881|P7|STARTED|Overall Study||20
5165322|NCT01229176|12703882|P6|STARTED|Overall Study||20
5165323|NCT01229176|12703883|P5|STARTED|Overall Study||20
5165324|NCT01229176|12703884|P4|STARTED|Overall Study||20
5165325|NCT01229176|12703885|P3|STARTED|Overall Study||20
5165326|NCT01229176|12703886|P2|STARTED|Overall Study||40
5165327|NCT01229176|12703887|P1|STARTED|Overall Study||40
5165328|NCT01229150|12703941|P4|NOT COMPLETED|Overall Study||0
5165329|NCT01229150|12703942|P3|NOT COMPLETED|Overall Study||0
5165330|NCT01229150|12703943|P2|NOT COMPLETED|Overall Study||2
5165331|NCT01229150|12703944|P1|NOT COMPLETED|Overall Study||2
5165332|NCT01229150|12703941|P4|COMPLETED|Overall Study||19
5165333|NCT01229150|12703942|P3|COMPLETED|Overall Study||19
5165334|NCT01229150|12703943|P2|COMPLETED|Overall Study||9
5165335|NCT01229150|12703944|P1|COMPLETED|Overall Study||28
5165336|NCT01229150|12703941|P4|STARTED|Overall Study||19
5165337|NCT01229150|12703942|P3|STARTED|Overall Study||19
5165338|NCT01229150|12703943|P2|STARTED|Overall Study||11
5165339|NCT01229150|12703944|P1|STARTED|Overall Study||30
5165340|NCT01229111|12704001|P1|NOT COMPLETED|Overall Study||1
5165341|NCT01229111|12704001|P1|COMPLETED|Overall Study||13
5165342|NCT01229111|12704001|P1|STARTED|Overall Study||14
5165343|NCT01228968|12704009|P1|NOT COMPLETED|Overall Study||0
5165344|NCT01228968|12704009|P1|COMPLETED|Overall Study||9
5165345|NCT01228968|12704009|P1|STARTED|Overall Study||9
5165346|NCT01228929|12704019|P3|NOT COMPLETED|High Temperature Condition||0
5165347|NCT01228929|12704020|P2|NOT COMPLETED|High Temperature Condition||0
5165348|NCT01228929|12704021|P1|NOT COMPLETED|High Temperature Condition||0
5165349|NCT01228929|12704019|P3|COMPLETED|High Temperature Condition||6
5165350|NCT01228929|12704020|P2|COMPLETED|High Temperature Condition||6
5165351|NCT01228929|12704021|P1|COMPLETED|High Temperature Condition||6
5165352|NCT01228929|12704019|P3|STARTED|High Temperature Condition||6
5165353|NCT01228929|12704020|P2|STARTED|High Temperature Condition||6
5165354|NCT01228929|12704021|P1|STARTED|High Temperature Condition||6
5165355|NCT01228929|12704019|P3|NOT COMPLETED|Low Humidity Condition||0
5165356|NCT01228929|12704020|P2|NOT COMPLETED|Low Humidity Condition||0
5165357|NCT01228929|12704021|P1|NOT COMPLETED|Low Humidity Condition||0
5165358|NCT01228929|12704019|P3|COMPLETED|Low Humidity Condition||6
5165359|NCT01228929|12704020|P2|COMPLETED|Low Humidity Condition||6
5165360|NCT01228929|12704021|P1|COMPLETED|Low Humidity Condition||6
5165361|NCT01228929|12704019|P3|STARTED|Low Humidity Condition||6
5165362|NCT01228929|12704020|P2|STARTED|Low Humidity Condition||6
5165363|NCT01228929|12704021|P1|STARTED|Low Humidity Condition||6
5165364|NCT01228929|12704019|P3|NOT COMPLETED|Nominal Condition||0
5165365|NCT01228929|12704020|P2|NOT COMPLETED|Nominal Condition||0
5165366|NCT01228929|12704021|P1|NOT COMPLETED|Nominal Condition||0
5165367|NCT01228929|12704019|P3|COMPLETED|Nominal Condition||6
5165368|NCT01228929|12704020|P2|COMPLETED|Nominal Condition||6
5165369|NCT01228929|12704021|P1|COMPLETED|Nominal Condition||6
5165370|NCT01228929|12704019|P3|STARTED|Nominal Condition||6
5165371|NCT01228929|12704020|P2|STARTED|Nominal Condition||6
5165372|NCT01228929|12704021|P1|STARTED|Nominal Condition||6
5165373|NCT01228903|12704031|P2|NOT COMPLETED|Overall Study||5
5165374|NCT01228903|12704032|P1|NOT COMPLETED|Overall Study||5
5165375|NCT01228903|12704031|P2|COMPLETED|Overall Study||34
5165376|NCT01228903|12704032|P1|COMPLETED|Overall Study||36
5165377|NCT01228903|12704031|P2|STARTED|Overall Study||39
5165378|NCT01228903|12704032|P1|STARTED|Overall Study||41
5165379|NCT01228747|12704050|P2|NOT COMPLETED|Overall Study||45
5165380|NCT01228747|12704051|P1|NOT COMPLETED|Overall Study||65
5165381|NCT01228747|12704050|P2|COMPLETED|Overall Study||81
5165382|NCT01228747|12704051|P1|COMPLETED|Overall Study||60
5165383|NCT01228747|12704050|P2|STARTED|Overall Study||126
5165384|NCT01228747|12704051|P1|STARTED|Overall Study||125
5165385|NCT01228734|12704067|P2|NOT COMPLETED|Overall Study||4
5165386|NCT01228734|12704068|P1|NOT COMPLETED|Overall Study||0
5165387|NCT01228734|12704067|P2|COMPLETED|Overall Study||200
5165388|NCT01228734|12704068|P1|COMPLETED|Overall Study||193
5165389|NCT01228734|12704067|P2|Modified Safety Population|Overall Study||199
5165390|NCT01228734|12704068|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
5165391|NCT01228734|12704067|P2|Modified Intent-to-treat Population|Overall Study||200
5165392|NCT01228734|12704068|P1|Modified Intent-to-treat Population|Overall Study||193
5165393|NCT01228734|12704067|P2|STARTED|Overall Study||204
5165394|NCT01228734|12704068|P1|STARTED|Overall Study||193
5165395|NCT01228591|12704082|P2|NOT COMPLETED|Final Visit||0
5165396|NCT01228591|12704083|P1|NOT COMPLETED|Final Visit||0
5165397|NCT01228591|12704082|P2|COMPLETED|Final Visit||16
5165398|NCT01228591|12704083|P1|COMPLETED|Final Visit||17
5165399|NCT01228591|12704082|P2|STARTED|Final Visit||16
5165400|NCT01228591|12704083|P1|STARTED|Final Visit||17
5165401|NCT01228591|12704082|P2|NOT COMPLETED|1-Week Follow-Up||0
5165402|NCT01228591|12704083|P1|NOT COMPLETED|1-Week Follow-Up||0
5165403|NCT01228591|12704082|P2|COMPLETED|1-Week Follow-Up||16
5165404|NCT01228591|12704083|P1|COMPLETED|1-Week Follow-Up||17
5165405|NCT01228591|12704082|P2|STARTED|1-Week Follow-Up||16
5165406|NCT01228591|12704083|P1|STARTED|1-Week Follow-Up||17
5165407|NCT01228591|12704082|P2|NOT COMPLETED|Baseline||2
5165408|NCT01228591|12704083|P1|NOT COMPLETED|Baseline||1
5165409|NCT01228591|12704082|P2|COMPLETED|Baseline||16
5165410|NCT01228591|12704083|P1|COMPLETED|Baseline||17
5165411|NCT01228591|12704082|P2|STARTED|Baseline||18
5165412|NCT01228591|12704083|P1|STARTED|Baseline||18
5165413|NCT01228435|12704101|P2|NOT COMPLETED|Overall Study||0
5165414|NCT01228435|12704102|P1|NOT COMPLETED|Overall Study||0
5165415|NCT01228435|12704101|P2|COMPLETED|Overall Study||2
5165416|NCT01228435|12704102|P1|COMPLETED|Overall Study||1
5165417|NCT01228435|12704101|P2|STARTED|Overall Study||2
5165418|NCT01228435|12704102|P1|STARTED|Overall Study||1
5165419|NCT01228318|12704112|P2|NOT COMPLETED|Overall Study||7
5165420|NCT01228318|12704113|P1|NOT COMPLETED|Overall Study||4
5165421|NCT01228318|12704112|P2|COMPLETED|Overall Study||22
5165422|NCT01228318|12704113|P1|COMPLETED|Overall Study||30
5165423|NCT01228318|12704112|P2|STARTED|Overall Study||29
5165424|NCT01228318|12704113|P1|STARTED|Overall Study||34
5165425|NCT01228175|12704129|P2|NOT COMPLETED|Overall Study||53
5165426|NCT01228175|12704130|P1|NOT COMPLETED|Overall Study||66
5165427|NCT01228175|12704129|P2|COMPLETED|Overall Study||46
5165428|NCT01228175|12704130|P1|COMPLETED|Overall Study||53
5165429|NCT01228175|12704129|P2|STARTED|Overall Study||99
5165430|NCT01228175|12704130|P1|STARTED|Overall Study||119
5165431|NCT01228149|12704138|P2|NOT COMPLETED|Overall Study||4
5165432|NCT01228149|12704139|P1|NOT COMPLETED|Overall Study||5
5165433|NCT01228149|12704138|P2|COMPLETED|Overall Study||26
5165434|NCT01228149|12704139|P1|COMPLETED|Overall Study||27
5165435|NCT01228149|12704138|P2|STARTED|Overall Study||30
5165436|NCT01228149|12704139|P1|STARTED|Overall Study||32
5165437|NCT01228084|12704161|P1|NOT COMPLETED|Overall Study||4
5165438|NCT01228084|12704161|P1|COMPLETED|Overall Study||16
5165439|NCT01228084|12704161|P1|STARTED|Overall Study||20
5165440|NCT01228071|12704172|P1|NOT COMPLETED|Overall Study||2
5165441|NCT01228071|12704172|P1|COMPLETED|Overall Study||32
5165442|NCT01228071|12704172|P1|STARTED|Overall Study||34
5165443|NCT01228019|12704178|P1|NOT COMPLETED|Overall Study||304
5165444|NCT01228019|12704178|P1|COMPLETED|Overall Study||862
5165445|NCT01228019|12704178|P1|STARTED|Overall Study||1166
5165446|NCT01227993|12704193|P1|NOT COMPLETED|Overall Study||0
5165447|NCT01227993|12704193|P1|COMPLETED|Overall Study||3
5165448|NCT01227993|12704193|P1|STARTED|Overall Study||3
5165449|NCT01227980|12704205|P2|NOT COMPLETED|Overall Study||5
5165450|NCT01227980|12704206|P1|NOT COMPLETED|Overall Study||2
5165451|NCT01227980|12704205|P2|COMPLETED|Overall Study||25
5165452|NCT01227980|12704206|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
5165453|NCT01227980|12704205|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
5165454|NCT01227980|12704206|P1|Measure Drug Level Concentration|Overall Study||10
5165455|NCT01227980|12704205|P2|Scripts Challenge Sessions|Overall Study||25
5165456|NCT01227980|12704206|P1|Scripts Challenge Sessions|Overall Study||26
5165457|NCT01227980|12704205|P2|STARTED|Overall Study||30
5165458|NCT01227980|12704206|P1|STARTED|Overall Study||40
5165459|NCT01227967|12704244|P2|NOT COMPLETED|Overall Study||13
5165460|NCT01227967|12704245|P1|NOT COMPLETED|Overall Study||16
5165461|NCT01227967|12704244|P2|COMPLETED|Overall Study||303
5165462|NCT01227967|12704245|P1|COMPLETED|Overall Study||298
5165463|NCT01227967|12704244|P2|STARTED|Overall Study||316
5165464|NCT01227967|12704245|P1|STARTED|Overall Study||314
5165465|NCT01227954|12704279|P1|NOT COMPLETED|Overall Study||13
5165466|NCT01227954|12704279|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
5165467|NCT01227954|12704279|P1|STARTED|Overall Study||113
5165468|NCT01227928|12704293|P2|NOT COMPLETED|Overall Study||17
5165469|NCT01227928|12704294|P1|NOT COMPLETED|Overall Study||22
5165470|NCT01227928|12704293|P2|COMPLETED|Overall Study||56
5165471|NCT01227928|12704294|P1|COMPLETED|Overall Study||50
5165472|NCT01227928|12704293|P2|STARTED|Overall Study||73
5165473|NCT01227928|12704294|P1|STARTED|Overall Study||72
5165474|NCT01227902|12704332|P4|NOT COMPLETED|Overall Study||10
5165475|NCT01227902|12704333|P3|NOT COMPLETED|Overall Study||19
5165476|NCT01227902|12704334|P2|NOT COMPLETED|Overall Study||13
5165477|NCT01227902|12704335|P1|NOT COMPLETED|Overall Study||18
5165478|NCT01227902|12704332|P4|COMPLETED|Overall Study||42
5165479|NCT01227902|12704333|P3|COMPLETED|Overall Study||25
5165480|NCT01227902|12704334|P2|COMPLETED|Overall Study||38
5165481|NCT01227902|12704335|P1|COMPLETED|Overall Study||38
5165482|NCT01227902|12704332|P4|STARTED|Overall Study||52
5165483|NCT01227902|12704333|P3|STARTED|Overall Study||44
5165484|NCT01227902|12704334|P2|STARTED|Overall Study||51
5165485|NCT01227902|12704335|P1|STARTED|Overall Study||56
5165486|NCT01227889|12704428|P2|NOT COMPLETED|Crossover Phase||37
5165487|NCT01227889|12704429|P1|NOT COMPLETED|Crossover Phase||0
5165488|NCT01227889|12704428|P2|COMPLETED|Crossover Phase||0
5165489|NCT01227889|12704429|P1|COMPLETED|Crossover Phase||0
5165490|NCT01227889|12704428|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
5165491|NCT01227889|12704429|P1|STARTED|Crossover Phase||0
5165492|NCT01227889|12704428|P2|NOT COMPLETED|Randomized Phase (RP)||63
5165493|NCT01227889|12704429|P1|NOT COMPLETED|Randomized Phase (RP)||187
5165494|NCT01227889|12704428|P2|COMPLETED|Randomized Phase (RP)||0
5165495|NCT01227889|12704429|P1|COMPLETED|Randomized Phase (RP)||0
5165496|NCT01227889|12704428|P2|STARTED|Randomized Phase (RP)||63
5165497|NCT01227889|12704429|P1|STARTED|Randomized Phase (RP)||187
5165498|NCT01227824|12704456|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
5165499|NCT01227824|12704457|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
5165500|NCT01227824|12704458|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
5165501|NCT01227824|12704456|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
5165502|NCT01227824|12704457|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
5165503|NCT01227824|12704458|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
5165504|NCT01227824|12704456|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
5165505|NCT01227824|12704457|P2|STARTED|Open-label Phase: Median of 1267 Days||0
5165506|NCT01227824|12704458|P1|STARTED|Open-label Phase: Median of 1267 Days||0
5165507|NCT01227824|12704456|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
5165508|NCT01227824|12704457|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
5165509|NCT01227824|12704458|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
5165510|NCT01227824|12704456|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
5165511|NCT01227824|12704457|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
5165512|NCT01227824|12704458|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
5165513|NCT01227824|12704456|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
5165514|NCT01227824|12704457|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
5165515|NCT01227824|12704458|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
5165516|NCT01227785|12704487|P1|NOT COMPLETED|Overall Study||12
5165517|NCT01227785|12704487|P1|COMPLETED|Overall Study||108
5165518|NCT01227785|12704487|P1|STARTED|Overall Study||120
5165519|NCT01227707|12704553|P1|NOT COMPLETED|Overall Study||24
5165520|NCT01227707|12704553|P1|COMPLETED|Overall Study||19
5165521|NCT01227707|12704553|P1|STARTED|Overall Study||43
5165522|NCT01227681|12704572|P3|NOT COMPLETED|Overall Study||0
5165523|NCT01227681|12704573|P2|NOT COMPLETED|Overall Study||0
5165524|NCT01227681|12704574|P1|NOT COMPLETED|Overall Study||0
5165525|NCT01227681|12704572|P3|COMPLETED|Overall Study||0
5165526|NCT01227681|12704573|P2|COMPLETED|Overall Study||0
5165527|NCT01227681|12704574|P1|COMPLETED|Overall Study||4
5165528|NCT01227681|12704572|P3|STARTED|Overall Study||0
5165529|NCT01227681|12704573|P2|STARTED|Overall Study||0
5165530|NCT01227681|12704574|P1|STARTED|Overall Study||4
5165531|NCT01227668|12704580|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
5165532|NCT01227668|12704581|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
5165533|NCT01227668|12704580|P2|COMPLETED|Phase 2 (Randomization Phase)||19
5165534|NCT01227668|12704581|P1|COMPLETED|Phase 2 (Randomization Phase)||22
5165535|NCT01227668|12704580|P2|Received Treatment|Phase 2 (Randomization Phase)||43
5165536|NCT01227668|12704581|P1|Received Treatment|Phase 2 (Randomization Phase)||39
5165537|NCT01227668|12704580|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
5165538|NCT01227668|12704581|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
5165539|NCT01227668|12704580|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
5165540|NCT01227668|12704581|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
5165541|NCT01227668|12704580|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
5165542|NCT01227668|12704581|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
5165543|NCT01227668|12704580|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
5165544|NCT01227668|12704581|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
5165545|NCT01227668|12704580|P2|STARTED|Phase 1 (Stabilization Phase)||0
5165546|NCT01227668|12704581|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
5165547|NCT01227655|12704598|P3|NOT COMPLETED|Overall Study||14
5165548|NCT01227655|12704599|P2|NOT COMPLETED|Overall Study||26
5165549|NCT01227655|12704600|P1|NOT COMPLETED|Overall Study||11
5165550|NCT01227655|12704598|P3|COMPLETED|Overall Study||130
5165551|NCT01227655|12704599|P2|COMPLETED|Overall Study||128
5165552|NCT01227655|12704600|P1|COMPLETED|Overall Study||118
5165553|NCT01227655|12704598|P3|Full Analysis Set|Overall Study||135
5165554|NCT01227655|12704599|P2|Full Analysis Set|Overall Study||147
5165555|NCT01227655|12704600|P1|Full Analysis Set|Overall Study||125
5165556|NCT01227655|12704598|P3|Safety Set|Overall Study||136
5165557|NCT01227655|12704599|P2|Safety Set|Overall Study||150
5165558|NCT01227655|12704600|P1|Safety Set|Overall Study||125
5165559|NCT01227655|12704598|P3|STARTED|Overall Study||144
5165560|NCT01227655|12704599|P2|STARTED|Overall Study||154
5165561|NCT01227655|12704600|P1|STARTED|Overall Study||129
5165562|NCT01227629|12704627|P10|NOT COMPLETED|Overall Study||2
5165563|NCT01227629|12704628|P9|NOT COMPLETED|Overall Study||6
5165564|NCT01227629|12704629|P8|NOT COMPLETED|Overall Study||6
5165565|NCT01227629|12704630|P7|NOT COMPLETED|Overall Study||8
5165566|NCT01227629|12704631|P6|NOT COMPLETED|Overall Study||1
5165567|NCT01227629|12704632|P5|NOT COMPLETED|Overall Study||2
5165568|NCT01227629|12704633|P4|NOT COMPLETED|Overall Study||8
5165569|NCT01227629|12704634|P3|NOT COMPLETED|Overall Study||1
5165570|NCT01227629|12704635|P2|NOT COMPLETED|Overall Study||2
5165571|NCT01227629|12704636|P1|NOT COMPLETED|Overall Study||2
5165572|NCT01227629|12704627|P10|COMPLETED|Overall Study||68
5165573|NCT01227629|12704628|P9|COMPLETED|Overall Study||24
5165574|NCT01227629|12704629|P8|COMPLETED|Overall Study||27
5165575|NCT01227629|12704630|P7|COMPLETED|Overall Study||90
5165576|NCT01227629|12704631|P6|COMPLETED|Overall Study||32
5165577|NCT01227629|12704632|P5|COMPLETED|Overall Study||32
5165578|NCT01227629|12704633|P4|COMPLETED|Overall Study||91
5165579|NCT01227629|12704634|P3|COMPLETED|Overall Study||26
5165580|NCT01227629|12704635|P2|COMPLETED|Overall Study||18
5165581|NCT01227629|12704636|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
5165582|NCT01227629|12704627|P10|STARTED|Overall Study||70
5165583|NCT01227629|12704628|P9|STARTED|Overall Study||30
5165584|NCT01227629|12704629|P8|STARTED|Overall Study||33
5165585|NCT01227629|12704630|P7|STARTED|Overall Study||98
5165586|NCT01227629|12704631|P6|STARTED|Overall Study||33
5165587|NCT01227629|12704632|P5|STARTED|Overall Study||34
5165588|NCT01227629|12704633|P4|STARTED|Overall Study||99
5165589|NCT01227629|12704634|P3|STARTED|Overall Study||27
5165590|NCT01227629|12704635|P2|STARTED|Overall Study||20
5165591|NCT01227629|12704636|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
5165592|NCT01227616|12704874|P2|NOT COMPLETED|Overall Study||23
5165593|NCT01227616|12704875|P1|NOT COMPLETED|Overall Study||54
5165594|NCT01227616|12704874|P2|COMPLETED|Overall Study||74
5165595|NCT01227616|12704875|P1|COMPLETED|Overall Study||142
5165596|NCT01227616|12704874|P2|STARTED|Overall Study||97
5165597|NCT01227616|12704875|P1|STARTED|Overall Study||196
5165598|NCT01227577|12704885|P1|NOT COMPLETED|Overall Study||35
5165599|NCT01227577|12704885|P1|COMPLETED|Overall Study||93
5165600|NCT01227577|12704885|P1|STARTED|Overall Study||128
5165601|NCT01227564|12704900|P3|NOT COMPLETED|Overall Study||6
5165602|NCT01227564|12704901|P2|NOT COMPLETED|Overall Study||2
5165603|NCT01227564|12704902|P1|NOT COMPLETED|Overall Study||4
5165604|NCT01227564|12704900|P3|COMPLETED|Overall Study|Completed study|15
5165605|NCT01227564|12704901|P2|COMPLETED|Overall Study|Completed study|18
5165606|NCT01227564|12704902|P1|COMPLETED|Overall Study|Completed study|18
5165607|NCT01227564|12704900|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
5165608|NCT01227564|12704901|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
5165609|NCT01227564|12704902|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
5165610|NCT01227564|12704900|P3|Treated|Overall Study||21
5165611|NCT01227564|12704901|P2|Treated|Overall Study||20
5165612|NCT01227564|12704902|P1|Treated|Overall Study||22
5165613|NCT01227564|12704900|P3|STARTED|Overall Study||21
5165614|NCT01227564|12704901|P2|STARTED|Overall Study||20
5165615|NCT01227564|12704902|P1|STARTED|Overall Study||22
5165616|NCT01227551|12705033|P1|NOT COMPLETED|Overall Study||34
5165617|NCT01227551|12705033|P1|COMPLETED|Overall Study||23
5165618|NCT01227551|12705033|P1|STARTED|Overall Study||57
5165619|NCT01227512|12705040|P2|NOT COMPLETED|Overall Study||10
5165620|NCT01227512|12705041|P1|NOT COMPLETED|Overall Study||13
5165621|NCT01227512|12705040|P2|COMPLETED|Overall Study||48
5165622|NCT01227512|12705041|P1|COMPLETED|Overall Study||53
5165623|NCT01227512|12705040|P2|STARTED|Overall Study||58
5165624|NCT01227512|12705041|P1|STARTED|Overall Study||66
5165625|NCT01227434|12705063|P2|NOT COMPLETED|Overall Study||0
5165626|NCT01227434|12705064|P1|NOT COMPLETED|Overall Study||0
5165627|NCT01227434|12705063|P2|COMPLETED|Overall Study||16
5165628|NCT01227434|12705064|P1|COMPLETED|Overall Study||6
5165629|NCT01227434|12705063|P2|STARTED|Overall Study||16
5165630|NCT01227434|12705064|P1|STARTED|Overall Study||6
5165631|NCT01227421|12705075|P3|NOT COMPLETED|Overall Study||10
5165632|NCT01227421|12705076|P2|NOT COMPLETED|Overall Study||18
5165633|NCT01227421|12705077|P1|NOT COMPLETED|Overall Study||11
5165634|NCT01227421|12705075|P3|COMPLETED|Overall Study||201
5165635|NCT01227421|12705076|P2|COMPLETED|Overall Study||194
5165636|NCT01227421|12705077|P1|COMPLETED|Overall Study||190
5165637|NCT01227421|12705075|P3|STARTED|Overall Study||211
5165638|NCT01227421|12705076|P2|STARTED|Overall Study||212
5165639|NCT01227421|12705077|P1|STARTED|Overall Study||201
5165640|NCT01227395|12705129|P2|NOT COMPLETED|Overall Study||1
5165641|NCT01227395|12705130|P1|NOT COMPLETED|Overall Study||0
5165642|NCT01227395|12705129|P2|COMPLETED|Overall Study||84
5165643|NCT01227395|12705130|P1|COMPLETED|Overall Study||391
5165644|NCT01227395|12705129|P2|STARTED|Overall Study||85
5165645|NCT01227395|12705130|P1|STARTED|Overall Study||391
5165646|NCT01227382|12705158|P1|NOT COMPLETED|Overall Study||0
5165647|NCT01227382|12705158|P1|COMPLETED|Overall Study||26
5165648|NCT01227382|12705158|P1|STARTED|Overall Study||26
5165649|NCT01227278|12705170|P2|NOT COMPLETED|Overall Study||8
5165650|NCT01227278|12705171|P1|NOT COMPLETED|Overall Study||5
5165651|NCT01227278|12705170|P2|COMPLETED|Overall Study||43
5165652|NCT01227278|12705171|P1|COMPLETED|Overall Study||45
5165653|NCT01227278|12705170|P2|STARTED|Overall Study||51
5165654|NCT01227278|12705171|P1|STARTED|Overall Study||50
5165655|NCT01227265|12705198|P3|NOT COMPLETED|Overall Study||14
5165656|NCT01227265|12705199|P2|NOT COMPLETED|Overall Study||20
5165657|NCT01227265|12705200|P1|NOT COMPLETED|Overall Study||19
5165658|NCT01227265|12705198|P3|COMPLETED|Overall Study||145
5165659|NCT01227265|12705199|P2|COMPLETED|Overall Study||139
5165660|NCT01227265|12705200|P1|COMPLETED|Overall Study||139
5165661|NCT01227265|12705198|P3|Treated|Overall Study||159
5165662|NCT01227265|12705199|P2|Treated|Overall Study||157
5165663|NCT01227265|12705200|P1|Treated|Overall Study||157
5165664|NCT01227265|12705198|P3|STARTED|Overall Study||159
5165665|NCT01227265|12705199|P2|STARTED|Overall Study||159
5165666|NCT01227265|12705200|P1|STARTED|Overall Study||158
5165667|NCT01227252|12705230|P4|NOT COMPLETED|Overall Study||0
5165668|NCT01227252|12705231|P3|NOT COMPLETED|Overall Study||0
5165669|NCT01227252|12705232|P2|NOT COMPLETED|Overall Study||3
5165670|NCT01227252|12705233|P1|NOT COMPLETED|Overall Study||0
5165671|NCT01227252|12705230|P4|COMPLETED|Overall Study||10
5165672|NCT01227252|12705231|P3|COMPLETED|Overall Study||10
5165673|NCT01227252|12705232|P2|COMPLETED|Overall Study||7
5165674|NCT01227252|12705233|P1|COMPLETED|Overall Study||12
5165675|NCT01227252|12705230|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
5165676|NCT01227252|12705231|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
5165677|NCT01227252|12705232|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
5165678|NCT01227252|12705233|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
5165679|NCT01227252|12705230|P4|STARTED|Overall Study||10
5165680|NCT01227252|12705231|P3|STARTED|Overall Study||10
5165681|NCT01227252|12705232|P2|STARTED|Overall Study||10
5165682|NCT01227252|12705233|P1|STARTED|Overall Study||12
5165683|NCT01227057|12705262|P2|NOT COMPLETED|Overall Study||8
5165684|NCT01227057|12705263|P1|NOT COMPLETED|Overall Study||6
5165685|NCT01227057|12705262|P2|COMPLETED|Overall Study||19
5165686|NCT01227057|12705263|P1|COMPLETED|Overall Study||25
5165687|NCT01227057|12705262|P2|STARTED|Overall Study||27
5165688|NCT01227057|12705263|P1|STARTED|Overall Study||31
5165689|NCT01227044|12705275|P2|NOT COMPLETED|Overall Study||9
5165690|NCT01227044|12705276|P1|NOT COMPLETED|Overall Study||6
5165691|NCT01227044|12705275|P2|COMPLETED|Overall Study||17
5165692|NCT01227044|12705276|P1|COMPLETED|Overall Study||19
5165693|NCT01227044|12705275|P2|STARTED|Overall Study||26
5165694|NCT01227044|12705276|P1|STARTED|Overall Study||25
5165695|NCT01227018|12705284|P1|NOT COMPLETED|Overall Study||15
5165696|NCT01227018|12705284|P1|COMPLETED|Overall Study||0
5165697|NCT01227018|12705284|P1|STARTED|Overall Study||15
5165698|NCT01227005|12705294|P2|NOT COMPLETED|Overall Study||1
5165699|NCT01227005|12705295|P1|NOT COMPLETED|Overall Study||5
5165700|NCT01227005|12705294|P2|COMPLETED|Overall Study||51
5165701|NCT01227005|12705295|P1|COMPLETED|Overall Study||50
5165702|NCT01227005|12705294|P2|STARTED|Overall Study||52
5165703|NCT01227005|12705295|P1|STARTED|Overall Study||55
5165704|NCT01226914|12705307|P2|NOT COMPLETED|Overall Study||0
5165705|NCT01226914|12705308|P1|NOT COMPLETED|Overall Study||0
5165706|NCT01226914|12705307|P2|COMPLETED|Overall Study||27
5165707|NCT01226914|12705308|P1|COMPLETED|Overall Study||28
5165708|NCT01226914|12705307|P2|STARTED|Overall Study||27
5165709|NCT01226914|12705308|P1|STARTED|Overall Study||28
5165710|NCT01226745|12705320|P6|NOT COMPLETED|Overall Study||5
5165711|NCT01226745|12705321|P5|NOT COMPLETED|Overall Study||4
5165712|NCT01226745|12705322|P4|NOT COMPLETED|Overall Study||5
5165713|NCT01226745|12705323|P3|NOT COMPLETED|Overall Study||20
5165714|NCT01226745|12705324|P2|NOT COMPLETED|Overall Study||16
5165715|NCT01226745|12705325|P1|NOT COMPLETED|Overall Study||17
5165716|NCT01226745|12705320|P6|COMPLETED|Overall Study||24
5165717|NCT01226745|12705321|P5|COMPLETED|Overall Study||22
5165718|NCT01226745|12705322|P4|COMPLETED|Overall Study||24
5165719|NCT01226745|12705323|P3|COMPLETED|Overall Study||69
5165720|NCT01226745|12705324|P2|COMPLETED|Overall Study||71
5165721|NCT01226745|12705325|P1|COMPLETED|Overall Study||63
5165722|NCT01226745|12705320|P6|STARTED|Overall Study||29
5165723|NCT01226745|12705321|P5|STARTED|Overall Study||26
5165724|NCT01226745|12705322|P4|STARTED|Overall Study||29
5165725|NCT01226745|12705323|P3|STARTED|Overall Study||89
5165726|NCT01226745|12705324|P2|STARTED|Overall Study||87
5165727|NCT01226745|12705325|P1|STARTED|Overall Study||80
5165728|NCT01226732|12705405|P6|NOT COMPLETED|Overall Study||6
5165729|NCT01226732|12705406|P5|NOT COMPLETED|Overall Study||3
5165730|NCT01226732|12705407|P4|NOT COMPLETED|Overall Study||5
5165731|NCT01226732|12705408|P3|NOT COMPLETED|Overall Study||3
5165732|NCT01226732|12705409|P2|NOT COMPLETED|Overall Study||3
5165733|NCT01226732|12705410|P1|NOT COMPLETED|Overall Study||3
5165734|NCT01226732|12705405|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165735|NCT01226732|12705406|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165736|NCT01226732|12705407|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165737|NCT01226732|12705408|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165738|NCT01226732|12705409|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165739|NCT01226732|12705410|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
5165740|NCT01226732|12705405|P6|STARTED|Overall Study||6
5165741|NCT01226732|12705406|P5|STARTED|Overall Study||3
5165742|NCT01226732|12705407|P4|STARTED|Overall Study||5
5165743|NCT01226732|12705408|P3|STARTED|Overall Study||3
5165744|NCT01226732|12705409|P2|STARTED|Overall Study||3
5165745|NCT01226732|12705410|P1|STARTED|Overall Study||3
5165746|NCT01226719|12705426|P1|NOT COMPLETED|Overall Study||13
5165747|NCT01226719|12705426|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
5165748|NCT01226719|12705426|P1|STARTED|Overall Study||15
5165749|NCT01226706|12705436|P2|NOT COMPLETED|Overall Study||0
5165750|NCT01226706|12705437|P1|NOT COMPLETED|Overall Study||0
5165751|NCT01226706|12705436|P2|COMPLETED|Overall Study||11
5165752|NCT01226706|12705437|P1|COMPLETED|Overall Study||10
5165753|NCT01226706|12705436|P2|STARTED|Overall Study||11
5165754|NCT01226706|12705437|P1|STARTED|Overall Study||10
5165755|NCT01226511|12705521|P2|NOT COMPLETED|Taper Period||3
5165756|NCT01226511|12705522|P1|NOT COMPLETED|Taper Period||5
5165757|NCT01226511|12705521|P2|COMPLETED|Taper Period||54
5165758|NCT01226511|12705522|P1|COMPLETED|Taper Period||46
5165759|NCT01226511|12705521|P2|STARTED|Taper Period||57
5165760|NCT01226511|12705522|P1|STARTED|Taper Period||51
5165761|NCT01226511|12705521|P2|NOT COMPLETED|Extension Treatment Period||27
5165762|NCT01226511|12705522|P1|NOT COMPLETED|Extension Treatment Period||27
5165763|NCT01226511|12705521|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
5165764|NCT01226511|12705522|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
5165765|NCT01226511|12705521|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
5165766|NCT01226511|12705522|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
5165767|NCT01226511|12705521|P2|NOT COMPLETED|Acute Treatment Period||31
5165768|NCT01226511|12705522|P1|NOT COMPLETED|Acute Treatment Period||32
5165769|NCT01226511|12705521|P2|COMPLETED|Acute Treatment Period||110
5165770|NCT01226511|12705522|P1|COMPLETED|Acute Treatment Period||108
5165771|NCT01226511|12705521|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
5165772|NCT01226511|12705522|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
5165773|NCT01226485|12705565|P7|NOT COMPLETED|Overall Study||0
5165774|NCT01226485|12705566|P6|NOT COMPLETED|Overall Study||0
5165775|NCT01226485|12705567|P5|NOT COMPLETED|Overall Study||0
5165776|NCT01226485|12705568|P4|NOT COMPLETED|Overall Study||0
5165777|NCT01226485|12705569|P3|NOT COMPLETED|Overall Study||0
5165778|NCT01226485|12705570|P2|NOT COMPLETED|Overall Study||0
5165779|NCT01226485|12705571|P1|NOT COMPLETED|Overall Study||0
5165780|NCT01226485|12705565|P7|COMPLETED|Overall Study||40
5165781|NCT01226485|12705566|P6|COMPLETED|Overall Study||19
5165782|NCT01226485|12705567|P5|COMPLETED|Overall Study||7
5165783|NCT01226485|12705568|P4|COMPLETED|Overall Study||6
5165784|NCT01226485|12705569|P3|COMPLETED|Overall Study||3
5165785|NCT01226485|12705570|P2|COMPLETED|Overall Study||6
5165786|NCT01226485|12705571|P1|COMPLETED|Overall Study||3
5165787|NCT01226485|12705565|P7|Received at Least One Dose of Drug|Overall Study||40
5165788|NCT01226485|12705566|P6|Received at Least One Dose of Drug|Overall Study||19
5165789|NCT01226485|12705567|P5|Received at Least One Dose of Drug|Overall Study||7
5165790|NCT01226485|12705568|P4|Received at Least One Dose of Drug|Overall Study||6
5165791|NCT01226485|12705569|P3|Received at Least One Dose of Drug|Overall Study||3
5165792|NCT01226485|12705570|P2|Received at Least One Dose of Drug|Overall Study||6
5165793|NCT01226485|12705571|P1|Received at Least One Dose of Drug|Overall Study||3
5165794|NCT01226485|12705565|P7|STARTED|Overall Study||40
5165795|NCT01226485|12705566|P6|STARTED|Overall Study||19
5165796|NCT01226485|12705567|P5|STARTED|Overall Study||7
5165797|NCT01226485|12705568|P4|STARTED|Overall Study||6
5165798|NCT01226485|12705569|P3|STARTED|Overall Study||3
5165799|NCT01226485|12705570|P2|STARTED|Overall Study||6
5165800|NCT01226485|12705571|P1|STARTED|Overall Study||3
5165801|NCT01226459|12705622|P2|NOT COMPLETED|Overall Study||32
5165802|NCT01226459|12705623|P1|NOT COMPLETED|Overall Study||21
5165803|NCT01226459|12705622|P2|COMPLETED|Overall Study||171
5165804|NCT01226459|12705623|P1|COMPLETED|Overall Study||180
5165805|NCT01226459|12705622|P2|STARTED|Overall Study||203
5165806|NCT01226459|12705623|P1|STARTED|Overall Study||201
5165807|NCT01226420|12705633|P1|NOT COMPLETED|Overall Study||0
5165808|NCT01226420|12705633|P1|COMPLETED|Overall Study||6
5165809|NCT01226420|12705633|P1|STARTED|Overall Study||6
5165810|NCT01226121|12705641|P3|NOT COMPLETED|Overall Study||1
5165811|NCT01226121|12705642|P2|NOT COMPLETED|Overall Study||0
5165812|NCT01226121|12705643|P1|NOT COMPLETED|Overall Study||2
5165813|NCT01226121|12705641|P3|COMPLETED|Overall Study||12
5165814|NCT01226121|12705642|P2|COMPLETED|Overall Study||11
5165815|NCT01226121|12705643|P1|COMPLETED|Overall Study||11
5165816|NCT01226121|12705641|P3|30 Day Evaluation|Overall Study||13
5165817|NCT01226121|12705642|P2|30 Day Evaluation|Overall Study||11
5165818|NCT01226121|12705643|P1|30 Day Evaluation|Overall Study||12
5165819|NCT01226121|12705641|P3|STARTED|Overall Study||13
5165820|NCT01226121|12705642|P2|STARTED|Overall Study||11
5165821|NCT01226121|12705643|P1|STARTED|Overall Study||13
5165822|NCT01226095|12705654|P1|NOT COMPLETED|Overall Study||1
5165823|NCT01226095|12705654|P1|COMPLETED|Overall Study||518
5165824|NCT01226095|12705654|P1|STARTED|Overall Study||519
5165825|NCT01226043|12705679|P4|NOT COMPLETED|30-week Observational Phase||13
5165826|NCT01226043|12705680|P3|NOT COMPLETED|30-week Observational Phase||6
5165827|NCT01226043|12705681|P2|NOT COMPLETED|30-week Observational Phase||0
5165828|NCT01226043|12705682|P1|NOT COMPLETED|30-week Observational Phase||0
5165829|NCT01226043|12705679|P4|COMPLETED|30-week Observational Phase||140
5165830|NCT01226043|12705680|P3|COMPLETED|30-week Observational Phase||153
5165831|NCT01226043|12705681|P2|COMPLETED|30-week Observational Phase||0
5165832|NCT01226043|12705682|P1|COMPLETED|30-week Observational Phase||0
5165833|NCT01226043|12705679|P4|TREATED|30-week Observational Phase||153
5165834|NCT01226043|12705680|P3|TREATED|30-week Observational Phase||159
5165835|NCT01226043|12705681|P2|TREATED|30-week Observational Phase||0
5165836|NCT01226043|12705682|P1|TREATED|30-week Observational Phase||0
5165837|NCT01226043|12705679|P4|STARTED|30-week Observational Phase||153
5165838|NCT01226043|12705680|P3|STARTED|30-week Observational Phase||159
5165839|NCT01226043|12705681|P2|STARTED|30-week Observational Phase||0
5165840|NCT01226043|12705682|P1|STARTED|30-week Observational Phase||0
5165841|NCT01226043|12705679|P4|NOT COMPLETED|6-week Re-randomization Phase||11
5165842|NCT01226043|12705680|P3|NOT COMPLETED|6-week Re-randomization Phase||7
5165843|NCT01226043|12705681|P2|NOT COMPLETED|6-week Re-randomization Phase||0
5165844|NCT01226043|12705682|P1|NOT COMPLETED|6-week Re-randomization Phase||0
5165845|NCT01226043|12705679|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
5165846|NCT01226043|12705680|P3|COMPLETED|6-week Re-randomization Phase||159
5165847|NCT01226043|12705681|P2|COMPLETED|6-week Re-randomization Phase||0
5165848|NCT01226043|12705682|P1|COMPLETED|6-week Re-randomization Phase||0
5165849|NCT01226043|12705679|P4|TREATED|6-week Re-randomization Phase||165
5165850|NCT01226043|12705680|P3|TREATED|6-week Re-randomization Phase||165
5165851|NCT01226043|12705681|P2|TREATED|6-week Re-randomization Phase||0
5165852|NCT01226043|12705682|P1|TREATED|6-week Re-randomization Phase||0
5165853|NCT01226043|12705679|P4|STARTED|6-week Re-randomization Phase||167
5165854|NCT01226043|12705680|P3|STARTED|6-week Re-randomization Phase||166
5165855|NCT01226043|12705681|P2|STARTED|6-week Re-randomization Phase||0
5165856|NCT01226043|12705682|P1|STARTED|6-week Re-randomization Phase||0
5165857|NCT01226043|12705679|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
5165858|NCT01226043|12705680|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
5165859|NCT01226043|12705681|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
5165860|NCT01226043|12705682|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
5165861|NCT01226043|12705679|P4|COMPLETED|4-week Crossover Phase - Period 2||0
5165862|NCT01226043|12705680|P3|COMPLETED|4-week Crossover Phase - Period 2||0
5165863|NCT01226043|12705681|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
5165864|NCT01226043|12705682|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
5165865|NCT01226043|12705679|P4|TREATED|4-week Crossover Phase - Period 2||0
5165866|NCT01226043|12705680|P3|TREATED|4-week Crossover Phase - Period 2||0
5165867|NCT01226043|12705681|P2|TREATED|4-week Crossover Phase - Period 2||194
5165868|NCT01226043|12705682|P1|TREATED|4-week Crossover Phase - Period 2||199
5165869|NCT01226043|12705679|P4|STARTED|4-week Crossover Phase - Period 2||0
5165870|NCT01226043|12705680|P3|STARTED|4-week Crossover Phase - Period 2||0
5165871|NCT01226043|12705681|P2|STARTED|4-week Crossover Phase - Period 2||194
5165872|NCT01226043|12705682|P1|STARTED|4-week Crossover Phase - Period 2||199
5165873|NCT01226043|12705679|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
5165874|NCT01226043|12705680|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
5165875|NCT01226043|12705681|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
5165876|NCT01226043|12705682|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
5165877|NCT01226043|12705679|P4|COMPLETED|4-week Crossover Phase - Period 1||0
5165878|NCT01226043|12705680|P3|COMPLETED|4-week Crossover Phase - Period 1||0
5165879|NCT01226043|12705681|P2|COMPLETED|4-week Crossover Phase - Period 1||194
5165880|NCT01226043|12705682|P1|COMPLETED|4-week Crossover Phase - Period 1||199
5165881|NCT01226043|12705679|P4|TREATED|4-week Crossover Phase - Period 1||0
5165882|NCT01226043|12705680|P3|TREATED|4-week Crossover Phase - Period 1||0
5165883|NCT01226043|12705681|P2|TREATED|4-week Crossover Phase - Period 1||200
5165884|NCT01226043|12705682|P1|TREATED|4-week Crossover Phase - Period 1||202
5165885|NCT01226043|12705679|P4|STARTED|4-week Crossover Phase - Period 1||0
5165886|NCT01226043|12705680|P3|STARTED|4-week Crossover Phase - Period 1||0
5165887|NCT01226043|12705681|P2|STARTED|4-week Crossover Phase - Period 1||203
5165888|NCT01226043|12705682|P1|STARTED|4-week Crossover Phase - Period 1||202
5165889|NCT01225991|12705720|P1|NOT COMPLETED|Overall Study||6
5165890|NCT01225991|12705720|P1|COMPLETED|Overall Study||12
5165891|NCT01225991|12705720|P1|STARTED|Overall Study||18
5165892|NCT01225952|12705731|P3|NOT COMPLETED|Overall Study||6
5165893|NCT01225952|12705732|P2|NOT COMPLETED|Overall Study||4
5165894|NCT01225952|12705733|P1|NOT COMPLETED|Overall Study||6
5165895|NCT01225952|12705731|P3|COMPLETED|Overall Study||25
5165896|NCT01225952|12705732|P2|COMPLETED|Overall Study||27
5165897|NCT01225952|12705733|P1|COMPLETED|Overall Study||25
5165898|NCT01225952|12705731|P3|STARTED|Overall Study||31
5165899|NCT01225952|12705732|P2|STARTED|Overall Study||31
5165900|NCT01225952|12705733|P1|STARTED|Overall Study||31
5165901|NCT01225926|12705818|P2|NOT COMPLETED|Overall Study||0
5165902|NCT01225926|12705819|P1|NOT COMPLETED|Overall Study||0
5165903|NCT01225926|12705818|P2|COMPLETED|Overall Study||12
5165904|NCT01225926|12705819|P1|COMPLETED|Overall Study||12
5165905|NCT01225926|12705818|P2|STARTED|Overall Study||12
5165906|NCT01225926|12705819|P1|STARTED|Overall Study||12
5165907|NCT01225887|12705825|P1|NOT COMPLETED|Overall Study||5
5165908|NCT01225887|12705825|P1|COMPLETED|Overall Study||32
5165909|NCT01225887|12705825|P1|STARTED|Overall Study||37
5165910|NCT01225835|12705835|P2|NOT COMPLETED|Overall Study||3
5165911|NCT01225835|12705836|P1|NOT COMPLETED|Overall Study||7
5165912|NCT01225835|12705835|P2|COMPLETED|Overall Study|hCG criterion met|59
5165913|NCT01225835|12705836|P1|COMPLETED|Overall Study|hCG criterion met|55
5165914|NCT01225835|12705835|P2|Per Protocol Population|Overall Study||58
5165915|NCT01225835|12705836|P1|Per Protocol Population|Overall Study||48
5165916|NCT01225835|12705835|P2|STARTED|Overall Study||62
5165917|NCT01225835|12705836|P1|STARTED|Overall Study||62
5165918|NCT01225822|12705884|P5|NOT COMPLETED|Overall Study||31
5165919|NCT01225822|12705885|P4|NOT COMPLETED|Overall Study||52
5165920|NCT01225822|12705886|P3|NOT COMPLETED|Overall Study||38
5165921|NCT01225822|12705887|P2|NOT COMPLETED|Overall Study||56
5165922|NCT01225822|12705888|P1|NOT COMPLETED|Overall Study||38
5165923|NCT01225822|12705884|P5|COMPLETED|Overall Study||361
5165924|NCT01225822|12705885|P4|COMPLETED|Overall Study||333
5165925|NCT01225822|12705886|P3|COMPLETED|Overall Study||355
5165926|NCT01225822|12705887|P2|COMPLETED|Overall Study||334
5165927|NCT01225822|12705888|P1|COMPLETED|Overall Study||351
5165928|NCT01225822|12705884|P5|STARTED|Overall Study||392
5165929|NCT01225822|12705885|P4|STARTED|Overall Study||385
5165930|NCT01225822|12705886|P3|STARTED|Overall Study||393
5165931|NCT01225822|12705887|P2|STARTED|Overall Study||390
5165932|NCT01225822|12705888|P1|STARTED|Overall Study||389
5165933|NCT01225731|12705955|P13|NOT COMPLETED|Part 3||7
5165934|NCT01225731|12705956|P12|NOT COMPLETED|Part 3||10
5165935|NCT01225731|12705957|P11|NOT COMPLETED|Part 3||6
5165936|NCT01225731|12705958|P10|NOT COMPLETED|Part 3||0
5165937|NCT01225731|12705959|P9|NOT COMPLETED|Part 3||0
5165938|NCT01225731|12705960|P8|NOT COMPLETED|Part 3||0
5165939|NCT01225731|12705961|P7|NOT COMPLETED|Part 3||0
5165940|NCT01225731|12705962|P6|NOT COMPLETED|Part 3||0
5165941|NCT01225731|12705963|P5|NOT COMPLETED|Part 3||0
5165942|NCT01225731|12705964|P4|NOT COMPLETED|Part 3||0
5165943|NCT01225731|12705965|P3|NOT COMPLETED|Part 3||0
5165944|NCT01225731|12705966|P2|NOT COMPLETED|Part 3||0
5165945|NCT01225731|12705967|P1|NOT COMPLETED|Part 3||0
5165946|NCT01225731|12705955|P13|COMPLETED|Part 3||60
5165947|NCT01225731|12705956|P12|COMPLETED|Part 3||116
5165948|NCT01225731|12705957|P11|COMPLETED|Part 3||80
5165949|NCT01225731|12705958|P10|COMPLETED|Part 3||10
5165950|NCT01225731|12705959|P9|COMPLETED|Part 3||0
5165951|NCT01225731|12705960|P8|COMPLETED|Part 3||0
5165952|NCT01225731|12705961|P7|COMPLETED|Part 3||0
5165953|NCT01225731|12705962|P6|COMPLETED|Part 3||0
5165954|NCT01225731|12705963|P5|COMPLETED|Part 3||0
5165955|NCT01225731|12705964|P4|COMPLETED|Part 3||0
5165956|NCT01225731|12705965|P3|COMPLETED|Part 3||0
5165957|NCT01225731|12705966|P2|COMPLETED|Part 3||0
5165958|NCT01225731|12705967|P1|COMPLETED|Part 3||0
5165959|NCT01225731|12705955|P13|STARTED|Part 3|Not all participants entered follow-up|67
5165960|NCT01225731|12705956|P12|STARTED|Part 3|Not all participants entered follow-up|126
5165961|NCT01225731|12705957|P11|STARTED|Part 3|Not all participants entered follow-up|86
5165962|NCT01225731|12705958|P10|STARTED|Part 3|Not all participants entered follow-up|10
5165963|NCT01225731|12705959|P9|STARTED|Part 3|Participants could enter the follow-up period|0
5165964|NCT01225731|12705960|P8|STARTED|Part 3|Participants could enter the follow-up period|0
5165965|NCT01225731|12705961|P7|STARTED|Part 3|Participants could enter the follow-up period|0
5165966|NCT01225731|12705962|P6|STARTED|Part 3|Participants could enter the follow-up period|0
5165967|NCT01225731|12705963|P5|STARTED|Part 3||0
5165968|NCT01225731|12705964|P4|STARTED|Part 3||0
5165969|NCT01225731|12705965|P3|STARTED|Part 3||0
5165970|NCT01225731|12705966|P2|STARTED|Part 3||0
5165971|NCT01225731|12705967|P1|STARTED|Part 3||0
5165972|NCT01225731|12705955|P13|NOT COMPLETED|Part 2||0
5165973|NCT01225731|12705956|P12|NOT COMPLETED|Part 2||0
5165974|NCT01225731|12705957|P11|NOT COMPLETED|Part 2||0
5165975|NCT01225731|12705958|P10|NOT COMPLETED|Part 2||0
5165976|NCT01225731|12705959|P9|NOT COMPLETED|Part 2||11
5165977|NCT01225731|12705960|P8|NOT COMPLETED|Part 2||25
5165978|NCT01225731|12705961|P7|NOT COMPLETED|Part 2||8
5165979|NCT01225731|12705962|P6|NOT COMPLETED|Part 2||3
5165980|NCT01225731|12705963|P5|NOT COMPLETED|Part 2||0
5165981|NCT01225731|12705964|P4|NOT COMPLETED|Part 2||0
5165982|NCT01225731|12705965|P3|NOT COMPLETED|Part 2||0
5165983|NCT01225731|12705966|P2|NOT COMPLETED|Part 2||0
5165984|NCT01225731|12705967|P1|NOT COMPLETED|Part 2||0
5165985|NCT01225731|12705955|P13|COMPLETED|Part 2||0
5165986|NCT01225731|12705956|P12|COMPLETED|Part 2||0
5165987|NCT01225731|12705957|P11|COMPLETED|Part 2||0
5165988|NCT01225731|12705958|P10|COMPLETED|Part 2||0
5165989|NCT01225731|12705959|P9|COMPLETED|Part 2||68
5165990|NCT01225731|12705960|P8|COMPLETED|Part 2||128
5165991|NCT01225731|12705961|P7|COMPLETED|Part 2||86
5165992|NCT01225731|12705962|P6|COMPLETED|Part 2||10
5165993|NCT01225731|12705963|P5|COMPLETED|Part 2||0
5165994|NCT01225731|12705964|P4|COMPLETED|Part 2||0
5165995|NCT01225731|12705965|P3|COMPLETED|Part 2||0
5165996|NCT01225731|12705966|P2|COMPLETED|Part 2||0
5165997|NCT01225731|12705967|P1|COMPLETED|Part 2||0
5165998|NCT01225731|12705955|P13|STARTED|Part 2||0
5165999|NCT01225731|12705956|P12|STARTED|Part 2||0
5166000|NCT01225731|12705957|P11|STARTED|Part 2||0
5166001|NCT01225731|12705958|P10|STARTED|Part 2||0
5166002|NCT01225731|12705959|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
5166003|NCT01225731|12705960|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
5166004|NCT01225731|12705961|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
5166005|NCT01225731|12705962|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
5166006|NCT01225731|12705963|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
5166007|NCT01225731|12705964|P4|STARTED|Part 2|Participants could progress into Part 2|0
5166008|NCT01225731|12705965|P3|STARTED|Part 2|Participants could progress into Part 2|0
5166009|NCT01225731|12705966|P2|STARTED|Part 2|Participants could progress into Part 2|0
5166010|NCT01225731|12705967|P1|STARTED|Part 2|Participants could progress into Part 2|0
5166011|NCT01225731|12705955|P13|NOT COMPLETED|Part 1||0
5166012|NCT01225731|12705956|P12|NOT COMPLETED|Part 1||0
5166013|NCT01225731|12705957|P11|NOT COMPLETED|Part 1||0
5166014|NCT01225731|12705958|P10|NOT COMPLETED|Part 1||0
5166015|NCT01225731|12705959|P9|NOT COMPLETED|Part 1||0
5166016|NCT01225731|12705960|P8|NOT COMPLETED|Part 1||0
5166017|NCT01225731|12705961|P7|NOT COMPLETED|Part 1||0
5166018|NCT01225731|12705962|P6|NOT COMPLETED|Part 1||0
5166019|NCT01225731|12705963|P5|NOT COMPLETED|Part 1||6
5166020|NCT01225731|12705964|P4|NOT COMPLETED|Part 1||2
5166021|NCT01225731|12705965|P3|NOT COMPLETED|Part 1||1
5166022|NCT01225731|12705966|P2|NOT COMPLETED|Part 1||5
5166023|NCT01225731|12705967|P1|NOT COMPLETED|Part 1||2
5166024|NCT01225731|12705955|P13|COMPLETED|Part 1||0
5166025|NCT01225731|12705956|P12|COMPLETED|Part 1||0
5166026|NCT01225731|12705957|P11|COMPLETED|Part 1||0
5166027|NCT01225731|12705958|P10|COMPLETED|Part 1||0
5166028|NCT01225731|12705959|P9|COMPLETED|Part 1||0
5166029|NCT01225731|12705960|P8|COMPLETED|Part 1||0
5166030|NCT01225731|12705961|P7|COMPLETED|Part 1||0
5166031|NCT01225731|12705962|P6|COMPLETED|Part 1||0
5166032|NCT01225731|12705963|P5|COMPLETED|Part 1||40
5166033|NCT01225731|12705964|P4|COMPLETED|Part 1||84
5166034|NCT01225731|12705965|P3|COMPLETED|Part 1||88
5166035|NCT01225731|12705966|P2|COMPLETED|Part 1||87
5166036|NCT01225731|12705967|P1|COMPLETED|Part 1||40
5166037|NCT01225731|12705955|P13|STARTED|Part 1||0
5166038|NCT01225731|12705956|P12|STARTED|Part 1||0
5166039|NCT01225731|12705957|P11|STARTED|Part 1||0
5166040|NCT01225731|12705958|P10|STARTED|Part 1||0
5166041|NCT01225731|12705959|P9|STARTED|Part 1||0
5166042|NCT01225731|12705960|P8|STARTED|Part 1||0
5166043|NCT01225731|12705961|P7|STARTED|Part 1||0
5166044|NCT01225731|12705962|P6|STARTED|Part 1||0
5166045|NCT01225731|12705963|P5|STARTED|Part 1||46
5166046|NCT01225731|12705964|P4|STARTED|Part 1||86
5166047|NCT01225731|12705965|P3|STARTED|Part 1||89
5166048|NCT01225731|12705966|P2|STARTED|Part 1||92
5166049|NCT01225731|12705967|P1|STARTED|Part 1||42
5166050|NCT01225562|12706062|P3|NOT COMPLETED|Overall Study||53
5166051|NCT01225562|12706063|P2|NOT COMPLETED|Overall Study||56
5166052|NCT01225562|12706064|P1|NOT COMPLETED|Overall Study||55
5166053|NCT01225562|12706062|P3|COMPLETED|Overall Study||7014
5166054|NCT01225562|12706063|P2|COMPLETED|Overall Study||6989
5166055|NCT01225562|12706064|P1|COMPLETED|Overall Study||6995
5166056|NCT01225562|12706062|P3|STARTED|Overall Study||7067
5166057|NCT01225562|12706063|P2|STARTED|Overall Study||7045
5166058|NCT01225562|12706064|P1|STARTED|Overall Study||7050
5166059|NCT01225549|12706081|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166060|NCT01225549|12706082|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166061|NCT01225549|12706083|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166062|NCT01225549|12706084|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166063|NCT01225549|12706085|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166064|NCT01225549|12706086|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166065|NCT01225549|12706087|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166066|NCT01225549|12706088|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166067|NCT01225549|12706089|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166068|NCT01225549|12706090|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
5166069|NCT01225549|12706081|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
5166070|NCT01225549|12706082|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
5166071|NCT01225549|12706083|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
5166072|NCT01225549|12706084|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
5166073|NCT01225549|12706085|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
5166074|NCT01225549|12706086|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
5166075|NCT01225549|12706087|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
5166076|NCT01225549|12706088|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
5166077|NCT01225549|12706089|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
5166078|NCT01225549|12706090|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
5166079|NCT01225549|12706081|P10|STARTED|Period 7 - Fourth Treatment Period||1
5166080|NCT01225549|12706082|P9|STARTED|Period 7 - Fourth Treatment Period||4
5166081|NCT01225549|12706083|P8|STARTED|Period 7 - Fourth Treatment Period||1
5166082|NCT01225549|12706084|P7|STARTED|Period 7 - Fourth Treatment Period||3
5166083|NCT01225549|12706085|P6|STARTED|Period 7 - Fourth Treatment Period||1
5166084|NCT01225549|12706086|P5|STARTED|Period 7 - Fourth Treatment Period||1
5166085|NCT01225549|12706087|P4|STARTED|Period 7 - Fourth Treatment Period||0
5166086|NCT01225549|12706088|P3|STARTED|Period 7 - Fourth Treatment Period||3
5166087|NCT01225549|12706089|P2|STARTED|Period 7 - Fourth Treatment Period||3
5166088|NCT01225549|12706090|P1|STARTED|Period 7 - Fourth Treatment Period||1
5166089|NCT01225549|12706081|P10|NOT COMPLETED|Period 6 - Washout||0
5166090|NCT01225549|12706082|P9|NOT COMPLETED|Period 6 - Washout||0
5166091|NCT01225549|12706083|P8|NOT COMPLETED|Period 6 - Washout||0
5166092|NCT01225549|12706084|P7|NOT COMPLETED|Period 6 - Washout||0
5166093|NCT01225549|12706085|P6|NOT COMPLETED|Period 6 - Washout||0
5166094|NCT01225549|12706086|P5|NOT COMPLETED|Period 6 - Washout||0
5166095|NCT01225549|12706087|P4|NOT COMPLETED|Period 6 - Washout||1
5166096|NCT01225549|12706088|P3|NOT COMPLETED|Period 6 - Washout||0
5166097|NCT01225549|12706089|P2|NOT COMPLETED|Period 6 - Washout||0
5166098|NCT01225549|12706090|P1|NOT COMPLETED|Period 6 - Washout||0
5166099|NCT01225549|12706081|P10|COMPLETED|Period 6 - Washout||1
5166100|NCT01225549|12706082|P9|COMPLETED|Period 6 - Washout||4
5166101|NCT01225549|12706083|P8|COMPLETED|Period 6 - Washout||1
5166102|NCT01225549|12706084|P7|COMPLETED|Period 6 - Washout||3
5166103|NCT01225549|12706085|P6|COMPLETED|Period 6 - Washout||1
5166104|NCT01225549|12706086|P5|COMPLETED|Period 6 - Washout||1
5166105|NCT01225549|12706087|P4|COMPLETED|Period 6 - Washout||0
5166106|NCT01225549|12706088|P3|COMPLETED|Period 6 - Washout||3
5166107|NCT01225549|12706089|P2|COMPLETED|Period 6 - Washout||3
5166108|NCT01225549|12706090|P1|COMPLETED|Period 6 - Washout||1
5166109|NCT01225549|12706081|P10|STARTED|Period 6 - Washout||1
5166110|NCT01225549|12706082|P9|STARTED|Period 6 - Washout||4
5166111|NCT01225549|12706083|P8|STARTED|Period 6 - Washout||1
5166112|NCT01225549|12706084|P7|STARTED|Period 6 - Washout||3
5166113|NCT01225549|12706085|P6|STARTED|Period 6 - Washout||1
5166114|NCT01225549|12706086|P5|STARTED|Period 6 - Washout||1
5166115|NCT01225549|12706087|P4|STARTED|Period 6 - Washout||1
5166116|NCT01225549|12706088|P3|STARTED|Period 6 - Washout||3
5166117|NCT01225549|12706089|P2|STARTED|Period 6 - Washout||3
5166118|NCT01225549|12706090|P1|STARTED|Period 6 - Washout||1
5166119|NCT01225549|12706081|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166120|NCT01225549|12706082|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166121|NCT01225549|12706083|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166122|NCT01225549|12706084|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166123|NCT01225549|12706085|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166124|NCT01225549|12706086|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166125|NCT01225549|12706087|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166126|NCT01225549|12706088|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166127|NCT01225549|12706089|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166128|NCT01225549|12706090|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
5166129|NCT01225549|12706081|P10|COMPLETED|Period 5 - Third Treatment Period||1
5166130|NCT01225549|12706082|P9|COMPLETED|Period 5 - Third Treatment Period||4
5166131|NCT01225549|12706083|P8|COMPLETED|Period 5 - Third Treatment Period||1
5166132|NCT01225549|12706084|P7|COMPLETED|Period 5 - Third Treatment Period||3
5166133|NCT01225549|12706085|P6|COMPLETED|Period 5 - Third Treatment Period||1
5166134|NCT01225549|12706086|P5|COMPLETED|Period 5 - Third Treatment Period||1
5166135|NCT01225549|12706087|P4|COMPLETED|Period 5 - Third Treatment Period||1
5166136|NCT01225549|12706088|P3|COMPLETED|Period 5 - Third Treatment Period||3
5166137|NCT01225549|12706089|P2|COMPLETED|Period 5 - Third Treatment Period||3
5166138|NCT01225549|12706090|P1|COMPLETED|Period 5 - Third Treatment Period||1
5166139|NCT01225549|12706081|P10|STARTED|Period 5 - Third Treatment Period||1
5166140|NCT01225549|12706082|P9|STARTED|Period 5 - Third Treatment Period||4
5166141|NCT01225549|12706083|P8|STARTED|Period 5 - Third Treatment Period||1
5166142|NCT01225549|12706084|P7|STARTED|Period 5 - Third Treatment Period||3
5166143|NCT01225549|12706085|P6|STARTED|Period 5 - Third Treatment Period||1
5166144|NCT01225549|12706086|P5|STARTED|Period 5 - Third Treatment Period||1
5166145|NCT01225549|12706087|P4|STARTED|Period 5 - Third Treatment Period||1
5166146|NCT01225549|12706088|P3|STARTED|Period 5 - Third Treatment Period||3
5166147|NCT01225549|12706089|P2|STARTED|Period 5 - Third Treatment Period||3
5166148|NCT01225549|12706090|P1|STARTED|Period 5 - Third Treatment Period||1
5166149|NCT01225549|12706081|P10|NOT COMPLETED|Period 4 - Washout||0
5166150|NCT01225549|12706082|P9|NOT COMPLETED|Period 4 - Washout||0
5166151|NCT01225549|12706083|P8|NOT COMPLETED|Period 4 - Washout||0
5166152|NCT01225549|12706084|P7|NOT COMPLETED|Period 4 - Washout||0
5166153|NCT01225549|12706085|P6|NOT COMPLETED|Period 4 - Washout||0
5166154|NCT01225549|12706086|P5|NOT COMPLETED|Period 4 - Washout||0
5166155|NCT01225549|12706087|P4|NOT COMPLETED|Period 4 - Washout||0
5166156|NCT01225549|12706088|P3|NOT COMPLETED|Period 4 - Washout||0
5166157|NCT01225549|12706089|P2|NOT COMPLETED|Period 4 - Washout||1
5166158|NCT01225549|12706090|P1|NOT COMPLETED|Period 4 - Washout||0
5166159|NCT01225549|12706081|P10|COMPLETED|Period 4 - Washout||1
5166160|NCT01225549|12706082|P9|COMPLETED|Period 4 - Washout||4
5166161|NCT01225549|12706083|P8|COMPLETED|Period 4 - Washout||1
5166162|NCT01225549|12706084|P7|COMPLETED|Period 4 - Washout||3
5166163|NCT01225549|12706085|P6|COMPLETED|Period 4 - Washout||1
5166164|NCT01225549|12706086|P5|COMPLETED|Period 4 - Washout||1
5166165|NCT01225549|12706087|P4|COMPLETED|Period 4 - Washout||1
5166166|NCT01225549|12706088|P3|COMPLETED|Period 4 - Washout||3
5166167|NCT01225549|12706089|P2|COMPLETED|Period 4 - Washout||3
5166168|NCT01225549|12706090|P1|COMPLETED|Period 4 - Washout||1
5166169|NCT01225549|12706081|P10|STARTED|Period 4 - Washout||1
5166170|NCT01225549|12706082|P9|STARTED|Period 4 - Washout||4
5166171|NCT01225549|12706083|P8|STARTED|Period 4 - Washout||1
5166172|NCT01225549|12706084|P7|STARTED|Period 4 - Washout||3
5166173|NCT01225549|12706085|P6|STARTED|Period 4 - Washout||1
5166174|NCT01225549|12706086|P5|STARTED|Period 4 - Washout||1
5166175|NCT01225549|12706087|P4|STARTED|Period 4 - Washout||1
5166176|NCT01225549|12706088|P3|STARTED|Period 4 - Washout||3
5166177|NCT01225549|12706089|P2|STARTED|Period 4 - Washout||4
5166178|NCT01225549|12706090|P1|STARTED|Period 4 - Washout||1
5166179|NCT01225549|12706081|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166180|NCT01225549|12706082|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166181|NCT01225549|12706083|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166182|NCT01225549|12706084|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166183|NCT01225549|12706085|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166184|NCT01225549|12706086|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166185|NCT01225549|12706087|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166186|NCT01225549|12706088|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166187|NCT01225549|12706089|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166188|NCT01225549|12706090|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
5166189|NCT01225549|12706081|P10|COMPLETED|Period 3 - Second Treatment Period||1
5166190|NCT01225549|12706082|P9|COMPLETED|Period 3 - Second Treatment Period||4
5166191|NCT01225549|12706083|P8|COMPLETED|Period 3 - Second Treatment Period||1
5166192|NCT01225549|12706084|P7|COMPLETED|Period 3 - Second Treatment Period||3
5166193|NCT01225549|12706085|P6|COMPLETED|Period 3 - Second Treatment Period||1
5166194|NCT01225549|12706086|P5|COMPLETED|Period 3 - Second Treatment Period||1
5166195|NCT01225549|12706087|P4|COMPLETED|Period 3 - Second Treatment Period||1
5166196|NCT01225549|12706088|P3|COMPLETED|Period 3 - Second Treatment Period||3
5166197|NCT01225549|12706089|P2|COMPLETED|Period 3 - Second Treatment Period||4
5166198|NCT01225549|12706090|P1|COMPLETED|Period 3 - Second Treatment Period||1
5166199|NCT01225549|12706081|P10|STARTED|Period 3 - Second Treatment Period||1
5166200|NCT01225549|12706082|P9|STARTED|Period 3 - Second Treatment Period||4
5166201|NCT01225549|12706083|P8|STARTED|Period 3 - Second Treatment Period||1
5166202|NCT01225549|12706084|P7|STARTED|Period 3 - Second Treatment Period||3
5166203|NCT01225549|12706085|P6|STARTED|Period 3 - Second Treatment Period||1
5166204|NCT01225549|12706086|P5|STARTED|Period 3 - Second Treatment Period||1
5166205|NCT01225549|12706087|P4|STARTED|Period 3 - Second Treatment Period||1
5166206|NCT01225549|12706088|P3|STARTED|Period 3 - Second Treatment Period||3
5166207|NCT01225549|12706089|P2|STARTED|Period 3 - Second Treatment Period||4
5166208|NCT01225549|12706090|P1|STARTED|Period 3 - Second Treatment Period||1
5166209|NCT01225549|12706081|P10|NOT COMPLETED|Period 2 - Washout||0
5166210|NCT01225549|12706082|P9|NOT COMPLETED|Period 2 - Washout||0
5166211|NCT01225549|12706083|P8|NOT COMPLETED|Period 2 - Washout||0
5166212|NCT01225549|12706084|P7|NOT COMPLETED|Period 2 - Washout||0
5166213|NCT01225549|12706085|P6|NOT COMPLETED|Period 2 - Washout||0
5166214|NCT01225549|12706086|P5|NOT COMPLETED|Period 2 - Washout||0
5166215|NCT01225549|12706087|P4|NOT COMPLETED|Period 2 - Washout||0
5166216|NCT01225549|12706088|P3|NOT COMPLETED|Period 2 - Washout||0
5166217|NCT01225549|12706089|P2|NOT COMPLETED|Period 2 - Washout||0
5166218|NCT01225549|12706090|P1|NOT COMPLETED|Period 2 - Washout||0
5166219|NCT01225549|12706081|P10|COMPLETED|Period 2 - Washout||1
5166220|NCT01225549|12706082|P9|COMPLETED|Period 2 - Washout||4
5166221|NCT01225549|12706083|P8|COMPLETED|Period 2 - Washout||1
5166222|NCT01225549|12706084|P7|COMPLETED|Period 2 - Washout||3
5166223|NCT01225549|12706085|P6|COMPLETED|Period 2 - Washout||1
5166224|NCT01225549|12706086|P5|COMPLETED|Period 2 - Washout||1
5166225|NCT01225549|12706087|P4|COMPLETED|Period 2 - Washout||1
5166226|NCT01225549|12706088|P3|COMPLETED|Period 2 - Washout||3
5166227|NCT01225549|12706089|P2|COMPLETED|Period 2 - Washout||4
5166228|NCT01225549|12706090|P1|COMPLETED|Period 2 - Washout||1
5166229|NCT01225549|12706081|P10|STARTED|Period 2 - Washout||1
5166230|NCT01225549|12706082|P9|STARTED|Period 2 - Washout||4
5166231|NCT01225549|12706083|P8|STARTED|Period 2 - Washout||1
5166232|NCT01225549|12706084|P7|STARTED|Period 2 - Washout||3
5166233|NCT01225549|12706085|P6|STARTED|Period 2 - Washout||1
5166234|NCT01225549|12706086|P5|STARTED|Period 2 - Washout||1
5166235|NCT01225549|12706087|P4|STARTED|Period 2 - Washout||1
5166236|NCT01225549|12706088|P3|STARTED|Period 2 - Washout||3
5166237|NCT01225549|12706089|P2|STARTED|Period 2 - Washout||4
5166238|NCT01225549|12706090|P1|STARTED|Period 2 - Washout||1
5166239|NCT01225549|12706081|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
5166240|NCT01225549|12706082|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
5166241|NCT01225549|12706083|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
5166242|NCT01225549|12706084|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
5166243|NCT01225549|12706085|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
5166244|NCT01225549|12706086|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
5166245|NCT01225549|12706087|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
5166246|NCT01225549|12706088|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
5166247|NCT01225549|12706089|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
5166248|NCT01225549|12706090|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
5166249|NCT01225549|12706081|P10|COMPLETED|Period 1 - First Treatment Period||1
5166250|NCT01225549|12706082|P9|COMPLETED|Period 1 - First Treatment Period||4
5166251|NCT01225549|12706083|P8|COMPLETED|Period 1 - First Treatment Period||1
5166252|NCT01225549|12706084|P7|COMPLETED|Period 1 - First Treatment Period||3
5166253|NCT01225549|12706085|P6|COMPLETED|Period 1 - First Treatment Period||1
5166254|NCT01225549|12706086|P5|COMPLETED|Period 1 - First Treatment Period||1
5166255|NCT01225549|12706087|P4|COMPLETED|Period 1 - First Treatment Period||1
5166256|NCT01225549|12706088|P3|COMPLETED|Period 1 - First Treatment Period||3
5166257|NCT01225549|12706089|P2|COMPLETED|Period 1 - First Treatment Period||4
5166258|NCT01225549|12706090|P1|COMPLETED|Period 1 - First Treatment Period||1
5166259|NCT01225549|12706081|P10|STARTED|Period 1 - First Treatment Period||1
5166260|NCT01225549|12706082|P9|STARTED|Period 1 - First Treatment Period||4
5166261|NCT01225549|12706083|P8|STARTED|Period 1 - First Treatment Period||1
5166262|NCT01225549|12706084|P7|STARTED|Period 1 - First Treatment Period||3
5166263|NCT01225549|12706085|P6|STARTED|Period 1 - First Treatment Period||1
5166264|NCT01225549|12706086|P5|STARTED|Period 1 - First Treatment Period||1
5166265|NCT01225549|12706087|P4|STARTED|Period 1 - First Treatment Period||1
5166266|NCT01225549|12706088|P3|STARTED|Period 1 - First Treatment Period||3
5166267|NCT01225549|12706089|P2|STARTED|Period 1 - First Treatment Period||4
5166268|NCT01225549|12706090|P1|STARTED|Period 1 - First Treatment Period||1
5166269|NCT01225354|12706132|P1|NOT COMPLETED|Overall Study||1
5166270|NCT01225354|12706132|P1|COMPLETED|Overall Study||19
5166271|NCT01225354|12706132|P1|STARTED|Overall Study||20
5166272|NCT01225289|12706139|P2|NOT COMPLETED|Overall Study||1
5166273|NCT01225289|12706140|P1|NOT COMPLETED|Overall Study||0
5166274|NCT01225289|12706139|P2|COMPLETED|Overall Study||17
5166275|NCT01225289|12706140|P1|COMPLETED|Overall Study||18
5166276|NCT01225289|12706139|P2|STARTED|Overall Study||18
5166277|NCT01225289|12706140|P1|STARTED|Overall Study||18
5166278|NCT01225263|12706154|P2|NOT COMPLETED|Weeks 13 to 24||1
5166279|NCT01225263|12706155|P1|NOT COMPLETED|Weeks 13 to 24||4
5166280|NCT01225263|12706154|P2|COMPLETED|Weeks 13 to 24||28
5166281|NCT01225263|12706155|P1|COMPLETED|Weeks 13 to 24||24
5166282|NCT01225263|12706154|P2|STARTED|Weeks 13 to 24||29
5166283|NCT01225263|12706155|P1|STARTED|Weeks 13 to 24||28
5166284|NCT01225263|12706154|P2|NOT COMPLETED|Weeks 1 to 12||0
5166285|NCT01225263|12706155|P1|NOT COMPLETED|Weeks 1 to 12||0
5166286|NCT01225263|12706154|P2|COMPLETED|Weeks 1 to 12||29
5166287|NCT01225263|12706155|P1|COMPLETED|Weeks 1 to 12||28
5166288|NCT01225263|12706154|P2|STARTED|Weeks 1 to 12||29
5166289|NCT01225263|12706155|P1|STARTED|Weeks 1 to 12||28
5166290|NCT01225211|12706173|P10|NOT COMPLETED|Overall Study||5
5166291|NCT01225211|12706174|P9|NOT COMPLETED|Overall Study||1
5166292|NCT01225211|12706175|P8|NOT COMPLETED|Overall Study||0
5166293|NCT01225211|12706176|P7|NOT COMPLETED|Overall Study||1
5166294|NCT01225211|12706177|P6|NOT COMPLETED|Overall Study||0
5166295|NCT01225211|12706178|P5|NOT COMPLETED|Overall Study||0
5166296|NCT01225211|12706179|P4|NOT COMPLETED|Overall Study||0
5166297|NCT01225211|12706180|P3|NOT COMPLETED|Overall Study||1
5166298|NCT01225211|12706181|P2|NOT COMPLETED|Overall Study||0
5166299|NCT01225211|12706182|P1|NOT COMPLETED|Overall Study||0
5166300|NCT01225211|12706173|P10|COMPLETED|Overall Study||57
5166301|NCT01225211|12706174|P9|COMPLETED|Overall Study||62
5166302|NCT01225211|12706175|P8|COMPLETED|Overall Study||11
5166303|NCT01225211|12706176|P7|COMPLETED|Overall Study||41
5166304|NCT01225211|12706177|P6|COMPLETED|Overall Study||21
5166305|NCT01225211|12706178|P5|COMPLETED|Overall Study||23
5166306|NCT01225211|12706179|P4|COMPLETED|Overall Study||27
5166307|NCT01225211|12706180|P3|COMPLETED|Overall Study||20
5166308|NCT01225211|12706181|P2|COMPLETED|Overall Study||20
5166309|NCT01225211|12706182|P1|COMPLETED|Overall Study||21
5166310|NCT01225211|12706173|P10|STARTED|Overall Study||62
5166311|NCT01225211|12706174|P9|STARTED|Overall Study||63
5166312|NCT01225211|12706175|P8|STARTED|Overall Study||11
5166313|NCT01225211|12706176|P7|STARTED|Overall Study||42
5166314|NCT01225211|12706177|P6|STARTED|Overall Study||21
5166315|NCT01225211|12706178|P5|STARTED|Overall Study||23
5166316|NCT01225211|12706179|P4|STARTED|Overall Study||27
5166317|NCT01225211|12706180|P3|STARTED|Overall Study||21
5166318|NCT01225211|12706181|P2|STARTED|Overall Study||20
5166319|NCT01225211|12706182|P1|STARTED|Overall Study||21
5166320|NCT01225172|12706285|P2|NOT COMPLETED|Overall Study||1
5166321|NCT01225172|12706286|P1|NOT COMPLETED|Overall Study||6
5166322|NCT01225172|12706285|P2|COMPLETED|Overall Study||6
5166323|NCT01225172|12706286|P1|COMPLETED|Overall Study||46
5166324|NCT01225172|12706285|P2|STARTED|Overall Study||7
5166325|NCT01225172|12706286|P1|STARTED|Overall Study||52
5166326|NCT01225159|12706308|P2|NOT COMPLETED|Overall Study||0
5166327|NCT01225159|12706309|P1|NOT COMPLETED|Overall Study||1
5166328|NCT01225159|12706308|P2|COMPLETED|Overall Study||100
5166329|NCT01225159|12706309|P1|COMPLETED|Overall Study||99
5166330|NCT01225159|12706308|P2|STARTED|Overall Study||100
5166331|NCT01225159|12706309|P1|STARTED|Overall Study||100
5166332|NCT01225146|12706319|P2|NOT COMPLETED|Overall Study||2
5166333|NCT01225146|12706320|P1|NOT COMPLETED|Overall Study||0
5166334|NCT01225146|12706319|P2|COMPLETED|Overall Study||0
5166335|NCT01225146|12706320|P1|COMPLETED|Overall Study||6
5166336|NCT01225146|12706319|P2|STARTED|Overall Study||2
5166337|NCT01225146|12706320|P1|STARTED|Overall Study||6
5166338|NCT01225068|12706338|P2|NOT COMPLETED|Overall Study||1
5166339|NCT01225068|12706339|P1|NOT COMPLETED|Overall Study||4
5166340|NCT01225068|12706338|P2|COMPLETED|Overall Study||19
5166341|NCT01225068|12706339|P1|COMPLETED|Overall Study||16
5166342|NCT01225068|12706338|P2|STARTED|Overall Study||20
5166343|NCT01225068|12706339|P1|STARTED|Overall Study||20
5166344|NCT01225055|12706348|P3|NOT COMPLETED|Overall Study||3
5166345|NCT01225055|12706349|P2|NOT COMPLETED|Overall Study||2
5166346|NCT01225055|12706350|P1|NOT COMPLETED|Overall Study||0
5166347|NCT01225055|12706348|P3|COMPLETED|Overall Study||18
5166348|NCT01225055|12706349|P2|COMPLETED|Overall Study||18
5166349|NCT01225055|12706350|P1|COMPLETED|Overall Study||20
5166350|NCT01225055|12706348|P3|STARTED|Overall Study||21
5166351|NCT01225055|12706349|P2|STARTED|Overall Study||20
5166352|NCT01225055|12706350|P1|STARTED|Overall Study||20
5166353|NCT01225029|12706375|P2|NOT COMPLETED|Overall Study||0
5166354|NCT01225029|12706376|P1|NOT COMPLETED|Overall Study||0
5166355|NCT01225029|12706375|P2|COMPLETED|Overall Study||32
5166356|NCT01225029|12706376|P1|COMPLETED|Overall Study||32
5166357|NCT01225029|12706375|P2|STARTED|Overall Study||32
5166358|NCT01225029|12706376|P1|STARTED|Overall Study||32
5166359|NCT01224925|12706388|P2|NOT COMPLETED|Overall Study||2
5166360|NCT01224925|12706389|P1|NOT COMPLETED|Overall Study||3
5166361|NCT01224925|12706388|P2|COMPLETED|Overall Study||31
5166362|NCT01224925|12706389|P1|COMPLETED|Overall Study||34
5166363|NCT01224925|12706388|P2|STARTED|Overall Study||33
5166364|NCT01224925|12706389|P1|STARTED|Overall Study||37
5166365|NCT01224821|12706397|P1|NOT COMPLETED|Long-Term Follow-Up||11
5166366|NCT01224821|12706397|P1|COMPLETED|Long-Term Follow-Up||0
5166367|NCT01224821|12706397|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
5166368|NCT01224821|12706397|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
5166369|NCT01224821|12706397|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
5166370|NCT01224821|12706397|P1|STARTED|Dosimetric and Therapeutic Treatment||47
5166371|NCT01224782|12706416|P1|NOT COMPLETED|Overall Study||264
5166372|NCT01224782|12706416|P1|COMPLETED|Overall Study||730
5166373|NCT01224782|12706416|P1|STARTED|Overall Study||994
5166374|NCT01224678|12706427|P2|NOT COMPLETED|Overall Study||0
5166375|NCT01224678|12706428|P1|NOT COMPLETED|Overall Study||0
5166376|NCT01224678|12706427|P2|COMPLETED|Overall Study||150
5166377|NCT01224678|12706428|P1|COMPLETED|Overall Study||150
5166378|NCT01224678|12706427|P2|STARTED|Overall Study||150
5166379|NCT01224678|12706428|P1|STARTED|Overall Study||150
5166380|NCT01224639|12706442|P8|NOT COMPLETED|Overall Study||2
5166381|NCT01224639|12706443|P7|NOT COMPLETED|Overall Study||1
5166382|NCT01224639|12706444|P6|NOT COMPLETED|Overall Study||0
5166383|NCT01224639|12706445|P5|NOT COMPLETED|Overall Study||2
5166384|NCT01224639|12706446|P4|NOT COMPLETED|Overall Study||0
5166385|NCT01224639|12706447|P3|NOT COMPLETED|Overall Study||0
5166386|NCT01224639|12706448|P2|NOT COMPLETED|Overall Study||0
5166387|NCT01224639|12706449|P1|NOT COMPLETED|Overall Study||0
5166388|NCT01224639|12706442|P8|COMPLETED|Overall Study||3
5166389|NCT01224639|12706443|P7|COMPLETED|Overall Study||17
5166390|NCT01224639|12706444|P6|COMPLETED|Overall Study||4
5166391|NCT01224639|12706445|P5|COMPLETED|Overall Study||19
5166392|NCT01224639|12706446|P4|COMPLETED|Overall Study||3
5166393|NCT01224639|12706447|P3|COMPLETED|Overall Study||21
5166394|NCT01224639|12706448|P2|COMPLETED|Overall Study||5
5166395|NCT01224639|12706449|P1|COMPLETED|Overall Study||19
5166396|NCT01224639|12706442|P8|STARTED|Overall Study||5
5166397|NCT01224639|12706443|P7|STARTED|Overall Study||18
5166398|NCT01224639|12706444|P6|STARTED|Overall Study||4
5166399|NCT01224639|12706445|P5|STARTED|Overall Study||21
5166400|NCT01224639|12706446|P4|STARTED|Overall Study||3
5166401|NCT01224639|12706447|P3|STARTED|Overall Study||21
5166402|NCT01224639|12706448|P2|STARTED|Overall Study||5
5166403|NCT01224639|12706449|P1|STARTED|Overall Study||19
5166404|NCT01224626|12706555|P1|NOT COMPLETED|Overall Study||1
5166405|NCT01224626|12706555|P1|COMPLETED|Overall Study||41
5166406|NCT01224626|12706555|P1|STARTED|Overall Study||42
5166407|NCT01224444|12706561|P1|NOT COMPLETED|Overall Study||0
5166408|NCT01224444|12706561|P1|COMPLETED|Overall Study||269
5166409|NCT01224444|12706561|P1|STARTED|Overall Study||269
5166410|NCT01224431|12706567|P2|NOT COMPLETED|Overall Study||5
5166411|NCT01224431|12706568|P1|NOT COMPLETED|Overall Study||0
5166412|NCT01224431|12706567|P2|COMPLETED|Overall Study||25
5166413|NCT01224431|12706568|P1|COMPLETED|Overall Study||30
5166414|NCT01224431|12706567|P2|STARTED|Overall Study||30
5166415|NCT01224431|12706568|P1|STARTED|Overall Study||30
5166416|NCT01224236|12706578|P2|NOT COMPLETED|Overall Study||1
5166417|NCT01224236|12706579|P1|NOT COMPLETED|Overall Study||1
5166418|NCT01224236|12706578|P2|COMPLETED|Overall Study||73
5166419|NCT01224236|12706579|P1|COMPLETED|Overall Study||75
5166420|NCT01224236|12706578|P2|STARTED|Overall Study||74
5166421|NCT01224236|12706579|P1|STARTED|Overall Study||76
5166422|NCT01224171|12706589|P2|NOT COMPLETED|Overall Study||13
5166423|NCT01224171|12706590|P1|NOT COMPLETED|Overall Study||15
5166424|NCT01224171|12706589|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
5166425|NCT01224171|12706590|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
5166426|NCT01224171|12706589|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
5166427|NCT01224171|12706590|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
5166428|NCT01224171|12706589|P2|STARTED|Overall Study||209
5166429|NCT01224171|12706590|P1|STARTED|Overall Study||207
5166430|NCT01224158|12706612|P2|NOT COMPLETED|Overall Study||0
5166431|NCT01224158|12706613|P1|NOT COMPLETED|Overall Study||1
5166432|NCT01224158|12706612|P2|COMPLETED|Overall Study||77
5166433|NCT01224158|12706613|P1|COMPLETED|Overall Study||75
5166434|NCT01224158|12706612|P2|STARTED|Overall Study||77
5166435|NCT01224158|12706613|P1|STARTED|Overall Study||76
5166436|NCT01224015|12706632|P3|NOT COMPLETED|Overall Study||13
5166437|NCT01224015|12706633|P2|NOT COMPLETED|Overall Study||16
5166438|NCT01224015|12706634|P1|NOT COMPLETED|Overall Study||14
5166439|NCT01224015|12706632|P3|COMPLETED|Overall Study||83
5166440|NCT01224015|12706633|P2|COMPLETED|Overall Study||211
5166441|NCT01224015|12706634|P1|COMPLETED|Overall Study||347
5166442|NCT01224015|12706632|P3|STARTED|Overall Study||96
5166443|NCT01224015|12706633|P2|STARTED|Overall Study||227
5166444|NCT01224015|12706634|P1|STARTED|Overall Study||361
5166445|NCT01223963|12706642|P1|NOT COMPLETED|Overall Study||0
5166446|NCT01223963|12706642|P1|COMPLETED|Overall Study||93
5166447|NCT01223963|12706642|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
5166448|NCT01223937|12706649|P2|NOT COMPLETED|Overall Study||18
5166449|NCT01223937|12706650|P1|NOT COMPLETED|Overall Study||17
5166450|NCT01223937|12706649|P2|COMPLETED|Overall Study||119
5166451|NCT01223937|12706650|P1|COMPLETED|Overall Study||114
5166452|NCT01223937|12706649|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
5166453|NCT01223937|12706650|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
5166454|NCT01223937|12706649|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
5166455|NCT01223937|12706650|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
5166541|NCT01223365|12706765|P1|STARTED|Open-label Treatment Period||291
5166456|NCT01223937|12706649|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
5166457|NCT01223937|12706650|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
5166458|NCT01223703|12706674|P2|NOT COMPLETED|Overall Study||0
5166459|NCT01223703|12706675|P1|NOT COMPLETED|Overall Study||0
5166460|NCT01223703|12706674|P2|COMPLETED|Overall Study||66
5166461|NCT01223703|12706675|P1|COMPLETED|Overall Study||67
5166462|NCT01223703|12706674|P2|STARTED|Overall Study||66
5166463|NCT01223703|12706675|P1|STARTED|Overall Study||67
5166464|NCT01223469|12706689|P2|NOT COMPLETED|Overall Study||0
5166465|NCT01223469|12706690|P1|NOT COMPLETED|Overall Study||0
5166466|NCT01223469|12706689|P2|COMPLETED|Overall Study||43
5166467|NCT01223469|12706690|P1|COMPLETED|Overall Study||34
5166468|NCT01223469|12706689|P2|STARTED|Overall Study||43
5166469|NCT01223469|12706690|P1|STARTED|Overall Study||34
5166470|NCT01223404|12706696|P6|NOT COMPLETED|Third Intervention (1 Day)||0
5166471|NCT01223404|12706697|P5|NOT COMPLETED|Third Intervention (1 Day)||0
5166472|NCT01223404|12706698|P4|NOT COMPLETED|Third Intervention (1 Day)||1
5166473|NCT01223404|12706699|P3|NOT COMPLETED|Third Intervention (1 Day)||0
5166474|NCT01223404|12706700|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5166475|NCT01223404|12706701|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5166476|NCT01223404|12706696|P6|COMPLETED|Third Intervention (1 Day)||3
5166477|NCT01223404|12706697|P5|COMPLETED|Third Intervention (1 Day)||2
5166478|NCT01223404|12706698|P4|COMPLETED|Third Intervention (1 Day)||3
5166479|NCT01223404|12706699|P3|COMPLETED|Third Intervention (1 Day)||4
5166480|NCT01223404|12706700|P2|COMPLETED|Third Intervention (1 Day)||3
5166481|NCT01223404|12706701|P1|COMPLETED|Third Intervention (1 Day)||3
5166482|NCT01223404|12706696|P6|STARTED|Third Intervention (1 Day)||3
5166483|NCT01223404|12706697|P5|STARTED|Third Intervention (1 Day)||2
5166484|NCT01223404|12706698|P4|STARTED|Third Intervention (1 Day)||4
5166485|NCT01223404|12706699|P3|STARTED|Third Intervention (1 Day)||4
5166486|NCT01223404|12706700|P2|STARTED|Third Intervention (1 Day)||3
5166487|NCT01223404|12706701|P1|STARTED|Third Intervention (1 Day)||3
5166488|NCT01223404|12706696|P6|NOT COMPLETED|Second Intervention (1 Day)||0
5166489|NCT01223404|12706697|P5|NOT COMPLETED|Second Intervention (1 Day)||0
5166490|NCT01223404|12706698|P4|NOT COMPLETED|Second Intervention (1 Day)||0
5166491|NCT01223404|12706699|P3|NOT COMPLETED|Second Intervention (1 Day)||0
5166492|NCT01223404|12706700|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5166493|NCT01223404|12706701|P1|NOT COMPLETED|Second Intervention (1 Day)||1
5166494|NCT01223404|12706696|P6|COMPLETED|Second Intervention (1 Day)||3
5166495|NCT01223404|12706697|P5|COMPLETED|Second Intervention (1 Day)||2
5166496|NCT01223404|12706698|P4|COMPLETED|Second Intervention (1 Day)||4
5166497|NCT01223404|12706699|P3|COMPLETED|Second Intervention (1 Day)||4
5166498|NCT01223404|12706700|P2|COMPLETED|Second Intervention (1 Day)||3
5166499|NCT01223404|12706701|P1|COMPLETED|Second Intervention (1 Day)||3
5166500|NCT01223404|12706696|P6|STARTED|Second Intervention (1 Day)||3
5166501|NCT01223404|12706697|P5|STARTED|Second Intervention (1 Day)||2
5166502|NCT01223404|12706698|P4|STARTED|Second Intervention (1 Day)||4
5166503|NCT01223404|12706699|P3|STARTED|Second Intervention (1 Day)||4
5166504|NCT01223404|12706700|P2|STARTED|Second Intervention (1 Day)||3
5166505|NCT01223404|12706701|P1|STARTED|Second Intervention (1 Day)||4
5166506|NCT01223404|12706696|P6|NOT COMPLETED|First Intervention (1 Day)||0
5166507|NCT01223404|12706697|P5|NOT COMPLETED|First Intervention (1 Day)||0
5166508|NCT01223404|12706698|P4|NOT COMPLETED|First Intervention (1 Day)||1
5166509|NCT01223404|12706699|P3|NOT COMPLETED|First Intervention (1 Day)||0
5166510|NCT01223404|12706700|P2|NOT COMPLETED|First Intervention (1 Day)||0
5166511|NCT01223404|12706701|P1|NOT COMPLETED|First Intervention (1 Day)||0
5166512|NCT01223404|12706696|P6|COMPLETED|First Intervention (1 Day)||3
5166513|NCT01223404|12706697|P5|COMPLETED|First Intervention (1 Day)||2
5166514|NCT01223404|12706698|P4|COMPLETED|First Intervention (1 Day)||4
5166515|NCT01223404|12706699|P3|COMPLETED|First Intervention (1 Day)||4
5166516|NCT01223404|12706700|P2|COMPLETED|First Intervention (1 Day)||3
5166517|NCT01223404|12706701|P1|COMPLETED|First Intervention (1 Day)||4
5166518|NCT01223404|12706696|P6|STARTED|First Intervention (1 Day)||3
5166519|NCT01223404|12706697|P5|STARTED|First Intervention (1 Day)||2
5166520|NCT01223404|12706698|P4|STARTED|First Intervention (1 Day)||5
5166521|NCT01223404|12706699|P3|STARTED|First Intervention (1 Day)||4
5166522|NCT01223404|12706700|P2|STARTED|First Intervention (1 Day)||3
5166523|NCT01223404|12706701|P1|STARTED|First Intervention (1 Day)||4
5166524|NCT01223378|12706729|P5|NOT COMPLETED|Overall Study||3
5166525|NCT01223378|12706730|P4|NOT COMPLETED|Overall Study||1
5166526|NCT01223378|12706731|P3|NOT COMPLETED|Overall Study||3
5166527|NCT01223378|12706732|P2|NOT COMPLETED|Overall Study||4
5166528|NCT01223378|12706733|P1|NOT COMPLETED|Overall Study||6
5166529|NCT01223378|12706729|P5|COMPLETED|Overall Study||79
5166530|NCT01223378|12706730|P4|COMPLETED|Overall Study||80
5166531|NCT01223378|12706731|P3|COMPLETED|Overall Study||80
5166532|NCT01223378|12706732|P2|COMPLETED|Overall Study||81
5166533|NCT01223378|12706733|P1|COMPLETED|Overall Study||76
5166534|NCT01223378|12706729|P5|STARTED|Overall Study||82
5166535|NCT01223378|12706730|P4|STARTED|Overall Study||81
5166536|NCT01223378|12706731|P3|STARTED|Overall Study||83
5166537|NCT01223378|12706732|P2|STARTED|Overall Study||85
5166538|NCT01223378|12706733|P1|STARTED|Overall Study||82
5166539|NCT01223365|12706765|P1|NOT COMPLETED|Open-label Treatment Period||102
5166540|NCT01223365|12706765|P1|COMPLETED|Open-label Treatment Period||189
5166542|NCT01223365|12706765|P1|NOT COMPLETED|Open-label Titration Period||39
5166543|NCT01223365|12706765|P1|COMPLETED|Open-label Titration Period||291
5166544|NCT01223365|12706765|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
5166545|NCT01223365|12706765|P1|Safety Analysis Set|Open-label Titration Period||329
5166546|NCT01223365|12706765|P1|STARTED|Open-label Titration Period||330
5166547|NCT01223352|12706808|P2|NOT COMPLETED|Overall Study||0
5166548|NCT01223352|12706809|P1|NOT COMPLETED|Overall Study||0
5166549|NCT01223352|12706808|P2|COMPLETED|Overall Study||33
5166550|NCT01223352|12706809|P1|COMPLETED|Overall Study||31
5166551|NCT01223352|12706808|P2|STARTED|Overall Study||33
5166552|NCT01223352|12706809|P1|STARTED|Overall Study||31
5166553|NCT01223235|12706829|P1|NOT COMPLETED|Overall Study||1
5166554|NCT01223235|12706829|P1|COMPLETED|Overall Study||21
5166555|NCT01223235|12706829|P1|STARTED|Overall Study||22
5166556|NCT01223196|12706837|P2|NOT COMPLETED|Overall Study||0
5166557|NCT01223196|12706838|P1|NOT COMPLETED|Overall Study||4
5166558|NCT01223196|12706837|P2|COMPLETED|Overall Study||11
5166559|NCT01223196|12706838|P1|COMPLETED|Overall Study||9
5166560|NCT01223196|12706837|P2|STARTED|Overall Study||11
5166561|NCT01223196|12706838|P1|STARTED|Overall Study||13
5166562|NCT01223183|12706850|P2|NOT COMPLETED|Imaging Day 2||0
5166563|NCT01223183|12706851|P1|NOT COMPLETED|Imaging Day 2||0
5166564|NCT01223183|12706850|P2|COMPLETED|Imaging Day 2||9
5166565|NCT01223183|12706851|P1|COMPLETED|Imaging Day 2||8
5166566|NCT01223183|12706850|P2|STARTED|Imaging Day 2||9
5166567|NCT01223183|12706851|P1|STARTED|Imaging Day 2||8
5166568|NCT01223183|12706850|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
5166569|NCT01223183|12706851|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
5166570|NCT01223183|12706850|P2|COMPLETED|Washout Period (5-24 Days)||9
5166571|NCT01223183|12706851|P1|COMPLETED|Washout Period (5-24 Days)||8
5166572|NCT01223183|12706850|P2|STARTED|Washout Period (5-24 Days)||9
5166573|NCT01223183|12706851|P1|STARTED|Washout Period (5-24 Days)||10
5166574|NCT01223183|12706850|P2|NOT COMPLETED|Imaging Day 1||1
5166575|NCT01223183|12706851|P1|NOT COMPLETED|Imaging Day 1||0
5166576|NCT01223183|12706850|P2|COMPLETED|Imaging Day 1||9
5166577|NCT01223183|12706851|P1|COMPLETED|Imaging Day 1||10
5166578|NCT01223183|12706850|P2|STARTED|Imaging Day 1||10
5166579|NCT01223183|12706851|P1|STARTED|Imaging Day 1||10
5166580|NCT01223027|12706861|P2|NOT COMPLETED|Overall Study||277
5166581|NCT01223027|12706862|P1|NOT COMPLETED|Overall Study||274
5166582|NCT01223027|12706861|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
5166583|NCT01223027|12706862|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
5166584|NCT01223027|12706861|P2|STARTED|Overall Study||286
5166585|NCT01223027|12706862|P1|STARTED|Overall Study||284
5166586|NCT01223001|12706885|P2|NOT COMPLETED|Overall Study||4
5166587|NCT01223001|12706886|P1|NOT COMPLETED|Overall Study||4
5166588|NCT01223001|12706885|P2|COMPLETED|Overall Study||0
5166589|NCT01223001|12706886|P1|COMPLETED|Overall Study||0
5166590|NCT01223001|12706885|P2|STARTED|Overall Study||4
5166591|NCT01223001|12706886|P1|STARTED|Overall Study||4
5166592|NCT01222884|12706894|P2|NOT COMPLETED|Overall Study||4
5166593|NCT01222884|12706895|P1|NOT COMPLETED|Overall Study||24
5166594|NCT01222884|12706894|P2|COMPLETED|Overall Study||113
5166595|NCT01222884|12706895|P1|COMPLETED|Overall Study||210
5166596|NCT01222884|12706894|P2|STARTED|Overall Study||117
5166597|NCT01222884|12706895|P1|STARTED|Overall Study||234
5166598|NCT01222871|12706905|P2|NOT COMPLETED|Overall Study||0
5166599|NCT01222871|12706906|P1|NOT COMPLETED|Overall Study||0
5166600|NCT01222871|12706905|P2|COMPLETED|Overall Study||0
5166601|NCT01222871|12706906|P1|COMPLETED|Overall Study||0
5166602|NCT01222871|12706905|P2|STARTED|Overall Study||0
5166603|NCT01222871|12706906|P1|STARTED|Overall Study||0
5166604|NCT01222832|12706915|P2|NOT COMPLETED|Overall Study||1
5166605|NCT01222832|12706916|P1|NOT COMPLETED|Overall Study||0
5166606|NCT01222832|12706915|P2|COMPLETED|Overall Study||112
5166607|NCT01222832|12706916|P1|COMPLETED|Overall Study||113
5166608|NCT01222832|12706915|P2|STARTED|Overall Study||113
5166609|NCT01222832|12706916|P1|STARTED|Overall Study||113
5166610|NCT01222715|12706924|P2|NOT COMPLETED|Overall Study||27
5166611|NCT01222715|12706925|P1|NOT COMPLETED|Overall Study||36
5166612|NCT01222715|12706924|P2|COMPLETED|Overall Study||16
5166613|NCT01222715|12706925|P1|COMPLETED|Overall Study||8
5166614|NCT01222715|12706924|P2|STARTED|Overall Study||43
5166615|NCT01222715|12706925|P1|STARTED|Overall Study||44
5166616|NCT01222689|12706935|P1|NOT COMPLETED|Overall Study||0
5166617|NCT01222689|12706935|P1|COMPLETED|Overall Study||46
5166618|NCT01222689|12706935|P1|STARTED|Overall Study||46
5166619|NCT01222585|12706948|P1|NOT COMPLETED|Overall Study||0
5166620|NCT01222585|12706948|P1|COMPLETED|Overall Study||24
5166621|NCT01222585|12706948|P1|STARTED|Overall Study||24
5166622|NCT01222572|12706958|P3|NOT COMPLETED|Overall Study||0
5166623|NCT01222572|12706959|P2|NOT COMPLETED|Overall Study||0
5166624|NCT01222572|12706960|P1|NOT COMPLETED|Overall Study||0
5166625|NCT01222572|12706958|P3|COMPLETED|Overall Study||0
5166626|NCT01222572|12706959|P2|COMPLETED|Overall Study||0
5166627|NCT01222572|12706960|P1|COMPLETED|Overall Study||1
5166628|NCT01222572|12706958|P3|STARTED|Overall Study||0
5166629|NCT01222572|12706959|P2|STARTED|Overall Study||0
5166630|NCT01222572|12706960|P1|STARTED|Overall Study||1
5166631|NCT01222533|12706964|P1|NOT COMPLETED|Overall Study||14
5166632|NCT01222533|12706964|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
5166633|NCT01222533|12706964|P1|Received Tio HH18|Overall Study||146
5166634|NCT01222533|12706964|P1|Received Tio R5|Overall Study||150
5166635|NCT01222533|12706964|P1|Received Tio R2.5|Overall Study||145
5166636|NCT01222533|12706964|P1|Received Tio R1.25|Overall Study||147
5166637|NCT01222533|12706964|P1|Received Placebo|Overall Study||147
5166638|NCT01222533|12706964|P1|STARTED|Overall Study|Entered and treated.|154
5166639|NCT01222520|12707103|P2|NOT COMPLETED|Double-blind Period||2
5166640|NCT01222520|12707104|P1|NOT COMPLETED|Double-blind Period||1
5166641|NCT01222520|12707103|P2|COMPLETED|Double-blind Period||85
5166642|NCT01222520|12707104|P1|COMPLETED|Double-blind Period||86
5166643|NCT01222520|12707103|P2|STARTED|Double-blind Period||87
5166644|NCT01222520|12707104|P1|STARTED|Double-blind Period||87
5166645|NCT01222520|12707103|P2|NOT COMPLETED|Open-label run-in Period||23
5166646|NCT01222520|12707104|P1|NOT COMPLETED|Open-label run-in Period||0
5166647|NCT01222520|12707103|P2|COMPLETED|Open-label run-in Period||174
5166648|NCT01222520|12707104|P1|COMPLETED|Open-label run-in Period||0
5166649|NCT01222520|12707103|P2|STARTED|Open-label run-in Period||197
5166650|NCT01222520|12707104|P1|STARTED|Open-label run-in Period||0
5166651|NCT01222507|12707122|P1|NOT COMPLETED|Overall Study||2
5166652|NCT01222507|12707122|P1|COMPLETED|Overall Study||60
5166653|NCT01222507|12707122|P1|STARTED|Overall Study||62
5166654|NCT01222494|12707129|P3|NOT COMPLETED|Overall Study||4
5166655|NCT01222494|12707130|P2|NOT COMPLETED|Overall Study||4
5166656|NCT01222494|12707131|P1|NOT COMPLETED|Overall Study||1
5166657|NCT01222494|12707129|P3|COMPLETED|Overall Study||17
5166658|NCT01222494|12707130|P2|COMPLETED|Overall Study||15
5166659|NCT01222494|12707131|P1|COMPLETED|Overall Study||6
5166660|NCT01222494|12707129|P3|STARTED|Overall Study||21
5166661|NCT01222494|12707130|P2|STARTED|Overall Study||19
5166662|NCT01222494|12707131|P1|STARTED|Overall Study||7
5166663|NCT01222416|12707150|P2|NOT COMPLETED|Overall Study||0
5166664|NCT01222416|12707151|P1|NOT COMPLETED|Overall Study||20
5166665|NCT01222416|12707150|P2|COMPLETED|Overall Study||0
5166666|NCT01222416|12707151|P1|COMPLETED|Overall Study||30
5166667|NCT01222416|12707150|P2|STARTED|Overall Study||0
5166668|NCT01222416|12707151|P1|STARTED|Overall Study||50
5166669|NCT01222403|12707161|P2|NOT COMPLETED|Overall Study||2
5166670|NCT01222403|12707162|P1|NOT COMPLETED|Overall Study||0
5166671|NCT01222403|12707161|P2|COMPLETED|Overall Study||379
5166672|NCT01222403|12707162|P1|COMPLETED|Overall Study||386
5166673|NCT01222403|12707161|P2|STARTED|Overall Study||381
5166674|NCT01222403|12707162|P1|STARTED|Overall Study||386
5166675|NCT01222390|12707172|P1|NOT COMPLETED|Overall Study||0
5166676|NCT01222390|12707172|P1|COMPLETED|Overall Study||12
5166677|NCT01222390|12707172|P1|STARTED|Overall Study||12
5166678|NCT01222286|12707178|P2|NOT COMPLETED|Overall Study||0
5166679|NCT01222286|12707179|P1|NOT COMPLETED|Overall Study||0
5166680|NCT01222286|12707178|P2|COMPLETED|Overall Study||14
5166681|NCT01222286|12707179|P1|COMPLETED|Overall Study||16
5166682|NCT01222286|12707178|P2|STARTED|Overall Study||14
5166683|NCT01222286|12707179|P1|STARTED|Overall Study||16
5166684|NCT01222273|12707191|P1|NOT COMPLETED|Overall Study||0
5166685|NCT01222273|12707191|P1|COMPLETED|Overall Study||7
5166686|NCT01222273|12707191|P1|STARTED|Overall Study||7
5166687|NCT01222260|12707197|P1|NOT COMPLETED|Overall Study||2
5166688|NCT01222260|12707197|P1|COMPLETED|Overall Study||29
5166689|NCT01222260|12707197|P1|STARTED|Overall Study||31
5166690|NCT01222247|12707206|P2|NOT COMPLETED|Overall Study||2
5166691|NCT01222247|12707207|P1|NOT COMPLETED|Overall Study||2
5166692|NCT01222247|12707206|P2|COMPLETED|Overall Study||1400
5166693|NCT01222247|12707207|P1|COMPLETED|Overall Study||1427
5166694|NCT01222247|12707206|P2|Did Not Receive Assigned Medication|Overall Study||5
5166695|NCT01222247|12707207|P1|Did Not Receive Assigned Medication|Overall Study||1
5166696|NCT01222247|12707206|P2|Received 1 Dose|Overall Study||571
5166697|NCT01222247|12707207|P1|Received 1 Dose|Overall Study||568
5166698|NCT01222247|12707206|P2|Received 2 Doses|Overall Study||826
5166699|NCT01222247|12707207|P1|Received 2 Doses|Overall Study||860
5166700|NCT01222247|12707206|P2|STARTED|Overall Study||1402
5166701|NCT01222247|12707207|P1|STARTED|Overall Study||1429
5166702|NCT01222234|12707272|P3|NOT COMPLETED|Overall Study||2
5166703|NCT01222234|12707273|P2|NOT COMPLETED|Overall Study||2
5166704|NCT01222234|12707274|P1|NOT COMPLETED|Overall Study||0
5166705|NCT01222234|12707272|P3|COMPLETED|Overall Study||22
5166706|NCT01222234|12707273|P2|COMPLETED|Overall Study||15
5166707|NCT01222234|12707274|P1|COMPLETED|Overall Study||15
5166708|NCT01222234|12707272|P3|STARTED|Overall Study||24
5166709|NCT01222234|12707273|P2|STARTED|Overall Study||17
5166710|NCT01222234|12707274|P1|STARTED|Overall Study||15
5166711|NCT01222195|12707283|P1|NOT COMPLETED|Overall Study||0
5166712|NCT01222195|12707283|P1|COMPLETED|Overall Study||1
5166713|NCT01222195|12707283|P1|STARTED|Overall Study||1
5166714|NCT01222117|12707298|P11|NOT COMPLETED|Overall Study||0
5166715|NCT01222117|12707299|P10|NOT COMPLETED|Overall Study||2
5166716|NCT01222117|12707300|P9|NOT COMPLETED|Overall Study||3
5166717|NCT01222117|12707301|P8|NOT COMPLETED|Overall Study||0
5166718|NCT01222117|12707302|P7|NOT COMPLETED|Overall Study||0
5166719|NCT01222117|12707303|P6|NOT COMPLETED|Overall Study||1
5166720|NCT01222117|12707304|P5|NOT COMPLETED|Overall Study||1
5166721|NCT01222117|12707305|P4|NOT COMPLETED|Overall Study||1
5166722|NCT01222117|12707306|P3|NOT COMPLETED|Overall Study||0
5166723|NCT01222117|12707307|P2|NOT COMPLETED|Overall Study||1
5166724|NCT01222117|12707308|P1|NOT COMPLETED|Overall Study||3
5166725|NCT01222117|12707298|P11|COMPLETED|Overall Study||6
5166726|NCT01222117|12707299|P10|COMPLETED|Overall Study||17
5166727|NCT01222117|12707300|P9|COMPLETED|Overall Study||20
5166728|NCT01222117|12707301|P8|COMPLETED|Overall Study||12
5166729|NCT01222117|12707302|P7|COMPLETED|Overall Study||13
5166730|NCT01222117|12707303|P6|COMPLETED|Overall Study||9
5166731|NCT01222117|12707304|P5|COMPLETED|Overall Study||8
5166732|NCT01222117|12707305|P4|COMPLETED|Overall Study||19
5166733|NCT01222117|12707306|P3|COMPLETED|Overall Study||22
5166734|NCT01222117|12707307|P2|COMPLETED|Overall Study||19
5166735|NCT01222117|12707308|P1|COMPLETED|Overall Study||17
5166736|NCT01222117|12707298|P11|STARTED|Overall Study||6
5166737|NCT01222117|12707299|P10|STARTED|Overall Study||19
5166738|NCT01222117|12707300|P9|STARTED|Overall Study||23
5166739|NCT01222117|12707301|P8|STARTED|Overall Study||12
5166740|NCT01222117|12707302|P7|STARTED|Overall Study||13
5166741|NCT01222117|12707303|P6|STARTED|Overall Study||10
5166742|NCT01222117|12707304|P5|STARTED|Overall Study||9
5166743|NCT01222117|12707305|P4|STARTED|Overall Study||20
5166744|NCT01222117|12707306|P3|STARTED|Overall Study||22
5166745|NCT01222117|12707307|P2|STARTED|Overall Study||20
5166746|NCT01222117|12707308|P1|STARTED|Overall Study||20
5166747|NCT01222104|12707343|P1|NOT COMPLETED|Overall Study||47
5166748|NCT01222104|12707343|P1|COMPLETED|Overall Study||587
5166749|NCT01222104|12707343|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
5166750|NCT01222104|12707343|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
5166751|NCT01222104|12707343|P1|Successful Deployment and Hemostasis|Overall Study||524
5166752|NCT01222104|12707343|P1|Successful Deployment|Overall Study||529
5166753|NCT01222104|12707343|P1|Angio-Seal Deployment Attempted|Overall Study||534
5166754|NCT01222104|12707343|P1|STARTED|Overall Study||634
5166755|NCT01222091|12707357|P2|NOT COMPLETED|Overall Study||0
5166756|NCT01222091|12707358|P1|NOT COMPLETED|Overall Study||0
5166757|NCT01222091|12707357|P2|COMPLETED|Overall Study||5
5166758|NCT01222091|12707358|P1|COMPLETED|Overall Study||5
5166759|NCT01222091|12707357|P2|STARTED|Overall Study||5
5166760|NCT01222091|12707358|P1|STARTED|Overall Study||5
5166761|NCT01222078|12707366|P1|NOT COMPLETED|Overall Study||1
5166762|NCT01222078|12707366|P1|COMPLETED|Overall Study||0
5166763|NCT01222078|12707366|P1|STARTED|Overall Study||1
5166764|NCT01221948|12707400|P1|NOT COMPLETED|Overall Study||14
5166765|NCT01221948|12707400|P1|COMPLETED|Overall Study||39
5166766|NCT01221948|12707400|P1|STARTED|Overall Study||53
5166767|NCT01221857|12707411|P1|NOT COMPLETED|Overall Study||0
5166768|NCT01221857|12707411|P1|COMPLETED|Overall Study||12
5166769|NCT01221857|12707411|P1|STARTED|Overall Study||12
5166770|NCT01221753|12707419|P1|NOT COMPLETED|Overall Study||1
5166771|NCT01221753|12707419|P1|COMPLETED|Overall Study||6
5166772|NCT01221753|12707419|P1|STARTED|Overall Study||7
5166773|NCT01221727|12707426|P2|NOT COMPLETED|Overall Study||1
5166774|NCT01221727|12707427|P1|NOT COMPLETED|Overall Study||3
5166775|NCT01221727|12707426|P2|COMPLETED|Overall Study||8
5166776|NCT01221727|12707427|P1|COMPLETED|Overall Study||18
5166777|NCT01221727|12707426|P2|Treated|Overall Study|Number of subjects received investigational product|8
5166778|NCT01221727|12707427|P1|Treated|Overall Study|Number of subjects received investigational product|19
5166779|NCT01221727|12707426|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
5166780|NCT01221727|12707427|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
5166781|NCT01221623|12707448|P2|NOT COMPLETED|Overall Study||14
5166782|NCT01221623|12707449|P1|NOT COMPLETED|Overall Study||38
5166783|NCT01221623|12707448|P2|COMPLETED|Overall Study||127
5166784|NCT01221623|12707449|P1|COMPLETED|Overall Study||236
5166785|NCT01221623|12707448|P2|STARTED|Overall Study||141
5166786|NCT01221623|12707449|P1|STARTED|Overall Study||274
5166787|NCT01221597|12707473|P2|NOT COMPLETED|Overall Study||16
5166788|NCT01221597|12707474|P1|NOT COMPLETED|Overall Study||36
5166789|NCT01221597|12707473|P2|COMPLETED|Overall Study||124
5166790|NCT01221597|12707474|P1|COMPLETED|Overall Study||241
5166791|NCT01221597|12707473|P2|STARTED|Overall Study||140
5166792|NCT01221597|12707474|P1|STARTED|Overall Study||277
5166793|NCT01221441|12707498|P2|NOT COMPLETED|Overall Study||12
5166794|NCT01221441|12707499|P1|NOT COMPLETED|Overall Study||22
5166795|NCT01221441|12707498|P2|COMPLETED|Overall Study||23
5166796|NCT01221441|12707499|P1|COMPLETED|Overall Study||45
5166797|NCT01221441|12707498|P2|STARTED|Overall Study||35
5166798|NCT01221441|12707499|P1|STARTED|Overall Study||67
5166799|NCT01221363|12707531|P2|NOT COMPLETED|Overall Study||5
5166800|NCT01221363|12707532|P1|NOT COMPLETED|Overall Study||12
5166801|NCT01221363|12707531|P2|COMPLETED|Overall Study||68
5166802|NCT01221363|12707532|P1|COMPLETED|Overall Study||81
5166803|NCT01221363|12707531|P2|STARTED|Overall Study||73
5166804|NCT01221363|12707532|P1|STARTED|Overall Study||93
5166805|NCT01221350|12707542|P2|NOT COMPLETED|Overall Study||3
5166806|NCT01221350|12707543|P1|NOT COMPLETED|Overall Study||5
5166807|NCT01221350|12707542|P2|COMPLETED|Overall Study||24
5166808|NCT01221350|12707543|P1|COMPLETED|Overall Study||23
5166809|NCT01221350|12707542|P2|Analysis Population|Overall Study||24
5166810|NCT01221350|12707543|P1|Analysis Population|Overall Study||23
5166811|NCT01221350|12707542|P2|Received Intervention|Overall Study||27
5166812|NCT01221350|12707543|P1|Received Intervention|Overall Study||28
5166813|NCT01221350|12707542|P2|STARTED|Overall Study||27
5166814|NCT01221350|12707543|P1|STARTED|Overall Study||28
5166815|NCT01221311|12707585|P2|NOT COMPLETED|Overall Study||0
5166816|NCT01221311|12707586|P1|NOT COMPLETED|Overall Study||0
5166817|NCT01221311|12707585|P2|COMPLETED|Overall Study||55
5166818|NCT01221311|12707586|P1|COMPLETED|Overall Study||57
5166819|NCT01221311|12707585|P2|STARTED|Overall Study||55
5166820|NCT01221311|12707586|P1|STARTED|Overall Study||57
5166821|NCT01221298|12707592|P1|NOT COMPLETED|Overall Study||0
5166822|NCT01221298|12707592|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
5166823|NCT01221298|12707592|P1|STARTED|Overall Study||11
5166824|NCT01221285|12707602|P1|NOT COMPLETED|Overall Study||1
5166825|NCT01221285|12707602|P1|COMPLETED|Overall Study||10
5166826|NCT01221285|12707602|P1|STARTED|Overall Study||11
5166827|NCT01221272|12707611|P2|NOT COMPLETED|Period 2||2
5166828|NCT01221272|12707612|P1|NOT COMPLETED|Period 2||0
5166829|NCT01221272|12707611|P2|COMPLETED|Period 2||37
5166830|NCT01221272|12707612|P1|COMPLETED|Period 2||39
5166831|NCT01221272|12707611|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
5166832|NCT01221272|12707612|P1|STARTED|Period 2||39
5166833|NCT01221272|12707611|P2|NOT COMPLETED|Period 1||2
5166834|NCT01221272|12707612|P1|NOT COMPLETED|Period 1||2
5166835|NCT01221272|12707611|P2|COMPLETED|Period 1||38
5166836|NCT01221272|12707612|P1|COMPLETED|Period 1||39
5166837|NCT01221272|12707611|P2|STARTED|Period 1||40
5166838|NCT01221272|12707612|P1|STARTED|Period 1||41
5166839|NCT01221233|12707629|P2|NOT COMPLETED|Overall Study||1
5166840|NCT01221233|12707630|P1|NOT COMPLETED|Overall Study||3
5166841|NCT01221233|12707629|P2|COMPLETED|Overall Study||19
5166842|NCT01221233|12707630|P1|COMPLETED|Overall Study||15
5166843|NCT01221233|12707629|P2|STARTED|Overall Study||20
5166844|NCT01221233|12707630|P1|STARTED|Overall Study||18
5166845|NCT01221181|12707636|P1|NOT COMPLETED|Overall Study||1
5166846|NCT01221181|12707636|P1|COMPLETED|Overall Study||5
5166847|NCT01221181|12707636|P1|STARTED|Overall Study||6
5166848|NCT01221090|12707644|P4|NOT COMPLETED|Overall Study||22
5166849|NCT01221090|12707645|P3|NOT COMPLETED|Overall Study||42
5166850|NCT01221090|12707646|P2|NOT COMPLETED|Overall Study||34
5166851|NCT01221090|12707647|P1|NOT COMPLETED|Overall Study||15
5166852|NCT01221090|12707644|P4|COMPLETED|Overall Study||73
5166853|NCT01221090|12707645|P3|COMPLETED|Overall Study||57
5166854|NCT01221090|12707646|P2|COMPLETED|Overall Study||47
5166855|NCT01221090|12707647|P1|COMPLETED|Overall Study||86
5166856|NCT01221090|12707644|P4|STARTED|Overall Study||95
5166857|NCT01221090|12707645|P3|STARTED|Overall Study||99
5166858|NCT01221090|12707646|P2|STARTED|Overall Study||81
5166859|NCT01221090|12707647|P1|STARTED|Overall Study||101
5166860|NCT01220999|12707678|P5|NOT COMPLETED|Overall Study||0
5166861|NCT01220999|12707679|P4|NOT COMPLETED|Overall Study||0
5166862|NCT01220999|12707680|P3|NOT COMPLETED|Overall Study||1
5166863|NCT01220999|12707681|P2|NOT COMPLETED|Overall Study||0
5166864|NCT01220999|12707682|P1|NOT COMPLETED|Overall Study||0
5166865|NCT01220999|12707678|P5|COMPLETED|Overall Study||5
5166866|NCT01220999|12707679|P4|COMPLETED|Overall Study||3
5166867|NCT01220999|12707680|P3|COMPLETED|Overall Study||4
5166868|NCT01220999|12707681|P2|COMPLETED|Overall Study||4
5166869|NCT01220999|12707682|P1|COMPLETED|Overall Study||2
5166870|NCT01220999|12707678|P5|STARTED|Overall Study||5
5166871|NCT01220999|12707679|P4|STARTED|Overall Study||3
5166872|NCT01220999|12707680|P3|STARTED|Overall Study||5
5166873|NCT01220999|12707681|P2|STARTED|Overall Study||4
5166874|NCT01220999|12707682|P1|STARTED|Overall Study||2
5166875|NCT01220973|12707759|P1|NOT COMPLETED|Overall Study||4
5166876|NCT01220973|12707759|P1|COMPLETED|Overall Study||23
5166877|NCT01220973|12707759|P1|STARTED|Overall Study||27
5166878|NCT01220869|12707763|P1|NOT COMPLETED|Overall Study||6
5166879|NCT01220869|12707763|P1|COMPLETED|Overall Study||104
5166880|NCT01220869|12707763|P1|STARTED|Overall Study||110
5166881|NCT01220739|12707773|P2|NOT COMPLETED|Overall Study||0
5166882|NCT01220739|12707774|P1|NOT COMPLETED|Overall Study||0
5166883|NCT01220739|12707773|P2|COMPLETED|Overall Study||5
5166884|NCT01220739|12707774|P1|COMPLETED|Overall Study||7
5166885|NCT01220739|12707773|P2|STARTED|Overall Study||5
5166886|NCT01220739|12707774|P1|STARTED|Overall Study||7
5166887|NCT01220726|12707784|P2|NOT COMPLETED|Overall Study||2
5166888|NCT01220726|12707785|P1|NOT COMPLETED|Overall Study||0
5166889|NCT01220726|12707784|P2|COMPLETED|Overall Study||13
5166890|NCT01220726|12707785|P1|COMPLETED|Overall Study||15
5166891|NCT01220726|12707784|P2|STARTED|Overall Study||15
5166892|NCT01220726|12707785|P1|STARTED|Overall Study||15
5166893|NCT01220609|12707803|P1|NOT COMPLETED|Overall Study||3
5166894|NCT01220609|12707803|P1|COMPLETED|Overall Study|Eligible and treated patients|23
5166895|NCT01220609|12707803|P1|STARTED|Overall Study||26
5166896|NCT01220557|12707817|P2|NOT COMPLETED|Overall Study||5
5166897|NCT01220557|12707818|P1|NOT COMPLETED|Overall Study||6
5166898|NCT01220557|12707817|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
5166899|NCT01220557|12707818|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
5166900|NCT01220557|12707817|P2|STARTED|Overall Study||79
5166901|NCT01220557|12707818|P1|STARTED|Overall Study||81
5166902|NCT01220466|12707827|P3|NOT COMPLETED|Overall Study||0
5166903|NCT01220466|12707828|P2|NOT COMPLETED|Overall Study||0
5166904|NCT01220466|12707829|P1|NOT COMPLETED|Overall Study||0
5166905|NCT01220466|12707827|P3|COMPLETED|Overall Study|16 eyes|10
5166906|NCT01220466|12707828|P2|COMPLETED|Overall Study|108 eyes|56
5166907|NCT01220466|12707829|P1|COMPLETED|Overall Study|19 eyes|11
5166908|NCT01220466|12707827|P3|STARTED|Overall Study|16 eyes|10
5166909|NCT01220466|12707828|P2|STARTED|Overall Study|108 eyes|56
5166910|NCT01220466|12707829|P1|STARTED|Overall Study|19 eyes|11
5166911|NCT01220414|12707851|P4|NOT COMPLETED|Overall Study||1
5166912|NCT01220414|12707852|P3|NOT COMPLETED|Overall Study||0
5166913|NCT01220414|12707853|P2|NOT COMPLETED|Overall Study||0
5166914|NCT01220414|12707854|P1|NOT COMPLETED|Overall Study||1
5166915|NCT01220414|12707851|P4|COMPLETED|Overall Study||14
5166916|NCT01220414|12707852|P3|COMPLETED|Overall Study||14
5166917|NCT01220414|12707853|P2|COMPLETED|Overall Study||14
5166918|NCT01220414|12707854|P1|COMPLETED|Overall Study||14
5166919|NCT01220414|12707851|P4|STARTED|Overall Study||15
5166920|NCT01220414|12707852|P3|STARTED|Overall Study||14
5166921|NCT01220414|12707853|P2|STARTED|Overall Study||14
5166922|NCT01220414|12707854|P1|STARTED|Overall Study||15
5166923|NCT01220401|12707861|P1|NOT COMPLETED|Overall Study||3
5166924|NCT01220401|12707861|P1|COMPLETED|Overall Study||18
5166925|NCT01220401|12707861|P1|STARTED|Overall Study||21
5166926|NCT01220297|12707870|P1|NOT COMPLETED|Overall Study||3
5166927|NCT01220297|12707870|P1|COMPLETED|Overall Study||0
5166928|NCT01220297|12707870|P1|STARTED|Overall Study||3
5166929|NCT01220180|12707887|P1|NOT COMPLETED|Overall Study||207
5166930|NCT01220180|12707887|P1|COMPLETED|Overall Study||3968
5166931|NCT01220180|12707887|P1|Treated|Overall Study||4174
5166932|NCT01220180|12707887|P1|STARTED|Overall Study||4175
5166933|NCT01220128|12707917|P7|NOT COMPLETED|Overall Study||5
5166934|NCT01220128|12707918|P6|NOT COMPLETED|Overall Study||0
5166935|NCT01220128|12707919|P5|NOT COMPLETED|Overall Study||0
5166936|NCT01220128|12707920|P4|NOT COMPLETED|Overall Study||0
5166937|NCT01220128|12707921|P3|NOT COMPLETED|Overall Study||3
5166938|NCT01220128|12707922|P2|NOT COMPLETED|Overall Study||1
5166939|NCT01220128|12707923|P1|NOT COMPLETED|Overall Study||4
5166940|NCT01220128|12707917|P7|COMPLETED|Overall Study||3
5166941|NCT01220128|12707918|P6|COMPLETED|Overall Study||4
5166942|NCT01220128|12707919|P5|COMPLETED|Overall Study||11
5166943|NCT01220128|12707920|P4|COMPLETED|Overall Study||6
5166944|NCT01220128|12707921|P3|COMPLETED|Overall Study||6
5166945|NCT01220128|12707922|P2|COMPLETED|Overall Study||6
5166946|NCT01220128|12707923|P1|COMPLETED|Overall Study||11
5166947|NCT01220128|12707917|P7|STARTED|Overall Study||8
5166948|NCT01220128|12707918|P6|STARTED|Overall Study||4
5166949|NCT01220128|12707919|P5|STARTED|Overall Study||11
5166950|NCT01220128|12707920|P4|STARTED|Overall Study||6
5166951|NCT01220128|12707921|P3|STARTED|Overall Study||9
5166952|NCT01220128|12707922|P2|STARTED|Overall Study||7
5166953|NCT01220128|12707923|P1|STARTED|Overall Study||15
5166954|NCT01219985|12708128|P1|NOT COMPLETED|Overall Study||20
5166955|NCT01219985|12708128|P1|COMPLETED|Overall Study||30
5166956|NCT01219985|12708128|P1|STARTED|Overall Study||50
5166957|NCT01219959|12708136|P2|NOT COMPLETED|Overall Study||23
5166958|NCT01219959|12708137|P1|NOT COMPLETED|Overall Study||7
5166959|NCT01219959|12708136|P2|COMPLETED|Overall Study||101
5166960|NCT01219959|12708137|P1|COMPLETED|Overall Study||120
5166961|NCT01219959|12708136|P2|STARTED|Overall Study||124
5166962|NCT01219959|12708137|P1|STARTED|Overall Study||127
5166963|NCT01219933|12708185|P1|NOT COMPLETED|Overall Study||38
5166964|NCT01219933|12708185|P1|COMPLETED|Overall Study||30
5166965|NCT01219933|12708185|P1|STARTED|Overall Study||68
5166966|NCT01219881|12708224|P2|NOT COMPLETED|Overall Study||5
5166967|NCT01219881|12708225|P1|NOT COMPLETED|Overall Study||4
5166968|NCT01219881|12708224|P2|COMPLETED|Overall Study||32
5166969|NCT01219881|12708225|P1|COMPLETED|Overall Study||34
5166970|NCT01219881|12708224|P2|STARTED|Overall Study||37
5166971|NCT01219881|12708225|P1|STARTED|Overall Study||38
5166972|NCT01219855|12708242|P5|NOT COMPLETED|Overall Study||1
5166973|NCT01219855|12708243|P4|NOT COMPLETED|Overall Study||1
5166974|NCT01219855|12708244|P3|NOT COMPLETED|Overall Study||1
5166975|NCT01219855|12708245|P2|NOT COMPLETED|Overall Study||5
5166976|NCT01219855|12708246|P1|NOT COMPLETED|Overall Study||1
5166977|NCT01219855|12708242|P5|COMPLETED|Overall Study||13
5166978|NCT01219855|12708243|P4|COMPLETED|Overall Study||12
5166979|NCT01219855|12708244|P3|COMPLETED|Overall Study||16
5166980|NCT01219855|12708245|P2|COMPLETED|Overall Study||12
5166981|NCT01219855|12708246|P1|COMPLETED|Overall Study||16
5166982|NCT01219855|12708242|P5|STARTED|Overall Study||14
5166983|NCT01219855|12708243|P4|STARTED|Overall Study||13
5166984|NCT01219855|12708244|P3|STARTED|Overall Study||17
5166985|NCT01219855|12708245|P2|STARTED|Overall Study||17
5166986|NCT01219855|12708246|P1|STARTED|Overall Study||17
5166987|NCT01219777|12708282|P1|NOT COMPLETED|Overall Study||0
5166988|NCT01219777|12708282|P1|COMPLETED|Overall Study||9
5166989|NCT01219777|12708282|P1|STARTED|Overall Study||9
5166990|NCT01219738|12708287|P1|NOT COMPLETED|Overall Study||0
5166991|NCT01219738|12708287|P1|COMPLETED|Overall Study||20
5166992|NCT01219738|12708287|P1|Budesonide 720- 4 Times|Overall Study||20
5166993|NCT01219738|12708287|P1|Budesonide 1440|Overall Study||20
5166994|NCT01219738|12708287|P1|Budesonide 720|Overall Study||20
5166995|NCT01219738|12708287|P1|Budesonide 360|Overall Study||20
5166996|NCT01219738|12708287|P1|STARTED|Overall Study||20
5166997|NCT01219673|12708308|P8|NOT COMPLETED|Overall Study||0
5166998|NCT01219673|12708309|P7|NOT COMPLETED|Overall Study||0
5166999|NCT01219673|12708310|P6|NOT COMPLETED|Overall Study||0
5167000|NCT01219673|12708311|P5|NOT COMPLETED|Overall Study||0
5167001|NCT01219673|12708312|P4|NOT COMPLETED|Overall Study||0
5167002|NCT01219673|12708313|P3|NOT COMPLETED|Overall Study||0
5167003|NCT01219673|12708314|P2|NOT COMPLETED|Overall Study||0
5167004|NCT01219673|12708315|P1|NOT COMPLETED|Overall Study||0
5167005|NCT01219673|12708308|P8|COMPLETED|Overall Study||0
5167006|NCT01219673|12708309|P7|COMPLETED|Overall Study||0
5167007|NCT01219673|12708310|P6|COMPLETED|Overall Study||0
5167008|NCT01219673|12708311|P5|COMPLETED|Overall Study||0
5167009|NCT01219673|12708312|P4|COMPLETED|Overall Study||0
5167010|NCT01219673|12708313|P3|COMPLETED|Overall Study||1
5167011|NCT01219673|12708314|P2|COMPLETED|Overall Study||0
5167012|NCT01219673|12708315|P1|COMPLETED|Overall Study||0
5167013|NCT01219673|12708308|P8|STARTED|Overall Study||0
5167014|NCT01219673|12708309|P7|STARTED|Overall Study||0
5167015|NCT01219673|12708310|P6|STARTED|Overall Study||0
5167016|NCT01219673|12708311|P5|STARTED|Overall Study||0
5167017|NCT01219673|12708312|P4|STARTED|Overall Study||0
5167018|NCT01219673|12708313|P3|STARTED|Overall Study||1
5167019|NCT01219673|12708314|P2|STARTED|Overall Study||0
5167020|NCT01219673|12708315|P1|STARTED|Overall Study||0
5167021|NCT01218997|12708335|P2|NOT COMPLETED|Overall Study||41
5167022|NCT01218997|12708336|P1|NOT COMPLETED|Overall Study||245
5167023|NCT01218997|12708335|P2|COMPLETED|Overall Study||24
5167024|NCT01218997|12708336|P1|COMPLETED|Overall Study||126
5167025|NCT01218997|12708335|P2|STARTED|Overall Study||65
5167026|NCT01218997|12708336|P1|STARTED|Overall Study||371
5167027|NCT01218984|12708345|P3|NOT COMPLETED|Overall Study||3
5167028|NCT01218984|12708346|P2|NOT COMPLETED|Overall Study||2
5167029|NCT01218984|12708347|P1|NOT COMPLETED|Overall Study||1
5167030|NCT01218984|12708345|P3|COMPLETED|Overall Study||7
5167031|NCT01218984|12708346|P2|COMPLETED|Overall Study||6
5167032|NCT01218984|12708347|P1|COMPLETED|Overall Study||8
5167033|NCT01218984|12708345|P3|STARTED|Overall Study||10
5167034|NCT01218984|12708346|P2|STARTED|Overall Study||8
5167035|NCT01218984|12708347|P1|STARTED|Overall Study||9
5167036|NCT01218971|12708357|P2|NOT COMPLETED|Overall Study||80
5167037|NCT01218971|12708358|P1|NOT COMPLETED|Overall Study||104
5167038|NCT01218971|12708357|P2|COMPLETED|Overall Study||77
5167039|NCT01218971|12708358|P1|COMPLETED|Overall Study||71
5167040|NCT01218971|12708357|P2|STARTED|Overall Study||157
5167041|NCT01218971|12708358|P1|STARTED|Overall Study||175
5167042|NCT01218958|12708371|P3|NOT COMPLETED|Overall Study||81
5167043|NCT01218958|12708372|P2|NOT COMPLETED|Overall Study||81
5167044|NCT01218958|12708373|P1|NOT COMPLETED|Overall Study||84
5167045|NCT01218958|12708371|P3|COMPLETED|Overall Study||128
5167046|NCT01218958|12708372|P2|COMPLETED|Overall Study||124
5167047|NCT01218958|12708373|P1|COMPLETED|Overall Study||126
5167048|NCT01218958|12708371|P3|STARTED|Overall Study||209
5167049|NCT01218958|12708372|P2|STARTED|Overall Study||205
5167050|NCT01218958|12708373|P1|STARTED|Overall Study||210
5167051|NCT01218867|12708395|P11|NOT COMPLETED|Overall Study||0
5167052|NCT01218867|12708396|P10|NOT COMPLETED|Overall Study||0
5167053|NCT01218867|12708397|P9|NOT COMPLETED|Overall Study||0
5167054|NCT01218867|12708398|P8|NOT COMPLETED|Overall Study||0
5167055|NCT01218867|12708399|P7|NOT COMPLETED|Overall Study||1
5167056|NCT01218867|12708400|P6|NOT COMPLETED|Overall Study||0
5167057|NCT01218867|12708401|P5|NOT COMPLETED|Overall Study||0
5167058|NCT01218867|12708402|P4|NOT COMPLETED|Overall Study||0
5167059|NCT01218867|12708403|P3|NOT COMPLETED|Overall Study||0
5167060|NCT01218867|12708404|P2|NOT COMPLETED|Overall Study||0
5167061|NCT01218867|12708405|P1|NOT COMPLETED|Overall Study||0
5167062|NCT01218867|12708395|P11|COMPLETED|Overall Study||2
5167063|NCT01218867|12708396|P10|COMPLETED|Overall Study||4
5167064|NCT01218867|12708397|P9|COMPLETED|Overall Study||3
5167065|NCT01218867|12708398|P8|COMPLETED|Overall Study||3
5167066|NCT01218867|12708399|P7|COMPLETED|Overall Study||3
5167067|NCT01218867|12708400|P6|COMPLETED|Overall Study||1
5167068|NCT01218867|12708401|P5|COMPLETED|Overall Study||1
5167069|NCT01218867|12708402|P4|COMPLETED|Overall Study||1
5167070|NCT01218867|12708403|P3|COMPLETED|Overall Study||3
5167071|NCT01218867|12708404|P2|COMPLETED|Overall Study||1
5167072|NCT01218867|12708405|P1|COMPLETED|Overall Study||1
5167073|NCT01218867|12708395|P11|STARTED|Overall Study||2
5167074|NCT01218867|12708396|P10|STARTED|Overall Study||4
5167075|NCT01218867|12708397|P9|STARTED|Overall Study||3
5167076|NCT01218867|12708398|P8|STARTED|Overall Study||3
5167077|NCT01218867|12708399|P7|STARTED|Overall Study||4
5167078|NCT01218867|12708400|P6|STARTED|Overall Study||1
5167079|NCT01218867|12708401|P5|STARTED|Overall Study||1
5167080|NCT01218867|12708402|P4|STARTED|Overall Study||1
5167081|NCT01218867|12708403|P3|STARTED|Overall Study||3
5167082|NCT01218867|12708404|P2|STARTED|Overall Study||1
5167083|NCT01218867|12708405|P1|STARTED|Overall Study||1
5167084|NCT01218802|12708453|P2|NOT COMPLETED|Overall Study||18
5167085|NCT01218802|12708454|P1|NOT COMPLETED|Overall Study||10
5167086|NCT01218802|12708453|P2|COMPLETED|Overall Study||57
5167087|NCT01218802|12708454|P1|COMPLETED|Overall Study||62
5167088|NCT01218802|12708453|P2|STARTED|Overall Study||75
5167089|NCT01218802|12708454|P1|STARTED|Overall Study||72
5167090|NCT01218659|12708464|P3|NOT COMPLETED|12-Month OLE||10
5167091|NCT01218659|12708465|P2|NOT COMPLETED|12-Month OLE||0
5167092|NCT01218659|12708466|P1|NOT COMPLETED|12-Month OLE||0
5167093|NCT01218659|12708464|P3|COMPLETED|12-Month OLE||42
5167094|NCT01218659|12708465|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167095|NCT01218659|12708466|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167096|NCT01218659|12708464|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
5167097|NCT01218659|12708465|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167098|NCT01218659|12708466|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167099|NCT01218659|12708464|P3|Safety Population|12-Month OLE||51
5167100|NCT01218659|12708465|P2|Safety Population|12-Month OLE||0
5167101|NCT01218659|12708466|P1|Safety Population|12-Month OLE||0
5167102|NCT01218659|12708464|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
5167103|NCT01218659|12708465|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167104|NCT01218659|12708466|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
5167105|NCT01218659|12708464|P3|NOT COMPLETED|18-Month Randomized Period||0
5167106|NCT01218659|12708465|P2|NOT COMPLETED|18-Month Randomized Period||6
5167107|NCT01218659|12708466|P1|NOT COMPLETED|18-Month Randomized Period||2
5167108|NCT01218659|12708464|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
5167109|NCT01218659|12708465|P2|COMPLETED|18-Month Randomized Period||18
5167110|NCT01218659|12708466|P1|COMPLETED|18-Month Randomized Period||34
5167111|NCT01218659|12708464|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
5167112|NCT01218659|12708465|P2|Safety Population|18-Month Randomized Period||21
5167113|NCT01218659|12708466|P1|Safety Population|18-Month Randomized Period||36
5167114|NCT01218659|12708464|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
5167115|NCT01218659|12708465|P2|STARTED|18-Month Randomized Period||24
5167116|NCT01218659|12708466|P1|STARTED|18-Month Randomized Period||36
5167117|NCT01218646|12708481|P4|NOT COMPLETED|Overall Study||1
5167118|NCT01218646|12708482|P3|NOT COMPLETED|Overall Study||2
5167119|NCT01218646|12708483|P2|NOT COMPLETED|Overall Study||0
5167120|NCT01218646|12708484|P1|NOT COMPLETED|Overall Study||1
5167121|NCT01218646|12708481|P4|COMPLETED|Overall Study||63
5167122|NCT01218646|12708482|P3|COMPLETED|Overall Study||223
5167123|NCT01218646|12708483|P2|COMPLETED|Overall Study||225
5167124|NCT01218646|12708484|P1|COMPLETED|Overall Study||224
5167125|NCT01218646|12708481|P4|STARTED|Overall Study||64
5167126|NCT01218646|12708482|P3|STARTED|Overall Study||225
5167127|NCT01218646|12708483|P2|STARTED|Overall Study||225
5167128|NCT01218646|12708484|P1|STARTED|Overall Study||225
5167129|NCT01218594|12708522|P1|NOT COMPLETED|Overall Study||12
5167130|NCT01218594|12708522|P1|COMPLETED|Overall Study||36
5167131|NCT01218594|12708522|P1|STARTED|Overall Study||48
5167132|NCT01218477|12708530|P4|NOT COMPLETED|Overall Study||2
5167133|NCT01218477|12708531|P3|NOT COMPLETED|Overall Study||14
5167134|NCT01218477|12708532|P2|NOT COMPLETED|Overall Study||8
5167135|NCT01218477|12708533|P1|NOT COMPLETED|Overall Study||3
5167136|NCT01218477|12708530|P4|COMPLETED|Overall Study|Still receiving study drug|0
5167137|NCT01218477|12708531|P3|COMPLETED|Overall Study|Still receiving study drug|0
5167138|NCT01218477|12708532|P2|COMPLETED|Overall Study|Still receiving study drug|0
5167139|NCT01218477|12708533|P1|COMPLETED|Overall Study|Still receiving study drug|0
5167140|NCT01218477|12708530|P4|STARTED|Overall Study|Participants who received treatment|2
5167141|NCT01218477|12708531|P3|STARTED|Overall Study|Participants who received treatment|14
5167142|NCT01218477|12708532|P2|STARTED|Overall Study|Participants who received treatment|8
5167143|NCT01218477|12708533|P1|STARTED|Overall Study|Participants who received treatment|3
5167144|NCT01218438|12708550|P1|NOT COMPLETED|Epoch 4||3
5167145|NCT01218438|12708550|P1|COMPLETED|Epoch 4||67
5167146|NCT01218438|12708550|P1|STARTED|Epoch 4||70
5167147|NCT01218438|12708550|P1|NOT COMPLETED|Epoch 3||4
5167148|NCT01218438|12708550|P1|COMPLETED|Epoch 3||70
5167149|NCT01218438|12708550|P1|STARTED|Epoch 3||74
5167150|NCT01218438|12708550|P1|NOT COMPLETED|Epoch 2||0
5167151|NCT01218438|12708550|P1|COMPLETED|Epoch 2||45
5167152|NCT01218438|12708550|P1|STARTED|Epoch 2||45
5167153|NCT01218438|12708550|P1|NOT COMPLETED|Epoch 1||3
5167154|NCT01218438|12708550|P1|COMPLETED|Epoch 1||74
5167155|NCT01218438|12708550|P1|STARTED|Epoch 1||77
5167156|NCT01218399|12708705|P2|NOT COMPLETED|Overall Study||0
5167157|NCT01218399|12708706|P1|NOT COMPLETED|Overall Study||0
5167158|NCT01218399|12708705|P2|COMPLETED|Overall Study||5
5167159|NCT01218399|12708706|P1|COMPLETED|Overall Study||5
5167160|NCT01218399|12708705|P2|STARTED|Overall Study||5
5167161|NCT01218399|12708706|P1|STARTED|Overall Study||5
5167162|NCT01218308|12708716|P2|NOT COMPLETED|Overall Study||120
5167163|NCT01218308|12708717|P1|NOT COMPLETED|Overall Study||103
5167164|NCT01218308|12708716|P2|COMPLETED|Overall Study||2464
5167165|NCT01218308|12708717|P1|COMPLETED|Overall Study||2481
5167166|NCT01218308|12708716|P2|STARTED|Overall Study||2584
5167167|NCT01218308|12708717|P1|STARTED|Overall Study||2584
5167168|NCT01218243|12708761|P2|NOT COMPLETED|Overall Study||14
5167169|NCT01218243|12708762|P1|NOT COMPLETED|Overall Study||9
5167170|NCT01218243|12708761|P2|COMPLETED|Overall Study||36
5167171|NCT01218243|12708762|P1|COMPLETED|Overall Study||41
5167172|NCT01218243|12708761|P2|Treatment Completed|Overall Study||42
5167173|NCT01218243|12708762|P1|Treatment Completed|Overall Study||45
5167174|NCT01218243|12708761|P2|STARTED|Overall Study||50
5167175|NCT01218243|12708762|P1|STARTED|Overall Study||50
5167176|NCT01218204|12708778|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
5167177|NCT01218204|12708779|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
5167178|NCT01218204|12708780|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
5167179|NCT01218204|12708781|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
5167180|NCT01218204|12708778|P4|COMPLETED|Part B Pooled Treatment Arm||127
5167181|NCT01218204|12708779|P3|COMPLETED|Part B Pooled Treatment Arm||0
5167182|NCT01218204|12708780|P2|COMPLETED|Part B Pooled Treatment Arm||0
5167183|NCT01218204|12708781|P1|COMPLETED|Part B Pooled Treatment Arm||0
5167184|NCT01218204|12708778|P4|STARTED|Part B Pooled Treatment Arm||130
5167185|NCT01218204|12708779|P3|STARTED|Part B Pooled Treatment Arm||0
5167186|NCT01218204|12708780|P2|STARTED|Part B Pooled Treatment Arm||0
5167187|NCT01218204|12708781|P1|STARTED|Part B Pooled Treatment Arm||0
5167188|NCT01218204|12708778|P4|NOT COMPLETED|Part B Run-in||0
5167189|NCT01218204|12708779|P3|NOT COMPLETED|Part B Run-in||6
5167190|NCT01218204|12708780|P2|NOT COMPLETED|Part B Run-in||0
5167191|NCT01218204|12708781|P1|NOT COMPLETED|Part B Run-in||0
5167192|NCT01218204|12708778|P4|COMPLETED|Part B Run-in||0
5167193|NCT01218204|12708779|P3|COMPLETED|Part B Run-in||83
5167194|NCT01218204|12708780|P2|COMPLETED|Part B Run-in||0
5167195|NCT01218204|12708781|P1|COMPLETED|Part B Run-in||0
5167196|NCT01218204|12708778|P4|STARTED|Part B Run-in||0
5167197|NCT01218204|12708779|P3|STARTED|Part B Run-in||89
5167198|NCT01218204|12708780|P2|STARTED|Part B Run-in||0
5167199|NCT01218204|12708781|P1|STARTED|Part B Run-in||0
5167200|NCT01218204|12708778|P4|NOT COMPLETED|Part B Washout||0
5167201|NCT01218204|12708779|P3|NOT COMPLETED|Part B Washout||0
5167202|NCT01218204|12708780|P2|NOT COMPLETED|Part B Washout||145
5167203|NCT01218204|12708781|P1|NOT COMPLETED|Part B Washout||0
5167204|NCT01218204|12708778|P4|COMPLETED|Part B Washout||0
5167205|NCT01218204|12708779|P3|COMPLETED|Part B Washout||0
5167206|NCT01218204|12708780|P2|COMPLETED|Part B Washout||136
5167207|NCT01218204|12708781|P1|COMPLETED|Part B Washout||0
5167208|NCT01218204|12708778|P4|STARTED|Part B Washout||0
5167209|NCT01218204|12708779|P3|STARTED|Part B Washout||0
5167210|NCT01218204|12708780|P2|STARTED|Part B Washout||281
5167211|NCT01218204|12708781|P1|STARTED|Part B Washout||0
5167212|NCT01218204|12708778|P4|NOT COMPLETED|Part A||0
5167213|NCT01218204|12708779|P3|NOT COMPLETED|Part A||0
5167214|NCT01218204|12708780|P2|NOT COMPLETED|Part A||0
5167215|NCT01218204|12708781|P1|NOT COMPLETED|Part A||0
5167216|NCT01218204|12708778|P4|COMPLETED|Part A||0
5167217|NCT01218204|12708779|P3|COMPLETED|Part A||0
5167218|NCT01218204|12708780|P2|COMPLETED|Part A||0
5167219|NCT01218204|12708781|P1|COMPLETED|Part A||6
5167220|NCT01218204|12708778|P4|STARTED|Part A||0
5167221|NCT01218204|12708779|P3|STARTED|Part A||0
5167222|NCT01218204|12708780|P2|STARTED|Part A||0
5167223|NCT01218204|12708781|P1|STARTED|Part A||6
5167224|NCT01218126|12709045|P4|NOT COMPLETED|Overall Study||35
5167225|NCT01218126|12709046|P3|NOT COMPLETED|Overall Study||24
5167226|NCT01218126|12709047|P2|NOT COMPLETED|Overall Study||22
5167227|NCT01218126|12709048|P1|NOT COMPLETED|Overall Study||24
5167228|NCT01218126|12709045|P4|COMPLETED|Overall Study||114
5167229|NCT01218126|12709046|P3|COMPLETED|Overall Study||127
5167230|NCT01218126|12709047|P2|COMPLETED|Overall Study||127
5167231|NCT01218126|12709048|P1|COMPLETED|Overall Study||129
5167232|NCT01218126|12709045|P4|STARTED|Overall Study||149
5167233|NCT01218126|12709046|P3|STARTED|Overall Study||151
5167234|NCT01218126|12709047|P2|STARTED|Overall Study||149
5167235|NCT01218126|12709048|P1|STARTED|Overall Study||153
5167236|NCT01218113|12709089|P3|NOT COMPLETED|Overall Study||6
5167237|NCT01218113|12709090|P2|NOT COMPLETED|Overall Study||1
5167238|NCT01218113|12709091|P1|NOT COMPLETED|Overall Study||5
5167239|NCT01218113|12709089|P3|COMPLETED|Overall Study||58
5167240|NCT01218113|12709090|P2|COMPLETED|Overall Study||63
5167241|NCT01218113|12709091|P1|COMPLETED|Overall Study||57
5167242|NCT01218113|12709089|P3|STARTED|Overall Study||64
5167243|NCT01218113|12709090|P2|STARTED|Overall Study||64
5167244|NCT01218113|12709091|P1|STARTED|Overall Study||62
5167245|NCT01218100|12709272|P4|NOT COMPLETED|Overall Study||34
5167246|NCT01218100|12709273|P3|NOT COMPLETED|Overall Study||27
5167247|NCT01218100|12709274|P2|NOT COMPLETED|Overall Study||25
5167248|NCT01218100|12709275|P1|NOT COMPLETED|Overall Study||24
5167249|NCT01218100|12709272|P4|COMPLETED|Overall Study||156
5167250|NCT01218100|12709273|P3|COMPLETED|Overall Study||162
5167251|NCT01218100|12709274|P2|COMPLETED|Overall Study||165
5167252|NCT01218100|12709275|P1|COMPLETED|Overall Study||71
5167253|NCT01218100|12709272|P4|STARTED|Overall Study||190
5167254|NCT01218100|12709273|P3|STARTED|Overall Study||189
5167255|NCT01218100|12709274|P2|STARTED|Overall Study||190
5167256|NCT01218100|12709275|P1|STARTED|Overall Study||95
5167257|NCT01218087|12709291|P2|NOT COMPLETED|Overall Study||6
5167258|NCT01218087|12709292|P1|NOT COMPLETED|Overall Study||15
5167259|NCT01218087|12709291|P2|COMPLETED|Overall Study||35
5167260|NCT01218087|12709292|P1|COMPLETED|Overall Study||27
5167261|NCT01218087|12709291|P2|STARTED|Overall Study||41
5167262|NCT01218087|12709292|P1|STARTED|Overall Study||42
5167263|NCT01218048|12709300|P1|NOT COMPLETED|Overall Study||0
5167264|NCT01218048|12709300|P1|COMPLETED|Overall Study||40
5167265|NCT01218048|12709300|P1|STARTED|Overall Study||40
5167266|NCT01218009|12709314|P2|NOT COMPLETED|Overall Study||165
5167267|NCT01218009|12709315|P1|NOT COMPLETED|Overall Study||166
5167268|NCT01218009|12709314|P2|COMPLETED|Overall Study||0
5167269|NCT01218009|12709315|P1|COMPLETED|Overall Study||0
5167270|NCT01218009|12709314|P2|STARTED|Overall Study||165
5167271|NCT01218009|12709315|P1|STARTED|Overall Study||166
5167272|NCT01217957|12709338|P5|NOT COMPLETED|Phase 2||1
5167273|NCT01217957|12709339|P4|NOT COMPLETED|Phase 2||0
5167274|NCT01217957|12709340|P3|NOT COMPLETED|Phase 2||0
5167275|NCT01217957|12709341|P2|NOT COMPLETED|Phase 2||0
5167276|NCT01217957|12709342|P1|NOT COMPLETED|Phase 2||0
5167277|NCT01217957|12709338|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
5167278|NCT01217957|12709339|P4|COMPLETED|Phase 2||0
5167279|NCT01217957|12709340|P3|COMPLETED|Phase 2||0
5167280|NCT01217957|12709341|P2|COMPLETED|Phase 2||0
5167281|NCT01217957|12709342|P1|COMPLETED|Phase 2||0
5167282|NCT01217957|12709338|P5|STARTED|Phase 2||50
5167283|NCT01217957|12709339|P4|STARTED|Phase 2||0
5167284|NCT01217957|12709340|P3|STARTED|Phase 2||0
5167285|NCT01217957|12709341|P2|STARTED|Phase 2||0
5167286|NCT01217957|12709342|P1|STARTED|Phase 2||0
5167287|NCT01217957|12709338|P5|NOT COMPLETED|Phase 1||0
5167288|NCT01217957|12709339|P4|NOT COMPLETED|Phase 1||1
5167289|NCT01217957|12709340|P3|NOT COMPLETED|Phase 1||1
5167290|NCT01217957|12709341|P2|NOT COMPLETED|Phase 1||0
5167291|NCT01217957|12709342|P1|NOT COMPLETED|Phase 1||1
5167292|NCT01217957|12709338|P5|COMPLETED|Phase 1||0
5167293|NCT01217957|12709339|P4|COMPLETED|Phase 1||2
5167294|NCT01217957|12709340|P3|COMPLETED|Phase 1||5
5167295|NCT01217957|12709341|P2|COMPLETED|Phase 1||3
5167296|NCT01217957|12709342|P1|COMPLETED|Phase 1||2
5167297|NCT01217957|12709338|P5|STARTED|Phase 1||0
5167298|NCT01217957|12709339|P4|STARTED|Phase 1||3
5167299|NCT01217957|12709340|P3|STARTED|Phase 1||6
5167300|NCT01217957|12709341|P2|STARTED|Phase 1||3
5167301|NCT01217957|12709342|P1|STARTED|Phase 1||3
5167302|NCT01217944|12709401|P3|NOT COMPLETED|Overall Study||0
5167303|NCT01217944|12709402|P2|NOT COMPLETED|Overall Study||4
5167304|NCT01217944|12709403|P1|NOT COMPLETED|Overall Study||6
5167305|NCT01217944|12709401|P3|COMPLETED|Overall Study||55
5167306|NCT01217944|12709402|P2|COMPLETED|Overall Study||112
5167307|NCT01217944|12709403|P1|COMPLETED|Overall Study||100
5167308|NCT01217944|12709401|P3|Completed 6 Months|Overall Study||55
5167309|NCT01217944|12709402|P2|Completed 6 Months|Overall Study||116
5167310|NCT01217944|12709403|P1|Completed 6 Months|Overall Study||103
5167311|NCT01217944|12709401|P3|Completed 3 Months|Overall Study||55
5167312|NCT01217944|12709402|P2|Completed 3 Months|Overall Study||116
5167313|NCT01217944|12709403|P1|Completed 3 Months|Overall Study||105
5167314|NCT01217944|12709401|P3|STARTED|Overall Study||55
5167315|NCT01217944|12709402|P2|STARTED|Overall Study||116
5167316|NCT01217944|12709403|P1|STARTED|Overall Study||106
5167317|NCT01217892|12709446|P4|NOT COMPLETED|Overall Study||8
5167318|NCT01217892|12709447|P3|NOT COMPLETED|Overall Study||9
5167319|NCT01217892|12709448|P2|NOT COMPLETED|Overall Study||6
5167320|NCT01217892|12709449|P1|NOT COMPLETED|Overall Study||7
5167321|NCT01217892|12709446|P4|COMPLETED|Overall Study||93
5167322|NCT01217892|12709447|P3|COMPLETED|Overall Study||90
5167323|NCT01217892|12709448|P2|COMPLETED|Overall Study||94
5167324|NCT01217892|12709449|P1|COMPLETED|Overall Study||93
5167325|NCT01217892|12709446|P4|STARTED|Overall Study||101
5167326|NCT01217892|12709447|P3|STARTED|Overall Study||99
5167327|NCT01217892|12709448|P2|STARTED|Overall Study||100
5167328|NCT01217892|12709449|P1|STARTED|Overall Study||100
5167329|NCT01217840|12709477|P2|NOT COMPLETED|Overall Study||3
5167330|NCT01217840|12709478|P1|NOT COMPLETED|Overall Study||6
5167331|NCT01217840|12709477|P2|COMPLETED|Overall Study||17
5167332|NCT01217840|12709478|P1|COMPLETED|Overall Study||14
5167333|NCT01217840|12709477|P2|STARTED|Overall Study||20
5167334|NCT01217840|12709478|P1|STARTED|Overall Study||20
5167335|NCT01217827|12709502|P2|NOT COMPLETED|Overall Study||0
5167336|NCT01217827|12709503|P1|NOT COMPLETED|Overall Study||0
5167337|NCT01217827|12709502|P2|COMPLETED|Overall Study||43
5167338|NCT01217827|12709503|P1|COMPLETED|Overall Study||46
5167339|NCT01217827|12709502|P2|STARTED|Overall Study||43
5167340|NCT01217827|12709503|P1|STARTED|Overall Study||46
5167341|NCT01217814|12709512|P3|NOT COMPLETED|Overall Study||1
5167342|NCT01217814|12709513|P2|NOT COMPLETED|Overall Study||1
5167343|NCT01217814|12709514|P1|NOT COMPLETED|Overall Study||1
5167344|NCT01217814|12709512|P3|COMPLETED|Overall Study||6
5167345|NCT01217814|12709513|P2|COMPLETED|Overall Study||4
5167346|NCT01217814|12709514|P1|COMPLETED|Overall Study||3
5167347|NCT01217814|12709512|P3|STARTED|Overall Study||7
5167348|NCT01217814|12709513|P2|STARTED|Overall Study||5
5167349|NCT01217814|12709514|P1|STARTED|Overall Study||4
5167350|NCT01217801|12709540|P2|NOT COMPLETED|Period 2||0
5167351|NCT01217801|12709541|P1|NOT COMPLETED|Period 2||0
5167352|NCT01217801|12709540|P2|COMPLETED|Period 2||22
5167353|NCT01217801|12709541|P1|COMPLETED|Period 2||23
5167354|NCT01217801|12709540|P2|STARTED|Period 2||22
5167355|NCT01217801|12709541|P1|STARTED|Period 2||23
5167356|NCT01217801|12709540|P2|NOT COMPLETED|Period 1||2
5167357|NCT01217801|12709541|P1|NOT COMPLETED|Period 1||1
5167358|NCT01217801|12709540|P2|COMPLETED|Period 1||22
5167359|NCT01217801|12709541|P1|COMPLETED|Period 1||23
5167360|NCT01217801|12709540|P2|STARTED|Period 1||24
5167361|NCT01217801|12709541|P1|STARTED|Period 1||24
5167362|NCT01217749|12709550|P3|NOT COMPLETED|Overall Study||2
5167363|NCT01217749|12709551|P2|NOT COMPLETED|Overall Study||3
5167364|NCT01217749|12709552|P1|NOT COMPLETED|Overall Study||3
5167365|NCT01217749|12709550|P3|COMPLETED|Overall Study||22
5167366|NCT01217749|12709551|P2|COMPLETED|Overall Study||17
5167367|NCT01217749|12709552|P1|COMPLETED|Overall Study||24
5167368|NCT01217749|12709550|P3|STARTED|Overall Study||24
5167369|NCT01217749|12709551|P2|STARTED|Overall Study||20
5167370|NCT01217749|12709552|P1|STARTED|Overall Study||27
5167371|NCT01217606|12709570|P2|NOT COMPLETED|9-Month Masked Extension||11
5167372|NCT01217606|12709571|P1|NOT COMPLETED|9-Month Masked Extension||13
5167373|NCT01217606|12709570|P2|COMPLETED|9-Month Masked Extension||62
5167374|NCT01217606|12709571|P1|COMPLETED|9-Month Masked Extension||54
5167375|NCT01217606|12709570|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
5167376|NCT01217606|12709571|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
5167377|NCT01217606|12709570|P2|STARTED|9-Month Masked Extension||73
5167378|NCT01217606|12709571|P1|STARTED|9-Month Masked Extension||67
5167379|NCT01217606|12709570|P2|NOT COMPLETED|Initial Treatment Phase||12
5167380|NCT01217606|12709571|P1|NOT COMPLETED|Initial Treatment Phase||14
5167381|NCT01217606|12709570|P2|COMPLETED|Initial Treatment Phase||83
5167382|NCT01217606|12709571|P1|COMPLETED|Initial Treatment Phase||76
5167383|NCT01217606|12709570|P2|STARTED|Initial Treatment Phase||95
5167384|NCT01217606|12709571|P1|STARTED|Initial Treatment Phase||90
5167385|NCT01217515|12709584|P3|NOT COMPLETED|Overall Study||10
5167386|NCT01217515|12709585|P2|NOT COMPLETED|Overall Study||8
5167387|NCT01217515|12709586|P1|NOT COMPLETED|Overall Study||7
5167388|NCT01217515|12709584|P3|COMPLETED|Overall Study||145
5167389|NCT01217515|12709585|P2|COMPLETED|Overall Study||148
5167390|NCT01217515|12709586|P1|COMPLETED|Overall Study||147
5167391|NCT01217515|12709584|P3|STARTED|Overall Study||155
5167392|NCT01217515|12709585|P2|STARTED|Overall Study||156
5167393|NCT01217515|12709586|P1|STARTED|Overall Study||154
5167394|NCT01217476|12709602|P2|NOT COMPLETED|Overall Study||7
5167395|NCT01217476|12709603|P1|NOT COMPLETED|Overall Study||12
5167396|NCT01217476|12709602|P2|COMPLETED|Overall Study||95
5167397|NCT01217476|12709603|P1|COMPLETED|Overall Study||93
5167398|NCT01217476|12709602|P2|STARTED|Overall Study||102
5167399|NCT01217476|12709603|P1|STARTED|Overall Study||105
5167400|NCT01217463|12709613|P2|NOT COMPLETED|Overall Study||8
5167401|NCT01217463|12709614|P1|NOT COMPLETED|Overall Study||13
5167402|NCT01217463|12709613|P2|COMPLETED|Overall Study||94
5167403|NCT01217463|12709614|P1|COMPLETED|Overall Study||86
5167404|NCT01217463|12709613|P2|STARTED|Overall Study||102
5167405|NCT01217463|12709614|P1|STARTED|Overall Study||99
5167406|NCT01217437|12709624|P2|NOT COMPLETED|Overall Study||41
5167407|NCT01217437|12709625|P1|NOT COMPLETED|Overall Study||43
5167408|NCT01217437|12709624|P2|COMPLETED|Overall Study||12
5167409|NCT01217437|12709625|P1|COMPLETED|Overall Study||12
5167410|NCT01217437|12709624|P2|STARTED|Overall Study||53
5167411|NCT01217437|12709625|P1|STARTED|Overall Study||55
5167412|NCT01217411|12709637|P2|NOT COMPLETED|Overall Study||2
5167413|NCT01217411|12709638|P1|NOT COMPLETED|Overall Study||3
5167414|NCT01217411|12709637|P2|COMPLETED|Overall Study||0
5167415|NCT01217411|12709638|P1|COMPLETED|Overall Study||0
5167416|NCT01217411|12709637|P2|20mg|Overall Study||0
5167417|NCT01217411|12709638|P1|20mg|Overall Study||0
5167418|NCT01217411|12709637|P2|10mg|Overall Study||0
5167419|NCT01217411|12709638|P1|10mg|Overall Study||0
5167420|NCT01217411|12709637|P2|5mg|Overall Study||2
5167421|NCT01217411|12709638|P1|5mg|Overall Study||3
5167422|NCT01217411|12709637|P2|STARTED|Overall Study||2
5167423|NCT01217411|12709638|P1|STARTED|Overall Study||3
5167424|NCT01217385|12709646|P1|NOT COMPLETED|Overall Study||26
5167425|NCT01217385|12709646|P1|COMPLETED|Overall Study||34
5167426|NCT01217385|12709646|P1|STARTED|Overall Study||60
5167427|NCT01217307|12709658|P2|NOT COMPLETED|Overall Study||1
5167428|NCT01217307|12709659|P1|NOT COMPLETED|Overall Study||0
5167429|NCT01217307|12709658|P2|COMPLETED|Overall Study||188
5167430|NCT01217307|12709659|P1|COMPLETED|Overall Study||191
5167431|NCT01217307|12709658|P2|STARTED|Overall Study||189
5167432|NCT01217307|12709659|P1|STARTED|Overall Study||191
5167433|NCT01217229|12709665|P1|NOT COMPLETED|Overall Study||20
5167434|NCT01217229|12709665|P1|COMPLETED|Overall Study||0
5167435|NCT01217229|12709665|P1|STARTED|Overall Study||20
5167436|NCT01217190|12709674|P2|NOT COMPLETED|Second Dosing||2
5167437|NCT01217190|12709675|P1|NOT COMPLETED|Second Dosing||0
5167438|NCT01217190|12709674|P2|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
5167439|NCT01217190|12709675|P1|COMPLETED|Second Dosing||24
5167440|NCT01217190|12709674|P2|STARTED|Second Dosing||24
5167441|NCT01217190|12709675|P1|STARTED|Second Dosing||24
5167442|NCT01217190|12709674|P2|NOT COMPLETED|First Dosing||0
5167443|NCT01217190|12709675|P1|NOT COMPLETED|First Dosing||0
5167444|NCT01217190|12709674|P2|COMPLETED|First Dosing||24
5167445|NCT01217190|12709675|P1|COMPLETED|First Dosing||24
5167446|NCT01217190|12709674|P2|STARTED|First Dosing||24
5167447|NCT01217190|12709675|P1|STARTED|First Dosing||24
5167448|NCT01217112|12709690|P5|NOT COMPLETED|Overall Study||1
5167449|NCT01217112|12709691|P4|NOT COMPLETED|Overall Study||2
5167450|NCT01217112|12709692|P3|NOT COMPLETED|Overall Study||1
5167451|NCT01217112|12709693|P2|NOT COMPLETED|Overall Study||2
5167452|NCT01217112|12709694|P1|NOT COMPLETED|Overall Study||0
5167453|NCT01217112|12709690|P5|COMPLETED|Overall Study||13
5167454|NCT01217112|12709691|P4|COMPLETED|Overall Study||10
5167455|NCT01217112|12709692|P3|COMPLETED|Overall Study||12
5167456|NCT01217112|12709693|P2|COMPLETED|Overall Study||10
5167457|NCT01217112|12709694|P1|COMPLETED|Overall Study||11
5167458|NCT01217112|12709690|P5|STARTED|Overall Study||14
5167459|NCT01217112|12709691|P4|STARTED|Overall Study||12
5167460|NCT01217112|12709692|P3|STARTED|Overall Study||13
5167461|NCT01217112|12709693|P2|STARTED|Overall Study||12
5167462|NCT01217112|12709694|P1|STARTED|Overall Study||11
5167463|NCT01217073|12709927|P8|NOT COMPLETED|Extension Period||20
5167464|NCT01217073|12709928|P7|NOT COMPLETED|Extension Period||91
5167465|NCT01217073|12709929|P6|NOT COMPLETED|Extension Period||0
5167466|NCT01217073|12709930|P5|NOT COMPLETED|Extension Period||0
5167467|NCT01217073|12709931|P4|NOT COMPLETED|Extension Period||0
5167468|NCT01217073|12709932|P3|NOT COMPLETED|Extension Period||0
5167469|NCT01217073|12709933|P2|NOT COMPLETED|Extension Period||0
5167470|NCT01217073|12709934|P1|NOT COMPLETED|Extension Period||0
5167471|NCT01217073|12709927|P8|COMPLETED|Extension Period||60
5167472|NCT01217073|12709928|P7|COMPLETED|Extension Period||314
5167473|NCT01217073|12709929|P6|COMPLETED|Extension Period||0
5167474|NCT01217073|12709930|P5|COMPLETED|Extension Period||0
5167475|NCT01217073|12709931|P4|COMPLETED|Extension Period||0
5167476|NCT01217073|12709932|P3|COMPLETED|Extension Period||0
5167477|NCT01217073|12709933|P2|COMPLETED|Extension Period||0
5167478|NCT01217073|12709934|P1|COMPLETED|Extension Period||0
5167479|NCT01217073|12709927|P8|STARTED|Extension Period||80
5167480|NCT01217073|12709928|P7|STARTED|Extension Period||405
5167481|NCT01217073|12709929|P6|STARTED|Extension Period||0
5167482|NCT01217073|12709930|P5|STARTED|Extension Period||0
5167483|NCT01217073|12709931|P4|STARTED|Extension Period||0
5167484|NCT01217073|12709932|P3|STARTED|Extension Period||0
5167485|NCT01217073|12709933|P2|STARTED|Extension Period||0
5167486|NCT01217073|12709934|P1|STARTED|Extension Period||0
5167487|NCT01217073|12709927|P8|NOT COMPLETED|Base Period||0
5167488|NCT01217073|12709928|P7|NOT COMPLETED|Base Period||0
5167489|NCT01217073|12709929|P6|NOT COMPLETED|Base Period||9
5167490|NCT01217073|12709930|P5|NOT COMPLETED|Base Period||15
5167491|NCT01217073|12709931|P4|NOT COMPLETED|Base Period||2
5167492|NCT01217073|12709932|P3|NOT COMPLETED|Base Period||7
5167493|NCT01217073|12709933|P2|NOT COMPLETED|Base Period||5
5167494|NCT01217073|12709934|P1|NOT COMPLETED|Base Period||7
5167495|NCT01217073|12709927|P8|COMPLETED|Base Period||0
5167496|NCT01217073|12709928|P7|COMPLETED|Base Period||0
5167497|NCT01217073|12709929|P6|COMPLETED|Base Period||105
5167498|NCT01217073|12709930|P5|COMPLETED|Base Period||99
5167499|NCT01217073|12709931|P4|COMPLETED|Base Period||113
5167500|NCT01217073|12709932|P3|COMPLETED|Base Period||107
5167501|NCT01217073|12709933|P2|COMPLETED|Base Period||110
5167502|NCT01217073|12709934|P1|COMPLETED|Base Period||106
5167503|NCT01217073|12709927|P8|STARTED|Base Period||0
5167504|NCT01217073|12709928|P7|STARTED|Base Period||0
5167505|NCT01217073|12709929|P6|STARTED|Base Period||114
5167506|NCT01217073|12709930|P5|STARTED|Base Period||114
5167507|NCT01217073|12709931|P4|STARTED|Base Period||115
5167508|NCT01217073|12709932|P3|STARTED|Base Period||114
5167509|NCT01217073|12709933|P2|STARTED|Base Period||115
5167510|NCT01217073|12709934|P1|STARTED|Base Period||113
5167511|NCT01216943|12710002|P1|NOT COMPLETED|Overall Study||13
5167512|NCT01216943|12710002|P1|COMPLETED|Overall Study||113
5167513|NCT01216943|12710002|P1|STARTED|Overall Study||126
5167514|NCT01216761|12710006|P3|NOT COMPLETED|Overall Study||0
5167515|NCT01216761|12710007|P2|NOT COMPLETED|Overall Study||0
5167516|NCT01216761|12710008|P1|NOT COMPLETED|Overall Study||0
5167517|NCT01216761|12710006|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
5167518|NCT01216761|12710007|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
5167519|NCT01216761|12710008|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
5167520|NCT01216761|12710006|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
5167521|NCT01216761|12710007|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
5167522|NCT01216761|12710008|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
5167523|NCT01216748|12710016|P1|NOT COMPLETED|Overall Study||0
5167524|NCT01216748|12710016|P1|COMPLETED|Overall Study||10
5167525|NCT01216748|12710016|P1|Eucapnic Hyperventilation|Overall Study||10
5167526|NCT01216748|12710016|P1|Hypercapnic Hyperventilation|Overall Study||10
5167527|NCT01216748|12710016|P1|Hypocapnic Hyperventilation|Overall Study||10
5167528|NCT01216748|12710016|P1|Quiet Breathing|Overall Study||10
5167529|NCT01216748|12710016|P1|STARTED|Overall Study||10
5167530|NCT01216735|12710023|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5167531|NCT01216735|12710024|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
5167532|NCT01216735|12710023|P2|COMPLETED|Second Intervention (3 Weeks)||7
5167533|NCT01216735|12710024|P1|COMPLETED|Second Intervention (3 Weeks)||8
5167534|NCT01216735|12710023|P2|STARTED|Second Intervention (3 Weeks)||7
5167535|NCT01216735|12710024|P1|STARTED|Second Intervention (3 Weeks)||8
5167536|NCT01216735|12710023|P2|NOT COMPLETED|Washout (3 Weeks)||0
5167537|NCT01216735|12710024|P1|NOT COMPLETED|Washout (3 Weeks)||0
5167538|NCT01216735|12710023|P2|COMPLETED|Washout (3 Weeks)||7
5167539|NCT01216735|12710024|P1|COMPLETED|Washout (3 Weeks)||8
5167540|NCT01216735|12710023|P2|STARTED|Washout (3 Weeks)||7
5167541|NCT01216735|12710024|P1|STARTED|Washout (3 Weeks)||8
5167542|NCT01216735|12710023|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
5167543|NCT01216735|12710024|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
5167544|NCT01216735|12710023|P2|COMPLETED|First Intervention (3 Weeks)||7
5167545|NCT01216735|12710024|P1|COMPLETED|First Intervention (3 Weeks)||8
5167546|NCT01216735|12710023|P2|STARTED|First Intervention (3 Weeks)||7
5167547|NCT01216735|12710024|P1|STARTED|First Intervention (3 Weeks)||8
5167548|NCT01216631|12710035|P3|NOT COMPLETED|Overall Study||0
5167549|NCT01216631|12710036|P2|NOT COMPLETED|Overall Study||0
5167550|NCT01216631|12710037|P1|NOT COMPLETED|Overall Study||0
5167551|NCT01216631|12710035|P3|COMPLETED|Overall Study||1
5167552|NCT01216631|12710036|P2|COMPLETED|Overall Study||0
5167553|NCT01216631|12710037|P1|COMPLETED|Overall Study||0
5167554|NCT01216631|12710035|P3|STARTED|Overall Study||1
5167555|NCT01216631|12710036|P2|STARTED|Overall Study||0
5167556|NCT01216631|12710037|P1|STARTED|Overall Study||0
5167557|NCT01216410|12710048|P3|NOT COMPLETED|Overall Study||3
5167558|NCT01216410|12710049|P2|NOT COMPLETED|Overall Study||1
5167559|NCT01216410|12710050|P1|NOT COMPLETED|Overall Study||2
5167560|NCT01216410|12710048|P3|COMPLETED|Overall Study||100
5167561|NCT01216410|12710049|P2|COMPLETED|Overall Study||99
5167562|NCT01216410|12710050|P1|COMPLETED|Overall Study||101
5167563|NCT01216410|12710048|P3|STARTED|Overall Study||103
5167564|NCT01216410|12710049|P2|STARTED|Overall Study||100
5167565|NCT01216410|12710050|P1|STARTED|Overall Study||103
5167566|NCT01216397|12710070|P2|NOT COMPLETED|Period 2||0
5167567|NCT01216397|12710071|P1|NOT COMPLETED|Period 2||0
5167568|NCT01216397|12710070|P2|COMPLETED|Period 2||20
5167569|NCT01216397|12710071|P1|COMPLETED|Period 2||20
5167570|NCT01216397|12710070|P2|STARTED|Period 2||20
5167571|NCT01216397|12710071|P1|STARTED|Period 2||20
5167572|NCT01216397|12710070|P2|NOT COMPLETED|Washout (35 Days)||0
5167573|NCT01216397|12710071|P1|NOT COMPLETED|Washout (35 Days)||0
5167574|NCT01216397|12710070|P2|COMPLETED|Washout (35 Days)||20
5167575|NCT01216397|12710071|P1|COMPLETED|Washout (35 Days)||20
5167576|NCT01216397|12710070|P2|STARTED|Washout (35 Days)||20
5167577|NCT01216397|12710071|P1|STARTED|Washout (35 Days)||20
5167578|NCT01216397|12710070|P2|NOT COMPLETED|Period 1||0
5167579|NCT01216397|12710071|P1|NOT COMPLETED|Period 1||0
5167580|NCT01216397|12710070|P2|COMPLETED|Period 1||20
5167581|NCT01216397|12710071|P1|COMPLETED|Period 1||20
5167582|NCT01216397|12710070|P2|STARTED|Period 1||20
5167583|NCT01216397|12710071|P1|STARTED|Period 1||20
5167584|NCT01216332|12710125|P2|NOT COMPLETED|Overall Study||0
5167585|NCT01216332|12710126|P1|NOT COMPLETED|Overall Study||4
5167586|NCT01216332|12710125|P2|COMPLETED|Overall Study||16
5167587|NCT01216332|12710126|P1|COMPLETED|Overall Study||30
5167588|NCT01216332|12710125|P2|STARTED|Overall Study||16
5167589|NCT01216332|12710126|P1|STARTED|Overall Study||34
5167590|NCT01216319|12710144|P1|NOT COMPLETED|Overall Study||4
5167591|NCT01216319|12710144|P1|COMPLETED|Overall Study||46
5167592|NCT01216319|12710144|P1|STARTED|Overall Study||50
5167593|NCT01216241|12710151|P2|NOT COMPLETED|Overall Study||0
5167594|NCT01216241|12710152|P1|NOT COMPLETED|Overall Study||0
5167595|NCT01216241|12710151|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
5167596|NCT01216241|12710152|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
5167597|NCT01216241|12710151|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
5167598|NCT01216241|12710152|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
5167599|NCT01216176|12710161|P3|NOT COMPLETED|Overall Study||1
5167600|NCT01216176|12710162|P2|NOT COMPLETED|Overall Study||8
5167601|NCT01216176|12710163|P1|NOT COMPLETED|Overall Study||0
5167602|NCT01216176|12710161|P3|COMPLETED|Overall Study||19
5167603|NCT01216176|12710162|P2|COMPLETED|Overall Study||31
5167604|NCT01216176|12710163|P1|COMPLETED|Overall Study||12
5167605|NCT01216176|12710161|P3|STARTED|Overall Study||20
5167606|NCT01216176|12710162|P2|STARTED|Overall Study||39
5167607|NCT01216176|12710163|P1|STARTED|Overall Study||12
5167608|NCT01216163|12710186|P3|NOT COMPLETED|Overall Study||0
5167609|NCT01216163|12710187|P2|NOT COMPLETED|Overall Study||1
5167610|NCT01216163|12710188|P1|NOT COMPLETED|Overall Study||1
5167611|NCT01216163|12710186|P3|COMPLETED|Overall Study||85
5167612|NCT01216163|12710187|P2|COMPLETED|Overall Study||87
5167613|NCT01216163|12710188|P1|COMPLETED|Overall Study||44
5167614|NCT01216163|12710186|P3|STARTED|Overall Study||85
5167615|NCT01216163|12710187|P2|STARTED|Overall Study||88
5167616|NCT01216163|12710188|P1|STARTED|Overall Study||45
5167617|NCT01216072|12710240|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
5167618|NCT01216072|12710241|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
5167619|NCT01216072|12710240|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
5167620|NCT01216072|12710241|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
5167621|NCT01216072|12710240|P2|Safety Set|Open-Label Extension Period (3 Months)||193
5167622|NCT01216072|12710241|P1|Safety Set|Open-Label Extension Period (3 Months)||0
5167623|NCT01216072|12710240|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
5167624|NCT01216072|12710241|P1|STARTED|Open-Label Extension Period (3 Months)||0
5167625|NCT01216072|12710240|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
5167626|NCT01216072|12710241|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
5167627|NCT01216072|12710240|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
5167628|NCT01216072|12710241|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
5167629|NCT01216072|12710240|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
5167630|NCT01216072|12710241|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
5167631|NCT01216072|12710240|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
5167632|NCT01216072|12710241|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
5167633|NCT01216072|12710240|P2|STARTED|Open-Label Core Period ( 6 Months)||263
5167634|NCT01216072|12710241|P1|STARTED|Open-Label Core Period ( 6 Months)||790
5167635|NCT01215981|12710269|P2|NOT COMPLETED|Overall Study||1
5167636|NCT01215981|12710270|P1|NOT COMPLETED|Overall Study||2
5167637|NCT01215981|12710269|P2|COMPLETED|Overall Study||32
5167638|NCT01215981|12710270|P1|COMPLETED|Overall Study||33
5167639|NCT01215981|12710269|P2|STARTED|Overall Study||33
5167640|NCT01215981|12710270|P1|STARTED|Overall Study||35
5167641|NCT01215968|12710280|P2|NOT COMPLETED|Overall Study||7
5167642|NCT01215968|12710281|P1|NOT COMPLETED|Overall Study||2
5167643|NCT01215968|12710280|P2|COMPLETED|Overall Study||18
5167644|NCT01215968|12710281|P1|COMPLETED|Overall Study||11
5167645|NCT01215968|12710280|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
5167646|NCT01215968|12710281|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
5167647|NCT01215968|12710280|P2|STARTED|Overall Study||25
5167648|NCT01215968|12710281|P1|STARTED|Overall Study||13
5167649|NCT01215955|12710301|P4|NOT COMPLETED|Overall Study||53
5167650|NCT01215955|12710302|P3|NOT COMPLETED|Overall Study||48
5167651|NCT01215955|12710303|P2|NOT COMPLETED|Overall Study||53
5167652|NCT01215955|12710304|P1|NOT COMPLETED|Overall Study||45
5167653|NCT01215955|12710301|P4|COMPLETED|Overall Study||241
5167654|NCT01215955|12710302|P3|COMPLETED|Overall Study||244
5167655|NCT01215955|12710303|P2|COMPLETED|Overall Study||210
5167656|NCT01215955|12710304|P1|COMPLETED|Overall Study||223
5167657|NCT01215955|12710301|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
5167658|NCT01215955|12710302|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
5167659|NCT01215955|12710303|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
5167660|NCT01215955|12710304|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
5167661|NCT01215955|12710301|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
5167662|NCT01215955|12710302|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
5167663|NCT01215955|12710303|P2|STARTED|Overall Study||263
5167664|NCT01215955|12710304|P1|STARTED|Overall Study||268
5167665|NCT01215942|12710372|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
5167666|NCT01215942|12710373|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
5167667|NCT01215942|12710372|P2|COMPLETED|Post-Treatment Follow-Up Period||445
5167668|NCT01215942|12710373|P1|COMPLETED|Post-Treatment Follow-Up Period||283
5167669|NCT01215942|12710372|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
5167670|NCT01215942|12710373|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
5167671|NCT01215942|12710372|P2|NOT COMPLETED|Treatment Period||672
5167672|NCT01215942|12710373|P1|NOT COMPLETED|Treatment Period||414
5167673|NCT01215942|12710372|P2|COMPLETED|Treatment Period||0
5167674|NCT01215942|12710373|P1|COMPLETED|Treatment Period||0
5167675|NCT01215942|12710372|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
5167676|NCT01215942|12710373|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
5167677|NCT01215929|12710490|P2|NOT COMPLETED|Overall Study||5
5167678|NCT01215929|12710491|P1|NOT COMPLETED|Overall Study||6
5167679|NCT01215929|12710490|P2|COMPLETED|Overall Study||12
5167680|NCT01215929|12710491|P1|COMPLETED|Overall Study||12
5167681|NCT01215929|12710490|P2|STARTED|Overall Study||17
5167682|NCT01215929|12710491|P1|STARTED|Overall Study||18
5167683|NCT01215916|12710506|P9|NOT COMPLETED|Overall Study||2
5167684|NCT01215916|12710507|P8|NOT COMPLETED|Overall Study||3
5167685|NCT01215916|12710508|P7|NOT COMPLETED|Overall Study||9
5167686|NCT01215916|12710509|P6|NOT COMPLETED|Overall Study||4
5167687|NCT01215916|12710510|P5|NOT COMPLETED|Overall Study||6
5167688|NCT01215916|12710511|P4|NOT COMPLETED|Overall Study||6
5167689|NCT01215916|12710512|P3|NOT COMPLETED|Overall Study||3
5167690|NCT01215916|12710513|P2|NOT COMPLETED|Overall Study||5
5167691|NCT01215916|12710514|P1|NOT COMPLETED|Overall Study||1
5167692|NCT01215916|12710506|P9|COMPLETED|Overall Study||0
5167693|NCT01215916|12710507|P8|COMPLETED|Overall Study||0
5167694|NCT01215916|12710508|P7|COMPLETED|Overall Study||0
5167695|NCT01215916|12710509|P6|COMPLETED|Overall Study||0
5167696|NCT01215916|12710510|P5|COMPLETED|Overall Study||0
5167697|NCT01215916|12710511|P4|COMPLETED|Overall Study||0
5167698|NCT01215916|12710512|P3|COMPLETED|Overall Study||0
5167699|NCT01215916|12710513|P2|COMPLETED|Overall Study||0
5167700|NCT01215916|12710514|P1|COMPLETED|Overall Study||0
5167701|NCT01215916|12710506|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
5167702|NCT01215916|12710507|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
5167703|NCT01215916|12710508|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
5167704|NCT01215916|12710509|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
5167705|NCT01215916|12710510|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
5167706|NCT01215916|12710511|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
5167707|NCT01215916|12710512|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
5167708|NCT01215916|12710513|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
5167709|NCT01215916|12710514|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
5167710|NCT01215916|12710506|P9|STARTED|Overall Study||2
5167711|NCT01215916|12710507|P8|STARTED|Overall Study||3
5167712|NCT01215916|12710508|P7|STARTED|Overall Study||9
5167713|NCT01215916|12710509|P6|STARTED|Overall Study||4
5167714|NCT01215916|12710510|P5|STARTED|Overall Study||6
5167715|NCT01215916|12710511|P4|STARTED|Overall Study||6
5167716|NCT01215916|12710512|P3|STARTED|Overall Study||3
5167717|NCT01215916|12710513|P2|STARTED|Overall Study||5
5167718|NCT01215916|12710514|P1|STARTED|Overall Study||1
5167719|NCT01215851|12710548|P6|NOT COMPLETED|Follow up Period||1
5167720|NCT01215851|12710549|P5|NOT COMPLETED|Follow up Period||0
5167721|NCT01215851|12710550|P4|NOT COMPLETED|Follow up Period||0
5167722|NCT01215851|12710551|P3|NOT COMPLETED|Follow up Period||0
5167723|NCT01215851|12710552|P2|NOT COMPLETED|Follow up Period||0
5167724|NCT01215851|12710553|P1|NOT COMPLETED|Follow up Period||0
5167725|NCT01215851|12710548|P6|COMPLETED|Follow up Period||13
5167726|NCT01215851|12710549|P5|COMPLETED|Follow up Period||10
5167727|NCT01215851|12710550|P4|COMPLETED|Follow up Period||12
5167728|NCT01215851|12710551|P3|COMPLETED|Follow up Period||14
5167729|NCT01215851|12710552|P2|COMPLETED|Follow up Period||14
5167730|NCT01215851|12710553|P1|COMPLETED|Follow up Period||14
5167731|NCT01215851|12710548|P6|STARTED|Follow up Period||14
5167732|NCT01215851|12710549|P5|STARTED|Follow up Period||10
5167733|NCT01215851|12710550|P4|STARTED|Follow up Period||12
5167734|NCT01215851|12710551|P3|STARTED|Follow up Period||14
5167735|NCT01215851|12710552|P2|STARTED|Follow up Period||14
5167736|NCT01215851|12710553|P1|STARTED|Follow up Period||14
5167737|NCT01215851|12710548|P6|NOT COMPLETED|Treatment Period||1
5167738|NCT01215851|12710549|P5|NOT COMPLETED|Treatment Period||0
5167739|NCT01215851|12710550|P4|NOT COMPLETED|Treatment Period||3
5167740|NCT01215851|12710551|P3|NOT COMPLETED|Treatment Period||1
5167741|NCT01215851|12710552|P2|NOT COMPLETED|Treatment Period||1
5167742|NCT01215851|12710553|P1|NOT COMPLETED|Treatment Period||1
5167743|NCT01215851|12710548|P6|COMPLETED|Treatment Period||14
5167744|NCT01215851|12710549|P5|COMPLETED|Treatment Period||10
5167745|NCT01215851|12710550|P4|COMPLETED|Treatment Period||12
5167746|NCT01215851|12710551|P3|COMPLETED|Treatment Period||14
5167747|NCT01215851|12710552|P2|COMPLETED|Treatment Period||14
5167748|NCT01215851|12710553|P1|COMPLETED|Treatment Period||14
5167749|NCT01215851|12710548|P6|STARTED|Treatment Period||15
5167750|NCT01215851|12710549|P5|STARTED|Treatment Period||10
5167751|NCT01215851|12710550|P4|STARTED|Treatment Period||15
5167752|NCT01215851|12710551|P3|STARTED|Treatment Period||15
5167753|NCT01215851|12710552|P2|STARTED|Treatment Period||15
5167754|NCT01215851|12710553|P1|STARTED|Treatment Period||15
5167755|NCT01215786|12710594|P3|NOT COMPLETED|Overall Study||0
5167756|NCT01215786|12710595|P2|NOT COMPLETED|Overall Study||0
5167757|NCT01215786|12710596|P1|NOT COMPLETED|Overall Study||0
5167758|NCT01215786|12710594|P3|COMPLETED|Overall Study||10
5167759|NCT01215786|12710595|P2|COMPLETED|Overall Study||19
5167760|NCT01215786|12710596|P1|COMPLETED|Overall Study||21
5167761|NCT01215786|12710594|P3|STARTED|Overall Study||10
5167762|NCT01215786|12710595|P2|STARTED|Overall Study||19
5167763|NCT01215786|12710596|P1|STARTED|Overall Study||21
5167764|NCT01215734|12710612|P2|NOT COMPLETED|Overall Study||1
5167765|NCT01215734|12710613|P1|NOT COMPLETED|Overall Study||0
5167766|NCT01215734|12710612|P2|COMPLETED|Overall Study||14
5167767|NCT01215734|12710613|P1|COMPLETED|Overall Study||29
5167768|NCT01215734|12710612|P2|STARTED|Overall Study||15
5167769|NCT01215734|12710613|P1|STARTED|Overall Study||29
5167770|NCT01215721|12710621|P1|NOT COMPLETED|Overall Study||2
5167771|NCT01215721|12710621|P1|COMPLETED|Overall Study||38
5167772|NCT01215721|12710621|P1|STARTED|Overall Study||40
5167773|NCT01215695|12710627|P2|NOT COMPLETED|Overall Study||0
5167774|NCT01215695|12710628|P1|NOT COMPLETED|Overall Study||0
5167775|NCT01215695|12710627|P2|COMPLETED|Overall Study||70
5167776|NCT01215695|12710628|P1|COMPLETED|Overall Study||70
5167777|NCT01215695|12710627|P2|STARTED|Overall Study||70
5167778|NCT01215695|12710628|P1|STARTED|Overall Study||70
5167779|NCT01215643|12710647|P5|NOT COMPLETED|Overall Study||11
5167780|NCT01215643|12710648|P4|NOT COMPLETED|Overall Study||4
5167781|NCT01215643|12710649|P3|NOT COMPLETED|Overall Study||12
5167782|NCT01215643|12710650|P2|NOT COMPLETED|Overall Study||4
5167783|NCT01215643|12710651|P1|NOT COMPLETED|Overall Study||9
5167784|NCT01215643|12710647|P5|COMPLETED|Overall Study||29
5167785|NCT01215643|12710648|P4|COMPLETED|Overall Study||35
5167786|NCT01215643|12710649|P3|COMPLETED|Overall Study||82
5167787|NCT01215643|12710650|P2|COMPLETED|Overall Study||80
5167788|NCT01215643|12710651|P1|COMPLETED|Overall Study||74
5167789|NCT01215643|12710647|P5|STARTED|Overall Study||40
5167790|NCT01215643|12710648|P4|STARTED|Overall Study||39
5167791|NCT01215643|12710649|P3|STARTED|Overall Study||94
5167792|NCT01215643|12710650|P2|STARTED|Overall Study||84
5167793|NCT01215643|12710651|P1|STARTED|Overall Study||83
5167794|NCT01215513|12710753|P1|NOT COMPLETED|Overall Study||45
5167795|NCT01215513|12710753|P1|COMPLETED|Overall Study||112
5167796|NCT01215513|12710753|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
5167797|NCT01215513|12710753|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
5167798|NCT01215513|12710753|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
5167799|NCT01215513|12710753|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
5167800|NCT01215435|12710762|P2|NOT COMPLETED|Overall Study||16
5167801|NCT01215435|12710763|P1|NOT COMPLETED|Overall Study||19
5167802|NCT01215435|12710762|P2|COMPLETED|Overall Study||107
5167803|NCT01215435|12710763|P1|COMPLETED|Overall Study||103
5167804|NCT01215435|12710762|P2|STARTED|Overall Study||123
5167805|NCT01215435|12710763|P1|STARTED|Overall Study||122
5167806|NCT01215422|12710777|P4|NOT COMPLETED|Overall Study||8
5167807|NCT01215422|12710778|P3|NOT COMPLETED|Overall Study||3
5167808|NCT01215422|12710779|P2|NOT COMPLETED|Overall Study||0
5167809|NCT01215422|12710780|P1|NOT COMPLETED|Overall Study||8
5167810|NCT01215422|12710777|P4|COMPLETED|Overall Study||193
5167811|NCT01215422|12710778|P3|COMPLETED|Overall Study||193
5167812|NCT01215422|12710779|P2|COMPLETED|Overall Study||249
5167813|NCT01215422|12710780|P1|COMPLETED|Overall Study||6
5167814|NCT01215422|12710777|P4|STARTED|Overall Study||201
5167815|NCT01215422|12710778|P3|STARTED|Overall Study||196
5167816|NCT01215422|12710779|P2|STARTED|Overall Study||249
5167817|NCT01215422|12710780|P1|STARTED|Overall Study||14
5167818|NCT01215357|12710802|P1|NOT COMPLETED|Overall Study||12
5167819|NCT01215357|12710802|P1|COMPLETED|Overall Study||22
5167820|NCT01215357|12710802|P1|STARTED|Overall Study||34
5167821|NCT01215344|12710808|P2|NOT COMPLETED|Overall Study||0
5167822|NCT01215344|12710809|P1|NOT COMPLETED|Overall Study||10
5167823|NCT01215344|12710808|P2|COMPLETED|Overall Study||3
5167824|NCT01215344|12710809|P1|COMPLETED|Overall Study||23
5167825|NCT01215344|12710808|P2|STARTED|Overall Study||3
5167826|NCT01215344|12710809|P1|STARTED|Overall Study||33
5167827|NCT01215318|12710819|P2|NOT COMPLETED|Overall Study||0
5167828|NCT01215318|12710820|P1|NOT COMPLETED|Overall Study||0
5167829|NCT01215318|12710819|P2|COMPLETED|Overall Study||24
5167830|NCT01215318|12710820|P1|COMPLETED|Overall Study||20
5167831|NCT01215318|12710819|P2|STARTED|Overall Study||24
5167832|NCT01215318|12710820|P1|STARTED|Overall Study||20
5167833|NCT01215292|12710833|P5|NOT COMPLETED|Overall Study||0
5167834|NCT01215292|12710834|P4|NOT COMPLETED|Overall Study||0
5167835|NCT01215292|12710835|P3|NOT COMPLETED|Overall Study||0
5167836|NCT01215292|12710836|P2|NOT COMPLETED|Overall Study||0
5167837|NCT01215292|12710837|P1|NOT COMPLETED|Overall Study||0
5167838|NCT01215292|12710833|P5|COMPLETED|Overall Study||8
5167839|NCT01215292|12710834|P4|COMPLETED|Overall Study||8
5167840|NCT01215292|12710835|P3|COMPLETED|Overall Study||8
5167841|NCT01215292|12710836|P2|COMPLETED|Overall Study||8
5167842|NCT01215292|12710837|P1|COMPLETED|Overall Study||8
5167843|NCT01215292|12710833|P5|STARTED|Overall Study||8
5167844|NCT01215292|12710834|P4|STARTED|Overall Study||8
5167845|NCT01215292|12710835|P3|STARTED|Overall Study||8
5167846|NCT01215292|12710836|P2|STARTED|Overall Study||8
5167847|NCT01215292|12710837|P1|STARTED|Overall Study||8
5167848|NCT01215279|12710861|P2|NOT COMPLETED|Overall Study||0
5167849|NCT01215279|12710862|P1|NOT COMPLETED|Overall Study||0
5167850|NCT01215279|12710861|P2|COMPLETED|Overall Study||32
5167851|NCT01215279|12710862|P1|COMPLETED|Overall Study||31
5167852|NCT01215279|12710861|P2|STARTED|Overall Study||32
5167853|NCT01215279|12710862|P1|STARTED|Overall Study||31
5167854|NCT01215253|12710928|P2|NOT COMPLETED|Overall Study||63
5167855|NCT01215253|12710929|P1|NOT COMPLETED|Overall Study||86
5167856|NCT01215253|12710928|P2|COMPLETED|Overall Study||439
5167857|NCT01215253|12710929|P1|COMPLETED|Overall Study||424
5167858|NCT01215253|12710928|P2|STARTED|Overall Study||502
5167859|NCT01215253|12710929|P1|STARTED|Overall Study||510
5167860|NCT01215240|12710959|P2|NOT COMPLETED|Overall Study||0
5167861|NCT01215240|12710960|P1|NOT COMPLETED|Overall Study||0
5167862|NCT01215240|12710959|P2|COMPLETED|Overall Study||12
5167863|NCT01215240|12710960|P1|COMPLETED|Overall Study||10
5167864|NCT01215240|12710959|P2|STARTED|Overall Study||12
5167865|NCT01215240|12710960|P1|STARTED|Overall Study||10
5167866|NCT01215227|12710982|P6|NOT COMPLETED|Overall Study||58
5167867|NCT01215227|12710983|P5|NOT COMPLETED|Overall Study||48
5167868|NCT01215227|12710984|P4|NOT COMPLETED|Overall Study||49
5167869|NCT01215227|12710985|P3|NOT COMPLETED|Overall Study||57
5167870|NCT01215227|12710986|P2|NOT COMPLETED|Overall Study||119
5167871|NCT01215227|12710987|P1|NOT COMPLETED|Overall Study||121
5167872|NCT01215227|12710982|P6|COMPLETED|Overall Study||51
5167873|NCT01215227|12710983|P5|COMPLETED|Overall Study||45
5167874|NCT01215227|12710984|P4|COMPLETED|Overall Study||48
5167875|NCT01215227|12710985|P3|COMPLETED|Overall Study||50
5167876|NCT01215227|12710986|P2|COMPLETED|Overall Study||96
5167877|NCT01215227|12710987|P1|COMPLETED|Overall Study||97
5167878|NCT01215227|12710982|P6|Treated|Overall Study||108
5167879|NCT01215227|12710983|P5|Treated|Overall Study||93
5167880|NCT01215227|12710984|P4|Treated|Overall Study||96
5167881|NCT01215227|12710985|P3|Treated|Overall Study||106
5167882|NCT01215227|12710986|P2|Treated|Overall Study||215
5167883|NCT01215227|12710987|P1|Treated|Overall Study||218
5167884|NCT01215227|12710982|P6|STARTED|Overall Study||109
5167885|NCT01215227|12710983|P5|STARTED|Overall Study||93
5167886|NCT01215227|12710984|P4|STARTED|Overall Study||97
5167887|NCT01215227|12710985|P3|STARTED|Overall Study||107
5167888|NCT01215227|12710986|P2|STARTED|Overall Study||215
5167889|NCT01215227|12710987|P1|STARTED|Overall Study||218
5167890|NCT01215188|12711034|P3|NOT COMPLETED|Overall Study||52
5167891|NCT01215188|12711035|P2|NOT COMPLETED|Overall Study||59
5167892|NCT01215188|12711036|P1|NOT COMPLETED|Overall Study||58
5167893|NCT01215188|12711034|P3|COMPLETED|Overall Study||326
5167894|NCT01215188|12711035|P2|COMPLETED|Overall Study||327
5167895|NCT01215188|12711036|P1|COMPLETED|Overall Study||320
5167896|NCT01215188|12711034|P3|STARTED|Overall Study||378
5167897|NCT01215188|12711035|P2|STARTED|Overall Study||386
5167898|NCT01215188|12711036|P1|STARTED|Overall Study||378
5167899|NCT01215175|12711088|P5|NOT COMPLETED|Overall Study||0
5167900|NCT01215175|12711089|P4|NOT COMPLETED|Overall Study||1
5167901|NCT01215175|12711090|P3|NOT COMPLETED|Overall Study||0
5167902|NCT01215175|12711091|P2|NOT COMPLETED|Overall Study||1
5167903|NCT01215175|12711092|P1|NOT COMPLETED|Overall Study||0
5167904|NCT01215175|12711088|P5|COMPLETED|Overall Study||28
5167905|NCT01215175|12711089|P4|COMPLETED|Overall Study||28
5167906|NCT01215175|12711090|P3|COMPLETED|Overall Study||33
5167907|NCT01215175|12711091|P2|COMPLETED|Overall Study||29
5167908|NCT01215175|12711092|P1|COMPLETED|Overall Study||30
5167909|NCT01215175|12711088|P5|Treated|Overall Study||28
5167910|NCT01215175|12711089|P4|Treated|Overall Study||29
5167911|NCT01215175|12711090|P3|Treated|Overall Study||33
5167912|NCT01215175|12711091|P2|Treated|Overall Study||30
5167913|NCT01215175|12711092|P1|Treated|Overall Study||30
5167914|NCT01215175|12711088|P5|STARTED|Overall Study||28
5167915|NCT01215175|12711089|P4|STARTED|Overall Study||29
5167916|NCT01215175|12711090|P3|STARTED|Overall Study||33
5167917|NCT01215175|12711091|P2|STARTED|Overall Study||30
5167918|NCT01215175|12711092|P1|STARTED|Overall Study||30
5167919|NCT01215123|12711134|P1|NOT COMPLETED|Overall Study||0
5167920|NCT01215123|12711134|P1|COMPLETED|Overall Study||28
5167921|NCT01215123|12711134|P1|STARTED|Overall Study||28
5167922|NCT01215110|12711144|P5|NOT COMPLETED|Overall Study||0
5167923|NCT01215110|12711145|P4|NOT COMPLETED|Overall Study||1
5167924|NCT01215110|12711146|P3|NOT COMPLETED|Overall Study||2
5167925|NCT01215110|12711147|P2|NOT COMPLETED|Overall Study||0
5167926|NCT01215110|12711148|P1|NOT COMPLETED|Overall Study||0
5167927|NCT01215110|12711144|P5|COMPLETED|Overall Study||8
5167928|NCT01215110|12711145|P4|COMPLETED|Overall Study||14
5167929|NCT01215110|12711146|P3|COMPLETED|Overall Study||13
5167930|NCT01215110|12711147|P2|COMPLETED|Overall Study||15
5167931|NCT01215110|12711148|P1|COMPLETED|Overall Study||15
5167932|NCT01215110|12711144|P5|STARTED|Overall Study||8
5167933|NCT01215110|12711145|P4|STARTED|Overall Study||15
5167934|NCT01215110|12711146|P3|STARTED|Overall Study||15
5167935|NCT01215110|12711147|P2|STARTED|Overall Study||15
5167936|NCT01215110|12711148|P1|STARTED|Overall Study||15
5167937|NCT01215097|12711209|P2|NOT COMPLETED|Overall Study||14
5167938|NCT01215097|12711210|P1|NOT COMPLETED|Overall Study||12
5167939|NCT01215097|12711209|P2|COMPLETED|Overall Study||191
5167940|NCT01215097|12711210|P1|COMPLETED|Overall Study||88
5167941|NCT01215097|12711209|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
5167942|NCT01215097|12711210|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
5167943|NCT01215032|12711242|P1|NOT COMPLETED|Overall Study||20
5167944|NCT01215032|12711242|P1|COMPLETED|Overall Study||1
5167945|NCT01215032|12711242|P1|STARTED|Overall Study||21
5167946|NCT01214980|12711252|P2|NOT COMPLETED|Overall Study||2
5167947|NCT01214980|12711253|P1|NOT COMPLETED|Overall Study||3
5167948|NCT01214980|12711252|P2|COMPLETED|Overall Study||14
5167949|NCT01214980|12711253|P1|COMPLETED|Overall Study||13
5167950|NCT01214980|12711252|P2|STARTED|Overall Study||16
5167951|NCT01214980|12711253|P1|STARTED|Overall Study||16
5167952|NCT01214915|12711267|P1|NOT COMPLETED|Overall Study||11
5167953|NCT01214915|12711267|P1|COMPLETED|Overall Study||42
5167954|NCT01214915|12711267|P1|STARTED|Overall Study||53
5167955|NCT01214850|12711278|P3|NOT COMPLETED|Overall Study||161
5167956|NCT01214850|12711279|P2|NOT COMPLETED|Overall Study||144
5167957|NCT01214850|12711280|P1|NOT COMPLETED|Overall Study||183
5167958|NCT01214850|12711278|P3|COMPLETED|Overall Study||826
5167959|NCT01214850|12711279|P2|COMPLETED|Overall Study||844
5167960|NCT01214850|12711280|P1|COMPLETED|Overall Study||796
5167961|NCT01214850|12711278|P3|STARTED|Overall Study||987
5167962|NCT01214850|12711279|P2|STARTED|Overall Study||988
5167963|NCT01214850|12711280|P1|STARTED|Overall Study||979
5167964|NCT01214837|12711364|P3|NOT COMPLETED|Overall Study||62
5167965|NCT01214837|12711365|P2|NOT COMPLETED|Overall Study||64
5167966|NCT01214837|12711366|P1|NOT COMPLETED|Overall Study||54
5167967|NCT01214837|12711364|P3|COMPLETED|Overall Study||184
5167968|NCT01214837|12711365|P2|COMPLETED|Overall Study||192
5167969|NCT01214837|12711366|P1|COMPLETED|Overall Study||195
5167970|NCT01214837|12711364|P3|STARTED|Overall Study||246
5167971|NCT01214837|12711365|P2|STARTED|Overall Study||256
5167972|NCT01214837|12711366|P1|STARTED|Overall Study||249
5167973|NCT01214824|12711403|P1|NOT COMPLETED|Overall Study||3
5167974|NCT01214824|12711403|P1|COMPLETED|Overall Study||29
5167975|NCT01214824|12711403|P1|STARTED|Overall Study||32
5167976|NCT01214811|12711410|P1|NOT COMPLETED|Overall Study||3
5167977|NCT01214811|12711410|P1|COMPLETED|Overall Study||24
5167978|NCT01214811|12711410|P1|STARTED|Overall Study||27
5167979|NCT01214759|12711414|P1|NOT COMPLETED|Overall Study||48
5167980|NCT01214759|12711414|P1|COMPLETED|Overall Study||55
5167981|NCT01214759|12711414|P1|28 Days nPEP Completion|Overall Study||85
5167982|NCT01214759|12711414|P1|STARTED|Overall Study||103
5167983|NCT01214720|12711422|P2|NOT COMPLETED|Overall Study||68
5167984|NCT01214720|12711423|P1|NOT COMPLETED|Overall Study||85
5167985|NCT01214720|12711422|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
5167986|NCT01214720|12711423|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
5167987|NCT01214720|12711422|P2|STARTED|Overall Study||301
5167988|NCT01214720|12711423|P1|STARTED|Overall Study||306
5167989|NCT01214668|12711446|P6|NOT COMPLETED|Overall Study||6
5167990|NCT01214668|12711447|P5|NOT COMPLETED|Overall Study||6
5167991|NCT01214668|12711448|P4|NOT COMPLETED|Overall Study||6
5167992|NCT01214668|12711449|P3|NOT COMPLETED|Overall Study||6
5167993|NCT01214668|12711450|P2|NOT COMPLETED|Overall Study||3
5167994|NCT01214668|12711451|P1|NOT COMPLETED|Overall Study||4
5167995|NCT01214668|12711446|P6|COMPLETED|Overall Study||0
5167996|NCT01214668|12711447|P5|COMPLETED|Overall Study||0
5167997|NCT01214668|12711448|P4|COMPLETED|Overall Study||0
5167998|NCT01214668|12711449|P3|COMPLETED|Overall Study||0
5167999|NCT01214668|12711450|P2|COMPLETED|Overall Study||0
5168000|NCT01214668|12711451|P1|COMPLETED|Overall Study||0
5168001|NCT01214668|12711446|P6|Received at Least One Dose of Study Drug|Overall Study||6
5168002|NCT01214668|12711447|P5|Received at Least One Dose of Study Drug|Overall Study||6
5168003|NCT01214668|12711448|P4|Received at Least One Dose of Study Drug|Overall Study||6
5168004|NCT01214668|12711449|P3|Received at Least One Dose of Study Drug|Overall Study||6
5168005|NCT01214668|12711450|P2|Received at Least One Dose of Study Drug|Overall Study||3
5168006|NCT01214668|12711451|P1|Received at Least One Dose of Study Drug|Overall Study||4
5168007|NCT01214668|12711446|P6|STARTED|Overall Study||6
5168008|NCT01214668|12711447|P5|STARTED|Overall Study||6
5168009|NCT01214668|12711448|P4|STARTED|Overall Study||6
5168010|NCT01214668|12711449|P3|STARTED|Overall Study||6
5168011|NCT01214668|12711450|P2|STARTED|Overall Study||3
5168012|NCT01214668|12711451|P1|STARTED|Overall Study||4
5168013|NCT01214655|12711488|P3|NOT COMPLETED|Part C||7
5168014|NCT01214655|12711489|P2|NOT COMPLETED|Part C||0
5168015|NCT01214655|12711490|P1|NOT COMPLETED|Part C||0
5168016|NCT01214655|12711488|P3|COMPLETED|Part C||1
5168017|NCT01214655|12711489|P2|COMPLETED|Part C||0
5168018|NCT01214655|12711490|P1|COMPLETED|Part C||0
5168019|NCT01214655|12711488|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
5168020|NCT01214655|12711489|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
5168021|NCT01214655|12711490|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
5168022|NCT01214655|12711488|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
5168023|NCT01214655|12711489|P2|STARTED|Part C||0
5168024|NCT01214655|12711490|P1|STARTED|Part C||0
5168025|NCT01214655|12711488|P3|NOT COMPLETED|Part B||0
5168026|NCT01214655|12711489|P2|NOT COMPLETED|Part B||13
5168027|NCT01214655|12711490|P1|NOT COMPLETED|Part B||0
5168028|NCT01214655|12711488|P3|COMPLETED|Part B||0
5168029|NCT01214655|12711489|P2|COMPLETED|Part B||2
5168030|NCT01214655|12711490|P1|COMPLETED|Part B||0
5168031|NCT01214655|12711488|P3|Joined 14 mg/m²/Day|Part B||0
5168032|NCT01214655|12711489|P2|Joined 14 mg/m²/Day|Part B||3
5168033|NCT01214655|12711490|P1|Joined 14 mg/m²/Day|Part B||0
5168034|NCT01214655|12711488|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
5168035|NCT01214655|12711489|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
5168036|NCT01214655|12711490|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
5168037|NCT01214655|12711488|P3|Joined 12 mg/m²/Day|Part B||0
5168038|NCT01214655|12711489|P2|Joined 12 mg/m²/Day|Part B||5
5168039|NCT01214655|12711490|P1|Joined 12 mg/m²/Day|Part B||0
5168040|NCT01214655|12711488|P3|Escalated to 12 mg/m²/Day|Part B||0
5168041|NCT01214655|12711489|P2|Escalated to 12 mg/m²/Day|Part B||2
5168042|NCT01214655|12711490|P1|Escalated to 12 mg/m²/Day|Part B||0
5168043|NCT01214655|12711488|P3|Joined 10 mg/m²/Day Study D|Part B||0
5168044|NCT01214655|12711489|P2|Joined 10 mg/m²/Day Study D|Part B||3
5168045|NCT01214655|12711490|P1|Joined 10 mg/m²/Day Study D|Part B||0
5168046|NCT01214655|12711488|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
5168047|NCT01214655|12711489|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
5168048|NCT01214655|12711490|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
5168049|NCT01214655|12711488|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
5168050|NCT01214655|12711489|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
5168051|NCT01214655|12711490|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
5168052|NCT01214655|12711488|P3|Received at Least 1 Dose of Study Drug|Part B||0
5168053|NCT01214655|12711489|P2|Received at Least 1 Dose of Study Drug|Part B||15
5168054|NCT01214655|12711490|P1|Received at Least 1 Dose of Study Drug|Part B||0
5168055|NCT01214655|12711488|P3|STARTED|Part B||0
5168056|NCT01214655|12711489|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
5168057|NCT01214655|12711490|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
5168058|NCT01214655|12711488|P3|NOT COMPLETED|Part A||0
5168059|NCT01214655|12711489|P2|NOT COMPLETED|Part A||0
5168060|NCT01214655|12711490|P1|NOT COMPLETED|Part A||8
5168061|NCT01214655|12711488|P3|COMPLETED|Part A||0
5168062|NCT01214655|12711489|P2|COMPLETED|Part A||0
5168063|NCT01214655|12711490|P1|COMPLETED|Part A||2
5168064|NCT01214655|12711488|P3|Received 6 mg Study Drug|Part A||0
5168065|NCT01214655|12711489|P2|Received 6 mg Study Drug|Part A||0
5168066|NCT01214655|12711490|P1|Received 6 mg Study Drug|Part A||5
5168067|NCT01214655|12711488|P3|Joined 6 mg Group|Part A||0
5168068|NCT01214655|12711489|P2|Joined 6 mg Group|Part A||0
5168069|NCT01214655|12711490|P1|Joined 6 mg Group|Part A||4
5168070|NCT01214655|12711488|P3|Escalated From 5 mg Study Drug|Part A||0
5168071|NCT01214655|12711489|P2|Escalated From 5 mg Study Drug|Part A||0
5168072|NCT01214655|12711490|P1|Escalated From 5 mg Study Drug|Part A||1
5168073|NCT01214655|12711488|P3|Joined 5 mg Study Drug|Part A||0
5168074|NCT01214655|12711489|P2|Joined 5 mg Study Drug|Part A||0
5168075|NCT01214655|12711490|P1|Joined 5 mg Study Drug|Part A||2
5168076|NCT01214655|12711488|P3|Escalated From 4 mg Study Drug|Part A||0
5168077|NCT01214655|12711489|P2|Escalated From 4 mg Study Drug|Part A||0
5168078|NCT01214655|12711490|P1|Escalated From 4 mg Study Drug|Part A||0
5168079|NCT01214655|12711488|P3|Joined 4 mg Group|Part A||0
5168080|NCT01214655|12711489|P2|Joined 4 mg Group|Part A||0
5168081|NCT01214655|12711490|P1|Joined 4 mg Group|Part A||1
5168082|NCT01214655|12711488|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
5168083|NCT01214655|12711489|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
5168084|NCT01214655|12711490|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
5168085|NCT01214655|12711488|P3|Received 2 mg Study Drug|Part A||0
5168086|NCT01214655|12711489|P2|Received 2 mg Study Drug|Part A||0
5168087|NCT01214655|12711490|P1|Received 2 mg Study Drug|Part A||3
5168088|NCT01214655|12711488|P3|STARTED|Part A||0
5168089|NCT01214655|12711489|P2|STARTED|Part A||0
5168090|NCT01214655|12711490|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
5168091|NCT01214642|12711563|P12|NOT COMPLETED|Overall Study||6
5168092|NCT01214642|12711564|P11|NOT COMPLETED|Overall Study||4
5168093|NCT01214642|12711565|P10|NOT COMPLETED|Overall Study||4
5168094|NCT01214642|12711566|P9|NOT COMPLETED|Overall Study||13
5168095|NCT01214642|12711567|P8|NOT COMPLETED|Overall Study||3
5168096|NCT01214642|12711568|P7|NOT COMPLETED|Overall Study||6
5168097|NCT01214642|12711569|P6|NOT COMPLETED|Overall Study||3
5168098|NCT01214642|12711570|P5|NOT COMPLETED|Overall Study||6
5168099|NCT01214642|12711571|P4|NOT COMPLETED|Overall Study||6
5168100|NCT01214642|12711572|P3|NOT COMPLETED|Overall Study||6
5168101|NCT01214642|12711573|P2|NOT COMPLETED|Overall Study||3
5168102|NCT01214642|12711574|P1|NOT COMPLETED|Overall Study||3
5168103|NCT01214642|12711563|P12|COMPLETED|Overall Study||0
5168104|NCT01214642|12711564|P11|COMPLETED|Overall Study||0
5168105|NCT01214642|12711565|P10|COMPLETED|Overall Study||0
5168106|NCT01214642|12711566|P9|COMPLETED|Overall Study||0
5168107|NCT01214642|12711567|P8|COMPLETED|Overall Study||0
5168108|NCT01214642|12711568|P7|COMPLETED|Overall Study||0
5168109|NCT01214642|12711569|P6|COMPLETED|Overall Study||0
5168110|NCT01214642|12711570|P5|COMPLETED|Overall Study||0
5168111|NCT01214642|12711571|P4|COMPLETED|Overall Study||0
5168112|NCT01214642|12711572|P3|COMPLETED|Overall Study||0
5168113|NCT01214642|12711573|P2|COMPLETED|Overall Study||0
5168114|NCT01214642|12711574|P1|COMPLETED|Overall Study||0
5168115|NCT01214642|12711563|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
5168116|NCT01214642|12711564|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
5168117|NCT01214642|12711565|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
5168118|NCT01214642|12711566|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
5168119|NCT01214642|12711567|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
5168120|NCT01214642|12711568|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
5168121|NCT01214642|12711569|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
5168122|NCT01214642|12711570|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
5168123|NCT01214642|12711571|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
5168124|NCT01214642|12711572|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
5168125|NCT01214642|12711573|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
5168126|NCT01214642|12711574|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
5168127|NCT01214642|12711563|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
5168128|NCT01214642|12711564|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
5168129|NCT01214642|12711565|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
5168130|NCT01214642|12711566|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
5168131|NCT01214642|12711567|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
5168132|NCT01214642|12711568|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5168133|NCT01214642|12711569|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
5168134|NCT01214642|12711570|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5168135|NCT01214642|12711571|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
5168136|NCT01214642|12711572|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5168137|NCT01214642|12711573|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5168138|NCT01214642|12711574|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5168139|NCT01214642|12711563|P12|STARTED|Overall Study||6
5168140|NCT01214642|12711564|P11|STARTED|Overall Study||4
5168141|NCT01214642|12711565|P10|STARTED|Overall Study||4
5168142|NCT01214642|12711566|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
5168143|NCT01214642|12711567|P8|STARTED|Overall Study||3
5168144|NCT01214642|12711568|P7|STARTED|Overall Study||6
5168145|NCT01214642|12711569|P6|STARTED|Overall Study||3
5168146|NCT01214642|12711570|P5|STARTED|Overall Study||6
5168147|NCT01214642|12711571|P4|STARTED|Overall Study||6
5168148|NCT01214642|12711572|P3|STARTED|Overall Study||6
5168149|NCT01214642|12711573|P2|STARTED|Overall Study||3
5168150|NCT01214642|12711574|P1|STARTED|Overall Study||3
5168151|NCT01214629|12711654|P11|NOT COMPLETED|Overall Study||2
5168152|NCT01214629|12711655|P10|NOT COMPLETED|Overall Study||7
5168153|NCT01214629|12711656|P9|NOT COMPLETED|Overall Study||1
5168154|NCT01214629|12711657|P8|NOT COMPLETED|Overall Study||1
5168155|NCT01214629|12711658|P7|NOT COMPLETED|Overall Study||1
5168156|NCT01214629|12711659|P6|NOT COMPLETED|Overall Study||4
5168157|NCT01214629|12711660|P5|NOT COMPLETED|Overall Study||2
5168158|NCT01214629|12711661|P4|NOT COMPLETED|Overall Study||2
5168159|NCT01214629|12711662|P3|NOT COMPLETED|Overall Study||0
5168160|NCT01214629|12711663|P2|NOT COMPLETED|Overall Study||1
5168161|NCT01214629|12711664|P1|NOT COMPLETED|Overall Study||1
5168162|NCT01214629|12711654|P11|COMPLETED|Overall Study||1
5168163|NCT01214629|12711655|P10|COMPLETED|Overall Study||11
5168164|NCT01214629|12711656|P9|COMPLETED|Overall Study||2
5168165|NCT01214629|12711657|P8|COMPLETED|Overall Study||2
5168166|NCT01214629|12711658|P7|COMPLETED|Overall Study||4
5168167|NCT01214629|12711659|P6|COMPLETED|Overall Study||9
5168168|NCT01214629|12711660|P5|COMPLETED|Overall Study||1
5168169|NCT01214629|12711661|P4|COMPLETED|Overall Study||1
5168170|NCT01214629|12711662|P3|COMPLETED|Overall Study||1
5168171|NCT01214629|12711663|P2|COMPLETED|Overall Study||0
5168172|NCT01214629|12711664|P1|COMPLETED|Overall Study||0
5168173|NCT01214629|12711654|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
5168174|NCT01214629|12711655|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
5168175|NCT01214629|12711656|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
5168176|NCT01214629|12711657|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
5168177|NCT01214629|12711658|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
5168178|NCT01214629|12711659|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
5168179|NCT01214629|12711660|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5168180|NCT01214629|12711661|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5168181|NCT01214629|12711662|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
5168182|NCT01214629|12711663|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
5168183|NCT01214629|12711664|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
5168184|NCT01214629|12711654|P11|STARTED|Overall Study||3
5168185|NCT01214629|12711655|P10|STARTED|Overall Study||18
5168186|NCT01214629|12711656|P9|STARTED|Overall Study||3
5168187|NCT01214629|12711657|P8|STARTED|Overall Study||3
5168188|NCT01214629|12711658|P7|STARTED|Overall Study||5
5168189|NCT01214629|12711659|P6|STARTED|Overall Study||13
5168190|NCT01214629|12711660|P5|STARTED|Overall Study||3
5168191|NCT01214629|12711661|P4|STARTED|Overall Study||3
5168192|NCT01214629|12711662|P3|STARTED|Overall Study||1
5168193|NCT01214629|12711663|P2|STARTED|Overall Study||1
5168194|NCT01214629|12711664|P1|STARTED|Overall Study||1
5168195|NCT01214616|12711729|P4|NOT COMPLETED|Overall Study||6
5168196|NCT01214616|12711730|P3|NOT COMPLETED|Overall Study||3
5168197|NCT01214616|12711731|P2|NOT COMPLETED|Overall Study||5
5168198|NCT01214616|12711732|P1|NOT COMPLETED|Overall Study||3
5168199|NCT01214616|12711729|P4|COMPLETED|Overall Study||0
5168200|NCT01214616|12711730|P3|COMPLETED|Overall Study||0
5168201|NCT01214616|12711731|P2|COMPLETED|Overall Study||0
5168202|NCT01214616|12711732|P1|COMPLETED|Overall Study||0
5168203|NCT01214616|12711729|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
5168204|NCT01214616|12711730|P3|STARTED|Overall Study||3
5168205|NCT01214616|12711731|P2|STARTED|Overall Study||5
5168206|NCT01214616|12711732|P1|STARTED|Overall Study||3
5168207|NCT01214603|12711769|P3|NOT COMPLETED|Overall Study||4
5168208|NCT01214603|12711770|P2|NOT COMPLETED|Overall Study||1
5168209|NCT01214603|12711771|P1|NOT COMPLETED|Overall Study||5
5168210|NCT01214603|12711769|P3|COMPLETED|Overall Study||3
5168211|NCT01214603|12711770|P2|COMPLETED|Overall Study||5
5168212|NCT01214603|12711771|P1|COMPLETED|Overall Study||2
5168213|NCT01214603|12711769|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
5168214|NCT01214603|12711770|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
5168215|NCT01214603|12711771|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
5168216|NCT01214603|12711769|P3|STARTED|Overall Study||7
5168217|NCT01214603|12711770|P2|STARTED|Overall Study||6
5168218|NCT01214603|12711771|P1|STARTED|Overall Study||7
5168219|NCT01214434|12711794|P2|NOT COMPLETED|Overall Study||2
5168220|NCT01214434|12711795|P1|NOT COMPLETED|Overall Study||4
5168221|NCT01214434|12711794|P2|COMPLETED|Overall Study||25
5168222|NCT01214434|12711795|P1|COMPLETED|Overall Study||11
5168223|NCT01214434|12711794|P2|STARTED|Overall Study||27
5168224|NCT01214434|12711795|P1|STARTED|Overall Study||15
5168225|NCT01214395|12711811|P1|NOT COMPLETED|Overall Study||5
5168226|NCT01214395|12711811|P1|COMPLETED|Overall Study||0
5168227|NCT01214395|12711811|P1|STARTED|Overall Study||5
5168228|NCT01214356|12711818|P2|NOT COMPLETED|Overall Study||14
5168229|NCT01214356|12711819|P1|NOT COMPLETED|Overall Study||17
5168230|NCT01214356|12711818|P2|COMPLETED|Overall Study||13
5168231|NCT01214356|12711819|P1|COMPLETED|Overall Study||10
5168232|NCT01214356|12711818|P2|STARTED|Overall Study||27
5168233|NCT01214356|12711819|P1|STARTED|Overall Study||27
5168234|NCT01214330|12711825|P1|NOT COMPLETED|Overall Study||48
5168235|NCT01214330|12711825|P1|COMPLETED|Overall Study||102
5168236|NCT01214330|12711825|P1|STARTED|Overall Study||150
5168237|NCT01214252|12711829|P1|NOT COMPLETED|Overall Study||82
5168238|NCT01214252|12711829|P1|COMPLETED|Overall Study||343
5168239|NCT01214252|12711829|P1|STARTED|Overall Study||425
5168240|NCT01214239|12711837|P2|NOT COMPLETED|Overall Study||18
5168241|NCT01214239|12711838|P1|NOT COMPLETED|Overall Study||12
5168242|NCT01214239|12711837|P2|COMPLETED|Overall Study||182
5168243|NCT01214239|12711838|P1|COMPLETED|Overall Study||87
5168244|NCT01214239|12711837|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
5168245|NCT01214239|12711838|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
5168246|NCT01214200|12711870|P1|NOT COMPLETED|Overall Study||11
5168247|NCT01214200|12711870|P1|COMPLETED|Overall Study||9
5168248|NCT01214200|12711870|P1|STARTED|Overall Study||20
5168249|NCT01214187|12711884|P2|NOT COMPLETED|Overall Study||6
5168250|NCT01214187|12711885|P1|NOT COMPLETED|Overall Study||7
5168251|NCT01214187|12711884|P2|COMPLETED|Overall Study||23
5168252|NCT01214187|12711885|P1|COMPLETED|Overall Study||22
5168253|NCT01214187|12711884|P2|STARTED|Overall Study||29
5168254|NCT01214187|12711885|P1|STARTED|Overall Study||29
5168255|NCT01214174|12711902|P3|NOT COMPLETED|Overall Study||1
5168256|NCT01214174|12711903|P2|NOT COMPLETED|Overall Study||0
5168257|NCT01214174|12711904|P1|NOT COMPLETED|Overall Study||0
5168258|NCT01214174|12711902|P3|COMPLETED|Overall Study||13
5168259|NCT01214174|12711903|P2|COMPLETED|Overall Study||16
5168260|NCT01214174|12711904|P1|COMPLETED|Overall Study||13
5168261|NCT01214174|12711902|P3|STARTED|Overall Study||14
5168262|NCT01214174|12711903|P2|STARTED|Overall Study||16
5168263|NCT01214174|12711904|P1|STARTED|Overall Study||13
5168264|NCT01214161|12711914|P2|NOT COMPLETED|Overall Study||0
5168265|NCT01214161|12711915|P1|NOT COMPLETED|Overall Study||0
5168266|NCT01214161|12711914|P2|COMPLETED|Overall Study||100
5168267|NCT01214161|12711915|P1|COMPLETED|Overall Study||100
5168268|NCT01214161|12711914|P2|STARTED|Overall Study||100
5168269|NCT01214161|12711915|P1|STARTED|Overall Study||100
5168270|NCT01214109|12711925|P4|NOT COMPLETED|Overall Study||0
5168271|NCT01214109|12711926|P3|NOT COMPLETED|Overall Study||0
5168272|NCT01214109|12711927|P2|NOT COMPLETED|Overall Study||0
5168273|NCT01214109|12711928|P1|NOT COMPLETED|Overall Study||0
5168274|NCT01214109|12711925|P4|COMPLETED|Overall Study||24
5168275|NCT01214109|12711926|P3|COMPLETED|Overall Study||24
5168276|NCT01214109|12711927|P2|COMPLETED|Overall Study||24
5168277|NCT01214109|12711928|P1|COMPLETED|Overall Study||24
5168278|NCT01214109|12711925|P4|STARTED|Overall Study||24
5168279|NCT01214109|12711926|P3|STARTED|Overall Study||24
5168280|NCT01214109|12711927|P2|STARTED|Overall Study||24
5168281|NCT01214109|12711928|P1|STARTED|Overall Study||24
5168282|NCT01214083|12712020|P3|NOT COMPLETED|Overall Study||10
5168283|NCT01214083|12712021|P2|NOT COMPLETED|Overall Study||10
5168284|NCT01214083|12712022|P1|NOT COMPLETED|Overall Study||12
5168285|NCT01214083|12712020|P3|COMPLETED|Overall Study||21
5168286|NCT01214083|12712021|P2|COMPLETED|Overall Study||23
5168287|NCT01214083|12712022|P1|COMPLETED|Overall Study||19
5168288|NCT01214083|12712020|P3|STARTED|Overall Study||31
5168289|NCT01214083|12712021|P2|STARTED|Overall Study||33
5168290|NCT01214083|12712022|P1|STARTED|Overall Study||31
5168291|NCT01214044|12712054|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
5168292|NCT01214044|12712054|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
5168293|NCT01214044|12712054|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
5168294|NCT01214044|12712054|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
5168295|NCT01214044|12712054|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
5168296|NCT01214044|12712054|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
5168297|NCT01214044|12712054|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
5168298|NCT01214044|12712054|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
5168299|NCT01214044|12712054|P1|STARTED|Visit 2: End Washout & Start Placebo||19
5168300|NCT01214044|12712054|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
5168301|NCT01214044|12712054|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
5168302|NCT01214044|12712054|P1|STARTED|Visit 1: Screening and Consent, Washout||31
5168303|NCT01213966|12712068|P4|NOT COMPLETED|Overall Study||1
5168304|NCT01213966|12712069|P3|NOT COMPLETED|Overall Study||3
5168305|NCT01213966|12712070|P2|NOT COMPLETED|Overall Study||0
5168306|NCT01213966|12712071|P1|NOT COMPLETED|Overall Study||1
5168307|NCT01213966|12712068|P4|COMPLETED|Overall Study||20
5168308|NCT01213966|12712069|P3|COMPLETED|Overall Study||17
5168309|NCT01213966|12712070|P2|COMPLETED|Overall Study||20
5168310|NCT01213966|12712071|P1|COMPLETED|Overall Study||19
5168311|NCT01213966|12712068|P4|STARTED|Overall Study||21
5168312|NCT01213966|12712069|P3|STARTED|Overall Study||20
5168313|NCT01213966|12712070|P2|STARTED|Overall Study||20
5168314|NCT01213966|12712071|P1|STARTED|Overall Study||20
5168315|NCT01213836|12712083|P2|NOT COMPLETED|Period 2, Second Intervention||0
5168316|NCT01213836|12712084|P1|NOT COMPLETED|Period 2, Second Intervention||0
5168317|NCT01213836|12712083|P2|COMPLETED|Period 2, Second Intervention||29
5168318|NCT01213836|12712084|P1|COMPLETED|Period 2, Second Intervention||31
5168319|NCT01213836|12712083|P2|STARTED|Period 2, Second Intervention||29
5168320|NCT01213836|12712084|P1|STARTED|Period 2, Second Intervention||31
5168321|NCT01213836|12712083|P2|NOT COMPLETED|Period 1, First Intervention||3
5168322|NCT01213836|12712084|P1|NOT COMPLETED|Period 1, First Intervention||3
5168323|NCT01213836|12712083|P2|COMPLETED|Period 1, First Intervention||29
5168324|NCT01213836|12712084|P1|COMPLETED|Period 1, First Intervention||31
5168325|NCT01213836|12712083|P2|STARTED|Period 1, First Intervention||32
5168326|NCT01213836|12712084|P1|STARTED|Period 1, First Intervention||34
5168327|NCT01213823|12712104|P2|NOT COMPLETED|Overall Study||0
5168328|NCT01213823|12712105|P1|NOT COMPLETED|Overall Study||0
5168329|NCT01213823|12712104|P2|COMPLETED|Overall Study||467
5168330|NCT01213823|12712105|P1|COMPLETED|Overall Study||69
5168331|NCT01213823|12712104|P2|STARTED|Overall Study||467
5168332|NCT01213823|12712105|P1|STARTED|Overall Study||69
5168333|NCT01213706|12712111|P1|NOT COMPLETED|WBPA||0
5168334|NCT01213706|12712111|P1|COMPLETED|WBPA||45
5168335|NCT01213706|12712111|P1|STARTED|WBPA||45
5168336|NCT01213706|12712111|P1|NOT COMPLETED|Washout (1 Hour)||0
5168337|NCT01213706|12712111|P1|COMPLETED|Washout (1 Hour)||45
5168338|NCT01213706|12712111|P1|STARTED|Washout (1 Hour)||45
5168339|NCT01213706|12712111|P1|NOT COMPLETED|Sham WBPA||0
5168340|NCT01213706|12712111|P1|COMPLETED|Sham WBPA||45
5168341|NCT01213706|12712111|P1|STARTED|Sham WBPA||45
5168342|NCT01213589|12712120|P3|NOT COMPLETED|Overall Study||8
5168343|NCT01213589|12712121|P2|NOT COMPLETED|Overall Study||5
5168344|NCT01213589|12712122|P1|NOT COMPLETED|Overall Study||13
5168345|NCT01213589|12712120|P3|COMPLETED|Overall Study||18
5168346|NCT01213589|12712121|P2|COMPLETED|Overall Study||19
5168347|NCT01213589|12712122|P1|COMPLETED|Overall Study||37
5168348|NCT01213589|12712120|P3|STARTED|Overall Study||26
5168349|NCT01213589|12712121|P2|STARTED|Overall Study||24
5168350|NCT01213589|12712122|P1|STARTED|Overall Study||50
5168351|NCT01213576|12712152|P4|NOT COMPLETED|Overall Study||4
5168352|NCT01213576|12712153|P3|NOT COMPLETED|Overall Study||5
5168353|NCT01213576|12712154|P2|NOT COMPLETED|Overall Study||4
5168354|NCT01213576|12712155|P1|NOT COMPLETED|Overall Study||3
5168355|NCT01213576|12712152|P4|COMPLETED|Overall Study||13
5168356|NCT01213576|12712153|P3|COMPLETED|Overall Study||13
5168357|NCT01213576|12712154|P2|COMPLETED|Overall Study||13
5168358|NCT01213576|12712155|P1|COMPLETED|Overall Study||15
5168359|NCT01213576|12712152|P4|STARTED|Overall Study||17
5168360|NCT01213576|12712153|P3|STARTED|Overall Study||18
5168361|NCT01213576|12712154|P2|STARTED|Overall Study||17
5168362|NCT01213576|12712155|P1|STARTED|Overall Study||18
5168363|NCT01213472|12712169|P1|NOT COMPLETED|Overall Study||27
5168364|NCT01213472|12712169|P1|COMPLETED|Overall Study||6
5168365|NCT01213472|12712169|P1|STARTED|Overall Study||33
5168366|NCT01213329|12712192|P2|NOT COMPLETED|Phase 2||0
5168367|NCT01213329|12712193|P1|NOT COMPLETED|Phase 2||0
5168368|NCT01213329|12712192|P2|COMPLETED|Phase 2||0
5168369|NCT01213329|12712193|P1|COMPLETED|Phase 2||0
5168370|NCT01213329|12712192|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
5168371|NCT01213329|12712193|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
5168372|NCT01213329|12712192|P2|NOT COMPLETED|Screening||0
5168373|NCT01213329|12712193|P1|NOT COMPLETED|Screening||0
5168374|NCT01213329|12712192|P2|COMPLETED|Screening||25
5168375|NCT01213329|12712193|P1|COMPLETED|Screening||25
5168376|NCT01213329|12712192|P2|STARTED|Screening||25
5168377|NCT01213329|12712193|P1|STARTED|Screening||25
5168378|NCT01213316|12712199|P1|NOT COMPLETED|Overall Study||0
5168379|NCT01213316|12712199|P1|COMPLETED|Overall Study||451
5168380|NCT01213316|12712199|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
5168381|NCT01213316|12712199|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
5168382|NCT01213316|12712199|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
5168383|NCT01213316|12712199|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
5168384|NCT01213316|12712199|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
5168385|NCT01213264|12712218|P3|NOT COMPLETED|Overall Study||6
5168386|NCT01213264|12712219|P2|NOT COMPLETED|Overall Study||2
5168387|NCT01213264|12712220|P1|NOT COMPLETED|Overall Study||2
5168388|NCT01213264|12712218|P3|COMPLETED|Overall Study||321
5168389|NCT01213264|12712219|P2|COMPLETED|Overall Study||175
5168390|NCT01213264|12712220|P1|COMPLETED|Overall Study||153
5168391|NCT01213264|12712218|P3|STARTED|Overall Study||327
5168392|NCT01213264|12712219|P2|STARTED|Overall Study||177
5168393|NCT01213264|12712220|P1|STARTED|Overall Study||155
5168394|NCT01213251|12712240|P3|NOT COMPLETED|Overall Study||11
5168395|NCT01213251|12712241|P2|NOT COMPLETED|Overall Study||4
5168396|NCT01213251|12712242|P1|NOT COMPLETED|Overall Study||6
5168397|NCT01213251|12712240|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
5168398|NCT01213251|12712241|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
5168399|NCT01213251|12712242|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
5168400|NCT01213251|12712240|P3|STARTED|Overall Study||45
5168401|NCT01213251|12712241|P2|STARTED|Overall Study||41
5168402|NCT01213251|12712242|P1|STARTED|Overall Study||40
5168403|NCT01213199|12712263|P1|NOT COMPLETED|Overall Study||4
5168404|NCT01213199|12712263|P1|COMPLETED|Overall Study||16
5168405|NCT01213199|12712263|P1|STARTED|Overall Study||20
5168406|NCT01213173|12712269|P2|NOT COMPLETED|Overall Study||16
5168407|NCT01213173|12712270|P1|NOT COMPLETED|Overall Study||12
5168408|NCT01213173|12712269|P2|COMPLETED|Overall Study|Patients who completed the study|110
5168409|NCT01213173|12712270|P1|COMPLETED|Overall Study|Patients who completed the study|113
5168410|NCT01213173|12712269|P2|Patients Included in PP Population|Overall Study||89
5168411|NCT01213173|12712270|P1|Patients Included in PP Population|Overall Study||102
5168412|NCT01213173|12712269|P2|Patients Included in ITT Population|Overall Study||115
5168413|NCT01213173|12712270|P1|Patients Included in ITT Population|Overall Study||116
5168414|NCT01213173|12712269|P2|Patients Included in Safety Population|Overall Study||112
5168415|NCT01213173|12712270|P1|Patients Included in Safety Population|Overall Study||139
5168416|NCT01213173|12712269|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
5168417|NCT01213173|12712270|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
5168418|NCT01213082|12712303|P3|NOT COMPLETED|Overall Study||5
5168419|NCT01213082|12712304|P2|NOT COMPLETED|Overall Study||7
5168420|NCT01213082|12712305|P1|NOT COMPLETED|Overall Study||6
5168421|NCT01213082|12712303|P3|COMPLETED|Overall Study||6
5168422|NCT01213082|12712304|P2|COMPLETED|Overall Study||4
5168423|NCT01213082|12712305|P1|COMPLETED|Overall Study||6
5168424|NCT01213082|12712303|P3|STARTED|Overall Study||11
5168425|NCT01213082|12712304|P2|STARTED|Overall Study||11
5168426|NCT01213082|12712305|P1|STARTED|Overall Study||12
5168427|NCT01213043|12712318|P2|NOT COMPLETED|Follow-up||0
5168428|NCT01213043|12712319|P1|NOT COMPLETED|Follow-up||0
5168429|NCT01213043|12712318|P2|COMPLETED|Follow-up||15
5168430|NCT01213043|12712319|P1|COMPLETED|Follow-up||15
5168431|NCT01213043|12712318|P2|STARTED|Follow-up||15
5168432|NCT01213043|12712319|P1|STARTED|Follow-up||15
5168433|NCT01213043|12712318|P2|NOT COMPLETED|Treatment Period 2||0
5168434|NCT01213043|12712319|P1|NOT COMPLETED|Treatment Period 2||0
5168435|NCT01213043|12712318|P2|COMPLETED|Treatment Period 2||15
5168436|NCT01213043|12712319|P1|COMPLETED|Treatment Period 2||15
5168437|NCT01213043|12712318|P2|STARTED|Treatment Period 2||15
5168438|NCT01213043|12712319|P1|STARTED|Treatment Period 2||15
5168439|NCT01213043|12712318|P2|NOT COMPLETED|Washout Period||0
5168440|NCT01213043|12712319|P1|NOT COMPLETED|Washout Period||0
5168441|NCT01213043|12712318|P2|COMPLETED|Washout Period||15
5168442|NCT01213043|12712319|P1|COMPLETED|Washout Period||15
5168443|NCT01213043|12712318|P2|STARTED|Washout Period||15
5168444|NCT01213043|12712319|P1|STARTED|Washout Period||15
5168445|NCT01213043|12712318|P2|NOT COMPLETED|Treatment Period 1||0
5168446|NCT01213043|12712319|P1|NOT COMPLETED|Treatment Period 1||0
5168447|NCT01213043|12712318|P2|COMPLETED|Treatment Period 1||15
5168448|NCT01213043|12712319|P1|COMPLETED|Treatment Period 1||15
5168449|NCT01213043|12712318|P2|STARTED|Treatment Period 1||15
5168450|NCT01213043|12712319|P1|STARTED|Treatment Period 1||15
5168451|NCT01212991|12712347|P3|NOT COMPLETED|Open-label||234
5168452|NCT01212991|12712348|P2|NOT COMPLETED|Open-label||0
5168453|NCT01212991|12712349|P1|NOT COMPLETED|Open-label||0
5168454|NCT01212991|12712347|P3|COMPLETED|Open-label||0
5168455|NCT01212991|12712348|P2|COMPLETED|Open-label||0
5168456|NCT01212991|12712349|P1|COMPLETED|Open-label||0
5168457|NCT01212991|12712347|P3|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
5168458|NCT01212991|12712348|P2|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
5168459|NCT01212991|12712349|P1|STARTED|Open-label||0
5168460|NCT01212991|12712347|P3|NOT COMPLETED|Double-blind||0
5168461|NCT01212991|12712348|P2|NOT COMPLETED|Double-blind||611
5168462|NCT01212991|12712349|P1|NOT COMPLETED|Double-blind||872
5168463|NCT01212991|12712347|P3|COMPLETED|Double-blind||0
5168464|NCT01212991|12712348|P2|COMPLETED|Double-blind||234
5168465|NCT01212991|12712349|P1|COMPLETED|Double-blind||0
5168466|NCT01212991|12712347|P3|Safety Population|Double-blind||0
5168467|NCT01212991|12712348|P2|Safety Population|Double-blind||844
5168468|NCT01212991|12712349|P1|Safety Population|Double-blind||871
5168469|NCT01212991|12712347|P3|STARTED|Double-blind||0
5168470|NCT01212991|12712348|P2|STARTED|Double-blind||845
5168471|NCT01212991|12712349|P1|STARTED|Double-blind||872
5168472|NCT01212952|12712380|P3|NOT COMPLETED|Overall Study||0
5168473|NCT01212952|12712381|P2|NOT COMPLETED|Overall Study||0
5168474|NCT01212952|12712382|P1|NOT COMPLETED|Overall Study||0
5168475|NCT01212952|12712380|P3|COMPLETED|Overall Study||41
5168476|NCT01212952|12712381|P2|COMPLETED|Overall Study||6
5168477|NCT01212952|12712382|P1|COMPLETED|Overall Study||3
5168478|NCT01212952|12712380|P3|STARTED|Overall Study||41
5168479|NCT01212952|12712381|P2|STARTED|Overall Study||6
5168480|NCT01212952|12712382|P1|STARTED|Overall Study||3
5168481|NCT01212900|12712400|P2|NOT COMPLETED|Overall Study||7
5168482|NCT01212900|12712401|P1|NOT COMPLETED|Overall Study||12
5168483|NCT01212900|12712400|P2|COMPLETED|Overall Study||107
5168484|NCT01212900|12712401|P1|COMPLETED|Overall Study||104
5168485|NCT01212900|12712400|P2|STARTED|Overall Study||114
5168486|NCT01212900|12712401|P1|STARTED|Overall Study||116
5168487|NCT01212874|12712409|P2|NOT COMPLETED|Overall Study||23
5168488|NCT01212874|12712410|P1|NOT COMPLETED|Overall Study||22
5168489|NCT01212874|12712409|P2|COMPLETED|Overall Study||12
5168490|NCT01212874|12712410|P1|COMPLETED|Overall Study||13
5168491|NCT01212874|12712409|P2|Received Allocated Intervention|Overall Study||12
5168492|NCT01212874|12712410|P1|Received Allocated Intervention|Overall Study||13
5168493|NCT01212874|12712409|P2|STARTED|Overall Study||35
5168494|NCT01212874|12712410|P1|STARTED|Overall Study||35
5168495|NCT01212770|12712421|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
5168496|NCT01212770|12712422|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
5168497|NCT01212770|12712423|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5168498|NCT01212770|12712424|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5168499|NCT01212770|12712425|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5168500|NCT01212770|12712426|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5168501|NCT01212770|12712427|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
5168502|NCT01212770|12712428|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
5168503|NCT01212770|12712429|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
5168504|NCT01212770|12712421|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
5168505|NCT01212770|12712422|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
5168506|NCT01212770|12712423|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
5168507|NCT01212770|12712424|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
5168508|NCT01212770|12712425|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
5168509|NCT01212770|12712426|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
5168510|NCT01212770|12712427|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
5168511|NCT01212770|12712428|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
5168512|NCT01212770|12712429|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
5168513|NCT01212770|12712421|P9|STARTED|Long-term Safety Phase (Year 5)||42
5168514|NCT01212770|12712422|P8|STARTED|Long-term Safety Phase (Year 5)||32
5168515|NCT01212770|12712423|P7|STARTED|Long-term Safety Phase (Year 5)||0
5168516|NCT01212770|12712424|P6|STARTED|Long-term Safety Phase (Year 5)||0
5168517|NCT01212770|12712425|P5|STARTED|Long-term Safety Phase (Year 5)||0
5168518|NCT01212770|12712426|P4|STARTED|Long-term Safety Phase (Year 5)||0
5168519|NCT01212770|12712427|P3|STARTED|Long-term Safety Phase (Year 5)||83
5168520|NCT01212770|12712428|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
5168521|NCT01212770|12712429|P1|STARTED|Long-term Safety Phase (Year 5)||0
5168522|NCT01212770|12712421|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
5168523|NCT01212770|12712422|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
5168524|NCT01212770|12712423|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5168525|NCT01212770|12712424|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5168526|NCT01212770|12712425|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5168527|NCT01212770|12712426|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5168528|NCT01212770|12712427|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
5168529|NCT01212770|12712428|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
5168530|NCT01212770|12712429|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
5168531|NCT01212770|12712421|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
5168532|NCT01212770|12712422|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
5168533|NCT01212770|12712423|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
5168534|NCT01212770|12712424|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
5168535|NCT01212770|12712425|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
5168536|NCT01212770|12712426|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
5168537|NCT01212770|12712427|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
5168538|NCT01212770|12712428|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
5168539|NCT01212770|12712429|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
5168540|NCT01212770|12712421|P9|STARTED|Long-term Safety Phase (Year 4)||44
5168541|NCT01212770|12712422|P8|STARTED|Long-term Safety Phase (Year 4)||35
5168542|NCT01212770|12712423|P7|STARTED|Long-term Safety Phase (Year 4)||0
5168543|NCT01212770|12712424|P6|STARTED|Long-term Safety Phase (Year 4)||0
5168544|NCT01212770|12712425|P5|STARTED|Long-term Safety Phase (Year 4)||0
5168545|NCT01212770|12712426|P4|STARTED|Long-term Safety Phase (Year 4)||0
5168546|NCT01212770|12712427|P3|STARTED|Long-term Safety Phase (Year 4)||94
5168547|NCT01212770|12712428|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
5168548|NCT01212770|12712429|P1|STARTED|Long-term Safety Phase (Year 4)||0
5168549|NCT01212770|12712421|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
5168550|NCT01212770|12712422|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
5168551|NCT01212770|12712423|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5168552|NCT01212770|12712424|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5168553|NCT01212770|12712425|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5168554|NCT01212770|12712426|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5168555|NCT01212770|12712427|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
5168556|NCT01212770|12712428|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
5168557|NCT01212770|12712429|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
5168558|NCT01212770|12712421|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
5168559|NCT01212770|12712422|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
5168560|NCT01212770|12712423|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
5168561|NCT01212770|12712424|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
5168562|NCT01212770|12712425|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
5168563|NCT01212770|12712426|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
5168564|NCT01212770|12712427|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
5168565|NCT01212770|12712428|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
5168566|NCT01212770|12712429|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
5168567|NCT01212770|12712421|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
5168568|NCT01212770|12712422|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
5168569|NCT01212770|12712423|P7|STARTED|Long-term Safety Phase (Year 3)||0
5168570|NCT01212770|12712424|P6|STARTED|Long-term Safety Phase (Year 3)||0
5168571|NCT01212770|12712425|P5|STARTED|Long-term Safety Phase (Year 3)||0
5168572|NCT01212770|12712426|P4|STARTED|Long-term Safety Phase (Year 3)||0
5168573|NCT01212770|12712427|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
5168574|NCT01212770|12712428|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
5168575|NCT01212770|12712429|P1|STARTED|Long-term Safety Phase (Year 3)||0
5168576|NCT01212770|12712421|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
5168577|NCT01212770|12712422|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
5168578|NCT01212770|12712423|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5168579|NCT01212770|12712424|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5168580|NCT01212770|12712425|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5168581|NCT01212770|12712426|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5168582|NCT01212770|12712427|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
5168583|NCT01212770|12712428|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
5168584|NCT01212770|12712429|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
5168585|NCT01212770|12712421|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
5168586|NCT01212770|12712422|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
5168587|NCT01212770|12712423|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
5168588|NCT01212770|12712424|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
5168589|NCT01212770|12712425|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
5168590|NCT01212770|12712426|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
5168591|NCT01212770|12712427|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
5168592|NCT01212770|12712428|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
5168593|NCT01212770|12712429|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
5168594|NCT01212770|12712421|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
5168595|NCT01212770|12712422|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
5168596|NCT01212770|12712423|P7|STARTED|Long-term Safety Phase (Year 2)||0
5168597|NCT01212770|12712424|P6|STARTED|Long-term Safety Phase (Year 2)||0
5168598|NCT01212770|12712425|P5|STARTED|Long-term Safety Phase (Year 2)||0
5168599|NCT01212770|12712426|P4|STARTED|Long-term Safety Phase (Year 2)||0
5168600|NCT01212770|12712427|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
5168601|NCT01212770|12712428|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
5168602|NCT01212770|12712429|P1|STARTED|Long-term Safety Phase (Year 2)||0
5168603|NCT01212770|12712421|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168604|NCT01212770|12712422|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168605|NCT01212770|12712423|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
5168606|NCT01212770|12712424|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
5168607|NCT01212770|12712425|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
5168608|NCT01212770|12712426|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
5168609|NCT01212770|12712427|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
5168610|NCT01212770|12712428|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
5168611|NCT01212770|12712429|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168612|NCT01212770|12712421|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168613|NCT01212770|12712422|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168614|NCT01212770|12712423|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
5168615|NCT01212770|12712424|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
5168616|NCT01212770|12712425|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
5168617|NCT01212770|12712426|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
5168618|NCT01212770|12712427|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
5168619|NCT01212770|12712428|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
5168620|NCT01212770|12712429|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
5168621|NCT01212770|12712421|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
5168622|NCT01212770|12712422|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
5168623|NCT01212770|12712423|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
5168624|NCT01212770|12712424|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
5168625|NCT01212770|12712425|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
5168626|NCT01212770|12712426|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
5168627|NCT01212770|12712427|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
5168628|NCT01212770|12712428|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
5168629|NCT01212770|12712429|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
5168630|NCT01212770|12712421|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168631|NCT01212770|12712422|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168632|NCT01212770|12712423|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168633|NCT01212770|12712424|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168634|NCT01212770|12712425|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168635|NCT01212770|12712426|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168636|NCT01212770|12712427|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
5168637|NCT01212770|12712428|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
5168638|NCT01212770|12712429|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
5168639|NCT01212770|12712421|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168640|NCT01212770|12712422|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168641|NCT01212770|12712423|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168642|NCT01212770|12712424|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168643|NCT01212770|12712425|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168644|NCT01212770|12712426|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168645|NCT01212770|12712427|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
5168646|NCT01212770|12712428|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
5168647|NCT01212770|12712429|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
5168648|NCT01212770|12712421|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168649|NCT01212770|12712422|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168650|NCT01212770|12712423|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168651|NCT01212770|12712424|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168652|NCT01212770|12712425|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168653|NCT01212770|12712426|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168654|NCT01212770|12712427|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
5168655|NCT01212770|12712428|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
5168656|NCT01212770|12712429|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
5168657|NCT01212770|12712421|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168658|NCT01212770|12712422|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168659|NCT01212770|12712423|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168660|NCT01212770|12712424|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168661|NCT01212770|12712425|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168662|NCT01212770|12712426|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168663|NCT01212770|12712427|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
5168664|NCT01212770|12712428|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
5168665|NCT01212770|12712429|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
5168666|NCT01212770|12712421|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168667|NCT01212770|12712422|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168668|NCT01212770|12712423|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168669|NCT01212770|12712424|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168670|NCT01212770|12712425|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168671|NCT01212770|12712426|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168672|NCT01212770|12712427|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
5168673|NCT01212770|12712428|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
5168674|NCT01212770|12712429|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
5168675|NCT01212770|12712421|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168676|NCT01212770|12712422|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168677|NCT01212770|12712423|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168678|NCT01212770|12712424|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168679|NCT01212770|12712425|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168680|NCT01212770|12712426|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168681|NCT01212770|12712427|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
5168682|NCT01212770|12712428|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
5168683|NCT01212770|12712429|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
5168684|NCT01212757|12712626|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
5168685|NCT01212757|12712627|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
5168686|NCT01212757|12712628|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
5168687|NCT01212757|12712629|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
5168688|NCT01212757|12712630|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
5168689|NCT01212757|12712631|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
5168690|NCT01212757|12712632|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
5168691|NCT01212757|12712633|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
5168692|NCT01212757|12712634|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
5168693|NCT01212757|12712626|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
5168694|NCT01212757|12712627|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
5168695|NCT01212757|12712628|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
5168696|NCT01212757|12712629|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
5168697|NCT01212757|12712630|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
5168698|NCT01212757|12712631|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
5168699|NCT01212757|12712632|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
5168700|NCT01212757|12712633|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
5168701|NCT01212757|12712634|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
5168702|NCT01212757|12712626|P9|STARTED|Long-Term Safety Phase (Year 5)||39
5168703|NCT01212757|12712627|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
5168704|NCT01212757|12712628|P7|STARTED|Long-Term Safety Phase (Year 5)||0
5168705|NCT01212757|12712629|P6|STARTED|Long-Term Safety Phase (Year 5)||0
5168706|NCT01212757|12712630|P5|STARTED|Long-Term Safety Phase (Year 5)||0
5168707|NCT01212757|12712631|P4|STARTED|Long-Term Safety Phase (Year 5)||0
5168708|NCT01212757|12712632|P3|STARTED|Long-Term Safety Phase (Year 5)||77
5168709|NCT01212757|12712633|P2|STARTED|Long-Term Safety Phase (Year 5)||80
5168710|NCT01212757|12712634|P1|STARTED|Long-Term Safety Phase (Year 5)||0
5168711|NCT01212757|12712626|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
5168712|NCT01212757|12712627|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
5168713|NCT01212757|12712628|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
5168714|NCT01212757|12712629|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
5168715|NCT01212757|12712630|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
5168716|NCT01212757|12712631|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
5168717|NCT01212757|12712632|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
5168718|NCT01212757|12712633|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
5168719|NCT01212757|12712634|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
5168720|NCT01212757|12712626|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
5168721|NCT01212757|12712627|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
5168722|NCT01212757|12712628|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
5168723|NCT01212757|12712629|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
5168724|NCT01212757|12712630|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
5168725|NCT01212757|12712631|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
5168726|NCT01212757|12712632|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
5168727|NCT01212757|12712633|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
5168728|NCT01212757|12712634|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
5168729|NCT01212757|12712626|P9|STARTED|Long-Term Safety Phase (Year 4)||46
5168730|NCT01212757|12712627|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
5168731|NCT01212757|12712628|P7|STARTED|Long-Term Safety Phase (Year 4)||0
5168732|NCT01212757|12712629|P6|STARTED|Long-Term Safety Phase (Year 4)||0
5168733|NCT01212757|12712630|P5|STARTED|Long-Term Safety Phase (Year 4)||0
5168734|NCT01212757|12712631|P4|STARTED|Long-Term Safety Phase (Year 4)||0
5168735|NCT01212757|12712632|P3|STARTED|Long-Term Safety Phase (Year 4)||84
5168736|NCT01212757|12712633|P2|STARTED|Long-Term Safety Phase (Year 4)||89
5168737|NCT01212757|12712634|P1|STARTED|Long-Term Safety Phase (Year 4)||0
5168738|NCT01212757|12712626|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
5168739|NCT01212757|12712627|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
5168740|NCT01212757|12712628|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
5168741|NCT01212757|12712629|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
5168742|NCT01212757|12712630|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
5168743|NCT01212757|12712631|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
5168744|NCT01212757|12712632|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
5168745|NCT01212757|12712633|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
5168746|NCT01212757|12712634|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
5168747|NCT01212757|12712626|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
5168748|NCT01212757|12712627|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
5168749|NCT01212757|12712628|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
5168750|NCT01212757|12712629|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
5168751|NCT01212757|12712630|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
5168752|NCT01212757|12712631|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
5168753|NCT01212757|12712632|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
5168754|NCT01212757|12712633|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
5168755|NCT01212757|12712634|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
5168756|NCT01212757|12712626|P9|STARTED|Long-Term Safety Phase (Year 3)||51
5168757|NCT01212757|12712627|P8|STARTED|Long-Term Safety Phase (Year 3)||48
5168758|NCT01212757|12712628|P7|STARTED|Long-Term Safety Phase (Year 3)||0
5168759|NCT01212757|12712629|P6|STARTED|Long-Term Safety Phase (Year 3)||0
5168760|NCT01212757|12712630|P5|STARTED|Long-Term Safety Phase (Year 3)||0
5168761|NCT01212757|12712631|P4|STARTED|Long-Term Safety Phase (Year 3)||0
5168762|NCT01212757|12712632|P3|STARTED|Long-Term Safety Phase (Year 3)||95
5168763|NCT01212757|12712633|P2|STARTED|Long-Term Safety Phase (Year 3)||107
5168764|NCT01212757|12712634|P1|STARTED|Long-Term Safety Phase (Year 3)||0
5168765|NCT01212757|12712626|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
5168766|NCT01212757|12712627|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
5168767|NCT01212757|12712628|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
5168768|NCT01212757|12712629|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
5168769|NCT01212757|12712630|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
5168770|NCT01212757|12712631|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
5168771|NCT01212757|12712632|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
5168772|NCT01212757|12712633|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
5168773|NCT01212757|12712634|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
5168774|NCT01212757|12712626|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
5168775|NCT01212757|12712627|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
5168776|NCT01212757|12712628|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
5168777|NCT01212757|12712629|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
5168778|NCT01212757|12712630|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
5168779|NCT01212757|12712631|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
5168780|NCT01212757|12712632|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
5168781|NCT01212757|12712633|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
5168782|NCT01212757|12712634|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
5168783|NCT01212757|12712626|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
5168784|NCT01212757|12712627|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
5168785|NCT01212757|12712628|P7|STARTED|Long-Term Safety Phase (Year 2)||0
5168786|NCT01212757|12712629|P6|STARTED|Long-Term Safety Phase (Year 2)||0
5168787|NCT01212757|12712630|P5|STARTED|Long-Term Safety Phase (Year 2)||0
5168788|NCT01212757|12712631|P4|STARTED|Long-Term Safety Phase (Year 2)||0
5168789|NCT01212757|12712632|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
5168790|NCT01212757|12712633|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
5168791|NCT01212757|12712634|P1|STARTED|Long-Term Safety Phase (Year 2)||0
5168792|NCT01212757|12712626|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168793|NCT01212757|12712627|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168794|NCT01212757|12712628|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168795|NCT01212757|12712629|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
5168796|NCT01212757|12712630|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
5168797|NCT01212757|12712631|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
5168798|NCT01212757|12712632|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
5168799|NCT01212757|12712633|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
5168800|NCT01212757|12712634|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168801|NCT01212757|12712626|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168802|NCT01212757|12712627|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168803|NCT01212757|12712628|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
5168804|NCT01212757|12712629|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
5168805|NCT01212757|12712630|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
5168806|NCT01212757|12712631|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
5168807|NCT01212757|12712632|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
5168808|NCT01212757|12712633|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
5168809|NCT01212757|12712634|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
5168810|NCT01212757|12712626|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
5168811|NCT01212757|12712627|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
5168812|NCT01212757|12712628|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
5168813|NCT01212757|12712629|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
5168814|NCT01212757|12712630|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
5168815|NCT01212757|12712631|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
5168816|NCT01212757|12712632|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
5168817|NCT01212757|12712633|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
5168818|NCT01212757|12712634|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
5168819|NCT01212757|12712626|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168820|NCT01212757|12712627|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168821|NCT01212757|12712628|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168822|NCT01212757|12712629|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168823|NCT01212757|12712630|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168824|NCT01212757|12712631|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168825|NCT01212757|12712632|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
5168826|NCT01212757|12712633|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
5168827|NCT01212757|12712634|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
5168828|NCT01212757|12712626|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168829|NCT01212757|12712627|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168830|NCT01212757|12712628|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168831|NCT01212757|12712629|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168832|NCT01212757|12712630|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168833|NCT01212757|12712631|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
5168834|NCT01212757|12712632|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
5168835|NCT01212757|12712633|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
5168836|NCT01212757|12712634|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
5168837|NCT01212757|12712626|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168838|NCT01212757|12712627|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168839|NCT01212757|12712628|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168840|NCT01212757|12712629|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168841|NCT01212757|12712630|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168842|NCT01212757|12712631|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168843|NCT01212757|12712632|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
5168844|NCT01212757|12712633|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
5168845|NCT01212757|12712634|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
5168846|NCT01212757|12712626|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168847|NCT01212757|12712627|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168848|NCT01212757|12712628|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168849|NCT01212757|12712629|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168850|NCT01212757|12712630|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168851|NCT01212757|12712631|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
5168852|NCT01212757|12712632|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
5168853|NCT01212757|12712633|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
5168854|NCT01212757|12712634|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
5168855|NCT01212757|12712626|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168856|NCT01212757|12712627|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168857|NCT01212757|12712628|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168858|NCT01212757|12712629|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168859|NCT01212757|12712630|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168860|NCT01212757|12712631|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
5168861|NCT01212757|12712632|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
5168862|NCT01212757|12712633|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
5168863|NCT01212757|12712634|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
5168864|NCT01212757|12712626|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168865|NCT01212757|12712627|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168866|NCT01212757|12712628|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168867|NCT01212757|12712629|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168868|NCT01212757|12712630|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168869|NCT01212757|12712631|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
5168870|NCT01212757|12712632|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
5168871|NCT01212757|12712633|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
5168872|NCT01212757|12712634|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
5168873|NCT01212744|12712818|P1|NOT COMPLETED|Overall Study||1
5168874|NCT01212744|12712818|P1|COMPLETED|Overall Study||15
5168875|NCT01212744|12712818|P1|STARTED|Overall Study||16
5168876|NCT01212627|12712831|P1|NOT COMPLETED|Overall Study||0
5168877|NCT01212627|12712831|P1|COMPLETED|Overall Study||12
5168878|NCT01212627|12712831|P1|STARTED|Overall Study||12
5168879|NCT01212588|12712837|P2|NOT COMPLETED|Overall Study||2
5168880|NCT01212588|12712838|P1|NOT COMPLETED|Overall Study||1
5168881|NCT01212588|12712837|P2|COMPLETED|Overall Study||10
5168882|NCT01212588|12712838|P1|COMPLETED|Overall Study||9
5168883|NCT01212588|12712837|P2|STARTED|Overall Study||12
5168884|NCT01212588|12712838|P1|STARTED|Overall Study||10
5168885|NCT01212484|12712872|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
5168886|NCT01212484|12712873|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5168887|NCT01212484|12712872|P2|COMPLETED|Second Intervention (4 Weeks)||3
5168888|NCT01212484|12712873|P1|COMPLETED|Second Intervention (4 Weeks)||5
5168889|NCT01212484|12712872|P2|STARTED|Second Intervention (4 Weeks)||4
5168890|NCT01212484|12712873|P1|STARTED|Second Intervention (4 Weeks)||5
5168891|NCT01212484|12712872|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
5168892|NCT01212484|12712873|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5168893|NCT01212484|12712872|P2|COMPLETED|First Intervention (4 Weeks)||4
5168894|NCT01212484|12712873|P1|COMPLETED|First Intervention (4 Weeks)||5
5168895|NCT01212484|12712872|P2|STARTED|First Intervention (4 Weeks)||6
5168896|NCT01212484|12712873|P1|STARTED|First Intervention (4 Weeks)||5
5168897|NCT01212484|12712872|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
5168898|NCT01212484|12712873|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
5168899|NCT01212484|12712872|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
5168900|NCT01212484|12712873|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
5168901|NCT01212484|12712872|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
5168902|NCT01212484|12712873|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
5168903|NCT01212445|12712886|P3|NOT COMPLETED|Overall Study||0
5168904|NCT01212445|12712887|P2|NOT COMPLETED|Overall Study||0
5168905|NCT01212445|12712888|P1|NOT COMPLETED|Overall Study||0
5168906|NCT01212445|12712886|P3|COMPLETED|Overall Study||51
5168907|NCT01212445|12712887|P2|COMPLETED|Overall Study||51
5168908|NCT01212445|12712888|P1|COMPLETED|Overall Study||52
5168909|NCT01212445|12712886|P3|STARTED|Overall Study||51
5168910|NCT01212445|12712887|P2|STARTED|Overall Study||51
5168911|NCT01212445|12712888|P1|STARTED|Overall Study||52
5168912|NCT01212302|12712917|P1|NOT COMPLETED|Overall Study||0
5168913|NCT01212302|12712917|P1|COMPLETED|Overall Study||504
5168914|NCT01212302|12712917|P1|STARTED|Overall Study||504
5168915|NCT01212185|12712923|P2|NOT COMPLETED|Overall Study||1
5168916|NCT01212185|12712924|P1|NOT COMPLETED|Overall Study||2
5168917|NCT01212185|12712923|P2|COMPLETED|Overall Study||7
5168918|NCT01212185|12712924|P1|COMPLETED|Overall Study||4
5168919|NCT01212185|12712923|P2|STARTED|Overall Study||8
5168920|NCT01212185|12712924|P1|STARTED|Overall Study||6
5168921|NCT01212172|12712932|P2|NOT COMPLETED|Overall Study||1
5168922|NCT01212172|12712933|P1|NOT COMPLETED|Overall Study||1
5168923|NCT01212172|12712932|P2|COMPLETED|Overall Study||9
5168924|NCT01212172|12712933|P1|COMPLETED|Overall Study||9
5168925|NCT01212172|12712932|P2|STARTED|Overall Study||10
5168926|NCT01212172|12712933|P1|STARTED|Overall Study||10
5168927|NCT01212159|12712943|P2|NOT COMPLETED|Overall Study||12
5168928|NCT01212159|12712944|P1|NOT COMPLETED|Overall Study||12
5168929|NCT01212159|12712943|P2|COMPLETED|Overall Study||32
5168930|NCT01212159|12712944|P1|COMPLETED|Overall Study||14
5168931|NCT01212159|12712943|P2|STARTED|Overall Study||44
5168932|NCT01212159|12712944|P1|STARTED|Overall Study||26
5168933|NCT01212107|12712966|P12|NOT COMPLETED|Overall Study||32
5168934|NCT01212107|12712967|P11|NOT COMPLETED|Overall Study||1
5168935|NCT01212107|12712968|P10|NOT COMPLETED|Overall Study||2
5168936|NCT01212107|12712969|P9|NOT COMPLETED|Overall Study||2
5168937|NCT01212107|12712970|P8|NOT COMPLETED|Overall Study||1
5168938|NCT01212107|12712971|P7|NOT COMPLETED|Overall Study||0
5168939|NCT01212107|12712972|P6|NOT COMPLETED|Overall Study||1
5168940|NCT01212107|12712973|P5|NOT COMPLETED|Overall Study||1
5168941|NCT01212107|12712974|P4|NOT COMPLETED|Overall Study||0
5168942|NCT01212107|12712975|P3|NOT COMPLETED|Overall Study||3
5168943|NCT01212107|12712976|P2|NOT COMPLETED|Overall Study||1
5168944|NCT01212107|12712977|P1|NOT COMPLETED|Overall Study||1
5168945|NCT01212107|12712966|P12|COMPLETED|Overall Study||26
5168946|NCT01212107|12712967|P11|COMPLETED|Overall Study||2
5168947|NCT01212107|12712968|P10|COMPLETED|Overall Study||1
5168948|NCT01212107|12712969|P9|COMPLETED|Overall Study||1
5168949|NCT01212107|12712970|P8|COMPLETED|Overall Study||2
5168950|NCT01212107|12712971|P7|COMPLETED|Overall Study||3
5168951|NCT01212107|12712972|P6|COMPLETED|Overall Study||2
5168952|NCT01212107|12712973|P5|COMPLETED|Overall Study||2
5168953|NCT01212107|12712974|P4|COMPLETED|Overall Study||3
5168954|NCT01212107|12712975|P3|COMPLETED|Overall Study||3
5168955|NCT01212107|12712976|P2|COMPLETED|Overall Study||2
5168956|NCT01212107|12712977|P1|COMPLETED|Overall Study||2
5168957|NCT01212107|12712966|P12|STARTED|Overall Study||58
5168958|NCT01212107|12712967|P11|STARTED|Overall Study||3
5168959|NCT01212107|12712968|P10|STARTED|Overall Study||3
5168960|NCT01212107|12712969|P9|STARTED|Overall Study||3
5168961|NCT01212107|12712970|P8|STARTED|Overall Study||3
5168962|NCT01212107|12712971|P7|STARTED|Overall Study||3
5168963|NCT01212107|12712972|P6|STARTED|Overall Study||3
5168964|NCT01212107|12712973|P5|STARTED|Overall Study||3
5168965|NCT01212107|12712974|P4|STARTED|Overall Study||3
5168966|NCT01212107|12712975|P3|STARTED|Overall Study||6
5168967|NCT01212107|12712976|P2|STARTED|Overall Study||3
5168968|NCT01212107|12712977|P1|STARTED|Overall Study||3
5168969|NCT01212094|12713043|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
5168970|NCT01212094|12713044|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
5168971|NCT01212094|12713045|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
5168972|NCT01212094|12713043|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
5168973|NCT01212094|12713044|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
5168974|NCT01212094|12713045|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
5168975|NCT01212094|12713043|P3|STARTED|Years 2 & 3: Treatment Randomization||18
5168976|NCT01212094|12713044|P2|STARTED|Years 2 & 3: Treatment Randomization||9
5168977|NCT01212094|12713045|P1|STARTED|Years 2 & 3: Treatment Randomization||0
5168978|NCT01212094|12713043|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
5168979|NCT01212094|12713044|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
5168980|NCT01212094|12713045|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
5168981|NCT01212094|12713043|P3|COMPLETED|Year 1: Baseline Monitoring||0
5168982|NCT01212094|12713044|P2|COMPLETED|Year 1: Baseline Monitoring||0
5168983|NCT01212094|12713045|P1|COMPLETED|Year 1: Baseline Monitoring||27
5168984|NCT01212094|12713043|P3|STARTED|Year 1: Baseline Monitoring||0
5168985|NCT01212094|12713044|P2|STARTED|Year 1: Baseline Monitoring||0
5168986|NCT01212094|12713045|P1|STARTED|Year 1: Baseline Monitoring||43
5168987|NCT01211873|12713079|P3|NOT COMPLETED|Overall Study||2
5168988|NCT01211873|12713080|P2|NOT COMPLETED|Overall Study||2
5168989|NCT01211873|12713081|P1|NOT COMPLETED|Overall Study||5
5168990|NCT01211873|12713079|P3|COMPLETED|Overall Study||36
5168991|NCT01211873|12713080|P2|COMPLETED|Overall Study||117
5168992|NCT01211873|12713081|P1|COMPLETED|Overall Study||240
5168993|NCT01211873|12713079|P3|STARTED|Overall Study||38
5168994|NCT01211873|12713080|P2|STARTED|Overall Study||119
5168995|NCT01211873|12713081|P1|STARTED|Overall Study||245
5168996|NCT01211769|12713104|P4|NOT COMPLETED|Overall Study||11
5168997|NCT01211769|12713105|P3|NOT COMPLETED|Overall Study||8
5168998|NCT01211769|12713106|P2|NOT COMPLETED|Overall Study||10
5168999|NCT01211769|12713107|P1|NOT COMPLETED|Overall Study||9
5169000|NCT01211769|12713104|P4|COMPLETED|Overall Study||9
5169001|NCT01211769|12713105|P3|COMPLETED|Overall Study||12
5169002|NCT01211769|12713106|P2|COMPLETED|Overall Study||10
5169003|NCT01211769|12713107|P1|COMPLETED|Overall Study||11
5169004|NCT01211769|12713104|P4|Participants/Group|Overall Study||20
5169005|NCT01211769|12713105|P3|Participants/Group|Overall Study||20
5169006|NCT01211769|12713106|P2|Participants/Group|Overall Study||20
5169007|NCT01211769|12713107|P1|Participants/Group|Overall Study||20
5169008|NCT01211769|12713104|P4|STARTED|Overall Study||20
5169009|NCT01211769|12713105|P3|STARTED|Overall Study||20
5169010|NCT01211769|12713106|P2|STARTED|Overall Study||20
5169011|NCT01211769|12713107|P1|STARTED|Overall Study||20
5169012|NCT01211756|12713125|P1|NOT COMPLETED|Overall Study||0
5169013|NCT01211756|12713125|P1|COMPLETED|Overall Study||1
5169014|NCT01211756|12713125|P1|STARTED|Overall Study||1
5169015|NCT01211730|12713143|P2|NOT COMPLETED|Overall Study||0
5169016|NCT01211730|12713144|P1|NOT COMPLETED|Overall Study||0
5169017|NCT01211730|12713143|P2|COMPLETED|Overall Study||82
5169018|NCT01211730|12713144|P1|COMPLETED|Overall Study||82
5169019|NCT01211730|12713143|P2|STARTED|Overall Study||82
5169020|NCT01211730|12713144|P1|STARTED|Overall Study||82
5169021|NCT01211665|12713162|P2|NOT COMPLETED|Overall Study||0
5169022|NCT01211665|12713163|P1|NOT COMPLETED|Overall Study||2
5169023|NCT01211665|12713162|P2|COMPLETED|Overall Study|completed treatment with study drug|1
5169024|NCT01211665|12713163|P1|COMPLETED|Overall Study||0
5169025|NCT01211665|12713162|P2|STARTED|Overall Study||1
5169026|NCT01211665|12713163|P1|STARTED|Overall Study||2
5169027|NCT01211613|12713190|P3|NOT COMPLETED|Overall Study||2
5169028|NCT01211613|12713191|P2|NOT COMPLETED|Overall Study||2
5169029|NCT01211613|12713192|P1|NOT COMPLETED|Overall Study||3
5169030|NCT01211613|12713190|P3|COMPLETED|Overall Study||33
5169031|NCT01211613|12713191|P2|COMPLETED|Overall Study||33
5169032|NCT01211613|12713192|P1|COMPLETED|Overall Study||34
5169033|NCT01211613|12713190|P3|STARTED|Overall Study||35
5169034|NCT01211613|12713191|P2|STARTED|Overall Study||35
5169035|NCT01211613|12713192|P1|STARTED|Overall Study||37
5169036|NCT01211600|12713205|P2|NOT COMPLETED|Overall Study||0
5169037|NCT01211600|12713206|P1|NOT COMPLETED|Overall Study||0
5169038|NCT01211600|12713205|P2|COMPLETED|Overall Study||376
5169039|NCT01211600|12713206|P1|COMPLETED|Overall Study||370
5169040|NCT01211600|12713205|P2|STARTED|Overall Study||376
5169041|NCT01211600|12713206|P1|STARTED|Overall Study||370
5169042|NCT01211535|12713238|P2|NOT COMPLETED|Overall Study||1
5169043|NCT01211535|12713239|P1|NOT COMPLETED|Overall Study||0
5169044|NCT01211535|12713238|P2|COMPLETED|Overall Study||51
5169045|NCT01211535|12713239|P1|COMPLETED|Overall Study||52
5169046|NCT01211535|12713238|P2|STARTED|Overall Study||52
5169047|NCT01211535|12713239|P1|STARTED|Overall Study||52
5169048|NCT01211522|12713248|P3|NOT COMPLETED|Overall Study||5
5169049|NCT01211522|12713249|P2|NOT COMPLETED|Overall Study||7
5169050|NCT01211522|12713250|P1|NOT COMPLETED|Overall Study||3
5169051|NCT01211522|12713248|P3|COMPLETED|Overall Study||179
5169052|NCT01211522|12713249|P2|COMPLETED|Overall Study||183
5169053|NCT01211522|12713250|P1|COMPLETED|Overall Study||189
5169054|NCT01211522|12713248|P3|STARTED|Overall Study||184
5169055|NCT01211522|12713249|P2|STARTED|Overall Study||190
5169056|NCT01211522|12713250|P1|STARTED|Overall Study||192
5169057|NCT01211340|12713287|P2|NOT COMPLETED|Overall Study||0
5169058|NCT01211340|12713288|P1|NOT COMPLETED|Overall Study||0
5169059|NCT01211340|12713287|P2|COMPLETED|Overall Study||223
5169060|NCT01211340|12713288|P1|COMPLETED|Overall Study||223
5169061|NCT01211340|12713287|P2|STARTED|Overall Study||223
5169062|NCT01211340|12713288|P1|STARTED|Overall Study||223
5169063|NCT01211288|12713300|P2|NOT COMPLETED|Overall Study||1
5169064|NCT01211288|12713301|P1|NOT COMPLETED|Overall Study||1
5169065|NCT01211288|12713300|P2|COMPLETED|Overall Study||19
5169066|NCT01211288|12713301|P1|COMPLETED|Overall Study||20
5169067|NCT01211288|12713300|P2|STARTED|Overall Study||20
5169068|NCT01211288|12713301|P1|STARTED|Overall Study||21
5169069|NCT01211262|12713319|P2|NOT COMPLETED|Overall Study||10
5169070|NCT01211262|12713320|P1|NOT COMPLETED|Overall Study||23
5169071|NCT01211262|12713319|P2|COMPLETED|Overall Study||8
5169072|NCT01211262|12713320|P1|COMPLETED|Overall Study||43
5169073|NCT01211262|12713319|P2|STARTED|Overall Study||18
5169074|NCT01211262|12713320|P1|STARTED|Overall Study||66
5169075|NCT01211197|12713360|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169076|NCT01211197|12713361|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169077|NCT01211197|12713362|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169078|NCT01211197|12713363|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169079|NCT01211197|12713364|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169080|NCT01211197|12713365|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
5169081|NCT01211197|12713360|P6|COMPLETED|Treatment Period 3 (1 Day)||2
5169082|NCT01211197|12713361|P5|COMPLETED|Treatment Period 3 (1 Day)||2
5169083|NCT01211197|12713362|P4|COMPLETED|Treatment Period 3 (1 Day)||3
5169084|NCT01211197|12713363|P3|COMPLETED|Treatment Period 3 (1 Day)||2
5169085|NCT01211197|12713364|P2|COMPLETED|Treatment Period 3 (1 Day)||3
5169086|NCT01211197|12713365|P1|COMPLETED|Treatment Period 3 (1 Day)||2
5169087|NCT01211197|12713360|P6|STARTED|Treatment Period 3 (1 Day)||2
5169088|NCT01211197|12713361|P5|STARTED|Treatment Period 3 (1 Day)||2
5169089|NCT01211197|12713362|P4|STARTED|Treatment Period 3 (1 Day)||3
5169090|NCT01211197|12713363|P3|STARTED|Treatment Period 3 (1 Day)||2
5169091|NCT01211197|12713364|P2|STARTED|Treatment Period 3 (1 Day)||3
5169092|NCT01211197|12713365|P1|STARTED|Treatment Period 3 (1 Day)||2
5169093|NCT01211197|12713360|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5169094|NCT01211197|12713361|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5169095|NCT01211197|12713362|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5169096|NCT01211197|12713363|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5169097|NCT01211197|12713364|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5169098|NCT01211197|12713365|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
5169099|NCT01211197|12713360|P6|COMPLETED|Washout Period 2 (7 Days)||2
5169100|NCT01211197|12713361|P5|COMPLETED|Washout Period 2 (7 Days)||2
5169101|NCT01211197|12713362|P4|COMPLETED|Washout Period 2 (7 Days)||3
5169102|NCT01211197|12713363|P3|COMPLETED|Washout Period 2 (7 Days)||2
5169103|NCT01211197|12713364|P2|COMPLETED|Washout Period 2 (7 Days)||3
5169104|NCT01211197|12713365|P1|COMPLETED|Washout Period 2 (7 Days)||2
5169105|NCT01211197|12713360|P6|STARTED|Washout Period 2 (7 Days)||2
5169106|NCT01211197|12713361|P5|STARTED|Washout Period 2 (7 Days)||2
5169107|NCT01211197|12713362|P4|STARTED|Washout Period 2 (7 Days)||3
5169108|NCT01211197|12713363|P3|STARTED|Washout Period 2 (7 Days)||2
5169109|NCT01211197|12713364|P2|STARTED|Washout Period 2 (7 Days)||3
5169110|NCT01211197|12713365|P1|STARTED|Washout Period 2 (7 Days)||3
5169111|NCT01211197|12713360|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169112|NCT01211197|12713361|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169113|NCT01211197|12713362|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169114|NCT01211197|12713363|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169115|NCT01211197|12713364|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169116|NCT01211197|12713365|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5169117|NCT01211197|12713360|P6|COMPLETED|Treatment Period 2 (1 Day)||2
5169118|NCT01211197|12713361|P5|COMPLETED|Treatment Period 2 (1 Day)||2
5169119|NCT01211197|12713362|P4|COMPLETED|Treatment Period 2 (1 Day)||3
5169120|NCT01211197|12713363|P3|COMPLETED|Treatment Period 2 (1 Day)||2
5169121|NCT01211197|12713364|P2|COMPLETED|Treatment Period 2 (1 Day)||3
5169122|NCT01211197|12713365|P1|COMPLETED|Treatment Period 2 (1 Day)||3
5169123|NCT01211197|12713360|P6|STARTED|Treatment Period 2 (1 Day)||2
5169124|NCT01211197|12713361|P5|STARTED|Treatment Period 2 (1 Day)||2
5169125|NCT01211197|12713362|P4|STARTED|Treatment Period 2 (1 Day)||3
5169126|NCT01211197|12713363|P3|STARTED|Treatment Period 2 (1 Day)||2
5169127|NCT01211197|12713364|P2|STARTED|Treatment Period 2 (1 Day)||3
5169128|NCT01211197|12713365|P1|STARTED|Treatment Period 2 (1 Day)||3
5169129|NCT01211197|12713360|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
5169130|NCT01211197|12713361|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5169131|NCT01211197|12713362|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5169132|NCT01211197|12713363|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
5169133|NCT01211197|12713364|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5169134|NCT01211197|12713365|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5169135|NCT01211197|12713360|P6|COMPLETED|Washout Period 1 (7 Days)||2
5169136|NCT01211197|12713361|P5|COMPLETED|Washout Period 1 (7 Days)||2
5169137|NCT01211197|12713362|P4|COMPLETED|Washout Period 1 (7 Days)||3
5169138|NCT01211197|12713363|P3|COMPLETED|Washout Period 1 (7 Days)||2
5169139|NCT01211197|12713364|P2|COMPLETED|Washout Period 1 (7 Days)||3
5169140|NCT01211197|12713365|P1|COMPLETED|Washout Period 1 (7 Days)||3
5169141|NCT01211197|12713360|P6|STARTED|Washout Period 1 (7 Days)||2
5169142|NCT01211197|12713361|P5|STARTED|Washout Period 1 (7 Days)||2
5169143|NCT01211197|12713362|P4|STARTED|Washout Period 1 (7 Days)||3
5169144|NCT01211197|12713363|P3|STARTED|Washout Period 1 (7 Days)||3
5169145|NCT01211197|12713364|P2|STARTED|Washout Period 1 (7 Days)||3
5169146|NCT01211197|12713365|P1|STARTED|Washout Period 1 (7 Days)||3
5169147|NCT01211197|12713360|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169148|NCT01211197|12713361|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169149|NCT01211197|12713362|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169150|NCT01211197|12713363|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169151|NCT01211197|12713364|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169152|NCT01211197|12713365|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5169153|NCT01211197|12713360|P6|COMPLETED|Treatment Period 1 (1 Day)||2
5169154|NCT01211197|12713361|P5|COMPLETED|Treatment Period 1 (1 Day)||2
5169155|NCT01211197|12713362|P4|COMPLETED|Treatment Period 1 (1 Day)||3
5169156|NCT01211197|12713363|P3|COMPLETED|Treatment Period 1 (1 Day)||3
5169157|NCT01211197|12713364|P2|COMPLETED|Treatment Period 1 (1 Day)||3
5169158|NCT01211197|12713365|P1|COMPLETED|Treatment Period 1 (1 Day)||3
5169159|NCT01211197|12713360|P6|STARTED|Treatment Period 1 (1 Day)||2
5169160|NCT01211197|12713361|P5|STARTED|Treatment Period 1 (1 Day)||2
5169161|NCT01211197|12713362|P4|STARTED|Treatment Period 1 (1 Day)||3
5169162|NCT01211197|12713363|P3|STARTED|Treatment Period 1 (1 Day)||3
5169163|NCT01211197|12713364|P2|STARTED|Treatment Period 1 (1 Day)||3
5169164|NCT01211197|12713365|P1|STARTED|Treatment Period 1 (1 Day)||3
5169165|NCT01211184|12713412|P3|NOT COMPLETED|Overall Study||1
5169166|NCT01211184|12713413|P2|NOT COMPLETED|Overall Study||2
5169167|NCT01211184|12713414|P1|NOT COMPLETED|Overall Study||0
5169168|NCT01211184|12713412|P3|COMPLETED|Overall Study||19
5169169|NCT01211184|12713413|P2|COMPLETED|Overall Study||18
5169170|NCT01211184|12713414|P1|COMPLETED|Overall Study||20
5169171|NCT01211184|12713412|P3|STARTED|Overall Study||20
5169172|NCT01211184|12713413|P2|STARTED|Overall Study||20
5169173|NCT01211184|12713414|P1|STARTED|Overall Study||20
5169174|NCT01211145|12713429|P4|NOT COMPLETED|Overall Study||20
5169175|NCT01211145|12713430|P3|NOT COMPLETED|Overall Study||13
5169176|NCT01211145|12713431|P2|NOT COMPLETED|Overall Study||17
5169177|NCT01211145|12713432|P1|NOT COMPLETED|Overall Study||26
5169178|NCT01211145|12713429|P4|COMPLETED|Overall Study||268
5169179|NCT01211145|12713430|P3|COMPLETED|Overall Study||86
5169180|NCT01211145|12713431|P2|COMPLETED|Overall Study||98
5169181|NCT01211145|12713432|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
5169182|NCT01211145|12713429|P4|STARTED|Overall Study||288
5169183|NCT01211145|12713430|P3|STARTED|Overall Study||99
5169184|NCT01211145|12713431|P2|STARTED|Overall Study||115
5169185|NCT01211145|12713432|P1|STARTED|Overall Study||296
5169186|NCT01211106|12713464|P2|NOT COMPLETED|Overall Study||11
5169187|NCT01211106|12713465|P1|NOT COMPLETED|Overall Study||13
5169188|NCT01211106|12713464|P2|COMPLETED|Overall Study||77
5169189|NCT01211106|12713465|P1|COMPLETED|Overall Study||82
5169190|NCT01211106|12713464|P2|STARTED|Overall Study||88
5169191|NCT01211106|12713465|P1|STARTED|Overall Study||95
5169192|NCT01210820|12713475|P2|NOT COMPLETED|Overall Study||0
5169193|NCT01210820|12713476|P1|NOT COMPLETED|Overall Study||0
5169194|NCT01210820|12713475|P2|COMPLETED|Overall Study||4
5169195|NCT01210820|12713476|P1|COMPLETED|Overall Study||17
5169196|NCT01210820|12713475|P2|STARTED|Overall Study||4
5169197|NCT01210820|12713476|P1|STARTED|Overall Study||17
5169198|NCT01210807|12713486|P2|NOT COMPLETED|Overall Study||3
5169199|NCT01210807|12713487|P1|NOT COMPLETED|Overall Study||3
5169200|NCT01210807|12713486|P2|COMPLETED|Overall Study||31
5169201|NCT01210807|12713487|P1|COMPLETED|Overall Study||33
5169202|NCT01210807|12713486|P2|STARTED|Overall Study||34
5169203|NCT01210807|12713487|P1|STARTED|Overall Study||36
5169204|NCT01210716|12713495|P2|NOT COMPLETED|Second TPE Procedure||0
5169205|NCT01210716|12713496|P1|NOT COMPLETED|Second TPE Procedure||3
5169206|NCT01210716|12713495|P2|COMPLETED|Second TPE Procedure||15
5169207|NCT01210716|12713496|P1|COMPLETED|Second TPE Procedure||15
5169208|NCT01210716|12713495|P2|STARTED|Second TPE Procedure||15
5169209|NCT01210716|12713496|P1|STARTED|Second TPE Procedure||18
5169210|NCT01210716|12713495|P2|NOT COMPLETED|First TPE Procedure||2
5169211|NCT01210716|12713496|P1|NOT COMPLETED|First TPE Procedure||2
5169212|NCT01210716|12713495|P2|COMPLETED|First TPE Procedure||15
5169213|NCT01210716|12713496|P1|COMPLETED|First TPE Procedure||18
5169214|NCT01210716|12713495|P2|STARTED|First TPE Procedure||17
5169215|NCT01210716|12713496|P1|STARTED|First TPE Procedure||20
5169216|NCT01210690|12713502|P1|NOT COMPLETED|Overall Study||26
5169217|NCT01210690|12713502|P1|COMPLETED|Overall Study||75
5169218|NCT01210690|12713502|P1|STARTED|Overall Study||101
5169219|NCT01210664|12713515|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
5169220|NCT01210664|12713516|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169221|NCT01210664|12713517|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169222|NCT01210664|12713518|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169223|NCT01210664|12713515|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
5169224|NCT01210664|12713516|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169225|NCT01210664|12713517|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169226|NCT01210664|12713518|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169227|NCT01210664|12713515|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
5169228|NCT01210664|12713516|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169229|NCT01210664|12713517|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169230|NCT01210664|12713518|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169231|NCT01210664|12713515|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
5169232|NCT01210664|12713516|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169233|NCT01210664|12713517|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169234|NCT01210664|12713518|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
5169235|NCT01210664|12713515|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169236|NCT01210664|12713516|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
5169237|NCT01210664|12713517|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169238|NCT01210664|12713518|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169239|NCT01210664|12713515|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169240|NCT01210664|12713516|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
5169241|NCT01210664|12713517|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169242|NCT01210664|12713518|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169243|NCT01210664|12713515|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169244|NCT01210664|12713516|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
5169245|NCT01210664|12713517|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169246|NCT01210664|12713518|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169247|NCT01210664|12713515|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169248|NCT01210664|12713516|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
5169249|NCT01210664|12713517|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169250|NCT01210664|12713518|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
5169251|NCT01210664|12713515|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169252|NCT01210664|12713516|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169253|NCT01210664|12713517|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169254|NCT01210664|12713518|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169255|NCT01210664|12713515|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169256|NCT01210664|12713516|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169257|NCT01210664|12713517|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
5169258|NCT01210664|12713518|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169259|NCT01210664|12713515|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169260|NCT01210664|12713516|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169261|NCT01210664|12713517|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
5169262|NCT01210664|12713518|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169263|NCT01210664|12713515|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169264|NCT01210664|12713516|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169265|NCT01210664|12713517|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
5169266|NCT01210664|12713518|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
5169267|NCT01210664|12713515|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169268|NCT01210664|12713516|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169269|NCT01210664|12713517|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169270|NCT01210664|12713518|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169271|NCT01210664|12713515|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169272|NCT01210664|12713516|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169273|NCT01210664|12713517|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169274|NCT01210664|12713518|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
5169275|NCT01210664|12713515|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169276|NCT01210664|12713516|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169277|NCT01210664|12713517|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169278|NCT01210664|12713518|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
5169279|NCT01210664|12713515|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169280|NCT01210664|12713516|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169281|NCT01210664|12713517|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
5169282|NCT01210664|12713518|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
5169283|NCT01210651|12713546|P2|NOT COMPLETED|Overall Study||8
5169284|NCT01210651|12713547|P1|NOT COMPLETED|Overall Study||5
5169285|NCT01210651|12713546|P2|COMPLETED|Overall Study||10
5169286|NCT01210651|12713547|P1|COMPLETED|Overall Study||15
5169287|NCT01210651|12713546|P2|Number Attending 1st Assigned Session|Overall Study||12
5169288|NCT01210651|12713547|P1|Number Attending 1st Assigned Session|Overall Study||18
5169289|NCT01210651|12713546|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
5169290|NCT01210651|12713547|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
5169291|NCT01210560|12713563|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
5169292|NCT01210560|12713564|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
5169293|NCT01210560|12713565|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
5169294|NCT01210560|12713566|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
5169295|NCT01210560|12713567|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
5169296|NCT01210560|12713568|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
5169297|NCT01210560|12713569|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
5169298|NCT01210560|12713570|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
5169299|NCT01210560|12713571|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
5169300|NCT01210560|12713563|P9|COMPLETED|Intervention 3 (7 Days)||5
5169301|NCT01210560|12713564|P8|COMPLETED|Intervention 3 (7 Days)||4
5169302|NCT01210560|12713565|P7|COMPLETED|Intervention 3 (7 Days)||4
5169303|NCT01210560|12713566|P6|COMPLETED|Intervention 3 (7 Days)||2
5169304|NCT01210560|12713567|P5|COMPLETED|Intervention 3 (7 Days)||2
5169305|NCT01210560|12713568|P4|COMPLETED|Intervention 3 (7 Days)||2
5169306|NCT01210560|12713569|P3|COMPLETED|Intervention 3 (7 Days)||2
5169307|NCT01210560|12713570|P2|COMPLETED|Intervention 3 (7 Days)||2
5169308|NCT01210560|12713571|P1|COMPLETED|Intervention 3 (7 Days)||2
5169309|NCT01210560|12713563|P9|STARTED|Intervention 3 (7 Days)||5
5169310|NCT01210560|12713564|P8|STARTED|Intervention 3 (7 Days)||4
5169311|NCT01210560|12713565|P7|STARTED|Intervention 3 (7 Days)||4
5169312|NCT01210560|12713566|P6|STARTED|Intervention 3 (7 Days)||2
5169313|NCT01210560|12713567|P5|STARTED|Intervention 3 (7 Days)||2
5169314|NCT01210560|12713568|P4|STARTED|Intervention 3 (7 Days)||2
5169315|NCT01210560|12713569|P3|STARTED|Intervention 3 (7 Days)||2
5169316|NCT01210560|12713570|P2|STARTED|Intervention 3 (7 Days)||2
5169317|NCT01210560|12713571|P1|STARTED|Intervention 3 (7 Days)||2
5169318|NCT01210560|12713563|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
5169319|NCT01210560|12713564|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
5169320|NCT01210560|12713565|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
5169321|NCT01210560|12713566|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
5169322|NCT01210560|12713567|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
5169323|NCT01210560|12713568|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
5169324|NCT01210560|12713569|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
5169325|NCT01210560|12713570|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
5169326|NCT01210560|12713571|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
5169327|NCT01210560|12713563|P9|COMPLETED|Intervention 2 (7 Days)||5
5169328|NCT01210560|12713564|P8|COMPLETED|Intervention 2 (7 Days)||4
5169329|NCT01210560|12713565|P7|COMPLETED|Intervention 2 (7 Days)||4
5169330|NCT01210560|12713566|P6|COMPLETED|Intervention 2 (7 Days)||2
5169331|NCT01210560|12713567|P5|COMPLETED|Intervention 2 (7 Days)||2
5169332|NCT01210560|12713568|P4|COMPLETED|Intervention 2 (7 Days)||2
5169333|NCT01210560|12713569|P3|COMPLETED|Intervention 2 (7 Days)||2
5169334|NCT01210560|12713570|P2|COMPLETED|Intervention 2 (7 Days)||2
5169335|NCT01210560|12713571|P1|COMPLETED|Intervention 2 (7 Days)||2
5169336|NCT01210560|12713563|P9|STARTED|Intervention 2 (7 Days)||5
5169337|NCT01210560|12713564|P8|STARTED|Intervention 2 (7 Days)||4
5169338|NCT01210560|12713565|P7|STARTED|Intervention 2 (7 Days)||4
5169339|NCT01210560|12713566|P6|STARTED|Intervention 2 (7 Days)||2
5169340|NCT01210560|12713567|P5|STARTED|Intervention 2 (7 Days)||2
5169341|NCT01210560|12713568|P4|STARTED|Intervention 2 (7 Days)||2
5169342|NCT01210560|12713569|P3|STARTED|Intervention 2 (7 Days)||2
5169343|NCT01210560|12713570|P2|STARTED|Intervention 2 (7 Days)||2
5169344|NCT01210560|12713571|P1|STARTED|Intervention 2 (7 Days)||2
5169345|NCT01210560|12713563|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
5169346|NCT01210560|12713564|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
5169347|NCT01210560|12713565|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
5169348|NCT01210560|12713566|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
5169349|NCT01210560|12713567|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
5169350|NCT01210560|12713568|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
5169351|NCT01210560|12713569|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
5169352|NCT01210560|12713570|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
5169353|NCT01210560|12713571|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
5169354|NCT01210560|12713563|P9|COMPLETED|Intervention 1 (7 Days)||5
5169355|NCT01210560|12713564|P8|COMPLETED|Intervention 1 (7 Days)||4
5169356|NCT01210560|12713565|P7|COMPLETED|Intervention 1 (7 Days)||4
5169357|NCT01210560|12713566|P6|COMPLETED|Intervention 1 (7 Days)||2
5169358|NCT01210560|12713567|P5|COMPLETED|Intervention 1 (7 Days)||2
5169359|NCT01210560|12713568|P4|COMPLETED|Intervention 1 (7 Days)||2
5169360|NCT01210560|12713569|P3|COMPLETED|Intervention 1 (7 Days)||2
5169361|NCT01210560|12713570|P2|COMPLETED|Intervention 1 (7 Days)||2
5169362|NCT01210560|12713571|P1|COMPLETED|Intervention 1 (7 Days)||2
5169363|NCT01210560|12713563|P9|STARTED|Intervention 1 (7 Days)||5
5169364|NCT01210560|12713564|P8|STARTED|Intervention 1 (7 Days)||4
5169365|NCT01210560|12713565|P7|STARTED|Intervention 1 (7 Days)||4
5169366|NCT01210560|12713566|P6|STARTED|Intervention 1 (7 Days)||2
5169367|NCT01210560|12713567|P5|STARTED|Intervention 1 (7 Days)||2
5169368|NCT01210560|12713568|P4|STARTED|Intervention 1 (7 Days)||2
5169369|NCT01210560|12713569|P3|STARTED|Intervention 1 (7 Days)||2
5169370|NCT01210560|12713570|P2|STARTED|Intervention 1 (7 Days)||2
5169371|NCT01210560|12713571|P1|STARTED|Intervention 1 (7 Days)||2
5169372|NCT01210495|12713667|P4|NOT COMPLETED|Overall Study||68
5169373|NCT01210495|12713668|P3|NOT COMPLETED|Overall Study||134
5169374|NCT01210495|12713669|P2|NOT COMPLETED|Overall Study||7
5169375|NCT01210495|12713670|P1|NOT COMPLETED|Overall Study||15
5169376|NCT01210495|12713667|P4|COMPLETED|Overall Study||0
5169377|NCT01210495|12713668|P3|COMPLETED|Overall Study||0
5169378|NCT01210495|12713669|P2|COMPLETED|Overall Study||0
5169379|NCT01210495|12713670|P1|COMPLETED|Overall Study||0
5169380|NCT01210495|12713667|P4|STARTED|Overall Study||68
5169381|NCT01210495|12713668|P3|STARTED|Overall Study||134
5169382|NCT01210495|12713669|P2|STARTED|Overall Study||7
5169383|NCT01210495|12713670|P1|STARTED|Overall Study||15
5169384|NCT01210443|12713732|P1|NOT COMPLETED|Overall Study||2
5169385|NCT01210443|12713732|P1|COMPLETED|Overall Study||0
5169386|NCT01210443|12713732|P1|STARTED|Overall Study||2
5169387|NCT01210352|12713749|P9|NOT COMPLETED|Overall Study||4
5169388|NCT01210352|12713750|P8|NOT COMPLETED|Overall Study||3
5169389|NCT01210352|12713751|P7|NOT COMPLETED|Overall Study||2
5169390|NCT01210352|12713752|P6|NOT COMPLETED|Overall Study||0
5169391|NCT01210352|12713753|P5|NOT COMPLETED|Overall Study||0
5169392|NCT01210352|12713754|P4|NOT COMPLETED|Overall Study||0
5169393|NCT01210352|12713755|P3|NOT COMPLETED|Overall Study||2
5169394|NCT01210352|12713756|P2|NOT COMPLETED|Overall Study||0
5169395|NCT01210352|12713757|P1|NOT COMPLETED|Overall Study||0
5169396|NCT01210352|12713749|P9|COMPLETED|Overall Study||2
5169397|NCT01210352|12713750|P8|COMPLETED|Overall Study||7
5169398|NCT01210352|12713751|P7|COMPLETED|Overall Study||5
5169399|NCT01210352|12713752|P6|COMPLETED|Overall Study||6
5169400|NCT01210352|12713753|P5|COMPLETED|Overall Study||6
5169401|NCT01210352|12713754|P4|COMPLETED|Overall Study||7
5169402|NCT01210352|12713755|P3|COMPLETED|Overall Study||5
5169403|NCT01210352|12713756|P2|COMPLETED|Overall Study||6
5169404|NCT01210352|12713757|P1|COMPLETED|Overall Study||6
5169405|NCT01210352|12713749|P9|STARTED|Overall Study||6
5169406|NCT01210352|12713750|P8|STARTED|Overall Study||10
5169407|NCT01210352|12713751|P7|STARTED|Overall Study||7
5169408|NCT01210352|12713752|P6|STARTED|Overall Study||6
5169409|NCT01210352|12713753|P5|STARTED|Overall Study||6
5169410|NCT01210352|12713754|P4|STARTED|Overall Study||7
5169411|NCT01210352|12713755|P3|STARTED|Overall Study||7
5169412|NCT01210352|12713756|P2|STARTED|Overall Study||6
5169413|NCT01210352|12713757|P1|STARTED|Overall Study||6
5169414|NCT01210222|12713948|P1|NOT COMPLETED|Overall Study||3
5169415|NCT01210222|12713948|P1|COMPLETED|Overall Study||32
5169416|NCT01210222|12713948|P1|STARTED|Overall Study||35
5169417|NCT01210170|12713961|P1|NOT COMPLETED|Overall Study||7
5169418|NCT01210170|12713961|P1|COMPLETED|Overall Study||15
5169419|NCT01210170|12713961|P1|STARTED|Overall Study||22
5169420|NCT01210144|12713984|P2|NOT COMPLETED|Overall Study||0
5169421|NCT01210144|12713985|P1|NOT COMPLETED|Overall Study||3
5169422|NCT01210144|12713984|P2|COMPLETED|Overall Study||11
5169423|NCT01210144|12713985|P1|COMPLETED|Overall Study||10
5169424|NCT01210144|12713984|P2|STARTED|Overall Study||11
5169425|NCT01210144|12713985|P1|STARTED|Overall Study||13
5169426|NCT01210118|12714007|P2|NOT COMPLETED|Overall Study||5
5169427|NCT01210118|12714008|P1|NOT COMPLETED|Overall Study||3
5169428|NCT01210118|12714007|P2|COMPLETED|Overall Study||42
5169429|NCT01210118|12714008|P1|COMPLETED|Overall Study||42
5169430|NCT01210118|12714007|P2|STARTED|Overall Study||47
5169431|NCT01210118|12714008|P1|STARTED|Overall Study||45
5169432|NCT01210079|12714022|P2|NOT COMPLETED|Overall Study||0
5169433|NCT01210079|12714023|P1|NOT COMPLETED|Overall Study||0
5169434|NCT01210079|12714022|P2|COMPLETED|Overall Study||16
5169435|NCT01210079|12714023|P1|COMPLETED|Overall Study||10
5169436|NCT01210079|12714022|P2|STARTED|Overall Study||16
5169437|NCT01210079|12714023|P1|STARTED|Overall Study||10
5169438|NCT01210001|12714032|P3|NOT COMPLETED|Overall Study||12
5169439|NCT01210001|12714033|P2|NOT COMPLETED|Overall Study||11
5169440|NCT01210001|12714034|P1|NOT COMPLETED|Overall Study||19
5169441|NCT01210001|12714032|P3|COMPLETED|Overall Study||156
5169442|NCT01210001|12714033|P2|COMPLETED|Overall Study||154
5169443|NCT01210001|12714034|P1|COMPLETED|Overall Study||147
5169444|NCT01210001|12714032|P3|STARTED|Overall Study||168
5169445|NCT01210001|12714033|P2|STARTED|Overall Study||165
5169446|NCT01210001|12714034|P1|STARTED|Overall Study||166
5169447|NCT01209949|12714054|P1|NOT COMPLETED|Overall Study||3
5169448|NCT01209949|12714054|P1|COMPLETED|Overall Study||27
5169449|NCT01209949|12714054|P1|STARTED|Overall Study||30
5169450|NCT01209832|12714060|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
5169451|NCT01209832|12714060|P1|COMPLETED|Maintenance Period 2 (M1)||3
5169452|NCT01209832|12714060|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
5169453|NCT01209832|12714060|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
5169454|NCT01209832|12714060|P1|COMPLETED|Maintenance Period 1 (M1)||4
5169455|NCT01209832|12714060|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
5169456|NCT01209832|12714060|P1|NOT COMPLETED|Period 2||1
5169457|NCT01209832|12714060|P1|COMPLETED|Period 2||9
5169458|NCT01209832|12714060|P1|STARTED|Period 2||10
5169459|NCT01209832|12714060|P1|NOT COMPLETED|Period 1||1
5169460|NCT01209832|12714060|P1|COMPLETED|Period 1||10
5169461|NCT01209832|12714060|P1|Received At Least 1 Dose of Study Drug|Period 1||10
5169462|NCT01209832|12714060|P1|STARTED|Period 1||11
5169463|NCT01209780|12714079|P5|NOT COMPLETED|Overall Study||5
5169464|NCT01209780|12714080|P4|NOT COMPLETED|Overall Study||10
5169465|NCT01209780|12714081|P3|NOT COMPLETED|Overall Study||4
5169466|NCT01209780|12714082|P2|NOT COMPLETED|Overall Study||18
5169467|NCT01209780|12714083|P1|NOT COMPLETED|Overall Study||26
5169468|NCT01209780|12714079|P5|COMPLETED|Overall Study||407
5169469|NCT01209780|12714080|P4|COMPLETED|Overall Study||807
5169470|NCT01209780|12714081|P3|COMPLETED|Overall Study||44
5169471|NCT01209780|12714082|P2|COMPLETED|Overall Study||467
5169472|NCT01209780|12714083|P1|COMPLETED|Overall Study||1016
5169473|NCT01209780|12714079|P5|STARTED|Overall Study||412
5169474|NCT01209780|12714080|P4|STARTED|Overall Study||817
5169475|NCT01209780|12714081|P3|STARTED|Overall Study||48
5169476|NCT01209780|12714082|P2|STARTED|Overall Study||485
5169477|NCT01209780|12714083|P1|STARTED|Overall Study||1042
5169478|NCT01209767|12714109|P1|NOT COMPLETED|Overall Study||4
5169479|NCT01209767|12714109|P1|COMPLETED|Overall Study||18
5169480|NCT01209767|12714109|P1|STARTED|Overall Study||22
5169481|NCT01209702|12714119|P4|NOT COMPLETED|Overall Study||153
5169482|NCT01209702|12714120|P3|NOT COMPLETED|Overall Study||51
5169483|NCT01209702|12714121|P2|NOT COMPLETED|Overall Study||51
5169484|NCT01209702|12714122|P1|NOT COMPLETED|Overall Study||51
5169485|NCT01209702|12714119|P4|COMPLETED|Overall Study||0
5169486|NCT01209702|12714120|P3|COMPLETED|Overall Study||0
5169487|NCT01209702|12714121|P2|COMPLETED|Overall Study||0
5169488|NCT01209702|12714122|P1|COMPLETED|Overall Study||0
5169489|NCT01209702|12714119|P4|Completed 24 Weeks Treatment|Overall Study||10
5169490|NCT01209702|12714120|P3|Completed 24 Weeks Treatment|Overall Study||3
5169491|NCT01209702|12714121|P2|Completed 24 Weeks Treatment|Overall Study||28
5169492|NCT01209702|12714122|P1|Completed 24 Weeks Treatment|Overall Study||19
5169493|NCT01209702|12714119|P4|Completed 12 Weeks Treatment|Overall Study||59
5169494|NCT01209702|12714120|P3|Completed 12 Weeks Treatment|Overall Study||12
5169495|NCT01209702|12714121|P2|Completed 12 Weeks Treatment|Overall Study||48
5169496|NCT01209702|12714122|P1|Completed 12 Weeks Treatment|Overall Study||50
5169497|NCT01209702|12714119|P4|Escape or Switched to Tocilizumab|Overall Study||0
5169498|NCT01209702|12714120|P3|Escape or Switched to Tocilizumab|Overall Study||6
5169499|NCT01209702|12714121|P2|Escape or Switched to Tocilizumab|Overall Study||0
5169500|NCT01209702|12714122|P1|Escape or Switched to Tocilizumab|Overall Study||51
5169501|NCT01209702|12714119|P4|Treated|Overall Study||152
5169502|NCT01209702|12714120|P3|Treated|Overall Study||51
5169503|NCT01209702|12714121|P2|Treated|Overall Study||51
5169504|NCT01209702|12714122|P1|Treated|Overall Study||51
5169505|NCT01209702|12714119|P4|STARTED|Overall Study||153
5169506|NCT01209702|12714120|P3|STARTED|Overall Study||51
5169507|NCT01209702|12714121|P2|STARTED|Overall Study||51
5169508|NCT01209702|12714122|P1|STARTED|Overall Study||51
5169509|NCT01209689|12714178|P2|NOT COMPLETED|Overall Study||22
5169510|NCT01209689|12714179|P1|NOT COMPLETED|Overall Study||91
5169511|NCT01209689|12714178|P2|COMPLETED|Overall Study||0
5169512|NCT01209689|12714179|P1|COMPLETED|Overall Study||0
5169513|NCT01209689|12714178|P2|STARTED|Overall Study||22
5169514|NCT01209689|12714179|P1|STARTED|Overall Study||91
5169515|NCT01209624|12714185|P1|NOT COMPLETED|Overall Study||326
5169516|NCT01209624|12714185|P1|COMPLETED|Overall Study||576
5169517|NCT01209624|12714185|P1|Per Protocol Population|Overall Study||469
5169518|NCT01209624|12714185|P1|STARTED|Overall Study||902
5169519|NCT01209598|12714218|P2|NOT COMPLETED|Overall Study||0
5169520|NCT01209598|12714219|P1|NOT COMPLETED|Overall Study||1
5169521|NCT01209598|12714218|P2|COMPLETED|Overall Study||60
5169522|NCT01209598|12714219|P1|COMPLETED|Overall Study||29
5169523|NCT01209598|12714218|P2|STARTED|Overall Study||60
5169524|NCT01209598|12714219|P1|STARTED|Overall Study||30
5169525|NCT01209520|12714227|P1|NOT COMPLETED|Overall Study||3
5169526|NCT01209520|12714227|P1|COMPLETED|Overall Study||3
5169527|NCT01209520|12714227|P1|STARTED|Overall Study||6
5169528|NCT01209442|12714232|P1|NOT COMPLETED|Overall Study||0
5169529|NCT01209442|12714232|P1|COMPLETED|Overall Study||30
5169530|NCT01209442|12714232|P1|STARTED|Overall Study||30
5169531|NCT01209325|12714237|P1|NOT COMPLETED|Overall Study||43
5169532|NCT01209325|12714237|P1|COMPLETED|Overall Study||106
5169533|NCT01209325|12714237|P1|Returned After Week 28|Overall Study||124
5169534|NCT01209325|12714237|P1|Received Third Vaccine Infjection|Overall Study||138
5169535|NCT01209325|12714237|P1|Received Second Vaccine Injection|Overall Study||141
5169536|NCT01209325|12714237|P1|Received First Vaccine Injection|Overall Study||144
5169537|NCT01209325|12714237|P1|Eligible|Overall Study||145
5169538|NCT01209325|12714237|P1|STARTED|Overall Study||149
5169539|NCT01209286|12714292|P3|NOT COMPLETED|Overall Study||3
5169540|NCT01209286|12714293|P2|NOT COMPLETED|Overall Study||10
5169541|NCT01209286|12714294|P1|NOT COMPLETED|Overall Study||5
5169542|NCT01209286|12714292|P3|COMPLETED|Overall Study||3
5169543|NCT01209286|12714293|P2|COMPLETED|Overall Study||13
5169544|NCT01209286|12714294|P1|COMPLETED|Overall Study||2
5169545|NCT01209286|12714292|P3|STARTED|Overall Study||6
5169546|NCT01209286|12714293|P2|STARTED|Overall Study||23
5169547|NCT01209286|12714294|P1|STARTED|Overall Study||7
5169548|NCT01209260|12714347|P2|NOT COMPLETED|Overall Study||0
5169549|NCT01209260|12714348|P1|NOT COMPLETED|Overall Study||0
5169550|NCT01209260|12714347|P2|COMPLETED|Overall Study||36
5169551|NCT01209260|12714348|P1|COMPLETED|Overall Study||36
5169552|NCT01209260|12714347|P2|STARTED|Overall Study||36
5169553|NCT01209260|12714348|P1|STARTED|Overall Study||36
5169554|NCT01209195|12714362|P6|NOT COMPLETED|Overall Study||0
5169555|NCT01209195|12714363|P5|NOT COMPLETED|Overall Study||0
5169556|NCT01209195|12714364|P4|NOT COMPLETED|Overall Study||0
5169557|NCT01209195|12714365|P3|NOT COMPLETED|Overall Study||0
5169558|NCT01209195|12714366|P2|NOT COMPLETED|Overall Study||0
5169559|NCT01209195|12714367|P1|NOT COMPLETED|Overall Study||0
5169560|NCT01209195|12714362|P6|COMPLETED|Overall Study||13
5169561|NCT01209195|12714363|P5|COMPLETED|Overall Study||6
5169562|NCT01209195|12714364|P4|COMPLETED|Overall Study||6
5169563|NCT01209195|12714365|P3|COMPLETED|Overall Study||6
5169564|NCT01209195|12714366|P2|COMPLETED|Overall Study||3
5169565|NCT01209195|12714367|P1|COMPLETED|Overall Study||7
5169566|NCT01209195|12714362|P6|STARTED|Overall Study||13
5169567|NCT01209195|12714363|P5|STARTED|Overall Study||6
5169568|NCT01209195|12714364|P4|STARTED|Overall Study||6
5169569|NCT01209195|12714365|P3|STARTED|Overall Study||6
5169570|NCT01209195|12714366|P2|STARTED|Overall Study||3
5169571|NCT01209195|12714367|P1|STARTED|Overall Study||7
5169572|NCT01209143|12714403|P2|NOT COMPLETED|Overall Study||20
5169573|NCT01209143|12714404|P1|NOT COMPLETED|Overall Study||19
5169574|NCT01209143|12714403|P2|COMPLETED|Overall Study||8
5169575|NCT01209143|12714404|P1|COMPLETED|Overall Study||5
5169576|NCT01209143|12714403|P2|STARTED|Overall Study||28
5169577|NCT01209143|12714404|P1|STARTED|Overall Study||24
5169578|NCT01209078|12714414|P2|NOT COMPLETED|Overall Study||3
5169579|NCT01209078|12714415|P1|NOT COMPLETED|Overall Study||16
5169580|NCT01209078|12714414|P2|COMPLETED|Overall Study||24
5169581|NCT01209078|12714415|P1|COMPLETED|Overall Study||41
5169582|NCT01209078|12714414|P2|STARTED|Overall Study||27
5169583|NCT01209078|12714415|P1|STARTED|Overall Study||57
5169584|NCT01208961|12714490|P2|NOT COMPLETED|High-Fat Period IV||0
5169585|NCT01208961|12714491|P1|NOT COMPLETED|High-Fat Period IV||0
5169586|NCT01208961|12714490|P2|COMPLETED|High-Fat Period IV||26
5169587|NCT01208961|12714491|P1|COMPLETED|High-Fat Period IV||25
5169588|NCT01208961|12714490|P2|STARTED|High-Fat Period IV||26
5169589|NCT01208961|12714491|P1|STARTED|High-Fat Period IV||25
5169590|NCT01208961|12714490|P2|NOT COMPLETED|High-Fat Period III||0
5169591|NCT01208961|12714491|P1|NOT COMPLETED|High-Fat Period III||1
5169592|NCT01208961|12714490|P2|COMPLETED|High-Fat Period III||26
5169593|NCT01208961|12714491|P1|COMPLETED|High-Fat Period III||25
5169594|NCT01208961|12714490|P2|STARTED|High-Fat Period III||26
5169595|NCT01208961|12714491|P1|STARTED|High-Fat Period III||26
5169596|NCT01208961|12714490|P2|NOT COMPLETED|Low-Fat Period II||0
5169597|NCT01208961|12714491|P1|NOT COMPLETED|Low-Fat Period II||0
5169598|NCT01208961|12714490|P2|COMPLETED|Low-Fat Period II||27
5169599|NCT01208961|12714491|P1|COMPLETED|Low-Fat Period II||26
5169600|NCT01208961|12714490|P2|STARTED|Low-Fat Period II||27
5169601|NCT01208961|12714491|P1|STARTED|Low-Fat Period II||26
5169602|NCT01208961|12714490|P2|NOT COMPLETED|Low-Fat Period I||0
5169603|NCT01208961|12714491|P1|NOT COMPLETED|Low-Fat Period I||0
5169604|NCT01208961|12714490|P2|COMPLETED|Low-Fat Period I||27
5169605|NCT01208961|12714491|P1|COMPLETED|Low-Fat Period I||27
5169606|NCT01208961|12714490|P2|STARTED|Low-Fat Period I||27
5169607|NCT01208961|12714491|P1|STARTED|Low-Fat Period I||27
5169608|NCT01208922|12714502|P2|NOT COMPLETED|Overall Study||10
5169609|NCT01208922|12714503|P1|NOT COMPLETED|Overall Study||11
5169610|NCT01208922|12714502|P2|COMPLETED|Overall Study||405
5169611|NCT01208922|12714503|P1|COMPLETED|Overall Study||409
5169612|NCT01208922|12714502|P2|STARTED|Overall Study||415
5169613|NCT01208922|12714503|P1|STARTED|Overall Study||420
5169614|NCT01208870|12714513|P2|NOT COMPLETED|Overall Study||8
5169615|NCT01208870|12714514|P1|NOT COMPLETED|Overall Study||2
5169616|NCT01208870|12714513|P2|COMPLETED|Overall Study||36
5169617|NCT01208870|12714514|P1|COMPLETED|Overall Study||44
5169618|NCT01208870|12714513|P2|Pilot 2|Overall Study||22
5169619|NCT01208870|12714514|P1|Pilot 2|Overall Study||26
5169620|NCT01208870|12714513|P2|Pilot 1|Overall Study||22
5169621|NCT01208870|12714514|P1|Pilot 1|Overall Study||20
5169622|NCT01208870|12714513|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
5169623|NCT01208870|12714514|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
5169624|NCT01208415|12714530|P1|NOT COMPLETED|Overall Study||40
5169625|NCT01208415|12714530|P1|COMPLETED|Overall Study||0
5169626|NCT01208415|12714530|P1|6 Months|Overall Study||37
5169627|NCT01208415|12714530|P1|STARTED|Overall Study||40
5169628|NCT01208402|12714536|P2|NOT COMPLETED|Overall Study||0
5169629|NCT01208402|12714537|P1|NOT COMPLETED|Overall Study||1
5169630|NCT01208402|12714536|P2|COMPLETED|Overall Study||28
5169631|NCT01208402|12714537|P1|COMPLETED|Overall Study||30
5169632|NCT01208402|12714536|P2|STARTED|Overall Study||28
5169633|NCT01208402|12714537|P1|STARTED|Overall Study||31
5169634|NCT01208337|12714553|P1|NOT COMPLETED|Overall Study||3
5169635|NCT01208337|12714553|P1|COMPLETED|Overall Study||20
5169636|NCT01208337|12714553|P1|Five-year Follow-up|Overall Study||20
5169637|NCT01208337|12714553|P1|One-year Follow-up|Overall Study||23
5169638|NCT01208337|12714553|P1|STARTED|Overall Study||23
5169639|NCT01208233|12714567|P6|NOT COMPLETED|Overall Study||21
5169640|NCT01208233|12714568|P5|NOT COMPLETED|Overall Study||24
5169641|NCT01208233|12714569|P4|NOT COMPLETED|Overall Study||1
5169642|NCT01208233|12714570|P3|NOT COMPLETED|Overall Study||4
5169643|NCT01208233|12714571|P2|NOT COMPLETED|Overall Study||3
5169644|NCT01208233|12714572|P1|NOT COMPLETED|Overall Study||5
5169645|NCT01208233|12714567|P6|COMPLETED|Overall Study||46
5169646|NCT01208233|12714568|P5|COMPLETED|Overall Study||46
5169647|NCT01208233|12714569|P4|COMPLETED|Overall Study||9
5169648|NCT01208233|12714570|P3|COMPLETED|Overall Study||7
5169649|NCT01208233|12714571|P2|COMPLETED|Overall Study||6
5169650|NCT01208233|12714572|P1|COMPLETED|Overall Study||6
5169651|NCT01208233|12714567|P6|STARTED|Overall Study||67
5169652|NCT01208233|12714568|P5|STARTED|Overall Study||70
5169653|NCT01208233|12714569|P4|STARTED|Overall Study||10
5169654|NCT01208233|12714570|P3|STARTED|Overall Study||11
5169655|NCT01208233|12714571|P2|STARTED|Overall Study||9
5169656|NCT01208233|12714572|P1|STARTED|Overall Study||11
5169657|NCT01208220|12714685|P2|NOT COMPLETED|Overall Study||0
5169658|NCT01208220|12714686|P1|NOT COMPLETED|Overall Study||0
5169659|NCT01208220|12714685|P2|COMPLETED|Overall Study||1
5169660|NCT01208220|12714686|P1|COMPLETED|Overall Study||1
5169661|NCT01208220|12714685|P2|STARTED|Overall Study||1
5169662|NCT01208220|12714686|P1|STARTED|Overall Study||1
5169663|NCT01208207|12714697|P7|NOT COMPLETED|Part II||11
5169664|NCT01208207|12714698|P6|NOT COMPLETED|Part II||16
5169665|NCT01208207|12714699|P5|NOT COMPLETED|Part II||23
5169666|NCT01208207|12714700|P4|NOT COMPLETED|Part II||32
5169667|NCT01208207|12714701|P3|NOT COMPLETED|Part II||0
5169668|NCT01208207|12714702|P2|NOT COMPLETED|Part II||0
5169669|NCT01208207|12714703|P1|NOT COMPLETED|Part II||0
5169670|NCT01208207|12714697|P7|COMPLETED|Part II||131
5169671|NCT01208207|12714698|P6|COMPLETED|Part II||129
5169672|NCT01208207|12714699|P5|COMPLETED|Part II||295
5169673|NCT01208207|12714700|P4|COMPLETED|Part II||282
5169674|NCT01208207|12714701|P3|COMPLETED|Part II||0
5169675|NCT01208207|12714702|P2|COMPLETED|Part II||0
5169676|NCT01208207|12714703|P1|COMPLETED|Part II||0
5169677|NCT01208207|12714697|P7|STARTED|Part II||142
5169678|NCT01208207|12714698|P6|STARTED|Part II||145
5169679|NCT01208207|12714699|P5|STARTED|Part II||318
5169680|NCT01208207|12714700|P4|STARTED|Part II||314
5169681|NCT01208207|12714701|P3|STARTED|Part II||0
5169682|NCT01208207|12714702|P2|STARTED|Part II||0
5169683|NCT01208207|12714703|P1|STARTED|Part II||0
5169684|NCT01208207|12714697|P7|NOT COMPLETED|Part I||0
5169685|NCT01208207|12714698|P6|NOT COMPLETED|Part I||0
5169686|NCT01208207|12714699|P5|NOT COMPLETED|Part I||0
5169687|NCT01208207|12714700|P4|NOT COMPLETED|Part I||0
5169688|NCT01208207|12714701|P3|NOT COMPLETED|Part I||15
5169689|NCT01208207|12714702|P2|NOT COMPLETED|Part I||11
5169690|NCT01208207|12714703|P1|NOT COMPLETED|Part I||70
5169691|NCT01208207|12714697|P7|COMPLETED|Part I||0
5169692|NCT01208207|12714698|P6|COMPLETED|Part I||0
5169693|NCT01208207|12714699|P5|COMPLETED|Part I||0
5169694|NCT01208207|12714700|P4|COMPLETED|Part I||0
5169695|NCT01208207|12714701|P3|COMPLETED|Part I||142
5169696|NCT01208207|12714702|P2|COMPLETED|Part I||145
5169697|NCT01208207|12714703|P1|COMPLETED|Part I||632
5169698|NCT01208207|12714697|P7|STARTED|Part I||0
5169699|NCT01208207|12714698|P6|STARTED|Part I||0
5169700|NCT01208207|12714699|P5|STARTED|Part I||0
5169701|NCT01208207|12714700|P4|STARTED|Part I||0
5169702|NCT01208207|12714701|P3|STARTED|Part I||157
5169703|NCT01208207|12714702|P2|STARTED|Part I||156
5169704|NCT01208207|12714703|P1|STARTED|Part I||702
5169705|NCT01208181|12714730|P5|NOT COMPLETED|Part 2||0
5169706|NCT01208181|12714731|P4|NOT COMPLETED|Part 2||20
5169707|NCT01208181|12714732|P3|NOT COMPLETED|Part 2||16
5169708|NCT01208181|12714733|P2|NOT COMPLETED|Part 2||0
5169709|NCT01208181|12714734|P1|NOT COMPLETED|Part 2||0
5169710|NCT01208181|12714730|P5|COMPLETED|Part 2||0
5169711|NCT01208181|12714731|P4|COMPLETED|Part 2||343
5169712|NCT01208181|12714732|P3|COMPLETED|Part 2||334
5169713|NCT01208181|12714733|P2|COMPLETED|Part 2||0
5169714|NCT01208181|12714734|P1|COMPLETED|Part 2||0
5169715|NCT01208181|12714730|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
5169716|NCT01208181|12714731|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
5169717|NCT01208181|12714732|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
5169718|NCT01208181|12714733|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
5169719|NCT01208181|12714734|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
5169720|NCT01208181|12714730|P5|NOT COMPLETED|Part 1||22
5169721|NCT01208181|12714731|P4|NOT COMPLETED|Part 1||0
5169722|NCT01208181|12714732|P3|NOT COMPLETED|Part 1||0
5169723|NCT01208181|12714733|P2|NOT COMPLETED|Part 1||55
5169724|NCT01208181|12714734|P1|NOT COMPLETED|Part 1||99
5169725|NCT01208181|12714730|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
5169726|NCT01208181|12714731|P4|COMPLETED|Part 1||0
5169727|NCT01208181|12714732|P3|COMPLETED|Part 1||0
5169728|NCT01208181|12714733|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
5169729|NCT01208181|12714734|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
5169730|NCT01208181|12714730|P5|STARTED|Part 1||118
5169731|NCT01208181|12714731|P4|STARTED|Part 1||0
5169732|NCT01208181|12714732|P3|STARTED|Part 1||0
5169733|NCT01208181|12714733|P2|STARTED|Part 1||468
5169734|NCT01208181|12714734|P1|STARTED|Part 1||818
5169735|NCT01208103|12714763|P1|NOT COMPLETED|Overall Study||2
5169736|NCT01208103|12714763|P1|COMPLETED|Overall Study||28
5169737|NCT01208103|12714763|P1|STARTED|Overall Study||30
5169738|NCT01208038|12714771|P1|NOT COMPLETED|Overall Study||1
5169739|NCT01208038|12714771|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
5169740|NCT01208038|12714771|P1|STARTED|Overall Study||22
5169741|NCT01207934|12714781|P3|NOT COMPLETED|Overall Study||0
5169742|NCT01207934|12714782|P2|NOT COMPLETED|Overall Study||0
5169743|NCT01207934|12714783|P1|NOT COMPLETED|Overall Study||0
5169744|NCT01207934|12714781|P3|COMPLETED|Overall Study||6
5169745|NCT01207934|12714782|P2|COMPLETED|Overall Study||6
5169746|NCT01207934|12714783|P1|COMPLETED|Overall Study||6
5169747|NCT01207934|12714781|P3|STARTED|Overall Study||6
5169748|NCT01207934|12714782|P2|STARTED|Overall Study||6
5169749|NCT01207934|12714783|P1|STARTED|Overall Study||6
5169750|NCT01207765|12714800|P1|NOT COMPLETED|Overall Study||0
5169751|NCT01207765|12714800|P1|COMPLETED|Overall Study||8
5169752|NCT01207765|12714800|P1|STARTED|Overall Study||8
5169753|NCT01207726|12714808|P2|NOT COMPLETED|Overall Study||0
5169754|NCT01207726|12714809|P1|NOT COMPLETED|Overall Study||0
5169755|NCT01207726|12714808|P2|COMPLETED|Overall Study||6
5169756|NCT01207726|12714809|P1|COMPLETED|Overall Study||7
5169757|NCT01207726|12714808|P2|STARTED|Overall Study||6
5169758|NCT01207726|12714809|P1|STARTED|Overall Study||7
5169759|NCT01207687|12714827|P1|NOT COMPLETED|Overall Study||2
5169760|NCT01207687|12714827|P1|COMPLETED|Overall Study||12
5169761|NCT01207687|12714827|P1|STARTED|Overall Study||14
5169762|NCT01207648|12714857|P1|NOT COMPLETED|Overall Study||0
5169763|NCT01207648|12714857|P1|COMPLETED|Overall Study||307
5169764|NCT01207648|12714857|P1|STARTED|Overall Study||307
5169765|NCT01207596|12714865|P1|NOT COMPLETED|Overall Study||9
5169766|NCT01207596|12714865|P1|COMPLETED|Overall Study||21
5169767|NCT01207596|12714865|P1|STARTED|Overall Study||30
5169768|NCT01207583|12714878|P3|NOT COMPLETED|Overall Study||1
5169769|NCT01207583|12714879|P2|NOT COMPLETED|Overall Study||5
5169770|NCT01207583|12714880|P1|NOT COMPLETED|Overall Study||1
5169771|NCT01207583|12714878|P3|COMPLETED|Overall Study||54
5169772|NCT01207583|12714879|P2|COMPLETED|Overall Study||26
5169773|NCT01207583|12714880|P1|COMPLETED|Overall Study||13
5169774|NCT01207583|12714878|P3|Dose 4|Overall Study||0
5169775|NCT01207583|12714879|P2|Dose 4|Overall Study||0
5169776|NCT01207583|12714880|P1|Dose 4|Overall Study||7
5169777|NCT01207583|12714878|P3|Dose 3|Overall Study||0
5169778|NCT01207583|12714879|P2|Dose 3|Overall Study||27
5169779|NCT01207583|12714880|P1|Dose 3|Overall Study||13
5169780|NCT01207583|12714878|P3|Dose 2|Overall Study||54
5169781|NCT01207583|12714879|P2|Dose 2|Overall Study||29
5169782|NCT01207583|12714880|P1|Dose 2|Overall Study||13
5169783|NCT01207583|12714878|P3|Dose 1|Overall Study||55
5169784|NCT01207583|12714879|P2|Dose 1|Overall Study||31
5169785|NCT01207583|12714880|P1|Dose 1|Overall Study||14
5169786|NCT01207583|12714878|P3|STARTED|Overall Study||55
5169787|NCT01207583|12714879|P2|STARTED|Overall Study||31
5169788|NCT01207583|12714880|P1|STARTED|Overall Study||14
5169789|NCT01207570|12714920|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
5169790|NCT01207570|12714921|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
5169791|NCT01207570|12714920|P2|COMPLETED|The Second Stage (After Crossover)||23
5169792|NCT01207570|12714921|P1|COMPLETED|The Second Stage (After Crossover)||31
5169793|NCT01207570|12714920|P2|STARTED|The Second Stage (After Crossover)||23
5169794|NCT01207570|12714921|P1|STARTED|The Second Stage (After Crossover)||31
5169795|NCT01207570|12714920|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
5169796|NCT01207570|12714921|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
5169797|NCT01207570|12714920|P2|COMPLETED|The First Stage (Before Crossover)||31
5169798|NCT01207570|12714921|P1|COMPLETED|The First Stage (Before Crossover)||23
5169799|NCT01207570|12714920|P2|STARTED|The First Stage (Before Crossover)||31
5169800|NCT01207570|12714921|P1|STARTED|The First Stage (Before Crossover)||23
5169801|NCT01207492|12714933|P1|NOT COMPLETED|Overall Study||15
5169802|NCT01207492|12714933|P1|COMPLETED|Overall Study||2
5169803|NCT01207492|12714933|P1|STARTED|Overall Study||17
5169804|NCT01207466|12714939|P2|NOT COMPLETED|Period 2, One Week of Wear||0
5169805|NCT01207466|12714940|P1|NOT COMPLETED|Period 2, One Week of Wear||0
5169806|NCT01207466|12714939|P2|COMPLETED|Period 2, One Week of Wear||48
5169807|NCT01207466|12714940|P1|COMPLETED|Period 2, One Week of Wear||45
5169808|NCT01207466|12714939|P2|STARTED|Period 2, One Week of Wear||48
5169809|NCT01207466|12714940|P1|STARTED|Period 2, One Week of Wear||45
5169810|NCT01207466|12714939|P2|NOT COMPLETED|Period 1, One Week of Wear||0
5169811|NCT01207466|12714940|P1|NOT COMPLETED|Period 1, One Week of Wear||0
5169812|NCT01207466|12714939|P2|COMPLETED|Period 1, One Week of Wear||48
5169813|NCT01207466|12714940|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
5169814|NCT01207466|12714939|P2|STARTED|Period 1, One Week of Wear||48
5169815|NCT01207466|12714940|P1|STARTED|Period 1, One Week of Wear||46
5169816|NCT01207453|12714948|P2|NOT COMPLETED|2nd Intervention||2
5169817|NCT01207453|12714949|P1|NOT COMPLETED|2nd Intervention||2
5169818|NCT01207453|12714948|P2|COMPLETED|2nd Intervention||15
5169819|NCT01207453|12714949|P1|COMPLETED|2nd Intervention||17
5169820|NCT01207453|12714948|P2|STARTED|2nd Intervention||17
5169821|NCT01207453|12714949|P1|STARTED|2nd Intervention||19
5169822|NCT01207453|12714948|P2|NOT COMPLETED|Washout||0
5169823|NCT01207453|12714949|P1|NOT COMPLETED|Washout||2
5169824|NCT01207453|12714948|P2|COMPLETED|Washout||17
5169825|NCT01207453|12714949|P1|COMPLETED|Washout||19
5169826|NCT01207453|12714948|P2|STARTED|Washout||17
5169827|NCT01207453|12714949|P1|STARTED|Washout||21
5169828|NCT01207453|12714948|P2|NOT COMPLETED|First Intervention||1
5169829|NCT01207453|12714949|P1|NOT COMPLETED|First Intervention||2
5169830|NCT01207453|12714948|P2|COMPLETED|First Intervention||17
5169831|NCT01207453|12714949|P1|COMPLETED|First Intervention||21
5169832|NCT01207453|12714948|P2|STARTED|First Intervention||18
5169833|NCT01207453|12714949|P1|STARTED|First Intervention||23
5169834|NCT01207440|12714975|P7|NOT COMPLETED|Overall Study||5
5169835|NCT01207440|12714976|P6|NOT COMPLETED|Overall Study||46
5169836|NCT01207440|12714977|P5|NOT COMPLETED|Overall Study||48
5169837|NCT01207440|12714978|P4|NOT COMPLETED|Overall Study||18
5169838|NCT01207440|12714979|P3|NOT COMPLETED|Overall Study||65
5169839|NCT01207440|12714980|P2|NOT COMPLETED|Overall Study||64
5169840|NCT01207440|12714981|P1|NOT COMPLETED|Overall Study||203
5169841|NCT01207440|12714975|P7|COMPLETED|Overall Study||0
5169842|NCT01207440|12714976|P6|COMPLETED|Overall Study||0
5169843|NCT01207440|12714977|P5|COMPLETED|Overall Study||0
5169844|NCT01207440|12714978|P4|COMPLETED|Overall Study||0
5169845|NCT01207440|12714979|P3|COMPLETED|Overall Study||0
5169846|NCT01207440|12714980|P2|COMPLETED|Overall Study||0
5169847|NCT01207440|12714981|P1|COMPLETED|Overall Study||0
5169848|NCT01207440|12714975|P7|STARTED|Overall Study||5
5169849|NCT01207440|12714976|P6|STARTED|Overall Study||46
5169850|NCT01207440|12714977|P5|STARTED|Overall Study||48
5169851|NCT01207440|12714978|P4|STARTED|Overall Study||18
5169852|NCT01207440|12714979|P3|STARTED|Overall Study||65
5169853|NCT01207440|12714980|P2|STARTED|Overall Study||64
5169854|NCT01207440|12714981|P1|STARTED|Overall Study||203
5169855|NCT01207427|12715048|P3|NOT COMPLETED|Run-out Placebo Period||0
5169856|NCT01207427|12715049|P2|NOT COMPLETED|Run-out Placebo Period||0
5169857|NCT01207427|12715050|P1|NOT COMPLETED|Run-out Placebo Period||0
5169858|NCT01207427|12715048|P3|COMPLETED|Run-out Placebo Period||41
5169859|NCT01207427|12715049|P2|COMPLETED|Run-out Placebo Period||43
5169860|NCT01207427|12715050|P1|COMPLETED|Run-out Placebo Period||40
5169861|NCT01207427|12715048|P3|STARTED|Run-out Placebo Period||41
5169862|NCT01207427|12715049|P2|STARTED|Run-out Placebo Period||43
5169863|NCT01207427|12715050|P1|STARTED|Run-out Placebo Period||40
5169864|NCT01207427|12715048|P3|NOT COMPLETED|Double-blind Treatment Period||2
5169865|NCT01207427|12715049|P2|NOT COMPLETED|Double-blind Treatment Period||2
5169866|NCT01207427|12715050|P1|NOT COMPLETED|Double-blind Treatment Period||3
5169867|NCT01207427|12715048|P3|COMPLETED|Double-blind Treatment Period||41
5169868|NCT01207427|12715049|P2|COMPLETED|Double-blind Treatment Period||43
5169869|NCT01207427|12715050|P1|COMPLETED|Double-blind Treatment Period||40
5169870|NCT01207427|12715048|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
5169871|NCT01207427|12715049|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
5169872|NCT01207427|12715050|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
5169873|NCT01207427|12715048|P3|STARTED|Double-blind Treatment Period||43
5169874|NCT01207427|12715049|P2|STARTED|Double-blind Treatment Period||45
5169875|NCT01207427|12715050|P1|STARTED|Double-blind Treatment Period||43
5169876|NCT01207427|12715048|P3|NOT COMPLETED|Run-in Placebo Period||0
5169877|NCT01207427|12715049|P2|NOT COMPLETED|Run-in Placebo Period||0
5169878|NCT01207427|12715050|P1|NOT COMPLETED|Run-in Placebo Period||0
5169879|NCT01207427|12715048|P3|COMPLETED|Run-in Placebo Period||43
5169880|NCT01207427|12715049|P2|COMPLETED|Run-in Placebo Period||45
5169881|NCT01207427|12715050|P1|COMPLETED|Run-in Placebo Period||43
5169882|NCT01207427|12715048|P3|STARTED|Run-in Placebo Period||43
5169883|NCT01207427|12715049|P2|STARTED|Run-in Placebo Period||45
5169884|NCT01207427|12715050|P1|STARTED|Run-in Placebo Period||43
5169885|NCT01207414|12715060|P2|NOT COMPLETED|Overall Study||82
5169886|NCT01207414|12715061|P1|NOT COMPLETED|Overall Study||73
5169887|NCT01207414|12715060|P2|COMPLETED|Overall Study||178
5169888|NCT01207414|12715061|P1|COMPLETED|Overall Study||168
5169889|NCT01207414|12715060|P2|Safety Population: Received Study Drug|Overall Study||260
5169890|NCT01207414|12715061|P1|Safety Population: Received Study Drug|Overall Study||240
5169891|NCT01207414|12715060|P2|STARTED|Overall Study||260
5169892|NCT01207414|12715061|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
5169893|NCT01207401|12715079|P2|NOT COMPLETED|Overall Study||0
5169894|NCT01207401|12715080|P1|NOT COMPLETED|Overall Study||0
5169895|NCT01207401|12715079|P2|COMPLETED|Overall Study||24
5169896|NCT01207401|12715080|P1|COMPLETED|Overall Study||26
5169897|NCT01207401|12715079|P2|STARTED|Overall Study||24
5169898|NCT01207401|12715080|P1|STARTED|Overall Study||26
5169899|NCT01207388|12715086|P1|NOT COMPLETED|Overall Study||68
5169900|NCT01207388|12715086|P1|COMPLETED|Overall Study||48
5169901|NCT01207388|12715086|P1|STARTED|Overall Study||116
5169902|NCT01207219|12715111|P3|NOT COMPLETED|Overall Study||7
5169903|NCT01207219|12715112|P2|NOT COMPLETED|Overall Study||11
5169904|NCT01207219|12715113|P1|NOT COMPLETED|Overall Study||11
5169905|NCT01207219|12715111|P3|COMPLETED|Overall Study||32
5169906|NCT01207219|12715112|P2|COMPLETED|Overall Study||29
5169907|NCT01207219|12715113|P1|COMPLETED|Overall Study||34
5169908|NCT01207219|12715111|P3|Included in ITT Analysis|Overall Study||38
5169909|NCT01207219|12715112|P2|Included in ITT Analysis|Overall Study||37
5169910|NCT01207219|12715113|P1|Included in ITT Analysis|Overall Study||40
5169911|NCT01207219|12715111|P3|STARTED|Overall Study||39
5169912|NCT01207219|12715112|P2|STARTED|Overall Study||40
5169913|NCT01207219|12715113|P1|STARTED|Overall Study||45
5169914|NCT01207102|12715133|P1|NOT COMPLETED|Overall Study||10
5169915|NCT01207102|12715133|P1|COMPLETED|Overall Study||0
5169916|NCT01207102|12715133|P1|STARTED|Overall Study||10
5169917|NCT01206816|12715145|P7|NOT COMPLETED|Overall Study||6
5169918|NCT01206816|12715146|P6|NOT COMPLETED|Overall Study||19
5169919|NCT01206816|12715147|P5|NOT COMPLETED|Overall Study||3
5169920|NCT01206816|12715148|P4|NOT COMPLETED|Overall Study||3
5169921|NCT01206816|12715149|P3|NOT COMPLETED|Overall Study||20
5169922|NCT01206816|12715150|P2|NOT COMPLETED|Overall Study||3
5169923|NCT01206816|12715151|P1|NOT COMPLETED|Overall Study||3
5169924|NCT01206816|12715145|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,‘PD’ from aftb.|0
5169925|NCT01206816|12715146|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, ‘Other AE’ from aftb|0
5169926|NCT01206816|12715147|P5|COMPLETED|Overall Study||0
5169927|NCT01206816|12715148|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, ‘Other AE’ from aftb|0
5169928|NCT01206816|12715149|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,‘DLT’ from aftb|0
5169929|NCT01206816|12715150|P2|COMPLETED|Overall Study||0
5169930|NCT01206816|12715151|P1|COMPLETED|Overall Study||0
5169931|NCT01206816|12715145|P7|STARTED|Overall Study|Started=Treated|6
5169932|NCT01206816|12715146|P6|STARTED|Overall Study|Started=Treated|19
5169933|NCT01206816|12715147|P5|STARTED|Overall Study|Started=Treated|3
5169934|NCT01206816|12715148|P4|STARTED|Overall Study|Started=Treated|3
5169935|NCT01206816|12715149|P3|STARTED|Overall Study|Started=Treated|20
5169936|NCT01206816|12715150|P2|STARTED|Overall Study|Started=Treated|3
5169937|NCT01206816|12715151|P1|STARTED|Overall Study|Started=Treated|3
5169938|NCT01206777|12715197|P1|NOT COMPLETED|Overall Study||2
5169939|NCT01206777|12715197|P1|COMPLETED|Overall Study||50
5169940|NCT01206777|12715197|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
5169941|NCT01206777|12715197|P1|STARTED|Overall Study||52
5169942|NCT01206764|12715203|P1|NOT COMPLETED|Overall Study||138
5169943|NCT01206764|12715203|P1|COMPLETED|Overall Study||4
5169944|NCT01206764|12715203|P1|STARTED|Overall Study||142
5169945|NCT01206738|12715214|P3|NOT COMPLETED|Overall Study||19
5169946|NCT01206738|12715215|P2|NOT COMPLETED|Overall Study||25
5169947|NCT01206738|12715216|P1|NOT COMPLETED|Overall Study||23
5169948|NCT01206738|12715214|P3|COMPLETED|Overall Study||42
5169949|NCT01206738|12715215|P2|COMPLETED|Overall Study||49
5169950|NCT01206738|12715216|P1|COMPLETED|Overall Study||40
5169951|NCT01206738|12715214|P3|STARTED|Overall Study||61
5169952|NCT01206738|12715215|P2|STARTED|Overall Study||74
5169953|NCT01206738|12715216|P1|STARTED|Overall Study||63
5169954|NCT01206660|12715228|P2|NOT COMPLETED|Overall Study||0
5169955|NCT01206660|12715229|P1|NOT COMPLETED|Overall Study||0
5169956|NCT01206660|12715228|P2|COMPLETED|Overall Study||60
5169957|NCT01206660|12715229|P1|COMPLETED|Overall Study||60
5169958|NCT01206660|12715228|P2|STARTED|Overall Study||60
5169959|NCT01206660|12715229|P1|STARTED|Overall Study||60
5169960|NCT01206608|12715241|P2|NOT COMPLETED|Overall Study||0
5169961|NCT01206608|12715242|P1|NOT COMPLETED|Overall Study||0
5169962|NCT01206608|12715241|P2|COMPLETED|Overall Study||20
5169963|NCT01206608|12715242|P1|COMPLETED|Overall Study||20
5169964|NCT01206608|12715241|P2|STARTED|Overall Study||20
5169965|NCT01206608|12715242|P1|STARTED|Overall Study||20
5169966|NCT01206595|12715250|P2|NOT COMPLETED|Overall Study||0
5169967|NCT01206595|12715251|P1|NOT COMPLETED|Overall Study||0
5169968|NCT01206595|12715250|P2|COMPLETED|Overall Study||20
5169969|NCT01206595|12715251|P1|COMPLETED|Overall Study||38
5169970|NCT01206595|12715250|P2|STARTED|Overall Study||20
5169971|NCT01206595|12715251|P1|STARTED|Overall Study||38
5169972|NCT01206582|12715261|P2|NOT COMPLETED|Overall Study||2
5169973|NCT01206582|12715262|P1|NOT COMPLETED|Overall Study||2
5169974|NCT01206582|12715261|P2|COMPLETED|Overall Study||7
5169975|NCT01206582|12715262|P1|COMPLETED|Overall Study||9
5169976|NCT01206582|12715261|P2|STARTED|Overall Study||9
5169977|NCT01206582|12715262|P1|STARTED|Overall Study||11
5169978|NCT01206517|12715294|P6|NOT COMPLETED|Overall Study||0
5169979|NCT01206517|12715295|P5|NOT COMPLETED|Overall Study||1
5169980|NCT01206517|12715296|P4|NOT COMPLETED|Overall Study||0
5169981|NCT01206517|12715297|P3|NOT COMPLETED|Overall Study||2
5169982|NCT01206517|12715298|P2|NOT COMPLETED|Overall Study||0
5169983|NCT01206517|12715299|P1|NOT COMPLETED|Overall Study||0
5169984|NCT01206517|12715294|P6|COMPLETED|Overall Study||4
5169985|NCT01206517|12715295|P5|COMPLETED|Overall Study||3
5169986|NCT01206517|12715296|P4|COMPLETED|Overall Study||4
5169987|NCT01206517|12715297|P3|COMPLETED|Overall Study||4
5169988|NCT01206517|12715298|P2|COMPLETED|Overall Study||6
5169989|NCT01206517|12715299|P1|COMPLETED|Overall Study||6
5169990|NCT01206517|12715294|P6|STARTED|Overall Study||4
5169991|NCT01206517|12715295|P5|STARTED|Overall Study||4
5169992|NCT01206517|12715296|P4|STARTED|Overall Study||4
5169993|NCT01206517|12715297|P3|STARTED|Overall Study||6
5169994|NCT01206517|12715298|P2|STARTED|Overall Study||6
5169995|NCT01206517|12715299|P1|STARTED|Overall Study||6
5169996|NCT01206478|12715330|P2|NOT COMPLETED|Overall Study||5
5169997|NCT01206478|12715331|P1|NOT COMPLETED|Overall Study||2
5169998|NCT01206478|12715330|P2|COMPLETED|Overall Study||7
5169999|NCT01206478|12715331|P1|COMPLETED|Overall Study||7
5170000|NCT01206478|12715330|P2|STARTED|Overall Study||12
5170001|NCT01206478|12715331|P1|STARTED|Overall Study||9
5170002|NCT01206465|12715339|P5|NOT COMPLETED|Overall Study||0
5170003|NCT01206465|12715340|P4|NOT COMPLETED|Overall Study||0
5170004|NCT01206465|12715341|P3|NOT COMPLETED|Overall Study||0
5170005|NCT01206465|12715342|P2|NOT COMPLETED|Overall Study||0
5170006|NCT01206465|12715343|P1|NOT COMPLETED|Overall Study||0
5170007|NCT01206465|12715339|P5|COMPLETED|Overall Study||6
5170008|NCT01206465|12715340|P4|COMPLETED|Overall Study||6
5170009|NCT01206465|12715341|P3|COMPLETED|Overall Study||6
5170010|NCT01206465|12715342|P2|COMPLETED|Overall Study||6
5170011|NCT01206465|12715343|P1|COMPLETED|Overall Study||3
5170012|NCT01206465|12715339|P5|STARTED|Overall Study||6
5170013|NCT01206465|12715340|P4|STARTED|Overall Study||6
5170014|NCT01206465|12715341|P3|STARTED|Overall Study||6
5170015|NCT01206465|12715342|P2|STARTED|Overall Study||6
5170016|NCT01206465|12715343|P1|STARTED|Overall Study||3
5170017|NCT01206452|12715364|P2|NOT COMPLETED|Overall Study||0
5170018|NCT01206452|12715365|P1|NOT COMPLETED|Overall Study||0
5170019|NCT01206452|12715364|P2|COMPLETED|Overall Study||30
5170020|NCT01206452|12715365|P1|COMPLETED|Overall Study||30
5170021|NCT01206452|12715364|P2|STARTED|Overall Study||30
5170022|NCT01206452|12715365|P1|STARTED|Overall Study||30
5170023|NCT01206439|12715379|P1|NOT COMPLETED|Overall Study||1
5170024|NCT01206439|12715379|P1|COMPLETED|Overall Study||1
5170025|NCT01206439|12715379|P1|STARTED|Overall Study||2
5170026|NCT01206387|12715385|P2|NOT COMPLETED|Overall Study||0
5170027|NCT01206387|12715386|P1|NOT COMPLETED|Overall Study||1
5170028|NCT01206387|12715385|P2|COMPLETED|Overall Study||60
5170029|NCT01206387|12715386|P1|COMPLETED|Overall Study||59
5170030|NCT01206387|12715385|P2|STARTED|Overall Study||60
5170031|NCT01206387|12715386|P1|STARTED|Overall Study||60
5170032|NCT01206322|12715402|P4|NOT COMPLETED|Overall Study||1
5170033|NCT01206322|12715403|P3|NOT COMPLETED|Overall Study||0
5170034|NCT01206322|12715404|P2|NOT COMPLETED|Overall Study||0
5170035|NCT01206322|12715405|P1|NOT COMPLETED|Overall Study||0
5170036|NCT01206322|12715402|P4|COMPLETED|Overall Study||5
5170037|NCT01206322|12715403|P3|COMPLETED|Overall Study||9
5170038|NCT01206322|12715404|P2|COMPLETED|Overall Study||11
5170039|NCT01206322|12715405|P1|COMPLETED|Overall Study||4
5170040|NCT01206322|12715402|P4|STARTED|Overall Study||6
5170041|NCT01206322|12715403|P3|STARTED|Overall Study||9
5170042|NCT01206322|12715404|P2|STARTED|Overall Study||11
5170043|NCT01206322|12715405|P1|STARTED|Overall Study||4
5170044|NCT01206140|12715421|P2|NOT COMPLETED|Overall Study||0
5170045|NCT01206140|12715422|P1|NOT COMPLETED|Overall Study||1
5170046|NCT01206140|12715421|P2|COMPLETED|Overall Study||35
5170047|NCT01206140|12715422|P1|COMPLETED|Overall Study||34
5170048|NCT01206140|12715421|P2|STARTED|Overall Study||35
5170049|NCT01206140|12715422|P1|STARTED|Overall Study||35
5170050|NCT01206101|12715434|P2|NOT COMPLETED|Overall Study||1
5170051|NCT01206101|12715435|P1|NOT COMPLETED|Overall Study||2
5170052|NCT01206101|12715434|P2|COMPLETED|Overall Study||0
5170053|NCT01206101|12715435|P1|COMPLETED|Overall Study||0
5170054|NCT01206101|12715434|P2|STARTED|Overall Study||1
5170055|NCT01206101|12715435|P1|STARTED|Overall Study||2
5170056|NCT01206062|12715453|P2|NOT COMPLETED|Overall Study||0
5170057|NCT01206062|12715454|P1|NOT COMPLETED|Overall Study||0
5170058|NCT01206062|12715453|P2|COMPLETED|Overall Study||4683
5170059|NCT01206062|12715454|P1|COMPLETED|Overall Study||4678
5170060|NCT01206062|12715453|P2|STARTED|Overall Study||4683
5170061|NCT01206062|12715454|P1|STARTED|Overall Study||4678
5170062|NCT01205828|12715466|P1|NOT COMPLETED|Overall Study||0
5170063|NCT01205828|12715466|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
5170064|NCT01205828|12715466|P1|STARTED|Overall Study||16
5170065|NCT01205776|12715476|P2|NOT COMPLETED|Overall Study||95
5170066|NCT01205776|12715477|P1|NOT COMPLETED|Overall Study||64
5170067|NCT01205776|12715476|P2|COMPLETED|Overall Study||862
5170068|NCT01205776|12715477|P1|COMPLETED|Overall Study||884
5170069|NCT01205776|12715476|P2|STARTED|Overall Study||957
5170070|NCT01205776|12715477|P1|STARTED|Overall Study||948
5170071|NCT01205685|12715665|P1|NOT COMPLETED|Overall Study||11
5170072|NCT01205685|12715665|P1|COMPLETED|Overall Study||0
5170073|NCT01205685|12715665|P1|STARTED|Overall Study||11
5170074|NCT01205646|12715672|P1|NOT COMPLETED|Overall Study||0
5170075|NCT01205646|12715672|P1|COMPLETED|Overall Study||11
5170076|NCT01205646|12715672|P1|STARTED|Overall Study||11
5170077|NCT01205581|12715685|P6|NOT COMPLETED|Overall Study||0
5170078|NCT01205581|12715686|P5|NOT COMPLETED|Overall Study||0
5170079|NCT01205581|12715687|P4|NOT COMPLETED|Overall Study||0
5170080|NCT01205581|12715688|P3|NOT COMPLETED|Overall Study||0
5170081|NCT01205581|12715689|P2|NOT COMPLETED|Overall Study||0
5170082|NCT01205581|12715690|P1|NOT COMPLETED|Overall Study||1
5170083|NCT01205581|12715685|P6|COMPLETED|Overall Study||20
5170084|NCT01205581|12715686|P5|COMPLETED|Overall Study||20
5170085|NCT01205581|12715687|P4|COMPLETED|Overall Study||9
5170086|NCT01205581|12715688|P3|COMPLETED|Overall Study||8
5170087|NCT01205581|12715689|P2|COMPLETED|Overall Study||13
5170088|NCT01205581|12715690|P1|COMPLETED|Overall Study||13
5170089|NCT01205581|12715685|P6|STARTED|Overall Study||20
5170090|NCT01205581|12715686|P5|STARTED|Overall Study||20
5170091|NCT01205581|12715687|P4|STARTED|Overall Study||9
5170092|NCT01205581|12715688|P3|STARTED|Overall Study||8
5170093|NCT01205581|12715689|P2|STARTED|Overall Study||13
5170094|NCT01205581|12715690|P1|STARTED|Overall Study||14
5170095|NCT01205568|12715754|P2|NOT COMPLETED|Overall Study||0
5170096|NCT01205568|12715755|P1|NOT COMPLETED|Overall Study||0
5170097|NCT01205568|12715754|P2|COMPLETED|Overall Study||47
5170098|NCT01205568|12715755|P1|COMPLETED|Overall Study||65
5170099|NCT01205568|12715754|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
5170100|NCT01205568|12715755|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
5170101|NCT01205529|12715760|P1|NOT COMPLETED|Overall Study||55
5170102|NCT01205529|12715760|P1|COMPLETED|Overall Study||106
5170103|NCT01205529|12715760|P1|STARTED|Overall Study||161
5170104|NCT01205503|12715766|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
5170105|NCT01205503|12715767|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
5170106|NCT01205503|12715766|P2|COMPLETED|Second Intervention (2nd Cycle)||16
5170107|NCT01205503|12715767|P1|COMPLETED|Second Intervention (2nd Cycle)||16
5170108|NCT01205503|12715766|P2|STARTED|Second Intervention (2nd Cycle)||16
5170109|NCT01205503|12715767|P1|STARTED|Second Intervention (2nd Cycle)||16
5170110|NCT01205503|12715766|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
5170111|NCT01205503|12715767|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
5170112|NCT01205503|12715766|P2|COMPLETED|First Intervention (1st Cycle)||16
5170113|NCT01205503|12715767|P1|COMPLETED|First Intervention (1st Cycle)||16
5170114|NCT01205503|12715766|P2|STARTED|First Intervention (1st Cycle)||16
5170115|NCT01205503|12715767|P1|STARTED|First Intervention (1st Cycle)||16
5170116|NCT01205451|12715783|P2|NOT COMPLETED|Overall Study||10
5170117|NCT01205451|12715784|P1|NOT COMPLETED|Overall Study||6
5170118|NCT01205451|12715783|P2|COMPLETED|Overall Study||46
5170119|NCT01205451|12715784|P1|COMPLETED|Overall Study||47
5170120|NCT01205451|12715783|P2|STARTED|Overall Study||56
5170121|NCT01205451|12715784|P1|STARTED|Overall Study||53
5170122|NCT01205438|12715829|P3|NOT COMPLETED|Overall Study||88
5170123|NCT01205438|12715830|P2|NOT COMPLETED|Overall Study||87
5170124|NCT01205438|12715831|P1|NOT COMPLETED|Overall Study||77
5170125|NCT01205438|12715829|P3|COMPLETED|Overall Study||288
5170126|NCT01205438|12715830|P2|COMPLETED|Overall Study||289
5170127|NCT01205438|12715831|P1|COMPLETED|Overall Study||295
5170128|NCT01205438|12715829|P3|Participated in Follow Up|Overall Study||66
5170129|NCT01205438|12715830|P2|Participated in Follow Up|Overall Study||78
5170130|NCT01205438|12715831|P1|Participated in Follow Up|Overall Study||72
5170131|NCT01205438|12715829|P3|Received At Least One Dose of Study Drug|Overall Study||376
5170132|NCT01205438|12715830|P2|Received At Least One Dose of Study Drug|Overall Study||374
5170133|NCT01205438|12715831|P1|Received At Least One Dose of Study Drug|Overall Study||371
5170134|NCT01205438|12715829|P3|STARTED|Overall Study||376
5170135|NCT01205438|12715830|P2|STARTED|Overall Study||376
5170136|NCT01205438|12715831|P1|STARTED|Overall Study||372
5170137|NCT01205399|12715881|P1|NOT COMPLETED|Overall Study||0
5170138|NCT01205399|12715881|P1|COMPLETED|Overall Study||78
5170139|NCT01205399|12715881|P1|STARTED|Overall Study||78
5170140|NCT01205269|12715887|P6|NOT COMPLETED|Period 5 - Third Intervention||0
5170141|NCT01205269|12715888|P5|NOT COMPLETED|Period 5 - Third Intervention||0
5170142|NCT01205269|12715889|P4|NOT COMPLETED|Period 5 - Third Intervention||0
5170143|NCT01205269|12715890|P3|NOT COMPLETED|Period 5 - Third Intervention||0
5170144|NCT01205269|12715891|P2|NOT COMPLETED|Period 5 - Third Intervention||0
5170145|NCT01205269|12715892|P1|NOT COMPLETED|Period 5 - Third Intervention||0
5170146|NCT01205269|12715887|P6|COMPLETED|Period 5 - Third Intervention||5
5170147|NCT01205269|12715888|P5|COMPLETED|Period 5 - Third Intervention||5
5170148|NCT01205269|12715889|P4|COMPLETED|Period 5 - Third Intervention||5
5170149|NCT01205269|12715890|P3|COMPLETED|Period 5 - Third Intervention||4
5170150|NCT01205269|12715891|P2|COMPLETED|Period 5 - Third Intervention||4
5170151|NCT01205269|12715892|P1|COMPLETED|Period 5 - Third Intervention||4
5170152|NCT01205269|12715887|P6|STARTED|Period 5 - Third Intervention||5
5170153|NCT01205269|12715888|P5|STARTED|Period 5 - Third Intervention||5
5170154|NCT01205269|12715889|P4|STARTED|Period 5 - Third Intervention||5
5170155|NCT01205269|12715890|P3|STARTED|Period 5 - Third Intervention||4
5170156|NCT01205269|12715891|P2|STARTED|Period 5 - Third Intervention||4
5170157|NCT01205269|12715892|P1|STARTED|Period 5 - Third Intervention||4
5170158|NCT01205269|12715887|P6|NOT COMPLETED|Period 4 - Washout||0
5170159|NCT01205269|12715888|P5|NOT COMPLETED|Period 4 - Washout||0
5170160|NCT01205269|12715889|P4|NOT COMPLETED|Period 4 - Washout||1
5170161|NCT01205269|12715890|P3|NOT COMPLETED|Period 4 - Washout||0
5170162|NCT01205269|12715891|P2|NOT COMPLETED|Period 4 - Washout||0
5170163|NCT01205269|12715892|P1|NOT COMPLETED|Period 4 - Washout||0
5170164|NCT01205269|12715887|P6|COMPLETED|Period 4 - Washout||5
5170165|NCT01205269|12715888|P5|COMPLETED|Period 4 - Washout||5
5170166|NCT01205269|12715889|P4|COMPLETED|Period 4 - Washout||5
5170167|NCT01205269|12715890|P3|COMPLETED|Period 4 - Washout||4
5170168|NCT01205269|12715891|P2|COMPLETED|Period 4 - Washout||4
5170169|NCT01205269|12715892|P1|COMPLETED|Period 4 - Washout||4
5170170|NCT01205269|12715887|P6|STARTED|Period 4 - Washout||5
5170171|NCT01205269|12715888|P5|STARTED|Period 4 - Washout||5
5170172|NCT01205269|12715889|P4|STARTED|Period 4 - Washout||6
5170173|NCT01205269|12715890|P3|STARTED|Period 4 - Washout||4
5170174|NCT01205269|12715891|P2|STARTED|Period 4 - Washout||4
5170175|NCT01205269|12715892|P1|STARTED|Period 4 - Washout||4
5170176|NCT01205269|12715887|P6|NOT COMPLETED|Period 3 - Second Intervention||0
5170177|NCT01205269|12715888|P5|NOT COMPLETED|Period 3 - Second Intervention||0
5170178|NCT01205269|12715889|P4|NOT COMPLETED|Period 3 - Second Intervention||0
5170179|NCT01205269|12715890|P3|NOT COMPLETED|Period 3 - Second Intervention||0
5170180|NCT01205269|12715891|P2|NOT COMPLETED|Period 3 - Second Intervention||0
5170181|NCT01205269|12715892|P1|NOT COMPLETED|Period 3 - Second Intervention||0
5170182|NCT01205269|12715887|P6|COMPLETED|Period 3 - Second Intervention||5
5170183|NCT01205269|12715888|P5|COMPLETED|Period 3 - Second Intervention||5
5170184|NCT01205269|12715889|P4|COMPLETED|Period 3 - Second Intervention||6
5170185|NCT01205269|12715890|P3|COMPLETED|Period 3 - Second Intervention||4
5170186|NCT01205269|12715891|P2|COMPLETED|Period 3 - Second Intervention||4
5170187|NCT01205269|12715892|P1|COMPLETED|Period 3 - Second Intervention||4
5170188|NCT01205269|12715887|P6|STARTED|Period 3 - Second Intervention||5
5170189|NCT01205269|12715888|P5|STARTED|Period 3 - Second Intervention||5
5170190|NCT01205269|12715889|P4|STARTED|Period 3 - Second Intervention||6
5170191|NCT01205269|12715890|P3|STARTED|Period 3 - Second Intervention||4
5170192|NCT01205269|12715891|P2|STARTED|Period 3 - Second Intervention||4
5170193|NCT01205269|12715892|P1|STARTED|Period 3 - Second Intervention||4
5170194|NCT01205269|12715887|P6|NOT COMPLETED|Period 2 - Washout||0
5170195|NCT01205269|12715888|P5|NOT COMPLETED|Period 2 - Washout||0
5170196|NCT01205269|12715889|P4|NOT COMPLETED|Period 2 - Washout||0
5170197|NCT01205269|12715890|P3|NOT COMPLETED|Period 2 - Washout||0
5170198|NCT01205269|12715891|P2|NOT COMPLETED|Period 2 - Washout||0
5170199|NCT01205269|12715892|P1|NOT COMPLETED|Period 2 - Washout||0
5170200|NCT01205269|12715887|P6|COMPLETED|Period 2 - Washout||5
5170201|NCT01205269|12715888|P5|COMPLETED|Period 2 - Washout||5
5170202|NCT01205269|12715889|P4|COMPLETED|Period 2 - Washout||6
5170203|NCT01205269|12715890|P3|COMPLETED|Period 2 - Washout||4
5170204|NCT01205269|12715891|P2|COMPLETED|Period 2 - Washout||4
5170205|NCT01205269|12715892|P1|COMPLETED|Period 2 - Washout||4
5170206|NCT01205269|12715887|P6|STARTED|Period 2 - Washout||5
5170207|NCT01205269|12715888|P5|STARTED|Period 2 - Washout||5
5170208|NCT01205269|12715889|P4|STARTED|Period 2 - Washout||6
5170209|NCT01205269|12715890|P3|STARTED|Period 2 - Washout||4
5170210|NCT01205269|12715891|P2|STARTED|Period 2 - Washout||4
5170211|NCT01205269|12715892|P1|STARTED|Period 2 - Washout||4
5170212|NCT01205269|12715887|P6|NOT COMPLETED|Period 1 - First Intervention||0
5170213|NCT01205269|12715888|P5|NOT COMPLETED|Period 1 - First Intervention||0
5170214|NCT01205269|12715889|P4|NOT COMPLETED|Period 1 - First Intervention||0
5170215|NCT01205269|12715890|P3|NOT COMPLETED|Period 1 - First Intervention||0
5170216|NCT01205269|12715891|P2|NOT COMPLETED|Period 1 - First Intervention||0
5170217|NCT01205269|12715892|P1|NOT COMPLETED|Period 1 - First Intervention||0
5170218|NCT01205269|12715887|P6|COMPLETED|Period 1 - First Intervention||5
5170219|NCT01205269|12715888|P5|COMPLETED|Period 1 - First Intervention||5
5170220|NCT01205269|12715889|P4|COMPLETED|Period 1 - First Intervention||6
5170221|NCT01205269|12715890|P3|COMPLETED|Period 1 - First Intervention||4
5170222|NCT01205269|12715891|P2|COMPLETED|Period 1 - First Intervention||4
5170223|NCT01205269|12715892|P1|COMPLETED|Period 1 - First Intervention||4
5170224|NCT01205269|12715887|P6|STARTED|Period 1 - First Intervention||5
5170225|NCT01205269|12715888|P5|STARTED|Period 1 - First Intervention||5
5170226|NCT01205269|12715889|P4|STARTED|Period 1 - First Intervention||6
5170227|NCT01205269|12715890|P3|STARTED|Period 1 - First Intervention||4
5170228|NCT01205269|12715891|P2|STARTED|Period 1 - First Intervention||4
5170229|NCT01205269|12715892|P1|STARTED|Period 1 - First Intervention||4
5170230|NCT01205230|12715932|P2|NOT COMPLETED|Overall Study||0
5170231|NCT01205230|12715933|P1|NOT COMPLETED|Overall Study||5
5170232|NCT01205230|12715932|P2|COMPLETED|Overall Study||13
5170233|NCT01205230|12715933|P1|COMPLETED|Overall Study||16
5170234|NCT01205230|12715932|P2|Combination Therapy|Overall Study||13
5170235|NCT01205230|12715933|P1|Combination Therapy|Overall Study||21
5170236|NCT01205230|12715932|P2|STARTED|Overall Study||13
5170237|NCT01205230|12715933|P1|STARTED|Overall Study||21
5170238|NCT01205165|12715976|P1|NOT COMPLETED|Overall Study||2
5170239|NCT01205165|12715976|P1|COMPLETED|Overall Study||102
5170240|NCT01205165|12715976|P1|STARTED|Overall Study||104
5170241|NCT01205152|12715989|P1|NOT COMPLETED|Overall Study||1
5170242|NCT01205152|12715989|P1|COMPLETED|Overall Study||9
5170243|NCT01205152|12715989|P1|STARTED|Overall Study||10
5170244|NCT01205126|12716002|P2|NOT COMPLETED|Maintenance Phase||40
5170245|NCT01205126|12716003|P1|NOT COMPLETED|Maintenance Phase||37
5170246|NCT01205126|12716002|P2|COMPLETED|Maintenance Phase||67
5170247|NCT01205126|12716003|P1|COMPLETED|Maintenance Phase||70
5170248|NCT01205126|12716002|P2|STARTED|Maintenance Phase||107
5170249|NCT01205126|12716003|P1|STARTED|Maintenance Phase||107
5170250|NCT01205126|12716002|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
5170251|NCT01205126|12716003|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
5170252|NCT01205126|12716002|P2|COMPLETED|Between Titration & Maintenance Phase||107
5170253|NCT01205126|12716003|P1|COMPLETED|Between Titration & Maintenance Phase||107
5170254|NCT01205126|12716002|P2|STARTED|Between Titration & Maintenance Phase||111
5170255|NCT01205126|12716003|P1|STARTED|Between Titration & Maintenance Phase||107
5170256|NCT01205126|12716002|P2|NOT COMPLETED|Titration Phase||19
5170257|NCT01205126|12716003|P1|NOT COMPLETED|Titration Phase||23
5170258|NCT01205126|12716002|P2|COMPLETED|Titration Phase||111
5170259|NCT01205126|12716003|P1|COMPLETED|Titration Phase||107
5170260|NCT01205126|12716002|P2|STARTED|Titration Phase||130
5170261|NCT01205126|12716003|P1|STARTED|Titration Phase||130
5170262|NCT01205035|12716021|P2|NOT COMPLETED|Overall Study||0
5170263|NCT01205035|12716022|P1|NOT COMPLETED|Overall Study||2
5170264|NCT01205035|12716021|P2|COMPLETED|Overall Study||3
5170265|NCT01205035|12716022|P1|COMPLETED|Overall Study||1
5170266|NCT01205035|12716021|P2|STARTED|Overall Study||3
5170267|NCT01205035|12716022|P1|STARTED|Overall Study||3
5170268|NCT01204918|12716039|P3|NOT COMPLETED|Overall Study||5
5170269|NCT01204918|12716040|P2|NOT COMPLETED|Overall Study||10
5170270|NCT01204918|12716041|P1|NOT COMPLETED|Overall Study||4
5170271|NCT01204918|12716039|P3|COMPLETED|Overall Study||35
5170272|NCT01204918|12716040|P2|COMPLETED|Overall Study||29
5170273|NCT01204918|12716041|P1|COMPLETED|Overall Study||21
5170274|NCT01204918|12716039|P3|Stage 2 End|Overall Study||35
5170275|NCT01204918|12716040|P2|Stage 2 End|Overall Study||29
5170276|NCT01204918|12716041|P1|Stage 2 End|Overall Study||21
5170277|NCT01204918|12716039|P3|Stage 2 Begin|Overall Study||36
5170278|NCT01204918|12716040|P2|Stage 2 Begin|Overall Study||35
5170279|NCT01204918|12716041|P1|Stage 2 Begin|Overall Study||22
5170280|NCT01204918|12716039|P3|Stage 1 End|Overall Study||36
5170281|NCT01204918|12716040|P2|Stage 1 End|Overall Study||35
5170282|NCT01204918|12716041|P1|Stage 1 End|Overall Study||22
5170283|NCT01204918|12716039|P3|Stage 1 Begin|Overall Study||40
5170284|NCT01204918|12716040|P2|Stage 1 Begin|Overall Study||39
5170285|NCT01204918|12716041|P1|Stage 1 Begin|Overall Study||25
5170286|NCT01204918|12716039|P3|STARTED|Overall Study||40
5170287|NCT01204918|12716040|P2|STARTED|Overall Study||39
5170288|NCT01204918|12716041|P1|STARTED|Overall Study||25
5170289|NCT01204905|12716058|P1|NOT COMPLETED|Overall Study||2
5170290|NCT01204905|12716058|P1|COMPLETED|Overall Study||5
5170291|NCT01204905|12716058|P1|STARTED|Overall Study||7
5170292|NCT01204853|12716063|P1|NOT COMPLETED|Overall Study||0
5170293|NCT01204853|12716063|P1|COMPLETED|Overall Study||2
5170294|NCT01204853|12716063|P1|STARTED|Overall Study||2
5170295|NCT01204788|12716075|P2|NOT COMPLETED|Overall Study||3
5170296|NCT01204788|12716076|P1|NOT COMPLETED|Overall Study||1
5170297|NCT01204788|12716075|P2|COMPLETED|Overall Study||0
5170298|NCT01204788|12716076|P1|COMPLETED|Overall Study||0
5170299|NCT01204788|12716075|P2|STARTED|Overall Study||3
5170300|NCT01204788|12716076|P1|STARTED|Overall Study||1
5170301|NCT01204775|12716084|P2|NOT COMPLETED|Overall Study||1
5170302|NCT01204775|12716085|P1|NOT COMPLETED|Overall Study||1
5170303|NCT01204775|12716084|P2|COMPLETED|Overall Study||3
5170304|NCT01204775|12716085|P1|COMPLETED|Overall Study||3
5170305|NCT01204775|12716084|P2|Double-blind Treatment Period|Overall Study||4
5170306|NCT01204775|12716085|P1|Double-blind Treatment Period|Overall Study||4
5170307|NCT01204775|12716084|P2|STARTED|Overall Study||4
5170308|NCT01204775|12716085|P1|STARTED|Overall Study||4
5170309|NCT01204736|12716095|P4|NOT COMPLETED|Overall Study||0
5170310|NCT01204736|12716096|P3|NOT COMPLETED|Overall Study||0
5170311|NCT01204736|12716097|P2|NOT COMPLETED|Overall Study||0
5170312|NCT01204736|12716098|P1|NOT COMPLETED|Overall Study||0
5170313|NCT01204736|12716095|P4|COMPLETED|Overall Study||2
5170314|NCT01204736|12716096|P3|COMPLETED|Overall Study||3
5170315|NCT01204736|12716097|P2|COMPLETED|Overall Study||5
5170316|NCT01204736|12716098|P1|COMPLETED|Overall Study||4
5170317|NCT01204736|12716095|P4|STARTED|Overall Study||2
5170318|NCT01204736|12716096|P3|STARTED|Overall Study||3
5170319|NCT01204736|12716097|P2|STARTED|Overall Study||5
5170320|NCT01204736|12716098|P1|STARTED|Overall Study||4
5170321|NCT01204710|12716110|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
5170322|NCT01204710|12716111|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
5170323|NCT01204710|12716110|P2|COMPLETED|Optional Olaratumab Monotherapy||16
5170324|NCT01204710|12716111|P1|COMPLETED|Optional Olaratumab Monotherapy||0
5170413|NCT01203956|12716414|P1|NOT COMPLETED|Second Two-week Period||5
5170325|NCT01204710|12716110|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
5170326|NCT01204710|12716111|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
5170327|NCT01204710|12716110|P2|NOT COMPLETED|Randomization Treatment||13
5170328|NCT01204710|12716111|P1|NOT COMPLETED|Randomization Treatment||14
5170329|NCT01204710|12716110|P2|COMPLETED|Randomization Treatment||47
5170330|NCT01204710|12716111|P1|COMPLETED|Randomization Treatment||49
5170331|NCT01204710|12716110|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
5170332|NCT01204710|12716111|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
5170333|NCT01204710|12716110|P2|STARTED|Randomization Treatment||60
5170334|NCT01204710|12716111|P1|STARTED|Randomization Treatment||63
5170335|NCT01204697|12716147|P2|NOT COMPLETED|Overall Study||36
5170336|NCT01204697|12716148|P1|NOT COMPLETED|Overall Study||31
5170337|NCT01204697|12716147|P2|COMPLETED|Overall Study||2
5170338|NCT01204697|12716148|P1|COMPLETED|Overall Study||5
5170339|NCT01204697|12716147|P2|Treated|Overall Study||37
5170340|NCT01204697|12716148|P1|Treated|Overall Study||36
5170341|NCT01204697|12716147|P2|STARTED|Overall Study||38
5170342|NCT01204697|12716148|P1|STARTED|Overall Study||36
5170343|NCT01204671|12716169|P5|NOT COMPLETED|Overall Study||4
5170344|NCT01204671|12716170|P4|NOT COMPLETED|Overall Study||13
5170345|NCT01204671|12716171|P3|NOT COMPLETED|Overall Study||13
5170346|NCT01204671|12716172|P2|NOT COMPLETED|Overall Study||15
5170347|NCT01204671|12716173|P1|NOT COMPLETED|Overall Study||14
5170348|NCT01204671|12716169|P5|COMPLETED|Overall Study||606
5170349|NCT01204671|12716170|P4|COMPLETED|Overall Study||997
5170350|NCT01204671|12716171|P3|COMPLETED|Overall Study||998
5170351|NCT01204671|12716172|P2|COMPLETED|Overall Study||998
5170352|NCT01204671|12716173|P1|COMPLETED|Overall Study||998
5170353|NCT01204671|12716169|P5|STARTED|Overall Study||610
5170354|NCT01204671|12716170|P4|STARTED|Overall Study||1010
5170355|NCT01204671|12716171|P3|STARTED|Overall Study||1011
5170356|NCT01204671|12716172|P2|STARTED|Overall Study||1013
5170357|NCT01204671|12716173|P1|STARTED|Overall Study||1012
5170358|NCT01204658|12716235|P4|NOT COMPLETED|Booster Phase||0
5170359|NCT01204658|12716236|P3|NOT COMPLETED|Booster Phase||0
5170360|NCT01204658|12716237|P2|NOT COMPLETED|Booster Phase||0
5170361|NCT01204658|12716238|P1|NOT COMPLETED|Booster Phase||0
5170362|NCT01204658|12716235|P4|COMPLETED|Booster Phase||140
5170363|NCT01204658|12716236|P3|COMPLETED|Booster Phase||140
5170364|NCT01204658|12716237|P2|COMPLETED|Booster Phase||140
5170365|NCT01204658|12716238|P1|COMPLETED|Booster Phase||144
5170366|NCT01204658|12716235|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
5170367|NCT01204658|12716236|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
5170368|NCT01204658|12716237|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
5170369|NCT01204658|12716238|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
5170370|NCT01204658|12716235|P4|NOT COMPLETED|Primary Phase||0
5170371|NCT01204658|12716236|P3|NOT COMPLETED|Primary Phase||1
5170372|NCT01204658|12716237|P2|NOT COMPLETED|Primary Phase||0
5170373|NCT01204658|12716238|P1|NOT COMPLETED|Primary Phase||0
5170374|NCT01204658|12716235|P4|COMPLETED|Primary Phase||142
5170375|NCT01204658|12716236|P3|COMPLETED|Primary Phase||144
5170376|NCT01204658|12716237|P2|COMPLETED|Primary Phase||142
5170377|NCT01204658|12716238|P1|COMPLETED|Primary Phase||146
5170378|NCT01204658|12716235|P4|STARTED|Primary Phase||142
5170379|NCT01204658|12716236|P3|STARTED|Primary Phase||145
5170380|NCT01204658|12716237|P2|STARTED|Primary Phase||142
5170381|NCT01204658|12716238|P1|STARTED|Primary Phase||146
5170382|NCT01204398|12716356|P1|NOT COMPLETED|Overall Study||1
5170383|NCT01204398|12716356|P1|COMPLETED|Overall Study|Completed trial medication.|26
5170384|NCT01204398|12716356|P1|STARTED|Overall Study|Entered and treated.|27
5170385|NCT01204294|12716373|P7|NOT COMPLETED|Overall Study||2
5170386|NCT01204294|12716374|P6|NOT COMPLETED|Overall Study||5
5170387|NCT01204294|12716375|P5|NOT COMPLETED|Overall Study||2
5170388|NCT01204294|12716376|P4|NOT COMPLETED|Overall Study||11
5170389|NCT01204294|12716377|P3|NOT COMPLETED|Overall Study||5
5170390|NCT01204294|12716378|P2|NOT COMPLETED|Overall Study||8
5170391|NCT01204294|12716379|P1|NOT COMPLETED|Overall Study||3
5170392|NCT01204294|12716373|P7|COMPLETED|Overall Study||59
5170393|NCT01204294|12716374|P6|COMPLETED|Overall Study||58
5170394|NCT01204294|12716375|P5|COMPLETED|Overall Study||83
5170395|NCT01204294|12716376|P4|COMPLETED|Overall Study||132
5170396|NCT01204294|12716377|P3|COMPLETED|Overall Study||69
5170397|NCT01204294|12716378|P2|COMPLETED|Overall Study||58
5170398|NCT01204294|12716379|P1|COMPLETED|Overall Study||79
5170399|NCT01204294|12716373|P7|STARTED|Overall Study||61
5170400|NCT01204294|12716374|P6|STARTED|Overall Study||63
5170401|NCT01204294|12716375|P5|STARTED|Overall Study||85
5170402|NCT01204294|12716376|P4|STARTED|Overall Study||143
5170403|NCT01204294|12716377|P3|STARTED|Overall Study||74
5170404|NCT01204294|12716378|P2|STARTED|Overall Study||66
5170405|NCT01204294|12716379|P1|STARTED|Overall Study||82
5170406|NCT01204255|12716402|P1|NOT COMPLETED|Overall Study||1
5170407|NCT01204255|12716402|P1|COMPLETED|Overall Study||10
5170408|NCT01204255|12716402|P1|STARTED|Overall Study||11
5170409|NCT01204203|12716407|P1|NOT COMPLETED|Overall Study||0
5170410|NCT01204203|12716407|P1|COMPLETED|Overall Study||8
5170411|NCT01204203|12716407|P1|STARTED|Overall Study||8
5170412|NCT01203956|12716413|P2|NOT COMPLETED|Second Two-week Period||6
5170414|NCT01203956|12716413|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
5170415|NCT01203956|12716414|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
5170416|NCT01203956|12716413|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
5170417|NCT01203956|12716414|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
5170418|NCT01203956|12716413|P2|STARTED|Second Two-week Period||13
5170419|NCT01203956|12716414|P1|STARTED|Second Two-week Period||15
5170420|NCT01203956|12716413|P2|NOT COMPLETED|First Two-week Period||0
5170421|NCT01203956|12716414|P1|NOT COMPLETED|First Two-week Period||0
5170422|NCT01203956|12716413|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
5170423|NCT01203956|12716414|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
5170424|NCT01203956|12716413|P2|STARTED|First Two-week Period||13
5170425|NCT01203956|12716414|P1|STARTED|First Two-week Period||15
5170426|NCT01203930|12716423|P2|NOT COMPLETED|Overall Study||41
5170427|NCT01203930|12716424|P1|NOT COMPLETED|Overall Study||21
5170428|NCT01203930|12716423|P2|COMPLETED|Overall Study||0
5170429|NCT01203930|12716424|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
5170430|NCT01203930|12716423|P2|STARTED|Overall Study||41
5170431|NCT01203930|12716424|P1|STARTED|Overall Study||64
5170432|NCT01203917|12716446|P1|NOT COMPLETED|Overall Study||36
5170433|NCT01203917|12716446|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
5170434|NCT01203917|12716446|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
5170435|NCT01203878|12716459|P3|NOT COMPLETED|Overall Study||3
5170436|NCT01203878|12716460|P2|NOT COMPLETED|Overall Study||0
5170437|NCT01203878|12716461|P1|NOT COMPLETED|Overall Study||0
5170438|NCT01203878|12716459|P3|COMPLETED|Overall Study||0
5170439|NCT01203878|12716460|P2|COMPLETED|Overall Study||9
5170440|NCT01203878|12716461|P1|COMPLETED|Overall Study||9
5170441|NCT01203878|12716459|P3|STARTED|Overall Study||3
5170442|NCT01203878|12716460|P2|STARTED|Overall Study||9
5170443|NCT01203878|12716461|P1|STARTED|Overall Study||9
5170444|NCT01203852|12716472|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
5170445|NCT01203852|12716472|P1|COMPLETED|Chlorthalidone 8 Weeks||328
5170446|NCT01203852|12716472|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
5170447|NCT01203852|12716472|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
5170448|NCT01203852|12716472|P1|NOT COMPLETED|Washout 2 Weeks||46
5170449|NCT01203852|12716472|P1|COMPLETED|Washout 2 Weeks||282
5170450|NCT01203852|12716472|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
5170451|NCT01203852|12716472|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
5170452|NCT01203852|12716472|P1|COMPLETED|Metoprolol 8 Weeks||369
5170453|NCT01203852|12716472|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
5170454|NCT01203826|12716481|P2|NOT COMPLETED|Overall Study||0
5170455|NCT01203826|12716482|P1|NOT COMPLETED|Overall Study||0
5170456|NCT01203826|12716481|P2|COMPLETED|Overall Study||6
5170457|NCT01203826|12716482|P1|COMPLETED|Overall Study||6
5170458|NCT01203826|12716481|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
5170459|NCT01203826|12716482|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
5170460|NCT01203787|12716490|P2|NOT COMPLETED|Overall Study||27
5170461|NCT01203787|12716491|P1|NOT COMPLETED|Overall Study||31
5170462|NCT01203787|12716490|P2|COMPLETED|Overall Study||30
5170463|NCT01203787|12716491|P1|COMPLETED|Overall Study||32
5170464|NCT01203787|12716490|P2|STARTED|Overall Study||57
5170465|NCT01203787|12716491|P1|STARTED|Overall Study||63
5170466|NCT01203644|12716511|P2|NOT COMPLETED|Overall Study||0
5170467|NCT01203644|12716512|P1|NOT COMPLETED|Overall Study||0
5170468|NCT01203644|12716511|P2|COMPLETED|Overall Study||50
5170469|NCT01203644|12716512|P1|COMPLETED|Overall Study||26
5170470|NCT01203644|12716511|P2|STARTED|Overall Study||50
5170471|NCT01203644|12716512|P1|STARTED|Overall Study||26
5170472|NCT01203319|12716524|P3|NOT COMPLETED|Overall Study||5
5170473|NCT01203319|12716525|P2|NOT COMPLETED|Overall Study||9
5170474|NCT01203319|12716526|P1|NOT COMPLETED|Overall Study||6
5170475|NCT01203319|12716524|P3|COMPLETED|Overall Study||217
5170476|NCT01203319|12716525|P2|COMPLETED|Overall Study||426
5170477|NCT01203319|12716526|P1|COMPLETED|Overall Study||428
5170478|NCT01203319|12716524|P3|STARTED|Overall Study||222
5170479|NCT01203319|12716525|P2|STARTED|Overall Study||435
5170480|NCT01203319|12716526|P1|STARTED|Overall Study||434
5170481|NCT01203189|12716543|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
5170482|NCT01203189|12716544|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
5170483|NCT01203189|12716545|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
5170484|NCT01203189|12716543|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
5170485|NCT01203189|12716544|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
5170486|NCT01203189|12716545|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
5170487|NCT01203189|12716543|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
5170488|NCT01203189|12716544|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
5170489|NCT01203189|12716545|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
5170490|NCT01203189|12716543|P3|NOT COMPLETED|First 4 Weeks Treatment||0
5170491|NCT01203189|12716544|P2|NOT COMPLETED|First 4 Weeks Treatment||2
5170492|NCT01203189|12716545|P1|NOT COMPLETED|First 4 Weeks Treatment||2
5170493|NCT01203189|12716543|P3|COMPLETED|First 4 Weeks Treatment||3
5170494|NCT01203189|12716544|P2|COMPLETED|First 4 Weeks Treatment||8
5170495|NCT01203189|12716545|P1|COMPLETED|First 4 Weeks Treatment||8
5170496|NCT01203189|12716543|P3|STARTED|First 4 Weeks Treatment||3
5170497|NCT01203189|12716544|P2|STARTED|First 4 Weeks Treatment||10
5170498|NCT01203189|12716545|P1|STARTED|First 4 Weeks Treatment||10
5170499|NCT01203098|12716562|P3|NOT COMPLETED|Overall Study||11
5170500|NCT01203098|12716563|P2|NOT COMPLETED|Overall Study||4
5170501|NCT01203098|12716564|P1|NOT COMPLETED|Overall Study||6
5170502|NCT01203098|12716562|P3|COMPLETED|Overall Study||78
5170503|NCT01203098|12716563|P2|COMPLETED|Overall Study||82
5170504|NCT01203098|12716564|P1|COMPLETED|Overall Study||83
5170505|NCT01203098|12716562|P3|Safety Analysis Dataset|Overall Study||87
5170506|NCT01203098|12716563|P2|Safety Analysis Dataset|Overall Study||85
5170507|NCT01203098|12716564|P1|Safety Analysis Dataset|Overall Study||89
5170508|NCT01203098|12716562|P3|STARTED|Overall Study||89
5170509|NCT01203098|12716563|P2|STARTED|Overall Study||86
5170510|NCT01203098|12716564|P1|STARTED|Overall Study||89
5170511|NCT01203072|12716580|P5|NOT COMPLETED|Overall Study||6
5170512|NCT01203072|12716581|P4|NOT COMPLETED|Overall Study||6
5170513|NCT01203072|12716582|P3|NOT COMPLETED|Overall Study||3
5170514|NCT01203072|12716583|P2|NOT COMPLETED|Overall Study||6
5170515|NCT01203072|12716584|P1|NOT COMPLETED|Overall Study||10
5170516|NCT01203072|12716580|P5|COMPLETED|Overall Study||96
5170517|NCT01203072|12716581|P4|COMPLETED|Overall Study||100
5170518|NCT01203072|12716582|P3|COMPLETED|Overall Study||101
5170519|NCT01203072|12716583|P2|COMPLETED|Overall Study||100
5170520|NCT01203072|12716584|P1|COMPLETED|Overall Study||95
5170521|NCT01203072|12716580|P5|STARTED|Overall Study||102
5170522|NCT01203072|12716581|P4|STARTED|Overall Study||106
5170523|NCT01203072|12716582|P3|STARTED|Overall Study||104
5170524|NCT01203072|12716583|P2|STARTED|Overall Study||106
5170525|NCT01203072|12716584|P1|STARTED|Overall Study||105
5170526|NCT01203046|12716603|P2|NOT COMPLETED|Overall Study||0
5170527|NCT01203046|12716604|P1|NOT COMPLETED|Overall Study||0
5170528|NCT01203046|12716603|P2|COMPLETED|Overall Study||28
5170529|NCT01203046|12716604|P1|COMPLETED|Overall Study||28
5170530|NCT01203046|12716603|P2|STARTED|Overall Study||28
5170531|NCT01203046|12716604|P1|STARTED|Overall Study||28
5170532|NCT01202994|12716612|P1|NOT COMPLETED|Overall Study||0
5170533|NCT01202994|12716612|P1|COMPLETED|Overall Study||27
5170534|NCT01202994|12716612|P1|STARTED|Overall Study||27
5170535|NCT01202955|12716619|P2|NOT COMPLETED|Period 3: 10 Days||0
5170536|NCT01202955|12716620|P1|NOT COMPLETED|Period 3: 10 Days||0
5170537|NCT01202955|12716619|P2|COMPLETED|Period 3: 10 Days||8
5170538|NCT01202955|12716620|P1|COMPLETED|Period 3: 10 Days||9
5170539|NCT01202955|12716619|P2|STARTED|Period 3: 10 Days||8
5170540|NCT01202955|12716620|P1|STARTED|Period 3: 10 Days||9
5170541|NCT01202955|12716619|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
5170542|NCT01202955|12716620|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
5170543|NCT01202955|12716619|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
5170544|NCT01202955|12716620|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
5170545|NCT01202955|12716619|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
5170546|NCT01202955|12716620|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
5170547|NCT01202955|12716619|P2|NOT COMPLETED|Period 1: 10 Days||2
5170548|NCT01202955|12716620|P1|NOT COMPLETED|Period 1: 10 Days||0
5170549|NCT01202955|12716619|P2|COMPLETED|Period 1: 10 Days||8
5170550|NCT01202955|12716620|P1|COMPLETED|Period 1: 10 Days||9
5170551|NCT01202955|12716619|P2|STARTED|Period 1: 10 Days||10
5170552|NCT01202955|12716620|P1|STARTED|Period 1: 10 Days||9
5170553|NCT01202903|12716632|P2|NOT COMPLETED|Overall Study||16
5170554|NCT01202903|12716633|P1|NOT COMPLETED|Overall Study||11
5170555|NCT01202903|12716632|P2|COMPLETED|Overall Study||292
5170556|NCT01202903|12716633|P1|COMPLETED|Overall Study||297
5170557|NCT01202903|12716632|P2|Safety Set*|Overall Study||299
5170558|NCT01202903|12716633|P1|Safety Set*|Overall Study||310
5170559|NCT01202903|12716632|P2|Full Analysis Set|Overall Study||302
5170560|NCT01202903|12716633|P1|Full Analysis Set|Overall Study||306
5170561|NCT01202903|12716632|P2|STARTED|Overall Study||308
5170562|NCT01202903|12716633|P1|STARTED|Overall Study||308
5170563|NCT01202877|12716660|P3|NOT COMPLETED|Overall Study||6
5170564|NCT01202877|12716661|P2|NOT COMPLETED|Overall Study||1
5170565|NCT01202877|12716662|P1|NOT COMPLETED|Overall Study||0
5170566|NCT01202877|12716660|P3|COMPLETED|Overall Study||34
5170567|NCT01202877|12716661|P2|COMPLETED|Overall Study||7
5170568|NCT01202877|12716662|P1|COMPLETED|Overall Study||6
5170569|NCT01202877|12716660|P3|STARTED|Overall Study||40
5170570|NCT01202877|12716661|P2|STARTED|Overall Study||8
5170571|NCT01202877|12716662|P1|STARTED|Overall Study||6
5170572|NCT01202773|12716676|P3|NOT COMPLETED|Overall Study||55
5170573|NCT01202773|12716677|P2|NOT COMPLETED|Overall Study||43
5170574|NCT01202773|12716678|P1|NOT COMPLETED|Overall Study||57
5170575|NCT01202773|12716676|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
5170576|NCT01202773|12716677|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
5170577|NCT01202773|12716678|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
5170578|NCT01202773|12716676|P3|Post-Treatment Follow-Up Population|Overall Study||51
5170579|NCT01202773|12716677|P2|Post-Treatment Follow-Up Population|Overall Study||36
5170580|NCT01202773|12716678|P1|Post-Treatment Follow-Up Population|Overall Study||46
5170581|NCT01202773|12716676|P3|Week 16 NR|Overall Study||37
5170582|NCT01202773|12716677|P2|Week 16 NR|Overall Study||33
5170583|NCT01202773|12716678|P1|Week 16 NR|Overall Study||23
5170584|NCT01202773|12716676|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
5170585|NCT01202773|12716677|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
5170586|NCT01202773|12716678|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
5170587|NCT01202773|12716676|P3|STARTED|Overall Study||155
5170588|NCT01202773|12716677|P2|STARTED|Overall Study||148
5170589|NCT01202773|12716678|P1|STARTED|Overall Study||153
5170590|NCT01202760|12716755|P3|NOT COMPLETED|Overall Study||35
5170591|NCT01202760|12716756|P2|NOT COMPLETED|Overall Study||52
5170592|NCT01202760|12716757|P1|NOT COMPLETED|Overall Study||47
5170593|NCT01202760|12716755|P3|COMPLETED|Overall Study||216
5170594|NCT01202760|12716756|P2|COMPLETED|Overall Study||322
5170595|NCT01202760|12716757|P1|COMPLETED|Overall Study||332
5170596|NCT01202760|12716755|P3|Received at Least One Dose of Study Drug|Overall Study||250
5170597|NCT01202760|12716756|P2|Received at Least One Dose of Study Drug|Overall Study||371
5170598|NCT01202760|12716757|P1|Received at Least One Dose of Study Drug|Overall Study||379
5170599|NCT01202760|12716755|P3|STARTED|Overall Study||251
5170600|NCT01202760|12716756|P2|STARTED|Overall Study||374
5170601|NCT01202760|12716757|P1|STARTED|Overall Study||379
5170602|NCT01202747|12716825|P1|NOT COMPLETED|Overall Study||1
5170603|NCT01202747|12716825|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
5170604|NCT01202747|12716825|P1|STARTED|Overall Study||50
5170605|NCT01202721|12716833|P4|NOT COMPLETED|Overall Study||0
5170606|NCT01202721|12716834|P3|NOT COMPLETED|Overall Study||0
5170607|NCT01202721|12716835|P2|NOT COMPLETED|Overall Study||0
5170608|NCT01202721|12716836|P1|NOT COMPLETED|Overall Study||0
5170609|NCT01202721|12716833|P4|COMPLETED|Overall Study||27
5170610|NCT01202721|12716834|P3|COMPLETED|Overall Study||14
5170611|NCT01202721|12716835|P2|COMPLETED|Overall Study||26
5170612|NCT01202721|12716836|P1|COMPLETED|Overall Study||18
5170613|NCT01202721|12716833|P4|STARTED|Overall Study||27
5170614|NCT01202721|12716834|P3|STARTED|Overall Study||14
5170615|NCT01202721|12716835|P2|STARTED|Overall Study||26
5170616|NCT01202721|12716836|P1|STARTED|Overall Study||18
5170617|NCT01202656|12716852|P2|NOT COMPLETED|CrossoverCycle||0
5170618|NCT01202656|12716853|P1|NOT COMPLETED|CrossoverCycle||0
5170619|NCT01202656|12716852|P2|COMPLETED|CrossoverCycle||14
5170620|NCT01202656|12716853|P1|COMPLETED|CrossoverCycle||18
5170621|NCT01202656|12716852|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
5170622|NCT01202656|12716853|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
5170623|NCT01202656|12716852|P2|NOT COMPLETED|Cycle 1||0
5170624|NCT01202656|12716853|P1|NOT COMPLETED|Cycle 1||0
5170625|NCT01202656|12716852|P2|COMPLETED|Cycle 1||62
5170626|NCT01202656|12716853|P1|COMPLETED|Cycle 1||67
5170627|NCT01202656|12716852|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
5170628|NCT01202656|12716853|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
5170629|NCT01202643|12716863|P2|NOT COMPLETED|Crossover Cycle||0
5170630|NCT01202643|12716864|P1|NOT COMPLETED|Crossover Cycle||0
5170631|NCT01202643|12716863|P2|COMPLETED|Crossover Cycle||2
5170632|NCT01202643|12716864|P1|COMPLETED|Crossover Cycle||1
5170633|NCT01202643|12716863|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
5170634|NCT01202643|12716864|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
5170635|NCT01202643|12716863|P2|NOT COMPLETED|Period 1||0
5170636|NCT01202643|12716864|P1|NOT COMPLETED|Period 1||0
5170637|NCT01202643|12716863|P2|COMPLETED|Period 1||6
5170638|NCT01202643|12716864|P1|COMPLETED|Period 1||6
5170639|NCT01202643|12716863|P2|STARTED|Period 1||6
5170640|NCT01202643|12716864|P1|STARTED|Period 1||6
5170641|NCT01202591|12716878|P6|NOT COMPLETED|Overall Study||4
5170642|NCT01202591|12716879|P5|NOT COMPLETED|Overall Study||5
5170643|NCT01202591|12716880|P4|NOT COMPLETED|Overall Study||7
5170644|NCT01202591|12716881|P3|NOT COMPLETED|Overall Study||11
5170645|NCT01202591|12716882|P2|NOT COMPLETED|Overall Study||5
5170646|NCT01202591|12716883|P1|NOT COMPLETED|Overall Study||5
5170647|NCT01202591|12716878|P6|COMPLETED|Overall Study||0
5170648|NCT01202591|12716879|P5|COMPLETED|Overall Study||0
5170649|NCT01202591|12716880|P4|COMPLETED|Overall Study||2
5170650|NCT01202591|12716881|P3|COMPLETED|Overall Study||1
5170651|NCT01202591|12716882|P2|COMPLETED|Overall Study||0
5170652|NCT01202591|12716883|P1|COMPLETED|Overall Study||0
5170653|NCT01202591|12716878|P6|STARTED|Overall Study||4
5170654|NCT01202591|12716879|P5|STARTED|Overall Study||5
5170655|NCT01202591|12716880|P4|STARTED|Overall Study||9
5170656|NCT01202591|12716881|P3|STARTED|Overall Study||12
5170657|NCT01202591|12716882|P2|STARTED|Overall Study||5
5170658|NCT01202591|12716883|P1|STARTED|Overall Study||5
5170659|NCT01202578|12716897|P1|NOT COMPLETED|Overall Study||0
5170660|NCT01202578|12716897|P1|COMPLETED|Overall Study||53
5170661|NCT01202578|12716897|P1|STARTED|Overall Study||53
5170662|NCT01202565|12716904|P1|NOT COMPLETED|Overall Study||67
5170663|NCT01202565|12716904|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
5170664|NCT01202565|12716904|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
5170665|NCT01202565|12716904|P1|STARTED|Overall Study||506
5170666|NCT01202409|12716927|P1|NOT COMPLETED|Overall Study||8
5170667|NCT01202409|12716927|P1|COMPLETED|Overall Study||11
5170668|NCT01202409|12716927|P1|STARTED|Overall Study||19
5170669|NCT01202279|12716934|P2|NOT COMPLETED|Overall Study||27
5170670|NCT01202279|12716935|P1|NOT COMPLETED|Overall Study||37
5170671|NCT01202279|12716934|P2|COMPLETED|Overall Study||561
5170672|NCT01202279|12716935|P1|COMPLETED|Overall Study||554
5170673|NCT01202279|12716934|P2|STARTED|Overall Study||588
5170674|NCT01202279|12716935|P1|STARTED|Overall Study||591
5170675|NCT01202253|12716943|P1|NOT COMPLETED|Overall Study||0
5170676|NCT01202253|12716943|P1|COMPLETED|Overall Study||50
5170677|NCT01202253|12716943|P1|STARTED|Overall Study||50
5170678|NCT01202227|12716987|P1|NOT COMPLETED|Overall Study||19
5170679|NCT01202227|12716987|P1|COMPLETED|Overall Study||84
5170680|NCT01202227|12716987|P1|STARTED|Overall Study|Treated|103
5170681|NCT01202188|12717011|P5|NOT COMPLETED|Overall Study||45
5170682|NCT01202188|12717012|P4|NOT COMPLETED|Overall Study||42
5170683|NCT01202188|12717013|P3|NOT COMPLETED|Overall Study||53
5170684|NCT01202188|12717014|P2|NOT COMPLETED|Overall Study||56
5170685|NCT01202188|12717015|P1|NOT COMPLETED|Overall Study||38
5170686|NCT01202188|12717011|P5|COMPLETED|Overall Study||189
5170687|NCT01202188|12717012|P4|COMPLETED|Overall Study||441
5170688|NCT01202188|12717013|P3|COMPLETED|Overall Study||422
5170689|NCT01202188|12717014|P2|COMPLETED|Overall Study||421
5170690|NCT01202188|12717015|P1|COMPLETED|Overall Study||437
5170691|NCT01202188|12717011|P5|Safety Set; Received Study Drug|Overall Study||232
5170692|NCT01202188|12717012|P4|Safety Set; Received Study Drug|Overall Study||480
5170693|NCT01202188|12717013|P3|Safety Set; Received Study Drug|Overall Study||473
5170694|NCT01202188|12717014|P2|Safety Set; Received Study Drug|Overall Study||476
5170695|NCT01202188|12717015|P1|Safety Set; Received Study Drug|Overall Study||474
5170696|NCT01202188|12717011|P5|STARTED|Overall Study||234
5170697|NCT01202188|12717012|P4|STARTED|Overall Study||483
5170698|NCT01202188|12717013|P3|STARTED|Overall Study||475
5170699|NCT01202188|12717014|P2|STARTED|Overall Study||477
5170700|NCT01202188|12717015|P1|STARTED|Overall Study||475
5170701|NCT01202175|12717123|P1|NOT COMPLETED|Overall Study||5
5170702|NCT01202175|12717123|P1|COMPLETED|Overall Study||45
5170703|NCT01202175|12717123|P1|Pacebo|Overall Study||25
5170704|NCT01202175|12717123|P1|Nebivolol|Overall Study||25
5170705|NCT01202175|12717123|P1|STARTED|Overall Study||50
5170706|NCT01202162|12717152|P2|NOT COMPLETED|Overall Study||2
5170707|NCT01202162|12717153|P1|NOT COMPLETED|Overall Study||3
5170708|NCT01202162|12717152|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
5170709|NCT01202162|12717153|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
5170710|NCT01202162|12717152|P2|STARTED|Overall Study||42
5170711|NCT01202162|12717153|P1|STARTED|Overall Study||43
5170712|NCT01202110|12717163|P2|NOT COMPLETED|Overall Study||0
5170713|NCT01202110|12717164|P1|NOT COMPLETED|Overall Study||0
5170714|NCT01202110|12717163|P2|COMPLETED|Overall Study||0
5170715|NCT01202110|12717164|P1|COMPLETED|Overall Study||10
5170716|NCT01202110|12717163|P2|STARTED|Overall Study||0
5170717|NCT01202110|12717164|P1|STARTED|Overall Study||10
5170718|NCT01202071|12717168|P4|NOT COMPLETED|Overall Study||0
5170719|NCT01202071|12717169|P3|NOT COMPLETED|Overall Study||0
5170720|NCT01202071|12717170|P2|NOT COMPLETED|Overall Study||0
5170721|NCT01202071|12717171|P1|NOT COMPLETED|Overall Study||0
5170722|NCT01202071|12717168|P4|COMPLETED|Overall Study||6
5170723|NCT01202071|12717169|P3|COMPLETED|Overall Study||6
5170724|NCT01202071|12717170|P2|COMPLETED|Overall Study||6
5170725|NCT01202071|12717171|P1|COMPLETED|Overall Study||6
5170726|NCT01202071|12717168|P4|STARTED|Overall Study||6
5170727|NCT01202071|12717169|P3|STARTED|Overall Study||6
5170728|NCT01202071|12717170|P2|STARTED|Overall Study||6
5170729|NCT01202071|12717171|P1|STARTED|Overall Study||6
5170730|NCT01201967|12717191|P2|NOT COMPLETED|Overall Study||5
5170731|NCT01201967|12717192|P1|NOT COMPLETED|Overall Study||6
5170732|NCT01201967|12717191|P2|COMPLETED|Overall Study||86
5170733|NCT01201967|12717192|P1|COMPLETED|Overall Study||86
5170734|NCT01201967|12717191|P2|STARTED|Overall Study||91
5170735|NCT01201967|12717192|P1|STARTED|Overall Study||92
5170736|NCT01201915|12717217|P3|NOT COMPLETED|Overall Study||6
5170737|NCT01201915|12717218|P2|NOT COMPLETED|Overall Study||11
5170738|NCT01201915|12717219|P1|NOT COMPLETED|Overall Study||8
5170739|NCT01201915|12717217|P3|COMPLETED|Overall Study||19
5170740|NCT01201915|12717218|P2|COMPLETED|Overall Study||14
5170741|NCT01201915|12717219|P1|COMPLETED|Overall Study||16
5170742|NCT01201915|12717217|P3|STARTED|Overall Study||25
5170743|NCT01201915|12717218|P2|STARTED|Overall Study||25
5170744|NCT01201915|12717219|P1|STARTED|Overall Study||24
5170745|NCT01201811|12717230|P1|NOT COMPLETED|Overall Study||19
5170746|NCT01201811|12717230|P1|COMPLETED|Overall Study||25
5170747|NCT01201811|12717230|P1|STARTED|Overall Study||44
5170748|NCT01201798|12717252|P2|NOT COMPLETED|Overall Study||15
5170749|NCT01201798|12717253|P1|NOT COMPLETED|Overall Study||9
5170750|NCT01201798|12717252|P2|COMPLETED|Overall Study||39
5170751|NCT01201798|12717253|P1|COMPLETED|Overall Study||47
5170752|NCT01201798|12717252|P2|STARTED|Overall Study||54
5170753|NCT01201798|12717253|P1|STARTED|Overall Study||56
5170754|NCT01201785|12717277|P1|NOT COMPLETED|Overall Study||16
5170755|NCT01201785|12717277|P1|COMPLETED|Overall Study||20
5170756|NCT01201785|12717277|P1|STARTED|Overall Study||36
5170757|NCT01201772|12717284|P3|NOT COMPLETED|Overall Study||0
5170758|NCT01201772|12717285|P2|NOT COMPLETED|Overall Study||0
5170759|NCT01201772|12717286|P1|NOT COMPLETED|Overall Study||1
5170760|NCT01201772|12717284|P3|COMPLETED|Overall Study||21
5170761|NCT01201772|12717285|P2|COMPLETED|Overall Study||21
5170762|NCT01201772|12717286|P1|COMPLETED|Overall Study||22
5170763|NCT01201772|12717284|P3|STARTED|Overall Study||21
5170764|NCT01201772|12717285|P2|STARTED|Overall Study||21
5170765|NCT01201772|12717286|P1|STARTED|Overall Study||23
5170766|NCT01201759|12717294|P2|NOT COMPLETED|Visit 5||0
5170767|NCT01201759|12717295|P1|NOT COMPLETED|Visit 5||0
5170768|NCT01201759|12717294|P2|COMPLETED|Visit 5||3
5170769|NCT01201759|12717295|P1|COMPLETED|Visit 5||7
5170770|NCT01201759|12717294|P2|STARTED|Visit 5||3
5170771|NCT01201759|12717295|P1|STARTED|Visit 5||7
5170772|NCT01201759|12717294|P2|NOT COMPLETED|Visit 4 Crossover||1
5170773|NCT01201759|12717295|P1|NOT COMPLETED|Visit 4 Crossover||0
5170774|NCT01201759|12717294|P2|COMPLETED|Visit 4 Crossover||3
5170775|NCT01201759|12717295|P1|COMPLETED|Visit 4 Crossover||7
5170776|NCT01201759|12717294|P2|STARTED|Visit 4 Crossover||4
5170777|NCT01201759|12717295|P1|STARTED|Visit 4 Crossover||7
5170778|NCT01201759|12717294|P2|NOT COMPLETED|Visit 3 - Washout||3
5170779|NCT01201759|12717295|P1|NOT COMPLETED|Visit 3 - Washout||1
5170780|NCT01201759|12717294|P2|COMPLETED|Visit 3 - Washout||4
5170781|NCT01201759|12717295|P1|COMPLETED|Visit 3 - Washout||7
5170782|NCT01201759|12717294|P2|STARTED|Visit 3 - Washout||7
5170783|NCT01201759|12717295|P1|STARTED|Visit 3 - Washout||8
5170784|NCT01201759|12717294|P2|NOT COMPLETED|Visit 2||0
5170785|NCT01201759|12717295|P1|NOT COMPLETED|Visit 2||0
5170786|NCT01201759|12717294|P2|COMPLETED|Visit 2||7
5170787|NCT01201759|12717295|P1|COMPLETED|Visit 2||8
5170788|NCT01201759|12717294|P2|STARTED|Visit 2||7
5170789|NCT01201759|12717295|P1|STARTED|Visit 2||8
5170790|NCT01201759|12717294|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
5170791|NCT01201759|12717295|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
5170792|NCT01201759|12717294|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
5170793|NCT01201759|12717295|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
5170794|NCT01201759|12717294|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
5170795|NCT01201759|12717295|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
5170796|NCT01201629|12717309|P2|NOT COMPLETED|Overall Study||0
5170797|NCT01201629|12717310|P1|NOT COMPLETED|Overall Study||0
5170798|NCT01201629|12717309|P2|COMPLETED|Overall Study||8
5170799|NCT01201629|12717310|P1|COMPLETED|Overall Study||8
5170800|NCT01201629|12717309|P2|STARTED|Overall Study||8
5170801|NCT01201629|12717310|P1|STARTED|Overall Study||8
5170802|NCT01201486|12717320|P1|NOT COMPLETED|Overall Study||0
5170803|NCT01201486|12717320|P1|COMPLETED|Overall Study||6781
5170804|NCT01201486|12717320|P1|STARTED|Overall Study||6781
5170805|NCT01201356|12717324|P1|NOT COMPLETED|Overall Study||644
5170806|NCT01201356|12717324|P1|COMPLETED|Overall Study||3481
5170807|NCT01201356|12717324|P1|Fingolimod Full Analysis Set|Overall Study||4046
5170808|NCT01201356|12717324|P1|Safety Set|Overall Study||4083
5170809|NCT01201356|12717324|P1|STARTED|Overall Study||4125
5170810|NCT01201343|12717338|P1|NOT COMPLETED|Overall Study||19
5170811|NCT01201343|12717338|P1|COMPLETED|Overall Study||60
5170812|NCT01201343|12717338|P1|Treated|Overall Study||76
5170813|NCT01201343|12717338|P1|STARTED|Overall Study||79
5170814|NCT01201317|12717352|P3|NOT COMPLETED|Overall Study||8
5170815|NCT01201317|12717353|P2|NOT COMPLETED|Overall Study||7
5170816|NCT01201317|12717354|P1|NOT COMPLETED|Overall Study||9
5170817|NCT01201317|12717352|P3|COMPLETED|Overall Study||33
5170818|NCT01201317|12717353|P2|COMPLETED|Overall Study||38
5170819|NCT01201317|12717354|P1|COMPLETED|Overall Study||39
5170820|NCT01201317|12717352|P3|STARTED|Overall Study||41
5170821|NCT01201317|12717353|P2|STARTED|Overall Study||45
5170822|NCT01201317|12717354|P1|STARTED|Overall Study||48
5170823|NCT01201265|12717374|P1|NOT COMPLETED|Overall Study||38
5170824|NCT01201265|12717374|P1|COMPLETED|Overall Study||2
5170825|NCT01201265|12717374|P1|STARTED|Overall Study||40
5170826|NCT01201057|12717390|P4|NOT COMPLETED|Overall Study||4
5170827|NCT01201057|12717391|P3|NOT COMPLETED|Overall Study||5
5170828|NCT01201057|12717392|P2|NOT COMPLETED|Overall Study||4
5170829|NCT01201057|12717393|P1|NOT COMPLETED|Overall Study||2
5170830|NCT01201057|12717390|P4|COMPLETED|Overall Study||29
5170831|NCT01201057|12717391|P3|COMPLETED|Overall Study||27
5170832|NCT01201057|12717392|P2|COMPLETED|Overall Study||29
5170833|NCT01201057|12717393|P1|COMPLETED|Overall Study||32
5170834|NCT01201057|12717390|P4|STARTED|Overall Study||33
5170835|NCT01201057|12717391|P3|STARTED|Overall Study||32
5170836|NCT01201057|12717392|P2|STARTED|Overall Study||33
5170837|NCT01201057|12717393|P1|STARTED|Overall Study||34
5170838|NCT01200992|12717421|P2|NOT COMPLETED|Overall Study||41
5170839|NCT01200992|12717422|P1|NOT COMPLETED|Overall Study||37
5170840|NCT01200992|12717421|P2|COMPLETED|Overall Study||4
5170841|NCT01200992|12717422|P1|COMPLETED|Overall Study||2
5170842|NCT01200992|12717421|P2|STARTED|Overall Study||45
5170843|NCT01200992|12717422|P1|STARTED|Overall Study||39
5170844|NCT01200875|12717430|P1|NOT COMPLETED|Overall Study||0
5170845|NCT01200875|12717430|P1|COMPLETED|Overall Study||25
5170846|NCT01200875|12717430|P1|STARTED|Overall Study||25
5170847|NCT01200810|12717436|P2|NOT COMPLETED|Overall Study||5
5170848|NCT01200810|12717437|P1|NOT COMPLETED|Overall Study||5
5170849|NCT01200810|12717436|P2|COMPLETED|Overall Study||0
5170850|NCT01200810|12717437|P1|COMPLETED|Overall Study||0
5170851|NCT01200810|12717436|P2|STARTED|Overall Study||5
5170852|NCT01200810|12717437|P1|STARTED|Overall Study||5
5170853|NCT01200797|12717457|P1|NOT COMPLETED|Overall Study||19
5170854|NCT01200797|12717457|P1|COMPLETED|Overall Study||0
5170855|NCT01200797|12717457|P1|STARTED|Overall Study||19
5170856|NCT01200758|12717467|P4|NOT COMPLETED|Stage 2||50
5170857|NCT01200758|12717468|P3|NOT COMPLETED|Stage 2||41
5170858|NCT01200758|12717469|P2|NOT COMPLETED|Stage 2||0
5170859|NCT01200758|12717470|P1|NOT COMPLETED|Stage 2||0
5170860|NCT01200758|12717467|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
5170861|NCT01200758|12717468|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
5170862|NCT01200758|12717469|P2|COMPLETED|Stage 2||0
5170863|NCT01200758|12717470|P1|COMPLETED|Stage 2||0
5170864|NCT01200758|12717467|P4|STARTED|Stage 2||142
5170865|NCT01200758|12717468|P3|STARTED|Stage 2||141
5170866|NCT01200758|12717469|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
5170867|NCT01200758|12717470|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
5170868|NCT01200758|12717467|P4|NOT COMPLETED|Stage I||0
5170869|NCT01200758|12717468|P3|NOT COMPLETED|Stage I||0
5170870|NCT01200758|12717469|P2|NOT COMPLETED|Stage I||17
5170871|NCT01200758|12717470|P1|NOT COMPLETED|Stage I||18
5170872|NCT01200758|12717467|P4|COMPLETED|Stage I||0
5170873|NCT01200758|12717468|P3|COMPLETED|Stage I||0
5170874|NCT01200758|12717469|P2|COMPLETED|Stage I|Participants completed treatment period.|46
5170875|NCT01200758|12717470|P1|COMPLETED|Stage I|Participants completed treatment period.|46
5170876|NCT01200758|12717467|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
5170877|NCT01200758|12717468|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
5170878|NCT01200758|12717469|P2|STARTED|Stage I||63
5170879|NCT01200758|12717470|P1|STARTED|Stage I||64
5170880|NCT01200602|12717526|P2|NOT COMPLETED|Overall Study||0
5170881|NCT01200602|12717527|P1|NOT COMPLETED|Overall Study||0
5170882|NCT01200602|12717526|P2|COMPLETED|Overall Study||0
5170883|NCT01200602|12717527|P1|COMPLETED|Overall Study||0
5170884|NCT01200602|12717526|P2|STARTED|Overall Study||0
5170885|NCT01200602|12717527|P1|STARTED|Overall Study||0
5170886|NCT01200589|12717543|P2|NOT COMPLETED|Overall Study||189
5170887|NCT01200589|12717544|P1|NOT COMPLETED|Overall Study||190
5170888|NCT01200589|12717543|P2|COMPLETED|Overall Study||30
5170889|NCT01200589|12717544|P1|COMPLETED|Overall Study||29
5170890|NCT01200589|12717543|P2|Safety Set|Overall Study||218
5170891|NCT01200589|12717544|P1|Safety Set|Overall Study||217
5170892|NCT01200589|12717543|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
5170893|NCT01200589|12717544|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
5170894|NCT01200589|12717543|P2|STARTED|Overall Study||219
5170895|NCT01200589|12717544|P1|STARTED|Overall Study||219
5170896|NCT01200524|12717571|P3|NOT COMPLETED|Overall Study||4
5170897|NCT01200524|12717572|P2|NOT COMPLETED|Overall Study||1
5170898|NCT01200524|12717573|P1|NOT COMPLETED|Overall Study||2
5170899|NCT01200524|12717571|P3|COMPLETED|Overall Study||40
5170900|NCT01200524|12717572|P2|COMPLETED|Overall Study||47
5170901|NCT01200524|12717573|P1|COMPLETED|Overall Study||39
5170902|NCT01200524|12717571|P3|STARTED|Overall Study||44
5170903|NCT01200524|12717572|P2|STARTED|Overall Study||48
5170904|NCT01200524|12717573|P1|STARTED|Overall Study||41
5170905|NCT01200511|12717593|P1|NOT COMPLETED|Overall Study||5
5170906|NCT01200511|12717593|P1|COMPLETED|Overall Study||44
5170907|NCT01200511|12717593|P1|STARTED|Overall Study||49
5170908|NCT01200498|12717601|P1|NOT COMPLETED|Overall Study||0
5170909|NCT01200498|12717601|P1|COMPLETED|Overall Study||22
5170910|NCT01200498|12717601|P1|STARTED|Overall Study||22
5170911|NCT01200485|12717605|P3|NOT COMPLETED|Cycle 2: Randomization||0
5170912|NCT01200485|12717606|P2|NOT COMPLETED|Cycle 2: Randomization||0
5170913|NCT01200485|12717607|P1|NOT COMPLETED|Cycle 2: Randomization||0
5170914|NCT01200485|12717605|P3|COMPLETED|Cycle 2: Randomization||25
5170915|NCT01200485|12717606|P2|COMPLETED|Cycle 2: Randomization||21
5170916|NCT01200485|12717607|P1|COMPLETED|Cycle 2: Randomization||0
5170917|NCT01200485|12717605|P3|STARTED|Cycle 2: Randomization||25
5170918|NCT01200485|12717606|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
5170919|NCT01200485|12717607|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
5170920|NCT01200485|12717605|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
5170921|NCT01200485|12717606|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
5170922|NCT01200485|12717607|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
5170923|NCT01200485|12717605|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
5170924|NCT01200485|12717606|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
5170925|NCT01200485|12717607|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
5170926|NCT01200485|12717605|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
5170927|NCT01200485|12717606|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
5170928|NCT01200485|12717607|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
5170929|NCT01200433|12717618|P2|NOT COMPLETED|Overall Study||0
5170930|NCT01200433|12717619|P1|NOT COMPLETED|Overall Study||0
5170931|NCT01200433|12717618|P2|COMPLETED|Overall Study||23
5170932|NCT01200433|12717619|P1|COMPLETED|Overall Study||21
5170933|NCT01200433|12717618|P2|STARTED|Overall Study||23
5170934|NCT01200433|12717619|P1|STARTED|Overall Study||21
5170935|NCT01200394|12717641|P2|NOT COMPLETED|Overall Study||28
5170936|NCT01200394|12717642|P1|NOT COMPLETED|Overall Study||2
5170937|NCT01200394|12717641|P2|COMPLETED|Overall Study||164
5170938|NCT01200394|12717642|P1|COMPLETED|Overall Study||62
5170939|NCT01200394|12717641|P2|STARTED|Overall Study||192
5170940|NCT01200394|12717642|P1|STARTED|Overall Study||64
5170941|NCT01200368|12717680|P3|NOT COMPLETED|Toddler Dose||1
5170942|NCT01200368|12717681|P2|NOT COMPLETED|Toddler Dose||3
5170943|NCT01200368|12717682|P1|NOT COMPLETED|Toddler Dose||0
5170944|NCT01200368|12717680|P3|COMPLETED|Toddler Dose||168
5170945|NCT01200368|12717681|P2|COMPLETED|Toddler Dose||159
5170946|NCT01200368|12717682|P1|COMPLETED|Toddler Dose||162
5170947|NCT01200368|12717680|P3|STARTED|Toddler Dose||169
5170948|NCT01200368|12717681|P2|STARTED|Toddler Dose||162
5170949|NCT01200368|12717682|P1|STARTED|Toddler Dose||162
5170950|NCT01200368|12717680|P3|NOT COMPLETED|After Infant Series||9
5170951|NCT01200368|12717681|P2|NOT COMPLETED|After Infant Series||16
5170952|NCT01200368|12717682|P1|NOT COMPLETED|After Infant Series||18
5170953|NCT01200368|12717680|P3|COMPLETED|After Infant Series||169
5170954|NCT01200368|12717681|P2|COMPLETED|After Infant Series||162
5170955|NCT01200368|12717682|P1|COMPLETED|After Infant Series||162
5170956|NCT01200368|12717680|P3|STARTED|After Infant Series||178
5170957|NCT01200368|12717681|P2|STARTED|After Infant Series||178
5170958|NCT01200368|12717682|P1|STARTED|After Infant Series||180
5170959|NCT01200368|12717680|P3|NOT COMPLETED|Infant Series||6
5170960|NCT01200368|12717681|P2|NOT COMPLETED|Infant Series||6
5170961|NCT01200368|12717682|P1|NOT COMPLETED|Infant Series||3
5170962|NCT01200368|12717680|P3|COMPLETED|Infant Series||178
5170963|NCT01200368|12717681|P2|COMPLETED|Infant Series||178
5170964|NCT01200368|12717682|P1|COMPLETED|Infant Series||180
5170965|NCT01200368|12717680|P3|Vaccinated Dose 3|Infant Series||182
5170966|NCT01200368|12717681|P2|Vaccinated Dose 3|Infant Series||178
5170967|NCT01200368|12717682|P1|Vaccinated Dose 3|Infant Series||181
5170968|NCT01200368|12717680|P3|Vaccinated Dose 2|Infant Series||183
5170969|NCT01200368|12717681|P2|Vaccinated Dose 2|Infant Series||182
5170970|NCT01200368|12717682|P1|Vaccinated Dose 2|Infant Series||183
5170971|NCT01200368|12717680|P3|Vaccinated Dose 1|Infant Series||183
5170972|NCT01200368|12717681|P2|Vaccinated Dose 1|Infant Series||183
5170973|NCT01200368|12717682|P1|Vaccinated Dose 1|Infant Series||183
5170974|NCT01200368|12717680|P3|STARTED|Infant Series||184
5170975|NCT01200368|12717681|P2|STARTED|Infant Series||184
5170976|NCT01200368|12717682|P1|STARTED|Infant Series||183
5170977|NCT01200355|12717748|P2|NOT COMPLETED|Overall Study||2
5170978|NCT01200355|12717749|P1|NOT COMPLETED|Overall Study||7
5170979|NCT01200355|12717748|P2|COMPLETED|Overall Study||53
5170980|NCT01200355|12717749|P1|COMPLETED|Overall Study||51
5170981|NCT01200355|12717748|P2|STARTED|Overall Study||55
5170982|NCT01200355|12717749|P1|STARTED|Overall Study||58
5170983|NCT01200342|12717763|P1|NOT COMPLETED|Overall Study||1
5170984|NCT01200342|12717763|P1|COMPLETED|Overall Study||6
5170985|NCT01200342|12717763|P1|STARTED|Overall Study||7
5170986|NCT01200329|12717768|P1|NOT COMPLETED|Overall Study||3
5170987|NCT01200329|12717768|P1|COMPLETED|Overall Study||78
5170988|NCT01200329|12717768|P1|STARTED|Overall Study||81
5170989|NCT01200290|12717773|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
5170990|NCT01200290|12717773|P1|COMPLETED|Post-Treatment Follow-Up Period||16
5170991|NCT01200290|12717773|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
5170992|NCT01200290|12717773|P1|NOT COMPLETED|Treatment Period||1
5170993|NCT01200290|12717773|P1|COMPLETED|Treatment Period||17
5170994|NCT01200290|12717773|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
5170995|NCT01200290|12717773|P1|STARTED|Treatment Period||18
5170996|NCT01200238|12717786|P2|NOT COMPLETED|Overall Study||10
5170997|NCT01200238|12717787|P1|NOT COMPLETED|Overall Study||7
5170998|NCT01200238|12717786|P2|COMPLETED|Overall Study||0
5170999|NCT01200238|12717787|P1|COMPLETED|Overall Study||0
5171000|NCT01200238|12717786|P2|STARTED|Overall Study||10
5171001|NCT01200238|12717787|P1|STARTED|Overall Study||7
5171002|NCT01200160|12717805|P1|NOT COMPLETED|Overall Study||62
5171003|NCT01200160|12717805|P1|COMPLETED|Overall Study||66
5171004|NCT01200160|12717805|P1|STARTED|Overall Study||128
5171005|NCT01200069|12717811|P2|NOT COMPLETED|Overall Study||1
5171006|NCT01200069|12717812|P1|NOT COMPLETED|Overall Study||0
5171007|NCT01200069|12717811|P2|COMPLETED|Overall Study||5
5171008|NCT01200069|12717812|P1|COMPLETED|Overall Study||8
5171009|NCT01200069|12717811|P2|STARTED|Overall Study||6
5171010|NCT01200069|12717812|P1|STARTED|Overall Study||8
5171011|NCT01200030|12717867|P3|NOT COMPLETED|Overall Study||0
5171012|NCT01200030|12717868|P2|NOT COMPLETED|Overall Study||0
5171013|NCT01200030|12717869|P1|NOT COMPLETED|Overall Study||0
5171014|NCT01200030|12717867|P3|COMPLETED|Overall Study||12
5171015|NCT01200030|12717868|P2|COMPLETED|Overall Study||13
5171016|NCT01200030|12717869|P1|COMPLETED|Overall Study||12
5171017|NCT01200030|12717867|P3|STARTED|Overall Study||12
5171018|NCT01200030|12717868|P2|STARTED|Overall Study||13
5171019|NCT01200030|12717869|P1|STARTED|Overall Study||12
5171020|NCT01199965|12717882|P2|NOT COMPLETED|Overall Study||0
5171021|NCT01199965|12717883|P1|NOT COMPLETED|Overall Study||1
5171022|NCT01199965|12717882|P2|COMPLETED|Overall Study||24
5171023|NCT01199965|12717883|P1|COMPLETED|Overall Study||22
5171024|NCT01199965|12717882|P2|STARTED|Overall Study||24
5171025|NCT01199965|12717883|P1|STARTED|Overall Study||23
5171026|NCT01199952|12717899|P2|NOT COMPLETED|Overall Study||45
5171027|NCT01199952|12717900|P1|NOT COMPLETED|Overall Study||52
5171028|NCT01199952|12717899|P2|COMPLETED|Overall Study||59
5171029|NCT01199952|12717900|P1|COMPLETED|Overall Study||51
5171030|NCT01199952|12717899|P2|STARTED|Overall Study||104
5171031|NCT01199952|12717900|P1|STARTED|Overall Study||103
5171032|NCT01199939|12717908|P1|NOT COMPLETED|Overall Study||13
5171033|NCT01199939|12717908|P1|COMPLETED|Overall Study||41
5171034|NCT01199939|12717908|P1|STARTED|Overall Study|Number of enrolled participants|54
5171035|NCT01199926|12717927|P2|NOT COMPLETED|Overall Study||4
5171036|NCT01199926|12717928|P1|NOT COMPLETED|Overall Study||7
5171037|NCT01199926|12717927|P2|COMPLETED|Overall Study||13
5171038|NCT01199926|12717928|P1|COMPLETED|Overall Study||10
5171039|NCT01199926|12717927|P2|STARTED|Overall Study||17
5171040|NCT01199926|12717928|P1|STARTED|Overall Study||17
5171041|NCT01199861|12717940|P2|NOT COMPLETED|Overall Study||0
5171042|NCT01199861|12717941|P1|NOT COMPLETED|Overall Study||2
5171043|NCT01199861|12717940|P2|COMPLETED|Overall Study||43
5171044|NCT01199861|12717941|P1|COMPLETED|Overall Study||93
5171045|NCT01199861|12717940|P2|STARTED|Overall Study||43
5171046|NCT01199861|12717941|P1|STARTED|Overall Study||95
5171047|NCT01199822|12717962|P3|NOT COMPLETED|Overall Study||0
5171048|NCT01199822|12717963|P2|NOT COMPLETED|Overall Study||1
5171049|NCT01199822|12717964|P1|NOT COMPLETED|Overall Study||0
5171050|NCT01199822|12717962|P3|COMPLETED|Overall Study||6
5171051|NCT01199822|12717963|P2|COMPLETED|Overall Study||6
5171052|NCT01199822|12717964|P1|COMPLETED|Overall Study||3
5171053|NCT01199822|12717962|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5171054|NCT01199822|12717963|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
5171055|NCT01199822|12717964|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5171056|NCT01199822|12717962|P3|STARTED|Overall Study||6
5171057|NCT01199822|12717963|P2|STARTED|Overall Study||7
5171058|NCT01199822|12717964|P1|STARTED|Overall Study||3
5171059|NCT01199744|12717997|P1|NOT COMPLETED|Overall Study||0
5171060|NCT01199744|12717997|P1|COMPLETED|Overall Study||1575
5171061|NCT01199744|12717997|P1|STARTED|Overall Study||1575
5171062|NCT01199731|12718013|P3|NOT COMPLETED|Overall Study||10
5171063|NCT01199731|12718014|P2|NOT COMPLETED|Overall Study||11
5171064|NCT01199731|12718015|P1|NOT COMPLETED|Overall Study||9
5171065|NCT01199731|12718013|P3|COMPLETED|Overall Study||0
5171066|NCT01199731|12718014|P2|COMPLETED|Overall Study||0
5171067|NCT01199731|12718015|P1|COMPLETED|Overall Study||0
5171068|NCT01199731|12718013|P3|STARTED|Overall Study||10
5171069|NCT01199731|12718014|P2|STARTED|Overall Study||11
5171070|NCT01199731|12718015|P1|STARTED|Overall Study||9
5171071|NCT01199705|12718053|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
5171072|NCT01199705|12718053|P1|COMPLETED|SCIG Treatment (Efficacy)||24
5171073|NCT01199705|12718053|P1|STARTED|SCIG Treatment (Efficacy)||24
5171074|NCT01199705|12718053|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
5171075|NCT01199705|12718053|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
5171076|NCT01199705|12718053|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
5171077|NCT01199705|12718053|P1|NOT COMPLETED|IVIG Treatment||0
5171078|NCT01199705|12718053|P1|COMPLETED|IVIG Treatment||25
5171079|NCT01199705|12718053|P1|STARTED|IVIG Treatment||25
5171080|NCT01199601|12718085|P2|NOT COMPLETED|Overall Study||78
5171081|NCT01199601|12718086|P1|NOT COMPLETED|Overall Study||69
5171082|NCT01199601|12718085|P2|COMPLETED|Overall Study||344
5171083|NCT01199601|12718086|P1|COMPLETED|Overall Study||353
5171084|NCT01199601|12718085|P2|STARTED|Overall Study|Intervention Group|422
5171085|NCT01199601|12718086|P1|STARTED|Overall Study|Control Group|422
5171086|NCT01199575|12718096|P1|NOT COMPLETED|Overall Study||5
5171087|NCT01199575|12718096|P1|COMPLETED|Overall Study||25
5171088|NCT01199575|12718096|P1|STARTED|Overall Study||30
5171089|NCT01199471|12718101|P1|NOT COMPLETED|Overall Study||6
5171090|NCT01199471|12718101|P1|COMPLETED|Overall Study||3994
5171091|NCT01199471|12718101|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
5171092|NCT01199263|12718112|P2|NOT COMPLETED|Overall Study||2
5171093|NCT01199263|12718113|P1|NOT COMPLETED|Overall Study||6
5171094|NCT01199263|12718112|P2|COMPLETED|Overall Study||52
5171095|NCT01199263|12718113|P1|COMPLETED|Overall Study||48
5171096|NCT01199263|12718112|P2|STARTED|Overall Study||54
5171097|NCT01199263|12718113|P1|STARTED|Overall Study||54
5171098|NCT01199237|12718129|P2|NOT COMPLETED|Overall Study||0
5171099|NCT01199237|12718130|P1|NOT COMPLETED|Overall Study||0
5171100|NCT01199237|12718129|P2|COMPLETED|Overall Study||40
5171101|NCT01199237|12718130|P1|COMPLETED|Overall Study||41
5171102|NCT01199237|12718129|P2|STARTED|Overall Study||40
5171103|NCT01199237|12718130|P1|STARTED|Overall Study||41
5171104|NCT01199146|12718144|P1|NOT COMPLETED|Overall Study||3
5171105|NCT01199146|12718144|P1|COMPLETED|Overall Study||39
5171106|NCT01199146|12718144|P1|STARTED|Overall Study||42
5171107|NCT01199068|12718153|P3|NOT COMPLETED|Overall Study||9
5171108|NCT01199068|12718154|P2|NOT COMPLETED|Overall Study||3
5171109|NCT01199068|12718155|P1|NOT COMPLETED|Overall Study||3
5171110|NCT01199068|12718153|P3|COMPLETED|Overall Study||0
5171111|NCT01199068|12718154|P2|COMPLETED|Overall Study||0
5171112|NCT01199068|12718155|P1|COMPLETED|Overall Study||0
5171113|NCT01199068|12718153|P3|Received Treatment|Overall Study||8
5171114|NCT01199068|12718154|P2|Received Treatment|Overall Study||3
5171115|NCT01199068|12718155|P1|Received Treatment|Overall Study||3
5171116|NCT01199068|12718153|P3|STARTED|Overall Study||9
5171117|NCT01199068|12718154|P2|STARTED|Overall Study||3
5171118|NCT01199068|12718155|P1|STARTED|Overall Study||3
5171119|NCT01199055|12718189|P3|NOT COMPLETED|Overall Study||4
5171120|NCT01199055|12718190|P2|NOT COMPLETED|Overall Study||3
5171121|NCT01199055|12718191|P1|NOT COMPLETED|Overall Study||2
5171122|NCT01199055|12718189|P3|COMPLETED|Overall Study||5
5171123|NCT01199055|12718190|P2|COMPLETED|Overall Study||1
5171124|NCT01199055|12718191|P1|COMPLETED|Overall Study||1
5171125|NCT01199055|12718189|P3|STARTED|Overall Study||9
5171126|NCT01199055|12718190|P2|STARTED|Overall Study||4
5171127|NCT01199055|12718191|P1|STARTED|Overall Study||3
5171128|NCT01199042|12718216|P1|NOT COMPLETED|At Home (3 Months)||1
5171129|NCT01199042|12718216|P1|COMPLETED|At Home (3 Months)||26
5171130|NCT01199042|12718216|P1|STARTED|At Home (3 Months)||27
5171131|NCT01199042|12718216|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
5171132|NCT01199042|12718216|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
5171133|NCT01199042|12718216|P1|STARTED|Sleep Laboratory (3 Nights)||29
5171134|NCT01199016|12718225|P1|NOT COMPLETED|Overall Study||77
5171135|NCT01199016|12718225|P1|COMPLETED|Overall Study||162
5171136|NCT01199016|12718225|P1|Treated|Overall Study||236
5171137|NCT01199016|12718225|P1|STARTED|Overall Study||239
5171138|NCT01198977|12718234|P2|NOT COMPLETED|Overall Study||0
5171139|NCT01198977|12718235|P1|NOT COMPLETED|Overall Study||1
5171140|NCT01198977|12718234|P2|COMPLETED|Overall Study||33
5171141|NCT01198977|12718235|P1|COMPLETED|Overall Study||30
5171142|NCT01198977|12718234|P2|STARTED|Overall Study||33
5171143|NCT01198977|12718235|P1|STARTED|Overall Study||31
5171144|NCT01198873|12718247|P2|NOT COMPLETED|Overall Study||32
5171145|NCT01198873|12718248|P1|NOT COMPLETED|Overall Study||37
5171146|NCT01198873|12718247|P2|COMPLETED|Overall Study||3
5171147|NCT01198873|12718248|P1|COMPLETED|Overall Study||4
5171148|NCT01198873|12718247|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
5171149|NCT01198873|12718248|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
5171150|NCT01198873|12718247|P2|Treated|Overall Study||35
5171151|NCT01198873|12718248|P1|Treated|Overall Study||41
5171152|NCT01198873|12718247|P2|STARTED|Overall Study||35
5171153|NCT01198873|12718248|P1|STARTED|Overall Study||41
5171154|NCT01198795|12718262|P1|NOT COMPLETED|Overall Study||82
5171155|NCT01198795|12718262|P1|COMPLETED|Overall Study||80
5171156|NCT01198795|12718262|P1|STARTED|Overall Study||162
5171157|NCT01198769|12718266|P1|NOT COMPLETED|Overall Study||0
5171158|NCT01198769|12718266|P1|COMPLETED|Overall Study||15
5171159|NCT01198769|12718266|P1|STARTED|Overall Study||15
5171160|NCT01198756|12718279|P4|NOT COMPLETED|Overall Study||26
5171161|NCT01198756|12718280|P3|NOT COMPLETED|Overall Study||30
5171162|NCT01198756|12718281|P2|NOT COMPLETED|Overall Study||40
5171163|NCT01198756|12718282|P1|NOT COMPLETED|Overall Study||38
5171164|NCT01198756|12718279|P4|COMPLETED|Overall Study||275
5171165|NCT01198756|12718280|P3|COMPLETED|Overall Study||902
5171166|NCT01198756|12718281|P2|COMPLETED|Overall Study||889
5171167|NCT01198756|12718282|P1|COMPLETED|Overall Study||894
5171168|NCT01198756|12718279|P4|STARTED|Overall Study||301
5171169|NCT01198756|12718280|P3|STARTED|Overall Study||932
5171170|NCT01198756|12718281|P2|STARTED|Overall Study||929
5171171|NCT01198756|12718282|P1|STARTED|Overall Study||932
5171172|NCT01198691|12718380|P2|NOT COMPLETED|6 Week Post-partum Survey||24
5171173|NCT01198691|12718381|P1|NOT COMPLETED|6 Week Post-partum Survey||29
5171174|NCT01198691|12718380|P2|COMPLETED|6 Week Post-partum Survey||26
5171175|NCT01198691|12718381|P1|COMPLETED|6 Week Post-partum Survey||21
5171176|NCT01198691|12718380|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
5171177|NCT01198691|12718381|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
5171178|NCT01198691|12718380|P2|NOT COMPLETED|Survey Prior to Discharge||33
5171179|NCT01198691|12718381|P1|NOT COMPLETED|Survey Prior to Discharge||32
5171180|NCT01198691|12718380|P2|COMPLETED|Survey Prior to Discharge||17
5171181|NCT01198691|12718381|P1|COMPLETED|Survey Prior to Discharge||18
5171182|NCT01198691|12718380|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
5171183|NCT01198691|12718381|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
5171184|NCT01198691|12718380|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
5171185|NCT01198691|12718381|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
5171186|NCT01198691|12718380|P2|COMPLETED|Completed VAS Score at Discharge||44
5171187|NCT01198691|12718381|P1|COMPLETED|Completed VAS Score at Discharge||45
5171188|NCT01198691|12718380|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
5171189|NCT01198691|12718381|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
5171190|NCT01198691|12718380|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
5171191|NCT01198691|12718381|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
5171192|NCT01198691|12718380|P2|COMPLETED|Completed VAS Score Postop Day 1||46
5171193|NCT01198691|12718381|P1|COMPLETED|Completed VAS Score Postop Day 1||47
5171194|NCT01198691|12718380|P2|STARTED|Completed VAS Score Postop Day 1||50
5171195|NCT01198691|12718381|P1|STARTED|Completed VAS Score Postop Day 1||50
5171196|NCT01198691|12718380|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
5171197|NCT01198691|12718381|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
5171198|NCT01198691|12718380|P2|COMPLETED|Completed Surgery -Received Intervention||50
5171199|NCT01198691|12718381|P1|COMPLETED|Completed Surgery -Received Intervention||50
5171200|NCT01198691|12718380|P2|STARTED|Completed Surgery -Received Intervention||50
5171201|NCT01198691|12718381|P1|STARTED|Completed Surgery -Received Intervention||50
5171202|NCT01198600|12718393|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
5171203|NCT01198600|12718394|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
5171204|NCT01198600|12718395|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
5171205|NCT01198600|12718396|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
5171206|NCT01198600|12718393|P4|COMPLETED|Phase 3: 43 Days of Wear||38
5171207|NCT01198600|12718394|P3|COMPLETED|Phase 3: 43 Days of Wear||0
5171208|NCT01198600|12718395|P2|COMPLETED|Phase 3: 43 Days of Wear||0
5171209|NCT01198600|12718396|P1|COMPLETED|Phase 3: 43 Days of Wear||0
5171210|NCT01198600|12718393|P4|STARTED|Phase 3: 43 Days of Wear||38
5171211|NCT01198600|12718394|P3|STARTED|Phase 3: 43 Days of Wear||0
5171212|NCT01198600|12718395|P2|STARTED|Phase 3: 43 Days of Wear||0
5171213|NCT01198600|12718396|P1|STARTED|Phase 3: 43 Days of Wear||0
5171214|NCT01198600|12718393|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
5171215|NCT01198600|12718394|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
5171216|NCT01198600|12718395|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
5171217|NCT01198600|12718396|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
5171218|NCT01198600|12718393|P4|COMPLETED|Phase 2: 56 Days of Wear||0
5171219|NCT01198600|12718394|P3|COMPLETED|Phase 2: 56 Days of Wear||62
5171220|NCT01198600|12718395|P2|COMPLETED|Phase 2: 56 Days of Wear||0
5171221|NCT01198600|12718396|P1|COMPLETED|Phase 2: 56 Days of Wear||0
5171222|NCT01198600|12718393|P4|STARTED|Phase 2: 56 Days of Wear||0
5171223|NCT01198600|12718394|P3|STARTED|Phase 2: 56 Days of Wear||67
5171224|NCT01198600|12718395|P2|STARTED|Phase 2: 56 Days of Wear||0
5171225|NCT01198600|12718396|P1|STARTED|Phase 2: 56 Days of Wear||0
5171226|NCT01198600|12718393|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
5171227|NCT01198600|12718394|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
5171228|NCT01198600|12718395|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
5171229|NCT01198600|12718396|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
5171230|NCT01198600|12718393|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
5171231|NCT01198600|12718394|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
5171232|NCT01198600|12718395|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
5171233|NCT01198600|12718396|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
5171234|NCT01198600|12718393|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
5171235|NCT01198600|12718394|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
5171236|NCT01198600|12718395|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
5171237|NCT01198600|12718396|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
5171238|NCT01198600|12718393|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
5171239|NCT01198600|12718394|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
5171240|NCT01198600|12718395|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
5171241|NCT01198600|12718396|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
5171242|NCT01198600|12718393|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
5171243|NCT01198600|12718394|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
5171244|NCT01198600|12718395|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
5171245|NCT01198600|12718396|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
5171246|NCT01198600|12718393|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
5171247|NCT01198600|12718394|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
5171248|NCT01198600|12718395|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
5171249|NCT01198600|12718396|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
5171250|NCT01198587|12718422|P4|NOT COMPLETED|Overall Study||0
5171251|NCT01198587|12718423|P3|NOT COMPLETED|Overall Study||9
5171252|NCT01198587|12718424|P2|NOT COMPLETED|Overall Study||0
5171253|NCT01198587|12718425|P1|NOT COMPLETED|Overall Study||8
5171254|NCT01198587|12718422|P4|COMPLETED|Overall Study||5
5171255|NCT01198587|12718423|P3|COMPLETED|Overall Study||21
5171256|NCT01198587|12718424|P2|COMPLETED|Overall Study||5
5171257|NCT01198587|12718425|P1|COMPLETED|Overall Study||23
5171258|NCT01198587|12718422|P4|STARTED|Overall Study||5
5171259|NCT01198587|12718423|P3|STARTED|Overall Study||30
5171260|NCT01198587|12718424|P2|STARTED|Overall Study||5
5171261|NCT01198587|12718425|P1|STARTED|Overall Study||31
5171262|NCT01198574|12718447|P4|NOT COMPLETED|Overall Study||4
5171263|NCT01198574|12718448|P3|NOT COMPLETED|Overall Study||1
5171264|NCT01198574|12718449|P2|NOT COMPLETED|Overall Study||1
5171265|NCT01198574|12718450|P1|NOT COMPLETED|Overall Study||4
5171266|NCT01198574|12718447|P4|COMPLETED|Overall Study||98
5171267|NCT01198574|12718448|P3|COMPLETED|Overall Study||99
5171268|NCT01198574|12718449|P2|COMPLETED|Overall Study||101
5171269|NCT01198574|12718450|P1|COMPLETED|Overall Study||94
5171270|NCT01198574|12718447|P4|STARTED|Overall Study||102
5171271|NCT01198574|12718448|P3|STARTED|Overall Study||100
5171272|NCT01198574|12718449|P2|STARTED|Overall Study||102
5171273|NCT01198574|12718450|P1|STARTED|Overall Study||98
5171274|NCT01198548|12718468|P1|NOT COMPLETED|Overall Study||10
5171275|NCT01198548|12718468|P1|COMPLETED|Overall Study||0
5171276|NCT01198548|12718468|P1|STARTED|Overall Study||10
5171277|NCT01198509|12718483|P6|NOT COMPLETED|Overall Study||0
5171278|NCT01198509|12718484|P5|NOT COMPLETED|Overall Study||0
5171279|NCT01198509|12718485|P4|NOT COMPLETED|Overall Study||0
5171280|NCT01198509|12718486|P3|NOT COMPLETED|Overall Study||0
5171281|NCT01198509|12718487|P2|NOT COMPLETED|Overall Study||0
5171282|NCT01198509|12718488|P1|NOT COMPLETED|Overall Study||1
5171283|NCT01198509|12718483|P6|COMPLETED|Overall Study||58
5171284|NCT01198509|12718484|P5|COMPLETED|Overall Study||20
5171285|NCT01198509|12718485|P4|COMPLETED|Overall Study||66
5171286|NCT01198509|12718486|P3|COMPLETED|Overall Study||19
5171287|NCT01198509|12718487|P2|COMPLETED|Overall Study||10
5171288|NCT01198509|12718488|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
5171289|NCT01198509|12718483|P6|STARTED|Overall Study||58
5171290|NCT01198509|12718484|P5|STARTED|Overall Study||20
5171291|NCT01198509|12718485|P4|STARTED|Overall Study||66
5171292|NCT01198509|12718486|P3|STARTED|Overall Study||19
5171293|NCT01198509|12718487|P2|STARTED|Overall Study||10
5171294|NCT01198509|12718488|P1|STARTED|Overall Study||5
5171295|NCT01198470|12718505|P1|NOT COMPLETED|Overall Study||2
5171296|NCT01198470|12718505|P1|COMPLETED|Overall Study||18
5171297|NCT01198470|12718505|P1|STARTED|Overall Study||20
5171298|NCT01198366|12718518|P6|NOT COMPLETED|Overall Study||13
5171299|NCT01198366|12718519|P5|NOT COMPLETED|Overall Study||15
5171300|NCT01198366|12718520|P4|NOT COMPLETED|Overall Study||5
5171301|NCT01198366|12718521|P3|NOT COMPLETED|Overall Study||8
5171302|NCT01198366|12718522|P2|NOT COMPLETED|Overall Study||7
5171303|NCT01198366|12718523|P1|NOT COMPLETED|Overall Study||12
5171304|NCT01198366|12718518|P6|COMPLETED|Overall Study||128
5171305|NCT01198366|12718519|P5|COMPLETED|Overall Study||125
5171306|NCT01198366|12718520|P4|COMPLETED|Overall Study||47
5171307|NCT01198366|12718521|P3|COMPLETED|Overall Study||43
5171308|NCT01198366|12718522|P2|COMPLETED|Overall Study||44
5171309|NCT01198366|12718523|P1|COMPLETED|Overall Study||40
5171310|NCT01198366|12718518|P6|STARTED|Overall Study||141
5171311|NCT01198366|12718519|P5|STARTED|Overall Study||140
5171312|NCT01198366|12718520|P4|STARTED|Overall Study||52
5171313|NCT01198366|12718521|P3|STARTED|Overall Study||51
5171314|NCT01198366|12718522|P2|STARTED|Overall Study||51
5171315|NCT01198366|12718523|P1|STARTED|Overall Study||52
5171316|NCT01198327|12718561|P1|NOT COMPLETED|Overall Study||10
5171317|NCT01198327|12718561|P1|COMPLETED|Overall Study||56
5171318|NCT01198327|12718561|P1|STARTED|Overall Study||66
5171319|NCT01198275|12718571|P2|NOT COMPLETED|Overall Study||5
5171320|NCT01198275|12718572|P1|NOT COMPLETED|Overall Study||6
5171321|NCT01198275|12718571|P2|COMPLETED|Overall Study||94
5171322|NCT01198275|12718572|P1|COMPLETED|Overall Study||94
5171323|NCT01198275|12718571|P2|STARTED|Overall Study||99
5171324|NCT01198275|12718572|P1|STARTED|Overall Study||100
5171325|NCT01198158|12718580|P2|NOT COMPLETED|Overall Study||0
5171326|NCT01198158|12718581|P1|NOT COMPLETED|Overall Study||0
5171327|NCT01198158|12718580|P2|COMPLETED|Overall Study||36
5171328|NCT01198158|12718581|P1|COMPLETED|Overall Study||41
5171329|NCT01198158|12718580|P2|STARTED|Overall Study||36
5171330|NCT01198158|12718581|P1|STARTED|Overall Study||41
5171331|NCT01198145|12718595|P2|NOT COMPLETED|Overall Study||1
5171332|NCT01198145|12718596|P1|NOT COMPLETED|Overall Study||1
5171333|NCT01198145|12718595|P2|COMPLETED|Overall Study||42
5171334|NCT01198145|12718596|P1|COMPLETED|Overall Study||43
5171335|NCT01198145|12718595|P2|STARTED|Overall Study||43
5171336|NCT01198145|12718596|P1|STARTED|Overall Study||44
5171337|NCT01198132|12718618|P2|NOT COMPLETED|Overall Study||21
5171338|NCT01198132|12718619|P1|NOT COMPLETED|Overall Study||18
5171339|NCT01198132|12718618|P2|COMPLETED|Overall Study||45
5171340|NCT01198132|12718619|P1|COMPLETED|Overall Study||45
5171341|NCT01198132|12718618|P2|STARTED|Overall Study||66
5171342|NCT01198132|12718619|P1|STARTED|Overall Study||63
5171343|NCT01198028|12718643|P1|NOT COMPLETED|Overall Study||10
5171344|NCT01198028|12718643|P1|COMPLETED|Overall Study||29
5171345|NCT01198028|12718643|P1|STARTED|Overall Study||39
5171346|NCT01198002|12718655|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
5171347|NCT01198002|12718656|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
5171348|NCT01198002|12718657|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
5171349|NCT01198002|12718655|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
5171350|NCT01198002|12718656|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
5171351|NCT01198002|12718657|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
5171352|NCT01198002|12718655|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
5171353|NCT01198002|12718656|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
5171354|NCT01198002|12718657|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
5171355|NCT01198002|12718655|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
5171356|NCT01198002|12718656|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
5171357|NCT01198002|12718657|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
5171358|NCT01198002|12718655|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
5171359|NCT01198002|12718656|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
5171360|NCT01198002|12718657|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
5171361|NCT01198002|12718655|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
5171362|NCT01198002|12718656|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
5171363|NCT01198002|12718657|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
5171364|NCT01198002|12718655|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
5171365|NCT01198002|12718656|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
5171366|NCT01198002|12718657|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
5171367|NCT01198002|12718655|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
5171368|NCT01198002|12718656|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
5171369|NCT01198002|12718657|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
5171370|NCT01198002|12718655|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
5171371|NCT01198002|12718656|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
5171372|NCT01198002|12718657|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
5171373|NCT01197911|12718772|P3|NOT COMPLETED|Overall Study||1
5171374|NCT01197911|12718773|P2|NOT COMPLETED|Overall Study||0
5171375|NCT01197911|12718774|P1|NOT COMPLETED|Overall Study||0
5171376|NCT01197911|12718772|P3|COMPLETED|Overall Study||9
5171377|NCT01197911|12718773|P2|COMPLETED|Overall Study||10
5171378|NCT01197911|12718774|P1|COMPLETED|Overall Study||18
5171379|NCT01197911|12718772|P3|STARTED|Overall Study||10
5171380|NCT01197911|12718773|P2|STARTED|Overall Study||10
5171381|NCT01197911|12718774|P1|STARTED|Overall Study||18
5171382|NCT01197898|12718859|P2|NOT COMPLETED|Overall Study||0
5171383|NCT01197898|12718860|P1|NOT COMPLETED|Overall Study||0
5171384|NCT01197898|12718859|P2|COMPLETED|Overall Study||5
5171385|NCT01197898|12718860|P1|COMPLETED|Overall Study||5
5171386|NCT01197898|12718859|P2|STARTED|Overall Study||5
5171387|NCT01197898|12718860|P1|STARTED|Overall Study||5
5171388|NCT01197833|12718869|P3|NOT COMPLETED|Overall Study||0
5171389|NCT01197833|12718870|P2|NOT COMPLETED|Overall Study||0
5171390|NCT01197833|12718871|P1|NOT COMPLETED|Overall Study||0
5171391|NCT01197833|12718869|P3|COMPLETED|Overall Study||40
5171392|NCT01197833|12718870|P2|COMPLETED|Overall Study||39
5171393|NCT01197833|12718871|P1|COMPLETED|Overall Study||38
5171394|NCT01197833|12718869|P3|STARTED|Overall Study||40
5171395|NCT01197833|12718870|P2|STARTED|Overall Study||39
5171396|NCT01197833|12718871|P1|STARTED|Overall Study||38
5171397|NCT01197794|12718889|P7|NOT COMPLETED|Overall Study||21
5171398|NCT01197794|12718890|P6|NOT COMPLETED|Overall Study||19
5171399|NCT01197794|12718891|P5|NOT COMPLETED|Overall Study||14
5171400|NCT01197794|12718892|P4|NOT COMPLETED|Overall Study||12
5171401|NCT01197794|12718893|P3|NOT COMPLETED|Overall Study||13
5171402|NCT01197794|12718894|P2|NOT COMPLETED|Overall Study||15
5171403|NCT01197794|12718895|P1|NOT COMPLETED|Overall Study||16
5171404|NCT01197794|12718889|P7|COMPLETED|Overall Study||142
5171405|NCT01197794|12718890|P6|COMPLETED|Overall Study||144
5171406|NCT01197794|12718891|P5|COMPLETED|Overall Study||149
5171407|NCT01197794|12718892|P4|COMPLETED|Overall Study||152
5171408|NCT01197794|12718893|P3|COMPLETED|Overall Study||153
5171409|NCT01197794|12718894|P2|COMPLETED|Overall Study||146
5171410|NCT01197794|12718895|P1|COMPLETED|Overall Study||148
5171411|NCT01197794|12718889|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
5171412|NCT01197794|12718890|P6|STARTED|Overall Study||163
5171413|NCT01197794|12718891|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
5171414|NCT01197794|12718892|P4|STARTED|Overall Study||164
5171415|NCT01197794|12718893|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
5171416|NCT01197794|12718894|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
5171417|NCT01197794|12718895|P1|STARTED|Overall Study||164
5171418|NCT01197755|12718977|P3|NOT COMPLETED|Overall Study||54
5171419|NCT01197755|12718978|P2|NOT COMPLETED|Overall Study||43
5171420|NCT01197755|12718979|P1|NOT COMPLETED|Overall Study||38
5171421|NCT01197755|12718977|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
5171422|NCT01197755|12718978|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
5171423|NCT01197755|12718979|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
5171424|NCT01197755|12718977|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
5171425|NCT01197755|12718978|P2|Randomised But Did Not Receive Treatment|Overall Study||0
5171426|NCT01197755|12718979|P1|Randomised But Did Not Receive Treatment|Overall Study||0
5171427|NCT01197755|12718977|P3|STARTED|Overall Study|Patients who received treatment|109
5171428|NCT01197755|12718978|P2|STARTED|Overall Study|Patients who received treatment|108
5171429|NCT01197755|12718979|P1|STARTED|Overall Study|Patients who received treatment|105
5171430|NCT01197612|12719019|P1|NOT COMPLETED|Overall Study||12
5171431|NCT01197612|12719019|P1|COMPLETED|Overall Study||6
5171432|NCT01197612|12719019|P1|Returned for Week 24|Overall Study||6
5171433|NCT01197612|12719019|P1|Week 3|Overall Study||16
5171434|NCT01197612|12719019|P1|STARTED|Overall Study||18
5171435|NCT01197573|12719034|P4|NOT COMPLETED|Overall Study||0
5171436|NCT01197573|12719035|P3|NOT COMPLETED|Overall Study||0
5171437|NCT01197573|12719036|P2|NOT COMPLETED|Overall Study||0
5171438|NCT01197573|12719037|P1|NOT COMPLETED|Overall Study||0
5171439|NCT01197573|12719034|P4|COMPLETED|Overall Study||12
5171440|NCT01197573|12719035|P3|COMPLETED|Overall Study||12
5171441|NCT01197573|12719036|P2|COMPLETED|Overall Study||46
5171442|NCT01197573|12719037|P1|COMPLETED|Overall Study||33
5171443|NCT01197573|12719034|P4|STARTED|Overall Study||12
5171444|NCT01197573|12719035|P3|STARTED|Overall Study||12
5171445|NCT01197573|12719036|P2|STARTED|Overall Study||46
5171446|NCT01197573|12719037|P1|STARTED|Overall Study||33
5171447|NCT01197560|12719051|P2|NOT COMPLETED|Overall Study||53
5171448|NCT01197560|12719052|P1|NOT COMPLETED|Overall Study||54
5171449|NCT01197560|12719051|P2|COMPLETED|Overall Study||4
5171450|NCT01197560|12719052|P1|COMPLETED|Overall Study||0
5171451|NCT01197560|12719051|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
5171452|NCT01197560|12719052|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
5171453|NCT01197560|12719051|P2|Lenalidomide Crossover|Overall Study||29
5171454|NCT01197560|12719052|P1|Lenalidomide Crossover|Overall Study||0
5171455|NCT01197560|12719051|P2|Received ≥ One Dose Study Drug|Overall Study||55
5171456|NCT01197560|12719052|P1|Received ≥ One Dose Study Drug|Overall Study||54
5171457|NCT01197560|12719051|P2|STARTED|Overall Study|This is the intent to treat population|57
5171458|NCT01197560|12719052|P1|STARTED|Overall Study|This is the intent to treat population|54
5171459|NCT01197547|12719090|P1|NOT COMPLETED|Overall Study||22
5171460|NCT01197547|12719090|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
5171461|NCT01197547|12719090|P1|STARTED|Overall Study||1014
5171462|NCT01197534|12719099|P3|NOT COMPLETED|Overall Study||173
5171463|NCT01197534|12719100|P2|NOT COMPLETED|Overall Study||130
5171464|NCT01197534|12719101|P1|NOT COMPLETED|Overall Study||134
5171465|NCT01197534|12719099|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
5171466|NCT01197534|12719100|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
5171467|NCT01197534|12719101|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
5171468|NCT01197534|12719099|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
5171469|NCT01197534|12719100|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
5171470|NCT01197534|12719101|P1|Randomised But Did Not Receive Treatment|Overall Study||0
5171471|NCT01197534|12719099|P3|STARTED|Overall Study|Patients who received treatment|302
5171472|NCT01197534|12719100|P2|STARTED|Overall Study|Patients who received treatment|298
5171473|NCT01197534|12719101|P1|STARTED|Overall Study|Patients who received treatment|308
5171474|NCT01197521|12719145|P3|NOT COMPLETED|Overall Study||143
5171475|NCT01197521|12719146|P2|NOT COMPLETED|Overall Study||113
5171476|NCT01197521|12719147|P1|NOT COMPLETED|Overall Study||103
5171477|NCT01197521|12719145|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
5171478|NCT01197521|12719146|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
5171479|NCT01197521|12719147|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
5171480|NCT01197521|12719145|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
5171481|NCT01197521|12719146|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
5171482|NCT01197521|12719147|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
5171483|NCT01197521|12719145|P3|STARTED|Overall Study|Patients who received treatment|304
5171484|NCT01197521|12719146|P2|STARTED|Overall Study|Patients who received treatment|304
5171485|NCT01197521|12719147|P1|STARTED|Overall Study|Patients who received treatment|310
5171486|NCT01197508|12719192|P4|NOT COMPLETED|Overall Study||16
5171487|NCT01197508|12719193|P3|NOT COMPLETED|Overall Study||49
5171488|NCT01197508|12719194|P2|NOT COMPLETED|Overall Study||30
5171489|NCT01197508|12719195|P1|NOT COMPLETED|Overall Study||23
5171490|NCT01197508|12719192|P4|COMPLETED|Overall Study||158
5171491|NCT01197508|12719193|P3|COMPLETED|Overall Study||125
5171492|NCT01197508|12719194|P2|COMPLETED|Overall Study||144
5171493|NCT01197508|12719195|P1|COMPLETED|Overall Study||151
5171494|NCT01197508|12719192|P4|Received Treatment|Overall Study||174
5171495|NCT01197508|12719193|P3|Received Treatment|Overall Study||171
5171496|NCT01197508|12719194|P2|Received Treatment|Overall Study||174
5171497|NCT01197508|12719195|P1|Received Treatment|Overall Study||174
5171498|NCT01197508|12719192|P4|STARTED|Overall Study||174
5171499|NCT01197508|12719193|P3|STARTED|Overall Study||174
5171500|NCT01197508|12719194|P2|STARTED|Overall Study||174
5171501|NCT01197508|12719195|P1|STARTED|Overall Study||174
5171502|NCT01197495|12719291|P2|NOT COMPLETED|Overall Study||7
5171503|NCT01197495|12719292|P1|NOT COMPLETED|Overall Study||13
5171504|NCT01197495|12719291|P2|COMPLETED|Overall Study||49
5171505|NCT01197495|12719292|P1|COMPLETED|Overall Study||144
5171506|NCT01197495|12719291|P2|STARTED|Overall Study||56
5171507|NCT01197495|12719292|P1|STARTED|Overall Study||157
5171508|NCT01197456|12719305|P2|NOT COMPLETED|Overall Study||0
5171509|NCT01197456|12719306|P1|NOT COMPLETED|Overall Study||0
5171510|NCT01197456|12719305|P2|COMPLETED|Overall Study||61
5171511|NCT01197456|12719306|P1|COMPLETED|Overall Study||171
5171512|NCT01197456|12719305|P2|STARTED|Overall Study||61
5171513|NCT01197456|12719306|P1|STARTED|Overall Study||171
5171514|NCT01197417|12719316|P2|NOT COMPLETED|Overall Study||18
5171515|NCT01197417|12719317|P1|NOT COMPLETED|Overall Study||8
5171516|NCT01197417|12719316|P2|COMPLETED|Overall Study||86
5171517|NCT01197417|12719317|P1|COMPLETED|Overall Study||96
5171518|NCT01197417|12719316|P2|Received Study Drug|Overall Study||103
5171519|NCT01197417|12719317|P1|Received Study Drug|Overall Study||101
5171520|NCT01197417|12719316|P2|STARTED|Overall Study||104
5171521|NCT01197417|12719317|P1|STARTED|Overall Study||104
5171522|NCT01197378|12719335|P1|NOT COMPLETED|Overall Study||7
5171523|NCT01197378|12719335|P1|COMPLETED|Overall Study||53
5171524|NCT01197378|12719335|P1|Received Treatment|Overall Study||59
5171525|NCT01197378|12719335|P1|STARTED|Overall Study||60
5171526|NCT01197326|12719343|P2|NOT COMPLETED|Overall Study||0
5171527|NCT01197326|12719344|P1|NOT COMPLETED|Overall Study||0
5171528|NCT01197326|12719343|P2|COMPLETED|Overall Study||209
5171529|NCT01197326|12719344|P1|COMPLETED|Overall Study||205
5171530|NCT01197326|12719343|P2|STARTED|Overall Study||209
5171531|NCT01197326|12719344|P1|STARTED|Overall Study||205
5171532|NCT01197300|12719354|P2|NOT COMPLETED|Overall Study||2
5171533|NCT01197300|12719355|P1|NOT COMPLETED|Overall Study||0
5171534|NCT01197300|12719354|P2|COMPLETED|Overall Study||13
5171535|NCT01197300|12719355|P1|COMPLETED|Overall Study||10
5171536|NCT01197300|12719354|P2|STARTED|Overall Study||15
5171537|NCT01197300|12719355|P1|STARTED|Overall Study||10
5171538|NCT01196988|12719387|P4|NOT COMPLETED|Overall Study||1
5171539|NCT01196988|12719388|P3|NOT COMPLETED|Overall Study||25
5171540|NCT01196988|12719389|P2|NOT COMPLETED|Overall Study||32
5171541|NCT01196988|12719390|P1|NOT COMPLETED|Overall Study||24
5171542|NCT01196988|12719387|P4|COMPLETED|Overall Study||276
5171543|NCT01196988|12719388|P3|COMPLETED|Overall Study||886
5171544|NCT01196988|12719389|P2|COMPLETED|Overall Study||880
5171545|NCT01196988|12719390|P1|COMPLETED|Overall Study||891
5171546|NCT01196988|12719387|P4|STARTED|Overall Study||277
5171547|NCT01196988|12719388|P3|STARTED|Overall Study||911
5171548|NCT01196988|12719389|P2|STARTED|Overall Study||912
5171549|NCT01196988|12719390|P1|STARTED|Overall Study||915
5171550|NCT01196975|12719484|P5|NOT COMPLETED|Overall Study||13
5171551|NCT01196975|12719485|P4|NOT COMPLETED|Overall Study||6
5171552|NCT01196975|12719486|P3|NOT COMPLETED|Overall Study||5
5171553|NCT01196975|12719487|P2|NOT COMPLETED|Overall Study||9
5171554|NCT01196975|12719488|P1|NOT COMPLETED|Overall Study||15
5171555|NCT01196975|12719484|P5|COMPLETED|Overall Study||205
5171556|NCT01196975|12719485|P4|COMPLETED|Overall Study||207
5171557|NCT01196975|12719486|P3|COMPLETED|Overall Study||420
5171558|NCT01196975|12719487|P2|COMPLETED|Overall Study||415
5171559|NCT01196975|12719488|P1|COMPLETED|Overall Study||408
5171560|NCT01196975|12719484|P5|STARTED|Overall Study||218
5171561|NCT01196975|12719485|P4|STARTED|Overall Study||213
5171562|NCT01196975|12719486|P3|STARTED|Overall Study||425
5171563|NCT01196975|12719487|P2|STARTED|Overall Study||424
5171564|NCT01196975|12719488|P1|STARTED|Overall Study||423
5171565|NCT01196936|12719622|P2|NOT COMPLETED|Overall Study||17
5171566|NCT01196936|12719623|P1|NOT COMPLETED|Overall Study||11
5171567|NCT01196936|12719622|P2|COMPLETED|Overall Study||21
5171568|NCT01196936|12719623|P1|COMPLETED|Overall Study||23
5171569|NCT01196936|12719622|P2|Year One Post Treatment|Overall Study||28
5171570|NCT01196936|12719623|P1|Year One Post Treatment|Overall Study||27
5171571|NCT01196936|12719622|P2|STARTED|Overall Study||38
5171572|NCT01196936|12719623|P1|STARTED|Overall Study||34
5171573|NCT01196923|12719645|P1|NOT COMPLETED|Overall Study||0
5171574|NCT01196923|12719645|P1|COMPLETED|Overall Study||20
5171575|NCT01196923|12719645|P1|STARTED|Overall Study||20
5171576|NCT01196871|12719655|P6|NOT COMPLETED|Stage 2: Period 2||0
5171577|NCT01196871|12719656|P5|NOT COMPLETED|Stage 2: Period 2||0
5171578|NCT01196871|12719657|P4|NOT COMPLETED|Stage 2: Period 2||0
5171579|NCT01196871|12719658|P3|NOT COMPLETED|Stage 2: Period 2||0
5171580|NCT01196871|12719659|P2|NOT COMPLETED|Stage 2: Period 2||0
5171581|NCT01196871|12719660|P1|NOT COMPLETED|Stage 2: Period 2||0
5171582|NCT01196871|12719655|P6|COMPLETED|Stage 2: Period 2||4
5171583|NCT01196871|12719656|P5|COMPLETED|Stage 2: Period 2||6
5171584|NCT01196871|12719657|P4|COMPLETED|Stage 2: Period 2||1
5171585|NCT01196871|12719658|P3|COMPLETED|Stage 2: Period 2||0
5171586|NCT01196871|12719659|P2|COMPLETED|Stage 2: Period 2||0
5171587|NCT01196871|12719660|P1|COMPLETED|Stage 2: Period 2||0
5171588|NCT01196871|12719655|P6|PK Population|Stage 2: Period 2||4
5171589|NCT01196871|12719656|P5|PK Population|Stage 2: Period 2||6
5171590|NCT01196871|12719657|P4|PK Population|Stage 2: Period 2||1
5171591|NCT01196871|12719658|P3|PK Population|Stage 2: Period 2||0
5171592|NCT01196871|12719659|P2|PK Population|Stage 2: Period 2||0
5171593|NCT01196871|12719660|P1|PK Population|Stage 2: Period 2||0
5171594|NCT01196871|12719655|P6|STARTED|Stage 2: Period 2||4
5171595|NCT01196871|12719656|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
5171596|NCT01196871|12719657|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
5171597|NCT01196871|12719658|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
5171598|NCT01196871|12719659|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
5171599|NCT01196871|12719660|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
5171600|NCT01196871|12719655|P6|NOT COMPLETED|Stage 2: Period 1||0
5171601|NCT01196871|12719656|P5|NOT COMPLETED|Stage 2: Period 1||0
5171602|NCT01196871|12719657|P4|NOT COMPLETED|Stage 2: Period 1||0
5171603|NCT01196871|12719658|P3|NOT COMPLETED|Stage 2: Period 1||0
5171604|NCT01196871|12719659|P2|NOT COMPLETED|Stage 2: Period 1||0
5171605|NCT01196871|12719660|P1|NOT COMPLETED|Stage 2: Period 1||0
5171606|NCT01196871|12719655|P6|COMPLETED|Stage 2: Period 1||4
5171607|NCT01196871|12719656|P5|COMPLETED|Stage 2: Period 1||5
5171608|NCT01196871|12719657|P4|COMPLETED|Stage 2: Period 1||2
5171609|NCT01196871|12719658|P3|COMPLETED|Stage 2: Period 1||0
5171610|NCT01196871|12719659|P2|COMPLETED|Stage 2: Period 1||0
5171611|NCT01196871|12719660|P1|COMPLETED|Stage 2: Period 1||0
5171612|NCT01196871|12719655|P6|PK Population|Stage 2: Period 1||4
5171613|NCT01196871|12719656|P5|PK Population|Stage 2: Period 1||5
5171614|NCT01196871|12719657|P4|PK Population|Stage 2: Period 1||1
5171615|NCT01196871|12719658|P3|PK Population|Stage 2: Period 1||0
5171616|NCT01196871|12719659|P2|PK Population|Stage 2: Period 1||0
5171617|NCT01196871|12719660|P1|PK Population|Stage 2: Period 1||0
5171618|NCT01196871|12719655|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
5171619|NCT01196871|12719656|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
5171620|NCT01196871|12719657|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
5171621|NCT01196871|12719658|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
5171622|NCT01196871|12719659|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
5171623|NCT01196871|12719660|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
5171624|NCT01196871|12719655|P6|STARTED|Stage 2: Period 1||4
5171625|NCT01196871|12719656|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
5171626|NCT01196871|12719657|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
5171627|NCT01196871|12719658|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
5171628|NCT01196871|12719659|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
5171629|NCT01196871|12719660|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
5171630|NCT01196871|12719655|P6|NOT COMPLETED|Stage 1: Period 3||0
5171631|NCT01196871|12719656|P5|NOT COMPLETED|Stage 1: Period 3||0
5171632|NCT01196871|12719657|P4|NOT COMPLETED|Stage 1: Period 3||0
5171633|NCT01196871|12719658|P3|NOT COMPLETED|Stage 1: Period 3||0
5171634|NCT01196871|12719659|P2|NOT COMPLETED|Stage 1: Period 3||0
5171635|NCT01196871|12719660|P1|NOT COMPLETED|Stage 1: Period 3||0
5171636|NCT01196871|12719655|P6|COMPLETED|Stage 1: Period 3||0
5171637|NCT01196871|12719656|P5|COMPLETED|Stage 1: Period 3||0
5171638|NCT01196871|12719657|P4|COMPLETED|Stage 1: Period 3||0
5171639|NCT01196871|12719658|P3|COMPLETED|Stage 1: Period 3||4
5171640|NCT01196871|12719659|P2|COMPLETED|Stage 1: Period 3||3
5171641|NCT01196871|12719660|P1|COMPLETED|Stage 1: Period 3||5
5171642|NCT01196871|12719655|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
5171643|NCT01196871|12719656|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
5171644|NCT01196871|12719657|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
5171645|NCT01196871|12719658|P3|STARTED|Stage 1: Period 3||4
5171646|NCT01196871|12719659|P2|STARTED|Stage 1: Period 3||3
5171647|NCT01196871|12719660|P1|STARTED|Stage 1: Period 3||5
5171648|NCT01196871|12719655|P6|NOT COMPLETED|Stage 1: Period 2||0
5171649|NCT01196871|12719656|P5|NOT COMPLETED|Stage 1: Period 2||0
5171650|NCT01196871|12719657|P4|NOT COMPLETED|Stage 1: Period 2||0
5171651|NCT01196871|12719658|P3|NOT COMPLETED|Stage 1: Period 2||0
5171652|NCT01196871|12719659|P2|NOT COMPLETED|Stage 1: Period 2||0
5171653|NCT01196871|12719660|P1|NOT COMPLETED|Stage 1: Period 2||0
5171654|NCT01196871|12719655|P6|COMPLETED|Stage 1: Period 2||0
5171655|NCT01196871|12719656|P5|COMPLETED|Stage 1: Period 2||0
5171656|NCT01196871|12719657|P4|COMPLETED|Stage 1: Period 2||0
5171657|NCT01196871|12719658|P3|COMPLETED|Stage 1: Period 2||4
5171658|NCT01196871|12719659|P2|COMPLETED|Stage 1: Period 2||3
5171659|NCT01196871|12719660|P1|COMPLETED|Stage 1: Period 2||5
5171660|NCT01196871|12719655|P6|PK Population|Stage 1: Period 2||0
5171661|NCT01196871|12719656|P5|PK Population|Stage 1: Period 2||0
5171662|NCT01196871|12719657|P4|PK Population|Stage 1: Period 2||0
5171663|NCT01196871|12719658|P3|PK Population|Stage 1: Period 2||4
5171664|NCT01196871|12719659|P2|PK Population|Stage 1: Period 2||3
5171665|NCT01196871|12719660|P1|PK Population|Stage 1: Period 2||5
5171666|NCT01196871|12719655|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
5171667|NCT01196871|12719656|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
5171668|NCT01196871|12719657|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
5171669|NCT01196871|12719658|P3|STARTED|Stage 1: Period 2||4
5171670|NCT01196871|12719659|P2|STARTED|Stage 1: Period 2||3
5171671|NCT01196871|12719660|P1|STARTED|Stage 1: Period 2||5
5171672|NCT01196871|12719655|P6|NOT COMPLETED|Stage 1: Period 1||0
5171673|NCT01196871|12719656|P5|NOT COMPLETED|Stage 1: Period 1||0
5171674|NCT01196871|12719657|P4|NOT COMPLETED|Stage 1: Period 1||0
5171675|NCT01196871|12719658|P3|NOT COMPLETED|Stage 1: Period 1||0
5171676|NCT01196871|12719659|P2|NOT COMPLETED|Stage 1: Period 1||0
5171677|NCT01196871|12719660|P1|NOT COMPLETED|Stage 1: Period 1||0
5171678|NCT01196871|12719655|P6|COMPLETED|Stage 1: Period 1||0
5171679|NCT01196871|12719656|P5|COMPLETED|Stage 1: Period 1||0
5171680|NCT01196871|12719657|P4|COMPLETED|Stage 1: Period 1||0
5171681|NCT01196871|12719658|P3|COMPLETED|Stage 1: Period 1||4
5171682|NCT01196871|12719659|P2|COMPLETED|Stage 1: Period 1||3
5171683|NCT01196871|12719660|P1|COMPLETED|Stage 1: Period 1||5
5171684|NCT01196871|12719655|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
5171685|NCT01196871|12719656|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
5171686|NCT01196871|12719657|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
5171687|NCT01196871|12719658|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
5171688|NCT01196871|12719659|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
5171689|NCT01196871|12719660|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
5171690|NCT01196871|12719655|P6|PK Population|Stage 1: Period 1||0
5171691|NCT01196871|12719656|P5|PK Population|Stage 1: Period 1||0
5171692|NCT01196871|12719657|P4|PK Population|Stage 1: Period 1||0
5171693|NCT01196871|12719658|P3|PK Population|Stage 1: Period 1||4
5171694|NCT01196871|12719659|P2|PK Population|Stage 1: Period 1||3
5171695|NCT01196871|12719660|P1|PK Population|Stage 1: Period 1||5
5171696|NCT01196871|12719655|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
5171697|NCT01196871|12719656|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
5171698|NCT01196871|12719657|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
5171699|NCT01196871|12719658|P3|STARTED|Stage 1: Period 1||4
5171700|NCT01196871|12719659|P2|STARTED|Stage 1: Period 1||3
5171701|NCT01196871|12719660|P1|STARTED|Stage 1: Period 1||5
5171702|NCT01196819|12719745|P2|NOT COMPLETED|Overall Study||0
5171703|NCT01196819|12719746|P1|NOT COMPLETED|Overall Study||6
5171704|NCT01196819|12719745|P2|COMPLETED|Overall Study||227
5171705|NCT01196819|12719746|P1|COMPLETED|Overall Study||225
5171706|NCT01196819|12719745|P2|STARTED|Overall Study||227
5171707|NCT01196819|12719746|P1|STARTED|Overall Study||231
5171708|NCT01196793|12719766|P1|NOT COMPLETED|Overall Study||0
5171709|NCT01196793|12719766|P1|COMPLETED|Overall Study||108
5171710|NCT01196793|12719766|P1|STARTED|Overall Study||108
5171711|NCT01196741|12719772|P2|NOT COMPLETED|Overall Study||28
5171712|NCT01196741|12719773|P1|NOT COMPLETED|Overall Study||60
5171713|NCT01196741|12719772|P2|COMPLETED|Overall Study||8
5171714|NCT01196741|12719773|P1|COMPLETED|Overall Study||11
5171715|NCT01196741|12719772|P2|STARTED|Overall Study||36
5171716|NCT01196741|12719773|P1|STARTED|Overall Study||71
5171717|NCT01196533|12719787|P1|NOT COMPLETED|Overall Study||0
5171718|NCT01196533|12719787|P1|COMPLETED|Overall Study||94
5171719|NCT01196533|12719787|P1|STARTED|Overall Study||94
5171720|NCT01196442|12719791|P1|NOT COMPLETED|Overall Study||0
5171721|NCT01196442|12719791|P1|COMPLETED|Overall Study||39
5171722|NCT01196442|12719791|P1|STARTED|Overall Study||39
5171723|NCT01196429|12719803|P2|NOT COMPLETED|Overall Study||0
5171724|NCT01196429|12719804|P1|NOT COMPLETED|Overall Study||3
5171725|NCT01196429|12719803|P2|COMPLETED|Overall Study||45
5171726|NCT01196429|12719804|P1|COMPLETED|Overall Study||42
5171727|NCT01196429|12719803|P2|STARTED|Overall Study||45
5171728|NCT01196429|12719804|P1|STARTED|Overall Study||45
5171729|NCT01196416|12719820|P1|NOT COMPLETED|Overall Study||2
5171730|NCT01196416|12719820|P1|COMPLETED|Overall Study||12
5171731|NCT01196416|12719820|P1|STARTED|Overall Study||14
5171732|NCT01196377|12719838|P4|NOT COMPLETED|Overall Study||0
5171733|NCT01196377|12719839|P3|NOT COMPLETED|Overall Study||0
5171734|NCT01196377|12719840|P2|NOT COMPLETED|Overall Study||0
5171735|NCT01196377|12719841|P1|NOT COMPLETED|Overall Study||0
5171736|NCT01196377|12719838|P4|COMPLETED|Overall Study||4
5171737|NCT01196377|12719839|P3|COMPLETED|Overall Study||4
5171738|NCT01196377|12719840|P2|COMPLETED|Overall Study||4
5171739|NCT01196377|12719841|P1|COMPLETED|Overall Study||4
5171740|NCT01196377|12719838|P4|STARTED|Overall Study||4
5171741|NCT01196377|12719839|P3|STARTED|Overall Study||4
5171742|NCT01196377|12719840|P2|STARTED|Overall Study||4
5171743|NCT01196377|12719841|P1|STARTED|Overall Study||4
5171744|NCT01196117|12719851|P2|NOT COMPLETED|CPAP||0
5171745|NCT01196117|12719852|P1|NOT COMPLETED|CPAP||0
5171746|NCT01196117|12719851|P2|COMPLETED|CPAP||18
5171747|NCT01196117|12719852|P1|COMPLETED|CPAP||0
5171748|NCT01196117|12719851|P2|STARTED|CPAP||18
5171749|NCT01196117|12719852|P1|STARTED|CPAP||0
5171750|NCT01196117|12719851|P2|NOT COMPLETED|Placebo, Then CPAP||0
5171751|NCT01196117|12719852|P1|NOT COMPLETED|Placebo, Then CPAP||0
5171752|NCT01196117|12719851|P2|COMPLETED|Placebo, Then CPAP||0
5171753|NCT01196117|12719852|P1|COMPLETED|Placebo, Then CPAP||18
5171754|NCT01196117|12719851|P2|STARTED|Placebo, Then CPAP||0
5171755|NCT01196117|12719852|P1|STARTED|Placebo, Then CPAP||18
5171756|NCT01196104|12719878|P2|NOT COMPLETED|Overall Study||5
5171757|NCT01196104|12719879|P1|NOT COMPLETED|Overall Study||4
5171758|NCT01196104|12719878|P2|COMPLETED|Overall Study||15
5171759|NCT01196104|12719879|P1|COMPLETED|Overall Study||15
5171760|NCT01196104|12719878|P2|STARTED|Overall Study||20
5171761|NCT01196104|12719879|P1|STARTED|Overall Study||19
5171762|NCT01196091|12719922|P3|NOT COMPLETED|Overall Study||104
5171763|NCT01196091|12719923|P2|NOT COMPLETED|Overall Study||98
5171764|NCT01196091|12719924|P1|NOT COMPLETED|Overall Study||88
5171765|NCT01196091|12719922|P3|COMPLETED|Overall Study||284
5171766|NCT01196091|12719923|P2|COMPLETED|Overall Study||291
5171767|NCT01196091|12719924|P1|COMPLETED|Overall Study||299
5171768|NCT01196091|12719922|P3|Follow-Up|Overall Study||128
5171769|NCT01196091|12719923|P2|Follow-Up|Overall Study||105
5171770|NCT01196091|12719924|P1|Follow-Up|Overall Study||103
5171771|NCT01196091|12719922|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
5171772|NCT01196091|12719923|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
5171773|NCT01196091|12719924|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
5171774|NCT01196091|12719922|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
5171775|NCT01196091|12719923|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
5171776|NCT01196091|12719924|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
5171777|NCT01196091|12719922|P3|STARTED|Overall Study||388
5171778|NCT01196091|12719923|P2|STARTED|Overall Study||389
5171779|NCT01196091|12719924|P1|STARTED|Overall Study||387
5171780|NCT01196078|12719976|P2|NOT COMPLETED|Overall Study||37
5171781|NCT01196078|12719977|P1|NOT COMPLETED|Overall Study||33
5171782|NCT01196078|12719976|P2|COMPLETED|Overall Study||20
5171783|NCT01196078|12719977|P1|COMPLETED|Overall Study||24
5171784|NCT01196078|12719976|P2|STARTED|Overall Study||57
5171785|NCT01196078|12719977|P1|STARTED|Overall Study||57
5171786|NCT01196052|12720005|P1|NOT COMPLETED|Overall Study||23
5171787|NCT01196052|12720005|P1|COMPLETED|Overall Study||130
5171788|NCT01196052|12720005|P1|Received Trastuzumab Emtansine|Overall Study||148
5171789|NCT01196052|12720005|P1|STARTED|Overall Study||153
5171790|NCT01196026|12720022|P6|NOT COMPLETED|Overall Study||0
5171791|NCT01196026|12720023|P5|NOT COMPLETED|Overall Study||1
5171792|NCT01196026|12720024|P4|NOT COMPLETED|Overall Study||0
5171793|NCT01196026|12720025|P3|NOT COMPLETED|Overall Study||0
5171794|NCT01196026|12720026|P2|NOT COMPLETED|Overall Study||8
5171795|NCT01196026|12720027|P1|NOT COMPLETED|Overall Study||1
5171796|NCT01196026|12720022|P6|COMPLETED|Overall Study||24
5171797|NCT01196026|12720023|P5|COMPLETED|Overall Study||42
5171798|NCT01196026|12720024|P4|COMPLETED|Overall Study||10
5171799|NCT01196026|12720025|P3|COMPLETED|Overall Study||23
5171800|NCT01196026|12720026|P2|COMPLETED|Overall Study||36
5171801|NCT01196026|12720027|P1|COMPLETED|Overall Study||9
5171802|NCT01196026|12720022|P6|Completed at Day 28|Overall Study||24
5171803|NCT01196026|12720023|P5|Completed at Day 28|Overall Study||42
5171804|NCT01196026|12720024|P4|Completed at Day 28|Overall Study||10
5171805|NCT01196026|12720025|P3|Completed at Day 28|Overall Study||23
5171806|NCT01196026|12720026|P2|Completed at Day 28|Overall Study||41
5171807|NCT01196026|12720027|P1|Completed at Day 28|Overall Study||9
5171808|NCT01196026|12720022|P6|STARTED|Overall Study||24
5171809|NCT01196026|12720023|P5|STARTED|Overall Study||43
5171810|NCT01196026|12720024|P4|STARTED|Overall Study||10
5171811|NCT01196026|12720025|P3|STARTED|Overall Study||23
5171812|NCT01196026|12720026|P2|STARTED|Overall Study||44
5171813|NCT01196026|12720027|P1|STARTED|Overall Study||10
5171814|NCT01195948|12720261|P3|NOT COMPLETED|Overall Study||2
5171815|NCT01195948|12720262|P2|NOT COMPLETED|Overall Study||1
5171816|NCT01195948|12720263|P1|NOT COMPLETED|Overall Study||0
5171817|NCT01195948|12720261|P3|COMPLETED|Overall Study||9
5171818|NCT01195948|12720262|P2|COMPLETED|Overall Study||9
5171819|NCT01195948|12720263|P1|COMPLETED|Overall Study||10
5171820|NCT01195948|12720261|P3|Week 24|Overall Study||10
5171821|NCT01195948|12720262|P2|Week 24|Overall Study||10
5171822|NCT01195948|12720263|P1|Week 24|Overall Study||10
5171823|NCT01195948|12720261|P3|STARTED|Overall Study||11
5171824|NCT01195948|12720262|P2|STARTED|Overall Study||10
5171825|NCT01195948|12720263|P1|STARTED|Overall Study||10
5171826|NCT01195922|12720295|P1|NOT COMPLETED|Overall Study||0
5171827|NCT01195922|12720295|P1|COMPLETED|Overall Study||16
5171828|NCT01195922|12720295|P1|STARTED|Overall Study||16
5171829|NCT01195883|12720303|P2|NOT COMPLETED|Overall Study||26
5171830|NCT01195883|12720304|P1|NOT COMPLETED|Overall Study||19
5171831|NCT01195883|12720303|P2|COMPLETED|Overall Study||523
5171832|NCT01195883|12720304|P1|COMPLETED|Overall Study||534
5171833|NCT01195883|12720303|P2|STARTED|Overall Study||549
5171834|NCT01195883|12720304|P1|STARTED|Overall Study||553
5171835|NCT01195844|12720316|P1|NOT COMPLETED|Overall Study||40
5171836|NCT01195844|12720316|P1|COMPLETED|Overall Study||190
5171837|NCT01195844|12720316|P1|STARTED|Overall Study||230
5171838|NCT01195831|12720333|P2|NOT COMPLETED|Overall Study||10
5171839|NCT01195831|12720334|P1|NOT COMPLETED|Overall Study||8
5171840|NCT01195831|12720333|P2|COMPLETED|Overall Study||114
5171841|NCT01195831|12720334|P1|COMPLETED|Overall Study||112
5171842|NCT01195831|12720333|P2|STARTED|Overall Study||124
5171843|NCT01195831|12720334|P1|STARTED|Overall Study||120
5171844|NCT01195779|12720362|P14|NOT COMPLETED|Overall Study||0
5171845|NCT01195779|12720363|P13|NOT COMPLETED|Overall Study||0
5171846|NCT01195779|12720364|P12|NOT COMPLETED|Overall Study||0
5171847|NCT01195779|12720365|P11|NOT COMPLETED|Overall Study||0
5171848|NCT01195779|12720366|P10|NOT COMPLETED|Overall Study||0
5171849|NCT01195779|12720367|P9|NOT COMPLETED|Overall Study||0
5171850|NCT01195779|12720368|P8|NOT COMPLETED|Overall Study||0
5171851|NCT01195779|12720369|P7|NOT COMPLETED|Overall Study||0
5171852|NCT01195779|12720370|P6|NOT COMPLETED|Overall Study||0
5171853|NCT01195779|12720371|P5|NOT COMPLETED|Overall Study||0
5171854|NCT01195779|12720372|P4|NOT COMPLETED|Overall Study||0
5171855|NCT01195779|12720373|P3|NOT COMPLETED|Overall Study||0
5171856|NCT01195779|12720374|P2|NOT COMPLETED|Overall Study||0
5171857|NCT01195779|12720375|P1|NOT COMPLETED|Overall Study||0
5171858|NCT01195779|12720362|P14|COMPLETED|Overall Study||1
5171859|NCT01195779|12720363|P13|COMPLETED|Overall Study||0
5171860|NCT01195779|12720364|P12|COMPLETED|Overall Study||1
5171861|NCT01195779|12720365|P11|COMPLETED|Overall Study||0
5171862|NCT01195779|12720366|P10|COMPLETED|Overall Study||0
5171863|NCT01195779|12720367|P9|COMPLETED|Overall Study||0
5171864|NCT01195779|12720368|P8|COMPLETED|Overall Study||1
5171865|NCT01195779|12720369|P7|COMPLETED|Overall Study||0
5171866|NCT01195779|12720370|P6|COMPLETED|Overall Study||0
5171867|NCT01195779|12720371|P5|COMPLETED|Overall Study||1
5171868|NCT01195779|12720372|P4|COMPLETED|Overall Study||0
5171869|NCT01195779|12720373|P3|COMPLETED|Overall Study||0
5171870|NCT01195779|12720374|P2|COMPLETED|Overall Study||0
5171871|NCT01195779|12720375|P1|COMPLETED|Overall Study||0
5171872|NCT01195779|12720362|P14|STARTED|Overall Study||1
5171873|NCT01195779|12720363|P13|STARTED|Overall Study||0
5171874|NCT01195779|12720364|P12|STARTED|Overall Study||1
5171875|NCT01195779|12720365|P11|STARTED|Overall Study||0
5171876|NCT01195779|12720366|P10|STARTED|Overall Study||0
5171877|NCT01195779|12720367|P9|STARTED|Overall Study||0
5171878|NCT01195779|12720368|P8|STARTED|Overall Study||1
5171879|NCT01195779|12720369|P7|STARTED|Overall Study||0
5171880|NCT01195779|12720370|P6|STARTED|Overall Study||0
5171881|NCT01195779|12720371|P5|STARTED|Overall Study||1
5171882|NCT01195779|12720372|P4|STARTED|Overall Study||0
5171883|NCT01195779|12720373|P3|STARTED|Overall Study||0
5171884|NCT01195779|12720374|P2|STARTED|Overall Study||0
5171885|NCT01195779|12720375|P1|STARTED|Overall Study||0
5171886|NCT01195701|12720547|P2|NOT COMPLETED|Overall Study||5
5171887|NCT01195701|12720548|P1|NOT COMPLETED|Overall Study||0
5171888|NCT01195701|12720547|P2|COMPLETED|Overall Study||20
5171889|NCT01195701|12720548|P1|COMPLETED|Overall Study||10
5171890|NCT01195701|12720547|P2|STARTED|Overall Study||25
5171891|NCT01195701|12720548|P1|STARTED|Overall Study||10
5171892|NCT01195675|12720574|P1|NOT COMPLETED|Overall Study||3
5171893|NCT01195675|12720574|P1|COMPLETED|Overall Study||27
5171894|NCT01195675|12720574|P1|Received Placebo 2|Overall Study||28
5171895|NCT01195675|12720574|P1|Received Placebo 1|Overall Study||29
5171896|NCT01195675|12720574|P1|Received Moxifloxacin|Overall Study||29
5171897|NCT01195675|12720574|P1|Received Empa 200mg|Overall Study||30
5171898|NCT01195675|12720574|P1|Received Empa 25mg|Overall Study||28
5171899|NCT01195675|12720574|P1|STARTED|Overall Study||30
5171900|NCT01195662|12720607|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
5171901|NCT01195662|12720608|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
5171902|NCT01195662|12720609|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
5171903|NCT01195662|12720607|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
5171904|NCT01195662|12720608|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
5171905|NCT01195662|12720609|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
5171906|NCT01195662|12720607|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
5171907|NCT01195662|12720608|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
5171908|NCT01195662|12720609|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
5171909|NCT01195662|12720607|P3|NOT COMPLETED|Double Blind Treatment Period||14
5171910|NCT01195662|12720608|P2|NOT COMPLETED|Double Blind Treatment Period||14
5171911|NCT01195662|12720609|P1|NOT COMPLETED|Double Blind Treatment Period||22
5171912|NCT01195662|12720607|P3|COMPLETED|Double Blind Treatment Period||119
5171913|NCT01195662|12720608|P2|COMPLETED|Double Blind Treatment Period||211
5171914|NCT01195662|12720609|P1|COMPLETED|Double Blind Treatment Period||202
5171915|NCT01195662|12720607|P3|STARTED|Double Blind Treatment Period||133
5171916|NCT01195662|12720608|P2|STARTED|Double Blind Treatment Period||225
5171917|NCT01195662|12720609|P1|STARTED|Double Blind Treatment Period||224
5171918|NCT01195636|12720639|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
5171919|NCT01195636|12720640|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
5171920|NCT01195636|12720639|P2|COMPLETED|Second Intervention (3 Weeks)||27
5171921|NCT01195636|12720640|P1|COMPLETED|Second Intervention (3 Weeks)||27
5171922|NCT01195636|12720639|P2|STARTED|Second Intervention (3 Weeks)||29
5171923|NCT01195636|12720640|P1|STARTED|Second Intervention (3 Weeks)||28
5171924|NCT01195636|12720639|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
5171925|NCT01195636|12720640|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
5171926|NCT01195636|12720639|P2|COMPLETED|Washout Period (2 Weeks)||29
5171927|NCT01195636|12720640|P1|COMPLETED|Washout Period (2 Weeks)||28
5171928|NCT01195636|12720639|P2|STARTED|Washout Period (2 Weeks)||32
5171929|NCT01195636|12720640|P1|STARTED|Washout Period (2 Weeks)||30
5171930|NCT01195636|12720639|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
5171931|NCT01195636|12720640|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
5171932|NCT01195636|12720639|P2|COMPLETED|First Intervention (3 Weeks)||32
5171933|NCT01195636|12720640|P1|COMPLETED|First Intervention (3 Weeks)||30
5171934|NCT01195636|12720639|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
5171935|NCT01195636|12720640|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
5171936|NCT01195636|12720639|P2|STARTED|First Intervention (3 Weeks)||35
5171937|NCT01195636|12720640|P1|STARTED|First Intervention (3 Weeks)||35
5171938|NCT01195623|12720666|P2|NOT COMPLETED|Overall Study||37
5171939|NCT01195623|12720667|P1|NOT COMPLETED|Overall Study||35
5171940|NCT01195623|12720666|P2|COMPLETED|Overall Study|129 legs|108
5171941|NCT01195623|12720667|P1|COMPLETED|Overall Study|127 legs|113
5171942|NCT01195623|12720666|P2|STARTED|Overall Study|177 legs total operated|145
5171943|NCT01195623|12720667|P1|STARTED|Overall Study|166 legs total operated|148
5171944|NCT01195597|12720675|P1|NOT COMPLETED|Overall Study||13
5171945|NCT01195597|12720675|P1|COMPLETED|Overall Study||27
5171946|NCT01195597|12720675|P1|STARTED|Overall Study||40
5171947|NCT01195584|12720683|P3|NOT COMPLETED|Overall Study||0
5171948|NCT01195584|12720684|P2|NOT COMPLETED|Overall Study||0
5171949|NCT01195584|12720685|P1|NOT COMPLETED|Overall Study||0
5171950|NCT01195584|12720683|P3|COMPLETED|Overall Study||27
5171951|NCT01195584|12720684|P2|COMPLETED|Overall Study||25
5171952|NCT01195584|12720685|P1|COMPLETED|Overall Study||20
5171953|NCT01195584|12720683|P3|STARTED|Overall Study||27
5171954|NCT01195584|12720684|P2|STARTED|Overall Study||25
5171955|NCT01195584|12720685|P1|STARTED|Overall Study||20
5171956|NCT01195545|12720696|P1|NOT COMPLETED|Overall Study||4
5171957|NCT01195545|12720696|P1|COMPLETED|Overall Study||16
5171958|NCT01195545|12720696|P1|STARTED|Overall Study||20
5171959|NCT01195467|12720703|P1|NOT COMPLETED|Overall Study||10
5171960|NCT01195467|12720703|P1|COMPLETED|Overall Study||30
5171961|NCT01195467|12720703|P1|STARTED|Overall Study||40
5171962|NCT01195415|12720708|P1|NOT COMPLETED|Overall Study||2
5171963|NCT01195415|12720708|P1|COMPLETED|Overall Study||23
5171964|NCT01195415|12720708|P1|STARTED|Overall Study||25
5171965|NCT01195363|12720717|P2|NOT COMPLETED|Overall Study||9
5171966|NCT01195363|12720718|P1|NOT COMPLETED|Overall Study||11
5171967|NCT01195363|12720717|P2|COMPLETED|Overall Study||4
5171968|NCT01195363|12720718|P1|COMPLETED|Overall Study||4
5171969|NCT01195363|12720717|P2|STARTED|Overall Study||13
5171970|NCT01195363|12720718|P1|STARTED|Overall Study||15
5171971|NCT01195272|12720724|P1|NOT COMPLETED|Overall Study||4
5171972|NCT01195272|12720724|P1|COMPLETED|Overall Study||17
5171973|NCT01195272|12720724|P1|STARTED|Overall Study||21
5171974|NCT01195116|12720743|P2|NOT COMPLETED|Overall Study||0
5171975|NCT01195116|12720744|P1|NOT COMPLETED|Overall Study||0
5171976|NCT01195116|12720743|P2|COMPLETED|Overall Study||20
5171977|NCT01195116|12720744|P1|COMPLETED|Overall Study||21
5171978|NCT01195116|12720743|P2|STARTED|Overall Study||20
5171979|NCT01195116|12720744|P1|STARTED|Overall Study||21
5171980|NCT01195103|12720753|P3|NOT COMPLETED|Overall Study||0
5171981|NCT01195103|12720754|P2|NOT COMPLETED|Overall Study||0
5171982|NCT01195103|12720755|P1|NOT COMPLETED|Overall Study||1
5171983|NCT01195103|12720753|P3|COMPLETED|Overall Study||5
5171984|NCT01195103|12720754|P2|COMPLETED|Overall Study||2
5171985|NCT01195103|12720755|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
5171986|NCT01195103|12720753|P3|STARTED|Overall Study||5
5171987|NCT01195103|12720754|P2|STARTED|Overall Study||2
5171988|NCT01195103|12720755|P1|STARTED|Overall Study||6
5171989|NCT01195090|12720765|P2|NOT COMPLETED|Overall Study||8
5171990|NCT01195090|12720766|P1|NOT COMPLETED|Overall Study||6
5171991|NCT01195090|12720765|P2|COMPLETED|Overall Study||52
5171992|NCT01195090|12720766|P1|COMPLETED|Overall Study||54
5171993|NCT01195090|12720765|P2|STARTED|Overall Study||60
5171994|NCT01195090|12720766|P1|STARTED|Overall Study||60
5171995|NCT01195025|12720824|P5|NOT COMPLETED|Third Intervention C||0
5171996|NCT01195025|12720825|P4|NOT COMPLETED|Third Intervention C||0
5171997|NCT01195025|12720826|P3|NOT COMPLETED|Third Intervention C||0
5171998|NCT01195025|12720827|P2|NOT COMPLETED|Third Intervention C||0
5171999|NCT01195025|12720828|P1|NOT COMPLETED|Third Intervention C||0
5172000|NCT01195025|12720824|P5|COMPLETED|Third Intervention C||1
5172001|NCT01195025|12720825|P4|COMPLETED|Third Intervention C||2
5172002|NCT01195025|12720826|P3|COMPLETED|Third Intervention C||2
5172003|NCT01195025|12720827|P2|COMPLETED|Third Intervention C||3
5172004|NCT01195025|12720828|P1|COMPLETED|Third Intervention C||2
5172005|NCT01195025|12720824|P5|STARTED|Third Intervention C||1
5172006|NCT01195025|12720825|P4|STARTED|Third Intervention C||2
5172007|NCT01195025|12720826|P3|STARTED|Third Intervention C||2
5172008|NCT01195025|12720827|P2|STARTED|Third Intervention C||3
5172009|NCT01195025|12720828|P1|STARTED|Third Intervention C||2
5172010|NCT01195025|12720824|P5|NOT COMPLETED|Second Intervention B||0
5172011|NCT01195025|12720825|P4|NOT COMPLETED|Second Intervention B||0
5172012|NCT01195025|12720826|P3|NOT COMPLETED|Second Intervention B||0
5172013|NCT01195025|12720827|P2|NOT COMPLETED|Second Intervention B||0
5172014|NCT01195025|12720828|P1|NOT COMPLETED|Second Intervention B||0
5172015|NCT01195025|12720824|P5|COMPLETED|Second Intervention B||1
5172016|NCT01195025|12720825|P4|COMPLETED|Second Intervention B||2
5172017|NCT01195025|12720826|P3|COMPLETED|Second Intervention B||2
5172018|NCT01195025|12720827|P2|COMPLETED|Second Intervention B||3
5172019|NCT01195025|12720828|P1|COMPLETED|Second Intervention B||2
5172020|NCT01195025|12720824|P5|STARTED|Second Intervention B||1
5172021|NCT01195025|12720825|P4|STARTED|Second Intervention B||2
5172022|NCT01195025|12720826|P3|STARTED|Second Intervention B||2
5172023|NCT01195025|12720827|P2|STARTED|Second Intervention B||3
5172024|NCT01195025|12720828|P1|STARTED|Second Intervention B||2
5172025|NCT01195025|12720824|P5|NOT COMPLETED|First Intervention A||0
5172026|NCT01195025|12720825|P4|NOT COMPLETED|First Intervention A||0
5172027|NCT01195025|12720826|P3|NOT COMPLETED|First Intervention A||0
5172028|NCT01195025|12720827|P2|NOT COMPLETED|First Intervention A||0
5172029|NCT01195025|12720828|P1|NOT COMPLETED|First Intervention A||0
5172030|NCT01195025|12720824|P5|COMPLETED|First Intervention A||1
5172031|NCT01195025|12720825|P4|COMPLETED|First Intervention A||2
5172032|NCT01195025|12720826|P3|COMPLETED|First Intervention A||2
5172033|NCT01195025|12720827|P2|COMPLETED|First Intervention A||3
5172034|NCT01195025|12720828|P1|COMPLETED|First Intervention A||2
5172035|NCT01195025|12720824|P5|STARTED|First Intervention A||1
5172036|NCT01195025|12720825|P4|STARTED|First Intervention A||2
5172037|NCT01195025|12720826|P3|STARTED|First Intervention A||2
5172038|NCT01195025|12720827|P2|STARTED|First Intervention A||3
5172039|NCT01195025|12720828|P1|STARTED|First Intervention A||2
5172040|NCT01194999|12720835|P1|NOT COMPLETED|Overall Study||17
5172041|NCT01194999|12720835|P1|COMPLETED|Overall Study||115
5172042|NCT01194999|12720835|P1|STARTED|Overall Study||132
5172043|NCT01194973|12720839|P1|NOT COMPLETED|26 Week Treatment Period||3
5172044|NCT01194973|12720839|P1|COMPLETED|26 Week Treatment Period||38
5172045|NCT01194973|12720839|P1|STARTED|26 Week Treatment Period||41
5172046|NCT01194973|12720839|P1|NOT COMPLETED|Screening Period||3
5172047|NCT01194973|12720839|P1|COMPLETED|Screening Period||41
5172048|NCT01194973|12720839|P1|STARTED|Screening Period||44
5172049|NCT01194908|12720854|P1|NOT COMPLETED|Overall Study||0
5172050|NCT01194908|12720854|P1|COMPLETED|Overall Study||5
5172051|NCT01194908|12720854|P1|STARTED|Overall Study||5
5172052|NCT01194869|12720859|P1|NOT COMPLETED|Overall Study||4
5172053|NCT01194869|12720859|P1|COMPLETED|Overall Study||21
5172054|NCT01194869|12720859|P1|STARTED|Overall Study||25
5172055|NCT01194856|12720867|P2|NOT COMPLETED|Overall Study||0
5172056|NCT01194856|12720868|P1|NOT COMPLETED|Overall Study||1
5172057|NCT01194856|12720867|P2|COMPLETED|Overall Study||0
5172058|NCT01194856|12720868|P1|COMPLETED|Overall Study||0
5172059|NCT01194856|12720867|P2|STARTED|Overall Study||0
5172060|NCT01194856|12720868|P1|STARTED|Overall Study||1
5172061|NCT01194830|12720890|P2|NOT COMPLETED|Overall Study||27
5172062|NCT01194830|12720891|P1|NOT COMPLETED|Overall Study||36
5172063|NCT01194830|12720890|P2|COMPLETED|Overall Study||83
5172064|NCT01194830|12720891|P1|COMPLETED|Overall Study||88
5172065|NCT01194830|12720890|P2|STARTED|Overall Study||110
5172066|NCT01194830|12720891|P1|STARTED|Overall Study||124
5172067|NCT01194804|12720913|P1|NOT COMPLETED|Overall Study||1
5172068|NCT01194804|12720913|P1|COMPLETED|Overall Study||26
5172069|NCT01194804|12720913|P1|STARTED|Overall Study||27
5172070|NCT01194674|12720921|P1|NOT COMPLETED|Overall Study||0
5172071|NCT01194674|12720921|P1|COMPLETED|Overall Study||2
5172072|NCT01194674|12720921|P1|STARTED|Overall Study||2
5172073|NCT01194570|12720935|P2|NOT COMPLETED|Overall Study||488
5172074|NCT01194570|12720936|P1|NOT COMPLETED|Overall Study||244
5172075|NCT01194570|12720935|P2|COMPLETED|Overall Study||0
5172076|NCT01194570|12720936|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
5172077|NCT01194570|12720935|P2|STARTED|Overall Study||488
5172078|NCT01194570|12720936|P1|STARTED|Overall Study||244
5172079|NCT01194531|12720956|P2|NOT COMPLETED|Overall Study||3
5172080|NCT01194531|12720957|P1|NOT COMPLETED|Overall Study||5
5172081|NCT01194531|12720956|P2|COMPLETED|Overall Study||27
5172082|NCT01194531|12720957|P1|COMPLETED|Overall Study||24
5172083|NCT01194531|12720956|P2|STARTED|Overall Study||30
5172084|NCT01194531|12720957|P1|STARTED|Overall Study||29
5172085|NCT01194479|12720965|P4|NOT COMPLETED|Overall Study||0
5172086|NCT01194479|12720966|P3|NOT COMPLETED|Overall Study||0
5172087|NCT01194479|12720967|P2|NOT COMPLETED|Overall Study||0
5172088|NCT01194479|12720968|P1|NOT COMPLETED|Overall Study||0
5172089|NCT01194479|12720965|P4|COMPLETED|Overall Study||5
5172090|NCT01194479|12720966|P3|COMPLETED|Overall Study||2
5172091|NCT01194479|12720967|P2|COMPLETED|Overall Study||4
5172092|NCT01194479|12720968|P1|COMPLETED|Overall Study||3
5172093|NCT01194479|12720965|P4|Cross-over at Second Visit|Overall Study||5
5172094|NCT01194479|12720966|P3|Cross-over at Second Visit|Overall Study||2
5172095|NCT01194479|12720967|P2|Cross-over at Second Visit|Overall Study||4
5172096|NCT01194479|12720968|P1|Cross-over at Second Visit|Overall Study||3
5172097|NCT01194479|12720965|P4|STARTED|Overall Study||5
5172098|NCT01194479|12720966|P3|STARTED|Overall Study||2
5172099|NCT01194479|12720967|P2|STARTED|Overall Study||4
5172100|NCT01194479|12720968|P1|STARTED|Overall Study||3
5172101|NCT01194466|12720990|P3|NOT COMPLETED|Overall Study||0
5172102|NCT01194466|12720991|P2|NOT COMPLETED|Overall Study||0
5172103|NCT01194466|12720992|P1|NOT COMPLETED|Overall Study||0
5172104|NCT01194466|12720990|P3|COMPLETED|Overall Study||13
5172105|NCT01194466|12720991|P2|COMPLETED|Overall Study||14
5172106|NCT01194466|12720992|P1|COMPLETED|Overall Study||14
5172107|NCT01194466|12720990|P3|STARTED|Overall Study||13
5172108|NCT01194466|12720991|P2|STARTED|Overall Study||14
5172109|NCT01194466|12720992|P1|STARTED|Overall Study||14
5172110|NCT01194453|12721002|P2|NOT COMPLETED|Overall Study||17
5172111|NCT01194453|12721003|P1|NOT COMPLETED|Overall Study||17
5172112|NCT01194453|12721002|P2|COMPLETED|Overall Study||127
5172113|NCT01194453|12721003|P1|COMPLETED|Overall Study||127
5172114|NCT01194453|12721002|P2|STARTED|Overall Study||144
5172115|NCT01194453|12721003|P1|STARTED|Overall Study||144
5172116|NCT01194440|12721011|P1|NOT COMPLETED|6-months (2nd Dose)||4
5172117|NCT01194440|12721011|P1|COMPLETED|6-months (2nd Dose)||48
5172118|NCT01194440|12721011|P1|STARTED|6-months (2nd Dose)||52
5172119|NCT01194440|12721011|P1|NOT COMPLETED|Baseline (First Dose)||7
5172120|NCT01194440|12721011|P1|COMPLETED|Baseline (First Dose)||52
5172121|NCT01194440|12721011|P1|STARTED|Baseline (First Dose)||59
5172122|NCT01194427|12721018|P1|NOT COMPLETED|Overall Study||0
5172123|NCT01194427|12721018|P1|COMPLETED|Overall Study||2
5172124|NCT01194427|12721018|P1|STARTED|Overall Study||2
5172125|NCT01194414|12721024|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
5172126|NCT01194414|12721025|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
5172127|NCT01194414|12721026|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
5172128|NCT01194414|12721027|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
5172129|NCT01194414|12721024|P4|COMPLETED|72 Weeks Open Label Extension||160
5172130|NCT01194414|12721025|P3|COMPLETED|72 Weeks Open Label Extension||40
5172131|NCT01194414|12721026|P2|COMPLETED|72 Weeks Open Label Extension||311
5172132|NCT01194414|12721027|P1|COMPLETED|72 Weeks Open Label Extension||445
5172133|NCT01194414|12721024|P4|STARTED|72 Weeks Open Label Extension||186
5172134|NCT01194414|12721025|P3|STARTED|72 Weeks Open Label Extension||48
5172135|NCT01194414|12721026|P2|STARTED|72 Weeks Open Label Extension||377
5172136|NCT01194414|12721027|P1|STARTED|72 Weeks Open Label Extension||524
5172137|NCT01194414|12721024|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
5172138|NCT01194414|12721025|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
5172139|NCT01194414|12721026|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
5172140|NCT01194414|12721027|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
5172141|NCT01194414|12721024|P4|COMPLETED|24 Weeks Double Blind Period||0
5172142|NCT01194414|12721025|P3|COMPLETED|24 Weeks Double Blind Period||0
5172143|NCT01194414|12721026|P2|COMPLETED|24 Weeks Double Blind Period||564
5172144|NCT01194414|12721027|P1|COMPLETED|24 Weeks Double Blind Period||572
5172145|NCT01194414|12721024|P4|Per Protocol Population|24 Weeks Double Blind Period||0
5172146|NCT01194414|12721025|P3|Per Protocol Population|24 Weeks Double Blind Period||0
5172147|NCT01194414|12721026|P2|Per Protocol Population|24 Weeks Double Blind Period||537
5172148|NCT01194414|12721027|P1|Per Protocol Population|24 Weeks Double Blind Period||558
5172149|NCT01194414|12721024|P4|STARTED|24 Weeks Double Blind Period||0
5172150|NCT01194414|12721025|P3|STARTED|24 Weeks Double Blind Period||0
5172151|NCT01194414|12721026|P2|STARTED|24 Weeks Double Blind Period||631
5172152|NCT01194414|12721027|P1|STARTED|24 Weeks Double Blind Period||631
5172153|NCT01194297|12721089|P2|NOT COMPLETED|Overall Study||0
5172154|NCT01194297|12721090|P1|NOT COMPLETED|Overall Study||0
5172155|NCT01194297|12721089|P2|COMPLETED|Overall Study||1
5172156|NCT01194297|12721090|P1|COMPLETED|Overall Study||2
5172157|NCT01194297|12721089|P2|STARTED|Overall Study||1
5172158|NCT01194297|12721090|P1|STARTED|Overall Study||2
5172159|NCT01194258|12721098|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
5172160|NCT01194258|12721099|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
5172161|NCT01194258|12721100|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
5172162|NCT01194258|12721101|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
5172163|NCT01194258|12721102|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
5172164|NCT01194258|12721098|P5|COMPLETED|Period 2 (12 Weeks)||30
5172165|NCT01194258|12721099|P4|COMPLETED|Period 2 (12 Weeks)||29
5172166|NCT01194258|12721100|P3|COMPLETED|Period 2 (12 Weeks)||29
5172167|NCT01194258|12721101|P2|COMPLETED|Period 2 (12 Weeks)||27
5172168|NCT01194258|12721102|P1|COMPLETED|Period 2 (12 Weeks)||0
5172169|NCT01194258|12721098|P5|STARTED|Period 2 (12 Weeks)||32
5172170|NCT01194258|12721099|P4|STARTED|Period 2 (12 Weeks)||29
5172171|NCT01194258|12721100|P3|STARTED|Period 2 (12 Weeks)||30
5172172|NCT01194258|12721101|P2|STARTED|Period 2 (12 Weeks)||29
5172173|NCT01194258|12721102|P1|STARTED|Period 2 (12 Weeks)||0
5172174|NCT01194258|12721098|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
5172175|NCT01194258|12721099|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
5172176|NCT01194258|12721100|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
5172177|NCT01194258|12721101|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
5172178|NCT01194258|12721102|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
5172179|NCT01194258|12721098|P5|COMPLETED|Period 1 (12 Weeks)||32
5172180|NCT01194258|12721099|P4|COMPLETED|Period 1 (12 Weeks)||29
5172181|NCT01194258|12721100|P3|COMPLETED|Period 1 (12 Weeks)||30
5172182|NCT01194258|12721101|P2|COMPLETED|Period 1 (12 Weeks)||29
5172183|NCT01194258|12721102|P1|COMPLETED|Period 1 (12 Weeks)||0
5172184|NCT01194258|12721098|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
5172185|NCT01194258|12721099|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
5172186|NCT01194258|12721100|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
5172187|NCT01194258|12721101|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
5172188|NCT01194258|12721102|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
5172189|NCT01194258|12721098|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
5172190|NCT01194258|12721099|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
5172191|NCT01194258|12721100|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
5172192|NCT01194258|12721101|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
5172193|NCT01194258|12721102|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
5172194|NCT01194258|12721098|P5|NOT COMPLETED|Titration Period||0
5172195|NCT01194258|12721099|P4|NOT COMPLETED|Titration Period||0
5172196|NCT01194258|12721100|P3|NOT COMPLETED|Titration Period||0
5172197|NCT01194258|12721101|P2|NOT COMPLETED|Titration Period||0
5172198|NCT01194258|12721102|P1|NOT COMPLETED|Titration Period||11
5172199|NCT01194258|12721098|P5|COMPLETED|Titration Period||0
5172200|NCT01194258|12721099|P4|COMPLETED|Titration Period||0
5172201|NCT01194258|12721100|P3|COMPLETED|Titration Period||0
5172202|NCT01194258|12721101|P2|COMPLETED|Titration Period||0
5172203|NCT01194258|12721102|P1|COMPLETED|Titration Period||121
5172204|NCT01194258|12721098|P5|STARTED|Titration Period||0
5172205|NCT01194258|12721099|P4|STARTED|Titration Period||0
5172206|NCT01194258|12721100|P3|STARTED|Titration Period||0
5172207|NCT01194258|12721101|P2|STARTED|Titration Period||0
5172208|NCT01194258|12721102|P1|STARTED|Titration Period||132
5172209|NCT01194245|12721126|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172210|NCT01194245|12721127|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172211|NCT01194245|12721128|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172212|NCT01194245|12721129|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172213|NCT01194245|12721130|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172214|NCT01194245|12721126|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
5172215|NCT01194245|12721127|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
5172216|NCT01194245|12721128|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
5172217|NCT01194245|12721129|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
5172218|NCT01194245|12721130|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
5172219|NCT01194245|12721126|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
5172220|NCT01194245|12721127|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
5172221|NCT01194245|12721128|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
5172222|NCT01194245|12721129|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
5172223|NCT01194245|12721130|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
5172224|NCT01194245|12721126|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
5172225|NCT01194245|12721127|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
5172226|NCT01194245|12721128|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
5172227|NCT01194245|12721129|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
5172228|NCT01194245|12721130|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
5172229|NCT01194245|12721126|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
5172230|NCT01194245|12721127|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
5172231|NCT01194245|12721128|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
5172232|NCT01194245|12721129|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
5172233|NCT01194245|12721130|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
5172234|NCT01194245|12721126|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
5172235|NCT01194245|12721127|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
5172236|NCT01194245|12721128|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
5172237|NCT01194245|12721129|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
5172238|NCT01194245|12721130|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
5172239|NCT01194245|12721126|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
5172240|NCT01194245|12721127|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
5172241|NCT01194245|12721128|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
5172242|NCT01194245|12721129|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
5172243|NCT01194245|12721130|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
5172244|NCT01194245|12721126|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
5172245|NCT01194245|12721127|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
5172246|NCT01194245|12721128|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
5172247|NCT01194245|12721129|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
5172248|NCT01194245|12721130|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
5172249|NCT01194245|12721126|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
5172250|NCT01194245|12721127|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
5172251|NCT01194245|12721128|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
5172252|NCT01194245|12721129|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
5172253|NCT01194245|12721130|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
5172254|NCT01194245|12721126|P5|STARTED|Titration Period (4 to 6 Weeks)||0
5172255|NCT01194245|12721127|P4|STARTED|Titration Period (4 to 6 Weeks)||0
5172256|NCT01194245|12721128|P3|STARTED|Titration Period (4 to 6 Weeks)||0
5172257|NCT01194245|12721129|P2|STARTED|Titration Period (4 to 6 Weeks)||0
5172258|NCT01194245|12721130|P1|STARTED|Titration Period (4 to 6 Weeks)||135
5172259|NCT01194219|12721151|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
5172260|NCT01194219|12721152|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
5172261|NCT01194219|12721153|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172262|NCT01194219|12721154|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172263|NCT01194219|12721155|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172264|NCT01194219|12721156|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172265|NCT01194219|12721157|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172266|NCT01194219|12721158|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172267|NCT01194219|12721159|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172268|NCT01194219|12721160|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172269|NCT01194219|12721151|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
5172270|NCT01194219|12721152|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
5172271|NCT01194219|12721153|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172272|NCT01194219|12721154|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172273|NCT01194219|12721155|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172274|NCT01194219|12721156|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172275|NCT01194219|12721157|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172276|NCT01194219|12721158|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172277|NCT01194219|12721159|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172278|NCT01194219|12721160|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
5172279|NCT01194219|12721151|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
5172280|NCT01194219|12721152|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
5172281|NCT01194219|12721153|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172282|NCT01194219|12721154|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172283|NCT01194219|12721155|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172284|NCT01194219|12721156|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172285|NCT01194219|12721157|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172286|NCT01194219|12721158|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172287|NCT01194219|12721159|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172288|NCT01194219|12721160|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
5172289|NCT01194219|12721151|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
5172290|NCT01194219|12721152|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
5172291|NCT01194219|12721153|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
5172292|NCT01194219|12721154|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
5172293|NCT01194219|12721155|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
5172294|NCT01194219|12721156|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
5172295|NCT01194219|12721157|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
5172296|NCT01194219|12721158|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
5172297|NCT01194219|12721159|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
5172298|NCT01194219|12721160|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
5172299|NCT01194219|12721151|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172300|NCT01194219|12721152|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172301|NCT01194219|12721153|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
5172302|NCT01194219|12721154|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
5172303|NCT01194219|12721155|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
5172304|NCT01194219|12721156|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
5172305|NCT01194219|12721157|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172306|NCT01194219|12721158|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172307|NCT01194219|12721159|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172308|NCT01194219|12721160|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172309|NCT01194219|12721151|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172310|NCT01194219|12721152|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172311|NCT01194219|12721153|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
5172312|NCT01194219|12721154|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
5172313|NCT01194219|12721155|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
5172314|NCT01194219|12721156|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
5172315|NCT01194219|12721157|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172316|NCT01194219|12721158|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172317|NCT01194219|12721159|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172318|NCT01194219|12721160|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
5172319|NCT01194219|12721151|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172320|NCT01194219|12721152|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172321|NCT01194219|12721153|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
5172322|NCT01194219|12721154|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
5172323|NCT01194219|12721155|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172324|NCT01194219|12721156|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172325|NCT01194219|12721157|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172326|NCT01194219|12721158|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172327|NCT01194219|12721159|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172328|NCT01194219|12721160|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
5172329|NCT01194219|12721151|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172330|NCT01194219|12721152|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172331|NCT01194219|12721153|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
5172332|NCT01194219|12721154|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
5172333|NCT01194219|12721155|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
5172334|NCT01194219|12721156|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
5172335|NCT01194219|12721157|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172336|NCT01194219|12721158|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172337|NCT01194219|12721159|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172338|NCT01194219|12721160|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
5172339|NCT01194219|12721151|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172340|NCT01194219|12721152|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172341|NCT01194219|12721153|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172342|NCT01194219|12721154|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172343|NCT01194219|12721155|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172344|NCT01194219|12721156|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172345|NCT01194219|12721157|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
5172346|NCT01194219|12721158|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
5172347|NCT01194219|12721159|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172348|NCT01194219|12721160|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
5172349|NCT01194219|12721151|P10|COMPLETED|Maintenance Phase Weeks16-32||0
5172350|NCT01194219|12721152|P9|COMPLETED|Maintenance Phase Weeks16-32||0
5172351|NCT01194219|12721153|P8|COMPLETED|Maintenance Phase Weeks16-32||0
5172352|NCT01194219|12721154|P7|COMPLETED|Maintenance Phase Weeks16-32||0
5172353|NCT01194219|12721155|P6|COMPLETED|Maintenance Phase Weeks16-32||0
5172354|NCT01194219|12721156|P5|COMPLETED|Maintenance Phase Weeks16-32||0
5172355|NCT01194219|12721157|P4|COMPLETED|Maintenance Phase Weeks16-32||215
5172356|NCT01194219|12721158|P3|COMPLETED|Maintenance Phase Weeks16-32||424
5172357|NCT01194219|12721159|P2|COMPLETED|Maintenance Phase Weeks16-32||0
5172358|NCT01194219|12721160|P1|COMPLETED|Maintenance Phase Weeks16-32||0
5172359|NCT01194219|12721151|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
5172360|NCT01194219|12721152|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
5172361|NCT01194219|12721153|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
5172362|NCT01194219|12721154|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
5172363|NCT01194219|12721155|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
5172364|NCT01194219|12721156|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
5172365|NCT01194219|12721157|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
5172366|NCT01194219|12721158|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
5172367|NCT01194219|12721159|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
5172368|NCT01194219|12721160|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
5172369|NCT01194219|12721151|P10|STARTED|Maintenance Phase Weeks16-32||0
5172370|NCT01194219|12721152|P9|STARTED|Maintenance Phase Weeks16-32||0
5172371|NCT01194219|12721153|P8|STARTED|Maintenance Phase Weeks16-32||0
5172372|NCT01194219|12721154|P7|STARTED|Maintenance Phase Weeks16-32||0
5172373|NCT01194219|12721155|P6|STARTED|Maintenance Phase Weeks16-32||0
5172374|NCT01194219|12721156|P5|STARTED|Maintenance Phase Weeks16-32||0
5172375|NCT01194219|12721157|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
5172376|NCT01194219|12721158|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
5172377|NCT01194219|12721159|P2|STARTED|Maintenance Phase Weeks16-32||0
5172378|NCT01194219|12721160|P1|STARTED|Maintenance Phase Weeks16-32||0
5172379|NCT01194219|12721151|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172380|NCT01194219|12721152|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172381|NCT01194219|12721153|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172382|NCT01194219|12721154|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172383|NCT01194219|12721155|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172384|NCT01194219|12721156|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172385|NCT01194219|12721157|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172386|NCT01194219|12721158|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172387|NCT01194219|12721159|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
5172388|NCT01194219|12721160|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
5172389|NCT01194219|12721151|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172390|NCT01194219|12721152|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172391|NCT01194219|12721153|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172392|NCT01194219|12721154|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172393|NCT01194219|12721155|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172394|NCT01194219|12721156|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172395|NCT01194219|12721157|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172396|NCT01194219|12721158|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
5172397|NCT01194219|12721159|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
5172398|NCT01194219|12721160|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
5172399|NCT01194219|12721151|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172400|NCT01194219|12721152|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172401|NCT01194219|12721153|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172402|NCT01194219|12721154|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172403|NCT01194219|12721155|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172404|NCT01194219|12721156|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172405|NCT01194219|12721157|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172406|NCT01194219|12721158|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
5172407|NCT01194219|12721159|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
5172408|NCT01194219|12721160|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
5172409|NCT01194219|12721151|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172410|NCT01194219|12721152|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172411|NCT01194219|12721153|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172412|NCT01194219|12721154|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172413|NCT01194219|12721155|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172414|NCT01194219|12721156|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172415|NCT01194219|12721157|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172416|NCT01194219|12721158|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
5172417|NCT01194219|12721159|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
5172418|NCT01194219|12721160|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
5172419|NCT01194154|12721194|P2|NOT COMPLETED|Overall Study||33
5172420|NCT01194154|12721195|P1|NOT COMPLETED|Overall Study||49
5172421|NCT01194154|12721194|P2|COMPLETED|Overall Study||91
5172422|NCT01194154|12721195|P1|COMPLETED|Overall Study||68
5172423|NCT01194154|12721194|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
5172424|NCT01194154|12721195|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
5172425|NCT01194154|12721194|P2|Full Analysis Set|Overall Study||120
5172426|NCT01194154|12721195|P1|Full Analysis Set|Overall Study||115
5172427|NCT01194154|12721194|P2|STARTED|Overall Study||124
5172428|NCT01194154|12721195|P1|STARTED|Overall Study||117
5172429|NCT01194089|12721215|P2|NOT COMPLETED|Overall Study||0
5172430|NCT01194089|12721216|P1|NOT COMPLETED|Overall Study||0
5172431|NCT01194089|12721215|P2|COMPLETED|Overall Study||47
5172432|NCT01194089|12721216|P1|COMPLETED|Overall Study||42
5172433|NCT01194089|12721215|P2|STARTED|Overall Study||47
5172434|NCT01194089|12721216|P1|STARTED|Overall Study||42
5172435|NCT01193920|12721236|P10|NOT COMPLETED|Overall Study||7
5172436|NCT01193920|12721237|P9|NOT COMPLETED|Overall Study||5
5172437|NCT01193920|12721238|P8|NOT COMPLETED|Overall Study||4
5172438|NCT01193920|12721239|P7|NOT COMPLETED|Overall Study||6
5172439|NCT01193920|12721240|P6|NOT COMPLETED|Overall Study||4
5172440|NCT01193920|12721241|P5|NOT COMPLETED|Overall Study||6
5172441|NCT01193920|12721242|P4|NOT COMPLETED|Overall Study||4
5172442|NCT01193920|12721243|P3|NOT COMPLETED|Overall Study||6
5172443|NCT01193920|12721244|P2|NOT COMPLETED|Overall Study||0
5172444|NCT01193920|12721245|P1|NOT COMPLETED|Overall Study||3
5172445|NCT01193920|12721236|P10|COMPLETED|Overall Study||74
5172446|NCT01193920|12721237|P9|COMPLETED|Overall Study||71
5172447|NCT01193920|12721238|P8|COMPLETED|Overall Study||76
5172448|NCT01193920|12721239|P7|COMPLETED|Overall Study||74
5172449|NCT01193920|12721240|P6|COMPLETED|Overall Study||76
5172450|NCT01193920|12721241|P5|COMPLETED|Overall Study||74
5172451|NCT01193920|12721242|P4|COMPLETED|Overall Study||76
5172452|NCT01193920|12721243|P3|COMPLETED|Overall Study||74
5172453|NCT01193920|12721244|P2|COMPLETED|Overall Study||20
5172454|NCT01193920|12721245|P1|COMPLETED|Overall Study||37
5172455|NCT01193920|12721236|P10|STARTED|Overall Study||81
5172456|NCT01193920|12721237|P9|STARTED|Overall Study||76
5172457|NCT01193920|12721238|P8|STARTED|Overall Study||80
5172458|NCT01193920|12721239|P7|STARTED|Overall Study||80
5172459|NCT01193920|12721240|P6|STARTED|Overall Study||80
5172460|NCT01193920|12721241|P5|STARTED|Overall Study||80
5172461|NCT01193920|12721242|P4|STARTED|Overall Study||80
5172462|NCT01193920|12721243|P3|STARTED|Overall Study||80
5172463|NCT01193920|12721244|P2|STARTED|Overall Study||20
5172464|NCT01193920|12721245|P1|STARTED|Overall Study||40
5172465|NCT01193907|12721299|P4|NOT COMPLETED|Overall Study||1
5172466|NCT01193907|12721300|P3|NOT COMPLETED|Overall Study||0
5172467|NCT01193907|12721301|P2|NOT COMPLETED|Overall Study||0
5172468|NCT01193907|12721302|P1|NOT COMPLETED|Overall Study||1
5172469|NCT01193907|12721299|P4|COMPLETED|Overall Study||21
5172470|NCT01193907|12721300|P3|COMPLETED|Overall Study||22
5172471|NCT01193907|12721301|P2|COMPLETED|Overall Study||22
5172472|NCT01193907|12721302|P1|COMPLETED|Overall Study||21
5172473|NCT01193907|12721299|P4|STARTED|Overall Study||22
5172474|NCT01193907|12721300|P3|STARTED|Overall Study||22
5172475|NCT01193907|12721301|P2|STARTED|Overall Study||22
5172476|NCT01193907|12721302|P1|STARTED|Overall Study||22
5172477|NCT01193868|12721324|P1|NOT COMPLETED|Overall Study||0
5172478|NCT01193868|12721324|P1|COMPLETED|Overall Study||6
5172479|NCT01193868|12721324|P1|STARTED|Overall Study||6
5172480|NCT01193842|12721341|P5|NOT COMPLETED|Phase II: Randomized Groups||10
5172481|NCT01193842|12721342|P4|NOT COMPLETED|Phase II: Randomized Groups||12
5172482|NCT01193842|12721343|P3|NOT COMPLETED|Phase II: Randomized Groups||0
5172483|NCT01193842|12721344|P2|NOT COMPLETED|Phase II: Randomized Groups||0
5172484|NCT01193842|12721345|P1|NOT COMPLETED|Phase II: Randomized Groups||0
5172485|NCT01193842|12721341|P5|COMPLETED|Phase II: Randomized Groups||36
5172486|NCT01193842|12721342|P4|COMPLETED|Phase II: Randomized Groups||33
5172487|NCT01193842|12721343|P3|COMPLETED|Phase II: Randomized Groups||0
5172488|NCT01193842|12721344|P2|COMPLETED|Phase II: Randomized Groups||0
5172489|NCT01193842|12721345|P1|COMPLETED|Phase II: Randomized Groups||0
5172490|NCT01193842|12721341|P5|STARTED|Phase II: Randomized Groups||46
5172491|NCT01193842|12721342|P4|STARTED|Phase II: Randomized Groups||45
5172492|NCT01193842|12721343|P3|STARTED|Phase II: Randomized Groups||0
5172493|NCT01193842|12721344|P2|STARTED|Phase II: Randomized Groups||0
5172494|NCT01193842|12721345|P1|STARTED|Phase II: Randomized Groups||0
5172495|NCT01193842|12721341|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
5172496|NCT01193842|12721342|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
5172497|NCT01193842|12721343|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
5172498|NCT01193842|12721344|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
5172499|NCT01193842|12721345|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
5172500|NCT01193842|12721341|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
5172501|NCT01193842|12721342|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
5172502|NCT01193842|12721343|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
5172503|NCT01193842|12721344|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
5172504|NCT01193842|12721345|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
5172505|NCT01193842|12721341|P5|STARTED|Phase I: VR-CHOP, DL 1||0
5172506|NCT01193842|12721342|P4|STARTED|Phase I: VR-CHOP, DL 1||0
5172507|NCT01193842|12721343|P3|STARTED|Phase I: VR-CHOP, DL 1||2
5172508|NCT01193842|12721344|P2|STARTED|Phase I: VR-CHOP, DL 1||0
5172509|NCT01193842|12721345|P1|STARTED|Phase I: VR-CHOP, DL 1||0
5172510|NCT01193842|12721341|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172511|NCT01193842|12721342|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172512|NCT01193842|12721343|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172513|NCT01193842|12721344|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172514|NCT01193842|12721345|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
5172515|NCT01193842|12721341|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172516|NCT01193842|12721342|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172517|NCT01193842|12721343|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172518|NCT01193842|12721344|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172519|NCT01193842|12721345|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
5172520|NCT01193842|12721341|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172521|NCT01193842|12721342|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172522|NCT01193842|12721343|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172523|NCT01193842|12721344|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
5172524|NCT01193842|12721345|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
5172525|NCT01193842|12721341|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172526|NCT01193842|12721342|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172527|NCT01193842|12721343|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172528|NCT01193842|12721344|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
5172529|NCT01193842|12721345|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172530|NCT01193842|12721341|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172531|NCT01193842|12721342|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172532|NCT01193842|12721343|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172533|NCT01193842|12721344|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
5172534|NCT01193842|12721345|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
5172535|NCT01193842|12721341|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
5172536|NCT01193842|12721342|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
5172537|NCT01193842|12721343|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
5172538|NCT01193842|12721344|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
5172539|NCT01193842|12721345|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
5172540|NCT01193842|12721341|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172541|NCT01193842|12721342|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172542|NCT01193842|12721343|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172543|NCT01193842|12721344|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172544|NCT01193842|12721345|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172545|NCT01193842|12721341|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172546|NCT01193842|12721342|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172547|NCT01193842|12721343|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172548|NCT01193842|12721344|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172549|NCT01193842|12721345|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
5172550|NCT01193842|12721341|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172551|NCT01193842|12721342|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172552|NCT01193842|12721343|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172553|NCT01193842|12721344|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
5172554|NCT01193842|12721345|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
5172555|NCT01193686|12721380|P2|NOT COMPLETED|Overall Study||1
5172556|NCT01193686|12721381|P1|NOT COMPLETED|Overall Study||7
5172557|NCT01193686|12721380|P2|COMPLETED|Overall Study||8
5172558|NCT01193686|12721381|P1|COMPLETED|Overall Study||8
5172559|NCT01193686|12721380|P2|Completed Visits and Final Assessment|Overall Study||8
5172560|NCT01193686|12721381|P1|Completed Visits and Final Assessment|Overall Study||8
5172561|NCT01193686|12721380|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
5172562|NCT01193686|12721381|P1|Completed Mentor Training|Overall Study||9
5172563|NCT01193686|12721380|P2|Completed Baseline Assessment|Overall Study||9
5172564|NCT01193686|12721381|P1|Completed Baseline Assessment|Overall Study||15
5172565|NCT01193686|12721380|P2|STARTED|Overall Study||9
5172566|NCT01193686|12721381|P1|STARTED|Overall Study||15
5172567|NCT01193660|12721398|P3|NOT COMPLETED|Overall Study||2
5172568|NCT01193660|12721399|P2|NOT COMPLETED|Overall Study||3
5172569|NCT01193660|12721400|P1|NOT COMPLETED|Overall Study||4
5172570|NCT01193660|12721398|P3|COMPLETED|Overall Study||32
5172571|NCT01193660|12721399|P2|COMPLETED|Overall Study||33
5172572|NCT01193660|12721400|P1|COMPLETED|Overall Study||31
5172573|NCT01193660|12721398|P3|STARTED|Overall Study||34
5172574|NCT01193660|12721399|P2|STARTED|Overall Study||36
5172575|NCT01193660|12721400|P1|STARTED|Overall Study||35
5172576|NCT01193608|12721444|P6|NOT COMPLETED|Overall Study||2
5172577|NCT01193608|12721445|P5|NOT COMPLETED|Overall Study||5
5172578|NCT01193608|12721446|P4|NOT COMPLETED|Overall Study||3
5172579|NCT01193608|12721447|P3|NOT COMPLETED|Overall Study||2
5172580|NCT01193608|12721448|P2|NOT COMPLETED|Overall Study||2
5172581|NCT01193608|12721449|P1|NOT COMPLETED|Overall Study||0
5172582|NCT01193608|12721444|P6|COMPLETED|Overall Study||17
5172583|NCT01193608|12721445|P5|COMPLETED|Overall Study||19
5172584|NCT01193608|12721446|P4|COMPLETED|Overall Study||14
5172585|NCT01193608|12721447|P3|COMPLETED|Overall Study||14
5172586|NCT01193608|12721448|P2|COMPLETED|Overall Study||4
5172587|NCT01193608|12721449|P1|COMPLETED|Overall Study||6
5172588|NCT01193608|12721444|P6|STARTED|Overall Study||19
5172589|NCT01193608|12721445|P5|STARTED|Overall Study||24
5172590|NCT01193608|12721446|P4|STARTED|Overall Study||17
5172591|NCT01193608|12721447|P3|STARTED|Overall Study||16
5172592|NCT01193608|12721448|P2|STARTED|Overall Study||6
5172593|NCT01193608|12721449|P1|STARTED|Overall Study||6
5172594|NCT01193582|12721686|P4|NOT COMPLETED|12 Month Follow-up||11
5172595|NCT01193582|12721687|P3|NOT COMPLETED|12 Month Follow-up||4
5172596|NCT01193582|12721688|P2|NOT COMPLETED|12 Month Follow-up||0
5172597|NCT01193582|12721689|P1|NOT COMPLETED|12 Month Follow-up||6
5172598|NCT01193582|12721686|P4|COMPLETED|12 Month Follow-up||166
5172599|NCT01193582|12721687|P3|COMPLETED|12 Month Follow-up||113
5172600|NCT01193582|12721688|P2|COMPLETED|12 Month Follow-up||88
5172601|NCT01193582|12721689|P1|COMPLETED|12 Month Follow-up||83
5172602|NCT01193582|12721686|P4|STARTED|12 Month Follow-up||177
5172603|NCT01193582|12721687|P3|STARTED|12 Month Follow-up||117
5172604|NCT01193582|12721688|P2|STARTED|12 Month Follow-up||88
5172605|NCT01193582|12721689|P1|STARTED|12 Month Follow-up||89
5172606|NCT01193582|12721686|P4|NOT COMPLETED|Vaccination Series||3
5172607|NCT01193582|12721687|P3|NOT COMPLETED|Vaccination Series||8
5172608|NCT01193582|12721688|P2|NOT COMPLETED|Vaccination Series||13
5172609|NCT01193582|12721689|P1|NOT COMPLETED|Vaccination Series||11
5172610|NCT01193582|12721686|P4|COMPLETED|Vaccination Series||177
5172611|NCT01193582|12721687|P3|COMPLETED|Vaccination Series||117
5172612|NCT01193582|12721688|P2|COMPLETED|Vaccination Series||88
5172613|NCT01193582|12721689|P1|COMPLETED|Vaccination Series||89
5172614|NCT01193582|12721686|P4|Vaccinated Dose 4|Vaccination Series||0
5172615|NCT01193582|12721687|P3|Vaccinated Dose 4|Vaccination Series||0
5172616|NCT01193582|12721688|P2|Vaccinated Dose 4|Vaccination Series||0
5172617|NCT01193582|12721689|P1|Vaccinated Dose 4|Vaccination Series||90
5172618|NCT01193582|12721686|P4|Vaccinated Dose 3|Vaccination Series||0
5172619|NCT01193582|12721687|P3|Vaccinated Dose 3|Vaccination Series||0
5172620|NCT01193582|12721688|P2|Vaccinated Dose 3|Vaccination Series||89
5172621|NCT01193582|12721689|P1|Vaccinated Dose 3|Vaccination Series||90
5172622|NCT01193582|12721686|P4|Vaccinated Dose 2|Vaccination Series||0
5172623|NCT01193582|12721687|P3|Vaccinated Dose 2|Vaccination Series||118
5172624|NCT01193582|12721688|P2|Vaccinated Dose 2|Vaccination Series||91
5172625|NCT01193582|12721689|P1|Vaccinated Dose 2|Vaccination Series||92
5172626|NCT01193582|12721686|P4|Vaccinated Dose 1|Vaccination Series||180
5172627|NCT01193582|12721687|P3|Vaccinated Dose 1|Vaccination Series||125
5172628|NCT01193582|12721688|P2|Vaccinated Dose 1|Vaccination Series||100
5172629|NCT01193582|12721689|P1|Vaccinated Dose 1|Vaccination Series||100
5172630|NCT01193582|12721686|P4|STARTED|Vaccination Series||180
5172631|NCT01193582|12721687|P3|STARTED|Vaccination Series||125
5172632|NCT01193582|12721688|P2|STARTED|Vaccination Series||101
5172633|NCT01193582|12721689|P1|STARTED|Vaccination Series||100
5172634|NCT01193556|12721719|P2|NOT COMPLETED|Overall Study||25
5172635|NCT01193556|12721720|P1|NOT COMPLETED|Overall Study||26
5172636|NCT01193556|12721719|P2|COMPLETED|Overall Study||0
5172637|NCT01193556|12721720|P1|COMPLETED|Overall Study||0
5172638|NCT01193556|12721719|P2|STARTED|Overall Study||25
5172639|NCT01193556|12721720|P1|STARTED|Overall Study||26
5172640|NCT01193530|12721730|P2|NOT COMPLETED|Overall Study||5
5172641|NCT01193530|12721731|P1|NOT COMPLETED|Overall Study||3
5172642|NCT01193530|12721730|P2|COMPLETED|Overall Study||3
5172643|NCT01193530|12721731|P1|COMPLETED|Overall Study||1
5172644|NCT01193530|12721730|P2|STARTED|Overall Study||8
5172645|NCT01193530|12721731|P1|STARTED|Overall Study||4
5172646|NCT01193517|12721740|P3|NOT COMPLETED|Overall Study||0
5172647|NCT01193517|12721741|P2|NOT COMPLETED|Overall Study||0
5172648|NCT01193517|12721742|P1|NOT COMPLETED|Overall Study||1
5172649|NCT01193517|12721740|P3|COMPLETED|Overall Study||11
5172650|NCT01193517|12721741|P2|COMPLETED|Overall Study||12
5172651|NCT01193517|12721742|P1|COMPLETED|Overall Study||2
5172652|NCT01193517|12721740|P3|STARTED|Overall Study||11
5172653|NCT01193517|12721741|P2|STARTED|Overall Study||12
5172654|NCT01193517|12721742|P1|STARTED|Overall Study||3
5172655|NCT01193348|12721751|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
5172656|NCT01193348|12721751|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
5172657|NCT01193348|12721751|P1|STARTED|Post Treatment Period (Patients Who Disc||10
5172658|NCT01193348|12721751|P1|NOT COMPLETED|Extension Treatment Period||1
5172659|NCT01193348|12721751|P1|COMPLETED|Extension Treatment Period||16
5172660|NCT01193348|12721751|P1|STARTED|Extension Treatment Period||17
5172661|NCT01193348|12721751|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
5172662|NCT01193348|12721751|P1|COMPLETED|Treatment Period (26 Weeks)||19
5172663|NCT01193348|12721751|P1|STARTED|Treatment Period (26 Weeks)||22
5172664|NCT01193348|12721751|P1|NOT COMPLETED|Screening Period||5
5172665|NCT01193348|12721751|P1|COMPLETED|Screening Period||22
5172666|NCT01193348|12721751|P1|STARTED|Screening Period||27
5172667|NCT01193335|12721771|P2|NOT COMPLETED|2-Year Follow-up||8
5172668|NCT01193335|12721772|P1|NOT COMPLETED|2-Year Follow-up||7
5172669|NCT01193335|12721771|P2|COMPLETED|2-Year Follow-up||80
5172670|NCT01193335|12721772|P1|COMPLETED|2-Year Follow-up||81
5172671|NCT01193335|12721771|P2|STARTED|2-Year Follow-up||88
5172672|NCT01193335|12721772|P1|STARTED|2-Year Follow-up||88
5172673|NCT01193335|12721771|P2|NOT COMPLETED|1-Year Follow-up||9
5172674|NCT01193335|12721772|P1|NOT COMPLETED|1-Year Follow-up||11
5172675|NCT01193335|12721771|P2|COMPLETED|1-Year Follow-up||88
5172676|NCT01193335|12721772|P1|COMPLETED|1-Year Follow-up||88
5172677|NCT01193335|12721771|P2|STARTED|1-Year Follow-up||97
5172678|NCT01193335|12721772|P1|STARTED|1-Year Follow-up||99
5172679|NCT01193335|12721771|P2|NOT COMPLETED|Toddler Dose||0
5172680|NCT01193335|12721772|P1|NOT COMPLETED|Toddler Dose||0
5172681|NCT01193335|12721771|P2|COMPLETED|Toddler Dose||97
5172682|NCT01193335|12721772|P1|COMPLETED|Toddler Dose||99
5172683|NCT01193335|12721771|P2|STARTED|Toddler Dose||97
5172684|NCT01193335|12721772|P1|STARTED|Toddler Dose||99
5172685|NCT01193335|12721771|P2|NOT COMPLETED|After Infant Series||3
5172686|NCT01193335|12721772|P1|NOT COMPLETED|After Infant Series||1
5172687|NCT01193335|12721771|P2|COMPLETED|After Infant Series||97
5172688|NCT01193335|12721772|P1|COMPLETED|After Infant Series||99
5172689|NCT01193335|12721771|P2|STARTED|After Infant Series||100
5172690|NCT01193335|12721772|P1|STARTED|After Infant Series||100
5172691|NCT01193335|12721771|P2|NOT COMPLETED|Infant Series||0
5172692|NCT01193335|12721772|P1|NOT COMPLETED|Infant Series||0
5172693|NCT01193335|12721771|P2|COMPLETED|Infant Series||100
5172694|NCT01193335|12721772|P1|COMPLETED|Infant Series||100
5172695|NCT01193335|12721771|P2|STARTED|Infant Series||100
5172696|NCT01193335|12721772|P1|STARTED|Infant Series||100
5172697|NCT01193283|12721867|P1|NOT COMPLETED|Overall Study||1
5172698|NCT01193283|12721867|P1|COMPLETED|Overall Study||21
5172699|NCT01193283|12721867|P1|STARTED|Overall Study||22
5172700|NCT01193257|12721873|P2|NOT COMPLETED|Overall Study||734
5172701|NCT01193257|12721874|P1|NOT COMPLETED|Overall Study||365
5172702|NCT01193257|12721873|P2|COMPLETED|Overall Study||0
5172703|NCT01193257|12721874|P1|COMPLETED|Overall Study||0
5172704|NCT01193257|12721873|P2|Treated|Overall Study||732
5172705|NCT01193257|12721874|P1|Treated|Overall Study||363
5172706|NCT01193257|12721873|P2|STARTED|Overall Study||734
5172707|NCT01193257|12721874|P1|STARTED|Overall Study||365
5172708|NCT01193244|12721924|P2|NOT COMPLETED|Overall Study||390
5172709|NCT01193244|12721925|P1|NOT COMPLETED|Overall Study||388
5172710|NCT01193244|12721924|P2|COMPLETED|Overall Study||391
5172711|NCT01193244|12721925|P1|COMPLETED|Overall Study||391
5172712|NCT01193244|12721924|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
5172713|NCT01193244|12721925|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
5172714|NCT01193244|12721924|P2|STARTED|Overall Study||781
5172715|NCT01193244|12721925|P1|STARTED|Overall Study||779
5172716|NCT01193218|12721980|P8|NOT COMPLETED|12-52 Weeks||4
5172717|NCT01193218|12721981|P7|NOT COMPLETED|12-52 Weeks||3
5172718|NCT01193218|12721982|P6|NOT COMPLETED|12-52 Weeks||5
5172719|NCT01193218|12721983|P5|NOT COMPLETED|12-52 Weeks||4
5172720|NCT01193218|12721984|P4|NOT COMPLETED|12-52 Weeks||3
5172721|NCT01193218|12721985|P3|NOT COMPLETED|12-52 Weeks||4
5172722|NCT01193218|12721986|P2|NOT COMPLETED|12-52 Weeks||0
5172723|NCT01193218|12721987|P1|NOT COMPLETED|12-52 Weeks||5
5172724|NCT01193218|12721980|P8|COMPLETED|12-52 Weeks||49
5172725|NCT01193218|12721981|P7|COMPLETED|12-52 Weeks||51
5172726|NCT01193218|12721982|P6|COMPLETED|12-52 Weeks||101
5172727|NCT01193218|12721983|P5|COMPLETED|12-52 Weeks||104
5172728|NCT01193218|12721984|P4|COMPLETED|12-52 Weeks||50
5172729|NCT01193218|12721985|P3|COMPLETED|12-52 Weeks||50
5172730|NCT01193218|12721986|P2|COMPLETED|12-52 Weeks||50
5172731|NCT01193218|12721987|P1|COMPLETED|12-52 Weeks||45
5172732|NCT01193218|12721980|P8|STARTED|12-52 Weeks||53
5172733|NCT01193218|12721981|P7|STARTED|12-52 Weeks||54
5172734|NCT01193218|12721982|P6|STARTED|12-52 Weeks||106
5172735|NCT01193218|12721983|P5|STARTED|12-52 Weeks||108
5172736|NCT01193218|12721984|P4|STARTED|12-52 Weeks||53
5172737|NCT01193218|12721985|P3|STARTED|12-52 Weeks||54
5172738|NCT01193218|12721986|P2|STARTED|12-52 Weeks||50
5172739|NCT01193218|12721987|P1|STARTED|12-52 Weeks||50
5172740|NCT01193218|12721980|P8|NOT COMPLETED|0-12 Weeks||0
5172741|NCT01193218|12721981|P7|NOT COMPLETED|0-12 Weeks||3
5172742|NCT01193218|12721982|P6|NOT COMPLETED|0-12 Weeks||3
5172743|NCT01193218|12721983|P5|NOT COMPLETED|0-12 Weeks||1
5172744|NCT01193218|12721984|P4|NOT COMPLETED|0-12 Weeks||0
5172745|NCT01193218|12721985|P3|NOT COMPLETED|0-12 Weeks||3
5172746|NCT01193218|12721986|P2|NOT COMPLETED|0-12 Weeks||0
5172747|NCT01193218|12721987|P1|NOT COMPLETED|0-12 Weeks||9
5172748|NCT01193218|12721980|P8|COMPLETED|0-12 Weeks||0
5172749|NCT01193218|12721981|P7|COMPLETED|0-12 Weeks||107
5172750|NCT01193218|12721982|P6|COMPLETED|0-12 Weeks||106
5172751|NCT01193218|12721983|P5|COMPLETED|0-12 Weeks||108
5172752|NCT01193218|12721984|P4|COMPLETED|0-12 Weeks||0
5172753|NCT01193218|12721985|P3|COMPLETED|0-12 Weeks||107
5172754|NCT01193218|12721986|P2|COMPLETED|0-12 Weeks||0
5172755|NCT01193218|12721987|P1|COMPLETED|0-12 Weeks||100
5172756|NCT01193218|12721980|P8|STARTED|0-12 Weeks|It is actually N/A|0
5172757|NCT01193218|12721981|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
5172758|NCT01193218|12721982|P6|STARTED|0-12 Weeks||109
5172759|NCT01193218|12721983|P5|STARTED|0-12 Weeks||109
5172760|NCT01193218|12721984|P4|STARTED|0-12 Weeks|It is actually N/A|0
5172761|NCT01193218|12721985|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
5172762|NCT01193218|12721986|P2|STARTED|0-12 Weeks|It is actually N/A|0
5172763|NCT01193218|12721987|P1|STARTED|0-12 Weeks|It is actually placebo group|109
5172764|NCT01193153|12722018|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
5172765|NCT01193153|12722019|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
5172766|NCT01193153|12722018|P2|COMPLETED|Double Blind Relapse Prevention Period||65
5172767|NCT01193153|12722019|P1|COMPLETED|Double Blind Relapse Prevention Period||100
5172768|NCT01193153|12722018|P2|STARTED|Double Blind Relapse Prevention Period||170
5172769|NCT01193153|12722019|P1|STARTED|Double Blind Relapse Prevention Period||164
5172770|NCT01193153|12722018|P2|NOT COMPLETED|Open-label Stabilization Period||0
5172771|NCT01193153|12722019|P1|NOT COMPLETED|Open-label Stabilization Period||98
5172772|NCT01193153|12722018|P2|COMPLETED|Open-label Stabilization Period||0
5172773|NCT01193153|12722019|P1|COMPLETED|Open-label Stabilization Period||334
5172774|NCT01193153|12722018|P2|STARTED|Open-label Stabilization Period||0
5172775|NCT01193153|12722019|P1|STARTED|Open-label Stabilization Period||432
5172776|NCT01193153|12722018|P2|NOT COMPLETED|Open-label Lead in Period||0
5172777|NCT01193153|12722019|P1|NOT COMPLETED|Open-label Lead in Period||235
5172778|NCT01193153|12722018|P2|COMPLETED|Open-label Lead in Period||0
5172779|NCT01193153|12722019|P1|COMPLETED|Open-label Lead in Period||432
5172780|NCT01193153|12722018|P2|STARTED|Open-label Lead in Period||0
5172781|NCT01193153|12722019|P1|STARTED|Open-label Lead in Period||667
5172782|NCT01193127|12722054|P4|NOT COMPLETED|Treated||1
5172783|NCT01193127|12722055|P3|NOT COMPLETED|Treated||0
5172784|NCT01193127|12722056|P2|NOT COMPLETED|Treated||0
5172785|NCT01193127|12722057|P1|NOT COMPLETED|Treated||0
5172786|NCT01193127|12722054|P4|COMPLETED|Treated||55
5172787|NCT01193127|12722055|P3|COMPLETED|Treated||55
5172788|NCT01193127|12722056|P2|COMPLETED|Treated||54
5172789|NCT01193127|12722057|P1|COMPLETED|Treated||57
5172790|NCT01193127|12722054|P4|STARTED|Treated||56
5172791|NCT01193127|12722055|P3|STARTED|Treated||55
5172792|NCT01193127|12722056|P2|STARTED|Treated||54
5172793|NCT01193127|12722057|P1|STARTED|Treated||57
5172794|NCT01193127|12722054|P4|NOT COMPLETED|Randomized||1
5172795|NCT01193127|12722055|P3|NOT COMPLETED|Randomized||0
5172796|NCT01193127|12722056|P2|NOT COMPLETED|Randomized||0
5172797|NCT01193127|12722057|P1|NOT COMPLETED|Randomized||0
5172798|NCT01193127|12722054|P4|COMPLETED|Randomized||56
5172799|NCT01193127|12722055|P3|COMPLETED|Randomized||55
5172800|NCT01193127|12722056|P2|COMPLETED|Randomized||54
5172801|NCT01193127|12722057|P1|COMPLETED|Randomized||57
5172802|NCT01193127|12722054|P4|STARTED|Randomized||57
5172803|NCT01193127|12722055|P3|STARTED|Randomized||55
5172804|NCT01193127|12722056|P2|STARTED|Randomized||54
5172805|NCT01193127|12722057|P1|STARTED|Randomized||57
5172806|NCT01193114|12722361|P2|NOT COMPLETED|Overall Study||0
5172807|NCT01193114|12722362|P1|NOT COMPLETED|Overall Study||0
5172808|NCT01193114|12722361|P2|COMPLETED|Overall Study||30
5172809|NCT01193114|12722362|P1|COMPLETED|Overall Study||30
5172810|NCT01193114|12722361|P2|STARTED|Overall Study||30
5172811|NCT01193114|12722362|P1|STARTED|Overall Study||30
5172812|NCT01193101|12722382|P4|NOT COMPLETED|Overall Study||12
5172813|NCT01193101|12722383|P3|NOT COMPLETED|Overall Study||3
5172814|NCT01193101|12722384|P2|NOT COMPLETED|Overall Study||7
5172815|NCT01193101|12722385|P1|NOT COMPLETED|Overall Study||5
5172816|NCT01193101|12722382|P4|COMPLETED|Overall Study||80
5172817|NCT01193101|12722383|P3|COMPLETED|Overall Study||93
5172818|NCT01193101|12722384|P2|COMPLETED|Overall Study||94
5172819|NCT01193101|12722385|P1|COMPLETED|Overall Study||95
5172820|NCT01193101|12722382|P4|Placebo Withdrawal Set|Overall Study||80
5172821|NCT01193101|12722383|P3|Placebo Withdrawal Set|Overall Study||93
5172822|NCT01193101|12722384|P2|Placebo Withdrawal Set|Overall Study||94
5172823|NCT01193101|12722385|P1|Placebo Withdrawal Set|Overall Study||95
5172824|NCT01193101|12722382|P4|Full Analysis Set|Overall Study||92
5172825|NCT01193101|12722383|P3|Full Analysis Set|Overall Study||96
5172826|NCT01193101|12722384|P2|Full Analysis Set|Overall Study||101
5172827|NCT01193101|12722385|P1|Full Analysis Set|Overall Study||100
5172828|NCT01193101|12722382|P4|STARTED|Overall Study||92
5172829|NCT01193101|12722383|P3|STARTED|Overall Study||96
5172830|NCT01193101|12722384|P2|STARTED|Overall Study||101
5172831|NCT01193101|12722385|P1|STARTED|Overall Study||100
5172832|NCT01193049|12722441|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
5172833|NCT01193049|12722442|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
5172834|NCT01193049|12722441|P2|COMPLETED|Period 3 : Double Blind Crossover||6
5172835|NCT01193049|12722442|P1|COMPLETED|Period 3 : Double Blind Crossover||5
5172836|NCT01193049|12722441|P2|STARTED|Period 3 : Double Blind Crossover||6
5172837|NCT01193049|12722442|P1|STARTED|Period 3 : Double Blind Crossover||5
5172838|NCT01193049|12722441|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
5172839|NCT01193049|12722442|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
5172840|NCT01193049|12722441|P2|COMPLETED|Washout 2 : 21 Day Washout||6
5172841|NCT01193049|12722442|P1|COMPLETED|Washout 2 : 21 Day Washout||5
5172842|NCT01193049|12722441|P2|STARTED|Washout 2 : 21 Day Washout||6
5172843|NCT01193049|12722442|P1|STARTED|Washout 2 : 21 Day Washout||5
5172844|NCT01193049|12722441|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
5172845|NCT01193049|12722442|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
5172846|NCT01193049|12722441|P2|COMPLETED|Period 2 : Double Blind Crossover||6
5172847|NCT01193049|12722442|P1|COMPLETED|Period 2 : Double Blind Crossover||5
5172848|NCT01193049|12722441|P2|STARTED|Period 2 : Double Blind Crossover||6
5172849|NCT01193049|12722442|P1|STARTED|Period 2 : Double Blind Crossover||5
5172850|NCT01193049|12722441|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
5172851|NCT01193049|12722442|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
5172852|NCT01193049|12722441|P2|COMPLETED|Washout 1 : 21 Day Washout||6
5172853|NCT01193049|12722442|P1|COMPLETED|Washout 1 : 21 Day Washout||5
5172854|NCT01193049|12722441|P2|STARTED|Washout 1 : 21 Day Washout||6
5172855|NCT01193049|12722442|P1|STARTED|Washout 1 : 21 Day Washout||5
5172856|NCT01193049|12722441|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
5172857|NCT01193049|12722442|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
5172858|NCT01193049|12722441|P2|COMPLETED|Period 1: Placebo Run-In||6
5172859|NCT01193049|12722442|P1|COMPLETED|Period 1: Placebo Run-In||5
5172860|NCT01193049|12722441|P2|STARTED|Period 1: Placebo Run-In||6
5172861|NCT01193049|12722442|P1|STARTED|Period 1: Placebo Run-In||5
5172862|NCT01193010|12722474|P2|NOT COMPLETED|Overall Study||0
5172863|NCT01193010|12722475|P1|NOT COMPLETED|Overall Study||3
5172864|NCT01193010|12722474|P2|COMPLETED|Overall Study||20
5172865|NCT01193010|12722475|P1|COMPLETED|Overall Study||17
5172866|NCT01193010|12722474|P2|STARTED|Overall Study||20
5172867|NCT01193010|12722475|P1|STARTED|Overall Study||20
5172868|NCT01192828|12722487|P1|NOT COMPLETED|Overall Study||0
5172869|NCT01192828|12722487|P1|COMPLETED|Overall Study||14
5172870|NCT01192828|12722487|P1|STARTED|Overall Study||14
5172871|NCT01192815|12722502|P1|NOT COMPLETED|Overall Study||2
5172872|NCT01192815|12722502|P1|COMPLETED|Overall Study||0
5172873|NCT01192815|12722502|P1|STARTED|Overall Study||2
5172874|NCT01192776|12722517|P4|NOT COMPLETED|Overall Study||20
5172875|NCT01192776|12722518|P3|NOT COMPLETED|Overall Study||21
5172876|NCT01192776|12722519|P2|NOT COMPLETED|Overall Study||21
5172877|NCT01192776|12722520|P1|NOT COMPLETED|Overall Study||11
5172878|NCT01192776|12722517|P4|COMPLETED|Overall Study||63
5172879|NCT01192776|12722518|P3|COMPLETED|Overall Study||75
5172880|NCT01192776|12722519|P2|COMPLETED|Overall Study||69
5172881|NCT01192776|12722520|P1|COMPLETED|Overall Study||84
5172882|NCT01192776|12722517|P4|Died After Discharge|Overall Study||1
5172883|NCT01192776|12722518|P3|Died After Discharge|Overall Study||3
5172884|NCT01192776|12722519|P2|Died After Discharge|Overall Study||2
5172885|NCT01192776|12722520|P1|Died After Discharge|Overall Study||1
5172886|NCT01192776|12722517|P4|Died Prior to Discharge|Overall Study||14
5172887|NCT01192776|12722518|P3|Died Prior to Discharge|Overall Study||15
5172888|NCT01192776|12722519|P2|Died Prior to Discharge|Overall Study||13
5172889|NCT01192776|12722520|P1|Died Prior to Discharge|Overall Study||7
5172890|NCT01192776|12722517|P4|STARTED|Overall Study||83
5172891|NCT01192776|12722518|P3|STARTED|Overall Study||96
5172892|NCT01192776|12722519|P2|STARTED|Overall Study||90
5172893|NCT01192776|12722520|P1|STARTED|Overall Study||95
5172894|NCT01192698|12722576|P2|NOT COMPLETED|Overall Study||0
5172895|NCT01192698|12722577|P1|NOT COMPLETED|Overall Study||0
5172896|NCT01192698|12722576|P2|COMPLETED|Overall Study||5
5172897|NCT01192698|12722577|P1|COMPLETED|Overall Study||10
5172898|NCT01192698|12722576|P2|STARTED|Overall Study||5
5172899|NCT01192698|12722577|P1|STARTED|Overall Study||10
5172900|NCT01192542|12722583|P2|NOT COMPLETED|Period 2||0
5172901|NCT01192542|12722584|P1|NOT COMPLETED|Period 2||0
5172902|NCT01192542|12722583|P2|COMPLETED|Period 2||20
5172903|NCT01192542|12722584|P1|COMPLETED|Period 2||18
5172904|NCT01192542|12722583|P2|STARTED|Period 2||20
5172905|NCT01192542|12722584|P1|STARTED|Period 2||18
5172906|NCT01192542|12722583|P2|NOT COMPLETED|Period 1||0
5172907|NCT01192542|12722584|P1|NOT COMPLETED|Period 1||0
5172908|NCT01192542|12722583|P2|COMPLETED|Period 1||20
5172909|NCT01192542|12722584|P1|COMPLETED|Period 1||18
5172910|NCT01192542|12722583|P2|STARTED|Period 1||20
5172911|NCT01192542|12722584|P1|STARTED|Period 1||18
5172912|NCT01192516|12722598|P3|NOT COMPLETED|Overall Study||8
5172913|NCT01192516|12722599|P2|NOT COMPLETED|Overall Study||17
5172914|NCT01192516|12722600|P1|NOT COMPLETED|Overall Study||20
5172915|NCT01192516|12722598|P3|COMPLETED|Overall Study||55
5172916|NCT01192516|12722599|P2|COMPLETED|Overall Study||49
5172917|NCT01192516|12722600|P1|COMPLETED|Overall Study||46
5172918|NCT01192516|12722598|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
5172919|NCT01192516|12722599|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
5172920|NCT01192516|12722600|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
5172921|NCT01192412|12722634|P2|NOT COMPLETED|Overall Study||2
5172922|NCT01192412|12722635|P1|NOT COMPLETED|Overall Study||4
5172923|NCT01192412|12722634|P2|COMPLETED|Overall Study||488
5172924|NCT01192412|12722635|P1|COMPLETED|Overall Study||493
5172925|NCT01192412|12722634|P2|STARTED|Overall Study||490
5172926|NCT01192412|12722635|P1|STARTED|Overall Study||497
5172927|NCT01192399|12722643|P1|NOT COMPLETED|Overall Study||2
5172928|NCT01192399|12722643|P1|COMPLETED|Overall Study||27
5172929|NCT01192399|12722643|P1|STARTED|Overall Study||29
5172930|NCT01192347|12722653|P1|NOT COMPLETED|Overall Study||12
5172931|NCT01192347|12722653|P1|COMPLETED|Overall Study||163
5172932|NCT01192347|12722653|P1|STARTED|Overall Study||175
5172933|NCT01192295|12722676|P2|NOT COMPLETED|Overall Study||23
5172934|NCT01192295|12722677|P1|NOT COMPLETED|Overall Study||10
5172935|NCT01192295|12722676|P2|COMPLETED|Overall Study||105
5172936|NCT01192295|12722677|P1|COMPLETED|Overall Study||17
5172937|NCT01192295|12722676|P2|STARTED|Overall Study||128
5172938|NCT01192295|12722677|P1|STARTED|Overall Study||27
5172939|NCT01192282|12722698|P1|NOT COMPLETED|Overall Study||0
5172940|NCT01192282|12722698|P1|COMPLETED|Overall Study||156
5172941|NCT01192282|12722698|P1|STARTED|Overall Study||156
5172942|NCT01192204|12722715|P2|NOT COMPLETED|Overall Study||0
5172943|NCT01192204|12722716|P1|NOT COMPLETED|Overall Study||1
5172944|NCT01192204|12722715|P2|COMPLETED|Overall Study||18
5172945|NCT01192204|12722716|P1|COMPLETED|Overall Study||22
5172946|NCT01192204|12722715|P2|STARTED|Overall Study||18
5172947|NCT01192204|12722716|P1|STARTED|Overall Study||23
5172948|NCT01192191|12722728|P2|NOT COMPLETED|Overall Study||21
5172949|NCT01192191|12722729|P1|NOT COMPLETED|Overall Study||11
5172950|NCT01192191|12722728|P2|COMPLETED|Overall Study||106
5172951|NCT01192191|12722729|P1|COMPLETED|Overall Study||49
5172952|NCT01192191|12722728|P2|STARTED|Overall Study||127
5172953|NCT01192191|12722729|P1|STARTED|Overall Study||60
5172954|NCT01192178|12722755|P2|NOT COMPLETED|Overall Study||23
5172955|NCT01192178|12722756|P1|NOT COMPLETED|Overall Study||24
5172956|NCT01192178|12722755|P2|COMPLETED|Overall Study||145
5172957|NCT01192178|12722756|P1|COMPLETED|Overall Study||147
5172958|NCT01192178|12722755|P2|STARTED|Overall Study||168
5172959|NCT01192178|12722756|P1|STARTED|Overall Study||171
5172960|NCT01192152|12722776|P2|NOT COMPLETED|Period 3||0
5172961|NCT01192152|12722777|P1|NOT COMPLETED|Period 3||1
5172962|NCT01192152|12722776|P2|COMPLETED|Period 3||0
5172963|NCT01192152|12722777|P1|COMPLETED|Period 3||14
5172964|NCT01192152|12722776|P2|STARTED|Period 3||0
5172965|NCT01192152|12722777|P1|STARTED|Period 3||15
5172966|NCT01192152|12722776|P2|NOT COMPLETED|Period 2||0
5172967|NCT01192152|12722777|P1|NOT COMPLETED|Period 2||0
5172968|NCT01192152|12722776|P2|COMPLETED|Period 2||14
5172969|NCT01192152|12722777|P1|COMPLETED|Period 2||15
5172970|NCT01192152|12722776|P2|STARTED|Period 2||14
5172971|NCT01192152|12722777|P1|STARTED|Period 2||15
5172972|NCT01192152|12722776|P2|NOT COMPLETED|Period 1||1
5172973|NCT01192152|12722777|P1|NOT COMPLETED|Period 1||0
5172974|NCT01192152|12722776|P2|COMPLETED|Period 1||14
5172975|NCT01192152|12722777|P1|COMPLETED|Period 1||15
5172976|NCT01192152|12722776|P2|STARTED|Period 1||15
5172977|NCT01192152|12722777|P1|STARTED|Period 1||15
5172978|NCT01192139|12722878|P6|NOT COMPLETED|Period 3||0
5172979|NCT01192139|12722879|P5|NOT COMPLETED|Period 3||0
5172980|NCT01192139|12722880|P4|NOT COMPLETED|Period 3||0
5172981|NCT01192139|12722881|P3|NOT COMPLETED|Period 3||0
5172982|NCT01192139|12722882|P2|NOT COMPLETED|Period 3||0
5172983|NCT01192139|12722883|P1|NOT COMPLETED|Period 3||0
5172984|NCT01192139|12722878|P6|COMPLETED|Period 3||5
5172985|NCT01192139|12722879|P5|COMPLETED|Period 3||5
5172986|NCT01192139|12722880|P4|COMPLETED|Period 3||5
5172987|NCT01192139|12722881|P3|COMPLETED|Period 3||5
5172988|NCT01192139|12722882|P2|COMPLETED|Period 3||5
5172989|NCT01192139|12722883|P1|COMPLETED|Period 3||5
5172990|NCT01192139|12722878|P6|STARTED|Period 3||5
5172991|NCT01192139|12722879|P5|STARTED|Period 3||5
5172992|NCT01192139|12722880|P4|STARTED|Period 3||5
5172993|NCT01192139|12722881|P3|STARTED|Period 3||5
5172994|NCT01192139|12722882|P2|STARTED|Period 3||5
5172995|NCT01192139|12722883|P1|STARTED|Period 3||5
5172996|NCT01192139|12722878|P6|NOT COMPLETED|Period 2||0
5172997|NCT01192139|12722879|P5|NOT COMPLETED|Period 2||0
5172998|NCT01192139|12722880|P4|NOT COMPLETED|Period 2||0
5172999|NCT01192139|12722881|P3|NOT COMPLETED|Period 2||0
5173000|NCT01192139|12722882|P2|NOT COMPLETED|Period 2||0
5173001|NCT01192139|12722883|P1|NOT COMPLETED|Period 2||0
5173002|NCT01192139|12722878|P6|COMPLETED|Period 2||5
5173003|NCT01192139|12722879|P5|COMPLETED|Period 2||5
5173004|NCT01192139|12722880|P4|COMPLETED|Period 2||5
5173005|NCT01192139|12722881|P3|COMPLETED|Period 2||5
5173006|NCT01192139|12722882|P2|COMPLETED|Period 2||5
5173007|NCT01192139|12722883|P1|COMPLETED|Period 2||5
5173008|NCT01192139|12722878|P6|STARTED|Period 2||5
5173009|NCT01192139|12722879|P5|STARTED|Period 2||5
5173010|NCT01192139|12722880|P4|STARTED|Period 2||5
5173011|NCT01192139|12722881|P3|STARTED|Period 2||5
5173012|NCT01192139|12722882|P2|STARTED|Period 2||5
5173013|NCT01192139|12722883|P1|STARTED|Period 2||5
5173014|NCT01192139|12722878|P6|NOT COMPLETED|Period 1||0
5173015|NCT01192139|12722879|P5|NOT COMPLETED|Period 1||0
5173016|NCT01192139|12722880|P4|NOT COMPLETED|Period 1||0
5173017|NCT01192139|12722881|P3|NOT COMPLETED|Period 1||0
5173018|NCT01192139|12722882|P2|NOT COMPLETED|Period 1||0
5173019|NCT01192139|12722883|P1|NOT COMPLETED|Period 1||0
5173020|NCT01192139|12722878|P6|COMPLETED|Period 1||5
5173021|NCT01192139|12722879|P5|COMPLETED|Period 1||5
5173022|NCT01192139|12722880|P4|COMPLETED|Period 1||5
5173023|NCT01192139|12722881|P3|COMPLETED|Period 1||5
5173024|NCT01192139|12722882|P2|COMPLETED|Period 1||5
5173025|NCT01192139|12722883|P1|COMPLETED|Period 1||5
5173026|NCT01192139|12722878|P6|STARTED|Period 1||5
5173027|NCT01192139|12722879|P5|STARTED|Period 1||5
5173028|NCT01192139|12722880|P4|STARTED|Period 1||5
5173029|NCT01192139|12722881|P3|STARTED|Period 1||5
5173030|NCT01192139|12722882|P2|STARTED|Period 1||5
5173031|NCT01192139|12722883|P1|STARTED|Period 1||5
5173032|NCT01192126|12722948|P2|NOT COMPLETED|Second Intervention (1 Week)||0
5173033|NCT01192126|12722949|P1|NOT COMPLETED|Second Intervention (1 Week)||0
5173034|NCT01192126|12722948|P2|COMPLETED|Second Intervention (1 Week)||50
5173035|NCT01192126|12722949|P1|COMPLETED|Second Intervention (1 Week)||49
5173036|NCT01192126|12722948|P2|STARTED|Second Intervention (1 Week)||50
5173037|NCT01192126|12722949|P1|STARTED|Second Intervention (1 Week)||49
5173038|NCT01192126|12722948|P2|NOT COMPLETED|First Intervention (1 Week)||1
5173039|NCT01192126|12722949|P1|NOT COMPLETED|First Intervention (1 Week)||2
5173040|NCT01192126|12722948|P2|COMPLETED|First Intervention (1 Week)||50
5173041|NCT01192126|12722949|P1|COMPLETED|First Intervention (1 Week)||49
5173042|NCT01192126|12722948|P2|STARTED|First Intervention (1 Week)||51
5173043|NCT01192126|12722949|P1|STARTED|First Intervention (1 Week)||51
5173044|NCT01192100|12722957|P6|NOT COMPLETED|Overall Study||0
5173045|NCT01192100|12722958|P5|NOT COMPLETED|Overall Study||1
5173046|NCT01192100|12722959|P4|NOT COMPLETED|Overall Study||1
5173047|NCT01192100|12722960|P3|NOT COMPLETED|Overall Study||0
5173048|NCT01192100|12722961|P2|NOT COMPLETED|Overall Study||0
5173049|NCT01192100|12722962|P1|NOT COMPLETED|Overall Study||0
5173050|NCT01192100|12722957|P6|COMPLETED|Overall Study||2
5173051|NCT01192100|12722958|P5|COMPLETED|Overall Study||2
5173052|NCT01192100|12722959|P4|COMPLETED|Overall Study||3
5173053|NCT01192100|12722960|P3|COMPLETED|Overall Study||3
5173054|NCT01192100|12722961|P2|COMPLETED|Overall Study||4
5173055|NCT01192100|12722962|P1|COMPLETED|Overall Study||6
5173056|NCT01192100|12722957|P6|Began 3rd Intervention Week|Overall Study||2
5173057|NCT01192100|12722958|P5|Began 3rd Intervention Week|Overall Study||2
5173058|NCT01192100|12722959|P4|Began 3rd Intervention Week|Overall Study||3
5173059|NCT01192100|12722960|P3|Began 3rd Intervention Week|Overall Study||3
5173060|NCT01192100|12722961|P2|Began 3rd Intervention Week|Overall Study||4
5173061|NCT01192100|12722962|P1|Began 3rd Intervention Week|Overall Study||6
5173062|NCT01192100|12722957|P6|Began 2nd Intervention Week|Overall Study||2
5173063|NCT01192100|12722958|P5|Began 2nd Intervention Week|Overall Study||2
5173064|NCT01192100|12722959|P4|Began 2nd Intervention Week|Overall Study||3
5173065|NCT01192100|12722960|P3|Began 2nd Intervention Week|Overall Study||3
5173066|NCT01192100|12722961|P2|Began 2nd Intervention Week|Overall Study||4
5173067|NCT01192100|12722962|P1|Began 2nd Intervention Week|Overall Study||6
5173068|NCT01192100|12722957|P6|Began 1st Intervention Week|Overall Study||2
5173069|NCT01192100|12722958|P5|Began 1st Intervention Week|Overall Study||3
5173070|NCT01192100|12722959|P4|Began 1st Intervention Week|Overall Study||4
5173071|NCT01192100|12722960|P3|Began 1st Intervention Week|Overall Study||3
5173072|NCT01192100|12722961|P2|Began 1st Intervention Week|Overall Study||4
5173073|NCT01192100|12722962|P1|Began 1st Intervention Week|Overall Study||6
5173074|NCT01192100|12722957|P6|STARTED|Overall Study||2
5173075|NCT01192100|12722958|P5|STARTED|Overall Study||3
5173076|NCT01192100|12722959|P4|STARTED|Overall Study||4
5173077|NCT01192100|12722960|P3|STARTED|Overall Study||3
5173078|NCT01192100|12722961|P2|STARTED|Overall Study||4
5173079|NCT01192100|12722962|P1|STARTED|Overall Study||6
5173080|NCT01192022|12722982|P5|NOT COMPLETED|Overall Study||1
5173081|NCT01192022|12722983|P4|NOT COMPLETED|Overall Study||2
5173082|NCT01192022|12722984|P3|NOT COMPLETED|Overall Study||1
5173083|NCT01192022|12722985|P2|NOT COMPLETED|Overall Study||11
5173084|NCT01192022|12722986|P1|NOT COMPLETED|Overall Study||13
5173085|NCT01192022|12722982|P5|COMPLETED|Overall Study||11
5173086|NCT01192022|12722983|P4|COMPLETED|Overall Study||7
5173087|NCT01192022|12722984|P3|COMPLETED|Overall Study||7
5173088|NCT01192022|12722985|P2|COMPLETED|Overall Study||99
5173089|NCT01192022|12722986|P1|COMPLETED|Overall Study||101
5173090|NCT01192022|12722982|P5|Safety Population-Received Treatment|Overall Study||12
5173091|NCT01192022|12722983|P4|Safety Population-Received Treatment|Overall Study||9
5173092|NCT01192022|12722984|P3|Safety Population-Received Treatment|Overall Study||8
5173093|NCT01192022|12722985|P2|Safety Population-Received Treatment|Overall Study||109
5173094|NCT01192022|12722986|P1|Safety Population-Received Treatment|Overall Study||114
5173095|NCT01192022|12722982|P5|STARTED|Overall Study||12
5173096|NCT01192022|12722983|P4|STARTED|Overall Study||9
5173097|NCT01192022|12722984|P3|STARTED|Overall Study||8
5173098|NCT01192022|12722985|P2|STARTED|Overall Study||110
5173099|NCT01192022|12722986|P1|STARTED|Overall Study||114
5173100|NCT01191944|12723009|P2|NOT COMPLETED|Overall Study||19
5173101|NCT01191944|12723010|P1|NOT COMPLETED|Overall Study||17
5173102|NCT01191944|12723009|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
5173103|NCT01191944|12723010|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
5173104|NCT01191944|12723009|P2|STARTED|Overall Study|Treated titration/maintenance|239
5173105|NCT01191944|12723010|P1|STARTED|Overall Study|Treated titration/maintenance|234
5173106|NCT01191840|12723056|P2|NOT COMPLETED|Overall Study||15
5173107|NCT01191840|12723057|P1|NOT COMPLETED|Overall Study||14
5173108|NCT01191840|12723056|P2|COMPLETED|Overall Study||240
5173109|NCT01191840|12723057|P1|COMPLETED|Overall Study||240
5173110|NCT01191840|12723056|P2|STARTED|Overall Study||255
5173111|NCT01191840|12723057|P1|STARTED|Overall Study||254
5173112|NCT01191827|12723073|P2|NOT COMPLETED|Overall Study||0
5173113|NCT01191827|12723074|P1|NOT COMPLETED|Overall Study||0
5173114|NCT01191827|12723073|P2|COMPLETED|Overall Study||20
5173115|NCT01191827|12723074|P1|COMPLETED|Overall Study||20
5173116|NCT01191827|12723073|P2|STARTED|Overall Study||20
5173117|NCT01191827|12723074|P1|STARTED|Overall Study||20
5173118|NCT01191801|12723082|P2|NOT COMPLETED|Overall Study||337
5173119|NCT01191801|12723083|P1|NOT COMPLETED|Overall Study||316
5173120|NCT01191801|12723082|P2|COMPLETED|Overall Study||18
5173121|NCT01191801|12723083|P1|COMPLETED|Overall Study||40
5173122|NCT01191801|12723082|P2|STARTED|Overall Study||355
5173123|NCT01191801|12723083|P1|STARTED|Overall Study||356
5173124|NCT01191788|12723103|P2|NOT COMPLETED|Overall Study||22
5173125|NCT01191788|12723104|P1|NOT COMPLETED|Overall Study||21
5173126|NCT01191788|12723103|P2|COMPLETED|Overall Study|Completed 3-month followup|137
5173127|NCT01191788|12723104|P1|COMPLETED|Overall Study|Completed 3-month followup|119
5173128|NCT01191788|12723103|P2|STARTED|Overall Study||159
5173129|NCT01191788|12723104|P1|STARTED|Overall Study||140
5173130|NCT01191762|12723114|P2|NOT COMPLETED|Overall Study||0
5173131|NCT01191762|12723115|P1|NOT COMPLETED|Overall Study||1
5173132|NCT01191762|12723114|P2|COMPLETED|Overall Study||15
5173133|NCT01191762|12723115|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
5173134|NCT01191762|12723114|P2|STARTED|Overall Study||15
5173135|NCT01191762|12723115|P1|STARTED|Overall Study||15
5173136|NCT01191749|12723121|P1|NOT COMPLETED|Overall Study||0
5173137|NCT01191749|12723121|P1|COMPLETED|Overall Study||7
5173138|NCT01191749|12723121|P1|STARTED|Overall Study||7
5173139|NCT01191736|12723132|P7|NOT COMPLETED|Overall Study||0
5173140|NCT01191736|12723133|P6|NOT COMPLETED|Overall Study||0
5173141|NCT01191736|12723134|P5|NOT COMPLETED|Overall Study||0
5173142|NCT01191736|12723135|P4|NOT COMPLETED|Overall Study||0
5173143|NCT01191736|12723136|P3|NOT COMPLETED|Overall Study||0
5173144|NCT01191736|12723137|P2|NOT COMPLETED|Overall Study||0
5173145|NCT01191736|12723138|P1|NOT COMPLETED|Overall Study||0
5173146|NCT01191736|12723132|P7|COMPLETED|Overall Study||45
5173147|NCT01191736|12723133|P6|COMPLETED|Overall Study||50
5173148|NCT01191736|12723134|P5|COMPLETED|Overall Study||48
5173149|NCT01191736|12723135|P4|COMPLETED|Overall Study||46
5173150|NCT01191736|12723136|P3|COMPLETED|Overall Study||49
5173151|NCT01191736|12723137|P2|COMPLETED|Overall Study||47
5173152|NCT01191736|12723138|P1|COMPLETED|Overall Study||51
5173153|NCT01191736|12723132|P7|STARTED|Overall Study||45
5173154|NCT01191736|12723133|P6|STARTED|Overall Study||50
5173155|NCT01191736|12723134|P5|STARTED|Overall Study||48
5173156|NCT01191736|12723135|P4|STARTED|Overall Study||46
5173157|NCT01191736|12723136|P3|STARTED|Overall Study||49
5173158|NCT01191736|12723137|P2|STARTED|Overall Study||47
5173159|NCT01191736|12723138|P1|STARTED|Overall Study||51
5173160|NCT01191723|12723161|P6|NOT COMPLETED|Overall Study||0
5173161|NCT01191723|12723162|P5|NOT COMPLETED|Overall Study||0
5173162|NCT01191723|12723163|P4|NOT COMPLETED|Overall Study||0
5173163|NCT01191723|12723164|P3|NOT COMPLETED|Overall Study||0
5173164|NCT01191723|12723165|P2|NOT COMPLETED|Overall Study||0
5173165|NCT01191723|12723166|P1|NOT COMPLETED|Overall Study||0
5173166|NCT01191723|12723161|P6|COMPLETED|Overall Study||9
5173167|NCT01191723|12723162|P5|COMPLETED|Overall Study||9
5173168|NCT01191723|12723163|P4|COMPLETED|Overall Study||9
5173169|NCT01191723|12723164|P3|COMPLETED|Overall Study||9
5173170|NCT01191723|12723165|P2|COMPLETED|Overall Study||9
5173171|NCT01191723|12723166|P1|COMPLETED|Overall Study||9
5173172|NCT01191723|12723161|P6|STARTED|Overall Study||9
5173173|NCT01191723|12723162|P5|STARTED|Overall Study||9
5173174|NCT01191723|12723163|P4|STARTED|Overall Study||9
5173175|NCT01191723|12723164|P3|STARTED|Overall Study||9
5173176|NCT01191723|12723165|P2|STARTED|Overall Study||9
5173177|NCT01191723|12723166|P1|STARTED|Overall Study||9
5173178|NCT01191476|12723187|P3|NOT COMPLETED|Overall Study||0
5173179|NCT01191476|12723188|P2|NOT COMPLETED|Overall Study||4
5173180|NCT01191476|12723189|P1|NOT COMPLETED|Overall Study||3
5173181|NCT01191476|12723187|P3|COMPLETED|Overall Study||111
5173182|NCT01191476|12723188|P2|COMPLETED|Overall Study||107
5173183|NCT01191476|12723189|P1|COMPLETED|Overall Study||109
5173184|NCT01191476|12723187|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
5173185|NCT01191476|12723188|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
5173186|NCT01191476|12723189|P1|STARTED|Overall Study||112
5173187|NCT01191411|12723212|P3|NOT COMPLETED|Overall Study||3427
5173188|NCT01191411|12723213|P2|NOT COMPLETED|Overall Study||361
5173189|NCT01191411|12723214|P1|NOT COMPLETED|Overall Study||945
5173190|NCT01191411|12723212|P3|COMPLETED|Overall Study||471
5173191|NCT01191411|12723213|P2|COMPLETED|Overall Study||118
5173192|NCT01191411|12723214|P1|COMPLETED|Overall Study||648
5173193|NCT01191411|12723212|P3|STARTED|Overall Study||3898
5173194|NCT01191411|12723213|P2|STARTED|Overall Study||479
5173195|NCT01191411|12723214|P1|STARTED|Overall Study||1593
5173196|NCT01191398|12723225|P3|NOT COMPLETED|Overall Study||0
5173197|NCT01191398|12723226|P2|NOT COMPLETED|Overall Study||0
5173198|NCT01191398|12723227|P1|NOT COMPLETED|Overall Study||0
5173199|NCT01191398|12723225|P3|COMPLETED|Overall Study||18
5173200|NCT01191398|12723226|P2|COMPLETED|Overall Study||17
5173201|NCT01191398|12723227|P1|COMPLETED|Overall Study||17
5173202|NCT01191398|12723225|P3|STARTED|Overall Study||18
5173203|NCT01191398|12723226|P2|STARTED|Overall Study||17
5173204|NCT01191398|12723227|P1|STARTED|Overall Study||17
5173205|NCT01191333|12723240|P2|NOT COMPLETED|Overall Study||18
5173206|NCT01191333|12723241|P1|NOT COMPLETED|Overall Study||21
5173207|NCT01191333|12723240|P2|COMPLETED|Overall Study||65
5173208|NCT01191333|12723241|P1|COMPLETED|Overall Study||60
5173209|NCT01191333|12723240|P2|STARTED|Overall Study||83
5173210|NCT01191333|12723241|P1|STARTED|Overall Study||81
5173211|NCT01191320|12723260|P3|NOT COMPLETED|Overall Study||7
5173212|NCT01191320|12723261|P2|NOT COMPLETED|Overall Study||6
5173213|NCT01191320|12723262|P1|NOT COMPLETED|Overall Study||7
5173214|NCT01191320|12723260|P3|COMPLETED|Overall Study||31
5173215|NCT01191320|12723261|P2|COMPLETED|Overall Study||32
5173216|NCT01191320|12723262|P1|COMPLETED|Overall Study||36
5173217|NCT01191320|12723260|P3|STARTED|Overall Study||38
5173218|NCT01191320|12723261|P2|STARTED|Overall Study||38
5173219|NCT01191320|12723262|P1|STARTED|Overall Study||43
5173220|NCT01191268|12723273|P3|NOT COMPLETED|Overall Study||52
5173221|NCT01191268|12723274|P2|NOT COMPLETED|Overall Study||55
5173222|NCT01191268|12723275|P1|NOT COMPLETED|Overall Study||58
5173223|NCT01191268|12723273|P3|COMPLETED|Overall Study||244
5173224|NCT01191268|12723274|P2|COMPLETED|Overall Study||238
5173225|NCT01191268|12723275|P1|COMPLETED|Overall Study||237
5173226|NCT01191268|12723273|P3|Received at Least One Dose of Study Drug|Overall Study||296
5173227|NCT01191268|12723274|P2|Received at Least One Dose of Study Drug|Overall Study||293
5173228|NCT01191268|12723275|P1|Received at Least One Dose of Study Drug|Overall Study||295
5173229|NCT01191268|12723273|P3|STARTED|Overall Study||296
5173230|NCT01191268|12723274|P2|STARTED|Overall Study||293
5173231|NCT01191268|12723275|P1|STARTED|Overall Study||295
5173232|NCT01191255|12723372|P4|NOT COMPLETED|Efficacy Assessment Period||6
5173233|NCT01191255|12723373|P3|NOT COMPLETED|Efficacy Assessment Period||26
5173234|NCT01191255|12723374|P2|NOT COMPLETED|Efficacy Assessment Period||0
5173235|NCT01191255|12723375|P1|NOT COMPLETED|Efficacy Assessment Period||0
5173236|NCT01191255|12723372|P4|COMPLETED|Efficacy Assessment Period||90
5173237|NCT01191255|12723373|P3|COMPLETED|Efficacy Assessment Period||70
5173238|NCT01191255|12723374|P2|COMPLETED|Efficacy Assessment Period||0
5173239|NCT01191255|12723375|P1|COMPLETED|Efficacy Assessment Period||0
5173240|NCT01191255|12723372|P4|STARTED|Efficacy Assessment Period||96
5173241|NCT01191255|12723373|P3|STARTED|Efficacy Assessment Period||96
5173242|NCT01191255|12723374|P2|STARTED|Efficacy Assessment Period||0
5173243|NCT01191255|12723375|P1|STARTED|Efficacy Assessment Period||0
5173244|NCT01191255|12723372|P4|NOT COMPLETED|Safety Assessment Period||0
5173245|NCT01191255|12723373|P3|NOT COMPLETED|Safety Assessment Period||0
5173246|NCT01191255|12723374|P2|NOT COMPLETED|Safety Assessment Period||99
5173247|NCT01191255|12723375|P1|NOT COMPLETED|Safety Assessment Period||38
5173248|NCT01191255|12723372|P4|COMPLETED|Safety Assessment Period||0
5173249|NCT01191255|12723373|P3|COMPLETED|Safety Assessment Period||0
5173250|NCT01191255|12723374|P2|COMPLETED|Safety Assessment Period||193
5173251|NCT01191255|12723375|P1|COMPLETED|Safety Assessment Period||111
5173252|NCT01191255|12723372|P4|Safety Population|Safety Assessment Period||0
5173253|NCT01191255|12723373|P3|Safety Population|Safety Assessment Period||0
5173254|NCT01191255|12723374|P2|Safety Population|Safety Assessment Period||289
5173255|NCT01191255|12723375|P1|Safety Population|Safety Assessment Period||149
5173256|NCT01191255|12723372|P4|STARTED|Safety Assessment Period||0
5173257|NCT01191255|12723373|P3|STARTED|Safety Assessment Period||0
5173258|NCT01191255|12723374|P2|STARTED|Safety Assessment Period||292
5173259|NCT01191255|12723375|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
5173260|NCT01191242|12723401|P1|NOT COMPLETED|Overall Study||0
5173261|NCT01191242|12723401|P1|COMPLETED|Overall Study||31
5173262|NCT01191242|12723401|P1|STARTED|Overall Study||31
5173263|NCT01191190|12723416|P1|NOT COMPLETED|Overall Study||1
5173264|NCT01191190|12723416|P1|COMPLETED|Overall Study||20
5173265|NCT01191190|12723416|P1|STARTED|Overall Study||21
5173266|NCT01191086|12723429|P1|NOT COMPLETED|Overall Study||62
5173267|NCT01191086|12723429|P1|COMPLETED|Overall Study||148
5173268|NCT01191086|12723429|P1|STARTED|Overall Study||210
5173269|NCT01191008|12723433|P1|NOT COMPLETED|Overall Study||15
5173270|NCT01191008|12723433|P1|COMPLETED|Overall Study||618
5173271|NCT01191008|12723433|P1|STARTED|Overall Study||633
5173272|NCT01190930|12723441|P10|NOT COMPLETED|Maintenance||37
5173273|NCT01190930|12723442|P9|NOT COMPLETED|Maintenance||46
5173274|NCT01190930|12723443|P8|NOT COMPLETED|Maintenance||46
5173275|NCT01190930|12723444|P7|NOT COMPLETED|Maintenance||26
5173276|NCT01190930|12723445|P6|NOT COMPLETED|Maintenance||12
5173277|NCT01190930|12723446|P5|NOT COMPLETED|Maintenance||9
5173278|NCT01190930|12723447|P4|NOT COMPLETED|Maintenance||40
5173279|NCT01190930|12723448|P3|NOT COMPLETED|Maintenance||0
5173280|NCT01190930|12723449|P2|NOT COMPLETED|Maintenance||10
5173281|NCT01190930|12723450|P1|NOT COMPLETED|Maintenance||0
5173282|NCT01190930|12723441|P10|COMPLETED|Maintenance||555
5173283|NCT01190930|12723442|P9|COMPLETED|Maintenance||540
5173284|NCT01190930|12723443|P8|COMPLETED|Maintenance||540
5173285|NCT01190930|12723444|P7|COMPLETED|Maintenance||574
5173286|NCT01190930|12723445|P6|COMPLETED|Maintenance||284
5173287|NCT01190930|12723446|P5|COMPLETED|Maintenance||287
5173288|NCT01190930|12723447|P4|COMPLETED|Maintenance||167
5173289|NCT01190930|12723448|P3|COMPLETED|Maintenance||0
5173290|NCT01190930|12723449|P2|COMPLETED|Maintenance||27
5173291|NCT01190930|12723450|P1|COMPLETED|Maintenance||0
5173292|NCT01190930|12723441|P10|STARTED|Maintenance||592
5173293|NCT01190930|12723442|P9|STARTED|Maintenance||586
5173294|NCT01190930|12723443|P8|STARTED|Maintenance||586
5173295|NCT01190930|12723444|P7|STARTED|Maintenance||600
5173296|NCT01190930|12723445|P6|STARTED|Maintenance||296
5173297|NCT01190930|12723446|P5|STARTED|Maintenance||296
5173298|NCT01190930|12723447|P4|STARTED|Maintenance||207
5173299|NCT01190930|12723448|P3|STARTED|Maintenance||0
5173300|NCT01190930|12723449|P2|STARTED|Maintenance||37
5173301|NCT01190930|12723450|P1|STARTED|Maintenance||0
5173302|NCT01190930|12723441|P10|NOT COMPLETED|Post Induction Pre-Maintenance||0
5173303|NCT01190930|12723442|P9|NOT COMPLETED|Post Induction Pre-Maintenance||0
5173304|NCT01190930|12723443|P8|NOT COMPLETED|Post Induction Pre-Maintenance||0
5173305|NCT01190930|12723444|P7|NOT COMPLETED|Post Induction Pre-Maintenance||0
5173306|NCT01190930|12723445|P6|NOT COMPLETED|Post Induction Pre-Maintenance||6
5173307|NCT01190930|12723446|P5|NOT COMPLETED|Post Induction Pre-Maintenance||5
5173308|NCT01190930|12723447|P4|NOT COMPLETED|Post Induction Pre-Maintenance||17
5173309|NCT01190930|12723448|P3|NOT COMPLETED|Post Induction Pre-Maintenance||758
5173310|NCT01190930|12723449|P2|NOT COMPLETED|Post Induction Pre-Maintenance||6
5173311|NCT01190930|12723450|P1|NOT COMPLETED|Post Induction Pre-Maintenance||0
5173312|NCT01190930|12723441|P10|COMPLETED|Post Induction Pre-Maintenance||0
5173313|NCT01190930|12723442|P9|COMPLETED|Post Induction Pre-Maintenance||0
5173314|NCT01190930|12723443|P8|COMPLETED|Post Induction Pre-Maintenance||0
5173315|NCT01190930|12723444|P7|COMPLETED|Post Induction Pre-Maintenance||0
5173316|NCT01190930|12723445|P6|COMPLETED|Post Induction Pre-Maintenance||296
5173317|NCT01190930|12723446|P5|COMPLETED|Post Induction Pre-Maintenance||296
5173318|NCT01190930|12723447|P4|COMPLETED|Post Induction Pre-Maintenance||207
5173319|NCT01190930|12723448|P3|COMPLETED|Post Induction Pre-Maintenance||2364
5173320|NCT01190930|12723449|P2|COMPLETED|Post Induction Pre-Maintenance||37
5173321|NCT01190930|12723450|P1|COMPLETED|Post Induction Pre-Maintenance||0
5173322|NCT01190930|12723441|P10|STARTED|Post Induction Pre-Maintenance||0
5173323|NCT01190930|12723442|P9|STARTED|Post Induction Pre-Maintenance||0
5173324|NCT01190930|12723443|P8|STARTED|Post Induction Pre-Maintenance||0
5173325|NCT01190930|12723444|P7|STARTED|Post Induction Pre-Maintenance||0
5173326|NCT01190930|12723445|P6|STARTED|Post Induction Pre-Maintenance||302
5173327|NCT01190930|12723446|P5|STARTED|Post Induction Pre-Maintenance||301
5173328|NCT01190930|12723447|P4|STARTED|Post Induction Pre-Maintenance||224
5173329|NCT01190930|12723448|P3|STARTED|Post Induction Pre-Maintenance||3122
5173330|NCT01190930|12723449|P2|STARTED|Post Induction Pre-Maintenance||43
5173331|NCT01190930|12723450|P1|STARTED|Post Induction Pre-Maintenance||0
5173332|NCT01190930|12723441|P10|NOT COMPLETED|Induction||0
5173333|NCT01190930|12723442|P9|NOT COMPLETED|Induction||0
5173334|NCT01190930|12723443|P8|NOT COMPLETED|Induction||0
5173335|NCT01190930|12723444|P7|NOT COMPLETED|Induction||0
5173336|NCT01190930|12723445|P6|NOT COMPLETED|Induction||0
5173337|NCT01190930|12723446|P5|NOT COMPLETED|Induction||0
5173338|NCT01190930|12723447|P4|NOT COMPLETED|Induction||0
5173339|NCT01190930|12723448|P3|NOT COMPLETED|Induction||0
5173340|NCT01190930|12723449|P2|NOT COMPLETED|Induction||9
5173341|NCT01190930|12723450|P1|NOT COMPLETED|Induction||5349
5173342|NCT01190930|12723441|P10|COMPLETED|Induction||0
5173343|NCT01190930|12723442|P9|COMPLETED|Induction||0
5173344|NCT01190930|12723443|P8|COMPLETED|Induction||0
5173345|NCT01190930|12723444|P7|COMPLETED|Induction||0
5173346|NCT01190930|12723445|P6|COMPLETED|Induction||0
5173347|NCT01190930|12723446|P5|COMPLETED|Induction||0
5173348|NCT01190930|12723447|P4|COMPLETED|Induction||0
5173349|NCT01190930|12723448|P3|COMPLETED|Induction||0
5173350|NCT01190930|12723449|P2|COMPLETED|Induction||43
5173351|NCT01190930|12723450|P1|COMPLETED|Induction||3949
5173352|NCT01190930|12723441|P10|STARTED|Induction||0
5173353|NCT01190930|12723442|P9|STARTED|Induction||0
5173354|NCT01190930|12723443|P8|STARTED|Induction||0
5173355|NCT01190930|12723444|P7|STARTED|Induction||0
5173356|NCT01190930|12723445|P6|STARTED|Induction||0
5173357|NCT01190930|12723446|P5|STARTED|Induction||0
5173358|NCT01190930|12723447|P4|STARTED|Induction||0
5173359|NCT01190930|12723448|P3|STARTED|Induction||0
5173360|NCT01190930|12723449|P2|STARTED|Induction||52
5173361|NCT01190930|12723450|P1|STARTED|Induction||9298
5173362|NCT01190891|12723474|P2|NOT COMPLETED|Overall Study||0
5173363|NCT01190891|12723475|P1|NOT COMPLETED|Overall Study||6
5173364|NCT01190891|12723474|P2|COMPLETED|Overall Study||52
5173365|NCT01190891|12723475|P1|COMPLETED|Overall Study||46
5173366|NCT01190891|12723474|P2|STARTED|Overall Study||52
5173367|NCT01190891|12723475|P1|STARTED|Overall Study||52
5173368|NCT01190878|12723487|P4|NOT COMPLETED|Overall Study||20
5173369|NCT01190878|12723488|P3|NOT COMPLETED|Overall Study||5
5173370|NCT01190878|12723489|P2|NOT COMPLETED|Overall Study||3
5173371|NCT01190878|12723490|P1|NOT COMPLETED|Overall Study||3
5173372|NCT01190878|12723487|P4|COMPLETED|Overall Study||22
5173373|NCT01190878|12723488|P3|COMPLETED|Overall Study||37
5173374|NCT01190878|12723489|P2|COMPLETED|Overall Study||42
5173375|NCT01190878|12723490|P1|COMPLETED|Overall Study||37
5173376|NCT01190878|12723487|P4|STARTED|Overall Study||42
5173377|NCT01190878|12723488|P3|STARTED|Overall Study||42
5173378|NCT01190878|12723489|P2|STARTED|Overall Study||45
5173379|NCT01190878|12723490|P1|STARTED|Overall Study||40
5173380|NCT01190865|12723500|P1|NOT COMPLETED|Overall Study||3
5173381|NCT01190865|12723500|P1|COMPLETED|Overall Study||25
5173382|NCT01190865|12723500|P1|STARTED|Overall Study||28
5173383|NCT01190839|12723507|P2|NOT COMPLETED|Overall Study||147
5173384|NCT01190839|12723508|P1|NOT COMPLETED|Overall Study||150
5173385|NCT01190839|12723507|P2|COMPLETED|Overall Study||0
5173386|NCT01190839|12723508|P1|COMPLETED|Overall Study||0
5173387|NCT01190839|12723507|P2|Treated|Overall Study||143
5173388|NCT01190839|12723508|P1|Treated|Overall Study||148
5173389|NCT01190839|12723507|P2|STARTED|Overall Study||147
5173390|NCT01190839|12723508|P1|STARTED|Overall Study||150
5173391|NCT01190813|12723522|P2|NOT COMPLETED|Overall Study||4
5173392|NCT01190813|12723523|P1|NOT COMPLETED|Overall Study||4
5173393|NCT01190813|12723522|P2|COMPLETED|Overall Study||45
5173394|NCT01190813|12723523|P1|COMPLETED|Overall Study||86
5173395|NCT01190813|12723522|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
5173396|NCT01190813|12723523|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
5173397|NCT01190813|12723522|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
5173398|NCT01190813|12723523|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
5173399|NCT01190813|12723522|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
5173400|NCT01190813|12723523|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
5173401|NCT01190813|12723522|P2|16-week Visit|Overall Study|2 dropped|46
5173402|NCT01190813|12723523|P1|16-week Visit|Overall Study|1 dropped|87
5173403|NCT01190813|12723522|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
5173404|NCT01190813|12723523|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
5173405|NCT01190813|12723522|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
5173406|NCT01190813|12723523|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
5173407|NCT01190813|12723522|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
5173408|NCT01190813|12723523|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
5173409|NCT01190813|12723522|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
5173410|NCT01190813|12723523|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
5173411|NCT01190813|12723522|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
5173412|NCT01190813|12723523|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
5173413|NCT01190813|12723522|P2|STARTED|Overall Study||49
5173414|NCT01190813|12723523|P1|STARTED|Overall Study||90
5173415|NCT01190566|12723615|P2|NOT COMPLETED|Overall Study||0
5173416|NCT01190566|12723616|P1|NOT COMPLETED|Overall Study||0
5173417|NCT01190566|12723615|P2|COMPLETED|Overall Study||42
5173418|NCT01190566|12723616|P1|COMPLETED|Overall Study||6
5173419|NCT01190566|12723615|P2|STARTED|Overall Study||42
5173420|NCT01190566|12723616|P1|STARTED|Overall Study||6
5173421|NCT01190527|12723637|P1|NOT COMPLETED|Overall Study||0
5173422|NCT01190527|12723637|P1|COMPLETED|Overall Study||42
5173423|NCT01190527|12723637|P1|STARTED|Overall Study||42
5173424|NCT01190514|12723644|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
5173425|NCT01190514|12723645|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
5173426|NCT01190514|12723646|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
5173427|NCT01190514|12723647|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
5173428|NCT01190514|12723644|P4|COMPLETED|Fourth Intervention (Period 4)||10
5173429|NCT01190514|12723645|P3|COMPLETED|Fourth Intervention (Period 4)||10
5173430|NCT01190514|12723646|P2|COMPLETED|Fourth Intervention (Period 4)||10
5173431|NCT01190514|12723647|P1|COMPLETED|Fourth Intervention (Period 4)||9
5173432|NCT01190514|12723644|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
5173433|NCT01190514|12723645|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
5173434|NCT01190514|12723646|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
5173435|NCT01190514|12723647|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
5173436|NCT01190514|12723644|P4|NOT COMPLETED|Third Intervention (Period 3)||0
5173437|NCT01190514|12723645|P3|NOT COMPLETED|Third Intervention (Period 3)||0
5173438|NCT01190514|12723646|P2|NOT COMPLETED|Third Intervention (Period 3)||0
5173439|NCT01190514|12723647|P1|NOT COMPLETED|Third Intervention (Period 3)||1
5173440|NCT01190514|12723644|P4|COMPLETED|Third Intervention (Period 3)||10
5173441|NCT01190514|12723645|P3|COMPLETED|Third Intervention (Period 3)||10
5173442|NCT01190514|12723646|P2|COMPLETED|Third Intervention (Period 3)||10
5173443|NCT01190514|12723647|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
5173444|NCT01190514|12723644|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
5173445|NCT01190514|12723645|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
5173446|NCT01190514|12723646|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
5173447|NCT01190514|12723647|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
5173448|NCT01190514|12723644|P4|NOT COMPLETED|Second Intervention (Period 2)||0
5173449|NCT01190514|12723645|P3|NOT COMPLETED|Second Intervention (Period 2)||0
5173450|NCT01190514|12723646|P2|NOT COMPLETED|Second Intervention (Period 2)||0
5173451|NCT01190514|12723647|P1|NOT COMPLETED|Second Intervention (Period 2)||0
5173452|NCT01190514|12723644|P4|COMPLETED|Second Intervention (Period 2)||10
5173453|NCT01190514|12723645|P3|COMPLETED|Second Intervention (Period 2)||10
5173454|NCT01190514|12723646|P2|COMPLETED|Second Intervention (Period 2)||10
5173455|NCT01190514|12723647|P1|COMPLETED|Second Intervention (Period 2)||10
5173456|NCT01190514|12723644|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
5173457|NCT01190514|12723645|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
5173458|NCT01190514|12723646|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
5173459|NCT01190514|12723647|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
5173460|NCT01190514|12723644|P4|NOT COMPLETED|First Intervention (Period 1)||0
5173461|NCT01190514|12723645|P3|NOT COMPLETED|First Intervention (Period 1)||0
5173462|NCT01190514|12723646|P2|NOT COMPLETED|First Intervention (Period 1)||0
5173463|NCT01190514|12723647|P1|NOT COMPLETED|First Intervention (Period 1)||1
5173464|NCT01190514|12723644|P4|COMPLETED|First Intervention (Period 1)||10
5173465|NCT01190514|12723645|P3|COMPLETED|First Intervention (Period 1)||10
5173466|NCT01190514|12723646|P2|COMPLETED|First Intervention (Period 1)||10
5173467|NCT01190514|12723647|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
5173468|NCT01190514|12723644|P4|STARTED|First Intervention (Period 1)||10
5173469|NCT01190514|12723645|P3|STARTED|First Intervention (Period 1)||10
5173470|NCT01190514|12723646|P2|STARTED|First Intervention (Period 1)||10
5173471|NCT01190514|12723647|P1|STARTED|First Intervention (Period 1)||11
5173472|NCT01190475|12723680|P3|NOT COMPLETED|Overall Study||1
5173473|NCT01190475|12723681|P2|NOT COMPLETED|Overall Study||0
5173474|NCT01190475|12723682|P1|NOT COMPLETED|Overall Study||0
5173475|NCT01190475|12723680|P3|COMPLETED|Overall Study||1
5173476|NCT01190475|12723681|P2|COMPLETED|Overall Study||2
5173477|NCT01190475|12723682|P1|COMPLETED|Overall Study||2
5173478|NCT01190475|12723680|P3|STARTED|Overall Study||2
5173479|NCT01190475|12723681|P2|STARTED|Overall Study||2
5173480|NCT01190475|12723682|P1|STARTED|Overall Study||2
5173481|NCT01190449|12723692|P2|NOT COMPLETED|Overall Study||4
5173482|NCT01190449|12723693|P1|NOT COMPLETED|Overall Study||0
5173483|NCT01190449|12723692|P2|COMPLETED|Overall Study||32
5173484|NCT01190449|12723693|P1|COMPLETED|Overall Study||15
5173485|NCT01190449|12723692|P2|STARTED|Overall Study||36
5173486|NCT01190449|12723693|P1|STARTED|Overall Study||15
5173487|NCT01190436|12723701|P1|NOT COMPLETED|Overall Study||39
5173488|NCT01190436|12723701|P1|COMPLETED|Overall Study||86
5173489|NCT01190436|12723701|P1|STARTED|Overall Study||125
5173490|NCT01190410|12723717|P2|NOT COMPLETED|Overall Study||9
5173491|NCT01190410|12723718|P1|NOT COMPLETED|Overall Study||1
5173492|NCT01190410|12723717|P2|COMPLETED|Overall Study||3
5173493|NCT01190410|12723718|P1|COMPLETED|Overall Study||3
5173494|NCT01190410|12723717|P2|Re-Induction|Overall Study||2
5173495|NCT01190410|12723718|P1|Re-Induction|Overall Study||0
5173496|NCT01190410|12723717|P2|STARTED|Overall Study||12
5173497|NCT01190410|12723718|P1|STARTED|Overall Study||4
5173498|NCT01190306|12723737|P2|NOT COMPLETED|Overall Study||0
5173499|NCT01190306|12723738|P1|NOT COMPLETED|Overall Study||0
5173500|NCT01190306|12723737|P2|COMPLETED|Overall Study||66
5173501|NCT01190306|12723738|P1|COMPLETED|Overall Study||61
5173502|NCT01190306|12723737|P2|STARTED|Overall Study||66
5173503|NCT01190306|12723738|P1|STARTED|Overall Study||61
5173504|NCT01190267|12723746|P2|NOT COMPLETED|Overall Study||4
5173505|NCT01190267|12723747|P1|NOT COMPLETED|Overall Study||41
5173506|NCT01190267|12723746|P2|COMPLETED|Overall Study||4
5173507|NCT01190267|12723747|P1|COMPLETED|Overall Study||155
5173508|NCT01190267|12723746|P2|STARTED|Overall Study||8
5173509|NCT01190267|12723747|P1|STARTED|Overall Study||196
5173510|NCT01190254|12723758|P3|NOT COMPLETED|Overall Study||22
5173511|NCT01190254|12723759|P2|NOT COMPLETED|Overall Study||17
5173512|NCT01190254|12723760|P1|NOT COMPLETED|Overall Study||21
5173513|NCT01190254|12723758|P3|COMPLETED|Overall Study||84
5173514|NCT01190254|12723759|P2|COMPLETED|Overall Study||81
5173515|NCT01190254|12723760|P1|COMPLETED|Overall Study||81
5173516|NCT01190254|12723758|P3|Treated|Overall Study||106
5173517|NCT01190254|12723759|P2|Treated|Overall Study||98
5173518|NCT01190254|12723760|P1|Treated|Overall Study||102
5173519|NCT01190254|12723758|P3|STARTED|Overall Study||106
5173520|NCT01190254|12723759|P2|STARTED|Overall Study||98
5173521|NCT01190254|12723760|P1|STARTED|Overall Study||102
5173522|NCT01190228|12723825|P3|NOT COMPLETED|Overall Study||0
5173523|NCT01190228|12723826|P2|NOT COMPLETED|Overall Study||0
5173524|NCT01190228|12723827|P1|NOT COMPLETED|Overall Study||5
5173525|NCT01190228|12723825|P3|COMPLETED|Overall Study||59
5173526|NCT01190228|12723826|P2|COMPLETED|Overall Study||46
5173527|NCT01190228|12723827|P1|COMPLETED|Overall Study||344
5173528|NCT01190228|12723825|P3|STARTED|Overall Study||59
5173529|NCT01190228|12723826|P2|STARTED|Overall Study||46
5173530|NCT01190228|12723827|P1|STARTED|Overall Study||349
5173531|NCT01190215|12723850|P2|NOT COMPLETED|Up to Month 6||0
5173532|NCT01190215|12723851|P1|NOT COMPLETED|Up to Month 6||2
5173533|NCT01190215|12723850|P2|COMPLETED|Up to Month 6||39
5173534|NCT01190215|12723851|P1|COMPLETED|Up to Month 6||36
5173535|NCT01190215|12723850|P2|STARTED|Up to Month 6||39
5173536|NCT01190215|12723851|P1|STARTED|Up to Month 6||38
5173537|NCT01190215|12723850|P2|NOT COMPLETED|Up to Day 28||0
5173538|NCT01190215|12723851|P1|NOT COMPLETED|Up to Day 28||0
5173539|NCT01190215|12723850|P2|COMPLETED|Up to Day 28||39
5173540|NCT01190215|12723851|P1|COMPLETED|Up to Day 28||38
5173541|NCT01190215|12723850|P2|STARTED|Up to Day 28||39
5173542|NCT01190215|12723851|P1|STARTED|Up to Day 28||38
5173543|NCT01190189|12723919|P1|NOT COMPLETED|Overall Study||6
5173544|NCT01190189|12723919|P1|COMPLETED|Overall Study||131
5173545|NCT01190189|12723919|P1|STARTED|Overall Study||137
5173546|NCT01190176|12723926|P1|NOT COMPLETED|Overall Study||2
5173547|NCT01190176|12723926|P1|COMPLETED|Overall Study||30
5173548|NCT01190176|12723926|P1|STARTED|Overall Study||32
5173549|NCT01190150|12723947|P2|NOT COMPLETED|Second Treatment||0
5173550|NCT01190150|12723948|P1|NOT COMPLETED|Second Treatment||0
5173551|NCT01190150|12723947|P2|COMPLETED|Second Treatment||7
5173552|NCT01190150|12723948|P1|COMPLETED|Second Treatment||10
5173553|NCT01190150|12723947|P2|STARTED|Second Treatment||7
5173554|NCT01190150|12723948|P1|STARTED|Second Treatment||10
5173555|NCT01190150|12723947|P2|NOT COMPLETED|Washout||2
5173556|NCT01190150|12723948|P1|NOT COMPLETED|Washout||0
5173557|NCT01190150|12723947|P2|COMPLETED|Washout||7
5173558|NCT01190150|12723948|P1|COMPLETED|Washout||10
5173559|NCT01190150|12723947|P2|STARTED|Washout||9
5173560|NCT01190150|12723948|P1|STARTED|Washout||10
5173561|NCT01190150|12723947|P2|NOT COMPLETED|First Treatment||0
5173562|NCT01190150|12723948|P1|NOT COMPLETED|First Treatment||1
5173563|NCT01190150|12723947|P2|COMPLETED|First Treatment||9
5173564|NCT01190150|12723948|P1|COMPLETED|First Treatment||10
5173565|NCT01190150|12723947|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
5173566|NCT01190150|12723948|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
5173567|NCT01190124|12723975|P3|NOT COMPLETED|Overall Study||1
5173568|NCT01190124|12723976|P2|NOT COMPLETED|Overall Study||0
5173569|NCT01190124|12723977|P1|NOT COMPLETED|Overall Study||17
5173570|NCT01190124|12723975|P3|COMPLETED|Overall Study||19
5173571|NCT01190124|12723976|P2|COMPLETED|Overall Study||24
5173572|NCT01190124|12723977|P1|COMPLETED|Overall Study||90
5173573|NCT01190124|12723975|P3|STARTED|Overall Study||20
5173574|NCT01190124|12723976|P2|STARTED|Overall Study||24
5173575|NCT01190124|12723977|P1|STARTED|Overall Study||107
5173576|NCT01190098|12724015|P2|NOT COMPLETED|Overall Study||2
5173577|NCT01190098|12724016|P1|NOT COMPLETED|Overall Study||3
5173578|NCT01190098|12724015|P2|COMPLETED|Overall Study||8
5173579|NCT01190098|12724016|P1|COMPLETED|Overall Study||39
5173580|NCT01190098|12724015|P2|STARTED|Overall Study||10
5173581|NCT01190098|12724016|P1|STARTED|Overall Study||42
5173582|NCT01190085|12724039|P3|NOT COMPLETED|Overall Study||0
5173583|NCT01190085|12724040|P2|NOT COMPLETED|Overall Study||0
5173584|NCT01190085|12724041|P1|NOT COMPLETED|Overall Study||0
5173585|NCT01190085|12724039|P3|COMPLETED|Overall Study||18
5173586|NCT01190085|12724040|P2|COMPLETED|Overall Study||14
5173587|NCT01190085|12724041|P1|COMPLETED|Overall Study||13
5173588|NCT01190085|12724039|P3|STARTED|Overall Study||18
5173589|NCT01190085|12724040|P2|STARTED|Overall Study||14
5173590|NCT01190085|12724041|P1|STARTED|Overall Study||13
5173591|NCT01190020|12724057|P2|NOT COMPLETED|Overall Study||0
5173592|NCT01190020|12724058|P1|NOT COMPLETED|Overall Study||7
5173593|NCT01190020|12724057|P2|COMPLETED|Overall Study||12
5173594|NCT01190020|12724058|P1|COMPLETED|Overall Study||22
5173595|NCT01190020|12724057|P2|STARTED|Overall Study||12
5173596|NCT01190020|12724058|P1|STARTED|Overall Study||29
5173597|NCT01190007|12724070|P1|NOT COMPLETED|Overall Study||14
5173598|NCT01190007|12724070|P1|COMPLETED|Overall Study||145
5173599|NCT01190007|12724070|P1|STARTED|Overall Study|Treated|159
5173600|NCT01189890|12724087|P2|NOT COMPLETED|Overall Study||39
5173601|NCT01189890|12724088|P1|NOT COMPLETED|Overall Study||37
5173602|NCT01189890|12724087|P2|COMPLETED|Overall Study||200
5173603|NCT01189890|12724088|P1|COMPLETED|Overall Study||204
5173604|NCT01189890|12724087|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
5173605|NCT01189890|12724088|P1|STARTED|Overall Study||241
5173606|NCT01189812|12724110|P2|NOT COMPLETED|Overall Study||8
5173607|NCT01189812|12724111|P1|NOT COMPLETED|Overall Study||8
5173608|NCT01189812|12724110|P2|COMPLETED|Overall Study||32
5173609|NCT01189812|12724111|P1|COMPLETED|Overall Study||32
5173610|NCT01189812|12724110|P2|STARTED|Overall Study||40
5173611|NCT01189812|12724111|P1|STARTED|Overall Study||40
5173612|NCT01189760|12724120|P3|NOT COMPLETED|Overall Study||51
5173613|NCT01189760|12724121|P2|NOT COMPLETED|Overall Study||23
5173614|NCT01189760|12724122|P1|NOT COMPLETED|Overall Study||14
5173615|NCT01189760|12724120|P3|COMPLETED|Overall Study||255
5173616|NCT01189760|12724121|P2|COMPLETED|Overall Study||283
5173617|NCT01189760|12724122|P1|COMPLETED|Overall Study||291
5173618|NCT01189760|12724120|P3|STARTED|Overall Study||306
5173619|NCT01189760|12724121|P2|STARTED|Overall Study||306
5173620|NCT01189760|12724122|P1|STARTED|Overall Study||305
5173621|NCT01189747|12724156|P2|NOT COMPLETED|Overall Study||18
5173622|NCT01189747|12724157|P1|NOT COMPLETED|Overall Study||12
5173623|NCT01189747|12724156|P2|COMPLETED|Overall Study||206
5173624|NCT01189747|12724157|P1|COMPLETED|Overall Study||210
5173625|NCT01189747|12724156|P2|STARTED|Overall Study||224
5173626|NCT01189747|12724157|P1|STARTED|Overall Study||222
5173627|NCT01189617|12724181|P2|NOT COMPLETED|Overall Study||0
5173628|NCT01189617|12724182|P1|NOT COMPLETED|Overall Study||0
5173629|NCT01189617|12724181|P2|COMPLETED|Overall Study||35
5173630|NCT01189617|12724182|P1|COMPLETED|Overall Study||35
5173631|NCT01189617|12724181|P2|STARTED|Overall Study||35
5173632|NCT01189617|12724182|P1|STARTED|Overall Study||35
5173633|NCT01189604|12724195|P7|NOT COMPLETED|Overall Study||1
5173634|NCT01189604|12724196|P6|NOT COMPLETED|Overall Study||1
5173635|NCT01189604|12724197|P5|NOT COMPLETED|Overall Study||2
5173636|NCT01189604|12724198|P4|NOT COMPLETED|Overall Study||0
5173637|NCT01189604|12724199|P3|NOT COMPLETED|Overall Study||0
5173638|NCT01189604|12724200|P2|NOT COMPLETED|Overall Study||1
5173639|NCT01189604|12724201|P1|NOT COMPLETED|Overall Study||1
5173640|NCT01189604|12724195|P7|COMPLETED|Overall Study||9
5173641|NCT01189604|12724196|P6|COMPLETED|Overall Study||10
5173642|NCT01189604|12724197|P5|COMPLETED|Overall Study||18
5173643|NCT01189604|12724198|P4|COMPLETED|Overall Study||20
5173644|NCT01189604|12724199|P3|COMPLETED|Overall Study||20
5173645|NCT01189604|12724200|P2|COMPLETED|Overall Study||20
5173646|NCT01189604|12724201|P1|COMPLETED|Overall Study||20
5173647|NCT01189604|12724195|P7|Administered Study Drug|Overall Study||10
5173648|NCT01189604|12724196|P6|Administered Study Drug|Overall Study||10
5173649|NCT01189604|12724197|P5|Administered Study Drug|Overall Study||20
5173650|NCT01189604|12724198|P4|Administered Study Drug|Overall Study||20
5173651|NCT01189604|12724199|P3|Administered Study Drug|Overall Study||20
5173652|NCT01189604|12724200|P2|Administered Study Drug|Overall Study||20
5173653|NCT01189604|12724201|P1|Administered Study Drug|Overall Study||20
5173654|NCT01189604|12724195|P7|STARTED|Overall Study||10
5173655|NCT01189604|12724196|P6|STARTED|Overall Study||11
5173656|NCT01189604|12724197|P5|STARTED|Overall Study||20
5173657|NCT01189604|12724198|P4|STARTED|Overall Study||20
5173658|NCT01189604|12724199|P3|STARTED|Overall Study||20
5173659|NCT01189604|12724200|P2|STARTED|Overall Study||21
5173660|NCT01189604|12724201|P1|STARTED|Overall Study||21
5173661|NCT01189500|12724245|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
5173662|NCT01189500|12724245|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
5173663|NCT01189500|12724245|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
5173664|NCT01189500|12724245|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
5173665|NCT01189500|12724245|P1|COMPLETED|Period 1: TAMOX Alone||29
5173666|NCT01189500|12724245|P1|STARTED|Period 1: TAMOX Alone||30
5173667|NCT01189487|12724306|P1|NOT COMPLETED|Overall Study||3
5173668|NCT01189487|12724306|P1|COMPLETED|Overall Study||44
5173669|NCT01189487|12724306|P1|STARTED|Overall Study|Treated participants|47
5173670|NCT01189461|12724314|P1|NOT COMPLETED|Overall Study||34
5173671|NCT01189461|12724314|P1|COMPLETED|Overall Study||12
5173672|NCT01189461|12724314|P1|STARTED|Overall Study||46
5173673|NCT01189435|12724321|P1|NOT COMPLETED|Overall Study||2
5173674|NCT01189435|12724321|P1|COMPLETED|Overall Study||0
5173675|NCT01189435|12724321|P1|STARTED|Overall Study||2
5173676|NCT01189409|12724327|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
5173677|NCT01189409|12724328|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
5173678|NCT01189409|12724327|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
5173679|NCT01189409|12724328|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
5173680|NCT01189409|12724327|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
5173681|NCT01189409|12724328|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
5173682|NCT01189409|12724327|P2|NOT COMPLETED|First 3 Weeks||10
5173683|NCT01189409|12724328|P1|NOT COMPLETED|First 3 Weeks||18
5173684|NCT01189409|12724327|P2|COMPLETED|First 3 Weeks||23
5173685|NCT01189409|12724328|P1|COMPLETED|First 3 Weeks||19
5173686|NCT01189409|12724327|P2|STARTED|First 3 Weeks||33
5173687|NCT01189409|12724328|P1|STARTED|First 3 Weeks||37
5173688|NCT01189370|12724343|P3|NOT COMPLETED|Dose Level 3||6
5173689|NCT01189370|12724344|P2|NOT COMPLETED|Dose Level 3||0
5173690|NCT01189370|12724345|P1|NOT COMPLETED|Dose Level 3||0
5173691|NCT01189370|12724343|P3|COMPLETED|Dose Level 3||6
5173692|NCT01189370|12724344|P2|COMPLETED|Dose Level 3||0
5173693|NCT01189370|12724345|P1|COMPLETED|Dose Level 3||0
5173694|NCT01189370|12724343|P3|STARTED|Dose Level 3||12
5173695|NCT01189370|12724344|P2|STARTED|Dose Level 3||0
5173696|NCT01189370|12724345|P1|STARTED|Dose Level 3||0
5173697|NCT01189370|12724343|P3|NOT COMPLETED|Dose Level 2||0
5173698|NCT01189370|12724344|P2|NOT COMPLETED|Dose Level 2||4
5173699|NCT01189370|12724345|P1|NOT COMPLETED|Dose Level 2||0
5173700|NCT01189370|12724343|P3|COMPLETED|Dose Level 2||0
5173701|NCT01189370|12724344|P2|COMPLETED|Dose Level 2||12
5173702|NCT01189370|12724345|P1|COMPLETED|Dose Level 2||0
5173703|NCT01189370|12724343|P3|STARTED|Dose Level 2||0
5173704|NCT01189370|12724344|P2|STARTED|Dose Level 2||16
5173705|NCT01189370|12724345|P1|STARTED|Dose Level 2||0
5173706|NCT01189370|12724343|P3|NOT COMPLETED|Dose Level 1||0
5173707|NCT01189370|12724344|P2|NOT COMPLETED|Dose Level 1||0
5173708|NCT01189370|12724345|P1|NOT COMPLETED|Dose Level 1||9
5173709|NCT01189370|12724343|P3|COMPLETED|Dose Level 1||0
5173710|NCT01189370|12724344|P2|COMPLETED|Dose Level 1||0
5173711|NCT01189370|12724345|P1|COMPLETED|Dose Level 1||16
5173712|NCT01189370|12724343|P3|STARTED|Dose Level 1||0
5173713|NCT01189370|12724344|P2|STARTED|Dose Level 1||0
5173714|NCT01189370|12724345|P1|STARTED|Dose Level 1||25
5173715|NCT01189292|12724354|P2|NOT COMPLETED|Per Protocol Analysis||16
5173716|NCT01189292|12724355|P1|NOT COMPLETED|Per Protocol Analysis||11
5173717|NCT01189292|12724354|P2|COMPLETED|Per Protocol Analysis||60
5173718|NCT01189292|12724355|P1|COMPLETED|Per Protocol Analysis||65
5173719|NCT01189292|12724354|P2|STARTED|Per Protocol Analysis||76
5173720|NCT01189292|12724355|P1|STARTED|Per Protocol Analysis||76
5173721|NCT01189292|12724354|P2|NOT COMPLETED|Intention to Treat Analysis||0
5173722|NCT01189292|12724355|P1|NOT COMPLETED|Intention to Treat Analysis||0
5173723|NCT01189292|12724354|P2|COMPLETED|Intention to Treat Analysis||76
5173724|NCT01189292|12724355|P1|COMPLETED|Intention to Treat Analysis||76
5173725|NCT01189292|12724354|P2|STARTED|Intention to Treat Analysis||76
5173726|NCT01189292|12724355|P1|STARTED|Intention to Treat Analysis||76
5173727|NCT01189279|12724376|P3|NOT COMPLETED|Overall Study||1
5173728|NCT01189279|12724377|P2|NOT COMPLETED|Overall Study||0
5173729|NCT01189279|12724378|P1|NOT COMPLETED|Overall Study||1
5173730|NCT01189279|12724376|P3|COMPLETED|Overall Study||13
5173731|NCT01189279|12724377|P2|COMPLETED|Overall Study||14
5173732|NCT01189279|12724378|P1|COMPLETED|Overall Study||13
5173733|NCT01189279|12724376|P3|STARTED|Overall Study||14
5173734|NCT01189279|12724377|P2|STARTED|Overall Study||14
5173735|NCT01189279|12724378|P1|STARTED|Overall Study||14
5173736|NCT01189266|12724401|P3|NOT COMPLETED|Overall Study||65
5173737|NCT01189266|12724402|P2|NOT COMPLETED|Overall Study||6
5173738|NCT01189266|12724403|P1|NOT COMPLETED|Overall Study||6
5173739|NCT01189266|12724401|P3|COMPLETED|Overall Study||2
5173740|NCT01189266|12724402|P2|COMPLETED|Overall Study||0
5173741|NCT01189266|12724403|P1|COMPLETED|Overall Study||0
5173742|NCT01189266|12724401|P3|STARTED|Overall Study||67
5173743|NCT01189266|12724402|P2|STARTED|Overall Study||6
5173744|NCT01189266|12724403|P1|STARTED|Overall Study||6
5173745|NCT01189240|12724430|P3|NOT COMPLETED|Overall Study||0
5173746|NCT01189240|12724431|P2|NOT COMPLETED|Overall Study||0
5173747|NCT01189240|12724432|P1|NOT COMPLETED|Overall Study||0
5173748|NCT01189240|12724430|P3|COMPLETED|Overall Study||3
5173749|NCT01189240|12724431|P2|COMPLETED|Overall Study||6
5173750|NCT01189240|12724432|P1|COMPLETED|Overall Study||4
5173751|NCT01189240|12724430|P3|STARTED|Overall Study||3
5173752|NCT01189240|12724431|P2|STARTED|Overall Study||6
5173753|NCT01189240|12724432|P1|STARTED|Overall Study||4
5173754|NCT01189227|12724453|P2|NOT COMPLETED|Overall Study||3
5173755|NCT01189227|12724454|P1|NOT COMPLETED|Overall Study||6
5173756|NCT01189227|12724453|P2|COMPLETED|Overall Study||0
5173757|NCT01189227|12724454|P1|COMPLETED|Overall Study||0
5173758|NCT01189227|12724453|P2|STARTED|Overall Study||3
5173759|NCT01189227|12724454|P1|STARTED|Overall Study||6
5173760|NCT01189201|12724460|P1|NOT COMPLETED|Overall Study||1
5173761|NCT01189201|12724460|P1|COMPLETED|Overall Study||41
5173762|NCT01189201|12724460|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
5173763|NCT01189201|12724460|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
5173764|NCT01189201|12724460|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
5173765|NCT01189201|12724460|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
5173766|NCT01189201|12724460|P1|STARTED|Overall Study||42
5173767|NCT01189136|12724516|P2|NOT COMPLETED|Overall Study||0
5173768|NCT01189136|12724517|P1|NOT COMPLETED|Overall Study||0
5173769|NCT01189136|12724516|P2|COMPLETED|Overall Study||42
5173770|NCT01189136|12724517|P1|COMPLETED|Overall Study||42
5173771|NCT01189136|12724516|P2|STARTED|Overall Study||42
5173772|NCT01189136|12724517|P1|STARTED|Overall Study||42
5173773|NCT01189123|12724531|P2|NOT COMPLETED|Overall Study||6
5173774|NCT01189123|12724532|P1|NOT COMPLETED|Overall Study||2
5173775|NCT01189123|12724531|P2|COMPLETED|Overall Study||47
5173776|NCT01189123|12724532|P1|COMPLETED|Overall Study||50
5173777|NCT01189123|12724531|P2|STARTED|Overall Study||53
5173778|NCT01189123|12724532|P1|STARTED|Overall Study||52
5173779|NCT01189110|12724542|P2|NOT COMPLETED|Overall Study||0
5173780|NCT01189110|12724543|P1|NOT COMPLETED|Overall Study||0
5173781|NCT01189110|12724542|P2|COMPLETED|Overall Study||61
5173782|NCT01189110|12724543|P1|COMPLETED|Overall Study|February, 2011|64
5173783|NCT01189110|12724542|P2|STARTED|Overall Study||61
5173784|NCT01189110|12724543|P1|STARTED|Overall Study|September, 2010|64
5173785|NCT01189071|12724551|P2|NOT COMPLETED|Overall Study||0
5173786|NCT01189071|12724552|P1|NOT COMPLETED|Overall Study||0
5173787|NCT01189071|12724551|P2|COMPLETED|Overall Study||0
5173788|NCT01189071|12724552|P1|COMPLETED|Overall Study||0
5173789|NCT01189071|12724551|P2|STARTED|Overall Study||0
5173790|NCT01189071|12724552|P1|STARTED|Overall Study||0
5173791|NCT01189032|12724563|P3|NOT COMPLETED|Overall Study||6
5173792|NCT01189032|12724564|P2|NOT COMPLETED|Overall Study||7
5173793|NCT01189032|12724565|P1|NOT COMPLETED|Overall Study||5
5173794|NCT01189032|12724563|P3|COMPLETED|Overall Study||90
5173795|NCT01189032|12724564|P2|COMPLETED|Overall Study||89
5173796|NCT01189032|12724565|P1|COMPLETED|Overall Study||89
5173797|NCT01189032|12724563|P3|STARTED|Overall Study||96
5173798|NCT01189032|12724564|P2|STARTED|Overall Study||96
5173799|NCT01189032|12724565|P1|STARTED|Overall Study||94
5173800|NCT01188967|12724575|P2|NOT COMPLETED|Overall Study||4
5173801|NCT01188967|12724576|P1|NOT COMPLETED|Overall Study||5
5173802|NCT01188967|12724575|P2|COMPLETED|Overall Study||4
5173803|NCT01188967|12724576|P1|COMPLETED|Overall Study||5
5173804|NCT01188967|12724575|P2|STARTED|Overall Study||8
5173805|NCT01188967|12724576|P1|STARTED|Overall Study||10
5173806|NCT01188928|12724592|P4|NOT COMPLETED|Overall Study||18
5173807|NCT01188928|12724593|P3|NOT COMPLETED|Overall Study||14
5173808|NCT01188928|12724594|P2|NOT COMPLETED|Overall Study||62
5173809|NCT01188928|12724595|P1|NOT COMPLETED|Overall Study||38
5173810|NCT01188928|12724592|P4|COMPLETED|Overall Study||77
5173811|NCT01188928|12724593|P3|COMPLETED|Overall Study||82
5173812|NCT01188928|12724594|P2|COMPLETED|Overall Study||417
5173813|NCT01188928|12724595|P1|COMPLETED|Overall Study||444
5173814|NCT01188928|12724592|P4|STARTED|Overall Study||95
5173815|NCT01188928|12724593|P3|STARTED|Overall Study||96
5173816|NCT01188928|12724594|P2|STARTED|Overall Study||479
5173817|NCT01188928|12724595|P1|STARTED|Overall Study||482
5173818|NCT01188876|12724617|P1|NOT COMPLETED|Overall Study||0
5173819|NCT01188876|12724617|P1|COMPLETED|Overall Study||50
5173820|NCT01188876|12724617|P1|STARTED|Overall Study||50
5173821|NCT01188811|12724629|P2|NOT COMPLETED|Overall Study||2
5173822|NCT01188811|12724630|P1|NOT COMPLETED|Overall Study||6
5173823|NCT01188811|12724629|P2|COMPLETED|Overall Study||24
5173824|NCT01188811|12724630|P1|COMPLETED|Overall Study||22
5173825|NCT01188811|12724629|P2|STARTED|Overall Study||26
5173826|NCT01188811|12724630|P1|STARTED|Overall Study||28
5173827|NCT01188798|12724642|P2|NOT COMPLETED|Overall Study||3
5173828|NCT01188798|12724643|P1|NOT COMPLETED|Overall Study||2
5173829|NCT01188798|12724642|P2|COMPLETED|Overall Study||1
5173830|NCT01188798|12724643|P1|COMPLETED|Overall Study||0
5173831|NCT01188798|12724642|P2|STARTED|Overall Study||4
5173832|NCT01188798|12724643|P1|STARTED|Overall Study||2
5173833|NCT01188772|12724655|P4|NOT COMPLETED|Overall Study||1
5173834|NCT01188772|12724656|P3|NOT COMPLETED|Overall Study||11
5173835|NCT01188772|12724657|P2|NOT COMPLETED|Overall Study||3
5173836|NCT01188772|12724658|P1|NOT COMPLETED|Overall Study||5
5173837|NCT01188772|12724655|P4|COMPLETED|Overall Study||24
5173838|NCT01188772|12724656|P3|COMPLETED|Overall Study||15
5173839|NCT01188772|12724657|P2|COMPLETED|Overall Study||45
5173840|NCT01188772|12724658|P1|COMPLETED|Overall Study||43
5173841|NCT01188772|12724655|P4|Randomized and Treated|Overall Study||25
5173842|NCT01188772|12724656|P3|Randomized and Treated|Overall Study||26
5173843|NCT01188772|12724657|P2|Randomized and Treated|Overall Study||47
5173844|NCT01188772|12724658|P1|Randomized and Treated|Overall Study||48
5173845|NCT01188772|12724655|P4|STARTED|Overall Study||25
5173846|NCT01188772|12724656|P3|STARTED|Overall Study||26
5173847|NCT01188772|12724657|P2|STARTED|Overall Study||48
5173848|NCT01188772|12724658|P1|STARTED|Overall Study||48
5173849|NCT01188694|12724716|P3|NOT COMPLETED|Overall Study||1
5173850|NCT01188694|12724717|P2|NOT COMPLETED|Overall Study||1
5173851|NCT01188694|12724718|P1|NOT COMPLETED|Overall Study||5
5173852|NCT01188694|12724716|P3|COMPLETED|Overall Study||10
5173853|NCT01188694|12724717|P2|COMPLETED|Overall Study||15
5173854|NCT01188694|12724718|P1|COMPLETED|Overall Study||10
5173855|NCT01188694|12724716|P3|STARTED|Overall Study||11
5173856|NCT01188694|12724717|P2|STARTED|Overall Study||16
5173857|NCT01188694|12724718|P1|STARTED|Overall Study||15
5173858|NCT01188681|12724730|P4|NOT COMPLETED|Overall Study||1
5173859|NCT01188681|12724731|P3|NOT COMPLETED|Overall Study||1
5173860|NCT01188681|12724732|P2|NOT COMPLETED|Overall Study||0
5173861|NCT01188681|12724733|P1|NOT COMPLETED|Overall Study||0
5173862|NCT01188681|12724730|P4|COMPLETED|Overall Study||33
5173863|NCT01188681|12724731|P3|COMPLETED|Overall Study||32
5173864|NCT01188681|12724732|P2|COMPLETED|Overall Study||6
5173865|NCT01188681|12724733|P1|COMPLETED|Overall Study||6
5173866|NCT01188681|12724730|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
5173867|NCT01188681|12724731|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
5173868|NCT01188681|12724732|P2|STARTED|Overall Study||6
5173869|NCT01188681|12724733|P1|STARTED|Overall Study||6
5173870|NCT01188668|12724747|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
5173871|NCT01188668|12724747|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
5173872|NCT01188668|12724747|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
5173873|NCT01188668|12724747|P1|NOT COMPLETED|Period 1: ARIP Alone||2
5173874|NCT01188668|12724747|P1|COMPLETED|Period 1: ARIP Alone||36
5173875|NCT01188668|12724747|P1|STARTED|Period 1: ARIP Alone||38
5173876|NCT01188655|12724780|P1|NOT COMPLETED|Overall Study||13
5173877|NCT01188655|12724780|P1|COMPLETED|Overall Study||76
5173878|NCT01188655|12724780|P1|STARTED|Overall Study||89
5173879|NCT01188603|12724795|P1|NOT COMPLETED|Overall Study||0
5173880|NCT01188603|12724795|P1|COMPLETED|Overall Study||24
5173881|NCT01188603|12724795|P1|STARTED|Overall Study||24
5173882|NCT01188577|12724805|P2|NOT COMPLETED|Visit 2||0
5173883|NCT01188577|12724806|P1|NOT COMPLETED|Visit 2||0
5173884|NCT01188577|12724805|P2|COMPLETED|Visit 2||12
5173885|NCT01188577|12724806|P1|COMPLETED|Visit 2||11
5173886|NCT01188577|12724805|P2|STARTED|Visit 2||12
5173887|NCT01188577|12724806|P1|STARTED|Visit 2||11
5173888|NCT01188577|12724805|P2|NOT COMPLETED|3-14 Day Washout||0
5173889|NCT01188577|12724806|P1|NOT COMPLETED|3-14 Day Washout||0
5173890|NCT01188577|12724805|P2|COMPLETED|3-14 Day Washout||12
5173891|NCT01188577|12724806|P1|COMPLETED|3-14 Day Washout||11
5173892|NCT01188577|12724805|P2|STARTED|3-14 Day Washout||12
5173893|NCT01188577|12724806|P1|STARTED|3-14 Day Washout||11
5173894|NCT01188577|12724805|P2|NOT COMPLETED|Visit 1||0
5173895|NCT01188577|12724806|P1|NOT COMPLETED|Visit 1||0
5173896|NCT01188577|12724805|P2|COMPLETED|Visit 1||12
5173897|NCT01188577|12724806|P1|COMPLETED|Visit 1||11
5173898|NCT01188577|12724805|P2|STARTED|Visit 1||12
5173899|NCT01188577|12724806|P1|STARTED|Visit 1||11
5173900|NCT01188564|12724824|P2|NOT COMPLETED|Open Label Phase||0
5173901|NCT01188564|12724825|P1|NOT COMPLETED|Open Label Phase||0
5173902|NCT01188564|12724824|P2|COMPLETED|Open Label Phase||20
5173903|NCT01188564|12724825|P1|COMPLETED|Open Label Phase||24
5173904|NCT01188564|12724824|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
5173905|NCT01188564|12724825|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
5173906|NCT01188564|12724824|P2|NOT COMPLETED|Double-blind Phase||0
5173907|NCT01188564|12724825|P1|NOT COMPLETED|Double-blind Phase||1
5173908|NCT01188564|12724824|P2|COMPLETED|Double-blind Phase||31
5173909|NCT01188564|12724825|P1|COMPLETED|Double-blind Phase||43
5173910|NCT01188564|12724824|P2|STARTED|Double-blind Phase||31
5173911|NCT01188564|12724825|P1|STARTED|Double-blind Phase||44
5173912|NCT01188551|12724837|P4|NOT COMPLETED|Overall Study||0
5173913|NCT01188551|12724838|P3|NOT COMPLETED|Overall Study||0
5173914|NCT01188551|12724839|P2|NOT COMPLETED|Overall Study||0
5173915|NCT01188551|12724840|P1|NOT COMPLETED|Overall Study||1
5173916|NCT01188551|12724837|P4|COMPLETED|Overall Study||25
5173917|NCT01188551|12724838|P3|COMPLETED|Overall Study||25
5173918|NCT01188551|12724839|P2|COMPLETED|Overall Study||25
5173919|NCT01188551|12724840|P1|COMPLETED|Overall Study||24
5173920|NCT01188551|12724837|P4|STARTED|Overall Study||25
5173921|NCT01188551|12724838|P3|STARTED|Overall Study||25
5173922|NCT01188551|12724839|P2|STARTED|Overall Study||25
5173923|NCT01188551|12724840|P1|STARTED|Overall Study||25
5173924|NCT01188538|12724856|P2|NOT COMPLETED|Overall Study||1
5173925|NCT01188538|12724857|P1|NOT COMPLETED|Overall Study||0
5173926|NCT01188538|12724856|P2|COMPLETED|Overall Study||19
5173927|NCT01188538|12724857|P1|COMPLETED|Overall Study||20
5173928|NCT01188538|12724856|P2|STARTED|Overall Study||20
5173929|NCT01188538|12724857|P1|STARTED|Overall Study||20
5173930|NCT01188499|12724870|P5|NOT COMPLETED|Overall Study||0
5173931|NCT01188499|12724871|P4|NOT COMPLETED|Overall Study||0
5173932|NCT01188499|12724872|P3|NOT COMPLETED|Overall Study||0
5173933|NCT01188499|12724873|P2|NOT COMPLETED|Overall Study||0
5173934|NCT01188499|12724874|P1|NOT COMPLETED|Overall Study||0
5173935|NCT01188499|12724870|P5|COMPLETED|Overall Study||18
5173936|NCT01188499|12724871|P4|COMPLETED|Overall Study||18
5173937|NCT01188499|12724872|P3|COMPLETED|Overall Study||33
5173938|NCT01188499|12724873|P2|COMPLETED|Overall Study||83
5173939|NCT01188499|12724874|P1|COMPLETED|Overall Study||24
5173940|NCT01188499|12724870|P5|STARTED|Overall Study||18
5173941|NCT01188499|12724871|P4|STARTED|Overall Study||18
5173942|NCT01188499|12724872|P3|STARTED|Overall Study||33
5173943|NCT01188499|12724873|P2|STARTED|Overall Study||83
5173944|NCT01188499|12724874|P1|STARTED|Overall Study||24
5173945|NCT01188460|12724893|P2|NOT COMPLETED|Overall Study||0
5173946|NCT01188460|12724894|P1|NOT COMPLETED|Overall Study||0
5173947|NCT01188460|12724893|P2|COMPLETED|Overall Study||23
5173948|NCT01188460|12724894|P1|COMPLETED|Overall Study||25
5173949|NCT01188460|12724893|P2|STARTED|Overall Study||23
5173950|NCT01188460|12724894|P1|STARTED|Overall Study||25
5173951|NCT01188447|12724920|P1|NOT COMPLETED|Overall Study||0
5173952|NCT01188447|12724920|P1|COMPLETED|Overall Study||4034
5173953|NCT01188447|12724920|P1|STARTED|Overall Study||4034
5173954|NCT01188421|12724931|P3|NOT COMPLETED|Overall Study||14
5173955|NCT01188421|12724932|P2|NOT COMPLETED|Overall Study||10
5173956|NCT01188421|12724933|P1|NOT COMPLETED|Overall Study||3
5173957|NCT01188421|12724931|P3|COMPLETED|Overall Study||22
5173958|NCT01188421|12724932|P2|COMPLETED|Overall Study||26
5173959|NCT01188421|12724933|P1|COMPLETED|Overall Study||28
5173960|NCT01188421|12724931|P3|STARTED|Overall Study||36
5173961|NCT01188421|12724932|P2|STARTED|Overall Study||36
5173962|NCT01188421|12724933|P1|STARTED|Overall Study||31
5173963|NCT01188369|12724943|P2|NOT COMPLETED|Overall Study||0
5173964|NCT01188369|12724944|P1|NOT COMPLETED|Overall Study||0
5173965|NCT01188369|12724943|P2|COMPLETED|Overall Study||10
5173966|NCT01188369|12724944|P1|COMPLETED|Overall Study||10
5173967|NCT01188369|12724943|P2|STARTED|Overall Study||10
5173968|NCT01188369|12724944|P1|STARTED|Overall Study||10
5173969|NCT01188343|12724953|P3|NOT COMPLETED|Overall Study||1
5173970|NCT01188343|12724954|P2|NOT COMPLETED|Overall Study||26
5173971|NCT01188343|12724955|P1|NOT COMPLETED|Overall Study||1
5173972|NCT01188343|12724953|P3|COMPLETED|Overall Study||220
5173973|NCT01188343|12724954|P2|COMPLETED|Overall Study||193
5173974|NCT01188343|12724955|P1|COMPLETED|Overall Study||101
5173975|NCT01188343|12724953|P3|STARTED|Overall Study||221
5173976|NCT01188343|12724954|P2|STARTED|Overall Study||219
5173977|NCT01188343|12724955|P1|STARTED|Overall Study||102
5173978|NCT01188226|12724981|P1|NOT COMPLETED|Overall Study||4
5173979|NCT01188226|12724981|P1|COMPLETED|Overall Study||6
5173980|NCT01188226|12724981|P1|STARTED|Overall Study||10
5173981|NCT01188109|12725020|P1|NOT COMPLETED|Overall Study||0
5173982|NCT01188109|12725020|P1|COMPLETED|Overall Study||22
5173983|NCT01188109|12725020|P1|STARTED|Overall Study||22
5173984|NCT01187953|12725027|P2|NOT COMPLETED|Overall Study||21
5173985|NCT01187953|12725028|P1|NOT COMPLETED|Overall Study||15
5173986|NCT01187953|12725027|P2|COMPLETED|Overall Study||254
5173987|NCT01187953|12725028|P1|COMPLETED|Overall Study||253
5173988|NCT01187953|12725027|P2|Dosed|Overall Study||271
5173989|NCT01187953|12725028|P1|Dosed|Overall Study||266
5173990|NCT01187953|12725027|P2|STARTED|Overall Study||275
5173991|NCT01187953|12725028|P1|STARTED|Overall Study||268
5173992|NCT01187914|12725036|P1|NOT COMPLETED|Overall Study||0
5173993|NCT01187914|12725036|P1|COMPLETED|Overall Study||40
5173994|NCT01187914|12725036|P1|STARTED|Overall Study||40
5173995|NCT01187901|12725042|P2|NOT COMPLETED|Overall Study||10
5173996|NCT01187901|12725043|P1|NOT COMPLETED|Overall Study||9
5173997|NCT01187901|12725042|P2|COMPLETED|Overall Study||36
5173998|NCT01187901|12725043|P1|COMPLETED|Overall Study||37
5173999|NCT01187901|12725042|P2|STARTED|Overall Study||46
5174000|NCT01187901|12725043|P1|STARTED|Overall Study||46
5174001|NCT01187771|12725061|P2|NOT COMPLETED|Overall Study||3
5174002|NCT01187771|12725062|P1|NOT COMPLETED|Overall Study||3
5174003|NCT01187771|12725061|P2|COMPLETED|Overall Study||18
5174004|NCT01187771|12725062|P1|COMPLETED|Overall Study||25
5174005|NCT01187771|12725061|P2|STARTED|Overall Study||21
5174006|NCT01187771|12725062|P1|STARTED|Overall Study||28
5174007|NCT01187550|12725084|P2|NOT COMPLETED|Overall Study||1
5174008|NCT01187550|12725085|P1|NOT COMPLETED|Overall Study||14
5174009|NCT01187550|12725084|P2|COMPLETED|Overall Study||29
5174010|NCT01187550|12725085|P1|COMPLETED|Overall Study||169
5174011|NCT01187550|12725084|P2|Treated|Overall Study||30
5174012|NCT01187550|12725085|P1|Treated|Overall Study||175
5174013|NCT01187550|12725084|P2|STARTED|Overall Study||30
5174014|NCT01187550|12725085|P1|STARTED|Overall Study||183
5174015|NCT01187511|12725103|P2|NOT COMPLETED|Overall Study||1
5174016|NCT01187511|12725104|P1|NOT COMPLETED|Overall Study||8
5174017|NCT01187511|12725103|P2|COMPLETED|Overall Study||21
5174018|NCT01187511|12725104|P1|COMPLETED|Overall Study||14
5174019|NCT01187511|12725103|P2|STARTED|Overall Study||22
5174020|NCT01187511|12725104|P1|STARTED|Overall Study||22
5174021|NCT01187498|12725212|P2|NOT COMPLETED|Overall Study||10
5174022|NCT01187498|12725213|P1|NOT COMPLETED|Overall Study||9
5174023|NCT01187498|12725212|P2|COMPLETED|Overall Study||60
5174024|NCT01187498|12725213|P1|COMPLETED|Overall Study||64
5174025|NCT01187498|12725212|P2|STARTED|Overall Study||70
5174026|NCT01187498|12725213|P1|STARTED|Overall Study||73
5174027|NCT01187446|12725241|P2|NOT COMPLETED|Overall Study||1
5174028|NCT01187446|12725242|P1|NOT COMPLETED|Overall Study||0
5174029|NCT01187446|12725241|P2|COMPLETED|Overall Study||13
5174030|NCT01187446|12725242|P1|COMPLETED|Overall Study||14
5174031|NCT01187446|12725241|P2|STARTED|Overall Study||14
5174032|NCT01187446|12725242|P1|STARTED|Overall Study||14
5174033|NCT01187433|12725258|P2|NOT COMPLETED|Overall Study||4
5174034|NCT01187433|12725259|P1|NOT COMPLETED|Overall Study||11
5174035|NCT01187433|12725258|P2|COMPLETED|Overall Study||46
5174036|NCT01187433|12725259|P1|COMPLETED|Overall Study||89
5174037|NCT01187433|12725258|P2|STARTED|Overall Study||50
5174038|NCT01187433|12725259|P1|STARTED|Overall Study||100
5174039|NCT01187407|12725289|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
5174040|NCT01187407|12725290|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
5174041|NCT01187407|12725291|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
5174042|NCT01187407|12725292|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
5174043|NCT01187407|12725293|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174044|NCT01187407|12725289|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
5174045|NCT01187407|12725290|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
5174046|NCT01187407|12725291|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
5174047|NCT01187407|12725292|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
5174048|NCT01187407|12725293|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174049|NCT01187407|12725289|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
5174050|NCT01187407|12725290|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
5174051|NCT01187407|12725291|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
5174052|NCT01187407|12725292|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
5174053|NCT01187407|12725293|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174054|NCT01187407|12725289|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
5174055|NCT01187407|12725290|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
5174056|NCT01187407|12725291|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
5174057|NCT01187407|12725292|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
5174058|NCT01187407|12725293|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174059|NCT01187407|12725289|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174060|NCT01187407|12725290|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174061|NCT01187407|12725291|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174062|NCT01187407|12725292|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174063|NCT01187407|12725293|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
5174064|NCT01187407|12725289|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174065|NCT01187407|12725290|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174066|NCT01187407|12725291|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174067|NCT01187407|12725292|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174068|NCT01187407|12725293|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
5174069|NCT01187407|12725289|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174070|NCT01187407|12725290|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174071|NCT01187407|12725291|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174072|NCT01187407|12725292|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174073|NCT01187407|12725293|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
5174074|NCT01187407|12725289|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174075|NCT01187407|12725290|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174076|NCT01187407|12725291|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174077|NCT01187407|12725292|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174078|NCT01187407|12725293|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
5174079|NCT01187381|12725363|P1|NOT COMPLETED|Overall Study||0
5174080|NCT01187381|12725363|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
5174081|NCT01187381|12725363|P1|STARTED|Overall Study||250
5174082|NCT01187355|12725375|P2|NOT COMPLETED|Overall Study||20
5174083|NCT01187355|12725376|P1|NOT COMPLETED|Overall Study||18
5174084|NCT01187355|12725375|P2|COMPLETED|Overall Study||277
5174085|NCT01187355|12725376|P1|COMPLETED|Overall Study||276
5174086|NCT01187355|12725375|P2|STARTED|Overall Study||297
5174087|NCT01187355|12725376|P1|STARTED|Overall Study||294
5174088|NCT01187329|12725388|P2|NOT COMPLETED|Overall Study||2
5174089|NCT01187329|12725389|P1|NOT COMPLETED|Overall Study||1
5174090|NCT01187329|12725388|P2|COMPLETED|Overall Study||48
5174091|NCT01187329|12725389|P1|COMPLETED|Overall Study||49
5174092|NCT01187329|12725388|P2|STARTED|Overall Study||50
5174093|NCT01187329|12725389|P1|STARTED|Overall Study||50
5174094|NCT01187043|12725406|P5|NOT COMPLETED|Overall Study||2
5174095|NCT01187043|12725407|P4|NOT COMPLETED|Overall Study||0
5174096|NCT01187043|12725408|P3|NOT COMPLETED|Overall Study||4
5174097|NCT01187043|12725409|P2|NOT COMPLETED|Overall Study||0
5174098|NCT01187043|12725410|P1|NOT COMPLETED|Overall Study||1
5174099|NCT01187043|12725406|P5|COMPLETED|Overall Study||10
5174100|NCT01187043|12725407|P4|COMPLETED|Overall Study||12
5174101|NCT01187043|12725408|P3|COMPLETED|Overall Study||8
5174102|NCT01187043|12725409|P2|COMPLETED|Overall Study||10
5174103|NCT01187043|12725410|P1|COMPLETED|Overall Study||11
5174104|NCT01187043|12725406|P5|STARTED|Overall Study||12
5174105|NCT01187043|12725407|P4|STARTED|Overall Study||12
5174106|NCT01187043|12725408|P3|STARTED|Overall Study||12
5174107|NCT01187043|12725409|P2|STARTED|Overall Study||10
5174108|NCT01187043|12725410|P1|STARTED|Overall Study||12
5174109|NCT01187017|12725422|P1|NOT COMPLETED|Overall Study||0
5174110|NCT01187017|12725422|P1|COMPLETED|Overall Study||1
5174111|NCT01187017|12725422|P1|STARTED|Overall Study||1
5174112|NCT01187004|12725428|P2|NOT COMPLETED|Overall Study||0
5174113|NCT01187004|12725429|P1|NOT COMPLETED|Overall Study||0
5174114|NCT01187004|12725428|P2|COMPLETED|Overall Study||144
5174115|NCT01187004|12725429|P1|COMPLETED|Overall Study||20
5174116|NCT01187004|12725428|P2|STARTED|Overall Study||144
5174117|NCT01187004|12725429|P1|STARTED|Overall Study||20
5174118|NCT01186978|12725436|P1|NOT COMPLETED|Overall Study||1
5174119|NCT01186978|12725436|P1|COMPLETED|Overall Study||62
5174120|NCT01186978|12725436|P1|STARTED|Overall Study||63
5174121|NCT01186939|12725443|P1|NOT COMPLETED|Overall Study||40
5174122|NCT01186939|12725443|P1|COMPLETED|Overall Study||0
5174123|NCT01186939|12725443|P1|STARTED|Overall Study||40
5174124|NCT01186848|12725447|P1|NOT COMPLETED|Overall Study||8
5174125|NCT01186848|12725447|P1|COMPLETED|Overall Study||22
5174126|NCT01186848|12725447|P1|STARTED|Overall Study||30
5174127|NCT01186809|12725453|P1|NOT COMPLETED|Overall Study||30
5174128|NCT01186809|12725453|P1|COMPLETED|Overall Study||43
5174129|NCT01186809|12725453|P1|STARTED|Overall Study||73
5174130|NCT01186796|12725459|P2|NOT COMPLETED|Overall Study||2
5174131|NCT01186796|12725460|P1|NOT COMPLETED|Overall Study||4
5174132|NCT01186796|12725459|P2|COMPLETED|Overall Study||14
5174133|NCT01186796|12725460|P1|COMPLETED|Overall Study||10
5174134|NCT01186796|12725459|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
5174135|NCT01186796|12725460|P1|STARTED|Overall Study||14
5174136|NCT01186770|12725478|P4|NOT COMPLETED|Overall Study||58
5174137|NCT01186770|12725479|P3|NOT COMPLETED|Overall Study||52
5174138|NCT01186770|12725480|P2|NOT COMPLETED|Overall Study||46
5174139|NCT01186770|12725481|P1|NOT COMPLETED|Overall Study||41
5174140|NCT01186770|12725478|P4|COMPLETED|Overall Study||143
5174141|NCT01186770|12725479|P3|COMPLETED|Overall Study||148
5174142|NCT01186770|12725480|P2|COMPLETED|Overall Study||156
5174143|NCT01186770|12725481|P1|COMPLETED|Overall Study||160
5174144|NCT01186770|12725478|P4|Intent-to-treat (ITT Population)|Overall Study||201
5174145|NCT01186770|12725479|P3|Intent-to-treat (ITT Population)|Overall Study||200
5174146|NCT01186770|12725480|P2|Intent-to-treat (ITT Population)|Overall Study||201
5174147|NCT01186770|12725481|P1|Intent-to-treat (ITT Population)|Overall Study||201
5174148|NCT01186770|12725478|P4|STARTED|Overall Study||201
5174149|NCT01186770|12725479|P3|STARTED|Overall Study||200
5174150|NCT01186770|12725480|P2|STARTED|Overall Study||202
5174151|NCT01186770|12725481|P1|STARTED|Overall Study||201
5174152|NCT01186744|12725505|P6|NOT COMPLETED|Overall Study||26
5174153|NCT01186744|12725506|P5|NOT COMPLETED|Overall Study||6
5174154|NCT01186744|12725507|P4|NOT COMPLETED|Overall Study||12
5174155|NCT01186744|12725508|P3|NOT COMPLETED|Overall Study||6
5174156|NCT01186744|12725509|P2|NOT COMPLETED|Overall Study||152
5174157|NCT01186744|12725510|P1|NOT COMPLETED|Overall Study||208
5174158|NCT01186744|12725505|P6|COMPLETED|Overall Study||107
5174159|NCT01186744|12725506|P5|COMPLETED|Overall Study||39
5174160|NCT01186744|12725507|P4|COMPLETED|Overall Study||70
5174161|NCT01186744|12725508|P3|COMPLETED|Overall Study||25
5174162|NCT01186744|12725509|P2|COMPLETED|Overall Study||5
5174163|NCT01186744|12725510|P1|COMPLETED|Overall Study||10
5174164|NCT01186744|12725505|P6|STARTED|Overall Study||133
5174165|NCT01186744|12725506|P5|STARTED|Overall Study||45
5174166|NCT01186744|12725507|P4|STARTED|Overall Study||82
5174167|NCT01186744|12725508|P3|STARTED|Overall Study||31
5174168|NCT01186744|12725509|P2|STARTED|Overall Study||157
5174169|NCT01186744|12725510|P1|STARTED|Overall Study||218
5174170|NCT01186705|12725926|P1|NOT COMPLETED|Overall Study||0
5174171|NCT01186705|12725926|P1|COMPLETED|Overall Study||1
5174172|NCT01186705|12725926|P1|STARTED|Overall Study||1
5174173|NCT01186692|12725930|P1|NOT COMPLETED|Overall Study||32
5174174|NCT01186692|12725930|P1|COMPLETED|Overall Study||99
5174175|NCT01186692|12725930|P1|STARTED|Overall Study||131
5174176|NCT01186562|12725940|P2|NOT COMPLETED|Overall Study||2
5174177|NCT01186562|12725941|P1|NOT COMPLETED|Overall Study||4
5174178|NCT01186562|12725940|P2|COMPLETED|Overall Study||27
5174179|NCT01186562|12725941|P1|COMPLETED|Overall Study||50
5174180|NCT01186562|12725940|P2|STARTED|Overall Study||29
5174181|NCT01186562|12725941|P1|STARTED|Overall Study||54
5174182|NCT01186458|12725957|P1|NOT COMPLETED|Overall Study||1
5174183|NCT01186458|12725957|P1|COMPLETED|Overall Study||3
5174184|NCT01186458|12725957|P1|STARTED|Overall Study||4
5174185|NCT01186419|12725966|P2|NOT COMPLETED|Overall Study||9
5174186|NCT01186419|12725967|P1|NOT COMPLETED|Overall Study||7
5174187|NCT01186419|12725966|P2|COMPLETED|Overall Study||18
5174188|NCT01186419|12725967|P1|COMPLETED|Overall Study||17
5174189|NCT01186419|12725966|P2|STARTED|Overall Study||27
5174190|NCT01186419|12725967|P1|STARTED|Overall Study||24
5174191|NCT01186406|12725974|P1|NOT COMPLETED|Overall Study||0
5174192|NCT01186406|12725974|P1|COMPLETED|Overall Study||41
5174193|NCT01186406|12725974|P1|STARTED|Overall Study||41
5174194|NCT01186328|12725981|P3|NOT COMPLETED|Overall Study||0
5174195|NCT01186328|12725982|P2|NOT COMPLETED|Overall Study||0
5174196|NCT01186328|12725983|P1|NOT COMPLETED|Overall Study||1
5174197|NCT01186328|12725981|P3|COMPLETED|Overall Study||0
5174198|NCT01186328|12725982|P2|COMPLETED|Overall Study||0
5174199|NCT01186328|12725983|P1|COMPLETED|Overall Study||5
5174200|NCT01186328|12725981|P3|STARTED|Overall Study||0
5174201|NCT01186328|12725982|P2|STARTED|Overall Study||0
5174202|NCT01186328|12725983|P1|STARTED|Overall Study||6
5174203|NCT01186250|12725991|P2|NOT COMPLETED|Overall Study||0
5174204|NCT01186250|12725992|P1|NOT COMPLETED|Overall Study||1
5174205|NCT01186250|12725991|P2|COMPLETED|Overall Study||9
5174206|NCT01186250|12725992|P1|COMPLETED|Overall Study||8
5174207|NCT01186250|12725991|P2|STARTED|Overall Study||9
5174208|NCT01186250|12725992|P1|STARTED|Overall Study||9
5174209|NCT01185964|12726013|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
5174210|NCT01185964|12726014|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174211|NCT01185964|12726015|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174212|NCT01185964|12726016|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174213|NCT01185964|12726013|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
5174214|NCT01185964|12726014|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174215|NCT01185964|12726015|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174216|NCT01185964|12726016|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
5174217|NCT01185964|12726013|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
5174218|NCT01185964|12726014|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
5174219|NCT01185964|12726015|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
5174220|NCT01185964|12726016|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
5174221|NCT01185964|12726013|P4|NOT COMPLETED|Phase 1b and Phase 2||0
5174222|NCT01185964|12726014|P3|NOT COMPLETED|Phase 1b and Phase 2||9
5174223|NCT01185964|12726015|P2|NOT COMPLETED|Phase 1b and Phase 2||10
5174224|NCT01185964|12726016|P1|NOT COMPLETED|Phase 1b and Phase 2||2
5174225|NCT01185964|12726013|P4|COMPLETED|Phase 1b and Phase 2||0
5174226|NCT01185964|12726014|P3|COMPLETED|Phase 1b and Phase 2||58
5174227|NCT01185964|12726015|P2|COMPLETED|Phase 1b and Phase 2||56
5174228|NCT01185964|12726016|P1|COMPLETED|Phase 1b and Phase 2||13
5174229|NCT01185964|12726013|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
5174230|NCT01185964|12726014|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
5174231|NCT01185964|12726015|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
5174232|NCT01185964|12726016|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
5174233|NCT01185964|12726013|P4|STARTED|Phase 1b and Phase 2||0
5174234|NCT01185964|12726014|P3|STARTED|Phase 1b and Phase 2||67
5174235|NCT01185964|12726015|P2|STARTED|Phase 1b and Phase 2||66
5174236|NCT01185964|12726016|P1|STARTED|Phase 1b and Phase 2||15
5174237|NCT01185834|12726042|P1|NOT COMPLETED|Overall Study||14
5174238|NCT01185834|12726042|P1|COMPLETED|Overall Study||104
5174239|NCT01185834|12726042|P1|STARTED|Overall Study||118
5174240|NCT01185821|12726052|P5|NOT COMPLETED|Overall Study||24
5174241|NCT01185821|12726053|P4|NOT COMPLETED|Overall Study||6
5174242|NCT01185821|12726054|P3|NOT COMPLETED|Overall Study||10
5174243|NCT01185821|12726055|P2|NOT COMPLETED|Overall Study||9
5174244|NCT01185821|12726056|P1|NOT COMPLETED|Overall Study||7
5174245|NCT01185821|12726052|P5|COMPLETED|Overall Study||26
5174246|NCT01185821|12726053|P4|COMPLETED|Overall Study||23
5174247|NCT01185821|12726054|P3|COMPLETED|Overall Study||33
5174248|NCT01185821|12726055|P2|COMPLETED|Overall Study||20
5174249|NCT01185821|12726056|P1|COMPLETED|Overall Study||26
5174250|NCT01185821|12726052|P5|Patients on Placebo in Core|Overall Study||2
5174251|NCT01185821|12726053|P4|Patients on Placebo in Core|Overall Study||8
5174252|NCT01185821|12726054|P3|Patients on Placebo in Core|Overall Study||9
5174253|NCT01185821|12726055|P2|Patients on Placebo in Core|Overall Study||7
5174254|NCT01185821|12726056|P1|Patients on Placebo in Core|Overall Study||8
5174255|NCT01185821|12726052|P5|Patients Without Washout|Overall Study||17
5174256|NCT01185821|12726053|P4|Patients Without Washout|Overall Study||0
5174257|NCT01185821|12726054|P3|Patients Without Washout|Overall Study||4
5174258|NCT01185821|12726055|P2|Patients Without Washout|Overall Study||0
5174259|NCT01185821|12726056|P1|Patients Without Washout|Overall Study||0
5174260|NCT01185821|12726052|P5|Patients With Washout|Overall Study||33
5174261|NCT01185821|12726053|P4|Patients With Washout|Overall Study||29
5174262|NCT01185821|12726054|P3|Patients With Washout|Overall Study||39
5174263|NCT01185821|12726055|P2|Patients With Washout|Overall Study||29
5174264|NCT01185821|12726056|P1|Patients With Washout|Overall Study||33
5174265|NCT01185821|12726052|P5|STARTED|Overall Study||50
5174266|NCT01185821|12726053|P4|STARTED|Overall Study||29
5174267|NCT01185821|12726054|P3|STARTED|Overall Study||43
5174268|NCT01185821|12726055|P2|STARTED|Overall Study||29
5174269|NCT01185821|12726056|P1|STARTED|Overall Study||33
5174270|NCT01185782|12726107|P2|NOT COMPLETED|Overall Study||11
5174271|NCT01185782|12726108|P1|NOT COMPLETED|Overall Study||6
5174272|NCT01185782|12726107|P2|COMPLETED|Overall Study||125
5174273|NCT01185782|12726108|P1|COMPLETED|Overall Study||123
5174274|NCT01185782|12726107|P2|Treated|Overall Study||132
5174275|NCT01185782|12726108|P1|Treated|Overall Study||129
5174276|NCT01185782|12726107|P2|STARTED|Overall Study||136
5174277|NCT01185782|12726108|P1|STARTED|Overall Study||129
5174278|NCT01185704|12726136|P2|NOT COMPLETED|Overall Study||8
5174279|NCT01185704|12726137|P1|NOT COMPLETED|Overall Study||13
5174280|NCT01185704|12726136|P2|COMPLETED|Overall Study||60
5174281|NCT01185704|12726137|P1|COMPLETED|Overall Study||55
5174282|NCT01185704|12726136|P2|Treated|Overall Study||65
5174283|NCT01185704|12726137|P1|Treated|Overall Study||65
5174284|NCT01185704|12726136|P2|STARTED|Overall Study||68
5174285|NCT01185704|12726137|P1|STARTED|Overall Study||68
5174286|NCT01185639|12726171|P1|NOT COMPLETED|Overall Study||2
5174287|NCT01185639|12726171|P1|COMPLETED|Overall Study||27
5174288|NCT01185639|12726171|P1|STARTED|Overall Study||29
5174289|NCT01185600|12726181|P2|NOT COMPLETED|Overall Study||45
5174290|NCT01185600|12726182|P1|NOT COMPLETED|Overall Study||32
5174291|NCT01185600|12726181|P2|COMPLETED|Overall Study||59
5174292|NCT01185600|12726182|P1|COMPLETED|Overall Study||41
5174293|NCT01185600|12726181|P2|STARTED|Overall Study||104
5174294|NCT01185600|12726182|P1|STARTED|Overall Study||73
5174295|NCT01185561|12726204|P2|NOT COMPLETED|Overall Study||12
5174296|NCT01185561|12726205|P1|NOT COMPLETED|Overall Study||2
5174297|NCT01185561|12726204|P2|COMPLETED|Overall Study||26
5174298|NCT01185561|12726205|P1|COMPLETED|Overall Study||34
5174299|NCT01185561|12726204|P2|STARTED|Overall Study||38
5174300|NCT01185561|12726205|P1|STARTED|Overall Study||36
5174301|NCT01185548|12726217|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
5174302|NCT01185548|12726217|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
5174303|NCT01185548|12726217|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
5174304|NCT01185548|12726217|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
5174305|NCT01185548|12726217|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
5174306|NCT01185548|12726217|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
5174307|NCT01185548|12726217|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
5174308|NCT01185548|12726217|P1|COMPLETED|Period 1 : Tolbutamide||4
5174309|NCT01185548|12726217|P1|STARTED|Period 1 : Tolbutamide||4
5174310|NCT01185522|12726230|P1|NOT COMPLETED|Overall Study||108
5174311|NCT01185522|12726230|P1|COMPLETED|Overall Study||585
5174312|NCT01185522|12726230|P1|STARTED|Overall Study||693
5174313|NCT01185509|12726256|P2|NOT COMPLETED|Overall Study||20
5174314|NCT01185509|12726257|P1|NOT COMPLETED|Overall Study||11
5174315|NCT01185509|12726256|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
5174316|NCT01185509|12726257|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
5174317|NCT01185509|12726256|P2|STARTED|Overall Study||20
5174318|NCT01185509|12726257|P1|STARTED|Overall Study||11
5174319|NCT01185353|12726273|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
5174320|NCT01185353|12726274|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
5174321|NCT01185353|12726275|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
5174322|NCT01185353|12726276|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174323|NCT01185353|12726277|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174324|NCT01185353|12726278|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174325|NCT01185353|12726279|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174326|NCT01185353|12726280|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174327|NCT01185353|12726281|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174328|NCT01185353|12726282|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
5174329|NCT01185353|12726273|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
5174330|NCT01185353|12726274|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
5174331|NCT01185353|12726275|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
5174332|NCT01185353|12726276|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
5174333|NCT01185353|12726277|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
5174334|NCT01185353|12726278|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
5174335|NCT01185353|12726279|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
5174336|NCT01185353|12726280|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
5174337|NCT01185353|12726281|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
5174338|NCT01185353|12726282|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
5174339|NCT01185353|12726273|P10|STARTED|Part D (Weeks 76 Through 128)||18
5174340|NCT01185353|12726274|P9|STARTED|Part D (Weeks 76 Through 128)||47
5174341|NCT01185353|12726275|P8|STARTED|Part D (Weeks 76 Through 128)||79
5174342|NCT01185353|12726276|P7|STARTED|Part D (Weeks 76 Through 128)||0
5174343|NCT01185353|12726277|P6|STARTED|Part D (Weeks 76 Through 128)||0
5174344|NCT01185353|12726278|P5|STARTED|Part D (Weeks 76 Through 128)||0
5174345|NCT01185353|12726279|P4|STARTED|Part D (Weeks 76 Through 128)||0
5174346|NCT01185353|12726280|P3|STARTED|Part D (Weeks 76 Through 128)||0
5174347|NCT01185353|12726281|P2|STARTED|Part D (Weeks 76 Through 128)||0
5174348|NCT01185353|12726282|P1|STARTED|Part D (Weeks 76 Through 128)||0
5174349|NCT01185353|12726273|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
5174350|NCT01185353|12726274|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
5174351|NCT01185353|12726275|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
5174352|NCT01185353|12726276|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174353|NCT01185353|12726277|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174354|NCT01185353|12726278|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174355|NCT01185353|12726279|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174356|NCT01185353|12726280|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174357|NCT01185353|12726281|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174358|NCT01185353|12726282|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
5174359|NCT01185353|12726273|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
5174360|NCT01185353|12726274|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
5174361|NCT01185353|12726275|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
5174362|NCT01185353|12726276|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
5174363|NCT01185353|12726277|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
5174364|NCT01185353|12726278|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
5174365|NCT01185353|12726279|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
5174366|NCT01185353|12726280|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
5174367|NCT01185353|12726281|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
5174368|NCT01185353|12726282|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
5174369|NCT01185353|12726273|P10|STARTED|Part C (Weeks 24 Through 76)||32
5174370|NCT01185353|12726274|P9|STARTED|Part C (Weeks 24 Through 76)||61
5174371|NCT01185353|12726275|P8|STARTED|Part C (Weeks 24 Through 76)||108
5174372|NCT01185353|12726276|P7|STARTED|Part C (Weeks 24 Through 76)||0
5174373|NCT01185353|12726277|P6|STARTED|Part C (Weeks 24 Through 76)||0
5174374|NCT01185353|12726278|P5|STARTED|Part C (Weeks 24 Through 76)||0
5174375|NCT01185353|12726279|P4|STARTED|Part C (Weeks 24 Through 76)||0
5174376|NCT01185353|12726280|P3|STARTED|Part C (Weeks 24 Through 76)||0
5174377|NCT01185353|12726281|P2|STARTED|Part C (Weeks 24 Through 76)||0
5174378|NCT01185353|12726282|P1|STARTED|Part C (Weeks 24 Through 76)||0
5174379|NCT01185353|12726273|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
5174380|NCT01185353|12726274|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
5174381|NCT01185353|12726275|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
5174382|NCT01185353|12726276|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
5174383|NCT01185353|12726277|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
5174384|NCT01185353|12726278|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
5174385|NCT01185353|12726279|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
5174386|NCT01185353|12726280|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
5174387|NCT01185353|12726281|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
5174388|NCT01185353|12726282|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
5174389|NCT01185353|12726273|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
5174390|NCT01185353|12726274|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
5174391|NCT01185353|12726275|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
5174392|NCT01185353|12726276|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
5174393|NCT01185353|12726277|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
5174394|NCT01185353|12726278|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
5174395|NCT01185353|12726279|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
5174396|NCT01185353|12726280|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
5174397|NCT01185353|12726281|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
5174398|NCT01185353|12726282|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
5174399|NCT01185353|12726273|P10|STARTED|Part B (Weeks 12 Through 24)||0
5174400|NCT01185353|12726274|P9|STARTED|Part B (Weeks 12 Through 24)||0
5174401|NCT01185353|12726275|P8|STARTED|Part B (Weeks 12 Through 24)||0
5174402|NCT01185353|12726276|P7|STARTED|Part B (Weeks 12 Through 24)||63
5174403|NCT01185353|12726277|P6|STARTED|Part B (Weeks 12 Through 24)||63
5174404|NCT01185353|12726278|P5|STARTED|Part B (Weeks 12 Through 24)||0
5174405|NCT01185353|12726279|P4|STARTED|Part B (Weeks 12 Through 24)||49
5174406|NCT01185353|12726280|P3|STARTED|Part B (Weeks 12 Through 24)||50
5174407|NCT01185353|12726281|P2|STARTED|Part B (Weeks 12 Through 24)||51
5174408|NCT01185353|12726282|P1|STARTED|Part B (Weeks 12 Through 24)||0
5174409|NCT01185353|12726273|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
5174410|NCT01185353|12726274|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
5174411|NCT01185353|12726275|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
5174412|NCT01185353|12726276|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
5174413|NCT01185353|12726277|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
5174414|NCT01185353|12726278|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
5174415|NCT01185353|12726279|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
5174416|NCT01185353|12726280|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
5174417|NCT01185353|12726281|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
5174418|NCT01185353|12726282|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
5174419|NCT01185353|12726273|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
5174420|NCT01185353|12726274|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
5174421|NCT01185353|12726275|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
5174422|NCT01185353|12726276|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
5174423|NCT01185353|12726277|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
5174424|NCT01185353|12726278|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
5174425|NCT01185353|12726279|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
5174426|NCT01185353|12726280|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
5174427|NCT01185353|12726281|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
5174428|NCT01185353|12726282|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
5174429|NCT01185353|12726273|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
5174430|NCT01185353|12726274|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
5174431|NCT01185353|12726275|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
5174432|NCT01185353|12726276|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
5174433|NCT01185353|12726277|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
5174434|NCT01185353|12726278|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
5174435|NCT01185353|12726279|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
5174436|NCT01185353|12726280|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
5174437|NCT01185353|12726281|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
5174438|NCT01185353|12726282|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
5174439|NCT01185353|12726273|P10|STARTED|Part A (Weeks 0 Through 12)||0
5174440|NCT01185353|12726274|P9|STARTED|Part A (Weeks 0 Through 12)||0
5174441|NCT01185353|12726275|P8|STARTED|Part A (Weeks 0 Through 12)||0
5174442|NCT01185353|12726276|P7|STARTED|Part A (Weeks 0 Through 12)||0
5174443|NCT01185353|12726277|P6|STARTED|Part A (Weeks 0 Through 12)||0
5174444|NCT01185353|12726278|P5|STARTED|Part A (Weeks 0 Through 12)||98
5174445|NCT01185353|12726279|P4|STARTED|Part A (Weeks 0 Through 12)||50
5174446|NCT01185353|12726280|P3|STARTED|Part A (Weeks 0 Through 12)||52
5174447|NCT01185353|12726281|P2|STARTED|Part A (Weeks 0 Through 12)||52
5174448|NCT01185353|12726282|P1|STARTED|Part A (Weeks 0 Through 12)||49
5174449|NCT01185340|12726443|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
5174450|NCT01185340|12726444|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
5174451|NCT01185340|12726445|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
5174452|NCT01185340|12726446|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174453|NCT01185340|12726443|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
5174454|NCT01185340|12726444|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
5174455|NCT01185340|12726445|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
5174456|NCT01185340|12726446|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174457|NCT01185340|12726443|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
5174458|NCT01185340|12726444|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
5174459|NCT01185340|12726445|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
5174460|NCT01185340|12726446|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174461|NCT01185340|12726443|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
5174462|NCT01185340|12726444|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
5174463|NCT01185340|12726445|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
5174464|NCT01185340|12726446|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5174465|NCT01185340|12726443|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174466|NCT01185340|12726444|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174467|NCT01185340|12726445|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174468|NCT01185340|12726446|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
5174469|NCT01185340|12726443|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174470|NCT01185340|12726444|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174471|NCT01185340|12726445|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5174472|NCT01185340|12726446|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
5174473|NCT01185340|12726443|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174474|NCT01185340|12726444|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174475|NCT01185340|12726445|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
5174476|NCT01185340|12726446|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
5174477|NCT01185340|12726443|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174478|NCT01185340|12726444|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174479|NCT01185340|12726445|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5174480|NCT01185340|12726446|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
5174481|NCT01185301|12726498|P4|NOT COMPLETED|Overall Study||9
5174482|NCT01185301|12726499|P3|NOT COMPLETED|Overall Study||6
5174483|NCT01185301|12726500|P2|NOT COMPLETED|Overall Study||7
5174484|NCT01185301|12726501|P1|NOT COMPLETED|Overall Study||15
5174485|NCT01185301|12726498|P4|COMPLETED|Overall Study||89
5174486|NCT01185301|12726499|P3|COMPLETED|Overall Study||93
5174487|NCT01185301|12726500|P2|COMPLETED|Overall Study||93
5174488|NCT01185301|12726501|P1|COMPLETED|Overall Study||83
5174489|NCT01185301|12726498|P4|STARTED|Overall Study||98
5174490|NCT01185301|12726499|P3|STARTED|Overall Study||99
5174491|NCT01185301|12726500|P2|STARTED|Overall Study||100
5174492|NCT01185301|12726501|P1|STARTED|Overall Study||98
5174493|NCT01185288|12726561|P2|NOT COMPLETED|Overall Study||16
5174494|NCT01185288|12726562|P1|NOT COMPLETED|Overall Study||19
5174495|NCT01185288|12726561|P2|COMPLETED|Overall Study||139
5174496|NCT01185288|12726562|P1|COMPLETED|Overall Study||135
5174497|NCT01185288|12726561|P2|STARTED|Overall Study||155
5174498|NCT01185288|12726562|P1|STARTED|Overall Study||154
5174499|NCT01185249|12726580|P1|NOT COMPLETED|Overall Study||42
5174500|NCT01185249|12726580|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
5174501|NCT01185249|12726580|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
5174502|NCT01185171|12726585|P1|NOT COMPLETED|Maintenance||12
5174503|NCT01185171|12726585|P1|COMPLETED|Maintenance||48
5174504|NCT01185171|12726585|P1|STARTED|Maintenance||60
5174505|NCT01185171|12726585|P1|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
5174506|NCT01185171|12726585|P1|COMPLETED|Concurrent Chemo and Radiation Treatment||66
5174507|NCT01185171|12726585|P1|STARTED|Concurrent Chemo and Radiation Treatment||69
5174508|NCT01185171|12726585|P1|NOT COMPLETED|Induction Chemotherapy||2
5174509|NCT01185171|12726585|P1|COMPLETED|Induction Chemotherapy||57
5174510|NCT01185171|12726585|P1|STARTED|Induction Chemotherapy||59
5174511|NCT01185080|12726595|P3|NOT COMPLETED|Overall Study||1
5174512|NCT01185080|12726596|P2|NOT COMPLETED|Overall Study||1
5174513|NCT01185080|12726597|P1|NOT COMPLETED|Overall Study||1
5174514|NCT01185080|12726595|P3|COMPLETED|Overall Study||16
5174515|NCT01185080|12726596|P2|COMPLETED|Overall Study||15
5174516|NCT01185080|12726597|P1|COMPLETED|Overall Study||49
5174517|NCT01185080|12726595|P3|STARTED|Overall Study||17
5174518|NCT01185080|12726596|P2|STARTED|Overall Study||16
5174519|NCT01185080|12726597|P1|STARTED|Overall Study||50
5174520|NCT01185028|12726644|P1|NOT COMPLETED|Overall Study||4
5174521|NCT01185028|12726644|P1|COMPLETED|Overall Study||4
5174522|NCT01185028|12726644|P1|STARTED|Overall Study||8
5174523|NCT01184989|12726649|P1|NOT COMPLETED|Overall Study||12
5174524|NCT01184989|12726649|P1|COMPLETED|Overall Study||100
5174525|NCT01184989|12726649|P1|STARTED|Overall Study|Treated Patients|112
5174526|NCT01184898|12726655|P1|NOT COMPLETED|Overall Study||0
5174527|NCT01184898|12726655|P1|COMPLETED|Overall Study||36
5174528|NCT01184898|12726655|P1|STARTED|Overall Study||36
5174529|NCT01184885|12726662|P1|NOT COMPLETED|Overall Study||0
5174530|NCT01184885|12726662|P1|COMPLETED|Overall Study||7
5174531|NCT01184885|12726662|P1|STARTED|Overall Study||7
5174532|NCT01184872|12726669|P2|NOT COMPLETED|Overall Study||8
5174533|NCT01184872|12726670|P1|NOT COMPLETED|Overall Study||10
5174534|NCT01184872|12726669|P2|COMPLETED|Overall Study||31
5174535|NCT01184872|12726670|P1|COMPLETED|Overall Study||71
5174536|NCT01184872|12726669|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
5174537|NCT01184872|12726670|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
5174538|NCT01184872|12726669|P2|Clinical Evaluable Set (CES)|Overall Study||30
5174539|NCT01184872|12726670|P1|Clinical Evaluable Set (CES)|Overall Study||73
5174540|NCT01184872|12726669|P2|Safety Set|Overall Study||40
5174541|NCT01184872|12726670|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
5174542|NCT01184872|12726669|P2|STARTED|Overall Study||39
5174543|NCT01184872|12726670|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
5174544|NCT01184859|12726689|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
5174545|NCT01184859|12726690|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
5174546|NCT01184859|12726691|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
5174547|NCT01184859|12726692|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
5174548|NCT01184859|12726693|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
5174549|NCT01184859|12726689|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
5174550|NCT01184859|12726690|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
5174551|NCT01184859|12726691|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
5174552|NCT01184859|12726692|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
5174553|NCT01184859|12726693|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
5174554|NCT01184859|12726689|P5|STARTED|Period 2: Daily Dose for 28 Days||23
5174555|NCT01184859|12726690|P4|STARTED|Period 2: Daily Dose for 28 Days||22
5174556|NCT01184859|12726691|P3|STARTED|Period 2: Daily Dose for 28 Days||22
5174557|NCT01184859|12726692|P2|STARTED|Period 2: Daily Dose for 28 Days||23
5174558|NCT01184859|12726693|P1|STARTED|Period 2: Daily Dose for 28 Days||23
5174559|NCT01184859|12726689|P5|NOT COMPLETED|Washout Period||0
5174560|NCT01184859|12726690|P4|NOT COMPLETED|Washout Period||0
5174561|NCT01184859|12726691|P3|NOT COMPLETED|Washout Period||0
5174562|NCT01184859|12726692|P2|NOT COMPLETED|Washout Period||0
5174563|NCT01184859|12726693|P1|NOT COMPLETED|Washout Period||0
5174564|NCT01184859|12726689|P5|COMPLETED|Washout Period||23
5174565|NCT01184859|12726690|P4|COMPLETED|Washout Period||22
5174566|NCT01184859|12726691|P3|COMPLETED|Washout Period||22
5174567|NCT01184859|12726692|P2|COMPLETED|Washout Period||23
5174568|NCT01184859|12726693|P1|COMPLETED|Washout Period||23
5174569|NCT01184859|12726689|P5|STARTED|Washout Period||23
5174570|NCT01184859|12726690|P4|STARTED|Washout Period||22
5174571|NCT01184859|12726691|P3|STARTED|Washout Period||22
5174572|NCT01184859|12726692|P2|STARTED|Washout Period||23
5174573|NCT01184859|12726693|P1|STARTED|Washout Period||23
5174574|NCT01184859|12726689|P5|NOT COMPLETED|Period 1: Single Dose||1
5174575|NCT01184859|12726690|P4|NOT COMPLETED|Period 1: Single Dose||0
5174576|NCT01184859|12726691|P3|NOT COMPLETED|Period 1: Single Dose||0
5174577|NCT01184859|12726692|P2|NOT COMPLETED|Period 1: Single Dose||2
5174578|NCT01184859|12726693|P1|NOT COMPLETED|Period 1: Single Dose||0
5174579|NCT01184859|12726689|P5|COMPLETED|Period 1: Single Dose||23
5174580|NCT01184859|12726690|P4|COMPLETED|Period 1: Single Dose||22
5174581|NCT01184859|12726691|P3|COMPLETED|Period 1: Single Dose||22
5174582|NCT01184859|12726692|P2|COMPLETED|Period 1: Single Dose||23
5174583|NCT01184859|12726693|P1|COMPLETED|Period 1: Single Dose||23
5174584|NCT01184859|12726689|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
5174585|NCT01184859|12726690|P4|Per Protocol (PP)|Period 1: Single Dose||21
5174586|NCT01184859|12726691|P3|Per Protocol (PP)|Period 1: Single Dose||22
5174587|NCT01184859|12726692|P2|Per Protocol (PP)|Period 1: Single Dose||23
5174588|NCT01184859|12726693|P1|Per Protocol (PP)|Period 1: Single Dose||23
5174589|NCT01184859|12726689|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
5174590|NCT01184859|12726690|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
5174591|NCT01184859|12726691|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
5174592|NCT01184859|12726692|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
5174593|NCT01184859|12726693|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
5174594|NCT01184859|12726689|P5|STARTED|Period 1: Single Dose||24
5174595|NCT01184859|12726690|P4|STARTED|Period 1: Single Dose||22
5174596|NCT01184859|12726691|P3|STARTED|Period 1: Single Dose||22
5174597|NCT01184859|12726692|P2|STARTED|Period 1: Single Dose||25
5174598|NCT01184859|12726693|P1|STARTED|Period 1: Single Dose||23
5174599|NCT01184846|12726785|P1|NOT COMPLETED|Overall Study||3
5174600|NCT01184846|12726785|P1|COMPLETED|Overall Study||25
5174601|NCT01184846|12726785|P1|STARTED|Overall Study||28
5174602|NCT01184755|12726806|P3|NOT COMPLETED|Overall Study||6
5174603|NCT01184755|12726807|P2|NOT COMPLETED|Overall Study||11
5174604|NCT01184755|12726808|P1|NOT COMPLETED|Overall Study||25
5174605|NCT01184755|12726806|P3|COMPLETED|Overall Study||56
5174606|NCT01184755|12726807|P2|COMPLETED|Overall Study||54
5174607|NCT01184755|12726808|P1|COMPLETED|Overall Study||101
5174608|NCT01184755|12726806|P3|STARTED|Overall Study||62
5174609|NCT01184755|12726807|P2|STARTED|Overall Study||65
5174610|NCT01184755|12726808|P1|STARTED|Overall Study||126
5174611|NCT01184508|12726818|P2|NOT COMPLETED|Overall Study||15
5174612|NCT01184508|12726819|P1|NOT COMPLETED|Overall Study||16
5174613|NCT01184508|12726818|P2|COMPLETED|Overall Study||27
5174614|NCT01184508|12726819|P1|COMPLETED|Overall Study||29
5174615|NCT01184508|12726818|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
5174616|NCT01184508|12726819|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
5174617|NCT01184508|12726818|P2|STARTED|Overall Study||42
5174618|NCT01184508|12726819|P1|STARTED|Overall Study||45
5174619|NCT01184456|12726846|P2|NOT COMPLETED|Overall Study||0
5174620|NCT01184456|12726847|P1|NOT COMPLETED|Overall Study||0
5174621|NCT01184456|12726846|P2|COMPLETED|Overall Study||0
5174622|NCT01184456|12726847|P1|COMPLETED|Overall Study||0
5174623|NCT01184456|12726846|P2|STARTED|Overall Study||0
5174624|NCT01184456|12726847|P1|STARTED|Overall Study||0
5174625|NCT01184417|12726855|P2|NOT COMPLETED|Overall Study||0
5174626|NCT01184417|12726856|P1|NOT COMPLETED|Overall Study||0
5174627|NCT01184417|12726855|P2|COMPLETED|Overall Study||51
5174628|NCT01184417|12726856|P1|COMPLETED|Overall Study||51
5174629|NCT01184417|12726855|P2|STARTED|Overall Study||51
5174630|NCT01184417|12726856|P1|STARTED|Overall Study||51
5174631|NCT01184326|12726879|P3|NOT COMPLETED|Overall Study||14
5174632|NCT01184326|12726880|P2|NOT COMPLETED|Overall Study||6
5174633|NCT01184326|12726881|P1|NOT COMPLETED|Overall Study||3
5174634|NCT01184326|12726879|P3|COMPLETED|Overall Study||0
5174635|NCT01184326|12726880|P2|COMPLETED|Overall Study||0
5174636|NCT01184326|12726881|P1|COMPLETED|Overall Study||0
5174637|NCT01184326|12726879|P3|STARTED|Overall Study||14
5174638|NCT01184326|12726880|P2|STARTED|Overall Study||6
5174639|NCT01184326|12726881|P1|STARTED|Overall Study||3
5174640|NCT01184118|12726895|P1|NOT COMPLETED|Overall Study||18
5174641|NCT01184118|12726895|P1|COMPLETED|Overall Study||18
5174642|NCT01184118|12726895|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
5174643|NCT01184118|12726895|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
5174644|NCT01184118|12726895|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
5174645|NCT01184118|12726895|P1|STARTED|Overall Study||36
5174646|NCT01184079|12726903|P2|NOT COMPLETED|Overall Study||2
5174647|NCT01184079|12726904|P1|NOT COMPLETED|Overall Study||14
5174648|NCT01184079|12726903|P2|COMPLETED|Overall Study||107
5174649|NCT01184079|12726904|P1|COMPLETED|Overall Study||97
5174650|NCT01184079|12726903|P2|Final Blood Draw|Overall Study||107
5174651|NCT01184079|12726904|P1|Final Blood Draw|Overall Study||97
5174652|NCT01184079|12726903|P2|Dose 3|Overall Study||107
5174653|NCT01184079|12726904|P1|Dose 3|Overall Study||101
5174654|NCT01184079|12726903|P2|Dose 2|Overall Study||108
5174655|NCT01184079|12726904|P1|Dose 2|Overall Study||110
5174656|NCT01184079|12726903|P2|STARTED|Overall Study||109
5174657|NCT01184079|12726904|P1|STARTED|Overall Study||111
5174658|NCT01184053|12726914|P1|NOT COMPLETED|Overall Study||3
5174659|NCT01184053|12726914|P1|COMPLETED|Overall Study||0
5174660|NCT01184053|12726914|P1|STARTED|Overall Study||3
5174661|NCT01184014|12726923|P2|NOT COMPLETED|Overall Study||6
5174662|NCT01184014|12726924|P1|NOT COMPLETED|Overall Study||5
5174663|NCT01184014|12726923|P2|COMPLETED|Overall Study||31
5174664|NCT01184014|12726924|P1|COMPLETED|Overall Study||30
5174665|NCT01184014|12726923|P2|STARTED|Overall Study||37
5174666|NCT01184014|12726924|P1|STARTED|Overall Study||35
5174667|NCT01183975|12726930|P1|NOT COMPLETED|Overall Study||73
5174668|NCT01183975|12726930|P1|COMPLETED|Overall Study||444
5174669|NCT01183975|12726930|P1|STARTED|Overall Study||517
5174670|NCT01183923|12726935|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
5174671|NCT01183923|12726936|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
5174672|NCT01183923|12726935|P2|COMPLETED|Intervention 2 (7 Days)||0
5174673|NCT01183923|12726936|P1|COMPLETED|Intervention 2 (7 Days)||1
5174674|NCT01183923|12726935|P2|STARTED|Intervention 2 (7 Days)||0
5174675|NCT01183923|12726936|P1|STARTED|Intervention 2 (7 Days)||1
5174676|NCT01183923|12726935|P2|NOT COMPLETED|Washout (14 Days)||0
5174677|NCT01183923|12726936|P1|NOT COMPLETED|Washout (14 Days)||0
5174678|NCT01183923|12726935|P2|COMPLETED|Washout (14 Days)||0
5174679|NCT01183923|12726936|P1|COMPLETED|Washout (14 Days)||1
5174680|NCT01183923|12726935|P2|STARTED|Washout (14 Days)||0
5174681|NCT01183923|12726936|P1|STARTED|Washout (14 Days)||1
5174682|NCT01183923|12726935|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
5174683|NCT01183923|12726936|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
5174684|NCT01183923|12726935|P2|COMPLETED|Intervention 1 (7 Days)||0
5174685|NCT01183923|12726936|P1|COMPLETED|Intervention 1 (7 Days)||1
5174686|NCT01183923|12726935|P2|STARTED|Intervention 1 (7 Days)||0
5174687|NCT01183923|12726936|P1|STARTED|Intervention 1 (7 Days)||1
5174688|NCT01183897|12726941|P1|NOT COMPLETED|Overall Study||0
5174689|NCT01183897|12726941|P1|COMPLETED|Overall Study||31
5174690|NCT01183897|12726941|P1|STARTED|Overall Study||31
5174691|NCT01183884|12726947|P1|NOT COMPLETED|Overall Study||38
5174692|NCT01183884|12726947|P1|COMPLETED|Overall Study||8
5174693|NCT01183884|12726947|P1|STARTED|Overall Study||46
5174694|NCT01183858|12726955|P2|NOT COMPLETED|Overall Study||156
5174695|NCT01183858|12726956|P1|NOT COMPLETED|Overall Study||153
5174696|NCT01183858|12726955|P2|COMPLETED|Overall Study||3
5174697|NCT01183858|12726956|P1|COMPLETED|Overall Study||1
5174698|NCT01183858|12726955|P2|Safety Population|Overall Study||158
5174699|NCT01183858|12726956|P1|Safety Population|Overall Study||154
5174700|NCT01183858|12726955|P2|STARTED|Overall Study||159
5174701|NCT01183858|12726956|P1|STARTED|Overall Study||154
5174702|NCT01183780|12726978|P2|NOT COMPLETED|Overall Study||25
5174703|NCT01183780|12726979|P1|NOT COMPLETED|Overall Study||31
5174704|NCT01183780|12726978|P2|COMPLETED|Overall Study||511
5174705|NCT01183780|12726979|P1|COMPLETED|Overall Study||505
5174706|NCT01183780|12726978|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
5174707|NCT01183780|12726979|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
5174708|NCT01183780|12726978|P2|STARTED|Overall Study||536
5174709|NCT01183780|12726979|P1|STARTED|Overall Study||536
5174710|NCT01183728|12726996|P1|NOT COMPLETED|Overall Study||0
5174711|NCT01183728|12726996|P1|COMPLETED|Overall Study||12
5174712|NCT01183728|12726996|P1|STARTED|Overall Study||12
5174713|NCT01183689|12727004|P3|NOT COMPLETED|Overall Study||0
5174714|NCT01183689|12727005|P2|NOT COMPLETED|Overall Study||0
5174715|NCT01183689|12727006|P1|NOT COMPLETED|Overall Study||0
5174716|NCT01183689|12727004|P3|COMPLETED|Overall Study||197
5174717|NCT01183689|12727005|P2|COMPLETED|Overall Study||200
5174718|NCT01183689|12727006|P1|COMPLETED|Overall Study||202
5174719|NCT01183689|12727004|P3|Year 4 Visit|Overall Study||30
5174720|NCT01183689|12727005|P2|Year 4 Visit|Overall Study||33
5174721|NCT01183689|12727006|P1|Year 4 Visit|Overall Study||38
5174722|NCT01183689|12727004|P3|Year 3 Visit|Overall Study||126
5174723|NCT01183689|12727005|P2|Year 3 Visit|Overall Study||125
5174724|NCT01183689|12727006|P1|Year 3 Visit|Overall Study||139
5174725|NCT01183689|12727004|P3|Year 2 Visit|Overall Study||174
5174726|NCT01183689|12727005|P2|Year 2 Visit|Overall Study||172
5174727|NCT01183689|12727006|P1|Year 2 Visit|Overall Study||178
5174728|NCT01183689|12727004|P3|Year 1 Visit|Overall Study||183
5174729|NCT01183689|12727005|P2|Year 1 Visit|Overall Study||172
5174730|NCT01183689|12727006|P1|Year 1 Visit|Overall Study||187
5174731|NCT01183689|12727004|P3|Month 4 Visit|Overall Study||187
5174732|NCT01183689|12727005|P2|Month 4 Visit|Overall Study||192
5174733|NCT01183689|12727006|P1|Month 4 Visit|Overall Study||197
5174734|NCT01183689|12727004|P3|STARTED|Overall Study||197
5174735|NCT01183689|12727005|P2|STARTED|Overall Study||200
5174736|NCT01183689|12727006|P1|STARTED|Overall Study||202
5174737|NCT01183650|12727076|P2|NOT COMPLETED|Overall Study||0
5174738|NCT01183650|12727077|P1|NOT COMPLETED|Overall Study||0
5174739|NCT01183650|12727076|P2|COMPLETED|Overall Study||12
5174740|NCT01183650|12727077|P1|COMPLETED|Overall Study||12
5174741|NCT01183650|12727076|P2|STARTED|Overall Study||12
5174742|NCT01183650|12727077|P1|STARTED|Overall Study||12
5174743|NCT01183546|12727087|P1|NOT COMPLETED|Overall Study||0
5174744|NCT01183546|12727087|P1|COMPLETED|Overall Study||53
5174745|NCT01183546|12727087|P1|STARTED|Overall Study||53
5174746|NCT01183533|12727094|P1|NOT COMPLETED|Overall Study||0
5174747|NCT01183533|12727094|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
5174748|NCT01183533|12727094|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
5174749|NCT01183481|12727100|P1|NOT COMPLETED|Overall Study||0
5174750|NCT01183481|12727100|P1|COMPLETED|Overall Study||19
5174751|NCT01183481|12727100|P1|STARTED|Overall Study||19
5174752|NCT01183468|12727112|P4|NOT COMPLETED|Overall Study||0
5174753|NCT01183468|12727113|P3|NOT COMPLETED|Overall Study||0
5174754|NCT01183468|12727114|P2|NOT COMPLETED|Overall Study||2
5174755|NCT01183468|12727115|P1|NOT COMPLETED|Overall Study||3
5174756|NCT01183468|12727112|P4|COMPLETED|Overall Study||0
5174757|NCT01183468|12727113|P3|COMPLETED|Overall Study||0
5174758|NCT01183468|12727114|P2|COMPLETED|Overall Study||7
5174759|NCT01183468|12727115|P1|COMPLETED|Overall Study||5
5174760|NCT01183468|12727112|P4|STARTED|Overall Study||0
5174761|NCT01183468|12727113|P3|STARTED|Overall Study||0
5174762|NCT01183468|12727114|P2|STARTED|Overall Study||9
5174763|NCT01183468|12727115|P1|STARTED|Overall Study||8
5174764|NCT01183429|12727123|P1|NOT COMPLETED|Overall Study||0
5174765|NCT01183429|12727123|P1|COMPLETED|Overall Study||39
5174766|NCT01183429|12727123|P1|STARTED|Overall Study||39
5174767|NCT01183416|12727129|P1|NOT COMPLETED|Overall Study||0
5174768|NCT01183416|12727129|P1|COMPLETED|Overall Study||4
5174769|NCT01183416|12727129|P1|STARTED|Overall Study||4
5174770|NCT01183390|12727137|P2|NOT COMPLETED|Second Intervention||0
5174771|NCT01183390|12727138|P1|NOT COMPLETED|Second Intervention||0
5174772|NCT01183390|12727137|P2|COMPLETED|Second Intervention||10
5174773|NCT01183390|12727138|P1|COMPLETED|Second Intervention||11
5174774|NCT01183390|12727137|P2|STARTED|Second Intervention||10
5174775|NCT01183390|12727138|P1|STARTED|Second Intervention||11
5174776|NCT01183390|12727137|P2|NOT COMPLETED|Washout of 21 Days||0
5174777|NCT01183390|12727138|P1|NOT COMPLETED|Washout of 21 Days||0
5174778|NCT01183390|12727137|P2|COMPLETED|Washout of 21 Days||10
5174779|NCT01183390|12727138|P1|COMPLETED|Washout of 21 Days||11
5174780|NCT01183390|12727137|P2|STARTED|Washout of 21 Days||10
5174781|NCT01183390|12727138|P1|STARTED|Washout of 21 Days||11
5174782|NCT01183390|12727137|P2|NOT COMPLETED|First Intervention||1
5174783|NCT01183390|12727138|P1|NOT COMPLETED|First Intervention||0
5174784|NCT01183390|12727137|P2|COMPLETED|First Intervention||10
5174785|NCT01183390|12727138|P1|COMPLETED|First Intervention||11
5174786|NCT01183390|12727137|P2|STARTED|First Intervention||11
5174787|NCT01183390|12727138|P1|STARTED|First Intervention||11
5174788|NCT01183312|12727148|P2|NOT COMPLETED|Second Intervention Day||0
5174789|NCT01183312|12727149|P1|NOT COMPLETED|Second Intervention Day||0
5174790|NCT01183312|12727148|P2|COMPLETED|Second Intervention Day||5
5174791|NCT01183312|12727149|P1|COMPLETED|Second Intervention Day||5
5174792|NCT01183312|12727148|P2|STARTED|Second Intervention Day||5
5174793|NCT01183312|12727149|P1|STARTED|Second Intervention Day||5
5174794|NCT01183312|12727148|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
5174795|NCT01183312|12727149|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
5174796|NCT01183312|12727148|P2|COMPLETED|Washout Period of at Least 1 Week||5
5174797|NCT01183312|12727149|P1|COMPLETED|Washout Period of at Least 1 Week||5
5174798|NCT01183312|12727148|P2|STARTED|Washout Period of at Least 1 Week||5
5174799|NCT01183312|12727149|P1|STARTED|Washout Period of at Least 1 Week||5
5174800|NCT01183312|12727148|P2|NOT COMPLETED|First Intervention Day||0
5174801|NCT01183312|12727149|P1|NOT COMPLETED|First Intervention Day||0
5174802|NCT01183312|12727148|P2|COMPLETED|First Intervention Day||5
5174803|NCT01183312|12727149|P1|COMPLETED|First Intervention Day||5
5174804|NCT01183312|12727148|P2|STARTED|First Intervention Day||5
5174805|NCT01183312|12727149|P1|STARTED|First Intervention Day||5
5174806|NCT01183260|12727171|P2|NOT COMPLETED|Overall Study||2
5174807|NCT01183260|12727172|P1|NOT COMPLETED|Overall Study||4
5174808|NCT01183260|12727171|P2|COMPLETED|Overall Study||9
5174809|NCT01183260|12727172|P1|COMPLETED|Overall Study||10
5174810|NCT01183260|12727171|P2|STARTED|Overall Study||11
5174811|NCT01183260|12727172|P1|STARTED|Overall Study||14
5174812|NCT01183234|12727182|P2|NOT COMPLETED|Second Intervention||0
5174813|NCT01183234|12727183|P1|NOT COMPLETED|Second Intervention||0
5174814|NCT01183234|12727182|P2|COMPLETED|Second Intervention||14
5174815|NCT01183234|12727183|P1|COMPLETED|Second Intervention||13
5174816|NCT01183234|12727182|P2|STARTED|Second Intervention||14
5174817|NCT01183234|12727183|P1|STARTED|Second Intervention||13
5174818|NCT01183234|12727182|P2|NOT COMPLETED|Washout||0
5174819|NCT01183234|12727183|P1|NOT COMPLETED|Washout||0
5174820|NCT01183234|12727182|P2|COMPLETED|Washout||14
5174821|NCT01183234|12727183|P1|COMPLETED|Washout||13
5174822|NCT01183234|12727182|P2|STARTED|Washout||14
5174823|NCT01183234|12727183|P1|STARTED|Washout||13
5174824|NCT01183234|12727182|P2|NOT COMPLETED|First Intervention||0
5174825|NCT01183234|12727183|P1|NOT COMPLETED|First Intervention||1
5174826|NCT01183234|12727182|P2|COMPLETED|First Intervention||14
5174827|NCT01183234|12727183|P1|COMPLETED|First Intervention||13
5174828|NCT01183234|12727182|P2|STARTED|First Intervention||14
5174829|NCT01183234|12727183|P1|STARTED|First Intervention||14
5174830|NCT01183169|12727197|P7|NOT COMPLETED|Post-switch Phase||9
5174831|NCT01183169|12727198|P6|NOT COMPLETED|Post-switch Phase||14
5174832|NCT01183169|12727199|P5|NOT COMPLETED|Post-switch Phase||0
5174833|NCT01183169|12727200|P4|NOT COMPLETED|Post-switch Phase||0
5174834|NCT01183169|12727201|P3|NOT COMPLETED|Post-switch Phase||0
5174835|NCT01183169|12727202|P2|NOT COMPLETED|Post-switch Phase||0
5174836|NCT01183169|12727203|P1|NOT COMPLETED|Post-switch Phase||0
5174837|NCT01183169|12727197|P7|COMPLETED|Post-switch Phase||21
5174838|NCT01183169|12727198|P6|COMPLETED|Post-switch Phase||21
5174839|NCT01183169|12727199|P5|COMPLETED|Post-switch Phase||0
5174840|NCT01183169|12727200|P4|COMPLETED|Post-switch Phase||0
5174841|NCT01183169|12727201|P3|COMPLETED|Post-switch Phase||0
5174842|NCT01183169|12727202|P2|COMPLETED|Post-switch Phase||0
5174843|NCT01183169|12727203|P1|COMPLETED|Post-switch Phase||0
5174844|NCT01183169|12727197|P7|Completed Treatment|Post-switch Phase||13
5174845|NCT01183169|12727198|P6|Completed Treatment|Post-switch Phase||12
5174846|NCT01183169|12727199|P5|Completed Treatment|Post-switch Phase||0
5174847|NCT01183169|12727200|P4|Completed Treatment|Post-switch Phase||0
5174848|NCT01183169|12727201|P3|Completed Treatment|Post-switch Phase||0
5174849|NCT01183169|12727202|P2|Completed Treatment|Post-switch Phase||0
5174850|NCT01183169|12727203|P1|Completed Treatment|Post-switch Phase||0
5174851|NCT01183169|12727197|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
5174852|NCT01183169|12727198|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
5174853|NCT01183169|12727199|P5|STARTED|Post-switch Phase|Not a post-switch group|0
5174854|NCT01183169|12727200|P4|STARTED|Post-switch Phase|Not a post-switch group|0
5174855|NCT01183169|12727201|P3|STARTED|Post-switch Phase|Not a post-switch group|0
5174856|NCT01183169|12727202|P2|STARTED|Post-switch Phase|Not a post-switch group|0
5174857|NCT01183169|12727203|P1|STARTED|Post-switch Phase|Not a post-switch group|0
5174858|NCT01183169|12727197|P7|NOT COMPLETED|Main Phase||0
5174859|NCT01183169|12727198|P6|NOT COMPLETED|Main Phase||0
5174860|NCT01183169|12727199|P5|NOT COMPLETED|Main Phase||26
5174861|NCT01183169|12727200|P4|NOT COMPLETED|Main Phase||37
5174862|NCT01183169|12727201|P3|NOT COMPLETED|Main Phase||41
5174863|NCT01183169|12727202|P2|NOT COMPLETED|Main Phase||22
5174864|NCT01183169|12727203|P1|NOT COMPLETED|Main Phase||27
5174865|NCT01183169|12727197|P7|COMPLETED|Main Phase||0
5174866|NCT01183169|12727198|P6|COMPLETED|Main Phase||0
5174867|NCT01183169|12727199|P5|COMPLETED|Main Phase||83
5174868|NCT01183169|12727200|P4|COMPLETED|Main Phase||18
5174869|NCT01183169|12727201|P3|COMPLETED|Main Phase||18
5174870|NCT01183169|12727202|P2|COMPLETED|Main Phase||93
5174871|NCT01183169|12727203|P1|COMPLETED|Main Phase||94
5174872|NCT01183169|12727197|P7|Switched to ALV|Main Phase||0
5174873|NCT01183169|12727198|P6|Switched to ALV|Main Phase||0
5174874|NCT01183169|12727199|P5|Switched to ALV|Main Phase||0
5174875|NCT01183169|12727200|P4|Switched to ALV|Main Phase||30
5174876|NCT01183169|12727201|P3|Switched to ALV|Main Phase||35
5174877|NCT01183169|12727202|P2|Switched to ALV|Main Phase||0
5174878|NCT01183169|12727203|P1|Switched to ALV|Main Phase||0
5174879|NCT01183169|12727197|P7|Completed Treatment|Main Phase||0
5174880|NCT01183169|12727198|P6|Completed Treatment|Main Phase||0
5174881|NCT01183169|12727199|P5|Completed Treatment|Main Phase||77
5174882|NCT01183169|12727200|P4|Completed Treatment|Main Phase||17
5174883|NCT01183169|12727201|P3|Completed Treatment|Main Phase||17
5174884|NCT01183169|12727202|P2|Completed Treatment|Main Phase||78
5174885|NCT01183169|12727203|P1|Completed Treatment|Main Phase||72
5174886|NCT01183169|12727197|P7|STARTED|Main Phase||0
5174887|NCT01183169|12727198|P6|STARTED|Main Phase||0
5174888|NCT01183169|12727199|P5|STARTED|Main Phase||109
5174889|NCT01183169|12727200|P4|STARTED|Main Phase||55
5174890|NCT01183169|12727201|P3|STARTED|Main Phase||59
5174891|NCT01183169|12727202|P2|STARTED|Main Phase||115
5174892|NCT01183169|12727203|P1|STARTED|Main Phase||121
5174893|NCT01183143|12727275|P1|NOT COMPLETED|Overall Study||150
5174894|NCT01183143|12727275|P1|COMPLETED|Overall Study||65
5174895|NCT01183143|12727275|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
5174896|NCT01183143|12727275|P1|STARTED|Overall Study||215
5174897|NCT01183104|12727291|P2|NOT COMPLETED|Overall Study||92
5174898|NCT01183104|12727292|P1|NOT COMPLETED|Overall Study||77
5174899|NCT01183104|12727291|P2|COMPLETED|Overall Study||60
5174900|NCT01183104|12727292|P1|COMPLETED|Overall Study||76
5174901|NCT01183104|12727291|P2|Enrolled in Extension Study|Overall Study||61
5174902|NCT01183104|12727292|P1|Enrolled in Extension Study|Overall Study||80
5174903|NCT01183104|12727291|P2|Completed 52-week Treatment|Overall Study||111
5174904|NCT01183104|12727292|P1|Completed 52-week Treatment|Overall Study||119
5174905|NCT01183104|12727291|P2|Continued Treatment for 12 Weeks|Overall Study||129
5174906|NCT01183104|12727292|P1|Continued Treatment for 12 Weeks|Overall Study||143
5174907|NCT01183104|12727291|P2|Received Study Drug|Overall Study||143
5174908|NCT01183104|12727292|P1|Received Study Drug|Overall Study||148
5174909|NCT01183104|12727291|P2|STARTED|Overall Study||152
5174910|NCT01183104|12727292|P1|STARTED|Overall Study||153
5174911|NCT01183065|12727308|P1|NOT COMPLETED|Overall Study||1
5174912|NCT01183065|12727308|P1|COMPLETED|Overall Study||12
5174913|NCT01183065|12727308|P1|STARTED|Overall Study||13
5174914|NCT01183013|12727319|P7|NOT COMPLETED|Overall Study||37
5174915|NCT01183013|12727320|P6|NOT COMPLETED|Overall Study||45
5174916|NCT01183013|12727321|P5|NOT COMPLETED|Overall Study||36
5174917|NCT01183013|12727322|P4|NOT COMPLETED|Overall Study||30
5174918|NCT01183013|12727323|P3|NOT COMPLETED|Overall Study||41
5174919|NCT01183013|12727324|P2|NOT COMPLETED|Overall Study||39
5174920|NCT01183013|12727325|P1|NOT COMPLETED|Overall Study||45
5174921|NCT01183013|12727319|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
5174922|NCT01183013|12727320|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
5174923|NCT01183013|12727321|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
5174924|NCT01183013|12727322|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
5174925|NCT01183013|12727323|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
5174926|NCT01183013|12727324|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
5174927|NCT01183013|12727325|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
5174928|NCT01183013|12727319|P7|STARTED|Overall Study||133
5174929|NCT01183013|12727320|P6|STARTED|Overall Study||133
5174930|NCT01183013|12727321|P5|STARTED|Overall Study||126
5174931|NCT01183013|12727322|P4|STARTED|Overall Study||135
5174932|NCT01183013|12727323|P3|STARTED|Overall Study||138
5174933|NCT01183013|12727324|P2|STARTED|Overall Study||140
5174934|NCT01183013|12727325|P1|STARTED|Overall Study||131
5174935|NCT01182844|12727406|P2|NOT COMPLETED|Overall Study||0
5174936|NCT01182844|12727407|P1|NOT COMPLETED|Overall Study||0
5174937|NCT01182844|12727406|P2|COMPLETED|Overall Study||13
5174938|NCT01182844|12727407|P1|COMPLETED|Overall Study||15
5174939|NCT01182844|12727406|P2|STARTED|Overall Study||13
5174940|NCT01182844|12727407|P1|STARTED|Overall Study||15
5174941|NCT01182805|12727425|P1|NOT COMPLETED|Overall Study||0
5174942|NCT01182805|12727425|P1|COMPLETED|Overall Study||50
5174943|NCT01182805|12727425|P1|STARTED|Overall Study||50
5174944|NCT01182727|12727434|P1|NOT COMPLETED|Overall Study||0
5174945|NCT01182727|12727434|P1|COMPLETED|Overall Study||10
5174946|NCT01182727|12727434|P1|STARTED|Overall Study||10
5174947|NCT01182675|12727440|P2|NOT COMPLETED|Overall Study||0
5174948|NCT01182675|12727441|P1|NOT COMPLETED|Overall Study||0
5174949|NCT01182675|12727440|P2|COMPLETED|Overall Study||0
5174950|NCT01182675|12727441|P1|COMPLETED|Overall Study||7
5174951|NCT01182675|12727440|P2|STARTED|Overall Study||0
5174952|NCT01182675|12727441|P1|STARTED|Overall Study||7
5174953|NCT01182610|12727457|P1|NOT COMPLETED|Overall Study||0
5174954|NCT01182610|12727457|P1|COMPLETED|Overall Study||1
5174955|NCT01182610|12727457|P1|STARTED|Overall Study||1
5174956|NCT01182493|12727467|P2|NOT COMPLETED|Overall Study||7
5174957|NCT01182493|12727468|P1|NOT COMPLETED|Overall Study||16
5174958|NCT01182493|12727467|P2|COMPLETED|Overall Study||156
5174959|NCT01182493|12727468|P1|COMPLETED|Overall Study||152
5174960|NCT01182493|12727467|P2|STARTED|Overall Study||163
5174961|NCT01182493|12727468|P1|STARTED|Overall Study||168
5174962|NCT01182480|12727486|P1|NOT COMPLETED|Overall Study||0
5174963|NCT01182480|12727486|P1|COMPLETED|Overall Study||47
5174964|NCT01182480|12727486|P1|STARTED|Overall Study||47
5174965|NCT01182441|12727492|P2|NOT COMPLETED|Overall Study||119
5174966|NCT01182441|12727493|P1|NOT COMPLETED|Overall Study||220
5174967|NCT01182441|12727492|P2|COMPLETED|Overall Study||19
5174968|NCT01182441|12727493|P1|COMPLETED|Overall Study||49
5174969|NCT01182441|12727492|P2|STARTED|Overall Study||138
5174970|NCT01182441|12727493|P1|STARTED|Overall Study||269
5174971|NCT01182428|12727504|P2|NOT COMPLETED|Overall Study||1
5174972|NCT01182428|12727505|P1|NOT COMPLETED|Overall Study||11
5174973|NCT01182428|12727504|P2|COMPLETED|Overall Study||150
5174974|NCT01182428|12727505|P1|COMPLETED|Overall Study||293
5174975|NCT01182428|12727504|P2|STARTED|Overall Study||151
5174976|NCT01182428|12727505|P1|STARTED|Overall Study||304
5174977|NCT01182415|12727569|P1|NOT COMPLETED|Overall Study||1
5174978|NCT01182415|12727569|P1|COMPLETED|Overall Study||29
5174979|NCT01182415|12727569|P1|STARTED|Overall Study||30
5174980|NCT01182376|12727578|P2|NOT COMPLETED|Overall Study||5
5174981|NCT01182376|12727579|P1|NOT COMPLETED|Overall Study||11
5174982|NCT01182376|12727578|P2|COMPLETED|Overall Study||13
5174983|NCT01182376|12727579|P1|COMPLETED|Overall Study||4
5174984|NCT01182376|12727578|P2|STARTED|Overall Study||18
5174985|NCT01182376|12727579|P1|STARTED|Overall Study||15
5174986|NCT01182350|12727585|P5|NOT COMPLETED|Overall Study||3
5174987|NCT01182350|12727586|P4|NOT COMPLETED|Overall Study||3
5174988|NCT01182350|12727587|P3|NOT COMPLETED|Overall Study||3
5174989|NCT01182350|12727588|P2|NOT COMPLETED|Overall Study||14
5174990|NCT01182350|12727589|P1|NOT COMPLETED|Overall Study||27
5174991|NCT01182350|12727585|P5|COMPLETED|Overall Study||0
5174992|NCT01182350|12727586|P4|COMPLETED|Overall Study||0
5174993|NCT01182350|12727587|P3|COMPLETED|Overall Study||0
5174994|NCT01182350|12727588|P2|COMPLETED|Overall Study||0
5174995|NCT01182350|12727589|P1|COMPLETED|Overall Study||3
5174996|NCT01182350|12727585|P5|Started Assigned Chemoradiation|Overall Study||0
5174997|NCT01182350|12727586|P4|Started Assigned Chemoradiation|Overall Study||2
5174998|NCT01182350|12727587|P3|Started Assigned Chemoradiation|Overall Study||2
5174999|NCT01182350|12727588|P2|Started Assigned Chemoradiation|Overall Study||14
5175000|NCT01182350|12727589|P1|Started Assigned Chemoradiation|Overall Study||27
5175001|NCT01182350|12727585|P5|Underwent Stereotactic Biopsy|Overall Study||0
5175002|NCT01182350|12727586|P4|Underwent Stereotactic Biopsy|Overall Study||3
5175003|NCT01182350|12727587|P3|Underwent Stereotactic Biopsy|Overall Study||3
5175004|NCT01182350|12727588|P2|Underwent Stereotactic Biopsy|Overall Study||14
5175005|NCT01182350|12727589|P1|Underwent Stereotactic Biopsy|Overall Study||30
5175006|NCT01182350|12727585|P5|STARTED|Overall Study||3
5175007|NCT01182350|12727586|P4|STARTED|Overall Study||3
5175008|NCT01182350|12727587|P3|STARTED|Overall Study||3
5175009|NCT01182350|12727588|P2|STARTED|Overall Study||14
5175010|NCT01182350|12727589|P1|STARTED|Overall Study||30
5175011|NCT01182337|12727611|P2|NOT COMPLETED|Overall Study||2
5175012|NCT01182337|12727612|P1|NOT COMPLETED|Overall Study||3
5175013|NCT01182337|12727611|P2|COMPLETED|Overall Study||7
5175014|NCT01182337|12727612|P1|COMPLETED|Overall Study||19
5175015|NCT01182337|12727611|P2|STARTED|Overall Study||9
5175016|NCT01182337|12727612|P1|STARTED|Overall Study||22
5175017|NCT01182298|12727630|P1|NOT COMPLETED|Overall Study||6
5175018|NCT01182298|12727630|P1|COMPLETED|Overall Study||4
5175019|NCT01182298|12727630|P1|STARTED|Overall Study||10
5175020|NCT01182285|12727634|P3|NOT COMPLETED|Third Intervention Week 11-52||8
5175021|NCT01182285|12727635|P2|NOT COMPLETED|Third Intervention Week 11-52||0
5175022|NCT01182285|12727636|P1|NOT COMPLETED|Third Intervention Week 11-52||0
5175023|NCT01182285|12727634|P3|COMPLETED|Third Intervention Week 11-52||0
5175024|NCT01182285|12727635|P2|COMPLETED|Third Intervention Week 11-52||0
5175025|NCT01182285|12727636|P1|COMPLETED|Third Intervention Week 11-52||0
5175026|NCT01182285|12727634|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
5175027|NCT01182285|12727635|P2|STARTED|Third Intervention Week 11-52||0
5175028|NCT01182285|12727636|P1|STARTED|Third Intervention Week 11-52||0
5175029|NCT01182285|12727634|P3|NOT COMPLETED|Second Intervention Week 11-17||0
5175030|NCT01182285|12727635|P2|NOT COMPLETED|Second Intervention Week 11-17||0
5175031|NCT01182285|12727636|P1|NOT COMPLETED|Second Intervention Week 11-17||0
5175032|NCT01182285|12727634|P3|COMPLETED|Second Intervention Week 11-17||0
5175033|NCT01182285|12727635|P2|COMPLETED|Second Intervention Week 11-17||0
5175034|NCT01182285|12727636|P1|COMPLETED|Second Intervention Week 11-17||0
5175035|NCT01182285|12727634|P3|STARTED|Second Intervention Week 11-17||0
5175036|NCT01182285|12727635|P2|STARTED|Second Intervention Week 11-17||0
5175037|NCT01182285|12727636|P1|STARTED|Second Intervention Week 11-17||0
5175038|NCT01182285|12727634|P3|NOT COMPLETED|First Intervention Week 1-10||0
5175039|NCT01182285|12727635|P2|NOT COMPLETED|First Intervention Week 1-10||0
5175040|NCT01182285|12727636|P1|NOT COMPLETED|First Intervention Week 1-10||3
5175041|NCT01182285|12727634|P3|COMPLETED|First Intervention Week 1-10||0
5175042|NCT01182285|12727635|P2|COMPLETED|First Intervention Week 1-10||0
5175043|NCT01182285|12727636|P1|COMPLETED|First Intervention Week 1-10||10
5175044|NCT01182285|12727634|P3|STARTED|First Intervention Week 1-10||0
5175045|NCT01182285|12727635|P2|STARTED|First Intervention Week 1-10||0
5175046|NCT01182285|12727636|P1|STARTED|First Intervention Week 1-10||13
5175047|NCT01182207|12727646|P2|NOT COMPLETED|Second Intervention||0
5175048|NCT01182207|12727647|P1|NOT COMPLETED|Second Intervention||1
5175049|NCT01182207|12727646|P2|COMPLETED|Second Intervention||14
5175050|NCT01182207|12727647|P1|COMPLETED|Second Intervention||17
5175051|NCT01182207|12727646|P2|STARTED|Second Intervention||14
5175052|NCT01182207|12727647|P1|STARTED|Second Intervention||18
5175053|NCT01182207|12727646|P2|NOT COMPLETED|Washout of 28 Days||0
5175054|NCT01182207|12727647|P1|NOT COMPLETED|Washout of 28 Days||0
5175055|NCT01182207|12727646|P2|COMPLETED|Washout of 28 Days||14
5175056|NCT01182207|12727647|P1|COMPLETED|Washout of 28 Days||18
5175057|NCT01182207|12727646|P2|STARTED|Washout of 28 Days||14
5175058|NCT01182207|12727647|P1|STARTED|Washout of 28 Days||18
5175059|NCT01182207|12727646|P2|NOT COMPLETED|First Intervention||1
5175060|NCT01182207|12727647|P1|NOT COMPLETED|First Intervention||0
5175061|NCT01182207|12727646|P2|COMPLETED|First Intervention||14
5175062|NCT01182207|12727647|P1|COMPLETED|First Intervention||18
5175063|NCT01182207|12727646|P2|STARTED|First Intervention||15
5175064|NCT01182207|12727647|P1|STARTED|First Intervention||18
5175065|NCT01182194|12727665|P2|NOT COMPLETED|Second Intervention||0
5175066|NCT01182194|12727666|P1|NOT COMPLETED|Second Intervention||0
5175067|NCT01182194|12727665|P2|COMPLETED|Second Intervention||16
5175068|NCT01182194|12727666|P1|COMPLETED|Second Intervention||15
5175069|NCT01182194|12727665|P2|STARTED|Second Intervention||16
5175070|NCT01182194|12727666|P1|STARTED|Second Intervention||15
5175071|NCT01182194|12727665|P2|NOT COMPLETED|Washout of 28 Days||0
5175072|NCT01182194|12727666|P1|NOT COMPLETED|Washout of 28 Days||1
5175073|NCT01182194|12727665|P2|COMPLETED|Washout of 28 Days||16
5175074|NCT01182194|12727666|P1|COMPLETED|Washout of 28 Days||15
5175075|NCT01182194|12727665|P2|STARTED|Washout of 28 Days||16
5175076|NCT01182194|12727666|P1|STARTED|Washout of 28 Days||16
5175077|NCT01182194|12727665|P2|NOT COMPLETED|First Intervention||0
5175078|NCT01182194|12727666|P1|NOT COMPLETED|First Intervention||0
5175079|NCT01182194|12727665|P2|COMPLETED|First Intervention||16
5175080|NCT01182194|12727666|P1|COMPLETED|First Intervention||16
5175081|NCT01182194|12727665|P2|STARTED|First Intervention||16
5175082|NCT01182194|12727666|P1|STARTED|First Intervention||16
5175083|NCT01182181|12727684|P2|NOT COMPLETED|Second Intervention||0
5175084|NCT01182181|12727685|P1|NOT COMPLETED|Second Intervention||0
5175085|NCT01182181|12727684|P2|COMPLETED|Second Intervention||10
5175086|NCT01182181|12727685|P1|COMPLETED|Second Intervention||10
5175087|NCT01182181|12727684|P2|STARTED|Second Intervention||10
5175088|NCT01182181|12727685|P1|STARTED|Second Intervention||10
5175089|NCT01182181|12727684|P2|NOT COMPLETED|Washout of 21 Days||1
5175090|NCT01182181|12727685|P1|NOT COMPLETED|Washout of 21 Days||0
5175091|NCT01182181|12727684|P2|COMPLETED|Washout of 21 Days||10
5175092|NCT01182181|12727685|P1|COMPLETED|Washout of 21 Days||10
5175093|NCT01182181|12727684|P2|STARTED|Washout of 21 Days||11
5175094|NCT01182181|12727685|P1|STARTED|Washout of 21 Days||10
5175095|NCT01182181|12727684|P2|NOT COMPLETED|First Intervention||0
5175096|NCT01182181|12727685|P1|NOT COMPLETED|First Intervention||1
5175097|NCT01182181|12727684|P2|COMPLETED|First Intervention||11
5175098|NCT01182181|12727685|P1|COMPLETED|First Intervention||10
5175099|NCT01182181|12727684|P2|STARTED|First Intervention||11
5175100|NCT01182181|12727685|P1|STARTED|First Intervention||11
5175101|NCT01182103|12727695|P2|NOT COMPLETED|Overall Study||0
5175102|NCT01182103|12727696|P1|NOT COMPLETED|Overall Study||0
5175103|NCT01182103|12727695|P2|COMPLETED|Overall Study||62
5175104|NCT01182103|12727696|P1|COMPLETED|Overall Study||48
5175105|NCT01182103|12727695|P2|STARTED|Overall Study||62
5175106|NCT01182103|12727696|P1|STARTED|Overall Study||48
5175107|NCT01181986|12727710|P3|NOT COMPLETED|Phase 2||0
5175108|NCT01181986|12727711|P2|NOT COMPLETED|Phase 2||4
5175109|NCT01181986|12727712|P1|NOT COMPLETED|Phase 2||0
5175110|NCT01181986|12727710|P3|COMPLETED|Phase 2||0
5175111|NCT01181986|12727711|P2|COMPLETED|Phase 2||18
5175112|NCT01181986|12727712|P1|COMPLETED|Phase 2||18
5175113|NCT01181986|12727710|P3|STARTED|Phase 2|N/A for Sub-study 2|0
5175114|NCT01181986|12727711|P2|STARTED|Phase 2||22
5175115|NCT01181986|12727712|P1|STARTED|Phase 2||18
5175116|NCT01181986|12727710|P3|NOT COMPLETED|Phase 1||2
5175117|NCT01181986|12727711|P2|NOT COMPLETED|Phase 1||1
5175118|NCT01181986|12727712|P1|NOT COMPLETED|Phase 1||1
5175119|NCT01181986|12727710|P3|COMPLETED|Phase 1||32
5175120|NCT01181986|12727711|P2|COMPLETED|Phase 1||22
5175121|NCT01181986|12727712|P1|COMPLETED|Phase 1||18
5175122|NCT01181986|12727710|P3|Exendin-9+Exenatide|Phase 1||33
5175123|NCT01181986|12727711|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
5175124|NCT01181986|12727712|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
5175125|NCT01181986|12727710|P3|Saline+Placebo|Phase 1||33
5175126|NCT01181986|12727711|P2|Saline+Placebo|Phase 1|N/A for this arm|0
5175127|NCT01181986|12727712|P1|Saline+Placebo|Phase 1|N/A for this arm|0
5175128|NCT01181986|12727710|P3|Saline+Exenatide|Phase 1||32
5175129|NCT01181986|12727711|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
5175130|NCT01181986|12727712|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
5175131|NCT01181986|12727710|P3|STARTED|Phase 1||34
5175132|NCT01181986|12727711|P2|STARTED|Phase 1||23
5175133|NCT01181986|12727712|P1|STARTED|Phase 1||19
5175134|NCT01181947|12727728|P1|NOT COMPLETED|Overall Study||0
5175135|NCT01181947|12727728|P1|COMPLETED|Overall Study||100
5175136|NCT01181947|12727728|P1|STARTED|Overall Study||100
5175137|NCT01181921|12727733|P1|NOT COMPLETED|Overall Study||1
5175138|NCT01181921|12727733|P1|COMPLETED|Overall Study||0
5175139|NCT01181921|12727733|P1|STARTED|Overall Study||1
5175140|NCT01181895|12727740|P3|NOT COMPLETED|Overall Study||18
5175141|NCT01181895|12727741|P2|NOT COMPLETED|Overall Study||14
5175142|NCT01181895|12727742|P1|NOT COMPLETED|Overall Study||17
5175143|NCT01181895|12727740|P3|COMPLETED|Overall Study||98
5175144|NCT01181895|12727741|P2|COMPLETED|Overall Study||101
5175145|NCT01181895|12727742|P1|COMPLETED|Overall Study||99
5175146|NCT01181895|12727740|P3|STARTED|Overall Study||116
5175147|NCT01181895|12727741|P2|STARTED|Overall Study||115
5175148|NCT01181895|12727742|P1|STARTED|Overall Study||116
5175149|NCT01181804|12727775|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
5175150|NCT01181804|12727776|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
5175151|NCT01181804|12727777|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
5175152|NCT01181804|12727778|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
5175153|NCT01181804|12727775|P4|COMPLETED|Period 4, Fasted (Part 2)||58
5175154|NCT01181804|12727776|P3|COMPLETED|Period 4, Fasted (Part 2)||58
5175155|NCT01181804|12727777|P2|COMPLETED|Period 4, Fasted (Part 2)||0
5175156|NCT01181804|12727778|P1|COMPLETED|Period 4, Fasted (Part 2)||0
5175157|NCT01181804|12727775|P4|STARTED|Period 4, Fasted (Part 2)||58
5175158|NCT01181804|12727776|P3|STARTED|Period 4, Fasted (Part 2)||59
5175159|NCT01181804|12727777|P2|STARTED|Period 4, Fasted (Part 2)||0
5175160|NCT01181804|12727778|P1|STARTED|Period 4, Fasted (Part 2)||0
5175161|NCT01181804|12727775|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
5175162|NCT01181804|12727776|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
5175163|NCT01181804|12727777|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
5175164|NCT01181804|12727778|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
5175165|NCT01181804|12727775|P4|COMPLETED|Period 3, Fasted (Part 2)||58
5175166|NCT01181804|12727776|P3|COMPLETED|Period 3, Fasted (Part 2)||59
5175167|NCT01181804|12727777|P2|COMPLETED|Period 3, Fasted (Part 2)||0
5175168|NCT01181804|12727778|P1|COMPLETED|Period 3, Fasted (Part 2)||0
5175169|NCT01181804|12727775|P4|STARTED|Period 3, Fasted (Part 2)||58
5175170|NCT01181804|12727776|P3|STARTED|Period 3, Fasted (Part 2)||59
5175171|NCT01181804|12727777|P2|STARTED|Period 3, Fasted (Part 2)||0
5175172|NCT01181804|12727778|P1|STARTED|Period 3, Fasted (Part 2)||0
5175173|NCT01181804|12727775|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
5175174|NCT01181804|12727776|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
5175175|NCT01181804|12727777|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
5175176|NCT01181804|12727778|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
5175177|NCT01181804|12727775|P4|COMPLETED|Period 2, Fed (Part 1)||0
5175178|NCT01181804|12727776|P3|COMPLETED|Period 2, Fed (Part 1)||0
5175179|NCT01181804|12727777|P2|COMPLETED|Period 2, Fed (Part 1)||30
5175180|NCT01181804|12727778|P1|COMPLETED|Period 2, Fed (Part 1)||30
5175181|NCT01181804|12727775|P4|STARTED|Period 2, Fed (Part 1)||0
5175182|NCT01181804|12727776|P3|STARTED|Period 2, Fed (Part 1)||0
5175183|NCT01181804|12727777|P2|STARTED|Period 2, Fed (Part 1)||30
5175184|NCT01181804|12727778|P1|STARTED|Period 2, Fed (Part 1)||30
5175185|NCT01181804|12727775|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
5175186|NCT01181804|12727776|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
5175187|NCT01181804|12727777|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
5175188|NCT01181804|12727778|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
5175189|NCT01181804|12727775|P4|COMPLETED|Period 1, Fed (Part 1)||0
5175190|NCT01181804|12727776|P3|COMPLETED|Period 1, Fed (Part 1)||0
5175191|NCT01181804|12727777|P2|COMPLETED|Period 1, Fed (Part 1)||30
5175192|NCT01181804|12727778|P1|COMPLETED|Period 1, Fed (Part 1)||30
5175193|NCT01181804|12727775|P4|STARTED|Period 1, Fed (Part 1)||0
5175194|NCT01181804|12727776|P3|STARTED|Period 1, Fed (Part 1)||0
5175195|NCT01181804|12727777|P2|STARTED|Period 1, Fed (Part 1)||30
5175196|NCT01181804|12727778|P1|STARTED|Period 1, Fed (Part 1)||30
5175197|NCT01181778|12727800|P1|NOT COMPLETED|Overall Study||48
5175198|NCT01181778|12727800|P1|COMPLETED|Overall Study||1871
5175199|NCT01181778|12727800|P1|STARTED|Overall Study||1919
5175200|NCT01181726|12727808|P2|NOT COMPLETED|Second Intervention||0
5175201|NCT01181726|12727809|P1|NOT COMPLETED|Second Intervention||0
5175202|NCT01181726|12727808|P2|COMPLETED|Second Intervention||20
5175203|NCT01181726|12727809|P1|COMPLETED|Second Intervention||19
5175204|NCT01181726|12727808|P2|STARTED|Second Intervention||20
5175205|NCT01181726|12727809|P1|STARTED|Second Intervention||19
5175206|NCT01181726|12727808|P2|NOT COMPLETED|Washout of 28 Days||0
5175207|NCT01181726|12727809|P1|NOT COMPLETED|Washout of 28 Days||0
5175208|NCT01181726|12727808|P2|COMPLETED|Washout of 28 Days||20
5175209|NCT01181726|12727809|P1|COMPLETED|Washout of 28 Days||19
5175210|NCT01181726|12727808|P2|STARTED|Washout of 28 Days||20
5175211|NCT01181726|12727809|P1|STARTED|Washout of 28 Days||19
5175212|NCT01181726|12727808|P2|NOT COMPLETED|First Intervention||0
5175213|NCT01181726|12727809|P1|NOT COMPLETED|First Intervention||1
5175214|NCT01181726|12727808|P2|COMPLETED|First Intervention||20
5175215|NCT01181726|12727809|P1|COMPLETED|First Intervention||19
5175216|NCT01181726|12727808|P2|STARTED|First Intervention||20
5175217|NCT01181726|12727809|P1|STARTED|First Intervention||20
5175218|NCT01181674|12727858|P3|NOT COMPLETED|Overall Study||2
5175219|NCT01181674|12727859|P2|NOT COMPLETED|Overall Study||0
5175220|NCT01181674|12727860|P1|NOT COMPLETED|Overall Study||0
5175221|NCT01181674|12727858|P3|COMPLETED|Overall Study|28 included in analyses|26
5175222|NCT01181674|12727859|P2|COMPLETED|Overall Study||27
5175223|NCT01181674|12727860|P1|COMPLETED|Overall Study||28
5175224|NCT01181674|12727858|P3|STARTED|Overall Study||28
5175225|NCT01181674|12727859|P2|STARTED|Overall Study||27
5175226|NCT01181674|12727860|P1|STARTED|Overall Study||28
5175227|NCT01181609|12727889|P1|NOT COMPLETED|Overall Study||53
5175228|NCT01181609|12727889|P1|COMPLETED|Overall Study||1
5175229|NCT01181609|12727889|P1|STARTED|Overall Study||54
5175230|NCT01181596|12727900|P1|NOT COMPLETED|Overall Study||0
5175231|NCT01181596|12727900|P1|COMPLETED|Overall Study||31
5175232|NCT01181596|12727900|P1|STARTED|Overall Study||31
5175233|NCT01181531|12727907|P2|NOT COMPLETED|Overall Study||53
5175234|NCT01181531|12727908|P1|NOT COMPLETED|Overall Study||61
5175235|NCT01181531|12727907|P2|COMPLETED|Overall Study||102
5175236|NCT01181531|12727908|P1|COMPLETED|Overall Study||96
5175237|NCT01181531|12727907|P2|Received Investigational Product|Overall Study||153
5175238|NCT01181531|12727908|P1|Received Investigational Product|Overall Study||155
5175239|NCT01181531|12727907|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
5175240|NCT01181531|12727908|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
5175241|NCT01181492|12727921|P3|NOT COMPLETED|Overall Study||0
5175242|NCT01181492|12727922|P2|NOT COMPLETED|Overall Study||0
5175243|NCT01181492|12727923|P1|NOT COMPLETED|Overall Study||0
5175244|NCT01181492|12727921|P3|COMPLETED|Overall Study||7
5175245|NCT01181492|12727922|P2|COMPLETED|Overall Study||66
5175246|NCT01181492|12727923|P1|COMPLETED|Overall Study||103
5175247|NCT01181492|12727921|P3|STARTED|Overall Study||7
5175248|NCT01181492|12727922|P2|STARTED|Overall Study||66
5175249|NCT01181492|12727923|P1|STARTED|Overall Study||103
5175250|NCT01181479|12727939|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
5175251|NCT01181479|12727940|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
5175252|NCT01181479|12727941|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
5175253|NCT01181479|12727939|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
5175254|NCT01181479|12727940|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
5175255|NCT01181479|12727941|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
5175256|NCT01181479|12727939|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
5175257|NCT01181479|12727940|P2|STARTED|Crossover Subjects Recieve AG200-15||0
5175258|NCT01181479|12727941|P1|STARTED|Crossover Subjects Recieve AG200-15||0
5175259|NCT01181479|12727939|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
5175260|NCT01181479|12727940|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
5175261|NCT01181479|12727941|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
5175262|NCT01181479|12727939|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
5175263|NCT01181479|12727940|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
5175264|NCT01181479|12727941|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
5175265|NCT01181479|12727939|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
5175266|NCT01181479|12727940|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
5175267|NCT01181479|12727941|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
5175268|NCT01181349|12727956|P1|NOT COMPLETED|Overall Study||0
5175269|NCT01181349|12727956|P1|COMPLETED|Overall Study||350
5175270|NCT01181349|12727956|P1|STARTED|Overall Study||350
5175271|NCT01181323|12727972|P4|NOT COMPLETED|Overall Study||3
5175272|NCT01181323|12727973|P3|NOT COMPLETED|Overall Study||1
5175273|NCT01181323|12727974|P2|NOT COMPLETED|Overall Study||3
5175274|NCT01181323|12727975|P1|NOT COMPLETED|Overall Study||1
5175275|NCT01181323|12727972|P4|COMPLETED|Overall Study||122
5175276|NCT01181323|12727973|P3|COMPLETED|Overall Study||123
5175277|NCT01181323|12727974|P2|COMPLETED|Overall Study||121
5175278|NCT01181323|12727975|P1|COMPLETED|Overall Study||123
5175279|NCT01181323|12727972|P4|STARTED|Overall Study||125
5175280|NCT01181323|12727973|P3|STARTED|Overall Study||124
5175281|NCT01181323|12727974|P2|STARTED|Overall Study||124
5175282|NCT01181323|12727975|P1|STARTED|Overall Study||124
5175283|NCT01181271|12728050|P1|NOT COMPLETED|Allogeneic Transplant||0
5175284|NCT01181271|12728050|P1|COMPLETED|Allogeneic Transplant||29
5175285|NCT01181271|12728050|P1|STARTED|Allogeneic Transplant||29
5175286|NCT01181271|12728050|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
5175287|NCT01181271|12728050|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
5175288|NCT01181271|12728050|P1|STARTED|Evaluation for Allogeneic Transplant||42
5175289|NCT01181271|12728050|P1|NOT COMPLETED|Autologous Transplant||0
5175290|NCT01181271|12728050|P1|COMPLETED|Autologous Transplant||42
5175291|NCT01181271|12728050|P1|STARTED|Autologous Transplant||42
5175292|NCT01181258|12728065|P1|NOT COMPLETED|Overall Study||0
5175293|NCT01181258|12728065|P1|COMPLETED|Overall Study||16
5175294|NCT01181258|12728065|P1|STARTED|Overall Study||16
5175295|NCT01181167|12728074|P2|NOT COMPLETED|Overall Study||32
5175296|NCT01181167|12728075|P1|NOT COMPLETED|Overall Study||23
5175297|NCT01181167|12728074|P2|COMPLETED|Overall Study||271
5175298|NCT01181167|12728075|P1|COMPLETED|Overall Study||284
5175299|NCT01181167|12728074|P2|Efficacy Analysis Population|Overall Study||248
5175300|NCT01181167|12728075|P1|Efficacy Analysis Population|Overall Study||255
5175301|NCT01181167|12728074|P2|STARTED|Overall Study||303
5175302|NCT01181167|12728075|P1|STARTED|Overall Study||307
5175303|NCT01181141|12728085|P2|NOT COMPLETED|Overall Study||4
5175304|NCT01181141|12728086|P1|NOT COMPLETED|Overall Study||12
5175305|NCT01181141|12728085|P2|COMPLETED|Overall Study||26
5175306|NCT01181141|12728086|P1|COMPLETED|Overall Study||50
5175307|NCT01181141|12728085|P2|Safety Analysis Population|Overall Study||29
5175308|NCT01181141|12728086|P1|Safety Analysis Population|Overall Study||59
5175309|NCT01181141|12728085|P2|STARTED|Overall Study||30
5175310|NCT01181141|12728086|P1|STARTED|Overall Study||62
5175311|NCT01181128|12728095|P3|NOT COMPLETED|Overall Study||1
5175312|NCT01181128|12728096|P2|NOT COMPLETED|Overall Study||5
5175313|NCT01181128|12728097|P1|NOT COMPLETED|Overall Study||6
5175314|NCT01181128|12728095|P3|COMPLETED|Overall Study||22
5175315|NCT01181128|12728096|P2|COMPLETED|Overall Study||19
5175316|NCT01181128|12728097|P1|COMPLETED|Overall Study||112
5175317|NCT01181128|12728095|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
5175318|NCT01181128|12728096|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
5175412|NCT01180647|12728433|P1|NOT COMPLETED|Overall Study||5
5175319|NCT01181128|12728097|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
5175320|NCT01181128|12728095|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
5175321|NCT01181128|12728096|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
5175322|NCT01181128|12728097|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
5175323|NCT01181128|12728095|P3|STARTED|Overall Study||23
5175324|NCT01181128|12728096|P2|STARTED|Overall Study||24
5175325|NCT01181128|12728097|P1|STARTED|Overall Study||118
5175326|NCT01181102|12728185|P2|NOT COMPLETED|Overall Study||46
5175327|NCT01181102|12728186|P1|NOT COMPLETED|Overall Study||51
5175328|NCT01181102|12728185|P2|COMPLETED|Overall Study||310
5175329|NCT01181102|12728186|P1|COMPLETED|Overall Study||309
5175330|NCT01181102|12728185|P2|Efficacy Analysis Population|Overall Study||295
5175331|NCT01181102|12728186|P1|Efficacy Analysis Population|Overall Study||299
5175332|NCT01181102|12728185|P2|Safety Analysis Set|Overall Study||349
5175333|NCT01181102|12728186|P1|Safety Analysis Set|Overall Study||354
5175334|NCT01181102|12728185|P2|STARTED|Overall Study||356
5175335|NCT01181102|12728186|P1|STARTED|Overall Study||360
5175336|NCT01181076|12728196|P2|NOT COMPLETED|Overall Study||12
5175337|NCT01181076|12728197|P1|NOT COMPLETED|Overall Study||19
5175338|NCT01181076|12728196|P2|COMPLETED|Overall Study|As determined|48
5175339|NCT01181076|12728197|P1|COMPLETED|Overall Study||40
5175340|NCT01181076|12728196|P2|STARTED|Overall Study||60
5175341|NCT01181076|12728197|P1|STARTED|Overall Study||59
5175342|NCT01181050|12728219|P2|NOT COMPLETED|Overall Study||0
5175343|NCT01181050|12728220|P1|NOT COMPLETED|Overall Study||0
5175344|NCT01181050|12728219|P2|COMPLETED|Overall Study||22
5175345|NCT01181050|12728220|P1|COMPLETED|Overall Study||41
5175346|NCT01181050|12728219|P2|STARTED|Overall Study||22
5175347|NCT01181050|12728220|P1|STARTED|Overall Study||41
5175348|NCT01181011|12728230|P1|NOT COMPLETED|Overall Study||3
5175349|NCT01181011|12728230|P1|COMPLETED|Overall Study||25
5175350|NCT01181011|12728230|P1|Received Amlodipine 5mg|Overall Study||26
5175351|NCT01181011|12728230|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
5175352|NCT01181011|12728230|P1|Received Telmisartan 80mg|Overall Study||27
5175353|NCT01181011|12728230|P1|STARTED|Overall Study||28
5175354|NCT01180998|12728280|P3|NOT COMPLETED|Overall Study||10
5175355|NCT01180998|12728281|P2|NOT COMPLETED|Overall Study||4
5175356|NCT01180998|12728282|P1|NOT COMPLETED|Overall Study||4
5175357|NCT01180998|12728280|P3|COMPLETED|Overall Study||51
5175358|NCT01180998|12728281|P2|COMPLETED|Overall Study||68
5175359|NCT01180998|12728282|P1|COMPLETED|Overall Study||63
5175360|NCT01180998|12728280|P3|STARTED|Overall Study||61
5175361|NCT01180998|12728281|P2|STARTED|Overall Study||72
5175362|NCT01180998|12728282|P1|STARTED|Overall Study||67
5175363|NCT01180985|12728296|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
5175364|NCT01180985|12728297|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
5175365|NCT01180985|12728296|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
5175366|NCT01180985|12728297|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
5175367|NCT01180985|12728296|P2|STARTED|Period 2 (7 +/- 1 Days)||26
5175368|NCT01180985|12728297|P1|STARTED|Period 2 (7 +/- 1 Days)||27
5175369|NCT01180985|12728296|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
5175370|NCT01180985|12728297|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
5175371|NCT01180985|12728296|P2|COMPLETED|Period 1 (7 +/- Days)||26
5175372|NCT01180985|12728297|P1|COMPLETED|Period 1 (7 +/- Days)||27
5175373|NCT01180985|12728296|P2|STARTED|Period 1 (7 +/- Days)||26
5175374|NCT01180985|12728297|P1|STARTED|Period 1 (7 +/- Days)||27
5175375|NCT01180894|12728316|P2|NOT COMPLETED|Overall Study||0
5175376|NCT01180894|12728317|P1|NOT COMPLETED|Overall Study||0
5175377|NCT01180894|12728316|P2|COMPLETED|Overall Study||75
5175378|NCT01180894|12728317|P1|COMPLETED|Overall Study||75
5175379|NCT01180894|12728316|P2|STARTED|Overall Study||75
5175380|NCT01180894|12728317|P1|STARTED|Overall Study||75
5175381|NCT01180790|12728336|P7|NOT COMPLETED|Overall Study||1
5175382|NCT01180790|12728337|P6|NOT COMPLETED|Overall Study||7
5175383|NCT01180790|12728338|P5|NOT COMPLETED|Overall Study||5
5175384|NCT01180790|12728339|P4|NOT COMPLETED|Overall Study||9
5175385|NCT01180790|12728340|P3|NOT COMPLETED|Overall Study||13
5175386|NCT01180790|12728341|P2|NOT COMPLETED|Overall Study||5
5175387|NCT01180790|12728342|P1|NOT COMPLETED|Overall Study||9
5175388|NCT01180790|12728336|P7|COMPLETED|Overall Study||18
5175389|NCT01180790|12728337|P6|COMPLETED|Overall Study||13
5175390|NCT01180790|12728338|P5|COMPLETED|Overall Study||14
5175391|NCT01180790|12728339|P4|COMPLETED|Overall Study||6
5175392|NCT01180790|12728340|P3|COMPLETED|Overall Study||4
5175393|NCT01180790|12728341|P2|COMPLETED|Overall Study||11
5175394|NCT01180790|12728342|P1|COMPLETED|Overall Study||7
5175395|NCT01180790|12728336|P7|STARTED|Overall Study||19
5175396|NCT01180790|12728337|P6|STARTED|Overall Study||20
5175397|NCT01180790|12728338|P5|STARTED|Overall Study||19
5175398|NCT01180790|12728339|P4|STARTED|Overall Study||15
5175399|NCT01180790|12728340|P3|STARTED|Overall Study||17
5175400|NCT01180790|12728341|P2|STARTED|Overall Study||16
5175401|NCT01180790|12728342|P1|STARTED|Overall Study||16
5175402|NCT01180777|12728407|P1|NOT COMPLETED|Overall Study||12
5175403|NCT01180777|12728407|P1|COMPLETED|Overall Study||80
5175404|NCT01180777|12728407|P1|STARTED|Overall Study||92
5175405|NCT01180660|12728421|P2|NOT COMPLETED|Overall Study||0
5175406|NCT01180660|12728422|P1|NOT COMPLETED|Overall Study||1
5175407|NCT01180660|12728421|P2|COMPLETED|Overall Study||26
5175408|NCT01180660|12728422|P1|COMPLETED|Overall Study||24
5175409|NCT01180660|12728421|P2|STARTED|Overall Study||26
5175410|NCT01180660|12728422|P1|STARTED|Overall Study||25
5175411|NCT01180647|12728432|P2|NOT COMPLETED|Overall Study||6
5175413|NCT01180647|12728432|P2|COMPLETED|Overall Study||11
5175414|NCT01180647|12728433|P1|COMPLETED|Overall Study||12
5175415|NCT01180647|12728432|P2|STARTED|Overall Study||17
5175416|NCT01180647|12728433|P1|STARTED|Overall Study||17
5175417|NCT01180478|12728451|P2|NOT COMPLETED|Overall Study||188
5175418|NCT01180478|12728452|P1|NOT COMPLETED|Overall Study||181
5175419|NCT01180478|12728451|P2|COMPLETED|Overall Study||293
5175420|NCT01180478|12728452|P1|COMPLETED|Overall Study||303
5175421|NCT01180478|12728451|P2|STARTED|Overall Study||481
5175422|NCT01180478|12728452|P1|STARTED|Overall Study||484
5175423|NCT01180400|12728468|P2|NOT COMPLETED|Overall Study||27
5175424|NCT01180400|12728469|P1|NOT COMPLETED|Overall Study||25
5175425|NCT01180400|12728468|P2|COMPLETED|Overall Study||121
5175426|NCT01180400|12728469|P1|COMPLETED|Overall Study||122
5175427|NCT01180400|12728468|P2|Received Treatment|Overall Study||146
5175428|NCT01180400|12728469|P1|Received Treatment|Overall Study||147
5175429|NCT01180400|12728468|P2|STARTED|Overall Study||148
5175430|NCT01180400|12728469|P1|STARTED|Overall Study||147
5175431|NCT01180296|12728517|P2|NOT COMPLETED|Overall Study||2
5175432|NCT01180296|12728518|P1|NOT COMPLETED|Overall Study||1
5175433|NCT01180296|12728517|P2|COMPLETED|Overall Study||14
5175434|NCT01180296|12728518|P1|COMPLETED|Overall Study||19
5175435|NCT01180296|12728517|P2|STARTED|Overall Study||16
5175436|NCT01180296|12728518|P1|STARTED|Overall Study||20
5175437|NCT01180244|12728528|P2|NOT COMPLETED|Overall Study||8
5175438|NCT01180244|12728529|P1|NOT COMPLETED|Overall Study||6
5175439|NCT01180244|12728528|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
5175440|NCT01180244|12728529|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
5175441|NCT01180244|12728528|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
5175442|NCT01180244|12728529|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
5175443|NCT01180244|12728528|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
5175444|NCT01180244|12728529|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
5175445|NCT01180127|12728547|P4|NOT COMPLETED|Overall Study||1
5175446|NCT01180127|12728548|P3|NOT COMPLETED|Overall Study||1
5175447|NCT01180127|12728549|P2|NOT COMPLETED|Overall Study||0
5175448|NCT01180127|12728550|P1|NOT COMPLETED|Overall Study||2
5175449|NCT01180127|12728547|P4|COMPLETED|Overall Study||9
5175450|NCT01180127|12728548|P3|COMPLETED|Overall Study||9
5175451|NCT01180127|12728549|P2|COMPLETED|Overall Study||11
5175452|NCT01180127|12728550|P1|COMPLETED|Overall Study||8
5175453|NCT01180127|12728547|P4|STARTED|Overall Study||10
5175454|NCT01180127|12728548|P3|STARTED|Overall Study||10
5175455|NCT01180127|12728549|P2|STARTED|Overall Study||11
5175456|NCT01180127|12728550|P1|STARTED|Overall Study||10
5175457|NCT01180049|12728574|P2|NOT COMPLETED|Overall Study||48
5175458|NCT01180049|12728575|P1|NOT COMPLETED|Overall Study||53
5175459|NCT01180049|12728574|P2|COMPLETED|Overall Study||0
5175460|NCT01180049|12728575|P1|COMPLETED|Overall Study||0
5175461|NCT01180049|12728574|P2|STARTED|Overall Study||48
5175462|NCT01180049|12728575|P1|STARTED|Overall Study||53
5175463|NCT01180036|12728597|P2|NOT COMPLETED|Overall Study||0
5175464|NCT01180036|12728598|P1|NOT COMPLETED|Overall Study||0
5175465|NCT01180036|12728597|P2|COMPLETED|Overall Study||65
5175466|NCT01180036|12728598|P1|COMPLETED|Overall Study||65
5175467|NCT01180036|12728597|P2|STARTED|Overall Study||65
5175468|NCT01180036|12728598|P1|STARTED|Overall Study||65
5175469|NCT01179984|12728606|P1|NOT COMPLETED|Overall Study||18
5175470|NCT01179984|12728606|P1|COMPLETED|Overall Study||58
5175471|NCT01179984|12728606|P1|STARTED|Overall Study||76
5175472|NCT01179919|12728612|P1|NOT COMPLETED|Overall Study||2
5175473|NCT01179919|12728612|P1|COMPLETED|Overall Study||19
5175474|NCT01179919|12728612|P1|STARTED|Overall Study||21
5175475|NCT01179737|12728621|P4|NOT COMPLETED|Extension||0
5175476|NCT01179737|12728622|P3|NOT COMPLETED|Extension||0
5175477|NCT01179737|12728623|P2|NOT COMPLETED|Extension||0
5175478|NCT01179737|12728624|P1|NOT COMPLETED|Extension||3
5175479|NCT01179737|12728621|P4|COMPLETED|Extension||0
5175480|NCT01179737|12728622|P3|COMPLETED|Extension||0
5175481|NCT01179737|12728623|P2|COMPLETED|Extension||0
5175482|NCT01179737|12728624|P1|COMPLETED|Extension||0
5175483|NCT01179737|12728621|P4|STARTED|Extension||0
5175484|NCT01179737|12728622|P3|STARTED|Extension||0
5175485|NCT01179737|12728623|P2|STARTED|Extension|One patient did not enrol in the extension|0
5175486|NCT01179737|12728624|P1|STARTED|Extension|Two patients did not enrol in the extension|3
5175487|NCT01179737|12728621|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
5175488|NCT01179737|12728622|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
5175489|NCT01179737|12728623|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
5175490|NCT01179737|12728624|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
5175491|NCT01179737|12728621|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
5175492|NCT01179737|12728622|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
5175493|NCT01179737|12728623|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
5175494|NCT01179737|12728624|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
5175495|NCT01179737|12728621|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
5175496|NCT01179737|12728622|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
5175497|NCT01179737|12728623|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
5175498|NCT01179737|12728624|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
5175499|NCT01179737|12728621|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
5175500|NCT01179737|12728622|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
5175501|NCT01179737|12728623|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
5175502|NCT01179737|12728624|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
5175503|NCT01179737|12728621|P4|COMPLETED|Cohort 1 & Cohort 2||0
5175504|NCT01179737|12728622|P3|COMPLETED|Cohort 1 & Cohort 2||0
5175505|NCT01179737|12728623|P2|COMPLETED|Cohort 1 & Cohort 2||1
5175506|NCT01179737|12728624|P1|COMPLETED|Cohort 1 & Cohort 2||7
5175507|NCT01179737|12728621|P4|STARTED|Cohort 1 & Cohort 2||4
5175508|NCT01179737|12728622|P3|STARTED|Cohort 1 & Cohort 2||4
5175509|NCT01179737|12728623|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
5175510|NCT01179737|12728624|P1|STARTED|Cohort 1 & Cohort 2||12
5175511|NCT01179672|12728635|P2|NOT COMPLETED|Overall Study||26
5175512|NCT01179672|12728636|P1|NOT COMPLETED|Overall Study||30
5175513|NCT01179672|12728635|P2|COMPLETED|Overall Study||176
5175514|NCT01179672|12728636|P1|COMPLETED|Overall Study||173
5175515|NCT01179672|12728635|P2|Entered Taper|Overall Study||177
5175516|NCT01179672|12728636|P1|Entered Taper|Overall Study||181
5175517|NCT01179672|12728635|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
5175518|NCT01179672|12728636|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
5175519|NCT01179672|12728635|P2|STARTED|Overall Study||202
5175520|NCT01179672|12728636|P1|STARTED|Overall Study||203
5175521|NCT01179568|12728666|P4|NOT COMPLETED|Overall Study||20
5175522|NCT01179568|12728667|P3|NOT COMPLETED|Overall Study||23
5175523|NCT01179568|12728668|P2|NOT COMPLETED|Overall Study||38
5175524|NCT01179568|12728669|P1|NOT COMPLETED|Overall Study||28
5175525|NCT01179568|12728666|P4|COMPLETED|Overall Study||76
5175526|NCT01179568|12728667|P3|COMPLETED|Overall Study||76
5175527|NCT01179568|12728668|P2|COMPLETED|Overall Study||61
5175528|NCT01179568|12728669|P1|COMPLETED|Overall Study||73
5175529|NCT01179568|12728666|P4|Completed Week 12 Assessment|Overall Study||75
5175530|NCT01179568|12728667|P3|Completed Week 12 Assessment|Overall Study||76
5175531|NCT01179568|12728668|P2|Completed Week 12 Assessment|Overall Study||69
5175532|NCT01179568|12728669|P1|Completed Week 12 Assessment|Overall Study||69
5175533|NCT01179568|12728666|P4|STARTED|Overall Study||96
5175534|NCT01179568|12728667|P3|STARTED|Overall Study||99
5175535|NCT01179568|12728668|P2|STARTED|Overall Study||99
5175536|NCT01179568|12728669|P1|STARTED|Overall Study||101
5175537|NCT01179516|12728692|P3|NOT COMPLETED|Overall Study||31
5175538|NCT01179516|12728693|P2|NOT COMPLETED|Overall Study||26
5175539|NCT01179516|12728694|P1|NOT COMPLETED|Overall Study||27
5175540|NCT01179516|12728692|P3|COMPLETED|Overall Study||121
5175541|NCT01179516|12728693|P2|COMPLETED|Overall Study||131
5175542|NCT01179516|12728694|P1|COMPLETED|Overall Study||133
5175543|NCT01179516|12728692|P3|Treated|Overall Study||151
5175544|NCT01179516|12728693|P2|Treated|Overall Study||154
5175545|NCT01179516|12728694|P1|Treated|Overall Study||160
5175546|NCT01179516|12728692|P3|STARTED|Overall Study||152
5175547|NCT01179516|12728693|P2|STARTED|Overall Study||157
5175548|NCT01179516|12728694|P1|STARTED|Overall Study||160
5175549|NCT01179490|12728717|P1|NOT COMPLETED|Overall Study||0
5175550|NCT01179490|12728717|P1|COMPLETED|Overall Study||5
5175551|NCT01179490|12728717|P1|STARTED|Overall Study||5
5175552|NCT01179477|12728738|P1|NOT COMPLETED|Overall Study||1087
5175553|NCT01179477|12728738|P1|COMPLETED|Overall Study||843
5175554|NCT01179477|12728738|P1|STARTED|Overall Study||1930
5175555|NCT01179399|12728743|P1|NOT COMPLETED|Overall Study||32
5175556|NCT01179399|12728743|P1|COMPLETED|Overall Study||0
5175557|NCT01179399|12728743|P1|STARTED|Overall Study||32
5175558|NCT01179347|12728749|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
5175559|NCT01179347|12728750|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
5175560|NCT01179347|12728749|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
5175561|NCT01179347|12728750|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
5175562|NCT01179347|12728749|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
5175563|NCT01179347|12728750|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
5175564|NCT01179347|12728749|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
5175565|NCT01179347|12728750|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
5175566|NCT01179347|12728749|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
5175567|NCT01179347|12728750|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
5175568|NCT01179347|12728749|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
5175569|NCT01179347|12728750|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
5175570|NCT01179334|12728772|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
5175571|NCT01179334|12728773|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
5175572|NCT01179334|12728772|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
5175573|NCT01179334|12728773|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
5175574|NCT01179334|12728772|P2|STARTED|Long-term Extension (LTE) Period||6
5175575|NCT01179334|12728773|P1|STARTED|Long-term Extension (LTE) Period||11
5175576|NCT01179334|12728772|P2|NOT COMPLETED|Treatment Period||0
5175577|NCT01179334|12728773|P1|NOT COMPLETED|Treatment Period||1
5175578|NCT01179334|12728772|P2|COMPLETED|Treatment Period||6
5175579|NCT01179334|12728773|P1|COMPLETED|Treatment Period||11
5175580|NCT01179334|12728772|P2|Participants Received Treatment|Treatment Period||6
5175581|NCT01179334|12728773|P1|Participants Received Treatment|Treatment Period||12
5175582|NCT01179334|12728772|P2|STARTED|Treatment Period||6
5175583|NCT01179334|12728773|P1|STARTED|Treatment Period||12
5175584|NCT01179217|12728803|P2|NOT COMPLETED|Overall Study||19
5175585|NCT01179217|12728804|P1|NOT COMPLETED|Overall Study||55
5175586|NCT01179217|12728803|P2|COMPLETED|Overall Study||59
5175587|NCT01179217|12728804|P1|COMPLETED|Overall Study||97
5175588|NCT01179217|12728803|P2|STARTED|Overall Study||78
5175589|NCT01179217|12728804|P1|STARTED|Overall Study||152
5175590|NCT01179191|12728828|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
5175591|NCT01179191|12728828|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
5175592|NCT01179191|12728828|P1|STARTED|Maintenance Phase (8 Weeks)||351
5175593|NCT01179191|12728828|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
5175594|NCT01179191|12728828|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
5175595|NCT01179191|12728828|P1|STARTED|Titration Phase (up to 6 Weeks)||684
5175596|NCT01179113|12728847|P2|NOT COMPLETED|Overall Study||0
5175597|NCT01179113|12728848|P1|NOT COMPLETED|Overall Study||0
5175598|NCT01179113|12728847|P2|COMPLETED|Overall Study||16
5175599|NCT01179113|12728848|P1|COMPLETED|Overall Study||17
5175600|NCT01179113|12728847|P2|STARTED|Overall Study||16
5175601|NCT01179113|12728848|P1|STARTED|Overall Study||17
5175602|NCT01179048|12728860|P2|NOT COMPLETED|Overall Study||159
5175603|NCT01179048|12728861|P1|NOT COMPLETED|Overall Study||139
5175604|NCT01179048|12728860|P2|COMPLETED|Overall Study||4513
5175605|NCT01179048|12728861|P1|COMPLETED|Overall Study||4529
5175606|NCT01179048|12728860|P2|STARTED|Overall Study||4672
5175607|NCT01179048|12728861|P1|STARTED|Overall Study||4668
5175608|NCT01178944|12728877|P1|NOT COMPLETED|Overall Study||0
5175609|NCT01178944|12728877|P1|COMPLETED|Overall Study||35
5175610|NCT01178944|12728877|P1|STARTED|Overall Study||35
5175611|NCT01178853|12728888|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
5175612|NCT01178853|12728889|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
5175613|NCT01178853|12728888|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
5175614|NCT01178853|12728889|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
5175615|NCT01178853|12728888|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
5175616|NCT01178853|12728889|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
5175617|NCT01178853|12728888|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
5175618|NCT01178853|12728889|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
5175619|NCT01178853|12728888|P2|COMPLETED|Period 3 (Warfarin Titration)||22
5175620|NCT01178853|12728889|P1|COMPLETED|Period 3 (Warfarin Titration)||21
5175621|NCT01178853|12728888|P2|STARTED|Period 3 (Warfarin Titration)||22
5175622|NCT01178853|12728889|P1|STARTED|Period 3 (Warfarin Titration)||22
5175623|NCT01178853|12728888|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
5175624|NCT01178853|12728889|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
5175625|NCT01178853|12728888|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
5175626|NCT01178853|12728889|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
5175627|NCT01178853|12728888|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
5175628|NCT01178853|12728889|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
5175629|NCT01178853|12728888|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
5175630|NCT01178853|12728889|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
5175631|NCT01178853|12728888|P2|COMPLETED|Period 1 (Warfarin Titration)||22
5175632|NCT01178853|12728889|P1|COMPLETED|Period 1 (Warfarin Titration)||23
5175633|NCT01178853|12728888|P2|STARTED|Period 1 (Warfarin Titration)||24
5175634|NCT01178853|12728889|P1|STARTED|Period 1 (Warfarin Titration)||24
5175635|NCT01178827|12728898|P3|NOT COMPLETED|Overall Study||0
5175636|NCT01178827|12728899|P2|NOT COMPLETED|Overall Study||0
5175637|NCT01178827|12728900|P1|NOT COMPLETED|Overall Study||0
5175638|NCT01178827|12728898|P3|COMPLETED|Overall Study||4
5175639|NCT01178827|12728899|P2|COMPLETED|Overall Study||10
5175640|NCT01178827|12728900|P1|COMPLETED|Overall Study||6
5175641|NCT01178827|12728898|P3|STARTED|Overall Study||4
5175642|NCT01178827|12728899|P2|STARTED|Overall Study||10
5175643|NCT01178827|12728900|P1|STARTED|Overall Study||6
5175644|NCT01178762|12728929|P1|NOT COMPLETED|Overall Study||15
5175645|NCT01178762|12728929|P1|COMPLETED|Overall Study||27
5175646|NCT01178762|12728929|P1|STARTED|Overall Study||42
5175647|NCT01178671|12728935|P2|NOT COMPLETED|Overall Study||15
5175648|NCT01178671|12728936|P1|NOT COMPLETED|Overall Study||12
5175649|NCT01178671|12728935|P2|COMPLETED|Overall Study||3
5175650|NCT01178671|12728936|P1|COMPLETED|Overall Study||6
5175651|NCT01178671|12728935|P2|STARTED|Overall Study||18
5175652|NCT01178671|12728936|P1|STARTED|Overall Study||18
5175653|NCT01178528|12728963|P3|NOT COMPLETED|Overall Study||0
5175654|NCT01178528|12728964|P2|NOT COMPLETED|Overall Study||0
5175655|NCT01178528|12728965|P1|NOT COMPLETED|Overall Study||0
5175656|NCT01178528|12728963|P3|COMPLETED|Overall Study||42
5175657|NCT01178528|12728964|P2|COMPLETED|Overall Study||38
5175658|NCT01178528|12728965|P1|COMPLETED|Overall Study||41
5175659|NCT01178528|12728963|P3|STARTED|Overall Study||42
5175660|NCT01178528|12728964|P2|STARTED|Overall Study||38
5175661|NCT01178528|12728965|P1|STARTED|Overall Study||41
5175662|NCT01178385|12728984|P2|NOT COMPLETED|Overall Study||0
5175663|NCT01178385|12728985|P1|NOT COMPLETED|Overall Study||2
5175664|NCT01178385|12728984|P2|COMPLETED|Overall Study||21
5175665|NCT01178385|12728985|P1|COMPLETED|Overall Study||22
5175666|NCT01178385|12728984|P2|STARTED|Overall Study||21
5175667|NCT01178385|12728985|P1|STARTED|Overall Study||24
5175668|NCT01178333|12728998|P3|NOT COMPLETED|Overall Study||0
5175669|NCT01178333|12728999|P2|NOT COMPLETED|Overall Study||0
5175670|NCT01178333|12729000|P1|NOT COMPLETED|Overall Study||0
5175671|NCT01178333|12728998|P3|COMPLETED|Overall Study||87
5175672|NCT01178333|12728999|P2|COMPLETED|Overall Study||284
5175673|NCT01178333|12729000|P1|COMPLETED|Overall Study||71
5175674|NCT01178333|12728998|P3|STARTED|Overall Study||87
5175675|NCT01178333|12728999|P2|STARTED|Overall Study||284
5175676|NCT01178333|12729000|P1|STARTED|Overall Study||71
5175677|NCT01178294|12729054|P1|NOT COMPLETED|Overall Study||11
5175678|NCT01178294|12729054|P1|COMPLETED|Overall Study||18
5175679|NCT01178294|12729054|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
5175680|NCT01178281|12729078|P3|NOT COMPLETED|Overall Study||0
5175681|NCT01178281|12729079|P2|NOT COMPLETED|Overall Study||0
5175682|NCT01178281|12729080|P1|NOT COMPLETED|Overall Study||0
5175683|NCT01178281|12729078|P3|COMPLETED|Overall Study||15
5175684|NCT01178281|12729079|P2|COMPLETED|Overall Study||84
5175685|NCT01178281|12729080|P1|COMPLETED|Overall Study||168
5175686|NCT01178281|12729078|P3|Received Study Drug|Overall Study||15
5175687|NCT01178281|12729079|P2|Received Study Drug|Overall Study||83
5175688|NCT01178281|12729080|P1|Received Study Drug|Overall Study||167
5175689|NCT01178281|12729078|P3|STARTED|Overall Study||15
5175690|NCT01178281|12729079|P2|STARTED|Overall Study||84
5175691|NCT01178281|12729080|P1|STARTED|Overall Study||168
5175692|NCT01178268|12729107|P2|NOT COMPLETED|Overall Study||1
5175693|NCT01178268|12729108|P1|NOT COMPLETED|Overall Study||7
5175694|NCT01178268|12729107|P2|COMPLETED|Overall Study||120
5175695|NCT01178268|12729108|P1|COMPLETED|Overall Study||360
5175696|NCT01178268|12729107|P2|STARTED|Overall Study||121
5175697|NCT01178268|12729108|P1|STARTED|Overall Study||367
5175698|NCT01178216|12729325|P1|NOT COMPLETED|Overall Study||2
5175699|NCT01178216|12729325|P1|COMPLETED|Overall Study||39
5175700|NCT01178216|12729325|P1|STARTED|Overall Study||41
5175701|NCT01178138|12729334|P1|NOT COMPLETED|Overall Study||23
5175702|NCT01178138|12729334|P1|COMPLETED|Overall Study||1
5175703|NCT01178138|12729334|P1|Completed 3 Sessions|Overall Study||1
5175704|NCT01178138|12729334|P1|Completed 5 Sessions|Overall Study||1
5175705|NCT01178138|12729334|P1|Completed 6 Sessions|Overall Study||1
5175706|NCT01178138|12729334|P1|STARTED|Overall Study||24
5175707|NCT01178125|12729355|P1|NOT COMPLETED|Overall Study||1178
5175708|NCT01178125|12729355|P1|COMPLETED|Overall Study||1680
5175709|NCT01178125|12729355|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
5175710|NCT01178125|12729355|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
5175711|NCT01178125|12729355|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
5175712|NCT01178125|12729355|P1|STARTED|Overall Study|Number enrolled.|2858
5175713|NCT01178099|12729386|P2|NOT COMPLETED|Overall Study||1
5175714|NCT01178099|12729387|P1|NOT COMPLETED|Overall Study||0
5175715|NCT01178099|12729386|P2|COMPLETED|Overall Study||12
5175716|NCT01178099|12729387|P1|COMPLETED|Overall Study||13
5175717|NCT01178099|12729386|P2|STARTED|Overall Study||13
5175718|NCT01178099|12729387|P1|STARTED|Overall Study||13
5175719|NCT01178086|12729427|P1|NOT COMPLETED|Overall Study||332
5175720|NCT01178086|12729427|P1|COMPLETED|Overall Study||349
5175721|NCT01178086|12729427|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
5175722|NCT01178086|12729427|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
5175723|NCT01178073|12729454|P3|NOT COMPLETED|Overall Study||46
5175724|NCT01178073|12729455|P2|NOT COMPLETED|Overall Study||44
5175725|NCT01178073|12729456|P1|NOT COMPLETED|Overall Study||62
5175726|NCT01178073|12729454|P3|COMPLETED|Overall Study||105
5175727|NCT01178073|12729455|P2|COMPLETED|Overall Study||108
5175728|NCT01178073|12729456|P1|COMPLETED|Overall Study||240
5175729|NCT01178073|12729454|P3|STARTED|Overall Study||151
5175730|NCT01178073|12729455|P2|STARTED|Overall Study||152
5175731|NCT01178073|12729456|P1|STARTED|Overall Study||302
5175732|NCT01177969|12729487|P2|NOT COMPLETED|Overall Study||3
5175733|NCT01177969|12729488|P1|NOT COMPLETED|Overall Study||3
5175734|NCT01177969|12729487|P2|COMPLETED|Overall Study||11
5175735|NCT01177969|12729488|P1|COMPLETED|Overall Study||16
5175736|NCT01177969|12729487|P2|STARTED|Overall Study||14
5175737|NCT01177969|12729488|P1|STARTED|Overall Study||19
5175738|NCT01177956|12729496|P1|NOT COMPLETED|Overall Study||0
5175739|NCT01177956|12729496|P1|COMPLETED|Overall Study||68
5175740|NCT01177956|12729496|P1|STARTED|Overall Study||68
5175741|NCT01177943|12729511|P2|NOT COMPLETED|Second Intervention||0
5175742|NCT01177943|12729512|P1|NOT COMPLETED|Second Intervention||0
5175743|NCT01177943|12729511|P2|COMPLETED|Second Intervention||21
5175744|NCT01177943|12729512|P1|COMPLETED|Second Intervention||19
5175745|NCT01177943|12729511|P2|STARTED|Second Intervention||21
5175746|NCT01177943|12729512|P1|STARTED|Second Intervention||19
5175747|NCT01177943|12729511|P2|NOT COMPLETED|First Intervention||0
5175748|NCT01177943|12729512|P1|NOT COMPLETED|First Intervention||2
5175749|NCT01177943|12729511|P2|COMPLETED|First Intervention||21
5175750|NCT01177943|12729512|P1|COMPLETED|First Intervention||19
5175751|NCT01177943|12729511|P2|STARTED|First Intervention||21
5175752|NCT01177943|12729512|P1|STARTED|First Intervention||21
5175753|NCT01177813|12729525|P5|NOT COMPLETED|Overall Study||9
5175754|NCT01177813|12729526|P4|NOT COMPLETED|Overall Study||17
5175755|NCT01177813|12729527|P3|NOT COMPLETED|Overall Study||20
5175756|NCT01177813|12729528|P2|NOT COMPLETED|Overall Study||18
5175757|NCT01177813|12729529|P1|NOT COMPLETED|Overall Study||41
5175758|NCT01177813|12729525|P5|COMPLETED|Overall Study||78
5175759|NCT01177813|12729526|P4|COMPLETED|Overall Study||206
5175760|NCT01177813|12729527|P3|COMPLETED|Overall Study||204
5175761|NCT01177813|12729528|P2|COMPLETED|Overall Study||206
5175762|NCT01177813|12729529|P1|COMPLETED|Overall Study||187
5175763|NCT01177813|12729525|P5|STARTED|Overall Study||87
5175764|NCT01177813|12729526|P4|STARTED|Overall Study||223
5175765|NCT01177813|12729527|P3|STARTED|Overall Study||224
5175766|NCT01177813|12729528|P2|STARTED|Overall Study||224
5175767|NCT01177813|12729529|P1|STARTED|Overall Study||228
5175768|NCT01177800|12729558|P2|NOT COMPLETED|Overall Study||5
5175769|NCT01177800|12729559|P1|NOT COMPLETED|Overall Study||10
5175770|NCT01177800|12729558|P2|COMPLETED|Overall Study||40
5175771|NCT01177800|12729559|P1|COMPLETED|Overall Study||74
5175772|NCT01177800|12729558|P2|STARTED|Overall Study||45
5175773|NCT01177800|12729559|P1|STARTED|Overall Study||84
5175774|NCT01177735|12729573|P1|NOT COMPLETED|Overall Study||71
5175775|NCT01177735|12729573|P1|COMPLETED|Overall Study||0
5175776|NCT01177735|12729573|P1|STARTED|Overall Study||71
5175777|NCT01177722|12729581|P4|NOT COMPLETED|Overall Study||7
5175778|NCT01177722|12729582|P3|NOT COMPLETED|Overall Study||9
5175779|NCT01177722|12729583|P2|NOT COMPLETED|Overall Study||10
5175780|NCT01177722|12729584|P1|NOT COMPLETED|Overall Study||13
5175781|NCT01177722|12729581|P4|COMPLETED|Overall Study||338
5175782|NCT01177722|12729582|P3|COMPLETED|Overall Study||333
5175783|NCT01177722|12729583|P2|COMPLETED|Overall Study||334
5175784|NCT01177722|12729584|P1|COMPLETED|Overall Study||331
5175785|NCT01177722|12729581|P4|STARTED|Overall Study||345
5175786|NCT01177722|12729582|P3|STARTED|Overall Study||342
5175787|NCT01177722|12729583|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
5175788|NCT01177722|12729584|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
5175789|NCT01177709|12729610|P1|NOT COMPLETED|Overall Study||0
5175790|NCT01177709|12729610|P1|COMPLETED|Overall Study||12
5175791|NCT01177709|12729610|P1|STARTED|Overall Study||12
5175792|NCT01177670|12729616|P1|NOT COMPLETED|Overall Study||169
5175793|NCT01177670|12729616|P1|COMPLETED|Overall Study||0
5175794|NCT01177670|12729616|P1|STARTED|Overall Study||169
5175795|NCT01177553|12729623|P2|NOT COMPLETED|Overall Study||0
5175796|NCT01177553|12729624|P1|NOT COMPLETED|Overall Study||1
5175797|NCT01177553|12729623|P2|COMPLETED|Overall Study|data as of March 2009|2
5175798|NCT01177553|12729624|P1|COMPLETED|Overall Study|data as of March 2009|2
5175799|NCT01177553|12729623|P2|STARTED|Overall Study||2
5175800|NCT01177553|12729624|P1|STARTED|Overall Study||3
5175801|NCT01177410|12729633|P3|NOT COMPLETED|Overall Study||5
5175802|NCT01177410|12729634|P2|NOT COMPLETED|Overall Study||7
5175803|NCT01177410|12729635|P1|NOT COMPLETED|Overall Study||1
5175804|NCT01177410|12729633|P3|COMPLETED|Overall Study||45
5175805|NCT01177410|12729634|P2|COMPLETED|Overall Study||40
5175806|NCT01177410|12729635|P1|COMPLETED|Overall Study||50
5175807|NCT01177410|12729633|P3|STARTED|Overall Study||50
5175808|NCT01177410|12729634|P2|STARTED|Overall Study||47
5175809|NCT01177410|12729635|P1|STARTED|Overall Study||51
5175810|NCT01177384|12729648|P2|NOT COMPLETED|Overall Study||26
5175811|NCT01177384|12729649|P1|NOT COMPLETED|Overall Study||14
5175812|NCT01177384|12729648|P2|COMPLETED|Overall Study||164
5175813|NCT01177384|12729649|P1|COMPLETED|Overall Study||177
5175814|NCT01177384|12729648|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
5175815|NCT01177384|12729649|P1|STARTED|Overall Study||191
5175816|NCT01177293|12729661|P2|NOT COMPLETED|Second Intervention Period||0
5175817|NCT01177293|12729662|P1|NOT COMPLETED|Second Intervention Period||0
5175818|NCT01177293|12729661|P2|COMPLETED|Second Intervention Period||6
5175819|NCT01177293|12729662|P1|COMPLETED|Second Intervention Period||7
5175820|NCT01177293|12729661|P2|STARTED|Second Intervention Period||6
5175821|NCT01177293|12729662|P1|STARTED|Second Intervention Period||7
5175822|NCT01177293|12729661|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
5175823|NCT01177293|12729662|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
5175824|NCT01177293|12729661|P2|COMPLETED|Washout Period (of 14 Days)||6
5175825|NCT01177293|12729662|P1|COMPLETED|Washout Period (of 14 Days)||7
5175826|NCT01177293|12729661|P2|STARTED|Washout Period (of 14 Days)||7
5175827|NCT01177293|12729662|P1|STARTED|Washout Period (of 14 Days)||7
5175828|NCT01177293|12729661|P2|NOT COMPLETED|First Intervention Period||0
5175829|NCT01177293|12729662|P1|NOT COMPLETED|First Intervention Period||0
5175830|NCT01177293|12729661|P2|COMPLETED|First Intervention Period||7
5175831|NCT01177293|12729662|P1|COMPLETED|First Intervention Period||7
5175832|NCT01177293|12729661|P2|STARTED|First Intervention Period||7
5175833|NCT01177293|12729662|P1|STARTED|First Intervention Period||7
5175834|NCT01177228|12729680|P4|NOT COMPLETED|Overall Study||0
5175835|NCT01177228|12729681|P3|NOT COMPLETED|Overall Study||0
5175836|NCT01177228|12729682|P2|NOT COMPLETED|Overall Study||2
5175837|NCT01177228|12729683|P1|NOT COMPLETED|Overall Study||1
5175838|NCT01177228|12729680|P4|COMPLETED|Overall Study||11
5175839|NCT01177228|12729681|P3|COMPLETED|Overall Study||14
5175840|NCT01177228|12729682|P2|COMPLETED|Overall Study||11
5175841|NCT01177228|12729683|P1|COMPLETED|Overall Study||8
5175842|NCT01177228|12729680|P4|Received Treatment|Overall Study||11
5175843|NCT01177228|12729681|P3|Received Treatment|Overall Study||14
5175844|NCT01177228|12729682|P2|Received Treatment|Overall Study||12
5175845|NCT01177228|12729683|P1|Received Treatment|Overall Study||9
5175846|NCT01177228|12729680|P4|STARTED|Overall Study||11
5175847|NCT01177228|12729681|P3|STARTED|Overall Study||14
5175848|NCT01177228|12729682|P2|STARTED|Overall Study||13
5175849|NCT01177228|12729683|P1|STARTED|Overall Study||9
5175850|NCT01177189|12729723|P2|NOT COMPLETED|Overall Study||0
5175851|NCT01177189|12729724|P1|NOT COMPLETED|Overall Study||0
5175852|NCT01177189|12729723|P2|COMPLETED|Overall Study||45
5175853|NCT01177189|12729724|P1|COMPLETED|Overall Study||42
5175854|NCT01177189|12729723|P2|STARTED|Overall Study||45
5175855|NCT01177189|12729724|P1|STARTED|Overall Study||42
5175856|NCT01177137|12729737|P3|NOT COMPLETED|Overall Study||2
5175857|NCT01177137|12729738|P2|NOT COMPLETED|Overall Study||10
5175858|NCT01177137|12729739|P1|NOT COMPLETED|Overall Study||10
5175859|NCT01177137|12729737|P3|COMPLETED|Overall Study||47
5175860|NCT01177137|12729738|P2|COMPLETED|Overall Study||41
5175861|NCT01177137|12729739|P1|COMPLETED|Overall Study||41
5175862|NCT01177137|12729737|P3|STARTED|Overall Study||49
5175863|NCT01177137|12729738|P2|STARTED|Overall Study||51
5175864|NCT01177137|12729739|P1|STARTED|Overall Study||51
5175865|NCT01177098|12729806|P2|NOT COMPLETED|Overall Study||12
5175866|NCT01177098|12729807|P1|NOT COMPLETED|Overall Study||9
5175867|NCT01177098|12729806|P2|COMPLETED|Overall Study||271
5175868|NCT01177098|12729807|P1|COMPLETED|Overall Study||269
5175869|NCT01177098|12729806|P2|STARTED|Overall Study||283
5175870|NCT01177098|12729807|P1|STARTED|Overall Study||278
5175871|NCT01177059|12729823|P1|NOT COMPLETED|Overall Study||50
5175872|NCT01177059|12729823|P1|COMPLETED|Overall Study||18
5175873|NCT01177059|12729823|P1|STARTED|Overall Study||68
5175874|NCT01177007|12729829|P1|NOT COMPLETED|Overall Study||38
5175875|NCT01177007|12729829|P1|COMPLETED|Overall Study||12
5175876|NCT01177007|12729829|P1|Completed First Clinical and Imaging|Overall Study||43
5175877|NCT01177007|12729829|P1|Completed First Y90 Treatment|Overall Study||50
5175878|NCT01177007|12729829|P1|STARTED|Overall Study||50
5175879|NCT01176968|12729843|P2|NOT COMPLETED|Overall Study||82
5175880|NCT01176968|12729844|P1|NOT COMPLETED|Overall Study||84
5175881|NCT01176968|12729843|P2|COMPLETED|Overall Study||424
5175882|NCT01176968|12729844|P1|COMPLETED|Overall Study||422
5175883|NCT01176968|12729843|P2|Treated|Overall Study||505
5175884|NCT01176968|12729844|P1|Treated|Overall Study||505
5175885|NCT01176968|12729843|P2|STARTED|Overall Study||506
5175886|NCT01176968|12729844|P1|STARTED|Overall Study||506
5175887|NCT01176955|12729878|P2|NOT COMPLETED|Overall Study||2
5175888|NCT01176955|12729879|P1|NOT COMPLETED|Overall Study||3
5175889|NCT01176955|12729878|P2|COMPLETED|Overall Study||8
5175890|NCT01176955|12729879|P1|COMPLETED|Overall Study||7
5175891|NCT01176955|12729878|P2|STARTED|Overall Study||10
5175892|NCT01176955|12729879|P1|STARTED|Overall Study||10
5175893|NCT01176877|12729890|P1|NOT COMPLETED|Overall Study||9
5175894|NCT01176877|12729890|P1|COMPLETED|Overall Study||31
5175895|NCT01176877|12729890|P1|STARTED|Overall Study||40
5175896|NCT01176773|12729895|P1|NOT COMPLETED|Overall Study||3
5175897|NCT01176773|12729895|P1|COMPLETED|Overall Study||59
5175898|NCT01176773|12729895|P1|STARTED|Overall Study||62
5175899|NCT01176617|12729906|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
5175900|NCT01176617|12729907|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
5175901|NCT01176617|12729908|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
5175902|NCT01176617|12729906|P3|COMPLETED|6 - 12 Months (Randomized)||0
5175903|NCT01176617|12729907|P2|COMPLETED|6 - 12 Months (Randomized)||20
5175904|NCT01176617|12729908|P1|COMPLETED|6 - 12 Months (Randomized)||13
5175905|NCT01176617|12729906|P3|STARTED|6 - 12 Months (Randomized)||0
5175906|NCT01176617|12729907|P2|STARTED|6 - 12 Months (Randomized)||20
5175907|NCT01176617|12729908|P1|STARTED|6 - 12 Months (Randomized)||18
5175908|NCT01176617|12729906|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
5175909|NCT01176617|12729907|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
5175910|NCT01176617|12729908|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
5175911|NCT01176617|12729906|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
5175912|NCT01176617|12729907|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
5175913|NCT01176617|12729908|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
5175914|NCT01176617|12729906|P3|STARTED|1 - 6 Months (Ron-randomized)||38
5175915|NCT01176617|12729907|P2|STARTED|1 - 6 Months (Ron-randomized)||0
5175916|NCT01176617|12729908|P1|STARTED|1 - 6 Months (Ron-randomized)||0
5175917|NCT01176591|12729919|P2|NOT COMPLETED|Session 2||0
5175918|NCT01176591|12729920|P1|NOT COMPLETED|Session 2||0
5175919|NCT01176591|12729919|P2|COMPLETED|Session 2||3
5175920|NCT01176591|12729920|P1|COMPLETED|Session 2||10
5175921|NCT01176591|12729919|P2|STARTED|Session 2||3
5175922|NCT01176591|12729920|P1|STARTED|Session 2||10
5175923|NCT01176591|12729919|P2|NOT COMPLETED|Session 1||0
5175924|NCT01176591|12729920|P1|NOT COMPLETED|Session 1||0
5175925|NCT01176591|12729919|P2|COMPLETED|Session 1||3
5175926|NCT01176591|12729920|P1|COMPLETED|Session 1||10
5175927|NCT01176591|12729919|P2|STARTED|Session 1||3
5175928|NCT01176591|12729920|P1|STARTED|Session 1||10
5175929|NCT01176565|12729938|P2|NOT COMPLETED|Overall Study||19
5175930|NCT01176565|12729939|P1|NOT COMPLETED|Overall Study||20
5175931|NCT01176565|12729938|P2|COMPLETED|Overall Study||481
5175932|NCT01176565|12729939|P1|COMPLETED|Overall Study||480
5175933|NCT01176565|12729938|P2|STARTED|Overall Study||500
5175934|NCT01176565|12729939|P1|STARTED|Overall Study||500
5175935|NCT01176513|12729957|P1|NOT COMPLETED|Overall Study||3
5175936|NCT01176513|12729957|P1|COMPLETED|Overall Study||22
5175937|NCT01176513|12729957|P1|STARTED|Overall Study||25
5175938|NCT01176448|12729962|P1|NOT COMPLETED|Overall Study||0
5175939|NCT01176448|12729962|P1|COMPLETED|Overall Study||6
5175940|NCT01176448|12729962|P1|STARTED|Overall Study||6
5175941|NCT01176435|12729973|P3|NOT COMPLETED|Overall Study||0
5175942|NCT01176435|12729974|P2|NOT COMPLETED|Overall Study||0
5175943|NCT01176435|12729975|P1|NOT COMPLETED|Overall Study||0
5175944|NCT01176435|12729973|P3|COMPLETED|Overall Study||15
5175945|NCT01176435|12729974|P2|COMPLETED|Overall Study||15
5175946|NCT01176435|12729975|P1|COMPLETED|Overall Study||15
5175947|NCT01176435|12729973|P3|STARTED|Overall Study||15
5175948|NCT01176435|12729974|P2|STARTED|Overall Study||15
5175949|NCT01176435|12729975|P1|STARTED|Overall Study||15
5175950|NCT01176292|12729985|P2|NOT COMPLETED|Overall Study||9
5175951|NCT01176292|12729986|P1|NOT COMPLETED|Overall Study||5
5175952|NCT01176292|12729985|P2|COMPLETED|Overall Study||62
5175953|NCT01176292|12729986|P1|COMPLETED|Overall Study||66
5175954|NCT01176292|12729985|P2|STARTED|Overall Study||71
5175955|NCT01176292|12729986|P1|STARTED|Overall Study||71
5175956|NCT01176266|12730004|P1|NOT COMPLETED|Overall Study||9
5175957|NCT01176266|12730004|P1|COMPLETED|Overall Study||60
5175958|NCT01176266|12730004|P1|STARTED|Overall Study||69
5175959|NCT01176240|12730028|P2|NOT COMPLETED|Study 306B||17
5175960|NCT01176240|12730029|P1|NOT COMPLETED|Study 306B||26
5175961|NCT01176240|12730028|P2|COMPLETED|Study 306B||68
5175962|NCT01176240|12730029|P1|COMPLETED|Study 306B||63
5175963|NCT01176240|12730028|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
5175964|NCT01176240|12730029|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
5175965|NCT01176240|12730028|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
5175966|NCT01176240|12730029|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
5175967|NCT01176240|12730028|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
5175968|NCT01176240|12730029|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
5175969|NCT01176240|12730028|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
5175970|NCT01176240|12730029|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
5175971|NCT01176240|12730028|P2|STARTED|Study 306B||85
5175972|NCT01176240|12730029|P1|STARTED|Study 306B||89
5175973|NCT01176240|12730028|P2|NOT COMPLETED|Study 306A||3
5175974|NCT01176240|12730029|P1|NOT COMPLETED|Study 306A||3
5175975|NCT01176240|12730028|P2|COMPLETED|Study 306A||24
5175976|NCT01176240|12730029|P1|COMPLETED|Study 306A||21
5175977|NCT01176240|12730028|P2|STARTED|Study 306A||27
5175978|NCT01176240|12730029|P1|STARTED|Study 306A||24
5175979|NCT01176058|12730055|P2|NOT COMPLETED|Overall Study||3
5175980|NCT01176058|12730056|P1|NOT COMPLETED|Overall Study||4
5175981|NCT01176058|12730055|P2|COMPLETED|Overall Study||5
5175982|NCT01176058|12730056|P1|COMPLETED|Overall Study||5
5175983|NCT01176058|12730055|P2|STARTED|Overall Study||8
5175984|NCT01176058|12730056|P1|STARTED|Overall Study||9
5175985|NCT01176032|12730080|P2|NOT COMPLETED|Overall Study||1
5175986|NCT01176032|12730081|P1|NOT COMPLETED|Overall Study||6
5175987|NCT01176032|12730080|P2|COMPLETED|Overall Study||36
5175988|NCT01176032|12730081|P1|COMPLETED|Overall Study||31
5175989|NCT01176032|12730080|P2|Intention-to-treat (ITT) Population|Overall Study||37
5175990|NCT01176032|12730081|P1|Intention-to-treat (ITT) Population|Overall Study||32
5175991|NCT01176032|12730080|P2|STARTED|Overall Study||37
5175992|NCT01176032|12730081|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
5175993|NCT01175902|12730141|P2|NOT COMPLETED|Overall Study||0
5175994|NCT01175902|12730142|P1|NOT COMPLETED|Overall Study||0
5175995|NCT01175902|12730141|P2|COMPLETED|Overall Study||22
5175996|NCT01175902|12730142|P1|COMPLETED|Overall Study||22
5175997|NCT01175902|12730141|P2|STARTED|Overall Study||22
5175998|NCT01175902|12730142|P1|STARTED|Overall Study||22
5175999|NCT01175850|12730160|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
5176000|NCT01175850|12730161|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
5176001|NCT01175850|12730160|P2|COMPLETED|IN.PACT SFA II Phase||55
5176002|NCT01175850|12730161|P1|COMPLETED|IN.PACT SFA II Phase||109
5176003|NCT01175850|12730160|P2|STARTED|IN.PACT SFA II Phase||60
5176004|NCT01175850|12730161|P1|STARTED|IN.PACT SFA II Phase||121
5176005|NCT01175850|12730160|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
5176006|NCT01175850|12730161|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
5176007|NCT01175850|12730160|P2|COMPLETED|IN.PACT SFA I Phase||49
5176008|NCT01175850|12730161|P1|COMPLETED|IN.PACT SFA I Phase||88
5176009|NCT01175850|12730160|P2|STARTED|IN.PACT SFA I Phase||51
5176010|NCT01175850|12730161|P1|STARTED|IN.PACT SFA I Phase||99
5176011|NCT01175824|12730205|P2|NOT COMPLETED|Overall Study||22
5176012|NCT01175824|12730206|P1|NOT COMPLETED|Overall Study||16
5176013|NCT01175824|12730205|P2|COMPLETED|Overall Study||220
5176014|NCT01175824|12730206|P1|COMPLETED|Overall Study||220
5176015|NCT01175824|12730205|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
5176016|NCT01175824|12730206|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
5176017|NCT01175824|12730205|P2|STARTED|Overall Study||242
5176018|NCT01175824|12730206|P1|STARTED|Overall Study||236
5176019|NCT01175811|12730240|P2|NOT COMPLETED|Overall Study||14
5176020|NCT01175811|12730241|P1|NOT COMPLETED|Overall Study||16
5176021|NCT01175811|12730240|P2|COMPLETED|Overall Study||189
5176022|NCT01175811|12730241|P1|COMPLETED|Overall Study||183
5176023|NCT01175811|12730240|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
5176024|NCT01175811|12730241|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
5176025|NCT01175811|12730240|P2|STARTED|Overall Study||203
5176026|NCT01175811|12730241|P1|STARTED|Overall Study||199
5176027|NCT01175798|12730267|P2|NOT COMPLETED|Overall Study||21
5176028|NCT01175798|12730268|P1|NOT COMPLETED|Overall Study||7
5176029|NCT01175798|12730267|P2|COMPLETED|Overall Study||41
5176030|NCT01175798|12730268|P1|COMPLETED|Overall Study||27
5176031|NCT01175798|12730267|P2|STARTED|Overall Study||62
5176032|NCT01175798|12730268|P1|STARTED|Overall Study||34
5176033|NCT01175707|12730276|P2|NOT COMPLETED|Overall Study||6
5176034|NCT01175707|12730277|P1|NOT COMPLETED|Overall Study||4
5176035|NCT01175707|12730276|P2|COMPLETED|Overall Study||34
5176036|NCT01175707|12730277|P1|COMPLETED|Overall Study||36
5176037|NCT01175707|12730276|P2|STARTED|Overall Study||40
5176038|NCT01175707|12730277|P1|STARTED|Overall Study||40
5176039|NCT01175668|12730313|P2|NOT COMPLETED|Overall Study||0
5176040|NCT01175668|12730314|P1|NOT COMPLETED|Overall Study||2
5176041|NCT01175668|12730313|P2|COMPLETED|Overall Study||34
5176042|NCT01175668|12730314|P1|COMPLETED|Overall Study||32
5176043|NCT01175668|12730313|P2|STARTED|Overall Study||34
5176044|NCT01175668|12730314|P1|STARTED|Overall Study||34
5176045|NCT01175590|12730324|P2|NOT COMPLETED|Overall Study||10
5176046|NCT01175590|12730325|P1|NOT COMPLETED|Overall Study||12
5176047|NCT01175590|12730324|P2|COMPLETED|Overall Study||161
5176048|NCT01175590|12730325|P1|COMPLETED|Overall Study||335
5176049|NCT01175590|12730324|P2|Safety Population|Overall Study||170
5176050|NCT01175590|12730325|P1|Safety Population|Overall Study||344
5176051|NCT01175590|12730324|P2|Modified Intent to Treat Population|Overall Study||87
5176052|NCT01175590|12730325|P1|Modified Intent to Treat Population|Overall Study||212
5176053|NCT01175590|12730324|P2|STARTED|Overall Study||171
5176054|NCT01175590|12730325|P1|STARTED|Overall Study||347
5176055|NCT01175473|12730359|P2|NOT COMPLETED|Overall Study||2
5176056|NCT01175473|12730360|P1|NOT COMPLETED|Overall Study||2
5176057|NCT01175473|12730359|P2|COMPLETED|Overall Study||69
5176058|NCT01175473|12730360|P1|COMPLETED|Overall Study||75
5176059|NCT01175473|12730359|P2|Pharmacodynamic (PD) Population|Overall Study||68
5176060|NCT01175473|12730360|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
5176061|NCT01175473|12730359|P2|Safety Population|Overall Study||71
5176062|NCT01175473|12730360|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
5176063|NCT01175473|12730359|P2|STARTED|Overall Study||71
5176064|NCT01175473|12730360|P1|STARTED|Overall Study|Randomized and treated.|77
5176065|NCT01175434|12730386|P2|NOT COMPLETED|Overall Study||0
5176066|NCT01175434|12730387|P1|NOT COMPLETED|Overall Study||0
5176067|NCT01175434|12730386|P2|COMPLETED|Overall Study||51
5176068|NCT01175434|12730387|P1|COMPLETED|Overall Study||48
5176069|NCT01175434|12730386|P2|STARTED|Overall Study||51
5176070|NCT01175434|12730387|P1|STARTED|Overall Study||48
5176071|NCT01175395|12730393|P1|NOT COMPLETED|Overall Study||0
5176072|NCT01175395|12730393|P1|COMPLETED|Overall Study||10
5176073|NCT01175395|12730393|P1|STARTED|Overall Study||10
5176074|NCT01175382|12730401|P3|NOT COMPLETED|Overall Study||6
5176075|NCT01175382|12730402|P2|NOT COMPLETED|Overall Study||7
5176076|NCT01175382|12730403|P1|NOT COMPLETED|Overall Study||8
5176077|NCT01175382|12730401|P3|COMPLETED|Overall Study||59
5176078|NCT01175382|12730402|P2|COMPLETED|Overall Study||61
5176079|NCT01175382|12730403|P1|COMPLETED|Overall Study||63
5176080|NCT01175382|12730401|P3|STARTED|Overall Study||65
5176081|NCT01175382|12730402|P2|STARTED|Overall Study||68
5176082|NCT01175382|12730403|P1|STARTED|Overall Study||71
5176083|NCT01175369|12730482|P2|NOT COMPLETED|Overall Study||5
5176084|NCT01175369|12730483|P1|NOT COMPLETED|Overall Study||2
5176085|NCT01175369|12730482|P2|COMPLETED|Overall Study||260
5176086|NCT01175369|12730483|P1|COMPLETED|Overall Study||263
5176087|NCT01175369|12730482|P2|STARTED|Overall Study||265
5176088|NCT01175369|12730483|P1|STARTED|Overall Study||265
5176089|NCT01175356|12730489|P1|NOT COMPLETED|Overall Study||81
5176090|NCT01175356|12730489|P1|COMPLETED|Overall Study||18
5176091|NCT01175356|12730489|P1|STARTED|Overall Study||99
5176092|NCT01175343|12730495|P1|NOT COMPLETED|Overall Study||0
5176093|NCT01175343|12730495|P1|COMPLETED|Overall Study||44
5176094|NCT01175343|12730495|P1|STARTED|Overall Study||44
5176095|NCT01175317|12730507|P2|NOT COMPLETED|Overall Study||0
5176096|NCT01175317|12730508|P1|NOT COMPLETED|Overall Study||0
5176097|NCT01175317|12730507|P2|COMPLETED|Overall Study||31
5176098|NCT01175317|12730508|P1|COMPLETED|Overall Study||27
5176099|NCT01175317|12730507|P2|STARTED|Overall Study||31
5176100|NCT01175317|12730508|P1|STARTED|Overall Study||27
5176101|NCT01175226|12730518|P2|NOT COMPLETED|Overall Study||5
5176102|NCT01175226|12730519|P1|NOT COMPLETED|Overall Study||11
5176103|NCT01175226|12730518|P2|COMPLETED|Overall Study||140
5176104|NCT01175226|12730519|P1|COMPLETED|Overall Study||144
5176105|NCT01175226|12730518|P2|STARTED|Overall Study||145
5176106|NCT01175226|12730519|P1|STARTED|Overall Study||155
5176107|NCT01175213|12730529|P2|NOT COMPLETED|Safety Follow-up||0
5176108|NCT01175213|12730530|P1|NOT COMPLETED|Safety Follow-up||1
5176109|NCT01175213|12730529|P2|COMPLETED|Safety Follow-up||3
5176110|NCT01175213|12730530|P1|COMPLETED|Safety Follow-up||47
5176111|NCT01175213|12730529|P2|STARTED|Safety Follow-up||3
5176112|NCT01175213|12730530|P1|STARTED|Safety Follow-up||48
5176113|NCT01175213|12730529|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
5176114|NCT01175213|12730530|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
5176115|NCT01175213|12730529|P2|COMPLETED|IGSC, 10%/rHuPH20||3
5176116|NCT01175213|12730530|P1|COMPLETED|IGSC, 10%/rHuPH20||48
5176117|NCT01175213|12730529|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
5176118|NCT01175213|12730530|P1|STARTED|IGSC, 10%/rHuPH20||63
5176119|NCT01175148|12730577|P2|NOT COMPLETED|Overall Study||0
5176120|NCT01175148|12730578|P1|NOT COMPLETED|Overall Study||0
5176121|NCT01175148|12730577|P2|COMPLETED|Overall Study||30
5176122|NCT01175148|12730578|P1|COMPLETED|Overall Study||30
5176123|NCT01175148|12730577|P2|STARTED|Overall Study||30
5176124|NCT01175148|12730578|P1|STARTED|Overall Study||30
5176125|NCT01175135|12730587|P4|NOT COMPLETED|Overall Study||14
5176126|NCT01175135|12730588|P3|NOT COMPLETED|Overall Study||12
5176127|NCT01175135|12730589|P2|NOT COMPLETED|Overall Study||22
5176128|NCT01175135|12730590|P1|NOT COMPLETED|Overall Study||16
5176129|NCT01175135|12730587|P4|COMPLETED|Overall Study||60
5176130|NCT01175135|12730588|P3|COMPLETED|Overall Study||25
5176131|NCT01175135|12730589|P2|COMPLETED|Overall Study||52
5176132|NCT01175135|12730590|P1|COMPLETED|Overall Study||58
5176133|NCT01175135|12730587|P4|Analyzed for Efficacy|Overall Study||73
5176134|NCT01175135|12730588|P3|Analyzed for Efficacy|Overall Study||34
5176135|NCT01175135|12730589|P2|Analyzed for Efficacy|Overall Study||73
5176136|NCT01175135|12730590|P1|Analyzed for Efficacy|Overall Study||74
5176137|NCT01175135|12730587|P4|Treated|Overall Study||74
5176138|NCT01175135|12730588|P3|Treated|Overall Study||36
5176139|NCT01175135|12730589|P2|Treated|Overall Study||74
5176140|NCT01175135|12730590|P1|Treated|Overall Study||74
5176141|NCT01175135|12730587|P4|STARTED|Overall Study||74
5176142|NCT01175135|12730588|P3|STARTED|Overall Study||37
5176143|NCT01175135|12730589|P2|STARTED|Overall Study||74
5176144|NCT01175135|12730590|P1|STARTED|Overall Study||74
5176145|NCT01175083|12730678|P6|NOT COMPLETED|Booster Epoch||0
5176146|NCT01175083|12730679|P5|NOT COMPLETED|Booster Epoch||0
5176147|NCT01175083|12730680|P4|NOT COMPLETED|Booster Epoch||1
5176148|NCT01175083|12730681|P3|NOT COMPLETED|Booster Epoch||1
5176149|NCT01175083|12730682|P2|NOT COMPLETED|Booster Epoch||0
5176150|NCT01175083|12730683|P1|NOT COMPLETED|Booster Epoch||0
5176151|NCT01175083|12730678|P6|COMPLETED|Booster Epoch||0
5176152|NCT01175083|12730679|P5|COMPLETED|Booster Epoch||0
5176153|NCT01175083|12730680|P4|COMPLETED|Booster Epoch||49
5176154|NCT01175083|12730681|P3|COMPLETED|Booster Epoch||49
5176155|NCT01175083|12730682|P2|COMPLETED|Booster Epoch||49
5176156|NCT01175083|12730683|P1|COMPLETED|Booster Epoch||49
5176157|NCT01175083|12730678|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
5176158|NCT01175083|12730679|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
5176159|NCT01175083|12730680|P4|STARTED|Booster Epoch||50
5176160|NCT01175083|12730681|P3|STARTED|Booster Epoch||50
5176161|NCT01175083|12730682|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
5176162|NCT01175083|12730683|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
5176163|NCT01175083|12730678|P6|NOT COMPLETED|Primary Epoch||3
5176164|NCT01175083|12730679|P5|NOT COMPLETED|Primary Epoch||0
5176165|NCT01175083|12730680|P4|NOT COMPLETED|Primary Epoch||0
5176166|NCT01175083|12730681|P3|NOT COMPLETED|Primary Epoch||0
5176167|NCT01175083|12730682|P2|NOT COMPLETED|Primary Epoch||0
5176168|NCT01175083|12730683|P1|NOT COMPLETED|Primary Epoch||0
5176169|NCT01175083|12730678|P6|COMPLETED|Primary Epoch||47
5176170|NCT01175083|12730679|P5|COMPLETED|Primary Epoch||50
5176171|NCT01175083|12730680|P4|COMPLETED|Primary Epoch||50
5176172|NCT01175083|12730681|P3|COMPLETED|Primary Epoch||50
5176173|NCT01175083|12730682|P2|COMPLETED|Primary Epoch||50
5176174|NCT01175083|12730683|P1|COMPLETED|Primary Epoch||50
5176175|NCT01175083|12730678|P6|STARTED|Primary Epoch||50
5176176|NCT01175083|12730679|P5|STARTED|Primary Epoch||50
5176177|NCT01175083|12730680|P4|STARTED|Primary Epoch||50
5176178|NCT01175083|12730681|P3|STARTED|Primary Epoch||50
5176179|NCT01175083|12730682|P2|STARTED|Primary Epoch||50
5176180|NCT01175083|12730683|P1|STARTED|Primary Epoch||50
5176181|NCT01175031|12730765|P1|NOT COMPLETED|Overall Study||0
5176182|NCT01175031|12730765|P1|COMPLETED|Overall Study||45
5176183|NCT01175031|12730765|P1|STARTED|Overall Study||45
5176184|NCT01175018|12730775|P2|NOT COMPLETED|Overall Study||1
5176185|NCT01175018|12730776|P1|NOT COMPLETED|Overall Study||3
5176186|NCT01175018|12730775|P2|COMPLETED|Overall Study||14
5176187|NCT01175018|12730776|P1|COMPLETED|Overall Study||12
5176188|NCT01175018|12730775|P2|STARTED|Overall Study||15
5176189|NCT01175018|12730776|P1|STARTED|Overall Study||15
5176190|NCT01175005|12730812|P1|NOT COMPLETED|Overall Study||0
5176191|NCT01175005|12730812|P1|COMPLETED|Overall Study||62
5176192|NCT01175005|12730812|P1|STARTED|Overall Study||62
5176193|NCT01174784|12730817|P1|NOT COMPLETED|Overall Study||4
5176194|NCT01174784|12730817|P1|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
5176195|NCT01174784|12730817|P1|STARTED|Overall Study||88
5176196|NCT01174576|12730822|P1|NOT COMPLETED|Overall Study||0
5176197|NCT01174576|12730822|P1|COMPLETED|Overall Study||16
5176198|NCT01174576|12730822|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
5176199|NCT01174563|12730863|P1|NOT COMPLETED|Overall Study||60
5176200|NCT01174563|12730863|P1|COMPLETED|Overall Study||0
5176201|NCT01174563|12730863|P1|Safety Set|Overall Study||59
5176202|NCT01174563|12730863|P1|Efficacy Set|Overall Study||59
5176203|NCT01174563|12730863|P1|STARTED|Overall Study||60
5176204|NCT01174550|12730871|P2|NOT COMPLETED|Overall Study||873
5176205|NCT01174550|12730872|P1|NOT COMPLETED|Overall Study||1270
5176206|NCT01174550|12730871|P2|COMPLETED|Overall Study||4123
5176207|NCT01174550|12730872|P1|COMPLETED|Overall Study||3737
5176208|NCT01174550|12730871|P2|STARTED|Overall Study||4996
5176209|NCT01174550|12730872|P1|STARTED|Overall Study||5007
5176210|NCT01174459|12730900|P1|NOT COMPLETED|Overall Study||5
5176211|NCT01174459|12730900|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
5176212|NCT01174459|12730900|P1|STARTED|Overall Study|Registered patients|571
5176213|NCT01174446|12730905|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
5176214|NCT01174446|12730906|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
5176215|NCT01174446|12730907|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
5176216|NCT01174446|12730908|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
5176217|NCT01174446|12730905|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
5176218|NCT01174446|12730906|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
5176219|NCT01174446|12730907|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
5176220|NCT01174446|12730908|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
5176221|NCT01174446|12730905|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
5176222|NCT01174446|12730906|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
5176223|NCT01174446|12730907|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
5176224|NCT01174446|12730908|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
5176225|NCT01174446|12730905|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
5176226|NCT01174446|12730906|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
5176227|NCT01174446|12730907|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
5176228|NCT01174446|12730908|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
5176229|NCT01174446|12730905|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
5176230|NCT01174446|12730906|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
5176231|NCT01174446|12730907|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
5176232|NCT01174446|12730908|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
5176233|NCT01174446|12730905|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
5176234|NCT01174446|12730906|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
5176235|NCT01174446|12730907|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
5176236|NCT01174446|12730908|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
5176237|NCT01174446|12730905|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176238|NCT01174446|12730906|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176239|NCT01174446|12730907|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176240|NCT01174446|12730908|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176241|NCT01174446|12730905|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176242|NCT01174446|12730906|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
5176243|NCT01174446|12730907|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
5176244|NCT01174446|12730908|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
5176245|NCT01174446|12730905|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
5176246|NCT01174446|12730906|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
5176247|NCT01174446|12730907|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
5176248|NCT01174446|12730908|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
5176249|NCT01174368|12731095|P1|NOT COMPLETED|Overall Study||1
5176250|NCT01174368|12731095|P1|COMPLETED|Overall Study||0
5176251|NCT01174368|12731095|P1|STARTED|Overall Study||1
5176252|NCT01174342|12731101|P1|NOT COMPLETED|Overall Study||4
5176253|NCT01174342|12731101|P1|COMPLETED|Overall Study||26
5176254|NCT01174342|12731101|P1|STARTED|Overall Study||30
5176255|NCT01174264|12731108|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
5176256|NCT01174264|12731109|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
5176257|NCT01174264|12731110|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
5176258|NCT01174264|12731108|P3|COMPLETED|Steady-state Pharmacokinetics||27
5176259|NCT01174264|12731109|P2|COMPLETED|Steady-state Pharmacokinetics||0
5176260|NCT01174264|12731110|P1|COMPLETED|Steady-state Pharmacokinetics||25
5176261|NCT01174264|12731108|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
5176262|NCT01174264|12731109|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
5176263|NCT01174264|12731110|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
5176264|NCT01174264|12731108|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
5176265|NCT01174264|12731109|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
5176266|NCT01174264|12731110|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
5176267|NCT01174264|12731108|P3|COMPLETED|Single Dose Pharmacokinetics||18
5176268|NCT01174264|12731109|P2|COMPLETED|Single Dose Pharmacokinetics||20
5176269|NCT01174264|12731110|P1|COMPLETED|Single Dose Pharmacokinetics||22
5176270|NCT01174264|12731108|P3|STARTED|Single Dose Pharmacokinetics||20
5176271|NCT01174264|12731109|P2|STARTED|Single Dose Pharmacokinetics||20
5176272|NCT01174264|12731110|P1|STARTED|Single Dose Pharmacokinetics||23
5176273|NCT01174238|12731142|P1|NOT COMPLETED|Overall Study||2
5176274|NCT01174238|12731142|P1|COMPLETED|Overall Study||36
5176275|NCT01174238|12731142|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
5176276|NCT01174238|12731142|P1|STARTED|Overall Study||38
5176277|NCT01174186|12731153|P2|NOT COMPLETED|Overall Study||3
5176278|NCT01174186|12731154|P1|NOT COMPLETED|Overall Study||0
5176279|NCT01174186|12731153|P2|COMPLETED|Overall Study||12
5176280|NCT01174186|12731154|P1|COMPLETED|Overall Study||15
5176281|NCT01174186|12731153|P2|STARTED|Overall Study||15
5176282|NCT01174186|12731154|P1|STARTED|Overall Study|Patients were included over three years|15
5176283|NCT01174173|12731161|P1|NOT COMPLETED|Overall Study||1
5176284|NCT01174173|12731161|P1|COMPLETED|Overall Study||10
5176285|NCT01174173|12731161|P1|STARTED|Overall Study||11
5176286|NCT01174160|12731172|P2|NOT COMPLETED|Overall Study||6
5176287|NCT01174160|12731173|P1|NOT COMPLETED|Overall Study||8
5176288|NCT01174160|12731172|P2|COMPLETED|Overall Study||56
5176289|NCT01174160|12731173|P1|COMPLETED|Overall Study||53
5176290|NCT01174160|12731172|P2|Discontinued Post Dose|Overall Study||0
5176291|NCT01174160|12731173|P1|Discontinued Post Dose|Overall Study||2
5176292|NCT01174160|12731172|P2|Dosed|Overall Study||56
5176293|NCT01174160|12731173|P1|Dosed|Overall Study||55
5176294|NCT01174160|12731172|P2|Discontinued Pre Dose|Overall Study||6
5176295|NCT01174160|12731173|P1|Discontinued Pre Dose|Overall Study||6
5176296|NCT01174160|12731172|P2|STARTED|Overall Study||62
5176297|NCT01174160|12731173|P1|STARTED|Overall Study||61
5176298|NCT01174082|12731181|P2|NOT COMPLETED|Overall Study||0
5176299|NCT01174082|12731182|P1|NOT COMPLETED|Overall Study||0
5176300|NCT01174082|12731181|P2|COMPLETED|Overall Study||1
5176301|NCT01174082|12731182|P1|COMPLETED|Overall Study||1
5176302|NCT01174082|12731181|P2|STARTED|Overall Study||1
5176303|NCT01174082|12731182|P1|STARTED|Overall Study||1
5176304|NCT01174043|12731188|P1|NOT COMPLETED|Overall Study||11
5176305|NCT01174043|12731188|P1|COMPLETED|Overall Study||0
5176306|NCT01174043|12731188|P1|STARTED|Overall Study||11
5176307|NCT01174030|12731199|P5|NOT COMPLETED|Overall Study||1
5176308|NCT01174030|12731200|P4|NOT COMPLETED|Overall Study||2
5176309|NCT01174030|12731201|P3|NOT COMPLETED|Overall Study||2
5176310|NCT01174030|12731202|P2|NOT COMPLETED|Overall Study||2
5176311|NCT01174030|12731203|P1|NOT COMPLETED|Overall Study||2
5176312|NCT01174030|12731199|P5|COMPLETED|Overall Study||52
5176313|NCT01174030|12731200|P4|COMPLETED|Overall Study||53
5176314|NCT01174030|12731201|P3|COMPLETED|Overall Study||52
5176315|NCT01174030|12731202|P2|COMPLETED|Overall Study||52
5176316|NCT01174030|12731203|P1|COMPLETED|Overall Study||51
5176317|NCT01174030|12731199|P5|STARTED|Overall Study||53
5176318|NCT01174030|12731200|P4|STARTED|Overall Study||55
5176319|NCT01174030|12731201|P3|STARTED|Overall Study||54
5176320|NCT01174030|12731202|P2|STARTED|Overall Study||54
5176321|NCT01174030|12731203|P1|STARTED|Overall Study||53
5176322|NCT01174004|12731227|P2|NOT COMPLETED|Overall Study||16
5176323|NCT01174004|12731228|P1|NOT COMPLETED|Overall Study||7
5176324|NCT01174004|12731227|P2|COMPLETED|Overall Study||89
5176325|NCT01174004|12731228|P1|COMPLETED|Overall Study||87
5176326|NCT01174004|12731227|P2|STARTED|Overall Study||105
5176327|NCT01174004|12731228|P1|STARTED|Overall Study||94
5176328|NCT01173874|12731238|P2|NOT COMPLETED|Overall Study||23
5176329|NCT01173874|12731239|P1|NOT COMPLETED|Overall Study||23
5176330|NCT01173874|12731238|P2|COMPLETED|Overall Study||41
5176331|NCT01173874|12731239|P1|COMPLETED|Overall Study||33
5176332|NCT01173874|12731238|P2|STARTED|Overall Study||64
5176333|NCT01173874|12731239|P1|STARTED|Overall Study||56
5176334|NCT01173848|12731253|P2|NOT COMPLETED|Overall Study||8
5176335|NCT01173848|12731254|P1|NOT COMPLETED|Overall Study||4
5176336|NCT01173848|12731253|P2|COMPLETED|Overall Study||3
5176337|NCT01173848|12731254|P1|COMPLETED|Overall Study||4
5176338|NCT01173848|12731253|P2|STARTED|Overall Study||11
5176339|NCT01173848|12731254|P1|STARTED|Overall Study||8
5176340|NCT01173718|12731259|P1|NOT COMPLETED|Overall Study||44
5176341|NCT01173718|12731259|P1|COMPLETED|Overall Study||94
5176342|NCT01173718|12731259|P1|STARTED|Overall Study||138
5176343|NCT01173679|12731268|P1|NOT COMPLETED|Overall Study||1
5176344|NCT01173679|12731268|P1|COMPLETED|Overall Study||9
5176345|NCT01173679|12731268|P1|STARTED|Overall Study||10
5176346|NCT01173653|12731276|P2|NOT COMPLETED|Overall Study||41
5176347|NCT01173653|12731277|P1|NOT COMPLETED|Overall Study||53
5176348|NCT01173653|12731276|P2|COMPLETED|Overall Study||49
5176349|NCT01173653|12731277|P1|COMPLETED|Overall Study||56
5176350|NCT01173653|12731276|P2|STARTED|Overall Study||90
5176351|NCT01173653|12731277|P1|STARTED|Overall Study||109
5176352|NCT01173601|12731287|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
5176353|NCT01173601|12731288|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
5176354|NCT01173601|12731289|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
5176355|NCT01173601|12731290|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
5176356|NCT01173601|12731291|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176357|NCT01173601|12731287|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
5176358|NCT01173601|12731288|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
5176359|NCT01173601|12731289|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
5176360|NCT01173601|12731290|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
5176361|NCT01173601|12731291|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176362|NCT01173601|12731287|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
5176363|NCT01173601|12731288|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
5176364|NCT01173601|12731289|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
5176365|NCT01173601|12731290|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
5176366|NCT01173601|12731291|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176367|NCT01173601|12731287|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176368|NCT01173601|12731288|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176369|NCT01173601|12731289|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
5176370|NCT01173601|12731290|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
5176371|NCT01173601|12731291|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176372|NCT01173601|12731287|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
5176373|NCT01173601|12731288|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
5176374|NCT01173601|12731289|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
5176375|NCT01173601|12731290|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
5176376|NCT01173601|12731291|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
5176377|NCT01173601|12731287|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176378|NCT01173601|12731288|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176379|NCT01173601|12731289|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176380|NCT01173601|12731290|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176381|NCT01173601|12731291|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
5176382|NCT01173601|12731287|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176383|NCT01173601|12731288|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176384|NCT01173601|12731289|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176385|NCT01173601|12731290|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
5176386|NCT01173601|12731291|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
5176387|NCT01173601|12731287|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
5176388|NCT01173601|12731288|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
5176389|NCT01173601|12731289|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
5176390|NCT01173601|12731290|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
5176391|NCT01173601|12731291|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
5176392|NCT01173601|12731287|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5176393|NCT01173601|12731288|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5176394|NCT01173601|12731289|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5176395|NCT01173601|12731290|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
5176396|NCT01173601|12731291|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
5176397|NCT01173523|12731368|P2|NOT COMPLETED|Overall Study||12
5176398|NCT01173523|12731369|P1|NOT COMPLETED|Overall Study||13
5176399|NCT01173523|12731368|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
5176400|NCT01173523|12731369|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
5176401|NCT01173523|12731368|P2|STARTED|Overall Study||12
5176402|NCT01173523|12731369|P1|STARTED|Overall Study||13
5176403|NCT01173471|12731385|P4|NOT COMPLETED|Overall Study||1
5176404|NCT01173471|12731386|P3|NOT COMPLETED|Overall Study||3
5176405|NCT01173471|12731387|P2|NOT COMPLETED|Overall Study||0
5176406|NCT01173471|12731388|P1|NOT COMPLETED|Overall Study||2
5176407|NCT01173471|12731385|P4|COMPLETED|Overall Study|Completed study|18
5176408|NCT01173471|12731386|P3|COMPLETED|Overall Study|Completed study|15
5176409|NCT01173471|12731387|P2|COMPLETED|Overall Study|Completed study|7
5176410|NCT01173471|12731388|P1|COMPLETED|Overall Study|Completed study|4
5176411|NCT01173471|12731385|P4|Completed Treatment|Overall Study||18
5176412|NCT01173471|12731386|P3|Completed Treatment|Overall Study||15
5176413|NCT01173471|12731387|P2|Completed Treatment|Overall Study||7
5176414|NCT01173471|12731388|P1|Completed Treatment|Overall Study||4
5176415|NCT01173471|12731385|P4|Received Treatment|Overall Study||19
5176416|NCT01173471|12731386|P3|Received Treatment|Overall Study||18
5176417|NCT01173471|12731387|P2|Received Treatment|Overall Study||7
5176418|NCT01173471|12731388|P1|Received Treatment|Overall Study||6
5176419|NCT01173471|12731385|P4|STARTED|Overall Study|Randomized|19
5176420|NCT01173471|12731386|P3|STARTED|Overall Study|Randomized|18
5176421|NCT01173471|12731387|P2|STARTED|Overall Study|Randomized|7
5176422|NCT01173471|12731388|P1|STARTED|Overall Study|Randomized|6
5176423|NCT01173211|12731412|P6|NOT COMPLETED|Overall Study||0
5176424|NCT01173211|12731413|P5|NOT COMPLETED|Overall Study||0
5176425|NCT01173211|12731414|P4|NOT COMPLETED|Overall Study||0
5176426|NCT01173211|12731415|P3|NOT COMPLETED|Overall Study||2
5176427|NCT01173211|12731416|P2|NOT COMPLETED|Overall Study||1
5176428|NCT01173211|12731417|P1|NOT COMPLETED|Overall Study||2
5176429|NCT01173211|12731412|P6|COMPLETED|Overall Study||13
5176430|NCT01173211|12731413|P5|COMPLETED|Overall Study||16
5176431|NCT01173211|12731414|P4|COMPLETED|Overall Study||15
5176432|NCT01173211|12731415|P3|COMPLETED|Overall Study||44
5176433|NCT01173211|12731416|P2|COMPLETED|Overall Study||44
5176434|NCT01173211|12731417|P1|COMPLETED|Overall Study||46
5176435|NCT01173211|12731412|P6|STARTED|Overall Study||13
5176436|NCT01173211|12731413|P5|STARTED|Overall Study||16
5176437|NCT01173211|12731414|P4|STARTED|Overall Study||15
5176438|NCT01173211|12731415|P3|STARTED|Overall Study||46
5176439|NCT01173211|12731416|P2|STARTED|Overall Study||45
5176440|NCT01173211|12731417|P1|STARTED|Overall Study||48
5176441|NCT01173159|12731518|P1|NOT COMPLETED|Overall Study||0
5176442|NCT01173159|12731518|P1|COMPLETED|Overall Study||10
5176443|NCT01173159|12731518|P1|STARTED|Overall Study||10
5176444|NCT01173120|12731528|P1|NOT COMPLETED|Overall Study||62
5176445|NCT01173120|12731528|P1|COMPLETED|Overall Study||0
5176446|NCT01173120|12731528|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
5176447|NCT01173120|12731528|P1|Switched Back to Main Study|Overall Study||57
5176448|NCT01173120|12731528|P1|STARTED|Overall Study||62
5176449|NCT01173055|12731546|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
5176450|NCT01173055|12731547|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
5176451|NCT01173055|12731546|P2|COMPLETED|Period 2 - Day 64 to 112||9
5176452|NCT01173055|12731547|P1|COMPLETED|Period 2 - Day 64 to 112||8
5176453|NCT01173055|12731546|P2|STARTED|Period 2 - Day 64 to 112||10
5176454|NCT01173055|12731547|P1|STARTED|Period 2 - Day 64 to 112||8
5176455|NCT01173055|12731546|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
5176456|NCT01173055|12731547|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
5176457|NCT01173055|12731546|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
5176458|NCT01173055|12731547|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
5176459|NCT01173055|12731546|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
5176460|NCT01173055|12731547|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
5176461|NCT01173055|12731546|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
5176462|NCT01173055|12731547|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
5176463|NCT01173055|12731546|P2|COMPLETED|Period 1 - Day 1 to 49||10
5176464|NCT01173055|12731547|P1|COMPLETED|Period 1 - Day 1 to 49||8
5176465|NCT01173055|12731546|P2|STARTED|Period 1 - Day 1 to 49||12
5176466|NCT01173055|12731547|P1|STARTED|Period 1 - Day 1 to 49||10
5176467|NCT01173029|12731565|P2|NOT COMPLETED|Overall Study||0
5176468|NCT01173029|12731566|P1|NOT COMPLETED|Overall Study||0
5176469|NCT01173029|12731565|P2|COMPLETED|Overall Study||31
5176470|NCT01173029|12731566|P1|COMPLETED|Overall Study||61
5176471|NCT01173029|12731565|P2|STARTED|Overall Study||31
5176472|NCT01173029|12731566|P1|STARTED|Overall Study||61
5176473|NCT01173016|12731583|P1|NOT COMPLETED|Overall Study||1
5176474|NCT01173016|12731583|P1|COMPLETED|Overall Study||10
5176475|NCT01173016|12731583|P1|STARTED|Overall Study||11
5176476|NCT01172938|12731598|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
5176477|NCT01172938|12731599|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
5176478|NCT01172938|12731600|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176479|NCT01172938|12731601|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176480|NCT01172938|12731602|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176481|NCT01172938|12731603|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176482|NCT01172938|12731604|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
5176483|NCT01172938|12731605|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
5176484|NCT01172938|12731606|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176485|NCT01172938|12731598|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
5176486|NCT01172938|12731599|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
5176487|NCT01172938|12731600|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176488|NCT01172938|12731601|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176489|NCT01172938|12731602|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176490|NCT01172938|12731603|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176491|NCT01172938|12731604|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
5176492|NCT01172938|12731605|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
5176493|NCT01172938|12731606|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
5176494|NCT01172938|12731598|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176495|NCT01172938|12731599|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
5176496|NCT01172938|12731600|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176497|NCT01172938|12731601|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176498|NCT01172938|12731602|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176499|NCT01172938|12731603|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176500|NCT01172938|12731604|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176501|NCT01172938|12731605|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176502|NCT01172938|12731606|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
5176503|NCT01172938|12731598|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
5176504|NCT01172938|12731599|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
5176505|NCT01172938|12731600|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
5176506|NCT01172938|12731601|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
5176507|NCT01172938|12731602|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
5176508|NCT01172938|12731603|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
5176509|NCT01172938|12731604|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
5176510|NCT01172938|12731605|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
5176511|NCT01172938|12731606|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
5176512|NCT01172938|12731598|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
5176513|NCT01172938|12731599|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
5176514|NCT01172938|12731600|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176515|NCT01172938|12731601|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176516|NCT01172938|12731602|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176517|NCT01172938|12731603|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176518|NCT01172938|12731604|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
5176519|NCT01172938|12731605|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
5176520|NCT01172938|12731606|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176521|NCT01172938|12731598|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
5176522|NCT01172938|12731599|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
5176523|NCT01172938|12731600|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176524|NCT01172938|12731601|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176525|NCT01172938|12731602|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176526|NCT01172938|12731603|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176527|NCT01172938|12731604|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
5176528|NCT01172938|12731605|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
5176529|NCT01172938|12731606|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
5176530|NCT01172938|12731598|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
5176531|NCT01172938|12731599|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
5176532|NCT01172938|12731600|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
5176533|NCT01172938|12731601|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
5176534|NCT01172938|12731602|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
5176535|NCT01172938|12731603|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
5176536|NCT01172938|12731604|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
5176537|NCT01172938|12731605|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
5176538|NCT01172938|12731606|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
5176539|NCT01172938|12731598|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
5176540|NCT01172938|12731599|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
5176541|NCT01172938|12731600|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176542|NCT01172938|12731601|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176543|NCT01172938|12731602|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176544|NCT01172938|12731603|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176545|NCT01172938|12731604|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
5176546|NCT01172938|12731605|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
5176547|NCT01172938|12731606|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176548|NCT01172938|12731598|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
5176549|NCT01172938|12731599|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
5176550|NCT01172938|12731600|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176551|NCT01172938|12731601|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176552|NCT01172938|12731602|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176553|NCT01172938|12731603|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176554|NCT01172938|12731604|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
5176555|NCT01172938|12731605|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
5176556|NCT01172938|12731606|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
5176557|NCT01172938|12731598|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
5176558|NCT01172938|12731599|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
5176559|NCT01172938|12731600|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
5176560|NCT01172938|12731601|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
5176561|NCT01172938|12731602|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
5176562|NCT01172938|12731603|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
5176563|NCT01172938|12731604|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
5176564|NCT01172938|12731605|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
5176565|NCT01172938|12731606|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
5176566|NCT01172938|12731598|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
5176567|NCT01172938|12731599|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
5176568|NCT01172938|12731600|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176569|NCT01172938|12731601|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176570|NCT01172938|12731602|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176571|NCT01172938|12731603|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176572|NCT01172938|12731604|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
5176573|NCT01172938|12731605|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
5176574|NCT01172938|12731606|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176575|NCT01172938|12731598|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
5176576|NCT01172938|12731599|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
5176577|NCT01172938|12731600|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176578|NCT01172938|12731601|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176579|NCT01172938|12731602|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176580|NCT01172938|12731603|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176581|NCT01172938|12731604|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
5176582|NCT01172938|12731605|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
5176583|NCT01172938|12731606|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
5176584|NCT01172938|12731598|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
5176585|NCT01172938|12731599|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
5176586|NCT01172938|12731600|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
5176587|NCT01172938|12731601|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
5176588|NCT01172938|12731602|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
5176589|NCT01172938|12731603|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
5176590|NCT01172938|12731604|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
5176591|NCT01172938|12731605|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
5176592|NCT01172938|12731606|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
5176593|NCT01172938|12731598|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176594|NCT01172938|12731599|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176595|NCT01172938|12731600|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
5176596|NCT01172938|12731601|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
5176597|NCT01172938|12731602|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
5176598|NCT01172938|12731603|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
5176599|NCT01172938|12731604|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
5176600|NCT01172938|12731605|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
5176601|NCT01172938|12731606|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176602|NCT01172938|12731598|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176603|NCT01172938|12731599|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176604|NCT01172938|12731600|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
5176605|NCT01172938|12731601|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
5176606|NCT01172938|12731602|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
5176607|NCT01172938|12731603|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
5176608|NCT01172938|12731604|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
5176609|NCT01172938|12731605|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
5176610|NCT01172938|12731606|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
5176611|NCT01172938|12731598|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
5176612|NCT01172938|12731599|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
5176613|NCT01172938|12731600|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
5176614|NCT01172938|12731601|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
5176615|NCT01172938|12731602|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
5176616|NCT01172938|12731603|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
5176617|NCT01172938|12731604|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
5176618|NCT01172938|12731605|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
5176619|NCT01172938|12731606|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
5176620|NCT01172938|12731598|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176621|NCT01172938|12731599|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176622|NCT01172938|12731600|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176623|NCT01172938|12731601|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176624|NCT01172938|12731602|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176625|NCT01172938|12731603|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176626|NCT01172938|12731604|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
5176627|NCT01172938|12731605|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
5176628|NCT01172938|12731606|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
5176629|NCT01172938|12731598|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176630|NCT01172938|12731599|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176631|NCT01172938|12731600|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176632|NCT01172938|12731601|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176633|NCT01172938|12731602|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176634|NCT01172938|12731603|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
5176635|NCT01172938|12731604|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
5176636|NCT01172938|12731605|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
5176637|NCT01172938|12731606|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
5176638|NCT01172938|12731598|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176639|NCT01172938|12731599|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176640|NCT01172938|12731600|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176641|NCT01172938|12731601|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176642|NCT01172938|12731602|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176643|NCT01172938|12731603|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
5176644|NCT01172938|12731604|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
5176645|NCT01172938|12731605|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
5176646|NCT01172938|12731606|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
5176647|NCT01172938|12731598|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176648|NCT01172938|12731599|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176649|NCT01172938|12731600|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176650|NCT01172938|12731601|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176651|NCT01172938|12731602|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176652|NCT01172938|12731603|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
5176653|NCT01172938|12731604|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
5176654|NCT01172938|12731605|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
5176655|NCT01172938|12731606|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
5176656|NCT01172938|12731598|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176657|NCT01172938|12731599|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176658|NCT01172938|12731600|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176659|NCT01172938|12731601|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176660|NCT01172938|12731602|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176661|NCT01172938|12731603|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
5176662|NCT01172938|12731604|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
5176663|NCT01172938|12731605|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
5176664|NCT01172938|12731606|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
5176665|NCT01172938|12731598|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176666|NCT01172938|12731599|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176667|NCT01172938|12731600|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176668|NCT01172938|12731601|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176669|NCT01172938|12731602|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176670|NCT01172938|12731603|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
5176671|NCT01172938|12731604|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
5176672|NCT01172938|12731605|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
5176673|NCT01172938|12731606|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
5176674|NCT01172873|12731792|P2|NOT COMPLETED|Overall Study||2
5176675|NCT01172873|12731793|P1|NOT COMPLETED|Overall Study||3
5176676|NCT01172873|12731792|P2|COMPLETED|Overall Study||3
5176677|NCT01172873|12731793|P1|COMPLETED|Overall Study||8
5176678|NCT01172873|12731792|P2|STARTED|Overall Study||5
5176679|NCT01172873|12731793|P1|STARTED|Overall Study||11
5176680|NCT01172847|12731803|P1|NOT COMPLETED|Overall Study||3
5176681|NCT01172847|12731803|P1|COMPLETED|Overall Study||21
5176682|NCT01172847|12731803|P1|Oseltamivir + Rimantadine|Overall Study||21
5176683|NCT01172847|12731803|P1|Rimantadine|Overall Study||22
5176684|NCT01172847|12731803|P1|Oseltamivir|Overall Study||24
5176685|NCT01172847|12731803|P1|STARTED|Overall Study||24
5176686|NCT01172821|12731832|P4|NOT COMPLETED|Overall Study||17
5176687|NCT01172821|12731833|P3|NOT COMPLETED|Overall Study||13
5176688|NCT01172821|12731834|P2|NOT COMPLETED|Overall Study||12
5176689|NCT01172821|12731835|P1|NOT COMPLETED|Overall Study||14
5176690|NCT01172821|12731832|P4|COMPLETED|Overall Study||249
5176691|NCT01172821|12731833|P3|COMPLETED|Overall Study||240
5176692|NCT01172821|12731834|P2|COMPLETED|Overall Study||245
5176693|NCT01172821|12731835|P1|COMPLETED|Overall Study||240
5176694|NCT01172821|12731832|P4|STARTED|Overall Study|Entered and Treated|266
5176695|NCT01172821|12731833|P3|STARTED|Overall Study|Entered and Treated|253
5176696|NCT01172821|12731834|P2|STARTED|Overall Study|Entered and Treated|257
5176697|NCT01172821|12731835|P1|STARTED|Overall Study|Entered and Treated|254
5176698|NCT01172808|12731925|P4|NOT COMPLETED|Overall Study||15
5176699|NCT01172808|12731926|P3|NOT COMPLETED|Overall Study||23
5176700|NCT01172808|12731927|P2|NOT COMPLETED|Overall Study||13
5176701|NCT01172808|12731928|P1|NOT COMPLETED|Overall Study||21
5176702|NCT01172808|12731925|P4|COMPLETED|Overall Study||260
5176703|NCT01172808|12731926|P3|COMPLETED|Overall Study||241
5176704|NCT01172808|12731927|P2|COMPLETED|Overall Study||249
5176705|NCT01172808|12731928|P1|COMPLETED|Overall Study||248
5176706|NCT01172808|12731925|P4|STARTED|Overall Study|Entered and Treated|275
5176707|NCT01172808|12731926|P3|STARTED|Overall Study|Entered and Treated|264
5176708|NCT01172808|12731927|P2|STARTED|Overall Study|Entered and Treated|262
5176709|NCT01172808|12731928|P1|STARTED|Overall Study|Entered and Treated|269
5176710|NCT01172639|12732019|P5|NOT COMPLETED|Overall Study||6
5176711|NCT01172639|12732020|P4|NOT COMPLETED|Overall Study||11
5176712|NCT01172639|12732021|P3|NOT COMPLETED|Overall Study||16
5176713|NCT01172639|12732022|P2|NOT COMPLETED|Overall Study||11
5176714|NCT01172639|12732023|P1|NOT COMPLETED|Overall Study||13
5176715|NCT01172639|12732019|P5|COMPLETED|Overall Study||41
5176716|NCT01172639|12732020|P4|COMPLETED|Overall Study||32
5176717|NCT01172639|12732021|P3|COMPLETED|Overall Study||77
5176718|NCT01172639|12732022|P2|COMPLETED|Overall Study||87
5176719|NCT01172639|12732023|P1|COMPLETED|Overall Study||85
5176720|NCT01172639|12732019|P5|Week 52|Overall Study||45
5176721|NCT01172639|12732020|P4|Week 52|Overall Study||38
5176722|NCT01172639|12732021|P3|Week 52|Overall Study||88
5176723|NCT01172639|12732022|P2|Week 52|Overall Study||89
5176724|NCT01172639|12732023|P1|Week 52|Overall Study||89
5176725|NCT01172639|12732019|P5|Week 16|Overall Study||47
5176726|NCT01172639|12732020|P4|Week 16|Overall Study||39
5176727|NCT01172639|12732021|P3|Week 16|Overall Study||91
5176728|NCT01172639|12732022|P2|Week 16|Overall Study||96
5176729|NCT01172639|12732023|P1|Week 16|Overall Study||94
5176730|NCT01172639|12732019|P5|STARTED|Overall Study||47
5176731|NCT01172639|12732020|P4|STARTED|Overall Study||43
5176732|NCT01172639|12732021|P3|STARTED|Overall Study||93
5176733|NCT01172639|12732022|P2|STARTED|Overall Study||98
5176734|NCT01172639|12732023|P1|STARTED|Overall Study||98
5176735|NCT01172600|12732067|P2|NOT COMPLETED|Overall Study||0
5176736|NCT01172600|12732068|P1|NOT COMPLETED|Overall Study||0
5176737|NCT01172600|12732067|P2|COMPLETED|Overall Study||39
5176738|NCT01172600|12732068|P1|COMPLETED|Overall Study||39
5176739|NCT01172600|12732067|P2|STARTED|Overall Study||39
5176740|NCT01172600|12732068|P1|STARTED|Overall Study||39
5176741|NCT01172535|12732098|P1|NOT COMPLETED|Overall Study||8
5176742|NCT01172535|12732098|P1|COMPLETED|Overall Study||89
5176743|NCT01172535|12732098|P1|STARTED|Overall Study||97
5176744|NCT01172522|12732115|P2|NOT COMPLETED|Overall Study||0
5176745|NCT01172522|12732116|P1|NOT COMPLETED|Overall Study||0
5176746|NCT01172522|12732115|P2|COMPLETED|Overall Study||15
5176747|NCT01172522|12732116|P1|COMPLETED|Overall Study||15
5176748|NCT01172522|12732115|P2|STARTED|Overall Study||15
5176749|NCT01172522|12732116|P1|STARTED|Overall Study||15
5176750|NCT01172418|12732123|P2|NOT COMPLETED|Overall Study||0
5176751|NCT01172418|12732124|P1|NOT COMPLETED|Overall Study||0
5176752|NCT01172418|12732123|P2|COMPLETED|Overall Study||100
5176753|NCT01172418|12732124|P1|COMPLETED|Overall Study||100
5176754|NCT01172418|12732123|P2|STARTED|Overall Study||100
5176755|NCT01172418|12732124|P1|STARTED|Overall Study||100
5176756|NCT01172353|12732140|P2|NOT COMPLETED|Overall Study||0
5176757|NCT01172353|12732141|P1|NOT COMPLETED|Overall Study||0
5176758|NCT01172353|12732140|P2|COMPLETED|Overall Study||151
5176759|NCT01172353|12732141|P1|COMPLETED|Overall Study||150
5176760|NCT01172353|12732140|P2|STARTED|Overall Study||151
5176761|NCT01172353|12732141|P1|STARTED|Overall Study||150
5176762|NCT01172288|12732151|P2|NOT COMPLETED|Overall Study||1
5176763|NCT01172288|12732152|P1|NOT COMPLETED|Overall Study||1
5176764|NCT01172288|12732151|P2|COMPLETED|Overall Study||13
5176765|NCT01172288|12732152|P1|COMPLETED|Overall Study||16
5176766|NCT01172288|12732151|P2|STARTED|Overall Study||14
5176767|NCT01172288|12732152|P1|STARTED|Overall Study||17
5176768|NCT01172275|12732168|P2|NOT COMPLETED|Overall Study||0
5176769|NCT01172275|12732169|P1|NOT COMPLETED|Overall Study||2
5176770|NCT01172275|12732168|P2|COMPLETED|Overall Study||6
5176771|NCT01172275|12732169|P1|COMPLETED|Overall Study||3
5176772|NCT01172275|12732168|P2|STARTED|Overall Study||6
5176773|NCT01172275|12732169|P1|STARTED|Overall Study||5
5176774|NCT01172197|12732179|P2|NOT COMPLETED|Overall Study||0
5176775|NCT01172197|12732180|P1|NOT COMPLETED|Overall Study||0
5176776|NCT01172197|12732179|P2|COMPLETED|Overall Study||7
5176777|NCT01172197|12732180|P1|COMPLETED|Overall Study||7
5176778|NCT01172197|12732179|P2|STARTED|Overall Study||7
5176779|NCT01172197|12732180|P1|STARTED|Overall Study||7
5176780|NCT01172184|12732186|P1|NOT COMPLETED|Overall Study||0
5176781|NCT01172184|12732186|P1|COMPLETED|Overall Study||111
5176782|NCT01172184|12732186|P1|STARTED|Overall Study||111
5176783|NCT01172145|12732194|P2|NOT COMPLETED|Overall Study||0
5176784|NCT01172145|12732195|P1|NOT COMPLETED|Overall Study||0
5176785|NCT01172145|12732194|P2|COMPLETED|Overall Study||11
5176786|NCT01172145|12732195|P1|COMPLETED|Overall Study||11
5176787|NCT01172145|12732194|P2|STARTED|Overall Study||11
5176788|NCT01172145|12732195|P1|STARTED|Overall Study||11
5176789|NCT01172067|12732217|P2|NOT COMPLETED|Overall Study||37
5176790|NCT01172067|12732218|P1|NOT COMPLETED|Overall Study||47
5176791|NCT01172067|12732217|P2|COMPLETED|Overall Study||163
5176792|NCT01172067|12732218|P1|COMPLETED|Overall Study||153
5176793|NCT01172067|12732217|P2|STARTED|Overall Study||200
5176794|NCT01172067|12732218|P1|STARTED|Overall Study||200
5176795|NCT01171989|12732227|P3|NOT COMPLETED|Overall Study||1
5176796|NCT01171989|12732228|P2|NOT COMPLETED|Overall Study||0
5176797|NCT01171989|12732229|P1|NOT COMPLETED|Overall Study||0
5176798|NCT01171989|12732227|P3|COMPLETED|Overall Study||120
5176799|NCT01171989|12732228|P2|COMPLETED|Overall Study||133
5176800|NCT01171989|12732229|P1|COMPLETED|Overall Study||137
5176801|NCT01171989|12732227|P3|STARTED|Overall Study||121
5176802|NCT01171989|12732228|P2|STARTED|Overall Study||133
5176803|NCT01171989|12732229|P1|STARTED|Overall Study||137
5176804|NCT01171976|12732303|P3|NOT COMPLETED|Overall Study||15
5176805|NCT01171976|12732304|P2|NOT COMPLETED|Overall Study||11
5176806|NCT01171976|12732305|P1|NOT COMPLETED|Overall Study||14
5176807|NCT01171976|12732303|P3|COMPLETED|Overall Study||108
5176808|NCT01171976|12732304|P2|COMPLETED|Overall Study||117
5176809|NCT01171976|12732305|P1|COMPLETED|Overall Study||107
5176810|NCT01171976|12732303|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
5176811|NCT01171976|12732304|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
5176812|NCT01171976|12732305|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
5176813|NCT01171976|12732303|P3|STARTED|Overall Study||123
5176814|NCT01171976|12732304|P2|STARTED|Overall Study||128
5176815|NCT01171976|12732305|P1|STARTED|Overall Study||121
5176816|NCT01171963|12732342|P2|NOT COMPLETED|Overall Study||168
5176817|NCT01171963|12732343|P1|NOT COMPLETED|Overall Study||148
5176818|NCT01171963|12732342|P2|COMPLETED|Overall Study||1499
5176819|NCT01171963|12732343|P1|COMPLETED|Overall Study||1518
5176820|NCT01171963|12732342|P2|STARTED|Overall Study||1667
5176821|NCT01171963|12732343|P1|STARTED|Overall Study||1666
5176822|NCT01171924|12732401|P2|NOT COMPLETED|Overall Study||23
5176823|NCT01171924|12732402|P1|NOT COMPLETED|Overall Study||23
5176824|NCT01171924|12732401|P2|COMPLETED|Overall Study||0
5176825|NCT01171924|12732402|P1|COMPLETED|Overall Study||0
5176826|NCT01171924|12732401|P2|STARTED|Overall Study||23
5176827|NCT01171924|12732402|P1|STARTED|Overall Study||23
5176828|NCT01171898|12732412|P4|NOT COMPLETED|Overall Study||6
5176829|NCT01171898|12732413|P3|NOT COMPLETED|Overall Study||12
5176830|NCT01171898|12732414|P2|NOT COMPLETED|Overall Study||19
5176831|NCT01171898|12732415|P1|NOT COMPLETED|Overall Study||4
5176832|NCT01171898|12732412|P4|COMPLETED|Overall Study||15
5176833|NCT01171898|12732413|P3|COMPLETED|Overall Study||13
5176834|NCT01171898|12732414|P2|COMPLETED|Overall Study||32
5176835|NCT01171898|12732415|P1|COMPLETED|Overall Study||26
5176836|NCT01171898|12732412|P4|STARTED|Overall Study||21
5176837|NCT01171898|12732413|P3|STARTED|Overall Study||25
5176838|NCT01171898|12732414|P2|STARTED|Overall Study||51
5176839|NCT01171898|12732415|P1|STARTED|Overall Study||30
5176840|NCT01171820|12732439|P2|NOT COMPLETED|Overall Study||6
5176841|NCT01171820|12732440|P1|NOT COMPLETED|Overall Study||6
5176842|NCT01171820|12732439|P2|COMPLETED|Overall Study||212
5176843|NCT01171820|12732440|P1|COMPLETED|Overall Study||100
5176844|NCT01171820|12732439|P2|STARTED|Overall Study||218
5176845|NCT01171820|12732440|P1|STARTED|Overall Study||106
5176846|NCT01171794|12732496|P2|NOT COMPLETED|Overall Study||0
5176847|NCT01171794|12732497|P1|NOT COMPLETED|Overall Study||3
5176848|NCT01171794|12732496|P2|COMPLETED|Overall Study||42
5176849|NCT01171794|12732497|P1|COMPLETED|Overall Study||44
5176850|NCT01171794|12732496|P2|STARTED|Overall Study||42
5176851|NCT01171794|12732497|P1|STARTED|Overall Study||47
5176852|NCT01171690|12732507|P2|NOT COMPLETED|Overall Study||0
5176853|NCT01171690|12732508|P1|NOT COMPLETED|Overall Study||0
5176854|NCT01171690|12732507|P2|COMPLETED|Overall Study||5
5176855|NCT01171690|12732508|P1|COMPLETED|Overall Study||5
5176856|NCT01171690|12732507|P2|STARTED|Overall Study||5
5176857|NCT01171690|12732508|P1|STARTED|Overall Study||5
5176858|NCT01171677|12732518|P2|NOT COMPLETED|Overall Study||3
5176859|NCT01171677|12732519|P1|NOT COMPLETED|Overall Study||6
5176860|NCT01171677|12732518|P2|COMPLETED|Overall Study||12
5176861|NCT01171677|12732519|P1|COMPLETED|Overall Study||11
5176862|NCT01171677|12732518|P2|STARTED|Overall Study||15
5176863|NCT01171677|12732519|P1|STARTED|Overall Study||17
5176864|NCT01171625|12732551|P1|NOT COMPLETED|Overall Study||180
5176865|NCT01171625|12732551|P1|COMPLETED|Overall Study||103
5176866|NCT01171625|12732551|P1|Subjects Implanted With Device|Overall Study||258
5176867|NCT01171625|12732551|P1|STARTED|Overall Study||283
5176868|NCT01171612|12732584|P1|NOT COMPLETED|Overall Study||51
5176869|NCT01171612|12732584|P1|COMPLETED|Overall Study||432
5176870|NCT01171612|12732584|P1|STARTED|Overall Study||483
5176871|NCT01171534|12732594|P2|NOT COMPLETED|Overall Study||3
5176872|NCT01171534|12732595|P1|NOT COMPLETED|Overall Study||0
5176873|NCT01171534|12732594|P2|COMPLETED|Overall Study||4
5176874|NCT01171534|12732595|P1|COMPLETED|Overall Study||0
5176875|NCT01171534|12732594|P2|STARTED|Overall Study||7
5176876|NCT01171534|12732595|P1|STARTED|Overall Study|retrospective arm never performed on study|0
5176877|NCT01171521|12732607|P1|NOT COMPLETED|Overall Study||6
5176878|NCT01171521|12732607|P1|COMPLETED|Overall Study||0
5176879|NCT01171521|12732607|P1|STARTED|Overall Study||6
5176880|NCT01171183|12732614|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
5176881|NCT01171183|12732615|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
5176882|NCT01171183|12732614|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
5176883|NCT01171183|12732615|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
5176884|NCT01171183|12732614|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
5176885|NCT01171183|12732615|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
5176886|NCT01171183|12732614|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
5176887|NCT01171183|12732615|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
5176888|NCT01171183|12732614|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
5176889|NCT01171183|12732615|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
5176890|NCT01171183|12732614|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
5176891|NCT01171183|12732615|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
5176892|NCT01171118|12732623|P1|NOT COMPLETED|Overall Study||0
5176893|NCT01171118|12732623|P1|COMPLETED|Overall Study||10
5176894|NCT01171118|12732623|P1|STARTED|Overall Study||10
5176895|NCT01170962|12732636|P3|NOT COMPLETED|Follow up Period||6
5176896|NCT01170962|12732637|P2|NOT COMPLETED|Follow up Period||27
5176897|NCT01170962|12732638|P1|NOT COMPLETED|Follow up Period||39
5176898|NCT01170962|12732636|P3|COMPLETED|Follow up Period||9
5176899|NCT01170962|12732637|P2|COMPLETED|Follow up Period||165
5176900|NCT01170962|12732638|P1|COMPLETED|Follow up Period||159
5176901|NCT01170962|12732636|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
5176902|NCT01170962|12732637|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
5176903|NCT01170962|12732638|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
5176904|NCT01170962|12732636|P3|NOT COMPLETED|Treatment Period||12
5176905|NCT01170962|12732637|P2|NOT COMPLETED|Treatment Period||111
5176906|NCT01170962|12732638|P1|NOT COMPLETED|Treatment Period||127
5176907|NCT01170962|12732636|P3|COMPLETED|Treatment Period||5
5176908|NCT01170962|12732637|P2|COMPLETED|Treatment Period||88
5176909|NCT01170962|12732638|P1|COMPLETED|Treatment Period||76
5176910|NCT01170962|12732636|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
5176911|NCT01170962|12732637|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
5176912|NCT01170962|12732638|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
5176913|NCT01170962|12732636|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
5176914|NCT01170962|12732637|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
5176915|NCT01170962|12732638|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
5176916|NCT01170962|12732636|P3|No PDR|Treatment Period||17
5176917|NCT01170962|12732637|P2|No PDR|Treatment Period||127
5176918|NCT01170962|12732638|P1|No PDR|Treatment Period||145
5176919|NCT01170962|12732636|P3|STARTED|Treatment Period||17
5176920|NCT01170962|12732637|P2|STARTED|Treatment Period||199
5176921|NCT01170962|12732638|P1|STARTED|Treatment Period||203
5176922|NCT01170949|12732684|P2|NOT COMPLETED|Overall Study||4
5176923|NCT01170949|12732685|P1|NOT COMPLETED|Overall Study||7
5176924|NCT01170949|12732684|P2|COMPLETED|Overall Study||22
5176925|NCT01170949|12732685|P1|COMPLETED|Overall Study||43
5176926|NCT01170949|12732684|P2|STARTED|Overall Study||26
5176927|NCT01170949|12732685|P1|STARTED|Overall Study||50
5176928|NCT01170884|12732693|P2|NOT COMPLETED|Overall Study||2
5176929|NCT01170884|12732694|P1|NOT COMPLETED|Overall Study||5
5176930|NCT01170884|12732693|P2|COMPLETED|Overall Study||60
5176931|NCT01170884|12732694|P1|COMPLETED|Overall Study||54
5176932|NCT01170884|12732693|P2|STARTED|Overall Study||62
5176933|NCT01170884|12732694|P1|STARTED|Overall Study||59
5176934|NCT01170754|12732702|P2|NOT COMPLETED|Overall Study||0
5176935|NCT01170754|12732703|P1|NOT COMPLETED|Overall Study||0
5176936|NCT01170754|12732702|P2|COMPLETED|Overall Study||70
5176937|NCT01170754|12732703|P1|COMPLETED|Overall Study||66
5176938|NCT01170754|12732702|P2|STARTED|Overall Study||70
5176939|NCT01170754|12732703|P1|STARTED|Overall Study||66
5176940|NCT01170663|12732733|P2|NOT COMPLETED|Overall Study||20
5176941|NCT01170663|12732734|P1|NOT COMPLETED|Overall Study||14
5176942|NCT01170663|12732733|P2|COMPLETED|Overall Study||315
5176943|NCT01170663|12732734|P1|COMPLETED|Overall Study||316
5176944|NCT01170663|12732733|P2|Received Any Treatment (Safety Pop)|Overall Study||329
5176945|NCT01170663|12732734|P1|Received Any Treatment (Safety Pop)|Overall Study||327
5176946|NCT01170663|12732733|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
5176947|NCT01170663|12732734|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
5176948|NCT01170598|12732762|P1|NOT COMPLETED|Overall Study||6
5176949|NCT01170598|12732762|P1|COMPLETED|Overall Study||29
5176950|NCT01170598|12732762|P1|STARTED|Overall Study||35
5176951|NCT01170546|12732781|P4|NOT COMPLETED|Overall Study||0
5176952|NCT01170546|12732782|P3|NOT COMPLETED|Overall Study||0
5176953|NCT01170546|12732783|P2|NOT COMPLETED|Overall Study||0
5176954|NCT01170546|12732784|P1|NOT COMPLETED|Overall Study||0
5176955|NCT01170546|12732781|P4|COMPLETED|Overall Study||8
5176956|NCT01170546|12732782|P3|COMPLETED|Overall Study||6
5176957|NCT01170546|12732783|P2|COMPLETED|Overall Study||7
5176958|NCT01170546|12732784|P1|COMPLETED|Overall Study||7
5176959|NCT01170546|12732781|P4|STARTED|Overall Study||8
5176960|NCT01170546|12732782|P3|STARTED|Overall Study||6
5176961|NCT01170546|12732783|P2|STARTED|Overall Study||7
5176962|NCT01170546|12732784|P1|STARTED|Overall Study||7
5176963|NCT01170533|12732794|P2|NOT COMPLETED|Pantoprazole Cross-over||0
5176964|NCT01170533|12732795|P1|NOT COMPLETED|Pantoprazole Cross-over||0
5176965|NCT01170533|12732794|P2|COMPLETED|Pantoprazole Cross-over||20
5176966|NCT01170533|12732795|P1|COMPLETED|Pantoprazole Cross-over||0
5176967|NCT01170533|12732794|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
5176968|NCT01170533|12732795|P1|STARTED|Pantoprazole Cross-over||0
5176969|NCT01170533|12732794|P2|NOT COMPLETED|Omeprazole Cross-over||0
5176970|NCT01170533|12732795|P1|NOT COMPLETED|Omeprazole Cross-over||0
5176971|NCT01170533|12732794|P2|COMPLETED|Omeprazole Cross-over||0
5176972|NCT01170533|12732795|P1|COMPLETED|Omeprazole Cross-over||20
5176973|NCT01170533|12732794|P2|STARTED|Omeprazole Cross-over||0
5176974|NCT01170533|12732795|P1|STARTED|Omeprazole Cross-over||20
5176975|NCT01170390|12732807|P3|NOT COMPLETED|Randomized Treatment||0
5176976|NCT01170390|12732808|P2|NOT COMPLETED|Randomized Treatment||1
5176977|NCT01170390|12732809|P1|NOT COMPLETED|Randomized Treatment||0
5176978|NCT01170390|12732807|P3|COMPLETED|Randomized Treatment||15
5176979|NCT01170390|12732808|P2|COMPLETED|Randomized Treatment||16
5176980|NCT01170390|12732809|P1|COMPLETED|Randomized Treatment||0
5176981|NCT01170390|12732807|P3|STARTED|Randomized Treatment||15
5176982|NCT01170390|12732808|P2|STARTED|Randomized Treatment||17
5176983|NCT01170390|12732809|P1|STARTED|Randomized Treatment||0
5176984|NCT01170390|12732807|P3|NOT COMPLETED|Oral Contraceptives||0
5176985|NCT01170390|12732808|P2|NOT COMPLETED|Oral Contraceptives||0
5176986|NCT01170390|12732809|P1|NOT COMPLETED|Oral Contraceptives||1
5176987|NCT01170390|12732807|P3|COMPLETED|Oral Contraceptives||0
5176988|NCT01170390|12732808|P2|COMPLETED|Oral Contraceptives||0
5176989|NCT01170390|12732809|P1|COMPLETED|Oral Contraceptives||31
5176990|NCT01170390|12732807|P3|STARTED|Oral Contraceptives||0
5176991|NCT01170390|12732808|P2|STARTED|Oral Contraceptives||0
5176992|NCT01170390|12732809|P1|STARTED|Oral Contraceptives||32
5176993|NCT01170364|12732825|P2|NOT COMPLETED|Overall Study||1
5176994|NCT01170364|12732826|P1|NOT COMPLETED|Overall Study||4
5176995|NCT01170364|12732825|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
5176996|NCT01170364|12732826|P1|COMPLETED|Overall Study||4
5176997|NCT01170364|12732825|P2|STARTED|Overall Study||6
5176998|NCT01170364|12732826|P1|STARTED|Overall Study||8
5176999|NCT01170273|12732834|P2|NOT COMPLETED|Overall Study||9
5177000|NCT01170273|12732835|P1|NOT COMPLETED|Overall Study||8
5177001|NCT01170273|12732834|P2|COMPLETED|Overall Study||57
5177002|NCT01170273|12732835|P1|COMPLETED|Overall Study||56
5177003|NCT01170273|12732834|P2|STARTED|Overall Study||66
5177004|NCT01170273|12732835|P1|STARTED|Overall Study||64
5177005|NCT01170247|12732843|P2|NOT COMPLETED|Overall Study||0
5177006|NCT01170247|12732844|P1|NOT COMPLETED|Overall Study||0
5177007|NCT01170247|12732843|P2|COMPLETED|Overall Study||1
5177008|NCT01170247|12732844|P1|COMPLETED|Overall Study||2
5177009|NCT01170247|12732843|P2|STARTED|Overall Study||1
5177010|NCT01170247|12732844|P1|STARTED|Overall Study||2
5177011|NCT01170221|12732852|P2|NOT COMPLETED|Overall Study||28
5177012|NCT01170221|12732853|P1|NOT COMPLETED|Overall Study||33
5177013|NCT01170221|12732852|P2|COMPLETED|Overall Study||307
5177014|NCT01170221|12732853|P1|COMPLETED|Overall Study||299
5177015|NCT01170221|12732852|P2|STARTED|Overall Study||335
5177016|NCT01170221|12732853|P1|STARTED|Overall Study||332
5177017|NCT01170208|12732876|P3|NOT COMPLETED|Overall Study||2
5177018|NCT01170208|12732877|P2|NOT COMPLETED|Overall Study||0
5177019|NCT01170208|12732878|P1|NOT COMPLETED|Overall Study||6
5177020|NCT01170208|12732876|P3|COMPLETED|Overall Study||4
5177021|NCT01170208|12732877|P2|COMPLETED|Overall Study||20
5177022|NCT01170208|12732878|P1|COMPLETED|Overall Study||14
5177023|NCT01170208|12732876|P3|STARTED|Overall Study||6
5177024|NCT01170208|12732877|P2|STARTED|Overall Study||20
5177025|NCT01170208|12732878|P1|STARTED|Overall Study||20
5177026|NCT01170117|12732897|P2|NOT COMPLETED|Overall Study||20
5177027|NCT01170117|12732898|P1|NOT COMPLETED|Overall Study||30
5177028|NCT01170117|12732897|P2|COMPLETED|Overall Study||55
5177029|NCT01170117|12732898|P1|COMPLETED|Overall Study||47
5177030|NCT01170117|12732897|P2|STARTED|Overall Study||75
5177031|NCT01170117|12732898|P1|STARTED|Overall Study||77
5177032|NCT01170091|12732906|P1|NOT COMPLETED|Overall Study||24
5177033|NCT01170091|12732906|P1|COMPLETED|Overall Study||627
5177034|NCT01170091|12732906|P1|STARTED|Overall Study||651
5177035|NCT01170065|12732916|P3|NOT COMPLETED|Overall Study||26
5177036|NCT01170065|12732917|P2|NOT COMPLETED|Overall Study||92
5177037|NCT01170065|12732918|P1|NOT COMPLETED|Overall Study||28
5177038|NCT01170065|12732916|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
5177039|NCT01170065|12732917|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|34
5177040|NCT01170065|12732918|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
5177041|NCT01170065|12732916|P3|STARTED|Overall Study||35
5177042|NCT01170065|12732917|P2|STARTED|Overall Study||126
5177043|NCT01170065|12732918|P1|STARTED|Overall Study||37
5177044|NCT01170039|12732949|P2|NOT COMPLETED|Overall Study||6
5177045|NCT01170039|12732950|P1|NOT COMPLETED|Overall Study||8
5177046|NCT01170039|12732949|P2|COMPLETED|Overall Study||33
5177047|NCT01170039|12732950|P1|COMPLETED|Overall Study||29
5177048|NCT01170039|12732949|P2|STARTED|Overall Study||39
5177049|NCT01170039|12732950|P1|STARTED|Overall Study||37
5177050|NCT01169987|12732962|P1|NOT COMPLETED|Overall Study||31
5177051|NCT01169987|12732962|P1|COMPLETED|Overall Study||160
5177052|NCT01169987|12732962|P1|STARTED|Overall Study||191
5177053|NCT01169779|12733028|P2|NOT COMPLETED|Overall Study||17
5177054|NCT01169779|12733029|P1|NOT COMPLETED|Overall Study||11
5177055|NCT01169779|12733028|P2|COMPLETED|Overall Study||179
5177056|NCT01169779|12733029|P1|COMPLETED|Overall Study||184
5177057|NCT01169779|12733028|P2|Subgroup for Standardized Meal Test|Overall Study||121
5177058|NCT01169779|12733029|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
5177059|NCT01169779|12733028|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
5177060|NCT01169779|12733029|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
5177061|NCT01169779|12733028|P2|Treated/Safety Population|Overall Study||196
5177062|NCT01169779|12733029|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
5177063|NCT01169779|12733028|P2|STARTED|Overall Study||196
5177064|NCT01169779|12733029|P1|STARTED|Overall Study|Randomized.|195
5177065|NCT01169753|12733055|P2|NOT COMPLETED|Overall Study||1
5177066|NCT01169753|12733056|P1|NOT COMPLETED|Overall Study||0
5177067|NCT01169753|12733055|P2|COMPLETED|Overall Study||0
5177068|NCT01169753|12733056|P1|COMPLETED|Overall Study||0
5177069|NCT01169753|12733055|P2|STARTED|Overall Study||1
5177070|NCT01169753|12733056|P1|STARTED|Overall Study||0
5177071|NCT01169701|12733064|P2|NOT COMPLETED|Overall Study||10
5177072|NCT01169701|12733065|P1|NOT COMPLETED|Overall Study||5
5177073|NCT01169701|12733064|P2|COMPLETED|Overall Study||25
5177074|NCT01169701|12733065|P1|COMPLETED|Overall Study||31
5177075|NCT01169701|12733064|P2|Intent to Treat (ITT) Set|Overall Study||28
5177076|NCT01169701|12733065|P1|Intent to Treat (ITT) Set|Overall Study||32
5177077|NCT01169701|12733064|P2|Safety Set|Overall Study||35
5177078|NCT01169701|12733065|P1|Safety Set|Overall Study||36
5177079|NCT01169701|12733064|P2|STARTED|Overall Study||35
5177080|NCT01169701|12733065|P1|STARTED|Overall Study||36
5177081|NCT01169675|12733102|P5|NOT COMPLETED|Overall Study||6
5177082|NCT01169675|12733103|P4|NOT COMPLETED|Overall Study||17
5177083|NCT01169675|12733104|P3|NOT COMPLETED|Overall Study||7
5177084|NCT01169675|12733105|P2|NOT COMPLETED|Overall Study||3
5177085|NCT01169675|12733106|P1|NOT COMPLETED|Overall Study||20
5177086|NCT01169675|12733102|P5|COMPLETED|Overall Study||0
5177087|NCT01169675|12733103|P4|COMPLETED|Overall Study||0
5177088|NCT01169675|12733104|P3|COMPLETED|Overall Study||0
5177089|NCT01169675|12733105|P2|COMPLETED|Overall Study||0
5177090|NCT01169675|12733106|P1|COMPLETED|Overall Study||0
5177091|NCT01169675|12733102|P5|STARTED|Overall Study||6
5177092|NCT01169675|12733103|P4|STARTED|Overall Study||17
5177093|NCT01169675|12733104|P3|STARTED|Overall Study||7
5177094|NCT01169675|12733105|P2|STARTED|Overall Study||3
5177095|NCT01169675|12733106|P1|STARTED|Overall Study||20
5177096|NCT01169649|12733143|P1|NOT COMPLETED|Overall Study||3
5177097|NCT01169649|12733143|P1|COMPLETED|Overall Study||8
5177098|NCT01169649|12733143|P1|STARTED|Overall Study||11
5177099|NCT01169610|12733147|P1|NOT COMPLETED|Overall Study||0
5177100|NCT01169610|12733147|P1|COMPLETED|Overall Study||1
5177101|NCT01169610|12733147|P1|STARTED|Overall Study||1
5177102|NCT01169558|12733155|P1|NOT COMPLETED|Overall Study||156
5177103|NCT01169558|12733155|P1|COMPLETED|Overall Study||6
5177104|NCT01169558|12733155|P1|STARTED|Overall Study||162
5177105|NCT01169519|12733162|P1|NOT COMPLETED|Overall Study||0
5177106|NCT01169519|12733162|P1|COMPLETED|Overall Study||21
5177107|NCT01169519|12733162|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
5177108|NCT01169493|12733180|P6|NOT COMPLETED|Period 3 (6 Months)||0
5177109|NCT01169493|12733181|P5|NOT COMPLETED|Period 3 (6 Months)||0
5177110|NCT01169493|12733182|P4|NOT COMPLETED|Period 3 (6 Months)||0
5177111|NCT01169493|12733183|P3|NOT COMPLETED|Period 3 (6 Months)||1
5177112|NCT01169493|12733184|P2|NOT COMPLETED|Period 3 (6 Months)||2
5177113|NCT01169493|12733185|P1|NOT COMPLETED|Period 3 (6 Months)||0
5177114|NCT01169493|12733180|P6|COMPLETED|Period 3 (6 Months)||2
5177115|NCT01169493|12733181|P5|COMPLETED|Period 3 (6 Months)||0
5177116|NCT01169493|12733182|P4|COMPLETED|Period 3 (6 Months)||0
5177117|NCT01169493|12733183|P3|COMPLETED|Period 3 (6 Months)||2
5177118|NCT01169493|12733184|P2|COMPLETED|Period 3 (6 Months)||1
5177119|NCT01169493|12733185|P1|COMPLETED|Period 3 (6 Months)||2
5177120|NCT01169493|12733180|P6|STARTED|Period 3 (6 Months)||2
5177121|NCT01169493|12733181|P5|STARTED|Period 3 (6 Months)||0
5177122|NCT01169493|12733182|P4|STARTED|Period 3 (6 Months)||0
5177123|NCT01169493|12733183|P3|STARTED|Period 3 (6 Months)||3
5177124|NCT01169493|12733184|P2|STARTED|Period 3 (6 Months)||3
5177125|NCT01169493|12733185|P1|STARTED|Period 3 (6 Months)||2
5177126|NCT01169493|12733180|P6|NOT COMPLETED|Period 2 (6 Months)||0
5177127|NCT01169493|12733181|P5|NOT COMPLETED|Period 2 (6 Months)||0
5177128|NCT01169493|12733182|P4|NOT COMPLETED|Period 2 (6 Months)||0
5177129|NCT01169493|12733183|P3|NOT COMPLETED|Period 2 (6 Months)||0
5177130|NCT01169493|12733184|P2|NOT COMPLETED|Period 2 (6 Months)||0
5177131|NCT01169493|12733185|P1|NOT COMPLETED|Period 2 (6 Months)||0
5177132|NCT01169493|12733180|P6|COMPLETED|Period 2 (6 Months)||2
5177133|NCT01169493|12733181|P5|COMPLETED|Period 2 (6 Months)||0
5177134|NCT01169493|12733182|P4|COMPLETED|Period 2 (6 Months)||0
5177135|NCT01169493|12733183|P3|COMPLETED|Period 2 (6 Months)||3
5177136|NCT01169493|12733184|P2|COMPLETED|Period 2 (6 Months)||3
5177137|NCT01169493|12733185|P1|COMPLETED|Period 2 (6 Months)||2
5177138|NCT01169493|12733180|P6|STARTED|Period 2 (6 Months)||2
5177139|NCT01169493|12733181|P5|STARTED|Period 2 (6 Months)||0
5177140|NCT01169493|12733182|P4|STARTED|Period 2 (6 Months)||0
5177141|NCT01169493|12733183|P3|STARTED|Period 2 (6 Months)||3
5177142|NCT01169493|12733184|P2|STARTED|Period 2 (6 Months)||3
5177143|NCT01169493|12733185|P1|STARTED|Period 2 (6 Months)||2
5177144|NCT01169493|12733180|P6|NOT COMPLETED|Period 1 (6 Months)||3
5177145|NCT01169493|12733181|P5|NOT COMPLETED|Period 1 (6 Months)||0
5177146|NCT01169493|12733182|P4|NOT COMPLETED|Period 1 (6 Months)||0
5177147|NCT01169493|12733183|P3|NOT COMPLETED|Period 1 (6 Months)||2
5177148|NCT01169493|12733184|P2|NOT COMPLETED|Period 1 (6 Months)||1
5177149|NCT01169493|12733185|P1|NOT COMPLETED|Period 1 (6 Months)||0
5177150|NCT01169493|12733180|P6|COMPLETED|Period 1 (6 Months)||2
5177151|NCT01169493|12733181|P5|COMPLETED|Period 1 (6 Months)||0
5177152|NCT01169493|12733182|P4|COMPLETED|Period 1 (6 Months)||0
5177153|NCT01169493|12733183|P3|COMPLETED|Period 1 (6 Months)||3
5177154|NCT01169493|12733184|P2|COMPLETED|Period 1 (6 Months)||3
5177155|NCT01169493|12733185|P1|COMPLETED|Period 1 (6 Months)||2
5177156|NCT01169493|12733180|P6|STARTED|Period 1 (6 Months)||5
5177157|NCT01169493|12733181|P5|STARTED|Period 1 (6 Months)||0
5177158|NCT01169493|12733182|P4|STARTED|Period 1 (6 Months)||0
5177159|NCT01169493|12733183|P3|STARTED|Period 1 (6 Months)||5
5177160|NCT01169493|12733184|P2|STARTED|Period 1 (6 Months)||4
5177161|NCT01169493|12733185|P1|STARTED|Period 1 (6 Months)||2
5177162|NCT01169467|12733216|P2|NOT COMPLETED|Overall Study||4
5177163|NCT01169467|12733217|P1|NOT COMPLETED|Overall Study||7
5177164|NCT01169467|12733216|P2|COMPLETED|Overall Study||36
5177165|NCT01169467|12733217|P1|COMPLETED|Overall Study||37
5177166|NCT01169467|12733216|P2|STARTED|Overall Study||40
5177167|NCT01169467|12733217|P1|STARTED|Overall Study||44
5177168|NCT01169350|12733231|P1|NOT COMPLETED|Overall Study||5
5177169|NCT01169350|12733231|P1|COMPLETED|Overall Study||3
5177170|NCT01169350|12733231|P1|STARTED|Overall Study||8
5177171|NCT01169311|12733238|P1|NOT COMPLETED|Overall Study||0
5177172|NCT01169311|12733238|P1|COMPLETED|Overall Study||27
5177173|NCT01169311|12733238|P1|STARTED|Overall Study||27
5177174|NCT01169259|12733254|P4|NOT COMPLETED|Overall Study||0
5177175|NCT01169259|12733255|P3|NOT COMPLETED|Overall Study||0
5177176|NCT01169259|12733256|P2|NOT COMPLETED|Overall Study||0
5177177|NCT01169259|12733257|P1|NOT COMPLETED|Overall Study||0
5177178|NCT01169259|12733254|P4|COMPLETED|Overall Study||6474
5177179|NCT01169259|12733255|P3|COMPLETED|Overall Study||6470
5177180|NCT01169259|12733256|P2|COMPLETED|Overall Study||6464
5177181|NCT01169259|12733257|P1|COMPLETED|Overall Study||6463
5177182|NCT01169259|12733254|P4|STARTED|Overall Study||6474
5177183|NCT01169259|12733255|P3|STARTED|Overall Study||6470
5177184|NCT01169259|12733256|P2|STARTED|Overall Study||6464
5177185|NCT01169259|12733257|P1|STARTED|Overall Study||6463
5177186|NCT01169103|12733369|P2|NOT COMPLETED|Overall Study||4
5177187|NCT01169103|12733370|P1|NOT COMPLETED|Overall Study||6
5177188|NCT01169103|12733369|P2|COMPLETED|Overall Study||7
5177189|NCT01169103|12733370|P1|COMPLETED|Overall Study||5
5177190|NCT01169103|12733369|P2|STARTED|Overall Study||11
5177191|NCT01169103|12733370|P1|STARTED|Overall Study||11
5177192|NCT01169064|12733386|P2|NOT COMPLETED|Overall Study||0
5177193|NCT01169064|12733387|P1|NOT COMPLETED|Overall Study||0
5177194|NCT01169064|12733386|P2|COMPLETED|Overall Study||236
5177195|NCT01169064|12733387|P1|COMPLETED|Overall Study||239
5177196|NCT01169064|12733386|P2|STARTED|Overall Study||236
5177197|NCT01169064|12733387|P1|STARTED|Overall Study||239
5177198|NCT01169038|12733397|P1|NOT COMPLETED|Overall Study||7
5177199|NCT01169038|12733397|P1|COMPLETED|Overall Study||8
5177200|NCT01169038|12733397|P1|STARTED|Overall Study||15
5177201|NCT01168999|12733405|P4|NOT COMPLETED|Overall Study||0
5177202|NCT01168999|12733406|P3|NOT COMPLETED|Overall Study||0
5177203|NCT01168999|12733407|P2|NOT COMPLETED|Overall Study||1
5177204|NCT01168999|12733408|P1|NOT COMPLETED|Overall Study||2
5177205|NCT01168999|12733405|P4|COMPLETED|Overall Study||28
5177206|NCT01168999|12733406|P3|COMPLETED|Overall Study||27
5177207|NCT01168999|12733407|P2|COMPLETED|Overall Study||26
5177208|NCT01168999|12733408|P1|COMPLETED|Overall Study||26
5177209|NCT01168999|12733405|P4|STARTED|Overall Study||28
5177210|NCT01168999|12733406|P3|STARTED|Overall Study||27
5177211|NCT01168999|12733407|P2|STARTED|Overall Study||27
5177212|NCT01168999|12733408|P1|STARTED|Overall Study||28
5177213|NCT01168986|12733453|P3|NOT COMPLETED|Overall Study||0
5177214|NCT01168986|12733454|P2|NOT COMPLETED|Overall Study||1
5177215|NCT01168986|12733455|P1|NOT COMPLETED|Overall Study||2
5177216|NCT01168986|12733453|P3|COMPLETED|Overall Study||21
5177217|NCT01168986|12733454|P2|COMPLETED|Overall Study||20
5177218|NCT01168986|12733455|P1|COMPLETED|Overall Study||18
5177219|NCT01168986|12733453|P3|STARTED|Overall Study||21
5177220|NCT01168986|12733454|P2|STARTED|Overall Study||21
5177221|NCT01168986|12733455|P1|STARTED|Overall Study||20
5177222|NCT01168973|12733474|P2|NOT COMPLETED|Overall Study||611
5177223|NCT01168973|12733475|P1|NOT COMPLETED|Overall Study||613
5177224|NCT01168973|12733474|P2|COMPLETED|Overall Study||14
5177225|NCT01168973|12733475|P1|COMPLETED|Overall Study||15
5177226|NCT01168973|12733474|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
5177227|NCT01168973|12733475|P1|Received Any Quantity of Any Study Drug|Overall Study||624
5177228|NCT01168973|12733474|P2|STARTED|Overall Study||625
5177229|NCT01168973|12733475|P1|STARTED|Overall Study||628
5177230|NCT01168934|12733496|P2|NOT COMPLETED|Second Intervention Period||0
5177231|NCT01168934|12733497|P1|NOT COMPLETED|Second Intervention Period||0
5177232|NCT01168934|12733496|P2|COMPLETED|Second Intervention Period||7
5177233|NCT01168934|12733497|P1|COMPLETED|Second Intervention Period||7
5177234|NCT01168934|12733496|P2|STARTED|Second Intervention Period||7
5177235|NCT01168934|12733497|P1|STARTED|Second Intervention Period||7
5177236|NCT01168934|12733496|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5177237|NCT01168934|12733497|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5177238|NCT01168934|12733496|P2|COMPLETED|Washout Period (at Least 14 Days)||7
5177239|NCT01168934|12733497|P1|COMPLETED|Washout Period (at Least 14 Days)||7
5177240|NCT01168934|12733496|P2|STARTED|Washout Period (at Least 14 Days)||7
5177241|NCT01168934|12733497|P1|STARTED|Washout Period (at Least 14 Days)||7
5177242|NCT01168934|12733496|P2|NOT COMPLETED|First Intervention Period||0
5177243|NCT01168934|12733497|P1|NOT COMPLETED|First Intervention Period||0
5177244|NCT01168934|12733496|P2|COMPLETED|First Intervention Period||7
5177245|NCT01168934|12733497|P1|COMPLETED|First Intervention Period||7
5177246|NCT01168934|12733496|P2|STARTED|First Intervention Period||7
5177247|NCT01168934|12733497|P1|STARTED|First Intervention Period||7
5177248|NCT01168908|12733531|P2|NOT COMPLETED|Open Label||1
5177249|NCT01168908|12733532|P1|NOT COMPLETED|Open Label||1
5177250|NCT01168908|12733531|P2|COMPLETED|Open Label||7
5177251|NCT01168908|12733532|P1|COMPLETED|Open Label||6
5177252|NCT01168908|12733531|P2|STARTED|Open Label||8
5177253|NCT01168908|12733532|P1|STARTED|Open Label||7
5177254|NCT01168908|12733531|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
5177255|NCT01168908|12733532|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
5177256|NCT01168908|12733531|P2|COMPLETED|Double Blind, Placebo Controlled||8
5177257|NCT01168908|12733532|P1|COMPLETED|Double Blind, Placebo Controlled||7
5177258|NCT01168908|12733531|P2|STARTED|Double Blind, Placebo Controlled||10
5177259|NCT01168908|12733532|P1|STARTED|Double Blind, Placebo Controlled||10
5177260|NCT01168856|12733550|P2|NOT COMPLETED|Overall Study||343
5177261|NCT01168856|12733551|P1|NOT COMPLETED|Overall Study||18
5177262|NCT01168856|12733550|P2|COMPLETED|Overall Study||215
5177263|NCT01168856|12733551|P1|COMPLETED|Overall Study||158
5177264|NCT01168856|12733550|P2|STARTED|Overall Study||558
5177265|NCT01168856|12733551|P1|STARTED|Overall Study||176
5177266|NCT01168726|12733611|P3|NOT COMPLETED|Overall Study||5
5177267|NCT01168726|12733612|P2|NOT COMPLETED|Overall Study||9
5177268|NCT01168726|12733613|P1|NOT COMPLETED|Overall Study||8
5177269|NCT01168726|12733611|P3|COMPLETED|Overall Study||128
5177270|NCT01168726|12733612|P2|COMPLETED|Overall Study||112
5177271|NCT01168726|12733613|P1|COMPLETED|Overall Study||103
5177272|NCT01168726|12733611|P3|STARTED|Overall Study||133
5177273|NCT01168726|12733612|P2|STARTED|Overall Study||121
5177274|NCT01168726|12733613|P1|STARTED|Overall Study||111
5177275|NCT01168687|12733632|P2|NOT COMPLETED|Overall Study||0
5177276|NCT01168687|12733633|P1|NOT COMPLETED|Overall Study||0
5177277|NCT01168687|12733632|P2|COMPLETED|Overall Study||23
5177278|NCT01168687|12733633|P1|COMPLETED|Overall Study||23
5177279|NCT01168687|12733632|P2|STARTED|Overall Study||23
5177280|NCT01168687|12733633|P1|STARTED|Overall Study||23
5177281|NCT01168674|12733639|P2|NOT COMPLETED|Overall Study||0
5177282|NCT01168674|12733640|P1|NOT COMPLETED|Overall Study||0
5177283|NCT01168674|12733639|P2|COMPLETED|Overall Study||24
5177284|NCT01168674|12733640|P1|COMPLETED|Overall Study||25
5177285|NCT01168674|12733639|P2|STARTED|Overall Study||24
5177286|NCT01168674|12733640|P1|STARTED|Overall Study||25
5177287|NCT01168596|12733649|P2|NOT COMPLETED|Overall Study||1
5177288|NCT01168596|12733650|P1|NOT COMPLETED|Overall Study||3
5177289|NCT01168596|12733649|P2|COMPLETED|Overall Study||13
5177290|NCT01168596|12733650|P1|COMPLETED|Overall Study||13
5177291|NCT01168596|12733649|P2|STARTED|Overall Study||14
5177292|NCT01168596|12733650|P1|STARTED|Overall Study||16
5177293|NCT01168427|12733694|P1|NOT COMPLETED|Overall Study||1
5177294|NCT01168427|12733694|P1|COMPLETED|Overall Study||65
5177295|NCT01168427|12733694|P1|STARTED|Overall Study||66
5177296|NCT01168401|12733710|P11|NOT COMPLETED|Overall Study||0
5177297|NCT01168401|12733711|P10|NOT COMPLETED|Overall Study||0
5177298|NCT01168401|12733712|P9|NOT COMPLETED|Overall Study||0
5177299|NCT01168401|12733713|P8|NOT COMPLETED|Overall Study||0
5177300|NCT01168401|12733714|P7|NOT COMPLETED|Overall Study||0
5177301|NCT01168401|12733715|P6|NOT COMPLETED|Overall Study||0
5177302|NCT01168401|12733716|P5|NOT COMPLETED|Overall Study||0
5177303|NCT01168401|12733717|P4|NOT COMPLETED|Overall Study||2
5177304|NCT01168401|12733718|P3|NOT COMPLETED|Overall Study||2
5177305|NCT01168401|12733719|P2|NOT COMPLETED|Overall Study||1
5177306|NCT01168401|12733720|P1|NOT COMPLETED|Overall Study||1
5177307|NCT01168401|12733710|P11|COMPLETED|Overall Study||8
5177308|NCT01168401|12733711|P10|COMPLETED|Overall Study||8
5177309|NCT01168401|12733712|P9|COMPLETED|Overall Study||9
5177310|NCT01168401|12733713|P8|COMPLETED|Overall Study||10
5177311|NCT01168401|12733714|P7|COMPLETED|Overall Study||10
5177312|NCT01168401|12733715|P6|COMPLETED|Overall Study||9
5177313|NCT01168401|12733716|P5|COMPLETED|Overall Study||9
5177314|NCT01168401|12733717|P4|COMPLETED|Overall Study||7
5177315|NCT01168401|12733718|P3|COMPLETED|Overall Study||8
5177316|NCT01168401|12733719|P2|COMPLETED|Overall Study||9
5177317|NCT01168401|12733720|P1|COMPLETED|Overall Study||9
5177318|NCT01168401|12733710|P11|STARTED|Overall Study||8
5177319|NCT01168401|12733711|P10|STARTED|Overall Study||8
5177320|NCT01168401|12733712|P9|STARTED|Overall Study||9
5177321|NCT01168401|12733713|P8|STARTED|Overall Study||10
5177322|NCT01168401|12733714|P7|STARTED|Overall Study||10
5177323|NCT01168401|12733715|P6|STARTED|Overall Study||9
5177324|NCT01168401|12733716|P5|STARTED|Overall Study||9
5177325|NCT01168401|12733717|P4|STARTED|Overall Study||9
5177326|NCT01168401|12733718|P3|STARTED|Overall Study||10
5177327|NCT01168401|12733719|P2|STARTED|Overall Study||10
5177328|NCT01168401|12733720|P1|STARTED|Overall Study||10
5177329|NCT01168349|12733953|P1|NOT COMPLETED|Overall Study||301
5177330|NCT01168349|12733953|P1|COMPLETED|Overall Study||754
5177331|NCT01168349|12733953|P1|STARTED|Overall Study||1055
5177332|NCT01168232|12734059|P1|NOT COMPLETED|Overall Study||8
5177333|NCT01168232|12734059|P1|COMPLETED|Overall Study|Eligible and treated patients|34
5177334|NCT01168232|12734059|P1|STARTED|Overall Study||42
5177335|NCT01168219|12734066|P1|NOT COMPLETED|Overall Study||5
5177336|NCT01168219|12734066|P1|COMPLETED|Overall Study||63
5177337|NCT01168219|12734066|P1|STARTED|Overall Study||68
5177338|NCT01168024|12734074|P2|NOT COMPLETED|Overall Study||0
5177339|NCT01168024|12734075|P1|NOT COMPLETED|Overall Study||0
5177340|NCT01168024|12734074|P2|COMPLETED|Overall Study||3
5177341|NCT01168024|12734075|P1|COMPLETED|Overall Study||13
5177342|NCT01168024|12734074|P2|STARTED|Overall Study||3
5177343|NCT01168024|12734075|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
5177344|NCT01167907|12734089|P2|NOT COMPLETED|Overall Study||1
5177345|NCT01167907|12734090|P1|NOT COMPLETED|Overall Study||2
5177346|NCT01167907|12734089|P2|COMPLETED|Overall Study||14
5177347|NCT01167907|12734090|P1|COMPLETED|Overall Study||15
5177348|NCT01167907|12734089|P2|STARTED|Overall Study||15
5177349|NCT01167907|12734090|P1|STARTED|Overall Study||17
5177350|NCT01167881|12734108|P2|NOT COMPLETED|Overall Study||191
5177351|NCT01167881|12734109|P1|NOT COMPLETED|Overall Study||159
5177352|NCT01167881|12734108|P2|COMPLETED|Overall Study||589
5177353|NCT01167881|12734109|P1|COMPLETED|Overall Study||610
5177354|NCT01167881|12734108|P2|Completed After 4 Years Treatment|Overall Study||462
5177355|NCT01167881|12734109|P1|Completed After 4 Years Treatment|Overall Study||515
5177356|NCT01167881|12734108|P2|Completed After 2 Years Treatment|Overall Study||127
5177357|NCT01167881|12734109|P1|Completed After 2 Years Treatment|Overall Study||95
5177358|NCT01167881|12734108|P2|STARTED|Overall Study||780
5177359|NCT01167881|12734109|P1|STARTED|Overall Study||769
5177360|NCT01167829|12734133|P1|NOT COMPLETED|Overall Study||0
5177361|NCT01167829|12734133|P1|COMPLETED|Overall Study||12
5177362|NCT01167829|12734133|P1|STARTED|Overall Study||12
5177363|NCT01167712|12734148|P2|NOT COMPLETED|Overall Study||0
5177364|NCT01167712|12734149|P1|NOT COMPLETED|Overall Study||0
5177365|NCT01167712|12734148|P2|COMPLETED|Overall Study||346
5177366|NCT01167712|12734149|P1|COMPLETED|Overall Study||346
5177367|NCT01167712|12734148|P2|STARTED|Overall Study||346
5177368|NCT01167712|12734149|P1|STARTED|Overall Study||346
5177369|NCT01167634|12734163|P4|NOT COMPLETED|Overall Study||4
5177370|NCT01167634|12734164|P3|NOT COMPLETED|Overall Study||3
5177371|NCT01167634|12734165|P2|NOT COMPLETED|Overall Study||4
5177372|NCT01167634|12734166|P1|NOT COMPLETED|Overall Study||2
5177373|NCT01167634|12734163|P4|COMPLETED|Overall Study||29
5177374|NCT01167634|12734164|P3|COMPLETED|Overall Study||30
5177375|NCT01167634|12734165|P2|COMPLETED|Overall Study||29
5177376|NCT01167634|12734166|P1|COMPLETED|Overall Study||31
5177377|NCT01167634|12734163|P4|STARTED|Overall Study||33
5177378|NCT01167634|12734164|P3|STARTED|Overall Study||33
5177379|NCT01167634|12734165|P2|STARTED|Overall Study||33
5177380|NCT01167634|12734166|P1|STARTED|Overall Study||33
5177381|NCT01167608|12734176|P1|NOT COMPLETED|Overall Study||114
5177382|NCT01167608|12734176|P1|COMPLETED|Overall Study||769
5177383|NCT01167608|12734176|P1|STARTED|Overall Study||883
5177384|NCT01167582|12734187|P2|NOT COMPLETED|Overall Study||1
5177385|NCT01167582|12734188|P1|NOT COMPLETED|Overall Study||0
5177386|NCT01167582|12734187|P2|COMPLETED|Overall Study||54
5177387|NCT01167582|12734188|P1|COMPLETED|Overall Study||55
5177388|NCT01167582|12734187|P2|STARTED|Overall Study||55
5177389|NCT01167582|12734188|P1|STARTED|Overall Study||55
5177390|NCT01167504|12734218|P1|NOT COMPLETED|Overall Study||3
5177391|NCT01167504|12734218|P1|COMPLETED|Overall Study||12
5177392|NCT01167504|12734218|P1|STARTED|Overall Study||15
5177393|NCT01167452|12734223|P1|NOT COMPLETED|Overall Study||0
5177394|NCT01167452|12734223|P1|COMPLETED|Overall Study||36
5177395|NCT01167452|12734223|P1|STARTED|Overall Study||36
5177396|NCT01167426|12734228|P1|NOT COMPLETED|Overall Study||10
5177397|NCT01167426|12734228|P1|COMPLETED|Overall Study||138
5177398|NCT01167426|12734228|P1|STARTED|Overall Study||148
5177399|NCT01167257|12734236|P2|NOT COMPLETED|Overall Study||3
5177400|NCT01167257|12734237|P1|NOT COMPLETED|Overall Study||3
5177401|NCT01167257|12734236|P2|COMPLETED|Overall Study||28
5177402|NCT01167257|12734237|P1|COMPLETED|Overall Study||28
5177403|NCT01167257|12734236|P2|STARTED|Overall Study||31
5177404|NCT01167257|12734237|P1|STARTED|Overall Study||31
5177405|NCT01167192|12734259|P1|NOT COMPLETED|Overall Study||4
5177406|NCT01167192|12734259|P1|COMPLETED|Overall Study||6
5177407|NCT01167192|12734259|P1|STARTED|Overall Study||10
5177408|NCT01167179|12734276|P2|NOT COMPLETED|Overall Study||21
5177409|NCT01167179|12734277|P1|NOT COMPLETED|Overall Study||15
5177410|NCT01167179|12734276|P2|COMPLETED|Overall Study||59
5177411|NCT01167179|12734277|P1|COMPLETED|Overall Study||65
5177412|NCT01167179|12734276|P2|STARTED|Overall Study||80
5177413|NCT01167179|12734277|P1|STARTED|Overall Study||80
5177414|NCT01167153|12734287|P2|NOT COMPLETED|Overall Study||33
5177415|NCT01167153|12734288|P1|NOT COMPLETED|Overall Study||18
5177416|NCT01167153|12734287|P2|COMPLETED|Overall Study||249
5177417|NCT01167153|12734288|P1|COMPLETED|Overall Study||264
5177418|NCT01167153|12734287|P2|Intention to Treat (ITT)|Overall Study||268
5177419|NCT01167153|12734288|P1|Intention to Treat (ITT)|Overall Study||272
5177420|NCT01167153|12734287|P2|STARTED|Overall Study||282
5177421|NCT01167153|12734288|P1|STARTED|Overall Study||282
5177422|NCT01167140|12734306|P1|NOT COMPLETED|Overall Study||1
5177423|NCT01167140|12734306|P1|COMPLETED|Overall Study||41
5177424|NCT01167140|12734306|P1|STARTED|Overall Study||42
5177425|NCT01167023|12734314|P3|NOT COMPLETED|Overall Study||2
5177426|NCT01167023|12734315|P2|NOT COMPLETED|Overall Study||3
5177427|NCT01167023|12734316|P1|NOT COMPLETED|Overall Study||0
5177428|NCT01167023|12734314|P3|COMPLETED|Overall Study||39
5177429|NCT01167023|12734315|P2|COMPLETED|Overall Study||18
5177430|NCT01167023|12734316|P1|COMPLETED|Overall Study||0
5177431|NCT01167023|12734314|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
5177432|NCT01167023|12734315|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
5177433|NCT01167023|12734316|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
5177434|NCT01167023|12734314|P3|STARTED|Overall Study||41
5177435|NCT01167023|12734315|P2|STARTED|Overall Study||21
5177436|NCT01167023|12734316|P1|STARTED|Overall Study||0
5177437|NCT01166997|12734336|P2|NOT COMPLETED|Overall Study||0
5177438|NCT01166997|12734337|P1|NOT COMPLETED|Overall Study||2
5177439|NCT01166997|12734336|P2|COMPLETED|Overall Study||30
5177440|NCT01166997|12734337|P1|COMPLETED|Overall Study||27
5177441|NCT01166997|12734336|P2|STARTED|Overall Study||30
5177442|NCT01166997|12734337|P1|STARTED|Overall Study||29
5177443|NCT01166971|12734347|P2|NOT COMPLETED|Overall Study||1
5177444|NCT01166971|12734348|P1|NOT COMPLETED|Overall Study||1
5177445|NCT01166971|12734347|P2|COMPLETED|Overall Study||30
5177446|NCT01166971|12734348|P1|COMPLETED|Overall Study||32
5177447|NCT01166971|12734347|P2|STARTED|Overall Study||31
5177448|NCT01166971|12734348|P1|STARTED|Overall Study||33
5177449|NCT01166958|12734356|P2|NOT COMPLETED|Overall Study||0
5177450|NCT01166958|12734357|P1|NOT COMPLETED|Overall Study||1
5177451|NCT01166958|12734356|P2|COMPLETED|Overall Study||13
5177452|NCT01166958|12734357|P1|COMPLETED|Overall Study||12
5177453|NCT01166958|12734356|P2|STARTED|Overall Study||13
5177454|NCT01166958|12734357|P1|STARTED|Overall Study||13
5177455|NCT01166945|12734373|P2|NOT COMPLETED|Day 30||3
5177456|NCT01166945|12734374|P1|NOT COMPLETED|Day 30||4
5177457|NCT01166945|12734373|P2|COMPLETED|Day 30||37
5177458|NCT01166945|12734374|P1|COMPLETED|Day 30||38
5177459|NCT01166945|12734373|P2|STARTED|Day 30||40
5177460|NCT01166945|12734374|P1|STARTED|Day 30||42
5177461|NCT01166945|12734373|P2|NOT COMPLETED|Day 20||0
5177462|NCT01166945|12734374|P1|NOT COMPLETED|Day 20||0
5177463|NCT01166945|12734373|P2|COMPLETED|Day 20||40
5177464|NCT01166945|12734374|P1|COMPLETED|Day 20||42
5177465|NCT01166945|12734373|P2|STARTED|Day 20||40
5177466|NCT01166945|12734374|P1|STARTED|Day 20||42
5177467|NCT01166945|12734373|P2|NOT COMPLETED|Day 15||1
5177468|NCT01166945|12734374|P1|NOT COMPLETED|Day 15||2
5177469|NCT01166945|12734373|P2|COMPLETED|Day 15||40
5177470|NCT01166945|12734374|P1|COMPLETED|Day 15||42
5177471|NCT01166945|12734373|P2|STARTED|Day 15||41
5177472|NCT01166945|12734374|P1|STARTED|Day 15||44
5177473|NCT01166945|12734373|P2|NOT COMPLETED|Day 10||2
5177474|NCT01166945|12734374|P1|NOT COMPLETED|Day 10||3
5177475|NCT01166945|12734373|P2|COMPLETED|Day 10||41
5177476|NCT01166945|12734374|P1|COMPLETED|Day 10||44
5177477|NCT01166945|12734373|P2|STARTED|Day 10||43
5177478|NCT01166945|12734374|P1|STARTED|Day 10||47
5177479|NCT01166945|12734373|P2|NOT COMPLETED|Day 5||0
5177480|NCT01166945|12734374|P1|NOT COMPLETED|Day 5||0
5177481|NCT01166945|12734373|P2|COMPLETED|Day 5||43
5177482|NCT01166945|12734374|P1|COMPLETED|Day 5||47
5177483|NCT01166945|12734373|P2|STARTED|Day 5||43
5177484|NCT01166945|12734374|P1|STARTED|Day 5||47
5177485|NCT01166945|12734373|P2|NOT COMPLETED|Randomized||4
5177486|NCT01166945|12734374|P1|NOT COMPLETED|Randomized||4
5177487|NCT01166945|12734373|P2|COMPLETED|Randomized||43
5177488|NCT01166945|12734374|P1|COMPLETED|Randomized||47
5177489|NCT01166945|12734373|P2|STARTED|Randomized||47
5177490|NCT01166945|12734374|P1|STARTED|Randomized||51
5177491|NCT01166763|12734382|P1|NOT COMPLETED|Overall Study||3
5177492|NCT01166763|12734382|P1|COMPLETED|Overall Study||27
5177493|NCT01166763|12734382|P1|STARTED|Overall Study||30
5177494|NCT01166750|12734390|P2|NOT COMPLETED|Overall Study||0
5177495|NCT01166750|12734391|P1|NOT COMPLETED|Overall Study||1
5177496|NCT01166750|12734390|P2|COMPLETED|Overall Study||13
5177497|NCT01166750|12734391|P1|COMPLETED|Overall Study||9
5177498|NCT01166750|12734390|P2|STARTED|Overall Study||13
5177499|NCT01166750|12734391|P1|STARTED|Overall Study||10
5177500|NCT01166724|12734399|P2|NOT COMPLETED|Overall Study||5
5177501|NCT01166724|12734400|P1|NOT COMPLETED|Overall Study||7
5177502|NCT01166724|12734399|P2|COMPLETED|Overall Study||0
5177503|NCT01166724|12734400|P1|COMPLETED|Overall Study||0
5177504|NCT01166724|12734399|P2|STARTED|Overall Study||5
5177505|NCT01166724|12734400|P1|STARTED|Overall Study||7
5177506|NCT01166659|12734408|P1|NOT COMPLETED|Overall Study||13
5177507|NCT01166659|12734408|P1|COMPLETED|Overall Study||35
5177508|NCT01166659|12734408|P1|STARTED|Overall Study||48
5177509|NCT01166646|12734417|P2|NOT COMPLETED|Overall Study||1
5177510|NCT01166646|12734418|P1|NOT COMPLETED|Overall Study||1
5177511|NCT01166646|12734417|P2|COMPLETED|Overall Study||21
5177512|NCT01166646|12734418|P1|COMPLETED|Overall Study||20
5177513|NCT01166646|12734417|P2|STARTED|Overall Study||22
5177514|NCT01166646|12734418|P1|STARTED|Overall Study||21
5177515|NCT01166568|12734437|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
5177516|NCT01166568|12734438|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
5177517|NCT01166568|12734439|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
5177518|NCT01166568|12734437|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
5177519|NCT01166568|12734438|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
5177520|NCT01166568|12734439|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
5177521|NCT01166568|12734437|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
5177522|NCT01166568|12734438|P2|STARTED|Implantation- Nonrandomized & Randomized||33
5177523|NCT01166568|12734439|P1|STARTED|Implantation- Nonrandomized & Randomized||288
5177524|NCT01166568|12734437|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
5177525|NCT01166568|12734438|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
5177526|NCT01166568|12734439|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
5177527|NCT01166568|12734437|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
5177528|NCT01166568|12734438|P2|COMPLETED|Deferred Implantation- Randomized||0
5177529|NCT01166568|12734439|P1|COMPLETED|Deferred Implantation- Randomized||0
5177530|NCT01166568|12734437|P3|STARTED|Deferred Implantation- Randomized||16
5177531|NCT01166568|12734438|P2|STARTED|Deferred Implantation- Randomized||0
5177532|NCT01166568|12734439|P1|STARTED|Deferred Implantation- Randomized||0
5177533|NCT01166438|12734452|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
5177534|NCT01166438|12734453|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
5177535|NCT01166438|12734452|P2|COMPLETED|Off Treatment Follow-up Phase||33
5177536|NCT01166438|12734453|P1|COMPLETED|Off Treatment Follow-up Phase||51
5177537|NCT01166438|12734452|P2|STARTED|Off Treatment Follow-up Phase||89
5177538|NCT01166438|12734453|P1|STARTED|Off Treatment Follow-up Phase||85
5177539|NCT01166438|12734452|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
5177540|NCT01166438|12734453|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
5177541|NCT01166438|12734452|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
5177542|NCT01166438|12734453|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
5177543|NCT01166438|12734452|P2|Treated|Double-blind Phase: 1st 6 Months||126
5177544|NCT01166438|12734453|P1|Treated|Double-blind Phase: 1st 6 Months||121
5177545|NCT01166438|12734452|P2|STARTED|Double-blind Phase: 1st 6 Months||127
5177546|NCT01166438|12734453|P1|STARTED|Double-blind Phase: 1st 6 Months||122
5177547|NCT01166347|12734469|P2|NOT COMPLETED|Overall Study||1
5177548|NCT01166347|12734470|P1|NOT COMPLETED|Overall Study||2
5177549|NCT01166347|12734469|P2|COMPLETED|Overall Study||148
5177550|NCT01166347|12734470|P1|COMPLETED|Overall Study||295
5177551|NCT01166347|12734469|P2|STARTED|Overall Study||149
5177552|NCT01166347|12734470|P1|STARTED|Overall Study||297
5177553|NCT01166282|12734502|P3|NOT COMPLETED|Open-label Period||17
5177554|NCT01166282|12734503|P2|NOT COMPLETED|Open-label Period||0
5177555|NCT01166282|12734504|P1|NOT COMPLETED|Open-label Period||0
5177556|NCT01166282|12734502|P3|COMPLETED|Open-label Period||29
5177557|NCT01166282|12734503|P2|COMPLETED|Open-label Period||0
5177558|NCT01166282|12734504|P1|COMPLETED|Open-label Period||0
5177559|NCT01166282|12734502|P3|STARTED|Open-label Period||46
5177560|NCT01166282|12734503|P2|STARTED|Open-label Period||0
5177561|NCT01166282|12734504|P1|STARTED|Open-label Period||0
5177562|NCT01166282|12734502|P3|NOT COMPLETED|Double-blind Period||0
5177563|NCT01166282|12734503|P2|NOT COMPLETED|Double-blind Period||0
5177564|NCT01166282|12734504|P1|NOT COMPLETED|Double-blind Period||0
5177565|NCT01166282|12734502|P3|COMPLETED|Double-blind Period||0
5177566|NCT01166282|12734503|P2|COMPLETED|Double-blind Period||31
5177567|NCT01166282|12734504|P1|COMPLETED|Double-blind Period||15
5177568|NCT01166282|12734502|P3|STARTED|Double-blind Period||0
5177569|NCT01166282|12734503|P2|STARTED|Double-blind Period||31
5177570|NCT01166282|12734504|P1|STARTED|Double-blind Period||15
5177571|NCT01166230|12734528|P2|NOT COMPLETED|Overall Study||16
5177572|NCT01166230|12734529|P1|NOT COMPLETED|Overall Study||19
5177573|NCT01166230|12734528|P2|COMPLETED|Overall Study||255
5177574|NCT01166230|12734529|P1|COMPLETED|Overall Study||261
5177575|NCT01166230|12734528|P2|STARTED|Overall Study||271
5177576|NCT01166230|12734529|P1|STARTED|Overall Study||280
5177577|NCT01166178|12734543|P2|NOT COMPLETED|Overall Study||8
5177578|NCT01166178|12734544|P1|NOT COMPLETED|Overall Study||21
5177579|NCT01166178|12734543|P2|COMPLETED|Overall Study||0
5177580|NCT01166178|12734544|P1|COMPLETED|Overall Study||0
5177581|NCT01166178|12734543|P2|STARTED|Overall Study||8
5177582|NCT01166178|12734544|P1|STARTED|Overall Study||21
5177583|NCT01166139|12734570|P1|NOT COMPLETED|Overall Study||3
5177584|NCT01166139|12734570|P1|COMPLETED|Overall Study||7
5177585|NCT01166139|12734570|P1|STARTED|Overall Study||10
5177586|NCT01166126|12734576|P1|NOT COMPLETED|Overall Study||0
5177587|NCT01166126|12734576|P1|COMPLETED|Overall Study||4
5177588|NCT01166126|12734576|P1|STARTED|Overall Study||4
5177589|NCT01165996|12734583|P1|NOT COMPLETED|Overall Study||2
5177590|NCT01165996|12734583|P1|COMPLETED|Overall Study||23
5177591|NCT01165996|12734583|P1|Maintenance Phase|Overall Study||23
5177592|NCT01165996|12734583|P1|Induction Phase|Overall Study||25
5177593|NCT01165996|12734583|P1|STARTED|Overall Study||25
5177594|NCT01165983|12734595|P2|NOT COMPLETED|Overall Study||7
5177595|NCT01165983|12734596|P1|NOT COMPLETED|Overall Study||5
5177596|NCT01165983|12734595|P2|COMPLETED|Overall Study||42
5177597|NCT01165983|12734596|P1|COMPLETED|Overall Study||46
5177598|NCT01165983|12734595|P2|STARTED|Overall Study||49
5177599|NCT01165983|12734596|P1|STARTED|Overall Study||51
5177600|NCT01165840|12734640|P1|NOT COMPLETED|Overall Study||0
5177601|NCT01165840|12734640|P1|COMPLETED|Overall Study||36
5177602|NCT01165840|12734640|P1|STARTED|Overall Study||36
5177603|NCT01165775|12734644|P1|NOT COMPLETED|Overall Study||2
5177604|NCT01165775|12734644|P1|COMPLETED|Overall Study||15
5177605|NCT01165775|12734644|P1|STARTED|Overall Study||17
5177606|NCT01165684|12734654|P2|NOT COMPLETED|Overall Study||52
5177607|NCT01165684|12734655|P1|NOT COMPLETED|Overall Study||28
5177608|NCT01165684|12734654|P2|COMPLETED|Overall Study||148
5177609|NCT01165684|12734655|P1|COMPLETED|Overall Study||173
5177610|NCT01165684|12734654|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
5177611|NCT01165684|12734655|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
5177612|NCT01165684|12734654|P2|STARTED|Overall Study||200
5177613|NCT01165684|12734655|P1|STARTED|Overall Study||201
5177614|NCT01165554|12734689|P1|NOT COMPLETED|Overall Study||23
5177615|NCT01165554|12734689|P1|COMPLETED|Overall Study||180
5177616|NCT01165554|12734689|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
5177617|NCT01165541|12734696|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
5177618|NCT01165541|12734696|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
5177619|NCT01165541|12734696|P1|STARTED|Quetiapine XR and Mirtazepine||16
5177620|NCT01165541|12734696|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
5177621|NCT01165541|12734696|P1|COMPLETED|Quetiapine XR Monotherapy||16
5177622|NCT01165541|12734696|P1|STARTED|Quetiapine XR Monotherapy||20
5177623|NCT01165450|12734702|P1|NOT COMPLETED|Overall Study||0
5177624|NCT01165450|12734702|P1|COMPLETED|Overall Study||2
5177625|NCT01165450|12734702|P1|STARTED|Overall Study||2
5177626|NCT01165424|12734712|P1|NOT COMPLETED|Overall Study||4
5177627|NCT01165424|12734712|P1|COMPLETED|Overall Study||76
5177628|NCT01165424|12734712|P1|STARTED|Overall Study||80
5177629|NCT01165320|12734719|P3|NOT COMPLETED|Overall Study||0
5177630|NCT01165320|12734720|P2|NOT COMPLETED|Overall Study||4
5177631|NCT01165320|12734721|P1|NOT COMPLETED|Overall Study||3
5177632|NCT01165320|12734719|P3|COMPLETED|Overall Study||0
5177633|NCT01165320|12734720|P2|COMPLETED|Overall Study||4
5177634|NCT01165320|12734721|P1|COMPLETED|Overall Study||9
5177635|NCT01165320|12734719|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
5177636|NCT01165320|12734720|P2|STARTED|Overall Study||8
5177637|NCT01165320|12734721|P1|STARTED|Overall Study||12
5177638|NCT01165307|12734731|P2|NOT COMPLETED|Overall Study||3
5177639|NCT01165307|12734732|P1|NOT COMPLETED|Overall Study||14
5177640|NCT01165307|12734731|P2|COMPLETED|Overall Study||31
5177641|NCT01165307|12734732|P1|COMPLETED|Overall Study||19
5177642|NCT01165307|12734731|P2|STARTED|Overall Study||34
5177643|NCT01165307|12734732|P1|STARTED|Overall Study||33
5177644|NCT01165281|12734762|P2|NOT COMPLETED|Overall Study||51
5177645|NCT01165281|12734763|P1|NOT COMPLETED|Overall Study||58
5177646|NCT01165281|12734762|P2|COMPLETED|Overall Study||121
5177647|NCT01165281|12734763|P1|COMPLETED|Overall Study||110
5177648|NCT01165281|12734762|P2|STARTED|Overall Study||172
5177649|NCT01165281|12734763|P1|STARTED|Overall Study||168
5177650|NCT01165242|12734784|P3|NOT COMPLETED|Overall Study||14
5177651|NCT01165242|12734785|P2|NOT COMPLETED|Overall Study||10
5177652|NCT01165242|12734786|P1|NOT COMPLETED|Overall Study||10
5177653|NCT01165242|12734784|P3|COMPLETED|Overall Study||324
5177654|NCT01165242|12734785|P2|COMPLETED|Overall Study||326
5177655|NCT01165242|12734786|P1|COMPLETED|Overall Study||327
5177656|NCT01165242|12734784|P3|STARTED|Overall Study||338
5177657|NCT01165242|12734785|P2|STARTED|Overall Study||336
5177658|NCT01165242|12734786|P1|STARTED|Overall Study||337
5177659|NCT01165229|12734820|P2|NOT COMPLETED|Overall Study||1190
5177660|NCT01165229|12734821|P1|NOT COMPLETED|Overall Study||1180
5177661|NCT01165229|12734820|P2|COMPLETED|Overall Study||5760
5177662|NCT01165229|12734821|P1|COMPLETED|Overall Study||5770
5177663|NCT01165229|12734820|P2|STARTED|Overall Study||6950
5177664|NCT01165229|12734821|P1|STARTED|Overall Study||6950
5177665|NCT01165216|12734955|P2|NOT COMPLETED|Overall Study||7
5177666|NCT01165216|12734956|P1|NOT COMPLETED|Overall Study||8
5177667|NCT01165216|12734955|P2|COMPLETED|Overall Study|Completed=still on study drug|0
5177668|NCT01165216|12734956|P1|COMPLETED|Overall Study|Completed=still on study drug|0
5177669|NCT01165216|12734955|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
5177670|NCT01165216|12734956|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
5177671|NCT01165216|12734955|P2|STARTED|Overall Study|Participants who received any study drug|7
5177672|NCT01165216|12734956|P1|STARTED|Overall Study|Participants who received any study drug|8
5177673|NCT01165203|12734978|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
5177674|NCT01165203|12734979|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
5177675|NCT01165203|12734978|P2|COMPLETED|Extended Safety Follow-up Phase||45
5177676|NCT01165203|12734979|P1|COMPLETED|Extended Safety Follow-up Phase||67
5177677|NCT01165203|12734978|P2|STARTED|Extended Safety Follow-up Phase||49
5177678|NCT01165203|12734979|P1|STARTED|Extended Safety Follow-up Phase||74
5177679|NCT01165203|12734978|P2|NOT COMPLETED|Active Phase||2
5177680|NCT01165203|12734979|P1|NOT COMPLETED|Active Phase||5
5177681|NCT01165203|12734978|P2|COMPLETED|Active Phase||47
5177682|NCT01165203|12734979|P1|COMPLETED|Active Phase||69
5177683|NCT01165203|12734978|P2|STARTED|Active Phase||49
5177684|NCT01165203|12734979|P1|STARTED|Active Phase||74
5177685|NCT01165177|12735069|P2|NOT COMPLETED|Overall Study||902
5177686|NCT01165177|12735070|P1|NOT COMPLETED|Overall Study||922
5177687|NCT01165177|12735069|P2|COMPLETED|Overall Study||6808
5177688|NCT01165177|12735070|P1|COMPLETED|Overall Study||6773
5177689|NCT01165177|12735069|P2|STARTED|Overall Study||7710
5177690|NCT01165177|12735070|P1|STARTED|Overall Study||7695
5177691|NCT01165138|12735199|P4|NOT COMPLETED|Overall Study||22
5177692|NCT01165138|12735200|P3|NOT COMPLETED|Overall Study||20
5177693|NCT01165138|12735201|P2|NOT COMPLETED|Overall Study||52
5177694|NCT01165138|12735202|P1|NOT COMPLETED|Overall Study||0
5177695|NCT01165138|12735199|P4|COMPLETED|Overall Study||179
5177696|NCT01165138|12735200|P3|COMPLETED|Overall Study||185
5177697|NCT01165138|12735201|P2|COMPLETED|Overall Study||151
5177698|NCT01165138|12735202|P1|COMPLETED|Overall Study||0
5177699|NCT01165138|12735199|P4|STARTED|Overall Study||201
5177700|NCT01165138|12735200|P3|STARTED|Overall Study||205
5177701|NCT01165138|12735201|P2|STARTED|Overall Study||203
5177702|NCT01165138|12735202|P1|STARTED|Overall Study||0
5177703|NCT01165112|12735261|P1|NOT COMPLETED|Overall Study||0
5177704|NCT01165112|12735261|P1|COMPLETED|Overall Study||48
5177705|NCT01165112|12735261|P1|STARTED|Overall Study||48
5177706|NCT01165047|12735268|P1|NOT COMPLETED|Overall Study||0
5177707|NCT01165047|12735268|P1|COMPLETED|Overall Study||10
5177708|NCT01165047|12735268|P1|STARTED|Overall Study||10
5177709|NCT01165021|12735272|P1|NOT COMPLETED|Overall Study||1
5177710|NCT01165021|12735272|P1|COMPLETED|Overall Study||18
5177711|NCT01165021|12735272|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
5177712|NCT01165021|12735272|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
5177713|NCT01165021|12735272|P1|≥1 Dose Chemo|Overall Study||19
5177714|NCT01165021|12735272|P1|STARTED|Overall Study||19
5177715|NCT01164956|12735280|P3|NOT COMPLETED|Overall Study||1
5177716|NCT01164956|12735281|P2|NOT COMPLETED|Overall Study||0
5177717|NCT01164956|12735282|P1|NOT COMPLETED|Overall Study||1
5177718|NCT01164956|12735280|P3|COMPLETED|Overall Study||0
5177719|NCT01164956|12735281|P2|COMPLETED|Overall Study||1
5177720|NCT01164956|12735282|P1|COMPLETED|Overall Study||0
5177721|NCT01164956|12735280|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
5177722|NCT01164956|12735281|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
5177723|NCT01164956|12735282|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
5177724|NCT01164956|12735280|P3|STARTED|Overall Study||1
5177725|NCT01164956|12735281|P2|STARTED|Overall Study||1
5177726|NCT01164956|12735282|P1|STARTED|Overall Study||1
5177727|NCT01164891|12735290|P1|NOT COMPLETED|Overall Study||6
5177728|NCT01164891|12735290|P1|COMPLETED|Overall Study||1
5177729|NCT01164891|12735290|P1|STARTED|Overall Study||7
5177730|NCT01164865|12735310|P2|NOT COMPLETED|Overall Study||1
5177731|NCT01164865|12735311|P1|NOT COMPLETED|Overall Study||2
5177732|NCT01164865|12735310|P2|COMPLETED|Overall Study||38
5177733|NCT01164865|12735311|P1|COMPLETED|Overall Study||37
5177734|NCT01164865|12735310|P2|STARTED|Overall Study||39
5177735|NCT01164865|12735311|P1|STARTED|Overall Study||39
5177736|NCT01164722|12735321|P2|NOT COMPLETED|Overall Study||15
5177737|NCT01164722|12735322|P1|NOT COMPLETED|Overall Study||18
5177738|NCT01164722|12735321|P2|COMPLETED|Overall Study||45
5177739|NCT01164722|12735322|P1|COMPLETED|Overall Study||42
5177740|NCT01164722|12735321|P2|STARTED|Overall Study||60
5177741|NCT01164722|12735322|P1|STARTED|Overall Study||60
5177742|NCT01164644|12735338|P2|NOT COMPLETED|Overall Study||1
5177743|NCT01164644|12735339|P1|NOT COMPLETED|Overall Study||3
5177744|NCT01164644|12735338|P2|COMPLETED|Overall Study||13
5177745|NCT01164644|12735339|P1|COMPLETED|Overall Study||9
5177746|NCT01164644|12735338|P2|STARTED|Overall Study||14
5177747|NCT01164644|12735339|P1|STARTED|Overall Study||12
5177748|NCT01164579|12735352|P3|NOT COMPLETED|Overall Study||16
5177749|NCT01164579|12735353|P2|NOT COMPLETED|Overall Study||9
5177750|NCT01164579|12735354|P1|NOT COMPLETED|Overall Study||8
5177751|NCT01164579|12735352|P3|COMPLETED|Overall Study||21
5177752|NCT01164579|12735353|P2|COMPLETED|Overall Study||27
5177753|NCT01164579|12735354|P1|COMPLETED|Overall Study||28
5177754|NCT01164579|12735352|P3|STARTED|Overall Study||37
5177755|NCT01164579|12735353|P2|STARTED|Overall Study||36
5177756|NCT01164579|12735354|P1|STARTED|Overall Study||36
5177757|NCT01164501|12735434|P3|NOT COMPLETED|Overall Study||42
5177758|NCT01164501|12735435|P2|NOT COMPLETED|Overall Study||10
5177759|NCT01164501|12735436|P1|NOT COMPLETED|Overall Study||43
5177760|NCT01164501|12735434|P3|COMPLETED|Overall Study||280
5177761|NCT01164501|12735435|P2|COMPLETED|Overall Study||88
5177762|NCT01164501|12735436|P1|COMPLETED|Overall Study||278
5177763|NCT01164501|12735434|P3|STARTED|Overall Study||322
5177764|NCT01164501|12735435|P2|STARTED|Overall Study||98
5177765|NCT01164501|12735436|P1|STARTED|Overall Study||321
5177766|NCT01164475|12735453|P2|NOT COMPLETED|Overall Study||2
5177767|NCT01164475|12735454|P1|NOT COMPLETED|Overall Study||2
5177768|NCT01164475|12735453|P2|COMPLETED|Overall Study||29
5177769|NCT01164475|12735454|P1|COMPLETED|Overall Study||28
5177770|NCT01164475|12735453|P2|STARTED|Overall Study||31
5177771|NCT01164475|12735454|P1|STARTED|Overall Study||30
5177772|NCT01164137|12735480|P2|NOT COMPLETED|Overall Study||0
5177773|NCT01164137|12735481|P1|NOT COMPLETED|Overall Study||3
5177774|NCT01164137|12735480|P2|COMPLETED|Overall Study||76
5177775|NCT01164137|12735481|P1|COMPLETED|Overall Study||77
5177776|NCT01164137|12735480|P2|STARTED|Overall Study||76
5177777|NCT01164137|12735481|P1|STARTED|Overall Study||80
5177778|NCT01164098|12735497|P2|NOT COMPLETED|Overall Study||0
5177779|NCT01164098|12735498|P1|NOT COMPLETED|Overall Study||0
5177780|NCT01164098|12735497|P2|COMPLETED|Overall Study||15
5177781|NCT01164098|12735498|P1|COMPLETED|Overall Study||15
5177782|NCT01164098|12735497|P2|STARTED|Overall Study||15
5177783|NCT01164098|12735498|P1|STARTED|Overall Study||15
5177784|NCT01164007|12735508|P1|NOT COMPLETED|Overall Study||40
5177785|NCT01164007|12735508|P1|COMPLETED|Overall Study||0
5177786|NCT01164007|12735508|P1|Treated|Overall Study||37
5177787|NCT01164007|12735508|P1|STARTED|Overall Study||40
5177788|NCT01163955|12735524|P2|NOT COMPLETED|Overall Study||4
5177789|NCT01163955|12735525|P1|NOT COMPLETED|Overall Study||0
5177790|NCT01163955|12735524|P2|COMPLETED|Overall Study||26
5177791|NCT01163955|12735525|P1|COMPLETED|Overall Study||26
5177792|NCT01163955|12735524|P2|STARTED|Overall Study||30
5177793|NCT01163955|12735525|P1|STARTED|Overall Study||26
5177794|NCT01163916|12735534|P3|NOT COMPLETED|Overall Study||20
5177795|NCT01163916|12735535|P2|NOT COMPLETED|Overall Study||4
5177796|NCT01163916|12735536|P1|NOT COMPLETED|Overall Study||30
5177797|NCT01163916|12735534|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
5177798|NCT01163916|12735535|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
5177799|NCT01163916|12735536|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
5177800|NCT01163916|12735534|P3|Safety Population|Overall Study||91
5177801|NCT01163916|12735535|P2|Safety Population|Overall Study||35
5177802|NCT01163916|12735536|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
5177803|NCT01163916|12735534|P3|STARTED|Overall Study||91
5177804|NCT01163916|12735535|P2|STARTED|Overall Study||35
5177805|NCT01163916|12735536|P1|STARTED|Overall Study||126
5177806|NCT01163851|12735574|P2|NOT COMPLETED|Overall Study||1
5177807|NCT01163851|12735575|P1|NOT COMPLETED|Overall Study||1
5177808|NCT01163851|12735574|P2|COMPLETED|Overall Study||11
5177809|NCT01163851|12735575|P1|COMPLETED|Overall Study||12
5177810|NCT01163851|12735574|P2|Treated|Overall Study||12
5177811|NCT01163851|12735575|P1|Treated|Overall Study||12
5177812|NCT01163851|12735574|P2|STARTED|Overall Study||12
5177813|NCT01163851|12735575|P1|STARTED|Overall Study||13
5177814|NCT01163786|12735653|P1|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
5177815|NCT01163786|12735653|P1|COMPLETED|Completed Follow up (Visit 9 and 10)||13
5177816|NCT01163786|12735653|P1|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
5177817|NCT01163786|12735653|P1|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
5177818|NCT01163786|12735653|P1|STARTED|Completed Follow up (Visit 9 and 10)||14
5177819|NCT01163786|12735653|P1|NOT COMPLETED|Treatment With Bortezomib||3
5177820|NCT01163786|12735653|P1|COMPLETED|Treatment With Bortezomib||14
5177821|NCT01163786|12735653|P1|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
5177822|NCT01163786|12735653|P1|Completed 1st Cycle|Treatment With Bortezomib||17
5177823|NCT01163786|12735653|P1|STARTED|Treatment With Bortezomib||17
5177824|NCT01163760|12735659|P4|NOT COMPLETED|Period 4 (Follow-up)||0
5177825|NCT01163760|12735660|P3|NOT COMPLETED|Period 4 (Follow-up)||0
5177826|NCT01163760|12735661|P2|NOT COMPLETED|Period 4 (Follow-up)||0
5177827|NCT01163760|12735662|P1|NOT COMPLETED|Period 4 (Follow-up)||0
5177828|NCT01163760|12735659|P4|COMPLETED|Period 4 (Follow-up)||12
5177829|NCT01163760|12735660|P3|COMPLETED|Period 4 (Follow-up)||13
5177830|NCT01163760|12735661|P2|COMPLETED|Period 4 (Follow-up)||13
5177831|NCT01163760|12735662|P1|COMPLETED|Period 4 (Follow-up)||12
5177832|NCT01163760|12735659|P4|STARTED|Period 4 (Follow-up)||12
5177833|NCT01163760|12735660|P3|STARTED|Period 4 (Follow-up)||13
5177834|NCT01163760|12735661|P2|STARTED|Period 4 (Follow-up)||13
5177835|NCT01163760|12735662|P1|STARTED|Period 4 (Follow-up)||12
5177836|NCT01163760|12735659|P4|NOT COMPLETED|Period 3 (Fit)||0
5177837|NCT01163760|12735660|P3|NOT COMPLETED|Period 3 (Fit)||0
5177838|NCT01163760|12735661|P2|NOT COMPLETED|Period 3 (Fit)||0
5177839|NCT01163760|12735662|P1|NOT COMPLETED|Period 3 (Fit)||0
5177840|NCT01163760|12735659|P4|COMPLETED|Period 3 (Fit)||12
5177841|NCT01163760|12735660|P3|COMPLETED|Period 3 (Fit)||13
5177842|NCT01163760|12735661|P2|COMPLETED|Period 3 (Fit)||13
5177843|NCT01163760|12735662|P1|COMPLETED|Period 3 (Fit)||12
5177844|NCT01163760|12735659|P4|STARTED|Period 3 (Fit)||12
5177845|NCT01163760|12735660|P3|STARTED|Period 3 (Fit)||13
5177846|NCT01163760|12735661|P2|STARTED|Period 3 (Fit)||13
5177847|NCT01163760|12735662|P1|STARTED|Period 3 (Fit)||12
5177848|NCT01163760|12735659|P4|NOT COMPLETED|Period 2 (Follow-up)||0
5177849|NCT01163760|12735660|P3|NOT COMPLETED|Period 2 (Follow-up)||0
5177850|NCT01163760|12735661|P2|NOT COMPLETED|Period 2 (Follow-up)||0
5177851|NCT01163760|12735662|P1|NOT COMPLETED|Period 2 (Follow-up)||0
5177852|NCT01163760|12735659|P4|COMPLETED|Period 2 (Follow-up)||12
5177853|NCT01163760|12735660|P3|COMPLETED|Period 2 (Follow-up)||13
5177854|NCT01163760|12735661|P2|COMPLETED|Period 2 (Follow-up)||13
5177855|NCT01163760|12735662|P1|COMPLETED|Period 2 (Follow-up)||12
5177856|NCT01163760|12735659|P4|STARTED|Period 2 (Follow-up)||12
5177857|NCT01163760|12735660|P3|STARTED|Period 2 (Follow-up)||13
5177858|NCT01163760|12735661|P2|STARTED|Period 2 (Follow-up)||13
5177859|NCT01163760|12735662|P1|STARTED|Period 2 (Follow-up)||12
5177860|NCT01163760|12735659|P4|NOT COMPLETED|Period 1 (Fit)||0
5177861|NCT01163760|12735660|P3|NOT COMPLETED|Period 1 (Fit)||0
5177862|NCT01163760|12735661|P2|NOT COMPLETED|Period 1 (Fit)||0
5177863|NCT01163760|12735662|P1|NOT COMPLETED|Period 1 (Fit)||0
5177864|NCT01163760|12735659|P4|COMPLETED|Period 1 (Fit)||12
5177865|NCT01163760|12735660|P3|COMPLETED|Period 1 (Fit)||13
5177866|NCT01163760|12735661|P2|COMPLETED|Period 1 (Fit)||13
5177867|NCT01163760|12735662|P1|COMPLETED|Period 1 (Fit)||12
5177868|NCT01163760|12735659|P4|STARTED|Period 1 (Fit)||12
5177869|NCT01163760|12735660|P3|STARTED|Period 1 (Fit)||13
5177870|NCT01163760|12735661|P2|STARTED|Period 1 (Fit)||13
5177871|NCT01163760|12735662|P1|STARTED|Period 1 (Fit)||12
5177872|NCT01163747|12735676|P2|NOT COMPLETED|Overall Study||11
5177873|NCT01163747|12735677|P1|NOT COMPLETED|Overall Study||6
5177874|NCT01163747|12735676|P2|COMPLETED|Overall Study||49
5177875|NCT01163747|12735677|P1|COMPLETED|Overall Study||25
5177876|NCT01163747|12735676|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
5177877|NCT01163747|12735677|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
5177878|NCT01163747|12735676|P2|STARTED|Overall Study||60
5177879|NCT01163747|12735677|P1|STARTED|Overall Study||31
5177880|NCT01163721|12735697|P2|NOT COMPLETED|Overall Study||12
5177881|NCT01163721|12735698|P1|NOT COMPLETED|Overall Study||8
5177882|NCT01163721|12735697|P2|COMPLETED|Overall Study||29
5177883|NCT01163721|12735698|P1|COMPLETED|Overall Study||31
5177884|NCT01163721|12735697|P2|STARTED|Overall Study||41
5177885|NCT01163721|12735698|P1|STARTED|Overall Study||39
5177886|NCT01163656|12735710|P2|NOT COMPLETED|Overall Study||3
5177887|NCT01163656|12735711|P1|NOT COMPLETED|Overall Study||3
5177888|NCT01163656|12735710|P2|COMPLETED|Overall Study||30
5177889|NCT01163656|12735711|P1|COMPLETED|Overall Study||30
5177890|NCT01163656|12735710|P2|STARTED|Overall Study||33
5177891|NCT01163656|12735711|P1|STARTED|Overall Study||33
5177892|NCT01163617|12735717|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177893|NCT01163617|12735718|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177894|NCT01163617|12735719|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177895|NCT01163617|12735720|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177896|NCT01163617|12735721|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177897|NCT01163617|12735722|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177898|NCT01163617|12735723|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177899|NCT01163617|12735724|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
5177900|NCT01163617|12735717|P8|COMPLETED|Phase B (Injection Time), Week 4||20
5177901|NCT01163617|12735718|P7|COMPLETED|Phase B (Injection Time), Week 4||16
5177902|NCT01163617|12735719|P6|COMPLETED|Phase B (Injection Time), Week 4||27
5177903|NCT01163617|12735720|P5|COMPLETED|Phase B (Injection Time), Week 4||18
5177904|NCT01163617|12735721|P4|COMPLETED|Phase B (Injection Time), Week 4||0
5177905|NCT01163617|12735722|P3|COMPLETED|Phase B (Injection Time), Week 4||0
5177906|NCT01163617|12735723|P2|COMPLETED|Phase B (Injection Time), Week 4||0
5177907|NCT01163617|12735724|P1|COMPLETED|Phase B (Injection Time), Week 4||0
5177908|NCT01163617|12735717|P8|STARTED|Phase B (Injection Time), Week 4||20
5177909|NCT01163617|12735718|P7|STARTED|Phase B (Injection Time), Week 4||16
5177910|NCT01163617|12735719|P6|STARTED|Phase B (Injection Time), Week 4||27
5177911|NCT01163617|12735720|P5|STARTED|Phase B (Injection Time), Week 4||18
5177912|NCT01163617|12735721|P4|STARTED|Phase B (Injection Time), Week 4||0
5177913|NCT01163617|12735722|P3|STARTED|Phase B (Injection Time), Week 4||0
5177914|NCT01163617|12735723|P2|STARTED|Phase B (Injection Time), Week 4||0
5177915|NCT01163617|12735724|P1|STARTED|Phase B (Injection Time), Week 4||0
5177916|NCT01163617|12735717|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177917|NCT01163617|12735718|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177918|NCT01163617|12735719|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177919|NCT01163617|12735720|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177920|NCT01163617|12735721|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177921|NCT01163617|12735722|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
5177922|NCT01163617|12735723|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
5177923|NCT01163617|12735724|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177924|NCT01163617|12735717|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177925|NCT01163617|12735718|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177926|NCT01163617|12735719|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177927|NCT01163617|12735720|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
5177928|NCT01163617|12735721|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
5177929|NCT01163617|12735722|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
5177930|NCT01163617|12735723|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
5177931|NCT01163617|12735724|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
5177932|NCT01163617|12735717|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
5177933|NCT01163617|12735718|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
5177934|NCT01163617|12735719|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
5177935|NCT01163617|12735720|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
5177936|NCT01163617|12735721|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
5177937|NCT01163617|12735722|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
5177938|NCT01163617|12735723|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
5177939|NCT01163617|12735724|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
5177940|NCT01163604|12735746|P2|NOT COMPLETED|Overall Study||0
5177941|NCT01163604|12735747|P1|NOT COMPLETED|Overall Study||0
5177942|NCT01163604|12735746|P2|COMPLETED|Overall Study|August 2011|56
5177943|NCT01163604|12735747|P1|COMPLETED|Overall Study|August 2011|58
5177944|NCT01163604|12735746|P2|STARTED|Overall Study|August 2010|56
5177945|NCT01163604|12735747|P1|STARTED|Overall Study|August 2010|58
5177946|NCT01163474|12735753|P1|NOT COMPLETED|Overall Study||16
5177947|NCT01163474|12735753|P1|COMPLETED|Overall Study||24
5177948|NCT01163474|12735753|P1|STARTED|Overall Study||40
5177949|NCT01163461|12735760|P2|NOT COMPLETED|Overall Study||0
5177950|NCT01163461|12735761|P1|NOT COMPLETED|Overall Study||0
5177951|NCT01163461|12735760|P2|COMPLETED|Overall Study||14
5177952|NCT01163461|12735761|P1|COMPLETED|Overall Study||14
5177953|NCT01163461|12735760|P2|STARTED|Overall Study||14
5177954|NCT01163461|12735761|P1|STARTED|Overall Study||14
5177955|NCT01163318|12735765|P1|NOT COMPLETED|Overall Study||268
5177956|NCT01163318|12735765|P1|COMPLETED|Overall Study||284
5177957|NCT01163318|12735765|P1|STARTED|Overall Study||552
5177958|NCT01163292|12735774|P2|NOT COMPLETED|Overall Study||22
5177959|NCT01163292|12735775|P1|NOT COMPLETED|Overall Study||41
5177960|NCT01163292|12735774|P2|COMPLETED|Overall Study||92
5177961|NCT01163292|12735775|P1|COMPLETED|Overall Study||65
5177962|NCT01163292|12735774|P2|STARTED|Overall Study||114
5177963|NCT01163292|12735775|P1|STARTED|Overall Study||106
5177964|NCT01163279|12735791|P2|NOT COMPLETED|Overall Study||0
5177965|NCT01163279|12735792|P1|NOT COMPLETED|Overall Study||2
5177966|NCT01163279|12735791|P2|COMPLETED|Overall Study||9
5177967|NCT01163279|12735792|P1|COMPLETED|Overall Study||8
5177968|NCT01163279|12735791|P2|STARTED|Overall Study||9
5177969|NCT01163279|12735792|P1|STARTED|Overall Study||10
5177970|NCT01163266|12735821|P3|NOT COMPLETED|Overall Study||28
5177971|NCT01163266|12735822|P2|NOT COMPLETED|Overall Study||31
5177972|NCT01163266|12735823|P1|NOT COMPLETED|Overall Study||18
5177973|NCT01163266|12735821|P3|COMPLETED|Overall Study||122
5177974|NCT01163266|12735822|P2|COMPLETED|Overall Study||124
5177975|NCT01163266|12735823|P1|COMPLETED|Overall Study||139
5177976|NCT01163266|12735821|P3|Treated|Overall Study||150
5177977|NCT01163266|12735822|P2|Treated|Overall Study||155
5177978|NCT01163266|12735823|P1|Treated|Overall Study||157
5177979|NCT01163266|12735821|P3|STARTED|Overall Study||150
5177980|NCT01163266|12735822|P2|STARTED|Overall Study||155
5177981|NCT01163266|12735823|P1|STARTED|Overall Study||157
5177982|NCT01163253|12735848|P2|NOT COMPLETED|Overall Study||586
5177983|NCT01163253|12735849|P1|NOT COMPLETED|Overall Study||2281
5177984|NCT01163253|12735848|P2|COMPLETED|Overall Study||0
5177985|NCT01163253|12735849|P1|COMPLETED|Overall Study||0
5177986|NCT01163253|12735848|P2|STARTED|Overall Study||586
5177987|NCT01163253|12735849|P1|STARTED|Overall Study||2281
5177988|NCT01163214|12736011|P2|NOT COMPLETED|Overall Study||0
5177989|NCT01163214|12736012|P1|NOT COMPLETED|Overall Study||0
5177990|NCT01163214|12736011|P2|COMPLETED|Overall Study||81
5177991|NCT01163214|12736012|P1|COMPLETED|Overall Study||79
5177992|NCT01163214|12736011|P2|STARTED|Overall Study||81
5177993|NCT01163214|12736012|P1|STARTED|Overall Study||79
5177994|NCT01163162|12736028|P1|NOT COMPLETED|Overall Study||0
5177995|NCT01163162|12736028|P1|COMPLETED|Overall Study||16
5177996|NCT01163162|12736028|P1|STARTED|Overall Study||16
5177997|NCT01163149|12736037|P3|NOT COMPLETED|Extension Treatment Period||2
5177998|NCT01163149|12736038|P2|NOT COMPLETED|Extension Treatment Period||1
5177999|NCT01163149|12736039|P1|NOT COMPLETED|Extension Treatment Period||2
5178000|NCT01163149|12736037|P3|COMPLETED|Extension Treatment Period||4
5178001|NCT01163149|12736038|P2|COMPLETED|Extension Treatment Period||5
5178002|NCT01163149|12736039|P1|COMPLETED|Extension Treatment Period||5
5178003|NCT01163149|12736037|P3|STARTED|Extension Treatment Period||6
5178004|NCT01163149|12736038|P2|STARTED|Extension Treatment Period||6
5178005|NCT01163149|12736039|P1|STARTED|Extension Treatment Period||7
5178006|NCT01163149|12736037|P3|NOT COMPLETED|Primary Treatment Period||0
5178007|NCT01163149|12736038|P2|NOT COMPLETED|Primary Treatment Period||0
5178008|NCT01163149|12736039|P1|NOT COMPLETED|Primary Treatment Period||0
5178009|NCT01163149|12736037|P3|COMPLETED|Primary Treatment Period||6
5178010|NCT01163149|12736038|P2|COMPLETED|Primary Treatment Period||6
5178011|NCT01163149|12736039|P1|COMPLETED|Primary Treatment Period||7
5178012|NCT01163149|12736037|P3|STARTED|Primary Treatment Period||6
5178013|NCT01163149|12736038|P2|STARTED|Primary Treatment Period||6
5178014|NCT01163149|12736039|P1|STARTED|Primary Treatment Period||7
5178015|NCT01163097|12736084|P3|NOT COMPLETED|Overall Study||0
5178016|NCT01163097|12736085|P2|NOT COMPLETED|Overall Study||0
5178017|NCT01163097|12736086|P1|NOT COMPLETED|Overall Study||6
5178018|NCT01163097|12736084|P3|COMPLETED|Overall Study||8
5178019|NCT01163097|12736085|P2|COMPLETED|Overall Study||16
5178020|NCT01163097|12736086|P1|COMPLETED|Overall Study||14
5178021|NCT01163097|12736084|P3|STARTED|Overall Study||8
5178022|NCT01163097|12736085|P2|STARTED|Overall Study||16
5178023|NCT01163097|12736086|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
5178024|NCT01163084|12736138|P2|NOT COMPLETED|Overall Study||0
5178025|NCT01163084|12736139|P1|NOT COMPLETED|Overall Study||0
5178026|NCT01163084|12736138|P2|COMPLETED|Overall Study||5
5178027|NCT01163084|12736139|P1|COMPLETED|Overall Study||4
5178028|NCT01163084|12736138|P2|STARTED|Overall Study||5
5178029|NCT01163084|12736139|P1|STARTED|Overall Study||4
5178030|NCT01163032|12736148|P3|NOT COMPLETED|Open Label Extension Phase||16
5178031|NCT01163032|12736149|P2|NOT COMPLETED|Open Label Extension Phase||0
5178032|NCT01163032|12736150|P1|NOT COMPLETED|Open Label Extension Phase||0
5178033|NCT01163032|12736148|P3|COMPLETED|Open Label Extension Phase||39
5178034|NCT01163032|12736149|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
5178035|NCT01163032|12736150|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
5178036|NCT01163032|12736148|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
5178037|NCT01163032|12736149|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
5178038|NCT01163032|12736150|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
5178039|NCT01163032|12736148|P3|NOT COMPLETED|Randomization Phase||0
5178040|NCT01163032|12736149|P2|NOT COMPLETED|Randomization Phase||12
5178041|NCT01163032|12736150|P1|NOT COMPLETED|Randomization Phase||10
5178042|NCT01163032|12736148|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
5178043|NCT01163032|12736149|P2|COMPLETED|Randomization Phase||30
5178044|NCT01163032|12736150|P1|COMPLETED|Randomization Phase||32
5178045|NCT01163032|12736148|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
5178046|NCT01163032|12736149|P2|STARTED|Randomization Phase||42
5178047|NCT01163032|12736150|P1|STARTED|Randomization Phase||42
5178048|NCT01162863|12736183|P3|NOT COMPLETED|Overall Study||0
5178049|NCT01162863|12736184|P2|NOT COMPLETED|Overall Study||1
5178050|NCT01162863|12736185|P1|NOT COMPLETED|Overall Study||1
5178051|NCT01162863|12736183|P3|COMPLETED|Overall Study||17
5178052|NCT01162863|12736184|P2|COMPLETED|Overall Study||16
5178053|NCT01162863|12736185|P1|COMPLETED|Overall Study||17
5178054|NCT01162863|12736183|P3|STARTED|Overall Study||17
5178055|NCT01162863|12736184|P2|STARTED|Overall Study||17
5178056|NCT01162863|12736185|P1|STARTED|Overall Study||18
5178057|NCT01162733|12736201|P2|NOT COMPLETED|Overall Study||25
5178058|NCT01162733|12736202|P1|NOT COMPLETED|Overall Study||27
5178059|NCT01162733|12736201|P2|COMPLETED|Overall Study||25
5178060|NCT01162733|12736202|P1|COMPLETED|Overall Study||22
5178061|NCT01162733|12736201|P2|STARTED|Overall Study||50
5178062|NCT01162733|12736202|P1|STARTED|Overall Study||49
5178063|NCT01162551|12736210|P1|NOT COMPLETED|Overall Study||0
5178064|NCT01162551|12736210|P1|COMPLETED|Overall Study||3
5178065|NCT01162551|12736210|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
5178066|NCT01162499|12736215|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
5178067|NCT01162499|12736216|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
5178068|NCT01162499|12736215|P2|COMPLETED|Intervention 2 (4 Hours)||3
5178069|NCT01162499|12736216|P1|COMPLETED|Intervention 2 (4 Hours)||3
5178070|NCT01162499|12736215|P2|STARTED|Intervention 2 (4 Hours)||3
5178071|NCT01162499|12736216|P1|STARTED|Intervention 2 (4 Hours)||3
5178072|NCT01162499|12736215|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
5178073|NCT01162499|12736216|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
5178074|NCT01162499|12736215|P2|COMPLETED|Intervention 1 (4 Hours)||3
5178075|NCT01162499|12736216|P1|COMPLETED|Intervention 1 (4 Hours)||3
5178076|NCT01162499|12736215|P2|Received Intervention|Intervention 1 (4 Hours)||3
5178077|NCT01162499|12736216|P1|Received Intervention|Intervention 1 (4 Hours)||3
5178078|NCT01162499|12736215|P2|STARTED|Intervention 1 (4 Hours)||4
5178079|NCT01162499|12736216|P1|STARTED|Intervention 1 (4 Hours)||3
5178080|NCT01162486|12736241|P5|NOT COMPLETED|Overall Study||0
5178081|NCT01162486|12736242|P4|NOT COMPLETED|Overall Study||1
5178082|NCT01162486|12736243|P3|NOT COMPLETED|Overall Study||1
5178083|NCT01162486|12736244|P2|NOT COMPLETED|Overall Study||0
5178084|NCT01162486|12736245|P1|NOT COMPLETED|Overall Study||2
5178085|NCT01162486|12736241|P5|COMPLETED|Overall Study||6
5178086|NCT01162486|12736242|P4|COMPLETED|Overall Study||6
5178087|NCT01162486|12736243|P3|COMPLETED|Overall Study||5
5178088|NCT01162486|12736244|P2|COMPLETED|Overall Study||6
5178089|NCT01162486|12736245|P1|COMPLETED|Overall Study||6
5178090|NCT01162486|12736241|P5|Took at Least One Dose Study Drug|Overall Study||6
5178091|NCT01162486|12736242|P4|Took at Least One Dose Study Drug|Overall Study||7
5178092|NCT01162486|12736243|P3|Took at Least One Dose Study Drug|Overall Study||6
5178093|NCT01162486|12736244|P2|Took at Least One Dose Study Drug|Overall Study||6
5178094|NCT01162486|12736245|P1|Took at Least One Dose Study Drug|Overall Study||8
5178095|NCT01162486|12736241|P5|STARTED|Overall Study||6
5178096|NCT01162486|12736242|P4|STARTED|Overall Study||7
5178097|NCT01162486|12736243|P3|STARTED|Overall Study||6
5178098|NCT01162486|12736244|P2|STARTED|Overall Study||6
5178099|NCT01162486|12736245|P1|STARTED|Overall Study||8
5178100|NCT01162473|12736278|P2|NOT COMPLETED|Overall Study||5
5178101|NCT01162473|12736279|P1|NOT COMPLETED|Overall Study||2
5178102|NCT01162473|12736278|P2|COMPLETED|Overall Study||12
5178103|NCT01162473|12736279|P1|COMPLETED|Overall Study||6
5178104|NCT01162473|12736278|P2|STARTED|Overall Study||17
5178105|NCT01162473|12736279|P1|STARTED|Overall Study||8
5178106|NCT01162421|12736287|P2|NOT COMPLETED|Overall Study||13
5178107|NCT01162421|12736288|P1|NOT COMPLETED|Overall Study||8
5178108|NCT01162421|12736287|P2|COMPLETED|Overall Study||27
5178109|NCT01162421|12736288|P1|COMPLETED|Overall Study||29
5178110|NCT01162421|12736287|P2|STARTED|Overall Study||40
5178111|NCT01162421|12736288|P1|STARTED|Overall Study||37
5178112|NCT01162382|12736366|P1|NOT COMPLETED|Overall Study||0
5178113|NCT01162382|12736366|P1|COMPLETED|Overall Study||0
5178114|NCT01162382|12736366|P1|STARTED|Overall Study||0
5178115|NCT01162343|12736371|P1|NOT COMPLETED|Overall Study||92
5178116|NCT01162343|12736371|P1|COMPLETED|Overall Study||406
5178117|NCT01162343|12736371|P1|STARTED|Overall Study||498
5178118|NCT01162317|12736377|P2|NOT COMPLETED|Overall Study||2
5178119|NCT01162317|12736378|P1|NOT COMPLETED|Overall Study||3
5178120|NCT01162317|12736377|P2|COMPLETED|Overall Study||28
5178121|NCT01162317|12736378|P1|COMPLETED|Overall Study||27
5178122|NCT01162317|12736377|P2|STARTED|Overall Study||30
5178123|NCT01162317|12736378|P1|STARTED|Overall Study||30
5178124|NCT01162304|12736386|P1|NOT COMPLETED|Overall Study||11
5178125|NCT01162304|12736386|P1|COMPLETED|Overall Study||7
5178126|NCT01162304|12736386|P1|STARTED|Overall Study||18
5178127|NCT01162135|12736400|P1|NOT COMPLETED|Overall Study||3
5178128|NCT01162135|12736400|P1|COMPLETED|Overall Study||13
5178129|NCT01162135|12736400|P1|STARTED|Overall Study||16
5178130|NCT01162122|12736406|P2|NOT COMPLETED|Overall Study||196
5178131|NCT01162122|12736407|P1|NOT COMPLETED|Overall Study||191
5178132|NCT01162122|12736406|P2|COMPLETED|Overall Study||3356
5178133|NCT01162122|12736407|P1|COMPLETED|Overall Study||3361
5178134|NCT01162122|12736406|P2|Vaccinated|Overall Study||3541
5178135|NCT01162122|12736407|P1|Vaccinated|Overall Study||3541
5178136|NCT01162122|12736406|P2|STARTED|Overall Study||3552
5178137|NCT01162122|12736407|P1|STARTED|Overall Study||3552
5178138|NCT01162096|12736464|P1|NOT COMPLETED|Overall Study||0
5178139|NCT01162096|12736464|P1|COMPLETED|Overall Study||34
5178140|NCT01162096|12736464|P1|STARTED|Overall Study||34
5178141|NCT01162005|12736472|P2|NOT COMPLETED|Overall Study||0
5178142|NCT01162005|12736473|P1|NOT COMPLETED|Overall Study||0
5178143|NCT01162005|12736472|P2|COMPLETED|Overall Study||33
5178144|NCT01162005|12736473|P1|COMPLETED|Overall Study||44
5178145|NCT01162005|12736472|P2|STARTED|Overall Study||33
5178146|NCT01162005|12736473|P1|STARTED|Overall Study||44
5178147|NCT01161862|12736483|P2|NOT COMPLETED|Overall Study||0
5178148|NCT01161862|12736484|P1|NOT COMPLETED|Overall Study||0
5178149|NCT01161862|12736483|P2|COMPLETED|Overall Study||12
5178150|NCT01161862|12736484|P1|COMPLETED|Overall Study||12
5178151|NCT01161862|12736483|P2|STARTED|Overall Study||12
5178152|NCT01161862|12736484|P1|STARTED|Overall Study||12
5178153|NCT01161771|12736504|P1|NOT COMPLETED|Overall Study||0
5178154|NCT01161771|12736504|P1|COMPLETED|Overall Study||32
5178155|NCT01161771|12736504|P1|STARTED|Overall Study||32
5178156|NCT01161628|12736513|P1|NOT COMPLETED|Overall Study||8
5178157|NCT01161628|12736513|P1|COMPLETED|Overall Study||17
5178158|NCT01161628|12736513|P1|STARTED|Overall Study||25
5178159|NCT01161563|12736527|P2|NOT COMPLETED|Overall Study||6
5178160|NCT01161563|12736528|P1|NOT COMPLETED|Overall Study||5
5178161|NCT01161563|12736527|P2|COMPLETED|Overall Study||49
5178162|NCT01161563|12736528|P1|COMPLETED|Overall Study||58
5178163|NCT01161563|12736527|P2|STARTED|Overall Study||55
5178164|NCT01161563|12736528|P1|STARTED|Overall Study||63
5178165|NCT01161537|12736536|P1|NOT COMPLETED|Part B||2
5178166|NCT01161537|12736536|P1|COMPLETED|Part B||7
5178167|NCT01161537|12736536|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
5178168|NCT01161537|12736536|P1|NOT COMPLETED|Part A||0
5178169|NCT01161537|12736536|P1|COMPLETED|Part A||8
5178170|NCT01161537|12736536|P1|STARTED|Part A||8
5178171|NCT01161524|12736554|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
5178172|NCT01161524|12736555|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
5178173|NCT01161524|12736556|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
5178174|NCT01161524|12736554|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
5178175|NCT01161524|12736555|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
5178176|NCT01161524|12736556|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
5178177|NCT01161524|12736554|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
5178178|NCT01161524|12736555|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
5178179|NCT01161524|12736556|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
5178180|NCT01161524|12736554|P3|NOT COMPLETED|Core Study (23 Weeks)||0
5178181|NCT01161524|12736555|P2|NOT COMPLETED|Core Study (23 Weeks)||5
5178182|NCT01161524|12736556|P1|NOT COMPLETED|Core Study (23 Weeks)||9
5178183|NCT01161524|12736554|P3|COMPLETED|Core Study (23 Weeks)||0
5178184|NCT01161524|12736555|P2|COMPLETED|Core Study (23 Weeks)||43
5178185|NCT01161524|12736556|P1|COMPLETED|Core Study (23 Weeks)||76
5178186|NCT01161524|12736554|P3|STARTED|Core Study (23 Weeks)||0
5178187|NCT01161524|12736555|P2|STARTED|Core Study (23 Weeks)||48
5178188|NCT01161524|12736556|P1|STARTED|Core Study (23 Weeks)||85
5178189|NCT01161498|12736595|P2|NOT COMPLETED|Overall Study||1
5178190|NCT01161498|12736596|P1|NOT COMPLETED|Overall Study||0
5178191|NCT01161498|12736595|P2|COMPLETED|Overall Study||1
5178192|NCT01161498|12736596|P1|COMPLETED|Overall Study||3
5178193|NCT01161498|12736595|P2|STARTED|Overall Study||2
5178194|NCT01161498|12736596|P1|STARTED|Overall Study||3
5178195|NCT01161472|12736620|P4|NOT COMPLETED|Fourth Intervention Period||0
5178196|NCT01161472|12736621|P3|NOT COMPLETED|Fourth Intervention Period||0
5178197|NCT01161472|12736622|P2|NOT COMPLETED|Fourth Intervention Period||0
5178198|NCT01161472|12736623|P1|NOT COMPLETED|Fourth Intervention Period||0
5178199|NCT01161472|12736620|P4|COMPLETED|Fourth Intervention Period||5
5178200|NCT01161472|12736621|P3|COMPLETED|Fourth Intervention Period||5
5178201|NCT01161472|12736622|P2|COMPLETED|Fourth Intervention Period||5
5178202|NCT01161472|12736623|P1|COMPLETED|Fourth Intervention Period||4
5178203|NCT01161472|12736620|P4|STARTED|Fourth Intervention Period||5
5178204|NCT01161472|12736621|P3|STARTED|Fourth Intervention Period||5
5178205|NCT01161472|12736622|P2|STARTED|Fourth Intervention Period||5
5178206|NCT01161472|12736623|P1|STARTED|Fourth Intervention Period||4
5178207|NCT01161472|12736620|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178208|NCT01161472|12736621|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178209|NCT01161472|12736622|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178210|NCT01161472|12736623|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178211|NCT01161472|12736620|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178212|NCT01161472|12736621|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178213|NCT01161472|12736622|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178214|NCT01161472|12736623|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
5178215|NCT01161472|12736620|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178216|NCT01161472|12736621|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178217|NCT01161472|12736622|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178218|NCT01161472|12736623|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
5178219|NCT01161472|12736620|P4|NOT COMPLETED|Third Intervention Period||0
5178220|NCT01161472|12736621|P3|NOT COMPLETED|Third Intervention Period||0
5178221|NCT01161472|12736622|P2|NOT COMPLETED|Third Intervention Period||0
5178222|NCT01161472|12736623|P1|NOT COMPLETED|Third Intervention Period||0
5178223|NCT01161472|12736620|P4|COMPLETED|Third Intervention Period||5
5178224|NCT01161472|12736621|P3|COMPLETED|Third Intervention Period||5
5178225|NCT01161472|12736622|P2|COMPLETED|Third Intervention Period||5
5178226|NCT01161472|12736623|P1|COMPLETED|Third Intervention Period||4
5178227|NCT01161472|12736620|P4|STARTED|Third Intervention Period||5
5178228|NCT01161472|12736621|P3|STARTED|Third Intervention Period||5
5178229|NCT01161472|12736622|P2|STARTED|Third Intervention Period||5
5178230|NCT01161472|12736623|P1|STARTED|Third Intervention Period||4
5178231|NCT01161472|12736620|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178232|NCT01161472|12736621|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178233|NCT01161472|12736622|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178234|NCT01161472|12736623|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
5178235|NCT01161472|12736620|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178236|NCT01161472|12736621|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178237|NCT01161472|12736622|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178238|NCT01161472|12736623|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
5178239|NCT01161472|12736620|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178240|NCT01161472|12736621|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178241|NCT01161472|12736622|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178242|NCT01161472|12736623|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178243|NCT01161472|12736620|P4|NOT COMPLETED|Second Intervention Period||0
5178244|NCT01161472|12736621|P3|NOT COMPLETED|Second Intervention Period||0
5178245|NCT01161472|12736622|P2|NOT COMPLETED|Second Intervention Period||0
5178246|NCT01161472|12736623|P1|NOT COMPLETED|Second Intervention Period||0
5178247|NCT01161472|12736620|P4|COMPLETED|Second Intervention Period||5
5178248|NCT01161472|12736621|P3|COMPLETED|Second Intervention Period||5
5178249|NCT01161472|12736622|P2|COMPLETED|Second Intervention Period||5
5178250|NCT01161472|12736623|P1|COMPLETED|Second Intervention Period||5
5178251|NCT01161472|12736620|P4|STARTED|Second Intervention Period||5
5178252|NCT01161472|12736621|P3|STARTED|Second Intervention Period||5
5178253|NCT01161472|12736622|P2|STARTED|Second Intervention Period||5
5178254|NCT01161472|12736623|P1|STARTED|Second Intervention Period||5
5178255|NCT01161472|12736620|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178256|NCT01161472|12736621|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178257|NCT01161472|12736622|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178258|NCT01161472|12736623|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
5178259|NCT01161472|12736620|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178260|NCT01161472|12736621|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178261|NCT01161472|12736622|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178262|NCT01161472|12736623|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
5178263|NCT01161472|12736620|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178264|NCT01161472|12736621|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178265|NCT01161472|12736622|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178266|NCT01161472|12736623|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
5178267|NCT01161472|12736620|P4|NOT COMPLETED|First Intervention Period||0
5178268|NCT01161472|12736621|P3|NOT COMPLETED|First Intervention Period||0
5178269|NCT01161472|12736622|P2|NOT COMPLETED|First Intervention Period||0
5178270|NCT01161472|12736623|P1|NOT COMPLETED|First Intervention Period||0
5178271|NCT01161472|12736620|P4|COMPLETED|First Intervention Period||5
5178272|NCT01161472|12736621|P3|COMPLETED|First Intervention Period||5
5178273|NCT01161472|12736622|P2|COMPLETED|First Intervention Period||5
5178274|NCT01161472|12736623|P1|COMPLETED|First Intervention Period||5
5178275|NCT01161472|12736620|P4|Treated|First Intervention Period||5
5178276|NCT01161472|12736621|P3|Treated|First Intervention Period||5
5178277|NCT01161472|12736622|P2|Treated|First Intervention Period||5
5178278|NCT01161472|12736623|P1|Treated|First Intervention Period||5
5178279|NCT01161472|12736620|P4|STARTED|First Intervention Period||5
5178280|NCT01161472|12736621|P3|STARTED|First Intervention Period||5
5178281|NCT01161472|12736622|P2|STARTED|First Intervention Period||5
5178282|NCT01161472|12736623|P1|STARTED|First Intervention Period||5
5178283|NCT01161446|12736679|P2|NOT COMPLETED|Overall Study||15
5178284|NCT01161446|12736680|P1|NOT COMPLETED|Overall Study||18
5178285|NCT01161446|12736679|P2|COMPLETED|Overall Study||99
5178286|NCT01161446|12736680|P1|COMPLETED|Overall Study||98
5178287|NCT01161446|12736679|P2|STARTED|Overall Study||114
5178288|NCT01161446|12736680|P1|STARTED|Overall Study||116
5178289|NCT01161420|12736692|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
5178290|NCT01161420|12736692|P1|COMPLETED|Withdrawal Study - Withdrawal||23
5178291|NCT01161420|12736692|P1|STARTED|Withdrawal Study - Withdrawal||23
5178292|NCT01161420|12736692|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
5178293|NCT01161420|12736692|P1|COMPLETED|Withdrawal Study - Maintenance||23
5178294|NCT01161420|12736692|P1|STARTED|Withdrawal Study - Maintenance||23
5178295|NCT01161420|12736692|P1|NOT COMPLETED|Inspire Therapy||2
5178296|NCT01161420|12736692|P1|COMPLETED|Inspire Therapy||124
5178297|NCT01161420|12736692|P1|STARTED|Inspire Therapy||126
5178298|NCT01161407|12736706|P2|NOT COMPLETED|Overall Study||1
5178299|NCT01161407|12736707|P1|NOT COMPLETED|Overall Study||3
5178300|NCT01161407|12736706|P2|COMPLETED|Overall Study||5
5178301|NCT01161407|12736707|P1|COMPLETED|Overall Study||3
5178302|NCT01161407|12736706|P2|STARTED|Overall Study||6
5178303|NCT01161407|12736707|P1|STARTED|Overall Study||6
5178304|NCT01161329|12736719|P2|NOT COMPLETED|Overall Study||10
5178305|NCT01161329|12736720|P1|NOT COMPLETED|Overall Study||4
5178306|NCT01161329|12736719|P2|COMPLETED|Overall Study||24
5178307|NCT01161329|12736720|P1|COMPLETED|Overall Study||29
5178308|NCT01161329|12736719|P2|STARTED|Overall Study||34
5178309|NCT01161329|12736720|P1|STARTED|Overall Study||33
5178310|NCT01161225|12736731|P3|NOT COMPLETED|Overall Study||2
5178311|NCT01161225|12736732|P2|NOT COMPLETED|Overall Study||9
5178312|NCT01161225|12736733|P1|NOT COMPLETED|Overall Study||14
5178313|NCT01161225|12736731|P3|COMPLETED|Overall Study||12
5178314|NCT01161225|12736732|P2|COMPLETED|Overall Study||44
5178315|NCT01161225|12736733|P1|COMPLETED|Overall Study||45
5178316|NCT01161225|12736731|P3|STARTED|Overall Study||14
5178317|NCT01161225|12736732|P2|STARTED|Overall Study||53
5178318|NCT01161225|12736733|P1|STARTED|Overall Study||59
5178319|NCT01161173|12736762|P1|NOT COMPLETED|Overall Study||347
5178320|NCT01161173|12736762|P1|COMPLETED|Overall Study||0
5178321|NCT01161173|12736762|P1|STARTED|Overall Study||347
5178322|NCT01161160|12736774|P3|NOT COMPLETED|Overall Study||0
5178323|NCT01161160|12736775|P2|NOT COMPLETED|Overall Study||0
5178324|NCT01161160|12736776|P1|NOT COMPLETED|Overall Study||0
5178325|NCT01161160|12736774|P3|COMPLETED|Overall Study||58
5178326|NCT01161160|12736775|P2|COMPLETED|Overall Study||75
5178327|NCT01161160|12736776|P1|COMPLETED|Overall Study||76
5178328|NCT01161160|12736774|P3|STARTED|Overall Study||58
5178329|NCT01161160|12736775|P2|STARTED|Overall Study||75
5178330|NCT01161160|12736776|P1|STARTED|Overall Study||76
5178331|NCT01161121|12736847|P1|NOT COMPLETED|Overall Study||0
5178332|NCT01161121|12736847|P1|COMPLETED|Overall Study||46
5178333|NCT01161121|12736847|P1|STARTED|Overall Study||46
5178334|NCT01160848|12736859|P2|NOT COMPLETED|Overall Study||0
5178335|NCT01160848|12736860|P1|NOT COMPLETED|Overall Study||0
5178336|NCT01160848|12736859|P2|COMPLETED|Overall Study||8
5178337|NCT01160848|12736860|P1|COMPLETED|Overall Study||12
5178338|NCT01160848|12736859|P2|STARTED|Overall Study||8
5178339|NCT01160848|12736860|P1|STARTED|Overall Study||12
5178340|NCT01160822|12736889|P7|NOT COMPLETED|Overall Study||9
5178341|NCT01160822|12736890|P6|NOT COMPLETED|Overall Study||7
5178342|NCT01160822|12736891|P5|NOT COMPLETED|Overall Study||9
5178343|NCT01160822|12736892|P4|NOT COMPLETED|Overall Study||0
5178344|NCT01160822|12736893|P3|NOT COMPLETED|Overall Study||0
5178345|NCT01160822|12736894|P2|NOT COMPLETED|Overall Study||0
5178346|NCT01160822|12736895|P1|NOT COMPLETED|Overall Study||0
5178347|NCT01160822|12736889|P7|COMPLETED|Overall Study||44
5178348|NCT01160822|12736890|P6|COMPLETED|Overall Study||40
5178349|NCT01160822|12736891|P5|COMPLETED|Overall Study||36
5178350|NCT01160822|12736892|P4|COMPLETED|Overall Study||5
5178351|NCT01160822|12736893|P3|COMPLETED|Overall Study||6
5178352|NCT01160822|12736894|P2|COMPLETED|Overall Study||7
5178353|NCT01160822|12736895|P1|COMPLETED|Overall Study||6
5178354|NCT01160822|12736889|P7|STARTED|Overall Study||53
5178355|NCT01160822|12736890|P6|STARTED|Overall Study||47
5178356|NCT01160822|12736891|P5|STARTED|Overall Study||45
5178357|NCT01160822|12736892|P4|STARTED|Overall Study||5
5178358|NCT01160822|12736893|P3|STARTED|Overall Study||6
5178359|NCT01160822|12736894|P2|STARTED|Overall Study||7
5178360|NCT01160822|12736895|P1|STARTED|Overall Study||6
5178361|NCT01160770|12736984|P1|NOT COMPLETED|Overall Study||79
5178362|NCT01160770|12736984|P1|COMPLETED|Overall Study||188
5178363|NCT01160770|12736984|P1|STARTED|Overall Study||267
5178364|NCT01160744|12736997|P4|NOT COMPLETED|Overall Study||4
5178365|NCT01160744|12736998|P3|NOT COMPLETED|Overall Study||7
5178366|NCT01160744|12736999|P2|NOT COMPLETED|Overall Study||5
5178367|NCT01160744|12737000|P1|NOT COMPLETED|Overall Study||11
5178368|NCT01160744|12736997|P4|COMPLETED|Overall Study||67
5178369|NCT01160744|12736998|P3|COMPLETED|Overall Study||62
5178370|NCT01160744|12736999|P2|COMPLETED|Overall Study||64
5178371|NCT01160744|12737000|P1|COMPLETED|Overall Study||60
5178372|NCT01160744|12736997|P4|Received Study Drug|Overall Study||71
5178373|NCT01160744|12736998|P3|Received Study Drug|Overall Study||63
5178374|NCT01160744|12736999|P2|Received Study Drug|Overall Study||67
5178375|NCT01160744|12737000|P1|Received Study Drug|Overall Study||69
5178376|NCT01160744|12736997|P4|STARTED|Overall Study||71
5178377|NCT01160744|12736998|P3|STARTED|Overall Study||69
5178378|NCT01160744|12736999|P2|STARTED|Overall Study||69
5178379|NCT01160744|12737000|P1|STARTED|Overall Study||71
5178380|NCT01160640|12737036|P2|NOT COMPLETED|Overall Study||6
5178381|NCT01160640|12737037|P1|NOT COMPLETED|Overall Study||4
5178382|NCT01160640|12737036|P2|COMPLETED|Overall Study||110
5178383|NCT01160640|12737037|P1|COMPLETED|Overall Study||113
5178384|NCT01160640|12737036|P2|STARTED|Overall Study||116
5178385|NCT01160640|12737037|P1|STARTED|Overall Study||117
5178386|NCT01160614|12737053|P2|NOT COMPLETED|Overall Study||2
5178387|NCT01160614|12737054|P1|NOT COMPLETED|Overall Study||0
5178388|NCT01160614|12737053|P2|COMPLETED|Overall Study||23
5178389|NCT01160614|12737054|P1|COMPLETED|Overall Study||5
5178390|NCT01160614|12737053|P2|STARTED|Overall Study||25
5178391|NCT01160614|12737054|P1|STARTED|Overall Study||5
5178392|NCT01160484|12737102|P1|NOT COMPLETED|Overall Study||18
5178393|NCT01160484|12737102|P1|COMPLETED|Overall Study||22
5178394|NCT01160484|12737102|P1|STARTED|Overall Study||40
5178395|NCT01160458|12737112|P1|NOT COMPLETED|Overall Study||0
5178396|NCT01160458|12737112|P1|COMPLETED|Overall Study||20
5178397|NCT01160458|12737112|P1|STARTED|Overall Study||20
5178398|NCT01160445|12737122|P2|NOT COMPLETED|Overall Study||0
5178399|NCT01160445|12737123|P1|NOT COMPLETED|Overall Study||0
5178400|NCT01160445|12737122|P2|COMPLETED|Overall Study||2
5178401|NCT01160445|12737123|P1|COMPLETED|Overall Study||7
5178402|NCT01160445|12737122|P2|STARTED|Overall Study||2
5178403|NCT01160445|12737123|P1|STARTED|Overall Study||7
5178404|NCT01160380|12737133|P2|NOT COMPLETED|Overall Study||5
5178405|NCT01160380|12737134|P1|NOT COMPLETED|Overall Study||8
5178406|NCT01160380|12737133|P2|COMPLETED|Overall Study||20
5178407|NCT01160380|12737134|P1|COMPLETED|Overall Study||17
5178408|NCT01160380|12737133|P2|STARTED|Overall Study||25
5178409|NCT01160380|12737134|P1|STARTED|Overall Study||25
5178410|NCT01160354|12737155|P3|NOT COMPLETED|Overall Study||1
5178411|NCT01160354|12737156|P2|NOT COMPLETED|Overall Study||1
5178412|NCT01160354|12737157|P1|NOT COMPLETED|Overall Study||0
5178413|NCT01160354|12737155|P3|COMPLETED|Overall Study||14
5178414|NCT01160354|12737156|P2|COMPLETED|Overall Study||3
5178415|NCT01160354|12737157|P1|COMPLETED|Overall Study||3
5178416|NCT01160354|12737155|P3|STARTED|Overall Study||15
5178417|NCT01160354|12737156|P2|STARTED|Overall Study||4
5178418|NCT01160354|12737157|P1|STARTED|Overall Study||3
5178419|NCT01160289|12737176|P6|NOT COMPLETED|Post-Randomization Period||14
5178420|NCT01160289|12737177|P5|NOT COMPLETED|Post-Randomization Period||9
5178421|NCT01160289|12737178|P4|NOT COMPLETED|Post-Randomization Period||21
5178422|NCT01160289|12737179|P3|NOT COMPLETED|Post-Randomization Period||24
5178423|NCT01160289|12737180|P2|NOT COMPLETED|Post-Randomization Period||20
5178424|NCT01160289|12737181|P1|NOT COMPLETED|Post-Randomization Period||0
5178425|NCT01160289|12737176|P6|COMPLETED|Post-Randomization Period||73
5178426|NCT01160289|12737177|P5|COMPLETED|Post-Randomization Period||80
5178427|NCT01160289|12737178|P4|COMPLETED|Post-Randomization Period||31
5178428|NCT01160289|12737179|P3|COMPLETED|Post-Randomization Period||73
5178429|NCT01160289|12737180|P2|COMPLETED|Post-Randomization Period||65
5178430|NCT01160289|12737181|P1|COMPLETED|Post-Randomization Period||0
5178431|NCT01160289|12737176|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
5178432|NCT01160289|12737177|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
5178433|NCT01160289|12737178|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
5178434|NCT01160289|12737179|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
5178435|NCT01160289|12737180|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
5178436|NCT01160289|12737181|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
5178437|NCT01160289|12737176|P6|STARTED|Post-Randomization Period||87
5178438|NCT01160289|12737177|P5|STARTED|Post-Randomization Period||89
5178439|NCT01160289|12737178|P4|STARTED|Post-Randomization Period||52
5178440|NCT01160289|12737179|P3|STARTED|Post-Randomization Period||97
5178441|NCT01160289|12737180|P2|STARTED|Post-Randomization Period||85
5178442|NCT01160289|12737181|P1|STARTED|Post-Randomization Period||0
5178443|NCT01160289|12737176|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
5178444|NCT01160289|12737177|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
5178445|NCT01160289|12737178|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
5178446|NCT01160289|12737179|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
5178447|NCT01160289|12737180|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
5178448|NCT01160289|12737181|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
5178449|NCT01160289|12737176|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
5178450|NCT01160289|12737177|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
5178451|NCT01160289|12737178|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
5178452|NCT01160289|12737179|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
5178453|NCT01160289|12737180|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
5178454|NCT01160289|12737181|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
5178455|NCT01160289|12737176|P6|STARTED|Screening, Washout, and Lead-In Period||0
5178456|NCT01160289|12737177|P5|STARTED|Screening, Washout, and Lead-In Period||0
5178457|NCT01160289|12737178|P4|STARTED|Screening, Washout, and Lead-In Period||0
5178458|NCT01160289|12737179|P3|STARTED|Screening, Washout, and Lead-In Period||0
5178459|NCT01160289|12737180|P2|STARTED|Screening, Washout, and Lead-In Period||0
5178460|NCT01160289|12737181|P1|STARTED|Screening, Washout, and Lead-In Period||894
5178461|NCT01160237|12737242|P3|NOT COMPLETED|Overall Study||0
5178462|NCT01160237|12737243|P2|NOT COMPLETED|Overall Study||0
5178463|NCT01160237|12737244|P1|NOT COMPLETED|Overall Study||0
5178464|NCT01160237|12737242|P3|COMPLETED|Overall Study||0
5178465|NCT01160237|12737243|P2|COMPLETED|Overall Study||3
5178466|NCT01160237|12737244|P1|COMPLETED|Overall Study||4
5178467|NCT01160237|12737242|P3|STARTED|Overall Study||0
5178468|NCT01160237|12737243|P2|STARTED|Overall Study||3
5178469|NCT01160237|12737244|P1|STARTED|Overall Study||4
5178470|NCT01160211|12737270|P3|NOT COMPLETED|Overall Study||87
5178471|NCT01160211|12737271|P2|NOT COMPLETED|Overall Study||87
5178472|NCT01160211|12737272|P1|NOT COMPLETED|Overall Study||99
5178473|NCT01160211|12737270|P3|COMPLETED|Overall Study||30
5178474|NCT01160211|12737271|P2|COMPLETED|Overall Study||31
5178475|NCT01160211|12737272|P1|COMPLETED|Overall Study||21
5178476|NCT01160211|12737270|P3|Ongoing|Overall Study||79
5178477|NCT01160211|12737271|P2|Ongoing|Overall Study||75
5178478|NCT01160211|12737272|P1|Ongoing|Overall Study||90
5178479|NCT01160211|12737270|P3|STARTED|Overall Study||117
5178480|NCT01160211|12737271|P2|STARTED|Overall Study||118
5178481|NCT01160211|12737272|P1|STARTED|Overall Study||120
5178482|NCT01160198|12737305|P3|NOT COMPLETED|Overall Study||1
5178483|NCT01160198|12737306|P2|NOT COMPLETED|Overall Study||3
5178484|NCT01160198|12737307|P1|NOT COMPLETED|Overall Study||2
5178485|NCT01160198|12737305|P3|COMPLETED|Overall Study||89
5178486|NCT01160198|12737306|P2|COMPLETED|Overall Study||88
5178487|NCT01160198|12737307|P1|COMPLETED|Overall Study||87
5178488|NCT01160198|12737305|P3|STARTED|Overall Study||90
5178489|NCT01160198|12737306|P2|STARTED|Overall Study||91
5178490|NCT01160198|12737307|P1|STARTED|Overall Study||89
5178491|NCT01159938|12737329|P5|NOT COMPLETED|Second Study Period||0
5178492|NCT01159938|12737330|P4|NOT COMPLETED|Second Study Period||0
5178493|NCT01159938|12737331|P3|NOT COMPLETED|Second Study Period||0
5178494|NCT01159938|12737332|P2|NOT COMPLETED|Second Study Period||0
5178495|NCT01159938|12737333|P1|NOT COMPLETED|Second Study Period||0
5178496|NCT01159938|12737329|P5|COMPLETED|Second Study Period||12
5178497|NCT01159938|12737330|P4|COMPLETED|Second Study Period||12
5178498|NCT01159938|12737331|P3|COMPLETED|Second Study Period||10
5178499|NCT01159938|12737332|P2|COMPLETED|Second Study Period||11
5178500|NCT01159938|12737333|P1|COMPLETED|Second Study Period||0
5178501|NCT01159938|12737329|P5|STARTED|Second Study Period||12
5178502|NCT01159938|12737330|P4|STARTED|Second Study Period||12
5178503|NCT01159938|12737331|P3|STARTED|Second Study Period||10
5178504|NCT01159938|12737332|P2|STARTED|Second Study Period||11
5178505|NCT01159938|12737333|P1|STARTED|Second Study Period||0
5178506|NCT01159938|12737329|P5|NOT COMPLETED|First Study Period||0
5178507|NCT01159938|12737330|P4|NOT COMPLETED|First Study Period||0
5178508|NCT01159938|12737331|P3|NOT COMPLETED|First Study Period||1
5178509|NCT01159938|12737332|P2|NOT COMPLETED|First Study Period||0
5178510|NCT01159938|12737333|P1|NOT COMPLETED|First Study Period||0
5178511|NCT01159938|12737329|P5|COMPLETED|First Study Period||12
5178512|NCT01159938|12737330|P4|COMPLETED|First Study Period||12
5178513|NCT01159938|12737331|P3|COMPLETED|First Study Period||10
5178514|NCT01159938|12737332|P2|COMPLETED|First Study Period||11
5178515|NCT01159938|12737333|P1|COMPLETED|First Study Period||26
5178516|NCT01159938|12737329|P5|Safety and Efficacy Analysis Population|First Study Period||12
5178517|NCT01159938|12737330|P4|Safety and Efficacy Analysis Population|First Study Period||12
5178518|NCT01159938|12737331|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
5178519|NCT01159938|12737332|P2|Safety and Efficacy Analysis Population|First Study Period||11
5178520|NCT01159938|12737333|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
5178521|NCT01159938|12737329|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
5178522|NCT01159938|12737330|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
5178523|NCT01159938|12737331|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
5178524|NCT01159938|12737332|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
5178525|NCT01159938|12737333|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
5178526|NCT01159938|12737329|P5|STARTED|First Study Period||12
5178527|NCT01159938|12737330|P4|STARTED|First Study Period||12
5178528|NCT01159938|12737331|P3|STARTED|First Study Period||11
5178529|NCT01159938|12737332|P2|STARTED|First Study Period||11
5178530|NCT01159938|12737333|P1|STARTED|First Study Period||26
5178531|NCT01159912|12737396|P3|NOT COMPLETED|Overall Study||26
5178532|NCT01159912|12737397|P2|NOT COMPLETED|Overall Study||22
5178533|NCT01159912|12737398|P1|NOT COMPLETED|Overall Study||40
5178534|NCT01159912|12737396|P3|COMPLETED|Overall Study||88
5178535|NCT01159912|12737397|P2|COMPLETED|Overall Study||92
5178536|NCT01159912|12737398|P1|COMPLETED|Overall Study||75
5178537|NCT01159912|12737396|P3|STARTED|Overall Study||114
5178538|NCT01159912|12737397|P2|STARTED|Overall Study||114
5178539|NCT01159912|12737398|P1|STARTED|Overall Study||115
5178540|NCT01159769|12737421|P1|NOT COMPLETED|Overall Study||1
5178541|NCT01159769|12737421|P1|COMPLETED|Overall Study||214
5178542|NCT01159769|12737421|P1|STARTED|Overall Study||215
5178543|NCT01159743|12737428|P2|NOT COMPLETED|Overall Study||0
5178544|NCT01159743|12737429|P1|NOT COMPLETED|Overall Study||0
5178545|NCT01159743|12737428|P2|COMPLETED|Overall Study||109
5178546|NCT01159743|12737429|P1|COMPLETED|Overall Study||237
5178547|NCT01159743|12737428|P2|STARTED|Overall Study||109
5178548|NCT01159743|12737429|P1|STARTED|Overall Study||237
5178549|NCT01159691|12737441|P1|NOT COMPLETED|Overall Study||22
5178550|NCT01159691|12737441|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
5178551|NCT01159691|12737441|P1|STARTED|Overall Study||76
5178552|NCT01159665|12737454|P6|NOT COMPLETED|Overall Study||0
5178553|NCT01159665|12737455|P5|NOT COMPLETED|Overall Study||0
5178554|NCT01159665|12737456|P4|NOT COMPLETED|Overall Study||0
5178555|NCT01159665|12737457|P3|NOT COMPLETED|Overall Study||0
5178556|NCT01159665|12737458|P2|NOT COMPLETED|Overall Study||1
5178557|NCT01159665|12737459|P1|NOT COMPLETED|Overall Study||0
5178558|NCT01159665|12737454|P6|COMPLETED|Overall Study||4
5178559|NCT01159665|12737455|P5|COMPLETED|Overall Study||4
5178560|NCT01159665|12737456|P4|COMPLETED|Overall Study||4
5178561|NCT01159665|12737457|P3|COMPLETED|Overall Study||8
5178562|NCT01159665|12737458|P2|COMPLETED|Overall Study||8
5178563|NCT01159665|12737459|P1|COMPLETED|Overall Study||9
5178564|NCT01159665|12737454|P6|STARTED|Overall Study||4
5178565|NCT01159665|12737455|P5|STARTED|Overall Study||4
5178566|NCT01159665|12737456|P4|STARTED|Overall Study||4
5178567|NCT01159665|12737457|P3|STARTED|Overall Study||8
5178568|NCT01159665|12737458|P2|STARTED|Overall Study||9
5178569|NCT01159665|12737459|P1|STARTED|Overall Study||9
5178570|NCT01159600|12737487|P8|NOT COMPLETED|Overall Study||18
5178571|NCT01159600|12737488|P7|NOT COMPLETED|Overall Study||19
5178572|NCT01159600|12737489|P6|NOT COMPLETED|Overall Study||18
5178573|NCT01159600|12737490|P5|NOT COMPLETED|Overall Study||24
5178574|NCT01159600|12737491|P4|NOT COMPLETED|Overall Study||11
5178575|NCT01159600|12737492|P3|NOT COMPLETED|Overall Study||18
5178576|NCT01159600|12737493|P2|NOT COMPLETED|Overall Study||8
5178577|NCT01159600|12737494|P1|NOT COMPLETED|Overall Study||21
5178578|NCT01159600|12737487|P8|COMPLETED|Overall Study||85
5178579|NCT01159600|12737488|P7|COMPLETED|Overall Study||199
5178580|NCT01159600|12737489|P6|COMPLETED|Overall Study||208
5178581|NCT01159600|12737490|P5|COMPLETED|Overall Study||201
5178582|NCT01159600|12737491|P4|COMPLETED|Overall Study||58
5178583|NCT01159600|12737492|P3|COMPLETED|Overall Study||196
5178584|NCT01159600|12737493|P2|COMPLETED|Overall Study||209
5178585|NCT01159600|12737494|P1|COMPLETED|Overall Study||186
5178586|NCT01159600|12737487|P8|STARTED|Overall Study||103
5178587|NCT01159600|12737488|P7|STARTED|Overall Study||218
5178588|NCT01159600|12737489|P6|STARTED|Overall Study||226
5178589|NCT01159600|12737490|P5|STARTED|Overall Study||225
5178590|NCT01159600|12737491|P4|STARTED|Overall Study||69
5178591|NCT01159600|12737492|P3|STARTED|Overall Study||214
5178592|NCT01159600|12737493|P2|STARTED|Overall Study||217
5178593|NCT01159600|12737494|P1|STARTED|Overall Study||207
5178594|NCT01159574|12737536|P1|NOT COMPLETED|Follow Up Phase||20
5178595|NCT01159574|12737536|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
5178596|NCT01159574|12737536|P1|STARTED|Follow Up Phase||112
5178597|NCT01159574|12737536|P1|NOT COMPLETED|Treatment Phase||21
5178598|NCT01159574|12737536|P1|COMPLETED|Treatment Phase||100
5178599|NCT01159574|12737536|P1|STARTED|Treatment Phase||121
5178600|NCT01159535|12737545|P3|NOT COMPLETED|Overall Study||31
5178601|NCT01159535|12737546|P2|NOT COMPLETED|Overall Study||24
5178602|NCT01159535|12737547|P1|NOT COMPLETED|Overall Study||24
5178603|NCT01159535|12737545|P3|COMPLETED|Overall Study||64
5178604|NCT01159535|12737546|P2|COMPLETED|Overall Study||64
5178605|NCT01159535|12737547|P1|COMPLETED|Overall Study||79
5178606|NCT01159535|12737545|P3|STARTED|Overall Study||95
5178607|NCT01159535|12737546|P2|STARTED|Overall Study||88
5178608|NCT01159535|12737547|P1|STARTED|Overall Study||103
5178609|NCT01159431|12737557|P2|NOT COMPLETED|Overall Study||6
5178610|NCT01159431|12737558|P1|NOT COMPLETED|Overall Study||2
5178611|NCT01159431|12737557|P2|COMPLETED|Overall Study||19
5178612|NCT01159431|12737558|P1|COMPLETED|Overall Study||23
5178613|NCT01159431|12737557|P2|STARTED|Overall Study||25
5178614|NCT01159431|12737558|P1|STARTED|Overall Study||25
5178615|NCT01159262|12737577|P3|NOT COMPLETED|Overall Study||0
5178616|NCT01159262|12737578|P2|NOT COMPLETED|Overall Study||0
5178617|NCT01159262|12737579|P1|NOT COMPLETED|Overall Study||0
5178618|NCT01159262|12737577|P3|COMPLETED|Overall Study||8
5178619|NCT01159262|12737578|P2|COMPLETED|Overall Study||14
5178620|NCT01159262|12737579|P1|COMPLETED|Overall Study||14
5178621|NCT01159262|12737577|P3|STARTED|Overall Study||8
5178622|NCT01159262|12737578|P2|STARTED|Overall Study||14
5178623|NCT01159262|12737579|P1|STARTED|Overall Study||14
5178624|NCT01159171|12737611|P1|NOT COMPLETED|Overall Study||50
5178625|NCT01159171|12737611|P1|COMPLETED|Overall Study||0
5178626|NCT01159171|12737611|P1|STARTED|Overall Study||50
5178627|NCT01159067|12737626|P1|NOT COMPLETED|Overall Study||0
5178628|NCT01159067|12737626|P1|COMPLETED|Overall Study||1
5178629|NCT01159067|12737626|P1|STARTED|Overall Study||1
5178630|NCT01159054|12737633|P1|NOT COMPLETED|Overall Study||20
5178631|NCT01159054|12737633|P1|COMPLETED|Overall Study||2
5178632|NCT01159054|12737633|P1|STARTED|Overall Study||22
5178633|NCT01158976|12737647|P2|NOT COMPLETED|Overall Study||4
5178634|NCT01158976|12737648|P1|NOT COMPLETED|Overall Study||9
5178635|NCT01158976|12737647|P2|COMPLETED|Overall Study||17
5178636|NCT01158976|12737648|P1|COMPLETED|Overall Study||34
5178637|NCT01158976|12737647|P2|STARTED|Overall Study||21
5178638|NCT01158976|12737648|P1|STARTED|Overall Study||43
5178639|NCT01158924|12737692|P2|NOT COMPLETED|Overall Study||3
5178640|NCT01158924|12737693|P1|NOT COMPLETED|Overall Study||1
5178641|NCT01158924|12737692|P2|COMPLETED|Overall Study||23
5178642|NCT01158924|12737693|P1|COMPLETED|Overall Study||13
5178643|NCT01158924|12737692|P2|STARTED|Overall Study||26
5178644|NCT01158924|12737693|P1|STARTED|Overall Study||14
5178645|NCT01158885|12737707|P1|NOT COMPLETED|Treatment Course 2||0
5178646|NCT01158885|12737707|P1|COMPLETED|Treatment Course 2||0
5178647|NCT01158885|12737707|P1|STARTED|Treatment Course 2||0
5178648|NCT01158885|12737707|P1|NOT COMPLETED|Treatment Course 1||0
5178649|NCT01158885|12737707|P1|COMPLETED|Treatment Course 1||2
5178650|NCT01158885|12737707|P1|STARTED|Treatment Course 1||2
5178651|NCT01158820|12737715|P2|NOT COMPLETED|Overall Study||0
5178652|NCT01158820|12737716|P1|NOT COMPLETED|Overall Study||0
5178653|NCT01158820|12737715|P2|COMPLETED|Overall Study||25
5178654|NCT01158820|12737716|P1|COMPLETED|Overall Study||25
5178655|NCT01158820|12737715|P2|STARTED|Overall Study||25
5178656|NCT01158820|12737716|P1|STARTED|Overall Study||25
5178657|NCT01158716|12737738|P2|NOT COMPLETED|Overall Study||1
5178658|NCT01158716|12737739|P1|NOT COMPLETED|Overall Study||1
5178659|NCT01158716|12737738|P2|COMPLETED|Overall Study||47
5178660|NCT01158716|12737739|P1|COMPLETED|Overall Study||47
5178661|NCT01158716|12737738|P2|STARTED|Overall Study||48
5178662|NCT01158716|12737739|P1|STARTED|Overall Study||48
5178663|NCT01158703|12737747|P2|NOT COMPLETED|Overall Study||0
5178664|NCT01158703|12737748|P1|NOT COMPLETED|Overall Study||0
5178665|NCT01158703|12737747|P2|COMPLETED|Overall Study||8
5178666|NCT01158703|12737748|P1|COMPLETED|Overall Study||12
5178667|NCT01158703|12737747|P2|STARTED|Overall Study||8
5178668|NCT01158703|12737748|P1|STARTED|Overall Study||12
5178669|NCT01158651|12737764|P1|NOT COMPLETED|Overall Study||1
5178670|NCT01158651|12737764|P1|COMPLETED|Overall Study||22
5178671|NCT01158651|12737764|P1|STARTED|Overall Study||23
5178672|NCT01158573|12737773|P4|NOT COMPLETED|Overall Study||0
5178673|NCT01158573|12737774|P3|NOT COMPLETED|Overall Study||0
5178674|NCT01158573|12737775|P2|NOT COMPLETED|Overall Study||0
5178675|NCT01158573|12737776|P1|NOT COMPLETED|Overall Study||0
5178676|NCT01158573|12737773|P4|COMPLETED|Overall Study||28
5178677|NCT01158573|12737774|P3|COMPLETED|Overall Study||29
5178678|NCT01158573|12737775|P2|COMPLETED|Overall Study||30
5178679|NCT01158573|12737776|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
5178680|NCT01158573|12737773|P4|STARTED|Overall Study||28
5178681|NCT01158573|12737774|P3|STARTED|Overall Study||29
5178682|NCT01158573|12737775|P2|STARTED|Overall Study||30
5178683|NCT01158573|12737776|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
5178684|NCT01158534|12737798|P1|NOT COMPLETED|Overall Study||3
5178685|NCT01158534|12737798|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
5178686|NCT01158534|12737798|P1|STARTED|Overall Study||17
5178687|NCT01158521|12737806|P1|NOT COMPLETED|Overall Study||0
5178688|NCT01158521|12737806|P1|COMPLETED|Overall Study||25
5178689|NCT01158521|12737806|P1|STARTED|Overall Study||25
5178690|NCT01158404|12737823|P8|NOT COMPLETED|Overall Study||2
5178691|NCT01158404|12737824|P7|NOT COMPLETED|Overall Study||1
5178692|NCT01158404|12737825|P6|NOT COMPLETED|Overall Study||1
5178693|NCT01158404|12737826|P5|NOT COMPLETED|Overall Study||3
5178694|NCT01158404|12737827|P4|NOT COMPLETED|Overall Study||0
5178695|NCT01158404|12737828|P3|NOT COMPLETED|Overall Study||0
5178696|NCT01158404|12737829|P2|NOT COMPLETED|Overall Study||1
5178697|NCT01158404|12737830|P1|NOT COMPLETED|Overall Study||0
5178698|NCT01158404|12737823|P8|COMPLETED|Overall Study||6
5178699|NCT01158404|12737824|P7|COMPLETED|Overall Study||2
5178700|NCT01158404|12737825|P6|COMPLETED|Overall Study||4
5178701|NCT01158404|12737826|P5|COMPLETED|Overall Study||3
5178702|NCT01158404|12737827|P4|COMPLETED|Overall Study||3
5178703|NCT01158404|12737828|P3|COMPLETED|Overall Study||3
5178704|NCT01158404|12737829|P2|COMPLETED|Overall Study||3
5178705|NCT01158404|12737830|P1|COMPLETED|Overall Study||3
5178706|NCT01158404|12737823|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
5178707|NCT01158404|12737824|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
5178708|NCT01158404|12737825|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
5178709|NCT01158404|12737826|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
5178710|NCT01158404|12737827|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5178711|NCT01158404|12737828|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5178712|NCT01158404|12737829|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
5178713|NCT01158404|12737830|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5178714|NCT01158404|12737823|P8|STARTED|Overall Study||8
5178715|NCT01158404|12737824|P7|STARTED|Overall Study||3
5178716|NCT01158404|12737825|P6|STARTED|Overall Study||5
5178717|NCT01158404|12737826|P5|STARTED|Overall Study||6
5178718|NCT01158404|12737827|P4|STARTED|Overall Study||3
5178719|NCT01158404|12737828|P3|STARTED|Overall Study||3
5178720|NCT01158404|12737829|P2|STARTED|Overall Study||4
5178721|NCT01158404|12737830|P1|STARTED|Overall Study||3
5178722|NCT01158378|12737872|P2|NOT COMPLETED|Overall Study||9
5178723|NCT01158378|12737873|P1|NOT COMPLETED|Overall Study||10
5178724|NCT01158378|12737872|P2|COMPLETED|Overall Study||117
5178725|NCT01158378|12737873|P1|COMPLETED|Overall Study||114
5178726|NCT01158378|12737872|P2|STARTED|Overall Study||126
5178727|NCT01158378|12737873|P1|STARTED|Overall Study||124
5178728|NCT01158261|12737885|P1|NOT COMPLETED|Overall Study||17
5178729|NCT01158261|12737885|P1|COMPLETED|Overall Study||283
5178730|NCT01158261|12737885|P1|STARTED|Overall Study||300
5178731|NCT01158222|12737889|P1|NOT COMPLETED|Overall Study||17
5178732|NCT01158222|12737889|P1|COMPLETED|Overall Study||20
5178733|NCT01158222|12737889|P1|STARTED|Overall Study||37
5178734|NCT01158157|12737895|P1|NOT COMPLETED|Overall Study||0
5178735|NCT01158157|12737895|P1|COMPLETED|Overall Study||25
5178736|NCT01158157|12737895|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
5178737|NCT01158118|12737901|P2|NOT COMPLETED|Overall Study||3
5178738|NCT01158118|12737902|P1|NOT COMPLETED|Overall Study||1
5178739|NCT01158118|12737901|P2|COMPLETED|Overall Study||21
5178740|NCT01158118|12737902|P1|COMPLETED|Overall Study||23
5178741|NCT01158118|12737901|P2|STARTED|Overall Study||24
5178742|NCT01158118|12737902|P1|STARTED|Overall Study||24
5178743|NCT01157897|12737922|P4|NOT COMPLETED|Overall Study||1
5178744|NCT01157897|12737923|P3|NOT COMPLETED|Overall Study||0
5178745|NCT01157897|12737924|P2|NOT COMPLETED|Overall Study||2
5178746|NCT01157897|12737925|P1|NOT COMPLETED|Overall Study||2
5178747|NCT01157897|12737922|P4|COMPLETED|Overall Study||5
5178748|NCT01157897|12737923|P3|COMPLETED|Overall Study||10
5178749|NCT01157897|12737924|P2|COMPLETED|Overall Study||8
5178750|NCT01157897|12737925|P1|COMPLETED|Overall Study||8
5178751|NCT01157897|12737922|P4|STARTED|Overall Study||6
5178752|NCT01157897|12737923|P3|STARTED|Overall Study||10
5178753|NCT01157897|12737924|P2|STARTED|Overall Study||10
5178754|NCT01157897|12737925|P1|STARTED|Overall Study||10
5178755|NCT01157845|12737950|P1|NOT COMPLETED|Overall Study||35
5178756|NCT01157845|12737950|P1|COMPLETED|Overall Study||130
5178757|NCT01157845|12737950|P1|STARTED|Overall Study||165
5178758|NCT01157676|12737957|P2|NOT COMPLETED|Surgery||9
5178759|NCT01157676|12737958|P1|NOT COMPLETED|Surgery||1
5178760|NCT01157676|12737957|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
5178761|NCT01157676|12737958|P1|COMPLETED|Surgery||152
5178762|NCT01157676|12737957|P2|STARTED|Surgery||159
5178763|NCT01157676|12737958|P1|STARTED|Surgery||153
5178764|NCT01157676|12737957|P2|NOT COMPLETED|Randomization||17
5178765|NCT01157676|12737958|P1|NOT COMPLETED|Randomization||21
5178766|NCT01157676|12737957|P2|COMPLETED|Randomization||159
5178767|NCT01157676|12737958|P1|COMPLETED|Randomization||153
5178768|NCT01157676|12737957|P2|STARTED|Randomization||176
5178769|NCT01157676|12737958|P1|STARTED|Randomization||174
5178770|NCT01157676|12737957|P2|NOT COMPLETED|Enrollment||0
5178771|NCT01157676|12737958|P1|NOT COMPLETED|Enrollment||0
5178772|NCT01157676|12737957|P2|COMPLETED|Enrollment||176
5178773|NCT01157676|12737958|P1|COMPLETED|Enrollment||174
5178774|NCT01157676|12737957|P2|STARTED|Enrollment||176
5178775|NCT01157676|12737958|P1|STARTED|Enrollment||174
5178776|NCT01157533|12738004|P1|NOT COMPLETED|Overall Study||0
5178777|NCT01157533|12738004|P1|COMPLETED|Overall Study||1
5178778|NCT01157533|12738004|P1|STARTED|Overall Study||1
5178779|NCT01157429|12738010|P2|NOT COMPLETED|Overall Study||4
5178780|NCT01157429|12738011|P1|NOT COMPLETED|Overall Study||4
5178781|NCT01157429|12738010|P2|COMPLETED|Overall Study||8
5178782|NCT01157429|12738011|P1|COMPLETED|Overall Study||8
5178783|NCT01157429|12738010|P2|STARTED|Overall Study||12
5178784|NCT01157429|12738011|P1|STARTED|Overall Study||12
5178785|NCT01157416|12738019|P2|NOT COMPLETED|Overall Study||0
5178786|NCT01157416|12738020|P1|NOT COMPLETED|Overall Study||2
5178787|NCT01157416|12738019|P2|COMPLETED|Overall Study||16
5178788|NCT01157416|12738020|P1|COMPLETED|Overall Study||15
5178789|NCT01157416|12738019|P2|STARTED|Overall Study||16
5178790|NCT01157416|12738020|P1|STARTED|Overall Study||17
5178791|NCT01157377|12738033|P7|NOT COMPLETED|Overall Study||2
5178792|NCT01157377|12738034|P6|NOT COMPLETED|Overall Study||3
5178793|NCT01157377|12738035|P5|NOT COMPLETED|Overall Study||2
5178794|NCT01157377|12738036|P4|NOT COMPLETED|Overall Study||1
5178795|NCT01157377|12738037|P3|NOT COMPLETED|Overall Study||1
5178796|NCT01157377|12738038|P2|NOT COMPLETED|Overall Study||3
5178797|NCT01157377|12738039|P1|NOT COMPLETED|Overall Study||2
5178798|NCT01157377|12738033|P7|COMPLETED|Overall Study||27
5178799|NCT01157377|12738034|P6|COMPLETED|Overall Study||16
5178800|NCT01157377|12738035|P5|COMPLETED|Overall Study||18
5178801|NCT01157377|12738036|P4|COMPLETED|Overall Study||14
5178802|NCT01157377|12738037|P3|COMPLETED|Overall Study||26
5178803|NCT01157377|12738038|P2|COMPLETED|Overall Study||20
5178804|NCT01157377|12738039|P1|COMPLETED|Overall Study||21
5178805|NCT01157377|12738033|P7|STARTED|Overall Study||29
5178806|NCT01157377|12738034|P6|STARTED|Overall Study||19
5178807|NCT01157377|12738035|P5|STARTED|Overall Study||20
5178808|NCT01157377|12738036|P4|STARTED|Overall Study||15
5178809|NCT01157377|12738037|P3|STARTED|Overall Study||27
5178810|NCT01157377|12738038|P2|STARTED|Overall Study||23
5178811|NCT01157377|12738039|P1|STARTED|Overall Study||23
5178812|NCT01157364|12738061|P6|NOT COMPLETED|Overall Study||1
5178813|NCT01157364|12738062|P5|NOT COMPLETED|Overall Study||2
5178814|NCT01157364|12738063|P4|NOT COMPLETED|Overall Study||2
5178815|NCT01157364|12738064|P3|NOT COMPLETED|Overall Study||4
5178816|NCT01157364|12738065|P2|NOT COMPLETED|Overall Study||4
5178817|NCT01157364|12738066|P1|NOT COMPLETED|Overall Study||2
5178818|NCT01157364|12738061|P6|COMPLETED|Overall Study||22
5178819|NCT01157364|12738062|P5|COMPLETED|Overall Study||9
5178820|NCT01157364|12738063|P4|COMPLETED|Overall Study||16
5178821|NCT01157364|12738064|P3|COMPLETED|Overall Study||17
5178822|NCT01157364|12738065|P2|COMPLETED|Overall Study||17
5178823|NCT01157364|12738066|P1|COMPLETED|Overall Study||13
5178824|NCT01157364|12738061|P6|STARTED|Overall Study||23
5178825|NCT01157364|12738062|P5|STARTED|Overall Study||11
5178826|NCT01157364|12738063|P4|STARTED|Overall Study||18
5178827|NCT01157364|12738064|P3|STARTED|Overall Study||21
5178828|NCT01157364|12738065|P2|STARTED|Overall Study||21
5178829|NCT01157364|12738066|P1|STARTED|Overall Study||15
5178830|NCT01157351|12738100|P2|NOT COMPLETED|Overall Study||132
5178831|NCT01157351|12738101|P1|NOT COMPLETED|Overall Study||137
5178832|NCT01157351|12738100|P2|COMPLETED|Overall Study||88
5178833|NCT01157351|12738101|P1|COMPLETED|Overall Study||93
5178834|NCT01157351|12738100|P2|Treated|Overall Study||218
5178835|NCT01157351|12738101|P1|Treated|Overall Study||226
5178836|NCT01157351|12738100|P2|STARTED|Overall Study||220
5178837|NCT01157351|12738101|P1|STARTED|Overall Study||230
5178838|NCT01157234|12738119|P2|NOT COMPLETED|Overall Study||0
5178839|NCT01157234|12738120|P1|NOT COMPLETED|Overall Study||1
5178840|NCT01157234|12738119|P2|COMPLETED|Overall Study||15
5178841|NCT01157234|12738120|P1|COMPLETED|Overall Study||14
5178842|NCT01157234|12738119|P2|STARTED|Overall Study||15
5178843|NCT01157234|12738120|P1|STARTED|Overall Study||15
5178844|NCT01157182|12738152|P2|NOT COMPLETED|Second Intervention||0
5178845|NCT01157182|12738153|P1|NOT COMPLETED|Second Intervention||0
5178846|NCT01157182|12738152|P2|COMPLETED|Second Intervention||18
5178847|NCT01157182|12738153|P1|COMPLETED|Second Intervention||16
5178848|NCT01157182|12738152|P2|STARTED|Second Intervention||18
5178849|NCT01157182|12738153|P1|STARTED|Second Intervention||16
5178850|NCT01157182|12738152|P2|NOT COMPLETED|Washout of 28 Days||0
5178851|NCT01157182|12738153|P1|NOT COMPLETED|Washout of 28 Days||2
5178852|NCT01157182|12738152|P2|COMPLETED|Washout of 28 Days||18
5178853|NCT01157182|12738153|P1|COMPLETED|Washout of 28 Days||16
5178854|NCT01157182|12738152|P2|STARTED|Washout of 28 Days||18
5178855|NCT01157182|12738153|P1|STARTED|Washout of 28 Days||18
5178856|NCT01157182|12738152|P2|NOT COMPLETED|First Intervention||0
5178857|NCT01157182|12738153|P1|NOT COMPLETED|First Intervention||0
5178858|NCT01157182|12738152|P2|COMPLETED|First Intervention||18
5178859|NCT01157182|12738153|P1|COMPLETED|First Intervention||18
5178860|NCT01157182|12738152|P2|STARTED|First Intervention||18
5178861|NCT01157182|12738153|P1|STARTED|First Intervention||18
5178862|NCT01157169|12738201|P2|NOT COMPLETED|Second Intervention||1
5178863|NCT01157169|12738202|P1|NOT COMPLETED|Second Intervention||0
5178864|NCT01157169|12738201|P2|COMPLETED|Second Intervention||17
5178865|NCT01157169|12738202|P1|COMPLETED|Second Intervention||16
5178866|NCT01157169|12738201|P2|STARTED|Second Intervention||18
5178867|NCT01157169|12738202|P1|STARTED|Second Intervention||16
5178868|NCT01157169|12738201|P2|NOT COMPLETED|Washout of 10 Days||0
5178869|NCT01157169|12738202|P1|NOT COMPLETED|Washout of 10 Days||0
5178870|NCT01157169|12738201|P2|COMPLETED|Washout of 10 Days||18
5178871|NCT01157169|12738202|P1|COMPLETED|Washout of 10 Days||16
5178872|NCT01157169|12738201|P2|STARTED|Washout of 10 Days||18
5178873|NCT01157169|12738202|P1|STARTED|Washout of 10 Days||16
5178874|NCT01157169|12738201|P2|NOT COMPLETED|First Intervention||2
5178875|NCT01157169|12738202|P1|NOT COMPLETED|First Intervention||4
5178876|NCT01157169|12738201|P2|COMPLETED|First Intervention||18
5178877|NCT01157169|12738202|P1|COMPLETED|First Intervention||16
5178878|NCT01157169|12738201|P2|STARTED|First Intervention||20
5178879|NCT01157169|12738202|P1|STARTED|First Intervention||20
5178880|NCT01157117|12738221|P3|NOT COMPLETED|Overall Study||15
5178881|NCT01157117|12738222|P2|NOT COMPLETED|Overall Study||11
5178882|NCT01157117|12738223|P1|NOT COMPLETED|Overall Study||9
5178883|NCT01157117|12738221|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
5178884|NCT01157117|12738222|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
5178885|NCT01157117|12738223|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
5178886|NCT01157117|12738221|P3|Completed Final Month 38 Study Visit|Overall Study||3
5178887|NCT01157117|12738222|P2|Completed Final Month 38 Study Visit|Overall Study||18
5178888|NCT01157117|12738223|P1|Completed Final Month 38 Study Visit|Overall Study||19
5178889|NCT01157117|12738221|P3|Completed Month 32 Tolerance OFC|Overall Study||0
5178890|NCT01157117|12738222|P2|Completed Month 32 Tolerance OFC|Overall Study||20
5178891|NCT01157117|12738223|P1|Completed Month 32 Tolerance OFC|Overall Study||24
5178892|NCT01157117|12738221|P3|Discontinued Milk OIT at Month 30|Overall Study||0
5178893|NCT01157117|12738222|P2|Discontinued Milk OIT at Month 30|Overall Study||20
5178894|NCT01157117|12738223|P1|Discontinued Milk OIT at Month 30|Overall Study||24
5178895|NCT01157117|12738221|P3|Completed Month 28 Desensitization OFC|Overall Study||0
5178896|NCT01157117|12738222|P2|Completed Month 28 Desensitization OFC|Overall Study||24
5178897|NCT01157117|12738223|P1|Completed Month 28 Desensitization OFC|Overall Study||26
5178898|NCT01157117|12738221|P3|Unblinded at Month 16|Overall Study||0
5178899|NCT01157117|12738222|P2|Unblinded at Month 16|Overall Study||26
5178900|NCT01157117|12738223|P1|Unblinded at Month 16|Overall Study||26
5178901|NCT01157117|12738221|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
5178902|NCT01157117|12738222|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
5178903|NCT01157117|12738223|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
5178904|NCT01157117|12738221|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
5178905|NCT01157117|12738222|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
5178906|NCT01157117|12738223|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
5178907|NCT01157117|12738221|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
5178908|NCT01157117|12738222|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
5178909|NCT01157117|12738223|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
5178910|NCT01157117|12738221|P3|STARTED|Overall Study||20
5178911|NCT01157117|12738222|P2|STARTED|Overall Study||29
5178912|NCT01157117|12738223|P1|STARTED|Overall Study||28
5178913|NCT01157078|12738264|P2|NOT COMPLETED|Overall Study||36
5178914|NCT01157078|12738265|P1|NOT COMPLETED|Overall Study||35
5178915|NCT01157078|12738264|P2|COMPLETED|Overall Study||124
5178916|NCT01157078|12738265|P1|COMPLETED|Overall Study||124
5178917|NCT01157078|12738264|P2|Received Treatment|Overall Study||159
5178918|NCT01157078|12738265|P1|Received Treatment|Overall Study||157
5178919|NCT01157078|12738264|P2|STARTED|Overall Study||160
5178920|NCT01157078|12738265|P1|STARTED|Overall Study||159
5178921|NCT01157065|12738315|P2|NOT COMPLETED|Overall Study||1
5178922|NCT01157065|12738316|P1|NOT COMPLETED|Overall Study||0
5178923|NCT01157065|12738315|P2|COMPLETED|Overall Study||10
5178924|NCT01157065|12738316|P1|COMPLETED|Overall Study||38
5178925|NCT01157065|12738315|P2|STARTED|Overall Study||11
5178926|NCT01157065|12738316|P1|STARTED|Overall Study||38
5178927|NCT01156987|12738326|P2|NOT COMPLETED|Overall Study||11
5178928|NCT01156987|12738327|P1|NOT COMPLETED|Overall Study||0
5178929|NCT01156987|12738326|P2|COMPLETED|Overall Study||12
5178930|NCT01156987|12738327|P1|COMPLETED|Overall Study||8
5178931|NCT01156987|12738326|P2|STARTED|Overall Study||23
5178932|NCT01156987|12738327|P1|STARTED|Overall Study||8
5178933|NCT01156844|12738337|P4|NOT COMPLETED|Overall Study||6
5178934|NCT01156844|12738338|P3|NOT COMPLETED|Overall Study||6
5178935|NCT01156844|12738339|P2|NOT COMPLETED|Overall Study||2
5178936|NCT01156844|12738340|P1|NOT COMPLETED|Overall Study||2
5178937|NCT01156844|12738337|P4|COMPLETED|Overall Study||41
5178938|NCT01156844|12738338|P3|COMPLETED|Overall Study||42
5178939|NCT01156844|12738339|P2|COMPLETED|Overall Study||46
5178940|NCT01156844|12738340|P1|COMPLETED|Overall Study||46
5178941|NCT01156844|12738337|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
5178942|NCT01156844|12738338|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
5178943|NCT01156844|12738339|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
5178944|NCT01156844|12738340|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
5178945|NCT01156844|12738337|P4|STARTED|Overall Study||47
5178946|NCT01156844|12738338|P3|STARTED|Overall Study||48
5178947|NCT01156844|12738339|P2|STARTED|Overall Study||48
5178948|NCT01156844|12738340|P1|STARTED|Overall Study|Randomized participants.|48
5178949|NCT01156805|12738361|P2|NOT COMPLETED|Overall Study||56
5178950|NCT01156805|12738362|P1|NOT COMPLETED|Overall Study||56
5178951|NCT01156805|12738361|P2|COMPLETED|Overall Study||216
5178952|NCT01156805|12738362|P1|COMPLETED|Overall Study||181
5178953|NCT01156805|12738361|P2|STARTED|Overall Study||272
5178954|NCT01156805|12738362|P1|STARTED|Overall Study||237
5178955|NCT01156792|12738374|P1|NOT COMPLETED|Overall Study||69
5178956|NCT01156792|12738374|P1|COMPLETED|Overall Study||93
5178957|NCT01156792|12738374|P1|STARTED|Overall Study||162
5178958|NCT01156714|12738442|P3|NOT COMPLETED|Overall Study||3
5178959|NCT01156714|12738443|P2|NOT COMPLETED|Overall Study||4
5178960|NCT01156714|12738444|P1|NOT COMPLETED|Overall Study||9
5178961|NCT01156714|12738442|P3|COMPLETED|Overall Study||17
5178962|NCT01156714|12738443|P2|COMPLETED|Overall Study||15
5178963|NCT01156714|12738444|P1|COMPLETED|Overall Study||11
5178964|NCT01156714|12738442|P3|STARTED|Overall Study||20
5178965|NCT01156714|12738443|P2|STARTED|Overall Study||19
5178966|NCT01156714|12738444|P1|STARTED|Overall Study||20
5178967|NCT01156701|12738467|P4|NOT COMPLETED|Overall Study||0
5178968|NCT01156701|12738468|P3|NOT COMPLETED|Overall Study||0
5178969|NCT01156701|12738469|P2|NOT COMPLETED|Overall Study||0
5178970|NCT01156701|12738470|P1|NOT COMPLETED|Overall Study||0
5178971|NCT01156701|12738467|P4|COMPLETED|Overall Study||6725
5178972|NCT01156701|12738468|P3|COMPLETED|Overall Study||163716
5178973|NCT01156701|12738469|P2|COMPLETED|Overall Study||1007
5178974|NCT01156701|12738470|P1|COMPLETED|Overall Study||257
5178975|NCT01156701|12738467|P4|STARTED|Overall Study||6725
5178976|NCT01156701|12738468|P3|STARTED|Overall Study||163716
5178977|NCT01156701|12738469|P2|STARTED|Overall Study||1007
5178978|NCT01156701|12738470|P1|STARTED|Overall Study||257
5178979|NCT01156675|12738507|P3|NOT COMPLETED|Overall Study||2
5178980|NCT01156675|12738508|P2|NOT COMPLETED|Overall Study||25
5178981|NCT01156675|12738509|P1|NOT COMPLETED|Overall Study||34
5178982|NCT01156675|12738507|P3|COMPLETED|Overall Study||0
5178983|NCT01156675|12738508|P2|COMPLETED|Overall Study||81
5178984|NCT01156675|12738509|P1|COMPLETED|Overall Study||73
5178985|NCT01156675|12738507|P3|STARTED|Overall Study||2
5178986|NCT01156675|12738508|P2|STARTED|Overall Study||106
5178987|NCT01156675|12738509|P1|STARTED|Overall Study||107
5178988|NCT01156597|12738543|P2|NOT COMPLETED|Overall Study||1
5178989|NCT01156597|12738544|P1|NOT COMPLETED|Overall Study||3
5178990|NCT01156597|12738543|P2|COMPLETED|Overall Study||13
5178991|NCT01156597|12738544|P1|COMPLETED|Overall Study||13
5178992|NCT01156597|12738543|P2|STARTED|Overall Study||14
5178993|NCT01156597|12738544|P1|STARTED|Overall Study||16
5178994|NCT01156571|12738556|P2|NOT COMPLETED|Overall Study||19
5178995|NCT01156571|12738557|P1|NOT COMPLETED|Overall Study||17
5178996|NCT01156571|12738556|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
5178997|NCT01156571|12738557|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
5178998|NCT01156571|12738556|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
5178999|NCT01156571|12738557|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
5179000|NCT01156532|12738567|P1|NOT COMPLETED|Overall Study||2
5179001|NCT01156532|12738567|P1|COMPLETED|Overall Study||28
5179002|NCT01156532|12738567|P1|STARTED|Overall Study||30
5179003|NCT01156480|12738579|P2|NOT COMPLETED|Overall Study||1
5179004|NCT01156480|12738580|P1|NOT COMPLETED|Overall Study||0
5179005|NCT01156480|12738579|P2|COMPLETED|Overall Study||1
5179006|NCT01156480|12738580|P1|COMPLETED|Overall Study||0
5179007|NCT01156480|12738579|P2|STARTED|Overall Study||2
5179008|NCT01156480|12738580|P1|STARTED|Overall Study||0
5179009|NCT01156376|12738609|P3|NOT COMPLETED|Overall Study||4
5179010|NCT01156376|12738610|P2|NOT COMPLETED|Overall Study||0
5179011|NCT01156376|12738611|P1|NOT COMPLETED|Overall Study||1
5179012|NCT01156376|12738609|P3|COMPLETED|Overall Study||23
5179013|NCT01156376|12738610|P2|COMPLETED|Overall Study||26
5179014|NCT01156376|12738611|P1|COMPLETED|Overall Study||26
5179015|NCT01156376|12738609|P3|STARTED|Overall Study||27
5179016|NCT01156376|12738610|P2|STARTED|Overall Study||26
5179017|NCT01156376|12738611|P1|STARTED|Overall Study||27
5179018|NCT01156363|12738832|P1|NOT COMPLETED|Overall Study||22
5179019|NCT01156363|12738832|P1|COMPLETED|Overall Study||64
5179020|NCT01156363|12738832|P1|STARTED|Overall Study||86
5179021|NCT01156311|12738854|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
5179022|NCT01156311|12738855|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
5179023|NCT01156311|12738856|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
5179024|NCT01156311|12738857|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
5179025|NCT01156311|12738854|P4|COMPLETED|6-month Add-on Therapy Period||37
5179026|NCT01156311|12738855|P3|COMPLETED|6-month Add-on Therapy Period||45
5179027|NCT01156311|12738856|P2|COMPLETED|6-month Add-on Therapy Period||0
5179028|NCT01156311|12738857|P1|COMPLETED|6-month Add-on Therapy Period||0
5179029|NCT01156311|12738854|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
5179030|NCT01156311|12738855|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
5179031|NCT01156311|12738856|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
5179032|NCT01156311|12738857|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
5179033|NCT01156311|12738854|P4|STARTED|6-month Add-on Therapy Period||47
5179034|NCT01156311|12738855|P3|STARTED|6-month Add-on Therapy Period||57
5179035|NCT01156311|12738856|P2|STARTED|6-month Add-on Therapy Period||0
5179036|NCT01156311|12738857|P1|STARTED|6-month Add-on Therapy Period||0
5179037|NCT01156311|12738854|P4|NOT COMPLETED|2-Month Monotherapy Period||0
5179038|NCT01156311|12738855|P3|NOT COMPLETED|2-Month Monotherapy Period||0
5179039|NCT01156311|12738856|P2|NOT COMPLETED|2-Month Monotherapy Period||2
5179040|NCT01156311|12738857|P1|NOT COMPLETED|2-Month Monotherapy Period||2
5179041|NCT01156311|12738854|P4|COMPLETED|2-Month Monotherapy Period||0
5179042|NCT01156311|12738855|P3|COMPLETED|2-Month Monotherapy Period||0
5179043|NCT01156311|12738856|P2|COMPLETED|2-Month Monotherapy Period||47
5179044|NCT01156311|12738857|P1|COMPLETED|2-Month Monotherapy Period||57
5179045|NCT01156311|12738854|P4|STARTED|2-Month Monotherapy Period||0
5179046|NCT01156311|12738855|P3|STARTED|2-Month Monotherapy Period||0
5179047|NCT01156311|12738856|P2|STARTED|2-Month Monotherapy Period||49
5179048|NCT01156311|12738857|P1|STARTED|2-Month Monotherapy Period||59
5179049|NCT01156142|12738881|P2|NOT COMPLETED|Overall Study||7
5179050|NCT01156142|12738882|P1|NOT COMPLETED|Overall Study||8
5179051|NCT01156142|12738881|P2|COMPLETED|Overall Study||71
5179052|NCT01156142|12738882|P1|COMPLETED|Overall Study||69
5179053|NCT01156142|12738881|P2|STARTED|Overall Study||78
5179054|NCT01156142|12738882|P1|STARTED|Overall Study||77
5179055|NCT01156116|12738900|P2|NOT COMPLETED|Overall Study||1
5179056|NCT01156116|12738901|P1|NOT COMPLETED|Overall Study||5
5179057|NCT01156116|12738900|P2|COMPLETED|Overall Study||12
5179058|NCT01156116|12738901|P1|COMPLETED|Overall Study||21
5179059|NCT01156116|12738900|P2|STARTED|Overall Study||13
5179060|NCT01156116|12738901|P1|STARTED|Overall Study||26
5179061|NCT01156051|12738915|P2|NOT COMPLETED|Overall Study||1
5179062|NCT01156051|12738916|P1|NOT COMPLETED|Overall Study||1
5179063|NCT01156051|12738915|P2|COMPLETED|Overall Study||16
5179064|NCT01156051|12738916|P1|COMPLETED|Overall Study||11
5179065|NCT01156051|12738915|P2|STARTED|Overall Study||17
5179066|NCT01156051|12738916|P1|STARTED|Overall Study||12
5179067|NCT01156012|12738930|P2|NOT COMPLETED|Overall Study||3
5179068|NCT01156012|12738931|P1|NOT COMPLETED|Overall Study||7
5179069|NCT01156012|12738930|P2|COMPLETED|Overall Study||186
5179070|NCT01156012|12738931|P1|COMPLETED|Overall Study||206
5179071|NCT01156012|12738930|P2|STARTED|Overall Study||189
5179072|NCT01156012|12738931|P1|STARTED|Overall Study||213
5179073|NCT01155999|12738939|P2|NOT COMPLETED|Overall Study||4
5179074|NCT01155999|12738940|P1|NOT COMPLETED|Overall Study||7
5179075|NCT01155999|12738939|P2|COMPLETED|Overall Study||136
5179076|NCT01155999|12738940|P1|COMPLETED|Overall Study||139
5179077|NCT01155999|12738939|P2|STARTED|Overall Study||140
5179078|NCT01155999|12738940|P1|STARTED|Overall Study||146
5179079|NCT01155869|12738948|P2|NOT COMPLETED|Overall Study||1
5179080|NCT01155869|12738949|P1|NOT COMPLETED|Overall Study||3
5179081|NCT01155869|12738948|P2|COMPLETED|Overall Study||3
5179082|NCT01155869|12738949|P1|COMPLETED|Overall Study||0
5179083|NCT01155869|12738948|P2|STARTED|Overall Study||4
5179084|NCT01155869|12738949|P1|STARTED|Overall Study||3
5179085|NCT01155830|12738960|P3|NOT COMPLETED|Overall Study||0
5179086|NCT01155830|12738961|P2|NOT COMPLETED|Overall Study||0
5179087|NCT01155830|12738962|P1|NOT COMPLETED|Overall Study||0
5179088|NCT01155830|12738960|P3|COMPLETED|Overall Study||21
5179089|NCT01155830|12738961|P2|COMPLETED|Overall Study||0
5179090|NCT01155830|12738962|P1|COMPLETED|Overall Study||0
5179091|NCT01155830|12738960|P3|STARTED|Overall Study||21
5179092|NCT01155830|12738961|P2|STARTED|Overall Study||0
5179093|NCT01155830|12738962|P1|STARTED|Overall Study||0
5179094|NCT01155778|12738976|P3|NOT COMPLETED|Overall Study||0
5179095|NCT01155778|12738977|P2|NOT COMPLETED|Overall Study||0
5179096|NCT01155778|12738978|P1|NOT COMPLETED|Overall Study||0
5179097|NCT01155778|12738976|P3|COMPLETED|Overall Study||4
5179098|NCT01155778|12738977|P2|COMPLETED|Overall Study||4
5179099|NCT01155778|12738978|P1|COMPLETED|Overall Study||4
5179100|NCT01155778|12738976|P3|STARTED|Overall Study||4
5179101|NCT01155778|12738977|P2|STARTED|Overall Study||4
5179102|NCT01155778|12738978|P1|STARTED|Overall Study||4
5179103|NCT01155726|12739058|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
5179104|NCT01155726|12739059|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
5179105|NCT01155726|12739060|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
5179106|NCT01155726|12739061|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
5179107|NCT01155726|12739058|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
5179108|NCT01155726|12739059|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
5179109|NCT01155726|12739060|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
5179110|NCT01155726|12739061|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
5179111|NCT01155726|12739058|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
5179112|NCT01155726|12739059|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
5179113|NCT01155726|12739060|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
5179114|NCT01155726|12739061|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
5179115|NCT01155726|12739058|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
5179116|NCT01155726|12739059|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
5179117|NCT01155726|12739060|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
5179118|NCT01155726|12739061|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
5179119|NCT01155726|12739058|P4|COMPLETED|Period 1, 3 Days (Masked)||25
5179120|NCT01155726|12739059|P3|COMPLETED|Period 1, 3 Days (Masked)||28
5179121|NCT01155726|12739060|P2|COMPLETED|Period 1, 3 Days (Masked)||20
5179122|NCT01155726|12739061|P1|COMPLETED|Period 1, 3 Days (Masked)||23
5179123|NCT01155726|12739058|P4|STARTED|Period 1, 3 Days (Masked)||25
5179124|NCT01155726|12739059|P3|STARTED|Period 1, 3 Days (Masked)||30
5179125|NCT01155726|12739060|P2|STARTED|Period 1, 3 Days (Masked)||20
5179126|NCT01155726|12739061|P1|STARTED|Period 1, 3 Days (Masked)||24
5179127|NCT01155661|12739083|P1|NOT COMPLETED|Overall Study||280
5179128|NCT01155661|12739083|P1|COMPLETED|Overall Study||328
5179129|NCT01155661|12739083|P1|STARTED|Overall Study||608
5179130|NCT01155570|12739109|P1|NOT COMPLETED|Overall Study||142
5179131|NCT01155570|12739109|P1|COMPLETED|Overall Study||592
5179132|NCT01155570|12739109|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
5179133|NCT01155570|12739109|P1|STARTED|Overall Study|Safety Analysis Population|734
5179134|NCT01155531|12739143|P4|NOT COMPLETED|Overall Study||1
5179135|NCT01155531|12739144|P3|NOT COMPLETED|Overall Study||2
5179136|NCT01155531|12739145|P2|NOT COMPLETED|Overall Study||0
5179137|NCT01155531|12739146|P1|NOT COMPLETED|Overall Study||1
5179138|NCT01155531|12739143|P4|COMPLETED|Overall Study||9
5179139|NCT01155531|12739144|P3|COMPLETED|Overall Study||8
5179140|NCT01155531|12739145|P2|COMPLETED|Overall Study||10
5179141|NCT01155531|12739146|P1|COMPLETED|Overall Study||9
5179142|NCT01155531|12739143|P4|STARTED|Overall Study||10
5179143|NCT01155531|12739144|P3|STARTED|Overall Study||10
5179144|NCT01155531|12739145|P2|STARTED|Overall Study||10
5179145|NCT01155531|12739146|P1|STARTED|Overall Study||10
5179146|NCT01155518|12739170|P6|NOT COMPLETED|Overall Study||0
5179147|NCT01155518|12739171|P5|NOT COMPLETED|Overall Study||0
5179148|NCT01155518|12739172|P4|NOT COMPLETED|Overall Study||0
5179149|NCT01155518|12739173|P3|NOT COMPLETED|Overall Study||0
5179150|NCT01155518|12739174|P2|NOT COMPLETED|Overall Study||1
5179151|NCT01155518|12739175|P1|NOT COMPLETED|Overall Study||0
5179152|NCT01155518|12739170|P6|COMPLETED|Overall Study||2
5179153|NCT01155518|12739171|P5|COMPLETED|Overall Study||1
5179154|NCT01155518|12739172|P4|COMPLETED|Overall Study||0
5179155|NCT01155518|12739173|P3|COMPLETED|Overall Study||0
5179156|NCT01155518|12739174|P2|COMPLETED|Overall Study|never started the study|0
5179157|NCT01155518|12739175|P1|COMPLETED|Overall Study||1
5179158|NCT01155518|12739170|P6|STARTED|Overall Study||2
5179159|NCT01155518|12739171|P5|STARTED|Overall Study||1
5179160|NCT01155518|12739172|P4|STARTED|Overall Study||0
5179161|NCT01155518|12739173|P3|STARTED|Overall Study||0
5179162|NCT01155518|12739174|P2|STARTED|Overall Study||1
5179163|NCT01155518|12739175|P1|STARTED|Overall Study||1
5179164|NCT01155479|12739194|P5|NOT COMPLETED|Part II||55
5179165|NCT01155479|12739195|P4|NOT COMPLETED|Part II||50
5179166|NCT01155479|12739196|P3|NOT COMPLETED|Part II||58
5179167|NCT01155479|12739197|P2|NOT COMPLETED|Part II||61
5179168|NCT01155479|12739198|P1|NOT COMPLETED|Part II||59
5179169|NCT01155479|12739194|P5|COMPLETED|Part II||126
5179170|NCT01155479|12739195|P4|COMPLETED|Part II||127
5179171|NCT01155479|12739196|P3|COMPLETED|Part II||109
5179172|NCT01155479|12739197|P2|COMPLETED|Part II||116
5179173|NCT01155479|12739198|P1|COMPLETED|Part II||107
5179174|NCT01155479|12739194|P5|STARTED|Part II||181
5179175|NCT01155479|12739195|P4|STARTED|Part II||177
5179176|NCT01155479|12739196|P3|STARTED|Part II||167
5179177|NCT01155479|12739197|P2|STARTED|Part II||177
5179178|NCT01155479|12739198|P1|STARTED|Part II||166
5179179|NCT01155479|12739194|P5|NOT COMPLETED|Part I||23
5179180|NCT01155479|12739195|P4|NOT COMPLETED|Part I||27
5179181|NCT01155479|12739196|P3|NOT COMPLETED|Part I||39
5179182|NCT01155479|12739197|P2|NOT COMPLETED|Part I||27
5179183|NCT01155479|12739198|P1|NOT COMPLETED|Part I||38
5179184|NCT01155479|12739194|P5|COMPLETED|Part I||181
5179185|NCT01155479|12739195|P4|COMPLETED|Part I||177
5179186|NCT01155479|12739196|P3|COMPLETED|Part I||167
5179187|NCT01155479|12739197|P2|COMPLETED|Part I||177
5179188|NCT01155479|12739198|P1|COMPLETED|Part I||166
5179189|NCT01155479|12739194|P5|Treated|Part I||203
5179190|NCT01155479|12739195|P4|Treated|Part I||198
5179191|NCT01155479|12739196|P3|Treated|Part I||204
5179192|NCT01155479|12739197|P2|Treated|Part I||202
5179193|NCT01155479|12739198|P1|Treated|Part I||200
5179194|NCT01155479|12739194|P5|STARTED|Part I||204
5179195|NCT01155479|12739195|P4|STARTED|Part I||204
5179196|NCT01155479|12739196|P3|STARTED|Part I||206
5179197|NCT01155479|12739197|P2|STARTED|Part I||204
5179198|NCT01155479|12739198|P1|STARTED|Part I||204
5179199|NCT01155466|12739250|P5|NOT COMPLETED|Overall Study||27
5179200|NCT01155466|12739251|P4|NOT COMPLETED|Overall Study||21
5179201|NCT01155466|12739252|P3|NOT COMPLETED|Overall Study||20
5179202|NCT01155466|12739253|P2|NOT COMPLETED|Overall Study||25
5179203|NCT01155466|12739254|P1|NOT COMPLETED|Overall Study||22
5179204|NCT01155466|12739250|P5|COMPLETED|Overall Study|Completed treatment phase|129
5179205|NCT01155466|12739251|P4|COMPLETED|Overall Study|Completed treatment phase|134
5179206|NCT01155466|12739252|P3|COMPLETED|Overall Study|Completed treatment phase|136
5179207|NCT01155466|12739253|P2|COMPLETED|Overall Study|Completed treatment phase|130
5179208|NCT01155466|12739254|P1|COMPLETED|Overall Study|Completed treatment phase|134
5179209|NCT01155466|12739250|P5|Treated|Overall Study||154
5179210|NCT01155466|12739251|P4|Treated|Overall Study||155
5179211|NCT01155466|12739252|P3|Treated|Overall Study||153
5179212|NCT01155466|12739253|P2|Treated|Overall Study||153
5179213|NCT01155466|12739254|P1|Treated|Overall Study||154
5179214|NCT01155466|12739250|P5|STARTED|Overall Study||156
5179215|NCT01155466|12739251|P4|STARTED|Overall Study||155
5179216|NCT01155466|12739252|P3|STARTED|Overall Study||156
5179217|NCT01155466|12739253|P2|STARTED|Overall Study||155
5179218|NCT01155466|12739254|P1|STARTED|Overall Study||156
5179219|NCT01155388|12739308|P2|NOT COMPLETED|Overall Study||0
5179220|NCT01155388|12739309|P1|NOT COMPLETED|Overall Study||1
5179221|NCT01155388|12739308|P2|COMPLETED|Overall Study||6
5179222|NCT01155388|12739309|P1|COMPLETED|Overall Study||7
5179223|NCT01155388|12739308|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5179224|NCT01155388|12739309|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5179225|NCT01155388|12739308|P2|STARTED|Overall Study||6
5179226|NCT01155388|12739309|P1|STARTED|Overall Study||8
5179227|NCT01155375|12739319|P2|NOT COMPLETED|Overall Study||0
5179228|NCT01155375|12739320|P1|NOT COMPLETED|Overall Study||1
5179229|NCT01155375|12739319|P2|COMPLETED|Overall Study||6
5179230|NCT01155375|12739320|P1|COMPLETED|Overall Study||7
5179231|NCT01155375|12739319|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5179232|NCT01155375|12739320|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5179233|NCT01155375|12739319|P2|STARTED|Overall Study||6
5179234|NCT01155375|12739320|P1|STARTED|Overall Study||8
5179235|NCT01155336|12739330|P2|NOT COMPLETED|Overall Study||0
5179236|NCT01155336|12739331|P1|NOT COMPLETED|Overall Study||0
5179237|NCT01155336|12739330|P2|COMPLETED|Overall Study|We did not complete the study.|4
5179238|NCT01155336|12739331|P1|COMPLETED|Overall Study|We did not complete the study.|0
5179239|NCT01155336|12739330|P2|STARTED|Overall Study|We did not complete the study.|4
5179240|NCT01155336|12739331|P1|STARTED|Overall Study|We did not complete the study.|0
5179241|NCT01155323|12739339|P2|NOT COMPLETED|Second Intervention||1
5179242|NCT01155323|12739340|P1|NOT COMPLETED|Second Intervention||1
5179243|NCT01155323|12739339|P2|COMPLETED|Second Intervention||56
5179244|NCT01155323|12739340|P1|COMPLETED|Second Intervention||58
5179245|NCT01155323|12739339|P2|STARTED|Second Intervention||57
5179246|NCT01155323|12739340|P1|STARTED|Second Intervention||59
5179247|NCT01155323|12739339|P2|NOT COMPLETED|First Intervention||1
5179248|NCT01155323|12739340|P1|NOT COMPLETED|First Intervention||1
5179249|NCT01155323|12739339|P2|COMPLETED|First Intervention||57
5179250|NCT01155323|12739340|P1|COMPLETED|First Intervention||59
5179251|NCT01155323|12739339|P2|STARTED|First Intervention||58
5179252|NCT01155323|12739340|P1|STARTED|First Intervention||60
5179253|NCT01155284|12739358|P2|NOT COMPLETED|Overall Study||5
5179254|NCT01155284|12739359|P1|NOT COMPLETED|Overall Study||7
5179255|NCT01155284|12739358|P2|COMPLETED|Overall Study||18
5179256|NCT01155284|12739359|P1|COMPLETED|Overall Study||40
5179257|NCT01155284|12739358|P2|STARTED|Overall Study||23
5179258|NCT01155284|12739359|P1|STARTED|Overall Study||47
5179259|NCT01155219|12739369|P2|NOT COMPLETED|Overall Study||3
5179260|NCT01155219|12739370|P1|NOT COMPLETED|Overall Study||4
5179261|NCT01155219|12739369|P2|COMPLETED|Overall Study||70
5179262|NCT01155219|12739370|P1|COMPLETED|Overall Study||73
5179263|NCT01155219|12739369|P2|STARTED|Overall Study||73
5179264|NCT01155219|12739370|P1|STARTED|Overall Study||77
5179265|NCT01155193|12739380|P4|NOT COMPLETED|Overall Study||91
5179266|NCT01155193|12739381|P3|NOT COMPLETED|Overall Study||12
5179267|NCT01155193|12739382|P2|NOT COMPLETED|Overall Study||13
5179268|NCT01155193|12739383|P1|NOT COMPLETED|Overall Study||238
5179269|NCT01155193|12739380|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
5179270|NCT01155193|12739381|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
5179271|NCT01155193|12739382|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
5179272|NCT01155193|12739383|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
5179273|NCT01155193|12739380|P4|STARTED|Overall Study||13802
5179274|NCT01155193|12739381|P3|STARTED|Overall Study||2260
5179275|NCT01155193|12739382|P2|STARTED|Overall Study||3818
5179276|NCT01155193|12739383|P1|STARTED|Overall Study||10924
5179277|NCT01155180|12739410|P2|NOT COMPLETED|Overall Study||0
5179278|NCT01155180|12739411|P1|NOT COMPLETED|Overall Study||0
5179279|NCT01155180|12739410|P2|COMPLETED|Overall Study||6
5179280|NCT01155180|12739411|P1|COMPLETED|Overall Study||18
5179281|NCT01155180|12739410|P2|STARTED|Overall Study||6
5179282|NCT01155180|12739411|P1|STARTED|Overall Study||18
5179283|NCT01155167|12739419|P2|NOT COMPLETED|Overall Study||0
5179284|NCT01155167|12739420|P1|NOT COMPLETED|Overall Study||3
5179285|NCT01155167|12739419|P2|COMPLETED|Overall Study||43
5179286|NCT01155167|12739420|P1|COMPLETED|Overall Study||40
5179287|NCT01155167|12739419|P2|STARTED|Overall Study||43
5179288|NCT01155167|12739420|P1|STARTED|Overall Study||43
5179289|NCT01155154|12739433|P3|NOT COMPLETED|Overall Study||0
5179290|NCT01155154|12739434|P2|NOT COMPLETED|Overall Study||0
5179291|NCT01155154|12739435|P1|NOT COMPLETED|Overall Study||0
5179292|NCT01155154|12739433|P3|COMPLETED|Overall Study||24
5179293|NCT01155154|12739434|P2|COMPLETED|Overall Study||24
5179294|NCT01155154|12739435|P1|COMPLETED|Overall Study||25
5179295|NCT01155154|12739433|P3|STARTED|Overall Study||24
5179296|NCT01155154|12739434|P2|STARTED|Overall Study||24
5179297|NCT01155154|12739435|P1|STARTED|Overall Study||25
5179298|NCT01155141|12739443|P1|NOT COMPLETED|Overall Study||2
5179299|NCT01155141|12739443|P1|COMPLETED|Overall Study||14
5179300|NCT01155141|12739443|P1|STARTED|Overall Study||16
5179301|NCT01155063|12739455|P1|NOT COMPLETED|Overall Study||89
5179302|NCT01155063|12739455|P1|COMPLETED|Overall Study||0
5179303|NCT01155063|12739455|P1|STARTED|Overall Study||89
5179304|NCT01155024|12739465|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
5179305|NCT01155024|12739466|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
5179306|NCT01155024|12739465|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
5179307|NCT01155024|12739466|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
5179308|NCT01155024|12739465|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
5179309|NCT01155024|12739466|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
5179310|NCT01155024|12739465|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
5179311|NCT01155024|12739466|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
5179312|NCT01155024|12739465|P2|COMPLETED|Second Socket Intervention Fitting||5
5179313|NCT01155024|12739466|P1|COMPLETED|Second Socket Intervention Fitting||5
5179314|NCT01155024|12739465|P2|STARTED|Second Socket Intervention Fitting||5
5179315|NCT01155024|12739466|P1|STARTED|Second Socket Intervention Fitting||5
5179316|NCT01155024|12739465|P2|NOT COMPLETED|First Socket Intervention Fitting||0
5179317|NCT01155024|12739466|P1|NOT COMPLETED|First Socket Intervention Fitting||0
5179318|NCT01155024|12739465|P2|COMPLETED|First Socket Intervention Fitting||5
5179319|NCT01155024|12739466|P1|COMPLETED|First Socket Intervention Fitting||5
5179320|NCT01155024|12739465|P2|STARTED|First Socket Intervention Fitting||5
5179321|NCT01155024|12739466|P1|STARTED|First Socket Intervention Fitting||5
5179322|NCT01155011|12739476|P2|NOT COMPLETED|6 to 12 Months||10
5179323|NCT01155011|12739477|P1|NOT COMPLETED|6 to 12 Months||9
5179324|NCT01155011|12739476|P2|COMPLETED|6 to 12 Months||121
5179325|NCT01155011|12739477|P1|COMPLETED|6 to 12 Months||120
5179326|NCT01155011|12739476|P2|STARTED|6 to 12 Months||131
5179327|NCT01155011|12739477|P1|STARTED|6 to 12 Months||129
5179328|NCT01155011|12739476|P2|NOT COMPLETED|Baseline to 6 Months||25
5179329|NCT01155011|12739477|P1|NOT COMPLETED|Baseline to 6 Months||22
5179330|NCT01155011|12739476|P2|COMPLETED|Baseline to 6 Months||131
5179331|NCT01155011|12739477|P1|COMPLETED|Baseline to 6 Months||129
5179332|NCT01155011|12739476|P2|STARTED|Baseline to 6 Months||156
5179333|NCT01155011|12739477|P1|STARTED|Baseline to 6 Months||151
5179334|NCT01154985|12739490|P3|NOT COMPLETED|Overall Study||18
5179335|NCT01154985|12739491|P2|NOT COMPLETED|Overall Study||27
5179336|NCT01154985|12739492|P1|NOT COMPLETED|Overall Study||17
5179337|NCT01154985|12739490|P3|COMPLETED|Overall Study||68
5179338|NCT01154985|12739491|P2|COMPLETED|Overall Study||55
5179339|NCT01154985|12739492|P1|COMPLETED|Overall Study||58
5179340|NCT01154985|12739490|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
5179341|NCT01154985|12739491|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
5179342|NCT01154985|12739492|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
5179343|NCT01154985|12739490|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
5179344|NCT01154985|12739491|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
5179345|NCT01154985|12739492|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
5179346|NCT01154985|12739490|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
5179347|NCT01154985|12739491|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
5179348|NCT01154985|12739492|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
5179349|NCT01154985|12739490|P3|STARTED|Overall Study|Randomized|86
5179350|NCT01154985|12739491|P2|STARTED|Overall Study|Randomized|82
5179351|NCT01154985|12739492|P1|STARTED|Overall Study|Randomized|75
5179352|NCT01154816|12739518|P12|NOT COMPLETED|Overall Study||4
5179353|NCT01154816|12739519|P11|NOT COMPLETED|Overall Study||11
5179354|NCT01154816|12739520|P10|NOT COMPLETED|Overall Study||10
5179355|NCT01154816|12739521|P9|NOT COMPLETED|Overall Study||9
5179356|NCT01154816|12739522|P8|NOT COMPLETED|Overall Study||7
5179357|NCT01154816|12739523|P7|NOT COMPLETED|Overall Study||6
5179358|NCT01154816|12739524|P6|NOT COMPLETED|Overall Study||8
5179359|NCT01154816|12739525|P5|NOT COMPLETED|Overall Study||10
5179360|NCT01154816|12739526|P4|NOT COMPLETED|Overall Study||10
5179361|NCT01154816|12739527|P3|NOT COMPLETED|Overall Study||10
5179362|NCT01154816|12739528|P2|NOT COMPLETED|Overall Study||10
5179363|NCT01154816|12739529|P1|NOT COMPLETED|Overall Study||20
5179364|NCT01154816|12739518|P12|COMPLETED|Overall Study||0
5179365|NCT01154816|12739519|P11|COMPLETED|Overall Study||0
5179366|NCT01154816|12739520|P10|COMPLETED|Overall Study||0
5179367|NCT01154816|12739521|P9|COMPLETED|Overall Study||1
5179368|NCT01154816|12739522|P8|COMPLETED|Overall Study||0
5179369|NCT01154816|12739523|P7|COMPLETED|Overall Study||0
5179370|NCT01154816|12739524|P6|COMPLETED|Overall Study||0
5179371|NCT01154816|12739525|P5|COMPLETED|Overall Study||0
5179372|NCT01154816|12739526|P4|COMPLETED|Overall Study||0
5179373|NCT01154816|12739527|P3|COMPLETED|Overall Study||0
5179374|NCT01154816|12739528|P2|COMPLETED|Overall Study||2
5179375|NCT01154816|12739529|P1|COMPLETED|Overall Study||0
5179376|NCT01154816|12739518|P12|STARTED|Overall Study||4
5179377|NCT01154816|12739519|P11|STARTED|Overall Study||11
5179378|NCT01154816|12739520|P10|STARTED|Overall Study||10
5179379|NCT01154816|12739521|P9|STARTED|Overall Study||10
5179380|NCT01154816|12739522|P8|STARTED|Overall Study||7
5179381|NCT01154816|12739523|P7|STARTED|Overall Study||6
5179382|NCT01154816|12739524|P6|STARTED|Overall Study||8
5179383|NCT01154816|12739525|P5|STARTED|Overall Study||10
5179384|NCT01154816|12739526|P4|STARTED|Overall Study||10
5179385|NCT01154816|12739527|P3|STARTED|Overall Study||10
5179386|NCT01154816|12739528|P2|STARTED|Overall Study||12
5179387|NCT01154816|12739529|P1|STARTED|Overall Study||20
5179388|NCT01154751|12739562|P1|NOT COMPLETED|3-year Follow-up||49
5179389|NCT01154751|12739562|P1|COMPLETED|3-year Follow-up||34
5179390|NCT01154751|12739562|P1|STARTED|3-year Follow-up||83
5179391|NCT01154751|12739562|P1|NOT COMPLETED|2-year Follow-up||10
5179392|NCT01154751|12739562|P1|COMPLETED|2-year Follow-up||83
5179393|NCT01154751|12739562|P1|STARTED|2-year Follow-up||93
5179394|NCT01154751|12739562|P1|NOT COMPLETED|1-year Follow-up||5
5179395|NCT01154751|12739562|P1|COMPLETED|1-year Follow-up||93
5179396|NCT01154751|12739562|P1|STARTED|1-year Follow-up||98
5179397|NCT01154751|12739562|P1|NOT COMPLETED|6-month Follow-up||11
5179398|NCT01154751|12739562|P1|COMPLETED|6-month Follow-up||98
5179399|NCT01154751|12739562|P1|STARTED|6-month Follow-up||109
5179400|NCT01154699|12739587|P2|NOT COMPLETED|Second Intervention||0
5179401|NCT01154699|12739588|P1|NOT COMPLETED|Second Intervention||0
5179402|NCT01154699|12739587|P2|COMPLETED|Second Intervention||8
5179403|NCT01154699|12739588|P1|COMPLETED|Second Intervention||13
5179404|NCT01154699|12739587|P2|Subjects With Asthma + OSA|Second Intervention||2
5179405|NCT01154699|12739588|P1|Subjects With Asthma + OSA|Second Intervention||6
5179406|NCT01154699|12739587|P2|Subjects With Asthma Only|Second Intervention||6
5179407|NCT01154699|12739588|P1|Subjects With Asthma Only|Second Intervention||7
5179408|NCT01154699|12739587|P2|STARTED|Second Intervention||8
5179409|NCT01154699|12739588|P1|STARTED|Second Intervention||13
5179410|NCT01154699|12739587|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
5179411|NCT01154699|12739588|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
5179412|NCT01154699|12739587|P2|COMPLETED|Washout Period (4 Weeks)||8
5179413|NCT01154699|12739588|P1|COMPLETED|Washout Period (4 Weeks)||13
5179414|NCT01154699|12739587|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
5179415|NCT01154699|12739588|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
5179416|NCT01154699|12739587|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
5179417|NCT01154699|12739588|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
5179418|NCT01154699|12739587|P2|STARTED|Washout Period (4 Weeks)||8
5179419|NCT01154699|12739588|P1|STARTED|Washout Period (4 Weeks)||13
5179420|NCT01154699|12739587|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
5179421|NCT01154699|12739588|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5179422|NCT01154699|12739587|P2|COMPLETED|First Intervention (4 Weeks)||8
5179423|NCT01154699|12739588|P1|COMPLETED|First Intervention (4 Weeks)||13
5179424|NCT01154699|12739587|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
5179425|NCT01154699|12739588|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
5179426|NCT01154699|12739587|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
5179427|NCT01154699|12739588|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
5179428|NCT01154699|12739587|P2|STARTED|First Intervention (4 Weeks)||8
5179429|NCT01154699|12739588|P1|STARTED|First Intervention (4 Weeks)||13
5179430|NCT01154673|12739606|P2|NOT COMPLETED|Overall Study||0
5179431|NCT01154673|12739607|P1|NOT COMPLETED|Overall Study||2
5179432|NCT01154673|12739606|P2|COMPLETED|Overall Study||16
5179433|NCT01154673|12739607|P1|COMPLETED|Overall Study||14
5179434|NCT01154673|12739606|P2|STARTED|Overall Study||16
5179435|NCT01154673|12739607|P1|STARTED|Overall Study||16
5179436|NCT01154634|12739617|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
5179437|NCT01154634|12739618|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
5179438|NCT01154634|12739619|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
5179439|NCT01154634|12739620|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
5179440|NCT01154634|12739617|P4|COMPLETED|Period 7 - Fourth Intervention||5
5179441|NCT01154634|12739618|P3|COMPLETED|Period 7 - Fourth Intervention||4
5179442|NCT01154634|12739619|P2|COMPLETED|Period 7 - Fourth Intervention||7
5179443|NCT01154634|12739620|P1|COMPLETED|Period 7 - Fourth Intervention||4
5179444|NCT01154634|12739617|P4|STARTED|Period 7 - Fourth Intervention||5
5179445|NCT01154634|12739618|P3|STARTED|Period 7 - Fourth Intervention||4
5179446|NCT01154634|12739619|P2|STARTED|Period 7 - Fourth Intervention||7
5179447|NCT01154634|12739620|P1|STARTED|Period 7 - Fourth Intervention||4
5179448|NCT01154634|12739617|P4|NOT COMPLETED|Period 6 - Washout||0
5179449|NCT01154634|12739618|P3|NOT COMPLETED|Period 6 - Washout||0
5179450|NCT01154634|12739619|P2|NOT COMPLETED|Period 6 - Washout||0
5179451|NCT01154634|12739620|P1|NOT COMPLETED|Period 6 - Washout||0
5179452|NCT01154634|12739617|P4|COMPLETED|Period 6 - Washout||5
5179453|NCT01154634|12739618|P3|COMPLETED|Period 6 - Washout||4
5179454|NCT01154634|12739619|P2|COMPLETED|Period 6 - Washout||7
5179455|NCT01154634|12739620|P1|COMPLETED|Period 6 - Washout||4
5179456|NCT01154634|12739617|P4|STARTED|Period 6 - Washout||5
5179457|NCT01154634|12739618|P3|STARTED|Period 6 - Washout||4
5179458|NCT01154634|12739619|P2|STARTED|Period 6 - Washout||7
5179459|NCT01154634|12739620|P1|STARTED|Period 6 - Washout||4
5179460|NCT01154634|12739617|P4|NOT COMPLETED|Period 5 - Third Intervention||0
5179461|NCT01154634|12739618|P3|NOT COMPLETED|Period 5 - Third Intervention||0
5179462|NCT01154634|12739619|P2|NOT COMPLETED|Period 5 - Third Intervention||0
5179463|NCT01154634|12739620|P1|NOT COMPLETED|Period 5 - Third Intervention||0
5179464|NCT01154634|12739617|P4|COMPLETED|Period 5 - Third Intervention||5
5179465|NCT01154634|12739618|P3|COMPLETED|Period 5 - Third Intervention||4
5179466|NCT01154634|12739619|P2|COMPLETED|Period 5 - Third Intervention||7
5179467|NCT01154634|12739620|P1|COMPLETED|Period 5 - Third Intervention||4
5179468|NCT01154634|12739617|P4|STARTED|Period 5 - Third Intervention||5
5179469|NCT01154634|12739618|P3|STARTED|Period 5 - Third Intervention||4
5179470|NCT01154634|12739619|P2|STARTED|Period 5 - Third Intervention||7
5179471|NCT01154634|12739620|P1|STARTED|Period 5 - Third Intervention||4
5179472|NCT01154634|12739617|P4|NOT COMPLETED|Period 4 - Washout||0
5179473|NCT01154634|12739618|P3|NOT COMPLETED|Period 4 - Washout||0
5179474|NCT01154634|12739619|P2|NOT COMPLETED|Period 4 - Washout||0
5179475|NCT01154634|12739620|P1|NOT COMPLETED|Period 4 - Washout||0
5179476|NCT01154634|12739617|P4|COMPLETED|Period 4 - Washout||5
5179477|NCT01154634|12739618|P3|COMPLETED|Period 4 - Washout||4
5179478|NCT01154634|12739619|P2|COMPLETED|Period 4 - Washout||7
5179479|NCT01154634|12739620|P1|COMPLETED|Period 4 - Washout||4
5179480|NCT01154634|12739617|P4|STARTED|Period 4 - Washout||5
5179481|NCT01154634|12739618|P3|STARTED|Period 4 - Washout||4
5179482|NCT01154634|12739619|P2|STARTED|Period 4 - Washout||7
5179483|NCT01154634|12739620|P1|STARTED|Period 4 - Washout||4
5179484|NCT01154634|12739617|P4|NOT COMPLETED|Period 3- Second Intervention||0
5179485|NCT01154634|12739618|P3|NOT COMPLETED|Period 3- Second Intervention||0
5179486|NCT01154634|12739619|P2|NOT COMPLETED|Period 3- Second Intervention||0
5179487|NCT01154634|12739620|P1|NOT COMPLETED|Period 3- Second Intervention||0
5179488|NCT01154634|12739617|P4|COMPLETED|Period 3- Second Intervention||5
5179489|NCT01154634|12739618|P3|COMPLETED|Period 3- Second Intervention||4
5179490|NCT01154634|12739619|P2|COMPLETED|Period 3- Second Intervention||7
5179491|NCT01154634|12739620|P1|COMPLETED|Period 3- Second Intervention||4
5179492|NCT01154634|12739617|P4|STARTED|Period 3- Second Intervention||5
5179493|NCT01154634|12739618|P3|STARTED|Period 3- Second Intervention||4
5179494|NCT01154634|12739619|P2|STARTED|Period 3- Second Intervention||7
5179495|NCT01154634|12739620|P1|STARTED|Period 3- Second Intervention||4
5179496|NCT01154634|12739617|P4|NOT COMPLETED|Period 2 - Washout||0
5179497|NCT01154634|12739618|P3|NOT COMPLETED|Period 2 - Washout||0
5179498|NCT01154634|12739619|P2|NOT COMPLETED|Period 2 - Washout||0
5179499|NCT01154634|12739620|P1|NOT COMPLETED|Period 2 - Washout||0
5179500|NCT01154634|12739617|P4|COMPLETED|Period 2 - Washout||5
5179501|NCT01154634|12739618|P3|COMPLETED|Period 2 - Washout||4
5179502|NCT01154634|12739619|P2|COMPLETED|Period 2 - Washout||7
5179503|NCT01154634|12739620|P1|COMPLETED|Period 2 - Washout||4
5179504|NCT01154634|12739617|P4|STARTED|Period 2 - Washout||5
5179505|NCT01154634|12739618|P3|STARTED|Period 2 - Washout||4
5179506|NCT01154634|12739619|P2|STARTED|Period 2 - Washout||7
5179507|NCT01154634|12739620|P1|STARTED|Period 2 - Washout||4
5179508|NCT01154634|12739617|P4|NOT COMPLETED|Period 1 - First Intervention||0
5179509|NCT01154634|12739618|P3|NOT COMPLETED|Period 1 - First Intervention||0
5179510|NCT01154634|12739619|P2|NOT COMPLETED|Period 1 - First Intervention||0
5179511|NCT01154634|12739620|P1|NOT COMPLETED|Period 1 - First Intervention||0
5179512|NCT01154634|12739617|P4|COMPLETED|Period 1 - First Intervention||5
5179513|NCT01154634|12739618|P3|COMPLETED|Period 1 - First Intervention||4
5179514|NCT01154634|12739619|P2|COMPLETED|Period 1 - First Intervention||7
5179515|NCT01154634|12739620|P1|COMPLETED|Period 1 - First Intervention||4
5179516|NCT01154634|12739617|P4|STARTED|Period 1 - First Intervention||5
5179517|NCT01154634|12739618|P3|STARTED|Period 1 - First Intervention||4
5179518|NCT01154634|12739619|P2|STARTED|Period 1 - First Intervention||7
5179519|NCT01154634|12739620|P1|STARTED|Period 1 - First Intervention||4
5179520|NCT01154452|12739662|P4|NOT COMPLETED|Phase II||6
5179521|NCT01154452|12739663|P3|NOT COMPLETED|Phase II||5
5179522|NCT01154452|12739664|P2|NOT COMPLETED|Phase II||0
5179523|NCT01154452|12739665|P1|NOT COMPLETED|Phase II||0
5179524|NCT01154452|12739662|P4|COMPLETED|Phase II||27
5179525|NCT01154452|12739663|P3|COMPLETED|Phase II||30
5179526|NCT01154452|12739664|P2|COMPLETED|Phase II||0
5179527|NCT01154452|12739665|P1|COMPLETED|Phase II||0
5179528|NCT01154452|12739662|P4|STARTED|Phase II||33
5179529|NCT01154452|12739663|P3|STARTED|Phase II||35
5179530|NCT01154452|12739664|P2|STARTED|Phase II||0
5179531|NCT01154452|12739665|P1|STARTED|Phase II||0
5179532|NCT01154452|12739662|P4|NOT COMPLETED|Phase Ib||0
5179533|NCT01154452|12739663|P3|NOT COMPLETED|Phase Ib||0
5179534|NCT01154452|12739664|P2|NOT COMPLETED|Phase Ib||1
5179535|NCT01154452|12739665|P1|NOT COMPLETED|Phase Ib||3
5179536|NCT01154452|12739662|P4|COMPLETED|Phase Ib||0
5179537|NCT01154452|12739663|P3|COMPLETED|Phase Ib||0
5179538|NCT01154452|12739664|P2|COMPLETED|Phase Ib||3
5179539|NCT01154452|12739665|P1|COMPLETED|Phase Ib||3
5179540|NCT01154452|12739662|P4|STARTED|Phase Ib||0
5179541|NCT01154452|12739663|P3|STARTED|Phase Ib||0
5179542|NCT01154452|12739664|P2|STARTED|Phase Ib||4
5179543|NCT01154452|12739665|P1|STARTED|Phase Ib||6
5179544|NCT01154335|12739681|P3|NOT COMPLETED|Overall Study||5
5179545|NCT01154335|12739682|P2|NOT COMPLETED|Overall Study||6
5179546|NCT01154335|12739683|P1|NOT COMPLETED|Overall Study||7
5179547|NCT01154335|12739681|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
5179548|NCT01154335|12739682|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
5179549|NCT01154335|12739683|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
5179550|NCT01154335|12739681|P3|STARTED|Overall Study||5
5179551|NCT01154335|12739682|P2|STARTED|Overall Study||6
5179552|NCT01154335|12739683|P1|STARTED|Overall Study||7
5179553|NCT01154322|12739690|P1|NOT COMPLETED|Overall Study||2
5179554|NCT01154322|12739690|P1|COMPLETED|Overall Study||14
5179555|NCT01154322|12739690|P1|STARTED|Overall Study||16
5179556|NCT01154296|12739697|P2|NOT COMPLETED|6-month Follow-up||328
5179557|NCT01154296|12739698|P1|NOT COMPLETED|6-month Follow-up||328
5179558|NCT01154296|12739697|P2|COMPLETED|6-month Follow-up||2179
5179559|NCT01154296|12739698|P1|COMPLETED|6-month Follow-up||2177
5179560|NCT01154296|12739697|P2|STARTED|6-month Follow-up||2507
5179561|NCT01154296|12739698|P1|STARTED|6-month Follow-up||2505
5179562|NCT01154296|12739697|P2|NOT COMPLETED|Randomization and Intervention||2
5179563|NCT01154296|12739698|P1|NOT COMPLETED|Randomization and Intervention||5
5179564|NCT01154296|12739697|P2|COMPLETED|Randomization and Intervention||2505
5179565|NCT01154296|12739698|P1|COMPLETED|Randomization and Intervention||2500
5179566|NCT01154296|12739697|P2|STARTED|Randomization and Intervention||2507
5179567|NCT01154296|12739698|P1|STARTED|Randomization and Intervention||2505
5179568|NCT01154283|12739716|P2|NOT COMPLETED|7-12 Weeks||1
5179569|NCT01154283|12739717|P1|NOT COMPLETED|7-12 Weeks||1
5179570|NCT01154283|12739716|P2|COMPLETED|7-12 Weeks||10
5179571|NCT01154283|12739717|P1|COMPLETED|7-12 Weeks||6
5179572|NCT01154283|12739716|P2|STARTED|7-12 Weeks||11
5179573|NCT01154283|12739717|P1|STARTED|7-12 Weeks||7
5179574|NCT01154283|12739716|P2|NOT COMPLETED|0-6 Weeks||3
5179575|NCT01154283|12739717|P1|NOT COMPLETED|0-6 Weeks||7
5179576|NCT01154283|12739716|P2|COMPLETED|0-6 Weeks||11
5179577|NCT01154283|12739717|P1|COMPLETED|0-6 Weeks||7
5179578|NCT01154283|12739716|P2|STARTED|0-6 Weeks||14
5179579|NCT01154283|12739717|P1|STARTED|0-6 Weeks||14
5179580|NCT01154231|12739729|P1|NOT COMPLETED|Overall Study||2
5179581|NCT01154231|12739729|P1|COMPLETED|Overall Study||312
5179582|NCT01154231|12739729|P1|STARTED|Overall Study||314
5179583|NCT01154218|12739735|P4|NOT COMPLETED|Fourth Intervention Period||0
5179584|NCT01154218|12739736|P3|NOT COMPLETED|Fourth Intervention Period||0
5179585|NCT01154218|12739737|P2|NOT COMPLETED|Fourth Intervention Period||0
5179586|NCT01154218|12739738|P1|NOT COMPLETED|Fourth Intervention Period||1
5179587|NCT01154218|12739735|P4|COMPLETED|Fourth Intervention Period||8
5179588|NCT01154218|12739736|P3|COMPLETED|Fourth Intervention Period||9
5179589|NCT01154218|12739737|P2|COMPLETED|Fourth Intervention Period||8
5179590|NCT01154218|12739738|P1|COMPLETED|Fourth Intervention Period||8
5179591|NCT01154218|12739735|P4|STARTED|Fourth Intervention Period||8
5179592|NCT01154218|12739736|P3|STARTED|Fourth Intervention Period||9
5179593|NCT01154218|12739737|P2|STARTED|Fourth Intervention Period||8
5179594|NCT01154218|12739738|P1|STARTED|Fourth Intervention Period||9
5179595|NCT01154218|12739735|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
5179596|NCT01154218|12739736|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179597|NCT01154218|12739737|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179598|NCT01154218|12739738|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179599|NCT01154218|12739735|P4|COMPLETED|Washout Period (at Least 14 Days)||8
5179600|NCT01154218|12739736|P3|COMPLETED|Washout Period (at Least 14 Days)||9
5179601|NCT01154218|12739737|P2|COMPLETED|Washout Period (at Least 14 Days)||8
5179602|NCT01154218|12739738|P1|COMPLETED|Washout Period (at Least 14 Days)||9
5179603|NCT01154218|12739735|P4|STARTED|Washout Period (at Least 14 Days)||9
5179604|NCT01154218|12739736|P3|STARTED|Washout Period (at Least 14 Days)||9
5179605|NCT01154218|12739737|P2|STARTED|Washout Period (at Least 14 Days)||8
5179606|NCT01154218|12739738|P1|STARTED|Washout Period (at Least 14 Days)||9
5179607|NCT01154218|12739735|P4|NOT COMPLETED|Third Intervention Period||0
5179608|NCT01154218|12739736|P3|NOT COMPLETED|Third Intervention Period||0
5179609|NCT01154218|12739737|P2|NOT COMPLETED|Third Intervention Period||1
5179610|NCT01154218|12739738|P1|NOT COMPLETED|Third Intervention Period||0
5179611|NCT01154218|12739735|P4|COMPLETED|Third Intervention Period||9
5179612|NCT01154218|12739736|P3|COMPLETED|Third Intervention Period||9
5179613|NCT01154218|12739737|P2|COMPLETED|Third Intervention Period||8
5179614|NCT01154218|12739738|P1|COMPLETED|Third Intervention Period||9
5179615|NCT01154218|12739735|P4|STARTED|Third Intervention Period||9
5179616|NCT01154218|12739736|P3|STARTED|Third Intervention Period||9
5179617|NCT01154218|12739737|P2|STARTED|Third Intervention Period||9
5179618|NCT01154218|12739738|P1|STARTED|Third Intervention Period||9
5179619|NCT01154218|12739735|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179620|NCT01154218|12739736|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179621|NCT01154218|12739737|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179622|NCT01154218|12739738|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179623|NCT01154218|12739735|P4|COMPLETED|Washout Period (at Least 14 Days)||9
5179624|NCT01154218|12739736|P3|COMPLETED|Washout Period (at Least 14 Days)||9
5179625|NCT01154218|12739737|P2|COMPLETED|Washout Period (at Least 14 Days)||9
5179626|NCT01154218|12739738|P1|COMPLETED|Washout Period (at Least 14 Days)||9
5179627|NCT01154218|12739735|P4|STARTED|Washout Period (at Least 14 Days)||9
5179628|NCT01154218|12739736|P3|STARTED|Washout Period (at Least 14 Days)||9
5179629|NCT01154218|12739737|P2|STARTED|Washout Period (at Least 14 Days)||9
5179630|NCT01154218|12739738|P1|STARTED|Washout Period (at Least 14 Days)||9
5179631|NCT01154218|12739735|P4|NOT COMPLETED|Second Intervention Period||0
5179632|NCT01154218|12739736|P3|NOT COMPLETED|Second Intervention Period||0
5179633|NCT01154218|12739737|P2|NOT COMPLETED|Second Intervention Period||0
5179634|NCT01154218|12739738|P1|NOT COMPLETED|Second Intervention Period||0
5179635|NCT01154218|12739735|P4|COMPLETED|Second Intervention Period||9
5179636|NCT01154218|12739736|P3|COMPLETED|Second Intervention Period||9
5179637|NCT01154218|12739737|P2|COMPLETED|Second Intervention Period||9
5179638|NCT01154218|12739738|P1|COMPLETED|Second Intervention Period||9
5179639|NCT01154218|12739735|P4|STARTED|Second Intervention Period||9
5179640|NCT01154218|12739736|P3|STARTED|Second Intervention Period||9
5179641|NCT01154218|12739737|P2|STARTED|Second Intervention Period||9
5179642|NCT01154218|12739738|P1|STARTED|Second Intervention Period||9
5179643|NCT01154218|12739735|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179644|NCT01154218|12739736|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179645|NCT01154218|12739737|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179646|NCT01154218|12739738|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5179647|NCT01154218|12739735|P4|COMPLETED|Washout Period (at Least 14 Days)||9
5179648|NCT01154218|12739736|P3|COMPLETED|Washout Period (at Least 14 Days)||9
5179649|NCT01154218|12739737|P2|COMPLETED|Washout Period (at Least 14 Days)||9
5179650|NCT01154218|12739738|P1|COMPLETED|Washout Period (at Least 14 Days)||9
5179651|NCT01154218|12739735|P4|STARTED|Washout Period (at Least 14 Days)||9
5179652|NCT01154218|12739736|P3|STARTED|Washout Period (at Least 14 Days)||9
5179653|NCT01154218|12739737|P2|STARTED|Washout Period (at Least 14 Days)||9
5179654|NCT01154218|12739738|P1|STARTED|Washout Period (at Least 14 Days)||9
5179655|NCT01154218|12739735|P4|NOT COMPLETED|First Intervention Period||0
5179656|NCT01154218|12739736|P3|NOT COMPLETED|First Intervention Period||0
5179657|NCT01154218|12739737|P2|NOT COMPLETED|First Intervention Period||0
5179658|NCT01154218|12739738|P1|NOT COMPLETED|First Intervention Period||0
5179659|NCT01154218|12739735|P4|COMPLETED|First Intervention Period||9
5179660|NCT01154218|12739736|P3|COMPLETED|First Intervention Period||9
5179661|NCT01154218|12739737|P2|COMPLETED|First Intervention Period||9
5179662|NCT01154218|12739738|P1|COMPLETED|First Intervention Period||9
5179663|NCT01154218|12739735|P4|STARTED|First Intervention Period||9
5179664|NCT01154218|12739736|P3|STARTED|First Intervention Period||9
5179665|NCT01154218|12739737|P2|STARTED|First Intervention Period||9
5179666|NCT01154218|12739738|P1|STARTED|First Intervention Period||9
5179667|NCT01154192|12739791|P3|NOT COMPLETED|Overall Study||0
5179668|NCT01154192|12739792|P2|NOT COMPLETED|Overall Study||0
5179669|NCT01154192|12739793|P1|NOT COMPLETED|Overall Study||0
5179670|NCT01154192|12739791|P3|COMPLETED|Overall Study||0
5179671|NCT01154192|12739792|P2|COMPLETED|Overall Study||10
5179672|NCT01154192|12739793|P1|COMPLETED|Overall Study||14
5179673|NCT01154192|12739791|P3|STARTED|Overall Study||0
5179674|NCT01154192|12739792|P2|STARTED|Overall Study||10
5179675|NCT01154192|12739793|P1|STARTED|Overall Study||14
5179676|NCT01154166|12739812|P2|NOT COMPLETED|Overall Study||12
5179677|NCT01154166|12739813|P1|NOT COMPLETED|Overall Study||34
5179678|NCT01154166|12739812|P2|COMPLETED|Overall Study||163
5179679|NCT01154166|12739813|P1|COMPLETED|Overall Study||135
5179680|NCT01154166|12739812|P2|STARTED|Overall Study||175
5179681|NCT01154166|12739813|P1|STARTED|Overall Study||169
5179682|NCT01154153|12739845|P2|NOT COMPLETED|Overall Study||3
5179683|NCT01154153|12739846|P1|NOT COMPLETED|Overall Study||5
5179684|NCT01154153|12739845|P2|COMPLETED|Overall Study||66
5179685|NCT01154153|12739846|P1|COMPLETED|Overall Study||66
5179686|NCT01154153|12739845|P2|STARTED|Overall Study||69
5179687|NCT01154153|12739846|P1|STARTED|Overall Study||71
5179688|NCT01154140|12739864|P2|NOT COMPLETED|Overall Study||102
5179689|NCT01154140|12739865|P1|NOT COMPLETED|Overall Study||91
5179690|NCT01154140|12739864|P2|COMPLETED|Overall Study||69
5179691|NCT01154140|12739865|P1|COMPLETED|Overall Study||81
5179692|NCT01154140|12739864|P2|Treated|Overall Study||169
5179693|NCT01154140|12739865|P1|Treated|Overall Study||171
5179694|NCT01154140|12739864|P2|STARTED|Overall Study||171
5179695|NCT01154140|12739865|P1|STARTED|Overall Study||172
5179696|NCT01154127|12739918|P2|NOT COMPLETED|Period 2 (21 Days)||1
5179697|NCT01154127|12739919|P1|NOT COMPLETED|Period 2 (21 Days)||0
5179698|NCT01154127|12739918|P2|COMPLETED|Period 2 (21 Days)||46
5179699|NCT01154127|12739919|P1|COMPLETED|Period 2 (21 Days)||49
5179700|NCT01154127|12739918|P2|STARTED|Period 2 (21 Days)||47
5179701|NCT01154127|12739919|P1|STARTED|Period 2 (21 Days)||49
5179702|NCT01154127|12739918|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
5179703|NCT01154127|12739919|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
5179704|NCT01154127|12739918|P2|COMPLETED|Washout (14 - 28 Days)||47
5179705|NCT01154127|12739919|P1|COMPLETED|Washout (14 - 28 Days)||49
5179706|NCT01154127|12739918|P2|STARTED|Washout (14 - 28 Days)||47
5179707|NCT01154127|12739919|P1|STARTED|Washout (14 - 28 Days)||52
5179708|NCT01154127|12739918|P2|NOT COMPLETED|Period 1 (21 Days)||6
5179709|NCT01154127|12739919|P1|NOT COMPLETED|Period 1 (21 Days)||3
5179710|NCT01154127|12739918|P2|COMPLETED|Period 1 (21 Days)||47
5179711|NCT01154127|12739919|P1|COMPLETED|Period 1 (21 Days)||52
5179712|NCT01154127|12739918|P2|STARTED|Period 1 (21 Days)||53
5179713|NCT01154127|12739919|P1|STARTED|Period 1 (21 Days)||55
5179714|NCT01154101|12739946|P5|NOT COMPLETED|Overall Study||1
5179715|NCT01154101|12739947|P4|NOT COMPLETED|Overall Study||2
5179716|NCT01154101|12739948|P3|NOT COMPLETED|Overall Study||3
5179717|NCT01154101|12739949|P2|NOT COMPLETED|Overall Study||4
5179718|NCT01154101|12739950|P1|NOT COMPLETED|Overall Study||0
5179719|NCT01154101|12739946|P5|COMPLETED|Overall Study||0
5179720|NCT01154101|12739947|P4|COMPLETED|Overall Study||9
5179721|NCT01154101|12739948|P3|COMPLETED|Overall Study||9
5179722|NCT01154101|12739949|P2|COMPLETED|Overall Study||5
5179723|NCT01154101|12739950|P1|COMPLETED|Overall Study||7
5179724|NCT01154101|12739946|P5|STARTED|Overall Study||1
5179725|NCT01154101|12739947|P4|STARTED|Overall Study||11
5179726|NCT01154101|12739948|P3|STARTED|Overall Study||12
5179727|NCT01154101|12739949|P2|STARTED|Overall Study||9
5179728|NCT01154101|12739950|P1|STARTED|Overall Study||7
5179729|NCT01154088|12740005|P3|NOT COMPLETED|Overall Study||7
5179730|NCT01154088|12740006|P2|NOT COMPLETED|Overall Study||6
5179731|NCT01154088|12740007|P1|NOT COMPLETED|Overall Study||4
5179732|NCT01154088|12740005|P3|COMPLETED|Overall Study||383
5179733|NCT01154088|12740006|P2|COMPLETED|Overall Study||384
5179734|NCT01154088|12740007|P1|COMPLETED|Overall Study||386
5179735|NCT01154088|12740005|P3|STARTED|Overall Study||390
5179736|NCT01154088|12740006|P2|STARTED|Overall Study||390
5179737|NCT01154088|12740007|P1|STARTED|Overall Study||390
5179738|NCT01154036|12740047|P8|NOT COMPLETED|Phase II||6
5179739|NCT01154036|12740048|P7|NOT COMPLETED|Phase II||9
5179740|NCT01154036|12740049|P6|NOT COMPLETED|Phase II||5
5179741|NCT01154036|12740050|P5|NOT COMPLETED|Phase II||8
5179742|NCT01154036|12740051|P4|NOT COMPLETED|Phase II||1
5179743|NCT01154036|12740052|P3|NOT COMPLETED|Phase II||0
5179744|NCT01154036|12740053|P2|NOT COMPLETED|Phase II||0
5179745|NCT01154036|12740054|P1|NOT COMPLETED|Phase II||0
5179746|NCT01154036|12740047|P8|COMPLETED|Phase II||200
5179747|NCT01154036|12740048|P7|COMPLETED|Phase II||225
5179748|NCT01154036|12740049|P6|COMPLETED|Phase II||121
5179749|NCT01154036|12740050|P5|COMPLETED|Phase II||116
5179750|NCT01154036|12740051|P4|COMPLETED|Phase II||27
5179751|NCT01154036|12740052|P3|COMPLETED|Phase II||0
5179752|NCT01154036|12740053|P2|COMPLETED|Phase II||0
5179753|NCT01154036|12740054|P1|COMPLETED|Phase II||0
5179754|NCT01154036|12740047|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
5179755|NCT01154036|12740048|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
5179756|NCT01154036|12740049|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
5179757|NCT01154036|12740050|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
5179758|NCT01154036|12740051|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
5179759|NCT01154036|12740052|P3|STARTED|Phase II||0
5179760|NCT01154036|12740053|P2|STARTED|Phase II||0
5179761|NCT01154036|12740054|P1|STARTED|Phase II||0
5179762|NCT01154036|12740047|P8|NOT COMPLETED|Phase I||0
5179763|NCT01154036|12740048|P7|NOT COMPLETED|Phase I||0
5179764|NCT01154036|12740049|P6|NOT COMPLETED|Phase I||0
5179765|NCT01154036|12740050|P5|NOT COMPLETED|Phase I||0
5179766|NCT01154036|12740051|P4|NOT COMPLETED|Phase I||0
5179767|NCT01154036|12740052|P3|NOT COMPLETED|Phase I||56
5179768|NCT01154036|12740053|P2|NOT COMPLETED|Phase I||28
5179769|NCT01154036|12740054|P1|NOT COMPLETED|Phase I||3
5179770|NCT01154036|12740047|P8|COMPLETED|Phase I||0
5179771|NCT01154036|12740048|P7|COMPLETED|Phase I||0
5179772|NCT01154036|12740049|P6|COMPLETED|Phase I||0
5179773|NCT01154036|12740050|P5|COMPLETED|Phase I||0
5179774|NCT01154036|12740051|P4|COMPLETED|Phase I||0
5179775|NCT01154036|12740052|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
5179776|NCT01154036|12740053|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
5179777|NCT01154036|12740054|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
5179778|NCT01154036|12740047|P8|STARTED|Phase I||0
5179779|NCT01154036|12740048|P7|STARTED|Phase I||0
5179780|NCT01154036|12740049|P6|STARTED|Phase I||0
5179781|NCT01154036|12740050|P5|STARTED|Phase I||0
5179782|NCT01154036|12740051|P4|STARTED|Phase I||0
5179783|NCT01154036|12740052|P3|STARTED|Phase I||944
5179784|NCT01154036|12740053|P2|STARTED|Phase I||483
5179785|NCT01154036|12740054|P1|STARTED|Phase I||120
5179786|NCT01154010|12740178|P2|NOT COMPLETED|Overall Study||1
5179787|NCT01154010|12740179|P1|NOT COMPLETED|Overall Study||0
5179788|NCT01154010|12740178|P2|COMPLETED|Overall Study||8
5179789|NCT01154010|12740179|P1|COMPLETED|Overall Study||9
5179790|NCT01154010|12740178|P2|STARTED|Overall Study||9
5179791|NCT01154010|12740179|P1|STARTED|Overall Study||9
5179792|NCT01153984|12740185|P1|NOT COMPLETED|Overall Study||2
5179793|NCT01153984|12740185|P1|COMPLETED|Overall Study||21
5179794|NCT01153984|12740185|P1|STARTED|Overall Study||23
5179795|NCT01153971|12740196|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
5179796|NCT01153971|12740196|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
5179797|NCT01153971|12740196|P1|STARTED|Follow-up (Months 17-40 of Study)||41
5179798|NCT01153971|12740196|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
5179799|NCT01153971|12740196|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
5179800|NCT01153971|12740196|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
5179801|NCT01153971|12740196|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
5179802|NCT01153971|12740196|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
5179803|NCT01153971|12740196|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
5179804|NCT01153958|12740219|P2|NOT COMPLETED|Overall Study||32
5179805|NCT01153958|12740220|P1|NOT COMPLETED|Overall Study||36
5179806|NCT01153958|12740219|P2|COMPLETED|Overall Study||35
5179807|NCT01153958|12740220|P1|COMPLETED|Overall Study||30
5179808|NCT01153958|12740219|P2|STARTED|Overall Study||67
5179809|NCT01153958|12740220|P1|STARTED|Overall Study||66
5179810|NCT01153893|12740238|P2|NOT COMPLETED|Overall Study||0
5179811|NCT01153893|12740239|P1|NOT COMPLETED|Overall Study||1
5179812|NCT01153893|12740238|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
5179813|NCT01153893|12740239|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
5179814|NCT01153893|12740238|P2|STARTED|Overall Study||36
5179815|NCT01153893|12740239|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
5179816|NCT01153841|12740265|P2|NOT COMPLETED|Overall Study||0
5179817|NCT01153841|12740266|P1|NOT COMPLETED|Overall Study||6
5179818|NCT01153841|12740265|P2|COMPLETED|Overall Study||99
5179819|NCT01153841|12740266|P1|COMPLETED|Overall Study||193
5179820|NCT01153841|12740265|P2|STARTED|Overall Study||99
5179821|NCT01153841|12740266|P1|STARTED|Overall Study||199
5179822|NCT01153815|12740282|P2|NOT COMPLETED|Overall Study||5
5179823|NCT01153815|12740283|P1|NOT COMPLETED|Overall Study||9
5179824|NCT01153815|12740282|P2|COMPLETED|Overall Study||82
5179825|NCT01153815|12740283|P1|COMPLETED|Overall Study||74
5179826|NCT01153815|12740282|P2|STARTED|Overall Study||87
5179827|NCT01153815|12740283|P1|STARTED|Overall Study||83
5179828|NCT01153763|12740305|P1|NOT COMPLETED|Overall Study||21
5179829|NCT01153763|12740305|P1|COMPLETED|Overall Study||71
5179830|NCT01153763|12740305|P1|STARTED|Overall Study||92
5179831|NCT01153724|12740321|P1|NOT COMPLETED|Treatment Period 2||2
5179832|NCT01153724|12740321|P1|COMPLETED|Treatment Period 2||32
5179833|NCT01153724|12740321|P1|STARTED|Treatment Period 2||34
5179834|NCT01153724|12740321|P1|NOT COMPLETED|Treatment Period 1||1
5179835|NCT01153724|12740321|P1|COMPLETED|Treatment Period 1||34
5179836|NCT01153724|12740321|P1|STARTED|Treatment Period 1||35
5179837|NCT01153711|12740341|P1|NOT COMPLETED|Overall Study||0
5179838|NCT01153711|12740341|P1|COMPLETED|Overall Study||32
5179839|NCT01153711|12740341|P1|STARTED|Overall Study||32
5179840|NCT01153698|12740361|P1|NOT COMPLETED|Overall Study||29
5179841|NCT01153698|12740361|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
5179842|NCT01153698|12740361|P1|STARTED|Overall Study|Entered and treated.|168
5179843|NCT01153685|12740377|P2|NOT COMPLETED|Overall Study||0
5179844|NCT01153685|12740378|P1|NOT COMPLETED|Overall Study||0
5179845|NCT01153685|12740377|P2|COMPLETED|Overall Study||70
5179846|NCT01153685|12740378|P1|COMPLETED|Overall Study||50
5179847|NCT01153685|12740377|P2|STARTED|Overall Study||70
5179848|NCT01153685|12740378|P1|STARTED|Overall Study||50
5179849|NCT01153672|12740402|P1|NOT COMPLETED|Overall Study||2
5179850|NCT01153672|12740402|P1|COMPLETED|Overall Study||6
5179851|NCT01153672|12740402|P1|STARTED|Overall Study||8
5179852|NCT01153633|12740412|P2|NOT COMPLETED|Overall Study||4
5179853|NCT01153633|12740413|P1|NOT COMPLETED|Overall Study||4
5179854|NCT01153633|12740412|P2|COMPLETED|Overall Study||13
5179855|NCT01153633|12740413|P1|COMPLETED|Overall Study||13
5179856|NCT01153633|12740412|P2|STARTED|Overall Study||17
5179857|NCT01153633|12740413|P1|STARTED|Overall Study||17
5179858|NCT01153620|12740431|P2|NOT COMPLETED|Overall Study||0
5179859|NCT01153620|12740432|P1|NOT COMPLETED|Overall Study||0
5179860|NCT01153620|12740431|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
5179861|NCT01153620|12740432|P1|COMPLETED|Overall Study||30
5179862|NCT01153620|12740431|P2|STARTED|Overall Study|30 patients (31 wounds)|30
5179863|NCT01153620|12740432|P1|STARTED|Overall Study||30
5179864|NCT01153581|12740438|P1|NOT COMPLETED|Overall Study||0
5179865|NCT01153581|12740438|P1|COMPLETED|Overall Study||109
5179866|NCT01153581|12740438|P1|STARTED|Overall Study||109
5179867|NCT01153516|12740450|P2|NOT COMPLETED|Overall Study||0
5179868|NCT01153516|12740451|P1|NOT COMPLETED|Overall Study||2
5179869|NCT01153516|12740450|P2|COMPLETED|Overall Study||10
5179870|NCT01153516|12740451|P1|COMPLETED|Overall Study||10
5179871|NCT01153516|12740450|P2|STARTED|Overall Study||10
5179872|NCT01153516|12740451|P1|STARTED|Overall Study||12
5179873|NCT01153503|12740464|P3|NOT COMPLETED|Overall Study||0
5179874|NCT01153503|12740465|P2|NOT COMPLETED|Overall Study||1
5179875|NCT01153503|12740466|P1|NOT COMPLETED|Overall Study||0
5179876|NCT01153503|12740464|P3|COMPLETED|Overall Study||25
5179877|NCT01153503|12740465|P2|COMPLETED|Overall Study||24
5179878|NCT01153503|12740466|P1|COMPLETED|Overall Study||25
5179879|NCT01153503|12740464|P3|STARTED|Overall Study||25
5179880|NCT01153503|12740465|P2|STARTED|Overall Study||25
5179881|NCT01153503|12740466|P1|STARTED|Overall Study||25
5179882|NCT01153425|12740476|P2|NOT COMPLETED|Overall Study||3
5179883|NCT01153425|12740477|P1|NOT COMPLETED|Overall Study||3
5179884|NCT01153425|12740476|P2|COMPLETED|Overall Study||14
5179885|NCT01153425|12740477|P1|COMPLETED|Overall Study||13
5179886|NCT01153425|12740476|P2|STARTED|Overall Study||17
5179887|NCT01153425|12740477|P1|STARTED|Overall Study||16
5179888|NCT01153347|12740489|P4|NOT COMPLETED|Overall Study||32
5179889|NCT01153347|12740490|P3|NOT COMPLETED|Overall Study||50
5179890|NCT01153347|12740491|P2|NOT COMPLETED|Overall Study||44
5179891|NCT01153347|12740492|P1|NOT COMPLETED|Overall Study||33
5179892|NCT01153347|12740489|P4|COMPLETED|Overall Study||129
5179893|NCT01153347|12740490|P3|COMPLETED|Overall Study||110
5179894|NCT01153347|12740491|P2|COMPLETED|Overall Study||116
5179895|NCT01153347|12740492|P1|COMPLETED|Overall Study||127
5179896|NCT01153347|12740489|P4|Received Treatment|Overall Study||160
5179897|NCT01153347|12740490|P3|Received Treatment|Overall Study||158
5179898|NCT01153347|12740491|P2|Received Treatment|Overall Study||158
5179899|NCT01153347|12740492|P1|Received Treatment|Overall Study||160
5179900|NCT01153347|12740489|P4|STARTED|Overall Study||161
5179901|NCT01153347|12740490|P3|STARTED|Overall Study||160
5179902|NCT01153347|12740491|P2|STARTED|Overall Study||160
5179903|NCT01153347|12740492|P1|STARTED|Overall Study||160
5179904|NCT01153321|12740592|P2|NOT COMPLETED|Overall Study||3
5179905|NCT01153321|12740593|P1|NOT COMPLETED|Overall Study||1
5179906|NCT01153321|12740592|P2|COMPLETED|Overall Study||19
5179907|NCT01153321|12740593|P1|COMPLETED|Overall Study||21
5179908|NCT01153321|12740592|P2|STARTED|Overall Study||22
5179909|NCT01153321|12740593|P1|STARTED|Overall Study||22
5179910|NCT01153269|12740705|P1|NOT COMPLETED|Overall Study||2
5179911|NCT01153269|12740705|P1|COMPLETED|Overall Study||31
5179912|NCT01153269|12740705|P1|Participants Analyzed|Overall Study||33
5179913|NCT01153269|12740705|P1|STARTED|Overall Study||33
5179914|NCT01153009|12740768|P4|NOT COMPLETED|Overall Study||37
5179915|NCT01153009|12740769|P3|NOT COMPLETED|Overall Study||41
5179916|NCT01153009|12740770|P2|NOT COMPLETED|Overall Study||34
5179917|NCT01153009|12740771|P1|NOT COMPLETED|Overall Study||32
5179918|NCT01153009|12740768|P4|COMPLETED|Overall Study||115
5179919|NCT01153009|12740769|P3|COMPLETED|Overall Study||113
5179920|NCT01153009|12740770|P2|COMPLETED|Overall Study||113
5179921|NCT01153009|12740771|P1|COMPLETED|Overall Study||129
5179922|NCT01153009|12740768|P4|Treated|Overall Study||150
5179923|NCT01153009|12740769|P3|Treated|Overall Study||154
5179924|NCT01153009|12740770|P2|Treated|Overall Study||147
5179925|NCT01153009|12740771|P1|Treated|Overall Study||159
5179926|NCT01153009|12740768|P4|STARTED|Overall Study||152
5179927|NCT01153009|12740769|P3|STARTED|Overall Study||154
5179928|NCT01153009|12740770|P2|STARTED|Overall Study||147
5179929|NCT01153009|12740771|P1|STARTED|Overall Study||161
5179930|NCT01152996|12740801|P1|NOT COMPLETED|Overall Study||537
5179931|NCT01152996|12740801|P1|COMPLETED|Overall Study||538
5179932|NCT01152996|12740801|P1|Treated|Overall Study||1073
5179933|NCT01152996|12740801|P1|STARTED|Overall Study||1075
5179934|NCT01152814|12740814|P1|NOT COMPLETED|Overall Study||2
5179935|NCT01152814|12740814|P1|COMPLETED|Overall Study||62
5179936|NCT01152814|12740814|P1|STARTED|Overall Study||64
5179937|NCT01152788|12740823|P2|NOT COMPLETED|Overall Study||4
5179938|NCT01152788|12740824|P1|NOT COMPLETED|Overall Study||0
5179939|NCT01152788|12740823|P2|COMPLETED|Overall Study||28
5179940|NCT01152788|12740824|P1|COMPLETED|Overall Study||32
5179941|NCT01152788|12740823|P2|STARTED|Overall Study||32
5179942|NCT01152788|12740824|P1|STARTED|Overall Study||32
5179943|NCT01152697|12740836|P1|NOT COMPLETED|Overall Study||19
5179944|NCT01152697|12740836|P1|COMPLETED|Overall Study||11
5179945|NCT01152697|12740836|P1|STARTED|Overall Study||30
5179946|NCT01152580|12740861|P2|NOT COMPLETED|Overall Study||1
5179947|NCT01152580|12740862|P1|NOT COMPLETED|Overall Study||0
5179948|NCT01152580|12740861|P2|COMPLETED|Overall Study||13
5179949|NCT01152580|12740862|P1|COMPLETED|Overall Study||5
5179950|NCT01152580|12740861|P2|STARTED|Overall Study||14
5179951|NCT01152580|12740862|P1|STARTED|Overall Study||5
5179952|NCT01152554|12740884|P2|NOT COMPLETED|Overall Study||111
5179953|NCT01152554|12740885|P1|NOT COMPLETED|Overall Study||334
5179954|NCT01152554|12740884|P2|COMPLETED|Overall Study||92
5179955|NCT01152554|12740885|P1|COMPLETED|Overall Study||276
5179956|NCT01152554|12740884|P2|Received Treatment|Overall Study||201
5179957|NCT01152554|12740885|P1|Received Treatment|Overall Study||607
5179958|NCT01152554|12740884|P2|STARTED|Overall Study||203
5179959|NCT01152554|12740885|P1|STARTED|Overall Study||610
5179960|NCT01152515|12740909|P2|NOT COMPLETED|Overall Study||0
5179961|NCT01152515|12740910|P1|NOT COMPLETED|Overall Study||0
5179962|NCT01152515|12740909|P2|COMPLETED|Overall Study||25
5179963|NCT01152515|12740910|P1|COMPLETED|Overall Study||25
5179964|NCT01152515|12740909|P2|STARTED|Overall Study||25
5179965|NCT01152515|12740910|P1|STARTED|Overall Study||25
5179966|NCT01152450|12740924|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
5179967|NCT01152450|12740925|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
5179968|NCT01152450|12740926|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
5179969|NCT01152450|12740927|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
5179970|NCT01152450|12740928|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
5179971|NCT01152450|12740929|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
5179972|NCT01152450|12740924|P6|COMPLETED|Period 3 (4 Weeks)||12
5179973|NCT01152450|12740925|P5|COMPLETED|Period 3 (4 Weeks)||16
5179974|NCT01152450|12740926|P4|COMPLETED|Period 3 (4 Weeks)||15
5179975|NCT01152450|12740927|P3|COMPLETED|Period 3 (4 Weeks)||16
5179976|NCT01152450|12740928|P2|COMPLETED|Period 3 (4 Weeks)||15
5179977|NCT01152450|12740929|P1|COMPLETED|Period 3 (4 Weeks)||15
5179978|NCT01152450|12740924|P6|STARTED|Period 3 (4 Weeks)||12
5179979|NCT01152450|12740925|P5|STARTED|Period 3 (4 Weeks)||16
5179980|NCT01152450|12740926|P4|STARTED|Period 3 (4 Weeks)||15
5179981|NCT01152450|12740927|P3|STARTED|Period 3 (4 Weeks)||16
5179982|NCT01152450|12740928|P2|STARTED|Period 3 (4 Weeks)||15
5179983|NCT01152450|12740929|P1|STARTED|Period 3 (4 Weeks)||15
5179984|NCT01152450|12740924|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
5179985|NCT01152450|12740925|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
5179986|NCT01152450|12740926|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
5179987|NCT01152450|12740927|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
5179988|NCT01152450|12740928|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
5179989|NCT01152450|12740929|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
5179990|NCT01152450|12740924|P6|COMPLETED|Period 2 (4 Weeks)||12
5179991|NCT01152450|12740925|P5|COMPLETED|Period 2 (4 Weeks)||16
5179992|NCT01152450|12740926|P4|COMPLETED|Period 2 (4 Weeks)||15
5179993|NCT01152450|12740927|P3|COMPLETED|Period 2 (4 Weeks)||16
5179994|NCT01152450|12740928|P2|COMPLETED|Period 2 (4 Weeks)||15
5179995|NCT01152450|12740929|P1|COMPLETED|Period 2 (4 Weeks)||15
5179996|NCT01152450|12740924|P6|STARTED|Period 2 (4 Weeks)||12
5179997|NCT01152450|12740925|P5|STARTED|Period 2 (4 Weeks)||16
5179998|NCT01152450|12740926|P4|STARTED|Period 2 (4 Weeks)||15
5179999|NCT01152450|12740927|P3|STARTED|Period 2 (4 Weeks)||16
5180000|NCT01152450|12740928|P2|STARTED|Period 2 (4 Weeks)||15
5180001|NCT01152450|12740929|P1|STARTED|Period 2 (4 Weeks)||15
5180002|NCT01152450|12740924|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
5180003|NCT01152450|12740925|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
5180004|NCT01152450|12740926|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
5180005|NCT01152450|12740927|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
5180006|NCT01152450|12740928|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
5180007|NCT01152450|12740929|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
5180008|NCT01152450|12740924|P6|COMPLETED|Period 1 (4 Weeks)||12
5180009|NCT01152450|12740925|P5|COMPLETED|Period 1 (4 Weeks)||16
5180010|NCT01152450|12740926|P4|COMPLETED|Period 1 (4 Weeks)||15
5180011|NCT01152450|12740927|P3|COMPLETED|Period 1 (4 Weeks)||16
5180012|NCT01152450|12740928|P2|COMPLETED|Period 1 (4 Weeks)||15
5180013|NCT01152450|12740929|P1|COMPLETED|Period 1 (4 Weeks)||15
5180014|NCT01152450|12740924|P6|STARTED|Period 1 (4 Weeks)||13
5180015|NCT01152450|12740925|P5|STARTED|Period 1 (4 Weeks)||18
5180016|NCT01152450|12740926|P4|STARTED|Period 1 (4 Weeks)||15
5180017|NCT01152450|12740927|P3|STARTED|Period 1 (4 Weeks)||17
5180018|NCT01152450|12740928|P2|STARTED|Period 1 (4 Weeks)||16
5180019|NCT01152450|12740929|P1|STARTED|Period 1 (4 Weeks)||15
5180020|NCT01152437|12741000|P3|NOT COMPLETED|Overall Study||43
5180021|NCT01152437|12741001|P2|NOT COMPLETED|Overall Study||15
5180022|NCT01152437|12741002|P1|NOT COMPLETED|Overall Study||36
5180023|NCT01152437|12741000|P3|COMPLETED|Overall Study||0
5180024|NCT01152437|12741001|P2|COMPLETED|Overall Study||0
5180025|NCT01152437|12741002|P1|COMPLETED|Overall Study||0
5180026|NCT01152437|12741000|P3|STARTED|Overall Study|entered|43
5180027|NCT01152437|12741001|P2|STARTED|Overall Study|randomised|15
5180028|NCT01152437|12741002|P1|STARTED|Overall Study|randomised|36
5180029|NCT01152385|12741022|P4|NOT COMPLETED|Overall Study||5
5180030|NCT01152385|12741023|P3|NOT COMPLETED|Overall Study||5
5180031|NCT01152385|12741024|P2|NOT COMPLETED|Overall Study||6
5180032|NCT01152385|12741025|P1|NOT COMPLETED|Overall Study||9
5180033|NCT01152385|12741022|P4|COMPLETED|Overall Study||50
5180034|NCT01152385|12741023|P3|COMPLETED|Overall Study||51
5180035|NCT01152385|12741024|P2|COMPLETED|Overall Study||52
5180036|NCT01152385|12741025|P1|COMPLETED|Overall Study||46
5180037|NCT01152385|12741022|P4|STARTED|Overall Study||55
5180038|NCT01152385|12741023|P3|STARTED|Overall Study||56
5180039|NCT01152385|12741024|P2|STARTED|Overall Study||58
5180040|NCT01152385|12741025|P1|STARTED|Overall Study||55
5180041|NCT01152359|12741065|P2|NOT COMPLETED|Overall Study||22
5180042|NCT01152359|12741066|P1|NOT COMPLETED|Overall Study||24
5180043|NCT01152359|12741065|P2|COMPLETED|Overall Study||80
5180044|NCT01152359|12741066|P1|COMPLETED|Overall Study||81
5180045|NCT01152359|12741065|P2|STARTED|Overall Study||102
5180046|NCT01152359|12741066|P1|STARTED|Overall Study||105
5180047|NCT01152307|12741078|P2|NOT COMPLETED|Overall Study||0
5180048|NCT01152307|12741079|P1|NOT COMPLETED|Overall Study||0
5180049|NCT01152307|12741078|P2|COMPLETED|Overall Study||214
5180050|NCT01152307|12741079|P1|COMPLETED|Overall Study||191
5180051|NCT01152307|12741078|P2|STARTED|Overall Study||214
5180052|NCT01152307|12741079|P1|STARTED|Overall Study||191
5180053|NCT01152294|12741087|P2|NOT COMPLETED|Overall Study||0
5180054|NCT01152294|12741088|P1|NOT COMPLETED|Overall Study||0
5180055|NCT01152294|12741087|P2|COMPLETED|Overall Study||188
5180056|NCT01152294|12741088|P1|COMPLETED|Overall Study||213
5180057|NCT01152294|12741087|P2|STARTED|Overall Study||188
5180058|NCT01152294|12741088|P1|STARTED|Overall Study||213
5180059|NCT01152190|12741096|P2|NOT COMPLETED|Overall Study||8
5180060|NCT01152190|12741097|P1|NOT COMPLETED|Overall Study||5
5180061|NCT01152190|12741096|P2|COMPLETED|Overall Study||39
5180062|NCT01152190|12741097|P1|COMPLETED|Overall Study||45
5180063|NCT01152190|12741096|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
5180064|NCT01152190|12741097|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
5180065|NCT01152190|12741096|P2|STARTED|Overall Study||47
5180066|NCT01152190|12741097|P1|STARTED|Overall Study||50
5180067|NCT01152112|12741111|P2|NOT COMPLETED|Overall Study||0
5180068|NCT01152112|12741112|P1|NOT COMPLETED|Overall Study||0
5180069|NCT01152112|12741111|P2|COMPLETED|Overall Study||32
5180070|NCT01152112|12741112|P1|COMPLETED|Overall Study||42
5180071|NCT01152112|12741111|P2|STARTED|Overall Study||32
5180072|NCT01152112|12741112|P1|STARTED|Overall Study||42
5180073|NCT01152021|12741120|P2|NOT COMPLETED|Overall Study||6
5180074|NCT01152021|12741121|P1|NOT COMPLETED|Overall Study||6
5180075|NCT01152021|12741120|P2|COMPLETED|Overall Study||1
5180076|NCT01152021|12741121|P1|COMPLETED|Overall Study||2
5180077|NCT01152021|12741120|P2|STARTED|Overall Study||7
5180078|NCT01152021|12741121|P1|STARTED|Overall Study||8
5180079|NCT01151904|12741129|P1|NOT COMPLETED|Overall Study||0
5180080|NCT01151904|12741129|P1|COMPLETED|Overall Study||17
5180081|NCT01151904|12741129|P1|STARTED|Overall Study||17
5180082|NCT01151852|12741137|P2|NOT COMPLETED|Overall Study||0
5180083|NCT01151852|12741138|P1|NOT COMPLETED|Overall Study||0
5180084|NCT01151852|12741137|P2|COMPLETED|Overall Study||40
5180085|NCT01151852|12741138|P1|COMPLETED|Overall Study||41
5180086|NCT01151852|12741137|P2|STARTED|Overall Study||40
5180087|NCT01151852|12741138|P1|STARTED|Overall Study||41
5180088|NCT01151761|12741154|P1|NOT COMPLETED|Overall Study||0
5180089|NCT01151761|12741154|P1|COMPLETED|Overall Study||2
5180090|NCT01151761|12741154|P1|STARTED|Overall Study||2
5180091|NCT01151618|12741165|P1|NOT COMPLETED|Overall Study||9
5180092|NCT01151618|12741165|P1|COMPLETED|Overall Study||13
5180093|NCT01151618|12741165|P1|STARTED|Overall Study||22
5180094|NCT01151579|12741173|P2|NOT COMPLETED|Overall Study||7
5180095|NCT01151579|12741174|P1|NOT COMPLETED|Overall Study||12
5180096|NCT01151579|12741173|P2|COMPLETED|Overall Study||24
5180097|NCT01151579|12741174|P1|COMPLETED|Overall Study||46
5180098|NCT01151579|12741173|P2|STARTED|Overall Study||31
5180099|NCT01151579|12741174|P1|STARTED|Overall Study||58
5180100|NCT01151553|12741184|P1|NOT COMPLETED|Overall Study||0
5180101|NCT01151553|12741184|P1|COMPLETED|Overall Study||5
5180102|NCT01151553|12741184|P1|STARTED|Overall Study||5
5180103|NCT01151540|12741188|P1|NOT COMPLETED|Overall Study||13
5180104|NCT01151540|12741188|P1|COMPLETED|Overall Study||41
5180105|NCT01151540|12741188|P1|STARTED|Overall Study||54
5180106|NCT01151449|12741197|P1|NOT COMPLETED|Overall Study||0
5180107|NCT01151449|12741197|P1|COMPLETED|Overall Study||6
5180108|NCT01151449|12741197|P1|STARTED|Overall Study||6
5180109|NCT01151436|12741205|P1|NOT COMPLETED|Overall Study||1
5180110|NCT01151436|12741205|P1|COMPLETED|Overall Study||76
5180111|NCT01151436|12741205|P1|STARTED|Overall Study||77
5180112|NCT01151423|12741237|P2|NOT COMPLETED|Overall Study||18
5180113|NCT01151423|12741238|P1|NOT COMPLETED|Overall Study||16
5180114|NCT01151423|12741237|P2|COMPLETED|Overall Study||21
5180115|NCT01151423|12741238|P1|COMPLETED|Overall Study||20
5180116|NCT01151423|12741237|P2|Received Study Drug|Overall Study||37
5180117|NCT01151423|12741238|P1|Received Study Drug|Overall Study||35
5180118|NCT01151423|12741237|P2|STARTED|Overall Study||39
5180119|NCT01151423|12741238|P1|STARTED|Overall Study||36
5180120|NCT01151410|12741286|P2|NOT COMPLETED|Overall Study||15
5180121|NCT01151410|12741287|P1|NOT COMPLETED|Overall Study||11
5180122|NCT01151410|12741286|P2|COMPLETED|Overall Study||89
5180123|NCT01151410|12741287|P1|COMPLETED|Overall Study||93
5180124|NCT01151410|12741286|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
5180125|NCT01151410|12741287|P1|Safety Set (SAF)|Overall Study||105
5180126|NCT01151410|12741286|P2|STARTED|Overall Study||104
5180127|NCT01151410|12741287|P1|STARTED|Overall Study||104
5180128|NCT01151371|12741300|P3|NOT COMPLETED|Overall Study||7
5180129|NCT01151371|12741301|P2|NOT COMPLETED|Overall Study||1
5180130|NCT01151371|12741302|P1|NOT COMPLETED|Overall Study||5
5180131|NCT01151371|12741300|P3|COMPLETED|Overall Study||146
5180132|NCT01151371|12741301|P2|COMPLETED|Overall Study||149
5180133|NCT01151371|12741302|P1|COMPLETED|Overall Study||144
5180134|NCT01151371|12741300|P3|STARTED|Overall Study||153
5180135|NCT01151371|12741301|P2|STARTED|Overall Study||150
5180136|NCT01151371|12741302|P1|STARTED|Overall Study||149
5180137|NCT01151345|12741331|P2|NOT COMPLETED|Second Intervention Period||0
5180138|NCT01151345|12741332|P1|NOT COMPLETED|Second Intervention Period||0
5180139|NCT01151345|12741331|P2|COMPLETED|Second Intervention Period||12
5180140|NCT01151345|12741332|P1|COMPLETED|Second Intervention Period||13
5180141|NCT01151345|12741331|P2|STARTED|Second Intervention Period||12
5180142|NCT01151345|12741332|P1|STARTED|Second Intervention Period||13
5180143|NCT01151345|12741331|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
5180144|NCT01151345|12741332|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
5180145|NCT01151345|12741331|P2|COMPLETED|Wash-out Period (7 Days)||12
5180146|NCT01151345|12741332|P1|COMPLETED|Wash-out Period (7 Days)||13
5180147|NCT01151345|12741331|P2|STARTED|Wash-out Period (7 Days)||12
5180148|NCT01151345|12741332|P1|STARTED|Wash-out Period (7 Days)||13
5180149|NCT01151345|12741331|P2|NOT COMPLETED|First Intervention Period||1
5180150|NCT01151345|12741332|P1|NOT COMPLETED|First Intervention Period||0
5180151|NCT01151345|12741331|P2|COMPLETED|First Intervention Period||12
5180152|NCT01151345|12741332|P1|COMPLETED|First Intervention Period||13
5180153|NCT01151345|12741331|P2|Treated|First Intervention Period||12
5180154|NCT01151345|12741332|P1|Treated|First Intervention Period||13
5180155|NCT01151345|12741331|P2|STARTED|First Intervention Period||13
5180156|NCT01151345|12741332|P1|STARTED|First Intervention Period||13
5180157|NCT01151280|12741346|P1|NOT COMPLETED|Overall Study||4
5180158|NCT01151280|12741346|P1|COMPLETED|Overall Study||6
5180159|NCT01151280|12741346|P1|STARTED|Overall Study||10
5180160|NCT01151215|12741359|P3|NOT COMPLETED|Overall Study||19
5180161|NCT01151215|12741360|P2|NOT COMPLETED|Overall Study||23
5180162|NCT01151215|12741361|P1|NOT COMPLETED|Overall Study||20
5180163|NCT01151215|12741359|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
5180164|NCT01151215|12741360|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
5180165|NCT01151215|12741361|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
5180166|NCT01151215|12741359|P3|STARTED|Overall Study||121
5180167|NCT01151215|12741360|P2|STARTED|Overall Study||118
5180168|NCT01151215|12741361|P1|STARTED|Overall Study||120
5180169|NCT01151189|12741374|P2|NOT COMPLETED|Overall Study||10
5180170|NCT01151189|12741375|P1|NOT COMPLETED|Overall Study||15
5180171|NCT01151189|12741374|P2|COMPLETED|Overall Study||314
5180172|NCT01151189|12741375|P1|COMPLETED|Overall Study||311
5180173|NCT01151189|12741374|P2|Received Vaccine|Overall Study||324
5180174|NCT01151189|12741375|P1|Received Vaccine|Overall Study||325
5180175|NCT01151189|12741374|P2|STARTED|Overall Study||324
5180176|NCT01151189|12741375|P1|STARTED|Overall Study||326
5180177|NCT01151137|12741399|P2|NOT COMPLETED|Overall Study||28
5180178|NCT01151137|12741400|P1|NOT COMPLETED|Overall Study||16
5180179|NCT01151137|12741399|P2|COMPLETED|Overall Study||1591
5180180|NCT01151137|12741400|P1|COMPLETED|Overall Study||1601
5180181|NCT01151137|12741399|P2|Discontinued Treatment|Overall Study||342
5180182|NCT01151137|12741400|P1|Discontinued Treatment|Overall Study||171
5180183|NCT01151137|12741399|P2|Treated|Overall Study||1613
5180184|NCT01151137|12741400|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
5180185|NCT01151137|12741399|P2|STARTED|Overall Study||1619
5180186|NCT01151137|12741400|P1|STARTED|Overall Study||1617
5180187|NCT01151098|12741418|P1|NOT COMPLETED|Overall Study||117
5180188|NCT01151098|12741418|P1|COMPLETED|Overall Study||72
5180189|NCT01151098|12741418|P1|STARTED|Overall Study|Extension Safety Population|189
5180190|NCT01151085|12741422|P1|NOT COMPLETED|Overall Study||56
5180191|NCT01151085|12741422|P1|COMPLETED|Overall Study||946
5180192|NCT01151085|12741422|P1|STARTED|Overall Study||1002
5180193|NCT01151046|12741440|P2|NOT COMPLETED|Overall Study||0
5180194|NCT01151046|12741441|P1|NOT COMPLETED|Overall Study||3
5180195|NCT01151046|12741440|P2|COMPLETED|Overall Study||59
5180196|NCT01151046|12741441|P1|COMPLETED|Overall Study||56
5180197|NCT01151046|12741440|P2|STARTED|Overall Study||59
5180198|NCT01151046|12741441|P1|STARTED|Overall Study||59
5180199|NCT01151020|12741453|P1|NOT COMPLETED|Overall Study||110
5180200|NCT01151020|12741453|P1|COMPLETED|Overall Study||0
5180201|NCT01151020|12741453|P1|12-month|Overall Study||99
5180202|NCT01151020|12741453|P1|30-day|Overall Study||110
5180203|NCT01151020|12741453|P1|STARTED|Overall Study||110
5180204|NCT01150981|12741460|P2|NOT COMPLETED|Overall Study||2
5180205|NCT01150981|12741461|P1|NOT COMPLETED|Overall Study||4
5180206|NCT01150981|12741460|P2|COMPLETED|Overall Study||13
5180207|NCT01150981|12741461|P1|COMPLETED|Overall Study||16
5180208|NCT01150981|12741460|P2|STARTED|Overall Study||15
5180209|NCT01150981|12741461|P1|STARTED|Overall Study||20
5180210|NCT01150903|12741471|P2|NOT COMPLETED|Overall Study||0
5180211|NCT01150903|12741472|P1|NOT COMPLETED|Overall Study||0
5180212|NCT01150903|12741471|P2|COMPLETED|Overall Study||74124
5180213|NCT01150903|12741472|P1|COMPLETED|Overall Study||24708
5180214|NCT01150903|12741471|P2|STARTED|Overall Study||74124
5180215|NCT01150903|12741472|P1|STARTED|Overall Study||24708
5180216|NCT01150760|12741488|P2|NOT COMPLETED|Overall Study||0
5180217|NCT01150760|12741489|P1|NOT COMPLETED|Overall Study||0
5180218|NCT01150760|12741488|P2|COMPLETED|Overall Study||3525
5180219|NCT01150760|12741489|P1|COMPLETED|Overall Study||3525
5180220|NCT01150760|12741488|P2|STARTED|Overall Study||3525
5180221|NCT01150760|12741489|P1|STARTED|Overall Study||3525
5180222|NCT01150500|12741521|P1|NOT COMPLETED|Overall Study||65
5180223|NCT01150500|12741521|P1|COMPLETED|Overall Study||0
5180224|NCT01150500|12741521|P1|STARTED|Overall Study||65
5180225|NCT01150474|12741532|P2|NOT COMPLETED|Overall Study||3
5180226|NCT01150474|12741533|P1|NOT COMPLETED|Overall Study||10
5180227|NCT01150474|12741532|P2|COMPLETED|Overall Study||49
5180228|NCT01150474|12741533|P1|COMPLETED|Overall Study||41
5180229|NCT01150474|12741532|P2|STARTED|Overall Study||52
5180230|NCT01150474|12741533|P1|STARTED|Overall Study||51
5180231|NCT01150461|12741557|P2|NOT COMPLETED|Overall Study||0
5180232|NCT01150461|12741558|P1|NOT COMPLETED|Overall Study||0
5180233|NCT01150461|12741557|P2|COMPLETED|Overall Study||9
5180234|NCT01150461|12741558|P1|COMPLETED|Overall Study||11
5180235|NCT01150461|12741557|P2|STARTED|Overall Study||9
5180236|NCT01150461|12741558|P1|STARTED|Overall Study||11
5180237|NCT01150409|12741568|P2|NOT COMPLETED|Overall Study||0
5180238|NCT01150409|12741569|P1|NOT COMPLETED|Overall Study||0
5180239|NCT01150409|12741568|P2|COMPLETED|Overall Study||0
5180240|NCT01150409|12741569|P1|COMPLETED|Overall Study||11
5180241|NCT01150409|12741568|P2|STARTED|Overall Study||0
5180242|NCT01150409|12741569|P1|STARTED|Overall Study||11
5180243|NCT01150357|12741578|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
5180244|NCT01150357|12741579|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
5180245|NCT01150357|12741580|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
5180246|NCT01150357|12741578|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
5180247|NCT01150357|12741579|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
5180248|NCT01150357|12741580|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
5180249|NCT01150357|12741578|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
5180250|NCT01150357|12741579|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
5180251|NCT01150357|12741580|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
5180252|NCT01150357|12741578|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
5180253|NCT01150357|12741579|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
5180254|NCT01150357|12741580|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
5180255|NCT01150357|12741578|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
5180256|NCT01150357|12741579|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
5180257|NCT01150357|12741580|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
5180258|NCT01150357|12741578|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
5180259|NCT01150357|12741579|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
5180260|NCT01150357|12741580|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
5180261|NCT01150357|12741578|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
5180262|NCT01150357|12741579|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
5180263|NCT01150357|12741580|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
5180264|NCT01150357|12741578|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
5180265|NCT01150357|12741579|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
5180266|NCT01150357|12741580|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
5180267|NCT01150357|12741578|P3|COMPLETED|Dose Response Phase (Phase 1)||102
5180268|NCT01150357|12741579|P2|COMPLETED|Dose Response Phase (Phase 1)||51
5180269|NCT01150357|12741580|P1|COMPLETED|Dose Response Phase (Phase 1)||107
5180270|NCT01150357|12741578|P3|STARTED|Dose Response Phase (Phase 1)||105
5180271|NCT01150357|12741579|P2|STARTED|Dose Response Phase (Phase 1)||54
5180272|NCT01150357|12741580|P1|STARTED|Dose Response Phase (Phase 1)||108
5180273|NCT01150123|12741660|P18|NOT COMPLETED|Overall Study||1
5180274|NCT01150123|12741661|P17|NOT COMPLETED|Overall Study||0
5180275|NCT01150123|12741662|P16|NOT COMPLETED|Overall Study||1
5180276|NCT01150123|12741663|P15|NOT COMPLETED|Overall Study||0
5180277|NCT01150123|12741664|P14|NOT COMPLETED|Overall Study||0
5180278|NCT01150123|12741665|P13|NOT COMPLETED|Overall Study||3
5180279|NCT01150123|12741666|P12|NOT COMPLETED|Overall Study||1
5180280|NCT01150123|12741667|P11|NOT COMPLETED|Overall Study||2
5180281|NCT01150123|12741668|P10|NOT COMPLETED|Overall Study||1
5180282|NCT01150123|12741669|P9|NOT COMPLETED|Overall Study||5
5180283|NCT01150123|12741670|P8|NOT COMPLETED|Overall Study||3
5180284|NCT01150123|12741671|P7|NOT COMPLETED|Overall Study||0
5180285|NCT01150123|12741672|P6|NOT COMPLETED|Overall Study||6
5180286|NCT01150123|12741673|P5|NOT COMPLETED|Overall Study||3
5180287|NCT01150123|12741674|P4|NOT COMPLETED|Overall Study||3
5180288|NCT01150123|12741675|P3|NOT COMPLETED|Overall Study||4
5180289|NCT01150123|12741676|P2|NOT COMPLETED|Overall Study||2
5180290|NCT01150123|12741677|P1|NOT COMPLETED|Overall Study||3
5180291|NCT01150123|12741660|P18|COMPLETED|Overall Study||19
5180292|NCT01150123|12741661|P17|COMPLETED|Overall Study||40
5180293|NCT01150123|12741662|P16|COMPLETED|Overall Study||39
5180294|NCT01150123|12741663|P15|COMPLETED|Overall Study||40
5180295|NCT01150123|12741664|P14|COMPLETED|Overall Study||40
5180296|NCT01150123|12741665|P13|COMPLETED|Overall Study||37
5180297|NCT01150123|12741666|P12|COMPLETED|Overall Study||39
5180298|NCT01150123|12741667|P11|COMPLETED|Overall Study||38
5180299|NCT01150123|12741668|P10|COMPLETED|Overall Study||39
5180300|NCT01150123|12741669|P9|COMPLETED|Overall Study||15
5180301|NCT01150123|12741670|P8|COMPLETED|Overall Study||37
5180302|NCT01150123|12741671|P7|COMPLETED|Overall Study||39
5180303|NCT01150123|12741672|P6|COMPLETED|Overall Study||34
5180304|NCT01150123|12741673|P5|COMPLETED|Overall Study||37
5180305|NCT01150123|12741674|P4|COMPLETED|Overall Study||37
5180306|NCT01150123|12741675|P3|COMPLETED|Overall Study||35
5180307|NCT01150123|12741676|P2|COMPLETED|Overall Study||38
5180308|NCT01150123|12741677|P1|COMPLETED|Overall Study||37
5180309|NCT01150123|12741660|P18|STARTED|Overall Study||20
5180310|NCT01150123|12741661|P17|STARTED|Overall Study||40
5180311|NCT01150123|12741662|P16|STARTED|Overall Study||40
5180312|NCT01150123|12741663|P15|STARTED|Overall Study||40
5180313|NCT01150123|12741664|P14|STARTED|Overall Study||40
5180314|NCT01150123|12741665|P13|STARTED|Overall Study||40
5180315|NCT01150123|12741666|P12|STARTED|Overall Study||40
5180316|NCT01150123|12741667|P11|STARTED|Overall Study||40
5180317|NCT01150123|12741668|P10|STARTED|Overall Study||40
5180318|NCT01150123|12741669|P9|STARTED|Overall Study||20
5180319|NCT01150123|12741670|P8|STARTED|Overall Study||40
5180320|NCT01150123|12741671|P7|STARTED|Overall Study||39
5180321|NCT01150123|12741672|P6|STARTED|Overall Study||40
5180322|NCT01150123|12741673|P5|STARTED|Overall Study||40
5180323|NCT01150123|12741674|P4|STARTED|Overall Study||40
5180324|NCT01150123|12741675|P3|STARTED|Overall Study||39
5180325|NCT01150123|12741676|P2|STARTED|Overall Study||40
5180326|NCT01150123|12741677|P1|STARTED|Overall Study||40
5180327|NCT01150097|12741853|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
5180328|NCT01150097|12741854|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
5180329|NCT01150097|12741855|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
5180330|NCT01150097|12741853|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
5180331|NCT01150097|12741854|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
5180332|NCT01150097|12741855|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
5180333|NCT01150097|12741853|P3|STARTED|Months 24 to 48 Post-transplantation||0
5180334|NCT01150097|12741854|P2|STARTED|Months 24 to 48 Post-transplantation||51
5180335|NCT01150097|12741855|P1|STARTED|Months 24 to 48 Post-transplantation||106
5180336|NCT01150097|12741853|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
5180337|NCT01150097|12741854|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
5180338|NCT01150097|12741855|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
5180339|NCT01150097|12741853|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
5180340|NCT01150097|12741854|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
5180341|NCT01150097|12741855|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
5180342|NCT01150097|12741853|P3|STARTED|Months 24 to 36 Post-transplantation||125
5180343|NCT01150097|12741854|P2|STARTED|Months 24 to 36 Post-transplantation||51
5180344|NCT01150097|12741855|P1|STARTED|Months 24 to 36 Post-transplantation||106
5180345|NCT01149876|12741882|P4|NOT COMPLETED|Overall Study||0
5180346|NCT01149876|12741883|P3|NOT COMPLETED|Overall Study||1
5180347|NCT01149876|12741884|P2|NOT COMPLETED|Overall Study||0
5180348|NCT01149876|12741885|P1|NOT COMPLETED|Overall Study||1
5180349|NCT01149876|12741882|P4|COMPLETED|Overall Study||18
5180350|NCT01149876|12741883|P3|COMPLETED|Overall Study||20
5180351|NCT01149876|12741884|P2|COMPLETED|Overall Study||20
5180352|NCT01149876|12741885|P1|COMPLETED|Overall Study||20
5180353|NCT01149876|12741882|P4|STARTED|Overall Study||18
5180354|NCT01149876|12741883|P3|STARTED|Overall Study||21
5180355|NCT01149876|12741884|P2|STARTED|Overall Study||20
5180356|NCT01149876|12741885|P1|STARTED|Overall Study||21
5180357|NCT01149863|12741899|P1|NOT COMPLETED|Overall Study||3
5180358|NCT01149863|12741899|P1|COMPLETED|Overall Study||31
5180359|NCT01149863|12741899|P1|STARTED|Overall Study||34
5180360|NCT01149785|12741904|P2|NOT COMPLETED|Second Intervention||0
5180361|NCT01149785|12741905|P1|NOT COMPLETED|Second Intervention||0
5180362|NCT01149785|12741904|P2|COMPLETED|Second Intervention||15
5180363|NCT01149785|12741905|P1|COMPLETED|Second Intervention||0
5180364|NCT01149785|12741904|P2|STARTED|Second Intervention||15
5180365|NCT01149785|12741905|P1|STARTED|Second Intervention||0
5180366|NCT01149785|12741904|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
5180367|NCT01149785|12741905|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
5180368|NCT01149785|12741904|P2|COMPLETED|Washout Period of at Least 14 Days||0
5180369|NCT01149785|12741905|P1|COMPLETED|Washout Period of at Least 14 Days||15
5180370|NCT01149785|12741904|P2|STARTED|Washout Period of at Least 14 Days||0
5180371|NCT01149785|12741905|P1|STARTED|Washout Period of at Least 14 Days||15
5180372|NCT01149785|12741904|P2|NOT COMPLETED|First Intervention||0
5180373|NCT01149785|12741905|P1|NOT COMPLETED|First Intervention||0
5180374|NCT01149785|12741904|P2|COMPLETED|First Intervention||0
5180375|NCT01149785|12741905|P1|COMPLETED|First Intervention||15
5180376|NCT01149785|12741904|P2|STARTED|First Intervention||0
5180377|NCT01149785|12741905|P1|STARTED|First Intervention||15
5180378|NCT01149772|12741939|P2|NOT COMPLETED|Overall Study||21
5180379|NCT01149772|12741940|P1|NOT COMPLETED|Overall Study||48
5180380|NCT01149772|12741939|P2|COMPLETED|Overall Study||101
5180381|NCT01149772|12741940|P1|COMPLETED|Overall Study||132
5180382|NCT01149772|12741939|P2|STARTED|Overall Study||122
5180383|NCT01149772|12741940|P1|STARTED|Overall Study||180
5180384|NCT01149759|12741956|P1|NOT COMPLETED|Overall Study||0
5180385|NCT01149759|12741956|P1|COMPLETED|Overall Study||9
5180386|NCT01149759|12741956|P1|STARTED|Overall Study||9
5180387|NCT01149733|12741963|P2|NOT COMPLETED|Overall Study||0
5180388|NCT01149733|12741964|P1|NOT COMPLETED|Overall Study||0
5180389|NCT01149733|12741963|P2|COMPLETED|Overall Study||16
5180390|NCT01149733|12741964|P1|COMPLETED|Overall Study||16
5180391|NCT01149733|12741963|P2|STARTED|Overall Study||16
5180392|NCT01149733|12741964|P1|STARTED|Overall Study||16
5180393|NCT01149655|12741976|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
5180394|NCT01149655|12741977|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
5180395|NCT01149655|12741978|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
5180396|NCT01149655|12741979|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
5180397|NCT01149655|12741976|P4|COMPLETED|Period 3-DB Maintenance Phase||6
5180398|NCT01149655|12741977|P3|COMPLETED|Period 3-DB Maintenance Phase||15
5180399|NCT01149655|12741978|P2|COMPLETED|Period 3-DB Maintenance Phase||0
5180400|NCT01149655|12741979|P1|COMPLETED|Period 3-DB Maintenance Phase||0
5180401|NCT01149655|12741976|P4|STARTED|Period 3-DB Maintenance Phase||48
5180402|NCT01149655|12741977|P3|STARTED|Period 3-DB Maintenance Phase||98
5180403|NCT01149655|12741978|P2|STARTED|Period 3-DB Maintenance Phase||0
5180404|NCT01149655|12741979|P1|STARTED|Period 3-DB Maintenance Phase||0
5180405|NCT01149655|12741976|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
5180406|NCT01149655|12741977|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
5180407|NCT01149655|12741978|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
5180408|NCT01149655|12741979|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
5180409|NCT01149655|12741976|P4|COMPLETED|Period 2-Stabilization Phase||0
5180410|NCT01149655|12741977|P3|COMPLETED|Period 2-Stabilization Phase||0
5180411|NCT01149655|12741978|P2|COMPLETED|Period 2-Stabilization Phase||146
5180412|NCT01149655|12741979|P1|COMPLETED|Period 2-Stabilization Phase||0
5180413|NCT01149655|12741976|P4|STARTED|Period 2-Stabilization Phase||0
5180414|NCT01149655|12741977|P3|STARTED|Period 2-Stabilization Phase||0
5180415|NCT01149655|12741978|P2|STARTED|Period 2-Stabilization Phase||183
5180416|NCT01149655|12741979|P1|STARTED|Period 2-Stabilization Phase||0
5180417|NCT01149655|12741976|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
5180418|NCT01149655|12741977|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
5180419|NCT01149655|12741978|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
5180420|NCT01149655|12741979|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
5180421|NCT01149655|12741976|P4|COMPLETED|Period 1 - Conversion Phase||0
5180422|NCT01149655|12741977|P3|COMPLETED|Period 1 - Conversion Phase||0
5180423|NCT01149655|12741978|P2|COMPLETED|Period 1 - Conversion Phase||0
5180424|NCT01149655|12741979|P1|COMPLETED|Period 1 - Conversion Phase||168
5180425|NCT01149655|12741976|P4|STARTED|Period 1 - Conversion Phase||0
5180426|NCT01149655|12741977|P3|STARTED|Period 1 - Conversion Phase||0
5180427|NCT01149655|12741978|P2|STARTED|Period 1 - Conversion Phase||0
5180428|NCT01149655|12741979|P1|STARTED|Period 1 - Conversion Phase||186
5180429|NCT01149616|12742009|P2|NOT COMPLETED|Overall Study||0
5180430|NCT01149616|12742010|P1|NOT COMPLETED|Overall Study||0
5180431|NCT01149616|12742009|P2|COMPLETED|Overall Study||41
5180432|NCT01149616|12742010|P1|COMPLETED|Overall Study||41
5180433|NCT01149616|12742009|P2|STARTED|Overall Study||41
5180434|NCT01149616|12742010|P1|STARTED|Overall Study||41
5180435|NCT01149538|12742022|P2|NOT COMPLETED|Overall Study||4
5180436|NCT01149538|12742023|P1|NOT COMPLETED|Overall Study||5
5180437|NCT01149538|12742022|P2|COMPLETED|Overall Study||25
5180438|NCT01149538|12742023|P1|COMPLETED|Overall Study||26
5180439|NCT01149538|12742022|P2|STARTED|Overall Study||29
5180440|NCT01149538|12742023|P1|STARTED|Overall Study||31
5180441|NCT01149512|12742037|P1|NOT COMPLETED|Overall Study||0
5180442|NCT01149512|12742037|P1|COMPLETED|Overall Study||178
5180443|NCT01149512|12742037|P1|STARTED|Overall Study||178
5180444|NCT01149486|12742044|P2|NOT COMPLETED|Second Intervention||0
5180445|NCT01149486|12742045|P1|NOT COMPLETED|Second Intervention||0
5180446|NCT01149486|12742044|P2|COMPLETED|Second Intervention||9
5180447|NCT01149486|12742045|P1|COMPLETED|Second Intervention||10
5180448|NCT01149486|12742044|P2|STARTED|Second Intervention||9
5180449|NCT01149486|12742045|P1|STARTED|Second Intervention||10
5180450|NCT01149486|12742044|P2|NOT COMPLETED|Washout of 7 Days||0
5180451|NCT01149486|12742045|P1|NOT COMPLETED|Washout of 7 Days||0
5180452|NCT01149486|12742044|P2|COMPLETED|Washout of 7 Days||9
5180453|NCT01149486|12742045|P1|COMPLETED|Washout of 7 Days||10
5180454|NCT01149486|12742044|P2|STARTED|Washout of 7 Days||9
5180455|NCT01149486|12742045|P1|STARTED|Washout of 7 Days||10
5180456|NCT01149486|12742044|P2|NOT COMPLETED|First Intervention||1
5180457|NCT01149486|12742045|P1|NOT COMPLETED|First Intervention||0
5180458|NCT01149486|12742044|P2|COMPLETED|First Intervention||9
5180459|NCT01149486|12742045|P1|COMPLETED|First Intervention||10
5180460|NCT01149486|12742044|P2|STARTED|First Intervention||10
5180461|NCT01149486|12742045|P1|STARTED|First Intervention||10
5180462|NCT01149473|12742069|P2|NOT COMPLETED|Second Intervention||0
5180463|NCT01149473|12742070|P1|NOT COMPLETED|Second Intervention||0
5180464|NCT01149473|12742069|P2|COMPLETED|Second Intervention||38
5180465|NCT01149473|12742070|P1|COMPLETED|Second Intervention||38
5180466|NCT01149473|12742069|P2|STARTED|Second Intervention||38
5180467|NCT01149473|12742070|P1|STARTED|Second Intervention||38
5180468|NCT01149473|12742069|P2|NOT COMPLETED|Washout of 7 Days||1
5180469|NCT01149473|12742070|P1|NOT COMPLETED|Washout of 7 Days||1
5180470|NCT01149473|12742069|P2|COMPLETED|Washout of 7 Days||38
5180471|NCT01149473|12742070|P1|COMPLETED|Washout of 7 Days||38
5180472|NCT01149473|12742069|P2|STARTED|Washout of 7 Days||39
5180473|NCT01149473|12742070|P1|STARTED|Washout of 7 Days||39
5180474|NCT01149473|12742069|P2|NOT COMPLETED|First Intervention||1
5180475|NCT01149473|12742070|P1|NOT COMPLETED|First Intervention||1
5180476|NCT01149473|12742069|P2|COMPLETED|First Intervention||39
5180477|NCT01149473|12742070|P1|COMPLETED|First Intervention||39
5180478|NCT01149473|12742069|P2|STARTED|First Intervention||40
5180479|NCT01149473|12742070|P1|STARTED|First Intervention||40
5180480|NCT01149460|12742088|P2|NOT COMPLETED|Overall Study||2
5180481|NCT01149460|12742089|P1|NOT COMPLETED|Overall Study||0
5180482|NCT01149460|12742088|P2|COMPLETED|Overall Study||16
5180483|NCT01149460|12742089|P1|COMPLETED|Overall Study||18
5180484|NCT01149460|12742088|P2|STARTED|Overall Study||18
5180485|NCT01149460|12742089|P1|STARTED|Overall Study||18
5180486|NCT01149434|12742107|P2|NOT COMPLETED|Overall Study||5
5180487|NCT01149434|12742108|P1|NOT COMPLETED|Overall Study||0
5180488|NCT01149434|12742107|P2|COMPLETED|Overall Study||10
5180489|NCT01149434|12742108|P1|COMPLETED|Overall Study||4
5180490|NCT01149434|12742107|P2|STARTED|Overall Study||15
5180491|NCT01149434|12742108|P1|STARTED|Overall Study||4
5180492|NCT01149421|12742122|P3|NOT COMPLETED|Overall Study||44
5180493|NCT01149421|12742123|P2|NOT COMPLETED|Overall Study||29
5180494|NCT01149421|12742124|P1|NOT COMPLETED|Overall Study||52
5180495|NCT01149421|12742122|P3|COMPLETED|Overall Study||206
5180496|NCT01149421|12742123|P2|COMPLETED|Overall Study||225
5180497|NCT01149421|12742124|P1|COMPLETED|Overall Study||199
5180498|NCT01149421|12742122|P3|Received at Least One Dose of Study Drug|Overall Study||250
5180499|NCT01149421|12742123|P2|Received at Least One Dose of Study Drug|Overall Study||254
5180500|NCT01149421|12742124|P1|Received at Least One Dose of Study Drug|Overall Study||251
5180501|NCT01149421|12742122|P3|STARTED|Overall Study||250
5180502|NCT01149421|12742123|P2|STARTED|Overall Study||254
5180503|NCT01149421|12742124|P1|STARTED|Overall Study||251
5180504|NCT01149369|12742205|P2|NOT COMPLETED|Overall Study||3
5180505|NCT01149369|12742206|P1|NOT COMPLETED|Overall Study||6
5180506|NCT01149369|12742205|P2|COMPLETED|Overall Study||60
5180507|NCT01149369|12742206|P1|COMPLETED|Overall Study||57
5180508|NCT01149369|12742205|P2|STARTED|Overall Study||63
5180509|NCT01149369|12742206|P1|STARTED|Overall Study||63
5180510|NCT01149343|12742374|P4|NOT COMPLETED|Overall Study||40
5180511|NCT01149343|12742375|P3|NOT COMPLETED|Overall Study||22
5180512|NCT01149343|12742376|P2|NOT COMPLETED|Overall Study||24
5180513|NCT01149343|12742377|P1|NOT COMPLETED|Overall Study||20
5180514|NCT01149343|12742374|P4|COMPLETED|Overall Study||0
5180515|NCT01149343|12742375|P3|COMPLETED|Overall Study||0
5180516|NCT01149343|12742376|P2|COMPLETED|Overall Study||0
5180517|NCT01149343|12742377|P1|COMPLETED|Overall Study||0
5180518|NCT01149343|12742374|P4|STARTED|Overall Study||40
5180519|NCT01149343|12742375|P3|STARTED|Overall Study||22
5180520|NCT01149343|12742376|P2|STARTED|Overall Study||24
5180521|NCT01149343|12742377|P1|STARTED|Overall Study||20
5180522|NCT01149148|12742462|P2|NOT COMPLETED|Overall Study||2
5180523|NCT01149148|12742463|P1|NOT COMPLETED|Overall Study||2
5180524|NCT01149148|12742462|P2|COMPLETED|Overall Study||11
5180525|NCT01149148|12742463|P1|COMPLETED|Overall Study||10
5180526|NCT01149148|12742462|P2|STARTED|Overall Study||13
5180527|NCT01149148|12742463|P1|STARTED|Overall Study||12
5180528|NCT01149096|12742473|P2|NOT COMPLETED|Overall Study||1
5180529|NCT01149096|12742474|P1|NOT COMPLETED|Overall Study||0
5180530|NCT01149096|12742473|P2|COMPLETED|Overall Study||6
5180531|NCT01149096|12742474|P1|COMPLETED|Overall Study||6
5180532|NCT01149096|12742473|P2|STARTED|Overall Study||7
5180533|NCT01149096|12742474|P1|STARTED|Overall Study||6
5180534|NCT01149057|12742498|P1|NOT COMPLETED|Overall Study||57
5180535|NCT01149057|12742498|P1|COMPLETED|Overall Study||88
5180536|NCT01149057|12742498|P1|STARTED|Overall Study||145
5180537|NCT01148979|12742525|P2|NOT COMPLETED|Overall Study||1
5180538|NCT01148979|12742526|P1|NOT COMPLETED|Overall Study||0
5180539|NCT01148979|12742525|P2|COMPLETED|Overall Study||15
5180540|NCT01148979|12742526|P1|COMPLETED|Overall Study||13
5180541|NCT01148979|12742525|P2|STARTED|Overall Study||16
5180542|NCT01148979|12742526|P1|STARTED|Overall Study||13
5180543|NCT01148940|12742534|P3|NOT COMPLETED|Overall Study||0
5180544|NCT01148940|12742535|P2|NOT COMPLETED|Overall Study||0
5180545|NCT01148940|12742536|P1|NOT COMPLETED|Overall Study||0
5180546|NCT01148940|12742534|P3|COMPLETED|Overall Study||0
5180547|NCT01148940|12742535|P2|COMPLETED|Overall Study||27
5180548|NCT01148940|12742536|P1|COMPLETED|Overall Study||7
5180549|NCT01148940|12742534|P3|STARTED|Overall Study||0
5180550|NCT01148940|12742535|P2|STARTED|Overall Study||27
5180551|NCT01148940|12742536|P1|STARTED|Overall Study||7
5180552|NCT01148862|12742544|P2|NOT COMPLETED|Second Intervention||2
5180553|NCT01148862|12742545|P1|NOT COMPLETED|Second Intervention||0
5180554|NCT01148862|12742544|P2|COMPLETED|Second Intervention||23
5180555|NCT01148862|12742545|P1|COMPLETED|Second Intervention||25
5180556|NCT01148862|12742544|P2|STARTED|Second Intervention||25
5180557|NCT01148862|12742545|P1|STARTED|Second Intervention||25
5180558|NCT01148862|12742544|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5180559|NCT01148862|12742545|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5180560|NCT01148862|12742544|P2|COMPLETED|Washout Period of 2 Weeks||25
5180561|NCT01148862|12742545|P1|COMPLETED|Washout Period of 2 Weeks||25
5180562|NCT01148862|12742544|P2|STARTED|Washout Period of 2 Weeks||25
5180563|NCT01148862|12742545|P1|STARTED|Washout Period of 2 Weeks||25
5180564|NCT01148862|12742544|P2|NOT COMPLETED|First Intervention||0
5180565|NCT01148862|12742545|P1|NOT COMPLETED|First Intervention||0
5180566|NCT01148862|12742544|P2|COMPLETED|First Intervention||25
5180567|NCT01148862|12742545|P1|COMPLETED|First Intervention||25
5180568|NCT01148862|12742544|P2|STARTED|First Intervention||25
5180569|NCT01148862|12742545|P1|STARTED|First Intervention||25
5180570|NCT01148836|12742555|P2|NOT COMPLETED|Overall Study||2
5180571|NCT01148836|12742556|P1|NOT COMPLETED|Overall Study||1
5180572|NCT01148836|12742555|P2|COMPLETED|Overall Study||8
5180573|NCT01148836|12742556|P1|COMPLETED|Overall Study|Enrollment completed|7
5180574|NCT01148836|12742555|P2|STARTED|Overall Study||10
5180575|NCT01148836|12742556|P1|STARTED|Overall Study|Enrollment completed|8
5180576|NCT01148810|12742577|P2|NOT COMPLETED|Overall Study||5
5180577|NCT01148810|12742578|P1|NOT COMPLETED|Overall Study||1
5180578|NCT01148810|12742577|P2|COMPLETED|Overall Study||5
5180579|NCT01148810|12742578|P1|COMPLETED|Overall Study||7
5180580|NCT01148810|12742577|P2|STARTED|Overall Study||10
5180581|NCT01148810|12742578|P1|STARTED|Overall Study||8
5180582|NCT01148771|12742605|P2|NOT COMPLETED|Second Intervention||0
5180583|NCT01148771|12742606|P1|NOT COMPLETED|Second Intervention||0
5180584|NCT01148771|12742605|P2|COMPLETED|Second Intervention||5
5180585|NCT01148771|12742606|P1|COMPLETED|Second Intervention||6
5180586|NCT01148771|12742605|P2|STARTED|Second Intervention||5
5180587|NCT01148771|12742606|P1|STARTED|Second Intervention||6
5180588|NCT01148771|12742605|P2|NOT COMPLETED|Washout Period||1
5180589|NCT01148771|12742606|P1|NOT COMPLETED|Washout Period||0
5180590|NCT01148771|12742605|P2|COMPLETED|Washout Period||5
5180591|NCT01148771|12742606|P1|COMPLETED|Washout Period||6
5180592|NCT01148771|12742605|P2|STARTED|Washout Period||6
5180593|NCT01148771|12742606|P1|STARTED|Washout Period||6
5180594|NCT01148771|12742605|P2|NOT COMPLETED|First Intervention||0
5180595|NCT01148771|12742606|P1|NOT COMPLETED|First Intervention||0
5180596|NCT01148771|12742605|P2|COMPLETED|First Intervention||6
5180597|NCT01148771|12742606|P1|COMPLETED|First Intervention||6
5180598|NCT01148771|12742605|P2|STARTED|First Intervention||6
5180599|NCT01148771|12742606|P1|STARTED|First Intervention||6
5180600|NCT01148745|12742618|P1|NOT COMPLETED|Overall Study||0
5180601|NCT01148745|12742618|P1|COMPLETED|Overall Study||15
5180602|NCT01148745|12742618|P1|STARTED|Overall Study||15
5180603|NCT01148693|12742626|P2|NOT COMPLETED|Overall Study||10
5180604|NCT01148693|12742627|P1|NOT COMPLETED|Overall Study||13
5180605|NCT01148693|12742626|P2|COMPLETED|Overall Study||57
5180606|NCT01148693|12742627|P1|COMPLETED|Overall Study||57
5180607|NCT01148693|12742626|P2|STARTED|Overall Study||67
5180608|NCT01148693|12742627|P1|STARTED|Overall Study||70
5180609|NCT01148563|12742635|P2|NOT COMPLETED|Overall Study||30
5180610|NCT01148563|12742636|P1|NOT COMPLETED|Overall Study||29
5180611|NCT01148563|12742635|P2|COMPLETED|Overall Study||37
5180612|NCT01148563|12742636|P1|COMPLETED|Overall Study||40
5180613|NCT01148563|12742635|P2|STARTED|Overall Study||67
5180614|NCT01148563|12742636|P1|STARTED|Overall Study||69
5180615|NCT01148537|12742647|P3|NOT COMPLETED|Overall Study||3
5180616|NCT01148537|12742648|P2|NOT COMPLETED|Overall Study||0
5180617|NCT01148537|12742649|P1|NOT COMPLETED|Overall Study||3
5180618|NCT01148537|12742647|P3|COMPLETED|Overall Study||41
5180619|NCT01148537|12742648|P2|COMPLETED|Overall Study||44
5180620|NCT01148537|12742649|P1|COMPLETED|Overall Study||41
5180621|NCT01148537|12742647|P3|STARTED|Overall Study||44
5180622|NCT01148537|12742648|P2|STARTED|Overall Study||44
5180623|NCT01148537|12742649|P1|STARTED|Overall Study||44
5180624|NCT01148524|12742679|P9|NOT COMPLETED|Overall Study||0
5180625|NCT01148524|12742680|P8|NOT COMPLETED|Overall Study||0
5180626|NCT01148524|12742681|P7|NOT COMPLETED|Overall Study||0
5180627|NCT01148524|12742682|P6|NOT COMPLETED|Overall Study||0
5180628|NCT01148524|12742683|P5|NOT COMPLETED|Overall Study||0
5180629|NCT01148524|12742684|P4|NOT COMPLETED|Overall Study||0
5180630|NCT01148524|12742685|P3|NOT COMPLETED|Overall Study||0
5180631|NCT01148524|12742686|P2|NOT COMPLETED|Overall Study||0
5180632|NCT01148524|12742687|P1|NOT COMPLETED|Overall Study||0
5180633|NCT01148524|12742679|P9|COMPLETED|Overall Study||151
5180634|NCT01148524|12742680|P8|COMPLETED|Overall Study||51
5180635|NCT01148524|12742681|P7|COMPLETED|Overall Study||153
5180636|NCT01148524|12742682|P6|COMPLETED|Overall Study||106
5180637|NCT01148524|12742683|P5|COMPLETED|Overall Study||57
5180638|NCT01148524|12742684|P4|COMPLETED|Overall Study||102
5180639|NCT01148524|12742685|P3|COMPLETED|Overall Study||53
5180640|NCT01148524|12742686|P2|COMPLETED|Overall Study||95
5180641|NCT01148524|12742687|P1|COMPLETED|Overall Study||49
5180642|NCT01148524|12742679|P9|STARTED|Overall Study||151
5180643|NCT01148524|12742680|P8|STARTED|Overall Study||51
5180644|NCT01148524|12742681|P7|STARTED|Overall Study||153
5180645|NCT01148524|12742682|P6|STARTED|Overall Study||106
5180646|NCT01148524|12742683|P5|STARTED|Overall Study||57
5180647|NCT01148524|12742684|P4|STARTED|Overall Study||102
5180648|NCT01148524|12742685|P3|STARTED|Overall Study||53
5180649|NCT01148524|12742686|P2|STARTED|Overall Study||95
5180650|NCT01148524|12742687|P1|STARTED|Overall Study||49
5180651|NCT01148511|12742735|P3|NOT COMPLETED|Randomized||6
5180652|NCT01148511|12742736|P2|NOT COMPLETED|Randomized||10
5180653|NCT01148511|12742737|P1|NOT COMPLETED|Randomized||0
5180654|NCT01148511|12742735|P3|COMPLETED|Randomized||39
5180655|NCT01148511|12742736|P2|COMPLETED|Randomized||38
5180656|NCT01148511|12742737|P1|COMPLETED|Randomized||0
5180657|NCT01148511|12742735|P3|STARTED|Randomized||45
5180658|NCT01148511|12742736|P2|STARTED|Randomized||48
5180659|NCT01148511|12742737|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
5180660|NCT01148511|12742735|P3|NOT COMPLETED|Exposed to Study Drug||0
5180661|NCT01148511|12742736|P2|NOT COMPLETED|Exposed to Study Drug||0
5180662|NCT01148511|12742737|P1|NOT COMPLETED|Exposed to Study Drug||6
5180663|NCT01148511|12742735|P3|COMPLETED|Exposed to Study Drug||0
5180664|NCT01148511|12742736|P2|COMPLETED|Exposed to Study Drug||0
5180665|NCT01148511|12742737|P1|COMPLETED|Exposed to Study Drug||93
5180666|NCT01148511|12742735|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
5180667|NCT01148511|12742736|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
5180668|NCT01148511|12742737|P1|STARTED|Exposed to Study Drug||99
5180669|NCT01148459|12742758|P2|NOT COMPLETED|Overall Study||11
5180670|NCT01148459|12742759|P1|NOT COMPLETED|Overall Study||12
5180671|NCT01148459|12742758|P2|COMPLETED|Overall Study||90
5180672|NCT01148459|12742759|P1|COMPLETED|Overall Study||87
5180673|NCT01148459|12742758|P2|STARTED|Overall Study||101
5180674|NCT01148459|12742759|P1|STARTED|Overall Study||99
5180675|NCT01148420|12742801|P1|NOT COMPLETED|Overall Study||0
5180676|NCT01148420|12742801|P1|COMPLETED|Overall Study||48
5180677|NCT01148420|12742801|P1|STARTED|Overall Study||48
5180678|NCT01148225|12742807|P1|NOT COMPLETED|Overall Study||185
5180679|NCT01148225|12742807|P1|COMPLETED|Overall Study||239
5180680|NCT01148225|12742807|P1|STARTED|Overall Study||424
5180681|NCT01148056|12742845|P1|NOT COMPLETED|Overall Study||0
5180682|NCT01148056|12742845|P1|COMPLETED|Overall Study||2
5180683|NCT01148056|12742845|P1|STARTED|Overall Study||2
5180684|NCT01148017|12742858|P4|NOT COMPLETED|Overall Study||0
5180685|NCT01148017|12742859|P3|NOT COMPLETED|Overall Study||0
5180686|NCT01148017|12742860|P2|NOT COMPLETED|Overall Study||34
5180687|NCT01148017|12742861|P1|NOT COMPLETED|Overall Study||80
5180688|NCT01148017|12742858|P4|COMPLETED|Overall Study||45
5180689|NCT01148017|12742859|P3|COMPLETED|Overall Study||53
5180690|NCT01148017|12742860|P2|COMPLETED|Overall Study||87
5180691|NCT01148017|12742861|P1|COMPLETED|Overall Study||134
5180692|NCT01148017|12742858|P4|STARTED|Overall Study||45
5180693|NCT01148017|12742859|P3|STARTED|Overall Study||53
5180694|NCT01148017|12742860|P2|STARTED|Overall Study||121
5180695|NCT01148017|12742861|P1|STARTED|Overall Study||214
5180696|NCT01147926|12742900|P2|NOT COMPLETED|Overall Study||29
5180697|NCT01147926|12742901|P1|NOT COMPLETED|Overall Study||27
5180698|NCT01147926|12742900|P2|COMPLETED|Overall Study||158
5180699|NCT01147926|12742901|P1|COMPLETED|Overall Study||160
5180700|NCT01147926|12742900|P2|STARTED|Overall Study||187
5180701|NCT01147926|12742901|P1|STARTED|Overall Study||187
5180702|NCT01147900|12742936|P3|NOT COMPLETED|At Year 10||0
5180703|NCT01147900|12742937|P2|NOT COMPLETED|At Year 10||1
5180704|NCT01147900|12742938|P1|NOT COMPLETED|At Year 10||0
5180705|NCT01147900|12742936|P3|COMPLETED|At Year 10||62
5180706|NCT01147900|12742937|P2|COMPLETED|At Year 10||59
5180707|NCT01147900|12742938|P1|COMPLETED|At Year 10||55
5180708|NCT01147900|12742936|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
5180709|NCT01147900|12742937|P2|STARTED|At Year 10||60
5180710|NCT01147900|12742938|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
5180711|NCT01147900|12742936|P3|NOT COMPLETED|At Year 8.5||0
5180712|NCT01147900|12742937|P2|NOT COMPLETED|At Year 8.5||0
5180713|NCT01147900|12742938|P1|NOT COMPLETED|At Year 8.5||0
5180714|NCT01147900|12742936|P3|COMPLETED|At Year 8.5||66
5180715|NCT01147900|12742937|P2|COMPLETED|At Year 8.5||60
5180716|NCT01147900|12742938|P1|COMPLETED|At Year 8.5||54
5180717|NCT01147900|12742936|P3|STARTED|At Year 8.5||66
5180718|NCT01147900|12742937|P2|STARTED|At Year 8.5||60
5180719|NCT01147900|12742938|P1|STARTED|At Year 8.5||54
5180720|NCT01147874|12742997|P1|NOT COMPLETED|Overall Study||67
5180721|NCT01147874|12742997|P1|COMPLETED|Overall Study||946
5180722|NCT01147874|12742997|P1|STARTED|Overall Study||1013
5180723|NCT01147848|12743005|P3|NOT COMPLETED|Randomized Phase||46
5180724|NCT01147848|12743006|P2|NOT COMPLETED|Randomized Phase||45
5180725|NCT01147848|12743007|P1|NOT COMPLETED|Randomized Phase||0
5180726|NCT01147848|12743005|P3|COMPLETED|Randomized Phase||357
5180727|NCT01147848|12743006|P2|COMPLETED|Randomized Phase||358
5180728|NCT01147848|12743007|P1|COMPLETED|Randomized Phase||0
5180729|NCT01147848|12743005|P3|STARTED|Randomized Phase||403
5180730|NCT01147848|12743006|P2|STARTED|Randomized Phase||403
5180731|NCT01147848|12743007|P1|STARTED|Randomized Phase||0
5180732|NCT01147848|12743005|P3|NOT COMPLETED|Run-in Period||0
5180733|NCT01147848|12743006|P2|NOT COMPLETED|Run-in Period||0
5180734|NCT01147848|12743007|P1|NOT COMPLETED|Run-in Period||758
5180735|NCT01147848|12743005|P3|COMPLETED|Run-in Period||0
5180736|NCT01147848|12743006|P2|COMPLETED|Run-in Period||0
5180737|NCT01147848|12743007|P1|COMPLETED|Run-in Period||806
5180738|NCT01147848|12743005|P3|STARTED|Run-in Period||0
5180739|NCT01147848|12743006|P2|STARTED|Run-in Period||0
5180740|NCT01147848|12743007|P1|STARTED|Run-in Period||1564
5180741|NCT01147822|12743039|P2|NOT COMPLETED|Overall Study||179
5180742|NCT01147822|12743040|P1|NOT COMPLETED|Overall Study||188
5180743|NCT01147822|12743039|P2|COMPLETED|Overall Study||0
5180744|NCT01147822|12743040|P1|COMPLETED|Overall Study||0
5180745|NCT01147822|12743039|P2|Not Completed/Ongoing|Overall Study||102
5180746|NCT01147822|12743040|P1|Not Completed/Ongoing|Overall Study||111
5180747|NCT01147822|12743039|P2|STARTED|Overall Study||179
5180748|NCT01147822|12743040|P1|STARTED|Overall Study||188
5180749|NCT01147809|12743060|P6|NOT COMPLETED|Phase II (168 Days)||33
5180750|NCT01147809|12743061|P5|NOT COMPLETED|Phase II (168 Days)||16
5180751|NCT01147809|12743062|P4|NOT COMPLETED|Phase II (168 Days)||0
5180752|NCT01147809|12743063|P3|NOT COMPLETED|Phase II (168 Days)||0
5180753|NCT01147809|12743064|P2|NOT COMPLETED|Phase II (168 Days)||0
5180754|NCT01147809|12743065|P1|NOT COMPLETED|Phase II (168 Days)||0
5180755|NCT01147809|12743060|P6|COMPLETED|Phase II (168 Days)||19
5180756|NCT01147809|12743061|P5|COMPLETED|Phase II (168 Days)||7
5180757|NCT01147809|12743062|P4|COMPLETED|Phase II (168 Days)||0
5180758|NCT01147809|12743063|P3|COMPLETED|Phase II (168 Days)||0
5180759|NCT01147809|12743064|P2|COMPLETED|Phase II (168 Days)||0
5180760|NCT01147809|12743065|P1|COMPLETED|Phase II (168 Days)||0
5180761|NCT01147809|12743060|P6|Ongoing|Phase II (168 Days)||0
5180762|NCT01147809|12743061|P5|Ongoing|Phase II (168 Days)||1
5180763|NCT01147809|12743062|P4|Ongoing|Phase II (168 Days)||0
5180764|NCT01147809|12743063|P3|Ongoing|Phase II (168 Days)||0
5180765|NCT01147809|12743064|P2|Ongoing|Phase II (168 Days)||0
5180766|NCT01147809|12743065|P1|Ongoing|Phase II (168 Days)||0
5180767|NCT01147809|12743060|P6|STARTED|Phase II (168 Days)||52
5180768|NCT01147809|12743061|P5|STARTED|Phase II (168 Days)||23
5180769|NCT01147809|12743062|P4|STARTED|Phase II (168 Days)||0
5180770|NCT01147809|12743063|P3|STARTED|Phase II (168 Days)||0
5180771|NCT01147809|12743064|P2|STARTED|Phase II (168 Days)||0
5180772|NCT01147809|12743065|P1|STARTED|Phase II (168 Days)||0
5180773|NCT01147809|12743060|P6|NOT COMPLETED|Phase I (168 Days)||0
5180774|NCT01147809|12743061|P5|NOT COMPLETED|Phase I (168 Days)||0
5180775|NCT01147809|12743062|P4|NOT COMPLETED|Phase I (168 Days)||5
5180776|NCT01147809|12743063|P3|NOT COMPLETED|Phase I (168 Days)||2
5180777|NCT01147809|12743064|P2|NOT COMPLETED|Phase I (168 Days)||1
5180778|NCT01147809|12743065|P1|NOT COMPLETED|Phase I (168 Days)||1
5180779|NCT01147809|12743060|P6|COMPLETED|Phase I (168 Days)||0
5180780|NCT01147809|12743061|P5|COMPLETED|Phase I (168 Days)||0
5180781|NCT01147809|12743062|P4|COMPLETED|Phase I (168 Days)||5
5180782|NCT01147809|12743063|P3|COMPLETED|Phase I (168 Days)||2
5180783|NCT01147809|12743064|P2|COMPLETED|Phase I (168 Days)||8
5180784|NCT01147809|12743065|P1|COMPLETED|Phase I (168 Days)||2
5180785|NCT01147809|12743060|P6|STARTED|Phase I (168 Days)||0
5180786|NCT01147809|12743061|P5|STARTED|Phase I (168 Days)||0
5180787|NCT01147809|12743062|P4|STARTED|Phase I (168 Days)||10
5180788|NCT01147809|12743063|P3|STARTED|Phase I (168 Days)||4
5180789|NCT01147809|12743064|P2|STARTED|Phase I (168 Days)||9
5180790|NCT01147809|12743065|P1|STARTED|Phase I (168 Days)||3
5180791|NCT01147744|12743186|P7|NOT COMPLETED|Overall Study||19
5180792|NCT01147744|12743187|P6|NOT COMPLETED|Overall Study||20
5180793|NCT01147744|12743188|P5|NOT COMPLETED|Overall Study||25
5180794|NCT01147744|12743189|P4|NOT COMPLETED|Overall Study||18
5180795|NCT01147744|12743190|P3|NOT COMPLETED|Overall Study||18
5180796|NCT01147744|12743191|P2|NOT COMPLETED|Overall Study||23
5180797|NCT01147744|12743192|P1|NOT COMPLETED|Overall Study||29
5180798|NCT01147744|12743186|P7|COMPLETED|Overall Study||78
5180799|NCT01147744|12743187|P6|COMPLETED|Overall Study||83
5180800|NCT01147744|12743188|P5|COMPLETED|Overall Study||76
5180801|NCT01147744|12743189|P4|COMPLETED|Overall Study||82
5180802|NCT01147744|12743190|P3|COMPLETED|Overall Study||82
5180803|NCT01147744|12743191|P2|COMPLETED|Overall Study||76
5180804|NCT01147744|12743192|P1|COMPLETED|Overall Study||71
5180805|NCT01147744|12743186|P7|STARTED|Overall Study||97
5180806|NCT01147744|12743187|P6|STARTED|Overall Study||103
5180807|NCT01147744|12743188|P5|STARTED|Overall Study||101
5180808|NCT01147744|12743189|P4|STARTED|Overall Study||100
5180809|NCT01147744|12743190|P3|STARTED|Overall Study||100
5180810|NCT01147744|12743191|P2|STARTED|Overall Study||99
5180811|NCT01147744|12743192|P1|STARTED|Overall Study||100
5180812|NCT01147653|12743287|P2|NOT COMPLETED|Year 2||3
5180813|NCT01147653|12743288|P1|NOT COMPLETED|Year 2||2
5180814|NCT01147653|12743287|P2|COMPLETED|Year 2||28
5180815|NCT01147653|12743288|P1|COMPLETED|Year 2||30
5180816|NCT01147653|12743287|P2|STARTED|Year 2||31
5180817|NCT01147653|12743288|P1|STARTED|Year 2||32
5180818|NCT01147653|12743287|P2|NOT COMPLETED|Year 1||0
5180819|NCT01147653|12743288|P1|NOT COMPLETED|Year 1||0
5180820|NCT01147653|12743287|P2|COMPLETED|Year 1||31
5180821|NCT01147653|12743288|P1|COMPLETED|Year 1||32
5180822|NCT01147653|12743287|P2|STARTED|Year 1||31
5180823|NCT01147653|12743288|P1|STARTED|Year 1||32
5180824|NCT01147640|12743349|P2|NOT COMPLETED|Overall Study||1
5180825|NCT01147640|12743350|P1|NOT COMPLETED|Overall Study||5
5180826|NCT01147640|12743349|P2|COMPLETED|Overall Study||38
5180827|NCT01147640|12743350|P1|COMPLETED|Overall Study||78
5180828|NCT01147640|12743349|P2|STARTED|Overall Study||39
5180829|NCT01147640|12743350|P1|STARTED|Overall Study||83
5180830|NCT01147627|12743361|P3|NOT COMPLETED|Overall Study||18
5180831|NCT01147627|12743362|P2|NOT COMPLETED|Overall Study||24
5180832|NCT01147627|12743363|P1|NOT COMPLETED|Overall Study||32
5180833|NCT01147627|12743361|P3|COMPLETED|Overall Study||118
5180834|NCT01147627|12743362|P2|COMPLETED|Overall Study||114
5180835|NCT01147627|12743363|P1|COMPLETED|Overall Study||110
5180836|NCT01147627|12743361|P3|STARTED|Overall Study||136
5180837|NCT01147627|12743362|P2|STARTED|Overall Study||138
5180838|NCT01147627|12743363|P1|STARTED|Overall Study||142
5180839|NCT01147601|12743373|P2|NOT COMPLETED|Overall Study||0
5180840|NCT01147601|12743374|P1|NOT COMPLETED|Overall Study||3
5180841|NCT01147601|12743373|P2|COMPLETED|Overall Study||1
5180842|NCT01147601|12743374|P1|COMPLETED|Overall Study||2
5180843|NCT01147601|12743373|P2|STARTED|Overall Study||1
5180844|NCT01147601|12743374|P1|STARTED|Overall Study||5
5180845|NCT01147497|12743382|P2|NOT COMPLETED|Overall Study||0
5180846|NCT01147497|12743383|P1|NOT COMPLETED|Overall Study||2
5180847|NCT01147497|12743382|P2|COMPLETED|Overall Study||36
5180848|NCT01147497|12743383|P1|COMPLETED|Overall Study||35
5180849|NCT01147497|12743382|P2|STARTED|Overall Study||36
5180850|NCT01147497|12743383|P1|STARTED|Overall Study||37
5180851|NCT01147471|12743403|P2|NOT COMPLETED|6 Month Follow Up||2
5180852|NCT01147471|12743404|P1|NOT COMPLETED|6 Month Follow Up||4
5180853|NCT01147471|12743403|P2|COMPLETED|6 Month Follow Up||4
5180854|NCT01147471|12743404|P1|COMPLETED|6 Month Follow Up||8
5180855|NCT01147471|12743403|P2|STARTED|6 Month Follow Up||6
5180856|NCT01147471|12743404|P1|STARTED|6 Month Follow Up||12
5180857|NCT01147471|12743403|P2|NOT COMPLETED|3 Month Follow Up||2
5180858|NCT01147471|12743404|P1|NOT COMPLETED|3 Month Follow Up||1
5180859|NCT01147471|12743403|P2|COMPLETED|3 Month Follow Up||6
5180860|NCT01147471|12743404|P1|COMPLETED|3 Month Follow Up||12
5180861|NCT01147471|12743403|P2|STARTED|3 Month Follow Up||8
5180862|NCT01147471|12743404|P1|STARTED|3 Month Follow Up||13
5180863|NCT01147471|12743403|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
5180864|NCT01147471|12743404|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
5180865|NCT01147471|12743403|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
5180866|NCT01147471|12743404|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
5180867|NCT01147471|12743403|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
5180868|NCT01147471|12743404|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
5180869|NCT01147471|12743403|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
5180870|NCT01147471|12743404|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
5180871|NCT01147471|12743403|P2|COMPLETED|Through Initial Hospital Discharge||11
5180872|NCT01147471|12743404|P1|COMPLETED|Through Initial Hospital Discharge||13
5180873|NCT01147471|12743403|P2|STARTED|Through Initial Hospital Discharge||11
5180874|NCT01147471|12743404|P1|STARTED|Through Initial Hospital Discharge||13
5180875|NCT01147458|12743418|P4|NOT COMPLETED|Second Intervention||4
5180876|NCT01147458|12743419|P3|NOT COMPLETED|Second Intervention||8
5180877|NCT01147458|12743420|P2|NOT COMPLETED|Second Intervention||7
5180878|NCT01147458|12743421|P1|NOT COMPLETED|Second Intervention||9
5180879|NCT01147458|12743418|P4|COMPLETED|Second Intervention||30
5180880|NCT01147458|12743419|P3|COMPLETED|Second Intervention||27
5180881|NCT01147458|12743420|P2|COMPLETED|Second Intervention||24
5180882|NCT01147458|12743421|P1|COMPLETED|Second Intervention||25
5180883|NCT01147458|12743418|P4|STARTED|Second Intervention||34
5180884|NCT01147458|12743419|P3|STARTED|Second Intervention||35
5180885|NCT01147458|12743420|P2|STARTED|Second Intervention||31
5180886|NCT01147458|12743421|P1|STARTED|Second Intervention||34
5180887|NCT01147458|12743418|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
5180888|NCT01147458|12743419|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
5180889|NCT01147458|12743420|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5180890|NCT01147458|12743421|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5180891|NCT01147458|12743418|P4|COMPLETED|Washout Period of 2 Weeks||34
5180892|NCT01147458|12743419|P3|COMPLETED|Washout Period of 2 Weeks||35
5180893|NCT01147458|12743420|P2|COMPLETED|Washout Period of 2 Weeks||31
5180894|NCT01147458|12743421|P1|COMPLETED|Washout Period of 2 Weeks||34
5180895|NCT01147458|12743418|P4|STARTED|Washout Period of 2 Weeks||34
5180896|NCT01147458|12743419|P3|STARTED|Washout Period of 2 Weeks||35
5180897|NCT01147458|12743420|P2|STARTED|Washout Period of 2 Weeks||31
5180898|NCT01147458|12743421|P1|STARTED|Washout Period of 2 Weeks||34
5180899|NCT01147458|12743418|P4|NOT COMPLETED|First Intervention||14
5180900|NCT01147458|12743419|P3|NOT COMPLETED|First Intervention||12
5180901|NCT01147458|12743420|P2|NOT COMPLETED|First Intervention||16
5180902|NCT01147458|12743421|P1|NOT COMPLETED|First Intervention||14
5180903|NCT01147458|12743418|P4|COMPLETED|First Intervention||34
5180904|NCT01147458|12743419|P3|COMPLETED|First Intervention||35
5180905|NCT01147458|12743420|P2|COMPLETED|First Intervention||31
5180906|NCT01147458|12743421|P1|COMPLETED|First Intervention||34
5180907|NCT01147458|12743418|P4|STARTED|First Intervention||48
5180908|NCT01147458|12743419|P3|STARTED|First Intervention||47
5180909|NCT01147458|12743420|P2|STARTED|First Intervention||47
5180910|NCT01147458|12743421|P1|STARTED|First Intervention||48
5180911|NCT01147406|12743475|P6|NOT COMPLETED|Overall Study||0
5180912|NCT01147406|12743476|P5|NOT COMPLETED|Overall Study||0
5180913|NCT01147406|12743477|P4|NOT COMPLETED|Overall Study||0
5180914|NCT01147406|12743478|P3|NOT COMPLETED|Overall Study||0
5180915|NCT01147406|12743479|P2|NOT COMPLETED|Overall Study||0
5180916|NCT01147406|12743480|P1|NOT COMPLETED|Overall Study||0
5180917|NCT01147406|12743475|P6|COMPLETED|Overall Study||10
5180918|NCT01147406|12743476|P5|COMPLETED|Overall Study||6
5180919|NCT01147406|12743477|P4|COMPLETED|Overall Study||6
5180920|NCT01147406|12743478|P3|COMPLETED|Overall Study||1
5180921|NCT01147406|12743479|P2|COMPLETED|Overall Study||12
5180922|NCT01147406|12743480|P1|COMPLETED|Overall Study||6
5180923|NCT01147406|12743475|P6|STARTED|Overall Study||10
5180924|NCT01147406|12743476|P5|STARTED|Overall Study||6
5180925|NCT01147406|12743477|P4|STARTED|Overall Study||6
5180926|NCT01147406|12743478|P3|STARTED|Overall Study||1
5180927|NCT01147406|12743479|P2|STARTED|Overall Study||12
5180928|NCT01147406|12743480|P1|STARTED|Overall Study||6
5180929|NCT01147393|12743500|P1|NOT COMPLETED|Dose Level -1||1
5180930|NCT01147393|12743500|P1|COMPLETED|Dose Level -1||0
5180931|NCT01147393|12743500|P1|STARTED|Dose Level -1||1
5180932|NCT01147393|12743500|P1|NOT COMPLETED|Dose Level 1||2
5180933|NCT01147393|12743500|P1|COMPLETED|Dose Level 1||1
5180934|NCT01147393|12743500|P1|STARTED|Dose Level 1||3
5180935|NCT01147380|12743510|P2|NOT COMPLETED|Overall Study||0
5180936|NCT01147380|12743511|P1|NOT COMPLETED|Overall Study||0
5180937|NCT01147380|12743510|P2|COMPLETED|Overall Study||12
5180938|NCT01147380|12743511|P1|COMPLETED|Overall Study||6
5180939|NCT01147380|12743510|P2|STARTED|Overall Study||12
5180940|NCT01147380|12743511|P1|STARTED|Overall Study||6
5180941|NCT01147341|12743521|P2|NOT COMPLETED|Open Label Period||0
5180942|NCT01147341|12743522|P1|NOT COMPLETED|Open Label Period||4
5180943|NCT01147341|12743521|P2|COMPLETED|Open Label Period||8
5180944|NCT01147341|12743522|P1|COMPLETED|Open Label Period||22
5180945|NCT01147341|12743521|P2|STARTED|Open Label Period||8
5180946|NCT01147341|12743522|P1|STARTED|Open Label Period||26
5180947|NCT01147341|12743521|P2|NOT COMPLETED|Double Blind Period||2
5180948|NCT01147341|12743522|P1|NOT COMPLETED|Double Blind Period||1
5180949|NCT01147341|12743521|P2|COMPLETED|Double Blind Period||8
5180950|NCT01147341|12743522|P1|COMPLETED|Double Blind Period||26
5180951|NCT01147341|12743521|P2|STARTED|Double Blind Period||10
5180952|NCT01147341|12743522|P1|STARTED|Double Blind Period||27
5180953|NCT01147302|12743552|P2|NOT COMPLETED|Overall Study||0
5180954|NCT01147302|12743553|P1|NOT COMPLETED|Overall Study||0
5180955|NCT01147302|12743552|P2|COMPLETED|Overall Study||9
5180956|NCT01147302|12743553|P1|COMPLETED|Overall Study||9
5180957|NCT01147302|12743552|P2|STARTED|Overall Study||9
5180958|NCT01147302|12743553|P1|STARTED|Overall Study||9
5180959|NCT01147250|12743585|P2|NOT COMPLETED|Overall Study||105
5180960|NCT01147250|12743586|P1|NOT COMPLETED|Overall Study||110
5180961|NCT01147250|12743585|P2|COMPLETED|Overall Study||2929
5180962|NCT01147250|12743586|P1|COMPLETED|Overall Study||2924
5180963|NCT01147250|12743585|P2|Treated|Overall Study||3031
5180964|NCT01147250|12743586|P1|Treated|Overall Study||3032
5180965|NCT01147250|12743585|P2|STARTED|Overall Study||3034
5180966|NCT01147250|12743586|P1|STARTED|Overall Study||3034
5180967|NCT01147172|12743598|P1|NOT COMPLETED|Overall Study||4
5180968|NCT01147172|12743598|P1|COMPLETED|Overall Study||96
5180969|NCT01147172|12743598|P1|STARTED|Overall Study||100
5180970|NCT01147068|12743616|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
5180971|NCT01147068|12743617|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
5180972|NCT01147068|12743618|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
5180973|NCT01147068|12743619|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
5180974|NCT01147068|12743620|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
5180975|NCT01147068|12743621|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
5180976|NCT01147068|12743622|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
5180977|NCT01147068|12743616|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
5180978|NCT01147068|12743617|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
5180979|NCT01147068|12743618|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
5180980|NCT01147068|12743619|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
5180981|NCT01147068|12743620|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
5180982|NCT01147068|12743621|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
5180983|NCT01147068|12743622|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
5180984|NCT01147068|12743616|P7|STARTED|Subjects That Completed Safety Follow-up||55
5180985|NCT01147068|12743617|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
5180986|NCT01147068|12743618|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
5180987|NCT01147068|12743619|P4|STARTED|Subjects That Completed Safety Follow-up||56
5180988|NCT01147068|12743620|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
5180989|NCT01147068|12743621|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
5180990|NCT01147068|12743622|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
5180991|NCT01147068|12743616|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
5180992|NCT01147068|12743617|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
5180993|NCT01147068|12743618|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
5180994|NCT01147068|12743619|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
5180995|NCT01147068|12743620|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
5180996|NCT01147068|12743621|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
5180997|NCT01147068|12743622|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
5180998|NCT01147068|12743616|P7|COMPLETED|Subjects That Received 2nd Dose||55
5180999|NCT01147068|12743617|P6|COMPLETED|Subjects That Received 2nd Dose||51
5181000|NCT01147068|12743618|P5|COMPLETED|Subjects That Received 2nd Dose||55
5181001|NCT01147068|12743619|P4|COMPLETED|Subjects That Received 2nd Dose||56
5181002|NCT01147068|12743620|P3|COMPLETED|Subjects That Received 2nd Dose||52
5181003|NCT01147068|12743621|P2|COMPLETED|Subjects That Received 2nd Dose||52
5181004|NCT01147068|12743622|P1|COMPLETED|Subjects That Received 2nd Dose||59
5181005|NCT01147068|12743616|P7|STARTED|Subjects That Received 2nd Dose||55
5181006|NCT01147068|12743617|P6|STARTED|Subjects That Received 2nd Dose||53
5181007|NCT01147068|12743618|P5|STARTED|Subjects That Received 2nd Dose||56
5181008|NCT01147068|12743619|P4|STARTED|Subjects That Received 2nd Dose||56
5181009|NCT01147068|12743620|P3|STARTED|Subjects That Received 2nd Dose||55
5181010|NCT01147068|12743621|P2|STARTED|Subjects That Received 2nd Dose||57
5181011|NCT01147068|12743622|P1|STARTED|Subjects That Received 2nd Dose||60
5181012|NCT01147068|12743616|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
5181013|NCT01147068|12743617|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
5181014|NCT01147068|12743618|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
5181015|NCT01147068|12743619|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
5181016|NCT01147068|12743620|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
5181017|NCT01147068|12743621|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
5181018|NCT01147068|12743622|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
5181019|NCT01147068|12743616|P7|COMPLETED|Subjects That Received 1st Dose||55
5181020|NCT01147068|12743617|P6|COMPLETED|Subjects That Received 1st Dose||53
5181021|NCT01147068|12743618|P5|COMPLETED|Subjects That Received 1st Dose||56
5181022|NCT01147068|12743619|P4|COMPLETED|Subjects That Received 1st Dose||56
5181023|NCT01147068|12743620|P3|COMPLETED|Subjects That Received 1st Dose||55
5181024|NCT01147068|12743621|P2|COMPLETED|Subjects That Received 1st Dose||57
5181025|NCT01147068|12743622|P1|COMPLETED|Subjects That Received 1st Dose||60
5181026|NCT01147068|12743616|P7|STARTED|Subjects That Received 1st Dose||55
5181027|NCT01147068|12743617|P6|STARTED|Subjects That Received 1st Dose||53
5181028|NCT01147068|12743618|P5|STARTED|Subjects That Received 1st Dose||56
5181029|NCT01147068|12743619|P4|STARTED|Subjects That Received 1st Dose||56
5181030|NCT01147068|12743620|P3|STARTED|Subjects That Received 1st Dose||55
5181031|NCT01147068|12743621|P2|STARTED|Subjects That Received 1st Dose||57
5181032|NCT01147068|12743622|P1|STARTED|Subjects That Received 1st Dose||60
5181033|NCT01147055|12743652|P2|NOT COMPLETED|Second Intervention Period||0
5181034|NCT01147055|12743653|P1|NOT COMPLETED|Second Intervention Period||0
5181035|NCT01147055|12743652|P2|COMPLETED|Second Intervention Period||14
5181036|NCT01147055|12743653|P1|COMPLETED|Second Intervention Period||0
5181037|NCT01147055|12743652|P2|STARTED|Second Intervention Period||14
5181038|NCT01147055|12743653|P1|STARTED|Second Intervention Period||0
5181039|NCT01147055|12743652|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5181040|NCT01147055|12743653|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5181041|NCT01147055|12743652|P2|COMPLETED|Washout Period (at Least 14 Days)||0
5181042|NCT01147055|12743653|P1|COMPLETED|Washout Period (at Least 14 Days)||14
5181043|NCT01147055|12743652|P2|STARTED|Washout Period (at Least 14 Days)||0
5181044|NCT01147055|12743653|P1|STARTED|Washout Period (at Least 14 Days)||14
5181045|NCT01147055|12743652|P2|NOT COMPLETED|First Intervention Period||0
5181046|NCT01147055|12743653|P1|NOT COMPLETED|First Intervention Period||1
5181047|NCT01147055|12743652|P2|COMPLETED|First Intervention Period||0
5181048|NCT01147055|12743653|P1|COMPLETED|First Intervention Period||14
5181049|NCT01147055|12743652|P2|STARTED|First Intervention Period||0
5181050|NCT01147055|12743653|P1|STARTED|First Intervention Period||15
5181051|NCT01147042|12743687|P2|NOT COMPLETED|Overall Study||0
5181052|NCT01147042|12743688|P1|NOT COMPLETED|Overall Study||0
5181053|NCT01147042|12743687|P2|COMPLETED|Overall Study||0
5181054|NCT01147042|12743688|P1|COMPLETED|Overall Study||2
5181055|NCT01147042|12743687|P2|STARTED|Overall Study||0
5181056|NCT01147042|12743688|P1|STARTED|Overall Study||2
5181057|NCT01146951|12743695|P2|NOT COMPLETED|Overall Study||1
5181058|NCT01146951|12743696|P1|NOT COMPLETED|Overall Study||4
5181059|NCT01146951|12743695|P2|COMPLETED|Overall Study||29
5181060|NCT01146951|12743696|P1|COMPLETED|Overall Study||25
5181061|NCT01146951|12743695|P2|STARTED|Overall Study||30
5181062|NCT01146951|12743696|P1|STARTED|Overall Study||29
5181063|NCT01146912|12743717|P8|NOT COMPLETED|Overall Study||0
5181064|NCT01146912|12743718|P7|NOT COMPLETED|Overall Study||56
5181065|NCT01146912|12743719|P6|NOT COMPLETED|Overall Study||61
5181066|NCT01146912|12743720|P5|NOT COMPLETED|Overall Study||41
5181067|NCT01146912|12743721|P4|NOT COMPLETED|Overall Study||17
5181068|NCT01146912|12743722|P3|NOT COMPLETED|Overall Study||17
5181069|NCT01146912|12743723|P2|NOT COMPLETED|Overall Study||822
5181070|NCT01146912|12743724|P1|NOT COMPLETED|Overall Study||817
5181071|NCT01146912|12743717|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
5181072|NCT01146912|12743718|P7|COMPLETED|Overall Study||1764
5181073|NCT01146912|12743719|P6|COMPLETED|Overall Study||1760
5181074|NCT01146912|12743720|P5|COMPLETED|Overall Study||1780
5181075|NCT01146912|12743721|P4|COMPLETED|Overall Study||577
5181076|NCT01146912|12743722|P3|COMPLETED|Overall Study||576
5181077|NCT01146912|12743723|P2|COMPLETED|Overall Study||3784
5181078|NCT01146912|12743724|P1|COMPLETED|Overall Study||3790
5181079|NCT01146912|12743717|P8|STARTED|Overall Study||14675
5181080|NCT01146912|12743718|P7|STARTED|Overall Study||1820
5181081|NCT01146912|12743719|P6|STARTED|Overall Study||1821
5181082|NCT01146912|12743720|P5|STARTED|Overall Study||1821
5181083|NCT01146912|12743721|P4|STARTED|Overall Study||594
5181084|NCT01146912|12743722|P3|STARTED|Overall Study||593
5181085|NCT01146912|12743723|P2|STARTED|Overall Study||4606
5181086|NCT01146912|12743724|P1|STARTED|Overall Study||4607
5181087|NCT01146873|12743746|P2|NOT COMPLETED|Overall Study||6
5181088|NCT01146873|12743747|P1|NOT COMPLETED|Overall Study||0
5181089|NCT01146873|12743746|P2|COMPLETED|Overall Study||144
5181090|NCT01146873|12743747|P1|COMPLETED|Overall Study||148
5181091|NCT01146873|12743746|P2|STARTED|Overall Study||150
5181092|NCT01146873|12743747|P1|STARTED|Overall Study||148
5181093|NCT01146860|12743763|P2|NOT COMPLETED|Overall Study||1
5181094|NCT01146860|12743764|P1|NOT COMPLETED|Overall Study||0
5181095|NCT01146860|12743763|P2|COMPLETED|Overall Study||191
5181096|NCT01146860|12743764|P1|COMPLETED|Overall Study||194
5181097|NCT01146860|12743763|P2|STARTED|Overall Study||192
5181098|NCT01146860|12743764|P1|STARTED|Overall Study||194
5181099|NCT01146834|12743783|P5|NOT COMPLETED|Overall Study||0
5181100|NCT01146834|12743784|P4|NOT COMPLETED|Overall Study||0
5181101|NCT01146834|12743785|P3|NOT COMPLETED|Overall Study||2
5181102|NCT01146834|12743786|P2|NOT COMPLETED|Overall Study||0
5181103|NCT01146834|12743787|P1|NOT COMPLETED|Overall Study||3
5181104|NCT01146834|12743783|P5|COMPLETED|Overall Study||0
5181105|NCT01146834|12743784|P4|COMPLETED|Overall Study||0
5181106|NCT01146834|12743785|P3|COMPLETED|Overall Study||21
5181107|NCT01146834|12743786|P2|COMPLETED|Overall Study||4
5181108|NCT01146834|12743787|P1|COMPLETED|Overall Study||17
5181109|NCT01146834|12743783|P5|STARTED|Overall Study||0
5181110|NCT01146834|12743784|P4|STARTED|Overall Study||0
5181111|NCT01146834|12743785|P3|STARTED|Overall Study||23
5181112|NCT01146834|12743786|P2|STARTED|Overall Study||4
5181113|NCT01146834|12743787|P1|STARTED|Overall Study||20
5181114|NCT01146808|12743809|P1|NOT COMPLETED|Overall Study||0
5181115|NCT01146808|12743809|P1|COMPLETED|Overall Study||16
5181116|NCT01146808|12743809|P1|STARTED|Overall Study||16
5181117|NCT01146782|12743815|P1|NOT COMPLETED|Primary Endpoint Cohort||6
5181118|NCT01146782|12743815|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
5181119|NCT01146782|12743815|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
5181120|NCT01146782|12743815|P1|NOT COMPLETED|Safety Cohort||83
5181121|NCT01146782|12743815|P1|COMPLETED|Safety Cohort||63
5181122|NCT01146782|12743815|P1|STARTED|Safety Cohort||146
5181123|NCT01146782|12743815|P1|NOT COMPLETED|Screening Cohort||221
5181124|NCT01146782|12743815|P1|COMPLETED|Screening Cohort||146
5181125|NCT01146782|12743815|P1|STARTED|Screening Cohort||367
5181126|NCT01146704|12743824|P2|NOT COMPLETED|Overall Study||0
5181127|NCT01146704|12743825|P1|NOT COMPLETED|Overall Study||0
5181128|NCT01146704|12743824|P2|COMPLETED|Overall Study||15
5181129|NCT01146704|12743825|P1|COMPLETED|Overall Study||16
5181130|NCT01146704|12743824|P2|STARTED|Overall Study||15
5181131|NCT01146704|12743825|P1|STARTED|Overall Study||16
5181132|NCT01146665|12743833|P2|NOT COMPLETED|Overall Study||16
5181133|NCT01146665|12743834|P1|NOT COMPLETED|Overall Study||10
5181134|NCT01146665|12743833|P2|COMPLETED|Overall Study||10
5181135|NCT01146665|12743834|P1|COMPLETED|Overall Study||8
5181136|NCT01146665|12743833|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
5181137|NCT01146665|12743834|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
5181138|NCT01146665|12743833|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
5181139|NCT01146665|12743834|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
5181140|NCT01146665|12743833|P2|STARTED|Overall Study||26
5181141|NCT01146665|12743834|P1|STARTED|Overall Study||18
5181142|NCT01146613|12743866|P2|NOT COMPLETED|Overall Study||12
5181143|NCT01146613|12743867|P1|NOT COMPLETED|Overall Study||7
5181144|NCT01146613|12743866|P2|COMPLETED|Overall Study||89
5181145|NCT01146613|12743867|P1|COMPLETED|Overall Study||92
5181146|NCT01146613|12743866|P2|STARTED|Overall Study||101
5181147|NCT01146613|12743867|P1|STARTED|Overall Study||99
5181148|NCT01146600|12743875|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
5181149|NCT01146600|12743876|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
5181150|NCT01146600|12743875|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
5181151|NCT01146600|12743876|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
5181152|NCT01146600|12743875|P2|STARTED|Period 2 (Weeks 4 & 5)||10
5181153|NCT01146600|12743876|P1|STARTED|Period 2 (Weeks 4 & 5)||10
5181154|NCT01146600|12743875|P2|NOT COMPLETED|Washout (Week 3)||0
5181155|NCT01146600|12743876|P1|NOT COMPLETED|Washout (Week 3)||0
5181156|NCT01146600|12743875|P2|COMPLETED|Washout (Week 3)||10
5181157|NCT01146600|12743876|P1|COMPLETED|Washout (Week 3)||10
5181158|NCT01146600|12743875|P2|STARTED|Washout (Week 3)||10
5181159|NCT01146600|12743876|P1|STARTED|Washout (Week 3)||10
5181160|NCT01146600|12743875|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
5181161|NCT01146600|12743876|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
5181162|NCT01146600|12743875|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
5181163|NCT01146600|12743876|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
5181164|NCT01146600|12743875|P2|STARTED|Period 1 (Weeks 1 & 2)||10
5181165|NCT01146600|12743876|P1|STARTED|Period 1 (Weeks 1 & 2)||13
5181166|NCT01146496|12743903|P2|NOT COMPLETED|Overall Study||0
5181167|NCT01146496|12743904|P1|NOT COMPLETED|Overall Study||0
5181168|NCT01146496|12743903|P2|COMPLETED|Overall Study||109693
5181169|NCT01146496|12743904|P1|COMPLETED|Overall Study||114168
5181170|NCT01146496|12743903|P2|STARTED|Overall Study||109693
5181171|NCT01146496|12743904|P1|STARTED|Overall Study||114168
5181172|NCT01146457|12743925|P5|NOT COMPLETED|Overall Study||0
5181173|NCT01146457|12743926|P4|NOT COMPLETED|Overall Study||0
5181174|NCT01146457|12743927|P3|NOT COMPLETED|Overall Study||1
5181175|NCT01146457|12743928|P2|NOT COMPLETED|Overall Study||0
5181176|NCT01146457|12743929|P1|NOT COMPLETED|Overall Study||0
5181177|NCT01146457|12743925|P5|COMPLETED|Overall Study||13
5181178|NCT01146457|12743926|P4|COMPLETED|Overall Study||13
5181179|NCT01146457|12743927|P3|COMPLETED|Overall Study||20
5181180|NCT01146457|12743928|P2|COMPLETED|Overall Study||17
5181181|NCT01146457|12743929|P1|COMPLETED|Overall Study||19
5181182|NCT01146457|12743925|P5|STARTED|Overall Study||13
5181183|NCT01146457|12743926|P4|STARTED|Overall Study||13
5181184|NCT01146457|12743927|P3|STARTED|Overall Study||21
5181185|NCT01146457|12743928|P2|STARTED|Overall Study||17
5181186|NCT01146457|12743929|P1|STARTED|Overall Study||19
5181187|NCT01146418|12743943|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
5181188|NCT01146418|12743944|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
5181189|NCT01146418|12743945|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
5181190|NCT01146418|12743946|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
5181191|NCT01146418|12743943|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
5181192|NCT01146418|12743944|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
5181193|NCT01146418|12743945|P2|COMPLETED|Live-Born Infant Follow Up||0
5181194|NCT01146418|12743946|P1|COMPLETED|Live-Born Infant Follow Up||0
5181195|NCT01146418|12743943|P4|STARTED|Live-Born Infant Follow Up||56
5181196|NCT01146418|12743944|P3|STARTED|Live-Born Infant Follow Up||61
5181197|NCT01146418|12743945|P2|STARTED|Live-Born Infant Follow Up||0
5181198|NCT01146418|12743946|P1|STARTED|Live-Born Infant Follow Up||0
5181199|NCT01146418|12743943|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
5181200|NCT01146418|12743944|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
5181201|NCT01146418|12743945|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
5181202|NCT01146418|12743946|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
5181203|NCT01146418|12743943|P4|COMPLETED|Women/Expectant Mother Follow Up||0
5181204|NCT01146418|12743944|P3|COMPLETED|Women/Expectant Mother Follow Up||0
5181205|NCT01146418|12743945|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
5181206|NCT01146418|12743946|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
5181207|NCT01146418|12743943|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
5181208|NCT01146418|12743944|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
5181209|NCT01146418|12743945|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
5181210|NCT01146418|12743946|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
5181211|NCT01146418|12743943|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
5181212|NCT01146418|12743944|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
5181213|NCT01146418|12743945|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
5181214|NCT01146418|12743946|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
5181215|NCT01146418|12743943|P4|STARTED|Women/Expectant Mother Follow Up||0
5181216|NCT01146418|12743944|P3|STARTED|Women/Expectant Mother Follow Up||0
5181217|NCT01146418|12743945|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
5181218|NCT01146418|12743946|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
5181219|NCT01146418|12743943|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
5181220|NCT01146418|12743944|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
5181221|NCT01146418|12743945|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
5181222|NCT01146418|12743946|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
5181223|NCT01146418|12743943|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
5181224|NCT01146418|12743944|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
5181225|NCT01146418|12743945|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
5181226|NCT01146418|12743946|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
5181227|NCT01146418|12743943|P4|STARTED|Base Study P06029 (NCT01144416)||0
5181228|NCT01146418|12743944|P3|STARTED|Base Study P06029 (NCT01144416)||0
5181229|NCT01146418|12743945|P2|STARTED|Base Study P06029 (NCT01144416)||696
5181230|NCT01146418|12743946|P1|STARTED|Base Study P06029 (NCT01144416)||694
5181231|NCT01146379|12743962|P4|NOT COMPLETED|Overall Study||1
5181232|NCT01146379|12743963|P3|NOT COMPLETED|Overall Study||0
5181233|NCT01146379|12743964|P2|NOT COMPLETED|Overall Study||1
5181234|NCT01146379|12743965|P1|NOT COMPLETED|Overall Study||1
5181235|NCT01146379|12743962|P4|COMPLETED|Overall Study||20
5181236|NCT01146379|12743963|P3|COMPLETED|Overall Study||21
5181237|NCT01146379|12743964|P2|COMPLETED|Overall Study||21
5181238|NCT01146379|12743965|P1|COMPLETED|Overall Study||20
5181239|NCT01146379|12743962|P4|STARTED|Overall Study||21
5181240|NCT01146379|12743963|P3|STARTED|Overall Study||21
5181241|NCT01146379|12743964|P2|STARTED|Overall Study||22
5181242|NCT01146379|12743965|P1|STARTED|Overall Study||21
5181243|NCT01146288|12743977|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5181244|NCT01146288|12743978|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5181245|NCT01146288|12743977|P2|COMPLETED|Second Intervention (1 Day)||5
5181246|NCT01146288|12743978|P1|COMPLETED|Second Intervention (1 Day)||7
5181247|NCT01146288|12743977|P2|STARTED|Second Intervention (1 Day)||5
5181248|NCT01146288|12743978|P1|STARTED|Second Intervention (1 Day)||7
5181249|NCT01146288|12743977|P2|NOT COMPLETED|First Intervention(1 Day)||1
5181250|NCT01146288|12743978|P1|NOT COMPLETED|First Intervention(1 Day)||0
5181251|NCT01146288|12743977|P2|COMPLETED|First Intervention(1 Day)||5
5181252|NCT01146288|12743978|P1|COMPLETED|First Intervention(1 Day)||7
5181253|NCT01146288|12743977|P2|STARTED|First Intervention(1 Day)||6
5181254|NCT01146288|12743978|P1|STARTED|First Intervention(1 Day)||7
5181255|NCT01146275|12743987|P1|NOT COMPLETED|Overall Study||0
5181256|NCT01146275|12743987|P1|COMPLETED|Overall Study||6
5181257|NCT01146275|12743987|P1|STARTED|Overall Study||6
5181258|NCT01146054|12743992|P1|NOT COMPLETED|Overall Study||10
5181259|NCT01146054|12743992|P1|COMPLETED|Overall Study||49
5181260|NCT01146054|12743992|P1|STARTED|Overall Study||59
5181261|NCT01145898|12744002|P2|NOT COMPLETED|3-year Treatment||16
5181262|NCT01145898|12744003|P1|NOT COMPLETED|3-year Treatment||3
5181263|NCT01145898|12744002|P2|COMPLETED|3-year Treatment||28
5181264|NCT01145898|12744003|P1|COMPLETED|3-year Treatment||9
5181265|NCT01145898|12744002|P2|STARTED|3-year Treatment||44
5181266|NCT01145898|12744003|P1|STARTED|3-year Treatment||12
5181267|NCT01145898|12744002|P2|NOT COMPLETED|6-month Treatment||0
5181268|NCT01145898|12744003|P1|NOT COMPLETED|6-month Treatment||0
5181269|NCT01145898|12744002|P2|COMPLETED|6-month Treatment||44
5181270|NCT01145898|12744003|P1|COMPLETED|6-month Treatment||12
5181271|NCT01145898|12744002|P2|STARTED|6-month Treatment||44
5181272|NCT01145898|12744003|P1|STARTED|6-month Treatment||12
5181273|NCT01145885|12744034|P1|NOT COMPLETED|Overall Study||7
5181274|NCT01145885|12744034|P1|COMPLETED|Overall Study||0
5181275|NCT01145885|12744034|P1|STARTED|Overall Study||7
5181276|NCT01145755|12744069|P3|NOT COMPLETED|Overall Study||25
5181277|NCT01145755|12744070|P2|NOT COMPLETED|Overall Study||28
5181278|NCT01145755|12744071|P1|NOT COMPLETED|Overall Study||20
5181279|NCT01145755|12744069|P3|COMPLETED|Overall Study||19
5181280|NCT01145755|12744070|P2|COMPLETED|Overall Study||19
5181281|NCT01145755|12744071|P1|COMPLETED|Overall Study||20
5181282|NCT01145755|12744069|P3|STARTED|Overall Study||44
5181283|NCT01145755|12744070|P2|STARTED|Overall Study||47
5181284|NCT01145755|12744071|P1|STARTED|Overall Study||40
5181285|NCT01145638|12744087|P2|NOT COMPLETED|Overall Study||57
5181286|NCT01145638|12744088|P1|NOT COMPLETED|Overall Study||90
5181287|NCT01145638|12744087|P2|COMPLETED|Overall Study||62
5181288|NCT01145638|12744088|P1|COMPLETED|Overall Study||141
5181289|NCT01145638|12744087|P2|STARTED|Overall Study||119
5181290|NCT01145638|12744088|P1|STARTED|Overall Study||231
5181291|NCT01145625|12744098|P2|NOT COMPLETED|Overall Study||31
5181292|NCT01145625|12744099|P1|NOT COMPLETED|Overall Study||24
5181293|NCT01145625|12744098|P2|COMPLETED|Overall Study||130
5181294|NCT01145625|12744099|P1|COMPLETED|Overall Study||137
5181295|NCT01145625|12744098|P2|STARTED|Overall Study||161
5181296|NCT01145625|12744099|P1|STARTED|Overall Study||161
5181297|NCT01145560|12744112|P3|NOT COMPLETED|Overall Study||2
5181298|NCT01145560|12744113|P2|NOT COMPLETED|Overall Study||4
5181299|NCT01145560|12744114|P1|NOT COMPLETED|Overall Study||4
5181300|NCT01145560|12744112|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
5181301|NCT01145560|12744113|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
5181302|NCT01145560|12744114|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
5181303|NCT01145560|12744112|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
5181304|NCT01145560|12744113|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
5181305|NCT01145560|12744114|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
5181306|NCT01145560|12744112|P3|Received Treatment|Overall Study||99
5181307|NCT01145560|12744113|P2|Received Treatment|Overall Study||98
5181308|NCT01145560|12744114|P1|Received Treatment|Overall Study||99
5181309|NCT01145560|12744112|P3|STARTED|Overall Study||100
5181310|NCT01145560|12744113|P2|STARTED|Overall Study||100
5181311|NCT01145560|12744114|P1|STARTED|Overall Study||100
5181312|NCT01145547|12744131|P2|NOT COMPLETED|Overall Study||0
5181313|NCT01145547|12744132|P1|NOT COMPLETED|Overall Study||0
5181314|NCT01145547|12744131|P2|COMPLETED|Overall Study||3
5181315|NCT01145547|12744132|P1|COMPLETED|Overall Study||4
5181316|NCT01145547|12744131|P2|STARTED|Overall Study||3
5181317|NCT01145547|12744132|P1|STARTED|Overall Study||4
5181318|NCT01145508|12744140|P2|NOT COMPLETED|Overall Study||2
5181319|NCT01145508|12744141|P1|NOT COMPLETED|Overall Study||5
5181320|NCT01145508|12744140|P2|COMPLETED|Overall Study||1
5181321|NCT01145508|12744141|P1|COMPLETED|Overall Study||2
5181322|NCT01145508|12744140|P2|Treated|Overall Study||2
5181323|NCT01145508|12744141|P1|Treated|Overall Study||6
5181324|NCT01145508|12744140|P2|STARTED|Overall Study||3
5181325|NCT01145508|12744141|P1|STARTED|Overall Study||7
5181326|NCT01145495|12744147|P1|NOT COMPLETED|Overall Study||12
5181327|NCT01145495|12744147|P1|COMPLETED|Overall Study||51
5181328|NCT01145495|12744147|P1|STARTED|Overall Study||63
5181329|NCT01145482|12744153|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5181330|NCT01145482|12744154|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5181331|NCT01145482|12744153|P2|COMPLETED|Second Intervention (1 Day)||6
5181332|NCT01145482|12744154|P1|COMPLETED|Second Intervention (1 Day)||5
5181333|NCT01145482|12744153|P2|STARTED|Second Intervention (1 Day)||6
5181334|NCT01145482|12744154|P1|STARTED|Second Intervention (1 Day)||5
5181335|NCT01145482|12744153|P2|NOT COMPLETED|First Intervention (1 Day)||1
5181336|NCT01145482|12744154|P1|NOT COMPLETED|First Intervention (1 Day)||0
5181337|NCT01145482|12744153|P2|COMPLETED|First Intervention (1 Day)||5
5181338|NCT01145482|12744154|P1|COMPLETED|First Intervention (1 Day)||6
5181339|NCT01145482|12744153|P2|STARTED|First Intervention (1 Day)||6
5181340|NCT01145482|12744154|P1|STARTED|First Intervention (1 Day)||6
5181341|NCT01145417|12744164|P2|NOT COMPLETED|Overall Study||47
5181342|NCT01145417|12744165|P1|NOT COMPLETED|Overall Study||41
5181343|NCT01145417|12744164|P2|COMPLETED|Overall Study||62
5181344|NCT01145417|12744165|P1|COMPLETED|Overall Study||67
5181345|NCT01145417|12744164|P2|STARTED|Overall Study||109
5181346|NCT01145417|12744165|P1|STARTED|Overall Study||108
5181347|NCT01145391|12744189|P2|NOT COMPLETED|Overall Study||0
5181348|NCT01145391|12744190|P1|NOT COMPLETED|Overall Study||0
5181349|NCT01145391|12744189|P2|COMPLETED|Overall Study||298
5181350|NCT01145391|12744190|P1|COMPLETED|Overall Study||293
5181351|NCT01145391|12744189|P2|9 Months Post-randomization|Overall Study||298
5181352|NCT01145391|12744190|P1|9 Months Post-randomization|Overall Study||293
5181353|NCT01145391|12744189|P2|STARTED|Overall Study||298
5181354|NCT01145391|12744190|P1|STARTED|Overall Study||293
5181355|NCT01145352|12744198|P1|NOT COMPLETED|Overall Study||11
5181356|NCT01145352|12744198|P1|COMPLETED|Overall Study||102
5181357|NCT01145352|12744198|P1|STARTED|Overall Study||113
5181358|NCT01145222|12744210|P4|NOT COMPLETED|Overall Study||1
5181359|NCT01145222|12744211|P3|NOT COMPLETED|Overall Study||1
5181360|NCT01145222|12744212|P2|NOT COMPLETED|Overall Study||0
5181361|NCT01145222|12744213|P1|NOT COMPLETED|Overall Study||0
5181362|NCT01145222|12744210|P4|COMPLETED|Overall Study||40
5181363|NCT01145222|12744211|P3|COMPLETED|Overall Study||40
5181364|NCT01145222|12744212|P2|COMPLETED|Overall Study||40
5181365|NCT01145222|12744213|P1|COMPLETED|Overall Study||40
5181366|NCT01145222|12744210|P4|Intention to Treat (ITT) Population|Overall Study||40
5181367|NCT01145222|12744211|P3|Intention to Treat (ITT) Population|Overall Study||40
5181368|NCT01145222|12744212|P2|Intention to Treat (ITT) Population|Overall Study||40
5181369|NCT01145222|12744213|P1|Intention to Treat (ITT) Population|Overall Study||40
5181370|NCT01145222|12744210|P4|Safety Population|Overall Study||41
5181371|NCT01145222|12744211|P3|Safety Population|Overall Study||40
5181372|NCT01145222|12744212|P2|Safety Population|Overall Study||40
5181373|NCT01145222|12744213|P1|Safety Population|Overall Study||40
5181374|NCT01145222|12744210|P4|STARTED|Overall Study||41
5181375|NCT01145222|12744211|P3|STARTED|Overall Study||41
5181376|NCT01145222|12744212|P2|STARTED|Overall Study||40
5181377|NCT01145222|12744213|P1|STARTED|Overall Study||40
5181378|NCT01145209|12744233|P2|NOT COMPLETED|Overall Study||1
5181379|NCT01145209|12744234|P1|NOT COMPLETED|Overall Study||3
5181380|NCT01145209|12744233|P2|COMPLETED|Overall Study||18
5181381|NCT01145209|12744234|P1|COMPLETED|Overall Study||10
5181382|NCT01145209|12744233|P2|STARTED|Overall Study||19
5181383|NCT01145209|12744234|P1|STARTED|Overall Study||13
5181384|NCT01145183|12744244|P4|NOT COMPLETED|Overall Study||0
5181385|NCT01145183|12744245|P3|NOT COMPLETED|Overall Study||0
5181386|NCT01145183|12744246|P2|NOT COMPLETED|Overall Study||0
5181387|NCT01145183|12744247|P1|NOT COMPLETED|Overall Study||0
5181388|NCT01145183|12744244|P4|COMPLETED|Overall Study||10
5181389|NCT01145183|12744245|P3|COMPLETED|Overall Study||19
5181390|NCT01145183|12744246|P2|COMPLETED|Overall Study||26
5181391|NCT01145183|12744247|P1|COMPLETED|Overall Study||21
5181392|NCT01145183|12744244|P4|STARTED|Overall Study||10
5181393|NCT01145183|12744245|P3|STARTED|Overall Study||19
5181394|NCT01145183|12744246|P2|STARTED|Overall Study||26
5181395|NCT01145183|12744247|P1|STARTED|Overall Study||21
5181396|NCT01145066|12744260|P3|NOT COMPLETED|Overall Study||4
5181397|NCT01145066|12744261|P2|NOT COMPLETED|Overall Study||4
5181398|NCT01145066|12744262|P1|NOT COMPLETED|Overall Study||4
5181399|NCT01145066|12744260|P3|COMPLETED|Overall Study||21
5181400|NCT01145066|12744261|P2|COMPLETED|Overall Study||16
5181401|NCT01145066|12744262|P1|COMPLETED|Overall Study||22
5181402|NCT01145066|12744260|P3|STARTED|Overall Study||25
5181403|NCT01145066|12744261|P2|STARTED|Overall Study||20
5181404|NCT01145066|12744262|P1|STARTED|Overall Study||26
5181405|NCT01145053|12744330|P1|NOT COMPLETED|Overall Study||93
5181406|NCT01145053|12744330|P1|COMPLETED|Overall Study||248
5181407|NCT01145053|12744330|P1|STARTED|Overall Study||341
5181408|NCT01145001|12744344|P4|NOT COMPLETED|Overall Study||6
5181409|NCT01145001|12744345|P3|NOT COMPLETED|Overall Study||5
5181410|NCT01145001|12744346|P2|NOT COMPLETED|Overall Study||6
5181411|NCT01145001|12744347|P1|NOT COMPLETED|Overall Study||8
5181412|NCT01145001|12744344|P4|COMPLETED|Overall Study||31
5181413|NCT01145001|12744345|P3|COMPLETED|Overall Study||39
5181414|NCT01145001|12744346|P2|COMPLETED|Overall Study||31
5181415|NCT01145001|12744347|P1|COMPLETED|Overall Study||28
5181416|NCT01145001|12744344|P4|STARTED|Overall Study||37
5181417|NCT01145001|12744345|P3|STARTED|Overall Study||44
5181418|NCT01145001|12744346|P2|STARTED|Overall Study||37
5181419|NCT01145001|12744347|P1|STARTED|Overall Study||36
5181420|NCT01144949|12744363|P2|NOT COMPLETED|Overall Study||14
5181421|NCT01144949|12744364|P1|NOT COMPLETED|Overall Study||11
5181422|NCT01144949|12744363|P2|COMPLETED|Overall Study||106
5181423|NCT01144949|12744364|P1|COMPLETED|Overall Study||108
5181424|NCT01144949|12744363|P2|STARTED|Overall Study||120
5181425|NCT01144949|12744364|P1|STARTED|Overall Study||119
5181426|NCT01144715|12744382|P2|NOT COMPLETED|Overall Study||3
5181427|NCT01144715|12744383|P1|NOT COMPLETED|Overall Study||4
5181428|NCT01144715|12744382|P2|COMPLETED|Overall Study||45
5181429|NCT01144715|12744383|P1|COMPLETED|Overall Study||47
5181430|NCT01144715|12744382|P2|STARTED|Overall Study||48
5181431|NCT01144715|12744383|P1|STARTED|Overall Study||51
5181432|NCT01144663|12744399|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
5181433|NCT01144663|12744400|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
5181434|NCT01144663|12744401|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
5181435|NCT01144663|12744402|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
5181436|NCT01144663|12744399|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
5181437|NCT01144663|12744400|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
5181438|NCT01144663|12744401|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
5181439|NCT01144663|12744402|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
5181440|NCT01144663|12744399|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
5181441|NCT01144663|12744400|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
5181442|NCT01144663|12744401|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
5181443|NCT01144663|12744402|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
5181444|NCT01144663|12744399|P4|NOT COMPLETED|Booster Vaccination Phase||1
5181445|NCT01144663|12744400|P3|NOT COMPLETED|Booster Vaccination Phase||5
5181446|NCT01144663|12744401|P2|NOT COMPLETED|Booster Vaccination Phase||2
5181447|NCT01144663|12744402|P1|NOT COMPLETED|Booster Vaccination Phase||3
5181448|NCT01144663|12744399|P4|COMPLETED|Booster Vaccination Phase||505
5181449|NCT01144663|12744400|P3|COMPLETED|Booster Vaccination Phase||498
5181450|NCT01144663|12744401|P2|COMPLETED|Booster Vaccination Phase||509
5181451|NCT01144663|12744402|P1|COMPLETED|Booster Vaccination Phase||494
5181452|NCT01144663|12744399|P4|STARTED|Booster Vaccination Phase||506
5181453|NCT01144663|12744400|P3|STARTED|Booster Vaccination Phase||503
5181454|NCT01144663|12744401|P2|STARTED|Booster Vaccination Phase||511
5181455|NCT01144663|12744402|P1|STARTED|Booster Vaccination Phase||497
5181456|NCT01144663|12744399|P4|NOT COMPLETED|Primary Vaccination Phase||18
5181457|NCT01144663|12744400|P3|NOT COMPLETED|Primary Vaccination Phase||8
5181458|NCT01144663|12744401|P2|NOT COMPLETED|Primary Vaccination Phase||7
5181459|NCT01144663|12744402|P1|NOT COMPLETED|Primary Vaccination Phase||20
5181460|NCT01144663|12744399|P4|COMPLETED|Primary Vaccination Phase||509
5181461|NCT01144663|12744400|P3|COMPLETED|Primary Vaccination Phase||508
5181462|NCT01144663|12744401|P2|COMPLETED|Primary Vaccination Phase||517
5181463|NCT01144663|12744402|P1|COMPLETED|Primary Vaccination Phase||508
5181464|NCT01144663|12744399|P4|STARTED|Primary Vaccination Phase||527
5181465|NCT01144663|12744400|P3|STARTED|Primary Vaccination Phase||516
5181466|NCT01144663|12744401|P2|STARTED|Primary Vaccination Phase||524
5181467|NCT01144663|12744402|P1|STARTED|Primary Vaccination Phase||528
5181468|NCT01144637|12744606|P4|NOT COMPLETED|Overall Study||56
5181469|NCT01144637|12744607|P3|NOT COMPLETED|Overall Study||60
5181470|NCT01144637|12744608|P2|NOT COMPLETED|Overall Study||76
5181471|NCT01144637|12744609|P1|NOT COMPLETED|Overall Study||74
5181472|NCT01144637|12744606|P4|COMPLETED|Overall Study||946
5181473|NCT01144637|12744607|P3|COMPLETED|Overall Study||939
5181474|NCT01144637|12744608|P2|COMPLETED|Overall Study||929
5181475|NCT01144637|12744609|P1|COMPLETED|Overall Study||925
5181476|NCT01144637|12744606|P4|STARTED|Overall Study||1002
5181477|NCT01144637|12744607|P3|STARTED|Overall Study||999
5181478|NCT01144637|12744608|P2|STARTED|Overall Study||1005
5181479|NCT01144637|12744609|P1|STARTED|Overall Study||999
5181480|NCT01144624|12744666|P3|NOT COMPLETED|Overall Study||0
5181481|NCT01144624|12744667|P2|NOT COMPLETED|Overall Study||0
5181482|NCT01144624|12744668|P1|NOT COMPLETED|Overall Study||0
5181483|NCT01144624|12744666|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
5181484|NCT01144624|12744667|P2|COMPLETED|Overall Study||7
5181485|NCT01144624|12744668|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
5181486|NCT01144624|12744666|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
5181487|NCT01144624|12744667|P2|Completed Treatment|Overall Study||7
5181488|NCT01144624|12744668|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
5181489|NCT01144624|12744666|P3|Received Treatment|Overall Study||6
5181490|NCT01144624|12744667|P2|Received Treatment|Overall Study||7
5181491|NCT01144624|12744668|P1|Received Treatment|Overall Study||7
5181492|NCT01144624|12744666|P3|STARTED|Overall Study||6
5181493|NCT01144624|12744667|P2|STARTED|Overall Study||7
5181494|NCT01144624|12744668|P1|STARTED|Overall Study||7
5181495|NCT01144598|12744682|P1|NOT COMPLETED|Overall Study||0
5181496|NCT01144598|12744682|P1|COMPLETED|Overall Study||356
5181497|NCT01144598|12744682|P1|Analysis Population|Overall Study||356
5181498|NCT01144598|12744682|P1|STARTED|Overall Study||356
5181499|NCT01144494|12744700|P2|NOT COMPLETED|Overall Study||4
5181500|NCT01144494|12744701|P1|NOT COMPLETED|Overall Study||0
5181501|NCT01144494|12744700|P2|COMPLETED|Overall Study||14
5181502|NCT01144494|12744701|P1|COMPLETED|Overall Study||15
5181503|NCT01144494|12744700|P2|STARTED|Overall Study||18
5181504|NCT01144494|12744701|P1|STARTED|Overall Study||15
5181505|NCT01144455|12744720|P3|NOT COMPLETED|Overall Study||36
5181506|NCT01144455|12744721|P2|NOT COMPLETED|Overall Study||42
5181507|NCT01144455|12744722|P1|NOT COMPLETED|Overall Study||50
5181508|NCT01144455|12744720|P3|COMPLETED|Overall Study||38
5181509|NCT01144455|12744721|P2|COMPLETED|Overall Study||29
5181510|NCT01144455|12744722|P1|COMPLETED|Overall Study||19
5181511|NCT01144455|12744720|P3|STARTED|Overall Study||74
5181512|NCT01144455|12744721|P2|STARTED|Overall Study||71
5181513|NCT01144455|12744722|P1|STARTED|Overall Study||69
5181514|NCT01144442|12744730|P1|NOT COMPLETED|Overall Study||0
5181515|NCT01144442|12744730|P1|COMPLETED|Overall Study||10
5181516|NCT01144442|12744730|P1|STARTED|Overall Study||10
5181517|NCT01144416|12744740|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
5181518|NCT01144416|12744741|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
5181519|NCT01144416|12744740|P2|COMPLETED|Pregnancy Follow-up Period||157
5181520|NCT01144416|12744741|P1|COMPLETED|Pregnancy Follow-up Period||146
5181521|NCT01144416|12744740|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
5181522|NCT01144416|12744741|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
5181523|NCT01144416|12744740|P2|NOT COMPLETED|Intervention Period||49
5181524|NCT01144416|12744741|P1|NOT COMPLETED|Intervention Period||62
5181525|NCT01144416|12744740|P2|COMPLETED|Intervention Period||647
5181526|NCT01144416|12744741|P1|COMPLETED|Intervention Period||632
5181527|NCT01144416|12744740|P2|STARTED|Intervention Period||696
5181528|NCT01144416|12744741|P1|STARTED|Intervention Period||694
5181529|NCT01144403|12744757|P1|NOT COMPLETED|Overall Study||5
5181530|NCT01144403|12744757|P1|COMPLETED|Overall Study||3
5181531|NCT01144403|12744757|P1|STARTED|Overall Study||8
5181532|NCT01144377|12744769|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
5181533|NCT01144377|12744770|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
5181534|NCT01144377|12744771|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
5181535|NCT01144377|12744772|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
5181536|NCT01144377|12744773|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
5181537|NCT01144377|12744769|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
5181538|NCT01144377|12744770|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
5181539|NCT01144377|12744771|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
5181540|NCT01144377|12744772|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
5181541|NCT01144377|12744773|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
5181542|NCT01144377|12744769|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
5181543|NCT01144377|12744770|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
5181544|NCT01144377|12744771|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
5181545|NCT01144377|12744772|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
5181546|NCT01144377|12744773|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
5181547|NCT01144377|12744769|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
5181548|NCT01144377|12744770|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
5181549|NCT01144377|12744771|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
5181550|NCT01144377|12744772|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
5181551|NCT01144377|12744773|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
5181552|NCT01144377|12744769|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
5181553|NCT01144377|12744770|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
5181554|NCT01144377|12744771|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
5181555|NCT01144377|12744772|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
5181556|NCT01144377|12744773|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
5181557|NCT01144377|12744769|P5|STARTED|12 Week Safety Follow-up Period||34
5181558|NCT01144377|12744770|P4|STARTED|12 Week Safety Follow-up Period||22
5181559|NCT01144377|12744771|P3|STARTED|12 Week Safety Follow-up Period||25
5181560|NCT01144377|12744772|P2|STARTED|12 Week Safety Follow-up Period||29
5181561|NCT01144377|12744773|P1|STARTED|12 Week Safety Follow-up Period||26
5181562|NCT01144377|12744769|P5|NOT COMPLETED|52 Week Treatment Period||3
5181563|NCT01144377|12744770|P4|NOT COMPLETED|52 Week Treatment Period||4
5181564|NCT01144377|12744771|P3|NOT COMPLETED|52 Week Treatment Period||5
5181565|NCT01144377|12744772|P2|NOT COMPLETED|52 Week Treatment Period||1
5181566|NCT01144377|12744773|P1|NOT COMPLETED|52 Week Treatment Period||5
5181567|NCT01144377|12744769|P5|COMPLETED|52 Week Treatment Period||34
5181568|NCT01144377|12744770|P4|COMPLETED|52 Week Treatment Period||22
5181569|NCT01144377|12744771|P3|COMPLETED|52 Week Treatment Period||25
5181570|NCT01144377|12744772|P2|COMPLETED|52 Week Treatment Period||29
5181571|NCT01144377|12744773|P1|COMPLETED|52 Week Treatment Period||26
5181572|NCT01144377|12744769|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
5181573|NCT01144377|12744770|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
5181574|NCT01144377|12744771|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
5181575|NCT01144377|12744772|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
5181576|NCT01144377|12744773|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
5181577|NCT01144377|12744769|P5|STARTED|52 Week Treatment Period||37
5181578|NCT01144377|12744770|P4|STARTED|52 Week Treatment Period||26
5181579|NCT01144377|12744771|P3|STARTED|52 Week Treatment Period||30
5181580|NCT01144377|12744772|P2|STARTED|52 Week Treatment Period||30
5181581|NCT01144377|12744773|P1|STARTED|52 Week Treatment Period||31
5181582|NCT01144364|12744822|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
5181583|NCT01144364|12744823|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
5181584|NCT01144364|12744824|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
5181585|NCT01144364|12744822|P3|COMPLETED|Follow-Up/Maintenance Phase||60
5181586|NCT01144364|12744823|P2|COMPLETED|Follow-Up/Maintenance Phase||66
5181587|NCT01144364|12744824|P1|COMPLETED|Follow-Up/Maintenance Phase||0
5181588|NCT01144364|12744822|P3|STARTED|Follow-Up/Maintenance Phase||101
5181589|NCT01144364|12744823|P2|STARTED|Follow-Up/Maintenance Phase||101
5181590|NCT01144364|12744824|P1|STARTED|Follow-Up/Maintenance Phase||0
5181591|NCT01144364|12744822|P3|NOT COMPLETED|Induction Phase||0
5181592|NCT01144364|12744823|P2|NOT COMPLETED|Induction Phase||0
5181593|NCT01144364|12744824|P1|NOT COMPLETED|Induction Phase||32
5181594|NCT01144364|12744822|P3|COMPLETED|Induction Phase||0
5181595|NCT01144364|12744823|P2|COMPLETED|Induction Phase||0
5181596|NCT01144364|12744824|P1|COMPLETED|Induction Phase||202
5181597|NCT01144364|12744822|P3|STARTED|Induction Phase||0
5181598|NCT01144364|12744823|P2|STARTED|Induction Phase||0
5181599|NCT01144364|12744824|P1|STARTED|Induction Phase||234
5181600|NCT01144338|12744850|P2|NOT COMPLETED|Overall Study||262
5181601|NCT01144338|12744851|P1|NOT COMPLETED|Overall Study||303
5181602|NCT01144338|12744850|P2|COMPLETED|Overall Study||7094
5181603|NCT01144338|12744851|P1|COMPLETED|Overall Study||7093
5181604|NCT01144338|12744850|P2|STARTED|Overall Study||7356
5181605|NCT01144338|12744851|P1|STARTED|Overall Study||7396
5181606|NCT01144299|12744873|P2|NOT COMPLETED|Overall Study||0
5181607|NCT01144299|12744874|P1|NOT COMPLETED|Overall Study||2
5181608|NCT01144299|12744873|P2|COMPLETED|Overall Study||54
5181609|NCT01144299|12744874|P1|COMPLETED|Overall Study||58
5181610|NCT01144299|12744873|P2|STARTED|Overall Study||54
5181611|NCT01144299|12744874|P1|STARTED|Overall Study||60
5181612|NCT01144286|12744900|P4|NOT COMPLETED|Overall Study||0
5181613|NCT01144286|12744901|P3|NOT COMPLETED|Overall Study||0
5181614|NCT01144286|12744902|P2|NOT COMPLETED|Overall Study||0
5181615|NCT01144286|12744903|P1|NOT COMPLETED|Overall Study||0
5181616|NCT01144286|12744900|P4|COMPLETED|Overall Study||56
5181617|NCT01144286|12744901|P3|COMPLETED|Overall Study||58
5181618|NCT01144286|12744902|P2|COMPLETED|Overall Study||58
5181619|NCT01144286|12744903|P1|COMPLETED|Overall Study||57
5181620|NCT01144286|12744900|P4|STARTED|Overall Study||56
5181621|NCT01144286|12744901|P3|STARTED|Overall Study||58
5181622|NCT01144286|12744902|P2|STARTED|Overall Study||58
5181623|NCT01144286|12744903|P1|STARTED|Overall Study||57
5181624|NCT01144182|12744919|P2|NOT COMPLETED|Overall Study||21
5181625|NCT01144182|12744920|P1|NOT COMPLETED|Overall Study||17
5181626|NCT01144182|12744919|P2|COMPLETED|Overall Study||47
5181627|NCT01144182|12744920|P1|COMPLETED|Overall Study||51
5181628|NCT01144182|12744919|P2|STARTED|Overall Study||68
5181629|NCT01144182|12744920|P1|STARTED|Overall Study||68
5181630|NCT01144143|12744953|P3|NOT COMPLETED|Overall Study||0
5181631|NCT01144143|12744954|P2|NOT COMPLETED|Overall Study||0
5181632|NCT01144143|12744955|P1|NOT COMPLETED|Overall Study||0
5181633|NCT01144143|12744953|P3|COMPLETED|Overall Study||4
5181634|NCT01144143|12744954|P2|COMPLETED|Overall Study||4
5181635|NCT01144143|12744955|P1|COMPLETED|Overall Study||8
5181636|NCT01144143|12744953|P3|STARTED|Overall Study||4
5181637|NCT01144143|12744954|P2|STARTED|Overall Study||4
5181638|NCT01144143|12744955|P1|STARTED|Overall Study||8
5181639|NCT01144052|12744980|P2|NOT COMPLETED|Overall Study||1
5181640|NCT01144052|12744981|P1|NOT COMPLETED|Overall Study||1
5181641|NCT01144052|12744980|P2|COMPLETED|Overall Study||8
5181642|NCT01144052|12744981|P1|COMPLETED|Overall Study||9
5181643|NCT01144052|12744980|P2|STARTED|Overall Study||9
5181644|NCT01144052|12744981|P1|STARTED|Overall Study||10
5181645|NCT01144026|12745003|P2|NOT COMPLETED|Overall Study||0
5181646|NCT01144026|12745004|P1|NOT COMPLETED|Overall Study||0
5181647|NCT01144026|12745003|P2|COMPLETED|Overall Study||5
5181648|NCT01144026|12745004|P1|COMPLETED|Overall Study||10
5181649|NCT01144026|12745003|P2|STARTED|Overall Study||5
5181650|NCT01144026|12745004|P1|STARTED|Overall Study||10
5181651|NCT01143896|12745012|P2|NOT COMPLETED|Overall Study||25
5181652|NCT01143896|12745013|P1|NOT COMPLETED|Overall Study||42
5181653|NCT01143896|12745012|P2|COMPLETED|Overall Study||128
5181654|NCT01143896|12745013|P1|COMPLETED|Overall Study||114
5181655|NCT01143896|12745012|P2|STARTED|Overall Study||153
5181656|NCT01143896|12745013|P1|STARTED|Overall Study||156
5181657|NCT01143883|12745031|P2|NOT COMPLETED|Overall Study||0
5181658|NCT01143883|12745032|P1|NOT COMPLETED|Overall Study||0
5181659|NCT01143883|12745031|P2|COMPLETED|Overall Study||55
5181660|NCT01143883|12745032|P1|COMPLETED|Overall Study||55
5181661|NCT01143883|12745031|P2|STARTED|Overall Study||55
5181662|NCT01143883|12745032|P1|STARTED|Overall Study||55
5181663|NCT01143870|12745041|P3|NOT COMPLETED|Overall Study||0
5181664|NCT01143870|12745042|P2|NOT COMPLETED|Overall Study||0
5181665|NCT01143870|12745043|P1|NOT COMPLETED|Overall Study||0
5181666|NCT01143870|12745041|P3|COMPLETED|Overall Study||61
5181667|NCT01143870|12745042|P2|COMPLETED|Overall Study||58
5181668|NCT01143870|12745043|P1|COMPLETED|Overall Study||58
5181669|NCT01143870|12745041|P3|A1C Imputed|Overall Study||30
5181670|NCT01143870|12745042|P2|A1C Imputed|Overall Study||29
5181671|NCT01143870|12745043|P1|A1C Imputed|Overall Study||31
5181672|NCT01143870|12745041|P3|Had Available 6-month A1C|Overall Study||31
5181673|NCT01143870|12745042|P2|Had Available 6-month A1C|Overall Study||29
5181674|NCT01143870|12745043|P1|Had Available 6-month A1C|Overall Study||27
5181675|NCT01143870|12745041|P3|Post-intervention Survey|Overall Study||61
5181676|NCT01143870|12745042|P2|Post-intervention Survey|Overall Study||50
5181677|NCT01143870|12745043|P1|Post-intervention Survey|Overall Study||53
5181678|NCT01143870|12745041|P3|STARTED|Overall Study||61
5181679|NCT01143870|12745042|P2|STARTED|Overall Study||58
5181680|NCT01143870|12745043|P1|STARTED|Overall Study||58
5181681|NCT01143818|12745051|P1|NOT COMPLETED|Overall Study||250
5181682|NCT01143818|12745051|P1|COMPLETED|Overall Study||799
5181683|NCT01143818|12745051|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
5181684|NCT01143792|12745061|P3|NOT COMPLETED|Overall Study||0
5181685|NCT01143792|12745062|P2|NOT COMPLETED|Overall Study||0
5181686|NCT01143792|12745063|P1|NOT COMPLETED|Overall Study||0
5181687|NCT01143792|12745061|P3|COMPLETED|Overall Study||91
5181688|NCT01143792|12745062|P2|COMPLETED|Overall Study||86
5181689|NCT01143792|12745063|P1|COMPLETED|Overall Study||93
5181690|NCT01143792|12745061|P3|STARTED|Overall Study||91
5181691|NCT01143792|12745062|P2|STARTED|Overall Study||86
5181692|NCT01143792|12745063|P1|STARTED|Overall Study||93
5181693|NCT01143766|12745097|P2|NOT COMPLETED|Overall Study||0
5181694|NCT01143766|12745098|P1|NOT COMPLETED|Overall Study||0
5181695|NCT01143766|12745097|P2|COMPLETED|Overall Study||31
5181696|NCT01143766|12745098|P1|COMPLETED|Overall Study||25
5181697|NCT01143766|12745097|P2|STARTED|Overall Study||31
5181698|NCT01143766|12745098|P1|STARTED|Overall Study||25
5181699|NCT01143727|12745114|P2|NOT COMPLETED|Overall Study||0
5181700|NCT01143727|12745115|P1|NOT COMPLETED|Overall Study||0
5181701|NCT01143727|12745114|P2|COMPLETED|Overall Study||8
5181702|NCT01143727|12745115|P1|COMPLETED|Overall Study||9
5181703|NCT01143727|12745114|P2|STARTED|Overall Study||8
5181704|NCT01143727|12745115|P1|STARTED|Overall Study||9
5181705|NCT01143714|12745125|P2|NOT COMPLETED|Overall Study||3
5181706|NCT01143714|12745126|P1|NOT COMPLETED|Overall Study||7
5181707|NCT01143714|12745125|P2|COMPLETED|Overall Study||25
5181708|NCT01143714|12745126|P1|COMPLETED|Overall Study||22
5181709|NCT01143714|12745125|P2|STARTED|Overall Study||28
5181710|NCT01143714|12745126|P1|STARTED|Overall Study||29
5181711|NCT01143701|12745136|P2|NOT COMPLETED|Overall Study||32
5181712|NCT01143701|12745137|P1|NOT COMPLETED|Overall Study||23
5181713|NCT01143701|12745136|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
5181714|NCT01143701|12745137|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
5181715|NCT01143701|12745136|P2|STARTED|Overall Study||319
5181716|NCT01143701|12745137|P1|STARTED|Overall Study||258
5181717|NCT01143688|12745145|P1|NOT COMPLETED|Overall Study||0
5181718|NCT01143688|12745145|P1|COMPLETED|Overall Study||39
5181719|NCT01143688|12745145|P1|STARTED|Overall Study||39
5181720|NCT01143649|12745164|P6|NOT COMPLETED|Overall Study||2
5181721|NCT01143649|12745165|P5|NOT COMPLETED|Overall Study||1
5181722|NCT01143649|12745166|P4|NOT COMPLETED|Overall Study||0
5181723|NCT01143649|12745167|P3|NOT COMPLETED|Overall Study||0
5181724|NCT01143649|12745168|P2|NOT COMPLETED|Overall Study||0
5181725|NCT01143649|12745169|P1|NOT COMPLETED|Overall Study||0
5181726|NCT01143649|12745164|P6|COMPLETED|Overall Study||3
5181727|NCT01143649|12745165|P5|COMPLETED|Overall Study||4
5181728|NCT01143649|12745166|P4|COMPLETED|Overall Study||10
5181729|NCT01143649|12745167|P3|COMPLETED|Overall Study||10
5181730|NCT01143649|12745168|P2|COMPLETED|Overall Study||7
5181731|NCT01143649|12745169|P1|COMPLETED|Overall Study||7
5181732|NCT01143649|12745164|P6|STARTED|Overall Study||5
5181733|NCT01143649|12745165|P5|STARTED|Overall Study||5
5181734|NCT01143649|12745166|P4|STARTED|Overall Study||10
5181735|NCT01143649|12745167|P3|STARTED|Overall Study||10
5181736|NCT01143649|12745168|P2|STARTED|Overall Study||7
5181737|NCT01143649|12745169|P1|STARTED|Overall Study||7
5181738|NCT01143636|12745186|P4|NOT COMPLETED|Overall Study||0
5181739|NCT01143636|12745187|P3|NOT COMPLETED|Overall Study||0
5181740|NCT01143636|12745188|P2|NOT COMPLETED|Overall Study||1
5181741|NCT01143636|12745189|P1|NOT COMPLETED|Overall Study||1
5181742|NCT01143636|12745186|P4|COMPLETED|Overall Study||7
5181743|NCT01143636|12745187|P3|COMPLETED|Overall Study||8
5181744|NCT01143636|12745188|P2|COMPLETED|Overall Study||4
5181745|NCT01143636|12745189|P1|COMPLETED|Overall Study||5
5181746|NCT01143636|12745186|P4|STARTED|Overall Study||7
5181747|NCT01143636|12745187|P3|STARTED|Overall Study||8
5181748|NCT01143636|12745188|P2|STARTED|Overall Study||5
5181749|NCT01143636|12745189|P1|STARTED|Overall Study||6
5181750|NCT01143610|12745219|P2|NOT COMPLETED|Overall Study||0
5181751|NCT01143610|12745220|P1|NOT COMPLETED|Overall Study||0
5181752|NCT01143610|12745219|P2|COMPLETED|Overall Study||8
5181753|NCT01143610|12745220|P1|COMPLETED|Overall Study||7
5181754|NCT01143610|12745219|P2|STARTED|Overall Study||8
5181755|NCT01143610|12745220|P1|STARTED|Overall Study||7
5181756|NCT01143402|12745231|P3|NOT COMPLETED|Overall Study||1
5181757|NCT01143402|12745232|P2|NOT COMPLETED|Overall Study||1
5181758|NCT01143402|12745233|P1|NOT COMPLETED|Overall Study||1
5181759|NCT01143402|12745231|P3|COMPLETED|Overall Study||18
5181760|NCT01143402|12745232|P2|COMPLETED|Overall Study||49
5181761|NCT01143402|12745233|P1|COMPLETED|Overall Study||50
5181762|NCT01143402|12745231|P3|STARTED|Overall Study||19
5181763|NCT01143402|12745232|P2|STARTED|Overall Study||50
5181764|NCT01143402|12745233|P1|STARTED|Overall Study||51
5181765|NCT01143389|12745244|P2|NOT COMPLETED|Overall Study||25
5181766|NCT01143389|12745245|P1|NOT COMPLETED|Overall Study||26
5181767|NCT01143389|12745244|P2|COMPLETED|Overall Study||232
5181768|NCT01143389|12745245|P1|COMPLETED|Overall Study||227
5181769|NCT01143389|12745244|P2|STARTED|Overall Study||257
5181770|NCT01143389|12745245|P1|STARTED|Overall Study||253
5181771|NCT01143337|12745259|P3|NOT COMPLETED|Overall Study||12
5181772|NCT01143337|12745260|P2|NOT COMPLETED|Overall Study||11
5181773|NCT01143337|12745261|P1|NOT COMPLETED|Overall Study||10
5181774|NCT01143337|12745259|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
5181775|NCT01143337|12745260|P2|COMPLETED|Overall Study||39
5181776|NCT01143337|12745261|P1|COMPLETED|Overall Study||39
5181777|NCT01143337|12745259|P3|STARTED|Overall Study||13
5181778|NCT01143337|12745260|P2|STARTED|Overall Study||50
5181779|NCT01143337|12745261|P1|STARTED|Overall Study||49
5181780|NCT01143324|12745275|P1|NOT COMPLETED|Overall Study||19
5181781|NCT01143324|12745275|P1|COMPLETED|Overall Study||233
5181782|NCT01143324|12745275|P1|STARTED|Overall Study||252
5181783|NCT01143272|12745293|P2|NOT COMPLETED|Overall Study||0
5181784|NCT01143272|12745294|P1|NOT COMPLETED|Overall Study||0
5181785|NCT01143272|12745293|P2|COMPLETED|Overall Study||231
5181786|NCT01143272|12745294|P1|COMPLETED|Overall Study||246
5181787|NCT01143272|12745293|P2|STARTED|Overall Study||231
5181788|NCT01143272|12745294|P1|STARTED|Overall Study||246
5181789|NCT01143259|12745314|P2|NOT COMPLETED|Overall Study||20
5181790|NCT01143259|12745315|P1|NOT COMPLETED|Overall Study||23
5181791|NCT01143259|12745314|P2|COMPLETED|Overall Study||118
5181792|NCT01143259|12745315|P1|COMPLETED|Overall Study||113
5181793|NCT01143259|12745314|P2|STARTED|Overall Study||138
5181794|NCT01143259|12745315|P1|STARTED|Overall Study||136
5181795|NCT01143207|12745323|P1|NOT COMPLETED|Overall Study||2
5181796|NCT01143207|12745323|P1|COMPLETED|Overall Study||24
5181797|NCT01143207|12745323|P1|STARTED|Overall Study||26
5181798|NCT01143142|12745334|P2|NOT COMPLETED|Overall Study||0
5181799|NCT01143142|12745335|P1|NOT COMPLETED|Overall Study||0
5181800|NCT01143142|12745334|P2|COMPLETED|Overall Study||34
5181801|NCT01143142|12745335|P1|COMPLETED|Overall Study||36
5181802|NCT01143142|12745334|P2|STARTED|Overall Study||34
5181803|NCT01143142|12745335|P1|STARTED|Overall Study||36
5181804|NCT01143090|12745343|P1|NOT COMPLETED|Overall Study||51
5181805|NCT01143090|12745343|P1|COMPLETED|Overall Study||98
5181806|NCT01143090|12745343|P1|STARTED|Overall Study||149
5181807|NCT01143077|12745350|P3|NOT COMPLETED|Overall Study||15
5181808|NCT01143077|12745351|P2|NOT COMPLETED|Overall Study||15
5181809|NCT01143077|12745352|P1|NOT COMPLETED|Overall Study||16
5181810|NCT01143077|12745350|P3|COMPLETED|Overall Study||67
5181811|NCT01143077|12745351|P2|COMPLETED|Overall Study||73
5181812|NCT01143077|12745352|P1|COMPLETED|Overall Study||58
5181813|NCT01143077|12745350|P3|STARTED|Overall Study||82
5181814|NCT01143077|12745351|P2|STARTED|Overall Study||88
5181815|NCT01143077|12745352|P1|STARTED|Overall Study||74
5181816|NCT01143051|12745369|P6|NOT COMPLETED|Visit 3||0
5181817|NCT01143051|12745370|P5|NOT COMPLETED|Visit 3||0
5181818|NCT01143051|12745371|P4|NOT COMPLETED|Visit 3||0
5181819|NCT01143051|12745372|P3|NOT COMPLETED|Visit 3||0
5181820|NCT01143051|12745373|P2|NOT COMPLETED|Visit 3||0
5181821|NCT01143051|12745374|P1|NOT COMPLETED|Visit 3||0
5181822|NCT01143051|12745369|P6|COMPLETED|Visit 3||3
5181823|NCT01143051|12745370|P5|COMPLETED|Visit 3||4
5181824|NCT01143051|12745371|P4|COMPLETED|Visit 3||4
5181825|NCT01143051|12745372|P3|COMPLETED|Visit 3||3
5181826|NCT01143051|12745373|P2|COMPLETED|Visit 3||4
5181827|NCT01143051|12745374|P1|COMPLETED|Visit 3||4
5181828|NCT01143051|12745369|P6|STARTED|Visit 3||3
5181829|NCT01143051|12745370|P5|STARTED|Visit 3||4
5181830|NCT01143051|12745371|P4|STARTED|Visit 3||4
5181831|NCT01143051|12745372|P3|STARTED|Visit 3||3
5181832|NCT01143051|12745373|P2|STARTED|Visit 3||4
5181833|NCT01143051|12745374|P1|STARTED|Visit 3||4
5181834|NCT01143051|12745369|P6|NOT COMPLETED|3-14 Day Washout||1
5181835|NCT01143051|12745370|P5|NOT COMPLETED|3-14 Day Washout||0
5181836|NCT01143051|12745371|P4|NOT COMPLETED|3-14 Day Washout||0
5181837|NCT01143051|12745372|P3|NOT COMPLETED|3-14 Day Washout||0
5181838|NCT01143051|12745373|P2|NOT COMPLETED|3-14 Day Washout||0
5181839|NCT01143051|12745374|P1|NOT COMPLETED|3-14 Day Washout||0
5181840|NCT01143051|12745369|P6|COMPLETED|3-14 Day Washout||3
5181841|NCT01143051|12745370|P5|COMPLETED|3-14 Day Washout||4
5181842|NCT01143051|12745371|P4|COMPLETED|3-14 Day Washout||4
5181843|NCT01143051|12745372|P3|COMPLETED|3-14 Day Washout||3
5181844|NCT01143051|12745373|P2|COMPLETED|3-14 Day Washout||4
5181845|NCT01143051|12745374|P1|COMPLETED|3-14 Day Washout||4
5181846|NCT01143051|12745369|P6|STARTED|3-14 Day Washout||4
5181847|NCT01143051|12745370|P5|STARTED|3-14 Day Washout||4
5181848|NCT01143051|12745371|P4|STARTED|3-14 Day Washout||4
5181849|NCT01143051|12745372|P3|STARTED|3-14 Day Washout||3
5181850|NCT01143051|12745373|P2|STARTED|3-14 Day Washout||4
5181851|NCT01143051|12745374|P1|STARTED|3-14 Day Washout||4
5181852|NCT01143051|12745369|P6|NOT COMPLETED|Visit 2||0
5181853|NCT01143051|12745370|P5|NOT COMPLETED|Visit 2||0
5181854|NCT01143051|12745371|P4|NOT COMPLETED|Visit 2||0
5181855|NCT01143051|12745372|P3|NOT COMPLETED|Visit 2||0
5181856|NCT01143051|12745373|P2|NOT COMPLETED|Visit 2||0
5181857|NCT01143051|12745374|P1|NOT COMPLETED|Visit 2||0
5181858|NCT01143051|12745369|P6|COMPLETED|Visit 2||4
5181859|NCT01143051|12745370|P5|COMPLETED|Visit 2||4
5181860|NCT01143051|12745371|P4|COMPLETED|Visit 2||4
5181861|NCT01143051|12745372|P3|COMPLETED|Visit 2||3
5181862|NCT01143051|12745373|P2|COMPLETED|Visit 2||4
5181863|NCT01143051|12745374|P1|COMPLETED|Visit 2||4
5181864|NCT01143051|12745369|P6|STARTED|Visit 2||4
5181865|NCT01143051|12745370|P5|STARTED|Visit 2||4
5181866|NCT01143051|12745371|P4|STARTED|Visit 2||4
5181867|NCT01143051|12745372|P3|STARTED|Visit 2||3
5181868|NCT01143051|12745373|P2|STARTED|Visit 2||4
5181869|NCT01143051|12745374|P1|STARTED|Visit 2||4
5181870|NCT01143051|12745369|P6|NOT COMPLETED|3-14 Day Washout||0
5181871|NCT01143051|12745370|P5|NOT COMPLETED|3-14 Day Washout||0
5181872|NCT01143051|12745371|P4|NOT COMPLETED|3-14 Day Washout||0
5181873|NCT01143051|12745372|P3|NOT COMPLETED|3-14 Day Washout||1
5181874|NCT01143051|12745373|P2|NOT COMPLETED|3-14 Day Washout||0
5181875|NCT01143051|12745374|P1|NOT COMPLETED|3-14 Day Washout||0
5181876|NCT01143051|12745369|P6|COMPLETED|3-14 Day Washout||4
5181877|NCT01143051|12745370|P5|COMPLETED|3-14 Day Washout||4
5181878|NCT01143051|12745371|P4|COMPLETED|3-14 Day Washout||4
5181879|NCT01143051|12745372|P3|COMPLETED|3-14 Day Washout||3
5181880|NCT01143051|12745373|P2|COMPLETED|3-14 Day Washout||4
5181881|NCT01143051|12745374|P1|COMPLETED|3-14 Day Washout||4
5181882|NCT01143051|12745369|P6|STARTED|3-14 Day Washout||4
5181883|NCT01143051|12745370|P5|STARTED|3-14 Day Washout||4
5181884|NCT01143051|12745371|P4|STARTED|3-14 Day Washout||4
5181885|NCT01143051|12745372|P3|STARTED|3-14 Day Washout||4
5181886|NCT01143051|12745373|P2|STARTED|3-14 Day Washout||4
5181887|NCT01143051|12745374|P1|STARTED|3-14 Day Washout||4
5181888|NCT01143051|12745369|P6|NOT COMPLETED|Visit 1||0
5181889|NCT01143051|12745370|P5|NOT COMPLETED|Visit 1||0
5181890|NCT01143051|12745371|P4|NOT COMPLETED|Visit 1||0
5181891|NCT01143051|12745372|P3|NOT COMPLETED|Visit 1||0
5181892|NCT01143051|12745373|P2|NOT COMPLETED|Visit 1||0
5181893|NCT01143051|12745374|P1|NOT COMPLETED|Visit 1||0
5181894|NCT01143051|12745369|P6|COMPLETED|Visit 1||4
5181895|NCT01143051|12745370|P5|COMPLETED|Visit 1||4
5181896|NCT01143051|12745371|P4|COMPLETED|Visit 1||4
5181897|NCT01143051|12745372|P3|COMPLETED|Visit 1||4
5181898|NCT01143051|12745373|P2|COMPLETED|Visit 1||4
5181899|NCT01143051|12745374|P1|COMPLETED|Visit 1||4
5181900|NCT01143051|12745369|P6|STARTED|Visit 1||4
5181901|NCT01143051|12745370|P5|STARTED|Visit 1||4
5181902|NCT01143051|12745371|P4|STARTED|Visit 1||4
5181903|NCT01143051|12745372|P3|STARTED|Visit 1||4
5181904|NCT01143051|12745373|P2|STARTED|Visit 1||4
5181905|NCT01143051|12745374|P1|STARTED|Visit 1||4
5181906|NCT01143038|12745423|P1|NOT COMPLETED|Overall Study||16
5181907|NCT01143038|12745423|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
5181908|NCT01143038|12745423|P1|STARTED|Overall Study||75
5181909|NCT01142947|12745431|P1|NOT COMPLETED|Overall Study||118
5181910|NCT01142947|12745431|P1|COMPLETED|Overall Study||244
5181911|NCT01142947|12745431|P1|STARTED|Overall Study||362
5181912|NCT01142908|12745437|P2|NOT COMPLETED|Overall Study||22
5181913|NCT01142908|12745438|P1|NOT COMPLETED|Overall Study||32
5181914|NCT01142908|12745437|P2|COMPLETED|Overall Study||191
5181915|NCT01142908|12745438|P1|COMPLETED|Overall Study||183
5181916|NCT01142908|12745437|P2|6 Month f/u|Overall Study||196
5181917|NCT01142908|12745438|P1|6 Month f/u|Overall Study||188
5181918|NCT01142908|12745437|P2|STARTED|Overall Study||213
5181919|NCT01142908|12745438|P1|STARTED|Overall Study||215
5181920|NCT01142791|12745484|P2|NOT COMPLETED|Overall Study||6
5181921|NCT01142791|12745485|P1|NOT COMPLETED|Overall Study||7
5181922|NCT01142791|12745484|P2|COMPLETED|Overall Study||0
5181923|NCT01142791|12745485|P1|COMPLETED|Overall Study||108
5181924|NCT01142791|12745484|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
5181925|NCT01142791|12745485|P1|Safety|Overall Study||115
5181926|NCT01142791|12745484|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
5181927|NCT01142791|12745485|P1|STARTED|Overall Study||115
5181928|NCT01142726|12745492|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
5181929|NCT01142726|12745493|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
5181930|NCT01142726|12745494|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
5181931|NCT01142726|12745492|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
5181932|NCT01142726|12745493|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
5181933|NCT01142726|12745494|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
5181934|NCT01142726|12745492|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
5181935|NCT01142726|12745493|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
5181936|NCT01142726|12745494|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
5181937|NCT01142726|12745492|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
5181938|NCT01142726|12745493|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
5181939|NCT01142726|12745494|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
5181940|NCT01142726|12745492|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
5181941|NCT01142726|12745493|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
5181942|NCT01142726|12745494|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
5181943|NCT01142726|12745492|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
5181944|NCT01142726|12745493|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
5181945|NCT01142726|12745494|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
5181946|NCT01142726|12745492|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
5181947|NCT01142726|12745493|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
5181948|NCT01142726|12745494|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
5181949|NCT01142726|12745492|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
5181950|NCT01142726|12745493|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
5181951|NCT01142726|12745494|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
5181952|NCT01142726|12745492|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
5181953|NCT01142726|12745493|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
5181954|NCT01142726|12745494|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
5181955|NCT01142661|12745557|P1|NOT COMPLETED|Overall Study||4
5181956|NCT01142661|12745557|P1|COMPLETED|Overall Study||5
5181957|NCT01142661|12745557|P1|STARTED|Overall Study||9
5181958|NCT01142596|12745564|P2|NOT COMPLETED|Overall Study||86
5181959|NCT01142596|12745565|P1|NOT COMPLETED|Overall Study||29
5181960|NCT01142596|12745564|P2|COMPLETED|Overall Study||71
5181961|NCT01142596|12745565|P1|COMPLETED|Overall Study||15
5181962|NCT01142596|12745564|P2|STARTED|Overall Study||157
5181963|NCT01142596|12745565|P1|STARTED|Overall Study||44
5181964|NCT01142466|12745617|P2|NOT COMPLETED|Overall Study||2
5181965|NCT01142466|12745618|P1|NOT COMPLETED|Overall Study||3
5181966|NCT01142466|12745617|P2|COMPLETED|Overall Study||13
5181967|NCT01142466|12745618|P1|COMPLETED|Overall Study||12
5181968|NCT01142466|12745617|P2|STARTED|Overall Study||15
5181969|NCT01142466|12745618|P1|STARTED|Overall Study||15
5181970|NCT01142388|12745638|P2|NOT COMPLETED|Overall Study||47
5181971|NCT01142388|12745639|P1|NOT COMPLETED|Overall Study||47
5181972|NCT01142388|12745638|P2|COMPLETED|Overall Study||0
5181973|NCT01142388|12745639|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
5181974|NCT01142388|12745638|P2|Treated|Overall Study||44
5181975|NCT01142388|12745639|P1|Treated|Overall Study||40
5181976|NCT01142388|12745638|P2|Eligible|Overall Study||44
5181977|NCT01142388|12745639|P1|Eligible|Overall Study||43
5181978|NCT01142388|12745638|P2|STARTED|Overall Study||47
5181979|NCT01142388|12745639|P1|STARTED|Overall Study||47
5181980|NCT01142336|12745651|P2|NOT COMPLETED|Overall Study||2
5181981|NCT01142336|12745652|P1|NOT COMPLETED|Overall Study||1
5181982|NCT01142336|12745651|P2|COMPLETED|Overall Study||21
5181983|NCT01142336|12745652|P1|COMPLETED|Overall Study||25
5181984|NCT01142336|12745651|P2|STARTED|Overall Study||23
5181985|NCT01142336|12745652|P1|STARTED|Overall Study||26
5181986|NCT01142323|12745662|P1|NOT COMPLETED|Overall Study||0
5181987|NCT01142323|12745662|P1|COMPLETED|Overall Study||8
5181988|NCT01142323|12745662|P1|STARTED|Overall Study||8
5181989|NCT01142310|12745670|P2|NOT COMPLETED|Overall Study||12
5181990|NCT01142310|12745671|P1|NOT COMPLETED|Overall Study||9
5181991|NCT01142310|12745670|P2|COMPLETED|Overall Study||16
5181992|NCT01142310|12745671|P1|COMPLETED|Overall Study||17
5181993|NCT01142310|12745670|P2|STARTED|Overall Study||28
5181994|NCT01142310|12745671|P1|STARTED|Overall Study||26
5181995|NCT01142297|12745677|P1|NOT COMPLETED|Overall Study||6
5181996|NCT01142297|12745677|P1|COMPLETED|Overall Study||18
5181997|NCT01142297|12745677|P1|STARTED|Overall Study||24
5181998|NCT01142232|12745689|P5|NOT COMPLETED|Overall Study||34
5181999|NCT01142232|12745690|P4|NOT COMPLETED|Overall Study||5
5182000|NCT01142232|12745691|P3|NOT COMPLETED|Overall Study||3
5182001|NCT01142232|12745692|P2|NOT COMPLETED|Overall Study||4
5182002|NCT01142232|12745693|P1|NOT COMPLETED|Overall Study||3
5182003|NCT01142232|12745689|P5|COMPLETED|Overall Study||10
5182004|NCT01142232|12745690|P4|COMPLETED|Overall Study||1
5182005|NCT01142232|12745691|P3|COMPLETED|Overall Study||0
5182006|NCT01142232|12745692|P2|COMPLETED|Overall Study||0
5182007|NCT01142232|12745693|P1|COMPLETED|Overall Study||0
5182008|NCT01142232|12745689|P5|STARTED|Overall Study||44
5182009|NCT01142232|12745690|P4|STARTED|Overall Study||6
5182010|NCT01142232|12745691|P3|STARTED|Overall Study||3
5182011|NCT01142232|12745692|P2|STARTED|Overall Study||4
5182012|NCT01142232|12745693|P1|STARTED|Overall Study||3
5182013|NCT01142193|12745708|P2|NOT COMPLETED|Overall Study||11
5182014|NCT01142193|12745709|P1|NOT COMPLETED|Overall Study||21
5182015|NCT01142193|12745708|P2|COMPLETED|Overall Study||114
5182016|NCT01142193|12745709|P1|COMPLETED|Overall Study||103
5182017|NCT01142193|12745708|P2|STARTED|Overall Study||125
5182018|NCT01142193|12745709|P1|STARTED|Overall Study||124
5182019|NCT01142128|12745737|P1|NOT COMPLETED|Overall Study||4
5182020|NCT01142128|12745737|P1|COMPLETED|Overall Study||4
5182021|NCT01142128|12745737|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
5182022|NCT01142128|12745737|P1|Viokase 16 Plus Nexium|Overall Study||2
5182023|NCT01142128|12745737|P1|Placebo to Nexium, Alone|Overall Study||3
5182024|NCT01142128|12745737|P1|Nexium Alone|Overall Study||3
5182025|NCT01142128|12745737|P1|STARTED|Overall Study||8
5182026|NCT01142115|12745747|P2|NOT COMPLETED|Second Intervention||0
5182027|NCT01142115|12745748|P1|NOT COMPLETED|Second Intervention||0
5182028|NCT01142115|12745747|P2|COMPLETED|Second Intervention||19
5182029|NCT01142115|12745748|P1|COMPLETED|Second Intervention||19
5182030|NCT01142115|12745747|P2|STARTED|Second Intervention||19
5182031|NCT01142115|12745748|P1|STARTED|Second Intervention||19
5182032|NCT01142115|12745747|P2|NOT COMPLETED|First Intervention||1
5182033|NCT01142115|12745748|P1|NOT COMPLETED|First Intervention||2
5182034|NCT01142115|12745747|P2|COMPLETED|First Intervention||19
5182035|NCT01142115|12745748|P1|COMPLETED|First Intervention||19
5182036|NCT01142115|12745747|P2|STARTED|First Intervention||20
5182037|NCT01142115|12745748|P1|STARTED|First Intervention||21
5182038|NCT01142089|12745765|P2|NOT COMPLETED|Overall Study||21
5182039|NCT01142089|12745766|P1|NOT COMPLETED|Overall Study||12
5182040|NCT01142089|12745765|P2|COMPLETED|Overall Study||178
5182041|NCT01142089|12745766|P1|COMPLETED|Overall Study||53
5182042|NCT01142089|12745765|P2|STARTED|Overall Study||199
5182043|NCT01142089|12745766|P1|STARTED|Overall Study||65
5182044|NCT01141907|12745776|P2|NOT COMPLETED|Overall Study||0
5182045|NCT01141907|12745777|P1|NOT COMPLETED|Overall Study||0
5182046|NCT01141907|12745776|P2|COMPLETED|Overall Study||5
5182047|NCT01141907|12745777|P1|COMPLETED|Overall Study||6
5182048|NCT01141907|12745776|P2|STARTED|Overall Study||5
5182049|NCT01141907|12745777|P1|STARTED|Overall Study||6
5182050|NCT01141725|12745783|P3|NOT COMPLETED|Overall Study||0
5182051|NCT01141725|12745784|P2|NOT COMPLETED|Overall Study||0
5182052|NCT01141725|12745785|P1|NOT COMPLETED|Overall Study||0
5182053|NCT01141725|12745783|P3|COMPLETED|Overall Study||3
5182054|NCT01141725|12745784|P2|COMPLETED|Overall Study||33
5182055|NCT01141725|12745785|P1|COMPLETED|Overall Study||3
5182056|NCT01141725|12745783|P3|STARTED|Overall Study||3
5182057|NCT01141725|12745784|P2|STARTED|Overall Study||33
5182058|NCT01141725|12745785|P1|STARTED|Overall Study||3
5182059|NCT01141712|12745797|P1|NOT COMPLETED|Overall Study||3
5182060|NCT01141712|12745797|P1|COMPLETED|Overall Study||40
5182061|NCT01141712|12745797|P1|STARTED|Overall Study||43
5182062|NCT01141660|12745818|P2|NOT COMPLETED|Overall Study||12
5182063|NCT01141660|12745819|P1|NOT COMPLETED|Overall Study||0
5182064|NCT01141660|12745818|P2|COMPLETED|Overall Study||48
5182065|NCT01141660|12745819|P1|COMPLETED|Overall Study||71
5182066|NCT01141660|12745818|P2|STARTED|Overall Study||60
5182067|NCT01141660|12745819|P1|STARTED|Overall Study||71
5182068|NCT01141647|12745827|P1|NOT COMPLETED|Overall Study||46
5182069|NCT01141647|12745827|P1|COMPLETED|Overall Study||167
5182070|NCT01141647|12745827|P1|STARTED|Overall Study||213
5182071|NCT01141608|12745842|P2|NOT COMPLETED|Overall Study||0
5182072|NCT01141608|12745843|P1|NOT COMPLETED|Overall Study||0
5182073|NCT01141608|12745842|P2|COMPLETED|Overall Study||150
5182074|NCT01141608|12745843|P1|COMPLETED|Overall Study||152
5182075|NCT01141608|12745842|P2|STARTED|Overall Study||150
5182076|NCT01141608|12745843|P1|STARTED|Overall Study||152
5182077|NCT01141595|12745849|P1|NOT COMPLETED|Overall Study||2
5182078|NCT01141595|12745849|P1|COMPLETED|Overall Study||8
5182079|NCT01141595|12745849|P1|STARTED|Overall Study||10
5182080|NCT01141569|12745853|P1|NOT COMPLETED|Overall Study||0
5182081|NCT01141569|12745853|P1|COMPLETED|Overall Study||12
5182082|NCT01141569|12745853|P1|STARTED|Overall Study||12
5182083|NCT01141491|12745864|P2|NOT COMPLETED|Overall Study||47
5182084|NCT01141491|12745865|P1|NOT COMPLETED|Overall Study||48
5182085|NCT01141491|12745864|P2|COMPLETED|Overall Study||21
5182086|NCT01141491|12745865|P1|COMPLETED|Overall Study||20
5182087|NCT01141491|12745864|P2|STARTED|Overall Study||68
5182088|NCT01141491|12745865|P1|STARTED|Overall Study||68
5182089|NCT01141374|12745874|P3|NOT COMPLETED|Overall Study||0
5182090|NCT01141374|12745875|P2|NOT COMPLETED|Overall Study||0
5182091|NCT01141374|12745876|P1|NOT COMPLETED|Overall Study||0
5182092|NCT01141374|12745874|P3|COMPLETED|Overall Study||22
5182093|NCT01141374|12745875|P2|COMPLETED|Overall Study||27
5182094|NCT01141374|12745876|P1|COMPLETED|Overall Study||26
5182095|NCT01141374|12745874|P3|STARTED|Overall Study||22
5182096|NCT01141374|12745875|P2|STARTED|Overall Study||27
5182097|NCT01141374|12745876|P1|STARTED|Overall Study||26
5182098|NCT01141283|12745887|P1|NOT COMPLETED|Overall Study||88
5182099|NCT01141283|12745887|P1|COMPLETED|Overall Study||202
5182100|NCT01141283|12745887|P1|STARTED|Overall Study||290
5182101|NCT01141205|12745893|P2|NOT COMPLETED|Overall Study||2
5182102|NCT01141205|12745894|P1|NOT COMPLETED|Overall Study||3
5182103|NCT01141205|12745893|P2|COMPLETED|Overall Study||3
5182104|NCT01141205|12745894|P1|COMPLETED|Overall Study||15
5182105|NCT01141205|12745893|P2|STARTED|Overall Study||5
5182106|NCT01141205|12745894|P1|STARTED|Overall Study||18
5182107|NCT01141075|12745906|P1|NOT COMPLETED|Cycle 2||0
5182108|NCT01141075|12745906|P1|COMPLETED|Cycle 2||11
5182109|NCT01141075|12745906|P1|Received at Least 1 Dose of Study Drug|Cycle 2||11
5182110|NCT01141075|12745906|P1|STARTED|Cycle 2||11
5182111|NCT01141075|12745906|P1|NOT COMPLETED|Cycle 1||0
5182112|NCT01141075|12745906|P1|COMPLETED|Cycle 1||11
5182113|NCT01141075|12745906|P1|Received at Least 1 Dose of Study Drug|Cycle 1||11
5182114|NCT01141075|12745906|P1|STARTED|Cycle 1||11
5182115|NCT01141049|12745920|P2|NOT COMPLETED|Overall Study||8
5182116|NCT01141049|12745921|P1|NOT COMPLETED|Overall Study||5
5182117|NCT01141049|12745920|P2|COMPLETED|Overall Study||13
5182118|NCT01141049|12745921|P1|COMPLETED|Overall Study||14
5182119|NCT01141049|12745920|P2|STARTED|Overall Study||21
5182120|NCT01141049|12745921|P1|STARTED|Overall Study||19
5182121|NCT01140906|12745933|P4|NOT COMPLETED|Overall Study||16
5182122|NCT01140906|12745934|P3|NOT COMPLETED|Overall Study||26
5182123|NCT01140906|12745935|P2|NOT COMPLETED|Overall Study||34
5182124|NCT01140906|12745936|P1|NOT COMPLETED|Overall Study||25
5182125|NCT01140906|12745933|P4|COMPLETED|Overall Study||131
5182126|NCT01140906|12745934|P3|COMPLETED|Overall Study||125
5182127|NCT01140906|12745935|P2|COMPLETED|Overall Study||117
5182128|NCT01140906|12745936|P1|COMPLETED|Overall Study||133
5182129|NCT01140906|12745933|P4|STARTED|Overall Study||147
5182130|NCT01140906|12745934|P3|STARTED|Overall Study||151
5182131|NCT01140906|12745935|P2|STARTED|Overall Study||151
5182132|NCT01140906|12745936|P1|STARTED|Overall Study||158
5182133|NCT01140880|12745976|P2|NOT COMPLETED|Overall Study||44
5182134|NCT01140880|12745977|P1|NOT COMPLETED|Overall Study||14
5182135|NCT01140880|12745976|P2|COMPLETED|Overall Study||56
5182136|NCT01140880|12745977|P1|COMPLETED|Overall Study||56
5182137|NCT01140880|12745976|P2|STARTED|Overall Study||100
5182138|NCT01140880|12745977|P1|STARTED|Overall Study||70
5182139|NCT01140867|12745989|P1|NOT COMPLETED|Overall Study||33
5182140|NCT01140867|12745989|P1|COMPLETED|Overall Study||88
5182141|NCT01140867|12745989|P1|STARTED|Overall Study||121
5182142|NCT01140815|12745998|P2|NOT COMPLETED|Overall Study||0
5182143|NCT01140815|12745999|P1|NOT COMPLETED|Overall Study||0
5182144|NCT01140815|12745998|P2|COMPLETED|Overall Study||25
5182145|NCT01140815|12745999|P1|COMPLETED|Overall Study||25
5182146|NCT01140815|12745998|P2|STARTED|Overall Study||25
5182147|NCT01140815|12745999|P1|STARTED|Overall Study||25
5182148|NCT01140646|12746029|P1|NOT COMPLETED|Overall Study||9
5182149|NCT01140646|12746029|P1|COMPLETED|Overall Study||34
5182150|NCT01140646|12746029|P1|STARTED|Overall Study||43
5182151|NCT01140568|12746037|P1|NOT COMPLETED|Overall Study||36
5182152|NCT01140568|12746037|P1|COMPLETED|Overall Study||2
5182153|NCT01140568|12746037|P1|Treated With Study Drug|Overall Study||34
5182154|NCT01140568|12746037|P1|Screen Fail|Overall Study||4
5182155|NCT01140568|12746037|P1|STARTED|Overall Study||38
5182156|NCT01140503|12746042|P1|NOT COMPLETED|Overall Study||1
5182157|NCT01140503|12746042|P1|COMPLETED|Overall Study||4
5182158|NCT01140503|12746042|P1|STARTED|Overall Study||5
5182159|NCT01140477|12746050|P2|NOT COMPLETED|Overall Study||6
5182160|NCT01140477|12746051|P1|NOT COMPLETED|Overall Study||8
5182161|NCT01140477|12746050|P2|COMPLETED|Overall Study||70
5182162|NCT01140477|12746051|P1|COMPLETED|Overall Study||145
5182163|NCT01140477|12746050|P2|STARTED|Overall Study||76
5182164|NCT01140477|12746051|P1|STARTED|Overall Study||153
5182165|NCT01140360|12746060|P1|NOT COMPLETED|Overall Study||6
5182166|NCT01140360|12746060|P1|COMPLETED|Overall Study||15
5182167|NCT01140360|12746060|P1|STARTED|Overall Study||21
5182168|NCT01140347|12746066|P2|NOT COMPLETED|Overall Study||14
5182169|NCT01140347|12746067|P1|NOT COMPLETED|Overall Study||18
5182170|NCT01140347|12746066|P2|COMPLETED|Overall Study||268
5182171|NCT01140347|12746067|P1|COMPLETED|Overall Study||265
5182172|NCT01140347|12746066|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
5182173|NCT01140347|12746067|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
5182174|NCT01140347|12746066|P2|STARTED|Overall Study||282
5182175|NCT01140347|12746067|P1|STARTED|Overall Study||283
5182176|NCT01140295|12746092|P2|NOT COMPLETED|Overall Study||2
5182177|NCT01140295|12746093|P1|NOT COMPLETED|Overall Study||1
5182178|NCT01140295|12746092|P2|COMPLETED|Overall Study||14
5182179|NCT01140295|12746093|P1|COMPLETED|Overall Study||16
5182180|NCT01140295|12746092|P2|STARTED|Overall Study||16
5182181|NCT01140295|12746093|P1|STARTED|Overall Study||17
5182182|NCT01140191|12746101|P1|NOT COMPLETED|Overall Study||0
5182183|NCT01140191|12746101|P1|COMPLETED|Overall Study||1
5182184|NCT01140191|12746101|P1|STARTED|Overall Study||1
5182185|NCT01140061|12746120|P10|NOT COMPLETED|Extension||1
5182186|NCT01140061|12746121|P9|NOT COMPLETED|Extension||0
5182187|NCT01140061|12746122|P8|NOT COMPLETED|Extension||0
5182188|NCT01140061|12746123|P7|NOT COMPLETED|Extension||0
5182189|NCT01140061|12746124|P6|NOT COMPLETED|Extension||0
5182190|NCT01140061|12746125|P5|NOT COMPLETED|Extension||0
5182191|NCT01140061|12746126|P4|NOT COMPLETED|Extension||0
5182192|NCT01140061|12746127|P3|NOT COMPLETED|Extension||0
5182193|NCT01140061|12746128|P2|NOT COMPLETED|Extension||0
5182194|NCT01140061|12746129|P1|NOT COMPLETED|Extension||0
5182195|NCT01140061|12746120|P10|COMPLETED|Extension||1
5182196|NCT01140061|12746121|P9|COMPLETED|Extension||7
5182197|NCT01140061|12746122|P8|COMPLETED|Extension||0
5182198|NCT01140061|12746123|P7|COMPLETED|Extension||0
5182199|NCT01140061|12746124|P6|COMPLETED|Extension||0
5182200|NCT01140061|12746125|P5|COMPLETED|Extension||0
5182201|NCT01140061|12746126|P4|COMPLETED|Extension||0
5182202|NCT01140061|12746127|P3|COMPLETED|Extension||0
5182203|NCT01140061|12746128|P2|COMPLETED|Extension||0
5182204|NCT01140061|12746129|P1|COMPLETED|Extension||0
5182205|NCT01140061|12746120|P10|STARTED|Extension||2
5182206|NCT01140061|12746121|P9|STARTED|Extension||7
5182207|NCT01140061|12746122|P8|STARTED|Extension||0
5182208|NCT01140061|12746123|P7|STARTED|Extension||0
5182209|NCT01140061|12746124|P6|STARTED|Extension||0
5182210|NCT01140061|12746125|P5|STARTED|Extension||0
5182211|NCT01140061|12746126|P4|STARTED|Extension||0
5182212|NCT01140061|12746127|P3|STARTED|Extension||0
5182213|NCT01140061|12746128|P2|STARTED|Extension||0
5182214|NCT01140061|12746129|P1|STARTED|Extension||0
5182215|NCT01140061|12746120|P10|NOT COMPLETED|Part III||0
5182216|NCT01140061|12746121|P9|NOT COMPLETED|Part III||0
5182217|NCT01140061|12746122|P8|NOT COMPLETED|Part III||0
5182218|NCT01140061|12746123|P7|NOT COMPLETED|Part III||0
5182219|NCT01140061|12746124|P6|NOT COMPLETED|Part III||0
5182220|NCT01140061|12746125|P5|NOT COMPLETED|Part III||0
5182221|NCT01140061|12746126|P4|NOT COMPLETED|Part III||0
5182222|NCT01140061|12746127|P3|NOT COMPLETED|Part III||0
5182223|NCT01140061|12746128|P2|NOT COMPLETED|Part III||0
5182224|NCT01140061|12746129|P1|NOT COMPLETED|Part III||0
5182225|NCT01140061|12746120|P10|COMPLETED|Part III||2
5182226|NCT01140061|12746121|P9|COMPLETED|Part III||7
5182227|NCT01140061|12746122|P8|COMPLETED|Part III||0
5182228|NCT01140061|12746123|P7|COMPLETED|Part III||0
5182229|NCT01140061|12746124|P6|COMPLETED|Part III||0
5182230|NCT01140061|12746125|P5|COMPLETED|Part III||0
5182231|NCT01140061|12746126|P4|COMPLETED|Part III||0
5182232|NCT01140061|12746127|P3|COMPLETED|Part III||0
5182233|NCT01140061|12746128|P2|COMPLETED|Part III||0
5182234|NCT01140061|12746129|P1|COMPLETED|Part III||0
5182235|NCT01140061|12746120|P10|STARTED|Part III|Includes 1 replacement participant|2
5182236|NCT01140061|12746121|P9|STARTED|Part III||7
5182237|NCT01140061|12746122|P8|STARTED|Part III||0
5182238|NCT01140061|12746123|P7|STARTED|Part III||0
5182239|NCT01140061|12746124|P6|STARTED|Part III||0
5182240|NCT01140061|12746125|P5|STARTED|Part III||0
5182241|NCT01140061|12746126|P4|STARTED|Part III||0
5182242|NCT01140061|12746127|P3|STARTED|Part III||0
5182243|NCT01140061|12746128|P2|STARTED|Part III||0
5182244|NCT01140061|12746129|P1|STARTED|Part III||0
5182245|NCT01140061|12746120|P10|NOT COMPLETED|Part II||0
5182246|NCT01140061|12746121|P9|NOT COMPLETED|Part II||0
5182247|NCT01140061|12746122|P8|NOT COMPLETED|Part II||0
5182248|NCT01140061|12746123|P7|NOT COMPLETED|Part II||0
5182249|NCT01140061|12746124|P6|NOT COMPLETED|Part II||0
5182250|NCT01140061|12746125|P5|NOT COMPLETED|Part II||0
5182251|NCT01140061|12746126|P4|NOT COMPLETED|Part II||0
5182252|NCT01140061|12746127|P3|NOT COMPLETED|Part II||0
5182253|NCT01140061|12746128|P2|NOT COMPLETED|Part II||0
5182254|NCT01140061|12746129|P1|NOT COMPLETED|Part II||0
5182255|NCT01140061|12746120|P10|COMPLETED|Part II||0
5182256|NCT01140061|12746121|P9|COMPLETED|Part II||0
5182257|NCT01140061|12746122|P8|COMPLETED|Part II||2
5182258|NCT01140061|12746123|P7|COMPLETED|Part II||6
5182259|NCT01140061|12746124|P6|COMPLETED|Part II||2
5182260|NCT01140061|12746125|P5|COMPLETED|Part II||6
5182261|NCT01140061|12746126|P4|COMPLETED|Part II||2
5182262|NCT01140061|12746127|P3|COMPLETED|Part II||6
5182263|NCT01140061|12746128|P2|COMPLETED|Part II||0
5182264|NCT01140061|12746129|P1|COMPLETED|Part II||0
5182265|NCT01140061|12746120|P10|STARTED|Part II||0
5182266|NCT01140061|12746121|P9|STARTED|Part II||0
5182267|NCT01140061|12746122|P8|STARTED|Part II||2
5182268|NCT01140061|12746123|P7|STARTED|Part II||6
5182269|NCT01140061|12746124|P6|STARTED|Part II||2
5182270|NCT01140061|12746125|P5|STARTED|Part II||6
5182271|NCT01140061|12746126|P4|STARTED|Part II||2
5182272|NCT01140061|12746127|P3|STARTED|Part II||6
5182273|NCT01140061|12746128|P2|STARTED|Part II||0
5182274|NCT01140061|12746129|P1|STARTED|Part II||0
5182275|NCT01140061|12746120|P10|NOT COMPLETED|Part I||0
5182276|NCT01140061|12746121|P9|NOT COMPLETED|Part I||0
5182277|NCT01140061|12746122|P8|NOT COMPLETED|Part I||0
5182278|NCT01140061|12746123|P7|NOT COMPLETED|Part I||0
5182279|NCT01140061|12746124|P6|NOT COMPLETED|Part I||0
5182280|NCT01140061|12746125|P5|NOT COMPLETED|Part I||0
5182281|NCT01140061|12746126|P4|NOT COMPLETED|Part I||0
5182282|NCT01140061|12746127|P3|NOT COMPLETED|Part I||0
5182283|NCT01140061|12746128|P2|NOT COMPLETED|Part I||0
5182284|NCT01140061|12746129|P1|NOT COMPLETED|Part I||1
5182285|NCT01140061|12746120|P10|COMPLETED|Part I||0
5182286|NCT01140061|12746121|P9|COMPLETED|Part I||0
5182287|NCT01140061|12746122|P8|COMPLETED|Part I||0
5182288|NCT01140061|12746123|P7|COMPLETED|Part I||0
5182289|NCT01140061|12746124|P6|COMPLETED|Part I||0
5182290|NCT01140061|12746125|P5|COMPLETED|Part I||0
5182291|NCT01140061|12746126|P4|COMPLETED|Part I||0
5182292|NCT01140061|12746127|P3|COMPLETED|Part I||0
5182293|NCT01140061|12746128|P2|COMPLETED|Part I||2
5182294|NCT01140061|12746129|P1|COMPLETED|Part I||6
5182295|NCT01140061|12746120|P10|STARTED|Part I||0
5182296|NCT01140061|12746121|P9|STARTED|Part I||0
5182297|NCT01140061|12746122|P8|STARTED|Part I||0
5182298|NCT01140061|12746123|P7|STARTED|Part I||0
5182299|NCT01140061|12746124|P6|STARTED|Part I||0
5182300|NCT01140061|12746125|P5|STARTED|Part I||0
5182301|NCT01140061|12746126|P4|STARTED|Part I||0
5182302|NCT01140061|12746127|P3|STARTED|Part I||0
5182303|NCT01140061|12746128|P2|STARTED|Part I||2
5182304|NCT01140061|12746129|P1|STARTED|Part I|Includes 1 replacement participant|7
5182305|NCT01140048|12746156|P1|NOT COMPLETED|Overall Study||45
5182306|NCT01140048|12746156|P1|COMPLETED|Overall Study||298
5182307|NCT01140048|12746156|P1|STARTED|Overall Study||343
5182308|NCT01139996|12746164|P2|NOT COMPLETED|Overall Study||0
5182309|NCT01139996|12746165|P1|NOT COMPLETED|Overall Study||0
5182310|NCT01139996|12746164|P2|COMPLETED|Overall Study||11
5182311|NCT01139996|12746165|P1|COMPLETED|Overall Study||11
5182312|NCT01139996|12746164|P2|STARTED|Overall Study||11
5182313|NCT01139996|12746165|P1|STARTED|Overall Study||11
5182314|NCT01139879|12746171|P1|NOT COMPLETED|Overall Study||0
5182315|NCT01139879|12746171|P1|COMPLETED|Overall Study||10
5182316|NCT01139879|12746171|P1|STARTED|Overall Study||10
5182317|NCT01139814|12746177|P1|NOT COMPLETED|Overall Study||0
5182318|NCT01139814|12746177|P1|COMPLETED|Overall Study||181
5182319|NCT01139814|12746177|P1|STARTED|Overall Study||181
5182320|NCT01139801|12746184|P2|NOT COMPLETED|Overall Study||0
5182321|NCT01139801|12746185|P1|NOT COMPLETED|Overall Study||0
5182322|NCT01139801|12746184|P2|COMPLETED|Overall Study||25
5182323|NCT01139801|12746185|P1|COMPLETED|Overall Study||25
5182324|NCT01139801|12746184|P2|STARTED|Overall Study||25
5182325|NCT01139801|12746185|P1|STARTED|Overall Study||25
5182326|NCT01139775|12746196|P3|NOT COMPLETED|Overall Study||6
5182327|NCT01139775|12746197|P2|NOT COMPLETED|Overall Study||13
5182328|NCT01139775|12746198|P1|NOT COMPLETED|Overall Study||1
5182329|NCT01139775|12746196|P3|COMPLETED|Overall Study||17
5182330|NCT01139775|12746197|P2|COMPLETED|Overall Study||26
5182331|NCT01139775|12746198|P1|COMPLETED|Overall Study||13
5182332|NCT01139775|12746196|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
5182333|NCT01139775|12746197|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
5182334|NCT01139775|12746198|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
5182335|NCT01139775|12746196|P3|STARTED|Overall Study||23
5182336|NCT01139775|12746197|P2|STARTED|Overall Study||39
5182337|NCT01139775|12746198|P1|STARTED|Overall Study||14
5182338|NCT01139762|12746230|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
5182339|NCT01139762|12746231|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
5182340|NCT01139762|12746232|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
5182341|NCT01139762|12746230|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
5182342|NCT01139762|12746231|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
5182343|NCT01139762|12746232|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
5182344|NCT01139762|12746230|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
5182345|NCT01139762|12746231|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
5182346|NCT01139762|12746232|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
5182347|NCT01139762|12746230|P3|STARTED|Double-Blind Randomized Active Treatment||350
5182348|NCT01139762|12746231|P2|STARTED|Double-Blind Randomized Active Treatment||346
5182349|NCT01139762|12746232|P1|STARTED|Double-Blind Randomized Active Treatment||0
5182350|NCT01139762|12746230|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
5182351|NCT01139762|12746231|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
5182352|NCT01139762|12746232|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
5182353|NCT01139762|12746230|P3|COMPLETED|Washout and Placebo Lead-In Period||0
5182354|NCT01139762|12746231|P2|COMPLETED|Washout and Placebo Lead-In Period||0
5182355|NCT01139762|12746232|P1|COMPLETED|Washout and Placebo Lead-In Period||696
5182356|NCT01139762|12746230|P3|STARTED|Washout and Placebo Lead-In Period||0
5182357|NCT01139762|12746231|P2|STARTED|Washout and Placebo Lead-In Period||0
5182358|NCT01139762|12746232|P1|STARTED|Washout and Placebo Lead-In Period||1070
5182359|NCT01139658|12746267|P2|NOT COMPLETED|Overall Study||113
5182360|NCT01139658|12746268|P1|NOT COMPLETED|Overall Study||56
5182361|NCT01139658|12746267|P2|COMPLETED|Overall Study||816
5182362|NCT01139658|12746268|P1|COMPLETED|Overall Study||691
5182363|NCT01139658|12746267|P2|STARTED|Overall Study||929
5182364|NCT01139658|12746268|P1|STARTED|Overall Study||747
5182365|NCT01139580|12746306|P2|NOT COMPLETED|Overall Study||18
5182366|NCT01139580|12746307|P1|NOT COMPLETED|Overall Study||23
5182367|NCT01139580|12746306|P2|COMPLETED|Overall Study||164
5182368|NCT01139580|12746307|P1|COMPLETED|Overall Study||158
5182369|NCT01139580|12746306|P2|STARTED|Overall Study||182
5182370|NCT01139580|12746307|P1|STARTED|Overall Study||181
5182371|NCT01139515|12746323|P4|NOT COMPLETED|Fourth Intervention Period||0
5182372|NCT01139515|12746324|P3|NOT COMPLETED|Fourth Intervention Period||0
5182373|NCT01139515|12746325|P2|NOT COMPLETED|Fourth Intervention Period||0
5182374|NCT01139515|12746326|P1|NOT COMPLETED|Fourth Intervention Period||0
5182375|NCT01139515|12746323|P4|COMPLETED|Fourth Intervention Period||4
5182376|NCT01139515|12746324|P3|COMPLETED|Fourth Intervention Period||4
5182377|NCT01139515|12746325|P2|COMPLETED|Fourth Intervention Period||4
5182378|NCT01139515|12746326|P1|COMPLETED|Fourth Intervention Period||4
5182379|NCT01139515|12746323|P4|STARTED|Fourth Intervention Period||4
5182380|NCT01139515|12746324|P3|STARTED|Fourth Intervention Period||4
5182381|NCT01139515|12746325|P2|STARTED|Fourth Intervention Period||4
5182382|NCT01139515|12746326|P1|STARTED|Fourth Intervention Period||4
5182383|NCT01139515|12746323|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
5182384|NCT01139515|12746324|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
5182385|NCT01139515|12746325|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
5182386|NCT01139515|12746326|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
5182387|NCT01139515|12746323|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
5182388|NCT01139515|12746324|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
5182389|NCT01139515|12746325|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
5182390|NCT01139515|12746326|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
5182391|NCT01139515|12746323|P4|STARTED|Washout Period 3 (46 Hrs)||4
5182392|NCT01139515|12746324|P3|STARTED|Washout Period 3 (46 Hrs)||4
5182393|NCT01139515|12746325|P2|STARTED|Washout Period 3 (46 Hrs)||4
5182394|NCT01139515|12746326|P1|STARTED|Washout Period 3 (46 Hrs)||4
5182395|NCT01139515|12746323|P4|NOT COMPLETED|Third Intervention Period||0
5182396|NCT01139515|12746324|P3|NOT COMPLETED|Third Intervention Period||0
5182397|NCT01139515|12746325|P2|NOT COMPLETED|Third Intervention Period||0
5182398|NCT01139515|12746326|P1|NOT COMPLETED|Third Intervention Period||0
5182399|NCT01139515|12746323|P4|COMPLETED|Third Intervention Period||4
5182400|NCT01139515|12746324|P3|COMPLETED|Third Intervention Period||4
5182401|NCT01139515|12746325|P2|COMPLETED|Third Intervention Period||4
5182402|NCT01139515|12746326|P1|COMPLETED|Third Intervention Period||4
5182403|NCT01139515|12746323|P4|STARTED|Third Intervention Period||4
5182404|NCT01139515|12746324|P3|STARTED|Third Intervention Period||4
5182405|NCT01139515|12746325|P2|STARTED|Third Intervention Period||4
5182406|NCT01139515|12746326|P1|STARTED|Third Intervention Period||4
5182407|NCT01139515|12746323|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
5182408|NCT01139515|12746324|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
5182409|NCT01139515|12746325|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
5182410|NCT01139515|12746326|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
5182411|NCT01139515|12746323|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
5182412|NCT01139515|12746324|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
5182413|NCT01139515|12746325|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
5182414|NCT01139515|12746326|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
5182415|NCT01139515|12746323|P4|STARTED|Washout Period 2 (46 Hrs)||4
5182416|NCT01139515|12746324|P3|STARTED|Washout Period 2 (46 Hrs)||4
5182417|NCT01139515|12746325|P2|STARTED|Washout Period 2 (46 Hrs)||4
5182418|NCT01139515|12746326|P1|STARTED|Washout Period 2 (46 Hrs)||4
5182419|NCT01139515|12746323|P4|NOT COMPLETED|Second Intervention Period||0
5182420|NCT01139515|12746324|P3|NOT COMPLETED|Second Intervention Period||0
5182421|NCT01139515|12746325|P2|NOT COMPLETED|Second Intervention Period||0
5182422|NCT01139515|12746326|P1|NOT COMPLETED|Second Intervention Period||0
5182423|NCT01139515|12746323|P4|COMPLETED|Second Intervention Period||4
5182424|NCT01139515|12746324|P3|COMPLETED|Second Intervention Period||4
5182425|NCT01139515|12746325|P2|COMPLETED|Second Intervention Period||4
5182426|NCT01139515|12746326|P1|COMPLETED|Second Intervention Period||4
5182427|NCT01139515|12746323|P4|STARTED|Second Intervention Period||4
5182428|NCT01139515|12746324|P3|STARTED|Second Intervention Period||4
5182429|NCT01139515|12746325|P2|STARTED|Second Intervention Period||4
5182430|NCT01139515|12746326|P1|STARTED|Second Intervention Period||4
5182431|NCT01139515|12746323|P4|NOT COMPLETED|Washout Period I (46hrs)||0
5182432|NCT01139515|12746324|P3|NOT COMPLETED|Washout Period I (46hrs)||0
5182433|NCT01139515|12746325|P2|NOT COMPLETED|Washout Period I (46hrs)||0
5182434|NCT01139515|12746326|P1|NOT COMPLETED|Washout Period I (46hrs)||0
5182435|NCT01139515|12746323|P4|COMPLETED|Washout Period I (46hrs)||4
5182436|NCT01139515|12746324|P3|COMPLETED|Washout Period I (46hrs)||4
5182437|NCT01139515|12746325|P2|COMPLETED|Washout Period I (46hrs)||4
5182438|NCT01139515|12746326|P1|COMPLETED|Washout Period I (46hrs)||4
5182439|NCT01139515|12746323|P4|STARTED|Washout Period I (46hrs)||4
5182440|NCT01139515|12746324|P3|STARTED|Washout Period I (46hrs)||4
5182441|NCT01139515|12746325|P2|STARTED|Washout Period I (46hrs)||4
5182442|NCT01139515|12746326|P1|STARTED|Washout Period I (46hrs)||4
5182443|NCT01139515|12746323|P4|NOT COMPLETED|First Intervention Period||0
5182444|NCT01139515|12746324|P3|NOT COMPLETED|First Intervention Period||0
5182445|NCT01139515|12746325|P2|NOT COMPLETED|First Intervention Period||0
5182446|NCT01139515|12746326|P1|NOT COMPLETED|First Intervention Period||0
5182447|NCT01139515|12746323|P4|COMPLETED|First Intervention Period||4
5182448|NCT01139515|12746324|P3|COMPLETED|First Intervention Period||4
5182449|NCT01139515|12746325|P2|COMPLETED|First Intervention Period||4
5182450|NCT01139515|12746326|P1|COMPLETED|First Intervention Period||4
5182451|NCT01139515|12746323|P4|STARTED|First Intervention Period||4
5182452|NCT01139515|12746324|P3|STARTED|First Intervention Period||4
5182453|NCT01139515|12746325|P2|STARTED|First Intervention Period||4
5182454|NCT01139515|12746326|P1|STARTED|First Intervention Period||4
5182455|NCT01139450|12746355|P3|NOT COMPLETED|Overall Study||38
5182456|NCT01139450|12746356|P2|NOT COMPLETED|Overall Study||25
5182457|NCT01139450|12746357|P1|NOT COMPLETED|Overall Study||27
5182458|NCT01139450|12746355|P3|COMPLETED|Overall Study||262
5182459|NCT01139450|12746356|P2|COMPLETED|Overall Study||272
5182460|NCT01139450|12746357|P1|COMPLETED|Overall Study||275
5182461|NCT01139450|12746355|P3|STARTED|Overall Study||300
5182462|NCT01139450|12746356|P2|STARTED|Overall Study||297
5182463|NCT01139450|12746357|P1|STARTED|Overall Study||302
5182464|NCT01139411|12746367|P2|NOT COMPLETED|Overall Study||4
5182465|NCT01139411|12746368|P1|NOT COMPLETED|Overall Study||2
5182466|NCT01139411|12746367|P2|COMPLETED|Overall Study||19
5182467|NCT01139411|12746368|P1|COMPLETED|Overall Study||24
5182468|NCT01139411|12746367|P2|STARTED|Overall Study||23
5182469|NCT01139411|12746368|P1|STARTED|Overall Study||26
5182470|NCT01139294|12746388|P2|NOT COMPLETED|Overall Study||0
5182471|NCT01139294|12746389|P1|NOT COMPLETED|Overall Study||0
5182472|NCT01139294|12746388|P2|COMPLETED|Overall Study||0
5182473|NCT01139294|12746389|P1|COMPLETED|Overall Study||0
5182474|NCT01139294|12746388|P2|STARTED|Overall Study||0
5182475|NCT01139294|12746389|P1|STARTED|Overall Study||0
5182476|NCT01139190|12746399|P2|NOT COMPLETED|Overall Study||1
5182477|NCT01139190|12746400|P1|NOT COMPLETED|Overall Study||0
5182478|NCT01139190|12746399|P2|COMPLETED|Overall Study||38
5182479|NCT01139190|12746400|P1|COMPLETED|Overall Study||38
5182480|NCT01139190|12746399|P2|STARTED|Overall Study||39
5182481|NCT01139190|12746400|P1|STARTED|Overall Study||38
5182482|NCT01139164|12746409|P3|NOT COMPLETED|Overall Study||0
5182483|NCT01139164|12746410|P2|NOT COMPLETED|Overall Study||2
5182484|NCT01139164|12746411|P1|NOT COMPLETED|Overall Study||0
5182485|NCT01139164|12746409|P3|COMPLETED|Overall Study||7
5182486|NCT01139164|12746410|P2|COMPLETED|Overall Study||65
5182487|NCT01139164|12746411|P1|COMPLETED|Overall Study||4
5182488|NCT01139164|12746409|P3|STARTED|Overall Study||7
5182489|NCT01139164|12746410|P2|STARTED|Overall Study||67
5182490|NCT01139164|12746411|P1|STARTED|Overall Study||4
5182491|NCT01139125|12746425|P1|NOT COMPLETED|Overall Study||1
5182492|NCT01139125|12746425|P1|COMPLETED|Overall Study||2
5182493|NCT01139125|12746425|P1|STARTED|Overall Study||3
5182494|NCT01139047|12746429|P1|NOT COMPLETED|Overall Study||1
5182495|NCT01139047|12746429|P1|COMPLETED|Overall Study||76
5182496|NCT01139047|12746429|P1|STARTED|Overall Study||77
5182497|NCT01139021|12746444|P6|NOT COMPLETED|Overall Study||0
5182498|NCT01139021|12746445|P5|NOT COMPLETED|Overall Study||9
5182499|NCT01139021|12746446|P4|NOT COMPLETED|Overall Study||1
5182500|NCT01139021|12746447|P3|NOT COMPLETED|Overall Study||0
5182501|NCT01139021|12746448|P2|NOT COMPLETED|Overall Study||0
5182502|NCT01139021|12746449|P1|NOT COMPLETED|Overall Study||1
5182503|NCT01139021|12746444|P6|COMPLETED|Overall Study||1
5182504|NCT01139021|12746445|P5|COMPLETED|Overall Study||107
5182505|NCT01139021|12746446|P4|COMPLETED|Overall Study||18
5182506|NCT01139021|12746447|P3|COMPLETED|Overall Study||67
5182507|NCT01139021|12746448|P2|COMPLETED|Overall Study||153
5182508|NCT01139021|12746449|P1|COMPLETED|Overall Study||151
5182509|NCT01139021|12746444|P6|STARTED|Overall Study||1
5182510|NCT01139021|12746445|P5|STARTED|Overall Study||116
5182511|NCT01139021|12746446|P4|STARTED|Overall Study||19
5182512|NCT01139021|12746447|P3|STARTED|Overall Study||67
5182513|NCT01139021|12746448|P2|STARTED|Overall Study||153
5182514|NCT01139021|12746449|P1|STARTED|Overall Study||152
5182515|NCT01139008|12746485|P1|NOT COMPLETED|Overall Study||6
5182516|NCT01139008|12746485|P1|COMPLETED|Overall Study||74
5182517|NCT01139008|12746485|P1|STARTED|Overall Study||80
5182518|NCT01138995|12746496|P2|NOT COMPLETED|Overall Study||25
5182519|NCT01138995|12746497|P1|NOT COMPLETED|Overall Study||10
5182520|NCT01138995|12746496|P2|COMPLETED|Overall Study||74
5182521|NCT01138995|12746497|P1|COMPLETED|Overall Study||88
5182522|NCT01138995|12746496|P2|STARTED|Overall Study||99
5182523|NCT01138995|12746497|P1|STARTED|Overall Study||98
5182524|NCT01138969|12746509|P2|NOT COMPLETED|Overall Study||0
5182525|NCT01138969|12746510|P1|NOT COMPLETED|Overall Study||0
5182526|NCT01138969|12746509|P2|COMPLETED|Overall Study||82
5182527|NCT01138969|12746510|P1|COMPLETED|Overall Study||83
5182528|NCT01138969|12746509|P2|STARTED|Overall Study||82
5182529|NCT01138969|12746510|P1|STARTED|Overall Study||83
5182530|NCT01138917|12746518|P1|NOT COMPLETED|Overall Study||24
5182531|NCT01138917|12746518|P1|COMPLETED|Overall Study||77
5182532|NCT01138917|12746518|P1|STARTED|Overall Study||101
5182533|NCT01138826|12746532|P6|NOT COMPLETED|Third Intervention Period||0
5182534|NCT01138826|12746533|P5|NOT COMPLETED|Third Intervention Period||0
5182535|NCT01138826|12746534|P4|NOT COMPLETED|Third Intervention Period||0
5182536|NCT01138826|12746535|P3|NOT COMPLETED|Third Intervention Period||0
5182537|NCT01138826|12746536|P2|NOT COMPLETED|Third Intervention Period||0
5182538|NCT01138826|12746537|P1|NOT COMPLETED|Third Intervention Period||0
5182539|NCT01138826|12746532|P6|COMPLETED|Third Intervention Period||3
5182540|NCT01138826|12746533|P5|COMPLETED|Third Intervention Period||2
5182541|NCT01138826|12746534|P4|COMPLETED|Third Intervention Period||3
5182542|NCT01138826|12746535|P3|COMPLETED|Third Intervention Period||3
5182543|NCT01138826|12746536|P2|COMPLETED|Third Intervention Period||2
5182544|NCT01138826|12746537|P1|COMPLETED|Third Intervention Period||2
5182545|NCT01138826|12746532|P6|STARTED|Third Intervention Period||3
5182546|NCT01138826|12746533|P5|STARTED|Third Intervention Period||2
5182547|NCT01138826|12746534|P4|STARTED|Third Intervention Period||3
5182548|NCT01138826|12746535|P3|STARTED|Third Intervention Period||3
5182549|NCT01138826|12746536|P2|STARTED|Third Intervention Period||2
5182550|NCT01138826|12746537|P1|STARTED|Third Intervention Period||2
5182551|NCT01138826|12746532|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182552|NCT01138826|12746533|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182553|NCT01138826|12746534|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182554|NCT01138826|12746535|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182555|NCT01138826|12746536|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182556|NCT01138826|12746537|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
5182557|NCT01138826|12746532|P6|COMPLETED|Washout Period II (of 16 Days)||3
5182558|NCT01138826|12746533|P5|COMPLETED|Washout Period II (of 16 Days)||2
5182559|NCT01138826|12746534|P4|COMPLETED|Washout Period II (of 16 Days)||3
5182560|NCT01138826|12746535|P3|COMPLETED|Washout Period II (of 16 Days)||3
5182561|NCT01138826|12746536|P2|COMPLETED|Washout Period II (of 16 Days)||2
5182562|NCT01138826|12746537|P1|COMPLETED|Washout Period II (of 16 Days)||2
5182563|NCT01138826|12746532|P6|STARTED|Washout Period II (of 16 Days)||3
5182564|NCT01138826|12746533|P5|STARTED|Washout Period II (of 16 Days)||2
5182565|NCT01138826|12746534|P4|STARTED|Washout Period II (of 16 Days)||3
5182566|NCT01138826|12746535|P3|STARTED|Washout Period II (of 16 Days)||3
5182567|NCT01138826|12746536|P2|STARTED|Washout Period II (of 16 Days)||2
5182568|NCT01138826|12746537|P1|STARTED|Washout Period II (of 16 Days)||2
5182569|NCT01138826|12746532|P6|NOT COMPLETED|Second Intervention Period||0
5182570|NCT01138826|12746533|P5|NOT COMPLETED|Second Intervention Period||0
5182571|NCT01138826|12746534|P4|NOT COMPLETED|Second Intervention Period||0
5182572|NCT01138826|12746535|P3|NOT COMPLETED|Second Intervention Period||0
5182573|NCT01138826|12746536|P2|NOT COMPLETED|Second Intervention Period||0
5182574|NCT01138826|12746537|P1|NOT COMPLETED|Second Intervention Period||0
5182575|NCT01138826|12746532|P6|COMPLETED|Second Intervention Period||3
5182576|NCT01138826|12746533|P5|COMPLETED|Second Intervention Period||2
5182577|NCT01138826|12746534|P4|COMPLETED|Second Intervention Period||3
5182578|NCT01138826|12746535|P3|COMPLETED|Second Intervention Period||3
5182579|NCT01138826|12746536|P2|COMPLETED|Second Intervention Period||2
5182580|NCT01138826|12746537|P1|COMPLETED|Second Intervention Period||2
5182581|NCT01138826|12746532|P6|STARTED|Second Intervention Period||3
5182582|NCT01138826|12746533|P5|STARTED|Second Intervention Period||2
5182583|NCT01138826|12746534|P4|STARTED|Second Intervention Period||3
5182584|NCT01138826|12746535|P3|STARTED|Second Intervention Period||3
5182585|NCT01138826|12746536|P2|STARTED|Second Intervention Period||2
5182586|NCT01138826|12746537|P1|STARTED|Second Intervention Period||2
5182587|NCT01138826|12746532|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
5182588|NCT01138826|12746533|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
5182589|NCT01138826|12746534|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
5182590|NCT01138826|12746535|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
5182591|NCT01138826|12746536|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
5182592|NCT01138826|12746537|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
5182593|NCT01138826|12746532|P6|COMPLETED|Washout Period I (of 16 Days)||3
5182594|NCT01138826|12746533|P5|COMPLETED|Washout Period I (of 16 Days)||2
5182595|NCT01138826|12746534|P4|COMPLETED|Washout Period I (of 16 Days)||3
5182596|NCT01138826|12746535|P3|COMPLETED|Washout Period I (of 16 Days)||3
5182597|NCT01138826|12746536|P2|COMPLETED|Washout Period I (of 16 Days)||2
5182598|NCT01138826|12746537|P1|COMPLETED|Washout Period I (of 16 Days)||2
5182599|NCT01138826|12746532|P6|STARTED|Washout Period I (of 16 Days)||3
5182600|NCT01138826|12746533|P5|STARTED|Washout Period I (of 16 Days)||3
5182601|NCT01138826|12746534|P4|STARTED|Washout Period I (of 16 Days)||3
5182602|NCT01138826|12746535|P3|STARTED|Washout Period I (of 16 Days)||3
5182603|NCT01138826|12746536|P2|STARTED|Washout Period I (of 16 Days)||3
5182604|NCT01138826|12746537|P1|STARTED|Washout Period I (of 16 Days)||3
5182605|NCT01138826|12746532|P6|NOT COMPLETED|First Intervention Period||0
5182606|NCT01138826|12746533|P5|NOT COMPLETED|First Intervention Period||0
5182607|NCT01138826|12746534|P4|NOT COMPLETED|First Intervention Period||0
5182608|NCT01138826|12746535|P3|NOT COMPLETED|First Intervention Period||0
5182609|NCT01138826|12746536|P2|NOT COMPLETED|First Intervention Period||0
5182610|NCT01138826|12746537|P1|NOT COMPLETED|First Intervention Period||0
5182611|NCT01138826|12746532|P6|COMPLETED|First Intervention Period||3
5182612|NCT01138826|12746533|P5|COMPLETED|First Intervention Period||3
5182613|NCT01138826|12746534|P4|COMPLETED|First Intervention Period||3
5182614|NCT01138826|12746535|P3|COMPLETED|First Intervention Period||3
5182615|NCT01138826|12746536|P2|COMPLETED|First Intervention Period||3
5182616|NCT01138826|12746537|P1|COMPLETED|First Intervention Period||3
5182617|NCT01138826|12746532|P6|STARTED|First Intervention Period||3
5182618|NCT01138826|12746533|P5|STARTED|First Intervention Period||3
5182619|NCT01138826|12746534|P4|STARTED|First Intervention Period||3
5182620|NCT01138826|12746535|P3|STARTED|First Intervention Period||3
5182621|NCT01138826|12746536|P2|STARTED|First Intervention Period||3
5182622|NCT01138826|12746537|P1|STARTED|First Intervention Period||3
5182623|NCT01138735|12746559|P2|NOT COMPLETED|Overall Study||17
5182624|NCT01138735|12746560|P1|NOT COMPLETED|Overall Study||8
5182625|NCT01138735|12746559|P2|COMPLETED|Overall Study||126
5182626|NCT01138735|12746560|P1|COMPLETED|Overall Study||134
5182627|NCT01138735|12746559|P2|STARTED|Overall Study||143
5182628|NCT01138735|12746560|P1|STARTED|Overall Study||142
5182629|NCT01138657|12746574|P2|NOT COMPLETED|Overall Study||18
5182630|NCT01138657|12746575|P1|NOT COMPLETED|Overall Study||8
5182631|NCT01138657|12746574|P2|COMPLETED|Overall Study||101
5182632|NCT01138657|12746575|P1|COMPLETED|Overall Study||112
5182633|NCT01138657|12746574|P2|Enrolled in Japan Sub-study|Overall Study||8
5182634|NCT01138657|12746575|P1|Enrolled in Japan Sub-study|Overall Study||8
5182635|NCT01138657|12746574|P2|Enrolled in Main Study|Overall Study||111
5182636|NCT01138657|12746575|P1|Enrolled in Main Study|Overall Study||112
5182637|NCT01138657|12746574|P2|STARTED|Overall Study||119
5182638|NCT01138657|12746575|P1|STARTED|Overall Study||120
5182639|NCT01138514|12746622|P3|NOT COMPLETED|Overall Study||93
5182640|NCT01138514|12746623|P2|NOT COMPLETED|Overall Study||53
5182641|NCT01138514|12746624|P1|NOT COMPLETED|Overall Study||48
5182642|NCT01138514|12746622|P3|COMPLETED|Overall Study||424
5182643|NCT01138514|12746623|P2|COMPLETED|Overall Study||463
5182644|NCT01138514|12746624|P1|COMPLETED|Overall Study||474
5182645|NCT01138514|12746622|P3|STARTED|Overall Study||517
5182646|NCT01138514|12746623|P2|STARTED|Overall Study||516
5182647|NCT01138514|12746624|P1|STARTED|Overall Study||522
5182648|NCT01138501|12746638|P1|NOT COMPLETED|Overall Study||5
5182649|NCT01138501|12746638|P1|COMPLETED|Overall Study||60
5182650|NCT01138501|12746638|P1|Exposed|Overall Study||63
5182651|NCT01138501|12746638|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
5182652|NCT01138475|12746646|P3|NOT COMPLETED|Overall Study||0
5182653|NCT01138475|12746647|P2|NOT COMPLETED|Overall Study||0
5182654|NCT01138475|12746648|P1|NOT COMPLETED|Overall Study||0
5182655|NCT01138475|12746646|P3|COMPLETED|Overall Study||17
5182656|NCT01138475|12746647|P2|COMPLETED|Overall Study||16
5182657|NCT01138475|12746648|P1|COMPLETED|Overall Study||16
5182658|NCT01138475|12746646|P3|STARTED|Overall Study||17
5182659|NCT01138475|12746647|P2|STARTED|Overall Study||16
5182660|NCT01138475|12746648|P1|STARTED|Overall Study||16
5182661|NCT01138150|12746682|P2|NOT COMPLETED|Overall Study||1
5182662|NCT01138150|12746683|P1|NOT COMPLETED|Overall Study||1
5182663|NCT01138150|12746682|P2|COMPLETED|Overall Study||17
5182664|NCT01138150|12746683|P1|COMPLETED|Overall Study||17
5182665|NCT01138150|12746682|P2|STARTED|Overall Study||18
5182666|NCT01138150|12746683|P1|STARTED|Overall Study||18
5182667|NCT01138124|12746739|P4|NOT COMPLETED|Overall Study||0
5182668|NCT01138124|12746740|P3|NOT COMPLETED|Overall Study||0
5182669|NCT01138124|12746741|P2|NOT COMPLETED|Overall Study||0
5182670|NCT01138124|12746742|P1|NOT COMPLETED|Overall Study||0
5182671|NCT01138124|12746739|P4|COMPLETED|Overall Study||19046
5182672|NCT01138124|12746740|P3|COMPLETED|Overall Study||1981
5182673|NCT01138124|12746741|P2|COMPLETED|Overall Study||30026
5182674|NCT01138124|12746742|P1|COMPLETED|Overall Study||3149
5182675|NCT01138124|12746739|P4|STARTED|Overall Study||19046
5182676|NCT01138124|12746740|P3|STARTED|Overall Study||1981
5182677|NCT01138124|12746741|P2|STARTED|Overall Study||30026
5182678|NCT01138124|12746742|P1|STARTED|Overall Study||3149
5182679|NCT01138111|12746764|P1|NOT COMPLETED|Overall Study||9
5182680|NCT01138111|12746764|P1|COMPLETED|Overall Study||36
5182681|NCT01138111|12746764|P1|STARTED|Overall Study||45
5182682|NCT01138098|12746795|P2|NOT COMPLETED|Overall Study||0
5182683|NCT01138098|12746796|P1|NOT COMPLETED|Overall Study||0
5182684|NCT01138098|12746795|P2|COMPLETED|Overall Study||90
5182685|NCT01138098|12746796|P1|COMPLETED|Overall Study||95
5182686|NCT01138098|12746795|P2|STARTED|Overall Study||90
5182687|NCT01138098|12746796|P1|STARTED|Overall Study||95
5182688|NCT01138046|12746818|P1|NOT COMPLETED|Overall Study||6
5182689|NCT01138046|12746818|P1|COMPLETED|Overall Study||6
5182690|NCT01138046|12746818|P1|STARTED|Overall Study||12
5182691|NCT01138007|12746838|P3|NOT COMPLETED|Overall Study||48
5182692|NCT01138007|12746839|P2|NOT COMPLETED|Overall Study||30
5182693|NCT01138007|12746840|P1|NOT COMPLETED|Overall Study||22
5182694|NCT01138007|12746838|P3|COMPLETED|Overall Study||144
5182695|NCT01138007|12746839|P2|COMPLETED|Overall Study||160
5182696|NCT01138007|12746840|P1|COMPLETED|Overall Study||165
5182697|NCT01138007|12746838|P3|STARTED|Overall Study||192
5182698|NCT01138007|12746839|P2|STARTED|Overall Study||190
5182699|NCT01138007|12746840|P1|STARTED|Overall Study||187
5182700|NCT01137890|12746874|P2|NOT COMPLETED|Overall Study||3
5182701|NCT01137890|12746875|P1|NOT COMPLETED|Overall Study||6
5182702|NCT01137890|12746874|P2|COMPLETED|Overall Study||2
5182703|NCT01137890|12746875|P1|COMPLETED|Overall Study||8
5182704|NCT01137890|12746874|P2|STARTED|Overall Study||5
5182705|NCT01137890|12746875|P1|STARTED|Overall Study||14
5182706|NCT01137812|12746947|P2|NOT COMPLETED|Overall Study||168
5182707|NCT01137812|12746948|P1|NOT COMPLETED|Overall Study||123
5182708|NCT01137812|12746947|P2|COMPLETED|Overall Study||210
5182709|NCT01137812|12746948|P1|COMPLETED|Overall Study||254
5182710|NCT01137812|12746947|P2|STARTED|Overall Study||378
5182711|NCT01137812|12746948|P1|STARTED|Overall Study||377
5182712|NCT01137786|12746968|P2|NOT COMPLETED|Overall Study||3
5182713|NCT01137786|12746969|P1|NOT COMPLETED|Overall Study||1
5182714|NCT01137786|12746968|P2|COMPLETED|Overall Study||21
5182715|NCT01137786|12746969|P1|COMPLETED|Overall Study||24
5182716|NCT01137786|12746968|P2|STARTED|Overall Study||24
5182717|NCT01137786|12746969|P1|STARTED|Overall Study||25
5182718|NCT01137773|12746979|P2|NOT COMPLETED|Overall Study||3
5182719|NCT01137773|12746980|P1|NOT COMPLETED|Overall Study||9
5182720|NCT01137773|12746979|P2|COMPLETED|Overall Study||20
5182721|NCT01137773|12746980|P1|COMPLETED|Overall Study||24
5182722|NCT01137773|12746979|P2|STARTED|Overall Study||23
5182723|NCT01137773|12746980|P1|STARTED|Overall Study||33
5182724|NCT01137682|12746991|P3|NOT COMPLETED|Overall Study||34
5182725|NCT01137682|12746992|P2|NOT COMPLETED|Overall Study||40
5182726|NCT01137682|12746993|P1|NOT COMPLETED|Overall Study||37
5182727|NCT01137682|12746991|P3|COMPLETED|Overall Study||34
5182728|NCT01137682|12746992|P2|COMPLETED|Overall Study||25
5182729|NCT01137682|12746993|P1|COMPLETED|Overall Study||28
5182730|NCT01137682|12746991|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
5182731|NCT01137682|12746992|P2|Safety Set - Extension|Overall Study||54
5182732|NCT01137682|12746993|P1|Safety Set - Extension|Overall Study||57
5182733|NCT01137682|12746991|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
5182734|NCT01137682|12746992|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
5182735|NCT01137682|12746993|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
5182736|NCT01137682|12746991|P3|Continuing Into Extension|Overall Study||63
5182737|NCT01137682|12746992|P2|Continuing Into Extension|Overall Study||54
5182738|NCT01137682|12746993|P1|Continuing Into Extension|Overall Study||57
5182739|NCT01137682|12746991|P3|Not Continuing Into Extension|Overall Study||2
5182740|NCT01137682|12746992|P2|Not Continuing Into Extension|Overall Study||3
5182741|NCT01137682|12746993|P1|Not Continuing Into Extension|Overall Study||2
5182742|NCT01137682|12746991|P3|Completed 24-Week Core Phase|Overall Study||65
5182743|NCT01137682|12746992|P2|Completed 24-Week Core Phase|Overall Study||57
5182744|NCT01137682|12746993|P1|Completed 24-Week Core Phase|Overall Study||59
5182745|NCT01137682|12746991|P3|Treated|Overall Study||67
5182746|NCT01137682|12746992|P2|Treated|Overall Study||63
5182747|NCT01137682|12746993|P1|Treated|Overall Study||63
5182748|NCT01137682|12746991|P3|Not Treated|Overall Study||1
5182749|NCT01137682|12746992|P2|Not Treated|Overall Study||2
5182750|NCT01137682|12746993|P1|Not Treated|Overall Study||2
5182751|NCT01137682|12746991|P3|STARTED|Overall Study||68
5182752|NCT01137682|12746992|P2|STARTED|Overall Study||65
5182753|NCT01137682|12746993|P1|STARTED|Overall Study||65
5182754|NCT01137604|12747043|P4|NOT COMPLETED|Overall Study||11
5182755|NCT01137604|12747044|P3|NOT COMPLETED|Overall Study||13
5182756|NCT01137604|12747045|P2|NOT COMPLETED|Overall Study||10
5182757|NCT01137604|12747046|P1|NOT COMPLETED|Overall Study||2
5182758|NCT01137604|12747043|P4|COMPLETED|Overall Study||21
5182759|NCT01137604|12747044|P3|COMPLETED|Overall Study||26
5182760|NCT01137604|12747045|P2|COMPLETED|Overall Study||32
5182761|NCT01137604|12747046|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
5182762|NCT01137604|12747043|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
5182763|NCT01137604|12747044|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
5182764|NCT01137604|12747045|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
5182765|NCT01137604|12747046|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
5182766|NCT01137604|12747043|P4|Disease Progression|Overall Study||21
5182767|NCT01137604|12747044|P3|Disease Progression|Overall Study||25
5182768|NCT01137604|12747045|P2|Disease Progression|Overall Study||29
5182769|NCT01137604|12747046|P1|Disease Progression|Overall Study||34
5182770|NCT01137604|12747043|P4|STARTED|Overall Study||32
5182771|NCT01137604|12747044|P3|STARTED|Overall Study||39
5182772|NCT01137604|12747045|P2|STARTED|Overall Study||42
5182773|NCT01137604|12747046|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
5182774|NCT01137578|12747080|P3|NOT COMPLETED|Overall Study||6
5182775|NCT01137578|12747081|P2|NOT COMPLETED|Overall Study||2
5182776|NCT01137578|12747082|P1|NOT COMPLETED|Overall Study||16
5182777|NCT01137578|12747080|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
5182778|NCT01137578|12747081|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
5182779|NCT01137578|12747082|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
5182780|NCT01137578|12747080|P3|STARTED|Overall Study||43
5182781|NCT01137578|12747081|P2|STARTED|Overall Study||14
5182782|NCT01137578|12747082|P1|STARTED|Overall Study||77
5182783|NCT01137539|12747122|P1|NOT COMPLETED|Overall Study||0
5182784|NCT01137539|12747122|P1|COMPLETED|Overall Study||50
5182785|NCT01137539|12747122|P1|STARTED|Overall Study||50
5182786|NCT01137474|12747131|P4|NOT COMPLETED|Overall Study||21
5182787|NCT01137474|12747132|P3|NOT COMPLETED|Overall Study||7
5182788|NCT01137474|12747133|P2|NOT COMPLETED|Overall Study||12
5182789|NCT01137474|12747134|P1|NOT COMPLETED|Overall Study||24
5182790|NCT01137474|12747131|P4|COMPLETED|Overall Study||281
5182791|NCT01137474|12747132|P3|COMPLETED|Overall Study||158
5182792|NCT01137474|12747133|P2|COMPLETED|Overall Study||154
5182793|NCT01137474|12747134|P1|COMPLETED|Overall Study||287
5182794|NCT01137474|12747131|P4|Received Treatment|Overall Study||302
5182795|NCT01137474|12747132|P3|Received Treatment|Overall Study||165
5182796|NCT01137474|12747133|P2|Received Treatment|Overall Study||166
5182797|NCT01137474|12747134|P1|Received Treatment|Overall Study||311
5182798|NCT01137474|12747131|P4|STARTED|Overall Study||302
5182799|NCT01137474|12747132|P3|STARTED|Overall Study||165
5182800|NCT01137474|12747133|P2|STARTED|Overall Study||166
5182801|NCT01137474|12747134|P1|STARTED|Overall Study||311
5182802|NCT01137435|12747152|P1|NOT COMPLETED|Overall Study||28
5182803|NCT01137435|12747152|P1|COMPLETED|Overall Study||659
5182804|NCT01137435|12747152|P1|STARTED|Overall Study||687
5182805|NCT01137396|12747161|P2|NOT COMPLETED|Overall Study||2
5182806|NCT01137396|12747162|P1|NOT COMPLETED|Overall Study||8
5182807|NCT01137396|12747161|P2|COMPLETED|Overall Study||25
5182808|NCT01137396|12747162|P1|COMPLETED|Overall Study||22
5182809|NCT01137396|12747161|P2|STARTED|Overall Study||27
5182810|NCT01137396|12747162|P1|STARTED|Overall Study||30
5182811|NCT01137370|12747172|P2|NOT COMPLETED|Overall Study||0
5182812|NCT01137370|12747173|P1|NOT COMPLETED|Overall Study||0
5182813|NCT01137370|12747172|P2|COMPLETED|Overall Study||87
5182814|NCT01137370|12747173|P1|COMPLETED|Overall Study||116
5182815|NCT01137370|12747172|P2|STARTED|Overall Study||87
5182816|NCT01137370|12747173|P1|STARTED|Overall Study||116
5182817|NCT01137292|12747179|P1|NOT COMPLETED|Overall Study||54
5182818|NCT01137292|12747179|P1|COMPLETED|Overall Study||123
5182819|NCT01137292|12747179|P1|STARTED|Overall Study||177
5182820|NCT01137110|12747188|P2|NOT COMPLETED|Overall Study||0
5182821|NCT01137110|12747189|P1|NOT COMPLETED|Overall Study||1
5182822|NCT01137110|12747188|P2|COMPLETED|Overall Study||49
5182823|NCT01137110|12747189|P1|COMPLETED|Overall Study||34
5182824|NCT01137110|12747188|P2|STARTED|Overall Study||49
5182825|NCT01137110|12747189|P1|STARTED|Overall Study||35
5182826|NCT01137071|12747195|P1|NOT COMPLETED|Overall Study||14
5182827|NCT01137071|12747195|P1|COMPLETED|Overall Study|Of the eligible patients|15
5182828|NCT01137071|12747195|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
5182829|NCT01137032|12747256|P1|NOT COMPLETED|Overall Study||0
5182830|NCT01137032|12747256|P1|COMPLETED|Overall Study||19
5182831|NCT01137032|12747256|P1|STARTED|Overall Study||19
5182832|NCT01137006|12747269|P7|NOT COMPLETED|Overall Study||0
5182833|NCT01137006|12747270|P6|NOT COMPLETED|Overall Study||0
5182834|NCT01137006|12747271|P5|NOT COMPLETED|Overall Study||0
5182835|NCT01137006|12747272|P4|NOT COMPLETED|Overall Study||0
5182836|NCT01137006|12747273|P3|NOT COMPLETED|Overall Study||0
5182837|NCT01137006|12747274|P2|NOT COMPLETED|Overall Study||0
5182838|NCT01137006|12747275|P1|NOT COMPLETED|Overall Study||0
5182839|NCT01137006|12747269|P7|COMPLETED|Overall Study||3
5182840|NCT01137006|12747270|P6|COMPLETED|Overall Study||4
5182841|NCT01137006|12747271|P5|COMPLETED|Overall Study||3
5182842|NCT01137006|12747272|P4|COMPLETED|Overall Study||3
5182843|NCT01137006|12747273|P3|COMPLETED|Overall Study||8
5182844|NCT01137006|12747274|P2|COMPLETED|Overall Study||3
5182845|NCT01137006|12747275|P1|COMPLETED|Overall Study||3
5182846|NCT01137006|12747269|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
5182847|NCT01137006|12747270|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
5182848|NCT01137006|12747271|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
5182849|NCT01137006|12747272|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
5182850|NCT01137006|12747273|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
5182851|NCT01137006|12747274|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
5182852|NCT01137006|12747275|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
5182853|NCT01137006|12747269|P7|STARTED|Overall Study||3
5182854|NCT01137006|12747270|P6|STARTED|Overall Study||4
5182855|NCT01137006|12747271|P5|STARTED|Overall Study||3
5182856|NCT01137006|12747272|P4|STARTED|Overall Study||3
5182857|NCT01137006|12747273|P3|STARTED|Overall Study||8
5182858|NCT01137006|12747274|P2|STARTED|Overall Study||3
5182859|NCT01137006|12747275|P1|STARTED|Overall Study||3
5182860|NCT01136967|12747351|P2|NOT COMPLETED|Overall Study||27
5182861|NCT01136967|12747352|P1|NOT COMPLETED|Overall Study||24
5182862|NCT01136967|12747351|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
5182863|NCT01136967|12747352|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
5182864|NCT01136967|12747351|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
5182865|NCT01136967|12747352|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
5182866|NCT01136967|12747351|P2|Disease Progression|Overall Study||56
5182867|NCT01136967|12747352|P1|Disease Progression|Overall Study||55
5182868|NCT01136967|12747351|P2|STARTED|Overall Study||89
5182869|NCT01136967|12747352|P1|STARTED|Overall Study||93
5182870|NCT01136954|12747374|P2|NOT COMPLETED|Overall Study||21
5182871|NCT01136954|12747375|P1|NOT COMPLETED|Overall Study||24
5182872|NCT01136954|12747374|P2|COMPLETED|Overall Study||51
5182873|NCT01136954|12747375|P1|COMPLETED|Overall Study||48
5182874|NCT01136954|12747374|P2|STARTED|Overall Study||72
5182875|NCT01136954|12747375|P1|STARTED|Overall Study||72
5182876|NCT01136915|12747389|P2|NOT COMPLETED|Overall Study||1
5182877|NCT01136915|12747390|P1|NOT COMPLETED|Overall Study||2
5182878|NCT01136915|12747389|P2|COMPLETED|Overall Study||6
5182879|NCT01136915|12747390|P1|COMPLETED|Overall Study||6
5182880|NCT01136915|12747389|P2|STARTED|Overall Study||7
5182881|NCT01136915|12747390|P1|STARTED|Overall Study||8
5182882|NCT01136876|12747400|P2|NOT COMPLETED|Overall Study||6
5182883|NCT01136876|12747401|P1|NOT COMPLETED|Overall Study||3
5182884|NCT01136876|12747400|P2|COMPLETED|Overall Study||23
5182885|NCT01136876|12747401|P1|COMPLETED|Overall Study||25
5182886|NCT01136876|12747400|P2|STARTED|Overall Study||29
5182887|NCT01136876|12747401|P1|STARTED|Overall Study||28
5182888|NCT01136798|12747411|P2|NOT COMPLETED|Overall Study||0
5182889|NCT01136798|12747412|P1|NOT COMPLETED|Overall Study||0
5182890|NCT01136798|12747411|P2|COMPLETED|Overall Study||8
5182891|NCT01136798|12747412|P1|COMPLETED|Overall Study||10
5182892|NCT01136798|12747411|P2|STARTED|Overall Study||8
5182893|NCT01136798|12747412|P1|STARTED|Overall Study||10
5182894|NCT01136785|12747430|P2|NOT COMPLETED|Overall Study||1
5182895|NCT01136785|12747431|P1|NOT COMPLETED|Overall Study||2
5182896|NCT01136785|12747430|P2|COMPLETED|Overall Study||6
5182897|NCT01136785|12747431|P1|COMPLETED|Overall Study||13
5182898|NCT01136785|12747430|P2|STARTED|Overall Study||7
5182899|NCT01136785|12747431|P1|STARTED|Overall Study||15
5182900|NCT01136772|12747446|P2|NOT COMPLETED|Overall Study||110
5182901|NCT01136772|12747447|P1|NOT COMPLETED|Overall Study||116
5182902|NCT01136772|12747446|P2|COMPLETED|Overall Study||44
5182903|NCT01136772|12747447|P1|COMPLETED|Overall Study||41
5182904|NCT01136772|12747446|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
5182905|NCT01136772|12747447|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
5182906|NCT01136772|12747446|P2|STARTED|Overall Study||154
5182907|NCT01136772|12747447|P1|STARTED|Overall Study||157
5182908|NCT01136746|12747457|P2|NOT COMPLETED|Overall Study||3
5182909|NCT01136746|12747458|P1|NOT COMPLETED|Overall Study||3
5182910|NCT01136746|12747457|P2|COMPLETED|Overall Study||4
5182911|NCT01136746|12747458|P1|COMPLETED|Overall Study||6
5182912|NCT01136746|12747457|P2|STARTED|Overall Study||7
5182913|NCT01136746|12747458|P1|STARTED|Overall Study||9
5182914|NCT01136733|12747525|P7|NOT COMPLETED|Phase 2||50
5182915|NCT01136733|12747526|P6|NOT COMPLETED|Phase 2||52
5182916|NCT01136733|12747527|P5|NOT COMPLETED|Phase 2||51
5182917|NCT01136733|12747528|P4|NOT COMPLETED|Phase 2||0
5182918|NCT01136733|12747529|P3|NOT COMPLETED|Phase 2||0
5182919|NCT01136733|12747530|P2|NOT COMPLETED|Phase 2||0
5182920|NCT01136733|12747531|P1|NOT COMPLETED|Phase 2||0
5182921|NCT01136733|12747525|P7|COMPLETED|Phase 2||0
5182922|NCT01136733|12747526|P6|COMPLETED|Phase 2||0
5182923|NCT01136733|12747527|P5|COMPLETED|Phase 2||0
5182924|NCT01136733|12747528|P4|COMPLETED|Phase 2||0
5182925|NCT01136733|12747529|P3|COMPLETED|Phase 2||0
5182926|NCT01136733|12747530|P2|COMPLETED|Phase 2||0
5182927|NCT01136733|12747531|P1|COMPLETED|Phase 2||0
5182928|NCT01136733|12747525|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
5182929|NCT01136733|12747526|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
5182930|NCT01136733|12747527|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
5182931|NCT01136733|12747528|P4|STARTED|Phase 2||0
5182932|NCT01136733|12747529|P3|STARTED|Phase 2||0
5182933|NCT01136733|12747530|P2|STARTED|Phase 2||0
5182934|NCT01136733|12747531|P1|STARTED|Phase 2||0
5182935|NCT01136733|12747525|P7|NOT COMPLETED|Phase 1b||0
5182936|NCT01136733|12747526|P6|NOT COMPLETED|Phase 1b||0
5182937|NCT01136733|12747527|P5|NOT COMPLETED|Phase 1b||0
5182938|NCT01136733|12747528|P4|NOT COMPLETED|Phase 1b||0
5182939|NCT01136733|12747529|P3|NOT COMPLETED|Phase 1b||2
5182940|NCT01136733|12747530|P2|NOT COMPLETED|Phase 1b||5
5182941|NCT01136733|12747531|P1|NOT COMPLETED|Phase 1b||1
5182942|NCT01136733|12747525|P7|COMPLETED|Phase 1b||0
5182943|NCT01136733|12747526|P6|COMPLETED|Phase 1b||0
5182944|NCT01136733|12747527|P5|COMPLETED|Phase 1b||0
5182945|NCT01136733|12747528|P4|COMPLETED|Phase 1b||0
5182946|NCT01136733|12747529|P3|COMPLETED|Phase 1b||0
5182947|NCT01136733|12747530|P2|COMPLETED|Phase 1b||6
5182948|NCT01136733|12747531|P1|COMPLETED|Phase 1b||6
5182949|NCT01136733|12747525|P7|STARTED|Phase 1b||0
5182950|NCT01136733|12747526|P6|STARTED|Phase 1b||0
5182951|NCT01136733|12747527|P5|STARTED|Phase 1b||0
5182952|NCT01136733|12747528|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
5182953|NCT01136733|12747529|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
5182954|NCT01136733|12747530|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
5182955|NCT01136733|12747531|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
5182956|NCT01136655|12747614|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
5182957|NCT01136655|12747614|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
5182958|NCT01136655|12747614|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
5182959|NCT01136655|12747614|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
5182960|NCT01136655|12747614|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
5182961|NCT01136655|12747614|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
5182962|NCT01136655|12747614|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
5182963|NCT01136655|12747614|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
5182964|NCT01136655|12747614|P1|STARTED|Washout After BUD 160 (7 Days)||51
5182965|NCT01136655|12747614|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
5182966|NCT01136655|12747614|P1|COMPLETED|BUD 160 (1 Dose)||51
5182967|NCT01136655|12747614|P1|STARTED|BUD 160 (1 Dose)||51
5182968|NCT01136655|12747614|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
5182969|NCT01136655|12747614|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
5182970|NCT01136655|12747614|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
5182971|NCT01136655|12747614|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
5182972|NCT01136655|12747614|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
5182973|NCT01136655|12747614|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
5182974|NCT01136655|12747614|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
5182975|NCT01136655|12747614|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
5182976|NCT01136655|12747614|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
5182977|NCT01136655|12747614|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
5182978|NCT01136655|12747614|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
5182979|NCT01136655|12747614|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
5182980|NCT01136655|12747614|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
5182981|NCT01136655|12747614|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
5182982|NCT01136655|12747614|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
5182983|NCT01136655|12747614|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
5182984|NCT01136655|12747614|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
5182985|NCT01136655|12747614|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
5182986|NCT01136486|12747640|P1|NOT COMPLETED|Overall Study||0
5182987|NCT01136486|12747640|P1|COMPLETED|Overall Study||56
5182988|NCT01136486|12747640|P1|STARTED|Overall Study||56
5182989|NCT01136408|12747647|P3|NOT COMPLETED|Overall Study||5
5182990|NCT01136408|12747648|P2|NOT COMPLETED|Overall Study||9
5182991|NCT01136408|12747649|P1|NOT COMPLETED|Overall Study||5
5182992|NCT01136408|12747647|P3|COMPLETED|Overall Study||57
5182993|NCT01136408|12747648|P2|COMPLETED|Overall Study||49
5182994|NCT01136408|12747649|P1|COMPLETED|Overall Study||41
5182995|NCT01136408|12747647|P3|STARTED|Overall Study||62
5182996|NCT01136408|12747648|P2|STARTED|Overall Study||58
5182997|NCT01136408|12747649|P1|STARTED|Overall Study||46
5182998|NCT01136382|12747706|P2|NOT COMPLETED|Overall Study||31
5182999|NCT01136382|12747707|P1|NOT COMPLETED|Overall Study||60
5183000|NCT01136382|12747706|P2|COMPLETED|Overall Study||121
5183001|NCT01136382|12747707|P1|COMPLETED|Overall Study||92
5183002|NCT01136382|12747706|P2|STARTED|Overall Study||152
5183003|NCT01136382|12747707|P1|STARTED|Overall Study||152
5183004|NCT01136356|12747733|P2|NOT COMPLETED|Second 18-day Withdrawal||1
5183005|NCT01136356|12747734|P1|NOT COMPLETED|Second 18-day Withdrawal||0
5183006|NCT01136356|12747733|P2|COMPLETED|Second 18-day Withdrawal||5
5183007|NCT01136356|12747734|P1|COMPLETED|Second 18-day Withdrawal||2
5183008|NCT01136356|12747733|P2|STARTED|Second 18-day Withdrawal||6
5183009|NCT01136356|12747734|P1|STARTED|Second 18-day Withdrawal||2
5183010|NCT01136356|12747733|P2|NOT COMPLETED|Second Intervention||0
5183011|NCT01136356|12747734|P1|NOT COMPLETED|Second Intervention||0
5183012|NCT01136356|12747733|P2|COMPLETED|Second Intervention||6
5183013|NCT01136356|12747734|P1|COMPLETED|Second Intervention||2
5183014|NCT01136356|12747733|P2|STARTED|Second Intervention||6
5183015|NCT01136356|12747734|P1|STARTED|Second Intervention||2
5183016|NCT01136356|12747733|P2|NOT COMPLETED|First 18-day Withdrawal||0
5183017|NCT01136356|12747734|P1|NOT COMPLETED|First 18-day Withdrawal||4
5183018|NCT01136356|12747733|P2|COMPLETED|First 18-day Withdrawal||6
5183019|NCT01136356|12747734|P1|COMPLETED|First 18-day Withdrawal||2
5183020|NCT01136356|12747733|P2|STARTED|First 18-day Withdrawal||6
5183021|NCT01136356|12747734|P1|STARTED|First 18-day Withdrawal||6
5183022|NCT01136356|12747733|P2|NOT COMPLETED|First Intervention||0
5183023|NCT01136356|12747734|P1|NOT COMPLETED|First Intervention||0
5183024|NCT01136356|12747733|P2|COMPLETED|First Intervention||6
5183025|NCT01136356|12747734|P1|COMPLETED|First Intervention||6
5183026|NCT01136356|12747733|P2|STARTED|First Intervention||6
5183027|NCT01136356|12747734|P1|STARTED|First Intervention||6
5183028|NCT01136291|12747745|P2|NOT COMPLETED|Overall Study||1
5183029|NCT01136291|12747746|P1|NOT COMPLETED|Overall Study||1
5183030|NCT01136291|12747745|P2|COMPLETED|Overall Study||41
5183031|NCT01136291|12747746|P1|COMPLETED|Overall Study||39
5183032|NCT01136291|12747745|P2|Follow|Overall Study||42
5183033|NCT01136291|12747746|P1|Follow|Overall Study||40
5183034|NCT01136291|12747745|P2|STARTED|Overall Study||42
5183035|NCT01136291|12747746|P1|STARTED|Overall Study||40
5183036|NCT01136226|12747756|P1|NOT COMPLETED|Overall Study||13
5183037|NCT01136226|12747756|P1|COMPLETED|Overall Study||29
5183038|NCT01136226|12747756|P1|STARTED|Overall Study||42
5183039|NCT01136174|12747765|P4|NOT COMPLETED|Overall Study||4
5183040|NCT01136174|12747766|P3|NOT COMPLETED|Overall Study||0
5183041|NCT01136174|12747767|P2|NOT COMPLETED|Overall Study||0
5183042|NCT01136174|12747768|P1|NOT COMPLETED|Overall Study||0
5183043|NCT01136174|12747765|P4|COMPLETED|Overall Study||20
5183044|NCT01136174|12747766|P3|COMPLETED|Overall Study||8
5183045|NCT01136174|12747767|P2|COMPLETED|Overall Study||6
5183046|NCT01136174|12747768|P1|COMPLETED|Overall Study||12
5183047|NCT01136174|12747765|P4|STARTED|Overall Study||24
5183048|NCT01136174|12747766|P3|STARTED|Overall Study||8
5183049|NCT01136174|12747767|P2|STARTED|Overall Study||6
5183050|NCT01136174|12747768|P1|STARTED|Overall Study||12
5183051|NCT01135992|12747848|P1|NOT COMPLETED|Overall Study||21
5183052|NCT01135992|12747848|P1|COMPLETED|Overall Study||122
5183053|NCT01135992|12747848|P1|Full Analysis Set|Overall Study||129
5183054|NCT01135992|12747848|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
5183055|NCT01135992|12747848|P1|STARTED|Overall Study||143
5183056|NCT01135914|12747860|P3|NOT COMPLETED|Overall Study||22
5183057|NCT01135914|12747861|P2|NOT COMPLETED|Overall Study||5
5183058|NCT01135914|12747862|P1|NOT COMPLETED|Overall Study||4
5183059|NCT01135914|12747860|P3|COMPLETED|Overall Study||59
5183060|NCT01135914|12747861|P2|COMPLETED|Overall Study||75
5183061|NCT01135914|12747862|P1|COMPLETED|Overall Study||74
5183062|NCT01135914|12747860|P3|Safety Population|Overall Study||74
5183063|NCT01135914|12747861|P2|Safety Population|Overall Study||75
5183064|NCT01135914|12747862|P1|Safety Population|Overall Study||73
5183065|NCT01135914|12747860|P3|Intent to Treat (ITT) Population|Overall Study||72
5183066|NCT01135914|12747861|P2|Intent to Treat (ITT) Population|Overall Study||75
5183067|NCT01135914|12747862|P1|Intent to Treat (ITT) Population|Overall Study||73
5183068|NCT01135914|12747860|P3|STARTED|Overall Study||81
5183069|NCT01135914|12747861|P2|STARTED|Overall Study||80
5183070|NCT01135914|12747862|P1|STARTED|Overall Study||78
5183071|NCT01135537|12747891|P1|NOT COMPLETED|Overall Study||13
5183072|NCT01135537|12747891|P1|COMPLETED|Overall Study||17
5183073|NCT01135537|12747891|P1|STARTED|Overall Study||30
5183074|NCT01135524|12747895|P1|NOT COMPLETED|Overall Study||196
5183075|NCT01135524|12747895|P1|COMPLETED|Overall Study||0
5183076|NCT01135524|12747895|P1|STARTED|Overall Study||196
5183077|NCT01135511|12747908|P9|NOT COMPLETED|Overall Study||1
5183078|NCT01135511|12747909|P8|NOT COMPLETED|Overall Study||1
5183079|NCT01135511|12747910|P7|NOT COMPLETED|Overall Study||1
5183080|NCT01135511|12747911|P6|NOT COMPLETED|Overall Study||1
5183081|NCT01135511|12747912|P5|NOT COMPLETED|Overall Study||1
5183082|NCT01135511|12747913|P4|NOT COMPLETED|Overall Study||3
5183083|NCT01135511|12747914|P3|NOT COMPLETED|Overall Study||8
5183084|NCT01135511|12747915|P2|NOT COMPLETED|Overall Study||3
5183085|NCT01135511|12747916|P1|NOT COMPLETED|Overall Study||0
5183086|NCT01135511|12747908|P9|COMPLETED|Overall Study||20
5183087|NCT01135511|12747909|P8|COMPLETED|Overall Study||20
5183088|NCT01135511|12747910|P7|COMPLETED|Overall Study||18
5183089|NCT01135511|12747911|P6|COMPLETED|Overall Study||20
5183090|NCT01135511|12747912|P5|COMPLETED|Overall Study||38
5183091|NCT01135511|12747913|P4|COMPLETED|Overall Study||37
5183092|NCT01135511|12747914|P3|COMPLETED|Overall Study||33
5183093|NCT01135511|12747915|P2|COMPLETED|Overall Study||39
5183094|NCT01135511|12747916|P1|COMPLETED|Overall Study||41
5183095|NCT01135511|12747908|P9|STARTED|Overall Study||21
5183096|NCT01135511|12747909|P8|STARTED|Overall Study||21
5183097|NCT01135511|12747910|P7|STARTED|Overall Study||19
5183098|NCT01135511|12747911|P6|STARTED|Overall Study||21
5183099|NCT01135511|12747912|P5|STARTED|Overall Study||39
5183100|NCT01135511|12747913|P4|STARTED|Overall Study||40
5183101|NCT01135511|12747914|P3|STARTED|Overall Study||41
5183102|NCT01135511|12747915|P2|STARTED|Overall Study||42
5183103|NCT01135511|12747916|P1|STARTED|Overall Study||41
5183104|NCT01135498|12748198|P1|NOT COMPLETED|Overall Study||90
5183105|NCT01135498|12748198|P1|COMPLETED|Overall Study||0
5183106|NCT01135498|12748198|P1|STARTED|Overall Study||90
5183107|NCT01135420|12748209|P2|NOT COMPLETED|Overall Study||32
5183108|NCT01135420|12748210|P1|NOT COMPLETED|Overall Study||44
5183109|NCT01135420|12748209|P2|COMPLETED|Overall Study||175
5183110|NCT01135420|12748210|P1|COMPLETED|Overall Study||155
5183111|NCT01135420|12748209|P2|STARTED|Overall Study||207
5183112|NCT01135420|12748210|P1|STARTED|Overall Study||199
5183113|NCT01135381|12748220|P4|NOT COMPLETED|Overall Study||1
5183114|NCT01135381|12748221|P3|NOT COMPLETED|Overall Study||4
5183115|NCT01135381|12748222|P2|NOT COMPLETED|Overall Study||7
5183116|NCT01135381|12748223|P1|NOT COMPLETED|Overall Study||21
5183117|NCT01135381|12748220|P4|COMPLETED|Overall Study||67
5183118|NCT01135381|12748221|P3|COMPLETED|Overall Study||65
5183119|NCT01135381|12748222|P2|COMPLETED|Overall Study||178
5183120|NCT01135381|12748223|P1|COMPLETED|Overall Study||168
5183121|NCT01135381|12748220|P4|STARTED|Overall Study||68
5183122|NCT01135381|12748221|P3|STARTED|Overall Study||69
5183123|NCT01135381|12748222|P2|STARTED|Overall Study||185
5183124|NCT01135381|12748223|P1|STARTED|Overall Study||189
5183125|NCT01135368|12748241|P1|NOT COMPLETED|Overall Study||251
5183126|NCT01135368|12748241|P1|COMPLETED|Overall Study||255
5183127|NCT01135368|12748241|P1|STARTED|Overall Study||506
5183128|NCT01135329|12748357|P1|NOT COMPLETED|Overall Study||0
5183129|NCT01135329|12748357|P1|COMPLETED|Overall Study||15
5183130|NCT01135329|12748357|P1|STARTED|Overall Study||15
5183131|NCT01135186|12748368|P1|NOT COMPLETED|Overall Study||0
5183132|NCT01135186|12748368|P1|COMPLETED|Overall Study||9
5183133|NCT01135186|12748368|P1|STARTED|Overall Study||9
5183134|NCT01135134|12748377|P2|NOT COMPLETED|Overall Study||1
5183135|NCT01135134|12748378|P1|NOT COMPLETED|Overall Study||2
5183136|NCT01135134|12748377|P2|COMPLETED|Overall Study||112
5183137|NCT01135134|12748378|P1|COMPLETED|Overall Study||218
5183138|NCT01135134|12748377|P2|STARTED|Overall Study||113
5183139|NCT01135134|12748378|P1|STARTED|Overall Study||220
5183140|NCT01135069|12748389|P3|NOT COMPLETED|Overall Study||10
5183141|NCT01135069|12748390|P2|NOT COMPLETED|Overall Study||32
5183142|NCT01135069|12748391|P1|NOT COMPLETED|Overall Study||36
5183143|NCT01135069|12748389|P3|COMPLETED|Overall Study||56
5183144|NCT01135069|12748390|P2|COMPLETED|Overall Study||177
5183145|NCT01135069|12748391|P1|COMPLETED|Overall Study||169
5183146|NCT01135069|12748389|P3|STARTED|Overall Study||66
5183147|NCT01135069|12748390|P2|STARTED|Overall Study||209
5183148|NCT01135069|12748391|P1|STARTED|Overall Study||205
5183149|NCT01135017|12748401|P2|NOT COMPLETED|Overall Study||12
5183150|NCT01135017|12748402|P1|NOT COMPLETED|Overall Study||6
5183151|NCT01135017|12748401|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
5183152|NCT01135017|12748402|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
5183153|NCT01135017|12748401|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
5183154|NCT01135017|12748402|P1|Evaluable for Efficacy|Overall Study||55
5183155|NCT01135017|12748401|P2|Treated|Overall Study||57
5183156|NCT01135017|12748402|P1|Treated|Overall Study||55
5183157|NCT01135017|12748401|P2|STARTED|Overall Study||57
5183158|NCT01135017|12748402|P1|STARTED|Overall Study||55
5183159|NCT01134952|12748418|P1|NOT COMPLETED|Overall Study||0
5183160|NCT01134952|12748418|P1|COMPLETED|Overall Study||11
5183161|NCT01134952|12748418|P1|STARTED|Overall Study||11
5183162|NCT01134939|12748440|P8|NOT COMPLETED|Overall Study||0
5183163|NCT01134939|12748441|P7|NOT COMPLETED|Overall Study||9
5183164|NCT01134939|12748442|P6|NOT COMPLETED|Overall Study||9
5183165|NCT01134939|12748443|P5|NOT COMPLETED|Overall Study||10
5183166|NCT01134939|12748444|P4|NOT COMPLETED|Overall Study||14
5183167|NCT01134939|12748445|P3|NOT COMPLETED|Overall Study||10
5183168|NCT01134939|12748446|P2|NOT COMPLETED|Overall Study||18
5183169|NCT01134939|12748447|P1|NOT COMPLETED|Overall Study||17
5183170|NCT01134939|12748440|P8|COMPLETED|Overall Study||1
5183171|NCT01134939|12748441|P7|COMPLETED|Overall Study||10
5183172|NCT01134939|12748442|P6|COMPLETED|Overall Study||5
5183173|NCT01134939|12748443|P5|COMPLETED|Overall Study||23
5183174|NCT01134939|12748444|P4|COMPLETED|Overall Study||32
5183175|NCT01134939|12748445|P3|COMPLETED|Overall Study||41
5183176|NCT01134939|12748446|P2|COMPLETED|Overall Study||24
5183177|NCT01134939|12748447|P1|COMPLETED|Overall Study||42
5183178|NCT01134939|12748440|P8|STARTED|Overall Study||1
5183179|NCT01134939|12748441|P7|STARTED|Overall Study||19
5183180|NCT01134939|12748442|P6|STARTED|Overall Study||14
5183181|NCT01134939|12748443|P5|STARTED|Overall Study||33
5183182|NCT01134939|12748444|P4|STARTED|Overall Study||46
5183183|NCT01134939|12748445|P3|STARTED|Overall Study||51
5183184|NCT01134939|12748446|P2|STARTED|Overall Study||42
5183185|NCT01134939|12748447|P1|STARTED|Overall Study||59
5183186|NCT01134900|12748559|P2|NOT COMPLETED|Overall Study||0
5183187|NCT01134900|12748560|P1|NOT COMPLETED|Overall Study||0
5183188|NCT01134900|12748559|P2|COMPLETED|Overall Study||196
5183189|NCT01134900|12748560|P1|COMPLETED|Overall Study||200
5183190|NCT01134900|12748559|P2|STARTED|Overall Study||196
5183191|NCT01134900|12748560|P1|STARTED|Overall Study||200
5183192|NCT01134887|12748572|P4|NOT COMPLETED|Overall Study||0
5183193|NCT01134887|12748573|P3|NOT COMPLETED|Overall Study||0
5183194|NCT01134887|12748574|P2|NOT COMPLETED|Overall Study||4
5183195|NCT01134887|12748575|P1|NOT COMPLETED|Overall Study||0
5183196|NCT01134887|12748572|P4|COMPLETED|Overall Study||5
5183197|NCT01134887|12748573|P3|COMPLETED|Overall Study||5
5183198|NCT01134887|12748574|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
5183199|NCT01134887|12748575|P1|COMPLETED|Overall Study||9
5183200|NCT01134887|12748572|P4|STARTED|Overall Study||5
5183201|NCT01134887|12748573|P3|STARTED|Overall Study||5
5183202|NCT01134887|12748574|P2|STARTED|Overall Study||11
5183203|NCT01134887|12748575|P1|STARTED|Overall Study||9
5183204|NCT01134783|12748585|P2|NOT COMPLETED|Overall Study||37
5183205|NCT01134783|12748586|P1|NOT COMPLETED|Overall Study||36
5183206|NCT01134783|12748585|P2|COMPLETED|Overall Study||180
5183207|NCT01134783|12748586|P1|COMPLETED|Overall Study||188
5183208|NCT01134783|12748585|P2|STARTED|Overall Study||217
5183209|NCT01134783|12748586|P1|STARTED|Overall Study||224
5183210|NCT01134731|12748605|P3|NOT COMPLETED|Overall Study||8
5183211|NCT01134731|12748606|P2|NOT COMPLETED|Overall Study||11
5183212|NCT01134731|12748607|P1|NOT COMPLETED|Overall Study||13
5183213|NCT01134731|12748605|P3|COMPLETED|Overall Study||2
5183214|NCT01134731|12748606|P2|COMPLETED|Overall Study||10
5183215|NCT01134731|12748607|P1|COMPLETED|Overall Study||10
5183216|NCT01134731|12748605|P3|STARTED|Overall Study||10
5183217|NCT01134731|12748606|P2|STARTED|Overall Study||21
5183218|NCT01134731|12748607|P1|STARTED|Overall Study||23
5183219|NCT01134705|12748620|P2|NOT COMPLETED|Overall Study||22
5183220|NCT01134705|12748621|P1|NOT COMPLETED|Overall Study||15
5183221|NCT01134705|12748620|P2|COMPLETED|Overall Study||216
5183222|NCT01134705|12748621|P1|COMPLETED|Overall Study||221
5183223|NCT01134705|12748620|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
5183224|NCT01134705|12748621|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
5183225|NCT01134705|12748620|P2|STARTED|Overall Study||238
5183226|NCT01134705|12748621|P1|STARTED|Overall Study||236
5183227|NCT01134627|12748633|P2|NOT COMPLETED|Overall Study||67
5183228|NCT01134627|12748634|P1|NOT COMPLETED|Overall Study||69
5183229|NCT01134627|12748633|P2|COMPLETED|Overall Study||88
5183230|NCT01134627|12748634|P1|COMPLETED|Overall Study||80
5183231|NCT01134627|12748633|P2|STARTED|Overall Study|Number of participants treated.|155
5183232|NCT01134627|12748634|P1|STARTED|Overall Study|Number of participants treated.|149
5183233|NCT01134614|12748664|P2|NOT COMPLETED|Overall Study||122
5183234|NCT01134614|12748665|P1|NOT COMPLETED|Overall Study||123
5183235|NCT01134614|12748664|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
5183236|NCT01134614|12748665|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
5183237|NCT01134614|12748664|P2|Treated and Toxicity Assessed|Overall Study||120
5183238|NCT01134614|12748665|P1|Treated and Toxicity Assessed|Overall Study||118
5183239|NCT01134614|12748664|P2|Treated|Overall Study||121
5183240|NCT01134614|12748665|P1|Treated|Overall Study||119
5183241|NCT01134614|12748664|P2|STARTED|Overall Study||122
5183242|NCT01134614|12748665|P1|STARTED|Overall Study||123
5183243|NCT01134575|12748678|P3|NOT COMPLETED|Overall Study||0
5183244|NCT01134575|12748679|P2|NOT COMPLETED|Overall Study||0
5183245|NCT01134575|12748680|P1|NOT COMPLETED|Overall Study||0
5183246|NCT01134575|12748678|P3|COMPLETED|Overall Study||42
5183247|NCT01134575|12748679|P2|COMPLETED|Overall Study||45
5183248|NCT01134575|12748680|P1|COMPLETED|Overall Study||3
5183249|NCT01134575|12748678|P3|STARTED|Overall Study||42
5183250|NCT01134575|12748679|P2|STARTED|Overall Study||45
5183251|NCT01134575|12748680|P1|STARTED|Overall Study||3
5183252|NCT01134562|12748693|P5|NOT COMPLETED|Overall Study||0
5183253|NCT01134562|12748694|P4|NOT COMPLETED|Overall Study||0
5183254|NCT01134562|12748695|P3|NOT COMPLETED|Overall Study||0
5183255|NCT01134562|12748696|P2|NOT COMPLETED|Overall Study||1
5183256|NCT01134562|12748697|P1|NOT COMPLETED|Overall Study||0
5183257|NCT01134562|12748693|P5|COMPLETED|Overall Study||8
5183258|NCT01134562|12748694|P4|COMPLETED|Overall Study||8
5183259|NCT01134562|12748695|P3|COMPLETED|Overall Study||4
5183260|NCT01134562|12748696|P2|COMPLETED|Overall Study||3
5183261|NCT01134562|12748697|P1|COMPLETED|Overall Study||4
5183262|NCT01134562|12748693|P5|STARTED|Overall Study||8
5183263|NCT01134562|12748694|P4|STARTED|Overall Study||8
5183264|NCT01134562|12748695|P3|STARTED|Overall Study||4
5183265|NCT01134562|12748696|P2|STARTED|Overall Study||4
5183266|NCT01134562|12748697|P1|STARTED|Overall Study||4
5183267|NCT01134549|12748766|P5|NOT COMPLETED|Overall Study||0
5183268|NCT01134549|12748767|P4|NOT COMPLETED|Overall Study||0
5183269|NCT01134549|12748768|P3|NOT COMPLETED|Overall Study||0
5183270|NCT01134549|12748769|P2|NOT COMPLETED|Overall Study||0
5183271|NCT01134549|12748770|P1|NOT COMPLETED|Overall Study||0
5183272|NCT01134549|12748766|P5|COMPLETED|Overall Study||6
5183273|NCT01134549|12748767|P4|COMPLETED|Overall Study||6
5183274|NCT01134549|12748768|P3|COMPLETED|Overall Study||6
5183275|NCT01134549|12748769|P2|COMPLETED|Overall Study||6
5183276|NCT01134549|12748770|P1|COMPLETED|Overall Study||8
5183277|NCT01134549|12748766|P5|STARTED|Overall Study||6
5183278|NCT01134549|12748767|P4|STARTED|Overall Study||6
5183279|NCT01134549|12748768|P3|STARTED|Overall Study||6
5183280|NCT01134549|12748769|P2|STARTED|Overall Study||6
5183281|NCT01134549|12748770|P1|STARTED|Overall Study||8
5183282|NCT01134510|12748856|P2|NOT COMPLETED|Overall Study||1
5183283|NCT01134510|12748857|P1|NOT COMPLETED|Overall Study||0
5183284|NCT01134510|12748856|P2|COMPLETED|Overall Study||9
5183285|NCT01134510|12748857|P1|COMPLETED|Overall Study||10
5183286|NCT01134510|12748856|P2|Month 3|Overall Study||9
5183287|NCT01134510|12748857|P1|Month 3|Overall Study||10
5183288|NCT01134510|12748856|P2|Month 1|Overall Study||10
5183289|NCT01134510|12748857|P1|Month 1|Overall Study||10
5183290|NCT01134510|12748856|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
5183291|NCT01134510|12748857|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
5183292|NCT01134510|12748856|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
5183293|NCT01134510|12748857|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
5183294|NCT01134510|12748856|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
5183295|NCT01134510|12748857|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
5183296|NCT01134510|12748856|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
5183297|NCT01134510|12748857|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
5183298|NCT01134510|12748856|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
5183299|NCT01134510|12748857|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
5183300|NCT01134510|12748856|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
5183301|NCT01134510|12748857|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
5183302|NCT01134510|12748856|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
5183303|NCT01134510|12748857|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
5183304|NCT01134510|12748856|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
5183305|NCT01134510|12748857|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
5183306|NCT01134393|12748869|P1|NOT COMPLETED|Overall Study||52
5183307|NCT01134393|12748869|P1|COMPLETED|Overall Study|Completed trial medication.|449
5183308|NCT01134393|12748869|P1|STARTED|Overall Study|Entered and treated.|501
5183309|NCT01134328|12748887|P4|NOT COMPLETED|Overall Study||4
5183310|NCT01134328|12748888|P3|NOT COMPLETED|Overall Study||3
5183311|NCT01134328|12748889|P2|NOT COMPLETED|Overall Study||3
5183312|NCT01134328|12748890|P1|NOT COMPLETED|Overall Study||2
5183313|NCT01134328|12748887|P4|COMPLETED|Overall Study||17
5183314|NCT01134328|12748888|P3|COMPLETED|Overall Study||17
5183315|NCT01134328|12748889|P2|COMPLETED|Overall Study||18
5183316|NCT01134328|12748890|P1|COMPLETED|Overall Study||19
5183317|NCT01134328|12748887|P4|STARTED|Overall Study||21
5183318|NCT01134328|12748888|P3|STARTED|Overall Study||20
5183319|NCT01134328|12748889|P2|STARTED|Overall Study||21
5183320|NCT01134328|12748890|P1|STARTED|Overall Study||21
5183321|NCT01134315|12748990|P2|NOT COMPLETED|Overall Study||19
5183322|NCT01134315|12748991|P1|NOT COMPLETED|Overall Study||9
5183323|NCT01134315|12748990|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
5183324|NCT01134315|12748991|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
5183325|NCT01134315|12748990|P2|STARTED|Overall Study||40
5183326|NCT01134315|12748991|P1|STARTED|Overall Study||21
5183327|NCT01134276|12749013|P2|NOT COMPLETED|Overall Study||0
5183328|NCT01134276|12749014|P1|NOT COMPLETED|Overall Study||0
5183329|NCT01134276|12749013|P2|COMPLETED|Overall Study||107
5183330|NCT01134276|12749014|P1|COMPLETED|Overall Study||104
5183331|NCT01134276|12749013|P2|STARTED|Overall Study||107
5183332|NCT01134276|12749014|P1|STARTED|Overall Study||104
5183333|NCT01134263|12749029|P5|NOT COMPLETED|Overall Study||9
5183334|NCT01134263|12749030|P4|NOT COMPLETED|Overall Study||19
5183335|NCT01134263|12749031|P3|NOT COMPLETED|Overall Study||29
5183336|NCT01134263|12749032|P2|NOT COMPLETED|Overall Study||20
5183337|NCT01134263|12749033|P1|NOT COMPLETED|Overall Study||24
5183338|NCT01134263|12749029|P5|COMPLETED|Overall Study||48
5183339|NCT01134263|12749030|P4|COMPLETED|Overall Study||149
5183340|NCT01134263|12749031|P3|COMPLETED|Overall Study||134
5183341|NCT01134263|12749032|P2|COMPLETED|Overall Study||143
5183342|NCT01134263|12749033|P1|COMPLETED|Overall Study||140
5183343|NCT01134263|12749029|P5|Safety Population|Overall Study||57
5183344|NCT01134263|12749030|P4|Safety Population|Overall Study||167
5183345|NCT01134263|12749031|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
5183346|NCT01134263|12749032|P2|Safety Population|Overall Study||161
5183347|NCT01134263|12749033|P1|Safety Population|Overall Study||163
5183348|NCT01134263|12749029|P5|Received Vaccination 3|Overall Study||49
5183349|NCT01134263|12749030|P4|Received Vaccination 3|Overall Study||151
5183350|NCT01134263|12749031|P3|Received Vaccination 3|Overall Study||134
5183351|NCT01134263|12749032|P2|Received Vaccination 3|Overall Study||145
5183352|NCT01134263|12749033|P1|Received Vaccination 3|Overall Study||140
5183353|NCT01134263|12749029|P5|Received Vaccination 2|Overall Study||53
5183354|NCT01134263|12749030|P4|Received Vaccination 2|Overall Study||154
5183355|NCT01134263|12749031|P3|Received Vaccination 2|Overall Study||139
5183356|NCT01134263|12749032|P2|Received Vaccination 2|Overall Study||152
5183357|NCT01134263|12749033|P1|Received Vaccination 2|Overall Study||151
5183358|NCT01134263|12749029|P5|Received Vaccination 1|Overall Study||57
5183359|NCT01134263|12749030|P4|Received Vaccination 1|Overall Study||167
5183360|NCT01134263|12749031|P3|Received Vaccination 1|Overall Study||163
5183361|NCT01134263|12749032|P2|Received Vaccination 1|Overall Study||162
5183362|NCT01134263|12749033|P1|Received Vaccination 1|Overall Study||163
5183363|NCT01134263|12749029|P5|STARTED|Overall Study||57
5183364|NCT01134263|12749030|P4|STARTED|Overall Study||168
5183365|NCT01134263|12749031|P3|STARTED|Overall Study||163
5183366|NCT01134263|12749032|P2|STARTED|Overall Study||163
5183367|NCT01134263|12749033|P1|STARTED|Overall Study||164
5183368|NCT01134198|12749057|P2|NOT COMPLETED|Phase 2||4
5183369|NCT01134198|12749058|P1|NOT COMPLETED|Phase 2||0
5183370|NCT01134198|12749057|P2|COMPLETED|Phase 2||7
5183371|NCT01134198|12749058|P1|COMPLETED|Phase 2||9
5183372|NCT01134198|12749057|P2|STARTED|Phase 2||11
5183373|NCT01134198|12749058|P1|STARTED|Phase 2||9
5183374|NCT01134198|12749057|P2|NOT COMPLETED|Phase 1||2
5183375|NCT01134198|12749058|P1|NOT COMPLETED|Phase 1||7
5183376|NCT01134198|12749057|P2|COMPLETED|Phase 1||11
5183377|NCT01134198|12749058|P1|COMPLETED|Phase 1||9
5183378|NCT01134198|12749057|P2|STARTED|Phase 1||13
5183379|NCT01134198|12749058|P1|STARTED|Phase 1||16
5183380|NCT01134107|12749066|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
5183381|NCT01134107|12749067|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
5183382|NCT01134107|12749066|P2|COMPLETED|Period 2-Second Treatment Intervention||61
5183383|NCT01134107|12749067|P1|COMPLETED|Period 2-Second Treatment Intervention||57
5183384|NCT01134107|12749066|P2|STARTED|Period 2-Second Treatment Intervention||61
5183385|NCT01134107|12749067|P1|STARTED|Period 2-Second Treatment Intervention||61
5183386|NCT01134107|12749066|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
5183387|NCT01134107|12749067|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
5183388|NCT01134107|12749066|P2|COMPLETED|Period 1-First Treatment Intervention||61
5183389|NCT01134107|12749067|P1|COMPLETED|Period 1-First Treatment Intervention||61
5183390|NCT01134107|12749066|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
5183391|NCT01134107|12749067|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
5183392|NCT01134107|12749066|P2|STARTED|Period 1-First Treatment Intervention||66
5183393|NCT01134107|12749067|P1|STARTED|Period 1-First Treatment Intervention||67
5183394|NCT01134081|12749099|P1|NOT COMPLETED|Overall Study||0
5183395|NCT01134081|12749099|P1|COMPLETED|Overall Study||44
5183396|NCT01134081|12749099|P1|STARTED|Overall Study||44
5183397|NCT01134055|12749114|P7|NOT COMPLETED|Overall Study||11
5183398|NCT01134055|12749115|P6|NOT COMPLETED|Overall Study||7
5183399|NCT01134055|12749116|P5|NOT COMPLETED|Overall Study||6
5183400|NCT01134055|12749117|P4|NOT COMPLETED|Overall Study||6
5183401|NCT01134055|12749118|P3|NOT COMPLETED|Overall Study||3
5183402|NCT01134055|12749119|P2|NOT COMPLETED|Overall Study||6
5183403|NCT01134055|12749120|P1|NOT COMPLETED|Overall Study||8
5183404|NCT01134055|12749114|P7|COMPLETED|Overall Study||62
5183405|NCT01134055|12749115|P6|COMPLETED|Overall Study||65
5183406|NCT01134055|12749116|P5|COMPLETED|Overall Study||67
5183407|NCT01134055|12749117|P4|COMPLETED|Overall Study||67
5183408|NCT01134055|12749118|P3|COMPLETED|Overall Study||71
5183409|NCT01134055|12749119|P2|COMPLETED|Overall Study||66
5183410|NCT01134055|12749120|P1|COMPLETED|Overall Study||65
5183411|NCT01134055|12749114|P7|STARTED|Overall Study||73
5183412|NCT01134055|12749115|P6|STARTED|Overall Study||72
5183413|NCT01134055|12749116|P5|STARTED|Overall Study||73
5183414|NCT01134055|12749117|P4|STARTED|Overall Study||73
5183415|NCT01134055|12749118|P3|STARTED|Overall Study||74
5183416|NCT01134055|12749119|P2|STARTED|Overall Study||72
5183417|NCT01134055|12749120|P1|STARTED|Overall Study||73
5183418|NCT01134042|12749254|P3|NOT COMPLETED|Overall Study||34
5183419|NCT01134042|12749255|P2|NOT COMPLETED|Overall Study||28
5183420|NCT01134042|12749256|P1|NOT COMPLETED|Overall Study||48
5183421|NCT01134042|12749254|P3|COMPLETED|Overall Study||161
5183422|NCT01134042|12749255|P2|COMPLETED|Overall Study||169
5183423|NCT01134042|12749256|P1|COMPLETED|Overall Study||146
5183424|NCT01134042|12749254|P3|STARTED|Overall Study||195
5183425|NCT01134042|12749255|P2|STARTED|Overall Study||197
5183426|NCT01134042|12749256|P1|STARTED|Overall Study||194
5183427|NCT01134016|12749294|P1|NOT COMPLETED|Overall Study||3
5183428|NCT01134016|12749294|P1|COMPLETED|Overall Study||10
5183429|NCT01134016|12749294|P1|STARTED|Overall Study||13
5183430|NCT01133977|12749332|P5|NOT COMPLETED|Overall Study||38
5183431|NCT01133977|12749333|P4|NOT COMPLETED|Overall Study||39
5183432|NCT01133977|12749334|P3|NOT COMPLETED|Overall Study||6
5183433|NCT01133977|12749335|P2|NOT COMPLETED|Overall Study||7
5183434|NCT01133977|12749336|P1|NOT COMPLETED|Overall Study||3
5183435|NCT01133977|12749332|P5|COMPLETED|Overall Study||1
5183436|NCT01133977|12749333|P4|COMPLETED|Overall Study||3
5183437|NCT01133977|12749334|P3|COMPLETED|Overall Study||0
5183438|NCT01133977|12749335|P2|COMPLETED|Overall Study||0
5183439|NCT01133977|12749336|P1|COMPLETED|Overall Study||0
5183440|NCT01133977|12749332|P5|STARTED|Overall Study|Treated|39
5183441|NCT01133977|12749333|P4|STARTED|Overall Study|Treated|42
5183442|NCT01133977|12749334|P3|STARTED|Overall Study|Treated|6
5183443|NCT01133977|12749335|P2|STARTED|Overall Study|Treated|7
5183444|NCT01133977|12749336|P1|STARTED|Overall Study|Treated|3
5183445|NCT01133860|12749353|P1|NOT COMPLETED|Overall Study||0
5183446|NCT01133860|12749353|P1|COMPLETED|Overall Study||12
5183447|NCT01133860|12749353|P1|STARTED|Overall Study||12
5183448|NCT01133847|12749363|P3|NOT COMPLETED|Follow-Up Phase||7
5183449|NCT01133847|12749364|P2|NOT COMPLETED|Follow-Up Phase||3
5183450|NCT01133847|12749365|P1|NOT COMPLETED|Follow-Up Phase||1
5183451|NCT01133847|12749363|P3|COMPLETED|Follow-Up Phase||60
5183452|NCT01133847|12749364|P2|COMPLETED|Follow-Up Phase||70
5183453|NCT01133847|12749365|P1|COMPLETED|Follow-Up Phase||72
5183454|NCT01133847|12749363|P3|STARTED|Follow-Up Phase||67
5183455|NCT01133847|12749364|P2|STARTED|Follow-Up Phase||73
5183456|NCT01133847|12749365|P1|STARTED|Follow-Up Phase||73
5183457|NCT01133847|12749363|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
5183458|NCT01133847|12749364|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
5183459|NCT01133847|12749365|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
5183460|NCT01133847|12749363|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
5183461|NCT01133847|12749364|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
5183462|NCT01133847|12749365|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
5183463|NCT01133847|12749363|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
5183464|NCT01133847|12749364|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
5183465|NCT01133847|12749365|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
5183466|NCT01133821|12749405|P2|NOT COMPLETED|Overall Study||19
5183467|NCT01133821|12749406|P1|NOT COMPLETED|Overall Study||18
5183468|NCT01133821|12749405|P2|COMPLETED|Overall Study||28
5183469|NCT01133821|12749406|P1|COMPLETED|Overall Study||27
5183470|NCT01133821|12749405|P2|STARTED|Overall Study||47
5183471|NCT01133821|12749406|P1|STARTED|Overall Study||45
5183472|NCT01133756|12749417|P3|NOT COMPLETED|Overall Study||2
5183473|NCT01133756|12749418|P2|NOT COMPLETED|Overall Study||3
5183474|NCT01133756|12749419|P1|NOT COMPLETED|Overall Study||2
5183475|NCT01133756|12749417|P3|COMPLETED|Overall Study||0
5183476|NCT01133756|12749418|P2|COMPLETED|Overall Study||0
5183477|NCT01133756|12749419|P1|COMPLETED|Overall Study||0
5183478|NCT01133756|12749417|P3|Completed 6 Cycles|Overall Study||0
5183479|NCT01133756|12749418|P2|Completed 6 Cycles|Overall Study||0
5183480|NCT01133756|12749419|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
5183481|NCT01133756|12749417|P3|STARTED|Overall Study||2
5183482|NCT01133756|12749418|P2|STARTED|Overall Study||3
5183483|NCT01133756|12749419|P1|STARTED|Overall Study||2
5183484|NCT01133704|12749435|P2|NOT COMPLETED|Overall Study||26
5183485|NCT01133704|12749436|P1|NOT COMPLETED|Overall Study||49
5183486|NCT01133704|12749435|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
5183487|NCT01133704|12749436|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
5183488|NCT01133704|12749435|P2|STARTED|Overall Study||33
5183489|NCT01133704|12749436|P1|STARTED|Overall Study||65
5183490|NCT01133678|12749446|P2|NOT COMPLETED|Overall Study||1
5183491|NCT01133678|12749447|P1|NOT COMPLETED|Overall Study||1
5183492|NCT01133678|12749446|P2|COMPLETED|Overall Study||24
5183493|NCT01133678|12749447|P1|COMPLETED|Overall Study||24
5183494|NCT01133678|12749446|P2|STARTED|Overall Study||25
5183495|NCT01133678|12749447|P1|STARTED|Overall Study||25
5183496|NCT01133665|12749453|P1|NOT COMPLETED|Overall Study||2
5183497|NCT01133665|12749453|P1|COMPLETED|Overall Study||40
5183498|NCT01133665|12749453|P1|STARTED|Overall Study||42
5183499|NCT01133639|12749496|P2|NOT COMPLETED|Overall Study||0
5183500|NCT01133639|12749497|P1|NOT COMPLETED|Overall Study||0
5183501|NCT01133639|12749496|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
5183502|NCT01133639|12749497|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
5183503|NCT01133639|12749496|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
5183504|NCT01133639|12749497|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
5183505|NCT01133626|12749513|P3|NOT COMPLETED|Overall Study||2
5183506|NCT01133626|12749514|P2|NOT COMPLETED|Overall Study||5
5183507|NCT01133626|12749515|P1|NOT COMPLETED|Overall Study||1
5183508|NCT01133626|12749513|P3|COMPLETED|Overall Study||9
5183509|NCT01133626|12749514|P2|COMPLETED|Overall Study||41
5183510|NCT01133626|12749515|P1|COMPLETED|Overall Study||49
5183511|NCT01133626|12749513|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
5183512|NCT01133626|12749514|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
5183513|NCT01133626|12749515|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
5183514|NCT01133626|12749513|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
5183515|NCT01133626|12749514|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
5183516|NCT01133626|12749515|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
5183517|NCT01133626|12749513|P3|STARTED|Overall Study||11
5183518|NCT01133626|12749514|P2|STARTED|Overall Study||46
5183519|NCT01133626|12749515|P1|STARTED|Overall Study||50
5183520|NCT01133522|12749533|P10|NOT COMPLETED|Overall Study||0
5183521|NCT01133522|12749534|P9|NOT COMPLETED|Overall Study||0
5183522|NCT01133522|12749535|P8|NOT COMPLETED|Overall Study||0
5183523|NCT01133522|12749536|P7|NOT COMPLETED|Overall Study||0
5183524|NCT01133522|12749537|P6|NOT COMPLETED|Overall Study||0
5183525|NCT01133522|12749538|P5|NOT COMPLETED|Overall Study||1
5183526|NCT01133522|12749539|P4|NOT COMPLETED|Overall Study||1
5183527|NCT01133522|12749540|P3|NOT COMPLETED|Overall Study||0
5183528|NCT01133522|12749541|P2|NOT COMPLETED|Overall Study||1
5183529|NCT01133522|12749542|P1|NOT COMPLETED|Overall Study||0
5183530|NCT01133522|12749533|P10|COMPLETED|Overall Study||4
5183531|NCT01133522|12749534|P9|COMPLETED|Overall Study||2
5183532|NCT01133522|12749535|P8|COMPLETED|Overall Study||9
5183533|NCT01133522|12749536|P7|COMPLETED|Overall Study||2
5183534|NCT01133522|12749537|P6|COMPLETED|Overall Study||6
5183535|NCT01133522|12749538|P5|COMPLETED|Overall Study||6
5183536|NCT01133522|12749539|P4|COMPLETED|Overall Study||6
5183537|NCT01133522|12749540|P3|COMPLETED|Overall Study||6
5183538|NCT01133522|12749541|P2|COMPLETED|Overall Study||6
5183539|NCT01133522|12749542|P1|COMPLETED|Overall Study||10
5183540|NCT01133522|12749533|P10|Received Treatment|Overall Study||4
5183541|NCT01133522|12749534|P9|Received Treatment|Overall Study||2
5183542|NCT01133522|12749535|P8|Received Treatment|Overall Study||9
5183543|NCT01133522|12749536|P7|Received Treatment|Overall Study||2
5183544|NCT01133522|12749537|P6|Received Treatment|Overall Study||6
5183545|NCT01133522|12749538|P5|Received Treatment|Overall Study||6
5183546|NCT01133522|12749539|P4|Received Treatment|Overall Study||6
5183547|NCT01133522|12749540|P3|Received Treatment|Overall Study||6
5183548|NCT01133522|12749541|P2|Received Treatment|Overall Study||6
5183549|NCT01133522|12749542|P1|Received Treatment|Overall Study||10
5183550|NCT01133522|12749533|P10|STARTED|Overall Study||4
5183551|NCT01133522|12749534|P9|STARTED|Overall Study||2
5183552|NCT01133522|12749535|P8|STARTED|Overall Study||9
5183553|NCT01133522|12749536|P7|STARTED|Overall Study||2
5183554|NCT01133522|12749537|P6|STARTED|Overall Study||6
5183555|NCT01133522|12749538|P5|STARTED|Overall Study||7
5183556|NCT01133522|12749539|P4|STARTED|Overall Study||7
5183557|NCT01133522|12749540|P3|STARTED|Overall Study||6
5183558|NCT01133522|12749541|P2|STARTED|Overall Study||7
5183559|NCT01133522|12749542|P1|STARTED|Overall Study||10
5183560|NCT01133418|12749610|P2|NOT COMPLETED|Overall Study||6
5183561|NCT01133418|12749611|P1|NOT COMPLETED|Overall Study||5
5183562|NCT01133418|12749610|P2|COMPLETED|Overall Study||32
5183563|NCT01133418|12749611|P1|COMPLETED|Overall Study||29
5183564|NCT01133418|12749610|P2|STARTED|Overall Study||38
5183565|NCT01133418|12749611|P1|STARTED|Overall Study||34
5183566|NCT01133405|12749633|P10|NOT COMPLETED|Period 3||0
5183567|NCT01133405|12749634|P9|NOT COMPLETED|Period 3||0
5183568|NCT01133405|12749635|P8|NOT COMPLETED|Period 3||0
5183569|NCT01133405|12749636|P7|NOT COMPLETED|Period 3||0
5183570|NCT01133405|12749637|P6|NOT COMPLETED|Period 3||0
5183571|NCT01133405|12749638|P5|NOT COMPLETED|Period 3||0
5183572|NCT01133405|12749639|P4|NOT COMPLETED|Period 3||0
5183573|NCT01133405|12749640|P3|NOT COMPLETED|Period 3||0
5183574|NCT01133405|12749641|P2|NOT COMPLETED|Period 3||0
5183575|NCT01133405|12749642|P1|NOT COMPLETED|Period 3||0
5183576|NCT01133405|12749633|P10|COMPLETED|Period 3||0
5183577|NCT01133405|12749634|P9|COMPLETED|Period 3||0
5183578|NCT01133405|12749635|P8|COMPLETED|Period 3||0
5183579|NCT01133405|12749636|P7|COMPLETED|Period 3||0
5183580|NCT01133405|12749637|P6|COMPLETED|Period 3||2
5183581|NCT01133405|12749638|P5|COMPLETED|Period 3||3
5183582|NCT01133405|12749639|P4|COMPLETED|Period 3||2
5183583|NCT01133405|12749640|P3|COMPLETED|Period 3||4
5183584|NCT01133405|12749641|P2|COMPLETED|Period 3||4
5183585|NCT01133405|12749642|P1|COMPLETED|Period 3||2
5183586|NCT01133405|12749633|P10|Received at Least 1 Dose of Study Drug|Period 3||0
5183587|NCT01133405|12749634|P9|Received at Least 1 Dose of Study Drug|Period 3||0
5183588|NCT01133405|12749635|P8|Received at Least 1 Dose of Study Drug|Period 3||0
5183589|NCT01133405|12749636|P7|Received at Least 1 Dose of Study Drug|Period 3||0
5183590|NCT01133405|12749637|P6|Received at Least 1 Dose of Study Drug|Period 3||2
5183591|NCT01133405|12749638|P5|Received at Least 1 Dose of Study Drug|Period 3||3
5183592|NCT01133405|12749639|P4|Received at Least 1 Dose of Study Drug|Period 3||2
5183593|NCT01133405|12749640|P3|Received at Least 1 Dose of Study Drug|Period 3||4
5183594|NCT01133405|12749641|P2|Received at Least 1 Dose of Study Drug|Period 3||4
5183595|NCT01133405|12749642|P1|Received at Least 1 Dose of Study Drug|Period 3||2
5183596|NCT01133405|12749633|P10|STARTED|Period 3||0
5183597|NCT01133405|12749634|P9|STARTED|Period 3||0
5183598|NCT01133405|12749635|P8|STARTED|Period 3||0
5183599|NCT01133405|12749636|P7|STARTED|Period 3||0
5183600|NCT01133405|12749637|P6|STARTED|Period 3||2
5183601|NCT01133405|12749638|P5|STARTED|Period 3||3
5183602|NCT01133405|12749639|P4|STARTED|Period 3||2
5183603|NCT01133405|12749640|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
5183604|NCT01133405|12749641|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
5183605|NCT01133405|12749642|P1|STARTED|Period 3||2
5183606|NCT01133405|12749633|P10|NOT COMPLETED|Period 2||0
5183607|NCT01133405|12749634|P9|NOT COMPLETED|Period 2||0
5183608|NCT01133405|12749635|P8|NOT COMPLETED|Period 2||0
5183609|NCT01133405|12749636|P7|NOT COMPLETED|Period 2||0
5183610|NCT01133405|12749637|P6|NOT COMPLETED|Period 2||2
5183611|NCT01133405|12749638|P5|NOT COMPLETED|Period 2||0
5183612|NCT01133405|12749639|P4|NOT COMPLETED|Period 2||1
5183613|NCT01133405|12749640|P3|NOT COMPLETED|Period 2||1
5183614|NCT01133405|12749641|P2|NOT COMPLETED|Period 2||1
5183615|NCT01133405|12749642|P1|NOT COMPLETED|Period 2||0
5183616|NCT01133405|12749633|P10|COMPLETED|Period 2||0
5183617|NCT01133405|12749634|P9|COMPLETED|Period 2||0
5183618|NCT01133405|12749635|P8|COMPLETED|Period 2||0
5183619|NCT01133405|12749636|P7|COMPLETED|Period 2||0
5183620|NCT01133405|12749637|P6|COMPLETED|Period 2||2
5183621|NCT01133405|12749638|P5|COMPLETED|Period 2||3
5183622|NCT01133405|12749639|P4|COMPLETED|Period 2||2
5183623|NCT01133405|12749640|P3|COMPLETED|Period 2||3
5183624|NCT01133405|12749641|P2|COMPLETED|Period 2||3
5183625|NCT01133405|12749642|P1|COMPLETED|Period 2||2
5183626|NCT01133405|12749633|P10|Received at Least 1 Dose of Study Drug|Period 2||0
5183627|NCT01133405|12749634|P9|Received at Least 1 Dose of Study Drug|Period 2||0
5183628|NCT01133405|12749635|P8|Received at Least 1 Dose of Study Drug|Period 2||0
5183629|NCT01133405|12749636|P7|Received at Least 1 Dose of Study Drug|Period 2||0
5183630|NCT01133405|12749637|P6|Received at Least 1 Dose of Study Drug|Period 2||4
5183631|NCT01133405|12749638|P5|Received at Least 1 Dose of Study Drug|Period 2||3
5183632|NCT01133405|12749639|P4|Received at Least 1 Dose of Study Drug|Period 2||3
5183633|NCT01133405|12749640|P3|Received at Least 1 Dose of Study Drug|Period 2||4
5183634|NCT01133405|12749641|P2|Received at Least 1 Dose of Study Drug|Period 2||4
5183635|NCT01133405|12749642|P1|Received at Least 1 Dose of Study Drug|Period 2||2
5183636|NCT01133405|12749633|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
5183637|NCT01133405|12749634|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
5183638|NCT01133405|12749635|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
5183639|NCT01133405|12749636|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
5183640|NCT01133405|12749637|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
5183641|NCT01133405|12749638|P5|STARTED|Period 2||3
5183642|NCT01133405|12749639|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
5183643|NCT01133405|12749640|P3|STARTED|Period 2||4
5183644|NCT01133405|12749641|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
5183645|NCT01133405|12749642|P1|STARTED|Period 2||2
5183646|NCT01133405|12749633|P10|NOT COMPLETED|Period 1||0
5183647|NCT01133405|12749634|P9|NOT COMPLETED|Period 1||0
5183648|NCT01133405|12749635|P8|NOT COMPLETED|Period 1||0
5183649|NCT01133405|12749636|P7|NOT COMPLETED|Period 1||1
5183650|NCT01133405|12749637|P6|NOT COMPLETED|Period 1||2
5183651|NCT01133405|12749638|P5|NOT COMPLETED|Period 1||0
5183652|NCT01133405|12749639|P4|NOT COMPLETED|Period 1||4
5183653|NCT01133405|12749640|P3|NOT COMPLETED|Period 1||1
5183654|NCT01133405|12749641|P2|NOT COMPLETED|Period 1||3
5183655|NCT01133405|12749642|P1|NOT COMPLETED|Period 1||1
5183656|NCT01133405|12749633|P10|COMPLETED|Period 1||2
5183657|NCT01133405|12749634|P9|COMPLETED|Period 1||4
5183658|NCT01133405|12749635|P8|COMPLETED|Period 1||2
5183659|NCT01133405|12749636|P7|COMPLETED|Period 1||4
5183660|NCT01133405|12749637|P6|COMPLETED|Period 1||3
5183661|NCT01133405|12749638|P5|COMPLETED|Period 1||3
5183662|NCT01133405|12749639|P4|COMPLETED|Period 1||1
5183663|NCT01133405|12749640|P3|COMPLETED|Period 1||4
5183664|NCT01133405|12749641|P2|COMPLETED|Period 1||3
5183665|NCT01133405|12749642|P1|COMPLETED|Period 1||2
5183666|NCT01133405|12749633|P10|Received at Least 1 Dose of Drug|Period 1||2
5183667|NCT01133405|12749634|P9|Received at Least 1 Dose of Drug|Period 1||4
5183668|NCT01133405|12749635|P8|Received at Least 1 Dose of Drug|Period 1||2
5183669|NCT01133405|12749636|P7|Received at Least 1 Dose of Drug|Period 1||4
5183670|NCT01133405|12749637|P6|Received at Least 1 Dose of Drug|Period 1||4
5183671|NCT01133405|12749638|P5|Received at Least 1 Dose of Drug|Period 1||3
5183672|NCT01133405|12749639|P4|Received at Least 1 Dose of Drug|Period 1||3
5183673|NCT01133405|12749640|P3|Received at Least 1 Dose of Drug|Period 1||4
5183674|NCT01133405|12749641|P2|Received at Least 1 Dose of Drug|Period 1||4
5183675|NCT01133405|12749642|P1|Received at Least 1 Dose of Drug|Period 1||2
5183676|NCT01133405|12749633|P10|Safety Analysis Population|Period 1||2
5183677|NCT01133405|12749634|P9|Safety Analysis Population|Period 1||4
5183678|NCT01133405|12749635|P8|Safety Analysis Population|Period 1||2
5183679|NCT01133405|12749636|P7|Safety Analysis Population|Period 1||5
5183680|NCT01133405|12749637|P6|Safety Analysis Population|Period 1||5
5183681|NCT01133405|12749638|P5|Safety Analysis Population|Period 1||3
5183682|NCT01133405|12749639|P4|Safety Analysis Population|Period 1||5
5183683|NCT01133405|12749640|P3|Safety Analysis Population|Period 1||5
5183684|NCT01133405|12749641|P2|Safety Analysis Population|Period 1||6
5183685|NCT01133405|12749642|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
5183686|NCT01133405|12749633|P10|STARTED|Period 1||2
5183687|NCT01133405|12749634|P9|STARTED|Period 1||4
5183688|NCT01133405|12749635|P8|STARTED|Period 1||2
5183689|NCT01133405|12749636|P7|STARTED|Period 1||5
5183690|NCT01133405|12749637|P6|STARTED|Period 1||5
5183691|NCT01133405|12749638|P5|STARTED|Period 1||3
5183692|NCT01133405|12749639|P4|STARTED|Period 1||5
5183693|NCT01133405|12749640|P3|STARTED|Period 1||5
5183694|NCT01133405|12749641|P2|STARTED|Period 1||6
5183695|NCT01133405|12749642|P1|STARTED|Period 1||3
5183696|NCT01133392|12749693|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
5183697|NCT01133392|12749694|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
5183698|NCT01133392|12749693|P2|COMPLETED|Fourth Intervention (1 Day)||16
5183699|NCT01133392|12749694|P1|COMPLETED|Fourth Intervention (1 Day)||20
5183700|NCT01133392|12749693|P2|STARTED|Fourth Intervention (1 Day)||16
5183701|NCT01133392|12749694|P1|STARTED|Fourth Intervention (1 Day)||20
5183702|NCT01133392|12749693|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
5183703|NCT01133392|12749694|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
5183704|NCT01133392|12749693|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
5183705|NCT01133392|12749694|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
5183706|NCT01133392|12749693|P2|STARTED|Interval Between Dosing (4-7 Days)||17
5183707|NCT01133392|12749694|P1|STARTED|Interval Between Dosing (4-7 Days)||20
5183708|NCT01133392|12749693|P2|NOT COMPLETED|Third Intervention (1 Day)||0
5183709|NCT01133392|12749694|P1|NOT COMPLETED|Third Intervention (1 Day)||0
5183710|NCT01133392|12749693|P2|COMPLETED|Third Intervention (1 Day)||17
5183711|NCT01133392|12749694|P1|COMPLETED|Third Intervention (1 Day)||20
5183712|NCT01133392|12749693|P2|STARTED|Third Intervention (1 Day)||17
5183713|NCT01133392|12749694|P1|STARTED|Third Intervention (1 Day)||20
5183714|NCT01133392|12749693|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
5183715|NCT01133392|12749694|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
5183716|NCT01133392|12749693|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
5183717|NCT01133392|12749694|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
5183718|NCT01133392|12749693|P2|STARTED|Interval Between Dosing (4-7 Days)||17
5183719|NCT01133392|12749694|P1|STARTED|Interval Between Dosing (4-7 Days)||20
5183720|NCT01133392|12749693|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5183721|NCT01133392|12749694|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5183722|NCT01133392|12749693|P2|COMPLETED|Second Intervention (1 Day)||17
5183723|NCT01133392|12749694|P1|COMPLETED|Second Intervention (1 Day)||20
5183724|NCT01133392|12749693|P2|STARTED|Second Intervention (1 Day)||17
5183725|NCT01133392|12749694|P1|STARTED|Second Intervention (1 Day)||20
5183726|NCT01133392|12749693|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
5183727|NCT01133392|12749694|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
5183728|NCT01133392|12749693|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
5183729|NCT01133392|12749694|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
5183730|NCT01133392|12749693|P2|STARTED|Interval Between Dosing (4-7 Days)||18
5183731|NCT01133392|12749694|P1|STARTED|Interval Between Dosing (4-7 Days)||20
5183732|NCT01133392|12749693|P2|NOT COMPLETED|First Intervention (1 Day )||0
5183733|NCT01133392|12749694|P1|NOT COMPLETED|First Intervention (1 Day )||0
5183734|NCT01133392|12749693|P2|COMPLETED|First Intervention (1 Day )||18
5183735|NCT01133392|12749694|P1|COMPLETED|First Intervention (1 Day )||20
5183736|NCT01133392|12749693|P2|STARTED|First Intervention (1 Day )||18
5183737|NCT01133392|12749694|P1|STARTED|First Intervention (1 Day )||20
5183738|NCT01133379|12749711|P3|NOT COMPLETED|Overall Study||2
5183739|NCT01133379|12749712|P2|NOT COMPLETED|Overall Study||2
5183740|NCT01133379|12749713|P1|NOT COMPLETED|Overall Study||1
5183741|NCT01133379|12749711|P3|COMPLETED|Overall Study||56
5183742|NCT01133379|12749712|P2|COMPLETED|Overall Study||56
5183743|NCT01133379|12749713|P1|COMPLETED|Overall Study||57
5183744|NCT01133379|12749711|P3|STARTED|Overall Study||58
5183745|NCT01133379|12749712|P2|STARTED|Overall Study||58
5183746|NCT01133379|12749713|P1|STARTED|Overall Study||58
5183747|NCT01133288|12749766|P1|NOT COMPLETED|Intervention Allocation||2
5183748|NCT01133288|12749766|P1|COMPLETED|Intervention Allocation||0
5183749|NCT01133288|12749766|P1|STARTED|Intervention Allocation||2
5183750|NCT01133288|12749766|P1|NOT COMPLETED|Eligibility Assessment||5
5183751|NCT01133288|12749766|P1|COMPLETED|Eligibility Assessment||2
5183752|NCT01133288|12749766|P1|STARTED|Eligibility Assessment||7
5183753|NCT01133275|12749771|P1|NOT COMPLETED|Overall Study||2
5183754|NCT01133275|12749771|P1|COMPLETED|Overall Study||26
5183755|NCT01133275|12749771|P1|STARTED|Overall Study||28
5183756|NCT01133171|12749779|P3|NOT COMPLETED|Overall Study||0
5183757|NCT01133171|12749780|P2|NOT COMPLETED|Overall Study||2
5183758|NCT01133171|12749781|P1|NOT COMPLETED|Overall Study||1
5183759|NCT01133171|12749779|P3|COMPLETED|Overall Study||25
5183760|NCT01133171|12749780|P2|COMPLETED|Overall Study||25
5183761|NCT01133171|12749781|P1|COMPLETED|Overall Study||24
5183762|NCT01133171|12749779|P3|STARTED|Overall Study||25
5183763|NCT01133171|12749780|P2|STARTED|Overall Study||27
5183764|NCT01133171|12749781|P1|STARTED|Overall Study||25
5183765|NCT01133158|12749791|P1|NOT COMPLETED|Overall Study||17
5183766|NCT01133158|12749791|P1|COMPLETED|Overall Study||43
5183767|NCT01133158|12749791|P1|STARTED|Overall Study||60
5183768|NCT01133067|12749797|P1|NOT COMPLETED|Overall Study||139
5183769|NCT01133067|12749797|P1|COMPLETED|Overall Study||61
5183770|NCT01133067|12749797|P1|STARTED|Overall Study||200
5183771|NCT01132846|12749805|P3|NOT COMPLETED|Overall Study||11
5183772|NCT01132846|12749806|P2|NOT COMPLETED|Overall Study||18
5183773|NCT01132846|12749807|P1|NOT COMPLETED|Overall Study||16
5183774|NCT01132846|12749805|P3|COMPLETED|Overall Study||108
5183775|NCT01132846|12749806|P2|COMPLETED|Overall Study||101
5183776|NCT01132846|12749807|P1|COMPLETED|Overall Study||106
5183777|NCT01132846|12749805|P3|STARTED|Overall Study||119
5183778|NCT01132846|12749806|P2|STARTED|Overall Study||119
5183779|NCT01132846|12749807|P1|STARTED|Overall Study||122
5183780|NCT01132820|12749857|P1|NOT COMPLETED|Overall Study||5
5183781|NCT01132820|12749857|P1|COMPLETED|Overall Study||48
5183782|NCT01132820|12749857|P1|STARTED|Overall Study||53
5183783|NCT01132755|12749866|P1|NOT COMPLETED|Overall Study||42
5183784|NCT01132755|12749866|P1|COMPLETED|Overall Study||70
5183785|NCT01132755|12749866|P1|STARTED|Overall Study||112
5183786|NCT01132690|12749873|P2|NOT COMPLETED|Overall Study||0
5183787|NCT01132690|12749874|P1|NOT COMPLETED|Overall Study||0
5183788|NCT01132690|12749873|P2|COMPLETED|Overall Study||5
5183789|NCT01132690|12749874|P1|COMPLETED|Overall Study||6
5183790|NCT01132690|12749873|P2|STARTED|Overall Study||5
5183791|NCT01132690|12749874|P1|STARTED|Overall Study||6
5183792|NCT01132664|12749895|P5|NOT COMPLETED|BM Cohort||6
5183793|NCT01132664|12749896|P4|NOT COMPLETED|BM Cohort||3
5183794|NCT01132664|12749897|P3|NOT COMPLETED|BM Cohort||0
5183795|NCT01132664|12749898|P2|NOT COMPLETED|BM Cohort||0
5183796|NCT01132664|12749899|P1|NOT COMPLETED|BM Cohort||0
5183797|NCT01132664|12749895|P5|COMPLETED|BM Cohort||0
5183798|NCT01132664|12749896|P4|COMPLETED|BM Cohort||0
5183799|NCT01132664|12749897|P3|COMPLETED|BM Cohort||0
5183800|NCT01132664|12749898|P2|COMPLETED|BM Cohort||0
5183801|NCT01132664|12749899|P1|COMPLETED|BM Cohort||0
5183802|NCT01132664|12749895|P5|STARTED|BM Cohort||6
5183803|NCT01132664|12749896|P4|STARTED|BM Cohort||3
5183804|NCT01132664|12749897|P3|STARTED|BM Cohort||0
5183805|NCT01132664|12749898|P2|STARTED|BM Cohort||0
5183806|NCT01132664|12749899|P1|STARTED|BM Cohort||0
5183807|NCT01132664|12749895|P5|NOT COMPLETED|Phase ll||0
5183808|NCT01132664|12749896|P4|NOT COMPLETED|Phase ll||0
5183809|NCT01132664|12749897|P3|NOT COMPLETED|Phase ll||50
5183810|NCT01132664|12749898|P2|NOT COMPLETED|Phase ll||0
5183811|NCT01132664|12749899|P1|NOT COMPLETED|Phase ll||0
5183812|NCT01132664|12749895|P5|COMPLETED|Phase ll||0
5183813|NCT01132664|12749896|P4|COMPLETED|Phase ll||0
5183814|NCT01132664|12749897|P3|COMPLETED|Phase ll||0
5183815|NCT01132664|12749898|P2|COMPLETED|Phase ll||0
5183816|NCT01132664|12749899|P1|COMPLETED|Phase ll||0
5183817|NCT01132664|12749895|P5|STARTED|Phase ll||0
5183818|NCT01132664|12749896|P4|STARTED|Phase ll||0
5183819|NCT01132664|12749897|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
5183820|NCT01132664|12749898|P2|STARTED|Phase ll||0
5183821|NCT01132664|12749899|P1|STARTED|Phase ll||0
5183822|NCT01132664|12749895|P5|NOT COMPLETED|Phase lb||0
5183823|NCT01132664|12749896|P4|NOT COMPLETED|Phase lb||0
5183824|NCT01132664|12749897|P3|NOT COMPLETED|Phase lb||0
5183825|NCT01132664|12749898|P2|NOT COMPLETED|Phase lb||12
5183826|NCT01132664|12749899|P1|NOT COMPLETED|Phase lb||5
5183827|NCT01132664|12749895|P5|COMPLETED|Phase lb||0
5183828|NCT01132664|12749896|P4|COMPLETED|Phase lb||0
5183829|NCT01132664|12749897|P3|COMPLETED|Phase lb||0
5183830|NCT01132664|12749898|P2|COMPLETED|Phase lb||0
5183831|NCT01132664|12749899|P1|COMPLETED|Phase lb||0
5183832|NCT01132664|12749895|P5|STARTED|Phase lb||0
5183833|NCT01132664|12749896|P4|STARTED|Phase lb||0
5183834|NCT01132664|12749897|P3|STARTED|Phase lb||0
5183835|NCT01132664|12749898|P2|STARTED|Phase lb||12
5183836|NCT01132664|12749899|P1|STARTED|Phase lb||5
5183837|NCT01132651|12749933|P2|NOT COMPLETED|Overall Study||1
5183838|NCT01132651|12749934|P1|NOT COMPLETED|Overall Study||1
5183839|NCT01132651|12749933|P2|COMPLETED|Overall Study||4
5183840|NCT01132651|12749934|P1|COMPLETED|Overall Study||3
5183841|NCT01132651|12749933|P2|STARTED|Overall Study||5
5183842|NCT01132651|12749934|P1|STARTED|Overall Study||4
5183843|NCT01132612|12749945|P3|NOT COMPLETED|Overall Study||170
5183844|NCT01132612|12749946|P2|NOT COMPLETED|Overall Study||35
5183845|NCT01132612|12749947|P1|NOT COMPLETED|Overall Study||40
5183846|NCT01132612|12749945|P3|COMPLETED|Overall Study||17
5183847|NCT01132612|12749946|P2|COMPLETED|Overall Study||7
5183848|NCT01132612|12749947|P1|COMPLETED|Overall Study||6
5183849|NCT01132612|12749945|P3|STARTED|Overall Study||187
5183850|NCT01132612|12749946|P2|STARTED|Overall Study||42
5183851|NCT01132612|12749947|P1|STARTED|Overall Study||46
5183852|NCT01132547|12749963|P2|NOT COMPLETED|Overall Study||1
5183853|NCT01132547|12749964|P1|NOT COMPLETED|Overall Study||4
5183854|NCT01132547|12749963|P2|COMPLETED|Overall Study||12
5183855|NCT01132547|12749964|P1|COMPLETED|Overall Study||5
5183856|NCT01132547|12749963|P2|STARTED|Overall Study||13
5183857|NCT01132547|12749964|P1|STARTED|Overall Study||9
5183858|NCT01132508|12749974|P1|NOT COMPLETED|Overall Study||9
5183859|NCT01132508|12749974|P1|COMPLETED|Overall Study||24
5183860|NCT01132508|12749974|P1|104 Weeks|Overall Study||27
5183861|NCT01132508|12749974|P1|78 Weeks|Overall Study||28
5183862|NCT01132508|12749974|P1|52 Weeks|Overall Study||30
5183863|NCT01132508|12749974|P1|26 Weeks|Overall Study||33
5183864|NCT01132508|12749974|P1|12 Weeks|Overall Study||33
5183865|NCT01132508|12749974|P1|6 Weeks|Overall Study||33
5183866|NCT01132508|12749974|P1|Treated at Baseline|Overall Study||33
5183867|NCT01132508|12749974|P1|STARTED|Overall Study||33
5183868|NCT01132495|12750034|P4|NOT COMPLETED|Overall Study||12
5183869|NCT01132495|12750035|P3|NOT COMPLETED|Overall Study||20
5183870|NCT01132495|12750036|P2|NOT COMPLETED|Overall Study||38
5183871|NCT01132495|12750037|P1|NOT COMPLETED|Overall Study||40
5183872|NCT01132495|12750034|P4|COMPLETED|Overall Study||104
5183873|NCT01132495|12750035|P3|COMPLETED|Overall Study||146
5183874|NCT01132495|12750036|P2|COMPLETED|Overall Study||403
5183875|NCT01132495|12750037|P1|COMPLETED|Overall Study||407
5183876|NCT01132495|12750034|P4|STARTED|Overall Study||116
5183877|NCT01132495|12750035|P3|STARTED|Overall Study||166
5183878|NCT01132495|12750036|P2|STARTED|Overall Study||441
5183879|NCT01132495|12750037|P1|STARTED|Overall Study||447
5183880|NCT01132482|12750050|P2|NOT COMPLETED|Overall Study||0
5183881|NCT01132482|12750051|P1|NOT COMPLETED|Overall Study||1
5183882|NCT01132482|12750050|P2|COMPLETED|Overall Study||6
5183883|NCT01132482|12750051|P1|COMPLETED|Overall Study||12
5183884|NCT01132482|12750050|P2|STARTED|Overall Study||6
5183885|NCT01132482|12750051|P1|STARTED|Overall Study||13
5183886|NCT01132378|12750069|P1|NOT COMPLETED|Overall Study||0
5183887|NCT01132378|12750069|P1|COMPLETED|Overall Study||40
5183888|NCT01132378|12750069|P1|STARTED|Overall Study||40
5183889|NCT01132326|12750074|P1|NOT COMPLETED|Overall Study||218
5183890|NCT01132326|12750074|P1|COMPLETED|Overall Study||132
5183891|NCT01132326|12750074|P1|STARTED|Overall Study||350
5183892|NCT01132313|12750090|P12|NOT COMPLETED|Overall Study||0
5183893|NCT01132313|12750091|P11|NOT COMPLETED|Overall Study||1
5183894|NCT01132313|12750092|P10|NOT COMPLETED|Overall Study||20
5183895|NCT01132313|12750093|P9|NOT COMPLETED|Overall Study||21
5183896|NCT01132313|12750094|P8|NOT COMPLETED|Overall Study||8
5183897|NCT01132313|12750095|P7|NOT COMPLETED|Overall Study||30
5183898|NCT01132313|12750096|P6|NOT COMPLETED|Overall Study||25
5183899|NCT01132313|12750097|P5|NOT COMPLETED|Overall Study||45
5183900|NCT01132313|12750098|P4|NOT COMPLETED|Overall Study||32
5183901|NCT01132313|12750099|P3|NOT COMPLETED|Overall Study||20
5183902|NCT01132313|12750100|P2|NOT COMPLETED|Overall Study||0
5183903|NCT01132313|12750101|P1|NOT COMPLETED|Overall Study||3
5183904|NCT01132313|12750090|P12|COMPLETED|Overall Study||2
5183905|NCT01132313|12750091|P11|COMPLETED|Overall Study||0
5183906|NCT01132313|12750092|P10|COMPLETED|Overall Study||5
5183907|NCT01132313|12750093|P9|COMPLETED|Overall Study||5
5183908|NCT01132313|12750094|P8|COMPLETED|Overall Study||24
5183909|NCT01132313|12750095|P7|COMPLETED|Overall Study||19
5183910|NCT01132313|12750096|P6|COMPLETED|Overall Study||54
5183911|NCT01132313|12750097|P5|COMPLETED|Overall Study||34
5183912|NCT01132313|12750098|P4|COMPLETED|Overall Study||48
5183913|NCT01132313|12750099|P3|COMPLETED|Overall Study||61
5183914|NCT01132313|12750100|P2|COMPLETED|Overall Study||17
5183915|NCT01132313|12750101|P1|COMPLETED|Overall Study||14
5183916|NCT01132313|12750090|P12|STARTED|Overall Study||2
5183917|NCT01132313|12750091|P11|STARTED|Overall Study||1
5183918|NCT01132313|12750092|P10|STARTED|Overall Study||25
5183919|NCT01132313|12750093|P9|STARTED|Overall Study||26
5183920|NCT01132313|12750094|P8|STARTED|Overall Study||32
5183921|NCT01132313|12750095|P7|STARTED|Overall Study||49
5183922|NCT01132313|12750096|P6|STARTED|Overall Study||79
5183923|NCT01132313|12750097|P5|STARTED|Overall Study||79
5183924|NCT01132313|12750098|P4|STARTED|Overall Study||80
5183925|NCT01132313|12750099|P3|STARTED|Overall Study||81
5183926|NCT01132313|12750100|P2|STARTED|Overall Study||17
5183927|NCT01132313|12750101|P1|STARTED|Overall Study||17
5183928|NCT01132144|12750158|P2|NOT COMPLETED|Overall Study||0
5183929|NCT01132144|12750159|P1|NOT COMPLETED|Overall Study||0
5183930|NCT01132144|12750158|P2|COMPLETED|Overall Study||79
5183931|NCT01132144|12750159|P1|COMPLETED|Overall Study||79
5183932|NCT01132144|12750158|P2|STARTED|Overall Study||79
5183933|NCT01132144|12750159|P1|STARTED|Overall Study||79
5183934|NCT01132118|12750181|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
5183935|NCT01132118|12750182|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
5183936|NCT01132118|12750181|P2|COMPLETED|Second Intervention (8 Weeks)||11
5183937|NCT01132118|12750182|P1|COMPLETED|Second Intervention (8 Weeks)||12
5183938|NCT01132118|12750181|P2|STARTED|Second Intervention (8 Weeks)||12
5183939|NCT01132118|12750182|P1|STARTED|Second Intervention (8 Weeks)||12
5183940|NCT01132118|12750181|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
5183941|NCT01132118|12750182|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
5183942|NCT01132118|12750181|P2|COMPLETED|First Intervention (8 Weeks)||12
5183943|NCT01132118|12750182|P1|COMPLETED|First Intervention (8 Weeks)||12
5183944|NCT01132118|12750181|P2|STARTED|First Intervention (8 Weeks)||15
5183945|NCT01132118|12750182|P1|STARTED|First Intervention (8 Weeks)||15
5183946|NCT01131884|12750202|P2|NOT COMPLETED|Overall Study||0
5183947|NCT01131884|12750203|P1|NOT COMPLETED|Overall Study||0
5183948|NCT01131884|12750202|P2|COMPLETED|Overall Study||0
5183949|NCT01131884|12750203|P1|COMPLETED|Overall Study||1
5183950|NCT01131884|12750202|P2|STARTED|Overall Study||0
5183951|NCT01131884|12750203|P1|STARTED|Overall Study||1
5183952|NCT01131676|12750212|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
5183953|NCT01131676|12750213|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
5183954|NCT01131676|12750214|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
5183955|NCT01131676|12750212|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
5183956|NCT01131676|12750213|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
5183957|NCT01131676|12750214|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
5183958|NCT01131676|12750212|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
5183959|NCT01131676|12750213|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
5183960|NCT01131676|12750214|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
5183961|NCT01131676|12750212|P3|STARTED|Discontinuation From Study (Treated Set)||2342
5183962|NCT01131676|12750213|P2|STARTED|Discontinuation From Study (Treated Set)||2345
5183963|NCT01131676|12750214|P1|STARTED|Discontinuation From Study (Treated Set)||2333
5183964|NCT01131676|12750212|P3|NOT COMPLETED|Discontinuation From Treatment||544
5183965|NCT01131676|12750213|P2|NOT COMPLETED|Discontinuation From Treatment||557
5183966|NCT01131676|12750214|P1|NOT COMPLETED|Discontinuation From Treatment||687
5183967|NCT01131676|12750212|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
5183968|NCT01131676|12750213|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
5183969|NCT01131676|12750214|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
5183970|NCT01131676|12750212|P3|STARTED|Discontinuation From Treatment|Randomised|2344
5183971|NCT01131676|12750213|P2|STARTED|Discontinuation From Treatment|Randomised|2347
5183972|NCT01131676|12750214|P1|STARTED|Discontinuation From Treatment|Randomised|2337
5183973|NCT01131585|12750249|P2|NOT COMPLETED|Overall Study||43
5183974|NCT01131585|12750250|P1|NOT COMPLETED|Overall Study||85
5183975|NCT01131585|12750249|P2|COMPLETED|Overall Study||0
5183976|NCT01131585|12750250|P1|COMPLETED|Overall Study||0
5183977|NCT01131585|12750249|P2|STARTED|Overall Study||43
5183978|NCT01131585|12750250|P1|STARTED|Overall Study||85
5183979|NCT01131520|12750258|P2|NOT COMPLETED|Overall Study||4
5183980|NCT01131520|12750259|P1|NOT COMPLETED|Overall Study||1
5183981|NCT01131520|12750258|P2|COMPLETED|Overall Study||176
5183982|NCT01131520|12750259|P1|COMPLETED|Overall Study||179
5183983|NCT01131520|12750258|P2|STARTED|Overall Study||180
5183984|NCT01131520|12750259|P1|STARTED|Overall Study||180
5183985|NCT01131507|12750281|P1|NOT COMPLETED|Overall Study||3
5183986|NCT01131507|12750281|P1|COMPLETED|Overall Study||12
5183987|NCT01131507|12750281|P1|STARTED|Overall Study||15
5183988|NCT01131494|12750286|P1|NOT COMPLETED|Overall Study||2
5183989|NCT01131494|12750286|P1|COMPLETED|Overall Study||15
5183990|NCT01131494|12750286|P1|STARTED|Overall Study||17
5183991|NCT01131455|12750296|P3|NOT COMPLETED|Overall Study||0
5183992|NCT01131455|12750297|P2|NOT COMPLETED|Overall Study||4
5183993|NCT01131455|12750298|P1|NOT COMPLETED|Overall Study||6
5183994|NCT01131455|12750296|P3|COMPLETED|Overall Study||0
5183995|NCT01131455|12750297|P2|COMPLETED|Overall Study||0
5183996|NCT01131455|12750298|P1|COMPLETED|Overall Study||0
5183997|NCT01131455|12750296|P3|STARTED|Overall Study||0
5183998|NCT01131455|12750297|P2|STARTED|Overall Study||4
5183999|NCT01131455|12750298|P1|STARTED|Overall Study||6
5184000|NCT01131312|12750309|P3|NOT COMPLETED|Overall Study||351
5184001|NCT01131312|12750310|P2|NOT COMPLETED|Overall Study||229
5184002|NCT01131312|12750311|P1|NOT COMPLETED|Overall Study||425
5184003|NCT01131312|12750309|P3|COMPLETED|Overall Study||1485
5184004|NCT01131312|12750310|P2|COMPLETED|Overall Study||1156
5184005|NCT01131312|12750311|P1|COMPLETED|Overall Study||1414
5184006|NCT01131312|12750309|P3|STARTED|Overall Study||1836
5184007|NCT01131312|12750310|P2|STARTED|Overall Study||1385
5184008|NCT01131312|12750311|P1|STARTED|Overall Study||1839
5184009|NCT01131299|12750322|P2|NOT COMPLETED|Overall Study||7
5184010|NCT01131299|12750323|P1|NOT COMPLETED|Overall Study||4
5184011|NCT01131299|12750322|P2|COMPLETED|Overall Study||37
5184012|NCT01131299|12750323|P1|COMPLETED|Overall Study||38
5184013|NCT01131299|12750322|P2|STARTED|Overall Study||44
5184014|NCT01131299|12750323|P1|STARTED|Overall Study||42
5184015|NCT01131260|12750336|P2|NOT COMPLETED|Overall Study||47
5184016|NCT01131260|12750337|P1|NOT COMPLETED|Overall Study||44
5184017|NCT01131260|12750336|P2|COMPLETED|Overall Study||5529
5184018|NCT01131260|12750337|P1|COMPLETED|Overall Study||5488
5184019|NCT01131260|12750336|P2|STARTED|Overall Study||5576
5184020|NCT01131260|12750337|P1|STARTED|Overall Study||5532
5184021|NCT01131182|12750385|P2|NOT COMPLETED|Overall Study||16
5184022|NCT01131182|12750386|P1|NOT COMPLETED|Overall Study||16
5184023|NCT01131182|12750385|P2|COMPLETED|Overall Study||521
5184024|NCT01131182|12750386|P1|COMPLETED|Overall Study||513
5184025|NCT01131182|12750385|P2|STARTED|Overall Study||537
5184026|NCT01131182|12750386|P1|STARTED|Overall Study||529
5184027|NCT01131130|12750394|P1|NOT COMPLETED|Period 3- Crossover||1
5184028|NCT01131130|12750394|P1|COMPLETED|Period 3- Crossover||116
5184029|NCT01131130|12750394|P1|STARTED|Period 3- Crossover||117
5184030|NCT01131130|12750394|P1|NOT COMPLETED|Period 2 - Crossover||0
5184031|NCT01131130|12750394|P1|COMPLETED|Period 2 - Crossover||117
5184032|NCT01131130|12750394|P1|STARTED|Period 2 - Crossover||117
5184033|NCT01131130|12750394|P1|NOT COMPLETED|Period 1 - Baseline||1
5184034|NCT01131130|12750394|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
5184035|NCT01131130|12750394|P1|STARTED|Period 1 - Baseline||118
5184036|NCT01131104|12750407|P1|NOT COMPLETED|Overall Study||13
5184037|NCT01131104|12750407|P1|COMPLETED|Overall Study||332
5184038|NCT01131104|12750407|P1|12-Month Analysis Set|Overall Study||26
5184039|NCT01131104|12750407|P1|42-Day Analysis Set|Overall Study||28
5184040|NCT01131104|12750407|P1|30-Day Analysis Set|Overall Study||24
5184041|NCT01131104|12750407|P1|Adjudication-Confirmed NAION Set|Overall Study||279
5184042|NCT01131104|12750407|P1|Study Set|Overall Study||344
5184043|NCT01131104|12750407|P1|STARTED|Overall Study||345
5184044|NCT01131078|12750414|P3|NOT COMPLETED|Overall Study||102
5184045|NCT01131078|12750415|P2|NOT COMPLETED|Overall Study||101
5184046|NCT01131078|12750416|P1|NOT COMPLETED|Overall Study||101
5184047|NCT01131078|12750414|P3|COMPLETED|Overall Study||1
5184048|NCT01131078|12750415|P2|COMPLETED|Overall Study||1
5184049|NCT01131078|12750416|P1|COMPLETED|Overall Study||0
5184050|NCT01131078|12750414|P3|STARTED|Overall Study||103
5184051|NCT01131078|12750415|P2|STARTED|Overall Study||102
5184052|NCT01131078|12750416|P1|STARTED|Overall Study||101
5184053|NCT01131065|12750472|P1|NOT COMPLETED|Overall Study||0
5184054|NCT01131065|12750472|P1|COMPLETED|Overall Study||15
5184055|NCT01131065|12750472|P1|STARTED|Overall Study||15
5184056|NCT01131052|12750480|P2|NOT COMPLETED|Overall Study||0
5184057|NCT01131052|12750481|P1|NOT COMPLETED|Overall Study||0
5184058|NCT01131052|12750480|P2|COMPLETED|Overall Study||75
5184059|NCT01131052|12750481|P1|COMPLETED|Overall Study||75
5184060|NCT01131052|12750480|P2|STARTED|Overall Study||75
5184061|NCT01131052|12750481|P1|STARTED|Overall Study||75
5184062|NCT01130974|12750503|P2|NOT COMPLETED|Overall Study||13
5184063|NCT01130974|12750504|P1|NOT COMPLETED|Overall Study||15
5184064|NCT01130974|12750503|P2|COMPLETED|Overall Study||87
5184065|NCT01130974|12750504|P1|COMPLETED|Overall Study||85
5184066|NCT01130974|12750503|P2|STARTED|Overall Study||100
5184067|NCT01130974|12750504|P1|STARTED|Overall Study||100
5184068|NCT01130896|12750524|P1|NOT COMPLETED|Overall Study||0
5184069|NCT01130896|12750524|P1|COMPLETED|Overall Study||1509
5184070|NCT01130896|12750524|P1|STARTED|Overall Study||1509
5184071|NCT01130883|12750530|P1|NOT COMPLETED|Overall Study||10
5184072|NCT01130883|12750530|P1|COMPLETED|Overall Study||3120
5184073|NCT01130883|12750530|P1|Participants Analyzed|Overall Study||3128
5184074|NCT01130883|12750530|P1|STARTED|Overall Study||3130
5184075|NCT01130844|12750547|P3|NOT COMPLETED|Overall Study||0
5184076|NCT01130844|12750548|P2|NOT COMPLETED|Overall Study||0
5184077|NCT01130844|12750549|P1|NOT COMPLETED|Overall Study||0
5184078|NCT01130844|12750547|P3|COMPLETED|Overall Study||9
5184079|NCT01130844|12750548|P2|COMPLETED|Overall Study||22
5184080|NCT01130844|12750549|P1|COMPLETED|Overall Study||21
5184081|NCT01130844|12750547|P3|STARTED|Overall Study||9
5184082|NCT01130844|12750548|P2|STARTED|Overall Study||22
5184083|NCT01130844|12750549|P1|STARTED|Overall Study||21
5184084|NCT01130831|12750587|P1|NOT COMPLETED|Overall Study||14
5184085|NCT01130831|12750587|P1|COMPLETED|Overall Study||52
5184086|NCT01130831|12750587|P1|STARTED|Overall Study||66
5184087|NCT01130740|12750615|P2|NOT COMPLETED|Overall Study||15
5184088|NCT01130740|12750616|P1|NOT COMPLETED|Overall Study||12
5184089|NCT01130740|12750615|P2|COMPLETED|Overall Study||136
5184090|NCT01130740|12750616|P1|COMPLETED|Overall Study||137
5184091|NCT01130740|12750615|P2|STARTED|Overall Study||151
5184092|NCT01130740|12750616|P1|STARTED|Overall Study||149
5184093|NCT01130597|12750626|P1|NOT COMPLETED|Overall Study||7
5184094|NCT01130597|12750626|P1|COMPLETED|Overall Study||56
5184095|NCT01130597|12750626|P1|STARTED|Overall Study||63
5184096|NCT01130532|12750651|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
5184097|NCT01130532|12750652|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
5184098|NCT01130532|12750653|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
5184099|NCT01130532|12750654|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
5184100|NCT01130532|12750651|P4|COMPLETED|Period IV (Weeks 13-16)||552
5184101|NCT01130532|12750652|P3|COMPLETED|Period IV (Weeks 13-16)||0
5184102|NCT01130532|12750653|P2|COMPLETED|Period IV (Weeks 13-16)||0
5184103|NCT01130532|12750654|P1|COMPLETED|Period IV (Weeks 13-16)||0
5184104|NCT01130532|12750651|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
5184105|NCT01130532|12750652|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
5184106|NCT01130532|12750653|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
5184107|NCT01130532|12750654|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
5184108|NCT01130532|12750651|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
5184109|NCT01130532|12750652|P3|STARTED|Period IV (Weeks 13-16)||0
5184110|NCT01130532|12750653|P2|STARTED|Period IV (Weeks 13-16)||0
5184111|NCT01130532|12750654|P1|STARTED|Period IV (Weeks 13-16)||0
5184112|NCT01130532|12750651|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
5184113|NCT01130532|12750652|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
5184114|NCT01130532|12750653|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
5184115|NCT01130532|12750654|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
5184116|NCT01130532|12750651|P4|COMPLETED|Period III (Weeks 0-12)||0
5184117|NCT01130532|12750652|P3|COMPLETED|Period III (Weeks 0-12)||190
5184118|NCT01130532|12750653|P2|COMPLETED|Period III (Weeks 0-12)||189
5184119|NCT01130532|12750654|P1|COMPLETED|Period III (Weeks 0-12)||186
5184120|NCT01130532|12750651|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
5184121|NCT01130532|12750652|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
5184122|NCT01130532|12750653|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
5184123|NCT01130532|12750654|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
5184124|NCT01130532|12750651|P4|STARTED|Period III (Weeks 0-12)||0
5184125|NCT01130532|12750652|P3|STARTED|Period III (Weeks 0-12)||209
5184126|NCT01130532|12750653|P2|STARTED|Period III (Weeks 0-12)||207
5184127|NCT01130532|12750654|P1|STARTED|Period III (Weeks 0-12)||207
5184128|NCT01130493|12750699|P3|NOT COMPLETED|Part 2: OLE||5
5184129|NCT01130493|12750700|P2|NOT COMPLETED|Part 2: OLE||3
5184130|NCT01130493|12750701|P1|NOT COMPLETED|Part 2: OLE||0
5184131|NCT01130493|12750699|P3|COMPLETED|Part 2: OLE||30
5184132|NCT01130493|12750700|P2|COMPLETED|Part 2: OLE||36
5184133|NCT01130493|12750701|P1|COMPLETED|Part 2: OLE||0
5184134|NCT01130493|12750699|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
5184135|NCT01130493|12750700|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
5184136|NCT01130493|12750701|P1|STARTED|Part 2: OLE||0
5184137|NCT01130493|12750699|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
5184138|NCT01130493|12750700|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
5184139|NCT01130493|12750701|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
5184140|NCT01130493|12750699|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
5184141|NCT01130493|12750700|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
5184142|NCT01130493|12750701|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
5184143|NCT01130493|12750699|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
5184144|NCT01130493|12750700|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
5184145|NCT01130493|12750701|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
5184146|NCT01130493|12750699|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
5184147|NCT01130493|12750700|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
5184148|NCT01130493|12750701|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
5184149|NCT01130493|12750699|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
5184150|NCT01130493|12750700|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
5184151|NCT01130493|12750701|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
5184152|NCT01130493|12750699|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
5184153|NCT01130493|12750700|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
5184154|NCT01130493|12750701|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
5184155|NCT01130493|12750699|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
5184156|NCT01130493|12750700|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
5184157|NCT01130493|12750701|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
5184158|NCT01130493|12750699|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
5184159|NCT01130493|12750700|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
5184160|NCT01130493|12750701|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
5184161|NCT01130493|12750699|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
5184162|NCT01130493|12750700|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
5184163|NCT01130493|12750701|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
5184164|NCT01130493|12750699|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
5184165|NCT01130493|12750700|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
5184166|NCT01130493|12750701|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
5184167|NCT01130493|12750699|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
5184168|NCT01130493|12750700|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
5184169|NCT01130493|12750701|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
5184170|NCT01130493|12750699|P3|STARTED|Open-label Dose Conversion to IPX066||0
5184171|NCT01130493|12750700|P2|STARTED|Open-label Dose Conversion to IPX066||0
5184172|NCT01130493|12750701|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
5184173|NCT01130337|12750718|P1|NOT COMPLETED|Overall Study||14
5184174|NCT01130337|12750718|P1|COMPLETED|Overall Study||22
5184175|NCT01130337|12750718|P1|STARTED|Overall Study||36
5184176|NCT01130272|12750730|P5|NOT COMPLETED|Overall Study||52
5184177|NCT01130272|12750731|P4|NOT COMPLETED|Overall Study||68
5184178|NCT01130272|12750732|P3|NOT COMPLETED|Overall Study||48
5184179|NCT01130272|12750733|P2|NOT COMPLETED|Overall Study||42
5184180|NCT01130272|12750734|P1|NOT COMPLETED|Overall Study||59
5184181|NCT01130272|12750730|P5|COMPLETED|Overall Study||117
5184182|NCT01130272|12750731|P4|COMPLETED|Overall Study||103
5184183|NCT01130272|12750732|P3|COMPLETED|Overall Study||121
5184184|NCT01130272|12750733|P2|COMPLETED|Overall Study||131
5184185|NCT01130272|12750734|P1|COMPLETED|Overall Study||48
5184186|NCT01130272|12750730|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
5184187|NCT01130272|12750731|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
5184188|NCT01130272|12750732|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
5184189|NCT01130272|12750733|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
5184190|NCT01130272|12750734|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
5184191|NCT01130272|12750730|P5|Safety Analysis Set: as Randomized|Overall Study||162
5184192|NCT01130272|12750731|P4|Safety Analysis Set: as Randomized|Overall Study||167
5184193|NCT01130272|12750732|P3|Safety Analysis Set: as Randomized|Overall Study||166
5184194|NCT01130272|12750733|P2|Safety Analysis Set: as Randomized|Overall Study||171
5184195|NCT01130272|12750734|P1|Safety Analysis Set: as Randomized|Overall Study||105
5184196|NCT01130272|12750730|P5|STARTED|Overall Study||169
5184197|NCT01130272|12750731|P4|STARTED|Overall Study||171
5184198|NCT01130272|12750732|P3|STARTED|Overall Study||169
5184199|NCT01130272|12750733|P2|STARTED|Overall Study||173
5184200|NCT01130272|12750734|P1|STARTED|Overall Study||107
5184201|NCT01130168|12750771|P6|NOT COMPLETED|Period 3||0
5184202|NCT01130168|12750772|P5|NOT COMPLETED|Period 3||0
5184203|NCT01130168|12750773|P4|NOT COMPLETED|Period 3||0
5184204|NCT01130168|12750774|P3|NOT COMPLETED|Period 3||0
5184205|NCT01130168|12750775|P2|NOT COMPLETED|Period 3||0
5184206|NCT01130168|12750776|P1|NOT COMPLETED|Period 3||0
5184207|NCT01130168|12750771|P6|COMPLETED|Period 3||6
5184208|NCT01130168|12750772|P5|COMPLETED|Period 3||5
5184209|NCT01130168|12750773|P4|COMPLETED|Period 3||5
5184210|NCT01130168|12750774|P3|COMPLETED|Period 3||5
5184211|NCT01130168|12750775|P2|COMPLETED|Period 3||6
5184212|NCT01130168|12750776|P1|COMPLETED|Period 3||6
5184213|NCT01130168|12750771|P6|STARTED|Period 3||6
5184214|NCT01130168|12750772|P5|STARTED|Period 3||5
5184215|NCT01130168|12750773|P4|STARTED|Period 3||5
5184216|NCT01130168|12750774|P3|STARTED|Period 3||5
5184217|NCT01130168|12750775|P2|STARTED|Period 3||6
5184218|NCT01130168|12750776|P1|STARTED|Period 3||6
5184219|NCT01130168|12750771|P6|NOT COMPLETED|Period 2||0
5184220|NCT01130168|12750772|P5|NOT COMPLETED|Period 2||0
5184221|NCT01130168|12750773|P4|NOT COMPLETED|Period 2||0
5184222|NCT01130168|12750774|P3|NOT COMPLETED|Period 2||0
5184223|NCT01130168|12750775|P2|NOT COMPLETED|Period 2||0
5184224|NCT01130168|12750776|P1|NOT COMPLETED|Period 2||0
5184225|NCT01130168|12750771|P6|COMPLETED|Period 2||6
5184226|NCT01130168|12750772|P5|COMPLETED|Period 2||5
5184227|NCT01130168|12750773|P4|COMPLETED|Period 2||5
5184228|NCT01130168|12750774|P3|COMPLETED|Period 2||5
5184229|NCT01130168|12750775|P2|COMPLETED|Period 2||6
5184230|NCT01130168|12750776|P1|COMPLETED|Period 2||6
5184231|NCT01130168|12750771|P6|STARTED|Period 2||6
5184232|NCT01130168|12750772|P5|STARTED|Period 2||5
5184233|NCT01130168|12750773|P4|STARTED|Period 2||5
5184234|NCT01130168|12750774|P3|STARTED|Period 2||5
5184235|NCT01130168|12750775|P2|STARTED|Period 2||6
5184236|NCT01130168|12750776|P1|STARTED|Period 2||6
5184237|NCT01130168|12750771|P6|NOT COMPLETED|Period 1||0
5184238|NCT01130168|12750772|P5|NOT COMPLETED|Period 1||0
5184239|NCT01130168|12750773|P4|NOT COMPLETED|Period 1||3
5184240|NCT01130168|12750774|P3|NOT COMPLETED|Period 1||1
5184241|NCT01130168|12750775|P2|NOT COMPLETED|Period 1||1
5184242|NCT01130168|12750776|P1|NOT COMPLETED|Period 1||0
5184243|NCT01130168|12750771|P6|COMPLETED|Period 1||6
5184244|NCT01130168|12750772|P5|COMPLETED|Period 1||5
5184245|NCT01130168|12750773|P4|COMPLETED|Period 1||5
5184246|NCT01130168|12750774|P3|COMPLETED|Period 1||5
5184247|NCT01130168|12750775|P2|COMPLETED|Period 1||6
5184248|NCT01130168|12750776|P1|COMPLETED|Period 1||6
5184249|NCT01130168|12750771|P6|STARTED|Period 1||6
5184250|NCT01130168|12750772|P5|STARTED|Period 1||5
5184251|NCT01130168|12750773|P4|STARTED|Period 1||8
5184252|NCT01130168|12750774|P3|STARTED|Period 1||6
5184253|NCT01130168|12750775|P2|STARTED|Period 1||7
5184254|NCT01130168|12750776|P1|STARTED|Period 1||6
5184255|NCT01130103|12750813|P2|NOT COMPLETED|Maintenance Treatment||2
5184256|NCT01130103|12750814|P1|NOT COMPLETED|Maintenance Treatment||2
5184257|NCT01130103|12750813|P2|COMPLETED|Maintenance Treatment||11
5184258|NCT01130103|12750814|P1|COMPLETED|Maintenance Treatment||11
5184259|NCT01130103|12750813|P2|STARTED|Maintenance Treatment||13
5184260|NCT01130103|12750814|P1|STARTED|Maintenance Treatment||13
5184261|NCT01130103|12750813|P2|NOT COMPLETED|Randomized Treatment||5
5184262|NCT01130103|12750814|P1|NOT COMPLETED|Randomized Treatment||6
5184263|NCT01130103|12750813|P2|COMPLETED|Randomized Treatment||13
5184264|NCT01130103|12750814|P1|COMPLETED|Randomized Treatment||13
5184265|NCT01130103|12750813|P2|STARTED|Randomized Treatment||18
5184266|NCT01130103|12750814|P1|STARTED|Randomized Treatment||19
5184267|NCT01130051|12750828|P2|NOT COMPLETED|Period 2||0
5184268|NCT01130051|12750829|P1|NOT COMPLETED|Period 2||0
5184269|NCT01130051|12750828|P2|COMPLETED|Period 2||6
5184270|NCT01130051|12750829|P1|COMPLETED|Period 2||7
5184271|NCT01130051|12750828|P2|STARTED|Period 2||6
5184272|NCT01130051|12750829|P1|STARTED|Period 2||7
5184273|NCT01130051|12750828|P2|NOT COMPLETED|Washout Period of 14 Days||2
5184274|NCT01130051|12750829|P1|NOT COMPLETED|Washout Period of 14 Days||1
5184275|NCT01130051|12750828|P2|COMPLETED|Washout Period of 14 Days||6
5184276|NCT01130051|12750829|P1|COMPLETED|Washout Period of 14 Days||7
5184277|NCT01130051|12750828|P2|STARTED|Washout Period of 14 Days||8
5184278|NCT01130051|12750829|P1|STARTED|Washout Period of 14 Days||8
5184279|NCT01130051|12750828|P2|NOT COMPLETED|Period 1||0
5184280|NCT01130051|12750829|P1|NOT COMPLETED|Period 1||0
5184281|NCT01130051|12750828|P2|COMPLETED|Period 1||8
5184282|NCT01130051|12750829|P1|COMPLETED|Period 1||8
5184283|NCT01130051|12750828|P2|STARTED|Period 1||8
5184284|NCT01130051|12750829|P1|STARTED|Period 1||8
5184285|NCT01129960|12750843|P4|NOT COMPLETED|Overall Study||13
5184286|NCT01129960|12750844|P3|NOT COMPLETED|Overall Study||26
5184287|NCT01129960|12750845|P2|NOT COMPLETED|Overall Study||22
5184288|NCT01129960|12750846|P1|NOT COMPLETED|Overall Study||30
5184289|NCT01129960|12750843|P4|COMPLETED|Overall Study||70
5184290|NCT01129960|12750844|P3|COMPLETED|Overall Study||56
5184291|NCT01129960|12750845|P2|COMPLETED|Overall Study||61
5184292|NCT01129960|12750846|P1|COMPLETED|Overall Study||54
5184293|NCT01129960|12750843|P4|Full Analysis Set (FAS|Overall Study||71
5184294|NCT01129960|12750844|P3|Full Analysis Set (FAS|Overall Study||68
5184295|NCT01129960|12750845|P2|Full Analysis Set (FAS|Overall Study||67
5184296|NCT01129960|12750846|P1|Full Analysis Set (FAS|Overall Study||71
5184297|NCT01129960|12750843|P4|Per-Protocol|Overall Study||55
5184298|NCT01129960|12750844|P3|Per-Protocol|Overall Study||49
5184299|NCT01129960|12750845|P2|Per-Protocol|Overall Study||52
5184300|NCT01129960|12750846|P1|Per-Protocol|Overall Study||34
5184301|NCT01129960|12750843|P4|Intent-to-Treat|Overall Study||83
5184302|NCT01129960|12750844|P3|Intent-to-Treat|Overall Study||82
5184303|NCT01129960|12750845|P2|Intent-to-Treat|Overall Study||83
5184304|NCT01129960|12750846|P1|Intent-to-Treat|Overall Study||84
5184305|NCT01129960|12750843|P4|Safety|Overall Study||82
5184306|NCT01129960|12750844|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
5184307|NCT01129960|12750845|P2|Safety|Overall Study||83
5184308|NCT01129960|12750846|P1|Safety|Overall Study||84
5184309|NCT01129960|12750843|P4|STARTED|Overall Study||83
5184310|NCT01129960|12750844|P3|STARTED|Overall Study||82
5184311|NCT01129960|12750845|P2|STARTED|Overall Study||83
5184312|NCT01129960|12750846|P1|STARTED|Overall Study||84
5184313|NCT01129921|12750858|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
5184314|NCT01129921|12750859|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
5184315|NCT01129921|12750858|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
5184316|NCT01129921|12750859|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
5184317|NCT01129921|12750858|P2|STARTED|After Sham Cross-over to Mild, One Year||20
5184318|NCT01129921|12750859|P1|STARTED|After Sham Cross-over to Mild, One Year||20
5184319|NCT01129921|12750858|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
5184320|NCT01129921|12750859|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
5184321|NCT01129921|12750858|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
5184322|NCT01129921|12750859|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
5184323|NCT01129921|12750858|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
5184324|NCT01129921|12750859|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
5184325|NCT01129882|12750869|P1|NOT COMPLETED|Overall Study||278
5184326|NCT01129882|12750869|P1|COMPLETED|Overall Study||431
5184327|NCT01129882|12750869|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
5184328|NCT01129882|12750869|P1|STARTED|Overall Study||709
5184329|NCT01129778|12750874|P1|NOT COMPLETED|Overall Study||7
5184330|NCT01129778|12750874|P1|COMPLETED|Overall Study||15
5184331|NCT01129778|12750874|P1|STARTED|Overall Study||22
5184332|NCT01129765|12750879|P1|NOT COMPLETED|Overall Study||0
5184333|NCT01129765|12750879|P1|COMPLETED|Overall Study||30
5184334|NCT01129765|12750879|P1|STARTED|Overall Study||30
5184335|NCT01129622|12750888|P1|NOT COMPLETED|Overall Study||2
5184336|NCT01129622|12750888|P1|COMPLETED|Overall Study||14
5184337|NCT01129622|12750888|P1|STARTED|Overall Study||16
5184338|NCT01129609|12750893|P1|NOT COMPLETED|Overall Study||2
5184339|NCT01129609|12750893|P1|COMPLETED|Overall Study||18
5184340|NCT01129609|12750893|P1|STARTED|Overall Study||20
5184341|NCT01129583|12750899|P2|NOT COMPLETED|Overall Study||2
5184342|NCT01129583|12750900|P1|NOT COMPLETED|Overall Study||3
5184343|NCT01129583|12750899|P2|COMPLETED|Overall Study||7
5184344|NCT01129583|12750900|P1|COMPLETED|Overall Study||6
5184345|NCT01129583|12750899|P2|STARTED|Overall Study||9
5184346|NCT01129583|12750900|P1|STARTED|Overall Study||9
5184347|NCT01129557|12750913|P3|NOT COMPLETED|Overall Study||4
5184348|NCT01129557|12750914|P2|NOT COMPLETED|Overall Study||5
5184349|NCT01129557|12750915|P1|NOT COMPLETED|Overall Study||4
5184350|NCT01129557|12750913|P3|COMPLETED|Overall Study||10
5184351|NCT01129557|12750914|P2|COMPLETED|Overall Study||12
5184352|NCT01129557|12750915|P1|COMPLETED|Overall Study||11
5184353|NCT01129557|12750913|P3|STARTED|Overall Study||14
5184354|NCT01129557|12750914|P2|STARTED|Overall Study||17
5184355|NCT01129557|12750915|P1|STARTED|Overall Study||15
5184356|NCT01129531|12750986|P3|NOT COMPLETED|Treatment Cycle 2||5
5184357|NCT01129531|12750987|P2|NOT COMPLETED|Treatment Cycle 2||3
5184358|NCT01129531|12750988|P1|NOT COMPLETED|Treatment Cycle 2||6
5184359|NCT01129531|12750986|P3|COMPLETED|Treatment Cycle 2||74
5184360|NCT01129531|12750987|P2|COMPLETED|Treatment Cycle 2||92
5184361|NCT01129531|12750988|P1|COMPLETED|Treatment Cycle 2||88
5184362|NCT01129531|12750986|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
5184363|NCT01129531|12750987|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
5184364|NCT01129531|12750988|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
5184365|NCT01129531|12750986|P3|NOT COMPLETED|Treatment Cycle 1||16
5184366|NCT01129531|12750987|P2|NOT COMPLETED|Treatment Cycle 1||6
5184367|NCT01129531|12750988|P1|NOT COMPLETED|Treatment Cycle 1||4
5184368|NCT01129531|12750986|P3|COMPLETED|Treatment Cycle 1||110
5184369|NCT01129531|12750987|P2|COMPLETED|Treatment Cycle 1||78
5184370|NCT01129531|12750988|P1|COMPLETED|Treatment Cycle 1||80
5184371|NCT01129531|12750986|P3|STARTED|Treatment Cycle 1||126
5184372|NCT01129531|12750987|P2|STARTED|Treatment Cycle 1||84
5184373|NCT01129531|12750988|P1|STARTED|Treatment Cycle 1||84
5184374|NCT01129440|12751010|P2|NOT COMPLETED|Overall Study||42
5184375|NCT01129440|12751011|P1|NOT COMPLETED|Overall Study||51
5184376|NCT01129440|12751010|P2|COMPLETED|Overall Study||258
5184377|NCT01129440|12751011|P1|COMPLETED|Overall Study||246
5184378|NCT01129440|12751010|P2|24 Month Follow-up|Overall Study||258
5184379|NCT01129440|12751011|P1|24 Month Follow-up|Overall Study||239
5184380|NCT01129440|12751010|P2|12 Month Follow-up|Overall Study||256
5184381|NCT01129440|12751011|P1|12 Month Follow-up|Overall Study||249
5184382|NCT01129440|12751010|P2|STARTED|Overall Study||300
5184383|NCT01129440|12751011|P1|STARTED|Overall Study||297
5184384|NCT01129336|12751028|P2|NOT COMPLETED|Overall Study||16
5184385|NCT01129336|12751029|P1|NOT COMPLETED|Overall Study||12
5184386|NCT01129336|12751028|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
5184387|NCT01129336|12751029|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
5184388|NCT01129336|12751028|P2|Completed Treatment|Overall Study||3
5184389|NCT01129336|12751029|P1|Completed Treatment|Overall Study||1
5184390|NCT01129336|12751028|P2|STARTED|Overall Study||29
5184391|NCT01129336|12751029|P1|STARTED|Overall Study||15
5184392|NCT01129284|12751044|P3|NOT COMPLETED|Overall Study||1
5184393|NCT01129284|12751045|P2|NOT COMPLETED|Overall Study||0
5184394|NCT01129284|12751046|P1|NOT COMPLETED|Overall Study||2
5184395|NCT01129284|12751044|P3|COMPLETED|Overall Study||4
5184396|NCT01129284|12751045|P2|COMPLETED|Overall Study||5
5184397|NCT01129284|12751046|P1|COMPLETED|Overall Study||3
5184398|NCT01129284|12751044|P3|STARTED|Overall Study||5
5184399|NCT01129284|12751045|P2|STARTED|Overall Study||5
5184400|NCT01129284|12751046|P1|STARTED|Overall Study||5
5184401|NCT01129245|12751059|P2|NOT COMPLETED|Treatment Cycle 2||0
5184402|NCT01129245|12751060|P1|NOT COMPLETED|Treatment Cycle 2||0
5184403|NCT01129245|12751059|P2|COMPLETED|Treatment Cycle 2||10
5184404|NCT01129245|12751060|P1|COMPLETED|Treatment Cycle 2||10
5184405|NCT01129245|12751059|P2|STARTED|Treatment Cycle 2||10
5184406|NCT01129245|12751060|P1|STARTED|Treatment Cycle 2||10
5184407|NCT01129245|12751059|P2|NOT COMPLETED|Washout Cycle||0
5184408|NCT01129245|12751060|P1|NOT COMPLETED|Washout Cycle||0
5184409|NCT01129245|12751059|P2|COMPLETED|Washout Cycle||10
5184410|NCT01129245|12751060|P1|COMPLETED|Washout Cycle||10
5184411|NCT01129245|12751059|P2|STARTED|Washout Cycle||10
5184412|NCT01129245|12751060|P1|STARTED|Washout Cycle||10
5184413|NCT01129245|12751059|P2|NOT COMPLETED|Treatment Cycle 1||0
5184414|NCT01129245|12751060|P1|NOT COMPLETED|Treatment Cycle 1||0
5184415|NCT01129245|12751059|P2|COMPLETED|Treatment Cycle 1||10
5184416|NCT01129245|12751060|P1|COMPLETED|Treatment Cycle 1||10
5184417|NCT01129245|12751059|P2|STARTED|Treatment Cycle 1||10
5184418|NCT01129245|12751060|P1|STARTED|Treatment Cycle 1||10
5184419|NCT01129245|12751059|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
5184420|NCT01129245|12751060|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
5184421|NCT01129245|12751059|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
5184422|NCT01129245|12751060|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
5184423|NCT01129245|12751059|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
5184424|NCT01129245|12751060|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
5184425|NCT01129206|12751074|P1|NOT COMPLETED|Overall Study||0
5184426|NCT01129206|12751074|P1|COMPLETED|Overall Study||6
5184427|NCT01129206|12751074|P1|STARTED|Overall Study||6
5184428|NCT01129141|12751084|P2|NOT COMPLETED|Overall Study||13
5184429|NCT01129141|12751085|P1|NOT COMPLETED|Overall Study||15
5184430|NCT01129141|12751084|P2|COMPLETED|Overall Study||91
5184431|NCT01129141|12751085|P1|COMPLETED|Overall Study||86
5184432|NCT01129141|12751084|P2|STARTED|Overall Study||104
5184433|NCT01129141|12751085|P1|STARTED|Overall Study||101
5184434|NCT01129128|12751094|P3|NOT COMPLETED|Overall Study||4
5184435|NCT01129128|12751095|P2|NOT COMPLETED|Overall Study||4
5184436|NCT01129128|12751096|P1|NOT COMPLETED|Overall Study||3
5184437|NCT01129128|12751094|P3|COMPLETED|Overall Study||19
5184438|NCT01129128|12751095|P2|COMPLETED|Overall Study||18
5184439|NCT01129128|12751096|P1|COMPLETED|Overall Study||19
5184440|NCT01129128|12751094|P3|STARTED|Overall Study||23
5184441|NCT01129128|12751095|P2|STARTED|Overall Study||22
5184442|NCT01129128|12751096|P1|STARTED|Overall Study||22
5184443|NCT01129115|12751120|P4|NOT COMPLETED|Overall Study||9
5184444|NCT01129115|12751121|P3|NOT COMPLETED|Overall Study||6
5184445|NCT01129115|12751122|P2|NOT COMPLETED|Overall Study||7
5184446|NCT01129115|12751123|P1|NOT COMPLETED|Overall Study||2
5184447|NCT01129115|12751120|P4|COMPLETED|Overall Study||15
5184448|NCT01129115|12751121|P3|COMPLETED|Overall Study||21
5184449|NCT01129115|12751122|P2|COMPLETED|Overall Study||18
5184450|NCT01129115|12751123|P1|COMPLETED|Overall Study||23
5184451|NCT01129115|12751120|P4|STARTED|Overall Study||24
5184452|NCT01129115|12751121|P3|STARTED|Overall Study||27
5184453|NCT01129115|12751122|P2|STARTED|Overall Study||25
5184454|NCT01129115|12751123|P1|STARTED|Overall Study||25
5184455|NCT01129102|12751160|P3|NOT COMPLETED|Overall Study||7
5184456|NCT01129102|12751161|P2|NOT COMPLETED|Overall Study||6
5184457|NCT01129102|12751162|P1|NOT COMPLETED|Overall Study||8
5184458|NCT01129102|12751160|P3|COMPLETED|Overall Study||48
5184459|NCT01129102|12751161|P2|COMPLETED|Overall Study||44
5184460|NCT01129102|12751162|P1|COMPLETED|Overall Study||102
5184461|NCT01129102|12751160|P3|STARTED|Overall Study||55
5184462|NCT01129102|12751161|P2|STARTED|Overall Study||50
5184463|NCT01129102|12751162|P1|STARTED|Overall Study||110
5184464|NCT01129011|12751173|P2|NOT COMPLETED|Overall Study||57
5184465|NCT01129011|12751174|P1|NOT COMPLETED|Overall Study||59
5184466|NCT01129011|12751173|P2|COMPLETED|Overall Study||153
5184467|NCT01129011|12751174|P1|COMPLETED|Overall Study||151
5184468|NCT01129011|12751173|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
5184469|NCT01129011|12751174|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
5184470|NCT01128972|12751196|P5|NOT COMPLETED|Period V||0
5184471|NCT01128972|12751197|P4|NOT COMPLETED|Period V||0
5184472|NCT01128972|12751198|P3|NOT COMPLETED|Period V||0
5184473|NCT01128972|12751199|P2|NOT COMPLETED|Period V||0
5184474|NCT01128972|12751200|P1|NOT COMPLETED|Period V||0
5184475|NCT01128972|12751196|P5|COMPLETED|Period V||7
5184476|NCT01128972|12751197|P4|COMPLETED|Period V||7
5184477|NCT01128972|12751198|P3|COMPLETED|Period V||7
5184478|NCT01128972|12751199|P2|COMPLETED|Period V||7
5184479|NCT01128972|12751200|P1|COMPLETED|Period V||8
5184480|NCT01128972|12751196|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
5184481|NCT01128972|12751197|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
5184482|NCT01128972|12751198|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
5184483|NCT01128972|12751199|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
5184484|NCT01128972|12751200|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
5184485|NCT01128972|12751196|P5|NOT COMPLETED|Period IV||0
5184486|NCT01128972|12751197|P4|NOT COMPLETED|Period IV||0
5184487|NCT01128972|12751198|P3|NOT COMPLETED|Period IV||0
5184488|NCT01128972|12751199|P2|NOT COMPLETED|Period IV||0
5184489|NCT01128972|12751200|P1|NOT COMPLETED|Period IV||0
5184490|NCT01128972|12751196|P5|COMPLETED|Period IV||7
5184491|NCT01128972|12751197|P4|COMPLETED|Period IV||7
5184492|NCT01128972|12751198|P3|COMPLETED|Period IV||7
5184493|NCT01128972|12751199|P2|COMPLETED|Period IV||8
5184494|NCT01128972|12751200|P1|COMPLETED|Period IV||7
5184495|NCT01128972|12751196|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
5184496|NCT01128972|12751197|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
5184497|NCT01128972|12751198|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
5184498|NCT01128972|12751199|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
5184499|NCT01128972|12751200|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
5184500|NCT01128972|12751196|P5|NOT COMPLETED|Period III||0
5184501|NCT01128972|12751197|P4|NOT COMPLETED|Period III||0
5184502|NCT01128972|12751198|P3|NOT COMPLETED|Period III||0
5184503|NCT01128972|12751199|P2|NOT COMPLETED|Period III||0
5184504|NCT01128972|12751200|P1|NOT COMPLETED|Period III||0
5184505|NCT01128972|12751196|P5|COMPLETED|Period III||7
5184506|NCT01128972|12751197|P4|COMPLETED|Period III||7
5184507|NCT01128972|12751198|P3|COMPLETED|Period III||8
5184508|NCT01128972|12751199|P2|COMPLETED|Period III||7
5184509|NCT01128972|12751200|P1|COMPLETED|Period III||7
5184510|NCT01128972|12751196|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
5184511|NCT01128972|12751197|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
5184512|NCT01128972|12751198|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
5184513|NCT01128972|12751199|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
5184514|NCT01128972|12751200|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
5184515|NCT01128972|12751196|P5|NOT COMPLETED|Period II||0
5184516|NCT01128972|12751197|P4|NOT COMPLETED|Period II||0
5184517|NCT01128972|12751198|P3|NOT COMPLETED|Period II||0
5184518|NCT01128972|12751199|P2|NOT COMPLETED|Period II||0
5184519|NCT01128972|12751200|P1|NOT COMPLETED|Period II||0
5184520|NCT01128972|12751196|P5|COMPLETED|Period II||7
5184521|NCT01128972|12751197|P4|COMPLETED|Period II||8
5184522|NCT01128972|12751198|P3|COMPLETED|Period II||7
5184523|NCT01128972|12751199|P2|COMPLETED|Period II||7
5184524|NCT01128972|12751200|P1|COMPLETED|Period II||7
5184525|NCT01128972|12751196|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
5184526|NCT01128972|12751197|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
5184527|NCT01128972|12751198|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
5184528|NCT01128972|12751199|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
5184529|NCT01128972|12751200|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
5184530|NCT01128972|12751196|P5|NOT COMPLETED|Period I||0
5184531|NCT01128972|12751197|P4|NOT COMPLETED|Period I||0
5184532|NCT01128972|12751198|P3|NOT COMPLETED|Period I||0
5184533|NCT01128972|12751199|P2|NOT COMPLETED|Period I||0
5184534|NCT01128972|12751200|P1|NOT COMPLETED|Period I||0
5184535|NCT01128972|12751196|P5|COMPLETED|Period I||8
5184536|NCT01128972|12751197|P4|COMPLETED|Period I||7
5184537|NCT01128972|12751198|P3|COMPLETED|Period I||7
5184538|NCT01128972|12751199|P2|COMPLETED|Period I||7
5184539|NCT01128972|12751200|P1|COMPLETED|Period I||7
5184540|NCT01128972|12751196|P5|STARTED|Period I||8
5184541|NCT01128972|12751197|P4|STARTED|Period I||7
5184542|NCT01128972|12751198|P3|STARTED|Period I||7
5184543|NCT01128972|12751199|P2|STARTED|Period I||7
5184544|NCT01128972|12751200|P1|STARTED|Period I||7
5184545|NCT01128959|12751229|P1|NOT COMPLETED|Treatment Period||4
5184546|NCT01128959|12751229|P1|COMPLETED|Treatment Period||101
5184547|NCT01128959|12751229|P1|STARTED|Treatment Period||105
5184548|NCT01128959|12751229|P1|NOT COMPLETED|Lead in Period||3
5184549|NCT01128959|12751229|P1|COMPLETED|Lead in Period||105
5184550|NCT01128959|12751229|P1|STARTED|Lead in Period||108
5184551|NCT01128946|12751235|P4|NOT COMPLETED|Period IV||0
5184552|NCT01128946|12751236|P3|NOT COMPLETED|Period IV||0
5184553|NCT01128946|12751237|P2|NOT COMPLETED|Period IV||0
5184554|NCT01128946|12751238|P1|NOT COMPLETED|Period IV||0
5184555|NCT01128946|12751235|P4|COMPLETED|Period IV||19
5184556|NCT01128946|12751236|P3|COMPLETED|Period IV||19
5184557|NCT01128946|12751237|P2|COMPLETED|Period IV||20
5184558|NCT01128946|12751238|P1|COMPLETED|Period IV||19
5184559|NCT01128946|12751235|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
5184560|NCT01128946|12751236|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
5184561|NCT01128946|12751237|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
5184562|NCT01128946|12751238|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
5184563|NCT01128946|12751235|P4|NOT COMPLETED|Period III||0
5184564|NCT01128946|12751236|P3|NOT COMPLETED|Period III||0
5184565|NCT01128946|12751237|P2|NOT COMPLETED|Period III||0
5184566|NCT01128946|12751238|P1|NOT COMPLETED|Period III||1
5184567|NCT01128946|12751235|P4|COMPLETED|Period III||19
5184568|NCT01128946|12751236|P3|COMPLETED|Period III||20
5184569|NCT01128946|12751237|P2|COMPLETED|Period III||19
5184570|NCT01128946|12751238|P1|COMPLETED|Period III||19
5184571|NCT01128946|12751235|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
5184572|NCT01128946|12751236|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
5184573|NCT01128946|12751237|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
5184574|NCT01128946|12751238|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
5184575|NCT01128946|12751235|P4|NOT COMPLETED|Period II||1
5184576|NCT01128946|12751236|P3|NOT COMPLETED|Period II||0
5184577|NCT01128946|12751237|P2|NOT COMPLETED|Period II||1
5184578|NCT01128946|12751238|P1|NOT COMPLETED|Period II||0
5184579|NCT01128946|12751235|P4|COMPLETED|Period II||19
5184580|NCT01128946|12751236|P3|COMPLETED|Period II||20
5184581|NCT01128946|12751237|P2|COMPLETED|Period II||19
5184582|NCT01128946|12751238|P1|COMPLETED|Period II||20
5184583|NCT01128946|12751235|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
5184584|NCT01128946|12751236|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
5184585|NCT01128946|12751237|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
5184586|NCT01128946|12751238|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
5184587|NCT01128946|12751235|P4|NOT COMPLETED|Period I||1
5184588|NCT01128946|12751236|P3|NOT COMPLETED|Period I||1
5184589|NCT01128946|12751237|P2|NOT COMPLETED|Period I||1
5184590|NCT01128946|12751238|P1|NOT COMPLETED|Period I||0
5184591|NCT01128946|12751235|P4|COMPLETED|Period I||20
5184592|NCT01128946|12751236|P3|COMPLETED|Period I||20
5184593|NCT01128946|12751237|P2|COMPLETED|Period I||20
5184594|NCT01128946|12751238|P1|COMPLETED|Period I||20
5184595|NCT01128946|12751235|P4|STARTED|Period I||21
5184596|NCT01128946|12751236|P3|STARTED|Period I||21
5184597|NCT01128946|12751237|P2|STARTED|Period I||21
5184598|NCT01128946|12751238|P1|STARTED|Period I||20
5184599|NCT01128894|12751256|P2|NOT COMPLETED|Overall Study||68
5184600|NCT01128894|12751257|P1|NOT COMPLETED|Overall Study||58
5184601|NCT01128894|12751256|P2|COMPLETED|Overall Study||340
5184602|NCT01128894|12751257|P1|COMPLETED|Overall Study||346
5184603|NCT01128894|12751256|P2|STARTED|Overall Study||408
5184604|NCT01128894|12751257|P1|STARTED|Overall Study||404
5184605|NCT01128842|12751275|P1|NOT COMPLETED|Overall Study||7
5184606|NCT01128842|12751275|P1|COMPLETED|Overall Study||0
5184607|NCT01128842|12751275|P1|STARTED|Overall Study||7
5184608|NCT01128829|12751285|P2|NOT COMPLETED|Overall Study||0
5184609|NCT01128829|12751286|P1|NOT COMPLETED|Overall Study||0
5184610|NCT01128829|12751285|P2|COMPLETED|Overall Study||11
5184611|NCT01128829|12751286|P1|COMPLETED|Overall Study||6
5184612|NCT01128829|12751285|P2|STARTED|Overall Study||11
5184613|NCT01128829|12751286|P1|STARTED|Overall Study||6
5184614|NCT01128738|12751292|P2|NOT COMPLETED|Second TP||3
5184615|NCT01128738|12751293|P1|NOT COMPLETED|Second TP||0
5184616|NCT01128738|12751292|P2|COMPLETED|Second TP||63
5184617|NCT01128738|12751293|P1|COMPLETED|Second TP||34
5184618|NCT01128738|12751292|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
5184619|NCT01128738|12751293|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
5184620|NCT01128738|12751292|P2|NOT COMPLETED|First Treatment Phase (TP)||1
5184621|NCT01128738|12751293|P1|NOT COMPLETED|First Treatment Phase (TP)||4
5184622|NCT01128738|12751292|P2|COMPLETED|First Treatment Phase (TP)||73
5184623|NCT01128738|12751293|P1|COMPLETED|First Treatment Phase (TP)||74
5184624|NCT01128738|12751292|P2|STARTED|First Treatment Phase (TP)||74
5184625|NCT01128738|12751293|P1|STARTED|First Treatment Phase (TP)||78
5184626|NCT01128621|12751418|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
5184627|NCT01128621|12751419|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
5184628|NCT01128621|12751418|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
5184629|NCT01128621|12751419|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
5184630|NCT01128621|12751418|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
5184631|NCT01128621|12751419|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
5184632|NCT01128621|12751418|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
5184633|NCT01128621|12751419|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
5184634|NCT01128621|12751418|P2|COMPLETED|Part A: GSK1292263 300 mg||0
5184635|NCT01128621|12751419|P1|COMPLETED|Part A: GSK1292263 300 mg||6
5184636|NCT01128621|12751418|P2|STARTED|Part A: GSK1292263 300 mg||0
5184637|NCT01128621|12751419|P1|STARTED|Part A: GSK1292263 300 mg||6
5184638|NCT01128595|12751540|P4|NOT COMPLETED|Treatment Period 4||0
5184639|NCT01128595|12751541|P3|NOT COMPLETED|Treatment Period 4||0
5184640|NCT01128595|12751542|P2|NOT COMPLETED|Treatment Period 4||0
5184641|NCT01128595|12751543|P1|NOT COMPLETED|Treatment Period 4||0
5184642|NCT01128595|12751540|P4|COMPLETED|Treatment Period 4||7
5184643|NCT01128595|12751541|P3|COMPLETED|Treatment Period 4||7
5184644|NCT01128595|12751542|P2|COMPLETED|Treatment Period 4||5
5184645|NCT01128595|12751543|P1|COMPLETED|Treatment Period 4||7
5184646|NCT01128595|12751540|P4|STARTED|Treatment Period 4||7
5184647|NCT01128595|12751541|P3|STARTED|Treatment Period 4||7
5184648|NCT01128595|12751542|P2|STARTED|Treatment Period 4||5
5184649|NCT01128595|12751543|P1|STARTED|Treatment Period 4||7
5184650|NCT01128595|12751540|P4|NOT COMPLETED|Washout Period 3||0
5184651|NCT01128595|12751541|P3|NOT COMPLETED|Washout Period 3||0
5184652|NCT01128595|12751542|P2|NOT COMPLETED|Washout Period 3||0
5184653|NCT01128595|12751543|P1|NOT COMPLETED|Washout Period 3||0
5184654|NCT01128595|12751540|P4|COMPLETED|Washout Period 3||7
5184655|NCT01128595|12751541|P3|COMPLETED|Washout Period 3||7
5184656|NCT01128595|12751542|P2|COMPLETED|Washout Period 3||5
5184657|NCT01128595|12751543|P1|COMPLETED|Washout Period 3||7
5184658|NCT01128595|12751540|P4|STARTED|Washout Period 3||7
5184659|NCT01128595|12751541|P3|STARTED|Washout Period 3||7
5184660|NCT01128595|12751542|P2|STARTED|Washout Period 3||5
5184661|NCT01128595|12751543|P1|STARTED|Washout Period 3||7
5184662|NCT01128595|12751540|P4|NOT COMPLETED|Treatment Period 3||0
5184663|NCT01128595|12751541|P3|NOT COMPLETED|Treatment Period 3||0
5184664|NCT01128595|12751542|P2|NOT COMPLETED|Treatment Period 3||1
5184665|NCT01128595|12751543|P1|NOT COMPLETED|Treatment Period 3||0
5184666|NCT01128595|12751540|P4|COMPLETED|Treatment Period 3||7
5184667|NCT01128595|12751541|P3|COMPLETED|Treatment Period 3||7
5184668|NCT01128595|12751542|P2|COMPLETED|Treatment Period 3||5
5184669|NCT01128595|12751543|P1|COMPLETED|Treatment Period 3||7
5184670|NCT01128595|12751540|P4|STARTED|Treatment Period 3||7
5184671|NCT01128595|12751541|P3|STARTED|Treatment Period 3||7
5184672|NCT01128595|12751542|P2|STARTED|Treatment Period 3||6
5184673|NCT01128595|12751543|P1|STARTED|Treatment Period 3||7
5184674|NCT01128595|12751540|P4|NOT COMPLETED|Washout Period 2||0
5184675|NCT01128595|12751541|P3|NOT COMPLETED|Washout Period 2||0
5184676|NCT01128595|12751542|P2|NOT COMPLETED|Washout Period 2||0
5184677|NCT01128595|12751543|P1|NOT COMPLETED|Washout Period 2||0
5184678|NCT01128595|12751540|P4|COMPLETED|Washout Period 2||7
5184679|NCT01128595|12751541|P3|COMPLETED|Washout Period 2||7
5184680|NCT01128595|12751542|P2|COMPLETED|Washout Period 2||6
5184681|NCT01128595|12751543|P1|COMPLETED|Washout Period 2||7
5184682|NCT01128595|12751540|P4|STARTED|Washout Period 2||7
5184683|NCT01128595|12751541|P3|STARTED|Washout Period 2||7
5184684|NCT01128595|12751542|P2|STARTED|Washout Period 2||6
5184685|NCT01128595|12751543|P1|STARTED|Washout Period 2||7
5184686|NCT01128595|12751540|P4|NOT COMPLETED|Treatment Period 2||0
5184687|NCT01128595|12751541|P3|NOT COMPLETED|Treatment Period 2||0
5184688|NCT01128595|12751542|P2|NOT COMPLETED|Treatment Period 2||0
5184689|NCT01128595|12751543|P1|NOT COMPLETED|Treatment Period 2||0
5184690|NCT01128595|12751540|P4|COMPLETED|Treatment Period 2||7
5184691|NCT01128595|12751541|P3|COMPLETED|Treatment Period 2||7
5184692|NCT01128595|12751542|P2|COMPLETED|Treatment Period 2||6
5184693|NCT01128595|12751543|P1|COMPLETED|Treatment Period 2||7
5184694|NCT01128595|12751540|P4|STARTED|Treatment Period 2||7
5184695|NCT01128595|12751541|P3|STARTED|Treatment Period 2||7
5184696|NCT01128595|12751542|P2|STARTED|Treatment Period 2||6
5184697|NCT01128595|12751543|P1|STARTED|Treatment Period 2||7
5184698|NCT01128595|12751540|P4|NOT COMPLETED|Washout Period 1||0
5184699|NCT01128595|12751541|P3|NOT COMPLETED|Washout Period 1||0
5184700|NCT01128595|12751542|P2|NOT COMPLETED|Washout Period 1||0
5184701|NCT01128595|12751543|P1|NOT COMPLETED|Washout Period 1||0
5184702|NCT01128595|12751540|P4|COMPLETED|Washout Period 1||7
5184703|NCT01128595|12751541|P3|COMPLETED|Washout Period 1||7
5184704|NCT01128595|12751542|P2|COMPLETED|Washout Period 1||6
5184705|NCT01128595|12751543|P1|COMPLETED|Washout Period 1||7
5184706|NCT01128595|12751540|P4|STARTED|Washout Period 1||7
5184707|NCT01128595|12751541|P3|STARTED|Washout Period 1||7
5184708|NCT01128595|12751542|P2|STARTED|Washout Period 1||6
5184709|NCT01128595|12751543|P1|STARTED|Washout Period 1||7
5184710|NCT01128595|12751540|P4|NOT COMPLETED|Treatment Period 1||0
5184711|NCT01128595|12751541|P3|NOT COMPLETED|Treatment Period 1||0
5184712|NCT01128595|12751542|P2|NOT COMPLETED|Treatment Period 1||0
5184713|NCT01128595|12751543|P1|NOT COMPLETED|Treatment Period 1||0
5184714|NCT01128595|12751540|P4|COMPLETED|Treatment Period 1||7
5184715|NCT01128595|12751541|P3|COMPLETED|Treatment Period 1||7
5184716|NCT01128595|12751542|P2|COMPLETED|Treatment Period 1||6
5184717|NCT01128595|12751543|P1|COMPLETED|Treatment Period 1||7
5184718|NCT01128595|12751540|P4|STARTED|Treatment Period 1||7
5184719|NCT01128595|12751541|P3|STARTED|Treatment Period 1||7
5184720|NCT01128595|12751542|P2|STARTED|Treatment Period 1||6
5184721|NCT01128595|12751543|P1|STARTED|Treatment Period 1||7
5184722|NCT01128569|12751573|P6|NOT COMPLETED|Treatment Period 3||0
5184723|NCT01128569|12751574|P5|NOT COMPLETED|Treatment Period 3||0
5184724|NCT01128569|12751575|P4|NOT COMPLETED|Treatment Period 3||0
5184725|NCT01128569|12751576|P3|NOT COMPLETED|Treatment Period 3||0
5184726|NCT01128569|12751577|P2|NOT COMPLETED|Treatment Period 3||0
5184727|NCT01128569|12751578|P1|NOT COMPLETED|Treatment Period 3||0
5184728|NCT01128569|12751573|P6|COMPLETED|Treatment Period 3||9
5184729|NCT01128569|12751574|P5|COMPLETED|Treatment Period 3||9
5184730|NCT01128569|12751575|P4|COMPLETED|Treatment Period 3||8
5184731|NCT01128569|12751576|P3|COMPLETED|Treatment Period 3||8
5184732|NCT01128569|12751577|P2|COMPLETED|Treatment Period 3||7
5184733|NCT01128569|12751578|P1|COMPLETED|Treatment Period 3||9
5184734|NCT01128569|12751573|P6|STARTED|Treatment Period 3||9
5184735|NCT01128569|12751574|P5|STARTED|Treatment Period 3||9
5184736|NCT01128569|12751575|P4|STARTED|Treatment Period 3||8
5184737|NCT01128569|12751576|P3|STARTED|Treatment Period 3||8
5184738|NCT01128569|12751577|P2|STARTED|Treatment Period 3||7
5184739|NCT01128569|12751578|P1|STARTED|Treatment Period 3||9
5184740|NCT01128569|12751573|P6|NOT COMPLETED|Washout Period 2||0
5184741|NCT01128569|12751574|P5|NOT COMPLETED|Washout Period 2||0
5184742|NCT01128569|12751575|P4|NOT COMPLETED|Washout Period 2||0
5184743|NCT01128569|12751576|P3|NOT COMPLETED|Washout Period 2||0
5184744|NCT01128569|12751577|P2|NOT COMPLETED|Washout Period 2||0
5184745|NCT01128569|12751578|P1|NOT COMPLETED|Washout Period 2||0
5184746|NCT01128569|12751573|P6|COMPLETED|Washout Period 2||9
5184747|NCT01128569|12751574|P5|COMPLETED|Washout Period 2||9
5184748|NCT01128569|12751575|P4|COMPLETED|Washout Period 2||8
5184749|NCT01128569|12751576|P3|COMPLETED|Washout Period 2||8
5184750|NCT01128569|12751577|P2|COMPLETED|Washout Period 2||7
5184751|NCT01128569|12751578|P1|COMPLETED|Washout Period 2||9
5184752|NCT01128569|12751573|P6|STARTED|Washout Period 2||9
5184753|NCT01128569|12751574|P5|STARTED|Washout Period 2||9
5184754|NCT01128569|12751575|P4|STARTED|Washout Period 2||8
5184755|NCT01128569|12751576|P3|STARTED|Washout Period 2||8
5184756|NCT01128569|12751577|P2|STARTED|Washout Period 2||7
5184757|NCT01128569|12751578|P1|STARTED|Washout Period 2||9
5184758|NCT01128569|12751573|P6|NOT COMPLETED|Treatment Period 2||0
5184759|NCT01128569|12751574|P5|NOT COMPLETED|Treatment Period 2||0
5184760|NCT01128569|12751575|P4|NOT COMPLETED|Treatment Period 2||0
5184761|NCT01128569|12751576|P3|NOT COMPLETED|Treatment Period 2||0
5184762|NCT01128569|12751577|P2|NOT COMPLETED|Treatment Period 2||1
5184763|NCT01128569|12751578|P1|NOT COMPLETED|Treatment Period 2||0
5184764|NCT01128569|12751573|P6|COMPLETED|Treatment Period 2||9
5184765|NCT01128569|12751574|P5|COMPLETED|Treatment Period 2||9
5184766|NCT01128569|12751575|P4|COMPLETED|Treatment Period 2||8
5184767|NCT01128569|12751576|P3|COMPLETED|Treatment Period 2||8
5184768|NCT01128569|12751577|P2|COMPLETED|Treatment Period 2||7
5184769|NCT01128569|12751578|P1|COMPLETED|Treatment Period 2||9
5184770|NCT01128569|12751573|P6|STARTED|Treatment Period 2||9
5184771|NCT01128569|12751574|P5|STARTED|Treatment Period 2||9
5184772|NCT01128569|12751575|P4|STARTED|Treatment Period 2||8
5184773|NCT01128569|12751576|P3|STARTED|Treatment Period 2||8
5184774|NCT01128569|12751577|P2|STARTED|Treatment Period 2||8
5184775|NCT01128569|12751578|P1|STARTED|Treatment Period 2||9
5184776|NCT01128569|12751573|P6|NOT COMPLETED|Washout Period 1||0
5184777|NCT01128569|12751574|P5|NOT COMPLETED|Washout Period 1||0
5184778|NCT01128569|12751575|P4|NOT COMPLETED|Washout Period 1||0
5184779|NCT01128569|12751576|P3|NOT COMPLETED|Washout Period 1||1
5184780|NCT01128569|12751577|P2|NOT COMPLETED|Washout Period 1||0
5184781|NCT01128569|12751578|P1|NOT COMPLETED|Washout Period 1||0
5184782|NCT01128569|12751573|P6|COMPLETED|Washout Period 1||9
5184783|NCT01128569|12751574|P5|COMPLETED|Washout Period 1||9
5184784|NCT01128569|12751575|P4|COMPLETED|Washout Period 1||8
5184785|NCT01128569|12751576|P3|COMPLETED|Washout Period 1||8
5184786|NCT01128569|12751577|P2|COMPLETED|Washout Period 1||8
5184787|NCT01128569|12751578|P1|COMPLETED|Washout Period 1||9
5184788|NCT01128569|12751573|P6|STARTED|Washout Period 1||9
5184789|NCT01128569|12751574|P5|STARTED|Washout Period 1||9
5184790|NCT01128569|12751575|P4|STARTED|Washout Period 1||8
5184791|NCT01128569|12751576|P3|STARTED|Washout Period 1||9
5184792|NCT01128569|12751577|P2|STARTED|Washout Period 1||8
5184793|NCT01128569|12751578|P1|STARTED|Washout Period 1||9
5184794|NCT01128569|12751573|P6|NOT COMPLETED|Treatment Period 1||0
5184795|NCT01128569|12751574|P5|NOT COMPLETED|Treatment Period 1||0
5184796|NCT01128569|12751575|P4|NOT COMPLETED|Treatment Period 1||0
5184797|NCT01128569|12751576|P3|NOT COMPLETED|Treatment Period 1||0
5184798|NCT01128569|12751577|P2|NOT COMPLETED|Treatment Period 1||0
5184799|NCT01128569|12751578|P1|NOT COMPLETED|Treatment Period 1||0
5184800|NCT01128569|12751573|P6|COMPLETED|Treatment Period 1||9
5184801|NCT01128569|12751574|P5|COMPLETED|Treatment Period 1||9
5184802|NCT01128569|12751575|P4|COMPLETED|Treatment Period 1||8
5184803|NCT01128569|12751576|P3|COMPLETED|Treatment Period 1||9
5184804|NCT01128569|12751577|P2|COMPLETED|Treatment Period 1||8
5184805|NCT01128569|12751578|P1|COMPLETED|Treatment Period 1||9
5184806|NCT01128569|12751573|P6|STARTED|Treatment Period 1||9
5184807|NCT01128569|12751574|P5|STARTED|Treatment Period 1||9
5184808|NCT01128569|12751575|P4|STARTED|Treatment Period 1||8
5184809|NCT01128569|12751576|P3|STARTED|Treatment Period 1||9
5184810|NCT01128569|12751577|P2|STARTED|Treatment Period 1||8
5184811|NCT01128569|12751578|P1|STARTED|Treatment Period 1||9
5184812|NCT01128543|12751595|P1|NOT COMPLETED|Overall Study||4
5184813|NCT01128543|12751595|P1|COMPLETED|Overall Study||25
5184814|NCT01128543|12751595|P1|STARTED|Overall Study||29
5184815|NCT01128426|12751601|P1|NOT COMPLETED|Overall Study||0
5184816|NCT01128426|12751601|P1|COMPLETED|Overall Study||53902
5184817|NCT01128426|12751601|P1|STARTED|Overall Study||53902
5184818|NCT01128413|12751621|P2|NOT COMPLETED|Overall Study||1
5184819|NCT01128413|12751622|P1|NOT COMPLETED|Overall Study||4
5184820|NCT01128413|12751621|P2|COMPLETED|Overall Study||10
5184821|NCT01128413|12751622|P1|COMPLETED|Overall Study||7
5184822|NCT01128413|12751621|P2|STARTED|Overall Study||11
5184823|NCT01128413|12751622|P1|STARTED|Overall Study||11
5184824|NCT01128400|12751631|P3|NOT COMPLETED|Overall Study||16
5184825|NCT01128400|12751632|P2|NOT COMPLETED|Overall Study||1
5184826|NCT01128400|12751633|P1|NOT COMPLETED|Overall Study||2
5184827|NCT01128400|12751631|P3|COMPLETED|Overall Study||7
5184828|NCT01128400|12751632|P2|COMPLETED|Overall Study||8
5184829|NCT01128400|12751633|P1|COMPLETED|Overall Study||6
5184830|NCT01128400|12751631|P3|STARTED|Overall Study||23
5184831|NCT01128400|12751632|P2|STARTED|Overall Study||9
5184832|NCT01128400|12751633|P1|STARTED|Overall Study||8
5184833|NCT01128387|12751646|P2|NOT COMPLETED|Overall Study||1
5184834|NCT01128387|12751647|P1|NOT COMPLETED|Overall Study||0
5184835|NCT01128387|12751646|P2|COMPLETED|Overall Study||5
5184836|NCT01128387|12751647|P1|COMPLETED|Overall Study||5
5184837|NCT01128387|12751646|P2|STARTED|Overall Study||6
5184838|NCT01128387|12751647|P1|STARTED|Overall Study||5
5184839|NCT01128361|12751657|P2|NOT COMPLETED|Overall Study||3
5184840|NCT01128361|12751658|P1|NOT COMPLETED|Overall Study||5
5184841|NCT01128361|12751657|P2|COMPLETED|Overall Study||34
5184842|NCT01128361|12751658|P1|COMPLETED|Overall Study||34
5184843|NCT01128361|12751657|P2|STARTED|Overall Study||37
5184844|NCT01128361|12751658|P1|STARTED|Overall Study||39
5184845|NCT01128296|12751670|P6|NOT COMPLETED|Overall Study||5
5184846|NCT01128296|12751671|P5|NOT COMPLETED|Overall Study||0
5184847|NCT01128296|12751672|P4|NOT COMPLETED|Overall Study||0
5184848|NCT01128296|12751673|P3|NOT COMPLETED|Overall Study||0
5184849|NCT01128296|12751674|P2|NOT COMPLETED|Overall Study||0
5184850|NCT01128296|12751675|P1|NOT COMPLETED|Overall Study||0
5184851|NCT01128296|12751670|P6|COMPLETED|Overall Study||21
5184852|NCT01128296|12751671|P5|COMPLETED|Overall Study||1
5184853|NCT01128296|12751672|P4|COMPLETED|Overall Study||1
5184854|NCT01128296|12751673|P3|COMPLETED|Overall Study||1
5184855|NCT01128296|12751674|P2|COMPLETED|Overall Study||1
5184856|NCT01128296|12751675|P1|COMPLETED|Overall Study||1
5184857|NCT01128296|12751670|P6|STARTED|Overall Study||26
5184858|NCT01128296|12751671|P5|STARTED|Overall Study||1
5184859|NCT01128296|12751672|P4|STARTED|Overall Study||1
5184860|NCT01128296|12751673|P3|STARTED|Overall Study||1
5184861|NCT01128296|12751674|P2|STARTED|Overall Study||1
5184862|NCT01128296|12751675|P1|STARTED|Overall Study||1
5184863|NCT01128270|12751693|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
5184864|NCT01128270|12751693|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
5184865|NCT01128270|12751693|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
5184866|NCT01128270|12751693|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
5184867|NCT01128270|12751693|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
5184868|NCT01128270|12751693|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
5184869|NCT01128270|12751693|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
5184870|NCT01128270|12751693|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
5184871|NCT01128270|12751693|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
5184872|NCT01128270|12751693|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
5184873|NCT01128270|12751693|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
5184874|NCT01128270|12751693|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
5184875|NCT01128244|12751706|P1|NOT COMPLETED|Overall Study||3
5184876|NCT01128244|12751706|P1|COMPLETED|Overall Study||10
5184877|NCT01128244|12751706|P1|STARTED|Overall Study||13
5184878|NCT01128192|12751716|P3|NOT COMPLETED|Overall Study||0
5184879|NCT01128192|12751717|P2|NOT COMPLETED|Overall Study||0
5184880|NCT01128192|12751718|P1|NOT COMPLETED|Overall Study||0
5184881|NCT01128192|12751716|P3|COMPLETED|Overall Study||7
5184882|NCT01128192|12751717|P2|COMPLETED|Overall Study||19
5184883|NCT01128192|12751718|P1|COMPLETED|Overall Study||19
5184884|NCT01128192|12751716|P3|STARTED|Overall Study||7
5184885|NCT01128192|12751717|P2|STARTED|Overall Study||19
5184886|NCT01128192|12751718|P1|STARTED|Overall Study||19
5184887|NCT01128179|12751747|P2|NOT COMPLETED|Overall Study||0
5184888|NCT01128179|12751748|P1|NOT COMPLETED|Overall Study||2
5184889|NCT01128179|12751747|P2|COMPLETED|Overall Study||12
5184890|NCT01128179|12751748|P1|COMPLETED|Overall Study||21
5184891|NCT01128179|12751747|P2|STARTED|Overall Study||12
5184892|NCT01128179|12751748|P1|STARTED|Overall Study||23
5184893|NCT01128153|12751768|P2|NOT COMPLETED|Overall Study||15
5184894|NCT01128153|12751769|P1|NOT COMPLETED|Overall Study||16
5184895|NCT01128153|12751768|P2|COMPLETED|Overall Study|Completed 24 weeks|113
5184896|NCT01128153|12751769|P1|COMPLETED|Overall Study|Completed 24 weeks|113
5184897|NCT01128153|12751768|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
5184898|NCT01128153|12751769|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
5184899|NCT01128153|12751768|P2|STARTED|Overall Study|Randomised|128
5184900|NCT01128153|12751769|P1|STARTED|Overall Study|Randomised|129
5184901|NCT01128114|12751785|P1|NOT COMPLETED|Overall Study||8
5184902|NCT01128114|12751785|P1|COMPLETED|Overall Study||24
5184903|NCT01128114|12751785|P1|STARTED|Overall Study||32
5184904|NCT01128049|12751792|P3|NOT COMPLETED|Overall Study||0
5184905|NCT01128049|12751793|P2|NOT COMPLETED|Overall Study||0
5184906|NCT01128049|12751794|P1|NOT COMPLETED|Overall Study||0
5184907|NCT01128049|12751792|P3|COMPLETED|Overall Study||5
5184908|NCT01128049|12751793|P2|COMPLETED|Overall Study||5
5184909|NCT01128049|12751794|P1|COMPLETED|Overall Study||5
5184910|NCT01128049|12751792|P3|STARTED|Overall Study||5
5184911|NCT01128049|12751793|P2|STARTED|Overall Study||5
5184912|NCT01128049|12751794|P1|STARTED|Overall Study||5
5184913|NCT01127763|12751802|P1|NOT COMPLETED|Overall Study||5
5184914|NCT01127763|12751802|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
5184915|NCT01127763|12751802|P1|STARTED|Overall Study||25
5184916|NCT01127737|12751813|P2|NOT COMPLETED|Overall Study||0
5184917|NCT01127737|12751814|P1|NOT COMPLETED|Overall Study||0
5184918|NCT01127737|12751813|P2|COMPLETED|Overall Study||38
5184919|NCT01127737|12751814|P1|COMPLETED|Overall Study||37
5184920|NCT01127737|12751813|P2|STARTED|Overall Study||38
5184921|NCT01127737|12751814|P1|STARTED|Overall Study||37
5184922|NCT01127659|12751826|P6|NOT COMPLETED|Overall Study||0
5184923|NCT01127659|12751827|P5|NOT COMPLETED|Overall Study||0
5184924|NCT01127659|12751828|P4|NOT COMPLETED|Overall Study||4
5184925|NCT01127659|12751829|P3|NOT COMPLETED|Overall Study||2
5184926|NCT01127659|12751830|P2|NOT COMPLETED|Overall Study||8
5184927|NCT01127659|12751831|P1|NOT COMPLETED|Overall Study||2
5184928|NCT01127659|12751826|P6|COMPLETED|Overall Study||21
5184929|NCT01127659|12751827|P5|COMPLETED|Overall Study||50
5184930|NCT01127659|12751828|P4|COMPLETED|Overall Study||6
5184931|NCT01127659|12751829|P3|COMPLETED|Overall Study||10
5184932|NCT01127659|12751830|P2|COMPLETED|Overall Study||14
5184933|NCT01127659|12751831|P1|COMPLETED|Overall Study||20
5184934|NCT01127659|12751826|P6|STARTED|Overall Study||21
5184935|NCT01127659|12751827|P5|STARTED|Overall Study||50
5184936|NCT01127659|12751828|P4|STARTED|Overall Study||10
5184937|NCT01127659|12751829|P3|STARTED|Overall Study||12
5184938|NCT01127659|12751830|P2|STARTED|Overall Study||22
5184939|NCT01127659|12751831|P1|STARTED|Overall Study||22
5184940|NCT01127646|12751847|P2|NOT COMPLETED|Overall Study||1
5184941|NCT01127646|12751848|P1|NOT COMPLETED|Overall Study||1
5184942|NCT01127646|12751847|P2|COMPLETED|Overall Study||7
5184943|NCT01127646|12751848|P1|COMPLETED|Overall Study||14
5184944|NCT01127646|12751847|P2|STARTED|Overall Study||8
5184945|NCT01127646|12751848|P1|STARTED|Overall Study||15
5184946|NCT01127633|12751882|P2|NOT COMPLETED|Overall Study||673
5184947|NCT01127633|12751883|P1|NOT COMPLETED|Overall Study||653
5184948|NCT01127633|12751882|P2|COMPLETED|Overall Study||61
5184949|NCT01127633|12751883|P1|COMPLETED|Overall Study||70
5184950|NCT01127633|12751882|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
5184951|NCT01127633|12751883|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
5184952|NCT01127633|12751882|P2|STARTED|Overall Study||734
5184953|NCT01127633|12751883|P1|STARTED|Overall Study||723
5184954|NCT01127607|12751915|P2|NOT COMPLETED|Phase II (Between Subjects)||2
5184955|NCT01127607|12751916|P1|NOT COMPLETED|Phase II (Between Subjects)||1
5184956|NCT01127607|12751915|P2|COMPLETED|Phase II (Between Subjects)||11
5184957|NCT01127607|12751916|P1|COMPLETED|Phase II (Between Subjects)||13
5184958|NCT01127607|12751915|P2|STARTED|Phase II (Between Subjects)||13
5184959|NCT01127607|12751916|P1|STARTED|Phase II (Between Subjects)||14
5184960|NCT01127607|12751915|P2|NOT COMPLETED|Phase I (Within Subjects)||0
5184961|NCT01127607|12751916|P1|NOT COMPLETED|Phase I (Within Subjects)||0
5184962|NCT01127607|12751915|P2|COMPLETED|Phase I (Within Subjects)||13
5184963|NCT01127607|12751916|P1|COMPLETED|Phase I (Within Subjects)||14
5184964|NCT01127607|12751915|P2|STARTED|Phase I (Within Subjects)||13
5184965|NCT01127607|12751916|P1|STARTED|Phase I (Within Subjects)||14
5184966|NCT01127581|12751989|P2|NOT COMPLETED|Overall Study||0
5184967|NCT01127581|12751990|P1|NOT COMPLETED|Overall Study||0
5184968|NCT01127581|12751989|P2|COMPLETED|Overall Study||680
5184969|NCT01127581|12751990|P1|COMPLETED|Overall Study||678
5184970|NCT01127581|12751989|P2|STARTED|Overall Study||680
5184971|NCT01127581|12751990|P1|STARTED|Overall Study||678
5184972|NCT01127503|12752018|P2|NOT COMPLETED|Overall Study||0
5184973|NCT01127503|12752019|P1|NOT COMPLETED|Overall Study||0
5184974|NCT01127503|12752018|P2|COMPLETED|Overall Study||1
5184975|NCT01127503|12752019|P1|COMPLETED|Overall Study||1
5184976|NCT01127503|12752018|P2|STARTED|Overall Study||1
5184977|NCT01127503|12752019|P1|STARTED|Overall Study||1
5184978|NCT01127438|12752033|P6|NOT COMPLETED|Overall Study||0
5184979|NCT01127438|12752034|P5|NOT COMPLETED|Overall Study||0
5184980|NCT01127438|12752035|P4|NOT COMPLETED|Overall Study||0
5184981|NCT01127438|12752036|P3|NOT COMPLETED|Overall Study||0
5184982|NCT01127438|12752037|P2|NOT COMPLETED|Overall Study||0
5184983|NCT01127438|12752038|P1|NOT COMPLETED|Overall Study||0
5184984|NCT01127438|12752033|P6|COMPLETED|Overall Study||25
5184985|NCT01127438|12752034|P5|COMPLETED|Overall Study||28
5184986|NCT01127438|12752035|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
5184987|NCT01127438|12752036|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
5184988|NCT01127438|12752037|P2|COMPLETED|Overall Study||25
5184989|NCT01127438|12752038|P1|COMPLETED|Overall Study||25
5184990|NCT01127438|12752033|P6|STARTED|Overall Study||25
5184991|NCT01127438|12752034|P5|STARTED|Overall Study||28
5184992|NCT01127438|12752035|P4|STARTED|Overall Study||24
5184993|NCT01127438|12752036|P3|STARTED|Overall Study||26
5184994|NCT01127438|12752037|P2|STARTED|Overall Study||25
5184995|NCT01127438|12752038|P1|STARTED|Overall Study||25
5184996|NCT01127321|12752065|P5|NOT COMPLETED|Overall Study||0
5184997|NCT01127321|12752066|P4|NOT COMPLETED|Overall Study||0
5184998|NCT01127321|12752067|P3|NOT COMPLETED|Overall Study||0
5184999|NCT01127321|12752068|P2|NOT COMPLETED|Overall Study||0
5185000|NCT01127321|12752069|P1|NOT COMPLETED|Overall Study||0
5185001|NCT01127321|12752065|P5|COMPLETED|Overall Study||5
5185002|NCT01127321|12752066|P4|COMPLETED|Overall Study||7
5185003|NCT01127321|12752067|P3|COMPLETED|Overall Study||1
5185004|NCT01127321|12752068|P2|COMPLETED|Overall Study||1
5185005|NCT01127321|12752069|P1|COMPLETED|Overall Study||3
5185006|NCT01127321|12752065|P5|STARTED|Overall Study||5
5185007|NCT01127321|12752066|P4|STARTED|Overall Study||7
5185008|NCT01127321|12752067|P3|STARTED|Overall Study||1
5185009|NCT01127321|12752068|P2|STARTED|Overall Study||1
5185010|NCT01127321|12752069|P1|STARTED|Overall Study||3
5185011|NCT01127256|12752093|P2|NOT COMPLETED|Overall Study||39
5185012|NCT01127256|12752094|P1|NOT COMPLETED|Overall Study||39
5185013|NCT01127256|12752093|P2|COMPLETED|Overall Study||65
5185014|NCT01127256|12752094|P1|COMPLETED|Overall Study||57
5185015|NCT01127256|12752093|P2|STARTED|Overall Study||104
5185016|NCT01127256|12752094|P1|STARTED|Overall Study||96
5185017|NCT01127165|12752106|P2|NOT COMPLETED|Overall Study||19
5185018|NCT01127165|12752107|P1|NOT COMPLETED|Overall Study||16
5185019|NCT01127165|12752106|P2|COMPLETED|Overall Study||41
5185020|NCT01127165|12752107|P1|COMPLETED|Overall Study||49
5185021|NCT01127165|12752106|P2|STARTED|Overall Study||60
5185022|NCT01127165|12752107|P1|STARTED|Overall Study||65
5185023|NCT01127139|12752119|P1|NOT COMPLETED|Overall Study||57
5185024|NCT01127139|12752119|P1|COMPLETED|Overall Study||3771
5185025|NCT01127139|12752119|P1|Number of Participants Analyzed|Overall Study||3828
5185026|NCT01127139|12752119|P1|STARTED|Overall Study||3828
5185027|NCT01127087|12752136|P2|NOT COMPLETED|Overall Study||0
5185028|NCT01127087|12752137|P1|NOT COMPLETED|Overall Study||0
5185029|NCT01127087|12752136|P2|COMPLETED|Overall Study||2
5185030|NCT01127087|12752137|P1|COMPLETED|Overall Study||8
5185031|NCT01127087|12752136|P2|STARTED|Overall Study||2
5185032|NCT01127087|12752137|P1|STARTED|Overall Study||8
5185033|NCT01127061|12752147|P2|NOT COMPLETED|Overall Study||13
5185034|NCT01127061|12752148|P1|NOT COMPLETED|Overall Study||10
5185035|NCT01127061|12752147|P2|COMPLETED|Overall Study||56
5185036|NCT01127061|12752148|P1|COMPLETED|Overall Study||57
5185037|NCT01127061|12752147|P2|STARTED|Overall Study||69
5185038|NCT01127061|12752148|P1|STARTED|Overall Study||67
5185039|NCT01126957|12752178|P1|NOT COMPLETED|Overall Study||0
5185040|NCT01126957|12752178|P1|COMPLETED|Overall Study||103
5185041|NCT01126957|12752178|P1|STARTED|Overall Study||103
5185042|NCT01126879|12752185|P2|NOT COMPLETED|Overall Study||2
5185043|NCT01126879|12752186|P1|NOT COMPLETED|Overall Study||5
5185044|NCT01126879|12752185|P2|COMPLETED|Overall Study||2
5185045|NCT01126879|12752186|P1|COMPLETED|Overall Study||3
5185046|NCT01126879|12752185|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
5185047|NCT01126879|12752186|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
5185048|NCT01126879|12752185|P2|Prostatectomy or Radiation|Overall Study||4
5185049|NCT01126879|12752186|P1|Prostatectomy or Radiation|Overall Study||8
5185050|NCT01126879|12752185|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
5185051|NCT01126879|12752186|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
5185052|NCT01126879|12752185|P2|STARTED|Overall Study||4
5185053|NCT01126879|12752186|P1|STARTED|Overall Study||8
5185054|NCT01126801|12752200|P2|NOT COMPLETED|Overall Study||0
5185055|NCT01126801|12752201|P1|NOT COMPLETED|Overall Study||0
5185056|NCT01126801|12752200|P2|COMPLETED|Overall Study||1
5185057|NCT01126801|12752201|P1|COMPLETED|Overall Study||1
5185058|NCT01126801|12752200|P2|STARTED|Overall Study||1
5185059|NCT01126801|12752201|P1|STARTED|Overall Study||1
5185060|NCT01126723|12752211|P2|NOT COMPLETED|Overall Study||3
5185061|NCT01126723|12752212|P1|NOT COMPLETED|Overall Study||6
5185062|NCT01126723|12752211|P2|COMPLETED|Overall Study||28
5185063|NCT01126723|12752212|P1|COMPLETED|Overall Study||29
5185064|NCT01126723|12752211|P2|STARTED|Overall Study||31
5185065|NCT01126723|12752212|P1|STARTED|Overall Study||35
5185066|NCT01126671|12752220|P2|NOT COMPLETED|Overall Study||1
5185067|NCT01126671|12752221|P1|NOT COMPLETED|Overall Study||2
5185068|NCT01126671|12752220|P2|COMPLETED|Overall Study||29
5185069|NCT01126671|12752221|P1|COMPLETED|Overall Study||24
5185070|NCT01126671|12752220|P2|STARTED|Overall Study||30
5185071|NCT01126671|12752221|P1|STARTED|Overall Study||26
5185072|NCT01126619|12752233|P1|NOT COMPLETED|Overall Study||17
5185073|NCT01126619|12752233|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
5185074|NCT01126619|12752233|P1|STARTED|Overall Study||103
5185075|NCT01126593|12752248|P3|NOT COMPLETED|Overall Study||2
5185076|NCT01126593|12752249|P2|NOT COMPLETED|Overall Study||2
5185077|NCT01126593|12752250|P1|NOT COMPLETED|Overall Study||4
5185078|NCT01126593|12752248|P3|COMPLETED|Overall Study||32
5185079|NCT01126593|12752249|P2|COMPLETED|Overall Study||27
5185080|NCT01126593|12752250|P1|COMPLETED|Overall Study||29
5185081|NCT01126593|12752248|P3|STARTED|Overall Study||34
5185082|NCT01126593|12752249|P2|STARTED|Overall Study||29
5185083|NCT01126593|12752250|P1|STARTED|Overall Study||33
5185084|NCT01126580|12752261|P3|NOT COMPLETED|Overall Study||55
5185085|NCT01126580|12752262|P2|NOT COMPLETED|Overall Study||52
5185086|NCT01126580|12752263|P1|NOT COMPLETED|Overall Study||49
5185087|NCT01126580|12752261|P3|COMPLETED|Overall Study||213
5185088|NCT01126580|12752262|P2|COMPLETED|Overall Study||218
5185089|NCT01126580|12752263|P1|COMPLETED|Overall Study||220
5185090|NCT01126580|12752261|P3|Completed 26 Weeks|Overall Study||226
5185091|NCT01126580|12752262|P2|Completed 26 Weeks|Overall Study||242
5185092|NCT01126580|12752263|P1|Completed 26 Weeks|Overall Study||233
5185093|NCT01126580|12752261|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
5185094|NCT01126580|12752262|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
5185095|NCT01126580|12752263|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
5185096|NCT01126580|12752261|P3|STARTED|Overall Study||268
5185097|NCT01126580|12752262|P2|STARTED|Overall Study||270
5185098|NCT01126580|12752263|P1|STARTED|Overall Study||269
5185099|NCT01126541|12752358|P3|NOT COMPLETED|Overall Study||26
5185100|NCT01126541|12752359|P2|NOT COMPLETED|Overall Study||12
5185101|NCT01126541|12752360|P1|NOT COMPLETED|Overall Study||10
5185102|NCT01126541|12752358|P3|COMPLETED|Overall Study||55
5185103|NCT01126541|12752359|P2|COMPLETED|Overall Study||61
5185104|NCT01126541|12752360|P1|COMPLETED|Overall Study||60
5185105|NCT01126541|12752358|P3|STARTED|Overall Study||81
5185106|NCT01126541|12752359|P2|STARTED|Overall Study||73
5185107|NCT01126541|12752360|P1|STARTED|Overall Study||70
5185108|NCT01126437|12752444|P3|NOT COMPLETED|Overall Study||1313
5185109|NCT01126437|12752445|P2|NOT COMPLETED|Overall Study||1330
5185110|NCT01126437|12752446|P1|NOT COMPLETED|Overall Study||1341
5185111|NCT01126437|12752444|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
5185112|NCT01126437|12752445|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
5185113|NCT01126437|12752446|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
5185114|NCT01126437|12752444|P3|STARTED|Overall Study||5713
5185115|NCT01126437|12752445|P2|STARTED|Overall Study||5729
5185116|NCT01126437|12752446|P1|STARTED|Overall Study||5741
5185117|NCT01126424|12752484|P6|NOT COMPLETED|Overall Study||0
5185118|NCT01126424|12752485|P5|NOT COMPLETED|Overall Study||2
5185119|NCT01126424|12752486|P4|NOT COMPLETED|Overall Study||3
5185120|NCT01126424|12752487|P3|NOT COMPLETED|Overall Study||1
5185121|NCT01126424|12752488|P2|NOT COMPLETED|Overall Study||0
5185122|NCT01126424|12752489|P1|NOT COMPLETED|Overall Study||0
5185123|NCT01126424|12752484|P6|COMPLETED|Overall Study||4
5185124|NCT01126424|12752485|P5|COMPLETED|Overall Study||2
5185125|NCT01126424|12752486|P4|COMPLETED|Overall Study||3
5185126|NCT01126424|12752487|P3|COMPLETED|Overall Study||4
5185127|NCT01126424|12752488|P2|COMPLETED|Overall Study||4
5185128|NCT01126424|12752489|P1|COMPLETED|Overall Study||3
5185129|NCT01126424|12752484|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
5185130|NCT01126424|12752485|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
5185131|NCT01126424|12752486|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
5185132|NCT01126424|12752487|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
5185133|NCT01126424|12752488|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
5185134|NCT01126424|12752489|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
5185135|NCT01126424|12752484|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
5185136|NCT01126424|12752485|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
5185137|NCT01126424|12752486|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
5185138|NCT01126424|12752487|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
5185139|NCT01126424|12752488|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
5185140|NCT01126424|12752489|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
5185141|NCT01126359|12752512|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
5185142|NCT01126359|12752513|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
5185143|NCT01126359|12752512|P2|COMPLETED|Second Intervention (20-minutes)||5
5185144|NCT01126359|12752513|P1|COMPLETED|Second Intervention (20-minutes)||5
5185145|NCT01126359|12752512|P2|STARTED|Second Intervention (20-minutes)||5
5185146|NCT01126359|12752513|P1|STARTED|Second Intervention (20-minutes)||5
5185147|NCT01126359|12752512|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
5185148|NCT01126359|12752513|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
5185149|NCT01126359|12752512|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
5185150|NCT01126359|12752513|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
5185151|NCT01126359|12752512|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
5185152|NCT01126359|12752513|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
5185153|NCT01126359|12752512|P2|NOT COMPLETED|First Intervention (20-minutes)||1
5185154|NCT01126359|12752513|P1|NOT COMPLETED|First Intervention (20-minutes)||0
5185155|NCT01126359|12752512|P2|COMPLETED|First Intervention (20-minutes)||5
5185156|NCT01126359|12752513|P1|COMPLETED|First Intervention (20-minutes)||5
5185157|NCT01126359|12752512|P2|STARTED|First Intervention (20-minutes)||6
5185158|NCT01126359|12752513|P1|STARTED|First Intervention (20-minutes)||5
5185159|NCT01126268|12752525|P1|NOT COMPLETED|Overall Study||1
5185160|NCT01126268|12752525|P1|COMPLETED|Overall Study||37
5185161|NCT01126268|12752525|P1|STARTED|Overall Study||38
5185162|NCT01126099|12752549|P2|NOT COMPLETED|Open-label Extension||1
5185163|NCT01126099|12752550|P1|NOT COMPLETED|Open-label Extension||1
5185164|NCT01126099|12752549|P2|COMPLETED|Open-label Extension||6
5185165|NCT01126099|12752550|P1|COMPLETED|Open-label Extension||4
5185166|NCT01126099|12752549|P2|STARTED|Open-label Extension||7
5185167|NCT01126099|12752550|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
5185168|NCT01126099|12752549|P2|NOT COMPLETED|Double Blind Phase||2
5185169|NCT01126099|12752550|P1|NOT COMPLETED|Double Blind Phase||4
5185170|NCT01126099|12752549|P2|COMPLETED|Double Blind Phase||7
5185171|NCT01126099|12752550|P1|COMPLETED|Double Blind Phase||7
5185172|NCT01126099|12752549|P2|STARTED|Double Blind Phase||9
5185173|NCT01126099|12752550|P1|STARTED|Double Blind Phase||11
5185174|NCT01126060|12752564|P2|NOT COMPLETED|Overall Study||2
5185175|NCT01126060|12752565|P1|NOT COMPLETED|Overall Study||0
5185176|NCT01126060|12752564|P2|COMPLETED|Overall Study||38
5185177|NCT01126060|12752565|P1|COMPLETED|Overall Study||40
5185178|NCT01126060|12752564|P2|STARTED|Overall Study||40
5185179|NCT01126060|12752565|P1|STARTED|Overall Study||40
5185180|NCT01125930|12752573|P2|NOT COMPLETED|Overall Study||10
5185181|NCT01125930|12752574|P1|NOT COMPLETED|Overall Study||1
5185182|NCT01125930|12752573|P2|COMPLETED|Overall Study||36
5185183|NCT01125930|12752574|P1|COMPLETED|Overall Study||21
5185184|NCT01125930|12752573|P2|STARTED|Overall Study||46
5185185|NCT01125930|12752574|P1|STARTED|Overall Study||22
5185186|NCT01125917|12752728|P1|NOT COMPLETED|Overall Study||339
5185187|NCT01125917|12752728|P1|COMPLETED|Overall Study||15
5185188|NCT01125917|12752728|P1|STARTED|Overall Study||354
5185189|NCT01125813|12752732|P1|NOT COMPLETED|Overall Study||6
5185190|NCT01125813|12752732|P1|COMPLETED|Overall Study||30
5185191|NCT01125813|12752732|P1|STARTED|Overall Study||36
5185192|NCT01125800|12752742|P5|NOT COMPLETED|Phase II||11
5185193|NCT01125800|12752743|P4|NOT COMPLETED|Phase II||1
5185194|NCT01125800|12752744|P3|NOT COMPLETED|Phase II||0
5185195|NCT01125800|12752745|P2|NOT COMPLETED|Phase II||0
5185196|NCT01125800|12752746|P1|NOT COMPLETED|Phase II||0
5185197|NCT01125800|12752742|P5|COMPLETED|Phase II||5
5185198|NCT01125800|12752743|P4|COMPLETED|Phase II||0
5185199|NCT01125800|12752744|P3|COMPLETED|Phase II||0
5185200|NCT01125800|12752745|P2|COMPLETED|Phase II||0
5185201|NCT01125800|12752746|P1|COMPLETED|Phase II||0
5185202|NCT01125800|12752742|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
5185203|NCT01125800|12752743|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
5185204|NCT01125800|12752744|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
5185205|NCT01125800|12752745|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
5185206|NCT01125800|12752746|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
5185207|NCT01125800|12752742|P5|NOT COMPLETED|Phase I||0
5185208|NCT01125800|12752743|P4|NOT COMPLETED|Phase I||11
5185209|NCT01125800|12752744|P3|NOT COMPLETED|Phase I||4
5185210|NCT01125800|12752745|P2|NOT COMPLETED|Phase I||9
5185211|NCT01125800|12752746|P1|NOT COMPLETED|Phase I||8
5185212|NCT01125800|12752742|P5|COMPLETED|Phase I||0
5185213|NCT01125800|12752743|P4|COMPLETED|Phase I||10
5185214|NCT01125800|12752744|P3|COMPLETED|Phase I||7
5185215|NCT01125800|12752745|P2|COMPLETED|Phase I||7
5185216|NCT01125800|12752746|P1|COMPLETED|Phase I||3
5185217|NCT01125800|12752742|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
5185218|NCT01125800|12752743|P4|STARTED|Phase I||21
5185219|NCT01125800|12752744|P3|STARTED|Phase I||11
5185220|NCT01125800|12752745|P2|STARTED|Phase I||16
5185221|NCT01125800|12752746|P1|STARTED|Phase I||11
5185222|NCT01125774|12752785|P4|NOT COMPLETED|Overall Study||3
5185223|NCT01125774|12752786|P3|NOT COMPLETED|Overall Study||9
5185224|NCT01125774|12752787|P2|NOT COMPLETED|Overall Study||554
5185225|NCT01125774|12752788|P1|NOT COMPLETED|Overall Study||1125
5185226|NCT01125774|12752785|P4|COMPLETED|Overall Study|Completed study at least once|3
5185227|NCT01125774|12752786|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
5185228|NCT01125774|12752787|P2|COMPLETED|Overall Study||948
5185229|NCT01125774|12752788|P1|COMPLETED|Overall Study||1893
5185230|NCT01125774|12752785|P4|Treated|Overall Study||5
5185231|NCT01125774|12752786|P3|Treated|Overall Study|Received telcagepant|21
5185232|NCT01125774|12752787|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
5185233|NCT01125774|12752788|P1|Treated|Overall Study||2638
5185234|NCT01125774|12752785|P4|STARTED|Overall Study|Unique participants randomized|6
5185235|NCT01125774|12752786|P3|STARTED|Overall Study|Unique participants randomized|22
5185236|NCT01125774|12752787|P2|STARTED|Overall Study|Randomized|1502
5185237|NCT01125774|12752788|P1|STARTED|Overall Study|Randomized|3018
5185238|NCT01125748|12752812|P2|NOT COMPLETED|Overall Study||14
5185239|NCT01125748|12752813|P1|NOT COMPLETED|Overall Study||10
5185240|NCT01125748|12752812|P2|COMPLETED|Overall Study||74
5185241|NCT01125748|12752813|P1|COMPLETED|Overall Study||78
5185242|NCT01125748|12752812|P2|STARTED|Overall Study||88
5185243|NCT01125748|12752813|P1|STARTED|Overall Study||88
5185244|NCT01125722|12752823|P2|NOT COMPLETED|Overall Study||1
5185245|NCT01125722|12752824|P1|NOT COMPLETED|Overall Study||3
5185246|NCT01125722|12752823|P2|COMPLETED|Overall Study||36
5185247|NCT01125722|12752824|P1|COMPLETED|Overall Study||34
5185248|NCT01125722|12752823|P2|STARTED|Overall Study||37
5185249|NCT01125722|12752824|P1|STARTED|Overall Study||37
5185250|NCT01125605|12752838|P1|NOT COMPLETED|Overall Study||0
5185251|NCT01125605|12752838|P1|COMPLETED|Overall Study||325
5185252|NCT01125605|12752838|P1|Safety|Overall Study|1 patient was only analysed for safety|326
5185253|NCT01125605|12752838|P1|STARTED|Overall Study|started = had baseline values|325
5185254|NCT01125566|12752871|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
5185255|NCT01125566|12752872|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
5185256|NCT01125566|12752873|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
5185257|NCT01125566|12752871|P3|COMPLETED|Patients Who Switched From AV to TV||2
5185258|NCT01125566|12752872|P2|COMPLETED|Patients Who Switched From AV to TV||0
5185259|NCT01125566|12752873|P1|COMPLETED|Patients Who Switched From AV to TV||0
5185260|NCT01125566|12752871|P3|STARTED|Patients Who Switched From AV to TV||75
5185261|NCT01125566|12752872|P2|STARTED|Patients Who Switched From AV to TV||0
5185262|NCT01125566|12752873|P1|STARTED|Patients Who Switched From AV to TV||0
5185263|NCT01125566|12752871|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
5185264|NCT01125566|12752872|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
5185265|NCT01125566|12752873|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
5185266|NCT01125566|12752871|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
5185267|NCT01125566|12752872|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
5185268|NCT01125566|12752873|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
5185269|NCT01125566|12752871|P3|Treated|Patients Before the Switch (26Apr2013)||0
5185270|NCT01125566|12752872|P2|Treated|Patients Before the Switch (26Apr2013)||169
5185271|NCT01125566|12752873|P1|Treated|Patients Before the Switch (26Apr2013)||337
5185272|NCT01125566|12752871|P3|STARTED|Patients Before the Switch (26Apr2013)||0
5185273|NCT01125566|12752872|P2|STARTED|Patients Before the Switch (26Apr2013)||169
5185274|NCT01125566|12752873|P1|STARTED|Patients Before the Switch (26Apr2013)||339
5185275|NCT01125514|12752886|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
5185276|NCT01125514|12752886|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
5185277|NCT01125514|12752886|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
5185278|NCT01125514|12752886|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
5185279|NCT01125514|12752886|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
5185280|NCT01125514|12752886|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
5185281|NCT01125514|12752886|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
5185282|NCT01125514|12752886|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
5185283|NCT01125514|12752886|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
5185284|NCT01125514|12752886|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
5185285|NCT01125514|12752886|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
5185286|NCT01125202|12752960|P2|NOT COMPLETED|Overall Study||7
5185287|NCT01125202|12752961|P1|NOT COMPLETED|Overall Study||12
5185288|NCT01125202|12752960|P2|COMPLETED|Overall Study||79
5185289|NCT01125202|12752961|P1|COMPLETED|Overall Study||81
5185290|NCT01125202|12752960|P2|STARTED|Overall Study||86
5185291|NCT01125202|12752961|P1|STARTED|Overall Study||93
5185292|NCT01125189|12752986|P3|NOT COMPLETED|Follow up Period||16
5185293|NCT01125189|12752987|P2|NOT COMPLETED|Follow up Period||15
5185294|NCT01125189|12752988|P1|NOT COMPLETED|Follow up Period||20
5185295|NCT01125189|12752986|P3|COMPLETED|Follow up Period||58
5185296|NCT01125189|12752987|P2|COMPLETED|Follow up Period||138
5185297|NCT01125189|12752988|P1|COMPLETED|Follow up Period||132
5185298|NCT01125189|12752986|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
5185299|NCT01125189|12752987|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
5185300|NCT01125189|12752988|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
5185301|NCT01125189|12752986|P3|NOT COMPLETED|Treatment Period||41
5185302|NCT01125189|12752987|P2|NOT COMPLETED|Treatment Period||35
5185303|NCT01125189|12752988|P1|NOT COMPLETED|Treatment Period||31
5185304|NCT01125189|12752986|P3|COMPLETED|Treatment Period||37
5185305|NCT01125189|12752987|P2|COMPLETED|Treatment Period||123
5185306|NCT01125189|12752988|P1|COMPLETED|Treatment Period||128
5185307|NCT01125189|12752986|P3|STARTED|Treatment Period||78
5185308|NCT01125189|12752987|P2|STARTED|Treatment Period||158
5185309|NCT01125189|12752988|P1|STARTED|Treatment Period||159
5185310|NCT01125176|12753014|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
5185311|NCT01125176|12753014|P1|COMPLETED|Post-treatment Follow-up Phase||2
5185312|NCT01125176|12753014|P1|STARTED|Post-treatment Follow-up Phase||13
5185313|NCT01125176|12753014|P1|NOT COMPLETED|Treatment Phase||1
5185314|NCT01125176|12753014|P1|COMPLETED|Treatment Phase||13
5185315|NCT01125176|12753014|P1|STARTED|Treatment Phase||14
5185316|NCT01125163|12753020|P2|NOT COMPLETED|Overall Study||0
5185317|NCT01125163|12753021|P1|NOT COMPLETED|Overall Study||0
5185318|NCT01125163|12753020|P2|COMPLETED|Overall Study||74
5185319|NCT01125163|12753021|P1|COMPLETED|Overall Study||76
5185320|NCT01125163|12753020|P2|STARTED|Overall Study||74
5185321|NCT01125163|12753021|P1|STARTED|Overall Study||76
5185322|NCT01125098|12753031|P2|NOT COMPLETED|Overall Study||0
5185323|NCT01125098|12753032|P1|NOT COMPLETED|Overall Study||3
5185324|NCT01125098|12753031|P2|COMPLETED|Overall Study||90
5185325|NCT01125098|12753032|P1|COMPLETED|Overall Study||88
5185326|NCT01125098|12753031|P2|STARTED|Overall Study||90
5185327|NCT01125098|12753032|P1|STARTED|Overall Study||91
5185328|NCT01124955|12753040|P2|NOT COMPLETED|Overall Study||0
5185329|NCT01124955|12753041|P1|NOT COMPLETED|Overall Study||0
5185330|NCT01124955|12753040|P2|COMPLETED|Overall Study||40
5185331|NCT01124955|12753041|P1|COMPLETED|Overall Study||40
5185332|NCT01124955|12753040|P2|STARTED|Overall Study||40
5185333|NCT01124955|12753041|P1|STARTED|Overall Study||40
5185334|NCT01124916|12753057|P2|NOT COMPLETED|Overall Study||2
5185335|NCT01124916|12753058|P1|NOT COMPLETED|Overall Study||3
5185336|NCT01124916|12753057|P2|COMPLETED|Overall Study||38
5185337|NCT01124916|12753058|P1|COMPLETED|Overall Study||35
5185338|NCT01124916|12753057|P2|STARTED|Overall Study||40
5185339|NCT01124916|12753058|P1|STARTED|Overall Study||38
5185340|NCT01124864|12753072|P6|NOT COMPLETED|Overall Study||3
5185341|NCT01124864|12753073|P5|NOT COMPLETED|Overall Study||30
5185342|NCT01124864|12753074|P4|NOT COMPLETED|Overall Study||21
5185343|NCT01124864|12753075|P3|NOT COMPLETED|Overall Study||34
5185344|NCT01124864|12753076|P2|NOT COMPLETED|Overall Study||35
5185345|NCT01124864|12753077|P1|NOT COMPLETED|Overall Study||28
5185346|NCT01124864|12753072|P6|COMPLETED|Overall Study||0
5185347|NCT01124864|12753073|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
5185348|NCT01124864|12753074|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
5185349|NCT01124864|12753075|P3|COMPLETED|Overall Study||0
5185350|NCT01124864|12753076|P2|COMPLETED|Overall Study||0
5185351|NCT01124864|12753077|P1|COMPLETED|Overall Study||0
5185352|NCT01124864|12753072|P6|STARTED|Overall Study||3
5185353|NCT01124864|12753073|P5|STARTED|Overall Study||31
5185354|NCT01124864|12753074|P4|STARTED|Overall Study||22
5185355|NCT01124864|12753075|P3|STARTED|Overall Study||34
5185356|NCT01124864|12753076|P2|STARTED|Overall Study||35
5185357|NCT01124864|12753077|P1|STARTED|Overall Study||28
5185358|NCT01124838|12753111|P2|NOT COMPLETED|Overall Study||15
5185359|NCT01124838|12753112|P1|NOT COMPLETED|Overall Study||18
5185360|NCT01124838|12753111|P2|COMPLETED|Overall Study||116
5185361|NCT01124838|12753112|P1|COMPLETED|Overall Study||112
5185362|NCT01124838|12753111|P2|Enrolled in Japan Sub-study|Overall Study||16
5185363|NCT01124838|12753112|P1|Enrolled in Japan Sub-study|Overall Study||16
5185364|NCT01124838|12753111|P2|Enrolled in Main Study|Overall Study||115
5185365|NCT01124838|12753112|P1|Enrolled in Main Study|Overall Study||114
5185366|NCT01124838|12753111|P2|STARTED|Overall Study||131
5185367|NCT01124838|12753112|P1|STARTED|Overall Study||130
5185368|NCT01124786|12753158|P2|NOT COMPLETED|Overall Study||5
5185369|NCT01124786|12753159|P1|NOT COMPLETED|Overall Study||4
5185370|NCT01124786|12753158|P2|COMPLETED|Overall Study||180
5185371|NCT01124786|12753159|P1|COMPLETED|Overall Study||178
5185372|NCT01124786|12753158|P2|Tumor Evaluable Population|Overall Study||180
5185373|NCT01124786|12753159|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
5185374|NCT01124786|12753158|P2|Safety Population|Overall Study||181
5185375|NCT01124786|12753159|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
5185376|NCT01124786|12753158|P2|Intent-to-Treat (ITT) Population|Overall Study||185
5185377|NCT01124786|12753159|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
5185378|NCT01124786|12753158|P2|STARTED|Overall Study||185
5185379|NCT01124786|12753159|P1|STARTED|Overall Study||182
5185380|NCT01124734|12753179|P1|NOT COMPLETED|Overall Study||17
5185381|NCT01124734|12753179|P1|COMPLETED|Overall Study|Closed to accrual|0
5185382|NCT01124734|12753179|P1|Initiation of Course 1 Cycle 2|Overall Study||17
5185383|NCT01124734|12753179|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
5185384|NCT01124734|12753179|P1|STARTED|Overall Study||17
5185385|NCT01124643|12753190|P1|NOT COMPLETED|Overall Study||1
5185386|NCT01124643|12753190|P1|COMPLETED|Overall Study||34
5185387|NCT01124643|12753190|P1|STARTED|Overall Study||35
5185388|NCT01124617|12753204|P2|NOT COMPLETED|Overall Study||6
5185389|NCT01124617|12753205|P1|NOT COMPLETED|Overall Study||19
5185390|NCT01124617|12753204|P2|COMPLETED|Overall Study||25
5185391|NCT01124617|12753205|P1|COMPLETED|Overall Study||41
5185392|NCT01124617|12753204|P2|STARTED|Overall Study||31
5185393|NCT01124617|12753205|P1|STARTED|Overall Study||60
5185394|NCT01124604|12753237|P2|NOT COMPLETED|Overall Study||2
5185395|NCT01124604|12753238|P1|NOT COMPLETED|Overall Study||15
5185396|NCT01124604|12753237|P2|COMPLETED|Overall Study||29
5185397|NCT01124604|12753238|P1|COMPLETED|Overall Study||45
5185398|NCT01124604|12753237|P2|STARTED|Overall Study||31
5185399|NCT01124604|12753238|P1|STARTED|Overall Study||60
5185400|NCT01124448|12753277|P2|NOT COMPLETED|Overall Study||3
5185401|NCT01124448|12753278|P1|NOT COMPLETED|Overall Study||2
5185402|NCT01124448|12753277|P2|COMPLETED|Overall Study||12
5185403|NCT01124448|12753278|P1|COMPLETED|Overall Study||23
5185404|NCT01124448|12753277|P2|STARTED|Overall Study||15
5185405|NCT01124448|12753278|P1|STARTED|Overall Study||25
5185406|NCT01124422|12753286|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
5185407|NCT01124422|12753287|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
5185408|NCT01124422|12753288|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
5185409|NCT01124422|12753286|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
5185410|NCT01124422|12753287|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
5185411|NCT01124422|12753288|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
5185412|NCT01124422|12753286|P3|STARTED|4-Week Double-blind Treatment Phase||124
5185413|NCT01124422|12753287|P2|STARTED|4-Week Double-blind Treatment Phase||131
5185414|NCT01124422|12753288|P1|STARTED|4-Week Double-blind Treatment Phase||0
5185415|NCT01124422|12753286|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
5185416|NCT01124422|12753287|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
5185417|NCT01124422|12753288|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
5185418|NCT01124422|12753286|P3|COMPLETED|4-Week Open-label Run-in Phase||0
5185419|NCT01124422|12753287|P2|COMPLETED|4-Week Open-label Run-in Phase||0
5185420|NCT01124422|12753288|P1|COMPLETED|4-Week Open-label Run-in Phase||255
5185421|NCT01124422|12753286|P3|STARTED|4-Week Open-label Run-in Phase||0
5185422|NCT01124422|12753287|P2|STARTED|4-Week Open-label Run-in Phase||0
5185423|NCT01124422|12753288|P1|STARTED|4-Week Open-label Run-in Phase||338
5185424|NCT01124370|12753330|P1|NOT COMPLETED|Overall Study||20
5185425|NCT01124370|12753330|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
5185426|NCT01124370|12753330|P1|3 Month Visit|Overall Study|Defines evaluable population|47
5185427|NCT01124370|12753330|P1|Therapy Initiated|Overall Study||48
5185428|NCT01124370|12753330|P1|Successfully Implanted|Overall Study||50
5185429|NCT01124370|12753330|P1|STARTED|Overall Study|Underwent implant attempt|57
5185430|NCT01124305|12753342|P2|NOT COMPLETED|Overall Study||10
5185431|NCT01124305|12753343|P1|NOT COMPLETED|Overall Study||8
5185432|NCT01124305|12753342|P2|COMPLETED|Overall Study||26
5185433|NCT01124305|12753343|P1|COMPLETED|Overall Study||26
5185434|NCT01124305|12753342|P2|STARTED|Overall Study||36
5185435|NCT01124305|12753343|P1|STARTED|Overall Study||34
5185436|NCT01124292|12753358|P3|NOT COMPLETED|Overall Study||10
5185437|NCT01124292|12753359|P2|NOT COMPLETED|Overall Study||15
5185438|NCT01124292|12753360|P1|NOT COMPLETED|Overall Study||2
5185439|NCT01124292|12753358|P3|COMPLETED|Overall Study||11
5185440|NCT01124292|12753359|P2|COMPLETED|Overall Study||9
5185441|NCT01124292|12753360|P1|COMPLETED|Overall Study||14
5185442|NCT01124292|12753358|P3|STARTED|Overall Study||21
5185443|NCT01124292|12753359|P2|STARTED|Overall Study||24
5185444|NCT01124292|12753360|P1|STARTED|Overall Study||16
5185445|NCT01124188|12753418|P2|NOT COMPLETED|Overall Study||6
5185446|NCT01124188|12753419|P1|NOT COMPLETED|Overall Study||8
5185447|NCT01124188|12753418|P2|COMPLETED|Overall Study||65
5185448|NCT01124188|12753419|P1|COMPLETED|Overall Study||60
5185449|NCT01124188|12753418|P2|STARTED|Overall Study||71
5185450|NCT01124188|12753419|P1|STARTED|Overall Study||68
5185451|NCT01124175|12753431|P2|NOT COMPLETED|Second Intervention||0
5185452|NCT01124175|12753432|P1|NOT COMPLETED|Second Intervention||0
5185453|NCT01124175|12753431|P2|COMPLETED|Second Intervention||38
5185454|NCT01124175|12753432|P1|COMPLETED|Second Intervention||40
5185455|NCT01124175|12753431|P2|STARTED|Second Intervention||38
5185456|NCT01124175|12753432|P1|STARTED|Second Intervention||40
5185457|NCT01124175|12753431|P2|NOT COMPLETED|Washout of 7 Days||2
5185458|NCT01124175|12753432|P1|NOT COMPLETED|Washout of 7 Days||0
5185459|NCT01124175|12753431|P2|COMPLETED|Washout of 7 Days||38
5185460|NCT01124175|12753432|P1|COMPLETED|Washout of 7 Days||40
5185461|NCT01124175|12753431|P2|STARTED|Washout of 7 Days||40
5185462|NCT01124175|12753432|P1|STARTED|Washout of 7 Days||40
5185463|NCT01124175|12753431|P2|NOT COMPLETED|First Intervention||0
5185464|NCT01124175|12753432|P1|NOT COMPLETED|First Intervention||0
5185465|NCT01124175|12753431|P2|COMPLETED|First Intervention||40
5185466|NCT01124175|12753432|P1|COMPLETED|First Intervention||40
5185467|NCT01124175|12753431|P2|STARTED|First Intervention||40
5185468|NCT01124175|12753432|P1|STARTED|First Intervention||40
5185469|NCT01124162|12753450|P2|NOT COMPLETED|Second Intervention||0
5185470|NCT01124162|12753451|P1|NOT COMPLETED|Second Intervention||0
5185471|NCT01124162|12753450|P2|COMPLETED|Second Intervention||40
5185472|NCT01124162|12753451|P1|COMPLETED|Second Intervention||37
5185473|NCT01124162|12753450|P2|STARTED|Second Intervention||40
5185474|NCT01124162|12753451|P1|STARTED|Second Intervention||37
5185475|NCT01124162|12753450|P2|NOT COMPLETED|Washout of 7 Days||0
5185476|NCT01124162|12753451|P1|NOT COMPLETED|Washout of 7 Days||1
5185477|NCT01124162|12753450|P2|COMPLETED|Washout of 7 Days||40
5185478|NCT01124162|12753451|P1|COMPLETED|Washout of 7 Days||37
5185479|NCT01124162|12753450|P2|STARTED|Washout of 7 Days||40
5185480|NCT01124162|12753451|P1|STARTED|Washout of 7 Days||38
5185481|NCT01124162|12753450|P2|NOT COMPLETED|First Intervention||0
5185482|NCT01124162|12753451|P1|NOT COMPLETED|First Intervention||2
5185483|NCT01124162|12753450|P2|COMPLETED|First Intervention||40
5185484|NCT01124162|12753451|P1|COMPLETED|First Intervention||38
5185485|NCT01124162|12753450|P2|STARTED|First Intervention||40
5185486|NCT01124162|12753451|P1|STARTED|First Intervention||40
5185487|NCT01124149|12753467|P1|NOT COMPLETED|Maintenance Phase||96
5185488|NCT01124149|12753467|P1|COMPLETED|Maintenance Phase||373
5185489|NCT01124149|12753467|P1|STARTED|Maintenance Phase||469
5185490|NCT01124149|12753467|P1|NOT COMPLETED|Acute Phase||83
5185491|NCT01124149|12753467|P1|COMPLETED|Acute Phase||639
5185492|NCT01124149|12753467|P1|STARTED|Acute Phase||722
5185493|NCT01124097|12753487|P4|NOT COMPLETED|Overall Study||14
5185494|NCT01124097|12753488|P3|NOT COMPLETED|Overall Study||20
5185495|NCT01124097|12753489|P2|NOT COMPLETED|Overall Study||22
5185496|NCT01124097|12753490|P1|NOT COMPLETED|Overall Study||34
5185497|NCT01124097|12753487|P4|COMPLETED|Overall Study||46
5185498|NCT01124097|12753488|P3|COMPLETED|Overall Study||40
5185499|NCT01124097|12753489|P2|COMPLETED|Overall Study||38
5185500|NCT01124097|12753490|P1|COMPLETED|Overall Study||26
5185501|NCT01124097|12753487|P4|Efficacy Population|Overall Study||51
5185502|NCT01124097|12753488|P3|Efficacy Population|Overall Study||53
5185503|NCT01124097|12753489|P2|Efficacy Population|Overall Study||53
5185504|NCT01124097|12753490|P1|Efficacy Population|Overall Study||52
5185505|NCT01124097|12753487|P4|Safety Population|Overall Study||60
5185506|NCT01124097|12753488|P3|Safety Population|Overall Study||60
5185507|NCT01124097|12753489|P2|Safety Population|Overall Study||60
5185508|NCT01124097|12753490|P1|Safety Population|Overall Study||60
5185509|NCT01124097|12753487|P4|STARTED|Overall Study||60
5185510|NCT01124097|12753488|P3|STARTED|Overall Study||60
5185511|NCT01124097|12753489|P2|STARTED|Overall Study||60
5185512|NCT01124097|12753490|P1|STARTED|Overall Study||60
5185513|NCT01124045|12753502|P2|NOT COMPLETED|Overall Study||3
5185514|NCT01124045|12753503|P1|NOT COMPLETED|Overall Study||0
5185515|NCT01124045|12753502|P2|COMPLETED|Overall Study||37
5185516|NCT01124045|12753503|P1|COMPLETED|Overall Study||39
5185517|NCT01124045|12753502|P2|STARTED|Overall Study||40
5185518|NCT01124045|12753503|P1|STARTED|Overall Study||39
5185519|NCT01124006|12753536|P3|NOT COMPLETED|Overall Study||2
5185520|NCT01124006|12753537|P2|NOT COMPLETED|Overall Study||2
5185521|NCT01124006|12753538|P1|NOT COMPLETED|Overall Study||3
5185522|NCT01124006|12753536|P3|COMPLETED|Overall Study||2
5185523|NCT01124006|12753537|P2|COMPLETED|Overall Study||8
5185524|NCT01124006|12753538|P1|COMPLETED|Overall Study||7
5185525|NCT01124006|12753536|P3|STARTED|Overall Study||4
5185526|NCT01124006|12753537|P2|STARTED|Overall Study||10
5185527|NCT01124006|12753538|P1|STARTED|Overall Study||10
5185528|NCT01123980|12753566|P2|NOT COMPLETED|Overall Study||24
5185529|NCT01123980|12753567|P1|NOT COMPLETED|Overall Study||19
5185530|NCT01123980|12753566|P2|COMPLETED|Overall Study||236
5185531|NCT01123980|12753567|P1|COMPLETED|Overall Study||242
5185532|NCT01123980|12753566|P2|STARTED|Overall Study||260
5185533|NCT01123980|12753567|P1|STARTED|Overall Study||261
5185534|NCT01123941|12753587|P2|NOT COMPLETED|Overall Study||1
5185535|NCT01123941|12753588|P1|NOT COMPLETED|Overall Study||2
5185536|NCT01123941|12753587|P2|COMPLETED|Overall Study||24
5185537|NCT01123941|12753588|P1|COMPLETED|Overall Study||23
5185538|NCT01123941|12753587|P2|STARTED|Overall Study||25
5185539|NCT01123941|12753588|P1|STARTED|Overall Study||25
5185540|NCT01123928|12753602|P2|NOT COMPLETED|Overall Study||0
5185541|NCT01123928|12753603|P1|NOT COMPLETED|Overall Study||0
5185542|NCT01123928|12753602|P2|COMPLETED|Overall Study||222
5185543|NCT01123928|12753603|P1|COMPLETED|Overall Study||212
5185544|NCT01123928|12753602|P2|STARTED|Overall Study||222
5185545|NCT01123928|12753603|P1|STARTED|Overall Study||212
5185546|NCT01123889|12753623|P2|NOT COMPLETED|Overall Study||1
5185547|NCT01123889|12753624|P1|NOT COMPLETED|Overall Study||3
5185548|NCT01123889|12753623|P2|COMPLETED|Overall Study||6
5185549|NCT01123889|12753624|P1|COMPLETED|Overall Study||2
5185550|NCT01123889|12753623|P2|STARTED|Overall Study||7
5185551|NCT01123889|12753624|P1|STARTED|Overall Study||5
5185552|NCT01123850|12753634|P1|NOT COMPLETED|Overall Study||45
5185553|NCT01123850|12753634|P1|COMPLETED|Overall Study||0
5185554|NCT01123850|12753634|P1|STARTED|Overall Study||45
5185555|NCT01123655|12753641|P3|NOT COMPLETED|Overall Study||1
5185556|NCT01123655|12753642|P2|NOT COMPLETED|Overall Study||1
5185557|NCT01123655|12753643|P1|NOT COMPLETED|Overall Study||1
5185558|NCT01123655|12753641|P3|COMPLETED|Overall Study||7
5185559|NCT01123655|12753642|P2|COMPLETED|Overall Study||3
5185560|NCT01123655|12753643|P1|COMPLETED|Overall Study||9
5185561|NCT01123655|12753641|P3|STARTED|Overall Study||8
5185562|NCT01123655|12753642|P2|STARTED|Overall Study||4
5185563|NCT01123655|12753643|P1|STARTED|Overall Study||10
5185564|NCT01123642|12753715|P1|NOT COMPLETED|Overall Study||68
5185565|NCT01123642|12753715|P1|COMPLETED|Overall Study||277
5185566|NCT01123642|12753715|P1|STARTED|Overall Study||345
5185567|NCT01123512|12753724|P2|NOT COMPLETED|Overall Study||21
5185568|NCT01123512|12753725|P1|NOT COMPLETED|Overall Study||26
5185569|NCT01123512|12753724|P2|COMPLETED|Overall Study||126
5185570|NCT01123512|12753725|P1|COMPLETED|Overall Study||127
5185571|NCT01123512|12753724|P2|STARTED|Overall Study||147
5185572|NCT01123512|12753725|P1|STARTED|Overall Study||153
5185573|NCT01123395|12753731|P2|NOT COMPLETED|Period 2||0
5185574|NCT01123395|12753732|P1|NOT COMPLETED|Period 2||0
5185575|NCT01123395|12753731|P2|COMPLETED|Period 2||7
5185576|NCT01123395|12753732|P1|COMPLETED|Period 2||8
5185577|NCT01123395|12753731|P2|STARTED|Period 2||7
5185578|NCT01123395|12753732|P1|STARTED|Period 2||8
5185579|NCT01123395|12753731|P2|NOT COMPLETED|Washout Period of 14 Days||1
5185580|NCT01123395|12753732|P1|NOT COMPLETED|Washout Period of 14 Days||0
5185581|NCT01123395|12753731|P2|COMPLETED|Washout Period of 14 Days||7
5185582|NCT01123395|12753732|P1|COMPLETED|Washout Period of 14 Days||8
5185583|NCT01123395|12753731|P2|STARTED|Washout Period of 14 Days||8
5185584|NCT01123395|12753732|P1|STARTED|Washout Period of 14 Days||8
5185585|NCT01123395|12753731|P2|NOT COMPLETED|Period 1||0
5185586|NCT01123395|12753732|P1|NOT COMPLETED|Period 1||0
5185587|NCT01123395|12753731|P2|COMPLETED|Period 1||8
5185588|NCT01123395|12753732|P1|COMPLETED|Period 1||8
5185589|NCT01123395|12753731|P2|STARTED|Period 1||8
5185590|NCT01123395|12753732|P1|STARTED|Period 1||8
5185591|NCT01123382|12753744|P2|NOT COMPLETED|Overall Study||6
5185592|NCT01123382|12753745|P1|NOT COMPLETED|Overall Study||2
5185593|NCT01123382|12753744|P2|COMPLETED|Overall Study||6
5185594|NCT01123382|12753745|P1|COMPLETED|Overall Study||11
5185595|NCT01123382|12753744|P2|Received Intervention|Overall Study||10
5185596|NCT01123382|12753745|P1|Received Intervention|Overall Study||12
5185597|NCT01123382|12753744|P2|STARTED|Overall Study||12
5185598|NCT01123382|12753745|P1|STARTED|Overall Study||13
5185599|NCT01123356|12753767|P1|NOT COMPLETED|Overall Study||7
5185600|NCT01123356|12753767|P1|COMPLETED|Overall Study||14
5185601|NCT01123356|12753767|P1|STARTED|Overall Study||21
5185602|NCT01123200|12753775|P1|NOT COMPLETED|Overall Study||1
5185603|NCT01123200|12753775|P1|COMPLETED|Overall Study||0
5185604|NCT01123200|12753775|P1|STARTED|Overall Study||1
5185605|NCT01123161|12753782|P2|NOT COMPLETED|Overall Study||0
5185606|NCT01123161|12753783|P1|NOT COMPLETED|Overall Study||2
5185607|NCT01123161|12753782|P2|COMPLETED|Overall Study||63
5185608|NCT01123161|12753783|P1|COMPLETED|Overall Study||55
5185609|NCT01123161|12753782|P2|STARTED|Overall Study||63
5185610|NCT01123161|12753783|P1|STARTED|Overall Study||57
5185611|NCT01123148|12753801|P1|NOT COMPLETED|Overall Study||2
5185612|NCT01123148|12753801|P1|COMPLETED|Overall Study||12
5185613|NCT01123148|12753801|P1|BCI Calibration >50% Accuracy|Overall Study||13
5185614|NCT01123148|12753801|P1|STARTED|Overall Study||14
5185615|NCT01123083|12753807|P2|NOT COMPLETED|Overall Study||15
5185616|NCT01123083|12753808|P1|NOT COMPLETED|Overall Study||11
5185617|NCT01123083|12753807|P2|COMPLETED|Overall Study||103
5185618|NCT01123083|12753808|P1|COMPLETED|Overall Study||50
5185619|NCT01123083|12753807|P2|STARTED|Overall Study||118
5185620|NCT01123083|12753808|P1|STARTED|Overall Study||61
5185621|NCT01122927|12753832|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
5185622|NCT01122927|12753833|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
5185623|NCT01122927|12753832|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
5185624|NCT01122927|12753833|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
5185625|NCT01122927|12753832|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
5185626|NCT01122927|12753833|P1|STARTED|Period 2- Open-label Treatment Phase||0
5185627|NCT01122927|12753832|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
5185628|NCT01122927|12753833|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
5185629|NCT01122927|12753832|P2|COMPLETED|Period 1 - Conversion Phase||0
5185630|NCT01122927|12753833|P1|COMPLETED|Period 1 - Conversion Phase||283
5185631|NCT01122927|12753832|P2|STARTED|Period 1 - Conversion Phase||0
5185632|NCT01122927|12753833|P1|STARTED|Period 1 - Conversion Phase||297
5185633|NCT01122901|12753866|P2|NOT COMPLETED|Overall Study||0
5185634|NCT01122901|12753867|P1|NOT COMPLETED|Overall Study||0
5185635|NCT01122901|12753866|P2|COMPLETED|Overall Study||7
5185636|NCT01122901|12753867|P1|COMPLETED|Overall Study||40
5185637|NCT01122901|12753866|P2|STARTED|Overall Study||7
5185638|NCT01122901|12753867|P1|STARTED|Overall Study||40
5185639|NCT01122862|12753885|P3|NOT COMPLETED|Period 3||0
5185640|NCT01122862|12753886|P2|NOT COMPLETED|Period 3||0
5185641|NCT01122862|12753887|P1|NOT COMPLETED|Period 3||0
5185642|NCT01122862|12753885|P3|COMPLETED|Period 3||8
5185643|NCT01122862|12753886|P2|COMPLETED|Period 3||7
5185644|NCT01122862|12753887|P1|COMPLETED|Period 3||6
5185645|NCT01122862|12753885|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
5185646|NCT01122862|12753886|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
5185647|NCT01122862|12753887|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
5185648|NCT01122862|12753885|P3|NOT COMPLETED|Period 2||1
5185649|NCT01122862|12753886|P2|NOT COMPLETED|Period 2||0
5185650|NCT01122862|12753887|P1|NOT COMPLETED|Period 2||0
5185651|NCT01122862|12753885|P3|COMPLETED|Period 2||6
5185652|NCT01122862|12753886|P2|COMPLETED|Period 2||7
5185653|NCT01122862|12753887|P1|COMPLETED|Period 2||8
5185654|NCT01122862|12753885|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
5185655|NCT01122862|12753886|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
5185656|NCT01122862|12753887|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
5185657|NCT01122862|12753885|P3|NOT COMPLETED|Period 1||0
5185658|NCT01122862|12753886|P2|NOT COMPLETED|Period 1||1
5185659|NCT01122862|12753887|P1|NOT COMPLETED|Period 1||0
5185660|NCT01122862|12753885|P3|COMPLETED|Period 1||7
5185661|NCT01122862|12753886|P2|COMPLETED|Period 1||7
5185662|NCT01122862|12753887|P1|COMPLETED|Period 1||8
5185663|NCT01122862|12753885|P3|STARTED|Period 1||7
5185664|NCT01122862|12753886|P2|STARTED|Period 1||8
5185665|NCT01122862|12753887|P1|STARTED|Period 1||8
5185666|NCT01122849|12753908|P3|NOT COMPLETED|Overall Study||0
5185667|NCT01122849|12753909|P2|NOT COMPLETED|Overall Study||0
5185668|NCT01122849|12753910|P1|NOT COMPLETED|Overall Study||0
5185669|NCT01122849|12753908|P3|COMPLETED|Overall Study||20
5185670|NCT01122849|12753909|P2|COMPLETED|Overall Study||21
5185671|NCT01122849|12753910|P1|COMPLETED|Overall Study||20
5185672|NCT01122849|12753908|P3|STARTED|Overall Study||20
5185673|NCT01122849|12753909|P2|STARTED|Overall Study||21
5185674|NCT01122849|12753910|P1|STARTED|Overall Study||20
5185675|NCT01122680|12753993|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
5185676|NCT01122680|12753994|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
5185677|NCT01122680|12753995|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
5185678|NCT01122680|12753996|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
5185679|NCT01122680|12753993|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
5185680|NCT01122680|12753994|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
5185681|NCT01122680|12753995|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
5185682|NCT01122680|12753996|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
5185683|NCT01122680|12753993|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
5185684|NCT01122680|12753994|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
5185685|NCT01122680|12753995|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
5185686|NCT01122680|12753996|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
5185687|NCT01122680|12753993|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
5185688|NCT01122680|12753994|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
5185689|NCT01122680|12753995|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
5185690|NCT01122680|12753996|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
5185691|NCT01122680|12753993|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
5185692|NCT01122680|12753994|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
5185693|NCT01122680|12753995|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
5185694|NCT01122680|12753996|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
5185695|NCT01122680|12753993|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
5185696|NCT01122680|12753994|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
5185697|NCT01122680|12753995|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
5185698|NCT01122680|12753996|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
5185699|NCT01122680|12753993|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
5185700|NCT01122680|12753994|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
5185701|NCT01122680|12753995|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
5185702|NCT01122680|12753996|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
5185703|NCT01122680|12753993|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
5185704|NCT01122680|12753994|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
5185705|NCT01122680|12753995|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
5185706|NCT01122680|12753996|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
5185707|NCT01122680|12753993|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
5185708|NCT01122680|12753994|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
5185709|NCT01122680|12753995|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
5185710|NCT01122680|12753996|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
5185711|NCT01122576|12754061|P3|NOT COMPLETED|Post-Cataract Surgery||2
5185712|NCT01122576|12754062|P2|NOT COMPLETED|Post-Cataract Surgery||0
5185713|NCT01122576|12754063|P1|NOT COMPLETED|Post-Cataract Surgery||0
5185714|NCT01122576|12754061|P3|COMPLETED|Post-Cataract Surgery||22
5185715|NCT01122576|12754062|P2|COMPLETED|Post-Cataract Surgery||25
5185716|NCT01122576|12754063|P1|COMPLETED|Post-Cataract Surgery||26
5185717|NCT01122576|12754061|P3|STARTED|Post-Cataract Surgery||24
5185718|NCT01122576|12754062|P2|STARTED|Post-Cataract Surgery||25
5185719|NCT01122576|12754063|P1|STARTED|Post-Cataract Surgery||26
5185720|NCT01122576|12754061|P3|NOT COMPLETED|Pre-Cataract Surgery||2
5185721|NCT01122576|12754062|P2|NOT COMPLETED|Pre-Cataract Surgery||1
5185722|NCT01122576|12754063|P1|NOT COMPLETED|Pre-Cataract Surgery||0
5185723|NCT01122576|12754061|P3|COMPLETED|Pre-Cataract Surgery||24
5185724|NCT01122576|12754062|P2|COMPLETED|Pre-Cataract Surgery||25
5185725|NCT01122576|12754063|P1|COMPLETED|Pre-Cataract Surgery||26
5185726|NCT01122576|12754061|P3|STARTED|Pre-Cataract Surgery||26
5185727|NCT01122576|12754062|P2|STARTED|Pre-Cataract Surgery||26
5185728|NCT01122576|12754063|P1|STARTED|Pre-Cataract Surgery||26
5185729|NCT01122511|12754202|P2|NOT COMPLETED|Overall Study||2
5185730|NCT01122511|12754203|P1|NOT COMPLETED|Overall Study||2
5185731|NCT01122511|12754202|P2|COMPLETED|Overall Study||0
5185732|NCT01122511|12754203|P1|COMPLETED|Overall Study||0
5185733|NCT01122511|12754202|P2|STARTED|Overall Study||2
5185734|NCT01122511|12754203|P1|STARTED|Overall Study||2
5185735|NCT01122446|12754217|P2|NOT COMPLETED|Overall Study||0
5185736|NCT01122446|12754218|P1|NOT COMPLETED|Overall Study||0
5185737|NCT01122446|12754217|P2|COMPLETED|Overall Study||25
5185738|NCT01122446|12754218|P1|COMPLETED|Overall Study||25
5185739|NCT01122446|12754217|P2|STARTED|Overall Study||25
5185740|NCT01122446|12754218|P1|STARTED|Overall Study||25
5185741|NCT01122394|12754244|P2|NOT COMPLETED|Overall Study||4
5185742|NCT01122394|12754245|P1|NOT COMPLETED|Overall Study||3
5185743|NCT01122394|12754244|P2|COMPLETED|Overall Study||70
5185744|NCT01122394|12754245|P1|COMPLETED|Overall Study||63
5185745|NCT01122394|12754244|P2|STARTED|Overall Study||74
5185746|NCT01122394|12754245|P1|STARTED|Overall Study||66
5185747|NCT01122381|12754261|P2|NOT COMPLETED|Overall Study||1
5185748|NCT01122381|12754262|P1|NOT COMPLETED|Overall Study||0
5185749|NCT01122381|12754261|P2|COMPLETED|Overall Study||0
5185750|NCT01122381|12754262|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
5185751|NCT01122381|12754261|P2|STARTED|Overall Study||1
5185752|NCT01122381|12754262|P1|STARTED|Overall Study||1
5185753|NCT01122264|12754271|P3|NOT COMPLETED|Overall Study||47
5185754|NCT01122264|12754272|P2|NOT COMPLETED|Overall Study||29
5185755|NCT01122264|12754273|P1|NOT COMPLETED|Overall Study||32
5185756|NCT01122264|12754271|P3|COMPLETED|Overall Study||214
5185757|NCT01122264|12754272|P2|COMPLETED|Overall Study||228
5185758|NCT01122264|12754273|P1|COMPLETED|Overall Study||220
5185759|NCT01122264|12754271|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
5185760|NCT01122264|12754272|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
5185761|NCT01122264|12754273|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
5185762|NCT01122264|12754271|P3|STARTED|Overall Study||261
5185763|NCT01122264|12754272|P2|STARTED|Overall Study||257
5185764|NCT01122264|12754273|P1|STARTED|Overall Study||252
5185765|NCT01122238|12754346|P16|NOT COMPLETED|Overall Study||0
5185766|NCT01122238|12754347|P15|NOT COMPLETED|Overall Study||0
5185767|NCT01122238|12754348|P14|NOT COMPLETED|Overall Study||1
5185768|NCT01122238|12754349|P13|NOT COMPLETED|Overall Study||2
5185769|NCT01122238|12754350|P12|NOT COMPLETED|Overall Study||2
5185770|NCT01122238|12754351|P11|NOT COMPLETED|Overall Study||0
5185771|NCT01122238|12754352|P10|NOT COMPLETED|Overall Study||1
5185772|NCT01122238|12754353|P9|NOT COMPLETED|Overall Study||1
5185773|NCT01122238|12754354|P8|NOT COMPLETED|Overall Study||0
5185774|NCT01122238|12754355|P7|NOT COMPLETED|Overall Study||1
5185775|NCT01122238|12754356|P6|NOT COMPLETED|Overall Study||1
5185776|NCT01122238|12754357|P5|NOT COMPLETED|Overall Study||0
5185777|NCT01122238|12754358|P4|NOT COMPLETED|Overall Study||0
5185778|NCT01122238|12754359|P3|NOT COMPLETED|Overall Study||5
5185779|NCT01122238|12754360|P2|NOT COMPLETED|Overall Study||1
5185780|NCT01122238|12754361|P1|NOT COMPLETED|Overall Study||2
5185781|NCT01122238|12754346|P16|COMPLETED|Overall Study||31
5185782|NCT01122238|12754347|P15|COMPLETED|Overall Study||28
5185783|NCT01122238|12754348|P14|COMPLETED|Overall Study||31
5185784|NCT01122238|12754349|P13|COMPLETED|Overall Study||28
5185785|NCT01122238|12754350|P12|COMPLETED|Overall Study||31
5185786|NCT01122238|12754351|P11|COMPLETED|Overall Study||32
5185787|NCT01122238|12754352|P10|COMPLETED|Overall Study||33
5185788|NCT01122238|12754353|P9|COMPLETED|Overall Study||31
5185789|NCT01122238|12754354|P8|COMPLETED|Overall Study||32
5185790|NCT01122238|12754355|P7|COMPLETED|Overall Study||34
5185791|NCT01122238|12754356|P6|COMPLETED|Overall Study||31
5185792|NCT01122238|12754357|P5|COMPLETED|Overall Study||33
5185793|NCT01122238|12754358|P4|COMPLETED|Overall Study||33
5185794|NCT01122238|12754359|P3|COMPLETED|Overall Study||28
5185795|NCT01122238|12754360|P2|COMPLETED|Overall Study||36
5185796|NCT01122238|12754361|P1|COMPLETED|Overall Study||28
5185797|NCT01122238|12754346|P16|STARTED|Overall Study||31
5185798|NCT01122238|12754347|P15|STARTED|Overall Study||28
5185799|NCT01122238|12754348|P14|STARTED|Overall Study||32
5185800|NCT01122238|12754349|P13|STARTED|Overall Study||30
5185801|NCT01122238|12754350|P12|STARTED|Overall Study||33
5185802|NCT01122238|12754351|P11|STARTED|Overall Study||32
5185803|NCT01122238|12754352|P10|STARTED|Overall Study||34
5185804|NCT01122238|12754353|P9|STARTED|Overall Study||32
5185805|NCT01122238|12754354|P8|STARTED|Overall Study||32
5185806|NCT01122238|12754355|P7|STARTED|Overall Study||35
5185807|NCT01122238|12754356|P6|STARTED|Overall Study||32
5185808|NCT01122238|12754357|P5|STARTED|Overall Study||33
5185809|NCT01122238|12754358|P4|STARTED|Overall Study||33
5185810|NCT01122238|12754359|P3|STARTED|Overall Study||33
5185811|NCT01122238|12754360|P2|STARTED|Overall Study||37
5185812|NCT01122238|12754361|P1|STARTED|Overall Study||30
5185813|NCT01122173|12754383|P1|NOT COMPLETED|Overall Study||9
5185814|NCT01122173|12754383|P1|COMPLETED|Overall Study||141
5185815|NCT01122173|12754383|P1|STARTED|Overall Study||150
5185816|NCT01122160|12754390|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5185817|NCT01122160|12754391|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5185818|NCT01122160|12754390|P2|COMPLETED|Second Intervention (7 Days)||5
5185819|NCT01122160|12754391|P1|COMPLETED|Second Intervention (7 Days)||6
5185820|NCT01122160|12754390|P2|STARTED|Second Intervention (7 Days)||5
5185821|NCT01122160|12754391|P1|STARTED|Second Intervention (7 Days)||6
5185822|NCT01122160|12754390|P2|NOT COMPLETED|Washout (7-14 Days)||0
5185823|NCT01122160|12754391|P1|NOT COMPLETED|Washout (7-14 Days)||0
5185824|NCT01122160|12754390|P2|COMPLETED|Washout (7-14 Days)||5
5185825|NCT01122160|12754391|P1|COMPLETED|Washout (7-14 Days)||6
5185826|NCT01122160|12754390|P2|STARTED|Washout (7-14 Days)||5
5185827|NCT01122160|12754391|P1|STARTED|Washout (7-14 Days)||6
5185828|NCT01122160|12754390|P2|NOT COMPLETED|First Intervention (7 Days)||0
5185829|NCT01122160|12754391|P1|NOT COMPLETED|First Intervention (7 Days)||0
5185830|NCT01122160|12754390|P2|COMPLETED|First Intervention (7 Days)||5
5185831|NCT01122160|12754391|P1|COMPLETED|First Intervention (7 Days)||6
5185832|NCT01122160|12754390|P2|STARTED|First Intervention (7 Days)||5
5185833|NCT01122160|12754391|P1|STARTED|First Intervention (7 Days)||6
5185834|NCT01122108|12754397|P2|NOT COMPLETED|Overall Study||0
5185835|NCT01122108|12754398|P1|NOT COMPLETED|Overall Study||0
5185836|NCT01122108|12754397|P2|COMPLETED|Overall Study||21
5185837|NCT01122108|12754398|P1|COMPLETED|Overall Study||21
5185838|NCT01122108|12754397|P2|STARTED|Overall Study||21
5185839|NCT01122108|12754398|P1|STARTED|Overall Study||21
5185840|NCT01122030|12754414|P7|NOT COMPLETED|Overall Study||0
5185841|NCT01122030|12754415|P6|NOT COMPLETED|Overall Study||0
5185842|NCT01122030|12754416|P5|NOT COMPLETED|Overall Study||0
5185843|NCT01122030|12754417|P4|NOT COMPLETED|Overall Study||0
5185844|NCT01122030|12754418|P3|NOT COMPLETED|Overall Study||0
5185845|NCT01122030|12754419|P2|NOT COMPLETED|Overall Study||0
5185846|NCT01122030|12754420|P1|NOT COMPLETED|Overall Study||0
5185847|NCT01122030|12754414|P7|COMPLETED|Overall Study||9
5185848|NCT01122030|12754415|P6|COMPLETED|Overall Study||9
5185849|NCT01122030|12754416|P5|COMPLETED|Overall Study||9
5185850|NCT01122030|12754417|P4|COMPLETED|Overall Study||9
5185851|NCT01122030|12754418|P3|COMPLETED|Overall Study||9
5185852|NCT01122030|12754419|P2|COMPLETED|Overall Study||9
5185853|NCT01122030|12754420|P1|COMPLETED|Overall Study||18
5185854|NCT01122030|12754414|P7|Received Treatment|Overall Study||9
5185855|NCT01122030|12754415|P6|Received Treatment|Overall Study||9
5185856|NCT01122030|12754416|P5|Received Treatment|Overall Study||9
5185857|NCT01122030|12754417|P4|Received Treatment|Overall Study||9
5185858|NCT01122030|12754418|P3|Received Treatment|Overall Study||9
5185859|NCT01122030|12754419|P2|Received Treatment|Overall Study||9
5185860|NCT01122030|12754420|P1|Received Treatment|Overall Study||18
5185861|NCT01122030|12754414|P7|STARTED|Overall Study||9
5185862|NCT01122030|12754415|P6|STARTED|Overall Study||9
5185863|NCT01122030|12754416|P5|STARTED|Overall Study||9
5185864|NCT01122030|12754417|P4|STARTED|Overall Study||9
5185865|NCT01122030|12754418|P3|STARTED|Overall Study||9
5185866|NCT01122030|12754419|P2|STARTED|Overall Study||9
5185867|NCT01122030|12754420|P1|STARTED|Overall Study||18
5185868|NCT01121991|12754606|P1|NOT COMPLETED|Overall Study||6
5185869|NCT01121991|12754606|P1|COMPLETED|Overall Study||46
5185870|NCT01121991|12754606|P1|STARTED|Overall Study|Number of participants treated|52
5185871|NCT01121939|12754617|P1|NOT COMPLETED|Overall Study||43
5185872|NCT01121939|12754617|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
5185873|NCT01121939|12754617|P1|STARTED|Overall Study||43
5185874|NCT01121926|12754631|P2|NOT COMPLETED|Second Intervention Period||0
5185875|NCT01121926|12754632|P1|NOT COMPLETED|Second Intervention Period||0
5185876|NCT01121926|12754631|P2|COMPLETED|Second Intervention Period||13
5185877|NCT01121926|12754632|P1|COMPLETED|Second Intervention Period||14
5185878|NCT01121926|12754631|P2|STARTED|Second Intervention Period||13
5185879|NCT01121926|12754632|P1|STARTED|Second Intervention Period||14
5185880|NCT01121926|12754631|P2|NOT COMPLETED|Washout Period||2
5185881|NCT01121926|12754632|P1|NOT COMPLETED|Washout Period||0
5185882|NCT01121926|12754631|P2|COMPLETED|Washout Period||13
5185883|NCT01121926|12754632|P1|COMPLETED|Washout Period||14
5185884|NCT01121926|12754631|P2|STARTED|Washout Period||15
5185885|NCT01121926|12754632|P1|STARTED|Washout Period||14
5185886|NCT01121926|12754631|P2|NOT COMPLETED|First Intervention Period||0
5185887|NCT01121926|12754632|P1|NOT COMPLETED|First Intervention Period||1
5185888|NCT01121926|12754631|P2|COMPLETED|First Intervention Period||15
5185889|NCT01121926|12754632|P1|COMPLETED|First Intervention Period||14
5185890|NCT01121926|12754631|P2|STARTED|First Intervention Period||15
5185891|NCT01121926|12754632|P1|STARTED|First Intervention Period||15
5185892|NCT01121913|12754650|P4|NOT COMPLETED|Fourth Intervention Period||0
5185893|NCT01121913|12754651|P3|NOT COMPLETED|Fourth Intervention Period||0
5185894|NCT01121913|12754652|P2|NOT COMPLETED|Fourth Intervention Period||0
5185895|NCT01121913|12754653|P1|NOT COMPLETED|Fourth Intervention Period||0
5185896|NCT01121913|12754650|P4|COMPLETED|Fourth Intervention Period||6
5185897|NCT01121913|12754651|P3|COMPLETED|Fourth Intervention Period||3
5185898|NCT01121913|12754652|P2|COMPLETED|Fourth Intervention Period||6
5185899|NCT01121913|12754653|P1|COMPLETED|Fourth Intervention Period||4
5185900|NCT01121913|12754650|P4|STARTED|Fourth Intervention Period||6
5185901|NCT01121913|12754651|P3|STARTED|Fourth Intervention Period||3
5185902|NCT01121913|12754652|P2|STARTED|Fourth Intervention Period||6
5185903|NCT01121913|12754653|P1|STARTED|Fourth Intervention Period||4
5185904|NCT01121913|12754650|P4|NOT COMPLETED|Third Washout Period||0
5185905|NCT01121913|12754651|P3|NOT COMPLETED|Third Washout Period||0
5185906|NCT01121913|12754652|P2|NOT COMPLETED|Third Washout Period||0
5185907|NCT01121913|12754653|P1|NOT COMPLETED|Third Washout Period||1
5185908|NCT01121913|12754650|P4|COMPLETED|Third Washout Period||6
5185909|NCT01121913|12754651|P3|COMPLETED|Third Washout Period||3
5185910|NCT01121913|12754652|P2|COMPLETED|Third Washout Period||6
5185911|NCT01121913|12754653|P1|COMPLETED|Third Washout Period||4
5185912|NCT01121913|12754650|P4|STARTED|Third Washout Period||6
5185913|NCT01121913|12754651|P3|STARTED|Third Washout Period||3
5185914|NCT01121913|12754652|P2|STARTED|Third Washout Period||6
5185915|NCT01121913|12754653|P1|STARTED|Third Washout Period||5
5185916|NCT01121913|12754650|P4|NOT COMPLETED|Third Intervention Period||0
5185917|NCT01121913|12754651|P3|NOT COMPLETED|Third Intervention Period||0
5185918|NCT01121913|12754652|P2|NOT COMPLETED|Third Intervention Period||0
5185919|NCT01121913|12754653|P1|NOT COMPLETED|Third Intervention Period||0
5185920|NCT01121913|12754650|P4|COMPLETED|Third Intervention Period||6
5185921|NCT01121913|12754651|P3|COMPLETED|Third Intervention Period||3
5185922|NCT01121913|12754652|P2|COMPLETED|Third Intervention Period||6
5185923|NCT01121913|12754653|P1|COMPLETED|Third Intervention Period||5
5185924|NCT01121913|12754650|P4|STARTED|Third Intervention Period||6
5185925|NCT01121913|12754651|P3|STARTED|Third Intervention Period||3
5185926|NCT01121913|12754652|P2|STARTED|Third Intervention Period||6
5185927|NCT01121913|12754653|P1|STARTED|Third Intervention Period||5
5185928|NCT01121913|12754650|P4|NOT COMPLETED|Second Washout Period||0
5185929|NCT01121913|12754651|P3|NOT COMPLETED|Second Washout Period||1
5185930|NCT01121913|12754652|P2|NOT COMPLETED|Second Washout Period||0
5185931|NCT01121913|12754653|P1|NOT COMPLETED|Second Washout Period||0
5185932|NCT01121913|12754650|P4|COMPLETED|Second Washout Period||6
5185933|NCT01121913|12754651|P3|COMPLETED|Second Washout Period||3
5185934|NCT01121913|12754652|P2|COMPLETED|Second Washout Period||6
5185935|NCT01121913|12754653|P1|COMPLETED|Second Washout Period||5
5185936|NCT01121913|12754650|P4|STARTED|Second Washout Period||6
5185937|NCT01121913|12754651|P3|STARTED|Second Washout Period||4
5185938|NCT01121913|12754652|P2|STARTED|Second Washout Period||6
5185939|NCT01121913|12754653|P1|STARTED|Second Washout Period||5
5185940|NCT01121913|12754650|P4|NOT COMPLETED|Second Intervention Period||0
5185941|NCT01121913|12754651|P3|NOT COMPLETED|Second Intervention Period||1
5185942|NCT01121913|12754652|P2|NOT COMPLETED|Second Intervention Period||0
5185943|NCT01121913|12754653|P1|NOT COMPLETED|Second Intervention Period||0
5185944|NCT01121913|12754650|P4|COMPLETED|Second Intervention Period||6
5185945|NCT01121913|12754651|P3|COMPLETED|Second Intervention Period||4
5185946|NCT01121913|12754652|P2|COMPLETED|Second Intervention Period||6
5185947|NCT01121913|12754653|P1|COMPLETED|Second Intervention Period||5
5185948|NCT01121913|12754650|P4|STARTED|Second Intervention Period||6
5185949|NCT01121913|12754651|P3|STARTED|Second Intervention Period||5
5185950|NCT01121913|12754652|P2|STARTED|Second Intervention Period||6
5185951|NCT01121913|12754653|P1|STARTED|Second Intervention Period||5
5185952|NCT01121913|12754650|P4|NOT COMPLETED|First Washout Period||0
5185953|NCT01121913|12754651|P3|NOT COMPLETED|First Washout Period||0
5185954|NCT01121913|12754652|P2|NOT COMPLETED|First Washout Period||0
5185955|NCT01121913|12754653|P1|NOT COMPLETED|First Washout Period||1
5185956|NCT01121913|12754650|P4|COMPLETED|First Washout Period||6
5185957|NCT01121913|12754651|P3|COMPLETED|First Washout Period||5
5185958|NCT01121913|12754652|P2|COMPLETED|First Washout Period||6
5185959|NCT01121913|12754653|P1|COMPLETED|First Washout Period||5
5185960|NCT01121913|12754650|P4|STARTED|First Washout Period||6
5185961|NCT01121913|12754651|P3|STARTED|First Washout Period||5
5185962|NCT01121913|12754652|P2|STARTED|First Washout Period||6
5185963|NCT01121913|12754653|P1|STARTED|First Washout Period||6
5185964|NCT01121913|12754650|P4|NOT COMPLETED|First Intervention Period||0
5185965|NCT01121913|12754651|P3|NOT COMPLETED|First Intervention Period||1
5185966|NCT01121913|12754652|P2|NOT COMPLETED|First Intervention Period||0
5185967|NCT01121913|12754653|P1|NOT COMPLETED|First Intervention Period||0
5185968|NCT01121913|12754650|P4|COMPLETED|First Intervention Period||6
5185969|NCT01121913|12754651|P3|COMPLETED|First Intervention Period||5
5185970|NCT01121913|12754652|P2|COMPLETED|First Intervention Period||6
5185971|NCT01121913|12754653|P1|COMPLETED|First Intervention Period||6
5185972|NCT01121913|12754650|P4|STARTED|First Intervention Period||6
5185973|NCT01121913|12754651|P3|STARTED|First Intervention Period||6
5185974|NCT01121913|12754652|P2|STARTED|First Intervention Period||6
5185975|NCT01121913|12754653|P1|STARTED|First Intervention Period||6
5185976|NCT01121900|12754683|P2|NOT COMPLETED|Second Intervention Period||0
5185977|NCT01121900|12754684|P1|NOT COMPLETED|Second Intervention Period||0
5185978|NCT01121900|12754683|P2|COMPLETED|Second Intervention Period||11
5185979|NCT01121900|12754684|P1|COMPLETED|Second Intervention Period||12
5185980|NCT01121900|12754683|P2|STARTED|Second Intervention Period||11
5185981|NCT01121900|12754684|P1|STARTED|Second Intervention Period||12
5185982|NCT01121900|12754683|P2|NOT COMPLETED|Washout Period of 7 Days||1
5185983|NCT01121900|12754684|P1|NOT COMPLETED|Washout Period of 7 Days||0
5185984|NCT01121900|12754683|P2|COMPLETED|Washout Period of 7 Days||11
5185985|NCT01121900|12754684|P1|COMPLETED|Washout Period of 7 Days||12
5185986|NCT01121900|12754683|P2|STARTED|Washout Period of 7 Days||12
5185987|NCT01121900|12754684|P1|STARTED|Washout Period of 7 Days||12
5185988|NCT01121900|12754683|P2|NOT COMPLETED|First Intervention Period||1
5185989|NCT01121900|12754684|P1|NOT COMPLETED|First Intervention Period||1
5185990|NCT01121900|12754683|P2|COMPLETED|First Intervention Period||12
5185991|NCT01121900|12754684|P1|COMPLETED|First Intervention Period||12
5185992|NCT01121900|12754683|P2|STARTED|First Intervention Period||13
5185993|NCT01121900|12754684|P1|STARTED|First Intervention Period||13
5185994|NCT01121757|12754704|P2|NOT COMPLETED|Combination||1
5185995|NCT01121757|12754705|P1|NOT COMPLETED|Combination||2
5185996|NCT01121757|12754704|P2|COMPLETED|Combination||0
5185997|NCT01121757|12754705|P1|COMPLETED|Combination||0
5185998|NCT01121757|12754704|P2|STARTED|Combination||1
5185999|NCT01121757|12754705|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
5186000|NCT01121757|12754704|P2|NOT COMPLETED|Second Drug||0
5186001|NCT01121757|12754705|P1|NOT COMPLETED|Second Drug||0
5186002|NCT01121757|12754704|P2|COMPLETED|Second Drug||1
5186003|NCT01121757|12754705|P1|COMPLETED|Second Drug||4
5186004|NCT01121757|12754704|P2|STARTED|Second Drug||1
5186005|NCT01121757|12754705|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
5186006|NCT01121757|12754704|P2|NOT COMPLETED|First Drug||2
5186007|NCT01121757|12754705|P1|NOT COMPLETED|First Drug||1
5186008|NCT01121757|12754704|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
5186009|NCT01121757|12754705|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
5186010|NCT01121757|12754704|P2|STARTED|First Drug||3
5186011|NCT01121757|12754705|P1|STARTED|First Drug||6
5186012|NCT01121666|12754721|P2|NOT COMPLETED|Overall Study||10
5186013|NCT01121666|12754722|P1|NOT COMPLETED|Overall Study||29
5186014|NCT01121666|12754721|P2|COMPLETED|Overall Study||113
5186015|NCT01121666|12754722|P1|COMPLETED|Overall Study||220
5186016|NCT01121666|12754721|P2|STARTED|Overall Study||123
5186017|NCT01121666|12754722|P1|STARTED|Overall Study||249
5186018|NCT01121575|12754778|P6|NOT COMPLETED|Overall Study||12
5186019|NCT01121575|12754779|P5|NOT COMPLETED|Overall Study||25
5186020|NCT01121575|12754780|P4|NOT COMPLETED|Overall Study||6
5186021|NCT01121575|12754781|P3|NOT COMPLETED|Overall Study||7
5186022|NCT01121575|12754782|P2|NOT COMPLETED|Overall Study||6
5186023|NCT01121575|12754783|P1|NOT COMPLETED|Overall Study||14
5186024|NCT01121575|12754778|P6|COMPLETED|Overall Study||0
5186025|NCT01121575|12754779|P5|COMPLETED|Overall Study||0
5186026|NCT01121575|12754780|P4|COMPLETED|Overall Study||0
5186027|NCT01121575|12754781|P3|COMPLETED|Overall Study||0
5186028|NCT01121575|12754782|P2|COMPLETED|Overall Study||0
5186029|NCT01121575|12754783|P1|COMPLETED|Overall Study||0
5186030|NCT01121575|12754778|P6|Treated|Overall Study||12
5186031|NCT01121575|12754779|P5|Treated|Overall Study||25
5186032|NCT01121575|12754780|P4|Treated|Overall Study||6
5186033|NCT01121575|12754781|P3|Treated|Overall Study||7
5186034|NCT01121575|12754782|P2|Treated|Overall Study||6
5186035|NCT01121575|12754783|P1|Treated|Overall Study||14
5186036|NCT01121575|12754778|P6|STARTED|Overall Study||12
5186037|NCT01121575|12754779|P5|STARTED|Overall Study||25
5186038|NCT01121575|12754780|P4|STARTED|Overall Study||6
5186039|NCT01121575|12754781|P3|STARTED|Overall Study||7
5186040|NCT01121575|12754782|P2|STARTED|Overall Study||6
5186041|NCT01121575|12754783|P1|STARTED|Overall Study||14
5186042|NCT01121562|12754907|P1|NOT COMPLETED|Overall Study||12
5186043|NCT01121562|12754907|P1|COMPLETED|Overall Study||0
5186044|NCT01121562|12754907|P1|STARTED|Overall Study||12
5186045|NCT01121549|12754916|P1|NOT COMPLETED|Overall Study||347
5186046|NCT01121549|12754916|P1|COMPLETED|Overall Study||31
5186047|NCT01121549|12754916|P1|STARTED|Overall Study||378
5186048|NCT01121536|12754927|P1|NOT COMPLETED|Overall Study||361
5186049|NCT01121536|12754927|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
5186050|NCT01121536|12754927|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
5186051|NCT01121536|12754927|P1|Safety Population|Overall Study|Participants treated|863
5186052|NCT01121536|12754927|P1|STARTED|Overall Study||867
5186053|NCT01121484|12754948|P2|NOT COMPLETED|Overall Study||43
5186054|NCT01121484|12754949|P1|NOT COMPLETED|Overall Study||33
5186055|NCT01121484|12754948|P2|COMPLETED|Overall Study||178
5186056|NCT01121484|12754949|P1|COMPLETED|Overall Study||185
5186057|NCT01121484|12754948|P2|Treated|Overall Study||217
5186058|NCT01121484|12754949|P1|Treated|Overall Study||217
5186059|NCT01121484|12754948|P2|STARTED|Overall Study||221
5186060|NCT01121484|12754949|P1|STARTED|Overall Study||218
5186061|NCT01121406|12754967|P2|NOT COMPLETED|Overall Study||55
5186062|NCT01121406|12754968|P1|NOT COMPLETED|Overall Study||55
5186063|NCT01121406|12754967|P2|COMPLETED|Overall Study||0
5186064|NCT01121406|12754968|P1|COMPLETED|Overall Study||0
5186065|NCT01121406|12754967|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
5186066|NCT01121406|12754968|P1|STARTED|Overall Study||55
5186067|NCT01121393|12755018|P2|NOT COMPLETED|Overall Study||84
5186068|NCT01121393|12755019|P1|NOT COMPLETED|Overall Study||242
5186069|NCT01121393|12755018|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
5186070|NCT01121393|12755019|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
5186071|NCT01121393|12755018|P2|Treated|Overall Study|Treated|113
5186072|NCT01121393|12755019|P1|Treated|Overall Study|Treated|239
5186073|NCT01121393|12755018|P2|STARTED|Overall Study|Randomised|122
5186074|NCT01121393|12755019|P1|STARTED|Overall Study|Randomised|242
5186075|NCT01121263|12755064|P2|NOT COMPLETED|Overall Study||15
5186076|NCT01121263|12755065|P1|NOT COMPLETED|Overall Study||25
5186077|NCT01121263|12755064|P2|COMPLETED|Overall Study||83
5186078|NCT01121263|12755065|P1|COMPLETED|Overall Study||175
5186079|NCT01121263|12755064|P2|STARTED|Overall Study||98
5186080|NCT01121263|12755065|P1|STARTED|Overall Study||200
5186081|NCT01121250|12755076|P3|NOT COMPLETED|Overall Study||1
5186082|NCT01121250|12755077|P2|NOT COMPLETED|Overall Study||0
5186083|NCT01121250|12755078|P1|NOT COMPLETED|Overall Study||0
5186084|NCT01121250|12755076|P3|COMPLETED|Overall Study||75
5186085|NCT01121250|12755077|P2|COMPLETED|Overall Study||76
5186086|NCT01121250|12755078|P1|COMPLETED|Overall Study||76
5186087|NCT01121250|12755076|P3|STARTED|Overall Study||76
5186088|NCT01121250|12755077|P2|STARTED|Overall Study||76
5186089|NCT01121250|12755078|P1|STARTED|Overall Study||76
5186090|NCT01121224|12755094|P2|NOT COMPLETED|Overall Study||17
5186091|NCT01121224|12755095|P1|NOT COMPLETED|Overall Study||25
5186092|NCT01121224|12755094|P2|COMPLETED|Overall Study||275
5186093|NCT01121224|12755095|P1|COMPLETED|Overall Study||280
5186094|NCT01121224|12755094|P2|STARTED|Overall Study||292
5186095|NCT01121224|12755095|P1|STARTED|Overall Study||305
5186096|NCT01121211|12755145|P2|NOT COMPLETED|Overall Study||12
5186097|NCT01121211|12755146|P1|NOT COMPLETED|Overall Study||11
5186098|NCT01121211|12755145|P2|COMPLETED|Overall Study||35
5186099|NCT01121211|12755146|P1|COMPLETED|Overall Study||32
5186100|NCT01121211|12755145|P2|STARTED|Overall Study||47
5186101|NCT01121211|12755146|P1|STARTED|Overall Study||43
5186102|NCT01121185|12755156|P2|NOT COMPLETED|Overall Study||1
5186103|NCT01121185|12755157|P1|NOT COMPLETED|Overall Study||1
5186104|NCT01121185|12755156|P2|COMPLETED|Overall Study||5
5186105|NCT01121185|12755157|P1|COMPLETED|Overall Study||6
5186106|NCT01121185|12755156|P2|Transplanted|Overall Study||5
5186107|NCT01121185|12755157|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
5186108|NCT01121185|12755156|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
5186109|NCT01121185|12755157|P1|Infused|Overall Study||7
5186110|NCT01121185|12755156|P2|STARTED|Overall Study||6
5186111|NCT01121185|12755157|P1|STARTED|Overall Study||7
5186112|NCT01121172|12755181|P2|NOT COMPLETED|Overall Study||0
5186113|NCT01121172|12755182|P1|NOT COMPLETED|Overall Study||0
5186114|NCT01121172|12755181|P2|COMPLETED|Overall Study||90
5186115|NCT01121172|12755182|P1|COMPLETED|Overall Study||90
5186116|NCT01121172|12755181|P2|STARTED|Overall Study||90
5186117|NCT01121172|12755182|P1|STARTED|Overall Study||90
5186118|NCT01121146|12755191|P2|NOT COMPLETED|Overall Study||42
5186119|NCT01121146|12755192|P1|NOT COMPLETED|Overall Study||26
5186120|NCT01121146|12755191|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
5186121|NCT01121146|12755192|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
5186122|NCT01121146|12755191|P2|STARTED|Overall Study||114
5186123|NCT01121146|12755192|P1|STARTED|Overall Study||116
5186124|NCT01120990|12755206|P1|NOT COMPLETED|Overall Study||0
5186125|NCT01120990|12755206|P1|COMPLETED|Overall Study||51
5186126|NCT01120990|12755206|P1|STARTED|Overall Study||51
5186127|NCT01120899|12755213|P1|NOT COMPLETED|Overall Study||3
5186128|NCT01120899|12755213|P1|COMPLETED|Overall Study||3
5186129|NCT01120899|12755213|P1|Month 18|Overall Study||3
5186130|NCT01120899|12755213|P1|Month 12|Overall Study||3
5186131|NCT01120899|12755213|P1|Month 6|Overall Study||5
5186132|NCT01120899|12755213|P1|STARTED|Overall Study||6
5186133|NCT01120834|12755233|P1|NOT COMPLETED|Overall Study||0
5186134|NCT01120834|12755233|P1|COMPLETED|Overall Study||18
5186135|NCT01120834|12755233|P1|STARTED|Overall Study||18
5186136|NCT01120808|12755237|P1|NOT COMPLETED|Overall Study||46
5186137|NCT01120808|12755237|P1|COMPLETED|Overall Study||90
5186138|NCT01120808|12755237|P1|STARTED|Overall Study||136
5186139|NCT01120782|12755241|P1|NOT COMPLETED|Overall Study||11
5186140|NCT01120782|12755241|P1|COMPLETED|Overall Study||34
5186141|NCT01120782|12755241|P1|STARTED|Overall Study||45
5186142|NCT01120756|12755247|P2|NOT COMPLETED|Overall Study||1
5186143|NCT01120756|12755248|P1|NOT COMPLETED|Overall Study||1
5186144|NCT01120756|12755247|P2|COMPLETED|Overall Study||13
5186145|NCT01120756|12755248|P1|COMPLETED|Overall Study||20
5186146|NCT01120756|12755247|P2|STARTED|Overall Study||14
5186147|NCT01120756|12755248|P1|STARTED|Overall Study||21
5186148|NCT01120717|12755258|P2|NOT COMPLETED|Overall Study||24
5186149|NCT01120717|12755259|P1|NOT COMPLETED|Overall Study||32
5186150|NCT01120717|12755258|P2|COMPLETED|Overall Study||89
5186151|NCT01120717|12755259|P1|COMPLETED|Overall Study||194
5186152|NCT01120717|12755258|P2|Safety Population: Received Study Drug|Overall Study||113
5186153|NCT01120717|12755259|P1|Safety Population: Received Study Drug|Overall Study||225
5186154|NCT01120717|12755258|P2|STARTED|Overall Study||113
5186155|NCT01120717|12755259|P1|STARTED|Overall Study||226
5186156|NCT01120704|12755307|P32|NOT COMPLETED|Overall Study||1
5186157|NCT01120704|12755308|P31|NOT COMPLETED|Overall Study||2
5186158|NCT01120704|12755309|P30|NOT COMPLETED|Overall Study||3
5186159|NCT01120704|12755310|P29|NOT COMPLETED|Overall Study||5
5186160|NCT01120704|12755311|P28|NOT COMPLETED|Overall Study||2
5186161|NCT01120704|12755312|P27|NOT COMPLETED|Overall Study||3
5186162|NCT01120704|12755313|P26|NOT COMPLETED|Overall Study||0
5186163|NCT01120704|12755314|P25|NOT COMPLETED|Overall Study||2
5186164|NCT01120704|12755315|P24|NOT COMPLETED|Overall Study||3
5186165|NCT01120704|12755316|P23|NOT COMPLETED|Overall Study||4
5186166|NCT01120704|12755317|P22|NOT COMPLETED|Overall Study||0
5186167|NCT01120704|12755318|P21|NOT COMPLETED|Overall Study||3
5186168|NCT01120704|12755319|P20|NOT COMPLETED|Overall Study||3
5186169|NCT01120704|12755320|P19|NOT COMPLETED|Overall Study||2
5186170|NCT01120704|12755321|P18|NOT COMPLETED|Overall Study||0
5186171|NCT01120704|12755322|P17|NOT COMPLETED|Overall Study||1
5186172|NCT01120704|12755323|P16|NOT COMPLETED|Overall Study||2
5186173|NCT01120704|12755324|P15|NOT COMPLETED|Overall Study||1
5186174|NCT01120704|12755325|P14|NOT COMPLETED|Overall Study||4
5186175|NCT01120704|12755326|P13|NOT COMPLETED|Overall Study||3
5186176|NCT01120704|12755327|P12|NOT COMPLETED|Overall Study||2
5186177|NCT01120704|12755328|P11|NOT COMPLETED|Overall Study||1
5186178|NCT01120704|12755329|P10|NOT COMPLETED|Overall Study||1
5186179|NCT01120704|12755330|P9|NOT COMPLETED|Overall Study||3
5186180|NCT01120704|12755331|P8|NOT COMPLETED|Overall Study||2
5186181|NCT01120704|12755332|P7|NOT COMPLETED|Overall Study||3
5186182|NCT01120704|12755333|P6|NOT COMPLETED|Overall Study||1
5186183|NCT01120704|12755334|P5|NOT COMPLETED|Overall Study||2
5186184|NCT01120704|12755335|P4|NOT COMPLETED|Overall Study||4
5186185|NCT01120704|12755336|P3|NOT COMPLETED|Overall Study||1
5186186|NCT01120704|12755337|P2|NOT COMPLETED|Overall Study||4
5186187|NCT01120704|12755338|P1|NOT COMPLETED|Overall Study||3
5186188|NCT01120704|12755307|P32|COMPLETED|Overall Study||17
5186189|NCT01120704|12755308|P31|COMPLETED|Overall Study||12
5186190|NCT01120704|12755309|P30|COMPLETED|Overall Study||12
5186191|NCT01120704|12755310|P29|COMPLETED|Overall Study||14
5186192|NCT01120704|12755311|P28|COMPLETED|Overall Study||16
5186193|NCT01120704|12755312|P27|COMPLETED|Overall Study||15
5186194|NCT01120704|12755313|P26|COMPLETED|Overall Study||14
5186195|NCT01120704|12755314|P25|COMPLETED|Overall Study||16
5186196|NCT01120704|12755315|P24|COMPLETED|Overall Study||13
5186197|NCT01120704|12755316|P23|COMPLETED|Overall Study||17
5186198|NCT01120704|12755317|P22|COMPLETED|Overall Study||16
5186199|NCT01120704|12755318|P21|COMPLETED|Overall Study||14
5186200|NCT01120704|12755319|P20|COMPLETED|Overall Study||15
5186201|NCT01120704|12755320|P19|COMPLETED|Overall Study||15
5186202|NCT01120704|12755321|P18|COMPLETED|Overall Study||16
5186203|NCT01120704|12755322|P17|COMPLETED|Overall Study||13
5186204|NCT01120704|12755323|P16|COMPLETED|Overall Study||16
5186205|NCT01120704|12755324|P15|COMPLETED|Overall Study||17
5186206|NCT01120704|12755325|P14|COMPLETED|Overall Study||15
5186207|NCT01120704|12755326|P13|COMPLETED|Overall Study||14
5186208|NCT01120704|12755327|P12|COMPLETED|Overall Study||14
5186209|NCT01120704|12755328|P11|COMPLETED|Overall Study||16
5186210|NCT01120704|12755329|P10|COMPLETED|Overall Study||19
5186211|NCT01120704|12755330|P9|COMPLETED|Overall Study||19
5186212|NCT01120704|12755331|P8|COMPLETED|Overall Study||13
5186213|NCT01120704|12755332|P7|COMPLETED|Overall Study||12
5186214|NCT01120704|12755333|P6|COMPLETED|Overall Study||18
5186215|NCT01120704|12755334|P5|COMPLETED|Overall Study||14
5186216|NCT01120704|12755335|P4|COMPLETED|Overall Study||15
5186217|NCT01120704|12755336|P3|COMPLETED|Overall Study||13
5186218|NCT01120704|12755337|P2|COMPLETED|Overall Study||13
5186219|NCT01120704|12755338|P1|COMPLETED|Overall Study||10
5186220|NCT01120704|12755307|P32|STARTED|Overall Study||18
5186221|NCT01120704|12755308|P31|STARTED|Overall Study||14
5186222|NCT01120704|12755309|P30|STARTED|Overall Study||15
5186223|NCT01120704|12755310|P29|STARTED|Overall Study||19
5186224|NCT01120704|12755311|P28|STARTED|Overall Study||18
5186225|NCT01120704|12755312|P27|STARTED|Overall Study||18
5186226|NCT01120704|12755313|P26|STARTED|Overall Study||14
5186227|NCT01120704|12755314|P25|STARTED|Overall Study||18
5186228|NCT01120704|12755315|P24|STARTED|Overall Study||16
5186229|NCT01120704|12755316|P23|STARTED|Overall Study||21
5186230|NCT01120704|12755317|P22|STARTED|Overall Study||16
5186231|NCT01120704|12755318|P21|STARTED|Overall Study||17
5186232|NCT01120704|12755319|P20|STARTED|Overall Study||18
5186233|NCT01120704|12755320|P19|STARTED|Overall Study||17
5186234|NCT01120704|12755321|P18|STARTED|Overall Study||16
5186235|NCT01120704|12755322|P17|STARTED|Overall Study||14
5186236|NCT01120704|12755323|P16|STARTED|Overall Study||18
5186237|NCT01120704|12755324|P15|STARTED|Overall Study||18
5186238|NCT01120704|12755325|P14|STARTED|Overall Study||19
5186239|NCT01120704|12755326|P13|STARTED|Overall Study||17
5186240|NCT01120704|12755327|P12|STARTED|Overall Study||16
5186241|NCT01120704|12755328|P11|STARTED|Overall Study||17
5186242|NCT01120704|12755329|P10|STARTED|Overall Study||20
5186243|NCT01120704|12755330|P9|STARTED|Overall Study||22
5186244|NCT01120704|12755331|P8|STARTED|Overall Study||15
5186245|NCT01120704|12755332|P7|STARTED|Overall Study||15
5186246|NCT01120704|12755333|P6|STARTED|Overall Study||19
5186247|NCT01120704|12755334|P5|STARTED|Overall Study||16
5186248|NCT01120704|12755335|P4|STARTED|Overall Study||19
5186249|NCT01120704|12755336|P3|STARTED|Overall Study||14
5186250|NCT01120704|12755337|P2|STARTED|Overall Study||17
5186251|NCT01120704|12755338|P1|STARTED|Overall Study||13
5186252|NCT01120691|12755365|P3|NOT COMPLETED|Overall Study||183
5186253|NCT01120691|12755366|P2|NOT COMPLETED|Overall Study||203
5186254|NCT01120691|12755367|P1|NOT COMPLETED|Overall Study||171
5186255|NCT01120691|12755365|P3|COMPLETED|Overall Study||559
5186256|NCT01120691|12755366|P2|COMPLETED|Overall Study||538
5186257|NCT01120691|12755367|P1|COMPLETED|Overall Study||570
5186258|NCT01120691|12755365|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
5186259|NCT01120691|12755366|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
5186260|NCT01120691|12755367|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
5186261|NCT01120691|12755365|P3|Modified Safety Set (mSAF)|Overall Study||737
5186262|NCT01120691|12755366|P2|Modified Safety Set (mSAF)|Overall Study||740
5186263|NCT01120691|12755367|P1|Modified Safety Set (mSAF)|Overall Study||729
5186264|NCT01120691|12755365|P3|Safety Set (SAF)|Overall Study||739
5186265|NCT01120691|12755366|P2|Safety Set (SAF)|Overall Study||740
5186266|NCT01120691|12755367|P1|Safety Set (SAF)|Overall Study||736
5186267|NCT01120691|12755365|P3|Full Analysis Set (FAS)|Overall Study||739
5186268|NCT01120691|12755366|P2|Full Analysis Set (FAS)|Overall Study||739
5186269|NCT01120691|12755367|P1|Full Analysis Set (FAS)|Overall Study||736
5186270|NCT01120691|12755365|P3|STARTED|Overall Study||742
5186271|NCT01120691|12755366|P2|STARTED|Overall Study||741
5186272|NCT01120691|12755367|P1|STARTED|Overall Study||741
5186273|NCT01120639|12755413|P4|NOT COMPLETED|Overall Study||0
5186274|NCT01120639|12755414|P3|NOT COMPLETED|Overall Study||0
5186275|NCT01120639|12755415|P2|NOT COMPLETED|Overall Study||0
5186276|NCT01120639|12755416|P1|NOT COMPLETED|Overall Study||0
5186277|NCT01120639|12755413|P4|COMPLETED|Overall Study||12
5186278|NCT01120639|12755414|P3|COMPLETED|Overall Study||6
5186279|NCT01120639|12755415|P2|COMPLETED|Overall Study||6
5186280|NCT01120639|12755416|P1|COMPLETED|Overall Study||6
5186281|NCT01120639|12755413|P4|STARTED|Overall Study||12
5186282|NCT01120639|12755414|P3|STARTED|Overall Study||6
5186283|NCT01120639|12755415|P2|STARTED|Overall Study||6
5186284|NCT01120639|12755416|P1|STARTED|Overall Study||6
5186285|NCT01120626|12755464|P2|NOT COMPLETED|Overall Study||0
5186286|NCT01120626|12755465|P1|NOT COMPLETED|Overall Study||1
5186287|NCT01120626|12755464|P2|COMPLETED|Overall Study||22
5186288|NCT01120626|12755465|P1|COMPLETED|Overall Study||19
5186289|NCT01120626|12755464|P2|STARTED|Overall Study||22
5186290|NCT01120626|12755465|P1|STARTED|Overall Study||20
5186291|NCT01120600|12755475|P2|NOT COMPLETED|Overall Study||32
5186292|NCT01120600|12755476|P1|NOT COMPLETED|Overall Study||19
5186293|NCT01120600|12755475|P2|COMPLETED|Overall Study||115
5186294|NCT01120600|12755476|P1|COMPLETED|Overall Study||128
5186295|NCT01120600|12755475|P2|Treated|Overall Study||146
5186296|NCT01120600|12755476|P1|Treated|Overall Study||146
5186297|NCT01120600|12755475|P2|STARTED|Overall Study||147
5186298|NCT01120600|12755476|P1|STARTED|Overall Study||147
5186299|NCT01120405|12755502|P2|NOT COMPLETED|Overall Study||33
5186300|NCT01120405|12755503|P1|NOT COMPLETED|Overall Study||27
5186301|NCT01120405|12755502|P2|COMPLETED|Overall Study||269
5186302|NCT01120405|12755503|P1|COMPLETED|Overall Study||271
5186303|NCT01120405|12755502|P2|STARTED|Overall Study||302
5186304|NCT01120405|12755503|P1|STARTED|Overall Study||298
5186305|NCT01120379|12755531|P1|NOT COMPLETED|Four Year Timepoint||368
5186306|NCT01120379|12755531|P1|COMPLETED|Four Year Timepoint||3923
5186307|NCT01120379|12755531|P1|STARTED|Four Year Timepoint||4291
5186308|NCT01120379|12755531|P1|NOT COMPLETED|Three Year Timepoint||214
5186309|NCT01120379|12755531|P1|COMPLETED|Three Year Timepoint||4291
5186310|NCT01120379|12755531|P1|STARTED|Three Year Timepoint||4505
5186311|NCT01120379|12755531|P1|NOT COMPLETED|Two Year Timepoint||237
5186312|NCT01120379|12755531|P1|COMPLETED|Two Year Timepoint||4505
5186313|NCT01120379|12755531|P1|STARTED|Two Year Timepoint||4742
5186314|NCT01120379|12755531|P1|NOT COMPLETED|One Year Timepoint||278
5186315|NCT01120379|12755531|P1|COMPLETED|One Year Timepoint||4742
5186316|NCT01120379|12755531|P1|STARTED|One Year Timepoint||5020
5186317|NCT01120275|12755567|P1|NOT COMPLETED|Overall Study||36
5186318|NCT01120275|12755567|P1|COMPLETED|Overall Study||0
5186319|NCT01120275|12755567|P1|Eligible and Treated|Overall Study||32
5186320|NCT01120275|12755567|P1|STARTED|Overall Study||36
5186321|NCT01120236|12755576|P2|NOT COMPLETED|Overall Study||1
5186322|NCT01120236|12755577|P1|NOT COMPLETED|Overall Study||0
5186323|NCT01120236|12755576|P2|COMPLETED|Overall Study||105
5186324|NCT01120236|12755577|P1|COMPLETED|Overall Study||105
5186325|NCT01120236|12755576|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
5186326|NCT01120236|12755577|P1|Ineligble|Overall Study||0
5186327|NCT01120236|12755576|P2|STARTED|Overall Study||106
5186328|NCT01120236|12755577|P1|STARTED|Overall Study||105
5186329|NCT01120223|12755604|P1|NOT COMPLETED|Overall Study||4
5186330|NCT01120223|12755604|P1|COMPLETED|Overall Study||74
5186331|NCT01120223|12755604|P1|STARTED|Overall Study||78
5186332|NCT01120210|12755634|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
5186333|NCT01120210|12755635|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
5186334|NCT01120210|12755634|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
5186335|NCT01120210|12755635|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
5186336|NCT01120210|12755634|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
5186337|NCT01120210|12755635|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
5186338|NCT01120210|12755634|P2|NOT COMPLETED|MAIN INFUSION||1
5186339|NCT01120210|12755635|P1|NOT COMPLETED|MAIN INFUSION||1
5186340|NCT01120210|12755634|P2|COMPLETED|MAIN INFUSION||45
5186341|NCT01120210|12755635|P1|COMPLETED|MAIN INFUSION||15
5186342|NCT01120210|12755634|P2|STARTED|MAIN INFUSION||46
5186343|NCT01120210|12755635|P1|STARTED|MAIN INFUSION||16
5186344|NCT01120197|12755667|P2|NOT COMPLETED|Overall Study||10
5186345|NCT01120197|12755668|P1|NOT COMPLETED|Overall Study||9
5186346|NCT01120197|12755667|P2|COMPLETED|Overall Study||32
5186347|NCT01120197|12755668|P1|COMPLETED|Overall Study||38
5186348|NCT01120197|12755667|P2|STARTED|Overall Study||42
5186349|NCT01120197|12755668|P1|STARTED|Overall Study||47
5186350|NCT01120184|12755685|P3|NOT COMPLETED|Overall Study||363
5186351|NCT01120184|12755686|P2|NOT COMPLETED|Overall Study||367
5186352|NCT01120184|12755687|P1|NOT COMPLETED|Overall Study||365
5186353|NCT01120184|12755685|P3|COMPLETED|Overall Study||0
5186354|NCT01120184|12755686|P2|COMPLETED|Overall Study||0
5186355|NCT01120184|12755687|P1|COMPLETED|Overall Study||0
5186356|NCT01120184|12755685|P3|Treated|Overall Study||360
5186357|NCT01120184|12755686|P2|Treated|Overall Study||365
5186358|NCT01120184|12755687|P1|Treated|Overall Study||355
5186359|NCT01120184|12755685|P3|STARTED|Overall Study||363
5186360|NCT01120184|12755686|P2|STARTED|Overall Study||367
5186361|NCT01120184|12755687|P1|STARTED|Overall Study||365
5186362|NCT01120093|12755809|P5|NOT COMPLETED|Treatment Period 5||0
5186363|NCT01120093|12755810|P4|NOT COMPLETED|Treatment Period 5||1
5186364|NCT01120093|12755811|P3|NOT COMPLETED|Treatment Period 5||0
5186365|NCT01120093|12755812|P2|NOT COMPLETED|Treatment Period 5||1
5186366|NCT01120093|12755813|P1|NOT COMPLETED|Treatment Period 5||0
5186367|NCT01120093|12755809|P5|COMPLETED|Treatment Period 5||13
5186368|NCT01120093|12755810|P4|COMPLETED|Treatment Period 5||11
5186369|NCT01120093|12755811|P3|COMPLETED|Treatment Period 5||15
5186370|NCT01120093|12755812|P2|COMPLETED|Treatment Period 5||12
5186371|NCT01120093|12755813|P1|COMPLETED|Treatment Period 5||17
5186372|NCT01120093|12755809|P5|STARTED|Treatment Period 5||13
5186373|NCT01120093|12755810|P4|STARTED|Treatment Period 5||12
5186374|NCT01120093|12755811|P3|STARTED|Treatment Period 5||15
5186375|NCT01120093|12755812|P2|STARTED|Treatment Period 5||13
5186376|NCT01120093|12755813|P1|STARTED|Treatment Period 5||17
5186377|NCT01120093|12755809|P5|NOT COMPLETED|Treatment Period 4||0
5186378|NCT01120093|12755810|P4|NOT COMPLETED|Treatment Period 4||0
5186379|NCT01120093|12755811|P3|NOT COMPLETED|Treatment Period 4||0
5186380|NCT01120093|12755812|P2|NOT COMPLETED|Treatment Period 4||0
5186381|NCT01120093|12755813|P1|NOT COMPLETED|Treatment Period 4||1
5186382|NCT01120093|12755809|P5|COMPLETED|Treatment Period 4||13
5186383|NCT01120093|12755810|P4|COMPLETED|Treatment Period 4||12
5186384|NCT01120093|12755811|P3|COMPLETED|Treatment Period 4||15
5186385|NCT01120093|12755812|P2|COMPLETED|Treatment Period 4||13
5186386|NCT01120093|12755813|P1|COMPLETED|Treatment Period 4||17
5186387|NCT01120093|12755809|P5|STARTED|Treatment Period 4||13
5186388|NCT01120093|12755810|P4|STARTED|Treatment Period 4||12
5186389|NCT01120093|12755811|P3|STARTED|Treatment Period 4||15
5186390|NCT01120093|12755812|P2|STARTED|Treatment Period 4||13
5186391|NCT01120093|12755813|P1|STARTED|Treatment Period 4||18
5186392|NCT01120093|12755809|P5|NOT COMPLETED|Treatment Period 3||1
5186393|NCT01120093|12755810|P4|NOT COMPLETED|Treatment Period 3||1
5186394|NCT01120093|12755811|P3|NOT COMPLETED|Treatment Period 3||1
5186395|NCT01120093|12755812|P2|NOT COMPLETED|Treatment Period 3||0
5186396|NCT01120093|12755813|P1|NOT COMPLETED|Treatment Period 3||0
5186397|NCT01120093|12755809|P5|COMPLETED|Treatment Period 3||13
5186398|NCT01120093|12755810|P4|COMPLETED|Treatment Period 3||12
5186399|NCT01120093|12755811|P3|COMPLETED|Treatment Period 3||15
5186400|NCT01120093|12755812|P2|COMPLETED|Treatment Period 3||13
5186401|NCT01120093|12755813|P1|COMPLETED|Treatment Period 3||18
5186402|NCT01120093|12755809|P5|STARTED|Treatment Period 3||14
5186403|NCT01120093|12755810|P4|STARTED|Treatment Period 3||13
5186404|NCT01120093|12755811|P3|STARTED|Treatment Period 3||16
5186405|NCT01120093|12755812|P2|STARTED|Treatment Period 3||13
5186406|NCT01120093|12755813|P1|STARTED|Treatment Period 3||18
5186407|NCT01120093|12755809|P5|NOT COMPLETED|Treatment Period 2||1
5186408|NCT01120093|12755810|P4|NOT COMPLETED|Treatment Period 2||1
5186409|NCT01120093|12755811|P3|NOT COMPLETED|Treatment Period 2||0
5186410|NCT01120093|12755812|P2|NOT COMPLETED|Treatment Period 2||0
5186411|NCT01120093|12755813|P1|NOT COMPLETED|Treatment Period 2||0
5186412|NCT01120093|12755809|P5|COMPLETED|Treatment Period 2||14
5186413|NCT01120093|12755810|P4|COMPLETED|Treatment Period 2||13
5186414|NCT01120093|12755811|P3|COMPLETED|Treatment Period 2||16
5186415|NCT01120093|12755812|P2|COMPLETED|Treatment Period 2||13
5186416|NCT01120093|12755813|P1|COMPLETED|Treatment Period 2||18
5186417|NCT01120093|12755809|P5|STARTED|Treatment Period 2||15
5186418|NCT01120093|12755810|P4|STARTED|Treatment Period 2||14
5186419|NCT01120093|12755811|P3|STARTED|Treatment Period 2||16
5186420|NCT01120093|12755812|P2|STARTED|Treatment Period 2||13
5186421|NCT01120093|12755813|P1|STARTED|Treatment Period 2||18
5186422|NCT01120093|12755809|P5|NOT COMPLETED|Treatment Period 1||1
5186423|NCT01120093|12755810|P4|NOT COMPLETED|Treatment Period 1||0
5186424|NCT01120093|12755811|P3|NOT COMPLETED|Treatment Period 1||1
5186425|NCT01120093|12755812|P2|NOT COMPLETED|Treatment Period 1||1
5186426|NCT01120093|12755813|P1|NOT COMPLETED|Treatment Period 1||0
5186427|NCT01120093|12755809|P5|COMPLETED|Treatment Period 1||15
5186428|NCT01120093|12755810|P4|COMPLETED|Treatment Period 1||14
5186429|NCT01120093|12755811|P3|COMPLETED|Treatment Period 1||16
5186430|NCT01120093|12755812|P2|COMPLETED|Treatment Period 1||13
5186431|NCT01120093|12755813|P1|COMPLETED|Treatment Period 1||18
5186432|NCT01120093|12755809|P5|STARTED|Treatment Period 1||16
5186433|NCT01120093|12755810|P4|STARTED|Treatment Period 1||14
5186434|NCT01120093|12755811|P3|STARTED|Treatment Period 1||17
5186435|NCT01120093|12755812|P2|STARTED|Treatment Period 1||14
5186436|NCT01120093|12755813|P1|STARTED|Treatment Period 1||18
5186437|NCT01120067|12755842|P2|NOT COMPLETED|Overall Study||1
5186438|NCT01120067|12755843|P1|NOT COMPLETED|Overall Study||5
5186439|NCT01120067|12755842|P2|COMPLETED|Overall Study||10
5186440|NCT01120067|12755843|P1|COMPLETED|Overall Study||7
5186441|NCT01120067|12755842|P2|STARTED|Overall Study||11
5186442|NCT01120067|12755843|P1|STARTED|Overall Study||12
5186443|NCT01120028|12755853|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186444|NCT01120028|12755854|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186445|NCT01120028|12755855|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186446|NCT01120028|12755856|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186447|NCT01120028|12755853|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
5186448|NCT01120028|12755854|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
5186449|NCT01120028|12755855|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186450|NCT01120028|12755856|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
5186451|NCT01120028|12755853|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
5186452|NCT01120028|12755854|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
5186453|NCT01120028|12755855|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
5186454|NCT01120028|12755856|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
5186455|NCT01120028|12755853|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
5186456|NCT01120028|12755854|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
5186457|NCT01120028|12755855|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
5186458|NCT01120028|12755856|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
5186459|NCT01120028|12755853|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
5186460|NCT01120028|12755854|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
5186461|NCT01120028|12755855|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
5186462|NCT01120028|12755856|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
5186463|NCT01120028|12755853|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
5186464|NCT01120028|12755854|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
5186465|NCT01120028|12755855|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
5186466|NCT01120028|12755856|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
5186467|NCT01119963|12755880|P2|NOT COMPLETED|Overall Study||1
5186468|NCT01119963|12755881|P1|NOT COMPLETED|Overall Study||1
5186469|NCT01119963|12755880|P2|COMPLETED|Overall Study||77
5186470|NCT01119963|12755881|P1|COMPLETED|Overall Study||73
5186471|NCT01119963|12755880|P2|STARTED|Overall Study||78
5186472|NCT01119963|12755881|P1|STARTED|Overall Study||74
5186473|NCT01119950|12755891|P1|NOT COMPLETED|Overall Study||47
5186474|NCT01119950|12755891|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
5186475|NCT01119950|12755891|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
5186476|NCT01119950|12755891|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
5186477|NCT01119950|12755891|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
5186478|NCT01119950|12755891|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
5186479|NCT01119950|12755891|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
5186480|NCT01119950|12755891|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
5186481|NCT01119950|12755891|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
5186482|NCT01119950|12755891|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
5186483|NCT01119950|12755891|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
5186484|NCT01119937|12756138|P2|NOT COMPLETED|Overall Study||7
5186485|NCT01119937|12756139|P1|NOT COMPLETED|Overall Study||19
5186486|NCT01119937|12756138|P2|COMPLETED|Overall Study||33
5186487|NCT01119937|12756139|P1|COMPLETED|Overall Study||104
5186488|NCT01119937|12756138|P2|STARTED|Overall Study||40
5186489|NCT01119937|12756139|P1|STARTED|Overall Study||123
5186490|NCT01119898|12756167|P2|NOT COMPLETED|Overall Study||12
5186491|NCT01119898|12756168|P1|NOT COMPLETED|Overall Study||8
5186492|NCT01119898|12756167|P2|COMPLETED|Overall Study||117
5186493|NCT01119898|12756168|P1|COMPLETED|Overall Study||123
5186494|NCT01119898|12756167|P2|Received Study Drug (mITT)|Overall Study||129
5186495|NCT01119898|12756168|P1|Received Study Drug (mITT)|Overall Study||130
5186496|NCT01119898|12756167|P2|STARTED|Overall Study||129
5186497|NCT01119898|12756168|P1|STARTED|Overall Study||131
5186498|NCT01119859|12756194|P2|NOT COMPLETED|Overall Study||30
5186499|NCT01119859|12756195|P1|NOT COMPLETED|Overall Study||24
5186500|NCT01119859|12756194|P2|COMPLETED|Overall Study||133
5186501|NCT01119859|12756195|P1|COMPLETED|Overall Study||139
5186502|NCT01119859|12756194|P2|STARTED|Overall Study||163
5186503|NCT01119859|12756195|P1|STARTED|Overall Study||163
5186504|NCT01119846|12756214|P3|NOT COMPLETED|Overall Study||11
5186505|NCT01119846|12756215|P2|NOT COMPLETED|Overall Study||0
5186506|NCT01119846|12756216|P1|NOT COMPLETED|Overall Study||2
5186507|NCT01119846|12756214|P3|COMPLETED|Overall Study||72
5186508|NCT01119846|12756215|P2|COMPLETED|Overall Study||4
5186509|NCT01119846|12756216|P1|COMPLETED|Overall Study||11
5186510|NCT01119846|12756214|P3|STARTED|Overall Study||83
5186511|NCT01119846|12756215|P2|STARTED|Overall Study||4
5186512|NCT01119846|12756216|P1|STARTED|Overall Study||13
5186513|NCT01119794|12756424|P1|NOT COMPLETED|Overall Study||0
5186514|NCT01119794|12756424|P1|COMPLETED|Overall Study||10
5186515|NCT01119794|12756424|P1|STARTED|Overall Study||10
5186516|NCT01119768|12756430|P2|NOT COMPLETED|Follow-up||2
5186517|NCT01119768|12756431|P1|NOT COMPLETED|Follow-up||1
5186518|NCT01119768|12756430|P2|COMPLETED|Follow-up||122
5186519|NCT01119768|12756431|P1|COMPLETED|Follow-up||135
5186520|NCT01119768|12756430|P2|STARTED|Follow-up||124
5186521|NCT01119768|12756431|P1|STARTED|Follow-up||136
5186522|NCT01119768|12756430|P2|NOT COMPLETED|Treatment Period||25
5186523|NCT01119768|12756431|P1|NOT COMPLETED|Treatment Period||18
5186524|NCT01119768|12756430|P2|COMPLETED|Treatment Period||126
5186525|NCT01119768|12756431|P1|COMPLETED|Treatment Period||136
5186526|NCT01119768|12756430|P2|STARTED|Treatment Period||151
5186527|NCT01119768|12756431|P1|STARTED|Treatment Period||154
5186528|NCT01119755|12756453|P1|NOT COMPLETED|Overall Study||0
5186529|NCT01119755|12756453|P1|COMPLETED|Overall Study||80
5186530|NCT01119755|12756453|P1|STARTED|Overall Study||80
5186531|NCT01119716|12756464|P1|NOT COMPLETED|Overall Study||0
5186532|NCT01119716|12756464|P1|COMPLETED|Overall Study||4658
5186533|NCT01119716|12756464|P1|STARTED|Overall Study||4658
5186534|NCT01119703|12756487|P2|NOT COMPLETED|Overall Study||1
5186535|NCT01119703|12756488|P1|NOT COMPLETED|Overall Study||0
5186536|NCT01119703|12756487|P2|COMPLETED|Overall Study||143
5186537|NCT01119703|12756488|P1|COMPLETED|Overall Study||30
5186538|NCT01119703|12756487|P2|STARTED|Overall Study||144
5186539|NCT01119703|12756488|P1|STARTED|Overall Study||30
5186540|NCT01119625|12756502|P2|NOT COMPLETED|Overall Study||4
5186541|NCT01119625|12756503|P1|NOT COMPLETED|Overall Study||3
5186542|NCT01119625|12756502|P2|COMPLETED|Overall Study||116
5186543|NCT01119625|12756503|P1|COMPLETED|Overall Study||115
5186544|NCT01119625|12756502|P2|STARTED|Overall Study||120
5186545|NCT01119625|12756503|P1|STARTED|Overall Study||118
5186546|NCT01119508|12756543|P1|NOT COMPLETED|Overall Study||59
5186547|NCT01119508|12756543|P1|COMPLETED|Overall Study||5
5186548|NCT01119508|12756543|P1|Received Fifth Consolidation Dose week12|Overall Study||32
5186549|NCT01119508|12756543|P1|Received Four Induction Doses|Overall Study||45
5186550|NCT01119508|12756543|P1|STARTED|Overall Study||64
5186551|NCT01119456|12756555|P8|NOT COMPLETED|Overall Study||0
5186552|NCT01119456|12756556|P7|NOT COMPLETED|Overall Study||0
5186553|NCT01119456|12756557|P6|NOT COMPLETED|Overall Study||0
5186554|NCT01119456|12756558|P5|NOT COMPLETED|Overall Study||0
5186555|NCT01119456|12756559|P4|NOT COMPLETED|Overall Study||0
5186556|NCT01119456|12756560|P3|NOT COMPLETED|Overall Study||0
5186557|NCT01119456|12756561|P2|NOT COMPLETED|Overall Study||0
5186558|NCT01119456|12756562|P1|NOT COMPLETED|Overall Study||0
5186559|NCT01119456|12756555|P8|COMPLETED|Overall Study||3
5186560|NCT01119456|12756556|P7|COMPLETED|Overall Study||3
5186561|NCT01119456|12756557|P6|COMPLETED|Overall Study||3
5186562|NCT01119456|12756558|P5|COMPLETED|Overall Study||4
5186563|NCT01119456|12756559|P4|COMPLETED|Overall Study||13
5186564|NCT01119456|12756560|P3|COMPLETED|Overall Study||3
5186565|NCT01119456|12756561|P2|COMPLETED|Overall Study||3
5186566|NCT01119456|12756562|P1|COMPLETED|Overall Study||7
5186567|NCT01119456|12756555|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
5186568|NCT01119456|12756556|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
5186569|NCT01119456|12756557|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
5186570|NCT01119456|12756558|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
5186571|NCT01119456|12756559|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
5186572|NCT01119456|12756560|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5186573|NCT01119456|12756561|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5186574|NCT01119456|12756562|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
5186575|NCT01119456|12756555|P8|STARTED|Overall Study||3
5186576|NCT01119456|12756556|P7|STARTED|Overall Study||3
5186577|NCT01119456|12756557|P6|STARTED|Overall Study||3
5186578|NCT01119456|12756558|P5|STARTED|Overall Study||4
5186579|NCT01119456|12756559|P4|STARTED|Overall Study||13
5186580|NCT01119456|12756560|P3|STARTED|Overall Study||3
5186581|NCT01119456|12756561|P2|STARTED|Overall Study||3
5186582|NCT01119456|12756562|P1|STARTED|Overall Study||7
5186583|NCT01119443|12756623|P2|NOT COMPLETED|End of Study (All Patients)||0
5186584|NCT01119443|12756624|P1|NOT COMPLETED|End of Study (All Patients)||0
5186585|NCT01119443|12756623|P2|COMPLETED|End of Study (All Patients)||14
5186586|NCT01119443|12756624|P1|COMPLETED|End of Study (All Patients)||14
5186587|NCT01119443|12756623|P2|STARTED|End of Study (All Patients)||14
5186588|NCT01119443|12756624|P1|STARTED|End of Study (All Patients)||14
5186589|NCT01119443|12756623|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
5186590|NCT01119443|12756624|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
5186591|NCT01119443|12756623|P2|COMPLETED|Down-titration Period (1 Day)||13
5186592|NCT01119443|12756624|P1|COMPLETED|Down-titration Period (1 Day)||14
5186593|NCT01119443|12756623|P2|STARTED|Down-titration Period (1 Day)||13
5186594|NCT01119443|12756624|P1|STARTED|Down-titration Period (1 Day)||14
5186595|NCT01119443|12756623|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
5186596|NCT01119443|12756624|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
5186597|NCT01119443|12756623|P2|COMPLETED|Crossover Period 4 (5 Days)||13
5186598|NCT01119443|12756624|P1|COMPLETED|Crossover Period 4 (5 Days)||14
5186599|NCT01119443|12756623|P2|STARTED|Crossover Period 4 (5 Days)||13
5186600|NCT01119443|12756624|P1|STARTED|Crossover Period 4 (5 Days)||14
5186601|NCT01119443|12756623|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
5186602|NCT01119443|12756624|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
5186603|NCT01119443|12756623|P2|COMPLETED|Crossover Period 3 (5 Days)||13
5186604|NCT01119443|12756624|P1|COMPLETED|Crossover Period 3 (5 Days)||14
5186605|NCT01119443|12756623|P2|STARTED|Crossover Period 3 (5 Days)||13
5186606|NCT01119443|12756624|P1|STARTED|Crossover Period 3 (5 Days)||14
5186607|NCT01119443|12756623|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
5186608|NCT01119443|12756624|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
5186609|NCT01119443|12756623|P2|COMPLETED|Crossover Period 2 (5 Days)||13
5186610|NCT01119443|12756624|P1|COMPLETED|Crossover Period 2 (5 Days)||14
5186611|NCT01119443|12756623|P2|STARTED|Crossover Period 2 (5 Days)||13
5186612|NCT01119443|12756624|P1|STARTED|Crossover Period 2 (5 Days)||14
5186613|NCT01119443|12756623|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
5186614|NCT01119443|12756624|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
5186615|NCT01119443|12756623|P2|COMPLETED|Crossover Period 1 (5 Days)||13
5186616|NCT01119443|12756624|P1|COMPLETED|Crossover Period 1 (5 Days)||14
5186617|NCT01119443|12756623|P2|STARTED|Crossover Period 1 (5 Days)||14
5186618|NCT01119443|12756624|P1|STARTED|Crossover Period 1 (5 Days)||14
5186619|NCT01119443|12756623|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
5186620|NCT01119443|12756624|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
5186621|NCT01119443|12756623|P2|COMPLETED|Up-titration Period (10 Days)||14
5186622|NCT01119443|12756624|P1|COMPLETED|Up-titration Period (10 Days)||14
5186623|NCT01119443|12756623|P2|STARTED|Up-titration Period (10 Days)||14
5186624|NCT01119443|12756624|P1|STARTED|Up-titration Period (10 Days)||14
5186625|NCT01119287|12756667|P6|NOT COMPLETED|Overall Study||0
5186626|NCT01119287|12756668|P5|NOT COMPLETED|Overall Study||1
5186627|NCT01119287|12756669|P4|NOT COMPLETED|Overall Study||2
5186628|NCT01119287|12756670|P3|NOT COMPLETED|Overall Study||2
5186629|NCT01119287|12756671|P2|NOT COMPLETED|Overall Study||0
5186630|NCT01119287|12756672|P1|NOT COMPLETED|Overall Study||0
5186631|NCT01119287|12756667|P6|COMPLETED|Overall Study||32
5186632|NCT01119287|12756668|P5|COMPLETED|Overall Study||30
5186633|NCT01119287|12756669|P4|COMPLETED|Overall Study||29
5186634|NCT01119287|12756670|P3|COMPLETED|Overall Study||24
5186635|NCT01119287|12756671|P2|COMPLETED|Overall Study||24
5186636|NCT01119287|12756672|P1|COMPLETED|Overall Study||26
5186637|NCT01119287|12756667|P6|STARTED|Overall Study||32
5186638|NCT01119287|12756668|P5|STARTED|Overall Study||31
5186639|NCT01119287|12756669|P4|STARTED|Overall Study||31
5186640|NCT01119287|12756670|P3|STARTED|Overall Study||26
5186641|NCT01119287|12756671|P2|STARTED|Overall Study||24
5186642|NCT01119287|12756672|P1|STARTED|Overall Study||26
5186643|NCT01119248|12756685|P1|NOT COMPLETED|Overall Study||5
5186644|NCT01119248|12756685|P1|COMPLETED|Overall Study||115
5186645|NCT01119248|12756685|P1|STARTED|Overall Study||120
5186646|NCT01119222|12756691|P4|NOT COMPLETED|Overall Study||0
5186647|NCT01119222|12756692|P3|NOT COMPLETED|Overall Study||0
5186648|NCT01119222|12756693|P2|NOT COMPLETED|Overall Study||0
5186649|NCT01119222|12756694|P1|NOT COMPLETED|Overall Study||0
5186650|NCT01119222|12756691|P4|COMPLETED|Overall Study||4
5186651|NCT01119222|12756692|P3|COMPLETED|Overall Study||5
5186652|NCT01119222|12756693|P2|COMPLETED|Overall Study||5
5186653|NCT01119222|12756694|P1|COMPLETED|Overall Study||5
5186654|NCT01119222|12756691|P4|STARTED|Overall Study||4
5186655|NCT01119222|12756692|P3|STARTED|Overall Study||5
5186656|NCT01119222|12756693|P2|STARTED|Overall Study||5
5186657|NCT01119222|12756694|P1|STARTED|Overall Study||5
5186658|NCT01119131|12756735|P3|NOT COMPLETED|Overall Study||6
5186659|NCT01119131|12756736|P2|NOT COMPLETED|Overall Study||1
5186660|NCT01119131|12756737|P1|NOT COMPLETED|Overall Study||2
5186661|NCT01119131|12756735|P3|COMPLETED|Overall Study||24
5186662|NCT01119131|12756736|P2|COMPLETED|Overall Study||27
5186663|NCT01119131|12756737|P1|COMPLETED|Overall Study||8
5186664|NCT01119131|12756735|P3|STARTED|Overall Study||30
5186665|NCT01119131|12756736|P2|STARTED|Overall Study||28
5186666|NCT01119131|12756737|P1|STARTED|Overall Study||10
5186667|NCT01119118|12756766|P1|NOT COMPLETED|Overall Study||1
5186668|NCT01119118|12756766|P1|COMPLETED|Overall Study||5
5186669|NCT01119118|12756766|P1|STARTED|Overall Study||6
5186670|NCT01119040|12756774|P1|NOT COMPLETED|Overall Study||1
5186671|NCT01119040|12756774|P1|COMPLETED|Overall Study||0
5186672|NCT01119040|12756774|P1|STARTED|Overall Study||1
5186673|NCT01119001|12756778|P1|NOT COMPLETED|Overall Study||2
5186674|NCT01119001|12756778|P1|COMPLETED|Overall Study||11
5186675|NCT01119001|12756778|P1|STARTED|Overall Study||13
5186676|NCT01118988|12756787|P3|NOT COMPLETED|Overall Study||4
5186677|NCT01118988|12756788|P2|NOT COMPLETED|Overall Study||1
5186678|NCT01118988|12756789|P1|NOT COMPLETED|Overall Study||5
5186679|NCT01118988|12756787|P3|COMPLETED|Overall Study||3
5186680|NCT01118988|12756788|P2|COMPLETED|Overall Study||3
5186681|NCT01118988|12756789|P1|COMPLETED|Overall Study||11
5186682|NCT01118988|12756787|P3|STARTED|Overall Study||7
5186683|NCT01118988|12756788|P2|STARTED|Overall Study||4
5186684|NCT01118988|12756789|P1|STARTED|Overall Study||16
5186685|NCT01118975|12756822|P2|NOT COMPLETED|Overall Study||1
5186686|NCT01118975|12756823|P1|NOT COMPLETED|Overall Study||0
5186687|NCT01118975|12756822|P2|COMPLETED|Overall Study||2
5186688|NCT01118975|12756823|P1|COMPLETED|Overall Study||9
5186689|NCT01118975|12756822|P2|STARTED|Overall Study||3
5186690|NCT01118975|12756823|P1|STARTED|Overall Study||9
5186691|NCT01118962|12756829|P1|NOT COMPLETED|Overall Study||10
5186692|NCT01118962|12756829|P1|COMPLETED|Overall Study||29
5186693|NCT01118962|12756829|P1|STARTED|Overall Study||39
5186694|NCT01118949|12756834|P1|NOT COMPLETED|Overall Study||9
5186695|NCT01118949|12756834|P1|COMPLETED|Overall Study||40
5186696|NCT01118949|12756834|P1|STARTED|Overall Study||49
5186697|NCT01118845|12756843|P1|NOT COMPLETED|Overall Study||42
5186698|NCT01118845|12756843|P1|COMPLETED|Overall Study||17
5186699|NCT01118845|12756843|P1|STARTED|Overall Study||59
5186700|NCT01118780|12756864|P2|NOT COMPLETED|Overall Study||35
5186701|NCT01118780|12756865|P1|NOT COMPLETED|Overall Study||36
5186702|NCT01118780|12756864|P2|COMPLETED|Overall Study||105
5186703|NCT01118780|12756865|P1|COMPLETED|Overall Study||115
5186704|NCT01118780|12756864|P2|STARTED|Overall Study||140
5186705|NCT01118780|12756865|P1|STARTED|Overall Study||151
5186706|NCT01118741|12756914|P2|NOT COMPLETED|Overall Study||0
5186707|NCT01118741|12756915|P1|NOT COMPLETED|Overall Study||0
5186708|NCT01118741|12756914|P2|COMPLETED|Overall Study||10
5186709|NCT01118741|12756915|P1|COMPLETED|Overall Study||9
5186710|NCT01118741|12756914|P2|STARTED|Overall Study||10
5186711|NCT01118741|12756915|P1|STARTED|Overall Study||9
5186712|NCT01118728|12756923|P1|NOT COMPLETED|Overall Study||223
5186713|NCT01118728|12756923|P1|COMPLETED|Overall Study||0
5186714|NCT01118728|12756923|P1|STARTED|Overall Study||223
5186715|NCT01118663|12756930|P2|NOT COMPLETED|Overall Study||2
5186716|NCT01118663|12756931|P1|NOT COMPLETED|Overall Study||2
5186717|NCT01118663|12756930|P2|COMPLETED|Overall Study||8
5186718|NCT01118663|12756931|P1|COMPLETED|Overall Study||5
5186719|NCT01118663|12756930|P2|STARTED|Overall Study||10
5186720|NCT01118663|12756931|P1|STARTED|Overall Study||7
5186721|NCT01118624|12756945|P1|NOT COMPLETED|Overall Study||22
5186722|NCT01118624|12756945|P1|COMPLETED|Overall Study||0
5186723|NCT01118624|12756945|P1|STARTED|Overall Study||22
5186724|NCT01118455|12756954|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
5186725|NCT01118455|12756955|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
5186726|NCT01118455|12756954|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
5186727|NCT01118455|12756955|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
5186728|NCT01118455|12756954|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
5186729|NCT01118455|12756955|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
5186730|NCT01118455|12756954|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
5186731|NCT01118455|12756955|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
5186732|NCT01118455|12756954|P2|COMPLETED|Baseline [Visits 1 & 2]||69
5186733|NCT01118455|12756955|P1|COMPLETED|Baseline [Visits 1 & 2]||65
5186734|NCT01118455|12756954|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
5186735|NCT01118455|12756955|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
5186736|NCT01118455|12756954|P2|STARTED|Baseline [Visits 1 & 2]||69
5186737|NCT01118455|12756955|P1|STARTED|Baseline [Visits 1 & 2]||66
5186738|NCT01118377|12756983|P1|NOT COMPLETED|Overall Study||42
5186739|NCT01118377|12756983|P1|COMPLETED|Overall Study||3
5186740|NCT01118377|12756983|P1|STARTED|Overall Study||45
5186741|NCT01118351|12756989|P1|NOT COMPLETED|Overall Study||4
5186742|NCT01118351|12756989|P1|COMPLETED|Overall Study||15
5186743|NCT01118351|12756989|P1|STARTED|Overall Study||19
5186744|NCT01118325|12757000|P3|NOT COMPLETED|Overall Study||1
5186745|NCT01118325|12757001|P2|NOT COMPLETED|Overall Study||0
5186746|NCT01118325|12757002|P1|NOT COMPLETED|Overall Study||1
5186747|NCT01118325|12757000|P3|COMPLETED|Overall Study||45
5186748|NCT01118325|12757001|P2|COMPLETED|Overall Study||43
5186749|NCT01118325|12757002|P1|COMPLETED|Overall Study||49
5186750|NCT01118325|12757000|P3|STARTED|Overall Study||46
5186751|NCT01118325|12757001|P2|STARTED|Overall Study||43
5186752|NCT01118325|12757002|P1|STARTED|Overall Study||50
5186753|NCT01118312|12757048|P2|NOT COMPLETED|Overall Study||35
5186754|NCT01118312|12757049|P1|NOT COMPLETED|Overall Study||34
5186755|NCT01118312|12757048|P2|COMPLETED|Overall Study||164
5186756|NCT01118312|12757049|P1|COMPLETED|Overall Study||155
5186757|NCT01118312|12757048|P2|STARTED|Overall Study||199
5186758|NCT01118312|12757049|P1|STARTED|Overall Study||189
5186759|NCT01118299|12757059|P2|NOT COMPLETED|Overall Study||29
5186760|NCT01118299|12757060|P1|NOT COMPLETED|Overall Study||23
5186761|NCT01118299|12757059|P2|COMPLETED|Overall Study||0
5186762|NCT01118299|12757060|P1|COMPLETED|Overall Study||45
5186763|NCT01118299|12757059|P2|STARTED|Overall Study||29
5186764|NCT01118299|12757060|P1|STARTED|Overall Study||68
5186765|NCT01118273|12757073|P6|NOT COMPLETED|Overall Study||0
5186766|NCT01118273|12757074|P5|NOT COMPLETED|Overall Study||0
5186767|NCT01118273|12757075|P4|NOT COMPLETED|Overall Study||0
5186768|NCT01118273|12757076|P3|NOT COMPLETED|Overall Study||0
5186769|NCT01118273|12757077|P2|NOT COMPLETED|Overall Study||0
5186770|NCT01118273|12757078|P1|NOT COMPLETED|Overall Study||0
5186771|NCT01118273|12757073|P6|COMPLETED|Overall Study||27
5186772|NCT01118273|12757074|P5|COMPLETED|Overall Study||27
5186773|NCT01118273|12757075|P4|COMPLETED|Overall Study||27
5186774|NCT01118273|12757076|P3|COMPLETED|Overall Study||27
5186775|NCT01118273|12757077|P2|COMPLETED|Overall Study||27
5186776|NCT01118273|12757078|P1|COMPLETED|Overall Study||27
5186777|NCT01118273|12757073|P6|STARTED|Overall Study||27
5186778|NCT01118273|12757074|P5|STARTED|Overall Study||27
5186779|NCT01118273|12757075|P4|STARTED|Overall Study||27
5186780|NCT01118273|12757076|P3|STARTED|Overall Study||27
5186781|NCT01118273|12757077|P2|STARTED|Overall Study||27
5186782|NCT01118273|12757078|P1|STARTED|Overall Study||27
5186783|NCT01118221|12757244|P2|NOT COMPLETED|Overall Study||1
5186784|NCT01118221|12757245|P1|NOT COMPLETED|Overall Study||3
5186785|NCT01118221|12757244|P2|COMPLETED|Overall Study||10
5186786|NCT01118221|12757245|P1|COMPLETED|Overall Study||11
5186787|NCT01118221|12757244|P2|STARTED|Overall Study||11
5186788|NCT01118221|12757245|P1|STARTED|Overall Study||14
5186789|NCT01118143|12757257|P2|NOT COMPLETED|Overall Study||5
5186790|NCT01118143|12757258|P1|NOT COMPLETED|Overall Study||2
5186791|NCT01118143|12757257|P2|COMPLETED|Overall Study||64
5186792|NCT01118143|12757258|P1|COMPLETED|Overall Study||62
5186793|NCT01118143|12757257|P2|STARTED|Overall Study||69
5186794|NCT01118143|12757258|P1|STARTED|Overall Study||64
5186795|NCT01118117|12757268|P2|NOT COMPLETED|Overall Study||0
5186796|NCT01118117|12757269|P1|NOT COMPLETED|Overall Study||21
5186797|NCT01118117|12757268|P2|COMPLETED|Overall Study||15
5186798|NCT01118117|12757269|P1|COMPLETED|Overall Study||240
5186799|NCT01118117|12757268|P2|STARTED|Overall Study||15
5186800|NCT01118117|12757269|P1|STARTED|Overall Study||261
5186801|NCT01118091|12757290|P2|NOT COMPLETED|Overall Study||0
5186802|NCT01118091|12757291|P1|NOT COMPLETED|Overall Study||0
5186803|NCT01118091|12757290|P2|COMPLETED|Overall Study||5
5186804|NCT01118091|12757291|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
5186805|NCT01118091|12757290|P2|STARTED|Overall Study||5
5186806|NCT01118091|12757291|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
5186807|NCT01118052|12757301|P1|NOT COMPLETED|Overall Study||2
5186808|NCT01118052|12757301|P1|COMPLETED|Overall Study||20
5186809|NCT01118052|12757301|P1|STARTED|Overall Study||22
5186810|NCT01118013|12757314|P1|NOT COMPLETED|Overall Study||0
5186811|NCT01118013|12757314|P1|COMPLETED|Overall Study||6
5186812|NCT01118013|12757314|P1|STARTED|Overall Study||6
5186813|NCT01117987|12757324|P2|NOT COMPLETED|Overall Study||74
5186814|NCT01117987|12757325|P1|NOT COMPLETED|Overall Study||61
5186815|NCT01117987|12757324|P2|COMPLETED|Overall Study||4
5186816|NCT01117987|12757325|P1|COMPLETED|Overall Study||5
5186817|NCT01117987|12757324|P2|STARTED|Overall Study||78
5186818|NCT01117987|12757325|P1|STARTED|Overall Study||66
5186819|NCT01117948|12757337|P2|NOT COMPLETED|Open Label||47
5186820|NCT01117948|12757338|P1|NOT COMPLETED|Open Label||52
5186821|NCT01117948|12757337|P2|COMPLETED|Open Label||51
5186822|NCT01117948|12757338|P1|COMPLETED|Open Label||41
5186823|NCT01117948|12757337|P2|STARTED|Open Label||98
5186824|NCT01117948|12757338|P1|STARTED|Open Label||93
5186825|NCT01117948|12757337|P2|NOT COMPLETED|Double Blind||10
5186826|NCT01117948|12757338|P1|NOT COMPLETED|Double Blind||18
5186827|NCT01117948|12757337|P2|COMPLETED|Double Blind||98
5186828|NCT01117948|12757338|P1|COMPLETED|Double Blind||93
5186829|NCT01117948|12757337|P2|STARTED|Double Blind||108
5186830|NCT01117948|12757338|P1|STARTED|Double Blind||111
5186831|NCT01117870|12757346|P2|NOT COMPLETED|Overall Study||0
5186832|NCT01117870|12757347|P1|NOT COMPLETED|Overall Study||1
5186833|NCT01117870|12757346|P2|COMPLETED|Overall Study||16
5186834|NCT01117870|12757347|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
5186835|NCT01117870|12757346|P2|STARTED|Overall Study||16
5186836|NCT01117870|12757347|P1|STARTED|Overall Study||15
5186837|NCT01117857|12757361|P1|NOT COMPLETED|Overall Study||9
5186838|NCT01117857|12757361|P1|COMPLETED|Overall Study||13
5186839|NCT01117857|12757361|P1|STARTED|Overall Study||22
5186840|NCT01117766|12757369|P2|NOT COMPLETED|Second Intervention||5
5186841|NCT01117766|12757370|P1|NOT COMPLETED|Second Intervention||2
5186842|NCT01117766|12757369|P2|COMPLETED|Second Intervention||9
5186843|NCT01117766|12757370|P1|COMPLETED|Second Intervention||11
5186844|NCT01117766|12757369|P2|STARTED|Second Intervention||14
5186845|NCT01117766|12757370|P1|STARTED|Second Intervention||13
5186846|NCT01117766|12757369|P2|NOT COMPLETED|Washout Period||2
5186847|NCT01117766|12757370|P1|NOT COMPLETED|Washout Period||0
5186848|NCT01117766|12757369|P2|COMPLETED|Washout Period||14
5186849|NCT01117766|12757370|P1|COMPLETED|Washout Period||13
5186850|NCT01117766|12757369|P2|STARTED|Washout Period||16
5186851|NCT01117766|12757370|P1|STARTED|Washout Period||13
5186852|NCT01117766|12757369|P2|NOT COMPLETED|First Intervention||1
5186853|NCT01117766|12757370|P1|NOT COMPLETED|First Intervention||1
5186854|NCT01117766|12757369|P2|COMPLETED|First Intervention||16
5186855|NCT01117766|12757370|P1|COMPLETED|First Intervention||13
5186856|NCT01117766|12757369|P2|Received Treatment|First Intervention||17
5186857|NCT01117766|12757370|P1|Received Treatment|First Intervention||14
5186858|NCT01117766|12757369|P2|STARTED|First Intervention||17
5186859|NCT01117766|12757370|P1|STARTED|First Intervention||14
5186860|NCT01117727|12757394|P1|NOT COMPLETED|Overall Study||0
5186861|NCT01117727|12757394|P1|COMPLETED|Overall Study||1
5186862|NCT01117727|12757394|P1|STARTED|Overall Study||1
5186863|NCT01117623|12757407|P8|NOT COMPLETED|Overall Study||26
5186864|NCT01117623|12757408|P7|NOT COMPLETED|Overall Study||6
5186865|NCT01117623|12757409|P6|NOT COMPLETED|Overall Study||16
5186866|NCT01117623|12757410|P5|NOT COMPLETED|Overall Study||10
5186867|NCT01117623|12757411|P4|NOT COMPLETED|Overall Study||6
5186868|NCT01117623|12757412|P3|NOT COMPLETED|Overall Study||11
5186869|NCT01117623|12757413|P2|NOT COMPLETED|Overall Study||8
5186870|NCT01117623|12757414|P1|NOT COMPLETED|Overall Study||3
5186871|NCT01117623|12757407|P8|COMPLETED|Overall Study||0
5186872|NCT01117623|12757408|P7|COMPLETED|Overall Study||0
5186873|NCT01117623|12757409|P6|COMPLETED|Overall Study||0
5186874|NCT01117623|12757410|P5|COMPLETED|Overall Study||0
5186875|NCT01117623|12757411|P4|COMPLETED|Overall Study||0
5186876|NCT01117623|12757412|P3|COMPLETED|Overall Study||0
5186877|NCT01117623|12757413|P2|COMPLETED|Overall Study||0
5186878|NCT01117623|12757414|P1|COMPLETED|Overall Study||0
5186879|NCT01117623|12757407|P8|PK Population|Overall Study||24
5186880|NCT01117623|12757408|P7|PK Population|Overall Study||6
5186881|NCT01117623|12757409|P6|PK Population|Overall Study||14
5186882|NCT01117623|12757410|P5|PK Population|Overall Study||10
5186883|NCT01117623|12757411|P4|PK Population|Overall Study||6
5186884|NCT01117623|12757412|P3|PK Population|Overall Study||10
5186885|NCT01117623|12757413|P2|PK Population|Overall Study||8
5186886|NCT01117623|12757414|P1|PK Population|Overall Study||3
5186887|NCT01117623|12757407|P8|ITT Efficacy Analysis Population|Overall Study||22
5186888|NCT01117623|12757408|P7|ITT Efficacy Analysis Population|Overall Study||6
5186889|NCT01117623|12757409|P6|ITT Efficacy Analysis Population|Overall Study||16
5186890|NCT01117623|12757410|P5|ITT Efficacy Analysis Population|Overall Study||10
5186891|NCT01117623|12757411|P4|ITT Efficacy Analysis Population|Overall Study||5
5186892|NCT01117623|12757412|P3|ITT Efficacy Analysis Population|Overall Study||11
5186893|NCT01117623|12757413|P2|ITT Efficacy Analysis Population|Overall Study||8
5186894|NCT01117623|12757414|P1|ITT Efficacy Analysis Population|Overall Study||3
5186895|NCT01117623|12757407|P8|STARTED|Overall Study||26
5186896|NCT01117623|12757408|P7|STARTED|Overall Study||6
5186897|NCT01117623|12757409|P6|STARTED|Overall Study||16
5186898|NCT01117623|12757410|P5|STARTED|Overall Study||10
5186899|NCT01117623|12757411|P4|STARTED|Overall Study||6
5186900|NCT01117623|12757412|P3|STARTED|Overall Study||11
5186901|NCT01117623|12757413|P2|STARTED|Overall Study||8
5186902|NCT01117623|12757414|P1|STARTED|Overall Study||3
5186903|NCT01117480|12757566|P1|NOT COMPLETED|Overall Study||28
5186904|NCT01117480|12757566|P1|COMPLETED|Overall Study||985
5186905|NCT01117480|12757566|P1|STARTED|Overall Study||1013
5186906|NCT01117454|12757574|P2|NOT COMPLETED|Overall Study||1
5186907|NCT01117454|12757575|P1|NOT COMPLETED|Overall Study||0
5186908|NCT01117454|12757574|P2|COMPLETED|Overall Study||7
5186909|NCT01117454|12757575|P1|COMPLETED|Overall Study||6
5186910|NCT01117454|12757574|P2|STARTED|Overall Study||8
5186911|NCT01117454|12757575|P1|STARTED|Overall Study||6
5186912|NCT01117428|12757587|P6|NOT COMPLETED|Overall Study||20
5186913|NCT01117428|12757588|P5|NOT COMPLETED|Overall Study||17
5186914|NCT01117428|12757589|P4|NOT COMPLETED|Overall Study||12
5186915|NCT01117428|12757590|P3|NOT COMPLETED|Overall Study||13
5186916|NCT01117428|12757591|P2|NOT COMPLETED|Overall Study||29
5186917|NCT01117428|12757592|P1|NOT COMPLETED|Overall Study||20
5186918|NCT01117428|12757587|P6|COMPLETED|Overall Study||0
5186919|NCT01117428|12757588|P5|COMPLETED|Overall Study||0
5186920|NCT01117428|12757589|P4|COMPLETED|Overall Study||0
5186921|NCT01117428|12757590|P3|COMPLETED|Overall Study||0
5186922|NCT01117428|12757591|P2|COMPLETED|Overall Study||0
5186923|NCT01117428|12757592|P1|COMPLETED|Overall Study||0
5186924|NCT01117428|12757587|P6|STARTED|Overall Study||20
5186925|NCT01117428|12757588|P5|STARTED|Overall Study||17
5186926|NCT01117428|12757589|P4|STARTED|Overall Study||12
5186927|NCT01117428|12757590|P3|STARTED|Overall Study||13
5186928|NCT01117428|12757591|P2|STARTED|Overall Study||29
5186929|NCT01117428|12757592|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
5186930|NCT01117350|12757626|P2|NOT COMPLETED|Extension Period||63
5186931|NCT01117350|12757627|P1|NOT COMPLETED|Extension Period||0
5186932|NCT01117350|12757626|P2|COMPLETED|Extension Period||147
5186933|NCT01117350|12757627|P1|COMPLETED|Extension Period||0
5186934|NCT01117350|12757626|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
5186935|NCT01117350|12757627|P1|mITT Population (Extension)|Extension Period||0
5186936|NCT01117350|12757626|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
5186937|NCT01117350|12757627|P1|TREATED = Safety Population (Extension)|Extension Period||0
5186938|NCT01117350|12757626|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
5186939|NCT01117350|12757627|P1|STARTED|Extension Period||0
5186940|NCT01117350|12757626|P2|NOT COMPLETED|Comparative Period||75
5186941|NCT01117350|12757627|P1|NOT COMPLETED|Comparative Period||42
5186942|NCT01117350|12757626|P2|COMPLETED|Comparative Period||414
5186943|NCT01117350|12757627|P1|COMPLETED|Comparative Period||447
5186944|NCT01117350|12757626|P2|mITT Population|Comparative Period||470
5186945|NCT01117350|12757627|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
5186946|NCT01117350|12757626|P2|TREATED = Safety Population|Comparative Period||481
5186947|NCT01117350|12757627|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
5186948|NCT01117350|12757626|P2|STARTED|Comparative Period||489
5186949|NCT01117350|12757627|P1|STARTED|Comparative Period|STARTED: randomized|489
5186950|NCT01117337|12757659|P2|NOT COMPLETED|Overall Study||0
5186951|NCT01117337|12757660|P1|NOT COMPLETED|Overall Study||4
5186952|NCT01117337|12757659|P2|COMPLETED|Overall Study||52
5186953|NCT01117337|12757660|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
5186954|NCT01117337|12757659|P2|Underwent Surgery|Overall Study||52
5186955|NCT01117337|12757660|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
5186956|NCT01117337|12757659|P2|STARTED|Overall Study||52
5186957|NCT01117337|12757660|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
5186958|NCT01117311|12757670|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
5186959|NCT01117311|12757671|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
5186960|NCT01117311|12757670|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
5186961|NCT01117311|12757671|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
5186962|NCT01117311|12757670|P2|STARTED|Second Intervention - Mixed Meal 3||4
5186963|NCT01117311|12757671|P1|STARTED|Second Intervention - Mixed Meal 3||3
5186964|NCT01117311|12757670|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
5186965|NCT01117311|12757671|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
5186966|NCT01117311|12757670|P2|COMPLETED|First Intervention - Mixed Meal 2||4
5186967|NCT01117311|12757671|P1|COMPLETED|First Intervention - Mixed Meal 2||3
5186968|NCT01117311|12757670|P2|STARTED|First Intervention - Mixed Meal 2||4
5186969|NCT01117311|12757671|P1|STARTED|First Intervention - Mixed Meal 2||3
5186970|NCT01117311|12757670|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
5186971|NCT01117311|12757671|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
5186972|NCT01117311|12757670|P2|COMPLETED|Lead-in Mixed Meal 1||4
5186973|NCT01117311|12757671|P1|COMPLETED|Lead-in Mixed Meal 1||3
5186974|NCT01117311|12757670|P2|STARTED|Lead-in Mixed Meal 1||4
5186975|NCT01117311|12757671|P1|STARTED|Lead-in Mixed Meal 1||3
5186976|NCT01117181|12757681|P2|NOT COMPLETED|Overall Study||2
5186977|NCT01117181|12757682|P1|NOT COMPLETED|Overall Study||1
5186978|NCT01117181|12757681|P2|COMPLETED|Overall Study||29
5186979|NCT01117181|12757682|P1|COMPLETED|Overall Study||28
5186980|NCT01117181|12757681|P2|STARTED|Overall Study||31
5186981|NCT01117181|12757682|P1|STARTED|Overall Study||29
5186982|NCT01117090|12757702|P1|NOT COMPLETED|Overall Study||0
5186983|NCT01117090|12757702|P1|COMPLETED|Overall Study||47
5186984|NCT01117090|12757702|P1|STARTED|Overall Study||47
5186985|NCT01117051|12757715|P2|NOT COMPLETED|Overall Study||11
5186986|NCT01117051|12757716|P1|NOT COMPLETED|Overall Study||13
5186987|NCT01117051|12757715|P2|COMPLETED|Overall Study||77
5186988|NCT01117051|12757716|P1|COMPLETED|Overall Study||73
5186989|NCT01117051|12757715|P2|STARTED|Overall Study||88
5186990|NCT01117051|12757716|P1|STARTED|Overall Study||86
5186991|NCT01117012|12757726|P2|NOT COMPLETED|Overall Study||5
5186992|NCT01117012|12757727|P1|NOT COMPLETED|Overall Study||8
5186993|NCT01117012|12757726|P2|COMPLETED|Overall Study||98
5186994|NCT01117012|12757727|P1|COMPLETED|Overall Study||81
5186995|NCT01117012|12757726|P2|STARTED|Overall Study||103
5186996|NCT01117012|12757727|P1|STARTED|Overall Study||89
5186997|NCT01116986|12757775|P32|NOT COMPLETED|Overall Study||3
5186998|NCT01116986|12757776|P31|NOT COMPLETED|Overall Study||1
5186999|NCT01116986|12757777|P30|NOT COMPLETED|Overall Study||0
5187000|NCT01116986|12757778|P29|NOT COMPLETED|Overall Study||0
5187001|NCT01116986|12757779|P28|NOT COMPLETED|Overall Study||1
5187002|NCT01116986|12757780|P27|NOT COMPLETED|Overall Study||4
5187003|NCT01116986|12757781|P26|NOT COMPLETED|Overall Study||0
5187004|NCT01116986|12757782|P25|NOT COMPLETED|Overall Study||3
5187005|NCT01116986|12757783|P24|NOT COMPLETED|Overall Study||2
5187006|NCT01116986|12757784|P23|NOT COMPLETED|Overall Study||4
5187007|NCT01116986|12757785|P22|NOT COMPLETED|Overall Study||2
5187008|NCT01116986|12757786|P21|NOT COMPLETED|Overall Study||2
5187009|NCT01116986|12757787|P20|NOT COMPLETED|Overall Study||2
5187010|NCT01116986|12757788|P19|NOT COMPLETED|Overall Study||3
5187011|NCT01116986|12757789|P18|NOT COMPLETED|Overall Study||5
5187012|NCT01116986|12757790|P17|NOT COMPLETED|Overall Study||3
5187013|NCT01116986|12757791|P16|NOT COMPLETED|Overall Study||6
5187014|NCT01116986|12757792|P15|NOT COMPLETED|Overall Study||0
5187015|NCT01116986|12757793|P14|NOT COMPLETED|Overall Study||3
5187016|NCT01116986|12757794|P13|NOT COMPLETED|Overall Study||1
5187017|NCT01116986|12757795|P12|NOT COMPLETED|Overall Study||0
5187018|NCT01116986|12757796|P11|NOT COMPLETED|Overall Study||1
5187019|NCT01116986|12757797|P10|NOT COMPLETED|Overall Study||4
5187020|NCT01116986|12757798|P9|NOT COMPLETED|Overall Study||1
5187021|NCT01116986|12757799|P8|NOT COMPLETED|Overall Study||2
5187022|NCT01116986|12757800|P7|NOT COMPLETED|Overall Study||2
5187023|NCT01116986|12757801|P6|NOT COMPLETED|Overall Study||2
5187024|NCT01116986|12757802|P5|NOT COMPLETED|Overall Study||4
5187025|NCT01116986|12757803|P4|NOT COMPLETED|Overall Study||2
5187026|NCT01116986|12757804|P3|NOT COMPLETED|Overall Study||2
5187027|NCT01116986|12757805|P2|NOT COMPLETED|Overall Study||3
5187028|NCT01116986|12757806|P1|NOT COMPLETED|Overall Study||2
5187029|NCT01116986|12757775|P32|COMPLETED|Overall Study||14
5187030|NCT01116986|12757776|P31|COMPLETED|Overall Study||16
5187031|NCT01116986|12757777|P30|COMPLETED|Overall Study||17
5187032|NCT01116986|12757778|P29|COMPLETED|Overall Study||17
5187033|NCT01116986|12757779|P28|COMPLETED|Overall Study||18
5187034|NCT01116986|12757780|P27|COMPLETED|Overall Study||14
5187035|NCT01116986|12757781|P26|COMPLETED|Overall Study||19
5187036|NCT01116986|12757782|P25|COMPLETED|Overall Study||15
5187037|NCT01116986|12757783|P24|COMPLETED|Overall Study||19
5187038|NCT01116986|12757784|P23|COMPLETED|Overall Study||19
5187039|NCT01116986|12757785|P22|COMPLETED|Overall Study||18
5187040|NCT01116986|12757786|P21|COMPLETED|Overall Study||22
5187041|NCT01116986|12757787|P20|COMPLETED|Overall Study||13
5187042|NCT01116986|12757788|P19|COMPLETED|Overall Study||20
5187043|NCT01116986|12757789|P18|COMPLETED|Overall Study||19
5187044|NCT01116986|12757790|P17|COMPLETED|Overall Study||13
5187045|NCT01116986|12757791|P16|COMPLETED|Overall Study||15
5187046|NCT01116986|12757792|P15|COMPLETED|Overall Study||17
5187047|NCT01116986|12757793|P14|COMPLETED|Overall Study||16
5187048|NCT01116986|12757794|P13|COMPLETED|Overall Study||16
5187049|NCT01116986|12757795|P12|COMPLETED|Overall Study||20
5187050|NCT01116986|12757796|P11|COMPLETED|Overall Study||18
5187051|NCT01116986|12757797|P10|COMPLETED|Overall Study||19
5187052|NCT01116986|12757798|P9|COMPLETED|Overall Study||19
5187053|NCT01116986|12757799|P8|COMPLETED|Overall Study||20
5187054|NCT01116986|12757800|P7|COMPLETED|Overall Study||20
5187055|NCT01116986|12757801|P6|COMPLETED|Overall Study||20
5187056|NCT01116986|12757802|P5|COMPLETED|Overall Study||20
5187057|NCT01116986|12757803|P4|COMPLETED|Overall Study||20
5187058|NCT01116986|12757804|P3|COMPLETED|Overall Study||16
5187059|NCT01116986|12757805|P2|COMPLETED|Overall Study||16
5187060|NCT01116986|12757806|P1|COMPLETED|Overall Study||22
5187061|NCT01116986|12757775|P32|STARTED|Overall Study||17
5187062|NCT01116986|12757776|P31|STARTED|Overall Study||17
5187063|NCT01116986|12757777|P30|STARTED|Overall Study||17
5187064|NCT01116986|12757778|P29|STARTED|Overall Study||17
5187065|NCT01116986|12757779|P28|STARTED|Overall Study||19
5187066|NCT01116986|12757780|P27|STARTED|Overall Study||18
5187067|NCT01116986|12757781|P26|STARTED|Overall Study||19
5187068|NCT01116986|12757782|P25|STARTED|Overall Study||18
5187069|NCT01116986|12757783|P24|STARTED|Overall Study||21
5187070|NCT01116986|12757784|P23|STARTED|Overall Study||23
5187071|NCT01116986|12757785|P22|STARTED|Overall Study||20
5187072|NCT01116986|12757786|P21|STARTED|Overall Study||24
5187073|NCT01116986|12757787|P20|STARTED|Overall Study||15
5187074|NCT01116986|12757788|P19|STARTED|Overall Study||23
5187075|NCT01116986|12757789|P18|STARTED|Overall Study||24
5187076|NCT01116986|12757790|P17|STARTED|Overall Study||16
5187077|NCT01116986|12757791|P16|STARTED|Overall Study||21
5187078|NCT01116986|12757792|P15|STARTED|Overall Study||17
5187079|NCT01116986|12757793|P14|STARTED|Overall Study||19
5187080|NCT01116986|12757794|P13|STARTED|Overall Study||17
5187081|NCT01116986|12757795|P12|STARTED|Overall Study||20
5187082|NCT01116986|12757796|P11|STARTED|Overall Study||19
5187083|NCT01116986|12757797|P10|STARTED|Overall Study||23
5187084|NCT01116986|12757798|P9|STARTED|Overall Study||20
5187085|NCT01116986|12757799|P8|STARTED|Overall Study||22
5187086|NCT01116986|12757800|P7|STARTED|Overall Study||22
5187087|NCT01116986|12757801|P6|STARTED|Overall Study||22
5187088|NCT01116986|12757802|P5|STARTED|Overall Study||24
5187089|NCT01116986|12757803|P4|STARTED|Overall Study||22
5187090|NCT01116986|12757804|P3|STARTED|Overall Study||18
5187091|NCT01116986|12757805|P2|STARTED|Overall Study||19
5187092|NCT01116986|12757806|P1|STARTED|Overall Study||24
5187093|NCT01116934|12757840|P2|NOT COMPLETED|Overall Study||0
5187094|NCT01116934|12757841|P1|NOT COMPLETED|Overall Study||0
5187095|NCT01116934|12757840|P2|COMPLETED|Overall Study||9
5187096|NCT01116934|12757841|P1|COMPLETED|Overall Study||8
5187097|NCT01116934|12757840|P2|STARTED|Overall Study||9
5187098|NCT01116934|12757841|P1|STARTED|Overall Study||8
5187099|NCT01116921|12757849|P2|NOT COMPLETED|Overall Study||0
5187100|NCT01116921|12757850|P1|NOT COMPLETED|Overall Study||0
5187101|NCT01116921|12757849|P2|COMPLETED|Overall Study||50
5187102|NCT01116921|12757850|P1|COMPLETED|Overall Study||53
5187103|NCT01116921|12757849|P2|STARTED|Overall Study||50
5187104|NCT01116921|12757850|P1|STARTED|Overall Study||53
5187105|NCT01116895|12757870|P4|NOT COMPLETED|Overall Study||3
5187106|NCT01116895|12757871|P3|NOT COMPLETED|Overall Study||4
5187107|NCT01116895|12757872|P2|NOT COMPLETED|Overall Study||7
5187108|NCT01116895|12757873|P1|NOT COMPLETED|Overall Study||4
5187109|NCT01116895|12757870|P4|COMPLETED|Overall Study||11
5187110|NCT01116895|12757871|P3|COMPLETED|Overall Study||14
5187111|NCT01116895|12757872|P2|COMPLETED|Overall Study||8
5187112|NCT01116895|12757873|P1|COMPLETED|Overall Study||12
5187113|NCT01116895|12757870|P4|STARTED|Overall Study||14
5187114|NCT01116895|12757871|P3|STARTED|Overall Study||18
5187115|NCT01116895|12757872|P2|STARTED|Overall Study||15
5187116|NCT01116895|12757873|P1|STARTED|Overall Study||16
5187117|NCT01116882|12757901|P2|NOT COMPLETED|12-month||99
5187118|NCT01116882|12757902|P1|NOT COMPLETED|12-month||267
5187119|NCT01116882|12757901|P2|COMPLETED|12-month||787
5187120|NCT01116882|12757902|P1|COMPLETED|12-month||2439
5187121|NCT01116882|12757901|P2|STARTED|12-month||886
5187122|NCT01116882|12757902|P1|STARTED|12-month||2706
5187123|NCT01116882|12757901|P2|NOT COMPLETED|30-day||31
5187124|NCT01116882|12757902|P1|NOT COMPLETED|30-day||68
5187125|NCT01116882|12757901|P2|COMPLETED|30-day||886
5187126|NCT01116882|12757902|P1|COMPLETED|30-day||2706
5187127|NCT01116882|12757901|P2|STARTED|30-day||917
5187128|NCT01116882|12757902|P1|STARTED|30-day||2774
5187129|NCT01116687|12757940|P1|NOT COMPLETED|Overall Study||4
5187130|NCT01116687|12757940|P1|COMPLETED|Overall Study||33
5187131|NCT01116687|12757940|P1|STARTED|Overall Study||37
5187132|NCT01116661|12757947|P1|NOT COMPLETED|Overall Study||2
5187133|NCT01116661|12757947|P1|COMPLETED|Overall Study||197
5187134|NCT01116661|12757947|P1|STARTED|Overall Study||199
5187135|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187136|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187137|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187138|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187139|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187140|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187141|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187142|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187143|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187144|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187145|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187146|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187147|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187148|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187149|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T PKCed Expansion||0
5187150|NCT01116648|12757967|P15|COMPLETED|Phase 1-T PKCed Expansion||7
5187151|NCT01116648|12757968|P14|COMPLETED|Phase 1-T PKCed Expansion||0
5187152|NCT01116648|12757969|P13|COMPLETED|Phase 1-T PKCed Expansion||0
5187153|NCT01116648|12757970|P12|COMPLETED|Phase 1-T PKCed Expansion||0
5187154|NCT01116648|12757971|P11|COMPLETED|Phase 1-T PKCed Expansion||0
5187155|NCT01116648|12757972|P10|COMPLETED|Phase 1-T PKCed Expansion||0
5187156|NCT01116648|12757973|P9|COMPLETED|Phase 1-T PKCed Expansion||0
5187157|NCT01116648|12757974|P8|COMPLETED|Phase 1-T PKCed Expansion||0
5187158|NCT01116648|12757975|P7|COMPLETED|Phase 1-T PKCed Expansion||0
5187159|NCT01116648|12757976|P6|COMPLETED|Phase 1-T PKCed Expansion||0
5187160|NCT01116648|12757977|P5|COMPLETED|Phase 1-T PKCed Expansion||0
5187161|NCT01116648|12757978|P4|COMPLETED|Phase 1-T PKCed Expansion||0
5187162|NCT01116648|12757979|P3|COMPLETED|Phase 1-T PKCed Expansion||0
5187163|NCT01116648|12757980|P2|COMPLETED|Phase 1-T PKCed Expansion||0
5187164|NCT01116648|12757981|P1|COMPLETED|Phase 1-T PKCed Expansion||0
5187165|NCT01116648|12757967|P15|STARTED|Phase 1-T PKCed Expansion||7
5187166|NCT01116648|12757968|P14|STARTED|Phase 1-T PKCed Expansion||0
5187167|NCT01116648|12757969|P13|STARTED|Phase 1-T PKCed Expansion||0
5187168|NCT01116648|12757970|P12|STARTED|Phase 1-T PKCed Expansion||0
5187169|NCT01116648|12757971|P11|STARTED|Phase 1-T PKCed Expansion||0
5187170|NCT01116648|12757972|P10|STARTED|Phase 1-T PKCed Expansion||0
5187171|NCT01116648|12757973|P9|STARTED|Phase 1-T PKCed Expansion||0
5187172|NCT01116648|12757974|P8|STARTED|Phase 1-T PKCed Expansion||0
5187173|NCT01116648|12757975|P7|STARTED|Phase 1-T PKCed Expansion||0
5187174|NCT01116648|12757976|P6|STARTED|Phase 1-T PKCed Expansion||0
5187175|NCT01116648|12757977|P5|STARTED|Phase 1-T PKCed Expansion||0
5187176|NCT01116648|12757978|P4|STARTED|Phase 1-T PKCed Expansion||0
5187177|NCT01116648|12757979|P3|STARTED|Phase 1-T PKCed Expansion||0
5187178|NCT01116648|12757980|P2|STARTED|Phase 1-T PKCed Expansion||0
5187179|NCT01116648|12757981|P1|STARTED|Phase 1-T PKCed Expansion||0
5187180|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187181|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187182|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187183|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187184|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187185|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187186|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187187|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187188|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187189|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187190|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187191|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187192|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187193|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187194|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
5187195|NCT01116648|12757967|P15|COMPLETED|Phase 1-T PKOlap Expansion||0
5187196|NCT01116648|12757968|P14|COMPLETED|Phase 1-T PKOlap Expansion||6
5187197|NCT01116648|12757969|P13|COMPLETED|Phase 1-T PKOlap Expansion||0
5187198|NCT01116648|12757970|P12|COMPLETED|Phase 1-T PKOlap Expansion||0
5187199|NCT01116648|12757971|P11|COMPLETED|Phase 1-T PKOlap Expansion||0
5187200|NCT01116648|12757972|P10|COMPLETED|Phase 1-T PKOlap Expansion||0
5187201|NCT01116648|12757973|P9|COMPLETED|Phase 1-T PKOlap Expansion||0
5187202|NCT01116648|12757974|P8|COMPLETED|Phase 1-T PKOlap Expansion||0
5187203|NCT01116648|12757975|P7|COMPLETED|Phase 1-T PKOlap Expansion||0
5187204|NCT01116648|12757976|P6|COMPLETED|Phase 1-T PKOlap Expansion||0
5187205|NCT01116648|12757977|P5|COMPLETED|Phase 1-T PKOlap Expansion||0
5187206|NCT01116648|12757978|P4|COMPLETED|Phase 1-T PKOlap Expansion||0
5187207|NCT01116648|12757979|P3|COMPLETED|Phase 1-T PKOlap Expansion||0
5187208|NCT01116648|12757980|P2|COMPLETED|Phase 1-T PKOlap Expansion||0
5187209|NCT01116648|12757981|P1|COMPLETED|Phase 1-T PKOlap Expansion||0
5187210|NCT01116648|12757967|P15|STARTED|Phase 1-T PKOlap Expansion||0
5187211|NCT01116648|12757968|P14|STARTED|Phase 1-T PKOlap Expansion||6
5187212|NCT01116648|12757969|P13|STARTED|Phase 1-T PKOlap Expansion||0
5187213|NCT01116648|12757970|P12|STARTED|Phase 1-T PKOlap Expansion||0
5187214|NCT01116648|12757971|P11|STARTED|Phase 1-T PKOlap Expansion||0
5187215|NCT01116648|12757972|P10|STARTED|Phase 1-T PKOlap Expansion||0
5187216|NCT01116648|12757973|P9|STARTED|Phase 1-T PKOlap Expansion||0
5187217|NCT01116648|12757974|P8|STARTED|Phase 1-T PKOlap Expansion||0
5187218|NCT01116648|12757975|P7|STARTED|Phase 1-T PKOlap Expansion||0
5187219|NCT01116648|12757976|P6|STARTED|Phase 1-T PKOlap Expansion||0
5187220|NCT01116648|12757977|P5|STARTED|Phase 1-T PKOlap Expansion||0
5187221|NCT01116648|12757978|P4|STARTED|Phase 1-T PKOlap Expansion||0
5187222|NCT01116648|12757979|P3|STARTED|Phase 1-T PKOlap Expansion||0
5187223|NCT01116648|12757980|P2|STARTED|Phase 1-T PKOlap Expansion||0
5187224|NCT01116648|12757981|P1|STARTED|Phase 1-T PKOlap Expansion||0
5187225|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187226|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187227|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187228|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187229|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187230|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187231|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187232|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187233|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187234|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187235|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187236|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187237|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187238|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187239|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
5187240|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187241|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187242|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 2-TB||6
5187243|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187244|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187245|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187246|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187247|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187248|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187249|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187250|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187251|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187252|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187253|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187254|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 2-TB||0
5187255|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 2-TB||0
5187256|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 2-TB||0
5187257|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 2-TB||6
5187258|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 2-TB||0
5187259|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 2-TB||0
5187260|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 2-TB||0
5187261|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 2-TB||0
5187262|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 2-TB||0
5187263|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 2-TB||0
5187264|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 2-TB||0
5187265|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 2-TB||0
5187266|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 2-TB||0
5187267|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 2-TB||0
5187268|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 2-TB||0
5187269|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 2-TB||0
5187270|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187271|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187272|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187273|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187274|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187275|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187276|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187277|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187278|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187279|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187280|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187281|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187282|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187283|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187284|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
5187285|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187286|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187287|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187288|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 1-TB||3
5187289|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187290|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187291|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187292|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187293|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187294|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187295|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187296|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187297|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187298|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187299|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 1-TB||0
5187300|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 1-TB||0
5187301|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 1-TB||0
5187302|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 1-TB||0
5187303|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 1-TB||3
5187304|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 1-TB||0
5187305|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 1-TB||0
5187306|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 1-TB||0
5187307|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 1-TB||0
5187308|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 1-TB||0
5187309|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 1-TB||0
5187310|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 1-TB||0
5187311|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 1-TB||0
5187312|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 1-TB||0
5187313|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 1-TB||0
5187314|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 1-TB||0
5187315|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187316|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187317|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187318|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187319|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187320|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187321|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187322|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187323|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187324|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187325|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187326|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187327|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187328|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187329|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
5187330|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187331|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187332|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187333|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187334|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 0-TB||3
5187335|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187336|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187337|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187338|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187339|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187340|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187341|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187342|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187343|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187344|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 0-TB||0
5187345|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 0-TB||0
5187346|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 0-TB||0
5187347|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 0-TB||0
5187348|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 0-TB||0
5187349|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 0-TB||3
5187350|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 0-TB||0
5187351|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 0-TB||0
5187352|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 0-TB||0
5187353|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 0-TB||0
5187354|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 0-TB||0
5187355|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 0-TB||0
5187356|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 0-TB||0
5187357|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 0-TB||0
5187358|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 0-TB||0
5187359|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 0-TB||0
5187360|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187361|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187362|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187363|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187364|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187365|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187366|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187367|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187368|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187369|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187370|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187371|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187372|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187373|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187374|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
5187375|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187376|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187377|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187378|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187379|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187380|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 2-TA||3
5187381|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187382|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187383|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187384|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187385|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187386|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187387|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187388|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187389|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 2-TA||0
5187390|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 2-TA||0
5187391|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 2-TA||0
5187392|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 2-TA||0
5187393|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 2-TA||0
5187394|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 2-TA||0
5187395|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 2-TA||3
5187396|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 2-TA||0
5187397|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 2-TA||0
5187398|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 2-TA||0
5187399|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 2-TA||0
5187400|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 2-TA||0
5187401|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 2-TA||0
5187402|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 2-TA||0
5187403|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 2-TA||0
5187404|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 2-TA||0
5187405|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187406|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187407|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187408|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187409|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187410|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187411|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187412|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187413|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187414|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187415|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187416|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187417|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187418|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187419|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
5187420|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187421|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187422|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187423|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187424|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187425|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187426|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 1-TA||6
5187427|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187428|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187429|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187430|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187431|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187432|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187433|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187434|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 1-TA||0
5187435|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 1-TA||0
5187436|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 1-TA||0
5187437|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 1-TA||0
5187438|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 1-TA||0
5187439|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 1-TA||0
5187440|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 1-TA||0
5187441|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 1-TA||6
5187442|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 1-TA||0
5187443|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 1-TA||0
5187444|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 1-TA||0
5187445|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 1-TA||0
5187446|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 1-TA||0
5187447|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 1-TA||0
5187448|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 1-TA||0
5187449|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 1-TA||0
5187450|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187451|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187452|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187453|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187454|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187455|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187456|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187457|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187458|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187459|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187460|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187461|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187462|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187463|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187464|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
5187465|NCT01116648|12757967|P15|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187466|NCT01116648|12757968|P14|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187467|NCT01116648|12757969|P13|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187468|NCT01116648|12757970|P12|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187469|NCT01116648|12757971|P11|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187470|NCT01116648|12757972|P10|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187471|NCT01116648|12757973|P9|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187472|NCT01116648|12757974|P8|COMPLETED|Phase 1-T Dose Level 0-TA||3
5187473|NCT01116648|12757975|P7|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187474|NCT01116648|12757976|P6|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187475|NCT01116648|12757977|P5|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187476|NCT01116648|12757978|P4|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187477|NCT01116648|12757979|P3|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187478|NCT01116648|12757980|P2|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187479|NCT01116648|12757981|P1|COMPLETED|Phase 1-T Dose Level 0-TA||0
5187480|NCT01116648|12757967|P15|STARTED|Phase 1-T Dose Level 0-TA||0
5187481|NCT01116648|12757968|P14|STARTED|Phase 1-T Dose Level 0-TA||0
5187482|NCT01116648|12757969|P13|STARTED|Phase 1-T Dose Level 0-TA||0
5187483|NCT01116648|12757970|P12|STARTED|Phase 1-T Dose Level 0-TA||0
5187484|NCT01116648|12757971|P11|STARTED|Phase 1-T Dose Level 0-TA||0
5187485|NCT01116648|12757972|P10|STARTED|Phase 1-T Dose Level 0-TA||0
5187486|NCT01116648|12757973|P9|STARTED|Phase 1-T Dose Level 0-TA||0
5187487|NCT01116648|12757974|P8|STARTED|Phase 1-T Dose Level 0-TA||3
5187488|NCT01116648|12757975|P7|STARTED|Phase 1-T Dose Level 0-TA||0
5187489|NCT01116648|12757976|P6|STARTED|Phase 1-T Dose Level 0-TA||0
5187490|NCT01116648|12757977|P5|STARTED|Phase 1-T Dose Level 0-TA||0
5187491|NCT01116648|12757978|P4|STARTED|Phase 1-T Dose Level 0-TA||0
5187492|NCT01116648|12757979|P3|STARTED|Phase 1-T Dose Level 0-TA||0
5187493|NCT01116648|12757980|P2|STARTED|Phase 1-T Dose Level 0-TA||0
5187494|NCT01116648|12757981|P1|STARTED|Phase 1-T Dose Level 0-TA||0
5187495|NCT01116648|12757967|P15|NOT COMPLETED|Phase 2||0
5187496|NCT01116648|12757968|P14|NOT COMPLETED|Phase 2||0
5187497|NCT01116648|12757969|P13|NOT COMPLETED|Phase 2||0
5187498|NCT01116648|12757970|P12|NOT COMPLETED|Phase 2||0
5187499|NCT01116648|12757971|P11|NOT COMPLETED|Phase 2||0
5187500|NCT01116648|12757972|P10|NOT COMPLETED|Phase 2||0
5187501|NCT01116648|12757973|P9|NOT COMPLETED|Phase 2||0
5187502|NCT01116648|12757974|P8|NOT COMPLETED|Phase 2||0
5187503|NCT01116648|12757975|P7|NOT COMPLETED|Phase 2||0
5187504|NCT01116648|12757976|P6|NOT COMPLETED|Phase 2||0
5187505|NCT01116648|12757977|P5|NOT COMPLETED|Phase 2||0
5187506|NCT01116648|12757978|P4|NOT COMPLETED|Phase 2||0
5187507|NCT01116648|12757979|P3|NOT COMPLETED|Phase 2||0
5187508|NCT01116648|12757980|P2|NOT COMPLETED|Phase 2||0
5187509|NCT01116648|12757981|P1|NOT COMPLETED|Phase 2||0
5187510|NCT01116648|12757967|P15|COMPLETED|Phase 2||0
5187511|NCT01116648|12757968|P14|COMPLETED|Phase 2||0
5187512|NCT01116648|12757969|P13|COMPLETED|Phase 2||0
5187513|NCT01116648|12757970|P12|COMPLETED|Phase 2||0
5187514|NCT01116648|12757971|P11|COMPLETED|Phase 2||0
5187515|NCT01116648|12757972|P10|COMPLETED|Phase 2||0
5187516|NCT01116648|12757973|P9|COMPLETED|Phase 2||0
5187517|NCT01116648|12757974|P8|COMPLETED|Phase 2||0
5187518|NCT01116648|12757975|P7|COMPLETED|Phase 2||44
5187519|NCT01116648|12757976|P6|COMPLETED|Phase 2||46
5187520|NCT01116648|12757977|P5|COMPLETED|Phase 2||0
5187521|NCT01116648|12757978|P4|COMPLETED|Phase 2||0
5187522|NCT01116648|12757979|P3|COMPLETED|Phase 2||0
5187523|NCT01116648|12757980|P2|COMPLETED|Phase 2||0
5187524|NCT01116648|12757981|P1|COMPLETED|Phase 2||0
5187525|NCT01116648|12757967|P15|STARTED|Phase 2||0
5187526|NCT01116648|12757968|P14|STARTED|Phase 2||0
5187527|NCT01116648|12757969|P13|STARTED|Phase 2||0
5187528|NCT01116648|12757970|P12|STARTED|Phase 2||0
5187529|NCT01116648|12757971|P11|STARTED|Phase 2||0
5187530|NCT01116648|12757972|P10|STARTED|Phase 2||0
5187531|NCT01116648|12757973|P9|STARTED|Phase 2||0
5187532|NCT01116648|12757974|P8|STARTED|Phase 2||0
5187533|NCT01116648|12757975|P7|STARTED|Phase 2||44
5187534|NCT01116648|12757976|P6|STARTED|Phase 2||46
5187535|NCT01116648|12757977|P5|STARTED|Phase 2||0
5187536|NCT01116648|12757978|P4|STARTED|Phase 2||0
5187537|NCT01116648|12757979|P3|STARTED|Phase 2||0
5187538|NCT01116648|12757980|P2|STARTED|Phase 2||0
5187539|NCT01116648|12757981|P1|STARTED|Phase 2||0
5187540|NCT01116648|12757967|P15|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187541|NCT01116648|12757968|P14|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187542|NCT01116648|12757969|P13|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187543|NCT01116648|12757970|P12|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187544|NCT01116648|12757971|P11|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187545|NCT01116648|12757972|P10|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187546|NCT01116648|12757973|P9|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187547|NCT01116648|12757974|P8|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187548|NCT01116648|12757975|P7|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187549|NCT01116648|12757976|P6|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187550|NCT01116648|12757977|P5|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187551|NCT01116648|12757978|P4|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187552|NCT01116648|12757979|P3|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187553|NCT01116648|12757980|P2|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187554|NCT01116648|12757981|P1|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
5187555|NCT01116648|12757967|P15|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187556|NCT01116648|12757968|P14|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187557|NCT01116648|12757969|P13|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187558|NCT01116648|12757970|P12|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187559|NCT01116648|12757971|P11|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187560|NCT01116648|12757972|P10|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187561|NCT01116648|12757973|P9|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187562|NCT01116648|12757974|P8|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187563|NCT01116648|12757975|P7|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187564|NCT01116648|12757976|P6|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187565|NCT01116648|12757977|P5|COMPLETED|Expansion at Maximum Tolerated Dose||9
5187566|NCT01116648|12757978|P4|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187567|NCT01116648|12757979|P3|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187568|NCT01116648|12757980|P2|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187569|NCT01116648|12757981|P1|COMPLETED|Expansion at Maximum Tolerated Dose||0
5187570|NCT01116648|12757967|P15|STARTED|Expansion at Maximum Tolerated Dose||0
5187571|NCT01116648|12757968|P14|STARTED|Expansion at Maximum Tolerated Dose||0
5187572|NCT01116648|12757969|P13|STARTED|Expansion at Maximum Tolerated Dose||0
5187573|NCT01116648|12757970|P12|STARTED|Expansion at Maximum Tolerated Dose||0
5187574|NCT01116648|12757971|P11|STARTED|Expansion at Maximum Tolerated Dose||0
5187575|NCT01116648|12757972|P10|STARTED|Expansion at Maximum Tolerated Dose||0
5187576|NCT01116648|12757973|P9|STARTED|Expansion at Maximum Tolerated Dose||0
5187577|NCT01116648|12757974|P8|STARTED|Expansion at Maximum Tolerated Dose||0
5187578|NCT01116648|12757975|P7|STARTED|Expansion at Maximum Tolerated Dose||0
5187579|NCT01116648|12757976|P6|STARTED|Expansion at Maximum Tolerated Dose||0
5187580|NCT01116648|12757977|P5|STARTED|Expansion at Maximum Tolerated Dose||9
5187581|NCT01116648|12757978|P4|STARTED|Expansion at Maximum Tolerated Dose||0
5187582|NCT01116648|12757979|P3|STARTED|Expansion at Maximum Tolerated Dose||0
5187583|NCT01116648|12757980|P2|STARTED|Expansion at Maximum Tolerated Dose||0
5187584|NCT01116648|12757981|P1|STARTED|Expansion at Maximum Tolerated Dose||0
5187585|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1 Dose Level 3||0
5187586|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1 Dose Level 3||0
5187587|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1 Dose Level 3||0
5187588|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1 Dose Level 3||0
5187589|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1 Dose Level 3||0
5187590|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1 Dose Level 3||0
5187591|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1 Dose Level 3||0
5187592|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1 Dose Level 3||0
5187593|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1 Dose Level 3||0
5187594|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1 Dose Level 3||0
5187595|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1 Dose Level 3||0
5187596|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1 Dose Level 3||2
5187597|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1 Dose Level 3||0
5187598|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1 Dose Level 3||0
5187599|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1 Dose Level 3||0
5187600|NCT01116648|12757967|P15|COMPLETED|Phase 1 Dose Level 3||0
5187601|NCT01116648|12757968|P14|COMPLETED|Phase 1 Dose Level 3||0
5187602|NCT01116648|12757969|P13|COMPLETED|Phase 1 Dose Level 3||0
5187603|NCT01116648|12757970|P12|COMPLETED|Phase 1 Dose Level 3||0
5187604|NCT01116648|12757971|P11|COMPLETED|Phase 1 Dose Level 3||0
5187605|NCT01116648|12757972|P10|COMPLETED|Phase 1 Dose Level 3||0
5187606|NCT01116648|12757973|P9|COMPLETED|Phase 1 Dose Level 3||0
5187607|NCT01116648|12757974|P8|COMPLETED|Phase 1 Dose Level 3||0
5187608|NCT01116648|12757975|P7|COMPLETED|Phase 1 Dose Level 3||0
5187609|NCT01116648|12757976|P6|COMPLETED|Phase 1 Dose Level 3||0
5187610|NCT01116648|12757977|P5|COMPLETED|Phase 1 Dose Level 3||0
5187611|NCT01116648|12757978|P4|COMPLETED|Phase 1 Dose Level 3||4
5187612|NCT01116648|12757979|P3|COMPLETED|Phase 1 Dose Level 3||0
5187613|NCT01116648|12757980|P2|COMPLETED|Phase 1 Dose Level 3||0
5187614|NCT01116648|12757981|P1|COMPLETED|Phase 1 Dose Level 3||0
5187615|NCT01116648|12757967|P15|STARTED|Phase 1 Dose Level 3||0
5187616|NCT01116648|12757968|P14|STARTED|Phase 1 Dose Level 3||0
5187617|NCT01116648|12757969|P13|STARTED|Phase 1 Dose Level 3||0
5187618|NCT01116648|12757970|P12|STARTED|Phase 1 Dose Level 3||0
5187619|NCT01116648|12757971|P11|STARTED|Phase 1 Dose Level 3||0
5187620|NCT01116648|12757972|P10|STARTED|Phase 1 Dose Level 3||0
5187621|NCT01116648|12757973|P9|STARTED|Phase 1 Dose Level 3||0
5187622|NCT01116648|12757974|P8|STARTED|Phase 1 Dose Level 3||0
5187623|NCT01116648|12757975|P7|STARTED|Phase 1 Dose Level 3||0
5187624|NCT01116648|12757976|P6|STARTED|Phase 1 Dose Level 3||0
5187625|NCT01116648|12757977|P5|STARTED|Phase 1 Dose Level 3||0
5187626|NCT01116648|12757978|P4|STARTED|Phase 1 Dose Level 3||6
5187627|NCT01116648|12757979|P3|STARTED|Phase 1 Dose Level 3||0
5187628|NCT01116648|12757980|P2|STARTED|Phase 1 Dose Level 3||0
5187629|NCT01116648|12757981|P1|STARTED|Phase 1 Dose Level 3||0
5187630|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1 Dose Level 2||0
5187631|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1 Dose Level 2||0
5187632|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1 Dose Level 2||0
5187633|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1 Dose Level 2||0
5187634|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1 Dose Level 2||0
5187635|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1 Dose Level 2||0
5187636|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1 Dose Level 2||0
5187637|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1 Dose Level 2||0
5187638|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1 Dose Level 2||0
5187639|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1 Dose Level 2||0
5187640|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1 Dose Level 2||0
5187641|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1 Dose Level 2||0
5187642|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1 Dose Level 2||0
5187643|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1 Dose Level 2||0
5187644|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1 Dose Level 2||0
5187645|NCT01116648|12757967|P15|COMPLETED|Phase 1 Dose Level 2||0
5187646|NCT01116648|12757968|P14|COMPLETED|Phase 1 Dose Level 2||0
5187647|NCT01116648|12757969|P13|COMPLETED|Phase 1 Dose Level 2||0
5187648|NCT01116648|12757970|P12|COMPLETED|Phase 1 Dose Level 2||0
5187649|NCT01116648|12757971|P11|COMPLETED|Phase 1 Dose Level 2||0
5187650|NCT01116648|12757972|P10|COMPLETED|Phase 1 Dose Level 2||0
5187651|NCT01116648|12757973|P9|COMPLETED|Phase 1 Dose Level 2||0
5187652|NCT01116648|12757974|P8|COMPLETED|Phase 1 Dose Level 2||0
5187653|NCT01116648|12757975|P7|COMPLETED|Phase 1 Dose Level 2||0
5187654|NCT01116648|12757976|P6|COMPLETED|Phase 1 Dose Level 2||0
5187655|NCT01116648|12757977|P5|COMPLETED|Phase 1 Dose Level 2||0
5187656|NCT01116648|12757978|P4|COMPLETED|Phase 1 Dose Level 2||0
5187657|NCT01116648|12757979|P3|COMPLETED|Phase 1 Dose Level 2||7
5187658|NCT01116648|12757980|P2|COMPLETED|Phase 1 Dose Level 2||0
5187659|NCT01116648|12757981|P1|COMPLETED|Phase 1 Dose Level 2||0
5187660|NCT01116648|12757967|P15|STARTED|Phase 1 Dose Level 2||0
5187661|NCT01116648|12757968|P14|STARTED|Phase 1 Dose Level 2||0
5187662|NCT01116648|12757969|P13|STARTED|Phase 1 Dose Level 2||0
5187663|NCT01116648|12757970|P12|STARTED|Phase 1 Dose Level 2||0
5187664|NCT01116648|12757971|P11|STARTED|Phase 1 Dose Level 2||0
5187665|NCT01116648|12757972|P10|STARTED|Phase 1 Dose Level 2||0
5187666|NCT01116648|12757973|P9|STARTED|Phase 1 Dose Level 2||0
5187667|NCT01116648|12757974|P8|STARTED|Phase 1 Dose Level 2||0
5187668|NCT01116648|12757975|P7|STARTED|Phase 1 Dose Level 2||0
5187669|NCT01116648|12757976|P6|STARTED|Phase 1 Dose Level 2||0
5187670|NCT01116648|12757977|P5|STARTED|Phase 1 Dose Level 2||0
5187671|NCT01116648|12757978|P4|STARTED|Phase 1 Dose Level 2||0
5187672|NCT01116648|12757979|P3|STARTED|Phase 1 Dose Level 2||7
5187673|NCT01116648|12757980|P2|STARTED|Phase 1 Dose Level 2||0
5187674|NCT01116648|12757981|P1|STARTED|Phase 1 Dose Level 2||0
5187675|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1 Dose Level 1||0
5187676|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1 Dose Level 1||0
5187677|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1 Dose Level 1||0
5187678|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1 Dose Level 1||0
5187679|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1 Dose Level 1||0
5187680|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1 Dose Level 1||0
5187681|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1 Dose Level 1||0
5187682|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1 Dose Level 1||0
5187683|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1 Dose Level 1||0
5187684|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1 Dose Level 1||0
5187685|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1 Dose Level 1||0
5187686|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1 Dose Level 1||0
5187687|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1 Dose Level 1||0
5187688|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1 Dose Level 1||0
5187689|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1 Dose Level 1||0
5187690|NCT01116648|12757967|P15|COMPLETED|Phase 1 Dose Level 1||0
5187691|NCT01116648|12757968|P14|COMPLETED|Phase 1 Dose Level 1||0
5187692|NCT01116648|12757969|P13|COMPLETED|Phase 1 Dose Level 1||0
5187693|NCT01116648|12757970|P12|COMPLETED|Phase 1 Dose Level 1||0
5187694|NCT01116648|12757971|P11|COMPLETED|Phase 1 Dose Level 1||0
5187695|NCT01116648|12757972|P10|COMPLETED|Phase 1 Dose Level 1||0
5187696|NCT01116648|12757973|P9|COMPLETED|Phase 1 Dose Level 1||0
5187697|NCT01116648|12757974|P8|COMPLETED|Phase 1 Dose Level 1||0
5187698|NCT01116648|12757975|P7|COMPLETED|Phase 1 Dose Level 1||0
5187699|NCT01116648|12757976|P6|COMPLETED|Phase 1 Dose Level 1||0
5187700|NCT01116648|12757977|P5|COMPLETED|Phase 1 Dose Level 1||0
5187701|NCT01116648|12757978|P4|COMPLETED|Phase 1 Dose Level 1||0
5187702|NCT01116648|12757979|P3|COMPLETED|Phase 1 Dose Level 1||0
5187703|NCT01116648|12757980|P2|COMPLETED|Phase 1 Dose Level 1||3
5187704|NCT01116648|12757981|P1|COMPLETED|Phase 1 Dose Level 1||0
5187705|NCT01116648|12757967|P15|STARTED|Phase 1 Dose Level 1||0
5187706|NCT01116648|12757968|P14|STARTED|Phase 1 Dose Level 1||0
5187707|NCT01116648|12757969|P13|STARTED|Phase 1 Dose Level 1||0
5187708|NCT01116648|12757970|P12|STARTED|Phase 1 Dose Level 1||0
5187709|NCT01116648|12757971|P11|STARTED|Phase 1 Dose Level 1||0
5187710|NCT01116648|12757972|P10|STARTED|Phase 1 Dose Level 1||0
5187711|NCT01116648|12757973|P9|STARTED|Phase 1 Dose Level 1||0
5187712|NCT01116648|12757974|P8|STARTED|Phase 1 Dose Level 1||0
5187713|NCT01116648|12757975|P7|STARTED|Phase 1 Dose Level 1||0
5187714|NCT01116648|12757976|P6|STARTED|Phase 1 Dose Level 1||0
5187715|NCT01116648|12757977|P5|STARTED|Phase 1 Dose Level 1||0
5187716|NCT01116648|12757978|P4|STARTED|Phase 1 Dose Level 1||0
5187717|NCT01116648|12757979|P3|STARTED|Phase 1 Dose Level 1||0
5187718|NCT01116648|12757980|P2|STARTED|Phase 1 Dose Level 1||3
5187719|NCT01116648|12757981|P1|STARTED|Phase 1 Dose Level 1||0
5187720|NCT01116648|12757967|P15|NOT COMPLETED|Phase 1 Dose Level 0||0
5187721|NCT01116648|12757968|P14|NOT COMPLETED|Phase 1 Dose Level 0||0
5187722|NCT01116648|12757969|P13|NOT COMPLETED|Phase 1 Dose Level 0||0
5187723|NCT01116648|12757970|P12|NOT COMPLETED|Phase 1 Dose Level 0||0
5187724|NCT01116648|12757971|P11|NOT COMPLETED|Phase 1 Dose Level 0||0
5187725|NCT01116648|12757972|P10|NOT COMPLETED|Phase 1 Dose Level 0||0
5187726|NCT01116648|12757973|P9|NOT COMPLETED|Phase 1 Dose Level 0||0
5187727|NCT01116648|12757974|P8|NOT COMPLETED|Phase 1 Dose Level 0||0
5187728|NCT01116648|12757975|P7|NOT COMPLETED|Phase 1 Dose Level 0||0
5187729|NCT01116648|12757976|P6|NOT COMPLETED|Phase 1 Dose Level 0||0
5187730|NCT01116648|12757977|P5|NOT COMPLETED|Phase 1 Dose Level 0||0
5187731|NCT01116648|12757978|P4|NOT COMPLETED|Phase 1 Dose Level 0||0
5187732|NCT01116648|12757979|P3|NOT COMPLETED|Phase 1 Dose Level 0||0
5187733|NCT01116648|12757980|P2|NOT COMPLETED|Phase 1 Dose Level 0||0
5187734|NCT01116648|12757981|P1|NOT COMPLETED|Phase 1 Dose Level 0||0
5187735|NCT01116648|12757967|P15|COMPLETED|Phase 1 Dose Level 0||0
5187736|NCT01116648|12757968|P14|COMPLETED|Phase 1 Dose Level 0||0
5187737|NCT01116648|12757969|P13|COMPLETED|Phase 1 Dose Level 0||0
5187738|NCT01116648|12757970|P12|COMPLETED|Phase 1 Dose Level 0||0
5187739|NCT01116648|12757971|P11|COMPLETED|Phase 1 Dose Level 0||0
5187740|NCT01116648|12757972|P10|COMPLETED|Phase 1 Dose Level 0||0
5187741|NCT01116648|12757973|P9|COMPLETED|Phase 1 Dose Level 0||0
5187742|NCT01116648|12757974|P8|COMPLETED|Phase 1 Dose Level 0||0
5187743|NCT01116648|12757975|P7|COMPLETED|Phase 1 Dose Level 0||0
5187744|NCT01116648|12757976|P6|COMPLETED|Phase 1 Dose Level 0||0
5187745|NCT01116648|12757977|P5|COMPLETED|Phase 1 Dose Level 0||0
5187746|NCT01116648|12757978|P4|COMPLETED|Phase 1 Dose Level 0||0
5187747|NCT01116648|12757979|P3|COMPLETED|Phase 1 Dose Level 0||0
5187748|NCT01116648|12757980|P2|COMPLETED|Phase 1 Dose Level 0||0
5187749|NCT01116648|12757981|P1|COMPLETED|Phase 1 Dose Level 0||3
5187750|NCT01116648|12757967|P15|STARTED|Phase 1 Dose Level 0||0
5187751|NCT01116648|12757968|P14|STARTED|Phase 1 Dose Level 0||0
5187752|NCT01116648|12757969|P13|STARTED|Phase 1 Dose Level 0||0
5187753|NCT01116648|12757970|P12|STARTED|Phase 1 Dose Level 0||0
5187754|NCT01116648|12757971|P11|STARTED|Phase 1 Dose Level 0||0
5187755|NCT01116648|12757972|P10|STARTED|Phase 1 Dose Level 0||0
5187756|NCT01116648|12757973|P9|STARTED|Phase 1 Dose Level 0||0
5187757|NCT01116648|12757974|P8|STARTED|Phase 1 Dose Level 0||0
5187758|NCT01116648|12757975|P7|STARTED|Phase 1 Dose Level 0||0
5187759|NCT01116648|12757976|P6|STARTED|Phase 1 Dose Level 0||0
5187760|NCT01116648|12757977|P5|STARTED|Phase 1 Dose Level 0||0
5187761|NCT01116648|12757978|P4|STARTED|Phase 1 Dose Level 0||0
5187762|NCT01116648|12757979|P3|STARTED|Phase 1 Dose Level 0||0
5187763|NCT01116648|12757980|P2|STARTED|Phase 1 Dose Level 0||0
5187764|NCT01116648|12757981|P1|STARTED|Phase 1 Dose Level 0||3
5187765|NCT01116544|12758008|P2|NOT COMPLETED|Overall Study||1
5187766|NCT01116544|12758009|P1|NOT COMPLETED|Overall Study||2
5187767|NCT01116544|12758008|P2|COMPLETED|Overall Study||22
5187768|NCT01116544|12758009|P1|COMPLETED|Overall Study||21
5187769|NCT01116544|12758008|P2|STARTED|Overall Study||23
5187770|NCT01116544|12758009|P1|STARTED|Overall Study||23
5187771|NCT01116466|12758025|P1|NOT COMPLETED|Overall Study||0
5187772|NCT01116466|12758025|P1|COMPLETED|Overall Study||5
5187773|NCT01116466|12758025|P1|STARTED|Overall Study||5
5187774|NCT01116427|12758035|P2|NOT COMPLETED|Extension Phase||2
5187775|NCT01116427|12758036|P1|NOT COMPLETED|Extension Phase||9
5187776|NCT01116427|12758035|P2|COMPLETED|Extension Phase||18
5187777|NCT01116427|12758036|P1|COMPLETED|Extension Phase||29
5187778|NCT01116427|12758035|P2|STARTED|Extension Phase||20
5187779|NCT01116427|12758036|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
5187780|NCT01116427|12758035|P2|NOT COMPLETED|Core Phase||1
5187781|NCT01116427|12758036|P1|NOT COMPLETED|Core Phase||5
5187782|NCT01116427|12758035|P2|COMPLETED|Core Phase||20
5187783|NCT01116427|12758036|P1|COMPLETED|Core Phase||39
5187784|NCT01116427|12758035|P2|STARTED|Core Phase||21
5187785|NCT01116427|12758036|P1|STARTED|Core Phase||44
5187786|NCT01116401|12758072|P1|NOT COMPLETED|Overall Study||0
5187787|NCT01116401|12758072|P1|COMPLETED|Overall Study||29
5187788|NCT01116401|12758072|P1|STARTED|Overall Study||29
5187789|NCT01116232|12758077|P1|NOT COMPLETED|Overall Study||4
5187790|NCT01116232|12758077|P1|COMPLETED|Overall Study||0
5187791|NCT01116232|12758077|P1|STARTED|Overall Study||4
5187792|NCT01116102|12758096|P8|NOT COMPLETED|Overall Study||0
5187793|NCT01116102|12758097|P7|NOT COMPLETED|Overall Study||0
5187794|NCT01116102|12758098|P6|NOT COMPLETED|Overall Study||0
5187795|NCT01116102|12758099|P5|NOT COMPLETED|Overall Study||0
5187796|NCT01116102|12758100|P4|NOT COMPLETED|Overall Study||0
5187797|NCT01116102|12758101|P3|NOT COMPLETED|Overall Study||0
5187798|NCT01116102|12758102|P2|NOT COMPLETED|Overall Study||0
5187799|NCT01116102|12758103|P1|NOT COMPLETED|Overall Study||0
5187800|NCT01116102|12758096|P8|COMPLETED|Overall Study||3
5187801|NCT01116102|12758097|P7|COMPLETED|Overall Study||2
5187802|NCT01116102|12758098|P6|COMPLETED|Overall Study||2
5187803|NCT01116102|12758099|P5|COMPLETED|Overall Study||2
5187804|NCT01116102|12758100|P4|COMPLETED|Overall Study||3
5187805|NCT01116102|12758101|P3|COMPLETED|Overall Study||3
5187806|NCT01116102|12758102|P2|COMPLETED|Overall Study||3
5187807|NCT01116102|12758103|P1|COMPLETED|Overall Study||2
5187808|NCT01116102|12758096|P8|STARTED|Overall Study||3
5187809|NCT01116102|12758097|P7|STARTED|Overall Study||2
5187810|NCT01116102|12758098|P6|STARTED|Overall Study||2
5187811|NCT01116102|12758099|P5|STARTED|Overall Study||2
5187812|NCT01116102|12758100|P4|STARTED|Overall Study||3
5187813|NCT01116102|12758101|P3|STARTED|Overall Study||3
5187814|NCT01116102|12758102|P2|STARTED|Overall Study||3
5187815|NCT01116102|12758103|P1|STARTED|Overall Study||2
5187816|NCT01116037|12758145|P1|NOT COMPLETED|Overall Study||25
5187817|NCT01116037|12758145|P1|COMPLETED|Overall Study||1
5187818|NCT01116037|12758145|P1|STARTED|Overall Study||26
5187819|NCT01116024|12758150|P1|NOT COMPLETED|Overall Study||52
5187820|NCT01116024|12758150|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
5187821|NCT01116024|12758150|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
5187822|NCT01115998|12758191|P2|NOT COMPLETED|Overall Study||6
5187823|NCT01115998|12758192|P1|NOT COMPLETED|Overall Study||6
5187824|NCT01115998|12758191|P2|COMPLETED|Overall Study||11
5187825|NCT01115998|12758192|P1|COMPLETED|Overall Study||11
5187826|NCT01115998|12758191|P2|STARTED|Overall Study||17
5187827|NCT01115998|12758192|P1|STARTED|Overall Study||17
5187828|NCT01115933|12758202|P1|NOT COMPLETED|Overall Study||1
5187829|NCT01115933|12758202|P1|COMPLETED|Overall Study||64
5187830|NCT01115933|12758202|P1|STARTED|Overall Study||65
5187831|NCT01115855|12758299|P2|NOT COMPLETED|Overall Study||36
5187832|NCT01115855|12758300|P1|NOT COMPLETED|Overall Study||36
5187833|NCT01115855|12758299|P2|COMPLETED|Overall Study||74
5187834|NCT01115855|12758300|P1|COMPLETED|Overall Study||75
5187835|NCT01115855|12758299|P2|STARTED|Overall Study||110
5187836|NCT01115855|12758300|P1|STARTED|Overall Study||111
5187837|NCT01115803|12758355|P7|NOT COMPLETED|Overall Study||2
5187838|NCT01115803|12758356|P6|NOT COMPLETED|Overall Study||0
5187839|NCT01115803|12758357|P5|NOT COMPLETED|Overall Study||0
5187840|NCT01115803|12758358|P4|NOT COMPLETED|Overall Study||0
5187841|NCT01115803|12758359|P3|NOT COMPLETED|Overall Study||1
5187842|NCT01115803|12758360|P2|NOT COMPLETED|Overall Study||0
5187843|NCT01115803|12758361|P1|NOT COMPLETED|Overall Study||0
5187844|NCT01115803|12758355|P7|COMPLETED|Overall Study||4
5187845|NCT01115803|12758356|P6|COMPLETED|Overall Study||3
5187846|NCT01115803|12758357|P5|COMPLETED|Overall Study||3
5187847|NCT01115803|12758358|P4|COMPLETED|Overall Study||5
5187848|NCT01115803|12758359|P3|COMPLETED|Overall Study||2
5187849|NCT01115803|12758360|P2|COMPLETED|Overall Study||5
5187850|NCT01115803|12758361|P1|COMPLETED|Overall Study||4
5187851|NCT01115803|12758355|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
5187852|NCT01115803|12758356|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
5187853|NCT01115803|12758357|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5187854|NCT01115803|12758358|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
5187855|NCT01115803|12758359|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5187856|NCT01115803|12758360|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
5187857|NCT01115803|12758361|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5187858|NCT01115803|12758355|P7|STARTED|Overall Study||6
5187859|NCT01115803|12758356|P6|STARTED|Overall Study||3
5187860|NCT01115803|12758357|P5|STARTED|Overall Study||3
5187861|NCT01115803|12758358|P4|STARTED|Overall Study||5
5187862|NCT01115803|12758359|P3|STARTED|Overall Study||3
5187863|NCT01115803|12758360|P2|STARTED|Overall Study||5
5187864|NCT01115803|12758361|P1|STARTED|Overall Study||4
5187865|NCT01115738|12758424|P3|NOT COMPLETED|Overall Study||27
5187866|NCT01115738|12758425|P2|NOT COMPLETED|Overall Study||21
5187867|NCT01115738|12758426|P1|NOT COMPLETED|Overall Study||25
5187868|NCT01115738|12758424|P3|COMPLETED|Overall Study||62
5187869|NCT01115738|12758425|P2|COMPLETED|Overall Study||62
5187870|NCT01115738|12758426|P1|COMPLETED|Overall Study||85
5187871|NCT01115738|12758424|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
5187872|NCT01115738|12758425|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
5187873|NCT01115738|12758426|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
5187874|NCT01115738|12758424|P3|Received Any Treatment|Overall Study||88
5187875|NCT01115738|12758425|P2|Received Any Treatment|Overall Study||79
5187876|NCT01115738|12758426|P1|Received Any Treatment|Overall Study||109
5187877|NCT01115738|12758424|P3|STARTED|Overall Study||89
5187878|NCT01115738|12758425|P2|STARTED|Overall Study||83
5187879|NCT01115738|12758426|P1|STARTED|Overall Study||110
5187880|NCT01115699|12758460|P1|NOT COMPLETED|Overall Study||0
5187881|NCT01115699|12758460|P1|COMPLETED|Overall Study||2
5187882|NCT01115699|12758460|P1|STARTED|Overall Study||2
5187883|NCT01115673|12758468|P3|NOT COMPLETED|Overall Study||0
5187884|NCT01115673|12758469|P2|NOT COMPLETED|Overall Study||0
5187885|NCT01115673|12758470|P1|NOT COMPLETED|Overall Study||0
5187886|NCT01115673|12758468|P3|COMPLETED|Overall Study||60
5187887|NCT01115673|12758469|P2|COMPLETED|Overall Study||241
5187888|NCT01115673|12758470|P1|COMPLETED|Overall Study||239
5187889|NCT01115673|12758468|P3|STARTED|Overall Study||60
5187890|NCT01115673|12758469|P2|STARTED|Overall Study||241
5187891|NCT01115673|12758470|P1|STARTED|Overall Study||239
5187892|NCT01115660|12758606|P2|NOT COMPLETED|Overall Study||0
5187893|NCT01115660|12758607|P1|NOT COMPLETED|Overall Study||1
5187894|NCT01115660|12758606|P2|COMPLETED|Overall Study||10
5187895|NCT01115660|12758607|P1|COMPLETED|Overall Study||19
5187896|NCT01115660|12758606|P2|STARTED|Overall Study||10
5187897|NCT01115660|12758607|P1|STARTED|Overall Study||20
5187898|NCT01115582|12758615|P1|NOT COMPLETED|Overall Study||0
5187899|NCT01115582|12758615|P1|COMPLETED|Overall Study||16
5187900|NCT01115582|12758615|P1|STARTED|Overall Study||16
5187901|NCT01115569|12758624|P2|NOT COMPLETED|Maintenance Phase||139
5187902|NCT01115569|12758625|P1|NOT COMPLETED|Maintenance Phase||0
5187903|NCT01115569|12758624|P2|COMPLETED|Maintenance Phase||285
5187904|NCT01115569|12758625|P1|COMPLETED|Maintenance Phase||0
5187905|NCT01115569|12758624|P2|STARTED|Maintenance Phase||424
5187906|NCT01115569|12758625|P1|STARTED|Maintenance Phase||0
5187907|NCT01115569|12758624|P2|NOT COMPLETED|Conversion/Titration Phase||0
5187908|NCT01115569|12758625|P1|NOT COMPLETED|Conversion/Titration Phase||214
5187909|NCT01115569|12758624|P2|COMPLETED|Conversion/Titration Phase||0
5187910|NCT01115569|12758625|P1|COMPLETED|Conversion/Titration Phase||424
5187911|NCT01115569|12758624|P2|STARTED|Conversion/Titration Phase||0
5187912|NCT01115569|12758625|P1|STARTED|Conversion/Titration Phase||638
5187913|NCT01115556|12758632|P2|NOT COMPLETED|Overall Study||0
5187914|NCT01115556|12758633|P1|NOT COMPLETED|Overall Study||0
5187915|NCT01115556|12758632|P2|COMPLETED|Overall Study||2
5187916|NCT01115556|12758633|P1|COMPLETED|Overall Study||7
5187917|NCT01115556|12758632|P2|STARTED|Overall Study||2
5187918|NCT01115556|12758633|P1|STARTED|Overall Study||7
5187919|NCT01115517|12758643|P2|NOT COMPLETED|Overall Study||5
5187920|NCT01115517|12758644|P1|NOT COMPLETED|Overall Study||4
5187921|NCT01115517|12758643|P2|COMPLETED|Overall Study||16
5187922|NCT01115517|12758644|P1|COMPLETED|Overall Study||14
5187923|NCT01115517|12758643|P2|STARTED|Overall Study||21
5187924|NCT01115517|12758644|P1|STARTED|Overall Study||18
5187925|NCT01115491|12758654|P1|NOT COMPLETED|Overall Study||30
5187926|NCT01115491|12758654|P1|COMPLETED|Overall Study||2
5187927|NCT01115491|12758654|P1|STARTED|Overall Study||32
5187928|NCT01115452|12758663|P1|NOT COMPLETED|Overall Study||0
5187929|NCT01115452|12758663|P1|COMPLETED|Overall Study||32
5187930|NCT01115452|12758663|P1|STARTED|Overall Study||32
5187931|NCT01115244|12758715|P2|NOT COMPLETED|Overall Study||0
5187932|NCT01115244|12758716|P1|NOT COMPLETED|Overall Study||0
5187933|NCT01115244|12758715|P2|COMPLETED|Overall Study||0
5187934|NCT01115244|12758716|P1|COMPLETED|Overall Study||0
5187935|NCT01115244|12758715|P2|STARTED|Overall Study||0
5187936|NCT01115244|12758716|P1|STARTED|Overall Study||0
5187937|NCT01115231|12758728|P2|NOT COMPLETED|Overall Study||0
5187938|NCT01115231|12758729|P1|NOT COMPLETED|Overall Study||0
5187939|NCT01115231|12758728|P2|COMPLETED|Overall Study||90
5187940|NCT01115231|12758729|P1|COMPLETED|Overall Study||133
5187941|NCT01115231|12758728|P2|STARTED|Overall Study||90
5187942|NCT01115231|12758729|P1|STARTED|Overall Study||133
5187943|NCT01115166|12758741|P1|NOT COMPLETED|Overall Study||0
5187944|NCT01115166|12758741|P1|COMPLETED|Overall Study||10
5187945|NCT01115166|12758741|P1|STARTED|Overall Study||10
5187946|NCT01115101|12758749|P2|NOT COMPLETED|Overall Study||0
5187947|NCT01115101|12758750|P1|NOT COMPLETED|Overall Study||0
5187948|NCT01115101|12758749|P2|COMPLETED|Overall Study||126
5187949|NCT01115101|12758750|P1|COMPLETED|Overall Study||113
5187950|NCT01115101|12758749|P2|STARTED|Overall Study||126
5187951|NCT01115101|12758750|P1|STARTED|Overall Study||113
5187952|NCT01114997|12758759|P3|NOT COMPLETED|Overall Study||0
5187953|NCT01114997|12758760|P2|NOT COMPLETED|Overall Study||0
5187954|NCT01114997|12758761|P1|NOT COMPLETED|Overall Study||0
5187955|NCT01114997|12758759|P3|COMPLETED|Overall Study||11
5187956|NCT01114997|12758760|P2|COMPLETED|Overall Study||10
5187957|NCT01114997|12758761|P1|COMPLETED|Overall Study||11
5187958|NCT01114997|12758759|P3|STARTED|Overall Study||11
5187959|NCT01114997|12758760|P2|STARTED|Overall Study||10
5187960|NCT01114997|12758761|P1|STARTED|Overall Study||11
5187961|NCT01114971|12758790|P3|NOT COMPLETED|Overall Study||0
5187962|NCT01114971|12758791|P2|NOT COMPLETED|Overall Study||0
5187963|NCT01114971|12758792|P1|NOT COMPLETED|Overall Study||0
5187964|NCT01114971|12758790|P3|COMPLETED|Overall Study||25
5187965|NCT01114971|12758791|P2|COMPLETED|Overall Study||25
5187966|NCT01114971|12758792|P1|COMPLETED|Overall Study||25
5187967|NCT01114971|12758790|P3|STARTED|Overall Study||25
5187968|NCT01114971|12758791|P2|STARTED|Overall Study||25
5187969|NCT01114971|12758792|P1|STARTED|Overall Study||25
5187970|NCT01114945|12758819|P4|NOT COMPLETED|Overall Study||0
5187971|NCT01114945|12758820|P3|NOT COMPLETED|Overall Study||0
5187972|NCT01114945|12758821|P2|NOT COMPLETED|Overall Study||0
5187973|NCT01114945|12758822|P1|NOT COMPLETED|Overall Study||0
5187974|NCT01114945|12758819|P4|COMPLETED|Overall Study||31
5187975|NCT01114945|12758820|P3|COMPLETED|Overall Study||30
5187976|NCT01114945|12758821|P2|COMPLETED|Overall Study||30
5187977|NCT01114945|12758822|P1|COMPLETED|Overall Study||30
5187978|NCT01114945|12758819|P4|STARTED|Overall Study||31
5187979|NCT01114945|12758820|P3|STARTED|Overall Study||30
5187980|NCT01114945|12758821|P2|STARTED|Overall Study||30
5187981|NCT01114945|12758822|P1|STARTED|Overall Study||30
5187982|NCT01114893|12758849|P5|NOT COMPLETED|Overall Study||0
5187983|NCT01114893|12758850|P4|NOT COMPLETED|Overall Study||0
5187984|NCT01114893|12758851|P3|NOT COMPLETED|Overall Study||0
5187985|NCT01114893|12758852|P2|NOT COMPLETED|Overall Study||0
5187986|NCT01114893|12758853|P1|NOT COMPLETED|Overall Study||0
5187987|NCT01114893|12758849|P5|COMPLETED|Overall Study||12
5187988|NCT01114893|12758850|P4|COMPLETED|Overall Study||13
5187989|NCT01114893|12758851|P3|COMPLETED|Overall Study||14
5187990|NCT01114893|12758852|P2|COMPLETED|Overall Study||14
5187991|NCT01114893|12758853|P1|COMPLETED|Overall Study||14
5187992|NCT01114893|12758849|P5|STARTED|Overall Study||12
5187993|NCT01114893|12758850|P4|STARTED|Overall Study||13
5187994|NCT01114893|12758851|P3|STARTED|Overall Study||14
5187995|NCT01114893|12758852|P2|STARTED|Overall Study||14
5187996|NCT01114893|12758853|P1|STARTED|Overall Study||14
5187997|NCT01114880|12758872|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
5187998|NCT01114880|12758873|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
5187999|NCT01114880|12758872|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
5188000|NCT01114880|12758873|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
5188001|NCT01114880|12758872|P2|STARTED|Period 2 (Week 12 to Week 24)||113
5188002|NCT01114880|12758873|P1|STARTED|Period 2 (Week 12 to Week 24)||224
5188003|NCT01114880|12758872|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
5188004|NCT01114880|12758873|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
5188005|NCT01114880|12758872|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
5188006|NCT01114880|12758873|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
5188007|NCT01114880|12758872|P2|STARTED|Period 1 (Week 0 to Week 12)||115
5188008|NCT01114880|12758873|P1|STARTED|Period 1 (Week 0 to Week 12)||229
5188009|NCT01114828|12758925|P2|NOT COMPLETED|Overall Study||4
5188010|NCT01114828|12758926|P1|NOT COMPLETED|Overall Study||3
5188011|NCT01114828|12758925|P2|COMPLETED|Overall Study||17
5188012|NCT01114828|12758926|P1|COMPLETED|Overall Study||16
5188013|NCT01114828|12758925|P2|STARTED|Overall Study||21
5188014|NCT01114828|12758926|P1|STARTED|Overall Study||19
5188015|NCT01114737|12758936|P2|NOT COMPLETED|Open-Label Treatment Period||2
5188016|NCT01114737|12758937|P1|NOT COMPLETED|Open-Label Treatment Period||5
5188017|NCT01114737|12758936|P2|COMPLETED|Open-Label Treatment Period||95
5188018|NCT01114737|12758937|P1|COMPLETED|Open-Label Treatment Period||100
5188019|NCT01114737|12758936|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
5188020|NCT01114737|12758937|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
5188021|NCT01114737|12758936|P2|NOT COMPLETED|Randomized Treatment Period||1
5188022|NCT01114737|12758937|P1|NOT COMPLETED|Randomized Treatment Period||3
5188023|NCT01114737|12758936|P2|COMPLETED|Randomized Treatment Period||97
5188024|NCT01114737|12758937|P1|COMPLETED|Randomized Treatment Period||105
5188025|NCT01114737|12758936|P2|STARTED|Randomized Treatment Period||98
5188026|NCT01114737|12758937|P1|STARTED|Randomized Treatment Period||108
5188027|NCT01114724|12758985|P1|NOT COMPLETED|Overall Study||10
5188028|NCT01114724|12758985|P1|COMPLETED|Overall Study||40
5188029|NCT01114724|12758985|P1|STARTED|Overall Study||50
5188030|NCT01114672|12759005|P2|NOT COMPLETED|Overall Study||2
5188031|NCT01114672|12759006|P1|NOT COMPLETED|Overall Study||4
5188032|NCT01114672|12759005|P2|COMPLETED|Overall Study||23
5188033|NCT01114672|12759006|P1|COMPLETED|Overall Study||21
5188034|NCT01114672|12759005|P2|STARTED|Overall Study||25
5188035|NCT01114672|12759006|P1|STARTED|Overall Study||25
5188036|NCT01114646|12759014|P2|NOT COMPLETED|Overall Study||2
5188037|NCT01114646|12759015|P1|NOT COMPLETED|Overall Study||3
5188038|NCT01114646|12759014|P2|COMPLETED|Overall Study||62
5188039|NCT01114646|12759015|P1|COMPLETED|Overall Study||63
5188040|NCT01114646|12759014|P2|STARTED|Overall Study||64
5188041|NCT01114646|12759015|P1|STARTED|Overall Study||66
5188042|NCT01114620|12759021|P1|NOT COMPLETED|Overall Study||0
5188043|NCT01114620|12759021|P1|COMPLETED|Overall Study||50
5188044|NCT01114620|12759021|P1|STARTED|Overall Study||50
5188045|NCT01114581|12759054|P2|NOT COMPLETED|Overall Study||0
5188046|NCT01114581|12759055|P1|NOT COMPLETED|Overall Study||0
5188047|NCT01114581|12759054|P2|COMPLETED|Overall Study||19
5188048|NCT01114581|12759055|P1|COMPLETED|Overall Study||19
5188049|NCT01114581|12759054|P2|STARTED|Overall Study||19
5188050|NCT01114581|12759055|P1|STARTED|Overall Study||19
5188051|NCT01114555|12759065|P1|NOT COMPLETED|Overall Study||0
5188052|NCT01114555|12759065|P1|COMPLETED|Overall Study||34
5188053|NCT01114555|12759065|P1|STARTED|Overall Study||34
5188054|NCT01114529|12759075|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
5188055|NCT01114529|12759076|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
5188056|NCT01114529|12759077|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
5188057|NCT01114529|12759075|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
5188058|NCT01114529|12759076|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
5188059|NCT01114529|12759077|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
5188060|NCT01114529|12759075|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
5188061|NCT01114529|12759076|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
5188062|NCT01114529|12759077|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
5188063|NCT01114529|12759075|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
5188064|NCT01114529|12759076|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
5188065|NCT01114529|12759077|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
5188066|NCT01114529|12759075|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
5188067|NCT01114529|12759076|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
5188068|NCT01114529|12759077|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
5188069|NCT01114529|12759075|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
5188070|NCT01114529|12759076|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
5188071|NCT01114529|12759077|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
5188072|NCT01114516|12759096|P2|NOT COMPLETED|Overall Study||1
5188073|NCT01114516|12759097|P1|NOT COMPLETED|Overall Study||2
5188074|NCT01114516|12759096|P2|COMPLETED|Overall Study||26
5188075|NCT01114516|12759097|P1|COMPLETED|Overall Study||24
5188076|NCT01114516|12759096|P2|STARTED|Overall Study||27
5188077|NCT01114516|12759097|P1|STARTED|Overall Study||26
5188078|NCT01114503|12759111|P1|NOT COMPLETED|Overall Study||0
5188079|NCT01114503|12759111|P1|COMPLETED|Overall Study||2
5188080|NCT01114503|12759111|P1|STARTED|Overall Study||2
5188081|NCT01114438|12759132|P1|NOT COMPLETED|Overall Study||14
5188082|NCT01114438|12759132|P1|COMPLETED|Overall Study||31
5188083|NCT01114438|12759132|P1|STARTED|Overall Study||45
5188084|NCT01114373|12759142|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
5188085|NCT01114373|12759143|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
5188086|NCT01114373|12759142|P2|COMPLETED|Intervention 2 (4 Weeks)||18
5188087|NCT01114373|12759143|P1|COMPLETED|Intervention 2 (4 Weeks)||18
5188088|NCT01114373|12759142|P2|STARTED|Intervention 2 (4 Weeks)||19
5188089|NCT01114373|12759143|P1|STARTED|Intervention 2 (4 Weeks)||18
5188090|NCT01114373|12759142|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
5188091|NCT01114373|12759143|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
5188092|NCT01114373|12759142|P2|COMPLETED|Intervention 1 (4 Weeks)||19
5188093|NCT01114373|12759143|P1|COMPLETED|Intervention 1 (4 Weeks)||18
5188094|NCT01114373|12759142|P2|STARTED|Intervention 1 (4 Weeks)||19
5188095|NCT01114373|12759143|P1|STARTED|Intervention 1 (4 Weeks)||21
5188096|NCT01114360|12759175|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
5188097|NCT01114360|12759176|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
5188098|NCT01114360|12759175|P2|COMPLETED|Intervention 2 (4 Weeks)||18
5188099|NCT01114360|12759176|P1|COMPLETED|Intervention 2 (4 Weeks)||18
5188100|NCT01114360|12759175|P2|STARTED|Intervention 2 (4 Weeks)||18
5188101|NCT01114360|12759176|P1|STARTED|Intervention 2 (4 Weeks)||18
5188102|NCT01114360|12759175|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
5188103|NCT01114360|12759176|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
5188104|NCT01114360|12759175|P2|COMPLETED|Intervention 1 (4 Weeks)||18
5188105|NCT01114360|12759176|P1|COMPLETED|Intervention 1 (4 Weeks)||18
5188106|NCT01114360|12759175|P2|STARTED|Intervention 1 (4 Weeks)||19
5188107|NCT01114360|12759176|P1|STARTED|Intervention 1 (4 Weeks)||18
5188108|NCT01114334|12759214|P2|NOT COMPLETED|Overall Study||22
5188109|NCT01114334|12759215|P1|NOT COMPLETED|Overall Study||21
5188110|NCT01114334|12759214|P2|COMPLETED|Overall Study||58
5188111|NCT01114334|12759215|P1|COMPLETED|Overall Study||67
5188112|NCT01114334|12759214|P2|STARTED|Overall Study||80
5188113|NCT01114334|12759215|P1|STARTED|Overall Study||88
5188114|NCT01114217|12759227|P2|NOT COMPLETED|Overall Study||98
5188115|NCT01114217|12759228|P1|NOT COMPLETED|Overall Study||75
5188116|NCT01114217|12759227|P2|COMPLETED|Overall Study||199
5188117|NCT01114217|12759228|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
5188118|NCT01114217|12759227|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
5188119|NCT01114217|12759228|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
5188120|NCT01114217|12759227|P2|STARTED|Overall Study||297
5188121|NCT01114217|12759228|P1|STARTED|Overall Study||337
5188122|NCT01114204|12759240|P2|NOT COMPLETED|Overall Study||8
5188123|NCT01114204|12759241|P1|NOT COMPLETED|Overall Study||21
5188124|NCT01114204|12759240|P2|COMPLETED|Overall Study||191
5188125|NCT01114204|12759241|P1|COMPLETED|Overall Study||385
5188126|NCT01114204|12759240|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
5188127|NCT01114204|12759241|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
5188128|NCT01114204|12759240|P2|STARTED|Overall Study||199
5188129|NCT01114204|12759241|P1|STARTED|Overall Study||406
5188130|NCT01114139|12759259|P2|NOT COMPLETED|Overall Study||16
5188131|NCT01114139|12759260|P1|NOT COMPLETED|Overall Study||40
5188132|NCT01114139|12759259|P2|COMPLETED|Overall Study||187
5188133|NCT01114139|12759260|P1|COMPLETED|Overall Study||569
5188134|NCT01114139|12759259|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
5188135|NCT01114139|12759260|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
5188136|NCT01114139|12759259|P2|STARTED|Overall Study||203
5188137|NCT01114139|12759260|P1|STARTED|Overall Study||609
5188138|NCT01113983|12759278|P2|NOT COMPLETED|Overall Study||17
5188139|NCT01113983|12759279|P1|NOT COMPLETED|Overall Study||25
5188140|NCT01113983|12759278|P2|COMPLETED|Overall Study||10
5188141|NCT01113983|12759279|P1|COMPLETED|Overall Study||12
5188142|NCT01113983|12759278|P2|STARTED|Overall Study||27
5188143|NCT01113983|12759279|P1|STARTED|Overall Study||37
5188144|NCT01113931|12759289|P2|NOT COMPLETED|Overall Study||17
5188145|NCT01113931|12759290|P1|NOT COMPLETED|Overall Study||19
5188146|NCT01113931|12759289|P2|COMPLETED|Overall Study||231
5188147|NCT01113931|12759290|P1|COMPLETED|Overall Study||228
5188148|NCT01113931|12759289|P2|mITT Population|Overall Study||190
5188149|NCT01113931|12759290|P1|mITT Population|Overall Study||188
5188150|NCT01113931|12759289|P2|Safety Population|Overall Study||248
5188151|NCT01113931|12759290|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
5188152|NCT01113931|12759289|P2|STARTED|Overall Study||248
5188153|NCT01113931|12759290|P1|STARTED|Overall Study||247
5188154|NCT01113892|12759304|P2|NOT COMPLETED|Overall Study||16
5188155|NCT01113892|12759305|P1|NOT COMPLETED|Overall Study||14
5188156|NCT01113892|12759304|P2|COMPLETED|Overall Study||90
5188157|NCT01113892|12759305|P1|COMPLETED|Overall Study||87
5188158|NCT01113892|12759304|P2|STARTED|Overall Study||106
5188159|NCT01113892|12759305|P1|STARTED|Overall Study||101
5188160|NCT01113879|12759333|P2|NOT COMPLETED|Period 2: Block 2||0
5188161|NCT01113879|12759334|P1|NOT COMPLETED|Period 2: Block 2||0
5188162|NCT01113879|12759333|P2|COMPLETED|Period 2: Block 2||2
5188163|NCT01113879|12759334|P1|COMPLETED|Period 2: Block 2||5
5188164|NCT01113879|12759333|P2|STARTED|Period 2: Block 2||2
5188165|NCT01113879|12759334|P1|STARTED|Period 2: Block 2||5
5188166|NCT01113879|12759333|P2|NOT COMPLETED|Period 1: Block 1||0
5188167|NCT01113879|12759334|P1|NOT COMPLETED|Period 1: Block 1||2
5188168|NCT01113879|12759333|P2|COMPLETED|Period 1: Block 1||2
5188169|NCT01113879|12759334|P1|COMPLETED|Period 1: Block 1||5
5188170|NCT01113879|12759333|P2|STARTED|Period 1: Block 1||2
5188171|NCT01113879|12759334|P1|STARTED|Period 1: Block 1||7
5188172|NCT01113801|12759346|P4|NOT COMPLETED|Overall Study||41
5188173|NCT01113801|12759347|P3|NOT COMPLETED|Overall Study||37
5188174|NCT01113801|12759348|P2|NOT COMPLETED|Overall Study||40
5188175|NCT01113801|12759349|P1|NOT COMPLETED|Overall Study||41
5188176|NCT01113801|12759346|P4|COMPLETED|Overall Study||65
5188177|NCT01113801|12759347|P3|COMPLETED|Overall Study||66
5188178|NCT01113801|12759348|P2|COMPLETED|Overall Study||65
5188179|NCT01113801|12759349|P1|COMPLETED|Overall Study||62
5188180|NCT01113801|12759346|P4|Received at Least One Dose of Drug|Overall Study||105
5188181|NCT01113801|12759347|P3|Received at Least One Dose of Drug|Overall Study||103
5188182|NCT01113801|12759348|P2|Received at Least One Dose of Drug|Overall Study||105
5188183|NCT01113801|12759349|P1|Received at Least One Dose of Drug|Overall Study||103
5188184|NCT01113801|12759346|P4|STARTED|Overall Study||106
5188185|NCT01113801|12759347|P3|STARTED|Overall Study||103
5188186|NCT01113801|12759348|P2|STARTED|Overall Study||105
5188187|NCT01113801|12759349|P1|STARTED|Overall Study||103
5188188|NCT01113749|12759377|P2|NOT COMPLETED|Overall Study||2
5188189|NCT01113749|12759378|P1|NOT COMPLETED|Overall Study||1
5188190|NCT01113749|12759377|P2|COMPLETED|Overall Study||127
5188191|NCT01113749|12759378|P1|COMPLETED|Overall Study||126
5188192|NCT01113749|12759377|P2|STARTED|Overall Study||129
5188193|NCT01113749|12759378|P1|STARTED|Overall Study||127
5188194|NCT01113723|12759390|P2|NOT COMPLETED|Overall Study||0
5188195|NCT01113723|12759391|P1|NOT COMPLETED|Overall Study||0
5188196|NCT01113723|12759390|P2|COMPLETED|Overall Study||70
5188197|NCT01113723|12759391|P1|COMPLETED|Overall Study||70
5188198|NCT01113723|12759390|P2|STARTED|Overall Study||70
5188199|NCT01113723|12759391|P1|STARTED|Overall Study||70
5188200|NCT01113710|12759401|P1|NOT COMPLETED|Overall Study||269
5188201|NCT01113710|12759401|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
5188202|NCT01113710|12759401|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
5188203|NCT01113632|12759412|P2|NOT COMPLETED|Overall Study||25
5188204|NCT01113632|12759413|P1|NOT COMPLETED|Overall Study||31
5188205|NCT01113632|12759412|P2|COMPLETED|Overall Study||19
5188206|NCT01113632|12759413|P1|COMPLETED|Overall Study||2
5188207|NCT01113632|12759412|P2|STARTED|Overall Study||44
5188208|NCT01113632|12759413|P1|STARTED|Overall Study||33
5188209|NCT01113580|12759429|P2|NOT COMPLETED|Overall Study||0
5188210|NCT01113580|12759430|P1|NOT COMPLETED|Overall Study||1
5188211|NCT01113580|12759429|P2|COMPLETED|Overall Study||60
5188212|NCT01113580|12759430|P1|COMPLETED|Overall Study||59
5188213|NCT01113580|12759429|P2|STARTED|Overall Study||60
5188214|NCT01113580|12759430|P1|STARTED|Overall Study||60
5188215|NCT01113541|12759444|P1|NOT COMPLETED|Overall Study||13
5188216|NCT01113541|12759444|P1|COMPLETED|Overall Study||0
5188217|NCT01113541|12759444|P1|STARTED|Overall Study||13
5188218|NCT01113463|12759477|P1|NOT COMPLETED|Overall Study||5
5188219|NCT01113463|12759477|P1|COMPLETED|Overall Study||12
5188220|NCT01113463|12759477|P1|STARTED|Overall Study||17
5188221|NCT01113398|12759482|P1|NOT COMPLETED|Overall Study||0
5188222|NCT01113398|12759482|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
5188223|NCT01113398|12759482|P1|STARTED|Overall Study||36
5188224|NCT01113385|12759489|P1|NOT COMPLETED|Overall Study||0
5188225|NCT01113385|12759489|P1|COMPLETED|Overall Study||7
5188226|NCT01113385|12759489|P1|STARTED|Overall Study||7
5188227|NCT01113008|12759496|P2|NOT COMPLETED|Overall Study||0
5188228|NCT01113008|12759497|P1|NOT COMPLETED|Overall Study||0
5188229|NCT01113008|12759496|P2|COMPLETED|Overall Study||133
5188230|NCT01113008|12759497|P1|COMPLETED|Overall Study||133
5188231|NCT01113008|12759496|P2|STARTED|Overall Study||133
5188232|NCT01113008|12759497|P1|STARTED|Overall Study||133
5188233|NCT01112982|12759507|P1|NOT COMPLETED|Overall Study||2
5188234|NCT01112982|12759507|P1|COMPLETED|Overall Study||72
5188235|NCT01112982|12759507|P1|STARTED|Overall Study||74
5188236|NCT01112917|12759519|P2|NOT COMPLETED|Overall Study||15
5188237|NCT01112917|12759520|P1|NOT COMPLETED|Overall Study||7
5188238|NCT01112917|12759519|P2|COMPLETED|Overall Study||38
5188239|NCT01112917|12759520|P1|COMPLETED|Overall Study||89
5188240|NCT01112917|12759519|P2|STARTED|Overall Study||53
5188241|NCT01112917|12759520|P1|STARTED|Overall Study||96
5188242|NCT01112865|12759525|P2|NOT COMPLETED|Second Intervention||0
5188243|NCT01112865|12759526|P1|NOT COMPLETED|Second Intervention||0
5188244|NCT01112865|12759525|P2|COMPLETED|Second Intervention||61
5188245|NCT01112865|12759526|P1|COMPLETED|Second Intervention||59
5188246|NCT01112865|12759525|P2|STARTED|Second Intervention||61
5188247|NCT01112865|12759526|P1|STARTED|Second Intervention||59
5188248|NCT01112865|12759525|P2|NOT COMPLETED|First Intervention||0
5188249|NCT01112865|12759526|P1|NOT COMPLETED|First Intervention||0
5188250|NCT01112865|12759525|P2|COMPLETED|First Intervention||61
5188251|NCT01112865|12759526|P1|COMPLETED|First Intervention||59
5188252|NCT01112865|12759525|P2|STARTED|First Intervention||61
5188253|NCT01112865|12759526|P1|STARTED|First Intervention||59
5188254|NCT01112735|12759538|P2|NOT COMPLETED|Overall Study||0
5188255|NCT01112735|12759539|P1|NOT COMPLETED|Overall Study||0
5188256|NCT01112735|12759538|P2|COMPLETED|Overall Study||20
5188257|NCT01112735|12759539|P1|COMPLETED|Overall Study||20
5188258|NCT01112735|12759538|P2|STARTED|Overall Study||20
5188259|NCT01112735|12759539|P1|STARTED|Overall Study||20
5188260|NCT01112696|12759563|P1|NOT COMPLETED|Overall Study||2
5188261|NCT01112696|12759563|P1|COMPLETED|Overall Study||98
5188262|NCT01112696|12759563|P1|STARTED|Overall Study||100
5188263|NCT01112683|12759570|P2|NOT COMPLETED|Overall Study||1
5188264|NCT01112683|12759571|P1|NOT COMPLETED|Overall Study||1
5188265|NCT01112683|12759570|P2|COMPLETED|Overall Study||19
5188266|NCT01112683|12759571|P1|COMPLETED|Overall Study||18
5188267|NCT01112683|12759570|P2|STARTED|Overall Study||20
5188268|NCT01112683|12759571|P1|STARTED|Overall Study||19
5188269|NCT01112670|12759581|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188270|NCT01112670|12759582|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188271|NCT01112670|12759583|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188272|NCT01112670|12759584|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188273|NCT01112670|12759585|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188274|NCT01112670|12759586|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188275|NCT01112670|12759581|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
5188276|NCT01112670|12759582|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188277|NCT01112670|12759583|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
5188278|NCT01112670|12759584|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188279|NCT01112670|12759585|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
5188280|NCT01112670|12759586|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188281|NCT01112670|12759581|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
5188282|NCT01112670|12759582|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188283|NCT01112670|12759583|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
5188284|NCT01112670|12759584|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188285|NCT01112670|12759585|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
5188286|NCT01112670|12759586|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
5188287|NCT01112670|12759581|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188288|NCT01112670|12759582|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
5188289|NCT01112670|12759583|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188290|NCT01112670|12759584|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
5188291|NCT01112670|12759585|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188292|NCT01112670|12759586|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
5188293|NCT01112670|12759581|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188294|NCT01112670|12759582|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
5188295|NCT01112670|12759583|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188296|NCT01112670|12759584|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
5188297|NCT01112670|12759585|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188298|NCT01112670|12759586|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
5188299|NCT01112670|12759581|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188300|NCT01112670|12759582|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
5188301|NCT01112670|12759583|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188302|NCT01112670|12759584|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
5188303|NCT01112670|12759585|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
5188304|NCT01112670|12759586|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
5188305|NCT01112579|12759624|P2|NOT COMPLETED|Overall Study||3
5188306|NCT01112579|12759625|P1|NOT COMPLETED|Overall Study||1
5188307|NCT01112579|12759624|P2|COMPLETED|Overall Study||21
5188308|NCT01112579|12759625|P1|COMPLETED|Overall Study||41
5188309|NCT01112579|12759624|P2|STARTED|Overall Study||24
5188310|NCT01112579|12759625|P1|STARTED|Overall Study||42
5188311|NCT01112514|12759635|P1|NOT COMPLETED|Overall Study||1
5188312|NCT01112514|12759635|P1|COMPLETED|Overall Study||3
5188313|NCT01112514|12759635|P1|STARTED|Overall Study||4
5188314|NCT01112358|12759641|P2|NOT COMPLETED|Overall Study||0
5188315|NCT01112358|12759642|P1|NOT COMPLETED|Overall Study||0
5188316|NCT01112358|12759641|P2|COMPLETED|Overall Study||33
5188317|NCT01112358|12759642|P1|COMPLETED|Overall Study||25
5188318|NCT01112358|12759641|P2|STARTED|Overall Study||33
5188319|NCT01112358|12759642|P1|STARTED|Overall Study||25
5188320|NCT01112293|12759678|P1|NOT COMPLETED|Overall Study||0
5188321|NCT01112293|12759678|P1|COMPLETED|Overall Study||14
5188322|NCT01112293|12759678|P1|STARTED|Overall Study||14
5188323|NCT01112267|12759691|P2|NOT COMPLETED|Overall Study||18
5188324|NCT01112267|12759692|P1|NOT COMPLETED|Overall Study||34
5188325|NCT01112267|12759691|P2|COMPLETED|Overall Study||104
5188326|NCT01112267|12759692|P1|COMPLETED|Overall Study||92
5188327|NCT01112267|12759691|P2|Treated|Overall Study||120
5188328|NCT01112267|12759692|P1|Treated|Overall Study||125
5188329|NCT01112267|12759691|P2|STARTED|Overall Study||122
5188330|NCT01112267|12759692|P1|STARTED|Overall Study||126
5188331|NCT01112241|12759710|P1|NOT COMPLETED|Overall Study||0
5188332|NCT01112241|12759710|P1|COMPLETED|Overall Study||17
5188333|NCT01112241|12759710|P1|STARTED|Overall Study||17
5188334|NCT01112059|12759725|P2|NOT COMPLETED|Overall Study||0
5188335|NCT01112059|12759726|P1|NOT COMPLETED|Overall Study||1
5188336|NCT01112059|12759725|P2|COMPLETED|Overall Study||20
5188337|NCT01112059|12759726|P1|COMPLETED|Overall Study||19
5188338|NCT01112059|12759725|P2|STARTED|Overall Study||20
5188339|NCT01112059|12759726|P1|STARTED|Overall Study||20
5188340|NCT01111851|12759740|P2|NOT COMPLETED|Overall Study||0
5188341|NCT01111851|12759741|P1|NOT COMPLETED|Overall Study||2
5188342|NCT01111851|12759740|P2|COMPLETED|Overall Study||8
5188343|NCT01111851|12759741|P1|COMPLETED|Overall Study||6
5188344|NCT01111851|12759740|P2|STARTED|Overall Study||8
5188345|NCT01111851|12759741|P1|STARTED|Overall Study||8
5188346|NCT01111838|12759753|P1|NOT COMPLETED|Overall Study||7
5188347|NCT01111838|12759753|P1|COMPLETED|Overall Study||15
5188348|NCT01111838|12759753|P1|STARTED|Overall Study||22
5188349|NCT01111825|12759761|P4|NOT COMPLETED|Overall Study||21
5188350|NCT01111825|12759762|P3|NOT COMPLETED|Overall Study||8
5188351|NCT01111825|12759763|P2|NOT COMPLETED|Overall Study||1
5188352|NCT01111825|12759764|P1|NOT COMPLETED|Overall Study||3
5188353|NCT01111825|12759761|P4|COMPLETED|Overall Study||27
5188354|NCT01111825|12759762|P3|COMPLETED|Overall Study||29
5188355|NCT01111825|12759763|P2|COMPLETED|Overall Study||5
5188356|NCT01111825|12759764|P1|COMPLETED|Overall Study||5
5188357|NCT01111825|12759761|P4|STARTED|Overall Study||48
5188358|NCT01111825|12759762|P3|STARTED|Overall Study||37
5188359|NCT01111825|12759763|P2|STARTED|Overall Study||6
5188360|NCT01111825|12759764|P1|STARTED|Overall Study||8
5188361|NCT01111604|12759786|P3|NOT COMPLETED|Overall Study||3
5188362|NCT01111604|12759787|P2|NOT COMPLETED|Overall Study||0
5188363|NCT01111604|12759788|P1|NOT COMPLETED|Overall Study||8
5188364|NCT01111604|12759786|P3|COMPLETED|Overall Study||49
5188365|NCT01111604|12759787|P2|COMPLETED|Overall Study||52
5188366|NCT01111604|12759788|P1|COMPLETED|Overall Study||46
5188367|NCT01111604|12759786|P3|Received at Least One Dose of Study Drug|Overall Study||52
5188368|NCT01111604|12759787|P2|Received at Least One Dose of Study Drug|Overall Study||52
5188369|NCT01111604|12759788|P1|Received at Least One Dose of Study Drug|Overall Study||49
5188370|NCT01111604|12759786|P3|STARTED|Overall Study||52
5188371|NCT01111604|12759787|P2|STARTED|Overall Study||52
5188372|NCT01111604|12759788|P1|STARTED|Overall Study||54
5188373|NCT01111526|12759826|P3|NOT COMPLETED|Overall Study||2
5188374|NCT01111526|12759827|P2|NOT COMPLETED|Overall Study||1
5188375|NCT01111526|12759828|P1|NOT COMPLETED|Overall Study||0
5188376|NCT01111526|12759826|P3|COMPLETED|Overall Study||8
5188377|NCT01111526|12759827|P2|COMPLETED|Overall Study||7
5188378|NCT01111526|12759828|P1|COMPLETED|Overall Study||4
5188379|NCT01111526|12759826|P3|STARTED|Overall Study||10
5188380|NCT01111526|12759827|P2|STARTED|Overall Study||8
5188381|NCT01111526|12759828|P1|STARTED|Overall Study||4
5188382|NCT01111461|12759840|P1|NOT COMPLETED|Overall Study||51
5188383|NCT01111461|12759840|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
5188384|NCT01111461|12759840|P1|STARTED|Overall Study||133
5188385|NCT01111370|12759853|P1|NOT COMPLETED|Overall Study||2
5188386|NCT01111370|12759853|P1|COMPLETED|Overall Study||58
5188387|NCT01111370|12759853|P1|STARTED|Overall Study||60
5188388|NCT01111331|12759857|P2|NOT COMPLETED|Overall Study||0
5188389|NCT01111331|12759858|P1|NOT COMPLETED|Overall Study||0
5188390|NCT01111331|12759857|P2|COMPLETED|Overall Study||9
5188391|NCT01111331|12759858|P1|COMPLETED|Overall Study||9
5188392|NCT01111331|12759857|P2|STARTED|Overall Study||9
5188393|NCT01111331|12759858|P1|STARTED|Overall Study||9
5188394|NCT01111318|12759940|P4|NOT COMPLETED|Overall Study||0
5188395|NCT01111318|12759941|P3|NOT COMPLETED|Overall Study||0
5188396|NCT01111318|12759942|P2|NOT COMPLETED|Overall Study||0
5188397|NCT01111318|12759943|P1|NOT COMPLETED|Overall Study||0
5188398|NCT01111318|12759940|P4|COMPLETED|Overall Study||8
5188399|NCT01111318|12759941|P3|COMPLETED|Overall Study||8
5188400|NCT01111318|12759942|P2|COMPLETED|Overall Study||8
5188401|NCT01111318|12759943|P1|COMPLETED|Overall Study||12
5188402|NCT01111318|12759940|P4|STARTED|Overall Study||8
5188403|NCT01111318|12759941|P3|STARTED|Overall Study||8
5188404|NCT01111318|12759942|P2|STARTED|Overall Study||8
5188405|NCT01111318|12759943|P1|STARTED|Overall Study||12
5188406|NCT01111305|12760007|P2|NOT COMPLETED|Overall Study||0
5188407|NCT01111305|12760008|P1|NOT COMPLETED|Overall Study||0
5188408|NCT01111305|12760007|P2|COMPLETED|Overall Study||4
5188409|NCT01111305|12760008|P1|COMPLETED|Overall Study||4
5188410|NCT01111305|12760007|P2|STARTED|Overall Study||4
5188411|NCT01111305|12760008|P1|STARTED|Overall Study||4
5188412|NCT01111292|12760020|P2|NOT COMPLETED|Follow-Up||0
5188413|NCT01111292|12760021|P1|NOT COMPLETED|Follow-Up||0
5188414|NCT01111292|12760020|P2|COMPLETED|Follow-Up||1
5188415|NCT01111292|12760021|P1|COMPLETED|Follow-Up||2
5188416|NCT01111292|12760020|P2|STARTED|Follow-Up||1
5188417|NCT01111292|12760021|P1|STARTED|Follow-Up||2
5188418|NCT01111292|12760020|P2|NOT COMPLETED|Post Treatment Biopsy||0
5188419|NCT01111292|12760021|P1|NOT COMPLETED|Post Treatment Biopsy||0
5188420|NCT01111292|12760020|P2|COMPLETED|Post Treatment Biopsy||1
5188421|NCT01111292|12760021|P1|COMPLETED|Post Treatment Biopsy||2
5188422|NCT01111292|12760020|P2|STARTED|Post Treatment Biopsy||1
5188423|NCT01111292|12760021|P1|STARTED|Post Treatment Biopsy||2
5188424|NCT01111292|12760020|P2|NOT COMPLETED|Treatment||1
5188425|NCT01111292|12760021|P1|NOT COMPLETED|Treatment||1
5188426|NCT01111292|12760020|P2|COMPLETED|Treatment||1
5188427|NCT01111292|12760021|P1|COMPLETED|Treatment||2
5188428|NCT01111292|12760020|P2|STARTED|Treatment||2
5188429|NCT01111292|12760021|P1|STARTED|Treatment||3
5188430|NCT01111292|12760020|P2|NOT COMPLETED|Randomization||0
5188431|NCT01111292|12760021|P1|NOT COMPLETED|Randomization||0
5188432|NCT01111292|12760020|P2|COMPLETED|Randomization||2
5188433|NCT01111292|12760021|P1|COMPLETED|Randomization||3
5188434|NCT01111292|12760020|P2|STARTED|Randomization||2
5188435|NCT01111292|12760021|P1|STARTED|Randomization||3
5188436|NCT01111240|12760027|P1|NOT COMPLETED|Overall Study||1066
5188437|NCT01111240|12760027|P1|COMPLETED|Overall Study||3569
5188438|NCT01111240|12760027|P1|STARTED|Overall Study||4635
5188439|NCT01111162|12760049|P1|NOT COMPLETED|Overall Study||0
5188440|NCT01111162|12760049|P1|COMPLETED|Overall Study||120
5188441|NCT01111162|12760049|P1|STARTED|Overall Study||120
5188442|NCT01111149|12760057|P3|NOT COMPLETED|Overall Study||4
5188443|NCT01111149|12760058|P2|NOT COMPLETED|Overall Study||1
5188444|NCT01111149|12760059|P1|NOT COMPLETED|Overall Study||2
5188445|NCT01111149|12760057|P3|COMPLETED|Overall Study||5
5188446|NCT01111149|12760058|P2|COMPLETED|Overall Study||5
5188447|NCT01111149|12760059|P1|COMPLETED|Overall Study||7
5188448|NCT01111149|12760057|P3|STARTED|Overall Study||9
5188449|NCT01111149|12760058|P2|STARTED|Overall Study||6
5188450|NCT01111149|12760059|P1|STARTED|Overall Study||9
5188451|NCT01111123|12760135|P2|NOT COMPLETED|Maintenance Phase||2
5188452|NCT01111123|12760136|P1|NOT COMPLETED|Maintenance Phase||0
5188453|NCT01111123|12760135|P2|COMPLETED|Maintenance Phase||18
5188454|NCT01111123|12760136|P1|COMPLETED|Maintenance Phase||21
5188455|NCT01111123|12760135|P2|STARTED|Maintenance Phase||20
5188456|NCT01111123|12760136|P1|STARTED|Maintenance Phase||21
5188457|NCT01111123|12760135|P2|NOT COMPLETED|Open- Label Phase||0
5188458|NCT01111123|12760136|P1|NOT COMPLETED|Open- Label Phase||14
5188459|NCT01111123|12760135|P2|COMPLETED|Open- Label Phase||0
5188460|NCT01111123|12760136|P1|COMPLETED|Open- Label Phase||41
5188461|NCT01111123|12760135|P2|STARTED|Open- Label Phase||0
5188462|NCT01111123|12760136|P1|STARTED|Open- Label Phase||55
5188463|NCT01111110|12760146|P2|NOT COMPLETED|Overall Study||0
5188464|NCT01111110|12760147|P1|NOT COMPLETED|Overall Study||0
5188465|NCT01111110|12760146|P2|COMPLETED|Overall Study||4
5188466|NCT01111110|12760147|P1|COMPLETED|Overall Study||3
5188467|NCT01111110|12760146|P2|STARTED|Overall Study||4
5188468|NCT01111110|12760147|P1|STARTED|Overall Study||3
5188469|NCT01111058|12760159|P2|NOT COMPLETED|Overall Study||0
5188470|NCT01111058|12760160|P1|NOT COMPLETED|Overall Study||0
5188471|NCT01111058|12760159|P2|COMPLETED|Overall Study||24
5188472|NCT01111058|12760160|P1|COMPLETED|Overall Study||28
5188473|NCT01111058|12760159|P2|STARTED|Overall Study||24
5188474|NCT01111058|12760160|P1|STARTED|Overall Study||28
5188475|NCT01111019|12760182|P1|NOT COMPLETED|Overall Study||3
5188476|NCT01111019|12760182|P1|COMPLETED|Overall Study||16
5188477|NCT01111019|12760182|P1|STARTED|Overall Study||19
5188478|NCT01110967|12760201|P1|NOT COMPLETED|Overall Study||9
5188479|NCT01110967|12760201|P1|COMPLETED|Overall Study||31
5188480|NCT01110967|12760201|P1|12 Months Follow up|Overall Study||31
5188481|NCT01110967|12760201|P1|6 Months Follow up|Overall Study||24
5188482|NCT01110967|12760201|P1|3 Months Follow up|Overall Study||28
5188483|NCT01110967|12760201|P1|1 Month Follow up|Overall Study||26
5188484|NCT01110967|12760201|P1|Surgery|Overall Study||40
5188485|NCT01110967|12760201|P1|STARTED|Overall Study||40
5188486|NCT01110915|12760214|P2|NOT COMPLETED|Overall Study||2
5188487|NCT01110915|12760215|P1|NOT COMPLETED|Overall Study||10
5188488|NCT01110915|12760214|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
5188489|NCT01110915|12760215|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
5188490|NCT01110915|12760214|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
5188491|NCT01110915|12760215|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
5188492|NCT01110707|12760232|P2|NOT COMPLETED|Overall Study||3
5188493|NCT01110707|12760233|P1|NOT COMPLETED|Overall Study||0
5188494|NCT01110707|12760232|P2|COMPLETED|Overall Study||65
5188495|NCT01110707|12760233|P1|COMPLETED|Overall Study||63
5188496|NCT01110707|12760232|P2|STARTED|Overall Study||68
5188497|NCT01110707|12760233|P1|STARTED|Overall Study||63
5188498|NCT01110681|12760255|P1|NOT COMPLETED|Overall Study||32
5188499|NCT01110681|12760255|P1|COMPLETED|Overall Study||83
5188500|NCT01110681|12760255|P1|STARTED|Overall Study||115
5188501|NCT01110499|12760271|P8|NOT COMPLETED|Overall Study||0
5188502|NCT01110499|12760272|P7|NOT COMPLETED|Overall Study||0
5188503|NCT01110499|12760273|P6|NOT COMPLETED|Overall Study||0
5188504|NCT01110499|12760274|P5|NOT COMPLETED|Overall Study||0
5188505|NCT01110499|12760275|P4|NOT COMPLETED|Overall Study||0
5188506|NCT01110499|12760276|P3|NOT COMPLETED|Overall Study||0
5188507|NCT01110499|12760277|P2|NOT COMPLETED|Overall Study||0
5188508|NCT01110499|12760278|P1|NOT COMPLETED|Overall Study||0
5188509|NCT01110499|12760271|P8|COMPLETED|Overall Study||40
5188510|NCT01110499|12760272|P7|COMPLETED|Overall Study||39
5188511|NCT01110499|12760273|P6|COMPLETED|Overall Study||14
5188512|NCT01110499|12760274|P5|COMPLETED|Overall Study||14
5188513|NCT01110499|12760275|P4|COMPLETED|Overall Study||14
5188514|NCT01110499|12760276|P3|COMPLETED|Overall Study||14
5188515|NCT01110499|12760277|P2|COMPLETED|Overall Study||14
5188516|NCT01110499|12760278|P1|COMPLETED|Overall Study||14
5188517|NCT01110499|12760271|P8|STARTED|Overall Study||40
5188518|NCT01110499|12760272|P7|STARTED|Overall Study||39
5188519|NCT01110499|12760273|P6|STARTED|Overall Study||14
5188520|NCT01110499|12760274|P5|STARTED|Overall Study||14
5188521|NCT01110499|12760275|P4|STARTED|Overall Study||14
5188522|NCT01110499|12760276|P3|STARTED|Overall Study||14
5188523|NCT01110499|12760277|P2|STARTED|Overall Study||14
5188524|NCT01110499|12760278|P1|STARTED|Overall Study||14
5188525|NCT01110421|12760300|P2|NOT COMPLETED|Overall Study||0
5188526|NCT01110421|12760301|P1|NOT COMPLETED|Overall Study||0
5188527|NCT01110421|12760300|P2|COMPLETED|Overall Study||2
5188528|NCT01110421|12760301|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
5188529|NCT01110421|12760300|P2|STARTED|Overall Study||2
5188530|NCT01110421|12760301|P1|STARTED|Overall Study||5
5188531|NCT01110408|12760321|P2|NOT COMPLETED|Overall Study||0
5188532|NCT01110408|12760322|P1|NOT COMPLETED|Overall Study||1
5188533|NCT01110408|12760321|P2|COMPLETED|Overall Study||10
5188534|NCT01110408|12760322|P1|COMPLETED|Overall Study||30
5188535|NCT01110408|12760321|P2|STARTED|Overall Study||10
5188536|NCT01110408|12760322|P1|STARTED|Overall Study||31
5188537|NCT01110382|12760342|P2|NOT COMPLETED|Overall Study||2
5188538|NCT01110382|12760343|P1|NOT COMPLETED|Overall Study||0
5188539|NCT01110382|12760342|P2|COMPLETED|Overall Study||8
5188540|NCT01110382|12760343|P1|COMPLETED|Overall Study||31
5188541|NCT01110382|12760342|P2|STARTED|Overall Study||10
5188542|NCT01110382|12760343|P1|STARTED|Overall Study||31
5188543|NCT01110330|12760364|P3|NOT COMPLETED|Overall Study||26
5188544|NCT01110330|12760365|P2|NOT COMPLETED|Overall Study||23
5188545|NCT01110330|12760366|P1|NOT COMPLETED|Overall Study||15
5188546|NCT01110330|12760364|P3|COMPLETED|Overall Study||208
5188547|NCT01110330|12760365|P2|COMPLETED|Overall Study||207
5188548|NCT01110330|12760366|P1|COMPLETED|Overall Study||104
5188549|NCT01110330|12760364|P3|Positive Baseline Culture Set|Overall Study||114
5188550|NCT01110330|12760365|P2|Positive Baseline Culture Set|Overall Study||111
5188551|NCT01110330|12760366|P1|Positive Baseline Culture Set|Overall Study||56
5188552|NCT01110330|12760364|P3|STARTED|Overall Study||234
5188553|NCT01110330|12760365|P2|STARTED|Overall Study||230
5188554|NCT01110330|12760366|P1|STARTED|Overall Study||119
5188555|NCT01110252|12760377|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
5188556|NCT01110252|12760377|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
5188557|NCT01110252|12760377|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
5188558|NCT01110252|12760377|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
5188559|NCT01110252|12760377|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
5188560|NCT01110252|12760377|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
5188561|NCT01110239|12760394|P4|NOT COMPLETED|10 Min Ischemia||0
5188562|NCT01110239|12760395|P3|NOT COMPLETED|10 Min Ischemia||0
5188563|NCT01110239|12760396|P2|NOT COMPLETED|10 Min Ischemia||0
5188564|NCT01110239|12760397|P1|NOT COMPLETED|10 Min Ischemia||0
5188565|NCT01110239|12760394|P4|COMPLETED|10 Min Ischemia||6
5188566|NCT01110239|12760395|P3|COMPLETED|10 Min Ischemia||0
5188567|NCT01110239|12760396|P2|COMPLETED|10 Min Ischemia||0
5188568|NCT01110239|12760397|P1|COMPLETED|10 Min Ischemia||0
5188569|NCT01110239|12760394|P4|STARTED|10 Min Ischemia||6
5188570|NCT01110239|12760395|P3|STARTED|10 Min Ischemia||0
5188571|NCT01110239|12760396|P2|STARTED|10 Min Ischemia||0
5188572|NCT01110239|12760397|P1|STARTED|10 Min Ischemia||0
5188573|NCT01110239|12760394|P4|NOT COMPLETED|7.5 Min Ischemia||0
5188574|NCT01110239|12760395|P3|NOT COMPLETED|7.5 Min Ischemia||1
5188575|NCT01110239|12760396|P2|NOT COMPLETED|7.5 Min Ischemia||0
5188576|NCT01110239|12760397|P1|NOT COMPLETED|7.5 Min Ischemia||0
5188577|NCT01110239|12760394|P4|COMPLETED|7.5 Min Ischemia||0
5188578|NCT01110239|12760395|P3|COMPLETED|7.5 Min Ischemia||6
5188579|NCT01110239|12760396|P2|COMPLETED|7.5 Min Ischemia||0
5188580|NCT01110239|12760397|P1|COMPLETED|7.5 Min Ischemia||0
5188581|NCT01110239|12760394|P4|STARTED|7.5 Min Ischemia||0
5188582|NCT01110239|12760395|P3|STARTED|7.5 Min Ischemia||7
5188583|NCT01110239|12760396|P2|STARTED|7.5 Min Ischemia||0
5188584|NCT01110239|12760397|P1|STARTED|7.5 Min Ischemia||0
5188585|NCT01110239|12760394|P4|NOT COMPLETED|5 Min Ischemia||0
5188586|NCT01110239|12760395|P3|NOT COMPLETED|5 Min Ischemia||0
5188587|NCT01110239|12760396|P2|NOT COMPLETED|5 Min Ischemia||14
5188588|NCT01110239|12760397|P1|NOT COMPLETED|5 Min Ischemia||0
5188589|NCT01110239|12760394|P4|COMPLETED|5 Min Ischemia||0
5188590|NCT01110239|12760395|P3|COMPLETED|5 Min Ischemia||0
5188591|NCT01110239|12760396|P2|COMPLETED|5 Min Ischemia||0
5188592|NCT01110239|12760397|P1|COMPLETED|5 Min Ischemia||0
5188593|NCT01110239|12760394|P4|STARTED|5 Min Ischemia||0
5188594|NCT01110239|12760395|P3|STARTED|5 Min Ischemia||0
5188595|NCT01110239|12760396|P2|STARTED|5 Min Ischemia||14
5188596|NCT01110239|12760397|P1|STARTED|5 Min Ischemia||0
5188597|NCT01110239|12760394|P4|NOT COMPLETED|Sham Preconditioning||0
5188598|NCT01110239|12760395|P3|NOT COMPLETED|Sham Preconditioning||1
5188599|NCT01110239|12760396|P2|NOT COMPLETED|Sham Preconditioning||0
5188600|NCT01110239|12760397|P1|NOT COMPLETED|Sham Preconditioning||0
5188601|NCT01110239|12760394|P4|COMPLETED|Sham Preconditioning||6
5188602|NCT01110239|12760395|P3|COMPLETED|Sham Preconditioning||6
5188603|NCT01110239|12760396|P2|COMPLETED|Sham Preconditioning||14
5188604|NCT01110239|12760397|P1|COMPLETED|Sham Preconditioning||7
5188605|NCT01110239|12760394|P4|STARTED|Sham Preconditioning||6
5188606|NCT01110239|12760395|P3|STARTED|Sham Preconditioning||7
5188607|NCT01110239|12760396|P2|STARTED|Sham Preconditioning||14
5188608|NCT01110239|12760397|P1|STARTED|Sham Preconditioning||7
5188609|NCT01110200|12760413|P2|NOT COMPLETED|Overall Study||121
5188610|NCT01110200|12760414|P1|NOT COMPLETED|Overall Study||106
5188611|NCT01110200|12760413|P2|COMPLETED|Overall Study||204
5188612|NCT01110200|12760414|P1|COMPLETED|Overall Study||208
5188613|NCT01110200|12760413|P2|STARTED|Overall Study||325
5188614|NCT01110200|12760414|P1|STARTED|Overall Study||314
5188615|NCT01110187|12760430|P2|NOT COMPLETED|Overall Study||0
5188616|NCT01110187|12760431|P1|NOT COMPLETED|Overall Study||0
5188617|NCT01110187|12760430|P2|COMPLETED|Overall Study|completed 7 day treatment|4
5188618|NCT01110187|12760431|P1|COMPLETED|Overall Study|completed 7 day treatment|7
5188619|NCT01110187|12760430|P2|STARTED|Overall Study||4
5188620|NCT01110187|12760431|P1|STARTED|Overall Study||7
5188621|NCT01110174|12760439|P1|NOT COMPLETED|Overall Study||0
5188622|NCT01110174|12760439|P1|COMPLETED|Overall Study||8
5188623|NCT01110174|12760439|P1|STARTED|Overall Study||8
5188624|NCT01110135|12760444|P1|NOT COMPLETED|Overall Study||9
5188625|NCT01110135|12760444|P1|COMPLETED|Overall Study||34
5188626|NCT01110135|12760444|P1|STARTED|Overall Study||43
5188627|NCT01110005|12760450|P2|NOT COMPLETED|Overall Study||5
5188628|NCT01110005|12760451|P1|NOT COMPLETED|Overall Study||4
5188629|NCT01110005|12760450|P2|COMPLETED|Overall Study||156
5188630|NCT01110005|12760451|P1|COMPLETED|Overall Study||153
5188631|NCT01110005|12760450|P2|STARTED|Overall Study||161
5188632|NCT01110005|12760451|P1|STARTED|Overall Study||157
5188633|NCT01109992|12760463|P2|NOT COMPLETED|Overall Study||2
5188634|NCT01109992|12760464|P1|NOT COMPLETED|Overall Study||0
5188635|NCT01109992|12760463|P2|COMPLETED|Overall Study||30
5188636|NCT01109992|12760464|P1|COMPLETED|Overall Study||11
5188637|NCT01109992|12760463|P2|Subjects Enrolled|Overall Study||32
5188638|NCT01109992|12760464|P1|Subjects Enrolled|Overall Study||11
5188639|NCT01109992|12760463|P2|STARTED|Overall Study||32
5188640|NCT01109992|12760464|P1|STARTED|Overall Study||11
5188641|NCT01109979|12760478|P2|NOT COMPLETED|Overall Study||1
5188642|NCT01109979|12760479|P1|NOT COMPLETED|Overall Study||2
5188643|NCT01109979|12760478|P2|COMPLETED|Overall Study||11
5188644|NCT01109979|12760479|P1|COMPLETED|Overall Study||10
5188645|NCT01109979|12760478|P2|STARTED|Overall Study||12
5188646|NCT01109979|12760479|P1|STARTED|Overall Study||12
5188647|NCT01109849|12760487|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
5188648|NCT01109849|12760488|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
5188649|NCT01109849|12760489|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
5188650|NCT01109849|12760490|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
5188651|NCT01109849|12760491|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
5188652|NCT01109849|12760487|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
5188653|NCT01109849|12760488|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
5188654|NCT01109849|12760489|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
5188655|NCT01109849|12760490|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
5188656|NCT01109849|12760491|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
5188657|NCT01109849|12760487|P5|STARTED|Adaptive Randomization: Weight Recovery||25
5188658|NCT01109849|12760488|P4|STARTED|Adaptive Randomization: Weight Recovery||23
5188659|NCT01109849|12760489|P3|STARTED|Adaptive Randomization: Weight Recovery||24
5188660|NCT01109849|12760490|P2|STARTED|Adaptive Randomization: Weight Recovery||0
5188661|NCT01109849|12760491|P1|STARTED|Adaptive Randomization: Weight Recovery||0
5188662|NCT01109849|12760487|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
5188663|NCT01109849|12760488|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
5188664|NCT01109849|12760489|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
5188665|NCT01109849|12760490|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
5188666|NCT01109849|12760491|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
5188667|NCT01109849|12760487|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
5188668|NCT01109849|12760488|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
5188669|NCT01109849|12760489|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
5188670|NCT01109849|12760490|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
5188671|NCT01109849|12760491|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
5188672|NCT01109849|12760487|P5|STARTED|Initial Randomization: ADHD Treatment||0
5188673|NCT01109849|12760488|P4|STARTED|Initial Randomization: ADHD Treatment||0
5188674|NCT01109849|12760489|P3|STARTED|Initial Randomization: ADHD Treatment||0
5188675|NCT01109849|12760490|P2|STARTED|Initial Randomization: ADHD Treatment||180
5188676|NCT01109849|12760491|P1|STARTED|Initial Randomization: ADHD Treatment||50
5188677|NCT01109602|12760543|P3|NOT COMPLETED|Overall Study||1
5188678|NCT01109602|12760544|P2|NOT COMPLETED|Overall Study||2
5188679|NCT01109602|12760545|P1|NOT COMPLETED|Overall Study||1
5188680|NCT01109602|12760543|P3|COMPLETED|Overall Study||9
5188681|NCT01109602|12760544|P2|COMPLETED|Overall Study||21
5188682|NCT01109602|12760545|P1|COMPLETED|Overall Study||13
5188683|NCT01109602|12760543|P3|STARTED|Overall Study||10
5188684|NCT01109602|12760544|P2|STARTED|Overall Study||23
5188685|NCT01109602|12760545|P1|STARTED|Overall Study||14
5188686|NCT01109576|12760556|P1|NOT COMPLETED|Overall Study||1
5188687|NCT01109576|12760556|P1|COMPLETED|Overall Study||12
5188688|NCT01109576|12760556|P1|STARTED|Overall Study||13
5188689|NCT01109524|12760560|P1|NOT COMPLETED|Overall Study||57
5188690|NCT01109524|12760560|P1|COMPLETED|Overall Study||3
5188691|NCT01109524|12760560|P1|STARTED|Overall Study||60
5188692|NCT01109381|12760570|P1|NOT COMPLETED|Overall Study||2
5188693|NCT01109381|12760570|P1|COMPLETED|Overall Study||31
5188694|NCT01109381|12760570|P1|STARTED|Overall Study||33
5188695|NCT01109316|12760582|P6|NOT COMPLETED|Study Period 3||0
5188696|NCT01109316|12760583|P5|NOT COMPLETED|Study Period 3||2
5188697|NCT01109316|12760584|P4|NOT COMPLETED|Study Period 3||0
5188698|NCT01109316|12760585|P3|NOT COMPLETED|Study Period 3||0
5188699|NCT01109316|12760586|P2|NOT COMPLETED|Study Period 3||0
5188700|NCT01109316|12760587|P1|NOT COMPLETED|Study Period 3||1
5188701|NCT01109316|12760582|P6|COMPLETED|Study Period 3||19
5188702|NCT01109316|12760583|P5|COMPLETED|Study Period 3||18
5188703|NCT01109316|12760584|P4|COMPLETED|Study Period 3||20
5188704|NCT01109316|12760585|P3|COMPLETED|Study Period 3||18
5188705|NCT01109316|12760586|P2|COMPLETED|Study Period 3||21
5188706|NCT01109316|12760587|P1|COMPLETED|Study Period 3||20
5188707|NCT01109316|12760582|P6|STARTED|Study Period 3||19
5188708|NCT01109316|12760583|P5|STARTED|Study Period 3||20
5188709|NCT01109316|12760584|P4|STARTED|Study Period 3||20
5188710|NCT01109316|12760585|P3|STARTED|Study Period 3||18
5188711|NCT01109316|12760586|P2|STARTED|Study Period 3||21
5188712|NCT01109316|12760587|P1|STARTED|Study Period 3||21
5188713|NCT01109316|12760582|P6|NOT COMPLETED|Study Period 2||1
5188714|NCT01109316|12760583|P5|NOT COMPLETED|Study Period 2||0
5188715|NCT01109316|12760584|P4|NOT COMPLETED|Study Period 2||1
5188716|NCT01109316|12760585|P3|NOT COMPLETED|Study Period 2||1
5188717|NCT01109316|12760586|P2|NOT COMPLETED|Study Period 2||1
5188718|NCT01109316|12760587|P1|NOT COMPLETED|Study Period 2||1
5188719|NCT01109316|12760582|P6|COMPLETED|Study Period 2||19
5188720|NCT01109316|12760583|P5|COMPLETED|Study Period 2||20
5188721|NCT01109316|12760584|P4|COMPLETED|Study Period 2||20
5188722|NCT01109316|12760585|P3|COMPLETED|Study Period 2||18
5188723|NCT01109316|12760586|P2|COMPLETED|Study Period 2||21
5188724|NCT01109316|12760587|P1|COMPLETED|Study Period 2||21
5188725|NCT01109316|12760582|P6|STARTED|Study Period 2||20
5188726|NCT01109316|12760583|P5|STARTED|Study Period 2||20
5188727|NCT01109316|12760584|P4|STARTED|Study Period 2||21
5188728|NCT01109316|12760585|P3|STARTED|Study Period 2||19
5188729|NCT01109316|12760586|P2|STARTED|Study Period 2||22
5188730|NCT01109316|12760587|P1|STARTED|Study Period 2||22
5188731|NCT01109316|12760582|P6|NOT COMPLETED|Study Period 1||2
5188732|NCT01109316|12760583|P5|NOT COMPLETED|Study Period 1||2
5188733|NCT01109316|12760584|P4|NOT COMPLETED|Study Period 1||1
5188734|NCT01109316|12760585|P3|NOT COMPLETED|Study Period 1||3
5188735|NCT01109316|12760586|P2|NOT COMPLETED|Study Period 1||0
5188736|NCT01109316|12760587|P1|NOT COMPLETED|Study Period 1||0
5188737|NCT01109316|12760582|P6|COMPLETED|Study Period 1||20
5188738|NCT01109316|12760583|P5|COMPLETED|Study Period 1||20
5188739|NCT01109316|12760584|P4|COMPLETED|Study Period 1||21
5188740|NCT01109316|12760585|P3|COMPLETED|Study Period 1||19
5188741|NCT01109316|12760586|P2|COMPLETED|Study Period 1||22
5188742|NCT01109316|12760587|P1|COMPLETED|Study Period 1||22
5188743|NCT01109316|12760582|P6|Received at Least One Dose of Study Drug|Study Period 1||20
5188744|NCT01109316|12760583|P5|Received at Least One Dose of Study Drug|Study Period 1||22
5188745|NCT01109316|12760584|P4|Received at Least One Dose of Study Drug|Study Period 1||22
5188746|NCT01109316|12760585|P3|Received at Least One Dose of Study Drug|Study Period 1||22
5188747|NCT01109316|12760586|P2|Received at Least One Dose of Study Drug|Study Period 1||22
5188748|NCT01109316|12760587|P1|Received at Least One Dose of Study Drug|Study Period 1||22
5188749|NCT01109316|12760582|P6|STARTED|Study Period 1||22
5188750|NCT01109316|12760583|P5|STARTED|Study Period 1||22
5188751|NCT01109316|12760584|P4|STARTED|Study Period 1||22
5188752|NCT01109316|12760585|P3|STARTED|Study Period 1||22
5188753|NCT01109316|12760586|P2|STARTED|Study Period 1||22
5188754|NCT01109316|12760587|P1|STARTED|Study Period 1||22
5188755|NCT01109173|12760635|P4|NOT COMPLETED|Overall Study||93
5188756|NCT01109173|12760636|P3|NOT COMPLETED|Overall Study||101
5188757|NCT01109173|12760637|P2|NOT COMPLETED|Overall Study||86
5188758|NCT01109173|12760638|P1|NOT COMPLETED|Overall Study||88
5188759|NCT01109173|12760635|P4|COMPLETED|Overall Study||120
5188760|NCT01109173|12760636|P3|COMPLETED|Overall Study||110
5188761|NCT01109173|12760637|P2|COMPLETED|Overall Study||759
5188762|NCT01109173|12760638|P1|COMPLETED|Overall Study||763
5188763|NCT01109173|12760635|P4|STARTED|Overall Study||213
5188764|NCT01109173|12760636|P3|STARTED|Overall Study||211
5188765|NCT01109173|12760637|P2|STARTED|Overall Study||845
5188766|NCT01109173|12760638|P1|STARTED|Overall Study||851
5188767|NCT01109147|12760655|P3|NOT COMPLETED|Overall Study||10
5188768|NCT01109147|12760656|P2|NOT COMPLETED|Overall Study||3
5188769|NCT01109147|12760657|P1|NOT COMPLETED|Overall Study||2
5188770|NCT01109147|12760655|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
5188771|NCT01109147|12760656|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
5188772|NCT01109147|12760657|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
5188773|NCT01109147|12760655|P3|STARTED|Overall Study||36
5188774|NCT01109147|12760656|P2|STARTED|Overall Study||14
5188775|NCT01109147|12760657|P1|STARTED|Overall Study||17
5188776|NCT01109108|12760667|P2|NOT COMPLETED|Overall Study||0
5188777|NCT01109108|12760668|P1|NOT COMPLETED|Overall Study||0
5188778|NCT01109108|12760667|P2|COMPLETED|Overall Study||4755
5188779|NCT01109108|12760668|P1|COMPLETED|Overall Study||4035
5188780|NCT01109108|12760667|P2|STARTED|Overall Study||4755
5188781|NCT01109108|12760668|P1|STARTED|Overall Study||4035
5188782|NCT01109069|12760674|P1|NOT COMPLETED|Overall Study||93
5188783|NCT01109069|12760674|P1|COMPLETED|Overall Study||106
5188784|NCT01109069|12760674|P1|STARTED|Overall Study||199
5188785|NCT01109056|12760683|P2|NOT COMPLETED|Overall Study||5
5188786|NCT01109056|12760684|P1|NOT COMPLETED|Overall Study||7
5188787|NCT01109056|12760683|P2|COMPLETED|Overall Study||53
5188788|NCT01109056|12760684|P1|COMPLETED|Overall Study||50
5188789|NCT01109056|12760683|P2|STARTED|Overall Study||58
5188790|NCT01109056|12760684|P1|STARTED|Overall Study||57
5188791|NCT01109004|12760697|P3|NOT COMPLETED|Overall Study||0
5188792|NCT01109004|12760698|P2|NOT COMPLETED|Overall Study||0
5188793|NCT01109004|12760699|P1|NOT COMPLETED|Overall Study||0
5188794|NCT01109004|12760697|P3|COMPLETED|Overall Study||257
5188795|NCT01109004|12760698|P2|COMPLETED|Overall Study||254
5188796|NCT01109004|12760699|P1|COMPLETED|Overall Study||247
5188797|NCT01109004|12760697|P3|STARTED|Overall Study||257
5188798|NCT01109004|12760698|P2|STARTED|Overall Study||254
5188799|NCT01109004|12760699|P1|STARTED|Overall Study||247
5188800|NCT01108835|12760736|P2|NOT COMPLETED|Overall Study||21
5188801|NCT01108835|12760737|P1|NOT COMPLETED|Overall Study||17
5188802|NCT01108835|12760736|P2|COMPLETED|Overall Study||69
5188803|NCT01108835|12760737|P1|COMPLETED|Overall Study||73
5188804|NCT01108835|12760736|P2|STARTED|Overall Study||90
5188805|NCT01108835|12760737|P1|STARTED|Overall Study||90
5188806|NCT01108809|12760751|P1|NOT COMPLETED|Overall Study||4
5188807|NCT01108809|12760751|P1|COMPLETED|Overall Study||291
5188808|NCT01108809|12760751|P1|STARTED|Overall Study||295
5188809|NCT01108796|12760768|P2|NOT COMPLETED|Overall Study||7
5188810|NCT01108796|12760769|P1|NOT COMPLETED|Overall Study||7
5188811|NCT01108796|12760768|P2|COMPLETED|Overall Study||1060
5188812|NCT01108796|12760769|P1|COMPLETED|Overall Study||767
5188813|NCT01108796|12760768|P2|STARTED|Overall Study||1067
5188814|NCT01108796|12760769|P1|STARTED|Overall Study||774
5188815|NCT01108757|12760803|P2|NOT COMPLETED|Overall Study||0
5188816|NCT01108757|12760804|P1|NOT COMPLETED|Overall Study||0
5188817|NCT01108757|12760803|P2|COMPLETED|Overall Study||26
5188818|NCT01108757|12760804|P1|COMPLETED|Overall Study||26
5188819|NCT01108757|12760803|P2|STARTED|Overall Study||26
5188820|NCT01108757|12760804|P1|STARTED|Overall Study||26
5188821|NCT01108731|12760812|P2|NOT COMPLETED|Overall Study||4
5188822|NCT01108731|12760813|P1|NOT COMPLETED|Overall Study||4
5188823|NCT01108731|12760812|P2|COMPLETED|Overall Study||13
5188824|NCT01108731|12760813|P1|COMPLETED|Overall Study||13
5188825|NCT01108731|12760812|P2|STARTED|Overall Study||17
5188826|NCT01108731|12760813|P1|STARTED|Overall Study||17
5188827|NCT01108718|12760825|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
5188828|NCT01108718|12760826|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
5188829|NCT01108718|12760825|P2|COMPLETED|Received Second Intervention (2 Months)||7
5188830|NCT01108718|12760826|P1|COMPLETED|Received Second Intervention (2 Months)||4
5188831|NCT01108718|12760825|P2|STARTED|Received Second Intervention (2 Months)||7
5188832|NCT01108718|12760826|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
5188833|NCT01108718|12760825|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
5188834|NCT01108718|12760826|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
5188835|NCT01108718|12760825|P2|COMPLETED|Received First Intervention (2 Months)||7
5188836|NCT01108718|12760826|P1|COMPLETED|Received First Intervention (2 Months)||5
5188837|NCT01108718|12760825|P2|STARTED|Received First Intervention (2 Months)||7
5188838|NCT01108718|12760826|P1|STARTED|Received First Intervention (2 Months)||5
5188839|NCT01108523|12760831|P1|NOT COMPLETED|Overall Study||4
5188840|NCT01108523|12760831|P1|COMPLETED|Overall Study||3
5188841|NCT01108523|12760831|P1|STARTED|Overall Study||7
5188842|NCT01108510|12760838|P2|NOT COMPLETED|Overall Study||268
5188843|NCT01108510|12760839|P1|NOT COMPLETED|Overall Study||279
5188844|NCT01108510|12760838|P2|COMPLETED|Overall Study||81
5188845|NCT01108510|12760839|P1|COMPLETED|Overall Study||70
5188846|NCT01108510|12760838|P2|STARTED|Overall Study||349
5188847|NCT01108510|12760839|P1|STARTED|Overall Study||349
5188848|NCT01108458|12760859|P1|NOT COMPLETED|Overall Study||1
5188849|NCT01108458|12760859|P1|COMPLETED|Overall Study||0
5188850|NCT01108458|12760859|P1|STARTED|Overall Study||1
5188851|NCT01108445|12760870|P2|NOT COMPLETED|Overall Study||49
5188852|NCT01108445|12760871|P1|NOT COMPLETED|Overall Study||56
5188853|NCT01108445|12760870|P2|COMPLETED|Overall Study||2
5188854|NCT01108445|12760871|P1|COMPLETED|Overall Study||1
5188855|NCT01108445|12760870|P2|STARTED|Overall Study||51
5188856|NCT01108445|12760871|P1|STARTED|Overall Study||57
5188857|NCT01108406|12760905|P1|NOT COMPLETED|Overall Study||0
5188858|NCT01108406|12760905|P1|COMPLETED|Overall Study||22
5188859|NCT01108406|12760905|P1|STARTED|Overall Study||22
5188860|NCT01108341|12760911|P1|NOT COMPLETED|Overall Study||5
5188861|NCT01108341|12760911|P1|COMPLETED|Overall Study||45
5188862|NCT01108341|12760911|P1|Safety Set (Enrolled and Treated)|Overall Study||49
5188863|NCT01108341|12760911|P1|STARTED|Overall Study||50
5188864|NCT01108263|12760918|P2|NOT COMPLETED|Overall Study||1
5188865|NCT01108263|12760919|P1|NOT COMPLETED|Overall Study||0
5188866|NCT01108263|12760918|P2|COMPLETED|Overall Study||2
5188867|NCT01108263|12760919|P1|COMPLETED|Overall Study||2
5188868|NCT01108263|12760918|P2|STARTED|Overall Study||3
5188869|NCT01108263|12760919|P1|STARTED|Overall Study||2
5188870|NCT01108237|12760929|P2|NOT COMPLETED|Overall Study||17
5188871|NCT01108237|12760930|P1|NOT COMPLETED|Overall Study||9
5188872|NCT01108237|12760929|P2|COMPLETED|Overall Study||84
5188873|NCT01108237|12760930|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
5188874|NCT01108237|12760929|P2|STARTED|Overall Study||101
5188875|NCT01108237|12760930|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
5188876|NCT01108185|12760936|P1|NOT COMPLETED|Overall Study||27
5188877|NCT01108185|12760936|P1|COMPLETED|Overall Study||3154
5188878|NCT01108185|12760936|P1|Per Protocol Population|Overall Study||3181
5188879|NCT01108185|12760936|P1|STARTED|Overall Study||3181
5188880|NCT01108094|12760953|P4|NOT COMPLETED|Overall Study||0
5188881|NCT01108094|12760954|P3|NOT COMPLETED|Overall Study||0
5188882|NCT01108094|12760955|P2|NOT COMPLETED|Overall Study||0
5188883|NCT01108094|12760956|P1|NOT COMPLETED|Overall Study||3
5188884|NCT01108094|12760953|P4|COMPLETED|Overall Study||10
5188885|NCT01108094|12760954|P3|COMPLETED|Overall Study||4
5188886|NCT01108094|12760955|P2|COMPLETED|Overall Study||3
5188887|NCT01108094|12760956|P1|COMPLETED|Overall Study||9
5188888|NCT01108094|12760953|P4|STARTED|Overall Study||10
5188889|NCT01108094|12760954|P3|STARTED|Overall Study||4
5188890|NCT01108094|12760955|P2|STARTED|Overall Study||3
5188891|NCT01108094|12760956|P1|STARTED|Overall Study||12
5188892|NCT01108081|12760981|P4|NOT COMPLETED|Overall Study||4
5188893|NCT01108081|12760982|P3|NOT COMPLETED|Overall Study||0
5188894|NCT01108081|12760983|P2|NOT COMPLETED|Overall Study||2
5188895|NCT01108081|12760984|P1|NOT COMPLETED|Overall Study||2
5188896|NCT01108081|12760981|P4|COMPLETED|Overall Study||39
5188897|NCT01108081|12760982|P3|COMPLETED|Overall Study||38
5188898|NCT01108081|12760983|P2|COMPLETED|Overall Study||40
5188899|NCT01108081|12760984|P1|COMPLETED|Overall Study||44
5188900|NCT01108081|12760981|P4|STARTED|Overall Study||43
5188901|NCT01108081|12760982|P3|STARTED|Overall Study||38
5188902|NCT01108081|12760983|P2|STARTED|Overall Study||42
5188903|NCT01108081|12760984|P1|STARTED|Overall Study||46
5188904|NCT01108068|12761000|P2|NOT COMPLETED|Overall Study||0
5188905|NCT01108068|12761001|P1|NOT COMPLETED|Overall Study||6
5188906|NCT01108068|12761000|P2|COMPLETED|Overall Study||16
5188907|NCT01108068|12761001|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
5188908|NCT01108068|12761000|P2|STARTED|Overall Study||16
5188909|NCT01108068|12761001|P1|STARTED|Overall Study||10
5188910|NCT01108055|12761008|P1|NOT COMPLETED|Overall Study||15
5188911|NCT01108055|12761008|P1|COMPLETED|Overall Study||28
5188912|NCT01108055|12761008|P1|Eligible and Started Treatment|Overall Study||32
5188913|NCT01108055|12761008|P1|STARTED|Overall Study||43
5188914|NCT01108003|12761018|P2|NOT COMPLETED|Overall Study||0
5188915|NCT01108003|12761019|P1|NOT COMPLETED|Overall Study||0
5188916|NCT01108003|12761018|P2|COMPLETED|Overall Study||3
5188917|NCT01108003|12761019|P1|COMPLETED|Overall Study||4
5188918|NCT01108003|12761018|P2|STARTED|Overall Study||3
5188919|NCT01108003|12761019|P1|STARTED|Overall Study||4
5188920|NCT01107964|12761029|P2|NOT COMPLETED|Overall Study||1
5188921|NCT01107964|12761030|P1|NOT COMPLETED|Overall Study||1
5188922|NCT01107964|12761029|P2|COMPLETED|Overall Study||13
5188923|NCT01107964|12761030|P1|COMPLETED|Overall Study||12
5188924|NCT01107964|12761029|P2|STARTED|Overall Study||14
5188925|NCT01107964|12761030|P1|STARTED|Overall Study||13
5188926|NCT01107925|12761046|P6|NOT COMPLETED|Period 3||0
5188927|NCT01107925|12761047|P5|NOT COMPLETED|Period 3||0
5188928|NCT01107925|12761048|P4|NOT COMPLETED|Period 3||0
5188929|NCT01107925|12761049|P3|NOT COMPLETED|Period 3||0
5188930|NCT01107925|12761050|P2|NOT COMPLETED|Period 3||0
5188931|NCT01107925|12761051|P1|NOT COMPLETED|Period 3||0
5188932|NCT01107925|12761046|P6|COMPLETED|Period 3||20
5188933|NCT01107925|12761047|P5|COMPLETED|Period 3||0
5188934|NCT01107925|12761048|P4|COMPLETED|Period 3||16
5188935|NCT01107925|12761049|P3|COMPLETED|Period 3||15
5188936|NCT01107925|12761050|P2|COMPLETED|Period 3||17
5188937|NCT01107925|12761051|P1|COMPLETED|Period 3||0
5188938|NCT01107925|12761046|P6|Took at Least 1 Dose of Study Drug|Period 3||20
5188939|NCT01107925|12761047|P5|Took at Least 1 Dose of Study Drug|Period 3||0
5188940|NCT01107925|12761048|P4|Took at Least 1 Dose of Study Drug|Period 3||16
5188941|NCT01107925|12761049|P3|Took at Least 1 Dose of Study Drug|Period 3||15
5188942|NCT01107925|12761050|P2|Took at Least 1 Dose of Study Drug|Period 3||17
5188943|NCT01107925|12761051|P1|Took at Least 1 Dose of Study Drug|Period 3||0
5188944|NCT01107925|12761046|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
5188945|NCT01107925|12761047|P5|STARTED|Period 3||0
5188946|NCT01107925|12761048|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
5188947|NCT01107925|12761049|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
5188948|NCT01107925|12761050|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
5188949|NCT01107925|12761051|P1|STARTED|Period 3||0
5188950|NCT01107925|12761046|P6|NOT COMPLETED|Period 2||1
5188951|NCT01107925|12761047|P5|NOT COMPLETED|Period 2||0
5188952|NCT01107925|12761048|P4|NOT COMPLETED|Period 2||0
5188953|NCT01107925|12761049|P3|NOT COMPLETED|Period 2||0
5188954|NCT01107925|12761050|P2|NOT COMPLETED|Period 2||1
5188955|NCT01107925|12761051|P1|NOT COMPLETED|Period 2||0
5188956|NCT01107925|12761046|P6|COMPLETED|Period 2||16
5188957|NCT01107925|12761047|P5|COMPLETED|Period 2||0
5188958|NCT01107925|12761048|P4|COMPLETED|Period 2||20
5188959|NCT01107925|12761049|P3|COMPLETED|Period 2||17
5188960|NCT01107925|12761050|P2|COMPLETED|Period 2||15
5188961|NCT01107925|12761051|P1|COMPLETED|Period 2||0
5188962|NCT01107925|12761046|P6|Took at Least 1 Dose of Study Drug|Period 2||17
5188963|NCT01107925|12761047|P5|Took at Least 1 Dose of Study Drug|Period 2||0
5188964|NCT01107925|12761048|P4|Took at Least 1 Dose of Study Drug|Period 2||20
5188965|NCT01107925|12761049|P3|Took at Least 1 Dose of Study Drug|Period 2||17
5188966|NCT01107925|12761050|P2|Took at Least 1 Dose of Study Drug|Period 2||16
5188967|NCT01107925|12761051|P1|Took at Least 1 Dose of Study Drug|Period 2||0
5188968|NCT01107925|12761046|P6|STARTED|Period 2||17
5188969|NCT01107925|12761047|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
5188970|NCT01107925|12761048|P4|STARTED|Period 2||20
5188971|NCT01107925|12761049|P3|STARTED|Period 2||17
5188972|NCT01107925|12761050|P2|STARTED|Period 2||16
5188973|NCT01107925|12761051|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
5188974|NCT01107925|12761046|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
5188975|NCT01107925|12761047|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
5188976|NCT01107925|12761048|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
5188977|NCT01107925|12761049|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
5188978|NCT01107925|12761050|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
5188979|NCT01107925|12761051|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
5188980|NCT01107925|12761046|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
5188981|NCT01107925|12761047|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
5188982|NCT01107925|12761048|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
5188983|NCT01107925|12761049|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
5188984|NCT01107925|12761050|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
5188985|NCT01107925|12761051|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
5188986|NCT01107925|12761046|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
5188987|NCT01107925|12761047|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
5188988|NCT01107925|12761048|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
5188989|NCT01107925|12761049|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
5188990|NCT01107925|12761050|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
5188991|NCT01107925|12761051|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
5188992|NCT01107925|12761046|P6|STARTED|Period 1-Randomization up Through Day 12||0
5188993|NCT01107925|12761047|P5|STARTED|Period 1-Randomization up Through Day 12||38
5188994|NCT01107925|12761048|P4|STARTED|Period 1-Randomization up Through Day 12||0
5188995|NCT01107925|12761049|P3|STARTED|Period 1-Randomization up Through Day 12||0
5188996|NCT01107925|12761050|P2|STARTED|Period 1-Randomization up Through Day 12||0
5188997|NCT01107925|12761051|P1|STARTED|Period 1-Randomization up Through Day 12||34
5188998|NCT01107912|12761089|P6|NOT COMPLETED|Period 3||0
5188999|NCT01107912|12761090|P5|NOT COMPLETED|Period 3||0
5189000|NCT01107912|12761091|P4|NOT COMPLETED|Period 3||1
5189001|NCT01107912|12761092|P3|NOT COMPLETED|Period 3||1
5189002|NCT01107912|12761093|P2|NOT COMPLETED|Period 3||1
5189003|NCT01107912|12761094|P1|NOT COMPLETED|Period 3||0
5189004|NCT01107912|12761089|P6|COMPLETED|Period 3||41
5189005|NCT01107912|12761090|P5|COMPLETED|Period 3||0
5189006|NCT01107912|12761091|P4|COMPLETED|Period 3||37
5189007|NCT01107912|12761092|P3|COMPLETED|Period 3||35
5189008|NCT01107912|12761093|P2|COMPLETED|Period 3||34
5189009|NCT01107912|12761094|P1|COMPLETED|Period 3||0
5189010|NCT01107912|12761089|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
5189011|NCT01107912|12761090|P5|STARTED|Period 3||0
5189012|NCT01107912|12761091|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
5189013|NCT01107912|12761092|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
5189014|NCT01107912|12761093|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
5189015|NCT01107912|12761094|P1|STARTED|Period 3||0
5189016|NCT01107912|12761089|P6|NOT COMPLETED|Period 2||0
5189017|NCT01107912|12761090|P5|NOT COMPLETED|Period 2||0
5189018|NCT01107912|12761091|P4|NOT COMPLETED|Period 2||0
5189019|NCT01107912|12761092|P3|NOT COMPLETED|Period 2||1
5189020|NCT01107912|12761093|P2|NOT COMPLETED|Period 2||0
5189021|NCT01107912|12761094|P1|NOT COMPLETED|Period 2||0
5189022|NCT01107912|12761089|P6|COMPLETED|Period 2||38
5189023|NCT01107912|12761090|P5|COMPLETED|Period 2||0
5189024|NCT01107912|12761091|P4|COMPLETED|Period 2||41
5189025|NCT01107912|12761092|P3|COMPLETED|Period 2||35
5189026|NCT01107912|12761093|P2|COMPLETED|Period 2||36
5189027|NCT01107912|12761094|P1|COMPLETED|Period 2||0
5189028|NCT01107912|12761089|P6|STARTED|Period 2||38
5189029|NCT01107912|12761090|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
5189030|NCT01107912|12761091|P4|STARTED|Period 2||41
5189031|NCT01107912|12761092|P3|STARTED|Period 2||36
5189032|NCT01107912|12761093|P2|STARTED|Period 2||36
5189033|NCT01107912|12761094|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
5189034|NCT01107912|12761089|P6|NOT COMPLETED|Period 1||0
5189035|NCT01107912|12761090|P5|NOT COMPLETED|Period 1||3
5189036|NCT01107912|12761091|P4|NOT COMPLETED|Period 1||0
5189037|NCT01107912|12761092|P3|NOT COMPLETED|Period 1||0
5189038|NCT01107912|12761093|P2|NOT COMPLETED|Period 1||0
5189039|NCT01107912|12761094|P1|NOT COMPLETED|Period 1||1
5189040|NCT01107912|12761089|P6|COMPLETED|Period 1||0
5189041|NCT01107912|12761090|P5|COMPLETED|Period 1||79
5189042|NCT01107912|12761091|P4|COMPLETED|Period 1||0
5189043|NCT01107912|12761092|P3|COMPLETED|Period 1||0
5189044|NCT01107912|12761093|P2|COMPLETED|Period 1||0
5189045|NCT01107912|12761094|P1|COMPLETED|Period 1||72
5189046|NCT01107912|12761089|P6|Received at Least 1 Dose of Study Drug|Period 1||0
5189047|NCT01107912|12761090|P5|Received at Least 1 Dose of Study Drug|Period 1||82
5189048|NCT01107912|12761091|P4|Received at Least 1 Dose of Study Drug|Period 1||0
5189049|NCT01107912|12761092|P3|Received at Least 1 Dose of Study Drug|Period 1||0
5189050|NCT01107912|12761093|P2|Received at Least 1 Dose of Study Drug|Period 1||0
5189051|NCT01107912|12761094|P1|Received at Least 1 Dose of Study Drug|Period 1||73
5189052|NCT01107912|12761089|P6|STARTED|Period 1||0
5189053|NCT01107912|12761090|P5|STARTED|Period 1||82
5189054|NCT01107912|12761091|P4|STARTED|Period 1||0
5189055|NCT01107912|12761092|P3|STARTED|Period 1||0
5189056|NCT01107912|12761093|P2|STARTED|Period 1||0
5189057|NCT01107912|12761094|P1|STARTED|Period 1||73
5189058|NCT01107899|12761131|P3|NOT COMPLETED|Overall Study||4
5189059|NCT01107899|12761132|P2|NOT COMPLETED|Overall Study||0
5189060|NCT01107899|12761133|P1|NOT COMPLETED|Overall Study||5
5189061|NCT01107899|12761131|P3|COMPLETED|Overall Study||5
5189062|NCT01107899|12761132|P2|COMPLETED|Overall Study||10
5189063|NCT01107899|12761133|P1|COMPLETED|Overall Study||5
5189064|NCT01107899|12761131|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
5189065|NCT01107899|12761132|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
5189066|NCT01107899|12761133|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
5189067|NCT01107899|12761131|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
5189068|NCT01107899|12761132|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
5189069|NCT01107899|12761133|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
5189070|NCT01107899|12761131|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
5189071|NCT01107899|12761132|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
5189072|NCT01107899|12761133|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
5189073|NCT01107899|12761131|P3|Received at Least One Dose of Study Drug|Overall Study||8
5189074|NCT01107899|12761132|P2|Received at Least One Dose of Study Drug|Overall Study||10
5189075|NCT01107899|12761133|P1|Received at Least One Dose of Study Drug|Overall Study||10
5189076|NCT01107899|12761131|P3|STARTED|Overall Study||9
5189077|NCT01107899|12761132|P2|STARTED|Overall Study||10
5189078|NCT01107899|12761133|P1|STARTED|Overall Study||10
5189079|NCT01107886|12761179|P2|NOT COMPLETED|Overall Study||214
5189080|NCT01107886|12761180|P1|NOT COMPLETED|Overall Study||202
5189081|NCT01107886|12761179|P2|COMPLETED|Overall Study|Completed subjects|7998
5189082|NCT01107886|12761180|P1|COMPLETED|Overall Study|Completed subjects|8078
5189083|NCT01107886|12761179|P2|STARTED|Overall Study|Randomized subjects|8212
5189084|NCT01107886|12761180|P1|STARTED|Overall Study|Randomized subjects|8280
5189085|NCT01107834|12761192|P2|NOT COMPLETED|Overall Study||0
5189086|NCT01107834|12761193|P1|NOT COMPLETED|Overall Study||0
5189087|NCT01107834|12761192|P2|COMPLETED|Overall Study||30
5189088|NCT01107834|12761193|P1|COMPLETED|Overall Study||30
5189089|NCT01107834|12761192|P2|STARTED|Overall Study||30
5189090|NCT01107834|12761193|P1|STARTED|Overall Study||30
5189091|NCT01107795|12761209|P1|NOT COMPLETED|Overall Study||0
5189092|NCT01107795|12761209|P1|COMPLETED|Overall Study||41
5189093|NCT01107795|12761209|P1|STARTED|Overall Study||41
5189094|NCT01107743|12761213|P1|NOT COMPLETED|Overall Study||46
5189095|NCT01107743|12761213|P1|COMPLETED|Overall Study||1245
5189096|NCT01107743|12761213|P1|STARTED|Overall Study||1291
5189097|NCT01107730|12761302|P3|NOT COMPLETED|Overall Study||0
5189098|NCT01107730|12761303|P2|NOT COMPLETED|Overall Study||0
5189099|NCT01107730|12761304|P1|NOT COMPLETED|Overall Study||0
5189100|NCT01107730|12761302|P3|COMPLETED|Overall Study||11
5189101|NCT01107730|12761303|P2|COMPLETED|Overall Study||11
5189102|NCT01107730|12761304|P1|COMPLETED|Overall Study||11
5189103|NCT01107730|12761302|P3|STARTED|Overall Study||11
5189104|NCT01107730|12761303|P2|STARTED|Overall Study||11
5189105|NCT01107730|12761304|P1|STARTED|Overall Study||11
5189106|NCT01107665|12761312|P1|NOT COMPLETED|Overall Study||49
5189107|NCT01107665|12761312|P1|COMPLETED|Overall Study||11
5189108|NCT01107665|12761312|P1|STARTED|Overall Study||60
5189109|NCT01107535|12761327|P1|NOT COMPLETED|Overall Study||5
5189110|NCT01107535|12761327|P1|COMPLETED|Overall Study||77
5189111|NCT01107535|12761327|P1|Number of Participants Analyzed|Overall Study||82
5189112|NCT01107535|12761327|P1|STARTED|Overall Study||82
5189113|NCT01107457|12761340|P6|NOT COMPLETED|Part B and C||120
5189114|NCT01107457|12761341|P5|NOT COMPLETED|Part B and C||0
5189115|NCT01107457|12761342|P4|NOT COMPLETED|Part B and C||0
5189116|NCT01107457|12761343|P3|NOT COMPLETED|Part B and C||0
5189117|NCT01107457|12761344|P2|NOT COMPLETED|Part B and C||0
5189118|NCT01107457|12761345|P1|NOT COMPLETED|Part B and C||0
5189119|NCT01107457|12761340|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
5189120|NCT01107457|12761341|P5|COMPLETED|Part B and C||0
5189121|NCT01107457|12761342|P4|COMPLETED|Part B and C||0
5189122|NCT01107457|12761343|P3|COMPLETED|Part B and C||0
5189123|NCT01107457|12761344|P2|COMPLETED|Part B and C||0
5189124|NCT01107457|12761345|P1|COMPLETED|Part B and C||0
5189125|NCT01107457|12761340|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
5189126|NCT01107457|12761341|P5|Post Treatment Safety Visits|Part B and C||0
5189127|NCT01107457|12761342|P4|Post Treatment Safety Visits|Part B and C||0
5189128|NCT01107457|12761343|P3|Post Treatment Safety Visits|Part B and C||0
5189129|NCT01107457|12761344|P2|Post Treatment Safety Visits|Part B and C||0
5189130|NCT01107457|12761345|P1|Post Treatment Safety Visits|Part B and C||0
5189131|NCT01107457|12761340|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
5189132|NCT01107457|12761341|P5|Completed Part C|Part B and C||0
5189133|NCT01107457|12761342|P4|Completed Part C|Part B and C||0
5189134|NCT01107457|12761343|P3|Completed Part C|Part B and C||0
5189135|NCT01107457|12761344|P2|Completed Part C|Part B and C||0
5189136|NCT01107457|12761345|P1|Completed Part C|Part B and C||0
5189137|NCT01107457|12761340|P6|Completed Part B (Week 240)|Part B and C||74
5189138|NCT01107457|12761341|P5|Completed Part B (Week 240)|Part B and C||0
5189139|NCT01107457|12761342|P4|Completed Part B (Week 240)|Part B and C||0
5189140|NCT01107457|12761343|P3|Completed Part B (Week 240)|Part B and C||0
5189141|NCT01107457|12761344|P2|Completed Part B (Week 240)|Part B and C||0
5189142|NCT01107457|12761345|P1|Completed Part B (Week 240)|Part B and C||0
5189143|NCT01107457|12761340|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
5189144|NCT01107457|12761341|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
5189145|NCT01107457|12761342|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
5189146|NCT01107457|12761343|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
5189147|NCT01107457|12761344|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
5189148|NCT01107457|12761345|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
5189149|NCT01107457|12761340|P6|NOT COMPLETED|Part A||0
5189150|NCT01107457|12761341|P5|NOT COMPLETED|Part A||1
5189151|NCT01107457|12761342|P4|NOT COMPLETED|Part A||3
5189152|NCT01107457|12761343|P3|NOT COMPLETED|Part A||1
5189153|NCT01107457|12761344|P2|NOT COMPLETED|Part A||7
5189154|NCT01107457|12761345|P1|NOT COMPLETED|Part A||5
5189155|NCT01107457|12761340|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
5189156|NCT01107457|12761341|P5|COMPLETED|Part A||27
5189157|NCT01107457|12761342|P4|COMPLETED|Part A||26
5189158|NCT01107457|12761343|P3|COMPLETED|Part A||29
5189159|NCT01107457|12761344|P2|COMPLETED|Part A||21
5189160|NCT01107457|12761345|P1|COMPLETED|Part A||22
5189161|NCT01107457|12761340|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
5189162|NCT01107457|12761341|P5|Received at Least 1 Dose of Study Drug|Part A||28
5189163|NCT01107457|12761342|P4|Received at Least 1 Dose of Study Drug|Part A||29
5189164|NCT01107457|12761343|P3|Received at Least 1 Dose of Study Drug|Part A||30
5189165|NCT01107457|12761344|P2|Received at Least 1 Dose of Study Drug|Part A||28
5189166|NCT01107457|12761345|P1|Received at Least 1 Dose of Study Drug|Part A||27
5189167|NCT01107457|12761340|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
5189168|NCT01107457|12761341|P5|STARTED|Part A||28
5189169|NCT01107457|12761342|P4|STARTED|Part A||29
5189170|NCT01107457|12761343|P3|STARTED|Part A||30
5189171|NCT01107457|12761344|P2|STARTED|Part A||28
5189172|NCT01107457|12761345|P1|STARTED|Part A||27
5189173|NCT01107444|12761473|P2|NOT COMPLETED|Overall Study||13
5189174|NCT01107444|12761474|P1|NOT COMPLETED|Overall Study||8
5189175|NCT01107444|12761473|P2|COMPLETED|Overall Study||47
5189176|NCT01107444|12761474|P1|COMPLETED|Overall Study||112
5189177|NCT01107444|12761473|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
5189178|NCT01107444|12761474|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
5189179|NCT01107444|12761473|P2|STARTED|Overall Study||60
5189180|NCT01107444|12761474|P1|STARTED|Overall Study||120
5189181|NCT01107418|12761508|P1|NOT COMPLETED|Overall Study||52
5189182|NCT01107418|12761508|P1|COMPLETED|Overall Study||0
5189183|NCT01107418|12761508|P1|STARTED|Overall Study||52
5189184|NCT01107405|12761581|P5|NOT COMPLETED|Overall Study||3
5189185|NCT01107405|12761582|P4|NOT COMPLETED|Overall Study||3
5189186|NCT01107405|12761583|P3|NOT COMPLETED|Overall Study||2
5189187|NCT01107405|12761584|P2|NOT COMPLETED|Overall Study||1
5189188|NCT01107405|12761585|P1|NOT COMPLETED|Overall Study||2
5189189|NCT01107405|12761581|P5|COMPLETED|Overall Study||17
5189190|NCT01107405|12761582|P4|COMPLETED|Overall Study||17
5189191|NCT01107405|12761583|P3|COMPLETED|Overall Study||18
5189192|NCT01107405|12761584|P2|COMPLETED|Overall Study||19
5189193|NCT01107405|12761585|P1|COMPLETED|Overall Study||19
5189194|NCT01107405|12761581|P5|STARTED|Overall Study||20
5189195|NCT01107405|12761582|P4|STARTED|Overall Study||20
5189196|NCT01107405|12761583|P3|STARTED|Overall Study||20
5189197|NCT01107405|12761584|P2|STARTED|Overall Study||20
5189198|NCT01107405|12761585|P1|STARTED|Overall Study||21
5189199|NCT01107392|12761624|P2|NOT COMPLETED|Overall Study||3
5189200|NCT01107392|12761625|P1|NOT COMPLETED|Overall Study||5
5189201|NCT01107392|12761624|P2|COMPLETED|Overall Study||154
5189202|NCT01107392|12761625|P1|COMPLETED|Overall Study||153
5189203|NCT01107392|12761624|P2|STARTED|Overall Study||157
5189204|NCT01107392|12761625|P1|STARTED|Overall Study||158
5189205|NCT01107379|12761637|P1|NOT COMPLETED|Overall Study||21
5189206|NCT01107379|12761637|P1|COMPLETED|Overall Study||182
5189207|NCT01107379|12761637|P1|STARTED|Overall Study||203
5189208|NCT01107353|12761648|P2|NOT COMPLETED|Overall Study||0
5189209|NCT01107353|12761649|P1|NOT COMPLETED|Overall Study||1
5189210|NCT01107353|12761648|P2|COMPLETED|Overall Study||20
5189211|NCT01107353|12761649|P1|COMPLETED|Overall Study||19
5189212|NCT01107353|12761648|P2|STARTED|Overall Study||20
5189213|NCT01107353|12761649|P1|STARTED|Overall Study||20
5189214|NCT01107197|12761657|P2|NOT COMPLETED|Overall Study||23
5189215|NCT01107197|12761658|P1|NOT COMPLETED|Overall Study||20
5189216|NCT01107197|12761657|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
5189217|NCT01107197|12761658|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
5189218|NCT01107197|12761657|P2|STARTED|Overall Study||101
5189219|NCT01107197|12761658|P1|STARTED|Overall Study||99
5189220|NCT01107015|12761680|P4|NOT COMPLETED|Overall Study||18
5189221|NCT01107015|12761681|P3|NOT COMPLETED|Overall Study||11
5189222|NCT01107015|12761682|P2|NOT COMPLETED|Overall Study||15
5189223|NCT01107015|12761683|P1|NOT COMPLETED|Overall Study||6
5189224|NCT01107015|12761680|P4|COMPLETED|Overall Study||62
5189225|NCT01107015|12761681|P3|COMPLETED|Overall Study||22
5189226|NCT01107015|12761682|P2|COMPLETED|Overall Study||23
5189227|NCT01107015|12761683|P1|COMPLETED|Overall Study||56
5189228|NCT01107015|12761680|P4|STARTED|Overall Study||80
5189229|NCT01107015|12761681|P3|STARTED|Overall Study||33
5189230|NCT01107015|12761682|P2|STARTED|Overall Study||38
5189231|NCT01107015|12761683|P1|STARTED|Overall Study||62
5189232|NCT01106976|12761693|P1|NOT COMPLETED|Overall Study||8
5189233|NCT01106976|12761693|P1|COMPLETED|Overall Study||59
5189234|NCT01106976|12761693|P1|STARTED|Overall Study||67
5189235|NCT01106950|12761697|P1|NOT COMPLETED|Overall Study||0
5189236|NCT01106950|12761697|P1|COMPLETED|Overall Study||15
5189237|NCT01106950|12761697|P1|STARTED|Overall Study||15
5189238|NCT01106911|12761707|P1|NOT COMPLETED|Overall Study||5
5189239|NCT01106911|12761707|P1|COMPLETED|Overall Study||1080
5189240|NCT01106911|12761707|P1|STARTED|Overall Study||1085
5189241|NCT01106898|12761711|P1|NOT COMPLETED|Overall Study||6
5189242|NCT01106898|12761711|P1|COMPLETED|Overall Study||94
5189243|NCT01106898|12761711|P1|STARTED|Overall Study||100
5189244|NCT01106859|12761715|P1|NOT COMPLETED|Overall Study||0
5189245|NCT01106859|12761715|P1|COMPLETED|Overall Study||40
5189246|NCT01106859|12761715|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
5189247|NCT01106846|12761756|P2|NOT COMPLETED|Overall Study||1
5189248|NCT01106846|12761757|P1|NOT COMPLETED|Overall Study||0
5189249|NCT01106846|12761756|P2|COMPLETED|Overall Study||9
5189250|NCT01106846|12761757|P1|COMPLETED|Overall Study||12
5189251|NCT01106846|12761756|P2|STARTED|Overall Study||10
5189252|NCT01106846|12761757|P1|STARTED|Overall Study||12
5189253|NCT01106833|12761765|P2|NOT COMPLETED|Overall Study||0
5189254|NCT01106833|12761766|P1|NOT COMPLETED|Overall Study||0
5189255|NCT01106833|12761765|P2|COMPLETED|Overall Study||77
5189256|NCT01106833|12761766|P1|COMPLETED|Overall Study||74
5189257|NCT01106833|12761765|P2|STARTED|Overall Study||77
5189258|NCT01106833|12761766|P1|STARTED|Overall Study||74
5189259|NCT01106690|12761807|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
5189260|NCT01106690|12761808|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
5189261|NCT01106690|12761809|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
5189262|NCT01106690|12761807|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
5189263|NCT01106690|12761808|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
5189264|NCT01106690|12761809|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
5189265|NCT01106690|12761807|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
5189266|NCT01106690|12761808|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
5189267|NCT01106690|12761809|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
5189268|NCT01106690|12761807|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
5189269|NCT01106690|12761808|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
5189270|NCT01106690|12761809|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
5189271|NCT01106690|12761807|P3|COMPLETED|Core Period: Baseline to Week 26||101
5189272|NCT01106690|12761808|P2|COMPLETED|Core Period: Baseline to Week 26||104
5189273|NCT01106690|12761809|P1|COMPLETED|Core Period: Baseline to Week 26||91
5189274|NCT01106690|12761807|P3|STARTED|Core Period: Baseline to Week 26||114
5189275|NCT01106690|12761808|P2|STARTED|Core Period: Baseline to Week 26||113
5189276|NCT01106690|12761809|P1|STARTED|Core Period: Baseline to Week 26||115
5189277|NCT01106677|12761845|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
5189278|NCT01106677|12761846|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
5189279|NCT01106677|12761847|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
5189280|NCT01106677|12761848|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
5189281|NCT01106677|12761845|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
5189282|NCT01106677|12761846|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
5189283|NCT01106677|12761847|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
5189284|NCT01106677|12761848|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
5189285|NCT01106677|12761845|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
5189286|NCT01106677|12761846|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
5189287|NCT01106677|12761847|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
5189288|NCT01106677|12761848|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
5189289|NCT01106677|12761845|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
5189290|NCT01106677|12761846|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
5189291|NCT01106677|12761847|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
5189292|NCT01106677|12761848|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
5189293|NCT01106677|12761845|P4|COMPLETED|Core Period: Baseline to Week 26||319
5189294|NCT01106677|12761846|P3|COMPLETED|Core Period: Baseline to Week 26||323
5189295|NCT01106677|12761847|P2|COMPLETED|Core Period: Baseline to Week 26||322
5189296|NCT01106677|12761848|P1|COMPLETED|Core Period: Baseline to Week 26||155
5189297|NCT01106677|12761845|P4|STARTED|Core Period: Baseline to Week 26||366
5189298|NCT01106677|12761846|P3|STARTED|Core Period: Baseline to Week 26||367
5189299|NCT01106677|12761847|P2|STARTED|Core Period: Baseline to Week 26||368
5189300|NCT01106677|12761848|P1|STARTED|Core Period: Baseline to Week 26||183
5189301|NCT01106651|12761911|P3|NOT COMPLETED|Overall Study||58
5189302|NCT01106651|12761912|P2|NOT COMPLETED|Overall Study||57
5189303|NCT01106651|12761913|P1|NOT COMPLETED|Overall Study||79
5189304|NCT01106651|12761911|P3|COMPLETED|Overall Study||178
5189305|NCT01106651|12761912|P2|COMPLETED|Overall Study||184
5189306|NCT01106651|12761913|P1|COMPLETED|Overall Study||158
5189307|NCT01106651|12761911|P3|STARTED|Overall Study||236
5189308|NCT01106651|12761912|P2|STARTED|Overall Study||241
5189309|NCT01106651|12761913|P1|STARTED|Overall Study||237
5189310|NCT01106625|12761966|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
5189311|NCT01106625|12761967|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
5189312|NCT01106625|12761968|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
5189313|NCT01106625|12761966|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
5189314|NCT01106625|12761967|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
5189315|NCT01106625|12761968|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
5189316|NCT01106625|12761966|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
5189317|NCT01106625|12761967|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
5189318|NCT01106625|12761968|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
5189319|NCT01106625|12761966|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
5189320|NCT01106625|12761967|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
5189321|NCT01106625|12761968|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
5189322|NCT01106625|12761966|P3|COMPLETED|Core Period: Baseline to Week 26||129
5189323|NCT01106625|12761967|P2|COMPLETED|Core Period: Baseline to Week 26||129
5189324|NCT01106625|12761968|P1|COMPLETED|Core Period: Baseline to Week 26||123
5189325|NCT01106625|12761966|P3|STARTED|Core Period: Baseline to Week 26||156
5189326|NCT01106625|12761967|P2|STARTED|Core Period: Baseline to Week 26||157
5189327|NCT01106625|12761968|P1|STARTED|Core Period: Baseline to Week 26||156
5189328|NCT01106586|12761999|P2|NOT COMPLETED|Overall Study||285
5189329|NCT01106586|12762000|P1|NOT COMPLETED|Overall Study||285
5189330|NCT01106586|12761999|P2|COMPLETED|Overall Study||70
5189331|NCT01106586|12762000|P1|COMPLETED|Overall Study||68
5189332|NCT01106586|12761999|P2|STARTED|Overall Study||355
5189333|NCT01106586|12762000|P1|STARTED|Overall Study||353
5189334|NCT01106534|12762018|P1|NOT COMPLETED|Overall Study||37
5189335|NCT01106534|12762018|P1|COMPLETED|Overall Study||2960
5189336|NCT01106534|12762018|P1|STARTED|Overall Study||2997
5189337|NCT01106456|12762041|P2|NOT COMPLETED|Overall Study||124
5189338|NCT01106456|12762042|P1|NOT COMPLETED|Overall Study||103
5189339|NCT01106456|12762041|P2|COMPLETED|Overall Study||96
5189340|NCT01106456|12762042|P1|COMPLETED|Overall Study||140
5189341|NCT01106456|12762041|P2|STARTED|Overall Study||220
5189342|NCT01106456|12762042|P1|STARTED|Overall Study||243
5189343|NCT01106430|12762050|P2|NOT COMPLETED|Overall Study||33
5189344|NCT01106430|12762051|P1|NOT COMPLETED|Overall Study||33
5189345|NCT01106430|12762050|P2|COMPLETED|Overall Study||101
5189346|NCT01106430|12762051|P1|COMPLETED|Overall Study||100
5189347|NCT01106430|12762050|P2|STARTED|Overall Study||134
5189348|NCT01106430|12762051|P1|STARTED|Overall Study||133
5189349|NCT01106404|12762073|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
5189350|NCT01106404|12762074|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
5189351|NCT01106404|12762073|P2|COMPLETED|Period II (Second 6 Weeks)||38
5189352|NCT01106404|12762074|P1|COMPLETED|Period II (Second 6 Weeks)||33
5189353|NCT01106404|12762073|P2|STARTED|Period II (Second 6 Weeks)||38
5189354|NCT01106404|12762074|P1|STARTED|Period II (Second 6 Weeks)||33
5189355|NCT01106404|12762073|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
5189356|NCT01106404|12762074|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
5189357|NCT01106404|12762073|P2|COMPLETED|Period I (First 6 Weeks)||38
5189358|NCT01106404|12762074|P1|COMPLETED|Period I (First 6 Weeks)||33
5189359|NCT01106404|12762073|P2|STARTED|Period I (First 6 Weeks)||40
5189360|NCT01106404|12762074|P1|STARTED|Period I (First 6 Weeks)||36
5189361|NCT01106391|12762087|P1|NOT COMPLETED|Overall Study||0
5189362|NCT01106391|12762087|P1|COMPLETED|Overall Study||60
5189363|NCT01106391|12762087|P1|STARTED|Overall Study||60
5189364|NCT01106352|12762097|P5|NOT COMPLETED|Overall Study||8
5189365|NCT01106352|12762098|P4|NOT COMPLETED|Overall Study||13
5189366|NCT01106352|12762099|P3|NOT COMPLETED|Overall Study||2
5189367|NCT01106352|12762100|P2|NOT COMPLETED|Overall Study||0
5189368|NCT01106352|12762101|P1|NOT COMPLETED|Overall Study||1
5189369|NCT01106352|12762097|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
5189370|NCT01106352|12762098|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
5189371|NCT01106352|12762099|P3|COMPLETED|Overall Study||5
5189372|NCT01106352|12762100|P2|COMPLETED|Overall Study||3
5189373|NCT01106352|12762101|P1|COMPLETED|Overall Study||6
5189374|NCT01106352|12762097|P5|Completed Safety Cohort|Overall Study||9
5189375|NCT01106352|12762098|P4|Completed Safety Cohort|Overall Study||23
5189376|NCT01106352|12762099|P3|Completed Safety Cohort|Overall Study||0
5189377|NCT01106352|12762100|P2|Completed Safety Cohort|Overall Study||0
5189378|NCT01106352|12762101|P1|Completed Safety Cohort|Overall Study||0
5189379|NCT01106352|12762097|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
5189380|NCT01106352|12762098|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
5189381|NCT01106352|12762099|P3|Treated Safety Cohort|Overall Study||0
5189382|NCT01106352|12762100|P2|Treated Safety Cohort|Overall Study||0
5189383|NCT01106352|12762101|P1|Treated Safety Cohort|Overall Study||0
5189384|NCT01106352|12762097|P5|Started Safety Cohort|Overall Study||17
5189385|NCT01106352|12762098|P4|Started Safety Cohort|Overall Study||36
5189386|NCT01106352|12762099|P3|Started Safety Cohort|Overall Study||0
5189387|NCT01106352|12762100|P2|Started Safety Cohort|Overall Study||0
5189388|NCT01106352|12762101|P1|Started Safety Cohort|Overall Study||0
5189389|NCT01106352|12762097|P5|Completed Dose Escalation|Overall Study||0
5189390|NCT01106352|12762098|P4|Completed Dose Escalation|Overall Study||0
5189391|NCT01106352|12762099|P3|Completed Dose Escalation|Overall Study||5
5189392|NCT01106352|12762100|P2|Completed Dose Escalation|Overall Study||3
5189393|NCT01106352|12762101|P1|Completed Dose Escalation|Overall Study||6
5189394|NCT01106352|12762097|P5|Started Dose Escalation|Overall Study||0
5189395|NCT01106352|12762098|P4|Started Dose Escalation|Overall Study||0
5189396|NCT01106352|12762099|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
5189397|NCT01106352|12762100|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
5189398|NCT01106352|12762101|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
5189399|NCT01106352|12762097|P5|STARTED|Overall Study||17
5189400|NCT01106352|12762098|P4|STARTED|Overall Study||36
5189401|NCT01106352|12762099|P3|STARTED|Overall Study||7
5189402|NCT01106352|12762100|P2|STARTED|Overall Study||3
5189403|NCT01106352|12762101|P1|STARTED|Overall Study||7
5189404|NCT01106326|12762187|P1|NOT COMPLETED|Overall Study||2
5189405|NCT01106326|12762187|P1|COMPLETED|Overall Study||28
5189406|NCT01106326|12762187|P1|STARTED|Overall Study||30
5189407|NCT01106287|12762197|P4|NOT COMPLETED|Overall Study||0
5189408|NCT01106287|12762198|P3|NOT COMPLETED|Overall Study||0
5189409|NCT01106287|12762199|P2|NOT COMPLETED|Overall Study||0
5189410|NCT01106287|12762200|P1|NOT COMPLETED|Overall Study||1
5189411|NCT01106287|12762197|P4|COMPLETED|Overall Study||3
5189412|NCT01106287|12762198|P3|COMPLETED|Overall Study||3
5189413|NCT01106287|12762199|P2|COMPLETED|Overall Study||3
5189414|NCT01106287|12762200|P1|COMPLETED|Overall Study||3
5189415|NCT01106287|12762197|P4|STARTED|Overall Study||3
5189416|NCT01106287|12762198|P3|STARTED|Overall Study||3
5189417|NCT01106287|12762199|P2|STARTED|Overall Study||3
5189418|NCT01106287|12762200|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
5189419|NCT01106248|12762220|P1|NOT COMPLETED|Overall Study||3
5189420|NCT01106248|12762220|P1|COMPLETED|Overall Study||23
5189421|NCT01106248|12762220|P1|STARTED|Overall Study||26
5189422|NCT01106157|12762228|P2|NOT COMPLETED|Overall Study||0
5189423|NCT01106157|12762229|P1|NOT COMPLETED|Overall Study||1
5189424|NCT01106157|12762228|P2|COMPLETED|Overall Study||8
5189425|NCT01106157|12762229|P1|COMPLETED|Overall Study||16
5189426|NCT01106157|12762228|P2|STARTED|Overall Study||8
5189427|NCT01106157|12762229|P1|STARTED|Overall Study||17
5189428|NCT01106092|12762257|P4|NOT COMPLETED|Overall Study||1
5189429|NCT01106092|12762258|P3|NOT COMPLETED|Overall Study||0
5189430|NCT01106092|12762259|P2|NOT COMPLETED|Overall Study||0
5189431|NCT01106092|12762260|P1|NOT COMPLETED|Overall Study||0
5189432|NCT01106092|12762257|P4|COMPLETED|Overall Study||77
5189433|NCT01106092|12762258|P3|COMPLETED|Overall Study||78
5189434|NCT01106092|12762259|P2|COMPLETED|Overall Study||78
5189435|NCT01106092|12762260|P1|COMPLETED|Overall Study||78
5189436|NCT01106092|12762257|P4|STARTED|Overall Study||78
5189437|NCT01106092|12762258|P3|STARTED|Overall Study||78
5189438|NCT01106092|12762259|P2|STARTED|Overall Study||78
5189439|NCT01106092|12762260|P1|STARTED|Overall Study||78
5189440|NCT01106040|12762338|P1|NOT COMPLETED|Overall Study||11
5189441|NCT01106040|12762338|P1|COMPLETED|Overall Study||152
5189442|NCT01106040|12762338|P1|STARTED|Overall Study||163
5189443|NCT01106027|12762343|P1|NOT COMPLETED|Overall Study||1
5189444|NCT01106027|12762343|P1|COMPLETED|Overall Study||1
5189445|NCT01106027|12762343|P1|STARTED|Overall Study||2
5189446|NCT01106014|12762349|P2|NOT COMPLETED|Overall Study||330
5189447|NCT01106014|12762350|P1|NOT COMPLETED|Overall Study||285
5189448|NCT01106014|12762349|P2|COMPLETED|Overall Study||252
5189449|NCT01106014|12762350|P1|COMPLETED|Overall Study||289
5189450|NCT01106014|12762349|P2|STARTED|Overall Study||582
5189451|NCT01106014|12762350|P1|STARTED|Overall Study||574
5189452|NCT01105975|12762370|P10|NOT COMPLETED|Overall Study||9
5189453|NCT01105975|12762371|P9|NOT COMPLETED|Overall Study||6
5189454|NCT01105975|12762372|P8|NOT COMPLETED|Overall Study||7
5189455|NCT01105975|12762373|P7|NOT COMPLETED|Overall Study||8
5189456|NCT01105975|12762374|P6|NOT COMPLETED|Overall Study||5
5189457|NCT01105975|12762375|P5|NOT COMPLETED|Overall Study||6
5189458|NCT01105975|12762376|P4|NOT COMPLETED|Overall Study||2
5189459|NCT01105975|12762377|P3|NOT COMPLETED|Overall Study||10
5189460|NCT01105975|12762378|P2|NOT COMPLETED|Overall Study||5
5189461|NCT01105975|12762379|P1|NOT COMPLETED|Overall Study||5
5189462|NCT01105975|12762370|P10|COMPLETED|Overall Study||32
5189463|NCT01105975|12762371|P9|COMPLETED|Overall Study||34
5189464|NCT01105975|12762372|P8|COMPLETED|Overall Study||33
5189465|NCT01105975|12762373|P7|COMPLETED|Overall Study||34
5189466|NCT01105975|12762374|P6|COMPLETED|Overall Study||30
5189467|NCT01105975|12762375|P5|COMPLETED|Overall Study||35
5189468|NCT01105975|12762376|P4|COMPLETED|Overall Study||36
5189469|NCT01105975|12762377|P3|COMPLETED|Overall Study||32
5189470|NCT01105975|12762378|P2|COMPLETED|Overall Study||34
5189471|NCT01105975|12762379|P1|COMPLETED|Overall Study||35
5189472|NCT01105975|12762370|P10|Took at Least One Dose of Study Drug|Overall Study||41
5189473|NCT01105975|12762371|P9|Took at Least One Dose of Study Drug|Overall Study||39
5189474|NCT01105975|12762372|P8|Took at Least One Dose of Study Drug|Overall Study||40
5189475|NCT01105975|12762373|P7|Took at Least One Dose of Study Drug|Overall Study||41
5189476|NCT01105975|12762374|P6|Took at Least One Dose of Study Drug|Overall Study||35
5189477|NCT01105975|12762375|P5|Took at Least One Dose of Study Drug|Overall Study||41
5189478|NCT01105975|12762376|P4|Took at Least One Dose of Study Drug|Overall Study||38
5189479|NCT01105975|12762377|P3|Took at Least One Dose of Study Drug|Overall Study||40
5189480|NCT01105975|12762378|P2|Took at Least One Dose of Study Drug|Overall Study||38
5189481|NCT01105975|12762379|P1|Took at Least One Dose of Study Drug|Overall Study||40
5189482|NCT01105975|12762370|P10|STARTED|Overall Study||41
5189483|NCT01105975|12762371|P9|STARTED|Overall Study||40
5189484|NCT01105975|12762372|P8|STARTED|Overall Study||40
5189485|NCT01105975|12762373|P7|STARTED|Overall Study||42
5189486|NCT01105975|12762374|P6|STARTED|Overall Study||35
5189487|NCT01105975|12762375|P5|STARTED|Overall Study||41
5189488|NCT01105975|12762376|P4|STARTED|Overall Study||38
5189489|NCT01105975|12762377|P3|STARTED|Overall Study||42
5189490|NCT01105975|12762378|P2|STARTED|Overall Study||39
5189491|NCT01105975|12762379|P1|STARTED|Overall Study||40
5189492|NCT01105936|12762527|P4|NOT COMPLETED|Period 3||0
5189493|NCT01105936|12762528|P3|NOT COMPLETED|Period 3||0
5189494|NCT01105936|12762529|P2|NOT COMPLETED|Period 3||2
5189495|NCT01105936|12762530|P1|NOT COMPLETED|Period 3||0
5189496|NCT01105936|12762527|P4|COMPLETED|Period 3||7
5189497|NCT01105936|12762528|P3|COMPLETED|Period 3||7
5189498|NCT01105936|12762529|P2|COMPLETED|Period 3||6
5189499|NCT01105936|12762530|P1|COMPLETED|Period 3||7
5189500|NCT01105936|12762527|P4|STARTED|Period 3||7
5189501|NCT01105936|12762528|P3|STARTED|Period 3||7
5189502|NCT01105936|12762529|P2|STARTED|Period 3||8
5189503|NCT01105936|12762530|P1|STARTED|Period 3||7
5189504|NCT01105936|12762527|P4|NOT COMPLETED|Wash-out Period 2||0
5189505|NCT01105936|12762528|P3|NOT COMPLETED|Wash-out Period 2||0
5189506|NCT01105936|12762529|P2|NOT COMPLETED|Wash-out Period 2||0
5189507|NCT01105936|12762530|P1|NOT COMPLETED|Wash-out Period 2||0
5189508|NCT01105936|12762527|P4|COMPLETED|Wash-out Period 2||7
5189509|NCT01105936|12762528|P3|COMPLETED|Wash-out Period 2||7
5189510|NCT01105936|12762529|P2|COMPLETED|Wash-out Period 2||8
5189511|NCT01105936|12762530|P1|COMPLETED|Wash-out Period 2||7
5189512|NCT01105936|12762527|P4|STARTED|Wash-out Period 2||7
5189513|NCT01105936|12762528|P3|STARTED|Wash-out Period 2||7
5189514|NCT01105936|12762529|P2|STARTED|Wash-out Period 2||8
5189515|NCT01105936|12762530|P1|STARTED|Wash-out Period 2||7
5189516|NCT01105936|12762527|P4|NOT COMPLETED|Period 2||0
5189517|NCT01105936|12762528|P3|NOT COMPLETED|Period 2||0
5189518|NCT01105936|12762529|P2|NOT COMPLETED|Period 2||0
5189519|NCT01105936|12762530|P1|NOT COMPLETED|Period 2||1
5189520|NCT01105936|12762527|P4|COMPLETED|Period 2||7
5189521|NCT01105936|12762528|P3|COMPLETED|Period 2||7
5189522|NCT01105936|12762529|P2|COMPLETED|Period 2||8
5189523|NCT01105936|12762530|P1|COMPLETED|Period 2||7
5189524|NCT01105936|12762527|P4|STARTED|Period 2||7
5189525|NCT01105936|12762528|P3|STARTED|Period 2||7
5189526|NCT01105936|12762529|P2|STARTED|Period 2||8
5189527|NCT01105936|12762530|P1|STARTED|Period 2||8
5189528|NCT01105936|12762527|P4|NOT COMPLETED|Wash-out Period 1||0
5189529|NCT01105936|12762528|P3|NOT COMPLETED|Wash-out Period 1||0
5189530|NCT01105936|12762529|P2|NOT COMPLETED|Wash-out Period 1||0
5189531|NCT01105936|12762530|P1|NOT COMPLETED|Wash-out Period 1||0
5189532|NCT01105936|12762527|P4|COMPLETED|Wash-out Period 1||7
5189533|NCT01105936|12762528|P3|COMPLETED|Wash-out Period 1||7
5189534|NCT01105936|12762529|P2|COMPLETED|Wash-out Period 1||8
5189535|NCT01105936|12762530|P1|COMPLETED|Wash-out Period 1||8
5189536|NCT01105936|12762527|P4|STARTED|Wash-out Period 1||7
5189537|NCT01105936|12762528|P3|STARTED|Wash-out Period 1||7
5189538|NCT01105936|12762529|P2|STARTED|Wash-out Period 1||8
5189539|NCT01105936|12762530|P1|STARTED|Wash-out Period 1||8
5189540|NCT01105936|12762527|P4|NOT COMPLETED|Period 1||1
5189541|NCT01105936|12762528|P3|NOT COMPLETED|Period 1||0
5189542|NCT01105936|12762529|P2|NOT COMPLETED|Period 1||0
5189543|NCT01105936|12762530|P1|NOT COMPLETED|Period 1||0
5189544|NCT01105936|12762527|P4|COMPLETED|Period 1||7
5189545|NCT01105936|12762528|P3|COMPLETED|Period 1||7
5189546|NCT01105936|12762529|P2|COMPLETED|Period 1||8
5189547|NCT01105936|12762530|P1|COMPLETED|Period 1||8
5189548|NCT01105936|12762527|P4|STARTED|Period 1||8
5189549|NCT01105936|12762528|P3|STARTED|Period 1||7
5189550|NCT01105936|12762529|P2|STARTED|Period 1||8
5189551|NCT01105936|12762530|P1|STARTED|Period 1||8
5189552|NCT01105767|12762559|P3|NOT COMPLETED|Overall Study||1184
5189553|NCT01105767|12762560|P2|NOT COMPLETED|Overall Study||1614
5189554|NCT01105767|12762561|P1|NOT COMPLETED|Overall Study||1160
5189555|NCT01105767|12762559|P3|COMPLETED|Overall Study||8846
5189556|NCT01105767|12762560|P2|COMPLETED|Overall Study||9250
5189557|NCT01105767|12762561|P1|COMPLETED|Overall Study||8155
5189558|NCT01105767|12762559|P3|STARTED|Overall Study||10030
5189559|NCT01105767|12762560|P2|STARTED|Overall Study||10864
5189560|NCT01105767|12762561|P1|STARTED|Overall Study||9315
5189561|NCT01105754|12762574|P2|NOT COMPLETED|Overall Study||12
5189562|NCT01105754|12762575|P1|NOT COMPLETED|Overall Study||15
5189563|NCT01105754|12762574|P2|COMPLETED|Overall Study||307
5189564|NCT01105754|12762575|P1|COMPLETED|Overall Study||304
5189565|NCT01105754|12762574|P2|STARTED|Overall Study||319
5189566|NCT01105754|12762575|P1|STARTED|Overall Study||319
5189567|NCT01105702|12762583|P1|NOT COMPLETED|Overall Study||18
5189568|NCT01105702|12762583|P1|COMPLETED|Overall Study||10
5189569|NCT01105702|12762583|P1|STARTED|Overall Study||28
5189570|NCT01105650|12762593|P4|NOT COMPLETED|Overall Study||0
5189571|NCT01105650|12762594|P3|NOT COMPLETED|Overall Study||0
5189572|NCT01105650|12762595|P2|NOT COMPLETED|Overall Study||0
5189573|NCT01105650|12762596|P1|NOT COMPLETED|Overall Study||0
5189574|NCT01105650|12762593|P4|COMPLETED|Overall Study||0
5189575|NCT01105650|12762594|P3|COMPLETED|Overall Study||7
5189576|NCT01105650|12762595|P2|COMPLETED|Overall Study||3
5189577|NCT01105650|12762596|P1|COMPLETED|Overall Study||3
5189578|NCT01105650|12762593|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
5189579|NCT01105650|12762594|P3|STARTED|Overall Study||7
5189580|NCT01105650|12762595|P2|STARTED|Overall Study||3
5189581|NCT01105650|12762596|P1|STARTED|Overall Study||3
5189582|NCT01105533|12762613|P9|NOT COMPLETED|Overall Study||12
5189583|NCT01105533|12762614|P8|NOT COMPLETED|Overall Study||4
5189584|NCT01105533|12762615|P7|NOT COMPLETED|Overall Study||8
5189585|NCT01105533|12762616|P6|NOT COMPLETED|Overall Study||7
5189586|NCT01105533|12762617|P5|NOT COMPLETED|Overall Study||7
5189587|NCT01105533|12762618|P4|NOT COMPLETED|Overall Study||3
5189588|NCT01105533|12762619|P3|NOT COMPLETED|Overall Study||3
5189589|NCT01105533|12762620|P2|NOT COMPLETED|Overall Study||1
5189590|NCT01105533|12762621|P1|NOT COMPLETED|Overall Study||1
5189591|NCT01105533|12762613|P9|COMPLETED|Overall Study||0
5189592|NCT01105533|12762614|P8|COMPLETED|Overall Study||0
5189593|NCT01105533|12762615|P7|COMPLETED|Overall Study||0
5189594|NCT01105533|12762616|P6|COMPLETED|Overall Study||0
5189595|NCT01105533|12762617|P5|COMPLETED|Overall Study||0
5189596|NCT01105533|12762618|P4|COMPLETED|Overall Study||0
5189597|NCT01105533|12762619|P3|COMPLETED|Overall Study||0
5189598|NCT01105533|12762620|P2|COMPLETED|Overall Study||0
5189599|NCT01105533|12762621|P1|COMPLETED|Overall Study||0
5189600|NCT01105533|12762613|P9|STARTED|Overall Study||12
5189601|NCT01105533|12762614|P8|STARTED|Overall Study||4
5189602|NCT01105533|12762615|P7|STARTED|Overall Study||8
5189603|NCT01105533|12762616|P6|STARTED|Overall Study||7
5189604|NCT01105533|12762617|P5|STARTED|Overall Study||7
5189605|NCT01105533|12762618|P4|STARTED|Overall Study||3
5189606|NCT01105533|12762619|P3|STARTED|Overall Study||3
5189607|NCT01105533|12762620|P2|STARTED|Overall Study||1
5189608|NCT01105533|12762621|P1|STARTED|Overall Study||1
5189609|NCT01105377|12762711|P2|NOT COMPLETED|Overall Study||1
5189610|NCT01105377|12762712|P1|NOT COMPLETED|Overall Study||0
5189611|NCT01105377|12762711|P2|COMPLETED|Overall Study||22
5189612|NCT01105377|12762712|P1|COMPLETED|Overall Study||24
5189613|NCT01105377|12762711|P2|STARTED|Overall Study||23
5189614|NCT01105377|12762712|P1|STARTED|Overall Study||24
5189615|NCT01105312|12762723|P3|NOT COMPLETED|Overall Study||0
5189616|NCT01105312|12762724|P2|NOT COMPLETED|Overall Study||0
5189617|NCT01105312|12762725|P1|NOT COMPLETED|Overall Study||3
5189618|NCT01105312|12762723|P3|COMPLETED|Overall Study||6
5189619|NCT01105312|12762724|P2|COMPLETED|Overall Study||6
5189620|NCT01105312|12762725|P1|COMPLETED|Overall Study||13
5189621|NCT01105312|12762723|P3|STARTED|Overall Study||6
5189622|NCT01105312|12762724|P2|STARTED|Overall Study||6
5189623|NCT01105312|12762725|P1|STARTED|Overall Study||16
5189624|NCT01105247|12762743|P2|NOT COMPLETED|Overall Study||0
5189625|NCT01105247|12762744|P1|NOT COMPLETED|Overall Study||37
5189626|NCT01105247|12762743|P2|COMPLETED|Overall Study||16
5189627|NCT01105247|12762744|P1|COMPLETED|Overall Study||79
5189628|NCT01105247|12762743|P2|STARTED|Overall Study||16
5189629|NCT01105247|12762744|P1|STARTED|Overall Study||116
5189630|NCT01105130|12762760|P3|NOT COMPLETED|Overall Study||10
5189631|NCT01105130|12762761|P2|NOT COMPLETED|Overall Study||11
5189632|NCT01105130|12762762|P1|NOT COMPLETED|Overall Study||10
5189633|NCT01105130|12762760|P3|COMPLETED|Overall Study||37
5189634|NCT01105130|12762761|P2|COMPLETED|Overall Study||34
5189635|NCT01105130|12762762|P1|COMPLETED|Overall Study||38
5189636|NCT01105130|12762760|P3|STARTED|Overall Study||47
5189637|NCT01105130|12762761|P2|STARTED|Overall Study||45
5189638|NCT01105130|12762762|P1|STARTED|Overall Study||48
5189639|NCT01105117|12762781|P2|NOT COMPLETED|Overall Study||0
5189640|NCT01105117|12762782|P1|NOT COMPLETED|Overall Study||0
5189641|NCT01105117|12762781|P2|COMPLETED|Overall Study||1
5189642|NCT01105117|12762782|P1|COMPLETED|Overall Study||1
5189643|NCT01105117|12762781|P2|STARTED|Overall Study||1
5189644|NCT01105117|12762782|P1|STARTED|Overall Study||1
5189645|NCT01105091|12762792|P2|NOT COMPLETED|Overall Study||0
5189646|NCT01105091|12762793|P1|NOT COMPLETED|Overall Study||2
5189647|NCT01105091|12762792|P2|COMPLETED|Overall Study||10
5189648|NCT01105091|12762793|P1|COMPLETED|Overall Study||18
5189649|NCT01105091|12762792|P2|STARTED|Overall Study||10
5189650|NCT01105091|12762793|P1|STARTED|Overall Study||20
5189651|NCT01105065|12762817|P1|NOT COMPLETED|Overall Study||6
5189652|NCT01105065|12762817|P1|COMPLETED|Overall Study||17
5189653|NCT01105065|12762817|P1|STARTED|Overall Study||23
5189654|NCT01104870|12762826|P3|NOT COMPLETED|Overall Study||2
5189655|NCT01104870|12762827|P2|NOT COMPLETED|Overall Study||1
5189656|NCT01104870|12762828|P1|NOT COMPLETED|Overall Study||1
5189657|NCT01104870|12762826|P3|COMPLETED|Overall Study||18
5189658|NCT01104870|12762827|P2|COMPLETED|Overall Study||18
5189659|NCT01104870|12762828|P1|COMPLETED|Overall Study||10
5189660|NCT01104870|12762826|P3|STARTED|Overall Study||20
5189661|NCT01104870|12762827|P2|STARTED|Overall Study||19
5189662|NCT01104870|12762828|P1|STARTED|Overall Study||11
5189663|NCT01104792|12762857|P1|NOT COMPLETED|Overall Study||526
5189664|NCT01104792|12762857|P1|COMPLETED|Overall Study||226
5189665|NCT01104792|12762857|P1|STARTED|Overall Study||752
5189666|NCT01104779|12762865|P3|NOT COMPLETED|Overall Study||62
5189667|NCT01104779|12762866|P2|NOT COMPLETED|Overall Study||55
5189668|NCT01104779|12762867|P1|NOT COMPLETED|Overall Study||59
5189669|NCT01104779|12762865|P3|COMPLETED|Overall Study||86
5189670|NCT01104779|12762866|P2|COMPLETED|Overall Study||96
5189671|NCT01104779|12762867|P1|COMPLETED|Overall Study||88
5189672|NCT01104779|12762865|P3|STARTED|Overall Study||148
5189673|NCT01104779|12762866|P2|STARTED|Overall Study||151
5189674|NCT01104779|12762867|P1|STARTED|Overall Study||147
5189675|NCT01104766|12762882|P4|NOT COMPLETED|Overall Study||38
5189676|NCT01104766|12762883|P3|NOT COMPLETED|Overall Study||60
5189677|NCT01104766|12762884|P2|NOT COMPLETED|Overall Study||51
5189678|NCT01104766|12762885|P1|NOT COMPLETED|Overall Study||58
5189679|NCT01104766|12762882|P4|COMPLETED|Overall Study||114
5189680|NCT01104766|12762883|P3|COMPLETED|Overall Study||97
5189681|NCT01104766|12762884|P2|COMPLETED|Overall Study||104
5189682|NCT01104766|12762885|P1|COMPLETED|Overall Study||95
5189683|NCT01104766|12762882|P4|STARTED|Overall Study||152
5189684|NCT01104766|12762883|P3|STARTED|Overall Study||157
5189685|NCT01104766|12762884|P2|STARTED|Overall Study||155
5189686|NCT01104766|12762885|P1|STARTED|Overall Study||153
5189687|NCT01104701|12762903|P4|NOT COMPLETED|Overall Study||2
5189688|NCT01104701|12762904|P3|NOT COMPLETED|Overall Study||2
5189689|NCT01104701|12762905|P2|NOT COMPLETED|Overall Study||3
5189690|NCT01104701|12762906|P1|NOT COMPLETED|Overall Study||0
5189691|NCT01104701|12762903|P4|COMPLETED|Overall Study||28
5189692|NCT01104701|12762904|P3|COMPLETED|Overall Study||29
5189693|NCT01104701|12762905|P2|COMPLETED|Overall Study||27
5189694|NCT01104701|12762906|P1|COMPLETED|Overall Study||30
5189695|NCT01104701|12762903|P4|STARTED|Overall Study||30
5189696|NCT01104701|12762904|P3|STARTED|Overall Study||31
5189697|NCT01104701|12762905|P2|STARTED|Overall Study||30
5189698|NCT01104701|12762906|P1|STARTED|Overall Study||30
5189699|NCT01104662|12762968|P8|NOT COMPLETED|Overall Study||0
5189700|NCT01104662|12762969|P7|NOT COMPLETED|Overall Study||0
5189701|NCT01104662|12762970|P6|NOT COMPLETED|Overall Study||4
5189702|NCT01104662|12762971|P5|NOT COMPLETED|Overall Study||1
5189703|NCT01104662|12762972|P4|NOT COMPLETED|Overall Study||1
5189704|NCT01104662|12762973|P3|NOT COMPLETED|Overall Study||1
5189705|NCT01104662|12762974|P2|NOT COMPLETED|Overall Study||10
5189706|NCT01104662|12762975|P1|NOT COMPLETED|Overall Study||10
5189707|NCT01104662|12762968|P8|COMPLETED|Overall Study||6
5189708|NCT01104662|12762969|P7|COMPLETED|Overall Study||5
5189709|NCT01104662|12762970|P6|COMPLETED|Overall Study||12
5189710|NCT01104662|12762971|P5|COMPLETED|Overall Study||14
5189711|NCT01104662|12762972|P4|COMPLETED|Overall Study||3
5189712|NCT01104662|12762973|P3|COMPLETED|Overall Study||4
5189713|NCT01104662|12762974|P2|COMPLETED|Overall Study||11
5189714|NCT01104662|12762975|P1|COMPLETED|Overall Study||10
5189715|NCT01104662|12762968|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
5189716|NCT01104662|12762969|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
5189717|NCT01104662|12762970|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
5189718|NCT01104662|12762971|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
5189719|NCT01104662|12762972|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
5189720|NCT01104662|12762973|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
5189721|NCT01104662|12762974|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
5189722|NCT01104662|12762975|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
5189723|NCT01104662|12762968|P8|STARTED|Overall Study||6
5189724|NCT01104662|12762969|P7|STARTED|Overall Study||5
5189725|NCT01104662|12762970|P6|STARTED|Overall Study||16
5189726|NCT01104662|12762971|P5|STARTED|Overall Study||15
5189727|NCT01104662|12762972|P4|STARTED|Overall Study||4
5189728|NCT01104662|12762973|P3|STARTED|Overall Study||5
5189729|NCT01104662|12762974|P2|STARTED|Overall Study||21
5189730|NCT01104662|12762975|P1|STARTED|Overall Study||20
5189731|NCT01104636|12763001|P1|NOT COMPLETED|Overall Study||178
5189732|NCT01104636|12763001|P1|COMPLETED|Overall Study||999
5189733|NCT01104636|12763001|P1|STARTED|Overall Study||1177
5189734|NCT01104584|12763006|P1|NOT COMPLETED|Overall Study||23
5189735|NCT01104584|12763006|P1|COMPLETED|Overall Study|study course completed|437
5189736|NCT01104584|12763006|P1|Fulfilled Requirements of FAS Population|Overall Study||397
5189737|NCT01104584|12763006|P1|Received Treatment|Overall Study|treatment started|439
5189738|NCT01104584|12763006|P1|STARTED|Overall Study|screened and enrolled|460
5189739|NCT01104558|12763076|P1|NOT COMPLETED|Overall Study||17
5189740|NCT01104558|12763076|P1|COMPLETED|Overall Study||83
5189741|NCT01104558|12763076|P1|STARTED|Overall Study||100
5189742|NCT01104545|12763120|P3|NOT COMPLETED|Overall Study||2
5189743|NCT01104545|12763121|P2|NOT COMPLETED|Overall Study||1
5189744|NCT01104545|12763122|P1|NOT COMPLETED|Overall Study||0
5189745|NCT01104545|12763120|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
5189746|NCT01104545|12763121|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
5189747|NCT01104545|12763122|P1|COMPLETED|Overall Study||8
5189748|NCT01104545|12763120|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
5189749|NCT01104545|12763121|P2|STARTED|Overall Study||8
5189750|NCT01104545|12763122|P1|STARTED|Overall Study||8
5189751|NCT01104493|12763279|P2|NOT COMPLETED|Overall Study||2
5189752|NCT01104493|12763280|P1|NOT COMPLETED|Overall Study||0
5189753|NCT01104493|12763279|P2|COMPLETED|Overall Study||58
5189754|NCT01104493|12763280|P1|COMPLETED|Overall Study||240
5189755|NCT01104493|12763279|P2|STARTED|Overall Study||60
5189756|NCT01104493|12763280|P1|STARTED|Overall Study||240
5189757|NCT01104415|12763298|P2|NOT COMPLETED|Extension Period||11
5189758|NCT01104415|12763299|P1|NOT COMPLETED|Extension Period||0
5189759|NCT01104415|12763298|P2|COMPLETED|Extension Period||0
5189760|NCT01104415|12763299|P1|COMPLETED|Extension Period||0
5189761|NCT01104415|12763298|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
5189762|NCT01104415|12763299|P1|STARTED|Extension Period||0
5189763|NCT01104415|12763298|P2|NOT COMPLETED|Core Phase||0
5189764|NCT01104415|12763299|P1|NOT COMPLETED|Core Phase||1
5189765|NCT01104415|12763298|P2|COMPLETED|Core Phase||0
5189766|NCT01104415|12763299|P1|COMPLETED|Core Phase||14
5189767|NCT01104415|12763298|P2|STARTED|Core Phase||0
5189768|NCT01104415|12763299|P1|STARTED|Core Phase||15
5189769|NCT01104402|12763324|P2|NOT COMPLETED|Overall Study||33
5189770|NCT01104402|12763325|P1|NOT COMPLETED|Overall Study||21
5189771|NCT01104402|12763324|P2|COMPLETED|Overall Study||102
5189772|NCT01104402|12763325|P1|COMPLETED|Overall Study||111
5189773|NCT01104402|12763324|P2|STARTED|Overall Study||135
5189774|NCT01104402|12763325|P1|STARTED|Overall Study||132
5189775|NCT01104376|12763343|P1|NOT COMPLETED|Overall Study||28
5189776|NCT01104376|12763343|P1|COMPLETED|Overall Study||61
5189777|NCT01104376|12763343|P1|STARTED|Overall Study||89
5189778|NCT01104311|12763349|P2|NOT COMPLETED|Overall Study||12
5189779|NCT01104311|12763350|P1|NOT COMPLETED|Overall Study||10
5189780|NCT01104311|12763349|P2|COMPLETED|Overall Study||54
5189781|NCT01104311|12763350|P1|COMPLETED|Overall Study||56
5189782|NCT01104311|12763349|P2|STARTED|Overall Study||66
5189783|NCT01104311|12763350|P1|STARTED|Overall Study||66
5189784|NCT01104285|12763370|P2|NOT COMPLETED|Overall Study||0
5189785|NCT01104285|12763371|P1|NOT COMPLETED|Overall Study||0
5189786|NCT01104285|12763370|P2|COMPLETED|Overall Study||86
5189787|NCT01104285|12763371|P1|COMPLETED|Overall Study||112
5189788|NCT01104285|12763370|P2|STARTED|Overall Study||86
5189789|NCT01104285|12763371|P1|STARTED|Overall Study||112
5189790|NCT01104246|12763377|P1|NOT COMPLETED|Overall Study||5
5189791|NCT01104246|12763377|P1|COMPLETED|Overall Study||35
5189792|NCT01104246|12763377|P1|Baseline Characteristics Measured|Overall Study||35
5189793|NCT01104246|12763377|P1|STARTED|Overall Study||40
5189794|NCT01104207|12763383|P2|NOT COMPLETED|Overall Study||3
5189795|NCT01104207|12763384|P1|NOT COMPLETED|Overall Study||3
5189796|NCT01104207|12763383|P2|COMPLETED|Overall Study||32
5189797|NCT01104207|12763384|P1|COMPLETED|Overall Study||32
5189798|NCT01104207|12763383|P2|STARTED|Overall Study||35
5189799|NCT01104207|12763384|P1|STARTED|Overall Study||35
5189800|NCT01104155|12763392|P2|NOT COMPLETED|Overall Study||18
5189801|NCT01104155|12763393|P1|NOT COMPLETED|Overall Study||25
5189802|NCT01104155|12763392|P2|COMPLETED|Overall Study||42
5189803|NCT01104155|12763393|P1|COMPLETED|Overall Study||38
5189804|NCT01104155|12763392|P2|STARTED|Overall Study||60
5189805|NCT01104155|12763393|P1|STARTED|Overall Study||63
5189806|NCT01104116|12763407|P1|NOT COMPLETED|Overall Study||0
5189807|NCT01104116|12763407|P1|COMPLETED|Overall Study||1
5189808|NCT01104116|12763407|P1|STARTED|Overall Study||1
5189809|NCT01104103|12763414|P2|NOT COMPLETED|Overall Study||0
5189810|NCT01104103|12763415|P1|NOT COMPLETED|Overall Study||0
5189811|NCT01104103|12763414|P2|COMPLETED|Overall Study||224
5189812|NCT01104103|12763415|P1|COMPLETED|Overall Study||243
5189813|NCT01104103|12763414|P2|STARTED|Overall Study||224
5189814|NCT01104103|12763415|P1|STARTED|Overall Study||243
5189815|NCT01103973|12763425|P2|NOT COMPLETED|Overall Study||0
5189816|NCT01103973|12763426|P1|NOT COMPLETED|Overall Study||0
5189817|NCT01103973|12763425|P2|COMPLETED|Overall Study||46
5189818|NCT01103973|12763426|P1|COMPLETED|Overall Study||51
5189819|NCT01103973|12763425|P2|STARTED|Overall Study||46
5189820|NCT01103973|12763426|P1|STARTED|Overall Study||51
5189821|NCT01103960|12763436|P2|NOT COMPLETED|Overall Study||2
5189822|NCT01103960|12763437|P1|NOT COMPLETED|Overall Study||5
5189823|NCT01103960|12763436|P2|COMPLETED|Overall Study|Completed study medication.|158
5189824|NCT01103960|12763437|P1|COMPLETED|Overall Study|Completed study medication.|159
5189825|NCT01103960|12763436|P2|STARTED|Overall Study|Randomised and treated.|160
5189826|NCT01103960|12763437|P1|STARTED|Overall Study|Randomised and treated.|164
5189827|NCT01103934|12763463|P2|NOT COMPLETED|Overall Study||0
5189828|NCT01103934|12763464|P1|NOT COMPLETED|Overall Study||0
5189829|NCT01103934|12763463|P2|COMPLETED|Overall Study||18
5189830|NCT01103934|12763464|P1|COMPLETED|Overall Study||17
5189831|NCT01103934|12763463|P2|STARTED|Overall Study||18
5189832|NCT01103934|12763464|P1|STARTED|Overall Study||17
5189833|NCT01103778|12763472|P1|NOT COMPLETED|Overall Study||3
5189834|NCT01103778|12763472|P1|COMPLETED|Overall Study||8
5189835|NCT01103778|12763472|P1|STARTED|Overall Study||11
5189836|NCT01103713|12763479|P1|NOT COMPLETED|Overall Study||13
5189837|NCT01103713|12763479|P1|COMPLETED|Overall Study||155
5189838|NCT01103713|12763479|P1|STARTED|Overall Study||168
5189839|NCT01103505|12763507|P2|NOT COMPLETED|Overall Study||20
5189840|NCT01103505|12763508|P1|NOT COMPLETED|Overall Study||24
5189841|NCT01103505|12763507|P2|COMPLETED|Overall Study||737
5189842|NCT01103505|12763508|P1|COMPLETED|Overall Study||739
5189843|NCT01103505|12763507|P2|STARTED|Overall Study||757
5189844|NCT01103505|12763508|P1|STARTED|Overall Study||763
5189845|NCT01103492|12763522|P1|NOT COMPLETED|Overall Study||0
5189846|NCT01103492|12763522|P1|COMPLETED|Overall Study||1
5189847|NCT01103492|12763522|P1|STARTED|Overall Study||1
5189848|NCT01103479|12763529|P3|NOT COMPLETED|Overall Study||14
5189849|NCT01103479|12763530|P2|NOT COMPLETED|Overall Study||9
5189850|NCT01103479|12763531|P1|NOT COMPLETED|Overall Study||5
5189851|NCT01103479|12763529|P3|COMPLETED|Overall Study||174
5189852|NCT01103479|12763530|P2|COMPLETED|Overall Study||201
5189853|NCT01103479|12763531|P1|COMPLETED|Overall Study||163
5189854|NCT01103479|12763529|P3|STARTED|Overall Study||188
5189855|NCT01103479|12763530|P2|STARTED|Overall Study||210
5189856|NCT01103479|12763531|P1|STARTED|Overall Study||168
5189857|NCT01103466|12763544|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
5189858|NCT01103466|12763545|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
5189859|NCT01103466|12763546|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
5189860|NCT01103466|12763544|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
5189861|NCT01103466|12763545|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
5189862|NCT01103466|12763546|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
5189863|NCT01103466|12763544|P3|STARTED|Third Period (14 +/- 3 Days)||14
5189864|NCT01103466|12763545|P2|STARTED|Third Period (14 +/- 3 Days)||8
5189865|NCT01103466|12763546|P1|STARTED|Third Period (14 +/- 3 Days)||8
5189866|NCT01103466|12763544|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
5189867|NCT01103466|12763545|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
5189868|NCT01103466|12763546|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
5189869|NCT01103466|12763544|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
5189870|NCT01103466|12763545|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
5189871|NCT01103466|12763546|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
5189872|NCT01103466|12763544|P3|STARTED|Second Period (14 +/- 3 Days)||7
5189873|NCT01103466|12763545|P2|STARTED|Second Period (14 +/- 3 Days)||13
5189874|NCT01103466|12763546|P1|STARTED|Second Period (14 +/- 3 Days)||15
5189875|NCT01103466|12763544|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
5189876|NCT01103466|12763545|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
5189877|NCT01103466|12763546|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
5189878|NCT01103466|12763544|P3|COMPLETED|First Period (14 +/- 3 Days)||13
5189879|NCT01103466|12763545|P2|COMPLETED|First Period (14 +/- 3 Days)||12
5189880|NCT01103466|12763546|P1|COMPLETED|First Period (14 +/- 3 Days)||10
5189881|NCT01103466|12763544|P3|STARTED|First Period (14 +/- 3 Days)||13
5189882|NCT01103466|12763545|P2|STARTED|First Period (14 +/- 3 Days)||12
5189883|NCT01103466|12763546|P1|STARTED|First Period (14 +/- 3 Days)||12
5189884|NCT01103440|12763556|P2|NOT COMPLETED|Overall Study||0
5189885|NCT01103440|12763557|P1|NOT COMPLETED|Overall Study||0
5189886|NCT01103440|12763556|P2|COMPLETED|Overall Study||18
5189887|NCT01103440|12763557|P1|COMPLETED|Overall Study||18
5189888|NCT01103440|12763556|P2|STARTED|Overall Study||18
5189889|NCT01103440|12763557|P1|STARTED|Overall Study||18
5189890|NCT01103414|12763570|P5|NOT COMPLETED|Overall Study||15
5189891|NCT01103414|12763571|P4|NOT COMPLETED|Overall Study||7
5189892|NCT01103414|12763572|P3|NOT COMPLETED|Overall Study||15
5189893|NCT01103414|12763573|P2|NOT COMPLETED|Overall Study||9
5189894|NCT01103414|12763574|P1|NOT COMPLETED|Overall Study||13
5189895|NCT01103414|12763570|P5|COMPLETED|Overall Study||56
5189896|NCT01103414|12763571|P4|COMPLETED|Overall Study||64
5189897|NCT01103414|12763572|P3|COMPLETED|Overall Study||56
5189898|NCT01103414|12763573|P2|COMPLETED|Overall Study||62
5189899|NCT01103414|12763574|P1|COMPLETED|Overall Study||59
5189900|NCT01103414|12763570|P5|STARTED|Overall Study||71
5189901|NCT01103414|12763571|P4|STARTED|Overall Study||71
5189902|NCT01103414|12763572|P3|STARTED|Overall Study||71
5189903|NCT01103414|12763573|P2|STARTED|Overall Study||71
5189904|NCT01103414|12763574|P1|STARTED|Overall Study||72
5189905|NCT01103362|12763636|P1|NOT COMPLETED|Overall Study||596
5189906|NCT01103362|12763636|P1|COMPLETED|Overall Study||0
5189907|NCT01103362|12763636|P1|STARTED|Overall Study||596
5189908|NCT01103323|12763642|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
5189909|NCT01103323|12763643|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
5189910|NCT01103323|12763642|P2|COMPLETED|Switched From Placebo to Regorafenib||3
5189911|NCT01103323|12763643|P1|COMPLETED|Switched From Placebo to Regorafenib||0
5189912|NCT01103323|12763642|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
5189913|NCT01103323|12763643|P1|STARTED|Switched From Placebo to Regorafenib||0
5189914|NCT01103323|12763642|P2|NOT COMPLETED|Without/Before Drug Switch||18
5189915|NCT01103323|12763643|P1|NOT COMPLETED|Without/Before Drug Switch||76
5189916|NCT01103323|12763642|P2|COMPLETED|Without/Before Drug Switch||237
5189917|NCT01103323|12763643|P1|COMPLETED|Without/Before Drug Switch||429
5189918|NCT01103323|12763642|P2|Participants Received Treatment|Without/Before Drug Switch||253
5189919|NCT01103323|12763643|P1|Participants Received Treatment|Without/Before Drug Switch||500
5189920|NCT01103323|12763642|P2|STARTED|Without/Before Drug Switch||255
5189921|NCT01103323|12763643|P1|STARTED|Without/Before Drug Switch||505
5189922|NCT01103284|12763660|P2|NOT COMPLETED|Overall Study||44
5189923|NCT01103284|12763661|P1|NOT COMPLETED|Overall Study||42
5189924|NCT01103284|12763660|P2|COMPLETED|Overall Study||195
5189925|NCT01103284|12763661|P1|COMPLETED|Overall Study||194
5189926|NCT01103284|12763660|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
5189927|NCT01103284|12763661|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
5189928|NCT01103284|12763660|P2|Treated|Overall Study||238
5189929|NCT01103284|12763661|P1|Treated|Overall Study||236
5189930|NCT01103284|12763660|P2|STARTED|Overall Study||239
5189931|NCT01103284|12763661|P1|STARTED|Overall Study||236
5189932|NCT01103271|12763677|P2|NOT COMPLETED|Overall Study||4
5189933|NCT01103271|12763678|P1|NOT COMPLETED|Overall Study||1
5189934|NCT01103271|12763677|P2|COMPLETED|Overall Study||5
5189935|NCT01103271|12763678|P1|COMPLETED|Overall Study||10
5189936|NCT01103271|12763677|P2|STARTED|Overall Study||9
5189937|NCT01103271|12763678|P1|STARTED|Overall Study||11
5189938|NCT01103245|12763689|P4|NOT COMPLETED|Overall Study||0
5189939|NCT01103245|12763690|P3|NOT COMPLETED|Overall Study||4
5189940|NCT01103245|12763691|P2|NOT COMPLETED|Overall Study||2
5189941|NCT01103245|12763692|P1|NOT COMPLETED|Overall Study||3
5189942|NCT01103245|12763689|P4|COMPLETED|Overall Study||6
5189943|NCT01103245|12763690|P3|COMPLETED|Overall Study||8
5189944|NCT01103245|12763691|P2|COMPLETED|Overall Study||5
5189945|NCT01103245|12763692|P1|COMPLETED|Overall Study||10
5189946|NCT01103245|12763689|P4|STARTED|Overall Study||6
5189947|NCT01103245|12763690|P3|STARTED|Overall Study||12
5189948|NCT01103245|12763691|P2|STARTED|Overall Study||7
5189949|NCT01103245|12763692|P1|STARTED|Overall Study||13
5189950|NCT01103232|12763708|P2|NOT COMPLETED|Overall Study||2
5189951|NCT01103232|12763709|P1|NOT COMPLETED|Overall Study||1
5189952|NCT01103232|12763708|P2|COMPLETED|Overall Study||11
5189953|NCT01103232|12763709|P1|COMPLETED|Overall Study||12
5189954|NCT01103232|12763708|P2|STARTED|Overall Study||13
5189955|NCT01103232|12763709|P1|STARTED|Overall Study||13
5189956|NCT01103180|12763717|P2|NOT COMPLETED|Overall Study||21
5189957|NCT01103180|12763718|P1|NOT COMPLETED|Overall Study||22
5189958|NCT01103180|12763717|P2|COMPLETED|Overall Study||14
5189959|NCT01103180|12763718|P1|COMPLETED|Overall Study||13
5189960|NCT01103180|12763717|P2|STARTED|Overall Study||35
5189961|NCT01103180|12763718|P1|STARTED|Overall Study||35
5189962|NCT01103141|12763728|P2|NOT COMPLETED|Overall Study||2
5189963|NCT01103141|12763729|P1|NOT COMPLETED|Overall Study||2
5189964|NCT01103141|12763728|P2|COMPLETED|Overall Study||74
5189965|NCT01103141|12763729|P1|COMPLETED|Overall Study||65
5189966|NCT01103141|12763728|P2|STARTED|Overall Study||76
5189967|NCT01103141|12763729|P1|STARTED|Overall Study||67
5189968|NCT01103063|12763737|P2|NOT COMPLETED|Overall Study||421
5189969|NCT01103063|12763738|P1|NOT COMPLETED|Overall Study||477
5189970|NCT01103063|12763737|P2|COMPLETED|Overall Study||1024
5189971|NCT01103063|12763738|P1|COMPLETED|Overall Study||969
5189972|NCT01103063|12763737|P2|STARTED|Overall Study||1445
5189973|NCT01103063|12763738|P1|STARTED|Overall Study||1446
5189974|NCT01102972|12763806|P2|NOT COMPLETED|Overall Study||14
5189975|NCT01102972|12763807|P1|NOT COMPLETED|Overall Study||29
5189976|NCT01102972|12763806|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
5189977|NCT01102972|12763807|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
5189978|NCT01102972|12763806|P2|Completed Week 24|Overall Study||88
5189979|NCT01102972|12763807|P1|Completed Week 24|Overall Study||180
5189980|NCT01102972|12763806|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
5189981|NCT01102972|12763807|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
5189982|NCT01102894|12763859|P1|NOT COMPLETED|Overall Study||0
5189983|NCT01102894|12763859|P1|COMPLETED|Overall Study||10
5189984|NCT01102894|12763859|P1|STARTED|Overall Study||10
5189985|NCT01102803|12763871|P2|NOT COMPLETED|Post to Follow-Up||3
5189986|NCT01102803|12763872|P1|NOT COMPLETED|Post to Follow-Up||1
5189987|NCT01102803|12763871|P2|COMPLETED|Post to Follow-Up||12
5189988|NCT01102803|12763872|P1|COMPLETED|Post to Follow-Up||10
5189989|NCT01102803|12763871|P2|STARTED|Post to Follow-Up||15
5189990|NCT01102803|12763872|P1|STARTED|Post to Follow-Up||11
5189991|NCT01102803|12763871|P2|NOT COMPLETED|Baseline to Post-Treatment||0
5189992|NCT01102803|12763872|P1|NOT COMPLETED|Baseline to Post-Treatment||3
5189993|NCT01102803|12763871|P2|COMPLETED|Baseline to Post-Treatment||15
5189994|NCT01102803|12763872|P1|COMPLETED|Baseline to Post-Treatment||11
5189995|NCT01102803|12763871|P2|STARTED|Baseline to Post-Treatment||15
5189996|NCT01102803|12763872|P1|STARTED|Baseline to Post-Treatment||14
5189997|NCT01102777|12763886|P2|NOT COMPLETED|Overall Study||16
5189998|NCT01102777|12763887|P1|NOT COMPLETED|Overall Study||9
5189999|NCT01102777|12763886|P2|COMPLETED|Overall Study||139
5190000|NCT01102777|12763887|P1|COMPLETED|Overall Study||75
5190001|NCT01102777|12763886|P2|STARTED|Overall Study||155
5190002|NCT01102777|12763887|P1|STARTED|Overall Study||84
5190003|NCT01102764|12763913|P2|NOT COMPLETED|Overall Study||13
5190004|NCT01102764|12763914|P1|NOT COMPLETED|Overall Study||21
5190005|NCT01102764|12763913|P2|COMPLETED|Overall Study||55
5190006|NCT01102764|12763914|P1|COMPLETED|Overall Study||43
5190007|NCT01102764|12763913|P2|STARTED|Overall Study||68
5190008|NCT01102764|12763914|P1|STARTED|Overall Study||64
5190009|NCT01102738|12763940|P1|NOT COMPLETED|Overall Study||0
5190010|NCT01102738|12763940|P1|COMPLETED|Overall Study||369
5190011|NCT01102738|12763940|P1|STARTED|Overall Study||369
5190012|NCT01102491|12763946|P2|NOT COMPLETED|Overall Study||12
5190013|NCT01102491|12763947|P1|NOT COMPLETED|Overall Study||11
5190014|NCT01102491|12763946|P2|COMPLETED|Overall Study|12 patients were excluded|59
5190015|NCT01102491|12763947|P1|COMPLETED|Overall Study|11 patient excluded|60
5190016|NCT01102491|12763946|P2|STARTED|Overall Study||71
5190017|NCT01102491|12763947|P1|STARTED|Overall Study||71
5190018|NCT01102413|12763955|P2|NOT COMPLETED|Overall Study||12
5190019|NCT01102413|12763956|P1|NOT COMPLETED|Overall Study||25
5190020|NCT01102413|12763955|P2|COMPLETED|Overall Study||106
5190021|NCT01102413|12763956|P1|COMPLETED|Overall Study||208
5190022|NCT01102413|12763955|P2|STARTED|Overall Study||118
5190023|NCT01102413|12763956|P1|STARTED|Overall Study||233
5190024|NCT01102374|12763966|P2|NOT COMPLETED|Overall Study||19
5190025|NCT01102374|12763967|P1|NOT COMPLETED|Overall Study||16
5190026|NCT01102374|12763966|P2|COMPLETED|Overall Study||33
5190027|NCT01102374|12763967|P1|COMPLETED|Overall Study||39
5190028|NCT01102374|12763966|P2|STARTED|Overall Study||52
5190029|NCT01102374|12763967|P1|STARTED|Overall Study||55
5190030|NCT01102270|12764001|P2|NOT COMPLETED|Overall Study||0
5190031|NCT01102270|12764002|P1|NOT COMPLETED|Overall Study||0
5190032|NCT01102270|12764001|P2|COMPLETED|Overall Study||9
5190033|NCT01102270|12764002|P1|COMPLETED|Overall Study||8
5190034|NCT01102270|12764001|P2|STARTED|Overall Study||9
5190035|NCT01102270|12764002|P1|STARTED|Overall Study||8
5190036|NCT01102257|12764016|P2|NOT COMPLETED|Overall Study||0
5190037|NCT01102257|12764017|P1|NOT COMPLETED|Overall Study||2
5190038|NCT01102257|12764016|P2|COMPLETED|Overall Study||9
5190039|NCT01102257|12764017|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
5190040|NCT01102257|12764016|P2|STARTED|Overall Study||9
5190041|NCT01102257|12764017|P1|STARTED|Overall Study||9
5190042|NCT01102218|12764025|P2|NOT COMPLETED|Overall Study||10
5190043|NCT01102218|12764026|P1|NOT COMPLETED|Overall Study||11
5190044|NCT01102218|12764025|P2|COMPLETED|Overall Study||14
5190045|NCT01102218|12764026|P1|COMPLETED|Overall Study||13
5190046|NCT01102218|12764025|P2|STARTED|Overall Study||24
5190047|NCT01102218|12764026|P1|STARTED|Overall Study||24
5190048|NCT01102140|12764034|P2|NOT COMPLETED|Overall Study||2
5190049|NCT01102140|12764035|P1|NOT COMPLETED|Overall Study||3
5190050|NCT01102140|12764034|P2|COMPLETED|Overall Study||5
5190051|NCT01102140|12764035|P1|COMPLETED|Overall Study||10
5190052|NCT01102140|12764034|P2|STARTED|Overall Study||7
5190053|NCT01102140|12764035|P1|STARTED|Overall Study||13
5190054|NCT01101971|12764047|P1|NOT COMPLETED|Overall Study||0
5190055|NCT01101971|12764047|P1|COMPLETED|Overall Study||45
5190056|NCT01101971|12764047|P1|STARTED|Overall Study||45
5190057|NCT01101958|12764053|P2|NOT COMPLETED|Overall Study||5
5190058|NCT01101958|12764054|P1|NOT COMPLETED|Overall Study||11
5190059|NCT01101958|12764053|P2|COMPLETED|Overall Study||29
5190060|NCT01101958|12764054|P1|COMPLETED|Overall Study||51
5190061|NCT01101958|12764053|P2|STARTED|Overall Study||34
5190062|NCT01101958|12764054|P1|STARTED|Overall Study||62
5190063|NCT01101880|12764060|P1|NOT COMPLETED|Overall Study||0
5190064|NCT01101880|12764060|P1|COMPLETED|Overall Study||50
5190065|NCT01101880|12764060|P1|STARTED|Overall Study||50
5190066|NCT01101867|12764071|P2|NOT COMPLETED|Overall Study||4
5190067|NCT01101867|12764072|P1|NOT COMPLETED|Overall Study||1
5190068|NCT01101867|12764071|P2|COMPLETED|Overall Study||59
5190069|NCT01101867|12764072|P1|COMPLETED|Overall Study||62
5190070|NCT01101867|12764071|P2|STARTED|Overall Study||63
5190071|NCT01101867|12764072|P1|STARTED|Overall Study||63
5190072|NCT01101841|12764090|P2|NOT COMPLETED|Overall Study||67
5190073|NCT01101841|12764091|P1|NOT COMPLETED|Overall Study||50
5190074|NCT01101841|12764090|P2|COMPLETED|Overall Study||218
5190075|NCT01101841|12764091|P1|COMPLETED|Overall Study||235
5190076|NCT01101841|12764090|P2|STARTED|Overall Study||285
5190077|NCT01101841|12764091|P1|STARTED|Overall Study||285
5190078|NCT01101542|12764129|P1|NOT COMPLETED|Year 6 Surveillance Period||991
5190079|NCT01101542|12764129|P1|COMPLETED|Year 6 Surveillance Period||2100
5190080|NCT01101542|12764129|P1|STARTED|Year 6 Surveillance Period||3091
5190081|NCT01101542|12764129|P1|NOT COMPLETED|Year 5 Surveillance Period||141
5190082|NCT01101542|12764129|P1|COMPLETED|Year 5 Surveillance Period||668
5190083|NCT01101542|12764129|P1|STARTED|Year 5 Surveillance Period||809
5190084|NCT01101542|12764129|P1|NOT COMPLETED|Year 4 Surveillance Period||287
5190085|NCT01101542|12764129|P1|COMPLETED|Year 4 Surveillance Period||282
5190086|NCT01101542|12764129|P1|STARTED|Year 4 Surveillance Period||569
5190087|NCT01101542|12764129|P1|NOT COMPLETED|Year 3 Surveillance Period||11
5190088|NCT01101542|12764129|P1|COMPLETED|Year 3 Surveillance Period||94
5190089|NCT01101542|12764129|P1|STARTED|Year 3 Surveillance Period||105
5190090|NCT01101477|12764145|P3|NOT COMPLETED|Overall Study||1
5190091|NCT01101477|12764146|P2|NOT COMPLETED|Overall Study||3
5190092|NCT01101477|12764147|P1|NOT COMPLETED|Overall Study||5
5190093|NCT01101477|12764145|P3|COMPLETED|Overall Study||45
5190094|NCT01101477|12764146|P2|COMPLETED|Overall Study||46
5190095|NCT01101477|12764147|P1|COMPLETED|Overall Study||44
5190096|NCT01101477|12764145|P3|STARTED|Overall Study||46
5190097|NCT01101477|12764146|P2|STARTED|Overall Study||49
5190098|NCT01101477|12764147|P1|STARTED|Overall Study||49
5190099|NCT01101464|12764157|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
5190100|NCT01101464|12764158|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
5190101|NCT01101464|12764157|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
5190102|NCT01101464|12764158|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
5190103|NCT01101464|12764157|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
5190104|NCT01101464|12764158|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
5190105|NCT01101464|12764157|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
5190106|NCT01101464|12764158|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
5190107|NCT01101464|12764157|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
5190108|NCT01101464|12764158|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
5190109|NCT01101464|12764157|P2|STARTED|Day 1 Through AM Dose of Day 5||4
5190110|NCT01101464|12764158|P1|STARTED|Day 1 Through AM Dose of Day 5||4
5190111|NCT01101334|12764170|P2|NOT COMPLETED|Overall Study||45
5190112|NCT01101334|12764171|P1|NOT COMPLETED|Overall Study||45
5190113|NCT01101334|12764170|P2|COMPLETED|Overall Study||0
5190114|NCT01101334|12764171|P1|COMPLETED|Overall Study||0
5190115|NCT01101334|12764170|P2|Received Study Treatment|Overall Study||45
5190116|NCT01101334|12764171|P1|Received Study Treatment|Overall Study||44
5190117|NCT01101334|12764170|P2|STARTED|Overall Study||45
5190118|NCT01101334|12764171|P1|STARTED|Overall Study||45
5190119|NCT01101321|12764183|P2|NOT COMPLETED|Period 2||0
5190120|NCT01101321|12764184|P1|NOT COMPLETED|Period 2||0
5190121|NCT01101321|12764183|P2|COMPLETED|Period 2||24
5190122|NCT01101321|12764184|P1|COMPLETED|Period 2||26
5190123|NCT01101321|12764183|P2|STARTED|Period 2||24
5190124|NCT01101321|12764184|P1|STARTED|Period 2||26
5190125|NCT01101321|12764183|P2|NOT COMPLETED|Period 1||4
5190126|NCT01101321|12764184|P1|NOT COMPLETED|Period 1||4
5190127|NCT01101321|12764183|P2|COMPLETED|Period 1||24
5190128|NCT01101321|12764184|P1|COMPLETED|Period 1||26
5190129|NCT01101321|12764183|P2|STARTED|Period 1||28
5190130|NCT01101321|12764184|P1|STARTED|Period 1||30
5190131|NCT01101308|12764194|P2|NOT COMPLETED|Period 2||0
5190132|NCT01101308|12764195|P1|NOT COMPLETED|Period 2||0
5190133|NCT01101308|12764194|P2|COMPLETED|Period 2||27
5190134|NCT01101308|12764195|P1|COMPLETED|Period 2||24
5190135|NCT01101308|12764194|P2|STARTED|Period 2||27
5190136|NCT01101308|12764195|P1|STARTED|Period 2||24
5190137|NCT01101308|12764194|P2|NOT COMPLETED|Period 1||1
5190138|NCT01101308|12764195|P1|NOT COMPLETED|Period 1||3
5190139|NCT01101308|12764194|P2|COMPLETED|Period 1||27
5190140|NCT01101308|12764195|P1|COMPLETED|Period 1||24
5190141|NCT01101308|12764194|P2|STARTED|Period 1||28
5190142|NCT01101308|12764195|P1|STARTED|Period 1||27
5190143|NCT01101191|12764206|P2|NOT COMPLETED|Period 2||0
5190144|NCT01101191|12764207|P1|NOT COMPLETED|Period 2||0
5190145|NCT01101191|12764206|P2|COMPLETED|Period 2||40
5190146|NCT01101191|12764207|P1|COMPLETED|Period 2||40
5190147|NCT01101191|12764206|P2|STARTED|Period 2||40
5190148|NCT01101191|12764207|P1|STARTED|Period 2||40
5190149|NCT01101191|12764206|P2|NOT COMPLETED|Period 1||2
5190150|NCT01101191|12764207|P1|NOT COMPLETED|Period 1||2
5190151|NCT01101191|12764206|P2|COMPLETED|Period 1||40
5190152|NCT01101191|12764207|P1|COMPLETED|Period 1||40
5190153|NCT01101191|12764206|P2|STARTED|Period 1||42
5190154|NCT01101191|12764207|P1|STARTED|Period 1||42
5190155|NCT01101178|12764218|P2|NOT COMPLETED|Period 2||1
5190156|NCT01101178|12764219|P1|NOT COMPLETED|Period 2||0
5190157|NCT01101178|12764218|P2|COMPLETED|Period 2||34
5190158|NCT01101178|12764219|P1|COMPLETED|Period 2||36
5190159|NCT01101178|12764218|P2|STARTED|Period 2||35
5190160|NCT01101178|12764219|P1|STARTED|Period 2||36
5190161|NCT01101178|12764218|P2|NOT COMPLETED|Period 1||4
5190162|NCT01101178|12764219|P1|NOT COMPLETED|Period 1||4
5190163|NCT01101178|12764218|P2|COMPLETED|Period 1||35
5190164|NCT01101178|12764219|P1|COMPLETED|Period 1||36
5190165|NCT01101178|12764218|P2|STARTED|Period 1||39
5190166|NCT01101178|12764219|P1|STARTED|Period 1||40
5190167|NCT01101165|12764230|P2|NOT COMPLETED|Period 2||1
5190168|NCT01101165|12764231|P1|NOT COMPLETED|Period 2||4
5190169|NCT01101165|12764230|P2|COMPLETED|Period 2||39
5190170|NCT01101165|12764231|P1|COMPLETED|Period 2||41
5190171|NCT01101165|12764230|P2|STARTED|Period 2||40
5190172|NCT01101165|12764231|P1|STARTED|Period 2||45
5190173|NCT01101165|12764230|P2|NOT COMPLETED|Period 1||5
5190174|NCT01101165|12764231|P1|NOT COMPLETED|Period 1||2
5190175|NCT01101165|12764230|P2|COMPLETED|Period 1||40
5190176|NCT01101165|12764231|P1|COMPLETED|Period 1||45
5190177|NCT01101165|12764230|P2|STARTED|Period 1||45
5190178|NCT01101165|12764231|P1|STARTED|Period 1||47
5190179|NCT01101100|12764241|P1|NOT COMPLETED|Overall Study||55
5190180|NCT01101100|12764241|P1|COMPLETED|Overall Study||126
5190181|NCT01101100|12764241|P1|STARTED|Overall Study||181
5190182|NCT01101061|12764252|P6|NOT COMPLETED|Overall Study||0
5190183|NCT01101061|12764253|P5|NOT COMPLETED|Overall Study||0
5190184|NCT01101061|12764254|P4|NOT COMPLETED|Overall Study||0
5190185|NCT01101061|12764255|P3|NOT COMPLETED|Overall Study||1
5190186|NCT01101061|12764256|P2|NOT COMPLETED|Overall Study||0
5190187|NCT01101061|12764257|P1|NOT COMPLETED|Overall Study||0
5190188|NCT01101061|12764252|P6|COMPLETED|Overall Study||4
5190189|NCT01101061|12764253|P5|COMPLETED|Overall Study||2
5190190|NCT01101061|12764254|P4|COMPLETED|Overall Study||6
5190191|NCT01101061|12764255|P3|COMPLETED|Overall Study||6
5190192|NCT01101061|12764256|P2|COMPLETED|Overall Study||6
5190193|NCT01101061|12764257|P1|COMPLETED|Overall Study||6
5190194|NCT01101061|12764252|P6|Received Study Drug|Overall Study||4
5190195|NCT01101061|12764253|P5|Received Study Drug|Overall Study||2
5190196|NCT01101061|12764254|P4|Received Study Drug|Overall Study||6
5190197|NCT01101061|12764255|P3|Received Study Drug|Overall Study||6
5190198|NCT01101061|12764256|P2|Received Study Drug|Overall Study||6
5190199|NCT01101061|12764257|P1|Received Study Drug|Overall Study||6
5190200|NCT01101061|12764252|P6|STARTED|Overall Study||4
5190201|NCT01101061|12764253|P5|STARTED|Overall Study||2
5190202|NCT01101061|12764254|P4|STARTED|Overall Study||6
5190203|NCT01101061|12764255|P3|STARTED|Overall Study||7
5190204|NCT01101061|12764256|P2|STARTED|Overall Study||6
5190205|NCT01101061|12764257|P1|STARTED|Overall Study||6
5190206|NCT01101035|12764337|P2|NOT COMPLETED|Overall Study||1391
5190207|NCT01101035|12764338|P1|NOT COMPLETED|Overall Study||1397
5190208|NCT01101035|12764337|P2|COMPLETED|Overall Study||1706
5190209|NCT01101035|12764338|P1|COMPLETED|Overall Study||1704
5190210|NCT01101035|12764337|P2|STARTED|Overall Study||3097
5190211|NCT01101035|12764338|P1|STARTED|Overall Study||3101
5190212|NCT01101022|12764358|P2|NOT COMPLETED|Overall Study||27
5190213|NCT01101022|12764359|P1|NOT COMPLETED|Overall Study||17
5190214|NCT01101022|12764358|P2|COMPLETED|Overall Study||53
5190215|NCT01101022|12764359|P1|COMPLETED|Overall Study||62
5190216|NCT01101022|12764358|P2|STARTED|Overall Study||80
5190217|NCT01101022|12764359|P1|STARTED|Overall Study||79
5190218|NCT01100944|12764393|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
5190219|NCT01100944|12764394|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
5190220|NCT01100944|12764395|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
5190221|NCT01100944|12764393|P3|COMPLETED|Expansion Phase - Phase 2||18
5190222|NCT01100944|12764394|P2|COMPLETED|Expansion Phase - Phase 2||0
5190223|NCT01100944|12764395|P1|COMPLETED|Expansion Phase - Phase 2||0
5190224|NCT01100944|12764393|P3|STARTED|Expansion Phase - Phase 2||18
5190225|NCT01100944|12764394|P2|STARTED|Expansion Phase - Phase 2||0
5190226|NCT01100944|12764395|P1|STARTED|Expansion Phase - Phase 2||0
5190227|NCT01100944|12764393|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
5190228|NCT01100944|12764394|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
5190229|NCT01100944|12764395|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
5190230|NCT01100944|12764393|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
5190231|NCT01100944|12764394|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
5190232|NCT01100944|12764395|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
5190233|NCT01100944|12764393|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
5190234|NCT01100944|12764394|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
5190235|NCT01100944|12764395|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
5190236|NCT01100944|12764393|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
5190237|NCT01100944|12764394|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
5190238|NCT01100944|12764395|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
5190239|NCT01100944|12764393|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
5190240|NCT01100944|12764394|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
5190241|NCT01100944|12764395|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
5190242|NCT01100944|12764393|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
5190243|NCT01100944|12764394|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
5190244|NCT01100944|12764395|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
5190245|NCT01100931|12764442|P2|NOT COMPLETED|Phase II||0
5190246|NCT01100931|12764443|P1|NOT COMPLETED|Phase II||0
5190247|NCT01100931|12764442|P2|COMPLETED|Phase II||19
5190248|NCT01100931|12764443|P1|COMPLETED|Phase II||0
5190249|NCT01100931|12764442|P2|STARTED|Phase II||19
5190250|NCT01100931|12764443|P1|STARTED|Phase II||0
5190251|NCT01100931|12764442|P2|NOT COMPLETED|Phase I||0
5190252|NCT01100931|12764443|P1|NOT COMPLETED|Phase I||0
5190253|NCT01100931|12764442|P2|COMPLETED|Phase I||0
5190254|NCT01100931|12764443|P1|COMPLETED|Phase I||22
5190255|NCT01100931|12764442|P2|STARTED|Phase I||0
5190256|NCT01100931|12764443|P1|STARTED|Phase I||22
5190257|NCT01100853|12764453|P2|NOT COMPLETED|Overall Study||23
5190258|NCT01100853|12764454|P1|NOT COMPLETED|Overall Study||27
5190259|NCT01100853|12764453|P2|COMPLETED|Overall Study||26
5190260|NCT01100853|12764454|P1|COMPLETED|Overall Study||24
5190261|NCT01100853|12764453|P2|STARTED|Overall Study||49
5190262|NCT01100853|12764454|P1|STARTED|Overall Study||51
5190263|NCT01100762|12764470|P1|NOT COMPLETED|Overall Study||0
5190264|NCT01100762|12764470|P1|COMPLETED|Overall Study||10
5190265|NCT01100762|12764470|P1|STARTED|Overall Study||10
5190266|NCT01100723|12764491|P1|NOT COMPLETED|Overall Study||14
5190267|NCT01100723|12764491|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
5190268|NCT01100723|12764491|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
5190269|NCT01100723|12764491|P1|STARTED|Overall Study||92
5190270|NCT01100658|12764500|P1|NOT COMPLETED|Overall Study||1
5190271|NCT01100658|12764500|P1|COMPLETED|Overall Study||0
5190272|NCT01100658|12764500|P1|STARTED|Overall Study||1
5190273|NCT01100606|12764505|P2|NOT COMPLETED|Second Treatment Period||0
5190274|NCT01100606|12764506|P1|NOT COMPLETED|Second Treatment Period||0
5190275|NCT01100606|12764505|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
5190276|NCT01100606|12764506|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
5190277|NCT01100606|12764505|P2|STARTED|Second Treatment Period||7
5190278|NCT01100606|12764506|P1|STARTED|Second Treatment Period||8
5190279|NCT01100606|12764505|P2|NOT COMPLETED|First Treatment Period||0
5190280|NCT01100606|12764506|P1|NOT COMPLETED|First Treatment Period||0
5190281|NCT01100606|12764505|P2|COMPLETED|First Treatment Period||7
5190282|NCT01100606|12764506|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
5190283|NCT01100606|12764505|P2|STARTED|First Treatment Period||7
5190284|NCT01100606|12764506|P1|STARTED|First Treatment Period||8
5190285|NCT01100567|12764532|P2|NOT COMPLETED|Overall Study||16
5190286|NCT01100567|12764533|P1|NOT COMPLETED|Overall Study||12
5190287|NCT01100567|12764532|P2|COMPLETED|Overall Study||35
5190288|NCT01100567|12764533|P1|COMPLETED|Overall Study||38
5190289|NCT01100567|12764532|P2|STARTED|Overall Study||51
5190290|NCT01100567|12764533|P1|STARTED|Overall Study||50
5190291|NCT01100528|12764541|P1|NOT COMPLETED|Overall Study||3
5190292|NCT01100528|12764541|P1|COMPLETED|Overall Study||35
5190293|NCT01100528|12764541|P1|STARTED|Overall Study||38
5190294|NCT01100502|12764549|P2|NOT COMPLETED|Long-Term Follow-up||139
5190295|NCT01100502|12764550|P1|NOT COMPLETED|Long-Term Follow-up||137
5190296|NCT01100502|12764549|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
5190297|NCT01100502|12764550|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
5190298|NCT01100502|12764549|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
5190299|NCT01100502|12764550|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
5190300|NCT01100502|12764549|P2|NOT COMPLETED|Treatment Period||83
5190301|NCT01100502|12764550|P1|NOT COMPLETED|Treatment Period||87
5190302|NCT01100502|12764549|P2|COMPLETED|Treatment Period||81
5190303|NCT01100502|12764550|P1|COMPLETED|Treatment Period||78
5190304|NCT01100502|12764549|P2|STARTED|Treatment Period||164
5190305|NCT01100502|12764550|P1|STARTED|Treatment Period||165
5190306|NCT01100437|12764560|P3|NOT COMPLETED|Treatment 2||0
5190307|NCT01100437|12764561|P2|NOT COMPLETED|Treatment 2||0
5190308|NCT01100437|12764562|P1|NOT COMPLETED|Treatment 2||0
5190309|NCT01100437|12764560|P3|COMPLETED|Treatment 2||0
5190310|NCT01100437|12764561|P2|COMPLETED|Treatment 2||2
5190311|NCT01100437|12764562|P1|COMPLETED|Treatment 2||4
5190312|NCT01100437|12764560|P3|STARTED|Treatment 2||0
5190313|NCT01100437|12764561|P2|STARTED|Treatment 2||2
5190314|NCT01100437|12764562|P1|STARTED|Treatment 2||4
5190315|NCT01100437|12764560|P3|NOT COMPLETED|Washout (4 Days)||0
5190316|NCT01100437|12764561|P2|NOT COMPLETED|Washout (4 Days)||0
5190317|NCT01100437|12764562|P1|NOT COMPLETED|Washout (4 Days)||0
5190318|NCT01100437|12764560|P3|COMPLETED|Washout (4 Days)||0
5190319|NCT01100437|12764561|P2|COMPLETED|Washout (4 Days)||2
5190320|NCT01100437|12764562|P1|COMPLETED|Washout (4 Days)||4
5190321|NCT01100437|12764560|P3|STARTED|Washout (4 Days)||0
5190322|NCT01100437|12764561|P2|STARTED|Washout (4 Days)||2
5190323|NCT01100437|12764562|P1|STARTED|Washout (4 Days)||4
5190324|NCT01100437|12764560|P3|NOT COMPLETED|Treatment 1||0
5190325|NCT01100437|12764561|P2|NOT COMPLETED|Treatment 1||0
5190326|NCT01100437|12764562|P1|NOT COMPLETED|Treatment 1||0
5190327|NCT01100437|12764560|P3|COMPLETED|Treatment 1||0
5190328|NCT01100437|12764561|P2|COMPLETED|Treatment 1||2
5190329|NCT01100437|12764562|P1|COMPLETED|Treatment 1||4
5190330|NCT01100437|12764560|P3|STARTED|Treatment 1||0
5190331|NCT01100437|12764561|P2|STARTED|Treatment 1||2
5190332|NCT01100437|12764562|P1|STARTED|Treatment 1||4
5190333|NCT01100437|12764560|P3|NOT COMPLETED|Maintenance||2
5190334|NCT01100437|12764561|P2|NOT COMPLETED|Maintenance||0
5190335|NCT01100437|12764562|P1|NOT COMPLETED|Maintenance||0
5190336|NCT01100437|12764560|P3|COMPLETED|Maintenance||0
5190337|NCT01100437|12764561|P2|COMPLETED|Maintenance||2
5190338|NCT01100437|12764562|P1|COMPLETED|Maintenance||4
5190339|NCT01100437|12764560|P3|STARTED|Maintenance||2
5190340|NCT01100437|12764561|P2|STARTED|Maintenance||2
5190341|NCT01100437|12764562|P1|STARTED|Maintenance||4
5190342|NCT01100437|12764560|P3|NOT COMPLETED|Titration/Stabilization||6
5190343|NCT01100437|12764561|P2|NOT COMPLETED|Titration/Stabilization||0
5190344|NCT01100437|12764562|P1|NOT COMPLETED|Titration/Stabilization||0
5190345|NCT01100437|12764560|P3|COMPLETED|Titration/Stabilization||2
5190346|NCT01100437|12764561|P2|COMPLETED|Titration/Stabilization||2
5190347|NCT01100437|12764562|P1|COMPLETED|Titration/Stabilization||4
5190348|NCT01100437|12764560|P3|STARTED|Titration/Stabilization||8
5190349|NCT01100437|12764561|P2|STARTED|Titration/Stabilization||2
5190350|NCT01100437|12764562|P1|STARTED|Titration/Stabilization||4
5190351|NCT01100437|12764560|P3|NOT COMPLETED|Screening||0
5190352|NCT01100437|12764561|P2|NOT COMPLETED|Screening||0
5190353|NCT01100437|12764562|P1|NOT COMPLETED|Screening||0
5190354|NCT01100437|12764560|P3|COMPLETED|Screening||8
5190355|NCT01100437|12764561|P2|COMPLETED|Screening||2
5190356|NCT01100437|12764562|P1|COMPLETED|Screening||4
5190357|NCT01100437|12764560|P3|STARTED|Screening||8
5190358|NCT01100437|12764561|P2|STARTED|Screening||2
5190359|NCT01100437|12764562|P1|STARTED|Screening||4
5190360|NCT01100320|12764599|P2|NOT COMPLETED|Period 2||1
5190361|NCT01100320|12764600|P1|NOT COMPLETED|Period 2||1
5190362|NCT01100320|12764599|P2|COMPLETED|Period 2||37
5190363|NCT01100320|12764600|P1|COMPLETED|Period 2||37
5190364|NCT01100320|12764599|P2|STARTED|Period 2||38
5190365|NCT01100320|12764600|P1|STARTED|Period 2||38
5190366|NCT01100320|12764599|P2|NOT COMPLETED|Period 1||7
5190367|NCT01100320|12764600|P1|NOT COMPLETED|Period 1||5
5190368|NCT01100320|12764599|P2|COMPLETED|Period 1||38
5190369|NCT01100320|12764600|P1|COMPLETED|Period 1||38
5190370|NCT01100320|12764599|P2|STARTED|Period 1||45
5190371|NCT01100320|12764600|P1|STARTED|Period 1||43
5190372|NCT01100307|12764612|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
5190373|NCT01100307|12764613|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
5190374|NCT01100307|12764612|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
5190375|NCT01100307|12764613|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
5190376|NCT01100307|12764612|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
5190377|NCT01100307|12764613|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
5190378|NCT01100307|12764612|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
5190379|NCT01100307|12764613|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
5190380|NCT01100307|12764612|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
5190381|NCT01100307|12764613|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
5190382|NCT01100307|12764612|P2|STARTED|Double Masked Phase (Up to Week 24)||120
5190383|NCT01100307|12764613|P1|STARTED|Double Masked Phase (Up to Week 24)||123
5190384|NCT01100268|12764655|P1|NOT COMPLETED|Overall Study||0
5190385|NCT01100268|12764655|P1|COMPLETED|Overall Study||4
5190386|NCT01100268|12764655|P1|STARTED|Overall Study||4
5190387|NCT01100255|12764662|P2|NOT COMPLETED|Overall Study||0
5190388|NCT01100255|12764663|P1|NOT COMPLETED|Overall Study||0
5190389|NCT01100255|12764662|P2|COMPLETED|Overall Study||7
5190390|NCT01100255|12764663|P1|COMPLETED|Overall Study||8
5190391|NCT01100255|12764662|P2|STARTED|Overall Study||7
5190392|NCT01100255|12764663|P1|STARTED|Overall Study||8
5190393|NCT01100242|12764669|P1|NOT COMPLETED|Overall Study||0
5190394|NCT01100242|12764669|P1|COMPLETED|Overall Study||17
5190395|NCT01100242|12764669|P1|STARTED|Overall Study||17
5190396|NCT01100112|12764675|P1|NOT COMPLETED|Overall Study||8
5190397|NCT01100112|12764675|P1|COMPLETED|Overall Study||52
5190398|NCT01100112|12764675|P1|STARTED|Overall Study||60
5190399|NCT01100086|12764682|P2|NOT COMPLETED|Period 2||0
5190400|NCT01100086|12764683|P1|NOT COMPLETED|Period 2||0
5190401|NCT01100086|12764682|P2|COMPLETED|Period 2||41
5190402|NCT01100086|12764683|P1|COMPLETED|Period 2||42
5190403|NCT01100086|12764682|P2|STARTED|Period 2||41
5190404|NCT01100086|12764683|P1|STARTED|Period 2||42
5190405|NCT01100086|12764682|P2|NOT COMPLETED|Period 1||0
5190406|NCT01100086|12764683|P1|NOT COMPLETED|Period 1||1
5190407|NCT01100086|12764682|P2|COMPLETED|Period 1||41
5190408|NCT01100086|12764683|P1|COMPLETED|Period 1||42
5190409|NCT01100086|12764682|P2|STARTED|Period 1||41
5190410|NCT01100086|12764683|P1|STARTED|Period 1||43
5190411|NCT01100073|12764693|P1|NOT COMPLETED|Overall Study||100
5190412|NCT01100073|12764693|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
5190413|NCT01100073|12764693|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
5190414|NCT01100034|12764708|P1|NOT COMPLETED|Overall Study||43
5190415|NCT01100034|12764708|P1|COMPLETED|Overall Study||29
5190416|NCT01100034|12764708|P1|STARTED|Overall Study||72
5190417|NCT01099969|12764721|P4|NOT COMPLETED|Overall Study||0
5190418|NCT01099969|12764722|P3|NOT COMPLETED|Overall Study||0
5190419|NCT01099969|12764723|P2|NOT COMPLETED|Overall Study||0
5190420|NCT01099969|12764724|P1|NOT COMPLETED|Overall Study||0
5190421|NCT01099969|12764721|P4|COMPLETED|Overall Study||15
5190422|NCT01099969|12764722|P3|COMPLETED|Overall Study||15
5190423|NCT01099969|12764723|P2|COMPLETED|Overall Study||15
5190424|NCT01099969|12764724|P1|COMPLETED|Overall Study||15
5190425|NCT01099969|12764721|P4|STARTED|Overall Study||15
5190426|NCT01099969|12764722|P3|STARTED|Overall Study||15
5190427|NCT01099969|12764723|P2|STARTED|Overall Study||15
5190428|NCT01099969|12764724|P1|STARTED|Overall Study||15
5190429|NCT01099917|12764746|P1|NOT COMPLETED|Overall Study||27
5190430|NCT01099917|12764746|P1|COMPLETED|Overall Study||18
5190431|NCT01099917|12764746|P1|STARTED|Overall Study||45
5190432|NCT01099774|12764752|P2|NOT COMPLETED|Overall Study||6
5190433|NCT01099774|12764753|P1|NOT COMPLETED|Overall Study||6
5190434|NCT01099774|12764752|P2|COMPLETED|Overall Study||289
5190435|NCT01099774|12764753|P1|COMPLETED|Overall Study||296
5190436|NCT01099774|12764752|P2|STARTED|Overall Study||295
5190437|NCT01099774|12764753|P1|STARTED|Overall Study||302
5190438|NCT01099761|12764769|P4|NOT COMPLETED|Overall Study||0
5190439|NCT01099761|12764770|P3|NOT COMPLETED|Overall Study||0
5190440|NCT01099761|12764771|P2|NOT COMPLETED|Overall Study||0
5190441|NCT01099761|12764772|P1|NOT COMPLETED|Overall Study||0
5190442|NCT01099761|12764769|P4|COMPLETED|Overall Study||6
5190443|NCT01099761|12764770|P3|COMPLETED|Overall Study||0
5190444|NCT01099761|12764771|P2|COMPLETED|Overall Study||9
5190445|NCT01099761|12764772|P1|COMPLETED|Overall Study||9
5190446|NCT01099761|12764769|P4|STARTED|Overall Study||6
5190447|NCT01099761|12764770|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
5190448|NCT01099761|12764771|P2|STARTED|Overall Study||9
5190449|NCT01099761|12764772|P1|STARTED|Overall Study||9
5190450|NCT01099709|12764808|P2|NOT COMPLETED|Period 2||0
5190451|NCT01099709|12764809|P1|NOT COMPLETED|Period 2||0
5190452|NCT01099709|12764808|P2|COMPLETED|Period 2||41
5190453|NCT01099709|12764809|P1|COMPLETED|Period 2||41
5190454|NCT01099709|12764808|P2|STARTED|Period 2||41
5190455|NCT01099709|12764809|P1|STARTED|Period 2||41
5190456|NCT01099709|12764808|P2|NOT COMPLETED|Period 1||2
5190457|NCT01099709|12764809|P1|NOT COMPLETED|Period 1||1
5190458|NCT01099709|12764808|P2|COMPLETED|Period 1||41
5190459|NCT01099709|12764809|P1|COMPLETED|Period 1||41
5190460|NCT01099709|12764808|P2|STARTED|Period 1||43
5190461|NCT01099709|12764809|P1|STARTED|Period 1||42
5190462|NCT01099631|12764825|P6|NOT COMPLETED|Overall Study||0
5190463|NCT01099631|12764826|P5|NOT COMPLETED|Overall Study||0
5190464|NCT01099631|12764827|P4|NOT COMPLETED|Overall Study||0
5190465|NCT01099631|12764828|P3|NOT COMPLETED|Overall Study||0
5190466|NCT01099631|12764829|P2|NOT COMPLETED|Overall Study||0
5190467|NCT01099631|12764830|P1|NOT COMPLETED|Overall Study||0
5190468|NCT01099631|12764825|P6|COMPLETED|Overall Study||4
5190469|NCT01099631|12764826|P5|COMPLETED|Overall Study||3
5190470|NCT01099631|12764827|P4|COMPLETED|Overall Study||3
5190471|NCT01099631|12764828|P3|COMPLETED|Overall Study||3
5190472|NCT01099631|12764829|P2|COMPLETED|Overall Study||3
5190473|NCT01099631|12764830|P1|COMPLETED|Overall Study||6
5190474|NCT01099631|12764825|P6|STARTED|Overall Study||4
5190475|NCT01099631|12764826|P5|STARTED|Overall Study||3
5190476|NCT01099631|12764827|P4|STARTED|Overall Study||3
5190477|NCT01099631|12764828|P3|STARTED|Overall Study||3
5190478|NCT01099631|12764829|P2|STARTED|Overall Study||3
5190479|NCT01099631|12764830|P1|STARTED|Overall Study||6
5190480|NCT01099618|12764865|P3|NOT COMPLETED|Overall Study||0
5190481|NCT01099618|12764866|P2|NOT COMPLETED|Overall Study||0
5190482|NCT01099618|12764867|P1|NOT COMPLETED|Overall Study||0
5190483|NCT01099618|12764865|P3|COMPLETED|Overall Study||15
5190484|NCT01099618|12764866|P2|COMPLETED|Overall Study||16
5190485|NCT01099618|12764867|P1|COMPLETED|Overall Study||17
5190486|NCT01099618|12764865|P3|STARTED|Overall Study||15
5190487|NCT01099618|12764866|P2|STARTED|Overall Study||16
5190488|NCT01099618|12764867|P1|STARTED|Overall Study||17
5190489|NCT01099579|12764878|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
5190490|NCT01099579|12764879|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
5190491|NCT01099579|12764880|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
5190492|NCT01099579|12764878|P3|COMPLETED|Stage 2 (ATV Capsule)||9
5190493|NCT01099579|12764879|P2|COMPLETED|Stage 2 (ATV Capsule)||9
5190494|NCT01099579|12764880|P1|COMPLETED|Stage 2 (ATV Capsule)||10
5190495|NCT01099579|12764878|P3|STARTED|Stage 2 (ATV Capsule)||15
5190496|NCT01099579|12764879|P2|STARTED|Stage 2 (ATV Capsule)||14
5190497|NCT01099579|12764880|P1|STARTED|Stage 2 (ATV Capsule)||16
5190498|NCT01099579|12764878|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
5190499|NCT01099579|12764879|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
5190500|NCT01099579|12764880|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
5190501|NCT01099579|12764878|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
5190502|NCT01099579|12764879|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
5190503|NCT01099579|12764880|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
5190504|NCT01099579|12764878|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
5190505|NCT01099579|12764879|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
5190506|NCT01099579|12764880|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
5190507|NCT01099475|12764936|P2|NOT COMPLETED|Overall Study||0
5190508|NCT01099475|12764937|P1|NOT COMPLETED|Overall Study||0
5190509|NCT01099475|12764936|P2|COMPLETED|Overall Study||10
5190510|NCT01099475|12764937|P1|COMPLETED|Overall Study||10
5190511|NCT01099475|12764936|P2|STARTED|Overall Study||10
5190512|NCT01099475|12764937|P1|STARTED|Overall Study||10
5190513|NCT01099449|12764952|P3|NOT COMPLETED|Overall Study||0
5190514|NCT01099449|12764953|P2|NOT COMPLETED|Overall Study||0
5190515|NCT01099449|12764954|P1|NOT COMPLETED|Overall Study||0
5190516|NCT01099449|12764952|P3|COMPLETED|Overall Study||116
5190517|NCT01099449|12764953|P2|COMPLETED|Overall Study||119
5190518|NCT01099449|12764954|P1|COMPLETED|Overall Study||118
5190519|NCT01099449|12764952|P3|STARTED|Overall Study||116
5190520|NCT01099449|12764953|P2|STARTED|Overall Study||119
5190521|NCT01099449|12764954|P1|STARTED|Overall Study||118
5190522|NCT01099397|12764989|P1|NOT COMPLETED|Overall Study||13
5190523|NCT01099397|12764989|P1|COMPLETED|Overall Study||26
5190524|NCT01099397|12764989|P1|STARTED|Overall Study||39
5190525|NCT01099358|12764994|P4|NOT COMPLETED|Overall Study||4
5190526|NCT01099358|12764995|P3|NOT COMPLETED|Overall Study||8
5190527|NCT01099358|12764996|P2|NOT COMPLETED|Overall Study||1
5190528|NCT01099358|12764997|P1|NOT COMPLETED|Overall Study||3
5190529|NCT01099358|12764994|P4|COMPLETED|Overall Study||12
5190530|NCT01099358|12764995|P3|COMPLETED|Overall Study||13
5190531|NCT01099358|12764996|P2|COMPLETED|Overall Study||5
5190532|NCT01099358|12764997|P1|COMPLETED|Overall Study||1
5190533|NCT01099358|12764994|P4|Received at Least One Dose of Study Drug|Overall Study||15
5190534|NCT01099358|12764995|P3|Received at Least One Dose of Study Drug|Overall Study||20
5190535|NCT01099358|12764996|P2|Received at Least One Dose of Study Drug|Overall Study||6
5190536|NCT01099358|12764997|P1|Received at Least One Dose of Study Drug|Overall Study||3
5190537|NCT01099358|12764994|P4|STARTED|Overall Study||16
5190538|NCT01099358|12764995|P3|STARTED|Overall Study||21
5190539|NCT01099358|12764996|P2|STARTED|Overall Study||6
5190540|NCT01099358|12764997|P1|STARTED|Overall Study||4
5190541|NCT01099267|12765016|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
5190542|NCT01099267|12765016|P1|COMPLETED|MDS-009 Extension Follow-up||54
5190543|NCT01099267|12765016|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
5190544|NCT01099267|12765016|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
5190545|NCT01099267|12765016|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
5190546|NCT01099267|12765016|P1|NOT COMPLETED|MDS-003 Study||124
5190547|NCT01099267|12765016|P1|COMPLETED|MDS-003 Study||24
5190548|NCT01099267|12765016|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
5190549|NCT01099215|12765026|P2|NOT COMPLETED|Overall Study||1
5190550|NCT01099215|12765027|P1|NOT COMPLETED|Overall Study||1
5190551|NCT01099215|12765026|P2|COMPLETED|Overall Study||9
5190552|NCT01099215|12765027|P1|COMPLETED|Overall Study||10
5190553|NCT01099215|12765026|P2|STARTED|Overall Study||10
5190554|NCT01099215|12765027|P1|STARTED|Overall Study||11
5190555|NCT01099202|12765065|P2|NOT COMPLETED|Overall Study||0
5190556|NCT01099202|12765066|P1|NOT COMPLETED|Overall Study||0
5190557|NCT01099202|12765065|P2|COMPLETED|Overall Study||54
5190558|NCT01099202|12765066|P1|COMPLETED|Overall Study||55
5190559|NCT01099202|12765065|P2|STARTED|Overall Study||54
5190560|NCT01099202|12765066|P1|STARTED|Overall Study||55
5190561|NCT01099111|12765079|P5|NOT COMPLETED|Overall Study||0
5190562|NCT01099111|12765080|P4|NOT COMPLETED|Overall Study||0
5190563|NCT01099111|12765081|P3|NOT COMPLETED|Overall Study||0
5190564|NCT01099111|12765082|P2|NOT COMPLETED|Overall Study||0
5190565|NCT01099111|12765083|P1|NOT COMPLETED|Overall Study||0
5190566|NCT01099111|12765079|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
5190567|NCT01099111|12765080|P4|COMPLETED|Overall Study||29
5190568|NCT01099111|12765081|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
5190569|NCT01099111|12765082|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
5190570|NCT01099111|12765083|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
5190571|NCT01099111|12765079|P5|STARTED|Overall Study||50
5190572|NCT01099111|12765080|P4|STARTED|Overall Study||29
5190573|NCT01099111|12765081|P3|STARTED|Overall Study||46
5190574|NCT01099111|12765082|P2|STARTED|Overall Study||50
5190575|NCT01099111|12765083|P1|STARTED|Overall Study||50
5190576|NCT01098851|12765097|P2|NOT COMPLETED|Overall Study||0
5190577|NCT01098851|12765098|P1|NOT COMPLETED|Overall Study||1
5190578|NCT01098851|12765097|P2|COMPLETED|Overall Study||10
5190579|NCT01098851|12765098|P1|COMPLETED|Overall Study||10
5190580|NCT01098851|12765097|P2|STARTED|Overall Study||10
5190581|NCT01098851|12765098|P1|STARTED|Overall Study||11
5190582|NCT01098812|12765109|P3|NOT COMPLETED|Overall Study||1
5190583|NCT01098812|12765110|P2|NOT COMPLETED|Overall Study||1
5190584|NCT01098812|12765111|P1|NOT COMPLETED|Overall Study||2
5190585|NCT01098812|12765109|P3|COMPLETED|Overall Study||71
5190586|NCT01098812|12765110|P2|COMPLETED|Overall Study||101
5190587|NCT01098812|12765111|P1|COMPLETED|Overall Study||93
5190588|NCT01098812|12765109|P3|STARTED|Overall Study||72
5190589|NCT01098812|12765110|P2|STARTED|Overall Study||102
5190590|NCT01098812|12765111|P1|STARTED|Overall Study||95
5190591|NCT01098747|12765125|P4|NOT COMPLETED|Overall Study||0
5190592|NCT01098747|12765126|P3|NOT COMPLETED|Overall Study||0
5190593|NCT01098747|12765127|P2|NOT COMPLETED|Overall Study||0
5190594|NCT01098747|12765128|P1|NOT COMPLETED|Overall Study||0
5190595|NCT01098747|12765125|P4|COMPLETED|Overall Study||87
5190596|NCT01098747|12765126|P3|COMPLETED|Overall Study||86
5190597|NCT01098747|12765127|P2|COMPLETED|Overall Study||95
5190598|NCT01098747|12765128|P1|COMPLETED|Overall Study||48
5190599|NCT01098747|12765125|P4|STARTED|Overall Study||87
5190600|NCT01098747|12765126|P3|STARTED|Overall Study||86
5190601|NCT01098747|12765127|P2|STARTED|Overall Study||95
5190602|NCT01098747|12765128|P1|STARTED|Overall Study||48
5190603|NCT01098578|12765178|P1|NOT COMPLETED|Overall Study||0
5190604|NCT01098578|12765178|P1|COMPLETED|Overall Study||20
5190605|NCT01098578|12765178|P1|STARTED|Overall Study||20
5190606|NCT01098539|12765187|P2|NOT COMPLETED|Overall Study||68
5190607|NCT01098539|12765188|P1|NOT COMPLETED|Overall Study||51
5190608|NCT01098539|12765187|P2|COMPLETED|Overall Study||178
5190609|NCT01098539|12765188|P1|COMPLETED|Overall Study||198
5190610|NCT01098539|12765187|P2|STARTED|Overall Study||246
5190611|NCT01098539|12765188|P1|STARTED|Overall Study||249
5190612|NCT01098500|12765224|P1|NOT COMPLETED|Overall Study||0
5190613|NCT01098500|12765224|P1|COMPLETED|Overall Study||3800
5190614|NCT01098500|12765224|P1|STARTED|Overall Study||3800
5190615|NCT01098487|12765239|P1|NOT COMPLETED|Overall Study||44
5190616|NCT01098487|12765239|P1|COMPLETED|Overall Study||118
5190617|NCT01098487|12765239|P1|STARTED|Overall Study||162
5190618|NCT01098474|12765257|P6|NOT COMPLETED|Follow Up Phase||5
5190619|NCT01098474|12765258|P5|NOT COMPLETED|Follow Up Phase||2
5190620|NCT01098474|12765259|P4|NOT COMPLETED|Follow Up Phase||2
5190621|NCT01098474|12765260|P3|NOT COMPLETED|Follow Up Phase||0
5190622|NCT01098474|12765261|P2|NOT COMPLETED|Follow Up Phase||0
5190623|NCT01098474|12765262|P1|NOT COMPLETED|Follow Up Phase||0
5190624|NCT01098474|12765257|P6|COMPLETED|Follow Up Phase||44
5190625|NCT01098474|12765258|P5|COMPLETED|Follow Up Phase||50
5190626|NCT01098474|12765259|P4|COMPLETED|Follow Up Phase||47
5190627|NCT01098474|12765260|P3|COMPLETED|Follow Up Phase||45
5190628|NCT01098474|12765261|P2|COMPLETED|Follow Up Phase||49
5190629|NCT01098474|12765262|P1|COMPLETED|Follow Up Phase||48
5190630|NCT01098474|12765257|P6|STARTED|Follow Up Phase||49
5190631|NCT01098474|12765258|P5|STARTED|Follow Up Phase||52
5190632|NCT01098474|12765259|P4|STARTED|Follow Up Phase||49
5190633|NCT01098474|12765260|P3|STARTED|Follow Up Phase||45
5190634|NCT01098474|12765261|P2|STARTED|Follow Up Phase||49
5190635|NCT01098474|12765262|P1|STARTED|Follow Up Phase||48
5190636|NCT01098474|12765257|P6|NOT COMPLETED|Active Phase||0
5190637|NCT01098474|12765258|P5|NOT COMPLETED|Active Phase||0
5190638|NCT01098474|12765259|P4|NOT COMPLETED|Active Phase||0
5190639|NCT01098474|12765260|P3|NOT COMPLETED|Active Phase||5
5190640|NCT01098474|12765261|P2|NOT COMPLETED|Active Phase||1
5190641|NCT01098474|12765262|P1|NOT COMPLETED|Active Phase||2
5190642|NCT01098474|12765257|P6|COMPLETED|Active Phase||49
5190643|NCT01098474|12765258|P5|COMPLETED|Active Phase||52
5190644|NCT01098474|12765259|P4|COMPLETED|Active Phase||49
5190645|NCT01098474|12765260|P3|COMPLETED|Active Phase||45
5190646|NCT01098474|12765261|P2|COMPLETED|Active Phase||49
5190647|NCT01098474|12765262|P1|COMPLETED|Active Phase||48
5190648|NCT01098474|12765257|P6|STARTED|Active Phase||49
5190649|NCT01098474|12765258|P5|STARTED|Active Phase||52
5190650|NCT01098474|12765259|P4|STARTED|Active Phase||49
5190651|NCT01098474|12765260|P3|STARTED|Active Phase||50
5190652|NCT01098474|12765261|P2|STARTED|Active Phase||50
5190653|NCT01098474|12765262|P1|STARTED|Active Phase||50
5190654|NCT01098461|12765496|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
5190655|NCT01098461|12765497|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
5190656|NCT01098461|12765498|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
5190657|NCT01098461|12765499|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
5190658|NCT01098461|12765496|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
5190659|NCT01098461|12765497|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
5190660|NCT01098461|12765498|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
5190661|NCT01098461|12765499|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
5190662|NCT01098461|12765496|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
5190663|NCT01098461|12765497|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
5190664|NCT01098461|12765498|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
5190665|NCT01098461|12765499|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
5190666|NCT01098461|12765496|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
5190667|NCT01098461|12765497|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
5190668|NCT01098461|12765498|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
5190669|NCT01098461|12765499|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
5190670|NCT01098461|12765496|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
5190671|NCT01098461|12765497|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
5190672|NCT01098461|12765498|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
5190673|NCT01098461|12765499|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
5190674|NCT01098461|12765496|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
5190675|NCT01098461|12765497|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
5190676|NCT01098461|12765498|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
5190677|NCT01098461|12765499|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
5190678|NCT01098318|12765532|P3|NOT COMPLETED|Overall Study||3
5190679|NCT01098318|12765533|P2|NOT COMPLETED|Overall Study||7
5190680|NCT01098318|12765534|P1|NOT COMPLETED|Overall Study||3
5190681|NCT01098318|12765532|P3|COMPLETED|Overall Study||15
5190682|NCT01098318|12765533|P2|COMPLETED|Overall Study||12
5190683|NCT01098318|12765534|P1|COMPLETED|Overall Study||17
5190684|NCT01098318|12765532|P3|STARTED|Overall Study||18
5190685|NCT01098318|12765533|P2|STARTED|Overall Study||19
5190686|NCT01098318|12765534|P1|STARTED|Overall Study||20
5190687|NCT01098305|12765559|P2|NOT COMPLETED|Overall Study||33
5190688|NCT01098305|12765560|P1|NOT COMPLETED|Overall Study||31
5190689|NCT01098305|12765559|P2|COMPLETED|Overall Study||85
5190690|NCT01098305|12765560|P1|COMPLETED|Overall Study||88
5190691|NCT01098305|12765559|P2|STARTED|Overall Study||118
5190692|NCT01098305|12765560|P1|STARTED|Overall Study||119
5190693|NCT01098266|12765570|P2|NOT COMPLETED|Overall Study||7
5190694|NCT01098266|12765571|P1|NOT COMPLETED|Overall Study||7
5190695|NCT01098266|12765570|P2|COMPLETED|Overall Study||193
5190696|NCT01098266|12765571|P1|COMPLETED|Overall Study||193
5190697|NCT01098266|12765570|P2|STARTED|Overall Study||200
5190698|NCT01098266|12765571|P1|STARTED|Overall Study||200
5190699|NCT01098253|12765591|P2|NOT COMPLETED|Overall Study||0
5190700|NCT01098253|12765592|P1|NOT COMPLETED|Overall Study||2
5190701|NCT01098253|12765591|P2|COMPLETED|Overall Study||88
5190702|NCT01098253|12765592|P1|COMPLETED|Overall Study||92
5190703|NCT01098253|12765591|P2|STARTED|Overall Study||88
5190704|NCT01098253|12765592|P1|STARTED|Overall Study||94
5190705|NCT01098240|12765600|P3|NOT COMPLETED|Double-Blind Phase||22
5190706|NCT01098240|12765601|P2|NOT COMPLETED|Double-Blind Phase||17
5190707|NCT01098240|12765602|P1|NOT COMPLETED|Double-Blind Phase||0
5190708|NCT01098240|12765600|P3|COMPLETED|Double-Blind Phase||63
5190709|NCT01098240|12765601|P2|COMPLETED|Double-Blind Phase||60
5190710|NCT01098240|12765602|P1|COMPLETED|Double-Blind Phase||0
5190711|NCT01098240|12765600|P3|STARTED|Double-Blind Phase||85
5190712|NCT01098240|12765601|P2|STARTED|Double-Blind Phase||77
5190713|NCT01098240|12765602|P1|STARTED|Double-Blind Phase||0
5190714|NCT01098240|12765600|P3|NOT COMPLETED|Open-Label Phase||0
5190715|NCT01098240|12765601|P2|NOT COMPLETED|Open-Label Phase||0
5190716|NCT01098240|12765602|P1|NOT COMPLETED|Open-Label Phase||135
5190717|NCT01098240|12765600|P3|COMPLETED|Open-Label Phase||0
5190718|NCT01098240|12765601|P2|COMPLETED|Open-Label Phase||0
5190719|NCT01098240|12765602|P1|COMPLETED|Open-Label Phase||162
5190720|NCT01098240|12765600|P3|STARTED|Open-Label Phase||0
5190721|NCT01098240|12765601|P2|STARTED|Open-Label Phase||0
5190722|NCT01098240|12765602|P1|STARTED|Open-Label Phase||297
5190723|NCT01098162|12765632|P1|NOT COMPLETED|Overall Study||112
5190724|NCT01098162|12765632|P1|COMPLETED|Overall Study||461
5190725|NCT01098162|12765632|P1|STARTED|Overall Study||573
5190726|NCT01098110|12765644|P3|NOT COMPLETED|Overall Study||94
5190727|NCT01098110|12765645|P2|NOT COMPLETED|Overall Study||73
5190728|NCT01098110|12765646|P1|NOT COMPLETED|Overall Study||62
5190729|NCT01098110|12765644|P3|COMPLETED|Overall Study||80
5190730|NCT01098110|12765645|P2|COMPLETED|Overall Study||109
5190731|NCT01098110|12765646|P1|COMPLETED|Overall Study||114
5190732|NCT01098110|12765644|P3|Treated|Overall Study|Received at least one dose of trial medication|174
5190733|NCT01098110|12765645|P2|Treated|Overall Study|Received at least one dose of trial medication|181
5190734|NCT01098110|12765646|P1|Treated|Overall Study|Received at least one dose of trial medication|175
5190735|NCT01098110|12765644|P3|STARTED|Overall Study|Randomized participants|174
5190736|NCT01098110|12765645|P2|STARTED|Overall Study|Randomized participants|182
5190737|NCT01098110|12765646|P1|STARTED|Overall Study|Randomized participants|176
5190738|NCT01098097|12765687|P1|NOT COMPLETED|Overall Study||82
5190739|NCT01098097|12765687|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
5190740|NCT01098097|12765687|P1|STARTED|Overall Study||963
5190741|NCT01098071|12765696|P1|NOT COMPLETED|Overall Study||15
5190742|NCT01098071|12765696|P1|COMPLETED|Overall Study||19
5190743|NCT01098071|12765696|P1|STARTED|Overall Study||34
5190744|NCT01098032|12765709|P2|NOT COMPLETED|Overall Study||1
5190745|NCT01098032|12765710|P1|NOT COMPLETED|Overall Study||1
5190746|NCT01098032|12765709|P2|COMPLETED|Overall Study||146
5190747|NCT01098032|12765710|P1|COMPLETED|Overall Study||146
5190748|NCT01098032|12765709|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
5190749|NCT01098032|12765710|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
5190750|NCT01098006|12765720|P4|NOT COMPLETED|Overall Study||0
5190751|NCT01098006|12765721|P3|NOT COMPLETED|Overall Study||0
5190752|NCT01098006|12765722|P2|NOT COMPLETED|Overall Study||0
5190753|NCT01098006|12765723|P1|NOT COMPLETED|Overall Study||0
5190754|NCT01098006|12765720|P4|COMPLETED|Overall Study||21
5190755|NCT01098006|12765721|P3|COMPLETED|Overall Study||60
5190756|NCT01098006|12765722|P2|COMPLETED|Overall Study||11
5190757|NCT01098006|12765723|P1|COMPLETED|Overall Study||7
5190758|NCT01098006|12765720|P4|STARTED|Overall Study||21
5190759|NCT01098006|12765721|P3|STARTED|Overall Study||60
5190760|NCT01098006|12765722|P2|STARTED|Overall Study||11
5190761|NCT01098006|12765723|P1|STARTED|Overall Study||7
5190762|NCT01097915|12765800|P3|NOT COMPLETED|Overall Study||30
5190763|NCT01097915|12765801|P2|NOT COMPLETED|Overall Study||42
5190764|NCT01097915|12765802|P1|NOT COMPLETED|Overall Study||23
5190765|NCT01097915|12765800|P3|COMPLETED|Overall Study||20
5190766|NCT01097915|12765801|P2|COMPLETED|Overall Study||28
5190767|NCT01097915|12765802|P1|COMPLETED|Overall Study||27
5190768|NCT01097915|12765800|P3|STARTED|Overall Study||50
5190769|NCT01097915|12765801|P2|STARTED|Overall Study||70
5190770|NCT01097915|12765802|P1|STARTED|Overall Study||50
5190771|NCT01097863|12765827|P3|NOT COMPLETED|Overall Study||2
5190772|NCT01097863|12765828|P2|NOT COMPLETED|Overall Study||0
5190773|NCT01097863|12765829|P1|NOT COMPLETED|Overall Study||1
5190774|NCT01097863|12765827|P3|COMPLETED|Overall Study||89
5190775|NCT01097863|12765828|P2|COMPLETED|Overall Study||98
5190776|NCT01097863|12765829|P1|COMPLETED|Overall Study||89
5190777|NCT01097863|12765827|P3|STARTED|Overall Study||91
5190778|NCT01097863|12765828|P2|STARTED|Overall Study||98
5190779|NCT01097863|12765829|P1|STARTED|Overall Study||90
5190780|NCT01097785|12765839|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
5190781|NCT01097785|12765840|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
5190782|NCT01097785|12765839|P2|COMPLETED|Cycle 3 (30 Days)||6
5190783|NCT01097785|12765840|P1|COMPLETED|Cycle 3 (30 Days)||6
5190784|NCT01097785|12765839|P2|STARTED|Cycle 3 (30 Days)||6
5190785|NCT01097785|12765840|P1|STARTED|Cycle 3 (30 Days)||6
5190786|NCT01097785|12765839|P2|NOT COMPLETED|Washout (2 Weeks)||0
5190787|NCT01097785|12765840|P1|NOT COMPLETED|Washout (2 Weeks)||0
5190788|NCT01097785|12765839|P2|COMPLETED|Washout (2 Weeks)||6
5190789|NCT01097785|12765840|P1|COMPLETED|Washout (2 Weeks)||6
5190790|NCT01097785|12765839|P2|STARTED|Washout (2 Weeks)||6
5190791|NCT01097785|12765840|P1|STARTED|Washout (2 Weeks)||6
5190792|NCT01097785|12765839|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
5190793|NCT01097785|12765840|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
5190794|NCT01097785|12765839|P2|COMPLETED|Cycle 1 (30 Days)||6
5190795|NCT01097785|12765840|P1|COMPLETED|Cycle 1 (30 Days)||6
5190796|NCT01097785|12765839|P2|STARTED|Cycle 1 (30 Days)||6
5190797|NCT01097785|12765840|P1|STARTED|Cycle 1 (30 Days)||6
5190798|NCT01097707|12765853|P5|NOT COMPLETED|Overall Study||50
5190799|NCT01097707|12765854|P4|NOT COMPLETED|Overall Study||44
5190800|NCT01097707|12765855|P3|NOT COMPLETED|Overall Study||45
5190801|NCT01097707|12765856|P2|NOT COMPLETED|Overall Study||43
5190802|NCT01097707|12765857|P1|NOT COMPLETED|Overall Study||44
5190803|NCT01097707|12765853|P5|COMPLETED|Overall Study||35
5190804|NCT01097707|12765854|P4|COMPLETED|Overall Study||40
5190805|NCT01097707|12765855|P3|COMPLETED|Overall Study||37
5190806|NCT01097707|12765856|P2|COMPLETED|Overall Study||37
5190807|NCT01097707|12765857|P1|COMPLETED|Overall Study||39
5190808|NCT01097707|12765853|P5|STARTED|Overall Study||85
5190809|NCT01097707|12765854|P4|STARTED|Overall Study||84
5190810|NCT01097707|12765855|P3|STARTED|Overall Study||82
5190811|NCT01097707|12765856|P2|STARTED|Overall Study||80
5190812|NCT01097707|12765857|P1|STARTED|Overall Study||83
5190813|NCT01097694|12765906|P2|NOT COMPLETED|Overall Study||4
5190814|NCT01097694|12765907|P1|NOT COMPLETED|Overall Study||8
5190815|NCT01097694|12765906|P2|COMPLETED|Overall Study||26
5190816|NCT01097694|12765907|P1|COMPLETED|Overall Study||24
5190817|NCT01097694|12765906|P2|STARTED|Overall Study||30
5190818|NCT01097694|12765907|P1|STARTED|Overall Study||32
5190819|NCT01097668|12765969|P2|NOT COMPLETED|Overall Study||2
5190820|NCT01097668|12765970|P1|NOT COMPLETED|Overall Study||2
5190821|NCT01097668|12765969|P2|COMPLETED|Overall Study||20
5190822|NCT01097668|12765970|P1|COMPLETED|Overall Study||19
5190823|NCT01097668|12765969|P2|Week 48|Overall Study||20
5190824|NCT01097668|12765970|P1|Week 48|Overall Study||19
5190825|NCT01097668|12765969|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
5190826|NCT01097668|12765970|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
5190827|NCT01097668|12765969|P2|STARTED|Overall Study||22
5190828|NCT01097668|12765970|P1|STARTED|Overall Study||21
5190829|NCT01097655|12765980|P1|NOT COMPLETED|Overall Study||10
5190830|NCT01097655|12765980|P1|COMPLETED|Overall Study|participants included for analysis|3039
5190831|NCT01097655|12765980|P1|STARTED|Overall Study||3049
5190832|NCT01097629|12765990|P8|NOT COMPLETED|DB RO Phase||1
5190833|NCT01097629|12765991|P7|NOT COMPLETED|DB RO Phase||3
5190834|NCT01097629|12765992|P6|NOT COMPLETED|DB RO Phase||1
5190835|NCT01097629|12765993|P5|NOT COMPLETED|DB RO Phase||0
5190836|NCT01097629|12765994|P4|NOT COMPLETED|DB RO Phase||1
5190837|NCT01097629|12765995|P3|NOT COMPLETED|DB RO Phase||0
5190838|NCT01097629|12765996|P2|NOT COMPLETED|DB RO Phase||0
5190839|NCT01097629|12765997|P1|NOT COMPLETED|DB RO Phase||0
5190840|NCT01097629|12765990|P8|COMPLETED|DB RO Phase||326
5190841|NCT01097629|12765991|P7|COMPLETED|DB RO Phase||168
5190842|NCT01097629|12765992|P6|COMPLETED|DB RO Phase||172
5190843|NCT01097629|12765993|P5|COMPLETED|DB RO Phase||108
5190844|NCT01097629|12765994|P4|COMPLETED|DB RO Phase||96
5190845|NCT01097629|12765995|P3|COMPLETED|DB RO Phase||0
5190846|NCT01097629|12765996|P2|COMPLETED|DB RO Phase||0
5190847|NCT01097629|12765997|P1|COMPLETED|DB RO Phase||0
5190848|NCT01097629|12765990|P8|STARTED|DB RO Phase||327
5190849|NCT01097629|12765991|P7|STARTED|DB RO Phase||171
5190850|NCT01097629|12765992|P6|STARTED|DB RO Phase||173
5190851|NCT01097629|12765993|P5|STARTED|DB RO Phase||108
5190852|NCT01097629|12765994|P4|STARTED|DB RO Phase||97
5190853|NCT01097629|12765995|P3|STARTED|DB RO Phase||0
5190854|NCT01097629|12765996|P2|STARTED|DB RO Phase||0
5190855|NCT01097629|12765997|P1|STARTED|DB RO Phase||0
5190856|NCT01097629|12765990|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190857|NCT01097629|12765991|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190858|NCT01097629|12765992|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190859|NCT01097629|12765993|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190860|NCT01097629|12765994|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190861|NCT01097629|12765995|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
5190862|NCT01097629|12765996|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
5190863|NCT01097629|12765997|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
5190864|NCT01097629|12765990|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190865|NCT01097629|12765991|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190866|NCT01097629|12765992|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190867|NCT01097629|12765993|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190868|NCT01097629|12765994|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190869|NCT01097629|12765995|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
5190870|NCT01097629|12765996|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
5190871|NCT01097629|12765997|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
5190872|NCT01097629|12765990|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190873|NCT01097629|12765991|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190874|NCT01097629|12765992|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190875|NCT01097629|12765993|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190876|NCT01097629|12765994|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190877|NCT01097629|12765995|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
5190878|NCT01097629|12765996|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
5190879|NCT01097629|12765997|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
5190880|NCT01097629|12765990|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190881|NCT01097629|12765991|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190882|NCT01097629|12765992|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190883|NCT01097629|12765993|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190884|NCT01097629|12765994|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190885|NCT01097629|12765995|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
5190886|NCT01097629|12765996|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
5190887|NCT01097629|12765997|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
5190888|NCT01097616|12766048|P8|NOT COMPLETED|DB RO Phase||1
5190889|NCT01097616|12766049|P7|NOT COMPLETED|DB RO Phase||1
5190890|NCT01097616|12766050|P6|NOT COMPLETED|DB RO Phase||2
5190891|NCT01097616|12766051|P5|NOT COMPLETED|DB RO Phase||1
5190892|NCT01097616|12766052|P4|NOT COMPLETED|DB RO Phase||1
5190893|NCT01097616|12766053|P3|NOT COMPLETED|DB RO Phase||0
5190894|NCT01097616|12766054|P2|NOT COMPLETED|DB RO Phase||0
5190895|NCT01097616|12766055|P1|NOT COMPLETED|DB RO Phase||0
5190896|NCT01097616|12766048|P8|COMPLETED|DB RO Phase||326
5190897|NCT01097616|12766049|P7|COMPLETED|DB RO Phase||161
5190898|NCT01097616|12766050|P6|COMPLETED|DB RO Phase||159
5190899|NCT01097616|12766051|P5|COMPLETED|DB RO Phase||111
5190900|NCT01097616|12766052|P4|COMPLETED|DB RO Phase||100
5190901|NCT01097616|12766053|P3|COMPLETED|DB RO Phase||0
5190902|NCT01097616|12766054|P2|COMPLETED|DB RO Phase||0
5190903|NCT01097616|12766055|P1|COMPLETED|DB RO Phase||0
5190904|NCT01097616|12766048|P8|STARTED|DB RO Phase||327
5190905|NCT01097616|12766049|P7|STARTED|DB RO Phase||162
5190906|NCT01097616|12766050|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
5190907|NCT01097616|12766051|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
5190908|NCT01097616|12766052|P4|STARTED|DB RO Phase||101
5190909|NCT01097616|12766053|P3|STARTED|DB RO Phase||0
5190910|NCT01097616|12766054|P2|STARTED|DB RO Phase||0
5190911|NCT01097616|12766055|P1|STARTED|DB RO Phase||0
5190912|NCT01097616|12766048|P8|NOT COMPLETED|Optional DB EXT Phase||0
5190913|NCT01097616|12766049|P7|NOT COMPLETED|Optional DB EXT Phase||0
5190914|NCT01097616|12766050|P6|NOT COMPLETED|Optional DB EXT Phase||0
5190915|NCT01097616|12766051|P5|NOT COMPLETED|Optional DB EXT Phase||0
5190916|NCT01097616|12766052|P4|NOT COMPLETED|Optional DB EXT Phase||0
5190917|NCT01097616|12766053|P3|NOT COMPLETED|Optional DB EXT Phase||10
5190918|NCT01097616|12766054|P2|NOT COMPLETED|Optional DB EXT Phase||21
5190919|NCT01097616|12766055|P1|NOT COMPLETED|Optional DB EXT Phase||15
5190920|NCT01097616|12766048|P8|COMPLETED|Optional DB EXT Phase||0
5190921|NCT01097616|12766049|P7|COMPLETED|Optional DB EXT Phase||0
5190922|NCT01097616|12766050|P6|COMPLETED|Optional DB EXT Phase||0
5190923|NCT01097616|12766051|P5|COMPLETED|Optional DB EXT Phase||0
5190924|NCT01097616|12766052|P4|COMPLETED|Optional DB EXT Phase||0
5190925|NCT01097616|12766053|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
5190926|NCT01097616|12766054|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
5190927|NCT01097616|12766055|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
5190928|NCT01097616|12766048|P8|STARTED|Optional DB EXT Phase||0
5190929|NCT01097616|12766049|P7|STARTED|Optional DB EXT Phase||0
5190930|NCT01097616|12766050|P6|STARTED|Optional DB EXT Phase||0
5190931|NCT01097616|12766051|P5|STARTED|Optional DB EXT Phase||0
5190932|NCT01097616|12766052|P4|STARTED|Optional DB EXT Phase||0
5190933|NCT01097616|12766053|P3|STARTED|Optional DB EXT Phase||151
5190934|NCT01097616|12766054|P2|STARTED|Optional DB EXT Phase||172
5190935|NCT01097616|12766055|P1|STARTED|Optional DB EXT Phase||100
5190936|NCT01097616|12766048|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190937|NCT01097616|12766049|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190938|NCT01097616|12766050|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190939|NCT01097616|12766051|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190940|NCT01097616|12766052|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190941|NCT01097616|12766053|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
5190942|NCT01097616|12766054|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
5190943|NCT01097616|12766055|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
5190944|NCT01097616|12766048|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190945|NCT01097616|12766049|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190946|NCT01097616|12766050|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190947|NCT01097616|12766051|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190948|NCT01097616|12766052|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
5190949|NCT01097616|12766053|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
5190950|NCT01097616|12766054|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
5190951|NCT01097616|12766055|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
5190952|NCT01097616|12766048|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190953|NCT01097616|12766049|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190954|NCT01097616|12766050|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190955|NCT01097616|12766051|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190956|NCT01097616|12766052|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
5190957|NCT01097616|12766053|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
5190958|NCT01097616|12766054|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
5190959|NCT01097616|12766055|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
5190960|NCT01097616|12766048|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190961|NCT01097616|12766049|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190962|NCT01097616|12766050|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190963|NCT01097616|12766051|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190964|NCT01097616|12766052|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
5190965|NCT01097616|12766053|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
5190966|NCT01097616|12766054|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
5190967|NCT01097616|12766055|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
5190968|NCT01097460|12766126|P1|NOT COMPLETED|Overall Study||0
5190969|NCT01097460|12766126|P1|COMPLETED|Overall Study||16
5190970|NCT01097460|12766126|P1|STARTED|Overall Study||16
5190971|NCT01097421|12766130|P1|NOT COMPLETED|Overall Study||14
5190972|NCT01097421|12766130|P1|COMPLETED|Overall Study||314
5190973|NCT01097421|12766130|P1|STARTED|Overall Study||328
5190974|NCT01097343|12766140|P2|NOT COMPLETED|Second Intervention- 30 Days||0
5190975|NCT01097343|12766141|P1|NOT COMPLETED|Second Intervention- 30 Days||0
5190976|NCT01097343|12766140|P2|COMPLETED|Second Intervention- 30 Days||25
5190977|NCT01097343|12766141|P1|COMPLETED|Second Intervention- 30 Days||25
5190978|NCT01097343|12766140|P2|STARTED|Second Intervention- 30 Days||25
5190979|NCT01097343|12766141|P1|STARTED|Second Intervention- 30 Days||25
5190980|NCT01097343|12766140|P2|NOT COMPLETED|First Intervention- 30 Days||0
5190981|NCT01097343|12766141|P1|NOT COMPLETED|First Intervention- 30 Days||0
5190982|NCT01097343|12766140|P2|COMPLETED|First Intervention- 30 Days||25
5190983|NCT01097343|12766141|P1|COMPLETED|First Intervention- 30 Days||25
5190984|NCT01097343|12766140|P2|STARTED|First Intervention- 30 Days||25
5190985|NCT01097343|12766141|P1|STARTED|First Intervention- 30 Days||25
5190986|NCT01097330|12766149|P2|NOT COMPLETED|Overall Study||5
5190987|NCT01097330|12766150|P1|NOT COMPLETED|Overall Study||7
5190988|NCT01097330|12766149|P2|COMPLETED|Overall Study||0
5190989|NCT01097330|12766150|P1|COMPLETED|Overall Study||0
5190990|NCT01097330|12766149|P2|STARTED|Overall Study||5
5190991|NCT01097330|12766150|P1|STARTED|Overall Study||7
5190992|NCT01097304|12766160|P1|NOT COMPLETED|Overall Study||7
5190993|NCT01097304|12766160|P1|COMPLETED|Overall Study||29
5190994|NCT01097304|12766160|P1|STARTED|Overall Study||36
5190995|NCT01097057|12766167|P1|NOT COMPLETED|Overall Study||3
5190996|NCT01097057|12766167|P1|COMPLETED|Overall Study||17
5190997|NCT01097057|12766167|P1|STARTED|Overall Study||20
5190998|NCT01097044|12766176|P2|NOT COMPLETED|Overall Study||5
5190999|NCT01097044|12766177|P1|NOT COMPLETED|Overall Study||5
5191000|NCT01097044|12766176|P2|COMPLETED|Overall Study||33
5191001|NCT01097044|12766177|P1|COMPLETED|Overall Study||34
5191002|NCT01097044|12766176|P2|STARTED|Overall Study||38
5191003|NCT01097044|12766177|P1|STARTED|Overall Study||39
5191004|NCT01097005|12766195|P1|NOT COMPLETED|Overall Study||365
5191005|NCT01097005|12766195|P1|COMPLETED|Overall Study||101
5191006|NCT01097005|12766195|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
5191007|NCT01097005|12766195|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
5191008|NCT01097005|12766195|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
5191009|NCT01097005|12766195|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
5191010|NCT01097005|12766195|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
5191011|NCT01096992|12766206|P5|NOT COMPLETED|Overall Study||0
5191012|NCT01096992|12766207|P4|NOT COMPLETED|Overall Study||0
5191013|NCT01096992|12766208|P3|NOT COMPLETED|Overall Study||0
5191014|NCT01096992|12766209|P2|NOT COMPLETED|Overall Study||0
5191015|NCT01096992|12766210|P1|NOT COMPLETED|Overall Study||0
5191016|NCT01096992|12766206|P5|COMPLETED|Overall Study||30
5191017|NCT01096992|12766207|P4|COMPLETED|Overall Study||6
5191018|NCT01096992|12766208|P3|COMPLETED|Overall Study||6
5191019|NCT01096992|12766209|P2|COMPLETED|Overall Study||3
5191020|NCT01096992|12766210|P1|COMPLETED|Overall Study||6
5191021|NCT01096992|12766206|P5|STARTED|Overall Study||30
5191022|NCT01096992|12766207|P4|STARTED|Overall Study||6
5191023|NCT01096992|12766208|P3|STARTED|Overall Study||6
5191024|NCT01096992|12766209|P2|STARTED|Overall Study||3
5191025|NCT01096992|12766210|P1|STARTED|Overall Study||6
5191026|NCT01096875|12766225|P2|NOT COMPLETED|Overall Study||1
5191027|NCT01096875|12766226|P1|NOT COMPLETED|Overall Study||0
5191028|NCT01096875|12766225|P2|COMPLETED|Overall Study||29
5191029|NCT01096875|12766226|P1|COMPLETED|Overall Study||30
5191030|NCT01096875|12766225|P2|STARTED|Overall Study||30
5191031|NCT01096875|12766226|P1|STARTED|Overall Study||30
5191032|NCT01096849|12766241|P3|NOT COMPLETED|Overall Study||6
5191033|NCT01096849|12766242|P2|NOT COMPLETED|Overall Study||12
5191034|NCT01096849|12766243|P1|NOT COMPLETED|Overall Study||2
5191035|NCT01096849|12766241|P3|COMPLETED|Overall Study||41
5191036|NCT01096849|12766242|P2|COMPLETED|Overall Study||64
5191037|NCT01096849|12766243|P1|COMPLETED|Overall Study||20
5191038|NCT01096849|12766241|P3|STARTED|Overall Study||47
5191039|NCT01096849|12766242|P2|STARTED|Overall Study||76
5191040|NCT01096849|12766243|P1|STARTED|Overall Study||22
5191041|NCT01096823|12766298|P2|NOT COMPLETED|Overall Study||1
5191042|NCT01096823|12766299|P1|NOT COMPLETED|Overall Study||3
5191043|NCT01096823|12766298|P2|COMPLETED|Overall Study||15
5191044|NCT01096823|12766299|P1|COMPLETED|Overall Study||11
5191045|NCT01096823|12766298|P2|STARTED|Overall Study||16
5191046|NCT01096823|12766299|P1|STARTED|Overall Study||14
5191047|NCT01096810|12766311|P1|NOT COMPLETED|Overall Study||0
5191048|NCT01096810|12766311|P1|COMPLETED|Overall Study||20
5191049|NCT01096810|12766311|P1|STARTED|Overall Study||20
5191050|NCT01096784|12766319|P2|NOT COMPLETED|Overall Study||14
5191051|NCT01096784|12766320|P1|NOT COMPLETED|Overall Study||15
5191052|NCT01096784|12766319|P2|COMPLETED|Overall Study||46
5191053|NCT01096784|12766320|P1|COMPLETED|Overall Study||46
5191054|NCT01096784|12766319|P2|STARTED|Overall Study||60
5191055|NCT01096784|12766320|P1|STARTED|Overall Study||61
5191056|NCT01096771|12766354|P2|NOT COMPLETED|Overall Study||0
5191057|NCT01096771|12766355|P1|NOT COMPLETED|Overall Study||0
5191058|NCT01096771|12766354|P2|COMPLETED|Overall Study||7
5191059|NCT01096771|12766355|P1|COMPLETED|Overall Study||7
5191060|NCT01096771|12766354|P2|STARTED|Overall Study||7
5191061|NCT01096771|12766355|P1|STARTED|Overall Study||7
5191062|NCT01096680|12766384|P5|NOT COMPLETED|Overall Study||0
5191063|NCT01096680|12766385|P4|NOT COMPLETED|Overall Study||0
5191064|NCT01096680|12766386|P3|NOT COMPLETED|Overall Study||0
5191065|NCT01096680|12766387|P2|NOT COMPLETED|Overall Study||0
5191066|NCT01096680|12766388|P1|NOT COMPLETED|Overall Study||0
5191067|NCT01096680|12766384|P5|COMPLETED|Overall Study||27
5191068|NCT01096680|12766385|P4|COMPLETED|Overall Study||27
5191069|NCT01096680|12766386|P3|COMPLETED|Overall Study||27
5191070|NCT01096680|12766387|P2|COMPLETED|Overall Study||27
5191071|NCT01096680|12766388|P1|COMPLETED|Overall Study||27
5191072|NCT01096680|12766384|P5|STARTED|Overall Study||27
5191073|NCT01096680|12766385|P4|STARTED|Overall Study||27
5191074|NCT01096680|12766386|P3|STARTED|Overall Study||27
5191075|NCT01096680|12766387|P2|STARTED|Overall Study||27
5191076|NCT01096680|12766388|P1|STARTED|Overall Study||27
5191077|NCT01096667|12766425|P5|NOT COMPLETED|Overall Study||0
5191078|NCT01096667|12766426|P4|NOT COMPLETED|Overall Study||3
5191079|NCT01096667|12766427|P3|NOT COMPLETED|Overall Study||2
5191080|NCT01096667|12766428|P2|NOT COMPLETED|Overall Study||2
5191081|NCT01096667|12766429|P1|NOT COMPLETED|Overall Study||3
5191082|NCT01096667|12766425|P5|COMPLETED|Overall Study||39
5191083|NCT01096667|12766426|P4|COMPLETED|Overall Study||36
5191084|NCT01096667|12766427|P3|COMPLETED|Overall Study||36
5191085|NCT01096667|12766428|P2|COMPLETED|Overall Study||37
5191086|NCT01096667|12766429|P1|COMPLETED|Overall Study||36
5191087|NCT01096667|12766425|P5|Treated|Overall Study||39
5191088|NCT01096667|12766426|P4|Treated|Overall Study||39
5191089|NCT01096667|12766427|P3|Treated|Overall Study||38
5191090|NCT01096667|12766428|P2|Treated|Overall Study||39
5191091|NCT01096667|12766429|P1|Treated|Overall Study||38
5191092|NCT01096667|12766425|P5|STARTED|Overall Study||39
5191093|NCT01096667|12766426|P4|STARTED|Overall Study||39
5191094|NCT01096667|12766427|P3|STARTED|Overall Study||38
5191095|NCT01096667|12766428|P2|STARTED|Overall Study||39
5191096|NCT01096667|12766429|P1|STARTED|Overall Study||39
5191097|NCT01096589|12766571|P4|NOT COMPLETED|Overall Study||3
5191098|NCT01096589|12766572|P3|NOT COMPLETED|Overall Study||4
5191099|NCT01096589|12766573|P2|NOT COMPLETED|Overall Study||2
5191100|NCT01096589|12766574|P1|NOT COMPLETED|Overall Study||4
5191101|NCT01096589|12766571|P4|COMPLETED|Overall Study||15
5191102|NCT01096589|12766572|P3|COMPLETED|Overall Study||18
5191103|NCT01096589|12766573|P2|COMPLETED|Overall Study||18
5191104|NCT01096589|12766574|P1|COMPLETED|Overall Study||18
5191105|NCT01096589|12766571|P4|STARTED|Overall Study||18
5191106|NCT01096589|12766572|P3|STARTED|Overall Study||22
5191107|NCT01096589|12766573|P2|STARTED|Overall Study||20
5191108|NCT01096589|12766574|P1|STARTED|Overall Study||22
5191109|NCT01096550|12766590|P2|NOT COMPLETED|Overall Study||29
5191110|NCT01096550|12766591|P1|NOT COMPLETED|Overall Study||37
5191111|NCT01096550|12766590|P2|COMPLETED|Overall Study||146
5191112|NCT01096550|12766591|P1|COMPLETED|Overall Study||133
5191113|NCT01096550|12766590|P2|STARTED|Overall Study||175
5191114|NCT01096550|12766591|P1|STARTED|Overall Study||170
5191115|NCT01096446|12766599|P2|NOT COMPLETED|Overall Study||0
5191116|NCT01096446|12766600|P1|NOT COMPLETED|Overall Study||3
5191117|NCT01096446|12766599|P2|COMPLETED|Overall Study||10
5191212|NCT01095757|12766862|P1|STARTED|Overall Study||45
5191118|NCT01096446|12766600|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
5191119|NCT01096446|12766599|P2|STARTED|Overall Study||10
5191120|NCT01096446|12766600|P1|STARTED|Overall Study||12
5191121|NCT01096342|12766605|P1|NOT COMPLETED|Overall Study||1
5191122|NCT01096342|12766605|P1|COMPLETED|Overall Study||15
5191123|NCT01096342|12766605|P1|STARTED|Overall Study||16
5191124|NCT01096316|12766613|P2|NOT COMPLETED|Overall Study||9
5191125|NCT01096316|12766614|P1|NOT COMPLETED|Overall Study||15
5191126|NCT01096316|12766613|P2|COMPLETED|Overall Study||94
5191127|NCT01096316|12766614|P1|COMPLETED|Overall Study||87
5191128|NCT01096316|12766613|P2|STARTED|Overall Study||103
5191129|NCT01096316|12766614|P1|STARTED|Overall Study||102
5191130|NCT01096186|12766624|P1|NOT COMPLETED|Overall Study||50
5191131|NCT01096186|12766624|P1|COMPLETED|Overall Study||567
5191132|NCT01096186|12766624|P1|STARTED|Overall Study||617
5191133|NCT01096160|12766640|P10|NOT COMPLETED|Overall Study||1
5191134|NCT01096160|12766641|P9|NOT COMPLETED|Overall Study||2
5191135|NCT01096160|12766642|P8|NOT COMPLETED|Overall Study||0
5191136|NCT01096160|12766643|P7|NOT COMPLETED|Overall Study||2
5191137|NCT01096160|12766644|P6|NOT COMPLETED|Overall Study||0
5191138|NCT01096160|12766645|P5|NOT COMPLETED|Overall Study||1
5191139|NCT01096160|12766646|P4|NOT COMPLETED|Overall Study||0
5191140|NCT01096160|12766647|P3|NOT COMPLETED|Overall Study||1
5191141|NCT01096160|12766648|P2|NOT COMPLETED|Overall Study||0
5191142|NCT01096160|12766649|P1|NOT COMPLETED|Overall Study||0
5191143|NCT01096160|12766640|P10|COMPLETED|Overall Study||1
5191144|NCT01096160|12766641|P9|COMPLETED|Overall Study||4
5191145|NCT01096160|12766642|P8|COMPLETED|Overall Study||2
5191146|NCT01096160|12766643|P7|COMPLETED|Overall Study||4
5191147|NCT01096160|12766644|P6|COMPLETED|Overall Study||2
5191148|NCT01096160|12766645|P5|COMPLETED|Overall Study||5
5191149|NCT01096160|12766646|P4|COMPLETED|Overall Study||2
5191150|NCT01096160|12766647|P3|COMPLETED|Overall Study||5
5191151|NCT01096160|12766648|P2|COMPLETED|Overall Study||2
5191152|NCT01096160|12766649|P1|COMPLETED|Overall Study||6
5191153|NCT01096160|12766640|P10|STARTED|Overall Study||2
5191154|NCT01096160|12766641|P9|STARTED|Overall Study||6
5191155|NCT01096160|12766642|P8|STARTED|Overall Study||2
5191156|NCT01096160|12766643|P7|STARTED|Overall Study||6
5191157|NCT01096160|12766644|P6|STARTED|Overall Study||2
5191158|NCT01096160|12766645|P5|STARTED|Overall Study||6
5191159|NCT01096160|12766646|P4|STARTED|Overall Study||2
5191160|NCT01096160|12766647|P3|STARTED|Overall Study||6
5191161|NCT01096160|12766648|P2|STARTED|Overall Study||2
5191162|NCT01096160|12766649|P1|STARTED|Overall Study||6
5191163|NCT01096056|12766707|P2|NOT COMPLETED|Overall Study||1
5191164|NCT01096056|12766708|P1|NOT COMPLETED|Overall Study||0
5191165|NCT01096056|12766707|P2|COMPLETED|Overall Study||19
5191166|NCT01096056|12766708|P1|COMPLETED|Overall Study||20
5191167|NCT01096056|12766707|P2|Completed at Day 42|Overall Study||20
5191168|NCT01096056|12766708|P1|Completed at Day 42|Overall Study||20
5191169|NCT01096056|12766707|P2|STARTED|Overall Study||20
5191170|NCT01096056|12766708|P1|STARTED|Overall Study||20
5191171|NCT01096017|12766740|P2|NOT COMPLETED|Treatment Period 2||1
5191172|NCT01096017|12766741|P1|NOT COMPLETED|Treatment Period 2||1
5191173|NCT01096017|12766740|P2|COMPLETED|Treatment Period 2||11
5191174|NCT01096017|12766741|P1|COMPLETED|Treatment Period 2||11
5191175|NCT01096017|12766740|P2|STARTED|Treatment Period 2||12
5191176|NCT01096017|12766741|P1|STARTED|Treatment Period 2||12
5191177|NCT01096017|12766740|P2|NOT COMPLETED|Washout 1 - 14 Days||0
5191178|NCT01096017|12766741|P1|NOT COMPLETED|Washout 1 - 14 Days||0
5191179|NCT01096017|12766740|P2|COMPLETED|Washout 1 - 14 Days||12
5191180|NCT01096017|12766741|P1|COMPLETED|Washout 1 - 14 Days||12
5191181|NCT01096017|12766740|P2|STARTED|Washout 1 - 14 Days||12
5191182|NCT01096017|12766741|P1|STARTED|Washout 1 - 14 Days||12
5191183|NCT01096017|12766740|P2|NOT COMPLETED|Treatment Period 1||0
5191184|NCT01096017|12766741|P1|NOT COMPLETED|Treatment Period 1||0
5191185|NCT01096017|12766740|P2|COMPLETED|Treatment Period 1||12
5191186|NCT01096017|12766741|P1|COMPLETED|Treatment Period 1||12
5191187|NCT01096017|12766740|P2|STARTED|Treatment Period 1||12
5191188|NCT01096017|12766741|P1|STARTED|Treatment Period 1||12
5191189|NCT01095978|12766769|P1|NOT COMPLETED|Overall Study||3
5191190|NCT01095978|12766769|P1|COMPLETED|Overall Study||2819
5191191|NCT01095978|12766769|P1|STARTED|Overall Study||2822
5191192|NCT01095887|12766796|P1|NOT COMPLETED|Overall Study||0
5191193|NCT01095887|12766796|P1|COMPLETED|Overall Study||6
5191194|NCT01095887|12766796|P1|STARTED|Overall Study||6
5191195|NCT01095835|12766803|P3|NOT COMPLETED|Overall Study||8
5191196|NCT01095835|12766804|P2|NOT COMPLETED|Overall Study||12
5191197|NCT01095835|12766805|P1|NOT COMPLETED|Overall Study||10
5191198|NCT01095835|12766803|P3|COMPLETED|Overall Study||17
5191199|NCT01095835|12766804|P2|COMPLETED|Overall Study||40
5191200|NCT01095835|12766805|P1|COMPLETED|Overall Study||41
5191201|NCT01095835|12766803|P3|STARTED|Overall Study||25
5191202|NCT01095835|12766804|P2|STARTED|Overall Study||52
5191203|NCT01095835|12766805|P1|STARTED|Overall Study||51
5191204|NCT01095796|12766843|P2|NOT COMPLETED|Overall Study||289
5191205|NCT01095796|12766844|P1|NOT COMPLETED|Overall Study||295
5191206|NCT01095796|12766843|P2|COMPLETED|Overall Study||65
5191207|NCT01095796|12766844|P1|COMPLETED|Overall Study||58
5191208|NCT01095796|12766843|P2|STARTED|Overall Study||354
5191209|NCT01095796|12766844|P1|STARTED|Overall Study||353
5191210|NCT01095757|12766862|P1|NOT COMPLETED|Overall Study||0
5191211|NCT01095757|12766862|P1|COMPLETED|Overall Study||45
5191213|NCT01095666|12766874|P3|NOT COMPLETED|Overall Study||7
5191214|NCT01095666|12766875|P2|NOT COMPLETED|Overall Study||11
5191215|NCT01095666|12766876|P1|NOT COMPLETED|Overall Study||17
5191216|NCT01095666|12766874|P3|COMPLETED|Overall Study||145
5191217|NCT01095666|12766875|P2|COMPLETED|Overall Study||136
5191218|NCT01095666|12766876|P1|COMPLETED|Overall Study||128
5191219|NCT01095666|12766874|P3|STARTED|Overall Study||152
5191220|NCT01095666|12766875|P2|STARTED|Overall Study||147
5191221|NCT01095666|12766876|P1|STARTED|Overall Study||145
5191222|NCT01095653|12766899|P3|NOT COMPLETED|Overall Study||16
5191223|NCT01095653|12766900|P2|NOT COMPLETED|Overall Study||15
5191224|NCT01095653|12766901|P1|NOT COMPLETED|Overall Study||19
5191225|NCT01095653|12766899|P3|COMPLETED|Overall Study||117
5191226|NCT01095653|12766900|P2|COMPLETED|Overall Study||113
5191227|NCT01095653|12766901|P1|COMPLETED|Overall Study||113
5191228|NCT01095653|12766899|P3|STARTED|Overall Study||133
5191229|NCT01095653|12766900|P2|STARTED|Overall Study||128
5191230|NCT01095653|12766901|P1|STARTED|Overall Study||132
5191231|NCT01095510|12766924|P4|NOT COMPLETED|Overall Study||0
5191232|NCT01095510|12766925|P3|NOT COMPLETED|Overall Study||0
5191233|NCT01095510|12766926|P2|NOT COMPLETED|Overall Study||0
5191234|NCT01095510|12766927|P1|NOT COMPLETED|Overall Study||0
5191235|NCT01095510|12766924|P4|COMPLETED|Overall Study||3
5191236|NCT01095510|12766925|P3|COMPLETED|Overall Study||3
5191237|NCT01095510|12766926|P2|COMPLETED|Overall Study||0
5191238|NCT01095510|12766927|P1|COMPLETED|Overall Study||3
5191239|NCT01095510|12766924|P4|STARTED|Overall Study||3
5191240|NCT01095510|12766925|P3|STARTED|Overall Study||3
5191241|NCT01095510|12766926|P2|STARTED|Overall Study||0
5191242|NCT01095510|12766927|P1|STARTED|Overall Study||3
5191243|NCT01095497|12766946|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
5191244|NCT01095497|12766947|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
5191245|NCT01095497|12766946|P2|COMPLETED|Subcutaneous CINRYZE||12
5191246|NCT01095497|12766947|P1|COMPLETED|Subcutaneous CINRYZE||12
5191247|NCT01095497|12766946|P2|STARTED|Subcutaneous CINRYZE||12
5191248|NCT01095497|12766947|P1|STARTED|Subcutaneous CINRYZE||13
5191249|NCT01095497|12766946|P2|NOT COMPLETED|Intravenous CINRYZE||0
5191250|NCT01095497|12766947|P1|NOT COMPLETED|Intravenous CINRYZE||1
5191251|NCT01095497|12766946|P2|COMPLETED|Intravenous CINRYZE||12
5191252|NCT01095497|12766947|P1|COMPLETED|Intravenous CINRYZE||13
5191253|NCT01095497|12766946|P2|STARTED|Intravenous CINRYZE||12
5191254|NCT01095497|12766947|P1|STARTED|Intravenous CINRYZE||14
5191255|NCT01095250|12766959|P4|NOT COMPLETED|Overall Study||5
5191256|NCT01095250|12766960|P3|NOT COMPLETED|Overall Study||8
5191257|NCT01095250|12766961|P2|NOT COMPLETED|Overall Study||10
5191258|NCT01095250|12766962|P1|NOT COMPLETED|Overall Study||8
5191259|NCT01095250|12766959|P4|COMPLETED|Overall Study||0
5191260|NCT01095250|12766960|P3|COMPLETED|Overall Study||0
5191261|NCT01095250|12766961|P2|COMPLETED|Overall Study||0
5191262|NCT01095250|12766962|P1|COMPLETED|Overall Study||0
5191263|NCT01095250|12766959|P4|STARTED|Overall Study||5
5191264|NCT01095250|12766960|P3|STARTED|Overall Study||8
5191265|NCT01095250|12766961|P2|STARTED|Overall Study||10
5191266|NCT01095250|12766962|P1|STARTED|Overall Study||8
5191267|NCT01095094|12766992|P1|NOT COMPLETED|Overall Study||3
5191268|NCT01095094|12766992|P1|COMPLETED|Overall Study||16
5191269|NCT01095094|12766992|P1|STARTED|Overall Study||19
5191270|NCT01095003|12766999|P2|NOT COMPLETED|Overall Study||386
5191271|NCT01095003|12767000|P1|NOT COMPLETED|Overall Study||384
5191272|NCT01095003|12766999|P2|COMPLETED|Overall Study||0
5191273|NCT01095003|12767000|P1|COMPLETED|Overall Study||0
5191274|NCT01095003|12766999|P2|STARTED|Overall Study||386
5191275|NCT01095003|12767000|P1|STARTED|Overall Study||384
5191276|NCT01094886|12767014|P1|NOT COMPLETED|Overall Study||7
5191277|NCT01094886|12767014|P1|COMPLETED|Overall Study||46
5191278|NCT01094886|12767014|P1|STARTED|Overall Study||53
5191279|NCT01094808|12767024|P3|NOT COMPLETED|Overall Study||0
5191280|NCT01094808|12767025|P2|NOT COMPLETED|Overall Study||1
5191281|NCT01094808|12767026|P1|NOT COMPLETED|Overall Study||1
5191282|NCT01094808|12767024|P3|COMPLETED|Overall Study||21
5191283|NCT01094808|12767025|P2|COMPLETED|Overall Study||19
5191284|NCT01094808|12767026|P1|COMPLETED|Overall Study||20
5191285|NCT01094808|12767024|P3|STARTED|Overall Study||21
5191286|NCT01094808|12767025|P2|STARTED|Overall Study||20
5191287|NCT01094808|12767026|P1|STARTED|Overall Study||21
5191288|NCT01094782|12767067|P6|NOT COMPLETED|Overall Study||8
5191289|NCT01094782|12767068|P5|NOT COMPLETED|Overall Study||11
5191290|NCT01094782|12767069|P4|NOT COMPLETED|Overall Study||11
5191291|NCT01094782|12767070|P3|NOT COMPLETED|Overall Study||3
5191292|NCT01094782|12767071|P2|NOT COMPLETED|Overall Study||10
5191293|NCT01094782|12767072|P1|NOT COMPLETED|Overall Study||8
5191294|NCT01094782|12767067|P6|COMPLETED|Overall Study||30
5191295|NCT01094782|12767068|P5|COMPLETED|Overall Study||31
5191296|NCT01094782|12767069|P4|COMPLETED|Overall Study||45
5191297|NCT01094782|12767070|P3|COMPLETED|Overall Study||31
5191298|NCT01094782|12767071|P2|COMPLETED|Overall Study||29
5191299|NCT01094782|12767072|P1|COMPLETED|Overall Study||31
5191300|NCT01094782|12767067|P6|STARTED|Overall Study||38
5191301|NCT01094782|12767068|P5|STARTED|Overall Study||42
5191302|NCT01094782|12767069|P4|STARTED|Overall Study||56
5191303|NCT01094782|12767070|P3|STARTED|Overall Study||34
5191304|NCT01094782|12767071|P2|STARTED|Overall Study||39
5191305|NCT01094782|12767072|P1|STARTED|Overall Study||39
5191306|NCT01094743|12767116|P1|NOT COMPLETED|Period 2||0
5191307|NCT01094743|12767116|P1|COMPLETED|Period 2||50
5191308|NCT01094743|12767116|P1|STARTED|Period 2||50
5191309|NCT01094743|12767116|P1|NOT COMPLETED|Period 1||2
5191310|NCT01094743|12767116|P1|COMPLETED|Period 1||50
5191311|NCT01094743|12767116|P1|STARTED|Period 1||52
5191312|NCT01094730|12767133|P2|NOT COMPLETED|Period 2 (14 Days)||2
5191313|NCT01094730|12767134|P1|NOT COMPLETED|Period 2 (14 Days)||3
5191314|NCT01094730|12767133|P2|COMPLETED|Period 2 (14 Days)||84
5191315|NCT01094730|12767134|P1|COMPLETED|Period 2 (14 Days)||87
5191316|NCT01094730|12767133|P2|STARTED|Period 2 (14 Days)||86
5191317|NCT01094730|12767134|P1|STARTED|Period 2 (14 Days)||90
5191318|NCT01094730|12767133|P2|NOT COMPLETED|Period 1 (14 Days)||2
5191319|NCT01094730|12767134|P1|NOT COMPLETED|Period 1 (14 Days)||2
5191320|NCT01094730|12767133|P2|COMPLETED|Period 1 (14 Days)||86
5191321|NCT01094730|12767134|P1|COMPLETED|Period 1 (14 Days)||90
5191322|NCT01094730|12767133|P2|STARTED|Period 1 (14 Days)||88
5191323|NCT01094730|12767134|P1|STARTED|Period 1 (14 Days)||92
5191324|NCT01094717|12767147|P2|NOT COMPLETED|Overall Study||0
5191325|NCT01094717|12767148|P1|NOT COMPLETED|Overall Study||0
5191326|NCT01094717|12767147|P2|COMPLETED|Overall Study||10
5191327|NCT01094717|12767148|P1|COMPLETED|Overall Study||3
5191328|NCT01094717|12767147|P2|STARTED|Overall Study||10
5191329|NCT01094717|12767148|P1|STARTED|Overall Study||3
5191330|NCT01094704|12767166|P2|NOT COMPLETED|Overall Study||0
5191331|NCT01094704|12767167|P1|NOT COMPLETED|Overall Study||0
5191332|NCT01094704|12767166|P2|COMPLETED|Overall Study||8
5191333|NCT01094704|12767167|P1|COMPLETED|Overall Study||8
5191334|NCT01094704|12767166|P2|STARTED|Overall Study||8
5191335|NCT01094704|12767167|P1|STARTED|Overall Study||8
5191336|NCT01094574|12767179|P6|NOT COMPLETED|Overall Study||0
5191337|NCT01094574|12767180|P5|NOT COMPLETED|Overall Study||0
5191338|NCT01094574|12767181|P4|NOT COMPLETED|Overall Study||0
5191339|NCT01094574|12767182|P3|NOT COMPLETED|Overall Study||0
5191340|NCT01094574|12767183|P2|NOT COMPLETED|Overall Study||0
5191341|NCT01094574|12767184|P1|NOT COMPLETED|Overall Study||0
5191342|NCT01094574|12767179|P6|COMPLETED|Overall Study||2
5191343|NCT01094574|12767180|P5|COMPLETED|Overall Study||2
5191344|NCT01094574|12767181|P4|COMPLETED|Overall Study||2
5191345|NCT01094574|12767182|P3|COMPLETED|Overall Study||2
5191346|NCT01094574|12767183|P2|COMPLETED|Overall Study||1
5191347|NCT01094574|12767184|P1|COMPLETED|Overall Study||1
5191348|NCT01094574|12767179|P6|STARTED|Overall Study||2
5191349|NCT01094574|12767180|P5|STARTED|Overall Study||2
5191350|NCT01094574|12767181|P4|STARTED|Overall Study||2
5191351|NCT01094574|12767182|P3|STARTED|Overall Study||2
5191352|NCT01094574|12767183|P2|STARTED|Overall Study||1
5191353|NCT01094574|12767184|P1|STARTED|Overall Study||1
5191354|NCT01094561|12767231|P1|NOT COMPLETED|Overall Study||6
5191355|NCT01094561|12767231|P1|COMPLETED|Overall Study||17
5191356|NCT01094561|12767231|P1|STARTED|Overall Study||23
5191357|NCT01094548|12767238|P2|NOT COMPLETED|Overall Study||0
5191358|NCT01094548|12767239|P1|NOT COMPLETED|Overall Study||0
5191359|NCT01094548|12767238|P2|COMPLETED|Overall Study||17
5191360|NCT01094548|12767239|P1|COMPLETED|Overall Study||17
5191361|NCT01094548|12767238|P2|STARTED|Overall Study||17
5191362|NCT01094548|12767239|P1|STARTED|Overall Study||17
5191363|NCT01094522|12767259|P2|NOT COMPLETED|Overall Study||0
5191364|NCT01094522|12767260|P1|NOT COMPLETED|Overall Study||0
5191365|NCT01094522|12767259|P2|COMPLETED|Overall Study||20
5191366|NCT01094522|12767260|P1|COMPLETED|Overall Study||20
5191367|NCT01094522|12767259|P2|STARTED|Overall Study||20
5191368|NCT01094522|12767260|P1|STARTED|Overall Study||20
5191369|NCT01094301|12767270|P1|NOT COMPLETED|Implant Stage||8
5191370|NCT01094301|12767270|P1|COMPLETED|Implant Stage||5
5191371|NCT01094301|12767270|P1|Subjects Who Received SPR IPG|Implant Stage||5
5191372|NCT01094301|12767270|P1|Met Criteria for Implant Stage|Implant Stage||7
5191373|NCT01094301|12767270|P1|STARTED|Implant Stage||13
5191374|NCT01094301|12767270|P1|NOT COMPLETED|Trial Stage||1
5191375|NCT01094301|12767270|P1|COMPLETED|Trial Stage||27
5191376|NCT01094301|12767270|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
5191377|NCT01094301|12767270|P1|STARTED|Trial Stage||28
5191378|NCT01094288|12767300|P8|NOT COMPLETED|Overall Study||2
5191379|NCT01094288|12767301|P7|NOT COMPLETED|Overall Study||0
5191380|NCT01094288|12767302|P6|NOT COMPLETED|Overall Study||0
5191381|NCT01094288|12767303|P5|NOT COMPLETED|Overall Study||0
5191382|NCT01094288|12767304|P4|NOT COMPLETED|Overall Study||2
5191383|NCT01094288|12767305|P3|NOT COMPLETED|Overall Study||4
5191384|NCT01094288|12767306|P2|NOT COMPLETED|Overall Study||10
5191385|NCT01094288|12767307|P1|NOT COMPLETED|Overall Study||2
5191386|NCT01094288|12767300|P8|COMPLETED|Overall Study||2
5191387|NCT01094288|12767301|P7|COMPLETED|Overall Study||2
5191388|NCT01094288|12767302|P6|COMPLETED|Overall Study||4
5191389|NCT01094288|12767303|P5|COMPLETED|Overall Study||2
5191390|NCT01094288|12767304|P4|COMPLETED|Overall Study||1
5191391|NCT01094288|12767305|P3|COMPLETED|Overall Study||1
5191392|NCT01094288|12767306|P2|COMPLETED|Overall Study||5
5191393|NCT01094288|12767307|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
5191394|NCT01094288|12767300|P8|STARTED|Overall Study||4
5191395|NCT01094288|12767301|P7|STARTED|Overall Study||2
5191396|NCT01094288|12767302|P6|STARTED|Overall Study||4
5191397|NCT01094288|12767303|P5|STARTED|Overall Study||2
5191398|NCT01094288|12767304|P4|STARTED|Overall Study||3
5191399|NCT01094288|12767305|P3|STARTED|Overall Study||5
5191400|NCT01094288|12767306|P2|STARTED|Overall Study||15
5191401|NCT01094288|12767307|P1|STARTED|Overall Study||6
5191402|NCT01094184|12767419|P2|NOT COMPLETED|Overall Study||11
5191403|NCT01094184|12767420|P1|NOT COMPLETED|Overall Study||35
5191404|NCT01094184|12767419|P2|COMPLETED|Overall Study||2
5191405|NCT01094184|12767420|P1|COMPLETED|Overall Study||1
5191406|NCT01094184|12767419|P2|STARTED|Overall Study||13
5191407|NCT01094184|12767420|P1|STARTED|Overall Study||36
5191408|NCT01094171|12767654|P1|NOT COMPLETED|Overall Study||10
5191409|NCT01094171|12767654|P1|COMPLETED|Overall Study||390
5191410|NCT01094171|12767654|P1|STARTED|Overall Study||400
5191411|NCT01094119|12767663|P2|NOT COMPLETED|Overall Study||4
5191412|NCT01094119|12767664|P1|NOT COMPLETED|Overall Study||2
5191413|NCT01094119|12767663|P2|COMPLETED|Overall Study||32
5191414|NCT01094119|12767664|P1|COMPLETED|Overall Study||32
5191415|NCT01094119|12767663|P2|STARTED|Overall Study||36
5191416|NCT01094119|12767664|P1|STARTED|Overall Study||34
5191417|NCT01093976|12767672|P1|NOT COMPLETED|Overall Study||0
5191418|NCT01093976|12767672|P1|COMPLETED|Overall Study||14
5191419|NCT01093976|12767672|P1|STARTED|Overall Study||14
5191420|NCT01093885|12767676|P1|NOT COMPLETED|Overall Study||5
5191421|NCT01093885|12767676|P1|COMPLETED|Overall Study||10
5191422|NCT01093885|12767676|P1|STARTED|Overall Study||15
5191423|NCT01093846|12767684|P3|NOT COMPLETED|Overall Study||21
5191424|NCT01093846|12767685|P2|NOT COMPLETED|Overall Study||18
5191425|NCT01093846|12767686|P1|NOT COMPLETED|Overall Study||19
5191426|NCT01093846|12767684|P3|COMPLETED|Overall Study||1
5191427|NCT01093846|12767685|P2|COMPLETED|Overall Study||0
5191428|NCT01093846|12767686|P1|COMPLETED|Overall Study||0
5191429|NCT01093846|12767684|P3|STARTED|Overall Study||22
5191430|NCT01093846|12767685|P2|STARTED|Overall Study||18
5191431|NCT01093846|12767686|P1|STARTED|Overall Study||19
5191432|NCT01093794|12767692|P4|NOT COMPLETED|Treatment Period 4||0
5191433|NCT01093794|12767693|P3|NOT COMPLETED|Treatment Period 4||0
5191434|NCT01093794|12767694|P2|NOT COMPLETED|Treatment Period 4||0
5191435|NCT01093794|12767695|P1|NOT COMPLETED|Treatment Period 4||0
5191436|NCT01093794|12767692|P4|COMPLETED|Treatment Period 4||7
5191437|NCT01093794|12767693|P3|COMPLETED|Treatment Period 4||6
5191438|NCT01093794|12767694|P2|COMPLETED|Treatment Period 4||7
5191439|NCT01093794|12767695|P1|COMPLETED|Treatment Period 4||7
5191440|NCT01093794|12767692|P4|STARTED|Treatment Period 4||7
5191441|NCT01093794|12767693|P3|STARTED|Treatment Period 4||6
5191442|NCT01093794|12767694|P2|STARTED|Treatment Period 4||7
5191443|NCT01093794|12767695|P1|STARTED|Treatment Period 4||7
5191444|NCT01093794|12767692|P4|NOT COMPLETED|Treatment Period 3||0
5191445|NCT01093794|12767693|P3|NOT COMPLETED|Treatment Period 3||0
5191446|NCT01093794|12767694|P2|NOT COMPLETED|Treatment Period 3||0
5191447|NCT01093794|12767695|P1|NOT COMPLETED|Treatment Period 3||0
5191448|NCT01093794|12767692|P4|COMPLETED|Treatment Period 3||7
5191449|NCT01093794|12767693|P3|COMPLETED|Treatment Period 3||6
5191450|NCT01093794|12767694|P2|COMPLETED|Treatment Period 3||7
5191451|NCT01093794|12767695|P1|COMPLETED|Treatment Period 3||7
5191452|NCT01093794|12767692|P4|STARTED|Treatment Period 3||7
5191453|NCT01093794|12767693|P3|STARTED|Treatment Period 3||6
5191454|NCT01093794|12767694|P2|STARTED|Treatment Period 3||7
5191455|NCT01093794|12767695|P1|STARTED|Treatment Period 3||7
5191456|NCT01093794|12767692|P4|NOT COMPLETED|Treatment Period 2||0
5191457|NCT01093794|12767693|P3|NOT COMPLETED|Treatment Period 2||0
5191458|NCT01093794|12767694|P2|NOT COMPLETED|Treatment Period 2||0
5191459|NCT01093794|12767695|P1|NOT COMPLETED|Treatment Period 2||0
5191460|NCT01093794|12767692|P4|COMPLETED|Treatment Period 2||7
5191461|NCT01093794|12767693|P3|COMPLETED|Treatment Period 2||6
5191462|NCT01093794|12767694|P2|COMPLETED|Treatment Period 2||7
5191463|NCT01093794|12767695|P1|COMPLETED|Treatment Period 2||7
5191464|NCT01093794|12767692|P4|STARTED|Treatment Period 2||7
5191465|NCT01093794|12767693|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
5191466|NCT01093794|12767694|P2|STARTED|Treatment Period 2||7
5191467|NCT01093794|12767695|P1|STARTED|Treatment Period 2||7
5191468|NCT01093794|12767692|P4|NOT COMPLETED|Treatment Period 1||0
5191469|NCT01093794|12767693|P3|NOT COMPLETED|Treatment Period 1||0
5191470|NCT01093794|12767694|P2|NOT COMPLETED|Treatment Period 1||0
5191471|NCT01093794|12767695|P1|NOT COMPLETED|Treatment Period 1||0
5191472|NCT01093794|12767692|P4|COMPLETED|Treatment Period 1||7
5191473|NCT01093794|12767693|P3|COMPLETED|Treatment Period 1||7
5191474|NCT01093794|12767694|P2|COMPLETED|Treatment Period 1||7
5191475|NCT01093794|12767695|P1|COMPLETED|Treatment Period 1||7
5191476|NCT01093794|12767692|P4|STARTED|Treatment Period 1||7
5191477|NCT01093794|12767693|P3|STARTED|Treatment Period 1||7
5191478|NCT01093794|12767694|P2|STARTED|Treatment Period 1||7
5191479|NCT01093794|12767695|P1|STARTED|Treatment Period 1||7
5191480|NCT01093755|12767711|P2|NOT COMPLETED|Overall Study||4
5191481|NCT01093755|12767712|P1|NOT COMPLETED|Overall Study||3
5191482|NCT01093755|12767711|P2|COMPLETED|Overall Study||10
5191483|NCT01093755|12767712|P1|COMPLETED|Overall Study||13
5191484|NCT01093755|12767711|P2|STARTED|Overall Study||14
5191485|NCT01093755|12767712|P1|STARTED|Overall Study||16
5191486|NCT01093690|12767722|P2|NOT COMPLETED|Overall Study||0
5191487|NCT01093690|12767723|P1|NOT COMPLETED|Overall Study||0
5191488|NCT01093690|12767722|P2|COMPLETED|Overall Study||79
5191489|NCT01093690|12767723|P1|COMPLETED|Overall Study||83
5191490|NCT01093690|12767722|P2|STARTED|Overall Study||79
5191491|NCT01093690|12767723|P1|STARTED|Overall Study||83
5191492|NCT01093651|12767731|P2|NOT COMPLETED|Overall Study||0
5191493|NCT01093651|12767732|P1|NOT COMPLETED|Overall Study||0
5191494|NCT01093651|12767731|P2|COMPLETED|Overall Study||10
5191495|NCT01093651|12767732|P1|COMPLETED|Overall Study||10
5191496|NCT01093651|12767731|P2|STARTED|Overall Study||10
5191497|NCT01093651|12767732|P1|STARTED|Overall Study||10
5191498|NCT01093625|12767752|P2|NOT COMPLETED|1-Year Visit||3
5191499|NCT01093625|12767753|P1|NOT COMPLETED|1-Year Visit||5
5191500|NCT01093625|12767752|P2|COMPLETED|1-Year Visit||37
5191501|NCT01093625|12767753|P1|COMPLETED|1-Year Visit||29
5191502|NCT01093625|12767752|P2|STARTED|1-Year Visit||40
5191503|NCT01093625|12767753|P1|STARTED|1-Year Visit||34
5191504|NCT01093625|12767752|P2|NOT COMPLETED|6-Month Visit||9
5191505|NCT01093625|12767753|P1|NOT COMPLETED|6-Month Visit||8
5191506|NCT01093625|12767752|P2|COMPLETED|6-Month Visit||40
5191507|NCT01093625|12767753|P1|COMPLETED|6-Month Visit||34
5191508|NCT01093625|12767752|P2|STARTED|6-Month Visit||49
5191509|NCT01093625|12767753|P1|STARTED|6-Month Visit||42
5191510|NCT01093625|12767752|P2|NOT COMPLETED|3-Month Visit||0
5191511|NCT01093625|12767753|P1|NOT COMPLETED|3-Month Visit||2
5191512|NCT01093625|12767752|P2|COMPLETED|3-Month Visit||49
5191513|NCT01093625|12767753|P1|COMPLETED|3-Month Visit||42
5191514|NCT01093625|12767752|P2|STARTED|3-Month Visit||49
5191515|NCT01093625|12767753|P1|STARTED|3-Month Visit||44
5191516|NCT01093625|12767752|P2|NOT COMPLETED|1-Month Visit||0
5191517|NCT01093625|12767753|P1|NOT COMPLETED|1-Month Visit||2
5191518|NCT01093625|12767752|P2|COMPLETED|1-Month Visit||49
5191519|NCT01093625|12767753|P1|COMPLETED|1-Month Visit||44
5191520|NCT01093625|12767752|P2|STARTED|1-Month Visit||49
5191521|NCT01093625|12767753|P1|STARTED|1-Month Visit||46
5191522|NCT01093625|12767752|P2|NOT COMPLETED|2-Week Visit||0
5191523|NCT01093625|12767753|P1|NOT COMPLETED|2-Week Visit||1
5191524|NCT01093625|12767752|P2|COMPLETED|2-Week Visit||49
5191525|NCT01093625|12767753|P1|COMPLETED|2-Week Visit||46
5191526|NCT01093625|12767752|P2|STARTED|2-Week Visit||49
5191527|NCT01093625|12767753|P1|STARTED|2-Week Visit||47
5191528|NCT01093625|12767752|P2|NOT COMPLETED|Baseline and Dispensed||0
5191529|NCT01093625|12767753|P1|NOT COMPLETED|Baseline and Dispensed||2
5191530|NCT01093625|12767752|P2|COMPLETED|Baseline and Dispensed||49
5191531|NCT01093625|12767753|P1|COMPLETED|Baseline and Dispensed||47
5191532|NCT01093625|12767752|P2|STARTED|Baseline and Dispensed||49
5191533|NCT01093625|12767753|P1|STARTED|Baseline and Dispensed||49
5191534|NCT01093599|12767773|P2|NOT COMPLETED|Overall Study||46
5191535|NCT01093599|12767774|P1|NOT COMPLETED|Overall Study||32
5191536|NCT01093599|12767773|P2|COMPLETED|Overall Study||59
5191537|NCT01093599|12767774|P1|COMPLETED|Overall Study||59
5191538|NCT01093599|12767773|P2|STARTED|Overall Study||105
5191539|NCT01093599|12767774|P1|STARTED|Overall Study||91
5191540|NCT01093586|12767780|P1|NOT COMPLETED|Overall Study||3
5191541|NCT01093586|12767780|P1|COMPLETED|Overall Study||11
5191542|NCT01093586|12767780|P1|STARTED|Overall Study||14
5191543|NCT01093573|12767801|P3|NOT COMPLETED|Overall Study||2
5191544|NCT01093573|12767802|P2|NOT COMPLETED|Overall Study||0
5191545|NCT01093573|12767803|P1|NOT COMPLETED|Overall Study||0
5191546|NCT01093573|12767801|P3|COMPLETED|Overall Study||26
5191547|NCT01093573|12767802|P2|COMPLETED|Overall Study||3
5191548|NCT01093573|12767803|P1|COMPLETED|Overall Study||3
5191549|NCT01093573|12767801|P3|STARTED|Overall Study||28
5191550|NCT01093573|12767802|P2|STARTED|Overall Study||3
5191551|NCT01093573|12767803|P1|STARTED|Overall Study||3
5191552|NCT01093534|12767820|P3|NOT COMPLETED|Overall Study||9
5191553|NCT01093534|12767821|P2|NOT COMPLETED|Overall Study||16
5191554|NCT01093534|12767822|P1|NOT COMPLETED|Overall Study||10
5191555|NCT01093534|12767820|P3|COMPLETED|Overall Study||169
5191556|NCT01093534|12767821|P2|COMPLETED|Overall Study||167
5191557|NCT01093534|12767822|P1|COMPLETED|Overall Study||176
5191558|NCT01093534|12767820|P3|Received Study Treatment|Overall Study||175
5191559|NCT01093534|12767821|P2|Received Study Treatment|Overall Study||182
5191560|NCT01093534|12767822|P1|Received Study Treatment|Overall Study||186
5191561|NCT01093534|12767820|P3|STARTED|Overall Study||178
5191562|NCT01093534|12767821|P2|STARTED|Overall Study||183
5191563|NCT01093534|12767822|P1|STARTED|Overall Study||186
5191564|NCT01093521|12767927|P1|NOT COMPLETED|Overall Study||0
5191565|NCT01093521|12767927|P1|COMPLETED|Overall Study||20
5191566|NCT01093521|12767927|P1|STARTED|Overall Study||20
5191567|NCT01093482|12767942|P1|NOT COMPLETED|Overall Study||0
5191568|NCT01093482|12767942|P1|COMPLETED|Overall Study||8151
5191569|NCT01093482|12767942|P1|STARTED|Overall Study||8151
5191570|NCT01093469|12767949|P3|NOT COMPLETED|Overall Study||1
5191571|NCT01093469|12767950|P2|NOT COMPLETED|Overall Study||0
5191572|NCT01093469|12767951|P1|NOT COMPLETED|Overall Study||0
5191573|NCT01093469|12767949|P3|COMPLETED|Overall Study||12
5191574|NCT01093469|12767950|P2|COMPLETED|Overall Study||13
5191575|NCT01093469|12767951|P1|COMPLETED|Overall Study||13
5191576|NCT01093469|12767949|P3|STARTED|Overall Study||13
5191577|NCT01093469|12767950|P2|STARTED|Overall Study||13
5191578|NCT01093469|12767951|P1|STARTED|Overall Study||13
5191579|NCT01093417|12767961|P2|NOT COMPLETED|Overall Study||1
5191580|NCT01093417|12767962|P1|NOT COMPLETED|Overall Study||0
5191581|NCT01093417|12767961|P2|COMPLETED|Overall Study||29
5191582|NCT01093417|12767962|P1|COMPLETED|Overall Study||15
5191583|NCT01093417|12767961|P2|STARTED|Overall Study||30
5191584|NCT01093417|12767962|P1|STARTED|Overall Study||15
5191585|NCT01093222|12767970|P1|NOT COMPLETED|Overall Study||40
5191586|NCT01093222|12767970|P1|COMPLETED|Overall Study||0
5191587|NCT01093222|12767970|P1|Eligible and Began Protocol Therapy|Overall Study||34
5191588|NCT01093222|12767970|P1|STARTED|Overall Study||40
5191589|NCT01093183|12767977|P2|NOT COMPLETED|Overall Study||2
5191590|NCT01093183|12767978|P1|NOT COMPLETED|Overall Study||1
5191591|NCT01093183|12767977|P2|COMPLETED|Overall Study||4
5191592|NCT01093183|12767978|P1|COMPLETED|Overall Study||18
5191593|NCT01093183|12767977|P2|STARTED|Overall Study||6
5191594|NCT01093183|12767978|P1|STARTED|Overall Study||19
5191595|NCT01093027|12767988|P2|NOT COMPLETED|Visit 2||0
5191596|NCT01093027|12767989|P1|NOT COMPLETED|Visit 2||0
5191597|NCT01093027|12767988|P2|COMPLETED|Visit 2||10
5191598|NCT01093027|12767989|P1|COMPLETED|Visit 2||10
5191599|NCT01093027|12767988|P2|STARTED|Visit 2||10
5191600|NCT01093027|12767989|P1|STARTED|Visit 2||10
5191601|NCT01093027|12767988|P2|NOT COMPLETED|Visit 1||0
5191602|NCT01093027|12767989|P1|NOT COMPLETED|Visit 1||0
5191603|NCT01093027|12767988|P2|COMPLETED|Visit 1||10
5191604|NCT01093027|12767989|P1|COMPLETED|Visit 1||10
5191605|NCT01093027|12767988|P2|STARTED|Visit 1||10
5191606|NCT01093027|12767989|P1|STARTED|Visit 1||10
5191607|NCT01093014|12768000|P3|NOT COMPLETED|Overall Study||0
5191608|NCT01093014|12768001|P2|NOT COMPLETED|Overall Study||0
5191609|NCT01093014|12768002|P1|NOT COMPLETED|Overall Study||0
5191610|NCT01093014|12768000|P3|COMPLETED|Overall Study||12
5191611|NCT01093014|12768001|P2|COMPLETED|Overall Study||9
5191612|NCT01093014|12768002|P1|COMPLETED|Overall Study||12
5191613|NCT01093014|12768000|P3|STARTED|Overall Study||12
5191614|NCT01093014|12768001|P2|STARTED|Overall Study||9
5191615|NCT01093014|12768002|P1|STARTED|Overall Study||12
5191616|NCT01092923|12768021|P2|NOT COMPLETED|Overall Study||0
5191617|NCT01092923|12768022|P1|NOT COMPLETED|Overall Study||0
5191618|NCT01092923|12768021|P2|COMPLETED|Overall Study||10
5191619|NCT01092923|12768022|P1|COMPLETED|Overall Study||10
5191620|NCT01092923|12768021|P2|STARTED|Overall Study||10
5191621|NCT01092923|12768022|P1|STARTED|Overall Study||10
5191622|NCT01092910|12768031|P1|NOT COMPLETED|Overall Study||5
5191623|NCT01092910|12768031|P1|COMPLETED|Overall Study||52
5191624|NCT01092910|12768031|P1|10 Month Follow-up|Overall Study||52
5191625|NCT01092910|12768031|P1|4 Month Follow-up|Overall Study||54
5191626|NCT01092910|12768031|P1|STARTED|Overall Study||57
5191627|NCT01092832|12768046|P2|NOT COMPLETED|Overall Study||0
5191628|NCT01092832|12768047|P1|NOT COMPLETED|Overall Study||1
5191629|NCT01092832|12768046|P2|COMPLETED|Overall Study||8
5191630|NCT01092832|12768047|P1|COMPLETED|Overall Study||13
5191631|NCT01092832|12768046|P2|STARTED|Overall Study||8
5191632|NCT01092832|12768047|P1|STARTED|Overall Study||14
5191633|NCT01092780|12768059|P4|NOT COMPLETED|Treatment Period 4||0
5191634|NCT01092780|12768060|P3|NOT COMPLETED|Treatment Period 4||0
5191635|NCT01092780|12768061|P2|NOT COMPLETED|Treatment Period 4||0
5191636|NCT01092780|12768062|P1|NOT COMPLETED|Treatment Period 4||0
5191637|NCT01092780|12768059|P4|COMPLETED|Treatment Period 4||13
5191638|NCT01092780|12768060|P3|COMPLETED|Treatment Period 4||13
5191639|NCT01092780|12768061|P2|COMPLETED|Treatment Period 4||13
5191640|NCT01092780|12768062|P1|COMPLETED|Treatment Period 4||13
5191641|NCT01092780|12768059|P4|STARTED|Treatment Period 4||13
5191642|NCT01092780|12768060|P3|STARTED|Treatment Period 4||13
5191643|NCT01092780|12768061|P2|STARTED|Treatment Period 4||13
5191644|NCT01092780|12768062|P1|STARTED|Treatment Period 4||13
5191645|NCT01092780|12768059|P4|NOT COMPLETED|Washout Period 3||0
5191646|NCT01092780|12768060|P3|NOT COMPLETED|Washout Period 3||0
5191647|NCT01092780|12768061|P2|NOT COMPLETED|Washout Period 3||0
5191648|NCT01092780|12768062|P1|NOT COMPLETED|Washout Period 3||0
5191649|NCT01092780|12768059|P4|COMPLETED|Washout Period 3||13
5191650|NCT01092780|12768060|P3|COMPLETED|Washout Period 3||13
5191651|NCT01092780|12768061|P2|COMPLETED|Washout Period 3||13
5191652|NCT01092780|12768062|P1|COMPLETED|Washout Period 3||13
5191653|NCT01092780|12768059|P4|STARTED|Washout Period 3||13
5191654|NCT01092780|12768060|P3|STARTED|Washout Period 3||13
5191655|NCT01092780|12768061|P2|STARTED|Washout Period 3||13
5191656|NCT01092780|12768062|P1|STARTED|Washout Period 3||13
5191657|NCT01092780|12768059|P4|NOT COMPLETED|Treatment Period 3||0
5191658|NCT01092780|12768060|P3|NOT COMPLETED|Treatment Period 3||0
5191659|NCT01092780|12768061|P2|NOT COMPLETED|Treatment Period 3||0
5191660|NCT01092780|12768062|P1|NOT COMPLETED|Treatment Period 3||0
5191661|NCT01092780|12768059|P4|COMPLETED|Treatment Period 3||13
5191662|NCT01092780|12768060|P3|COMPLETED|Treatment Period 3||13
5191663|NCT01092780|12768061|P2|COMPLETED|Treatment Period 3||13
5191664|NCT01092780|12768062|P1|COMPLETED|Treatment Period 3||13
5191665|NCT01092780|12768059|P4|STARTED|Treatment Period 3||13
5191666|NCT01092780|12768060|P3|STARTED|Treatment Period 3||13
5191667|NCT01092780|12768061|P2|STARTED|Treatment Period 3||13
5191668|NCT01092780|12768062|P1|STARTED|Treatment Period 3||13
5191669|NCT01092780|12768059|P4|NOT COMPLETED|Washout Period 2||0
5191670|NCT01092780|12768060|P3|NOT COMPLETED|Washout Period 2||1
5191671|NCT01092780|12768061|P2|NOT COMPLETED|Washout Period 2||1
5191672|NCT01092780|12768062|P1|NOT COMPLETED|Washout Period 2||0
5191673|NCT01092780|12768059|P4|COMPLETED|Washout Period 2||13
5191674|NCT01092780|12768060|P3|COMPLETED|Washout Period 2||13
5191675|NCT01092780|12768061|P2|COMPLETED|Washout Period 2||13
5191676|NCT01092780|12768062|P1|COMPLETED|Washout Period 2||13
5191677|NCT01092780|12768059|P4|STARTED|Washout Period 2||13
5191678|NCT01092780|12768060|P3|STARTED|Washout Period 2||14
5191679|NCT01092780|12768061|P2|STARTED|Washout Period 2||14
5191680|NCT01092780|12768062|P1|STARTED|Washout Period 2||13
5191681|NCT01092780|12768059|P4|NOT COMPLETED|Treatment Period 2||0
5191682|NCT01092780|12768060|P3|NOT COMPLETED|Treatment Period 2||0
5191683|NCT01092780|12768061|P2|NOT COMPLETED|Treatment Period 2||0
5191684|NCT01092780|12768062|P1|NOT COMPLETED|Treatment Period 2||0
5191685|NCT01092780|12768059|P4|COMPLETED|Treatment Period 2||13
5191686|NCT01092780|12768060|P3|COMPLETED|Treatment Period 2||14
5191687|NCT01092780|12768061|P2|COMPLETED|Treatment Period 2||14
5191688|NCT01092780|12768062|P1|COMPLETED|Treatment Period 2||13
5191689|NCT01092780|12768059|P4|STARTED|Treatment Period 2||13
5191690|NCT01092780|12768060|P3|STARTED|Treatment Period 2||14
5191691|NCT01092780|12768061|P2|STARTED|Treatment Period 2||14
5191692|NCT01092780|12768062|P1|STARTED|Treatment Period 2||13
5191693|NCT01092780|12768059|P4|NOT COMPLETED|Washout Period 1||0
5191694|NCT01092780|12768060|P3|NOT COMPLETED|Washout Period 1||0
5191695|NCT01092780|12768061|P2|NOT COMPLETED|Washout Period 1||1
5191696|NCT01092780|12768062|P1|NOT COMPLETED|Washout Period 1||1
5191697|NCT01092780|12768059|P4|COMPLETED|Washout Period 1||13
5191698|NCT01092780|12768060|P3|COMPLETED|Washout Period 1||14
5191699|NCT01092780|12768061|P2|COMPLETED|Washout Period 1||14
5191700|NCT01092780|12768062|P1|COMPLETED|Washout Period 1||13
5191701|NCT01092780|12768059|P4|STARTED|Washout Period 1||13
5191702|NCT01092780|12768060|P3|STARTED|Washout Period 1||14
5191703|NCT01092780|12768061|P2|STARTED|Washout Period 1||15
5191704|NCT01092780|12768062|P1|STARTED|Washout Period 1||14
5191705|NCT01092780|12768059|P4|NOT COMPLETED|Treatment Period 1||0
5191706|NCT01092780|12768060|P3|NOT COMPLETED|Treatment Period 1||0
5191707|NCT01092780|12768061|P2|NOT COMPLETED|Treatment Period 1||0
5191708|NCT01092780|12768062|P1|NOT COMPLETED|Treatment Period 1||0
5191709|NCT01092780|12768059|P4|COMPLETED|Treatment Period 1||13
5191710|NCT01092780|12768060|P3|COMPLETED|Treatment Period 1||14
5191711|NCT01092780|12768061|P2|COMPLETED|Treatment Period 1||15
5191712|NCT01092780|12768062|P1|COMPLETED|Treatment Period 1||14
5191713|NCT01092780|12768059|P4|STARTED|Treatment Period 1||13
5191714|NCT01092780|12768060|P3|STARTED|Treatment Period 1||14
5191715|NCT01092780|12768061|P2|STARTED|Treatment Period 1||15
5191716|NCT01092780|12768062|P1|STARTED|Treatment Period 1||14
5191717|NCT01092767|12768092|P1|NOT COMPLETED|Overall Study||5
5191718|NCT01092767|12768092|P1|COMPLETED|Overall Study||45
5191719|NCT01092767|12768092|P1|STARTED|Overall Study||50
5191720|NCT01092728|12768098|P2|NOT COMPLETED|Overall Study||14
5191721|NCT01092728|12768099|P1|NOT COMPLETED|Overall Study||4
5191722|NCT01092728|12768098|P2|COMPLETED|Overall Study||0
5191723|NCT01092728|12768099|P1|COMPLETED|Overall Study||0
5191724|NCT01092728|12768098|P2|STARTED|Overall Study||14
5191725|NCT01092728|12768099|P1|STARTED|Overall Study||4
5191726|NCT01092702|12768107|P1|NOT COMPLETED|Overall Study||9
5191727|NCT01092702|12768107|P1|COMPLETED|Overall Study||23
5191728|NCT01092702|12768107|P1|STARTED|Overall Study||32
5191729|NCT01092676|12768113|P2|NOT COMPLETED|Overall Study||0
5191730|NCT01092676|12768114|P1|NOT COMPLETED|Overall Study||0
5191731|NCT01092676|12768113|P2|COMPLETED|Overall Study||49
5191732|NCT01092676|12768114|P1|COMPLETED|Overall Study||50
5191733|NCT01092676|12768113|P2|STARTED|Overall Study||49
5191734|NCT01092676|12768114|P1|STARTED|Overall Study||50
5191735|NCT01092663|12768124|P2|NOT COMPLETED|Overall Study||4
5191736|NCT01092663|12768125|P1|NOT COMPLETED|Overall Study||7
5191737|NCT01092663|12768124|P2|COMPLETED|Overall Study||26
5191738|NCT01092663|12768125|P1|COMPLETED|Overall Study||24
5191739|NCT01092663|12768124|P2|STARTED|Overall Study||30
5191740|NCT01092663|12768125|P1|STARTED|Overall Study||31
5191741|NCT01092637|12768173|P2|NOT COMPLETED|Overall Study||49
5191742|NCT01092637|12768174|P1|NOT COMPLETED|Overall Study||47
5191743|NCT01092637|12768173|P2|COMPLETED|Overall Study||86
5191744|NCT01092637|12768174|P1|COMPLETED|Overall Study||98
5191745|NCT01092637|12768173|P2|STARTED|Overall Study||135
5191746|NCT01092637|12768174|P1|STARTED|Overall Study||145
5191747|NCT01092559|12768184|P1|NOT COMPLETED|Overall Study||0
5191748|NCT01092559|12768184|P1|COMPLETED|Overall Study||10
5191749|NCT01092559|12768184|P1|STARTED|Overall Study||10
5191750|NCT01092546|12768189|P1|NOT COMPLETED|Overall Study||4
5191751|NCT01092546|12768189|P1|COMPLETED|Overall Study||12
5191752|NCT01092546|12768189|P1|STARTED|Overall Study||16
5191753|NCT01092507|12768196|P2|NOT COMPLETED|Overall Study||0
5191754|NCT01092507|12768197|P1|NOT COMPLETED|Overall Study||2
5191755|NCT01092507|12768196|P2|COMPLETED|Overall Study||150
5191756|NCT01092507|12768197|P1|COMPLETED|Overall Study||147
5191757|NCT01092507|12768196|P2|STARTED|Overall Study||150
5191758|NCT01092507|12768197|P1|STARTED|Overall Study||149
5191759|NCT01092442|12768217|P2|NOT COMPLETED|Overall Study||0
5191760|NCT01092442|12768218|P1|NOT COMPLETED|Overall Study||0
5191761|NCT01092442|12768217|P2|COMPLETED|Overall Study||60
5191762|NCT01092442|12768218|P1|COMPLETED|Overall Study||80
5191763|NCT01092442|12768217|P2|STARTED|Overall Study||60
5191764|NCT01092442|12768218|P1|STARTED|Overall Study||80
5191765|NCT01092416|12768232|P1|NOT COMPLETED|12-Month Follow-up||25
5191766|NCT01092416|12768232|P1|COMPLETED|12-Month Follow-up||413
5191767|NCT01092416|12768232|P1|STARTED|12-Month Follow-up||438
5191768|NCT01092416|12768232|P1|NOT COMPLETED|30-Day Follow-up||10
5191769|NCT01092416|12768232|P1|COMPLETED|30-Day Follow-up||430
5191770|NCT01092416|12768232|P1|STARTED|30-Day Follow-up||440
5191771|NCT01092416|12768232|P1|NOT COMPLETED|Enrollment||3
5191772|NCT01092416|12768232|P1|COMPLETED|Enrollment||440
5191773|NCT01092416|12768232|P1|STARTED|Enrollment||443
5191774|NCT01092364|12768244|P3|NOT COMPLETED|Overall Study||18
5191775|NCT01092364|12768245|P2|NOT COMPLETED|Overall Study||16
5191776|NCT01092364|12768246|P1|NOT COMPLETED|Overall Study||18
5191777|NCT01092364|12768244|P3|COMPLETED|Overall Study||105
5191778|NCT01092364|12768245|P2|COMPLETED|Overall Study||104
5191779|NCT01092364|12768246|P1|COMPLETED|Overall Study||104
5191780|NCT01092364|12768244|P3|STARTED|Overall Study||123
5191781|NCT01092364|12768245|P2|STARTED|Overall Study||120
5191782|NCT01092364|12768246|P1|STARTED|Overall Study||122
5191783|NCT01092338|12768256|P2|NOT COMPLETED|Overall Study||1
5191784|NCT01092338|12768257|P1|NOT COMPLETED|Overall Study||1
5191785|NCT01092338|12768256|P2|COMPLETED|Overall Study||21
5191786|NCT01092338|12768257|P1|COMPLETED|Overall Study||21
5191787|NCT01092338|12768256|P2|STARTED|Overall Study||22
5191788|NCT01092338|12768257|P1|STARTED|Overall Study||22
5191789|NCT01092195|12768268|P3|NOT COMPLETED|Overall Study||0
5191790|NCT01092195|12768269|P2|NOT COMPLETED|Overall Study||0
5191791|NCT01092195|12768270|P1|NOT COMPLETED|Overall Study||0
5191792|NCT01092195|12768268|P3|COMPLETED|Overall Study||20
5191793|NCT01092195|12768269|P2|COMPLETED|Overall Study||21
5191794|NCT01092195|12768270|P1|COMPLETED|Overall Study||23
5191795|NCT01092195|12768268|P3|STARTED|Overall Study||20
5191796|NCT01092195|12768269|P2|STARTED|Overall Study||21
5191797|NCT01092195|12768270|P1|STARTED|Overall Study||23
5191798|NCT01091974|12768282|P4|NOT COMPLETED|Overall Study||7
5191799|NCT01091974|12768283|P3|NOT COMPLETED|Overall Study||6
5191800|NCT01091974|12768284|P2|NOT COMPLETED|Overall Study||5
5191801|NCT01091974|12768285|P1|NOT COMPLETED|Overall Study||5
5191802|NCT01091974|12768282|P4|COMPLETED|Overall Study||17
5191803|NCT01091974|12768283|P3|COMPLETED|Overall Study||19
5191804|NCT01091974|12768284|P2|COMPLETED|Overall Study||18
5191805|NCT01091974|12768285|P1|COMPLETED|Overall Study||19
5191806|NCT01091974|12768282|P4|STARTED|Overall Study||24
5191807|NCT01091974|12768283|P3|STARTED|Overall Study||25
5191808|NCT01091974|12768284|P2|STARTED|Overall Study||23
5191809|NCT01091974|12768285|P1|STARTED|Overall Study||24
5191810|NCT01091948|12768301|P2|NOT COMPLETED|Overall Study||0
5191811|NCT01091948|12768302|P1|NOT COMPLETED|Overall Study||0
5191812|NCT01091948|12768301|P2|COMPLETED|Overall Study||38
5191813|NCT01091948|12768302|P1|COMPLETED|Overall Study||37
5191814|NCT01091948|12768301|P2|STARTED|Overall Study||38
5191815|NCT01091948|12768302|P1|STARTED|Overall Study||37
5191816|NCT01091675|12768320|P1|NOT COMPLETED|Overall Study||34
5191817|NCT01091675|12768320|P1|COMPLETED|Overall Study||23
5191818|NCT01091675|12768320|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
5191819|NCT01091662|12768326|P2|NOT COMPLETED|Overall Study||34
5191820|NCT01091662|12768327|P1|NOT COMPLETED|Overall Study||17
5191821|NCT01091662|12768326|P2|COMPLETED|Overall Study||80
5191822|NCT01091662|12768327|P1|COMPLETED|Overall Study||41
5191823|NCT01091662|12768326|P2|STARTED|Overall Study||114
5191824|NCT01091662|12768327|P1|STARTED|Overall Study||58
5191825|NCT01091519|12768365|P2|NOT COMPLETED|Overall Study||73
5191826|NCT01091519|12768366|P1|NOT COMPLETED|Overall Study||55
5191827|NCT01091519|12768365|P2|COMPLETED|Overall Study||362
5191828|NCT01091519|12768366|P1|COMPLETED|Overall Study||291
5191829|NCT01091519|12768365|P2|Treated|Overall Study||431
5191830|NCT01091519|12768366|P1|Treated|Overall Study||342
5191831|NCT01091519|12768365|P2|STARTED|Overall Study||435
5191832|NCT01091519|12768366|P1|STARTED|Overall Study||346
5191833|NCT01091454|12768378|P1|NOT COMPLETED|Overall Study||1
5191834|NCT01091454|12768378|P1|COMPLETED|Overall Study||47
5191835|NCT01091454|12768378|P1|STARTED|Overall Study||48
5191836|NCT01091428|12768391|P4|NOT COMPLETED|Phase 2||69
5191837|NCT01091428|12768392|P3|NOT COMPLETED|Phase 2||73
5191838|NCT01091428|12768393|P2|NOT COMPLETED|Phase 2||0
5191839|NCT01091428|12768394|P1|NOT COMPLETED|Phase 2||0
5191840|NCT01091428|12768391|P4|COMPLETED|Phase 2||0
5191841|NCT01091428|12768392|P3|COMPLETED|Phase 2||0
5191842|NCT01091428|12768393|P2|COMPLETED|Phase 2||0
5191843|NCT01091428|12768394|P1|COMPLETED|Phase 2||0
5191844|NCT01091428|12768391|P4|STARTED|Phase 2||69
5191845|NCT01091428|12768392|P3|STARTED|Phase 2||73
5191846|NCT01091428|12768393|P2|STARTED|Phase 2||0
5191847|NCT01091428|12768394|P1|STARTED|Phase 2||0
5191848|NCT01091428|12768391|P4|NOT COMPLETED|Phase 1||0
5191849|NCT01091428|12768392|P3|NOT COMPLETED|Phase 1||0
5191850|NCT01091428|12768393|P2|NOT COMPLETED|Phase 1||11
5191851|NCT01091428|12768394|P1|NOT COMPLETED|Phase 1||38
5191852|NCT01091428|12768391|P4|COMPLETED|Phase 1||0
5191853|NCT01091428|12768392|P3|COMPLETED|Phase 1||0
5191854|NCT01091428|12768393|P2|COMPLETED|Phase 1||0
5191855|NCT01091428|12768394|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
5191856|NCT01091428|12768391|P4|STARTED|Phase 1||0
5191857|NCT01091428|12768392|P3|STARTED|Phase 1||0
5191858|NCT01091428|12768393|P2|STARTED|Phase 1||11
5191859|NCT01091428|12768394|P1|STARTED|Phase 1||38
5191860|NCT01091363|12768497|P2|NOT COMPLETED|Overall Study||17
5191861|NCT01091363|12768498|P1|NOT COMPLETED|Overall Study||13
5191862|NCT01091363|12768497|P2|COMPLETED|Overall Study||37
5191863|NCT01091363|12768498|P1|COMPLETED|Overall Study||42
5191864|NCT01091363|12768497|P2|STARTED|Overall Study||54
5191865|NCT01091363|12768498|P1|STARTED|Overall Study||55
5191866|NCT01091259|12768508|P1|NOT COMPLETED|Overall Study||5
5191867|NCT01091259|12768508|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
5191868|NCT01091259|12768508|P1|STARTED|Overall Study||29
5191869|NCT01091246|12768519|P3|NOT COMPLETED|Overall Study||13
5191870|NCT01091246|12768520|P2|NOT COMPLETED|Overall Study||16
5191871|NCT01091246|12768521|P1|NOT COMPLETED|Overall Study||35
5191872|NCT01091246|12768519|P3|COMPLETED|Overall Study||450
5191873|NCT01091246|12768520|P2|COMPLETED|Overall Study||448
5191874|NCT01091246|12768521|P1|COMPLETED|Overall Study||1350
5191875|NCT01091246|12768519|P3|STARTED|Overall Study||463
5191876|NCT01091246|12768520|P2|STARTED|Overall Study||464
5191877|NCT01091246|12768521|P1|STARTED|Overall Study||1385
5191878|NCT01091168|12768597|P2|NOT COMPLETED|Overall Study||296
5191879|NCT01091168|12768598|P1|NOT COMPLETED|Overall Study||298
5191880|NCT01091168|12768597|P2|COMPLETED|Overall Study||0
5191881|NCT01091168|12768598|P1|COMPLETED|Overall Study||0
5191882|NCT01091168|12768597|P2|STARTED|Overall Study||296
5191883|NCT01091168|12768598|P1|STARTED|Overall Study||298
5191884|NCT01091155|12768608|P1|NOT COMPLETED|Overall Study||9
5191885|NCT01091155|12768608|P1|COMPLETED|Overall Study||279
5191886|NCT01091155|12768608|P1|STARTED|Overall Study||288
5191887|NCT01091116|12768617|P5|NOT COMPLETED|Overall Study||11
5191888|NCT01091116|12768618|P4|NOT COMPLETED|Overall Study||4
5191889|NCT01091116|12768619|P3|NOT COMPLETED|Overall Study||11
5191890|NCT01091116|12768620|P2|NOT COMPLETED|Overall Study||8
5191891|NCT01091116|12768621|P1|NOT COMPLETED|Overall Study||6
5191892|NCT01091116|12768617|P5|COMPLETED|Overall Study||73
5191893|NCT01091116|12768618|P4|COMPLETED|Overall Study||80
5191894|NCT01091116|12768619|P3|COMPLETED|Overall Study||73
5191895|NCT01091116|12768620|P2|COMPLETED|Overall Study||80
5191896|NCT01091116|12768621|P1|COMPLETED|Overall Study||77
5191897|NCT01091116|12768617|P5|STARTED|Overall Study||84
5191898|NCT01091116|12768618|P4|STARTED|Overall Study||84
5191899|NCT01091116|12768619|P3|STARTED|Overall Study||84
5191900|NCT01091116|12768620|P2|STARTED|Overall Study||88
5191901|NCT01091116|12768621|P1|STARTED|Overall Study||83
5191902|NCT01091103|12768673|P1|NOT COMPLETED|Overall Study||4
5191903|NCT01091103|12768673|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
5191904|NCT01091103|12768673|P1|STARTED|Overall Study||60
5191905|NCT01090973|12768693|P1|NOT COMPLETED|Overall Study||1
5191906|NCT01090973|12768693|P1|COMPLETED|Overall Study||0
5191907|NCT01090973|12768693|P1|STARTED|Overall Study||1
5191908|NCT01090765|12768709|P6|NOT COMPLETED|Overall Study||1
5191909|NCT01090765|12768710|P5|NOT COMPLETED|Overall Study||2
5191910|NCT01090765|12768711|P4|NOT COMPLETED|Overall Study||1
5191911|NCT01090765|12768712|P3|NOT COMPLETED|Overall Study||0
5191912|NCT01090765|12768713|P2|NOT COMPLETED|Overall Study||0
5191913|NCT01090765|12768714|P1|NOT COMPLETED|Overall Study||0
5191914|NCT01090765|12768709|P6|COMPLETED|Overall Study||3
5191915|NCT01090765|12768710|P5|COMPLETED|Overall Study||4
5191916|NCT01090765|12768711|P4|COMPLETED|Overall Study||1
5191917|NCT01090765|12768712|P3|COMPLETED|Overall Study||3
5191918|NCT01090765|12768713|P2|COMPLETED|Overall Study||3
5191919|NCT01090765|12768714|P1|COMPLETED|Overall Study||3
5191920|NCT01090765|12768709|P6|STARTED|Overall Study||4
5191921|NCT01090765|12768710|P5|STARTED|Overall Study||6
5191922|NCT01090765|12768711|P4|STARTED|Overall Study||2
5191923|NCT01090765|12768712|P3|STARTED|Overall Study||3
5191924|NCT01090765|12768713|P2|STARTED|Overall Study||3
5191925|NCT01090765|12768714|P1|STARTED|Overall Study||3
5191926|NCT01090752|12768749|P2|NOT COMPLETED|Overall Study||0
5191927|NCT01090752|12768750|P1|NOT COMPLETED|Overall Study||0
5191928|NCT01090752|12768749|P2|COMPLETED|Overall Study||8
5191929|NCT01090752|12768750|P1|COMPLETED|Overall Study||8
5191930|NCT01090752|12768749|P2|STARTED|Overall Study||8
5191931|NCT01090752|12768750|P1|STARTED|Overall Study||8
5191932|NCT01090739|12768760|P1|NOT COMPLETED|36 Month Follow-up||23
5191933|NCT01090739|12768760|P1|COMPLETED|36 Month Follow-up||115
5191934|NCT01090739|12768760|P1|STARTED|36 Month Follow-up||138
5191935|NCT01090739|12768760|P1|NOT COMPLETED|24 Month Follow-up||9
5191936|NCT01090739|12768760|P1|COMPLETED|24 Month Follow-up||138
5191937|NCT01090739|12768760|P1|STARTED|24 Month Follow-up||147
5191938|NCT01090739|12768760|P1|NOT COMPLETED|12 Month Follow-up||5
5191939|NCT01090739|12768760|P1|COMPLETED|12 Month Follow-up||147
5191940|NCT01090739|12768760|P1|STARTED|12 Month Follow-up||152
5191941|NCT01090739|12768760|P1|NOT COMPLETED|Enrollment||55
5191942|NCT01090739|12768760|P1|COMPLETED|Enrollment||152
5191943|NCT01090739|12768760|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
5191944|NCT01090492|12768785|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
5191945|NCT01090492|12768786|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
5191946|NCT01090492|12768787|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
5191947|NCT01090492|12768788|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
5191948|NCT01090492|12768789|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
5191949|NCT01090492|12768790|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
5191950|NCT01090492|12768791|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
5191951|NCT01090492|12768792|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
5191952|NCT01090492|12768785|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
5191953|NCT01090492|12768786|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
5191954|NCT01090492|12768787|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
5191955|NCT01090492|12768788|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
5191956|NCT01090492|12768789|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
5191957|NCT01090492|12768790|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
5191958|NCT01090492|12768791|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
5191959|NCT01090492|12768792|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
5191960|NCT01090492|12768785|P8|STARTED|Second Intervention Period (4 Weeks)||27
5191961|NCT01090492|12768786|P7|STARTED|Second Intervention Period (4 Weeks)||31
5191962|NCT01090492|12768787|P6|STARTED|Second Intervention Period (4 Weeks)||30
5191963|NCT01090492|12768788|P5|STARTED|Second Intervention Period (4 Weeks)||29
5191964|NCT01090492|12768789|P4|STARTED|Second Intervention Period (4 Weeks)||22
5191965|NCT01090492|12768790|P3|STARTED|Second Intervention Period (4 Weeks)||26
5191966|NCT01090492|12768791|P2|STARTED|Second Intervention Period (4 Weeks)||24
5191967|NCT01090492|12768792|P1|STARTED|Second Intervention Period (4 Weeks)||26
5191968|NCT01090492|12768785|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191969|NCT01090492|12768786|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191970|NCT01090492|12768787|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191971|NCT01090492|12768788|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191972|NCT01090492|12768789|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191973|NCT01090492|12768790|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191974|NCT01090492|12768791|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191975|NCT01090492|12768792|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
5191976|NCT01090492|12768785|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
5191977|NCT01090492|12768786|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
5191978|NCT01090492|12768787|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
5191979|NCT01090492|12768788|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
5191980|NCT01090492|12768789|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
5191981|NCT01090492|12768790|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
5191982|NCT01090492|12768791|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
5191983|NCT01090492|12768792|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
5191984|NCT01090492|12768785|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
5191985|NCT01090492|12768786|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
5191986|NCT01090492|12768787|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
5191987|NCT01090492|12768788|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
5191988|NCT01090492|12768789|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
5191989|NCT01090492|12768790|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
5191990|NCT01090492|12768791|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
5191991|NCT01090492|12768792|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
5191992|NCT01090492|12768785|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
5191993|NCT01090492|12768786|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
5191994|NCT01090492|12768787|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
5191995|NCT01090492|12768788|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
5191996|NCT01090492|12768789|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
5191997|NCT01090492|12768790|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
5191998|NCT01090492|12768791|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
5191999|NCT01090492|12768792|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
5192000|NCT01090492|12768785|P8|COMPLETED|First Intervention Period (4 Weeks)||27
5192001|NCT01090492|12768786|P7|COMPLETED|First Intervention Period (4 Weeks)||31
5192002|NCT01090492|12768787|P6|COMPLETED|First Intervention Period (4 Weeks)||30
5192003|NCT01090492|12768788|P5|COMPLETED|First Intervention Period (4 Weeks)||29
5192004|NCT01090492|12768789|P4|COMPLETED|First Intervention Period (4 Weeks)||22
5192005|NCT01090492|12768790|P3|COMPLETED|First Intervention Period (4 Weeks)||26
5192006|NCT01090492|12768791|P2|COMPLETED|First Intervention Period (4 Weeks)||24
5192007|NCT01090492|12768792|P1|COMPLETED|First Intervention Period (4 Weeks)||26
5192008|NCT01090492|12768785|P8|STARTED|First Intervention Period (4 Weeks)||33
5192009|NCT01090492|12768786|P7|STARTED|First Intervention Period (4 Weeks)||32
5192010|NCT01090492|12768787|P6|STARTED|First Intervention Period (4 Weeks)||32
5192011|NCT01090492|12768788|P5|STARTED|First Intervention Period (4 Weeks)||33
5192012|NCT01090492|12768789|P4|STARTED|First Intervention Period (4 Weeks)||28
5192013|NCT01090492|12768790|P3|STARTED|First Intervention Period (4 Weeks)||29
5192014|NCT01090492|12768791|P2|STARTED|First Intervention Period (4 Weeks)||29
5192015|NCT01090492|12768792|P1|STARTED|First Intervention Period (4 Weeks)||27
5192016|NCT01090479|12768851|P2|NOT COMPLETED|Overall Study||0
5192017|NCT01090479|12768852|P1|NOT COMPLETED|Overall Study||0
5192018|NCT01090479|12768851|P2|COMPLETED|Overall Study||50
5192019|NCT01090479|12768852|P1|COMPLETED|Overall Study||50
5192020|NCT01090479|12768851|P2|STARTED|Overall Study||50
5192021|NCT01090479|12768852|P1|STARTED|Overall Study||50
5192022|NCT01090453|12768860|P2|NOT COMPLETED|Overall Study||14
5192023|NCT01090453|12768861|P1|NOT COMPLETED|Overall Study||13
5192024|NCT01090453|12768860|P2|COMPLETED|Overall Study||228
5192025|NCT01090453|12768861|P1|COMPLETED|Overall Study||225
5192026|NCT01090453|12768860|P2|STARTED|Overall Study||242
5192027|NCT01090453|12768861|P1|STARTED|Overall Study||238
5192028|NCT01090427|12768912|P7|NOT COMPLETED|After Controlled Period||2
5192029|NCT01090427|12768913|P6|NOT COMPLETED|After Controlled Period||5
5192030|NCT01090427|12768914|P5|NOT COMPLETED|After Controlled Period||0
5192031|NCT01090427|12768915|P4|NOT COMPLETED|After Controlled Period||2
5192032|NCT01090427|12768916|P3|NOT COMPLETED|After Controlled Period||0
5192033|NCT01090427|12768917|P2|NOT COMPLETED|After Controlled Period||0
5192034|NCT01090427|12768918|P1|NOT COMPLETED|After Controlled Period||0
5192035|NCT01090427|12768912|P7|COMPLETED|After Controlled Period||34
5192036|NCT01090427|12768913|P6|COMPLETED|After Controlled Period||32
5192037|NCT01090427|12768914|P5|COMPLETED|After Controlled Period||18
5192038|NCT01090427|12768915|P4|COMPLETED|After Controlled Period||17
5192039|NCT01090427|12768916|P3|COMPLETED|After Controlled Period||0
5192040|NCT01090427|12768917|P2|COMPLETED|After Controlled Period||0
5192041|NCT01090427|12768918|P1|COMPLETED|After Controlled Period||0
5192042|NCT01090427|12768912|P7|STARTED|After Controlled Period||36
5192043|NCT01090427|12768913|P6|STARTED|After Controlled Period||37
5192044|NCT01090427|12768914|P5|STARTED|After Controlled Period||18
5192045|NCT01090427|12768915|P4|STARTED|After Controlled Period||19
5192046|NCT01090427|12768916|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5192047|NCT01090427|12768917|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5192048|NCT01090427|12768918|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5192049|NCT01090427|12768912|P7|NOT COMPLETED|Controlled Period||0
5192050|NCT01090427|12768913|P6|NOT COMPLETED|Controlled Period||0
5192051|NCT01090427|12768914|P5|NOT COMPLETED|Controlled Period||0
5192052|NCT01090427|12768915|P4|NOT COMPLETED|Controlled Period||0
5192053|NCT01090427|12768916|P3|NOT COMPLETED|Controlled Period||0
5192054|NCT01090427|12768917|P2|NOT COMPLETED|Controlled Period||0
5192055|NCT01090427|12768918|P1|NOT COMPLETED|Controlled Period||0
5192056|NCT01090427|12768912|P7|COMPLETED|Controlled Period||0
5192057|NCT01090427|12768913|P6|COMPLETED|Controlled Period||0
5192058|NCT01090427|12768914|P5|COMPLETED|Controlled Period||0
5192059|NCT01090427|12768915|P4|COMPLETED|Controlled Period||0
5192060|NCT01090427|12768916|P3|COMPLETED|Controlled Period||36
5192061|NCT01090427|12768917|P2|COMPLETED|Controlled Period||37
5192062|NCT01090427|12768918|P1|COMPLETED|Controlled Period||37
5192063|NCT01090427|12768912|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5192064|NCT01090427|12768913|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5192065|NCT01090427|12768914|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5192066|NCT01090427|12768915|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5192067|NCT01090427|12768916|P3|STARTED|Controlled Period||36
5192068|NCT01090427|12768917|P2|STARTED|Controlled Period||37
5192069|NCT01090427|12768918|P1|STARTED|Controlled Period||37
5192070|NCT01090414|12768955|P4|NOT COMPLETED|Study 101-99||5
5192071|NCT01090414|12768956|P3|NOT COMPLETED|Study 101-99||41
5192072|NCT01090414|12768957|P2|NOT COMPLETED|Study 101-99||108
5192073|NCT01090414|12768958|P1|NOT COMPLETED|Study 101-99||48
5192074|NCT01090414|12768955|P4|COMPLETED|Study 101-99||0
5192075|NCT01090414|12768956|P3|COMPLETED|Study 101-99||0
5192076|NCT01090414|12768957|P2|COMPLETED|Study 101-99||0
5192077|NCT01090414|12768958|P1|COMPLETED|Study 101-99||0
5192078|NCT01090414|12768955|P4|STARTED|Study 101-99||5
5192079|NCT01090414|12768956|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
5192080|NCT01090414|12768957|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
5192081|NCT01090414|12768958|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
5192082|NCT01090414|12768955|P4|NOT COMPLETED|Parent Studies||13
5192083|NCT01090414|12768956|P3|NOT COMPLETED|Parent Studies||21
5192084|NCT01090414|12768957|P2|NOT COMPLETED|Parent Studies||127
5192085|NCT01090414|12768958|P1|NOT COMPLETED|Parent Studies||141
5192086|NCT01090414|12768955|P4|COMPLETED|Parent Studies||5
5192087|NCT01090414|12768956|P3|COMPLETED|Parent Studies||43
5192088|NCT01090414|12768957|P2|COMPLETED|Parent Studies||114
5192089|NCT01090414|12768958|P1|COMPLETED|Parent Studies||50
5192090|NCT01090414|12768955|P4|STARTED|Parent Studies||18
5192091|NCT01090414|12768956|P3|STARTED|Parent Studies||64
5192092|NCT01090414|12768957|P2|STARTED|Parent Studies||241
5192093|NCT01090414|12768958|P1|STARTED|Parent Studies||191
5192094|NCT01090323|12769025|P2|NOT COMPLETED|Overall Study||34
5192095|NCT01090323|12769026|P1|NOT COMPLETED|Overall Study||89
5192096|NCT01090323|12769025|P2|COMPLETED|Overall Study||19
5192097|NCT01090323|12769026|P1|COMPLETED|Overall Study||43
5192098|NCT01090323|12769025|P2|STARTED|Overall Study||53
5192099|NCT01090323|12769026|P1|STARTED|Overall Study||132
5192100|NCT01090310|12769038|P4|NOT COMPLETED|Extension Study||20
5192101|NCT01090310|12769039|P3|NOT COMPLETED|Extension Study||15
5192102|NCT01090310|12769040|P2|NOT COMPLETED|Extension Study||16
5192103|NCT01090310|12769041|P1|NOT COMPLETED|Extension Study||14
5192104|NCT01090310|12769038|P4|COMPLETED|Extension Study||1
5192105|NCT01090310|12769039|P3|COMPLETED|Extension Study||1
5192106|NCT01090310|12769040|P2|COMPLETED|Extension Study||0
5192107|NCT01090310|12769041|P1|COMPLETED|Extension Study||3
5192108|NCT01090310|12769038|P4|STARTED|Extension Study||21
5192109|NCT01090310|12769039|P3|STARTED|Extension Study||16
5192110|NCT01090310|12769040|P2|STARTED|Extension Study||16
5192111|NCT01090310|12769041|P1|STARTED|Extension Study||17
5192112|NCT01090310|12769038|P4|NOT COMPLETED|Core Study||7
5192113|NCT01090310|12769039|P3|NOT COMPLETED|Core Study||7
5192114|NCT01090310|12769040|P2|NOT COMPLETED|Core Study||11
5192115|NCT01090310|12769041|P1|NOT COMPLETED|Core Study||8
5192116|NCT01090310|12769038|P4|COMPLETED|Core Study||27
5192117|NCT01090310|12769039|P3|COMPLETED|Core Study||24
5192118|NCT01090310|12769040|P2|COMPLETED|Core Study||20
5192119|NCT01090310|12769041|P1|COMPLETED|Core Study||21
5192120|NCT01090310|12769038|P4|STARTED|Core Study||34
5192121|NCT01090310|12769039|P3|STARTED|Core Study||31
5192122|NCT01090310|12769040|P2|STARTED|Core Study||31
5192123|NCT01090310|12769041|P1|STARTED|Core Study||29
5192124|NCT01090180|12769069|P2|NOT COMPLETED|Overall Study||8
5192125|NCT01090180|12769070|P1|NOT COMPLETED|Overall Study||11
5192126|NCT01090180|12769069|P2|COMPLETED|Overall Study||21
5192127|NCT01090180|12769070|P1|COMPLETED|Overall Study||22
5192128|NCT01090180|12769069|P2|STARTED|Overall Study||29
5192129|NCT01090180|12769070|P1|STARTED|Overall Study||33
5192130|NCT01090102|12769080|P2|NOT COMPLETED|Second 12 Weeks||1
5192131|NCT01090102|12769081|P1|NOT COMPLETED|Second 12 Weeks||0
5192132|NCT01090102|12769080|P2|COMPLETED|Second 12 Weeks||15
5192133|NCT01090102|12769081|P1|COMPLETED|Second 12 Weeks||11
5192134|NCT01090102|12769080|P2|STARTED|Second 12 Weeks||16
5192135|NCT01090102|12769081|P1|STARTED|Second 12 Weeks||11
5192136|NCT01090102|12769080|P2|NOT COMPLETED|First 12 Weeks||2
5192137|NCT01090102|12769081|P1|NOT COMPLETED|First 12 Weeks||4
5192138|NCT01090102|12769080|P2|COMPLETED|First 12 Weeks||16
5192139|NCT01090102|12769081|P1|COMPLETED|First 12 Weeks||11
5192140|NCT01090102|12769080|P2|STARTED|First 12 Weeks||18
5192141|NCT01090102|12769081|P1|STARTED|First 12 Weeks||15
5192142|NCT01090076|12769091|P2|NOT COMPLETED|Overall Study||2
5192143|NCT01090076|12769092|P1|NOT COMPLETED|Overall Study||1
5192144|NCT01090076|12769091|P2|COMPLETED|Overall Study||12
5192145|NCT01090076|12769092|P1|COMPLETED|Overall Study||11
5192146|NCT01090076|12769091|P2|STARTED|Overall Study||14
5192147|NCT01090076|12769092|P1|STARTED|Overall Study||12
5192148|NCT01090063|12769102|P1|NOT COMPLETED|Treatment||4
5192149|NCT01090063|12769102|P1|COMPLETED|Treatment||20
5192150|NCT01090063|12769102|P1|STARTED|Treatment||24
5192151|NCT01090063|12769102|P1|NOT COMPLETED|Screen||4
5192152|NCT01090063|12769102|P1|COMPLETED|Screen||24
5192153|NCT01090063|12769102|P1|STARTED|Screen||28
5192154|NCT01090050|12769118|P2|NOT COMPLETED|Overall Study||7
5192155|NCT01090050|12769119|P1|NOT COMPLETED|Overall Study||1
5192156|NCT01090050|12769118|P2|COMPLETED|Overall Study||5
5192157|NCT01090050|12769119|P1|COMPLETED|Overall Study||15
5192158|NCT01090050|12769118|P2|STARTED|Overall Study||12
5192159|NCT01090050|12769119|P1|STARTED|Overall Study||16
5192160|NCT01090011|12769139|P1|NOT COMPLETED|Overall Study||171
5192161|NCT01090011|12769139|P1|COMPLETED|Overall Study||0
5192162|NCT01090011|12769139|P1|STARTED|Overall Study||171
5192163|NCT01089751|12769209|P2|NOT COMPLETED|Overall Study||27
5192164|NCT01089751|12769210|P1|NOT COMPLETED|Overall Study||34
5192165|NCT01089751|12769209|P2|COMPLETED|Overall Study||132
5192166|NCT01089751|12769210|P1|COMPLETED|Overall Study||129
5192167|NCT01089751|12769209|P2|STARTED|Overall Study||159
5192168|NCT01089751|12769210|P1|STARTED|Overall Study||163
5192169|NCT01089647|12769232|P2|NOT COMPLETED|Overall Study||4
5192170|NCT01089647|12769233|P1|NOT COMPLETED|Overall Study||4
5192171|NCT01089647|12769232|P2|COMPLETED|Overall Study||13
5192172|NCT01089647|12769233|P1|COMPLETED|Overall Study||13
5192173|NCT01089647|12769232|P2|STARTED|Overall Study||17
5192174|NCT01089647|12769233|P1|STARTED|Overall Study||17
5192175|NCT01089608|12769241|P2|NOT COMPLETED|Overall Study||6
5192176|NCT01089608|12769242|P1|NOT COMPLETED|Overall Study||0
5192177|NCT01089608|12769241|P2|COMPLETED|Overall Study||44
5192178|NCT01089608|12769242|P1|COMPLETED|Overall Study||43
5192179|NCT01089608|12769241|P2|STARTED|Overall Study||50
5192180|NCT01089608|12769242|P1|STARTED|Overall Study||43
5192181|NCT01089595|12769250|P2|NOT COMPLETED|Overall Study||0
5192182|NCT01089595|12769251|P1|NOT COMPLETED|Overall Study||0
5192183|NCT01089595|12769250|P2|COMPLETED|Overall Study||3
5192184|NCT01089595|12769251|P1|COMPLETED|Overall Study||2
5192185|NCT01089595|12769250|P2|STARTED|Overall Study||3
5192186|NCT01089595|12769251|P1|STARTED|Overall Study||2
5192187|NCT01089582|12769259|P1|NOT COMPLETED|Overall Study||30
5192188|NCT01089582|12769259|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
5192189|NCT01089582|12769259|P1|STARTED|Overall Study||603
5192190|NCT01089569|12769272|P3|NOT COMPLETED|Overall Study||4
5192191|NCT01089569|12769273|P2|NOT COMPLETED|Overall Study||3
5192192|NCT01089569|12769274|P1|NOT COMPLETED|Overall Study||4
5192193|NCT01089569|12769272|P3|COMPLETED|Overall Study||16
5192194|NCT01089569|12769273|P2|COMPLETED|Overall Study||17
5192195|NCT01089569|12769274|P1|COMPLETED|Overall Study||16
5192196|NCT01089569|12769272|P3|STARTED|Overall Study||20
5192197|NCT01089569|12769273|P2|STARTED|Overall Study||20
5192198|NCT01089569|12769274|P1|STARTED|Overall Study||20
5192199|NCT01089556|12769302|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
5192200|NCT01089556|12769303|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
5192201|NCT01089556|12769304|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
5192202|NCT01089556|12769305|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
5192203|NCT01089556|12769306|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
5192204|NCT01089556|12769307|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
5192205|NCT01089556|12769302|P6|COMPLETED|Study Period III (Weeks 9-16)||92
5192206|NCT01089556|12769303|P5|COMPLETED|Study Period III (Weeks 9-16)||83
5192207|NCT01089556|12769304|P4|COMPLETED|Study Period III (Weeks 9-16)||66
5192208|NCT01089556|12769305|P3|COMPLETED|Study Period III (Weeks 9-16)||60
5192209|NCT01089556|12769306|P2|COMPLETED|Study Period III (Weeks 9-16)||0
5192210|NCT01089556|12769307|P1|COMPLETED|Study Period III (Weeks 9-16)||0
5192211|NCT01089556|12769302|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
5192212|NCT01089556|12769303|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
5192213|NCT01089556|12769304|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
5192214|NCT01089556|12769305|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
5192215|NCT01089556|12769306|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
5192216|NCT01089556|12769307|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
5192217|NCT01089556|12769302|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
5192218|NCT01089556|12769303|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
5192219|NCT01089556|12769304|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
5192220|NCT01089556|12769305|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
5192221|NCT01089556|12769306|P2|STARTED|Study Period III (Weeks 9-16)||0
5192222|NCT01089556|12769307|P1|STARTED|Study Period III (Weeks 9-16)||0
5192223|NCT01089556|12769302|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
5192224|NCT01089556|12769303|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
5192225|NCT01089556|12769304|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
5192226|NCT01089556|12769305|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
5192227|NCT01089556|12769306|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
5192228|NCT01089556|12769307|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
5192229|NCT01089556|12769302|P6|COMPLETED|Study Period II (Weeks 1-8)||0
5192230|NCT01089556|12769303|P5|COMPLETED|Study Period II (Weeks 1-8)||0
5192231|NCT01089556|12769304|P4|COMPLETED|Study Period II (Weeks 1-8)||0
5192232|NCT01089556|12769305|P3|COMPLETED|Study Period II (Weeks 1-8)||0
5192233|NCT01089556|12769306|P2|COMPLETED|Study Period II (Weeks 1-8)||333
5192234|NCT01089556|12769307|P1|COMPLETED|Study Period II (Weeks 1-8)||333
5192235|NCT01089556|12769302|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
5192236|NCT01089556|12769303|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
5192237|NCT01089556|12769304|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
5192238|NCT01089556|12769305|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
5192239|NCT01089556|12769306|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
5192240|NCT01089556|12769307|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
5192241|NCT01089556|12769302|P6|Safety Population|Study Period II (Weeks 1-8)||0
5192242|NCT01089556|12769303|P5|Safety Population|Study Period II (Weeks 1-8)||0
5192243|NCT01089556|12769304|P4|Safety Population|Study Period II (Weeks 1-8)||0
5192244|NCT01089556|12769305|P3|Safety Population|Study Period II (Weeks 1-8)||0
5192245|NCT01089556|12769306|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
5192246|NCT01089556|12769307|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
5192247|NCT01089556|12769302|P6|STARTED|Study Period II (Weeks 1-8)||0
5192248|NCT01089556|12769303|P5|STARTED|Study Period II (Weeks 1-8)||0
5192249|NCT01089556|12769304|P4|STARTED|Study Period II (Weeks 1-8)||0
5192250|NCT01089556|12769305|P3|STARTED|Study Period II (Weeks 1-8)||0
5192251|NCT01089556|12769306|P2|STARTED|Study Period II (Weeks 1-8)||407
5192252|NCT01089556|12769307|P1|STARTED|Study Period II (Weeks 1-8)||404
5192253|NCT01089543|12769381|P4|NOT COMPLETED|Overall Study||2
5192254|NCT01089543|12769382|P3|NOT COMPLETED|Overall Study||3
5192255|NCT01089543|12769383|P2|NOT COMPLETED|Overall Study||4
5192256|NCT01089543|12769384|P1|NOT COMPLETED|Overall Study||3
5192257|NCT01089543|12769381|P4|COMPLETED|Overall Study||83
5192258|NCT01089543|12769382|P3|COMPLETED|Overall Study||81
5192259|NCT01089543|12769383|P2|COMPLETED|Overall Study||81
5192260|NCT01089543|12769384|P1|COMPLETED|Overall Study||81
5192261|NCT01089543|12769381|P4|STARTED|Overall Study||85
5192262|NCT01089543|12769382|P3|STARTED|Overall Study||84
5192263|NCT01089543|12769383|P2|STARTED|Overall Study||85
5192264|NCT01089543|12769384|P1|STARTED|Overall Study||84
5192265|NCT01089517|12769401|P3|NOT COMPLETED|Overall Study||5
5192266|NCT01089517|12769402|P2|NOT COMPLETED|Overall Study||5
5192267|NCT01089517|12769403|P1|NOT COMPLETED|Overall Study||4
5192268|NCT01089517|12769401|P3|COMPLETED|Overall Study||147
5192269|NCT01089517|12769402|P2|COMPLETED|Overall Study||144
5192270|NCT01089517|12769403|P1|COMPLETED|Overall Study||144
5192271|NCT01089517|12769401|P3|STARTED|Overall Study||152
5192272|NCT01089517|12769402|P2|STARTED|Overall Study||149
5192273|NCT01089517|12769403|P1|STARTED|Overall Study||148
5192274|NCT01089504|12769419|P2|NOT COMPLETED|Overall Study||1
5192275|NCT01089504|12769420|P1|NOT COMPLETED|Overall Study||3
5192276|NCT01089504|12769419|P2|COMPLETED|Overall Study||4
5192277|NCT01089504|12769420|P1|COMPLETED|Overall Study||5
5192278|NCT01089504|12769419|P2|STARTED|Overall Study||5
5192279|NCT01089504|12769420|P1|STARTED|Overall Study||8
5192280|NCT01089413|12769433|P1|NOT COMPLETED|Overall Study||201
5192281|NCT01089413|12769433|P1|COMPLETED|Overall Study||0
5192282|NCT01089413|12769433|P1|Received Bevacizumab in First Line|Overall Study||199
5192283|NCT01089413|12769433|P1|STARTED|Overall Study||201
5192284|NCT01089361|12769452|P2|NOT COMPLETED|Overall Study||0
5192285|NCT01089361|12769453|P1|NOT COMPLETED|Overall Study||1
5192286|NCT01089361|12769452|P2|COMPLETED|Overall Study||10
5192287|NCT01089361|12769453|P1|COMPLETED|Overall Study||8
5192288|NCT01089361|12769452|P2|STARTED|Overall Study||10
5192289|NCT01089361|12769453|P1|STARTED|Overall Study||9
5192290|NCT01089231|12769475|P4|NOT COMPLETED|Overall Study||1
5192291|NCT01089231|12769476|P3|NOT COMPLETED|Overall Study||2
5192292|NCT01089231|12769477|P2|NOT COMPLETED|Overall Study||2
5192293|NCT01089231|12769478|P1|NOT COMPLETED|Overall Study||4
5192294|NCT01089231|12769475|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
5192295|NCT01089231|12769476|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
5192296|NCT01089231|12769477|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
5192297|NCT01089231|12769478|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
5192298|NCT01089231|12769475|P4|STARTED|Overall Study||10
5192299|NCT01089231|12769476|P3|STARTED|Overall Study||10
5192300|NCT01089231|12769477|P2|STARTED|Overall Study||10
5192301|NCT01089231|12769478|P1|STARTED|Overall Study||10
5192302|NCT01089127|12769502|P6|NOT COMPLETED|Overall Study||3
5192303|NCT01089127|12769503|P5|NOT COMPLETED|Overall Study||2
5192304|NCT01089127|12769504|P4|NOT COMPLETED|Overall Study||1
5192305|NCT01089127|12769505|P3|NOT COMPLETED|Overall Study||2
5192306|NCT01089127|12769506|P2|NOT COMPLETED|Overall Study||5
5192307|NCT01089127|12769507|P1|NOT COMPLETED|Overall Study||8
5192308|NCT01089127|12769502|P6|COMPLETED|Overall Study||88
5192309|NCT01089127|12769503|P5|COMPLETED|Overall Study||90
5192310|NCT01089127|12769504|P4|COMPLETED|Overall Study||91
5192311|NCT01089127|12769505|P3|COMPLETED|Overall Study||92
5192312|NCT01089127|12769506|P2|COMPLETED|Overall Study||86
5192313|NCT01089127|12769507|P1|COMPLETED|Overall Study||84
5192314|NCT01089127|12769502|P6|Exposed to Study Drug|Overall Study||91
5192315|NCT01089127|12769503|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
5192316|NCT01089127|12769504|P4|Exposed to Study Drug|Overall Study||92
5192317|NCT01089127|12769505|P3|Exposed to Study Drug|Overall Study||94
5192318|NCT01089127|12769506|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
5192319|NCT01089127|12769507|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
5192320|NCT01089127|12769502|P6|STARTED|Overall Study||91
5192321|NCT01089127|12769503|P5|STARTED|Overall Study||92
5192322|NCT01089127|12769504|P4|STARTED|Overall Study||92
5192323|NCT01089127|12769505|P3|STARTED|Overall Study||94
5192324|NCT01089127|12769506|P2|STARTED|Overall Study||91
5192325|NCT01089127|12769507|P1|STARTED|Overall Study||92
5192326|NCT01089062|12769533|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192327|NCT01089062|12769534|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192328|NCT01089062|12769535|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192329|NCT01089062|12769536|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192330|NCT01089062|12769537|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192331|NCT01089062|12769538|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5192332|NCT01089062|12769533|P6|COMPLETED|Follow-up Visit (Final Visit)||3
5192333|NCT01089062|12769534|P5|COMPLETED|Follow-up Visit (Final Visit)||3
5192334|NCT01089062|12769535|P4|COMPLETED|Follow-up Visit (Final Visit)||3
5192335|NCT01089062|12769536|P3|COMPLETED|Follow-up Visit (Final Visit)||3
5192336|NCT01089062|12769537|P2|COMPLETED|Follow-up Visit (Final Visit)||3
5192337|NCT01089062|12769538|P1|COMPLETED|Follow-up Visit (Final Visit)||3
5192338|NCT01089062|12769533|P6|STARTED|Follow-up Visit (Final Visit)||3
5192339|NCT01089062|12769534|P5|STARTED|Follow-up Visit (Final Visit)||3
5192340|NCT01089062|12769535|P4|STARTED|Follow-up Visit (Final Visit)||3
5192341|NCT01089062|12769536|P3|STARTED|Follow-up Visit (Final Visit)||3
5192342|NCT01089062|12769537|P2|STARTED|Follow-up Visit (Final Visit)||3
5192343|NCT01089062|12769538|P1|STARTED|Follow-up Visit (Final Visit)||3
5192344|NCT01089062|12769533|P6|NOT COMPLETED|Visit 4||0
5192345|NCT01089062|12769534|P5|NOT COMPLETED|Visit 4||0
5192346|NCT01089062|12769535|P4|NOT COMPLETED|Visit 4||0
5192347|NCT01089062|12769536|P3|NOT COMPLETED|Visit 4||0
5192348|NCT01089062|12769537|P2|NOT COMPLETED|Visit 4||0
5192349|NCT01089062|12769538|P1|NOT COMPLETED|Visit 4||0
5192350|NCT01089062|12769533|P6|COMPLETED|Visit 4||3
5192351|NCT01089062|12769534|P5|COMPLETED|Visit 4||3
5192352|NCT01089062|12769535|P4|COMPLETED|Visit 4||3
5192353|NCT01089062|12769536|P3|COMPLETED|Visit 4||3
5192354|NCT01089062|12769537|P2|COMPLETED|Visit 4||3
5192355|NCT01089062|12769538|P1|COMPLETED|Visit 4||3
5192356|NCT01089062|12769533|P6|STARTED|Visit 4||3
5192357|NCT01089062|12769534|P5|STARTED|Visit 4||3
5192358|NCT01089062|12769535|P4|STARTED|Visit 4||3
5192359|NCT01089062|12769536|P3|STARTED|Visit 4||3
5192360|NCT01089062|12769537|P2|STARTED|Visit 4||3
5192361|NCT01089062|12769538|P1|STARTED|Visit 4||3
5192362|NCT01089062|12769533|P6|NOT COMPLETED|Visit 3||0
5192363|NCT01089062|12769534|P5|NOT COMPLETED|Visit 3||0
5192364|NCT01089062|12769535|P4|NOT COMPLETED|Visit 3||1
5192365|NCT01089062|12769536|P3|NOT COMPLETED|Visit 3||0
5192366|NCT01089062|12769537|P2|NOT COMPLETED|Visit 3||0
5192367|NCT01089062|12769538|P1|NOT COMPLETED|Visit 3||0
5192368|NCT01089062|12769533|P6|COMPLETED|Visit 3||3
5192369|NCT01089062|12769534|P5|COMPLETED|Visit 3||3
5192370|NCT01089062|12769535|P4|COMPLETED|Visit 3||3
5192371|NCT01089062|12769536|P3|COMPLETED|Visit 3||3
5192372|NCT01089062|12769537|P2|COMPLETED|Visit 3||3
5192373|NCT01089062|12769538|P1|COMPLETED|Visit 3||3
5192374|NCT01089062|12769533|P6|STARTED|Visit 3||3
5192375|NCT01089062|12769534|P5|STARTED|Visit 3||3
5192376|NCT01089062|12769535|P4|STARTED|Visit 3||4
5192377|NCT01089062|12769536|P3|STARTED|Visit 3||3
5192378|NCT01089062|12769537|P2|STARTED|Visit 3||3
5192379|NCT01089062|12769538|P1|STARTED|Visit 3||3
5192380|NCT01089062|12769533|P6|NOT COMPLETED|Visit 2 (Randomization)||1
5192381|NCT01089062|12769534|P5|NOT COMPLETED|Visit 2 (Randomization)||1
5192382|NCT01089062|12769535|P4|NOT COMPLETED|Visit 2 (Randomization)||0
5192383|NCT01089062|12769536|P3|NOT COMPLETED|Visit 2 (Randomization)||1
5192384|NCT01089062|12769537|P2|NOT COMPLETED|Visit 2 (Randomization)||1
5192385|NCT01089062|12769538|P1|NOT COMPLETED|Visit 2 (Randomization)||1
5192386|NCT01089062|12769533|P6|COMPLETED|Visit 2 (Randomization)||3
5192387|NCT01089062|12769534|P5|COMPLETED|Visit 2 (Randomization)||3
5192388|NCT01089062|12769535|P4|COMPLETED|Visit 2 (Randomization)||4
5192389|NCT01089062|12769536|P3|COMPLETED|Visit 2 (Randomization)||3
5192390|NCT01089062|12769537|P2|COMPLETED|Visit 2 (Randomization)||3
5192391|NCT01089062|12769538|P1|COMPLETED|Visit 2 (Randomization)||3
5192392|NCT01089062|12769533|P6|STARTED|Visit 2 (Randomization)||4
5192393|NCT01089062|12769534|P5|STARTED|Visit 2 (Randomization)||4
5192394|NCT01089062|12769535|P4|STARTED|Visit 2 (Randomization)||4
5192395|NCT01089062|12769536|P3|STARTED|Visit 2 (Randomization)||4
5192396|NCT01089062|12769537|P2|STARTED|Visit 2 (Randomization)||4
5192397|NCT01089062|12769538|P1|STARTED|Visit 2 (Randomization)||4
5192398|NCT01089023|12769561|P1|NOT COMPLETED|Overall Study||7
5192399|NCT01089023|12769561|P1|COMPLETED|Overall Study||88
5192400|NCT01089023|12769561|P1|STARTED|Overall Study||95
5192401|NCT01088997|12769575|P2|NOT COMPLETED|Overall Study||3
5192402|NCT01088997|12769576|P1|NOT COMPLETED|Overall Study||3
5192403|NCT01088997|12769575|P2|COMPLETED|Overall Study||2
5192404|NCT01088997|12769576|P1|COMPLETED|Overall Study||4
5192405|NCT01088997|12769575|P2|STARTED|Overall Study||5
5192406|NCT01088997|12769576|P1|STARTED|Overall Study||7
5192407|NCT01088984|12769587|P2|NOT COMPLETED|Phase 2||32
5192408|NCT01088984|12769588|P1|NOT COMPLETED|Phase 2||0
5192409|NCT01088984|12769587|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
5192410|NCT01088984|12769588|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
5192411|NCT01088984|12769587|P2|STARTED|Phase 2||32
5192412|NCT01088984|12769588|P1|STARTED|Phase 2||0
5192413|NCT01088984|12769587|P2|NOT COMPLETED|Phase 1||6
5192414|NCT01088984|12769588|P1|NOT COMPLETED|Phase 1||5
5192415|NCT01088984|12769587|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
5192416|NCT01088984|12769588|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
5192417|NCT01088984|12769587|P2|STARTED|Phase 1||6
5192418|NCT01088984|12769588|P1|STARTED|Phase 1||5
5192419|NCT01088815|12769606|P1|NOT COMPLETED|Overall Study||0
5192420|NCT01088815|12769606|P1|COMPLETED|Overall Study||72
5192421|NCT01088815|12769606|P1|STARTED|Overall Study||72
5192422|NCT01088711|12769619|P4|NOT COMPLETED|Overall Study||0
5192423|NCT01088711|12769620|P3|NOT COMPLETED|Overall Study||0
5192424|NCT01088711|12769621|P2|NOT COMPLETED|Overall Study||0
5192425|NCT01088711|12769622|P1|NOT COMPLETED|Overall Study||0
5192426|NCT01088711|12769619|P4|COMPLETED|Overall Study||2
5192427|NCT01088711|12769620|P3|COMPLETED|Overall Study||6
5192428|NCT01088711|12769621|P2|COMPLETED|Overall Study||6
5192429|NCT01088711|12769622|P1|COMPLETED|Overall Study||18
5192430|NCT01088711|12769619|P4|STARTED|Overall Study||2
5192431|NCT01088711|12769620|P3|STARTED|Overall Study||6
5192432|NCT01088711|12769621|P2|STARTED|Overall Study||6
5192433|NCT01088711|12769622|P1|STARTED|Overall Study||18
5192434|NCT01088672|12769646|P1|NOT COMPLETED|Overall Study||0
5192435|NCT01088672|12769646|P1|COMPLETED|Overall Study||60
5192436|NCT01088672|12769646|P1|STARTED|Overall Study||60
5192437|NCT01088646|12769652|P1|NOT COMPLETED|Overall Study||0
5192438|NCT01088646|12769652|P1|COMPLETED|Overall Study||25
5192439|NCT01088646|12769652|P1|STARTED|Overall Study||25
5192440|NCT01088529|12769658|P2|NOT COMPLETED|Overall Study||1
5192441|NCT01088529|12769659|P1|NOT COMPLETED|Overall Study||0
5192442|NCT01088529|12769658|P2|COMPLETED|Overall Study||21
5192443|NCT01088529|12769659|P1|COMPLETED|Overall Study||44
5192444|NCT01088529|12769658|P2|Received Treatment|Overall Study||21
5192445|NCT01088529|12769659|P1|Received Treatment|Overall Study||44
5192446|NCT01088529|12769658|P2|STARTED|Overall Study||22
5192447|NCT01088529|12769659|P1|STARTED|Overall Study||44
5192448|NCT01088503|12769672|P3|NOT COMPLETED|Overall Study||17
5192449|NCT01088503|12769673|P2|NOT COMPLETED|Overall Study||685
5192450|NCT01088503|12769674|P1|NOT COMPLETED|Overall Study||182
5192451|NCT01088503|12769672|P3|COMPLETED|Overall Study||241
5192452|NCT01088503|12769673|P2|COMPLETED|Overall Study||8161
5192453|NCT01088503|12769674|P1|COMPLETED|Overall Study||2941
5192454|NCT01088503|12769672|P3|STARTED|Overall Study||258
5192455|NCT01088503|12769673|P2|STARTED|Overall Study||8846
5192456|NCT01088503|12769674|P1|STARTED|Overall Study||3123
5192457|NCT01088464|12769698|P3|NOT COMPLETED|Overall Study||0
5192458|NCT01088464|12769699|P2|NOT COMPLETED|Overall Study||0
5192459|NCT01088464|12769700|P1|NOT COMPLETED|Overall Study||0
5192460|NCT01088464|12769698|P3|COMPLETED|Overall Study||6
5192461|NCT01088464|12769699|P2|COMPLETED|Overall Study||6
5192462|NCT01088464|12769700|P1|COMPLETED|Overall Study||3
5192463|NCT01088464|12769698|P3|Received Any Quantity of Study Drug|Overall Study||6
5192464|NCT01088464|12769699|P2|Received Any Quantity of Study Drug|Overall Study||6
5192465|NCT01088464|12769700|P1|Received Any Quantity of Study Drug|Overall Study||3
5192466|NCT01088464|12769698|P3|STARTED|Overall Study||6
5192467|NCT01088464|12769699|P2|STARTED|Overall Study||6
5192468|NCT01088464|12769700|P1|STARTED|Overall Study||3
5192469|NCT01088438|12769752|P2|NOT COMPLETED|Overall Study||36
5192470|NCT01088438|12769753|P1|NOT COMPLETED|Overall Study||29
5192471|NCT01088438|12769752|P2|COMPLETED|Overall Study||59
5192472|NCT01088438|12769753|P1|COMPLETED|Overall Study||65
5192473|NCT01088438|12769752|P2|STARTED|Overall Study||95
5192474|NCT01088438|12769753|P1|STARTED|Overall Study||94
5192475|NCT01088412|12769766|P3|NOT COMPLETED|Overall Study||72
5192476|NCT01088412|12769767|P2|NOT COMPLETED|Overall Study||436
5192477|NCT01088412|12769768|P1|NOT COMPLETED|Overall Study||18017
5192478|NCT01088412|12769766|P3|COMPLETED|Overall Study||5
5192479|NCT01088412|12769767|P2|COMPLETED|Overall Study||21
5192480|NCT01088412|12769768|P1|COMPLETED|Overall Study||4294
5192481|NCT01088412|12769766|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
5192482|NCT01088412|12769767|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
5192483|NCT01088412|12769768|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
5192484|NCT01088412|12769766|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
5192485|NCT01088412|12769767|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
5192486|NCT01088412|12769768|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
5192487|NCT01088412|12769766|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
5192488|NCT01088412|12769767|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
5192489|NCT01088412|12769768|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
5192490|NCT01088412|12769766|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
5192491|NCT01088412|12769767|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
5192492|NCT01088412|12769768|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
5192493|NCT01088412|12769766|P3|Safety Modified Evaluable (SME)|Overall Study||0
5192494|NCT01088412|12769767|P2|Safety Modified Evaluable (SME)|Overall Study||456
5192495|NCT01088412|12769768|P1|Safety Modified Evaluable (SME)|Overall Study||22294
5192496|NCT01088412|12769766|P3|STARTED|Overall Study||77
5192497|NCT01088412|12769767|P2|STARTED|Overall Study||457
5192498|NCT01088412|12769768|P1|STARTED|Overall Study||22311
5192499|NCT01088399|12769787|P3|NOT COMPLETED|Overall Study||281
5192500|NCT01088399|12769788|P2|NOT COMPLETED|Overall Study||1347
5192501|NCT01088399|12769789|P1|NOT COMPLETED|Overall Study||7121
5192502|NCT01088399|12769787|P3|COMPLETED|Overall Study||21
5192503|NCT01088399|12769788|P2|COMPLETED|Overall Study||308
5192504|NCT01088399|12769789|P1|COMPLETED|Overall Study||1595
5192505|NCT01088399|12769787|P3|STARTED|Overall Study||302
5192506|NCT01088399|12769788|P2|STARTED|Overall Study||1655
5192507|NCT01088399|12769789|P1|STARTED|Overall Study||8716
5192508|NCT01088295|12769812|P1|NOT COMPLETED|Overall Study||1
5192509|NCT01088295|12769812|P1|COMPLETED|Overall Study||35
5192510|NCT01088295|12769812|P1|STARTED|Overall Study||36
5192511|NCT01088243|12769818|P2|NOT COMPLETED|Overall Study||0
5192512|NCT01088243|12769819|P1|NOT COMPLETED|Overall Study||1
5192513|NCT01088243|12769818|P2|COMPLETED|Overall Study||5
5192514|NCT01088243|12769819|P1|COMPLETED|Overall Study||12
5192515|NCT01088243|12769818|P2|STARTED|Overall Study||5
5192516|NCT01088243|12769819|P1|STARTED|Overall Study||13
5192517|NCT01087996|12769837|P2|NOT COMPLETED|Overall Study||0
5192518|NCT01087996|12769838|P1|NOT COMPLETED|Overall Study||0
5192519|NCT01087996|12769837|P2|COMPLETED|Overall Study||15
5192520|NCT01087996|12769838|P1|COMPLETED|Overall Study||15
5192521|NCT01087996|12769837|P2|STARTED|Overall Study||15
5192522|NCT01087996|12769838|P1|STARTED|Overall Study||15
5192523|NCT01087970|12769860|P1|NOT COMPLETED|Overall Study||2
5192524|NCT01087970|12769860|P1|COMPLETED|Overall Study||67
5192525|NCT01087970|12769860|P1|Received Carboplatin|Overall Study||63
5192526|NCT01087970|12769860|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
5192527|NCT01087970|12769860|P1|Completed 6 Cycles|Overall Study||69
5192528|NCT01087970|12769860|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
5192529|NCT01087970|12769860|P1|STARTED|Overall Study||69
5192530|NCT01087957|12769872|P2|NOT COMPLETED|Overall Study||55
5192531|NCT01087957|12769873|P1|NOT COMPLETED|Overall Study||41
5192532|NCT01087957|12769872|P2|COMPLETED|Overall Study||187
5192533|NCT01087957|12769873|P1|COMPLETED|Overall Study||212
5192534|NCT01087957|12769872|P2|STARTED|Overall Study||242
5192535|NCT01087957|12769873|P1|STARTED|Overall Study||253
5192536|NCT01087944|12769899|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
5192537|NCT01087944|12769900|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
5192538|NCT01087944|12769899|P2|COMPLETED|Period 2 (Week 4-6)||28
5192539|NCT01087944|12769900|P1|COMPLETED|Period 2 (Week 4-6)||29
5192540|NCT01087944|12769899|P2|STARTED|Period 2 (Week 4-6)||30
5192541|NCT01087944|12769900|P1|STARTED|Period 2 (Week 4-6)||29
5192542|NCT01087944|12769899|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
5192543|NCT01087944|12769900|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
5192544|NCT01087944|12769899|P2|COMPLETED|Period 1 (Week 1-3)||30
5192545|NCT01087944|12769900|P1|COMPLETED|Period 1 (Week 1-3)||29
5192546|NCT01087944|12769899|P2|STARTED|Period 1 (Week 1-3)||30
5192547|NCT01087944|12769900|P1|STARTED|Period 1 (Week 1-3)||30
5192548|NCT01087931|12769930|P2|NOT COMPLETED|Overall Study||0
5192549|NCT01087931|12769931|P1|NOT COMPLETED|Overall Study||0
5192550|NCT01087931|12769930|P2|COMPLETED|Overall Study||20
5192551|NCT01087931|12769931|P1|COMPLETED|Overall Study||20
5192552|NCT01087931|12769930|P2|Final Follow up|Overall Study||17
5192553|NCT01087931|12769931|P1|Final Follow up|Overall Study||19
5192554|NCT01087931|12769930|P2|1st Follow up|Overall Study||19
5192555|NCT01087931|12769931|P1|1st Follow up|Overall Study||20
5192556|NCT01087931|12769930|P2|STARTED|Overall Study||20
5192557|NCT01087931|12769931|P1|STARTED|Overall Study||20
5192558|NCT01087918|12769945|P2|NOT COMPLETED|Overall Study||0
5192559|NCT01087918|12769946|P1|NOT COMPLETED|Overall Study||0
5192560|NCT01087918|12769945|P2|COMPLETED|Overall Study||4
5192561|NCT01087918|12769946|P1|COMPLETED|Overall Study||5
5192562|NCT01087918|12769945|P2|STARTED|Overall Study||4
5192563|NCT01087918|12769946|P1|STARTED|Overall Study||5
5192564|NCT01087905|12769980|P8|NOT COMPLETED|Overall Study||29
5192565|NCT01087905|12769981|P7|NOT COMPLETED|Overall Study||23
5192566|NCT01087905|12769982|P6|NOT COMPLETED|Overall Study||28
5192567|NCT01087905|12769983|P5|NOT COMPLETED|Overall Study||31
5192568|NCT01087905|12769984|P4|NOT COMPLETED|Overall Study||36
5192569|NCT01087905|12769985|P3|NOT COMPLETED|Overall Study||22
5192570|NCT01087905|12769986|P2|NOT COMPLETED|Overall Study||32
5192571|NCT01087905|12769987|P1|NOT COMPLETED|Overall Study||29
5192572|NCT01087905|12769980|P8|COMPLETED|Overall Study||98
5192573|NCT01087905|12769981|P7|COMPLETED|Overall Study||98
5192574|NCT01087905|12769982|P6|COMPLETED|Overall Study||99
5192575|NCT01087905|12769983|P5|COMPLETED|Overall Study||91
5192576|NCT01087905|12769984|P4|COMPLETED|Overall Study||86
5192577|NCT01087905|12769985|P3|COMPLETED|Overall Study||101
5192578|NCT01087905|12769986|P2|COMPLETED|Overall Study||94
5192579|NCT01087905|12769987|P1|COMPLETED|Overall Study||90
5192580|NCT01087905|12769980|P8|STARTED|Overall Study||127
5192581|NCT01087905|12769981|P7|STARTED|Overall Study||121
5192582|NCT01087905|12769982|P6|STARTED|Overall Study||127
5192583|NCT01087905|12769983|P5|STARTED|Overall Study||122
5192584|NCT01087905|12769984|P4|STARTED|Overall Study||122
5192585|NCT01087905|12769985|P3|STARTED|Overall Study||123
5192586|NCT01087905|12769986|P2|STARTED|Overall Study||126
5192587|NCT01087905|12769987|P1|STARTED|Overall Study||119
5192588|NCT01087814|12770009|P2|NOT COMPLETED|Second Intervention (5 Days)||0
5192589|NCT01087814|12770010|P1|NOT COMPLETED|Second Intervention (5 Days)||1
5192590|NCT01087814|12770009|P2|COMPLETED|Second Intervention (5 Days)||6
5192591|NCT01087814|12770010|P1|COMPLETED|Second Intervention (5 Days)||4
5192592|NCT01087814|12770009|P2|STARTED|Second Intervention (5 Days)||6
5192593|NCT01087814|12770010|P1|STARTED|Second Intervention (5 Days)||5
5192594|NCT01087814|12770009|P2|NOT COMPLETED|First Intervention (5 Days)||1
5192595|NCT01087814|12770010|P1|NOT COMPLETED|First Intervention (5 Days)||3
5192596|NCT01087814|12770009|P2|COMPLETED|First Intervention (5 Days)||6
5192597|NCT01087814|12770010|P1|COMPLETED|First Intervention (5 Days)||5
5192598|NCT01087814|12770009|P2|STARTED|First Intervention (5 Days)||7
5192599|NCT01087814|12770010|P1|STARTED|First Intervention (5 Days)||8
5192600|NCT01087801|12770018|P2|NOT COMPLETED|Overall Study||5
5192601|NCT01087801|12770019|P1|NOT COMPLETED|Overall Study||4
5192602|NCT01087801|12770018|P2|COMPLETED|Overall Study||29
5192603|NCT01087801|12770019|P1|COMPLETED|Overall Study||26
5192604|NCT01087801|12770018|P2|STARTED|Overall Study||34
5192605|NCT01087801|12770019|P1|STARTED|Overall Study||30
5192606|NCT01087788|12770028|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
5192607|NCT01087788|12770029|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
5192608|NCT01087788|12770030|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
5192609|NCT01087788|12770028|P3|COMPLETED|Open-Label Period (OL-P)||86
5192610|NCT01087788|12770029|P2|COMPLETED|Open-Label Period (OL-P)||97
5192611|NCT01087788|12770030|P1|COMPLETED|Open-Label Period (OL-P)||81
5192612|NCT01087788|12770028|P3|STARTED|Open-Label Period (OL-P)||114
5192613|NCT01087788|12770029|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
5192614|NCT01087788|12770030|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
5192615|NCT01087788|12770028|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
5192616|NCT01087788|12770029|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
5192617|NCT01087788|12770030|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
5192618|NCT01087788|12770028|P3|COMPLETED|24-weeks Dose-blind Period||114
5192619|NCT01087788|12770029|P2|COMPLETED|24-weeks Dose-blind Period||123
5192620|NCT01087788|12770030|P1|COMPLETED|24-weeks Dose-blind Period||113
5192621|NCT01087788|12770028|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
5192622|NCT01087788|12770029|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
5192623|NCT01087788|12770030|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
5192624|NCT01087788|12770028|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
5192625|NCT01087788|12770029|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
5192626|NCT01087788|12770030|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
5192627|NCT01087788|12770028|P3|STARTED|24-weeks Dose-blind Period||120
5192628|NCT01087788|12770029|P2|STARTED|24-weeks Dose-blind Period||128
5192629|NCT01087788|12770030|P1|STARTED|24-weeks Dose-blind Period||120
5192630|NCT01087788|12770028|P3|NOT COMPLETED|24-weeks Double-blind Period||15
5192631|NCT01087788|12770029|P2|NOT COMPLETED|24-weeks Double-blind Period||10
5192632|NCT01087788|12770030|P1|NOT COMPLETED|24-weeks Double-blind Period||16
5192633|NCT01087788|12770028|P3|COMPLETED|24-weeks Double-blind Period||120
5192634|NCT01087788|12770029|P2|COMPLETED|24-weeks Double-blind Period||128
5192635|NCT01087788|12770030|P1|COMPLETED|24-weeks Double-blind Period||120
5192636|NCT01087788|12770028|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
5192637|NCT01087788|12770029|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
5192638|NCT01087788|12770030|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
5192639|NCT01087788|12770028|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
5192640|NCT01087788|12770029|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
5192641|NCT01087788|12770030|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
5192642|NCT01087788|12770028|P3|STARTED|24-weeks Double-blind Period||135
5192643|NCT01087788|12770029|P2|STARTED|24-weeks Double-blind Period||138
5192644|NCT01087788|12770030|P1|STARTED|24-weeks Double-blind Period||136
5192645|NCT01087775|12770057|P1|NOT COMPLETED|Overall Study||2
5192646|NCT01087775|12770057|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
5192647|NCT01087775|12770057|P1|STARTED|Overall Study||25
5192648|NCT01087762|12770065|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
5192649|NCT01087762|12770066|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
5192650|NCT01087762|12770067|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
5192651|NCT01087762|12770068|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
5192652|NCT01087762|12770069|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
5192653|NCT01087762|12770065|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
5192654|NCT01087762|12770066|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
5192655|NCT01087762|12770067|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
5192656|NCT01087762|12770068|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
5192657|NCT01087762|12770069|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
5192658|NCT01087762|12770065|P5|STARTED|Open-Label Period (Weeks 48-204)||157
5192659|NCT01087762|12770066|P4|STARTED|Open-Label Period (Weeks 48-204)||158
5192660|NCT01087762|12770067|P3|STARTED|Open-Label Period (Weeks 48-204)||0
5192661|NCT01087762|12770068|P2|STARTED|Open-Label Period (Weeks 48-204)||0
5192662|NCT01087762|12770069|P1|STARTED|Open-Label Period (Weeks 48-204)||0
5192663|NCT01087762|12770065|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
5192664|NCT01087762|12770066|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
5192665|NCT01087762|12770067|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
5192666|NCT01087762|12770068|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
5192667|NCT01087762|12770069|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
5192668|NCT01087762|12770065|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
5192669|NCT01087762|12770066|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
5192670|NCT01087762|12770067|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
5192671|NCT01087762|12770068|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
5192672|NCT01087762|12770069|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
5192673|NCT01087762|12770065|P5|STARTED|Double Blind Period (Weeks 0-24)||0
5192674|NCT01087762|12770066|P4|STARTED|Double Blind Period (Weeks 0-24)||0
5192675|NCT01087762|12770067|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
5192676|NCT01087762|12770068|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
5192677|NCT01087762|12770069|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
5192678|NCT01087736|12770117|P2|NOT COMPLETED|Overall Study||2
5192679|NCT01087736|12770118|P1|NOT COMPLETED|Overall Study||1
5192680|NCT01087736|12770117|P2|COMPLETED|Overall Study||14
5192681|NCT01087736|12770118|P1|COMPLETED|Overall Study||13
5192682|NCT01087736|12770117|P2|STARTED|Overall Study||16
5192683|NCT01087736|12770118|P1|STARTED|Overall Study||14
5192684|NCT01087723|12770128|P2|NOT COMPLETED|Overall Study||20
5192685|NCT01087723|12770129|P1|NOT COMPLETED|Overall Study||14
5192686|NCT01087723|12770128|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
5192687|NCT01087723|12770129|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
5192688|NCT01087723|12770128|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
5192689|NCT01087723|12770129|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
5192690|NCT01087723|12770128|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
5192691|NCT01087723|12770129|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
5192692|NCT01087541|12770153|P2|NOT COMPLETED|Overall Study||0
5192693|NCT01087541|12770154|P1|NOT COMPLETED|Overall Study||0
5192694|NCT01087541|12770153|P2|COMPLETED|Overall Study||3523
5192695|NCT01087541|12770154|P1|COMPLETED|Overall Study||3307
5192696|NCT01087541|12770153|P2|STARTED|Overall Study||3523
5192697|NCT01087541|12770154|P1|STARTED|Overall Study||3307
5192698|NCT01087528|12770170|P1|NOT COMPLETED|Overall Study||7
5192699|NCT01087528|12770170|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
5192700|NCT01087528|12770170|P1|STARTED|Overall Study||51
5192701|NCT01087502|12770176|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
5192702|NCT01087502|12770177|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
5192703|NCT01087502|12770176|P2|COMPLETED|Up to Final Analysis (Week 52)||95
5192704|NCT01087502|12770177|P1|COMPLETED|Up to Final Analysis (Week 52)||90
5192705|NCT01087502|12770176|P2|STARTED|Up to Final Analysis (Week 52)||118
5192706|NCT01087502|12770177|P1|STARTED|Up to Final Analysis (Week 52)||123
5192707|NCT01087502|12770176|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
5192708|NCT01087502|12770177|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
5192709|NCT01087502|12770176|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
5192710|NCT01087502|12770177|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
5192711|NCT01087502|12770176|P2|STARTED|Up to Interim Analysis (Week 12)||118
5192712|NCT01087502|12770177|P1|STARTED|Up to Interim Analysis (Week 12)||123
5192713|NCT01087489|12770196|P2|NOT COMPLETED|Overall Study||3
5192714|NCT01087489|12770197|P1|NOT COMPLETED|Overall Study||0
5192715|NCT01087489|12770196|P2|COMPLETED|Overall Study||31
5192716|NCT01087489|12770197|P1|COMPLETED|Overall Study||19
5192717|NCT01087489|12770196|P2|STARTED|Overall Study||34
5192718|NCT01087489|12770197|P1|STARTED|Overall Study||19
5192719|NCT01086969|12770210|P3|NOT COMPLETED|Overall Study||0
5192720|NCT01086969|12770211|P2|NOT COMPLETED|Overall Study||2
5192721|NCT01086969|12770212|P1|NOT COMPLETED|Overall Study||1
5192722|NCT01086969|12770210|P3|COMPLETED|Overall Study||100
5192723|NCT01086969|12770211|P2|COMPLETED|Overall Study||98
5192724|NCT01086969|12770212|P1|COMPLETED|Overall Study||99
5192725|NCT01086969|12770210|P3|STARTED|Overall Study||100
5192726|NCT01086969|12770211|P2|STARTED|Overall Study||100
5192727|NCT01086969|12770212|P1|STARTED|Overall Study||100
5192728|NCT01086852|12770229|P1|NOT COMPLETED|Overall Study||0
5192729|NCT01086852|12770229|P1|COMPLETED|Overall Study||4
5192730|NCT01086852|12770229|P1|STARTED|Overall Study||4
5192731|NCT01086761|12770245|P6|NOT COMPLETED|Overall Study||0
5192732|NCT01086761|12770246|P5|NOT COMPLETED|Overall Study||0
5192733|NCT01086761|12770247|P4|NOT COMPLETED|Overall Study||0
5192734|NCT01086761|12770248|P3|NOT COMPLETED|Overall Study||0
5192735|NCT01086761|12770249|P2|NOT COMPLETED|Overall Study||0
5192736|NCT01086761|12770250|P1|NOT COMPLETED|Overall Study||0
5192737|NCT01086761|12770245|P6|COMPLETED|Overall Study||0
5192738|NCT01086761|12770246|P5|COMPLETED|Overall Study||4
5192739|NCT01086761|12770247|P4|COMPLETED|Overall Study||6
5192740|NCT01086761|12770248|P3|COMPLETED|Overall Study||6
5192741|NCT01086761|12770249|P2|COMPLETED|Overall Study||7
5192742|NCT01086761|12770250|P1|COMPLETED|Overall Study||9
5192743|NCT01086761|12770245|P6|STARTED|Overall Study||0
5192744|NCT01086761|12770246|P5|STARTED|Overall Study||4
5192745|NCT01086761|12770247|P4|STARTED|Overall Study||6
5192746|NCT01086761|12770248|P3|STARTED|Overall Study||6
5192747|NCT01086761|12770249|P2|STARTED|Overall Study||7
5192748|NCT01086761|12770250|P1|STARTED|Overall Study||9
5192749|NCT01086605|12770290|P2|NOT COMPLETED|Overall Study||0
5192750|NCT01086605|12770291|P1|NOT COMPLETED|Overall Study||0
5192751|NCT01086605|12770290|P2|COMPLETED|Overall Study||22
5192752|NCT01086605|12770291|P1|COMPLETED|Overall Study||24
5192753|NCT01086605|12770290|P2|STARTED|Overall Study||22
5192754|NCT01086605|12770291|P1|STARTED|Overall Study||24
5192755|NCT01086475|12770308|P2|NOT COMPLETED|Overall Study||0
5192756|NCT01086475|12770309|P1|NOT COMPLETED|Overall Study||0
5192757|NCT01086475|12770308|P2|COMPLETED|Overall Study||33
5192758|NCT01086475|12770309|P1|COMPLETED|Overall Study||34
5192759|NCT01086475|12770308|P2|STARTED|Overall Study||33
5192760|NCT01086475|12770309|P1|STARTED|Overall Study||34
5192761|NCT01086423|12770322|P3|NOT COMPLETED|Overall Study||9
5192762|NCT01086423|12770323|P2|NOT COMPLETED|Overall Study||3
5192763|NCT01086423|12770324|P1|NOT COMPLETED|Overall Study||10
5192764|NCT01086423|12770322|P3|COMPLETED|Overall Study||321
5192765|NCT01086423|12770323|P2|COMPLETED|Overall Study||321
5192766|NCT01086423|12770324|P1|COMPLETED|Overall Study||320
5192767|NCT01086423|12770322|P3|STARTED|Overall Study||330
5192768|NCT01086423|12770323|P2|STARTED|Overall Study||324
5192769|NCT01086423|12770324|P1|STARTED|Overall Study||330
5192770|NCT01086410|12770369|P4|NOT COMPLETED|Overall Study||2
5192771|NCT01086410|12770370|P3|NOT COMPLETED|Overall Study||1
5192772|NCT01086410|12770371|P2|NOT COMPLETED|Overall Study||2
5192773|NCT01086410|12770372|P1|NOT COMPLETED|Overall Study||3
5192774|NCT01086410|12770369|P4|COMPLETED|Overall Study||13
5192775|NCT01086410|12770370|P3|COMPLETED|Overall Study||55
5192776|NCT01086410|12770371|P2|COMPLETED|Overall Study||54
5192777|NCT01086410|12770372|P1|COMPLETED|Overall Study||55
5192778|NCT01086410|12770369|P4|STARTED|Overall Study||15
5192779|NCT01086410|12770370|P3|STARTED|Overall Study||56
5192780|NCT01086410|12770371|P2|STARTED|Overall Study||56
5192781|NCT01086410|12770372|P1|STARTED|Overall Study||58
5192782|NCT01086384|12770468|P3|NOT COMPLETED|Treatment Period||124
5192783|NCT01086384|12770469|P2|NOT COMPLETED|Treatment Period||148
5192784|NCT01086384|12770470|P1|NOT COMPLETED|Treatment Period||0
5192785|NCT01086384|12770468|P3|COMPLETED|Treatment Period||885
5192786|NCT01086384|12770469|P2|COMPLETED|Treatment Period||863
5192787|NCT01086384|12770470|P1|COMPLETED|Treatment Period||0
5192788|NCT01086384|12770468|P3|STARTED|Treatment Period||1009
5192789|NCT01086384|12770469|P2|STARTED|Treatment Period||1011
5192790|NCT01086384|12770470|P1|STARTED|Treatment Period||0
5192791|NCT01086384|12770468|P3|NOT COMPLETED|2-week Run-in Period||0
5192792|NCT01086384|12770469|P2|NOT COMPLETED|2-week Run-in Period||0
5192793|NCT01086384|12770470|P1|NOT COMPLETED|2-week Run-in Period||163
5192794|NCT01086384|12770468|P3|COMPLETED|2-week Run-in Period||0
5192795|NCT01086384|12770469|P2|COMPLETED|2-week Run-in Period||0
5192796|NCT01086384|12770470|P1|COMPLETED|2-week Run-in Period||2020
5192797|NCT01086384|12770468|P3|STARTED|2-week Run-in Period||0
5192798|NCT01086384|12770469|P2|STARTED|2-week Run-in Period||0
5192799|NCT01086384|12770470|P1|STARTED|2-week Run-in Period||2183
5192800|NCT01086358|12770480|P2|NOT COMPLETED|Second Intervention||4
5192801|NCT01086358|12770481|P1|NOT COMPLETED|Second Intervention||4
5192802|NCT01086358|12770480|P2|COMPLETED|Second Intervention||20
5192803|NCT01086358|12770481|P1|COMPLETED|Second Intervention||17
5192804|NCT01086358|12770480|P2|STARTED|Second Intervention||24
5192805|NCT01086358|12770481|P1|STARTED|Second Intervention||21
5192806|NCT01086358|12770480|P2|NOT COMPLETED|First Intervention||5
5192807|NCT01086358|12770481|P1|NOT COMPLETED|First Intervention||9
5192808|NCT01086358|12770480|P2|COMPLETED|First Intervention||24
5192809|NCT01086358|12770481|P1|COMPLETED|First Intervention||21
5192810|NCT01086358|12770480|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
5192811|NCT01086358|12770481|P1|STARTED|First Intervention|30 subjects enrolled.|30
5192812|NCT01086228|12770493|P1|NOT COMPLETED|5-year Follow-up||652
5192813|NCT01086228|12770493|P1|COMPLETED|5-year Follow-up||1012
5192814|NCT01086228|12770493|P1|STARTED|5-year Follow-up||1664
5192815|NCT01086228|12770493|P1|NOT COMPLETED|4-year Follow-up||103
5192816|NCT01086228|12770493|P1|COMPLETED|4-year Follow-up||1664
5192817|NCT01086228|12770493|P1|STARTED|4-year Follow-up||1767
5192818|NCT01086228|12770493|P1|NOT COMPLETED|3-year Follow-up||67
5192819|NCT01086228|12770493|P1|COMPLETED|3-year Follow-up||1767
5192820|NCT01086228|12770493|P1|STARTED|3-year Follow-up||1834
5192821|NCT01086228|12770493|P1|NOT COMPLETED|2-year Follow-up||60
5192822|NCT01086228|12770493|P1|COMPLETED|2-year Follow-up||1834
5192823|NCT01086228|12770493|P1|STARTED|2-year Follow-up||1894
5192824|NCT01086228|12770493|P1|NOT COMPLETED|1-year Follow-up||44
5192825|NCT01086228|12770493|P1|COMPLETED|1-year Follow-up||1894
5192826|NCT01086228|12770493|P1|STARTED|1-year Follow-up||1938
5192827|NCT01086228|12770493|P1|NOT COMPLETED|8 Month Follow-up||71
5192828|NCT01086228|12770493|P1|COMPLETED|8 Month Follow-up||1938
5192829|NCT01086228|12770493|P1|STARTED|8 Month Follow-up|Analysis population|2009
5192830|NCT01086215|12770551|P4|NOT COMPLETED|Overall Study||3
5192831|NCT01086215|12770552|P3|NOT COMPLETED|Overall Study||26
5192832|NCT01086215|12770553|P2|NOT COMPLETED|Overall Study||47
5192833|NCT01086215|12770554|P1|NOT COMPLETED|Overall Study||36
5192834|NCT01086215|12770551|P4|COMPLETED|Overall Study||11
5192835|NCT01086215|12770552|P3|COMPLETED|Overall Study||47
5192836|NCT01086215|12770553|P2|COMPLETED|Overall Study||154
5192837|NCT01086215|12770554|P1|COMPLETED|Overall Study||176
5192838|NCT01086215|12770551|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
5192839|NCT01086215|12770552|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
5192840|NCT01086215|12770553|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
5192841|NCT01086215|12770554|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
5192842|NCT01086215|12770551|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
5192843|NCT01086215|12770552|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
5192844|NCT01086215|12770553|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
5192845|NCT01086215|12770554|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
5192846|NCT01086215|12770551|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
5192847|NCT01086215|12770552|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
5192848|NCT01086215|12770553|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
5192849|NCT01086215|12770554|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
5192850|NCT01086215|12770551|P4|STARTED|Overall Study||14
5192851|NCT01086215|12770552|P3|STARTED|Overall Study||73
5192852|NCT01086215|12770553|P2|STARTED|Overall Study||201
5192853|NCT01086215|12770554|P1|STARTED|Overall Study||212
5192854|NCT01086150|12770575|P3|NOT COMPLETED|Overall Study||1
5192855|NCT01086150|12770576|P2|NOT COMPLETED|Overall Study||6
5192856|NCT01086150|12770577|P1|NOT COMPLETED|Overall Study||0
5192857|NCT01086150|12770575|P3|COMPLETED|Overall Study||12
5192858|NCT01086150|12770576|P2|COMPLETED|Overall Study||21
5192859|NCT01086150|12770577|P1|COMPLETED|Overall Study||11
5192860|NCT01086150|12770575|P3|STARTED|Overall Study||13
5192861|NCT01086150|12770576|P2|STARTED|Overall Study||27
5192862|NCT01086150|12770577|P1|STARTED|Overall Study||11
5192863|NCT01086033|12770588|P1|NOT COMPLETED|Overall Study||304
5192864|NCT01086033|12770588|P1|COMPLETED|Overall Study||262
5192865|NCT01086033|12770588|P1|STARTED|Overall Study||566
5192866|NCT01085968|12770602|P2|NOT COMPLETED|Overall Study||4
5192867|NCT01085968|12770603|P1|NOT COMPLETED|Overall Study||10
5192868|NCT01085968|12770602|P2|COMPLETED|Overall Study||21
5192869|NCT01085968|12770603|P1|COMPLETED|Overall Study||19
5192870|NCT01085968|12770602|P2|STARTED|Overall Study||25
5192871|NCT01085968|12770603|P1|STARTED|Overall Study||29
5192872|NCT01085903|12770619|P3|NOT COMPLETED|Overall Study||0
5192873|NCT01085903|12770620|P2|NOT COMPLETED|Overall Study||0
5192874|NCT01085903|12770621|P1|NOT COMPLETED|Overall Study||0
5192875|NCT01085903|12770619|P3|COMPLETED|Overall Study||3
5192876|NCT01085903|12770620|P2|COMPLETED|Overall Study||4
5192877|NCT01085903|12770621|P1|COMPLETED|Overall Study||21
5192878|NCT01085903|12770619|P3|STARTED|Overall Study||3
5192879|NCT01085903|12770620|P2|STARTED|Overall Study||4
5192880|NCT01085903|12770621|P1|STARTED|Overall Study||21
5192881|NCT01085825|12770647|P2|NOT COMPLETED|Overall Study||1
5192882|NCT01085825|12770648|P1|NOT COMPLETED|Overall Study||1
5192883|NCT01085825|12770647|P2|COMPLETED|Overall Study||247
5192884|NCT01085825|12770648|P1|COMPLETED|Overall Study||251
5192885|NCT01085825|12770647|P2|STARTED|Overall Study||248
5192886|NCT01085825|12770648|P1|STARTED|Overall Study|1st participant enrolled|252
5192887|NCT01085812|12770654|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
5192888|NCT01085812|12770655|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
5192889|NCT01085812|12770654|P2|COMPLETED|Double-blind Intent-to-treat Population||174
5192890|NCT01085812|12770655|P1|COMPLETED|Double-blind Intent-to-treat Population||92
5192891|NCT01085812|12770654|P2|STARTED|Double-blind Intent-to-treat Population||230
5192892|NCT01085812|12770655|P1|STARTED|Double-blind Intent-to-treat Population||112
5192893|NCT01085812|12770654|P2|NOT COMPLETED|Double-Blind Period||58
5192894|NCT01085812|12770655|P1|NOT COMPLETED|Double-Blind Period||21
5192895|NCT01085812|12770654|P2|COMPLETED|Double-Blind Period||177
5192896|NCT01085812|12770655|P1|COMPLETED|Double-Blind Period||92
5192897|NCT01085812|12770654|P2|STARTED|Double-Blind Period||235
5192898|NCT01085812|12770655|P1|STARTED|Double-Blind Period||113
5192899|NCT01085812|12770654|P2|NOT COMPLETED|Open-Label Period||240
5192900|NCT01085812|12770655|P1|NOT COMPLETED|Open-Label Period||0
5192901|NCT01085812|12770654|P2|COMPLETED|Open-Label Period||494
5192902|NCT01085812|12770655|P1|COMPLETED|Open-Label Period||0
5192903|NCT01085812|12770654|P2|STARTED|Open-Label Period||734
5192904|NCT01085812|12770655|P1|STARTED|Open-Label Period||0
5192905|NCT01085786|12770664|P2|NOT COMPLETED|Overall Study||0
5192906|NCT01085786|12770665|P1|NOT COMPLETED|Overall Study||0
5192907|NCT01085786|12770664|P2|COMPLETED|Overall Study||117
5192908|NCT01085786|12770665|P1|COMPLETED|Overall Study||123
5192909|NCT01085786|12770664|P2|STARTED|Overall Study||117
5192910|NCT01085786|12770665|P1|STARTED|Overall Study||123
5192911|NCT01085760|12770675|P4|NOT COMPLETED|Overall Study||3
5192912|NCT01085760|12770676|P3|NOT COMPLETED|Overall Study||2
5192913|NCT01085760|12770677|P2|NOT COMPLETED|Overall Study||1
5192914|NCT01085760|12770678|P1|NOT COMPLETED|Overall Study||1
5192915|NCT01085760|12770675|P4|COMPLETED|Overall Study||6
5192916|NCT01085760|12770676|P3|COMPLETED|Overall Study||7
5192917|NCT01085760|12770677|P2|COMPLETED|Overall Study||8
5192918|NCT01085760|12770678|P1|COMPLETED|Overall Study||7
5192919|NCT01085760|12770675|P4|STARTED|Overall Study||9
5192920|NCT01085760|12770676|P3|STARTED|Overall Study||9
5192921|NCT01085760|12770677|P2|STARTED|Overall Study||9
5192922|NCT01085760|12770678|P1|STARTED|Overall Study||8
5192923|NCT01085734|12770702|P2|NOT COMPLETED|Overall Study||4
5192924|NCT01085734|12770703|P1|NOT COMPLETED|Overall Study||1
5192925|NCT01085734|12770702|P2|COMPLETED|Overall Study||11
5192926|NCT01085734|12770703|P1|COMPLETED|Overall Study||14
5192927|NCT01085734|12770702|P2|STARTED|Overall Study||15
5192928|NCT01085734|12770703|P1|STARTED|Overall Study||15
5192929|NCT01085682|12770715|P2|NOT COMPLETED|Overall Study||25
5192930|NCT01085682|12770716|P1|NOT COMPLETED|Overall Study||25
5192931|NCT01085682|12770715|P2|COMPLETED|Overall Study||3
5192932|NCT01085682|12770716|P1|COMPLETED|Overall Study||6
5192933|NCT01085682|12770715|P2|STARTED|Overall Study||28
5192934|NCT01085682|12770716|P1|STARTED|Overall Study||31
5192935|NCT01085643|12770722|P1|NOT COMPLETED|Overall Study||0
5192936|NCT01085643|12770722|P1|COMPLETED|Overall Study||4
5192937|NCT01085643|12770722|P1|STARTED|Overall Study||4
5192938|NCT01085630|12770733|P2|NOT COMPLETED|Overall Study||0
5192939|NCT01085630|12770734|P1|NOT COMPLETED|Overall Study||4
5192940|NCT01085630|12770733|P2|COMPLETED|Overall Study||27
5192941|NCT01085630|12770734|P1|COMPLETED|Overall Study||22
5192942|NCT01085630|12770733|P2|STARTED|Overall Study||27
5192943|NCT01085630|12770734|P1|STARTED|Overall Study||26
5192944|NCT01085591|12770747|P3|NOT COMPLETED|Overall Study||7
5192945|NCT01085591|12770748|P2|NOT COMPLETED|Overall Study||6
5192946|NCT01085591|12770749|P1|NOT COMPLETED|Overall Study||3
5192947|NCT01085591|12770747|P3|COMPLETED|Overall Study||63
5192948|NCT01085591|12770748|P2|COMPLETED|Overall Study||65
5192949|NCT01085591|12770749|P1|COMPLETED|Overall Study||66
5192950|NCT01085591|12770747|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
5192951|NCT01085591|12770748|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
5192952|NCT01085591|12770749|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
5192953|NCT01085591|12770747|P3|STARTED|Overall Study||70
5192954|NCT01085591|12770748|P2|STARTED|Overall Study||71
5192955|NCT01085591|12770749|P1|STARTED|Overall Study||69
5192956|NCT01085539|12770772|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
5192957|NCT01085539|12770772|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
5192958|NCT01085539|12770772|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
5192959|NCT01085539|12770772|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
5192960|NCT01085539|12770772|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
5192961|NCT01085539|12770772|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
5192962|NCT01085539|12770772|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
5192963|NCT01085539|12770772|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
5192964|NCT01085539|12770772|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
5192965|NCT01085539|12770772|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
5192966|NCT01085539|12770772|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
5192967|NCT01085539|12770772|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
5192968|NCT01085539|12770772|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
5192969|NCT01085539|12770772|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
5192970|NCT01085539|12770772|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
5192971|NCT01085513|12770778|P2|NOT COMPLETED|Phase II - Validation Phase||0
5192972|NCT01085513|12770779|P1|NOT COMPLETED|Phase II - Validation Phase||0
5192973|NCT01085513|12770778|P2|COMPLETED|Phase II - Validation Phase||16
5192974|NCT01085513|12770779|P1|COMPLETED|Phase II - Validation Phase||21
5192975|NCT01085513|12770778|P2|STARTED|Phase II - Validation Phase||16
5192976|NCT01085513|12770779|P1|STARTED|Phase II - Validation Phase||21
5192977|NCT01085513|12770778|P2|NOT COMPLETED|Phase I - Development Phase||0
5192978|NCT01085513|12770779|P1|NOT COMPLETED|Phase I - Development Phase||0
5192979|NCT01085513|12770778|P2|COMPLETED|Phase I - Development Phase||52
5192980|NCT01085513|12770779|P1|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
5192981|NCT01085513|12770778|P2|STARTED|Phase I - Development Phase||52
5192982|NCT01085513|12770779|P1|STARTED|Phase I - Development Phase||54
5192983|NCT01085500|12770789|P2|NOT COMPLETED|Overall Study||0
5192984|NCT01085500|12770790|P1|NOT COMPLETED|Overall Study||0
5192985|NCT01085500|12770789|P2|COMPLETED|Overall Study||24
5192986|NCT01085500|12770790|P1|COMPLETED|Overall Study||26
5192987|NCT01085500|12770789|P2|STARTED|Overall Study||24
5192988|NCT01085500|12770790|P1|STARTED|Overall Study||26
5192989|NCT01085357|12770802|P2|NOT COMPLETED|Overall Study||6
5192990|NCT01085357|12770803|P1|NOT COMPLETED|Overall Study||19
5192991|NCT01085357|12770802|P2|COMPLETED|Overall Study||125
5192992|NCT01085357|12770803|P1|COMPLETED|Overall Study||355
5192993|NCT01085357|12770802|P2|STARTED|Overall Study||131
5192994|NCT01085357|12770803|P1|STARTED|Overall Study||374
5192995|NCT01085344|12770813|P1|NOT COMPLETED|Overall Study||6
5192996|NCT01085344|12770813|P1|COMPLETED|Overall Study||50
5192997|NCT01085344|12770813|P1|STARTED|Overall Study||56
5192998|NCT01085331|12770825|P2|NOT COMPLETED|Overall Study||0
5192999|NCT01085331|12770826|P1|NOT COMPLETED|Overall Study||0
5193000|NCT01085331|12770825|P2|COMPLETED|Overall Study||6
5193001|NCT01085331|12770826|P1|COMPLETED|Overall Study||10
5193002|NCT01085331|12770825|P2|STARTED|Overall Study||6
5193003|NCT01085331|12770826|P1|STARTED|Overall Study||10
5193004|NCT01085318|12770865|P2|NOT COMPLETED|Overall Study||0
5193005|NCT01085318|12770866|P1|NOT COMPLETED|Overall Study||2
5193006|NCT01085318|12770865|P2|COMPLETED|Overall Study||15
5193007|NCT01085318|12770866|P1|COMPLETED|Overall Study||21
5193008|NCT01085318|12770865|P2|STARTED|Overall Study||15
5193009|NCT01085318|12770866|P1|STARTED|Overall Study||23
5193010|NCT01085214|12770876|P1|NOT COMPLETED|Overall Study||1
5193011|NCT01085214|12770876|P1|COMPLETED|Overall Study||36
5193012|NCT01085214|12770876|P1|STARTED|Overall Study||37
5193013|NCT01085201|12770888|P5|NOT COMPLETED|Overall Study||0
5193014|NCT01085201|12770889|P4|NOT COMPLETED|Overall Study||0
5193015|NCT01085201|12770890|P3|NOT COMPLETED|Overall Study||2
5193016|NCT01085201|12770891|P2|NOT COMPLETED|Overall Study||1
5193017|NCT01085201|12770892|P1|NOT COMPLETED|Overall Study||3
5193018|NCT01085201|12770888|P5|COMPLETED|Overall Study||3
5193019|NCT01085201|12770889|P4|COMPLETED|Overall Study||6
5193020|NCT01085201|12770890|P3|COMPLETED|Overall Study||3
5193021|NCT01085201|12770891|P2|COMPLETED|Overall Study||6
5193022|NCT01085201|12770892|P1|COMPLETED|Overall Study||15
5193023|NCT01085201|12770888|P5|STARTED|Overall Study||3
5193024|NCT01085201|12770889|P4|STARTED|Overall Study||6
5193025|NCT01085201|12770890|P3|STARTED|Overall Study||5
5193026|NCT01085201|12770891|P2|STARTED|Overall Study||7
5193027|NCT01085201|12770892|P1|STARTED|Overall Study||18
5193028|NCT01085136|12770914|P3|NOT COMPLETED|Part B||26
5193029|NCT01085136|12770915|P2|NOT COMPLETED|Part B||51
5193030|NCT01085136|12770916|P1|NOT COMPLETED|Part B||0
5193031|NCT01085136|12770914|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
5193032|NCT01085136|12770915|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
5193033|NCT01085136|12770916|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
5193034|NCT01085136|12770914|P3|STARTED|Part B||68
5193035|NCT01085136|12770915|P2|STARTED|Part B||138
5193036|NCT01085136|12770916|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
5193037|NCT01085136|12770914|P3|NOT COMPLETED|Part A||0
5193038|NCT01085136|12770915|P2|NOT COMPLETED|Part A||0
5193039|NCT01085136|12770916|P1|NOT COMPLETED|Part A||323
5193040|NCT01085136|12770914|P3|COMPLETED|Part A||0
5193041|NCT01085136|12770915|P2|COMPLETED|Part A||0
5193042|NCT01085136|12770916|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
5193043|NCT01085136|12770914|P3|Randomized to Part B|Part A||0
5193044|NCT01085136|12770915|P2|Randomized to Part B|Part A||0
5193045|NCT01085136|12770916|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
5193046|NCT01085136|12770914|P3|STARTED|Part A||0
5193047|NCT01085136|12770915|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
5193048|NCT01085136|12770916|P1|STARTED|Part A||1154
5193049|NCT01085045|12770932|P1|NOT COMPLETED|Part B||15
5193050|NCT01085045|12770932|P1|COMPLETED|Part B||89
5193051|NCT01085045|12770932|P1|GP MDI 36 µg (PT001)|Part B||0
5193052|NCT01085045|12770932|P1|Foradil 12 µg|Part B||41
5193053|NCT01085045|12770932|P1|Placebo MDI|Part B||47
5193054|NCT01085045|12770932|P1|FF MDI 7.2 µg (PT005)|Part B||43
5193055|NCT01085045|12770932|P1|FF MDI 9.6 µg (PT005)|Part B||43
5193056|NCT01085045|12770932|P1|Spiriva 18 µg|Part B||0
5193057|NCT01085045|12770932|P1|GFF MDI 36/9.6 µg|Part B||0
5193058|NCT01085045|12770932|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
5193059|NCT01085045|12770932|P1|STARTED|Part B||104
5193060|NCT01085045|12770932|P1|NOT COMPLETED|Part A||18
5193061|NCT01085045|12770932|P1|COMPLETED|Part A||104
5193062|NCT01085045|12770932|P1|Foradil 12 µg|Part A||14
5193063|NCT01085045|12770932|P1|Placebo MDI|Part A||5
5193064|NCT01085045|12770932|P1|FF MDI 7.2 µg (PT005)|Part A||21
5193065|NCT01085045|12770932|P1|FF MDI 9.6 µg (PT005)|Part A||20
5193066|NCT01085045|12770932|P1|Spiriva 18 µg|Part A||58
5193067|NCT01085045|12770932|P1|GP MDI 36 µg (PT001)|Part A||40
5193068|NCT01085045|12770932|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
5193069|NCT01085045|12770932|P1|GFF MDI 72/9.6mcg|Part A||40
5193070|NCT01085045|12770932|P1|STARTED|Part A||122
5193071|NCT01085006|12771034|P2|NOT COMPLETED|Overall Study||0
5193072|NCT01085006|12771035|P1|NOT COMPLETED|Overall Study||0
5193073|NCT01085006|12771034|P2|COMPLETED|Overall Study||50
5193074|NCT01085006|12771035|P1|COMPLETED|Overall Study||50
5193075|NCT01085006|12771034|P2|STARTED|Overall Study||50
5193076|NCT01085006|12771035|P1|STARTED|Overall Study||50
5193077|NCT01084772|12771043|P2|NOT COMPLETED|2 Years||4
5193078|NCT01084772|12771044|P1|NOT COMPLETED|2 Years||9
5193079|NCT01084772|12771043|P2|COMPLETED|2 Years||46
5193080|NCT01084772|12771044|P1|COMPLETED|2 Years||46
5193081|NCT01084772|12771043|P2|STARTED|2 Years||50
5193082|NCT01084772|12771044|P1|STARTED|2 Years||55
5193083|NCT01084772|12771043|P2|NOT COMPLETED|1 Year||8
5193084|NCT01084772|12771044|P1|NOT COMPLETED|1 Year||3
5193085|NCT01084772|12771043|P2|COMPLETED|1 Year||50
5193086|NCT01084772|12771044|P1|COMPLETED|1 Year||55
5193087|NCT01084772|12771043|P2|STARTED|1 Year||58
5193088|NCT01084772|12771044|P1|STARTED|1 Year||58
5193089|NCT01084772|12771043|P2|NOT COMPLETED|3 Months||2
5193090|NCT01084772|12771044|P1|NOT COMPLETED|3 Months||3
5193091|NCT01084772|12771043|P2|COMPLETED|3 Months||58
5193092|NCT01084772|12771044|P1|COMPLETED|3 Months||58
5193093|NCT01084772|12771043|P2|STARTED|3 Months||60
5193094|NCT01084772|12771044|P1|STARTED|3 Months||61
5193095|NCT01084772|12771043|P2|NOT COMPLETED|Baseline||6
5193096|NCT01084772|12771044|P1|NOT COMPLETED|Baseline||7
5193097|NCT01084772|12771043|P2|COMPLETED|Baseline||60
5193098|NCT01084772|12771044|P1|COMPLETED|Baseline||61
5193099|NCT01084772|12771043|P2|STARTED|Baseline||66
5193100|NCT01084772|12771044|P1|STARTED|Baseline||68
5193101|NCT01084759|12771074|P1|NOT COMPLETED|Overall Study||2
5193102|NCT01084759|12771074|P1|COMPLETED|Overall Study||14
5193103|NCT01084759|12771074|P1|STARTED|Overall Study||16
5193104|NCT01084707|12771080|P1|NOT COMPLETED|Overall Study||6
5193105|NCT01084707|12771080|P1|COMPLETED|Overall Study||34
5193106|NCT01084707|12771080|P1|STARTED|Overall Study||40
5193107|NCT01084694|12771116|P2|NOT COMPLETED|Overall Study||20
5193108|NCT01084694|12771117|P1|NOT COMPLETED|Overall Study||6
5193109|NCT01084694|12771116|P2|COMPLETED|Overall Study||30
5193110|NCT01084694|12771117|P1|COMPLETED|Overall Study||44
5193111|NCT01084694|12771116|P2|STARTED|Overall Study||50
5193112|NCT01084694|12771117|P1|STARTED|Overall Study||50
5193113|NCT01084668|12771133|P1|NOT COMPLETED|Overall Study||9
5193114|NCT01084668|12771133|P1|COMPLETED|Overall Study||33
5193115|NCT01084668|12771133|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
5193116|NCT01084655|12771145|P3|NOT COMPLETED|Overall Study||19
5193117|NCT01084655|12771146|P2|NOT COMPLETED|Overall Study||6
5193118|NCT01084655|12771147|P1|NOT COMPLETED|Overall Study||6
5193119|NCT01084655|12771145|P3|COMPLETED|Overall Study||5
5193120|NCT01084655|12771146|P2|COMPLETED|Overall Study||2
5193121|NCT01084655|12771147|P1|COMPLETED|Overall Study||0
5193122|NCT01084655|12771145|P3|Treated|Overall Study||23
5193123|NCT01084655|12771146|P2|Treated|Overall Study||8
5193124|NCT01084655|12771147|P1|Treated|Overall Study||6
5193125|NCT01084655|12771145|P3|STARTED|Overall Study||24
5193126|NCT01084655|12771146|P2|STARTED|Overall Study||8
5193127|NCT01084655|12771147|P1|STARTED|Overall Study||6
5193128|NCT01084603|12771182|P1|NOT COMPLETED|Oral Nicotine 4||0
5193129|NCT01084603|12771182|P1|COMPLETED|Oral Nicotine 4||39
5193130|NCT01084603|12771182|P1|STARTED|Oral Nicotine 4||39
5193131|NCT01084603|12771182|P1|NOT COMPLETED|Washout Period 4||1
5193132|NCT01084603|12771182|P1|COMPLETED|Washout Period 4||39
5193133|NCT01084603|12771182|P1|STARTED|Washout Period 4||40
5193134|NCT01084603|12771182|P1|NOT COMPLETED|Oral Nicotine 2||0
5193135|NCT01084603|12771182|P1|COMPLETED|Oral Nicotine 2||40
5193136|NCT01084603|12771182|P1|STARTED|Oral Nicotine 2||40
5193137|NCT01084603|12771182|P1|NOT COMPLETED|Washout Period 3||0
5193138|NCT01084603|12771182|P1|COMPLETED|Washout Period 3||40
5193139|NCT01084603|12771182|P1|STARTED|Washout Period 3||40
5193140|NCT01084603|12771182|P1|NOT COMPLETED|Oral Nicotine 1||1
5193141|NCT01084603|12771182|P1|COMPLETED|Oral Nicotine 1||40
5193142|NCT01084603|12771182|P1|STARTED|Oral Nicotine 1||41
5193143|NCT01084603|12771182|P1|NOT COMPLETED|Washout Period 2||0
5193144|NCT01084603|12771182|P1|COMPLETED|Washout Period 2||41
5193145|NCT01084603|12771182|P1|STARTED|Washout Period 2||41
5193146|NCT01084603|12771182|P1|NOT COMPLETED|Nicorette® Gum||1
5193147|NCT01084603|12771182|P1|COMPLETED|Nicorette® Gum||41
5193148|NCT01084603|12771182|P1|STARTED|Nicorette® Gum||42
5193149|NCT01084603|12771182|P1|NOT COMPLETED|Washout Period 1||0
5193150|NCT01084603|12771182|P1|COMPLETED|Washout Period 1||42
5193151|NCT01084603|12771182|P1|STARTED|Washout Period 1||42
5193152|NCT01084603|12771182|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
5193153|NCT01084603|12771182|P1|COMPLETED|NiQuitinTM Lozenge||42
5193154|NCT01084603|12771182|P1|STARTED|NiQuitinTM Lozenge||43
5193155|NCT01084603|12771182|P1|NOT COMPLETED|Baseline||2
5193156|NCT01084603|12771182|P1|COMPLETED|Baseline||43
5193157|NCT01084603|12771182|P1|STARTED|Baseline||45
5193158|NCT01084551|12771218|P3|NOT COMPLETED|Overall Study||8
5193159|NCT01084551|12771219|P2|NOT COMPLETED|Overall Study||14
5193160|NCT01084551|12771220|P1|NOT COMPLETED|Overall Study||9
5193161|NCT01084551|12771218|P3|COMPLETED|Overall Study||86
5193162|NCT01084551|12771219|P2|COMPLETED|Overall Study||81
5193163|NCT01084551|12771220|P1|COMPLETED|Overall Study||86
5193164|NCT01084551|12771218|P3|STARTED|Overall Study||94
5193165|NCT01084551|12771219|P2|STARTED|Overall Study||95
5193166|NCT01084551|12771220|P1|STARTED|Overall Study||95
5193167|NCT01084538|12771258|P1|NOT COMPLETED|Overall Study||68
5193168|NCT01084538|12771258|P1|COMPLETED|Overall Study||113
5193169|NCT01084538|12771258|P1|STARTED|Overall Study||181
5193170|NCT01084499|12771267|P2|NOT COMPLETED|Overall Study||0
5193171|NCT01084499|12771268|P1|NOT COMPLETED|Overall Study||0
5193172|NCT01084499|12771267|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
5193173|NCT01084499|12771268|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
5193174|NCT01084499|12771267|P2|Washout (5 Weeks)|Overall Study||13
5193175|NCT01084499|12771268|P1|Washout (5 Weeks)|Overall Study||13
5193176|NCT01084499|12771267|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
5193177|NCT01084499|12771268|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
5193178|NCT01084278|12771281|P5|NOT COMPLETED|Overall Study||0
5193179|NCT01084278|12771282|P4|NOT COMPLETED|Overall Study||0
5193180|NCT01084278|12771283|P3|NOT COMPLETED|Overall Study||0
5193181|NCT01084278|12771284|P2|NOT COMPLETED|Overall Study||0
5193182|NCT01084278|12771285|P1|NOT COMPLETED|Overall Study||0
5193183|NCT01084278|12771281|P5|COMPLETED|Overall Study||8
5193184|NCT01084278|12771282|P4|COMPLETED|Overall Study||8
5193185|NCT01084278|12771283|P3|COMPLETED|Overall Study||8
5193186|NCT01084278|12771284|P2|COMPLETED|Overall Study||8
5193187|NCT01084278|12771285|P1|COMPLETED|Overall Study||8
5193188|NCT01084278|12771281|P5|STARTED|Overall Study||8
5193189|NCT01084278|12771282|P4|STARTED|Overall Study||8
5193190|NCT01084278|12771283|P3|STARTED|Overall Study||8
5193191|NCT01084278|12771284|P2|STARTED|Overall Study||8
5193192|NCT01084278|12771285|P1|STARTED|Overall Study||8
5193193|NCT01084265|12771366|P1|NOT COMPLETED|Overall Study||0
5193194|NCT01084265|12771366|P1|COMPLETED|Overall Study||31
5193195|NCT01084265|12771366|P1|STARTED|Overall Study||31
5193196|NCT01084252|12771392|P14|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
5193197|NCT01084252|12771393|P13|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
5193198|NCT01084252|12771394|P12|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193199|NCT01084252|12771395|P11|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193200|NCT01084252|12771396|P10|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193201|NCT01084252|12771397|P9|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193202|NCT01084252|12771398|P8|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193203|NCT01084252|12771399|P7|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193204|NCT01084252|12771400|P6|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193205|NCT01084252|12771401|P5|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193206|NCT01084252|12771402|P4|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193207|NCT01084252|12771403|P3|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193208|NCT01084252|12771404|P2|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193209|NCT01084252|12771405|P1|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193210|NCT01084252|12771392|P14|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193211|NCT01084252|12771393|P13|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193212|NCT01084252|12771394|P12|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193213|NCT01084252|12771395|P11|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193214|NCT01084252|12771396|P10|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193215|NCT01084252|12771397|P9|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193216|NCT01084252|12771398|P8|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193217|NCT01084252|12771399|P7|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193218|NCT01084252|12771400|P6|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193219|NCT01084252|12771401|P5|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193220|NCT01084252|12771402|P4|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193221|NCT01084252|12771403|P3|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193222|NCT01084252|12771404|P2|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193223|NCT01084252|12771405|P1|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
5193224|NCT01084252|12771392|P14|AT Population|Phase 2 Stage 2 (97 Weeks)||55
5193225|NCT01084252|12771393|P13|AT Population|Phase 2 Stage 2 (97 Weeks)||109
5193226|NCT01084252|12771394|P12|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193227|NCT01084252|12771395|P11|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193228|NCT01084252|12771396|P10|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193229|NCT01084252|12771397|P9|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193230|NCT01084252|12771398|P8|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193231|NCT01084252|12771399|P7|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193232|NCT01084252|12771400|P6|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193233|NCT01084252|12771401|P5|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193234|NCT01084252|12771402|P4|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193235|NCT01084252|12771403|P3|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193236|NCT01084252|12771404|P2|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193237|NCT01084252|12771405|P1|AT Population|Phase 2 Stage 2 (97 Weeks)||0
5193238|NCT01084252|12771392|P14|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
5193239|NCT01084252|12771393|P13|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
5193240|NCT01084252|12771394|P12|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193241|NCT01084252|12771395|P11|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193242|NCT01084252|12771396|P10|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193243|NCT01084252|12771397|P9|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193244|NCT01084252|12771398|P8|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193245|NCT01084252|12771399|P7|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193246|NCT01084252|12771400|P6|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193247|NCT01084252|12771401|P5|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193248|NCT01084252|12771402|P4|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193249|NCT01084252|12771403|P3|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193250|NCT01084252|12771404|P2|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193251|NCT01084252|12771405|P1|STARTED|Phase 2 Stage 2 (97 Weeks)||0
5193252|NCT01084252|12771392|P14|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193253|NCT01084252|12771393|P13|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193254|NCT01084252|12771394|P12|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
5193255|NCT01084252|12771395|P11|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
5193256|NCT01084252|12771396|P10|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
5193257|NCT01084252|12771397|P9|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
5193258|NCT01084252|12771398|P8|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193259|NCT01084252|12771399|P7|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193260|NCT01084252|12771400|P6|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193261|NCT01084252|12771401|P5|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193262|NCT01084252|12771402|P4|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193263|NCT01084252|12771403|P3|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193264|NCT01084252|12771404|P2|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193265|NCT01084252|12771405|P1|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193266|NCT01084252|12771392|P14|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193267|NCT01084252|12771393|P13|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193268|NCT01084252|12771394|P12|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193269|NCT01084252|12771395|P11|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193270|NCT01084252|12771396|P10|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193271|NCT01084252|12771397|P9|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193272|NCT01084252|12771398|P8|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193273|NCT01084252|12771399|P7|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193274|NCT01084252|12771400|P6|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193275|NCT01084252|12771401|P5|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193276|NCT01084252|12771402|P4|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193277|NCT01084252|12771403|P3|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193278|NCT01084252|12771404|P2|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193279|NCT01084252|12771405|P1|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193280|NCT01084252|12771392|P14|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193281|NCT01084252|12771393|P13|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193282|NCT01084252|12771394|P12|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
5193283|NCT01084252|12771395|P11|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
5193284|NCT01084252|12771396|P10|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
5193285|NCT01084252|12771397|P9|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
5193286|NCT01084252|12771398|P8|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193287|NCT01084252|12771399|P7|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193288|NCT01084252|12771400|P6|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193289|NCT01084252|12771401|P5|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193290|NCT01084252|12771402|P4|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193291|NCT01084252|12771403|P3|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193292|NCT01084252|12771404|P2|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193293|NCT01084252|12771405|P1|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193294|NCT01084252|12771392|P14|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193295|NCT01084252|12771393|P13|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193296|NCT01084252|12771394|P12|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
5193297|NCT01084252|12771395|P11|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
5193298|NCT01084252|12771396|P10|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
5193299|NCT01084252|12771397|P9|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
5193300|NCT01084252|12771398|P8|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193301|NCT01084252|12771399|P7|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193302|NCT01084252|12771400|P6|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193303|NCT01084252|12771401|P5|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193304|NCT01084252|12771402|P4|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193305|NCT01084252|12771403|P3|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193306|NCT01084252|12771404|P2|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193307|NCT01084252|12771405|P1|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
5193308|NCT01084252|12771392|P14|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193309|NCT01084252|12771393|P13|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193310|NCT01084252|12771394|P12|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193311|NCT01084252|12771395|P11|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193312|NCT01084252|12771396|P10|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193313|NCT01084252|12771397|P9|NOT COMPLETED|Phase 1 (120 Weeks)||0
5193314|NCT01084252|12771398|P8|NOT COMPLETED|Phase 1 (120 Weeks)||7
5193315|NCT01084252|12771399|P7|NOT COMPLETED|Phase 1 (120 Weeks)||7
5193316|NCT01084252|12771400|P6|NOT COMPLETED|Phase 1 (120 Weeks)||6
5193317|NCT01084252|12771401|P5|NOT COMPLETED|Phase 1 (120 Weeks)||18
5193318|NCT01084252|12771402|P4|NOT COMPLETED|Phase 1 (120 Weeks)||26
5193319|NCT01084252|12771403|P3|NOT COMPLETED|Phase 1 (120 Weeks)||3
5193320|NCT01084252|12771404|P2|NOT COMPLETED|Phase 1 (120 Weeks)||6
5193321|NCT01084252|12771405|P1|NOT COMPLETED|Phase 1 (120 Weeks)||16
5193322|NCT01084252|12771392|P14|COMPLETED|Phase 1 (120 Weeks)||0
5193323|NCT01084252|12771393|P13|COMPLETED|Phase 1 (120 Weeks)||0
5193324|NCT01084252|12771394|P12|COMPLETED|Phase 1 (120 Weeks)||0
5193325|NCT01084252|12771395|P11|COMPLETED|Phase 1 (120 Weeks)||0
5193326|NCT01084252|12771396|P10|COMPLETED|Phase 1 (120 Weeks)||0
5193327|NCT01084252|12771397|P9|COMPLETED|Phase 1 (120 Weeks)||0
5193328|NCT01084252|12771398|P8|COMPLETED|Phase 1 (120 Weeks)||0
5193329|NCT01084252|12771399|P7|COMPLETED|Phase 1 (120 Weeks)||0
5193330|NCT01084252|12771400|P6|COMPLETED|Phase 1 (120 Weeks)||0
5193331|NCT01084252|12771401|P5|COMPLETED|Phase 1 (120 Weeks)||0
5193332|NCT01084252|12771402|P4|COMPLETED|Phase 1 (120 Weeks)||0
5193333|NCT01084252|12771403|P3|COMPLETED|Phase 1 (120 Weeks)||0
5193334|NCT01084252|12771404|P2|COMPLETED|Phase 1 (120 Weeks)||0
5193335|NCT01084252|12771405|P1|COMPLETED|Phase 1 (120 Weeks)||0
5193336|NCT01084252|12771392|P14|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193337|NCT01084252|12771393|P13|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193338|NCT01084252|12771394|P12|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193339|NCT01084252|12771395|P11|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193340|NCT01084252|12771396|P10|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193341|NCT01084252|12771397|P9|All Treated (AT) Population|Phase 1 (120 Weeks)||0
5193342|NCT01084252|12771398|P8|All Treated (AT) Population|Phase 1 (120 Weeks)||7
5193343|NCT01084252|12771399|P7|All Treated (AT) Population|Phase 1 (120 Weeks)||7
5193344|NCT01084252|12771400|P6|All Treated (AT) Population|Phase 1 (120 Weeks)||6
5193345|NCT01084252|12771401|P5|All Treated (AT) Population|Phase 1 (120 Weeks)||18
5193346|NCT01084252|12771402|P4|All Treated (AT) Population|Phase 1 (120 Weeks)||26
5193347|NCT01084252|12771403|P3|All Treated (AT) Population|Phase 1 (120 Weeks)||3
5193348|NCT01084252|12771404|P2|All Treated (AT) Population|Phase 1 (120 Weeks)||6
5193349|NCT01084252|12771405|P1|All Treated (AT) Population|Phase 1 (120 Weeks)||16
5193350|NCT01084252|12771392|P14|STARTED|Phase 1 (120 Weeks)||0
5193351|NCT01084252|12771393|P13|STARTED|Phase 1 (120 Weeks)||0
5193352|NCT01084252|12771394|P12|STARTED|Phase 1 (120 Weeks)||0
5193353|NCT01084252|12771395|P11|STARTED|Phase 1 (120 Weeks)||0
5193354|NCT01084252|12771396|P10|STARTED|Phase 1 (120 Weeks)||0
5193355|NCT01084252|12771397|P9|STARTED|Phase 1 (120 Weeks)||0
5193356|NCT01084252|12771398|P8|STARTED|Phase 1 (120 Weeks)||7
5193357|NCT01084252|12771399|P7|STARTED|Phase 1 (120 Weeks)||7
5193358|NCT01084252|12771400|P6|STARTED|Phase 1 (120 Weeks)||6
5193359|NCT01084252|12771401|P5|STARTED|Phase 1 (120 Weeks)||18
5193360|NCT01084252|12771402|P4|STARTED|Phase 1 (120 Weeks)||26
5193361|NCT01084252|12771403|P3|STARTED|Phase 1 (120 Weeks)||3
5193362|NCT01084252|12771404|P2|STARTED|Phase 1 (120 Weeks)||6
5193363|NCT01084252|12771405|P1|STARTED|Phase 1 (120 Weeks)||16
5193364|NCT01084239|12771589|P2|NOT COMPLETED|28-Day Follow-up||9
5193365|NCT01084239|12771590|P1|NOT COMPLETED|28-Day Follow-up||4
5193366|NCT01084239|12771589|P2|COMPLETED|28-Day Follow-up||490
5193367|NCT01084239|12771590|P1|COMPLETED|28-Day Follow-up||497
5193368|NCT01084239|12771589|P2|STARTED|28-Day Follow-up||499
5193369|NCT01084239|12771590|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
5193370|NCT01084239|12771589|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
5193371|NCT01084239|12771590|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
5193372|NCT01084239|12771589|P2|COMPLETED|Randomization - Index Hospitalization||499
5193373|NCT01084239|12771590|P1|COMPLETED|Randomization - Index Hospitalization||501
5193374|NCT01084239|12771589|P2|STARTED|Randomization - Index Hospitalization||499
5193375|NCT01084239|12771590|P1|STARTED|Randomization - Index Hospitalization||501
5193376|NCT01084174|12771608|P2|NOT COMPLETED|Overall Study||4
5193377|NCT01084174|12771609|P1|NOT COMPLETED|Overall Study||1
5193378|NCT01084174|12771608|P2|COMPLETED|Overall Study||7
5193379|NCT01084174|12771609|P1|COMPLETED|Overall Study||9
5193380|NCT01084174|12771608|P2|STARTED|Overall Study||11
5193381|NCT01084174|12771609|P1|STARTED|Overall Study||10
5193382|NCT01084148|12771629|P2|NOT COMPLETED|Overall Study||16
5193383|NCT01084148|12771630|P1|NOT COMPLETED|Overall Study||30
5193384|NCT01084148|12771629|P2|COMPLETED|Overall Study||102
5193385|NCT01084148|12771630|P1|COMPLETED|Overall Study||88
5193386|NCT01084148|12771629|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
5193387|NCT01084148|12771630|P1|Treated Patients|Overall Study||118
5193388|NCT01084148|12771629|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
5193389|NCT01084148|12771630|P1|STARTED|Overall Study||118
5193390|NCT01084135|12771642|P2|NOT COMPLETED|20 Week||1
5193391|NCT01084135|12771643|P1|NOT COMPLETED|20 Week||0
5193392|NCT01084135|12771642|P2|COMPLETED|20 Week||10
5193393|NCT01084135|12771643|P1|COMPLETED|20 Week||12
5193394|NCT01084135|12771642|P2|STARTED|20 Week||11
5193395|NCT01084135|12771643|P1|STARTED|20 Week||12
5193396|NCT01084135|12771642|P2|NOT COMPLETED|12 Week||0
5193397|NCT01084135|12771643|P1|NOT COMPLETED|12 Week||0
5193398|NCT01084135|12771642|P2|COMPLETED|12 Week||4
5193399|NCT01084135|12771643|P1|COMPLETED|12 Week||4
5193400|NCT01084135|12771642|P2|STARTED|12 Week||4
5193401|NCT01084135|12771643|P1|STARTED|12 Week||4
5193402|NCT01084083|12771653|P1|NOT COMPLETED|Overall Study||12
5193403|NCT01084083|12771653|P1|COMPLETED|Overall Study||78
5193404|NCT01084083|12771653|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
5193405|NCT01084083|12771653|P1|CR to Induction Therapy|Overall Study||56
5193406|NCT01084083|12771653|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
5193407|NCT01084083|12771653|P1|Eligible|Overall Study||81
5193408|NCT01084083|12771653|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
5193409|NCT01084083|12771653|P1|STARTED|Overall Study||90
5193410|NCT01084005|12771661|P2|NOT COMPLETED|Overall Study||16
5193411|NCT01084005|12771662|P1|NOT COMPLETED|Overall Study||5
5193412|NCT01084005|12771661|P2|COMPLETED|Overall Study||146
5193413|NCT01084005|12771662|P1|COMPLETED|Overall Study||74
5193414|NCT01084005|12771661|P2|STARTED|Overall Study||162
5193415|NCT01084005|12771662|P1|STARTED|Overall Study||79
5193416|NCT01083979|12771690|P1|NOT COMPLETED|Overall Study||0
5193417|NCT01083979|12771690|P1|COMPLETED|Overall Study||1
5193418|NCT01083979|12771690|P1|STARTED|Overall Study||1
5193419|NCT01083901|12771698|P3|NOT COMPLETED|Overall Study||2
5193420|NCT01083901|12771699|P2|NOT COMPLETED|Overall Study||2
5193421|NCT01083901|12771700|P1|NOT COMPLETED|Overall Study||1
5193422|NCT01083901|12771698|P3|COMPLETED|Overall Study||11
5193423|NCT01083901|12771699|P2|COMPLETED|Overall Study||6
5193424|NCT01083901|12771700|P1|COMPLETED|Overall Study||12
5193425|NCT01083901|12771698|P3|STARTED|Overall Study||13
5193426|NCT01083901|12771699|P2|STARTED|Overall Study||8
5193427|NCT01083901|12771700|P1|STARTED|Overall Study||13
5193428|NCT01083849|12771719|P2|NOT COMPLETED|Overall Study||111
5193429|NCT01083849|12771720|P1|NOT COMPLETED|Overall Study||60
5193430|NCT01083849|12771719|P2|COMPLETED|Overall Study||527
5193431|NCT01083849|12771720|P1|COMPLETED|Overall Study||61
5193432|NCT01083849|12771719|P2|STARTED|Overall Study||638
5193433|NCT01083849|12771720|P1|STARTED|Overall Study||121
5193434|NCT01083810|12771743|P3|NOT COMPLETED|Overall Study||20
5193435|NCT01083810|12771744|P2|NOT COMPLETED|Overall Study||45
5193436|NCT01083810|12771745|P1|NOT COMPLETED|Overall Study||65
5193437|NCT01083810|12771743|P3|COMPLETED|Overall Study||35
5193438|NCT01083810|12771744|P2|COMPLETED|Overall Study||47
5193439|NCT01083810|12771745|P1|COMPLETED|Overall Study||72
5193440|NCT01083810|12771743|P3|STARTED|Overall Study||55
5193441|NCT01083810|12771744|P2|STARTED|Overall Study||92
5193442|NCT01083810|12771745|P1|STARTED|Overall Study||137
5193443|NCT01083771|12771766|P1|NOT COMPLETED|Overall Study||5
5193444|NCT01083771|12771766|P1|COMPLETED|Overall Study||16
5193445|NCT01083771|12771766|P1|STARTED|Overall Study||21
5193446|NCT01083758|12771771|P1|NOT COMPLETED|Overall Study||2
5193447|NCT01083758|12771771|P1|COMPLETED|Overall Study||29
5193448|NCT01083758|12771771|P1|STARTED|Overall Study||31
5193449|NCT01083732|12771805|P3|NOT COMPLETED|Overall Study||0
5193450|NCT01083732|12771806|P2|NOT COMPLETED|Overall Study||0
5193451|NCT01083732|12771807|P1|NOT COMPLETED|Overall Study||0
5193452|NCT01083732|12771805|P3|COMPLETED|Overall Study||3
5193453|NCT01083732|12771806|P2|COMPLETED|Overall Study||9
5193454|NCT01083732|12771807|P1|COMPLETED|Overall Study||6
5193455|NCT01083732|12771805|P3|STARTED|Overall Study||3
5193456|NCT01083732|12771806|P2|STARTED|Overall Study||9
5193457|NCT01083732|12771807|P1|STARTED|Overall Study||6
5193458|NCT01083706|12771858|P1|NOT COMPLETED|Overall Study||0
5193459|NCT01083706|12771858|P1|COMPLETED|Overall Study||39
5193460|NCT01083706|12771858|P1|STARTED|Overall Study||39
5193461|NCT01083693|12771867|P3|NOT COMPLETED|Overall Study||7
5193462|NCT01083693|12771868|P2|NOT COMPLETED|Overall Study||6
5193463|NCT01083693|12771869|P1|NOT COMPLETED|Overall Study||20
5193464|NCT01083693|12771867|P3|COMPLETED|Overall Study||33
5193465|NCT01083693|12771868|P2|COMPLETED|Overall Study||22
5193466|NCT01083693|12771869|P1|COMPLETED|Overall Study||73
5193467|NCT01083693|12771867|P3|STARTED|Overall Study||40
5193468|NCT01083693|12771868|P2|STARTED|Overall Study||28
5193469|NCT01083693|12771869|P1|STARTED|Overall Study||93
5193470|NCT01083680|12771904|P1|NOT COMPLETED|Overall Study||3844
5193471|NCT01083680|12771904|P1|COMPLETED|Overall Study||263
5193472|NCT01083680|12771904|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
5193473|NCT01083680|12771904|P1|STARTED|Overall Study||4107
5193474|NCT01083667|12771913|P1|NOT COMPLETED|Overall Study||10
5193475|NCT01083667|12771913|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
5193476|NCT01083667|12771913|P1|STARTED|Overall Study|enrolled|32
5193477|NCT01083654|12771920|P2|NOT COMPLETED|Overall Study||0
5193478|NCT01083654|12771921|P1|NOT COMPLETED|Overall Study||0
5193479|NCT01083654|12771920|P2|COMPLETED|Overall Study||50
5193480|NCT01083654|12771921|P1|COMPLETED|Overall Study||53
5193481|NCT01083654|12771920|P2|STARTED|Overall Study||50
5193482|NCT01083654|12771921|P1|STARTED|Overall Study||53
5193483|NCT01083641|12771927|P1|NOT COMPLETED|Overall Study||2
5193484|NCT01083641|12771927|P1|COMPLETED|Overall Study||15
5193485|NCT01083641|12771927|P1|STARTED|Overall Study||17
5193486|NCT01083628|12771936|P2|NOT COMPLETED|Overall Study||0
5193487|NCT01083628|12771937|P1|NOT COMPLETED|Overall Study||0
5193488|NCT01083628|12771936|P2|COMPLETED|Overall Study||40
5193489|NCT01083628|12771937|P1|COMPLETED|Overall Study||45
5193490|NCT01083628|12771936|P2|STARTED|Overall Study||40
5193491|NCT01083628|12771937|P1|STARTED|Overall Study||45
5193492|NCT01083602|12771947|P1|NOT COMPLETED|Overall Study||55
5193493|NCT01083602|12771947|P1|COMPLETED|Overall Study||0
5193494|NCT01083602|12771947|P1|STARTED|Overall Study||55
5193495|NCT01083576|12771958|P2|NOT COMPLETED|Overall Study||1
5193496|NCT01083576|12771959|P1|NOT COMPLETED|Overall Study||6
5193497|NCT01083576|12771958|P2|COMPLETED|Overall Study||14
5193498|NCT01083576|12771959|P1|COMPLETED|Overall Study||9
5193499|NCT01083576|12771958|P2|STARTED|Overall Study||15
5193500|NCT01083576|12771959|P1|STARTED|Overall Study||15
5193501|NCT01083485|12771989|P2|NOT COMPLETED|Overall Study||3
5193502|NCT01083485|12771990|P1|NOT COMPLETED|Overall Study||7
5193503|NCT01083485|12771989|P2|COMPLETED|Overall Study||64
5193504|NCT01083485|12771990|P1|COMPLETED|Overall Study||63
5193505|NCT01083485|12771989|P2|STARTED|Overall Study||67
5193506|NCT01083485|12771990|P1|STARTED|Overall Study||70
5193507|NCT01083472|12772000|P2|NOT COMPLETED|Overall Study||0
5193508|NCT01083472|12772001|P1|NOT COMPLETED|Overall Study||0
5193509|NCT01083472|12772000|P2|COMPLETED|Overall Study||19
5193510|NCT01083472|12772001|P1|COMPLETED|Overall Study||18
5193511|NCT01083472|12772000|P2|STARTED|Overall Study||19
5193512|NCT01083472|12772001|P1|STARTED|Overall Study||18
5193513|NCT01083368|12772009|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
5193514|NCT01083368|12772010|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
5193515|NCT01083368|12772011|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
5193516|NCT01083368|12772012|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
5193517|NCT01083368|12772009|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
5193518|NCT01083368|12772010|P3|COMPLETED|Phase II - Efficacy/Safety||0
5193519|NCT01083368|12772011|P2|COMPLETED|Phase II - Efficacy/Safety||0
5193520|NCT01083368|12772012|P1|COMPLETED|Phase II - Efficacy/Safety||0
5193521|NCT01083368|12772009|P4|STARTED|Phase II - Efficacy/Safety||20
5193522|NCT01083368|12772010|P3|STARTED|Phase II - Efficacy/Safety||0
5193523|NCT01083368|12772011|P2|STARTED|Phase II - Efficacy/Safety||0
5193524|NCT01083368|12772012|P1|STARTED|Phase II - Efficacy/Safety||0
5193525|NCT01083368|12772009|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
5193526|NCT01083368|12772010|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
5193527|NCT01083368|12772011|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
5193528|NCT01083368|12772012|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
5193529|NCT01083368|12772009|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
5193530|NCT01083368|12772010|P3|COMPLETED|Dose Escalation Weeks 5-9||1
5193531|NCT01083368|12772011|P2|COMPLETED|Dose Escalation Weeks 5-9||0
5193532|NCT01083368|12772012|P1|COMPLETED|Dose Escalation Weeks 5-9||0
5193533|NCT01083368|12772009|P4|STARTED|Dose Escalation Weeks 5-9||6
5193534|NCT01083368|12772010|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
5193535|NCT01083368|12772011|P2|STARTED|Dose Escalation Weeks 5-9||0
5193536|NCT01083368|12772012|P1|STARTED|Dose Escalation Weeks 5-9||0
5193537|NCT01083368|12772009|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
5193538|NCT01083368|12772010|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
5193539|NCT01083368|12772011|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
5193540|NCT01083368|12772012|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
5193541|NCT01083368|12772009|P4|COMPLETED|Dose Escalation Weeks 1-4||0
5193542|NCT01083368|12772010|P3|COMPLETED|Dose Escalation Weeks 1-4||4
5193543|NCT01083368|12772011|P2|COMPLETED|Dose Escalation Weeks 1-4||0
5193544|NCT01083368|12772012|P1|COMPLETED|Dose Escalation Weeks 1-4||0
5193545|NCT01083368|12772009|P4|Disease Progression|Dose Escalation Weeks 1-4||0
5193546|NCT01083368|12772010|P3|Disease Progression|Dose Escalation Weeks 1-4||1
5193547|NCT01083368|12772011|P2|Disease Progression|Dose Escalation Weeks 1-4||0
5193548|NCT01083368|12772012|P1|Disease Progression|Dose Escalation Weeks 1-4||0
5193549|NCT01083368|12772009|P4|STARTED|Dose Escalation Weeks 1-4||0
5193550|NCT01083368|12772010|P3|STARTED|Dose Escalation Weeks 1-4||4
5193551|NCT01083368|12772011|P2|STARTED|Dose Escalation Weeks 1-4||0
5193552|NCT01083368|12772012|P1|STARTED|Dose Escalation Weeks 1-4||0
5193553|NCT01083316|12772022|P1|NOT COMPLETED|Overall Study||3
5193554|NCT01083316|12772022|P1|COMPLETED|Overall Study||32
5193555|NCT01083316|12772022|P1|STARTED|Overall Study||35
5193556|NCT01083199|12772029|P1|NOT COMPLETED|Overall Study||0
5193557|NCT01083199|12772029|P1|COMPLETED|Overall Study||10
5193558|NCT01083199|12772029|P1|STARTED|Overall Study||10
5193559|NCT01083186|12772034|P1|NOT COMPLETED|Overall Study||94
5193560|NCT01083186|12772034|P1|COMPLETED|Overall Study||406
5193561|NCT01083186|12772034|P1|STARTED|Overall Study||500
5193562|NCT01083173|12772075|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
5193563|NCT01083173|12772076|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
5193564|NCT01083173|12772075|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
5193565|NCT01083173|12772076|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
5193566|NCT01083173|12772075|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
5193567|NCT01083173|12772076|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
5193568|NCT01083173|12772075|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
5193569|NCT01083173|12772076|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
5193570|NCT01083173|12772075|P2|COMPLETED|Long-term Surveillance: Safety Group||479
5193571|NCT01083173|12772076|P1|COMPLETED|Long-term Surveillance: Safety Group||0
5193572|NCT01083173|12772075|P2|STARTED|Long-term Surveillance: Safety Group||595
5193573|NCT01083173|12772076|P1|STARTED|Long-term Surveillance: Safety Group||0
5193574|NCT01083173|12772075|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
5193575|NCT01083173|12772076|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
5193576|NCT01083173|12772075|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
5193577|NCT01083173|12772076|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
5193578|NCT01083173|12772075|P2|STARTED|Main Surveillance: Effectiveness Group||0
5193579|NCT01083173|12772076|P1|STARTED|Main Surveillance: Effectiveness Group||580
5193580|NCT01083173|12772075|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
5193581|NCT01083173|12772076|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
5193582|NCT01083173|12772075|P2|COMPLETED|Main Surveillance: Safety Group||0
5193583|NCT01083173|12772076|P1|COMPLETED|Main Surveillance: Safety Group||580
5193584|NCT01083173|12772075|P2|STARTED|Main Surveillance: Safety Group||0
5193585|NCT01083173|12772076|P1|STARTED|Main Surveillance: Safety Group||595
5193586|NCT01083160|12772094|P1|NOT COMPLETED|Overall Study||1
5193587|NCT01083160|12772094|P1|COMPLETED|Overall Study||81
5193588|NCT01083160|12772094|P1|Evaluable Population|Overall Study||71
5193589|NCT01083160|12772094|P1|STARTED|Overall Study||82
5193590|NCT01083121|12772101|P1|NOT COMPLETED|Overall Study||81
5193591|NCT01083121|12772101|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
5193592|NCT01083121|12772101|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
5193593|NCT01082965|12772111|P2|NOT COMPLETED|Overall Study||2
5193594|NCT01082965|12772112|P1|NOT COMPLETED|Overall Study||1
5193595|NCT01082965|12772111|P2|COMPLETED|Overall Study||6
5193596|NCT01082965|12772112|P1|COMPLETED|Overall Study||9
5193597|NCT01082965|12772111|P2|STARTED|Overall Study||8
5193598|NCT01082965|12772112|P1|STARTED|Overall Study||10
5193599|NCT01082952|12772132|P2|NOT COMPLETED|Overall Study||0
5193600|NCT01082952|12772133|P1|NOT COMPLETED|Overall Study||0
5193601|NCT01082952|12772132|P2|COMPLETED|Overall Study||6
5193602|NCT01082952|12772133|P1|COMPLETED|Overall Study||6
5193603|NCT01082952|12772132|P2|STARTED|Overall Study||6
5193604|NCT01082952|12772133|P1|STARTED|Overall Study||6
5193605|NCT01082939|12772141|P1|NOT COMPLETED|Overall Study||0
5193606|NCT01082939|12772141|P1|COMPLETED|Overall Study||80
5193607|NCT01082939|12772141|P1|STARTED|Overall Study||80
5193608|NCT01082874|12772149|P4|NOT COMPLETED|Overall Study||13
5193609|NCT01082874|12772150|P3|NOT COMPLETED|Overall Study||11
5193610|NCT01082874|12772151|P2|NOT COMPLETED|Overall Study||12
5193611|NCT01082874|12772152|P1|NOT COMPLETED|Overall Study||11
5193612|NCT01082874|12772149|P4|COMPLETED|Overall Study||2489
5193613|NCT01082874|12772150|P3|COMPLETED|Overall Study||2488
5193614|NCT01082874|12772151|P2|COMPLETED|Overall Study||2498
5193615|NCT01082874|12772152|P1|COMPLETED|Overall Study||2488
5193616|NCT01082874|12772149|P4|STARTED|Overall Study||2502
5193617|NCT01082874|12772150|P3|STARTED|Overall Study||2499
5193618|NCT01082874|12772151|P2|STARTED|Overall Study||2510
5193619|NCT01082874|12772152|P1|STARTED|Overall Study||2499
5193620|NCT01082640|12772165|P3|NOT COMPLETED|Overall Study||8
5193621|NCT01082640|12772166|P2|NOT COMPLETED|Overall Study||15
5193622|NCT01082640|12772167|P1|NOT COMPLETED|Overall Study||17
5193623|NCT01082640|12772165|P3|COMPLETED|Overall Study||24
5193624|NCT01082640|12772166|P2|COMPLETED|Overall Study||17
5193625|NCT01082640|12772167|P1|COMPLETED|Overall Study||15
5193626|NCT01082640|12772165|P3|STARTED|Overall Study||32
5193627|NCT01082640|12772166|P2|STARTED|Overall Study||32
5193628|NCT01082640|12772167|P1|STARTED|Overall Study||32
5193629|NCT01082614|12772189|P2|NOT COMPLETED|Overall Study||5
5193630|NCT01082614|12772190|P1|NOT COMPLETED|Overall Study||3
5193631|NCT01082614|12772189|P2|COMPLETED|Overall Study||18
5193632|NCT01082614|12772190|P1|COMPLETED|Overall Study||20
5193633|NCT01082614|12772189|P2|STARTED|Overall Study||23
5193634|NCT01082614|12772190|P1|STARTED|Overall Study||23
5193635|NCT01082588|12772202|P2|NOT COMPLETED|Overall Study||5
5193636|NCT01082588|12772203|P1|NOT COMPLETED|Overall Study||6
5193637|NCT01082588|12772202|P2|COMPLETED|Overall Study||25
5193638|NCT01082588|12772203|P1|COMPLETED|Overall Study||24
5193639|NCT01082588|12772202|P2|STARTED|Overall Study||30
5193640|NCT01082588|12772203|P1|STARTED|Overall Study||30
5193641|NCT01082575|12772221|P1|NOT COMPLETED|Overall Study||0
5193642|NCT01082575|12772221|P1|COMPLETED|Overall Study||100
5193643|NCT01082575|12772221|P1|STARTED|Overall Study||100
5193644|NCT01082380|12772226|P1|NOT COMPLETED|Overall Study||0
5193645|NCT01082380|12772226|P1|COMPLETED|Overall Study||6
5193646|NCT01082380|12772226|P1|STARTED|Overall Study||6
5193647|NCT01082367|12772261|P2|NOT COMPLETED|Follow-up (F-U) Period||1
5193648|NCT01082367|12772262|P1|NOT COMPLETED|Follow-up (F-U) Period||2
5193649|NCT01082367|12772261|P2|COMPLETED|Follow-up (F-U) Period||9
5193650|NCT01082367|12772262|P1|COMPLETED|Follow-up (F-U) Period||17
5193651|NCT01082367|12772261|P2|Treated in F-U|Follow-up (F-U) Period||5
5193652|NCT01082367|12772262|P1|Treated in F-U|Follow-up (F-U) Period||5
5193653|NCT01082367|12772261|P2|STARTED|Follow-up (F-U) Period||10
5193654|NCT01082367|12772262|P1|STARTED|Follow-up (F-U) Period||19
5193655|NCT01082367|12772261|P2|NOT COMPLETED|Double-blind Period||13
5193656|NCT01082367|12772262|P1|NOT COMPLETED|Double-blind Period||5
5193657|NCT01082367|12772261|P2|COMPLETED|Double-blind Period||12
5193658|NCT01082367|12772262|P1|COMPLETED|Double-blind Period||21
5193659|NCT01082367|12772261|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
5193660|NCT01082367|12772262|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
5193661|NCT01082367|12772261|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
5193662|NCT01082367|12772262|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
5193663|NCT01082367|12772261|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
5193664|NCT01082367|12772262|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
5193665|NCT01082367|12772261|P2|Entered OL TOBI|Double-blind Period||18
5193666|NCT01082367|12772262|P1|Entered OL TOBI|Double-blind Period||4
5193667|NCT01082367|12772261|P2|Stage 2:no tx|Double-blind Period||0
5193668|NCT01082367|12772262|P1|Stage 2:no tx|Double-blind Period||0
5193669|NCT01082367|12772261|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
5193670|NCT01082367|12772262|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
5193671|NCT01082367|12772261|P2|STARTED|Double-blind Period||25
5193672|NCT01082367|12772262|P1|STARTED|Double-blind Period||26
5193673|NCT01082328|12772276|P1|NOT COMPLETED|Overall Study||1
5193674|NCT01082328|12772276|P1|COMPLETED|Overall Study||58
5193675|NCT01082328|12772276|P1|STARTED|Overall Study||59
5193676|NCT01082211|12772285|P1|NOT COMPLETED|Overall Study||7
5193677|NCT01082211|12772285|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
5193678|NCT01082211|12772285|P1|All Eligible Patients|Overall Study||58
5193679|NCT01082211|12772285|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
5193680|NCT01082211|12772285|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
5193681|NCT01082211|12772285|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
5193682|NCT01082211|12772285|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
5193683|NCT01082211|12772285|P1|Has Baseline MD QOL Data|Overall Study||44
5193684|NCT01082211|12772285|P1|Has Baseline PT QOL Data|Overall Study||46
5193685|NCT01082211|12772285|P1|STARTED|Overall Study||65
5193686|NCT01082159|12772303|P1|NOT COMPLETED|Overall Study||9
5193687|NCT01082159|12772303|P1|COMPLETED|Overall Study||46
5193688|NCT01082159|12772303|P1|STARTED|Overall Study||55
5193689|NCT01082081|12772312|P3|NOT COMPLETED|Overall Study||2
5193690|NCT01082081|12772313|P2|NOT COMPLETED|Overall Study||1
5193691|NCT01082081|12772314|P1|NOT COMPLETED|Overall Study||0
5193692|NCT01082081|12772312|P3|COMPLETED|Overall Study||58
5193693|NCT01082081|12772313|P2|COMPLETED|Overall Study||118
5193694|NCT01082081|12772314|P1|COMPLETED|Overall Study||121
5193695|NCT01082081|12772312|P3|STARTED|Overall Study||60
5193696|NCT01082081|12772313|P2|STARTED|Overall Study||119
5193697|NCT01082081|12772314|P1|STARTED|Overall Study||121
5193698|NCT01081951|12772366|P2|NOT COMPLETED|Overall Study||55
5193699|NCT01081951|12772367|P1|NOT COMPLETED|Overall Study||56
5193700|NCT01081951|12772366|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
5193701|NCT01081951|12772367|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
5193702|NCT01081951|12772366|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
5193703|NCT01081951|12772367|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
5193704|NCT01081951|12772366|P2|Entered Maintenance Phase|Overall Study||55
5193705|NCT01081951|12772367|P1|Entered Maintenance Phase|Overall Study||66
5193706|NCT01081951|12772366|P2|Received Study Treatment|Overall Study||75
5193707|NCT01081951|12772367|P1|Received Study Treatment|Overall Study||81
5193708|NCT01081951|12772366|P2|STARTED|Overall Study||81
5193709|NCT01081951|12772367|P1|STARTED|Overall Study||81
5193710|NCT01081912|12772377|P3|NOT COMPLETED|Maintenance Treatment||92
5193711|NCT01081912|12772378|P2|NOT COMPLETED|Maintenance Treatment||27
5193712|NCT01081912|12772379|P1|NOT COMPLETED|Maintenance Treatment||0
5193713|NCT01081912|12772377|P3|COMPLETED|Maintenance Treatment||59
5193714|NCT01081912|12772378|P2|COMPLETED|Maintenance Treatment||124
5193715|NCT01081912|12772379|P1|COMPLETED|Maintenance Treatment||0
5193716|NCT01081912|12772377|P3|STARTED|Maintenance Treatment||151
5193717|NCT01081912|12772378|P2|STARTED|Maintenance Treatment||151
5193718|NCT01081912|12772379|P1|STARTED|Maintenance Treatment||0
5193719|NCT01081912|12772377|P3|NOT COMPLETED|Conversion/Titration||0
5193720|NCT01081912|12772378|P2|NOT COMPLETED|Conversion/Titration||0
5193721|NCT01081912|12772379|P1|NOT COMPLETED|Conversion/Titration||208
5193722|NCT01081912|12772377|P3|COMPLETED|Conversion/Titration||0
5193723|NCT01081912|12772378|P2|COMPLETED|Conversion/Titration||0
5193724|NCT01081912|12772379|P1|COMPLETED|Conversion/Titration||302
5193725|NCT01081912|12772377|P3|STARTED|Conversion/Titration||0
5193726|NCT01081912|12772378|P2|STARTED|Conversion/Titration||0
5193727|NCT01081912|12772379|P1|STARTED|Conversion/Titration||510
5193728|NCT01081886|12772388|P2|NOT COMPLETED|Overall Study||13
5193729|NCT01081886|12772389|P1|NOT COMPLETED|Overall Study||11
5193730|NCT01081886|12772388|P2|COMPLETED|Overall Study||0
5193731|NCT01081886|12772389|P1|COMPLETED|Overall Study||0
5193732|NCT01081886|12772388|P2|STARTED|Overall Study||13
5193733|NCT01081886|12772389|P1|STARTED|Overall Study||11
5193734|NCT01081873|12772397|P1|NOT COMPLETED|Overall Study||298
5193735|NCT01081873|12772397|P1|COMPLETED|Overall Study||2416
5193736|NCT01081873|12772397|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
5193737|NCT01081834|12772469|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
5193738|NCT01081834|12772470|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
5193739|NCT01081834|12772471|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
5193740|NCT01081834|12772472|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
5193741|NCT01081834|12772473|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
5193742|NCT01081834|12772469|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
5193743|NCT01081834|12772470|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
5193744|NCT01081834|12772471|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
5193745|NCT01081834|12772472|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
5193746|NCT01081834|12772473|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
5193747|NCT01081834|12772469|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
5193748|NCT01081834|12772470|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
5193749|NCT01081834|12772471|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
5193750|NCT01081834|12772472|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
5193751|NCT01081834|12772473|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
5193752|NCT01081834|12772469|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
5193753|NCT01081834|12772470|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
5193754|NCT01081834|12772471|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
5193755|NCT01081834|12772472|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
5193756|NCT01081834|12772473|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
5193757|NCT01081834|12772469|P5|COMPLETED|Core Period: Baseline to Week 26||40
5193758|NCT01081834|12772470|P4|COMPLETED|Core Period: Baseline to Week 26||40
5193759|NCT01081834|12772471|P3|COMPLETED|Core Period: Baseline to Week 26||175
5193760|NCT01081834|12772472|P2|COMPLETED|Core Period: Baseline to Week 26||172
5193761|NCT01081834|12772473|P1|COMPLETED|Core Period: Baseline to Week 26||160
5193762|NCT01081834|12772469|P5|STARTED|Core Period: Baseline to Week 26||44
5193763|NCT01081834|12772470|P4|STARTED|Core Period: Baseline to Week 26||47
5193764|NCT01081834|12772471|P3|STARTED|Core Period: Baseline to Week 26||197
5193765|NCT01081834|12772472|P2|STARTED|Core Period: Baseline to Week 26||195
5193766|NCT01081834|12772473|P1|STARTED|Core Period: Baseline to Week 26||192
5193767|NCT01081795|12772534|P3|NOT COMPLETED|Overall Study||30
5193768|NCT01081795|12772535|P2|NOT COMPLETED|Overall Study||35
5193769|NCT01081795|12772536|P1|NOT COMPLETED|Overall Study||33
5193770|NCT01081795|12772534|P3|COMPLETED|Overall Study||97
5193771|NCT01081795|12772535|P2|COMPLETED|Overall Study||95
5193772|NCT01081795|12772536|P1|COMPLETED|Overall Study||97
5193773|NCT01081795|12772534|P3|STARTED|Overall Study||127
5193774|NCT01081795|12772535|P2|STARTED|Overall Study||130
5193775|NCT01081795|12772536|P1|STARTED|Overall Study||130
5193776|NCT01081769|12772573|P2|NOT COMPLETED|CORE Intent-To-Treat||97
5193777|NCT01081769|12772574|P1|NOT COMPLETED|CORE Intent-To-Treat||80
5193778|NCT01081769|12772573|P2|COMPLETED|CORE Intent-To-Treat||266
5193779|NCT01081769|12772574|P1|COMPLETED|CORE Intent-To-Treat||272
5193780|NCT01081769|12772573|P2|STARTED|CORE Intent-To-Treat||363
5193781|NCT01081769|12772574|P1|STARTED|CORE Intent-To-Treat||352
5193782|NCT01081769|12772573|P2|NOT COMPLETED|Whole Intent-to-Treat||25
5193783|NCT01081769|12772574|P1|NOT COMPLETED|Whole Intent-to-Treat||24
5193784|NCT01081769|12772573|P2|COMPLETED|Whole Intent-to-Treat||363
5193785|NCT01081769|12772574|P1|COMPLETED|Whole Intent-to-Treat||352
5193786|NCT01081769|12772573|P2|STARTED|Whole Intent-to-Treat||388
5193787|NCT01081769|12772574|P1|STARTED|Whole Intent-to-Treat||376
5193788|NCT01081678|12772612|P4|NOT COMPLETED|Overall Study||29
5193789|NCT01081678|12772613|P3|NOT COMPLETED|Overall Study||31
5193790|NCT01081678|12772614|P2|NOT COMPLETED|Overall Study||16
5193791|NCT01081678|12772615|P1|NOT COMPLETED|Overall Study||27
5193792|NCT01081678|12772612|P4|COMPLETED|Overall Study||61
5193793|NCT01081678|12772613|P3|COMPLETED|Overall Study||62
5193794|NCT01081678|12772614|P2|COMPLETED|Overall Study||44
5193795|NCT01081678|12772615|P1|COMPLETED|Overall Study||62
5193796|NCT01081678|12772612|P4|Completed 24 Weeks of Study|Overall Study||68
5193797|NCT01081678|12772613|P3|Completed 24 Weeks of Study|Overall Study||72
5193798|NCT01081678|12772614|P2|Completed 24 Weeks of Study|Overall Study||50
5193799|NCT01081678|12772615|P1|Completed 24 Weeks of Study|Overall Study||73
5193800|NCT01081678|12772612|P4|Received Study Drug|Overall Study||89
5193801|NCT01081678|12772613|P3|Received Study Drug|Overall Study||89
5193802|NCT01081678|12772614|P2|Received Study Drug|Overall Study||60
5193803|NCT01081678|12772615|P1|Received Study Drug|Overall Study||87
5193804|NCT01081678|12772612|P4|STARTED|Overall Study||90
5193805|NCT01081678|12772613|P3|STARTED|Overall Study||93
5193806|NCT01081678|12772614|P2|STARTED|Overall Study||60
5193807|NCT01081678|12772615|P1|STARTED|Overall Study||89
5193808|NCT01081665|12772645|P1|NOT COMPLETED|Overall Study||95
5193809|NCT01081665|12772645|P1|COMPLETED|Overall Study||142
5193810|NCT01081665|12772645|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
5193811|NCT01081665|12772645|P1|Full Analysis Set|Overall Study||237
5193812|NCT01081665|12772645|P1|STARTED|Overall Study||237
5193813|NCT01081626|12772657|P2|NOT COMPLETED|Overall Study||61
5193814|NCT01081626|12772658|P1|NOT COMPLETED|Overall Study||60
5193815|NCT01081626|12772657|P2|COMPLETED|Overall Study||94
5193816|NCT01081626|12772658|P1|COMPLETED|Overall Study||95
5193817|NCT01081626|12772657|P2|Assessed for Efficacy|Overall Study||125
5193818|NCT01081626|12772658|P1|Assessed for Efficacy|Overall Study||122
5193819|NCT01081626|12772657|P2|STARTED|Overall Study||155
5193820|NCT01081626|12772658|P1|STARTED|Overall Study||155
5193821|NCT01081301|12772684|P1|NOT COMPLETED|Overall Study||14
5193822|NCT01081301|12772684|P1|COMPLETED|Overall Study||22
5193823|NCT01081301|12772684|P1|STARTED|Overall Study||36
5193824|NCT01081262|12772726|P4|NOT COMPLETED|Overall Study||0
5193825|NCT01081262|12772727|P3|NOT COMPLETED|Overall Study||0
5193826|NCT01081262|12772728|P2|NOT COMPLETED|Overall Study||0
5193827|NCT01081262|12772729|P1|NOT COMPLETED|Overall Study||0
5193828|NCT01081262|12772726|P4|COMPLETED|Overall Study||11
5193829|NCT01081262|12772727|P3|COMPLETED|Overall Study||13
5193830|NCT01081262|12772728|P2|COMPLETED|Overall Study||13
5193831|NCT01081262|12772729|P1|COMPLETED|Overall Study||13
5193832|NCT01081262|12772726|P4|STARTED|Overall Study||11
5193833|NCT01081262|12772727|P3|STARTED|Overall Study||13
5193834|NCT01081262|12772728|P2|STARTED|Overall Study||13
5193835|NCT01081262|12772729|P1|STARTED|Overall Study||13
5193836|NCT01081249|12772759|P2|NOT COMPLETED|Overall Study||1
5193837|NCT01081249|12772760|P1|NOT COMPLETED|Overall Study||0
5193838|NCT01081249|12772759|P2|COMPLETED|Overall Study||6
5193839|NCT01081249|12772760|P1|COMPLETED|Overall Study||11
5193840|NCT01081249|12772759|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
5193841|NCT01081249|12772760|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
5193842|NCT01081249|12772759|P2|Washout (5-10 Days)|Overall Study||6
5193843|NCT01081249|12772760|P1|Washout (5-10 Days)|Overall Study||11
5193844|NCT01081249|12772759|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
5193845|NCT01081249|12772760|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
5193846|NCT01081249|12772759|P2|STARTED|Overall Study||7
5193847|NCT01081249|12772760|P1|STARTED|Overall Study||11
5193848|NCT01081145|12772766|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
5193849|NCT01081145|12772767|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
5193850|NCT01081145|12772766|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
5193851|NCT01081145|12772767|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
5193852|NCT01081145|12772766|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
5193853|NCT01081145|12772767|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
5193854|NCT01081145|12772766|P2|NOT COMPLETED|Open-Label Phase||0
5193855|NCT01081145|12772767|P1|NOT COMPLETED|Open-Label Phase||212
5193856|NCT01081145|12772766|P2|COMPLETED|Open-Label Phase||0
5193857|NCT01081145|12772767|P1|COMPLETED|Open-Label Phase||316
5193858|NCT01081145|12772766|P2|STARTED|Open-Label Phase||0
5193859|NCT01081145|12772767|P1|STARTED|Open-Label Phase||528
5193860|NCT01081132|12772795|P2|NOT COMPLETED|Overall Study||52
5193861|NCT01081132|12772796|P1|NOT COMPLETED|Overall Study||55
5193862|NCT01081132|12772795|P2|COMPLETED|Overall Study||105
5193863|NCT01081132|12772796|P1|COMPLETED|Overall Study||102
5193864|NCT01081132|12772795|P2|STARTED|Overall Study||157
5193865|NCT01081132|12772796|P1|STARTED|Overall Study||157
5193866|NCT01081041|12772837|P3|NOT COMPLETED|Overall Study||2
5193867|NCT01081041|12772838|P2|NOT COMPLETED|Overall Study||4
5193868|NCT01081041|12772839|P1|NOT COMPLETED|Overall Study||0
5193869|NCT01081041|12772837|P3|COMPLETED|Overall Study||71
5193870|NCT01081041|12772838|P2|COMPLETED|Overall Study||77
5193871|NCT01081041|12772839|P1|COMPLETED|Overall Study||33
5193872|NCT01081041|12772837|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
5193873|NCT01081041|12772838|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
5193874|NCT01081041|12772839|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
5193875|NCT01081041|12772837|P3|STARTED|Overall Study||73
5193876|NCT01081041|12772838|P2|STARTED|Overall Study||81
5193877|NCT01081041|12772839|P1|STARTED|Overall Study||33
5193878|NCT01080976|12772869|P2|NOT COMPLETED|Overall Study||0
5193879|NCT01080976|12772870|P1|NOT COMPLETED|Overall Study||0
5193880|NCT01080976|12772869|P2|COMPLETED|Overall Study||5
5193881|NCT01080976|12772870|P1|COMPLETED|Overall Study||5
5193882|NCT01080976|12772869|P2|STARTED|Overall Study||5
5193883|NCT01080976|12772870|P1|STARTED|Overall Study||5
5193884|NCT01080807|12772880|P2|NOT COMPLETED|Overall Study||23
5193885|NCT01080807|12772881|P1|NOT COMPLETED|Overall Study||35
5193886|NCT01080807|12772880|P2|COMPLETED|Overall Study||167
5193887|NCT01080807|12772881|P1|COMPLETED|Overall Study||158
5193888|NCT01080807|12772880|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
5193889|NCT01080807|12772881|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
5193890|NCT01080794|12772939|P4|NOT COMPLETED|Overall Study||2
5193891|NCT01080794|12772940|P3|NOT COMPLETED|Overall Study||2
5193892|NCT01080794|12772941|P2|NOT COMPLETED|Overall Study||2
5193893|NCT01080794|12772942|P1|NOT COMPLETED|Overall Study||5
5193894|NCT01080794|12772939|P4|COMPLETED|Overall Study||13
5193895|NCT01080794|12772940|P3|COMPLETED|Overall Study||10
5193896|NCT01080794|12772941|P2|COMPLETED|Overall Study||12
5193897|NCT01080794|12772942|P1|COMPLETED|Overall Study||15
5193898|NCT01080794|12772939|P4|STARTED|Overall Study||15
5193899|NCT01080794|12772940|P3|STARTED|Overall Study||12
5193900|NCT01080794|12772941|P2|STARTED|Overall Study||14
5193901|NCT01080794|12772942|P1|STARTED|Overall Study||20
5193902|NCT01080768|12772990|P2|NOT COMPLETED|Overall Study||1
5193903|NCT01080768|12772991|P1|NOT COMPLETED|Overall Study||2
5193904|NCT01080768|12772990|P2|COMPLETED|Overall Study||16
5193905|NCT01080768|12772991|P1|COMPLETED|Overall Study||12
5193906|NCT01080768|12772990|P2|STARTED|Overall Study||17
5193907|NCT01080768|12772991|P1|STARTED|Overall Study||14
5193908|NCT01080716|12773001|P4|NOT COMPLETED|Part 2||0
5193909|NCT01080716|12773002|P3|NOT COMPLETED|Part 2||0
5193910|NCT01080716|12773003|P2|NOT COMPLETED|Part 2||0
5193911|NCT01080716|12773004|P1|NOT COMPLETED|Part 2||0
5193912|NCT01080716|12773001|P4|COMPLETED|Part 2||10
5193913|NCT01080716|12773002|P3|COMPLETED|Part 2||10
5193914|NCT01080716|12773003|P2|COMPLETED|Part 2||0
5193915|NCT01080716|12773004|P1|COMPLETED|Part 2||0
5193916|NCT01080716|12773001|P4|STARTED|Part 2||10
5193917|NCT01080716|12773002|P3|STARTED|Part 2||10
5193918|NCT01080716|12773003|P2|STARTED|Part 2||0
5193919|NCT01080716|12773004|P1|STARTED|Part 2||0
5193920|NCT01080716|12773001|P4|NOT COMPLETED|Part 1||0
5193921|NCT01080716|12773002|P3|NOT COMPLETED|Part 1||0
5193922|NCT01080716|12773003|P2|NOT COMPLETED|Part 1||0
5193923|NCT01080716|12773004|P1|NOT COMPLETED|Part 1||1
5193924|NCT01080716|12773001|P4|COMPLETED|Part 1||0
5193925|NCT01080716|12773002|P3|COMPLETED|Part 1||0
5193926|NCT01080716|12773003|P2|COMPLETED|Part 1||6
5193927|NCT01080716|12773004|P1|COMPLETED|Part 1||13
5193928|NCT01080716|12773001|P4|STARTED|Part 1||0
5193929|NCT01080716|12773002|P3|STARTED|Part 1||0
5193930|NCT01080716|12773003|P2|STARTED|Part 1||6
5193931|NCT01080716|12773004|P1|STARTED|Part 1||14
5193932|NCT01080677|12773021|P3|NOT COMPLETED|Overall Study||0
5193933|NCT01080677|12773022|P2|NOT COMPLETED|Overall Study||0
5193934|NCT01080677|12773023|P1|NOT COMPLETED|Overall Study||0
5193935|NCT01080677|12773021|P3|COMPLETED|Overall Study||20
5193936|NCT01080677|12773022|P2|COMPLETED|Overall Study||20
5193937|NCT01080677|12773023|P1|COMPLETED|Overall Study||20
5193938|NCT01080677|12773021|P3|STARTED|Overall Study||20
5193939|NCT01080677|12773022|P2|STARTED|Overall Study||20
5193940|NCT01080677|12773023|P1|STARTED|Overall Study||20
5193941|NCT01080625|12773043|P3|NOT COMPLETED|Overall Study||1
5193942|NCT01080625|12773044|P2|NOT COMPLETED|Overall Study||2
5193943|NCT01080625|12773045|P1|NOT COMPLETED|Overall Study||0
5193944|NCT01080625|12773043|P3|COMPLETED|Overall Study||31
5193945|NCT01080625|12773044|P2|COMPLETED|Overall Study||31
5193946|NCT01080625|12773045|P1|COMPLETED|Overall Study||31
5193947|NCT01080625|12773043|P3|STARTED|Overall Study||32
5193948|NCT01080625|12773044|P2|STARTED|Overall Study||33
5193949|NCT01080625|12773045|P1|STARTED|Overall Study||31
5193950|NCT01080391|12773055|P2|NOT COMPLETED|Overall Study||4
5193951|NCT01080391|12773056|P1|NOT COMPLETED|Overall Study||7
5193952|NCT01080391|12773055|P2|COMPLETED|Overall Study||392
5193953|NCT01080391|12773056|P1|COMPLETED|Overall Study||389
5193954|NCT01080391|12773055|P2|Treated|Overall Study||392
5193955|NCT01080391|12773056|P1|Treated|Overall Study||389
5193956|NCT01080391|12773055|P2|STARTED|Overall Study||396
5193957|NCT01080391|12773056|P1|STARTED|Overall Study||396
5193958|NCT01080326|12773074|P1|NOT COMPLETED|Overall Study||4
5193959|NCT01080326|12773074|P1|COMPLETED|Overall Study||3
5193960|NCT01080326|12773074|P1|STARTED|Overall Study||7
5193961|NCT01080300|12773080|P2|NOT COMPLETED|Overall Study||104
5193962|NCT01080300|12773081|P1|NOT COMPLETED|Overall Study||94
5193963|NCT01080300|12773080|P2|COMPLETED|Overall Study||191
5193964|NCT01080300|12773081|P1|COMPLETED|Overall Study||206
5193965|NCT01080300|12773080|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
5193966|NCT01080300|12773081|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
5193967|NCT01080261|12773109|P1|NOT COMPLETED|Overall Study||0
5193968|NCT01080261|12773109|P1|COMPLETED|Overall Study||60
5193969|NCT01080261|12773109|P1|STARTED|Overall Study||60
5193970|NCT01080248|12773124|P1|NOT COMPLETED|Overall Study||0
5193971|NCT01080248|12773124|P1|COMPLETED|Overall Study||2
5193972|NCT01080248|12773124|P1|STARTED|Overall Study||2
5193973|NCT01080209|12773138|P7|NOT COMPLETED|Overall Study||7
5193974|NCT01080209|12773139|P6|NOT COMPLETED|Overall Study||0
5193975|NCT01080209|12773140|P5|NOT COMPLETED|Overall Study||0
5193976|NCT01080209|12773141|P4|NOT COMPLETED|Overall Study||5
5193977|NCT01080209|12773142|P3|NOT COMPLETED|Overall Study||5
5193978|NCT01080209|12773143|P2|NOT COMPLETED|Overall Study||11
5193979|NCT01080209|12773144|P1|NOT COMPLETED|Overall Study||6
5193980|NCT01080209|12773138|P7|COMPLETED|Overall Study||44
5193981|NCT01080209|12773139|P6|COMPLETED|Overall Study||2
5193982|NCT01080209|12773140|P5|COMPLETED|Overall Study||6
5193983|NCT01080209|12773141|P4|COMPLETED|Overall Study||37
5193984|NCT01080209|12773142|P3|COMPLETED|Overall Study||28
5193985|NCT01080209|12773143|P2|COMPLETED|Overall Study||42
5193986|NCT01080209|12773144|P1|COMPLETED|Overall Study||22
5193987|NCT01080209|12773138|P7|STARTED|Overall Study||51
5193988|NCT01080209|12773139|P6|STARTED|Overall Study||2
5193989|NCT01080209|12773140|P5|STARTED|Overall Study||6
5193990|NCT01080209|12773141|P4|STARTED|Overall Study||42
5193991|NCT01080209|12773142|P3|STARTED|Overall Study||33
5193992|NCT01080209|12773143|P2|STARTED|Overall Study||53
5193993|NCT01080209|12773144|P1|STARTED|Overall Study||28
5193994|NCT01080196|12773169|P2|NOT COMPLETED|Overall Study||0
5193995|NCT01080196|12773170|P1|NOT COMPLETED|Overall Study||0
5193996|NCT01080196|12773169|P2|COMPLETED|Overall Study||66
5193997|NCT01080196|12773170|P1|COMPLETED|Overall Study||68
5193998|NCT01080196|12773169|P2|STARTED|Overall Study||66
5193999|NCT01080196|12773170|P1|STARTED|Overall Study||68
5194000|NCT01080131|12773186|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
5194001|NCT01080131|12773187|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
5194002|NCT01080131|12773186|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
5194003|NCT01080131|12773187|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
5194004|NCT01080131|12773186|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
5194005|NCT01080131|12773187|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
5194006|NCT01080131|12773186|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
5194007|NCT01080131|12773187|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
5194008|NCT01080131|12773186|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
5194009|NCT01080131|12773187|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
5194010|NCT01080131|12773186|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
5194011|NCT01080131|12773187|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
5194012|NCT01080131|12773186|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
5194013|NCT01080131|12773187|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
5194014|NCT01080131|12773186|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
5194015|NCT01080131|12773187|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
5194016|NCT01080131|12773186|P2|COMPLETED|Core Study (0- 12 Weeks)||103
5194017|NCT01080131|12773187|P1|COMPLETED|Core Study (0- 12 Weeks)||99
5194018|NCT01080131|12773186|P2|STARTED|Core Study (0- 12 Weeks)||114
5194019|NCT01080131|12773187|P1|STARTED|Core Study (0- 12 Weeks)||112
5194020|NCT01080118|12773266|P4|NOT COMPLETED|Overall Study||0
5194021|NCT01080118|12773267|P3|NOT COMPLETED|Overall Study||0
5194022|NCT01080118|12773268|P2|NOT COMPLETED|Overall Study||0
5194023|NCT01080118|12773269|P1|NOT COMPLETED|Overall Study||0
5194024|NCT01080118|12773266|P4|COMPLETED|Overall Study||30
5194025|NCT01080118|12773267|P3|COMPLETED|Overall Study||30
5194026|NCT01080118|12773268|P2|COMPLETED|Overall Study||15
5194027|NCT01080118|12773269|P1|COMPLETED|Overall Study||15
5194028|NCT01080118|12773266|P4|STARTED|Overall Study||30
5194029|NCT01080118|12773267|P3|STARTED|Overall Study||30
5194030|NCT01080118|12773268|P2|STARTED|Overall Study||15
5194031|NCT01080118|12773269|P1|STARTED|Overall Study||15
5194032|NCT01079988|12773282|P5|NOT COMPLETED|Overall Study||1
5194033|NCT01079988|12773283|P4|NOT COMPLETED|Overall Study||3
5194034|NCT01079988|12773284|P3|NOT COMPLETED|Overall Study||0
5194035|NCT01079988|12773285|P2|NOT COMPLETED|Overall Study||0
5194036|NCT01079988|12773286|P1|NOT COMPLETED|Overall Study||1
5194037|NCT01079988|12773282|P5|COMPLETED|Overall Study||1
5194038|NCT01079988|12773283|P4|COMPLETED|Overall Study||17
5194039|NCT01079988|12773284|P3|COMPLETED|Overall Study||8
5194040|NCT01079988|12773285|P2|COMPLETED|Overall Study||1
5194041|NCT01079988|12773286|P1|COMPLETED|Overall Study||9
5194042|NCT01079988|12773282|P5|STARTED|Overall Study||2
5194043|NCT01079988|12773283|P4|STARTED|Overall Study||20
5194044|NCT01079988|12773284|P3|STARTED|Overall Study||8
5194045|NCT01079988|12773285|P2|STARTED|Overall Study||1
5194046|NCT01079988|12773286|P1|STARTED|Overall Study||10
5194047|NCT01079962|12773305|P2|NOT COMPLETED|Overall Study||15
5194048|NCT01079962|12773306|P1|NOT COMPLETED|Overall Study||15
5194049|NCT01079962|12773305|P2|COMPLETED|Overall Study||89
5194050|NCT01079962|12773306|P1|COMPLETED|Overall Study||90
5194051|NCT01079962|12773305|P2|STARTED|Overall Study||104
5194052|NCT01079962|12773306|P1|STARTED|Overall Study||105
5194053|NCT01079949|12773334|P2|NOT COMPLETED|Overall Study||13
5194054|NCT01079949|12773335|P1|NOT COMPLETED|Overall Study||15
5194055|NCT01079949|12773334|P2|COMPLETED|Overall Study||34
5194056|NCT01079949|12773335|P1|COMPLETED|Overall Study||31
5194057|NCT01079949|12773334|P2|STARTED|Overall Study||47
5194058|NCT01079949|12773335|P1|STARTED|Overall Study||46
5194059|NCT01079936|12773381|P5|NOT COMPLETED|Phase II||1
5194060|NCT01079936|12773382|P4|NOT COMPLETED|Phase II||0
5194061|NCT01079936|12773383|P3|NOT COMPLETED|Phase II||1
5194062|NCT01079936|12773384|P2|NOT COMPLETED|Phase II||0
5194063|NCT01079936|12773385|P1|NOT COMPLETED|Phase II||0
5194064|NCT01079936|12773381|P5|COMPLETED|Phase II||25
5194065|NCT01079936|12773382|P4|COMPLETED|Phase II||24
5194066|NCT01079936|12773383|P3|COMPLETED|Phase II||5
5194067|NCT01079936|12773384|P2|COMPLETED|Phase II||3
5194068|NCT01079936|12773385|P1|COMPLETED|Phase II||0
5194069|NCT01079936|12773381|P5|STARTED|Phase II||26
5194070|NCT01079936|12773382|P4|STARTED|Phase II||24
5194071|NCT01079936|12773383|P3|STARTED|Phase II||6
5194072|NCT01079936|12773384|P2|STARTED|Phase II||3
5194073|NCT01079936|12773385|P1|STARTED|Phase II||0
5194074|NCT01079936|12773381|P5|NOT COMPLETED|Phase I: MTD||0
5194075|NCT01079936|12773382|P4|NOT COMPLETED|Phase I: MTD||0
5194076|NCT01079936|12773383|P3|NOT COMPLETED|Phase I: MTD||0
5194077|NCT01079936|12773384|P2|NOT COMPLETED|Phase I: MTD||0
5194078|NCT01079936|12773385|P1|NOT COMPLETED|Phase I: MTD||4
5194079|NCT01079936|12773381|P5|COMPLETED|Phase I: MTD||0
5194080|NCT01079936|12773382|P4|COMPLETED|Phase I: MTD||0
5194081|NCT01079936|12773383|P3|COMPLETED|Phase I: MTD||0
5194082|NCT01079936|12773384|P2|COMPLETED|Phase I: MTD||0
5194083|NCT01079936|12773385|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
5194084|NCT01079936|12773381|P5|STARTED|Phase I: MTD||0
5194085|NCT01079936|12773382|P4|STARTED|Phase I: MTD||0
5194086|NCT01079936|12773383|P3|STARTED|Phase I: MTD||0
5194087|NCT01079936|12773384|P2|STARTED|Phase I: MTD||0
5194088|NCT01079936|12773385|P1|STARTED|Phase I: MTD||16
5194089|NCT01079832|12773404|P1|NOT COMPLETED|Overall Study||1
5194090|NCT01079832|12773404|P1|COMPLETED|Overall Study||49
5194091|NCT01079832|12773404|P1|STARTED|Overall Study||50
5194092|NCT01079806|12773414|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
5194093|NCT01079806|12773415|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
5194094|NCT01079806|12773414|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
5194095|NCT01079806|12773415|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
5194096|NCT01079806|12773414|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
5194097|NCT01079806|12773415|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
5194098|NCT01079806|12773414|P2|NOT COMPLETED|Day 1 to Week 96||7
5194099|NCT01079806|12773415|P1|NOT COMPLETED|Day 1 to Week 96||7
5194100|NCT01079806|12773414|P2|COMPLETED|Day 1 to Week 96||53
5194101|NCT01079806|12773415|P1|COMPLETED|Day 1 to Week 96||113
5194102|NCT01079806|12773414|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
5194103|NCT01079806|12773415|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
5194104|NCT01079806|12773414|P2|Received Treatment|Day 1 to Week 96||60
5194105|NCT01079806|12773415|P1|Received Treatment|Day 1 to Week 96||120
5194106|NCT01079806|12773414|P2|STARTED|Day 1 to Week 96||60
5194107|NCT01079806|12773415|P1|STARTED|Day 1 to Week 96||120
5194108|NCT01079741|12773450|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
5194109|NCT01079741|12773451|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
5194110|NCT01079741|12773452|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
5194111|NCT01079741|12773453|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
5194112|NCT01079741|12773454|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
5194113|NCT01079741|12773450|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
5194114|NCT01079741|12773451|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
5194115|NCT01079741|12773452|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
5194116|NCT01079741|12773453|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
5194117|NCT01079741|12773454|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
5194118|NCT01079741|12773450|P5|STARTED|Phase 2 (Weeks 37-48)||12
5194119|NCT01079741|12773451|P4|STARTED|Phase 2 (Weeks 37-48)||12
5194120|NCT01079741|12773452|P3|STARTED|Phase 2 (Weeks 37-48)||0
5194121|NCT01079741|12773453|P2|STARTED|Phase 2 (Weeks 37-48)||0
5194122|NCT01079741|12773454|P1|STARTED|Phase 2 (Weeks 37-48)||0
5194123|NCT01079741|12773450|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194124|NCT01079741|12773451|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194125|NCT01079741|12773452|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
5194126|NCT01079741|12773453|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194127|NCT01079741|12773454|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194128|NCT01079741|12773450|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194129|NCT01079741|12773451|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194130|NCT01079741|12773452|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194131|NCT01079741|12773453|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194132|NCT01079741|12773454|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194133|NCT01079741|12773450|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194134|NCT01079741|12773451|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194135|NCT01079741|12773452|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
5194136|NCT01079741|12773453|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194137|NCT01079741|12773454|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
5194138|NCT01079741|12773450|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194139|NCT01079741|12773451|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194140|NCT01079741|12773452|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194141|NCT01079741|12773453|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
5194142|NCT01079741|12773454|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194143|NCT01079741|12773450|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194144|NCT01079741|12773451|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194145|NCT01079741|12773452|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194146|NCT01079741|12773453|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
5194147|NCT01079741|12773454|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194148|NCT01079741|12773450|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194149|NCT01079741|12773451|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194150|NCT01079741|12773452|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194151|NCT01079741|12773453|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
5194152|NCT01079741|12773454|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
5194153|NCT01079741|12773450|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194154|NCT01079741|12773451|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194155|NCT01079741|12773452|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194156|NCT01079741|12773453|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194157|NCT01079741|12773454|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194158|NCT01079741|12773450|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194159|NCT01079741|12773451|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194160|NCT01079741|12773452|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194161|NCT01079741|12773453|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194162|NCT01079741|12773454|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
5194163|NCT01079741|12773450|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194164|NCT01079741|12773451|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194165|NCT01079741|12773452|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194166|NCT01079741|12773453|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
5194167|NCT01079741|12773454|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
5194168|NCT01079598|12773468|P1|NOT COMPLETED|Overall Study||0
5194169|NCT01079598|12773468|P1|COMPLETED|Overall Study||8
5194170|NCT01079598|12773468|P1|STARTED|Overall Study||8
5194171|NCT01079390|12773478|P3|NOT COMPLETED|Overall Study||4
5194172|NCT01079390|12773479|P2|NOT COMPLETED|Overall Study||5
5194173|NCT01079390|12773480|P1|NOT COMPLETED|Overall Study||5
5194174|NCT01079390|12773478|P3|COMPLETED|Overall Study||10
5194175|NCT01079390|12773479|P2|COMPLETED|Overall Study||10
5194176|NCT01079390|12773480|P1|COMPLETED|Overall Study||10
5194177|NCT01079390|12773478|P3|STARTED|Overall Study||14
5194178|NCT01079390|12773479|P2|STARTED|Overall Study||15
5194179|NCT01079390|12773480|P1|STARTED|Overall Study||15
5194180|NCT01079299|12773492|P2|NOT COMPLETED|Overall Study||0
5194181|NCT01079299|12773493|P1|NOT COMPLETED|Overall Study||0
5194182|NCT01079299|12773492|P2|COMPLETED|Overall Study||25
5194183|NCT01079299|12773493|P1|COMPLETED|Overall Study||27
5194184|NCT01079299|12773492|P2|STARTED|Overall Study||25
5194185|NCT01079299|12773493|P1|STARTED|Overall Study||27
5194186|NCT01079234|12773502|P4|NOT COMPLETED|Extension: Week 27 to 52||16
5194187|NCT01079234|12773503|P3|NOT COMPLETED|Extension: Week 27 to 52||11
5194188|NCT01079234|12773504|P2|NOT COMPLETED|Extension: Week 27 to 52||0
5194189|NCT01079234|12773505|P1|NOT COMPLETED|Extension: Week 27 to 52||0
5194190|NCT01079234|12773502|P4|COMPLETED|Extension: Week 27 to 52||223
5194191|NCT01079234|12773503|P3|COMPLETED|Extension: Week 27 to 52||122
5194192|NCT01079234|12773504|P2|COMPLETED|Extension: Week 27 to 52||0
5194193|NCT01079234|12773505|P1|COMPLETED|Extension: Week 27 to 52||0
5194194|NCT01079234|12773502|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
5194195|NCT01079234|12773503|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
5194196|NCT01079234|12773504|P2|STARTED|Extension: Week 27 to 52||0
5194197|NCT01079234|12773505|P1|STARTED|Extension: Week 27 to 52||0
5194198|NCT01079234|12773502|P4|NOT COMPLETED|Main: Week 0 to 26||0
5194199|NCT01079234|12773503|P3|NOT COMPLETED|Main: Week 0 to 26||12
5194200|NCT01079234|12773504|P2|NOT COMPLETED|Main: Week 0 to 26||26
5194201|NCT01079234|12773505|P1|NOT COMPLETED|Main: Week 0 to 26||26
5194202|NCT01079234|12773502|P4|COMPLETED|Main: Week 0 to 26||0
5194203|NCT01079234|12773503|P3|COMPLETED|Main: Week 0 to 26||152
5194204|NCT01079234|12773504|P2|COMPLETED|Main: Week 0 to 26||139
5194205|NCT01079234|12773505|P1|COMPLETED|Main: Week 0 to 26||138
5194206|NCT01079234|12773502|P4|Exposed|Main: Week 0 to 26||0
5194207|NCT01079234|12773503|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
5194208|NCT01079234|12773504|P2|Exposed|Main: Week 0 to 26||165
5194209|NCT01079234|12773505|P1|Exposed|Main: Week 0 to 26||164
5194210|NCT01079234|12773502|P4|STARTED|Main: Week 0 to 26||0
5194211|NCT01079234|12773503|P3|STARTED|Main: Week 0 to 26||164
5194212|NCT01079234|12773504|P2|STARTED|Main: Week 0 to 26||165
5194213|NCT01079234|12773505|P1|STARTED|Main: Week 0 to 26||164
5194214|NCT01079195|12773523|P1|NOT COMPLETED|Overall Study||1431
5194215|NCT01079195|12773523|P1|COMPLETED|Overall Study||14442
5194216|NCT01079195|12773523|P1|STARTED|Overall Study||15873
5194217|NCT01079182|12773529|P1|NOT COMPLETED|Overall Study||2719
5194218|NCT01079182|12773529|P1|COMPLETED|Overall Study||1962
5194219|NCT01079182|12773529|P1|STARTED|Overall Study||4681
5194220|NCT01079143|12773560|P4|NOT COMPLETED|Overall Study||5
5194221|NCT01079143|12773561|P3|NOT COMPLETED|Overall Study||5
5194222|NCT01079143|12773562|P2|NOT COMPLETED|Overall Study||17
5194223|NCT01079143|12773563|P1|NOT COMPLETED|Overall Study||9
5194224|NCT01079143|12773560|P4|COMPLETED|Overall Study||54
5194225|NCT01079143|12773561|P3|COMPLETED|Overall Study||34
5194226|NCT01079143|12773562|P2|COMPLETED|Overall Study||43
5194227|NCT01079143|12773563|P1|COMPLETED|Overall Study||27
5194228|NCT01079143|12773560|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
5194229|NCT01079143|12773561|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
5194230|NCT01079143|12773562|P2|M3 and M12 Biopsies|Overall Study||43
5194231|NCT01079143|12773563|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
5194232|NCT01079143|12773560|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
5194233|NCT01079143|12773561|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
5194234|NCT01079143|12773562|P2|Month 12 (M12) Biopsies|Overall Study||43
5194235|NCT01079143|12773563|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
5194236|NCT01079143|12773560|P4|Month 3 (M3) Biopsies|Overall Study||59
5194237|NCT01079143|12773561|P3|Month 3 (M3) Biopsies|Overall Study||39
5194238|NCT01079143|12773562|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
5194239|NCT01079143|12773563|P1|Month 3 (M3) Biopsies|Overall Study||36
5194240|NCT01079143|12773560|P4|Exposed|Overall Study||59
5194241|NCT01079143|12773561|P3|Exposed|Overall Study||39
5194242|NCT01079143|12773562|P2|Exposed|Overall Study||60
5194243|NCT01079143|12773563|P1|Exposed|Overall Study||36
5194244|NCT01079143|12773560|P4|STARTED|Overall Study||59
5194245|NCT01079143|12773561|P3|STARTED|Overall Study||39
5194246|NCT01079143|12773562|P2|STARTED|Overall Study||60
5194247|NCT01079143|12773563|P1|STARTED|Overall Study||36
5194248|NCT01079130|12773637|P6|NOT COMPLETED|Overall Study||5
5194249|NCT01079130|12773638|P5|NOT COMPLETED|Overall Study||8
5194250|NCT01079130|12773639|P4|NOT COMPLETED|Overall Study||5
5194251|NCT01079130|12773640|P3|NOT COMPLETED|Overall Study||1
5194252|NCT01079130|12773641|P2|NOT COMPLETED|Overall Study||7
5194253|NCT01079130|12773642|P1|NOT COMPLETED|Overall Study||2
5194254|NCT01079130|12773637|P6|COMPLETED|Overall Study||80
5194255|NCT01079130|12773638|P5|COMPLETED|Overall Study||78
5194256|NCT01079130|12773639|P4|COMPLETED|Overall Study||81
5194257|NCT01079130|12773640|P3|COMPLETED|Overall Study||83
5194258|NCT01079130|12773641|P2|COMPLETED|Overall Study||78
5194259|NCT01079130|12773642|P1|COMPLETED|Overall Study||83
5194260|NCT01079130|12773637|P6|Full Analysis Set (FAS)|Overall Study||84
5194261|NCT01079130|12773638|P5|Full Analysis Set (FAS)|Overall Study||84
5194262|NCT01079130|12773639|P4|Full Analysis Set (FAS)|Overall Study||85
5194263|NCT01079130|12773640|P3|Full Analysis Set (FAS)|Overall Study||83
5194264|NCT01079130|12773641|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
5194265|NCT01079130|12773642|P1|Full Analysis Set (FAS)|Overall Study||84
5194266|NCT01079130|12773637|P6|Safety Set: Received Study Drug|Overall Study||84
5194267|NCT01079130|12773638|P5|Safety Set: Received Study Drug|Overall Study||84
5194268|NCT01079130|12773639|P4|Safety Set: Received Study Drug|Overall Study||85
5194269|NCT01079130|12773640|P3|Safety Set: Received Study Drug|Overall Study||84
5194270|NCT01079130|12773641|P2|Safety Set: Received Study Drug|Overall Study||81
5194271|NCT01079130|12773642|P1|Safety Set: Received Study Drug|Overall Study||84
5194272|NCT01079130|12773637|P6|STARTED|Overall Study||85
5194273|NCT01079130|12773638|P5|STARTED|Overall Study||86
5194274|NCT01079130|12773639|P4|STARTED|Overall Study||86
5194275|NCT01079130|12773640|P3|STARTED|Overall Study||84
5194276|NCT01079130|12773641|P2|STARTED|Overall Study||85
5194277|NCT01079130|12773642|P1|STARTED|Overall Study||85
5194278|NCT01078974|12773662|P1|NOT COMPLETED|Overall Study||3
5194279|NCT01078974|12773662|P1|COMPLETED|Overall Study||4
5194280|NCT01078974|12773662|P1|STARTED|Overall Study||7
5194281|NCT01078922|12773667|P1|NOT COMPLETED|Overall Study||1
5194282|NCT01078922|12773667|P1|COMPLETED|Overall Study||10
5194283|NCT01078922|12773667|P1|STARTED|Overall Study||11
5194284|NCT01078909|12773677|P5|NOT COMPLETED|Overall Study||2
5194285|NCT01078909|12773678|P4|NOT COMPLETED|Overall Study||1
5194286|NCT01078909|12773679|P3|NOT COMPLETED|Overall Study||1
5194287|NCT01078909|12773680|P2|NOT COMPLETED|Overall Study||4
5194288|NCT01078909|12773681|P1|NOT COMPLETED|Overall Study||2
5194289|NCT01078909|12773677|P5|COMPLETED|Overall Study||23
5194290|NCT01078909|12773678|P4|COMPLETED|Overall Study||24
5194291|NCT01078909|12773679|P3|COMPLETED|Overall Study||24
5194292|NCT01078909|12773680|P2|COMPLETED|Overall Study||21
5194293|NCT01078909|12773681|P1|COMPLETED|Overall Study||23
5194294|NCT01078909|12773677|P5|STARTED|Overall Study||25
5194295|NCT01078909|12773678|P4|STARTED|Overall Study||25
5194296|NCT01078909|12773679|P3|STARTED|Overall Study||25
5194297|NCT01078909|12773680|P2|STARTED|Overall Study||25
5194298|NCT01078909|12773681|P1|STARTED|Overall Study||25
5194299|NCT01078844|12773703|P1|NOT COMPLETED|Overall Study||4
5194300|NCT01078844|12773703|P1|COMPLETED|Overall Study||0
5194301|NCT01078844|12773703|P1|STARTED|Overall Study||4
5194302|NCT01078805|12773708|P1|NOT COMPLETED|Overall Study||2050
5194303|NCT01078805|12773708|P1|COMPLETED|Overall Study||2117
5194304|NCT01078805|12773708|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
5194305|NCT01078805|12773708|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
5194306|NCT01078805|12773708|P1|STARTED|Overall Study||4167
5194307|NCT01078753|12773722|P2|NOT COMPLETED|Treatment Period II||0
5194308|NCT01078753|12773723|P1|NOT COMPLETED|Treatment Period II||0
5194309|NCT01078753|12773722|P2|COMPLETED|Treatment Period II||44
5194310|NCT01078753|12773723|P1|COMPLETED|Treatment Period II||45
5194311|NCT01078753|12773722|P2|Full Analysis Set|Treatment Period II||44
5194312|NCT01078753|12773723|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
5194313|NCT01078753|12773722|P2|STARTED|Treatment Period II||44
5194314|NCT01078753|12773723|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
5194315|NCT01078753|12773722|P2|NOT COMPLETED|Treatment Period I||0
5194316|NCT01078753|12773723|P1|NOT COMPLETED|Treatment Period I||0
5194317|NCT01078753|12773722|P2|COMPLETED|Treatment Period I||44
5194318|NCT01078753|12773723|P1|COMPLETED|Treatment Period I||45
5194319|NCT01078753|12773722|P2|Full Analysis Set|Treatment Period I||44
5194320|NCT01078753|12773723|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
5194321|NCT01078753|12773722|P2|STARTED|Treatment Period I||44
5194322|NCT01078753|12773723|P1|STARTED|Treatment Period I||45
5194323|NCT01078675|12773735|P2|NOT COMPLETED|Overall Study||6
5194324|NCT01078675|12773736|P1|NOT COMPLETED|Overall Study||68
5194325|NCT01078675|12773735|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
5194326|NCT01078675|12773736|P1|COMPLETED|Overall Study||182
5194327|NCT01078675|12773735|P2|Patients Treated|Overall Study||0
5194328|NCT01078675|12773736|P1|Patients Treated|Overall Study||198
5194329|NCT01078675|12773735|P2|STARTED|Overall Study||65
5194330|NCT01078675|12773736|P1|STARTED|Overall Study||250
5194331|NCT01078662|12773758|P5|NOT COMPLETED|Overall Study||11
5194332|NCT01078662|12773759|P4|NOT COMPLETED|Overall Study||7
5194333|NCT01078662|12773760|P3|NOT COMPLETED|Overall Study||21
5194334|NCT01078662|12773761|P2|NOT COMPLETED|Overall Study||168
5194335|NCT01078662|12773762|P1|NOT COMPLETED|Overall Study||58
5194336|NCT01078662|12773758|P5|COMPLETED|Overall Study||1
5194337|NCT01078662|12773759|P4|COMPLETED|Overall Study||1
5194338|NCT01078662|12773760|P3|COMPLETED|Overall Study||2
5194339|NCT01078662|12773761|P2|COMPLETED|Overall Study||25
5194340|NCT01078662|12773762|P1|COMPLETED|Overall Study||4
5194341|NCT01078662|12773758|P5|STARTED|Overall Study||12
5194342|NCT01078662|12773759|P4|STARTED|Overall Study||8
5194343|NCT01078662|12773760|P3|STARTED|Overall Study||23
5194344|NCT01078662|12773761|P2|STARTED|Overall Study||193
5194345|NCT01078662|12773762|P1|STARTED|Overall Study||62
5194346|NCT01078623|12773801|P20|NOT COMPLETED|Treatment Period 4||0
5194347|NCT01078623|12773802|P19|NOT COMPLETED|Treatment Period 4||0
5194348|NCT01078623|12773803|P18|NOT COMPLETED|Treatment Period 4||0
5194349|NCT01078623|12773804|P17|NOT COMPLETED|Treatment Period 4||0
5194350|NCT01078623|12773805|P16|NOT COMPLETED|Treatment Period 4||1
5194351|NCT01078623|12773806|P15|NOT COMPLETED|Treatment Period 4||0
5194352|NCT01078623|12773807|P14|NOT COMPLETED|Treatment Period 4||0
5194353|NCT01078623|12773808|P13|NOT COMPLETED|Treatment Period 4||0
5194354|NCT01078623|12773809|P12|NOT COMPLETED|Treatment Period 4||0
5194355|NCT01078623|12773810|P11|NOT COMPLETED|Treatment Period 4||0
5194356|NCT01078623|12773811|P10|NOT COMPLETED|Treatment Period 4||0
5194357|NCT01078623|12773812|P9|NOT COMPLETED|Treatment Period 4||0
5194358|NCT01078623|12773813|P8|NOT COMPLETED|Treatment Period 4||0
5194359|NCT01078623|12773814|P7|NOT COMPLETED|Treatment Period 4||0
5194360|NCT01078623|12773815|P6|NOT COMPLETED|Treatment Period 4||0
5194361|NCT01078623|12773816|P5|NOT COMPLETED|Treatment Period 4||0
5194362|NCT01078623|12773817|P4|NOT COMPLETED|Treatment Period 4||0
5194363|NCT01078623|12773818|P3|NOT COMPLETED|Treatment Period 4||1
5194364|NCT01078623|12773819|P2|NOT COMPLETED|Treatment Period 4||0
5194365|NCT01078623|12773820|P1|NOT COMPLETED|Treatment Period 4||0
5194366|NCT01078623|12773801|P20|COMPLETED|Treatment Period 4||7
5194367|NCT01078623|12773802|P19|COMPLETED|Treatment Period 4||6
5194368|NCT01078623|12773803|P18|COMPLETED|Treatment Period 4||7
5194369|NCT01078623|12773804|P17|COMPLETED|Treatment Period 4||7
5194370|NCT01078623|12773805|P16|COMPLETED|Treatment Period 4||6
5194371|NCT01078623|12773806|P15|COMPLETED|Treatment Period 4||7
5194372|NCT01078623|12773807|P14|COMPLETED|Treatment Period 4||6
5194373|NCT01078623|12773808|P13|COMPLETED|Treatment Period 4||7
5194374|NCT01078623|12773809|P12|COMPLETED|Treatment Period 4||7
5194375|NCT01078623|12773810|P11|COMPLETED|Treatment Period 4||6
5194376|NCT01078623|12773811|P10|COMPLETED|Treatment Period 4||6
5194377|NCT01078623|12773812|P9|COMPLETED|Treatment Period 4||5
5194378|NCT01078623|12773813|P8|COMPLETED|Treatment Period 4||6
5194379|NCT01078623|12773814|P7|COMPLETED|Treatment Period 4||5
5194380|NCT01078623|12773815|P6|COMPLETED|Treatment Period 4||4
5194381|NCT01078623|12773816|P5|COMPLETED|Treatment Period 4||6
5194382|NCT01078623|12773817|P4|COMPLETED|Treatment Period 4||6
5194383|NCT01078623|12773818|P3|COMPLETED|Treatment Period 4||5
5194384|NCT01078623|12773819|P2|COMPLETED|Treatment Period 4||5
5194385|NCT01078623|12773820|P1|COMPLETED|Treatment Period 4||5
5194386|NCT01078623|12773801|P20|STARTED|Treatment Period 4||7
5194387|NCT01078623|12773802|P19|STARTED|Treatment Period 4||6
5194388|NCT01078623|12773803|P18|STARTED|Treatment Period 4||7
5194389|NCT01078623|12773804|P17|STARTED|Treatment Period 4||7
5194390|NCT01078623|12773805|P16|STARTED|Treatment Period 4||7
5194391|NCT01078623|12773806|P15|STARTED|Treatment Period 4||7
5194392|NCT01078623|12773807|P14|STARTED|Treatment Period 4||6
5194393|NCT01078623|12773808|P13|STARTED|Treatment Period 4||7
5194394|NCT01078623|12773809|P12|STARTED|Treatment Period 4||7
5194395|NCT01078623|12773810|P11|STARTED|Treatment Period 4||6
5194396|NCT01078623|12773811|P10|STARTED|Treatment Period 4||6
5194397|NCT01078623|12773812|P9|STARTED|Treatment Period 4||5
5194398|NCT01078623|12773813|P8|STARTED|Treatment Period 4||6
5194399|NCT01078623|12773814|P7|STARTED|Treatment Period 4||5
5194400|NCT01078623|12773815|P6|STARTED|Treatment Period 4||4
5194401|NCT01078623|12773816|P5|STARTED|Treatment Period 4||6
5194402|NCT01078623|12773817|P4|STARTED|Treatment Period 4||6
5194403|NCT01078623|12773818|P3|STARTED|Treatment Period 4||6
5194404|NCT01078623|12773819|P2|STARTED|Treatment Period 4||5
5194405|NCT01078623|12773820|P1|STARTED|Treatment Period 4||5
5194406|NCT01078623|12773801|P20|NOT COMPLETED|Treatment Period 3||0
5194407|NCT01078623|12773802|P19|NOT COMPLETED|Treatment Period 3||0
5194408|NCT01078623|12773803|P18|NOT COMPLETED|Treatment Period 3||0
5194409|NCT01078623|12773804|P17|NOT COMPLETED|Treatment Period 3||0
5194410|NCT01078623|12773805|P16|NOT COMPLETED|Treatment Period 3||0
5194411|NCT01078623|12773806|P15|NOT COMPLETED|Treatment Period 3||0
5194412|NCT01078623|12773807|P14|NOT COMPLETED|Treatment Period 3||1
5194413|NCT01078623|12773808|P13|NOT COMPLETED|Treatment Period 3||0
5194414|NCT01078623|12773809|P12|NOT COMPLETED|Treatment Period 3||0
5194415|NCT01078623|12773810|P11|NOT COMPLETED|Treatment Period 3||0
5194416|NCT01078623|12773811|P10|NOT COMPLETED|Treatment Period 3||0
5194417|NCT01078623|12773812|P9|NOT COMPLETED|Treatment Period 3||0
5194418|NCT01078623|12773813|P8|NOT COMPLETED|Treatment Period 3||0
5194419|NCT01078623|12773814|P7|NOT COMPLETED|Treatment Period 3||0
5194420|NCT01078623|12773815|P6|NOT COMPLETED|Treatment Period 3||0
5194421|NCT01078623|12773816|P5|NOT COMPLETED|Treatment Period 3||1
5194422|NCT01078623|12773817|P4|NOT COMPLETED|Treatment Period 3||0
5194423|NCT01078623|12773818|P3|NOT COMPLETED|Treatment Period 3||0
5194424|NCT01078623|12773819|P2|NOT COMPLETED|Treatment Period 3||0
5194425|NCT01078623|12773820|P1|NOT COMPLETED|Treatment Period 3||0
5194426|NCT01078623|12773801|P20|COMPLETED|Treatment Period 3||7
5194427|NCT01078623|12773802|P19|COMPLETED|Treatment Period 3||6
5194428|NCT01078623|12773803|P18|COMPLETED|Treatment Period 3||7
5194429|NCT01078623|12773804|P17|COMPLETED|Treatment Period 3||7
5194430|NCT01078623|12773805|P16|COMPLETED|Treatment Period 3||7
5194431|NCT01078623|12773806|P15|COMPLETED|Treatment Period 3||7
5194432|NCT01078623|12773807|P14|COMPLETED|Treatment Period 3||6
5194433|NCT01078623|12773808|P13|COMPLETED|Treatment Period 3||7
5194434|NCT01078623|12773809|P12|COMPLETED|Treatment Period 3||7
5194435|NCT01078623|12773810|P11|COMPLETED|Treatment Period 3||6
5194436|NCT01078623|12773811|P10|COMPLETED|Treatment Period 3||6
5194437|NCT01078623|12773812|P9|COMPLETED|Treatment Period 3||5
5194438|NCT01078623|12773813|P8|COMPLETED|Treatment Period 3||6
5194439|NCT01078623|12773814|P7|COMPLETED|Treatment Period 3||5
5194440|NCT01078623|12773815|P6|COMPLETED|Treatment Period 3||4
5194441|NCT01078623|12773816|P5|COMPLETED|Treatment Period 3||6
5194442|NCT01078623|12773817|P4|COMPLETED|Treatment Period 3||6
5194443|NCT01078623|12773818|P3|COMPLETED|Treatment Period 3||6
5194444|NCT01078623|12773819|P2|COMPLETED|Treatment Period 3||5
5194445|NCT01078623|12773820|P1|COMPLETED|Treatment Period 3||5
5194446|NCT01078623|12773801|P20|STARTED|Treatment Period 3||7
5194447|NCT01078623|12773802|P19|STARTED|Treatment Period 3||6
5194448|NCT01078623|12773803|P18|STARTED|Treatment Period 3||7
5194449|NCT01078623|12773804|P17|STARTED|Treatment Period 3||7
5194450|NCT01078623|12773805|P16|STARTED|Treatment Period 3||7
5194451|NCT01078623|12773806|P15|STARTED|Treatment Period 3||7
5194452|NCT01078623|12773807|P14|STARTED|Treatment Period 3||7
5194453|NCT01078623|12773808|P13|STARTED|Treatment Period 3||7
5194454|NCT01078623|12773809|P12|STARTED|Treatment Period 3||7
5194455|NCT01078623|12773810|P11|STARTED|Treatment Period 3||6
5194456|NCT01078623|12773811|P10|STARTED|Treatment Period 3||6
5194457|NCT01078623|12773812|P9|STARTED|Treatment Period 3||5
5194458|NCT01078623|12773813|P8|STARTED|Treatment Period 3||6
5194459|NCT01078623|12773814|P7|STARTED|Treatment Period 3||5
5194460|NCT01078623|12773815|P6|STARTED|Treatment Period 3||4
5194461|NCT01078623|12773816|P5|STARTED|Treatment Period 3||7
5194462|NCT01078623|12773817|P4|STARTED|Treatment Period 3||6
5194463|NCT01078623|12773818|P3|STARTED|Treatment Period 3||6
5194464|NCT01078623|12773819|P2|STARTED|Treatment Period 3||5
5194465|NCT01078623|12773820|P1|STARTED|Treatment Period 3||5
5194466|NCT01078623|12773801|P20|NOT COMPLETED|Treatment Period 2||0
5194467|NCT01078623|12773802|P19|NOT COMPLETED|Treatment Period 2||1
5194468|NCT01078623|12773803|P18|NOT COMPLETED|Treatment Period 2||0
5194469|NCT01078623|12773804|P17|NOT COMPLETED|Treatment Period 2||0
5194470|NCT01078623|12773805|P16|NOT COMPLETED|Treatment Period 2||0
5194471|NCT01078623|12773806|P15|NOT COMPLETED|Treatment Period 2||0
5194472|NCT01078623|12773807|P14|NOT COMPLETED|Treatment Period 2||0
5194473|NCT01078623|12773808|P13|NOT COMPLETED|Treatment Period 2||0
5194474|NCT01078623|12773809|P12|NOT COMPLETED|Treatment Period 2||0
5194475|NCT01078623|12773810|P11|NOT COMPLETED|Treatment Period 2||0
5194476|NCT01078623|12773811|P10|NOT COMPLETED|Treatment Period 2||0
5194477|NCT01078623|12773812|P9|NOT COMPLETED|Treatment Period 2||0
5194478|NCT01078623|12773813|P8|NOT COMPLETED|Treatment Period 2||0
5194479|NCT01078623|12773814|P7|NOT COMPLETED|Treatment Period 2||1
5194480|NCT01078623|12773815|P6|NOT COMPLETED|Treatment Period 2||1
5194481|NCT01078623|12773816|P5|NOT COMPLETED|Treatment Period 2||0
5194482|NCT01078623|12773817|P4|NOT COMPLETED|Treatment Period 2||0
5194483|NCT01078623|12773818|P3|NOT COMPLETED|Treatment Period 2||0
5194484|NCT01078623|12773819|P2|NOT COMPLETED|Treatment Period 2||0
5194485|NCT01078623|12773820|P1|NOT COMPLETED|Treatment Period 2||0
5194486|NCT01078623|12773801|P20|COMPLETED|Treatment Period 2||7
5194487|NCT01078623|12773802|P19|COMPLETED|Treatment Period 2||6
5194488|NCT01078623|12773803|P18|COMPLETED|Treatment Period 2||7
5194489|NCT01078623|12773804|P17|COMPLETED|Treatment Period 2||7
5194490|NCT01078623|12773805|P16|COMPLETED|Treatment Period 2||7
5194491|NCT01078623|12773806|P15|COMPLETED|Treatment Period 2||7
5194492|NCT01078623|12773807|P14|COMPLETED|Treatment Period 2||7
5194493|NCT01078623|12773808|P13|COMPLETED|Treatment Period 2||7
5194494|NCT01078623|12773809|P12|COMPLETED|Treatment Period 2||7
5194495|NCT01078623|12773810|P11|COMPLETED|Treatment Period 2||6
5194496|NCT01078623|12773811|P10|COMPLETED|Treatment Period 2||6
5194497|NCT01078623|12773812|P9|COMPLETED|Treatment Period 2||5
5194498|NCT01078623|12773813|P8|COMPLETED|Treatment Period 2||6
5194499|NCT01078623|12773814|P7|COMPLETED|Treatment Period 2||5
5194500|NCT01078623|12773815|P6|COMPLETED|Treatment Period 2||4
5194501|NCT01078623|12773816|P5|COMPLETED|Treatment Period 2||7
5194502|NCT01078623|12773817|P4|COMPLETED|Treatment Period 2||6
5194503|NCT01078623|12773818|P3|COMPLETED|Treatment Period 2||6
5194504|NCT01078623|12773819|P2|COMPLETED|Treatment Period 2||5
5194505|NCT01078623|12773820|P1|COMPLETED|Treatment Period 2||5
5194506|NCT01078623|12773801|P20|STARTED|Treatment Period 2||7
5194507|NCT01078623|12773802|P19|STARTED|Treatment Period 2||7
5194508|NCT01078623|12773803|P18|STARTED|Treatment Period 2||7
5194509|NCT01078623|12773804|P17|STARTED|Treatment Period 2||7
5194510|NCT01078623|12773805|P16|STARTED|Treatment Period 2||7
5194511|NCT01078623|12773806|P15|STARTED|Treatment Period 2||7
5194512|NCT01078623|12773807|P14|STARTED|Treatment Period 2||7
5194513|NCT01078623|12773808|P13|STARTED|Treatment Period 2||7
5194514|NCT01078623|12773809|P12|STARTED|Treatment Period 2||7
5194515|NCT01078623|12773810|P11|STARTED|Treatment Period 2||6
5194516|NCT01078623|12773811|P10|STARTED|Treatment Period 2||6
5194517|NCT01078623|12773812|P9|STARTED|Treatment Period 2||5
5194518|NCT01078623|12773813|P8|STARTED|Treatment Period 2||6
5194519|NCT01078623|12773814|P7|STARTED|Treatment Period 2||6
5194520|NCT01078623|12773815|P6|STARTED|Treatment Period 2||5
5194521|NCT01078623|12773816|P5|STARTED|Treatment Period 2||7
5194522|NCT01078623|12773817|P4|STARTED|Treatment Period 2||6
5194523|NCT01078623|12773818|P3|STARTED|Treatment Period 2||6
5194524|NCT01078623|12773819|P2|STARTED|Treatment Period 2||5
5194525|NCT01078623|12773820|P1|STARTED|Treatment Period 2||5
5194526|NCT01078623|12773801|P20|NOT COMPLETED|Treatment Period 1||0
5194527|NCT01078623|12773802|P19|NOT COMPLETED|Treatment Period 1||0
5194528|NCT01078623|12773803|P18|NOT COMPLETED|Treatment Period 1||0
5194529|NCT01078623|12773804|P17|NOT COMPLETED|Treatment Period 1||0
5194530|NCT01078623|12773805|P16|NOT COMPLETED|Treatment Period 1||0
5194531|NCT01078623|12773806|P15|NOT COMPLETED|Treatment Period 1||0
5194532|NCT01078623|12773807|P14|NOT COMPLETED|Treatment Period 1||0
5194533|NCT01078623|12773808|P13|NOT COMPLETED|Treatment Period 1||0
5194534|NCT01078623|12773809|P12|NOT COMPLETED|Treatment Period 1||0
5194535|NCT01078623|12773810|P11|NOT COMPLETED|Treatment Period 1||1
5194536|NCT01078623|12773811|P10|NOT COMPLETED|Treatment Period 1||1
5194537|NCT01078623|12773812|P9|NOT COMPLETED|Treatment Period 1||1
5194538|NCT01078623|12773813|P8|NOT COMPLETED|Treatment Period 1||1
5194539|NCT01078623|12773814|P7|NOT COMPLETED|Treatment Period 1||1
5194540|NCT01078623|12773815|P6|NOT COMPLETED|Treatment Period 1||1
5194541|NCT01078623|12773816|P5|NOT COMPLETED|Treatment Period 1||0
5194542|NCT01078623|12773817|P4|NOT COMPLETED|Treatment Period 1||0
5194543|NCT01078623|12773818|P3|NOT COMPLETED|Treatment Period 1||1
5194544|NCT01078623|12773819|P2|NOT COMPLETED|Treatment Period 1||1
5194545|NCT01078623|12773820|P1|NOT COMPLETED|Treatment Period 1||1
5194546|NCT01078623|12773801|P20|COMPLETED|Treatment Period 1||7
5194547|NCT01078623|12773802|P19|COMPLETED|Treatment Period 1||7
5194548|NCT01078623|12773803|P18|COMPLETED|Treatment Period 1||7
5194549|NCT01078623|12773804|P17|COMPLETED|Treatment Period 1||7
5194550|NCT01078623|12773805|P16|COMPLETED|Treatment Period 1||7
5194551|NCT01078623|12773806|P15|COMPLETED|Treatment Period 1||7
5194552|NCT01078623|12773807|P14|COMPLETED|Treatment Period 1||7
5194553|NCT01078623|12773808|P13|COMPLETED|Treatment Period 1||7
5194554|NCT01078623|12773809|P12|COMPLETED|Treatment Period 1||7
5194555|NCT01078623|12773810|P11|COMPLETED|Treatment Period 1||6
5194556|NCT01078623|12773811|P10|COMPLETED|Treatment Period 1||6
5194557|NCT01078623|12773812|P9|COMPLETED|Treatment Period 1||5
5194558|NCT01078623|12773813|P8|COMPLETED|Treatment Period 1||6
5194559|NCT01078623|12773814|P7|COMPLETED|Treatment Period 1||6
5194560|NCT01078623|12773815|P6|COMPLETED|Treatment Period 1||5
5194561|NCT01078623|12773816|P5|COMPLETED|Treatment Period 1||7
5194562|NCT01078623|12773817|P4|COMPLETED|Treatment Period 1||6
5194563|NCT01078623|12773818|P3|COMPLETED|Treatment Period 1||6
5194564|NCT01078623|12773819|P2|COMPLETED|Treatment Period 1||5
5194565|NCT01078623|12773820|P1|COMPLETED|Treatment Period 1||5
5194566|NCT01078623|12773801|P20|STARTED|Treatment Period 1||7
5194567|NCT01078623|12773802|P19|STARTED|Treatment Period 1||7
5194568|NCT01078623|12773803|P18|STARTED|Treatment Period 1||7
5194569|NCT01078623|12773804|P17|STARTED|Treatment Period 1||7
5194570|NCT01078623|12773805|P16|STARTED|Treatment Period 1||7
5194571|NCT01078623|12773806|P15|STARTED|Treatment Period 1||7
5194572|NCT01078623|12773807|P14|STARTED|Treatment Period 1||7
5194573|NCT01078623|12773808|P13|STARTED|Treatment Period 1||7
5194574|NCT01078623|12773809|P12|STARTED|Treatment Period 1||7
5194575|NCT01078623|12773810|P11|STARTED|Treatment Period 1||7
5194576|NCT01078623|12773811|P10|STARTED|Treatment Period 1||7
5194577|NCT01078623|12773812|P9|STARTED|Treatment Period 1||6
5194578|NCT01078623|12773813|P8|STARTED|Treatment Period 1||7
5194579|NCT01078623|12773814|P7|STARTED|Treatment Period 1||7
5194580|NCT01078623|12773815|P6|STARTED|Treatment Period 1||6
5194581|NCT01078623|12773816|P5|STARTED|Treatment Period 1||7
5194582|NCT01078623|12773817|P4|STARTED|Treatment Period 1||6
5194583|NCT01078623|12773818|P3|STARTED|Treatment Period 1||7
5194584|NCT01078623|12773819|P2|STARTED|Treatment Period 1||6
5194585|NCT01078623|12773820|P1|STARTED|Treatment Period 1||6
5194586|NCT01078584|12773842|P1|NOT COMPLETED|Overall Study||3010
5194587|NCT01078584|12773842|P1|COMPLETED|Overall Study||4983
5194588|NCT01078584|12773842|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
5194589|NCT01078584|12773842|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
5194590|NCT01078584|12773842|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
5194591|NCT01078584|12773842|P1|STARTED|Overall Study||7993
5194592|NCT01078571|12773923|P1|NOT COMPLETED|Overall Study||115
5194593|NCT01078571|12773923|P1|COMPLETED|Overall Study||590
5194594|NCT01078571|12773923|P1|Intent-to-treat (ITT) Population|Overall Study||591
5194595|NCT01078571|12773923|P1|Safety Population|Overall Study||675
5194596|NCT01078571|12773923|P1|STARTED|Overall Study||705
5194597|NCT01078558|12773942|P3|NOT COMPLETED|Overall Study||1361
5194598|NCT01078558|12773943|P2|NOT COMPLETED|Overall Study||755
5194599|NCT01078558|12773944|P1|NOT COMPLETED|Overall Study||2018
5194600|NCT01078558|12773942|P3|COMPLETED|Overall Study||596
5194601|NCT01078558|12773943|P2|COMPLETED|Overall Study||372
5194602|NCT01078558|12773944|P1|COMPLETED|Overall Study||818
5194603|NCT01078558|12773942|P3|Oligoarticular PsA|Overall Study||0
5194604|NCT01078558|12773943|P2|Oligoarticular PsA|Overall Study||197
5194605|NCT01078558|12773944|P1|Oligoarticular PsA|Overall Study||0
5194606|NCT01078558|12773942|P3|STARTED|Overall Study||1957
5194607|NCT01078558|12773943|P2|STARTED|Overall Study||1127
5194608|NCT01078558|12773944|P1|STARTED|Overall Study||2836
5194609|NCT01078545|12773974|P1|NOT COMPLETED|Overall Study||26
5194610|NCT01078545|12773974|P1|COMPLETED|Overall Study||703
5194611|NCT01078545|12773974|P1|Per Protocol Population|Overall Study||661
5194612|NCT01078545|12773974|P1|Intent-to-treat Population|Overall Study||729
5194613|NCT01078545|12773974|P1|STARTED|Overall Study||729
5194614|NCT01078454|12773984|P2|NOT COMPLETED|Overall Study||2
5194615|NCT01078454|12773985|P1|NOT COMPLETED|Overall Study||1
5194616|NCT01078454|12773984|P2|COMPLETED|Overall Study||3
5194617|NCT01078454|12773985|P1|COMPLETED|Overall Study||5
5194618|NCT01078454|12773984|P2|STARTED|Overall Study||5
5194619|NCT01078454|12773985|P1|STARTED|Overall Study||6
5194620|NCT01078441|12773991|P1|NOT COMPLETED|Overall Study||1
5194621|NCT01078441|12773991|P1|COMPLETED|Overall Study||1
5194622|NCT01078441|12773991|P1|STARTED|Overall Study||2
5194623|NCT01078402|12773998|P3|NOT COMPLETED|Overall Study||68
5194624|NCT01078402|12773999|P2|NOT COMPLETED|Overall Study||29
5194625|NCT01078402|12774000|P1|NOT COMPLETED|Overall Study||107
5194626|NCT01078402|12773998|P3|COMPLETED|Overall Study||166
5194627|NCT01078402|12773999|P2|COMPLETED|Overall Study||95
5194628|NCT01078402|12774000|P1|COMPLETED|Overall Study||324
5194629|NCT01078402|12773998|P3|STARTED|Overall Study||234
5194630|NCT01078402|12773999|P2|STARTED|Overall Study||124
5194631|NCT01078402|12774000|P1|STARTED|Overall Study||431
5194632|NCT01078389|12774031|P2|NOT COMPLETED|Overall Study||67
5194633|NCT01078389|12774032|P1|NOT COMPLETED|Overall Study||64
5194634|NCT01078389|12774031|P2|COMPLETED|Overall Study||90
5194635|NCT01078389|12774032|P1|COMPLETED|Overall Study||93
5194636|NCT01078389|12774031|P2|STARTED|Overall Study||157
5194637|NCT01078389|12774032|P1|STARTED|Overall Study||157
5194638|NCT01078376|12774050|P4|NOT COMPLETED|Overall Study||0
5194639|NCT01078376|12774051|P3|NOT COMPLETED|Overall Study||0
5194640|NCT01078376|12774052|P2|NOT COMPLETED|Overall Study||0
5194641|NCT01078376|12774053|P1|NOT COMPLETED|Overall Study||0
5194642|NCT01078376|12774050|P4|COMPLETED|Overall Study||3
5194643|NCT01078376|12774051|P3|COMPLETED|Overall Study||8
5194644|NCT01078376|12774052|P2|COMPLETED|Overall Study||9
5194645|NCT01078376|12774053|P1|COMPLETED|Overall Study||9
5194646|NCT01078376|12774050|P4|STARTED|Overall Study||3
5194647|NCT01078376|12774051|P3|STARTED|Overall Study||8
5194648|NCT01078376|12774052|P2|STARTED|Overall Study||9
5194649|NCT01078376|12774053|P1|STARTED|Overall Study||9
5194650|NCT01078363|12774174|P2|NOT COMPLETED|Overall Study||0
5194651|NCT01078363|12774175|P1|NOT COMPLETED|Overall Study||0
5194652|NCT01078363|12774174|P2|COMPLETED|Overall Study||49
5194653|NCT01078363|12774175|P1|COMPLETED|Overall Study||47
5194654|NCT01078363|12774174|P2|STARTED|Overall Study||49
5194655|NCT01078363|12774175|P1|STARTED|Overall Study||47
5194656|NCT01078298|12774193|P2|NOT COMPLETED|Overall Study||90
5194657|NCT01078298|12774194|P1|NOT COMPLETED|Overall Study||81
5194658|NCT01078298|12774193|P2|COMPLETED|Overall Study||179
5194659|NCT01078298|12774194|P1|COMPLETED|Overall Study||175
5194660|NCT01078298|12774193|P2|STARTED|Overall Study||269
5194661|NCT01078298|12774194|P1|STARTED|Overall Study||256
5194662|NCT01078246|12774227|P7|NOT COMPLETED|Overall Study||0
5194663|NCT01078246|12774228|P6|NOT COMPLETED|Overall Study||0
5194664|NCT01078246|12774229|P5|NOT COMPLETED|Overall Study||0
5194665|NCT01078246|12774230|P4|NOT COMPLETED|Overall Study||0
5194666|NCT01078246|12774231|P3|NOT COMPLETED|Overall Study||0
5194667|NCT01078246|12774232|P2|NOT COMPLETED|Overall Study||0
5194668|NCT01078246|12774233|P1|NOT COMPLETED|Overall Study||0
5194669|NCT01078246|12774227|P7|COMPLETED|Overall Study||22
5194670|NCT01078246|12774228|P6|COMPLETED|Overall Study||231
5194671|NCT01078246|12774229|P5|COMPLETED|Overall Study||3310
5194672|NCT01078246|12774230|P4|COMPLETED|Overall Study||152
5194673|NCT01078246|12774231|P3|COMPLETED|Overall Study||1963
5194674|NCT01078246|12774232|P2|COMPLETED|Overall Study||405
5194675|NCT01078246|12774233|P1|COMPLETED|Overall Study||1041
5194676|NCT01078246|12774227|P7|STARTED|Overall Study||22
5194677|NCT01078246|12774228|P6|STARTED|Overall Study||231
5194678|NCT01078246|12774229|P5|STARTED|Overall Study||3310
5194679|NCT01078246|12774230|P4|STARTED|Overall Study||152
5194680|NCT01078246|12774231|P3|STARTED|Overall Study||1963
5194681|NCT01078246|12774232|P2|STARTED|Overall Study||405
5194682|NCT01078246|12774233|P1|STARTED|Overall Study||1041
5194683|NCT01078233|12774265|P6|NOT COMPLETED|Overall Study||0
5194684|NCT01078233|12774266|P5|NOT COMPLETED|Overall Study||0
5194685|NCT01078233|12774267|P4|NOT COMPLETED|Overall Study||0
5194686|NCT01078233|12774268|P3|NOT COMPLETED|Overall Study||0
5194687|NCT01078233|12774269|P2|NOT COMPLETED|Overall Study||0
5194688|NCT01078233|12774270|P1|NOT COMPLETED|Overall Study||0
5194689|NCT01078233|12774265|P6|COMPLETED|Overall Study||154
5194690|NCT01078233|12774266|P5|COMPLETED|Overall Study||3199
5194691|NCT01078233|12774267|P4|COMPLETED|Overall Study||631
5194692|NCT01078233|12774268|P3|COMPLETED|Overall Study||1681
5194693|NCT01078233|12774269|P2|COMPLETED|Overall Study||296
5194694|NCT01078233|12774270|P1|COMPLETED|Overall Study||656
5194695|NCT01078233|12774265|P6|STARTED|Overall Study||154
5194696|NCT01078233|12774266|P5|STARTED|Overall Study||3199
5194697|NCT01078233|12774267|P4|STARTED|Overall Study||631
5194698|NCT01078233|12774268|P3|STARTED|Overall Study||1681
5194699|NCT01078233|12774269|P2|STARTED|Overall Study||296
5194700|NCT01078233|12774270|P1|STARTED|Overall Study||656
5194701|NCT01078220|12774287|P1|NOT COMPLETED|Overall Study||0
5194702|NCT01078220|12774287|P1|COMPLETED|Overall Study||189629
5194703|NCT01078220|12774287|P1|STARTED|Overall Study||189629
5194704|NCT01078207|12774297|P1|NOT COMPLETED|Overall Study||0
5194705|NCT01078207|12774297|P1|COMPLETED|Overall Study||100
5194706|NCT01078207|12774297|P1|STARTED|Overall Study||100
5194707|NCT01078168|12774304|P2|NOT COMPLETED|Overall Study||1
5194708|NCT01078168|12774305|P1|NOT COMPLETED|Overall Study||0
5194709|NCT01078168|12774304|P2|COMPLETED|Overall Study||10
5194710|NCT01078168|12774305|P1|COMPLETED|Overall Study||11
5194711|NCT01078168|12774304|P2|STARTED|Overall Study||11
5194712|NCT01078168|12774305|P1|STARTED|Overall Study||11
5194713|NCT01078155|12774311|P1|NOT COMPLETED|Overall Study||44
5194714|NCT01078155|12774311|P1|COMPLETED|Overall Study||87
5194715|NCT01078155|12774311|P1|STARTED|Overall Study||131
5194716|NCT01078116|12774327|P1|NOT COMPLETED|Overall Study||48
5194717|NCT01078116|12774327|P1|COMPLETED|Overall Study||76
5194718|NCT01078116|12774327|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
5194719|NCT01078090|12774335|P1|NOT COMPLETED|Overall Study||4593
5194720|NCT01078090|12774335|P1|COMPLETED|Overall Study||1152
5194721|NCT01078090|12774335|P1|STARTED|Overall Study||5745
5194722|NCT01077973|12774379|P3|NOT COMPLETED|Overall Study||0
5194723|NCT01077973|12774380|P2|NOT COMPLETED|Overall Study||0
5194724|NCT01077973|12774381|P1|NOT COMPLETED|Overall Study||0
5194725|NCT01077973|12774379|P3|COMPLETED|Overall Study||80
5194726|NCT01077973|12774380|P2|COMPLETED|Overall Study||79
5194727|NCT01077973|12774381|P1|COMPLETED|Overall Study||41
5194728|NCT01077973|12774379|P3|STARTED|Overall Study||80
5194729|NCT01077973|12774380|P2|STARTED|Overall Study||79
5194730|NCT01077973|12774381|P1|STARTED|Overall Study||41
5194731|NCT01077960|12774429|P1|NOT COMPLETED|Overall Study||16
5194732|NCT01077960|12774429|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
5194733|NCT01077960|12774429|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
5194734|NCT01077921|12774440|P2|NOT COMPLETED|Second Intervention||1
5194735|NCT01077921|12774441|P1|NOT COMPLETED|Second Intervention||0
5194736|NCT01077921|12774440|P2|COMPLETED|Second Intervention||9
5194737|NCT01077921|12774441|P1|COMPLETED|Second Intervention||13
5194738|NCT01077921|12774440|P2|STARTED|Second Intervention||10
5194739|NCT01077921|12774441|P1|STARTED|Second Intervention||13
5194740|NCT01077921|12774440|P2|NOT COMPLETED|Washout||2
5194741|NCT01077921|12774441|P1|NOT COMPLETED|Washout||0
5194742|NCT01077921|12774440|P2|COMPLETED|Washout||10
5194743|NCT01077921|12774441|P1|COMPLETED|Washout||13
5194744|NCT01077921|12774440|P2|STARTED|Washout||12
5194745|NCT01077921|12774441|P1|STARTED|Washout||13
5194746|NCT01077921|12774440|P2|NOT COMPLETED|First Intervention||1
5194747|NCT01077921|12774441|P1|NOT COMPLETED|First Intervention||1
5194748|NCT01077921|12774440|P2|COMPLETED|First Intervention||12
5194749|NCT01077921|12774441|P1|COMPLETED|First Intervention||13
5194750|NCT01077921|12774440|P2|STARTED|First Intervention||13
5194751|NCT01077921|12774441|P1|STARTED|First Intervention||14
5194752|NCT01077856|12774474|P3|NOT COMPLETED|Overall Study||0
5194753|NCT01077856|12774475|P2|NOT COMPLETED|Overall Study||0
5194754|NCT01077856|12774476|P1|NOT COMPLETED|Overall Study||0
5194755|NCT01077856|12774474|P3|COMPLETED|Overall Study||15713
5194756|NCT01077856|12774475|P2|COMPLETED|Overall Study||16604
5194757|NCT01077856|12774476|P1|COMPLETED|Overall Study||22199
5194758|NCT01077856|12774474|P3|STARTED|Overall Study||15713
5194759|NCT01077856|12774475|P2|STARTED|Overall Study||16604
5194760|NCT01077856|12774476|P1|STARTED|Overall Study||22199
5194761|NCT01077830|12774657|P2|NOT COMPLETED|Overall Study||0
5194762|NCT01077830|12774658|P1|NOT COMPLETED|Overall Study||0
5194763|NCT01077830|12774657|P2|COMPLETED|Overall Study||682
5194764|NCT01077830|12774658|P1|COMPLETED|Overall Study||677
5194765|NCT01077830|12774657|P2|STARTED|Overall Study||682
5194766|NCT01077830|12774658|P1|STARTED|Overall Study||677
5194767|NCT01077817|12774668|P1|NOT COMPLETED|Overall Study||0
5194768|NCT01077817|12774668|P1|COMPLETED|Overall Study||684815
5194769|NCT01077817|12774668|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
5194770|NCT01077804|12774679|P1|NOT COMPLETED|Overall Study||199
5194771|NCT01077804|12774679|P1|COMPLETED|Overall Study||7386
5194772|NCT01077804|12774679|P1|STARTED|Overall Study||7585
5194773|NCT01077739|12774688|P2|NOT COMPLETED|Overall Study||10
5194774|NCT01077739|12774689|P1|NOT COMPLETED|Overall Study||5
5194775|NCT01077739|12774688|P2|COMPLETED|Overall Study||40
5194776|NCT01077739|12774689|P1|COMPLETED|Overall Study||20
5194777|NCT01077739|12774688|P2|STARTED|Overall Study||50
5194778|NCT01077739|12774689|P1|STARTED|Overall Study||25
5194779|NCT01077713|12774703|P2|NOT COMPLETED|Overall Study||36
5194780|NCT01077713|12774704|P1|NOT COMPLETED|Overall Study||36
5194781|NCT01077713|12774703|P2|COMPLETED|Overall Study||6
5194782|NCT01077713|12774704|P1|COMPLETED|Overall Study||8
5194783|NCT01077713|12774703|P2|STARTED|Overall Study||42
5194784|NCT01077713|12774704|P1|STARTED|Overall Study||44
5194785|NCT01077622|12774728|P1|NOT COMPLETED|Overall Study||3
5194786|NCT01077622|12774728|P1|COMPLETED|Overall Study||7
5194787|NCT01077622|12774728|P1|STARTED|Overall Study||10
5194788|NCT01077596|12774786|P12|NOT COMPLETED|Overall Study||0
5194789|NCT01077596|12774787|P11|NOT COMPLETED|Overall Study||0
5194790|NCT01077596|12774788|P10|NOT COMPLETED|Overall Study||0
5194791|NCT01077596|12774789|P9|NOT COMPLETED|Overall Study||0
5194792|NCT01077596|12774790|P8|NOT COMPLETED|Overall Study||0
5194793|NCT01077596|12774791|P7|NOT COMPLETED|Overall Study||0
5194794|NCT01077596|12774792|P6|NOT COMPLETED|Overall Study||0
5194795|NCT01077596|12774793|P5|NOT COMPLETED|Overall Study||0
5194796|NCT01077596|12774794|P4|NOT COMPLETED|Overall Study||0
5194797|NCT01077596|12774795|P3|NOT COMPLETED|Overall Study||0
5194798|NCT01077596|12774796|P2|NOT COMPLETED|Overall Study||0
5194799|NCT01077596|12774797|P1|NOT COMPLETED|Overall Study||0
5194800|NCT01077596|12774786|P12|COMPLETED|Overall Study||22150
5194801|NCT01077596|12774787|P11|COMPLETED|Overall Study||2215
5194802|NCT01077596|12774788|P10|COMPLETED|Overall Study||28420
5194803|NCT01077596|12774789|P9|COMPLETED|Overall Study||2842
5194804|NCT01077596|12774790|P8|COMPLETED|Overall Study||837
5194805|NCT01077596|12774791|P7|COMPLETED|Overall Study||308
5194806|NCT01077596|12774792|P6|COMPLETED|Overall Study||882
5194807|NCT01077596|12774793|P5|COMPLETED|Overall Study||294
5194808|NCT01077596|12774794|P4|COMPLETED|Overall Study||1370
5194809|NCT01077596|12774795|P3|COMPLETED|Overall Study||457
5194810|NCT01077596|12774796|P2|COMPLETED|Overall Study||1050
5194811|NCT01077596|12774797|P1|COMPLETED|Overall Study||350
5194812|NCT01077596|12774786|P12|STARTED|Overall Study||22150
5194813|NCT01077596|12774787|P11|STARTED|Overall Study||2215
5194814|NCT01077596|12774788|P10|STARTED|Overall Study||28420
5194815|NCT01077596|12774789|P9|STARTED|Overall Study||2842
5194816|NCT01077596|12774790|P8|STARTED|Overall Study||837
5194817|NCT01077596|12774791|P7|STARTED|Overall Study||308
5194818|NCT01077596|12774792|P6|STARTED|Overall Study||882
5194819|NCT01077596|12774793|P5|STARTED|Overall Study||294
5194820|NCT01077596|12774794|P4|STARTED|Overall Study||1370
5194821|NCT01077596|12774795|P3|STARTED|Overall Study||457
5194822|NCT01077596|12774796|P2|STARTED|Overall Study||1050
5194823|NCT01077596|12774797|P1|STARTED|Overall Study||350
5194824|NCT01077544|12774848|P2|NOT COMPLETED|Overall Study||5
5194825|NCT01077544|12774849|P1|NOT COMPLETED|Overall Study||3
5194826|NCT01077544|12774848|P2|COMPLETED|Overall Study||2
5194827|NCT01077544|12774849|P1|COMPLETED|Overall Study||5
5194828|NCT01077544|12774848|P2|STARTED|Overall Study||7
5194829|NCT01077544|12774849|P1|STARTED|Overall Study||8
5194830|NCT01077518|12774877|P3|NOT COMPLETED|Optional Ofa Phase||16
5194831|NCT01077518|12774878|P2|NOT COMPLETED|Optional Ofa Phase||0
5194832|NCT01077518|12774879|P1|NOT COMPLETED|Optional Ofa Phase||0
5194833|NCT01077518|12774877|P3|COMPLETED|Optional Ofa Phase||16
5194834|NCT01077518|12774878|P2|COMPLETED|Optional Ofa Phase||0
5194835|NCT01077518|12774879|P1|COMPLETED|Optional Ofa Phase||0
5194836|NCT01077518|12774877|P3|Completed 5-year Follow-up|Optional Ofa Phase||12
5194837|NCT01077518|12774878|P2|Completed 5-year Follow-up|Optional Ofa Phase||0
5194838|NCT01077518|12774879|P1|Completed 5-year Follow-up|Optional Ofa Phase||0
5194839|NCT01077518|12774877|P3|STARTED|Optional Ofa Phase||32
5194840|NCT01077518|12774878|P2|STARTED|Optional Ofa Phase||0
5194841|NCT01077518|12774879|P1|STARTED|Optional Ofa Phase||0
5194842|NCT01077518|12774877|P3|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
5194843|NCT01077518|12774878|P2|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
5194844|NCT01077518|12774879|P1|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
5194845|NCT01077518|12774877|P3|COMPLETED|Treatment Phase - no Optional Ofa||0
5194846|NCT01077518|12774878|P2|COMPLETED|Treatment Phase - no Optional Ofa||108
5194847|NCT01077518|12774879|P1|COMPLETED|Treatment Phase - no Optional Ofa||95
5194848|NCT01077518|12774877|P3|Safety Population|Treatment Phase - no Optional Ofa||0
5194849|NCT01077518|12774878|P2|Safety Population|Treatment Phase - no Optional Ofa||170
5194850|NCT01077518|12774879|P1|Safety Population|Treatment Phase - no Optional Ofa||172
5194851|NCT01077518|12774877|P3|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
5194852|NCT01077518|12774878|P2|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
5194853|NCT01077518|12774879|P1|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
5194854|NCT01077518|12774877|P3|STARTED|Treatment Phase - no Optional Ofa||0
5194855|NCT01077518|12774878|P2|STARTED|Treatment Phase - no Optional Ofa||173
5194856|NCT01077518|12774879|P1|STARTED|Treatment Phase - no Optional Ofa||173
5194857|NCT01077401|12774939|P2|NOT COMPLETED|Overall Study||21
5194858|NCT01077401|12774940|P1|NOT COMPLETED|Overall Study||18
5194859|NCT01077401|12774939|P2|COMPLETED|Overall Study||54
5194860|NCT01077401|12774940|P1|COMPLETED|Overall Study||59
5194861|NCT01077401|12774939|P2|STARTED|Overall Study||75
5194862|NCT01077401|12774940|P1|STARTED|Overall Study||77
5194863|NCT01077375|12774952|P2|NOT COMPLETED|Overall Study||35
5194864|NCT01077375|12774953|P1|NOT COMPLETED|Overall Study||10
5194865|NCT01077375|12774952|P2|COMPLETED|Overall Study||51
5194866|NCT01077375|12774953|P1|COMPLETED|Overall Study||11
5194867|NCT01077375|12774952|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
5194868|NCT01077375|12774953|P1|STARTED|Overall Study||21
5194869|NCT01077362|12774964|P3|NOT COMPLETED|Overall Study||24
5194870|NCT01077362|12774965|P2|NOT COMPLETED|Overall Study||19
5194871|NCT01077362|12774966|P1|NOT COMPLETED|Overall Study||31
5194872|NCT01077362|12774964|P3|COMPLETED|Overall Study||81
5194873|NCT01077362|12774965|P2|COMPLETED|Overall Study||84
5194874|NCT01077362|12774966|P1|COMPLETED|Overall Study||73
5194875|NCT01077362|12774964|P3|STARTED|Overall Study||105
5194876|NCT01077362|12774965|P2|STARTED|Overall Study||103
5194877|NCT01077362|12774966|P1|STARTED|Overall Study||104
5194878|NCT01077323|12775002|P3|NOT COMPLETED|Overall Study||11912089
5194879|NCT01077323|12775003|P2|NOT COMPLETED|Overall Study||386263
5194880|NCT01077323|12775004|P1|NOT COMPLETED|Overall Study||11378
5194881|NCT01077323|12775002|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
5194882|NCT01077323|12775003|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
5194883|NCT01077323|12775004|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
5194884|NCT01077323|12775002|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
5194885|NCT01077323|12775003|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
5194886|NCT01077323|12775004|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
5194887|NCT01077310|12775023|P2|NOT COMPLETED|Overall Study||0
5194888|NCT01077310|12775024|P1|NOT COMPLETED|Overall Study||0
5194889|NCT01077310|12775023|P2|COMPLETED|Overall Study||33
5194890|NCT01077310|12775024|P1|COMPLETED|Overall Study||67
5194891|NCT01077310|12775023|P2|STARTED|Overall Study||33
5194892|NCT01077310|12775024|P1|STARTED|Overall Study||67
5194893|NCT01077284|12775047|P3|NOT COMPLETED|Overall Study||3
5194894|NCT01077284|12775048|P2|NOT COMPLETED|Overall Study||5
5194895|NCT01077284|12775049|P1|NOT COMPLETED|Overall Study||5
5194896|NCT01077284|12775047|P3|COMPLETED|Overall Study||30
5194897|NCT01077284|12775048|P2|COMPLETED|Overall Study||28
5194898|NCT01077284|12775049|P1|COMPLETED|Overall Study||28
5194899|NCT01077284|12775047|P3|STARTED|Overall Study||33
5194900|NCT01077284|12775048|P2|STARTED|Overall Study||33
5194901|NCT01077284|12775049|P1|STARTED|Overall Study||33
5194902|NCT01077271|12775070|P1|NOT COMPLETED|Overall Study||22
5194903|NCT01077271|12775070|P1|COMPLETED|Overall Study||102
5194904|NCT01077271|12775070|P1|Number of Participants Analyzed|Overall Study||120
5194905|NCT01077271|12775070|P1|Participants Treated With Palivizumab|Overall Study||120
5194906|NCT01077271|12775070|P1|STARTED|Overall Study||124
5194907|NCT01077258|12775108|P1|NOT COMPLETED|Overall Study||2568
5194908|NCT01077258|12775108|P1|COMPLETED|Overall Study||1640
5194909|NCT01077258|12775108|P1|STARTED|Overall Study||4208
5194910|NCT01077193|12775144|P1|NOT COMPLETED|Overall Study||44
5194911|NCT01077193|12775144|P1|COMPLETED|Overall Study||0
5194912|NCT01077193|12775144|P1|STARTED|Overall Study||44
5194913|NCT01077154|12775150|P2|NOT COMPLETED|Overall Study||2228
5194914|NCT01077154|12775151|P1|NOT COMPLETED|Overall Study||2226
5194915|NCT01077154|12775150|P2|COMPLETED|Overall Study||28
5194916|NCT01077154|12775151|P1|COMPLETED|Overall Study||27
5194917|NCT01077154|12775150|P2|Received Study Drug|Overall Study||2230
5194918|NCT01077154|12775151|P1|Received Study Drug|Overall Study||2229
5194919|NCT01077154|12775150|P2|STARTED|Overall Study||2256
5194920|NCT01077154|12775151|P1|STARTED|Overall Study||2253
5194921|NCT01077128|12775165|P1|NOT COMPLETED|Overall Study||67
5194922|NCT01077128|12775165|P1|COMPLETED|Overall Study||433
5194923|NCT01077128|12775165|P1|STARTED|Overall Study||500
5194924|NCT01077076|12775223|P6|NOT COMPLETED|Third Intervention||1
5194925|NCT01077076|12775224|P5|NOT COMPLETED|Third Intervention||0
5194926|NCT01077076|12775225|P4|NOT COMPLETED|Third Intervention||0
5194927|NCT01077076|12775226|P3|NOT COMPLETED|Third Intervention||0
5194928|NCT01077076|12775227|P2|NOT COMPLETED|Third Intervention||0
5194929|NCT01077076|12775228|P1|NOT COMPLETED|Third Intervention||0
5194930|NCT01077076|12775223|P6|COMPLETED|Third Intervention||4
5194931|NCT01077076|12775224|P5|COMPLETED|Third Intervention||5
5194932|NCT01077076|12775225|P4|COMPLETED|Third Intervention||5
5194933|NCT01077076|12775226|P3|COMPLETED|Third Intervention||5
5194934|NCT01077076|12775227|P2|COMPLETED|Third Intervention||5
5194935|NCT01077076|12775228|P1|COMPLETED|Third Intervention||4
5194936|NCT01077076|12775223|P6|STARTED|Third Intervention||5
5194937|NCT01077076|12775224|P5|STARTED|Third Intervention||5
5194938|NCT01077076|12775225|P4|STARTED|Third Intervention||5
5194939|NCT01077076|12775226|P3|STARTED|Third Intervention||5
5194940|NCT01077076|12775227|P2|STARTED|Third Intervention||5
5194941|NCT01077076|12775228|P1|STARTED|Third Intervention||4
5194942|NCT01077076|12775223|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
5194943|NCT01077076|12775224|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
5194944|NCT01077076|12775225|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
5194945|NCT01077076|12775226|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
5194946|NCT01077076|12775227|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5194947|NCT01077076|12775228|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5194948|NCT01077076|12775223|P6|COMPLETED|Washout Period of 2 Weeks||5
5194949|NCT01077076|12775224|P5|COMPLETED|Washout Period of 2 Weeks||5
5194950|NCT01077076|12775225|P4|COMPLETED|Washout Period of 2 Weeks||5
5194951|NCT01077076|12775226|P3|COMPLETED|Washout Period of 2 Weeks||5
5194952|NCT01077076|12775227|P2|COMPLETED|Washout Period of 2 Weeks||5
5194953|NCT01077076|12775228|P1|COMPLETED|Washout Period of 2 Weeks||4
5194954|NCT01077076|12775223|P6|STARTED|Washout Period of 2 Weeks||5
5194955|NCT01077076|12775224|P5|STARTED|Washout Period of 2 Weeks||5
5194956|NCT01077076|12775225|P4|STARTED|Washout Period of 2 Weeks||5
5194957|NCT01077076|12775226|P3|STARTED|Washout Period of 2 Weeks||5
5194958|NCT01077076|12775227|P2|STARTED|Washout Period of 2 Weeks||5
5194959|NCT01077076|12775228|P1|STARTED|Washout Period of 2 Weeks||4
5194960|NCT01077076|12775223|P6|NOT COMPLETED|Second Intervention||0
5194961|NCT01077076|12775224|P5|NOT COMPLETED|Second Intervention||0
5194962|NCT01077076|12775225|P4|NOT COMPLETED|Second Intervention||0
5194963|NCT01077076|12775226|P3|NOT COMPLETED|Second Intervention||0
5194964|NCT01077076|12775227|P2|NOT COMPLETED|Second Intervention||0
5194965|NCT01077076|12775228|P1|NOT COMPLETED|Second Intervention||0
5194966|NCT01077076|12775223|P6|COMPLETED|Second Intervention||5
5194967|NCT01077076|12775224|P5|COMPLETED|Second Intervention||5
5194968|NCT01077076|12775225|P4|COMPLETED|Second Intervention||5
5194969|NCT01077076|12775226|P3|COMPLETED|Second Intervention||5
5194970|NCT01077076|12775227|P2|COMPLETED|Second Intervention||5
5194971|NCT01077076|12775228|P1|COMPLETED|Second Intervention||4
5194972|NCT01077076|12775223|P6|STARTED|Second Intervention||5
5194973|NCT01077076|12775224|P5|STARTED|Second Intervention||5
5194974|NCT01077076|12775225|P4|STARTED|Second Intervention||5
5194975|NCT01077076|12775226|P3|STARTED|Second Intervention||5
5194976|NCT01077076|12775227|P2|STARTED|Second Intervention||5
5194977|NCT01077076|12775228|P1|STARTED|Second Intervention||4
5194978|NCT01077076|12775223|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
5194979|NCT01077076|12775224|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
5194980|NCT01077076|12775225|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
5194981|NCT01077076|12775226|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
5194982|NCT01077076|12775227|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5194983|NCT01077076|12775228|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5194984|NCT01077076|12775223|P6|COMPLETED|Washout Period of 2 Weeks||5
5194985|NCT01077076|12775224|P5|COMPLETED|Washout Period of 2 Weeks||5
5194986|NCT01077076|12775225|P4|COMPLETED|Washout Period of 2 Weeks||5
5194987|NCT01077076|12775226|P3|COMPLETED|Washout Period of 2 Weeks||5
5194988|NCT01077076|12775227|P2|COMPLETED|Washout Period of 2 Weeks||5
5194989|NCT01077076|12775228|P1|COMPLETED|Washout Period of 2 Weeks||4
5194990|NCT01077076|12775223|P6|STARTED|Washout Period of 2 Weeks||5
5194991|NCT01077076|12775224|P5|STARTED|Washout Period of 2 Weeks||5
5194992|NCT01077076|12775225|P4|STARTED|Washout Period of 2 Weeks||5
5194993|NCT01077076|12775226|P3|STARTED|Washout Period of 2 Weeks||5
5194994|NCT01077076|12775227|P2|STARTED|Washout Period of 2 Weeks||5
5194995|NCT01077076|12775228|P1|STARTED|Washout Period of 2 Weeks||4
5194996|NCT01077076|12775223|P6|NOT COMPLETED|First Intervention||0
5194997|NCT01077076|12775224|P5|NOT COMPLETED|First Intervention||0
5194998|NCT01077076|12775225|P4|NOT COMPLETED|First Intervention||0
5194999|NCT01077076|12775226|P3|NOT COMPLETED|First Intervention||0
5195000|NCT01077076|12775227|P2|NOT COMPLETED|First Intervention||0
5195001|NCT01077076|12775228|P1|NOT COMPLETED|First Intervention||1
5195002|NCT01077076|12775223|P6|COMPLETED|First Intervention||5
5195003|NCT01077076|12775224|P5|COMPLETED|First Intervention||5
5195004|NCT01077076|12775225|P4|COMPLETED|First Intervention||5
5195005|NCT01077076|12775226|P3|COMPLETED|First Intervention||5
5195006|NCT01077076|12775227|P2|COMPLETED|First Intervention||5
5195007|NCT01077076|12775228|P1|COMPLETED|First Intervention||4
5195008|NCT01077076|12775223|P6|STARTED|First Intervention||5
5195009|NCT01077076|12775224|P5|STARTED|First Intervention||5
5195010|NCT01077076|12775225|P4|STARTED|First Intervention||5
5195011|NCT01077076|12775226|P3|STARTED|First Intervention||5
5195012|NCT01077076|12775227|P2|STARTED|First Intervention||5
5195013|NCT01077076|12775228|P1|STARTED|First Intervention||5
5195014|NCT01077063|12775238|P2|NOT COMPLETED|Overall Study||3
5195015|NCT01077063|12775239|P1|NOT COMPLETED|Overall Study||4
5195016|NCT01077063|12775238|P2|COMPLETED|Overall Study||0
5195017|NCT01077063|12775239|P1|COMPLETED|Overall Study||0
5195018|NCT01077063|12775238|P2|STARTED|Overall Study||3
5195019|NCT01077063|12775239|P1|STARTED|Overall Study||4
5195020|NCT01077050|12775245|P1|NOT COMPLETED|Overall Study||9
5195021|NCT01077050|12775245|P1|COMPLETED|Overall Study||1942
5195022|NCT01077050|12775245|P1|STARTED|Overall Study||1951
5195023|NCT01077024|12775251|P2|NOT COMPLETED|Overall Study||28
5195024|NCT01077024|12775252|P1|NOT COMPLETED|Overall Study||31
5195025|NCT01077024|12775251|P2|COMPLETED|Overall Study||243
5195026|NCT01077024|12775252|P1|COMPLETED|Overall Study||236
5195027|NCT01077024|12775251|P2|STARTED|Overall Study||271
5195028|NCT01077024|12775252|P1|STARTED|Overall Study||267
5195029|NCT01076985|12775270|P1|NOT COMPLETED|Overall Study||0
5195030|NCT01076985|12775270|P1|COMPLETED|Overall Study||24
5195031|NCT01076985|12775270|P1|STARTED|Overall Study||24
5195032|NCT01076972|12775276|P1|NOT COMPLETED|Overall Study||0
5195033|NCT01076972|12775276|P1|COMPLETED|Overall Study||1184
5195034|NCT01076972|12775276|P1|STARTED|Overall Study||1184
5195035|NCT01076959|12775291|P1|NOT COMPLETED|Overall Study||2250
5195036|NCT01076959|12775291|P1|COMPLETED|Overall Study||5490
5195037|NCT01076959|12775291|P1|STARTED|Overall Study||7740
5195038|NCT01076686|12775312|P4|NOT COMPLETED|Overall Study||0
5195039|NCT01076686|12775313|P3|NOT COMPLETED|Overall Study||0
5195040|NCT01076686|12775314|P2|NOT COMPLETED|Overall Study||0
5195041|NCT01076686|12775315|P1|NOT COMPLETED|Overall Study||0
5195042|NCT01076686|12775312|P4|COMPLETED|Overall Study||31
5195043|NCT01076686|12775313|P3|COMPLETED|Overall Study||32
5195044|NCT01076686|12775314|P2|COMPLETED|Overall Study||14
5195045|NCT01076686|12775315|P1|COMPLETED|Overall Study||17
5195046|NCT01076686|12775312|P4|STARTED|Overall Study||31
5195047|NCT01076686|12775313|P3|STARTED|Overall Study||32
5195048|NCT01076686|12775314|P2|STARTED|Overall Study||14
5195049|NCT01076686|12775315|P1|STARTED|Overall Study||17
5195050|NCT01076647|12775327|P2|NOT COMPLETED|Overall Study||25
5195051|NCT01076647|12775328|P1|NOT COMPLETED|Overall Study||25
5195052|NCT01076647|12775327|P2|COMPLETED|Overall Study||209
5195053|NCT01076647|12775328|P1|COMPLETED|Overall Study||208
5195054|NCT01076647|12775327|P2|STARTED|Overall Study||234
5195055|NCT01076647|12775328|P1|STARTED|Overall Study||233
5195056|NCT01076543|12775342|P6|NOT COMPLETED|Overall Study||0
5195057|NCT01076543|12775343|P5|NOT COMPLETED|Overall Study||0
5195058|NCT01076543|12775344|P4|NOT COMPLETED|Overall Study||0
5195059|NCT01076543|12775345|P3|NOT COMPLETED|Overall Study||0
5195060|NCT01076543|12775346|P2|NOT COMPLETED|Overall Study||0
5195061|NCT01076543|12775347|P1|NOT COMPLETED|Overall Study||2
5195062|NCT01076543|12775342|P6|COMPLETED|Overall Study||39
5195063|NCT01076543|12775343|P5|COMPLETED|Overall Study||15
5195064|NCT01076543|12775344|P4|COMPLETED|Overall Study||39
5195065|NCT01076543|12775345|P3|COMPLETED|Overall Study||6
5195066|NCT01076543|12775346|P2|COMPLETED|Overall Study||3
5195067|NCT01076543|12775347|P1|COMPLETED|Overall Study||6
5195068|NCT01076543|12775342|P6|STARTED|Overall Study||39
5195069|NCT01076543|12775343|P5|STARTED|Overall Study||15
5195070|NCT01076543|12775344|P4|STARTED|Overall Study||39
5195071|NCT01076543|12775345|P3|STARTED|Overall Study||6
5195072|NCT01076543|12775346|P2|STARTED|Overall Study||3
5195073|NCT01076543|12775347|P1|STARTED|Overall Study||8
5195074|NCT01076504|12775385|P1|NOT COMPLETED|Overall Study||80
5195075|NCT01076504|12775385|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
5195076|NCT01076504|12775385|P1|STARTED|Overall Study||80
5195077|NCT01076452|12775395|P2|NOT COMPLETED|Overall Study||14
5195078|NCT01076452|12775396|P1|NOT COMPLETED|Overall Study||24
5195079|NCT01076452|12775395|P2|COMPLETED|Overall Study||138
5195080|NCT01076452|12775396|P1|COMPLETED|Overall Study||123
5195081|NCT01076452|12775395|P2|STARTED|Overall Study||152
5195082|NCT01076452|12775396|P1|STARTED|Overall Study||147
5195083|NCT01076400|12775408|P3|NOT COMPLETED|Overall Study||0
5195084|NCT01076400|12775409|P2|NOT COMPLETED|Overall Study||0
5195085|NCT01076400|12775410|P1|NOT COMPLETED|Overall Study||7
5195086|NCT01076400|12775408|P3|COMPLETED|Overall Study||0
5195087|NCT01076400|12775409|P2|COMPLETED|Overall Study||0
5195088|NCT01076400|12775410|P1|COMPLETED|Overall Study||0
5195089|NCT01076400|12775408|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
5195090|NCT01076400|12775409|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
5195091|NCT01076400|12775410|P1|STARTED|Overall Study||7
5195092|NCT01076361|12775416|P1|NOT COMPLETED|Overall Study||21
5195093|NCT01076361|12775416|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
5195094|NCT01076361|12775416|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
5195095|NCT01076348|12775420|P1|NOT COMPLETED|Overall Study||22
5195096|NCT01076348|12775420|P1|COMPLETED|Overall Study||51
5195097|NCT01076348|12775420|P1|STARTED|Overall Study||73
5195098|NCT01076335|12775424|P1|NOT COMPLETED|Overall Study||4
5195099|NCT01076335|12775424|P1|COMPLETED|Overall Study||36
5195100|NCT01076335|12775424|P1|STARTED|Overall Study||40
5195101|NCT01076296|12775428|P8|NOT COMPLETED|Overall Study||0
5195102|NCT01076296|12775429|P7|NOT COMPLETED|Overall Study||0
5195103|NCT01076296|12775430|P6|NOT COMPLETED|Overall Study||0
5195104|NCT01076296|12775431|P5|NOT COMPLETED|Overall Study||0
5195105|NCT01076296|12775432|P4|NOT COMPLETED|Overall Study||0
5195106|NCT01076296|12775433|P3|NOT COMPLETED|Overall Study||0
5195107|NCT01076296|12775434|P2|NOT COMPLETED|Overall Study||0
5195108|NCT01076296|12775435|P1|NOT COMPLETED|Overall Study||0
5195109|NCT01076296|12775428|P8|COMPLETED|Overall Study||199
5195110|NCT01076296|12775429|P7|COMPLETED|Overall Study||51
5195111|NCT01076296|12775430|P6|COMPLETED|Overall Study||191
5195112|NCT01076296|12775431|P5|COMPLETED|Overall Study||59
5195113|NCT01076296|12775432|P4|COMPLETED|Overall Study||199
5195114|NCT01076296|12775433|P3|COMPLETED|Overall Study||51
5195115|NCT01076296|12775434|P2|COMPLETED|Overall Study||196
5195116|NCT01076296|12775435|P1|COMPLETED|Overall Study||54
5195117|NCT01076296|12775428|P8|STARTED|Overall Study||199
5195118|NCT01076296|12775429|P7|STARTED|Overall Study||51
5195119|NCT01076296|12775430|P6|STARTED|Overall Study||191
5195120|NCT01076296|12775431|P5|STARTED|Overall Study||59
5195121|NCT01076296|12775432|P4|STARTED|Overall Study||199
5195122|NCT01076296|12775433|P3|STARTED|Overall Study||51
5195123|NCT01076296|12775434|P2|STARTED|Overall Study||196
5195124|NCT01076296|12775435|P1|STARTED|Overall Study||54
5195125|NCT01076283|12775455|P2|NOT COMPLETED|Overall Study||0
5195126|NCT01076283|12775456|P1|NOT COMPLETED|Overall Study||1
5195127|NCT01076283|12775455|P2|COMPLETED|Overall Study||7
5195128|NCT01076283|12775456|P1|COMPLETED|Overall Study||6
5195129|NCT01076283|12775455|P2|STARTED|Overall Study||7
5195130|NCT01076283|12775456|P1|STARTED|Overall Study||7
5195131|NCT01076270|12775464|P1|NOT COMPLETED|Overall Study||0
5195132|NCT01076270|12775464|P1|COMPLETED|Overall Study||1
5195133|NCT01076270|12775464|P1|STARTED|Overall Study||1
5195134|NCT01076244|12775469|P1|NOT COMPLETED|Overall Study||4
5195135|NCT01076244|12775469|P1|COMPLETED|Overall Study||42
5195136|NCT01076244|12775469|P1|STARTED|Overall Study||46
5195137|NCT01076205|12775476|P1|NOT COMPLETED|Overall Study||6019
5195138|NCT01076205|12775476|P1|COMPLETED|Overall Study||1210
5195139|NCT01076205|12775476|P1|STARTED|Overall Study||7229
5195140|NCT01076192|12775529|P1|NOT COMPLETED|Overall Study||197
5195141|NCT01076192|12775529|P1|COMPLETED|Overall Study||350
5195142|NCT01076192|12775529|P1|STARTED|Overall Study||547
5195143|NCT01076179|12775544|P1|NOT COMPLETED|Overall Study||1
5195144|NCT01076179|12775544|P1|COMPLETED|Overall Study||501
5195145|NCT01076179|12775544|P1|STARTED|Overall Study||502
5195146|NCT01076166|12775567|P1|NOT COMPLETED|Overall Study||9
5195147|NCT01076166|12775567|P1|COMPLETED|Overall Study||328
5195148|NCT01076166|12775567|P1|STARTED|Overall Study||337
5195149|NCT01076153|12775574|P1|NOT COMPLETED|Overall Study||11
5195150|NCT01076153|12775574|P1|COMPLETED|Overall Study||749
5195151|NCT01076153|12775574|P1|STARTED|Overall Study||760
5195152|NCT01076088|12775588|P6|NOT COMPLETED|Overall Study||23
5195153|NCT01076088|12775589|P5|NOT COMPLETED|Overall Study||16
5195154|NCT01076088|12775590|P4|NOT COMPLETED|Overall Study||15
5195155|NCT01076088|12775591|P3|NOT COMPLETED|Overall Study||17
5195156|NCT01076088|12775592|P2|NOT COMPLETED|Overall Study||18
5195157|NCT01076088|12775593|P1|NOT COMPLETED|Overall Study||11
5195158|NCT01076088|12775588|P6|COMPLETED|Overall Study||104
5195159|NCT01076088|12775589|P5|COMPLETED|Overall Study||104
5195160|NCT01076088|12775590|P4|COMPLETED|Overall Study||109
5195161|NCT01076088|12775591|P3|COMPLETED|Overall Study||109
5195162|NCT01076088|12775592|P2|COMPLETED|Overall Study||107
5195163|NCT01076088|12775593|P1|COMPLETED|Overall Study||111
5195164|NCT01076088|12775588|P6|STARTED|Overall Study||127
5195165|NCT01076088|12775589|P5|STARTED|Overall Study||120
5195166|NCT01076088|12775590|P4|STARTED|Overall Study||124
5195167|NCT01076088|12775591|P3|STARTED|Overall Study||126
5195168|NCT01076088|12775592|P2|STARTED|Overall Study||125
5195169|NCT01076088|12775593|P1|STARTED|Overall Study||122
5195170|NCT01076075|12775621|P2|NOT COMPLETED|Overall Study||47
5195171|NCT01076075|12775622|P1|NOT COMPLETED|Overall Study||41
5195172|NCT01076075|12775621|P2|COMPLETED|Overall Study||167
5195173|NCT01076075|12775622|P1|COMPLETED|Overall Study||172
5195174|NCT01076075|12775621|P2|Completed Phase A|Overall Study||189
5195175|NCT01076075|12775622|P1|Completed Phase A|Overall Study||199
5195176|NCT01076075|12775621|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
5195177|NCT01076075|12775622|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
5195178|NCT01076036|12775636|P1|NOT COMPLETED|Overall Study||2
5195179|NCT01076036|12775636|P1|COMPLETED|Overall Study||8
5195180|NCT01076036|12775636|P1|Complete CorPath Procedures|Overall Study||8
5195181|NCT01076036|12775636|P1|# of Procedures|Overall Study||8
5195182|NCT01076036|12775636|P1|STARTED|Overall Study||10
5195183|NCT01075984|12775646|P5|NOT COMPLETED|Follow-up Phase||47
5195184|NCT01075984|12775647|P4|NOT COMPLETED|Follow-up Phase||2
5195185|NCT01075984|12775648|P3|NOT COMPLETED|Follow-up Phase||1
5195186|NCT01075984|12775649|P2|NOT COMPLETED|Follow-up Phase||0
5195187|NCT01075984|12775650|P1|NOT COMPLETED|Follow-up Phase||0
5195188|NCT01075984|12775646|P5|COMPLETED|Follow-up Phase||165
5195189|NCT01075984|12775647|P4|COMPLETED|Follow-up Phase||19
5195190|NCT01075984|12775648|P3|COMPLETED|Follow-up Phase||19
5195191|NCT01075984|12775649|P2|COMPLETED|Follow-up Phase||10
5195192|NCT01075984|12775650|P1|COMPLETED|Follow-up Phase||10
5195193|NCT01075984|12775646|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
5195194|NCT01075984|12775647|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
5195195|NCT01075984|12775648|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
5195196|NCT01075984|12775649|P2|STARTED|Follow-up Phase||10
5195197|NCT01075984|12775650|P1|STARTED|Follow-up Phase||10
5195198|NCT01075984|12775646|P5|NOT COMPLETED|Treatment Phase||60
5195199|NCT01075984|12775647|P4|NOT COMPLETED|Treatment Phase||7
5195200|NCT01075984|12775648|P3|NOT COMPLETED|Treatment Phase||7
5195201|NCT01075984|12775649|P2|NOT COMPLETED|Treatment Phase||1
5195202|NCT01075984|12775650|P1|NOT COMPLETED|Treatment Phase||0
5195203|NCT01075984|12775646|P5|COMPLETED|Treatment Phase||153
5195204|NCT01075984|12775647|P4|COMPLETED|Treatment Phase||17
5195205|NCT01075984|12775648|P3|COMPLETED|Treatment Phase||14
5195206|NCT01075984|12775649|P2|COMPLETED|Treatment Phase||10
5195207|NCT01075984|12775650|P1|COMPLETED|Treatment Phase||10
5195208|NCT01075984|12775646|P5|STARTED|Treatment Phase||213
5195209|NCT01075984|12775647|P4|STARTED|Treatment Phase||24
5195210|NCT01075984|12775648|P3|STARTED|Treatment Phase||21
5195211|NCT01075984|12775649|P2|STARTED|Treatment Phase||11
5195212|NCT01075984|12775650|P1|STARTED|Treatment Phase||10
5195213|NCT01075971|12775704|P1|NOT COMPLETED|Overall Study||0
5195214|NCT01075971|12775704|P1|COMPLETED|Overall Study||52
5195215|NCT01075971|12775704|P1|STARTED|Overall Study||52
5195216|NCT01075958|12775708|P1|NOT COMPLETED|Overall Study||44
5195217|NCT01075958|12775708|P1|COMPLETED|Overall Study||239
5195218|NCT01075958|12775708|P1|STARTED|Overall Study||283
5195219|NCT01075815|12775724|P2|NOT COMPLETED|Overall Study||4
5195220|NCT01075815|12775725|P1|NOT COMPLETED|Overall Study||10
5195221|NCT01075815|12775724|P2|COMPLETED|Overall Study||31
5195222|NCT01075815|12775725|P1|COMPLETED|Overall Study||30
5195223|NCT01075815|12775724|P2|STARTED|Overall Study|Number of participants treated.|35
5195224|NCT01075815|12775725|P1|STARTED|Overall Study|Number of participants treated.|40
5195225|NCT01075763|12775763|P2|NOT COMPLETED|Overall Study||4
5195226|NCT01075763|12775764|P1|NOT COMPLETED|Overall Study||4
5195227|NCT01075763|12775763|P2|COMPLETED|Overall Study||15
5195228|NCT01075763|12775764|P1|COMPLETED|Overall Study||19
5195229|NCT01075763|12775763|P2|STARTED|Overall Study||19
5195230|NCT01075763|12775764|P1|STARTED|Overall Study||23
5195231|NCT01075685|12775788|P2|NOT COMPLETED|Overall Study||226
5195232|NCT01075685|12775789|P1|NOT COMPLETED|Overall Study||592
5195233|NCT01075685|12775788|P2|COMPLETED|Overall Study||188
5195234|NCT01075685|12775789|P1|COMPLETED|Overall Study||151
5195235|NCT01075685|12775788|P2|Completed Baseline Measures|Overall Study||263
5195236|NCT01075685|12775789|P1|Completed Baseline Measures|Overall Study||225
5195237|NCT01075685|12775788|P2|Met Inclusion Criteria|Overall Study||413
5195238|NCT01075685|12775789|P1|Met Inclusion Criteria|Overall Study||734
5195239|NCT01075685|12775788|P2|STARTED|Overall Study||414
5195240|NCT01075685|12775789|P1|STARTED|Overall Study||743
5195241|NCT01075646|12775805|P4|NOT COMPLETED|Overall Study||2
5195242|NCT01075646|12775806|P3|NOT COMPLETED|Overall Study||1
5195243|NCT01075646|12775807|P2|NOT COMPLETED|Overall Study||3
5195244|NCT01075646|12775808|P1|NOT COMPLETED|Overall Study||4
5195245|NCT01075646|12775805|P4|COMPLETED|Overall Study||44
5195246|NCT01075646|12775806|P3|COMPLETED|Overall Study||52
5195247|NCT01075646|12775807|P2|COMPLETED|Overall Study||31
5195248|NCT01075646|12775808|P1|COMPLETED|Overall Study||29
5195249|NCT01075646|12775805|P4|STARTED|Overall Study||46
5195250|NCT01075646|12775806|P3|STARTED|Overall Study||53
5195251|NCT01075646|12775807|P2|STARTED|Overall Study||34
5195252|NCT01075646|12775808|P1|STARTED|Overall Study||33
5195253|NCT01075412|12775840|P2|NOT COMPLETED|Overall Study||1
5195254|NCT01075412|12775841|P1|NOT COMPLETED|Overall Study||0
5195255|NCT01075412|12775840|P2|COMPLETED|Overall Study||1
5195256|NCT01075412|12775841|P1|COMPLETED|Overall Study||4
5195257|NCT01075412|12775840|P2|STARTED|Overall Study||2
5195258|NCT01075412|12775841|P1|STARTED|Overall Study||4
5195259|NCT01075399|12775851|P1|NOT COMPLETED|Overall Study||8
5195260|NCT01075399|12775851|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
5195261|NCT01075399|12775851|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
5195262|NCT01075347|12775857|P2|NOT COMPLETED|Overall Study||0
5195263|NCT01075347|12775858|P1|NOT COMPLETED|Overall Study||0
5195264|NCT01075347|12775857|P2|COMPLETED|Overall Study||83
5195265|NCT01075347|12775858|P1|COMPLETED|Overall Study||82
5195266|NCT01075347|12775857|P2|STARTED|Overall Study||83
5195267|NCT01075347|12775858|P1|STARTED|Overall Study||82
5195268|NCT01075321|12775866|P4|NOT COMPLETED|Overall Study||2
5195269|NCT01075321|12775867|P3|NOT COMPLETED|Overall Study||2
5195270|NCT01075321|12775868|P2|NOT COMPLETED|Overall Study||0
5195271|NCT01075321|12775869|P1|NOT COMPLETED|Overall Study||1
5195272|NCT01075321|12775866|P4|COMPLETED|Overall Study||31
5195273|NCT01075321|12775867|P3|COMPLETED|Overall Study||7
5195274|NCT01075321|12775868|P2|COMPLETED|Overall Study||9
5195275|NCT01075321|12775869|P1|COMPLETED|Overall Study||6
5195276|NCT01075321|12775866|P4|STARTED|Overall Study||33
5195277|NCT01075321|12775867|P3|STARTED|Overall Study||9
5195278|NCT01075321|12775868|P2|STARTED|Overall Study||9
5195279|NCT01075321|12775869|P1|STARTED|Overall Study||7
5195280|NCT01075282|12775887|P3|NOT COMPLETED|Overall Study||27
5195281|NCT01075282|12775888|P2|NOT COMPLETED|Overall Study||29
5195282|NCT01075282|12775889|P1|NOT COMPLETED|Overall Study||31
5195283|NCT01075282|12775887|P3|COMPLETED|Overall Study||238
5195284|NCT01075282|12775888|P2|COMPLETED|Overall Study||243
5195285|NCT01075282|12775889|P1|COMPLETED|Overall Study||242
5195286|NCT01075282|12775887|P3|Received at Least One Dose of Study Drug|Overall Study||262
5195287|NCT01075282|12775888|P2|Received at Least One Dose of Study Drug|Overall Study||272
5195288|NCT01075282|12775889|P1|Received at Least One Dose of Study Drug|Overall Study||273
5195289|NCT01075282|12775887|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
5195290|NCT01075282|12775888|P2|STARTED|Overall Study||272
5195291|NCT01075282|12775889|P1|STARTED|Overall Study||273
5195292|NCT01075256|12775972|P3|NOT COMPLETED|Overall Study||0
5195293|NCT01075256|12775973|P2|NOT COMPLETED|Overall Study||0
5195294|NCT01075256|12775974|P1|NOT COMPLETED|Overall Study||1
5195295|NCT01075256|12775972|P3|COMPLETED|Overall Study||65
5195296|NCT01075256|12775973|P2|COMPLETED|Overall Study||66
5195297|NCT01075256|12775974|P1|COMPLETED|Overall Study||63
5195298|NCT01075256|12775972|P3|STARTED|Overall Study||65
5195299|NCT01075256|12775973|P2|STARTED|Overall Study||66
5195300|NCT01075256|12775974|P1|STARTED|Overall Study||64
5195301|NCT01075243|12776006|P3|NOT COMPLETED|Overall Study||0
5195302|NCT01075243|12776007|P2|NOT COMPLETED|Overall Study||3
5195303|NCT01075243|12776008|P1|NOT COMPLETED|Overall Study||6
5195304|NCT01075243|12776006|P3|COMPLETED|Overall Study||80
5195305|NCT01075243|12776007|P2|COMPLETED|Overall Study||155
5195306|NCT01075243|12776008|P1|COMPLETED|Overall Study||157
5195307|NCT01075243|12776006|P3|STARTED|Overall Study||80
5195308|NCT01075243|12776007|P2|STARTED|Overall Study||158
5195309|NCT01075243|12776008|P1|STARTED|Overall Study||163
5195310|NCT01075217|12776060|P2|NOT COMPLETED|Overall Study||1
5195311|NCT01075217|12776061|P1|NOT COMPLETED|Overall Study||2
5195312|NCT01075217|12776060|P2|COMPLETED|Overall Study||84
5195313|NCT01075217|12776061|P1|COMPLETED|Overall Study||82
5195314|NCT01075217|12776060|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
5195315|NCT01075217|12776061|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
5195316|NCT01075204|12776077|P1|NOT COMPLETED|Overall Study||0
5195317|NCT01075204|12776077|P1|COMPLETED|Overall Study||335
5195318|NCT01075204|12776077|P1|STARTED|Overall Study||335
5195319|NCT01075191|12776094|P1|NOT COMPLETED|Overall Study||18
5195320|NCT01075191|12776094|P1|COMPLETED|Overall Study||42
5195321|NCT01075191|12776094|P1|Discontinued Year 3|Overall Study||5
5195322|NCT01075191|12776094|P1|Discontinued Year 2|Overall Study||6
5195323|NCT01075191|12776094|P1|Discontinued Year 1|Overall Study||7
5195324|NCT01075191|12776094|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
5195325|NCT01075178|12776105|P2|NOT COMPLETED|Subject Chart Review||9
5195326|NCT01075178|12776106|P1|NOT COMPLETED|Subject Chart Review||9
5195327|NCT01075178|12776105|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
5195328|NCT01075178|12776106|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
5195329|NCT01075178|12776105|P2|STARTED|Subject Chart Review|subjects matched|1018
5195330|NCT01075178|12776106|P1|STARTED|Subject Chart Review|subjects matched|1018
5195331|NCT01075178|12776105|P2|NOT COMPLETED|Subject Matching||403
5195332|NCT01075178|12776106|P1|NOT COMPLETED|Subject Matching||130
5195333|NCT01075178|12776105|P2|COMPLETED|Subject Matching|subjects matched|1018
5195334|NCT01075178|12776106|P1|COMPLETED|Subject Matching|subjects matched|1018
5195335|NCT01075178|12776105|P2|STARTED|Subject Matching|eligible for matching|1421
5195336|NCT01075178|12776106|P1|STARTED|Subject Matching|eligible for matching|1148
5195337|NCT01075152|12776120|P2|NOT COMPLETED|Overall Study||0
5195338|NCT01075152|12776121|P1|NOT COMPLETED|Overall Study||1
5195339|NCT01075152|12776120|P2|COMPLETED|Overall Study||89
5195340|NCT01075152|12776121|P1|COMPLETED|Overall Study||87
5195341|NCT01075152|12776120|P2|STARTED|Overall Study|randomized|89
5195342|NCT01075152|12776121|P1|STARTED|Overall Study|randomized|88
5195343|NCT01075100|12776147|P2|NOT COMPLETED|Overall Study||53
5195344|NCT01075100|12776148|P1|NOT COMPLETED|Overall Study||49
5195345|NCT01075100|12776147|P2|COMPLETED|Overall Study||1
5195346|NCT01075100|12776148|P1|COMPLETED|Overall Study||0
5195347|NCT01075100|12776147|P2|STARTED|Overall Study||54
5195348|NCT01075100|12776148|P1|STARTED|Overall Study||49
5195349|NCT01075087|12776166|P2|NOT COMPLETED|Overall Study||0
5195350|NCT01075087|12776167|P1|NOT COMPLETED|Overall Study||0
5195351|NCT01075087|12776166|P2|COMPLETED|Overall Study||10
5195352|NCT01075087|12776167|P1|COMPLETED|Overall Study||9
5195353|NCT01075087|12776166|P2|STARTED|Overall Study||10
5195354|NCT01075087|12776167|P1|STARTED|Overall Study||9
5195355|NCT01075074|12776178|P3|NOT COMPLETED|Overall Study||2
5195356|NCT01075074|12776179|P2|NOT COMPLETED|Overall Study||2
5195357|NCT01075074|12776180|P1|NOT COMPLETED|Overall Study||1
5195358|NCT01075074|12776178|P3|COMPLETED|Overall Study||23
5195359|NCT01075074|12776179|P2|COMPLETED|Overall Study||23
5195360|NCT01075074|12776180|P1|COMPLETED|Overall Study||24
5195361|NCT01075074|12776178|P3|STARTED|Overall Study||25
5195362|NCT01075074|12776179|P2|STARTED|Overall Study||25
5195363|NCT01075074|12776180|P1|STARTED|Overall Study||25
5195364|NCT01074944|12776197|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
5195365|NCT01074944|12776198|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
5195366|NCT01074944|12776199|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
5195367|NCT01074944|12776200|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
5195368|NCT01074944|12776201|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
5195369|NCT01074944|12776197|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
5195370|NCT01074944|12776198|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
5195371|NCT01074944|12776199|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
5195372|NCT01074944|12776200|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
5195373|NCT01074944|12776201|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
5195374|NCT01074944|12776197|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
5195375|NCT01074944|12776198|P4|STARTED|Extended Treatment (up to 42 Months)||0
5195376|NCT01074944|12776199|P3|STARTED|Extended Treatment (up to 42 Months)||0
5195377|NCT01074944|12776200|P2|STARTED|Extended Treatment (up to 42 Months)||0
5195378|NCT01074944|12776201|P1|STARTED|Extended Treatment (up to 42 Months)||0
5195379|NCT01074944|12776197|P5|NOT COMPLETED|Long Term Treatment||0
5195380|NCT01074944|12776198|P4|NOT COMPLETED|Long Term Treatment||26
5195381|NCT01074944|12776199|P3|NOT COMPLETED|Long Term Treatment||0
5195382|NCT01074944|12776200|P2|NOT COMPLETED|Long Term Treatment||0
5195383|NCT01074944|12776201|P1|NOT COMPLETED|Long Term Treatment||0
5195384|NCT01074944|12776197|P5|COMPLETED|Long Term Treatment||0
5195385|NCT01074944|12776198|P4|COMPLETED|Long Term Treatment||95
5195386|NCT01074944|12776199|P3|COMPLETED|Long Term Treatment||0
5195387|NCT01074944|12776200|P2|COMPLETED|Long Term Treatment||0
5195388|NCT01074944|12776201|P1|COMPLETED|Long Term Treatment||0
5195389|NCT01074944|12776197|P5|STARTED|Long Term Treatment||0
5195390|NCT01074944|12776198|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
5195391|NCT01074944|12776199|P3|STARTED|Long Term Treatment||0
5195392|NCT01074944|12776200|P2|STARTED|Long Term Treatment||0
5195393|NCT01074944|12776201|P1|STARTED|Long Term Treatment||0
5195394|NCT01074944|12776197|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195395|NCT01074944|12776198|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195396|NCT01074944|12776199|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
5195397|NCT01074944|12776200|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
5195398|NCT01074944|12776201|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195399|NCT01074944|12776197|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195400|NCT01074944|12776198|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195401|NCT01074944|12776199|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
5195402|NCT01074944|12776200|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
5195403|NCT01074944|12776201|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
5195404|NCT01074944|12776197|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
5195405|NCT01074944|12776198|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
5195406|NCT01074944|12776199|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
5195407|NCT01074944|12776200|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
5195408|NCT01074944|12776201|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
5195409|NCT01074944|12776197|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195410|NCT01074944|12776198|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195411|NCT01074944|12776199|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195412|NCT01074944|12776200|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195413|NCT01074944|12776201|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
5195414|NCT01074944|12776197|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195415|NCT01074944|12776198|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195416|NCT01074944|12776199|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195417|NCT01074944|12776200|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
5195418|NCT01074944|12776201|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
5195419|NCT01074944|12776197|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
5195420|NCT01074944|12776198|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
5195421|NCT01074944|12776199|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
5195422|NCT01074944|12776200|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
5195423|NCT01074944|12776201|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
5195424|NCT01074931|12776255|P1|NOT COMPLETED|Overall Study||6
5195425|NCT01074931|12776255|P1|COMPLETED|Overall Study||92
5195426|NCT01074931|12776255|P1|STARTED|Overall Study||98
5195427|NCT01074658|12776267|P1|NOT COMPLETED|Overall Study||19
5195428|NCT01074658|12776267|P1|COMPLETED|Overall Study||996
5195429|NCT01074658|12776267|P1|Attempted Implant|Overall Study||996
5195430|NCT01074658|12776267|P1|STARTED|Overall Study||1015
5195431|NCT01074554|12776275|P2|NOT COMPLETED|Overall Study||4
5195432|NCT01074554|12776276|P1|NOT COMPLETED|Overall Study||3
5195433|NCT01074554|12776275|P2|COMPLETED|Overall Study||11
5195434|NCT01074554|12776276|P1|COMPLETED|Overall Study||11
5195435|NCT01074554|12776275|P2|STARTED|Overall Study||15
5195436|NCT01074554|12776276|P1|STARTED|Overall Study||14
5195437|NCT01074502|12776286|P1|NOT COMPLETED|Overall Study||1
5195438|NCT01074502|12776286|P1|COMPLETED|Overall Study||2
5195439|NCT01074502|12776286|P1|STARTED|Overall Study||3
5195440|NCT01074463|12776297|P2|NOT COMPLETED|Second Intervention||0
5195441|NCT01074463|12776298|P1|NOT COMPLETED|Second Intervention||0
5195442|NCT01074463|12776297|P2|COMPLETED|Second Intervention||12
5195443|NCT01074463|12776298|P1|COMPLETED|Second Intervention||12
5195444|NCT01074463|12776297|P2|STARTED|Second Intervention||12
5195445|NCT01074463|12776298|P1|STARTED|Second Intervention||12
5195446|NCT01074463|12776297|P2|NOT COMPLETED|Washout of 7 Days||0
5195447|NCT01074463|12776298|P1|NOT COMPLETED|Washout of 7 Days||0
5195448|NCT01074463|12776297|P2|COMPLETED|Washout of 7 Days||12
5195449|NCT01074463|12776298|P1|COMPLETED|Washout of 7 Days||12
5195450|NCT01074463|12776297|P2|STARTED|Washout of 7 Days||12
5195451|NCT01074463|12776298|P1|STARTED|Washout of 7 Days||12
5195452|NCT01074463|12776297|P2|NOT COMPLETED|First Intervention||0
5195453|NCT01074463|12776298|P1|NOT COMPLETED|First Intervention||0
5195454|NCT01074463|12776297|P2|COMPLETED|First Intervention||12
5195455|NCT01074463|12776298|P1|COMPLETED|First Intervention||12
5195456|NCT01074463|12776297|P2|STARTED|First Intervention||12
5195457|NCT01074463|12776298|P1|STARTED|First Intervention||12
5195458|NCT01074450|12776310|P2|NOT COMPLETED|Second Intervention||1
5195459|NCT01074450|12776311|P1|NOT COMPLETED|Second Intervention||1
5195460|NCT01074450|12776310|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
5195461|NCT01074450|12776311|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
5195462|NCT01074450|12776310|P2|STARTED|Second Intervention||10
5195463|NCT01074450|12776311|P1|STARTED|Second Intervention||12
5195464|NCT01074450|12776310|P2|NOT COMPLETED|Washout of 7 Days||0
5195465|NCT01074450|12776311|P1|NOT COMPLETED|Washout of 7 Days||0
5195466|NCT01074450|12776310|P2|COMPLETED|Washout of 7 Days||10
5195467|NCT01074450|12776311|P1|COMPLETED|Washout of 7 Days||12
5195468|NCT01074450|12776310|P2|STARTED|Washout of 7 Days||10
5195469|NCT01074450|12776311|P1|STARTED|Washout of 7 Days||12
5195470|NCT01074450|12776310|P2|NOT COMPLETED|First Intervention||2
5195471|NCT01074450|12776311|P1|NOT COMPLETED|First Intervention||0
5195472|NCT01074450|12776310|P2|COMPLETED|First Intervention||10
5195473|NCT01074450|12776311|P1|COMPLETED|First Intervention||12
5195474|NCT01074450|12776310|P2|STARTED|First Intervention||12
5195475|NCT01074450|12776311|P1|STARTED|First Intervention||12
5195476|NCT01074437|12776323|P2|NOT COMPLETED|Overall Study||0
5195477|NCT01074437|12776324|P1|NOT COMPLETED|Overall Study||0
5195478|NCT01074437|12776323|P2|COMPLETED|Overall Study||5
5195479|NCT01074437|12776324|P1|COMPLETED|Overall Study||4
5195480|NCT01074437|12776323|P2|STARTED|Overall Study||5
5195481|NCT01074437|12776324|P1|STARTED|Overall Study||4
5195482|NCT01074307|12776340|P2|NOT COMPLETED|Overall Study||12
5195483|NCT01074307|12776341|P1|NOT COMPLETED|Overall Study||22
5195484|NCT01074307|12776340|P2|COMPLETED|Overall Study||102
5195485|NCT01074307|12776341|P1|COMPLETED|Overall Study||44
5195486|NCT01074307|12776340|P2|STARTED|Overall Study||114
5195487|NCT01074307|12776341|P1|STARTED|Overall Study||66
5195488|NCT01074268|12776363|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
5195489|NCT01074268|12776364|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
5195490|NCT01074268|12776363|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
5195491|NCT01074268|12776364|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
5195492|NCT01074268|12776363|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
5195493|NCT01074268|12776364|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
5195494|NCT01074268|12776363|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
5195495|NCT01074268|12776364|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
5195496|NCT01074268|12776363|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
5195497|NCT01074268|12776364|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
5195498|NCT01074268|12776363|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
5195499|NCT01074268|12776364|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
5195500|NCT01074268|12776363|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
5195501|NCT01074268|12776364|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
5195502|NCT01074268|12776363|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
5195503|NCT01074268|12776364|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
5195504|NCT01074255|12776390|P1|NOT COMPLETED|Overall Study||2
5195505|NCT01074255|12776390|P1|COMPLETED|Overall Study||3139
5195506|NCT01074255|12776390|P1|Treated|Overall Study||3139
5195507|NCT01074255|12776390|P1|STARTED|Overall Study||3141
5195508|NCT01074242|12776394|P1|NOT COMPLETED|Overall Study||403
5195509|NCT01074242|12776394|P1|COMPLETED|Overall Study||3395
5195510|NCT01074242|12776394|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
5195511|NCT01074242|12776394|P1|STARTED|Overall Study||3798
5195512|NCT01074229|12776402|P3|NOT COMPLETED|Overall Study||4
5195513|NCT01074229|12776403|P2|NOT COMPLETED|Overall Study||3
5195514|NCT01074229|12776404|P1|NOT COMPLETED|Overall Study||2
5195515|NCT01074229|12776402|P3|COMPLETED|Overall Study||21
5195516|NCT01074229|12776403|P2|COMPLETED|Overall Study||22
5195517|NCT01074229|12776404|P1|COMPLETED|Overall Study||23
5195518|NCT01074229|12776402|P3|STARTED|Overall Study||25
5195519|NCT01074229|12776403|P2|STARTED|Overall Study||25
5195520|NCT01074229|12776404|P1|STARTED|Overall Study||25
5195521|NCT01074216|12776415|P1|NOT COMPLETED|Overall Study||13
5195522|NCT01074216|12776415|P1|COMPLETED|Overall Study||41
5195523|NCT01074216|12776415|P1|STARTED|Overall Study||54
5195524|NCT01074177|12776419|P1|NOT COMPLETED|Overall Study||0
5195525|NCT01074177|12776419|P1|COMPLETED|Overall Study||24
5195526|NCT01074177|12776419|P1|STARTED|Overall Study||24
5195527|NCT01074164|12776428|P2|NOT COMPLETED|Overall Study||1
5195528|NCT01074164|12776429|P1|NOT COMPLETED|Overall Study||3
5195529|NCT01074164|12776428|P2|COMPLETED|Overall Study||7
5195530|NCT01074164|12776429|P1|COMPLETED|Overall Study||4
5195531|NCT01074164|12776428|P2|STARTED|Overall Study||8
5195532|NCT01074164|12776429|P1|STARTED|Overall Study||7
5195533|NCT01074125|12776450|P3|NOT COMPLETED|Overall Study||12
5195534|NCT01074125|12776451|P2|NOT COMPLETED|Overall Study||5
5195535|NCT01074125|12776452|P1|NOT COMPLETED|Overall Study||12
5195536|NCT01074125|12776450|P3|COMPLETED|Overall Study||36
5195537|NCT01074125|12776451|P2|COMPLETED|Overall Study||47
5195538|NCT01074125|12776452|P1|COMPLETED|Overall Study||39
5195539|NCT01074125|12776450|P3|STARTED|Overall Study||48
5195540|NCT01074125|12776451|P2|STARTED|Overall Study||52
5195541|NCT01074125|12776452|P1|STARTED|Overall Study||51
5195542|NCT01074099|12776468|P2|NOT COMPLETED|Overall Study||0
5195543|NCT01074099|12776469|P1|NOT COMPLETED|Overall Study||0
5195544|NCT01074099|12776468|P2|COMPLETED|Overall Study||3
5195545|NCT01074099|12776469|P1|COMPLETED|Overall Study||2
5195546|NCT01074099|12776468|P2|STARTED|Overall Study||3
5195547|NCT01074099|12776469|P1|STARTED|Overall Study||2
5195548|NCT01074047|12776479|P2|NOT COMPLETED|Extension Phase||0
5195549|NCT01074047|12776480|P1|NOT COMPLETED|Extension Phase||22
5195550|NCT01074047|12776479|P2|COMPLETED|Extension Phase||0
5195551|NCT01074047|12776480|P1|COMPLETED|Extension Phase||0
5195552|NCT01074047|12776479|P2|Safety Population|Extension Phase||0
5195553|NCT01074047|12776480|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
5195554|NCT01074047|12776479|P2|STARTED|Extension Phase||0
5195555|NCT01074047|12776480|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
5195556|NCT01074047|12776479|P2|NOT COMPLETED|Survival Follow-Up Phase||136
5195557|NCT01074047|12776480|P1|NOT COMPLETED|Survival Follow-Up Phase||124
5195558|NCT01074047|12776479|P2|COMPLETED|Survival Follow-Up Phase||27
5195559|NCT01074047|12776480|P1|COMPLETED|Survival Follow-Up Phase||16
5195560|NCT01074047|12776479|P2|STARTED|Survival Follow-Up Phase||163
5195561|NCT01074047|12776480|P1|STARTED|Survival Follow-Up Phase||140
5195562|NCT01074047|12776479|P2|NOT COMPLETED|Treatment Phase||234
5195563|NCT01074047|12776480|P1|NOT COMPLETED|Treatment Phase||217
5195564|NCT01074047|12776479|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
5195565|NCT01074047|12776480|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
5195566|NCT01074047|12776479|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
5195567|NCT01074047|12776480|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
5195568|NCT01074047|12776479|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
5195569|NCT01074047|12776480|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
5195570|NCT01074047|12776479|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
5195571|NCT01074047|12776480|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
5195572|NCT01074047|12776479|P2|STARTED|Treatment Phase||247
5195573|NCT01074047|12776480|P1|STARTED|Treatment Phase||241
5195574|NCT01074034|12776554|P1|NOT COMPLETED|Overall Study||6
5195575|NCT01074034|12776554|P1|COMPLETED|Overall Study||205
5195576|NCT01074034|12776554|P1|STARTED|Overall Study||211
5195577|NCT01074008|12776568|P9|NOT COMPLETED|Overall Study||4
5195578|NCT01074008|12776569|P8|NOT COMPLETED|Overall Study||0
5195579|NCT01074008|12776570|P7|NOT COMPLETED|Overall Study||1
5195580|NCT01074008|12776571|P6|NOT COMPLETED|Overall Study||0
5195581|NCT01074008|12776572|P5|NOT COMPLETED|Overall Study||2
5195582|NCT01074008|12776573|P4|NOT COMPLETED|Overall Study||1
5195583|NCT01074008|12776574|P3|NOT COMPLETED|Overall Study||2
5195584|NCT01074008|12776575|P2|NOT COMPLETED|Overall Study||3
5195585|NCT01074008|12776576|P1|NOT COMPLETED|Overall Study||1
5195586|NCT01074008|12776568|P9|COMPLETED|Overall Study||7
5195587|NCT01074008|12776569|P8|COMPLETED|Overall Study||8
5195588|NCT01074008|12776570|P7|COMPLETED|Overall Study||7
5195589|NCT01074008|12776571|P6|COMPLETED|Overall Study||7
5195590|NCT01074008|12776572|P5|COMPLETED|Overall Study||6
5195591|NCT01074008|12776573|P4|COMPLETED|Overall Study||7
5195592|NCT01074008|12776574|P3|COMPLETED|Overall Study||6
5195593|NCT01074008|12776575|P2|COMPLETED|Overall Study||5
5195594|NCT01074008|12776576|P1|COMPLETED|Overall Study||7
5195595|NCT01074008|12776568|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
5195596|NCT01074008|12776569|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
5195597|NCT01074008|12776570|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
5195598|NCT01074008|12776571|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
5195599|NCT01074008|12776572|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
5195600|NCT01074008|12776573|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
5195601|NCT01074008|12776574|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
5195602|NCT01074008|12776575|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
5195603|NCT01074008|12776576|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
5195604|NCT01074008|12776568|P9|STARTED|Overall Study||11
5195605|NCT01074008|12776569|P8|STARTED|Overall Study||8
5195606|NCT01074008|12776570|P7|STARTED|Overall Study||8
5195607|NCT01074008|12776571|P6|STARTED|Overall Study||7
5195608|NCT01074008|12776572|P5|STARTED|Overall Study||8
5195609|NCT01074008|12776573|P4|STARTED|Overall Study||8
5195610|NCT01074008|12776574|P3|STARTED|Overall Study||8
5195611|NCT01074008|12776575|P2|STARTED|Overall Study||8
5195612|NCT01074008|12776576|P1|STARTED|Overall Study||8
5195613|NCT01073943|12776686|P2|NOT COMPLETED|Overall Study||8
5195614|NCT01073943|12776687|P1|NOT COMPLETED|Overall Study||13
5195615|NCT01073943|12776686|P2|COMPLETED|Overall Study||295
5195616|NCT01073943|12776687|P1|COMPLETED|Overall Study||287
5195617|NCT01073943|12776686|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
5195618|NCT01073943|12776687|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
5195619|NCT01073943|12776686|P2|Safety Population (Treated)|Overall Study||302
5195620|NCT01073943|12776687|P1|Safety Population (Treated)|Overall Study||296
5195621|NCT01073943|12776686|P2|STARTED|Overall Study||303
5195622|NCT01073943|12776687|P1|STARTED|Overall Study||300
5195623|NCT01073930|12776713|P2|NOT COMPLETED|Overall Study||6
5195624|NCT01073930|12776714|P1|NOT COMPLETED|Overall Study||3
5195625|NCT01073930|12776713|P2|COMPLETED|Overall Study||295
5195626|NCT01073930|12776714|P1|COMPLETED|Overall Study||304
5195627|NCT01073930|12776713|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
5195628|NCT01073930|12776714|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
5195629|NCT01073930|12776713|P2|Safety Population (Treated)|Overall Study||298
5195630|NCT01073930|12776714|P1|Safety Population (Treated)|Overall Study||305
5195631|NCT01073930|12776713|P2|STARTED|Overall Study||301
5195632|NCT01073930|12776714|P1|STARTED|Overall Study||307
5195633|NCT01073865|12776738|P2|NOT COMPLETED|Overall Study||39
5195634|NCT01073865|12776739|P1|NOT COMPLETED|Overall Study||28
5195635|NCT01073865|12776738|P2|COMPLETED|Overall Study|Number of patients completed the study|74
5195636|NCT01073865|12776739|P1|COMPLETED|Overall Study|Number of patients completed the study|81
5195637|NCT01073865|12776738|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
5195638|NCT01073865|12776739|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
5195639|NCT01073865|12776738|P2|STARTED|Overall Study|Number of patients randomised|113
5195640|NCT01073865|12776739|P1|STARTED|Overall Study|Number of patients randomised|109
5195641|NCT01073657|12776751|P2|NOT COMPLETED|Overall Study||0
5195642|NCT01073657|12776752|P1|NOT COMPLETED|Overall Study||0
5195643|NCT01073657|12776751|P2|COMPLETED|Overall Study||16
5195644|NCT01073657|12776752|P1|COMPLETED|Overall Study||17
5195645|NCT01073657|12776751|P2|STARTED|Overall Study||16
5195646|NCT01073657|12776752|P1|STARTED|Overall Study||17
5195647|NCT01073631|12776758|P1|NOT COMPLETED|Overall Study||169
5195648|NCT01073631|12776758|P1|COMPLETED|Overall Study||374
5195649|NCT01073631|12776758|P1|STARTED|Overall Study||543
5195650|NCT01073618|12776763|P1|NOT COMPLETED|Overall Study||307
5195651|NCT01073618|12776763|P1|COMPLETED|Overall Study||385
5195652|NCT01073618|12776763|P1|STARTED|Overall Study||692
5195653|NCT01073605|12776771|P3|NOT COMPLETED|Overall Study||61
5195654|NCT01073605|12776772|P2|NOT COMPLETED|Overall Study||67
5195655|NCT01073605|12776773|P1|NOT COMPLETED|Overall Study||62
5195656|NCT01073605|12776771|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
5195657|NCT01073605|12776772|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
5195658|NCT01073605|12776773|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
5195659|NCT01073605|12776771|P3|Received Treatment|Overall Study||68
5195660|NCT01073605|12776772|P2|Received Treatment|Overall Study||70
5195661|NCT01073605|12776773|P1|Received Treatment|Overall Study||68
5195662|NCT01073605|12776771|P3|STARTED|Overall Study||69
5195663|NCT01073605|12776772|P2|STARTED|Overall Study||71
5195664|NCT01073605|12776773|P1|STARTED|Overall Study||68
5195665|NCT01073566|12776819|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
5195666|NCT01073566|12776820|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
5195667|NCT01073566|12776819|P2|COMPLETED|Period 2 (6 Weeks)||19
5195668|NCT01073566|12776820|P1|COMPLETED|Period 2 (6 Weeks)||18
5195669|NCT01073566|12776819|P2|STARTED|Period 2 (6 Weeks)||19
5195670|NCT01073566|12776820|P1|STARTED|Period 2 (6 Weeks)||19
5195671|NCT01073566|12776819|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
5195672|NCT01073566|12776820|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
5195673|NCT01073566|12776819|P2|COMPLETED|Period 1 (6 Weeks)||19
5195674|NCT01073566|12776820|P1|COMPLETED|Period 1 (6 Weeks)||19
5195675|NCT01073566|12776819|P2|STARTED|Period 1 (6 Weeks)||19
5195676|NCT01073566|12776820|P1|STARTED|Period 1 (6 Weeks)||19
5195677|NCT01073462|12776832|P1|NOT COMPLETED|Overall Study||41
5195678|NCT01073462|12776832|P1|COMPLETED|Overall Study||26
5195679|NCT01073462|12776832|P1|STARTED|Overall Study||67
5195680|NCT01073449|12776843|P1|NOT COMPLETED|Overall Study||0
5195681|NCT01073449|12776843|P1|COMPLETED|Overall Study||3362
5195682|NCT01073449|12776843|P1|STARTED|Overall Study||3362
5195683|NCT01073293|12776851|P2|NOT COMPLETED|Overall Study||11
5195684|NCT01073293|12776852|P1|NOT COMPLETED|Overall Study||5
5195685|NCT01073293|12776851|P2|COMPLETED|Overall Study||517
5195686|NCT01073293|12776852|P1|COMPLETED|Overall Study||521
5195687|NCT01073293|12776851|P2|STARTED|Overall Study||528
5195688|NCT01073293|12776852|P1|STARTED|Overall Study||526
5195689|NCT01073267|12776874|P1|NOT COMPLETED|Overall Study||3
5195690|NCT01073267|12776874|P1|COMPLETED|Overall Study||1
5195691|NCT01073267|12776874|P1|STARTED|Overall Study||4
5195692|NCT01073163|12776878|P1|NOT COMPLETED|Overall Study||3
5195693|NCT01073163|12776878|P1|COMPLETED|Overall Study|Patients completed study|51
5195694|NCT01073163|12776878|P1|Treated With >=6 Cycles|Overall Study||49
5195695|NCT01073163|12776878|P1|Treated With <6 Cycles|Overall Study||4
5195696|NCT01073163|12776878|P1|Enrolled But Not Treated|Overall Study||1
5195697|NCT01073163|12776878|P1|STARTED|Overall Study||54
5195698|NCT01072929|12776901|P3|NOT COMPLETED|Overall Study||9
5195699|NCT01072929|12776902|P2|NOT COMPLETED|Overall Study||51
5195700|NCT01072929|12776903|P1|NOT COMPLETED|Overall Study||44
5195701|NCT01072929|12776901|P3|COMPLETED|Overall Study||24
5195702|NCT01072929|12776902|P2|COMPLETED|Overall Study||150
5195703|NCT01072929|12776903|P1|COMPLETED|Overall Study||155
5195704|NCT01072929|12776901|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
5195705|NCT01072929|12776902|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
5195706|NCT01072929|12776903|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
5195707|NCT01072929|12776901|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
5195708|NCT01072929|12776902|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
5195709|NCT01072929|12776903|P1|Safety Population|Overall Study|Treated participants|199
5195710|NCT01072929|12776901|P3|STARTED|Overall Study||33
5195711|NCT01072929|12776902|P2|STARTED|Overall Study||201
5195712|NCT01072929|12776903|P1|STARTED|Overall Study||199
5195713|NCT01072877|12776982|P5|NOT COMPLETED|Overall Study||0
5195714|NCT01072877|12776983|P4|NOT COMPLETED|Overall Study||2
5195715|NCT01072877|12776984|P3|NOT COMPLETED|Overall Study||0
5195716|NCT01072877|12776985|P2|NOT COMPLETED|Overall Study||1
5195717|NCT01072877|12776986|P1|NOT COMPLETED|Overall Study||1
5195718|NCT01072877|12776982|P5|COMPLETED|Overall Study||63
5195719|NCT01072877|12776983|P4|COMPLETED|Overall Study||50
5195720|NCT01072877|12776984|P3|COMPLETED|Overall Study||51
5195721|NCT01072877|12776985|P2|COMPLETED|Overall Study||56
5195722|NCT01072877|12776986|P1|COMPLETED|Overall Study||55
5195723|NCT01072877|12776982|P5|STARTED|Overall Study||63
5195724|NCT01072877|12776983|P4|STARTED|Overall Study||52
5195725|NCT01072877|12776984|P3|STARTED|Overall Study||51
5195726|NCT01072877|12776985|P2|STARTED|Overall Study||57
5195727|NCT01072877|12776986|P1|STARTED|Overall Study||56
5195728|NCT01072773|12777008|P1|NOT COMPLETED|Overall Study||0
5195729|NCT01072773|12777008|P1|COMPLETED|Overall Study||2
5195730|NCT01072773|12777008|P1|STARTED|Overall Study||2
5195731|NCT01072669|12777019|P2|NOT COMPLETED|Overall Study||0
5195732|NCT01072669|12777020|P1|NOT COMPLETED|Overall Study||0
5195733|NCT01072669|12777019|P2|COMPLETED|Overall Study||5
5195734|NCT01072669|12777020|P1|COMPLETED|Overall Study||15
5195735|NCT01072669|12777019|P2|STARTED|Overall Study||5
5195736|NCT01072669|12777020|P1|STARTED|Overall Study||15
5195737|NCT01072656|12777028|P2|NOT COMPLETED|Second Intervention||0
5195738|NCT01072656|12777029|P1|NOT COMPLETED|Second Intervention||0
5195739|NCT01072656|12777028|P2|COMPLETED|Second Intervention||4
5195740|NCT01072656|12777029|P1|COMPLETED|Second Intervention||5
5195741|NCT01072656|12777028|P2|STARTED|Second Intervention||4
5195742|NCT01072656|12777029|P1|STARTED|Second Intervention||5
5195743|NCT01072656|12777028|P2|NOT COMPLETED|First Intervention||0
5195744|NCT01072656|12777029|P1|NOT COMPLETED|First Intervention||0
5195745|NCT01072656|12777028|P2|COMPLETED|First Intervention||4
5195746|NCT01072656|12777029|P1|COMPLETED|First Intervention||5
5195747|NCT01072656|12777028|P2|STARTED|First Intervention||4
5195748|NCT01072656|12777029|P1|STARTED|First Intervention||5
5195749|NCT01072643|12777039|P1|NOT COMPLETED|Overall Study||0
5195750|NCT01072643|12777039|P1|COMPLETED|Overall Study||4
5195751|NCT01072643|12777039|P1|STARTED|Overall Study||4
5195752|NCT01072630|12777065|P3|NOT COMPLETED|Overall Study||13
5195753|NCT01072630|12777066|P2|NOT COMPLETED|Overall Study||60
5195754|NCT01072630|12777067|P1|NOT COMPLETED|Overall Study||55
5195755|NCT01072630|12777065|P3|COMPLETED|Overall Study||17
5195756|NCT01072630|12777066|P2|COMPLETED|Overall Study||172
5195757|NCT01072630|12777067|P1|COMPLETED|Overall Study||175
5195758|NCT01072630|12777065|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
5195759|NCT01072630|12777066|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
5195760|NCT01072630|12777067|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
5195761|NCT01072630|12777065|P3|Safety Population|Overall Study|Treated participants.|30
5195762|NCT01072630|12777066|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
5195763|NCT01072630|12777067|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
5195764|NCT01072630|12777065|P3|STARTED|Overall Study||30
5195765|NCT01072630|12777066|P2|STARTED|Overall Study||232
5195766|NCT01072630|12777067|P1|STARTED|Overall Study||230
5195767|NCT01072617|12777141|P1|NOT COMPLETED|Overall Study||0
5195768|NCT01072617|12777141|P1|COMPLETED|Overall Study||8
5195769|NCT01072617|12777141|P1|STARTED|Overall Study||8
5195770|NCT01072539|12777148|P1|NOT COMPLETED|Overall Study||3
5195771|NCT01072539|12777148|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
5195772|NCT01072539|12777148|P1|STARTED|Overall Study||3172
5195773|NCT01072526|12777156|P2|NOT COMPLETED|Overall Study||0
5195774|NCT01072526|12777157|P1|NOT COMPLETED|Overall Study||0
5195775|NCT01072526|12777156|P2|COMPLETED|Overall Study||0
5195776|NCT01072526|12777157|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
5195777|NCT01072526|12777156|P2|STARTED|Overall Study||0
5195778|NCT01072526|12777157|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
5195779|NCT01072500|12777172|P2|NOT COMPLETED|Overall Study||14
5195780|NCT01072500|12777173|P1|NOT COMPLETED|Overall Study||24
5195781|NCT01072500|12777172|P2|COMPLETED|Overall Study||803
5195782|NCT01072500|12777173|P1|COMPLETED|Overall Study||794
5195783|NCT01072500|12777172|P2|STARTED|Overall Study||817
5195784|NCT01072500|12777173|P1|STARTED|Overall Study||818
5195785|NCT01072448|12777183|P2|NOT COMPLETED|Overall Study||30
5195786|NCT01072448|12777184|P1|NOT COMPLETED|Overall Study||19
5195787|NCT01072448|12777183|P2|COMPLETED|Overall Study||130
5195788|NCT01072448|12777184|P1|COMPLETED|Overall Study||144
5195789|NCT01072448|12777183|P2|STARTED|Overall Study||160
5195790|NCT01072448|12777184|P1|STARTED|Overall Study||163
5195791|NCT01072409|12777192|P1|NOT COMPLETED|Overall Study||7
5195792|NCT01072409|12777192|P1|COMPLETED|Overall Study||38
5195793|NCT01072409|12777192|P1|STARTED|Overall Study||45
5195794|NCT01072396|12777198|P2|NOT COMPLETED|Period Two||3
5195795|NCT01072396|12777199|P1|NOT COMPLETED|Period Two||1
5195796|NCT01072396|12777198|P2|COMPLETED|Period Two||57
5195797|NCT01072396|12777199|P1|COMPLETED|Period Two||57
5195798|NCT01072396|12777198|P2|STARTED|Period Two||60
5195799|NCT01072396|12777199|P1|STARTED|Period Two||58
5195800|NCT01072396|12777198|P2|NOT COMPLETED|Washout Period||1
5195801|NCT01072396|12777199|P1|NOT COMPLETED|Washout Period||0
5195802|NCT01072396|12777198|P2|COMPLETED|Washout Period||60
5195803|NCT01072396|12777199|P1|COMPLETED|Washout Period||58
5195804|NCT01072396|12777198|P2|STARTED|Washout Period||61
5195805|NCT01072396|12777199|P1|STARTED|Washout Period||58
5195806|NCT01072396|12777198|P2|NOT COMPLETED|Period One||2
5195807|NCT01072396|12777199|P1|NOT COMPLETED|Period One||5
5195808|NCT01072396|12777198|P2|COMPLETED|Period One||61
5195809|NCT01072396|12777199|P1|COMPLETED|Period One||58
5195810|NCT01072396|12777198|P2|STARTED|Period One||63
5195811|NCT01072396|12777199|P1|STARTED|Period One||63
5195812|NCT01072357|12777211|P2|NOT COMPLETED|Overall Study||1
5195813|NCT01072357|12777212|P1|NOT COMPLETED|Overall Study||0
5195814|NCT01072357|12777211|P2|COMPLETED|Overall Study||14
5195815|NCT01072357|12777212|P1|COMPLETED|Overall Study||15
5195816|NCT01072357|12777211|P2|STARTED|Overall Study||15
5195817|NCT01072357|12777212|P1|STARTED|Overall Study||15
5195818|NCT01072344|12777222|P2|NOT COMPLETED|Overall Study||18
5195819|NCT01072344|12777223|P1|NOT COMPLETED|Overall Study||11
5195820|NCT01072344|12777222|P2|COMPLETED|Overall Study||29
5195821|NCT01072344|12777223|P1|COMPLETED|Overall Study||35
5195822|NCT01072344|12777222|P2|STARTED|Overall Study||47
5195823|NCT01072344|12777223|P1|STARTED|Overall Study||46
5195824|NCT01072331|12777240|P3|NOT COMPLETED|Overall Study||0
5195825|NCT01072331|12777241|P2|NOT COMPLETED|Overall Study||0
5195826|NCT01072331|12777242|P1|NOT COMPLETED|Overall Study||0
5195827|NCT01072331|12777240|P3|COMPLETED|Overall Study||32
5195828|NCT01072331|12777241|P2|COMPLETED|Overall Study||33
5195829|NCT01072331|12777242|P1|COMPLETED|Overall Study||34
5195830|NCT01072331|12777240|P3|STARTED|Overall Study||32
5195831|NCT01072331|12777241|P2|STARTED|Overall Study||33
5195832|NCT01072331|12777242|P1|STARTED|Overall Study||34
5195833|NCT01072201|12777261|P2|NOT COMPLETED|Overall Study||1
5195834|NCT01072201|12777262|P1|NOT COMPLETED|Overall Study||0
5195835|NCT01072201|12777261|P2|COMPLETED|Overall Study||29
5195836|NCT01072201|12777262|P1|COMPLETED|Overall Study||30
5195837|NCT01072201|12777261|P2|STARTED|Overall Study||30
5195838|NCT01072201|12777262|P1|STARTED|Overall Study||30
5195839|NCT01072188|12777274|P2|NOT COMPLETED|Overall Study||0
5195840|NCT01072188|12777275|P1|NOT COMPLETED|Overall Study||0
5195841|NCT01072188|12777274|P2|COMPLETED|Overall Study||23
5195842|NCT01072188|12777275|P1|COMPLETED|Overall Study||22
5195843|NCT01072188|12777274|P2|STARTED|Overall Study||23
5195844|NCT01072188|12777275|P1|STARTED|Overall Study||22
5195845|NCT01072175|12777295|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
5195846|NCT01072175|12777296|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
5195847|NCT01072175|12777297|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
5195848|NCT01072175|12777298|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
5195849|NCT01072175|12777299|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
5195850|NCT01072175|12777300|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
5195851|NCT01072175|12777301|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
5195852|NCT01072175|12777302|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
5195853|NCT01072175|12777303|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
5195854|NCT01072175|12777304|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
5195855|NCT01072175|12777305|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
5195856|NCT01072175|12777306|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
5195857|NCT01072175|12777307|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
5195858|NCT01072175|12777295|P13|COMPLETED|Part D (HPMC Capsules)||0
5195859|NCT01072175|12777296|P12|COMPLETED|Part D (HPMC Capsules)||0
5195860|NCT01072175|12777297|P11|COMPLETED|Part D (HPMC Capsules)||0
5195861|NCT01072175|12777298|P10|COMPLETED|Part D (HPMC Capsules)||0
5195862|NCT01072175|12777299|P9|COMPLETED|Part D (HPMC Capsules)||0
5195863|NCT01072175|12777300|P8|COMPLETED|Part D (HPMC Capsules)||0
5195864|NCT01072175|12777301|P7|COMPLETED|Part D (HPMC Capsules)||0
5195865|NCT01072175|12777302|P6|COMPLETED|Part D (HPMC Capsules)||0
5195866|NCT01072175|12777303|P5|COMPLETED|Part D (HPMC Capsules)||0
5195867|NCT01072175|12777304|P4|COMPLETED|Part D (HPMC Capsules)||0
5195868|NCT01072175|12777305|P3|COMPLETED|Part D (HPMC Capsules)||0
5195869|NCT01072175|12777306|P2|COMPLETED|Part D (HPMC Capsules)||0
5195870|NCT01072175|12777307|P1|COMPLETED|Part D (HPMC Capsules)||0
5195871|NCT01072175|12777295|P13|STARTED|Part D (HPMC Capsules)||39
5195872|NCT01072175|12777296|P12|STARTED|Part D (HPMC Capsules)||43
5195873|NCT01072175|12777297|P11|STARTED|Part D (HPMC Capsules)||16
5195874|NCT01072175|12777298|P10|STARTED|Part D (HPMC Capsules)||12
5195875|NCT01072175|12777299|P9|STARTED|Part D (HPMC Capsules)||0
5195876|NCT01072175|12777300|P8|STARTED|Part D (HPMC Capsules)||0
5195877|NCT01072175|12777301|P7|STARTED|Part D (HPMC Capsules)||0
5195878|NCT01072175|12777302|P6|STARTED|Part D (HPMC Capsules)||0
5195879|NCT01072175|12777303|P5|STARTED|Part D (HPMC Capsules)||0
5195880|NCT01072175|12777304|P4|STARTED|Part D (HPMC Capsules)||0
5195881|NCT01072175|12777305|P3|STARTED|Part D (HPMC Capsules)||0
5195882|NCT01072175|12777306|P2|STARTED|Part D (HPMC Capsules)||0
5195883|NCT01072175|12777307|P1|STARTED|Part D (HPMC Capsules)||0
5195884|NCT01072175|12777295|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195885|NCT01072175|12777296|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195886|NCT01072175|12777297|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195887|NCT01072175|12777298|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195888|NCT01072175|12777299|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
5195889|NCT01072175|12777300|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195890|NCT01072175|12777301|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195891|NCT01072175|12777302|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195892|NCT01072175|12777303|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195893|NCT01072175|12777304|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195894|NCT01072175|12777305|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195895|NCT01072175|12777306|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195896|NCT01072175|12777307|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195897|NCT01072175|12777295|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195898|NCT01072175|12777296|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195899|NCT01072175|12777297|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195900|NCT01072175|12777298|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195901|NCT01072175|12777299|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195902|NCT01072175|12777300|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195903|NCT01072175|12777301|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195904|NCT01072175|12777302|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195905|NCT01072175|12777303|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195906|NCT01072175|12777304|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195907|NCT01072175|12777305|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195908|NCT01072175|12777306|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195909|NCT01072175|12777307|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
5195910|NCT01072175|12777295|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195911|NCT01072175|12777296|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195912|NCT01072175|12777297|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195913|NCT01072175|12777298|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195914|NCT01072175|12777299|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
5195915|NCT01072175|12777300|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195916|NCT01072175|12777301|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195917|NCT01072175|12777302|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195918|NCT01072175|12777303|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195919|NCT01072175|12777304|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195920|NCT01072175|12777305|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195921|NCT01072175|12777306|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195922|NCT01072175|12777307|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
5195923|NCT01072175|12777295|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195924|NCT01072175|12777296|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195925|NCT01072175|12777297|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195926|NCT01072175|12777298|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195927|NCT01072175|12777299|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195928|NCT01072175|12777300|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
5195929|NCT01072175|12777301|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
5195930|NCT01072175|12777302|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
5195931|NCT01072175|12777303|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195932|NCT01072175|12777304|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195933|NCT01072175|12777305|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195934|NCT01072175|12777306|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195935|NCT01072175|12777307|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
5195936|NCT01072175|12777295|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195937|NCT01072175|12777296|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195938|NCT01072175|12777297|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195939|NCT01072175|12777298|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195940|NCT01072175|12777299|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195941|NCT01072175|12777300|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195942|NCT01072175|12777301|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195943|NCT01072175|12777302|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195944|NCT01072175|12777303|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195945|NCT01072175|12777304|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195946|NCT01072175|12777305|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195947|NCT01072175|12777306|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195948|NCT01072175|12777307|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
5195949|NCT01072175|12777295|P13|STARTED|Part C (Phase II: Randomized Phase)||0
5195950|NCT01072175|12777296|P12|STARTED|Part C (Phase II: Randomized Phase)||0
5195951|NCT01072175|12777297|P11|STARTED|Part C (Phase II: Randomized Phase)||0
5195952|NCT01072175|12777298|P10|STARTED|Part C (Phase II: Randomized Phase)||0
5195953|NCT01072175|12777299|P9|STARTED|Part C (Phase II: Randomized Phase)||0
5195954|NCT01072175|12777300|P8|STARTED|Part C (Phase II: Randomized Phase)||54
5195955|NCT01072175|12777301|P7|STARTED|Part C (Phase II: Randomized Phase)||54
5195956|NCT01072175|12777302|P6|STARTED|Part C (Phase II: Randomized Phase)||54
5195957|NCT01072175|12777303|P5|STARTED|Part C (Phase II: Randomized Phase)||0
5195958|NCT01072175|12777304|P4|STARTED|Part C (Phase II: Randomized Phase)||0
5195959|NCT01072175|12777305|P3|STARTED|Part C (Phase II: Randomized Phase)||0
5195960|NCT01072175|12777306|P2|STARTED|Part C (Phase II: Randomized Phase)||0
5195961|NCT01072175|12777307|P1|STARTED|Part C (Phase II: Randomized Phase)||0
5195962|NCT01072175|12777295|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195963|NCT01072175|12777296|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195964|NCT01072175|12777297|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195965|NCT01072175|12777298|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195966|NCT01072175|12777299|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195967|NCT01072175|12777300|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195968|NCT01072175|12777301|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195969|NCT01072175|12777302|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195970|NCT01072175|12777303|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
5195971|NCT01072175|12777304|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
5195972|NCT01072175|12777305|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
5195973|NCT01072175|12777306|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
5195974|NCT01072175|12777307|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
5195975|NCT01072175|12777295|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195976|NCT01072175|12777296|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195977|NCT01072175|12777297|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195978|NCT01072175|12777298|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195979|NCT01072175|12777299|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195980|NCT01072175|12777300|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195981|NCT01072175|12777301|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195982|NCT01072175|12777302|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195983|NCT01072175|12777303|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195984|NCT01072175|12777304|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195985|NCT01072175|12777305|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195986|NCT01072175|12777306|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195987|NCT01072175|12777307|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
5195988|NCT01072175|12777295|P13|STARTED|Part B (Dose Escalation and Expansion)||0
5195989|NCT01072175|12777296|P12|STARTED|Part B (Dose Escalation and Expansion)||0
5195990|NCT01072175|12777297|P11|STARTED|Part B (Dose Escalation and Expansion)||0
5195991|NCT01072175|12777298|P10|STARTED|Part B (Dose Escalation and Expansion)||0
5195992|NCT01072175|12777299|P9|STARTED|Part B (Dose Escalation and Expansion)||0
5195993|NCT01072175|12777300|P8|STARTED|Part B (Dose Escalation and Expansion)||0
5195994|NCT01072175|12777301|P7|STARTED|Part B (Dose Escalation and Expansion)||0
5195995|NCT01072175|12777302|P6|STARTED|Part B (Dose Escalation and Expansion)||0
5195996|NCT01072175|12777303|P5|STARTED|Part B (Dose Escalation and Expansion)||94
5195997|NCT01072175|12777304|P4|STARTED|Part B (Dose Escalation and Expansion)||27
5195998|NCT01072175|12777305|P3|STARTED|Part B (Dose Escalation and Expansion)||23
5195999|NCT01072175|12777306|P2|STARTED|Part B (Dose Escalation and Expansion)||6
5196000|NCT01072175|12777307|P1|STARTED|Part B (Dose Escalation and Expansion)||0
5196001|NCT01072175|12777295|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196002|NCT01072175|12777296|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196003|NCT01072175|12777297|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196004|NCT01072175|12777298|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196005|NCT01072175|12777299|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196006|NCT01072175|12777300|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196007|NCT01072175|12777301|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196008|NCT01072175|12777302|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196009|NCT01072175|12777303|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196010|NCT01072175|12777304|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196011|NCT01072175|12777305|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196012|NCT01072175|12777306|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
5196013|NCT01072175|12777307|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
5196014|NCT01072175|12777295|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
5196015|NCT01072175|12777296|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
5196016|NCT01072175|12777297|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
5196017|NCT01072175|12777298|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
5196018|NCT01072175|12777299|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
5196019|NCT01072175|12777300|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
5196020|NCT01072175|12777301|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
5196021|NCT01072175|12777302|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
5196022|NCT01072175|12777303|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
5196023|NCT01072175|12777304|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
5196024|NCT01072175|12777305|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
5196025|NCT01072175|12777306|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
5196026|NCT01072175|12777307|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
5196027|NCT01072175|12777295|P13|STARTED|Part A (Drug-Drug Interaction)||0
5196028|NCT01072175|12777296|P12|STARTED|Part A (Drug-Drug Interaction)||0
5196029|NCT01072175|12777297|P11|STARTED|Part A (Drug-Drug Interaction)||0
5196030|NCT01072175|12777298|P10|STARTED|Part A (Drug-Drug Interaction)||0
5196031|NCT01072175|12777299|P9|STARTED|Part A (Drug-Drug Interaction)||0
5196032|NCT01072175|12777300|P8|STARTED|Part A (Drug-Drug Interaction)||0
5196033|NCT01072175|12777301|P7|STARTED|Part A (Drug-Drug Interaction)||0
5196034|NCT01072175|12777302|P6|STARTED|Part A (Drug-Drug Interaction)||0
5196035|NCT01072175|12777303|P5|STARTED|Part A (Drug-Drug Interaction)||0
5196036|NCT01072175|12777304|P4|STARTED|Part A (Drug-Drug Interaction)||0
5196037|NCT01072175|12777305|P3|STARTED|Part A (Drug-Drug Interaction)||0
5196038|NCT01072175|12777306|P2|STARTED|Part A (Drug-Drug Interaction)||0
5196039|NCT01072175|12777307|P1|STARTED|Part A (Drug-Drug Interaction)||8
5196040|NCT01072149|12777516|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196041|NCT01072149|12777517|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196042|NCT01072149|12777518|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196043|NCT01072149|12777519|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196044|NCT01072149|12777520|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5196045|NCT01072149|12777521|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196046|NCT01072149|12777522|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196047|NCT01072149|12777523|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196048|NCT01072149|12777524|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196049|NCT01072149|12777525|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196050|NCT01072149|12777526|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196051|NCT01072149|12777527|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196052|NCT01072149|12777528|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196053|NCT01072149|12777529|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196054|NCT01072149|12777530|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196055|NCT01072149|12777531|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5196056|NCT01072149|12777532|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196057|NCT01072149|12777533|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5196058|NCT01072149|12777516|P18|COMPLETED|Treatment Period 3 (28 Days)||2
5196059|NCT01072149|12777517|P17|COMPLETED|Treatment Period 3 (28 Days)||3
5196060|NCT01072149|12777518|P16|COMPLETED|Treatment Period 3 (28 Days)||1
5196061|NCT01072149|12777519|P15|COMPLETED|Treatment Period 3 (28 Days)||3
5196062|NCT01072149|12777520|P14|COMPLETED|Treatment Period 3 (28 Days)||2
5196063|NCT01072149|12777521|P13|COMPLETED|Treatment Period 3 (28 Days)||2
5196064|NCT01072149|12777522|P12|COMPLETED|Treatment Period 3 (28 Days)||3
5196065|NCT01072149|12777523|P11|COMPLETED|Treatment Period 3 (28 Days)||2
5196066|NCT01072149|12777524|P10|COMPLETED|Treatment Period 3 (28 Days)||3
5196067|NCT01072149|12777525|P9|COMPLETED|Treatment Period 3 (28 Days)||3
5196068|NCT01072149|12777526|P8|COMPLETED|Treatment Period 3 (28 Days)||2
5196069|NCT01072149|12777527|P7|COMPLETED|Treatment Period 3 (28 Days)||3
5196070|NCT01072149|12777528|P6|COMPLETED|Treatment Period 3 (28 Days)||3
5196071|NCT01072149|12777529|P5|COMPLETED|Treatment Period 3 (28 Days)||3
5196072|NCT01072149|12777530|P4|COMPLETED|Treatment Period 3 (28 Days)||3
5196073|NCT01072149|12777531|P3|COMPLETED|Treatment Period 3 (28 Days)||0
5196074|NCT01072149|12777532|P2|COMPLETED|Treatment Period 3 (28 Days)||2
5196075|NCT01072149|12777533|P1|COMPLETED|Treatment Period 3 (28 Days)||2
5196076|NCT01072149|12777516|P18|STARTED|Treatment Period 3 (28 Days)||2
5196077|NCT01072149|12777517|P17|STARTED|Treatment Period 3 (28 Days)||3
5196078|NCT01072149|12777518|P16|STARTED|Treatment Period 3 (28 Days)||1
5196079|NCT01072149|12777519|P15|STARTED|Treatment Period 3 (28 Days)||3
5196080|NCT01072149|12777520|P14|STARTED|Treatment Period 3 (28 Days)||3
5196081|NCT01072149|12777521|P13|STARTED|Treatment Period 3 (28 Days)||2
5196082|NCT01072149|12777522|P12|STARTED|Treatment Period 3 (28 Days)||3
5196083|NCT01072149|12777523|P11|STARTED|Treatment Period 3 (28 Days)||2
5196084|NCT01072149|12777524|P10|STARTED|Treatment Period 3 (28 Days)||3
5196085|NCT01072149|12777525|P9|STARTED|Treatment Period 3 (28 Days)||3
5196086|NCT01072149|12777526|P8|STARTED|Treatment Period 3 (28 Days)||2
5196087|NCT01072149|12777527|P7|STARTED|Treatment Period 3 (28 Days)||3
5196088|NCT01072149|12777528|P6|STARTED|Treatment Period 3 (28 Days)||3
5196089|NCT01072149|12777529|P5|STARTED|Treatment Period 3 (28 Days)||3
5196090|NCT01072149|12777530|P4|STARTED|Treatment Period 3 (28 Days)||3
5196091|NCT01072149|12777531|P3|STARTED|Treatment Period 3 (28 Days)||1
5196092|NCT01072149|12777532|P2|STARTED|Treatment Period 3 (28 Days)||2
5196093|NCT01072149|12777533|P1|STARTED|Treatment Period 3 (28 Days)||2
5196094|NCT01072149|12777516|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196095|NCT01072149|12777517|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196096|NCT01072149|12777518|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
5196097|NCT01072149|12777519|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196098|NCT01072149|12777520|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196099|NCT01072149|12777521|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
5196100|NCT01072149|12777522|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196101|NCT01072149|12777523|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196102|NCT01072149|12777524|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196103|NCT01072149|12777525|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196104|NCT01072149|12777526|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196105|NCT01072149|12777527|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196106|NCT01072149|12777528|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196107|NCT01072149|12777529|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196108|NCT01072149|12777530|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196109|NCT01072149|12777531|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196110|NCT01072149|12777532|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
5196111|NCT01072149|12777533|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
5196112|NCT01072149|12777516|P18|COMPLETED|Washout Period 2 (14 Days)||2
5196113|NCT01072149|12777517|P17|COMPLETED|Washout Period 2 (14 Days)||3
5196114|NCT01072149|12777518|P16|COMPLETED|Washout Period 2 (14 Days)||1
5196115|NCT01072149|12777519|P15|COMPLETED|Washout Period 2 (14 Days)||3
5196116|NCT01072149|12777520|P14|COMPLETED|Washout Period 2 (14 Days)||3
5196117|NCT01072149|12777521|P13|COMPLETED|Washout Period 2 (14 Days)||2
5196118|NCT01072149|12777522|P12|COMPLETED|Washout Period 2 (14 Days)||3
5196119|NCT01072149|12777523|P11|COMPLETED|Washout Period 2 (14 Days)||2
5196120|NCT01072149|12777524|P10|COMPLETED|Washout Period 2 (14 Days)||3
5196121|NCT01072149|12777525|P9|COMPLETED|Washout Period 2 (14 Days)||3
5196122|NCT01072149|12777526|P8|COMPLETED|Washout Period 2 (14 Days)||2
5196123|NCT01072149|12777527|P7|COMPLETED|Washout Period 2 (14 Days)||3
5196124|NCT01072149|12777528|P6|COMPLETED|Washout Period 2 (14 Days)||3
5196125|NCT01072149|12777529|P5|COMPLETED|Washout Period 2 (14 Days)||3
5196126|NCT01072149|12777530|P4|COMPLETED|Washout Period 2 (14 Days)||3
5196127|NCT01072149|12777531|P3|COMPLETED|Washout Period 2 (14 Days)||1
5196128|NCT01072149|12777532|P2|COMPLETED|Washout Period 2 (14 Days)||2
5196129|NCT01072149|12777533|P1|COMPLETED|Washout Period 2 (14 Days)||2
5196130|NCT01072149|12777516|P18|STARTED|Washout Period 2 (14 Days)||2
5196131|NCT01072149|12777517|P17|STARTED|Washout Period 2 (14 Days)||3
5196132|NCT01072149|12777518|P16|STARTED|Washout Period 2 (14 Days)||3
5196133|NCT01072149|12777519|P15|STARTED|Washout Period 2 (14 Days)||3
5196134|NCT01072149|12777520|P14|STARTED|Washout Period 2 (14 Days)||3
5196135|NCT01072149|12777521|P13|STARTED|Washout Period 2 (14 Days)||3
5196136|NCT01072149|12777522|P12|STARTED|Washout Period 2 (14 Days)||3
5196137|NCT01072149|12777523|P11|STARTED|Washout Period 2 (14 Days)||2
5196138|NCT01072149|12777524|P10|STARTED|Washout Period 2 (14 Days)||3
5196139|NCT01072149|12777525|P9|STARTED|Washout Period 2 (14 Days)||3
5196140|NCT01072149|12777526|P8|STARTED|Washout Period 2 (14 Days)||2
5196141|NCT01072149|12777527|P7|STARTED|Washout Period 2 (14 Days)||3
5196142|NCT01072149|12777528|P6|STARTED|Washout Period 2 (14 Days)||3
5196143|NCT01072149|12777529|P5|STARTED|Washout Period 2 (14 Days)||3
5196144|NCT01072149|12777530|P4|STARTED|Washout Period 2 (14 Days)||3
5196145|NCT01072149|12777531|P3|STARTED|Washout Period 2 (14 Days)||1
5196146|NCT01072149|12777532|P2|STARTED|Washout Period 2 (14 Days)||2
5196147|NCT01072149|12777533|P1|STARTED|Washout Period 2 (14 Days)||3
5196148|NCT01072149|12777516|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196149|NCT01072149|12777517|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196150|NCT01072149|12777518|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196151|NCT01072149|12777519|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196152|NCT01072149|12777520|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196153|NCT01072149|12777521|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196154|NCT01072149|12777522|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196155|NCT01072149|12777523|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196156|NCT01072149|12777524|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196157|NCT01072149|12777525|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196158|NCT01072149|12777526|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
5196159|NCT01072149|12777527|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196160|NCT01072149|12777528|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196161|NCT01072149|12777529|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196162|NCT01072149|12777530|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196163|NCT01072149|12777531|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
5196164|NCT01072149|12777532|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
5196165|NCT01072149|12777533|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5196166|NCT01072149|12777516|P18|COMPLETED|Treatment Period 2 (28 Days)||2
5196167|NCT01072149|12777517|P17|COMPLETED|Treatment Period 2 (28 Days)||3
5196168|NCT01072149|12777518|P16|COMPLETED|Treatment Period 2 (28 Days)||3
5196169|NCT01072149|12777519|P15|COMPLETED|Treatment Period 2 (28 Days)||3
5196170|NCT01072149|12777520|P14|COMPLETED|Treatment Period 2 (28 Days)||3
5196171|NCT01072149|12777521|P13|COMPLETED|Treatment Period 2 (28 Days)||3
5196172|NCT01072149|12777522|P12|COMPLETED|Treatment Period 2 (28 Days)||3
5196173|NCT01072149|12777523|P11|COMPLETED|Treatment Period 2 (28 Days)||2
5196174|NCT01072149|12777524|P10|COMPLETED|Treatment Period 2 (28 Days)||3
5196175|NCT01072149|12777525|P9|COMPLETED|Treatment Period 2 (28 Days)||3
5196176|NCT01072149|12777526|P8|COMPLETED|Treatment Period 2 (28 Days)||2
5196177|NCT01072149|12777527|P7|COMPLETED|Treatment Period 2 (28 Days)||3
5196178|NCT01072149|12777528|P6|COMPLETED|Treatment Period 2 (28 Days)||3
5196179|NCT01072149|12777529|P5|COMPLETED|Treatment Period 2 (28 Days)||3
5196180|NCT01072149|12777530|P4|COMPLETED|Treatment Period 2 (28 Days)||3
5196181|NCT01072149|12777531|P3|COMPLETED|Treatment Period 2 (28 Days)||1
5196182|NCT01072149|12777532|P2|COMPLETED|Treatment Period 2 (28 Days)||2
5196183|NCT01072149|12777533|P1|COMPLETED|Treatment Period 2 (28 Days)||3
5196184|NCT01072149|12777516|P18|STARTED|Treatment Period 2 (28 Days)||2
5196185|NCT01072149|12777517|P17|STARTED|Treatment Period 2 (28 Days)||3
5196186|NCT01072149|12777518|P16|STARTED|Treatment Period 2 (28 Days)||3
5196187|NCT01072149|12777519|P15|STARTED|Treatment Period 2 (28 Days)||3
5196188|NCT01072149|12777520|P14|STARTED|Treatment Period 2 (28 Days)||3
5196189|NCT01072149|12777521|P13|STARTED|Treatment Period 2 (28 Days)||3
5196190|NCT01072149|12777522|P12|STARTED|Treatment Period 2 (28 Days)||3
5196191|NCT01072149|12777523|P11|STARTED|Treatment Period 2 (28 Days)||2
5196192|NCT01072149|12777524|P10|STARTED|Treatment Period 2 (28 Days)||3
5196193|NCT01072149|12777525|P9|STARTED|Treatment Period 2 (28 Days)||3
5196194|NCT01072149|12777526|P8|STARTED|Treatment Period 2 (28 Days)||3
5196195|NCT01072149|12777527|P7|STARTED|Treatment Period 2 (28 Days)||3
5196196|NCT01072149|12777528|P6|STARTED|Treatment Period 2 (28 Days)||3
5196197|NCT01072149|12777529|P5|STARTED|Treatment Period 2 (28 Days)||3
5196198|NCT01072149|12777530|P4|STARTED|Treatment Period 2 (28 Days)||3
5196199|NCT01072149|12777531|P3|STARTED|Treatment Period 2 (28 Days)||2
5196200|NCT01072149|12777532|P2|STARTED|Treatment Period 2 (28 Days)||3
5196201|NCT01072149|12777533|P1|STARTED|Treatment Period 2 (28 Days)||3
5196202|NCT01072149|12777516|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196203|NCT01072149|12777517|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196204|NCT01072149|12777518|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196205|NCT01072149|12777519|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196206|NCT01072149|12777520|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196207|NCT01072149|12777521|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196208|NCT01072149|12777522|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196209|NCT01072149|12777523|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196210|NCT01072149|12777524|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196211|NCT01072149|12777525|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196212|NCT01072149|12777526|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196213|NCT01072149|12777527|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196214|NCT01072149|12777528|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196215|NCT01072149|12777529|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196216|NCT01072149|12777530|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196217|NCT01072149|12777531|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196218|NCT01072149|12777532|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196219|NCT01072149|12777533|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
5196220|NCT01072149|12777516|P18|COMPLETED|Washout Period 1 (14 Days)||2
5196221|NCT01072149|12777517|P17|COMPLETED|Washout Period 1 (14 Days)||3
5196222|NCT01072149|12777518|P16|COMPLETED|Washout Period 1 (14 Days)||3
5196223|NCT01072149|12777519|P15|COMPLETED|Washout Period 1 (14 Days)||3
5196224|NCT01072149|12777520|P14|COMPLETED|Washout Period 1 (14 Days)||3
5196225|NCT01072149|12777521|P13|COMPLETED|Washout Period 1 (14 Days)||3
5196226|NCT01072149|12777522|P12|COMPLETED|Washout Period 1 (14 Days)||3
5196227|NCT01072149|12777523|P11|COMPLETED|Washout Period 1 (14 Days)||2
5196228|NCT01072149|12777524|P10|COMPLETED|Washout Period 1 (14 Days)||3
5196229|NCT01072149|12777525|P9|COMPLETED|Washout Period 1 (14 Days)||3
5196230|NCT01072149|12777526|P8|COMPLETED|Washout Period 1 (14 Days)||3
5196231|NCT01072149|12777527|P7|COMPLETED|Washout Period 1 (14 Days)||3
5196232|NCT01072149|12777528|P6|COMPLETED|Washout Period 1 (14 Days)||3
5196233|NCT01072149|12777529|P5|COMPLETED|Washout Period 1 (14 Days)||3
5196234|NCT01072149|12777530|P4|COMPLETED|Washout Period 1 (14 Days)||3
5196235|NCT01072149|12777531|P3|COMPLETED|Washout Period 1 (14 Days)||2
5196236|NCT01072149|12777532|P2|COMPLETED|Washout Period 1 (14 Days)||3
5196237|NCT01072149|12777533|P1|COMPLETED|Washout Period 1 (14 Days)||3
5196238|NCT01072149|12777516|P18|STARTED|Washout Period 1 (14 Days)||2
5196239|NCT01072149|12777517|P17|STARTED|Washout Period 1 (14 Days)||3
5196240|NCT01072149|12777518|P16|STARTED|Washout Period 1 (14 Days)||3
5196241|NCT01072149|12777519|P15|STARTED|Washout Period 1 (14 Days)||3
5196242|NCT01072149|12777520|P14|STARTED|Washout Period 1 (14 Days)||3
5196243|NCT01072149|12777521|P13|STARTED|Washout Period 1 (14 Days)||3
5196244|NCT01072149|12777522|P12|STARTED|Washout Period 1 (14 Days)||3
5196245|NCT01072149|12777523|P11|STARTED|Washout Period 1 (14 Days)||2
5196246|NCT01072149|12777524|P10|STARTED|Washout Period 1 (14 Days)||3
5196247|NCT01072149|12777525|P9|STARTED|Washout Period 1 (14 Days)||3
5196248|NCT01072149|12777526|P8|STARTED|Washout Period 1 (14 Days)||3
5196249|NCT01072149|12777527|P7|STARTED|Washout Period 1 (14 Days)||3
5196250|NCT01072149|12777528|P6|STARTED|Washout Period 1 (14 Days)||3
5196251|NCT01072149|12777529|P5|STARTED|Washout Period 1 (14 Days)||3
5196252|NCT01072149|12777530|P4|STARTED|Washout Period 1 (14 Days)||3
5196253|NCT01072149|12777531|P3|STARTED|Washout Period 1 (14 Days)||2
5196254|NCT01072149|12777532|P2|STARTED|Washout Period 1 (14 Days)||3
5196255|NCT01072149|12777533|P1|STARTED|Washout Period 1 (14 Days)||3
5196256|NCT01072149|12777516|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5196257|NCT01072149|12777517|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196258|NCT01072149|12777518|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196259|NCT01072149|12777519|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196260|NCT01072149|12777520|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196261|NCT01072149|12777521|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196262|NCT01072149|12777522|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196263|NCT01072149|12777523|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5196264|NCT01072149|12777524|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196265|NCT01072149|12777525|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196266|NCT01072149|12777526|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196267|NCT01072149|12777527|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196268|NCT01072149|12777528|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196269|NCT01072149|12777529|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196270|NCT01072149|12777530|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196271|NCT01072149|12777531|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5196272|NCT01072149|12777532|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196273|NCT01072149|12777533|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5196274|NCT01072149|12777516|P18|COMPLETED|Treatment Period 1 (28 Days)||2
5196275|NCT01072149|12777517|P17|COMPLETED|Treatment Period 1 (28 Days)||3
5196276|NCT01072149|12777518|P16|COMPLETED|Treatment Period 1 (28 Days)||3
5196277|NCT01072149|12777519|P15|COMPLETED|Treatment Period 1 (28 Days)||3
5196278|NCT01072149|12777520|P14|COMPLETED|Treatment Period 1 (28 Days)||3
5196279|NCT01072149|12777521|P13|COMPLETED|Treatment Period 1 (28 Days)||3
5196280|NCT01072149|12777522|P12|COMPLETED|Treatment Period 1 (28 Days)||3
5196281|NCT01072149|12777523|P11|COMPLETED|Treatment Period 1 (28 Days)||2
5196282|NCT01072149|12777524|P10|COMPLETED|Treatment Period 1 (28 Days)||3
5196283|NCT01072149|12777525|P9|COMPLETED|Treatment Period 1 (28 Days)||3
5196284|NCT01072149|12777526|P8|COMPLETED|Treatment Period 1 (28 Days)||3
5196285|NCT01072149|12777527|P7|COMPLETED|Treatment Period 1 (28 Days)||3
5196286|NCT01072149|12777528|P6|COMPLETED|Treatment Period 1 (28 Days)||3
5196287|NCT01072149|12777529|P5|COMPLETED|Treatment Period 1 (28 Days)||3
5196288|NCT01072149|12777530|P4|COMPLETED|Treatment Period 1 (28 Days)||3
5196289|NCT01072149|12777531|P3|COMPLETED|Treatment Period 1 (28 Days)||2
5196290|NCT01072149|12777532|P2|COMPLETED|Treatment Period 1 (28 Days)||3
5196291|NCT01072149|12777533|P1|COMPLETED|Treatment Period 1 (28 Days)||3
5196292|NCT01072149|12777516|P18|STARTED|Treatment Period 1 (28 Days)||3
5196293|NCT01072149|12777517|P17|STARTED|Treatment Period 1 (28 Days)||3
5196294|NCT01072149|12777518|P16|STARTED|Treatment Period 1 (28 Days)||3
5196295|NCT01072149|12777519|P15|STARTED|Treatment Period 1 (28 Days)||3
5196296|NCT01072149|12777520|P14|STARTED|Treatment Period 1 (28 Days)||3
5196297|NCT01072149|12777521|P13|STARTED|Treatment Period 1 (28 Days)||3
5196298|NCT01072149|12777522|P12|STARTED|Treatment Period 1 (28 Days)||3
5196299|NCT01072149|12777523|P11|STARTED|Treatment Period 1 (28 Days)||3
5196300|NCT01072149|12777524|P10|STARTED|Treatment Period 1 (28 Days)||3
5196301|NCT01072149|12777525|P9|STARTED|Treatment Period 1 (28 Days)||3
5196302|NCT01072149|12777526|P8|STARTED|Treatment Period 1 (28 Days)||3
5196303|NCT01072149|12777527|P7|STARTED|Treatment Period 1 (28 Days)||3
5196304|NCT01072149|12777528|P6|STARTED|Treatment Period 1 (28 Days)||3
5196305|NCT01072149|12777529|P5|STARTED|Treatment Period 1 (28 Days)||3
5196306|NCT01072149|12777530|P4|STARTED|Treatment Period 1 (28 Days)||3
5196307|NCT01072149|12777531|P3|STARTED|Treatment Period 1 (28 Days)||3
5196308|NCT01072149|12777532|P2|STARTED|Treatment Period 1 (28 Days)||3
5196309|NCT01072149|12777533|P1|STARTED|Treatment Period 1 (28 Days)||3
5196310|NCT01072136|12777553|P2|NOT COMPLETED|Overall Study||31
5196311|NCT01072136|12777554|P1|NOT COMPLETED|Overall Study||23
5196312|NCT01072136|12777553|P2|COMPLETED|Overall Study||12
5196313|NCT01072136|12777554|P1|COMPLETED|Overall Study||21
5196314|NCT01072136|12777553|P2|Met All Enrollment Criteria|Overall Study||25
5196315|NCT01072136|12777554|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
5196316|NCT01072136|12777553|P2|STARTED|Overall Study||43
5196317|NCT01072136|12777554|P1|STARTED|Overall Study||44
5196318|NCT01072032|12777578|P2|NOT COMPLETED|Overall Study||9
5196319|NCT01072032|12777579|P1|NOT COMPLETED|Overall Study||8
5196320|NCT01072032|12777578|P2|COMPLETED|Overall Study||5
5196321|NCT01072032|12777579|P1|COMPLETED|Overall Study||5
5196322|NCT01072032|12777578|P2|STARTED|Overall Study||14
5196323|NCT01072032|12777579|P1|STARTED|Overall Study||13
5196324|NCT01072006|12777593|P4|NOT COMPLETED|Overall Study||0
5196325|NCT01072006|12777594|P3|NOT COMPLETED|Overall Study||0
5196326|NCT01072006|12777595|P2|NOT COMPLETED|Overall Study||0
5196327|NCT01072006|12777596|P1|NOT COMPLETED|Overall Study||0
5196328|NCT01072006|12777593|P4|COMPLETED|Overall Study||11
5196329|NCT01072006|12777594|P3|COMPLETED|Overall Study||0
5196330|NCT01072006|12777595|P2|COMPLETED|Overall Study||5
5196331|NCT01072006|12777596|P1|COMPLETED|Overall Study||14
5196332|NCT01072006|12777593|P4|STARTED|Overall Study||11
5196333|NCT01072006|12777594|P3|STARTED|Overall Study||0
5196334|NCT01072006|12777595|P2|STARTED|Overall Study||5
5196335|NCT01072006|12777596|P1|STARTED|Overall Study||14
5196336|NCT01071993|12777615|P2|NOT COMPLETED|Overall Study||0
5196337|NCT01071993|12777616|P1|NOT COMPLETED|Overall Study||0
5196338|NCT01071993|12777615|P2|COMPLETED|Overall Study||0
5196339|NCT01071993|12777616|P1|COMPLETED|Overall Study||0
5196340|NCT01071993|12777615|P2|STARTED|Overall Study||0
5196341|NCT01071993|12777616|P1|STARTED|Overall Study||0
5196342|NCT01071954|12777622|P1|NOT COMPLETED|Overall Study||27
5196343|NCT01071954|12777622|P1|COMPLETED|Overall Study||39
5196344|NCT01071954|12777622|P1|Received Treatment|Overall Study||65
5196345|NCT01071954|12777622|P1|STARTED|Overall Study||66
5196346|NCT01071915|12777631|P1|NOT COMPLETED|Overall Study||9
5196347|NCT01071915|12777631|P1|COMPLETED|Overall Study||148
5196348|NCT01071915|12777631|P1|Safety Analysis Set|Overall Study||156
5196349|NCT01071915|12777631|P1|Full Analysis Set (FAS)|Overall Study||155
5196350|NCT01071915|12777631|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
5196351|NCT01071798|12777641|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
5196352|NCT01071798|12777641|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
5196353|NCT01071798|12777641|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
5196354|NCT01071798|12777641|P1|STARTED|Subpopulation Who Received Two Cycles||820
5196355|NCT01071798|12777641|P1|NOT COMPLETED|Participants Who Received One Cycle||65
5196356|NCT01071798|12777641|P1|COMPLETED|Participants Who Received One Cycle||1588
5196357|NCT01071798|12777641|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
5196358|NCT01071798|12777641|P1|STARTED|Participants Who Received One Cycle||1653
5196359|NCT01071538|12777661|P1|NOT COMPLETED|Overall Study||2
5196360|NCT01071538|12777661|P1|COMPLETED|Overall Study||13
5196361|NCT01071538|12777661|P1|STARTED|Overall Study||15
5196362|NCT01071512|12777671|P1|NOT COMPLETED|Overall Study||5
5196363|NCT01071512|12777671|P1|COMPLETED|Overall Study||15
5196364|NCT01071512|12777671|P1|STARTED|Overall Study||20
5196365|NCT01071395|12777681|P2|NOT COMPLETED|Overall Study||2
5196366|NCT01071395|12777682|P1|NOT COMPLETED|Overall Study||5
5196367|NCT01071395|12777681|P2|COMPLETED|Overall Study||30
5196368|NCT01071395|12777682|P1|COMPLETED|Overall Study||31
5196369|NCT01071395|12777681|P2|STARTED|Overall Study||32
5196370|NCT01071395|12777682|P1|STARTED|Overall Study||36
5196371|NCT01071356|12777690|P2|NOT COMPLETED|Overall Study||9
5196372|NCT01071356|12777691|P1|NOT COMPLETED|Overall Study||7
5196373|NCT01071356|12777690|P2|COMPLETED|Overall Study||97
5196374|NCT01071356|12777691|P1|COMPLETED|Overall Study||104
5196375|NCT01071356|12777690|P2|STARTED|Overall Study||106
5196376|NCT01071356|12777691|P1|STARTED|Overall Study||111
5196377|NCT01071317|12777701|P2|NOT COMPLETED|Overall Study||2
5196378|NCT01071317|12777702|P1|NOT COMPLETED|Overall Study||2
5196379|NCT01071317|12777701|P2|COMPLETED|Overall Study||23
5196380|NCT01071317|12777702|P1|COMPLETED|Overall Study||23
5196381|NCT01071317|12777701|P2|STARTED|Overall Study||25
5196382|NCT01071317|12777702|P1|STARTED|Overall Study||25
5196383|NCT01071278|12777714|P1|NOT COMPLETED|Overall Study||713
5196384|NCT01071278|12777714|P1|COMPLETED|Overall Study||1677
5196385|NCT01071278|12777714|P1|STARTED|Overall Study||2390
5196386|NCT01071252|12777725|P5|NOT COMPLETED|Overall Study||11
5196387|NCT01071252|12777726|P4|NOT COMPLETED|Overall Study||7
5196388|NCT01071252|12777727|P3|NOT COMPLETED|Overall Study||4
5196389|NCT01071252|12777728|P2|NOT COMPLETED|Overall Study||10
5196390|NCT01071252|12777729|P1|NOT COMPLETED|Overall Study||15
5196391|NCT01071252|12777725|P5|COMPLETED|Overall Study||11
5196392|NCT01071252|12777726|P4|COMPLETED|Overall Study||20
5196393|NCT01071252|12777727|P3|COMPLETED|Overall Study||17
5196394|NCT01071252|12777728|P2|COMPLETED|Overall Study||16
5196395|NCT01071252|12777729|P1|COMPLETED|Overall Study||14
5196396|NCT01071252|12777725|P5|STARTED|Overall Study||22
5196397|NCT01071252|12777726|P4|STARTED|Overall Study||27
5196398|NCT01071252|12777727|P3|STARTED|Overall Study||21
5196399|NCT01071252|12777728|P2|STARTED|Overall Study||26
5196400|NCT01071252|12777729|P1|STARTED|Overall Study||29
5196401|NCT01071200|12777757|P2|NOT COMPLETED|Overall Study||3
5196402|NCT01071200|12777758|P1|NOT COMPLETED|Overall Study||7
5196403|NCT01071200|12777757|P2|COMPLETED|Overall Study||63
5196404|NCT01071200|12777758|P1|COMPLETED|Overall Study||60
5196405|NCT01071200|12777757|P2|STARTED|Overall Study||66
5196406|NCT01071200|12777758|P1|STARTED|Overall Study||67
5196407|NCT01071096|12777790|P2|NOT COMPLETED|Second Intervention (90 Days)||0
5196408|NCT01071096|12777791|P1|NOT COMPLETED|Second Intervention (90 Days)||0
5196409|NCT01071096|12777790|P2|COMPLETED|Second Intervention (90 Days)||10
5196410|NCT01071096|12777791|P1|COMPLETED|Second Intervention (90 Days)||9
5196411|NCT01071096|12777790|P2|STARTED|Second Intervention (90 Days)||10
5196412|NCT01071096|12777791|P1|STARTED|Second Intervention (90 Days)||9
5196413|NCT01071096|12777790|P2|NOT COMPLETED|Washout Period (30 Days)||0
5196414|NCT01071096|12777791|P1|NOT COMPLETED|Washout Period (30 Days)||0
5196415|NCT01071096|12777790|P2|COMPLETED|Washout Period (30 Days)||10
5196416|NCT01071096|12777791|P1|COMPLETED|Washout Period (30 Days)||9
5196417|NCT01071096|12777790|P2|STARTED|Washout Period (30 Days)||10
5196418|NCT01071096|12777791|P1|STARTED|Washout Period (30 Days)||9
5196419|NCT01071096|12777790|P2|NOT COMPLETED|First Intervention (90 Days)||0
5196420|NCT01071096|12777791|P1|NOT COMPLETED|First Intervention (90 Days)||1
5196421|NCT01071096|12777790|P2|COMPLETED|First Intervention (90 Days)||10
5196422|NCT01071096|12777791|P1|COMPLETED|First Intervention (90 Days)||9
5196423|NCT01071096|12777790|P2|STARTED|First Intervention (90 Days)||10
5196424|NCT01071096|12777791|P1|STARTED|First Intervention (90 Days)||10
5196425|NCT01071083|12777815|P5|NOT COMPLETED|Overall Study||8
5196426|NCT01071083|12777816|P4|NOT COMPLETED|Overall Study||2
5196427|NCT01071083|12777817|P3|NOT COMPLETED|Overall Study||5
5196428|NCT01071083|12777818|P2|NOT COMPLETED|Overall Study||2
5196429|NCT01071083|12777819|P1|NOT COMPLETED|Overall Study||7
5196430|NCT01071083|12777815|P5|COMPLETED|Overall Study||46
5196431|NCT01071083|12777816|P4|COMPLETED|Overall Study||15
5196432|NCT01071083|12777817|P3|COMPLETED|Overall Study||12
5196433|NCT01071083|12777818|P2|COMPLETED|Overall Study||43
5196434|NCT01071083|12777819|P1|COMPLETED|Overall Study||35
5196435|NCT01071083|12777815|P5|STARTED|Overall Study||54
5196436|NCT01071083|12777816|P4|STARTED|Overall Study||17
5196437|NCT01071083|12777817|P3|STARTED|Overall Study||17
5196438|NCT01071083|12777818|P2|STARTED|Overall Study||45
5196439|NCT01071083|12777819|P1|STARTED|Overall Study||42
5196440|NCT01071070|12777838|P2|NOT COMPLETED|Overall Study||3
5196441|NCT01071070|12777839|P1|NOT COMPLETED|Overall Study||4
5196442|NCT01071070|12777838|P2|COMPLETED|Overall Study||105
5196443|NCT01071070|12777839|P1|COMPLETED|Overall Study||104
5196444|NCT01071070|12777838|P2|STARTED|Overall Study||108
5196445|NCT01071070|12777839|P1|STARTED|Overall Study||108
5196446|NCT01071044|12777863|P2|NOT COMPLETED|Overall Study||0
5196447|NCT01071044|12777864|P1|NOT COMPLETED|Overall Study||2
5196448|NCT01071044|12777863|P2|COMPLETED|Overall Study||11
5196449|NCT01071044|12777864|P1|COMPLETED|Overall Study||13
5196450|NCT01071044|12777863|P2|STARTED|Overall Study||11
5196451|NCT01071044|12777864|P1|STARTED|Overall Study||15
5196452|NCT01070979|12777885|P3|NOT COMPLETED|Overall Study||13
5196453|NCT01070979|12777886|P2|NOT COMPLETED|Overall Study||12
5196454|NCT01070979|12777887|P1|NOT COMPLETED|Overall Study||11
5196455|NCT01070979|12777885|P3|COMPLETED|Overall Study||72
5196456|NCT01070979|12777886|P2|COMPLETED|Overall Study||73
5196457|NCT01070979|12777887|P1|COMPLETED|Overall Study||68
5196458|NCT01070979|12777885|P3|STARTED|Overall Study||85
5196459|NCT01070979|12777886|P2|STARTED|Overall Study||85
5196460|NCT01070979|12777887|P1|STARTED|Overall Study||79
5196461|NCT01070966|12777913|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
5196462|NCT01070966|12777913|P1|COMPLETED|Participants for Efficacy Evaluation||1929
5196463|NCT01070966|12777913|P1|STARTED|Participants for Efficacy Evaluation||2011
5196464|NCT01070966|12777913|P1|NOT COMPLETED|Participants for Safety Evaluation||78
5196465|NCT01070966|12777913|P1|COMPLETED|Participants for Safety Evaluation||2011
5196466|NCT01070966|12777913|P1|STARTED|Participants for Safety Evaluation||2089
5196467|NCT01070953|12777924|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
5196468|NCT01070953|12777924|P1|COMPLETED|Participants for Efficacy Evaluation||3309
5196469|NCT01070953|12777924|P1|STARTED|Participants for Efficacy Evaluation||3536
5196470|NCT01070953|12777924|P1|NOT COMPLETED|Participants for Safety Evaluation||931
5196471|NCT01070953|12777924|P1|COMPLETED|Participants for Safety Evaluation||3536
5196472|NCT01070953|12777924|P1|STARTED|Participants for Safety Evaluation||4467
5196473|NCT01070888|12777937|P2|NOT COMPLETED|Second Intervention (14 Days)||0
5196474|NCT01070888|12777938|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5196475|NCT01070888|12777937|P2|COMPLETED|Second Intervention (14 Days)||2
5196476|NCT01070888|12777938|P1|COMPLETED|Second Intervention (14 Days)||1
5196477|NCT01070888|12777937|P2|STARTED|Second Intervention (14 Days)||2
5196478|NCT01070888|12777938|P1|STARTED|Second Intervention (14 Days)||1
5196479|NCT01070888|12777937|P2|NOT COMPLETED|Washout (14 Days)||0
5196480|NCT01070888|12777938|P1|NOT COMPLETED|Washout (14 Days)||1
5196481|NCT01070888|12777937|P2|COMPLETED|Washout (14 Days)||2
5196482|NCT01070888|12777938|P1|COMPLETED|Washout (14 Days)||1
5196483|NCT01070888|12777937|P2|STARTED|Washout (14 Days)||2
5196484|NCT01070888|12777938|P1|STARTED|Washout (14 Days)||2
5196485|NCT01070888|12777937|P2|NOT COMPLETED|First Intervention (14 Days)||2
5196486|NCT01070888|12777938|P1|NOT COMPLETED|First Intervention (14 Days)||0
5196487|NCT01070888|12777937|P2|COMPLETED|First Intervention (14 Days)||2
5196488|NCT01070888|12777938|P1|COMPLETED|First Intervention (14 Days)||2
5196489|NCT01070888|12777937|P2|STARTED|First Intervention (14 Days)||4
5196490|NCT01070888|12777938|P1|STARTED|First Intervention (14 Days)||2
5196491|NCT01070810|12777946|P2|NOT COMPLETED|Overall Study||0
5196492|NCT01070810|12777947|P1|NOT COMPLETED|Overall Study||0
5196493|NCT01070810|12777946|P2|COMPLETED|Overall Study||43
5196494|NCT01070810|12777947|P1|COMPLETED|Overall Study||45
5196495|NCT01070810|12777946|P2|STARTED|Overall Study||43
5196496|NCT01070810|12777947|P1|STARTED|Overall Study||45
5196497|NCT01070784|12777963|P2|NOT COMPLETED|Overall Study||18
5196498|NCT01070784|12777964|P1|NOT COMPLETED|Overall Study||20
5196499|NCT01070784|12777963|P2|COMPLETED|Overall Study||112
5196500|NCT01070784|12777964|P1|COMPLETED|Overall Study||110
5196501|NCT01070784|12777963|P2|STARTED|Overall Study||130
5196502|NCT01070784|12777964|P1|STARTED|Overall Study||130
5196503|NCT01070771|12778052|P1|NOT COMPLETED|Overall Study||3
5196504|NCT01070771|12778052|P1|COMPLETED|Overall Study|August 2012|200
5196505|NCT01070771|12778052|P1|STARTED|Overall Study|September 2008|203
5196506|NCT01070693|12778059|P2|NOT COMPLETED|Overall Study||39
5196507|NCT01070693|12778060|P1|NOT COMPLETED|Overall Study||28
5196508|NCT01070693|12778059|P2|COMPLETED|Overall Study||110
5196509|NCT01070693|12778060|P1|COMPLETED|Overall Study||122
5196510|NCT01070693|12778059|P2|STARTED|Overall Study||149
5196511|NCT01070693|12778060|P1|STARTED|Overall Study||150
5196512|NCT01070550|12778072|P6|NOT COMPLETED|Overall Study||7
5196513|NCT01070550|12778073|P5|NOT COMPLETED|Overall Study||1
5196514|NCT01070550|12778074|P4|NOT COMPLETED|Overall Study||77
5196515|NCT01070550|12778075|P3|NOT COMPLETED|Overall Study||216
5196516|NCT01070550|12778076|P2|NOT COMPLETED|Overall Study||62
5196517|NCT01070550|12778077|P1|NOT COMPLETED|Overall Study||1285
5196518|NCT01070550|12778072|P6|COMPLETED|Overall Study||35
5196519|NCT01070550|12778073|P5|COMPLETED|Overall Study||20
5196520|NCT01070550|12778074|P4|COMPLETED|Overall Study||124
5196521|NCT01070550|12778075|P3|COMPLETED|Overall Study||528
5196522|NCT01070550|12778076|P2|COMPLETED|Overall Study||254
5196523|NCT01070550|12778077|P1|COMPLETED|Overall Study||2071
5196524|NCT01070550|12778072|P6|STARTED|Overall Study||42
5196525|NCT01070550|12778073|P5|STARTED|Overall Study||21
5196526|NCT01070550|12778074|P4|STARTED|Overall Study||201
5196527|NCT01070550|12778075|P3|STARTED|Overall Study||744
5196528|NCT01070550|12778076|P2|STARTED|Overall Study||316
5196529|NCT01070550|12778077|P1|STARTED|Overall Study||3356
5196530|NCT01070394|12778217|P1|NOT COMPLETED|Overall Study||7
5196531|NCT01070394|12778217|P1|COMPLETED|Overall Study||33
5196532|NCT01070394|12778217|P1|STARTED|Overall Study||40
5196533|NCT01070381|12778228|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
5196534|NCT01070381|12778229|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
5196535|NCT01070381|12778228|P2|COMPLETED|Period 2, 1 Week of Wear||106
5196536|NCT01070381|12778229|P1|COMPLETED|Period 2, 1 Week of Wear||108
5196537|NCT01070381|12778228|P2|STARTED|Period 2, 1 Week of Wear||107
5196538|NCT01070381|12778229|P1|STARTED|Period 2, 1 Week of Wear||109
5196539|NCT01070381|12778228|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
5196540|NCT01070381|12778229|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
5196541|NCT01070381|12778228|P2|COMPLETED|Period 1, 1 Week of Wear||107
5196542|NCT01070381|12778229|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
5196543|NCT01070381|12778228|P2|STARTED|Period 1, 1 Week of Wear||107
5196544|NCT01070381|12778229|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
5196545|NCT01070329|12778237|P2|NOT COMPLETED|Overall Study||49
5196546|NCT01070329|12778238|P1|NOT COMPLETED|Overall Study||52
5196547|NCT01070329|12778237|P2|COMPLETED|Overall Study||217
5196548|NCT01070329|12778238|P1|COMPLETED|Overall Study||209
5196549|NCT01070329|12778237|P2|STARTED|Overall Study||266
5196550|NCT01070329|12778238|P1|STARTED|Overall Study||261
5196551|NCT01070316|12778270|P1|NOT COMPLETED|Extension Phase||4
5196552|NCT01070316|12778270|P1|COMPLETED|Extension Phase||14
5196553|NCT01070316|12778270|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
5196554|NCT01070316|12778270|P1|NOT COMPLETED|Main Phase||0
5196555|NCT01070316|12778270|P1|COMPLETED|Main Phase||20
5196556|NCT01070316|12778270|P1|STARTED|Main Phase||20
5196557|NCT01070303|12778277|P1|NOT COMPLETED|Overall Study||89
5196558|NCT01070303|12778277|P1|COMPLETED|Overall Study||88
5196559|NCT01070303|12778277|P1|STARTED|Overall Study||177
5196560|NCT01070173|12778336|P3|NOT COMPLETED|Overall Study||0
5196561|NCT01070173|12778337|P2|NOT COMPLETED|Overall Study||0
5196562|NCT01070173|12778338|P1|NOT COMPLETED|Overall Study||0
5196563|NCT01070173|12778336|P3|COMPLETED|Overall Study||11
5196564|NCT01070173|12778337|P2|COMPLETED|Overall Study||8
5196565|NCT01070173|12778338|P1|COMPLETED|Overall Study||33
5196566|NCT01070173|12778336|P3|STARTED|Overall Study||11
5196567|NCT01070173|12778337|P2|STARTED|Overall Study||8
5196568|NCT01070173|12778338|P1|STARTED|Overall Study||33
5196569|NCT01070095|12778349|P2|NOT COMPLETED|Intervention Period||0
5196570|NCT01070095|12778350|P1|NOT COMPLETED|Intervention Period||0
5196571|NCT01070095|12778349|P2|COMPLETED|Intervention Period||890
5196572|NCT01070095|12778350|P1|COMPLETED|Intervention Period||18
5196573|NCT01070095|12778349|P2|STARTED|Intervention Period||890
5196574|NCT01070095|12778350|P1|STARTED|Intervention Period||18
5196575|NCT01070095|12778349|P2|NOT COMPLETED|Baseline Period||0
5196576|NCT01070095|12778350|P1|NOT COMPLETED|Baseline Period||1
5196577|NCT01070095|12778349|P2|COMPLETED|Baseline Period||830
5196578|NCT01070095|12778350|P1|COMPLETED|Baseline Period||18
5196579|NCT01070095|12778349|P2|STARTED|Baseline Period||830
5196580|NCT01070095|12778350|P1|STARTED|Baseline Period||19
5196581|NCT01070043|12778372|P3|NOT COMPLETED|Double-Blind Treatment||2
5196582|NCT01070043|12778373|P2|NOT COMPLETED|Double-Blind Treatment||0
5196583|NCT01070043|12778374|P1|NOT COMPLETED|Double-Blind Treatment||0
5196584|NCT01070043|12778372|P3|COMPLETED|Double-Blind Treatment||19
5196585|NCT01070043|12778373|P2|COMPLETED|Double-Blind Treatment||21
5196586|NCT01070043|12778374|P1|COMPLETED|Double-Blind Treatment||0
5196587|NCT01070043|12778372|P3|STARTED|Double-Blind Treatment||21
5196588|NCT01070043|12778373|P2|STARTED|Double-Blind Treatment||21
5196589|NCT01070043|12778374|P1|STARTED|Double-Blind Treatment||0
5196590|NCT01070043|12778372|P3|NOT COMPLETED|Run-In Phase||0
5196591|NCT01070043|12778373|P2|NOT COMPLETED|Run-In Phase||0
5196592|NCT01070043|12778374|P1|NOT COMPLETED|Run-In Phase||18
5196593|NCT01070043|12778372|P3|COMPLETED|Run-In Phase||0
5196594|NCT01070043|12778373|P2|COMPLETED|Run-In Phase||0
5196595|NCT01070043|12778374|P1|COMPLETED|Run-In Phase||42
5196596|NCT01070043|12778372|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
5196597|NCT01070043|12778373|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
5196598|NCT01070043|12778374|P1|STARTED|Run-In Phase||60
5196599|NCT01069939|12778390|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
5196600|NCT01069939|12778391|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
5196601|NCT01069939|12778390|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
5196602|NCT01069939|12778391|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
5196603|NCT01069939|12778390|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
5196604|NCT01069939|12778391|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
5196605|NCT01069939|12778390|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
5196606|NCT01069939|12778391|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
5196607|NCT01069939|12778390|P2|COMPLETED|Randomised and Included in the Analyses||137
5196608|NCT01069939|12778391|P1|COMPLETED|Randomised and Included in the Analyses||164
5196609|NCT01069939|12778390|P2|STARTED|Randomised and Included in the Analyses||214
5196610|NCT01069939|12778391|P1|STARTED|Randomised and Included in the Analyses||213
5196611|NCT01069900|12778417|P2|NOT COMPLETED|Overall Study||4
5196612|NCT01069900|12778418|P1|NOT COMPLETED|Overall Study||18
5196613|NCT01069900|12778417|P2|COMPLETED|Overall Study||149
5196614|NCT01069900|12778418|P1|COMPLETED|Overall Study||287
5196615|NCT01069900|12778417|P2|Treated|Overall Study||150
5196616|NCT01069900|12778418|P1|Treated|Overall Study||301
5196617|NCT01069900|12778417|P2|STARTED|Overall Study||153
5196618|NCT01069900|12778418|P1|STARTED|Overall Study||305
5196619|NCT01069861|12778462|P1|NOT COMPLETED|Overall Study||3
5196620|NCT01069861|12778462|P1|COMPLETED|Overall Study||1
5196621|NCT01069861|12778462|P1|STARTED|Overall Study||4
5196622|NCT01069627|12778475|P1|NOT COMPLETED|Overall Study||20
5196623|NCT01069627|12778475|P1|COMPLETED|Overall Study||0
5196624|NCT01069627|12778475|P1|STARTED|Overall Study||20
5196625|NCT01069562|12778498|P2|NOT COMPLETED|Overall Study||0
5196626|NCT01069562|12778499|P1|NOT COMPLETED|Overall Study||0
5196627|NCT01069562|12778498|P2|COMPLETED|Overall Study||20
5196628|NCT01069562|12778499|P1|COMPLETED|Overall Study||20
5196629|NCT01069562|12778498|P2|STARTED|Overall Study||20
5196630|NCT01069562|12778499|P1|STARTED|Overall Study||20
5196631|NCT01069523|12778525|P2|NOT COMPLETED|Overall Study||7
5196632|NCT01069523|12778526|P1|NOT COMPLETED|Overall Study||4
5196633|NCT01069523|12778525|P2|COMPLETED|Overall Study||9
5196634|NCT01069523|12778526|P1|COMPLETED|Overall Study||9
5196635|NCT01069523|12778525|P2|STARTED|Overall Study||16
5196636|NCT01069523|12778526|P1|STARTED|Overall Study||13
5196637|NCT01069510|12778536|P2|NOT COMPLETED|Overall Study||0
5196638|NCT01069510|12778537|P1|NOT COMPLETED|Overall Study||0
5196639|NCT01069510|12778536|P2|COMPLETED|Overall Study||7
5196640|NCT01069510|12778537|P1|COMPLETED|Overall Study||8
5196641|NCT01069510|12778536|P2|STARTED|Overall Study||7
5196642|NCT01069510|12778537|P1|STARTED|Overall Study||8
5196643|NCT01069484|12778549|P2|NOT COMPLETED|Overall Study||3
5196644|NCT01069484|12778550|P1|NOT COMPLETED|Overall Study||12
5196645|NCT01069484|12778549|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
5196646|NCT01069484|12778550|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
5196647|NCT01069484|12778549|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
5196648|NCT01069484|12778550|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
5196649|NCT01069419|12778558|P1|NOT COMPLETED|Overall Study||715
5196650|NCT01069419|12778558|P1|COMPLETED|Overall Study||402
5196651|NCT01069419|12778558|P1|Full Analysis Set|Overall Study||851
5196652|NCT01069419|12778558|P1|Safety Set|Overall Study||1111
5196653|NCT01069419|12778558|P1|STARTED|Overall Study||1117
5196654|NCT01069354|12778565|P1|NOT COMPLETED|Overall Study||1
5196655|NCT01069354|12778565|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
5196656|NCT01069354|12778565|P1|STARTED|Overall Study||102
5196657|NCT01069341|12778587|P1|NOT COMPLETED|Overall Study||1
5196658|NCT01069341|12778587|P1|COMPLETED|Overall Study||3
5196659|NCT01069341|12778587|P1|STARTED|Overall Study||4
5196660|NCT01069315|12778602|P4|NOT COMPLETED|Overall Study||7
5196661|NCT01069315|12778603|P3|NOT COMPLETED|Overall Study||5
5196662|NCT01069315|12778604|P2|NOT COMPLETED|Overall Study||6
5196663|NCT01069315|12778605|P1|NOT COMPLETED|Overall Study||4
5196664|NCT01069315|12778602|P4|COMPLETED|Overall Study||19
5196665|NCT01069315|12778603|P3|COMPLETED|Overall Study||23
5196666|NCT01069315|12778604|P2|COMPLETED|Overall Study||24
5196667|NCT01069315|12778605|P1|COMPLETED|Overall Study||23
5196668|NCT01069315|12778602|P4|STARTED|Overall Study||26
5196669|NCT01069315|12778603|P3|STARTED|Overall Study||28
5196670|NCT01069315|12778604|P2|STARTED|Overall Study||30
5196671|NCT01069315|12778605|P1|STARTED|Overall Study||27
5196672|NCT01069289|12778629|P2|NOT COMPLETED|Overall Study||56
5196673|NCT01069289|12778630|P1|NOT COMPLETED|Overall Study||42
5196674|NCT01069289|12778629|P2|COMPLETED|Overall Study||601
5196675|NCT01069289|12778630|P1|COMPLETED|Overall Study||594
5196676|NCT01069289|12778629|P2|STARTED|Overall Study||657
5196677|NCT01069289|12778630|P1|STARTED|Overall Study||636
5196678|NCT01069185|12778670|P2|NOT COMPLETED|Overall Study||0
5196679|NCT01069185|12778671|P1|NOT COMPLETED|Overall Study||0
5196680|NCT01069185|12778670|P2|COMPLETED|Overall Study||45
5196681|NCT01069185|12778671|P1|COMPLETED|Overall Study||47
5196682|NCT01069185|12778670|P2|STARTED|Overall Study||45
5196683|NCT01069185|12778671|P1|STARTED|Overall Study||47
5196684|NCT01069172|12778679|P2|NOT COMPLETED|Overall Study||0
5196685|NCT01069172|12778680|P1|NOT COMPLETED|Overall Study||1
5196686|NCT01069172|12778679|P2|COMPLETED|Overall Study|30 eyes|30
5196687|NCT01069172|12778680|P1|COMPLETED|Overall Study|29 eyes|29
5196688|NCT01069172|12778679|P2|STARTED|Overall Study|30 eyes|30
5196689|NCT01069172|12778680|P1|STARTED|Overall Study|30 eyes|30
5196690|NCT01069120|12778690|P1|NOT COMPLETED|Overall Study||27
5196691|NCT01069120|12778690|P1|COMPLETED|Overall Study||0
5196692|NCT01069120|12778690|P1|STARTED|Overall Study||27
5196693|NCT01069003|12778699|P3|NOT COMPLETED|Overall Study||475
5196694|NCT01069003|12778700|P2|NOT COMPLETED|Overall Study||54
5196695|NCT01069003|12778701|P1|NOT COMPLETED|Overall Study||46
5196696|NCT01069003|12778699|P3|COMPLETED|Overall Study||976
5196697|NCT01069003|12778700|P2|COMPLETED|Overall Study||358
5196698|NCT01069003|12778701|P1|COMPLETED|Overall Study||353
5196699|NCT01069003|12778699|P3|STARTED|Overall Study||1451
5196700|NCT01069003|12778700|P2|STARTED|Overall Study||412
5196701|NCT01069003|12778701|P1|STARTED|Overall Study||399
5196702|NCT01068964|12778717|P2|NOT COMPLETED|Overall Study||10
5196703|NCT01068964|12778718|P1|NOT COMPLETED|Overall Study||8
5196704|NCT01068964|12778717|P2|COMPLETED|Overall Study||104
5196705|NCT01068964|12778718|P1|COMPLETED|Overall Study||113
5196706|NCT01068964|12778717|P2|STARTED|Overall Study||114
5196707|NCT01068964|12778718|P1|STARTED|Overall Study||121
5196708|NCT01068912|12778727|P3|NOT COMPLETED|Overall Study||15
5196709|NCT01068912|12778728|P2|NOT COMPLETED|Overall Study||22
5196710|NCT01068912|12778729|P1|NOT COMPLETED|Overall Study||11
5196711|NCT01068912|12778727|P3|COMPLETED|Overall Study||186
5196712|NCT01068912|12778728|P2|COMPLETED|Overall Study||173
5196713|NCT01068912|12778729|P1|COMPLETED|Overall Study||123
5196714|NCT01068912|12778727|P3|STARTED|Overall Study||201
5196715|NCT01068912|12778728|P2|STARTED|Overall Study||195
5196716|NCT01068912|12778729|P1|STARTED|Overall Study||134
5196717|NCT01068860|12778747|P10|NOT COMPLETED|Overall Study||4
5196718|NCT01068860|12778748|P9|NOT COMPLETED|Overall Study||0
5196719|NCT01068860|12778749|P8|NOT COMPLETED|Overall Study||0
5196720|NCT01068860|12778750|P7|NOT COMPLETED|Overall Study||0
5196721|NCT01068860|12778751|P6|NOT COMPLETED|Overall Study||2
5196722|NCT01068860|12778752|P5|NOT COMPLETED|Overall Study||0
5196723|NCT01068860|12778753|P4|NOT COMPLETED|Overall Study||1
5196724|NCT01068860|12778754|P3|NOT COMPLETED|Overall Study||0
5196725|NCT01068860|12778755|P2|NOT COMPLETED|Overall Study||1
5196726|NCT01068860|12778756|P1|NOT COMPLETED|Overall Study||0
5196727|NCT01068860|12778747|P10|COMPLETED|Overall Study||23
5196728|NCT01068860|12778748|P9|COMPLETED|Overall Study||28
5196729|NCT01068860|12778749|P8|COMPLETED|Overall Study||15
5196730|NCT01068860|12778750|P7|COMPLETED|Overall Study||28
5196731|NCT01068860|12778751|P6|COMPLETED|Overall Study||14
5196732|NCT01068860|12778752|P5|COMPLETED|Overall Study||32
5196733|NCT01068860|12778753|P4|COMPLETED|Overall Study||16
5196734|NCT01068860|12778754|P3|COMPLETED|Overall Study||33
5196735|NCT01068860|12778755|P2|COMPLETED|Overall Study||16
5196736|NCT01068860|12778756|P1|COMPLETED|Overall Study||33
5196737|NCT01068860|12778747|P10|STARTED|Overall Study||27
5196738|NCT01068860|12778748|P9|STARTED|Overall Study||28
5196739|NCT01068860|12778749|P8|STARTED|Overall Study||15
5196740|NCT01068860|12778750|P7|STARTED|Overall Study||28
5196741|NCT01068860|12778751|P6|STARTED|Overall Study||16
5196742|NCT01068860|12778752|P5|STARTED|Overall Study||32
5196743|NCT01068860|12778753|P4|STARTED|Overall Study||17
5196744|NCT01068860|12778754|P3|STARTED|Overall Study||33
5196745|NCT01068860|12778755|P2|STARTED|Overall Study||17
5196746|NCT01068860|12778756|P1|STARTED|Overall Study||33
5196747|NCT01068821|12778930|P2|NOT COMPLETED|Overall Study||0
5196748|NCT01068821|12778931|P1|NOT COMPLETED|Overall Study||1
5196749|NCT01068821|12778930|P2|COMPLETED|Overall Study||29
5196750|NCT01068821|12778931|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
5196751|NCT01068821|12778930|P2|STARTED|Overall Study||29
5196752|NCT01068821|12778931|P1|STARTED|Overall Study||31
5196753|NCT01068769|12778939|P1|NOT COMPLETED|Overall Study||1
5196754|NCT01068769|12778939|P1|COMPLETED|Overall Study||33
5196755|NCT01068769|12778939|P1|STARTED|Overall Study||34
5196756|NCT01068743|12778944|P4|NOT COMPLETED|Period 4||0
5196757|NCT01068743|12778945|P3|NOT COMPLETED|Period 4||0
5196758|NCT01068743|12778946|P2|NOT COMPLETED|Period 4||0
5196759|NCT01068743|12778947|P1|NOT COMPLETED|Period 4||0
5196760|NCT01068743|12778944|P4|COMPLETED|Period 4||6
5196761|NCT01068743|12778945|P3|COMPLETED|Period 4||6
5196762|NCT01068743|12778946|P2|COMPLETED|Period 4||5
5196763|NCT01068743|12778947|P1|COMPLETED|Period 4||6
5196764|NCT01068743|12778944|P4|STARTED|Period 4||6
5196765|NCT01068743|12778945|P3|STARTED|Period 4||6
5196766|NCT01068743|12778946|P2|STARTED|Period 4||5
5196767|NCT01068743|12778947|P1|STARTED|Period 4||6
5196768|NCT01068743|12778944|P4|NOT COMPLETED|Period 3||0
5196769|NCT01068743|12778945|P3|NOT COMPLETED|Period 3||0
5196770|NCT01068743|12778946|P2|NOT COMPLETED|Period 3||1
5196771|NCT01068743|12778947|P1|NOT COMPLETED|Period 3||0
5196772|NCT01068743|12778944|P4|COMPLETED|Period 3||6
5196773|NCT01068743|12778945|P3|COMPLETED|Period 3||6
5196774|NCT01068743|12778946|P2|COMPLETED|Period 3||5
5196775|NCT01068743|12778947|P1|COMPLETED|Period 3||6
5196776|NCT01068743|12778944|P4|STARTED|Period 3||6
5196777|NCT01068743|12778945|P3|STARTED|Period 3||6
5196778|NCT01068743|12778946|P2|STARTED|Period 3||6
5196779|NCT01068743|12778947|P1|STARTED|Period 3||6
5196780|NCT01068743|12778944|P4|NOT COMPLETED|Period 2||0
5196781|NCT01068743|12778945|P3|NOT COMPLETED|Period 2||0
5196782|NCT01068743|12778946|P2|NOT COMPLETED|Period 2||0
5196783|NCT01068743|12778947|P1|NOT COMPLETED|Period 2||0
5196784|NCT01068743|12778944|P4|COMPLETED|Period 2||6
5196785|NCT01068743|12778945|P3|COMPLETED|Period 2||6
5196786|NCT01068743|12778946|P2|COMPLETED|Period 2||6
5196787|NCT01068743|12778947|P1|COMPLETED|Period 2||6
5196788|NCT01068743|12778944|P4|STARTED|Period 2||6
5196789|NCT01068743|12778945|P3|STARTED|Period 2||6
5196790|NCT01068743|12778946|P2|STARTED|Period 2||6
5196791|NCT01068743|12778947|P1|STARTED|Period 2||6
5196792|NCT01068743|12778944|P4|NOT COMPLETED|Period 1||0
5196793|NCT01068743|12778945|P3|NOT COMPLETED|Period 1||0
5196794|NCT01068743|12778946|P2|NOT COMPLETED|Period 1||0
5196795|NCT01068743|12778947|P1|NOT COMPLETED|Period 1||0
5196796|NCT01068743|12778944|P4|COMPLETED|Period 1||6
5196797|NCT01068743|12778945|P3|COMPLETED|Period 1||6
5196798|NCT01068743|12778946|P2|COMPLETED|Period 1||6
5196799|NCT01068743|12778947|P1|COMPLETED|Period 1||6
5196800|NCT01068743|12778944|P4|STARTED|Period 1||6
5196801|NCT01068743|12778945|P3|STARTED|Period 1||6
5196802|NCT01068743|12778946|P2|STARTED|Period 1||6
5196803|NCT01068743|12778947|P1|STARTED|Period 1||6
5196804|NCT01068730|12779021|P4|NOT COMPLETED|Period 4||0
5196805|NCT01068730|12779022|P3|NOT COMPLETED|Period 4||0
5196806|NCT01068730|12779023|P2|NOT COMPLETED|Period 4||1
5196807|NCT01068730|12779024|P1|NOT COMPLETED|Period 4||0
5196808|NCT01068730|12779021|P4|COMPLETED|Period 4||7
5196809|NCT01068730|12779022|P3|COMPLETED|Period 4||7
5196810|NCT01068730|12779023|P2|COMPLETED|Period 4||6
5196811|NCT01068730|12779024|P1|COMPLETED|Period 4||6
5196812|NCT01068730|12779021|P4|STARTED|Period 4||7
5196813|NCT01068730|12779022|P3|STARTED|Period 4||7
5196814|NCT01068730|12779023|P2|STARTED|Period 4||7
5196815|NCT01068730|12779024|P1|STARTED|Period 4||6
5196816|NCT01068730|12779021|P4|NOT COMPLETED|Period 3||0
5196817|NCT01068730|12779022|P3|NOT COMPLETED|Period 3||0
5196818|NCT01068730|12779023|P2|NOT COMPLETED|Period 3||0
5196819|NCT01068730|12779024|P1|NOT COMPLETED|Period 3||1
5196820|NCT01068730|12779021|P4|COMPLETED|Period 3||7
5196821|NCT01068730|12779022|P3|COMPLETED|Period 3||7
5196822|NCT01068730|12779023|P2|COMPLETED|Period 3||7
5196823|NCT01068730|12779024|P1|COMPLETED|Period 3||6
5196824|NCT01068730|12779021|P4|STARTED|Period 3||7
5196825|NCT01068730|12779022|P3|STARTED|Period 3||7
5196826|NCT01068730|12779023|P2|STARTED|Period 3||7
5196827|NCT01068730|12779024|P1|STARTED|Period 3||7
5196828|NCT01068730|12779021|P4|NOT COMPLETED|Period 2||0
5196829|NCT01068730|12779022|P3|NOT COMPLETED|Period 2||0
5196830|NCT01068730|12779023|P2|NOT COMPLETED|Period 2||0
5196831|NCT01068730|12779024|P1|NOT COMPLETED|Period 2||0
5196832|NCT01068730|12779021|P4|COMPLETED|Period 2||7
5196833|NCT01068730|12779022|P3|COMPLETED|Period 2||7
5196834|NCT01068730|12779023|P2|COMPLETED|Period 2||7
5196835|NCT01068730|12779024|P1|COMPLETED|Period 2||7
5196836|NCT01068730|12779021|P4|STARTED|Period 2||7
5196837|NCT01068730|12779022|P3|STARTED|Period 2||7
5196838|NCT01068730|12779023|P2|STARTED|Period 2||7
5196839|NCT01068730|12779024|P1|STARTED|Period 2||7
5196840|NCT01068730|12779021|P4|NOT COMPLETED|Period 1||0
5196841|NCT01068730|12779022|P3|NOT COMPLETED|Period 1||0
5196842|NCT01068730|12779023|P2|NOT COMPLETED|Period 1||0
5196843|NCT01068730|12779024|P1|NOT COMPLETED|Period 1||0
5196844|NCT01068730|12779021|P4|COMPLETED|Period 1||7
5196845|NCT01068730|12779022|P3|COMPLETED|Period 1||7
5196846|NCT01068730|12779023|P2|COMPLETED|Period 1||7
5196847|NCT01068730|12779024|P1|COMPLETED|Period 1||7
5196848|NCT01068730|12779021|P4|STARTED|Period 1||7
5196849|NCT01068730|12779022|P3|STARTED|Period 1||7
5196850|NCT01068730|12779023|P2|STARTED|Period 1||7
5196851|NCT01068730|12779024|P1|STARTED|Period 1||7
5196852|NCT01068717|12779078|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
5196853|NCT01068717|12779079|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
5196854|NCT01068717|12779080|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
5196855|NCT01068717|12779081|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
5196856|NCT01068717|12779078|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
5196857|NCT01068717|12779079|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
5196858|NCT01068717|12779080|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
5196859|NCT01068717|12779081|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
5196860|NCT01068717|12779078|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
5196861|NCT01068717|12779079|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
5196862|NCT01068717|12779080|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
5196863|NCT01068717|12779081|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
5196864|NCT01068717|12779078|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
5196865|NCT01068717|12779079|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
5196866|NCT01068717|12779080|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
5196867|NCT01068717|12779081|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
5196868|NCT01068717|12779078|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
5196869|NCT01068717|12779079|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
5196870|NCT01068717|12779080|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
5196871|NCT01068717|12779081|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
5196872|NCT01068717|12779078|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
5196873|NCT01068717|12779079|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
5196874|NCT01068717|12779080|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
5196875|NCT01068717|12779081|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
5196876|NCT01068717|12779078|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
5196877|NCT01068717|12779079|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
5196878|NCT01068717|12779080|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
5196879|NCT01068717|12779081|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
5196880|NCT01068717|12779078|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
5196881|NCT01068717|12779079|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
5196882|NCT01068717|12779080|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
5196883|NCT01068717|12779081|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
5196884|NCT01068717|12779078|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
5196885|NCT01068717|12779079|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
5196886|NCT01068717|12779080|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
5196887|NCT01068717|12779081|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
5196888|NCT01068717|12779078|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
5196889|NCT01068717|12779079|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
5196890|NCT01068717|12779080|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
5196891|NCT01068717|12779081|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
5196892|NCT01068717|12779078|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
5196893|NCT01068717|12779079|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
5196894|NCT01068717|12779080|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
5196895|NCT01068717|12779081|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
5196896|NCT01068717|12779078|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
5196897|NCT01068717|12779079|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
5196898|NCT01068717|12779080|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
5196899|NCT01068717|12779081|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
5196900|NCT01068678|12779137|P2|NOT COMPLETED|Overall Study||24
5196901|NCT01068678|12779138|P1|NOT COMPLETED|Overall Study||38
5196902|NCT01068678|12779137|P2|COMPLETED|Overall Study||206
5196903|NCT01068678|12779138|P1|COMPLETED|Overall Study||192
5196904|NCT01068678|12779137|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
5196905|NCT01068678|12779138|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
5196906|NCT01068678|12779137|P2|STARTED|Overall Study||230
5196907|NCT01068678|12779138|P1|STARTED|Overall Study||230
5196908|NCT01068665|12779148|P2|NOT COMPLETED|Overall Study||29
5196909|NCT01068665|12779149|P1|NOT COMPLETED|Overall Study||30
5196910|NCT01068665|12779148|P2|COMPLETED|Overall Study||201
5196911|NCT01068665|12779149|P1|COMPLETED|Overall Study||200
5196912|NCT01068665|12779148|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
5196913|NCT01068665|12779149|P1|Exposed|Overall Study||228
5196914|NCT01068665|12779148|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
5196915|NCT01068665|12779149|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
5196916|NCT01068665|12779148|P2|STARTED|Overall Study||230
5196917|NCT01068665|12779149|P1|STARTED|Overall Study||230
5196918|NCT01068652|12779159|P2|NOT COMPLETED|Overall Study||15
5196919|NCT01068652|12779160|P1|NOT COMPLETED|Overall Study||18
5196920|NCT01068652|12779159|P2|COMPLETED|Overall Study||188
5196921|NCT01068652|12779160|P1|COMPLETED|Overall Study||182
5196922|NCT01068652|12779159|P2|STARTED|Overall Study||203
5196923|NCT01068652|12779160|P1|STARTED|Overall Study||200
5196924|NCT01068626|12779200|P2|NOT COMPLETED|Overall Study||2
5196925|NCT01068626|12779201|P1|NOT COMPLETED|Overall Study||3
5196926|NCT01068626|12779200|P2|COMPLETED|Overall Study||27
5196927|NCT01068626|12779201|P1|COMPLETED|Overall Study||27
5196928|NCT01068626|12779200|P2|STARTED|Overall Study||29
5196929|NCT01068626|12779201|P1|STARTED|Overall Study||30
5196930|NCT01068600|12779219|P2|NOT COMPLETED|Overall Study||17
5196931|NCT01068600|12779220|P1|NOT COMPLETED|Overall Study||11
5196932|NCT01068600|12779219|P2|COMPLETED|Overall Study||142
5196933|NCT01068600|12779220|P1|COMPLETED|Overall Study||148
5196934|NCT01068600|12779219|P2|STARTED|Overall Study||159
5196935|NCT01068600|12779220|P1|STARTED|Overall Study||159
5196936|NCT01068548|12779230|P2|NOT COMPLETED|Overall Study||0
5196937|NCT01068548|12779231|P1|NOT COMPLETED|Overall Study||0
5196938|NCT01068548|12779230|P2|COMPLETED|Overall Study||63
5196939|NCT01068548|12779231|P1|COMPLETED|Overall Study||66
5196940|NCT01068548|12779230|P2|STARTED|Overall Study||63
5196941|NCT01068548|12779231|P1|STARTED|Overall Study||66
5196942|NCT01068509|12779242|P3|NOT COMPLETED|Overall Study||21
5196943|NCT01068509|12779243|P2|NOT COMPLETED|Overall Study||22
5196944|NCT01068509|12779244|P1|NOT COMPLETED|Overall Study||6
5196945|NCT01068509|12779242|P3|COMPLETED|Overall Study||6
5196946|NCT01068509|12779243|P2|COMPLETED|Overall Study||7
5196947|NCT01068509|12779244|P1|COMPLETED|Overall Study||1
5196948|NCT01068509|12779242|P3|STARTED|Overall Study||27
5196949|NCT01068509|12779243|P2|STARTED|Overall Study||29
5196950|NCT01068509|12779244|P1|STARTED|Overall Study||7
5196951|NCT01068418|12779257|P1|NOT COMPLETED|Overall Study||12
5196952|NCT01068418|12779257|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
5196953|NCT01068418|12779257|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
5196954|NCT01068418|12779257|P1|STARTED|Overall Study|26 participants found to be eligible|26
5196955|NCT01068262|12779266|P4|NOT COMPLETED|Overall Study||0
5196956|NCT01068262|12779267|P3|NOT COMPLETED|Overall Study||1
5196957|NCT01068262|12779268|P2|NOT COMPLETED|Overall Study||1
5196958|NCT01068262|12779269|P1|NOT COMPLETED|Overall Study||3
5196959|NCT01068262|12779266|P4|COMPLETED|Overall Study||2
5196960|NCT01068262|12779267|P3|COMPLETED|Overall Study||9
5196961|NCT01068262|12779268|P2|COMPLETED|Overall Study||8
5196962|NCT01068262|12779269|P1|COMPLETED|Overall Study||20
5196963|NCT01068262|12779266|P4|STARTED|Overall Study||2
5196964|NCT01068262|12779267|P3|STARTED|Overall Study||10
5196965|NCT01068262|12779268|P2|STARTED|Overall Study||9
5196966|NCT01068262|12779269|P1|STARTED|Overall Study||23
5196967|NCT01068158|12779299|P2|NOT COMPLETED|Overall Study||4
5196968|NCT01068158|12779300|P1|NOT COMPLETED|Overall Study||8
5196969|NCT01068158|12779299|P2|COMPLETED|Overall Study||198
5196970|NCT01068158|12779300|P1|COMPLETED|Overall Study||161
5196971|NCT01068158|12779299|P2|STARTED|Overall Study||202
5196972|NCT01068158|12779300|P1|STARTED|Overall Study||169
5196973|NCT01067976|12779312|P1|NOT COMPLETED|Overall Study||22
5196974|NCT01067976|12779312|P1|COMPLETED|Overall Study|study course completed|424
5196975|NCT01067976|12779312|P1|Fulfilled Requirements of FAS Population|Overall Study||390
5196976|NCT01067976|12779312|P1|Received Treatment|Overall Study|treatment started|426
5196977|NCT01067976|12779312|P1|STARTED|Overall Study|screened and enrolled|446
5196978|NCT01067846|12779373|P2|NOT COMPLETED|Overall Study||19
5196979|NCT01067846|12779374|P1|NOT COMPLETED|Overall Study||19
5196980|NCT01067846|12779373|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
5196981|NCT01067846|12779374|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
5196982|NCT01067846|12779373|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
5196983|NCT01067846|12779374|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
5196984|NCT01067846|12779373|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
5196985|NCT01067846|12779374|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
5196986|NCT01067781|12779386|P4|NOT COMPLETED|180 to Day 720||89
5196987|NCT01067781|12779387|P3|NOT COMPLETED|180 to Day 720||89
5196988|NCT01067781|12779388|P2|NOT COMPLETED|180 to Day 720||164
5196989|NCT01067781|12779389|P1|NOT COMPLETED|180 to Day 720||170
5196990|NCT01067781|12779386|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
5196991|NCT01067781|12779387|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
5196992|NCT01067781|12779388|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
5196993|NCT01067781|12779389|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
5196994|NCT01067781|12779386|P4|STARTED|180 to Day 720||89
5196995|NCT01067781|12779387|P3|STARTED|180 to Day 720||89
5196996|NCT01067781|12779388|P2|STARTED|180 to Day 720||168
5196997|NCT01067781|12779389|P1|STARTED|180 to Day 720||173
5196998|NCT01067781|12779386|P4|NOT COMPLETED|Up to Day 180||12
5196999|NCT01067781|12779387|P3|NOT COMPLETED|Up to Day 180||8
5197000|NCT01067781|12779388|P2|NOT COMPLETED|Up to Day 180||31
5197001|NCT01067781|12779389|P1|NOT COMPLETED|Up to Day 180||30
5197002|NCT01067781|12779386|P4|COMPLETED|Up to Day 180||89
5197003|NCT01067781|12779387|P3|COMPLETED|Up to Day 180||89
5197004|NCT01067781|12779388|P2|COMPLETED|Up to Day 180||168
5197005|NCT01067781|12779389|P1|COMPLETED|Up to Day 180||173
5197006|NCT01067781|12779386|P4|STARTED|Up to Day 180||101
5197007|NCT01067781|12779387|P3|STARTED|Up to Day 180||97
5197008|NCT01067781|12779388|P2|STARTED|Up to Day 180||199
5197009|NCT01067781|12779389|P1|STARTED|Up to Day 180||203
5197010|NCT01067768|12779411|P2|NOT COMPLETED|Overall Study||0
5197011|NCT01067768|12779412|P1|NOT COMPLETED|Overall Study||0
5197012|NCT01067768|12779411|P2|COMPLETED|Overall Study||605
5197013|NCT01067768|12779412|P1|COMPLETED|Overall Study||604
5197014|NCT01067768|12779411|P2|STARTED|Overall Study||605
5197015|NCT01067768|12779412|P1|STARTED|Overall Study||604
5197016|NCT01067716|12779423|P3|NOT COMPLETED|Overall Study||0
5197017|NCT01067716|12779424|P2|NOT COMPLETED|Overall Study||0
5197018|NCT01067716|12779425|P1|NOT COMPLETED|Overall Study||0
5197019|NCT01067716|12779423|P3|COMPLETED|Overall Study|15 eyes|9
5197020|NCT01067716|12779424|P2|COMPLETED|Overall Study|25 eyes|13
5197021|NCT01067716|12779425|P1|COMPLETED|Overall Study|110 eyes|57
5197022|NCT01067716|12779423|P3|STARTED|Overall Study|15 eyes|9
5197023|NCT01067716|12779424|P2|STARTED|Overall Study|25 eyes|13
5197024|NCT01067716|12779425|P1|STARTED|Overall Study|110 eyes|57
5197025|NCT01067521|12779444|P2|NOT COMPLETED|Open-Label Period||158
5197026|NCT01067521|12779445|P1|NOT COMPLETED|Open-Label Period||254
5197027|NCT01067521|12779444|P2|COMPLETED|Open-Label Period||261
5197028|NCT01067521|12779445|P1|COMPLETED|Open-Label Period||580
5197029|NCT01067521|12779444|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
5197030|NCT01067521|12779445|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
5197031|NCT01067521|12779444|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
5197032|NCT01067521|12779445|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
5197033|NCT01067521|12779444|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
5197034|NCT01067521|12779445|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
5197035|NCT01067521|12779444|P2|STARTED|Double-Blind Placebo-Controlled Period||461
5197036|NCT01067521|12779445|P1|STARTED|Double-Blind Placebo-Controlled Period||943
5197037|NCT01067508|12779471|P2|NOT COMPLETED|Overall Study||2
5197038|NCT01067508|12779472|P1|NOT COMPLETED|Overall Study||0
5197039|NCT01067508|12779471|P2|COMPLETED|Overall Study||7
5197040|NCT01067508|12779472|P1|COMPLETED|Overall Study||10
5197041|NCT01067508|12779471|P2|STARTED|Overall Study||9
5197042|NCT01067508|12779472|P1|STARTED|Overall Study||10
5197043|NCT01067469|12779480|P2|NOT COMPLETED|Overall Study||2
5197044|NCT01067469|12779481|P1|NOT COMPLETED|Overall Study||0
5197045|NCT01067469|12779480|P2|COMPLETED|Overall Study||33
5197046|NCT01067469|12779481|P1|COMPLETED|Overall Study||36
5197047|NCT01067469|12779480|P2|75 mg/m^2|Overall Study||21
5197048|NCT01067469|12779481|P1|75 mg/m^2|Overall Study||0
5197049|NCT01067469|12779480|P2|90 mg/m^2|Overall Study||12
5197050|NCT01067469|12779481|P1|90 mg/m^2|Overall Study||0
5197051|NCT01067469|12779480|P2|STARTED|Overall Study||35
5197052|NCT01067469|12779481|P1|STARTED|Overall Study||36
5197053|NCT01067456|12779499|P2|NOT COMPLETED|Overall Study||0
5197054|NCT01067456|12779500|P1|NOT COMPLETED|Overall Study||0
5197055|NCT01067456|12779499|P2|COMPLETED|Overall Study||29
5197056|NCT01067456|12779500|P1|COMPLETED|Overall Study||30
5197057|NCT01067456|12779499|P2|STARTED|Overall Study||29
5197058|NCT01067456|12779500|P1|STARTED|Overall Study||30
5197059|NCT01067352|12779513|P3|NOT COMPLETED|Overall Study||1
5197060|NCT01067352|12779514|P2|NOT COMPLETED|Overall Study||3
5197061|NCT01067352|12779515|P1|NOT COMPLETED|Overall Study||1
5197062|NCT01067352|12779513|P3|COMPLETED|Overall Study||9
5197063|NCT01067352|12779514|P2|COMPLETED|Overall Study||3
5197064|NCT01067352|12779515|P1|COMPLETED|Overall Study||8
5197065|NCT01067352|12779513|P3|STARTED|Overall Study||10
5197066|NCT01067352|12779514|P2|STARTED|Overall Study||6
5197067|NCT01067352|12779515|P1|STARTED|Overall Study||9
5197068|NCT01067339|12779531|P2|NOT COMPLETED|Overall Study||5
5197069|NCT01067339|12779532|P1|NOT COMPLETED|Overall Study||6
5197070|NCT01067339|12779531|P2|COMPLETED|Overall Study||29
5197071|NCT01067339|12779532|P1|COMPLETED|Overall Study||25
5197072|NCT01067339|12779531|P2|STARTED|Overall Study||34
5197073|NCT01067339|12779532|P1|STARTED|Overall Study||31
5197074|NCT01067326|12779542|P2|NOT COMPLETED|Overall Study||3
5197075|NCT01067326|12779543|P1|NOT COMPLETED|Overall Study||2
5197076|NCT01067326|12779542|P2|COMPLETED|Overall Study||5
5197077|NCT01067326|12779543|P1|COMPLETED|Overall Study||12
5197078|NCT01067326|12779542|P2|STARTED|Overall Study||8
5197079|NCT01067326|12779543|P1|STARTED|Overall Study||14
5197080|NCT01067144|12779557|P2|NOT COMPLETED|Follow-up||56
5197081|NCT01067144|12779558|P1|NOT COMPLETED|Follow-up||59
5197082|NCT01067144|12779557|P2|COMPLETED|Follow-up||152
5197083|NCT01067144|12779558|P1|COMPLETED|Follow-up||144
5197084|NCT01067144|12779557|P2|Intention-to-Treat Analysis Set|Follow-up||208
5197085|NCT01067144|12779558|P1|Intention-to-Treat Analysis Set|Follow-up||202
5197086|NCT01067144|12779557|P2|STARTED|Follow-up||208
5197087|NCT01067144|12779558|P1|STARTED|Follow-up||203
5197088|NCT01067144|12779557|P2|NOT COMPLETED|Treatment||7
5197089|NCT01067144|12779558|P1|NOT COMPLETED|Treatment||4
5197090|NCT01067144|12779557|P2|COMPLETED|Treatment||208
5197091|NCT01067144|12779558|P1|COMPLETED|Treatment||203
5197092|NCT01067144|12779557|P2|STARTED|Treatment||215
5197093|NCT01067144|12779558|P1|STARTED|Treatment||207
5197094|NCT01067105|12779574|P1|NOT COMPLETED|Overall Study||141
5197095|NCT01067105|12779574|P1|COMPLETED|Overall Study||683
5197096|NCT01067105|12779574|P1|STARTED|Overall Study||824
5197097|NCT01066936|12779591|P1|NOT COMPLETED|Overall Study||10
5197098|NCT01066936|12779591|P1|COMPLETED|Overall Study||10
5197099|NCT01066936|12779591|P1|STARTED|Overall Study||20
5197100|NCT01066923|12779627|P4|NOT COMPLETED|Overall Study||8
5197101|NCT01066923|12779628|P3|NOT COMPLETED|Overall Study||8
5197102|NCT01066923|12779629|P2|NOT COMPLETED|Overall Study||3
5197103|NCT01066923|12779630|P1|NOT COMPLETED|Overall Study||3
5197104|NCT01066923|12779627|P4|COMPLETED|Overall Study||23
5197105|NCT01066923|12779628|P3|COMPLETED|Overall Study||25
5197106|NCT01066923|12779629|P2|COMPLETED|Overall Study||29
5197107|NCT01066923|12779630|P1|COMPLETED|Overall Study||25
5197108|NCT01066923|12779627|P4|Retinal Imaging|Overall Study||0
5197109|NCT01066923|12779628|P3|Retinal Imaging|Overall Study||0
5197110|NCT01066923|12779629|P2|Retinal Imaging|Overall Study||0
5197111|NCT01066923|12779630|P1|Retinal Imaging|Overall Study||0
5197112|NCT01066923|12779627|P4|Activation of Coagulation|Overall Study||0
5197113|NCT01066923|12779628|P3|Activation of Coagulation|Overall Study||0
5197114|NCT01066923|12779629|P2|Activation of Coagulation|Overall Study||0
5197115|NCT01066923|12779630|P1|Activation of Coagulation|Overall Study||0
5197116|NCT01066923|12779627|P4|Vascular Function|Overall Study||13
5197117|NCT01066923|12779628|P3|Vascular Function|Overall Study||12
5197118|NCT01066923|12779629|P2|Vascular Function|Overall Study||14
5197119|NCT01066923|12779630|P1|Vascular Function|Overall Study||13
5197120|NCT01066923|12779627|P4|Platelet Closure Time|Overall Study||23
5197121|NCT01066923|12779628|P3|Platelet Closure Time|Overall Study||25
5197122|NCT01066923|12779629|P2|Platelet Closure Time|Overall Study||29
5197123|NCT01066923|12779630|P1|Platelet Closure Time|Overall Study||25
5197124|NCT01066923|12779627|P4|STARTED|Overall Study||31
5197125|NCT01066923|12779628|P3|STARTED|Overall Study||33
5197126|NCT01066923|12779629|P2|STARTED|Overall Study||32
5197127|NCT01066923|12779630|P1|STARTED|Overall Study||28
5197128|NCT01066897|12779654|P2|NOT COMPLETED|Overall Study||0
5197129|NCT01066897|12779655|P1|NOT COMPLETED|Overall Study||2
5197130|NCT01066897|12779654|P2|COMPLETED|Overall Study||9
5197131|NCT01066897|12779655|P1|COMPLETED|Overall Study||5
5197132|NCT01066897|12779654|P2|STARTED|Overall Study||9
5197133|NCT01066897|12779655|P1|STARTED|Overall Study||7
5197134|NCT01066871|12779669|P4|NOT COMPLETED|Overall Study||5
5197135|NCT01066871|12779670|P3|NOT COMPLETED|Overall Study||6
5197136|NCT01066871|12779671|P2|NOT COMPLETED|Overall Study||5
5197137|NCT01066871|12779672|P1|NOT COMPLETED|Overall Study||4
5197138|NCT01066871|12779669|P4|COMPLETED|Overall Study||13
5197139|NCT01066871|12779670|P3|COMPLETED|Overall Study||12
5197140|NCT01066871|12779671|P2|COMPLETED|Overall Study||13
5197141|NCT01066871|12779672|P1|COMPLETED|Overall Study||16
5197142|NCT01066871|12779669|P4|STARTED|Overall Study||18
5197143|NCT01066871|12779670|P3|STARTED|Overall Study||18
5197144|NCT01066871|12779671|P2|STARTED|Overall Study||18
5197145|NCT01066871|12779672|P1|STARTED|Overall Study||20
5197146|NCT01066819|12779736|P6|NOT COMPLETED|Overall Study||6
5197147|NCT01066819|12779737|P5|NOT COMPLETED|Overall Study||4
5197148|NCT01066819|12779738|P4|NOT COMPLETED|Overall Study||17
5197149|NCT01066819|12779739|P3|NOT COMPLETED|Overall Study||146
5197150|NCT01066819|12779740|P2|NOT COMPLETED|Overall Study||171
5197151|NCT01066819|12779741|P1|NOT COMPLETED|Overall Study||689
5197152|NCT01066819|12779736|P6|COMPLETED|Overall Study||7
5197153|NCT01066819|12779737|P5|COMPLETED|Overall Study||3
5197154|NCT01066819|12779738|P4|COMPLETED|Overall Study||8
5197155|NCT01066819|12779739|P3|COMPLETED|Overall Study||111
5197156|NCT01066819|12779740|P2|COMPLETED|Overall Study||177
5197157|NCT01066819|12779741|P1|COMPLETED|Overall Study||317
5197158|NCT01066819|12779736|P6|STARTED|Overall Study||13
5197159|NCT01066819|12779737|P5|STARTED|Overall Study||7
5197160|NCT01066819|12779738|P4|STARTED|Overall Study||25
5197161|NCT01066819|12779739|P3|STARTED|Overall Study||257
5197162|NCT01066819|12779740|P2|STARTED|Overall Study||348
5197163|NCT01066819|12779741|P1|STARTED|Overall Study||1006
5197164|NCT01066793|12779882|P6|NOT COMPLETED|Overall Study||1
5197165|NCT01066793|12779883|P5|NOT COMPLETED|Overall Study||0
5197166|NCT01066793|12779884|P4|NOT COMPLETED|Overall Study||49
5197167|NCT01066793|12779885|P3|NOT COMPLETED|Overall Study||115
5197168|NCT01066793|12779886|P2|NOT COMPLETED|Overall Study||77
5197169|NCT01066793|12779887|P1|NOT COMPLETED|Overall Study||374
5197170|NCT01066793|12779882|P6|COMPLETED|Overall Study||4
5197171|NCT01066793|12779883|P5|COMPLETED|Overall Study||11
5197172|NCT01066793|12779884|P4|COMPLETED|Overall Study||94
5197173|NCT01066793|12779885|P3|COMPLETED|Overall Study||369
5197174|NCT01066793|12779886|P2|COMPLETED|Overall Study||495
5197175|NCT01066793|12779887|P1|COMPLETED|Overall Study||754
5197176|NCT01066793|12779882|P6|STARTED|Overall Study||5
5197177|NCT01066793|12779883|P5|STARTED|Overall Study||11
5197178|NCT01066793|12779884|P4|STARTED|Overall Study||143
5197179|NCT01066793|12779885|P3|STARTED|Overall Study||484
5197180|NCT01066793|12779886|P2|STARTED|Overall Study||572
5197181|NCT01066793|12779887|P1|STARTED|Overall Study||1128
5197182|NCT01066780|12780027|P2|NOT COMPLETED|Overall Study||1
5197183|NCT01066780|12780028|P1|NOT COMPLETED|Overall Study||1
5197184|NCT01066780|12780027|P2|COMPLETED|Overall Study||23
5197185|NCT01066780|12780028|P1|COMPLETED|Overall Study||23
5197186|NCT01066780|12780027|P2|STARTED|Overall Study||24
5197187|NCT01066780|12780028|P1|STARTED|Overall Study||24
5197188|NCT01066624|12780035|P3|NOT COMPLETED|Overall Study||0
5197189|NCT01066624|12780036|P2|NOT COMPLETED|Overall Study||0
5197190|NCT01066624|12780037|P1|NOT COMPLETED|Overall Study||0
5197191|NCT01066624|12780035|P3|COMPLETED|Overall Study||39
5197192|NCT01066624|12780036|P2|COMPLETED|Overall Study||40
5197193|NCT01066624|12780037|P1|COMPLETED|Overall Study||38
5197194|NCT01066624|12780035|P3|STARTED|Overall Study||39
5197195|NCT01066624|12780036|P2|STARTED|Overall Study||40
5197196|NCT01066624|12780037|P1|STARTED|Overall Study||38
5197197|NCT01066585|12780047|P2|NOT COMPLETED|Overall Study||3
5197198|NCT01066585|12780048|P1|NOT COMPLETED|Overall Study||1
5197199|NCT01066585|12780047|P2|COMPLETED|Overall Study||196
5197200|NCT01066585|12780048|P1|COMPLETED|Overall Study||210
5197201|NCT01066585|12780047|P2|STARTED|Overall Study||199
5197202|NCT01066585|12780048|P1|STARTED|Overall Study||211
5197203|NCT01066546|12780060|P1|NOT COMPLETED|Overall Study||5
5197204|NCT01066546|12780060|P1|COMPLETED|Overall Study||0
5197205|NCT01066546|12780060|P1|STARTED|Overall Study||5
5197206|NCT01066520|12780074|P3|NOT COMPLETED|Overall Study||0
5197207|NCT01066520|12780075|P2|NOT COMPLETED|Overall Study||0
5197208|NCT01066520|12780076|P1|NOT COMPLETED|Overall Study||0
5197209|NCT01066520|12780074|P3|COMPLETED|Overall Study||137
5197210|NCT01066520|12780075|P2|COMPLETED|Overall Study||140
5197211|NCT01066520|12780076|P1|COMPLETED|Overall Study||143
5197212|NCT01066520|12780074|P3|STARTED|Overall Study||137
5197213|NCT01066520|12780075|P2|STARTED|Overall Study||140
5197214|NCT01066520|12780076|P1|STARTED|Overall Study||143
5197215|NCT01066364|12780092|P2|NOT COMPLETED|Overall Study||2
5197216|NCT01066364|12780093|P1|NOT COMPLETED|Overall Study||3
5197217|NCT01066364|12780092|P2|COMPLETED|Overall Study||23
5197218|NCT01066364|12780093|P1|COMPLETED|Overall Study||22
5197219|NCT01066364|12780092|P2|STARTED|Overall Study||25
5197220|NCT01066364|12780093|P1|STARTED|Overall Study||25
5197221|NCT01066156|12780105|P1|NOT COMPLETED|Overall Study||10
5197222|NCT01066156|12780105|P1|COMPLETED|Overall Study||24
5197223|NCT01066156|12780105|P1|STARTED|Overall Study||34
5197224|NCT01066143|12780109|P1|NOT COMPLETED|Overall Study||8
5197225|NCT01066143|12780109|P1|COMPLETED|Overall Study||0
5197226|NCT01066143|12780109|P1|STARTED|Overall Study||8
5197227|NCT01066104|12780115|P2|NOT COMPLETED|Overall Study||1
5197228|NCT01066104|12780116|P1|NOT COMPLETED|Overall Study||2
5197229|NCT01066104|12780115|P2|COMPLETED|Overall Study||12
5197230|NCT01066104|12780116|P1|COMPLETED|Overall Study||12
5197231|NCT01066104|12780115|P2|STARTED|Overall Study||13
5197232|NCT01066104|12780116|P1|STARTED|Overall Study||14
5197233|NCT01066052|12780126|P2|NOT COMPLETED|Overall Study||0
5197234|NCT01066052|12780127|P1|NOT COMPLETED|Overall Study||3
5197235|NCT01066052|12780126|P2|COMPLETED|Overall Study||51
5197236|NCT01066052|12780127|P1|COMPLETED|Overall Study||61
5197237|NCT01066052|12780126|P2|Treated|Overall Study||0
5197238|NCT01066052|12780127|P1|Treated|Overall Study||61
5197239|NCT01066052|12780126|P2|STARTED|Overall Study||51
5197240|NCT01066052|12780127|P1|STARTED|Overall Study||64
5197241|NCT01066039|12780138|P1|NOT COMPLETED|Overall Study||44
5197242|NCT01066039|12780138|P1|COMPLETED|Overall Study||158
5197243|NCT01066039|12780138|P1|Treated|Overall Study||200
5197244|NCT01066039|12780138|P1|STARTED|Overall Study||202
5197245|NCT01066000|12780151|P1|NOT COMPLETED|Overall Study||9
5197246|NCT01066000|12780151|P1|COMPLETED|Overall Study||24
5197247|NCT01066000|12780151|P1|STARTED|Overall Study||33
5197248|NCT01065844|12780162|P1|NOT COMPLETED|Overall Study||5
5197249|NCT01065844|12780162|P1|COMPLETED|Overall Study||10
5197250|NCT01065844|12780162|P1|STARTED|Overall Study||15
5197251|NCT01065818|12780166|P1|NOT COMPLETED|Overall Study||2
5197252|NCT01065818|12780166|P1|COMPLETED|Overall Study||4
5197253|NCT01065818|12780166|P1|STARTED|Overall Study||6
5197254|NCT01065779|12780170|P1|NOT COMPLETED|Overall Study||82
5197255|NCT01065779|12780170|P1|COMPLETED|Overall Study||798
5197256|NCT01065779|12780170|P1|STARTED|Overall Study||880
5197257|NCT01065766|12780181|P1|NOT COMPLETED|Overall Study||32
5197258|NCT01065766|12780181|P1|COMPLETED|Overall Study||4033
5197259|NCT01065766|12780181|P1|STARTED|Overall Study||4065
5197260|NCT01065714|12780193|P1|NOT COMPLETED|Overall Study||0
5197261|NCT01065714|12780193|P1|COMPLETED|Overall Study||20
5197262|NCT01065714|12780193|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
5197263|NCT01065597|12780200|P1|NOT COMPLETED|Overall Study||1
5197264|NCT01065597|12780200|P1|COMPLETED|Overall Study||12
5197265|NCT01065597|12780200|P1|STARTED|Overall Study||13
5197266|NCT01065571|12780209|P2|NOT COMPLETED|Overall Study||0
5197267|NCT01065571|12780210|P1|NOT COMPLETED|Overall Study||3
5197268|NCT01065571|12780209|P2|COMPLETED|Overall Study||5
5197269|NCT01065571|12780210|P1|COMPLETED|Overall Study||7
5197270|NCT01065571|12780209|P2|STARTED|Overall Study||5
5197271|NCT01065571|12780210|P1|STARTED|Overall Study||10
5197272|NCT01065558|12780220|P1|NOT COMPLETED|Overall Study||0
5197273|NCT01065558|12780220|P1|COMPLETED|Overall Study||5
5197274|NCT01065558|12780220|P1|STARTED|Overall Study||5
5197275|NCT01065506|12780227|P2|NOT COMPLETED|Overall Study||38
5197276|NCT01065506|12780228|P1|NOT COMPLETED|Overall Study||32
5197277|NCT01065506|12780227|P2|COMPLETED|Overall Study||34
5197278|NCT01065506|12780228|P1|COMPLETED|Overall Study||32
5197279|NCT01065506|12780227|P2|4-Month Follow-Up|Overall Study||34
5197280|NCT01065506|12780228|P1|4-Month Follow-Up|Overall Study||35
5197281|NCT01065506|12780227|P2|End of Treatment|Overall Study||37
5197282|NCT01065506|12780228|P1|End of Treatment|Overall Study||44
5197283|NCT01065506|12780227|P2|STARTED|Overall Study||72
5197284|NCT01065506|12780228|P1|STARTED|Overall Study||64
5197285|NCT01065480|12780236|P2|NOT COMPLETED|Overall Study||0
5197286|NCT01065480|12780237|P1|NOT COMPLETED|Overall Study||0
5197287|NCT01065480|12780236|P2|COMPLETED|Overall Study||43
5197288|NCT01065480|12780237|P1|COMPLETED|Overall Study||48
5197289|NCT01065480|12780236|P2|STARTED|Overall Study||43
5197290|NCT01065480|12780237|P1|STARTED|Overall Study||48
5197291|NCT01065454|12780247|P4|NOT COMPLETED|Follow up||44
5197292|NCT01065454|12780248|P3|NOT COMPLETED|Follow up||17
5197293|NCT01065454|12780249|P2|NOT COMPLETED|Follow up||24
5197294|NCT01065454|12780250|P1|NOT COMPLETED|Follow up||39
5197295|NCT01065454|12780247|P4|COMPLETED|Follow up||13
5197296|NCT01065454|12780248|P3|COMPLETED|Follow up||6
5197297|NCT01065454|12780249|P2|COMPLETED|Follow up||4
5197298|NCT01065454|12780250|P1|COMPLETED|Follow up||15
5197299|NCT01065454|12780247|P4|Entering Follow-up|Follow up||51
5197300|NCT01065454|12780248|P3|Entering Follow-up|Follow up||23
5197301|NCT01065454|12780249|P2|Entering Follow-up|Follow up||27
5197302|NCT01065454|12780250|P1|Entering Follow-up|Follow up||49
5197303|NCT01065454|12780247|P4|STARTED|Follow up||57
5197304|NCT01065454|12780248|P3|STARTED|Follow up||23
5197305|NCT01065454|12780249|P2|STARTED|Follow up||28
5197306|NCT01065454|12780250|P1|STARTED|Follow up||54
5197307|NCT01065454|12780247|P4|NOT COMPLETED|Treatment||12
5197308|NCT01065454|12780248|P3|NOT COMPLETED|Treatment||9
5197309|NCT01065454|12780249|P2|NOT COMPLETED|Treatment||5
5197310|NCT01065454|12780250|P1|NOT COMPLETED|Treatment||13
5197311|NCT01065454|12780247|P4|COMPLETED|Treatment||57
5197312|NCT01065454|12780248|P3|COMPLETED|Treatment||23
5197313|NCT01065454|12780249|P2|COMPLETED|Treatment||28
5197314|NCT01065454|12780250|P1|COMPLETED|Treatment||54
5197315|NCT01065454|12780247|P4|STARTED|Treatment||69
5197316|NCT01065454|12780248|P3|STARTED|Treatment||32
5197317|NCT01065454|12780249|P2|STARTED|Treatment||33
5197318|NCT01065454|12780250|P1|STARTED|Treatment||67
5197319|NCT01065428|12780362|P2|NOT COMPLETED|Overall Study||0
5197320|NCT01065428|12780363|P1|NOT COMPLETED|Overall Study||0
5197321|NCT01065428|12780362|P2|COMPLETED|Overall Study||35
5197322|NCT01065428|12780363|P1|COMPLETED|Overall Study||17
5197323|NCT01065428|12780362|P2|STARTED|Overall Study||35
5197324|NCT01065428|12780363|P1|STARTED|Overall Study||17
5197325|NCT01065350|12780373|P2|NOT COMPLETED|Overall Study||1
5197326|NCT01065350|12780374|P1|NOT COMPLETED|Overall Study||0
5197327|NCT01065350|12780373|P2|COMPLETED|Overall Study||41
5197328|NCT01065350|12780374|P1|COMPLETED|Overall Study||43
5197329|NCT01065350|12780373|P2|STARTED|Overall Study||42
5197330|NCT01065350|12780374|P1|STARTED|Overall Study||43
5197331|NCT01065051|12780408|P2|NOT COMPLETED|Overall Study||0
5197332|NCT01065051|12780409|P1|NOT COMPLETED|Overall Study||0
5197333|NCT01065051|12780408|P2|COMPLETED|Overall Study||0
5197334|NCT01065051|12780409|P1|COMPLETED|Overall Study||1
5197335|NCT01065051|12780408|P2|STARTED|Overall Study||0
5197336|NCT01065051|12780409|P1|STARTED|Overall Study||1
5197337|NCT01064947|12780435|P1|NOT COMPLETED|Overall Study||41
5197338|NCT01064947|12780435|P1|COMPLETED|Overall Study||29
5197339|NCT01064947|12780435|P1|STARTED|Overall Study||70
5197340|NCT01064882|12780446|P3|NOT COMPLETED|Overall Study||2
5197341|NCT01064882|12780447|P2|NOT COMPLETED|Overall Study||2
5197342|NCT01064882|12780448|P1|NOT COMPLETED|Overall Study||2
5197343|NCT01064882|12780446|P3|COMPLETED|Overall Study||32
5197344|NCT01064882|12780447|P2|COMPLETED|Overall Study||32
5197345|NCT01064882|12780448|P1|COMPLETED|Overall Study||34
5197346|NCT01064882|12780446|P3|STARTED|Overall Study||34
5197347|NCT01064882|12780447|P2|STARTED|Overall Study||34
5197348|NCT01064882|12780448|P1|STARTED|Overall Study||36
5197349|NCT01064856|12780476|P4|NOT COMPLETED|Open-label (OL) Period||20
5197350|NCT01064856|12780477|P3|NOT COMPLETED|Open-label (OL) Period||26
5197351|NCT01064856|12780478|P2|NOT COMPLETED|Open-label (OL) Period||0
5197352|NCT01064856|12780479|P1|NOT COMPLETED|Open-label (OL) Period||0
5197353|NCT01064856|12780476|P4|COMPLETED|Open-label (OL) Period||61
5197354|NCT01064856|12780477|P3|COMPLETED|Open-label (OL) Period||56
5197355|NCT01064856|12780478|P2|COMPLETED|Open-label (OL) Period||0
5197356|NCT01064856|12780479|P1|COMPLETED|Open-label (OL) Period||0
5197357|NCT01064856|12780476|P4|STARTED|Open-label (OL) Period||81
5197358|NCT01064856|12780477|P3|STARTED|Open-label (OL) Period||82
5197359|NCT01064856|12780478|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
5197360|NCT01064856|12780479|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
5197361|NCT01064856|12780476|P4|NOT COMPLETED|Double-blind (DB) Period||0
5197362|NCT01064856|12780477|P3|NOT COMPLETED|Double-blind (DB) Period||0
5197363|NCT01064856|12780478|P2|NOT COMPLETED|Double-blind (DB) Period||0
5197364|NCT01064856|12780479|P1|NOT COMPLETED|Double-blind (DB) Period||2
5197365|NCT01064856|12780476|P4|COMPLETED|Double-blind (DB) Period||0
5197366|NCT01064856|12780477|P3|COMPLETED|Double-blind (DB) Period||0
5197367|NCT01064856|12780478|P2|COMPLETED|Double-blind (DB) Period||81
5197368|NCT01064856|12780479|P1|COMPLETED|Double-blind (DB) Period||82
5197369|NCT01064856|12780476|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
5197370|NCT01064856|12780477|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
5197371|NCT01064856|12780478|P2|STARTED|Double-blind (DB) Period||81
5197372|NCT01064856|12780479|P1|STARTED|Double-blind (DB) Period||84
5197373|NCT01064830|12780512|P2|NOT COMPLETED|Overall Study||4
5197374|NCT01064830|12780513|P1|NOT COMPLETED|Overall Study||2
5197375|NCT01064830|12780512|P2|COMPLETED|Overall Study||7
5197376|NCT01064830|12780513|P1|COMPLETED|Overall Study||8
5197377|NCT01064830|12780512|P2|STARTED|Overall Study||11
5197378|NCT01064830|12780513|P1|STARTED|Overall Study||10
5197379|NCT01064817|12780523|P2|NOT COMPLETED|Study Completion||0
5197380|NCT01064817|12780524|P1|NOT COMPLETED|Study Completion||2
5197381|NCT01064817|12780523|P2|COMPLETED|Study Completion||62
5197382|NCT01064817|12780524|P1|COMPLETED|Study Completion||60
5197383|NCT01064817|12780523|P2|STARTED|Study Completion||62
5197384|NCT01064817|12780524|P1|STARTED|Study Completion||62
5197385|NCT01064817|12780523|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
5197386|NCT01064817|12780524|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
5197387|NCT01064817|12780523|P2|COMPLETED|All Study Treatment Days 1-9||62
5197388|NCT01064817|12780524|P1|COMPLETED|All Study Treatment Days 1-9||62
5197389|NCT01064817|12780523|P2|STARTED|All Study Treatment Days 1-9||62
5197390|NCT01064817|12780524|P1|STARTED|All Study Treatment Days 1-9||62
5197391|NCT01064739|12780536|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
5197392|NCT01064739|12780536|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
5197393|NCT01064739|12780536|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
5197394|NCT01064739|12780536|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
5197395|NCT01064739|12780536|P1|COMPLETED|Fixed Sodium Study Diet||14
5197396|NCT01064739|12780536|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
5197397|NCT01064713|12780594|P2|NOT COMPLETED|Overall Study||0
5197398|NCT01064713|12780595|P1|NOT COMPLETED|Overall Study||0
5197399|NCT01064713|12780594|P2|COMPLETED|Overall Study||4
5197400|NCT01064713|12780595|P1|COMPLETED|Overall Study||13
5197401|NCT01064713|12780594|P2|STARTED|Overall Study||4
5197402|NCT01064713|12780595|P1|STARTED|Overall Study||13
5197403|NCT01064687|12780607|P4|NOT COMPLETED|Overall Study||17
5197404|NCT01064687|12780608|P3|NOT COMPLETED|Overall Study||41
5197405|NCT01064687|12780609|P2|NOT COMPLETED|Overall Study||26
5197406|NCT01064687|12780610|P1|NOT COMPLETED|Overall Study||34
5197407|NCT01064687|12780607|P4|COMPLETED|Overall Study||124
5197408|NCT01064687|12780608|P3|COMPLETED|Overall Study||237
5197409|NCT01064687|12780609|P2|COMPLETED|Overall Study||254
5197410|NCT01064687|12780610|P1|COMPLETED|Overall Study||245
5197411|NCT01064687|12780607|P4|Completed 26 Weeks|Overall Study||124
5197412|NCT01064687|12780608|P3|Completed 26 Weeks|Overall Study||252
5197413|NCT01064687|12780609|P2|Completed 26 Weeks|Overall Study||263
5197414|NCT01064687|12780610|P1|Completed 26 Weeks|Overall Study||260
5197415|NCT01064687|12780607|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
5197416|NCT01064687|12780608|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
5197417|NCT01064687|12780609|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
5197418|NCT01064687|12780610|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
5197419|NCT01064687|12780607|P4|STARTED|Overall Study||141
5197420|NCT01064687|12780608|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
5197421|NCT01064687|12780609|P2|STARTED|Overall Study||280
5197422|NCT01064687|12780610|P1|STARTED|Overall Study||279
5197423|NCT01064648|12780790|P4|NOT COMPLETED|Phase II||48
5197424|NCT01064648|12780791|P3|NOT COMPLETED|Phase II||49
5197425|NCT01064648|12780792|P2|NOT COMPLETED|Phase II||0
5197426|NCT01064648|12780793|P1|NOT COMPLETED|Phase II||0
5197427|NCT01064648|12780790|P4|COMPLETED|Phase II||0
5197428|NCT01064648|12780791|P3|COMPLETED|Phase II||0
5197429|NCT01064648|12780792|P2|COMPLETED|Phase II||0
5197430|NCT01064648|12780793|P1|COMPLETED|Phase II||0
5197431|NCT01064648|12780790|P4|STARTED|Phase II||48
5197432|NCT01064648|12780791|P3|STARTED|Phase II||49
5197433|NCT01064648|12780792|P2|STARTED|Phase II||0
5197434|NCT01064648|12780793|P1|STARTED|Phase II||0
5197435|NCT01064648|12780790|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197436|NCT01064648|12780791|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197437|NCT01064648|12780792|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
5197438|NCT01064648|12780793|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197439|NCT01064648|12780790|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197440|NCT01064648|12780791|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197441|NCT01064648|12780792|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197442|NCT01064648|12780793|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
5197443|NCT01064648|12780790|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
5197444|NCT01064648|12780791|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
5197445|NCT01064648|12780792|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
5197446|NCT01064648|12780793|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
5197447|NCT01064648|12780790|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
5197448|NCT01064648|12780791|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
5197449|NCT01064648|12780792|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
5197450|NCT01064648|12780793|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
5197451|NCT01064648|12780790|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
5197452|NCT01064648|12780791|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
5197453|NCT01064648|12780792|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
5197454|NCT01064648|12780793|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
5197455|NCT01064648|12780790|P4|STARTED|Phase I Cohort1: Dose Level 1||0
5197456|NCT01064648|12780791|P3|STARTED|Phase I Cohort1: Dose Level 1||0
5197457|NCT01064648|12780792|P2|STARTED|Phase I Cohort1: Dose Level 1||0
5197458|NCT01064648|12780793|P1|STARTED|Phase I Cohort1: Dose Level 1||7
5197459|NCT01064622|12780819|P2|NOT COMPLETED|Crossover of Arm I||0
5197460|NCT01064622|12780820|P1|NOT COMPLETED|Crossover of Arm I||0
5197461|NCT01064622|12780819|P2|COMPLETED|Crossover of Arm I||0
5197462|NCT01064622|12780820|P1|COMPLETED|Crossover of Arm I||22
5197463|NCT01064622|12780819|P2|STARTED|Crossover of Arm I||0
5197464|NCT01064622|12780820|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
5197465|NCT01064622|12780819|P2|NOT COMPLETED|Randomized Phase II||3
5197466|NCT01064622|12780820|P1|NOT COMPLETED|Randomized Phase II||2
5197467|NCT01064622|12780819|P2|COMPLETED|Randomized Phase II||53
5197468|NCT01064622|12780820|P1|COMPLETED|Randomized Phase II||53
5197469|NCT01064622|12780819|P2|STARTED|Randomized Phase II||56
5197470|NCT01064622|12780820|P1|STARTED|Randomized Phase II||55
5197471|NCT01064622|12780819|P2|NOT COMPLETED|Lead-in Phase I||0
5197472|NCT01064622|12780820|P1|NOT COMPLETED|Lead-in Phase I||0
5197473|NCT01064622|12780819|P2|COMPLETED|Lead-in Phase I||7
5197474|NCT01064622|12780820|P1|COMPLETED|Lead-in Phase I||0
5197475|NCT01064622|12780819|P2|STARTED|Lead-in Phase I||7
5197476|NCT01064622|12780820|P1|STARTED|Lead-in Phase I||0
5197477|NCT01064531|12780843|P2|NOT COMPLETED|Overall Study||7
5197478|NCT01064531|12780844|P1|NOT COMPLETED|Overall Study||3
5197479|NCT01064531|12780843|P2|COMPLETED|Overall Study||13
5197480|NCT01064531|12780844|P1|COMPLETED|Overall Study||18
5197481|NCT01064531|12780843|P2|STARTED|Overall Study||20
5197482|NCT01064531|12780844|P1|STARTED|Overall Study||21
5197483|NCT01064414|12780891|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
5197484|NCT01064414|12780892|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
5197485|NCT01064414|12780893|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
5197486|NCT01064414|12780891|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
5197487|NCT01064414|12780892|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
5197488|NCT01064414|12780893|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
5197489|NCT01064414|12780891|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
5197490|NCT01064414|12780892|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
5197491|NCT01064414|12780893|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
5197492|NCT01064414|12780891|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
5197493|NCT01064414|12780892|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
5197494|NCT01064414|12780893|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
5197495|NCT01064414|12780891|P3|COMPLETED|Core Period: Baseline to Week 26||82
5197496|NCT01064414|12780892|P2|COMPLETED|Core Period: Baseline to Week 26||75
5197497|NCT01064414|12780893|P1|COMPLETED|Core Period: Baseline to Week 26||77
5197498|NCT01064414|12780891|P3|STARTED|Core Period: Baseline to Week 26||89
5197499|NCT01064414|12780892|P2|STARTED|Core Period: Baseline to Week 26||90
5197500|NCT01064414|12780893|P1|STARTED|Core Period: Baseline to Week 26||90
5197501|NCT01064401|12780912|P2|NOT COMPLETED|Overall Study||195
5197502|NCT01064401|12780913|P1|NOT COMPLETED|Overall Study||228
5197503|NCT01064401|12780912|P2|COMPLETED|Overall Study||724
5197504|NCT01064401|12780913|P1|COMPLETED|Overall Study||694
5197505|NCT01064401|12780912|P2|STARTED|Overall Study||919
5197506|NCT01064401|12780913|P1|STARTED|Overall Study||922
5197507|NCT01064362|12780929|P2|NOT COMPLETED|Overall Study||0
5197508|NCT01064362|12780930|P1|NOT COMPLETED|Overall Study||0
5197509|NCT01064362|12780929|P2|COMPLETED|Overall Study||11883
5197510|NCT01064362|12780930|P1|COMPLETED|Overall Study||1559
5197511|NCT01064362|12780929|P2|STARTED|Overall Study||11883
5197512|NCT01064362|12780930|P1|STARTED|Overall Study||1559
5197513|NCT01064323|12780938|P1|NOT COMPLETED|Overall Study||0
5197514|NCT01064323|12780938|P1|COMPLETED|Overall Study||10
5197515|NCT01064323|12780938|P1|STARTED|Overall Study||10
5197516|NCT01064310|12780962|P3|NOT COMPLETED|Open Label Pazopinib||84
5197517|NCT01064310|12780963|P2|NOT COMPLETED|Open Label Pazopinib||0
5197518|NCT01064310|12780964|P1|NOT COMPLETED|Open Label Pazopinib||0
5197519|NCT01064310|12780962|P3|COMPLETED|Open Label Pazopinib||0
5197520|NCT01064310|12780963|P2|COMPLETED|Open Label Pazopinib||0
5197521|NCT01064310|12780964|P1|COMPLETED|Open Label Pazopinib||0
5197522|NCT01064310|12780962|P3|STARTED|Open Label Pazopinib||84
5197523|NCT01064310|12780963|P2|STARTED|Open Label Pazopinib||0
5197524|NCT01064310|12780964|P1|STARTED|Open Label Pazopinib||0
5197525|NCT01064310|12780962|P3|NOT COMPLETED|Period 2||0
5197526|NCT01064310|12780963|P2|NOT COMPLETED|Period 2||6
5197527|NCT01064310|12780964|P1|NOT COMPLETED|Period 2||4
5197528|NCT01064310|12780962|P3|COMPLETED|Period 2||0
5197529|NCT01064310|12780963|P2|COMPLETED|Period 2||62
5197530|NCT01064310|12780964|P1|COMPLETED|Period 2||64
5197531|NCT01064310|12780962|P3|STARTED|Period 2||0
5197532|NCT01064310|12780963|P2|STARTED|Period 2||68
5197533|NCT01064310|12780964|P1|STARTED|Period 2||68
5197534|NCT01064310|12780962|P3|NOT COMPLETED|Period 1||0
5197535|NCT01064310|12780963|P2|NOT COMPLETED|Period 1||18
5197536|NCT01064310|12780964|P1|NOT COMPLETED|Period 1||14
5197537|NCT01064310|12780962|P3|COMPLETED|Period 1||0
5197538|NCT01064310|12780963|P2|COMPLETED|Period 1||68
5197539|NCT01064310|12780964|P1|COMPLETED|Period 1||68
5197540|NCT01064310|12780962|P3|STARTED|Period 1||0
5197541|NCT01064310|12780963|P2|STARTED|Period 1||86
5197542|NCT01064310|12780964|P1|STARTED|Period 1||82
5197543|NCT01064297|12780994|P3|NOT COMPLETED|Overall Study||133
5197544|NCT01064297|12780995|P2|NOT COMPLETED|Overall Study||48
5197545|NCT01064297|12780996|P1|NOT COMPLETED|Overall Study||791
5197546|NCT01064297|12780994|P3|COMPLETED|Overall Study||497
5197547|NCT01064297|12780995|P2|COMPLETED|Overall Study||171
5197548|NCT01064297|12780996|P1|COMPLETED|Overall Study||1776
5197549|NCT01064297|12780994|P3|STARTED|Overall Study||630
5197550|NCT01064297|12780995|P2|STARTED|Overall Study||219
5197551|NCT01064297|12780996|P1|STARTED|Overall Study||2567
5197552|NCT01064284|12781042|P2|NOT COMPLETED|Overall Study||17
5197553|NCT01064284|12781043|P1|NOT COMPLETED|Overall Study||18
5197554|NCT01064284|12781042|P2|COMPLETED|Overall Study||109
5197555|NCT01064284|12781043|P1|COMPLETED|Overall Study||107
5197556|NCT01064284|12781042|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
5197557|NCT01064284|12781043|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
5197558|NCT01064167|12781065|P2|NOT COMPLETED|Overall Study||15
5197559|NCT01064167|12781066|P1|NOT COMPLETED|Overall Study||14
5197560|NCT01064167|12781065|P2|COMPLETED|Overall Study||115
5197561|NCT01064167|12781066|P1|COMPLETED|Overall Study||116
5197562|NCT01064167|12781065|P2|STARTED|Overall Study||130
5197563|NCT01064167|12781066|P1|STARTED|Overall Study||130
5197564|NCT01064076|12781074|P1|NOT COMPLETED|Overall Study||18
5197565|NCT01064076|12781074|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
5197566|NCT01064076|12781074|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
5197567|NCT01063972|12781081|P2|NOT COMPLETED|Overall Study||12
5197568|NCT01063972|12781082|P1|NOT COMPLETED|Overall Study||14
5197569|NCT01063972|12781081|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
5197570|NCT01063972|12781082|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
5197571|NCT01063972|12781081|P2|STARTED|Overall Study||296
5197572|NCT01063972|12781082|P1|STARTED|Overall Study||310
5197573|NCT01063907|12781098|P2|NOT COMPLETED|Overall Study||0
5197574|NCT01063907|12781099|P1|NOT COMPLETED|Overall Study||0
5197575|NCT01063907|12781098|P2|COMPLETED|Overall Study||80
5197576|NCT01063907|12781099|P1|COMPLETED|Overall Study||15
5197577|NCT01063907|12781098|P2|STARTED|Overall Study||80
5197578|NCT01063907|12781099|P1|STARTED|Overall Study||15
5197579|NCT01063881|12781132|P3|NOT COMPLETED|Overall Study||1
5197580|NCT01063881|12781133|P2|NOT COMPLETED|Overall Study||11
5197581|NCT01063881|12781134|P1|NOT COMPLETED|Overall Study||55
5197582|NCT01063881|12781132|P3|COMPLETED|Overall Study||12
5197583|NCT01063881|12781133|P2|COMPLETED|Overall Study||114
5197584|NCT01063881|12781134|P1|COMPLETED|Overall Study||92
5197585|NCT01063881|12781132|P3|STARTED|Overall Study||13
5197586|NCT01063881|12781133|P2|STARTED|Overall Study||125
5197587|NCT01063881|12781134|P1|STARTED|Overall Study||147
5197588|NCT01063868|12781158|P2|NOT COMPLETED|Overall Study||12
5197589|NCT01063868|12781159|P1|NOT COMPLETED|Overall Study||35
5197590|NCT01063868|12781158|P2|COMPLETED|Overall Study||0
5197591|NCT01063868|12781159|P1|COMPLETED|Overall Study||0
5197592|NCT01063868|12781158|P2|STARTED|Overall Study||12
5197593|NCT01063868|12781159|P1|STARTED|Overall Study||35
5197594|NCT01063855|12781167|P2|NOT COMPLETED|Overall Study||29
5197595|NCT01063855|12781168|P1|NOT COMPLETED|Overall Study||37
5197596|NCT01063855|12781167|P2|COMPLETED|Overall Study||221
5197597|NCT01063855|12781168|P1|COMPLETED|Overall Study||208
5197598|NCT01063855|12781167|P2|STARTED|Overall Study||250
5197599|NCT01063855|12781168|P1|STARTED|Overall Study||245
5197600|NCT01063829|12781194|P4|NOT COMPLETED|Overall Study||21
5197601|NCT01063829|12781195|P3|NOT COMPLETED|Overall Study||10
5197602|NCT01063829|12781196|P2|NOT COMPLETED|Overall Study||10
5197603|NCT01063829|12781197|P1|NOT COMPLETED|Overall Study||16
5197604|NCT01063829|12781194|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
5197605|NCT01063829|12781195|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
5197606|NCT01063829|12781196|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
5197607|NCT01063829|12781197|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
5197608|NCT01063829|12781194|P4|STARTED|Overall Study||33
5197609|NCT01063829|12781195|P3|STARTED|Overall Study||34
5197610|NCT01063829|12781196|P2|STARTED|Overall Study||31
5197611|NCT01063829|12781197|P1|STARTED|Overall Study||33
5197612|NCT01063764|12781215|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
5197613|NCT01063764|12781215|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
5197614|NCT01063764|12781215|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
5197615|NCT01063764|12781215|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
5197616|NCT01063764|12781215|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
5197617|NCT01063764|12781215|P1|STARTED|1st Period (From Week 8 to Week 22)||73
5197618|NCT01063712|12781229|P1|NOT COMPLETED|Overall Study||0
5197619|NCT01063712|12781229|P1|COMPLETED|Overall Study||29
5197620|NCT01063712|12781229|P1|STARTED|Overall Study||29
5197621|NCT01063595|12781234|P2|NOT COMPLETED|Second Intervention||0
5197622|NCT01063595|12781235|P1|NOT COMPLETED|Second Intervention||0
5197623|NCT01063595|12781234|P2|COMPLETED|Second Intervention||24
5197624|NCT01063595|12781235|P1|COMPLETED|Second Intervention||29
5197625|NCT01063595|12781234|P2|STARTED|Second Intervention||24
5197626|NCT01063595|12781235|P1|STARTED|Second Intervention||29
5197627|NCT01063595|12781234|P2|NOT COMPLETED|First Intervention||5
5197628|NCT01063595|12781235|P1|NOT COMPLETED|First Intervention||2
5197629|NCT01063595|12781234|P2|COMPLETED|First Intervention||24
5197630|NCT01063595|12781235|P1|COMPLETED|First Intervention||29
5197631|NCT01063595|12781234|P2|STARTED|First Intervention||29
5197632|NCT01063595|12781235|P1|STARTED|First Intervention||31
5197633|NCT01063595|12781234|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
5197634|NCT01063595|12781235|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
5197635|NCT01063595|12781234|P2|COMPLETED|Enrolled in Study and Randomized||29
5197636|NCT01063595|12781235|P1|COMPLETED|Enrolled in Study and Randomized||31
5197637|NCT01063595|12781234|P2|Received Treatment|Enrolled in Study and Randomized||29
5197638|NCT01063595|12781235|P1|Received Treatment|Enrolled in Study and Randomized||31
5197639|NCT01063595|12781234|P2|STARTED|Enrolled in Study and Randomized||31
5197640|NCT01063595|12781235|P1|STARTED|Enrolled in Study and Randomized||32
5197641|NCT01063517|12781247|P2|NOT COMPLETED|Overall Study||60
5197642|NCT01063517|12781248|P1|NOT COMPLETED|Overall Study||58
5197643|NCT01063517|12781247|P2|COMPLETED|Overall Study||2
5197644|NCT01063517|12781248|P1|COMPLETED|Overall Study||4
5197645|NCT01063517|12781247|P2|Received Randomised Treatment|Overall Study||62
5197646|NCT01063517|12781248|P1|Received Randomised Treatment|Overall Study||61
5197647|NCT01063517|12781247|P2|STARTED|Overall Study||62
5197648|NCT01063517|12781248|P1|STARTED|Overall Study||62
5197649|NCT01063348|12781288|P2|NOT COMPLETED|Overall Study||10
5197650|NCT01063348|12781289|P1|NOT COMPLETED|Overall Study||3
5197651|NCT01063348|12781288|P2|COMPLETED|Overall Study||21
5197652|NCT01063348|12781289|P1|COMPLETED|Overall Study||32
5197653|NCT01063348|12781288|P2|STARTED|Overall Study||31
5197654|NCT01063348|12781289|P1|STARTED|Overall Study||35
5197655|NCT01063283|12781299|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
5197656|NCT01063283|12781300|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
5197657|NCT01063283|12781301|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
5197658|NCT01063283|12781299|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
5197659|NCT01063283|12781300|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
5197660|NCT01063283|12781301|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
5197661|NCT01063283|12781299|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
5197662|NCT01063283|12781300|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
5197663|NCT01063283|12781301|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
5197664|NCT01063283|12781299|P3|NOT COMPLETED|Cycle 1||0
5197665|NCT01063283|12781300|P2|NOT COMPLETED|Cycle 1||0
5197666|NCT01063283|12781301|P1|NOT COMPLETED|Cycle 1||3
5197667|NCT01063283|12781299|P3|COMPLETED|Cycle 1||0
5197668|NCT01063283|12781300|P2|COMPLETED|Cycle 1||0
5197669|NCT01063283|12781301|P1|COMPLETED|Cycle 1||17
5197670|NCT01063283|12781299|P3|STARTED|Cycle 1||0
5197671|NCT01063283|12781300|P2|STARTED|Cycle 1||0
5197672|NCT01063283|12781301|P1|STARTED|Cycle 1||20
5197673|NCT01063153|12781315|P2|NOT COMPLETED|Overall Study||12
5197674|NCT01063153|12781316|P1|NOT COMPLETED|Overall Study||2
5197675|NCT01063153|12781315|P2|COMPLETED|Overall Study||26
5197676|NCT01063153|12781316|P1|COMPLETED|Overall Study||31
5197677|NCT01063153|12781315|P2|STARTED|Overall Study||38
5197678|NCT01063153|12781316|P1|STARTED|Overall Study||33
5197679|NCT01063075|12781326|P4|NOT COMPLETED|Overall Study||1
5197680|NCT01063075|12781327|P3|NOT COMPLETED|Overall Study||5
5197681|NCT01063075|12781328|P2|NOT COMPLETED|Overall Study||2
5197682|NCT01063075|12781329|P1|NOT COMPLETED|Overall Study||1
5197683|NCT01063075|12781326|P4|COMPLETED|Overall Study||14
5197684|NCT01063075|12781327|P3|COMPLETED|Overall Study||9
5197685|NCT01063075|12781328|P2|COMPLETED|Overall Study||1
5197686|NCT01063075|12781329|P1|COMPLETED|Overall Study||1
5197687|NCT01063075|12781326|P4|STARTED|Overall Study||15
5197688|NCT01063075|12781327|P3|STARTED|Overall Study||14
5197689|NCT01063075|12781328|P2|STARTED|Overall Study||3
5197690|NCT01063075|12781329|P1|STARTED|Overall Study||2
5197691|NCT01063062|12781347|P2|NOT COMPLETED|Overall Study||12
5197692|NCT01063062|12781348|P1|NOT COMPLETED|Overall Study||8
5197693|NCT01063062|12781347|P2|COMPLETED|Overall Study||65
5197694|NCT01063062|12781348|P1|COMPLETED|Overall Study||22
5197695|NCT01063062|12781347|P2|Received Study Drug|Overall Study||76
5197696|NCT01063062|12781348|P1|Received Study Drug|Overall Study||29
5197697|NCT01063062|12781347|P2|STARTED|Overall Study||77
5197698|NCT01063062|12781348|P1|STARTED|Overall Study||30
5197699|NCT01063049|12781389|P3|NOT COMPLETED|Overall Study||0
5197700|NCT01063049|12781390|P2|NOT COMPLETED|Overall Study||0
5197701|NCT01063049|12781391|P1|NOT COMPLETED|Overall Study||0
5197702|NCT01063049|12781389|P3|COMPLETED|Overall Study||200
5197703|NCT01063049|12781390|P2|COMPLETED|Overall Study||200
5197704|NCT01063049|12781391|P1|COMPLETED|Overall Study||200
5197705|NCT01063049|12781389|P3|STARTED|Overall Study||200
5197706|NCT01063049|12781390|P2|STARTED|Overall Study||200
5197707|NCT01063049|12781391|P1|STARTED|Overall Study||200
5197708|NCT01063036|12781402|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
5197709|NCT01063036|12781402|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
5197710|NCT01063036|12781402|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
5197711|NCT01063036|12781402|P1|NOT COMPLETED|Participants Treated With Study Drug||6
5197712|NCT01063036|12781402|P1|COMPLETED|Participants Treated With Study Drug||86
5197713|NCT01063036|12781402|P1|STARTED|Participants Treated With Study Drug||92
5197714|NCT01062971|12781418|P2|NOT COMPLETED|Overall Study||7
5197715|NCT01062971|12781419|P1|NOT COMPLETED|Overall Study||4
5197716|NCT01062971|12781418|P2|COMPLETED|Overall Study||56
5197717|NCT01062971|12781419|P1|COMPLETED|Overall Study||56
5197718|NCT01062971|12781418|P2|STARTED|Overall Study||63
5197719|NCT01062971|12781419|P1|STARTED|Overall Study||60
5197720|NCT01062893|12781429|P2|NOT COMPLETED|Overall Study||13
5197721|NCT01062893|12781430|P1|NOT COMPLETED|Overall Study||14
5197722|NCT01062893|12781429|P2|COMPLETED|Overall Study||28
5197723|NCT01062893|12781430|P1|COMPLETED|Overall Study||27
5197724|NCT01062893|12781429|P2|STARTED|Overall Study||41
5197725|NCT01062893|12781430|P1|STARTED|Overall Study||41
5197726|NCT01062841|12781458|P2|NOT COMPLETED|Overall Study||53
5197727|NCT01062841|12781459|P1|NOT COMPLETED|Overall Study||49
5197728|NCT01062841|12781458|P2|COMPLETED|Overall Study||162
5197729|NCT01062841|12781459|P1|COMPLETED|Overall Study||154
5197730|NCT01062841|12781458|P2|STARTED|Overall Study||215
5197731|NCT01062841|12781459|P1|STARTED|Overall Study||203
5197732|NCT01062763|12781489|P2|NOT COMPLETED|Overall Study||4
5197733|NCT01062763|12781490|P1|NOT COMPLETED|Overall Study||3
5197734|NCT01062763|12781489|P2|COMPLETED|Overall Study||57
5197735|NCT01062763|12781490|P1|COMPLETED|Overall Study||55
5197736|NCT01062763|12781489|P2|STARTED|Overall Study||61
5197737|NCT01062763|12781490|P1|STARTED|Overall Study|119 randomized.|58
5197738|NCT01062568|12781502|P2|NOT COMPLETED|Overall Study||0
5197739|NCT01062568|12781503|P1|NOT COMPLETED|Overall Study||0
5197740|NCT01062568|12781502|P2|COMPLETED|Overall Study||40
5197741|NCT01062568|12781503|P1|COMPLETED|Overall Study||10
5197742|NCT01062568|12781502|P2|STARTED|Overall Study||40
5197743|NCT01062568|12781503|P1|STARTED|Overall Study||10
5197744|NCT01062425|12781516|P2|NOT COMPLETED|Overall Study||6
5197745|NCT01062425|12781517|P1|NOT COMPLETED|Overall Study||3
5197746|NCT01062425|12781516|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
5197747|NCT01062425|12781517|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
5197748|NCT01062425|12781516|P2|STARTED|Overall Study||103
5197749|NCT01062425|12781517|P1|STARTED|Overall Study||55
5197750|NCT01062399|12781534|P5|NOT COMPLETED|Overall Study||4
5197751|NCT01062399|12781535|P4|NOT COMPLETED|Overall Study||6
5197752|NCT01062399|12781536|P3|NOT COMPLETED|Overall Study||0
5197753|NCT01062399|12781537|P2|NOT COMPLETED|Overall Study||1
5197754|NCT01062399|12781538|P1|NOT COMPLETED|Overall Study||0
5197755|NCT01062399|12781534|P5|COMPLETED|Overall Study||88
5197756|NCT01062399|12781535|P4|COMPLETED|Overall Study||83
5197757|NCT01062399|12781536|P3|COMPLETED|Overall Study||8
5197758|NCT01062399|12781537|P2|COMPLETED|Overall Study||9
5197759|NCT01062399|12781538|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
5197760|NCT01062399|12781534|P5|STARTED|Overall Study||92
5197761|NCT01062399|12781535|P4|STARTED|Overall Study||89
5197762|NCT01062399|12781536|P3|STARTED|Overall Study||8
5197763|NCT01062399|12781537|P2|STARTED|Overall Study||10
5197764|NCT01062399|12781538|P1|STARTED|Overall Study||8
5197765|NCT01062308|12781559|P2|NOT COMPLETED|Overall Study||10
5197766|NCT01062308|12781560|P1|NOT COMPLETED|Overall Study||16
5197767|NCT01062308|12781559|P2|COMPLETED|Overall Study||72
5197768|NCT01062308|12781560|P1|COMPLETED|Overall Study||64
5197769|NCT01062308|12781559|P2|STARTED|Overall Study||82
5197770|NCT01062308|12781560|P1|STARTED|Overall Study||80
5197771|NCT01062269|12781568|P1|NOT COMPLETED|Overall Study||0
5197772|NCT01062269|12781568|P1|COMPLETED|Overall Study||42
5197773|NCT01062269|12781568|P1|STARTED|Overall Study||42
5197774|NCT01062256|12781582|P3|NOT COMPLETED|Overall Study||4
5197775|NCT01062256|12781583|P2|NOT COMPLETED|Overall Study||7
5197776|NCT01062256|12781584|P1|NOT COMPLETED|Overall Study||3
5197777|NCT01062256|12781582|P3|COMPLETED|Overall Study||103
5197778|NCT01062256|12781583|P2|COMPLETED|Overall Study||96
5197779|NCT01062256|12781584|P1|COMPLETED|Overall Study||52
5197780|NCT01062256|12781582|P3|STARTED|Overall Study||107
5197781|NCT01062256|12781583|P2|STARTED|Overall Study||103
5197782|NCT01062256|12781584|P1|STARTED|Overall Study||55
5197783|NCT01062230|12781607|P1|NOT COMPLETED|Overall Study||0
5197784|NCT01062230|12781607|P1|COMPLETED|Overall Study||6
5197785|NCT01062230|12781607|P1|STARTED|Overall Study||6
5197786|NCT01062165|12781611|P1|NOT COMPLETED|Overall Study||0
5197787|NCT01062165|12781611|P1|COMPLETED|Overall Study||18
5197788|NCT01062165|12781611|P1|STARTED|Overall Study||18
5197789|NCT01062113|12781618|P3|NOT COMPLETED|Overall Study||31
5197790|NCT01062113|12781619|P2|NOT COMPLETED|Overall Study||22
5197791|NCT01062113|12781620|P1|NOT COMPLETED|Overall Study||40
5197792|NCT01062113|12781618|P3|COMPLETED|Overall Study||27
5197793|NCT01062113|12781619|P2|COMPLETED|Overall Study||42
5197794|NCT01062113|12781620|P1|COMPLETED|Overall Study||93
5197795|NCT01062113|12781618|P3|STARTED|Overall Study||58
5197796|NCT01062113|12781619|P2|STARTED|Overall Study||64
5197797|NCT01062113|12781620|P1|STARTED|Overall Study||133
5197798|NCT01062074|12781633|P1|NOT COMPLETED|Overall Study||0
5197799|NCT01062074|12781633|P1|COMPLETED|Overall Study||3605
5197800|NCT01062074|12781633|P1|STARTED|Overall Study||3605
5197801|NCT01062061|12781638|P1|NOT COMPLETED|Overall Study||27
5197802|NCT01062061|12781638|P1|COMPLETED|Overall Study||727
5197803|NCT01062061|12781638|P1|STARTED|Overall Study||754
5197804|NCT01062009|12781656|P4|NOT COMPLETED|Overall Study||0
5197805|NCT01062009|12781657|P3|NOT COMPLETED|Overall Study||0
5197806|NCT01062009|12781658|P2|NOT COMPLETED|Overall Study||0
5197807|NCT01062009|12781659|P1|NOT COMPLETED|Overall Study||1
5197808|NCT01062009|12781656|P4|COMPLETED|Overall Study||6
5197809|NCT01062009|12781657|P3|COMPLETED|Overall Study||6
5197810|NCT01062009|12781658|P2|COMPLETED|Overall Study||6
5197811|NCT01062009|12781659|P1|COMPLETED|Overall Study||6
5197812|NCT01062009|12781656|P4|STARTED|Overall Study||6
5197813|NCT01062009|12781657|P3|STARTED|Overall Study||6
5197814|NCT01062009|12781658|P2|STARTED|Overall Study||6
5197815|NCT01062009|12781659|P1|STARTED|Overall Study||7
5197816|NCT01061866|12781677|P1|NOT COMPLETED|Overall Study||2
5197817|NCT01061866|12781677|P1|COMPLETED|Overall Study||5
5197818|NCT01061866|12781677|P1|STARTED|Overall Study||7
5197819|NCT01061775|12781681|P1|NOT COMPLETED|Overall Study||3
5197820|NCT01061775|12781681|P1|COMPLETED|Overall Study||16
5197821|NCT01061775|12781681|P1|STARTED|Overall Study||19
5197822|NCT01061736|12781698|P10|NOT COMPLETED|Overall Study||74
5197823|NCT01061736|12781699|P9|NOT COMPLETED|Overall Study||97
5197824|NCT01061736|12781700|P8|NOT COMPLETED|Overall Study||94
5197825|NCT01061736|12781701|P7|NOT COMPLETED|Overall Study||84
5197826|NCT01061736|12781702|P6|NOT COMPLETED|Overall Study||3
5197827|NCT01061736|12781703|P5|NOT COMPLETED|Overall Study||7
5197828|NCT01061736|12781704|P4|NOT COMPLETED|Overall Study||3
5197829|NCT01061736|12781705|P3|NOT COMPLETED|Overall Study||6
5197830|NCT01061736|12781706|P2|NOT COMPLETED|Overall Study||4
5197831|NCT01061736|12781707|P1|NOT COMPLETED|Overall Study||13
5197832|NCT01061736|12781698|P10|COMPLETED|Overall Study||354
5197833|NCT01061736|12781699|P9|COMPLETED|Overall Study||330
5197834|NCT01061736|12781700|P8|COMPLETED|Overall Study||336
5197835|NCT01061736|12781701|P7|COMPLETED|Overall Study||0
5197836|NCT01061736|12781702|P6|COMPLETED|Overall Study||49
5197837|NCT01061736|12781703|P5|COMPLETED|Overall Study||45
5197838|NCT01061736|12781704|P4|COMPLETED|Overall Study||48
5197839|NCT01061736|12781705|P3|COMPLETED|Overall Study||45
5197840|NCT01061736|12781706|P2|COMPLETED|Overall Study||46
5197841|NCT01061736|12781707|P1|COMPLETED|Overall Study||37
5197842|NCT01061736|12781698|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
5197843|NCT01061736|12781699|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
5197844|NCT01061736|12781700|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
5197845|NCT01061736|12781701|P7|Rescued|Overall Study||0
5197846|NCT01061736|12781702|P6|Rescued|Overall Study||0
5197847|NCT01061736|12781703|P5|Rescued|Overall Study||0
5197848|NCT01061736|12781704|P4|Rescued|Overall Study||0
5197849|NCT01061736|12781705|P3|Rescued|Overall Study||0
5197850|NCT01061736|12781706|P2|Rescued|Overall Study||0
5197851|NCT01061736|12781707|P1|Rescued|Overall Study||0
5197852|NCT01061736|12781698|P10|Treated|Overall Study||428
5197853|NCT01061736|12781699|P9|Treated|Overall Study||426
5197854|NCT01061736|12781700|P8|Treated|Overall Study||428
5197855|NCT01061736|12781701|P7|Treated|Overall Study||84
5197856|NCT01061736|12781702|P6|Treated|Overall Study||52
5197857|NCT01061736|12781703|P5|Treated|Overall Study||51
5197858|NCT01061736|12781704|P4|Treated|Overall Study||51
5197859|NCT01061736|12781705|P3|Treated|Overall Study||51
5197860|NCT01061736|12781706|P2|Treated|Overall Study||50
5197861|NCT01061736|12781707|P1|Treated|Overall Study||50
5197862|NCT01061736|12781698|P10|STARTED|Overall Study||428
5197863|NCT01061736|12781699|P9|STARTED|Overall Study||427
5197864|NCT01061736|12781700|P8|STARTED|Overall Study||430
5197865|NCT01061736|12781701|P7|STARTED|Overall Study||84
5197866|NCT01061736|12781702|P6|STARTED|Overall Study||52
5197867|NCT01061736|12781703|P5|STARTED|Overall Study||52
5197868|NCT01061736|12781704|P4|STARTED|Overall Study||51
5197869|NCT01061736|12781705|P3|STARTED|Overall Study||51
5197870|NCT01061736|12781706|P2|STARTED|Overall Study||50
5197871|NCT01061736|12781707|P1|STARTED|Overall Study||50
5197872|NCT01061723|12781746|P6|NOT COMPLETED|Overall Study||9
5197873|NCT01061723|12781747|P5|NOT COMPLETED|Overall Study||3
5197874|NCT01061723|12781748|P4|NOT COMPLETED|Overall Study||8
5197875|NCT01061723|12781749|P3|NOT COMPLETED|Overall Study||10
5197876|NCT01061723|12781750|P2|NOT COMPLETED|Overall Study||6
5197877|NCT01061723|12781751|P1|NOT COMPLETED|Overall Study||4
5197878|NCT01061723|12781746|P6|COMPLETED|Overall Study||41
5197879|NCT01061723|12781747|P5|COMPLETED|Overall Study||47
5197880|NCT01061723|12781748|P4|COMPLETED|Overall Study||44
5197881|NCT01061723|12781749|P3|COMPLETED|Overall Study||40
5197882|NCT01061723|12781750|P2|COMPLETED|Overall Study||43
5197883|NCT01061723|12781751|P1|COMPLETED|Overall Study||46
5197884|NCT01061723|12781746|P6|Treated|Overall Study||49
5197885|NCT01061723|12781747|P5|Treated|Overall Study||50
5197886|NCT01061723|12781748|P4|Treated|Overall Study||52
5197887|NCT01061723|12781749|P3|Treated|Overall Study||50
5197888|NCT01061723|12781750|P2|Treated|Overall Study||49
5197889|NCT01061723|12781751|P1|Treated|Overall Study||50
5197890|NCT01061723|12781746|P6|STARTED|Overall Study||50
5197891|NCT01061723|12781747|P5|STARTED|Overall Study||50
5197892|NCT01061723|12781748|P4|STARTED|Overall Study||52
5197893|NCT01061723|12781749|P3|STARTED|Overall Study||50
5197894|NCT01061723|12781750|P2|STARTED|Overall Study||49
5197895|NCT01061723|12781751|P1|STARTED|Overall Study||50
5197896|NCT01061710|12781831|P1|NOT COMPLETED|Overall Study||14
5197897|NCT01061710|12781831|P1|COMPLETED|Overall Study||6
5197898|NCT01061710|12781831|P1|STARTED|Overall Study||20
5197899|NCT01061671|12781841|P2|NOT COMPLETED|Overall Study||55
5197900|NCT01061671|12781842|P1|NOT COMPLETED|Overall Study||47
5197901|NCT01061671|12781841|P2|COMPLETED|Overall Study||397
5197902|NCT01061671|12781842|P1|COMPLETED|Overall Study||386
5197903|NCT01061671|12781841|P2|STARTED|Overall Study||452
5197904|NCT01061671|12781842|P1|STARTED|Overall Study||433
5197905|NCT01061606|12781854|P1|NOT COMPLETED|Overall Study||8
5197906|NCT01061606|12781854|P1|COMPLETED|Overall Study||0
5197907|NCT01061606|12781854|P1|STARTED|Overall Study||8
5197908|NCT01061567|12781863|P1|NOT COMPLETED|Overall Study||76
5197909|NCT01061567|12781863|P1|COMPLETED|Overall Study||1738
5197910|NCT01061567|12781863|P1|STARTED|Overall Study||1814
5197911|NCT01061528|12781874|P2|NOT COMPLETED|Overall Study||2
5197912|NCT01061528|12781875|P1|NOT COMPLETED|Overall Study||3
5197913|NCT01061528|12781874|P2|COMPLETED|Overall Study||52
5197914|NCT01061528|12781875|P1|COMPLETED|Overall Study||59
5197915|NCT01061528|12781874|P2|STARTED|Overall Study||54
5197916|NCT01061528|12781875|P1|STARTED|Overall Study||62
5197917|NCT01061476|12781881|P1|NOT COMPLETED|Overall Study||0
5197918|NCT01061476|12781881|P1|COMPLETED|Overall Study||12
5197919|NCT01061476|12781881|P1|STARTED|Overall Study||12
5197920|NCT01061385|12781887|P2|NOT COMPLETED|Overall Study||1
5197921|NCT01061385|12781888|P1|NOT COMPLETED|Overall Study||1
5197922|NCT01061385|12781887|P2|COMPLETED|Overall Study||8
5197923|NCT01061385|12781888|P1|COMPLETED|Overall Study||20
5197924|NCT01061385|12781887|P2|STARTED|Overall Study||9
5197925|NCT01061385|12781888|P1|STARTED|Overall Study||21
5197926|NCT01061359|12781896|P1|NOT COMPLETED|Overall Study||1302
5197927|NCT01061359|12781896|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
5197928|NCT01061359|12781896|P1|STARTED|Overall Study||1972
5197929|NCT01061333|12781902|P2|NOT COMPLETED|Period 7: Mometasone||0
5197930|NCT01061333|12781903|P1|NOT COMPLETED|Period 7: Mometasone||0
5197931|NCT01061333|12781902|P2|COMPLETED|Period 7: Mometasone||7
5197932|NCT01061333|12781903|P1|COMPLETED|Period 7: Mometasone||8
5197933|NCT01061333|12781902|P2|STARTED|Period 7: Mometasone||7
5197934|NCT01061333|12781903|P1|STARTED|Period 7: Mometasone||8
5197935|NCT01061333|12781902|P2|NOT COMPLETED|Period 6: 20-day Washout||0
5197936|NCT01061333|12781903|P1|NOT COMPLETED|Period 6: 20-day Washout||0
5197937|NCT01061333|12781902|P2|COMPLETED|Period 6: 20-day Washout||7
5197938|NCT01061333|12781903|P1|COMPLETED|Period 6: 20-day Washout||8
5197939|NCT01061333|12781902|P2|STARTED|Period 6: 20-day Washout||7
5197940|NCT01061333|12781903|P1|STARTED|Period 6: 20-day Washout||8
5197941|NCT01061333|12781902|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
5197942|NCT01061333|12781903|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
5197943|NCT01061333|12781902|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
5197944|NCT01061333|12781903|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
5197945|NCT01061333|12781902|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
5197946|NCT01061333|12781903|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
5197947|NCT01061333|12781902|P2|NOT COMPLETED|Period 4: 20-day Washout||1
5197948|NCT01061333|12781903|P1|NOT COMPLETED|Period 4: 20-day Washout||0
5197949|NCT01061333|12781902|P2|COMPLETED|Period 4: 20-day Washout||7
5197950|NCT01061333|12781903|P1|COMPLETED|Period 4: 20-day Washout||8
5197951|NCT01061333|12781902|P2|STARTED|Period 4: 20-day Washout||8
5197952|NCT01061333|12781903|P1|STARTED|Period 4: 20-day Washout||8
5197953|NCT01061333|12781902|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
5197954|NCT01061333|12781903|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
5197955|NCT01061333|12781902|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
5197956|NCT01061333|12781903|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
5197957|NCT01061333|12781902|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
5197958|NCT01061333|12781903|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
5197959|NCT01061333|12781902|P2|NOT COMPLETED|Period 2: 20-day Washout||0
5197960|NCT01061333|12781903|P1|NOT COMPLETED|Period 2: 20-day Washout||0
5197961|NCT01061333|12781902|P2|COMPLETED|Period 2: 20-day Washout||8
5197962|NCT01061333|12781903|P1|COMPLETED|Period 2: 20-day Washout||8
5197963|NCT01061333|12781902|P2|STARTED|Period 2: 20-day Washout||8
5197964|NCT01061333|12781903|P1|STARTED|Period 2: 20-day Washout||8
5197965|NCT01061333|12781902|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
5197966|NCT01061333|12781903|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
5197967|NCT01061333|12781902|P2|COMPLETED|Period 1: Placebo Run-in||8
5197968|NCT01061333|12781903|P1|COMPLETED|Period 1: Placebo Run-in||8
5197969|NCT01061333|12781902|P2|STARTED|Period 1: Placebo Run-in||8
5197970|NCT01061333|12781903|P1|STARTED|Period 1: Placebo Run-in||8
5197971|NCT01061177|12781941|P1|NOT COMPLETED|Overall Study||208
5197972|NCT01061177|12781941|P1|COMPLETED|Overall Study||881
5197973|NCT01061177|12781941|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
5197974|NCT01061177|12781941|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
5197975|NCT01061177|12781941|P1|STARTED|Overall Study||1089
5197976|NCT01061151|12781964|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
5197977|NCT01061151|12781965|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
5197978|NCT01061151|12781966|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
5197979|NCT01061151|12781967|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
5197980|NCT01061151|12781964|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
5197981|NCT01061151|12781965|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
5197982|NCT01061151|12781966|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
5197983|NCT01061151|12781967|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
5197984|NCT01061151|12781964|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
5197985|NCT01061151|12781965|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
5197986|NCT01061151|12781966|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
5197987|NCT01061151|12781967|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
5197988|NCT01061151|12781964|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
5197989|NCT01061151|12781965|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
5197990|NCT01061151|12781966|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
5197991|NCT01061151|12781967|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
5197992|NCT01061151|12781964|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
5197993|NCT01061151|12781965|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
5197994|NCT01061151|12781966|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
5197995|NCT01061151|12781967|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
5197996|NCT01061151|12781964|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
5197997|NCT01061151|12781965|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
5197998|NCT01061151|12781966|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
5197999|NCT01061151|12781967|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
5198000|NCT01061151|12781964|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
5198001|NCT01061151|12781965|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
5198002|NCT01061151|12781966|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
5198003|NCT01061151|12781967|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
5198004|NCT01061151|12781964|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
5198005|NCT01061151|12781965|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
5198006|NCT01061151|12781966|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
5198007|NCT01061151|12781967|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
5198008|NCT01061034|12782019|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
5198009|NCT01061034|12782019|P1|COMPLETED|Aspirin Plus Omeprazole||9
5198010|NCT01061034|12782019|P1|STARTED|Aspirin Plus Omeprazole||9
5198011|NCT01061034|12782019|P1|NOT COMPLETED|Aspirin||0
5198012|NCT01061034|12782019|P1|COMPLETED|Aspirin||9
5198013|NCT01061034|12782019|P1|STARTED|Aspirin||9
5198014|NCT01061008|12782026|P2|NOT COMPLETED|Overall Study||6
5198015|NCT01061008|12782027|P1|NOT COMPLETED|Overall Study||6
5198016|NCT01061008|12782026|P2|COMPLETED|Overall Study||9
5198017|NCT01061008|12782027|P1|COMPLETED|Overall Study||10
5198018|NCT01061008|12782026|P2|STARTED|Overall Study||15
5198019|NCT01061008|12782027|P1|STARTED|Overall Study||16
5198020|NCT01060670|12782035|P2|NOT COMPLETED|Follow up Phase||35
5198021|NCT01060670|12782036|P1|NOT COMPLETED|Follow up Phase||22
5198022|NCT01060670|12782035|P2|COMPLETED|Follow up Phase||82
5198023|NCT01060670|12782036|P1|COMPLETED|Follow up Phase||106
5198024|NCT01060670|12782035|P2|Withdrew From Follow up Phase|Follow up Phase||35
5198025|NCT01060670|12782036|P1|Withdrew From Follow up Phase|Follow up Phase||22
5198026|NCT01060670|12782035|P2|Recurrence|Follow up Phase||9
5198027|NCT01060670|12782036|P1|Recurrence|Follow up Phase||14
5198028|NCT01060670|12782035|P2|STARTED|Follow up Phase||117
5198029|NCT01060670|12782036|P1|STARTED|Follow up Phase||128
5198030|NCT01060670|12782035|P2|NOT COMPLETED|Treatment Phase||36
5198031|NCT01060670|12782036|P1|NOT COMPLETED|Treatment Phase||26
5198032|NCT01060670|12782035|P2|COMPLETED|Treatment Phase||117
5198033|NCT01060670|12782036|P1|COMPLETED|Treatment Phase||128
5198034|NCT01060670|12782035|P2|Withdrew From Treatment|Treatment Phase||36
5198035|NCT01060670|12782036|P1|Withdrew From Treatment|Treatment Phase||26
5198036|NCT01060670|12782035|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
5198037|NCT01060670|12782036|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
5198038|NCT01060670|12782035|P2|Healed at End of Treatment Phase|Treatment Phase||49
5198039|NCT01060670|12782036|P1|Healed at End of Treatment Phase|Treatment Phase||79
5198040|NCT01060670|12782035|P2|STARTED|Treatment Phase||153
5198041|NCT01060670|12782036|P1|STARTED|Treatment Phase||154
5198042|NCT01060670|12782035|P2|NOT COMPLETED|Run In||238
5198043|NCT01060670|12782036|P1|NOT COMPLETED|Run In||0
5198044|NCT01060670|12782035|P2|COMPLETED|Run In||307
5198045|NCT01060670|12782036|P1|COMPLETED|Run In||0
5198046|NCT01060670|12782035|P2|STARTED|Run In||545
5198047|NCT01060670|12782036|P1|STARTED|Run In||0
5198048|NCT01060592|12782056|P2|NOT COMPLETED|12m||18
5198049|NCT01060592|12782057|P1|NOT COMPLETED|12m||0
5198050|NCT01060592|12782056|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
5198051|NCT01060592|12782057|P1|COMPLETED|12m||35
5198052|NCT01060592|12782056|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
5198053|NCT01060592|12782057|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
5198054|NCT01060592|12782056|P2|NOT COMPLETED|4-6w||10
5198055|NCT01060592|12782057|P1|NOT COMPLETED|4-6w||12
5198056|NCT01060592|12782056|P2|COMPLETED|4-6w||39
5198057|NCT01060592|12782057|P1|COMPLETED|4-6w||23
5198058|NCT01060592|12782056|P2|STARTED|4-6w||49
5198059|NCT01060592|12782057|P1|STARTED|4-6w||35
5198060|NCT01060553|12782071|P2|NOT COMPLETED|Overall Study||10
5198061|NCT01060553|12782072|P1|NOT COMPLETED|Overall Study||9
5198062|NCT01060553|12782071|P2|COMPLETED|Overall Study||5
5198063|NCT01060553|12782072|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
5198064|NCT01060553|12782071|P2|STARTED|Overall Study||15
5198065|NCT01060553|12782072|P1|STARTED|Overall Study||15
5198066|NCT01060540|12782079|P2|NOT COMPLETED|Overall Study||65
5198067|NCT01060540|12782080|P1|NOT COMPLETED|Overall Study||64
5198068|NCT01060540|12782079|P2|COMPLETED|Overall Study||233
5198069|NCT01060540|12782080|P1|COMPLETED|Overall Study||239
5198070|NCT01060540|12782079|P2|STARTED|Overall Study||298
5198071|NCT01060540|12782080|P1|STARTED|Overall Study||303
5198072|NCT01060384|12782094|P5|NOT COMPLETED|Overall Study||2
5198073|NCT01060384|12782095|P4|NOT COMPLETED|Overall Study||0
5198074|NCT01060384|12782096|P3|NOT COMPLETED|Overall Study||0
5198075|NCT01060384|12782097|P2|NOT COMPLETED|Overall Study||1
5198076|NCT01060384|12782098|P1|NOT COMPLETED|Overall Study||0
5198077|NCT01060384|12782094|P5|COMPLETED|Overall Study||34
5198078|NCT01060384|12782095|P4|COMPLETED|Overall Study||0
5198079|NCT01060384|12782096|P3|COMPLETED|Overall Study||0
5198080|NCT01060384|12782097|P2|COMPLETED|Overall Study||3
5198081|NCT01060384|12782098|P1|COMPLETED|Overall Study||6
5198082|NCT01060384|12782094|P5|STARTED|Overall Study||36
5198083|NCT01060384|12782095|P4|STARTED|Overall Study||0
5198084|NCT01060384|12782096|P3|STARTED|Overall Study||0
5198085|NCT01060384|12782097|P2|STARTED|Overall Study||4
5198086|NCT01060384|12782098|P1|STARTED|Overall Study||6
5198087|NCT01060345|12782107|P1|NOT COMPLETED|Overall Study||0
5198088|NCT01060345|12782107|P1|COMPLETED|Overall Study||20
5198089|NCT01060345|12782107|P1|STARTED|Overall Study||20
5198090|NCT01060150|12782117|P1|NOT COMPLETED|Overall Study||23
5198091|NCT01060150|12782117|P1|COMPLETED|Overall Study||92
5198092|NCT01060150|12782117|P1|Treated|Overall Study||113
5198093|NCT01060150|12782117|P1|STARTED|Overall Study||115
5198094|NCT01060124|12782132|P1|NOT COMPLETED|Overall Study||37
5198095|NCT01060124|12782132|P1|COMPLETED|Overall Study||66
5198096|NCT01060124|12782132|P1|STARTED|Overall Study||103
5198097|NCT01060111|12782143|P3|NOT COMPLETED|Overall Study||35
5198098|NCT01060111|12782144|P2|NOT COMPLETED|Overall Study||23
5198099|NCT01060111|12782145|P1|NOT COMPLETED|Overall Study||27
5198100|NCT01060111|12782143|P3|COMPLETED|Overall Study||45
5198101|NCT01060111|12782144|P2|COMPLETED|Overall Study||61
5198102|NCT01060111|12782145|P1|COMPLETED|Overall Study||54
5198103|NCT01060111|12782143|P3|Treated|Overall Study||79
5198104|NCT01060111|12782144|P2|Treated|Overall Study||83
5198105|NCT01060111|12782145|P1|Treated|Overall Study||81
5198106|NCT01060111|12782143|P3|STARTED|Overall Study||80
5198107|NCT01060111|12782144|P2|STARTED|Overall Study||84
5198108|NCT01060111|12782145|P1|STARTED|Overall Study||81
5198109|NCT01060098|12782165|P3|NOT COMPLETED|Overall Study||0
5198110|NCT01060098|12782166|P2|NOT COMPLETED|Overall Study||0
5198111|NCT01060098|12782167|P1|NOT COMPLETED|Overall Study||0
5198112|NCT01060098|12782165|P3|COMPLETED|Overall Study||8
5198113|NCT01060098|12782166|P2|COMPLETED|Overall Study||15
5198114|NCT01060098|12782167|P1|COMPLETED|Overall Study||25
5198115|NCT01060098|12782165|P3|STARTED|Overall Study||8
5198116|NCT01060098|12782166|P2|STARTED|Overall Study||15
5198117|NCT01060098|12782167|P1|STARTED|Overall Study||25
5198118|NCT01060072|12782177|P2|NOT COMPLETED|Overall Study||5
5198119|NCT01060072|12782178|P1|NOT COMPLETED|Overall Study||2
5198120|NCT01060072|12782177|P2|COMPLETED|Overall Study||196
5198121|NCT01060072|12782178|P1|COMPLETED|Overall Study||204
5198122|NCT01060072|12782177|P2|STARTED|Overall Study||201
5198123|NCT01060072|12782178|P1|STARTED|Overall Study||206
5198124|NCT01060059|12782194|P2|NOT COMPLETED|Overall Study||67
5198125|NCT01060059|12782195|P1|NOT COMPLETED|Overall Study||67
5198126|NCT01060059|12782194|P2|COMPLETED|Overall Study||371
5198127|NCT01060059|12782195|P1|COMPLETED|Overall Study||377
5198128|NCT01060059|12782194|P2|STARTED|Overall Study||438
5198129|NCT01060059|12782195|P1|STARTED|Overall Study||444
5198130|NCT01060020|12782245|P1|NOT COMPLETED|Overall Study||0
5198131|NCT01060020|12782245|P1|COMPLETED|Overall Study||20
5198132|NCT01060020|12782245|P1|STARTED|Overall Study||20
5198133|NCT01060007|12782253|P1|NOT COMPLETED|Overall Study||4
5198134|NCT01060007|12782253|P1|COMPLETED|Overall Study||76
5198135|NCT01060007|12782253|P1|STARTED|Overall Study||80
5198136|NCT01059994|12782271|P4|NOT COMPLETED|Overall Study||1
5198137|NCT01059994|12782272|P3|NOT COMPLETED|Overall Study||0
5198138|NCT01059994|12782273|P2|NOT COMPLETED|Overall Study||0
5198139|NCT01059994|12782274|P1|NOT COMPLETED|Overall Study||0
5198140|NCT01059994|12782271|P4|COMPLETED|Overall Study||3
5198141|NCT01059994|12782272|P3|COMPLETED|Overall Study||3
5198142|NCT01059994|12782273|P2|COMPLETED|Overall Study||2
5198143|NCT01059994|12782274|P1|COMPLETED|Overall Study||3
5198144|NCT01059994|12782271|P4|STARTED|Overall Study||4
5198145|NCT01059994|12782272|P3|STARTED|Overall Study||3
5198146|NCT01059994|12782273|P2|STARTED|Overall Study||2
5198147|NCT01059994|12782274|P1|STARTED|Overall Study||3
5198148|NCT01059929|12782290|P2|NOT COMPLETED|Overall Study||0
5198149|NCT01059929|12782291|P1|NOT COMPLETED|Overall Study||0
5198150|NCT01059929|12782290|P2|COMPLETED|Overall Study||21
5198151|NCT01059929|12782291|P1|COMPLETED|Overall Study||20
5198152|NCT01059929|12782290|P2|STARTED|Overall Study||21
5198153|NCT01059929|12782291|P1|STARTED|Overall Study||20
5198154|NCT01059903|12782321|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
5198155|NCT01059903|12782322|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
5198156|NCT01059903|12782321|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
5198157|NCT01059903|12782322|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
5198158|NCT01059903|12782321|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
5198159|NCT01059903|12782322|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
5198160|NCT01059903|12782321|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
5198161|NCT01059903|12782322|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
5198162|NCT01059903|12782321|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
5198163|NCT01059903|12782322|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
5198164|NCT01059903|12782321|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
5198165|NCT01059903|12782322|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
5198166|NCT01059903|12782321|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
5198167|NCT01059903|12782322|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
5198168|NCT01059903|12782321|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
5198169|NCT01059903|12782322|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
5198170|NCT01059903|12782321|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
5198171|NCT01059903|12782322|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
5198172|NCT01059903|12782321|P2|STARTED|Period 1: First Intervention- 24 Hours||25
5198173|NCT01059903|12782322|P1|STARTED|Period 1: First Intervention- 24 Hours||25
5198174|NCT01059877|12782358|P2|NOT COMPLETED|Overall Study||2
5198175|NCT01059877|12782359|P1|NOT COMPLETED|Overall Study||0
5198176|NCT01059877|12782358|P2|COMPLETED|Overall Study||3
5198177|NCT01059877|12782359|P1|COMPLETED|Overall Study||6
5198178|NCT01059877|12782358|P2|STARTED|Overall Study||5
5198179|NCT01059877|12782359|P1|STARTED|Overall Study||6
5198180|NCT01059864|12782365|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
5198181|NCT01059864|12782366|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
5198182|NCT01059864|12782367|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
5198183|NCT01059864|12782365|P3|COMPLETED|Double-Blind Treatment Phase||45
5198184|NCT01059864|12782366|P2|COMPLETED|Double-Blind Treatment Phase||47
5198185|NCT01059864|12782367|P1|COMPLETED|Double-Blind Treatment Phase||0
5198186|NCT01059864|12782365|P3|Treated|Double-Blind Treatment Phase||47
5198187|NCT01059864|12782366|P2|Treated|Double-Blind Treatment Phase||50
5198188|NCT01059864|12782367|P1|Treated|Double-Blind Treatment Phase||0
5198189|NCT01059864|12782365|P3|STARTED|Double-Blind Treatment Phase||48
5198190|NCT01059864|12782366|P2|STARTED|Double-Blind Treatment Phase||50
5198191|NCT01059864|12782367|P1|STARTED|Double-Blind Treatment Phase||0
5198192|NCT01059864|12782365|P3|NOT COMPLETED|Open-Label Run-In Phase||0
5198193|NCT01059864|12782366|P2|NOT COMPLETED|Open-Label Run-In Phase||0
5198194|NCT01059864|12782367|P1|NOT COMPLETED|Open-Label Run-In Phase||13
5198195|NCT01059864|12782365|P3|COMPLETED|Open-Label Run-In Phase||0
5198196|NCT01059864|12782366|P2|COMPLETED|Open-Label Run-In Phase||0
5198197|NCT01059864|12782367|P1|COMPLETED|Open-Label Run-In Phase||98
5198198|NCT01059864|12782365|P3|STARTED|Open-Label Run-In Phase||0
5198199|NCT01059864|12782366|P2|STARTED|Open-Label Run-In Phase||0
5198200|NCT01059864|12782367|P1|STARTED|Open-Label Run-In Phase||111
5198201|NCT01059851|12782416|P6|NOT COMPLETED|Overall Study||0
5198202|NCT01059851|12782417|P5|NOT COMPLETED|Overall Study||0
5198203|NCT01059851|12782418|P4|NOT COMPLETED|Overall Study||0
5198204|NCT01059851|12782419|P3|NOT COMPLETED|Overall Study||0
5198205|NCT01059851|12782420|P2|NOT COMPLETED|Overall Study||0
5198206|NCT01059851|12782421|P1|NOT COMPLETED|Overall Study||0
5198207|NCT01059851|12782416|P6|COMPLETED|Overall Study||0
5198208|NCT01059851|12782417|P5|COMPLETED|Overall Study||0
5198209|NCT01059851|12782418|P4|COMPLETED|Overall Study||0
5198210|NCT01059851|12782419|P3|COMPLETED|Overall Study||0
5198211|NCT01059851|12782420|P2|COMPLETED|Overall Study||8
5198212|NCT01059851|12782421|P1|COMPLETED|Overall Study||8
5198213|NCT01059851|12782416|P6|STARTED|Overall Study||0
5198214|NCT01059851|12782417|P5|STARTED|Overall Study||0
5198215|NCT01059851|12782418|P4|STARTED|Overall Study||0
5198216|NCT01059851|12782419|P3|STARTED|Overall Study||0
5198217|NCT01059851|12782420|P2|STARTED|Overall Study||8
5198218|NCT01059851|12782421|P1|STARTED|Overall Study||8
5198219|NCT01059825|12782441|P7|NOT COMPLETED|Treatment Period||0
5198220|NCT01059825|12782442|P6|NOT COMPLETED|Treatment Period||3
5198221|NCT01059825|12782443|P5|NOT COMPLETED|Treatment Period||8
5198222|NCT01059825|12782444|P4|NOT COMPLETED|Treatment Period||11
5198223|NCT01059825|12782445|P3|NOT COMPLETED|Treatment Period||6
5198224|NCT01059825|12782446|P2|NOT COMPLETED|Treatment Period||4
5198225|NCT01059825|12782447|P1|NOT COMPLETED|Treatment Period||10
5198226|NCT01059825|12782441|P7|COMPLETED|Treatment Period||0
5198227|NCT01059825|12782442|P6|COMPLETED|Treatment Period||52
5198228|NCT01059825|12782443|P5|COMPLETED|Treatment Period||47
5198229|NCT01059825|12782444|P4|COMPLETED|Treatment Period||44
5198230|NCT01059825|12782445|P3|COMPLETED|Treatment Period||49
5198231|NCT01059825|12782446|P2|COMPLETED|Treatment Period||50
5198232|NCT01059825|12782447|P1|COMPLETED|Treatment Period||44
5198233|NCT01059825|12782441|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
5198234|NCT01059825|12782442|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
5198235|NCT01059825|12782443|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
5198236|NCT01059825|12782444|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
5198237|NCT01059825|12782445|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
5198238|NCT01059825|12782446|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
5198239|NCT01059825|12782447|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
5198240|NCT01059825|12782441|P7|NOT COMPLETED|Enrolled, Run-in Period||47
5198241|NCT01059825|12782442|P6|NOT COMPLETED|Enrolled, Run-in Period||0
5198242|NCT01059825|12782443|P5|NOT COMPLETED|Enrolled, Run-in Period||0
5198243|NCT01059825|12782444|P4|NOT COMPLETED|Enrolled, Run-in Period||0
5198244|NCT01059825|12782445|P3|NOT COMPLETED|Enrolled, Run-in Period||0
5198245|NCT01059825|12782446|P2|NOT COMPLETED|Enrolled, Run-in Period||0
5198246|NCT01059825|12782447|P1|NOT COMPLETED|Enrolled, Run-in Period||0
5198247|NCT01059825|12782441|P7|COMPLETED|Enrolled, Run-in Period||328
5198248|NCT01059825|12782442|P6|COMPLETED|Enrolled, Run-in Period||0
5198249|NCT01059825|12782443|P5|COMPLETED|Enrolled, Run-in Period||0
5198250|NCT01059825|12782444|P4|COMPLETED|Enrolled, Run-in Period||0
5198251|NCT01059825|12782445|P3|COMPLETED|Enrolled, Run-in Period||0
5198252|NCT01059825|12782446|P2|COMPLETED|Enrolled, Run-in Period||0
5198253|NCT01059825|12782447|P1|COMPLETED|Enrolled, Run-in Period||0
5198254|NCT01059825|12782441|P7|STARTED|Enrolled, Run-in Period||375
5198255|NCT01059825|12782442|P6|STARTED|Enrolled, Run-in Period||0
5198256|NCT01059825|12782443|P5|STARTED|Enrolled, Run-in Period||0
5198257|NCT01059825|12782444|P4|STARTED|Enrolled, Run-in Period||0
5198258|NCT01059825|12782445|P3|STARTED|Enrolled, Run-in Period||0
5198259|NCT01059825|12782446|P2|STARTED|Enrolled, Run-in Period||0
5198260|NCT01059825|12782447|P1|STARTED|Enrolled, Run-in Period||0
5198261|NCT01059812|12782634|P2|NOT COMPLETED|Overall Study||16
5198262|NCT01059812|12782635|P1|NOT COMPLETED|Overall Study||37
5198263|NCT01059812|12782634|P2|COMPLETED|Overall Study||126
5198264|NCT01059812|12782635|P1|COMPLETED|Overall Study||245
5198265|NCT01059812|12782634|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
5198266|NCT01059812|12782635|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
5198267|NCT01059812|12782634|P2|STARTED|Overall Study||142
5198268|NCT01059812|12782635|P1|STARTED|Overall Study||282
5198269|NCT01059799|12782651|P2|NOT COMPLETED|Overall Study||10
5198270|NCT01059799|12782652|P1|NOT COMPLETED|Overall Study||31
5198271|NCT01059799|12782651|P2|COMPLETED|Overall Study||136
5198272|NCT01059799|12782652|P1|COMPLETED|Overall Study||258
5198273|NCT01059799|12782651|P2|Exposed|Overall Study||146
5198274|NCT01059799|12782652|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
5198275|NCT01059799|12782651|P2|STARTED|Overall Study||146
5198276|NCT01059799|12782652|P1|STARTED|Overall Study||289
5198277|NCT01059773|12782666|P2|NOT COMPLETED|Overall Study||24
5198278|NCT01059773|12782667|P1|NOT COMPLETED|Overall Study||20
5198279|NCT01059773|12782666|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
5198280|NCT01059773|12782667|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
5198281|NCT01059773|12782666|P2|STARTED|Overall Study||245
5198282|NCT01059773|12782667|P1|STARTED|Overall Study||244
5198283|NCT01059760|12782699|P2|NOT COMPLETED|Overall Study||0
5198284|NCT01059760|12782700|P1|NOT COMPLETED|Overall Study||0
5198285|NCT01059760|12782699|P2|COMPLETED|Overall Study||14
5198286|NCT01059760|12782700|P1|COMPLETED|Overall Study||16
5198287|NCT01059760|12782699|P2|STARTED|Overall Study||14
5198288|NCT01059760|12782700|P1|STARTED|Overall Study||16
5198289|NCT01059682|12782808|P2|NOT COMPLETED|Overall Study||18
5198290|NCT01059682|12782809|P1|NOT COMPLETED|Overall Study||10
5198291|NCT01059682|12782808|P2|COMPLETED|Overall Study||444
5198292|NCT01059682|12782809|P1|COMPLETED|Overall Study||464
5198293|NCT01059682|12782808|P2|STARTED|Overall Study||462
5198294|NCT01059682|12782809|P1|STARTED|Overall Study||474
5198295|NCT01059643|12782823|P1|NOT COMPLETED|Overall Study||6
5198296|NCT01059643|12782823|P1|COMPLETED|Overall Study||97
5198297|NCT01059643|12782823|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
5198298|NCT01059643|12782823|P1|STARTED|Overall Study||103
5198299|NCT01059630|12782838|P2|NOT COMPLETED|Overall Study||103
5198300|NCT01059630|12782839|P1|NOT COMPLETED|Overall Study||127
5198301|NCT01059630|12782838|P2|COMPLETED|Overall Study||101
5198302|NCT01059630|12782839|P1|COMPLETED|Overall Study||82
5198303|NCT01059630|12782838|P2|STARTED|Overall Study||204
5198304|NCT01059630|12782839|P1|STARTED|Overall Study||209
5198305|NCT01059617|12782913|P4|NOT COMPLETED|Overall Study||6
5198306|NCT01059617|12782914|P3|NOT COMPLETED|Overall Study||8
5198307|NCT01059617|12782915|P2|NOT COMPLETED|Overall Study||1
5198308|NCT01059617|12782916|P1|NOT COMPLETED|Overall Study||7
5198309|NCT01059617|12782913|P4|COMPLETED|Overall Study||27
5198310|NCT01059617|12782914|P3|COMPLETED|Overall Study||25
5198311|NCT01059617|12782915|P2|COMPLETED|Overall Study||33
5198312|NCT01059617|12782916|P1|COMPLETED|Overall Study||26
5198313|NCT01059617|12782913|P4|STARTED|Overall Study||33
5198314|NCT01059617|12782914|P3|STARTED|Overall Study||33
5198315|NCT01059617|12782915|P2|STARTED|Overall Study||34
5198316|NCT01059617|12782916|P1|STARTED|Overall Study||33
5198317|NCT01059565|12783086|P2|NOT COMPLETED|24-Week Open-Label Phase||3
5198318|NCT01059565|12783087|P1|NOT COMPLETED|24-Week Open-Label Phase||5
5198319|NCT01059565|12783086|P2|COMPLETED|24-Week Open-Label Phase||42
5198320|NCT01059565|12783087|P1|COMPLETED|24-Week Open-Label Phase||34
5198321|NCT01059565|12783086|P2|STARTED|24-Week Open-Label Phase||45
5198322|NCT01059565|12783087|P1|STARTED|24-Week Open-Label Phase||39
5198323|NCT01059565|12783086|P2|NOT COMPLETED|24-Week Randomized Phase||7
5198324|NCT01059565|12783087|P1|NOT COMPLETED|24-Week Randomized Phase||10
5198325|NCT01059565|12783086|P2|COMPLETED|24-Week Randomized Phase||45
5198326|NCT01059565|12783087|P1|COMPLETED|24-Week Randomized Phase||39
5198327|NCT01059565|12783086|P2|Randomized and Treated|24-Week Randomized Phase||52
5198328|NCT01059565|12783087|P1|Randomized and Treated|24-Week Randomized Phase||48
5198329|NCT01059565|12783086|P2|STARTED|24-Week Randomized Phase||52
5198330|NCT01059565|12783087|P1|STARTED|24-Week Randomized Phase||49
5198331|NCT01059539|12783121|P1|NOT COMPLETED|Overall Study||271
5198332|NCT01059539|12783121|P1|COMPLETED|Overall Study||132
5198333|NCT01059539|12783121|P1|STARTED|Overall Study||403
5198334|NCT01059526|12783128|P2|NOT COMPLETED|Overall Study||22
5198335|NCT01059526|12783129|P1|NOT COMPLETED|Overall Study||30
5198336|NCT01059526|12783128|P2|COMPLETED|Overall Study||18
5198337|NCT01059526|12783129|P1|COMPLETED|Overall Study||11
5198338|NCT01059526|12783128|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
5198339|NCT01059526|12783129|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
5198340|NCT01059526|12783128|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
5198341|NCT01059526|12783129|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
5198342|NCT01059435|12783147|P10|NOT COMPLETED|Overall Study||0
5198343|NCT01059435|12783148|P9|NOT COMPLETED|Overall Study||0
5198344|NCT01059435|12783149|P8|NOT COMPLETED|Overall Study||0
5198345|NCT01059435|12783150|P7|NOT COMPLETED|Overall Study||0
5198346|NCT01059435|12783151|P6|NOT COMPLETED|Overall Study||0
5198347|NCT01059435|12783152|P5|NOT COMPLETED|Overall Study||0
5198348|NCT01059435|12783153|P4|NOT COMPLETED|Overall Study||0
5198349|NCT01059435|12783154|P3|NOT COMPLETED|Overall Study||2
5198350|NCT01059435|12783155|P2|NOT COMPLETED|Overall Study||0
5198351|NCT01059435|12783156|P1|NOT COMPLETED|Overall Study||0
5198352|NCT01059435|12783147|P10|COMPLETED|Overall Study||6
5198353|NCT01059435|12783148|P9|COMPLETED|Overall Study||6
5198354|NCT01059435|12783149|P8|COMPLETED|Overall Study||4
5198355|NCT01059435|12783150|P7|COMPLETED|Overall Study||6
5198356|NCT01059435|12783151|P6|COMPLETED|Overall Study||9
5198357|NCT01059435|12783152|P5|COMPLETED|Overall Study||6
5198358|NCT01059435|12783153|P4|COMPLETED|Overall Study||9
5198359|NCT01059435|12783154|P3|COMPLETED|Overall Study||6
5198360|NCT01059435|12783155|P2|COMPLETED|Overall Study||6
5198361|NCT01059435|12783156|P1|COMPLETED|Overall Study||14
5198362|NCT01059435|12783147|P10|Received Study Drug|Overall Study||6
5198363|NCT01059435|12783148|P9|Received Study Drug|Overall Study||6
5198364|NCT01059435|12783149|P8|Received Study Drug|Overall Study||4
5198365|NCT01059435|12783150|P7|Received Study Drug|Overall Study||6
5198366|NCT01059435|12783151|P6|Received Study Drug|Overall Study||9
5198367|NCT01059435|12783152|P5|Received Study Drug|Overall Study||6
5198368|NCT01059435|12783153|P4|Received Study Drug|Overall Study||9
5198369|NCT01059435|12783154|P3|Received Study Drug|Overall Study||6
5198370|NCT01059435|12783155|P2|Received Study Drug|Overall Study||6
5198371|NCT01059435|12783156|P1|Received Study Drug|Overall Study||14
5198372|NCT01059435|12783147|P10|STARTED|Overall Study||6
5198373|NCT01059435|12783148|P9|STARTED|Overall Study||6
5198374|NCT01059435|12783149|P8|STARTED|Overall Study||4
5198375|NCT01059435|12783150|P7|STARTED|Overall Study||6
5198376|NCT01059435|12783151|P6|STARTED|Overall Study||9
5198377|NCT01059435|12783152|P5|STARTED|Overall Study||6
5198378|NCT01059435|12783153|P4|STARTED|Overall Study||9
5198379|NCT01059435|12783154|P3|STARTED|Overall Study||8
5198380|NCT01059435|12783155|P2|STARTED|Overall Study||6
5198381|NCT01059435|12783156|P1|STARTED|Overall Study||14
5198382|NCT01059357|12783464|P1|NOT COMPLETED|Overall Study||4
5198383|NCT01059357|12783464|P1|COMPLETED|Overall Study||54
5198384|NCT01059357|12783464|P1|STARTED|Overall Study||58
5198385|NCT01059344|12783475|P2|NOT COMPLETED|Overall Study||46
5198386|NCT01059344|12783476|P1|NOT COMPLETED|Overall Study||22
5198387|NCT01059344|12783475|P2|COMPLETED|Overall Study||95
5198388|NCT01059344|12783476|P1|COMPLETED|Overall Study||118
5198389|NCT01059344|12783475|P2|STARTED|Overall Study||141
5198390|NCT01059344|12783476|P1|STARTED|Overall Study||140
5198391|NCT01059305|12783494|P1|NOT COMPLETED|Overall Study||0
5198392|NCT01059305|12783494|P1|COMPLETED|Overall Study||10
5198393|NCT01059305|12783494|P1|STARTED|Overall Study||10
5198394|NCT01059175|12783500|P2|NOT COMPLETED|Overall Study||20
5198395|NCT01059175|12783501|P1|NOT COMPLETED|Overall Study||21
5198396|NCT01059175|12783500|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
5198397|NCT01059175|12783501|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
5198398|NCT01059175|12783500|P2|STARTED|Overall Study||41
5198399|NCT01059175|12783501|P1|STARTED|Overall Study||43
5198400|NCT01059071|12783523|P4|NOT COMPLETED|Overall Study||6
5198401|NCT01059071|12783524|P3|NOT COMPLETED|Overall Study||2
5198402|NCT01059071|12783525|P2|NOT COMPLETED|Overall Study||4
5198403|NCT01059071|12783526|P1|NOT COMPLETED|Overall Study||2
5198404|NCT01059071|12783523|P4|COMPLETED|Overall Study||3
5198405|NCT01059071|12783524|P3|COMPLETED|Overall Study||1
5198406|NCT01059071|12783525|P2|COMPLETED|Overall Study||1
5198407|NCT01059071|12783526|P1|COMPLETED|Overall Study||2
5198408|NCT01059071|12783523|P4|STARTED|Overall Study||9
5198409|NCT01059071|12783524|P3|STARTED|Overall Study||3
5198410|NCT01059071|12783525|P2|STARTED|Overall Study||5
5198411|NCT01059071|12783526|P1|STARTED|Overall Study||4
5198412|NCT01058993|12783538|P1|NOT COMPLETED|Overall Study||0
5198413|NCT01058993|12783538|P1|COMPLETED|Overall Study||6
5198414|NCT01058993|12783538|P1|STARTED|Overall Study||6
5198415|NCT01058941|12783544|P2|NOT COMPLETED|Overall Study||11
5198416|NCT01058941|12783545|P1|NOT COMPLETED|Overall Study||9
5198417|NCT01058941|12783544|P2|COMPLETED|Overall Study||22
5198418|NCT01058941|12783545|P1|COMPLETED|Overall Study||25
5198419|NCT01058941|12783544|P2|STARTED|Overall Study||33
5198420|NCT01058941|12783545|P1|STARTED|Overall Study||34
5198421|NCT01058863|12783553|P1|NOT COMPLETED|Overall Study||4
5198422|NCT01058863|12783553|P1|COMPLETED|Overall Study||68
5198423|NCT01058863|12783553|P1|Treated With Placebo Inhaler|Overall Study||69
5198424|NCT01058863|12783553|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
5198425|NCT01058863|12783553|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
5198426|NCT01058863|12783553|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
5198427|NCT01058863|12783553|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
5198428|NCT01058863|12783553|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
5198429|NCT01058863|12783553|P1|STARTED|Overall Study||72
5198430|NCT01058707|12783578|P7|NOT COMPLETED|Overall Study||26
5198431|NCT01058707|12783579|P6|NOT COMPLETED|Overall Study||17
5198432|NCT01058707|12783580|P5|NOT COMPLETED|Overall Study||39
5198433|NCT01058707|12783581|P4|NOT COMPLETED|Overall Study||22
5198434|NCT01058707|12783582|P3|NOT COMPLETED|Overall Study||33
5198435|NCT01058707|12783583|P2|NOT COMPLETED|Overall Study||30
5198436|NCT01058707|12783584|P1|NOT COMPLETED|Overall Study||31
5198437|NCT01058707|12783578|P7|COMPLETED|Overall Study||0
5198438|NCT01058707|12783579|P6|COMPLETED|Overall Study||0
5198439|NCT01058707|12783580|P5|COMPLETED|Overall Study||0
5198440|NCT01058707|12783581|P4|COMPLETED|Overall Study||0
5198441|NCT01058707|12783582|P3|COMPLETED|Overall Study||0
5198442|NCT01058707|12783583|P2|COMPLETED|Overall Study||0
5198443|NCT01058707|12783584|P1|COMPLETED|Overall Study||0
5198444|NCT01058707|12783578|P7|STARTED|Overall Study||26
5198445|NCT01058707|12783579|P6|STARTED|Overall Study||17
5198446|NCT01058707|12783580|P5|STARTED|Overall Study||39
5198447|NCT01058707|12783581|P4|STARTED|Overall Study||22
5198448|NCT01058707|12783582|P3|STARTED|Overall Study||33
5198449|NCT01058707|12783583|P2|STARTED|Overall Study||30
5198450|NCT01058707|12783584|P1|STARTED|Overall Study||31
5198451|NCT01058668|12783750|P3|NOT COMPLETED|Safety Follow-up||7
5198452|NCT01058668|12783751|P2|NOT COMPLETED|Safety Follow-up||0
5198453|NCT01058668|12783752|P1|NOT COMPLETED|Safety Follow-up||5
5198454|NCT01058668|12783750|P3|COMPLETED|Safety Follow-up||141
5198455|NCT01058668|12783751|P2|COMPLETED|Safety Follow-up||146
5198456|NCT01058668|12783752|P1|COMPLETED|Safety Follow-up||139
5198457|NCT01058668|12783750|P3|STARTED|Safety Follow-up||148
5198458|NCT01058668|12783751|P2|STARTED|Safety Follow-up||146
5198459|NCT01058668|12783752|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
5198460|NCT01058668|12783750|P3|NOT COMPLETED|Double-blind Treatment Phase||50
5198461|NCT01058668|12783751|P2|NOT COMPLETED|Double-blind Treatment Phase||38
5198462|NCT01058668|12783752|P1|NOT COMPLETED|Double-blind Treatment Phase||39
5198463|NCT01058668|12783750|P3|COMPLETED|Double-blind Treatment Phase||119
5198464|NCT01058668|12783751|P2|COMPLETED|Double-blind Treatment Phase||129
5198465|NCT01058668|12783752|P1|COMPLETED|Double-blind Treatment Phase||122
5198466|NCT01058668|12783750|P3|STARTED|Double-blind Treatment Phase||169
5198467|NCT01058668|12783751|P2|STARTED|Double-blind Treatment Phase||167
5198468|NCT01058668|12783752|P1|STARTED|Double-blind Treatment Phase||161
5198469|NCT01058655|12783767|P4|NOT COMPLETED|Overall Study||42
5198470|NCT01058655|12783768|P3|NOT COMPLETED|Overall Study||8
5198471|NCT01058655|12783769|P2|NOT COMPLETED|Overall Study||3
5198472|NCT01058655|12783770|P1|NOT COMPLETED|Overall Study||3
5198473|NCT01058655|12783767|P4|COMPLETED|Overall Study||0
5198474|NCT01058655|12783768|P3|COMPLETED|Overall Study||0
5198475|NCT01058655|12783769|P2|COMPLETED|Overall Study||0
5198476|NCT01058655|12783770|P1|COMPLETED|Overall Study||0
5198477|NCT01058655|12783767|P4|Evaluable|Overall Study||40
5198478|NCT01058655|12783768|P3|Evaluable|Overall Study||6
5198479|NCT01058655|12783769|P2|Evaluable|Overall Study||3
5198480|NCT01058655|12783770|P1|Evaluable|Overall Study||3
5198481|NCT01058655|12783767|P4|STARTED|Overall Study||42
5198482|NCT01058655|12783768|P3|STARTED|Overall Study||8
5198483|NCT01058655|12783769|P2|STARTED|Overall Study||3
5198484|NCT01058655|12783770|P1|STARTED|Overall Study||3
5198485|NCT01058642|12783788|P4|NOT COMPLETED|Treatment Period 2||0
5198486|NCT01058642|12783789|P3|NOT COMPLETED|Treatment Period 2||0
5198487|NCT01058642|12783790|P2|NOT COMPLETED|Treatment Period 2||0
5198488|NCT01058642|12783791|P1|NOT COMPLETED|Treatment Period 2||0
5198489|NCT01058642|12783788|P4|COMPLETED|Treatment Period 2||7
5198490|NCT01058642|12783789|P3|COMPLETED|Treatment Period 2||9
5198491|NCT01058642|12783790|P2|COMPLETED|Treatment Period 2||11
5198492|NCT01058642|12783791|P1|COMPLETED|Treatment Period 2||7
5198493|NCT01058642|12783788|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
5198494|NCT01058642|12783789|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
5198495|NCT01058642|12783790|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
5198496|NCT01058642|12783791|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
5198497|NCT01058642|12783788|P4|STARTED|Treatment Period 2||7
5198498|NCT01058642|12783789|P3|STARTED|Treatment Period 2||9
5198499|NCT01058642|12783790|P2|STARTED|Treatment Period 2||11
5198500|NCT01058642|12783791|P1|STARTED|Treatment Period 2||7
5198501|NCT01058642|12783788|P4|NOT COMPLETED|Washout Period||0
5198502|NCT01058642|12783789|P3|NOT COMPLETED|Washout Period||0
5198503|NCT01058642|12783790|P2|NOT COMPLETED|Washout Period||0
5198504|NCT01058642|12783791|P1|NOT COMPLETED|Washout Period||0
5198505|NCT01058642|12783788|P4|COMPLETED|Washout Period||7
5198506|NCT01058642|12783789|P3|COMPLETED|Washout Period||9
5198507|NCT01058642|12783790|P2|COMPLETED|Washout Period||11
5198508|NCT01058642|12783791|P1|COMPLETED|Washout Period||7
5198509|NCT01058642|12783788|P4|STARTED|Washout Period||7
5198510|NCT01058642|12783789|P3|STARTED|Washout Period||9
5198511|NCT01058642|12783790|P2|STARTED|Washout Period||11
5198512|NCT01058642|12783791|P1|STARTED|Washout Period||7
5198513|NCT01058642|12783788|P4|NOT COMPLETED|Treatment Period 1||2
5198514|NCT01058642|12783789|P3|NOT COMPLETED|Treatment Period 1||2
5198515|NCT01058642|12783790|P2|NOT COMPLETED|Treatment Period 1||1
5198516|NCT01058642|12783791|P1|NOT COMPLETED|Treatment Period 1||2
5198517|NCT01058642|12783788|P4|COMPLETED|Treatment Period 1||7
5198518|NCT01058642|12783789|P3|COMPLETED|Treatment Period 1||9
5198519|NCT01058642|12783790|P2|COMPLETED|Treatment Period 1||11
5198520|NCT01058642|12783791|P1|COMPLETED|Treatment Period 1||7
5198521|NCT01058642|12783788|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
5198522|NCT01058642|12783789|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
5198523|NCT01058642|12783790|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
5198524|NCT01058642|12783791|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
5198525|NCT01058642|12783788|P4|STARTED|Treatment Period 1||9
5198526|NCT01058642|12783789|P3|STARTED|Treatment Period 1||11
5198527|NCT01058642|12783790|P2|STARTED|Treatment Period 1||12
5198528|NCT01058642|12783791|P1|STARTED|Treatment Period 1||9
5198529|NCT01058421|12783801|P2|NOT COMPLETED|6 Month Outcomes||26
5198530|NCT01058421|12783802|P1|NOT COMPLETED|6 Month Outcomes||19
5198531|NCT01058421|12783801|P2|COMPLETED|6 Month Outcomes||24
5198532|NCT01058421|12783802|P1|COMPLETED|6 Month Outcomes||27
5198533|NCT01058421|12783801|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
5198534|NCT01058421|12783802|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
5198535|NCT01058421|12783801|P2|NOT COMPLETED|3 Month Outcomes||26
5198536|NCT01058421|12783802|P1|NOT COMPLETED|3 Month Outcomes||20
5198537|NCT01058421|12783801|P2|COMPLETED|3 Month Outcomes||29
5198538|NCT01058421|12783802|P1|COMPLETED|3 Month Outcomes||29
5198539|NCT01058421|12783801|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
5198540|NCT01058421|12783802|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
5198541|NCT01058421|12783801|P2|NOT COMPLETED|1 Month Outcomes||42
5198542|NCT01058421|12783802|P1|NOT COMPLETED|1 Month Outcomes||39
5198543|NCT01058421|12783801|P2|COMPLETED|1 Month Outcomes||19
5198544|NCT01058421|12783802|P1|COMPLETED|1 Month Outcomes||20
5198545|NCT01058421|12783801|P2|STARTED|1 Month Outcomes||61
5198546|NCT01058421|12783802|P1|STARTED|1 Month Outcomes||59
5198547|NCT01058395|12783826|P2|NOT COMPLETED|Overall Study||1
5198548|NCT01058395|12783827|P1|NOT COMPLETED|Overall Study||3
5198549|NCT01058395|12783826|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
5198550|NCT01058395|12783827|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
5198551|NCT01058395|12783826|P2|STARTED|Overall Study||8
5198552|NCT01058395|12783827|P1|STARTED|Overall Study||7
5198553|NCT01058356|12783836|P1|NOT COMPLETED|Overall Study||42
5198554|NCT01058356|12783836|P1|COMPLETED|Overall Study||172
5198555|NCT01058356|12783836|P1|STARTED|Overall Study||214
5198556|NCT01058304|12783843|P2|NOT COMPLETED|Overall Study||33
5198557|NCT01058304|12783844|P1|NOT COMPLETED|Overall Study||27
5198558|NCT01058304|12783843|P2|COMPLETED|Overall Study||128
5198559|NCT01058304|12783844|P1|COMPLETED|Overall Study||132
5198560|NCT01058304|12783843|P2|STARTED|Overall Study||161
5198561|NCT01058304|12783844|P1|STARTED|Overall Study||159
5198562|NCT01058265|12783854|P2|NOT COMPLETED|Overall Study||12
5198563|NCT01058265|12783855|P1|NOT COMPLETED|Overall Study||11
5198564|NCT01058265|12783854|P2|COMPLETED|Overall Study||13
5198565|NCT01058265|12783855|P1|COMPLETED|Overall Study||11
5198566|NCT01058265|12783854|P2|STARTED|Overall Study||25
5198567|NCT01058265|12783855|P1|STARTED|Overall Study||22
5198568|NCT01058239|12783863|P1|NOT COMPLETED|Overall Study||0
5198569|NCT01058239|12783863|P1|COMPLETED|Overall Study||7
5198570|NCT01058239|12783863|P1|STARTED|Overall Study||7
5198571|NCT01058096|12783874|P2|NOT COMPLETED|Safety Follow-up||4
5198572|NCT01058096|12783875|P1|NOT COMPLETED|Safety Follow-up||4
5198573|NCT01058096|12783874|P2|COMPLETED|Safety Follow-up||130
5198574|NCT01058096|12783875|P1|COMPLETED|Safety Follow-up||129
5198575|NCT01058096|12783874|P2|STARTED|Safety Follow-up||134
5198576|NCT01058096|12783875|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
5198577|NCT01058096|12783874|P2|NOT COMPLETED|Double-blind Treatment Phase||50
5198578|NCT01058096|12783875|P1|NOT COMPLETED|Double-blind Treatment Phase||48
5198579|NCT01058096|12783874|P2|COMPLETED|Double-blind Treatment Phase||108
5198580|NCT01058096|12783875|P1|COMPLETED|Double-blind Treatment Phase||106
5198581|NCT01058096|12783874|P2|STARTED|Double-blind Treatment Phase||158
5198582|NCT01058096|12783875|P1|STARTED|Double-blind Treatment Phase||154
5198583|NCT01058070|12783883|P1|NOT COMPLETED|Overall Study||11
5198584|NCT01058070|12783883|P1|COMPLETED|Overall Study||33
5198585|NCT01058070|12783883|P1|STARTED|Overall Study||44
5198586|NCT01058005|12783891|P3|NOT COMPLETED|Overall Study||20
5198587|NCT01058005|12783892|P2|NOT COMPLETED|Overall Study||25
5198588|NCT01058005|12783893|P1|NOT COMPLETED|Overall Study||38
5198589|NCT01058005|12783891|P3|COMPLETED|Overall Study||1
5198590|NCT01058005|12783892|P2|COMPLETED|Overall Study||0
5198591|NCT01058005|12783893|P1|COMPLETED|Overall Study||0
5198592|NCT01058005|12783891|P3|Dosed With Study Treatment|Overall Study||17
5198593|NCT01058005|12783892|P2|Dosed With Study Treatment|Overall Study||22
5198594|NCT01058005|12783893|P1|Dosed With Study Treatment|Overall Study||36
5198595|NCT01058005|12783891|P3|STARTED|Overall Study||21
5198596|NCT01058005|12783892|P2|STARTED|Overall Study||25
5198597|NCT01058005|12783893|P1|STARTED|Overall Study||38
5198598|NCT01057901|12783903|P2|NOT COMPLETED|Overall Study||246
5198599|NCT01057901|12783904|P1|NOT COMPLETED|Overall Study||260
5198600|NCT01057901|12783903|P2|COMPLETED|Overall Study||126
5198601|NCT01057901|12783904|P1|COMPLETED|Overall Study||116
5198602|NCT01057901|12783903|P2|STARTED|Overall Study||372
5198603|NCT01057901|12783904|P1|STARTED|Overall Study||376
5198604|NCT01057888|12783915|P3|NOT COMPLETED|Overall Study||0
5198605|NCT01057888|12783916|P2|NOT COMPLETED|Overall Study||0
5198606|NCT01057888|12783917|P1|NOT COMPLETED|Overall Study||0
5198607|NCT01057888|12783915|P3|COMPLETED|Overall Study||2494
5198608|NCT01057888|12783916|P2|COMPLETED|Overall Study||2406
5198609|NCT01057888|12783917|P1|COMPLETED|Overall Study||2504
5198610|NCT01057888|12783915|P3|STARTED|Overall Study||2494
5198611|NCT01057888|12783916|P2|STARTED|Overall Study||2406
5198612|NCT01057888|12783917|P1|STARTED|Overall Study||2504
5198613|NCT01057862|12783928|P2|NOT COMPLETED|Overall Study||2
5198614|NCT01057862|12783929|P1|NOT COMPLETED|Overall Study||1
5198615|NCT01057862|12783928|P2|COMPLETED|Overall Study||2
5198616|NCT01057862|12783929|P1|COMPLETED|Overall Study||4
5198617|NCT01057862|12783928|P2|STARTED|Overall Study||4
5198618|NCT01057862|12783929|P1|STARTED|Overall Study||5
5198619|NCT01057810|12783939|P2|NOT COMPLETED|Overall Study||398
5198620|NCT01057810|12783940|P1|NOT COMPLETED|Overall Study||198
5198621|NCT01057810|12783939|P2|COMPLETED|Overall Study||1
5198622|NCT01057810|12783940|P1|COMPLETED|Overall Study||1
5198623|NCT01057810|12783939|P2|STARTED|Overall Study||399
5198624|NCT01057810|12783940|P1|STARTED|Overall Study||199
5198625|NCT01057693|12783956|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
5198626|NCT01057693|12783957|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
5198627|NCT01057693|12783958|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
5198628|NCT01057693|12783956|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
5198629|NCT01057693|12783957|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
5198630|NCT01057693|12783958|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
5198631|NCT01057693|12783956|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
5198632|NCT01057693|12783957|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
5198633|NCT01057693|12783958|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
5198634|NCT01057693|12783956|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
5198635|NCT01057693|12783957|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
5198636|NCT01057693|12783958|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
5198637|NCT01057693|12783956|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
5198638|NCT01057693|12783957|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
5198639|NCT01057693|12783958|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
5198640|NCT01057693|12783956|P3|COMPLETED|Between Single-Blind and Double-Blind||0
5198641|NCT01057693|12783957|P2|COMPLETED|Between Single-Blind and Double-Blind||0
5198642|NCT01057693|12783958|P1|COMPLETED|Between Single-Blind and Double-Blind||296
5198643|NCT01057693|12783956|P3|STARTED|Between Single-Blind and Double-Blind||0
5198644|NCT01057693|12783957|P2|STARTED|Between Single-Blind and Double-Blind||0
5198645|NCT01057693|12783958|P1|STARTED|Between Single-Blind and Double-Blind||566
5198646|NCT01057693|12783956|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
5198647|NCT01057693|12783957|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
5198648|NCT01057693|12783958|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
5198649|NCT01057693|12783956|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
5198650|NCT01057693|12783957|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
5198651|NCT01057693|12783958|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
5198652|NCT01057693|12783956|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
5198653|NCT01057693|12783957|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
5198654|NCT01057693|12783958|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
5198655|NCT01057589|12784004|P1|NOT COMPLETED|Overall Study||66
5198656|NCT01057589|12784004|P1|COMPLETED|Overall Study||0
5198657|NCT01057589|12784004|P1|STARTED|Overall Study||66
5198658|NCT01057433|12784013|P1|NOT COMPLETED|Overall Study||1
5198659|NCT01057433|12784013|P1|COMPLETED|Overall Study||23
5198660|NCT01057433|12784013|P1|STARTED|Overall Study||24
5198661|NCT01057394|12784017|P2|NOT COMPLETED|Overall Study||2
5198662|NCT01057394|12784018|P1|NOT COMPLETED|Overall Study||0
5198663|NCT01057394|12784017|P2|COMPLETED|Overall Study|19 treated participants|19
5198664|NCT01057394|12784018|P1|COMPLETED|Overall Study||0
5198665|NCT01057394|12784017|P2|STARTED|Overall Study|21 enrolled participants|21
5198666|NCT01057394|12784018|P1|STARTED|Overall Study||0
5198667|NCT01057277|12784022|P1|NOT COMPLETED|Overall Study||0
5198668|NCT01057277|12784022|P1|COMPLETED|Overall Study||3
5198669|NCT01057277|12784022|P1|STARTED|Overall Study||3
5198670|NCT01057251|12784028|P2|NOT COMPLETED|Overall Study||29
5198671|NCT01057251|12784029|P1|NOT COMPLETED|Overall Study||28
5198672|NCT01057251|12784028|P2|COMPLETED|Overall Study||114
5198673|NCT01057251|12784029|P1|COMPLETED|Overall Study||262
5198674|NCT01057251|12784028|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
5198675|NCT01057251|12784029|P1|STARTED|Overall Study||290
5198676|NCT01057225|12784037|P6|NOT COMPLETED|Overall Study||0
5198677|NCT01057225|12784038|P5|NOT COMPLETED|Overall Study||0
5198678|NCT01057225|12784039|P4|NOT COMPLETED|Overall Study||0
5198679|NCT01057225|12784040|P3|NOT COMPLETED|Overall Study||0
5198680|NCT01057225|12784041|P2|NOT COMPLETED|Overall Study||0
5198681|NCT01057225|12784042|P1|NOT COMPLETED|Overall Study||0
5198682|NCT01057225|12784037|P6|COMPLETED|Overall Study||23
5198683|NCT01057225|12784038|P5|COMPLETED|Overall Study||22
5198684|NCT01057225|12784039|P4|COMPLETED|Overall Study||7
5198685|NCT01057225|12784040|P3|COMPLETED|Overall Study||6
5198686|NCT01057225|12784041|P2|COMPLETED|Overall Study||3
5198687|NCT01057225|12784042|P1|COMPLETED|Overall Study||3
5198688|NCT01057225|12784037|P6|STARTED|Overall Study||23
5198689|NCT01057225|12784038|P5|STARTED|Overall Study||22
5198690|NCT01057225|12784039|P4|STARTED|Overall Study||7
5198691|NCT01057225|12784040|P3|STARTED|Overall Study||6
5198692|NCT01057225|12784041|P2|STARTED|Overall Study||3
5198693|NCT01057225|12784042|P1|STARTED|Overall Study||3
5198694|NCT01057121|12784064|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198695|NCT01057121|12784065|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198696|NCT01057121|12784066|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198697|NCT01057121|12784067|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198698|NCT01057121|12784068|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198699|NCT01057121|12784064|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
5198700|NCT01057121|12784065|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198701|NCT01057121|12784066|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198702|NCT01057121|12784067|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198703|NCT01057121|12784068|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
5198704|NCT01057121|12784064|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
5198705|NCT01057121|12784065|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
5198706|NCT01057121|12784066|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
5198707|NCT01057121|12784067|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
5198708|NCT01057121|12784068|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
5198709|NCT01057121|12784064|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198710|NCT01057121|12784065|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198711|NCT01057121|12784066|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198712|NCT01057121|12784067|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198713|NCT01057121|12784068|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198714|NCT01057121|12784064|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198715|NCT01057121|12784065|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
5198716|NCT01057121|12784066|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198717|NCT01057121|12784067|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198718|NCT01057121|12784068|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
5198719|NCT01057121|12784064|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
5198720|NCT01057121|12784065|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
5198721|NCT01057121|12784066|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
5198722|NCT01057121|12784067|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
5198723|NCT01057121|12784068|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
5198724|NCT01057121|12784064|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198725|NCT01057121|12784065|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198726|NCT01057121|12784066|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198727|NCT01057121|12784067|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198728|NCT01057121|12784068|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198729|NCT01057121|12784064|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198730|NCT01057121|12784065|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198731|NCT01057121|12784066|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
5198732|NCT01057121|12784067|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198733|NCT01057121|12784068|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
5198734|NCT01057121|12784064|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
5198735|NCT01057121|12784065|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
5198736|NCT01057121|12784066|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
5198737|NCT01057121|12784067|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
5198738|NCT01057121|12784068|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
5198739|NCT01057121|12784064|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198740|NCT01057121|12784065|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198741|NCT01057121|12784066|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198742|NCT01057121|12784067|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198743|NCT01057121|12784068|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198744|NCT01057121|12784064|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198745|NCT01057121|12784065|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198746|NCT01057121|12784066|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198747|NCT01057121|12784067|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
5198748|NCT01057121|12784068|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
5198749|NCT01057121|12784064|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
5198750|NCT01057121|12784065|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
5198751|NCT01057121|12784066|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
5198752|NCT01057121|12784067|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
5198753|NCT01057121|12784068|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
5198754|NCT01057121|12784064|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198755|NCT01057121|12784065|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198756|NCT01057121|12784066|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198757|NCT01057121|12784067|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198758|NCT01057121|12784068|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198759|NCT01057121|12784064|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198760|NCT01057121|12784065|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198761|NCT01057121|12784066|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198762|NCT01057121|12784067|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
5198763|NCT01057121|12784068|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
5198764|NCT01057121|12784064|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
5198765|NCT01057121|12784065|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
5198766|NCT01057121|12784066|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
5198767|NCT01057121|12784067|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
5198768|NCT01057121|12784068|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
5198769|NCT01057017|12784097|P1|NOT COMPLETED|Overall Study||0
5198770|NCT01057017|12784097|P1|COMPLETED|Overall Study||5
5198771|NCT01057017|12784097|P1|STARTED|Overall Study||5
5198772|NCT01056913|12784101|P1|NOT COMPLETED|Overall Study||0
5198773|NCT01056913|12784101|P1|COMPLETED|Overall Study||62
5198774|NCT01056913|12784101|P1|STARTED|Overall Study||62
5198775|NCT01056822|12784107|P2|NOT COMPLETED|Overall Study||7
5198776|NCT01056822|12784108|P1|NOT COMPLETED|Overall Study||8
5198777|NCT01056822|12784107|P2|COMPLETED|Overall Study||35
5198778|NCT01056822|12784108|P1|COMPLETED|Overall Study||39
5198779|NCT01056822|12784107|P2|Safety (SAF) Population: NO|Overall Study||2
5198780|NCT01056822|12784108|P1|Safety (SAF) Population: NO|Overall Study||1
5198781|NCT01056822|12784107|P2|Safety (SAF) Population: YES|Overall Study||40
5198782|NCT01056822|12784108|P1|Safety (SAF) Population: YES|Overall Study||46
5198783|NCT01056822|12784107|P2|Per-protocol (PP) Population: NO|Overall Study||17
5198784|NCT01056822|12784108|P1|Per-protocol (PP) Population: NO|Overall Study||18
5198785|NCT01056822|12784107|P2|Per-protocol (PP) Population: YES|Overall Study||25
5198786|NCT01056822|12784108|P1|Per-protocol (PP) Population: YES|Overall Study||29
5198787|NCT01056822|12784107|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
5198788|NCT01056822|12784108|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
5198789|NCT01056822|12784107|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
5198790|NCT01056822|12784108|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
5198791|NCT01056822|12784107|P2|STARTED|Overall Study||42
5198792|NCT01056822|12784108|P1|STARTED|Overall Study||47
5198793|NCT01056718|12784157|P1|NOT COMPLETED|Overall Study||3
5198794|NCT01056718|12784157|P1|COMPLETED|Overall Study||50
5198795|NCT01056718|12784157|P1|STARTED|Overall Study||53
5198796|NCT01056653|12784190|P3|NOT COMPLETED|Overall Study||2
5198797|NCT01056653|12784191|P2|NOT COMPLETED|Overall Study||0
5198798|NCT01056653|12784192|P1|NOT COMPLETED|Overall Study||0
5198799|NCT01056653|12784190|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
5198800|NCT01056653|12784191|P2|COMPLETED|Overall Study||23
5198801|NCT01056653|12784192|P1|COMPLETED|Overall Study||46
5198802|NCT01056653|12784190|P3|STARTED|Overall Study||44
5198803|NCT01056653|12784191|P2|STARTED|Overall Study||23
5198804|NCT01056653|12784192|P1|STARTED|Overall Study||46
5198805|NCT01056640|12784208|P2|NOT COMPLETED|Overall Study||12
5198806|NCT01056640|12784209|P1|NOT COMPLETED|Overall Study||26
5198807|NCT01056640|12784208|P2|COMPLETED|Overall Study||91
5198808|NCT01056640|12784209|P1|COMPLETED|Overall Study||76
5198809|NCT01056640|12784208|P2|STARTED|Overall Study||103
5198810|NCT01056640|12784209|P1|STARTED|Overall Study||102
5198811|NCT01056601|12784215|P1|NOT COMPLETED|Overall Study||0
5198812|NCT01056601|12784215|P1|COMPLETED|Overall Study||7
5198813|NCT01056601|12784215|P1|STARTED|Overall Study||7
5198814|NCT01056536|12784224|P3|NOT COMPLETED|Overall Study||248
5198815|NCT01056536|12784225|P2|NOT COMPLETED|Overall Study||116
5198816|NCT01056536|12784226|P1|NOT COMPLETED|Overall Study||202
5198817|NCT01056536|12784224|P3|COMPLETED|Overall Study||481
5198818|NCT01056536|12784225|P2|COMPLETED|Overall Study||240
5198819|NCT01056536|12784226|P1|COMPLETED|Overall Study||394
5198820|NCT01056536|12784224|P3|STARTED|Overall Study||729
5198821|NCT01056536|12784225|P2|STARTED|Overall Study||356
5198822|NCT01056536|12784226|P1|STARTED|Overall Study||596
5198823|NCT01056523|12784237|P7|NOT COMPLETED|Overall Study||1
5198824|NCT01056523|12784238|P6|NOT COMPLETED|Overall Study||0
5198825|NCT01056523|12784239|P5|NOT COMPLETED|Overall Study||0
5198826|NCT01056523|12784240|P4|NOT COMPLETED|Overall Study||3
5198827|NCT01056523|12784241|P3|NOT COMPLETED|Overall Study||2
5198828|NCT01056523|12784242|P2|NOT COMPLETED|Overall Study||0
5198829|NCT01056523|12784243|P1|NOT COMPLETED|Overall Study||1
5198830|NCT01056523|12784237|P7|COMPLETED|Overall Study||4
5198831|NCT01056523|12784238|P6|COMPLETED|Overall Study||3
5198832|NCT01056523|12784239|P5|COMPLETED|Overall Study||3
5198833|NCT01056523|12784240|P4|COMPLETED|Overall Study||3
5198834|NCT01056523|12784241|P3|COMPLETED|Overall Study||3
5198835|NCT01056523|12784242|P2|COMPLETED|Overall Study||3
5198836|NCT01056523|12784243|P1|COMPLETED|Overall Study||3
5198837|NCT01056523|12784237|P7|STARTED|Overall Study||5
5198838|NCT01056523|12784238|P6|STARTED|Overall Study||3
5198839|NCT01056523|12784239|P5|STARTED|Overall Study||3
5198840|NCT01056523|12784240|P4|STARTED|Overall Study||6
5198841|NCT01056523|12784241|P3|STARTED|Overall Study||5
5198842|NCT01056523|12784242|P2|STARTED|Overall Study||3
5198843|NCT01056523|12784243|P1|STARTED|Overall Study||4
5198844|NCT01056510|12784253|P2|NOT COMPLETED|Overall Study||64
5198845|NCT01056510|12784254|P1|NOT COMPLETED|Overall Study||54
5198846|NCT01056510|12784253|P2|COMPLETED|Overall Study||115
5198847|NCT01056510|12784254|P1|COMPLETED|Overall Study||124
5198848|NCT01056510|12784253|P2|STARTED|Overall Study||179
5198849|NCT01056510|12784254|P1|STARTED|Overall Study||178
5198850|NCT01056484|12784300|P2|NOT COMPLETED|Follow up - Non-randomized||2
5198851|NCT01056484|12784301|P1|NOT COMPLETED|Follow up - Non-randomized||0
5198852|NCT01056484|12784300|P2|COMPLETED|Follow up - Non-randomized||56
5198853|NCT01056484|12784301|P1|COMPLETED|Follow up - Non-randomized||57
5198854|NCT01056484|12784300|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
5198855|NCT01056484|12784301|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
5198856|NCT01056484|12784300|P2|NOT COMPLETED|Randomized Controlled Trial||1
5198857|NCT01056484|12784301|P1|NOT COMPLETED|Randomized Controlled Trial||7
5198858|NCT01056484|12784300|P2|COMPLETED|Randomized Controlled Trial||58
5198859|NCT01056484|12784301|P1|COMPLETED|Randomized Controlled Trial||57
5198860|NCT01056484|12784300|P2|STARTED|Randomized Controlled Trial||59
5198861|NCT01056484|12784301|P1|STARTED|Randomized Controlled Trial||64
5198862|NCT01056380|12784317|P2|NOT COMPLETED|Overall Study||3
5198863|NCT01056380|12784318|P1|NOT COMPLETED|Overall Study||2
5198864|NCT01056380|12784317|P2|COMPLETED|Overall Study||39
5198865|NCT01056380|12784318|P1|COMPLETED|Overall Study||35
5198866|NCT01056380|12784317|P2|STARTED|Overall Study||42
5198867|NCT01056380|12784318|P1|STARTED|Overall Study||37
5198868|NCT01056341|12784345|P5|NOT COMPLETED|Overall Study||14
5198869|NCT01056341|12784346|P4|NOT COMPLETED|Overall Study||36
5198870|NCT01056341|12784347|P3|NOT COMPLETED|Overall Study||15
5198871|NCT01056341|12784348|P2|NOT COMPLETED|Overall Study||36
5198872|NCT01056341|12784349|P1|NOT COMPLETED|Overall Study||36
5198873|NCT01056341|12784345|P5|COMPLETED|Overall Study||88
5198874|NCT01056341|12784346|P4|COMPLETED|Overall Study||65
5198875|NCT01056341|12784347|P3|COMPLETED|Overall Study||88
5198876|NCT01056341|12784348|P2|COMPLETED|Overall Study||63
5198877|NCT01056341|12784349|P1|COMPLETED|Overall Study||19
5198878|NCT01056341|12784345|P5|Interim Analysis|Overall Study||43
5198879|NCT01056341|12784346|P4|Interim Analysis|Overall Study||40
5198880|NCT01056341|12784347|P3|Interim Analysis|Overall Study||41
5198881|NCT01056341|12784348|P2|Interim Analysis|Overall Study||41
5198882|NCT01056341|12784349|P1|Interim Analysis|Overall Study||25
5198883|NCT01056341|12784345|P5|STARTED|Overall Study||102
5198884|NCT01056341|12784346|P4|STARTED|Overall Study||101
5198885|NCT01056341|12784347|P3|STARTED|Overall Study||103
5198886|NCT01056341|12784348|P2|STARTED|Overall Study||99
5198887|NCT01056341|12784349|P1|STARTED|Overall Study||55
5198888|NCT01056328|12784370|P2|NOT COMPLETED|Overall Study||16
5198889|NCT01056328|12784371|P1|NOT COMPLETED|Overall Study||17
5198890|NCT01056328|12784370|P2|COMPLETED|Overall Study||144
5198891|NCT01056328|12784371|P1|COMPLETED|Overall Study||147
5198892|NCT01056328|12784370|P2|STARTED|Overall Study||160
5198893|NCT01056328|12784371|P1|STARTED|Overall Study||164
5198894|NCT01056315|12784387|P2|NOT COMPLETED|Overall Study||11
5198895|NCT01056315|12784388|P1|NOT COMPLETED|Overall Study||14
5198896|NCT01056315|12784387|P2|COMPLETED|Overall Study||12
5198897|NCT01056315|12784388|P1|COMPLETED|Overall Study||13
5198898|NCT01056315|12784387|P2|STARTED|Overall Study||23
5198899|NCT01056315|12784388|P1|STARTED|Overall Study||27
5198900|NCT01056302|12784422|P1|NOT COMPLETED|Overall Study||0
5198901|NCT01056302|12784422|P1|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
5198902|NCT01056302|12784422|P1|STARTED|Overall Study||3
5198903|NCT01056289|12784428|P4|NOT COMPLETED|Double-blind Phase||10
5198904|NCT01056289|12784429|P3|NOT COMPLETED|Double-blind Phase||13
5198905|NCT01056289|12784430|P2|NOT COMPLETED|Double-blind Phase||4
5198906|NCT01056289|12784431|P1|NOT COMPLETED|Double-blind Phase||0
5198907|NCT01056289|12784428|P4|COMPLETED|Double-blind Phase||138
5198908|NCT01056289|12784429|P3|COMPLETED|Double-blind Phase||127
5198909|NCT01056289|12784430|P2|COMPLETED|Double-blind Phase||69
5198910|NCT01056289|12784431|P1|COMPLETED|Double-blind Phase||0
5198911|NCT01056289|12784428|P4|STARTED|Double-blind Phase||148
5198912|NCT01056289|12784429|P3|STARTED|Double-blind Phase||140
5198913|NCT01056289|12784430|P2|STARTED|Double-blind Phase||73
5198914|NCT01056289|12784431|P1|STARTED|Double-blind Phase||0
5198915|NCT01056289|12784428|P4|NOT COMPLETED|Open-label Phase||0
5198916|NCT01056289|12784429|P3|NOT COMPLETED|Open-label Phase||0
5198917|NCT01056289|12784430|P2|NOT COMPLETED|Open-label Phase||0
5198918|NCT01056289|12784431|P1|NOT COMPLETED|Open-label Phase||119
5198919|NCT01056289|12784428|P4|COMPLETED|Open-label Phase||0
5198920|NCT01056289|12784429|P3|COMPLETED|Open-label Phase||0
5198921|NCT01056289|12784430|P2|COMPLETED|Open-label Phase||0
5198922|NCT01056289|12784431|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
5198923|NCT01056289|12784428|P4|STARTED|Open-label Phase||0
5198924|NCT01056289|12784429|P3|STARTED|Open-label Phase||0
5198925|NCT01056289|12784430|P2|STARTED|Open-label Phase||0
5198926|NCT01056289|12784431|P1|STARTED|Open-label Phase||480
5198927|NCT01056276|12784448|P2|NOT COMPLETED|Maintenance Therapy||28
5198928|NCT01056276|12784449|P1|NOT COMPLETED|Maintenance Therapy||0
5198929|NCT01056276|12784448|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
5198930|NCT01056276|12784449|P1|COMPLETED|Maintenance Therapy||0
5198931|NCT01056276|12784448|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
5198932|NCT01056276|12784449|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
5198933|NCT01056276|12784448|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
5198934|NCT01056276|12784449|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
5198935|NCT01056276|12784448|P2|COMPLETED|Treatment Period-Cycles 1-8||33
5198936|NCT01056276|12784449|P1|COMPLETED|Treatment Period-Cycles 1-8||5
5198937|NCT01056276|12784448|P2|STARTED|Treatment Period-Cycles 1-8||41
5198938|NCT01056276|12784449|P1|STARTED|Treatment Period-Cycles 1-8||18
5198939|NCT01056263|12784463|P1|NOT COMPLETED|Overall Study||52
5198940|NCT01056263|12784463|P1|COMPLETED|Overall Study||0
5198941|NCT01056263|12784463|P1|STARTED|Overall Study||52
5198942|NCT01056198|12784469|P2|NOT COMPLETED|Overall Study||0
5198943|NCT01056198|12784470|P1|NOT COMPLETED|Overall Study||0
5198944|NCT01056198|12784469|P2|COMPLETED|Overall Study||24
5198945|NCT01056198|12784470|P1|COMPLETED|Overall Study||24
5198946|NCT01056198|12784469|P2|STARTED|Overall Study||24
5198947|NCT01056198|12784470|P1|STARTED|Overall Study||24
5198948|NCT01056107|12784486|P4|NOT COMPLETED|Overall Study||0
5198949|NCT01056107|12784487|P3|NOT COMPLETED|Overall Study||3
5198950|NCT01056107|12784488|P2|NOT COMPLETED|Overall Study||1
5198951|NCT01056107|12784489|P1|NOT COMPLETED|Overall Study||0
5198952|NCT01056107|12784486|P4|COMPLETED|Overall Study||12
5198953|NCT01056107|12784487|P3|COMPLETED|Overall Study||9
5198954|NCT01056107|12784488|P2|COMPLETED|Overall Study||10
5198955|NCT01056107|12784489|P1|COMPLETED|Overall Study||11
5198956|NCT01056107|12784486|P4|STARTED|Overall Study||12
5198957|NCT01056107|12784487|P3|STARTED|Overall Study||12
5198958|NCT01056107|12784488|P2|STARTED|Overall Study||11
5198959|NCT01056107|12784489|P1|STARTED|Overall Study||11
5198960|NCT01056016|12784537|P2|NOT COMPLETED|Overall Study||1
5198961|NCT01056016|12784538|P1|NOT COMPLETED|Overall Study||2
5198962|NCT01056016|12784537|P2|COMPLETED|Overall Study||26
5198963|NCT01056016|12784538|P1|COMPLETED|Overall Study||20
5198964|NCT01056016|12784537|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
5198965|NCT01056016|12784538|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
5198966|NCT01055886|12784546|P2|NOT COMPLETED|Overall Study||11
5198967|NCT01055886|12784547|P1|NOT COMPLETED|Overall Study||5
5198968|NCT01055886|12784546|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
5198969|NCT01055886|12784547|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
5198970|NCT01055886|12784546|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
5198971|NCT01055886|12784547|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
5198972|NCT01055886|12784546|P2|STARTED|Overall Study||32
5198973|NCT01055886|12784547|P1|STARTED|Overall Study||33
5198974|NCT01055834|12784559|P2|NOT COMPLETED|Treatment Period III||0
5198975|NCT01055834|12784560|P1|NOT COMPLETED|Treatment Period III||0
5198976|NCT01055834|12784559|P2|COMPLETED|Treatment Period III||14
5198977|NCT01055834|12784560|P1|COMPLETED|Treatment Period III||0
5198978|NCT01055834|12784559|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
5198979|NCT01055834|12784560|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
5198980|NCT01055834|12784559|P2|NOT COMPLETED|Treatment Period II||0
5198981|NCT01055834|12784560|P1|NOT COMPLETED|Treatment Period II||0
5198982|NCT01055834|12784559|P2|COMPLETED|Treatment Period II||21
5198983|NCT01055834|12784560|P1|COMPLETED|Treatment Period II||20
5198984|NCT01055834|12784559|P2|STARTED|Treatment Period II||21
5198985|NCT01055834|12784560|P1|STARTED|Treatment Period II||20
5198986|NCT01055834|12784559|P2|NOT COMPLETED|Treatment Period I||0
5198987|NCT01055834|12784560|P1|NOT COMPLETED|Treatment Period I||1
5198988|NCT01055834|12784559|P2|COMPLETED|Treatment Period I||21
5198989|NCT01055834|12784560|P1|COMPLETED|Treatment Period I||20
5198990|NCT01055834|12784559|P2|STARTED|Treatment Period I||21
5198991|NCT01055834|12784560|P1|STARTED|Treatment Period I||21
5198992|NCT01055782|12784574|P2|NOT COMPLETED|Overall Study||0
5198993|NCT01055782|12784575|P1|NOT COMPLETED|Overall Study||0
5198994|NCT01055782|12784574|P2|COMPLETED|Overall Study||449
5198995|NCT01055782|12784575|P1|COMPLETED|Overall Study||555
5198996|NCT01055782|12784574|P2|STARTED|Overall Study||449
5198997|NCT01055782|12784575|P1|STARTED|Overall Study||555
5198998|NCT01055769|12784583|P2|NOT COMPLETED|Second Intervention||0
5198999|NCT01055769|12784584|P1|NOT COMPLETED|Second Intervention||0
5199000|NCT01055769|12784583|P2|COMPLETED|Second Intervention||10
5199001|NCT01055769|12784584|P1|COMPLETED|Second Intervention||10
5199002|NCT01055769|12784583|P2|STARTED|Second Intervention||10
5199003|NCT01055769|12784584|P1|STARTED|Second Intervention||10
5199004|NCT01055769|12784583|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
5199005|NCT01055769|12784584|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
5199006|NCT01055769|12784583|P2|COMPLETED|Washout Period of Atleast 4 Days||10
5199007|NCT01055769|12784584|P1|COMPLETED|Washout Period of Atleast 4 Days||10
5199008|NCT01055769|12784583|P2|STARTED|Washout Period of Atleast 4 Days||10
5199009|NCT01055769|12784584|P1|STARTED|Washout Period of Atleast 4 Days||10
5199010|NCT01055769|12784583|P2|NOT COMPLETED|First Intervention||0
5199011|NCT01055769|12784584|P1|NOT COMPLETED|First Intervention||0
5199012|NCT01055769|12784583|P2|COMPLETED|First Intervention||10
5199013|NCT01055769|12784584|P1|COMPLETED|First Intervention||10
5199014|NCT01055769|12784583|P2|STARTED|First Intervention||10
5199015|NCT01055769|12784584|P1|STARTED|First Intervention||10
5199016|NCT01055704|12784602|P4|NOT COMPLETED|Overall Study||0
5199017|NCT01055704|12784603|P3|NOT COMPLETED|Overall Study||0
5199018|NCT01055704|12784604|P2|NOT COMPLETED|Overall Study||0
5199019|NCT01055704|12784605|P1|NOT COMPLETED|Overall Study||0
5199020|NCT01055704|12784602|P4|COMPLETED|Overall Study||8
5199021|NCT01055704|12784603|P3|COMPLETED|Overall Study||16
5199022|NCT01055704|12784604|P2|COMPLETED|Overall Study||8
5199023|NCT01055704|12784605|P1|COMPLETED|Overall Study||16
5199024|NCT01055704|12784602|P4|STARTED|Overall Study||8
5199025|NCT01055704|12784603|P3|STARTED|Overall Study||16
5199026|NCT01055704|12784604|P2|STARTED|Overall Study||8
5199027|NCT01055704|12784605|P1|STARTED|Overall Study||16
5199028|NCT01055639|12784645|P2|NOT COMPLETED|Overall Study||29
5199029|NCT01055639|12784646|P1|NOT COMPLETED|Overall Study||21
5199030|NCT01055639|12784645|P2|COMPLETED|Overall Study||31
5199031|NCT01055639|12784646|P1|COMPLETED|Overall Study||45
5199032|NCT01055639|12784645|P2|STARTED|Overall Study||60
5199033|NCT01055639|12784646|P1|STARTED|Overall Study||66
5199034|NCT01055613|12784670|P2|NOT COMPLETED|Overall Study||4
5199035|NCT01055613|12784671|P1|NOT COMPLETED|Overall Study||9
5199036|NCT01055613|12784670|P2|COMPLETED|Overall Study||96
5199037|NCT01055613|12784671|P1|COMPLETED|Overall Study||191
5199038|NCT01055613|12784670|P2|STARTED|Overall Study||100
5199039|NCT01055613|12784671|P1|STARTED|Overall Study||200
5199040|NCT01055496|12784681|P2|NOT COMPLETED|Overall Study||30
5199041|NCT01055496|12784682|P1|NOT COMPLETED|Overall Study||15
5199042|NCT01055496|12784681|P2|COMPLETED|Overall Study||25
5199043|NCT01055496|12784682|P1|COMPLETED|Overall Study||33
5199044|NCT01055496|12784681|P2|STARTED|Overall Study||55
5199045|NCT01055496|12784682|P1|STARTED|Overall Study||48
5199046|NCT01055457|12784739|P10|NOT COMPLETED|Overall Study||1
5199047|NCT01055457|12784740|P9|NOT COMPLETED|Overall Study||0
5199048|NCT01055457|12784741|P8|NOT COMPLETED|Overall Study||1
5199049|NCT01055457|12784742|P7|NOT COMPLETED|Overall Study||1
5199050|NCT01055457|12784743|P6|NOT COMPLETED|Overall Study||3
5199051|NCT01055457|12784744|P5|NOT COMPLETED|Overall Study||3
5199052|NCT01055457|12784745|P4|NOT COMPLETED|Overall Study||3
5199053|NCT01055457|12784746|P3|NOT COMPLETED|Overall Study||2
5199054|NCT01055457|12784747|P2|NOT COMPLETED|Overall Study||1
5199055|NCT01055457|12784748|P1|NOT COMPLETED|Overall Study||1
5199056|NCT01055457|12784739|P10|COMPLETED|Overall Study||19
5199057|NCT01055457|12784740|P9|COMPLETED|Overall Study||20
5199058|NCT01055457|12784741|P8|COMPLETED|Overall Study||18
5199059|NCT01055457|12784742|P7|COMPLETED|Overall Study||18
5199060|NCT01055457|12784743|P6|COMPLETED|Overall Study||15
5199061|NCT01055457|12784744|P5|COMPLETED|Overall Study||38
5199062|NCT01055457|12784745|P4|COMPLETED|Overall Study||37
5199063|NCT01055457|12784746|P3|COMPLETED|Overall Study||36
5199064|NCT01055457|12784747|P2|COMPLETED|Overall Study||39
5199065|NCT01055457|12784748|P1|COMPLETED|Overall Study||39
5199066|NCT01055457|12784739|P10|STARTED|Overall Study||20
5199067|NCT01055457|12784740|P9|STARTED|Overall Study||20
5199068|NCT01055457|12784741|P8|STARTED|Overall Study||19
5199069|NCT01055457|12784742|P7|STARTED|Overall Study||19
5199070|NCT01055457|12784743|P6|STARTED|Overall Study||18
5199071|NCT01055457|12784744|P5|STARTED|Overall Study||41
5199072|NCT01055457|12784745|P4|STARTED|Overall Study||40
5199073|NCT01055457|12784746|P3|STARTED|Overall Study||38
5199074|NCT01055457|12784747|P2|STARTED|Overall Study||40
5199075|NCT01055457|12784748|P1|STARTED|Overall Study||40
5199076|NCT01055314|12784782|P2|NOT COMPLETED|Overall Study||38
5199077|NCT01055314|12784783|P1|NOT COMPLETED|Overall Study||45
5199078|NCT01055314|12784782|P2|COMPLETED|Overall Study||37
5199079|NCT01055314|12784783|P1|COMPLETED|Overall Study||55
5199080|NCT01055314|12784782|P2|STARTED|Overall Study||75
5199081|NCT01055314|12784783|P1|STARTED|Overall Study||100
5199082|NCT01055262|12784795|P1|NOT COMPLETED|Overall Study||9
5199083|NCT01055262|12784795|P1|COMPLETED|Overall Study||160
5199084|NCT01055262|12784795|P1|STARTED|Overall Study||169
5199085|NCT01055223|12784806|P1|NOT COMPLETED|Overall Study||0
5199086|NCT01055223|12784806|P1|COMPLETED|Overall Study||98483
5199087|NCT01055223|12784806|P1|STARTED|Overall Study||98483
5199088|NCT01055197|12784836|P2|NOT COMPLETED|Overall Study||2
5199089|NCT01055197|12784837|P1|NOT COMPLETED|Overall Study||9
5199090|NCT01055197|12784836|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
5199091|NCT01055197|12784837|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
5199092|NCT01055197|12784836|P2|STARTED|Overall Study||46
5199093|NCT01055197|12784837|P1|STARTED|Overall Study||51
5199094|NCT01055184|12784851|P1|NOT COMPLETED|Overall Study||0
5199095|NCT01055184|12784851|P1|COMPLETED|Overall Study||34
5199096|NCT01055184|12784851|P1|STARTED|Overall Study||34
5199097|NCT01055171|12784857|P2|NOT COMPLETED|Overall Study||7
5199098|NCT01055171|12784858|P1|NOT COMPLETED|Overall Study||11
5199099|NCT01055171|12784857|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
5199100|NCT01055171|12784858|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
5199101|NCT01055171|12784857|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
5199102|NCT01055171|12784858|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
5199103|NCT01055171|12784857|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
5199104|NCT01055171|12784858|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
5199105|NCT01055171|12784857|P2|STARTED|Overall Study|Randomized to receive placebo.|28
5199106|NCT01055171|12784858|P1|STARTED|Overall Study|Randomized to receive medication.|29
5199107|NCT01055132|12784872|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
5199108|NCT01055132|12784873|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
5199109|NCT01055132|12784872|P2|COMPLETED|Period 2 (5-9 Days)||32
5199110|NCT01055132|12784873|P1|COMPLETED|Period 2 (5-9 Days)||35
5199111|NCT01055132|12784872|P2|STARTED|Period 2 (5-9 Days)||33
5199112|NCT01055132|12784873|P1|STARTED|Period 2 (5-9 Days)||35
5199113|NCT01055132|12784872|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
5199114|NCT01055132|12784873|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
5199115|NCT01055132|12784872|P2|COMPLETED|Period 1 (5-9 Days)||33
5199116|NCT01055132|12784873|P1|COMPLETED|Period 1 (5-9 Days)||35
5199117|NCT01055132|12784872|P2|STARTED|Period 1 (5-9 Days)||33
5199118|NCT01055132|12784873|P1|STARTED|Period 1 (5-9 Days)||36
5199119|NCT01055028|12784886|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
5199120|NCT01055028|12784887|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
5199121|NCT01055028|12784886|P2|COMPLETED|Treatment Cycles 4 to 6||2
5199122|NCT01055028|12784887|P1|COMPLETED|Treatment Cycles 4 to 6||6
5199123|NCT01055028|12784886|P2|STARTED|Treatment Cycles 4 to 6||2
5199124|NCT01055028|12784887|P1|STARTED|Treatment Cycles 4 to 6||6
5199125|NCT01055028|12784886|P2|NOT COMPLETED|Inter-treatment Period||3
5199126|NCT01055028|12784887|P1|NOT COMPLETED|Inter-treatment Period||0
5199127|NCT01055028|12784886|P2|COMPLETED|Inter-treatment Period||2
5199128|NCT01055028|12784887|P1|COMPLETED|Inter-treatment Period||6
5199129|NCT01055028|12784886|P2|STARTED|Inter-treatment Period||5
5199130|NCT01055028|12784887|P1|STARTED|Inter-treatment Period||6
5199131|NCT01055028|12784886|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
5199132|NCT01055028|12784887|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
5199133|NCT01055028|12784886|P2|COMPLETED|Treatment Cycles 1 to 3||5
5199134|NCT01055028|12784887|P1|COMPLETED|Treatment Cycles 1 to 3||6
5199135|NCT01055028|12784886|P2|STARTED|Treatment Cycles 1 to 3||8
5199136|NCT01055028|12784887|P1|STARTED|Treatment Cycles 1 to 3||8
5199137|NCT01055028|12784886|P2|NOT COMPLETED|Screening||1
5199138|NCT01055028|12784887|P1|NOT COMPLETED|Screening||1
5199139|NCT01055028|12784886|P2|COMPLETED|Screening||8
5199140|NCT01055028|12784887|P1|COMPLETED|Screening||8
5199141|NCT01055028|12784886|P2|STARTED|Screening||9
5199142|NCT01055028|12784887|P1|STARTED|Screening||9
5199143|NCT01054976|12784901|P1|NOT COMPLETED|Overall Study||35
5199144|NCT01054976|12784901|P1|COMPLETED|Overall Study||57
5199145|NCT01054976|12784901|P1|STARTED|Overall Study||92
5199146|NCT01054911|12784909|P1|NOT COMPLETED|Overall Study||0
5199147|NCT01054911|12784909|P1|COMPLETED|Overall Study||5
5199148|NCT01054911|12784909|P1|STARTED|Overall Study||5
5199149|NCT01054885|12784922|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
5199150|NCT01054885|12784923|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
5199151|NCT01054885|12784924|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
5199152|NCT01054885|12784925|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
5199153|NCT01054885|12784926|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
5199154|NCT01054885|12784927|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
5199155|NCT01054885|12784928|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
5199156|NCT01054885|12784922|P7|COMPLETED|24-week, Double-blind Treatment Period||158
5199157|NCT01054885|12784923|P6|COMPLETED|24-week, Double-blind Treatment Period||144
5199158|NCT01054885|12784924|P5|COMPLETED|24-week, Double-blind Treatment Period||161
5199159|NCT01054885|12784925|P4|COMPLETED|24-week, Double-blind Treatment Period||160
5199160|NCT01054885|12784926|P3|COMPLETED|24-week, Double-blind Treatment Period||155
5199161|NCT01054885|12784927|P2|COMPLETED|24-week, Double-blind Treatment Period||146
5199162|NCT01054885|12784928|P1|COMPLETED|24-week, Double-blind Treatment Period||0
5199163|NCT01054885|12784922|P7|STARTED|24-week, Double-blind Treatment Period||205
5199164|NCT01054885|12784923|P6|STARTED|24-week, Double-blind Treatment Period||204
5199165|NCT01054885|12784924|P5|STARTED|24-week, Double-blind Treatment Period||203
5199166|NCT01054885|12784925|P4|STARTED|24-week, Double-blind Treatment Period||203
5199167|NCT01054885|12784926|P3|STARTED|24-week, Double-blind Treatment Period||204
5199168|NCT01054885|12784927|P2|STARTED|24-week, Double-blind Treatment Period||205
5199169|NCT01054885|12784928|P1|STARTED|24-week, Double-blind Treatment Period||0
5199170|NCT01054885|12784922|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199171|NCT01054885|12784923|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199172|NCT01054885|12784924|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199173|NCT01054885|12784925|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199174|NCT01054885|12784926|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199175|NCT01054885|12784927|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199176|NCT01054885|12784928|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
5199177|NCT01054885|12784922|P7|COMPLETED|2-week, Single-blind Run-In Period||0
5199178|NCT01054885|12784923|P6|COMPLETED|2-week, Single-blind Run-In Period||0
5199179|NCT01054885|12784924|P5|COMPLETED|2-week, Single-blind Run-In Period||0
5199180|NCT01054885|12784925|P4|COMPLETED|2-week, Single-blind Run-In Period||0
5199181|NCT01054885|12784926|P3|COMPLETED|2-week, Single-blind Run-In Period||0
5199182|NCT01054885|12784927|P2|COMPLETED|2-week, Single-blind Run-In Period||0
5199183|NCT01054885|12784928|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
5199184|NCT01054885|12784922|P7|STARTED|2-week, Single-blind Run-In Period||0
5199185|NCT01054885|12784923|P6|STARTED|2-week, Single-blind Run-In Period||0
5199186|NCT01054885|12784924|P5|STARTED|2-week, Single-blind Run-In Period||0
5199187|NCT01054885|12784925|P4|STARTED|2-week, Single-blind Run-In Period||0
5199188|NCT01054885|12784926|P3|STARTED|2-week, Single-blind Run-In Period||0
5199189|NCT01054885|12784927|P2|STARTED|2-week, Single-blind Run-In Period||0
5199190|NCT01054885|12784928|P1|STARTED|2-week, Single-blind Run-In Period||1577
5199191|NCT01054846|12784968|P2|NOT COMPLETED|Overall Study||17
5199192|NCT01054846|12784969|P1|NOT COMPLETED|Overall Study||76
5199193|NCT01054846|12784968|P2|COMPLETED|Overall Study||51
5199194|NCT01054846|12784969|P1|COMPLETED|Overall Study||246
5199195|NCT01054846|12784968|P2|STARTED|Overall Study||68
5199196|NCT01054846|12784969|P1|STARTED|Overall Study||322
5199197|NCT01054820|12784976|P1|NOT COMPLETED|Overall Study||2
5199198|NCT01054820|12784976|P1|COMPLETED|Overall Study||121
5199199|NCT01054820|12784976|P1|STARTED|Overall Study||123
5199200|NCT01054742|12784990|P1|NOT COMPLETED|Overall Study||0
5199201|NCT01054742|12784990|P1|COMPLETED|Overall Study||2
5199202|NCT01054742|12784990|P1|STARTED|Overall Study||2
5199203|NCT01054729|12784998|P4|NOT COMPLETED|Overall Study||3
5199204|NCT01054729|12784999|P3|NOT COMPLETED|Overall Study||6
5199205|NCT01054729|12785000|P2|NOT COMPLETED|Overall Study||5
5199206|NCT01054729|12785001|P1|NOT COMPLETED|Overall Study||4
5199207|NCT01054729|12784998|P4|COMPLETED|Overall Study||11
5199208|NCT01054729|12784999|P3|COMPLETED|Overall Study||9
5199209|NCT01054729|12785000|P2|COMPLETED|Overall Study||14
5199210|NCT01054729|12785001|P1|COMPLETED|Overall Study||12
5199211|NCT01054729|12784998|P4|Randomized and Treated|Overall Study||14
5199212|NCT01054729|12784999|P3|Randomized and Treated|Overall Study||15
5199213|NCT01054729|12785000|P2|Randomized and Treated|Overall Study||18
5199214|NCT01054729|12785001|P1|Randomized and Treated|Overall Study||16
5199215|NCT01054729|12784998|P4|STARTED|Overall Study||14
5199216|NCT01054729|12784999|P3|STARTED|Overall Study||15
5199217|NCT01054729|12785000|P2|STARTED|Overall Study||19
5199218|NCT01054729|12785001|P1|STARTED|Overall Study||16
5199219|NCT01054703|12785062|P1|NOT COMPLETED|Overall Study||0
5199220|NCT01054703|12785062|P1|COMPLETED|Overall Study||14
5199221|NCT01054703|12785062|P1|STARTED|Overall Study||14
5199222|NCT01054625|12785069|P3|NOT COMPLETED|Overall Study||1
5199223|NCT01054625|12785070|P2|NOT COMPLETED|Overall Study||3
5199224|NCT01054625|12785071|P1|NOT COMPLETED|Overall Study||2
5199225|NCT01054625|12785069|P3|COMPLETED|Overall Study||9
5199226|NCT01054625|12785070|P2|COMPLETED|Overall Study||9
5199227|NCT01054625|12785071|P1|COMPLETED|Overall Study||6
5199228|NCT01054625|12785069|P3|STARTED|Overall Study||10
5199229|NCT01054625|12785070|P2|STARTED|Overall Study||12
5199230|NCT01054625|12785071|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
5199231|NCT01054599|12785099|P2|NOT COMPLETED|Overall Study||7
5199232|NCT01054599|12785100|P1|NOT COMPLETED|Overall Study||4
5199233|NCT01054599|12785099|P2|COMPLETED|Overall Study||9
5199234|NCT01054599|12785100|P1|COMPLETED|Overall Study||9
5199235|NCT01054599|12785099|P2|STARTED|Overall Study||16
5199236|NCT01054599|12785100|P1|STARTED|Overall Study||13
5199237|NCT01054586|12785112|P4|NOT COMPLETED|Overall Study||0
5199238|NCT01054586|12785113|P3|NOT COMPLETED|Overall Study||0
5199239|NCT01054586|12785114|P2|NOT COMPLETED|Overall Study||0
5199240|NCT01054586|12785115|P1|NOT COMPLETED|Overall Study||0
5199241|NCT01054586|12785112|P4|COMPLETED|Overall Study||101
5199242|NCT01054586|12785113|P3|COMPLETED|Overall Study||8
5199243|NCT01054586|12785114|P2|COMPLETED|Overall Study||15
5199244|NCT01054586|12785115|P1|COMPLETED|Overall Study||43
5199245|NCT01054586|12785112|P4|STARTED|Overall Study||101
5199246|NCT01054586|12785113|P3|STARTED|Overall Study||8
5199247|NCT01054586|12785114|P2|STARTED|Overall Study||15
5199248|NCT01054586|12785115|P1|STARTED|Overall Study||43
5199249|NCT01054573|12785207|P4|NOT COMPLETED|Overall Study||2
5199250|NCT01054573|12785208|P3|NOT COMPLETED|Overall Study||3
5199251|NCT01054573|12785209|P2|NOT COMPLETED|Overall Study||4
5199252|NCT01054573|12785210|P1|NOT COMPLETED|Overall Study||1
5199253|NCT01054573|12785207|P4|COMPLETED|Overall Study||25
5199254|NCT01054573|12785208|P3|COMPLETED|Overall Study||19
5199255|NCT01054573|12785209|P2|COMPLETED|Overall Study||28
5199256|NCT01054573|12785210|P1|COMPLETED|Overall Study||8
5199257|NCT01054573|12785207|P4|STARTED|Overall Study||27
5199258|NCT01054573|12785208|P3|STARTED|Overall Study||22
5199259|NCT01054573|12785209|P2|STARTED|Overall Study||32
5199260|NCT01054573|12785210|P1|STARTED|Overall Study||9
5199261|NCT01054560|12785256|P2|NOT COMPLETED|Overall Study||28
5199262|NCT01054560|12785257|P1|NOT COMPLETED|Overall Study||13
5199263|NCT01054560|12785256|P2|COMPLETED|Overall Study||27
5199264|NCT01054560|12785257|P1|COMPLETED|Overall Study||45
5199265|NCT01054560|12785256|P2|STARTED|Overall Study||55
5199266|NCT01054560|12785257|P1|STARTED|Overall Study||58
5199267|NCT01054404|12785281|P2|NOT COMPLETED|Overall Study||0
5199268|NCT01054404|12785282|P1|NOT COMPLETED|Overall Study||0
5199269|NCT01054404|12785281|P2|COMPLETED|Overall Study||13
5199270|NCT01054404|12785282|P1|COMPLETED|Overall Study||10
5199271|NCT01054404|12785281|P2|STARTED|Overall Study||13
5199272|NCT01054404|12785282|P1|STARTED|Overall Study||10
5199273|NCT01054339|12785291|P3|NOT COMPLETED|Overall Study||0
5199274|NCT01054339|12785292|P2|NOT COMPLETED|Overall Study||0
5199275|NCT01054339|12785293|P1|NOT COMPLETED|Overall Study||0
5199276|NCT01054339|12785291|P3|COMPLETED|Overall Study||3
5199277|NCT01054339|12785292|P2|COMPLETED|Overall Study||3
5199278|NCT01054339|12785293|P1|COMPLETED|Overall Study||3
5199279|NCT01054339|12785291|P3|STARTED|Overall Study||3
5199280|NCT01054339|12785292|P2|STARTED|Overall Study||3
5199281|NCT01054339|12785293|P1|STARTED|Overall Study||3
5199282|NCT01054300|12785309|P4|NOT COMPLETED|Period 2||0
5199283|NCT01054300|12785310|P3|NOT COMPLETED|Period 2||1
5199284|NCT01054300|12785311|P2|NOT COMPLETED|Period 2||0
5199285|NCT01054300|12785312|P1|NOT COMPLETED|Period 2||0
5199286|NCT01054300|12785309|P4|COMPLETED|Period 2||13
5199287|NCT01054300|12785310|P3|COMPLETED|Period 2||12
5199288|NCT01054300|12785311|P2|COMPLETED|Period 2||13
5199289|NCT01054300|12785312|P1|COMPLETED|Period 2||12
5199290|NCT01054300|12785309|P4|STARTED|Period 2||13
5199291|NCT01054300|12785310|P3|STARTED|Period 2||13
5199292|NCT01054300|12785311|P2|STARTED|Period 2||13
5199293|NCT01054300|12785312|P1|STARTED|Period 2||12
5199294|NCT01054300|12785309|P4|NOT COMPLETED|Period 1||0
5199295|NCT01054300|12785310|P3|NOT COMPLETED|Period 1||0
5199296|NCT01054300|12785311|P2|NOT COMPLETED|Period 1||0
5199297|NCT01054300|12785312|P1|NOT COMPLETED|Period 1||1
5199298|NCT01054300|12785309|P4|COMPLETED|Period 1||13
5199299|NCT01054300|12785310|P3|COMPLETED|Period 1||13
5199300|NCT01054300|12785311|P2|COMPLETED|Period 1||13
5199301|NCT01054300|12785312|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
5199302|NCT01054300|12785309|P4|STARTED|Period 1||13
5199303|NCT01054300|12785310|P3|STARTED|Period 1||13
5199304|NCT01054300|12785311|P2|STARTED|Period 1||13
5199305|NCT01054300|12785312|P1|STARTED|Period 1||13
5199306|NCT01054222|12785362|P1|NOT COMPLETED|Overall Study||11
5199307|NCT01054222|12785362|P1|COMPLETED|Overall Study||20
5199308|NCT01054222|12785362|P1|STARTED|Overall Study||31
5199309|NCT01054209|12785383|P2|NOT COMPLETED|Overall Study||0
5199310|NCT01054209|12785384|P1|NOT COMPLETED|Overall Study||0
5199311|NCT01054209|12785383|P2|COMPLETED|Overall Study||58
5199312|NCT01054209|12785384|P1|COMPLETED|Overall Study||58
5199313|NCT01054209|12785383|P2|STARTED|Overall Study||58
5199314|NCT01054209|12785384|P1|STARTED|Overall Study||58
5199315|NCT01054183|12785392|P2|NOT COMPLETED|Overall Study||0
5199316|NCT01054183|12785393|P1|NOT COMPLETED|Overall Study||0
5199317|NCT01054183|12785392|P2|COMPLETED|Overall Study||12
5199318|NCT01054183|12785393|P1|COMPLETED|Overall Study||10
5199319|NCT01054183|12785392|P2|STARTED|Overall Study||12
5199320|NCT01054183|12785393|P1|STARTED|Overall Study||10
5199321|NCT01054170|12785403|P2|NOT COMPLETED|Overall Study||6
5199322|NCT01054170|12785404|P1|NOT COMPLETED|Overall Study||4
5199323|NCT01054170|12785403|P2|COMPLETED|Overall Study||21
5199324|NCT01054170|12785404|P1|COMPLETED|Overall Study||21
5199325|NCT01054170|12785403|P2|STARTED|Overall Study||27
5199326|NCT01054170|12785404|P1|STARTED|Overall Study||25
5199327|NCT01054079|12785456|P1|NOT COMPLETED|Overall Study||0
5199328|NCT01054079|12785456|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
5199329|NCT01054079|12785456|P1|# Recieved Proper PSA Testing|Overall Study||10
5199330|NCT01054079|12785456|P1|STARTED|Overall Study||20
5199331|NCT01053988|12785469|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
5199332|NCT01053988|12785470|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
5199333|NCT01053988|12785471|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
5199334|NCT01053988|12785472|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
5199335|NCT01053988|12785473|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
5199336|NCT01053988|12785474|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
5199337|NCT01053988|12785469|P6|COMPLETED|24-week, Double-blind Treatment Period||151
5199338|NCT01053988|12785470|P5|COMPLETED|24-week, Double-blind Treatment Period||147
5199339|NCT01053988|12785471|P4|COMPLETED|24-week, Double-blind Treatment Period||142
5199340|NCT01053988|12785472|P3|COMPLETED|24-week, Double-blind Treatment Period||145
5199341|NCT01053988|12785473|P2|COMPLETED|24-week, Double-blind Treatment Period||138
5199342|NCT01053988|12785474|P1|COMPLETED|24-week, Double-blind Treatment Period||0
5199343|NCT01053988|12785469|P6|STARTED|24-week, Double-blind Treatment Period||206
5199344|NCT01053988|12785470|P5|STARTED|24-week, Double-blind Treatment Period||206
5199345|NCT01053988|12785471|P4|STARTED|24-week, Double-blind Treatment Period||205
5199346|NCT01053988|12785472|P3|STARTED|24-week, Double-blind Treatment Period||206
5199347|NCT01053988|12785473|P2|STARTED|24-week, Double-blind Treatment Period||207
5199348|NCT01053988|12785474|P1|STARTED|24-week, Double-blind Treatment Period||0
5199349|NCT01053988|12785469|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199350|NCT01053988|12785470|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199351|NCT01053988|12785471|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199352|NCT01053988|12785472|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199353|NCT01053988|12785473|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
5199354|NCT01053988|12785474|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
5199355|NCT01053988|12785469|P6|COMPLETED|2-week, Single-blind Run-In Period||0
5199356|NCT01053988|12785470|P5|COMPLETED|2-week, Single-blind Run-In Period||0
5199357|NCT01053988|12785471|P4|COMPLETED|2-week, Single-blind Run-In Period||0
5199358|NCT01053988|12785472|P3|COMPLETED|2-week, Single-blind Run-In Period||0
5199359|NCT01053988|12785473|P2|COMPLETED|2-week, Single-blind Run-In Period||0
5199360|NCT01053988|12785474|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
5199361|NCT01053988|12785469|P6|STARTED|2-week, Single-blind Run-In Period||0
5199362|NCT01053988|12785470|P5|STARTED|2-week, Single-blind Run-In Period||0
5199363|NCT01053988|12785471|P4|STARTED|2-week, Single-blind Run-In Period||0
5199364|NCT01053988|12785472|P3|STARTED|2-week, Single-blind Run-In Period||0
5199365|NCT01053988|12785473|P2|STARTED|2-week, Single-blind Run-In Period||0
5199366|NCT01053988|12785474|P1|STARTED|2-week, Single-blind Run-In Period||1390
5199367|NCT01053962|12785511|P5|NOT COMPLETED|Follow-up Period||0
5199368|NCT01053962|12785512|P4|NOT COMPLETED|Follow-up Period||0
5199369|NCT01053962|12785513|P3|NOT COMPLETED|Follow-up Period||0
5199370|NCT01053962|12785514|P2|NOT COMPLETED|Follow-up Period||0
5199371|NCT01053962|12785515|P1|NOT COMPLETED|Follow-up Period||0
5199372|NCT01053962|12785511|P5|COMPLETED|Follow-up Period||17
5199373|NCT01053962|12785512|P4|COMPLETED|Follow-up Period||15
5199374|NCT01053962|12785513|P3|COMPLETED|Follow-up Period||15
5199375|NCT01053962|12785514|P2|COMPLETED|Follow-up Period||14
5199376|NCT01053962|12785515|P1|COMPLETED|Follow-up Period||13
5199377|NCT01053962|12785511|P5|STARTED|Follow-up Period||17
5199378|NCT01053962|12785512|P4|STARTED|Follow-up Period||15
5199379|NCT01053962|12785513|P3|STARTED|Follow-up Period||15
5199380|NCT01053962|12785514|P2|STARTED|Follow-up Period||14
5199381|NCT01053962|12785515|P1|STARTED|Follow-up Period||13
5199382|NCT01053962|12785511|P5|NOT COMPLETED|Treatment Period||3
5199383|NCT01053962|12785512|P4|NOT COMPLETED|Treatment Period||0
5199384|NCT01053962|12785513|P3|NOT COMPLETED|Treatment Period||0
5199385|NCT01053962|12785514|P2|NOT COMPLETED|Treatment Period||0
5199386|NCT01053962|12785515|P1|NOT COMPLETED|Treatment Period||1
5199387|NCT01053962|12785511|P5|COMPLETED|Treatment Period||17
5199388|NCT01053962|12785512|P4|COMPLETED|Treatment Period||15
5199389|NCT01053962|12785513|P3|COMPLETED|Treatment Period||15
5199390|NCT01053962|12785514|P2|COMPLETED|Treatment Period||14
5199391|NCT01053962|12785515|P1|COMPLETED|Treatment Period||13
5199392|NCT01053962|12785511|P5|STARTED|Treatment Period||20
5199393|NCT01053962|12785512|P4|STARTED|Treatment Period||15
5199394|NCT01053962|12785513|P3|STARTED|Treatment Period||15
5199395|NCT01053962|12785514|P2|STARTED|Treatment Period||14
5199396|NCT01053962|12785515|P1|STARTED|Treatment Period||14
5199397|NCT01053962|12785511|P5|NOT COMPLETED|Pretreatment Period||2
5199398|NCT01053962|12785512|P4|NOT COMPLETED|Pretreatment Period||2
5199399|NCT01053962|12785513|P3|NOT COMPLETED|Pretreatment Period||1
5199400|NCT01053962|12785514|P2|NOT COMPLETED|Pretreatment Period||1
5199401|NCT01053962|12785515|P1|NOT COMPLETED|Pretreatment Period||0
5199402|NCT01053962|12785511|P5|COMPLETED|Pretreatment Period||20
5199403|NCT01053962|12785512|P4|COMPLETED|Pretreatment Period||15
5199404|NCT01053962|12785513|P3|COMPLETED|Pretreatment Period||15
5199405|NCT01053962|12785514|P2|COMPLETED|Pretreatment Period||14
5199406|NCT01053962|12785515|P1|COMPLETED|Pretreatment Period||14
5199407|NCT01053962|12785511|P5|STARTED|Pretreatment Period||22
5199408|NCT01053962|12785512|P4|STARTED|Pretreatment Period||17
5199409|NCT01053962|12785513|P3|STARTED|Pretreatment Period||16
5199410|NCT01053962|12785514|P2|STARTED|Pretreatment Period||15
5199411|NCT01053962|12785515|P1|STARTED|Pretreatment Period||14
5199412|NCT01053897|12785547|P1|NOT COMPLETED|Overall Study||0
5199413|NCT01053897|12785547|P1|COMPLETED|Overall Study||5
5199414|NCT01053897|12785547|P1|STARTED|Overall Study||5
5199415|NCT01053819|12785559|P1|NOT COMPLETED|Overall Study||0
5199416|NCT01053819|12785559|P1|COMPLETED|Overall Study||6
5199417|NCT01053819|12785559|P1|STARTED|Overall Study||6
5199418|NCT01053741|12785566|P2|NOT COMPLETED|2nd Study Intervention||1
5199419|NCT01053741|12785567|P1|NOT COMPLETED|2nd Study Intervention||0
5199420|NCT01053741|12785566|P2|COMPLETED|2nd Study Intervention||5
5199421|NCT01053741|12785567|P1|COMPLETED|2nd Study Intervention||5
5199422|NCT01053741|12785566|P2|STARTED|2nd Study Intervention||6
5199423|NCT01053741|12785567|P1|STARTED|2nd Study Intervention||5
5199424|NCT01053741|12785566|P2|NOT COMPLETED|14 Day Washout||0
5199425|NCT01053741|12785567|P1|NOT COMPLETED|14 Day Washout||0
5199426|NCT01053741|12785566|P2|COMPLETED|14 Day Washout||6
5199427|NCT01053741|12785567|P1|COMPLETED|14 Day Washout||5
5199428|NCT01053741|12785566|P2|STARTED|14 Day Washout||6
5199429|NCT01053741|12785567|P1|STARTED|14 Day Washout||5
5199430|NCT01053741|12785566|P2|NOT COMPLETED|1st Intervention||0
5199431|NCT01053741|12785567|P1|NOT COMPLETED|1st Intervention||0
5199432|NCT01053741|12785566|P2|COMPLETED|1st Intervention||6
5199433|NCT01053741|12785567|P1|COMPLETED|1st Intervention||5
5199434|NCT01053741|12785566|P2|STARTED|1st Intervention||6
5199435|NCT01053741|12785567|P1|STARTED|1st Intervention||5
5199436|NCT01053663|12785576|P1|NOT COMPLETED|Overall Study||6
5199437|NCT01053663|12785576|P1|COMPLETED|Overall Study||3
5199438|NCT01053663|12785576|P1|STARTED|Overall Study||9
5199439|NCT01053507|12785619|P2|NOT COMPLETED|Overall Study||1
5199440|NCT01053507|12785620|P1|NOT COMPLETED|Overall Study||3
5199441|NCT01053507|12785619|P2|COMPLETED|Overall Study||11
5199442|NCT01053507|12785620|P1|COMPLETED|Overall Study||8
5199443|NCT01053507|12785619|P2|STARTED|Overall Study||12
5199444|NCT01053507|12785620|P1|STARTED|Overall Study||11
5199445|NCT01053429|12785634|P1|NOT COMPLETED|Overall Study||373
5199446|NCT01053429|12785634|P1|COMPLETED|Overall Study||3018
5199447|NCT01053429|12785634|P1|STARTED|Overall Study||3391
5199448|NCT01053312|12785643|P1|NOT COMPLETED|Overall Study||0
5199449|NCT01053312|12785643|P1|COMPLETED|Overall Study||7
5199450|NCT01053312|12785643|P1|STARTED|Overall Study||7
5199451|NCT01053247|12785664|P3|NOT COMPLETED|Overall Study||28
5199452|NCT01053247|12785665|P2|NOT COMPLETED|Overall Study||19
5199453|NCT01053247|12785666|P1|NOT COMPLETED|Overall Study||20
5199454|NCT01053247|12785664|P3|COMPLETED|Overall Study||236
5199455|NCT01053247|12785665|P2|COMPLETED|Overall Study||241
5199456|NCT01053247|12785666|P1|COMPLETED|Overall Study||249
5199457|NCT01053247|12785664|P3|STARTED|Overall Study||264
5199458|NCT01053247|12785665|P2|STARTED|Overall Study||260
5199459|NCT01053247|12785666|P1|STARTED|Overall Study||269
5199460|NCT01053221|12785676|P2|NOT COMPLETED|Overall Study||9
5199461|NCT01053221|12785677|P1|NOT COMPLETED|Overall Study||5
5199462|NCT01053221|12785676|P2|COMPLETED|Overall Study||0
5199463|NCT01053221|12785677|P1|COMPLETED|Overall Study||0
5199464|NCT01053221|12785676|P2|STARTED|Overall Study||9
5199465|NCT01053221|12785677|P1|STARTED|Overall Study||5
5199466|NCT01053156|12785693|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
5199467|NCT01053156|12785694|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
5199468|NCT01053156|12785693|P2|COMPLETED|Second Intervention (Week 13-24)||22
5199469|NCT01053156|12785694|P1|COMPLETED|Second Intervention (Week 13-24)||26
5199470|NCT01053156|12785693|P2|STARTED|Second Intervention (Week 13-24)||27
5199471|NCT01053156|12785694|P1|STARTED|Second Intervention (Week 13-24)||28
5199472|NCT01053156|12785693|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
5199473|NCT01053156|12785694|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
5199474|NCT01053156|12785693|P2|COMPLETED|First Intervention (Week 1-12)||27
5199475|NCT01053156|12785694|P1|COMPLETED|First Intervention (Week 1-12)||28
5199476|NCT01053156|12785693|P2|STARTED|First Intervention (Week 1-12)||33
5199477|NCT01053156|12785694|P1|STARTED|First Intervention (Week 1-12)||33
5199478|NCT01053078|12785732|P2|NOT COMPLETED|Overall Study||3
5199479|NCT01053078|12785733|P1|NOT COMPLETED|Overall Study||4
5199480|NCT01053078|12785732|P2|COMPLETED|Overall Study||12
5199481|NCT01053078|12785733|P1|COMPLETED|Overall Study||10
5199482|NCT01053078|12785732|P2|STARTED|Overall Study||15
5199483|NCT01053078|12785733|P1|STARTED|Overall Study||14
5199484|NCT01053000|12785741|P2|NOT COMPLETED|Overall Study||0
5199485|NCT01053000|12785742|P1|NOT COMPLETED|Overall Study||0
5199486|NCT01053000|12785741|P2|COMPLETED|Overall Study||5
5199487|NCT01053000|12785742|P1|COMPLETED|Overall Study||5
5199488|NCT01053000|12785741|P2|STARTED|Overall Study||5
5199489|NCT01053000|12785742|P1|STARTED|Overall Study||5
5199490|NCT01052948|12785752|P4|NOT COMPLETED|Overall Study||0
5199491|NCT01052948|12785753|P3|NOT COMPLETED|Overall Study||0
5199492|NCT01052948|12785754|P2|NOT COMPLETED|Overall Study||0
5199493|NCT01052948|12785755|P1|NOT COMPLETED|Overall Study||0
5199494|NCT01052948|12785752|P4|COMPLETED|Overall Study||29311
5199495|NCT01052948|12785753|P3|COMPLETED|Overall Study||15147
5199496|NCT01052948|12785754|P2|COMPLETED|Overall Study||14669
5199497|NCT01052948|12785755|P1|COMPLETED|Overall Study||27812
5199498|NCT01052948|12785752|P4|STARTED|Overall Study||29311
5199499|NCT01052948|12785753|P3|STARTED|Overall Study||15147
5199500|NCT01052948|12785754|P2|STARTED|Overall Study||14669
5199501|NCT01052948|12785755|P1|STARTED|Overall Study||27812
5199502|NCT01052844|12785779|P2|NOT COMPLETED|Overall Study||1
5199503|NCT01052844|12785780|P1|NOT COMPLETED|Overall Study||0
5199504|NCT01052844|12785779|P2|COMPLETED|Overall Study||39
5199505|NCT01052844|12785780|P1|COMPLETED|Overall Study||40
5199506|NCT01052844|12785779|P2|STARTED|Overall Study||40
5199507|NCT01052844|12785780|P1|STARTED|Overall Study||40
5199508|NCT01052831|12785790|P2|NOT COMPLETED|Overall Study||1
5199509|NCT01052831|12785791|P1|NOT COMPLETED|Overall Study||4
5199510|NCT01052831|12785790|P2|COMPLETED|Overall Study||23
5199511|NCT01052831|12785791|P1|COMPLETED|Overall Study||22
5199512|NCT01052831|12785790|P2|STARTED|Overall Study||24
5199513|NCT01052831|12785791|P1|STARTED|Overall Study||26
5199514|NCT01052779|12785801|P2|NOT COMPLETED|Overall Study||9
5199515|NCT01052779|12785802|P1|NOT COMPLETED|Overall Study||5
5199516|NCT01052779|12785801|P2|COMPLETED|Overall Study||73
5199517|NCT01052779|12785802|P1|COMPLETED|Overall Study||75
5199518|NCT01052779|12785801|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
5199519|NCT01052779|12785802|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
5199520|NCT01052779|12785801|P2|STARTED|Overall Study||82
5199521|NCT01052779|12785802|P1|STARTED|Overall Study||80
5199522|NCT01052714|12785812|P3|NOT COMPLETED|Overall Study||2
5199523|NCT01052714|12785813|P2|NOT COMPLETED|Overall Study||29
5199524|NCT01052714|12785814|P1|NOT COMPLETED|Overall Study||25
5199525|NCT01052714|12785812|P3|COMPLETED|Overall Study||15
5199526|NCT01052714|12785813|P2|COMPLETED|Overall Study||33
5199527|NCT01052714|12785814|P1|COMPLETED|Overall Study||17
5199528|NCT01052714|12785812|P3|STARTED|Overall Study||17
5199529|NCT01052714|12785813|P2|STARTED|Overall Study||62
5199530|NCT01052714|12785814|P1|STARTED|Overall Study||42
5199531|NCT01052701|12785856|P2|NOT COMPLETED|Overall Study||0
5199532|NCT01052701|12785857|P1|NOT COMPLETED|Overall Study||0
5199533|NCT01052701|12785856|P2|COMPLETED|Overall Study||12
5199534|NCT01052701|12785857|P1|COMPLETED|Overall Study||14
5199535|NCT01052701|12785856|P2|STARTED|Overall Study||12
5199536|NCT01052701|12785857|P1|STARTED|Overall Study||14
5199537|NCT01052662|12785868|P3|NOT COMPLETED|Overall Study||22
5199538|NCT01052662|12785869|P2|NOT COMPLETED|Overall Study||22
5199539|NCT01052662|12785870|P1|NOT COMPLETED|Overall Study||22
5199540|NCT01052662|12785868|P3|COMPLETED|Overall Study||10
5199541|NCT01052662|12785869|P2|COMPLETED|Overall Study||5
5199542|NCT01052662|12785870|P1|COMPLETED|Overall Study||6
5199543|NCT01052662|12785868|P3|Discontinuation Phase|Overall Study||10
5199544|NCT01052662|12785869|P2|Discontinuation Phase|Overall Study||5
5199545|NCT01052662|12785870|P1|Discontinuation Phase|Overall Study||6
5199546|NCT01052662|12785868|P3|Stabilization Phase|Overall Study||26
5199547|NCT01052662|12785869|P2|Stabilization Phase|Overall Study||21
5199548|NCT01052662|12785870|P1|Stabilization Phase|Overall Study||21
5199549|NCT01052662|12785868|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
5199550|NCT01052662|12785869|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
5199551|NCT01052662|12785870|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
5199552|NCT01052545|12785886|P2|NOT COMPLETED|Overall Study||0
5199553|NCT01052545|12785887|P1|NOT COMPLETED|Overall Study||0
5199554|NCT01052545|12785886|P2|COMPLETED|Overall Study||731
5199555|NCT01052545|12785887|P1|COMPLETED|Overall Study||867
5199556|NCT01052545|12785886|P2|STARTED|Overall Study||731
5199557|NCT01052545|12785887|P1|STARTED|Overall Study||867
5199558|NCT01052480|12785911|P2|NOT COMPLETED|Overall Study||17
5199559|NCT01052480|12785912|P1|NOT COMPLETED|Overall Study||8
5199560|NCT01052480|12785911|P2|COMPLETED|Overall Study||32
5199561|NCT01052480|12785912|P1|COMPLETED|Overall Study||41
5199562|NCT01052480|12785911|P2|STARTED|Overall Study||49
5199563|NCT01052480|12785912|P1|STARTED|Overall Study||49
5199564|NCT01052428|12785962|P2|NOT COMPLETED|Overall Study||1
5199565|NCT01052428|12785963|P1|NOT COMPLETED|Overall Study||1
5199566|NCT01052428|12785962|P2|COMPLETED|Overall Study||18
5199567|NCT01052428|12785963|P1|COMPLETED|Overall Study||18
5199568|NCT01052428|12785962|P2|STARTED|Overall Study||19
5199569|NCT01052428|12785963|P1|STARTED|Overall Study||19
5199570|NCT01052272|12785985|P4|NOT COMPLETED|Overall Study||7
5199571|NCT01052272|12785986|P3|NOT COMPLETED|Overall Study||8
5199572|NCT01052272|12785987|P2|NOT COMPLETED|Overall Study||7
5199573|NCT01052272|12785988|P1|NOT COMPLETED|Overall Study||5
5199574|NCT01052272|12785985|P4|COMPLETED|Overall Study||11
5199575|NCT01052272|12785986|P3|COMPLETED|Overall Study||10
5199576|NCT01052272|12785987|P2|COMPLETED|Overall Study||11
5199577|NCT01052272|12785988|P1|COMPLETED|Overall Study||13
5199578|NCT01052272|12785985|P4|STARTED|Overall Study||18
5199579|NCT01052272|12785986|P3|STARTED|Overall Study||18
5199580|NCT01052272|12785987|P2|STARTED|Overall Study||18
5199581|NCT01052272|12785988|P1|STARTED|Overall Study||18
5199582|NCT01052207|12786024|P2|NOT COMPLETED|Overall Study||0
5199583|NCT01052207|12786025|P1|NOT COMPLETED|Overall Study||0
5199584|NCT01052207|12786024|P2|COMPLETED|Overall Study||42
5199585|NCT01052207|12786025|P1|COMPLETED|Overall Study||60
5199586|NCT01052207|12786024|P2|STARTED|Overall Study||42
5199587|NCT01052207|12786025|P1|STARTED|Overall Study||60
5199588|NCT01052116|12786033|P2|NOT COMPLETED|Overall Study||27
5199589|NCT01052116|12786034|P1|NOT COMPLETED|Overall Study||14
5199590|NCT01052116|12786033|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
5199591|NCT01052116|12786034|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
5199592|NCT01052116|12786033|P2|STARTED|Overall Study||193
5199593|NCT01052116|12786034|P1|STARTED|Overall Study||193
5199594|NCT01052077|12786042|P4|NOT COMPLETED|Phase A+||21
5199595|NCT01052077|12786043|P3|NOT COMPLETED|Phase A+||0
5199596|NCT01052077|12786044|P2|NOT COMPLETED|Phase A+||0
5199597|NCT01052077|12786045|P1|NOT COMPLETED|Phase A+||0
5199598|NCT01052077|12786042|P4|COMPLETED|Phase A+||230
5199599|NCT01052077|12786043|P3|COMPLETED|Phase A+||0
5199600|NCT01052077|12786044|P2|COMPLETED|Phase A+||0
5199601|NCT01052077|12786045|P1|COMPLETED|Phase A+||0
5199602|NCT01052077|12786042|P4|STARTED|Phase A+||251
5199603|NCT01052077|12786043|P3|STARTED|Phase A+||0
5199604|NCT01052077|12786044|P2|STARTED|Phase A+||0
5199605|NCT01052077|12786045|P1|STARTED|Phase A+||0
5199606|NCT01052077|12786042|P4|NOT COMPLETED|Phase B||0
5199607|NCT01052077|12786043|P3|NOT COMPLETED|Phase B||16
5199608|NCT01052077|12786044|P2|NOT COMPLETED|Phase B||18
5199609|NCT01052077|12786045|P1|NOT COMPLETED|Phase B||0
5199610|NCT01052077|12786042|P4|COMPLETED|Phase B||0
5199611|NCT01052077|12786043|P3|COMPLETED|Phase B||171
5199612|NCT01052077|12786044|P2|COMPLETED|Phase B||167
5199613|NCT01052077|12786045|P1|COMPLETED|Phase B||0
5199614|NCT01052077|12786042|P4|STARTED|Phase B||0
5199615|NCT01052077|12786043|P3|STARTED|Phase B||187
5199616|NCT01052077|12786044|P2|STARTED|Phase B||185
5199617|NCT01052077|12786045|P1|STARTED|Phase B||0
5199618|NCT01052077|12786042|P4|NOT COMPLETED|Phase A||0
5199619|NCT01052077|12786043|P3|NOT COMPLETED|Phase A||0
5199620|NCT01052077|12786044|P2|NOT COMPLETED|Phase A||0
5199621|NCT01052077|12786045|P1|NOT COMPLETED|Phase A||146
5199622|NCT01052077|12786042|P4|COMPLETED|Phase A||0
5199623|NCT01052077|12786043|P3|COMPLETED|Phase A||0
5199624|NCT01052077|12786044|P2|COMPLETED|Phase A||0
5199625|NCT01052077|12786045|P1|COMPLETED|Phase A||623
5199626|NCT01052077|12786042|P4|STARTED|Phase A||0
5199627|NCT01052077|12786043|P3|STARTED|Phase A||0
5199628|NCT01052077|12786044|P2|STARTED|Phase A||0
5199629|NCT01052077|12786045|P1|STARTED|Phase A||769
5199630|NCT01052038|12786072|P3|NOT COMPLETED|Overall Study||4
5199631|NCT01052038|12786073|P2|NOT COMPLETED|Overall Study||6
5199632|NCT01052038|12786074|P1|NOT COMPLETED|Overall Study||4
5199633|NCT01052038|12786072|P3|COMPLETED|Overall Study||36
5199634|NCT01052038|12786073|P2|COMPLETED|Overall Study||34
5199635|NCT01052038|12786074|P1|COMPLETED|Overall Study||36
5199636|NCT01052038|12786072|P3|STARTED|Overall Study||40
5199637|NCT01052038|12786073|P2|STARTED|Overall Study||40
5199638|NCT01052038|12786074|P1|STARTED|Overall Study||40
5199639|NCT01051986|12786096|P2|NOT COMPLETED|Overall Study||4
5199640|NCT01051986|12786097|P1|NOT COMPLETED|Overall Study||5
5199641|NCT01051986|12786096|P2|COMPLETED|Overall Study||108
5199642|NCT01051986|12786097|P1|COMPLETED|Overall Study||107
5199643|NCT01051986|12786096|P2|STARTED|Overall Study||112
5199644|NCT01051986|12786097|P1|STARTED|Overall Study||112
5199645|NCT01051921|12786111|P1|NOT COMPLETED|Overall Study||30
5199646|NCT01051921|12786111|P1|COMPLETED|Overall Study||37
5199647|NCT01051921|12786111|P1|STARTED|Overall Study||67
5199648|NCT01051856|12786118|P2|NOT COMPLETED|Overall Study||0
5199649|NCT01051856|12786119|P1|NOT COMPLETED|Overall Study||1
5199650|NCT01051856|12786118|P2|COMPLETED|Overall Study||35
5199651|NCT01051856|12786119|P1|COMPLETED|Overall Study||32
5199652|NCT01051856|12786118|P2|STARTED|Overall Study||35
5199653|NCT01051856|12786119|P1|STARTED|Overall Study||33
5199654|NCT01051817|12786129|P2|NOT COMPLETED|Overall Study||9
5199655|NCT01051817|12786130|P1|NOT COMPLETED|Overall Study||3
5199656|NCT01051817|12786129|P2|COMPLETED|Overall Study||26
5199657|NCT01051817|12786130|P1|COMPLETED|Overall Study||35
5199658|NCT01051817|12786129|P2|STARTED|Overall Study||35
5199659|NCT01051817|12786130|P1|STARTED|Overall Study||38
5199660|NCT01051791|12786140|P1|NOT COMPLETED|Overall Study||4
5199661|NCT01051791|12786140|P1|COMPLETED|Overall Study||9
5199662|NCT01051791|12786140|P1|STARTED|Overall Study||13
5199663|NCT01051778|12786149|P2|NOT COMPLETED|Overall Study||0
5199664|NCT01051778|12786150|P1|NOT COMPLETED|Overall Study||0
5199665|NCT01051778|12786149|P2|COMPLETED|Overall Study|November 2009|30
5199666|NCT01051778|12786150|P1|COMPLETED|Overall Study|November 2009|30
5199667|NCT01051778|12786149|P2|STARTED|Overall Study|June 2006|30
5199668|NCT01051778|12786150|P1|STARTED|Overall Study|June 2006|30
5199669|NCT01051739|12786158|P2|NOT COMPLETED|Overall Study||13
5199670|NCT01051739|12786159|P1|NOT COMPLETED|Overall Study||28
5199671|NCT01051739|12786158|P2|COMPLETED|Overall Study||47
5199672|NCT01051739|12786159|P1|COMPLETED|Overall Study||92
5199673|NCT01051739|12786158|P2|STARTED|Overall Study||60
5199674|NCT01051739|12786159|P1|STARTED|Overall Study||120
5199675|NCT01051661|12786171|P6|NOT COMPLETED|Overall Study||67
5199676|NCT01051661|12786172|P5|NOT COMPLETED|Overall Study||35
5199677|NCT01051661|12786173|P4|NOT COMPLETED|Overall Study||56
5199678|NCT01051661|12786174|P3|NOT COMPLETED|Overall Study||39
5199679|NCT01051661|12786175|P2|NOT COMPLETED|Overall Study||63
5199680|NCT01051661|12786176|P1|NOT COMPLETED|Overall Study||34
5199681|NCT01051661|12786171|P6|COMPLETED|Overall Study||1369
5199682|NCT01051661|12786172|P5|COMPLETED|Overall Study||578
5199683|NCT01051661|12786173|P4|COMPLETED|Overall Study||1380
5199684|NCT01051661|12786174|P3|COMPLETED|Overall Study||573
5199685|NCT01051661|12786175|P2|COMPLETED|Overall Study||1375
5199686|NCT01051661|12786176|P1|COMPLETED|Overall Study||576
5199687|NCT01051661|12786171|P6|STARTED|Overall Study||1436
5199688|NCT01051661|12786172|P5|STARTED|Overall Study||613
5199689|NCT01051661|12786173|P4|STARTED|Overall Study||1436
5199690|NCT01051661|12786174|P3|STARTED|Overall Study||612
5199691|NCT01051661|12786175|P2|STARTED|Overall Study||1438
5199692|NCT01051661|12786176|P1|STARTED|Overall Study||610
5199693|NCT01051596|12786355|P1|NOT COMPLETED|Overall Study||0
5199694|NCT01051596|12786355|P1|COMPLETED|Overall Study||75
5199695|NCT01051596|12786355|P1|STARTED|Overall Study||75
5199696|NCT01051570|12786362|P1|NOT COMPLETED|Overall Study||0
5199697|NCT01051570|12786362|P1|COMPLETED|Overall Study||26
5199698|NCT01051570|12786362|P1|STARTED|Overall Study||26
5199699|NCT01051557|12786373|P7|NOT COMPLETED|Overall Study||6
5199700|NCT01051557|12786374|P6|NOT COMPLETED|Overall Study||6
5199701|NCT01051557|12786375|P5|NOT COMPLETED|Overall Study||7
5199702|NCT01051557|12786376|P4|NOT COMPLETED|Overall Study||3
5199703|NCT01051557|12786377|P3|NOT COMPLETED|Overall Study||6
5199704|NCT01051557|12786378|P2|NOT COMPLETED|Overall Study||3
5199705|NCT01051557|12786379|P1|NOT COMPLETED|Overall Study||4
5199706|NCT01051557|12786373|P7|COMPLETED|Overall Study||0
5199707|NCT01051557|12786374|P6|COMPLETED|Overall Study||0
5199708|NCT01051557|12786375|P5|COMPLETED|Overall Study||1
5199709|NCT01051557|12786376|P4|COMPLETED|Overall Study||0
5199710|NCT01051557|12786377|P3|COMPLETED|Overall Study||0
5199711|NCT01051557|12786378|P2|COMPLETED|Overall Study||0
5199712|NCT01051557|12786379|P1|COMPLETED|Overall Study||0
5199713|NCT01051557|12786373|P7|STARTED|Overall Study||6
5199714|NCT01051557|12786374|P6|STARTED|Overall Study||6
5199715|NCT01051557|12786375|P5|STARTED|Overall Study||8
5199716|NCT01051557|12786376|P4|STARTED|Overall Study||3
5199717|NCT01051557|12786377|P3|STARTED|Overall Study||6
5199718|NCT01051557|12786378|P2|STARTED|Overall Study||3
5199719|NCT01051557|12786379|P1|STARTED|Overall Study||4
5199720|NCT01051518|12786398|P1|NOT COMPLETED|Overall Study||73
5199721|NCT01051518|12786398|P1|COMPLETED|Overall Study||53
5199722|NCT01051518|12786398|P1|STARTED|Overall Study||126
5199723|NCT01051466|12786410|P2|NOT COMPLETED|Overall Study||5
5199724|NCT01051466|12786411|P1|NOT COMPLETED|Overall Study||8
5199725|NCT01051466|12786410|P2|COMPLETED|Overall Study||23
5199726|NCT01051466|12786411|P1|COMPLETED|Overall Study||24
5199727|NCT01051466|12786410|P2|STARTED|Overall Study||28
5199728|NCT01051466|12786411|P1|STARTED|Overall Study||32
5199729|NCT01051440|12786445|P2|NOT COMPLETED|Overall Study||0
5199730|NCT01051440|12786446|P1|NOT COMPLETED|Overall Study||0
5199731|NCT01051440|12786445|P2|COMPLETED|Overall Study||1
5199732|NCT01051440|12786446|P1|COMPLETED|Overall Study||1
5199733|NCT01051440|12786445|P2|STARTED|Overall Study||1
5199734|NCT01051440|12786446|P1|STARTED|Overall Study||1
5199735|NCT01051349|12786456|P1|NOT COMPLETED|Overall Study||173
5199736|NCT01051349|12786456|P1|COMPLETED|Overall Study||237
5199737|NCT01051349|12786456|P1|STARTED|Overall Study||410
5199738|NCT01051323|12786485|P1|NOT COMPLETED|Overall Study||539
5199739|NCT01051323|12786485|P1|COMPLETED|Overall Study||1041
5199740|NCT01051323|12786485|P1|Received at Least One Dose|Overall Study||1547
5199741|NCT01051323|12786485|P1|STARTED|Overall Study||1580
5199742|NCT01051310|12786507|P1|NOT COMPLETED|Overall Study||5
5199743|NCT01051310|12786507|P1|COMPLETED|Overall Study||13
5199744|NCT01051310|12786507|P1|STARTED|Overall Study||18
5199745|NCT01051063|12786514|P2|NOT COMPLETED|Overall Study||4
5199746|NCT01051063|12786515|P1|NOT COMPLETED|Overall Study||10
5199747|NCT01051063|12786514|P2|COMPLETED|Overall Study||1
5199748|NCT01051063|12786515|P1|COMPLETED|Overall Study||2
5199749|NCT01051063|12786514|P2|STARTED|Overall Study||5
5199750|NCT01051063|12786515|P1|STARTED|Overall Study||12
5199751|NCT01050998|12786535|P5|NOT COMPLETED|Overall Study||14
5199752|NCT01050998|12786536|P4|NOT COMPLETED|Overall Study||3
5199753|NCT01050998|12786537|P3|NOT COMPLETED|Overall Study||3
5199754|NCT01050998|12786538|P2|NOT COMPLETED|Overall Study||2
5199755|NCT01050998|12786539|P1|NOT COMPLETED|Overall Study||4
5199756|NCT01050998|12786535|P5|COMPLETED|Overall Study||82
5199757|NCT01050998|12786536|P4|COMPLETED|Overall Study||45
5199758|NCT01050998|12786537|P3|COMPLETED|Overall Study||46
5199759|NCT01050998|12786538|P2|COMPLETED|Overall Study||47
5199760|NCT01050998|12786539|P1|COMPLETED|Overall Study||44
5199761|NCT01050998|12786535|P5|STARTED|Overall Study||96
5199762|NCT01050998|12786536|P4|STARTED|Overall Study||48
5199763|NCT01050998|12786537|P3|STARTED|Overall Study||49
5199764|NCT01050998|12786538|P2|STARTED|Overall Study||49
5199765|NCT01050998|12786539|P1|STARTED|Overall Study||48
5199766|NCT01050946|12786863|P1|NOT COMPLETED|Overall Study||0
5199767|NCT01050946|12786863|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
5199768|NCT01050946|12786863|P1|STARTED|Overall Study||1
5199769|NCT01050816|12786873|P1|NOT COMPLETED|Overall Study||4
5199770|NCT01050816|12786873|P1|COMPLETED|Overall Study||26
5199771|NCT01050816|12786873|P1|STARTED|Overall Study||30
5199772|NCT01050790|12786879|P1|NOT COMPLETED|Overall Study||1
5199773|NCT01050790|12786879|P1|COMPLETED|Overall Study||16
5199774|NCT01050790|12786879|P1|STARTED|Overall Study||17
5199775|NCT01050764|12786889|P1|NOT COMPLETED|Overall Study||3
5199776|NCT01050764|12786889|P1|COMPLETED|Overall Study||7
5199777|NCT01050764|12786889|P1|Received Infusion of T-con Cells|Overall Study||7
5199778|NCT01050764|12786889|P1|Received Infusion of T-reg Cells|Overall Study||7
5199779|NCT01050764|12786889|P1|Received HSCT Graft|Overall Study||8
5199780|NCT01050764|12786889|P1|STARTED|Overall Study||10
5199781|NCT01050673|12786900|P2|NOT COMPLETED|Overall Study||5
5199782|NCT01050673|12786901|P1|NOT COMPLETED|Overall Study||4
5199783|NCT01050673|12786900|P2|COMPLETED|Overall Study||14
5199784|NCT01050673|12786901|P1|COMPLETED|Overall Study||17
5199785|NCT01050673|12786900|P2|STARTED|Overall Study||19
5199786|NCT01050673|12786901|P1|STARTED|Overall Study||21
5199787|NCT01050660|12786925|P2|NOT COMPLETED|Overall Study||0
5199788|NCT01050660|12786926|P1|NOT COMPLETED|Overall Study||0
5199789|NCT01050660|12786925|P2|COMPLETED|Overall Study||69
5199790|NCT01050660|12786926|P1|COMPLETED|Overall Study||67
5199791|NCT01050660|12786925|P2|STARTED|Overall Study||69
5199792|NCT01050660|12786926|P1|STARTED|Overall Study||67
5199793|NCT01050647|12786952|P2|NOT COMPLETED|Overall Study||0
5199794|NCT01050647|12786953|P1|NOT COMPLETED|Overall Study||0
5199795|NCT01050647|12786952|P2|COMPLETED|Overall Study||11
5199796|NCT01050647|12786953|P1|COMPLETED|Overall Study||10
5199797|NCT01050647|12786952|P2|STARTED|Overall Study||11
5199798|NCT01050647|12786953|P1|STARTED|Overall Study||10
5199799|NCT01050634|12786969|P1|NOT COMPLETED|Overall Study||128
5199800|NCT01050634|12786969|P1|COMPLETED|Overall Study||852
5199801|NCT01050634|12786969|P1|Received Treatment|Overall Study||924
5199802|NCT01050634|12786969|P1|STARTED|Overall Study||980
5199803|NCT01050582|12786979|P2|NOT COMPLETED|Overall Study||0
5199804|NCT01050582|12786980|P1|NOT COMPLETED|Overall Study||0
5199805|NCT01050582|12786979|P2|COMPLETED|Overall Study||51
5199806|NCT01050582|12786980|P1|COMPLETED|Overall Study||133
5199807|NCT01050582|12786979|P2|STARTED|Overall Study||51
5199808|NCT01050582|12786980|P1|STARTED|Overall Study||133
5199809|NCT01050569|12786993|P3|NOT COMPLETED|Overall Study||33
5199810|NCT01050569|12786994|P2|NOT COMPLETED|Overall Study||24
5199811|NCT01050569|12786995|P1|NOT COMPLETED|Overall Study||38
5199812|NCT01050569|12786993|P3|COMPLETED|Overall Study||47
5199813|NCT01050569|12786994|P2|COMPLETED|Overall Study||52
5199814|NCT01050569|12786995|P1|COMPLETED|Overall Study||41
5199815|NCT01050569|12786993|P3|STARTED|Overall Study||80
5199816|NCT01050569|12786994|P2|STARTED|Overall Study||76
5199817|NCT01050569|12786995|P1|STARTED|Overall Study||79
5199818|NCT01050543|12787014|P2|NOT COMPLETED|Overall Study||4
5199819|NCT01050543|12787015|P1|NOT COMPLETED|Overall Study||4
5199820|NCT01050543|12787014|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
5199821|NCT01050543|12787015|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
5199822|NCT01050543|12787014|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
5199823|NCT01050543|12787015|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
5199824|NCT01050530|12787023|P2|NOT COMPLETED|Overall Study||10
5199825|NCT01050530|12787024|P1|NOT COMPLETED|Overall Study||8
5199826|NCT01050530|12787023|P2|COMPLETED|Overall Study||70
5199827|NCT01050530|12787024|P1|COMPLETED|Overall Study||74
5199828|NCT01050530|12787023|P2|STARTED|Overall Study||80
5199829|NCT01050530|12787024|P1|STARTED|Overall Study||82
5199830|NCT01050257|12787035|P3|NOT COMPLETED|Overall Study||7
5199831|NCT01050257|12787036|P2|NOT COMPLETED|Overall Study||13
5199832|NCT01050257|12787037|P1|NOT COMPLETED|Overall Study||11
5199833|NCT01050257|12787035|P3|COMPLETED|Overall Study||8
5199834|NCT01050257|12787036|P2|COMPLETED|Overall Study||40
5199835|NCT01050257|12787037|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
5199836|NCT01050257|12787035|P3|Switched to Oral Treatment|Overall Study||3
5199837|NCT01050257|12787036|P2|Switched to Oral Treatment|Overall Study||31
5199838|NCT01050257|12787037|P1|Switched to Oral Treatment|Overall Study||28
5199839|NCT01050257|12787035|P3|Intent-to-treat Infected Confirmed|Overall Study||10
5199840|NCT01050257|12787036|P2|Intent-to-treat Infected Confirmed|Overall Study||32
5199841|NCT01050257|12787037|P1|Intent-to-treat Infected Confirmed|Overall Study||30
5199842|NCT01050257|12787035|P3|Safety Population: Actual Dose Received|Overall Study||14
5199843|NCT01050257|12787036|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
5199844|NCT01050257|12787037|P1|Safety Population: Actual Dose Received|Overall Study||48
5199845|NCT01050257|12787035|P3|Received Treatment|Overall Study||14
5199846|NCT01050257|12787036|P2|Received Treatment|Overall Study||50
5199847|NCT01050257|12787037|P1|Received Treatment|Overall Study||49
5199848|NCT01050257|12787035|P3|STARTED|Overall Study||15
5199849|NCT01050257|12787036|P2|STARTED|Overall Study||53
5199850|NCT01050257|12787037|P1|STARTED|Overall Study||50
5199851|NCT01050218|12787072|P1|NOT COMPLETED|Overall Study||95
5199852|NCT01050218|12787072|P1|COMPLETED|Overall Study||142
5199853|NCT01050218|12787072|P1|STARTED|Overall Study||237
5199854|NCT01050205|12787078|P2|NOT COMPLETED|Overall Study||4
5199855|NCT01050205|12787079|P1|NOT COMPLETED|Overall Study||11
5199856|NCT01050205|12787078|P2|COMPLETED|Overall Study||71
5199857|NCT01050205|12787079|P1|COMPLETED|Overall Study||137
5199858|NCT01050205|12787078|P2|STARTED|Overall Study||75
5199859|NCT01050205|12787079|P1|STARTED|Overall Study||148
5199860|NCT01050153|12787109|P2|NOT COMPLETED|Overall Study||0
5199861|NCT01050153|12787110|P1|NOT COMPLETED|Overall Study||0
5199862|NCT01050153|12787109|P2|COMPLETED|Overall Study||25
5199863|NCT01050153|12787110|P1|COMPLETED|Overall Study||25
5199864|NCT01050153|12787109|P2|STARTED|Overall Study||25
5199865|NCT01050153|12787110|P1|STARTED|Overall Study||25
5199866|NCT01050062|12787136|P2|NOT COMPLETED|Overall Study||112
5199867|NCT01050062|12787137|P1|NOT COMPLETED|Overall Study||271
5199868|NCT01050062|12787136|P2|COMPLETED|Overall Study||243
5199869|NCT01050062|12787137|P1|COMPLETED|Overall Study||799
5199870|NCT01050062|12787136|P2|STARTED|Overall Study||355
5199871|NCT01050062|12787137|P1|STARTED|Overall Study||1070
5199872|NCT01049984|12787159|P2|NOT COMPLETED|Overall Study||19
5199873|NCT01049984|12787160|P1|NOT COMPLETED|Overall Study||19
5199874|NCT01049984|12787159|P2|COMPLETED|Overall Study||146
5199875|NCT01049984|12787160|P1|COMPLETED|Overall Study||144
5199876|NCT01049984|12787159|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
5199877|NCT01049984|12787160|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
5199878|NCT01049984|12787159|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
5199879|NCT01049984|12787160|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
5199880|NCT01049984|12787159|P2|STARTED|Overall Study||165
5199881|NCT01049984|12787160|P1|STARTED|Overall Study||163
5199882|NCT01049945|12787178|P6|NOT COMPLETED|Overall Study||0
5199883|NCT01049945|12787179|P5|NOT COMPLETED|Overall Study||0
5199884|NCT01049945|12787180|P4|NOT COMPLETED|Overall Study||0
5199885|NCT01049945|12787181|P3|NOT COMPLETED|Overall Study||0
5199886|NCT01049945|12787182|P2|NOT COMPLETED|Overall Study||0
5199887|NCT01049945|12787183|P1|NOT COMPLETED|Overall Study||0
5199888|NCT01049945|12787178|P6|COMPLETED|Overall Study||49
5199889|NCT01049945|12787179|P5|COMPLETED|Overall Study||3
5199890|NCT01049945|12787180|P4|COMPLETED|Overall Study||6
5199891|NCT01049945|12787181|P3|COMPLETED|Overall Study||3
5199892|NCT01049945|12787182|P2|COMPLETED|Overall Study||6
5199893|NCT01049945|12787183|P1|COMPLETED|Overall Study||3
5199894|NCT01049945|12787178|P6|STARTED|Overall Study||49
5199895|NCT01049945|12787179|P5|STARTED|Overall Study||3
5199896|NCT01049945|12787180|P4|STARTED|Overall Study||6
5199897|NCT01049945|12787181|P3|STARTED|Overall Study||3
5199898|NCT01049945|12787182|P2|STARTED|Overall Study||6
5199899|NCT01049945|12787183|P1|STARTED|Overall Study||3
5199900|NCT01049802|12787203|P2|NOT COMPLETED|Overall Study||0
5199901|NCT01049802|12787204|P1|NOT COMPLETED|Overall Study||0
5199902|NCT01049802|12787203|P2|COMPLETED|Overall Study||10
5199903|NCT01049802|12787204|P1|COMPLETED|Overall Study||20
5199904|NCT01049802|12787203|P2|STARTED|Overall Study||10
5199905|NCT01049802|12787204|P1|STARTED|Overall Study||20
5199906|NCT01049776|12787218|P1|NOT COMPLETED|Overall Study||20
5199907|NCT01049776|12787218|P1|COMPLETED|Overall Study||12
5199908|NCT01049776|12787218|P1|STARTED|Overall Study||32
5199909|NCT01049581|12787224|P2|NOT COMPLETED|Overall Study||1
5199910|NCT01049581|12787225|P1|NOT COMPLETED|Overall Study||2
5199911|NCT01049581|12787224|P2|COMPLETED|Overall Study||13
5199912|NCT01049581|12787225|P1|COMPLETED|Overall Study||11
5199913|NCT01049581|12787224|P2|STARTED|Overall Study||14
5199914|NCT01049581|12787225|P1|STARTED|Overall Study||13
5199915|NCT01049503|12787240|P6|NOT COMPLETED|Overall Study||8
5199916|NCT01049503|12787241|P5|NOT COMPLETED|Overall Study||27
5199917|NCT01049503|12787242|P4|NOT COMPLETED|Overall Study||26
5199918|NCT01049503|12787243|P3|NOT COMPLETED|Overall Study||24
5199919|NCT01049503|12787244|P2|NOT COMPLETED|Overall Study||12
5199920|NCT01049503|12787245|P1|NOT COMPLETED|Overall Study||11
5199921|NCT01049503|12787240|P6|COMPLETED|Overall Study||40
5199922|NCT01049503|12787241|P5|COMPLETED|Overall Study||29
5199923|NCT01049503|12787242|P4|COMPLETED|Overall Study||29
5199924|NCT01049503|12787243|P3|COMPLETED|Overall Study||32
5199925|NCT01049503|12787244|P2|COMPLETED|Overall Study||36
5199926|NCT01049503|12787245|P1|COMPLETED|Overall Study||41
5199927|NCT01049503|12787240|P6|STARTED|Overall Study||48
5199928|NCT01049503|12787241|P5|STARTED|Overall Study||56
5199929|NCT01049503|12787242|P4|STARTED|Overall Study||55
5199930|NCT01049503|12787243|P3|STARTED|Overall Study||56
5199931|NCT01049503|12787244|P2|STARTED|Overall Study||48
5199932|NCT01049503|12787245|P1|STARTED|Overall Study||52
5199933|NCT01049412|12787276|P2|NOT COMPLETED|Period II||3
5199934|NCT01049412|12787277|P1|NOT COMPLETED|Period II||4
5199935|NCT01049412|12787276|P2|COMPLETED|Period II||52
5199936|NCT01049412|12787277|P1|COMPLETED|Period II||58
5199937|NCT01049412|12787276|P2|STARTED|Period II||55
5199938|NCT01049412|12787277|P1|STARTED|Period II||62
5199939|NCT01049412|12787276|P2|NOT COMPLETED|Period I||13
5199940|NCT01049412|12787277|P1|NOT COMPLETED|Period I||8
5199941|NCT01049412|12787276|P2|COMPLETED|Period I||55
5199942|NCT01049412|12787277|P1|COMPLETED|Period I||62
5199943|NCT01049412|12787276|P2|Took at Least One Dose of Study Drug|Period I||68
5199944|NCT01049412|12787277|P1|Took at Least One Dose of Study Drug|Period I||69
5199945|NCT01049412|12787276|P2|STARTED|Period I||68
5199946|NCT01049412|12787277|P1|STARTED|Period I||70
5199947|NCT01049373|12787306|P2|NOT COMPLETED|Overall Study||44
5199948|NCT01049373|12787307|P1|NOT COMPLETED|Overall Study||39
5199949|NCT01049373|12787306|P2|COMPLETED|Overall Study||65
5199950|NCT01049373|12787307|P1|COMPLETED|Overall Study||73
5199951|NCT01049373|12787306|P2|STARTED|Overall Study||109
5199952|NCT01049373|12787307|P1|STARTED|Overall Study||112
5199953|NCT01049360|12787321|P20|NOT COMPLETED|Period 4||0
5199954|NCT01049360|12787322|P19|NOT COMPLETED|Period 4||0
5199955|NCT01049360|12787323|P18|NOT COMPLETED|Period 4||1
5199956|NCT01049360|12787324|P17|NOT COMPLETED|Period 4||0
5199957|NCT01049360|12787325|P16|NOT COMPLETED|Period 4||0
5199958|NCT01049360|12787326|P15|NOT COMPLETED|Period 4||0
5199959|NCT01049360|12787327|P14|NOT COMPLETED|Period 4||0
5199960|NCT01049360|12787328|P13|NOT COMPLETED|Period 4||0
5199961|NCT01049360|12787329|P12|NOT COMPLETED|Period 4||0
5199962|NCT01049360|12787330|P11|NOT COMPLETED|Period 4||0
5199963|NCT01049360|12787331|P10|NOT COMPLETED|Period 4||0
5199964|NCT01049360|12787332|P9|NOT COMPLETED|Period 4||0
5199965|NCT01049360|12787333|P8|NOT COMPLETED|Period 4||0
5199966|NCT01049360|12787334|P7|NOT COMPLETED|Period 4||0
5199967|NCT01049360|12787335|P6|NOT COMPLETED|Period 4||0
5199968|NCT01049360|12787336|P5|NOT COMPLETED|Period 4||0
5199969|NCT01049360|12787337|P4|NOT COMPLETED|Period 4||1
5199970|NCT01049360|12787338|P3|NOT COMPLETED|Period 4||0
5199971|NCT01049360|12787339|P2|NOT COMPLETED|Period 4||0
5199972|NCT01049360|12787340|P1|NOT COMPLETED|Period 4||0
5199973|NCT01049360|12787321|P20|COMPLETED|Period 4||5
5199974|NCT01049360|12787322|P19|COMPLETED|Period 4||5
5199975|NCT01049360|12787323|P18|COMPLETED|Period 4||5
5199976|NCT01049360|12787324|P17|COMPLETED|Period 4||5
5199977|NCT01049360|12787325|P16|COMPLETED|Period 4||6
5199978|NCT01049360|12787326|P15|COMPLETED|Period 4||5
5199979|NCT01049360|12787327|P14|COMPLETED|Period 4||6
5199980|NCT01049360|12787328|P13|COMPLETED|Period 4||4
5199981|NCT01049360|12787329|P12|COMPLETED|Period 4||6
5199982|NCT01049360|12787330|P11|COMPLETED|Period 4||5
5199983|NCT01049360|12787331|P10|COMPLETED|Period 4||6
5199984|NCT01049360|12787332|P9|COMPLETED|Period 4||4
5199985|NCT01049360|12787333|P8|COMPLETED|Period 4||4
5199986|NCT01049360|12787334|P7|COMPLETED|Period 4||6
5199987|NCT01049360|12787335|P6|COMPLETED|Period 4||5
5199988|NCT01049360|12787336|P5|COMPLETED|Period 4||7
5199989|NCT01049360|12787337|P4|COMPLETED|Period 4||3
5199990|NCT01049360|12787338|P3|COMPLETED|Period 4||7
5199991|NCT01049360|12787339|P2|COMPLETED|Period 4||4
5199992|NCT01049360|12787340|P1|COMPLETED|Period 4||6
5199993|NCT01049360|12787321|P20|STARTED|Period 4||5
5199994|NCT01049360|12787322|P19|STARTED|Period 4||5
5199995|NCT01049360|12787323|P18|STARTED|Period 4||6
5199996|NCT01049360|12787324|P17|STARTED|Period 4||5
5199997|NCT01049360|12787325|P16|STARTED|Period 4||6
5199998|NCT01049360|12787326|P15|STARTED|Period 4||5
5199999|NCT01049360|12787327|P14|STARTED|Period 4||6
5200000|NCT01049360|12787328|P13|STARTED|Period 4||4
5200001|NCT01049360|12787329|P12|STARTED|Period 4||6
5200002|NCT01049360|12787330|P11|STARTED|Period 4||5
5200003|NCT01049360|12787331|P10|STARTED|Period 4||6
5200004|NCT01049360|12787332|P9|STARTED|Period 4||4
5200005|NCT01049360|12787333|P8|STARTED|Period 4||4
5200006|NCT01049360|12787334|P7|STARTED|Period 4||6
5200007|NCT01049360|12787335|P6|STARTED|Period 4||5
5200008|NCT01049360|12787336|P5|STARTED|Period 4||7
5200009|NCT01049360|12787337|P4|STARTED|Period 4||4
5200010|NCT01049360|12787338|P3|STARTED|Period 4||7
5200011|NCT01049360|12787339|P2|STARTED|Period 4||4
5200012|NCT01049360|12787340|P1|STARTED|Period 4||6
5200013|NCT01049360|12787321|P20|NOT COMPLETED|Period 3||0
5200014|NCT01049360|12787322|P19|NOT COMPLETED|Period 3||0
5200015|NCT01049360|12787323|P18|NOT COMPLETED|Period 3||0
5200016|NCT01049360|12787324|P17|NOT COMPLETED|Period 3||0
5200017|NCT01049360|12787325|P16|NOT COMPLETED|Period 3||0
5200018|NCT01049360|12787326|P15|NOT COMPLETED|Period 3||0
5200019|NCT01049360|12787327|P14|NOT COMPLETED|Period 3||0
5200020|NCT01049360|12787328|P13|NOT COMPLETED|Period 3||0
5200021|NCT01049360|12787329|P12|NOT COMPLETED|Period 3||0
5200022|NCT01049360|12787330|P11|NOT COMPLETED|Period 3||0
5200023|NCT01049360|12787331|P10|NOT COMPLETED|Period 3||0
5200024|NCT01049360|12787332|P9|NOT COMPLETED|Period 3||0
5200025|NCT01049360|12787333|P8|NOT COMPLETED|Period 3||0
5200026|NCT01049360|12787334|P7|NOT COMPLETED|Period 3||0
5200027|NCT01049360|12787335|P6|NOT COMPLETED|Period 3||0
5200028|NCT01049360|12787336|P5|NOT COMPLETED|Period 3||0
5200029|NCT01049360|12787337|P4|NOT COMPLETED|Period 3||0
5200030|NCT01049360|12787338|P3|NOT COMPLETED|Period 3||0
5200031|NCT01049360|12787339|P2|NOT COMPLETED|Period 3||0
5200032|NCT01049360|12787340|P1|NOT COMPLETED|Period 3||0
5200033|NCT01049360|12787321|P20|COMPLETED|Period 3||5
5200034|NCT01049360|12787322|P19|COMPLETED|Period 3||5
5200035|NCT01049360|12787323|P18|COMPLETED|Period 3||6
5200036|NCT01049360|12787324|P17|COMPLETED|Period 3||5
5200037|NCT01049360|12787325|P16|COMPLETED|Period 3||6
5200038|NCT01049360|12787326|P15|COMPLETED|Period 3||5
5200039|NCT01049360|12787327|P14|COMPLETED|Period 3||6
5200040|NCT01049360|12787328|P13|COMPLETED|Period 3||4
5200041|NCT01049360|12787329|P12|COMPLETED|Period 3||6
5200042|NCT01049360|12787330|P11|COMPLETED|Period 3||5
5200043|NCT01049360|12787331|P10|COMPLETED|Period 3||6
5200044|NCT01049360|12787332|P9|COMPLETED|Period 3||4
5200045|NCT01049360|12787333|P8|COMPLETED|Period 3||4
5200046|NCT01049360|12787334|P7|COMPLETED|Period 3||6
5200047|NCT01049360|12787335|P6|COMPLETED|Period 3||5
5200048|NCT01049360|12787336|P5|COMPLETED|Period 3||7
5200049|NCT01049360|12787337|P4|COMPLETED|Period 3||4
5200050|NCT01049360|12787338|P3|COMPLETED|Period 3||7
5200051|NCT01049360|12787339|P2|COMPLETED|Period 3||4
5200052|NCT01049360|12787340|P1|COMPLETED|Period 3||6
5200053|NCT01049360|12787321|P20|STARTED|Period 3||5
5200054|NCT01049360|12787322|P19|STARTED|Period 3||5
5200055|NCT01049360|12787323|P18|STARTED|Period 3||6
5200056|NCT01049360|12787324|P17|STARTED|Period 3||5
5200057|NCT01049360|12787325|P16|STARTED|Period 3||6
5200058|NCT01049360|12787326|P15|STARTED|Period 3||5
5200059|NCT01049360|12787327|P14|STARTED|Period 3||6
5200060|NCT01049360|12787328|P13|STARTED|Period 3||4
5200061|NCT01049360|12787329|P12|STARTED|Period 3||6
5200062|NCT01049360|12787330|P11|STARTED|Period 3||5
5200063|NCT01049360|12787331|P10|STARTED|Period 3||6
5200064|NCT01049360|12787332|P9|STARTED|Period 3||4
5200065|NCT01049360|12787333|P8|STARTED|Period 3||4
5200066|NCT01049360|12787334|P7|STARTED|Period 3||6
5200067|NCT01049360|12787335|P6|STARTED|Period 3||5
5200068|NCT01049360|12787336|P5|STARTED|Period 3||7
5200069|NCT01049360|12787337|P4|STARTED|Period 3||4
5200070|NCT01049360|12787338|P3|STARTED|Period 3||7
5200071|NCT01049360|12787339|P2|STARTED|Period 3||4
5200072|NCT01049360|12787340|P1|STARTED|Period 3||6
5200073|NCT01049360|12787321|P20|NOT COMPLETED|Period 2||2
5200074|NCT01049360|12787322|P19|NOT COMPLETED|Period 2||0
5200075|NCT01049360|12787323|P18|NOT COMPLETED|Period 2||0
5200076|NCT01049360|12787324|P17|NOT COMPLETED|Period 2||0
5200077|NCT01049360|12787325|P16|NOT COMPLETED|Period 2||1
5200078|NCT01049360|12787326|P15|NOT COMPLETED|Period 2||2
5200079|NCT01049360|12787327|P14|NOT COMPLETED|Period 2||0
5200080|NCT01049360|12787328|P13|NOT COMPLETED|Period 2||0
5200081|NCT01049360|12787329|P12|NOT COMPLETED|Period 2||0
5200082|NCT01049360|12787330|P11|NOT COMPLETED|Period 2||0
5200083|NCT01049360|12787331|P10|NOT COMPLETED|Period 2||0
5200084|NCT01049360|12787332|P9|NOT COMPLETED|Period 2||1
5200085|NCT01049360|12787333|P8|NOT COMPLETED|Period 2||0
5200086|NCT01049360|12787334|P7|NOT COMPLETED|Period 2||0
5200087|NCT01049360|12787335|P6|NOT COMPLETED|Period 2||1
5200088|NCT01049360|12787336|P5|NOT COMPLETED|Period 2||0
5200089|NCT01049360|12787337|P4|NOT COMPLETED|Period 2||2
5200090|NCT01049360|12787338|P3|NOT COMPLETED|Period 2||0
5200091|NCT01049360|12787339|P2|NOT COMPLETED|Period 2||1
5200092|NCT01049360|12787340|P1|NOT COMPLETED|Period 2||0
5200093|NCT01049360|12787321|P20|COMPLETED|Period 2||5
5200094|NCT01049360|12787322|P19|COMPLETED|Period 2||5
5200095|NCT01049360|12787323|P18|COMPLETED|Period 2||6
5200096|NCT01049360|12787324|P17|COMPLETED|Period 2||5
5200097|NCT01049360|12787325|P16|COMPLETED|Period 2||6
5200098|NCT01049360|12787326|P15|COMPLETED|Period 2||5
5200099|NCT01049360|12787327|P14|COMPLETED|Period 2||6
5200100|NCT01049360|12787328|P13|COMPLETED|Period 2||4
5200101|NCT01049360|12787329|P12|COMPLETED|Period 2||6
5200102|NCT01049360|12787330|P11|COMPLETED|Period 2||5
5200103|NCT01049360|12787331|P10|COMPLETED|Period 2||6
5200104|NCT01049360|12787332|P9|COMPLETED|Period 2||4
5200105|NCT01049360|12787333|P8|COMPLETED|Period 2||4
5200106|NCT01049360|12787334|P7|COMPLETED|Period 2||6
5200107|NCT01049360|12787335|P6|COMPLETED|Period 2||5
5200108|NCT01049360|12787336|P5|COMPLETED|Period 2||7
5200109|NCT01049360|12787337|P4|COMPLETED|Period 2||4
5200110|NCT01049360|12787338|P3|COMPLETED|Period 2||7
5200111|NCT01049360|12787339|P2|COMPLETED|Period 2||4
5200112|NCT01049360|12787340|P1|COMPLETED|Period 2||6
5200113|NCT01049360|12787321|P20|STARTED|Period 2||7
5200114|NCT01049360|12787322|P19|STARTED|Period 2||5
5200115|NCT01049360|12787323|P18|STARTED|Period 2||6
5200116|NCT01049360|12787324|P17|STARTED|Period 2||5
5200117|NCT01049360|12787325|P16|STARTED|Period 2||7
5200118|NCT01049360|12787326|P15|STARTED|Period 2||7
5200119|NCT01049360|12787327|P14|STARTED|Period 2||6
5200120|NCT01049360|12787328|P13|STARTED|Period 2||4
5200121|NCT01049360|12787329|P12|STARTED|Period 2||6
5200122|NCT01049360|12787330|P11|STARTED|Period 2||5
5200123|NCT01049360|12787331|P10|STARTED|Period 2||6
5200124|NCT01049360|12787332|P9|STARTED|Period 2||5
5200125|NCT01049360|12787333|P8|STARTED|Period 2||4
5200126|NCT01049360|12787334|P7|STARTED|Period 2||6
5200127|NCT01049360|12787335|P6|STARTED|Period 2||6
5200128|NCT01049360|12787336|P5|STARTED|Period 2||7
5200129|NCT01049360|12787337|P4|STARTED|Period 2||6
5200130|NCT01049360|12787338|P3|STARTED|Period 2||7
5200131|NCT01049360|12787339|P2|STARTED|Period 2||5
5200132|NCT01049360|12787340|P1|STARTED|Period 2||6
5200133|NCT01049360|12787321|P20|NOT COMPLETED|Period 1||0
5200134|NCT01049360|12787322|P19|NOT COMPLETED|Period 1||1
5200135|NCT01049360|12787323|P18|NOT COMPLETED|Period 1||0
5200136|NCT01049360|12787324|P17|NOT COMPLETED|Period 1||1
5200137|NCT01049360|12787325|P16|NOT COMPLETED|Period 1||0
5200138|NCT01049360|12787326|P15|NOT COMPLETED|Period 1||0
5200139|NCT01049360|12787327|P14|NOT COMPLETED|Period 1||1
5200140|NCT01049360|12787328|P13|NOT COMPLETED|Period 1||2
5200141|NCT01049360|12787329|P12|NOT COMPLETED|Period 1||0
5200142|NCT01049360|12787330|P11|NOT COMPLETED|Period 1||1
5200143|NCT01049360|12787331|P10|NOT COMPLETED|Period 1||0
5200144|NCT01049360|12787332|P9|NOT COMPLETED|Period 1||2
5200145|NCT01049360|12787333|P8|NOT COMPLETED|Period 1||2
5200146|NCT01049360|12787334|P7|NOT COMPLETED|Period 1||0
5200147|NCT01049360|12787335|P6|NOT COMPLETED|Period 1||0
5200148|NCT01049360|12787336|P5|NOT COMPLETED|Period 1||0
5200149|NCT01049360|12787337|P4|NOT COMPLETED|Period 1||1
5200150|NCT01049360|12787338|P3|NOT COMPLETED|Period 1||0
5200151|NCT01049360|12787339|P2|NOT COMPLETED|Period 1||1
5200152|NCT01049360|12787340|P1|NOT COMPLETED|Period 1||0
5200153|NCT01049360|12787321|P20|COMPLETED|Period 1||7
5200154|NCT01049360|12787322|P19|COMPLETED|Period 1||5
5200155|NCT01049360|12787323|P18|COMPLETED|Period 1||6
5200156|NCT01049360|12787324|P17|COMPLETED|Period 1||5
5200157|NCT01049360|12787325|P16|COMPLETED|Period 1||7
5200158|NCT01049360|12787326|P15|COMPLETED|Period 1||7
5200159|NCT01049360|12787327|P14|COMPLETED|Period 1||6
5200160|NCT01049360|12787328|P13|COMPLETED|Period 1||4
5200161|NCT01049360|12787329|P12|COMPLETED|Period 1||6
5200162|NCT01049360|12787330|P11|COMPLETED|Period 1||5
5200163|NCT01049360|12787331|P10|COMPLETED|Period 1||6
5200164|NCT01049360|12787332|P9|COMPLETED|Period 1||5
5200165|NCT01049360|12787333|P8|COMPLETED|Period 1||4
5200166|NCT01049360|12787334|P7|COMPLETED|Period 1||6
5200167|NCT01049360|12787335|P6|COMPLETED|Period 1||6
5200168|NCT01049360|12787336|P5|COMPLETED|Period 1||7
5200169|NCT01049360|12787337|P4|COMPLETED|Period 1||6
5200170|NCT01049360|12787338|P3|COMPLETED|Period 1||7
5200171|NCT01049360|12787339|P2|COMPLETED|Period 1||5
5200172|NCT01049360|12787340|P1|COMPLETED|Period 1||6
5200173|NCT01049360|12787321|P20|STARTED|Period 1||7
5200174|NCT01049360|12787322|P19|STARTED|Period 1||6
5200175|NCT01049360|12787323|P18|STARTED|Period 1||6
5200176|NCT01049360|12787324|P17|STARTED|Period 1||6
5200177|NCT01049360|12787325|P16|STARTED|Period 1||7
5200178|NCT01049360|12787326|P15|STARTED|Period 1||7
5200179|NCT01049360|12787327|P14|STARTED|Period 1||7
5200180|NCT01049360|12787328|P13|STARTED|Period 1||6
5200181|NCT01049360|12787329|P12|STARTED|Period 1||6
5200182|NCT01049360|12787330|P11|STARTED|Period 1||6
5200183|NCT01049360|12787331|P10|STARTED|Period 1||6
5200184|NCT01049360|12787332|P9|STARTED|Period 1||7
5200185|NCT01049360|12787333|P8|STARTED|Period 1||6
5200186|NCT01049360|12787334|P7|STARTED|Period 1||6
5200187|NCT01049360|12787335|P6|STARTED|Period 1||6
5200188|NCT01049360|12787336|P5|STARTED|Period 1||7
5200189|NCT01049360|12787337|P4|STARTED|Period 1||7
5200190|NCT01049360|12787338|P3|STARTED|Period 1||7
5200191|NCT01049360|12787339|P2|STARTED|Period 1||6
5200192|NCT01049360|12787340|P1|STARTED|Period 1||6
5200193|NCT01049334|12787364|P2|NOT COMPLETED|Overall Study||7
5200194|NCT01049334|12787365|P1|NOT COMPLETED|Overall Study||9
5200195|NCT01049334|12787364|P2|COMPLETED|Overall Study||95
5200196|NCT01049334|12787365|P1|COMPLETED|Overall Study||93
5200197|NCT01049334|12787364|P2|STARTED|Overall Study||102
5200198|NCT01049334|12787365|P1|STARTED|Overall Study||102
5200199|NCT01049308|12787401|P1|NOT COMPLETED|Pill Counts||83
5200200|NCT01049308|12787401|P1|COMPLETED|Pill Counts||168
5200201|NCT01049308|12787401|P1|STARTED|Pill Counts||251
5200202|NCT01049308|12787401|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
5200203|NCT01049308|12787401|P1|COMPLETED|Evaluation of Cognitive Impairment||251
5200204|NCT01049308|12787401|P1|STARTED|Evaluation of Cognitive Impairment||251
5200205|NCT01049243|12787408|P1|NOT COMPLETED|Overall Study||2
5200206|NCT01049243|12787408|P1|COMPLETED|Overall Study||18
5200207|NCT01049243|12787408|P1|STARTED|Overall Study||20
5200208|NCT01049217|12787415|P2|NOT COMPLETED|Overall Study||63
5200209|NCT01049217|12787416|P1|NOT COMPLETED|Overall Study||56
5200210|NCT01049217|12787415|P2|COMPLETED|Overall Study||131
5200211|NCT01049217|12787416|P1|COMPLETED|Overall Study||127
5200212|NCT01049217|12787415|P2|Treated|Overall Study||192
5200213|NCT01049217|12787416|P1|Treated|Overall Study||183
5200214|NCT01049217|12787415|P2|STARTED|Overall Study||194
5200215|NCT01049217|12787416|P1|STARTED|Overall Study||183
5200216|NCT01049035|12787493|P7|NOT COMPLETED|Overall Study||15
5200217|NCT01049035|12787494|P6|NOT COMPLETED|Overall Study||12
5200218|NCT01049035|12787495|P5|NOT COMPLETED|Overall Study||4
5200219|NCT01049035|12787496|P4|NOT COMPLETED|Overall Study||11
5200220|NCT01049035|12787497|P3|NOT COMPLETED|Overall Study||27
5200221|NCT01049035|12787498|P2|NOT COMPLETED|Overall Study||21
5200222|NCT01049035|12787499|P1|NOT COMPLETED|Overall Study||33
5200223|NCT01049035|12787493|P7|COMPLETED|Overall Study||39
5200224|NCT01049035|12787494|P6|COMPLETED|Overall Study||42
5200225|NCT01049035|12787495|P5|COMPLETED|Overall Study||71
5200226|NCT01049035|12787496|P4|COMPLETED|Overall Study||64
5200227|NCT01049035|12787497|P3|COMPLETED|Overall Study||80
5200228|NCT01049035|12787498|P2|COMPLETED|Overall Study||87
5200229|NCT01049035|12787499|P1|COMPLETED|Overall Study||74
5200230|NCT01049035|12787493|P7|Safety Population|Overall Study||49
5200231|NCT01049035|12787494|P6|Safety Population|Overall Study||52
5200232|NCT01049035|12787495|P5|Safety Population|Overall Study||70
5200233|NCT01049035|12787496|P4|Safety Population|Overall Study||74
5200234|NCT01049035|12787497|P3|Safety Population|Overall Study||100
5200235|NCT01049035|12787498|P2|Safety Population|Overall Study||102
5200236|NCT01049035|12787499|P1|Safety Population|Overall Study||104
5200237|NCT01049035|12787493|P7|STARTED|Overall Study||54
5200238|NCT01049035|12787494|P6|STARTED|Overall Study||54
5200239|NCT01049035|12787495|P5|STARTED|Overall Study||75
5200240|NCT01049035|12787496|P4|STARTED|Overall Study||75
5200241|NCT01049035|12787497|P3|STARTED|Overall Study||107
5200242|NCT01049035|12787498|P2|STARTED|Overall Study||108
5200243|NCT01049035|12787499|P1|STARTED|Overall Study||107
5200244|NCT01049009|12787658|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
5200245|NCT01049009|12787659|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
5200246|NCT01049009|12787658|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
5200247|NCT01049009|12787659|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
5200248|NCT01049009|12787658|P2|STARTED|Treatment Period 2 (12 Weeks)||18
5200249|NCT01049009|12787659|P1|STARTED|Treatment Period 2 (12 Weeks)||21
5200250|NCT01049009|12787658|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
5200251|NCT01049009|12787659|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
5200252|NCT01049009|12787658|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
5200253|NCT01049009|12787659|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
5200254|NCT01049009|12787658|P2|STARTED|Treatment Period 1 (12 Weeks)||21
5200255|NCT01049009|12787659|P1|STARTED|Treatment Period 1 (12 Weeks)||23
5200256|NCT01048944|12787671|P4|NOT COMPLETED|Overall Study||2
5200257|NCT01048944|12787672|P3|NOT COMPLETED|Overall Study||10
5200258|NCT01048944|12787673|P2|NOT COMPLETED|Overall Study||10
5200259|NCT01048944|12787674|P1|NOT COMPLETED|Overall Study||8
5200260|NCT01048944|12787671|P4|COMPLETED|Overall Study||19
5200261|NCT01048944|12787672|P3|COMPLETED|Overall Study||25
5200262|NCT01048944|12787673|P2|COMPLETED|Overall Study||28
5200263|NCT01048944|12787674|P1|COMPLETED|Overall Study||24
5200264|NCT01048944|12787671|P4|STARTED|Overall Study||21
5200265|NCT01048944|12787672|P3|STARTED|Overall Study||35
5200266|NCT01048944|12787673|P2|STARTED|Overall Study||38
5200267|NCT01048944|12787674|P1|STARTED|Overall Study||32
5200268|NCT01048879|12787691|P3|NOT COMPLETED|Overall Study||0
5200269|NCT01048879|12787692|P2|NOT COMPLETED|Overall Study||0
5200270|NCT01048879|12787693|P1|NOT COMPLETED|Overall Study||0
5200271|NCT01048879|12787691|P3|COMPLETED|Overall Study||5
5200272|NCT01048879|12787692|P2|COMPLETED|Overall Study||9
5200273|NCT01048879|12787693|P1|COMPLETED|Overall Study||1
5200274|NCT01048879|12787691|P3|STARTED|Overall Study||5
5200275|NCT01048879|12787692|P2|STARTED|Overall Study||9
5200276|NCT01048879|12787693|P1|STARTED|Overall Study||1
5200277|NCT01048866|12787706|P2|NOT COMPLETED|Overall Study||5
5200278|NCT01048866|12787707|P1|NOT COMPLETED|Overall Study||4
5200279|NCT01048866|12787706|P2|COMPLETED|Overall Study||92
5200280|NCT01048866|12787707|P1|COMPLETED|Overall Study||97
5200281|NCT01048866|12787706|P2|STARTED|Overall Study||97
5200282|NCT01048866|12787707|P1|STARTED|Overall Study||101
5200283|NCT01048788|12787752|P3|NOT COMPLETED|Overall Study||2
5200284|NCT01048788|12787753|P2|NOT COMPLETED|Overall Study||2
5200285|NCT01048788|12787754|P1|NOT COMPLETED|Overall Study||5
5200286|NCT01048788|12787752|P3|COMPLETED|Overall Study||11
5200287|NCT01048788|12787753|P2|COMPLETED|Overall Study||28
5200288|NCT01048788|12787754|P1|COMPLETED|Overall Study||3
5200289|NCT01048788|12787752|P3|STARTED|Overall Study||13
5200290|NCT01048788|12787753|P2|STARTED|Overall Study||30
5200291|NCT01048788|12787754|P1|STARTED|Overall Study||8
5200292|NCT01048723|12787762|P1|NOT COMPLETED|Overall Study||0
5200293|NCT01048723|12787762|P1|COMPLETED|Overall Study||2
5200294|NCT01048723|12787762|P1|STARTED|Overall Study||2
5200295|NCT01048697|12787769|P1|NOT COMPLETED|Overall Study||0
5200296|NCT01048697|12787769|P1|COMPLETED|Overall Study||18
5200297|NCT01048697|12787769|P1|STARTED|Overall Study||18
5200298|NCT01048671|12787776|P3|NOT COMPLETED|Overall Study||1
5200299|NCT01048671|12787777|P2|NOT COMPLETED|Overall Study||1
5200300|NCT01048671|12787778|P1|NOT COMPLETED|Overall Study||0
5200301|NCT01048671|12787776|P3|COMPLETED|Overall Study||151
5200302|NCT01048671|12787777|P2|COMPLETED|Overall Study||263
5200303|NCT01048671|12787778|P1|COMPLETED|Overall Study||66
5200304|NCT01048671|12787776|P3|STARTED|Overall Study||152
5200305|NCT01048671|12787777|P2|STARTED|Overall Study||264
5200306|NCT01048671|12787778|P1|STARTED|Overall Study||66
5200307|NCT01048658|12787801|P2|NOT COMPLETED|Overall Study||0
5200308|NCT01048658|12787802|P1|NOT COMPLETED|Overall Study||0
5200309|NCT01048658|12787801|P2|COMPLETED|Overall Study||80
5200310|NCT01048658|12787802|P1|COMPLETED|Overall Study||80
5200311|NCT01048658|12787801|P2|STARTED|Overall Study||80
5200312|NCT01048658|12787802|P1|STARTED|Overall Study||80
5200313|NCT01048606|12787820|P4|NOT COMPLETED|Overall Study||5
5200314|NCT01048606|12787821|P3|NOT COMPLETED|Overall Study||10
5200315|NCT01048606|12787822|P2|NOT COMPLETED|Overall Study||7
5200316|NCT01048606|12787823|P1|NOT COMPLETED|Overall Study||12
5200317|NCT01048606|12787820|P4|COMPLETED|Overall Study||5
5200318|NCT01048606|12787821|P3|COMPLETED|Overall Study||16
5200319|NCT01048606|12787822|P2|COMPLETED|Overall Study||8
5200320|NCT01048606|12787823|P1|COMPLETED|Overall Study||16
5200321|NCT01048606|12787820|P4|STARTED|Overall Study||10
5200322|NCT01048606|12787821|P3|STARTED|Overall Study||26
5200323|NCT01048606|12787822|P2|STARTED|Overall Study||15
5200324|NCT01048606|12787823|P1|STARTED|Overall Study||28
5200325|NCT01048593|12787836|P3|NOT COMPLETED|Overall Study||0
5200326|NCT01048593|12787837|P2|NOT COMPLETED|Overall Study||0
5200327|NCT01048593|12787838|P1|NOT COMPLETED|Overall Study||0
5200328|NCT01048593|12787836|P3|COMPLETED|Overall Study||1
5200329|NCT01048593|12787837|P2|COMPLETED|Overall Study||2
5200330|NCT01048593|12787838|P1|COMPLETED|Overall Study||3
5200331|NCT01048593|12787836|P3|STARTED|Overall Study||1
5200332|NCT01048593|12787837|P2|STARTED|Overall Study||2
5200333|NCT01048593|12787838|P1|STARTED|Overall Study||3
5200334|NCT01048541|12787858|P2|NOT COMPLETED|Overall Study||0
5200335|NCT01048541|12787859|P1|NOT COMPLETED|Overall Study||1
5200336|NCT01048541|12787858|P2|COMPLETED|Overall Study||19
5200337|NCT01048541|12787859|P1|COMPLETED|Overall Study||17
5200338|NCT01048541|12787858|P2|STARTED|Overall Study||19
5200339|NCT01048541|12787859|P1|STARTED|Overall Study||18
5200340|NCT01048502|12787869|P4|NOT COMPLETED|Overall Study||4
5200341|NCT01048502|12787870|P3|NOT COMPLETED|Overall Study||5
5200342|NCT01048502|12787871|P2|NOT COMPLETED|Overall Study||7
5200343|NCT01048502|12787872|P1|NOT COMPLETED|Overall Study||4
5200344|NCT01048502|12787869|P4|COMPLETED|Overall Study||21
5200345|NCT01048502|12787870|P3|COMPLETED|Overall Study||23
5200346|NCT01048502|12787871|P2|COMPLETED|Overall Study||16
5200347|NCT01048502|12787872|P1|COMPLETED|Overall Study||20
5200348|NCT01048502|12787869|P4|STARTED|Overall Study||25
5200349|NCT01048502|12787870|P3|STARTED|Overall Study||28
5200350|NCT01048502|12787871|P2|STARTED|Overall Study||23
5200351|NCT01048502|12787872|P1|STARTED|Overall Study||24
5200352|NCT01048424|12787885|P2|NOT COMPLETED|Overall Study||0
5200353|NCT01048424|12787886|P1|NOT COMPLETED|Overall Study||2
5200354|NCT01048424|12787885|P2|COMPLETED|Overall Study||10
5200355|NCT01048424|12787886|P1|COMPLETED|Overall Study||8
5200356|NCT01048424|12787885|P2|STARTED|Overall Study||10
5200357|NCT01048424|12787886|P1|STARTED|Overall Study||10
5200358|NCT01048333|12787908|P6|NOT COMPLETED|Treatment Period 3||0
5200359|NCT01048333|12787909|P5|NOT COMPLETED|Treatment Period 3||0
5200360|NCT01048333|12787910|P4|NOT COMPLETED|Treatment Period 3||0
5200361|NCT01048333|12787911|P3|NOT COMPLETED|Treatment Period 3||0
5200362|NCT01048333|12787912|P2|NOT COMPLETED|Treatment Period 3||0
5200363|NCT01048333|12787913|P1|NOT COMPLETED|Treatment Period 3||0
5200364|NCT01048333|12787908|P6|COMPLETED|Treatment Period 3||18
5200365|NCT01048333|12787909|P5|COMPLETED|Treatment Period 3||17
5200366|NCT01048333|12787910|P4|COMPLETED|Treatment Period 3||18
5200367|NCT01048333|12787911|P3|COMPLETED|Treatment Period 3||16
5200368|NCT01048333|12787912|P2|COMPLETED|Treatment Period 3||18
5200369|NCT01048333|12787913|P1|COMPLETED|Treatment Period 3||21
5200370|NCT01048333|12787908|P6|STARTED|Treatment Period 3||18
5200371|NCT01048333|12787909|P5|STARTED|Treatment Period 3||17
5200372|NCT01048333|12787910|P4|STARTED|Treatment Period 3||18
5200373|NCT01048333|12787911|P3|STARTED|Treatment Period 3||16
5200374|NCT01048333|12787912|P2|STARTED|Treatment Period 3||18
5200375|NCT01048333|12787913|P1|STARTED|Treatment Period 3||21
5200376|NCT01048333|12787908|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
5200377|NCT01048333|12787909|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
5200378|NCT01048333|12787910|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
5200379|NCT01048333|12787911|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
5200380|NCT01048333|12787912|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
5200381|NCT01048333|12787913|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
5200382|NCT01048333|12787908|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
5200383|NCT01048333|12787909|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
5200384|NCT01048333|12787910|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
5200385|NCT01048333|12787911|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
5200386|NCT01048333|12787912|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
5200387|NCT01048333|12787913|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
5200388|NCT01048333|12787908|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
5200389|NCT01048333|12787909|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
5200390|NCT01048333|12787910|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
5200391|NCT01048333|12787911|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
5200392|NCT01048333|12787912|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
5200393|NCT01048333|12787913|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
5200394|NCT01048333|12787908|P6|NOT COMPLETED|Treatment Period 2||0
5200395|NCT01048333|12787909|P5|NOT COMPLETED|Treatment Period 2||0
5200396|NCT01048333|12787910|P4|NOT COMPLETED|Treatment Period 2||0
5200397|NCT01048333|12787911|P3|NOT COMPLETED|Treatment Period 2||0
5200398|NCT01048333|12787912|P2|NOT COMPLETED|Treatment Period 2||0
5200399|NCT01048333|12787913|P1|NOT COMPLETED|Treatment Period 2||0
5200400|NCT01048333|12787908|P6|COMPLETED|Treatment Period 2||18
5200401|NCT01048333|12787909|P5|COMPLETED|Treatment Period 2||17
5200402|NCT01048333|12787910|P4|COMPLETED|Treatment Period 2||18
5200403|NCT01048333|12787911|P3|COMPLETED|Treatment Period 2||16
5200404|NCT01048333|12787912|P2|COMPLETED|Treatment Period 2||19
5200405|NCT01048333|12787913|P1|COMPLETED|Treatment Period 2||21
5200406|NCT01048333|12787908|P6|STARTED|Treatment Period 2||18
5200407|NCT01048333|12787909|P5|STARTED|Treatment Period 2||17
5200408|NCT01048333|12787910|P4|STARTED|Treatment Period 2||18
5200409|NCT01048333|12787911|P3|STARTED|Treatment Period 2||16
5200410|NCT01048333|12787912|P2|STARTED|Treatment Period 2||19
5200411|NCT01048333|12787913|P1|STARTED|Treatment Period 2||21
5200412|NCT01048333|12787908|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200413|NCT01048333|12787909|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200414|NCT01048333|12787910|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200415|NCT01048333|12787911|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200416|NCT01048333|12787912|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200417|NCT01048333|12787913|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
5200418|NCT01048333|12787908|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
5200419|NCT01048333|12787909|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
5200420|NCT01048333|12787910|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
5200421|NCT01048333|12787911|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
5200422|NCT01048333|12787912|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
5200423|NCT01048333|12787913|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
5200424|NCT01048333|12787908|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
5200425|NCT01048333|12787909|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
5200426|NCT01048333|12787910|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
5200427|NCT01048333|12787911|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
5200428|NCT01048333|12787912|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
5200429|NCT01048333|12787913|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
5200430|NCT01048333|12787908|P6|NOT COMPLETED|Treatment Period 1||0
5200431|NCT01048333|12787909|P5|NOT COMPLETED|Treatment Period 1||0
5200432|NCT01048333|12787910|P4|NOT COMPLETED|Treatment Period 1||0
5200433|NCT01048333|12787911|P3|NOT COMPLETED|Treatment Period 1||0
5200434|NCT01048333|12787912|P2|NOT COMPLETED|Treatment Period 1||0
5200435|NCT01048333|12787913|P1|NOT COMPLETED|Treatment Period 1||0
5200436|NCT01048333|12787908|P6|COMPLETED|Treatment Period 1||18
5200437|NCT01048333|12787909|P5|COMPLETED|Treatment Period 1||17
5200438|NCT01048333|12787910|P4|COMPLETED|Treatment Period 1||18
5200439|NCT01048333|12787911|P3|COMPLETED|Treatment Period 1||16
5200440|NCT01048333|12787912|P2|COMPLETED|Treatment Period 1||19
5200441|NCT01048333|12787913|P1|COMPLETED|Treatment Period 1||21
5200442|NCT01048333|12787908|P6|STARTED|Treatment Period 1||18
5200443|NCT01048333|12787909|P5|STARTED|Treatment Period 1||17
5200444|NCT01048333|12787910|P4|STARTED|Treatment Period 1||18
5200445|NCT01048333|12787911|P3|STARTED|Treatment Period 1||16
5200446|NCT01048333|12787912|P2|STARTED|Treatment Period 1||19
5200447|NCT01048333|12787913|P1|STARTED|Treatment Period 1||21
5200448|NCT01048242|12787935|P2|NOT COMPLETED|Overall Study||2
5200449|NCT01048242|12787936|P1|NOT COMPLETED|Overall Study||4
5200450|NCT01048242|12787935|P2|COMPLETED|Overall Study||13
5200451|NCT01048242|12787936|P1|COMPLETED|Overall Study||8
5200452|NCT01048242|12787935|P2|STARTED|Overall Study||15
5200453|NCT01048242|12787936|P1|STARTED|Overall Study||12
5200454|NCT01048125|12787944|P2|NOT COMPLETED|Overall Study||0
5200455|NCT01048125|12787945|P1|NOT COMPLETED|Overall Study||0
5200456|NCT01048125|12787944|P2|COMPLETED|Overall Study||0
5200457|NCT01048125|12787945|P1|COMPLETED|Overall Study||0
5200458|NCT01048125|12787944|P2|STARTED|Overall Study||0
5200459|NCT01048125|12787945|P1|STARTED|Overall Study||0
5200460|NCT01048099|12787951|P1|NOT COMPLETED|Treatment Per Protocol||14
5200461|NCT01048099|12787951|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
5200462|NCT01048099|12787951|P1|STARTED|Treatment Per Protocol||14
5200463|NCT01048099|12787951|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
5200464|NCT01048099|12787951|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
5200465|NCT01048099|12787951|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
5200466|NCT01048099|12787951|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
5200467|NCT01048099|12787951|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
5200468|NCT01048099|12787951|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
5200469|NCT01048099|12787951|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
5200470|NCT01048099|12787951|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
5200471|NCT01048099|12787951|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
5200472|NCT01047839|12787962|P3|NOT COMPLETED|Overall Study||6
5200473|NCT01047839|12787963|P2|NOT COMPLETED|Overall Study||0
5200474|NCT01047839|12787964|P1|NOT COMPLETED|Overall Study||2
5200475|NCT01047839|12787962|P3|COMPLETED|Overall Study||53
5200476|NCT01047839|12787963|P2|COMPLETED|Overall Study||29
5200477|NCT01047839|12787964|P1|COMPLETED|Overall Study||10
5200478|NCT01047839|12787962|P3|STARTED|Overall Study||59
5200479|NCT01047839|12787963|P2|STARTED|Overall Study||29
5200480|NCT01047839|12787964|P1|STARTED|Overall Study||12
5200481|NCT01047709|12787990|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
5200482|NCT01047709|12787991|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
5200483|NCT01047709|12787990|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
5200484|NCT01047709|12787991|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
5200485|NCT01047709|12787990|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
5200486|NCT01047709|12787991|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
5200487|NCT01047709|12787990|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
5200488|NCT01047709|12787991|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
5200489|NCT01047709|12787990|P2|COMPLETED|Positional Therapy (1 Night)||9
5200490|NCT01047709|12787991|P1|COMPLETED|Positional Therapy (1 Night)||9
5200491|NCT01047709|12787990|P2|STARTED|Positional Therapy (1 Night)||9
5200492|NCT01047709|12787991|P1|STARTED|Positional Therapy (1 Night)||9
5200493|NCT01047553|12787999|P2|NOT COMPLETED|Overall Study||9
5200494|NCT01047553|12788000|P1|NOT COMPLETED|Overall Study||17
5200495|NCT01047553|12787999|P2|COMPLETED|Overall Study||117
5200496|NCT01047553|12788000|P1|COMPLETED|Overall Study||108
5200497|NCT01047553|12787999|P2|STARTED|Overall Study||126
5200498|NCT01047553|12788000|P1|STARTED|Overall Study||125
5200499|NCT01047527|12788085|P3|NOT COMPLETED|Overall Study||65
5200500|NCT01047527|12788086|P2|NOT COMPLETED|Overall Study||61
5200501|NCT01047527|12788087|P1|NOT COMPLETED|Overall Study||85
5200502|NCT01047527|12788085|P3|COMPLETED|Overall Study||107
5200503|NCT01047527|12788086|P2|COMPLETED|Overall Study||112
5200504|NCT01047527|12788087|P1|COMPLETED|Overall Study||95
5200505|NCT01047527|12788085|P3|24 Weeks|Overall Study||119
5200506|NCT01047527|12788086|P2|24 Weeks|Overall Study||123
5200507|NCT01047527|12788087|P1|24 Weeks|Overall Study||111
5200508|NCT01047527|12788085|P3|8 Weeks|Overall Study||138
5200509|NCT01047527|12788086|P2|8 Weeks|Overall Study||142
5200510|NCT01047527|12788087|P1|8 Weeks|Overall Study||148
5200511|NCT01047527|12788085|P3|STARTED|Overall Study||172
5200512|NCT01047527|12788086|P2|STARTED|Overall Study||173
5200513|NCT01047527|12788087|P1|STARTED|Overall Study||180
5200514|NCT01047475|12788098|P2|NOT COMPLETED|Overall Study||7
5200515|NCT01047475|12788099|P1|NOT COMPLETED|Overall Study||5
5200516|NCT01047475|12788098|P2|COMPLETED|Overall Study||31
5200517|NCT01047475|12788099|P1|COMPLETED|Overall Study||29
5200518|NCT01047475|12788098|P2|STARTED|Overall Study||38
5200519|NCT01047475|12788099|P1|STARTED|Overall Study||34
5200520|NCT01047436|12788107|P2|NOT COMPLETED|Overall Study||0
5200521|NCT01047436|12788108|P1|NOT COMPLETED|Overall Study||1
5200522|NCT01047436|12788107|P2|COMPLETED|Overall Study||15
5200523|NCT01047436|12788108|P1|COMPLETED|Overall Study||15
5200524|NCT01047436|12788107|P2|STARTED|Overall Study||15
5200525|NCT01047436|12788108|P1|STARTED|Overall Study||16
5200526|NCT01047358|12788124|P1|NOT COMPLETED|Overall Study||0
5200527|NCT01047358|12788124|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
5200528|NCT01047358|12788124|P1|STARTED|Overall Study||206
5200529|NCT01047345|12788133|P3|NOT COMPLETED|Extension||6
5200530|NCT01047345|12788134|P2|NOT COMPLETED|Extension||0
5200531|NCT01047345|12788135|P1|NOT COMPLETED|Extension||0
5200532|NCT01047345|12788133|P3|COMPLETED|Extension||96
5200533|NCT01047345|12788134|P2|COMPLETED|Extension||0
5200534|NCT01047345|12788135|P1|COMPLETED|Extension||0
5200535|NCT01047345|12788133|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
5200536|NCT01047345|12788134|P2|Vaccination 6|Extension||0
5200537|NCT01047345|12788135|P1|Vaccination 6|Extension||0
5200538|NCT01047345|12788133|P3|Vaccination 5|Extension||99
5200539|NCT01047345|12788134|P2|Vaccination 5|Extension||0
5200540|NCT01047345|12788135|P1|Vaccination 5|Extension||0
5200541|NCT01047345|12788133|P3|Vaccination 4|Extension||102
5200542|NCT01047345|12788134|P2|Vaccination 4|Extension||0
5200543|NCT01047345|12788135|P1|Vaccination 4|Extension||0
5200544|NCT01047345|12788133|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
5200545|NCT01047345|12788134|P2|STARTED|Extension||0
5200546|NCT01047345|12788135|P1|STARTED|Extension||0
5200547|NCT01047345|12788133|P3|NOT COMPLETED|Base Study||0
5200548|NCT01047345|12788134|P2|NOT COMPLETED|Base Study||6
5200549|NCT01047345|12788135|P1|NOT COMPLETED|Base Study||22
5200550|NCT01047345|12788133|P3|COMPLETED|Base Study||0
5200551|NCT01047345|12788134|P2|COMPLETED|Base Study||300
5200552|NCT01047345|12788135|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
5200553|NCT01047345|12788133|P3|Vaccination 3|Base Study||0
5200554|NCT01047345|12788134|P2|Vaccination 3|Base Study||300
5200555|NCT01047345|12788135|P1|Vaccination 3|Base Study||597
5200556|NCT01047345|12788133|P3|Vaccination 2|Base Study||0
5200557|NCT01047345|12788134|P2|Vaccination 2|Base Study||304
5200558|NCT01047345|12788135|P1|Vaccination 2|Base Study||604
5200559|NCT01047345|12788133|P3|Vaccination 1|Base Study||0
5200560|NCT01047345|12788134|P2|Vaccination 1|Base Study||306
5200561|NCT01047345|12788135|P1|Vaccination 1|Base Study||615
5200562|NCT01047345|12788133|P3|STARTED|Base Study||0
5200563|NCT01047345|12788134|P2|STARTED|Base Study||306
5200564|NCT01047345|12788135|P1|STARTED|Base Study||618
5200565|NCT01047332|12788157|P2|NOT COMPLETED|Overall Study||64
5200566|NCT01047332|12788158|P1|NOT COMPLETED|Overall Study||57
5200567|NCT01047332|12788157|P2|COMPLETED|Overall Study|Alive at final follow-up|4
5200568|NCT01047332|12788158|P1|COMPLETED|Overall Study|Alive at final follow-up|4
5200569|NCT01047332|12788157|P2|STARTED|Overall Study||68
5200570|NCT01047332|12788158|P1|STARTED|Overall Study||61
5200571|NCT01047319|12788173|P3|NOT COMPLETED|Overall Study||352
5200572|NCT01047319|12788174|P2|NOT COMPLETED|Overall Study||350
5200573|NCT01047319|12788175|P1|NOT COMPLETED|Overall Study||345
5200574|NCT01047319|12788173|P3|COMPLETED|Overall Study||0
5200575|NCT01047319|12788174|P2|COMPLETED|Overall Study||0
5200576|NCT01047319|12788175|P1|COMPLETED|Overall Study||0
5200577|NCT01047319|12788173|P3|STARTED|Overall Study||352
5200578|NCT01047319|12788174|P2|STARTED|Overall Study||350
5200579|NCT01047319|12788175|P1|STARTED|Overall Study||345
5200580|NCT01047306|12788197|P2|NOT COMPLETED|Overall Study||0
5200581|NCT01047306|12788198|P1|NOT COMPLETED|Overall Study||3
5200582|NCT01047306|12788197|P2|COMPLETED|Overall Study||6
5200583|NCT01047306|12788198|P1|COMPLETED|Overall Study||16
5200584|NCT01047306|12788197|P2|Discontinued From the Study|Overall Study||0
5200585|NCT01047306|12788198|P1|Discontinued From the Study|Overall Study||3
5200586|NCT01047306|12788197|P2|STARTED|Overall Study||6
5200587|NCT01047306|12788198|P1|STARTED|Overall Study||19
5200588|NCT01047293|12788272|P4|NOT COMPLETED|Overall Study||0
5200589|NCT01047293|12788273|P3|NOT COMPLETED|Overall Study||0
5200590|NCT01047293|12788274|P2|NOT COMPLETED|Overall Study||1
5200591|NCT01047293|12788275|P1|NOT COMPLETED|Overall Study||1
5200592|NCT01047293|12788272|P4|COMPLETED|Overall Study||26
5200593|NCT01047293|12788273|P3|COMPLETED|Overall Study||9
5200594|NCT01047293|12788274|P2|COMPLETED|Overall Study||7
5200595|NCT01047293|12788275|P1|COMPLETED|Overall Study||3
5200596|NCT01047293|12788272|P4|STARTED|Overall Study||26
5200597|NCT01047293|12788273|P3|STARTED|Overall Study||9
5200598|NCT01047293|12788274|P2|STARTED|Overall Study||8
5200599|NCT01047293|12788275|P1|STARTED|Overall Study||4
5200600|NCT01047241|12788282|P1|NOT COMPLETED|Overall Study||0
5200601|NCT01047241|12788282|P1|COMPLETED|Overall Study||50
5200602|NCT01047241|12788282|P1|STARTED|Overall Study||50
5200603|NCT01047189|12788293|P2|NOT COMPLETED|Overall Study||0
5200604|NCT01047189|12788294|P1|NOT COMPLETED|Overall Study||4
5200605|NCT01047189|12788293|P2|COMPLETED|Overall Study||13
5200606|NCT01047189|12788294|P1|COMPLETED|Overall Study||9
5200607|NCT01047189|12788293|P2|STARTED|Overall Study||13
5200608|NCT01047189|12788294|P1|STARTED|Overall Study||13
5200609|NCT01047007|12788306|P4|NOT COMPLETED|Overall Study||0
5200610|NCT01047007|12788307|P3|NOT COMPLETED|Overall Study||2
5200611|NCT01047007|12788308|P2|NOT COMPLETED|Overall Study||6
5200612|NCT01047007|12788309|P1|NOT COMPLETED|Overall Study||2
5200613|NCT01047007|12788306|P4|COMPLETED|Overall Study||0
5200614|NCT01047007|12788307|P3|COMPLETED|Overall Study||0
5200615|NCT01047007|12788308|P2|COMPLETED|Overall Study||0
5200616|NCT01047007|12788309|P1|COMPLETED|Overall Study||1
5200617|NCT01047007|12788306|P4|Treated|Overall Study||0
5200618|NCT01047007|12788307|P3|Treated|Overall Study||2
5200619|NCT01047007|12788308|P2|Treated|Overall Study||6
5200620|NCT01047007|12788309|P1|Treated|Overall Study||3
5200621|NCT01047007|12788306|P4|STARTED|Overall Study||0
5200622|NCT01047007|12788307|P3|STARTED|Overall Study||2
5200623|NCT01047007|12788308|P2|STARTED|Overall Study||6
5200624|NCT01047007|12788309|P1|STARTED|Overall Study||3
5200625|NCT01046903|12788320|P1|NOT COMPLETED|Overall Study||28
5200626|NCT01046903|12788320|P1|COMPLETED|Overall Study||475
5200627|NCT01046903|12788320|P1|STARTED|Overall Study||503
5200628|NCT01046877|12788333|P1|NOT COMPLETED|Overall Study||18
5200629|NCT01046877|12788333|P1|COMPLETED|Overall Study||7
5200630|NCT01046877|12788333|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
5200631|NCT01046877|12788333|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
5200632|NCT01046877|12788333|P1|STARTED|Overall Study||25
5200633|NCT01046695|12788349|P2|NOT COMPLETED|Overall Study||2
5200634|NCT01046695|12788350|P1|NOT COMPLETED|Overall Study||0
5200635|NCT01046695|12788349|P2|COMPLETED|Overall Study||20
5200636|NCT01046695|12788350|P1|COMPLETED|Overall Study||20
5200637|NCT01046695|12788349|P2|STARTED|Overall Study||22
5200638|NCT01046695|12788350|P1|STARTED|Overall Study||20
5200639|NCT01046682|12788362|P2|NOT COMPLETED|Overall Study||0
5200640|NCT01046682|12788363|P1|NOT COMPLETED|Overall Study||2
5200641|NCT01046682|12788362|P2|COMPLETED|Overall Study||20
5200642|NCT01046682|12788363|P1|COMPLETED|Overall Study||18
5200643|NCT01046682|12788362|P2|STARTED|Overall Study||20
5200644|NCT01046682|12788363|P1|STARTED|Overall Study||20
5200645|NCT01046669|12788371|P2|NOT COMPLETED|Overall Study||1
5200646|NCT01046669|12788372|P1|NOT COMPLETED|Overall Study||0
5200647|NCT01046669|12788371|P2|COMPLETED|Overall Study||223
5200648|NCT01046669|12788372|P1|COMPLETED|Overall Study||226
5200649|NCT01046669|12788371|P2|STARTED|Overall Study||224
5200650|NCT01046669|12788372|P1|STARTED|Overall Study||226
5200651|NCT01046643|12788380|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
5200652|NCT01046643|12788381|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
5200653|NCT01046643|12788382|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
5200654|NCT01046643|12788383|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
5200655|NCT01046643|12788380|P4|COMPLETED|Second Period Treatment or Placebo||7
5200656|NCT01046643|12788381|P3|COMPLETED|Second Period Treatment or Placebo||7
5200657|NCT01046643|12788382|P2|COMPLETED|Second Period Treatment or Placebo||6
5200658|NCT01046643|12788383|P1|COMPLETED|Second Period Treatment or Placebo||9
5200659|NCT01046643|12788380|P4|STARTED|Second Period Treatment or Placebo||7
5200660|NCT01046643|12788381|P3|STARTED|Second Period Treatment or Placebo||7
5200661|NCT01046643|12788382|P2|STARTED|Second Period Treatment or Placebo||6
5200662|NCT01046643|12788383|P1|STARTED|Second Period Treatment or Placebo||9
5200663|NCT01046643|12788380|P4|NOT COMPLETED|Washout Period||0
5200664|NCT01046643|12788381|P3|NOT COMPLETED|Washout Period||0
5200665|NCT01046643|12788382|P2|NOT COMPLETED|Washout Period||0
5200666|NCT01046643|12788383|P1|NOT COMPLETED|Washout Period||0
5200667|NCT01046643|12788380|P4|COMPLETED|Washout Period||7
5200668|NCT01046643|12788381|P3|COMPLETED|Washout Period||7
5200669|NCT01046643|12788382|P2|COMPLETED|Washout Period||6
5200670|NCT01046643|12788383|P1|COMPLETED|Washout Period||9
5200671|NCT01046643|12788380|P4|STARTED|Washout Period||7
5200672|NCT01046643|12788381|P3|STARTED|Washout Period||7
5200673|NCT01046643|12788382|P2|STARTED|Washout Period||6
5200674|NCT01046643|12788383|P1|STARTED|Washout Period||9
5200675|NCT01046643|12788380|P4|NOT COMPLETED|First Period Treatment or Placebo||0
5200676|NCT01046643|12788381|P3|NOT COMPLETED|First Period Treatment or Placebo||0
5200677|NCT01046643|12788382|P2|NOT COMPLETED|First Period Treatment or Placebo||1
5200678|NCT01046643|12788383|P1|NOT COMPLETED|First Period Treatment or Placebo||0
5200679|NCT01046643|12788380|P4|COMPLETED|First Period Treatment or Placebo||7
5200680|NCT01046643|12788381|P3|COMPLETED|First Period Treatment or Placebo||7
5200681|NCT01046643|12788382|P2|COMPLETED|First Period Treatment or Placebo||6
5200682|NCT01046643|12788383|P1|COMPLETED|First Period Treatment or Placebo||9
5200683|NCT01046643|12788380|P4|STARTED|First Period Treatment or Placebo||7
5200684|NCT01046643|12788381|P3|STARTED|First Period Treatment or Placebo||7
5200685|NCT01046643|12788382|P2|STARTED|First Period Treatment or Placebo||7
5200686|NCT01046643|12788383|P1|STARTED|First Period Treatment or Placebo||9
5200687|NCT01046565|12788405|P1|NOT COMPLETED|Overall Study||9
5200688|NCT01046565|12788405|P1|COMPLETED|Overall Study||66
5200689|NCT01046565|12788405|P1|STARTED|Overall Study||75
5200690|NCT01046396|12788414|P1|NOT COMPLETED|Overall Study||5
5200691|NCT01046396|12788414|P1|COMPLETED|Overall Study||64
5200692|NCT01046396|12788414|P1|STARTED|Overall Study||69
5200693|NCT01046253|12788425|P2|NOT COMPLETED|Fourth Intervention||0
5200694|NCT01046253|12788426|P1|NOT COMPLETED|Fourth Intervention||0
5200695|NCT01046253|12788425|P2|COMPLETED|Fourth Intervention||23
5200696|NCT01046253|12788426|P1|COMPLETED|Fourth Intervention||25
5200697|NCT01046253|12788425|P2|STARTED|Fourth Intervention||23
5200698|NCT01046253|12788426|P1|STARTED|Fourth Intervention||25
5200699|NCT01046253|12788425|P2|NOT COMPLETED|Third Washout of 7 Days||0
5200700|NCT01046253|12788426|P1|NOT COMPLETED|Third Washout of 7 Days||0
5200701|NCT01046253|12788425|P2|COMPLETED|Third Washout of 7 Days||23
5200702|NCT01046253|12788426|P1|COMPLETED|Third Washout of 7 Days||25
5200703|NCT01046253|12788425|P2|STARTED|Third Washout of 7 Days||23
5200704|NCT01046253|12788426|P1|STARTED|Third Washout of 7 Days||25
5200705|NCT01046253|12788425|P2|NOT COMPLETED|Third Intervention||0
5200706|NCT01046253|12788426|P1|NOT COMPLETED|Third Intervention||0
5200707|NCT01046253|12788425|P2|COMPLETED|Third Intervention||23
5200708|NCT01046253|12788426|P1|COMPLETED|Third Intervention||25
5200709|NCT01046253|12788425|P2|STARTED|Third Intervention||23
5200710|NCT01046253|12788426|P1|STARTED|Third Intervention||25
5200711|NCT01046253|12788425|P2|NOT COMPLETED|Second Washout of 7 Days||0
5200712|NCT01046253|12788426|P1|NOT COMPLETED|Second Washout of 7 Days||0
5200713|NCT01046253|12788425|P2|COMPLETED|Second Washout of 7 Days||23
5200714|NCT01046253|12788426|P1|COMPLETED|Second Washout of 7 Days||25
5200715|NCT01046253|12788425|P2|STARTED|Second Washout of 7 Days||23
5200716|NCT01046253|12788426|P1|STARTED|Second Washout of 7 Days||25
5200717|NCT01046253|12788425|P2|NOT COMPLETED|Second Intervention||2
5200718|NCT01046253|12788426|P1|NOT COMPLETED|Second Intervention||0
5200719|NCT01046253|12788425|P2|COMPLETED|Second Intervention||23
5200720|NCT01046253|12788426|P1|COMPLETED|Second Intervention||25
5200721|NCT01046253|12788425|P2|STARTED|Second Intervention||25
5200722|NCT01046253|12788426|P1|STARTED|Second Intervention||25
5200723|NCT01046253|12788425|P2|NOT COMPLETED|First Washout of 7 Days||0
5200724|NCT01046253|12788426|P1|NOT COMPLETED|First Washout of 7 Days||0
5200725|NCT01046253|12788425|P2|COMPLETED|First Washout of 7 Days||25
5200726|NCT01046253|12788426|P1|COMPLETED|First Washout of 7 Days||25
5200727|NCT01046253|12788425|P2|STARTED|First Washout of 7 Days||25
5200728|NCT01046253|12788426|P1|STARTED|First Washout of 7 Days||25
5200729|NCT01046253|12788425|P2|NOT COMPLETED|First Intervention||0
5200730|NCT01046253|12788426|P1|NOT COMPLETED|First Intervention||0
5200731|NCT01046253|12788425|P2|COMPLETED|First Intervention||25
5200732|NCT01046253|12788426|P1|COMPLETED|First Intervention||25
5200733|NCT01046253|12788425|P2|STARTED|First Intervention||25
5200734|NCT01046253|12788426|P1|STARTED|First Intervention||25
5200735|NCT01046136|12788438|P2|NOT COMPLETED|Overall Study||8
5200736|NCT01046136|12788439|P1|NOT COMPLETED|Overall Study||4
5200737|NCT01046136|12788438|P2|COMPLETED|Overall Study||182
5200738|NCT01046136|12788439|P1|COMPLETED|Overall Study||184
5200739|NCT01046136|12788438|P2|STARTED|Overall Study||190
5200740|NCT01046136|12788439|P1|STARTED|Overall Study||188
5200741|NCT01046110|12788451|P2|NOT COMPLETED|Overall Study||55
5200742|NCT01046110|12788452|P1|NOT COMPLETED|Overall Study||55
5200743|NCT01046110|12788451|P2|COMPLETED|Overall Study||174
5200744|NCT01046110|12788452|P1|COMPLETED|Overall Study||174
5200745|NCT01046110|12788451|P2|Exposed|Overall Study|1 subject was randomised in error|228
5200746|NCT01046110|12788452|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
5200747|NCT01046110|12788451|P2|STARTED|Overall Study||229
5200748|NCT01046110|12788452|P1|STARTED|Overall Study||229
5200749|NCT01046084|12788462|P2|NOT COMPLETED|Fourth Intervention||0
5200750|NCT01046084|12788463|P1|NOT COMPLETED|Fourth Intervention||0
5200751|NCT01046084|12788462|P2|COMPLETED|Fourth Intervention||25
5200752|NCT01046084|12788463|P1|COMPLETED|Fourth Intervention||23
5200753|NCT01046084|12788462|P2|STARTED|Fourth Intervention||25
5200754|NCT01046084|12788463|P1|STARTED|Fourth Intervention||23
5200755|NCT01046084|12788462|P2|NOT COMPLETED|Third Washout of 7 Days||0
5200756|NCT01046084|12788463|P1|NOT COMPLETED|Third Washout of 7 Days||2
5200757|NCT01046084|12788462|P2|COMPLETED|Third Washout of 7 Days||25
5200758|NCT01046084|12788463|P1|COMPLETED|Third Washout of 7 Days||23
5200759|NCT01046084|12788462|P2|STARTED|Third Washout of 7 Days||25
5200760|NCT01046084|12788463|P1|STARTED|Third Washout of 7 Days||25
5200761|NCT01046084|12788462|P2|NOT COMPLETED|Third Intervention||0
5200762|NCT01046084|12788463|P1|NOT COMPLETED|Third Intervention||0
5200763|NCT01046084|12788462|P2|COMPLETED|Third Intervention||25
5200764|NCT01046084|12788463|P1|COMPLETED|Third Intervention||25
5200765|NCT01046084|12788462|P2|STARTED|Third Intervention||25
5200766|NCT01046084|12788463|P1|STARTED|Third Intervention||25
5200767|NCT01046084|12788462|P2|NOT COMPLETED|Second Washout of 7 Days||0
5200768|NCT01046084|12788463|P1|NOT COMPLETED|Second Washout of 7 Days||0
5200769|NCT01046084|12788462|P2|COMPLETED|Second Washout of 7 Days||25
5200770|NCT01046084|12788463|P1|COMPLETED|Second Washout of 7 Days||25
5200771|NCT01046084|12788462|P2|STARTED|Second Washout of 7 Days||25
5200772|NCT01046084|12788463|P1|STARTED|Second Washout of 7 Days||25
5200773|NCT01046084|12788462|P2|NOT COMPLETED|Second Intervention||0
5200774|NCT01046084|12788463|P1|NOT COMPLETED|Second Intervention||0
5200775|NCT01046084|12788462|P2|COMPLETED|Second Intervention||25
5200776|NCT01046084|12788463|P1|COMPLETED|Second Intervention||25
5200777|NCT01046084|12788462|P2|STARTED|Second Intervention||25
5200778|NCT01046084|12788463|P1|STARTED|Second Intervention||25
5200779|NCT01046084|12788462|P2|NOT COMPLETED|First Washout of 7 Days||0
5200780|NCT01046084|12788463|P1|NOT COMPLETED|First Washout of 7 Days||0
5200781|NCT01046084|12788462|P2|COMPLETED|First Washout of 7 Days||25
5200782|NCT01046084|12788463|P1|COMPLETED|First Washout of 7 Days||25
5200783|NCT01046084|12788462|P2|STARTED|First Washout of 7 Days||25
5200784|NCT01046084|12788463|P1|STARTED|First Washout of 7 Days||25
5200785|NCT01046084|12788462|P2|NOT COMPLETED|First Intervention||0
5200786|NCT01046084|12788463|P1|NOT COMPLETED|First Intervention||0
5200787|NCT01046084|12788462|P2|COMPLETED|First Intervention||25
5200788|NCT01046084|12788463|P1|COMPLETED|First Intervention||25
5200789|NCT01046084|12788462|P2|STARTED|First Intervention||25
5200790|NCT01046084|12788463|P1|STARTED|First Intervention||25
5200791|NCT01045993|12788477|P4|NOT COMPLETED|Overall Study||0
5200792|NCT01045993|12788478|P3|NOT COMPLETED|Overall Study||0
5200793|NCT01045993|12788479|P2|NOT COMPLETED|Overall Study||1
5200794|NCT01045993|12788480|P1|NOT COMPLETED|Overall Study||0
5200795|NCT01045993|12788477|P4|COMPLETED|Overall Study||25
5200796|NCT01045993|12788478|P3|COMPLETED|Overall Study||5
5200797|NCT01045993|12788479|P2|COMPLETED|Overall Study||4
5200798|NCT01045993|12788480|P1|COMPLETED|Overall Study||26
5200799|NCT01045993|12788477|P4|STARTED|Overall Study||25
5200800|NCT01045993|12788478|P3|STARTED|Overall Study||5
5200801|NCT01045993|12788479|P2|STARTED|Overall Study||5
5200802|NCT01045993|12788480|P1|STARTED|Overall Study||26
5200803|NCT01045967|12788556|P2|NOT COMPLETED|Second Intervention||1
5200804|NCT01045967|12788557|P1|NOT COMPLETED|Second Intervention||0
5200805|NCT01045967|12788556|P2|COMPLETED|Second Intervention||27
5200806|NCT01045967|12788557|P1|COMPLETED|Second Intervention||28
5200807|NCT01045967|12788556|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
5200808|NCT01045967|12788557|P1|STARTED|Second Intervention||28
5200809|NCT01045967|12788556|P2|NOT COMPLETED|Washout of 7 Days||0
5200810|NCT01045967|12788557|P1|NOT COMPLETED|Washout of 7 Days||0
5200811|NCT01045967|12788556|P2|COMPLETED|Washout of 7 Days||28
5200812|NCT01045967|12788557|P1|COMPLETED|Washout of 7 Days||28
5200813|NCT01045967|12788556|P2|STARTED|Washout of 7 Days||28
5200814|NCT01045967|12788557|P1|STARTED|Washout of 7 Days||28
5200815|NCT01045967|12788556|P2|NOT COMPLETED|First Intervention||0
5200816|NCT01045967|12788557|P1|NOT COMPLETED|First Intervention||0
5200817|NCT01045967|12788556|P2|COMPLETED|First Intervention||28
5200818|NCT01045967|12788557|P1|COMPLETED|First Intervention||28
5200819|NCT01045967|12788556|P2|STARTED|First Intervention||28
5200820|NCT01045967|12788557|P1|STARTED|First Intervention||28
5200821|NCT01045798|12788569|P2|NOT COMPLETED|Overall Study||4
5200822|NCT01045798|12788570|P1|NOT COMPLETED|Overall Study||2
5200823|NCT01045798|12788569|P2|COMPLETED|Overall Study||5
5200824|NCT01045798|12788570|P1|COMPLETED|Overall Study||4
5200825|NCT01045798|12788569|P2|STARTED|Overall Study||9
5200826|NCT01045798|12788570|P1|STARTED|Overall Study||6
5200827|NCT01045707|12788578|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
5200828|NCT01045707|12788579|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
5200829|NCT01045707|12788578|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
5200830|NCT01045707|12788579|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
5200831|NCT01045707|12788578|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
5200832|NCT01045707|12788579|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
5200833|NCT01045707|12788578|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
5200834|NCT01045707|12788579|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
5200835|NCT01045707|12788578|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
5200836|NCT01045707|12788579|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
5200837|NCT01045707|12788578|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
5200838|NCT01045707|12788579|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
5200839|NCT01045707|12788578|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
5200840|NCT01045707|12788579|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
5200841|NCT01045694|12788595|P1|NOT COMPLETED|Overall Study||2
5200842|NCT01045694|12788595|P1|COMPLETED|Overall Study||6
5200843|NCT01045694|12788595|P1|STARTED|Overall Study||8
5200844|NCT01045551|12788601|P1|NOT COMPLETED|Overall Study||0
5200845|NCT01045551|12788601|P1|COMPLETED|Overall Study||10
5200846|NCT01045551|12788601|P1|STARTED|Overall Study||10
5200847|NCT01045499|12788609|P1|NOT COMPLETED|Overall Study||10
5200848|NCT01045499|12788609|P1|COMPLETED|Overall Study||127
5200849|NCT01045499|12788609|P1|STARTED|Overall Study||137
5200850|NCT01045460|12788616|P2|NOT COMPLETED|Overall Study||3
5200851|NCT01045460|12788617|P1|NOT COMPLETED|Overall Study||6
5200852|NCT01045460|12788616|P2|COMPLETED|Overall Study||15
5200853|NCT01045460|12788617|P1|COMPLETED|Overall Study||11
5200854|NCT01045460|12788616|P2|STARTED|Overall Study||18
5200855|NCT01045460|12788617|P1|STARTED|Overall Study||17
5200856|NCT01045447|12788629|P2|NOT COMPLETED|Overall Study||28
5200857|NCT01045447|12788630|P1|NOT COMPLETED|Overall Study||36
5200858|NCT01045447|12788629|P2|COMPLETED|Overall Study||205
5200859|NCT01045447|12788630|P1|COMPLETED|Overall Study||196
5200860|NCT01045447|12788629|P2|Exposed|Overall Study||233
5200861|NCT01045447|12788630|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
5200862|NCT01045447|12788629|P2|STARTED|Overall Study||233
5200863|NCT01045447|12788630|P1|STARTED|Overall Study||232
5200864|NCT01045421|12788644|P11|NOT COMPLETED|Phase 2||2
5200865|NCT01045421|12788645|P10|NOT COMPLETED|Phase 2||3
5200866|NCT01045421|12788646|P9|NOT COMPLETED|Phase 2||2
5200867|NCT01045421|12788647|P8|NOT COMPLETED|Phase 2||5
5200868|NCT01045421|12788648|P7|NOT COMPLETED|Phase 2||0
5200869|NCT01045421|12788649|P6|NOT COMPLETED|Phase 2||0
5200870|NCT01045421|12788650|P5|NOT COMPLETED|Phase 2||0
5200871|NCT01045421|12788651|P4|NOT COMPLETED|Phase 2||0
5200872|NCT01045421|12788652|P3|NOT COMPLETED|Phase 2||0
5200873|NCT01045421|12788653|P2|NOT COMPLETED|Phase 2||0
5200874|NCT01045421|12788654|P1|NOT COMPLETED|Phase 2||0
5200875|NCT01045421|12788644|P11|COMPLETED|Phase 2||58
5200876|NCT01045421|12788645|P10|COMPLETED|Phase 2||23
5200877|NCT01045421|12788646|P9|COMPLETED|Phase 2||53
5200878|NCT01045421|12788647|P8|COMPLETED|Phase 2||50
5200879|NCT01045421|12788648|P7|COMPLETED|Phase 2||53
5200880|NCT01045421|12788649|P6|COMPLETED|Phase 2||0
5200881|NCT01045421|12788650|P5|COMPLETED|Phase 2||0
5200882|NCT01045421|12788651|P4|COMPLETED|Phase 2||0
5200883|NCT01045421|12788652|P3|COMPLETED|Phase 2||0
5200884|NCT01045421|12788653|P2|COMPLETED|Phase 2||0
5200885|NCT01045421|12788654|P1|COMPLETED|Phase 2||0
5200886|NCT01045421|12788644|P11|STARTED|Phase 2||60
5200887|NCT01045421|12788645|P10|STARTED|Phase 2||26
5200888|NCT01045421|12788646|P9|STARTED|Phase 2||55
5200889|NCT01045421|12788647|P8|STARTED|Phase 2||55
5200890|NCT01045421|12788648|P7|STARTED|Phase 2||53
5200891|NCT01045421|12788649|P6|STARTED|Phase 2||0
5200892|NCT01045421|12788650|P5|STARTED|Phase 2||0
5200893|NCT01045421|12788651|P4|STARTED|Phase 2||0
5200894|NCT01045421|12788652|P3|STARTED|Phase 2||0
5200895|NCT01045421|12788653|P2|STARTED|Phase 2||0
5200896|NCT01045421|12788654|P1|STARTED|Phase 2||0
5200897|NCT01045421|12788644|P11|NOT COMPLETED|Phase 1||0
5200898|NCT01045421|12788645|P10|NOT COMPLETED|Phase 1||0
5200899|NCT01045421|12788646|P9|NOT COMPLETED|Phase 1||0
5200900|NCT01045421|12788647|P8|NOT COMPLETED|Phase 1||0
5200901|NCT01045421|12788648|P7|NOT COMPLETED|Phase 1||0
5200902|NCT01045421|12788649|P6|NOT COMPLETED|Phase 1||0
5200903|NCT01045421|12788650|P5|NOT COMPLETED|Phase 1||1
5200904|NCT01045421|12788651|P4|NOT COMPLETED|Phase 1||1
5200905|NCT01045421|12788652|P3|NOT COMPLETED|Phase 1||0
5200906|NCT01045421|12788653|P2|NOT COMPLETED|Phase 1||0
5200907|NCT01045421|12788654|P1|NOT COMPLETED|Phase 1||0
5200908|NCT01045421|12788644|P11|COMPLETED|Phase 1||0
5200909|NCT01045421|12788645|P10|COMPLETED|Phase 1||0
5200910|NCT01045421|12788646|P9|COMPLETED|Phase 1||0
5200911|NCT01045421|12788647|P8|COMPLETED|Phase 1||0
5200912|NCT01045421|12788648|P7|COMPLETED|Phase 1||0
5200913|NCT01045421|12788649|P6|COMPLETED|Phase 1||1
5200914|NCT01045421|12788650|P5|COMPLETED|Phase 1||2
5200915|NCT01045421|12788651|P4|COMPLETED|Phase 1||11
5200916|NCT01045421|12788652|P3|COMPLETED|Phase 1||4
5200917|NCT01045421|12788653|P2|COMPLETED|Phase 1||3
5200918|NCT01045421|12788654|P1|COMPLETED|Phase 1||1
5200919|NCT01045421|12788644|P11|STARTED|Phase 1||0
5200920|NCT01045421|12788645|P10|STARTED|Phase 1||0
5200921|NCT01045421|12788646|P9|STARTED|Phase 1||0
5200922|NCT01045421|12788647|P8|STARTED|Phase 1||0
5200923|NCT01045421|12788648|P7|STARTED|Phase 1||0
5200924|NCT01045421|12788649|P6|STARTED|Phase 1||1
5200925|NCT01045421|12788650|P5|STARTED|Phase 1||3
5200926|NCT01045421|12788651|P4|STARTED|Phase 1||12
5200927|NCT01045421|12788652|P3|STARTED|Phase 1||4
5200928|NCT01045421|12788653|P2|STARTED|Phase 1||3
5200929|NCT01045421|12788654|P1|STARTED|Phase 1||1
5200930|NCT01045265|12788734|P1|NOT COMPLETED|Overall Study||0
5200931|NCT01045265|12788734|P1|COMPLETED|Overall Study||16
5200932|NCT01045265|12788734|P1|STARTED|Overall Study||16
5200933|NCT01045187|12788741|P1|NOT COMPLETED|Overall Study||0
5200934|NCT01045187|12788741|P1|COMPLETED|Overall Study||15
5200935|NCT01045187|12788741|P1|STARTED|Overall Study||15
5200936|NCT01045161|12788748|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
5200937|NCT01045161|12788749|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
5200938|NCT01045161|12788750|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
5200939|NCT01045161|12788748|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
5200940|NCT01045161|12788749|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
5200941|NCT01045161|12788750|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
5200942|NCT01045161|12788748|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
5200943|NCT01045161|12788749|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
5200944|NCT01045161|12788750|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
5200945|NCT01045161|12788748|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
5200946|NCT01045161|12788749|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
5200947|NCT01045161|12788750|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
5200948|NCT01045161|12788748|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
5200949|NCT01045161|12788749|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
5200950|NCT01045161|12788750|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
5200951|NCT01045161|12788748|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
5200952|NCT01045161|12788749|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
5200953|NCT01045161|12788750|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
5200954|NCT01045135|12788770|P1|NOT COMPLETED|Overall Study||26
5200955|NCT01045135|12788770|P1|COMPLETED|Overall Study||274
5200956|NCT01045135|12788770|P1|STARTED|Overall Study||300
5200957|NCT01045122|12788777|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
5200958|NCT01045122|12788778|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
5200959|NCT01045122|12788777|P2|COMPLETED|Propofol Then Dexmedetomidine||6
5200960|NCT01045122|12788778|P1|COMPLETED|Propofol Then Dexmedetomidine||5
5200961|NCT01045122|12788777|P2|STARTED|Propofol Then Dexmedetomidine||6
5200962|NCT01045122|12788778|P1|STARTED|Propofol Then Dexmedetomidine||5
5200963|NCT01045122|12788777|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
5200964|NCT01045122|12788778|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
5200965|NCT01045122|12788777|P2|COMPLETED|Dexmedetomidine Then Propofol||6
5200966|NCT01045122|12788778|P1|COMPLETED|Dexmedetomidine Then Propofol||5
5200967|NCT01045122|12788777|P2|STARTED|Dexmedetomidine Then Propofol||6
5200968|NCT01045122|12788778|P1|STARTED|Dexmedetomidine Then Propofol||5
5200969|NCT01045096|12788787|P3|NOT COMPLETED|Overall Study||0
5200970|NCT01045096|12788788|P2|NOT COMPLETED|Overall Study||0
5200971|NCT01045096|12788789|P1|NOT COMPLETED|Overall Study||3
5200972|NCT01045096|12788787|P3|COMPLETED|Overall Study||12
5200973|NCT01045096|12788788|P2|COMPLETED|Overall Study||12
5200974|NCT01045096|12788789|P1|COMPLETED|Overall Study||9
5200975|NCT01045096|12788787|P3|Pharmacokinetic Set|Overall Study||11
5200976|NCT01045096|12788788|P2|Pharmacokinetic Set|Overall Study||11
5200977|NCT01045096|12788789|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
5200978|NCT01045096|12788787|P3|STARTED|Overall Study||12
5200979|NCT01045096|12788788|P2|STARTED|Overall Study||12
5200980|NCT01045096|12788789|P1|STARTED|Overall Study||12
5200981|NCT01045057|12788815|P1|NOT COMPLETED|Overall Study||0
5200982|NCT01045057|12788815|P1|COMPLETED|Overall Study||27
5200983|NCT01045057|12788815|P1|STARTED|Overall Study||27
5200984|NCT01045031|12788824|P2|NOT COMPLETED|Overall Study||6
5200985|NCT01045031|12788825|P1|NOT COMPLETED|Overall Study||9
5200986|NCT01045031|12788824|P2|COMPLETED|Overall Study||50
5200987|NCT01045031|12788825|P1|COMPLETED|Overall Study||49
5200988|NCT01045031|12788824|P2|STARTED|Overall Study||56
5200989|NCT01045031|12788825|P1|STARTED|Overall Study||58
5200990|NCT01044966|12788835|P1|NOT COMPLETED|Consolidation Phase||10
5200991|NCT01044966|12788835|P1|COMPLETED|Consolidation Phase||2
5200992|NCT01044966|12788835|P1|STARTED|Consolidation Phase||12
5200993|NCT01044966|12788835|P1|NOT COMPLETED|Induction Phase||0
5200994|NCT01044966|12788835|P1|COMPLETED|Induction Phase||12
5200995|NCT01044966|12788835|P1|STARTED|Induction Phase||12
5200996|NCT01044862|12788846|P3|NOT COMPLETED|Overall Study||52
5200997|NCT01044862|12788847|P2|NOT COMPLETED|Overall Study||49
5200998|NCT01044862|12788848|P1|NOT COMPLETED|Overall Study||53
5200999|NCT01044862|12788846|P3|COMPLETED|Overall Study||249
5201000|NCT01044862|12788847|P2|COMPLETED|Overall Study||251
5201001|NCT01044862|12788848|P1|COMPLETED|Overall Study||246
5201002|NCT01044862|12788846|P3|STARTED|Overall Study||301
5201003|NCT01044862|12788847|P2|STARTED|Overall Study||300
5201004|NCT01044862|12788848|P1|STARTED|Overall Study||299
5201005|NCT01044771|12788865|P1|NOT COMPLETED|Overall Study||0
5201006|NCT01044771|12788865|P1|COMPLETED|Overall Study||20
5201007|NCT01044771|12788865|P1|STARTED|Overall Study||20
5201008|NCT01044758|12788877|P7|NOT COMPLETED|Overall Study||10
5201009|NCT01044758|12788878|P6|NOT COMPLETED|Overall Study||3
5201010|NCT01044758|12788879|P5|NOT COMPLETED|Overall Study||2
5201011|NCT01044758|12788880|P4|NOT COMPLETED|Overall Study||2
5201012|NCT01044758|12788881|P3|NOT COMPLETED|Overall Study||4
5201013|NCT01044758|12788882|P2|NOT COMPLETED|Overall Study||0
5201014|NCT01044758|12788883|P1|NOT COMPLETED|Overall Study||4
5201015|NCT01044758|12788877|P7|COMPLETED|Overall Study||17
5201016|NCT01044758|12788878|P6|COMPLETED|Overall Study||8
5201017|NCT01044758|12788879|P5|COMPLETED|Overall Study||9
5201018|NCT01044758|12788880|P4|COMPLETED|Overall Study||10
5201019|NCT01044758|12788881|P3|COMPLETED|Overall Study||7
5201020|NCT01044758|12788882|P2|COMPLETED|Overall Study||12
5201021|NCT01044758|12788883|P1|COMPLETED|Overall Study||8
5201022|NCT01044758|12788877|P7|STARTED|Overall Study||27
5201023|NCT01044758|12788878|P6|STARTED|Overall Study||11
5201024|NCT01044758|12788879|P5|STARTED|Overall Study||11
5201025|NCT01044758|12788880|P4|STARTED|Overall Study||12
5201026|NCT01044758|12788881|P3|STARTED|Overall Study||11
5201027|NCT01044758|12788882|P2|STARTED|Overall Study||12
5201028|NCT01044758|12788883|P1|STARTED|Overall Study||12
5201029|NCT01044745|12788906|P1|NOT COMPLETED|Overall Study||2
5201030|NCT01044745|12788906|P1|COMPLETED|Overall Study||18
5201031|NCT01044745|12788906|P1|STARTED|Overall Study||20
5201032|NCT01044732|12788915|P2|NOT COMPLETED|Overall Study||50
5201033|NCT01044732|12788916|P1|NOT COMPLETED|Overall Study||49
5201034|NCT01044732|12788915|P2|COMPLETED|Overall Study||176
5201035|NCT01044732|12788916|P1|COMPLETED|Overall Study||173
5201036|NCT01044732|12788915|P2|STARTED|Overall Study||226
5201037|NCT01044732|12788916|P1|STARTED|Overall Study||222
5201038|NCT01044706|12788926|P2|NOT COMPLETED|Overall Study||0
5201039|NCT01044706|12788927|P1|NOT COMPLETED|Overall Study||0
5201040|NCT01044706|12788926|P2|COMPLETED|Overall Study||30
5201041|NCT01044706|12788927|P1|COMPLETED|Overall Study||30
5201042|NCT01044706|12788926|P2|STARTED|Overall Study||30
5201043|NCT01044706|12788927|P1|STARTED|Overall Study||30
5201044|NCT01044693|12788935|P16|NOT COMPLETED|Overall Study||0
5201045|NCT01044693|12788936|P15|NOT COMPLETED|Overall Study||0
5201046|NCT01044693|12788937|P14|NOT COMPLETED|Overall Study||0
5201047|NCT01044693|12788938|P13|NOT COMPLETED|Overall Study||0
5201048|NCT01044693|12788939|P12|NOT COMPLETED|Overall Study||0
5201049|NCT01044693|12788940|P11|NOT COMPLETED|Overall Study||0
5201050|NCT01044693|12788941|P10|NOT COMPLETED|Overall Study||0
5201051|NCT01044693|12788942|P9|NOT COMPLETED|Overall Study||0
5201052|NCT01044693|12788943|P8|NOT COMPLETED|Overall Study||0
5201053|NCT01044693|12788944|P7|NOT COMPLETED|Overall Study||0
5201054|NCT01044693|12788945|P6|NOT COMPLETED|Overall Study||0
5201055|NCT01044693|12788946|P5|NOT COMPLETED|Overall Study||0
5201056|NCT01044693|12788947|P4|NOT COMPLETED|Overall Study||0
5201057|NCT01044693|12788948|P3|NOT COMPLETED|Overall Study||0
5201058|NCT01044693|12788949|P2|NOT COMPLETED|Overall Study||0
5201059|NCT01044693|12788950|P1|NOT COMPLETED|Overall Study||0
5201060|NCT01044693|12788935|P16|COMPLETED|Overall Study||1
5201061|NCT01044693|12788936|P15|COMPLETED|Overall Study||1
5201062|NCT01044693|12788937|P14|COMPLETED|Overall Study||1
5201063|NCT01044693|12788938|P13|COMPLETED|Overall Study||2
5201064|NCT01044693|12788939|P12|COMPLETED|Overall Study||1
5201065|NCT01044693|12788940|P11|COMPLETED|Overall Study||1
5201066|NCT01044693|12788941|P10|COMPLETED|Overall Study||1
5201067|NCT01044693|12788942|P9|COMPLETED|Overall Study||1
5201068|NCT01044693|12788943|P8|COMPLETED|Overall Study||1
5201069|NCT01044693|12788944|P7|COMPLETED|Overall Study||1
5201070|NCT01044693|12788945|P6|COMPLETED|Overall Study||2
5201071|NCT01044693|12788946|P5|COMPLETED|Overall Study||1
5201072|NCT01044693|12788947|P4|COMPLETED|Overall Study||1
5201073|NCT01044693|12788948|P3|COMPLETED|Overall Study||1
5201074|NCT01044693|12788949|P2|COMPLETED|Overall Study||1
5201075|NCT01044693|12788950|P1|COMPLETED|Overall Study||3
5201076|NCT01044693|12788935|P16|STARTED|Overall Study||1
5201077|NCT01044693|12788936|P15|STARTED|Overall Study||1
5201078|NCT01044693|12788937|P14|STARTED|Overall Study||1
5201079|NCT01044693|12788938|P13|STARTED|Overall Study||2
5201080|NCT01044693|12788939|P12|STARTED|Overall Study||1
5201081|NCT01044693|12788940|P11|STARTED|Overall Study||1
5201082|NCT01044693|12788941|P10|STARTED|Overall Study||1
5201083|NCT01044693|12788942|P9|STARTED|Overall Study||1
5201084|NCT01044693|12788943|P8|STARTED|Overall Study||1
5201085|NCT01044693|12788944|P7|STARTED|Overall Study||1
5201086|NCT01044693|12788945|P6|STARTED|Overall Study||2
5201087|NCT01044693|12788946|P5|STARTED|Overall Study||1
5201088|NCT01044693|12788947|P4|STARTED|Overall Study||1
5201089|NCT01044693|12788948|P3|STARTED|Overall Study||1
5201090|NCT01044693|12788949|P2|STARTED|Overall Study||1
5201091|NCT01044693|12788950|P1|STARTED|Overall Study||3
5201092|NCT01044589|12788974|P2|NOT COMPLETED|Overall Study||5
5201093|NCT01044589|12788975|P1|NOT COMPLETED|Overall Study||3
5201094|NCT01044589|12788974|P2|COMPLETED|Overall Study||2
5201095|NCT01044589|12788975|P1|COMPLETED|Overall Study||3
5201096|NCT01044589|12788974|P2|STARTED|Overall Study||7
5201097|NCT01044589|12788975|P1|STARTED|Overall Study||6
5201098|NCT01044537|12788990|P7|NOT COMPLETED|Overall Study||0
5201099|NCT01044537|12788991|P6|NOT COMPLETED|Overall Study||0
5201100|NCT01044537|12788992|P5|NOT COMPLETED|Overall Study||0
5201101|NCT01044537|12788993|P4|NOT COMPLETED|Overall Study||0
5201102|NCT01044537|12788994|P3|NOT COMPLETED|Overall Study||0
5201103|NCT01044537|12788995|P2|NOT COMPLETED|Overall Study||0
5201104|NCT01044537|12788996|P1|NOT COMPLETED|Overall Study||0
5201105|NCT01044537|12788990|P7|COMPLETED|Overall Study||16
5201106|NCT01044537|12788991|P6|COMPLETED|Overall Study||5
5201107|NCT01044537|12788992|P5|COMPLETED|Overall Study||5
5201108|NCT01044537|12788993|P4|COMPLETED|Overall Study||6
5201109|NCT01044537|12788994|P3|COMPLETED|Overall Study||6
5201110|NCT01044537|12788995|P2|COMPLETED|Overall Study||6
5201111|NCT01044537|12788996|P1|COMPLETED|Overall Study||6
5201112|NCT01044537|12788990|P7|STARTED|Overall Study||16
5201113|NCT01044537|12788991|P6|STARTED|Overall Study||5
5201114|NCT01044537|12788992|P5|STARTED|Overall Study||5
5201115|NCT01044537|12788993|P4|STARTED|Overall Study||6
5201116|NCT01044537|12788994|P3|STARTED|Overall Study||6
5201117|NCT01044537|12788995|P2|STARTED|Overall Study||6
5201118|NCT01044537|12788996|P1|STARTED|Overall Study||6
5201119|NCT01044498|12789105|P2|NOT COMPLETED|Overall Study||2
5201120|NCT01044498|12789106|P1|NOT COMPLETED|Overall Study||3
5201121|NCT01044498|12789105|P2|COMPLETED|Overall Study||21
5201122|NCT01044498|12789106|P1|COMPLETED|Overall Study||20
5201123|NCT01044498|12789105|P2|STARTED|Overall Study||23
5201124|NCT01044498|12789106|P1|STARTED|Overall Study||23
5201125|NCT01044459|12789132|P2|NOT COMPLETED|Overall Study||131
5201126|NCT01044459|12789133|P1|NOT COMPLETED|Overall Study||133
5201127|NCT01044459|12789132|P2|COMPLETED|Overall Study||162
5201128|NCT01044459|12789133|P1|COMPLETED|Overall Study||179
5201129|NCT01044459|12789132|P2|STARTED|Overall Study||293
5201130|NCT01044459|12789133|P1|STARTED|Overall Study||312
5201131|NCT01044433|12789141|P1|NOT COMPLETED|Overall Study||6
5201132|NCT01044433|12789141|P1|COMPLETED|Overall Study||38
5201133|NCT01044433|12789141|P1|STARTED|Overall Study||44
5201134|NCT01044303|12789149|P1|NOT COMPLETED|Overall Study||2
5201135|NCT01044303|12789149|P1|COMPLETED|Overall Study||30
5201136|NCT01044303|12789149|P1|STARTED|Overall Study||32
5201137|NCT01044290|12789159|P3|NOT COMPLETED|Follow-Up 2||2
5201138|NCT01044290|12789160|P2|NOT COMPLETED|Follow-Up 2||2
5201139|NCT01044290|12789161|P1|NOT COMPLETED|Follow-Up 2||0
5201140|NCT01044290|12789159|P3|COMPLETED|Follow-Up 2||69
5201141|NCT01044290|12789160|P2|COMPLETED|Follow-Up 2||67
5201142|NCT01044290|12789161|P1|COMPLETED|Follow-Up 2||70
5201143|NCT01044290|12789159|P3|Completed F2 Interview|Follow-Up 2||64
5201144|NCT01044290|12789160|P2|Completed F2 Interview|Follow-Up 2||57
5201145|NCT01044290|12789161|P1|Completed F2 Interview|Follow-Up 2||64
5201146|NCT01044290|12789159|P3|STARTED|Follow-Up 2||71
5201147|NCT01044290|12789160|P2|STARTED|Follow-Up 2||69
5201148|NCT01044290|12789161|P1|STARTED|Follow-Up 2||70
5201149|NCT01044290|12789159|P3|NOT COMPLETED|Follow-up 1||1
5201150|NCT01044290|12789160|P2|NOT COMPLETED|Follow-up 1||5
5201151|NCT01044290|12789161|P1|NOT COMPLETED|Follow-up 1||5
5201152|NCT01044290|12789159|P3|COMPLETED|Follow-up 1||71
5201153|NCT01044290|12789160|P2|COMPLETED|Follow-up 1||69
5201154|NCT01044290|12789161|P1|COMPLETED|Follow-up 1||70
5201155|NCT01044290|12789159|P3|Completed F1 Interview|Follow-up 1||61
5201156|NCT01044290|12789160|P2|Completed F1 Interview|Follow-up 1||60
5201157|NCT01044290|12789161|P1|Completed F1 Interview|Follow-up 1||61
5201158|NCT01044290|12789159|P3|STARTED|Follow-up 1||72
5201159|NCT01044290|12789160|P2|STARTED|Follow-up 1||74
5201160|NCT01044290|12789161|P1|STARTED|Follow-up 1||75
5201161|NCT01044290|12789159|P3|NOT COMPLETED|Randomization||0
5201162|NCT01044290|12789160|P2|NOT COMPLETED|Randomization||0
5201163|NCT01044290|12789161|P1|NOT COMPLETED|Randomization||0
5201164|NCT01044290|12789159|P3|COMPLETED|Randomization||72
5201165|NCT01044290|12789160|P2|COMPLETED|Randomization||74
5201166|NCT01044290|12789161|P1|COMPLETED|Randomization||75
5201167|NCT01044290|12789159|P3|Randomized|Randomization||72
5201168|NCT01044290|12789160|P2|Randomized|Randomization||74
5201169|NCT01044290|12789161|P1|Randomized|Randomization||75
5201170|NCT01044290|12789159|P3|STARTED|Randomization||72
5201171|NCT01044290|12789160|P2|STARTED|Randomization||74
5201172|NCT01044290|12789161|P1|STARTED|Randomization||75
5201173|NCT01044264|12789187|P3|NOT COMPLETED|Overall Study||92
5201174|NCT01044264|12789188|P2|NOT COMPLETED|Overall Study||94
5201175|NCT01044264|12789189|P1|NOT COMPLETED|Overall Study||90
5201176|NCT01044264|12789187|P3|COMPLETED|Overall Study||108
5201177|NCT01044264|12789188|P2|COMPLETED|Overall Study||108
5201178|NCT01044264|12789189|P1|COMPLETED|Overall Study||110
5201179|NCT01044264|12789187|P3|STARTED|Overall Study||200
5201180|NCT01044264|12789188|P2|STARTED|Overall Study||202
5201181|NCT01044264|12789189|P1|STARTED|Overall Study||200
5201182|NCT01044212|12789199|P2|NOT COMPLETED|Overall Study||7
5201183|NCT01044212|12789200|P1|NOT COMPLETED|Overall Study||5
5201184|NCT01044212|12789199|P2|COMPLETED|Overall Study||30
5201185|NCT01044212|12789200|P1|COMPLETED|Overall Study||30
5201186|NCT01044212|12789199|P2|STARTED|Overall Study||37
5201187|NCT01044212|12789200|P1|STARTED|Overall Study||35
5201188|NCT01044056|12789213|P3|NOT COMPLETED|Overall Study||0
5201189|NCT01044056|12789214|P2|NOT COMPLETED|Overall Study||0
5201190|NCT01044056|12789215|P1|NOT COMPLETED|Overall Study||0
5201191|NCT01044056|12789213|P3|COMPLETED|Overall Study||8
5201192|NCT01044056|12789214|P2|COMPLETED|Overall Study||8
5201193|NCT01044056|12789215|P1|COMPLETED|Overall Study||8
5201194|NCT01044056|12789213|P3|STARTED|Overall Study||8
5201195|NCT01044056|12789214|P2|STARTED|Overall Study||8
5201196|NCT01044056|12789215|P1|STARTED|Overall Study||8
5201197|NCT01044030|12789234|P2|NOT COMPLETED|Overall Study||20
5201198|NCT01044030|12789235|P1|NOT COMPLETED|Overall Study||19
5201199|NCT01044030|12789234|P2|COMPLETED|Overall Study||146
5201200|NCT01044030|12789235|P1|COMPLETED|Overall Study||141
5201201|NCT01044030|12789234|P2|STARTED|Overall Study||166
5201202|NCT01044030|12789235|P1|STARTED|Overall Study||160
5201203|NCT01043939|12789249|P2|NOT COMPLETED|Second Intervention||0
5201204|NCT01043939|12789250|P1|NOT COMPLETED|Second Intervention||0
5201205|NCT01043939|12789249|P2|COMPLETED|Second Intervention||12
5201206|NCT01043939|12789250|P1|COMPLETED|Second Intervention||12
5201207|NCT01043939|12789249|P2|STARTED|Second Intervention||12
5201208|NCT01043939|12789250|P1|STARTED|Second Intervention||12
5201209|NCT01043939|12789249|P2|NOT COMPLETED|Washout Period||0
5201210|NCT01043939|12789250|P1|NOT COMPLETED|Washout Period||0
5201211|NCT01043939|12789249|P2|COMPLETED|Washout Period||12
5201212|NCT01043939|12789250|P1|COMPLETED|Washout Period||12
5201213|NCT01043939|12789249|P2|STARTED|Washout Period||12
5201214|NCT01043939|12789250|P1|STARTED|Washout Period||12
5201215|NCT01043939|12789249|P2|NOT COMPLETED|First Intervention||0
5201216|NCT01043939|12789250|P1|NOT COMPLETED|First Intervention||0
5201217|NCT01043939|12789249|P2|COMPLETED|First Intervention||12
5201218|NCT01043939|12789250|P1|COMPLETED|First Intervention||12
5201219|NCT01043939|12789249|P2|STARTED|First Intervention||12
5201220|NCT01043939|12789250|P1|STARTED|First Intervention||12
5201221|NCT01043926|12789264|P4|NOT COMPLETED|Overall Study||0
5201222|NCT01043926|12789265|P3|NOT COMPLETED|Overall Study||0
5201223|NCT01043926|12789266|P2|NOT COMPLETED|Overall Study||0
5201224|NCT01043926|12789267|P1|NOT COMPLETED|Overall Study||0
5201225|NCT01043926|12789264|P4|COMPLETED|Overall Study||0
5201226|NCT01043926|12789265|P3|COMPLETED|Overall Study||0
5201227|NCT01043926|12789266|P2|COMPLETED|Overall Study||8
5201228|NCT01043926|12789267|P1|COMPLETED|Overall Study||8
5201229|NCT01043926|12789264|P4|STARTED|Overall Study||0
5201230|NCT01043926|12789265|P3|STARTED|Overall Study||0
5201231|NCT01043926|12789266|P2|STARTED|Overall Study||8
5201232|NCT01043926|12789267|P1|STARTED|Overall Study||8
5201233|NCT01043874|12789281|P1|NOT COMPLETED|Overall Study||6
5201234|NCT01043874|12789281|P1|COMPLETED|Overall Study||39
5201235|NCT01043874|12789281|P1|STARTED|Overall Study||45
5201236|NCT01043705|12789291|P3|NOT COMPLETED|Overall Study||80
5201237|NCT01043705|12789292|P2|NOT COMPLETED|Overall Study||131
5201238|NCT01043705|12789293|P1|NOT COMPLETED|Overall Study||107
5201239|NCT01043705|12789291|P3|COMPLETED|Overall Study||498
5201240|NCT01043705|12789292|P2|COMPLETED|Overall Study||447
5201241|NCT01043705|12789293|P1|COMPLETED|Overall Study||352
5201242|NCT01043705|12789291|P3|STARTED|Overall Study||578
5201243|NCT01043705|12789292|P2|STARTED|Overall Study||578
5201244|NCT01043705|12789293|P1|STARTED|Overall Study||459
5201245|NCT01043653|12789303|P1|NOT COMPLETED|Overall Study||64
5201246|NCT01043653|12789303|P1|COMPLETED|Overall Study||186
5201247|NCT01043653|12789303|P1|STARTED|Overall Study||250
5201248|NCT01043640|12789308|P1|NOT COMPLETED|Overall Study||0
5201249|NCT01043640|12789308|P1|COMPLETED|Overall Study||46
5201250|NCT01043640|12789308|P1|STARTED|Overall Study||46
5201251|NCT01043562|12789323|P1|NOT COMPLETED|Overall Study||0
5201252|NCT01043562|12789323|P1|COMPLETED|Overall Study||20
5201253|NCT01043562|12789323|P1|STARTED|Overall Study||20
5201254|NCT01043523|12789330|P1|NOT COMPLETED|Overall Study||0
5201255|NCT01043523|12789330|P1|COMPLETED|Overall Study||52
5201256|NCT01043523|12789330|P1|Participants With Unenhanced Images|Overall Study||51
5201257|NCT01043523|12789330|P1|STARTED|Overall Study||52
5201258|NCT01043432|12789359|P4|NOT COMPLETED|Overall Study||0
5201259|NCT01043432|12789360|P3|NOT COMPLETED|Overall Study||0
5201260|NCT01043432|12789361|P2|NOT COMPLETED|Overall Study||0
5201261|NCT01043432|12789362|P1|NOT COMPLETED|Overall Study||0
5201262|NCT01043432|12789359|P4|COMPLETED|Overall Study||48
5201263|NCT01043432|12789360|P3|COMPLETED|Overall Study||12
5201264|NCT01043432|12789361|P2|COMPLETED|Overall Study||51
5201265|NCT01043432|12789362|P1|COMPLETED|Overall Study||22
5201266|NCT01043432|12789359|P4|STARTED|Overall Study||48
5201267|NCT01043432|12789360|P3|STARTED|Overall Study||12
5201268|NCT01043432|12789361|P2|STARTED|Overall Study||51
5201269|NCT01043432|12789362|P1|STARTED|Overall Study||22
5201270|NCT01043393|12789371|P2|NOT COMPLETED|Overall Study||0
5201271|NCT01043393|12789372|P1|NOT COMPLETED|Overall Study||0
5201272|NCT01043393|12789371|P2|COMPLETED|Overall Study||12
5201273|NCT01043393|12789372|P1|COMPLETED|Overall Study||12
5201274|NCT01043393|12789371|P2|STARTED|Overall Study||12
5201275|NCT01043393|12789372|P1|STARTED|Overall Study||12
5201276|NCT01043185|12789382|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201277|NCT01043185|12789383|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201278|NCT01043185|12789384|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201279|NCT01043185|12789385|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201280|NCT01043185|12789386|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201281|NCT01043185|12789387|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201282|NCT01043185|12789388|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201283|NCT01043185|12789389|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201284|NCT01043185|12789390|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201285|NCT01043185|12789391|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
5201286|NCT01043185|12789382|P10|COMPLETED|Period 7 - Fourth Intervention||3
5201287|NCT01043185|12789383|P9|COMPLETED|Period 7 - Fourth Intervention||2
5201288|NCT01043185|12789384|P8|COMPLETED|Period 7 - Fourth Intervention||3
5201289|NCT01043185|12789385|P7|COMPLETED|Period 7 - Fourth Intervention||3
5201290|NCT01043185|12789386|P6|COMPLETED|Period 7 - Fourth Intervention||3
5201291|NCT01043185|12789387|P5|COMPLETED|Period 7 - Fourth Intervention||2
5201292|NCT01043185|12789388|P4|COMPLETED|Period 7 - Fourth Intervention||2
5201293|NCT01043185|12789389|P3|COMPLETED|Period 7 - Fourth Intervention||3
5201294|NCT01043185|12789390|P2|COMPLETED|Period 7 - Fourth Intervention||2
5201295|NCT01043185|12789391|P1|COMPLETED|Period 7 - Fourth Intervention||3
5201296|NCT01043185|12789382|P10|STARTED|Period 7 - Fourth Intervention||3
5201297|NCT01043185|12789383|P9|STARTED|Period 7 - Fourth Intervention||2
5201298|NCT01043185|12789384|P8|STARTED|Period 7 - Fourth Intervention||3
5201299|NCT01043185|12789385|P7|STARTED|Period 7 - Fourth Intervention||3
5201300|NCT01043185|12789386|P6|STARTED|Period 7 - Fourth Intervention||3
5201301|NCT01043185|12789387|P5|STARTED|Period 7 - Fourth Intervention||2
5201302|NCT01043185|12789388|P4|STARTED|Period 7 - Fourth Intervention||2
5201303|NCT01043185|12789389|P3|STARTED|Period 7 - Fourth Intervention||3
5201304|NCT01043185|12789390|P2|STARTED|Period 7 - Fourth Intervention||2
5201305|NCT01043185|12789391|P1|STARTED|Period 7 - Fourth Intervention||3
5201306|NCT01043185|12789382|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
5201307|NCT01043185|12789383|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
5201308|NCT01043185|12789384|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
5201309|NCT01043185|12789385|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
5201310|NCT01043185|12789386|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
5201311|NCT01043185|12789387|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
5201312|NCT01043185|12789388|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
5201313|NCT01043185|12789389|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
5201314|NCT01043185|12789390|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
5201315|NCT01043185|12789391|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
5201316|NCT01043185|12789382|P10|COMPLETED|Period 6 - Third Washout Period||3
5201317|NCT01043185|12789383|P9|COMPLETED|Period 6 - Third Washout Period||2
5201318|NCT01043185|12789384|P8|COMPLETED|Period 6 - Third Washout Period||3
5201319|NCT01043185|12789385|P7|COMPLETED|Period 6 - Third Washout Period||3
5201320|NCT01043185|12789386|P6|COMPLETED|Period 6 - Third Washout Period||3
5201321|NCT01043185|12789387|P5|COMPLETED|Period 6 - Third Washout Period||2
5201322|NCT01043185|12789388|P4|COMPLETED|Period 6 - Third Washout Period||2
5201323|NCT01043185|12789389|P3|COMPLETED|Period 6 - Third Washout Period||3
5201324|NCT01043185|12789390|P2|COMPLETED|Period 6 - Third Washout Period||2
5201325|NCT01043185|12789391|P1|COMPLETED|Period 6 - Third Washout Period||3
5201326|NCT01043185|12789382|P10|STARTED|Period 6 - Third Washout Period||3
5201327|NCT01043185|12789383|P9|STARTED|Period 6 - Third Washout Period||3
5201328|NCT01043185|12789384|P8|STARTED|Period 6 - Third Washout Period||3
5201329|NCT01043185|12789385|P7|STARTED|Period 6 - Third Washout Period||3
5201330|NCT01043185|12789386|P6|STARTED|Period 6 - Third Washout Period||3
5201331|NCT01043185|12789387|P5|STARTED|Period 6 - Third Washout Period||2
5201332|NCT01043185|12789388|P4|STARTED|Period 6 - Third Washout Period||2
5201333|NCT01043185|12789389|P3|STARTED|Period 6 - Third Washout Period||3
5201334|NCT01043185|12789390|P2|STARTED|Period 6 - Third Washout Period||2
5201335|NCT01043185|12789391|P1|STARTED|Period 6 - Third Washout Period||3
5201336|NCT01043185|12789382|P10|NOT COMPLETED|Period 5 - Third Intervention||0
5201337|NCT01043185|12789383|P9|NOT COMPLETED|Period 5 - Third Intervention||0
5201338|NCT01043185|12789384|P8|NOT COMPLETED|Period 5 - Third Intervention||0
5201339|NCT01043185|12789385|P7|NOT COMPLETED|Period 5 - Third Intervention||0
5201340|NCT01043185|12789386|P6|NOT COMPLETED|Period 5 - Third Intervention||0
5201341|NCT01043185|12789387|P5|NOT COMPLETED|Period 5 - Third Intervention||0
5201342|NCT01043185|12789388|P4|NOT COMPLETED|Period 5 - Third Intervention||0
5201343|NCT01043185|12789389|P3|NOT COMPLETED|Period 5 - Third Intervention||0
5201344|NCT01043185|12789390|P2|NOT COMPLETED|Period 5 - Third Intervention||0
5201345|NCT01043185|12789391|P1|NOT COMPLETED|Period 5 - Third Intervention||0
5201346|NCT01043185|12789382|P10|COMPLETED|Period 5 - Third Intervention||3
5201347|NCT01043185|12789383|P9|COMPLETED|Period 5 - Third Intervention||3
5201348|NCT01043185|12789384|P8|COMPLETED|Period 5 - Third Intervention||3
5201349|NCT01043185|12789385|P7|COMPLETED|Period 5 - Third Intervention||3
5201350|NCT01043185|12789386|P6|COMPLETED|Period 5 - Third Intervention||3
5201351|NCT01043185|12789387|P5|COMPLETED|Period 5 - Third Intervention||2
5201352|NCT01043185|12789388|P4|COMPLETED|Period 5 - Third Intervention||2
5201353|NCT01043185|12789389|P3|COMPLETED|Period 5 - Third Intervention||3
5201354|NCT01043185|12789390|P2|COMPLETED|Period 5 - Third Intervention||2
5201355|NCT01043185|12789391|P1|COMPLETED|Period 5 - Third Intervention||3
5201356|NCT01043185|12789382|P10|STARTED|Period 5 - Third Intervention||3
5201357|NCT01043185|12789383|P9|STARTED|Period 5 - Third Intervention||3
5201358|NCT01043185|12789384|P8|STARTED|Period 5 - Third Intervention||3
5201359|NCT01043185|12789385|P7|STARTED|Period 5 - Third Intervention||3
5201360|NCT01043185|12789386|P6|STARTED|Period 5 - Third Intervention||3
5201361|NCT01043185|12789387|P5|STARTED|Period 5 - Third Intervention||2
5201362|NCT01043185|12789388|P4|STARTED|Period 5 - Third Intervention||2
5201363|NCT01043185|12789389|P3|STARTED|Period 5 - Third Intervention||3
5201364|NCT01043185|12789390|P2|STARTED|Period 5 - Third Intervention||2
5201365|NCT01043185|12789391|P1|STARTED|Period 5 - Third Intervention||3
5201366|NCT01043185|12789382|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
5201367|NCT01043185|12789383|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
5201368|NCT01043185|12789384|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
5201369|NCT01043185|12789385|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
5201370|NCT01043185|12789386|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
5201371|NCT01043185|12789387|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
5201372|NCT01043185|12789388|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
5201373|NCT01043185|12789389|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
5201374|NCT01043185|12789390|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
5201375|NCT01043185|12789391|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
5201376|NCT01043185|12789382|P10|COMPLETED|Period 4 - Second Washout Period||3
5201377|NCT01043185|12789383|P9|COMPLETED|Period 4 - Second Washout Period||3
5201378|NCT01043185|12789384|P8|COMPLETED|Period 4 - Second Washout Period||3
5201379|NCT01043185|12789385|P7|COMPLETED|Period 4 - Second Washout Period||3
5201380|NCT01043185|12789386|P6|COMPLETED|Period 4 - Second Washout Period||3
5201381|NCT01043185|12789387|P5|COMPLETED|Period 4 - Second Washout Period||2
5201382|NCT01043185|12789388|P4|COMPLETED|Period 4 - Second Washout Period||2
5201383|NCT01043185|12789389|P3|COMPLETED|Period 4 - Second Washout Period||3
5201384|NCT01043185|12789390|P2|COMPLETED|Period 4 - Second Washout Period||2
5201385|NCT01043185|12789391|P1|COMPLETED|Period 4 - Second Washout Period||3
5201386|NCT01043185|12789382|P10|STARTED|Period 4 - Second Washout Period||3
5201387|NCT01043185|12789383|P9|STARTED|Period 4 - Second Washout Period||3
5201388|NCT01043185|12789384|P8|STARTED|Period 4 - Second Washout Period||3
5201389|NCT01043185|12789385|P7|STARTED|Period 4 - Second Washout Period||3
5201390|NCT01043185|12789386|P6|STARTED|Period 4 - Second Washout Period||3
5201391|NCT01043185|12789387|P5|STARTED|Period 4 - Second Washout Period||2
5201392|NCT01043185|12789388|P4|STARTED|Period 4 - Second Washout Period||2
5201393|NCT01043185|12789389|P3|STARTED|Period 4 - Second Washout Period||3
5201394|NCT01043185|12789390|P2|STARTED|Period 4 - Second Washout Period||2
5201395|NCT01043185|12789391|P1|STARTED|Period 4 - Second Washout Period||3
5201396|NCT01043185|12789382|P10|NOT COMPLETED|Period 3 - Second Intervention||0
5201397|NCT01043185|12789383|P9|NOT COMPLETED|Period 3 - Second Intervention||0
5201398|NCT01043185|12789384|P8|NOT COMPLETED|Period 3 - Second Intervention||0
5201399|NCT01043185|12789385|P7|NOT COMPLETED|Period 3 - Second Intervention||0
5201400|NCT01043185|12789386|P6|NOT COMPLETED|Period 3 - Second Intervention||0
5201401|NCT01043185|12789387|P5|NOT COMPLETED|Period 3 - Second Intervention||0
5201402|NCT01043185|12789388|P4|NOT COMPLETED|Period 3 - Second Intervention||0
5201403|NCT01043185|12789389|P3|NOT COMPLETED|Period 3 - Second Intervention||0
5201404|NCT01043185|12789390|P2|NOT COMPLETED|Period 3 - Second Intervention||0
5201405|NCT01043185|12789391|P1|NOT COMPLETED|Period 3 - Second Intervention||0
5201406|NCT01043185|12789382|P10|COMPLETED|Period 3 - Second Intervention||3
5201407|NCT01043185|12789383|P9|COMPLETED|Period 3 - Second Intervention||3
5201408|NCT01043185|12789384|P8|COMPLETED|Period 3 - Second Intervention||3
5201409|NCT01043185|12789385|P7|COMPLETED|Period 3 - Second Intervention||3
5201410|NCT01043185|12789386|P6|COMPLETED|Period 3 - Second Intervention||3
5201411|NCT01043185|12789387|P5|COMPLETED|Period 3 - Second Intervention||2
5201412|NCT01043185|12789388|P4|COMPLETED|Period 3 - Second Intervention||2
5201413|NCT01043185|12789389|P3|COMPLETED|Period 3 - Second Intervention||3
5201414|NCT01043185|12789390|P2|COMPLETED|Period 3 - Second Intervention||2
5201415|NCT01043185|12789391|P1|COMPLETED|Period 3 - Second Intervention||3
5201416|NCT01043185|12789382|P10|STARTED|Period 3 - Second Intervention||3
5201417|NCT01043185|12789383|P9|STARTED|Period 3 - Second Intervention||3
5201418|NCT01043185|12789384|P8|STARTED|Period 3 - Second Intervention||3
5201419|NCT01043185|12789385|P7|STARTED|Period 3 - Second Intervention||3
5201420|NCT01043185|12789386|P6|STARTED|Period 3 - Second Intervention||3
5201421|NCT01043185|12789387|P5|STARTED|Period 3 - Second Intervention||2
5201422|NCT01043185|12789388|P4|STARTED|Period 3 - Second Intervention||2
5201423|NCT01043185|12789389|P3|STARTED|Period 3 - Second Intervention||3
5201424|NCT01043185|12789390|P2|STARTED|Period 3 - Second Intervention||2
5201425|NCT01043185|12789391|P1|STARTED|Period 3 - Second Intervention||3
5201426|NCT01043185|12789382|P10|NOT COMPLETED|Period 2 - First Washout Period||0
5201427|NCT01043185|12789383|P9|NOT COMPLETED|Period 2 - First Washout Period||0
5201428|NCT01043185|12789384|P8|NOT COMPLETED|Period 2 - First Washout Period||0
5201429|NCT01043185|12789385|P7|NOT COMPLETED|Period 2 - First Washout Period||0
5201430|NCT01043185|12789386|P6|NOT COMPLETED|Period 2 - First Washout Period||0
5201431|NCT01043185|12789387|P5|NOT COMPLETED|Period 2 - First Washout Period||0
5201432|NCT01043185|12789388|P4|NOT COMPLETED|Period 2 - First Washout Period||0
5201433|NCT01043185|12789389|P3|NOT COMPLETED|Period 2 - First Washout Period||0
5201434|NCT01043185|12789390|P2|NOT COMPLETED|Period 2 - First Washout Period||0
5201435|NCT01043185|12789391|P1|NOT COMPLETED|Period 2 - First Washout Period||0
5201436|NCT01043185|12789382|P10|COMPLETED|Period 2 - First Washout Period||3
5201437|NCT01043185|12789383|P9|COMPLETED|Period 2 - First Washout Period||3
5201438|NCT01043185|12789384|P8|COMPLETED|Period 2 - First Washout Period||3
5201439|NCT01043185|12789385|P7|COMPLETED|Period 2 - First Washout Period||3
5201440|NCT01043185|12789386|P6|COMPLETED|Period 2 - First Washout Period||3
5201441|NCT01043185|12789387|P5|COMPLETED|Period 2 - First Washout Period||2
5201442|NCT01043185|12789388|P4|COMPLETED|Period 2 - First Washout Period||2
5201443|NCT01043185|12789389|P3|COMPLETED|Period 2 - First Washout Period||3
5201444|NCT01043185|12789390|P2|COMPLETED|Period 2 - First Washout Period||2
5201445|NCT01043185|12789391|P1|COMPLETED|Period 2 - First Washout Period||3
5201446|NCT01043185|12789382|P10|STARTED|Period 2 - First Washout Period||3
5201447|NCT01043185|12789383|P9|STARTED|Period 2 - First Washout Period||3
5201448|NCT01043185|12789384|P8|STARTED|Period 2 - First Washout Period||3
5201449|NCT01043185|12789385|P7|STARTED|Period 2 - First Washout Period||3
5201450|NCT01043185|12789386|P6|STARTED|Period 2 - First Washout Period||3
5201451|NCT01043185|12789387|P5|STARTED|Period 2 - First Washout Period||2
5201452|NCT01043185|12789388|P4|STARTED|Period 2 - First Washout Period||2
5201453|NCT01043185|12789389|P3|STARTED|Period 2 - First Washout Period||3
5201454|NCT01043185|12789390|P2|STARTED|Period 2 - First Washout Period||2
5201455|NCT01043185|12789391|P1|STARTED|Period 2 - First Washout Period||3
5201456|NCT01043185|12789382|P10|NOT COMPLETED|Period 1 - First Intervention||0
5201457|NCT01043185|12789383|P9|NOT COMPLETED|Period 1 - First Intervention||0
5201458|NCT01043185|12789384|P8|NOT COMPLETED|Period 1 - First Intervention||0
5201459|NCT01043185|12789385|P7|NOT COMPLETED|Period 1 - First Intervention||0
5201460|NCT01043185|12789386|P6|NOT COMPLETED|Period 1 - First Intervention||0
5201461|NCT01043185|12789387|P5|NOT COMPLETED|Period 1 - First Intervention||0
5201462|NCT01043185|12789388|P4|NOT COMPLETED|Period 1 - First Intervention||0
5201463|NCT01043185|12789389|P3|NOT COMPLETED|Period 1 - First Intervention||0
5201464|NCT01043185|12789390|P2|NOT COMPLETED|Period 1 - First Intervention||0
5201465|NCT01043185|12789391|P1|NOT COMPLETED|Period 1 - First Intervention||0
5201466|NCT01043185|12789382|P10|COMPLETED|Period 1 - First Intervention||3
5201467|NCT01043185|12789383|P9|COMPLETED|Period 1 - First Intervention||3
5201468|NCT01043185|12789384|P8|COMPLETED|Period 1 - First Intervention||3
5201469|NCT01043185|12789385|P7|COMPLETED|Period 1 - First Intervention||3
5201470|NCT01043185|12789386|P6|COMPLETED|Period 1 - First Intervention||3
5201471|NCT01043185|12789387|P5|COMPLETED|Period 1 - First Intervention||2
5201472|NCT01043185|12789388|P4|COMPLETED|Period 1 - First Intervention||2
5201473|NCT01043185|12789389|P3|COMPLETED|Period 1 - First Intervention||3
5201474|NCT01043185|12789390|P2|COMPLETED|Period 1 - First Intervention||2
5201475|NCT01043185|12789391|P1|COMPLETED|Period 1 - First Intervention||3
5201476|NCT01043185|12789382|P10|STARTED|Period 1 - First Intervention||3
5201477|NCT01043185|12789383|P9|STARTED|Period 1 - First Intervention||3
5201478|NCT01043185|12789384|P8|STARTED|Period 1 - First Intervention||3
5201479|NCT01043185|12789385|P7|STARTED|Period 1 - First Intervention||3
5201480|NCT01043185|12789386|P6|STARTED|Period 1 - First Intervention||3
5201481|NCT01043185|12789387|P5|STARTED|Period 1 - First Intervention||2
5201482|NCT01043185|12789388|P4|STARTED|Period 1 - First Intervention||2
5201483|NCT01043185|12789389|P3|STARTED|Period 1 - First Intervention||3
5201484|NCT01043185|12789390|P2|STARTED|Period 1 - First Intervention||2
5201485|NCT01043185|12789391|P1|STARTED|Period 1 - First Intervention||3
5201486|NCT01043146|12789424|P6|NOT COMPLETED|Overall Study||0
5201487|NCT01043146|12789425|P5|NOT COMPLETED|Overall Study||0
5201488|NCT01043146|12789426|P4|NOT COMPLETED|Overall Study||0
5201489|NCT01043146|12789427|P3|NOT COMPLETED|Overall Study||0
5201490|NCT01043146|12789428|P2|NOT COMPLETED|Overall Study||0
5201491|NCT01043146|12789429|P1|NOT COMPLETED|Overall Study||0
5201492|NCT01043146|12789424|P6|COMPLETED|Overall Study||8
5201493|NCT01043146|12789425|P5|COMPLETED|Overall Study||8
5201494|NCT01043146|12789426|P4|COMPLETED|Overall Study||8
5201495|NCT01043146|12789427|P3|COMPLETED|Overall Study||8
5201496|NCT01043146|12789428|P2|COMPLETED|Overall Study||8
5201497|NCT01043146|12789429|P1|COMPLETED|Overall Study||10
5201498|NCT01043146|12789424|P6|STARTED|Overall Study||8
5201499|NCT01043146|12789425|P5|STARTED|Overall Study||8
5201500|NCT01043146|12789426|P4|STARTED|Overall Study||8
5201501|NCT01043146|12789427|P3|STARTED|Overall Study||8
5201502|NCT01043146|12789428|P2|STARTED|Overall Study||8
5201503|NCT01043146|12789429|P1|STARTED|Overall Study||10
5201504|NCT01043133|12789445|P2|NOT COMPLETED|Overall Study||2
5201505|NCT01043133|12789446|P1|NOT COMPLETED|Overall Study||1
5201506|NCT01043133|12789445|P2|COMPLETED|Overall Study||78
5201507|NCT01043133|12789446|P1|COMPLETED|Overall Study||74
5201508|NCT01043133|12789445|P2|STARTED|Overall Study||80
5201509|NCT01043133|12789446|P1|STARTED|Overall Study||75
5201510|NCT01043094|12789456|P2|NOT COMPLETED|Overall Study||0
5201511|NCT01043094|12789457|P1|NOT COMPLETED|Overall Study||0
5201512|NCT01043094|12789456|P2|COMPLETED|Overall Study||8
5201513|NCT01043094|12789457|P1|COMPLETED|Overall Study||8
5201514|NCT01043094|12789456|P2|STARTED|Overall Study||8
5201515|NCT01043094|12789457|P1|STARTED|Overall Study||8
5201516|NCT01042977|12789467|P2|NOT COMPLETED|Overall Study||55
5201517|NCT01042977|12789468|P1|NOT COMPLETED|Overall Study||41
5201518|NCT01042977|12789467|P2|COMPLETED|Overall Study||428
5201519|NCT01042977|12789468|P1|COMPLETED|Overall Study||441
5201520|NCT01042977|12789467|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
5201521|NCT01042977|12789468|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
5201522|NCT01042938|12789488|P2|NOT COMPLETED|Overall Study||2
5201523|NCT01042938|12789489|P1|NOT COMPLETED|Overall Study||3
5201524|NCT01042938|12789488|P2|COMPLETED|Overall Study||16
5201525|NCT01042938|12789489|P1|COMPLETED|Overall Study||14
5201526|NCT01042938|12789488|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
5201527|NCT01042938|12789489|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
5201528|NCT01042795|12789501|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
5201529|NCT01042795|12789501|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
5201530|NCT01042795|12789501|P1|STARTED|Follow up - 22 Months After Drug Start||2
5201531|NCT01042795|12789501|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
5201532|NCT01042795|12789501|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
5201533|NCT01042795|12789501|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
5201534|NCT01042678|12789508|P6|NOT COMPLETED|Overall Study||0
5201535|NCT01042678|12789509|P5|NOT COMPLETED|Overall Study||0
5201536|NCT01042678|12789510|P4|NOT COMPLETED|Overall Study||0
5201537|NCT01042678|12789511|P3|NOT COMPLETED|Overall Study||0
5201538|NCT01042678|12789512|P2|NOT COMPLETED|Overall Study||0
5201539|NCT01042678|12789513|P1|NOT COMPLETED|Overall Study||1
5201540|NCT01042678|12789508|P6|COMPLETED|Overall Study||0
5201541|NCT01042678|12789509|P5|COMPLETED|Overall Study||0
5201542|NCT01042678|12789510|P4|COMPLETED|Overall Study||0
5201543|NCT01042678|12789511|P3|COMPLETED|Overall Study||6
5201544|NCT01042678|12789512|P2|COMPLETED|Overall Study||6
5201545|NCT01042678|12789513|P1|COMPLETED|Overall Study||5
5201546|NCT01042678|12789508|P6|STARTED|Overall Study||0
5201547|NCT01042678|12789509|P5|STARTED|Overall Study||0
5201548|NCT01042678|12789510|P4|STARTED|Overall Study||0
5201549|NCT01042678|12789511|P3|STARTED|Overall Study||6
5201550|NCT01042678|12789512|P2|STARTED|Overall Study||6
5201551|NCT01042678|12789513|P1|STARTED|Overall Study||6
5201552|NCT01042613|12789538|P2|NOT COMPLETED|Overall Study||0
5201553|NCT01042613|12789539|P1|NOT COMPLETED|Overall Study||0
5201554|NCT01042613|12789538|P2|COMPLETED|Overall Study||74
5201555|NCT01042613|12789539|P1|COMPLETED|Overall Study||72
5201556|NCT01042613|12789538|P2|STARTED|Overall Study||74
5201557|NCT01042613|12789539|P1|STARTED|Overall Study||72
5201558|NCT01042600|12789551|P2|NOT COMPLETED|Overall Study||0
5201559|NCT01042600|12789552|P1|NOT COMPLETED|Overall Study||1
5201560|NCT01042600|12789551|P2|COMPLETED|Overall Study||30
5201561|NCT01042600|12789552|P1|COMPLETED|Overall Study||30
5201562|NCT01042600|12789551|P2|STARTED|Overall Study||30
5201563|NCT01042600|12789552|P1|STARTED|Overall Study||31
5201564|NCT01042535|12789572|P1|NOT COMPLETED|Overall Study||8
5201565|NCT01042535|12789572|P1|COMPLETED|Overall Study||36
5201566|NCT01042535|12789572|P1|STARTED|Overall Study||44
5201567|NCT01042509|12789580|P1|NOT COMPLETED|Overall Study||0
5201568|NCT01042509|12789580|P1|COMPLETED|Overall Study||15
5201569|NCT01042509|12789580|P1|STARTED|Overall Study||15
5201570|NCT01042496|12789587|P2|NOT COMPLETED|Overall Study||0
5201571|NCT01042496|12789588|P1|NOT COMPLETED|Overall Study||0
5201572|NCT01042496|12789587|P2|COMPLETED|Overall Study||33
5201573|NCT01042496|12789588|P1|COMPLETED|Overall Study||29
5201574|NCT01042496|12789587|P2|STARTED|Overall Study||33
5201575|NCT01042496|12789588|P1|STARTED|Overall Study||29
5201576|NCT01042392|12789606|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
5201577|NCT01042392|12789607|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
5201578|NCT01042392|12789608|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
5201579|NCT01042392|12789609|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
5201580|NCT01042392|12789606|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
5201581|NCT01042392|12789607|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
5201582|NCT01042392|12789608|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
5201583|NCT01042392|12789609|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
5201584|NCT01042392|12789606|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
5201585|NCT01042392|12789607|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
5201586|NCT01042392|12789608|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
5201587|NCT01042392|12789609|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
5201588|NCT01042392|12789606|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
5201589|NCT01042392|12789607|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
5201590|NCT01042392|12789608|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
5201591|NCT01042392|12789609|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
5201592|NCT01042392|12789606|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
5201593|NCT01042392|12789607|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
5201594|NCT01042392|12789608|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
5201595|NCT01042392|12789609|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
5201596|NCT01042392|12789606|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
5201597|NCT01042392|12789607|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
5201598|NCT01042392|12789608|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
5201599|NCT01042392|12789609|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
5201600|NCT01042392|12789606|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
5201601|NCT01042392|12789607|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
5201602|NCT01042392|12789608|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
5201603|NCT01042392|12789609|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
5201604|NCT01042392|12789606|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
5201605|NCT01042392|12789607|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
5201606|NCT01042392|12789608|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
5201607|NCT01042392|12789609|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
5201608|NCT01042366|12789638|P3|NOT COMPLETED|Overall Study||0
5201609|NCT01042366|12789639|P2|NOT COMPLETED|Overall Study||0
5201610|NCT01042366|12789640|P1|NOT COMPLETED|Overall Study||0
5201611|NCT01042366|12789638|P3|COMPLETED|Overall Study||4
5201612|NCT01042366|12789639|P2|COMPLETED|Overall Study||6
5201613|NCT01042366|12789640|P1|COMPLETED|Overall Study||5
5201614|NCT01042366|12789638|P3|STARTED|Overall Study||4
5201615|NCT01042366|12789639|P2|STARTED|Overall Study||6
5201616|NCT01042366|12789640|P1|STARTED|Overall Study||5
5201617|NCT01042288|12789649|P1|NOT COMPLETED|Overall Study||69
5201618|NCT01042288|12789649|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
5201619|NCT01042288|12789649|P1|Maintenance|Overall Study||27
5201620|NCT01042288|12789649|P1|STARTED|Overall Study||69
5201621|NCT01042236|12789657|P6|NOT COMPLETED|Treatment Period 3||0
5201622|NCT01042236|12789658|P5|NOT COMPLETED|Treatment Period 3||0
5201623|NCT01042236|12789659|P4|NOT COMPLETED|Treatment Period 3||2
5201624|NCT01042236|12789660|P3|NOT COMPLETED|Treatment Period 3||0
5201625|NCT01042236|12789661|P2|NOT COMPLETED|Treatment Period 3||0
5201626|NCT01042236|12789662|P1|NOT COMPLETED|Treatment Period 3||0
5201627|NCT01042236|12789657|P6|COMPLETED|Treatment Period 3||3
5201628|NCT01042236|12789658|P5|COMPLETED|Treatment Period 3||3
5201629|NCT01042236|12789659|P4|COMPLETED|Treatment Period 3||3
5201630|NCT01042236|12789660|P3|COMPLETED|Treatment Period 3||3
5201631|NCT01042236|12789661|P2|COMPLETED|Treatment Period 3||3
5201632|NCT01042236|12789662|P1|COMPLETED|Treatment Period 3||3
5201633|NCT01042236|12789657|P6|STARTED|Treatment Period 3||3
5201634|NCT01042236|12789658|P5|STARTED|Treatment Period 3||3
5201635|NCT01042236|12789659|P4|STARTED|Treatment Period 3||5
5201636|NCT01042236|12789660|P3|STARTED|Treatment Period 3||3
5201637|NCT01042236|12789661|P2|STARTED|Treatment Period 3||3
5201638|NCT01042236|12789662|P1|STARTED|Treatment Period 3||3
5201639|NCT01042236|12789657|P6|NOT COMPLETED|Treatment Period 2||0
5201640|NCT01042236|12789658|P5|NOT COMPLETED|Treatment Period 2||0
5201641|NCT01042236|12789659|P4|NOT COMPLETED|Treatment Period 2||0
5201642|NCT01042236|12789660|P3|NOT COMPLETED|Treatment Period 2||0
5201643|NCT01042236|12789661|P2|NOT COMPLETED|Treatment Period 2||0
5201644|NCT01042236|12789662|P1|NOT COMPLETED|Treatment Period 2||0
5201645|NCT01042236|12789657|P6|COMPLETED|Treatment Period 2||3
5201646|NCT01042236|12789658|P5|COMPLETED|Treatment Period 2||3
5201647|NCT01042236|12789659|P4|COMPLETED|Treatment Period 2||5
5201648|NCT01042236|12789660|P3|COMPLETED|Treatment Period 2||3
5201649|NCT01042236|12789661|P2|COMPLETED|Treatment Period 2||3
5201650|NCT01042236|12789662|P1|COMPLETED|Treatment Period 2||3
5201651|NCT01042236|12789657|P6|STARTED|Treatment Period 2||3
5201652|NCT01042236|12789658|P5|STARTED|Treatment Period 2||3
5201653|NCT01042236|12789659|P4|STARTED|Treatment Period 2||5
5201654|NCT01042236|12789660|P3|STARTED|Treatment Period 2||3
5201655|NCT01042236|12789661|P2|STARTED|Treatment Period 2||3
5201656|NCT01042236|12789662|P1|STARTED|Treatment Period 2||3
5201657|NCT01042236|12789657|P6|NOT COMPLETED|Treatment Period 1||0
5201658|NCT01042236|12789658|P5|NOT COMPLETED|Treatment Period 1||1
5201659|NCT01042236|12789659|P4|NOT COMPLETED|Treatment Period 1||0
5201660|NCT01042236|12789660|P3|NOT COMPLETED|Treatment Period 1||0
5201661|NCT01042236|12789661|P2|NOT COMPLETED|Treatment Period 1||1
5201662|NCT01042236|12789662|P1|NOT COMPLETED|Treatment Period 1||0
5201663|NCT01042236|12789657|P6|COMPLETED|Treatment Period 1||3
5201664|NCT01042236|12789658|P5|COMPLETED|Treatment Period 1||3
5201665|NCT01042236|12789659|P4|COMPLETED|Treatment Period 1||5
5201666|NCT01042236|12789660|P3|COMPLETED|Treatment Period 1||3
5201667|NCT01042236|12789661|P2|COMPLETED|Treatment Period 1||3
5201668|NCT01042236|12789662|P1|COMPLETED|Treatment Period 1||3
5201669|NCT01042236|12789657|P6|STARTED|Treatment Period 1||3
5201670|NCT01042236|12789658|P5|STARTED|Treatment Period 1||4
5201671|NCT01042236|12789659|P4|STARTED|Treatment Period 1||5
5201672|NCT01042236|12789660|P3|STARTED|Treatment Period 1||3
5201673|NCT01042236|12789661|P2|STARTED|Treatment Period 1||4
5201674|NCT01042236|12789662|P1|STARTED|Treatment Period 1||3
5201675|NCT01042158|12789699|P1|NOT COMPLETED|Overall Study||1
5201676|NCT01042158|12789699|P1|COMPLETED|Overall Study||24
5201677|NCT01042158|12789699|P1|STARTED|Overall Study||25
5201678|NCT01042145|12789708|P2|NOT COMPLETED|Overall Study||1
5201679|NCT01042145|12789709|P1|NOT COMPLETED|Overall Study||1
5201680|NCT01042145|12789708|P2|COMPLETED|Overall Study||45
5201681|NCT01042145|12789709|P1|COMPLETED|Overall Study||40
5201682|NCT01042145|12789708|P2|STARTED|Overall Study||46
5201683|NCT01042145|12789709|P1|STARTED|Overall Study||41
5201684|NCT01042093|12789729|P4|NOT COMPLETED|Overall Study||4
5201685|NCT01042093|12789730|P3|NOT COMPLETED|Overall Study||2
5201686|NCT01042093|12789731|P2|NOT COMPLETED|Overall Study||2
5201687|NCT01042093|12789732|P1|NOT COMPLETED|Overall Study||2
5201688|NCT01042093|12789729|P4|COMPLETED|Overall Study||36
5201689|NCT01042093|12789730|P3|COMPLETED|Overall Study||38
5201690|NCT01042093|12789731|P2|COMPLETED|Overall Study||38
5201691|NCT01042093|12789732|P1|COMPLETED|Overall Study||38
5201692|NCT01042093|12789729|P4|STARTED|Overall Study||40
5201693|NCT01042093|12789730|P3|STARTED|Overall Study||40
5201694|NCT01042093|12789731|P2|STARTED|Overall Study||40
5201695|NCT01042093|12789732|P1|STARTED|Overall Study||40
5201696|NCT01041976|12789752|P2|NOT COMPLETED|Overall Study||4
5201697|NCT01041976|12789753|P1|NOT COMPLETED|Overall Study||5
5201698|NCT01041976|12789752|P2|COMPLETED|Overall Study||38
5201699|NCT01041976|12789753|P1|COMPLETED|Overall Study||37
5201700|NCT01041976|12789752|P2|18 Month Follow-up|Overall Study||38
5201701|NCT01041976|12789753|P1|18 Month Follow-up|Overall Study||37
5201702|NCT01041976|12789752|P2|12 Month Follow-up|Overall Study||38
5201703|NCT01041976|12789753|P1|12 Month Follow-up|Overall Study||37
5201704|NCT01041976|12789752|P2|6 Month Follow-up|Overall Study||41
5201705|NCT01041976|12789753|P1|6 Month Follow-up|Overall Study||39
5201706|NCT01041976|12789752|P2|STARTED|Overall Study||42
5201707|NCT01041976|12789753|P1|STARTED|Overall Study||42
5201708|NCT01041859|12789763|P3|NOT COMPLETED|Double-Blind Maintenance||45
5201709|NCT01041859|12789764|P2|NOT COMPLETED|Double-Blind Maintenance||46
5201710|NCT01041859|12789765|P1|NOT COMPLETED|Double-Blind Maintenance||0
5201711|NCT01041859|12789763|P3|COMPLETED|Double-Blind Maintenance||107
5201712|NCT01041859|12789764|P2|COMPLETED|Double-Blind Maintenance||120
5201713|NCT01041859|12789765|P1|COMPLETED|Double-Blind Maintenance||0
5201714|NCT01041859|12789763|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
5201715|NCT01041859|12789764|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
5201716|NCT01041859|12789765|P1|STARTED|Double-Blind Maintenance||0
5201717|NCT01041859|12789763|P3|NOT COMPLETED|Open-Label Titration||0
5201718|NCT01041859|12789764|P2|NOT COMPLETED|Open-Label Titration||0
5201719|NCT01041859|12789765|P1|NOT COMPLETED|Open-Label Titration||101
5201720|NCT01041859|12789763|P3|COMPLETED|Open-Label Titration||0
5201721|NCT01041859|12789764|P2|COMPLETED|Open-Label Titration||0
5201722|NCT01041859|12789765|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
5201723|NCT01041859|12789763|P3|STARTED|Open-Label Titration||0
5201724|NCT01041859|12789764|P2|STARTED|Open-Label Titration||0
5201725|NCT01041859|12789765|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
5201726|NCT01041781|12789782|P2|NOT COMPLETED|Overall Study||0
5201727|NCT01041781|12789783|P1|NOT COMPLETED|Overall Study||0
5201728|NCT01041781|12789782|P2|COMPLETED|Overall Study||158
5201729|NCT01041781|12789783|P1|COMPLETED|Overall Study||154
5201730|NCT01041781|12789782|P2|STARTED|Overall Study||158
5201731|NCT01041781|12789783|P1|STARTED|Overall Study||154
5201732|NCT01041638|12789801|P1|NOT COMPLETED|Overall Study||27
5201733|NCT01041638|12789801|P1|COMPLETED|Overall Study||78
5201734|NCT01041638|12789801|P1|STARTED|Overall Study||105
5201735|NCT01041573|12789811|P4|NOT COMPLETED|Overall Study||2
5201736|NCT01041573|12789812|P3|NOT COMPLETED|Overall Study||7
5201737|NCT01041573|12789813|P2|NOT COMPLETED|Overall Study||13
5201738|NCT01041573|12789814|P1|NOT COMPLETED|Overall Study||5
5201739|NCT01041573|12789811|P4|COMPLETED|Overall Study||62
5201740|NCT01041573|12789812|P3|COMPLETED|Overall Study||387
5201741|NCT01041573|12789813|P2|COMPLETED|Overall Study||858
5201742|NCT01041573|12789814|P1|COMPLETED|Overall Study||535
5201743|NCT01041573|12789811|P4|STARTED|Overall Study||64
5201744|NCT01041573|12789812|P3|STARTED|Overall Study||394
5201745|NCT01041573|12789813|P2|STARTED|Overall Study||871
5201746|NCT01041573|12789814|P1|STARTED|Overall Study||540
5201747|NCT01041521|12789826|P2|NOT COMPLETED|Overall Study||16
5201748|NCT01041521|12789827|P1|NOT COMPLETED|Overall Study||17
5201749|NCT01041521|12789826|P2|COMPLETED|Overall Study||40
5201750|NCT01041521|12789827|P1|COMPLETED|Overall Study||44
5201751|NCT01041521|12789826|P2|STARTED|Overall Study||56
5201752|NCT01041521|12789827|P1|STARTED|Overall Study||61
5201753|NCT01041417|12789837|P2|NOT COMPLETED|Overall Study||3
5201754|NCT01041417|12789838|P1|NOT COMPLETED|Overall Study||7
5201755|NCT01041417|12789837|P2|COMPLETED|Overall Study||76
5201756|NCT01041417|12789838|P1|COMPLETED|Overall Study||73
5201757|NCT01041417|12789837|P2|STARTED|Overall Study||79
5201758|NCT01041417|12789838|P1|STARTED|Overall Study||80
5201759|NCT01041404|12789876|P2|NOT COMPLETED|Overall Study||294
5201760|NCT01041404|12789877|P1|NOT COMPLETED|Overall Study||290
5201761|NCT01041404|12789876|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
5201762|NCT01041404|12789877|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
5201763|NCT01041404|12789876|P2|Alive in Follow-up|Overall Study||41
5201764|NCT01041404|12789877|P1|Alive in Follow-up|Overall Study||40
5201765|NCT01041404|12789876|P2|Lost to Follow-up|Overall Study||10
5201766|NCT01041404|12789877|P1|Lost to Follow-up|Overall Study||12
5201767|NCT01041404|12789876|P2|Died in Follow-up|Overall Study||200
5201768|NCT01041404|12789877|P1|Died in Follow-up|Overall Study||199
5201769|NCT01041404|12789876|P2|Entered Follow-Up|Overall Study||251
5201770|NCT01041404|12789877|P1|Entered Follow-Up|Overall Study||251
5201771|NCT01041404|12789876|P2|STARTED|Overall Study||294
5201772|NCT01041404|12789877|P1|STARTED|Overall Study||290
5201773|NCT01041287|12789918|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
5201774|NCT01041287|12789919|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
5201775|NCT01041287|12789918|P2|COMPLETED|Treatment Period 2 (3 Months)||14
5201776|NCT01041287|12789919|P1|COMPLETED|Treatment Period 2 (3 Months)||16
5201777|NCT01041287|12789918|P2|STARTED|Treatment Period 2 (3 Months)||19
5201778|NCT01041287|12789919|P1|STARTED|Treatment Period 2 (3 Months)||19
5201779|NCT01041287|12789918|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
5201780|NCT01041287|12789919|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
5201781|NCT01041287|12789918|P2|COMPLETED|Treatment Period 1 (3 Months)||19
5201782|NCT01041287|12789919|P1|COMPLETED|Treatment Period 1 (3 Months)||19
5201783|NCT01041287|12789918|P2|STARTED|Treatment Period 1 (3 Months)||19
5201784|NCT01041287|12789919|P1|STARTED|Treatment Period 1 (3 Months)||19
5201785|NCT01041274|12789931|P2|NOT COMPLETED|Overall Study||21
5201786|NCT01041274|12789932|P1|NOT COMPLETED|Overall Study||23
5201787|NCT01041274|12789931|P2|COMPLETED|Overall Study||25
5201788|NCT01041274|12789932|P1|COMPLETED|Overall Study||26
5201789|NCT01041274|12789931|P2|STARTED|Overall Study||46
5201790|NCT01041274|12789932|P1|STARTED|Overall Study||49
5201791|NCT01041209|12789948|P2|NOT COMPLETED|Overall Study||0
5201792|NCT01041209|12789949|P1|NOT COMPLETED|Overall Study||0
5201793|NCT01041209|12789948|P2|COMPLETED|Overall Study||60
5201794|NCT01041209|12789949|P1|COMPLETED|Overall Study||60
5201795|NCT01041209|12789948|P2|STARTED|Overall Study||60
5201796|NCT01041209|12789949|P1|STARTED|Overall Study||60
5201797|NCT01040871|12789959|P2|NOT COMPLETED|Overall Study||7
5201798|NCT01040871|12789960|P1|NOT COMPLETED|Overall Study||13
5201799|NCT01040871|12789959|P2|COMPLETED|Overall Study||73
5201800|NCT01040871|12789960|P1|COMPLETED|Overall Study||71
5201801|NCT01040871|12789959|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
5201802|NCT01040871|12789960|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
5201803|NCT01040858|12789980|P2|NOT COMPLETED|Overall Study||0
5201804|NCT01040858|12789981|P1|NOT COMPLETED|Overall Study||9
5201805|NCT01040858|12789980|P2|COMPLETED|Overall Study||69
5201806|NCT01040858|12789981|P1|COMPLETED|Overall Study||50
5201807|NCT01040858|12789980|P2|STARTED|Overall Study||69
5201808|NCT01040858|12789981|P1|STARTED|Overall Study||59
5201809|NCT01040845|12790011|P2|NOT COMPLETED|Overall Study||1
5201810|NCT01040845|12790012|P1|NOT COMPLETED|Overall Study||2
5201811|NCT01040845|12790011|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
5201812|NCT01040845|12790012|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
5201813|NCT01040845|12790011|P2|STARTED|Overall Study||15
5201814|NCT01040845|12790012|P1|STARTED|Overall Study||15
5201815|NCT01040832|12790027|P2|NOT COMPLETED|Overall Study||37
5201816|NCT01040832|12790028|P1|NOT COMPLETED|Overall Study||46
5201817|NCT01040832|12790027|P2|COMPLETED|Overall Study||16
5201818|NCT01040832|12790028|P1|COMPLETED|Overall Study||8
5201819|NCT01040832|12790027|P2|STARTED|Overall Study||53
5201820|NCT01040832|12790028|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
5201821|NCT01040819|12790044|P2|NOT COMPLETED|Overall Study||0
5201822|NCT01040819|12790045|P1|NOT COMPLETED|Overall Study||0
5201823|NCT01040819|12790044|P2|COMPLETED|Overall Study||12
5201824|NCT01040819|12790045|P1|COMPLETED|Overall Study||13
5201825|NCT01040819|12790044|P2|STARTED|Overall Study||12
5201826|NCT01040819|12790045|P1|STARTED|Overall Study||13
5201827|NCT01040793|12790051|P6|NOT COMPLETED|Overall Study||1
5201828|NCT01040793|12790052|P5|NOT COMPLETED|Overall Study||4
5201829|NCT01040793|12790053|P4|NOT COMPLETED|Overall Study||4
5201830|NCT01040793|12790054|P3|NOT COMPLETED|Overall Study||3
5201831|NCT01040793|12790055|P2|NOT COMPLETED|Overall Study||5
5201832|NCT01040793|12790056|P1|NOT COMPLETED|Overall Study||6
5201833|NCT01040793|12790051|P6|COMPLETED|Overall Study||26
5201834|NCT01040793|12790052|P5|COMPLETED|Overall Study||22
5201835|NCT01040793|12790053|P4|COMPLETED|Overall Study||22
5201836|NCT01040793|12790054|P3|COMPLETED|Overall Study||23
5201837|NCT01040793|12790055|P2|COMPLETED|Overall Study||21
5201838|NCT01040793|12790056|P1|COMPLETED|Overall Study||20
5201839|NCT01040793|12790051|P6|STARTED|Overall Study||27
5201840|NCT01040793|12790052|P5|STARTED|Overall Study||26
5201841|NCT01040793|12790053|P4|STARTED|Overall Study||26
5201842|NCT01040793|12790054|P3|STARTED|Overall Study||26
5201843|NCT01040793|12790055|P2|STARTED|Overall Study||26
5201844|NCT01040793|12790056|P1|STARTED|Overall Study|Entered and treated|26
5201845|NCT01040780|12790135|P2|NOT COMPLETED|Overall Study||3
5201846|NCT01040780|12790136|P1|NOT COMPLETED|Overall Study||1
5201847|NCT01040780|12790135|P2|COMPLETED|Overall Study||196
5201848|NCT01040780|12790136|P1|COMPLETED|Overall Study||199
5201849|NCT01040780|12790135|P2|STARTED|Overall Study||199
5201850|NCT01040780|12790136|P1|STARTED|Overall Study||200
5201851|NCT01040728|12790150|P4|NOT COMPLETED|Overall Study||6
5201852|NCT01040728|12790151|P3|NOT COMPLETED|Overall Study||1
5201853|NCT01040728|12790152|P2|NOT COMPLETED|Overall Study||11
5201854|NCT01040728|12790153|P1|NOT COMPLETED|Overall Study||4
5201855|NCT01040728|12790150|P4|COMPLETED|Overall Study||24
5201856|NCT01040728|12790151|P3|COMPLETED|Overall Study||30
5201857|NCT01040728|12790152|P2|COMPLETED|Overall Study||19
5201858|NCT01040728|12790153|P1|COMPLETED|Overall Study||27
5201859|NCT01040728|12790150|P4|STARTED|Overall Study||30
5201860|NCT01040728|12790151|P3|STARTED|Overall Study||31
5201861|NCT01040728|12790152|P2|STARTED|Overall Study||30
5201862|NCT01040728|12790153|P1|STARTED|Overall Study||31
5201863|NCT01040689|12790223|P4|NOT COMPLETED|Overall Study||4
5201864|NCT01040689|12790224|P3|NOT COMPLETED|Overall Study||4
5201865|NCT01040689|12790225|P2|NOT COMPLETED|Overall Study||2
5201866|NCT01040689|12790226|P1|NOT COMPLETED|Overall Study||3
5201867|NCT01040689|12790223|P4|COMPLETED|Overall Study||23
5201868|NCT01040689|12790224|P3|COMPLETED|Overall Study||23
5201869|NCT01040689|12790225|P2|COMPLETED|Overall Study||25
5201870|NCT01040689|12790226|P1|COMPLETED|Overall Study||24
5201871|NCT01040689|12790223|P4|STARTED|Overall Study||27
5201872|NCT01040689|12790224|P3|STARTED|Overall Study||27
5201873|NCT01040689|12790225|P2|STARTED|Overall Study||27
5201874|NCT01040689|12790226|P1|STARTED|Overall Study||27
5201875|NCT01040624|12790298|P2|NOT COMPLETED|Overall Study||0
5201876|NCT01040624|12790299|P1|NOT COMPLETED|Overall Study||0
5201877|NCT01040624|12790298|P2|COMPLETED|Overall Study||19
5201878|NCT01040624|12790299|P1|COMPLETED|Overall Study||58
5201879|NCT01040624|12790298|P2|STARTED|Overall Study||19
5201880|NCT01040624|12790299|P1|STARTED|Overall Study||58
5201881|NCT01040403|12790305|P1|NOT COMPLETED|Overall Study||20
5201882|NCT01040403|12790305|P1|COMPLETED|Overall Study|All treatment periods|213
5201883|NCT01040403|12790305|P1|Completed T+O 5/10|Overall Study||107
5201884|NCT01040403|12790305|P1|Completed T+O 2.5/10|Overall Study||110
5201885|NCT01040403|12790305|P1|Completed T+O 1.25/10|Overall Study||106
5201886|NCT01040403|12790305|P1|Completed Olo 10|Overall Study||109
5201887|NCT01040403|12790305|P1|Completed T+O 5/5|Overall Study||106
5201888|NCT01040403|12790305|P1|Completed T+O 2.5/5|Overall Study||111
5201889|NCT01040403|12790305|P1|Completed T+O 1.25/5|Overall Study||105
5201890|NCT01040403|12790305|P1|Completed Olo 5|Overall Study||106
5201891|NCT01040403|12790305|P1|STARTED|Overall Study||233
5201892|NCT01040351|12790493|P2|NOT COMPLETED|Overall Study||2
5201893|NCT01040351|12790494|P1|NOT COMPLETED|Overall Study||1
5201894|NCT01040351|12790493|P2|COMPLETED|Overall Study|May 2010|53
5201895|NCT01040351|12790494|P1|COMPLETED|Overall Study|May 2010|54
5201896|NCT01040351|12790493|P2|STARTED|Overall Study|October 2006|55
5201897|NCT01040351|12790494|P1|STARTED|Overall Study|October 2006|55
5201898|NCT01040260|12790504|P2|NOT COMPLETED|Overall Study||11
5201899|NCT01040260|12790505|P1|NOT COMPLETED|Overall Study||15
5201900|NCT01040260|12790504|P2|COMPLETED|Overall Study||39
5201901|NCT01040260|12790505|P1|COMPLETED|Overall Study||38
5201902|NCT01040260|12790504|P2|STARTED|Overall Study||50
5201903|NCT01040260|12790505|P1|STARTED|Overall Study||53
5201904|NCT01040208|12790514|P3|NOT COMPLETED|Overall Study||3
5201905|NCT01040208|12790515|P2|NOT COMPLETED|Overall Study||13
5201906|NCT01040208|12790516|P1|NOT COMPLETED|Overall Study||6
5201907|NCT01040208|12790514|P3|COMPLETED|Overall Study||35
5201908|NCT01040208|12790515|P2|COMPLETED|Overall Study||15
5201909|NCT01040208|12790516|P1|COMPLETED|Overall Study||39
5201910|NCT01040208|12790514|P3|STARTED|Overall Study||38
5201911|NCT01040208|12790515|P2|STARTED|Overall Study||28
5201912|NCT01040208|12790516|P1|STARTED|Overall Study||45
5201913|NCT01040169|12790532|P2|NOT COMPLETED|Overall Study||8
5201914|NCT01040169|12790533|P1|NOT COMPLETED|Overall Study||3
5201915|NCT01040169|12790532|P2|COMPLETED|Overall Study||36
5201916|NCT01040169|12790533|P1|COMPLETED|Overall Study||32
5201917|NCT01040169|12790532|P2|STARTED|Overall Study||44
5201918|NCT01040169|12790533|P1|STARTED|Overall Study||35
5201919|NCT01040130|12790541|P6|NOT COMPLETED|Overall Study||4
5201920|NCT01040130|12790542|P5|NOT COMPLETED|Overall Study||0
5201921|NCT01040130|12790543|P4|NOT COMPLETED|Overall Study||5
5201922|NCT01040130|12790544|P3|NOT COMPLETED|Overall Study||2
5201923|NCT01040130|12790545|P2|NOT COMPLETED|Overall Study||3
5201924|NCT01040130|12790546|P1|NOT COMPLETED|Overall Study||3
5201925|NCT01040130|12790541|P6|COMPLETED|Overall Study||22
5201926|NCT01040130|12790542|P5|COMPLETED|Overall Study||25
5201927|NCT01040130|12790543|P4|COMPLETED|Overall Study||20
5201928|NCT01040130|12790544|P3|COMPLETED|Overall Study||23
5201929|NCT01040130|12790545|P2|COMPLETED|Overall Study||22
5201930|NCT01040130|12790546|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
5201931|NCT01040130|12790541|P6|STARTED|Overall Study||26
5201932|NCT01040130|12790542|P5|STARTED|Overall Study||25
5201933|NCT01040130|12790543|P4|STARTED|Overall Study||25
5201934|NCT01040130|12790544|P3|STARTED|Overall Study||25
5201935|NCT01040130|12790545|P2|STARTED|Overall Study||25
5201936|NCT01040130|12790546|P1|STARTED|Overall Study|Number of patients entered and treated|25
5201937|NCT01040052|12790623|P1|NOT COMPLETED|Overall Study||0
5201938|NCT01040052|12790623|P1|COMPLETED|Overall Study||30
5201939|NCT01040052|12790623|P1|STARTED|Overall Study||30
5201940|NCT01039792|12790629|P2|NOT COMPLETED|Overall Study||1
5201941|NCT01039792|12790630|P1|NOT COMPLETED|Overall Study||6
5201942|NCT01039792|12790629|P2|COMPLETED|Overall Study||27
5201943|NCT01039792|12790630|P1|COMPLETED|Overall Study||23
5201944|NCT01039792|12790629|P2|STARTED|Overall Study||28
5201945|NCT01039792|12790630|P1|STARTED|Overall Study||29
5201946|NCT01039688|12790639|P3|NOT COMPLETED|Overall Study||80
5201947|NCT01039688|12790640|P2|NOT COMPLETED|Overall Study||111
5201948|NCT01039688|12790641|P1|NOT COMPLETED|Overall Study||107
5201949|NCT01039688|12790639|P3|COMPLETED|Overall Study||106
5201950|NCT01039688|12790640|P2|COMPLETED|Overall Study||286
5201951|NCT01039688|12790641|P1|COMPLETED|Overall Study||266
5201952|NCT01039688|12790639|P3|STARTED|Overall Study||186
5201953|NCT01039688|12790640|P2|STARTED|Overall Study||397
5201954|NCT01039688|12790641|P1|STARTED|Overall Study||373
5201955|NCT01039675|12790912|P2|NOT COMPLETED|Overall Study||7
5201956|NCT01039675|12790913|P1|NOT COMPLETED|Overall Study||0
5201957|NCT01039675|12790912|P2|COMPLETED|Overall Study||35
5201958|NCT01039675|12790913|P1|COMPLETED|Overall Study||9
5201959|NCT01039675|12790912|P2|STARTED|Overall Study||42
5201960|NCT01039675|12790913|P1|STARTED|Overall Study||9
5201961|NCT01039584|12790926|P3|NOT COMPLETED|Overall Study||57
5201962|NCT01039584|12790927|P2|NOT COMPLETED|Overall Study||97
5201963|NCT01039584|12790928|P1|NOT COMPLETED|Overall Study||103
5201964|NCT01039584|12790926|P3|COMPLETED|Overall Study||65
5201965|NCT01039584|12790927|P2|COMPLETED|Overall Study||146
5201966|NCT01039584|12790928|P1|COMPLETED|Overall Study||143
5201967|NCT01039584|12790926|P3|STARTED|Overall Study||122
5201968|NCT01039584|12790927|P2|STARTED|Overall Study||243
5201969|NCT01039584|12790928|P1|STARTED|Overall Study||246
5201970|NCT01039519|12790942|P1|NOT COMPLETED|Survival Follow-up||27
5201971|NCT01039519|12790942|P1|COMPLETED|Survival Follow-up||0
5201972|NCT01039519|12790942|P1|STARTED|Survival Follow-up||27
5201973|NCT01039519|12790942|P1|NOT COMPLETED|Treatment||27
5201974|NCT01039519|12790942|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
5201975|NCT01039519|12790942|P1|STARTED|Treatment||27
5201976|NCT01039467|12790953|P2|NOT COMPLETED|Overall Study||49
5201977|NCT01039467|12790954|P1|NOT COMPLETED|Overall Study||40
5201978|NCT01039467|12790953|P2|COMPLETED|Overall Study||140
5201979|NCT01039467|12790954|P1|COMPLETED|Overall Study||156
5201980|NCT01039467|12790953|P2|STARTED|Overall Study||189
5201981|NCT01039467|12790954|P1|STARTED|Overall Study||196
5201982|NCT01039428|12790978|P2|NOT COMPLETED|Overall Study||0
5201983|NCT01039428|12790979|P1|NOT COMPLETED|Overall Study||2
5201984|NCT01039428|12790978|P2|COMPLETED|Overall Study||28
5201985|NCT01039428|12790979|P1|COMPLETED|Overall Study||33
5201986|NCT01039428|12790978|P2|STARTED|Overall Study||28
5201987|NCT01039428|12790979|P1|STARTED|Overall Study||35
5201988|NCT01039376|12791003|P2|NOT COMPLETED|Overall Study||126
5201989|NCT01039376|12791004|P1|NOT COMPLETED|Overall Study||130
5201990|NCT01039376|12791003|P2|COMPLETED|Overall Study||114
5201991|NCT01039376|12791004|P1|COMPLETED|Overall Study||110
5201992|NCT01039376|12791003|P2|STARTED|Overall Study||240
5201993|NCT01039376|12791004|P1|STARTED|Overall Study||240
5201994|NCT01039207|12791063|P1|NOT COMPLETED|Overall Study||0
5201995|NCT01039207|12791063|P1|COMPLETED|Overall Study||31
5201996|NCT01039207|12791063|P1|STARTED|Overall Study||31
5201997|NCT01038921|12791073|P2|NOT COMPLETED|Overall Study||0
5201998|NCT01038921|12791074|P1|NOT COMPLETED|Overall Study||2
5201999|NCT01038921|12791073|P2|COMPLETED|Overall Study||20
5202000|NCT01038921|12791074|P1|COMPLETED|Overall Study|2 subjects withdrew|17
5202001|NCT01038921|12791073|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
5202002|NCT01038921|12791074|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
5202003|NCT01038869|12791080|P1|NOT COMPLETED|Overall Study||7
5202004|NCT01038869|12791080|P1|COMPLETED|Overall Study||13
5202005|NCT01038869|12791080|P1|STARTED|Overall Study||20
5202006|NCT01038856|12791088|P1|NOT COMPLETED|Overall Study||2
5202007|NCT01038856|12791088|P1|COMPLETED|Overall Study||3
5202008|NCT01038856|12791088|P1|STARTED|Overall Study||5
5202009|NCT01038752|12791097|P2|NOT COMPLETED|Overall Study||5
5202010|NCT01038752|12791098|P1|NOT COMPLETED|Overall Study||5
5202011|NCT01038752|12791097|P2|COMPLETED|Overall Study||1
5202012|NCT01038752|12791098|P1|COMPLETED|Overall Study||3
5202013|NCT01038752|12791097|P2|STARTED|Overall Study||6
5202014|NCT01038752|12791098|P1|STARTED|Overall Study||8
5202015|NCT01038713|12791121|P3|NOT COMPLETED|Overall Study||1
5202016|NCT01038713|12791122|P2|NOT COMPLETED|Overall Study||3
5202017|NCT01038713|12791123|P1|NOT COMPLETED|Overall Study||5
5202018|NCT01038713|12791121|P3|COMPLETED|Overall Study||16
5202019|NCT01038713|12791122|P2|COMPLETED|Overall Study||17
5202020|NCT01038713|12791123|P1|COMPLETED|Overall Study||21
5202021|NCT01038713|12791121|P3|STARTED|Overall Study||17
5202022|NCT01038713|12791122|P2|STARTED|Overall Study||20
5202023|NCT01038713|12791123|P1|STARTED|Overall Study||26
5202024|NCT01038635|12791152|P9|NOT COMPLETED|Overall Study||2
5202025|NCT01038635|12791153|P8|NOT COMPLETED|Overall Study||5
5202026|NCT01038635|12791154|P7|NOT COMPLETED|Overall Study||2
5202027|NCT01038635|12791155|P6|NOT COMPLETED|Overall Study||0
5202028|NCT01038635|12791156|P5|NOT COMPLETED|Overall Study||1
5202029|NCT01038635|12791157|P4|NOT COMPLETED|Overall Study||0
5202030|NCT01038635|12791158|P3|NOT COMPLETED|Overall Study||0
5202031|NCT01038635|12791159|P2|NOT COMPLETED|Overall Study||0
5202032|NCT01038635|12791160|P1|NOT COMPLETED|Overall Study||2
5202033|NCT01038635|12791152|P9|COMPLETED|Overall Study||38
5202034|NCT01038635|12791153|P8|COMPLETED|Overall Study||15
5202035|NCT01038635|12791154|P7|COMPLETED|Overall Study||5
5202036|NCT01038635|12791155|P6|COMPLETED|Overall Study||3
5202037|NCT01038635|12791156|P5|COMPLETED|Overall Study||3
5202038|NCT01038635|12791157|P4|COMPLETED|Overall Study||3
5202039|NCT01038635|12791158|P3|COMPLETED|Overall Study||3
5202040|NCT01038635|12791159|P2|COMPLETED|Overall Study||3
5202041|NCT01038635|12791160|P1|COMPLETED|Overall Study||3
5202042|NCT01038635|12791152|P9|STARTED|Overall Study||40
5202043|NCT01038635|12791153|P8|STARTED|Overall Study||20
5202044|NCT01038635|12791154|P7|STARTED|Overall Study||7
5202045|NCT01038635|12791155|P6|STARTED|Overall Study||3
5202046|NCT01038635|12791156|P5|STARTED|Overall Study||4
5202047|NCT01038635|12791157|P4|STARTED|Overall Study||3
5202048|NCT01038635|12791158|P3|STARTED|Overall Study||3
5202049|NCT01038635|12791159|P2|STARTED|Overall Study||3
5202050|NCT01038635|12791160|P1|STARTED|Overall Study||5
5202051|NCT01038609|12791186|P5|NOT COMPLETED|Overall Study||1
5202052|NCT01038609|12791187|P4|NOT COMPLETED|Overall Study||1
5202053|NCT01038609|12791188|P3|NOT COMPLETED|Overall Study||1
5202054|NCT01038609|12791189|P2|NOT COMPLETED|Overall Study||1
5202055|NCT01038609|12791190|P1|NOT COMPLETED|Overall Study||1
5202056|NCT01038609|12791186|P5|COMPLETED|Overall Study||50
5202057|NCT01038609|12791187|P4|COMPLETED|Overall Study||47
5202058|NCT01038609|12791188|P3|COMPLETED|Overall Study||48
5202059|NCT01038609|12791189|P2|COMPLETED|Overall Study||51
5202060|NCT01038609|12791190|P1|COMPLETED|Overall Study||49
5202061|NCT01038609|12791186|P5|STARTED|Overall Study||51
5202062|NCT01038609|12791187|P4|STARTED|Overall Study||48
5202063|NCT01038609|12791188|P3|STARTED|Overall Study||49
5202064|NCT01038609|12791189|P2|STARTED|Overall Study||52
5202065|NCT01038609|12791190|P1|STARTED|Overall Study||50
5202066|NCT01038557|12791235|P3|NOT COMPLETED|Overall Study||0
5202067|NCT01038557|12791236|P2|NOT COMPLETED|Overall Study||0
5202068|NCT01038557|12791237|P1|NOT COMPLETED|Overall Study||0
5202069|NCT01038557|12791235|P3|COMPLETED|Overall Study||86
5202070|NCT01038557|12791236|P2|COMPLETED|Overall Study||86
5202071|NCT01038557|12791237|P1|COMPLETED|Overall Study||82
5202072|NCT01038557|12791235|P3|STARTED|Overall Study||86
5202073|NCT01038557|12791236|P2|STARTED|Overall Study||86
5202074|NCT01038557|12791237|P1|STARTED|Overall Study||82
5202075|NCT01038336|12791275|P3|NOT COMPLETED|Overall Study||0
5202076|NCT01038336|12791276|P2|NOT COMPLETED|Overall Study||0
5202077|NCT01038336|12791277|P1|NOT COMPLETED|Overall Study||0
5202078|NCT01038336|12791275|P3|COMPLETED|Overall Study||44
5202079|NCT01038336|12791276|P2|COMPLETED|Overall Study||42
5202080|NCT01038336|12791277|P1|COMPLETED|Overall Study||43
5202081|NCT01038336|12791275|P3|STARTED|Overall Study||44
5202082|NCT01038336|12791276|P2|STARTED|Overall Study||42
5202083|NCT01038336|12791277|P1|STARTED|Overall Study||43
5202084|NCT01038323|12791309|P3|NOT COMPLETED|Overall Study||4
5202085|NCT01038323|12791310|P2|NOT COMPLETED|Overall Study||2
5202086|NCT01038323|12791311|P1|NOT COMPLETED|Overall Study||3
5202087|NCT01038323|12791309|P3|COMPLETED|Overall Study||15
5202088|NCT01038323|12791310|P2|COMPLETED|Overall Study||17
5202089|NCT01038323|12791311|P1|COMPLETED|Overall Study||17
5202090|NCT01038323|12791309|P3|STARTED|Overall Study||19
5202091|NCT01038323|12791310|P2|STARTED|Overall Study||19
5202092|NCT01038323|12791311|P1|STARTED|Overall Study||20
5202093|NCT01038128|12791325|P1|NOT COMPLETED|Overall Study||4
5202094|NCT01038128|12791325|P1|COMPLETED|Overall Study||1
5202095|NCT01038128|12791325|P1|Baseline Visit|Overall Study||3
5202096|NCT01038128|12791325|P1|STARTED|Overall Study||5
5202097|NCT01037881|12791340|P7|NOT COMPLETED|Overall Study||2
5202098|NCT01037881|12791341|P6|NOT COMPLETED|Overall Study||3
5202099|NCT01037881|12791342|P5|NOT COMPLETED|Overall Study||3
5202100|NCT01037881|12791343|P4|NOT COMPLETED|Overall Study||1
5202101|NCT01037881|12791344|P3|NOT COMPLETED|Overall Study||3
5202102|NCT01037881|12791345|P2|NOT COMPLETED|Overall Study||2
5202103|NCT01037881|12791346|P1|NOT COMPLETED|Overall Study||6
5202104|NCT01037881|12791340|P7|COMPLETED|Overall Study||23
5202105|NCT01037881|12791341|P6|COMPLETED|Overall Study||27
5202106|NCT01037881|12791342|P5|COMPLETED|Overall Study||26
5202107|NCT01037881|12791343|P4|COMPLETED|Overall Study||24
5202108|NCT01037881|12791344|P3|COMPLETED|Overall Study||22
5202109|NCT01037881|12791345|P2|COMPLETED|Overall Study||22
5202110|NCT01037881|12791346|P1|COMPLETED|Overall Study||19
5202111|NCT01037881|12791340|P7|STARTED|Overall Study||25
5202112|NCT01037881|12791341|P6|STARTED|Overall Study||30
5202113|NCT01037881|12791342|P5|STARTED|Overall Study||29
5202114|NCT01037881|12791343|P4|STARTED|Overall Study||25
5202115|NCT01037881|12791344|P3|STARTED|Overall Study||25
5202116|NCT01037881|12791345|P2|STARTED|Overall Study||24
5202117|NCT01037881|12791346|P1|STARTED|Overall Study||25
5202118|NCT01037452|12791408|P4|NOT COMPLETED|Overall Study||0
5202119|NCT01037452|12791409|P3|NOT COMPLETED|Overall Study||0
5202120|NCT01037452|12791410|P2|NOT COMPLETED|Overall Study||0
5202121|NCT01037452|12791411|P1|NOT COMPLETED|Overall Study||0
5202122|NCT01037452|12791408|P4|COMPLETED|Overall Study||30
5202123|NCT01037452|12791409|P3|COMPLETED|Overall Study||30
5202124|NCT01037452|12791410|P2|COMPLETED|Overall Study||30
5202125|NCT01037452|12791411|P1|COMPLETED|Overall Study||30
5202126|NCT01037452|12791408|P4|STARTED|Overall Study||30
5202127|NCT01037452|12791409|P3|STARTED|Overall Study||30
5202128|NCT01037452|12791410|P2|STARTED|Overall Study||30
5202129|NCT01037452|12791411|P1|STARTED|Overall Study||30
5202130|NCT01037309|12791439|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
5202131|NCT01037309|12791440|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
5202132|NCT01037309|12791441|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
5202133|NCT01037309|12791442|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
5202134|NCT01037309|12791443|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
5202135|NCT01037309|12791444|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
5202136|NCT01037309|12791445|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
5202137|NCT01037309|12791446|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
5202138|NCT01037309|12791447|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
5202139|NCT01037309|12791439|P9|COMPLETED|Intravenous Period 7 - 9||3
5202140|NCT01037309|12791440|P8|COMPLETED|Intravenous Period 7 - 9||3
5202141|NCT01037309|12791441|P7|COMPLETED|Intravenous Period 7 - 9||3
5202142|NCT01037309|12791442|P6|COMPLETED|Intravenous Period 7 - 9||0
5202143|NCT01037309|12791443|P5|COMPLETED|Intravenous Period 7 - 9||0
5202144|NCT01037309|12791444|P4|COMPLETED|Intravenous Period 7 - 9||0
5202145|NCT01037309|12791445|P3|COMPLETED|Intravenous Period 7 - 9||0
5202146|NCT01037309|12791446|P2|COMPLETED|Intravenous Period 7 - 9||0
5202147|NCT01037309|12791447|P1|COMPLETED|Intravenous Period 7 - 9||0
5202148|NCT01037309|12791439|P9|STARTED|Intravenous Period 7 - 9||3
5202149|NCT01037309|12791440|P8|STARTED|Intravenous Period 7 - 9||3
5202150|NCT01037309|12791441|P7|STARTED|Intravenous Period 7 - 9||3
5202151|NCT01037309|12791442|P6|STARTED|Intravenous Period 7 - 9||0
5202152|NCT01037309|12791443|P5|STARTED|Intravenous Period 7 - 9||0
5202153|NCT01037309|12791444|P4|STARTED|Intravenous Period 7 - 9||0
5202154|NCT01037309|12791445|P3|STARTED|Intravenous Period 7 - 9||0
5202155|NCT01037309|12791446|P2|STARTED|Intravenous Period 7 - 9||0
5202156|NCT01037309|12791447|P1|STARTED|Intravenous Period 7 - 9||0
5202157|NCT01037309|12791439|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202158|NCT01037309|12791440|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202159|NCT01037309|12791441|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202160|NCT01037309|12791442|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202161|NCT01037309|12791443|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202162|NCT01037309|12791444|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202163|NCT01037309|12791445|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202164|NCT01037309|12791446|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202165|NCT01037309|12791447|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
5202166|NCT01037309|12791439|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
5202167|NCT01037309|12791440|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
5202168|NCT01037309|12791441|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
5202169|NCT01037309|12791442|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202170|NCT01037309|12791443|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202171|NCT01037309|12791444|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202172|NCT01037309|12791445|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202173|NCT01037309|12791446|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202174|NCT01037309|12791447|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
5202175|NCT01037309|12791439|P9|STARTED|Subcutaneous Cohort 1 - 6||0
5202176|NCT01037309|12791440|P8|STARTED|Subcutaneous Cohort 1 - 6||0
5202177|NCT01037309|12791441|P7|STARTED|Subcutaneous Cohort 1 - 6||0
5202178|NCT01037309|12791442|P6|STARTED|Subcutaneous Cohort 1 - 6||3
5202179|NCT01037309|12791443|P5|STARTED|Subcutaneous Cohort 1 - 6||3
5202180|NCT01037309|12791444|P4|STARTED|Subcutaneous Cohort 1 - 6||3
5202181|NCT01037309|12791445|P3|STARTED|Subcutaneous Cohort 1 - 6||3
5202182|NCT01037309|12791446|P2|STARTED|Subcutaneous Cohort 1 - 6||3
5202183|NCT01037309|12791447|P1|STARTED|Subcutaneous Cohort 1 - 6||3
5202184|NCT01037244|12791489|P4|NOT COMPLETED|Overall Study||14
5202185|NCT01037244|12791490|P3|NOT COMPLETED|Overall Study||14
5202186|NCT01037244|12791491|P2|NOT COMPLETED|Overall Study||14
5202187|NCT01037244|12791492|P1|NOT COMPLETED|Overall Study||13
5202188|NCT01037244|12791489|P4|COMPLETED|Overall Study||140
5202189|NCT01037244|12791490|P3|COMPLETED|Overall Study||144
5202190|NCT01037244|12791491|P2|COMPLETED|Overall Study||138
5202191|NCT01037244|12791492|P1|COMPLETED|Overall Study||141
5202192|NCT01037244|12791489|P4|Safety Population|Overall Study||152
5202193|NCT01037244|12791490|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
5202194|NCT01037244|12791491|P2|Safety Population|Overall Study||150
5202195|NCT01037244|12791492|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
5202196|NCT01037244|12791489|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
5202197|NCT01037244|12791490|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
5202198|NCT01037244|12791491|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
5202199|NCT01037244|12791492|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
5202200|NCT01037244|12791489|P4|STARTED|Overall Study||154
5202201|NCT01037244|12791490|P3|STARTED|Overall Study||158
5202202|NCT01037244|12791491|P2|STARTED|Overall Study||152
5202203|NCT01037244|12791492|P1|STARTED|Overall Study||154
5202204|NCT01037218|12791554|P4|NOT COMPLETED|Overall Study||16
5202205|NCT01037218|12791555|P3|NOT COMPLETED|Overall Study||21
5202206|NCT01037218|12791556|P2|NOT COMPLETED|Overall Study||21
5202207|NCT01037218|12791557|P1|NOT COMPLETED|Overall Study||16
5202208|NCT01037218|12791554|P4|COMPLETED|Overall Study||134
5202209|NCT01037218|12791555|P3|COMPLETED|Overall Study||134
5202210|NCT01037218|12791556|P2|COMPLETED|Overall Study||128
5202211|NCT01037218|12791557|P1|COMPLETED|Overall Study||131
5202212|NCT01037218|12791554|P4|mITT Population|Overall Study||141
5202213|NCT01037218|12791555|P3|mITT Population|Overall Study||147
5202214|NCT01037218|12791556|P2|mITT Population|Overall Study||140
5202215|NCT01037218|12791557|P1|mITT Population|Overall Study||141
5202216|NCT01037218|12791554|P4|Safety Population|Overall Study||150
5202217|NCT01037218|12791555|P3|Safety Population|Overall Study||154
5202218|NCT01037218|12791556|P2|Safety Population|Overall Study||148
5202219|NCT01037218|12791557|P1|Safety Population|Overall Study||147
5202220|NCT01037218|12791554|P4|STARTED|Overall Study||150
5202221|NCT01037218|12791555|P3|STARTED|Overall Study||155
5202222|NCT01037218|12791556|P2|STARTED|Overall Study||149
5202223|NCT01037218|12791557|P1|STARTED|Overall Study||147
5202224|NCT01037192|12791617|P2|NOT COMPLETED|Overall Study||0
5202225|NCT01037192|12791618|P1|NOT COMPLETED|Overall Study||0
5202226|NCT01037192|12791617|P2|COMPLETED|Overall Study||1
5202227|NCT01037192|12791618|P1|COMPLETED|Overall Study||3
5202228|NCT01037192|12791617|P2|STARTED|Overall Study||1
5202229|NCT01037192|12791618|P1|STARTED|Overall Study||3
5202230|NCT01037127|12791628|P2|NOT COMPLETED|Overall Study||21
5202231|NCT01037127|12791629|P1|NOT COMPLETED|Overall Study||5
5202232|NCT01037127|12791628|P2|COMPLETED|Overall Study||36
5202233|NCT01037127|12791629|P1|COMPLETED|Overall Study||35
5202234|NCT01037127|12791628|P2|STARTED|Overall Study||57
5202235|NCT01037127|12791629|P1|STARTED|Overall Study||40
5202236|NCT01037114|12791661|P1|NOT COMPLETED|Year 20||1
5202237|NCT01037114|12791661|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
5202238|NCT01037114|12791661|P1|STARTED|Year 20||45
5202239|NCT01037114|12791661|P1|NOT COMPLETED|Year 19||0
5202240|NCT01037114|12791661|P1|COMPLETED|Year 19||45
5202241|NCT01037114|12791661|P1|STARTED|Year 19||45
5202242|NCT01037114|12791661|P1|NOT COMPLETED|Year 18||0
5202243|NCT01037114|12791661|P1|COMPLETED|Year 18||44
5202244|NCT01037114|12791661|P1|STARTED|Year 18||44
5202245|NCT01037114|12791661|P1|NOT COMPLETED|Year 17||0
5202246|NCT01037114|12791661|P1|COMPLETED|Year 17||48
5202247|NCT01037114|12791661|P1|STARTED|Year 17||48
5202248|NCT01037114|12791661|P1|NOT COMPLETED|Year 16||0
5202249|NCT01037114|12791661|P1|COMPLETED|Year 16||49
5202250|NCT01037114|12791661|P1|STARTED|Year 16||49
5202251|NCT01037088|12791674|P1|NOT COMPLETED|Overall Study||3
5202252|NCT01037088|12791674|P1|COMPLETED|Overall Study||36
5202253|NCT01037088|12791674|P1|Received Placebo|Overall Study||38
5202254|NCT01037088|12791674|P1|Received 1.29% THC|Overall Study||37
5202255|NCT01037088|12791674|P1|Received 3.53% THC|Overall Study||36
5202256|NCT01037088|12791674|P1|STARTED|Overall Study||39
5202257|NCT01036802|12791687|P2|NOT COMPLETED|Overall Study||0
5202258|NCT01036802|12791688|P1|NOT COMPLETED|Overall Study||0
5202259|NCT01036802|12791687|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
5202260|NCT01036802|12791688|P1|COMPLETED|Overall Study||2
5202261|NCT01036802|12791687|P2|STARTED|Overall Study||1
5202262|NCT01036802|12791688|P1|STARTED|Overall Study||2
5202263|NCT01036763|12791706|P1|NOT COMPLETED|Overall Study||93
5202264|NCT01036763|12791706|P1|COMPLETED|Overall Study||1171
5202265|NCT01036763|12791706|P1|STARTED|Overall Study||1264
5202266|NCT01036724|12791718|P2|NOT COMPLETED|Overall Study||8
5202267|NCT01036724|12791719|P1|NOT COMPLETED|Overall Study||6
5202268|NCT01036724|12791718|P2|COMPLETED|Overall Study||47
5202269|NCT01036724|12791719|P1|COMPLETED|Overall Study||46
5202270|NCT01036724|12791718|P2|STARTED|Overall Study||55
5202271|NCT01036724|12791719|P1|STARTED|Overall Study||52
5202272|NCT01036594|12791727|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
5202273|NCT01036594|12791728|P1|NOT COMPLETED|Treatment Regiments Post Week 12||2
5202274|NCT01036594|12791727|P2|COMPLETED|Treatment Regiments Post Week 12||5
5202275|NCT01036594|12791728|P1|COMPLETED|Treatment Regiments Post Week 12||13
5202276|NCT01036594|12791727|P2|STARTED|Treatment Regiments Post Week 12||9
5202277|NCT01036594|12791728|P1|STARTED|Treatment Regiments Post Week 12||15
5202278|NCT01036594|12791727|P2|NOT COMPLETED|Week 12 Evaluation||0
5202279|NCT01036594|12791728|P1|NOT COMPLETED|Week 12 Evaluation||6
5202280|NCT01036594|12791727|P2|COMPLETED|Week 12 Evaluation||0
5202281|NCT01036594|12791728|P1|COMPLETED|Week 12 Evaluation||24
5202282|NCT01036594|12791727|P2|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
5202283|NCT01036594|12791728|P1|STARTED|Week 12 Evaluation||30
5202284|NCT01036594|12791727|P2|NOT COMPLETED|First Treatment Regimen||0
5202285|NCT01036594|12791728|P1|NOT COMPLETED|First Treatment Regimen||1
5202286|NCT01036594|12791727|P2|COMPLETED|First Treatment Regimen||0
5202287|NCT01036594|12791728|P1|COMPLETED|First Treatment Regimen||30
5202288|NCT01036594|12791727|P2|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
5202289|NCT01036594|12791728|P1|STARTED|First Treatment Regimen||31
5202290|NCT01036594|12791727|P2|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
5202291|NCT01036594|12791728|P1|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
5202292|NCT01036594|12791727|P2|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
5202293|NCT01036594|12791728|P1|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
5202294|NCT01036594|12791727|P2|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
5202295|NCT01036594|12791728|P1|STARTED|Run-In: Ketoconazole Only (200 mg)||32
5202296|NCT01036529|12791752|P2|NOT COMPLETED|Overall Study||15
5202297|NCT01036529|12791753|P1|NOT COMPLETED|Overall Study||13
5202298|NCT01036529|12791752|P2|COMPLETED|Overall Study||0
5202299|NCT01036529|12791753|P1|COMPLETED|Overall Study||0
5202300|NCT01036529|12791752|P2|Crossover to Other Group|Overall Study||1
5202301|NCT01036529|12791753|P1|Crossover to Other Group|Overall Study||1
5202302|NCT01036529|12791752|P2|Requested Crossover|Overall Study||2
5202303|NCT01036529|12791753|P1|Requested Crossover|Overall Study||1
5202304|NCT01036529|12791752|P2|12 Month Follow-up|Overall Study||3
5202305|NCT01036529|12791753|P1|12 Month Follow-up|Overall Study||4
5202306|NCT01036529|12791752|P2|6 Month Follow-up|Overall Study||7
5202307|NCT01036529|12791753|P1|6 Month Follow-up|Overall Study||6
5202308|NCT01036529|12791752|P2|3 Month Follow-up|Overall Study||9
5202309|NCT01036529|12791753|P1|3 Month Follow-up|Overall Study||7
5202310|NCT01036529|12791752|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
5202311|NCT01036529|12791753|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
5202312|NCT01036529|12791752|P2|Baseline Visit|Overall Study||13
5202313|NCT01036529|12791753|P1|Baseline Visit|Overall Study||10
5202314|NCT01036529|12791752|P2|STARTED|Overall Study||15
5202315|NCT01036529|12791753|P1|STARTED|Overall Study||13
5202316|NCT01036490|12791761|P2|NOT COMPLETED|Overall Study||0
5202317|NCT01036490|12791762|P1|NOT COMPLETED|Overall Study||4
5202318|NCT01036490|12791761|P2|COMPLETED|Overall Study||18
5202319|NCT01036490|12791762|P1|COMPLETED|Overall Study||14
5202320|NCT01036490|12791761|P2|STARTED|Overall Study||18
5202321|NCT01036490|12791762|P1|STARTED|Overall Study||18
5202322|NCT01036438|12791780|P2|NOT COMPLETED|Overall Study||10
5202323|NCT01036438|12791781|P1|NOT COMPLETED|Overall Study||10
5202324|NCT01036438|12791780|P2|COMPLETED|Overall Study||90
5202325|NCT01036438|12791781|P1|COMPLETED|Overall Study||91
5202326|NCT01036438|12791780|P2|STARTED|Overall Study||100
5202327|NCT01036438|12791781|P1|STARTED|Overall Study||101
5202328|NCT01036321|12791789|P2|NOT COMPLETED|Overall Study||4
5202329|NCT01036321|12791790|P1|NOT COMPLETED|Overall Study||5
5202330|NCT01036321|12791789|P2|COMPLETED|Overall Study||31
5202331|NCT01036321|12791790|P1|COMPLETED|Overall Study||31
5202332|NCT01036321|12791789|P2|STARTED|Overall Study||35
5202333|NCT01036321|12791790|P1|STARTED|Overall Study||36
5202334|NCT01036165|12791814|P1|NOT COMPLETED|Overall Study||15
5202335|NCT01036165|12791814|P1|COMPLETED|Overall Study||88
5202336|NCT01036165|12791814|P1|STARTED|Overall Study||103
5202337|NCT01036022|12791825|P6|NOT COMPLETED|Overall Study||3
5202338|NCT01036022|12791826|P5|NOT COMPLETED|Overall Study||3
5202339|NCT01036022|12791827|P4|NOT COMPLETED|Overall Study||2
5202340|NCT01036022|12791828|P3|NOT COMPLETED|Overall Study||4
5202341|NCT01036022|12791829|P2|NOT COMPLETED|Overall Study||4
5202342|NCT01036022|12791830|P1|NOT COMPLETED|Overall Study||2
5202343|NCT01036022|12791825|P6|COMPLETED|Overall Study||13
5202344|NCT01036022|12791826|P5|COMPLETED|Overall Study||9
5202345|NCT01036022|12791827|P4|COMPLETED|Overall Study||10
5202346|NCT01036022|12791828|P3|COMPLETED|Overall Study||8
5202347|NCT01036022|12791829|P2|COMPLETED|Overall Study||7
5202348|NCT01036022|12791830|P1|COMPLETED|Overall Study||13
5202349|NCT01036022|12791825|P6|STARTED|Overall Study||16
5202350|NCT01036022|12791826|P5|STARTED|Overall Study||12
5202351|NCT01036022|12791827|P4|STARTED|Overall Study||12
5202352|NCT01036022|12791828|P3|STARTED|Overall Study||12
5202353|NCT01036022|12791829|P2|STARTED|Overall Study||11
5202354|NCT01036022|12791830|P1|STARTED|Overall Study||15
5202355|NCT01036009|12791932|P2|NOT COMPLETED|Overall Study||0
5202356|NCT01036009|12791933|P1|NOT COMPLETED|Overall Study||0
5202357|NCT01036009|12791932|P2|COMPLETED|Overall Study||26
5202358|NCT01036009|12791933|P1|COMPLETED|Overall Study||17
5202359|NCT01036009|12791932|P2|STARTED|Overall Study||26
5202360|NCT01036009|12791933|P1|STARTED|Overall Study||17
5202361|NCT01035944|12791951|P4|NOT COMPLETED|Overall Study||0
5202362|NCT01035944|12791952|P3|NOT COMPLETED|Overall Study||1
5202363|NCT01035944|12791953|P2|NOT COMPLETED|Overall Study||1
5202364|NCT01035944|12791954|P1|NOT COMPLETED|Overall Study||3
5202365|NCT01035944|12791951|P4|COMPLETED|Overall Study||4
5202366|NCT01035944|12791952|P3|COMPLETED|Overall Study||4
5202367|NCT01035944|12791953|P2|COMPLETED|Overall Study||13
5202368|NCT01035944|12791954|P1|COMPLETED|Overall Study||11
5202369|NCT01035944|12791951|P4|STARTED|Overall Study||4
5202370|NCT01035944|12791952|P3|STARTED|Overall Study||5
5202371|NCT01035944|12791953|P2|STARTED|Overall Study||14
5202372|NCT01035944|12791954|P1|STARTED|Overall Study||14
5202373|NCT01035905|12791966|P2|NOT COMPLETED|Overall Study||1
5202374|NCT01035905|12791967|P1|NOT COMPLETED|Overall Study||1
5202375|NCT01035905|12791966|P2|COMPLETED|Overall Study||30
5202376|NCT01035905|12791967|P1|COMPLETED|Overall Study||31
5202377|NCT01035905|12791966|P2|STARTED|Overall Study||31
5202378|NCT01035905|12791967|P1|STARTED|Overall Study||32
5202379|NCT01035788|12791975|P2|NOT COMPLETED|Overall Study||14
5202380|NCT01035788|12791976|P1|NOT COMPLETED|Overall Study||6
5202381|NCT01035788|12791975|P2|COMPLETED|Overall Study||9
5202382|NCT01035788|12791976|P1|COMPLETED|Overall Study||17
5202383|NCT01035788|12791975|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
5202384|NCT01035788|12791976|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
5202385|NCT01035749|12791986|P4|NOT COMPLETED|Overall Study||0
5202386|NCT01035749|12791987|P3|NOT COMPLETED|Overall Study||0
5202387|NCT01035749|12791988|P2|NOT COMPLETED|Overall Study||0
5202388|NCT01035749|12791989|P1|NOT COMPLETED|Overall Study||0
5202389|NCT01035749|12791986|P4|COMPLETED|Overall Study||110
5202390|NCT01035749|12791987|P3|COMPLETED|Overall Study||68
5202391|NCT01035749|12791988|P2|COMPLETED|Overall Study||66
5202392|NCT01035749|12791989|P1|COMPLETED|Overall Study||66
5202393|NCT01035749|12791986|P4|STARTED|Overall Study||110
5202394|NCT01035749|12791987|P3|STARTED|Overall Study||68
5202395|NCT01035749|12791988|P2|STARTED|Overall Study||66
5202396|NCT01035749|12791989|P1|STARTED|Overall Study||66
5202397|NCT01035658|12792111|P4|NOT COMPLETED|Overall Study||0
5202398|NCT01035658|12792112|P3|NOT COMPLETED|Overall Study||0
5202399|NCT01035658|12792113|P2|NOT COMPLETED|Overall Study||0
5202400|NCT01035658|12792114|P1|NOT COMPLETED|Overall Study||0
5202401|NCT01035658|12792111|P4|COMPLETED|Overall Study||6
5202402|NCT01035658|12792112|P3|COMPLETED|Overall Study||3
5202403|NCT01035658|12792113|P2|COMPLETED|Overall Study||8
5202404|NCT01035658|12792114|P1|COMPLETED|Overall Study||5
5202405|NCT01035658|12792111|P4|STARTED|Overall Study||6
5202406|NCT01035658|12792112|P3|STARTED|Overall Study||3
5202407|NCT01035658|12792113|P2|STARTED|Overall Study||8
5202408|NCT01035658|12792114|P1|STARTED|Overall Study||5
5202409|NCT01035606|12792140|P3|NOT COMPLETED|Overall Study||4
5202410|NCT01035606|12792141|P2|NOT COMPLETED|Overall Study||3
5202411|NCT01035606|12792142|P1|NOT COMPLETED|Overall Study||3
5202412|NCT01035606|12792140|P3|COMPLETED|Overall Study||7
5202413|NCT01035606|12792141|P2|COMPLETED|Overall Study||16
5202414|NCT01035606|12792142|P1|COMPLETED|Overall Study||16
5202415|NCT01035606|12792140|P3|STARTED|Overall Study||11
5202416|NCT01035606|12792141|P2|STARTED|Overall Study||19
5202417|NCT01035606|12792142|P1|STARTED|Overall Study||19
5202418|NCT01035463|12792158|P6|NOT COMPLETED|Overall Study||18
5202419|NCT01035463|12792159|P5|NOT COMPLETED|Overall Study||6
5202420|NCT01035463|12792160|P4|NOT COMPLETED|Overall Study||2
5202421|NCT01035463|12792161|P3|NOT COMPLETED|Overall Study||5
5202422|NCT01035463|12792162|P2|NOT COMPLETED|Overall Study||2
5202423|NCT01035463|12792163|P1|NOT COMPLETED|Overall Study||0
5202424|NCT01035463|12792158|P6|COMPLETED|Overall Study||15
5202425|NCT01035463|12792159|P5|COMPLETED|Overall Study||1
5202426|NCT01035463|12792160|P4|COMPLETED|Overall Study||2
5202427|NCT01035463|12792161|P3|COMPLETED|Overall Study||1
5202428|NCT01035463|12792162|P2|COMPLETED|Overall Study||1
5202429|NCT01035463|12792163|P1|COMPLETED|Overall Study||6
5202430|NCT01035463|12792158|P6|STARTED|Overall Study||33
5202431|NCT01035463|12792159|P5|STARTED|Overall Study||7
5202432|NCT01035463|12792160|P4|STARTED|Overall Study||4
5202433|NCT01035463|12792161|P3|STARTED|Overall Study||6
5202434|NCT01035463|12792162|P2|STARTED|Overall Study||3
5202435|NCT01035463|12792163|P1|STARTED|Overall Study||6
5202436|NCT01035346|12792174|P2|NOT COMPLETED|Overall Study||0
5202437|NCT01035346|12792175|P1|NOT COMPLETED|Overall Study||0
5202438|NCT01035346|12792174|P2|COMPLETED|Overall Study||9
5202439|NCT01035346|12792175|P1|COMPLETED|Overall Study||7
5202440|NCT01035346|12792174|P2|STARTED|Overall Study||9
5202441|NCT01035346|12792175|P1|STARTED|Overall Study||7
5202442|NCT01035333|12792193|P1|NOT COMPLETED|Overall Study||10
5202443|NCT01035333|12792193|P1|COMPLETED|Overall Study||9
5202444|NCT01035333|12792193|P1|STARTED|Overall Study||19
5202445|NCT01035255|12792200|P2|NOT COMPLETED|Overall Study||862
5202446|NCT01035255|12792201|P1|NOT COMPLETED|Overall Study||741
5202447|NCT01035255|12792200|P2|COMPLETED|Overall Study||3371
5202448|NCT01035255|12792201|P1|COMPLETED|Overall Study||3468
5202449|NCT01035255|12792200|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
5202450|NCT01035255|12792201|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
5202451|NCT01035255|12792200|P2|Mis-randomized|Overall Study||2
5202452|NCT01035255|12792201|P1|Mis-randomized|Overall Study||4
5202453|NCT01035255|12792200|P2|GCP Violations|Overall Study||19
5202454|NCT01035255|12792201|P1|GCP Violations|Overall Study||18
5202455|NCT01035255|12792200|P2|STARTED|Overall Study||4233
5202456|NCT01035255|12792201|P1|STARTED|Overall Study||4209
5202457|NCT01035229|12792219|P2|NOT COMPLETED|Overall Study||184
5202458|NCT01035229|12792220|P1|NOT COMPLETED|Overall Study||362
5202459|NCT01035229|12792219|P2|COMPLETED|Overall Study||0
5202460|NCT01035229|12792220|P1|COMPLETED|Overall Study||0
5202461|NCT01035229|12792219|P2|STARTED|Overall Study||184
5202462|NCT01035229|12792220|P1|STARTED|Overall Study||362
5202463|NCT01035151|12792240|P2|NOT COMPLETED|Overall Study||15
5202464|NCT01035151|12792241|P1|NOT COMPLETED|Overall Study||21
5202465|NCT01035151|12792240|P2|COMPLETED|Overall Study||185
5202466|NCT01035151|12792241|P1|COMPLETED|Overall Study||188
5202467|NCT01035151|12792240|P2|STARTED|Overall Study||200
5202468|NCT01035151|12792241|P1|STARTED|Overall Study||209
5202469|NCT01035138|12792250|P3|NOT COMPLETED|Overall Study||47
5202470|NCT01035138|12792251|P2|NOT COMPLETED|Overall Study||60
5202471|NCT01035138|12792252|P1|NOT COMPLETED|Overall Study||73
5202472|NCT01035138|12792250|P3|COMPLETED|Overall Study||0
5202473|NCT01035138|12792251|P2|COMPLETED|Overall Study||0
5202474|NCT01035138|12792252|P1|COMPLETED|Overall Study||0
5202475|NCT01035138|12792250|P3|STARTED|Overall Study||47
5202476|NCT01035138|12792251|P2|STARTED|Overall Study||60
5202477|NCT01035138|12792252|P1|STARTED|Overall Study||73
5202478|NCT01035099|12792308|P2|NOT COMPLETED|Overall Study||0
5202479|NCT01035099|12792309|P1|NOT COMPLETED|Overall Study||0
5202480|NCT01035099|12792308|P2|COMPLETED|Overall Study||22
5202481|NCT01035099|12792309|P1|COMPLETED|Overall Study||18
5202482|NCT01035099|12792308|P2|STARTED|Overall Study||22
5202483|NCT01035099|12792309|P1|STARTED|Overall Study||18
5202484|NCT01035073|12792345|P1|NOT COMPLETED|Overall Study||0
5202485|NCT01035073|12792345|P1|COMPLETED|Overall Study||0
5202486|NCT01035073|12792345|P1|STARTED|Overall Study||0
5202487|NCT01035060|12792352|P2|NOT COMPLETED|Overall Study||14
5202488|NCT01035060|12792353|P1|NOT COMPLETED|Overall Study||24
5202489|NCT01035060|12792352|P2|COMPLETED|Overall Study||15
5202490|NCT01035060|12792353|P1|COMPLETED|Overall Study||15
5202491|NCT01035060|12792352|P2|STARTED|Overall Study||29
5202492|NCT01035060|12792353|P1|STARTED|Overall Study||39
5202493|NCT01035047|12792361|P2|NOT COMPLETED|Overall Study||0
5202494|NCT01035047|12792362|P1|NOT COMPLETED|Overall Study||0
5202495|NCT01035047|12792361|P2|COMPLETED|Overall Study||53
5202496|NCT01035047|12792362|P1|COMPLETED|Overall Study||52
5202497|NCT01035047|12792361|P2|STARTED|Overall Study||53
5202498|NCT01035047|12792362|P1|STARTED|Overall Study||52
5202499|NCT01034709|12792378|P2|NOT COMPLETED|Overall Study||16
5202500|NCT01034709|12792379|P1|NOT COMPLETED|Overall Study||9
5202501|NCT01034709|12792378|P2|COMPLETED|Overall Study||42
5202502|NCT01034709|12792379|P1|COMPLETED|Overall Study||44
5202503|NCT01034709|12792378|P2|STARTED|Overall Study||58
5202504|NCT01034709|12792379|P1|STARTED|Overall Study||53
5202505|NCT01034657|12792385|P3|NOT COMPLETED|Randomized Phase||1
5202506|NCT01034657|12792386|P2|NOT COMPLETED|Randomized Phase||6
5202507|NCT01034657|12792387|P1|NOT COMPLETED|Randomized Phase||5
5202508|NCT01034657|12792385|P3|COMPLETED|Randomized Phase||0
5202509|NCT01034657|12792386|P2|COMPLETED|Randomized Phase||0
5202510|NCT01034657|12792387|P1|COMPLETED|Randomized Phase||1
5202511|NCT01034657|12792385|P3|STARTED|Randomized Phase||1
5202512|NCT01034657|12792386|P2|STARTED|Randomized Phase||6
5202513|NCT01034657|12792387|P1|STARTED|Randomized Phase||6
5202514|NCT01034657|12792385|P3|NOT COMPLETED|Core Phase||0
5202515|NCT01034657|12792386|P2|NOT COMPLETED|Core Phase||0
5202516|NCT01034657|12792387|P1|NOT COMPLETED|Core Phase||14
5202517|NCT01034657|12792385|P3|COMPLETED|Core Phase||0
5202518|NCT01034657|12792386|P2|COMPLETED|Core Phase||0
5202519|NCT01034657|12792387|P1|COMPLETED|Core Phase||20
5202520|NCT01034657|12792385|P3|STARTED|Core Phase||0
5202521|NCT01034657|12792386|P2|STARTED|Core Phase||0
5202522|NCT01034657|12792387|P1|STARTED|Core Phase||34
5202523|NCT01034631|12792428|P3|NOT COMPLETED|Phase II||2
5202524|NCT01034631|12792429|P2|NOT COMPLETED|Phase II||1
5202525|NCT01034631|12792430|P1|NOT COMPLETED|Phase II||0
5202526|NCT01034631|12792428|P3|COMPLETED|Phase II||67
5202527|NCT01034631|12792429|P2|COMPLETED|Phase II||69
5202528|NCT01034631|12792430|P1|COMPLETED|Phase II||0
5202529|NCT01034631|12792428|P3|STARTED|Phase II||69
5202530|NCT01034631|12792429|P2|STARTED|Phase II||70
5202531|NCT01034631|12792430|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
5202532|NCT01034631|12792428|P3|NOT COMPLETED|Phase I||0
5202533|NCT01034631|12792429|P2|NOT COMPLETED|Phase I||0
5202534|NCT01034631|12792430|P1|NOT COMPLETED|Phase I||3
5202535|NCT01034631|12792428|P3|COMPLETED|Phase I||0
5202536|NCT01034631|12792429|P2|COMPLETED|Phase I||0
5202537|NCT01034631|12792430|P1|COMPLETED|Phase I||12
5202538|NCT01034631|12792428|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
5202539|NCT01034631|12792429|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
5202540|NCT01034631|12792430|P1|STARTED|Phase I||15
5202541|NCT01034592|12792449|P1|NOT COMPLETED|Overall Study||0
5202542|NCT01034592|12792449|P1|COMPLETED|Overall Study||2
5202543|NCT01034592|12792449|P1|STARTED|Overall Study||2
5202544|NCT01034579|12792461|P2|NOT COMPLETED|Overall Study||0
5202545|NCT01034579|12792462|P1|NOT COMPLETED|Overall Study||0
5202546|NCT01034579|12792461|P2|COMPLETED|Overall Study||166
5202547|NCT01034579|12792462|P1|COMPLETED|Overall Study||158
5202548|NCT01034579|12792461|P2|STARTED|Overall Study||166
5202549|NCT01034579|12792462|P1|STARTED|Overall Study||158
5202550|NCT01034553|12792476|P6|NOT COMPLETED|Overall Study||0
5202551|NCT01034553|12792477|P5|NOT COMPLETED|Overall Study||0
5202552|NCT01034553|12792478|P4|NOT COMPLETED|Overall Study||0
5202553|NCT01034553|12792479|P3|NOT COMPLETED|Overall Study||0
5202554|NCT01034553|12792480|P2|NOT COMPLETED|Overall Study||0
5202555|NCT01034553|12792481|P1|NOT COMPLETED|Overall Study||0
5202556|NCT01034553|12792476|P6|COMPLETED|Overall Study||7
5202557|NCT01034553|12792477|P5|COMPLETED|Overall Study||6
5202558|NCT01034553|12792478|P4|COMPLETED|Overall Study||3
5202559|NCT01034553|12792479|P3|COMPLETED|Overall Study||3
5202560|NCT01034553|12792480|P2|COMPLETED|Overall Study||4
5202561|NCT01034553|12792481|P1|COMPLETED|Overall Study||3
5202562|NCT01034553|12792476|P6|STARTED|Overall Study||7
5202563|NCT01034553|12792477|P5|STARTED|Overall Study||6
5202564|NCT01034553|12792478|P4|STARTED|Overall Study||3
5202565|NCT01034553|12792479|P3|STARTED|Overall Study||3
5202566|NCT01034553|12792480|P2|STARTED|Overall Study||4
5202567|NCT01034553|12792481|P1|STARTED|Overall Study||3
5202568|NCT01034540|12792497|P2|NOT COMPLETED|Overall Study||1
5202569|NCT01034540|12792498|P1|NOT COMPLETED|Overall Study||0
5202570|NCT01034540|12792497|P2|COMPLETED|Overall Study||11
5202571|NCT01034540|12792498|P1|COMPLETED|Overall Study||11
5202572|NCT01034540|12792497|P2|Completed 1st Treatment Intervention|Overall Study||11
5202573|NCT01034540|12792498|P1|Completed 1st Treatment Intervention|Overall Study||11
5202574|NCT01034540|12792497|P2|STARTED|Overall Study||12
5202575|NCT01034540|12792498|P1|STARTED|Overall Study||11
5202576|NCT01034527|12792508|P2|NOT COMPLETED|Overall Study||0
5202577|NCT01034527|12792509|P1|NOT COMPLETED|Overall Study||0
5202578|NCT01034527|12792508|P2|COMPLETED|Overall Study||216
5202579|NCT01034527|12792509|P1|COMPLETED|Overall Study||307
5202580|NCT01034527|12792508|P2|STARTED|Overall Study||216
5202581|NCT01034527|12792509|P1|STARTED|Overall Study||307
5202582|NCT01034462|12792517|P2|NOT COMPLETED|Overall Study||54
5202583|NCT01034462|12792518|P1|NOT COMPLETED|Overall Study||45
5202584|NCT01034462|12792517|P2|COMPLETED|Overall Study||163
5202585|NCT01034462|12792518|P1|COMPLETED|Overall Study||172
5202586|NCT01034462|12792517|P2|STARTED|Overall Study||217
5202587|NCT01034462|12792518|P1|STARTED|Overall Study||217
5202588|NCT01034397|12792528|P2|NOT COMPLETED|Overall Study||2
5202589|NCT01034397|12792529|P1|NOT COMPLETED|Overall Study||7
5202590|NCT01034397|12792528|P2|COMPLETED|Overall Study||17
5202591|NCT01034397|12792529|P1|COMPLETED|Overall Study||28
5202592|NCT01034397|12792528|P2|STARTED|Overall Study||19
5202593|NCT01034397|12792529|P1|STARTED|Overall Study||35
5202594|NCT01034358|12792678|P1|NOT COMPLETED|Overall Study||2
5202595|NCT01034358|12792678|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
5202596|NCT01034358|12792678|P1|STARTED|Overall Study||15
5202597|NCT01034306|12792684|P2|NOT COMPLETED|Overall Study||3
5202598|NCT01034306|12792685|P1|NOT COMPLETED|Overall Study||5
5202599|NCT01034306|12792684|P2|COMPLETED|Overall Study||34
5202600|NCT01034306|12792685|P1|COMPLETED|Overall Study||37
5202601|NCT01034306|12792684|P2|STARTED|Overall Study||37
5202602|NCT01034306|12792685|P1|STARTED|Overall Study||42
5202603|NCT01034176|12792693|P2|NOT COMPLETED|Overall Study||2
5202604|NCT01034176|12792694|P1|NOT COMPLETED|Overall Study||2
5202605|NCT01034176|12792693|P2|COMPLETED|Overall Study||19
5202606|NCT01034176|12792694|P1|COMPLETED|Overall Study||20
5202607|NCT01034176|12792693|P2|STARTED|Overall Study||21
5202608|NCT01034176|12792694|P1|STARTED|Overall Study||22
5202609|NCT01034163|12792704|P2|NOT COMPLETED|Overall Study||14
5202610|NCT01034163|12792705|P1|NOT COMPLETED|Overall Study||27
5202611|NCT01034163|12792704|P2|COMPLETED|Overall Study||0
5202612|NCT01034163|12792705|P1|COMPLETED|Overall Study||0
5202613|NCT01034163|12792704|P2|In Open Label Phase After Unblinding|Overall Study||0
5202614|NCT01034163|12792705|P1|In Open Label Phase After Unblinding|Overall Study||5
5202615|NCT01034163|12792704|P2|Safety Set|Overall Study||12
5202616|NCT01034163|12792705|P1|Safety Set|Overall Study||26
5202617|NCT01034163|12792704|P2|Untreated (Not in Safety Set)|Overall Study||2
5202618|NCT01034163|12792705|P1|Untreated (Not in Safety Set)|Overall Study||1
5202619|NCT01034163|12792704|P2|STARTED|Overall Study||14
5202620|NCT01034163|12792705|P1|STARTED|Overall Study||27
5202621|NCT01034137|12792714|P3|NOT COMPLETED|Overall Study||30
5202622|NCT01034137|12792715|P2|NOT COMPLETED|Overall Study||22
5202623|NCT01034137|12792716|P1|NOT COMPLETED|Overall Study||28
5202624|NCT01034137|12792714|P3|COMPLETED|Overall Study||78
5202625|NCT01034137|12792715|P2|COMPLETED|Overall Study||81
5202626|NCT01034137|12792716|P1|COMPLETED|Overall Study||78
5202627|NCT01034137|12792714|P3|STARTED|Overall Study||108
5202628|NCT01034137|12792715|P2|STARTED|Overall Study||103
5202629|NCT01034137|12792716|P1|STARTED|Overall Study||106
5202630|NCT01034111|12792847|P1|NOT COMPLETED|Overall Study||0
5202631|NCT01034111|12792847|P1|COMPLETED|Overall Study||30
5202632|NCT01034111|12792847|P1|STARTED|Overall Study||30
5202633|NCT01033942|12792855|P3|NOT COMPLETED|Overall Study||1
5202634|NCT01033942|12792856|P2|NOT COMPLETED|Overall Study||4
5202635|NCT01033942|12792857|P1|NOT COMPLETED|Overall Study||2
5202636|NCT01033942|12792855|P3|COMPLETED|Overall Study||18
5202637|NCT01033942|12792856|P2|COMPLETED|Overall Study||15
5202638|NCT01033942|12792857|P1|COMPLETED|Overall Study||18
5202639|NCT01033942|12792855|P3|STARTED|Overall Study||19
5202640|NCT01033942|12792856|P2|STARTED|Overall Study||19
5202641|NCT01033942|12792857|P1|STARTED|Overall Study||20
5202642|NCT01033864|12793129|P2|NOT COMPLETED|Overall Study||0
5202643|NCT01033864|12793130|P1|NOT COMPLETED|Overall Study||0
5202644|NCT01033864|12793129|P2|COMPLETED|Overall Study||11
5202645|NCT01033864|12793130|P1|COMPLETED|Overall Study||12
5202646|NCT01033864|12793129|P2|STARTED|Overall Study||11
5202647|NCT01033864|12793130|P1|STARTED|Overall Study||12
5202648|NCT01033851|12793155|P2|NOT COMPLETED|Overall Study||7
5202649|NCT01033851|12793156|P1|NOT COMPLETED|Overall Study||3
5202650|NCT01033851|12793155|P2|COMPLETED|Overall Study||34
5202651|NCT01033851|12793156|P1|COMPLETED|Overall Study||45
5202652|NCT01033851|12793155|P2|STARTED|Overall Study||41
5202653|NCT01033851|12793156|P1|STARTED|Overall Study||48
5202654|NCT01033825|12793171|P7|NOT COMPLETED|Overall Study||0
5202655|NCT01033825|12793172|P6|NOT COMPLETED|Overall Study||0
5202656|NCT01033825|12793173|P5|NOT COMPLETED|Overall Study||2
5202657|NCT01033825|12793174|P4|NOT COMPLETED|Overall Study||2
5202658|NCT01033825|12793175|P3|NOT COMPLETED|Overall Study||2
5202659|NCT01033825|12793176|P2|NOT COMPLETED|Overall Study||3
5202660|NCT01033825|12793177|P1|NOT COMPLETED|Overall Study||3
5202661|NCT01033825|12793171|P7|COMPLETED|Overall Study||18
5202662|NCT01033825|12793172|P6|COMPLETED|Overall Study||18
5202663|NCT01033825|12793173|P5|COMPLETED|Overall Study||56
5202664|NCT01033825|12793174|P4|COMPLETED|Overall Study||46
5202665|NCT01033825|12793175|P3|COMPLETED|Overall Study||55
5202666|NCT01033825|12793176|P2|COMPLETED|Overall Study||57
5202667|NCT01033825|12793177|P1|COMPLETED|Overall Study||48
5202668|NCT01033825|12793171|P7|STARTED|Overall Study||18
5202669|NCT01033825|12793172|P6|STARTED|Overall Study||18
5202670|NCT01033825|12793173|P5|STARTED|Overall Study||58
5202671|NCT01033825|12793174|P4|STARTED|Overall Study||48
5202672|NCT01033825|12793175|P3|STARTED|Overall Study||57
5202673|NCT01033825|12793176|P2|STARTED|Overall Study||60
5202674|NCT01033825|12793177|P1|STARTED|Overall Study||51
5202675|NCT01033747|12793398|P2|NOT COMPLETED|Overall Study||15
5202676|NCT01033747|12793399|P1|NOT COMPLETED|Overall Study||37
5202677|NCT01033747|12793398|P2|COMPLETED|Overall Study||4
5202678|NCT01033747|12793399|P1|COMPLETED|Overall Study||14
5202679|NCT01033747|12793398|P2|STARTED|Overall Study||19
5202680|NCT01033747|12793399|P1|STARTED|Overall Study||51
5202681|NCT01033734|12793407|P1|NOT COMPLETED|Overall Study||1
5202682|NCT01033734|12793407|P1|COMPLETED|Overall Study||7
5202683|NCT01033734|12793407|P1|STARTED|Overall Study||8
5202684|NCT01033565|12793459|P1|NOT COMPLETED|Overall Study||0
5202685|NCT01033565|12793459|P1|COMPLETED|Overall Study||1
5202686|NCT01033565|12793459|P1|STARTED|Overall Study||1
5202687|NCT01033487|12793463|P10|NOT COMPLETED|Fifth Intervention Period||0
5202688|NCT01033487|12793464|P9|NOT COMPLETED|Fifth Intervention Period||0
5202689|NCT01033487|12793465|P8|NOT COMPLETED|Fifth Intervention Period||0
5202690|NCT01033487|12793466|P7|NOT COMPLETED|Fifth Intervention Period||0
5202691|NCT01033487|12793467|P6|NOT COMPLETED|Fifth Intervention Period||0
5202692|NCT01033487|12793468|P5|NOT COMPLETED|Fifth Intervention Period||0
5202693|NCT01033487|12793469|P4|NOT COMPLETED|Fifth Intervention Period||0
5202694|NCT01033487|12793470|P3|NOT COMPLETED|Fifth Intervention Period||0
5202695|NCT01033487|12793471|P2|NOT COMPLETED|Fifth Intervention Period||0
5202696|NCT01033487|12793472|P1|NOT COMPLETED|Fifth Intervention Period||0
5202697|NCT01033487|12793463|P10|COMPLETED|Fifth Intervention Period||2
5202698|NCT01033487|12793464|P9|COMPLETED|Fifth Intervention Period||1
5202699|NCT01033487|12793465|P8|COMPLETED|Fifth Intervention Period||3
5202700|NCT01033487|12793466|P7|COMPLETED|Fifth Intervention Period||2
5202701|NCT01033487|12793467|P6|COMPLETED|Fifth Intervention Period||2
5202702|NCT01033487|12793468|P5|COMPLETED|Fifth Intervention Period||2
5202703|NCT01033487|12793469|P4|COMPLETED|Fifth Intervention Period||2
5202704|NCT01033487|12793470|P3|COMPLETED|Fifth Intervention Period||2
5202705|NCT01033487|12793471|P2|COMPLETED|Fifth Intervention Period||3
5202706|NCT01033487|12793472|P1|COMPLETED|Fifth Intervention Period||2
5202707|NCT01033487|12793463|P10|STARTED|Fifth Intervention Period||2
5202708|NCT01033487|12793464|P9|STARTED|Fifth Intervention Period||1
5202709|NCT01033487|12793465|P8|STARTED|Fifth Intervention Period||3
5202710|NCT01033487|12793466|P7|STARTED|Fifth Intervention Period||2
5202711|NCT01033487|12793467|P6|STARTED|Fifth Intervention Period||2
5202712|NCT01033487|12793468|P5|STARTED|Fifth Intervention Period||2
5202713|NCT01033487|12793469|P4|STARTED|Fifth Intervention Period||2
5202714|NCT01033487|12793470|P3|STARTED|Fifth Intervention Period||2
5202715|NCT01033487|12793471|P2|STARTED|Fifth Intervention Period||3
5202716|NCT01033487|12793472|P1|STARTED|Fifth Intervention Period||2
5202717|NCT01033487|12793463|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202718|NCT01033487|12793464|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202719|NCT01033487|12793465|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202720|NCT01033487|12793466|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202721|NCT01033487|12793467|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202722|NCT01033487|12793468|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202723|NCT01033487|12793469|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202724|NCT01033487|12793470|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202725|NCT01033487|12793471|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202726|NCT01033487|12793472|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
5202727|NCT01033487|12793463|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202728|NCT01033487|12793464|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
5202729|NCT01033487|12793465|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
5202730|NCT01033487|12793466|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202731|NCT01033487|12793467|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202732|NCT01033487|12793468|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202733|NCT01033487|12793469|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202734|NCT01033487|12793470|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202735|NCT01033487|12793471|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
5202736|NCT01033487|12793472|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
5202737|NCT01033487|12793463|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202738|NCT01033487|12793464|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
5202739|NCT01033487|12793465|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
5202740|NCT01033487|12793466|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202741|NCT01033487|12793467|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202742|NCT01033487|12793468|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202743|NCT01033487|12793469|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202744|NCT01033487|12793470|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202745|NCT01033487|12793471|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
5202746|NCT01033487|12793472|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
5202747|NCT01033487|12793463|P10|NOT COMPLETED|Fourth Intervention Period||0
5202748|NCT01033487|12793464|P9|NOT COMPLETED|Fourth Intervention Period||1
5202749|NCT01033487|12793465|P8|NOT COMPLETED|Fourth Intervention Period||0
5202750|NCT01033487|12793466|P7|NOT COMPLETED|Fourth Intervention Period||0
5202751|NCT01033487|12793467|P6|NOT COMPLETED|Fourth Intervention Period||0
5202752|NCT01033487|12793468|P5|NOT COMPLETED|Fourth Intervention Period||0
5202753|NCT01033487|12793469|P4|NOT COMPLETED|Fourth Intervention Period||0
5202754|NCT01033487|12793470|P3|NOT COMPLETED|Fourth Intervention Period||0
5202755|NCT01033487|12793471|P2|NOT COMPLETED|Fourth Intervention Period||0
5202756|NCT01033487|12793472|P1|NOT COMPLETED|Fourth Intervention Period||0
5202757|NCT01033487|12793463|P10|COMPLETED|Fourth Intervention Period||2
5202758|NCT01033487|12793464|P9|COMPLETED|Fourth Intervention Period||1
5202759|NCT01033487|12793465|P8|COMPLETED|Fourth Intervention Period||3
5202760|NCT01033487|12793466|P7|COMPLETED|Fourth Intervention Period||2
5202761|NCT01033487|12793467|P6|COMPLETED|Fourth Intervention Period||2
5202762|NCT01033487|12793468|P5|COMPLETED|Fourth Intervention Period||2
5202763|NCT01033487|12793469|P4|COMPLETED|Fourth Intervention Period||2
5202764|NCT01033487|12793470|P3|COMPLETED|Fourth Intervention Period||2
5202765|NCT01033487|12793471|P2|COMPLETED|Fourth Intervention Period||3
5202766|NCT01033487|12793472|P1|COMPLETED|Fourth Intervention Period||2
5202767|NCT01033487|12793463|P10|STARTED|Fourth Intervention Period||2
5202768|NCT01033487|12793464|P9|STARTED|Fourth Intervention Period||2
5202769|NCT01033487|12793465|P8|STARTED|Fourth Intervention Period||3
5202770|NCT01033487|12793466|P7|STARTED|Fourth Intervention Period||2
5202771|NCT01033487|12793467|P6|STARTED|Fourth Intervention Period||2
5202772|NCT01033487|12793468|P5|STARTED|Fourth Intervention Period||2
5202773|NCT01033487|12793469|P4|STARTED|Fourth Intervention Period||2
5202774|NCT01033487|12793470|P3|STARTED|Fourth Intervention Period||2
5202775|NCT01033487|12793471|P2|STARTED|Fourth Intervention Period||3
5202776|NCT01033487|12793472|P1|STARTED|Fourth Intervention Period||2
5202777|NCT01033487|12793463|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202778|NCT01033487|12793464|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202779|NCT01033487|12793465|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202780|NCT01033487|12793466|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202781|NCT01033487|12793467|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202782|NCT01033487|12793468|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202783|NCT01033487|12793469|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202784|NCT01033487|12793470|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202785|NCT01033487|12793471|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202786|NCT01033487|12793472|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
5202787|NCT01033487|12793463|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202788|NCT01033487|12793464|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202789|NCT01033487|12793465|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
5202790|NCT01033487|12793466|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202791|NCT01033487|12793467|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202792|NCT01033487|12793468|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202793|NCT01033487|12793469|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202794|NCT01033487|12793470|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202795|NCT01033487|12793471|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
5202796|NCT01033487|12793472|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
5202797|NCT01033487|12793463|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202798|NCT01033487|12793464|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202799|NCT01033487|12793465|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
5202800|NCT01033487|12793466|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202801|NCT01033487|12793467|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202802|NCT01033487|12793468|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202803|NCT01033487|12793469|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202804|NCT01033487|12793470|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202805|NCT01033487|12793471|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
5202806|NCT01033487|12793472|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
5202807|NCT01033487|12793463|P10|NOT COMPLETED|Third Intervention Period||0
5202808|NCT01033487|12793464|P9|NOT COMPLETED|Third Intervention Period||0
5202809|NCT01033487|12793465|P8|NOT COMPLETED|Third Intervention Period||0
5202810|NCT01033487|12793466|P7|NOT COMPLETED|Third Intervention Period||0
5202811|NCT01033487|12793467|P6|NOT COMPLETED|Third Intervention Period||0
5202812|NCT01033487|12793468|P5|NOT COMPLETED|Third Intervention Period||0
5202813|NCT01033487|12793469|P4|NOT COMPLETED|Third Intervention Period||0
5202814|NCT01033487|12793470|P3|NOT COMPLETED|Third Intervention Period||0
5202815|NCT01033487|12793471|P2|NOT COMPLETED|Third Intervention Period||0
5202816|NCT01033487|12793472|P1|NOT COMPLETED|Third Intervention Period||0
5202817|NCT01033487|12793463|P10|COMPLETED|Third Intervention Period||2
5202818|NCT01033487|12793464|P9|COMPLETED|Third Intervention Period||2
5202819|NCT01033487|12793465|P8|COMPLETED|Third Intervention Period||3
5202820|NCT01033487|12793466|P7|COMPLETED|Third Intervention Period||2
5202821|NCT01033487|12793467|P6|COMPLETED|Third Intervention Period||2
5202822|NCT01033487|12793468|P5|COMPLETED|Third Intervention Period||2
5202823|NCT01033487|12793469|P4|COMPLETED|Third Intervention Period||2
5202824|NCT01033487|12793470|P3|COMPLETED|Third Intervention Period||2
5202825|NCT01033487|12793471|P2|COMPLETED|Third Intervention Period||3
5202826|NCT01033487|12793472|P1|COMPLETED|Third Intervention Period||2
5202827|NCT01033487|12793463|P10|STARTED|Third Intervention Period||2
5202828|NCT01033487|12793464|P9|STARTED|Third Intervention Period||2
5202829|NCT01033487|12793465|P8|STARTED|Third Intervention Period||3
5202830|NCT01033487|12793466|P7|STARTED|Third Intervention Period||2
5202831|NCT01033487|12793467|P6|STARTED|Third Intervention Period||2
5202832|NCT01033487|12793468|P5|STARTED|Third Intervention Period||2
5202833|NCT01033487|12793469|P4|STARTED|Third Intervention Period||2
5202834|NCT01033487|12793470|P3|STARTED|Third Intervention Period||2
5202835|NCT01033487|12793471|P2|STARTED|Third Intervention Period||3
5202836|NCT01033487|12793472|P1|STARTED|Third Intervention Period||2
5202837|NCT01033487|12793463|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202838|NCT01033487|12793464|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202839|NCT01033487|12793465|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202840|NCT01033487|12793466|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202841|NCT01033487|12793467|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202842|NCT01033487|12793468|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202843|NCT01033487|12793469|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202844|NCT01033487|12793470|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202845|NCT01033487|12793471|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202846|NCT01033487|12793472|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
5202847|NCT01033487|12793463|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202848|NCT01033487|12793464|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202849|NCT01033487|12793465|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
5202850|NCT01033487|12793466|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202851|NCT01033487|12793467|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202852|NCT01033487|12793468|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202853|NCT01033487|12793469|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202854|NCT01033487|12793470|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202855|NCT01033487|12793471|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
5202856|NCT01033487|12793472|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
5202857|NCT01033487|12793463|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202858|NCT01033487|12793464|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202859|NCT01033487|12793465|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
5202860|NCT01033487|12793466|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202861|NCT01033487|12793467|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202862|NCT01033487|12793468|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202863|NCT01033487|12793469|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202864|NCT01033487|12793470|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202865|NCT01033487|12793471|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
5202866|NCT01033487|12793472|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
5202867|NCT01033487|12793463|P10|NOT COMPLETED|Second Intervention Period||0
5202868|NCT01033487|12793464|P9|NOT COMPLETED|Second Intervention Period||0
5202869|NCT01033487|12793465|P8|NOT COMPLETED|Second Intervention Period||0
5202870|NCT01033487|12793466|P7|NOT COMPLETED|Second Intervention Period||0
5202871|NCT01033487|12793467|P6|NOT COMPLETED|Second Intervention Period||0
5202872|NCT01033487|12793468|P5|NOT COMPLETED|Second Intervention Period||0
5202873|NCT01033487|12793469|P4|NOT COMPLETED|Second Intervention Period||0
5202874|NCT01033487|12793470|P3|NOT COMPLETED|Second Intervention Period||0
5202875|NCT01033487|12793471|P2|NOT COMPLETED|Second Intervention Period||0
5202876|NCT01033487|12793472|P1|NOT COMPLETED|Second Intervention Period||0
5202877|NCT01033487|12793463|P10|COMPLETED|Second Intervention Period||2
5202878|NCT01033487|12793464|P9|COMPLETED|Second Intervention Period||2
5202879|NCT01033487|12793465|P8|COMPLETED|Second Intervention Period||3
5202880|NCT01033487|12793466|P7|COMPLETED|Second Intervention Period||2
5202881|NCT01033487|12793467|P6|COMPLETED|Second Intervention Period||2
5202882|NCT01033487|12793468|P5|COMPLETED|Second Intervention Period||2
5202883|NCT01033487|12793469|P4|COMPLETED|Second Intervention Period||2
5202884|NCT01033487|12793470|P3|COMPLETED|Second Intervention Period||2
5202885|NCT01033487|12793471|P2|COMPLETED|Second Intervention Period||3
5202886|NCT01033487|12793472|P1|COMPLETED|Second Intervention Period||2
5202887|NCT01033487|12793463|P10|STARTED|Second Intervention Period||2
5202888|NCT01033487|12793464|P9|STARTED|Second Intervention Period||2
5202889|NCT01033487|12793465|P8|STARTED|Second Intervention Period||3
5202890|NCT01033487|12793466|P7|STARTED|Second Intervention Period||2
5202891|NCT01033487|12793467|P6|STARTED|Second Intervention Period||2
5202892|NCT01033487|12793468|P5|STARTED|Second Intervention Period||2
5202893|NCT01033487|12793469|P4|STARTED|Second Intervention Period||2
5202894|NCT01033487|12793470|P3|STARTED|Second Intervention Period||2
5202895|NCT01033487|12793471|P2|STARTED|Second Intervention Period||3
5202896|NCT01033487|12793472|P1|STARTED|Second Intervention Period||2
5202897|NCT01033487|12793463|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202898|NCT01033487|12793464|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202899|NCT01033487|12793465|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202900|NCT01033487|12793466|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202901|NCT01033487|12793467|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202902|NCT01033487|12793468|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202903|NCT01033487|12793469|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202904|NCT01033487|12793470|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202905|NCT01033487|12793471|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202906|NCT01033487|12793472|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
5202907|NCT01033487|12793463|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202908|NCT01033487|12793464|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202909|NCT01033487|12793465|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
5202910|NCT01033487|12793466|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202911|NCT01033487|12793467|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202912|NCT01033487|12793468|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202913|NCT01033487|12793469|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202914|NCT01033487|12793470|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202915|NCT01033487|12793471|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
5202916|NCT01033487|12793472|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
5202917|NCT01033487|12793463|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202918|NCT01033487|12793464|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202919|NCT01033487|12793465|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
5202920|NCT01033487|12793466|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202921|NCT01033487|12793467|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202922|NCT01033487|12793468|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202923|NCT01033487|12793469|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202924|NCT01033487|12793470|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202925|NCT01033487|12793471|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
5202926|NCT01033487|12793472|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
5202927|NCT01033487|12793463|P10|NOT COMPLETED|First Intervention Period||0
5202928|NCT01033487|12793464|P9|NOT COMPLETED|First Intervention Period||0
5202929|NCT01033487|12793465|P8|NOT COMPLETED|First Intervention Period||0
5202930|NCT01033487|12793466|P7|NOT COMPLETED|First Intervention Period||0
5202931|NCT01033487|12793467|P6|NOT COMPLETED|First Intervention Period||0
5202932|NCT01033487|12793468|P5|NOT COMPLETED|First Intervention Period||0
5202933|NCT01033487|12793469|P4|NOT COMPLETED|First Intervention Period||0
5202934|NCT01033487|12793470|P3|NOT COMPLETED|First Intervention Period||0
5202935|NCT01033487|12793471|P2|NOT COMPLETED|First Intervention Period||0
5202936|NCT01033487|12793472|P1|NOT COMPLETED|First Intervention Period||0
5202937|NCT01033487|12793463|P10|COMPLETED|First Intervention Period||2
5202938|NCT01033487|12793464|P9|COMPLETED|First Intervention Period||2
5202939|NCT01033487|12793465|P8|COMPLETED|First Intervention Period||3
5202940|NCT01033487|12793466|P7|COMPLETED|First Intervention Period||2
5202941|NCT01033487|12793467|P6|COMPLETED|First Intervention Period||2
5202942|NCT01033487|12793468|P5|COMPLETED|First Intervention Period||2
5202943|NCT01033487|12793469|P4|COMPLETED|First Intervention Period||2
5202944|NCT01033487|12793470|P3|COMPLETED|First Intervention Period||2
5202945|NCT01033487|12793471|P2|COMPLETED|First Intervention Period||3
5202946|NCT01033487|12793472|P1|COMPLETED|First Intervention Period||2
5202947|NCT01033487|12793463|P10|STARTED|First Intervention Period||2
5202948|NCT01033487|12793464|P9|STARTED|First Intervention Period||2
5202949|NCT01033487|12793465|P8|STARTED|First Intervention Period||3
5202950|NCT01033487|12793466|P7|STARTED|First Intervention Period||2
5202951|NCT01033487|12793467|P6|STARTED|First Intervention Period||2
5202952|NCT01033487|12793468|P5|STARTED|First Intervention Period||2
5202953|NCT01033487|12793469|P4|STARTED|First Intervention Period||2
5202954|NCT01033487|12793470|P3|STARTED|First Intervention Period||2
5202955|NCT01033487|12793471|P2|STARTED|First Intervention Period||3
5202956|NCT01033487|12793472|P1|STARTED|First Intervention Period||2
5202957|NCT01033448|12793526|P1|NOT COMPLETED|Overall Study||12
5202958|NCT01033448|12793526|P1|COMPLETED|Overall Study||47
5202959|NCT01033448|12793526|P1|STARTED|Overall Study||59
5202960|NCT01033422|12793537|P3|NOT COMPLETED|Overall Study||1
5202961|NCT01033422|12793538|P2|NOT COMPLETED|Overall Study||4
5202962|NCT01033422|12793539|P1|NOT COMPLETED|Overall Study||1
5202963|NCT01033422|12793537|P3|COMPLETED|Overall Study||22
5202964|NCT01033422|12793538|P2|COMPLETED|Overall Study||28
5202965|NCT01033422|12793539|P1|COMPLETED|Overall Study||33
5202966|NCT01033422|12793537|P3|STARTED|Overall Study||23
5202967|NCT01033422|12793538|P2|STARTED|Overall Study||32
5202968|NCT01033422|12793539|P1|STARTED|Overall Study||34
5202969|NCT01033383|12793551|P4|NOT COMPLETED|Overall Study||0
5202970|NCT01033383|12793552|P3|NOT COMPLETED|Overall Study||0
5202971|NCT01033383|12793553|P2|NOT COMPLETED|Overall Study||0
5202972|NCT01033383|12793554|P1|NOT COMPLETED|Overall Study||0
5202973|NCT01033383|12793551|P4|COMPLETED|Overall Study||20
5202974|NCT01033383|12793552|P3|COMPLETED|Overall Study||20
5202975|NCT01033383|12793553|P2|COMPLETED|Overall Study||20
5202976|NCT01033383|12793554|P1|COMPLETED|Overall Study||20
5202977|NCT01033383|12793551|P4|STARTED|Overall Study||20
5202978|NCT01033383|12793552|P3|STARTED|Overall Study||20
5202979|NCT01033383|12793553|P2|STARTED|Overall Study||20
5202980|NCT01033383|12793554|P1|STARTED|Overall Study||20
5202981|NCT01033227|12793574|P2|NOT COMPLETED|Overall Study||0
5202982|NCT01033227|12793575|P1|NOT COMPLETED|Overall Study||0
5202983|NCT01033227|12793574|P2|COMPLETED|Overall Study||2
5202984|NCT01033227|12793575|P1|COMPLETED|Overall Study||3
5202985|NCT01033227|12793574|P2|STARTED|Overall Study||2
5202986|NCT01033227|12793575|P1|STARTED|Overall Study||3
5202987|NCT01033136|12793585|P2|NOT COMPLETED|Follow-Up (3 Month)||2
5202988|NCT01033136|12793586|P1|NOT COMPLETED|Follow-Up (3 Month)||2
5202989|NCT01033136|12793585|P2|COMPLETED|Follow-Up (3 Month)||13
5202990|NCT01033136|12793586|P1|COMPLETED|Follow-Up (3 Month)||14
5202991|NCT01033136|12793585|P2|STARTED|Follow-Up (3 Month)||15
5202992|NCT01033136|12793586|P1|STARTED|Follow-Up (3 Month)||16
5202993|NCT01033136|12793585|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
5202994|NCT01033136|12793586|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
5202995|NCT01033136|12793585|P2|COMPLETED|Post-Treatment (1 Week)||15
5202996|NCT01033136|12793586|P1|COMPLETED|Post-Treatment (1 Week)||16
5202997|NCT01033136|12793585|P2|STARTED|Post-Treatment (1 Week)||26
5202998|NCT01033136|12793586|P1|STARTED|Post-Treatment (1 Week)||30
5202999|NCT01033136|12793585|P2|NOT COMPLETED|Baseline Assessment||6
5203000|NCT01033136|12793586|P1|NOT COMPLETED|Baseline Assessment||6
5203001|NCT01033136|12793585|P2|COMPLETED|Baseline Assessment||26
5203002|NCT01033136|12793586|P1|COMPLETED|Baseline Assessment||30
5203003|NCT01033136|12793585|P2|STARTED|Baseline Assessment||32
5203004|NCT01033136|12793586|P1|STARTED|Baseline Assessment||36
5203005|NCT01033071|12793597|P3|NOT COMPLETED|Overall Study||47
5203006|NCT01033071|12793598|P2|NOT COMPLETED|Overall Study||77
5203007|NCT01033071|12793599|P1|NOT COMPLETED|Overall Study||55
5203008|NCT01033071|12793597|P3|COMPLETED|Overall Study||317
5203009|NCT01033071|12793598|P2|COMPLETED|Overall Study||275
5203010|NCT01033071|12793599|P1|COMPLETED|Overall Study||300
5203011|NCT01033071|12793597|P3|STARTED|Overall Study||364
5203012|NCT01033071|12793598|P2|STARTED|Overall Study||352
5203013|NCT01033071|12793599|P1|STARTED|Overall Study||355
5203014|NCT01033032|12793658|P4|NOT COMPLETED|Phase II||0
5203015|NCT01033032|12793659|P3|NOT COMPLETED|Phase II||66
5203016|NCT01033032|12793660|P2|NOT COMPLETED|Phase II||0
5203017|NCT01033032|12793661|P1|NOT COMPLETED|Phase II||0
5203018|NCT01033032|12793658|P4|COMPLETED|Phase II||0
5203019|NCT01033032|12793659|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
5203020|NCT01033032|12793660|P2|COMPLETED|Phase II||0
5203021|NCT01033032|12793661|P1|COMPLETED|Phase II||0
5203022|NCT01033032|12793658|P4|STARTED|Phase II||0
5203023|NCT01033032|12793659|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
5203024|NCT01033032|12793660|P2|STARTED|Phase II||0
5203025|NCT01033032|12793661|P1|STARTED|Phase II||0
5203026|NCT01033032|12793658|P4|NOT COMPLETED|Phase I||6
5203027|NCT01033032|12793659|P3|NOT COMPLETED|Phase I||0
5203028|NCT01033032|12793660|P2|NOT COMPLETED|Phase I||3
5203029|NCT01033032|12793661|P1|NOT COMPLETED|Phase I||3
5203030|NCT01033032|12793658|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5203031|NCT01033032|12793659|P3|COMPLETED|Phase I||3
5203032|NCT01033032|12793660|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5203033|NCT01033032|12793661|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5203034|NCT01033032|12793658|P4|STARTED|Phase I||6
5203035|NCT01033032|12793659|P3|STARTED|Phase I||3
5203036|NCT01033032|12793660|P2|STARTED|Phase I||3
5203037|NCT01033032|12793661|P1|STARTED|Phase I||3
5203038|NCT01033019|12793670|P2|NOT COMPLETED|Overall Study||0
5203039|NCT01033019|12793671|P1|NOT COMPLETED|Overall Study||1
5203040|NCT01033019|12793670|P2|COMPLETED|Overall Study||8
5203041|NCT01033019|12793671|P1|COMPLETED|Overall Study||15
5203042|NCT01033019|12793670|P2|STARTED|Overall Study||8
5203043|NCT01033019|12793671|P1|STARTED|Overall Study||16
5203044|NCT01032993|12793680|P2|NOT COMPLETED|Overall Study||0
5203045|NCT01032993|12793681|P1|NOT COMPLETED|Overall Study||0
5203046|NCT01032993|12793680|P2|COMPLETED|Overall Study||20
5203047|NCT01032993|12793681|P1|COMPLETED|Overall Study||19
5203048|NCT01032993|12793680|P2|STARTED|Overall Study||20
5203049|NCT01032993|12793681|P1|STARTED|Overall Study||19
5203050|NCT01032928|12793693|P1|NOT COMPLETED|Overall Study||0
5203051|NCT01032928|12793693|P1|COMPLETED|Overall Study||30
5203052|NCT01032928|12793693|P1|STARTED|Overall Study||30
5203053|NCT01032915|12793709|P4|NOT COMPLETED|Overall Study||7
5203054|NCT01032915|12793710|P3|NOT COMPLETED|Overall Study||7
5203055|NCT01032915|12793711|P2|NOT COMPLETED|Overall Study||11
5203056|NCT01032915|12793712|P1|NOT COMPLETED|Overall Study||8
5203057|NCT01032915|12793709|P4|COMPLETED|Overall Study||27
5203058|NCT01032915|12793710|P3|COMPLETED|Overall Study||24
5203059|NCT01032915|12793711|P2|COMPLETED|Overall Study||20
5203060|NCT01032915|12793712|P1|COMPLETED|Overall Study||21
5203061|NCT01032915|12793709|P4|STARTED|Overall Study||34
5203062|NCT01032915|12793710|P3|STARTED|Overall Study||31
5203063|NCT01032915|12793711|P2|STARTED|Overall Study||31
5203064|NCT01032915|12793712|P1|STARTED|Overall Study||29
5203065|NCT01032889|12793737|P3|NOT COMPLETED|Overall Study||3
5203066|NCT01032889|12793738|P2|NOT COMPLETED|Overall Study||15
5203067|NCT01032889|12793739|P1|NOT COMPLETED|Overall Study||8
5203068|NCT01032889|12793737|P3|COMPLETED|Overall Study||42
5203069|NCT01032889|12793738|P2|COMPLETED|Overall Study||28
5203070|NCT01032889|12793739|P1|COMPLETED|Overall Study||33
5203071|NCT01032889|12793737|P3|Received Treatment|Overall Study||45
5203072|NCT01032889|12793738|P2|Received Treatment|Overall Study||43
5203073|NCT01032889|12793739|P1|Received Treatment|Overall Study||41
5203074|NCT01032889|12793737|P3|STARTED|Overall Study||45
5203075|NCT01032889|12793738|P2|STARTED|Overall Study||43
5203076|NCT01032889|12793739|P1|STARTED|Overall Study||41
5203077|NCT01032850|12793759|P1|NOT COMPLETED|Overall Study||2
5203078|NCT01032850|12793759|P1|COMPLETED|Overall Study||13
5203079|NCT01032850|12793759|P1|STARTED|Overall Study||15
5203080|NCT01032837|12793770|P4|NOT COMPLETED|Overall Study||3
5203081|NCT01032837|12793771|P3|NOT COMPLETED|Overall Study||1
5203082|NCT01032837|12793772|P2|NOT COMPLETED|Overall Study||3
5203083|NCT01032837|12793773|P1|NOT COMPLETED|Overall Study||0
5203084|NCT01032837|12793770|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
5203085|NCT01032837|12793771|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
5203086|NCT01032837|12793772|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
5203087|NCT01032837|12793773|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
5203088|NCT01032837|12793770|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
5203089|NCT01032837|12793771|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
5203090|NCT01032837|12793772|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
5203091|NCT01032837|12793773|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
5203092|NCT01032837|12793770|P4|STARTED|Overall Study||25
5203093|NCT01032837|12793771|P3|STARTED|Overall Study||25
5203094|NCT01032837|12793772|P2|STARTED|Overall Study||26
5203095|NCT01032837|12793773|P1|STARTED|Overall Study||26
5203096|NCT01032759|12793821|P2|NOT COMPLETED|Overall Study||3
5203097|NCT01032759|12793822|P1|NOT COMPLETED|Overall Study||1
5203098|NCT01032759|12793821|P2|COMPLETED|Overall Study||28
5203099|NCT01032759|12793822|P1|COMPLETED|Overall Study||31
5203100|NCT01032759|12793821|P2|Completed 48 Hour Assessment|Overall Study||28
5203101|NCT01032759|12793822|P1|Completed 48 Hour Assessment|Overall Study||31
5203102|NCT01032759|12793821|P2|Completed 24 Hour Assessment|Overall Study||30
5203103|NCT01032759|12793822|P1|Completed 24 Hour Assessment|Overall Study||32
5203104|NCT01032759|12793821|P2|STARTED|Overall Study||31
5203105|NCT01032759|12793822|P1|STARTED|Overall Study||32
5203106|NCT01032733|12793842|P2|NOT COMPLETED|Overall Study||1
5203107|NCT01032733|12793843|P1|NOT COMPLETED|Overall Study||1
5203108|NCT01032733|12793842|P2|COMPLETED|Overall Study||16
5203109|NCT01032733|12793843|P1|COMPLETED|Overall Study||16
5203110|NCT01032733|12793842|P2|STARTED|Overall Study||17
5203111|NCT01032733|12793843|P1|STARTED|Overall Study||17
5203112|NCT01032694|12793859|P2|NOT COMPLETED|Overall Study||0
5203113|NCT01032694|12793860|P1|NOT COMPLETED|Overall Study||0
5203114|NCT01032694|12793859|P2|COMPLETED|Overall Study||10
5203115|NCT01032694|12793860|P1|COMPLETED|Overall Study||20
5203116|NCT01032694|12793859|P2|STARTED|Overall Study||10
5203117|NCT01032694|12793860|P1|STARTED|Overall Study||20
5203118|NCT01032629|12793873|P3|NOT COMPLETED|Overall Study||88
5203119|NCT01032629|12793874|P2|NOT COMPLETED|Overall Study||101
5203120|NCT01032629|12793875|P1|NOT COMPLETED|Overall Study||145
5203121|NCT01032629|12793873|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
5203122|NCT01032629|12793874|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
5203123|NCT01032629|12793875|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
5203124|NCT01032629|12793873|P3|Treated|Overall Study||1441
5203125|NCT01032629|12793874|P2|Treated|Overall Study||1445
5203126|NCT01032629|12793875|P1|Treated|Overall Study||1441
5203127|NCT01032629|12793873|P3|STARTED|Overall Study||1443
5203128|NCT01032629|12793874|P2|STARTED|Overall Study||1445
5203129|NCT01032629|12793875|P1|STARTED|Overall Study||1442
5203130|NCT01032603|12793922|P2|NOT COMPLETED|Overall Study||19
5203131|NCT01032603|12793923|P1|NOT COMPLETED|Overall Study||15
5203132|NCT01032603|12793922|P2|COMPLETED|Overall Study||77
5203133|NCT01032603|12793923|P1|COMPLETED|Overall Study||86
5203134|NCT01032603|12793922|P2|STARTED|Overall Study||96
5203135|NCT01032603|12793923|P1|STARTED|Overall Study||101
5203136|NCT01032538|12793979|P1|NOT COMPLETED|Overall Study||0
5203137|NCT01032538|12793979|P1|COMPLETED|Overall Study|Knees|99
5203138|NCT01032538|12793979|P1|STARTED|Overall Study|Knees|99
5203139|NCT01032382|12793987|P2|NOT COMPLETED|Overall Study||5
5203140|NCT01032382|12793988|P1|NOT COMPLETED|Overall Study||5
5203141|NCT01032382|12793987|P2|COMPLETED|Overall Study||9
5203142|NCT01032382|12793988|P1|COMPLETED|Overall Study||11
5203143|NCT01032382|12793987|P2|STARTED|Overall Study||14
5203144|NCT01032382|12793988|P1|STARTED|Overall Study||16
5203145|NCT01032330|12794018|P4|NOT COMPLETED|Overall Study||14
5203146|NCT01032330|12794019|P3|NOT COMPLETED|Overall Study||10
5203147|NCT01032330|12794020|P2|NOT COMPLETED|Overall Study||24
5203148|NCT01032330|12794021|P1|NOT COMPLETED|Overall Study||18
5203149|NCT01032330|12794018|P4|COMPLETED|Overall Study||90
5203150|NCT01032330|12794019|P3|COMPLETED|Overall Study||87
5203151|NCT01032330|12794020|P2|COMPLETED|Overall Study||151
5203152|NCT01032330|12794021|P1|COMPLETED|Overall Study||165
5203153|NCT01032330|12794018|P4|STARTED|Overall Study||104
5203154|NCT01032330|12794019|P3|STARTED|Overall Study||97
5203155|NCT01032330|12794020|P2|STARTED|Overall Study||175
5203156|NCT01032330|12794021|P1|STARTED|Overall Study||183
5203157|NCT01032291|12794076|P3|NOT COMPLETED|Proof of Concept||3
5203158|NCT01032291|12794077|P2|NOT COMPLETED|Proof of Concept||8
5203159|NCT01032291|12794078|P1|NOT COMPLETED|Proof of Concept||0
5203160|NCT01032291|12794076|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
5203161|NCT01032291|12794077|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
5203162|NCT01032291|12794078|P1|COMPLETED|Proof of Concept||0
5203163|NCT01032291|12794076|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
5203164|NCT01032291|12794077|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
5203165|NCT01032291|12794078|P1|Intent to Treat and Safety Populations|Proof of Concept||0
5203166|NCT01032291|12794076|P3|STARTED|Proof of Concept||21
5203167|NCT01032291|12794077|P2|STARTED|Proof of Concept||22
5203168|NCT01032291|12794078|P1|STARTED|Proof of Concept||0
5203169|NCT01032291|12794076|P3|NOT COMPLETED|Safety Lead-in||0
5203170|NCT01032291|12794077|P2|NOT COMPLETED|Safety Lead-in||0
5203171|NCT01032291|12794078|P1|NOT COMPLETED|Safety Lead-in||2
5203172|NCT01032291|12794076|P3|COMPLETED|Safety Lead-in||0
5203173|NCT01032291|12794077|P2|COMPLETED|Safety Lead-in||0
5203174|NCT01032291|12794078|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
5203175|NCT01032291|12794076|P3|STARTED|Safety Lead-in||0
5203176|NCT01032291|12794077|P2|STARTED|Safety Lead-in||0
5203177|NCT01032291|12794078|P1|STARTED|Safety Lead-in||8
5203178|NCT01032265|12794104|P2|NOT COMPLETED|Overall Study||17
5203179|NCT01032265|12794105|P1|NOT COMPLETED|Overall Study||13
5203180|NCT01032265|12794104|P2|COMPLETED|Overall Study||107
5203181|NCT01032265|12794105|P1|COMPLETED|Overall Study||113
5203182|NCT01032265|12794104|P2|STARTED|Overall Study||124
5203183|NCT01032265|12794105|P1|STARTED|Overall Study||126
5203184|NCT01032239|12794125|P2|NOT COMPLETED|Overall Study||5
5203185|NCT01032239|12794126|P1|NOT COMPLETED|Overall Study||7
5203186|NCT01032239|12794125|P2|COMPLETED|Overall Study||24
5203187|NCT01032239|12794126|P1|COMPLETED|Overall Study||24
5203188|NCT01032239|12794125|P2|Implant|Overall Study||0
5203189|NCT01032239|12794126|P1|Implant|Overall Study|implanted|25
5203190|NCT01032239|12794125|P2|STARTED|Overall Study|randomized to BMT arm|29
5203191|NCT01032239|12794126|P1|STARTED|Overall Study|randomized to ITB arm|31
5203192|NCT01032200|12794156|P2|NOT COMPLETED|Overall Study||7
5203193|NCT01032200|12794157|P1|NOT COMPLETED|Overall Study||4
5203194|NCT01032200|12794156|P2|COMPLETED|Overall Study||21
5203195|NCT01032200|12794157|P1|COMPLETED|Overall Study||22
5203196|NCT01032200|12794156|P2|STARTED|Overall Study||28
5203197|NCT01032200|12794157|P1|STARTED|Overall Study||26
5203198|NCT01032174|12794173|P2|NOT COMPLETED|Overall Study||1
5203199|NCT01032174|12794174|P1|NOT COMPLETED|Overall Study||0
5203200|NCT01032174|12794173|P2|COMPLETED|Overall Study||59
5203201|NCT01032174|12794174|P1|COMPLETED|Overall Study||63
5203202|NCT01032174|12794173|P2|STARTED|Overall Study||60
5203203|NCT01032174|12794174|P1|STARTED|Overall Study||63
5203204|NCT01032135|12794189|P7|NOT COMPLETED|8 Week Randomization||18
5203205|NCT01032135|12794190|P6|NOT COMPLETED|8 Week Randomization||17
5203206|NCT01032135|12794191|P5|NOT COMPLETED|8 Week Randomization||9
5203207|NCT01032135|12794192|P4|NOT COMPLETED|8 Week Randomization||11
5203208|NCT01032135|12794193|P3|NOT COMPLETED|8 Week Randomization||0
5203209|NCT01032135|12794194|P2|NOT COMPLETED|8 Week Randomization||0
5203210|NCT01032135|12794195|P1|NOT COMPLETED|8 Week Randomization||26
5203211|NCT01032135|12794189|P7|COMPLETED|8 Week Randomization||36
5203212|NCT01032135|12794190|P6|COMPLETED|8 Week Randomization||31
5203213|NCT01032135|12794191|P5|COMPLETED|8 Week Randomization||34
5203214|NCT01032135|12794192|P4|COMPLETED|8 Week Randomization||30
5203215|NCT01032135|12794193|P3|COMPLETED|8 Week Randomization||0
5203216|NCT01032135|12794194|P2|COMPLETED|8 Week Randomization||0
5203217|NCT01032135|12794195|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
5203218|NCT01032135|12794189|P7|12 Week Follow up|8 Week Randomization||41
5203219|NCT01032135|12794190|P6|12 Week Follow up|8 Week Randomization||36
5203220|NCT01032135|12794191|P5|12 Week Follow up|8 Week Randomization||38
5203221|NCT01032135|12794192|P4|12 Week Follow up|8 Week Randomization||34
5203222|NCT01032135|12794193|P3|12 Week Follow up|8 Week Randomization||0
5203223|NCT01032135|12794194|P2|12 Week Follow up|8 Week Randomization||0
5203224|NCT01032135|12794195|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
5203225|NCT01032135|12794189|P7|STARTED|8 Week Randomization||54
5203226|NCT01032135|12794190|P6|STARTED|8 Week Randomization||48
5203227|NCT01032135|12794191|P5|STARTED|8 Week Randomization||43
5203228|NCT01032135|12794192|P4|STARTED|8 Week Randomization||41
5203229|NCT01032135|12794193|P3|STARTED|8 Week Randomization||0
5203230|NCT01032135|12794194|P2|STARTED|8 Week Randomization||0
5203231|NCT01032135|12794195|P1|STARTED|8 Week Randomization||227
5203232|NCT01032135|12794189|P7|NOT COMPLETED|2 Week Randomization||0
5203233|NCT01032135|12794190|P6|NOT COMPLETED|2 Week Randomization||0
5203234|NCT01032135|12794191|P5|NOT COMPLETED|2 Week Randomization||0
5203235|NCT01032135|12794192|P4|NOT COMPLETED|2 Week Randomization||0
5203236|NCT01032135|12794193|P3|NOT COMPLETED|2 Week Randomization||0
5203237|NCT01032135|12794194|P2|NOT COMPLETED|2 Week Randomization||0
5203238|NCT01032135|12794195|P1|NOT COMPLETED|2 Week Randomization||0
5203239|NCT01032135|12794189|P7|COMPLETED|2 Week Randomization||0
5203240|NCT01032135|12794190|P6|COMPLETED|2 Week Randomization||0
5203241|NCT01032135|12794191|P5|COMPLETED|2 Week Randomization||0
5203242|NCT01032135|12794192|P4|COMPLETED|2 Week Randomization||0
5203243|NCT01032135|12794193|P3|COMPLETED|2 Week Randomization||96
5203244|NCT01032135|12794194|P2|COMPLETED|2 Week Randomization||93
5203245|NCT01032135|12794195|P1|COMPLETED|2 Week Randomization||311
5203246|NCT01032135|12794189|P7|STARTED|2 Week Randomization||0
5203247|NCT01032135|12794190|P6|STARTED|2 Week Randomization||0
5203248|NCT01032135|12794191|P5|STARTED|2 Week Randomization||0
5203249|NCT01032135|12794192|P4|STARTED|2 Week Randomization||0
5203250|NCT01032135|12794193|P3|STARTED|2 Week Randomization||96
5203251|NCT01032135|12794194|P2|STARTED|2 Week Randomization||93
5203252|NCT01032135|12794195|P1|STARTED|2 Week Randomization||311
5203253|NCT01032070|12794414|P2|NOT COMPLETED|Overall Study||12
5203254|NCT01032070|12794415|P1|NOT COMPLETED|Overall Study||13
5203255|NCT01032070|12794414|P2|COMPLETED|Overall Study||0
5203256|NCT01032070|12794415|P1|COMPLETED|Overall Study||0
5203257|NCT01032070|12794414|P2|STARTED|Overall Study||12
5203258|NCT01032070|12794415|P1|STARTED|Overall Study||13
5203259|NCT01032044|12794444|P2|NOT COMPLETED|Overall Study||20
5203260|NCT01032044|12794445|P1|NOT COMPLETED|Overall Study||25
5203261|NCT01032044|12794444|P2|COMPLETED|Overall Study||62
5203262|NCT01032044|12794445|P1|COMPLETED|Overall Study||57
5203263|NCT01032044|12794444|P2|Procedure|Overall Study||75
5203264|NCT01032044|12794445|P1|Procedure|Overall Study||74
5203265|NCT01032044|12794444|P2|STARTED|Overall Study||82
5203266|NCT01032044|12794445|P1|STARTED|Overall Study||82
5203267|NCT01032018|12794453|P2|NOT COMPLETED|Overall Study||6
5203268|NCT01032018|12794454|P1|NOT COMPLETED|Overall Study||6
5203269|NCT01032018|12794453|P2|COMPLETED|Overall Study||67
5203270|NCT01032018|12794454|P1|COMPLETED|Overall Study||71
5203271|NCT01032018|12794453|P2|STARTED|Overall Study||73
5203272|NCT01032018|12794454|P1|STARTED|Overall Study||77
5203273|NCT01031979|12794464|P2|NOT COMPLETED|Overall Study||4
5203274|NCT01031979|12794465|P1|NOT COMPLETED|Overall Study||5
5203275|NCT01031979|12794464|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
5203276|NCT01031979|12794465|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
5203277|NCT01031979|12794464|P2|Completed Primary Outcome Measure|Overall Study||12
5203278|NCT01031979|12794465|P1|Completed Primary Outcome Measure|Overall Study||12
5203279|NCT01031979|12794464|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
5203280|NCT01031979|12794465|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
5203281|NCT01031953|12794477|P1|NOT COMPLETED|Overall Study||0
5203282|NCT01031953|12794477|P1|COMPLETED|Overall Study||11
5203283|NCT01031953|12794477|P1|STARTED|Overall Study||11
5203284|NCT01031914|12794488|P1|NOT COMPLETED|Overall Study||0
5203285|NCT01031914|12794488|P1|COMPLETED|Overall Study||36
5203286|NCT01031914|12794488|P1|STARTED|Overall Study||36
5203287|NCT01031836|12794498|P6|NOT COMPLETED|Stage II||1
5203288|NCT01031836|12794499|P5|NOT COMPLETED|Stage II||2
5203289|NCT01031836|12794500|P4|NOT COMPLETED|Stage II||3
5203290|NCT01031836|12794501|P3|NOT COMPLETED|Stage II||2
5203291|NCT01031836|12794502|P2|NOT COMPLETED|Stage II||0
5203292|NCT01031836|12794503|P1|NOT COMPLETED|Stage II||2
5203293|NCT01031836|12794498|P6|COMPLETED|Stage II||3
5203294|NCT01031836|12794499|P5|COMPLETED|Stage II||3
5203295|NCT01031836|12794500|P4|COMPLETED|Stage II||1
5203296|NCT01031836|12794501|P3|COMPLETED|Stage II||2
5203297|NCT01031836|12794502|P2|COMPLETED|Stage II||1
5203298|NCT01031836|12794503|P1|COMPLETED|Stage II||1
5203299|NCT01031836|12794498|P6|STARTED|Stage II||4
5203300|NCT01031836|12794499|P5|STARTED|Stage II||5
5203301|NCT01031836|12794500|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
5203302|NCT01031836|12794501|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
5203303|NCT01031836|12794502|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
5203304|NCT01031836|12794503|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
5203305|NCT01031836|12794498|P6|NOT COMPLETED|Stage I||1
5203306|NCT01031836|12794499|P5|NOT COMPLETED|Stage I||0
5203307|NCT01031836|12794500|P4|NOT COMPLETED|Stage I||0
5203308|NCT01031836|12794501|P3|NOT COMPLETED|Stage I||0
5203309|NCT01031836|12794502|P2|NOT COMPLETED|Stage I||2
5203310|NCT01031836|12794503|P1|NOT COMPLETED|Stage I||1
5203311|NCT01031836|12794498|P6|COMPLETED|Stage I||4
5203312|NCT01031836|12794499|P5|COMPLETED|Stage I||5
5203313|NCT01031836|12794500|P4|COMPLETED|Stage I||5
5203314|NCT01031836|12794501|P3|COMPLETED|Stage I||5
5203315|NCT01031836|12794502|P2|COMPLETED|Stage I||3
5203316|NCT01031836|12794503|P1|COMPLETED|Stage I||4
5203317|NCT01031836|12794498|P6|STARTED|Stage I||5
5203318|NCT01031836|12794499|P5|STARTED|Stage I||5
5203319|NCT01031836|12794500|P4|STARTED|Stage I||5
5203320|NCT01031836|12794501|P3|STARTED|Stage I||5
5203321|NCT01031836|12794502|P2|STARTED|Stage I||5
5203322|NCT01031836|12794503|P1|STARTED|Stage I||5
5203323|NCT01031810|12794553|P1|NOT COMPLETED|Overall Study||4
5203324|NCT01031810|12794553|P1|COMPLETED|Overall Study||9
5203325|NCT01031810|12794553|P1|STARTED|Overall Study||13
5203326|NCT01031706|12794564|P2|NOT COMPLETED|Overall Study||1
5203327|NCT01031706|12794565|P1|NOT COMPLETED|Overall Study||2
5203328|NCT01031706|12794564|P2|COMPLETED|Overall Study||8
5203329|NCT01031706|12794565|P1|COMPLETED|Overall Study||12
5203330|NCT01031706|12794564|P2|STARTED|Overall Study||9
5203331|NCT01031706|12794565|P1|STARTED|Overall Study||14
5203332|NCT01031680|12794575|P2|NOT COMPLETED|Overall Study||58
5203333|NCT01031680|12794576|P1|NOT COMPLETED|Overall Study||57
5203334|NCT01031680|12794575|P2|COMPLETED|Overall Study||404
5203335|NCT01031680|12794576|P1|COMPLETED|Overall Study||403
5203336|NCT01031680|12794575|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
5203337|NCT01031680|12794576|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
5203338|NCT01031628|12794596|P4|NOT COMPLETED|Overall Study||0
5203339|NCT01031628|12794597|P3|NOT COMPLETED|Overall Study||3
5203340|NCT01031628|12794598|P2|NOT COMPLETED|Overall Study||1
5203341|NCT01031628|12794599|P1|NOT COMPLETED|Overall Study||0
5203342|NCT01031628|12794596|P4|COMPLETED|Overall Study||0
5203343|NCT01031628|12794597|P3|COMPLETED|Overall Study||0
5203344|NCT01031628|12794598|P2|COMPLETED|Overall Study||0
5203345|NCT01031628|12794599|P1|COMPLETED|Overall Study||0
5203346|NCT01031628|12794596|P4|STARTED|Overall Study||0
5203347|NCT01031628|12794597|P3|STARTED|Overall Study||3
5203348|NCT01031628|12794598|P2|STARTED|Overall Study||1
5203349|NCT01031628|12794599|P1|STARTED|Overall Study||0
5203350|NCT01031550|12794611|P2|NOT COMPLETED|Overall Study||0
5203351|NCT01031550|12794612|P1|NOT COMPLETED|Overall Study||0
5203352|NCT01031550|12794611|P2|COMPLETED|Overall Study||3
5203353|NCT01031550|12794612|P1|COMPLETED|Overall Study||5
5203354|NCT01031550|12794611|P2|STARTED|Overall Study||3
5203355|NCT01031550|12794612|P1|STARTED|Overall Study||5
5203356|NCT01031537|12794624|P1|NOT COMPLETED|Overall Study||32
5203357|NCT01031537|12794624|P1|COMPLETED|Overall Study||34
5203358|NCT01031537|12794624|P1|STARTED|Overall Study||66
5203359|NCT01031498|12794632|P3|NOT COMPLETED|Overall Study||2
5203360|NCT01031498|12794633|P2|NOT COMPLETED|Overall Study||3
5203361|NCT01031498|12794634|P1|NOT COMPLETED|Overall Study||2
5203362|NCT01031498|12794632|P3|COMPLETED|Overall Study||48
5203363|NCT01031498|12794633|P2|COMPLETED|Overall Study||48
5203364|NCT01031498|12794634|P1|COMPLETED|Overall Study||47
5203365|NCT01031498|12794632|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
5203366|NCT01031498|12794633|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
5203367|NCT01031498|12794634|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
5203368|NCT01031446|12794642|P1|NOT COMPLETED|Overall Study||55
5203369|NCT01031446|12794642|P1|COMPLETED|Overall Study||0
5203370|NCT01031446|12794642|P1|STARTED|Overall Study||55
5203371|NCT01031420|12794651|P1|NOT COMPLETED|Overall Study||10
5203372|NCT01031420|12794651|P1|COMPLETED|Overall Study||44
5203373|NCT01031420|12794651|P1|STARTED|Overall Study||54
5203374|NCT01031381|12794656|P1|NOT COMPLETED|Overall Study||9
5203375|NCT01031381|12794656|P1|COMPLETED|Overall Study||50
5203376|NCT01031381|12794656|P1|STARTED|Overall Study||59
5203377|NCT01031134|12794663|P2|NOT COMPLETED|Overall Study||10
5203378|NCT01031134|12794664|P1|NOT COMPLETED|Overall Study||11
5203379|NCT01031134|12794663|P2|COMPLETED|Overall Study||78
5203380|NCT01031134|12794664|P1|COMPLETED|Overall Study||103
5203381|NCT01031134|12794663|P2|STARTED|Overall Study||88
5203382|NCT01031134|12794664|P1|STARTED|Overall Study||114
5203383|NCT01031095|12794674|P2|NOT COMPLETED|Overall Study||0
5203384|NCT01031095|12794675|P1|NOT COMPLETED|Overall Study||0
5203385|NCT01031095|12794674|P2|COMPLETED|Overall Study||100
5203386|NCT01031095|12794675|P1|COMPLETED|Overall Study||100
5203387|NCT01031095|12794674|P2|STARTED|Overall Study||100
5203388|NCT01031095|12794675|P1|STARTED|Overall Study||100
5203389|NCT01031069|12794685|P4|NOT COMPLETED|Overall Study||34
5203390|NCT01031069|12794686|P3|NOT COMPLETED|Overall Study||41
5203391|NCT01031069|12794687|P2|NOT COMPLETED|Overall Study||11
5203392|NCT01031069|12794688|P1|NOT COMPLETED|Overall Study||12
5203393|NCT01031069|12794685|P4|COMPLETED|Overall Study||111
5203394|NCT01031069|12794686|P3|COMPLETED|Overall Study||103
5203395|NCT01031069|12794687|P2|COMPLETED|Overall Study||117
5203396|NCT01031069|12794688|P1|COMPLETED|Overall Study||117
5203397|NCT01031069|12794685|P4|STARTED|Overall Study||145
5203398|NCT01031069|12794686|P3|STARTED|Overall Study||144
5203399|NCT01031069|12794687|P2|STARTED|Overall Study||128
5203400|NCT01031069|12794688|P1|STARTED|Overall Study||129
5203401|NCT01031043|12794784|P1|NOT COMPLETED|Overall Study||1
5203402|NCT01031043|12794784|P1|COMPLETED|Overall Study||4
5203403|NCT01031043|12794784|P1|STARTED|Overall Study||5
5203404|NCT01031004|12794790|P2|NOT COMPLETED|Overall Study||1
5203405|NCT01031004|12794791|P1|NOT COMPLETED|Overall Study||1
5203406|NCT01031004|12794790|P2|COMPLETED|Overall Study||24
5203407|NCT01031004|12794791|P1|COMPLETED|Overall Study||24
5203408|NCT01031004|12794790|P2|STARTED|Overall Study||25
5203409|NCT01031004|12794791|P1|STARTED|Overall Study||25
5203410|NCT01030965|12794835|P4|NOT COMPLETED|Overall Study||7
5203411|NCT01030965|12794836|P3|NOT COMPLETED|Overall Study||4
5203412|NCT01030965|12794837|P2|NOT COMPLETED|Overall Study||6
5203413|NCT01030965|12794838|P1|NOT COMPLETED|Overall Study||4
5203414|NCT01030965|12794835|P4|COMPLETED|Overall Study||64
5203415|NCT01030965|12794836|P3|COMPLETED|Overall Study||68
5203416|NCT01030965|12794837|P2|COMPLETED|Overall Study||65
5203417|NCT01030965|12794838|P1|COMPLETED|Overall Study||67
5203418|NCT01030965|12794835|P4|STARTED|Overall Study||71
5203419|NCT01030965|12794836|P3|STARTED|Overall Study||72
5203420|NCT01030965|12794837|P2|STARTED|Overall Study||71
5203421|NCT01030965|12794838|P1|STARTED|Overall Study||71
5203422|NCT01030952|12794858|P2|NOT COMPLETED|Overall Study||3
5203423|NCT01030952|12794859|P1|NOT COMPLETED|Overall Study||2
5203424|NCT01030952|12794858|P2|COMPLETED|Overall Study||49
5203425|NCT01030952|12794859|P1|COMPLETED|Overall Study||49
5203426|NCT01030952|12794858|P2|STARTED|Overall Study||52
5203427|NCT01030952|12794859|P1|STARTED|Overall Study||51
5203428|NCT01030822|12794896|P3|NOT COMPLETED|Overall Study||26
5203429|NCT01030822|12794897|P2|NOT COMPLETED|Overall Study||24
5203430|NCT01030822|12794898|P1|NOT COMPLETED|Overall Study||31
5203431|NCT01030822|12794896|P3|COMPLETED|Overall Study||61
5203432|NCT01030822|12794897|P2|COMPLETED|Overall Study||71
5203433|NCT01030822|12794898|P1|COMPLETED|Overall Study||69
5203434|NCT01030822|12794896|P3|STARTED|Overall Study||87
5203435|NCT01030822|12794897|P2|STARTED|Overall Study||95
5203436|NCT01030822|12794898|P1|STARTED|Overall Study||100
5203437|NCT01030783|12794947|P2|NOT COMPLETED|Overall Study||26
5203438|NCT01030783|12794948|P1|NOT COMPLETED|Overall Study||49
5203439|NCT01030783|12794947|P2|COMPLETED|Overall Study||231
5203440|NCT01030783|12794948|P1|COMPLETED|Overall Study||211
5203441|NCT01030783|12794947|P2|STARTED|Overall Study||257
5203442|NCT01030783|12794948|P1|STARTED|Overall Study||260
5203443|NCT01030757|12794965|P1|NOT COMPLETED|Overall Study||0
5203444|NCT01030757|12794965|P1|COMPLETED|Overall Study||2
5203445|NCT01030757|12794965|P1|STARTED|Overall Study||2
5203446|NCT01030718|12794973|P3|NOT COMPLETED|Study CA180-036 Only||5
5203447|NCT01030718|12794974|P2|NOT COMPLETED|Study CA180-036 Only||7
5203448|NCT01030718|12794975|P1|NOT COMPLETED|Study CA180-036 Only||3
5203449|NCT01030718|12794973|P3|COMPLETED|Study CA180-036 Only||1
5203450|NCT01030718|12794974|P2|COMPLETED|Study CA180-036 Only||2
5203451|NCT01030718|12794975|P1|COMPLETED|Study CA180-036 Only||26
5203452|NCT01030718|12794973|P3|STARTED|Study CA180-036 Only||6
5203453|NCT01030718|12794974|P2|STARTED|Study CA180-036 Only||9
5203454|NCT01030718|12794975|P1|STARTED|Study CA180-036 Only||29
5203455|NCT01030718|12794973|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
5203456|NCT01030718|12794974|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
5203457|NCT01030718|12794975|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
5203458|NCT01030718|12794973|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
5203459|NCT01030718|12794974|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
5203460|NCT01030718|12794975|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
5203461|NCT01030718|12794973|P3|STARTED|Studies CA180-031 and -036 Combined||13
5203462|NCT01030718|12794974|P2|STARTED|Studies CA180-031 and -036 Combined||11
5203463|NCT01030718|12794975|P1|STARTED|Studies CA180-031 and -036 Combined||30
5203464|NCT01030666|12795036|P2|NOT COMPLETED|Overall Study||2
5203465|NCT01030666|12795037|P1|NOT COMPLETED|Overall Study||3
5203466|NCT01030666|12795036|P2|COMPLETED|Overall Study||31
5203467|NCT01030666|12795037|P1|COMPLETED|Overall Study||25
5203468|NCT01030666|12795036|P2|STARTED|Overall Study||33
5203469|NCT01030666|12795037|P1|STARTED|Overall Study||28
5203470|NCT01030653|12795047|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
5203471|NCT01030653|12795048|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
5203472|NCT01030653|12795047|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
5203473|NCT01030653|12795048|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
5203474|NCT01030653|12795047|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
5203475|NCT01030653|12795048|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
5203476|NCT01030653|12795047|P2|NOT COMPLETED|7-Day Washout Period||0
5203477|NCT01030653|12795048|P1|NOT COMPLETED|7-Day Washout Period||0
5203478|NCT01030653|12795047|P2|COMPLETED|7-Day Washout Period||4
5203479|NCT01030653|12795048|P1|COMPLETED|7-Day Washout Period||4
5203480|NCT01030653|12795047|P2|STARTED|7-Day Washout Period||4
5203481|NCT01030653|12795048|P1|STARTED|7-Day Washout Period||4
5203482|NCT01030653|12795047|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
5203483|NCT01030653|12795048|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
5203484|NCT01030653|12795047|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
5203485|NCT01030653|12795048|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
5203486|NCT01030653|12795047|P2|STARTED|Loading Dose & First Maintenance Regimen||4
5203487|NCT01030653|12795048|P1|STARTED|Loading Dose & First Maintenance Regimen||4
5203488|NCT01030536|12795062|P5|NOT COMPLETED|Overall Study||1
5203489|NCT01030536|12795063|P4|NOT COMPLETED|Overall Study||3
5203490|NCT01030536|12795064|P3|NOT COMPLETED|Overall Study||6
5203491|NCT01030536|12795065|P2|NOT COMPLETED|Overall Study||6
5203492|NCT01030536|12795066|P1|NOT COMPLETED|Overall Study||7
5203493|NCT01030536|12795062|P5|COMPLETED|Overall Study||0
5203494|NCT01030536|12795063|P4|COMPLETED|Overall Study||0
5203495|NCT01030536|12795064|P3|COMPLETED|Overall Study||0
5203496|NCT01030536|12795065|P2|COMPLETED|Overall Study||0
5203497|NCT01030536|12795066|P1|COMPLETED|Overall Study||0
5203498|NCT01030536|12795062|P5|STARTED|Overall Study||1
5203499|NCT01030536|12795063|P4|STARTED|Overall Study||3
5203500|NCT01030536|12795064|P3|STARTED|Overall Study||6
5203501|NCT01030536|12795065|P2|STARTED|Overall Study||6
5203502|NCT01030536|12795066|P1|STARTED|Overall Study||7
5203503|NCT01030458|12795171|P2|NOT COMPLETED|Overall Study||32
5203504|NCT01030458|12795172|P1|NOT COMPLETED|Overall Study||27
5203505|NCT01030458|12795171|P2|COMPLETED|Overall Study||57
5203506|NCT01030458|12795172|P1|COMPLETED|Overall Study||67
5203507|NCT01030458|12795171|P2|STARTED|Overall Study||89
5203508|NCT01030458|12795172|P1|STARTED|Overall Study||94
5203509|NCT01030406|12795189|P5|NOT COMPLETED|Overall Study||0
5203510|NCT01030406|12795190|P4|NOT COMPLETED|Overall Study||1
5203511|NCT01030406|12795191|P3|NOT COMPLETED|Overall Study||1
5203512|NCT01030406|12795192|P2|NOT COMPLETED|Overall Study||0
5203513|NCT01030406|12795193|P1|NOT COMPLETED|Overall Study||0
5203514|NCT01030406|12795189|P5|COMPLETED|Overall Study||9
5203515|NCT01030406|12795190|P4|COMPLETED|Overall Study||9
5203516|NCT01030406|12795191|P3|COMPLETED|Overall Study||9
5203517|NCT01030406|12795192|P2|COMPLETED|Overall Study||10
5203518|NCT01030406|12795193|P1|COMPLETED|Overall Study||10
5203519|NCT01030406|12795189|P5|STARTED|Overall Study||9
5203520|NCT01030406|12795190|P4|STARTED|Overall Study||10
5203521|NCT01030406|12795191|P3|STARTED|Overall Study||10
5203522|NCT01030406|12795192|P2|STARTED|Overall Study||10
5203523|NCT01030406|12795193|P1|STARTED|Overall Study||10
5203524|NCT01030341|12795205|P1|NOT COMPLETED|Overall Study||3
5203525|NCT01030341|12795205|P1|COMPLETED|Overall Study|42 participants completed the study|42
5203526|NCT01030341|12795205|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
5203527|NCT01030289|12795210|P2|NOT COMPLETED|Overall Study||0
5203528|NCT01030289|12795211|P1|NOT COMPLETED|Overall Study||0
5203529|NCT01030289|12795210|P2|COMPLETED|Overall Study||10
5203530|NCT01030289|12795211|P1|COMPLETED|Overall Study||9
5203531|NCT01030289|12795210|P2|STARTED|Overall Study||10
5203532|NCT01030289|12795211|P1|STARTED|Overall Study||9
5203533|NCT01030133|12795228|P2|NOT COMPLETED|Overall Study||2
5203534|NCT01030133|12795229|P1|NOT COMPLETED|Overall Study||2
5203535|NCT01030133|12795228|P2|COMPLETED|Overall Study||12
5203536|NCT01030133|12795229|P1|COMPLETED|Overall Study||12
5203537|NCT01030133|12795228|P2|STARTED|Overall Study||14
5203538|NCT01030133|12795229|P1|STARTED|Overall Study||14
5203539|NCT01029925|12795241|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
5203540|NCT01029925|12795241|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
5203541|NCT01029925|12795241|P1|STARTED|Completion of Cycle 2 (56 Days)||3
5203542|NCT01029925|12795241|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
5203543|NCT01029925|12795241|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
5203544|NCT01029925|12795241|P1|STARTED|Completion of Cycle 1 (28 Days)||7
5203545|NCT01029912|12795247|P2|NOT COMPLETED|Overall Study||0
5203546|NCT01029912|12795248|P1|NOT COMPLETED|Overall Study||2
5203547|NCT01029912|12795247|P2|COMPLETED|Overall Study||12
5203548|NCT01029912|12795248|P1|COMPLETED|Overall Study||12
5203549|NCT01029912|12795247|P2|STARTED|Overall Study||12
5203550|NCT01029912|12795248|P1|STARTED|Overall Study||14
5203551|NCT01029886|12795260|P2|NOT COMPLETED|Overall Study||60
5203552|NCT01029886|12795261|P1|NOT COMPLETED|Overall Study||61
5203553|NCT01029886|12795260|P2|COMPLETED|Overall Study||391
5203554|NCT01029886|12795261|P1|COMPLETED|Overall Study||400
5203555|NCT01029886|12795260|P2|Intent to Treat (ITT)|Overall Study||450
5203556|NCT01029886|12795261|P1|Intent to Treat (ITT)|Overall Study||461
5203557|NCT01029886|12795260|P2|STARTED|Overall Study||451
5203558|NCT01029886|12795261|P1|STARTED|Overall Study||461
5203559|NCT01029795|12795289|P2|NOT COMPLETED|Overall Study||22
5203560|NCT01029795|12795290|P1|NOT COMPLETED|Overall Study||16
5203561|NCT01029795|12795289|P2|COMPLETED|Overall Study||0
5203562|NCT01029795|12795290|P1|COMPLETED|Overall Study||0
5203563|NCT01029795|12795289|P2|STARTED|Overall Study||22
5203564|NCT01029795|12795290|P1|STARTED|Overall Study||16
5203565|NCT01029782|12795344|P2|NOT COMPLETED|Overall Study||8
5203566|NCT01029782|12795345|P1|NOT COMPLETED|Overall Study||3
5203567|NCT01029782|12795344|P2|COMPLETED|Overall Study||96
5203568|NCT01029782|12795345|P1|COMPLETED|Overall Study||99
5203569|NCT01029782|12795344|P2|STARTED|Overall Study||104
5203570|NCT01029782|12795345|P1|STARTED|Overall Study||102
5203571|NCT01029730|12795351|P1|NOT COMPLETED|Maintenance Therapy||23
5203572|NCT01029730|12795351|P1|COMPLETED|Maintenance Therapy||14
5203573|NCT01029730|12795351|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
5203574|NCT01029730|12795351|P1|NOT COMPLETED|Combination Therapy||16
5203575|NCT01029730|12795351|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
5203576|NCT01029730|12795351|P1|STARTED|Combination Therapy||55
5203577|NCT01029704|12795363|P5|NOT COMPLETED|Overall Study||0
5203578|NCT01029704|12795364|P4|NOT COMPLETED|Overall Study||0
5203579|NCT01029704|12795365|P3|NOT COMPLETED|Overall Study||0
5203580|NCT01029704|12795366|P2|NOT COMPLETED|Overall Study||0
5203581|NCT01029704|12795367|P1|NOT COMPLETED|Overall Study||0
5203582|NCT01029704|12795363|P5|COMPLETED|Overall Study||26
5203583|NCT01029704|12795364|P4|COMPLETED|Overall Study||28
5203584|NCT01029704|12795365|P3|COMPLETED|Overall Study||23
5203585|NCT01029704|12795366|P2|COMPLETED|Overall Study||24
5203586|NCT01029704|12795367|P1|COMPLETED|Overall Study||28
5203587|NCT01029704|12795363|P5|STARTED|Overall Study||26
5203588|NCT01029704|12795364|P4|STARTED|Overall Study||28
5203589|NCT01029704|12795365|P3|STARTED|Overall Study||23
5203590|NCT01029704|12795366|P2|STARTED|Overall Study||24
5203591|NCT01029704|12795367|P1|STARTED|Overall Study||28
5203592|NCT01029691|12795397|P3|NOT COMPLETED|Continued APAP to Delivery||1
5203593|NCT01029691|12795398|P2|NOT COMPLETED|Continued APAP to Delivery||0
5203594|NCT01029691|12795399|P1|NOT COMPLETED|Continued APAP to Delivery||0
5203595|NCT01029691|12795397|P3|COMPLETED|Continued APAP to Delivery||76
5203596|NCT01029691|12795398|P2|COMPLETED|Continued APAP to Delivery||16
5203597|NCT01029691|12795399|P1|COMPLETED|Continued APAP to Delivery||20
5203598|NCT01029691|12795397|P3|STARTED|Continued APAP to Delivery||77
5203599|NCT01029691|12795398|P2|STARTED|Continued APAP to Delivery||16
5203600|NCT01029691|12795399|P1|STARTED|Continued APAP to Delivery||20
5203601|NCT01029691|12795397|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
5203602|NCT01029691|12795398|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
5203603|NCT01029691|12795399|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
5203604|NCT01029691|12795397|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
5203605|NCT01029691|12795398|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
5203606|NCT01029691|12795399|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
5203607|NCT01029691|12795397|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
5203608|NCT01029691|12795398|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
5203609|NCT01029691|12795399|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
5203610|NCT01029691|12795397|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
5203611|NCT01029691|12795398|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
5203612|NCT01029691|12795399|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
5203613|NCT01029691|12795397|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
5203614|NCT01029691|12795398|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
5203615|NCT01029691|12795399|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
5203616|NCT01029652|12795424|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
5203617|NCT01029652|12795425|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
5203618|NCT01029652|12795424|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
5203619|NCT01029652|12795425|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
5203620|NCT01029652|12795424|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
5203621|NCT01029652|12795425|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
5203622|NCT01029652|12795424|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
5203623|NCT01029652|12795425|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
5203624|NCT01029652|12795424|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
5203625|NCT01029652|12795425|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
5203626|NCT01029652|12795424|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
5203627|NCT01029652|12795425|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
5203628|NCT01029652|12795424|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
5203629|NCT01029652|12795425|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
5203630|NCT01029652|12795424|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
5203631|NCT01029652|12795425|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
5203632|NCT01029652|12795424|P2|COMPLETED|Core Study (0-12 Weeks)||105
5203633|NCT01029652|12795425|P1|COMPLETED|Core Study (0-12 Weeks)||109
5203634|NCT01029652|12795424|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
5203635|NCT01029652|12795425|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
5203636|NCT01029652|12795424|P2|STARTED|Core Study (0-12 Weeks)||115
5203637|NCT01029652|12795425|P1|STARTED|Core Study (0-12 Weeks)||115
5203638|NCT01029535|12795503|P1|NOT COMPLETED|Overall Study||31
5203639|NCT01029535|12795503|P1|COMPLETED|Overall Study||72
5203640|NCT01029535|12795503|P1|STARTED|Overall Study||103
5203641|NCT01029405|12795532|P4|NOT COMPLETED|Overall Study||5
5203642|NCT01029405|12795533|P3|NOT COMPLETED|Overall Study||4
5203643|NCT01029405|12795534|P2|NOT COMPLETED|Overall Study||3
5203644|NCT01029405|12795535|P1|NOT COMPLETED|Overall Study||2
5203645|NCT01029405|12795532|P4|COMPLETED|Overall Study||32
5203646|NCT01029405|12795533|P3|COMPLETED|Overall Study||31
5203647|NCT01029405|12795534|P2|COMPLETED|Overall Study||34
5203648|NCT01029405|12795535|P1|COMPLETED|Overall Study||34
5203649|NCT01029405|12795532|P4|STARTED|Overall Study||37
5203650|NCT01029405|12795533|P3|STARTED|Overall Study||35
5203651|NCT01029405|12795534|P2|STARTED|Overall Study||37
5203652|NCT01029405|12795535|P1|STARTED|Overall Study||36
5203653|NCT01029392|12795547|P2|NOT COMPLETED|Overall Study||11
5203654|NCT01029392|12795548|P1|NOT COMPLETED|Overall Study||20
5203655|NCT01029392|12795547|P2|COMPLETED|Overall Study||27
5203656|NCT01029392|12795548|P1|COMPLETED|Overall Study||17
5203657|NCT01029392|12795547|P2|STARTED|Overall Study||38
5203658|NCT01029392|12795548|P1|STARTED|Overall Study||37
5203659|NCT01029366|12795558|P2|NOT COMPLETED|Overall Study||2
5203660|NCT01029366|12795559|P1|NOT COMPLETED|Overall Study||4
5203661|NCT01029366|12795558|P2|COMPLETED|Overall Study||6
5203662|NCT01029366|12795559|P1|COMPLETED|Overall Study||14
5203663|NCT01029366|12795558|P2|STARTED|Overall Study||8
5203664|NCT01029366|12795559|P1|STARTED|Overall Study||18
5203665|NCT01029340|12795571|P6|NOT COMPLETED|Part C Follow up Period||0
5203666|NCT01029340|12795572|P5|NOT COMPLETED|Part C Follow up Period||0
5203667|NCT01029340|12795573|P4|NOT COMPLETED|Part C Follow up Period||0
5203668|NCT01029340|12795574|P3|NOT COMPLETED|Part C Follow up Period||0
5203669|NCT01029340|12795575|P2|NOT COMPLETED|Part C Follow up Period||0
5203670|NCT01029340|12795576|P1|NOT COMPLETED|Part C Follow up Period||0
5203671|NCT01029340|12795571|P6|COMPLETED|Part C Follow up Period||0
5203672|NCT01029340|12795572|P5|COMPLETED|Part C Follow up Period||5
5203673|NCT01029340|12795573|P4|COMPLETED|Part C Follow up Period||0
5203674|NCT01029340|12795574|P3|COMPLETED|Part C Follow up Period||0
5203675|NCT01029340|12795575|P2|COMPLETED|Part C Follow up Period||0
5203676|NCT01029340|12795576|P1|COMPLETED|Part C Follow up Period||0
5203677|NCT01029340|12795571|P6|STARTED|Part C Follow up Period||0
5203678|NCT01029340|12795572|P5|STARTED|Part C Follow up Period||5
5203679|NCT01029340|12795573|P4|STARTED|Part C Follow up Period||0
5203680|NCT01029340|12795574|P3|STARTED|Part C Follow up Period||0
5203681|NCT01029340|12795575|P2|STARTED|Part C Follow up Period||0
5203682|NCT01029340|12795576|P1|STARTED|Part C Follow up Period||0
5203683|NCT01029340|12795571|P6|NOT COMPLETED|Part C Treatment Period||0
5203684|NCT01029340|12795572|P5|NOT COMPLETED|Part C Treatment Period||0
5203685|NCT01029340|12795573|P4|NOT COMPLETED|Part C Treatment Period||0
5203686|NCT01029340|12795574|P3|NOT COMPLETED|Part C Treatment Period||0
5203687|NCT01029340|12795575|P2|NOT COMPLETED|Part C Treatment Period||0
5203688|NCT01029340|12795576|P1|NOT COMPLETED|Part C Treatment Period||0
5203689|NCT01029340|12795571|P6|COMPLETED|Part C Treatment Period||0
5203690|NCT01029340|12795572|P5|COMPLETED|Part C Treatment Period||5
5203691|NCT01029340|12795573|P4|COMPLETED|Part C Treatment Period||0
5203692|NCT01029340|12795574|P3|COMPLETED|Part C Treatment Period||0
5203693|NCT01029340|12795575|P2|COMPLETED|Part C Treatment Period||0
5203694|NCT01029340|12795576|P1|COMPLETED|Part C Treatment Period||0
5203695|NCT01029340|12795571|P6|Participants Received Treatment|Part C Treatment Period||0
5203696|NCT01029340|12795572|P5|Participants Received Treatment|Part C Treatment Period||5
5203697|NCT01029340|12795573|P4|Participants Received Treatment|Part C Treatment Period||0
5203698|NCT01029340|12795574|P3|Participants Received Treatment|Part C Treatment Period||0
5203699|NCT01029340|12795575|P2|Participants Received Treatment|Part C Treatment Period||0
5203700|NCT01029340|12795576|P1|Participants Received Treatment|Part C Treatment Period||0
5203701|NCT01029340|12795571|P6|STARTED|Part C Treatment Period||0
5203702|NCT01029340|12795572|P5|STARTED|Part C Treatment Period||5
5203703|NCT01029340|12795573|P4|STARTED|Part C Treatment Period||0
5203704|NCT01029340|12795574|P3|STARTED|Part C Treatment Period||0
5203705|NCT01029340|12795575|P2|STARTED|Part C Treatment Period||0
5203706|NCT01029340|12795576|P1|STARTED|Part C Treatment Period||0
5203707|NCT01029340|12795571|P6|NOT COMPLETED|Extension Period||12
5203708|NCT01029340|12795572|P5|NOT COMPLETED|Extension Period||0
5203709|NCT01029340|12795573|P4|NOT COMPLETED|Extension Period||0
5203710|NCT01029340|12795574|P3|NOT COMPLETED|Extension Period||0
5203711|NCT01029340|12795575|P2|NOT COMPLETED|Extension Period||0
5203712|NCT01029340|12795576|P1|NOT COMPLETED|Extension Period||0
5203713|NCT01029340|12795571|P6|COMPLETED|Extension Period||43
5203714|NCT01029340|12795572|P5|COMPLETED|Extension Period||0
5203715|NCT01029340|12795573|P4|COMPLETED|Extension Period||0
5203716|NCT01029340|12795574|P3|COMPLETED|Extension Period||0
5203717|NCT01029340|12795575|P2|COMPLETED|Extension Period||0
5203718|NCT01029340|12795576|P1|COMPLETED|Extension Period||0
5203719|NCT01029340|12795571|P6|STARTED|Extension Period||55
5203720|NCT01029340|12795572|P5|STARTED|Extension Period||0
5203721|NCT01029340|12795573|P4|STARTED|Extension Period||0
5203722|NCT01029340|12795574|P3|STARTED|Extension Period||0
5203723|NCT01029340|12795575|P2|STARTED|Extension Period||0
5203724|NCT01029340|12795576|P1|STARTED|Extension Period||0
5203725|NCT01029340|12795571|P6|NOT COMPLETED|Part B Follow up Period||0
5203726|NCT01029340|12795572|P5|NOT COMPLETED|Part B Follow up Period||0
5203727|NCT01029340|12795573|P4|NOT COMPLETED|Part B Follow up Period||0
5203728|NCT01029340|12795574|P3|NOT COMPLETED|Part B Follow up Period||0
5203729|NCT01029340|12795575|P2|NOT COMPLETED|Part B Follow up Period||0
5203730|NCT01029340|12795576|P1|NOT COMPLETED|Part B Follow up Period||0
5203731|NCT01029340|12795571|P6|COMPLETED|Part B Follow up Period||0
5203732|NCT01029340|12795572|P5|COMPLETED|Part B Follow up Period||0
5203733|NCT01029340|12795573|P4|COMPLETED|Part B Follow up Period||32
5203734|NCT01029340|12795574|P3|COMPLETED|Part B Follow up Period||29
5203735|NCT01029340|12795575|P2|COMPLETED|Part B Follow up Period||0
5203736|NCT01029340|12795576|P1|COMPLETED|Part B Follow up Period||0
5203737|NCT01029340|12795571|P6|STARTED|Part B Follow up Period||0
5203738|NCT01029340|12795572|P5|STARTED|Part B Follow up Period||0
5203739|NCT01029340|12795573|P4|STARTED|Part B Follow up Period||32
5203740|NCT01029340|12795574|P3|STARTED|Part B Follow up Period||29
5203741|NCT01029340|12795575|P2|STARTED|Part B Follow up Period||0
5203742|NCT01029340|12795576|P1|STARTED|Part B Follow up Period||0
5203743|NCT01029340|12795571|P6|NOT COMPLETED|Part B Treatment Period||0
5203744|NCT01029340|12795572|P5|NOT COMPLETED|Part B Treatment Period||0
5203745|NCT01029340|12795573|P4|NOT COMPLETED|Part B Treatment Period||0
5203746|NCT01029340|12795574|P3|NOT COMPLETED|Part B Treatment Period||2
5203747|NCT01029340|12795575|P2|NOT COMPLETED|Part B Treatment Period||0
5203748|NCT01029340|12795576|P1|NOT COMPLETED|Part B Treatment Period||0
5203749|NCT01029340|12795571|P6|COMPLETED|Part B Treatment Period||0
5203750|NCT01029340|12795572|P5|COMPLETED|Part B Treatment Period||0
5203751|NCT01029340|12795573|P4|COMPLETED|Part B Treatment Period||32
5203752|NCT01029340|12795574|P3|COMPLETED|Part B Treatment Period||29
5203753|NCT01029340|12795575|P2|COMPLETED|Part B Treatment Period||0
5203754|NCT01029340|12795576|P1|COMPLETED|Part B Treatment Period||0
5203755|NCT01029340|12795571|P6|Participants Received Treatment|Part B Treatment Period||0
5203756|NCT01029340|12795572|P5|Participants Received Treatment|Part B Treatment Period||0
5203757|NCT01029340|12795573|P4|Participants Received Treatment|Part B Treatment Period||32
5203758|NCT01029340|12795574|P3|Participants Received Treatment|Part B Treatment Period||30
5203759|NCT01029340|12795575|P2|Participants Received Treatment|Part B Treatment Period||0
5203760|NCT01029340|12795576|P1|Participants Received Treatment|Part B Treatment Period||0
5203761|NCT01029340|12795571|P6|STARTED|Part B Treatment Period||0
5203762|NCT01029340|12795572|P5|STARTED|Part B Treatment Period||0
5203763|NCT01029340|12795573|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
5203764|NCT01029340|12795574|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
5203765|NCT01029340|12795575|P2|STARTED|Part B Treatment Period||0
5203766|NCT01029340|12795576|P1|STARTED|Part B Treatment Period||0
5203767|NCT01029340|12795571|P6|NOT COMPLETED|Part A Follow up Period||0
5203768|NCT01029340|12795572|P5|NOT COMPLETED|Part A Follow up Period||0
5203769|NCT01029340|12795573|P4|NOT COMPLETED|Part A Follow up Period||0
5203770|NCT01029340|12795574|P3|NOT COMPLETED|Part A Follow up Period||0
5203771|NCT01029340|12795575|P2|NOT COMPLETED|Part A Follow up Period||0
5203772|NCT01029340|12795576|P1|NOT COMPLETED|Part A Follow up Period||0
5203773|NCT01029340|12795571|P6|COMPLETED|Part A Follow up Period||0
5203774|NCT01029340|12795572|P5|COMPLETED|Part A Follow up Period||0
5203775|NCT01029340|12795573|P4|COMPLETED|Part A Follow up Period||0
5203776|NCT01029340|12795574|P3|COMPLETED|Part A Follow up Period||0
5203777|NCT01029340|12795575|P2|COMPLETED|Part A Follow up Period||14
5203778|NCT01029340|12795576|P1|COMPLETED|Part A Follow up Period||14
5203779|NCT01029340|12795571|P6|STARTED|Part A Follow up Period||0
5203780|NCT01029340|12795572|P5|STARTED|Part A Follow up Period||0
5203781|NCT01029340|12795573|P4|STARTED|Part A Follow up Period||0
5203782|NCT01029340|12795574|P3|STARTED|Part A Follow up Period||0
5203783|NCT01029340|12795575|P2|STARTED|Part A Follow up Period||14
5203784|NCT01029340|12795576|P1|STARTED|Part A Follow up Period||14
5203785|NCT01029340|12795571|P6|NOT COMPLETED|Part A Treatment Period||0
5203786|NCT01029340|12795572|P5|NOT COMPLETED|Part A Treatment Period||0
5203787|NCT01029340|12795573|P4|NOT COMPLETED|Part A Treatment Period||0
5203788|NCT01029340|12795574|P3|NOT COMPLETED|Part A Treatment Period||0
5203789|NCT01029340|12795575|P2|NOT COMPLETED|Part A Treatment Period||0
5203790|NCT01029340|12795576|P1|NOT COMPLETED|Part A Treatment Period||0
5203791|NCT01029340|12795571|P6|COMPLETED|Part A Treatment Period||0
5203792|NCT01029340|12795572|P5|COMPLETED|Part A Treatment Period||0
5203793|NCT01029340|12795573|P4|COMPLETED|Part A Treatment Period||0
5203794|NCT01029340|12795574|P3|COMPLETED|Part A Treatment Period||0
5203795|NCT01029340|12795575|P2|COMPLETED|Part A Treatment Period||14
5203796|NCT01029340|12795576|P1|COMPLETED|Part A Treatment Period||14
5203797|NCT01029340|12795571|P6|Safety Population|Part A Treatment Period||0
5203798|NCT01029340|12795572|P5|Safety Population|Part A Treatment Period||0
5203799|NCT01029340|12795573|P4|Safety Population|Part A Treatment Period||0
5203800|NCT01029340|12795574|P3|Safety Population|Part A Treatment Period||0
5203801|NCT01029340|12795575|P2|Safety Population|Part A Treatment Period||14
5203802|NCT01029340|12795576|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
5203803|NCT01029340|12795571|P6|Participants Received Treatment|Part A Treatment Period||0
5203804|NCT01029340|12795572|P5|Participants Received Treatment|Part A Treatment Period||0
5203805|NCT01029340|12795573|P4|Participants Received Treatment|Part A Treatment Period||0
5203806|NCT01029340|12795574|P3|Participants Received Treatment|Part A Treatment Period||0
5203807|NCT01029340|12795575|P2|Participants Received Treatment|Part A Treatment Period||14
5203808|NCT01029340|12795576|P1|Participants Received Treatment|Part A Treatment Period||14
5203809|NCT01029340|12795571|P6|STARTED|Part A Treatment Period||0
5203810|NCT01029340|12795572|P5|STARTED|Part A Treatment Period||0
5203811|NCT01029340|12795573|P4|STARTED|Part A Treatment Period||0
5203812|NCT01029340|12795574|P3|STARTED|Part A Treatment Period||0
5203813|NCT01029340|12795575|P2|STARTED|Part A Treatment Period||14
5203814|NCT01029340|12795576|P1|STARTED|Part A Treatment Period||14
5203815|NCT01029262|12795607|P2|NOT COMPLETED|Overall Study||160
5203816|NCT01029262|12795608|P1|NOT COMPLETED|Overall Study||79
5203817|NCT01029262|12795607|P2|COMPLETED|Overall Study||0
5203818|NCT01029262|12795608|P1|COMPLETED|Overall Study||0
5203819|NCT01029262|12795607|P2|STARTED|Overall Study||160
5203820|NCT01029262|12795608|P1|STARTED|Overall Study||79
5203821|NCT01029054|12795670|P3|NOT COMPLETED|Phase II||0
5203822|NCT01029054|12795671|P2|NOT COMPLETED|Phase II||0
5203823|NCT01029054|12795672|P1|NOT COMPLETED|Phase II||0
5203824|NCT01029054|12795670|P3|COMPLETED|Phase II||18
5203825|NCT01029054|12795671|P2|COMPLETED|Phase II||0
5203826|NCT01029054|12795672|P1|COMPLETED|Phase II||0
5203827|NCT01029054|12795670|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
5203828|NCT01029054|12795671|P2|STARTED|Phase II||0
5203829|NCT01029054|12795672|P1|STARTED|Phase II||0
5203830|NCT01029054|12795670|P3|NOT COMPLETED|Phase I||0
5203831|NCT01029054|12795671|P2|NOT COMPLETED|Phase I||0
5203832|NCT01029054|12795672|P1|NOT COMPLETED|Phase I||0
5203833|NCT01029054|12795670|P3|COMPLETED|Phase I||18
5203834|NCT01029054|12795671|P2|COMPLETED|Phase I||13
5203835|NCT01029054|12795672|P1|COMPLETED|Phase I||4
5203836|NCT01029054|12795670|P3|STARTED|Phase I||18
5203837|NCT01029054|12795671|P2|STARTED|Phase I||13
5203838|NCT01029054|12795672|P1|STARTED|Phase I||4
5203839|NCT01028937|12795678|P1|NOT COMPLETED|Overall Study||0
5203840|NCT01028937|12795678|P1|COMPLETED|Overall Study||6
5203841|NCT01028937|12795678|P1|STARTED|Overall Study||6
5203842|NCT01028911|12795685|P2|NOT COMPLETED|Overall Study||0
5203843|NCT01028911|12795686|P1|NOT COMPLETED|Overall Study||0
5203844|NCT01028911|12795685|P2|COMPLETED|Overall Study||2
5203845|NCT01028911|12795686|P1|COMPLETED|Overall Study||7
5203846|NCT01028911|12795685|P2|STARTED|Overall Study||2
5203847|NCT01028911|12795686|P1|STARTED|Overall Study||7
5203848|NCT01028820|12795751|P1|NOT COMPLETED|Overall Study||1
5203849|NCT01028820|12795751|P1|COMPLETED|Overall Study||12
5203850|NCT01028820|12795751|P1|STARTED|Overall Study||13
5203851|NCT01028677|12795760|P2|NOT COMPLETED|Overall Study||1
5203852|NCT01028677|12795761|P1|NOT COMPLETED|Overall Study||2
5203853|NCT01028677|12795760|P2|COMPLETED|Overall Study||6
5203854|NCT01028677|12795761|P1|COMPLETED|Overall Study||8
5203855|NCT01028677|12795760|P2|STARTED|Overall Study||7
5203856|NCT01028677|12795761|P1|STARTED|Overall Study||10
5203857|NCT01028651|12795777|P1|NOT COMPLETED|Overall Study||3
5203858|NCT01028651|12795777|P1|COMPLETED|Overall Study||10
5203859|NCT01028651|12795777|P1|STARTED|Overall Study||13
5203860|NCT01028560|12795800|P2|NOT COMPLETED|Overall Study||18
5203861|NCT01028560|12795801|P1|NOT COMPLETED|Overall Study||10
5203862|NCT01028560|12795800|P2|COMPLETED|Overall Study||13
5203863|NCT01028560|12795801|P1|COMPLETED|Overall Study||17
5203864|NCT01028560|12795800|P2|Started Study Protocol|Overall Study||27
5203865|NCT01028560|12795801|P1|Started Study Protocol|Overall Study||23
5203866|NCT01028560|12795800|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
5203867|NCT01028560|12795801|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
5203868|NCT01028391|12795815|P2|NOT COMPLETED|Overall Study||11
5203869|NCT01028391|12795816|P1|NOT COMPLETED|Overall Study||14
5203870|NCT01028391|12795815|P2|COMPLETED|Overall Study||142
5203871|NCT01028391|12795816|P1|COMPLETED|Overall Study||150
5203872|NCT01028391|12795815|P2|STARTED|Overall Study||153
5203873|NCT01028391|12795816|P1|STARTED|Overall Study||164
5203874|NCT01028378|12795824|P1|NOT COMPLETED|Overall Study||17
5203875|NCT01028378|12795824|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
5203876|NCT01028378|12795824|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
5203877|NCT01028352|12795836|P1|NOT COMPLETED|Overall Study||6
5203878|NCT01028352|12795836|P1|COMPLETED|Overall Study||29
5203879|NCT01028352|12795836|P1|STARTED|Overall Study||35
5203880|NCT01028300|12795841|P1|NOT COMPLETED|Overall Study||4
5203881|NCT01028300|12795841|P1|COMPLETED|Overall Study||0
5203882|NCT01028300|12795841|P1|STARTED|Overall Study||4
5203883|NCT01028222|12795850|P2|NOT COMPLETED|Overall Study||13
5203884|NCT01028222|12795851|P1|NOT COMPLETED|Overall Study||38
5203885|NCT01028222|12795850|P2|COMPLETED|Overall Study||0
5203886|NCT01028222|12795851|P1|COMPLETED|Overall Study||4
5203887|NCT01028222|12795850|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
5203888|NCT01028222|12795851|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
5203889|NCT01028222|12795850|P2|STARTED|Overall Study||13
5203890|NCT01028222|12795851|P1|STARTED|Overall Study||42
5203891|NCT01028131|12795876|P4|NOT COMPLETED|Overall Study||4
5203892|NCT01028131|12795877|P3|NOT COMPLETED|Overall Study||6
5203893|NCT01028131|12795878|P2|NOT COMPLETED|Overall Study||3
5203894|NCT01028131|12795879|P1|NOT COMPLETED|Overall Study||3
5203895|NCT01028131|12795876|P4|COMPLETED|Overall Study||26
5203896|NCT01028131|12795877|P3|COMPLETED|Overall Study||22
5203897|NCT01028131|12795878|P2|COMPLETED|Overall Study||23
5203898|NCT01028131|12795879|P1|COMPLETED|Overall Study||23
5203899|NCT01028131|12795876|P4|Completed Intervention/Control Session|Overall Study||30
5203900|NCT01028131|12795877|P3|Completed Intervention/Control Session|Overall Study||28
5203901|NCT01028131|12795878|P2|Completed Intervention/Control Session|Overall Study||26
5203902|NCT01028131|12795879|P1|Completed Intervention/Control Session|Overall Study||26
5203903|NCT01028131|12795876|P4|STARTED|Overall Study||30
5203904|NCT01028131|12795877|P3|STARTED|Overall Study||28
5203905|NCT01028131|12795878|P2|STARTED|Overall Study||26
5203906|NCT01028131|12795879|P1|STARTED|Overall Study||26
5203907|NCT01028053|12795893|P1|NOT COMPLETED|Overall Study||133
5203908|NCT01028053|12795893|P1|COMPLETED|Overall Study||232
5203909|NCT01028053|12795893|P1|STARTED|Overall Study||365
5203910|NCT01028027|12795901|P2|NOT COMPLETED|Overall Study||13
5203911|NCT01028027|12795902|P1|NOT COMPLETED|Overall Study||16
5203912|NCT01028027|12795901|P2|COMPLETED|Overall Study||164
5203913|NCT01028027|12795902|P1|COMPLETED|Overall Study||164
5203914|NCT01028027|12795901|P2|STARTED|Overall Study||177
5203915|NCT01028027|12795902|P1|STARTED|Overall Study||180
5203916|NCT01028014|12795924|P6|NOT COMPLETED|Overall Study||2
5203917|NCT01028014|12795925|P5|NOT COMPLETED|Overall Study||1
5203918|NCT01028014|12795926|P4|NOT COMPLETED|Overall Study||1
5203919|NCT01028014|12795927|P3|NOT COMPLETED|Overall Study||0
5203920|NCT01028014|12795928|P2|NOT COMPLETED|Overall Study||2
5203921|NCT01028014|12795929|P1|NOT COMPLETED|Overall Study||1
5203922|NCT01028014|12795924|P6|COMPLETED|Overall Study||4
5203923|NCT01028014|12795925|P5|COMPLETED|Overall Study||9
5203924|NCT01028014|12795926|P4|COMPLETED|Overall Study||9
5203925|NCT01028014|12795927|P3|COMPLETED|Overall Study||10
5203926|NCT01028014|12795928|P2|COMPLETED|Overall Study||8
5203927|NCT01028014|12795929|P1|COMPLETED|Overall Study||9
5203928|NCT01028014|12795924|P6|STARTED|Overall Study||6
5203929|NCT01028014|12795925|P5|STARTED|Overall Study||10
5203930|NCT01028014|12795926|P4|STARTED|Overall Study||10
5203931|NCT01028014|12795927|P3|STARTED|Overall Study||10
5203932|NCT01028014|12795928|P2|STARTED|Overall Study||10
5203933|NCT01028014|12795929|P1|STARTED|Overall Study||10
5203934|NCT01027910|12795957|P2|NOT COMPLETED|Overall Study||0
5203935|NCT01027910|12795958|P1|NOT COMPLETED|Overall Study||0
5203936|NCT01027910|12795957|P2|COMPLETED|Overall Study||14
5203937|NCT01027910|12795958|P1|COMPLETED|Overall Study||6
5203938|NCT01027910|12795957|P2|STARTED|Overall Study||14
5203939|NCT01027910|12795958|P1|STARTED|Overall Study||6
5203940|NCT01027897|12795970|P1|NOT COMPLETED|Overall Study||2
5203941|NCT01027897|12795970|P1|COMPLETED|Overall Study||28
5203942|NCT01027897|12795970|P1|STARTED|Overall Study||30
5203943|NCT01027884|12795978|P2|NOT COMPLETED|Overall Study||7
5203944|NCT01027884|12795979|P1|NOT COMPLETED|Overall Study||4
5203945|NCT01027884|12795978|P2|COMPLETED|Overall Study||25
5203946|NCT01027884|12795979|P1|COMPLETED|Overall Study||30
5203947|NCT01027884|12795978|P2|STARTED|Overall Study||32
5203948|NCT01027884|12795979|P1|STARTED|Overall Study||34
5203949|NCT01027871|12795996|P3|NOT COMPLETED|Overall Study||7
5203950|NCT01027871|12795997|P2|NOT COMPLETED|Overall Study||13
5203951|NCT01027871|12795998|P1|NOT COMPLETED|Overall Study||2
5203952|NCT01027871|12795996|P3|COMPLETED|Overall Study||91
5203953|NCT01027871|12795997|P2|COMPLETED|Overall Study||85
5203954|NCT01027871|12795998|P1|COMPLETED|Overall Study||91
5203955|NCT01027871|12795996|P3|Received at Least One Dose of Study Drug|Overall Study||97
5203956|NCT01027871|12795997|P2|Received at Least One Dose of Study Drug|Overall Study||98
5203957|NCT01027871|12795998|P1|Received at Least One Dose of Study Drug|Overall Study||93
5203958|NCT01027871|12795996|P3|STARTED|Overall Study||98
5203959|NCT01027871|12795997|P2|STARTED|Overall Study||98
5203960|NCT01027871|12795998|P1|STARTED|Overall Study||93
5203961|NCT01027845|12796057|P4|NOT COMPLETED|Booster Vaccination Phase||0
5203962|NCT01027845|12796058|P3|NOT COMPLETED|Booster Vaccination Phase||0
5203963|NCT01027845|12796059|P2|NOT COMPLETED|Booster Vaccination Phase||0
5203964|NCT01027845|12796060|P1|NOT COMPLETED|Booster Vaccination Phase||2
5203965|NCT01027845|12796057|P4|COMPLETED|Booster Vaccination Phase||1
5203966|NCT01027845|12796058|P3|COMPLETED|Booster Vaccination Phase||119
5203967|NCT01027845|12796059|P2|COMPLETED|Booster Vaccination Phase||0
5203968|NCT01027845|12796060|P1|COMPLETED|Booster Vaccination Phase||226
5203969|NCT01027845|12796057|P4|STARTED|Booster Vaccination Phase||1
5203970|NCT01027845|12796058|P3|STARTED|Booster Vaccination Phase||119
5203971|NCT01027845|12796059|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
5203972|NCT01027845|12796060|P1|STARTED|Booster Vaccination Phase||228
5203973|NCT01027845|12796057|P4|NOT COMPLETED|Primary Vaccination Phase||0
5203974|NCT01027845|12796058|P3|NOT COMPLETED|Primary Vaccination Phase||0
5203975|NCT01027845|12796059|P2|NOT COMPLETED|Primary Vaccination Phase||1
5203976|NCT01027845|12796060|P1|NOT COMPLETED|Primary Vaccination Phase||4
5203977|NCT01027845|12796057|P4|COMPLETED|Primary Vaccination Phase||0
5203978|NCT01027845|12796058|P3|COMPLETED|Primary Vaccination Phase||0
5203979|NCT01027845|12796059|P2|COMPLETED|Primary Vaccination Phase||122
5203980|NCT01027845|12796060|P1|COMPLETED|Primary Vaccination Phase||233
5203981|NCT01027845|12796057|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
5203982|NCT01027845|12796058|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
5203983|NCT01027845|12796059|P2|STARTED|Primary Vaccination Phase||123
5203984|NCT01027845|12796060|P1|STARTED|Primary Vaccination Phase||237
5203985|NCT01027819|12796112|P2|NOT COMPLETED|Overall Study||0
5203986|NCT01027819|12796113|P1|NOT COMPLETED|Overall Study||0
5203987|NCT01027819|12796112|P2|COMPLETED|Overall Study||40
5203988|NCT01027819|12796113|P1|COMPLETED|Overall Study||40
5203989|NCT01027819|12796112|P2|STARTED|Overall Study||40
5203990|NCT01027819|12796113|P1|STARTED|Overall Study||40
5203991|NCT01027806|12796121|P2|NOT COMPLETED|Overall Study||3
5203992|NCT01027806|12796122|P1|NOT COMPLETED|Overall Study||4
5203993|NCT01027806|12796121|P2|COMPLETED|Overall Study||29
5203994|NCT01027806|12796122|P1|COMPLETED|Overall Study||28
5203995|NCT01027806|12796121|P2|STARTED|Overall Study||32
5203996|NCT01027806|12796122|P1|STARTED|Overall Study||32
5203997|NCT01027780|12796130|P2|NOT COMPLETED|Overall Study||1
5203998|NCT01027780|12796131|P1|NOT COMPLETED|Overall Study||0
5203999|NCT01027780|12796130|P2|COMPLETED|Overall Study||102
5204000|NCT01027780|12796131|P1|COMPLETED|Overall Study||105
5204001|NCT01027780|12796130|P2|STARTED|Overall Study||103
5204002|NCT01027780|12796131|P1|STARTED|Overall Study||105
5204003|NCT01027754|12796143|P2|NOT COMPLETED|Overall Study||8
5204004|NCT01027754|12796144|P1|NOT COMPLETED|Overall Study||2
5204005|NCT01027754|12796143|P2|COMPLETED|Overall Study||47
5204006|NCT01027754|12796144|P1|COMPLETED|Overall Study||55
5204007|NCT01027754|12796143|P2|STARTED|Overall Study||55
5204008|NCT01027754|12796144|P1|STARTED|Overall Study||57
5204009|NCT01027702|12796178|P7|NOT COMPLETED|Overall Study||1
5204010|NCT01027702|12796179|P6|NOT COMPLETED|Overall Study||0
5204011|NCT01027702|12796180|P5|NOT COMPLETED|Overall Study||1
5204012|NCT01027702|12796181|P4|NOT COMPLETED|Overall Study||4
5204013|NCT01027702|12796182|P3|NOT COMPLETED|Overall Study||1
5204014|NCT01027702|12796183|P2|NOT COMPLETED|Overall Study||2
5204015|NCT01027702|12796184|P1|NOT COMPLETED|Overall Study||1
5204016|NCT01027702|12796178|P7|COMPLETED|Overall Study||1
5204017|NCT01027702|12796179|P6|COMPLETED|Overall Study||1
5204018|NCT01027702|12796180|P5|COMPLETED|Overall Study||9
5204019|NCT01027702|12796181|P4|COMPLETED|Overall Study||10
5204020|NCT01027702|12796182|P3|COMPLETED|Overall Study||2
5204021|NCT01027702|12796183|P2|COMPLETED|Overall Study||2
5204022|NCT01027702|12796184|P1|COMPLETED|Overall Study||3
5204023|NCT01027702|12796178|P7|STARTED|Overall Study||2
5204024|NCT01027702|12796179|P6|STARTED|Overall Study||1
5204025|NCT01027702|12796180|P5|STARTED|Overall Study||10
5204026|NCT01027702|12796181|P4|STARTED|Overall Study||14
5204027|NCT01027702|12796182|P3|STARTED|Overall Study||3
5204028|NCT01027702|12796183|P2|STARTED|Overall Study||4
5204029|NCT01027702|12796184|P1|STARTED|Overall Study||4
5204030|NCT01027650|12796210|P8|NOT COMPLETED|Overall Study||0
5204031|NCT01027650|12796211|P7|NOT COMPLETED|Overall Study||1
5204032|NCT01027650|12796212|P6|NOT COMPLETED|Overall Study||2
5204033|NCT01027650|12796213|P5|NOT COMPLETED|Overall Study||2
5204034|NCT01027650|12796214|P4|NOT COMPLETED|Overall Study||0
5204035|NCT01027650|12796215|P3|NOT COMPLETED|Overall Study||0
5204036|NCT01027650|12796216|P2|NOT COMPLETED|Overall Study||0
5204037|NCT01027650|12796217|P1|NOT COMPLETED|Overall Study||0
5204038|NCT01027650|12796210|P8|COMPLETED|Overall Study||24
5204039|NCT01027650|12796211|P7|COMPLETED|Overall Study||24
5204040|NCT01027650|12796212|P6|COMPLETED|Overall Study||24
5204041|NCT01027650|12796213|P5|COMPLETED|Overall Study||23
5204042|NCT01027650|12796214|P4|COMPLETED|Overall Study||3
5204043|NCT01027650|12796215|P3|COMPLETED|Overall Study||6
5204044|NCT01027650|12796216|P2|COMPLETED|Overall Study||6
5204045|NCT01027650|12796217|P1|COMPLETED|Overall Study||6
5204046|NCT01027650|12796210|P8|STARTED|Overall Study||24
5204047|NCT01027650|12796211|P7|STARTED|Overall Study||25
5204048|NCT01027650|12796212|P6|STARTED|Overall Study||26
5204049|NCT01027650|12796213|P5|STARTED|Overall Study||25
5204050|NCT01027650|12796214|P4|STARTED|Overall Study||3
5204051|NCT01027650|12796215|P3|STARTED|Overall Study||6
5204052|NCT01027650|12796216|P2|STARTED|Overall Study||6
5204053|NCT01027650|12796217|P1|STARTED|Overall Study||6
5204054|NCT01027598|12796261|P2|NOT COMPLETED|Overall Study||67
5204055|NCT01027598|12796262|P1|NOT COMPLETED|Overall Study||134
5204056|NCT01027598|12796261|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
5204057|NCT01027598|12796262|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
5204058|NCT01027598|12796261|P2|STARTED|Overall Study||67
5204059|NCT01027598|12796262|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
5204060|NCT01027559|12796275|P3|NOT COMPLETED|Overall Study||9
5204061|NCT01027559|12796276|P2|NOT COMPLETED|Overall Study||8
5204062|NCT01027559|12796277|P1|NOT COMPLETED|Overall Study||6
5204063|NCT01027559|12796275|P3|COMPLETED|Overall Study||22
5204064|NCT01027559|12796276|P2|COMPLETED|Overall Study||26
5204065|NCT01027559|12796277|P1|COMPLETED|Overall Study||20
5204066|NCT01027559|12796275|P3|STARTED|Overall Study||31
5204067|NCT01027559|12796276|P2|STARTED|Overall Study||34
5204068|NCT01027559|12796277|P1|STARTED|Overall Study||26
5204069|NCT01027468|12796287|P1|NOT COMPLETED|Overall Study||0
5204070|NCT01027468|12796287|P1|COMPLETED|Overall Study||160
5204071|NCT01027468|12796287|P1|STARTED|Overall Study||160
5204072|NCT01027416|12796295|P2|NOT COMPLETED|Overall Study||5
5204073|NCT01027416|12796296|P1|NOT COMPLETED|Overall Study||1
5204074|NCT01027416|12796295|P2|COMPLETED|Overall Study||23
5204075|NCT01027416|12796296|P1|COMPLETED|Overall Study||30
5204076|NCT01027416|12796295|P2|STARTED|Overall Study||28
5204077|NCT01027416|12796296|P1|STARTED|Overall Study||31
5204078|NCT01027364|12796308|P4|NOT COMPLETED|Overall Study||1
5204079|NCT01027364|12796309|P3|NOT COMPLETED|Overall Study||1
5204080|NCT01027364|12796310|P2|NOT COMPLETED|Overall Study||2
5204081|NCT01027364|12796311|P1|NOT COMPLETED|Overall Study||4
5204082|NCT01027364|12796308|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
5204083|NCT01027364|12796309|P3|COMPLETED|Overall Study||26
5204084|NCT01027364|12796310|P2|COMPLETED|Overall Study||27
5204085|NCT01027364|12796311|P1|COMPLETED|Overall Study||59
5204086|NCT01027364|12796308|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
5204087|NCT01027364|12796309|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
5204088|NCT01027364|12796310|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
5204089|NCT01027364|12796311|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
5204090|NCT01027364|12796308|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
5204091|NCT01027364|12796309|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
5204092|NCT01027364|12796310|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
5204093|NCT01027364|12796311|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
5204094|NCT01027364|12796308|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
5204095|NCT01027364|12796309|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
5204096|NCT01027364|12796310|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
5204097|NCT01027364|12796311|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
5204098|NCT01027364|12796308|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
5204099|NCT01027364|12796309|P3|STARTED|Overall Study||27
5204100|NCT01027364|12796310|P2|STARTED|Overall Study||29
5204101|NCT01027364|12796311|P1|STARTED|Overall Study||63
5204102|NCT01027351|12796406|P6|NOT COMPLETED|Overall Study||5
5204103|NCT01027351|12796407|P5|NOT COMPLETED|Overall Study||11
5204104|NCT01027351|12796408|P4|NOT COMPLETED|Overall Study||2
5204105|NCT01027351|12796409|P3|NOT COMPLETED|Overall Study||1
5204106|NCT01027351|12796410|P2|NOT COMPLETED|Overall Study||1
5204107|NCT01027351|12796411|P1|NOT COMPLETED|Overall Study||3
5204108|NCT01027351|12796406|P6|COMPLETED|Overall Study||45
5204109|NCT01027351|12796407|P5|COMPLETED|Overall Study||32
5204110|NCT01027351|12796408|P4|COMPLETED|Overall Study||6
5204111|NCT01027351|12796409|P3|COMPLETED|Overall Study||13
5204112|NCT01027351|12796410|P2|COMPLETED|Overall Study||18
5204113|NCT01027351|12796411|P1|COMPLETED|Overall Study||26
5204114|NCT01027351|12796406|P6|STARTED|Overall Study||50
5204115|NCT01027351|12796407|P5|STARTED|Overall Study||43
5204116|NCT01027351|12796408|P4|STARTED|Overall Study||8
5204117|NCT01027351|12796409|P3|STARTED|Overall Study||14
5204118|NCT01027351|12796410|P2|STARTED|Overall Study||19
5204119|NCT01027351|12796411|P1|STARTED|Overall Study||29
5204120|NCT01027286|12796495|P2|NOT COMPLETED|Overall Study||1
5204121|NCT01027286|12796496|P1|NOT COMPLETED|Overall Study||1
5204122|NCT01027286|12796495|P2|COMPLETED|Overall Study||49
5204123|NCT01027286|12796496|P1|COMPLETED|Overall Study||49
5204124|NCT01027286|12796495|P2|12 Week Postoperative|Overall Study||49
5204125|NCT01027286|12796496|P1|12 Week Postoperative|Overall Study||49
5204126|NCT01027286|12796495|P2|4 Week Postoperative|Overall Study||50
5204127|NCT01027286|12796496|P1|4 Week Postoperative|Overall Study||49
5204128|NCT01027286|12796495|P2|Day of Surgery|Overall Study||50
5204129|NCT01027286|12796496|P1|Day of Surgery|Overall Study||50
5204130|NCT01027286|12796495|P2|Preoperative|Overall Study||50
5204131|NCT01027286|12796496|P1|Preoperative|Overall Study||50
5204132|NCT01027286|12796495|P2|STARTED|Overall Study||50
5204133|NCT01027286|12796496|P1|STARTED|Overall Study||50
5204134|NCT01027273|12796516|P2|NOT COMPLETED|Overall Study||33
5204135|NCT01027273|12796517|P1|NOT COMPLETED|Overall Study||59
5204136|NCT01027273|12796516|P2|COMPLETED|Overall Study||266
5204137|NCT01027273|12796517|P1|COMPLETED|Overall Study||242
5204138|NCT01027273|12796516|P2|STARTED|Overall Study||299
5204139|NCT01027273|12796517|P1|STARTED|Overall Study||301
5204140|NCT01027195|12796535|P2|NOT COMPLETED|Overall Study||0
5204141|NCT01027195|12796536|P1|NOT COMPLETED|Overall Study||0
5204142|NCT01027195|12796535|P2|COMPLETED|Overall Study||69
5204143|NCT01027195|12796536|P1|COMPLETED|Overall Study||71
5204144|NCT01027195|12796535|P2|STARTED|Overall Study||69
5204145|NCT01027195|12796536|P1|STARTED|Overall Study||71
5204146|NCT01027000|12796556|P1|NOT COMPLETED|Overall Study||0
5204147|NCT01027000|12796556|P1|COMPLETED|Overall Study||68
5204148|NCT01027000|12796556|P1|STARTED|Overall Study||68
5204149|NCT01026974|12796564|P4|NOT COMPLETED|Overall Study||3
5204150|NCT01026974|12796565|P3|NOT COMPLETED|Overall Study||12
5204151|NCT01026974|12796566|P2|NOT COMPLETED|Overall Study||2
5204152|NCT01026974|12796567|P1|NOT COMPLETED|Overall Study||1
5204153|NCT01026974|12796564|P4|COMPLETED|Overall Study||46
5204154|NCT01026974|12796565|P3|COMPLETED|Overall Study||29
5204155|NCT01026974|12796566|P2|COMPLETED|Overall Study||12
5204156|NCT01026974|12796567|P1|COMPLETED|Overall Study||15
5204157|NCT01026974|12796564|P4|STARTED|Overall Study||49
5204158|NCT01026974|12796565|P3|STARTED|Overall Study||41
5204159|NCT01026974|12796566|P2|STARTED|Overall Study||14
5204160|NCT01026974|12796567|P1|STARTED|Overall Study||16
5204161|NCT01026948|12796624|P1|NOT COMPLETED|Overall Study||8
5204162|NCT01026948|12796624|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
5204163|NCT01026948|12796624|P1|STARTED|Overall Study||70
5204164|NCT01026909|12796631|P2|NOT COMPLETED|Overall Study||0
5204165|NCT01026909|12796632|P1|NOT COMPLETED|Overall Study||0
5204166|NCT01026909|12796631|P2|COMPLETED|Overall Study||2
5204167|NCT01026909|12796632|P1|COMPLETED|Overall Study||1
5204168|NCT01026909|12796631|P2|STARTED|Overall Study||2
5204169|NCT01026909|12796632|P1|STARTED|Overall Study||1
5204170|NCT01026844|12796642|P2|NOT COMPLETED|Overall Study||0
5204171|NCT01026844|12796643|P1|NOT COMPLETED|Overall Study||0
5204172|NCT01026844|12796642|P2|COMPLETED|Overall Study||8
5204173|NCT01026844|12796643|P1|COMPLETED|Overall Study||19
5204174|NCT01026844|12796642|P2|STARTED|Overall Study||8
5204175|NCT01026844|12796643|P1|STARTED|Overall Study||19
5204176|NCT01026831|12796657|P2|NOT COMPLETED|Overall Study||11
5204177|NCT01026831|12796658|P1|NOT COMPLETED|Overall Study||14
5204178|NCT01026831|12796657|P2|COMPLETED|Overall Study||312
5204179|NCT01026831|12796658|P1|COMPLETED|Overall Study||306
5204180|NCT01026831|12796657|P2|STARTED|Overall Study|randomized|323
5204181|NCT01026831|12796658|P1|STARTED|Overall Study|randomized|320
5204182|NCT01026818|12796669|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
5204183|NCT01026818|12796670|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
5204184|NCT01026818|12796671|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
5204185|NCT01026818|12796672|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
5204186|NCT01026818|12796669|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
5204187|NCT01026818|12796670|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
5204188|NCT01026818|12796671|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
5204189|NCT01026818|12796672|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
5204190|NCT01026818|12796669|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
5204191|NCT01026818|12796670|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
5204192|NCT01026818|12796671|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
5204193|NCT01026818|12796672|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
5204194|NCT01026818|12796669|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
5204195|NCT01026818|12796670|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
5204196|NCT01026818|12796671|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
5204197|NCT01026818|12796672|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
5204198|NCT01026818|12796669|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
5204199|NCT01026818|12796670|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
5204200|NCT01026818|12796671|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
5204201|NCT01026818|12796672|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
5204202|NCT01026818|12796669|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
5204203|NCT01026818|12796670|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
5204204|NCT01026818|12796671|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
5204205|NCT01026818|12796672|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
5204206|NCT01026818|12796669|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
5204207|NCT01026818|12796670|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
5204208|NCT01026818|12796671|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
5204209|NCT01026818|12796672|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
5204210|NCT01026818|12796669|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
5204211|NCT01026818|12796670|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
5204212|NCT01026818|12796671|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
5204213|NCT01026818|12796672|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
5204214|NCT01026818|12796669|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
5204215|NCT01026818|12796670|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
5204216|NCT01026818|12796671|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
5204217|NCT01026818|12796672|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
5204218|NCT01026818|12796669|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
5204219|NCT01026818|12796670|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
5204220|NCT01026818|12796671|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
5204221|NCT01026818|12796672|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
5204222|NCT01026818|12796669|P4|NOT COMPLETED|Screening Period||0
5204223|NCT01026818|12796670|P3|NOT COMPLETED|Screening Period||0
5204224|NCT01026818|12796671|P2|NOT COMPLETED|Screening Period||0
5204225|NCT01026818|12796672|P1|NOT COMPLETED|Screening Period||160
5204226|NCT01026818|12796669|P4|COMPLETED|Screening Period||0
5204227|NCT01026818|12796670|P3|COMPLETED|Screening Period||0
5204228|NCT01026818|12796671|P2|COMPLETED|Screening Period||0
5204229|NCT01026818|12796672|P1|COMPLETED|Screening Period||423
5204230|NCT01026818|12796669|P4|STARTED|Screening Period||0
5204231|NCT01026818|12796670|P3|STARTED|Screening Period||0
5204232|NCT01026818|12796671|P2|STARTED|Screening Period||0
5204233|NCT01026818|12796672|P1|STARTED|Screening Period||583
5204234|NCT01026805|12796750|P1|NOT COMPLETED|Overall Study||0
5204235|NCT01026805|12796750|P1|COMPLETED|Overall Study||11
5204236|NCT01026805|12796750|P1|STARTED|Overall Study||11
5204237|NCT01026792|12796760|P1|NOT COMPLETED|Overall Study||1
5204238|NCT01026792|12796760|P1|COMPLETED|Overall Study||37
5204239|NCT01026792|12796760|P1|STARTED|Overall Study||38
5204240|NCT01026623|12796767|P3|NOT COMPLETED|Overall Study||0
5204241|NCT01026623|12796768|P2|NOT COMPLETED|Overall Study||0
5204242|NCT01026623|12796769|P1|NOT COMPLETED|Overall Study||0
5204243|NCT01026623|12796767|P3|COMPLETED|Overall Study||5
5204244|NCT01026623|12796768|P2|COMPLETED|Overall Study||5
5204245|NCT01026623|12796769|P1|COMPLETED|Overall Study||6
5204246|NCT01026623|12796767|P3|STARTED|Overall Study||5
5204247|NCT01026623|12796768|P2|STARTED|Overall Study||5
5204248|NCT01026623|12796769|P1|STARTED|Overall Study||6
5204249|NCT01026493|12796803|P8|NOT COMPLETED|Overall Study||1
5204250|NCT01026493|12796804|P7|NOT COMPLETED|Overall Study||4
5204251|NCT01026493|12796805|P6|NOT COMPLETED|Overall Study||3
5204252|NCT01026493|12796806|P5|NOT COMPLETED|Overall Study||2
5204253|NCT01026493|12796807|P4|NOT COMPLETED|Overall Study||0
5204254|NCT01026493|12796808|P3|NOT COMPLETED|Overall Study||0
5204255|NCT01026493|12796809|P2|NOT COMPLETED|Overall Study||1
5204256|NCT01026493|12796810|P1|NOT COMPLETED|Overall Study||0
5204257|NCT01026493|12796803|P8|COMPLETED|Overall Study||37
5204258|NCT01026493|12796804|P7|COMPLETED|Overall Study||32
5204259|NCT01026493|12796805|P6|COMPLETED|Overall Study||73
5204260|NCT01026493|12796806|P5|COMPLETED|Overall Study||73
5204261|NCT01026493|12796807|P4|COMPLETED|Overall Study||8
5204262|NCT01026493|12796808|P3|COMPLETED|Overall Study||9
5204263|NCT01026493|12796809|P2|COMPLETED|Overall Study||6
5204264|NCT01026493|12796810|P1|COMPLETED|Overall Study||8
5204265|NCT01026493|12796803|P8|STARTED|Overall Study||38
5204266|NCT01026493|12796804|P7|STARTED|Overall Study||36
5204267|NCT01026493|12796805|P6|STARTED|Overall Study||76
5204268|NCT01026493|12796806|P5|STARTED|Overall Study||75
5204269|NCT01026493|12796807|P4|STARTED|Overall Study||8
5204270|NCT01026493|12796808|P3|STARTED|Overall Study||9
5204271|NCT01026493|12796809|P2|STARTED|Overall Study||7
5204272|NCT01026493|12796810|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
5204273|NCT01026454|12796838|P2|NOT COMPLETED|Second Intervention||1
5204274|NCT01026454|12796839|P1|NOT COMPLETED|Second Intervention||1
5204275|NCT01026454|12796838|P2|COMPLETED|Second Intervention||13
5204276|NCT01026454|12796839|P1|COMPLETED|Second Intervention||16
5204277|NCT01026454|12796838|P2|STARTED|Second Intervention||14
5204278|NCT01026454|12796839|P1|STARTED|Second Intervention||17
5204279|NCT01026454|12796838|P2|NOT COMPLETED|Washout||0
5204280|NCT01026454|12796839|P1|NOT COMPLETED|Washout||0
5204281|NCT01026454|12796838|P2|COMPLETED|Washout||14
5204282|NCT01026454|12796839|P1|COMPLETED|Washout||18
5204283|NCT01026454|12796838|P2|STARTED|Washout||14
5204284|NCT01026454|12796839|P1|STARTED|Washout||18
5204285|NCT01026454|12796838|P2|NOT COMPLETED|First Intervention||0
5204286|NCT01026454|12796839|P1|NOT COMPLETED|First Intervention||0
5204287|NCT01026454|12796838|P2|COMPLETED|First Intervention||14
5204288|NCT01026454|12796839|P1|COMPLETED|First Intervention||18
5204289|NCT01026454|12796838|P2|STARTED|First Intervention||14
5204290|NCT01026454|12796839|P1|STARTED|First Intervention||18
5204291|NCT01026402|12796862|P17|NOT COMPLETED|Overall Study||0
5204292|NCT01026402|12796863|P16|NOT COMPLETED|Overall Study||0
5204293|NCT01026402|12796864|P15|NOT COMPLETED|Overall Study||0
5204294|NCT01026402|12796865|P14|NOT COMPLETED|Overall Study||0
5204295|NCT01026402|12796866|P13|NOT COMPLETED|Overall Study||0
5204296|NCT01026402|12796867|P12|NOT COMPLETED|Overall Study||0
5204297|NCT01026402|12796868|P11|NOT COMPLETED|Overall Study||0
5204298|NCT01026402|12796869|P10|NOT COMPLETED|Overall Study||0
5204299|NCT01026402|12796870|P9|NOT COMPLETED|Overall Study||0
5204300|NCT01026402|12796871|P8|NOT COMPLETED|Overall Study||0
5204301|NCT01026402|12796872|P7|NOT COMPLETED|Overall Study||0
5204302|NCT01026402|12796873|P6|NOT COMPLETED|Overall Study||0
5204303|NCT01026402|12796874|P5|NOT COMPLETED|Overall Study||0
5204304|NCT01026402|12796875|P4|NOT COMPLETED|Overall Study||0
5204305|NCT01026402|12796876|P3|NOT COMPLETED|Overall Study||0
5204306|NCT01026402|12796877|P2|NOT COMPLETED|Overall Study||0
5204307|NCT01026402|12796878|P1|NOT COMPLETED|Overall Study||0
5204308|NCT01026402|12796862|P17|COMPLETED|Overall Study||4
5204309|NCT01026402|12796863|P16|COMPLETED|Overall Study||5
5204310|NCT01026402|12796864|P15|COMPLETED|Overall Study||3
5204311|NCT01026402|12796865|P14|COMPLETED|Overall Study||6
5204312|NCT01026402|12796866|P13|COMPLETED|Overall Study||8
5204313|NCT01026402|12796867|P12|COMPLETED|Overall Study||8
5204314|NCT01026402|12796868|P11|COMPLETED|Overall Study||7
5204315|NCT01026402|12796869|P10|COMPLETED|Overall Study||3
5204316|NCT01026402|12796870|P9|COMPLETED|Overall Study||7
5204317|NCT01026402|12796871|P8|COMPLETED|Overall Study||3
5204318|NCT01026402|12796872|P7|COMPLETED|Overall Study||8
5204319|NCT01026402|12796873|P6|COMPLETED|Overall Study||5
5204320|NCT01026402|12796874|P5|COMPLETED|Overall Study||3
5204321|NCT01026402|12796875|P4|COMPLETED|Overall Study||18
5204322|NCT01026402|12796876|P3|COMPLETED|Overall Study||33
5204323|NCT01026402|12796877|P2|COMPLETED|Overall Study||8
5204324|NCT01026402|12796878|P1|COMPLETED|Overall Study||6
5204325|NCT01026402|12796862|P17|STARTED|Overall Study||4
5204326|NCT01026402|12796863|P16|STARTED|Overall Study||5
5204327|NCT01026402|12796864|P15|STARTED|Overall Study||3
5204328|NCT01026402|12796865|P14|STARTED|Overall Study||6
5204329|NCT01026402|12796866|P13|STARTED|Overall Study||8
5204330|NCT01026402|12796867|P12|STARTED|Overall Study||8
5204331|NCT01026402|12796868|P11|STARTED|Overall Study||7
5204332|NCT01026402|12796869|P10|STARTED|Overall Study||3
5204333|NCT01026402|12796870|P9|STARTED|Overall Study||7
5204334|NCT01026402|12796871|P8|STARTED|Overall Study||3
5204335|NCT01026402|12796872|P7|STARTED|Overall Study||8
5204336|NCT01026402|12796873|P6|STARTED|Overall Study||5
5204337|NCT01026402|12796874|P5|STARTED|Overall Study||3
5204338|NCT01026402|12796875|P4|STARTED|Overall Study||18
5204339|NCT01026402|12796876|P3|STARTED|Overall Study||33
5204340|NCT01026402|12796877|P2|STARTED|Overall Study||8
5204341|NCT01026402|12796878|P1|STARTED|Overall Study||6
5204342|NCT01026389|12797188|P2|NOT COMPLETED|Overall Study||5
5204343|NCT01026389|12797189|P1|NOT COMPLETED|Overall Study||5
5204344|NCT01026389|12797188|P2|COMPLETED|Overall Study||88
5204345|NCT01026389|12797189|P1|COMPLETED|Overall Study||88
5204346|NCT01026389|12797188|P2|STARTED|Overall Study||93
5204347|NCT01026389|12797189|P1|STARTED|Overall Study||93
5204348|NCT01026324|12797204|P3|NOT COMPLETED|Follow up/Survival||0
5204349|NCT01026324|12797205|P2|NOT COMPLETED|Follow up/Survival||0
5204350|NCT01026324|12797206|P1|NOT COMPLETED|Follow up/Survival||1
5204351|NCT01026324|12797204|P3|COMPLETED|Follow up/Survival||4
5204352|NCT01026324|12797205|P2|COMPLETED|Follow up/Survival||3
5204353|NCT01026324|12797206|P1|COMPLETED|Follow up/Survival||4
5204354|NCT01026324|12797204|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
5204355|NCT01026324|12797205|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
5204356|NCT01026324|12797206|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
5204357|NCT01026324|12797204|P3|STARTED|Follow up/Survival||4
5204358|NCT01026324|12797205|P2|STARTED|Follow up/Survival||3
5204359|NCT01026324|12797206|P1|STARTED|Follow up/Survival||5
5204360|NCT01026324|12797204|P3|NOT COMPLETED|Treatment Allocation||0
5204361|NCT01026324|12797205|P2|NOT COMPLETED|Treatment Allocation||0
5204362|NCT01026324|12797206|P1|NOT COMPLETED|Treatment Allocation||0
5204363|NCT01026324|12797204|P3|COMPLETED|Treatment Allocation||4
5204364|NCT01026324|12797205|P2|COMPLETED|Treatment Allocation||3
5204365|NCT01026324|12797206|P1|COMPLETED|Treatment Allocation||5
5204366|NCT01026324|12797204|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
5204367|NCT01026324|12797205|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
5204368|NCT01026324|12797206|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
5204369|NCT01026324|12797204|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
5204370|NCT01026324|12797205|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
5204371|NCT01026324|12797206|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
5204372|NCT01026324|12797204|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
5204373|NCT01026324|12797205|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
5204374|NCT01026324|12797206|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
5204375|NCT01026324|12797204|P3|STARTED|Treatment Allocation||4
5204376|NCT01026324|12797205|P2|STARTED|Treatment Allocation||3
5204377|NCT01026324|12797206|P1|STARTED|Treatment Allocation||5
5204378|NCT01026220|12797216|P3|NOT COMPLETED|Consolidation Maintenance||14
5204379|NCT01026220|12797217|P2|NOT COMPLETED|Consolidation Maintenance||6
5204380|NCT01026220|12797218|P1|NOT COMPLETED|Consolidation Maintenance||0
5204381|NCT01026220|12797216|P3|COMPLETED|Consolidation Maintenance||66
5204382|NCT01026220|12797217|P2|COMPLETED|Consolidation Maintenance||75
5204383|NCT01026220|12797218|P1|COMPLETED|Consolidation Maintenance||0
5204384|NCT01026220|12797216|P3|STARTED|Consolidation Maintenance||80
5204385|NCT01026220|12797217|P2|STARTED|Consolidation Maintenance||81
5204386|NCT01026220|12797218|P1|STARTED|Consolidation Maintenance||0
5204387|NCT01026220|12797216|P3|NOT COMPLETED|Induction||0
5204388|NCT01026220|12797217|P2|NOT COMPLETED|Induction||0
5204389|NCT01026220|12797218|P1|NOT COMPLETED|Induction||25
5204390|NCT01026220|12797216|P3|COMPLETED|Induction||0
5204391|NCT01026220|12797217|P2|COMPLETED|Induction||0
5204392|NCT01026220|12797218|P1|COMPLETED|Induction||141
5204393|NCT01026220|12797216|P3|STARTED|Induction||0
5204394|NCT01026220|12797217|P2|STARTED|Induction||0
5204395|NCT01026220|12797218|P1|STARTED|Induction||166
5204396|NCT01026194|12797242|P2|NOT COMPLETED|Period 2：Open-label Period||10
5204397|NCT01026194|12797243|P1|NOT COMPLETED|Period 2：Open-label Period||7
5204398|NCT01026194|12797242|P2|COMPLETED|Period 2：Open-label Period||88
5204399|NCT01026194|12797243|P1|COMPLETED|Period 2：Open-label Period||91
5204400|NCT01026194|12797242|P2|STARTED|Period 2：Open-label Period||98
5204401|NCT01026194|12797243|P1|STARTED|Period 2：Open-label Period||98
5204402|NCT01026194|12797242|P2|NOT COMPLETED|Period 1：Double Blind Period||5
5204403|NCT01026194|12797243|P1|NOT COMPLETED|Period 1：Double Blind Period||3
5204404|NCT01026194|12797242|P2|COMPLETED|Period 1：Double Blind Period||98
5204405|NCT01026194|12797243|P1|COMPLETED|Period 1：Double Blind Period||98
5204406|NCT01026194|12797242|P2|STARTED|Period 1：Double Blind Period||103
5204407|NCT01026194|12797243|P1|STARTED|Period 1：Double Blind Period||101
5204408|NCT01026181|12797260|P3|NOT COMPLETED|Overall Study||0
5204409|NCT01026181|12797261|P2|NOT COMPLETED|Overall Study||0
5204410|NCT01026181|12797262|P1|NOT COMPLETED|Overall Study||0
5204411|NCT01026181|12797260|P3|COMPLETED|Overall Study||48
5204412|NCT01026181|12797261|P2|COMPLETED|Overall Study||51
5204413|NCT01026181|12797262|P1|COMPLETED|Overall Study||51
5204414|NCT01026181|12797260|P3|STARTED|Overall Study||48
5204415|NCT01026181|12797261|P2|STARTED|Overall Study||51
5204416|NCT01026181|12797262|P1|STARTED|Overall Study||51
5204417|NCT01026142|12797275|P2|NOT COMPLETED|Overall Study||163
5204418|NCT01026142|12797276|P1|NOT COMPLETED|Overall Study||172
5204419|NCT01026142|12797275|P2|COMPLETED|Overall Study||65
5204420|NCT01026142|12797276|P1|COMPLETED|Overall Study||52
5204421|NCT01026142|12797275|P2|STARTED|Overall Study||228
5204422|NCT01026142|12797276|P1|STARTED|Overall Study||224
5204423|NCT01026103|12797298|P1|NOT COMPLETED|Overall Study||2
5204424|NCT01026103|12797298|P1|COMPLETED|Overall Study||28
5204425|NCT01026103|12797298|P1|Consented|Overall Study||30
5204426|NCT01026103|12797298|P1|STARTED|Overall Study||30
5204427|NCT01026038|12797308|P3|NOT COMPLETED|Overall Study||0
5204428|NCT01026038|12797309|P2|NOT COMPLETED|Overall Study||1
5204429|NCT01026038|12797310|P1|NOT COMPLETED|Overall Study||1
5204430|NCT01026038|12797308|P3|COMPLETED|Overall Study||67
5204431|NCT01026038|12797309|P2|COMPLETED|Overall Study||64
5204432|NCT01026038|12797310|P1|COMPLETED|Overall Study||129
5204433|NCT01026038|12797308|P3|STARTED|Overall Study||67
5204434|NCT01026038|12797309|P2|STARTED|Overall Study||65
5204435|NCT01026038|12797310|P1|STARTED|Overall Study||130
5204436|NCT01026012|12797345|P1|NOT COMPLETED|Overall Study||0
5204437|NCT01026012|12797345|P1|COMPLETED|Overall Study||40
5204438|NCT01026012|12797345|P1|STARTED|Overall Study||40
5204439|NCT01025843|12797359|P10|NOT COMPLETED|Period 5||0
5204440|NCT01025843|12797360|P9|NOT COMPLETED|Period 5||0
5204441|NCT01025843|12797361|P8|NOT COMPLETED|Period 5||0
5204442|NCT01025843|12797362|P7|NOT COMPLETED|Period 5||0
5204443|NCT01025843|12797363|P6|NOT COMPLETED|Period 5||0
5204444|NCT01025843|12797364|P5|NOT COMPLETED|Period 5||0
5204445|NCT01025843|12797365|P4|NOT COMPLETED|Period 5||0
5204446|NCT01025843|12797366|P3|NOT COMPLETED|Period 5||0
5204447|NCT01025843|12797367|P2|NOT COMPLETED|Period 5||0
5204448|NCT01025843|12797368|P1|NOT COMPLETED|Period 5||0
5204449|NCT01025843|12797359|P10|COMPLETED|Period 5||2
5204450|NCT01025843|12797360|P9|COMPLETED|Period 5||2
5204451|NCT01025843|12797361|P8|COMPLETED|Period 5||2
5204452|NCT01025843|12797362|P7|COMPLETED|Period 5||2
5204453|NCT01025843|12797363|P6|COMPLETED|Period 5||2
5204454|NCT01025843|12797364|P5|COMPLETED|Period 5||2
5204455|NCT01025843|12797365|P4|COMPLETED|Period 5||1
5204456|NCT01025843|12797366|P3|COMPLETED|Period 5||1
5204457|NCT01025843|12797367|P2|COMPLETED|Period 5||2
5204458|NCT01025843|12797368|P1|COMPLETED|Period 5||2
5204459|NCT01025843|12797359|P10|STARTED|Period 5||2
5204460|NCT01025843|12797360|P9|STARTED|Period 5||2
5204461|NCT01025843|12797361|P8|STARTED|Period 5||2
5204462|NCT01025843|12797362|P7|STARTED|Period 5||2
5204463|NCT01025843|12797363|P6|STARTED|Period 5||2
5204464|NCT01025843|12797364|P5|STARTED|Period 5||2
5204465|NCT01025843|12797365|P4|STARTED|Period 5||1
5204466|NCT01025843|12797366|P3|STARTED|Period 5||1
5204467|NCT01025843|12797367|P2|STARTED|Period 5||2
5204468|NCT01025843|12797368|P1|STARTED|Period 5||2
5204469|NCT01025843|12797359|P10|NOT COMPLETED|Washout 4||0
5204470|NCT01025843|12797360|P9|NOT COMPLETED|Washout 4||0
5204471|NCT01025843|12797361|P8|NOT COMPLETED|Washout 4||0
5204472|NCT01025843|12797362|P7|NOT COMPLETED|Washout 4||0
5204473|NCT01025843|12797363|P6|NOT COMPLETED|Washout 4||0
5204474|NCT01025843|12797364|P5|NOT COMPLETED|Washout 4||0
5204475|NCT01025843|12797365|P4|NOT COMPLETED|Washout 4||1
5204476|NCT01025843|12797366|P3|NOT COMPLETED|Washout 4||1
5204477|NCT01025843|12797367|P2|NOT COMPLETED|Washout 4||0
5204478|NCT01025843|12797368|P1|NOT COMPLETED|Washout 4||0
5204479|NCT01025843|12797359|P10|COMPLETED|Washout 4||2
5204480|NCT01025843|12797360|P9|COMPLETED|Washout 4||2
5204481|NCT01025843|12797361|P8|COMPLETED|Washout 4||2
5204482|NCT01025843|12797362|P7|COMPLETED|Washout 4||2
5204483|NCT01025843|12797363|P6|COMPLETED|Washout 4||2
5204484|NCT01025843|12797364|P5|COMPLETED|Washout 4||2
5204485|NCT01025843|12797365|P4|COMPLETED|Washout 4||1
5204486|NCT01025843|12797366|P3|COMPLETED|Washout 4||1
5204487|NCT01025843|12797367|P2|COMPLETED|Washout 4||2
5204488|NCT01025843|12797368|P1|COMPLETED|Washout 4||2
5204489|NCT01025843|12797359|P10|STARTED|Washout 4||2
5204490|NCT01025843|12797360|P9|STARTED|Washout 4||2
5204491|NCT01025843|12797361|P8|STARTED|Washout 4||2
5204492|NCT01025843|12797362|P7|STARTED|Washout 4||2
5204493|NCT01025843|12797363|P6|STARTED|Washout 4||2
5204494|NCT01025843|12797364|P5|STARTED|Washout 4||2
5204495|NCT01025843|12797365|P4|STARTED|Washout 4||2
5204496|NCT01025843|12797366|P3|STARTED|Washout 4||2
5204497|NCT01025843|12797367|P2|STARTED|Washout 4||2
5204498|NCT01025843|12797368|P1|STARTED|Washout 4||2
5204499|NCT01025843|12797359|P10|NOT COMPLETED|Period 4||0
5204500|NCT01025843|12797360|P9|NOT COMPLETED|Period 4||0
5204501|NCT01025843|12797361|P8|NOT COMPLETED|Period 4||0
5204502|NCT01025843|12797362|P7|NOT COMPLETED|Period 4||0
5204503|NCT01025843|12797363|P6|NOT COMPLETED|Period 4||0
5204504|NCT01025843|12797364|P5|NOT COMPLETED|Period 4||0
5204505|NCT01025843|12797365|P4|NOT COMPLETED|Period 4||0
5204506|NCT01025843|12797366|P3|NOT COMPLETED|Period 4||0
5204507|NCT01025843|12797367|P2|NOT COMPLETED|Period 4||0
5204508|NCT01025843|12797368|P1|NOT COMPLETED|Period 4||0
5204509|NCT01025843|12797359|P10|COMPLETED|Period 4||2
5204510|NCT01025843|12797360|P9|COMPLETED|Period 4||2
5204511|NCT01025843|12797361|P8|COMPLETED|Period 4||2
5204512|NCT01025843|12797362|P7|COMPLETED|Period 4||2
5204513|NCT01025843|12797363|P6|COMPLETED|Period 4||2
5204514|NCT01025843|12797364|P5|COMPLETED|Period 4||2
5204515|NCT01025843|12797365|P4|COMPLETED|Period 4||2
5204516|NCT01025843|12797366|P3|COMPLETED|Period 4||2
5204517|NCT01025843|12797367|P2|COMPLETED|Period 4||2
5204518|NCT01025843|12797368|P1|COMPLETED|Period 4||2
5204519|NCT01025843|12797359|P10|STARTED|Period 4||2
5204520|NCT01025843|12797360|P9|STARTED|Period 4||2
5204521|NCT01025843|12797361|P8|STARTED|Period 4||2
5204522|NCT01025843|12797362|P7|STARTED|Period 4||2
5204523|NCT01025843|12797363|P6|STARTED|Period 4||2
5204524|NCT01025843|12797364|P5|STARTED|Period 4||2
5204525|NCT01025843|12797365|P4|STARTED|Period 4||2
5204526|NCT01025843|12797366|P3|STARTED|Period 4||2
5204527|NCT01025843|12797367|P2|STARTED|Period 4||2
5204528|NCT01025843|12797368|P1|STARTED|Period 4||2
5204529|NCT01025843|12797359|P10|NOT COMPLETED|Washout 3||0
5204530|NCT01025843|12797360|P9|NOT COMPLETED|Washout 3||0
5204531|NCT01025843|12797361|P8|NOT COMPLETED|Washout 3||0
5204532|NCT01025843|12797362|P7|NOT COMPLETED|Washout 3||0
5204533|NCT01025843|12797363|P6|NOT COMPLETED|Washout 3||0
5204534|NCT01025843|12797364|P5|NOT COMPLETED|Washout 3||0
5204535|NCT01025843|12797365|P4|NOT COMPLETED|Washout 3||0
5204536|NCT01025843|12797366|P3|NOT COMPLETED|Washout 3||0
5204537|NCT01025843|12797367|P2|NOT COMPLETED|Washout 3||0
5204538|NCT01025843|12797368|P1|NOT COMPLETED|Washout 3||0
5204539|NCT01025843|12797359|P10|COMPLETED|Washout 3||2
5204540|NCT01025843|12797360|P9|COMPLETED|Washout 3||2
5204541|NCT01025843|12797361|P8|COMPLETED|Washout 3||2
5204542|NCT01025843|12797362|P7|COMPLETED|Washout 3||2
5204543|NCT01025843|12797363|P6|COMPLETED|Washout 3||2
5204544|NCT01025843|12797364|P5|COMPLETED|Washout 3||2
5204545|NCT01025843|12797365|P4|COMPLETED|Washout 3||2
5204546|NCT01025843|12797366|P3|COMPLETED|Washout 3||2
5204547|NCT01025843|12797367|P2|COMPLETED|Washout 3||2
5204548|NCT01025843|12797368|P1|COMPLETED|Washout 3||2
5204549|NCT01025843|12797359|P10|STARTED|Washout 3||2
5204550|NCT01025843|12797360|P9|STARTED|Washout 3||2
5204551|NCT01025843|12797361|P8|STARTED|Washout 3||2
5204552|NCT01025843|12797362|P7|STARTED|Washout 3||2
5204553|NCT01025843|12797363|P6|STARTED|Washout 3||2
5204554|NCT01025843|12797364|P5|STARTED|Washout 3||2
5204555|NCT01025843|12797365|P4|STARTED|Washout 3||2
5204556|NCT01025843|12797366|P3|STARTED|Washout 3||2
5204557|NCT01025843|12797367|P2|STARTED|Washout 3||2
5204558|NCT01025843|12797368|P1|STARTED|Washout 3||2
5204559|NCT01025843|12797359|P10|NOT COMPLETED|Period 3||0
5204560|NCT01025843|12797360|P9|NOT COMPLETED|Period 3||0
5204561|NCT01025843|12797361|P8|NOT COMPLETED|Period 3||0
5204562|NCT01025843|12797362|P7|NOT COMPLETED|Period 3||0
5204563|NCT01025843|12797363|P6|NOT COMPLETED|Period 3||0
5204564|NCT01025843|12797364|P5|NOT COMPLETED|Period 3||0
5204565|NCT01025843|12797365|P4|NOT COMPLETED|Period 3||0
5204566|NCT01025843|12797366|P3|NOT COMPLETED|Period 3||0
5204567|NCT01025843|12797367|P2|NOT COMPLETED|Period 3||0
5204568|NCT01025843|12797368|P1|NOT COMPLETED|Period 3||0
5204569|NCT01025843|12797359|P10|COMPLETED|Period 3||2
5204570|NCT01025843|12797360|P9|COMPLETED|Period 3||2
5204571|NCT01025843|12797361|P8|COMPLETED|Period 3||2
5204572|NCT01025843|12797362|P7|COMPLETED|Period 3||2
5204573|NCT01025843|12797363|P6|COMPLETED|Period 3||2
5204574|NCT01025843|12797364|P5|COMPLETED|Period 3||2
5204575|NCT01025843|12797365|P4|COMPLETED|Period 3||2
5204576|NCT01025843|12797366|P3|COMPLETED|Period 3||2
5204577|NCT01025843|12797367|P2|COMPLETED|Period 3||2
5204578|NCT01025843|12797368|P1|COMPLETED|Period 3||2
5204579|NCT01025843|12797359|P10|STARTED|Period 3||2
5204580|NCT01025843|12797360|P9|STARTED|Period 3||2
5204581|NCT01025843|12797361|P8|STARTED|Period 3||2
5204582|NCT01025843|12797362|P7|STARTED|Period 3||2
5204583|NCT01025843|12797363|P6|STARTED|Period 3||2
5204584|NCT01025843|12797364|P5|STARTED|Period 3||2
5204585|NCT01025843|12797365|P4|STARTED|Period 3||2
5204586|NCT01025843|12797366|P3|STARTED|Period 3||2
5204587|NCT01025843|12797367|P2|STARTED|Period 3||2
5204588|NCT01025843|12797368|P1|STARTED|Period 3||2
5204589|NCT01025843|12797359|P10|NOT COMPLETED|Washout 2||0
5204590|NCT01025843|12797360|P9|NOT COMPLETED|Washout 2||0
5204591|NCT01025843|12797361|P8|NOT COMPLETED|Washout 2||0
5204592|NCT01025843|12797362|P7|NOT COMPLETED|Washout 2||0
5204593|NCT01025843|12797363|P6|NOT COMPLETED|Washout 2||0
5204594|NCT01025843|12797364|P5|NOT COMPLETED|Washout 2||0
5204595|NCT01025843|12797365|P4|NOT COMPLETED|Washout 2||0
5204596|NCT01025843|12797366|P3|NOT COMPLETED|Washout 2||0
5204597|NCT01025843|12797367|P2|NOT COMPLETED|Washout 2||0
5204598|NCT01025843|12797368|P1|NOT COMPLETED|Washout 2||0
5204599|NCT01025843|12797359|P10|COMPLETED|Washout 2||2
5204600|NCT01025843|12797360|P9|COMPLETED|Washout 2||2
5204601|NCT01025843|12797361|P8|COMPLETED|Washout 2||2
5204602|NCT01025843|12797362|P7|COMPLETED|Washout 2||2
5204603|NCT01025843|12797363|P6|COMPLETED|Washout 2||2
5204604|NCT01025843|12797364|P5|COMPLETED|Washout 2||2
5204605|NCT01025843|12797365|P4|COMPLETED|Washout 2||2
5204606|NCT01025843|12797366|P3|COMPLETED|Washout 2||2
5204607|NCT01025843|12797367|P2|COMPLETED|Washout 2||2
5204608|NCT01025843|12797368|P1|COMPLETED|Washout 2||2
5204609|NCT01025843|12797359|P10|STARTED|Washout 2||2
5204610|NCT01025843|12797360|P9|STARTED|Washout 2||2
5204611|NCT01025843|12797361|P8|STARTED|Washout 2||2
5204612|NCT01025843|12797362|P7|STARTED|Washout 2||2
5204613|NCT01025843|12797363|P6|STARTED|Washout 2||2
5204614|NCT01025843|12797364|P5|STARTED|Washout 2||2
5204615|NCT01025843|12797365|P4|STARTED|Washout 2||2
5204616|NCT01025843|12797366|P3|STARTED|Washout 2||2
5204617|NCT01025843|12797367|P2|STARTED|Washout 2||2
5204618|NCT01025843|12797368|P1|STARTED|Washout 2||2
5204619|NCT01025843|12797359|P10|NOT COMPLETED|Period 2||0
5204620|NCT01025843|12797360|P9|NOT COMPLETED|Period 2||0
5204621|NCT01025843|12797361|P8|NOT COMPLETED|Period 2||0
5204622|NCT01025843|12797362|P7|NOT COMPLETED|Period 2||0
5204623|NCT01025843|12797363|P6|NOT COMPLETED|Period 2||0
5204624|NCT01025843|12797364|P5|NOT COMPLETED|Period 2||0
5204625|NCT01025843|12797365|P4|NOT COMPLETED|Period 2||0
5204626|NCT01025843|12797366|P3|NOT COMPLETED|Period 2||0
5204627|NCT01025843|12797367|P2|NOT COMPLETED|Period 2||0
5204628|NCT01025843|12797368|P1|NOT COMPLETED|Period 2||0
5204629|NCT01025843|12797359|P10|COMPLETED|Period 2||2
5204630|NCT01025843|12797360|P9|COMPLETED|Period 2||2
5204631|NCT01025843|12797361|P8|COMPLETED|Period 2||2
5204632|NCT01025843|12797362|P7|COMPLETED|Period 2||2
5204633|NCT01025843|12797363|P6|COMPLETED|Period 2||2
5204634|NCT01025843|12797364|P5|COMPLETED|Period 2||2
5204635|NCT01025843|12797365|P4|COMPLETED|Period 2||2
5204636|NCT01025843|12797366|P3|COMPLETED|Period 2||2
5204637|NCT01025843|12797367|P2|COMPLETED|Period 2||2
5204638|NCT01025843|12797368|P1|COMPLETED|Period 2||2
5204639|NCT01025843|12797359|P10|STARTED|Period 2||2
5204640|NCT01025843|12797360|P9|STARTED|Period 2||2
5204641|NCT01025843|12797361|P8|STARTED|Period 2||2
5204642|NCT01025843|12797362|P7|STARTED|Period 2||2
5204643|NCT01025843|12797363|P6|STARTED|Period 2||2
5204644|NCT01025843|12797364|P5|STARTED|Period 2||2
5204645|NCT01025843|12797365|P4|STARTED|Period 2||2
5204646|NCT01025843|12797366|P3|STARTED|Period 2||2
5204647|NCT01025843|12797367|P2|STARTED|Period 2||2
5204648|NCT01025843|12797368|P1|STARTED|Period 2||2
5204649|NCT01025843|12797359|P10|NOT COMPLETED|Washout 1||0
5204650|NCT01025843|12797360|P9|NOT COMPLETED|Washout 1||0
5204651|NCT01025843|12797361|P8|NOT COMPLETED|Washout 1||0
5204652|NCT01025843|12797362|P7|NOT COMPLETED|Washout 1||0
5204653|NCT01025843|12797363|P6|NOT COMPLETED|Washout 1||0
5204654|NCT01025843|12797364|P5|NOT COMPLETED|Washout 1||0
5204655|NCT01025843|12797365|P4|NOT COMPLETED|Washout 1||0
5204656|NCT01025843|12797366|P3|NOT COMPLETED|Washout 1||0
5204657|NCT01025843|12797367|P2|NOT COMPLETED|Washout 1||0
5204658|NCT01025843|12797368|P1|NOT COMPLETED|Washout 1||0
5204659|NCT01025843|12797359|P10|COMPLETED|Washout 1||2
5204660|NCT01025843|12797360|P9|COMPLETED|Washout 1||2
5204661|NCT01025843|12797361|P8|COMPLETED|Washout 1||2
5204662|NCT01025843|12797362|P7|COMPLETED|Washout 1||2
5204663|NCT01025843|12797363|P6|COMPLETED|Washout 1||2
5204664|NCT01025843|12797364|P5|COMPLETED|Washout 1||2
5204665|NCT01025843|12797365|P4|COMPLETED|Washout 1||2
5204666|NCT01025843|12797366|P3|COMPLETED|Washout 1||2
5204667|NCT01025843|12797367|P2|COMPLETED|Washout 1||2
5204668|NCT01025843|12797368|P1|COMPLETED|Washout 1||2
5204669|NCT01025843|12797359|P10|STARTED|Washout 1||2
5204670|NCT01025843|12797360|P9|STARTED|Washout 1||2
5204671|NCT01025843|12797361|P8|STARTED|Washout 1||2
5204672|NCT01025843|12797362|P7|STARTED|Washout 1||2
5204673|NCT01025843|12797363|P6|STARTED|Washout 1||2
5204674|NCT01025843|12797364|P5|STARTED|Washout 1||2
5204675|NCT01025843|12797365|P4|STARTED|Washout 1||2
5204676|NCT01025843|12797366|P3|STARTED|Washout 1||2
5204677|NCT01025843|12797367|P2|STARTED|Washout 1||2
5204678|NCT01025843|12797368|P1|STARTED|Washout 1||2
5204679|NCT01025843|12797359|P10|NOT COMPLETED|Period 1||0
5204680|NCT01025843|12797360|P9|NOT COMPLETED|Period 1||0
5204681|NCT01025843|12797361|P8|NOT COMPLETED|Period 1||0
5204682|NCT01025843|12797362|P7|NOT COMPLETED|Period 1||0
5204683|NCT01025843|12797363|P6|NOT COMPLETED|Period 1||0
5204684|NCT01025843|12797364|P5|NOT COMPLETED|Period 1||0
5204685|NCT01025843|12797365|P4|NOT COMPLETED|Period 1||0
5204686|NCT01025843|12797366|P3|NOT COMPLETED|Period 1||0
5204687|NCT01025843|12797367|P2|NOT COMPLETED|Period 1||0
5204688|NCT01025843|12797368|P1|NOT COMPLETED|Period 1||0
5204689|NCT01025843|12797359|P10|COMPLETED|Period 1||2
5204690|NCT01025843|12797360|P9|COMPLETED|Period 1||2
5204691|NCT01025843|12797361|P8|COMPLETED|Period 1||2
5204692|NCT01025843|12797362|P7|COMPLETED|Period 1||2
5204693|NCT01025843|12797363|P6|COMPLETED|Period 1||2
5204694|NCT01025843|12797364|P5|COMPLETED|Period 1||2
5204695|NCT01025843|12797365|P4|COMPLETED|Period 1||2
5204696|NCT01025843|12797366|P3|COMPLETED|Period 1||2
5204697|NCT01025843|12797367|P2|COMPLETED|Period 1||2
5204698|NCT01025843|12797368|P1|COMPLETED|Period 1||2
5204699|NCT01025843|12797359|P10|STARTED|Period 1||2
5204700|NCT01025843|12797360|P9|STARTED|Period 1||2
5204701|NCT01025843|12797361|P8|STARTED|Period 1||2
5204702|NCT01025843|12797362|P7|STARTED|Period 1||2
5204703|NCT01025843|12797363|P6|STARTED|Period 1||2
5204704|NCT01025843|12797364|P5|STARTED|Period 1||2
5204705|NCT01025843|12797365|P4|STARTED|Period 1||2
5204706|NCT01025843|12797366|P3|STARTED|Period 1||2
5204707|NCT01025843|12797367|P2|STARTED|Period 1||2
5204708|NCT01025843|12797368|P1|STARTED|Period 1||2
5204709|NCT01025830|12797442|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
5204710|NCT01025830|12797443|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
5204711|NCT01025830|12797442|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
5204712|NCT01025830|12797443|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
5204713|NCT01025830|12797442|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
5204714|NCT01025830|12797443|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
5204715|NCT01025830|12797442|P2|NOT COMPLETED|Washout Period of 30 Days||0
5204716|NCT01025830|12797443|P1|NOT COMPLETED|Washout Period of 30 Days||0
5204717|NCT01025830|12797442|P2|COMPLETED|Washout Period of 30 Days||12
5204718|NCT01025830|12797443|P1|COMPLETED|Washout Period of 30 Days||8
5204719|NCT01025830|12797442|P2|STARTED|Washout Period of 30 Days||12
5204720|NCT01025830|12797443|P1|STARTED|Washout Period of 30 Days||8
5204721|NCT01025830|12797442|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
5204722|NCT01025830|12797443|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
5204723|NCT01025830|12797442|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
5204724|NCT01025830|12797443|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
5204725|NCT01025830|12797442|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
5204726|NCT01025830|12797443|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
5204727|NCT01025817|12797462|P2|NOT COMPLETED|Completed Study||22
5204728|NCT01025817|12797463|P1|NOT COMPLETED|Completed Study||16
5204729|NCT01025817|12797462|P2|COMPLETED|Completed Study|Completed study phase|282
5204730|NCT01025817|12797463|P1|COMPLETED|Completed Study|Completed study phase|293
5204731|NCT01025817|12797462|P2|STARTED|Completed Study||304
5204732|NCT01025817|12797463|P1|STARTED|Completed Study||309
5204733|NCT01025817|12797462|P2|NOT COMPLETED|Completed Study Medication||72
5204734|NCT01025817|12797463|P1|NOT COMPLETED|Completed Study Medication||105
5204735|NCT01025817|12797462|P2|COMPLETED|Completed Study Medication||232
5204736|NCT01025817|12797463|P1|COMPLETED|Completed Study Medication||204
5204737|NCT01025817|12797462|P2|STARTED|Completed Study Medication||304
5204738|NCT01025817|12797463|P1|STARTED|Completed Study Medication||309
5204739|NCT01025791|12797484|P14|NOT COMPLETED|Period 5||0
5204740|NCT01025791|12797485|P13|NOT COMPLETED|Period 5||0
5204741|NCT01025791|12797486|P12|NOT COMPLETED|Period 5||0
5204742|NCT01025791|12797487|P11|NOT COMPLETED|Period 5||0
5204743|NCT01025791|12797488|P10|NOT COMPLETED|Period 5||0
5204744|NCT01025791|12797489|P9|NOT COMPLETED|Period 5||0
5204745|NCT01025791|12797490|P8|NOT COMPLETED|Period 5||0
5204746|NCT01025791|12797491|P7|NOT COMPLETED|Period 5||0
5204747|NCT01025791|12797492|P6|NOT COMPLETED|Period 5||0
5204748|NCT01025791|12797493|P5|NOT COMPLETED|Period 5||0
5204749|NCT01025791|12797494|P4|NOT COMPLETED|Period 5||0
5204750|NCT01025791|12797495|P3|NOT COMPLETED|Period 5||0
5204751|NCT01025791|12797496|P2|NOT COMPLETED|Period 5||0
5204752|NCT01025791|12797497|P1|NOT COMPLETED|Period 5||0
5204753|NCT01025791|12797484|P14|COMPLETED|Period 5||0
5204754|NCT01025791|12797485|P13|COMPLETED|Period 5||0
5204755|NCT01025791|12797486|P12|COMPLETED|Period 5||0
5204756|NCT01025791|12797487|P11|COMPLETED|Period 5||0
5204757|NCT01025791|12797488|P10|COMPLETED|Period 5||0
5204758|NCT01025791|12797489|P9|COMPLETED|Period 5||0
5204759|NCT01025791|12797490|P8|COMPLETED|Period 5||0
5204760|NCT01025791|12797491|P7|COMPLETED|Period 5||0
5204761|NCT01025791|12797492|P6|COMPLETED|Period 5||0
5204762|NCT01025791|12797493|P5|COMPLETED|Period 5||0
5204763|NCT01025791|12797494|P4|COMPLETED|Period 5||2
5204764|NCT01025791|12797495|P3|COMPLETED|Period 5||2
5204765|NCT01025791|12797496|P2|COMPLETED|Period 5||2
5204766|NCT01025791|12797497|P1|COMPLETED|Period 5||2
5204767|NCT01025791|12797484|P14|STARTED|Period 5||0
5204768|NCT01025791|12797485|P13|STARTED|Period 5||0
5204769|NCT01025791|12797486|P12|STARTED|Period 5||0
5204770|NCT01025791|12797487|P11|STARTED|Period 5||0
5204771|NCT01025791|12797488|P10|STARTED|Period 5||0
5204772|NCT01025791|12797489|P9|STARTED|Period 5||0
5204773|NCT01025791|12797490|P8|STARTED|Period 5||0
5204774|NCT01025791|12797491|P7|STARTED|Period 5||0
5204775|NCT01025791|12797492|P6|STARTED|Period 5||0
5204776|NCT01025791|12797493|P5|STARTED|Period 5||0
5204777|NCT01025791|12797494|P4|STARTED|Period 5||2
5204778|NCT01025791|12797495|P3|STARTED|Period 5||2
5204779|NCT01025791|12797496|P2|STARTED|Period 5||2
5204780|NCT01025791|12797497|P1|STARTED|Period 5||2
5204781|NCT01025791|12797484|P14|NOT COMPLETED|Period 4||0
5204782|NCT01025791|12797485|P13|NOT COMPLETED|Period 4||0
5204783|NCT01025791|12797486|P12|NOT COMPLETED|Period 4||0
5204784|NCT01025791|12797487|P11|NOT COMPLETED|Period 4||0
5204785|NCT01025791|12797488|P10|NOT COMPLETED|Period 4||0
5204786|NCT01025791|12797489|P9|NOT COMPLETED|Period 4||0
5204787|NCT01025791|12797490|P8|NOT COMPLETED|Period 4||0
5204788|NCT01025791|12797491|P7|NOT COMPLETED|Period 4||0
5204789|NCT01025791|12797492|P6|NOT COMPLETED|Period 4||0
5204790|NCT01025791|12797493|P5|NOT COMPLETED|Period 4||0
5204791|NCT01025791|12797494|P4|NOT COMPLETED|Period 4||0
5204792|NCT01025791|12797495|P3|NOT COMPLETED|Period 4||0
5204793|NCT01025791|12797496|P2|NOT COMPLETED|Period 4||0
5204794|NCT01025791|12797497|P1|NOT COMPLETED|Period 4||0
5204795|NCT01025791|12797484|P14|COMPLETED|Period 4||1
5204796|NCT01025791|12797485|P13|COMPLETED|Period 4||2
5204797|NCT01025791|12797486|P12|COMPLETED|Period 4||1
5204798|NCT01025791|12797487|P11|COMPLETED|Period 4||2
5204799|NCT01025791|12797488|P10|COMPLETED|Period 4||1
5204800|NCT01025791|12797489|P9|COMPLETED|Period 4||2
5204801|NCT01025791|12797490|P8|COMPLETED|Period 4||2
5204802|NCT01025791|12797491|P7|COMPLETED|Period 4||2
5204803|NCT01025791|12797492|P6|COMPLETED|Period 4||2
5204804|NCT01025791|12797493|P5|COMPLETED|Period 4||2
5204805|NCT01025791|12797494|P4|COMPLETED|Period 4||2
5204806|NCT01025791|12797495|P3|COMPLETED|Period 4||2
5204807|NCT01025791|12797496|P2|COMPLETED|Period 4||2
5204808|NCT01025791|12797497|P1|COMPLETED|Period 4||2
5204809|NCT01025791|12797484|P14|STARTED|Period 4||1
5204810|NCT01025791|12797485|P13|STARTED|Period 4||2
5204811|NCT01025791|12797486|P12|STARTED|Period 4||1
5204812|NCT01025791|12797487|P11|STARTED|Period 4||2
5204813|NCT01025791|12797488|P10|STARTED|Period 4||1
5204814|NCT01025791|12797489|P9|STARTED|Period 4||2
5204815|NCT01025791|12797490|P8|STARTED|Period 4||2
5204816|NCT01025791|12797491|P7|STARTED|Period 4||2
5204817|NCT01025791|12797492|P6|STARTED|Period 4||2
5204818|NCT01025791|12797493|P5|STARTED|Period 4||2
5204819|NCT01025791|12797494|P4|STARTED|Period 4||2
5204820|NCT01025791|12797495|P3|STARTED|Period 4||2
5204821|NCT01025791|12797496|P2|STARTED|Period 4||2
5204822|NCT01025791|12797497|P1|STARTED|Period 4||2
5204823|NCT01025791|12797484|P14|NOT COMPLETED|Period 3||0
5204824|NCT01025791|12797485|P13|NOT COMPLETED|Period 3||0
5204825|NCT01025791|12797486|P12|NOT COMPLETED|Period 3||0
5204826|NCT01025791|12797487|P11|NOT COMPLETED|Period 3||0
5204827|NCT01025791|12797488|P10|NOT COMPLETED|Period 3||0
5204828|NCT01025791|12797489|P9|NOT COMPLETED|Period 3||0
5204829|NCT01025791|12797490|P8|NOT COMPLETED|Period 3||0
5204830|NCT01025791|12797491|P7|NOT COMPLETED|Period 3||0
5204831|NCT01025791|12797492|P6|NOT COMPLETED|Period 3||0
5204832|NCT01025791|12797493|P5|NOT COMPLETED|Period 3||0
5204833|NCT01025791|12797494|P4|NOT COMPLETED|Period 3||0
5204834|NCT01025791|12797495|P3|NOT COMPLETED|Period 3||0
5204835|NCT01025791|12797496|P2|NOT COMPLETED|Period 3||0
5204836|NCT01025791|12797497|P1|NOT COMPLETED|Period 3||0
5204837|NCT01025791|12797484|P14|COMPLETED|Period 3||1
5204838|NCT01025791|12797485|P13|COMPLETED|Period 3||2
5204839|NCT01025791|12797486|P12|COMPLETED|Period 3||1
5204840|NCT01025791|12797487|P11|COMPLETED|Period 3||2
5204841|NCT01025791|12797488|P10|COMPLETED|Period 3||1
5204842|NCT01025791|12797489|P9|COMPLETED|Period 3||2
5204843|NCT01025791|12797490|P8|COMPLETED|Period 3||2
5204844|NCT01025791|12797491|P7|COMPLETED|Period 3||2
5204845|NCT01025791|12797492|P6|COMPLETED|Period 3||2
5204846|NCT01025791|12797493|P5|COMPLETED|Period 3||2
5204847|NCT01025791|12797494|P4|COMPLETED|Period 3||2
5204848|NCT01025791|12797495|P3|COMPLETED|Period 3||2
5204849|NCT01025791|12797496|P2|COMPLETED|Period 3||2
5204850|NCT01025791|12797497|P1|COMPLETED|Period 3||2
5204851|NCT01025791|12797484|P14|STARTED|Period 3||1
5204852|NCT01025791|12797485|P13|STARTED|Period 3||2
5204853|NCT01025791|12797486|P12|STARTED|Period 3||1
5204854|NCT01025791|12797487|P11|STARTED|Period 3||2
5204855|NCT01025791|12797488|P10|STARTED|Period 3||1
5204856|NCT01025791|12797489|P9|STARTED|Period 3||2
5204857|NCT01025791|12797490|P8|STARTED|Period 3||2
5204858|NCT01025791|12797491|P7|STARTED|Period 3||2
5204859|NCT01025791|12797492|P6|STARTED|Period 3||2
5204860|NCT01025791|12797493|P5|STARTED|Period 3||2
5204861|NCT01025791|12797494|P4|STARTED|Period 3||2
5204862|NCT01025791|12797495|P3|STARTED|Period 3||2
5204863|NCT01025791|12797496|P2|STARTED|Period 3||2
5204864|NCT01025791|12797497|P1|STARTED|Period 3||2
5204865|NCT01025791|12797484|P14|NOT COMPLETED|Period 2||0
5204866|NCT01025791|12797485|P13|NOT COMPLETED|Period 2||0
5204867|NCT01025791|12797486|P12|NOT COMPLETED|Period 2||0
5204868|NCT01025791|12797487|P11|NOT COMPLETED|Period 2||0
5204869|NCT01025791|12797488|P10|NOT COMPLETED|Period 2||0
5204870|NCT01025791|12797489|P9|NOT COMPLETED|Period 2||0
5204871|NCT01025791|12797490|P8|NOT COMPLETED|Period 2||0
5204872|NCT01025791|12797491|P7|NOT COMPLETED|Period 2||0
5204873|NCT01025791|12797492|P6|NOT COMPLETED|Period 2||0
5204874|NCT01025791|12797493|P5|NOT COMPLETED|Period 2||0
5204875|NCT01025791|12797494|P4|NOT COMPLETED|Period 2||0
5204876|NCT01025791|12797495|P3|NOT COMPLETED|Period 2||0
5204877|NCT01025791|12797496|P2|NOT COMPLETED|Period 2||0
5204878|NCT01025791|12797497|P1|NOT COMPLETED|Period 2||0
5204879|NCT01025791|12797484|P14|COMPLETED|Period 2||1
5204880|NCT01025791|12797485|P13|COMPLETED|Period 2||2
5204881|NCT01025791|12797486|P12|COMPLETED|Period 2||1
5204882|NCT01025791|12797487|P11|COMPLETED|Period 2||2
5204883|NCT01025791|12797488|P10|COMPLETED|Period 2||1
5204884|NCT01025791|12797489|P9|COMPLETED|Period 2||2
5204885|NCT01025791|12797490|P8|COMPLETED|Period 2||2
5204886|NCT01025791|12797491|P7|COMPLETED|Period 2||2
5204887|NCT01025791|12797492|P6|COMPLETED|Period 2||2
5204888|NCT01025791|12797493|P5|COMPLETED|Period 2||2
5204889|NCT01025791|12797494|P4|COMPLETED|Period 2||2
5204890|NCT01025791|12797495|P3|COMPLETED|Period 2||2
5204891|NCT01025791|12797496|P2|COMPLETED|Period 2||2
5204892|NCT01025791|12797497|P1|COMPLETED|Period 2||2
5204893|NCT01025791|12797484|P14|STARTED|Period 2||1
5204894|NCT01025791|12797485|P13|STARTED|Period 2||2
5204895|NCT01025791|12797486|P12|STARTED|Period 2||1
5204896|NCT01025791|12797487|P11|STARTED|Period 2||2
5204897|NCT01025791|12797488|P10|STARTED|Period 2||1
5204898|NCT01025791|12797489|P9|STARTED|Period 2||2
5204899|NCT01025791|12797490|P8|STARTED|Period 2||2
5204900|NCT01025791|12797491|P7|STARTED|Period 2||2
5204901|NCT01025791|12797492|P6|STARTED|Period 2||2
5204902|NCT01025791|12797493|P5|STARTED|Period 2||2
5204903|NCT01025791|12797494|P4|STARTED|Period 2||2
5204904|NCT01025791|12797495|P3|STARTED|Period 2||2
5204905|NCT01025791|12797496|P2|STARTED|Period 2||2
5204906|NCT01025791|12797497|P1|STARTED|Period 2||2
5204907|NCT01025791|12797484|P14|NOT COMPLETED|Period 1||0
5204908|NCT01025791|12797485|P13|NOT COMPLETED|Period 1||0
5204909|NCT01025791|12797486|P12|NOT COMPLETED|Period 1||0
5204910|NCT01025791|12797487|P11|NOT COMPLETED|Period 1||0
5204911|NCT01025791|12797488|P10|NOT COMPLETED|Period 1||0
5204912|NCT01025791|12797489|P9|NOT COMPLETED|Period 1||0
5204913|NCT01025791|12797490|P8|NOT COMPLETED|Period 1||0
5204914|NCT01025791|12797491|P7|NOT COMPLETED|Period 1||0
5204915|NCT01025791|12797492|P6|NOT COMPLETED|Period 1||0
5204916|NCT01025791|12797493|P5|NOT COMPLETED|Period 1||0
5204917|NCT01025791|12797494|P4|NOT COMPLETED|Period 1||0
5204918|NCT01025791|12797495|P3|NOT COMPLETED|Period 1||0
5204919|NCT01025791|12797496|P2|NOT COMPLETED|Period 1||0
5204920|NCT01025791|12797497|P1|NOT COMPLETED|Period 1||0
5204921|NCT01025791|12797484|P14|COMPLETED|Period 1||1
5204922|NCT01025791|12797485|P13|COMPLETED|Period 1||2
5204923|NCT01025791|12797486|P12|COMPLETED|Period 1||1
5204924|NCT01025791|12797487|P11|COMPLETED|Period 1||2
5204925|NCT01025791|12797488|P10|COMPLETED|Period 1||1
5204926|NCT01025791|12797489|P9|COMPLETED|Period 1||2
5204927|NCT01025791|12797490|P8|COMPLETED|Period 1||2
5204928|NCT01025791|12797491|P7|COMPLETED|Period 1||2
5204929|NCT01025791|12797492|P6|COMPLETED|Period 1||2
5204930|NCT01025791|12797493|P5|COMPLETED|Period 1||2
5204931|NCT01025791|12797494|P4|COMPLETED|Period 1||2
5204932|NCT01025791|12797495|P3|COMPLETED|Period 1||2
5204933|NCT01025791|12797496|P2|COMPLETED|Period 1||2
5204934|NCT01025791|12797497|P1|COMPLETED|Period 1||2
5204935|NCT01025791|12797484|P14|STARTED|Period 1||1
5204936|NCT01025791|12797485|P13|STARTED|Period 1||2
5204937|NCT01025791|12797486|P12|STARTED|Period 1||1
5204938|NCT01025791|12797487|P11|STARTED|Period 1||2
5204939|NCT01025791|12797488|P10|STARTED|Period 1||1
5204940|NCT01025791|12797489|P9|STARTED|Period 1||2
5204941|NCT01025791|12797490|P8|STARTED|Period 1||2
5204942|NCT01025791|12797491|P7|STARTED|Period 1||2
5204943|NCT01025791|12797492|P6|STARTED|Period 1||2
5204944|NCT01025791|12797493|P5|STARTED|Period 1||2
5204945|NCT01025791|12797494|P4|STARTED|Period 1||2
5204946|NCT01025791|12797495|P3|STARTED|Period 1||2
5204947|NCT01025791|12797496|P2|STARTED|Period 1||2
5204948|NCT01025791|12797497|P1|STARTED|Period 1||2
5204949|NCT01025752|12797629|P2|NOT COMPLETED|Overall Study||13
5204950|NCT01025752|12797630|P1|NOT COMPLETED|Overall Study||8
5204951|NCT01025752|12797629|P2|COMPLETED|Overall Study||50
5204952|NCT01025752|12797630|P1|COMPLETED|Overall Study||54
5204953|NCT01025752|12797629|P2|STARTED|Overall Study||63
5204954|NCT01025752|12797630|P1|STARTED|Overall Study||62
5204955|NCT01025635|12797650|P2|NOT COMPLETED|Overall Study||25
5204956|NCT01025635|12797651|P1|NOT COMPLETED|Overall Study||23
5204957|NCT01025635|12797650|P2|COMPLETED|Overall Study||178
5204958|NCT01025635|12797651|P1|COMPLETED|Overall Study||175
5204959|NCT01025635|12797650|P2|STARTED|Overall Study||203
5204960|NCT01025635|12797651|P1|STARTED|Overall Study||198
5204961|NCT01025492|12797663|P1|NOT COMPLETED|Overall Study||0
5204962|NCT01025492|12797663|P1|COMPLETED|Overall Study||24
5204963|NCT01025492|12797663|P1|STARTED|Overall Study||24
5204964|NCT01025453|12797667|P1|NOT COMPLETED|Overall Study||0
5204965|NCT01025453|12797667|P1|COMPLETED|Overall Study||37
5204966|NCT01025453|12797667|P1|STARTED|Overall Study||37
5204967|NCT01025427|12797674|P1|NOT COMPLETED|Overall Study||0
5204968|NCT01025427|12797674|P1|COMPLETED|Overall Study||16
5204969|NCT01025427|12797674|P1|STARTED|Overall Study||16
5204970|NCT01025336|12797683|P5|NOT COMPLETED|Overall Study||0
5204971|NCT01025336|12797684|P4|NOT COMPLETED|Overall Study||2
5204972|NCT01025336|12797685|P3|NOT COMPLETED|Overall Study||0
5204973|NCT01025336|12797686|P2|NOT COMPLETED|Overall Study||0
5204974|NCT01025336|12797687|P1|NOT COMPLETED|Overall Study||0
5204975|NCT01025336|12797683|P5|COMPLETED|Overall Study||222
5204976|NCT01025336|12797684|P4|COMPLETED|Overall Study||219
5204977|NCT01025336|12797685|P3|COMPLETED|Overall Study||179
5204978|NCT01025336|12797686|P2|COMPLETED|Overall Study||210
5204979|NCT01025336|12797687|P1|COMPLETED|Overall Study||130
5204980|NCT01025336|12797683|P5|STARTED|Overall Study||222
5204981|NCT01025336|12797684|P4|STARTED|Overall Study||221
5204982|NCT01025336|12797685|P3|STARTED|Overall Study||179
5204983|NCT01025336|12797686|P2|STARTED|Overall Study||210
5204984|NCT01025336|12797687|P1|STARTED|Overall Study||130
5204985|NCT01025284|12797742|P3|NOT COMPLETED|Overall Study||0
5204986|NCT01025284|12797743|P2|NOT COMPLETED|Overall Study||2
5204987|NCT01025284|12797744|P1|NOT COMPLETED|Overall Study||0
5204988|NCT01025284|12797742|P3|COMPLETED|Overall Study||8
5204989|NCT01025284|12797743|P2|COMPLETED|Overall Study||16
5204990|NCT01025284|12797744|P1|COMPLETED|Overall Study||38
5204991|NCT01025284|12797742|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
5204992|NCT01025284|12797743|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
5204993|NCT01025284|12797744|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
5204994|NCT01025284|12797742|P3|STARTED|Overall Study||8
5204995|NCT01025284|12797743|P2|STARTED|Overall Study||18
5204996|NCT01025284|12797744|P1|STARTED|Overall Study||38
5204997|NCT01025271|12797762|P1|NOT COMPLETED|Overall Study||0
5204998|NCT01025271|12797762|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
5204999|NCT01025271|12797762|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
5205000|NCT01025232|12797769|P2|NOT COMPLETED|Overall Study||6
5205001|NCT01025232|12797770|P1|NOT COMPLETED|Overall Study||3
5205002|NCT01025232|12797769|P2|COMPLETED|Overall Study||36
5205003|NCT01025232|12797770|P1|COMPLETED|Overall Study||43
5205004|NCT01025232|12797769|P2|STARTED|Overall Study||42
5205005|NCT01025232|12797770|P1|STARTED|Overall Study||46
5205006|NCT01025193|12797788|P1|NOT COMPLETED|Overall Study||4
5205007|NCT01025193|12797788|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
5205008|NCT01025193|12797788|P1|STARTED|Overall Study||8
5205009|NCT01025154|12797798|P1|NOT COMPLETED|Overall Study||2
5205010|NCT01025154|12797798|P1|COMPLETED|Overall Study||57
5205011|NCT01025154|12797798|P1|STARTED|Overall Study||59
5205012|NCT01025076|12797803|P1|NOT COMPLETED|Overall Study||0
5205013|NCT01025076|12797803|P1|COMPLETED|Overall Study||14
5205014|NCT01025076|12797803|P1|STARTED|Overall Study||14
5205015|NCT01025037|12797807|P1|NOT COMPLETED|Overall Study||11
5205016|NCT01025037|12797807|P1|COMPLETED|Overall Study||50
5205017|NCT01025037|12797807|P1|STARTED|Overall Study||61
5205018|NCT01024972|12797818|P2|NOT COMPLETED|Overall Study||0
5205019|NCT01024972|12797819|P1|NOT COMPLETED|Overall Study||0
5205020|NCT01024972|12797818|P2|COMPLETED|Overall Study||15
5205021|NCT01024972|12797819|P1|COMPLETED|Overall Study||16
5205022|NCT01024972|12797818|P2|STARTED|Overall Study||15
5205023|NCT01024972|12797819|P1|STARTED|Overall Study||16
5205024|NCT01024959|12797829|P1|NOT COMPLETED|Overall Study||41
5205025|NCT01024959|12797829|P1|COMPLETED|Overall Study||466
5205026|NCT01024959|12797829|P1|STARTED|Overall Study||507
5205027|NCT01024946|12797838|P1|NOT COMPLETED|Overall Study||5
5205028|NCT01024946|12797838|P1|COMPLETED|Overall Study||6
5205029|NCT01024946|12797838|P1|STARTED|Overall Study||11
5205030|NCT01024920|12797844|P2|NOT COMPLETED|Overall Study||22
5205031|NCT01024920|12797845|P1|NOT COMPLETED|Overall Study||45
5205032|NCT01024920|12797844|P2|COMPLETED|Overall Study||10
5205033|NCT01024920|12797845|P1|COMPLETED|Overall Study||22
5205034|NCT01024920|12797844|P2|Treated|Overall Study||32
5205035|NCT01024920|12797845|P1|Treated|Overall Study||64
5205036|NCT01024920|12797844|P2|STARTED|Overall Study||32
5205037|NCT01024920|12797845|P1|STARTED|Overall Study||67
5205038|NCT01024855|12797863|P1|NOT COMPLETED|Overall Study||1
5205039|NCT01024855|12797863|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
5205040|NCT01024855|12797863|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
5205041|NCT01024751|12797870|P2|NOT COMPLETED|Eligible Participants||3
5205042|NCT01024751|12797871|P1|NOT COMPLETED|Eligible Participants||0
5205043|NCT01024751|12797870|P2|COMPLETED|Eligible Participants||149
5205044|NCT01024751|12797871|P1|COMPLETED|Eligible Participants||153
5205045|NCT01024751|12797870|P2|STARTED|Eligible Participants||152
5205046|NCT01024751|12797871|P1|STARTED|Eligible Participants||153
5205047|NCT01024751|12797870|P2|NOT COMPLETED|Enrolled Participants||4
5205048|NCT01024751|12797871|P1|NOT COMPLETED|Enrolled Participants||3
5205049|NCT01024751|12797870|P2|COMPLETED|Enrolled Participants||152
5205050|NCT01024751|12797871|P1|COMPLETED|Enrolled Participants||153
5205051|NCT01024751|12797870|P2|STARTED|Enrolled Participants||156
5205052|NCT01024751|12797871|P1|STARTED|Enrolled Participants||156
5205053|NCT01024738|12797882|P3|NOT COMPLETED|Third Intervention:||0
5205054|NCT01024738|12797883|P2|NOT COMPLETED|Third Intervention:||0
5205055|NCT01024738|12797884|P1|NOT COMPLETED|Third Intervention:||0
5205056|NCT01024738|12797882|P3|COMPLETED|Third Intervention:||8
5205057|NCT01024738|12797883|P2|COMPLETED|Third Intervention:||7
5205058|NCT01024738|12797884|P1|COMPLETED|Third Intervention:||7
5205059|NCT01024738|12797882|P3|STARTED|Third Intervention:||8
5205060|NCT01024738|12797883|P2|STARTED|Third Intervention:||7
5205061|NCT01024738|12797884|P1|STARTED|Third Intervention:||7
5205062|NCT01024738|12797882|P3|NOT COMPLETED|Washout After 2nd Intervention||0
5205063|NCT01024738|12797883|P2|NOT COMPLETED|Washout After 2nd Intervention||0
5205064|NCT01024738|12797884|P1|NOT COMPLETED|Washout After 2nd Intervention||0
5205065|NCT01024738|12797882|P3|COMPLETED|Washout After 2nd Intervention||8
5205066|NCT01024738|12797883|P2|COMPLETED|Washout After 2nd Intervention||7
5205067|NCT01024738|12797884|P1|COMPLETED|Washout After 2nd Intervention||7
5205068|NCT01024738|12797882|P3|STARTED|Washout After 2nd Intervention||8
5205069|NCT01024738|12797883|P2|STARTED|Washout After 2nd Intervention||7
5205070|NCT01024738|12797884|P1|STARTED|Washout After 2nd Intervention||7
5205071|NCT01024738|12797882|P3|NOT COMPLETED|Second Intervention:||0
5205072|NCT01024738|12797883|P2|NOT COMPLETED|Second Intervention:||0
5205073|NCT01024738|12797884|P1|NOT COMPLETED|Second Intervention:||0
5205074|NCT01024738|12797882|P3|COMPLETED|Second Intervention:||8
5205075|NCT01024738|12797883|P2|COMPLETED|Second Intervention:||7
5205076|NCT01024738|12797884|P1|COMPLETED|Second Intervention:||7
5205077|NCT01024738|12797882|P3|STARTED|Second Intervention:||8
5205078|NCT01024738|12797883|P2|STARTED|Second Intervention:||7
5205079|NCT01024738|12797884|P1|STARTED|Second Intervention:||7
5205080|NCT01024738|12797882|P3|NOT COMPLETED|Washout After 1st Intervention||0
5205081|NCT01024738|12797883|P2|NOT COMPLETED|Washout After 1st Intervention||0
5205082|NCT01024738|12797884|P1|NOT COMPLETED|Washout After 1st Intervention||0
5205083|NCT01024738|12797882|P3|COMPLETED|Washout After 1st Intervention||8
5205084|NCT01024738|12797883|P2|COMPLETED|Washout After 1st Intervention||7
5205085|NCT01024738|12797884|P1|COMPLETED|Washout After 1st Intervention||7
5205086|NCT01024738|12797882|P3|STARTED|Washout After 1st Intervention||8
5205087|NCT01024738|12797883|P2|STARTED|Washout After 1st Intervention||7
5205088|NCT01024738|12797884|P1|STARTED|Washout After 1st Intervention||7
5205089|NCT01024738|12797882|P3|NOT COMPLETED|First Intervention:||0
5205090|NCT01024738|12797883|P2|NOT COMPLETED|First Intervention:||0
5205091|NCT01024738|12797884|P1|NOT COMPLETED|First Intervention:||0
5205092|NCT01024738|12797882|P3|COMPLETED|First Intervention:||8
5205093|NCT01024738|12797883|P2|COMPLETED|First Intervention:||7
5205094|NCT01024738|12797884|P1|COMPLETED|First Intervention:||7
5205095|NCT01024738|12797882|P3|STARTED|First Intervention:||8
5205096|NCT01024738|12797883|P2|STARTED|First Intervention:||7
5205097|NCT01024738|12797884|P1|STARTED|First Intervention:||7
5205098|NCT01024686|12797895|P3|NOT COMPLETED|Overall Study||0
5205099|NCT01024686|12797896|P2|NOT COMPLETED|Overall Study||0
5205100|NCT01024686|12797897|P1|NOT COMPLETED|Overall Study||0
5205101|NCT01024686|12797895|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
5205102|NCT01024686|12797896|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
5205103|NCT01024686|12797897|P1|COMPLETED|Overall Study||6
5205104|NCT01024686|12797895|P3|STARTED|Overall Study||0
5205105|NCT01024686|12797896|P2|STARTED|Overall Study||0
5205106|NCT01024686|12797897|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
5205107|NCT01024608|12797928|P2|NOT COMPLETED|Overall Study||4
5205108|NCT01024608|12797929|P1|NOT COMPLETED|Overall Study||4
5205109|NCT01024608|12797928|P2|COMPLETED|Overall Study||167
5205110|NCT01024608|12797929|P1|COMPLETED|Overall Study||165
5205111|NCT01024608|12797928|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
5205112|NCT01024608|12797929|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
5205113|NCT01024608|12797928|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
5205114|NCT01024608|12797929|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
5205115|NCT01024608|12797928|P2|STARTED|Overall Study||171
5205116|NCT01024608|12797929|P1|STARTED|Overall Study||169
5205117|NCT01024569|12797943|P2|NOT COMPLETED|Overall Study||11
5205118|NCT01024569|12797944|P1|NOT COMPLETED|Overall Study||25
5205119|NCT01024569|12797943|P2|COMPLETED|Overall Study||268
5205120|NCT01024569|12797944|P1|COMPLETED|Overall Study||251
5205121|NCT01024569|12797943|P2|STARTED|Overall Study||279
5205122|NCT01024569|12797944|P1|STARTED|Overall Study||276
5205123|NCT01024465|12797958|P1|NOT COMPLETED|Overall Study||3
5205124|NCT01024465|12797958|P1|COMPLETED|Overall Study||23
5205125|NCT01024465|12797958|P1|STARTED|Overall Study||26
5205126|NCT01024387|12797962|P1|NOT COMPLETED|Overall Study||60
5205127|NCT01024387|12797962|P1|COMPLETED|Overall Study||0
5205128|NCT01024387|12797962|P1|Evaluable for Response|Overall Study||53
5205129|NCT01024387|12797962|P1|Evaluable for PFS|Overall Study||54
5205130|NCT01024387|12797962|P1|STARTED|Overall Study||60
5205131|NCT01024335|12797972|P2|NOT COMPLETED|Overall Study||26
5205132|NCT01024335|12797973|P1|NOT COMPLETED|Overall Study||13
5205133|NCT01024335|12797972|P2|COMPLETED|Overall Study||14
5205134|NCT01024335|12797973|P1|COMPLETED|Overall Study||7
5205135|NCT01024335|12797972|P2|STARTED|Overall Study||40
5205136|NCT01024335|12797973|P1|STARTED|Overall Study||20
5205137|NCT01024309|12797983|P2|NOT COMPLETED|Overall Study||4
5205138|NCT01024309|12797984|P1|NOT COMPLETED|Overall Study||8
5205139|NCT01024309|12797983|P2|COMPLETED|Overall Study||27
5205140|NCT01024309|12797984|P1|COMPLETED|Overall Study||27
5205141|NCT01024309|12797983|P2|STARTED|Overall Study||31
5205142|NCT01024309|12797984|P1|STARTED|Overall Study||35
5205143|NCT01024296|12798006|P1|NOT COMPLETED|Overall Study||0
5205144|NCT01024296|12798006|P1|COMPLETED|Overall Study||4
5205145|NCT01024296|12798006|P1|STARTED|Overall Study||4
5205146|NCT01024244|12798016|P5|NOT COMPLETED|Overall Study||14
5205147|NCT01024244|12798017|P4|NOT COMPLETED|Overall Study||13
5205148|NCT01024244|12798018|P3|NOT COMPLETED|Overall Study||14
5205149|NCT01024244|12798019|P2|NOT COMPLETED|Overall Study||11
5205150|NCT01024244|12798020|P1|NOT COMPLETED|Overall Study||17
5205151|NCT01024244|12798016|P5|COMPLETED|Overall Study||1
5205152|NCT01024244|12798017|P4|COMPLETED|Overall Study||1
5205153|NCT01024244|12798018|P3|COMPLETED|Overall Study||1
5205154|NCT01024244|12798019|P2|COMPLETED|Overall Study||1
5205155|NCT01024244|12798020|P1|COMPLETED|Overall Study||5
5205156|NCT01024244|12798016|P5|STARTED|Overall Study||15
5205157|NCT01024244|12798017|P4|STARTED|Overall Study||14
5205158|NCT01024244|12798018|P3|STARTED|Overall Study||15
5205159|NCT01024244|12798019|P2|STARTED|Overall Study||12
5205160|NCT01024244|12798020|P1|STARTED|Overall Study||22
5205161|NCT01024036|12798134|P2|NOT COMPLETED|Follow-Up Period||3
5205162|NCT01024036|12798135|P1|NOT COMPLETED|Follow-Up Period||5
5205163|NCT01024036|12798134|P2|COMPLETED|Follow-Up Period||3
5205164|NCT01024036|12798135|P1|COMPLETED|Follow-Up Period||9
5205165|NCT01024036|12798134|P2|STARTED|Follow-Up Period||6
5205166|NCT01024036|12798135|P1|STARTED|Follow-Up Period||14
5205167|NCT01024036|12798134|P2|NOT COMPLETED|Unblinded Treatment||3
5205168|NCT01024036|12798135|P1|NOT COMPLETED|Unblinded Treatment||0
5205169|NCT01024036|12798134|P2|COMPLETED|Unblinded Treatment||10
5205170|NCT01024036|12798135|P1|COMPLETED|Unblinded Treatment||0
5205171|NCT01024036|12798134|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
5205172|NCT01024036|12798135|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
5205173|NCT01024036|12798134|P2|NOT COMPLETED|Blinded Treatment||20
5205174|NCT01024036|12798135|P1|NOT COMPLETED|Blinded Treatment||22
5205175|NCT01024036|12798134|P2|COMPLETED|Blinded Treatment||6
5205176|NCT01024036|12798135|P1|COMPLETED|Blinded Treatment||31
5205177|NCT01024036|12798134|P2|STARTED|Blinded Treatment||26
5205178|NCT01024036|12798135|P1|STARTED|Blinded Treatment||53
5205179|NCT01024010|12798168|P2|NOT COMPLETED|Overall Study||0
5205180|NCT01024010|12798169|P1|NOT COMPLETED|Overall Study||0
5205181|NCT01024010|12798168|P2|COMPLETED|Overall Study||34
5205182|NCT01024010|12798169|P1|COMPLETED|Overall Study||48
5205183|NCT01024010|12798168|P2|STARTED|Overall Study||34
5205184|NCT01024010|12798169|P1|STARTED|Overall Study||48
5205185|NCT01023958|12798182|P1|NOT COMPLETED|Overall Study||50
5205186|NCT01023958|12798182|P1|COMPLETED|Overall Study||0
5205187|NCT01023958|12798182|P1|STARTED|Overall Study||50
5205188|NCT01023841|12798211|P2|NOT COMPLETED|Overall Study||0
5205189|NCT01023841|12798212|P1|NOT COMPLETED|Overall Study||1
5205190|NCT01023841|12798211|P2|COMPLETED|Overall Study||23
5205191|NCT01023841|12798212|P1|COMPLETED|Overall Study||47
5205192|NCT01023841|12798211|P2|STARTED|Overall Study||23
5205193|NCT01023841|12798212|P1|STARTED|Overall Study||48
5205194|NCT01023815|12798230|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
5205195|NCT01023815|12798231|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
5205196|NCT01023815|12798232|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
5205197|NCT01023815|12798233|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
5205198|NCT01023815|12798230|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
5205199|NCT01023815|12798231|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
5205200|NCT01023815|12798232|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
5205201|NCT01023815|12798233|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
5205202|NCT01023815|12798230|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
5205203|NCT01023815|12798231|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
5205204|NCT01023815|12798232|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
5205205|NCT01023815|12798233|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
5205206|NCT01023815|12798230|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205207|NCT01023815|12798231|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205208|NCT01023815|12798232|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205209|NCT01023815|12798233|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
5205210|NCT01023815|12798230|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205211|NCT01023815|12798231|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205212|NCT01023815|12798232|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
5205213|NCT01023815|12798233|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
5205214|NCT01023815|12798230|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
5205215|NCT01023815|12798231|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
5205216|NCT01023815|12798232|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
5205217|NCT01023815|12798233|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
5205218|NCT01023789|12798252|P1|NOT COMPLETED|3 - Year Visit||43
5205219|NCT01023789|12798252|P1|COMPLETED|3 - Year Visit||769
5205220|NCT01023789|12798252|P1|STARTED|3 - Year Visit||812
5205221|NCT01023789|12798252|P1|NOT COMPLETED|2 - Year Visit||0
5205222|NCT01023789|12798252|P1|COMPLETED|2 - Year Visit||812
5205223|NCT01023789|12798252|P1|STARTED|2 - Year Visit||812
5205224|NCT01023789|12798252|P1|NOT COMPLETED|1 - Year Visit||0
5205225|NCT01023789|12798252|P1|COMPLETED|1 - Year Visit||812
5205226|NCT01023789|12798252|P1|STARTED|1 - Year Visit||812
5205227|NCT01023789|12798252|P1|NOT COMPLETED|180-day Clinical Follow-up||0
5205228|NCT01023789|12798252|P1|COMPLETED|180-day Clinical Follow-up||812
5205229|NCT01023789|12798252|P1|STARTED|180-day Clinical Follow-up||812
5205230|NCT01023789|12798252|P1|NOT COMPLETED|30-day Follow-up Visit||0
5205231|NCT01023789|12798252|P1|COMPLETED|30-day Follow-up Visit||812
5205232|NCT01023789|12798252|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
5205233|NCT01023776|12798319|P1|NOT COMPLETED|Overall Study||0
5205234|NCT01023776|12798319|P1|COMPLETED|Overall Study||20
5205235|NCT01023776|12798319|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
5205236|NCT01023724|12798326|P2|NOT COMPLETED|Overall Study||3
5205237|NCT01023724|12798327|P1|NOT COMPLETED|Overall Study||4
5205238|NCT01023724|12798326|P2|COMPLETED|Overall Study||22
5205239|NCT01023724|12798327|P1|COMPLETED|Overall Study||21
5205240|NCT01023724|12798326|P2|STARTED|Overall Study||25
5205241|NCT01023724|12798327|P1|STARTED|Overall Study||25
5205242|NCT01023711|12798333|P1|NOT COMPLETED|Overall Study||0
5205243|NCT01023711|12798333|P1|COMPLETED|Overall Study||107
5205244|NCT01023711|12798333|P1|STARTED|Overall Study||107
5205245|NCT01023672|12798338|P1|NOT COMPLETED|Overall Study||3
5205246|NCT01023672|12798338|P1|COMPLETED|Overall Study||17
5205247|NCT01023672|12798338|P1|STARTED|Overall Study||20
5205248|NCT01023659|12798345|P3|NOT COMPLETED|Overall Study||99
5205249|NCT01023659|12798346|P2|NOT COMPLETED|Overall Study||228
5205250|NCT01023659|12798347|P1|NOT COMPLETED|Overall Study||73
5205251|NCT01023659|12798345|P3|COMPLETED|Overall Study||165
5205252|NCT01023659|12798346|P2|COMPLETED|Overall Study||137
5205253|NCT01023659|12798347|P1|COMPLETED|Overall Study||185
5205254|NCT01023659|12798345|P3|STARTED|Overall Study||264
5205255|NCT01023659|12798346|P2|STARTED|Overall Study||365
5205256|NCT01023659|12798347|P1|STARTED|Overall Study||258
5205257|NCT01023620|12798358|P2|NOT COMPLETED|Overall Study||0
5205258|NCT01023620|12798359|P1|NOT COMPLETED|Overall Study||0
5205259|NCT01023620|12798358|P2|COMPLETED|Overall Study||0
5205260|NCT01023620|12798359|P1|COMPLETED|Overall Study||0
5205261|NCT01023620|12798358|P2|STARTED|Overall Study||0
5205262|NCT01023620|12798359|P1|STARTED|Overall Study||0
5205263|NCT01023581|12798374|P7|NOT COMPLETED|Overall Study||20
5205264|NCT01023581|12798375|P6|NOT COMPLETED|Overall Study||19
5205265|NCT01023581|12798376|P5|NOT COMPLETED|Overall Study||16
5205266|NCT01023581|12798377|P4|NOT COMPLETED|Overall Study||20
5205267|NCT01023581|12798378|P3|NOT COMPLETED|Overall Study||42
5205268|NCT01023581|12798379|P2|NOT COMPLETED|Overall Study||23
5205269|NCT01023581|12798380|P1|NOT COMPLETED|Overall Study||35
5205270|NCT01023581|12798374|P7|COMPLETED|Overall Study||94
5205271|NCT01023581|12798375|P6|COMPLETED|Overall Study||92
5205272|NCT01023581|12798376|P5|COMPLETED|Overall Study||95
5205273|NCT01023581|12798377|P4|COMPLETED|Overall Study||94
5205274|NCT01023581|12798378|P3|COMPLETED|Overall Study||71
5205275|NCT01023581|12798379|P2|COMPLETED|Overall Study||89
5205276|NCT01023581|12798380|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
5205277|NCT01023581|12798374|P7|Received Study Treatment|Overall Study||114
5205278|NCT01023581|12798375|P6|Received Study Treatment|Overall Study||106
5205279|NCT01023581|12798376|P5|Received Study Treatment|Overall Study||111
5205280|NCT01023581|12798377|P4|Received Study Treatment|Overall Study||109
5205281|NCT01023581|12798378|P3|Received Study Treatment|Overall Study||110
5205282|NCT01023581|12798379|P2|Received Study Treatment|Overall Study||112
5205283|NCT01023581|12798380|P1|Received Study Treatment|Overall Study||106
5205284|NCT01023581|12798374|P7|STARTED|Overall Study||114
5205285|NCT01023581|12798375|P6|STARTED|Overall Study||111
5205286|NCT01023581|12798376|P5|STARTED|Overall Study||111
5205287|NCT01023581|12798377|P4|STARTED|Overall Study||114
5205288|NCT01023581|12798378|P3|STARTED|Overall Study||113
5205289|NCT01023581|12798379|P2|STARTED|Overall Study||112
5205290|NCT01023581|12798380|P1|STARTED|Overall Study||109
5205291|NCT01023568|12798413|P3|NOT COMPLETED|Overall Study||0
5205292|NCT01023568|12798414|P2|NOT COMPLETED|Overall Study||0
5205293|NCT01023568|12798415|P1|NOT COMPLETED|Overall Study||0
5205294|NCT01023568|12798413|P3|COMPLETED|Overall Study||45
5205295|NCT01023568|12798414|P2|COMPLETED|Overall Study||44
5205296|NCT01023568|12798415|P1|COMPLETED|Overall Study||45
5205297|NCT01023568|12798413|P3|STARTED|Overall Study||45
5205298|NCT01023568|12798414|P2|STARTED|Overall Study||44
5205299|NCT01023568|12798415|P1|STARTED|Overall Study||45
5205300|NCT01023516|12798437|P2|NOT COMPLETED|Overall Study||18
5205301|NCT01023516|12798438|P1|NOT COMPLETED|Overall Study||24
5205302|NCT01023516|12798437|P2|COMPLETED|Overall Study||284
5205303|NCT01023516|12798438|P1|COMPLETED|Overall Study||289
5205304|NCT01023516|12798437|P2|STARTED|Overall Study||302
5205305|NCT01023516|12798438|P1|STARTED|Overall Study||313
5205306|NCT01023308|12798520|P2|NOT COMPLETED|Overall Study||279
5205307|NCT01023308|12798521|P1|NOT COMPLETED|Overall Study||285
5205308|NCT01023308|12798520|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
5205309|NCT01023308|12798521|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
5205310|NCT01023308|12798520|P2|STARTED|Overall Study||381
5205311|NCT01023308|12798521|P1|STARTED|Overall Study||387
5205312|NCT01023269|12798547|P2|NOT COMPLETED|Overall Study||0
5205313|NCT01023269|12798548|P1|NOT COMPLETED|Overall Study||2
5205314|NCT01023269|12798547|P2|COMPLETED|Overall Study||2
5205315|NCT01023269|12798548|P1|COMPLETED|Overall Study||1
5205316|NCT01023269|12798547|P2|STARTED|Overall Study||2
5205317|NCT01023269|12798548|P1|STARTED|Overall Study||3
5205318|NCT01023256|12798556|P4|NOT COMPLETED|Overall Study||5
5205319|NCT01023256|12798557|P3|NOT COMPLETED|Overall Study||1
5205320|NCT01023256|12798558|P2|NOT COMPLETED|Overall Study||3
5205321|NCT01023256|12798559|P1|NOT COMPLETED|Overall Study||4
5205322|NCT01023256|12798556|P4|COMPLETED|Overall Study||22
5205323|NCT01023256|12798557|P3|COMPLETED|Overall Study||23
5205324|NCT01023256|12798558|P2|COMPLETED|Overall Study||19
5205325|NCT01023256|12798559|P1|COMPLETED|Overall Study||21
5205326|NCT01023256|12798556|P4|STARTED|Overall Study||27
5205327|NCT01023256|12798557|P3|STARTED|Overall Study||24
5205328|NCT01023256|12798558|P2|STARTED|Overall Study||22
5205329|NCT01023256|12798559|P1|STARTED|Overall Study||25
5205330|NCT01023217|12798601|P2|NOT COMPLETED|Overall Study||0
5205331|NCT01023217|12798602|P1|NOT COMPLETED|Overall Study||1
5205332|NCT01023217|12798601|P2|COMPLETED|Overall Study||45
5205333|NCT01023217|12798602|P1|COMPLETED|Overall Study||44
5205334|NCT01023217|12798601|P2|STARTED|Overall Study||45
5205335|NCT01023217|12798602|P1|STARTED|Overall Study||45
5205336|NCT01023178|12798611|P3|NOT COMPLETED|Overall Study||3
5205337|NCT01023178|12798612|P2|NOT COMPLETED|Overall Study||2
5205338|NCT01023178|12798613|P1|NOT COMPLETED|Overall Study||2
5205339|NCT01023178|12798611|P3|COMPLETED|Overall Study||4
5205340|NCT01023178|12798612|P2|COMPLETED|Overall Study||6
5205341|NCT01023178|12798613|P1|COMPLETED|Overall Study||3
5205342|NCT01023178|12798611|P3|STARTED|Overall Study||7
5205343|NCT01023178|12798612|P2|STARTED|Overall Study||8
5205344|NCT01023178|12798613|P1|STARTED|Overall Study||5
5205345|NCT01023074|12798624|P3|NOT COMPLETED|Overall Study||0
5205346|NCT01023074|12798625|P2|NOT COMPLETED|Overall Study||0
5205347|NCT01023074|12798626|P1|NOT COMPLETED|Overall Study||0
5205348|NCT01023074|12798624|P3|COMPLETED|Overall Study||13
5205349|NCT01023074|12798625|P2|COMPLETED|Overall Study||13
5205350|NCT01023074|12798626|P1|COMPLETED|Overall Study||26
5205351|NCT01023074|12798624|P3|STARTED|Overall Study||13
5205352|NCT01023074|12798625|P2|STARTED|Overall Study||13
5205353|NCT01023074|12798626|P1|STARTED|Overall Study||26
5205354|NCT01023061|12798640|P1|NOT COMPLETED|Overall Study||2
5205355|NCT01023061|12798640|P1|COMPLETED|Overall Study||22
5205356|NCT01023061|12798640|P1|STARTED|Overall Study||24
5205357|NCT01023035|12798649|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
5205358|NCT01023035|12798650|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
5205359|NCT01023035|12798651|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
5205360|NCT01023035|12798649|P3|COMPLETED|Follow-up Period (up to Week 72)||108
5205361|NCT01023035|12798650|P2|COMPLETED|Follow-up Period (up to Week 72)||207
5205362|NCT01023035|12798651|P1|COMPLETED|Follow-up Period (up to Week 72)||210
5205363|NCT01023035|12798649|P3|STARTED|Follow-up Period (up to Week 72)||147
5205364|NCT01023035|12798650|P2|STARTED|Follow-up Period (up to Week 72)||235
5205365|NCT01023035|12798651|P1|STARTED|Follow-up Period (up to Week 72)||238
5205366|NCT01023035|12798649|P3|NOT COMPLETED|Treatment Period||118
5205367|NCT01023035|12798650|P2|NOT COMPLETED|Treatment Period||85
5205368|NCT01023035|12798651|P1|NOT COMPLETED|Treatment Period||72
5205369|NCT01023035|12798649|P3|COMPLETED|Treatment Period||69
5205370|NCT01023035|12798650|P2|COMPLETED|Treatment Period||166
5205371|NCT01023035|12798651|P1|COMPLETED|Treatment Period||177
5205372|NCT01023035|12798649|P3|STARTED|Treatment Period||187
5205373|NCT01023035|12798650|P2|STARTED|Treatment Period||251
5205374|NCT01023035|12798651|P1|STARTED|Treatment Period||249
5205375|NCT01023022|12798661|P1|NOT COMPLETED|Overall Study||14
5205376|NCT01023022|12798661|P1|COMPLETED|Overall Study||162
5205377|NCT01023022|12798661|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
5205378|NCT01022996|12798667|P1|NOT COMPLETED|Overall Study||57
5205379|NCT01022996|12798667|P1|COMPLETED|Overall Study||0
5205380|NCT01022996|12798667|P1|STARTED|Overall Study||57
5205381|NCT01022853|12798681|P5|NOT COMPLETED|Overall Study||2
5205382|NCT01022853|12798682|P4|NOT COMPLETED|Overall Study||8
5205383|NCT01022853|12798683|P3|NOT COMPLETED|Overall Study||13
5205384|NCT01022853|12798684|P2|NOT COMPLETED|Overall Study||4
5205385|NCT01022853|12798685|P1|NOT COMPLETED|Overall Study||3
5205386|NCT01022853|12798681|P5|COMPLETED|Overall Study||0
5205387|NCT01022853|12798682|P4|COMPLETED|Overall Study||0
5205388|NCT01022853|12798683|P3|COMPLETED|Overall Study||0
5205389|NCT01022853|12798684|P2|COMPLETED|Overall Study||0
5205390|NCT01022853|12798685|P1|COMPLETED|Overall Study||0
5205391|NCT01022853|12798681|P5|STARTED|Overall Study|entered and treated|2
5205392|NCT01022853|12798682|P4|STARTED|Overall Study|entered and treated|8
5205393|NCT01022853|12798683|P3|STARTED|Overall Study|entered and treated|13
5205394|NCT01022853|12798684|P2|STARTED|Overall Study|entered and treated|4
5205395|NCT01022853|12798685|P1|STARTED|Overall Study|entered and treated|3
5205396|NCT01022762|12798764|P2|NOT COMPLETED|Overall Study||28
5205397|NCT01022762|12798765|P1|NOT COMPLETED|Overall Study||22
5205398|NCT01022762|12798764|P2|COMPLETED|Overall Study||194
5205399|NCT01022762|12798765|P1|COMPLETED|Overall Study||196
5205400|NCT01022762|12798764|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
5205401|NCT01022762|12798765|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
5205402|NCT01022762|12798764|P2|STARTED|Overall Study||222
5205403|NCT01022762|12798765|P1|STARTED|Overall Study||218
5205404|NCT01022567|12798793|P2|NOT COMPLETED|Overall Study||15
5205405|NCT01022567|12798794|P1|NOT COMPLETED|Overall Study||1
5205406|NCT01022567|12798793|P2|COMPLETED|Overall Study||242
5205407|NCT01022567|12798794|P1|COMPLETED|Overall Study||272
5205408|NCT01022567|12798793|P2|STARTED|Overall Study||257
5205409|NCT01022567|12798794|P1|STARTED|Overall Study||273
5205410|NCT01022502|12798800|P1|NOT COMPLETED|Overall Study||3
5205411|NCT01022502|12798800|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
5205412|NCT01022502|12798800|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
5205413|NCT01022424|12798814|P1|NOT COMPLETED|Overall Study||4
5205414|NCT01022424|12798814|P1|COMPLETED|Overall Study||9
5205415|NCT01022424|12798814|P1|STARTED|Overall Study||13
5205416|NCT01022398|12798829|P2|NOT COMPLETED|Overall Study||2
5205417|NCT01022398|12798830|P1|NOT COMPLETED|Overall Study||2
5205418|NCT01022398|12798829|P2|COMPLETED|Overall Study||0
5205419|NCT01022398|12798830|P1|COMPLETED|Overall Study||0
5205420|NCT01022398|12798829|P2|STARTED|Overall Study||2
5205421|NCT01022398|12798830|P1|STARTED|Overall Study||2
5205422|NCT01022307|12798837|P2|NOT COMPLETED|Overall Study||4
5205423|NCT01022307|12798838|P1|NOT COMPLETED|Overall Study||0
5205424|NCT01022307|12798837|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
5205425|NCT01022307|12798838|P1|COMPLETED|Overall Study||184
5205426|NCT01022307|12798837|P2|STARTED|Overall Study||28
5205427|NCT01022307|12798838|P1|STARTED|Overall Study||184
5205428|NCT01022242|12798846|P2|NOT COMPLETED|Overall Study||19
5205429|NCT01022242|12798847|P1|NOT COMPLETED|Overall Study||21
5205430|NCT01022242|12798846|P2|COMPLETED|Overall Study||46
5205431|NCT01022242|12798847|P1|COMPLETED|Overall Study||49
5205432|NCT01022242|12798846|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
5205433|NCT01022242|12798847|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
5205434|NCT01022203|12798855|P2|NOT COMPLETED|Follow-Up Assessment||2
5205435|NCT01022203|12798856|P1|NOT COMPLETED|Follow-Up Assessment||2
5205436|NCT01022203|12798855|P2|COMPLETED|Follow-Up Assessment||40
5205437|NCT01022203|12798856|P1|COMPLETED|Follow-Up Assessment||42
5205438|NCT01022203|12798855|P2|STARTED|Follow-Up Assessment||42
5205439|NCT01022203|12798856|P1|STARTED|Follow-Up Assessment||44
5205440|NCT01022203|12798855|P2|NOT COMPLETED|Post Treatment Assessment||14
5205441|NCT01022203|12798856|P1|NOT COMPLETED|Post Treatment Assessment||14
5205442|NCT01022203|12798855|P2|COMPLETED|Post Treatment Assessment||42
5205443|NCT01022203|12798856|P1|COMPLETED|Post Treatment Assessment||44
5205444|NCT01022203|12798855|P2|STARTED|Post Treatment Assessment||56
5205445|NCT01022203|12798856|P1|STARTED|Post Treatment Assessment||58
5205446|NCT01022203|12798855|P2|NOT COMPLETED|PreTreatment Assessment||0
5205447|NCT01022203|12798856|P1|NOT COMPLETED|PreTreatment Assessment||0
5205448|NCT01022203|12798855|P2|COMPLETED|PreTreatment Assessment||56
5205449|NCT01022203|12798856|P1|COMPLETED|PreTreatment Assessment||58
5205450|NCT01022203|12798855|P2|STARTED|PreTreatment Assessment||56
5205451|NCT01022203|12798856|P1|STARTED|PreTreatment Assessment||58
5205452|NCT01022190|12798866|P1|NOT COMPLETED|Overall Study||0
5205453|NCT01022190|12798866|P1|COMPLETED|Overall Study||42
5205454|NCT01022190|12798866|P1|STARTED|Overall Study||42
5205455|NCT01022112|12798875|P5|NOT COMPLETED|Overall Study||10
5205456|NCT01022112|12798876|P4|NOT COMPLETED|Overall Study||3
5205457|NCT01022112|12798877|P3|NOT COMPLETED|Overall Study||3
5205458|NCT01022112|12798878|P2|NOT COMPLETED|Overall Study||3
5205459|NCT01022112|12798879|P1|NOT COMPLETED|Overall Study||3
5205460|NCT01022112|12798875|P5|COMPLETED|Overall Study||65
5205461|NCT01022112|12798876|P4|COMPLETED|Overall Study||72
5205462|NCT01022112|12798877|P3|COMPLETED|Overall Study||74
5205463|NCT01022112|12798878|P2|COMPLETED|Overall Study||71
5205464|NCT01022112|12798879|P1|COMPLETED|Overall Study||79
5205465|NCT01022112|12798875|P5|STARTED|Overall Study||75
5205466|NCT01022112|12798876|P4|STARTED|Overall Study||75
5205467|NCT01022112|12798877|P3|STARTED|Overall Study||77
5205468|NCT01022112|12798878|P2|STARTED|Overall Study||74
5205469|NCT01022112|12798879|P1|STARTED|Overall Study||82
5205470|NCT01022073|12798893|P2|NOT COMPLETED|Overall Study||18
5205471|NCT01022073|12798894|P1|NOT COMPLETED|Overall Study||19
5205472|NCT01022073|12798893|P2|COMPLETED|Overall Study||52
5205473|NCT01022073|12798894|P1|COMPLETED|Overall Study||67
5205474|NCT01022073|12798893|P2|STARTED|Overall Study||70
5205475|NCT01022073|12798894|P1|STARTED|Overall Study||86
5205476|NCT01021956|12798904|P4|NOT COMPLETED|Overall Study||0
5205477|NCT01021956|12798905|P3|NOT COMPLETED|Overall Study||0
5205478|NCT01021956|12798906|P2|NOT COMPLETED|Overall Study||0
5205479|NCT01021956|12798907|P1|NOT COMPLETED|Overall Study||0
5205480|NCT01021956|12798904|P4|COMPLETED|Overall Study||1
5205481|NCT01021956|12798905|P3|COMPLETED|Overall Study||3
5205482|NCT01021956|12798906|P2|COMPLETED|Overall Study||3
5205483|NCT01021956|12798907|P1|COMPLETED|Overall Study||3
5205484|NCT01021956|12798904|P4|STARTED|Overall Study||1
5205485|NCT01021956|12798905|P3|STARTED|Overall Study||3
5205486|NCT01021956|12798906|P2|STARTED|Overall Study||3
5205487|NCT01021956|12798907|P1|STARTED|Overall Study||3
5205488|NCT01021878|12798928|P2|NOT COMPLETED|Overall Study||10
5205489|NCT01021878|12798929|P1|NOT COMPLETED|Overall Study||16
5205490|NCT01021878|12798928|P2|COMPLETED|Overall Study||17
5205491|NCT01021878|12798929|P1|COMPLETED|Overall Study||17
5205492|NCT01021878|12798928|P2|Completed Follow-up|Overall Study||17
5205493|NCT01021878|12798929|P1|Completed Follow-up|Overall Study||17
5205494|NCT01021878|12798928|P2|STARTED|Overall Study||27
5205495|NCT01021878|12798929|P1|STARTED|Overall Study||33
5205496|NCT01021852|12798951|P8|NOT COMPLETED|Treatment Period 2||2
5205497|NCT01021852|12798952|P7|NOT COMPLETED|Treatment Period 2||3
5205498|NCT01021852|12798953|P6|NOT COMPLETED|Treatment Period 2||1
5205499|NCT01021852|12798954|P5|NOT COMPLETED|Treatment Period 2||2
5205500|NCT01021852|12798955|P4|NOT COMPLETED|Treatment Period 2||0
5205501|NCT01021852|12798956|P3|NOT COMPLETED|Treatment Period 2||1
5205502|NCT01021852|12798957|P2|NOT COMPLETED|Treatment Period 2||1
5205503|NCT01021852|12798958|P1|NOT COMPLETED|Treatment Period 2||0
5205504|NCT01021852|12798951|P8|COMPLETED|Treatment Period 2||38
5205505|NCT01021852|12798952|P7|COMPLETED|Treatment Period 2||37
5205506|NCT01021852|12798953|P6|COMPLETED|Treatment Period 2||37
5205507|NCT01021852|12798954|P5|COMPLETED|Treatment Period 2||37
5205508|NCT01021852|12798955|P4|COMPLETED|Treatment Period 2||37
5205509|NCT01021852|12798956|P3|COMPLETED|Treatment Period 2||38
5205510|NCT01021852|12798957|P2|COMPLETED|Treatment Period 2||38
5205511|NCT01021852|12798958|P1|COMPLETED|Treatment Period 2||37
5205512|NCT01021852|12798951|P8|STARTED|Treatment Period 2||40
5205513|NCT01021852|12798952|P7|STARTED|Treatment Period 2||40
5205514|NCT01021852|12798953|P6|STARTED|Treatment Period 2||38
5205515|NCT01021852|12798954|P5|STARTED|Treatment Period 2||39
5205516|NCT01021852|12798955|P4|STARTED|Treatment Period 2||37
5205517|NCT01021852|12798956|P3|STARTED|Treatment Period 2||39
5205518|NCT01021852|12798957|P2|STARTED|Treatment Period 2||39
5205519|NCT01021852|12798958|P1|STARTED|Treatment Period 2||37
5205520|NCT01021852|12798951|P8|NOT COMPLETED|Washout Period-No Drug||0
5205521|NCT01021852|12798952|P7|NOT COMPLETED|Washout Period-No Drug||0
5205522|NCT01021852|12798953|P6|NOT COMPLETED|Washout Period-No Drug||1
5205523|NCT01021852|12798954|P5|NOT COMPLETED|Washout Period-No Drug||0
5205524|NCT01021852|12798955|P4|NOT COMPLETED|Washout Period-No Drug||0
5205525|NCT01021852|12798956|P3|NOT COMPLETED|Washout Period-No Drug||0
5205526|NCT01021852|12798957|P2|NOT COMPLETED|Washout Period-No Drug||0
5205527|NCT01021852|12798958|P1|NOT COMPLETED|Washout Period-No Drug||1
5205528|NCT01021852|12798951|P8|COMPLETED|Washout Period-No Drug||40
5205529|NCT01021852|12798952|P7|COMPLETED|Washout Period-No Drug||40
5205530|NCT01021852|12798953|P6|COMPLETED|Washout Period-No Drug||38
5205531|NCT01021852|12798954|P5|COMPLETED|Washout Period-No Drug||39
5205532|NCT01021852|12798955|P4|COMPLETED|Washout Period-No Drug||37
5205533|NCT01021852|12798956|P3|COMPLETED|Washout Period-No Drug||39
5205534|NCT01021852|12798957|P2|COMPLETED|Washout Period-No Drug||39
5205535|NCT01021852|12798958|P1|COMPLETED|Washout Period-No Drug||37
5205536|NCT01021852|12798951|P8|STARTED|Washout Period-No Drug||40
5205537|NCT01021852|12798952|P7|STARTED|Washout Period-No Drug||40
5205538|NCT01021852|12798953|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
5205539|NCT01021852|12798954|P5|STARTED|Washout Period-No Drug||39
5205540|NCT01021852|12798955|P4|STARTED|Washout Period-No Drug||37
5205541|NCT01021852|12798956|P3|STARTED|Washout Period-No Drug||39
5205542|NCT01021852|12798957|P2|STARTED|Washout Period-No Drug||39
5205543|NCT01021852|12798958|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
5205544|NCT01021852|12798951|P8|NOT COMPLETED|Washout Period-Placebo||0
5205545|NCT01021852|12798952|P7|NOT COMPLETED|Washout Period-Placebo||1
5205546|NCT01021852|12798953|P6|NOT COMPLETED|Washout Period-Placebo||1
5205547|NCT01021852|12798954|P5|NOT COMPLETED|Washout Period-Placebo||1
5205548|NCT01021852|12798955|P4|NOT COMPLETED|Washout Period-Placebo||1
5205549|NCT01021852|12798956|P3|NOT COMPLETED|Washout Period-Placebo||0
5205550|NCT01021852|12798957|P2|NOT COMPLETED|Washout Period-Placebo||0
5205551|NCT01021852|12798958|P1|NOT COMPLETED|Washout Period-Placebo||0
5205552|NCT01021852|12798951|P8|COMPLETED|Washout Period-Placebo||40
5205553|NCT01021852|12798952|P7|COMPLETED|Washout Period-Placebo||40
5205554|NCT01021852|12798953|P6|COMPLETED|Washout Period-Placebo||38
5205555|NCT01021852|12798954|P5|COMPLETED|Washout Period-Placebo||39
5205556|NCT01021852|12798955|P4|COMPLETED|Washout Period-Placebo||37
5205557|NCT01021852|12798956|P3|COMPLETED|Washout Period-Placebo||39
5205558|NCT01021852|12798957|P2|COMPLETED|Washout Period-Placebo||39
5205559|NCT01021852|12798958|P1|COMPLETED|Washout Period-Placebo||37
5205560|NCT01021852|12798951|P8|STARTED|Washout Period-Placebo||40
5205561|NCT01021852|12798952|P7|STARTED|Washout Period-Placebo||41
5205562|NCT01021852|12798953|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
5205563|NCT01021852|12798954|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
5205564|NCT01021852|12798955|P4|STARTED|Washout Period-Placebo||38
5205565|NCT01021852|12798956|P3|STARTED|Washout Period-Placebo||39
5205566|NCT01021852|12798957|P2|STARTED|Washout Period-Placebo||39
5205567|NCT01021852|12798958|P1|STARTED|Washout Period-Placebo||37
5205568|NCT01021852|12798951|P8|NOT COMPLETED|Treatment Period 1||1
5205569|NCT01021852|12798952|P7|NOT COMPLETED|Treatment Period 1||0
5205570|NCT01021852|12798953|P6|NOT COMPLETED|Treatment Period 1||2
5205571|NCT01021852|12798954|P5|NOT COMPLETED|Treatment Period 1||3
5205572|NCT01021852|12798955|P4|NOT COMPLETED|Treatment Period 1||2
5205573|NCT01021852|12798956|P3|NOT COMPLETED|Treatment Period 1||2
5205574|NCT01021852|12798957|P2|NOT COMPLETED|Treatment Period 1||1
5205575|NCT01021852|12798958|P1|NOT COMPLETED|Treatment Period 1||3
5205576|NCT01021852|12798951|P8|COMPLETED|Treatment Period 1||40
5205577|NCT01021852|12798952|P7|COMPLETED|Treatment Period 1||41
5205578|NCT01021852|12798953|P6|COMPLETED|Treatment Period 1||39
5205579|NCT01021852|12798954|P5|COMPLETED|Treatment Period 1||39
5205580|NCT01021852|12798955|P4|COMPLETED|Treatment Period 1||38
5205581|NCT01021852|12798956|P3|COMPLETED|Treatment Period 1||39
5205582|NCT01021852|12798957|P2|COMPLETED|Treatment Period 1||39
5205583|NCT01021852|12798958|P1|COMPLETED|Treatment Period 1||37
5205584|NCT01021852|12798951|P8|Treated|Treatment Period 1||41
5205585|NCT01021852|12798952|P7|Treated|Treatment Period 1||41
5205586|NCT01021852|12798953|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
5205587|NCT01021852|12798954|P5|Treated|Treatment Period 1||42
5205588|NCT01021852|12798955|P4|Treated|Treatment Period 1||38
5205589|NCT01021852|12798956|P3|Treated|Treatment Period 1||41
5205590|NCT01021852|12798957|P2|Treated|Treatment Period 1||40
5205591|NCT01021852|12798958|P1|Treated|Treatment Period 1||40
5205592|NCT01021852|12798951|P8|STARTED|Treatment Period 1||41
5205593|NCT01021852|12798952|P7|STARTED|Treatment Period 1||41
5205594|NCT01021852|12798953|P6|STARTED|Treatment Period 1||41
5205595|NCT01021852|12798954|P5|STARTED|Treatment Period 1||42
5205596|NCT01021852|12798955|P4|STARTED|Treatment Period 1||40
5205597|NCT01021852|12798956|P3|STARTED|Treatment Period 1||41
5205598|NCT01021852|12798957|P2|STARTED|Treatment Period 1||40
5205599|NCT01021852|12798958|P1|STARTED|Treatment Period 1||40
5205600|NCT01021813|12798994|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
5205601|NCT01021813|12798995|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
5205602|NCT01021813|12798996|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
5205603|NCT01021813|12798997|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
5205604|NCT01021813|12798998|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
5205605|NCT01021813|12798994|P5|COMPLETED|DB Randomized Discontinuation Phase||157
5205606|NCT01021813|12798995|P4|COMPLETED|DB Randomized Discontinuation Phase||161
5205607|NCT01021813|12798996|P3|COMPLETED|DB Randomized Discontinuation Phase||152
5205608|NCT01021813|12798997|P2|COMPLETED|DB Randomized Discontinuation Phase||0
5205609|NCT01021813|12798998|P1|COMPLETED|DB Randomized Discontinuation Phase||0
5205610|NCT01021813|12798994|P5|STARTED|DB Randomized Discontinuation Phase||162
5205611|NCT01021813|12798995|P4|STARTED|DB Randomized Discontinuation Phase||166
5205612|NCT01021813|12798996|P3|STARTED|DB Randomized Discontinuation Phase||156
5205613|NCT01021813|12798997|P2|STARTED|DB Randomized Discontinuation Phase||0
5205614|NCT01021813|12798998|P1|STARTED|DB Randomized Discontinuation Phase||0
5205615|NCT01021813|12798994|P5|NOT COMPLETED|DB Treatment Phase||0
5205616|NCT01021813|12798995|P4|NOT COMPLETED|DB Treatment Phase||0
5205617|NCT01021813|12798996|P3|NOT COMPLETED|DB Treatment Phase||0
5205618|NCT01021813|12798997|P2|NOT COMPLETED|DB Treatment Phase||97
5205619|NCT01021813|12798998|P1|NOT COMPLETED|DB Treatment Phase||200
5205620|NCT01021813|12798994|P5|COMPLETED|DB Treatment Phase||0
5205621|NCT01021813|12798995|P4|COMPLETED|DB Treatment Phase||0
5205622|NCT01021813|12798996|P3|COMPLETED|DB Treatment Phase||0
5205623|NCT01021813|12798997|P2|COMPLETED|DB Treatment Phase||162
5205624|NCT01021813|12798998|P1|COMPLETED|DB Treatment Phase||322
5205625|NCT01021813|12798994|P5|Treated|DB Treatment Phase||0
5205626|NCT01021813|12798995|P4|Treated|DB Treatment Phase||0
5205627|NCT01021813|12798996|P3|Treated|DB Treatment Phase||0
5205628|NCT01021813|12798997|P2|Treated|DB Treatment Phase||258
5205629|NCT01021813|12798998|P1|Treated|DB Treatment Phase||521
5205630|NCT01021813|12798994|P5|STARTED|DB Treatment Phase||0
5205631|NCT01021813|12798995|P4|STARTED|DB Treatment Phase||0
5205632|NCT01021813|12798996|P3|STARTED|DB Treatment Phase||0
5205633|NCT01021813|12798997|P2|STARTED|DB Treatment Phase||259
5205634|NCT01021813|12798998|P1|STARTED|DB Treatment Phase||522
5205635|NCT01021761|12799040|P3|NOT COMPLETED|Overall Study||0
5205636|NCT01021761|12799041|P2|NOT COMPLETED|Overall Study||4
5205637|NCT01021761|12799042|P1|NOT COMPLETED|Overall Study||1
5205638|NCT01021761|12799040|P3|COMPLETED|Overall Study||42
5205639|NCT01021761|12799041|P2|COMPLETED|Overall Study||38
5205640|NCT01021761|12799042|P1|COMPLETED|Overall Study||41
5205641|NCT01021761|12799040|P3|STARTED|Overall Study||42
5205642|NCT01021761|12799041|P2|STARTED|Overall Study||42
5205643|NCT01021761|12799042|P1|STARTED|Overall Study||42
5205644|NCT01021748|12799059|P9|NOT COMPLETED|Overall Study||16
5205645|NCT01021748|12799060|P8|NOT COMPLETED|Overall Study||6
5205646|NCT01021748|12799061|P7|NOT COMPLETED|Overall Study||3
5205647|NCT01021748|12799062|P6|NOT COMPLETED|Overall Study||3
5205648|NCT01021748|12799063|P5|NOT COMPLETED|Overall Study||9
5205649|NCT01021748|12799064|P4|NOT COMPLETED|Overall Study||7
5205650|NCT01021748|12799065|P3|NOT COMPLETED|Overall Study||7
5205651|NCT01021748|12799066|P2|NOT COMPLETED|Overall Study||5
5205652|NCT01021748|12799067|P1|NOT COMPLETED|Overall Study||6
5205653|NCT01021748|12799059|P9|COMPLETED|Overall Study||1
5205654|NCT01021748|12799060|P8|COMPLETED|Overall Study||0
5205655|NCT01021748|12799061|P7|COMPLETED|Overall Study||0
5205656|NCT01021748|12799062|P6|COMPLETED|Overall Study||0
5205657|NCT01021748|12799063|P5|COMPLETED|Overall Study||0
5205658|NCT01021748|12799064|P4|COMPLETED|Overall Study||0
5205659|NCT01021748|12799065|P3|COMPLETED|Overall Study||0
5205660|NCT01021748|12799066|P2|COMPLETED|Overall Study||0
5205661|NCT01021748|12799067|P1|COMPLETED|Overall Study||0
5205662|NCT01021748|12799059|P9|Treated|Overall Study||17
5205663|NCT01021748|12799060|P8|Treated|Overall Study||6
5205664|NCT01021748|12799061|P7|Treated|Overall Study||3
5205665|NCT01021748|12799062|P6|Treated|Overall Study||3
5205666|NCT01021748|12799063|P5|Treated|Overall Study||9
5205667|NCT01021748|12799064|P4|Treated|Overall Study||7
5205668|NCT01021748|12799065|P3|Treated|Overall Study||7
5205669|NCT01021748|12799066|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
5205670|NCT01021748|12799067|P1|Treated|Overall Study||6
5205671|NCT01021748|12799059|P9|STARTED|Overall Study||17
5205672|NCT01021748|12799060|P8|STARTED|Overall Study||6
5205673|NCT01021748|12799061|P7|STARTED|Overall Study||3
5205674|NCT01021748|12799062|P6|STARTED|Overall Study||3
5205675|NCT01021748|12799063|P5|STARTED|Overall Study||9
5205676|NCT01021748|12799064|P4|STARTED|Overall Study||7
5205677|NCT01021748|12799065|P3|STARTED|Overall Study||7
5205678|NCT01021748|12799066|P2|STARTED|Overall Study||5
5205679|NCT01021748|12799067|P1|STARTED|Overall Study||6
5205680|NCT01021683|12799114|P1|NOT COMPLETED|Overall Study||71
5205681|NCT01021683|12799114|P1|COMPLETED|Overall Study||132
5205682|NCT01021683|12799114|P1|STARTED|Overall Study||203
5205683|NCT01021618|12799128|P2|NOT COMPLETED|Overall Study||0
5205684|NCT01021618|12799129|P1|NOT COMPLETED|Overall Study||0
5205685|NCT01021618|12799128|P2|COMPLETED|Overall Study||96
5205686|NCT01021618|12799129|P1|COMPLETED|Overall Study||44
5205687|NCT01021618|12799128|P2|STARTED|Overall Study||96
5205688|NCT01021618|12799129|P1|STARTED|Overall Study||44
5205689|NCT01021553|12799140|P3|NOT COMPLETED|Overall Study||3
5205690|NCT01021553|12799141|P2|NOT COMPLETED|Overall Study||5
5205691|NCT01021553|12799142|P1|NOT COMPLETED|Overall Study||4
5205692|NCT01021553|12799140|P3|COMPLETED|Overall Study||25
5205693|NCT01021553|12799141|P2|COMPLETED|Overall Study||17
5205694|NCT01021553|12799142|P1|COMPLETED|Overall Study||23
5205695|NCT01021553|12799140|P3|STARTED|Overall Study||28
5205696|NCT01021553|12799141|P2|STARTED|Overall Study||22
5205697|NCT01021553|12799142|P1|STARTED|Overall Study||27
5205698|NCT01021423|12799196|P2|NOT COMPLETED|Overall Study||5
5205699|NCT01021423|12799197|P1|NOT COMPLETED|Overall Study||4
5205700|NCT01021423|12799196|P2|COMPLETED|Overall Study||0
5205701|NCT01021423|12799197|P1|COMPLETED|Overall Study||0
5205702|NCT01021423|12799196|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
5205703|NCT01021423|12799197|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
5205704|NCT01021332|12799213|P1|NOT COMPLETED|Overall Study||106
5205705|NCT01021332|12799213|P1|COMPLETED|Overall Study||960
5205706|NCT01021332|12799213|P1|Full Analysis Set (FAS)|Overall Study||1009
5205707|NCT01021332|12799213|P1|Safety Analysis Set (SAF)|Overall Study||1066
5205708|NCT01021332|12799213|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
5205709|NCT01021306|12799251|P4|NOT COMPLETED|6 Month (Follow-up)||3
5205710|NCT01021306|12799252|P3|NOT COMPLETED|6 Month (Follow-up)||0
5205711|NCT01021306|12799253|P2|NOT COMPLETED|6 Month (Follow-up)||1
5205712|NCT01021306|12799254|P1|NOT COMPLETED|6 Month (Follow-up)||3
5205713|NCT01021306|12799251|P4|COMPLETED|6 Month (Follow-up)||14
5205714|NCT01021306|12799252|P3|COMPLETED|6 Month (Follow-up)||14
5205715|NCT01021306|12799253|P2|COMPLETED|6 Month (Follow-up)||13
5205716|NCT01021306|12799254|P1|COMPLETED|6 Month (Follow-up)||11
5205717|NCT01021306|12799251|P4|STARTED|6 Month (Follow-up)||17
5205718|NCT01021306|12799252|P3|STARTED|6 Month (Follow-up)||14
5205719|NCT01021306|12799253|P2|STARTED|6 Month (Follow-up)||14
5205720|NCT01021306|12799254|P1|STARTED|6 Month (Follow-up)||14
5205721|NCT01021306|12799251|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
5205722|NCT01021306|12799252|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
5205723|NCT01021306|12799253|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
5205724|NCT01021306|12799254|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
5205725|NCT01021306|12799251|P4|COMPLETED|2 Month (Primary Outcome)||17
5205726|NCT01021306|12799252|P3|COMPLETED|2 Month (Primary Outcome)||14
5205727|NCT01021306|12799253|P2|COMPLETED|2 Month (Primary Outcome)||14
5205728|NCT01021306|12799254|P1|COMPLETED|2 Month (Primary Outcome)||14
5205729|NCT01021306|12799251|P4|STARTED|2 Month (Primary Outcome)||21
5205730|NCT01021306|12799252|P3|STARTED|2 Month (Primary Outcome)||19
5205731|NCT01021306|12799253|P2|STARTED|2 Month (Primary Outcome)||20
5205732|NCT01021306|12799254|P1|STARTED|2 Month (Primary Outcome)||20
5205733|NCT01021293|12799274|P2|NOT COMPLETED|Overall Study||24
5205734|NCT01021293|12799275|P1|NOT COMPLETED|Overall Study||12
5205735|NCT01021293|12799274|P2|COMPLETED|Overall Study||526
5205736|NCT01021293|12799275|P1|COMPLETED|Overall Study||538
5205737|NCT01021293|12799274|P2|STARTED|Overall Study||550
5205738|NCT01021293|12799275|P1|STARTED|Overall Study||550
5205739|NCT01021215|12799294|P2|NOT COMPLETED|Overall Study||0
5205740|NCT01021215|12799295|P1|NOT COMPLETED|Overall Study||3
5205741|NCT01021215|12799294|P2|COMPLETED|Overall Study||20
5205742|NCT01021215|12799295|P1|COMPLETED|Overall Study||57
5205743|NCT01021215|12799294|P2|Received Allocated Intervention|Overall Study||20
5205744|NCT01021215|12799295|P1|Received Allocated Intervention|Overall Study||60
5205745|NCT01021215|12799294|P2|STARTED|Overall Study||20
5205746|NCT01021215|12799295|P1|STARTED|Overall Study||60
5205747|NCT01021137|12799309|P4|NOT COMPLETED|Overall Study||9
5205748|NCT01021137|12799310|P3|NOT COMPLETED|Overall Study||2
5205749|NCT01021137|12799311|P2|NOT COMPLETED|Overall Study||4
5205750|NCT01021137|12799312|P1|NOT COMPLETED|Overall Study||10
5205751|NCT01021137|12799309|P4|COMPLETED|Overall Study||32
5205752|NCT01021137|12799310|P3|COMPLETED|Overall Study||9
5205753|NCT01021137|12799311|P2|COMPLETED|Overall Study||16
5205754|NCT01021137|12799312|P1|COMPLETED|Overall Study||52
5205755|NCT01021137|12799309|P4|STARTED|Overall Study||41
5205756|NCT01021137|12799310|P3|STARTED|Overall Study||11
5205757|NCT01021137|12799311|P2|STARTED|Overall Study||20
5205758|NCT01021137|12799312|P1|STARTED|Overall Study||62
5205759|NCT01021111|12799350|P1|NOT COMPLETED|Overall Study||0
5205760|NCT01021111|12799350|P1|COMPLETED|Overall Study||17
5205761|NCT01021111|12799350|P1|STARTED|Overall Study||17
5205762|NCT01021020|12799355|P1|NOT COMPLETED|Period III||0
5205763|NCT01021020|12799355|P1|COMPLETED|Period III||25
5205764|NCT01021020|12799355|P1|STARTED|Period III||25
5205765|NCT01021020|12799355|P1|NOT COMPLETED|14 Day Washout Period B||0
5205766|NCT01021020|12799355|P1|COMPLETED|14 Day Washout Period B||25
5205767|NCT01021020|12799355|P1|STARTED|14 Day Washout Period B||25
5205768|NCT01021020|12799355|P1|NOT COMPLETED|Period II||0
5205769|NCT01021020|12799355|P1|COMPLETED|Period II||25
5205770|NCT01021020|12799355|P1|STARTED|Period II||25
5205771|NCT01021020|12799355|P1|NOT COMPLETED|14 Day Washout Period A||1
5205772|NCT01021020|12799355|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
5205773|NCT01021020|12799355|P1|STARTED|14 Day Washout Period A||26
5205774|NCT01021020|12799355|P1|NOT COMPLETED|Period I||2
5205775|NCT01021020|12799355|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
5205776|NCT01021020|12799355|P1|STARTED|Period I||28
5205777|NCT01021007|12799371|P2|NOT COMPLETED|Overall Study||4
5205778|NCT01021007|12799372|P1|NOT COMPLETED|Overall Study||2
5205779|NCT01021007|12799371|P2|COMPLETED|Overall Study||33
5205780|NCT01021007|12799372|P1|COMPLETED|Overall Study||34
5205781|NCT01021007|12799371|P2|STARTED|Overall Study||37
5205782|NCT01021007|12799372|P1|STARTED|Overall Study||36
5205783|NCT01020981|12799384|P2|NOT COMPLETED|Overall Study||90
5205784|NCT01020981|12799385|P1|NOT COMPLETED|Overall Study||84
5205785|NCT01020981|12799384|P2|COMPLETED|Overall Study||60
5205786|NCT01020981|12799385|P1|COMPLETED|Overall Study||66
5205787|NCT01020981|12799384|P2|STARTED|Overall Study||150
5205788|NCT01020981|12799385|P1|STARTED|Overall Study||150
5205789|NCT01020903|12799397|P2|NOT COMPLETED|Overall Study||0
5205790|NCT01020903|12799398|P1|NOT COMPLETED|Overall Study||0
5205791|NCT01020903|12799397|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
5205792|NCT01020903|12799398|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
5205793|NCT01020903|12799397|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
5205794|NCT01020903|12799398|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
5205795|NCT01020877|12799406|P2|NOT COMPLETED|Second Intervention||0
5205796|NCT01020877|12799407|P1|NOT COMPLETED|Second Intervention||1
5205797|NCT01020877|12799406|P2|COMPLETED|Second Intervention||19
5205798|NCT01020877|12799407|P1|COMPLETED|Second Intervention||18
5205799|NCT01020877|12799406|P2|STARTED|Second Intervention||19
5205800|NCT01020877|12799407|P1|STARTED|Second Intervention||19
5205801|NCT01020877|12799406|P2|NOT COMPLETED|Washout of 7 Days||0
5205802|NCT01020877|12799407|P1|NOT COMPLETED|Washout of 7 Days||0
5205803|NCT01020877|12799406|P2|COMPLETED|Washout of 7 Days||19
5205804|NCT01020877|12799407|P1|COMPLETED|Washout of 7 Days||19
5205805|NCT01020877|12799406|P2|STARTED|Washout of 7 Days||19
5205806|NCT01020877|12799407|P1|STARTED|Washout of 7 Days||19
5205807|NCT01020877|12799406|P2|NOT COMPLETED|First Intervention||0
5205808|NCT01020877|12799407|P1|NOT COMPLETED|First Intervention||0
5205809|NCT01020877|12799406|P2|COMPLETED|First Intervention||19
5205810|NCT01020877|12799407|P1|COMPLETED|First Intervention||19
5205811|NCT01020877|12799406|P2|STARTED|First Intervention||19
5205812|NCT01020877|12799407|P1|STARTED|First Intervention||19
5205813|NCT01020838|12799417|P1|NOT COMPLETED|Overall Study||183
5205814|NCT01020838|12799417|P1|COMPLETED|Overall Study||35
5205815|NCT01020838|12799417|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
5205816|NCT01020838|12799417|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
5205817|NCT01020838|12799417|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
5205818|NCT01020838|12799417|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
5205819|NCT01020838|12799417|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
5205820|NCT01020838|12799417|P1|STARTED|Overall Study||218
5205821|NCT01020812|12799432|P1|NOT COMPLETED|Overall Study||3
5205822|NCT01020812|12799432|P1|COMPLETED|Overall Study||8
5205823|NCT01020812|12799432|P1|STARTED|Overall Study||11
5205824|NCT01020799|12799442|P3|NOT COMPLETED|Overall Study||7
5205825|NCT01020799|12799443|P2|NOT COMPLETED|Overall Study||14
5205826|NCT01020799|12799444|P1|NOT COMPLETED|Overall Study||19
5205827|NCT01020799|12799442|P3|COMPLETED|Overall Study||43
5205828|NCT01020799|12799443|P2|COMPLETED|Overall Study||85
5205829|NCT01020799|12799444|P1|COMPLETED|Overall Study||79
5205830|NCT01020799|12799442|P3|Full Analysis Set|Overall Study||49
5205831|NCT01020799|12799443|P2|Full Analysis Set|Overall Study||94
5205832|NCT01020799|12799444|P1|Full Analysis Set|Overall Study||91
5205833|NCT01020799|12799442|P3|Patients Received Treatment|Overall Study||50
5205834|NCT01020799|12799443|P2|Patients Received Treatment|Overall Study||99
5205835|NCT01020799|12799444|P1|Patients Received Treatment|Overall Study||96
5205836|NCT01020799|12799442|P3|STARTED|Overall Study||50
5205837|NCT01020799|12799443|P2|STARTED|Overall Study||99
5205838|NCT01020799|12799444|P1|STARTED|Overall Study||98
5205839|NCT01020786|12799467|P1|NOT COMPLETED|Maintenance Period||60
5205840|NCT01020786|12799467|P1|COMPLETED|Maintenance Period||0
5205841|NCT01020786|12799467|P1|STARTED|Maintenance Period||60
5205842|NCT01020786|12799467|P1|NOT COMPLETED|Induction Period||49
5205843|NCT01020786|12799467|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
5205844|NCT01020786|12799467|P1|STARTED|Induction Period||109
5205845|NCT01020773|12799481|P2|NOT COMPLETED|Overall Study||3
5205846|NCT01020773|12799482|P1|NOT COMPLETED|Overall Study||4
5205847|NCT01020773|12799481|P2|COMPLETED|Overall Study||29
5205848|NCT01020773|12799482|P1|COMPLETED|Overall Study||31
5205849|NCT01020773|12799481|P2|STARTED|Overall Study||32
5205850|NCT01020773|12799482|P1|STARTED|Overall Study||35
5205851|NCT01020747|12799488|P1|NOT COMPLETED|Overall Study||1
5205852|NCT01020747|12799488|P1|COMPLETED|Overall Study||19
5205853|NCT01020747|12799488|P1|STARTED|Overall Study||20
5205854|NCT01020591|12799495|P2|NOT COMPLETED|Overall Study||0
5205855|NCT01020591|12799496|P1|NOT COMPLETED|Overall Study||0
5205856|NCT01020591|12799495|P2|COMPLETED|Overall Study||15
5205857|NCT01020591|12799496|P1|COMPLETED|Overall Study||15
5205858|NCT01020591|12799495|P2|STARTED|Overall Study||15
5205859|NCT01020591|12799496|P1|STARTED|Overall Study||15
5205860|NCT01020526|12799504|P1|NOT COMPLETED|Overall Study||14
5205861|NCT01020526|12799504|P1|COMPLETED|Overall Study||49
5205862|NCT01020526|12799504|P1|STARTED|Overall Study||63
5205863|NCT01020474|12799510|P2|NOT COMPLETED|Overall Study||17
5205864|NCT01020474|12799511|P1|NOT COMPLETED|Overall Study||10
5205865|NCT01020474|12799510|P2|COMPLETED|Overall Study||36
5205866|NCT01020474|12799511|P1|COMPLETED|Overall Study||44
5205867|NCT01020474|12799510|P2|STARTED|Overall Study||53
5205868|NCT01020474|12799511|P1|STARTED|Overall Study||54
5205869|NCT01020448|12799531|P1|NOT COMPLETED|Treatment||26
5205870|NCT01020448|12799531|P1|COMPLETED|Treatment||299
5205871|NCT01020448|12799531|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
5205872|NCT01020448|12799531|P1|NOT COMPLETED|Pre-assignment||13
5205873|NCT01020448|12799531|P1|COMPLETED|Pre-assignment||326
5205874|NCT01020448|12799531|P1|STARTED|Pre-assignment||339
5205875|NCT01020435|12799542|P2|NOT COMPLETED|Overall Study||1
5205876|NCT01020435|12799543|P1|NOT COMPLETED|Overall Study||0
5205877|NCT01020435|12799542|P2|COMPLETED|Overall Study||26
5205878|NCT01020435|12799543|P1|COMPLETED|Overall Study||24
5205879|NCT01020435|12799542|P2|STARTED|Overall Study||27
5205880|NCT01020435|12799543|P1|STARTED|Overall Study||24
5205881|NCT01020305|12799551|P1|NOT COMPLETED|Overall Study||2
5205882|NCT01020305|12799551|P1|COMPLETED|Overall Study||3
5205883|NCT01020305|12799551|P1|STARTED|Overall Study||5
5205884|NCT01020123|12799562|P7|NOT COMPLETED|Extention Period||1
5205885|NCT01020123|12799563|P6|NOT COMPLETED|Extention Period||2
5205886|NCT01020123|12799564|P5|NOT COMPLETED|Extention Period||0
5205887|NCT01020123|12799565|P4|NOT COMPLETED|Extention Period||1
5205888|NCT01020123|12799566|P3|NOT COMPLETED|Extention Period||2
5205889|NCT01020123|12799567|P2|NOT COMPLETED|Extention Period||2
5205890|NCT01020123|12799568|P1|NOT COMPLETED|Extention Period||3
5205891|NCT01020123|12799562|P7|COMPLETED|Extention Period||18
5205892|NCT01020123|12799563|P6|COMPLETED|Extention Period||36
5205893|NCT01020123|12799564|P5|COMPLETED|Extention Period||31
5205894|NCT01020123|12799565|P4|COMPLETED|Extention Period||12
5205895|NCT01020123|12799566|P3|COMPLETED|Extention Period||17
5205896|NCT01020123|12799567|P2|COMPLETED|Extention Period||33
5205897|NCT01020123|12799568|P1|COMPLETED|Extention Period||37
5205898|NCT01020123|12799562|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
5205899|NCT01020123|12799563|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
5205900|NCT01020123|12799564|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
5205901|NCT01020123|12799565|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
5205902|NCT01020123|12799566|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
5205903|NCT01020123|12799567|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
5205904|NCT01020123|12799568|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
5205905|NCT01020123|12799562|P7|NOT COMPLETED|Main Period||11
5205906|NCT01020123|12799563|P6|NOT COMPLETED|Main Period||11
5205907|NCT01020123|12799564|P5|NOT COMPLETED|Main Period||11
5205908|NCT01020123|12799565|P4|NOT COMPLETED|Main Period||7
5205909|NCT01020123|12799566|P3|NOT COMPLETED|Main Period||8
5205910|NCT01020123|12799567|P2|NOT COMPLETED|Main Period||14
5205911|NCT01020123|12799568|P1|NOT COMPLETED|Main Period||17
5205912|NCT01020123|12799562|P7|COMPLETED|Main Period||61
5205913|NCT01020123|12799563|P6|COMPLETED|Main Period||83
5205914|NCT01020123|12799564|P5|COMPLETED|Main Period||77
5205915|NCT01020123|12799565|P4|COMPLETED|Main Period||33
5205916|NCT01020123|12799566|P3|COMPLETED|Main Period||44
5205917|NCT01020123|12799567|P2|COMPLETED|Main Period||77
5205918|NCT01020123|12799568|P1|COMPLETED|Main Period||76
5205919|NCT01020123|12799562|P7|STARTED|Main Period||72
5205920|NCT01020123|12799563|P6|STARTED|Main Period||94
5205921|NCT01020123|12799564|P5|STARTED|Main Period||88
5205922|NCT01020123|12799565|P4|STARTED|Main Period||40
5205923|NCT01020123|12799566|P3|STARTED|Main Period||52
5205924|NCT01020123|12799567|P2|STARTED|Main Period||91
5205925|NCT01020123|12799568|P1|STARTED|Main Period||93
5205926|NCT01020019|12799763|P2|NOT COMPLETED|Overall Study||29
5205927|NCT01020019|12799764|P1|NOT COMPLETED|Overall Study||26
5205928|NCT01020019|12799763|P2|COMPLETED|Overall Study||32
5205929|NCT01020019|12799764|P1|COMPLETED|Overall Study||35
5205930|NCT01020019|12799763|P2|STARTED|Overall Study||61
5205931|NCT01020019|12799764|P1|STARTED|Overall Study||61
5205932|NCT01020006|12799773|P3|NOT COMPLETED|Overall Study||16
5205933|NCT01020006|12799774|P2|NOT COMPLETED|Overall Study||18
5205934|NCT01020006|12799775|P1|NOT COMPLETED|Overall Study||8
5205935|NCT01020006|12799773|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
5205936|NCT01020006|12799774|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
5205937|NCT01020006|12799775|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
5205938|NCT01020006|12799773|P3|STARTED|Overall Study||16
5205939|NCT01020006|12799774|P2|STARTED|Overall Study||18
5205940|NCT01020006|12799775|P1|STARTED|Overall Study||8
5205941|NCT01019980|12799785|P2|NOT COMPLETED|Overall Study||0
5205942|NCT01019980|12799786|P1|NOT COMPLETED|Overall Study||2
5205943|NCT01019980|12799785|P2|COMPLETED|Overall Study||0
5205944|NCT01019980|12799786|P1|COMPLETED|Overall Study||0
5205945|NCT01019980|12799785|P2|Discontinued|Overall Study||0
5205946|NCT01019980|12799786|P1|Discontinued|Overall Study||2
5205947|NCT01019980|12799785|P2|STARTED|Overall Study||0
5205948|NCT01019980|12799786|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
5205949|NCT01019928|12799794|P2|NOT COMPLETED|Period 3||0
5205950|NCT01019928|12799795|P1|NOT COMPLETED|Period 3||0
5205951|NCT01019928|12799794|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
5205952|NCT01019928|12799795|P1|COMPLETED|Period 3||7
5205953|NCT01019928|12799794|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
5205954|NCT01019928|12799795|P1|STARTED|Period 3||7
5205955|NCT01019928|12799794|P2|NOT COMPLETED|Period 2||1
5205956|NCT01019928|12799795|P1|NOT COMPLETED|Period 2||0
5205957|NCT01019928|12799794|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
5205958|NCT01019928|12799795|P1|COMPLETED|Period 2||7
5205959|NCT01019928|12799794|P2|STARTED|Period 2||7
5205960|NCT01019928|12799795|P1|STARTED|Period 2||7
5205961|NCT01019928|12799794|P2|NOT COMPLETED|Period 1||0
5205962|NCT01019928|12799795|P1|NOT COMPLETED|Period 1||0
5205963|NCT01019928|12799794|P2|COMPLETED|Period 1||7
5205964|NCT01019928|12799795|P1|COMPLETED|Period 1||7
5205965|NCT01019928|12799794|P2|STARTED|Period 1||7
5205966|NCT01019928|12799795|P1|STARTED|Period 1||7
5205967|NCT01019707|12799835|P2|NOT COMPLETED|Second Phase||0
5205968|NCT01019707|12799836|P1|NOT COMPLETED|Second Phase||0
5205969|NCT01019707|12799835|P2|COMPLETED|Second Phase||1
5205970|NCT01019707|12799836|P1|COMPLETED|Second Phase||3
5205971|NCT01019707|12799835|P2|STARTED|Second Phase||1
5205972|NCT01019707|12799836|P1|STARTED|Second Phase||3
5205973|NCT01019707|12799835|P2|NOT COMPLETED|Washout||2
5205974|NCT01019707|12799836|P1|NOT COMPLETED|Washout||0
5205975|NCT01019707|12799835|P2|COMPLETED|Washout||1
5205976|NCT01019707|12799836|P1|COMPLETED|Washout||3
5205977|NCT01019707|12799835|P2|STARTED|Washout||3
5205978|NCT01019707|12799836|P1|STARTED|Washout||3
5205979|NCT01019707|12799835|P2|NOT COMPLETED|First Phase||0
5205980|NCT01019707|12799836|P1|NOT COMPLETED|First Phase||0
5205981|NCT01019707|12799835|P2|COMPLETED|First Phase||3
5205982|NCT01019707|12799836|P1|COMPLETED|First Phase||3
5205983|NCT01019707|12799835|P2|STARTED|First Phase||3
5205984|NCT01019707|12799836|P1|STARTED|First Phase||3
5205985|NCT01019694|12799849|P3|NOT COMPLETED|Overall Study||47
5205986|NCT01019694|12799850|P2|NOT COMPLETED|Overall Study||38
5205987|NCT01019694|12799851|P1|NOT COMPLETED|Overall Study||24
5205988|NCT01019694|12799849|P3|COMPLETED|Overall Study||110
5205989|NCT01019694|12799850|P2|COMPLETED|Overall Study||118
5205990|NCT01019694|12799851|P1|COMPLETED|Overall Study||133
5205991|NCT01019694|12799849|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
5205992|NCT01019694|12799850|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
5205993|NCT01019694|12799851|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
5205994|NCT01019486|12799976|P3|NOT COMPLETED|Overall Study||1
5205995|NCT01019486|12799977|P2|NOT COMPLETED|Overall Study||1
5205996|NCT01019486|12799978|P1|NOT COMPLETED|Overall Study||1
5205997|NCT01019486|12799976|P3|COMPLETED|Overall Study||15
5205998|NCT01019486|12799977|P2|COMPLETED|Overall Study||4
5205999|NCT01019486|12799978|P1|COMPLETED|Overall Study||4
5206000|NCT01019486|12799976|P3|STARTED|Overall Study||16
5206001|NCT01019486|12799977|P2|STARTED|Overall Study||5
5206002|NCT01019486|12799978|P1|STARTED|Overall Study||5
5206003|NCT01019369|12799992|P2|NOT COMPLETED|Overall Study||7
5206004|NCT01019369|12799993|P1|NOT COMPLETED|Overall Study||10
5206005|NCT01019369|12799992|P2|COMPLETED|Overall Study||39
5206006|NCT01019369|12799993|P1|COMPLETED|Overall Study||76
5206007|NCT01019369|12799992|P2|STARTED|Overall Study||46
5206008|NCT01019369|12799993|P1|STARTED|Overall Study||86
5206009|NCT01019317|12800009|P1|NOT COMPLETED|Overall Study||4
5206010|NCT01019317|12800009|P1|COMPLETED|Overall Study||147
5206011|NCT01019317|12800009|P1|STARTED|Overall Study||151
5206012|NCT01019252|12800015|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
5206013|NCT01019252|12800016|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
5206014|NCT01019252|12800015|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
5206015|NCT01019252|12800016|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
5206016|NCT01019252|12800015|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
5206017|NCT01019252|12800016|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
5206018|NCT01019252|12800015|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
5206019|NCT01019252|12800016|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
5206020|NCT01019252|12800015|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
5206021|NCT01019252|12800016|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
5206022|NCT01019252|12800015|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
5206023|NCT01019252|12800016|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
5206024|NCT01019135|12800029|P3|NOT COMPLETED|Overall Study||31
5206025|NCT01019135|12800030|P2|NOT COMPLETED|Overall Study||19
5206026|NCT01019135|12800031|P1|NOT COMPLETED|Overall Study||20
5206027|NCT01019135|12800029|P3|COMPLETED|Overall Study||24
5206028|NCT01019135|12800030|P2|COMPLETED|Overall Study||40
5206029|NCT01019135|12800031|P1|COMPLETED|Overall Study||35
5206030|NCT01019135|12800029|P3|STARTED|Overall Study||55
5206031|NCT01019135|12800030|P2|STARTED|Overall Study||59
5206032|NCT01019135|12800031|P1|STARTED|Overall Study||55
5206033|NCT01018992|12800059|P2|NOT COMPLETED|Overall Study||16
5206034|NCT01018992|12800060|P1|NOT COMPLETED|Overall Study||16
5206035|NCT01018992|12800059|P2|COMPLETED|Overall Study||49
5206036|NCT01018992|12800060|P1|COMPLETED|Overall Study||47
5206037|NCT01018992|12800059|P2|STARTED|Overall Study||65
5206038|NCT01018992|12800060|P1|STARTED|Overall Study||63
5206039|NCT01018979|12800074|P2|NOT COMPLETED|Overall Study||10
5206040|NCT01018979|12800075|P1|NOT COMPLETED|Overall Study||3
5206041|NCT01018979|12800074|P2|COMPLETED|Overall Study||3
5206042|NCT01018979|12800075|P1|COMPLETED|Overall Study||4
5206043|NCT01018979|12800074|P2|Received at Least One Dose|Overall Study||12
5206044|NCT01018979|12800075|P1|Received at Least One Dose|Overall Study||7
5206045|NCT01018979|12800074|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
5206046|NCT01018979|12800075|P1|STARTED|Overall Study||7
5206047|NCT01018953|12800105|P1|NOT COMPLETED|Overall Study||8
5206048|NCT01018953|12800105|P1|COMPLETED|Overall Study||0
5206049|NCT01018953|12800105|P1|BIM 23A760 4 mg|Overall Study||3
5206050|NCT01018953|12800105|P1|BIM 23A760 2 mg|Overall Study||2
5206051|NCT01018953|12800105|P1|BIM 23A760 1 mg|Overall Study||3
5206052|NCT01018953|12800105|P1|STARTED|Overall Study||8
5206053|NCT01018862|12800118|P3|NOT COMPLETED|Overall Study||16
5206054|NCT01018862|12800119|P2|NOT COMPLETED|Overall Study||10
5206055|NCT01018862|12800120|P1|NOT COMPLETED|Overall Study||13
5206056|NCT01018862|12800118|P3|COMPLETED|Overall Study||146
5206057|NCT01018862|12800119|P2|COMPLETED|Overall Study||156
5206058|NCT01018862|12800120|P1|COMPLETED|Overall Study||148
5206059|NCT01018862|12800118|P3|STARTED|Overall Study||162
5206060|NCT01018862|12800119|P2|STARTED|Overall Study||166
5206061|NCT01018862|12800120|P1|STARTED|Overall Study||161
5206062|NCT01018810|12800142|P5|NOT COMPLETED|Overall Study||1
5206063|NCT01018810|12800143|P4|NOT COMPLETED|Overall Study||1
5206064|NCT01018810|12800144|P3|NOT COMPLETED|Overall Study||1
5206065|NCT01018810|12800145|P2|NOT COMPLETED|Overall Study||1
5206066|NCT01018810|12800146|P1|NOT COMPLETED|Overall Study||2
5206067|NCT01018810|12800142|P5|COMPLETED|Overall Study||0
5206068|NCT01018810|12800143|P4|COMPLETED|Overall Study||0
5206069|NCT01018810|12800144|P3|COMPLETED|Overall Study||0
5206070|NCT01018810|12800145|P2|COMPLETED|Overall Study||0
5206071|NCT01018810|12800146|P1|COMPLETED|Overall Study||2
5206072|NCT01018810|12800142|P5|STARTED|Overall Study||1
5206073|NCT01018810|12800143|P4|STARTED|Overall Study||1
5206074|NCT01018810|12800144|P3|STARTED|Overall Study||1
5206075|NCT01018810|12800145|P2|STARTED|Overall Study||1
5206076|NCT01018810|12800146|P1|STARTED|Overall Study||4
5206077|NCT01018732|12800206|P3|NOT COMPLETED|Overall Study||4
5206078|NCT01018732|12800207|P2|NOT COMPLETED|Overall Study||2
5206079|NCT01018732|12800208|P1|NOT COMPLETED|Overall Study||1
5206080|NCT01018732|12800206|P3|COMPLETED|Overall Study||50
5206081|NCT01018732|12800207|P2|COMPLETED|Overall Study||49
5206082|NCT01018732|12800208|P1|COMPLETED|Overall Study||49
5206083|NCT01018732|12800206|P3|STARTED|Overall Study||54
5206084|NCT01018732|12800207|P2|STARTED|Overall Study||51
5206085|NCT01018732|12800208|P1|STARTED|Overall Study||50
5206086|NCT01018680|12800242|P2|NOT COMPLETED|Overall Study||75
5206087|NCT01018680|12800243|P1|NOT COMPLETED|Overall Study||61
5206088|NCT01018680|12800242|P2|COMPLETED|Overall Study||189
5206089|NCT01018680|12800243|P1|COMPLETED|Overall Study||199
5206090|NCT01018680|12800242|P2|STARTED|Overall Study||264
5206091|NCT01018680|12800243|P1|STARTED|Overall Study||260
5206092|NCT01020487|12800286|P3|NOT COMPLETED|Part 2 Open-label Period||1
5206093|NCT01020487|12800287|P2|NOT COMPLETED|Part 2 Open-label Period||4
5206094|NCT01020487|12800288|P1|NOT COMPLETED|Part 2 Open-label Period||0
5206095|NCT01020487|12800286|P3|COMPLETED|Part 2 Open-label Period||12
5206096|NCT01020487|12800287|P2|COMPLETED|Part 2 Open-label Period||12
5206097|NCT01020487|12800288|P1|COMPLETED|Part 2 Open-label Period||0
5206098|NCT01020487|12800286|P3|STARTED|Part 2 Open-label Period||13
5206099|NCT01020487|12800287|P2|STARTED|Part 2 Open-label Period||16
5206100|NCT01020487|12800288|P1|STARTED|Part 2 Open-label Period||0
5206101|NCT01020487|12800286|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
5206102|NCT01020487|12800287|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
5206103|NCT01020487|12800288|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
5206104|NCT01020487|12800286|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
5206105|NCT01020487|12800287|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
5206106|NCT01020487|12800288|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
5206107|NCT01020487|12800286|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
5206108|NCT01020487|12800287|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
5206109|NCT01020487|12800288|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
5206110|NCT01020487|12800286|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
5206111|NCT01020487|12800287|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
5206112|NCT01020487|12800288|P1|STARTED|Part 2 Double-blind Treatment Period||0
5206113|NCT01020487|12800286|P3|NOT COMPLETED|Part 1||0
5206114|NCT01020487|12800287|P2|NOT COMPLETED|Part 1||0
5206115|NCT01020487|12800288|P1|NOT COMPLETED|Part 1||0
5206116|NCT01020487|12800286|P3|COMPLETED|Part 1||0
5206117|NCT01020487|12800287|P2|COMPLETED|Part 1||0
5206118|NCT01020487|12800288|P1|COMPLETED|Part 1||12
5206119|NCT01020487|12800286|P3|STARTED|Part 1||0
5206120|NCT01020487|12800287|P2|STARTED|Part 1||0
5206121|NCT01020487|12800288|P1|STARTED|Part 1||12
5206122|NCT01018511|12800313|P4|NOT COMPLETED|Overall Study||33
5206123|NCT01018511|12800314|P3|NOT COMPLETED|Overall Study||40
5206124|NCT01018511|12800315|P2|NOT COMPLETED|Overall Study||32
5206125|NCT01018511|12800316|P1|NOT COMPLETED|Overall Study||26
5206126|NCT01018511|12800313|P4|COMPLETED|Overall Study||294
5206127|NCT01018511|12800314|P3|COMPLETED|Overall Study||299
5206128|NCT01018511|12800315|P2|COMPLETED|Overall Study||295
5206129|NCT01018511|12800316|P1|COMPLETED|Overall Study||315
5206130|NCT01018511|12800313|P4|Randomized and Treated|Overall Study||324
5206131|NCT01018511|12800314|P3|Randomized and Treated|Overall Study||338
5206132|NCT01018511|12800315|P2|Randomized and Treated|Overall Study||326
5206133|NCT01018511|12800316|P1|Randomized and Treated|Overall Study||341
5206134|NCT01018511|12800313|P4|STARTED|Overall Study||327
5206135|NCT01018511|12800314|P3|STARTED|Overall Study||339
5206136|NCT01018511|12800315|P2|STARTED|Overall Study||327
5206137|NCT01018511|12800316|P1|STARTED|Overall Study||341
5206138|NCT01018420|12800485|P2|NOT COMPLETED|Overall Study||0
5206139|NCT01018420|12800486|P1|NOT COMPLETED|Overall Study||0
5206140|NCT01018420|12800485|P2|COMPLETED|Overall Study||3
5206141|NCT01018420|12800486|P1|COMPLETED|Overall Study||15
5206142|NCT01018420|12800485|P2|STARTED|Overall Study||3
5206143|NCT01018420|12800486|P1|STARTED|Overall Study||15
5206144|NCT01018394|12800513|P2|NOT COMPLETED|Overall Study||8
5206145|NCT01018394|12800514|P1|NOT COMPLETED|Overall Study||9
5206146|NCT01018394|12800513|P2|COMPLETED|Overall Study||33
5206147|NCT01018394|12800514|P1|COMPLETED|Overall Study||31
5206148|NCT01018394|12800513|P2|STARTED|Overall Study||41
5206149|NCT01018394|12800514|P1|STARTED|Overall Study||40
5206150|NCT01018264|12800524|P2|NOT COMPLETED|Overall Study||1
5206151|NCT01018264|12800525|P1|NOT COMPLETED|Overall Study||1
5206152|NCT01018264|12800524|P2|COMPLETED|Overall Study||12
5206153|NCT01018264|12800525|P1|COMPLETED|Overall Study||9
5206154|NCT01018264|12800524|P2|STARTED|Overall Study||13
5206155|NCT01018264|12800525|P1|STARTED|Overall Study||10
5206156|NCT01018186|12800542|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
5206157|NCT01018186|12800543|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
5206158|NCT01018186|12800544|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
5206159|NCT01018186|12800545|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
5206160|NCT01018186|12800542|P4|COMPLETED|52-week Double-blind Treatment Period||71
5206161|NCT01018186|12800543|P3|COMPLETED|52-week Double-blind Treatment Period||161
5206162|NCT01018186|12800544|P2|COMPLETED|52-week Double-blind Treatment Period||161
5206163|NCT01018186|12800545|P1|COMPLETED|52-week Double-blind Treatment Period||0
5206164|NCT01018186|12800542|P4|STARTED|52-week Double-blind Treatment Period||100
5206165|NCT01018186|12800543|P3|STARTED|52-week Double-blind Treatment Period||202
5206166|NCT01018186|12800544|P2|STARTED|52-week Double-blind Treatment Period||201
5206167|NCT01018186|12800545|P1|STARTED|52-week Double-blind Treatment Period||0
5206168|NCT01018186|12800542|P4|NOT COMPLETED|2-week Run-in Period||0
5206169|NCT01018186|12800543|P3|NOT COMPLETED|2-week Run-in Period||0
5206170|NCT01018186|12800544|P2|NOT COMPLETED|2-week Run-in Period||0
5206171|NCT01018186|12800545|P1|NOT COMPLETED|2-week Run-in Period||114
5206172|NCT01018186|12800542|P4|COMPLETED|2-week Run-in Period||0
5206173|NCT01018186|12800543|P3|COMPLETED|2-week Run-in Period||0
5206174|NCT01018186|12800544|P2|COMPLETED|2-week Run-in Period||0
5206175|NCT01018186|12800545|P1|COMPLETED|2-week Run-in Period||503
5206176|NCT01018186|12800542|P4|STARTED|2-week Run-in Period||0
5206177|NCT01018186|12800543|P3|STARTED|2-week Run-in Period||0
5206178|NCT01018186|12800544|P2|STARTED|2-week Run-in Period||0
5206179|NCT01018186|12800545|P1|STARTED|2-week Run-in Period||617
5206180|NCT01018134|12800637|P6|NOT COMPLETED|Overall Study||0
5206181|NCT01018134|12800638|P5|NOT COMPLETED|Overall Study||0
5206182|NCT01018134|12800639|P4|NOT COMPLETED|Overall Study||0
5206183|NCT01018134|12800640|P3|NOT COMPLETED|Overall Study||1
5206184|NCT01018134|12800641|P2|NOT COMPLETED|Overall Study||1
5206185|NCT01018134|12800642|P1|NOT COMPLETED|Overall Study||0
5206186|NCT01018134|12800637|P6|COMPLETED|Overall Study||15
5206187|NCT01018134|12800638|P5|COMPLETED|Overall Study||15
5206188|NCT01018134|12800639|P4|COMPLETED|Overall Study||29
5206189|NCT01018134|12800640|P3|COMPLETED|Overall Study||29
5206190|NCT01018134|12800641|P2|COMPLETED|Overall Study||30
5206191|NCT01018134|12800642|P1|COMPLETED|Overall Study||30
5206192|NCT01018134|12800637|P6|STARTED|Overall Study||15
5206193|NCT01018134|12800638|P5|STARTED|Overall Study||15
5206194|NCT01018134|12800639|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
5206195|NCT01018134|12800640|P3|STARTED|Overall Study||30
5206196|NCT01018134|12800641|P2|STARTED|Overall Study||31
5206197|NCT01018134|12800642|P1|STARTED|Overall Study||30
5206198|NCT01018095|12800682|P2|NOT COMPLETED|Overall Study||62
5206199|NCT01018095|12800683|P1|NOT COMPLETED|Overall Study||56
5206200|NCT01018095|12800682|P2|COMPLETED|Overall Study||73
5206201|NCT01018095|12800683|P1|COMPLETED|Overall Study||79
5206202|NCT01018095|12800682|P2|STARTED|Overall Study||135
5206203|NCT01018095|12800683|P1|STARTED|Overall Study||135
5206204|NCT01018056|12800694|P3|NOT COMPLETED|Overall Study||1
5206205|NCT01018056|12800695|P2|NOT COMPLETED|Overall Study||2
5206206|NCT01018056|12800696|P1|NOT COMPLETED|Overall Study||3
5206207|NCT01018056|12800694|P3|COMPLETED|Overall Study||5
5206208|NCT01018056|12800695|P2|COMPLETED|Overall Study||10
5206209|NCT01018056|12800696|P1|COMPLETED|Overall Study||9
5206210|NCT01018056|12800694|P3|STARTED|Overall Study||6
5206211|NCT01018056|12800695|P2|STARTED|Overall Study||12
5206212|NCT01018056|12800696|P1|STARTED|Overall Study||12
5206213|NCT01018030|12800746|P3|NOT COMPLETED|Overall Study||13
5206214|NCT01018030|12800747|P2|NOT COMPLETED|Overall Study||11
5206215|NCT01018030|12800748|P1|NOT COMPLETED|Overall Study||19
5206216|NCT01018030|12800746|P3|COMPLETED|Overall Study||239
5206217|NCT01018030|12800747|P2|COMPLETED|Overall Study||232
5206218|NCT01018030|12800748|P1|COMPLETED|Overall Study||227
5206219|NCT01018030|12800746|P3|STARTED|Overall Study||252
5206220|NCT01018030|12800747|P2|STARTED|Overall Study||243
5206221|NCT01018030|12800748|P1|STARTED|Overall Study||246
5206222|NCT01017952|12800799|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
5206223|NCT01017952|12800800|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
5206224|NCT01017952|12800801|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
5206225|NCT01017952|12800802|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
5206226|NCT01017952|12800803|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
5206227|NCT01017952|12800799|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
5206228|NCT01017952|12800800|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
5206229|NCT01017952|12800801|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
5206230|NCT01017952|12800802|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
5206231|NCT01017952|12800803|P1|COMPLETED|52-week, Double-blind Treatment Period||0
5206232|NCT01017952|12800799|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
5206233|NCT01017952|12800800|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
5206234|NCT01017952|12800801|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
5206319|NCT01017237|12801001|P2|STARTED|Overall Study||8
5206320|NCT01017237|12801002|P1|STARTED|Overall Study||10
5206235|NCT01017952|12800802|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
5206236|NCT01017952|12800803|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
5206237|NCT01017952|12800799|P5|STARTED|52-week, Double-blind Treatment Period||409
5206238|NCT01017952|12800800|P4|STARTED|52-week, Double-blind Treatment Period||403
5206239|NCT01017952|12800801|P3|STARTED|52-week, Double-blind Treatment Period||412
5206240|NCT01017952|12800802|P2|STARTED|52-week, Double-blind Treatment Period||409
5206241|NCT01017952|12800803|P1|STARTED|52-week, Double-blind Treatment Period||0
5206242|NCT01017952|12800799|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
5206243|NCT01017952|12800800|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
5206244|NCT01017952|12800801|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
5206245|NCT01017952|12800802|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
5206246|NCT01017952|12800803|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
5206247|NCT01017952|12800799|P5|COMPLETED|4-week, Open-label Run-In Period||0
5206248|NCT01017952|12800800|P4|COMPLETED|4-week, Open-label Run-In Period||0
5206249|NCT01017952|12800801|P3|COMPLETED|4-week, Open-label Run-In Period||0
5206250|NCT01017952|12800802|P2|COMPLETED|4-week, Open-label Run-In Period||0
5206251|NCT01017952|12800803|P1|COMPLETED|4-week, Open-label Run-In Period||1633
5206252|NCT01017952|12800799|P5|STARTED|4-week, Open-label Run-In Period||0
5206253|NCT01017952|12800800|P4|STARTED|4-week, Open-label Run-In Period||0
5206254|NCT01017952|12800801|P3|STARTED|4-week, Open-label Run-In Period||0
5206255|NCT01017952|12800802|P2|STARTED|4-week, Open-label Run-In Period||0
5206256|NCT01017952|12800803|P1|STARTED|4-week, Open-label Run-In Period||2092
5206257|NCT01017874|12800827|P2|NOT COMPLETED|Overall Study||26
5206258|NCT01017874|12800828|P1|NOT COMPLETED|Overall Study||30
5206259|NCT01017874|12800827|P2|COMPLETED|Overall Study||92
5206260|NCT01017874|12800828|P1|COMPLETED|Overall Study||88
5206261|NCT01017874|12800827|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
5206262|NCT01017874|12800828|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
5206263|NCT01017874|12800827|P2|STARTED|Overall Study||118
5206264|NCT01017874|12800828|P1|STARTED|Overall Study||118
5206265|NCT01017731|12800846|P1|NOT COMPLETED|Overall Study||8
5206266|NCT01017731|12800846|P1|COMPLETED|Overall Study||60
5206267|NCT01017731|12800846|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
5206268|NCT01017731|12800846|P1|STARTED|Overall Study||68
5206269|NCT01017653|12800863|P1|NOT COMPLETED|Overall Study||0
5206270|NCT01017653|12800863|P1|COMPLETED|Overall Study||16
5206271|NCT01017653|12800863|P1|STARTED|Overall Study||16
5206272|NCT01017601|12800875|P2|NOT COMPLETED|Overall Study||13
5206273|NCT01017601|12800876|P1|NOT COMPLETED|Overall Study||12
5206274|NCT01017601|12800875|P2|COMPLETED|Overall Study||11
5206275|NCT01017601|12800876|P1|COMPLETED|Overall Study||14
5206276|NCT01017601|12800875|P2|STARTED|Overall Study||24
5206277|NCT01017601|12800876|P1|STARTED|Overall Study||26
5206278|NCT01017575|12800903|P5|NOT COMPLETED|Overall Study||3
5206279|NCT01017575|12800904|P4|NOT COMPLETED|Overall Study||1
5206280|NCT01017575|12800905|P3|NOT COMPLETED|Overall Study||0
5206281|NCT01017575|12800906|P2|NOT COMPLETED|Overall Study||2
5206282|NCT01017575|12800907|P1|NOT COMPLETED|Overall Study||1
5206283|NCT01017575|12800903|P5|COMPLETED|Overall Study||6
5206284|NCT01017575|12800904|P4|COMPLETED|Overall Study||7
5206285|NCT01017575|12800905|P3|COMPLETED|Overall Study||8
5206286|NCT01017575|12800906|P2|COMPLETED|Overall Study||7
5206287|NCT01017575|12800907|P1|COMPLETED|Overall Study||7
5206288|NCT01017575|12800903|P5|STARTED|Overall Study||9
5206289|NCT01017575|12800904|P4|STARTED|Overall Study||8
5206290|NCT01017575|12800905|P3|STARTED|Overall Study||8
5206291|NCT01017575|12800906|P2|STARTED|Overall Study||9
5206292|NCT01017575|12800907|P1|STARTED|Overall Study||8
5206293|NCT01017549|12800944|P1|NOT COMPLETED|One-year Follow-up||7
5206294|NCT01017549|12800944|P1|COMPLETED|One-year Follow-up||36
5206295|NCT01017549|12800944|P1|STARTED|One-year Follow-up||43
5206296|NCT01017549|12800944|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
5206297|NCT01017549|12800944|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
5206298|NCT01017549|12800944|P1|STARTED|Eligibility Through 6 Month Follow-up||44
5206299|NCT01017536|12800951|P2|NOT COMPLETED|Overall Study||0
5206300|NCT01017536|12800952|P1|NOT COMPLETED|Overall Study||0
5206301|NCT01017536|12800951|P2|COMPLETED|Overall Study||13
5206302|NCT01017536|12800952|P1|COMPLETED|Overall Study||13
5206303|NCT01017536|12800951|P2|STARTED|Overall Study||13
5206304|NCT01017536|12800952|P1|STARTED|Overall Study||13
5206305|NCT01017497|12800962|P1|NOT COMPLETED|Overall Study||0
5206306|NCT01017497|12800962|P1|COMPLETED|Overall Study||49
5206307|NCT01017497|12800962|P1|STARTED|Overall Study||49
5206308|NCT01017263|12800975|P1|NOT COMPLETED|Overall Study||12
5206309|NCT01017263|12800975|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
5206310|NCT01017263|12800975|P1|STARTED|Overall Study||14
5206311|NCT01017250|12800979|P1|NOT COMPLETED|Overall Study||0
5206312|NCT01017250|12800979|P1|COMPLETED|Overall Study||15
5206313|NCT01017250|12800979|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
5206314|NCT01017250|12800979|P1|STARTED|Overall Study||15
5206315|NCT01017237|12801001|P2|NOT COMPLETED|Overall Study||2
5206316|NCT01017237|12801002|P1|NOT COMPLETED|Overall Study||5
5206317|NCT01017237|12801001|P2|COMPLETED|Overall Study||6
5206318|NCT01017237|12801002|P1|COMPLETED|Overall Study||5
5206321|NCT01017146|12801056|P2|NOT COMPLETED|Overall Study||39
5206322|NCT01017146|12801057|P1|NOT COMPLETED|Overall Study||66
5206323|NCT01017146|12801056|P2|COMPLETED|Overall Study||333
5206324|NCT01017146|12801057|P1|COMPLETED|Overall Study||306
5206325|NCT01017146|12801056|P2|STARTED|Overall Study||372
5206326|NCT01017146|12801057|P1|STARTED|Overall Study||372
5206327|NCT01017120|12801095|P2|NOT COMPLETED|Overall Study||35
5206328|NCT01017120|12801096|P1|NOT COMPLETED|Overall Study||66
5206329|NCT01017120|12801095|P2|COMPLETED|Overall Study||334
5206330|NCT01017120|12801096|P1|COMPLETED|Overall Study||307
5206331|NCT01017120|12801095|P2|STARTED|Overall Study||369
5206332|NCT01017120|12801096|P1|STARTED|Overall Study||373
5206333|NCT01017042|12801144|P1|NOT COMPLETED|Overall Study||0
5206334|NCT01017042|12801144|P1|COMPLETED|Overall Study||13
5206335|NCT01017042|12801144|P1|STARTED|Overall Study||13
5206336|NCT01017029|12801157|P2|NOT COMPLETED|Overall Study||2
5206337|NCT01017029|12801158|P1|NOT COMPLETED|Overall Study||4
5206338|NCT01017029|12801157|P2|COMPLETED|Overall Study||90
5206339|NCT01017029|12801158|P1|COMPLETED|Overall Study||85
5206340|NCT01017029|12801157|P2|STARTED|Overall Study||92
5206341|NCT01017029|12801158|P1|STARTED|Overall Study||89
5206342|NCT01017003|12801174|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
5206343|NCT01017003|12801174|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
5206344|NCT01017003|12801174|P1|STARTED|Colchicine 0.6 mg Final Dose||13
5206345|NCT01017003|12801174|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
5206346|NCT01017003|12801174|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
5206347|NCT01017003|12801174|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
5206348|NCT01017003|12801174|P1|NOT COMPLETED|14 Day Washout Period||0
5206349|NCT01017003|12801174|P1|COMPLETED|14 Day Washout Period||13
5206350|NCT01017003|12801174|P1|STARTED|14 Day Washout Period||13
5206351|NCT01017003|12801174|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
5206352|NCT01017003|12801174|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
5206353|NCT01017003|12801174|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
5206354|NCT01016977|12801186|P2|NOT COMPLETED|Overall Study||2
5206355|NCT01016977|12801187|P1|NOT COMPLETED|Overall Study||3
5206356|NCT01016977|12801186|P2|COMPLETED|Overall Study||18
5206357|NCT01016977|12801187|P1|COMPLETED|Overall Study||17
5206358|NCT01016977|12801186|P2|STARTED|Overall Study||20
5206359|NCT01016977|12801187|P1|STARTED|Overall Study||20
5206360|NCT01016964|12801223|P2|NOT COMPLETED|Overall Study||3
5206361|NCT01016964|12801224|P1|NOT COMPLETED|Overall Study||3
5206362|NCT01016964|12801223|P2|COMPLETED|Overall Study||39
5206363|NCT01016964|12801224|P1|COMPLETED|Overall Study||18
5206364|NCT01016964|12801223|P2|STARTED|Overall Study||42
5206365|NCT01016964|12801224|P1|STARTED|Overall Study||21
5206366|NCT01016938|12801230|P1|NOT COMPLETED|Overall Study||9
5206367|NCT01016938|12801230|P1|COMPLETED|Overall Study||7
5206368|NCT01016938|12801230|P1|STARTED|Overall Study||16
5206369|NCT01016912|12801240|P5|NOT COMPLETED|Follow-up Period||0
5206370|NCT01016912|12801241|P4|NOT COMPLETED|Follow-up Period||1
5206371|NCT01016912|12801242|P3|NOT COMPLETED|Follow-up Period||1
5206372|NCT01016912|12801243|P2|NOT COMPLETED|Follow-up Period||0
5206373|NCT01016912|12801244|P1|NOT COMPLETED|Follow-up Period||0
5206374|NCT01016912|12801240|P5|COMPLETED|Follow-up Period||9
5206375|NCT01016912|12801241|P4|COMPLETED|Follow-up Period||8
5206376|NCT01016912|12801242|P3|COMPLETED|Follow-up Period||9
5206377|NCT01016912|12801243|P2|COMPLETED|Follow-up Period||9
5206378|NCT01016912|12801244|P1|COMPLETED|Follow-up Period||8
5206379|NCT01016912|12801240|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
5206380|NCT01016912|12801241|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
5206381|NCT01016912|12801242|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
5206382|NCT01016912|12801243|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
5206383|NCT01016912|12801244|P1|STARTED|Follow-up Period||8
5206384|NCT01016912|12801240|P5|NOT COMPLETED|End of Treatment Period||4
5206385|NCT01016912|12801241|P4|NOT COMPLETED|End of Treatment Period||4
5206386|NCT01016912|12801242|P3|NOT COMPLETED|End of Treatment Period||1
5206387|NCT01016912|12801243|P2|NOT COMPLETED|End of Treatment Period||3
5206388|NCT01016912|12801244|P1|NOT COMPLETED|End of Treatment Period||0
5206389|NCT01016912|12801240|P5|COMPLETED|End of Treatment Period||5
5206390|NCT01016912|12801241|P4|COMPLETED|End of Treatment Period||5
5206391|NCT01016912|12801242|P3|COMPLETED|End of Treatment Period||9
5206392|NCT01016912|12801243|P2|COMPLETED|End of Treatment Period||6
5206393|NCT01016912|12801244|P1|COMPLETED|End of Treatment Period||8
5206394|NCT01016912|12801240|P5|Received Treatment|End of Treatment Period||9
5206395|NCT01016912|12801241|P4|Received Treatment|End of Treatment Period||9
5206396|NCT01016912|12801242|P3|Received Treatment|End of Treatment Period||10
5206397|NCT01016912|12801243|P2|Received Treatment|End of Treatment Period||9
5206398|NCT01016912|12801244|P1|Received Treatment|End of Treatment Period||8
5206399|NCT01016912|12801240|P5|STARTED|End of Treatment Period||9
5206400|NCT01016912|12801241|P4|STARTED|End of Treatment Period||9
5206401|NCT01016912|12801242|P3|STARTED|End of Treatment Period||10
5206402|NCT01016912|12801243|P2|STARTED|End of Treatment Period||9
5206403|NCT01016912|12801244|P1|STARTED|End of Treatment Period||8
5206404|NCT01016873|12801289|P3|NOT COMPLETED|36 Months||6
5206405|NCT01016873|12801290|P2|NOT COMPLETED|36 Months||4
5206406|NCT01016873|12801291|P1|NOT COMPLETED|36 Months||11
5206407|NCT01016873|12801289|P3|COMPLETED|36 Months||67
5206408|NCT01016873|12801290|P2|COMPLETED|36 Months||64
5206409|NCT01016873|12801291|P1|COMPLETED|36 Months||58
5206410|NCT01016873|12801289|P3|STARTED|36 Months||73
5206411|NCT01016873|12801290|P2|STARTED|36 Months||68
5206412|NCT01016873|12801291|P1|STARTED|36 Months||69
5206413|NCT01016873|12801289|P3|NOT COMPLETED|24 Months||6
5206414|NCT01016873|12801290|P2|NOT COMPLETED|24 Months||4
5206415|NCT01016873|12801291|P1|NOT COMPLETED|24 Months||5
5206416|NCT01016873|12801289|P3|COMPLETED|24 Months||73
5206417|NCT01016873|12801290|P2|COMPLETED|24 Months||68
5206418|NCT01016873|12801291|P1|COMPLETED|24 Months||69
5206419|NCT01016873|12801289|P3|STARTED|24 Months||79
5206420|NCT01016873|12801290|P2|STARTED|24 Months||72
5206421|NCT01016873|12801291|P1|STARTED|24 Months||74
5206422|NCT01016873|12801289|P3|NOT COMPLETED|12 Months||1
5206423|NCT01016873|12801290|P2|NOT COMPLETED|12 Months||3
5206424|NCT01016873|12801291|P1|NOT COMPLETED|12 Months||1
5206425|NCT01016873|12801289|P3|COMPLETED|12 Months||79
5206426|NCT01016873|12801290|P2|COMPLETED|12 Months||72
5206427|NCT01016873|12801291|P1|COMPLETED|12 Months||74
5206428|NCT01016873|12801289|P3|STARTED|12 Months||80
5206429|NCT01016873|12801290|P2|STARTED|12 Months||75
5206430|NCT01016873|12801291|P1|STARTED|12 Months||75
5206431|NCT01016847|12801322|P2|NOT COMPLETED|Overall Study||0
5206432|NCT01016847|12801323|P1|NOT COMPLETED|Overall Study||0
5206433|NCT01016847|12801322|P2|COMPLETED|Overall Study||2
5206434|NCT01016847|12801323|P1|COMPLETED|Overall Study||1
5206435|NCT01016847|12801322|P2|STARTED|Overall Study||2
5206436|NCT01016847|12801323|P1|STARTED|Overall Study||1
5206437|NCT01016834|12801339|P1|NOT COMPLETED|Overall Study||22
5206438|NCT01016834|12801339|P1|COMPLETED|Overall Study||220
5206439|NCT01016834|12801339|P1|STARTED|Overall Study||242
5206440|NCT01016769|12801349|P4|NOT COMPLETED|Overall Study||0
5206441|NCT01016769|12801350|P3|NOT COMPLETED|Overall Study||1
5206442|NCT01016769|12801351|P2|NOT COMPLETED|Overall Study||1
5206443|NCT01016769|12801352|P1|NOT COMPLETED|Overall Study||1
5206444|NCT01016769|12801349|P4|COMPLETED|Overall Study||30
5206445|NCT01016769|12801350|P3|COMPLETED|Overall Study||6
5206446|NCT01016769|12801351|P2|COMPLETED|Overall Study||6
5206447|NCT01016769|12801352|P1|COMPLETED|Overall Study||3
5206448|NCT01016769|12801349|P4|STARTED|Overall Study||30
5206449|NCT01016769|12801350|P3|STARTED|Overall Study||7
5206450|NCT01016769|12801351|P2|STARTED|Overall Study||7
5206451|NCT01016769|12801352|P1|STARTED|Overall Study||4
5206452|NCT01016691|12801366|P3|NOT COMPLETED|Overall Study||0
5206453|NCT01016691|12801367|P2|NOT COMPLETED|Overall Study||0
5206454|NCT01016691|12801368|P1|NOT COMPLETED|Overall Study||0
5206455|NCT01016691|12801366|P3|COMPLETED|Overall Study||18
5206456|NCT01016691|12801367|P2|COMPLETED|Overall Study||12
5206457|NCT01016691|12801368|P1|COMPLETED|Overall Study||17
5206458|NCT01016691|12801366|P3|STARTED|Overall Study||18
5206459|NCT01016691|12801367|P2|STARTED|Overall Study||12
5206460|NCT01016691|12801368|P1|STARTED|Overall Study||17
5206461|NCT01016678|12801376|P5|NOT COMPLETED|Overall Study||6
5206462|NCT01016678|12801377|P4|NOT COMPLETED|Overall Study||0
5206463|NCT01016678|12801378|P3|NOT COMPLETED|Overall Study||4
5206464|NCT01016678|12801379|P2|NOT COMPLETED|Overall Study||3
5206465|NCT01016678|12801380|P1|NOT COMPLETED|Overall Study||2
5206466|NCT01016678|12801376|P5|COMPLETED|Overall Study||13
5206467|NCT01016678|12801377|P4|COMPLETED|Overall Study||19
5206468|NCT01016678|12801378|P3|COMPLETED|Overall Study||15
5206469|NCT01016678|12801379|P2|COMPLETED|Overall Study||14
5206470|NCT01016678|12801380|P1|COMPLETED|Overall Study||18
5206471|NCT01016678|12801376|P5|STARTED|Overall Study||19
5206472|NCT01016678|12801377|P4|STARTED|Overall Study||19
5206473|NCT01016678|12801378|P3|STARTED|Overall Study||19
5206474|NCT01016678|12801379|P2|STARTED|Overall Study||17
5206475|NCT01016678|12801380|P1|STARTED|Overall Study||20
5206476|NCT01016652|12801402|P2|NOT COMPLETED|Period 2||0
5206477|NCT01016652|12801403|P1|NOT COMPLETED|Period 2||0
5206478|NCT01016652|12801402|P2|COMPLETED|Period 2||24
5206479|NCT01016652|12801403|P1|COMPLETED|Period 2||25
5206480|NCT01016652|12801402|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
5206481|NCT01016652|12801403|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
5206482|NCT01016652|12801402|P2|NOT COMPLETED|Period 1||0
5206483|NCT01016652|12801403|P1|NOT COMPLETED|Period 1||0
5206484|NCT01016652|12801402|P2|COMPLETED|Period 1||24
5206485|NCT01016652|12801403|P1|COMPLETED|Period 1||25
5206486|NCT01016652|12801402|P2|STARTED|Period 1||24
5206487|NCT01016652|12801403|P1|STARTED|Period 1||25
5206488|NCT01016600|12801423|P4|NOT COMPLETED|Overall Study||0
5206489|NCT01016600|12801424|P3|NOT COMPLETED|Overall Study||0
5206490|NCT01016600|12801425|P2|NOT COMPLETED|Overall Study||0
5206491|NCT01016600|12801426|P1|NOT COMPLETED|Overall Study||1
5206492|NCT01016600|12801423|P4|COMPLETED|Overall Study||12
5206493|NCT01016600|12801424|P3|COMPLETED|Overall Study||6
5206494|NCT01016600|12801425|P2|COMPLETED|Overall Study||4
5206495|NCT01016600|12801426|P1|COMPLETED|Overall Study||8
5206496|NCT01016600|12801423|P4|STARTED|Overall Study||12
5206497|NCT01016600|12801424|P3|STARTED|Overall Study||6
5206498|NCT01016600|12801425|P2|STARTED|Overall Study||4
5206499|NCT01016600|12801426|P1|STARTED|Overall Study||9
5206500|NCT01016483|12801493|P4|NOT COMPLETED|Phase II||0
5206501|NCT01016483|12801494|P3|NOT COMPLETED|Phase II||0
5206502|NCT01016483|12801495|P2|NOT COMPLETED|Phase II||0
5206503|NCT01016483|12801496|P1|NOT COMPLETED|Phase II||0
5206504|NCT01016483|12801493|P4|COMPLETED|Phase II||44
5206505|NCT01016483|12801494|P3|COMPLETED|Phase II||44
5206506|NCT01016483|12801495|P2|COMPLETED|Phase II||0
5206507|NCT01016483|12801496|P1|COMPLETED|Phase II||0
5206508|NCT01016483|12801493|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
5206509|NCT01016483|12801494|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
5206510|NCT01016483|12801495|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
5206511|NCT01016483|12801496|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
5206512|NCT01016483|12801493|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
5206513|NCT01016483|12801494|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
5206514|NCT01016483|12801495|P2|STARTED|Phase II||0
5206515|NCT01016483|12801496|P1|STARTED|Phase II||0
5206516|NCT01016483|12801493|P4|NOT COMPLETED|Safety Run-in Part||0
5206517|NCT01016483|12801494|P3|NOT COMPLETED|Safety Run-in Part||0
5206518|NCT01016483|12801495|P2|NOT COMPLETED|Safety Run-in Part||0
5206519|NCT01016483|12801496|P1|NOT COMPLETED|Safety Run-in Part||0
5206520|NCT01016483|12801493|P4|COMPLETED|Safety Run-in Part||0
5206521|NCT01016483|12801494|P3|COMPLETED|Safety Run-in Part||0
5206522|NCT01016483|12801495|P2|COMPLETED|Safety Run-in Part||26
5206523|NCT01016483|12801496|P1|COMPLETED|Safety Run-in Part||27
5206524|NCT01016483|12801493|P4|STARTED|Safety Run-in Part||0
5206525|NCT01016483|12801494|P3|STARTED|Safety Run-in Part||0
5206526|NCT01016483|12801495|P2|STARTED|Safety Run-in Part||26
5206527|NCT01016483|12801496|P1|STARTED|Safety Run-in Part||27
5206528|NCT01016353|12801604|P2|NOT COMPLETED|Overall Study||1
5206529|NCT01016353|12801605|P1|NOT COMPLETED|Overall Study||2
5206530|NCT01016353|12801604|P2|COMPLETED|Overall Study||102
5206531|NCT01016353|12801605|P1|COMPLETED|Overall Study||178
5206532|NCT01016353|12801604|P2|STARTED|Overall Study||103
5206533|NCT01016353|12801605|P1|STARTED|Overall Study||180
5206534|NCT01016262|12801614|P6|NOT COMPLETED|Open-Label Phase||0
5206535|NCT01016262|12801615|P5|NOT COMPLETED|Open-Label Phase||2
5206536|NCT01016262|12801616|P4|NOT COMPLETED|Open-Label Phase||2
5206537|NCT01016262|12801617|P3|NOT COMPLETED|Open-Label Phase||0
5206538|NCT01016262|12801618|P2|NOT COMPLETED|Open-Label Phase||0
5206539|NCT01016262|12801619|P1|NOT COMPLETED|Open-Label Phase||0
5206540|NCT01016262|12801614|P6|COMPLETED|Open-Label Phase||20
5206541|NCT01016262|12801615|P5|COMPLETED|Open-Label Phase||50
5206542|NCT01016262|12801616|P4|COMPLETED|Open-Label Phase||42
5206543|NCT01016262|12801617|P3|COMPLETED|Open-Label Phase||0
5206544|NCT01016262|12801618|P2|COMPLETED|Open-Label Phase||0
5206545|NCT01016262|12801619|P1|COMPLETED|Open-Label Phase||0
5206546|NCT01016262|12801614|P6|STARTED|Open-Label Phase||20
5206547|NCT01016262|12801615|P5|STARTED|Open-Label Phase||52
5206548|NCT01016262|12801616|P4|STARTED|Open-Label Phase||44
5206549|NCT01016262|12801617|P3|STARTED|Open-Label Phase||0
5206550|NCT01016262|12801618|P2|STARTED|Open-Label Phase||0
5206551|NCT01016262|12801619|P1|STARTED|Open-Label Phase||0
5206552|NCT01016262|12801614|P6|NOT COMPLETED|Double-blind Phase||0
5206553|NCT01016262|12801615|P5|NOT COMPLETED|Double-blind Phase||0
5206554|NCT01016262|12801616|P4|NOT COMPLETED|Double-blind Phase||0
5206555|NCT01016262|12801617|P3|NOT COMPLETED|Double-blind Phase||9
5206556|NCT01016262|12801618|P2|NOT COMPLETED|Double-blind Phase||1
5206557|NCT01016262|12801619|P1|NOT COMPLETED|Double-blind Phase||1
5206558|NCT01016262|12801614|P6|COMPLETED|Double-blind Phase||0
5206559|NCT01016262|12801615|P5|COMPLETED|Double-blind Phase||0
5206560|NCT01016262|12801616|P4|COMPLETED|Double-blind Phase||0
5206561|NCT01016262|12801617|P3|COMPLETED|Double-blind Phase||30
5206562|NCT01016262|12801618|P2|COMPLETED|Double-blind Phase||38
5206563|NCT01016262|12801619|P1|COMPLETED|Double-blind Phase||40
5206564|NCT01016262|12801614|P6|STARTED|Double-blind Phase||0
5206565|NCT01016262|12801615|P5|STARTED|Double-blind Phase||0
5206566|NCT01016262|12801616|P4|STARTED|Double-blind Phase||0
5206567|NCT01016262|12801617|P3|STARTED|Double-blind Phase||39
5206568|NCT01016262|12801618|P2|STARTED|Double-blind Phase||39
5206569|NCT01016262|12801619|P1|STARTED|Double-blind Phase||41
5206570|NCT01016132|12801642|P1|NOT COMPLETED|Overall Study||1
5206571|NCT01016132|12801642|P1|COMPLETED|Overall Study||151
5206572|NCT01016132|12801642|P1|STARTED|Overall Study||152
5206573|NCT01016106|12801648|P2|NOT COMPLETED|Overall Study||0
5206574|NCT01016106|12801649|P1|NOT COMPLETED|Overall Study||0
5206575|NCT01016106|12801648|P2|COMPLETED|Overall Study||18
5206576|NCT01016106|12801649|P1|COMPLETED|Overall Study||17
5206577|NCT01016106|12801648|P2|STARTED|Overall Study||18
5206578|NCT01016106|12801649|P1|STARTED|Overall Study||17
5206579|NCT01016067|12801657|P2|NOT COMPLETED|Overall Study||4
5206580|NCT01016067|12801658|P1|NOT COMPLETED|Overall Study||2
5206581|NCT01016067|12801657|P2|COMPLETED|Overall Study||8
5206582|NCT01016067|12801658|P1|COMPLETED|Overall Study||9
5206583|NCT01016067|12801657|P2|STARTED|Overall Study||12
5206584|NCT01016067|12801658|P1|STARTED|Overall Study||11
5206585|NCT01016015|12801676|P1|NOT COMPLETED|Overall Study||19
5206586|NCT01016015|12801676|P1|COMPLETED|Overall Study||159
5206587|NCT01016015|12801676|P1|STARTED|Overall Study||178
5206588|NCT01015976|12801680|P2|NOT COMPLETED|Overall Study||0
5206589|NCT01015976|12801681|P1|NOT COMPLETED|Overall Study||0
5206590|NCT01015976|12801680|P2|COMPLETED|Overall Study||5
5206591|NCT01015976|12801681|P1|COMPLETED|Overall Study||5
5206592|NCT01015976|12801680|P2|STARTED|Overall Study||5
5206593|NCT01015976|12801681|P1|STARTED|Overall Study||5
5206594|NCT01015833|12801687|P2|NOT COMPLETED|Overall Study||5
5206595|NCT01015833|12801688|P1|NOT COMPLETED|Overall Study||13
5206596|NCT01015833|12801687|P2|COMPLETED|Overall Study||171
5206597|NCT01015833|12801688|P1|COMPLETED|Overall Study||167
5206598|NCT01015833|12801687|P2|STARTED|Overall Study||176
5206599|NCT01015833|12801688|P1|STARTED|Overall Study||180
5206600|NCT01015820|12801704|P2|NOT COMPLETED|Overall Study||0
5206601|NCT01015820|12801705|P1|NOT COMPLETED|Overall Study||1
5206602|NCT01015820|12801704|P2|COMPLETED|Overall Study||15
5206603|NCT01015820|12801705|P1|COMPLETED|Overall Study||14
5206604|NCT01015820|12801704|P2|STARTED|Overall Study||15
5206605|NCT01015820|12801705|P1|STARTED|Overall Study||15
5206606|NCT01015807|12801716|P3|NOT COMPLETED|Overall Study||0
5206607|NCT01015807|12801717|P2|NOT COMPLETED|Overall Study||0
5206608|NCT01015807|12801718|P1|NOT COMPLETED|Overall Study||0
5206609|NCT01015807|12801716|P3|COMPLETED|Overall Study||30
5206610|NCT01015807|12801717|P2|COMPLETED|Overall Study||30
5206611|NCT01015807|12801718|P1|COMPLETED|Overall Study||30
5206612|NCT01015807|12801716|P3|STARTED|Overall Study||30
5206613|NCT01015807|12801717|P2|STARTED|Overall Study||30
5206614|NCT01015807|12801718|P1|STARTED|Overall Study||30
5206615|NCT01015781|12801728|P2|NOT COMPLETED|Overall Study||29
5206616|NCT01015781|12801729|P1|NOT COMPLETED|Overall Study||37
5206617|NCT01015781|12801728|P2|COMPLETED|Overall Study||121
5206618|NCT01015781|12801729|P1|COMPLETED|Overall Study||113
5206619|NCT01015781|12801728|P2|STARTED|Overall Study||150
5206620|NCT01015781|12801729|P1|STARTED|Overall Study||150
5206621|NCT01015703|12801740|P5|NOT COMPLETED|Overall Study||0
5206622|NCT01015703|12801741|P4|NOT COMPLETED|Overall Study||0
5206623|NCT01015703|12801742|P3|NOT COMPLETED|Overall Study||0
5206624|NCT01015703|12801743|P2|NOT COMPLETED|Overall Study||1
5206625|NCT01015703|12801744|P1|NOT COMPLETED|Overall Study||2
5206626|NCT01015703|12801740|P5|COMPLETED|Overall Study||10
5206627|NCT01015703|12801741|P4|COMPLETED|Overall Study||10
5206628|NCT01015703|12801742|P3|COMPLETED|Overall Study||10
5206629|NCT01015703|12801743|P2|COMPLETED|Overall Study||9
5206630|NCT01015703|12801744|P1|COMPLETED|Overall Study||8
5206631|NCT01015703|12801740|P5|STARTED|Overall Study||10
5206632|NCT01015703|12801741|P4|STARTED|Overall Study||10
5206633|NCT01015703|12801742|P3|STARTED|Overall Study||10
5206634|NCT01015703|12801743|P2|STARTED|Overall Study||10
5206635|NCT01015703|12801744|P1|STARTED|Overall Study||10
5206636|NCT01015677|12801759|P3|NOT COMPLETED|Overall Study||0
5206637|NCT01015677|12801760|P2|NOT COMPLETED|Overall Study||4
5206638|NCT01015677|12801761|P1|NOT COMPLETED|Overall Study||1
5206639|NCT01015677|12801759|P3|COMPLETED|Overall Study||33
5206640|NCT01015677|12801760|P2|COMPLETED|Overall Study||28
5206641|NCT01015677|12801761|P1|COMPLETED|Overall Study||33
5206642|NCT01015677|12801759|P3|STARTED|Overall Study||33
5206643|NCT01015677|12801760|P2|STARTED|Overall Study||32
5206644|NCT01015677|12801761|P1|STARTED|Overall Study||34
5206645|NCT01015638|12801783|P2|NOT COMPLETED|Overall Study||0
5206646|NCT01015638|12801784|P1|NOT COMPLETED|Overall Study||1
5206647|NCT01015638|12801783|P2|COMPLETED|Overall Study||19
5206648|NCT01015638|12801784|P1|COMPLETED|Overall Study||16
5206649|NCT01015638|12801783|P2|STARTED|Overall Study||19
5206650|NCT01015638|12801784|P1|STARTED|Overall Study||17
5206651|NCT01015612|12801812|P1|NOT COMPLETED|Overall Study||153
5206652|NCT01015612|12801812|P1|COMPLETED|Overall Study||481
5206653|NCT01015612|12801812|P1|STARTED|Overall Study||634
5206654|NCT01015586|12801824|P2|NOT COMPLETED|Overall Study||11
5206655|NCT01015586|12801825|P1|NOT COMPLETED|Overall Study||7
5206656|NCT01015586|12801824|P2|COMPLETED|Overall Study||11
5206657|NCT01015586|12801825|P1|COMPLETED|Overall Study||14
5206658|NCT01015586|12801824|P2|STARTED|Overall Study||22
5206659|NCT01015586|12801825|P1|STARTED|Overall Study||21
5206660|NCT01015560|12801843|P1|NOT COMPLETED|Overall Study||3
5206661|NCT01015560|12801843|P1|COMPLETED|Overall Study||41
5206662|NCT01015560|12801843|P1|Eligible and Analyzable|Overall Study||43
5206663|NCT01015560|12801843|P1|STARTED|Overall Study||44
5206664|NCT01015534|12801849|P2|NOT COMPLETED|Overall Study||0
5206665|NCT01015534|12801850|P1|NOT COMPLETED|Overall Study||1
5206666|NCT01015534|12801849|P2|COMPLETED|Overall Study||27
5206667|NCT01015534|12801850|P1|COMPLETED|Overall Study||27
5206668|NCT01015534|12801849|P2|STARTED|Overall Study||27
5206669|NCT01015534|12801850|P1|STARTED|Overall Study||28
5206670|NCT01015443|12801864|P2|NOT COMPLETED|Overall Study||0
5206671|NCT01015443|12801865|P1|NOT COMPLETED|Overall Study||0
5206672|NCT01015443|12801864|P2|COMPLETED|Overall Study||94
5206673|NCT01015443|12801865|P1|COMPLETED|Overall Study||191
5206674|NCT01015443|12801864|P2|Treated|Overall Study||93
5206675|NCT01015443|12801865|P1|Treated|Overall Study||191
5206676|NCT01015443|12801864|P2|STARTED|Overall Study||94
5206677|NCT01015443|12801865|P1|STARTED|Overall Study||191
5206678|NCT01015326|12801883|P2|NOT COMPLETED|Overall Study||2
5206679|NCT01015326|12801884|P1|NOT COMPLETED|Overall Study||1
5206680|NCT01015326|12801883|P2|COMPLETED|Overall Study||18
5206681|NCT01015326|12801884|P1|COMPLETED|Overall Study||11
5206682|NCT01015326|12801883|P2|STARTED|Overall Study||20
5206683|NCT01015326|12801884|P1|STARTED|Overall Study||12
5206684|NCT01015287|12801892|P2|NOT COMPLETED|Overall Study||79
5206685|NCT01015287|12801893|P1|NOT COMPLETED|Overall Study||72
5206686|NCT01015287|12801892|P2|COMPLETED|Overall Study||1958
5206687|NCT01015287|12801893|P1|COMPLETED|Overall Study||1924
5206688|NCT01015287|12801892|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
5206689|NCT01015287|12801893|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
5206690|NCT01015287|12801892|P2|STARTED|Overall Study||2037
5206691|NCT01015287|12801893|P1|STARTED|Overall Study||1996
5206692|NCT01015170|12801919|P1|NOT COMPLETED|Overall Study||239
5206693|NCT01015170|12801919|P1|COMPLETED|Overall Study||215
5206694|NCT01015170|12801919|P1|STARTED|Overall Study||454
5206695|NCT01015131|12801925|P1|NOT COMPLETED|Overall Study||8
5206696|NCT01015131|12801925|P1|COMPLETED|Overall Study||36
5206697|NCT01015131|12801925|P1|STARTED|Overall Study||44
5206698|NCT01015118|12801941|P2|NOT COMPLETED|Overall Study||327
5206699|NCT01015118|12801942|P1|NOT COMPLETED|Overall Study||669
5206700|NCT01015118|12801941|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
5206701|NCT01015118|12801942|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
5206702|NCT01015118|12801941|P2|STARTED|Overall Study||455
5206703|NCT01015118|12801942|P1|STARTED|Overall Study||911
5206704|NCT01014988|12801970|P6|NOT COMPLETED|Overall Study||3
5206705|NCT01014988|12801971|P5|NOT COMPLETED|Overall Study||1
5206706|NCT01014988|12801972|P4|NOT COMPLETED|Overall Study||0
5206707|NCT01014988|12801973|P3|NOT COMPLETED|Overall Study||2
5206708|NCT01014988|12801974|P2|NOT COMPLETED|Overall Study||0
5206709|NCT01014988|12801975|P1|NOT COMPLETED|Overall Study||23
5206710|NCT01014988|12801970|P6|COMPLETED|Overall Study||11
5206711|NCT01014988|12801971|P5|COMPLETED|Overall Study||26
5206712|NCT01014988|12801972|P4|COMPLETED|Overall Study||12
5206713|NCT01014988|12801973|P3|COMPLETED|Overall Study||9
5206714|NCT01014988|12801974|P2|COMPLETED|Overall Study||7
5206715|NCT01014988|12801975|P1|COMPLETED|Overall Study||107
5206716|NCT01014988|12801970|P6|STARTED|Overall Study||14
5206717|NCT01014988|12801971|P5|STARTED|Overall Study||27
5206718|NCT01014988|12801972|P4|STARTED|Overall Study||12
5206719|NCT01014988|12801973|P3|STARTED|Overall Study||11
5206720|NCT01014988|12801974|P2|STARTED|Overall Study||7
5206721|NCT01014988|12801975|P1|STARTED|Overall Study||130
5206722|NCT01014975|12802147|P3|NOT COMPLETED|Overall Study||6
5206723|NCT01014975|12802148|P2|NOT COMPLETED|Overall Study||3
5206724|NCT01014975|12802149|P1|NOT COMPLETED|Overall Study||4
5206725|NCT01014975|12802147|P3|COMPLETED|Overall Study||10
5206726|NCT01014975|12802148|P2|COMPLETED|Overall Study||13
5206727|NCT01014975|12802149|P1|COMPLETED|Overall Study||4
5206728|NCT01014975|12802147|P3|STARTED|Overall Study||16
5206729|NCT01014975|12802148|P2|STARTED|Overall Study||16
5206730|NCT01014975|12802149|P1|STARTED|Overall Study||8
5206731|NCT01014936|12802160|P3|NOT COMPLETED|Overall Study||0
5206732|NCT01014936|12802161|P2|NOT COMPLETED|Overall Study||0
5206733|NCT01014936|12802162|P1|NOT COMPLETED|Overall Study||0
5206734|NCT01014936|12802160|P3|COMPLETED|Overall Study||62
5206735|NCT01014936|12802161|P2|COMPLETED|Overall Study||45
5206736|NCT01014936|12802162|P1|COMPLETED|Overall Study||42
5206737|NCT01014936|12802160|P3|STARTED|Overall Study||62
5206738|NCT01014936|12802161|P2|STARTED|Overall Study||45
5206739|NCT01014936|12802162|P1|STARTED|Overall Study||42
5206740|NCT01014910|12802654|P2|NOT COMPLETED|Overall Study||2
5206741|NCT01014910|12802655|P1|NOT COMPLETED|Overall Study||0
5206742|NCT01014910|12802654|P2|COMPLETED|Overall Study||79
5206743|NCT01014910|12802655|P1|COMPLETED|Overall Study||80
5206744|NCT01014910|12802654|P2|STARTED|Overall Study||81
5206745|NCT01014910|12802655|P1|STARTED|Overall Study||80
5206746|NCT01014871|12802663|P1|NOT COMPLETED|Overall Study||0
5206747|NCT01014871|12802663|P1|COMPLETED|Overall Study||30
5206748|NCT01014871|12802663|P1|STARTED|Overall Study||30
5206749|NCT01014767|12802673|P4|NOT COMPLETED|Overall Study||1
5206750|NCT01014767|12802674|P3|NOT COMPLETED|Overall Study||4
5206751|NCT01014767|12802675|P2|NOT COMPLETED|Overall Study||1
5206752|NCT01014767|12802676|P1|NOT COMPLETED|Overall Study||12
5206753|NCT01014767|12802673|P4|COMPLETED|Overall Study||0
5206754|NCT01014767|12802674|P3|COMPLETED|Overall Study||0
5206755|NCT01014767|12802675|P2|COMPLETED|Overall Study||0
5206756|NCT01014767|12802676|P1|COMPLETED|Overall Study||0
5206757|NCT01014767|12802673|P4|STARTED|Overall Study||1
5206758|NCT01014767|12802674|P3|STARTED|Overall Study||4
5206759|NCT01014767|12802675|P2|STARTED|Overall Study||1
5206760|NCT01014767|12802676|P1|STARTED|Overall Study||12
5206761|NCT01014741|12802692|P2|NOT COMPLETED|Overall Study||5
5206762|NCT01014741|12802693|P1|NOT COMPLETED|Overall Study||11
5206763|NCT01014741|12802692|P2|COMPLETED|Overall Study||90
5206764|NCT01014741|12802693|P1|COMPLETED|Overall Study||94
5206765|NCT01014741|12802692|P2|STARTED|Overall Study||95
5206766|NCT01014741|12802693|P1|STARTED|Overall Study||105
5206767|NCT01014728|12802707|P2|NOT COMPLETED|Overall Study||0
5206768|NCT01014728|12802708|P1|NOT COMPLETED|Overall Study||0
5206769|NCT01014728|12802707|P2|COMPLETED|Overall Study||15
5206770|NCT01014728|12802708|P1|COMPLETED|Overall Study||18
5206771|NCT01014728|12802707|P2|STARTED|Overall Study||15
5206772|NCT01014728|12802708|P1|STARTED|Overall Study||18
5206773|NCT01014689|12802720|P2|NOT COMPLETED|Overall Study||13
5206774|NCT01014689|12802721|P1|NOT COMPLETED|Overall Study||13
5206775|NCT01014689|12802720|P2|COMPLETED|Overall Study||174
5206776|NCT01014689|12802721|P1|COMPLETED|Overall Study||178
5206777|NCT01014689|12802720|P2|STARTED|Overall Study||187
5206778|NCT01014689|12802721|P1|STARTED|Overall Study||191
5206779|NCT01014624|12802731|P2|NOT COMPLETED|Overall Study||1
5206780|NCT01014624|12802732|P1|NOT COMPLETED|Overall Study||2
5206781|NCT01014624|12802731|P2|COMPLETED|Overall Study||26
5206782|NCT01014624|12802732|P1|COMPLETED|Overall Study||27
5206783|NCT01014624|12802731|P2|STARTED|Overall Study||27
5206784|NCT01014624|12802732|P1|STARTED|Overall Study||29
5206785|NCT01014585|12802756|P4|NOT COMPLETED|Overall Study||30
5206786|NCT01014585|12802757|P3|NOT COMPLETED|Overall Study||23
5206787|NCT01014585|12802758|P2|NOT COMPLETED|Overall Study||25
5206788|NCT01014585|12802759|P1|NOT COMPLETED|Overall Study||20
5206789|NCT01014585|12802756|P4|COMPLETED|Overall Study||99
5206790|NCT01014585|12802757|P3|COMPLETED|Overall Study||37
5206791|NCT01014585|12802758|P2|COMPLETED|Overall Study||75
5206792|NCT01014585|12802759|P1|COMPLETED|Overall Study||31
5206793|NCT01014585|12802756|P4|STARTED|Overall Study||129
5206794|NCT01014585|12802757|P3|STARTED|Overall Study||60
5206795|NCT01014585|12802758|P2|STARTED|Overall Study||100
5206796|NCT01014585|12802759|P1|STARTED|Overall Study||51
5206797|NCT01014533|12802779|P2|NOT COMPLETED|Overall Study||5
5206798|NCT01014533|12802780|P1|NOT COMPLETED|Overall Study||5
5206799|NCT01014533|12802779|P2|COMPLETED|Overall Study||25
5206800|NCT01014533|12802780|P1|COMPLETED|Overall Study||24
5206801|NCT01014533|12802779|P2|STARTED|Overall Study||30
5206802|NCT01014533|12802780|P1|STARTED|Overall Study||29
5206803|NCT01014455|12802792|P2|NOT COMPLETED|Overall Study||0
5206804|NCT01014455|12802793|P1|NOT COMPLETED|Overall Study||0
5206805|NCT01014455|12802792|P2|COMPLETED|Overall Study||87
5206806|NCT01014455|12802793|P1|COMPLETED|Overall Study||82
5206807|NCT01014455|12802792|P2|STARTED|Overall Study||87
5206808|NCT01014455|12802793|P1|STARTED|Overall Study||82
5206809|NCT01014442|12802801|P2|NOT COMPLETED|Overall Study||19
5206810|NCT01014442|12802802|P1|NOT COMPLETED|Overall Study||7
5206811|NCT01014442|12802801|P2|COMPLETED|Overall Study||16
5206812|NCT01014442|12802802|P1|COMPLETED|Overall Study||26
5206813|NCT01014442|12802801|P2|STARTED|Overall Study||35
5206814|NCT01014442|12802802|P1|STARTED|Overall Study||33
5206815|NCT01014390|12802914|P1|NOT COMPLETED|Overall Study||10
5206816|NCT01014390|12802914|P1|COMPLETED|Overall Study||177
5206817|NCT01014390|12802914|P1|STARTED|Overall Study||187
5206818|NCT01014351|12802918|P1|NOT COMPLETED|Overall Study||37
5206819|NCT01014351|12802918|P1|COMPLETED|Overall Study||33
5206820|NCT01014351|12802918|P1|STARTED|Overall Study||70
5206821|NCT01014208|12802926|P2|NOT COMPLETED|Overall Study||100
5206822|NCT01014208|12802927|P1|NOT COMPLETED|Overall Study||94
5206823|NCT01014208|12802926|P2|COMPLETED|Overall Study||122
5206824|NCT01014208|12802927|P1|COMPLETED|Overall Study||131
5206825|NCT01014208|12802926|P2|Intent-to-Treat Population|Overall Study||222
5206826|NCT01014208|12802927|P1|Intent-to-Treat Population|Overall Study||223
5206827|NCT01014208|12802926|P2|STARTED|Overall Study||222
5206828|NCT01014208|12802927|P1|STARTED|Overall Study||225
5206829|NCT01014169|12802955|P2|NOT COMPLETED|Overall Study||13
5206830|NCT01014169|12802956|P1|NOT COMPLETED|Overall Study||7
5206831|NCT01014169|12802955|P2|COMPLETED|Overall Study||48
5206832|NCT01014169|12802956|P1|COMPLETED|Overall Study||58
5206833|NCT01014169|12802955|P2|STARTED|Overall Study||61
5206834|NCT01014169|12802956|P1|STARTED|Overall Study||65
5206835|NCT01014143|12802969|P3|NOT COMPLETED|Third Intervention||0
5206836|NCT01014143|12802970|P2|NOT COMPLETED|Third Intervention||0
5206837|NCT01014143|12802971|P1|NOT COMPLETED|Third Intervention||0
5206838|NCT01014143|12802969|P3|COMPLETED|Third Intervention||9
5206839|NCT01014143|12802970|P2|COMPLETED|Third Intervention||9
5206840|NCT01014143|12802971|P1|COMPLETED|Third Intervention||8
5206841|NCT01014143|12802969|P3|STARTED|Third Intervention||9
5206842|NCT01014143|12802970|P2|STARTED|Third Intervention||9
5206843|NCT01014143|12802971|P1|STARTED|Third Intervention||8
5206844|NCT01014143|12802969|P3|NOT COMPLETED|Washout After 2nd Intervention||0
5206845|NCT01014143|12802970|P2|NOT COMPLETED|Washout After 2nd Intervention||0
5206846|NCT01014143|12802971|P1|NOT COMPLETED|Washout After 2nd Intervention||0
5206847|NCT01014143|12802969|P3|COMPLETED|Washout After 2nd Intervention||9
5206848|NCT01014143|12802970|P2|COMPLETED|Washout After 2nd Intervention||9
5206849|NCT01014143|12802971|P1|COMPLETED|Washout After 2nd Intervention||8
5206850|NCT01014143|12802969|P3|STARTED|Washout After 2nd Intervention||9
5206851|NCT01014143|12802970|P2|STARTED|Washout After 2nd Intervention||9
5206852|NCT01014143|12802971|P1|STARTED|Washout After 2nd Intervention||8
5206853|NCT01014143|12802969|P3|NOT COMPLETED|Second Intervention||0
5206854|NCT01014143|12802970|P2|NOT COMPLETED|Second Intervention||0
5206855|NCT01014143|12802971|P1|NOT COMPLETED|Second Intervention||2
5206856|NCT01014143|12802969|P3|COMPLETED|Second Intervention||9
5206857|NCT01014143|12802970|P2|COMPLETED|Second Intervention||9
5206858|NCT01014143|12802971|P1|COMPLETED|Second Intervention||8
5206859|NCT01014143|12802969|P3|STARTED|Second Intervention||9
5206860|NCT01014143|12802970|P2|STARTED|Second Intervention||9
5206861|NCT01014143|12802971|P1|STARTED|Second Intervention||10
5206862|NCT01014143|12802969|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
5206863|NCT01014143|12802970|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
5206864|NCT01014143|12802971|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
5206865|NCT01014143|12802969|P3|COMPLETED|Washout Period After 1st Intervention||9
5206866|NCT01014143|12802970|P2|COMPLETED|Washout Period After 1st Intervention||9
5206867|NCT01014143|12802971|P1|COMPLETED|Washout Period After 1st Intervention||10
5206868|NCT01014143|12802969|P3|STARTED|Washout Period After 1st Intervention||9
5206869|NCT01014143|12802970|P2|STARTED|Washout Period After 1st Intervention||9
5206870|NCT01014143|12802971|P1|STARTED|Washout Period After 1st Intervention||10
5206871|NCT01014143|12802969|P3|NOT COMPLETED|First Intervention||0
5206872|NCT01014143|12802970|P2|NOT COMPLETED|First Intervention||0
5206873|NCT01014143|12802971|P1|NOT COMPLETED|First Intervention||0
5206874|NCT01014143|12802969|P3|COMPLETED|First Intervention||9
5206875|NCT01014143|12802970|P2|COMPLETED|First Intervention||9
5206876|NCT01014143|12802971|P1|COMPLETED|First Intervention||10
5206877|NCT01014143|12802969|P3|STARTED|First Intervention||9
5206878|NCT01014143|12802970|P2|STARTED|First Intervention||9
5206879|NCT01014143|12802971|P1|STARTED|First Intervention||10
5206880|NCT01014091|12802985|P6|NOT COMPLETED|Overall Study||0
5206881|NCT01014091|12802986|P5|NOT COMPLETED|Overall Study||0
5206882|NCT01014091|12802987|P4|NOT COMPLETED|Overall Study||0
5206883|NCT01014091|12802988|P3|NOT COMPLETED|Overall Study||0
5206884|NCT01014091|12802989|P2|NOT COMPLETED|Overall Study||0
5206885|NCT01014091|12802990|P1|NOT COMPLETED|Overall Study||0
5206886|NCT01014091|12802985|P6|COMPLETED|Overall Study||12
5206887|NCT01014091|12802986|P5|COMPLETED|Overall Study||6
5206888|NCT01014091|12802987|P4|COMPLETED|Overall Study||15
5206889|NCT01014091|12802988|P3|COMPLETED|Overall Study||5
5206890|NCT01014091|12802989|P2|COMPLETED|Overall Study||13
5206891|NCT01014091|12802990|P1|COMPLETED|Overall Study||7
5206892|NCT01014091|12802985|P6|STARTED|Overall Study||12
5206893|NCT01014091|12802986|P5|STARTED|Overall Study||6
5206894|NCT01014091|12802987|P4|STARTED|Overall Study||15
5206895|NCT01014091|12802988|P3|STARTED|Overall Study||5
5206896|NCT01014091|12802989|P2|STARTED|Overall Study||13
5206897|NCT01014091|12802990|P1|STARTED|Overall Study||7
5206898|NCT01014013|12803066|P2|NOT COMPLETED|Overall Study||56
5206899|NCT01014013|12803067|P1|NOT COMPLETED|Overall Study||51
5206900|NCT01014013|12803066|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
5206901|NCT01014013|12803067|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
5206902|NCT01014013|12803066|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
5206903|NCT01014013|12803067|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
5206904|NCT01014013|12803066|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
5206905|NCT01014013|12803067|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
5206906|NCT01014013|12803066|P2|STARTED|Overall Study||136
5206907|NCT01014013|12803067|P1|STARTED|Overall Study||135
5206908|NCT01013961|12803079|P2|NOT COMPLETED|Overall Study||3
5206909|NCT01013961|12803080|P1|NOT COMPLETED|Overall Study||3
5206910|NCT01013961|12803079|P2|COMPLETED|Overall Study||12
5206911|NCT01013961|12803080|P1|COMPLETED|Overall Study||13
5206912|NCT01013961|12803079|P2|STARTED|Overall Study||15
5206913|NCT01013961|12803080|P1|STARTED|Overall Study||16
5206914|NCT01013883|12803098|P2|NOT COMPLETED|Overall Study||2
5206915|NCT01013883|12803099|P1|NOT COMPLETED|Overall Study||2
5206916|NCT01013883|12803098|P2|COMPLETED|Overall Study||241
5206917|NCT01013883|12803099|P1|COMPLETED|Overall Study||268
5206918|NCT01013883|12803098|P2|STARTED|Overall Study||243
5206919|NCT01013883|12803099|P1|STARTED|Overall Study||270
5206920|NCT01013870|12803111|P2|NOT COMPLETED|Overall Study||3
5206921|NCT01013870|12803112|P1|NOT COMPLETED|Overall Study||1
5206922|NCT01013870|12803111|P2|COMPLETED|Overall Study||21
5206923|NCT01013870|12803112|P1|COMPLETED|Overall Study||27
5206924|NCT01013870|12803111|P2|STARTED|Overall Study||24
5206925|NCT01013870|12803112|P1|STARTED|Overall Study||28
5206926|NCT01013844|12803136|P2|NOT COMPLETED|Overall Study||0
5206927|NCT01013844|12803137|P1|NOT COMPLETED|Overall Study||0
5206928|NCT01013844|12803136|P2|COMPLETED|Overall Study||65
5206929|NCT01013844|12803137|P1|COMPLETED|Overall Study||65
5206930|NCT01013844|12803136|P2|STARTED|Overall Study||65
5206931|NCT01013844|12803137|P1|STARTED|Overall Study||65
5206932|NCT01013792|12803161|P2|NOT COMPLETED|Overall Study||5
5206933|NCT01013792|12803162|P1|NOT COMPLETED|Overall Study||2
5206934|NCT01013792|12803161|P2|COMPLETED|Overall Study||11
5206935|NCT01013792|12803162|P1|COMPLETED|Overall Study||12
5206936|NCT01013792|12803161|P2|STARTED|Overall Study||16
5206937|NCT01013792|12803162|P1|STARTED|Overall Study||14
5206938|NCT01013753|12803168|P1|NOT COMPLETED|Overall Study||16
5206939|NCT01013753|12803168|P1|COMPLETED|Overall Study||182
5206940|NCT01013753|12803168|P1|Received Form 12 mcg Bid|Overall Study||125
5206941|NCT01013753|12803168|P1|Received Olo 20 mcg qd|Overall Study||124
5206942|NCT01013753|12803168|P1|Received Olo 10 mcg qd|Overall Study||127
5206943|NCT01013753|12803168|P1|Received Olo 5 mcg qd|Overall Study||130
5206944|NCT01013753|12803168|P1|Received Olo 2 mcg qd|Overall Study||121
5206945|NCT01013753|12803168|P1|Received Placebo|Overall Study||125
5206946|NCT01013753|12803168|P1|STARTED|Overall Study|Entered and treated|198
5206947|NCT01013740|12803364|P2|NOT COMPLETED|Overall Study||19
5206948|NCT01013740|12803365|P1|NOT COMPLETED|Overall Study||11
5206949|NCT01013740|12803364|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
5206950|NCT01013740|12803365|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
5206951|NCT01013740|12803364|P2|Ongoing|Overall Study||0
5206952|NCT01013740|12803365|P1|Ongoing|Overall Study||0
5206953|NCT01013740|12803364|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
5206954|NCT01013740|12803365|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
5206955|NCT01013701|12803389|P1|NOT COMPLETED|Overall Study||7
5206956|NCT01013701|12803389|P1|COMPLETED|Overall Study||0
5206957|NCT01013701|12803389|P1|STARTED|Overall Study||7
5206958|NCT01013597|12803396|P1|NOT COMPLETED|Overall Study||1
5206959|NCT01013597|12803396|P1|COMPLETED|Overall Study||12
5206960|NCT01013597|12803396|P1|STARTED|Overall Study||13
5206961|NCT01013350|12803408|P2|NOT COMPLETED|Overall Study||192
5206962|NCT01013350|12803409|P1|NOT COMPLETED|Overall Study||38
5206963|NCT01013350|12803408|P2|COMPLETED|Overall Study||771
5206964|NCT01013350|12803409|P1|COMPLETED|Overall Study||160
5206965|NCT01013350|12803408|P2|Safety Analysis Set|Overall Study||950
5206966|NCT01013350|12803409|P1|Safety Analysis Set|Overall Study||198
5206967|NCT01013350|12803408|P2|STARTED|Overall Study||963
5206968|NCT01013350|12803409|P1|STARTED|Overall Study||198
5206969|NCT01013207|12803420|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
5206970|NCT01013207|12803420|P1|COMPLETED|CPAP Post Nexus (S9)||44
5206971|NCT01013207|12803420|P1|STARTED|CPAP Post Nexus (S9)||50
5206972|NCT01013207|12803420|P1|NOT COMPLETED|Nexus (S9)||0
5206973|NCT01013207|12803420|P1|COMPLETED|Nexus (S9)||50
5206974|NCT01013207|12803420|P1|STARTED|Nexus (S9)||50
5206975|NCT01013207|12803420|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
5206976|NCT01013207|12803420|P1|COMPLETED|CPAP Pre Nexus (S9)||50
5206977|NCT01013207|12803420|P1|STARTED|CPAP Pre Nexus (S9)||50
5206978|NCT01013194|12803427|P2|NOT COMPLETED|Overall Study||0
5206979|NCT01013194|12803428|P1|NOT COMPLETED|Overall Study||0
5206980|NCT01013194|12803427|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
5206981|NCT01013194|12803428|P1|COMPLETED|Overall Study|Consecutive patients|9
5206982|NCT01013194|12803427|P2|STARTED|Overall Study||16
5206983|NCT01013194|12803428|P1|STARTED|Overall Study||9
5206984|NCT01012999|12803438|P1|NOT COMPLETED|Overall Study||1
5206985|NCT01012999|12803438|P1|COMPLETED|Overall Study||15
5206986|NCT01012999|12803438|P1|STARTED|Overall Study||16
5206987|NCT01012973|12803444|P2|NOT COMPLETED|Overall Study||19
5206988|NCT01012973|12803445|P1|NOT COMPLETED|Overall Study||16
5206989|NCT01012973|12803444|P2|COMPLETED|Overall Study||52
5206990|NCT01012973|12803445|P1|COMPLETED|Overall Study||90
5206991|NCT01012973|12803444|P2|Completed Week 52, From FAS|Overall Study||52
5206992|NCT01012973|12803445|P1|Completed Week 52, From FAS|Overall Study||91
5206993|NCT01012973|12803444|P2|Completed Week 24, From FAS|Overall Study||57
5206994|NCT01012973|12803445|P1|Completed Week 24, From FAS|Overall Study||97
5206995|NCT01012973|12803444|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
5206996|NCT01012973|12803445|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
5206997|NCT01012973|12803444|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
5206998|NCT01012973|12803445|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
5206999|NCT01012973|12803444|P2|STARTED|Overall Study||71
5207000|NCT01012973|12803445|P1|STARTED|Overall Study||106
5207001|NCT01012947|12803470|P5|NOT COMPLETED|Overall Study||142
5207002|NCT01012947|12803471|P4|NOT COMPLETED|Overall Study||118
5207003|NCT01012947|12803472|P3|NOT COMPLETED|Overall Study||130
5207004|NCT01012947|12803473|P2|NOT COMPLETED|Overall Study||135
5207005|NCT01012947|12803474|P1|NOT COMPLETED|Overall Study||131
5207006|NCT01012947|12803470|P5|COMPLETED|Overall Study||94
5207007|NCT01012947|12803471|P4|COMPLETED|Overall Study||93
5207008|NCT01012947|12803472|P3|COMPLETED|Overall Study||111
5207009|NCT01012947|12803473|P2|COMPLETED|Overall Study||80
5207010|NCT01012947|12803474|P1|COMPLETED|Overall Study||81
5207011|NCT01012947|12803470|P5|STARTED|Overall Study||236
5207012|NCT01012947|12803471|P4|STARTED|Overall Study||211
5207013|NCT01012947|12803472|P3|STARTED|Overall Study||241
5207014|NCT01012947|12803473|P2|STARTED|Overall Study||215
5207015|NCT01012947|12803474|P1|STARTED|Overall Study||212
5207016|NCT01012921|12803488|P2|NOT COMPLETED|Overall Study||13
5207017|NCT01012921|12803489|P1|NOT COMPLETED|Overall Study||10
5207018|NCT01012921|12803488|P2|COMPLETED|Overall Study||47
5207019|NCT01012921|12803489|P1|COMPLETED|Overall Study||47
5207020|NCT01012921|12803488|P2|STARTED|Overall Study||60
5207021|NCT01012921|12803489|P1|STARTED|Overall Study||57
5207022|NCT01012765|12803495|P6|NOT COMPLETED|Treatment Period 3||0
5207023|NCT01012765|12803496|P5|NOT COMPLETED|Treatment Period 3||0
5207024|NCT01012765|12803497|P4|NOT COMPLETED|Treatment Period 3||0
5207025|NCT01012765|12803498|P3|NOT COMPLETED|Treatment Period 3||0
5207026|NCT01012765|12803499|P2|NOT COMPLETED|Treatment Period 3||0
5207027|NCT01012765|12803500|P1|NOT COMPLETED|Treatment Period 3||0
5207028|NCT01012765|12803495|P6|COMPLETED|Treatment Period 3||24
5207029|NCT01012765|12803496|P5|COMPLETED|Treatment Period 3||18
5207030|NCT01012765|12803497|P4|COMPLETED|Treatment Period 3||15
5207031|NCT01012765|12803498|P3|COMPLETED|Treatment Period 3||18
5207032|NCT01012765|12803499|P2|COMPLETED|Treatment Period 3||19
5207033|NCT01012765|12803500|P1|COMPLETED|Treatment Period 3||16
5207034|NCT01012765|12803495|P6|STARTED|Treatment Period 3||24
5207035|NCT01012765|12803496|P5|STARTED|Treatment Period 3||18
5207036|NCT01012765|12803497|P4|STARTED|Treatment Period 3||15
5207037|NCT01012765|12803498|P3|STARTED|Treatment Period 3||18
5207038|NCT01012765|12803499|P2|STARTED|Treatment Period 3||19
5207039|NCT01012765|12803500|P1|STARTED|Treatment Period 3||16
5207040|NCT01012765|12803495|P6|NOT COMPLETED|Treatment Period 2||1
5207041|NCT01012765|12803496|P5|NOT COMPLETED|Treatment Period 2||1
5207042|NCT01012765|12803497|P4|NOT COMPLETED|Treatment Period 2||0
5207043|NCT01012765|12803498|P3|NOT COMPLETED|Treatment Period 2||3
5207044|NCT01012765|12803499|P2|NOT COMPLETED|Treatment Period 2||2
5207045|NCT01012765|12803500|P1|NOT COMPLETED|Treatment Period 2||1
5207046|NCT01012765|12803495|P6|COMPLETED|Treatment Period 2||24
5207047|NCT01012765|12803496|P5|COMPLETED|Treatment Period 2||18
5207048|NCT01012765|12803497|P4|COMPLETED|Treatment Period 2||15
5207049|NCT01012765|12803498|P3|COMPLETED|Treatment Period 2||18
5207050|NCT01012765|12803499|P2|COMPLETED|Treatment Period 2||19
5207051|NCT01012765|12803500|P1|COMPLETED|Treatment Period 2||16
5207052|NCT01012765|12803495|P6|STARTED|Treatment Period 2||25
5207053|NCT01012765|12803496|P5|STARTED|Treatment Period 2||19
5207054|NCT01012765|12803497|P4|STARTED|Treatment Period 2||15
5207055|NCT01012765|12803498|P3|STARTED|Treatment Period 2||21
5207056|NCT01012765|12803499|P2|STARTED|Treatment Period 2||21
5207057|NCT01012765|12803500|P1|STARTED|Treatment Period 2||17
5207058|NCT01012765|12803495|P6|NOT COMPLETED|Treatment Period 1||0
5207059|NCT01012765|12803496|P5|NOT COMPLETED|Treatment Period 1||3
5207060|NCT01012765|12803497|P4|NOT COMPLETED|Treatment Period 1||3
5207061|NCT01012765|12803498|P3|NOT COMPLETED|Treatment Period 1||2
5207062|NCT01012765|12803499|P2|NOT COMPLETED|Treatment Period 1||0
5207063|NCT01012765|12803500|P1|NOT COMPLETED|Treatment Period 1||3
5207064|NCT01012765|12803495|P6|COMPLETED|Treatment Period 1||25
5207065|NCT01012765|12803496|P5|COMPLETED|Treatment Period 1||19
5207066|NCT01012765|12803497|P4|COMPLETED|Treatment Period 1||15
5207067|NCT01012765|12803498|P3|COMPLETED|Treatment Period 1||21
5207068|NCT01012765|12803499|P2|COMPLETED|Treatment Period 1||21
5207069|NCT01012765|12803500|P1|COMPLETED|Treatment Period 1||17
5207070|NCT01012765|12803495|P6|STARTED|Treatment Period 1||25
5207071|NCT01012765|12803496|P5|STARTED|Treatment Period 1||22
5207072|NCT01012765|12803497|P4|STARTED|Treatment Period 1||18
5207073|NCT01012765|12803498|P3|STARTED|Treatment Period 1||23
5207074|NCT01012765|12803499|P2|STARTED|Treatment Period 1||21
5207075|NCT01012765|12803500|P1|STARTED|Treatment Period 1||20
5207076|NCT01012739|12803529|P4|NOT COMPLETED|Treatment Period 4||0
5207077|NCT01012739|12803530|P3|NOT COMPLETED|Treatment Period 4||0
5207078|NCT01012739|12803531|P2|NOT COMPLETED|Treatment Period 4||0
5207079|NCT01012739|12803532|P1|NOT COMPLETED|Treatment Period 4||0
5207080|NCT01012739|12803529|P4|COMPLETED|Treatment Period 4||7
5207081|NCT01012739|12803530|P3|COMPLETED|Treatment Period 4||9
5207082|NCT01012739|12803531|P2|COMPLETED|Treatment Period 4||8
5207083|NCT01012739|12803532|P1|COMPLETED|Treatment Period 4||9
5207084|NCT01012739|12803529|P4|STARTED|Treatment Period 4||7
5207085|NCT01012739|12803530|P3|STARTED|Treatment Period 4||9
5207086|NCT01012739|12803531|P2|STARTED|Treatment Period 4||8
5207087|NCT01012739|12803532|P1|STARTED|Treatment Period 4||9
5207088|NCT01012739|12803529|P4|NOT COMPLETED|Treatment Period 3||0
5207089|NCT01012739|12803530|P3|NOT COMPLETED|Treatment Period 3||0
5207090|NCT01012739|12803531|P2|NOT COMPLETED|Treatment Period 3||0
5207091|NCT01012739|12803532|P1|NOT COMPLETED|Treatment Period 3||0
5207092|NCT01012739|12803529|P4|COMPLETED|Treatment Period 3||7
5207093|NCT01012739|12803530|P3|COMPLETED|Treatment Period 3||9
5207094|NCT01012739|12803531|P2|COMPLETED|Treatment Period 3||8
5207095|NCT01012739|12803532|P1|COMPLETED|Treatment Period 3||9
5207096|NCT01012739|12803529|P4|STARTED|Treatment Period 3||7
5207097|NCT01012739|12803530|P3|STARTED|Treatment Period 3||9
5207098|NCT01012739|12803531|P2|STARTED|Treatment Period 3||8
5207099|NCT01012739|12803532|P1|STARTED|Treatment Period 3||9
5207100|NCT01012739|12803529|P4|NOT COMPLETED|Treatment Period 2||1
5207101|NCT01012739|12803530|P3|NOT COMPLETED|Treatment Period 2||0
5207102|NCT01012739|12803531|P2|NOT COMPLETED|Treatment Period 2||0
5207103|NCT01012739|12803532|P1|NOT COMPLETED|Treatment Period 2||0
5207104|NCT01012739|12803529|P4|COMPLETED|Treatment Period 2||7
5207105|NCT01012739|12803530|P3|COMPLETED|Treatment Period 2||9
5207106|NCT01012739|12803531|P2|COMPLETED|Treatment Period 2||8
5207107|NCT01012739|12803532|P1|COMPLETED|Treatment Period 2||9
5207108|NCT01012739|12803529|P4|STARTED|Treatment Period 2||8
5207109|NCT01012739|12803530|P3|STARTED|Treatment Period 2||9
5207110|NCT01012739|12803531|P2|STARTED|Treatment Period 2||8
5207111|NCT01012739|12803532|P1|STARTED|Treatment Period 2||9
5207112|NCT01012739|12803529|P4|NOT COMPLETED|Treatment Period 1||1
5207113|NCT01012739|12803530|P3|NOT COMPLETED|Treatment Period 1||0
5207114|NCT01012739|12803531|P2|NOT COMPLETED|Treatment Period 1||0
5207115|NCT01012739|12803532|P1|NOT COMPLETED|Treatment Period 1||0
5207116|NCT01012739|12803529|P4|COMPLETED|Treatment Period 1||8
5207117|NCT01012739|12803530|P3|COMPLETED|Treatment Period 1||9
5207118|NCT01012739|12803531|P2|COMPLETED|Treatment Period 1||8
5207119|NCT01012739|12803532|P1|COMPLETED|Treatment Period 1||9
5207120|NCT01012739|12803529|P4|STARTED|Treatment Period 1||9
5207121|NCT01012739|12803530|P3|STARTED|Treatment Period 1||9
5207122|NCT01012739|12803531|P2|STARTED|Treatment Period 1||8
5207123|NCT01012739|12803532|P1|STARTED|Treatment Period 1||9
5207124|NCT01012713|12803560|P1|NOT COMPLETED|Overall Study||3
5207125|NCT01012713|12803560|P1|COMPLETED|Overall Study||27
5207126|NCT01012713|12803560|P1|STARTED|Overall Study||30
5207127|NCT01012674|12803566|P1|NOT COMPLETED|Overall Study||24
5207128|NCT01012674|12803566|P1|COMPLETED|Overall Study||187
5207129|NCT01012674|12803566|P1|STARTED|Overall Study||211
5207130|NCT01012661|12803578|P1|NOT COMPLETED|Overall Study||0
5207131|NCT01012661|12803578|P1|COMPLETED|Overall Study||50
5207132|NCT01012661|12803578|P1|STARTED|Overall Study||50
5207133|NCT01012622|12803586|P1|NOT COMPLETED|Overall Study||31
5207134|NCT01012622|12803586|P1|COMPLETED|Overall Study||111
5207135|NCT01012622|12803586|P1|STARTED|Overall Study||142
5207136|NCT01012492|12803605|P1|NOT COMPLETED|Overall Study||0
5207137|NCT01012492|12803605|P1|COMPLETED|Overall Study||10
5207138|NCT01012492|12803605|P1|STARTED|Overall Study||10
5207139|NCT01012440|12803612|P1|NOT COMPLETED|Overall Study||2
5207140|NCT01012440|12803612|P1|COMPLETED|Overall Study||3
5207141|NCT01012440|12803612|P1|STARTED|Overall Study||5
5207142|NCT01012414|12803616|P1|NOT COMPLETED|Overall Study||10
5207143|NCT01012414|12803616|P1|COMPLETED|Overall Study|No subjects completed the study.|0
5207144|NCT01012414|12803616|P1|STARTED|Overall Study||10
5207145|NCT01012388|12803623|P1|NOT COMPLETED|Overall Study||0
5207146|NCT01012388|12803623|P1|COMPLETED|Overall Study||100
5207147|NCT01012388|12803623|P1|STARTED|Overall Study||100
5207148|NCT01012362|12803633|P5|NOT COMPLETED|Overall Study||0
5207149|NCT01012362|12803634|P4|NOT COMPLETED|Overall Study||0
5207150|NCT01012362|12803635|P3|NOT COMPLETED|Overall Study||0
5207151|NCT01012362|12803636|P2|NOT COMPLETED|Overall Study||0
5207152|NCT01012362|12803637|P1|NOT COMPLETED|Overall Study||0
5207153|NCT01012362|12803633|P5|COMPLETED|Overall Study||9
5207154|NCT01012362|12803634|P4|COMPLETED|Overall Study||4
5207155|NCT01012362|12803635|P3|COMPLETED|Overall Study||3
5207156|NCT01012362|12803636|P2|COMPLETED|Overall Study||6
5207157|NCT01012362|12803637|P1|COMPLETED|Overall Study||9
5207158|NCT01012362|12803633|P5|STARTED|Overall Study||9
5207159|NCT01012362|12803634|P4|STARTED|Overall Study||4
5207160|NCT01012362|12803635|P3|STARTED|Overall Study||3
5207161|NCT01012362|12803636|P2|STARTED|Overall Study||6
5207162|NCT01012362|12803637|P1|STARTED|Overall Study||9
5207163|NCT01012336|12803653|P1|NOT COMPLETED|Overall Study||0
5207164|NCT01012336|12803653|P1|COMPLETED|Overall Study||85
5207165|NCT01012336|12803653|P1|STARTED|Overall Study||85
5207166|NCT01012323|12803657|P1|NOT COMPLETED|Overall Study||1
5207167|NCT01012323|12803657|P1|COMPLETED|Overall Study||50
5207168|NCT01012323|12803657|P1|STARTED|Overall Study||51
5207169|NCT01012297|12803681|P2|NOT COMPLETED|Overall Study||0
5207170|NCT01012297|12803682|P1|NOT COMPLETED|Overall Study||0
5207171|NCT01012297|12803681|P2|COMPLETED|Overall Study||53
5207172|NCT01012297|12803682|P1|COMPLETED|Overall Study||54
5207173|NCT01012297|12803681|P2|STARTED|Overall Study||53
5207174|NCT01012297|12803682|P1|STARTED|Overall Study||54
5207175|NCT01012258|12803694|P1|NOT COMPLETED|Overall Study||66
5207176|NCT01012258|12803694|P1|COMPLETED|Overall Study||0
5207177|NCT01012258|12803694|P1|STARTED|Overall Study||66
5207178|NCT01012245|12803704|P1|NOT COMPLETED|Overall Study||2427
5207179|NCT01012245|12803704|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
5207180|NCT01012245|12803704|P1|STARTED|Overall Study||28812
5207181|NCT01012219|12803741|P1|NOT COMPLETED|Period 3||0
5207182|NCT01012219|12803741|P1|COMPLETED|Period 3||20
5207183|NCT01012219|12803741|P1|STARTED|Period 3|of the 36 who started Period 1|20
5207184|NCT01012219|12803741|P1|NOT COMPLETED|Period 2||1
5207185|NCT01012219|12803741|P1|COMPLETED|Period 2||34
5207186|NCT01012219|12803741|P1|STARTED|Period 2|Number who completed Period 1|35
5207187|NCT01012219|12803741|P1|NOT COMPLETED|Period 1||1
5207188|NCT01012219|12803741|P1|COMPLETED|Period 1||35
5207189|NCT01012219|12803741|P1|STARTED|Period 1|Number randomized|36
5207190|NCT01012167|12803751|P3|NOT COMPLETED|Overall Study||4
5207191|NCT01012167|12803752|P2|NOT COMPLETED|Overall Study||2
5207192|NCT01012167|12803753|P1|NOT COMPLETED|Overall Study||2
5207193|NCT01012167|12803751|P3|COMPLETED|Overall Study||17
5207194|NCT01012167|12803752|P2|COMPLETED|Overall Study||18
5207195|NCT01012167|12803753|P1|COMPLETED|Overall Study||15
5207196|NCT01012167|12803751|P3|Exposed to Study Drug|Overall Study||20
5207197|NCT01012167|12803752|P2|Exposed to Study Drug|Overall Study||20
5207198|NCT01012167|12803753|P1|Exposed to Study Drug|Overall Study||16
5207199|NCT01012167|12803751|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
5207200|NCT01012167|12803752|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
5207201|NCT01012167|12803753|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
5207202|NCT01012167|12803751|P3|STARTED|Overall Study||21
5207203|NCT01012167|12803752|P2|STARTED|Overall Study||20
5207204|NCT01012167|12803753|P1|STARTED|Overall Study||17
5207205|NCT01012089|12804009|P1|NOT COMPLETED|Overall Study||0
5207206|NCT01012089|12804009|P1|COMPLETED|Overall Study||6
5207207|NCT01012089|12804009|P1|STARTED|Overall Study||6
5207208|NCT01012037|12804032|P3|NOT COMPLETED|Overall Study||10
5207209|NCT01012037|12804033|P2|NOT COMPLETED|Overall Study||16
5207210|NCT01012037|12804034|P1|NOT COMPLETED|Overall Study||1
5207211|NCT01012037|12804032|P3|COMPLETED|Overall Study||214
5207212|NCT01012037|12804033|P2|COMPLETED|Overall Study||207
5207213|NCT01012037|12804034|P1|COMPLETED|Overall Study||43
5207214|NCT01012037|12804032|P3|STARTED|Overall Study||224
5207215|NCT01012037|12804033|P2|STARTED|Overall Study||223
5207216|NCT01012037|12804034|P1|STARTED|Overall Study||44
5207217|NCT01011946|12804069|P1|NOT COMPLETED|Overall Study||3
5207218|NCT01011946|12804069|P1|COMPLETED|Overall Study||33
5207219|NCT01011946|12804069|P1|STARTED|Overall Study||36
5207220|NCT01011933|12804073|P1|NOT COMPLETED|Overall Study||4
5207221|NCT01011933|12804073|P1|COMPLETED|Overall Study|total eligible and evaluable|50
5207222|NCT01011933|12804073|P1|STARTED|Overall Study|total enrolled|54
5207223|NCT01011907|12804090|P2|NOT COMPLETED|Overall Study||15
5207224|NCT01011907|12804091|P1|NOT COMPLETED|Overall Study||14
5207225|NCT01011907|12804090|P2|COMPLETED|Overall Study||18
5207226|NCT01011907|12804091|P1|COMPLETED|Overall Study||17
5207227|NCT01011907|12804090|P2|STARTED|Overall Study||33
5207228|NCT01011907|12804091|P1|STARTED|Overall Study||31
5207229|NCT01011894|12804101|P1|NOT COMPLETED|Overall Study||0
5207230|NCT01011894|12804101|P1|COMPLETED|Overall Study||26
5207231|NCT01011894|12804101|P1|STARTED|Overall Study||26
5207232|NCT01011868|12804108|P3|NOT COMPLETED|After Week 78 Follow-up||44
5207233|NCT01011868|12804109|P2|NOT COMPLETED|After Week 78 Follow-up||38
5207234|NCT01011868|12804110|P1|NOT COMPLETED|After Week 78 Follow-up||52
5207235|NCT01011868|12804108|P3|COMPLETED|After Week 78 Follow-up||111
5207236|NCT01011868|12804109|P2|COMPLETED|After Week 78 Follow-up||131
5207237|NCT01011868|12804110|P1|COMPLETED|After Week 78 Follow-up||118
5207238|NCT01011868|12804108|P3|STARTED|After Week 78 Follow-up||155
5207239|NCT01011868|12804109|P2|STARTED|After Week 78 Follow-up||169
5207240|NCT01011868|12804110|P1|STARTED|After Week 78 Follow-up||170
5207241|NCT01011868|12804108|P3|NOT COMPLETED|After Week 18 Follow-up||26
5207242|NCT01011868|12804109|P2|NOT COMPLETED|After Week 18 Follow-up||16
5207243|NCT01011868|12804110|P1|NOT COMPLETED|After Week 18 Follow-up||23
5207244|NCT01011868|12804108|P3|COMPLETED|After Week 18 Follow-up||129
5207245|NCT01011868|12804109|P2|COMPLETED|After Week 18 Follow-up||153
5207246|NCT01011868|12804110|P1|COMPLETED|After Week 18 Follow-up||147
5207247|NCT01011868|12804108|P3|STARTED|After Week 18 Follow-up||155
5207248|NCT01011868|12804109|P2|STARTED|After Week 18 Follow-up||169
5207249|NCT01011868|12804110|P1|STARTED|After Week 18 Follow-up||170
5207250|NCT01011829|12804147|P2|NOT COMPLETED|Overall Study||9
5207251|NCT01011829|12804148|P1|NOT COMPLETED|Overall Study||4
5207252|NCT01011829|12804147|P2|COMPLETED|Overall Study||1
5207253|NCT01011829|12804148|P1|COMPLETED|Overall Study||6
5207254|NCT01011829|12804147|P2|STARTED|Overall Study||10
5207255|NCT01011829|12804148|P1|STARTED|Overall Study||10
5207256|NCT01011816|12804158|P2|NOT COMPLETED|78-Week Extended Follow-up||28
5207257|NCT01011816|12804159|P1|NOT COMPLETED|78-Week Extended Follow-up||72
5207258|NCT01011816|12804158|P2|COMPLETED|78-Week Extended Follow-up||26
5207259|NCT01011816|12804159|P1|COMPLETED|78-Week Extended Follow-up||85
5207260|NCT01011816|12804158|P2|STARTED|78-Week Extended Follow-up||54
5207261|NCT01011816|12804159|P1|STARTED|78-Week Extended Follow-up||157
5207262|NCT01011816|12804158|P2|NOT COMPLETED|26-Week Primary Endpoint||2
5207263|NCT01011816|12804159|P1|NOT COMPLETED|26-Week Primary Endpoint||7
5207264|NCT01011816|12804158|P2|COMPLETED|26-Week Primary Endpoint||54
5207265|NCT01011816|12804159|P1|COMPLETED|26-Week Primary Endpoint||157
5207266|NCT01011816|12804158|P2|STARTED|26-Week Primary Endpoint||56
5207267|NCT01011816|12804159|P1|STARTED|26-Week Primary Endpoint||164
5207268|NCT01011738|12804172|P3|NOT COMPLETED|Overall Study||17
5207269|NCT01011738|12804173|P2|NOT COMPLETED|Overall Study||294
5207270|NCT01011738|12804174|P1|NOT COMPLETED|Overall Study||324
5207271|NCT01011738|12804172|P3|COMPLETED|Overall Study||36
5207272|NCT01011738|12804173|P2|COMPLETED|Overall Study||618
5207273|NCT01011738|12804174|P1|COMPLETED|Overall Study||553
5207274|NCT01011738|12804172|P3|STARTED|Overall Study||53
5207275|NCT01011738|12804173|P2|STARTED|Overall Study||912
5207276|NCT01011738|12804174|P1|STARTED|Overall Study||877
5207277|NCT01011673|12804214|P2|NOT COMPLETED|24 Hour Follow-up||3
5207278|NCT01011673|12804215|P1|NOT COMPLETED|24 Hour Follow-up||3
5207279|NCT01011673|12804214|P2|COMPLETED|24 Hour Follow-up||57
5207280|NCT01011673|12804215|P1|COMPLETED|24 Hour Follow-up||57
5207281|NCT01011673|12804214|P2|STARTED|24 Hour Follow-up||60
5207282|NCT01011673|12804215|P1|STARTED|24 Hour Follow-up||60
5207283|NCT01011673|12804214|P2|NOT COMPLETED|Emergency Department Portion||0
5207284|NCT01011673|12804215|P1|NOT COMPLETED|Emergency Department Portion||0
5207285|NCT01011673|12804214|P2|COMPLETED|Emergency Department Portion||60
5207286|NCT01011673|12804215|P1|COMPLETED|Emergency Department Portion||60
5207287|NCT01011673|12804214|P2|STARTED|Emergency Department Portion||60
5207288|NCT01011673|12804215|P1|STARTED|Emergency Department Portion||60
5207289|NCT01011673|12804214|P2|NOT COMPLETED|Randomized||1
5207290|NCT01011673|12804215|P1|NOT COMPLETED|Randomized||2
5207291|NCT01011673|12804214|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
5207292|NCT01011673|12804215|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
5207293|NCT01011673|12804214|P2|STARTED|Randomized||61
5207294|NCT01011673|12804215|P1|STARTED|Randomized||62
5207295|NCT01011634|12804225|P2|NOT COMPLETED|Overall Study||1
5207296|NCT01011634|12804226|P1|NOT COMPLETED|Overall Study||0
5207297|NCT01011634|12804225|P2|COMPLETED|Overall Study||8
5207298|NCT01011634|12804226|P1|COMPLETED|Overall Study||9
5207299|NCT01011634|12804225|P2|STARTED|Overall Study||9
5207300|NCT01011634|12804226|P1|STARTED|Overall Study||9
5207301|NCT01011556|12804238|P4|NOT COMPLETED|Overall Study||13
5207302|NCT01011556|12804239|P3|NOT COMPLETED|Overall Study||10
5207303|NCT01011556|12804240|P2|NOT COMPLETED|Overall Study||8
5207304|NCT01011556|12804241|P1|NOT COMPLETED|Overall Study||6
5207305|NCT01011556|12804238|P4|COMPLETED|Overall Study||51
5207306|NCT01011556|12804239|P3|COMPLETED|Overall Study||45
5207307|NCT01011556|12804240|P2|COMPLETED|Overall Study||48
5207308|NCT01011556|12804241|P1|COMPLETED|Overall Study||52
5207309|NCT01011556|12804238|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
5207310|NCT01011556|12804239|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
5207311|NCT01011556|12804240|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
5207312|NCT01011556|12804241|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
5207313|NCT01011556|12804238|P4|STARTED|Overall Study||64
5207314|NCT01011556|12804239|P3|STARTED|Overall Study||55
5207315|NCT01011556|12804240|P2|STARTED|Overall Study||56
5207316|NCT01011556|12804241|P1|STARTED|Overall Study||58
5207317|NCT01011465|12804319|P8|NOT COMPLETED|Overall Study||0
5207318|NCT01011465|12804320|P7|NOT COMPLETED|Overall Study||1
5207319|NCT01011465|12804321|P6|NOT COMPLETED|Overall Study||0
5207320|NCT01011465|12804322|P5|NOT COMPLETED|Overall Study||1
5207321|NCT01011465|12804323|P4|NOT COMPLETED|Overall Study||0
5207322|NCT01011465|12804324|P3|NOT COMPLETED|Overall Study||0
5207323|NCT01011465|12804325|P2|NOT COMPLETED|Overall Study||1
5207324|NCT01011465|12804326|P1|NOT COMPLETED|Overall Study||2
5207325|NCT01011465|12804319|P8|COMPLETED|Overall Study||32
5207326|NCT01011465|12804320|P7|COMPLETED|Overall Study||51
5207327|NCT01011465|12804321|P6|COMPLETED|Overall Study||29
5207328|NCT01011465|12804322|P5|COMPLETED|Overall Study||46
5207329|NCT01011465|12804323|P4|COMPLETED|Overall Study||18
5207330|NCT01011465|12804324|P3|COMPLETED|Overall Study||36
5207331|NCT01011465|12804325|P2|COMPLETED|Overall Study||19
5207332|NCT01011465|12804326|P1|COMPLETED|Overall Study||34
5207333|NCT01011465|12804319|P8|STARTED|Overall Study||32
5207334|NCT01011465|12804320|P7|STARTED|Overall Study||52
5207335|NCT01011465|12804321|P6|STARTED|Overall Study||29
5207336|NCT01011465|12804322|P5|STARTED|Overall Study||47
5207337|NCT01011465|12804323|P4|STARTED|Overall Study||18
5207338|NCT01011465|12804324|P3|STARTED|Overall Study||36
5207339|NCT01011465|12804325|P2|STARTED|Overall Study||20
5207340|NCT01011465|12804326|P1|STARTED|Overall Study||36
5207341|NCT01011439|12804354|P1|NOT COMPLETED|Overall Study||57
5207342|NCT01011439|12804354|P1|COMPLETED|Overall Study||15
5207343|NCT01011439|12804354|P1|STARTED|Overall Study||72
5207344|NCT01011413|12804366|P2|NOT COMPLETED|Overall Study||25
5207345|NCT01011413|12804367|P1|NOT COMPLETED|Overall Study||26
5207346|NCT01011413|12804366|P2|COMPLETED|Overall Study||299
5207347|NCT01011413|12804367|P1|COMPLETED|Overall Study||286
5207348|NCT01011413|12804366|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
5207349|NCT01011413|12804367|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
5207350|NCT01011413|12804366|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
5207351|NCT01011413|12804367|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
5207352|NCT01011413|12804366|P2|Died Between Week 48 and 96|Overall Study||3
5207353|NCT01011413|12804367|P1|Died Between Week 48 and 96|Overall Study||2
5207354|NCT01011413|12804366|P2|Attended w48 Visit|Overall Study||311
5207355|NCT01011413|12804367|P1|Attended w48 Visit|Overall Study||295
5207356|NCT01011413|12804366|P2|Withdrew Consent Before w48|Overall Study||3
5207357|NCT01011413|12804367|P1|Withdrew Consent Before w48|Overall Study||3
5207358|NCT01011413|12804366|P2|Lost to Follow up Before w48|Overall Study||4
5207359|NCT01011413|12804367|P1|Lost to Follow up Before w48|Overall Study||3
5207360|NCT01011413|12804366|P2|Died Before Week 48|Overall Study||2
5207361|NCT01011413|12804367|P1|Died Before Week 48|Overall Study||3
5207362|NCT01011413|12804366|P2|In Modified ITT|Overall Study||321
5207363|NCT01011413|12804367|P1|In Modified ITT|Overall Study||309
5207364|NCT01011413|12804366|P2|Did Not Start Study Drug|Overall Study||3
5207365|NCT01011413|12804367|P1|Did Not Start Study Drug|Overall Study||3
5207366|NCT01011413|12804366|P2|STARTED|Overall Study|324 randomised|324
5207367|NCT01011413|12804367|P1|STARTED|Overall Study|312 randomised|312
5207368|NCT01011387|12804391|P1|NOT COMPLETED|Overall Study||6
5207369|NCT01011387|12804391|P1|COMPLETED|Overall Study||10
5207370|NCT01011387|12804391|P1|STARTED|Overall Study||16
5207371|NCT01011335|12804399|P13|NOT COMPLETED|Overall Study||3
5207372|NCT01011335|12804400|P12|NOT COMPLETED|Overall Study||1
5207373|NCT01011335|12804401|P11|NOT COMPLETED|Overall Study||6
5207374|NCT01011335|12804402|P10|NOT COMPLETED|Overall Study||0
5207375|NCT01011335|12804403|P9|NOT COMPLETED|Overall Study||2
5207376|NCT01011335|12804404|P8|NOT COMPLETED|Overall Study||2
5207377|NCT01011335|12804405|P7|NOT COMPLETED|Overall Study||3
5207378|NCT01011335|12804406|P6|NOT COMPLETED|Overall Study||1
5207379|NCT01011335|12804407|P5|NOT COMPLETED|Overall Study||1
5207380|NCT01011335|12804408|P4|NOT COMPLETED|Overall Study||2
5207381|NCT01011335|12804409|P3|NOT COMPLETED|Overall Study||1
5207382|NCT01011335|12804410|P2|NOT COMPLETED|Overall Study||1
5207383|NCT01011335|12804411|P1|NOT COMPLETED|Overall Study||1
5207384|NCT01011335|12804399|P13|COMPLETED|Overall Study||19
5207385|NCT01011335|12804400|P12|COMPLETED|Overall Study||21
5207386|NCT01011335|12804401|P11|COMPLETED|Overall Study||6
5207387|NCT01011335|12804402|P10|COMPLETED|Overall Study||12
5207388|NCT01011335|12804403|P9|COMPLETED|Overall Study||10
5207389|NCT01011335|12804404|P8|COMPLETED|Overall Study||10
5207390|NCT01011335|12804405|P7|COMPLETED|Overall Study||9
5207391|NCT01011335|12804406|P6|COMPLETED|Overall Study||11
5207392|NCT01011335|12804407|P5|COMPLETED|Overall Study||12
5207393|NCT01011335|12804408|P4|COMPLETED|Overall Study||10
5207394|NCT01011335|12804409|P3|COMPLETED|Overall Study||11
5207395|NCT01011335|12804410|P2|COMPLETED|Overall Study||11
5207396|NCT01011335|12804411|P1|COMPLETED|Overall Study||10
5207397|NCT01011335|12804399|P13|STARTED|Overall Study||22
5207398|NCT01011335|12804400|P12|STARTED|Overall Study||22
5207399|NCT01011335|12804401|P11|STARTED|Overall Study||12
5207400|NCT01011335|12804402|P10|STARTED|Overall Study||12
5207401|NCT01011335|12804403|P9|STARTED|Overall Study||12
5207402|NCT01011335|12804404|P8|STARTED|Overall Study||12
5207403|NCT01011335|12804405|P7|STARTED|Overall Study||12
5207404|NCT01011335|12804406|P6|STARTED|Overall Study||12
5207405|NCT01011335|12804407|P5|STARTED|Overall Study||13
5207406|NCT01011335|12804408|P4|STARTED|Overall Study||12
5207407|NCT01011335|12804409|P3|STARTED|Overall Study||12
5207408|NCT01011335|12804410|P2|STARTED|Overall Study||12
5207409|NCT01011335|12804411|P1|STARTED|Overall Study||11
5207410|NCT01011309|12804451|P3|NOT COMPLETED|Overall Study||5
5207411|NCT01011309|12804452|P2|NOT COMPLETED|Overall Study||3
5207412|NCT01011309|12804453|P1|NOT COMPLETED|Overall Study||2
5207413|NCT01011309|12804451|P3|COMPLETED|Overall Study||16
5207414|NCT01011309|12804452|P2|COMPLETED|Overall Study||7
5207415|NCT01011309|12804453|P1|COMPLETED|Overall Study||12
5207416|NCT01011309|12804451|P3|STARTED|Overall Study||21
5207417|NCT01011309|12804452|P2|STARTED|Overall Study||10
5207418|NCT01011309|12804453|P1|STARTED|Overall Study||14
5207419|NCT01011283|12804469|P2|NOT COMPLETED|Overall Study||11
5207420|NCT01011283|12804470|P1|NOT COMPLETED|Overall Study||11
5207421|NCT01011283|12804469|P2|COMPLETED|Overall Study||2
5207422|NCT01011283|12804470|P1|COMPLETED|Overall Study||2
5207423|NCT01011283|12804469|P2|STARTED|Overall Study||13
5207424|NCT01011283|12804470|P1|STARTED|Overall Study||13
5207425|NCT01011218|12804482|P4|NOT COMPLETED|Overall Study||0
5207426|NCT01011218|12804483|P3|NOT COMPLETED|Overall Study||0
5207427|NCT01011218|12804484|P2|NOT COMPLETED|Overall Study||0
5207428|NCT01011218|12804485|P1|NOT COMPLETED|Overall Study||0
5207429|NCT01011218|12804482|P4|COMPLETED|Overall Study||26
5207430|NCT01011218|12804483|P3|COMPLETED|Overall Study||26
5207431|NCT01011218|12804484|P2|COMPLETED|Overall Study||9
5207432|NCT01011218|12804485|P1|COMPLETED|Overall Study||9
5207433|NCT01011218|12804482|P4|STARTED|Overall Study||26
5207434|NCT01011218|12804483|P3|STARTED|Overall Study||26
5207435|NCT01011218|12804484|P2|STARTED|Overall Study||9
5207436|NCT01011218|12804485|P1|STARTED|Overall Study||9
5207437|NCT01011179|12804509|P2|NOT COMPLETED|Overall Study||2
5207438|NCT01011179|12804510|P1|NOT COMPLETED|Overall Study||4
5207439|NCT01011179|12804509|P2|COMPLETED|Overall Study||20
5207440|NCT01011179|12804510|P1|COMPLETED|Overall Study||20
5207441|NCT01011179|12804509|P2|STARTED|Overall Study||22
5207442|NCT01011179|12804510|P1|STARTED|Overall Study||24
5207443|NCT01011153|12804519|P3|NOT COMPLETED|Overall Study||9
5207444|NCT01011153|12804520|P2|NOT COMPLETED|Overall Study||11
5207445|NCT01011153|12804521|P1|NOT COMPLETED|Overall Study||8
5207446|NCT01011153|12804519|P3|COMPLETED|Overall Study||45
5207447|NCT01011153|12804520|P2|COMPLETED|Overall Study||64
5207448|NCT01011153|12804521|P1|COMPLETED|Overall Study||46
5207449|NCT01011153|12804519|P3|STARTED|Overall Study||54
5207450|NCT01011153|12804520|P2|STARTED|Overall Study||75
5207451|NCT01011153|12804521|P1|STARTED|Overall Study||54
5207452|NCT01011075|12804539|P1|NOT COMPLETED|Overall Study||0
5207453|NCT01011075|12804539|P1|COMPLETED|Overall Study||34
5207454|NCT01011075|12804539|P1|STARTED|Overall Study||34
5207455|NCT01011049|12804550|P4|NOT COMPLETED|Overall Study||0
5207456|NCT01011049|12804551|P3|NOT COMPLETED|Overall Study||4
5207457|NCT01011049|12804552|P2|NOT COMPLETED|Overall Study||2
5207458|NCT01011049|12804553|P1|NOT COMPLETED|Overall Study||1
5207459|NCT01011049|12804550|P4|COMPLETED|Overall Study||246
5207460|NCT01011049|12804551|P3|COMPLETED|Overall Study||239
5207461|NCT01011049|12804552|P2|COMPLETED|Overall Study||250
5207462|NCT01011049|12804553|P1|COMPLETED|Overall Study||506
5207463|NCT01011049|12804550|P4|STARTED|Overall Study||246
5207464|NCT01011049|12804551|P3|STARTED|Overall Study||243
5207465|NCT01011049|12804552|P2|STARTED|Overall Study||252
5207466|NCT01011049|12804553|P1|STARTED|Overall Study||507
5207467|NCT01010984|12804575|P1|NOT COMPLETED|Overall Study||0
5207468|NCT01010984|12804575|P1|COMPLETED|Overall Study||20
5207469|NCT01010984|12804575|P1|STARTED|Overall Study||20
5207470|NCT01010971|12804583|P3|NOT COMPLETED|Overall Study||13
5207471|NCT01010971|12804584|P2|NOT COMPLETED|Overall Study||8
5207472|NCT01010971|12804585|P1|NOT COMPLETED|Overall Study||3
5207473|NCT01010971|12804583|P3|COMPLETED|Overall Study||207
5207474|NCT01010971|12804584|P2|COMPLETED|Overall Study||218
5207475|NCT01010971|12804585|P1|COMPLETED|Overall Study||222
5207476|NCT01010971|12804583|P3|STARTED|Overall Study||220
5207477|NCT01010971|12804584|P2|STARTED|Overall Study||226
5207478|NCT01010971|12804585|P1|STARTED|Overall Study||225
5207479|NCT01010932|12804670|P1|NOT COMPLETED|Overall Study||22
5207480|NCT01010932|12804670|P1|COMPLETED|Overall Study||200
5207481|NCT01010932|12804670|P1|STARTED|Overall Study||222
5207482|NCT01010906|12804688|P6|NOT COMPLETED|Overall Study||0
5207483|NCT01010906|12804689|P5|NOT COMPLETED|Overall Study||0
5207484|NCT01010906|12804690|P4|NOT COMPLETED|Overall Study||0
5207485|NCT01010906|12804691|P3|NOT COMPLETED|Overall Study||0
5207486|NCT01010906|12804692|P2|NOT COMPLETED|Overall Study||0
5207487|NCT01010906|12804693|P1|NOT COMPLETED|Overall Study||0
5207488|NCT01010906|12804688|P6|COMPLETED|Overall Study||10
5207489|NCT01010906|12804689|P5|COMPLETED|Overall Study||10
5207490|NCT01010906|12804690|P4|COMPLETED|Overall Study||10
5207491|NCT01010906|12804691|P3|COMPLETED|Overall Study||10
5207492|NCT01010906|12804692|P2|COMPLETED|Overall Study||10
5207493|NCT01010906|12804693|P1|COMPLETED|Overall Study||10
5207494|NCT01010906|12804688|P6|STARTED|Overall Study||10
5207495|NCT01010906|12804689|P5|STARTED|Overall Study||10
5207496|NCT01010906|12804690|P4|STARTED|Overall Study||10
5207497|NCT01010906|12804691|P3|STARTED|Overall Study||10
5207498|NCT01010906|12804692|P2|STARTED|Overall Study||10
5207499|NCT01010906|12804693|P1|STARTED|Overall Study||10
5207500|NCT01010867|12804713|P1|NOT COMPLETED|Overall Study||1
5207501|NCT01010867|12804713|P1|COMPLETED|Overall Study||30
5207502|NCT01010867|12804713|P1|STARTED|Overall Study||31
5207503|NCT01010854|12804720|P1|NOT COMPLETED|Overall Study||0
5207504|NCT01010854|12804720|P1|COMPLETED|Overall Study||6
5207505|NCT01010854|12804720|P1|STARTED|Overall Study||6
5207506|NCT01010776|12804725|P1|NOT COMPLETED|Extension Phase||3
5207507|NCT01010776|12804725|P1|COMPLETED|Extension Phase||156
5207508|NCT01010776|12804725|P1|STARTED|Extension Phase||159
5207509|NCT01010776|12804725|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
5207510|NCT01010776|12804725|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
5207511|NCT01010776|12804725|P1|STARTED|In-Between Main Phase & Extension Phase||174
5207512|NCT01010776|12804725|P1|NOT COMPLETED|Main Phase||49
5207513|NCT01010776|12804725|P1|COMPLETED|Main Phase||174
5207514|NCT01010776|12804725|P1|Treated|Main Phase||218
5207515|NCT01010776|12804725|P1|STARTED|Main Phase||223
5207516|NCT01010763|12804749|P2|NOT COMPLETED|Overall Study||30
5207517|NCT01010763|12804750|P1|NOT COMPLETED|Overall Study||35
5207518|NCT01010763|12804749|P2|COMPLETED|Overall Study||54
5207519|NCT01010763|12804750|P1|COMPLETED|Overall Study||61
5207520|NCT01010763|12804749|P2|STARTED|Overall Study||84
5207521|NCT01010763|12804750|P1|STARTED|Overall Study||96
5207522|NCT01010750|12804782|P6|NOT COMPLETED|Third Intervention||0
5207523|NCT01010750|12804783|P5|NOT COMPLETED|Third Intervention||0
5207524|NCT01010750|12804784|P4|NOT COMPLETED|Third Intervention||0
5207525|NCT01010750|12804785|P3|NOT COMPLETED|Third Intervention||0
5207526|NCT01010750|12804786|P2|NOT COMPLETED|Third Intervention||0
5207527|NCT01010750|12804787|P1|NOT COMPLETED|Third Intervention||0
5207528|NCT01010750|12804782|P6|COMPLETED|Third Intervention||3
5207529|NCT01010750|12804783|P5|COMPLETED|Third Intervention||2
5207530|NCT01010750|12804784|P4|COMPLETED|Third Intervention||3
5207531|NCT01010750|12804785|P3|COMPLETED|Third Intervention||3
5207532|NCT01010750|12804786|P2|COMPLETED|Third Intervention||3
5207533|NCT01010750|12804787|P1|COMPLETED|Third Intervention||3
5207534|NCT01010750|12804782|P6|STARTED|Third Intervention||3
5207535|NCT01010750|12804783|P5|STARTED|Third Intervention||2
5207536|NCT01010750|12804784|P4|STARTED|Third Intervention||3
5207537|NCT01010750|12804785|P3|STARTED|Third Intervention||3
5207538|NCT01010750|12804786|P2|STARTED|Third Intervention||3
5207539|NCT01010750|12804787|P1|STARTED|Third Intervention||3
5207540|NCT01010750|12804782|P6|NOT COMPLETED|Second Intervention||0
5207541|NCT01010750|12804783|P5|NOT COMPLETED|Second Intervention||0
5207542|NCT01010750|12804784|P4|NOT COMPLETED|Second Intervention||0
5207543|NCT01010750|12804785|P3|NOT COMPLETED|Second Intervention||0
5207544|NCT01010750|12804786|P2|NOT COMPLETED|Second Intervention||1
5207545|NCT01010750|12804787|P1|NOT COMPLETED|Second Intervention||0
5207546|NCT01010750|12804782|P6|COMPLETED|Second Intervention||3
5207547|NCT01010750|12804783|P5|COMPLETED|Second Intervention||2
5207548|NCT01010750|12804784|P4|COMPLETED|Second Intervention||3
5207549|NCT01010750|12804785|P3|COMPLETED|Second Intervention||3
5207550|NCT01010750|12804786|P2|COMPLETED|Second Intervention||3
5207551|NCT01010750|12804787|P1|COMPLETED|Second Intervention||3
5207552|NCT01010750|12804782|P6|STARTED|Second Intervention||3
5207553|NCT01010750|12804783|P5|STARTED|Second Intervention||2
5207554|NCT01010750|12804784|P4|STARTED|Second Intervention||3
5207555|NCT01010750|12804785|P3|STARTED|Second Intervention||3
5207556|NCT01010750|12804786|P2|STARTED|Second Intervention||4
5207557|NCT01010750|12804787|P1|STARTED|Second Intervention||3
5207558|NCT01010750|12804782|P6|NOT COMPLETED|First Intervention||0
5207559|NCT01010750|12804783|P5|NOT COMPLETED|First Intervention||0
5207560|NCT01010750|12804784|P4|NOT COMPLETED|First Intervention||0
5207561|NCT01010750|12804785|P3|NOT COMPLETED|First Intervention||0
5207562|NCT01010750|12804786|P2|NOT COMPLETED|First Intervention||0
5207563|NCT01010750|12804787|P1|NOT COMPLETED|First Intervention||0
5207564|NCT01010750|12804782|P6|COMPLETED|First Intervention||3
5207565|NCT01010750|12804783|P5|COMPLETED|First Intervention||2
5207566|NCT01010750|12804784|P4|COMPLETED|First Intervention||3
5207567|NCT01010750|12804785|P3|COMPLETED|First Intervention||3
5207568|NCT01010750|12804786|P2|COMPLETED|First Intervention||4
5207569|NCT01010750|12804787|P1|COMPLETED|First Intervention||3
5207570|NCT01010750|12804782|P6|STARTED|First Intervention||3
5207571|NCT01010750|12804783|P5|STARTED|First Intervention||2
5207572|NCT01010750|12804784|P4|STARTED|First Intervention||3
5207573|NCT01010750|12804785|P3|STARTED|First Intervention||3
5207574|NCT01010750|12804786|P2|STARTED|First Intervention||4
5207575|NCT01010750|12804787|P1|STARTED|First Intervention||3
5207576|NCT01010633|12804812|P2|NOT COMPLETED|Overall Study||5
5207577|NCT01010633|12804813|P1|NOT COMPLETED|Overall Study||4
5207578|NCT01010633|12804812|P2|COMPLETED|Overall Study||198
5207579|NCT01010633|12804813|P1|COMPLETED|Overall Study||199
5207580|NCT01010633|12804812|P2|STARTED|Overall Study||203
5207581|NCT01010633|12804813|P1|STARTED|Overall Study||203
5207582|NCT01010568|12804823|P1|NOT COMPLETED|Overall Study||5
5207583|NCT01010568|12804823|P1|COMPLETED|Overall Study||5
5207584|NCT01010568|12804823|P1|STARTED|Overall Study||10
5207585|NCT01010555|12804829|P2|NOT COMPLETED|Second Four Weeks of Wear||0
5207586|NCT01010555|12804830|P1|NOT COMPLETED|Second Four Weeks of Wear||0
5207587|NCT01010555|12804829|P2|COMPLETED|Second Four Weeks of Wear||9
5207588|NCT01010555|12804830|P1|COMPLETED|Second Four Weeks of Wear||10
5207589|NCT01010555|12804829|P2|STARTED|Second Four Weeks of Wear||9
5207590|NCT01010555|12804830|P1|STARTED|Second Four Weeks of Wear||10
5207591|NCT01010555|12804829|P2|NOT COMPLETED|First Four Weeks of Wear||0
5207592|NCT01010555|12804830|P1|NOT COMPLETED|First Four Weeks of Wear||0
5207593|NCT01010555|12804829|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
5207594|NCT01010555|12804830|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
5207595|NCT01010555|12804829|P2|STARTED|First Four Weeks of Wear||10
5207596|NCT01010555|12804830|P1|STARTED|First Four Weeks of Wear||11
5207597|NCT01010503|12804840|P1|NOT COMPLETED|Overall Study||2
5207598|NCT01010503|12804840|P1|COMPLETED|Overall Study||30
5207599|NCT01010503|12804840|P1|STARTED|Overall Study||32
5207600|NCT01010477|12804860|P2|NOT COMPLETED|Overall Study||3
5207601|NCT01010477|12804861|P1|NOT COMPLETED|Overall Study||6
5207602|NCT01010477|12804860|P2|COMPLETED|Overall Study||22
5207603|NCT01010477|12804861|P1|COMPLETED|Overall Study||21
5207604|NCT01010477|12804860|P2|STARTED|Overall Study||25
5207605|NCT01010477|12804861|P1|STARTED|Overall Study||27
5207606|NCT01010399|12804867|P1|NOT COMPLETED|Overall Study||5
5207607|NCT01010399|12804867|P1|COMPLETED|Overall Study||31
5207608|NCT01010399|12804867|P1|STARTED|Overall Study||36
5207609|NCT01010282|12804875|P3|NOT COMPLETED|Overall Study||19
5207610|NCT01010282|12804876|P2|NOT COMPLETED|Overall Study||7
5207611|NCT01010282|12804877|P1|NOT COMPLETED|Overall Study||6
5207612|NCT01010282|12804875|P3|COMPLETED|Overall Study||77
5207613|NCT01010282|12804876|P2|COMPLETED|Overall Study||88
5207614|NCT01010282|12804877|P1|COMPLETED|Overall Study||91
5207615|NCT01010282|12804875|P3|STARTED|Overall Study||96
5207616|NCT01010282|12804876|P2|STARTED|Overall Study||95
5207617|NCT01010282|12804877|P1|STARTED|Overall Study||97
5207618|NCT01010230|12804899|P2|NOT COMPLETED|Overall Study||7
5207619|NCT01010230|12804900|P1|NOT COMPLETED|Overall Study||10
5207620|NCT01010230|12804899|P2|COMPLETED|Overall Study||26
5207621|NCT01010230|12804900|P1|COMPLETED|Overall Study||22
5207622|NCT01010230|12804899|P2|STARTED|Overall Study||33
5207623|NCT01010230|12804900|P1|STARTED|Overall Study||32
5207624|NCT01010217|12804935|P5|NOT COMPLETED|Overall Study||3
5207625|NCT01010217|12804936|P4|NOT COMPLETED|Overall Study||6
5207626|NCT01010217|12804937|P3|NOT COMPLETED|Overall Study||1
5207627|NCT01010217|12804938|P2|NOT COMPLETED|Overall Study||5
5207628|NCT01010217|12804939|P1|NOT COMPLETED|Overall Study||5
5207629|NCT01010217|12804935|P5|COMPLETED|Overall Study||0
5207630|NCT01010217|12804936|P4|COMPLETED|Overall Study||0
5207631|NCT01010217|12804937|P3|COMPLETED|Overall Study||21
5207632|NCT01010217|12804938|P2|COMPLETED|Overall Study||51
5207633|NCT01010217|12804939|P1|COMPLETED|Overall Study||84
5207634|NCT01010217|12804935|P5|STARTED|Overall Study||3
5207635|NCT01010217|12804936|P4|STARTED|Overall Study||6
5207636|NCT01010217|12804937|P3|STARTED|Overall Study||22
5207637|NCT01010217|12804938|P2|STARTED|Overall Study||56
5207638|NCT01010217|12804939|P1|STARTED|Overall Study||89
5207639|NCT01010204|12804978|P2|NOT COMPLETED|Overall Study||9
5207640|NCT01010204|12804979|P1|NOT COMPLETED|Overall Study||7
5207641|NCT01010204|12804978|P2|COMPLETED|Overall Study||20
5207642|NCT01010204|12804979|P1|COMPLETED|Overall Study||24
5207643|NCT01010204|12804978|P2|STARTED|Overall Study||29
5207644|NCT01010204|12804979|P1|STARTED|Overall Study||31
5207645|NCT01010126|12804995|P6|NOT COMPLETED|Overall Study||0
5207646|NCT01010126|12804996|P5|NOT COMPLETED|Overall Study||3
5207647|NCT01010126|12804997|P4|NOT COMPLETED|Overall Study||0
5207648|NCT01010126|12804998|P3|NOT COMPLETED|Overall Study||1
5207649|NCT01010126|12804999|P2|NOT COMPLETED|Overall Study||0
5207650|NCT01010126|12805000|P1|NOT COMPLETED|Overall Study||1
5207651|NCT01010126|12804995|P6|COMPLETED|Overall Study||24
5207652|NCT01010126|12804996|P5|COMPLETED|Overall Study||55
5207653|NCT01010126|12804997|P4|COMPLETED|Overall Study||57
5207654|NCT01010126|12804998|P3|COMPLETED|Overall Study||27
5207655|NCT01010126|12804999|P2|COMPLETED|Overall Study||58
5207656|NCT01010126|12805000|P1|COMPLETED|Overall Study||26
5207657|NCT01010126|12804995|P6|STARTED|Overall Study||24
5207658|NCT01010126|12804996|P5|STARTED|Overall Study||58
5207659|NCT01010126|12804997|P4|STARTED|Overall Study||57
5207660|NCT01010126|12804998|P3|STARTED|Overall Study||28
5207661|NCT01010126|12804999|P2|STARTED|Overall Study||58
5207662|NCT01010126|12805000|P1|STARTED|Overall Study||27
5207663|NCT01010061|12805052|P2|NOT COMPLETED|Overall Study||40
5207664|NCT01010061|12805053|P1|NOT COMPLETED|Overall Study||48
5207665|NCT01010061|12805052|P2|COMPLETED|Overall Study||78
5207666|NCT01010061|12805053|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
5207667|NCT01010061|12805052|P2|Received Study Drug|Overall Study||116
5207668|NCT01010061|12805053|P1|Received Study Drug|Overall Study||236
5207669|NCT01010061|12805052|P2|STARTED|Overall Study||118
5207670|NCT01010061|12805053|P1|STARTED|Overall Study||238
5207671|NCT01010009|12805088|P3|NOT COMPLETED|Overall Study||0
5207672|NCT01010009|12805089|P2|NOT COMPLETED|Overall Study||0
5207673|NCT01010009|12805090|P1|NOT COMPLETED|Overall Study||0
5207674|NCT01010009|12805088|P3|COMPLETED|Overall Study||8
5207675|NCT01010009|12805089|P2|COMPLETED|Overall Study||8
5207676|NCT01010009|12805090|P1|COMPLETED|Overall Study||8
5207677|NCT01010009|12805088|P3|STARTED|Overall Study||8
5207678|NCT01010009|12805089|P2|STARTED|Overall Study||8
5207679|NCT01010009|12805090|P1|STARTED|Overall Study||8
5207680|NCT01009983|12805104|P1|NOT COMPLETED|Overall Study||1
5207681|NCT01009983|12805104|P1|COMPLETED|Overall Study||13
5207682|NCT01009983|12805104|P1|STARTED|Overall Study||14
5207683|NCT01009931|12805111|P1|NOT COMPLETED|Overall Study||1
5207684|NCT01009931|12805111|P1|COMPLETED|Overall Study||0
5207685|NCT01009931|12805111|P1|STARTED|Overall Study||1
5207686|NCT01009840|12805117|P1|NOT COMPLETED|Overall Study||14
5207687|NCT01009840|12805117|P1|COMPLETED|Overall Study||16
5207688|NCT01009840|12805117|P1|STARTED|Overall Study||30
5207689|NCT01009814|12805135|P5|NOT COMPLETED|Overall Study||0
5207690|NCT01009814|12805136|P4|NOT COMPLETED|Overall Study||0
5207691|NCT01009814|12805137|P3|NOT COMPLETED|Overall Study||0
5207692|NCT01009814|12805138|P2|NOT COMPLETED|Overall Study||1
5207693|NCT01009814|12805139|P1|NOT COMPLETED|Overall Study||1
5207694|NCT01009814|12805135|P5|COMPLETED|Overall Study||10
5207695|NCT01009814|12805136|P4|COMPLETED|Overall Study||10
5207696|NCT01009814|12805137|P3|COMPLETED|Overall Study||10
5207697|NCT01009814|12805138|P2|COMPLETED|Overall Study||9
5207698|NCT01009814|12805139|P1|COMPLETED|Overall Study||9
5207699|NCT01009814|12805135|P5|STARTED|Overall Study||10
5207700|NCT01009814|12805136|P4|STARTED|Overall Study||10
5207701|NCT01009814|12805137|P3|STARTED|Overall Study||10
5207702|NCT01009814|12805138|P2|STARTED|Overall Study||10
5207703|NCT01009814|12805139|P1|STARTED|Overall Study||10
5207704|NCT01009762|12805248|P2|NOT COMPLETED|Overall Study||0
5207705|NCT01009762|12805249|P1|NOT COMPLETED|Overall Study||0
5207706|NCT01009762|12805248|P2|COMPLETED|Overall Study|10 participants received vaccine|10
5207707|NCT01009762|12805249|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
5207708|NCT01009762|12805248|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
5207709|NCT01009762|12805249|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
5207710|NCT01009762|12805248|P2|STARTED|Overall Study||10
5207711|NCT01009762|12805249|P1|STARTED|Overall Study||1
5207712|NCT01009645|12805263|P4|NOT COMPLETED|Overall Study||5
5207713|NCT01009645|12805264|P3|NOT COMPLETED|Overall Study||4
5207714|NCT01009645|12805265|P2|NOT COMPLETED|Overall Study||8
5207715|NCT01009645|12805266|P1|NOT COMPLETED|Overall Study||2
5207716|NCT01009645|12805263|P4|COMPLETED|Overall Study||26
5207717|NCT01009645|12805264|P3|COMPLETED|Overall Study||28
5207718|NCT01009645|12805265|P2|COMPLETED|Overall Study||23
5207719|NCT01009645|12805266|P1|COMPLETED|Overall Study||29
5207720|NCT01009645|12805263|P4|STARTED|Overall Study||31
5207721|NCT01009645|12805264|P3|STARTED|Overall Study||32
5207722|NCT01009645|12805265|P2|STARTED|Overall Study||31
5207723|NCT01009645|12805266|P1|STARTED|Overall Study||31
5207724|NCT01009619|12805282|P2|NOT COMPLETED|Overall Study||0
5207725|NCT01009619|12805283|P1|NOT COMPLETED|Overall Study||0
5207726|NCT01009619|12805282|P2|COMPLETED|Overall Study||43
5207727|NCT01009619|12805283|P1|COMPLETED|Overall Study||40
5207728|NCT01009619|12805282|P2|STARTED|Overall Study||43
5207729|NCT01009619|12805283|P1|STARTED|Overall Study||40
5207730|NCT01009580|12805303|P2|NOT COMPLETED|Overall Study||35
5207731|NCT01009580|12805304|P1|NOT COMPLETED|Overall Study||27
5207732|NCT01009580|12805303|P2|COMPLETED|Overall Study||188
5207733|NCT01009580|12805304|P1|COMPLETED|Overall Study||197
5207734|NCT01009580|12805303|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
5207735|NCT01009580|12805304|P1|Exposed|Overall Study||224
5207736|NCT01009580|12805303|P2|STARTED|Overall Study||223
5207737|NCT01009580|12805304|P1|STARTED|Overall Study||224
5207738|NCT01009554|12805318|P2|NOT COMPLETED|Overall Study||7
5207739|NCT01009554|12805319|P1|NOT COMPLETED|Overall Study||2
5207740|NCT01009554|12805318|P2|COMPLETED|Overall Study||41
5207741|NCT01009554|12805319|P1|COMPLETED|Overall Study||46
5207742|NCT01009554|12805318|P2|STARTED|Overall Study||48
5207743|NCT01009554|12805319|P1|STARTED|Overall Study||48
5207744|NCT01009515|12805451|P1|NOT COMPLETED|Overall Study||3
5207745|NCT01009515|12805451|P1|COMPLETED|Overall Study||16
5207746|NCT01009515|12805451|P1|STARTED|Overall Study||19
5207747|NCT01009463|12805462|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
5207748|NCT01009463|12805463|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
5207749|NCT01009463|12805464|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
5207750|NCT01009463|12805465|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
5207751|NCT01009463|12805466|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
5207752|NCT01009463|12805462|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
5207753|NCT01009463|12805463|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
5207754|NCT01009463|12805464|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
5207755|NCT01009463|12805465|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
5207756|NCT01009463|12805466|P1|COMPLETED|52-week, Double-blind Treatment Period||0
5207757|NCT01009463|12805462|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
5207758|NCT01009463|12805463|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
5207759|NCT01009463|12805464|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
5207760|NCT01009463|12805465|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
5207761|NCT01009463|12805466|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
5207762|NCT01009463|12805462|P5|STARTED|52-week, Double-blind Treatment Period||402
5207763|NCT01009463|12805463|P4|STARTED|52-week, Double-blind Treatment Period||403
5207764|NCT01009463|12805464|P3|STARTED|52-week, Double-blind Treatment Period||408
5207765|NCT01009463|12805465|P2|STARTED|52-week, Double-blind Treatment Period||409
5207766|NCT01009463|12805466|P1|STARTED|52-week, Double-blind Treatment Period||0
5207767|NCT01009463|12805462|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
5207768|NCT01009463|12805463|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
5207769|NCT01009463|12805464|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
5207770|NCT01009463|12805465|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
5207771|NCT01009463|12805466|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
5207772|NCT01009463|12805462|P5|COMPLETED|4-week, Open-label Run-In Period||0
5207773|NCT01009463|12805463|P4|COMPLETED|4-week, Open-label Run-In Period||0
5207774|NCT01009463|12805464|P3|COMPLETED|4-week, Open-label Run-In Period||0
5207775|NCT01009463|12805465|P2|COMPLETED|4-week, Open-label Run-In Period||0
5207776|NCT01009463|12805466|P1|COMPLETED|4-week, Open-label Run-In Period||1622
5207777|NCT01009463|12805462|P5|STARTED|4-week, Open-label Run-In Period||0
5207778|NCT01009463|12805463|P4|STARTED|4-week, Open-label Run-In Period||0
5207779|NCT01009463|12805464|P3|STARTED|4-week, Open-label Run-In Period||0
5207780|NCT01009463|12805465|P2|STARTED|4-week, Open-label Run-In Period||0
5207781|NCT01009463|12805466|P1|STARTED|4-week, Open-label Run-In Period||2071
5207782|NCT01009346|12805488|P1|NOT COMPLETED|Overall Study||4
5207783|NCT01009346|12805488|P1|COMPLETED|Overall Study||5
5207784|NCT01009346|12805488|P1|STARTED|Overall Study||9
5207785|NCT01009333|12805493|P6|NOT COMPLETED|Week 3||0
5207786|NCT01009333|12805494|P5|NOT COMPLETED|Week 3||0
5207787|NCT01009333|12805495|P4|NOT COMPLETED|Week 3||0
5207788|NCT01009333|12805496|P3|NOT COMPLETED|Week 3||0
5207789|NCT01009333|12805497|P2|NOT COMPLETED|Week 3||0
5207790|NCT01009333|12805498|P1|NOT COMPLETED|Week 3||0
5207791|NCT01009333|12805493|P6|COMPLETED|Week 3||2
5207792|NCT01009333|12805494|P5|COMPLETED|Week 3||2
5207793|NCT01009333|12805495|P4|COMPLETED|Week 3||2
5207794|NCT01009333|12805496|P3|COMPLETED|Week 3||2
5207795|NCT01009333|12805497|P2|COMPLETED|Week 3||2
5207796|NCT01009333|12805498|P1|COMPLETED|Week 3||2
5207797|NCT01009333|12805493|P6|STARTED|Week 3||2
5207798|NCT01009333|12805494|P5|STARTED|Week 3||2
5207799|NCT01009333|12805495|P4|STARTED|Week 3||2
5207800|NCT01009333|12805496|P3|STARTED|Week 3||2
5207801|NCT01009333|12805497|P2|STARTED|Week 3||2
5207802|NCT01009333|12805498|P1|STARTED|Week 3||2
5207803|NCT01009333|12805493|P6|NOT COMPLETED|Week 2||0
5207804|NCT01009333|12805494|P5|NOT COMPLETED|Week 2||0
5207805|NCT01009333|12805495|P4|NOT COMPLETED|Week 2||0
5207806|NCT01009333|12805496|P3|NOT COMPLETED|Week 2||0
5207807|NCT01009333|12805497|P2|NOT COMPLETED|Week 2||0
5207808|NCT01009333|12805498|P1|NOT COMPLETED|Week 2||0
5207809|NCT01009333|12805493|P6|COMPLETED|Week 2||2
5207810|NCT01009333|12805494|P5|COMPLETED|Week 2||2
5207811|NCT01009333|12805495|P4|COMPLETED|Week 2||2
5207812|NCT01009333|12805496|P3|COMPLETED|Week 2||2
5207813|NCT01009333|12805497|P2|COMPLETED|Week 2||2
5207814|NCT01009333|12805498|P1|COMPLETED|Week 2||2
5207815|NCT01009333|12805493|P6|STARTED|Week 2||2
5207816|NCT01009333|12805494|P5|STARTED|Week 2||2
5207817|NCT01009333|12805495|P4|STARTED|Week 2||2
5207818|NCT01009333|12805496|P3|STARTED|Week 2||2
5207819|NCT01009333|12805497|P2|STARTED|Week 2||2
5207820|NCT01009333|12805498|P1|STARTED|Week 2||2
5207821|NCT01009333|12805493|P6|NOT COMPLETED|Week 1||0
5207822|NCT01009333|12805494|P5|NOT COMPLETED|Week 1||0
5207823|NCT01009333|12805495|P4|NOT COMPLETED|Week 1||0
5207824|NCT01009333|12805496|P3|NOT COMPLETED|Week 1||0
5207825|NCT01009333|12805497|P2|NOT COMPLETED|Week 1||0
5207826|NCT01009333|12805498|P1|NOT COMPLETED|Week 1||0
5207827|NCT01009333|12805493|P6|COMPLETED|Week 1||2
5207828|NCT01009333|12805494|P5|COMPLETED|Week 1||2
5207829|NCT01009333|12805495|P4|COMPLETED|Week 1||2
5207830|NCT01009333|12805496|P3|COMPLETED|Week 1||2
5207831|NCT01009333|12805497|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
5207832|NCT01009333|12805498|P1|COMPLETED|Week 1||2
5207833|NCT01009333|12805493|P6|STARTED|Week 1||2
5207834|NCT01009333|12805494|P5|STARTED|Week 1||2
5207835|NCT01009333|12805495|P4|STARTED|Week 1||2
5207836|NCT01009333|12805496|P3|STARTED|Week 1||2
5207837|NCT01009333|12805497|P2|STARTED|Week 1||3
5207838|NCT01009333|12805498|P1|STARTED|Week 1||2
5207839|NCT01009294|12805512|P1|NOT COMPLETED|Overall Study||6
5207840|NCT01009294|12805512|P1|COMPLETED|Overall Study||0
5207841|NCT01009294|12805512|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
5207842|NCT01009294|12805512|P1|STARTED|Overall Study||6
5207843|NCT01009203|12805533|P1|NOT COMPLETED|Overall Study||7
5207844|NCT01009203|12805533|P1|COMPLETED|Overall Study||6
5207845|NCT01009203|12805533|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
5207846|NCT01009203|12805533|P1|STARTED|Overall Study||13
5207847|NCT01009138|12805542|P2|NOT COMPLETED|Overall Study||20
5207848|NCT01009138|12805543|P1|NOT COMPLETED|Overall Study||13
5207849|NCT01009138|12805542|P2|COMPLETED|Overall Study||88
5207850|NCT01009138|12805543|P1|COMPLETED|Overall Study||93
5207851|NCT01009138|12805542|P2|STARTED|Overall Study||108
5207852|NCT01009138|12805543|P1|STARTED|Overall Study||106
5207853|NCT01009099|12805573|P2|NOT COMPLETED|Overall Study||4
5207854|NCT01009099|12805574|P1|NOT COMPLETED|Overall Study||5
5207855|NCT01009099|12805573|P2|COMPLETED|Overall Study||57
5207856|NCT01009099|12805574|P1|COMPLETED|Overall Study||53
5207857|NCT01009099|12805573|P2|STARTED|Overall Study||61
5207858|NCT01009099|12805574|P1|STARTED|Overall Study||58
5207859|NCT01009086|12805583|P3|NOT COMPLETED|Overall Study||34
5207860|NCT01009086|12805584|P2|NOT COMPLETED|Overall Study||47
5207861|NCT01009086|12805585|P1|NOT COMPLETED|Overall Study||44
5207862|NCT01009086|12805583|P3|COMPLETED|Overall Study||170
5207863|NCT01009086|12805584|P2|COMPLETED|Overall Study||158
5207864|NCT01009086|12805585|P1|COMPLETED|Overall Study||162
5207865|NCT01009086|12805583|P3|STARTED|Overall Study||204
5207866|NCT01009086|12805584|P2|STARTED|Overall Study||205
5207867|NCT01009086|12805585|P1|STARTED|Overall Study||206
5207868|NCT01009060|12805620|P2|NOT COMPLETED|Overall Study||5
5207869|NCT01009060|12805621|P1|NOT COMPLETED|Overall Study||4
5207870|NCT01009060|12805620|P2|COMPLETED|Overall Study||20
5207871|NCT01009060|12805621|P1|COMPLETED|Overall Study||21
5207872|NCT01009060|12805620|P2|STARTED|Overall Study||25
5207873|NCT01009060|12805621|P1|STARTED|Overall Study||25
5207874|NCT01009047|12805659|P2|NOT COMPLETED|Overall Study||26
5207875|NCT01009047|12805660|P1|NOT COMPLETED|Overall Study||28
5207876|NCT01009047|12805659|P2|COMPLETED|Overall Study||89
5207877|NCT01009047|12805660|P1|COMPLETED|Overall Study||85
5207878|NCT01009047|12805659|P2|STARTED|Overall Study||115
5207879|NCT01009047|12805660|P1|STARTED|Overall Study||113
5207880|NCT01009034|12805682|P1|NOT COMPLETED|Overall Study||4
5207881|NCT01009034|12805682|P1|COMPLETED|Overall Study||10
5207882|NCT01009034|12805682|P1|STARTED|Overall Study||14
5207883|NCT01008995|12805690|P4|NOT COMPLETED|After Controlled Period||1
5207884|NCT01008995|12805691|P3|NOT COMPLETED|After Controlled Period||2
5207885|NCT01008995|12805692|P2|NOT COMPLETED|After Controlled Period||0
5207886|NCT01008995|12805693|P1|NOT COMPLETED|After Controlled Period||0
5207887|NCT01008995|12805690|P4|COMPLETED|After Controlled Period||156
5207888|NCT01008995|12805691|P3|COMPLETED|After Controlled Period||156
5207889|NCT01008995|12805692|P2|COMPLETED|After Controlled Period||0
5207890|NCT01008995|12805693|P1|COMPLETED|After Controlled Period||0
5207891|NCT01008995|12805690|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
5207892|NCT01008995|12805691|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
5207893|NCT01008995|12805692|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5207894|NCT01008995|12805693|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5207895|NCT01008995|12805690|P4|NOT COMPLETED|Controlled Period||0
5207896|NCT01008995|12805691|P3|NOT COMPLETED|Controlled Period||0
5207897|NCT01008995|12805692|P2|NOT COMPLETED|Controlled Period||3
5207898|NCT01008995|12805693|P1|NOT COMPLETED|Controlled Period||3
5207899|NCT01008995|12805690|P4|COMPLETED|Controlled Period||0
5207900|NCT01008995|12805691|P3|COMPLETED|Controlled Period||0
5207901|NCT01008995|12805692|P2|COMPLETED|Controlled Period||157
5207902|NCT01008995|12805693|P1|COMPLETED|Controlled Period||159
5207903|NCT01008995|12805690|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5207904|NCT01008995|12805691|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5207905|NCT01008995|12805692|P2|STARTED|Controlled Period||160
5207906|NCT01008995|12805693|P1|STARTED|Controlled Period||162
5207907|NCT01008969|12805705|P1|NOT COMPLETED|Overall Study||0
5207908|NCT01008969|12805705|P1|COMPLETED|Overall Study||10
5207909|NCT01008969|12805705|P1|STARTED|Overall Study||10
5207910|NCT01008943|12805710|P1|NOT COMPLETED|Overall Study||1
5207911|NCT01008943|12805710|P1|COMPLETED|Overall Study||15
5207912|NCT01008943|12805710|P1|STARTED|Overall Study||16
5207913|NCT01008904|12805717|P1|NOT COMPLETED|Overall Study||4
5207914|NCT01008904|12805717|P1|COMPLETED|Overall Study||25
5207915|NCT01008904|12805717|P1|STARTED|Overall Study||29
5207916|NCT01008748|12805722|P1|NOT COMPLETED|Overall Study||81
5207917|NCT01008748|12805722|P1|COMPLETED|Overall Study||119
5207918|NCT01008748|12805722|P1|Week 26|Overall Study||119
5207919|NCT01008748|12805722|P1|Week 3|Overall Study||168
5207920|NCT01008748|12805722|P1|Week 0|Overall Study||182
5207921|NCT01008748|12805722|P1|Baseline|Overall Study||188
5207922|NCT01008748|12805722|P1|STARTED|Overall Study||200
5207923|NCT01008722|12805736|P2|NOT COMPLETED|Overall Study||0
5207924|NCT01008722|12805737|P1|NOT COMPLETED|Overall Study||0
5207925|NCT01008722|12805736|P2|COMPLETED|Overall Study||71
5207926|NCT01008722|12805737|P1|COMPLETED|Overall Study||36
5207927|NCT01008722|12805736|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
5207928|NCT01008722|12805737|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
5207929|NCT01008696|12805747|P2|NOT COMPLETED|Overall Study||17
5207930|NCT01008696|12805748|P1|NOT COMPLETED|Overall Study||17
5207931|NCT01008696|12805747|P2|COMPLETED|Overall Study||92
5207932|NCT01008696|12805748|P1|COMPLETED|Overall Study||91
5207933|NCT01008696|12805747|P2|STARTED|Overall Study||109
5207934|NCT01008696|12805748|P1|STARTED|Overall Study||108
5207935|NCT01008618|12805758|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
5207936|NCT01008618|12805759|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
5207937|NCT01008618|12805760|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
5207938|NCT01008618|12805758|P3|COMPLETED|Period 2 (Double-Blind Period)||39
5207939|NCT01008618|12805759|P2|COMPLETED|Period 2 (Double-Blind Period)||37
5207940|NCT01008618|12805760|P1|COMPLETED|Period 2 (Double-Blind Period)||0
5207941|NCT01008618|12805758|P3|STARTED|Period 2 (Double-Blind Period)||77
5207942|NCT01008618|12805759|P2|STARTED|Period 2 (Double-Blind Period)||73
5207943|NCT01008618|12805760|P1|STARTED|Period 2 (Double-Blind Period)||0
5207944|NCT01008618|12805758|P3|NOT COMPLETED|Period 1 (Titration Period)||0
5207945|NCT01008618|12805759|P2|NOT COMPLETED|Period 1 (Titration Period)||0
5207946|NCT01008618|12805760|P1|NOT COMPLETED|Period 1 (Titration Period)||68
5207947|NCT01008618|12805758|P3|COMPLETED|Period 1 (Titration Period)||0
5207948|NCT01008618|12805759|P2|COMPLETED|Period 1 (Titration Period)||0
5207949|NCT01008618|12805760|P1|COMPLETED|Period 1 (Titration Period)||150
5207950|NCT01008618|12805758|P3|STARTED|Period 1 (Titration Period)||0
5207951|NCT01008618|12805759|P2|STARTED|Period 1 (Titration Period)||0
5207952|NCT01008618|12805760|P1|STARTED|Period 1 (Titration Period)||218
5207953|NCT01008605|12805785|P1|NOT COMPLETED|Overall Study||0
5207954|NCT01008605|12805785|P1|COMPLETED|Overall Study||48
5207955|NCT01008605|12805785|P1|STARTED|Overall Study||48
5207956|NCT01008553|12805809|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
5207957|NCT01008553|12805810|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
5207958|NCT01008553|12805811|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
5207959|NCT01008553|12805809|P3|COMPLETED|Period 2 (Double-Blind Period)||28
5207960|NCT01008553|12805810|P2|COMPLETED|Period 2 (Double-Blind Period)||47
5207961|NCT01008553|12805811|P1|COMPLETED|Period 2 (Double-Blind Period)||0
5207962|NCT01008553|12805809|P3|STARTED|Period 2 (Double-Blind Period)||79
5207963|NCT01008553|12805810|P2|STARTED|Period 2 (Double-Blind Period)||84
5207964|NCT01008553|12805811|P1|STARTED|Period 2 (Double-Blind Period)||0
5207965|NCT01008553|12805809|P3|NOT COMPLETED|Period 1 (Titration Period)||0
5207966|NCT01008553|12805810|P2|NOT COMPLETED|Period 1 (Titration Period)||0
5207967|NCT01008553|12805811|P1|NOT COMPLETED|Period 1 (Titration Period)||95
5207968|NCT01008553|12805809|P3|COMPLETED|Period 1 (Titration Period)||0
5207969|NCT01008553|12805810|P2|COMPLETED|Period 1 (Titration Period)||0
5207970|NCT01008553|12805811|P1|COMPLETED|Period 1 (Titration Period)||163
5207971|NCT01008553|12805809|P3|STARTED|Period 1 (Titration Period)||0
5207972|NCT01008553|12805810|P2|STARTED|Period 1 (Titration Period)||0
5207973|NCT01008553|12805811|P1|STARTED|Period 1 (Titration Period)||258
5207974|NCT01008475|12805843|P7|NOT COMPLETED|Overall Study||4
5207975|NCT01008475|12805844|P6|NOT COMPLETED|Overall Study||6
5207976|NCT01008475|12805845|P5|NOT COMPLETED|Overall Study||5
5207977|NCT01008475|12805846|P4|NOT COMPLETED|Overall Study||0
5207978|NCT01008475|12805847|P3|NOT COMPLETED|Overall Study||0
5207979|NCT01008475|12805848|P2|NOT COMPLETED|Overall Study||0
5207980|NCT01008475|12805849|P1|NOT COMPLETED|Overall Study||0
5207981|NCT01008475|12805843|P7|COMPLETED|Overall Study||67
5207982|NCT01008475|12805844|P6|COMPLETED|Overall Study||67
5207983|NCT01008475|12805845|P5|COMPLETED|Overall Study||67
5207984|NCT01008475|12805846|P4|COMPLETED|Overall Study||3
5207985|NCT01008475|12805847|P3|COMPLETED|Overall Study||7
5207986|NCT01008475|12805848|P2|COMPLETED|Overall Study||3
5207987|NCT01008475|12805849|P1|COMPLETED|Overall Study||3
5207988|NCT01008475|12805843|P7|Safety Analysis Set|Overall Study||69
5207989|NCT01008475|12805844|P6|Safety Analysis Set|Overall Study||72
5207990|NCT01008475|12805845|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
5207991|NCT01008475|12805846|P4|Safety Analysis Set|Overall Study||3
5207992|NCT01008475|12805847|P3|Safety Analysis Set|Overall Study||7
5207993|NCT01008475|12805848|P2|Safety Analysis Set|Overall Study||3
5207994|NCT01008475|12805849|P1|Safety Analysis Set|Overall Study||3
5207995|NCT01008475|12805843|P7|STARTED|Overall Study||71
5207996|NCT01008475|12805844|P6|STARTED|Overall Study||73
5207997|NCT01008475|12805845|P5|STARTED|Overall Study||72
5207998|NCT01008475|12805846|P4|STARTED|Overall Study||3
5207999|NCT01008475|12805847|P3|STARTED|Overall Study||7
5208000|NCT01008475|12805848|P2|STARTED|Overall Study||3
5208001|NCT01008475|12805849|P1|STARTED|Overall Study||3
5208002|NCT01008462|12805877|P1|NOT COMPLETED|Overall Study||0
5208003|NCT01008462|12805877|P1|COMPLETED|Overall Study||16
5208004|NCT01008462|12805877|P1|STARTED|Overall Study||16
5208005|NCT01008449|12805889|P2|NOT COMPLETED|Overall Study||19
5208006|NCT01008449|12805890|P1|NOT COMPLETED|Overall Study||29
5208007|NCT01008449|12805889|P2|COMPLETED|Overall Study||179
5208008|NCT01008449|12805890|P1|COMPLETED|Overall Study||171
5208009|NCT01008449|12805889|P2|STARTED|Overall Study||198
5208010|NCT01008449|12805890|P1|STARTED|Overall Study||200
5208011|NCT01008423|12805912|P2|NOT COMPLETED|Overall Study||22
5208012|NCT01008423|12805913|P1|NOT COMPLETED|Overall Study||19
5208013|NCT01008423|12805912|P2|COMPLETED|Overall Study||125
5208014|NCT01008423|12805913|P1|COMPLETED|Overall Study||115
5208015|NCT01008423|12805912|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
5208016|NCT01008423|12805913|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
5208017|NCT01008423|12805912|P2|STARTED|Overall Study||147
5208018|NCT01008423|12805913|P1|STARTED|Overall Study||134
5208019|NCT01008410|12805939|P2|NOT COMPLETED|Overall Study||16
5208020|NCT01008410|12805940|P1|NOT COMPLETED|Overall Study||25
5208021|NCT01008410|12805939|P2|COMPLETED|Overall Study||116
5208022|NCT01008410|12805940|P1|COMPLETED|Overall Study||108
5208023|NCT01008410|12805939|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
5208024|NCT01008410|12805940|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
5208025|NCT01008410|12805939|P2|STARTED|Overall Study||132
5208026|NCT01008410|12805940|P1|STARTED|Overall Study||133
5208027|NCT01008319|12805966|P2|NOT COMPLETED|Overall Study||0
5208028|NCT01008319|12805967|P1|NOT COMPLETED|Overall Study||0
5208029|NCT01008319|12805966|P2|COMPLETED|Overall Study||60
5208030|NCT01008319|12805967|P1|COMPLETED|Overall Study||60
5208031|NCT01008319|12805966|P2|STARTED|Overall Study||60
5208032|NCT01008319|12805967|P1|STARTED|Overall Study||60
5208033|NCT01008280|12805979|P2|NOT COMPLETED|Overall Study||19
5208034|NCT01008280|12805980|P1|NOT COMPLETED|Overall Study||21
5208035|NCT01008280|12805979|P2|COMPLETED|Overall Study||73
5208036|NCT01008280|12805980|P1|COMPLETED|Overall Study||67
5208037|NCT01008280|12805979|P2|STARTED|Overall Study||92
5208038|NCT01008280|12805980|P1|STARTED|Overall Study||88
5208039|NCT01008150|12805994|P4|NOT COMPLETED|Overall Study||0
5208040|NCT01008150|12805995|P3|NOT COMPLETED|Overall Study||1
5208041|NCT01008150|12805996|P2|NOT COMPLETED|Overall Study||1
5208042|NCT01008150|12805997|P1|NOT COMPLETED|Overall Study||1
5208043|NCT01008150|12805994|P4|COMPLETED|Overall Study||12
5208044|NCT01008150|12805995|P3|COMPLETED|Overall Study||42
5208045|NCT01008150|12805996|P2|COMPLETED|Overall Study||42
5208046|NCT01008150|12805997|P1|COMPLETED|Overall Study||42
5208047|NCT01008150|12805994|P4|STARTED|Overall Study||12
5208048|NCT01008150|12805995|P3|STARTED|Overall Study||43
5208049|NCT01008150|12805996|P2|STARTED|Overall Study||43
5208050|NCT01008150|12805997|P1|STARTED|Overall Study||43
5208051|NCT01008059|12806027|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208052|NCT01008059|12806028|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208053|NCT01008059|12806029|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208054|NCT01008059|12806030|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208055|NCT01008059|12806031|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208056|NCT01008059|12806032|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208057|NCT01008059|12806033|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208058|NCT01008059|12806034|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208059|NCT01008059|12806027|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
5208060|NCT01008059|12806028|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208061|NCT01008059|12806029|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208062|NCT01008059|12806030|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208063|NCT01008059|12806031|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208064|NCT01008059|12806032|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208065|NCT01008059|12806033|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208066|NCT01008059|12806034|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
5208067|NCT01008059|12806027|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
5208068|NCT01008059|12806028|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208069|NCT01008059|12806029|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208070|NCT01008059|12806030|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208071|NCT01008059|12806031|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208072|NCT01008059|12806032|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208073|NCT01008059|12806033|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208074|NCT01008059|12806034|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
5208075|NCT01008059|12806027|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208076|NCT01008059|12806028|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208077|NCT01008059|12806029|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208078|NCT01008059|12806030|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208079|NCT01008059|12806031|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208080|NCT01008059|12806032|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208081|NCT01008059|12806033|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208082|NCT01008059|12806034|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208083|NCT01008059|12806027|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208084|NCT01008059|12806028|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
5208085|NCT01008059|12806029|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208086|NCT01008059|12806030|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208087|NCT01008059|12806031|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208088|NCT01008059|12806032|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208089|NCT01008059|12806033|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208090|NCT01008059|12806034|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
5208091|NCT01008059|12806027|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208092|NCT01008059|12806028|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
5208093|NCT01008059|12806029|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208094|NCT01008059|12806030|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208095|NCT01008059|12806031|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208096|NCT01008059|12806032|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208097|NCT01008059|12806033|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208098|NCT01008059|12806034|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
5208099|NCT01008059|12806027|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208100|NCT01008059|12806028|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208101|NCT01008059|12806029|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208102|NCT01008059|12806030|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208103|NCT01008059|12806031|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208104|NCT01008059|12806032|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208105|NCT01008059|12806033|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208106|NCT01008059|12806034|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
5208107|NCT01008059|12806027|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208108|NCT01008059|12806028|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208109|NCT01008059|12806029|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
5208110|NCT01008059|12806030|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208111|NCT01008059|12806031|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208112|NCT01008059|12806032|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208113|NCT01008059|12806033|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208114|NCT01008059|12806034|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
5208115|NCT01008059|12806027|P8|STARTED|Rifampin Simultaneous Alfentanil||0
5208116|NCT01008059|12806028|P7|STARTED|Rifampin Simultaneous Alfentanil||0
5208117|NCT01008059|12806029|P6|STARTED|Rifampin Simultaneous Alfentanil||6
5208118|NCT01008059|12806030|P5|STARTED|Rifampin Simultaneous Alfentanil||0
5208119|NCT01008059|12806031|P4|STARTED|Rifampin Simultaneous Alfentanil||0
5208120|NCT01008059|12806032|P3|STARTED|Rifampin Simultaneous Alfentanil||0
5208121|NCT01008059|12806033|P2|STARTED|Rifampin Simultaneous Alfentanil||0
5208122|NCT01008059|12806034|P1|STARTED|Rifampin Simultaneous Alfentanil||0
5208123|NCT01008059|12806027|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208124|NCT01008059|12806028|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208125|NCT01008059|12806029|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208126|NCT01008059|12806030|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208127|NCT01008059|12806031|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208128|NCT01008059|12806032|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208129|NCT01008059|12806033|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208130|NCT01008059|12806034|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
5208131|NCT01008059|12806027|P8|COMPLETED|Control Simultaneous Alfentanil||0
5208132|NCT01008059|12806028|P7|COMPLETED|Control Simultaneous Alfentanil||0
5208133|NCT01008059|12806029|P6|COMPLETED|Control Simultaneous Alfentanil||0
5208134|NCT01008059|12806030|P5|COMPLETED|Control Simultaneous Alfentanil||6
5208135|NCT01008059|12806031|P4|COMPLETED|Control Simultaneous Alfentanil||0
5208136|NCT01008059|12806032|P3|COMPLETED|Control Simultaneous Alfentanil||0
5208137|NCT01008059|12806033|P2|COMPLETED|Control Simultaneous Alfentanil||0
5208138|NCT01008059|12806034|P1|COMPLETED|Control Simultaneous Alfentanil||0
5208139|NCT01008059|12806027|P8|STARTED|Control Simultaneous Alfentanil||0
5208140|NCT01008059|12806028|P7|STARTED|Control Simultaneous Alfentanil||0
5208141|NCT01008059|12806029|P6|STARTED|Control Simultaneous Alfentanil||0
5208142|NCT01008059|12806030|P5|STARTED|Control Simultaneous Alfentanil||6
5208143|NCT01008059|12806031|P4|STARTED|Control Simultaneous Alfentanil||0
5208144|NCT01008059|12806032|P3|STARTED|Control Simultaneous Alfentanil||0
5208145|NCT01008059|12806033|P2|STARTED|Control Simultaneous Alfentanil||0
5208146|NCT01008059|12806034|P1|STARTED|Control Simultaneous Alfentanil||0
5208147|NCT01008059|12806027|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208148|NCT01008059|12806028|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208149|NCT01008059|12806029|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208150|NCT01008059|12806030|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208151|NCT01008059|12806031|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208152|NCT01008059|12806032|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208153|NCT01008059|12806033|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208154|NCT01008059|12806034|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
5208155|NCT01008059|12806027|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208156|NCT01008059|12806028|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208157|NCT01008059|12806029|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208158|NCT01008059|12806030|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208159|NCT01008059|12806031|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
5208160|NCT01008059|12806032|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208161|NCT01008059|12806033|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208162|NCT01008059|12806034|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
5208163|NCT01008059|12806027|P8|STARTED|Ketoconazole Sequential Alfentanil||0
5208164|NCT01008059|12806028|P7|STARTED|Ketoconazole Sequential Alfentanil||0
5208165|NCT01008059|12806029|P6|STARTED|Ketoconazole Sequential Alfentanil||0
5208166|NCT01008059|12806030|P5|STARTED|Ketoconazole Sequential Alfentanil||0
5208167|NCT01008059|12806031|P4|STARTED|Ketoconazole Sequential Alfentanil||6
5208168|NCT01008059|12806032|P3|STARTED|Ketoconazole Sequential Alfentanil||0
5208169|NCT01008059|12806033|P2|STARTED|Ketoconazole Sequential Alfentanil||0
5208170|NCT01008059|12806034|P1|STARTED|Ketoconazole Sequential Alfentanil||0
5208171|NCT01008059|12806027|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208172|NCT01008059|12806028|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208173|NCT01008059|12806029|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208174|NCT01008059|12806030|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208175|NCT01008059|12806031|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208176|NCT01008059|12806032|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208177|NCT01008059|12806033|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208178|NCT01008059|12806034|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208179|NCT01008059|12806027|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208180|NCT01008059|12806028|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208181|NCT01008059|12806029|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208182|NCT01008059|12806030|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208183|NCT01008059|12806031|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208184|NCT01008059|12806032|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
5208185|NCT01008059|12806033|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208186|NCT01008059|12806034|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
5208187|NCT01008059|12806027|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208188|NCT01008059|12806028|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208189|NCT01008059|12806029|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208190|NCT01008059|12806030|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208191|NCT01008059|12806031|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208192|NCT01008059|12806032|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
5208193|NCT01008059|12806033|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208194|NCT01008059|12806034|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
5208195|NCT01008059|12806027|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208196|NCT01008059|12806028|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208197|NCT01008059|12806029|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208198|NCT01008059|12806030|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208199|NCT01008059|12806031|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208200|NCT01008059|12806032|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208201|NCT01008059|12806033|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208202|NCT01008059|12806034|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
5208203|NCT01008059|12806027|P8|COMPLETED|Rifampin Sequential Alfentanil||0
5208204|NCT01008059|12806028|P7|COMPLETED|Rifampin Sequential Alfentanil||0
5208205|NCT01008059|12806029|P6|COMPLETED|Rifampin Sequential Alfentanil||0
5208206|NCT01008059|12806030|P5|COMPLETED|Rifampin Sequential Alfentanil||0
5208207|NCT01008059|12806031|P4|COMPLETED|Rifampin Sequential Alfentanil||0
5208208|NCT01008059|12806032|P3|COMPLETED|Rifampin Sequential Alfentanil||0
5208209|NCT01008059|12806033|P2|COMPLETED|Rifampin Sequential Alfentanil||6
5208210|NCT01008059|12806034|P1|COMPLETED|Rifampin Sequential Alfentanil||0
5208211|NCT01008059|12806027|P8|STARTED|Rifampin Sequential Alfentanil||0
5208212|NCT01008059|12806028|P7|STARTED|Rifampin Sequential Alfentanil||0
5208213|NCT01008059|12806029|P6|STARTED|Rifampin Sequential Alfentanil||0
5208214|NCT01008059|12806030|P5|STARTED|Rifampin Sequential Alfentanil||0
5208215|NCT01008059|12806031|P4|STARTED|Rifampin Sequential Alfentanil||0
5208216|NCT01008059|12806032|P3|STARTED|Rifampin Sequential Alfentanil||0
5208217|NCT01008059|12806033|P2|STARTED|Rifampin Sequential Alfentanil||6
5208218|NCT01008059|12806034|P1|STARTED|Rifampin Sequential Alfentanil||0
5208219|NCT01008059|12806027|P8|NOT COMPLETED|Control Sequential Alfentanil||0
5208220|NCT01008059|12806028|P7|NOT COMPLETED|Control Sequential Alfentanil||0
5208221|NCT01008059|12806029|P6|NOT COMPLETED|Control Sequential Alfentanil||0
5208222|NCT01008059|12806030|P5|NOT COMPLETED|Control Sequential Alfentanil||0
5208223|NCT01008059|12806031|P4|NOT COMPLETED|Control Sequential Alfentanil||0
5208224|NCT01008059|12806032|P3|NOT COMPLETED|Control Sequential Alfentanil||0
5208225|NCT01008059|12806033|P2|NOT COMPLETED|Control Sequential Alfentanil||0
5208226|NCT01008059|12806034|P1|NOT COMPLETED|Control Sequential Alfentanil||0
5208227|NCT01008059|12806027|P8|COMPLETED|Control Sequential Alfentanil||0
5208228|NCT01008059|12806028|P7|COMPLETED|Control Sequential Alfentanil||0
5208229|NCT01008059|12806029|P6|COMPLETED|Control Sequential Alfentanil||0
5208230|NCT01008059|12806030|P5|COMPLETED|Control Sequential Alfentanil||0
5208231|NCT01008059|12806031|P4|COMPLETED|Control Sequential Alfentanil||0
5208232|NCT01008059|12806032|P3|COMPLETED|Control Sequential Alfentanil||0
5208233|NCT01008059|12806033|P2|COMPLETED|Control Sequential Alfentanil||0
5208234|NCT01008059|12806034|P1|COMPLETED|Control Sequential Alfentanil||6
5208235|NCT01008059|12806027|P8|STARTED|Control Sequential Alfentanil||0
5208236|NCT01008059|12806028|P7|STARTED|Control Sequential Alfentanil||0
5208237|NCT01008059|12806029|P6|STARTED|Control Sequential Alfentanil||0
5208238|NCT01008059|12806030|P5|STARTED|Control Sequential Alfentanil||0
5208239|NCT01008059|12806031|P4|STARTED|Control Sequential Alfentanil||0
5208240|NCT01008059|12806032|P3|STARTED|Control Sequential Alfentanil||0
5208241|NCT01008059|12806033|P2|STARTED|Control Sequential Alfentanil||0
5208242|NCT01008059|12806034|P1|STARTED|Control Sequential Alfentanil||6
5208243|NCT01007916|12806045|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
5208244|NCT01007916|12806046|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
5208245|NCT01007916|12806045|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
5208246|NCT01007916|12806046|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
5208247|NCT01007916|12806045|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
5208248|NCT01007916|12806046|P1|STARTED|Period 2, 4 Weeks of Wear||22
5208249|NCT01007916|12806045|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
5208250|NCT01007916|12806046|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
5208251|NCT01007916|12806045|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
5208252|NCT01007916|12806046|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
5208253|NCT01007916|12806045|P2|STARTED|Period 1, 4 Weeks of Wear||26
5208254|NCT01007916|12806046|P1|STARTED|Period 1, 4 Weeks of Wear||23
5208255|NCT01007942|12806054|P2|NOT COMPLETED|Overall Study||278
5208256|NCT01007942|12806055|P1|NOT COMPLETED|Overall Study||281
5208257|NCT01007942|12806054|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
5208258|NCT01007942|12806055|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
5208259|NCT01007942|12806054|P2|STARTED|Overall Study||285
5208260|NCT01007942|12806055|P1|STARTED|Overall Study||284
5208261|NCT01007838|12806081|P4|NOT COMPLETED|Overall Study||0
5208262|NCT01007838|12806082|P3|NOT COMPLETED|Overall Study||0
5208263|NCT01007838|12806083|P2|NOT COMPLETED|Overall Study||0
5208264|NCT01007838|12806084|P1|NOT COMPLETED|Overall Study||3
5208265|NCT01007838|12806081|P4|COMPLETED|Overall Study||4
5208266|NCT01007838|12806082|P3|COMPLETED|Overall Study||5
5208267|NCT01007838|12806083|P2|COMPLETED|Overall Study||11
5208268|NCT01007838|12806084|P1|COMPLETED|Overall Study||9
5208269|NCT01007838|12806081|P4|STARTED|Overall Study||4
5208270|NCT01007838|12806082|P3|STARTED|Overall Study||5
5208271|NCT01007838|12806083|P2|STARTED|Overall Study||11
5208272|NCT01007838|12806084|P1|STARTED|Overall Study||12
5208273|NCT01007812|12806094|P2|NOT COMPLETED|Period 2, One Week||0
5208274|NCT01007812|12806095|P1|NOT COMPLETED|Period 2, One Week||0
5208275|NCT01007812|12806094|P2|COMPLETED|Period 2, One Week||24
5208276|NCT01007812|12806095|P1|COMPLETED|Period 2, One Week||24
5208277|NCT01007812|12806094|P2|STARTED|Period 2, One Week||24
5208278|NCT01007812|12806095|P1|STARTED|Period 2, One Week||24
5208279|NCT01007812|12806094|P2|NOT COMPLETED|Period 1, One Week||1
5208280|NCT01007812|12806095|P1|NOT COMPLETED|Period 1, One Week||1
5208281|NCT01007812|12806094|P2|COMPLETED|Period 1, One Week||24
5208282|NCT01007812|12806095|P1|COMPLETED|Period 1, One Week||24
5208283|NCT01007812|12806094|P2|STARTED|Period 1, One Week||25
5208284|NCT01007812|12806095|P1|STARTED|Period 1, One Week||25
5208285|NCT01007656|12806101|P1|NOT COMPLETED|Overall Study||0
5208286|NCT01007656|12806101|P1|COMPLETED|Overall Study||31
5208287|NCT01007656|12806101|P1|STARTED|Overall Study||31
5208288|NCT01007643|12806121|P2|NOT COMPLETED|Overall Study||0
5208289|NCT01007643|12806122|P1|NOT COMPLETED|Overall Study||0
5208290|NCT01007643|12806121|P2|COMPLETED|Overall Study||14
5208291|NCT01007643|12806122|P1|COMPLETED|Overall Study||8
5208292|NCT01007643|12806121|P2|STARTED|Overall Study||14
5208293|NCT01007643|12806122|P1|STARTED|Overall Study||8
5208294|NCT01007591|12806130|P2|NOT COMPLETED|Overall Study||1
5208295|NCT01007591|12806131|P1|NOT COMPLETED|Overall Study||1
5208296|NCT01007591|12806130|P2|COMPLETED|Overall Study||12
5208297|NCT01007591|12806131|P1|COMPLETED|Overall Study||26
5208298|NCT01007591|12806130|P2|STARTED|Overall Study||13
5208299|NCT01007591|12806131|P1|STARTED|Overall Study||27
5208300|NCT01007552|12806145|P1|NOT COMPLETED|Overall Study||1
5208301|NCT01007552|12806145|P1|COMPLETED|Overall Study||49
5208302|NCT01007552|12806145|P1|STARTED|Overall Study||50
5208303|NCT01007526|12806155|P1|NOT COMPLETED|Overall Study||0
5208304|NCT01007526|12806155|P1|COMPLETED|Overall Study||31
5208305|NCT01007526|12806155|P1|STARTED|Overall Study||31
5208306|NCT01007448|12806161|P2|NOT COMPLETED|Overall Study||9
5208307|NCT01007448|12806162|P1|NOT COMPLETED|Overall Study||10
5208308|NCT01007448|12806161|P2|COMPLETED|Overall Study||20
5208309|NCT01007448|12806162|P1|COMPLETED|Overall Study||20
5208310|NCT01007448|12806161|P2|Safety Population|Overall Study||29
5208311|NCT01007448|12806162|P1|Safety Population|Overall Study||30
5208312|NCT01007448|12806161|P2|Full Analysis Population|Overall Study||29
5208313|NCT01007448|12806162|P1|Full Analysis Population|Overall Study||30
5208314|NCT01007448|12806161|P2|STARTED|Overall Study||29
5208315|NCT01007448|12806162|P1|STARTED|Overall Study||30
5208316|NCT01007435|12806194|P4|NOT COMPLETED|Overall Study||56
5208317|NCT01007435|12806195|P3|NOT COMPLETED|Overall Study||64
5208318|NCT01007435|12806196|P2|NOT COMPLETED|Overall Study||59
5208319|NCT01007435|12806197|P1|NOT COMPLETED|Overall Study||63
5208320|NCT01007435|12806194|P4|COMPLETED|Overall Study||236
5208321|NCT01007435|12806195|P3|COMPLETED|Overall Study||227
5208322|NCT01007435|12806196|P2|COMPLETED|Overall Study||231
5208323|NCT01007435|12806197|P1|COMPLETED|Overall Study||226
5208324|NCT01007435|12806194|P4|STARTED|Overall Study||292
5208325|NCT01007435|12806195|P3|STARTED|Overall Study||291
5208326|NCT01007435|12806196|P2|STARTED|Overall Study||290
5208327|NCT01007435|12806197|P1|STARTED|Overall Study||289
5208328|NCT01007396|12806239|P1|NOT COMPLETED|Overall Study||47
5208329|NCT01007396|12806239|P1|COMPLETED|Overall Study||275
5208330|NCT01007396|12806239|P1|STARTED|Overall Study||322
5208331|NCT01007253|12806244|P4|NOT COMPLETED|Fourth Intervention||0
5208332|NCT01007253|12806245|P3|NOT COMPLETED|Fourth Intervention||0
5208333|NCT01007253|12806246|P2|NOT COMPLETED|Fourth Intervention||0
5208334|NCT01007253|12806247|P1|NOT COMPLETED|Fourth Intervention||0
5208335|NCT01007253|12806244|P4|COMPLETED|Fourth Intervention||5
5208336|NCT01007253|12806245|P3|COMPLETED|Fourth Intervention||5
5208337|NCT01007253|12806246|P2|COMPLETED|Fourth Intervention||5
5208338|NCT01007253|12806247|P1|COMPLETED|Fourth Intervention||5
5208339|NCT01007253|12806244|P4|STARTED|Fourth Intervention||5
5208340|NCT01007253|12806245|P3|STARTED|Fourth Intervention||5
5208341|NCT01007253|12806246|P2|STARTED|Fourth Intervention||5
5208342|NCT01007253|12806247|P1|STARTED|Fourth Intervention||5
5208343|NCT01007253|12806244|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
5208344|NCT01007253|12806245|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
5208345|NCT01007253|12806246|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
5208346|NCT01007253|12806247|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
5208347|NCT01007253|12806244|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
5208348|NCT01007253|12806245|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
5208349|NCT01007253|12806246|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
5208350|NCT01007253|12806247|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
5208351|NCT01007253|12806244|P4|STARTED|Washout Period (2 Weeks) # 3||5
5208352|NCT01007253|12806245|P3|STARTED|Washout Period (2 Weeks) # 3||5
5208353|NCT01007253|12806246|P2|STARTED|Washout Period (2 Weeks) # 3||5
5208354|NCT01007253|12806247|P1|STARTED|Washout Period (2 Weeks) # 3||6
5208355|NCT01007253|12806244|P4|NOT COMPLETED|Third Intervention||0
5208356|NCT01007253|12806245|P3|NOT COMPLETED|Third Intervention||0
5208357|NCT01007253|12806246|P2|NOT COMPLETED|Third Intervention||0
5208358|NCT01007253|12806247|P1|NOT COMPLETED|Third Intervention||0
5208359|NCT01007253|12806244|P4|COMPLETED|Third Intervention||5
5208360|NCT01007253|12806245|P3|COMPLETED|Third Intervention||5
5208361|NCT01007253|12806246|P2|COMPLETED|Third Intervention||5
5208362|NCT01007253|12806247|P1|COMPLETED|Third Intervention||6
5208363|NCT01007253|12806244|P4|STARTED|Third Intervention||5
5208364|NCT01007253|12806245|P3|STARTED|Third Intervention||5
5208365|NCT01007253|12806246|P2|STARTED|Third Intervention||5
5208366|NCT01007253|12806247|P1|STARTED|Third Intervention||6
5208367|NCT01007253|12806244|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
5208368|NCT01007253|12806245|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
5208369|NCT01007253|12806246|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
5208370|NCT01007253|12806247|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
5208371|NCT01007253|12806244|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
5208372|NCT01007253|12806245|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
5208373|NCT01007253|12806246|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
5208374|NCT01007253|12806247|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
5208375|NCT01007253|12806244|P4|STARTED|Washout Period (2 Weeks) # 2||5
5208376|NCT01007253|12806245|P3|STARTED|Washout Period (2 Weeks) # 2||5
5208377|NCT01007253|12806246|P2|STARTED|Washout Period (2 Weeks) # 2||5
5208378|NCT01007253|12806247|P1|STARTED|Washout Period (2 Weeks) # 2||6
5208379|NCT01007253|12806244|P4|NOT COMPLETED|Second Intervention||0
5208380|NCT01007253|12806245|P3|NOT COMPLETED|Second Intervention||0
5208381|NCT01007253|12806246|P2|NOT COMPLETED|Second Intervention||0
5208382|NCT01007253|12806247|P1|NOT COMPLETED|Second Intervention||0
5208383|NCT01007253|12806244|P4|COMPLETED|Second Intervention||5
5208384|NCT01007253|12806245|P3|COMPLETED|Second Intervention||5
5208385|NCT01007253|12806246|P2|COMPLETED|Second Intervention||5
5208386|NCT01007253|12806247|P1|COMPLETED|Second Intervention||6
5208387|NCT01007253|12806244|P4|STARTED|Second Intervention||5
5208388|NCT01007253|12806245|P3|STARTED|Second Intervention||5
5208389|NCT01007253|12806246|P2|STARTED|Second Intervention||5
5208390|NCT01007253|12806247|P1|STARTED|Second Intervention||6
5208391|NCT01007253|12806244|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
5208392|NCT01007253|12806245|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
5208393|NCT01007253|12806246|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
5208394|NCT01007253|12806247|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
5208395|NCT01007253|12806244|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
5208396|NCT01007253|12806245|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
5208397|NCT01007253|12806246|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
5208398|NCT01007253|12806247|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
5208399|NCT01007253|12806244|P4|STARTED|Washout Period (2 Weeks) # 1||5
5208400|NCT01007253|12806245|P3|STARTED|Washout Period (2 Weeks) # 1||5
5208401|NCT01007253|12806246|P2|STARTED|Washout Period (2 Weeks) # 1||5
5208402|NCT01007253|12806247|P1|STARTED|Washout Period (2 Weeks) # 1||6
5208403|NCT01007253|12806244|P4|NOT COMPLETED|First Intervention||0
5208404|NCT01007253|12806245|P3|NOT COMPLETED|First Intervention||0
5208405|NCT01007253|12806246|P2|NOT COMPLETED|First Intervention||0
5208406|NCT01007253|12806247|P1|NOT COMPLETED|First Intervention||0
5208407|NCT01007253|12806244|P4|COMPLETED|First Intervention||5
5208408|NCT01007253|12806245|P3|COMPLETED|First Intervention||5
5208409|NCT01007253|12806246|P2|COMPLETED|First Intervention||5
5208410|NCT01007253|12806247|P1|COMPLETED|First Intervention||6
5208411|NCT01007253|12806244|P4|STARTED|First Intervention||5
5208412|NCT01007253|12806245|P3|STARTED|First Intervention||5
5208413|NCT01007253|12806246|P2|STARTED|First Intervention||5
5208414|NCT01007253|12806247|P1|STARTED|First Intervention||6
5208415|NCT01007149|12806279|P2|NOT COMPLETED|Overall Study||1
5208416|NCT01007149|12806280|P1|NOT COMPLETED|Overall Study||0
5208417|NCT01007149|12806279|P2|COMPLETED|Overall Study||20
5208418|NCT01007149|12806280|P1|COMPLETED|Overall Study||20
5208419|NCT01007149|12806279|P2|STARTED|Overall Study||21
5208420|NCT01007149|12806280|P1|STARTED|Overall Study||20
5208421|NCT01007123|12806306|P4|NOT COMPLETED|Overall Study||6
5208422|NCT01007123|12806307|P3|NOT COMPLETED|Overall Study||11
5208423|NCT01007123|12806308|P2|NOT COMPLETED|Overall Study||6
5208424|NCT01007123|12806309|P1|NOT COMPLETED|Overall Study||6
5208425|NCT01007123|12806306|P4|COMPLETED|Overall Study||41
5208426|NCT01007123|12806307|P3|COMPLETED|Overall Study||37
5208427|NCT01007123|12806308|P2|COMPLETED|Overall Study||41
5208428|NCT01007123|12806309|P1|COMPLETED|Overall Study||42
5208429|NCT01007123|12806306|P4|STARTED|Overall Study||47
5208430|NCT01007123|12806307|P3|STARTED|Overall Study||48
5208431|NCT01007123|12806308|P2|STARTED|Overall Study||47
5208432|NCT01007123|12806309|P1|STARTED|Overall Study||48
5208433|NCT01007110|12806340|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
5208434|NCT01007110|12806341|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
5208435|NCT01007110|12806340|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
5208436|NCT01007110|12806341|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
5208437|NCT01007110|12806340|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
5208438|NCT01007110|12806341|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
5208439|NCT01007110|12806340|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
5208440|NCT01007110|12806341|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
5208441|NCT01007110|12806340|P2|COMPLETED|Follow-Up at 36 Weeks||20
5208442|NCT01007110|12806341|P1|COMPLETED|Follow-Up at 36 Weeks||24
5208443|NCT01007110|12806340|P2|STARTED|Follow-Up at 36 Weeks||22
5208444|NCT01007110|12806341|P1|STARTED|Follow-Up at 36 Weeks||24
5208445|NCT01007110|12806340|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
5208446|NCT01007110|12806341|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
5208447|NCT01007110|12806340|P2|COMPLETED|Follow-Up at 32 Weeks||22
5208448|NCT01007110|12806341|P1|COMPLETED|Follow-Up at 32 Weeks||24
5208449|NCT01007110|12806340|P2|STARTED|Follow-Up at 32 Weeks||23
5208450|NCT01007110|12806341|P1|STARTED|Follow-Up at 32 Weeks||25
5208451|NCT01007110|12806340|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
5208452|NCT01007110|12806341|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
5208453|NCT01007110|12806340|P2|COMPLETED|Follow-Up at 24 Weeks||23
5208454|NCT01007110|12806341|P1|COMPLETED|Follow-Up at 24 Weeks||25
5208455|NCT01007110|12806340|P2|STARTED|Follow-Up at 24 Weeks||27
5208456|NCT01007110|12806341|P1|STARTED|Follow-Up at 24 Weeks||25
5208457|NCT01007110|12806340|P2|NOT COMPLETED|Allocation||8
5208458|NCT01007110|12806341|P1|NOT COMPLETED|Allocation||7
5208459|NCT01007110|12806340|P2|COMPLETED|Allocation||27
5208460|NCT01007110|12806341|P1|COMPLETED|Allocation||25
5208461|NCT01007110|12806340|P2|STARTED|Allocation||35
5208462|NCT01007110|12806341|P1|STARTED|Allocation||32
5208463|NCT01007071|12806357|P2|NOT COMPLETED|Overall Study||0
5208464|NCT01007071|12806358|P1|NOT COMPLETED|Overall Study||0
5208465|NCT01007071|12806357|P2|COMPLETED|Overall Study||5
5208466|NCT01007071|12806358|P1|COMPLETED|Overall Study||6
5208467|NCT01007071|12806357|P2|STARTED|Overall Study||5
5208468|NCT01007071|12806358|P1|STARTED|Overall Study||6
5208469|NCT01007032|12806370|P4|NOT COMPLETED|Overall Study||1
5208470|NCT01007032|12806371|P3|NOT COMPLETED|Overall Study||1
5208471|NCT01007032|12806372|P2|NOT COMPLETED|Overall Study||1
5208472|NCT01007032|12806373|P1|NOT COMPLETED|Overall Study||0
5208473|NCT01007032|12806370|P4|COMPLETED|Overall Study||6
5208474|NCT01007032|12806371|P3|COMPLETED|Overall Study||2
5208475|NCT01007032|12806372|P2|COMPLETED|Overall Study||6
5208476|NCT01007032|12806373|P1|COMPLETED|Overall Study||4
5208477|NCT01007032|12806370|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
5208478|NCT01007032|12806371|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5208479|NCT01007032|12806372|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
5208480|NCT01007032|12806373|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5208481|NCT01007032|12806370|P4|STARTED|Overall Study||7
5208482|NCT01007032|12806371|P3|STARTED|Overall Study||3
5208483|NCT01007032|12806372|P2|STARTED|Overall Study||7
5208484|NCT01007032|12806373|P1|STARTED|Overall Study||4
5208485|NCT01006980|12806417|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
5208486|NCT01006980|12806418|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
5208487|NCT01006980|12806417|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
5208488|NCT01006980|12806418|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
5208489|NCT01006980|12806417|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
5208490|NCT01006980|12806418|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
5208491|NCT01006980|12806417|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
5208492|NCT01006980|12806418|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
5208493|NCT01006980|12806417|P2|COMPLETED|Vemurafenib and Dacarbazine||0
5208494|NCT01006980|12806418|P1|COMPLETED|Vemurafenib and Dacarbazine||0
5208495|NCT01006980|12806417|P2|Treated|Vemurafenib and Dacarbazine||293
5208496|NCT01006980|12806418|P1|Treated|Vemurafenib and Dacarbazine||336
5208497|NCT01006980|12806417|P2|STARTED|Vemurafenib and Dacarbazine||338
5208498|NCT01006980|12806418|P1|STARTED|Vemurafenib and Dacarbazine||337
5208499|NCT01006967|12806440|P2|NOT COMPLETED|Overall Study||63
5208500|NCT01006967|12806441|P1|NOT COMPLETED|Overall Study||66
5208501|NCT01006967|12806440|P2|COMPLETED|Overall Study||190
5208502|NCT01006967|12806441|P1|COMPLETED|Overall Study||187
5208503|NCT01006967|12806440|P2|3 Month Follow-up|Overall Study||210
5208504|NCT01006967|12806441|P1|3 Month Follow-up|Overall Study||212
5208505|NCT01006967|12806440|P2|Received Treatment|Overall Study||245
5208506|NCT01006967|12806441|P1|Received Treatment|Overall Study||245
5208507|NCT01006967|12806440|P2|STARTED|Overall Study||253
5208508|NCT01006967|12806441|P1|STARTED|Overall Study||253
5208509|NCT01006889|12806457|P1|NOT COMPLETED|Overall Study||3
5208510|NCT01006889|12806457|P1|COMPLETED|Overall Study||17
5208511|NCT01006889|12806457|P1|STARTED|Overall Study||20
5208512|NCT01006707|12806468|P3|NOT COMPLETED|Study Session 3||0
5208513|NCT01006707|12806469|P2|NOT COMPLETED|Study Session 3||0
5208514|NCT01006707|12806470|P1|NOT COMPLETED|Study Session 3||0
5208515|NCT01006707|12806468|P3|COMPLETED|Study Session 3||6
5208516|NCT01006707|12806469|P2|COMPLETED|Study Session 3||4
5208517|NCT01006707|12806470|P1|COMPLETED|Study Session 3||0
5208518|NCT01006707|12806468|P3|STARTED|Study Session 3||6
5208519|NCT01006707|12806469|P2|STARTED|Study Session 3||4
5208520|NCT01006707|12806470|P1|STARTED|Study Session 3||0
5208521|NCT01006707|12806468|P3|NOT COMPLETED|Study Session 2||0
5208522|NCT01006707|12806469|P2|NOT COMPLETED|Study Session 2||0
5208523|NCT01006707|12806470|P1|NOT COMPLETED|Study Session 2||0
5208524|NCT01006707|12806468|P3|COMPLETED|Study Session 2||6
5208525|NCT01006707|12806469|P2|COMPLETED|Study Session 2||4
5208526|NCT01006707|12806470|P1|COMPLETED|Study Session 2||0
5208527|NCT01006707|12806468|P3|STARTED|Study Session 2||6
5208528|NCT01006707|12806469|P2|STARTED|Study Session 2||4
5208529|NCT01006707|12806470|P1|STARTED|Study Session 2||0
5208530|NCT01006707|12806468|P3|NOT COMPLETED|Study Session 1||0
5208531|NCT01006707|12806469|P2|NOT COMPLETED|Study Session 1||0
5208532|NCT01006707|12806470|P1|NOT COMPLETED|Study Session 1||5
5208533|NCT01006707|12806468|P3|COMPLETED|Study Session 1||0
5208534|NCT01006707|12806469|P2|COMPLETED|Study Session 1||0
5208535|NCT01006707|12806470|P1|COMPLETED|Study Session 1||10
5208536|NCT01006707|12806468|P3|STARTED|Study Session 1||0
5208537|NCT01006707|12806469|P2|STARTED|Study Session 1||0
5208538|NCT01006707|12806470|P1|STARTED|Study Session 1||15
5208539|NCT01006655|12806483|P2|NOT COMPLETED|Second Intervention||0
5208540|NCT01006655|12806484|P1|NOT COMPLETED|Second Intervention||0
5208541|NCT01006655|12806483|P2|COMPLETED|Second Intervention||10
5208542|NCT01006655|12806484|P1|COMPLETED|Second Intervention||11
5208543|NCT01006655|12806483|P2|STARTED|Second Intervention||10
5208544|NCT01006655|12806484|P1|STARTED|Second Intervention||11
5208545|NCT01006655|12806483|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5208546|NCT01006655|12806484|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5208547|NCT01006655|12806483|P2|COMPLETED|Washout Period of 2 Weeks||10
5208548|NCT01006655|12806484|P1|COMPLETED|Washout Period of 2 Weeks||11
5208549|NCT01006655|12806483|P2|STARTED|Washout Period of 2 Weeks||10
5208550|NCT01006655|12806484|P1|STARTED|Washout Period of 2 Weeks||11
5208551|NCT01006655|12806483|P2|NOT COMPLETED|First Intervention||0
5208552|NCT01006655|12806484|P1|NOT COMPLETED|First Intervention||0
5208553|NCT01006655|12806483|P2|COMPLETED|First Intervention||10
5208554|NCT01006655|12806484|P1|COMPLETED|First Intervention||11
5208555|NCT01006655|12806483|P2|STARTED|First Intervention||10
5208556|NCT01006655|12806484|P1|STARTED|First Intervention||11
5208557|NCT01006629|12806490|P1|NOT COMPLETED|Overall Study||6
5208558|NCT01006629|12806490|P1|COMPLETED|Overall Study||94
5208559|NCT01006629|12806490|P1|STARTED|Overall Study||100
5208560|NCT01006616|12806505|P4|NOT COMPLETED|Period 2 (18 Months)||82
5208561|NCT01006616|12806506|P3|NOT COMPLETED|Period 2 (18 Months)||55
5208562|NCT01006616|12806507|P2|NOT COMPLETED|Period 2 (18 Months)||63
5208563|NCT01006616|12806508|P1|NOT COMPLETED|Period 2 (18 Months)||75
5208564|NCT01006616|12806505|P4|COMPLETED|Period 2 (18 Months)||0
5208565|NCT01006616|12806506|P3|COMPLETED|Period 2 (18 Months)||0
5208566|NCT01006616|12806507|P2|COMPLETED|Period 2 (18 Months)||0
5208567|NCT01006616|12806508|P1|COMPLETED|Period 2 (18 Months)||0
5208568|NCT01006616|12806505|P4|Treated|Period 2 (18 Months)||82
5208569|NCT01006616|12806506|P3|Treated|Period 2 (18 Months)||55
5208570|NCT01006616|12806507|P2|Treated|Period 2 (18 Months)||63
5208571|NCT01006616|12806508|P1|Treated|Period 2 (18 Months)||75
5208572|NCT01006616|12806505|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
5208573|NCT01006616|12806506|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
5208574|NCT01006616|12806507|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
5208575|NCT01006616|12806508|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
5208576|NCT01006616|12806505|P4|NOT COMPLETED|Period 1 (6 Months)||27
5208577|NCT01006616|12806506|P3|NOT COMPLETED|Period 1 (6 Months)||51
5208578|NCT01006616|12806507|P2|NOT COMPLETED|Period 1 (6 Months)||54
5208579|NCT01006616|12806508|P1|NOT COMPLETED|Period 1 (6 Months)||26
5208580|NCT01006616|12806505|P4|COMPLETED|Period 1 (6 Months)||128
5208581|NCT01006616|12806506|P3|COMPLETED|Period 1 (6 Months)||102
5208582|NCT01006616|12806507|P2|COMPLETED|Period 1 (6 Months)||102
5208583|NCT01006616|12806508|P1|COMPLETED|Period 1 (6 Months)||126
5208584|NCT01006616|12806505|P4|Treated|Period 1 (6 Months)||154
5208585|NCT01006616|12806506|P3|Treated|Period 1 (6 Months)||152
5208586|NCT01006616|12806507|P2|Treated|Period 1 (6 Months)||156
5208587|NCT01006616|12806508|P1|Treated|Period 1 (6 Months)||152
5208588|NCT01006616|12806505|P4|STARTED|Period 1 (6 Months)||155
5208589|NCT01006616|12806506|P3|STARTED|Period 1 (6 Months)||153
5208590|NCT01006616|12806507|P2|STARTED|Period 1 (6 Months)||156
5208591|NCT01006616|12806508|P1|STARTED|Period 1 (6 Months)||152
5208592|NCT01006603|12806644|P2|NOT COMPLETED|Overall Study||75
5208593|NCT01006603|12806645|P1|NOT COMPLETED|Overall Study||71
5208594|NCT01006603|12806644|P2|COMPLETED|Overall Study||285
5208595|NCT01006603|12806645|P1|COMPLETED|Overall Study||289
5208596|NCT01006603|12806644|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
5208597|NCT01006603|12806645|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
5208598|NCT01006590|12806665|P2|NOT COMPLETED|Overall Study||32
5208599|NCT01006590|12806666|P1|NOT COMPLETED|Overall Study||28
5208600|NCT01006590|12806665|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
5208601|NCT01006590|12806666|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
5208602|NCT01006590|12806665|P2|STARTED|Overall Study|Randomised and treated|139
5208603|NCT01006590|12806666|P1|STARTED|Overall Study|Randomised and treated|147
5208604|NCT01006538|12806684|P2|NOT COMPLETED|Overall Study||4
5208605|NCT01006538|12806685|P1|NOT COMPLETED|Overall Study||11
5208606|NCT01006538|12806684|P2|COMPLETED|Overall Study||115
5208607|NCT01006538|12806685|P1|COMPLETED|Overall Study||233
5208608|NCT01006538|12806684|P2|STARTED|Overall Study||119
5208609|NCT01006538|12806685|P1|STARTED|Overall Study||244
5208610|NCT01006356|12806705|P1|NOT COMPLETED|Overall Study||42
5208611|NCT01006356|12806705|P1|COMPLETED|Overall Study||99
5208612|NCT01006356|12806705|P1|STARTED|Overall Study||141
5208613|NCT01006291|12806720|P3|NOT COMPLETED|Overall Study||27
5208614|NCT01006291|12806721|P2|NOT COMPLETED|Overall Study||24
5208615|NCT01006291|12806722|P1|NOT COMPLETED|Overall Study||26
5208616|NCT01006291|12806720|P3|COMPLETED|Overall Study||203
5208617|NCT01006291|12806721|P2|COMPLETED|Overall Study||204
5208618|NCT01006291|12806722|P1|COMPLETED|Overall Study||203
5208619|NCT01006291|12806720|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
5208620|NCT01006291|12806721|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
5208621|NCT01006291|12806722|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
5208622|NCT01006291|12806720|P3|STARTED|Overall Study||230
5208623|NCT01006291|12806721|P2|STARTED|Overall Study||228
5208624|NCT01006291|12806722|P1|STARTED|Overall Study||229
5208625|NCT01006252|12806741|P2|NOT COMPLETED|Overall Study||0
5208626|NCT01006252|12806742|P1|NOT COMPLETED|Overall Study||0
5208627|NCT01006252|12806741|P2|COMPLETED|Overall Study||168
5208628|NCT01006252|12806742|P1|COMPLETED|Overall Study||168
5208629|NCT01006252|12806741|P2|Received Treatment|Overall Study||161
5208630|NCT01006252|12806742|P1|Received Treatment|Overall Study||164
5208631|NCT01006252|12806741|P2|STARTED|Overall Study||168
5208632|NCT01006252|12806742|P1|STARTED|Overall Study||168
5208633|NCT01006135|12806772|P1|NOT COMPLETED|Overall Study||140
5208634|NCT01006135|12806772|P1|COMPLETED|Overall Study||4712
5208635|NCT01006135|12806772|P1|STARTED|Overall Study||4852
5208636|NCT01006122|12806779|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
5208637|NCT01006122|12806780|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
5208638|NCT01006122|12806779|P2|COMPLETED|Second Double-blind Intervention Period||24
5208639|NCT01006122|12806780|P1|COMPLETED|Second Double-blind Intervention Period||29
5208640|NCT01006122|12806779|P2|STARTED|Second Double-blind Intervention Period||31
5208641|NCT01006122|12806780|P1|STARTED|Second Double-blind Intervention Period||31
5208642|NCT01006122|12806779|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5208643|NCT01006122|12806780|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5208644|NCT01006122|12806779|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
5208645|NCT01006122|12806780|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
5208646|NCT01006122|12806779|P2|STARTED|Wash-out Period (at Least 7 Days)||31
5208647|NCT01006122|12806780|P1|STARTED|Wash-out Period (at Least 7 Days)||31
5208648|NCT01006122|12806779|P2|NOT COMPLETED|First Double-blind Intervention Period||17
5208649|NCT01006122|12806780|P1|NOT COMPLETED|First Double-blind Intervention Period||16
5208650|NCT01006122|12806779|P2|COMPLETED|First Double-blind Intervention Period||31
5208651|NCT01006122|12806780|P1|COMPLETED|First Double-blind Intervention Period||31
5208652|NCT01006122|12806779|P2|STARTED|First Double-blind Intervention Period||48
5208653|NCT01006122|12806780|P1|STARTED|First Double-blind Intervention Period||47
5208654|NCT01006018|12806821|P3|NOT COMPLETED|Overall Study||0
5208655|NCT01006018|12806822|P2|NOT COMPLETED|Overall Study||0
5208656|NCT01006018|12806823|P1|NOT COMPLETED|Overall Study||0
5208657|NCT01006018|12806821|P3|COMPLETED|Overall Study||0
5208658|NCT01006018|12806822|P2|COMPLETED|Overall Study||0
5208659|NCT01006018|12806823|P1|COMPLETED|Overall Study||0
5208660|NCT01006018|12806821|P3|STARTED|Overall Study||0
5208661|NCT01006018|12806822|P2|STARTED|Overall Study||0
5208662|NCT01006018|12806823|P1|STARTED|Overall Study||0
5208663|NCT01005966|12806831|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
5208664|NCT01005966|12806832|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
5208665|NCT01005966|12806833|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
5208666|NCT01005966|12806834|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
5208667|NCT01005966|12806835|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
5208668|NCT01005966|12806831|P5|COMPLETED|Treatment Period 5 (14 Days)||10
5208669|NCT01005966|12806832|P4|COMPLETED|Treatment Period 5 (14 Days)||11
5208670|NCT01005966|12806833|P3|COMPLETED|Treatment Period 5 (14 Days)||11
5208671|NCT01005966|12806834|P2|COMPLETED|Treatment Period 5 (14 Days)||12
5208672|NCT01005966|12806835|P1|COMPLETED|Treatment Period 5 (14 Days)||9
5208673|NCT01005966|12806831|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
5208674|NCT01005966|12806832|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
5208675|NCT01005966|12806833|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
5208676|NCT01005966|12806834|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
5208677|NCT01005966|12806835|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
5208678|NCT01005966|12806831|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
5208679|NCT01005966|12806832|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
5208680|NCT01005966|12806833|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
5208681|NCT01005966|12806834|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
5208682|NCT01005966|12806835|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
5208683|NCT01005966|12806831|P5|COMPLETED|Washout Period 4 (4 Days)||12
5208684|NCT01005966|12806832|P4|COMPLETED|Washout Period 4 (4 Days)||10
5208685|NCT01005966|12806833|P3|COMPLETED|Washout Period 4 (4 Days)||11
5208686|NCT01005966|12806834|P2|COMPLETED|Washout Period 4 (4 Days)||10
5208687|NCT01005966|12806835|P1|COMPLETED|Washout Period 4 (4 Days)||10
5208688|NCT01005966|12806831|P5|STARTED|Washout Period 4 (4 Days)||12
5208689|NCT01005966|12806832|P4|STARTED|Washout Period 4 (4 Days)||10
5208690|NCT01005966|12806833|P3|STARTED|Washout Period 4 (4 Days)||11
5208691|NCT01005966|12806834|P2|STARTED|Washout Period 4 (4 Days)||10
5208692|NCT01005966|12806835|P1|STARTED|Washout Period 4 (4 Days)||10
5208693|NCT01005966|12806831|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
5208694|NCT01005966|12806832|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
5208695|NCT01005966|12806833|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
5208696|NCT01005966|12806834|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
5208697|NCT01005966|12806835|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
5208698|NCT01005966|12806831|P5|COMPLETED|Treatment Period 4 (14 Days)||12
5208699|NCT01005966|12806832|P4|COMPLETED|Treatment Period 4 (14 Days)||10
5208700|NCT01005966|12806833|P3|COMPLETED|Treatment Period 4 (14 Days)||11
5208701|NCT01005966|12806834|P2|COMPLETED|Treatment Period 4 (14 Days)||10
5208702|NCT01005966|12806835|P1|COMPLETED|Treatment Period 4 (14 Days)||10
5208703|NCT01005966|12806831|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
5208704|NCT01005966|12806832|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
5208705|NCT01005966|12806833|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
5208706|NCT01005966|12806834|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
5208707|NCT01005966|12806835|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
5208708|NCT01005966|12806831|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
5208709|NCT01005966|12806832|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
5208710|NCT01005966|12806833|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
5208711|NCT01005966|12806834|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
5208712|NCT01005966|12806835|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
5208713|NCT01005966|12806831|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
5208714|NCT01005966|12806832|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
5208715|NCT01005966|12806833|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
5208716|NCT01005966|12806834|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
5208717|NCT01005966|12806835|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
5208718|NCT01005966|12806831|P5|STARTED|Washout Period 3 ( 4 Days)||11
5208719|NCT01005966|12806832|P4|STARTED|Washout Period 3 ( 4 Days)||13
5208720|NCT01005966|12806833|P3|STARTED|Washout Period 3 ( 4 Days)||12
5208721|NCT01005966|12806834|P2|STARTED|Washout Period 3 ( 4 Days)||7
5208722|NCT01005966|12806835|P1|STARTED|Washout Period 3 ( 4 Days)||12
5208723|NCT01005966|12806831|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5208724|NCT01005966|12806832|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5208725|NCT01005966|12806833|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5208726|NCT01005966|12806834|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
5208727|NCT01005966|12806835|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
5208728|NCT01005966|12806831|P5|COMPLETED|Treatment Period 3 (14 Days)||11
5208729|NCT01005966|12806832|P4|COMPLETED|Treatment Period 3 (14 Days)||13
5208730|NCT01005966|12806833|P3|COMPLETED|Treatment Period 3 (14 Days)||12
5208731|NCT01005966|12806834|P2|COMPLETED|Treatment Period 3 (14 Days)||7
5208732|NCT01005966|12806835|P1|COMPLETED|Treatment Period 3 (14 Days)||12
5208733|NCT01005966|12806831|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
5208734|NCT01005966|12806832|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
5208735|NCT01005966|12806833|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
5208736|NCT01005966|12806834|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
5208737|NCT01005966|12806835|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
5208738|NCT01005966|12806831|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
5208739|NCT01005966|12806832|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
5208740|NCT01005966|12806833|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
5208741|NCT01005966|12806834|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
5208742|NCT01005966|12806835|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
5208743|NCT01005966|12806831|P5|COMPLETED|Washout Period 2 (4 Days)||11
5208744|NCT01005966|12806832|P4|COMPLETED|Washout Period 2 (4 Days)||11
5208745|NCT01005966|12806833|P3|COMPLETED|Washout Period 2 (4 Days)||10
5208746|NCT01005966|12806834|P2|COMPLETED|Washout Period 2 (4 Days)||12
5208747|NCT01005966|12806835|P1|COMPLETED|Washout Period 2 (4 Days)||13
5208748|NCT01005966|12806831|P5|STARTED|Washout Period 2 (4 Days)||11
5208749|NCT01005966|12806832|P4|STARTED|Washout Period 2 (4 Days)||11
5208750|NCT01005966|12806833|P3|STARTED|Washout Period 2 (4 Days)||10
5208751|NCT01005966|12806834|P2|STARTED|Washout Period 2 (4 Days)||12
5208752|NCT01005966|12806835|P1|STARTED|Washout Period 2 (4 Days)||13
5208753|NCT01005966|12806831|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5208754|NCT01005966|12806832|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5208755|NCT01005966|12806833|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
5208756|NCT01005966|12806834|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
5208757|NCT01005966|12806835|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
5208758|NCT01005966|12806831|P5|COMPLETED|Treatment Period 2 (14 Days)||11
5208759|NCT01005966|12806832|P4|COMPLETED|Treatment Period 2 (14 Days)||11
5208760|NCT01005966|12806833|P3|COMPLETED|Treatment Period 2 (14 Days)||10
5208761|NCT01005966|12806834|P2|COMPLETED|Treatment Period 2 (14 Days)||12
5208762|NCT01005966|12806835|P1|COMPLETED|Treatment Period 2 (14 Days)||13
5208763|NCT01005966|12806831|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
5208764|NCT01005966|12806832|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
5208765|NCT01005966|12806833|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
5208766|NCT01005966|12806834|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
5208767|NCT01005966|12806835|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
5208768|NCT01005966|12806831|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
5208769|NCT01005966|12806832|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
5208770|NCT01005966|12806833|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
5208771|NCT01005966|12806834|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
5208772|NCT01005966|12806835|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
5208773|NCT01005966|12806831|P5|COMPLETED|Washout Period 1 (4 Days)||13
5208774|NCT01005966|12806832|P4|COMPLETED|Washout Period 1 (4 Days)||12
5208775|NCT01005966|12806833|P3|COMPLETED|Washout Period 1 (4 Days)||12
5208776|NCT01005966|12806834|P2|COMPLETED|Washout Period 1 (4 Days)||13
5208777|NCT01005966|12806835|P1|COMPLETED|Washout Period 1 (4 Days)||11
5208778|NCT01005966|12806831|P5|STARTED|Washout Period 1 (4 Days)||13
5208779|NCT01005966|12806832|P4|STARTED|Washout Period 1 (4 Days)||13
5208780|NCT01005966|12806833|P3|STARTED|Washout Period 1 (4 Days)||12
5208781|NCT01005966|12806834|P2|STARTED|Washout Period 1 (4 Days)||13
5208782|NCT01005966|12806835|P1|STARTED|Washout Period 1 (4 Days)||11
5208783|NCT01005966|12806831|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5208784|NCT01005966|12806832|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5208785|NCT01005966|12806833|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
5208786|NCT01005966|12806834|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
5208787|NCT01005966|12806835|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
5208788|NCT01005966|12806831|P5|COMPLETED|Treatment Period 1 (14 Days)||13
5208789|NCT01005966|12806832|P4|COMPLETED|Treatment Period 1 (14 Days)||13
5208790|NCT01005966|12806833|P3|COMPLETED|Treatment Period 1 (14 Days)||12
5208791|NCT01005966|12806834|P2|COMPLETED|Treatment Period 1 (14 Days)||13
5208792|NCT01005966|12806835|P1|COMPLETED|Treatment Period 1 (14 Days)||11
5208793|NCT01005966|12806831|P5|STARTED|Treatment Period 1 (14 Days)||13
5208794|NCT01005966|12806832|P4|STARTED|Treatment Period 1 (14 Days)||13
5208795|NCT01005966|12806833|P3|STARTED|Treatment Period 1 (14 Days)||13
5208796|NCT01005966|12806834|P2|STARTED|Treatment Period 1 (14 Days)||13
5208797|NCT01005966|12806835|P1|STARTED|Treatment Period 1 (14 Days)||13
5208798|NCT01005914|12806855|P1|NOT COMPLETED|Overall Study||10
5208799|NCT01005914|12806855|P1|COMPLETED|Overall Study||1
5208800|NCT01005914|12806855|P1|STARTED|Overall Study||11
5208801|NCT01005901|12806861|P2|NOT COMPLETED|Overall Study||58
5208802|NCT01005901|12806862|P1|NOT COMPLETED|Overall Study||102
5208803|NCT01005901|12806861|P2|COMPLETED|Overall Study||212
5208804|NCT01005901|12806862|P1|COMPLETED|Overall Study||450
5208805|NCT01005901|12806861|P2|Full Analysis Set|Overall Study||260
5208806|NCT01005901|12806862|P1|Full Analysis Set|Overall Study||534
5208807|NCT01005901|12806861|P2|Safety Population|Overall Study||267
5208808|NCT01005901|12806862|P1|Safety Population|Overall Study||550
5208809|NCT01005901|12806861|P2|STARTED|Overall Study||270
5208810|NCT01005901|12806862|P1|STARTED|Overall Study||552
5208811|NCT01005888|12806904|P2|NOT COMPLETED|Second Intervention||1
5208812|NCT01005888|12806905|P1|NOT COMPLETED|Second Intervention||1
5208813|NCT01005888|12806904|P2|COMPLETED|Second Intervention||10
5208814|NCT01005888|12806905|P1|COMPLETED|Second Intervention||10
5208815|NCT01005888|12806904|P2|STARTED|Second Intervention||11
5208816|NCT01005888|12806905|P1|STARTED|Second Intervention||11
5208817|NCT01005888|12806904|P2|NOT COMPLETED|First Intervention||1
5208818|NCT01005888|12806905|P1|NOT COMPLETED|First Intervention||1
5208819|NCT01005888|12806904|P2|COMPLETED|First Intervention||11
5208820|NCT01005888|12806905|P1|COMPLETED|First Intervention||11
5208821|NCT01005888|12806904|P2|STARTED|First Intervention||12
5208822|NCT01005888|12806905|P1|STARTED|First Intervention||12
5208823|NCT01005875|12806925|P1|NOT COMPLETED|Overall Study||3
5208824|NCT01005875|12806925|P1|COMPLETED|Overall Study||2
5208825|NCT01005875|12806925|P1|STARTED|Overall Study||5
5208826|NCT01005810|12806935|P2|NOT COMPLETED|Overall Study||25
5208827|NCT01005810|12806936|P1|NOT COMPLETED|Overall Study||21
5208828|NCT01005810|12806935|P2|COMPLETED|Overall Study||33
5208829|NCT01005810|12806936|P1|COMPLETED|Overall Study||37
5208830|NCT01005810|12806935|P2|STARTED|Overall Study||58
5208831|NCT01005810|12806936|P1|STARTED|Overall Study||58
5208832|NCT01005745|12806942|P1|NOT COMPLETED|Overall Study||6
5208833|NCT01005745|12806942|P1|COMPLETED|Overall Study||13
5208834|NCT01005745|12806942|P1|STARTED|Overall Study||19
5208835|NCT01005732|12806947|P1|NOT COMPLETED|Overall Study||11
5208836|NCT01005732|12806947|P1|COMPLETED|Overall Study||43
5208837|NCT01005732|12806947|P1|STARTED|Overall Study||54
5208838|NCT01005719|12806963|P6|NOT COMPLETED|Period 3||0
5208839|NCT01005719|12806964|P5|NOT COMPLETED|Period 3||0
5208840|NCT01005719|12806965|P4|NOT COMPLETED|Period 3||0
5208841|NCT01005719|12806966|P3|NOT COMPLETED|Period 3||0
5208842|NCT01005719|12806967|P2|NOT COMPLETED|Period 3||0
5208843|NCT01005719|12806968|P1|NOT COMPLETED|Period 3||0
5208844|NCT01005719|12806963|P6|COMPLETED|Period 3||9
5208845|NCT01005719|12806964|P5|COMPLETED|Period 3||10
5208846|NCT01005719|12806965|P4|COMPLETED|Period 3||10
5208847|NCT01005719|12806966|P3|COMPLETED|Period 3||10
5208848|NCT01005719|12806967|P2|COMPLETED|Period 3||10
5208849|NCT01005719|12806968|P1|COMPLETED|Period 3||10
5208850|NCT01005719|12806963|P6|STARTED|Period 3||9
5208851|NCT01005719|12806964|P5|STARTED|Period 3||10
5208852|NCT01005719|12806965|P4|STARTED|Period 3||10
5208853|NCT01005719|12806966|P3|STARTED|Period 3||10
5208854|NCT01005719|12806967|P2|STARTED|Period 3||10
5208855|NCT01005719|12806968|P1|STARTED|Period 3||10
5208856|NCT01005719|12806963|P6|NOT COMPLETED|Period 2||1
5208857|NCT01005719|12806964|P5|NOT COMPLETED|Period 2||1
5208858|NCT01005719|12806965|P4|NOT COMPLETED|Period 2||0
5208859|NCT01005719|12806966|P3|NOT COMPLETED|Period 2||0
5208860|NCT01005719|12806967|P2|NOT COMPLETED|Period 2||0
5208861|NCT01005719|12806968|P1|NOT COMPLETED|Period 2||0
5208862|NCT01005719|12806963|P6|COMPLETED|Period 2||9
5208863|NCT01005719|12806964|P5|COMPLETED|Period 2||10
5208864|NCT01005719|12806965|P4|COMPLETED|Period 2||10
5208865|NCT01005719|12806966|P3|COMPLETED|Period 2||10
5208866|NCT01005719|12806967|P2|COMPLETED|Period 2||10
5208867|NCT01005719|12806968|P1|COMPLETED|Period 2||10
5208868|NCT01005719|12806963|P6|STARTED|Period 2||10
5208869|NCT01005719|12806964|P5|STARTED|Period 2||11
5208870|NCT01005719|12806965|P4|STARTED|Period 2||10
5208871|NCT01005719|12806966|P3|STARTED|Period 2||10
5208872|NCT01005719|12806967|P2|STARTED|Period 2||10
5208873|NCT01005719|12806968|P1|STARTED|Period 2||10
5208874|NCT01005719|12806963|P6|NOT COMPLETED|Period 1||1
5208875|NCT01005719|12806964|P5|NOT COMPLETED|Period 1||0
5208876|NCT01005719|12806965|P4|NOT COMPLETED|Period 1||1
5208877|NCT01005719|12806966|P3|NOT COMPLETED|Period 1||0
5208878|NCT01005719|12806967|P2|NOT COMPLETED|Period 1||0
5208879|NCT01005719|12806968|P1|NOT COMPLETED|Period 1||0
5208880|NCT01005719|12806963|P6|COMPLETED|Period 1||10
5208881|NCT01005719|12806964|P5|COMPLETED|Period 1||11
5208882|NCT01005719|12806965|P4|COMPLETED|Period 1||10
5208883|NCT01005719|12806966|P3|COMPLETED|Period 1||10
5208884|NCT01005719|12806967|P2|COMPLETED|Period 1||10
5208885|NCT01005719|12806968|P1|COMPLETED|Period 1||10
5208886|NCT01005719|12806963|P6|STARTED|Period 1||11
5208887|NCT01005719|12806964|P5|STARTED|Period 1||11
5208888|NCT01005719|12806965|P4|STARTED|Period 1||11
5208889|NCT01005719|12806966|P3|STARTED|Period 1||10
5208890|NCT01005719|12806967|P2|STARTED|Period 1||10
5208891|NCT01005719|12806968|P1|STARTED|Period 1||10
5208892|NCT01005706|12807026|P2|NOT COMPLETED|Overall Study||0
5208893|NCT01005706|12807027|P1|NOT COMPLETED|Overall Study||0
5208894|NCT01005706|12807026|P2|COMPLETED|Overall Study||17
5208895|NCT01005706|12807027|P1|COMPLETED|Overall Study||23
5208896|NCT01005706|12807026|P2|STARTED|Overall Study||17
5208897|NCT01005706|12807027|P1|STARTED|Overall Study||23
5208898|NCT01005680|12807035|P2|NOT COMPLETED|Overall Study||11
5208899|NCT01005680|12807036|P1|NOT COMPLETED|Overall Study||6
5208900|NCT01005680|12807035|P2|COMPLETED|Overall Study||119
5208901|NCT01005680|12807036|P1|COMPLETED|Overall Study||120
5208902|NCT01005680|12807035|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
5208903|NCT01005680|12807036|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
5208904|NCT01005680|12807035|P2|STARTED|Overall Study||130
5208905|NCT01005680|12807036|P1|STARTED|Overall Study||126
5208906|NCT01005602|12807060|P2|NOT COMPLETED|Overall Study||0
5208907|NCT01005602|12807061|P1|NOT COMPLETED|Overall Study||1
5208908|NCT01005602|12807060|P2|COMPLETED|Overall Study||66
5208909|NCT01005602|12807061|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
5208910|NCT01005602|12807060|P2|STARTED|Overall Study||66
5208911|NCT01005602|12807061|P1|STARTED|Overall Study||66
5208912|NCT01005576|12807081|P1|NOT COMPLETED|Overall Study||0
5208913|NCT01005576|12807081|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
5208914|NCT01005576|12807081|P1|STARTED|Overall Study||21
5208915|NCT01005459|12807091|P2|NOT COMPLETED|Overall Study||0
5208916|NCT01005459|12807092|P1|NOT COMPLETED|Overall Study||0
5208917|NCT01005459|12807091|P2|COMPLETED|Overall Study||23
5208918|NCT01005459|12807092|P1|COMPLETED|Overall Study||23
5208919|NCT01005459|12807091|P2|STARTED|Overall Study||23
5208920|NCT01005459|12807092|P1|STARTED|Overall Study||23
5208921|NCT01005407|12807100|P2|NOT COMPLETED|Overall Study||32
5208922|NCT01005407|12807101|P1|NOT COMPLETED|Overall Study||151
5208923|NCT01005407|12807100|P2|COMPLETED|Overall Study||451
5208924|NCT01005407|12807101|P1|COMPLETED|Overall Study||1818
5208925|NCT01005407|12807100|P2|STARTED|Overall Study||483
5208926|NCT01005407|12807101|P1|STARTED|Overall Study||1969
5208927|NCT01005355|12807112|P3|NOT COMPLETED|Overall Study||0
5208928|NCT01005355|12807113|P2|NOT COMPLETED|Overall Study||0
5208929|NCT01005355|12807114|P1|NOT COMPLETED|Overall Study||0
5208930|NCT01005355|12807112|P3|COMPLETED|Overall Study||6
5208931|NCT01005355|12807113|P2|COMPLETED|Overall Study||6
5208932|NCT01005355|12807114|P1|COMPLETED|Overall Study||3
5208933|NCT01005355|12807112|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
5208934|NCT01005355|12807113|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
5208935|NCT01005355|12807114|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5208936|NCT01005355|12807112|P3|STARTED|Overall Study||6
5208937|NCT01005355|12807113|P2|STARTED|Overall Study||6
5208938|NCT01005355|12807114|P1|STARTED|Overall Study||3
5208939|NCT01005329|12807149|P1|NOT COMPLETED|Overall Study||4
5208940|NCT01005329|12807149|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
5208941|NCT01005329|12807149|P1|STARTED|Overall Study||34
5208942|NCT01005316|12807162|P4|NOT COMPLETED|Overall Study||108
5208943|NCT01005316|12807163|P3|NOT COMPLETED|Overall Study||11
5208944|NCT01005316|12807164|P2|NOT COMPLETED|Overall Study||76
5208945|NCT01005316|12807165|P1|NOT COMPLETED|Overall Study||50
5208946|NCT01005316|12807162|P4|COMPLETED|Overall Study||19
5208947|NCT01005316|12807163|P3|COMPLETED|Overall Study||5
5208948|NCT01005316|12807164|P2|COMPLETED|Overall Study||21
5208949|NCT01005316|12807165|P1|COMPLETED|Overall Study||0
5208950|NCT01005316|12807162|P4|STARTED|Overall Study||127
5208951|NCT01005316|12807163|P3|STARTED|Overall Study||16
5208952|NCT01005316|12807164|P2|STARTED|Overall Study||97
5208953|NCT01005316|12807165|P1|STARTED|Overall Study||50
5208954|NCT01005290|12807217|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
5208955|NCT01005290|12807218|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
5208956|NCT01005290|12807219|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
5208957|NCT01005290|12807217|P3|COMPLETED|Period 2 (5 Weeks)||7
5208958|NCT01005290|12807218|P2|COMPLETED|Period 2 (5 Weeks)||13
5208959|NCT01005290|12807219|P1|COMPLETED|Period 2 (5 Weeks)||0
5208960|NCT01005290|12807217|P3|STARTED|Period 2 (5 Weeks)||9
5208961|NCT01005290|12807218|P2|STARTED|Period 2 (5 Weeks)||13
5208962|NCT01005290|12807219|P1|STARTED|Period 2 (5 Weeks)||0
5208963|NCT01005290|12807217|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
5208964|NCT01005290|12807218|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
5208965|NCT01005290|12807219|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
5208966|NCT01005290|12807217|P3|COMPLETED|Washout Period (2 Weeks)||9
5208967|NCT01005290|12807218|P2|COMPLETED|Washout Period (2 Weeks)||13
5208968|NCT01005290|12807219|P1|COMPLETED|Washout Period (2 Weeks)||0
5208969|NCT01005290|12807217|P3|STARTED|Washout Period (2 Weeks)||9
5208970|NCT01005290|12807218|P2|STARTED|Washout Period (2 Weeks)||13
5208971|NCT01005290|12807219|P1|STARTED|Washout Period (2 Weeks)||0
5208972|NCT01005290|12807217|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
5208973|NCT01005290|12807218|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
5208974|NCT01005290|12807219|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
5208975|NCT01005290|12807217|P3|COMPLETED|Period 1 (5 Weeks)||9
5208976|NCT01005290|12807218|P2|COMPLETED|Period 1 (5 Weeks)||13
5208977|NCT01005290|12807219|P1|COMPLETED|Period 1 (5 Weeks)||0
5208978|NCT01005290|12807217|P3|STARTED|Period 1 (5 Weeks)||18
5208979|NCT01005290|12807218|P2|STARTED|Period 1 (5 Weeks)||20
5208980|NCT01005290|12807219|P1|STARTED|Period 1 (5 Weeks)||0
5208981|NCT01005290|12807217|P3|NOT COMPLETED|Run-In||0
5208982|NCT01005290|12807218|P2|NOT COMPLETED|Run-In||0
5208983|NCT01005290|12807219|P1|NOT COMPLETED|Run-In||14
5208984|NCT01005290|12807217|P3|COMPLETED|Run-In||0
5208985|NCT01005290|12807218|P2|COMPLETED|Run-In||0
5208986|NCT01005290|12807219|P1|COMPLETED|Run-In||38
5208987|NCT01005290|12807217|P3|STARTED|Run-In||0
5208988|NCT01005290|12807218|P2|STARTED|Run-In||0
5208989|NCT01005290|12807219|P1|STARTED|Run-In||52
5208990|NCT01005251|12807232|P5|NOT COMPLETED|Overall Study||18
5208991|NCT01005251|12807233|P4|NOT COMPLETED|Overall Study||12
5208992|NCT01005251|12807234|P3|NOT COMPLETED|Overall Study||22
5208993|NCT01005251|12807235|P2|NOT COMPLETED|Overall Study||16
5208994|NCT01005251|12807236|P1|NOT COMPLETED|Overall Study||13
5208995|NCT01005251|12807232|P5|COMPLETED|Overall Study||122
5208996|NCT01005251|12807233|P4|COMPLETED|Overall Study||114
5208997|NCT01005251|12807234|P3|COMPLETED|Overall Study||114
5208998|NCT01005251|12807235|P2|COMPLETED|Overall Study||109
5208999|NCT01005251|12807236|P1|COMPLETED|Overall Study||121
5209000|NCT01005251|12807232|P5|STARTED|Overall Study||140
5209001|NCT01005251|12807233|P4|STARTED|Overall Study||126
5209002|NCT01005251|12807234|P3|STARTED|Overall Study||136
5209003|NCT01005251|12807235|P2|STARTED|Overall Study||125
5209004|NCT01005251|12807236|P1|STARTED|Overall Study||134
5209005|NCT01004991|12807253|P1|NOT COMPLETED|Overall Study||0
5209006|NCT01004991|12807253|P1|COMPLETED|Overall Study||12
5209007|NCT01004991|12807253|P1|STARTED|Overall Study||12
5209008|NCT01004939|12807257|P1|NOT COMPLETED|Overall Study||0
5209009|NCT01004939|12807257|P1|COMPLETED|Overall Study||120
5209010|NCT01004939|12807257|P1|STARTED|Overall Study||120
5209011|NCT01004874|12807298|P1|NOT COMPLETED|Overall Study||0
5209012|NCT01004874|12807298|P1|COMPLETED|Overall Study||80
5209013|NCT01004874|12807298|P1|STARTED|Overall Study||80
5209014|NCT01004861|12807320|P13|NOT COMPLETED|Overall Study||20
5209015|NCT01004861|12807321|P12|NOT COMPLETED|Overall Study||8
5209016|NCT01004861|12807322|P11|NOT COMPLETED|Overall Study||9
5209017|NCT01004861|12807323|P10|NOT COMPLETED|Overall Study||11
5209018|NCT01004861|12807324|P9|NOT COMPLETED|Overall Study||39
5209019|NCT01004861|12807325|P8|NOT COMPLETED|Overall Study||4
5209020|NCT01004861|12807326|P7|NOT COMPLETED|Overall Study||7
5209021|NCT01004861|12807327|P6|NOT COMPLETED|Overall Study||6
5209022|NCT01004861|12807328|P5|NOT COMPLETED|Overall Study||7
5209023|NCT01004861|12807329|P4|NOT COMPLETED|Overall Study||6
5209024|NCT01004861|12807330|P3|NOT COMPLETED|Overall Study||6
5209025|NCT01004861|12807331|P2|NOT COMPLETED|Overall Study||6
5209026|NCT01004861|12807332|P1|NOT COMPLETED|Overall Study||3
5209027|NCT01004861|12807320|P13|COMPLETED|Overall Study||0
5209028|NCT01004861|12807321|P12|COMPLETED|Overall Study||0
5209029|NCT01004861|12807322|P11|COMPLETED|Overall Study||0
5209030|NCT01004861|12807323|P10|COMPLETED|Overall Study||0
5209031|NCT01004861|12807324|P9|COMPLETED|Overall Study||0
5209032|NCT01004861|12807325|P8|COMPLETED|Overall Study||0
5209033|NCT01004861|12807326|P7|COMPLETED|Overall Study||0
5209034|NCT01004861|12807327|P6|COMPLETED|Overall Study||0
5209035|NCT01004861|12807328|P5|COMPLETED|Overall Study||0
5209036|NCT01004861|12807329|P4|COMPLETED|Overall Study||0
5209037|NCT01004861|12807330|P3|COMPLETED|Overall Study||0
5209038|NCT01004861|12807331|P2|COMPLETED|Overall Study||0
5209039|NCT01004861|12807332|P1|COMPLETED|Overall Study||0
5209040|NCT01004861|12807320|P13|STARTED|Overall Study||20
5209041|NCT01004861|12807321|P12|STARTED|Overall Study||8
5209042|NCT01004861|12807322|P11|STARTED|Overall Study||9
5209043|NCT01004861|12807323|P10|STARTED|Overall Study||11
5209044|NCT01004861|12807324|P9|STARTED|Overall Study||39
5209045|NCT01004861|12807325|P8|STARTED|Overall Study||4
5209046|NCT01004861|12807326|P7|STARTED|Overall Study||7
5209047|NCT01004861|12807327|P6|STARTED|Overall Study||6
5209048|NCT01004861|12807328|P5|STARTED|Overall Study||7
5209049|NCT01004861|12807329|P4|STARTED|Overall Study||6
5209050|NCT01004861|12807330|P3|STARTED|Overall Study||6
5209051|NCT01004861|12807331|P2|STARTED|Overall Study||6
5209052|NCT01004861|12807332|P1|STARTED|Overall Study||3
5209053|NCT01004848|12807398|P2|NOT COMPLETED|Overall Study||45
5209054|NCT01004848|12807399|P1|NOT COMPLETED|Overall Study||55
5209055|NCT01004848|12807398|P2|COMPLETED|Overall Study||147
5209056|NCT01004848|12807399|P1|COMPLETED|Overall Study||155
5209057|NCT01004848|12807398|P2|STARTED|Overall Study||192
5209058|NCT01004848|12807399|P1|STARTED|Overall Study||210
5209059|NCT01004822|12807437|P8|NOT COMPLETED|Overall Study||5
5209060|NCT01004822|12807438|P7|NOT COMPLETED|Overall Study||4
5209061|NCT01004822|12807439|P6|NOT COMPLETED|Overall Study||4
5209062|NCT01004822|12807440|P5|NOT COMPLETED|Overall Study||4
5209063|NCT01004822|12807441|P4|NOT COMPLETED|Overall Study||4
5209064|NCT01004822|12807442|P3|NOT COMPLETED|Overall Study||4
5209065|NCT01004822|12807443|P2|NOT COMPLETED|Overall Study||3
5209066|NCT01004822|12807444|P1|NOT COMPLETED|Overall Study||3
5209067|NCT01004822|12807437|P8|COMPLETED|Overall Study||0
5209068|NCT01004822|12807438|P7|COMPLETED|Overall Study||0
5209069|NCT01004822|12807439|P6|COMPLETED|Overall Study||0
5209070|NCT01004822|12807440|P5|COMPLETED|Overall Study||0
5209071|NCT01004822|12807441|P4|COMPLETED|Overall Study||0
5209072|NCT01004822|12807442|P3|COMPLETED|Overall Study||0
5209073|NCT01004822|12807443|P2|COMPLETED|Overall Study||0
5209074|NCT01004822|12807444|P1|COMPLETED|Overall Study||0
5209075|NCT01004822|12807437|P8|Treated|Overall Study||5
5209076|NCT01004822|12807438|P7|Treated|Overall Study||4
5209077|NCT01004822|12807439|P6|Treated|Overall Study||4
5209078|NCT01004822|12807440|P5|Treated|Overall Study||4
5209079|NCT01004822|12807441|P4|Treated|Overall Study||4
5209080|NCT01004822|12807442|P3|Treated|Overall Study||3
5209081|NCT01004822|12807443|P2|Treated|Overall Study||3
5209082|NCT01004822|12807444|P1|Treated|Overall Study||3
5209083|NCT01004822|12807437|P8|STARTED|Overall Study||5
5209084|NCT01004822|12807438|P7|STARTED|Overall Study||4
5209085|NCT01004822|12807439|P6|STARTED|Overall Study||4
5209086|NCT01004822|12807440|P5|STARTED|Overall Study||4
5209087|NCT01004822|12807441|P4|STARTED|Overall Study||4
5209088|NCT01004822|12807442|P3|STARTED|Overall Study||4
5209089|NCT01004822|12807443|P2|STARTED|Overall Study||3
5209090|NCT01004822|12807444|P1|STARTED|Overall Study||3
5209091|NCT01004770|12807558|P5|NOT COMPLETED|Overall Study||0
5209092|NCT01004770|12807559|P4|NOT COMPLETED|Overall Study||0
5209093|NCT01004770|12807560|P3|NOT COMPLETED|Overall Study||0
5209094|NCT01004770|12807561|P2|NOT COMPLETED|Overall Study||0
5209095|NCT01004770|12807562|P1|NOT COMPLETED|Overall Study||0
5209096|NCT01004770|12807558|P5|COMPLETED|Overall Study||10
5209097|NCT01004770|12807559|P4|COMPLETED|Overall Study||10
5209098|NCT01004770|12807560|P3|COMPLETED|Overall Study||10
5209099|NCT01004770|12807561|P2|COMPLETED|Overall Study||10
5209100|NCT01004770|12807562|P1|COMPLETED|Overall Study||10
5209101|NCT01004770|12807558|P5|STARTED|Overall Study||10
5209102|NCT01004770|12807559|P4|STARTED|Overall Study||10
5209103|NCT01004770|12807560|P3|STARTED|Overall Study||10
5209104|NCT01004770|12807561|P2|STARTED|Overall Study||10
5209105|NCT01004770|12807562|P1|STARTED|Overall Study||10
5209106|NCT01004705|12807594|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
5209107|NCT01004705|12807595|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
5209108|NCT01004705|12807596|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
5209109|NCT01004705|12807594|P3|COMPLETED|Period 2 (12 Weeks)||9
5209110|NCT01004705|12807595|P2|COMPLETED|Period 2 (12 Weeks)||13
5209111|NCT01004705|12807596|P1|COMPLETED|Period 2 (12 Weeks)||0
5209112|NCT01004705|12807594|P3|STARTED|Period 2 (12 Weeks)||13
5209113|NCT01004705|12807595|P2|STARTED|Period 2 (12 Weeks)||13
5209114|NCT01004705|12807596|P1|STARTED|Period 2 (12 Weeks)||0
5209115|NCT01004705|12807594|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
5209116|NCT01004705|12807595|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
5209117|NCT01004705|12807596|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
5209118|NCT01004705|12807594|P3|COMPLETED|Washout Period (6 Weeks)||13
5209119|NCT01004705|12807595|P2|COMPLETED|Washout Period (6 Weeks)||13
5209120|NCT01004705|12807596|P1|COMPLETED|Washout Period (6 Weeks)||0
5209121|NCT01004705|12807594|P3|STARTED|Washout Period (6 Weeks)||13
5209122|NCT01004705|12807595|P2|STARTED|Washout Period (6 Weeks)||13
5209123|NCT01004705|12807596|P1|STARTED|Washout Period (6 Weeks)||0
5209124|NCT01004705|12807594|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
5209125|NCT01004705|12807595|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
5209126|NCT01004705|12807596|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
5209127|NCT01004705|12807594|P3|COMPLETED|Period 1 (12 Weeks)||13
5209128|NCT01004705|12807595|P2|COMPLETED|Period 1 (12 Weeks)||13
5209129|NCT01004705|12807596|P1|COMPLETED|Period 1 (12 Weeks)||0
5209130|NCT01004705|12807594|P3|STARTED|Period 1 (12 Weeks)||18
5209131|NCT01004705|12807595|P2|STARTED|Period 1 (12 Weeks)||18
5209132|NCT01004705|12807596|P1|STARTED|Period 1 (12 Weeks)||0
5209133|NCT01004705|12807594|P3|NOT COMPLETED|Run-In||0
5209134|NCT01004705|12807595|P2|NOT COMPLETED|Run-In||0
5209135|NCT01004705|12807596|P1|NOT COMPLETED|Run-In||8
5209136|NCT01004705|12807594|P3|COMPLETED|Run-In||0
5209137|NCT01004705|12807595|P2|COMPLETED|Run-In||0
5209138|NCT01004705|12807596|P1|COMPLETED|Run-In||36
5209139|NCT01004705|12807594|P3|STARTED|Run-In||0
5209140|NCT01004705|12807595|P2|STARTED|Run-In||0
5209141|NCT01004705|12807596|P1|STARTED|Run-In||44
5209142|NCT01004614|12807609|P4|NOT COMPLETED|Second Intervention||0
5209143|NCT01004614|12807610|P3|NOT COMPLETED|Second Intervention||0
5209144|NCT01004614|12807611|P2|NOT COMPLETED|Second Intervention||0
5209145|NCT01004614|12807612|P1|NOT COMPLETED|Second Intervention||0
5209146|NCT01004614|12807609|P4|COMPLETED|Second Intervention||12
5209147|NCT01004614|12807610|P3|COMPLETED|Second Intervention||12
5209148|NCT01004614|12807611|P2|COMPLETED|Second Intervention||11
5209149|NCT01004614|12807612|P1|COMPLETED|Second Intervention||12
5209150|NCT01004614|12807609|P4|STARTED|Second Intervention||12
5209151|NCT01004614|12807610|P3|STARTED|Second Intervention||12
5209152|NCT01004614|12807611|P2|STARTED|Second Intervention||11
5209153|NCT01004614|12807612|P1|STARTED|Second Intervention||12
5209154|NCT01004614|12807609|P4|NOT COMPLETED|Washout||0
5209155|NCT01004614|12807610|P3|NOT COMPLETED|Washout||0
5209156|NCT01004614|12807611|P2|NOT COMPLETED|Washout||1
5209157|NCT01004614|12807612|P1|NOT COMPLETED|Washout||0
5209158|NCT01004614|12807609|P4|COMPLETED|Washout||12
5209159|NCT01004614|12807610|P3|COMPLETED|Washout||12
5209160|NCT01004614|12807611|P2|COMPLETED|Washout||11
5209161|NCT01004614|12807612|P1|COMPLETED|Washout||12
5209162|NCT01004614|12807609|P4|STARTED|Washout||12
5209163|NCT01004614|12807610|P3|STARTED|Washout||12
5209164|NCT01004614|12807611|P2|STARTED|Washout||12
5209165|NCT01004614|12807612|P1|STARTED|Washout||12
5209166|NCT01004614|12807609|P4|NOT COMPLETED|First Intervention||0
5209167|NCT01004614|12807610|P3|NOT COMPLETED|First Intervention||0
5209168|NCT01004614|12807611|P2|NOT COMPLETED|First Intervention||0
5209169|NCT01004614|12807612|P1|NOT COMPLETED|First Intervention||0
5209170|NCT01004614|12807609|P4|COMPLETED|First Intervention||12
5209171|NCT01004614|12807610|P3|COMPLETED|First Intervention||12
5209172|NCT01004614|12807611|P2|COMPLETED|First Intervention||12
5209173|NCT01004614|12807612|P1|COMPLETED|First Intervention||12
5209174|NCT01004614|12807609|P4|STARTED|First Intervention||12
5209175|NCT01004614|12807610|P3|STARTED|First Intervention||12
5209176|NCT01004614|12807611|P2|STARTED|First Intervention||12
5209177|NCT01004614|12807612|P1|STARTED|First Intervention||12
5209178|NCT01004510|12807646|P1|NOT COMPLETED|Overall Study||1
5209179|NCT01004510|12807646|P1|COMPLETED|Overall Study||2
5209180|NCT01004510|12807646|P1|STARTED|Overall Study||3
5209181|NCT01004432|12807650|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
5209182|NCT01004432|12807651|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
5209183|NCT01004432|12807652|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
5209184|NCT01004432|12807653|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
5209185|NCT01004432|12807654|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
5209186|NCT01004432|12807650|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
5209187|NCT01004432|12807651|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
5209188|NCT01004432|12807652|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
5209189|NCT01004432|12807653|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
5209190|NCT01004432|12807654|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
5209191|NCT01004432|12807650|P5|STARTED|OL Study Extension (Week 52 - 76)||212
5209192|NCT01004432|12807651|P4|STARTED|OL Study Extension (Week 52 - 76)||0
5209193|NCT01004432|12807652|P3|STARTED|OL Study Extension (Week 52 - 76)||0
5209194|NCT01004432|12807653|P2|STARTED|OL Study Extension (Week 52 - 76)||0
5209195|NCT01004432|12807654|P1|STARTED|OL Study Extension (Week 52 - 76)||0
5209196|NCT01004432|12807650|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209197|NCT01004432|12807651|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
5209198|NCT01004432|12807652|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
5209199|NCT01004432|12807653|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
5209200|NCT01004432|12807654|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209201|NCT01004432|12807650|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209202|NCT01004432|12807651|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
5209203|NCT01004432|12807652|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
5209204|NCT01004432|12807653|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
5209205|NCT01004432|12807654|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209206|NCT01004432|12807650|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209207|NCT01004432|12807651|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
5209208|NCT01004432|12807652|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
5209209|NCT01004432|12807653|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
5209210|NCT01004432|12807654|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
5209211|NCT01004432|12807650|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209212|NCT01004432|12807651|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209213|NCT01004432|12807652|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209214|NCT01004432|12807653|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209215|NCT01004432|12807654|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
5209216|NCT01004432|12807650|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209217|NCT01004432|12807651|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209218|NCT01004432|12807652|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209219|NCT01004432|12807653|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
5209220|NCT01004432|12807654|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
5209221|NCT01004432|12807650|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
5209222|NCT01004432|12807651|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
5209223|NCT01004432|12807652|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
5209224|NCT01004432|12807653|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
5209225|NCT01004432|12807654|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
5209226|NCT01004406|12807676|P2|NOT COMPLETED|Overall Study||0
5209227|NCT01004406|12807677|P1|NOT COMPLETED|Overall Study||3
5209228|NCT01004406|12807676|P2|COMPLETED|Overall Study||10
5209229|NCT01004406|12807677|P1|COMPLETED|Overall Study||18
5209230|NCT01004406|12807676|P2|STARTED|Overall Study||10
5209231|NCT01004406|12807677|P1|STARTED|Overall Study||21
5209232|NCT01004393|12807689|P1|NOT COMPLETED|Overall Study||0
5209233|NCT01004393|12807689|P1|COMPLETED|Overall Study||12
5209234|NCT01004393|12807689|P1|STARTED|Overall Study||12
5209235|NCT01004354|12807700|P1|NOT COMPLETED|Overall Study||0
5209236|NCT01004354|12807700|P1|COMPLETED|Overall Study||12
5209237|NCT01004354|12807700|P1|STARTED|Overall Study||12
5209238|NCT01004263|12807712|P1|NOT COMPLETED|Overall Study||179
5209239|NCT01004263|12807712|P1|COMPLETED|Overall Study||427
5209240|NCT01004263|12807712|P1|STARTED|Overall Study|Participants who took study drug|606
5209241|NCT01004250|12807720|P1|NOT COMPLETED|Follow-Up (FU) Period||1
5209242|NCT01004250|12807720|P1|COMPLETED|Follow-Up (FU) Period||100
5209243|NCT01004250|12807720|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
5209244|NCT01004250|12807720|P1|NOT COMPLETED|Maintenance Therapy Period||26
5209245|NCT01004250|12807720|P1|COMPLETED|Maintenance Therapy Period||46
5209246|NCT01004250|12807720|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
5209247|NCT01004250|12807720|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
5209248|NCT01004250|12807720|P1|NOT COMPLETED|Induction Therapy Period||15
5209249|NCT01004250|12807720|P1|COMPLETED|Induction Therapy Period||94
5209250|NCT01004250|12807720|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
5209251|NCT01004250|12807720|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
5209252|NCT01004250|12807720|P1|STARTED|Induction Therapy Period||109
5209253|NCT01004185|12807732|P2|NOT COMPLETED|Overall Study||9
5209254|NCT01004185|12807733|P1|NOT COMPLETED|Overall Study||9
5209255|NCT01004185|12807732|P2|COMPLETED|Overall Study||11
5209256|NCT01004185|12807733|P1|COMPLETED|Overall Study||10
5209257|NCT01004185|12807732|P2|STARTED|Overall Study||20
5209258|NCT01004185|12807733|P1|STARTED|Overall Study||19
5209259|NCT01004172|12807741|P1|NOT COMPLETED|Overall Study||38
5209260|NCT01004172|12807741|P1|COMPLETED|Overall Study||0
5209261|NCT01004172|12807741|P1|STARTED|Overall Study||38
5209262|NCT01004159|12807749|P1|NOT COMPLETED|Overall Study||20
5209263|NCT01004159|12807749|P1|COMPLETED|Overall Study||0
5209264|NCT01004159|12807749|P1|STARTED|Overall Study||20
5209265|NCT01004146|12807756|P2|NOT COMPLETED|Overall Study||5
5209266|NCT01004146|12807757|P1|NOT COMPLETED|Overall Study||4
5209267|NCT01004146|12807756|P2|COMPLETED|Overall Study||20
5209268|NCT01004146|12807757|P1|COMPLETED|Overall Study||21
5209269|NCT01004146|12807756|P2|Have Incentive Spirometry Data|Overall Study||20
5209270|NCT01004146|12807757|P1|Have Incentive Spirometry Data|Overall Study||21
5209271|NCT01004146|12807756|P2|STARTED|Overall Study||25
5209272|NCT01004146|12807757|P1|STARTED|Overall Study||25
5209273|NCT01004107|12807765|P2|NOT COMPLETED|Overall Study||2
5209274|NCT01004107|12807766|P1|NOT COMPLETED|Overall Study||1
5209275|NCT01004107|12807765|P2|COMPLETED|Overall Study||23
5209276|NCT01004107|12807766|P1|COMPLETED|Overall Study||75
5209277|NCT01004107|12807765|P2|STARTED|Overall Study||25
5209278|NCT01004107|12807766|P1|STARTED|Overall Study||76
5209279|NCT01004003|12807851|P9|NOT COMPLETED|Overall Study||30
5209280|NCT01004003|12807852|P8|NOT COMPLETED|Overall Study||60
5209281|NCT01004003|12807853|P7|NOT COMPLETED|Overall Study||8
5209282|NCT01004003|12807854|P6|NOT COMPLETED|Overall Study||4
5209283|NCT01004003|12807855|P5|NOT COMPLETED|Overall Study||4
5209284|NCT01004003|12807856|P4|NOT COMPLETED|Overall Study||3
5209285|NCT01004003|12807857|P3|NOT COMPLETED|Overall Study||4
5209286|NCT01004003|12807858|P2|NOT COMPLETED|Overall Study||3
5209287|NCT01004003|12807859|P1|NOT COMPLETED|Overall Study||6
5209288|NCT01004003|12807851|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
5209289|NCT01004003|12807852|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
5209290|NCT01004003|12807853|P7|COMPLETED|Overall Study||0
5209291|NCT01004003|12807854|P6|COMPLETED|Overall Study||0
5209292|NCT01004003|12807855|P5|COMPLETED|Overall Study||0
5209293|NCT01004003|12807856|P4|COMPLETED|Overall Study||0
5209294|NCT01004003|12807857|P3|COMPLETED|Overall Study||0
5209295|NCT01004003|12807858|P2|COMPLETED|Overall Study||0
5209296|NCT01004003|12807859|P1|COMPLETED|Overall Study||0
5209297|NCT01004003|12807851|P9|STARTED|Overall Study||31
5209298|NCT01004003|12807852|P8|STARTED|Overall Study||62
5209299|NCT01004003|12807853|P7|STARTED|Overall Study||8
5209300|NCT01004003|12807854|P6|STARTED|Overall Study||4
5209301|NCT01004003|12807855|P5|STARTED|Overall Study||4
5209302|NCT01004003|12807856|P4|STARTED|Overall Study||3
5209303|NCT01004003|12807857|P3|STARTED|Overall Study||4
5209304|NCT01004003|12807858|P2|STARTED|Overall Study||3
5209305|NCT01004003|12807859|P1|STARTED|Overall Study||6
5209306|NCT01003990|12807890|P3|NOT COMPLETED|Overall Study||43
5209307|NCT01003990|12807891|P2|NOT COMPLETED|Overall Study||51
5209308|NCT01003990|12807892|P1|NOT COMPLETED|Overall Study||92
5209309|NCT01003990|12807890|P3|COMPLETED|Overall Study||53
5209310|NCT01003990|12807891|P2|COMPLETED|Overall Study||103
5209311|NCT01003990|12807892|P1|COMPLETED|Overall Study||367
5209312|NCT01003990|12807890|P3|STARTED|Overall Study||96
5209313|NCT01003990|12807891|P2|STARTED|Overall Study||154
5209314|NCT01003990|12807892|P1|STARTED|Overall Study||459
5209315|NCT01003938|12807900|P1|NOT COMPLETED|Overall Study||0
5209316|NCT01003938|12807900|P1|COMPLETED|Overall Study||6
5209317|NCT01003938|12807900|P1|STARTED|Overall Study||6
5209318|NCT01003899|12807909|P1|NOT COMPLETED|Overall Study||47
5209319|NCT01003899|12807909|P1|COMPLETED|Overall Study||0
5209320|NCT01003899|12807909|P1|STARTED|Overall Study|enrolled|47
5209321|NCT01003886|12807918|P1|NOT COMPLETED|Overall Study||230
5209322|NCT01003886|12807918|P1|COMPLETED|Overall Study||759
5209323|NCT01003886|12807918|P1|STARTED|Overall Study||989
5209324|NCT01003769|12807927|P1|NOT COMPLETED|Overall Study||0
5209325|NCT01003769|12807927|P1|COMPLETED|Overall Study||5
5209326|NCT01003769|12807927|P1|STARTED|Overall Study||5
5209327|NCT01003639|12807939|P2|NOT COMPLETED|Overall Study||22
5209328|NCT01003639|12807940|P1|NOT COMPLETED|Overall Study||17
5209329|NCT01003639|12807939|P2|COMPLETED|Overall Study||57
5209330|NCT01003639|12807940|P1|COMPLETED|Overall Study||69
5209331|NCT01003639|12807939|P2|STARTED|Overall Study||79
5209332|NCT01003639|12807940|P1|STARTED|Overall Study||86
5209333|NCT01003418|12807954|P2|NOT COMPLETED|Overall Study||0
5209334|NCT01003418|12807955|P1|NOT COMPLETED|Overall Study||0
5209335|NCT01003418|12807954|P2|COMPLETED|Overall Study||3
5209336|NCT01003418|12807955|P1|COMPLETED|Overall Study||5
5209337|NCT01003418|12807954|P2|STARTED|Overall Study||3
5209338|NCT01003418|12807955|P1|STARTED|Overall Study||5
5209339|NCT01003301|12807973|P2|NOT COMPLETED|Overall Study||0
5209340|NCT01003301|12807974|P1|NOT COMPLETED|Overall Study||0
5209341|NCT01003301|12807973|P2|COMPLETED|Overall Study||9
5209342|NCT01003301|12807974|P1|COMPLETED|Overall Study||10
5209343|NCT01003301|12807973|P2|STARTED|Overall Study||9
5209344|NCT01003301|12807974|P1|STARTED|Overall Study||10
5209345|NCT01003288|12807982|P1|NOT COMPLETED|Overall Study||0
5209346|NCT01003288|12807982|P1|COMPLETED|Overall Study||255
5209347|NCT01003288|12807982|P1|STARTED|Overall Study||255
5209348|NCT01003275|12807989|P2|NOT COMPLETED|Overall Study||0
5209349|NCT01003275|12807990|P1|NOT COMPLETED|Overall Study||1
5209350|NCT01003275|12807989|P2|COMPLETED|Overall Study||11
5209351|NCT01003275|12807990|P1|COMPLETED|Overall Study||10
5209352|NCT01003275|12807989|P2|STARTED|Overall Study||11
5209353|NCT01003275|12807990|P1|STARTED|Overall Study||11
5209354|NCT01003249|12807996|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
5209355|NCT01003249|12807997|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
5209356|NCT01003249|12807996|P2|COMPLETED|Second Intervention (4 Weeks)||2
5209357|NCT01003249|12807997|P1|COMPLETED|Second Intervention (4 Weeks)||3
5209358|NCT01003249|12807996|P2|STARTED|Second Intervention (4 Weeks)||3
5209359|NCT01003249|12807997|P1|STARTED|Second Intervention (4 Weeks)||4
5209360|NCT01003249|12807996|P2|NOT COMPLETED|Washout (3 Weeks)||0
5209361|NCT01003249|12807997|P1|NOT COMPLETED|Washout (3 Weeks)||0
5209362|NCT01003249|12807996|P2|COMPLETED|Washout (3 Weeks)||3
5209363|NCT01003249|12807997|P1|COMPLETED|Washout (3 Weeks)||4
5209364|NCT01003249|12807996|P2|STARTED|Washout (3 Weeks)||3
5209365|NCT01003249|12807997|P1|STARTED|Washout (3 Weeks)||4
5209366|NCT01003249|12807996|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
5209367|NCT01003249|12807997|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
5209368|NCT01003249|12807996|P2|COMPLETED|First Intervention (4 Weeks)||3
5209369|NCT01003249|12807997|P1|COMPLETED|First Intervention (4 Weeks)||5
5209370|NCT01003249|12807996|P2|Received Intervention|First Intervention (4 Weeks)||5
5209371|NCT01003249|12807997|P1|Received Intervention|First Intervention (4 Weeks)||7
5209372|NCT01003249|12807996|P2|STARTED|First Intervention (4 Weeks)||5
5209373|NCT01003249|12807997|P1|STARTED|First Intervention (4 Weeks)||7
5209374|NCT01003210|12808015|P2|NOT COMPLETED|Overall Study||3
5209375|NCT01003210|12808016|P1|NOT COMPLETED|Overall Study||1
5209376|NCT01003210|12808015|P2|COMPLETED|Overall Study||102
5209377|NCT01003210|12808016|P1|COMPLETED|Overall Study||104
5209378|NCT01003210|12808015|P2|STARTED|Overall Study||105
5209379|NCT01003210|12808016|P1|STARTED|Overall Study||105
5209380|NCT01003184|12808028|P2|NOT COMPLETED|Overall Study||12
5209381|NCT01003184|12808029|P1|NOT COMPLETED|Overall Study||19
5209382|NCT01003184|12808028|P2|COMPLETED|Overall Study||99
5209383|NCT01003184|12808029|P1|COMPLETED|Overall Study||92
5209384|NCT01003184|12808028|P2|Full Analysis Set (FAS)|Overall Study||105
5209385|NCT01003184|12808029|P1|Full Analysis Set (FAS)|Overall Study||111
5209386|NCT01003184|12808028|P2|STARTED|Overall Study||111
5209387|NCT01003184|12808029|P1|STARTED|Overall Study||111
5209388|NCT01003106|12808065|P8|NOT COMPLETED|Month 6-Month 36||0
5209389|NCT01003106|12808066|P7|NOT COMPLETED|Month 6-Month 36||1
5209390|NCT01003106|12808067|P6|NOT COMPLETED|Month 6-Month 36||0
5209391|NCT01003106|12808068|P5|NOT COMPLETED|Month 6-Month 36||0
5209392|NCT01003106|12808069|P4|NOT COMPLETED|Month 6-Month 36||0
5209393|NCT01003106|12808070|P3|NOT COMPLETED|Month 6-Month 36||1
5209394|NCT01003106|12808071|P2|NOT COMPLETED|Month 6-Month 36||0
5209395|NCT01003106|12808072|P1|NOT COMPLETED|Month 6-Month 36||0
5209396|NCT01003106|12808065|P8|COMPLETED|Month 6-Month 36||18
5209397|NCT01003106|12808066|P7|COMPLETED|Month 6-Month 36||19
5209398|NCT01003106|12808067|P6|COMPLETED|Month 6-Month 36||0
5209399|NCT01003106|12808068|P5|COMPLETED|Month 6-Month 36||0
5209400|NCT01003106|12808069|P4|COMPLETED|Month 6-Month 36||20
5209401|NCT01003106|12808070|P3|COMPLETED|Month 6-Month 36||18
5209402|NCT01003106|12808071|P2|COMPLETED|Month 6-Month 36||0
5209403|NCT01003106|12808072|P1|COMPLETED|Month 6-Month 36||0
5209404|NCT01003106|12808065|P8|STARTED|Month 6-Month 36||18
5209405|NCT01003106|12808066|P7|STARTED|Month 6-Month 36||20
5209406|NCT01003106|12808067|P6|STARTED|Month 6-Month 36||0
5209407|NCT01003106|12808068|P5|STARTED|Month 6-Month 36||0
5209408|NCT01003106|12808069|P4|STARTED|Month 6-Month 36||20
5209409|NCT01003106|12808070|P3|STARTED|Month 6-Month 36||19
5209410|NCT01003106|12808071|P2|STARTED|Month 6-Month 36||0
5209411|NCT01003106|12808072|P1|STARTED|Month 6-Month 36||0
5209412|NCT01003106|12808065|P8|NOT COMPLETED|Baseline to Month 6||0
5209413|NCT01003106|12808066|P7|NOT COMPLETED|Baseline to Month 6||0
5209414|NCT01003106|12808067|P6|NOT COMPLETED|Baseline to Month 6||0
5209415|NCT01003106|12808068|P5|NOT COMPLETED|Baseline to Month 6||0
5209416|NCT01003106|12808069|P4|NOT COMPLETED|Baseline to Month 6||0
5209417|NCT01003106|12808070|P3|NOT COMPLETED|Baseline to Month 6||0
5209418|NCT01003106|12808071|P2|NOT COMPLETED|Baseline to Month 6||0
5209419|NCT01003106|12808072|P1|NOT COMPLETED|Baseline to Month 6||0
5209420|NCT01003106|12808065|P8|COMPLETED|Baseline to Month 6||0
5209421|NCT01003106|12808066|P7|COMPLETED|Baseline to Month 6||0
5209422|NCT01003106|12808067|P6|COMPLETED|Baseline to Month 6||20
5209423|NCT01003106|12808068|P5|COMPLETED|Baseline to Month 6||19
5209424|NCT01003106|12808069|P4|COMPLETED|Baseline to Month 6||0
5209425|NCT01003106|12808070|P3|COMPLETED|Baseline to Month 6||0
5209426|NCT01003106|12808071|P2|COMPLETED|Baseline to Month 6||20
5209427|NCT01003106|12808072|P1|COMPLETED|Baseline to Month 6||22
5209428|NCT01003106|12808065|P8|STARTED|Baseline to Month 6||0
5209429|NCT01003106|12808066|P7|STARTED|Baseline to Month 6||0
5209430|NCT01003106|12808067|P6|STARTED|Baseline to Month 6||20
5209431|NCT01003106|12808068|P5|STARTED|Baseline to Month 6||19
5209432|NCT01003106|12808069|P4|STARTED|Baseline to Month 6||0
5209433|NCT01003106|12808070|P3|STARTED|Baseline to Month 6||0
5209434|NCT01003106|12808071|P2|STARTED|Baseline to Month 6||20
5209435|NCT01003106|12808072|P1|STARTED|Baseline to Month 6||22
5209436|NCT01003080|12808096|P2|NOT COMPLETED|Overall Study||0
5209437|NCT01003080|12808097|P1|NOT COMPLETED|Overall Study||0
5209438|NCT01003080|12808096|P2|COMPLETED|Overall Study||61
5209439|NCT01003080|12808097|P1|COMPLETED|Overall Study||50
5209440|NCT01003080|12808096|P2|STARTED|Overall Study||61
5209441|NCT01003080|12808097|P1|STARTED|Overall Study||50
5209442|NCT01003067|12808105|P2|NOT COMPLETED|Overall Study||24
5209443|NCT01003067|12808106|P1|NOT COMPLETED|Overall Study||33
5209444|NCT01003067|12808105|P2|COMPLETED|Overall Study||107
5209445|NCT01003067|12808106|P1|COMPLETED|Overall Study||103
5209446|NCT01003067|12808105|P2|STARTED|Overall Study||131
5209447|NCT01003067|12808106|P1|STARTED|Overall Study||136
5209448|NCT01002989|12808112|P1|NOT COMPLETED|Overall Study||5
5209449|NCT01002989|12808112|P1|COMPLETED|Overall Study||93
5209450|NCT01002989|12808112|P1|STARTED|Overall Study||98
5209451|NCT01002755|12808119|P1|NOT COMPLETED|Overall Study||0
5209452|NCT01002755|12808119|P1|COMPLETED|Overall Study||36
5209453|NCT01002755|12808119|P1|STARTED|Overall Study||36
5209454|NCT01002742|12808127|P2|NOT COMPLETED|Overall Study||1
5209455|NCT01002742|12808128|P1|NOT COMPLETED|Overall Study||0
5209456|NCT01002742|12808127|P2|COMPLETED|Overall Study||116
5209457|NCT01002742|12808128|P1|COMPLETED|Overall Study||119
5209458|NCT01002742|12808127|P2|STARTED|Overall Study||117
5209459|NCT01002742|12808128|P1|STARTED|Overall Study||119
5209460|NCT01002573|12808164|P2|NOT COMPLETED|Overall Study||7
5209461|NCT01002573|12808165|P1|NOT COMPLETED|Overall Study||11
5209462|NCT01002573|12808164|P2|COMPLETED|Overall Study||53
5209463|NCT01002573|12808165|P1|COMPLETED|Overall Study||47
5209464|NCT01002573|12808164|P2|STARTED|Overall Study||60
5209465|NCT01002573|12808165|P1|STARTED|Overall Study||58
5209466|NCT01002547|12808186|P3|NOT COMPLETED|Overall Study||8
5209467|NCT01002547|12808187|P2|NOT COMPLETED|Overall Study||3
5209468|NCT01002547|12808188|P1|NOT COMPLETED|Overall Study||8
5209469|NCT01002547|12808186|P3|COMPLETED|Overall Study||29
5209470|NCT01002547|12808187|P2|COMPLETED|Overall Study||33
5209471|NCT01002547|12808188|P1|COMPLETED|Overall Study||24
5209472|NCT01002547|12808186|P3|STARTED|Overall Study||37
5209473|NCT01002547|12808187|P2|STARTED|Overall Study||36
5209474|NCT01002547|12808188|P1|STARTED|Overall Study||32
5209475|NCT01002482|12808246|P2|NOT COMPLETED|Overall Study||21
5209476|NCT01002482|12808247|P1|NOT COMPLETED|Overall Study||15
5209477|NCT01002482|12808246|P2|COMPLETED|Overall Study||1312
5209478|NCT01002482|12808247|P1|COMPLETED|Overall Study||1336
5209479|NCT01002482|12808246|P2|STARTED|Overall Study||1333
5209480|NCT01002482|12808247|P1|STARTED|Overall Study||1351
5209481|NCT01002456|12808269|P2|NOT COMPLETED|Overall Study||0
5209482|NCT01002456|12808270|P1|NOT COMPLETED|Overall Study||0
5209483|NCT01002456|12808269|P2|COMPLETED|Overall Study||122
5209484|NCT01002456|12808270|P1|COMPLETED|Overall Study||98
5209485|NCT01002456|12808269|P2|STARTED|Overall Study||122
5209486|NCT01002456|12808270|P1|STARTED|Overall Study||98
5209487|NCT01002339|12808281|P3|NOT COMPLETED|Overall Study||5
5209488|NCT01002339|12808282|P2|NOT COMPLETED|Overall Study||1
5209489|NCT01002339|12808283|P1|NOT COMPLETED|Overall Study||0
5209490|NCT01002339|12808281|P3|COMPLETED|Overall Study||42
5209491|NCT01002339|12808282|P2|COMPLETED|Overall Study||42
5209492|NCT01002339|12808283|P1|COMPLETED|Overall Study||44
5209493|NCT01002339|12808281|P3|STARTED|Overall Study||47
5209494|NCT01002339|12808282|P2|STARTED|Overall Study||43
5209495|NCT01002339|12808283|P1|STARTED|Overall Study||44
5209496|NCT01002287|12808338|P2|NOT COMPLETED|Overall Study||0
5209497|NCT01002287|12808339|P1|NOT COMPLETED|Overall Study||0
5209498|NCT01002287|12808338|P2|COMPLETED|Overall Study||3
5209499|NCT01002287|12808339|P1|COMPLETED|Overall Study||8
5209500|NCT01002287|12808338|P2|STARTED|Overall Study||3
5209501|NCT01002287|12808339|P1|STARTED|Overall Study||8
5209502|NCT01002118|12808351|P1|NOT COMPLETED|Overall Study||0
5209503|NCT01002118|12808351|P1|COMPLETED|Overall Study||1
5209504|NCT01002118|12808351|P1|Randomized Only Patient|Overall Study||1
5209505|NCT01002118|12808351|P1|STARTED|Overall Study||1
5209506|NCT01002105|12808359|P2|NOT COMPLETED|Overall Study||21
5209507|NCT01002105|12808360|P1|NOT COMPLETED|Overall Study||19
5209508|NCT01002105|12808359|P2|COMPLETED|Overall Study||11
5209509|NCT01002105|12808360|P1|COMPLETED|Overall Study||13
5209510|NCT01002105|12808359|P2|STARTED|Overall Study||32
5209511|NCT01002105|12808360|P1|STARTED|Overall Study||32
5209512|NCT01001988|12808376|P1|NOT COMPLETED|Overall Study||117
5209513|NCT01001988|12808376|P1|COMPLETED|Overall Study||479
5209514|NCT01001988|12808376|P1|STARTED|Overall Study||596
5209515|NCT01001975|12808383|P2|NOT COMPLETED|Overall Study||0
5209516|NCT01001975|12808384|P1|NOT COMPLETED|Overall Study||0
5209517|NCT01001975|12808383|P2|COMPLETED|Overall Study||5
5209518|NCT01001975|12808384|P1|COMPLETED|Overall Study||5
5209519|NCT01001975|12808383|P2|STARTED|Overall Study||5
5209520|NCT01001975|12808384|P1|STARTED|Overall Study||5
5209521|NCT01001832|12808394|P2|NOT COMPLETED|Follow-up Period||21
5209522|NCT01001832|12808395|P1|NOT COMPLETED|Follow-up Period||18
5209523|NCT01001832|12808394|P2|COMPLETED|Follow-up Period||30
5209524|NCT01001832|12808395|P1|COMPLETED|Follow-up Period||34
5209525|NCT01001832|12808394|P2|STARTED|Follow-up Period||51
5209526|NCT01001832|12808395|P1|STARTED|Follow-up Period||52
5209527|NCT01001832|12808394|P2|NOT COMPLETED|Long-term Period||5
5209528|NCT01001832|12808395|P1|NOT COMPLETED|Long-term Period||4
5209529|NCT01001832|12808394|P2|COMPLETED|Long-term Period||51
5209530|NCT01001832|12808395|P1|COMPLETED|Long-term Period||52
5209531|NCT01001832|12808394|P2|STARTED|Long-term Period||56
5209532|NCT01001832|12808395|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
5209533|NCT01001832|12808394|P2|NOT COMPLETED|Short-term Period||3
5209534|NCT01001832|12808395|P1|NOT COMPLETED|Short-term Period||2
5209535|NCT01001832|12808394|P2|COMPLETED|Short-term Period||56
5209536|NCT01001832|12808395|P1|COMPLETED|Short-term Period||57
5209537|NCT01001832|12808394|P2|STARTED|Short-term Period||59
5209538|NCT01001832|12808395|P1|STARTED|Short-term Period||59
5209539|NCT01001806|12808441|P3|NOT COMPLETED|Overall Study||4
5209540|NCT01001806|12808442|P2|NOT COMPLETED|Overall Study||1
5209541|NCT01001806|12808443|P1|NOT COMPLETED|Overall Study||0
5209542|NCT01001806|12808441|P3|COMPLETED|Overall Study||38
5209543|NCT01001806|12808442|P2|COMPLETED|Overall Study||41
5209544|NCT01001806|12808443|P1|COMPLETED|Overall Study||42
5209545|NCT01001806|12808441|P3|STARTED|Overall Study||42
5209546|NCT01001806|12808442|P2|STARTED|Overall Study||42
5209547|NCT01001806|12808443|P1|STARTED|Overall Study||42
5209548|NCT01001767|12808453|P2|NOT COMPLETED|Overall Study||0
5209549|NCT01001767|12808454|P1|NOT COMPLETED|Overall Study||4
5209550|NCT01001767|12808453|P2|COMPLETED|Overall Study||17
5209551|NCT01001767|12808454|P1|COMPLETED|Overall Study||14
5209552|NCT01001767|12808453|P2|STARTED|Overall Study||17
5209553|NCT01001767|12808454|P1|STARTED|Overall Study||18
5209554|NCT01001702|12808460|P1|NOT COMPLETED|Overall Study||72
5209555|NCT01001702|12808460|P1|COMPLETED|Overall Study||13
5209556|NCT01001702|12808460|P1|STARTED|Overall Study||85
5209557|NCT01001598|12808471|P1|NOT COMPLETED|Overall Study||2
5209558|NCT01001598|12808471|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
5209559|NCT01001598|12808471|P1|STARTED|Overall Study||5
5209560|NCT01001572|12808479|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
5209561|NCT01001572|12808480|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
5209562|NCT01001572|12808481|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
5209563|NCT01001572|12808479|P3|COMPLETED|Double-Blind Treatment Phase||306
5209564|NCT01001572|12808480|P2|COMPLETED|Double-Blind Treatment Phase||319
5209565|NCT01001572|12808481|P1|COMPLETED|Double-Blind Treatment Phase||0
5209566|NCT01001572|12808479|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
5209567|NCT01001572|12808480|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
5209568|NCT01001572|12808481|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
5209569|NCT01001572|12808479|P3|STARTED|Double-Blind Treatment Phase||325
5209570|NCT01001572|12808480|P2|STARTED|Double-Blind Treatment Phase||329
5209571|NCT01001572|12808481|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
5209572|NCT01001572|12808479|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
5209573|NCT01001572|12808480|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
5209574|NCT01001572|12808481|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
5209575|NCT01001572|12808479|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
5209576|NCT01001572|12808480|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
5209577|NCT01001572|12808481|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
5209578|NCT01001572|12808479|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
5209579|NCT01001572|12808480|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
5209580|NCT01001572|12808481|P1|STARTED|Single-Blind Valsartan 160 mg||932
5209581|NCT01001559|12808497|P2|NOT COMPLETED|Overall Study||0
5209582|NCT01001559|12808498|P1|NOT COMPLETED|Overall Study||0
5209583|NCT01001559|12808497|P2|COMPLETED|Overall Study||147
5209584|NCT01001559|12808498|P1|COMPLETED|Overall Study||95
5209585|NCT01001559|12808497|P2|STARTED|Overall Study||147
5209586|NCT01001559|12808498|P1|STARTED|Overall Study||95
5209587|NCT01001546|12808512|P2|NOT COMPLETED|Overall Study||0
5209588|NCT01001546|12808513|P1|NOT COMPLETED|Overall Study||0
5209589|NCT01001546|12808512|P2|COMPLETED|Overall Study||207
5209590|NCT01001546|12808513|P1|COMPLETED|Overall Study||206
5209591|NCT01001546|12808512|P2|STARTED|Overall Study||207
5209592|NCT01001546|12808513|P1|STARTED|Overall Study||206
5209593|NCT01001520|12808519|P2|NOT COMPLETED|Medication Period 2||3
5209594|NCT01001520|12808520|P1|NOT COMPLETED|Medication Period 2||0
5209595|NCT01001520|12808519|P2|COMPLETED|Medication Period 2||13
5209596|NCT01001520|12808520|P1|COMPLETED|Medication Period 2||16
5209597|NCT01001520|12808519|P2|STARTED|Medication Period 2||16
5209598|NCT01001520|12808520|P1|STARTED|Medication Period 2||16
5209599|NCT01001520|12808519|P2|NOT COMPLETED|Washout Period||1
5209600|NCT01001520|12808520|P1|NOT COMPLETED|Washout Period||2
5209601|NCT01001520|12808519|P2|COMPLETED|Washout Period||16
5209602|NCT01001520|12808520|P1|COMPLETED|Washout Period||16
5209603|NCT01001520|12808519|P2|STARTED|Washout Period||17
5209604|NCT01001520|12808520|P1|STARTED|Washout Period||18
5209605|NCT01001520|12808519|P2|NOT COMPLETED|Medication Period 1||7
5209606|NCT01001520|12808520|P1|NOT COMPLETED|Medication Period 1||4
5209607|NCT01001520|12808519|P2|COMPLETED|Medication Period 1||17
5209608|NCT01001520|12808520|P1|COMPLETED|Medication Period 1||18
5209609|NCT01001520|12808519|P2|STARTED|Medication Period 1||24
5209610|NCT01001520|12808520|P1|STARTED|Medication Period 1||22
5209611|NCT01001494|12808547|P3|NOT COMPLETED|Overall Study||41
5209612|NCT01001494|12808548|P2|NOT COMPLETED|Overall Study||17
5209613|NCT01001494|12808549|P1|NOT COMPLETED|Overall Study||24
5209614|NCT01001494|12808547|P3|COMPLETED|Overall Study||232
5209615|NCT01001494|12808548|P2|COMPLETED|Overall Study||252
5209616|NCT01001494|12808549|P1|COMPLETED|Overall Study||253
5209617|NCT01001494|12808547|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
5209618|NCT01001494|12808548|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
5209619|NCT01001494|12808549|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
5209620|NCT01001442|12808577|P8|NOT COMPLETED|Overall Study||2
5209621|NCT01001442|12808578|P7|NOT COMPLETED|Overall Study||4
5209622|NCT01001442|12808579|P6|NOT COMPLETED|Overall Study||0
5209623|NCT01001442|12808580|P5|NOT COMPLETED|Overall Study||2
5209624|NCT01001442|12808581|P4|NOT COMPLETED|Overall Study||0
5209625|NCT01001442|12808582|P3|NOT COMPLETED|Overall Study||0
5209626|NCT01001442|12808583|P2|NOT COMPLETED|Overall Study||0
5209627|NCT01001442|12808584|P1|NOT COMPLETED|Overall Study||0
5209628|NCT01001442|12808577|P8|COMPLETED|Overall Study||2
5209629|NCT01001442|12808578|P7|COMPLETED|Overall Study||6
5209630|NCT01001442|12808579|P6|COMPLETED|Overall Study||3
5209631|NCT01001442|12808580|P5|COMPLETED|Overall Study||2
5209632|NCT01001442|12808581|P4|COMPLETED|Overall Study||3
5209633|NCT01001442|12808582|P3|COMPLETED|Overall Study||4
5209634|NCT01001442|12808583|P2|COMPLETED|Overall Study||3
5209635|NCT01001442|12808584|P1|COMPLETED|Overall Study||4
5209636|NCT01001442|12808577|P8|STARTED|Overall Study||4
5209637|NCT01001442|12808578|P7|STARTED|Overall Study||10
5209638|NCT01001442|12808579|P6|STARTED|Overall Study||3
5209639|NCT01001442|12808580|P5|STARTED|Overall Study||4
5209640|NCT01001442|12808581|P4|STARTED|Overall Study||3
5209641|NCT01001442|12808582|P3|STARTED|Overall Study||4
5209642|NCT01001442|12808583|P2|STARTED|Overall Study||3
5209643|NCT01001442|12808584|P1|STARTED|Overall Study||4
5209644|NCT01001429|12808634|P2|NOT COMPLETED|Overall Study||1
5209645|NCT01001429|12808635|P1|NOT COMPLETED|Overall Study||0
5209646|NCT01001429|12808634|P2|COMPLETED|Overall Study||37
5209647|NCT01001429|12808635|P1|COMPLETED|Overall Study||39
5209648|NCT01001429|12808634|P2|STARTED|Overall Study||38
5209649|NCT01001429|12808635|P1|STARTED|Overall Study||39
5209650|NCT01001403|12808667|P2|NOT COMPLETED|Overall Study||0
5209651|NCT01001403|12808668|P1|NOT COMPLETED|Overall Study||0
5209652|NCT01001403|12808667|P2|COMPLETED|Overall Study||31
5209653|NCT01001403|12808668|P1|COMPLETED|Overall Study||31
5209654|NCT01001403|12808667|P2|STARTED|Overall Study||31
5209655|NCT01001403|12808668|P1|STARTED|Overall Study||31
5209656|NCT01001390|12808674|P2|NOT COMPLETED|Overall Study||0
5209657|NCT01001390|12808675|P1|NOT COMPLETED|Overall Study||2
5209658|NCT01001390|12808674|P2|COMPLETED|Overall Study||0
5209659|NCT01001390|12808675|P1|COMPLETED|Overall Study||0
5209660|NCT01001390|12808674|P2|STARTED|Overall Study||0
5209661|NCT01001390|12808675|P1|STARTED|Overall Study||2
5209662|NCT01001377|12808683|P2|NOT COMPLETED|Overall Study||421
5209663|NCT01001377|12808684|P1|NOT COMPLETED|Overall Study||426
5209664|NCT01001377|12808683|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
5209665|NCT01001377|12808684|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
5209666|NCT01001377|12808683|P2|Received Treatment|Overall Study||499
5209667|NCT01001377|12808684|P1|Received Treatment|Overall Study||500
5209668|NCT01001377|12808683|P2|STARTED|Overall Study||506
5209669|NCT01001377|12808684|P1|STARTED|Overall Study||504
5209670|NCT01001325|12808714|P2|NOT COMPLETED|Overall Study||10
5209671|NCT01001325|12808715|P1|NOT COMPLETED|Overall Study||18
5209672|NCT01001325|12808714|P2|COMPLETED|Overall Study||224
5209673|NCT01001325|12808715|P1|COMPLETED|Overall Study||216
5209674|NCT01001325|12808714|P2|STARTED|Overall Study||234
5209675|NCT01001325|12808715|P1|STARTED|Overall Study||234
5209676|NCT01001299|12808721|P1|NOT COMPLETED|Overall Study||25
5209677|NCT01001299|12808721|P1|COMPLETED|Overall Study||0
5209678|NCT01001299|12808721|P1|STARTED|Overall Study||25
5209679|NCT01001234|12808750|P5|NOT COMPLETED|Overall Study||0
5209680|NCT01001234|12808751|P4|NOT COMPLETED|Overall Study||25
5209681|NCT01001234|12808752|P3|NOT COMPLETED|Overall Study||32
5209682|NCT01001234|12808753|P2|NOT COMPLETED|Overall Study||26
5209683|NCT01001234|12808754|P1|NOT COMPLETED|Overall Study||405
5209684|NCT01001234|12808750|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
5209685|NCT01001234|12808751|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
5209686|NCT01001234|12808752|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
5209687|NCT01001234|12808753|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
5209688|NCT01001234|12808754|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
5209689|NCT01001234|12808750|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
5209690|NCT01001234|12808751|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
5209691|NCT01001234|12808752|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
5209692|NCT01001234|12808753|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
5209693|NCT01001234|12808754|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
5209694|NCT01001234|12808750|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
5209695|NCT01001234|12808751|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
5209696|NCT01001234|12808752|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
5209697|NCT01001234|12808753|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
5209698|NCT01001234|12808754|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
5209699|NCT01001234|12808750|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
5209700|NCT01001234|12808751|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
5209701|NCT01001234|12808752|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
5209702|NCT01001234|12808753|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
5209703|NCT01001234|12808754|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
5209704|NCT01001221|12808770|P5|NOT COMPLETED|Overall Study||0
5209705|NCT01001221|12808771|P4|NOT COMPLETED|Overall Study||6
5209706|NCT01001221|12808772|P3|NOT COMPLETED|Overall Study||3
5209707|NCT01001221|12808773|P2|NOT COMPLETED|Overall Study||5
5209708|NCT01001221|12808774|P1|NOT COMPLETED|Overall Study||5
5209709|NCT01001221|12808770|P5|COMPLETED|Overall Study||0
5209710|NCT01001221|12808771|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
5209711|NCT01001221|12808772|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
5209712|NCT01001221|12808773|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
5209713|NCT01001221|12808774|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
5209714|NCT01001221|12808770|P5|Completed 1st Treatment Cycle|Overall Study||0
5209715|NCT01001221|12808771|P4|Completed 1st Treatment Cycle|Overall Study||6
5209716|NCT01001221|12808772|P3|Completed 1st Treatment Cycle|Overall Study||2
5209717|NCT01001221|12808773|P2|Completed 1st Treatment Cycle|Overall Study||5
5209718|NCT01001221|12808774|P1|Completed 1st Treatment Cycle|Overall Study||5
5209719|NCT01001221|12808770|P5|Treated|Overall Study||0
5209720|NCT01001221|12808771|P4|Treated|Overall Study||6
5209721|NCT01001221|12808772|P3|Treated|Overall Study||2
5209722|NCT01001221|12808773|P2|Treated|Overall Study||5
5209723|NCT01001221|12808774|P1|Treated|Overall Study||5
5209724|NCT01001221|12808770|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
5209725|NCT01001221|12808771|P4|STARTED|Overall Study||6
5209726|NCT01001221|12808772|P3|STARTED|Overall Study||3
5209727|NCT01001221|12808773|P2|STARTED|Overall Study||5
5209728|NCT01001221|12808774|P1|STARTED|Overall Study||5
5209729|NCT01001208|12808949|P2|NOT COMPLETED|Overall Study||33
5209730|NCT01001208|12808950|P1|NOT COMPLETED|Overall Study||28
5209731|NCT01001208|12808949|P2|COMPLETED|Overall Study||206
5209732|NCT01001208|12808950|P1|COMPLETED|Overall Study||211
5209733|NCT01001208|12808949|P2|STARTED|Overall Study||239
5209734|NCT01001208|12808950|P1|STARTED|Overall Study||239
5209735|NCT01001195|12808978|P4|NOT COMPLETED|Overall Study||0
5209736|NCT01001195|12808979|P3|NOT COMPLETED|Overall Study||0
5209737|NCT01001195|12808980|P2|NOT COMPLETED|Overall Study||2
5209738|NCT01001195|12808981|P1|NOT COMPLETED|Overall Study||2
5209739|NCT01001195|12808978|P4|COMPLETED|Overall Study||41
5209740|NCT01001195|12808979|P3|COMPLETED|Overall Study||44
5209741|NCT01001195|12808980|P2|COMPLETED|Overall Study||39
5209742|NCT01001195|12808981|P1|COMPLETED|Overall Study||37
5209743|NCT01001195|12808978|P4|STARTED|Overall Study||41
5209744|NCT01001195|12808979|P3|STARTED|Overall Study||44
5209745|NCT01001195|12808980|P2|STARTED|Overall Study||41
5209746|NCT01001195|12808981|P1|STARTED|Overall Study||39
5209747|NCT01001169|12808993|P2|NOT COMPLETED|Overall Study||1
5209748|NCT01001169|12808994|P1|NOT COMPLETED|Overall Study||2
5209749|NCT01001169|12808993|P2|COMPLETED|Overall Study||29
5209750|NCT01001169|12808994|P1|COMPLETED|Overall Study||28
5209751|NCT01001169|12808993|P2|STARTED|Overall Study||30
5209752|NCT01001169|12808994|P1|STARTED|Overall Study||30
5209753|NCT01001104|12809102|P4|NOT COMPLETED|Overall Study||3
5209754|NCT01001104|12809103|P3|NOT COMPLETED|Overall Study||1
5209755|NCT01001104|12809104|P2|NOT COMPLETED|Overall Study||1
5209756|NCT01001104|12809105|P1|NOT COMPLETED|Overall Study||2
5209757|NCT01001104|12809102|P4|COMPLETED|Overall Study||34
5209758|NCT01001104|12809103|P3|COMPLETED|Overall Study||35
5209759|NCT01001104|12809104|P2|COMPLETED|Overall Study||36
5209760|NCT01001104|12809105|P1|COMPLETED|Overall Study||33
5209761|NCT01001104|12809102|P4|STARTED|Overall Study||37
5209762|NCT01001104|12809103|P3|STARTED|Overall Study||36
5209763|NCT01001104|12809104|P2|STARTED|Overall Study||37
5209764|NCT01001104|12809105|P1|STARTED|Overall Study||35
5209765|NCT01001078|12809152|P2|NOT COMPLETED|Overall Study||0
5209766|NCT01001078|12809153|P1|NOT COMPLETED|Overall Study||0
5209767|NCT01001078|12809152|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
5209854|NCT01000662|12809396|P1|COMPLETED|Overall Study||202
5209768|NCT01001078|12809153|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
5209769|NCT01001078|12809152|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
5209770|NCT01001078|12809153|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
5209771|NCT01001078|12809152|P2|Intubated|Overall Study||1
5209772|NCT01001078|12809153|P1|Intubated|Overall Study||2
5209773|NCT01001078|12809152|P2|Received Crossover|Overall Study||3
5209774|NCT01001078|12809153|P1|Received Crossover|Overall Study||2
5209775|NCT01001078|12809152|P2|Received Allocated Intervention|Overall Study||46
5209776|NCT01001078|12809153|P1|Received Allocated Intervention|Overall Study||46
5209777|NCT01001078|12809152|P2|STARTED|Overall Study||50
5209778|NCT01001078|12809153|P1|STARTED|Overall Study||50
5209779|NCT01001052|12809169|P2|NOT COMPLETED|Overall Study||0
5209780|NCT01001052|12809170|P1|NOT COMPLETED|Overall Study||0
5209781|NCT01001052|12809169|P2|COMPLETED|Overall Study||18
5209782|NCT01001052|12809170|P1|COMPLETED|Overall Study||20
5209783|NCT01001052|12809169|P2|STARTED|Overall Study||18
5209784|NCT01001052|12809170|P1|STARTED|Overall Study||20
5209785|NCT01000987|12809183|P3|NOT COMPLETED|Overall Study||0
5209786|NCT01000987|12809184|P2|NOT COMPLETED|Overall Study||0
5209787|NCT01000987|12809185|P1|NOT COMPLETED|Overall Study||0
5209788|NCT01000987|12809183|P3|COMPLETED|Overall Study||17
5209789|NCT01000987|12809184|P2|COMPLETED|Overall Study||15
5209790|NCT01000987|12809185|P1|COMPLETED|Overall Study||12
5209791|NCT01000987|12809183|P3|STARTED|Overall Study||17
5209792|NCT01000987|12809184|P2|STARTED|Overall Study||15
5209793|NCT01000987|12809185|P1|STARTED|Overall Study||12
5209794|NCT01000974|12809196|P3|NOT COMPLETED|Booster Vaccination Phase||14
5209795|NCT01000974|12809197|P2|NOT COMPLETED|Booster Vaccination Phase||12
5209796|NCT01000974|12809198|P1|NOT COMPLETED|Booster Vaccination Phase||67
5209797|NCT01000974|12809196|P3|COMPLETED|Booster Vaccination Phase||386
5209798|NCT01000974|12809197|P2|COMPLETED|Booster Vaccination Phase||423
5209799|NCT01000974|12809198|P1|COMPLETED|Booster Vaccination Phase||2270
5209800|NCT01000974|12809196|P3|STARTED|Booster Vaccination Phase||400
5209801|NCT01000974|12809197|P2|STARTED|Booster Vaccination Phase||435
5209802|NCT01000974|12809198|P1|STARTED|Booster Vaccination Phase||2337
5209803|NCT01000974|12809196|P3|NOT COMPLETED|Primary Vaccination Phase||63
5209804|NCT01000974|12809197|P2|NOT COMPLETED|Primary Vaccination Phase||50
5209805|NCT01000974|12809198|P1|NOT COMPLETED|Primary Vaccination Phase||338
5209806|NCT01000974|12809196|P3|COMPLETED|Primary Vaccination Phase||457
5209807|NCT01000974|12809197|P2|COMPLETED|Primary Vaccination Phase||470
5209808|NCT01000974|12809198|P1|COMPLETED|Primary Vaccination Phase||2625
5209809|NCT01000974|12809196|P3|STARTED|Primary Vaccination Phase||520
5209810|NCT01000974|12809197|P2|STARTED|Primary Vaccination Phase||520
5209811|NCT01000974|12809198|P1|STARTED|Primary Vaccination Phase||2963
5209812|NCT01000961|12809305|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5209813|NCT01000961|12809306|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
5209814|NCT01000961|12809305|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
5209815|NCT01000961|12809306|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
5209816|NCT01000961|12809305|P2|STARTED|Second Intervention (3 Weeks)||20
5209817|NCT01000961|12809306|P1|STARTED|Second Intervention (3 Weeks)||21
5209818|NCT01000961|12809305|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
5209819|NCT01000961|12809306|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
5209820|NCT01000961|12809305|P2|COMPLETED|First Intervention (3 Weeks)||20
5209821|NCT01000961|12809306|P1|COMPLETED|First Intervention (3 Weeks)||21
5209822|NCT01000961|12809305|P2|STARTED|First Intervention (3 Weeks)||22
5209823|NCT01000961|12809306|P1|STARTED|First Intervention (3 Weeks)||21
5209824|NCT01000961|12809305|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
5209825|NCT01000961|12809306|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
5209826|NCT01000961|12809305|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
5209827|NCT01000961|12809306|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
5209828|NCT01000961|12809305|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
5209829|NCT01000961|12809306|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
5209830|NCT01000818|12809318|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
5209831|NCT01000818|12809318|P1|COMPLETED|Omeprazole + Raltegravir||18
5209832|NCT01000818|12809318|P1|STARTED|Omeprazole + Raltegravir||18
5209833|NCT01000818|12809318|P1|NOT COMPLETED|Famotidine + Raltegravir||0
5209834|NCT01000818|12809318|P1|COMPLETED|Famotidine + Raltegravir||18
5209835|NCT01000818|12809318|P1|STARTED|Famotidine + Raltegravir||18
5209836|NCT01000818|12809318|P1|NOT COMPLETED|Raltegravir||0
5209837|NCT01000818|12809318|P1|COMPLETED|Raltegravir||18
5209838|NCT01000818|12809318|P1|STARTED|Raltegravir||18
5209839|NCT01000805|12809329|P2|NOT COMPLETED|Overall Study||62
5209840|NCT01000805|12809330|P1|NOT COMPLETED|Overall Study||70
5209841|NCT01000805|12809329|P2|COMPLETED|Overall Study||204
5209842|NCT01000805|12809330|P1|COMPLETED|Overall Study||192
5209843|NCT01000805|12809329|P2|STARTED|Overall Study||266
5209844|NCT01000805|12809330|P1|STARTED|Overall Study||262
5209845|NCT01000727|12809364|P2|NOT COMPLETED|Overall Study||176
5209846|NCT01000727|12809365|P1|NOT COMPLETED|Overall Study||175
5209847|NCT01000727|12809364|P2|COMPLETED|Overall Study||6328
5209848|NCT01000727|12809365|P1|COMPLETED|Overall Study||6347
5209849|NCT01000727|12809364|P2|STARTED|Overall Study||6504
5209850|NCT01000727|12809365|P1|STARTED|Overall Study||6522
5209851|NCT01000662|12809395|P2|NOT COMPLETED|Overall Study||8
5209852|NCT01000662|12809396|P1|NOT COMPLETED|Overall Study||4
5209853|NCT01000662|12809395|P2|COMPLETED|Overall Study||198
5209855|NCT01000662|12809395|P2|STARTED|Overall Study||206
5209856|NCT01000662|12809396|P1|STARTED|Overall Study||206
5209857|NCT01000649|12809406|P4|NOT COMPLETED|Overall Study||6
5209858|NCT01000649|12809407|P3|NOT COMPLETED|Overall Study||2
5209859|NCT01000649|12809408|P2|NOT COMPLETED|Overall Study||3
5209860|NCT01000649|12809409|P1|NOT COMPLETED|Overall Study||5
5209861|NCT01000649|12809406|P4|COMPLETED|Overall Study||15
5209862|NCT01000649|12809407|P3|COMPLETED|Overall Study||0
5209863|NCT01000649|12809408|P2|COMPLETED|Overall Study||16
5209864|NCT01000649|12809409|P1|COMPLETED|Overall Study||5
5209865|NCT01000649|12809406|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
5209866|NCT01000649|12809407|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
5209867|NCT01000649|12809408|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
5209868|NCT01000649|12809409|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
5209869|NCT01000649|12809406|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
5209870|NCT01000649|12809407|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
5209871|NCT01000649|12809408|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
5209872|NCT01000649|12809409|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
5209873|NCT01000610|12809490|P1|NOT COMPLETED|Overall Study||6
5209874|NCT01000610|12809490|P1|COMPLETED|Overall Study||12
5209875|NCT01000610|12809490|P1|STARTED|Overall Study||18
5209876|NCT01000506|12809501|P4|NOT COMPLETED|Overall Study||23
5209877|NCT01000506|12809502|P3|NOT COMPLETED|Overall Study||21
5209878|NCT01000506|12809503|P2|NOT COMPLETED|Overall Study||24
5209879|NCT01000506|12809504|P1|NOT COMPLETED|Overall Study||28
5209880|NCT01000506|12809501|P4|COMPLETED|Overall Study||133
5209881|NCT01000506|12809502|P3|COMPLETED|Overall Study||131
5209882|NCT01000506|12809503|P2|COMPLETED|Overall Study||129
5209883|NCT01000506|12809504|P1|COMPLETED|Overall Study||127
5209884|NCT01000506|12809501|P4|STARTED|Overall Study||156
5209885|NCT01000506|12809502|P3|STARTED|Overall Study||152
5209886|NCT01000506|12809503|P2|STARTED|Overall Study||153
5209887|NCT01000506|12809504|P1|STARTED|Overall Study||155
5209888|NCT01000493|12809548|P2|NOT COMPLETED|Overall Study||55
5209889|NCT01000493|12809549|P1|NOT COMPLETED|Overall Study||39
5209890|NCT01000493|12809548|P2|COMPLETED|Overall Study||14
5209891|NCT01000493|12809549|P1|COMPLETED|Overall Study||21
5209892|NCT01000493|12809548|P2|STARTED|Overall Study||69
5209893|NCT01000493|12809549|P1|STARTED|Overall Study||60
5209894|NCT01000480|12809599|P1|NOT COMPLETED|Follow-Up Period||0
5209895|NCT01000480|12809599|P1|COMPLETED|Follow-Up Period||88
5209896|NCT01000480|12809599|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
5209897|NCT01000480|12809599|P1|NOT COMPLETED|Concurrent Therapy Phase||10
5209898|NCT01000480|12809599|P1|COMPLETED|Concurrent Therapy Phase||65
5209899|NCT01000480|12809599|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
5209900|NCT01000480|12809599|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
5209901|NCT01000480|12809599|P1|NOT COMPLETED|Induction Phase||7
5209902|NCT01000480|12809599|P1|COMPLETED|Induction Phase||83
5209903|NCT01000480|12809599|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
5209904|NCT01000480|12809599|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
5209905|NCT01000480|12809599|P1|STARTED|Induction Phase||90
5209906|NCT01000376|12809607|P2|NOT COMPLETED|Cycle 1 Day 15||0
5209907|NCT01000376|12809608|P1|NOT COMPLETED|Cycle 1 Day 15||0
5209908|NCT01000376|12809607|P2|COMPLETED|Cycle 1 Day 15||6
5209909|NCT01000376|12809608|P1|COMPLETED|Cycle 1 Day 15||4
5209910|NCT01000376|12809607|P2|STARTED|Cycle 1 Day 15||6
5209911|NCT01000376|12809608|P1|STARTED|Cycle 1 Day 15||4
5209912|NCT01000376|12809607|P2|NOT COMPLETED|Cycle 1 Day 1||0
5209913|NCT01000376|12809608|P1|NOT COMPLETED|Cycle 1 Day 1||2
5209914|NCT01000376|12809607|P2|COMPLETED|Cycle 1 Day 1||6
5209915|NCT01000376|12809608|P1|COMPLETED|Cycle 1 Day 1||4
5209916|NCT01000376|12809607|P2|STARTED|Cycle 1 Day 1||6
5209917|NCT01000376|12809608|P1|STARTED|Cycle 1 Day 1||6
5209918|NCT01000337|12809618|P2|NOT COMPLETED|Overall Study||3
5209919|NCT01000337|12809619|P1|NOT COMPLETED|Overall Study||4
5209920|NCT01000337|12809618|P2|COMPLETED|Overall Study||30
5209921|NCT01000337|12809619|P1|COMPLETED|Overall Study||30
5209922|NCT01000337|12809618|P2|STARTED|Overall Study||33
5209923|NCT01000337|12809619|P1|STARTED|Overall Study||34
5209924|NCT01000324|12809625|P1|NOT COMPLETED|Year 20||0
5209925|NCT01000324|12809625|P1|COMPLETED|Year 20||28
5209926|NCT01000324|12809625|P1|STARTED|Year 20||28
5209927|NCT01000324|12809625|P1|NOT COMPLETED|Year 19||0
5209928|NCT01000324|12809625|P1|COMPLETED|Year 19||28
5209929|NCT01000324|12809625|P1|STARTED|Year 19||28
5209930|NCT01000324|12809625|P1|NOT COMPLETED|Year 18||0
5209931|NCT01000324|12809625|P1|COMPLETED|Year 18||29
5209932|NCT01000324|12809625|P1|STARTED|Year 18||29
5209933|NCT01000324|12809625|P1|NOT COMPLETED|Year 17||0
5209934|NCT01000324|12809625|P1|COMPLETED|Year 17||32
5209935|NCT01000324|12809625|P1|STARTED|Year 17||32
5209936|NCT01000324|12809625|P1|NOT COMPLETED|Year 16||0
5209937|NCT01000324|12809625|P1|COMPLETED|Year 16||40
5209938|NCT01000324|12809625|P1|STARTED|Year 16||40
5209939|NCT01000311|12809637|P2|NOT COMPLETED|Overall Study||70
5209940|NCT01000311|12809638|P1|NOT COMPLETED|Overall Study||45
5209941|NCT01000311|12809637|P2|COMPLETED|Overall Study||201
5209942|NCT01000311|12809638|P1|COMPLETED|Overall Study||213
5209943|NCT01000311|12809637|P2|STARTED|Overall Study||271
5209944|NCT01000311|12809638|P1|STARTED|Overall Study||258
5209945|NCT01000285|12809668|P1|NOT COMPLETED|Overall Study||0
5209946|NCT01000285|12809668|P1|COMPLETED|Overall Study||18
5209947|NCT01000285|12809668|P1|STARTED|Overall Study||18
5209948|NCT01000155|12809688|P1|NOT COMPLETED|Overall Study||2
5209949|NCT01000155|12809688|P1|COMPLETED|Overall Study||3
5209950|NCT01000155|12809688|P1|STARTED|Overall Study||5
5209951|NCT01000064|12809694|P2|NOT COMPLETED|Overall Study||1
5209952|NCT01000064|12809695|P1|NOT COMPLETED|Overall Study||1
5209953|NCT01000064|12809694|P2|COMPLETED|Overall Study||5
5209954|NCT01000064|12809695|P1|COMPLETED|Overall Study||6
5209955|NCT01000064|12809694|P2|STARTED|Overall Study||6
5209956|NCT01000064|12809695|P1|STARTED|Overall Study||7
5209957|NCT01000051|12809718|P2|NOT COMPLETED|Overall Study||1
5209958|NCT01000051|12809719|P1|NOT COMPLETED|Overall Study||3
5209959|NCT01000051|12809718|P2|COMPLETED|Overall Study||17
5209960|NCT01000051|12809719|P1|COMPLETED|Overall Study||39
5209961|NCT01000051|12809718|P2|STARTED|Overall Study||18
5209962|NCT01000051|12809719|P1|STARTED|Overall Study||42
5209963|NCT01000025|12809727|P2|NOT COMPLETED|Overall Study||238
5209964|NCT01000025|12809728|P1|NOT COMPLETED|Overall Study||468
5209965|NCT01000025|12809727|P2|COMPLETED|Overall Study||2
5209966|NCT01000025|12809728|P1|COMPLETED|Overall Study||12
5209967|NCT01000025|12809727|P2|STARTED|Overall Study||240
5209968|NCT01000025|12809728|P1|STARTED|Overall Study||480
5209969|NCT00999921|12809746|P2|NOT COMPLETED|Overall Study||19
5209970|NCT00999921|12809747|P1|NOT COMPLETED|Overall Study||10
5209971|NCT00999921|12809746|P2|COMPLETED|Overall Study||110
5209972|NCT00999921|12809747|P1|COMPLETED|Overall Study||117
5209973|NCT00999921|12809746|P2|STARTED|Overall Study||129
5209974|NCT00999921|12809747|P1|STARTED|Overall Study||127
5209975|NCT00999908|12809757|P3|NOT COMPLETED|Treatment Period 3||0
5209976|NCT00999908|12809758|P2|NOT COMPLETED|Treatment Period 3||0
5209977|NCT00999908|12809759|P1|NOT COMPLETED|Treatment Period 3||0
5209978|NCT00999908|12809757|P3|COMPLETED|Treatment Period 3||19
5209979|NCT00999908|12809758|P2|COMPLETED|Treatment Period 3||16
5209980|NCT00999908|12809759|P1|COMPLETED|Treatment Period 3||16
5209981|NCT00999908|12809757|P3|STARTED|Treatment Period 3||19
5209982|NCT00999908|12809758|P2|STARTED|Treatment Period 3||16
5209983|NCT00999908|12809759|P1|STARTED|Treatment Period 3||16
5209984|NCT00999908|12809757|P3|NOT COMPLETED|Treatment Period 2||0
5209985|NCT00999908|12809758|P2|NOT COMPLETED|Treatment Period 2||0
5209986|NCT00999908|12809759|P1|NOT COMPLETED|Treatment Period 2||1
5209987|NCT00999908|12809757|P3|COMPLETED|Treatment Period 2||19
5209988|NCT00999908|12809758|P2|COMPLETED|Treatment Period 2||16
5209989|NCT00999908|12809759|P1|COMPLETED|Treatment Period 2||16
5209990|NCT00999908|12809757|P3|STARTED|Treatment Period 2||19
5209991|NCT00999908|12809758|P2|STARTED|Treatment Period 2||16
5209992|NCT00999908|12809759|P1|STARTED|Treatment Period 2||17
5209993|NCT00999908|12809757|P3|NOT COMPLETED|Treatment Period 1||0
5209994|NCT00999908|12809758|P2|NOT COMPLETED|Treatment Period 1||0
5209995|NCT00999908|12809759|P1|NOT COMPLETED|Treatment Period 1||2
5209996|NCT00999908|12809757|P3|COMPLETED|Treatment Period 1||19
5209997|NCT00999908|12809758|P2|COMPLETED|Treatment Period 1||16
5209998|NCT00999908|12809759|P1|COMPLETED|Treatment Period 1||17
5209999|NCT00999908|12809757|P3|STARTED|Treatment Period 1||19
5210000|NCT00999908|12809758|P2|STARTED|Treatment Period 1||16
5210001|NCT00999908|12809759|P1|STARTED|Treatment Period 1||19
5210002|NCT00999830|12809775|P2|NOT COMPLETED|Overall Study||0
5210003|NCT00999830|12809776|P1|NOT COMPLETED|Overall Study||0
5210004|NCT00999830|12809775|P2|COMPLETED|Overall Study||13
5210005|NCT00999830|12809776|P1|COMPLETED|Overall Study||14
5210006|NCT00999830|12809775|P2|STARTED|Overall Study||13
5210007|NCT00999830|12809776|P1|STARTED|Overall Study||14
5210008|NCT00999804|12809788|P2|NOT COMPLETED|Overall Study||5
5210009|NCT00999804|12809789|P1|NOT COMPLETED|Overall Study||21
5210010|NCT00999804|12809788|P2|COMPLETED|Overall Study||38
5210011|NCT00999804|12809789|P1|COMPLETED|Overall Study||64
5210012|NCT00999804|12809788|P2|STARTED|Overall Study||43
5210013|NCT00999804|12809789|P1|STARTED|Overall Study||85
5210014|NCT00999713|12809803|P2|NOT COMPLETED|Overall Study||0
5210015|NCT00999713|12809804|P1|NOT COMPLETED|Overall Study||2
5210016|NCT00999713|12809803|P2|COMPLETED|Overall Study||17
5210017|NCT00999713|12809804|P1|COMPLETED|Overall Study||24
5210018|NCT00999713|12809803|P2|STARTED|Overall Study||17
5210019|NCT00999713|12809804|P1|STARTED|Overall Study||26
5210020|NCT00999687|12809818|P1|NOT COMPLETED|Second Intervention||3
5210021|NCT00999687|12809818|P1|COMPLETED|Second Intervention||27
5210022|NCT00999687|12809818|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
5210023|NCT00999687|12809818|P1|NOT COMPLETED|First Intervention||1
5210024|NCT00999687|12809818|P1|COMPLETED|First Intervention||30
5210025|NCT00999687|12809818|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
5210026|NCT00999661|12809825|P1|NOT COMPLETED|Overall Study||70
5210027|NCT00999661|12809825|P1|COMPLETED|Overall Study||161
5210028|NCT00999661|12809825|P1|STARTED|Overall Study||231
5210029|NCT00999609|12809833|P2|NOT COMPLETED|Overall Study||1
5210030|NCT00999609|12809834|P1|NOT COMPLETED|Overall Study||1
5210031|NCT00999609|12809833|P2|COMPLETED|Overall Study|1 year post intervention|9
5210032|NCT00999609|12809834|P1|COMPLETED|Overall Study|1 year post intervention|20
5210033|NCT00999609|12809833|P2|STARTED|Overall Study||10
5210034|NCT00999609|12809834|P1|STARTED|Overall Study|Before intervention|21
5210035|NCT00999596|12809846|P1|NOT COMPLETED|Overall Study||101
5210036|NCT00999596|12809846|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
5210037|NCT00999596|12809846|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
5210038|NCT00999596|12809846|P1|STARTED|Overall Study||107
5210039|NCT00999544|12809851|P1|NOT COMPLETED|Overall Study||1
5210040|NCT00999544|12809851|P1|COMPLETED|Overall Study||8
5210041|NCT00999544|12809851|P1|STARTED|Overall Study||9
5210042|NCT00999466|12809887|P3|NOT COMPLETED|Main Part||4
5210043|NCT00999466|12809888|P2|NOT COMPLETED|Main Part||4
5210044|NCT00999466|12809889|P1|NOT COMPLETED|Main Part||0
5210045|NCT00999466|12809887|P3|COMPLETED|Main Part||21
5210046|NCT00999466|12809888|P2|COMPLETED|Main Part||22
5210047|NCT00999466|12809889|P1|COMPLETED|Main Part||0
5210048|NCT00999466|12809887|P3|STARTED|Main Part||25
5210049|NCT00999466|12809888|P2|STARTED|Main Part||26
5210050|NCT00999466|12809889|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
5210051|NCT00999466|12809887|P3|NOT COMPLETED|Pilot Part||0
5210052|NCT00999466|12809888|P2|NOT COMPLETED|Pilot Part||0
5210053|NCT00999466|12809889|P1|NOT COMPLETED|Pilot Part||0
5210054|NCT00999466|12809887|P3|COMPLETED|Pilot Part||3
5210055|NCT00999466|12809888|P2|COMPLETED|Pilot Part||0
5210056|NCT00999466|12809889|P1|COMPLETED|Pilot Part||6
5210057|NCT00999466|12809887|P3|STARTED|Pilot Part||3
5210058|NCT00999466|12809888|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
5210059|NCT00999466|12809889|P1|STARTED|Pilot Part||6
5210060|NCT00999167|12810166|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
5210061|NCT00999167|12810167|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
5210062|NCT00999167|12810168|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
5210063|NCT00999167|12810166|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
5210064|NCT00999167|12810167|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
5210065|NCT00999167|12810168|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
5210066|NCT00999167|12810166|P3|STARTED|Part B: Randomized, Placebo Controlled||88
5210067|NCT00999167|12810167|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
5210068|NCT00999167|12810168|P1|STARTED|Part B: Randomized, Placebo Controlled||0
5210069|NCT00999167|12810166|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
5210070|NCT00999167|12810167|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
5210071|NCT00999167|12810168|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
5210072|NCT00999167|12810166|P3|COMPLETED|Part A: Open Label Safety run-in||0
5210073|NCT00999167|12810167|P2|COMPLETED|Part A: Open Label Safety run-in||0
5210074|NCT00999167|12810168|P1|COMPLETED|Part A: Open Label Safety run-in||8
5210075|NCT00999167|12810166|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
5210076|NCT00999167|12810167|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
5210077|NCT00999167|12810168|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
5210078|NCT00999167|12810166|P3|STARTED|Part A: Open Label Safety run-in||0
5210079|NCT00999167|12810167|P2|STARTED|Part A: Open Label Safety run-in||0
5210080|NCT00999167|12810168|P1|STARTED|Part A: Open Label Safety run-in||15
5210081|NCT00999141|12810182|P1|NOT COMPLETED|Overall Study||0
5210082|NCT00999141|12810182|P1|COMPLETED|Overall Study||75
5210083|NCT00999141|12810182|P1|STARTED|Overall Study|Randomized and treated|75
5210084|NCT00999102|12810264|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
5210085|NCT00999102|12810265|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
5210086|NCT00999102|12810264|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
5210087|NCT00999102|12810265|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
5210088|NCT00999102|12810264|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
5210089|NCT00999102|12810265|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
5210090|NCT00999102|12810264|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
5210091|NCT00999102|12810265|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
5210092|NCT00999102|12810264|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
5210093|NCT00999102|12810265|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
5210094|NCT00999102|12810264|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
5210095|NCT00999102|12810265|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
5210096|NCT00999102|12810264|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
5210097|NCT00999102|12810265|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
5210098|NCT00999102|12810264|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
5210099|NCT00999102|12810265|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
5210100|NCT00999102|12810264|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
5210101|NCT00999102|12810265|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
5210102|NCT00999102|12810264|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
5210103|NCT00999102|12810265|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
5210104|NCT00999102|12810264|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
5210105|NCT00999102|12810265|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
5210106|NCT00999102|12810264|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
5210107|NCT00999102|12810265|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
5210108|NCT00999037|12810281|P2|NOT COMPLETED|Overall Study||0
5210109|NCT00999037|12810282|P1|NOT COMPLETED|Overall Study||0
5210110|NCT00999037|12810281|P2|COMPLETED|Overall Study||9
5210111|NCT00999037|12810282|P1|COMPLETED|Overall Study||9
5210112|NCT00999037|12810281|P2|STARTED|Overall Study|20|9
5210113|NCT00999037|12810282|P1|STARTED|Overall Study||9
5210114|NCT00998985|12810306|P14|NOT COMPLETED|Overall Study||0
5210115|NCT00998985|12810307|P13|NOT COMPLETED|Overall Study||0
5210116|NCT00998985|12810308|P12|NOT COMPLETED|Overall Study||0
5210117|NCT00998985|12810309|P11|NOT COMPLETED|Overall Study||0
5210118|NCT00998985|12810310|P10|NOT COMPLETED|Overall Study||0
5210119|NCT00998985|12810311|P9|NOT COMPLETED|Overall Study||1
5210120|NCT00998985|12810312|P8|NOT COMPLETED|Overall Study||0
5210121|NCT00998985|12810313|P7|NOT COMPLETED|Overall Study||0
5210122|NCT00998985|12810314|P6|NOT COMPLETED|Overall Study||1
5210123|NCT00998985|12810315|P5|NOT COMPLETED|Overall Study||0
5210124|NCT00998985|12810316|P4|NOT COMPLETED|Overall Study||0
5210125|NCT00998985|12810317|P3|NOT COMPLETED|Overall Study||0
5210126|NCT00998985|12810318|P2|NOT COMPLETED|Overall Study||0
5210127|NCT00998985|12810319|P1|NOT COMPLETED|Overall Study||0
5210128|NCT00998985|12810306|P14|COMPLETED|Overall Study||15
5210129|NCT00998985|12810307|P13|COMPLETED|Overall Study||5
5210130|NCT00998985|12810308|P12|COMPLETED|Overall Study||5
5210131|NCT00998985|12810309|P11|COMPLETED|Overall Study||5
5210132|NCT00998985|12810310|P10|COMPLETED|Overall Study||5
5210133|NCT00998985|12810311|P9|COMPLETED|Overall Study||5
5210134|NCT00998985|12810312|P8|COMPLETED|Overall Study||5
5210135|NCT00998985|12810313|P7|COMPLETED|Overall Study||5
5210136|NCT00998985|12810314|P6|COMPLETED|Overall Study||4
5210137|NCT00998985|12810315|P5|COMPLETED|Overall Study||5
5210138|NCT00998985|12810316|P4|COMPLETED|Overall Study||5
5210139|NCT00998985|12810317|P3|COMPLETED|Overall Study||15
5210140|NCT00998985|12810318|P2|COMPLETED|Overall Study||5
5210141|NCT00998985|12810319|P1|COMPLETED|Overall Study||5
5210142|NCT00998985|12810306|P14|STARTED|Overall Study||15
5210143|NCT00998985|12810307|P13|STARTED|Overall Study||5
5210144|NCT00998985|12810308|P12|STARTED|Overall Study||5
5210145|NCT00998985|12810309|P11|STARTED|Overall Study||5
5210146|NCT00998985|12810310|P10|STARTED|Overall Study||5
5210147|NCT00998985|12810311|P9|STARTED|Overall Study||6
5210148|NCT00998985|12810312|P8|STARTED|Overall Study||5
5210149|NCT00998985|12810313|P7|STARTED|Overall Study||5
5210150|NCT00998985|12810314|P6|STARTED|Overall Study||5
5210151|NCT00998985|12810315|P5|STARTED|Overall Study||5
5210152|NCT00998985|12810316|P4|STARTED|Overall Study||5
5210153|NCT00998985|12810317|P3|STARTED|Overall Study||15
5210154|NCT00998985|12810318|P2|STARTED|Overall Study||5
5210155|NCT00998985|12810319|P1|STARTED|Overall Study||5
5210156|NCT00998881|12810387|P2|NOT COMPLETED|Overall Study||2
5210157|NCT00998881|12810388|P1|NOT COMPLETED|Overall Study||8
5210158|NCT00998881|12810387|P2|COMPLETED|Overall Study||97
5210159|NCT00998881|12810388|P1|COMPLETED|Overall Study||96
5210160|NCT00998881|12810387|P2|STARTED|Overall Study||99
5210161|NCT00998881|12810388|P1|STARTED|Overall Study||104
5210162|NCT00998868|12810400|P1|NOT COMPLETED|Overall Study||0
5210163|NCT00998868|12810400|P1|COMPLETED|Overall Study||51
5210164|NCT00998868|12810400|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
5210165|NCT00998790|12810407|P1|NOT COMPLETED|Overall Study||21
5210166|NCT00998790|12810407|P1|COMPLETED|Overall Study||93
5210167|NCT00998790|12810407|P1|Participants Who Were Treated|Overall Study||113
5210168|NCT00998790|12810407|P1|STARTED|Overall Study||114
5210169|NCT00998764|12810417|P2|NOT COMPLETED|Overall Study||274
5210170|NCT00998764|12810418|P1|NOT COMPLETED|Overall Study||216
5210171|NCT00998764|12810417|P2|COMPLETED|Overall Study||2
5210172|NCT00998764|12810418|P1|COMPLETED|Overall Study||0
5210173|NCT00998764|12810417|P2|Treated|Overall Study||275
5210174|NCT00998764|12810418|P1|Treated|Overall Study||215
5210175|NCT00998764|12810417|P2|STARTED|Overall Study||276
5210176|NCT00998764|12810418|P1|STARTED|Overall Study||216
5210177|NCT00998738|12810440|P1|NOT COMPLETED|Overall Study||1
5210178|NCT00998738|12810440|P1|COMPLETED|Overall Study||0
5210179|NCT00998738|12810440|P1|STARTED|Overall Study||1
5210180|NCT00998660|12810455|P1|NOT COMPLETED|Overall Study||13
5210181|NCT00998660|12810455|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
5210182|NCT00998660|12810455|P1|Month 3 Visit|Overall Study||87
5210183|NCT00998660|12810455|P1|Implanted|Overall Study||93
5210184|NCT00998660|12810455|P1|STARTED|Overall Study||100
5210185|NCT00998582|12810461|P2|NOT COMPLETED|Overall Study||0
5210186|NCT00998582|12810462|P1|NOT COMPLETED|Overall Study||0
5210187|NCT00998582|12810461|P2|COMPLETED|Overall Study||14
5210188|NCT00998582|12810462|P1|COMPLETED|Overall Study||13
5210189|NCT00998582|12810461|P2|STARTED|Overall Study||14
5210190|NCT00998582|12810462|P1|STARTED|Overall Study||13
5210191|NCT00998517|12810473|P3|NOT COMPLETED|Overall Study||0
5210192|NCT00998517|12810474|P2|NOT COMPLETED|Overall Study||0
5210193|NCT00998517|12810475|P1|NOT COMPLETED|Overall Study||0
5210194|NCT00998517|12810473|P3|COMPLETED|Overall Study||918
5210195|NCT00998517|12810474|P2|COMPLETED|Overall Study||906
5210196|NCT00998517|12810475|P1|COMPLETED|Overall Study||888
5210197|NCT00998517|12810473|P3|STARTED|Overall Study||918
5210198|NCT00998517|12810474|P2|STARTED|Overall Study||906
5210199|NCT00998517|12810475|P1|STARTED|Overall Study||888
5210200|NCT00998426|12810501|P1|NOT COMPLETED|Overall Study||0
5210201|NCT00998426|12810501|P1|COMPLETED|Overall Study||5
5210202|NCT00998426|12810501|P1|Blood Glucose Monitoring|Overall Study||5
5210203|NCT00998426|12810501|P1|STARTED|Overall Study||5
5210204|NCT00998400|12810508|P2|NOT COMPLETED|Overall Study||2
5210205|NCT00998400|12810509|P1|NOT COMPLETED|Overall Study||2
5210206|NCT00998400|12810508|P2|COMPLETED|Overall Study||48
5210207|NCT00998400|12810509|P1|COMPLETED|Overall Study||48
5210208|NCT00998400|12810508|P2|STARTED|Overall Study||50
5210209|NCT00998400|12810509|P1|STARTED|Overall Study||50
5210210|NCT00998374|12810539|P2|NOT COMPLETED|Overall Study||11
5210211|NCT00998374|12810540|P1|NOT COMPLETED|Overall Study||12
5210212|NCT00998374|12810539|P2|COMPLETED|Overall Study||12
5210213|NCT00998374|12810540|P1|COMPLETED|Overall Study||27
5210214|NCT00998374|12810539|P2|STARTED|Overall Study||23
5210215|NCT00998374|12810540|P1|STARTED|Overall Study||39
5210216|NCT00998335|12810554|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
5210217|NCT00998335|12810555|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
5210218|NCT00998335|12810554|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
5210219|NCT00998335|12810555|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
5210220|NCT00998335|12810554|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
5210221|NCT00998335|12810555|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
5210222|NCT00998335|12810554|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
5210223|NCT00998335|12810555|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
5210224|NCT00998335|12810554|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
5210225|NCT00998335|12810555|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
5210226|NCT00998335|12810554|P2|STARTED|Initial Treatment (Months 0 - 3)||0
5210227|NCT00998335|12810555|P1|STARTED|Initial Treatment (Months 0 - 3)||30
5210228|NCT00998309|12810583|P1|NOT COMPLETED|Overall Study||4
5210229|NCT00998309|12810583|P1|COMPLETED|Overall Study||498
5210230|NCT00998309|12810583|P1|STARTED|Overall Study||502
5210231|NCT00998296|12810650|P11|NOT COMPLETED|Overall Study||7
5210232|NCT00998296|12810651|P10|NOT COMPLETED|Overall Study||18
5210233|NCT00998296|12810652|P9|NOT COMPLETED|Overall Study||2
5210234|NCT00998296|12810653|P8|NOT COMPLETED|Overall Study||2
5210235|NCT00998296|12810654|P7|NOT COMPLETED|Overall Study||1
5210236|NCT00998296|12810655|P6|NOT COMPLETED|Overall Study||0
5210237|NCT00998296|12810656|P5|NOT COMPLETED|Overall Study||2
5210238|NCT00998296|12810657|P4|NOT COMPLETED|Overall Study||0
5210239|NCT00998296|12810658|P3|NOT COMPLETED|Overall Study||0
5210240|NCT00998296|12810659|P2|NOT COMPLETED|Overall Study||1
5210241|NCT00998296|12810660|P1|NOT COMPLETED|Overall Study||0
5210242|NCT00998296|12810650|P11|COMPLETED|Overall Study||0
5210243|NCT00998296|12810651|P10|COMPLETED|Overall Study||0
5210244|NCT00998296|12810652|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
5210245|NCT00998296|12810653|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
5210246|NCT00998296|12810654|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
5210247|NCT00998296|12810655|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
5210248|NCT00998296|12810656|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
5210249|NCT00998296|12810657|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
5210250|NCT00998296|12810658|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
5210251|NCT00998296|12810659|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
5210252|NCT00998296|12810660|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
5210253|NCT00998296|12810650|P11|STARTED|Overall Study||7
5210254|NCT00998296|12810651|P10|STARTED|Overall Study||18
5210255|NCT00998296|12810652|P9|STARTED|Overall Study||6
5210256|NCT00998296|12810653|P8|STARTED|Overall Study||6
5210257|NCT00998296|12810654|P7|STARTED|Overall Study||7
5210258|NCT00998296|12810655|P6|STARTED|Overall Study||3
5210259|NCT00998296|12810656|P5|STARTED|Overall Study||8
5210260|NCT00998296|12810657|P4|STARTED|Overall Study||3
5210261|NCT00998296|12810658|P3|STARTED|Overall Study||3
5210262|NCT00998296|12810659|P2|STARTED|Overall Study||3
5210263|NCT00998296|12810660|P1|STARTED|Overall Study||6
5210264|NCT00998205|12810727|P1|NOT COMPLETED|Overall Study||0
5210265|NCT00998205|12810727|P1|COMPLETED|Overall Study||16
5210266|NCT00998205|12810727|P1|STARTED|Overall Study||16
5210267|NCT00998049|12810732|P1|NOT COMPLETED|Overall Study||0
5210268|NCT00998049|12810732|P1|COMPLETED|Overall Study||39
5210269|NCT00998049|12810732|P1|STARTED|Overall Study||39
5210270|NCT00998023|12810743|P2|NOT COMPLETED|Overall Study||0
5210271|NCT00998023|12810744|P1|NOT COMPLETED|Overall Study||0
5210272|NCT00998023|12810743|P2|COMPLETED|Overall Study||32
5210273|NCT00998023|12810744|P1|COMPLETED|Overall Study||32
5210274|NCT00998023|12810743|P2|STARTED|Overall Study||32
5210275|NCT00998023|12810744|P1|STARTED|Overall Study||32
5210276|NCT00998010|12810752|P1|NOT COMPLETED|Overall Study||0
5210277|NCT00998010|12810752|P1|COMPLETED|Overall Study||24
5210278|NCT00998010|12810752|P1|STARTED|Overall Study||24
5210279|NCT00997984|12810763|P3|NOT COMPLETED|Overall Study||26
5210280|NCT00997984|12810764|P2|NOT COMPLETED|Overall Study||34
5210281|NCT00997984|12810765|P1|NOT COMPLETED|Overall Study||37
5210282|NCT00997984|12810763|P3|COMPLETED|Overall Study||88
5210283|NCT00997984|12810764|P2|COMPLETED|Overall Study||79
5210284|NCT00997984|12810765|P1|COMPLETED|Overall Study||76
5210285|NCT00997984|12810763|P3|STARTED|Overall Study||114
5210286|NCT00997984|12810764|P2|STARTED|Overall Study||113
5210287|NCT00997984|12810765|P1|STARTED|Overall Study||113
5210288|NCT00997932|12810831|P1|NOT COMPLETED|Overall Study||2
5210289|NCT00997932|12810831|P1|COMPLETED|Overall Study||27
5210290|NCT00997932|12810831|P1|STARTED|Overall Study||29
5210291|NCT00997672|12810838|P2|NOT COMPLETED|Overall Study||4
5210292|NCT00997672|12810839|P1|NOT COMPLETED|Overall Study||4
5210293|NCT00997672|12810838|P2|COMPLETED|Overall Study||1
5210294|NCT00997672|12810839|P1|COMPLETED|Overall Study||0
5210295|NCT00997672|12810838|P2|STARTED|Overall Study||5
5210296|NCT00997672|12810839|P1|STARTED|Overall Study||4
5210297|NCT00997620|12810847|P2|NOT COMPLETED|Overall Study||0
5210298|NCT00997620|12810848|P1|NOT COMPLETED|Overall Study||0
5210299|NCT00997620|12810847|P2|COMPLETED|Overall Study||21
5210300|NCT00997620|12810848|P1|COMPLETED|Overall Study||19
5210301|NCT00997620|12810847|P2|STARTED|Overall Study||21
5210302|NCT00997620|12810848|P1|STARTED|Overall Study||19
5210303|NCT00997594|12810866|P2|NOT COMPLETED|Overall Study||0
5210304|NCT00997594|12810867|P1|NOT COMPLETED|Overall Study||0
5210305|NCT00997594|12810866|P2|COMPLETED|Overall Study||9
5210306|NCT00997594|12810867|P1|COMPLETED|Overall Study||9
5210307|NCT00997594|12810866|P2|Completion of Ablation Procedure|Overall Study||9
5210308|NCT00997594|12810867|P1|Completion of Ablation Procedure|Overall Study||9
5210309|NCT00997594|12810866|P2|STARTED|Overall Study||9
5210310|NCT00997594|12810867|P1|STARTED|Overall Study||9
5210311|NCT00997555|12810875|P2|NOT COMPLETED|Overall Study||0
5210312|NCT00997555|12810876|P1|NOT COMPLETED|Overall Study||0
5210313|NCT00997555|12810875|P2|COMPLETED|Overall Study||15
5210314|NCT00997555|12810876|P1|COMPLETED|Overall Study||13
5210315|NCT00997555|12810875|P2|STARTED|Overall Study||15
5210316|NCT00997555|12810876|P1|STARTED|Overall Study||13
5210317|NCT00997516|12810894|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
5210318|NCT00997516|12810895|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
5210319|NCT00997516|12810894|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
5210320|NCT00997516|12810895|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
5210321|NCT00997516|12810894|P2|STARTED|Long-term Follow-up (After 6 Months)||38
5210322|NCT00997516|12810895|P1|STARTED|Long-term Follow-up (After 6 Months)||37
5210323|NCT00997516|12810894|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
5210324|NCT00997516|12810895|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
5210325|NCT00997516|12810894|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
5210326|NCT00997516|12810895|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
5210327|NCT00997516|12810894|P2|STARTED|Short-term Follow-up (Post Operative)||38
5210328|NCT00997516|12810895|P1|STARTED|Short-term Follow-up (Post Operative)||37
5210329|NCT00997503|12810923|P1|NOT COMPLETED|Overall Study||273
5210330|NCT00997503|12810923|P1|COMPLETED|Overall Study||3926
5210331|NCT00997503|12810923|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
5210332|NCT00997503|12810923|P1|STARTED|Overall Study||4199
5210333|NCT00997438|12810966|P3|NOT COMPLETED|Overall Study||4
5210334|NCT00997438|12810967|P2|NOT COMPLETED|Overall Study||3
5210335|NCT00997438|12810968|P1|NOT COMPLETED|Overall Study||5
5210336|NCT00997438|12810966|P3|COMPLETED|Overall Study||20
5210337|NCT00997438|12810967|P2|COMPLETED|Overall Study||21
5210338|NCT00997438|12810968|P1|COMPLETED|Overall Study||16
5210339|NCT00997438|12810966|P3|STARTED|Overall Study||24
5210340|NCT00997438|12810967|P2|STARTED|Overall Study||24
5210341|NCT00997438|12810968|P1|STARTED|Overall Study||21
5210342|NCT00997425|12811003|P1|NOT COMPLETED|Overall Study||0
5210343|NCT00997425|12811003|P1|COMPLETED|Overall Study||19
5210344|NCT00997425|12811003|P1|STARTED|Overall Study||19
5210345|NCT00997386|12811008|P1|NOT COMPLETED|Overall Study||7
5210346|NCT00997386|12811008|P1|COMPLETED|Overall Study||9
5210347|NCT00997386|12811008|P1|STARTED|Overall Study||16
5210348|NCT00997373|12811017|P2|NOT COMPLETED|Overall Study||0
5210349|NCT00997373|12811018|P1|NOT COMPLETED|Overall Study||15
5210350|NCT00997373|12811017|P2|COMPLETED|Overall Study||15
5210351|NCT00997373|12811018|P1|COMPLETED|Overall Study||13
5210352|NCT00997373|12811017|P2|Completed Hysterectomy|Overall Study||15
5210353|NCT00997373|12811018|P1|Completed Hysterectomy|Overall Study||17
5210354|NCT00997373|12811017|P2|Received Letrozole|Overall Study||0
5210355|NCT00997373|12811018|P1|Received Letrozole|Overall Study||23
5210356|NCT00997373|12811017|P2|STARTED|Overall Study||15
5210357|NCT00997373|12811018|P1|STARTED|Overall Study||28
5210358|NCT00997334|12811024|P1|NOT COMPLETED|Overall Study||25
5210359|NCT00997334|12811024|P1|COMPLETED|Overall Study||35
5210360|NCT00997334|12811024|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
5210361|NCT00997334|12811024|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
5210362|NCT00997334|12811024|P1|STARTED|Overall Study||60
5210363|NCT00997321|12811033|P2|NOT COMPLETED|Overall Study||3
5210364|NCT00997321|12811034|P1|NOT COMPLETED|Overall Study||0
5210365|NCT00997321|12811033|P2|COMPLETED|Overall Study||47
5210366|NCT00997321|12811034|P1|COMPLETED|Overall Study||50
5210367|NCT00997321|12811033|P2|STARTED|Overall Study||50
5210368|NCT00997321|12811034|P1|STARTED|Overall Study||50
5210369|NCT00997243|12811046|P1|NOT COMPLETED|Overall Study||7
5210370|NCT00997243|12811046|P1|COMPLETED|Overall Study||0
5210371|NCT00997243|12811046|P1|STARTED|Overall Study||7
5210372|NCT00997204|12811058|P2|NOT COMPLETED|Self-administration Phase||1
5210373|NCT00997204|12811059|P1|NOT COMPLETED|Self-administration Phase||0
5210374|NCT00997204|12811058|P2|COMPLETED|Self-administration Phase||77
5210375|NCT00997204|12811059|P1|COMPLETED|Self-administration Phase||19
5210376|NCT00997204|12811058|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
5210377|NCT00997204|12811059|P1|STARTED|Self-administration Phase||19
5210378|NCT00997204|12811058|P2|NOT COMPLETED|Naive Treatment Phase||79
5210379|NCT00997204|12811059|P1|NOT COMPLETED|Naive Treatment Phase||6
5210380|NCT00997204|12811058|P2|COMPLETED|Naive Treatment Phase||0
5210381|NCT00997204|12811059|P1|COMPLETED|Naive Treatment Phase||19
5210382|NCT00997204|12811058|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
5210383|NCT00997204|12811059|P1|STARTED|Naive Treatment Phase||25
5210384|NCT00997139|12811070|P1|NOT COMPLETED|Overall Study||186
5210385|NCT00997139|12811070|P1|COMPLETED|Overall Study||30
5210386|NCT00997139|12811070|P1|Treated for Positive Baseline Culture|Overall Study||30
5210387|NCT00997139|12811070|P1|STARTED|Overall Study||216
5210388|NCT00997126|12811078|P2|NOT COMPLETED|Overall Study||11
5210389|NCT00997126|12811079|P1|NOT COMPLETED|Overall Study||7
5210390|NCT00997126|12811078|P2|COMPLETED|Overall Study||52
5210391|NCT00997126|12811079|P1|COMPLETED|Overall Study||56
5210392|NCT00997126|12811078|P2|STARTED|Overall Study||63
5210393|NCT00997126|12811079|P1|STARTED|Overall Study||63
5210394|NCT00997113|12811095|P2|NOT COMPLETED|Overall Study||0
5210395|NCT00997113|12811096|P1|NOT COMPLETED|Overall Study||0
5210396|NCT00997113|12811095|P2|COMPLETED|Overall Study||10
5210397|NCT00997113|12811096|P1|COMPLETED|Overall Study||10
5210398|NCT00997113|12811095|P2|STARTED|Overall Study||10
5210399|NCT00997113|12811096|P1|STARTED|Overall Study||10
5210400|NCT00997035|12811108|P2|NOT COMPLETED|3-month Follow-up Visit||6
5210401|NCT00997035|12811109|P1|NOT COMPLETED|3-month Follow-up Visit||12
5210402|NCT00997035|12811108|P2|COMPLETED|3-month Follow-up Visit||107
5210403|NCT00997035|12811109|P1|COMPLETED|3-month Follow-up Visit||100
5210404|NCT00997035|12811108|P2|STARTED|3-month Follow-up Visit||113
5210405|NCT00997035|12811109|P1|STARTED|3-month Follow-up Visit||112
5210406|NCT00997035|12811108|P2|NOT COMPLETED|3-week Followup Visit||6
5210407|NCT00997035|12811109|P1|NOT COMPLETED|3-week Followup Visit||9
5210408|NCT00997035|12811108|P2|COMPLETED|3-week Followup Visit||113
5210409|NCT00997035|12811109|P1|COMPLETED|3-week Followup Visit||112
5210410|NCT00997035|12811108|P2|STARTED|3-week Followup Visit||119
5210411|NCT00997035|12811109|P1|STARTED|3-week Followup Visit||121
5210412|NCT00996996|12811133|P1|NOT COMPLETED|Overall Study||33
5210413|NCT00996996|12811133|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
5210414|NCT00996996|12811133|P1|STARTED|Overall Study||77
5210415|NCT00996944|12811167|P2|NOT COMPLETED|Long-term Treatment Period||5
5210416|NCT00996944|12811168|P1|NOT COMPLETED|Long-term Treatment Period||12
5210417|NCT00996944|12811167|P2|COMPLETED|Long-term Treatment Period||0
5210418|NCT00996944|12811168|P1|COMPLETED|Long-term Treatment Period||0
5210419|NCT00996944|12811167|P2|STARTED|Long-term Treatment Period||5
5210420|NCT00996944|12811168|P1|STARTED|Long-term Treatment Period||12
5210421|NCT00996944|12811167|P2|NOT COMPLETED|Double-blind Treatment Period||7
5210422|NCT00996944|12811168|P1|NOT COMPLETED|Double-blind Treatment Period||10
5210423|NCT00996944|12811167|P2|COMPLETED|Double-blind Treatment Period||5
5210424|NCT00996944|12811168|P1|COMPLETED|Double-blind Treatment Period||12
5210425|NCT00996944|12811167|P2|STARTED|Double-blind Treatment Period||12
5210426|NCT00996944|12811168|P1|STARTED|Double-blind Treatment Period||22
5210427|NCT00996931|12811210|P1|NOT COMPLETED|Overall Study||0
5210428|NCT00996931|12811210|P1|COMPLETED|Overall Study||6
5210429|NCT00996931|12811210|P1|STARTED|Overall Study||6
5210430|NCT00996918|12811220|P5|NOT COMPLETED|Overall Study||4
5210431|NCT00996918|12811221|P4|NOT COMPLETED|Overall Study||56
5210432|NCT00996918|12811222|P3|NOT COMPLETED|Overall Study||37
5210433|NCT00996918|12811223|P2|NOT COMPLETED|Overall Study||66
5210434|NCT00996918|12811224|P1|NOT COMPLETED|Overall Study||39
5210435|NCT00996918|12811220|P5|COMPLETED|Overall Study||0
5210436|NCT00996918|12811221|P4|COMPLETED|Overall Study||0
5210437|NCT00996918|12811222|P3|COMPLETED|Overall Study||0
5210438|NCT00996918|12811223|P2|COMPLETED|Overall Study||0
5210439|NCT00996918|12811224|P1|COMPLETED|Overall Study||0
5210440|NCT00996918|12811220|P5|Treated|Overall Study||4
5210441|NCT00996918|12811221|P4|Treated|Overall Study||56
5210442|NCT00996918|12811222|P3|Treated|Overall Study||37
5210443|NCT00996918|12811223|P2|Treated|Overall Study||66
5210444|NCT00996918|12811224|P1|Treated|Overall Study||39
5210445|NCT00996918|12811220|P5|STARTED|Overall Study||4
5210446|NCT00996918|12811221|P4|STARTED|Overall Study||56
5210447|NCT00996918|12811222|P3|STARTED|Overall Study||37
5210448|NCT00996918|12811223|P2|STARTED|Overall Study||66
5210449|NCT00996918|12811224|P1|STARTED|Overall Study||39
5210450|NCT00996892|12811268|P20|NOT COMPLETED|Expansion Stage 2A||45
5210451|NCT00996892|12811269|P19|NOT COMPLETED|Expansion Stage 2A||0
5210452|NCT00996892|12811270|P18|NOT COMPLETED|Expansion Stage 2A||0
5210453|NCT00996892|12811271|P17|NOT COMPLETED|Expansion Stage 2A||0
5210454|NCT00996892|12811272|P16|NOT COMPLETED|Expansion Stage 2A||0
5210455|NCT00996892|12811273|P15|NOT COMPLETED|Expansion Stage 2A||0
5210456|NCT00996892|12811274|P14|NOT COMPLETED|Expansion Stage 2A||0
5210457|NCT00996892|12811275|P13|NOT COMPLETED|Expansion Stage 2A||0
5210458|NCT00996892|12811276|P12|NOT COMPLETED|Expansion Stage 2A||0
5210459|NCT00996892|12811277|P11|NOT COMPLETED|Expansion Stage 2A||0
5210460|NCT00996892|12811278|P10|NOT COMPLETED|Expansion Stage 2A||0
5210461|NCT00996892|12811279|P9|NOT COMPLETED|Expansion Stage 2A||0
5210462|NCT00996892|12811280|P8|NOT COMPLETED|Expansion Stage 2A||0
5210463|NCT00996892|12811281|P7|NOT COMPLETED|Expansion Stage 2A||0
5210464|NCT00996892|12811282|P6|NOT COMPLETED|Expansion Stage 2A||0
5210465|NCT00996892|12811283|P5|NOT COMPLETED|Expansion Stage 2A||0
5210466|NCT00996892|12811284|P4|NOT COMPLETED|Expansion Stage 2A||0
5210467|NCT00996892|12811285|P3|NOT COMPLETED|Expansion Stage 2A||0
5210468|NCT00996892|12811286|P2|NOT COMPLETED|Expansion Stage 2A||0
5210469|NCT00996892|12811287|P1|NOT COMPLETED|Expansion Stage 2A||0
5210470|NCT00996892|12811268|P20|COMPLETED|Expansion Stage 2A||0
5210471|NCT00996892|12811269|P19|COMPLETED|Expansion Stage 2A||0
5210472|NCT00996892|12811270|P18|COMPLETED|Expansion Stage 2A||0
5210473|NCT00996892|12811271|P17|COMPLETED|Expansion Stage 2A||0
5210474|NCT00996892|12811272|P16|COMPLETED|Expansion Stage 2A||0
5210475|NCT00996892|12811273|P15|COMPLETED|Expansion Stage 2A||0
5210476|NCT00996892|12811274|P14|COMPLETED|Expansion Stage 2A||0
5210477|NCT00996892|12811275|P13|COMPLETED|Expansion Stage 2A||0
5210478|NCT00996892|12811276|P12|COMPLETED|Expansion Stage 2A||0
5210479|NCT00996892|12811277|P11|COMPLETED|Expansion Stage 2A||0
5210480|NCT00996892|12811278|P10|COMPLETED|Expansion Stage 2A||0
5210481|NCT00996892|12811279|P9|COMPLETED|Expansion Stage 2A||0
5210482|NCT00996892|12811280|P8|COMPLETED|Expansion Stage 2A||0
5210483|NCT00996892|12811281|P7|COMPLETED|Expansion Stage 2A||0
5210484|NCT00996892|12811282|P6|COMPLETED|Expansion Stage 2A||0
5210485|NCT00996892|12811283|P5|COMPLETED|Expansion Stage 2A||0
5210486|NCT00996892|12811284|P4|COMPLETED|Expansion Stage 2A||0
5210487|NCT00996892|12811285|P3|COMPLETED|Expansion Stage 2A||0
5210488|NCT00996892|12811286|P2|COMPLETED|Expansion Stage 2A||0
5210489|NCT00996892|12811287|P1|COMPLETED|Expansion Stage 2A||0
5210490|NCT00996892|12811268|P20|STARTED|Expansion Stage 2A||45
5210491|NCT00996892|12811269|P19|STARTED|Expansion Stage 2A||0
5210492|NCT00996892|12811270|P18|STARTED|Expansion Stage 2A||0
5210493|NCT00996892|12811271|P17|STARTED|Expansion Stage 2A||0
5210494|NCT00996892|12811272|P16|STARTED|Expansion Stage 2A||0
5210495|NCT00996892|12811273|P15|STARTED|Expansion Stage 2A||0
5210496|NCT00996892|12811274|P14|STARTED|Expansion Stage 2A||0
5210497|NCT00996892|12811275|P13|STARTED|Expansion Stage 2A||0
5210498|NCT00996892|12811276|P12|STARTED|Expansion Stage 2A||0
5210499|NCT00996892|12811277|P11|STARTED|Expansion Stage 2A||0
5210500|NCT00996892|12811278|P10|STARTED|Expansion Stage 2A||0
5210501|NCT00996892|12811279|P9|STARTED|Expansion Stage 2A||0
5210502|NCT00996892|12811280|P8|STARTED|Expansion Stage 2A||0
5210503|NCT00996892|12811281|P7|STARTED|Expansion Stage 2A||0
5210504|NCT00996892|12811282|P6|STARTED|Expansion Stage 2A||0
5210505|NCT00996892|12811283|P5|STARTED|Expansion Stage 2A||0
5210506|NCT00996892|12811284|P4|STARTED|Expansion Stage 2A||0
5210507|NCT00996892|12811285|P3|STARTED|Expansion Stage 2A||0
5210508|NCT00996892|12811286|P2|STARTED|Expansion Stage 2A||0
5210509|NCT00996892|12811287|P1|STARTED|Expansion Stage 2A||0
5210510|NCT00996892|12811268|P20|NOT COMPLETED|Expansion Stage 2||0
5210511|NCT00996892|12811269|P19|NOT COMPLETED|Expansion Stage 2||35
5210512|NCT00996892|12811270|P18|NOT COMPLETED|Expansion Stage 2||0
5210513|NCT00996892|12811271|P17|NOT COMPLETED|Expansion Stage 2||0
5210514|NCT00996892|12811272|P16|NOT COMPLETED|Expansion Stage 2||0
5210515|NCT00996892|12811273|P15|NOT COMPLETED|Expansion Stage 2||0
5210516|NCT00996892|12811274|P14|NOT COMPLETED|Expansion Stage 2||0
5210517|NCT00996892|12811275|P13|NOT COMPLETED|Expansion Stage 2||0
5210518|NCT00996892|12811276|P12|NOT COMPLETED|Expansion Stage 2||0
5210519|NCT00996892|12811277|P11|NOT COMPLETED|Expansion Stage 2||0
5210520|NCT00996892|12811278|P10|NOT COMPLETED|Expansion Stage 2||0
5210521|NCT00996892|12811279|P9|NOT COMPLETED|Expansion Stage 2||0
5210522|NCT00996892|12811280|P8|NOT COMPLETED|Expansion Stage 2||0
5210523|NCT00996892|12811281|P7|NOT COMPLETED|Expansion Stage 2||0
5210524|NCT00996892|12811282|P6|NOT COMPLETED|Expansion Stage 2||0
5210525|NCT00996892|12811283|P5|NOT COMPLETED|Expansion Stage 2||0
5210526|NCT00996892|12811284|P4|NOT COMPLETED|Expansion Stage 2||0
5210527|NCT00996892|12811285|P3|NOT COMPLETED|Expansion Stage 2||0
5210528|NCT00996892|12811286|P2|NOT COMPLETED|Expansion Stage 2||0
5210529|NCT00996892|12811287|P1|NOT COMPLETED|Expansion Stage 2||0
5210530|NCT00996892|12811268|P20|COMPLETED|Expansion Stage 2||0
5210531|NCT00996892|12811269|P19|COMPLETED|Expansion Stage 2||0
5210532|NCT00996892|12811270|P18|COMPLETED|Expansion Stage 2||0
5210533|NCT00996892|12811271|P17|COMPLETED|Expansion Stage 2||0
5210534|NCT00996892|12811272|P16|COMPLETED|Expansion Stage 2||0
5210535|NCT00996892|12811273|P15|COMPLETED|Expansion Stage 2||0
5210536|NCT00996892|12811274|P14|COMPLETED|Expansion Stage 2||0
5210537|NCT00996892|12811275|P13|COMPLETED|Expansion Stage 2||0
5210538|NCT00996892|12811276|P12|COMPLETED|Expansion Stage 2||0
5210539|NCT00996892|12811277|P11|COMPLETED|Expansion Stage 2||0
5210540|NCT00996892|12811278|P10|COMPLETED|Expansion Stage 2||0
5210541|NCT00996892|12811279|P9|COMPLETED|Expansion Stage 2||0
5210542|NCT00996892|12811280|P8|COMPLETED|Expansion Stage 2||0
5210543|NCT00996892|12811281|P7|COMPLETED|Expansion Stage 2||0
5210544|NCT00996892|12811282|P6|COMPLETED|Expansion Stage 2||0
5210545|NCT00996892|12811283|P5|COMPLETED|Expansion Stage 2||0
5210546|NCT00996892|12811284|P4|COMPLETED|Expansion Stage 2||0
5210547|NCT00996892|12811285|P3|COMPLETED|Expansion Stage 2||0
5210548|NCT00996892|12811286|P2|COMPLETED|Expansion Stage 2||0
5210549|NCT00996892|12811287|P1|COMPLETED|Expansion Stage 2||0
5210550|NCT00996892|12811268|P20|STARTED|Expansion Stage 2||0
5210551|NCT00996892|12811269|P19|STARTED|Expansion Stage 2||35
5210552|NCT00996892|12811270|P18|STARTED|Expansion Stage 2||0
5210553|NCT00996892|12811271|P17|STARTED|Expansion Stage 2||0
5210554|NCT00996892|12811272|P16|STARTED|Expansion Stage 2||0
5210555|NCT00996892|12811273|P15|STARTED|Expansion Stage 2||0
5210556|NCT00996892|12811274|P14|STARTED|Expansion Stage 2||0
5210557|NCT00996892|12811275|P13|STARTED|Expansion Stage 2||0
5210558|NCT00996892|12811276|P12|STARTED|Expansion Stage 2||0
5210559|NCT00996892|12811277|P11|STARTED|Expansion Stage 2||0
5210560|NCT00996892|12811278|P10|STARTED|Expansion Stage 2||0
5210561|NCT00996892|12811279|P9|STARTED|Expansion Stage 2||0
5210562|NCT00996892|12811280|P8|STARTED|Expansion Stage 2||0
5210563|NCT00996892|12811281|P7|STARTED|Expansion Stage 2||0
5210564|NCT00996892|12811282|P6|STARTED|Expansion Stage 2||0
5210565|NCT00996892|12811283|P5|STARTED|Expansion Stage 2||0
5210566|NCT00996892|12811284|P4|STARTED|Expansion Stage 2||0
5210567|NCT00996892|12811285|P3|STARTED|Expansion Stage 2||0
5210568|NCT00996892|12811286|P2|STARTED|Expansion Stage 2||0
5210569|NCT00996892|12811287|P1|STARTED|Expansion Stage 2||0
5210570|NCT00996892|12811268|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210571|NCT00996892|12811269|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210572|NCT00996892|12811270|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
5210573|NCT00996892|12811271|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
5210574|NCT00996892|12811272|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
5210575|NCT00996892|12811273|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
5210576|NCT00996892|12811274|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210577|NCT00996892|12811275|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210578|NCT00996892|12811276|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210579|NCT00996892|12811277|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210580|NCT00996892|12811278|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210581|NCT00996892|12811279|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210582|NCT00996892|12811280|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210583|NCT00996892|12811281|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210584|NCT00996892|12811282|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210585|NCT00996892|12811283|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210586|NCT00996892|12811284|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210587|NCT00996892|12811285|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210588|NCT00996892|12811286|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210589|NCT00996892|12811287|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
5210590|NCT00996892|12811268|P20|COMPLETED|Dose-Escalation Stage 1B||0
5210591|NCT00996892|12811269|P19|COMPLETED|Dose-Escalation Stage 1B||0
5210592|NCT00996892|12811270|P18|COMPLETED|Dose-Escalation Stage 1B||0
5210593|NCT00996892|12811271|P17|COMPLETED|Dose-Escalation Stage 1B||0
5210594|NCT00996892|12811272|P16|COMPLETED|Dose-Escalation Stage 1B||0
5210595|NCT00996892|12811273|P15|COMPLETED|Dose-Escalation Stage 1B||0
5210596|NCT00996892|12811274|P14|COMPLETED|Dose-Escalation Stage 1B||0
5210597|NCT00996892|12811275|P13|COMPLETED|Dose-Escalation Stage 1B||0
5210598|NCT00996892|12811276|P12|COMPLETED|Dose-Escalation Stage 1B||0
5210599|NCT00996892|12811277|P11|COMPLETED|Dose-Escalation Stage 1B||0
5210600|NCT00996892|12811278|P10|COMPLETED|Dose-Escalation Stage 1B||0
5210601|NCT00996892|12811279|P9|COMPLETED|Dose-Escalation Stage 1B||0
5210602|NCT00996892|12811280|P8|COMPLETED|Dose-Escalation Stage 1B||0
5210603|NCT00996892|12811281|P7|COMPLETED|Dose-Escalation Stage 1B||0
5210604|NCT00996892|12811282|P6|COMPLETED|Dose-Escalation Stage 1B||0
5210605|NCT00996892|12811283|P5|COMPLETED|Dose-Escalation Stage 1B||0
5210606|NCT00996892|12811284|P4|COMPLETED|Dose-Escalation Stage 1B||0
5210607|NCT00996892|12811285|P3|COMPLETED|Dose-Escalation Stage 1B||0
5210608|NCT00996892|12811286|P2|COMPLETED|Dose-Escalation Stage 1B||0
5210609|NCT00996892|12811287|P1|COMPLETED|Dose-Escalation Stage 1B||0
5210610|NCT00996892|12811268|P20|STARTED|Dose-Escalation Stage 1B||0
5210611|NCT00996892|12811269|P19|STARTED|Dose-Escalation Stage 1B||0
5210612|NCT00996892|12811270|P18|STARTED|Dose-Escalation Stage 1B||5
5210613|NCT00996892|12811271|P17|STARTED|Dose-Escalation Stage 1B||3
5210614|NCT00996892|12811272|P16|STARTED|Dose-Escalation Stage 1B||3
5210615|NCT00996892|12811273|P15|STARTED|Dose-Escalation Stage 1B||4
5210616|NCT00996892|12811274|P14|STARTED|Dose-Escalation Stage 1B||0
5210617|NCT00996892|12811275|P13|STARTED|Dose-Escalation Stage 1B||0
5210618|NCT00996892|12811276|P12|STARTED|Dose-Escalation Stage 1B||0
5210619|NCT00996892|12811277|P11|STARTED|Dose-Escalation Stage 1B||0
5210620|NCT00996892|12811278|P10|STARTED|Dose-Escalation Stage 1B||0
5210621|NCT00996892|12811279|P9|STARTED|Dose-Escalation Stage 1B||0
5210622|NCT00996892|12811280|P8|STARTED|Dose-Escalation Stage 1B||0
5210623|NCT00996892|12811281|P7|STARTED|Dose-Escalation Stage 1B||0
5210624|NCT00996892|12811282|P6|STARTED|Dose-Escalation Stage 1B||0
5210625|NCT00996892|12811283|P5|STARTED|Dose-Escalation Stage 1B||0
5210626|NCT00996892|12811284|P4|STARTED|Dose-Escalation Stage 1B||0
5210627|NCT00996892|12811285|P3|STARTED|Dose-Escalation Stage 1B||0
5210628|NCT00996892|12811286|P2|STARTED|Dose-Escalation Stage 1B||0
5210629|NCT00996892|12811287|P1|STARTED|Dose-Escalation Stage 1B||0
5210630|NCT00996892|12811268|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210631|NCT00996892|12811269|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210632|NCT00996892|12811270|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210633|NCT00996892|12811271|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210634|NCT00996892|12811272|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210635|NCT00996892|12811273|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210636|NCT00996892|12811274|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
5210637|NCT00996892|12811275|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
5210638|NCT00996892|12811276|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
5210639|NCT00996892|12811277|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
5210640|NCT00996892|12811278|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
5210641|NCT00996892|12811279|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
5210642|NCT00996892|12811280|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
5210643|NCT00996892|12811281|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210644|NCT00996892|12811282|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210645|NCT00996892|12811283|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210646|NCT00996892|12811284|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210647|NCT00996892|12811285|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210648|NCT00996892|12811286|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210649|NCT00996892|12811287|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
5210650|NCT00996892|12811268|P20|COMPLETED|Dose-Escalation Stage 1A||0
5210651|NCT00996892|12811269|P19|COMPLETED|Dose-Escalation Stage 1A||0
5210652|NCT00996892|12811270|P18|COMPLETED|Dose-Escalation Stage 1A||0
5210653|NCT00996892|12811271|P17|COMPLETED|Dose-Escalation Stage 1A||0
5210654|NCT00996892|12811272|P16|COMPLETED|Dose-Escalation Stage 1A||0
5210655|NCT00996892|12811273|P15|COMPLETED|Dose-Escalation Stage 1A||0
5210656|NCT00996892|12811274|P14|COMPLETED|Dose-Escalation Stage 1A||0
5210657|NCT00996892|12811275|P13|COMPLETED|Dose-Escalation Stage 1A||0
5210658|NCT00996892|12811276|P12|COMPLETED|Dose-Escalation Stage 1A||0
5210659|NCT00996892|12811277|P11|COMPLETED|Dose-Escalation Stage 1A||0
5210660|NCT00996892|12811278|P10|COMPLETED|Dose-Escalation Stage 1A||0
5210661|NCT00996892|12811279|P9|COMPLETED|Dose-Escalation Stage 1A||0
5210662|NCT00996892|12811280|P8|COMPLETED|Dose-Escalation Stage 1A||0
5210663|NCT00996892|12811281|P7|COMPLETED|Dose-Escalation Stage 1A||0
5210664|NCT00996892|12811282|P6|COMPLETED|Dose-Escalation Stage 1A||0
5210665|NCT00996892|12811283|P5|COMPLETED|Dose-Escalation Stage 1A||0
5210666|NCT00996892|12811284|P4|COMPLETED|Dose-Escalation Stage 1A||0
5210667|NCT00996892|12811285|P3|COMPLETED|Dose-Escalation Stage 1A||0
5210668|NCT00996892|12811286|P2|COMPLETED|Dose-Escalation Stage 1A||0
5210669|NCT00996892|12811287|P1|COMPLETED|Dose-Escalation Stage 1A||0
5210670|NCT00996892|12811268|P20|STARTED|Dose-Escalation Stage 1A||0
5210671|NCT00996892|12811269|P19|STARTED|Dose-Escalation Stage 1A||0
5210672|NCT00996892|12811270|P18|STARTED|Dose-Escalation Stage 1A||0
5210673|NCT00996892|12811271|P17|STARTED|Dose-Escalation Stage 1A||0
5210674|NCT00996892|12811272|P16|STARTED|Dose-Escalation Stage 1A||0
5210675|NCT00996892|12811273|P15|STARTED|Dose-Escalation Stage 1A||0
5210676|NCT00996892|12811274|P14|STARTED|Dose-Escalation Stage 1A||5
5210677|NCT00996892|12811275|P13|STARTED|Dose-Escalation Stage 1A||8
5210678|NCT00996892|12811276|P12|STARTED|Dose-Escalation Stage 1A||9
5210679|NCT00996892|12811277|P11|STARTED|Dose-Escalation Stage 1A||7
5210680|NCT00996892|12811278|P10|STARTED|Dose-Escalation Stage 1A||4
5210681|NCT00996892|12811279|P9|STARTED|Dose-Escalation Stage 1A||3
5210682|NCT00996892|12811280|P8|STARTED|Dose-Escalation Stage 1A||3
5210683|NCT00996892|12811281|P7|STARTED|Dose-Escalation Stage 1A||0
5210684|NCT00996892|12811282|P6|STARTED|Dose-Escalation Stage 1A||0
5210685|NCT00996892|12811283|P5|STARTED|Dose-Escalation Stage 1A||0
5210686|NCT00996892|12811284|P4|STARTED|Dose-Escalation Stage 1A||0
5210687|NCT00996892|12811285|P3|STARTED|Dose-Escalation Stage 1A||0
5210688|NCT00996892|12811286|P2|STARTED|Dose-Escalation Stage 1A||0
5210689|NCT00996892|12811287|P1|STARTED|Dose-Escalation Stage 1A||0
5210690|NCT00996892|12811268|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
5210691|NCT00996892|12811269|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
5210692|NCT00996892|12811270|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
5210693|NCT00996892|12811271|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
5210694|NCT00996892|12811272|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
5210695|NCT00996892|12811273|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
5210696|NCT00996892|12811274|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
5210697|NCT00996892|12811275|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
5210698|NCT00996892|12811276|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
5210699|NCT00996892|12811277|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
5210700|NCT00996892|12811278|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
5210701|NCT00996892|12811279|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
5210702|NCT00996892|12811280|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
5210703|NCT00996892|12811281|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
5210704|NCT00996892|12811282|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
5210705|NCT00996892|12811283|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
5210706|NCT00996892|12811284|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
5210707|NCT00996892|12811285|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
5210708|NCT00996892|12811286|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
5210709|NCT00996892|12811287|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
5210710|NCT00996892|12811268|P20|COMPLETED|Dose-Escalation Stage 1||0
5210711|NCT00996892|12811269|P19|COMPLETED|Dose-Escalation Stage 1||0
5210712|NCT00996892|12811270|P18|COMPLETED|Dose-Escalation Stage 1||0
5210713|NCT00996892|12811271|P17|COMPLETED|Dose-Escalation Stage 1||0
5210714|NCT00996892|12811272|P16|COMPLETED|Dose-Escalation Stage 1||0
5210715|NCT00996892|12811273|P15|COMPLETED|Dose-Escalation Stage 1||0
5210716|NCT00996892|12811274|P14|COMPLETED|Dose-Escalation Stage 1||0
5210717|NCT00996892|12811275|P13|COMPLETED|Dose-Escalation Stage 1||0
5210718|NCT00996892|12811276|P12|COMPLETED|Dose-Escalation Stage 1||0
5210719|NCT00996892|12811277|P11|COMPLETED|Dose-Escalation Stage 1||0
5210720|NCT00996892|12811278|P10|COMPLETED|Dose-Escalation Stage 1||0
5210721|NCT00996892|12811279|P9|COMPLETED|Dose-Escalation Stage 1||0
5210722|NCT00996892|12811280|P8|COMPLETED|Dose-Escalation Stage 1||0
5210723|NCT00996892|12811281|P7|COMPLETED|Dose-Escalation Stage 1||0
5210724|NCT00996892|12811282|P6|COMPLETED|Dose-Escalation Stage 1||0
5210725|NCT00996892|12811283|P5|COMPLETED|Dose-Escalation Stage 1||0
5210726|NCT00996892|12811284|P4|COMPLETED|Dose-Escalation Stage 1||0
5210727|NCT00996892|12811285|P3|COMPLETED|Dose-Escalation Stage 1||0
5210728|NCT00996892|12811286|P2|COMPLETED|Dose-Escalation Stage 1||0
5210729|NCT00996892|12811287|P1|COMPLETED|Dose-Escalation Stage 1||0
5210730|NCT00996892|12811268|P20|STARTED|Dose-Escalation Stage 1||0
5210731|NCT00996892|12811269|P19|STARTED|Dose-Escalation Stage 1||0
5210732|NCT00996892|12811270|P18|STARTED|Dose-Escalation Stage 1||0
5210733|NCT00996892|12811271|P17|STARTED|Dose-Escalation Stage 1||0
5210734|NCT00996892|12811272|P16|STARTED|Dose-Escalation Stage 1||0
5210735|NCT00996892|12811273|P15|STARTED|Dose-Escalation Stage 1||0
5210736|NCT00996892|12811274|P14|STARTED|Dose-Escalation Stage 1||0
5210737|NCT00996892|12811275|P13|STARTED|Dose-Escalation Stage 1||0
5210738|NCT00996892|12811276|P12|STARTED|Dose-Escalation Stage 1||0
5210739|NCT00996892|12811277|P11|STARTED|Dose-Escalation Stage 1||0
5210740|NCT00996892|12811278|P10|STARTED|Dose-Escalation Stage 1||0
5210741|NCT00996892|12811279|P9|STARTED|Dose-Escalation Stage 1||0
5210742|NCT00996892|12811280|P8|STARTED|Dose-Escalation Stage 1||0
5210743|NCT00996892|12811281|P7|STARTED|Dose-Escalation Stage 1||4
5210744|NCT00996892|12811282|P6|STARTED|Dose-Escalation Stage 1||10
5210745|NCT00996892|12811283|P5|STARTED|Dose-Escalation Stage 1||11
5210746|NCT00996892|12811284|P4|STARTED|Dose-Escalation Stage 1||9
5210747|NCT00996892|12811285|P3|STARTED|Dose-Escalation Stage 1||3
5210748|NCT00996892|12811286|P2|STARTED|Dose-Escalation Stage 1||3
5210749|NCT00996892|12811287|P1|STARTED|Dose-Escalation Stage 1||4
5210750|NCT00996840|12811881|P5|NOT COMPLETED|Overall Study||2
5210751|NCT00996840|12811882|P4|NOT COMPLETED|Overall Study||1
5210752|NCT00996840|12811883|P3|NOT COMPLETED|Overall Study||1
5210753|NCT00996840|12811884|P2|NOT COMPLETED|Overall Study||2
5210754|NCT00996840|12811885|P1|NOT COMPLETED|Overall Study||1
5210755|NCT00996840|12811881|P5|COMPLETED|Overall Study||16
5210756|NCT00996840|12811882|P4|COMPLETED|Overall Study||17
5210757|NCT00996840|12811883|P3|COMPLETED|Overall Study||11
5210758|NCT00996840|12811884|P2|COMPLETED|Overall Study||7
5210759|NCT00996840|12811885|P1|COMPLETED|Overall Study||19
5210760|NCT00996840|12811881|P5|STARTED|Overall Study||18
5210761|NCT00996840|12811882|P4|STARTED|Overall Study||18
5210762|NCT00996840|12811883|P3|STARTED|Overall Study||12
5210763|NCT00996840|12811884|P2|STARTED|Overall Study||9
5210764|NCT00996840|12811885|P1|STARTED|Overall Study||20
5210765|NCT00996801|12812035|P6|NOT COMPLETED|Overall Study||19
5210766|NCT00996801|12812036|P5|NOT COMPLETED|Overall Study||88
5210767|NCT00996801|12812037|P4|NOT COMPLETED|Overall Study||31
5210768|NCT00996801|12812038|P3|NOT COMPLETED|Overall Study||23
5210769|NCT00996801|12812039|P2|NOT COMPLETED|Overall Study||16
5210770|NCT00996801|12812040|P1|NOT COMPLETED|Overall Study||20
5210771|NCT00996801|12812035|P6|COMPLETED|Overall Study||68
5210772|NCT00996801|12812036|P5|COMPLETED|Overall Study||0
5210773|NCT00996801|12812037|P4|COMPLETED|Overall Study||56
5210774|NCT00996801|12812038|P3|COMPLETED|Overall Study||65
5210775|NCT00996801|12812039|P2|COMPLETED|Overall Study||72
5210776|NCT00996801|12812040|P1|COMPLETED|Overall Study||68
5210777|NCT00996801|12812035|P6|STARTED|Overall Study||87
5210778|NCT00996801|12812036|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
5210779|NCT00996801|12812037|P4|STARTED|Overall Study||87
5210780|NCT00996801|12812038|P3|STARTED|Overall Study||88
5210781|NCT00996801|12812039|P2|STARTED|Overall Study||88
5210782|NCT00996801|12812040|P1|STARTED|Overall Study||88
5210783|NCT00996775|12812143|P2|NOT COMPLETED|Overall Study||14
5210784|NCT00996775|12812144|P1|NOT COMPLETED|Overall Study||11
5210785|NCT00996775|12812143|P2|COMPLETED|Overall Study||75
5210786|NCT00996775|12812144|P1|COMPLETED|Overall Study||67
5210787|NCT00996775|12812143|P2|STARTED|Overall Study||89
5210788|NCT00996775|12812144|P1|STARTED|Overall Study||78
5210789|NCT00996736|12812152|P2|NOT COMPLETED|Overall Study||18
5210790|NCT00996736|12812153|P1|NOT COMPLETED|Overall Study||21
5210791|NCT00996736|12812152|P2|COMPLETED|Overall Study||143
5210792|NCT00996736|12812153|P1|COMPLETED|Overall Study||141
5210793|NCT00996736|12812152|P2|3-month Visit|Overall Study||146
5210794|NCT00996736|12812153|P1|3-month Visit|Overall Study||146
5210795|NCT00996736|12812152|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
5210796|NCT00996736|12812153|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
5210797|NCT00996736|12812152|P2|STARTED|Overall Study||161
5210798|NCT00996736|12812153|P1|STARTED|Overall Study||162
5210799|NCT00996658|12812173|P2|NOT COMPLETED|Overall Study||21
5210800|NCT00996658|12812174|P1|NOT COMPLETED|Overall Study||16
5210801|NCT00996658|12812173|P2|COMPLETED|Overall Study||165
5210802|NCT00996658|12812174|P1|COMPLETED|Overall Study||76
5210803|NCT00996658|12812173|P2|STARTED|Overall Study||186
5210804|NCT00996658|12812174|P1|STARTED|Overall Study||92
5210805|NCT00996632|12812202|P2|NOT COMPLETED|Overall Study||0
5210806|NCT00996632|12812203|P1|NOT COMPLETED|Overall Study||0
5210807|NCT00996632|12812202|P2|COMPLETED|Overall Study||56
5210808|NCT00996632|12812203|P1|COMPLETED|Overall Study||38
5210809|NCT00996632|12812202|P2|STARTED|Overall Study||56
5210810|NCT00996632|12812203|P1|STARTED|Overall Study||38
5210811|NCT00996606|12812211|P1|NOT COMPLETED|Overall Study||8
5210812|NCT00996606|12812211|P1|COMPLETED|Overall Study||50
5210813|NCT00996606|12812211|P1|STARTED|Overall Study||58
5210814|NCT00996593|12812305|P1|NOT COMPLETED|Long-Term Follow-Up||3
5210815|NCT00996593|12812305|P1|COMPLETED|Long-Term Follow-Up||6
5210816|NCT00996593|12812305|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
5210817|NCT00996593|12812305|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
5210818|NCT00996593|12812305|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
5210912|NCT00995930|12812664|P1|NOT COMPLETED|Overall Study||21
5210819|NCT00996593|12812305|P1|STARTED|Dosimetric and Therapeutic Treatment||43
5210820|NCT00996580|12812333|P1|NOT COMPLETED|Overall Study||1453
5210821|NCT00996580|12812333|P1|COMPLETED|Overall Study||2144
5210822|NCT00996580|12812333|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
5210823|NCT00996580|12812333|P1|STARTED|Overall Study||3597
5210824|NCT00996502|12812361|P1|NOT COMPLETED|Overall Study||0
5210825|NCT00996502|12812361|P1|COMPLETED|Overall Study||4
5210826|NCT00996502|12812361|P1|STARTED|Overall Study||4
5210827|NCT00996489|12812368|P1|NOT COMPLETED|Overall Study||161
5210828|NCT00996489|12812368|P1|COMPLETED|Overall Study||298
5210829|NCT00996489|12812368|P1|STARTED|Overall Study||459
5210830|NCT00996476|12812388|P5|NOT COMPLETED|Overall Study||2
5210831|NCT00996476|12812389|P4|NOT COMPLETED|Overall Study||0
5210832|NCT00996476|12812390|P3|NOT COMPLETED|Overall Study||1
5210833|NCT00996476|12812391|P2|NOT COMPLETED|Overall Study||3
5210834|NCT00996476|12812392|P1|NOT COMPLETED|Overall Study||1
5210835|NCT00996476|12812388|P5|COMPLETED|Overall Study||11
5210836|NCT00996476|12812389|P4|COMPLETED|Overall Study||13
5210837|NCT00996476|12812390|P3|COMPLETED|Overall Study||12
5210838|NCT00996476|12812391|P2|COMPLETED|Overall Study||23
5210839|NCT00996476|12812392|P1|COMPLETED|Overall Study||26
5210840|NCT00996476|12812388|P5|STARTED|Overall Study||13
5210841|NCT00996476|12812389|P4|STARTED|Overall Study||13
5210842|NCT00996476|12812390|P3|STARTED|Overall Study||13
5210843|NCT00996476|12812391|P2|STARTED|Overall Study||26
5210844|NCT00996476|12812392|P1|STARTED|Overall Study||27
5210845|NCT00996437|12812460|P2|NOT COMPLETED|Overall Study||7
5210846|NCT00996437|12812461|P1|NOT COMPLETED|Overall Study||5
5210847|NCT00996437|12812460|P2|COMPLETED|Overall Study||129
5210848|NCT00996437|12812461|P1|COMPLETED|Overall Study||120
5210849|NCT00996437|12812460|P2|STARTED|Overall Study||136
5210850|NCT00996437|12812461|P1|STARTED|Overall Study||125
5210851|NCT00996372|12812483|P2|NOT COMPLETED|Overall Study||84
5210852|NCT00996372|12812484|P1|NOT COMPLETED|Overall Study||103
5210853|NCT00996372|12812483|P2|COMPLETED|Overall Study||397
5210854|NCT00996372|12812484|P1|COMPLETED|Overall Study||365
5210855|NCT00996372|12812483|P2|STARTED|Overall Study||481
5210856|NCT00996372|12812484|P1|STARTED|Overall Study||468
5210857|NCT00996346|12812497|P3|NOT COMPLETED|Overall Study||0
5210858|NCT00996346|12812498|P2|NOT COMPLETED|Overall Study||0
5210859|NCT00996346|12812499|P1|NOT COMPLETED|Overall Study||0
5210860|NCT00996346|12812497|P3|COMPLETED|Overall Study||3
5210861|NCT00996346|12812498|P2|COMPLETED|Overall Study||8
5210862|NCT00996346|12812499|P1|COMPLETED|Overall Study||6
5210863|NCT00996346|12812497|P3|STARTED|Overall Study||3
5210864|NCT00996346|12812498|P2|STARTED|Overall Study||8
5210865|NCT00996346|12812499|P1|STARTED|Overall Study||6
5210866|NCT00996333|12812506|P1|NOT COMPLETED|Overall Study||13
5210867|NCT00996333|12812506|P1|COMPLETED|Overall Study||33
5210868|NCT00996333|12812506|P1|STARTED|Overall Study||46
5210869|NCT00996307|12812516|P4|NOT COMPLETED|Overall Study||21
5210870|NCT00996307|12812517|P3|NOT COMPLETED|Overall Study||14
5210871|NCT00996307|12812518|P2|NOT COMPLETED|Overall Study||17
5210872|NCT00996307|12812519|P1|NOT COMPLETED|Overall Study||20
5210873|NCT00996307|12812516|P4|COMPLETED|Overall Study||144
5210874|NCT00996307|12812517|P3|COMPLETED|Overall Study||146
5210875|NCT00996307|12812518|P2|COMPLETED|Overall Study||148
5210876|NCT00996307|12812519|P1|COMPLETED|Overall Study||144
5210877|NCT00996307|12812516|P4|STARTED|Overall Study||165
5210878|NCT00996307|12812517|P3|STARTED|Overall Study||160
5210879|NCT00996307|12812518|P2|STARTED|Overall Study||165
5210880|NCT00996307|12812519|P1|STARTED|Overall Study||164
5210881|NCT00996281|12812579|P2|NOT COMPLETED|Overall Study||89
5210882|NCT00996281|12812580|P1|NOT COMPLETED|Overall Study||131
5210883|NCT00996281|12812579|P2|COMPLETED|Overall Study||330
5210884|NCT00996281|12812580|P1|COMPLETED|Overall Study||287
5210885|NCT00996281|12812579|P2|STARTED|Overall Study||419
5210886|NCT00996281|12812580|P1|STARTED|Overall Study||418
5210887|NCT00996216|12812588|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
5210888|NCT00996216|12812588|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
5210889|NCT00996216|12812588|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
5210890|NCT00996216|12812588|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
5210891|NCT00996216|12812588|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
5210892|NCT00996216|12812588|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
5210893|NCT00996203|12812604|P1|NOT COMPLETED|Overall Study||7
5210894|NCT00996203|12812604|P1|COMPLETED|Overall Study||194
5210895|NCT00996203|12812604|P1|STARTED|Overall Study||201
5210896|NCT00996164|12812625|P2|NOT COMPLETED|Overall Study||101
5210897|NCT00996164|12812626|P1|NOT COMPLETED|Overall Study||135
5210898|NCT00996164|12812625|P2|COMPLETED|Overall Study||446
5210899|NCT00996164|12812626|P1|COMPLETED|Overall Study||408
5210900|NCT00996164|12812625|P2|STARTED|Overall Study||547
5210901|NCT00996164|12812626|P1|STARTED|Overall Study||543
5210902|NCT00996125|12812636|P2|NOT COMPLETED|Overall Study||11
5210903|NCT00996125|12812637|P1|NOT COMPLETED|Overall Study||5
5210904|NCT00996125|12812636|P2|COMPLETED|Overall Study||365
5210905|NCT00996125|12812637|P1|COMPLETED|Overall Study||369
5210906|NCT00996125|12812636|P2|STARTED|Overall Study||376
5210907|NCT00996125|12812637|P1|STARTED|Overall Study||374
5210908|NCT00996034|12812657|P1|NOT COMPLETED|Overall Study||3
5210909|NCT00996034|12812657|P1|COMPLETED|Overall Study||11
5210910|NCT00996034|12812657|P1|STARTED|Overall Study||14
5210911|NCT00995930|12812663|P2|NOT COMPLETED|Overall Study||28
5210913|NCT00995930|12812663|P2|COMPLETED|Overall Study||67
5210914|NCT00995930|12812664|P1|COMPLETED|Overall Study||73
5210915|NCT00995930|12812663|P2|Imaging Analysis Set|Overall Study||92
5210916|NCT00995930|12812664|P1|Imaging Analysis Set|Overall Study||92
5210917|NCT00995930|12812663|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
5210918|NCT00995930|12812664|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
5210919|NCT00995930|12812663|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
5210920|NCT00995930|12812664|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
5210921|NCT00995930|12812663|P2|Safety Analysis Set|Overall Study||95
5210922|NCT00995930|12812664|P1|Safety Analysis Set|Overall Study||94
5210923|NCT00995930|12812663|P2|STARTED|Overall Study||95
5210924|NCT00995930|12812664|P1|STARTED|Overall Study||94
5210925|NCT00995904|12812693|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210926|NCT00995904|12812694|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210927|NCT00995904|12812695|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210928|NCT00995904|12812696|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210929|NCT00995904|12812697|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210930|NCT00995904|12812698|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
5210931|NCT00995904|12812693|P6|COMPLETED|Follow-up Visit (Final Visit)||3
5210932|NCT00995904|12812694|P5|COMPLETED|Follow-up Visit (Final Visit)||5
5210933|NCT00995904|12812695|P4|COMPLETED|Follow-up Visit (Final Visit)||5
5210934|NCT00995904|12812696|P3|COMPLETED|Follow-up Visit (Final Visit)||4
5210935|NCT00995904|12812697|P2|COMPLETED|Follow-up Visit (Final Visit)||3
5210936|NCT00995904|12812698|P1|COMPLETED|Follow-up Visit (Final Visit)||4
5210937|NCT00995904|12812693|P6|STARTED|Follow-up Visit (Final Visit)||3
5210938|NCT00995904|12812694|P5|STARTED|Follow-up Visit (Final Visit)||5
5210939|NCT00995904|12812695|P4|STARTED|Follow-up Visit (Final Visit)||5
5210940|NCT00995904|12812696|P3|STARTED|Follow-up Visit (Final Visit)||4
5210941|NCT00995904|12812697|P2|STARTED|Follow-up Visit (Final Visit)||3
5210942|NCT00995904|12812698|P1|STARTED|Follow-up Visit (Final Visit)||4
5210943|NCT00995904|12812693|P6|NOT COMPLETED|Visit 4||0
5210944|NCT00995904|12812694|P5|NOT COMPLETED|Visit 4||0
5210945|NCT00995904|12812695|P4|NOT COMPLETED|Visit 4||0
5210946|NCT00995904|12812696|P3|NOT COMPLETED|Visit 4||0
5210947|NCT00995904|12812697|P2|NOT COMPLETED|Visit 4||0
5210948|NCT00995904|12812698|P1|NOT COMPLETED|Visit 4||0
5210949|NCT00995904|12812693|P6|COMPLETED|Visit 4||3
5210950|NCT00995904|12812694|P5|COMPLETED|Visit 4||5
5210951|NCT00995904|12812695|P4|COMPLETED|Visit 4||5
5210952|NCT00995904|12812696|P3|COMPLETED|Visit 4||4
5210953|NCT00995904|12812697|P2|COMPLETED|Visit 4||3
5210954|NCT00995904|12812698|P1|COMPLETED|Visit 4||4
5210955|NCT00995904|12812693|P6|STARTED|Visit 4||3
5210956|NCT00995904|12812694|P5|STARTED|Visit 4||5
5210957|NCT00995904|12812695|P4|STARTED|Visit 4||5
5210958|NCT00995904|12812696|P3|STARTED|Visit 4||4
5210959|NCT00995904|12812697|P2|STARTED|Visit 4||3
5210960|NCT00995904|12812698|P1|STARTED|Visit 4||4
5210961|NCT00995904|12812693|P6|NOT COMPLETED|Visit 3||0
5210962|NCT00995904|12812694|P5|NOT COMPLETED|Visit 3||0
5210963|NCT00995904|12812695|P4|NOT COMPLETED|Visit 3||0
5210964|NCT00995904|12812696|P3|NOT COMPLETED|Visit 3||0
5210965|NCT00995904|12812697|P2|NOT COMPLETED|Visit 3||0
5210966|NCT00995904|12812698|P1|NOT COMPLETED|Visit 3||0
5210967|NCT00995904|12812693|P6|COMPLETED|Visit 3||3
5210968|NCT00995904|12812694|P5|COMPLETED|Visit 3||5
5210969|NCT00995904|12812695|P4|COMPLETED|Visit 3||5
5210970|NCT00995904|12812696|P3|COMPLETED|Visit 3||4
5210971|NCT00995904|12812697|P2|COMPLETED|Visit 3||3
5210972|NCT00995904|12812698|P1|COMPLETED|Visit 3||4
5210973|NCT00995904|12812693|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
5210974|NCT00995904|12812694|P5|STARTED|Visit 3||5
5210975|NCT00995904|12812695|P4|STARTED|Visit 3||5
5210976|NCT00995904|12812696|P3|STARTED|Visit 3||4
5210977|NCT00995904|12812697|P2|STARTED|Visit 3||3
5210978|NCT00995904|12812698|P1|STARTED|Visit 3||4
5210979|NCT00995904|12812693|P6|NOT COMPLETED|Visit 2 (Randomization)||0
5210980|NCT00995904|12812694|P5|NOT COMPLETED|Visit 2 (Randomization)||0
5210981|NCT00995904|12812695|P4|NOT COMPLETED|Visit 2 (Randomization)||0
5210982|NCT00995904|12812696|P3|NOT COMPLETED|Visit 2 (Randomization)||0
5210983|NCT00995904|12812697|P2|NOT COMPLETED|Visit 2 (Randomization)||0
5210984|NCT00995904|12812698|P1|NOT COMPLETED|Visit 2 (Randomization)||0
5210985|NCT00995904|12812693|P6|COMPLETED|Visit 2 (Randomization)||4
5210986|NCT00995904|12812694|P5|COMPLETED|Visit 2 (Randomization)||5
5210987|NCT00995904|12812695|P4|COMPLETED|Visit 2 (Randomization)||5
5210988|NCT00995904|12812696|P3|COMPLETED|Visit 2 (Randomization)||4
5210989|NCT00995904|12812697|P2|COMPLETED|Visit 2 (Randomization)||3
5210990|NCT00995904|12812698|P1|COMPLETED|Visit 2 (Randomization)||4
5210991|NCT00995904|12812693|P6|STARTED|Visit 2 (Randomization)||4
5210992|NCT00995904|12812694|P5|STARTED|Visit 2 (Randomization)||5
5210993|NCT00995904|12812695|P4|STARTED|Visit 2 (Randomization)||5
5210994|NCT00995904|12812696|P3|STARTED|Visit 2 (Randomization)||4
5210995|NCT00995904|12812697|P2|STARTED|Visit 2 (Randomization)||3
5210996|NCT00995904|12812698|P1|STARTED|Visit 2 (Randomization)||4
5210997|NCT00995865|12812715|P3|NOT COMPLETED|Overall Study||1
5210998|NCT00995865|12812716|P2|NOT COMPLETED|Overall Study||0
5210999|NCT00995865|12812717|P1|NOT COMPLETED|Overall Study||2
5211000|NCT00995865|12812715|P3|COMPLETED|Overall Study||11
5211001|NCT00995865|12812716|P2|COMPLETED|Overall Study||24
5211002|NCT00995865|12812717|P1|COMPLETED|Overall Study||22
5211003|NCT00995865|12812715|P3|STARTED|Overall Study||12
5211004|NCT00995865|12812716|P2|STARTED|Overall Study||24
5211005|NCT00995865|12812717|P1|STARTED|Overall Study||24
5211006|NCT00995774|12812739|P2|NOT COMPLETED|Training Period 2||0
5211007|NCT00995774|12812740|P1|NOT COMPLETED|Training Period 2||2
5211008|NCT00995774|12812739|P2|COMPLETED|Training Period 2||5
5211009|NCT00995774|12812740|P1|COMPLETED|Training Period 2||5
5211010|NCT00995774|12812739|P2|STARTED|Training Period 2||5
5211011|NCT00995774|12812740|P1|STARTED|Training Period 2||7
5211012|NCT00995774|12812739|P2|NOT COMPLETED|Washout Period||0
5211013|NCT00995774|12812740|P1|NOT COMPLETED|Washout Period||0
5211014|NCT00995774|12812739|P2|COMPLETED|Washout Period||5
5211015|NCT00995774|12812740|P1|COMPLETED|Washout Period||7
5211016|NCT00995774|12812739|P2|STARTED|Washout Period||5
5211017|NCT00995774|12812740|P1|STARTED|Washout Period||7
5211018|NCT00995774|12812739|P2|NOT COMPLETED|Training Period 1||0
5211019|NCT00995774|12812740|P1|NOT COMPLETED|Training Period 1||0
5211020|NCT00995774|12812739|P2|COMPLETED|Training Period 1||5
5211021|NCT00995774|12812740|P1|COMPLETED|Training Period 1||7
5211022|NCT00995774|12812739|P2|STARTED|Training Period 1||5
5211023|NCT00995774|12812740|P1|STARTED|Training Period 1||7
5211024|NCT00995761|12812750|P1|NOT COMPLETED|Overall Study||0
5211025|NCT00995761|12812750|P1|COMPLETED|Overall Study||48
5211026|NCT00995761|12812750|P1|STARTED|Overall Study||48
5211027|NCT00995722|12812756|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
5211028|NCT00995722|12812757|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
5211029|NCT00995722|12812756|P2|COMPLETED|Overall Study: 36 Weeks||2
5211030|NCT00995722|12812757|P1|COMPLETED|Overall Study: 36 Weeks||3
5211031|NCT00995722|12812756|P2|STARTED|Overall Study: 36 Weeks||4
5211032|NCT00995722|12812757|P1|STARTED|Overall Study: 36 Weeks||5
5211033|NCT00995722|12812756|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
5211034|NCT00995722|12812757|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
5211035|NCT00995722|12812756|P2|COMPLETED|Double Blinded: 16 Weeks||4
5211036|NCT00995722|12812757|P1|COMPLETED|Double Blinded: 16 Weeks||5
5211037|NCT00995722|12812756|P2|STARTED|Double Blinded: 16 Weeks||5
5211038|NCT00995722|12812757|P1|STARTED|Double Blinded: 16 Weeks||6
5211039|NCT00995709|12812774|P3|NOT COMPLETED|Overall Study||5
5211040|NCT00995709|12812775|P2|NOT COMPLETED|Overall Study||9
5211041|NCT00995709|12812776|P1|NOT COMPLETED|Overall Study||7
5211042|NCT00995709|12812774|P3|COMPLETED|Overall Study||34
5211043|NCT00995709|12812775|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
5211044|NCT00995709|12812776|P1|COMPLETED|Overall Study||32
5211045|NCT00995709|12812774|P3|STARTED|Overall Study||39
5211046|NCT00995709|12812775|P2|STARTED|Overall Study||40
5211047|NCT00995709|12812776|P1|STARTED|Overall Study||39
5211048|NCT00995670|12812802|P3|NOT COMPLETED|Overall Study||3
5211049|NCT00995670|12812803|P2|NOT COMPLETED|Overall Study||0
5211050|NCT00995670|12812804|P1|NOT COMPLETED|Overall Study||1
5211051|NCT00995670|12812802|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
5211052|NCT00995670|12812803|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
5211053|NCT00995670|12812804|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
5211054|NCT00995670|12812802|P3|STARTED|Overall Study||17
5211055|NCT00995670|12812803|P2|STARTED|Overall Study||16
5211056|NCT00995670|12812804|P1|STARTED|Overall Study||26
5211057|NCT00995566|12812812|P1|NOT COMPLETED|Overall Study||54
5211058|NCT00995566|12812812|P1|COMPLETED|Overall Study||0
5211059|NCT00995566|12812812|P1|STARTED|Overall Study||54
5211060|NCT00995553|12812826|P2|NOT COMPLETED|Overall Study||6
5211061|NCT00995553|12812827|P1|NOT COMPLETED|Overall Study||2
5211062|NCT00995553|12812826|P2|COMPLETED|Overall Study||35
5211063|NCT00995553|12812827|P1|COMPLETED|Overall Study||38
5211064|NCT00995553|12812826|P2|STARTED|Overall Study||41
5211065|NCT00995553|12812827|P1|STARTED|Overall Study||40
5211066|NCT00995501|12812843|P8|NOT COMPLETED|Overall Study||0
5211067|NCT00995501|12812844|P7|NOT COMPLETED|Overall Study||0
5211068|NCT00995501|12812845|P6|NOT COMPLETED|Overall Study||0
5211069|NCT00995501|12812846|P5|NOT COMPLETED|Overall Study||0
5211070|NCT00995501|12812847|P4|NOT COMPLETED|Overall Study||0
5211071|NCT00995501|12812848|P3|NOT COMPLETED|Overall Study||0
5211072|NCT00995501|12812849|P2|NOT COMPLETED|Overall Study||0
5211073|NCT00995501|12812850|P1|NOT COMPLETED|Overall Study||0
5211074|NCT00995501|12812843|P8|COMPLETED|Overall Study||46
5211075|NCT00995501|12812844|P7|COMPLETED|Overall Study||49
5211076|NCT00995501|12812845|P6|COMPLETED|Overall Study||44
5211077|NCT00995501|12812846|P5|COMPLETED|Overall Study||46
5211078|NCT00995501|12812847|P4|COMPLETED|Overall Study||46
5211079|NCT00995501|12812848|P3|COMPLETED|Overall Study||47
5211080|NCT00995501|12812849|P2|COMPLETED|Overall Study||51
5211081|NCT00995501|12812850|P1|COMPLETED|Overall Study||52
5211082|NCT00995501|12812843|P8|STARTED|Overall Study||46
5211083|NCT00995501|12812844|P7|STARTED|Overall Study||49
5211084|NCT00995501|12812845|P6|STARTED|Overall Study||44
5211085|NCT00995501|12812846|P5|STARTED|Overall Study||46
5211086|NCT00995501|12812847|P4|STARTED|Overall Study||46
5211087|NCT00995501|12812848|P3|STARTED|Overall Study||47
5211088|NCT00995501|12812849|P2|STARTED|Overall Study||51
5211089|NCT00995501|12812850|P1|STARTED|Overall Study||52
5211090|NCT00995488|12812876|P1|NOT COMPLETED|Overall Study||1
5211091|NCT00995488|12812876|P1|COMPLETED|Overall Study||15
5211092|NCT00995488|12812876|P1|STARTED|Overall Study||16
5211093|NCT00995475|12812881|P2|NOT COMPLETED|Second Intervention||0
5211094|NCT00995475|12812882|P1|NOT COMPLETED|Second Intervention||0
5211095|NCT00995475|12812881|P2|COMPLETED|Second Intervention||9
5211096|NCT00995475|12812882|P1|COMPLETED|Second Intervention||9
5211097|NCT00995475|12812881|P2|STARTED|Second Intervention||9
5211098|NCT00995475|12812882|P1|STARTED|Second Intervention||9
5211099|NCT00995475|12812881|P2|NOT COMPLETED|Wash-out Two Week||0
5211100|NCT00995475|12812882|P1|NOT COMPLETED|Wash-out Two Week||0
5211101|NCT00995475|12812881|P2|COMPLETED|Wash-out Two Week||9
5211102|NCT00995475|12812882|P1|COMPLETED|Wash-out Two Week||9
5211103|NCT00995475|12812881|P2|STARTED|Wash-out Two Week||9
5211104|NCT00995475|12812882|P1|STARTED|Wash-out Two Week||9
5211105|NCT00995475|12812881|P2|NOT COMPLETED|First Intervention||0
5211106|NCT00995475|12812882|P1|NOT COMPLETED|First Intervention||0
5211107|NCT00995475|12812881|P2|COMPLETED|First Intervention||9
5211108|NCT00995475|12812882|P1|COMPLETED|First Intervention||9
5211109|NCT00995475|12812881|P2|STARTED|First Intervention||9
5211110|NCT00995475|12812882|P1|STARTED|First Intervention||9
5211111|NCT00995449|12812896|P4|NOT COMPLETED|Overall Study||0
5211112|NCT00995449|12812897|P3|NOT COMPLETED|Overall Study||2
5211113|NCT00995449|12812898|P2|NOT COMPLETED|Overall Study||0
5211114|NCT00995449|12812899|P1|NOT COMPLETED|Overall Study||0
5211115|NCT00995449|12812896|P4|COMPLETED|Overall Study||2
5211116|NCT00995449|12812897|P3|COMPLETED|Overall Study||5
5211117|NCT00995449|12812898|P2|COMPLETED|Overall Study||0
5211118|NCT00995449|12812899|P1|COMPLETED|Overall Study||0
5211119|NCT00995449|12812896|P4|STARTED|Overall Study||2
5211120|NCT00995449|12812897|P3|STARTED|Overall Study||7
5211121|NCT00995449|12812898|P2|STARTED|Overall Study||0
5211122|NCT00995449|12812899|P1|STARTED|Overall Study||0
5211123|NCT00995436|12812910|P3|NOT COMPLETED|Overall Study||0
5211124|NCT00995436|12812911|P2|NOT COMPLETED|Overall Study||5
5211125|NCT00995436|12812912|P1|NOT COMPLETED|Overall Study||2
5211126|NCT00995436|12812910|P3|COMPLETED|Overall Study||26
5211127|NCT00995436|12812911|P2|COMPLETED|Overall Study||22
5211128|NCT00995436|12812912|P1|COMPLETED|Overall Study||23
5211129|NCT00995436|12812910|P3|STARTED|Overall Study||26
5211130|NCT00995436|12812911|P2|STARTED|Overall Study||27
5211131|NCT00995436|12812912|P1|STARTED|Overall Study|25|25
5211132|NCT00995410|12812920|P1|NOT COMPLETED|Overall Study||88
5211133|NCT00995410|12812920|P1|COMPLETED|Overall Study||292
5211134|NCT00995410|12812920|P1|Treated|Overall Study||379
5211135|NCT00995410|12812920|P1|STARTED|Overall Study||380
5211136|NCT00995371|12812927|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
5211137|NCT00995371|12812928|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
5211138|NCT00995371|12812927|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
5211139|NCT00995371|12812928|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
5211140|NCT00995371|12812927|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
5211141|NCT00995371|12812928|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
5211142|NCT00995371|12812927|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
5211143|NCT00995371|12812928|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
5211144|NCT00995371|12812927|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
5211145|NCT00995371|12812928|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
5211146|NCT00995371|12812927|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
5211147|NCT00995371|12812928|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
5211148|NCT00995345|12812946|P5|NOT COMPLETED|Overall Study||5
5211149|NCT00995345|12812947|P4|NOT COMPLETED|Overall Study||5
5211150|NCT00995345|12812948|P3|NOT COMPLETED|Overall Study||7
5211151|NCT00995345|12812949|P2|NOT COMPLETED|Overall Study||7
5211152|NCT00995345|12812950|P1|NOT COMPLETED|Overall Study||11
5211153|NCT00995345|12812946|P5|COMPLETED|Overall Study||75
5211154|NCT00995345|12812947|P4|COMPLETED|Overall Study||76
5211155|NCT00995345|12812948|P3|COMPLETED|Overall Study||73
5211156|NCT00995345|12812949|P2|COMPLETED|Overall Study||74
5211157|NCT00995345|12812950|P1|COMPLETED|Overall Study||70
5211158|NCT00995345|12812946|P5|STARTED|Overall Study||80
5211159|NCT00995345|12812947|P4|STARTED|Overall Study||81
5211160|NCT00995345|12812948|P3|STARTED|Overall Study||80
5211161|NCT00995345|12812949|P2|STARTED|Overall Study||81
5211162|NCT00995345|12812950|P1|STARTED|Overall Study||81
5211163|NCT00995215|12812977|P1|NOT COMPLETED|Overall Study||0
5211164|NCT00995215|12812977|P1|COMPLETED|Overall Study||6
5211165|NCT00995215|12812977|P1|STARTED|Overall Study||6
5211166|NCT00995085|12812982|P1|NOT COMPLETED|Overall Study||5
5211167|NCT00995085|12812982|P1|COMPLETED|Overall Study||38
5211168|NCT00995085|12812982|P1|STARTED|Overall Study||43
5211169|NCT00995072|12812988|P2|NOT COMPLETED|Overall Study||3
5211170|NCT00995072|12812989|P1|NOT COMPLETED|Overall Study||1
5211171|NCT00995072|12812988|P2|COMPLETED|Overall Study||12
5211172|NCT00995072|12812989|P1|COMPLETED|Overall Study||9
5211173|NCT00995072|12812988|P2|STARTED|Overall Study||15
5211174|NCT00995072|12812989|P1|STARTED|Overall Study||10
5211175|NCT00995020|12812999|P2|NOT COMPLETED|Overall Study||7
5211176|NCT00995020|12813000|P1|NOT COMPLETED|Overall Study||3
5211177|NCT00995020|12812999|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
5211178|NCT00995020|12813000|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
5211179|NCT00995020|12812999|P2|STARTED|Overall Study||52
5211180|NCT00995020|12813000|P1|STARTED|Overall Study||51
5211181|NCT00995007|12813010|P2|NOT COMPLETED|Overall Study||2
5211182|NCT00995007|12813011|P1|NOT COMPLETED|Overall Study||17
5211183|NCT00995007|12813010|P2|COMPLETED|Overall Study||54
5211184|NCT00995007|12813011|P1|COMPLETED|Overall Study||39
5211185|NCT00995007|12813010|P2|Crossover to Vandetanib|Overall Study||0
5211186|NCT00995007|12813011|P1|Crossover to Vandetanib|Overall Study||42
5211187|NCT00995007|12813010|P2|STARTED|Overall Study||56
5211188|NCT00995007|12813011|P1|STARTED|Overall Study||56
5211189|NCT00994929|12813027|P1|NOT COMPLETED|Overall Study||0
5211190|NCT00994929|12813027|P1|COMPLETED|Overall Study||9
5211191|NCT00994929|12813027|P1|STARTED|Overall Study||9
5211192|NCT00994760|12813033|P1|NOT COMPLETED|Overall Study||24
5211193|NCT00994760|12813033|P1|COMPLETED|Overall Study||107
5211194|NCT00994760|12813033|P1|STARTED|Overall Study||131
5211195|NCT00994682|12813074|P2|NOT COMPLETED|Pioglitazone Open Label||7
5211196|NCT00994682|12813075|P1|NOT COMPLETED|Pioglitazone Open Label||13
5211197|NCT00994682|12813074|P2|COMPLETED|Pioglitazone Open Label||34
5211198|NCT00994682|12813075|P1|COMPLETED|Pioglitazone Open Label||29
5211199|NCT00994682|12813074|P2|STARTED|Pioglitazone Open Label||41
5211200|NCT00994682|12813075|P1|STARTED|Pioglitazone Open Label||42
5211201|NCT00994682|12813074|P2|NOT COMPLETED|Double Bilnd||9
5211202|NCT00994682|12813075|P1|NOT COMPLETED|Double Bilnd||9
5211203|NCT00994682|12813074|P2|COMPLETED|Double Bilnd||41
5211204|NCT00994682|12813075|P1|COMPLETED|Double Bilnd||42
5211205|NCT00994682|12813074|P2|STARTED|Double Bilnd||50
5211206|NCT00994682|12813075|P1|STARTED|Double Bilnd||51
5211207|NCT00994643|12813119|P1|NOT COMPLETED|Overall Study||1
5211208|NCT00994643|12813119|P1|COMPLETED|Overall Study||10
5211209|NCT00994643|12813119|P1|STARTED|Overall Study||11
5211210|NCT00994604|12813123|P1|NOT COMPLETED|Overall Study||6
5211211|NCT00994604|12813123|P1|COMPLETED|Overall Study||45
5211212|NCT00994604|12813123|P1|STARTED|Overall Study||51
5211213|NCT00994461|12813133|P3|NOT COMPLETED|Overall Study||0
5211214|NCT00994461|12813134|P2|NOT COMPLETED|Overall Study||1
5211215|NCT00994461|12813135|P1|NOT COMPLETED|Overall Study||2
5211216|NCT00994461|12813133|P3|COMPLETED|Overall Study||37
5211217|NCT00994461|12813134|P2|COMPLETED|Overall Study||75
5211218|NCT00994461|12813135|P1|COMPLETED|Overall Study||74
5211219|NCT00994461|12813133|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
5211220|NCT00994461|12813134|P2|STARTED|Overall Study||76
5211221|NCT00994461|12813135|P1|STARTED|Overall Study||76
5211222|NCT00994448|12813163|P2|NOT COMPLETED|Overall Study||2
5211223|NCT00994448|12813164|P1|NOT COMPLETED|Overall Study||8
5211224|NCT00994448|12813163|P2|COMPLETED|Overall Study||5
5211225|NCT00994448|12813164|P1|COMPLETED|Overall Study||4
5211226|NCT00994448|12813163|P2|STARTED|Overall Study||7
5211227|NCT00994448|12813164|P1|STARTED|Overall Study||12
5211228|NCT00994422|12813172|P2|NOT COMPLETED|Overall Study||1
5211229|NCT00994422|12813173|P1|NOT COMPLETED|Overall Study||7
5211230|NCT00994422|12813172|P2|COMPLETED|Overall Study||54
5211231|NCT00994422|12813173|P1|COMPLETED|Overall Study||185
5211232|NCT00994422|12813172|P2|STARTED|Overall Study||55
5211233|NCT00994422|12813173|P1|STARTED|Overall Study||192
5211234|NCT00994318|12813186|P3|NOT COMPLETED|Overall Study||67
5211235|NCT00994318|12813187|P2|NOT COMPLETED|Overall Study||18
5211236|NCT00994318|12813188|P1|NOT COMPLETED|Overall Study||22
5211237|NCT00994318|12813186|P3|COMPLETED|Overall Study||250
5211238|NCT00994318|12813187|P2|COMPLETED|Overall Study||136
5211239|NCT00994318|12813188|P1|COMPLETED|Overall Study||133
5211240|NCT00994318|12813186|P3|STARTED|Overall Study||317
5211241|NCT00994318|12813187|P2|STARTED|Overall Study||154
5211242|NCT00994318|12813188|P1|STARTED|Overall Study||155
5211243|NCT00994279|12813198|P2|NOT COMPLETED|Overall Study||5
5211244|NCT00994279|12813199|P1|NOT COMPLETED|Overall Study||4
5211245|NCT00994279|12813198|P2|COMPLETED|Overall Study||13
5211246|NCT00994279|12813199|P1|COMPLETED|Overall Study||18
5211247|NCT00994279|12813198|P2|STARTED|Overall Study||18
5211248|NCT00994279|12813199|P1|STARTED|Overall Study||22
5211249|NCT00994240|12813209|P2|NOT COMPLETED|Overall Study||5
5211250|NCT00994240|12813210|P1|NOT COMPLETED|Overall Study||6
5211251|NCT00994240|12813209|P2|COMPLETED|Overall Study||39
5211252|NCT00994240|12813210|P1|COMPLETED|Overall Study||35
5211253|NCT00994240|12813209|P2|STARTED|Overall Study||44
5211254|NCT00994240|12813210|P1|STARTED|Overall Study||41
5211255|NCT00994214|12813220|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
5211256|NCT00994214|12813221|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
5211257|NCT00994214|12813222|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
5211258|NCT00994214|12813223|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
5211259|NCT00994214|12813220|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
5211260|NCT00994214|12813221|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
5211261|NCT00994214|12813222|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
5211262|NCT00994214|12813223|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
5211263|NCT00994214|12813220|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
5211264|NCT00994214|12813221|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
5211265|NCT00994214|12813222|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
5211266|NCT00994214|12813223|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
5211267|NCT00994214|12813220|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
5211268|NCT00994214|12813221|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
5211269|NCT00994214|12813222|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
5211270|NCT00994214|12813223|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
5211271|NCT00994214|12813220|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
5211272|NCT00994214|12813221|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
5211273|NCT00994214|12813222|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
5211274|NCT00994214|12813223|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
5211275|NCT00994214|12813220|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
5211276|NCT00994214|12813221|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
5211277|NCT00994214|12813222|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
5211278|NCT00994214|12813223|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
5211279|NCT00994214|12813220|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
5211280|NCT00994214|12813221|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
5211281|NCT00994214|12813222|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
5211282|NCT00994214|12813223|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
5211283|NCT00994214|12813220|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
5211284|NCT00994214|12813221|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
5211285|NCT00994214|12813222|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
5211286|NCT00994214|12813223|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
5211287|NCT00994214|12813220|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
5211288|NCT00994214|12813221|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
5211289|NCT00994214|12813222|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
5211290|NCT00994214|12813223|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
5211291|NCT00994214|12813220|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
5211292|NCT00994214|12813221|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
5211293|NCT00994214|12813222|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
5211294|NCT00994214|12813223|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
5211295|NCT00994175|12813267|P2|NOT COMPLETED|Second Intervention||0
5211296|NCT00994175|12813268|P1|NOT COMPLETED|Second Intervention||0
5211297|NCT00994175|12813267|P2|COMPLETED|Second Intervention||8
5211298|NCT00994175|12813268|P1|COMPLETED|Second Intervention||4
5211299|NCT00994175|12813267|P2|STARTED|Second Intervention||8
5211300|NCT00994175|12813268|P1|STARTED|Second Intervention||4
5211301|NCT00994175|12813267|P2|NOT COMPLETED|First Intervention||1
5211302|NCT00994175|12813268|P1|NOT COMPLETED|First Intervention||2
5211303|NCT00994175|12813267|P2|COMPLETED|First Intervention||8
5211304|NCT00994175|12813268|P1|COMPLETED|First Intervention||4
5211305|NCT00994175|12813267|P2|STARTED|First Intervention||9
5211306|NCT00994175|12813268|P1|STARTED|First Intervention||6
5211307|NCT00994123|12813279|P3|NOT COMPLETED|Overall Study||0
5211308|NCT00994123|12813280|P2|NOT COMPLETED|Overall Study||0
5211309|NCT00994123|12813281|P1|NOT COMPLETED|Overall Study||0
5211310|NCT00994123|12813279|P3|COMPLETED|Overall Study||44
5211311|NCT00994123|12813280|P2|COMPLETED|Overall Study||85
5211312|NCT00994123|12813281|P1|COMPLETED|Overall Study||33
5211313|NCT00994123|12813279|P3|STARTED|Overall Study||44
5211314|NCT00994123|12813280|P2|STARTED|Overall Study||85
5211315|NCT00994123|12813281|P1|STARTED|Overall Study||33
5211316|NCT00994110|12813302|P2|NOT COMPLETED|Overall Study||74
5211317|NCT00994110|12813303|P1|NOT COMPLETED|Overall Study||65
5211318|NCT00994110|12813302|P2|COMPLETED|Overall Study||148
5211319|NCT00994110|12813303|P1|COMPLETED|Overall Study||152
5211320|NCT00994110|12813302|P2|STARTED|Overall Study||222
5211321|NCT00994110|12813303|P1|STARTED|Overall Study||217
5211322|NCT00993967|12813309|P1|NOT COMPLETED|Overall Study||61
5211323|NCT00993967|12813309|P1|COMPLETED|Overall Study||139
5211324|NCT00993967|12813309|P1|STARTED|Overall Study||200
5211325|NCT00993954|12813316|P2|NOT COMPLETED|Overall Study||2
5211326|NCT00993954|12813317|P1|NOT COMPLETED|Overall Study||21
5211327|NCT00993954|12813316|P2|COMPLETED|Overall Study||121
5211328|NCT00993954|12813317|P1|COMPLETED|Overall Study||124
5211329|NCT00993954|12813316|P2|STARTED|Overall Study||123
5211330|NCT00993954|12813317|P1|STARTED|Overall Study||145
5211331|NCT00993928|12813330|P2|NOT COMPLETED|Overall Study||7
5211332|NCT00993928|12813331|P1|NOT COMPLETED|Overall Study||5
5211333|NCT00993928|12813330|P2|COMPLETED|Overall Study||38
5211334|NCT00993928|12813331|P1|COMPLETED|Overall Study||43
5211335|NCT00993928|12813330|P2|STARTED|Overall Study||45
5211336|NCT00993928|12813331|P1|STARTED|Overall Study||48
5211337|NCT00993915|12813345|P1|NOT COMPLETED|Overall Study||9
5211338|NCT00993915|12813345|P1|COMPLETED|Overall Study||678
5211339|NCT00993915|12813345|P1|STARTED|Overall Study||687
5211340|NCT00993824|12813356|P2|NOT COMPLETED|Overall Study||0
5211341|NCT00993824|12813357|P1|NOT COMPLETED|Overall Study||0
5211342|NCT00993824|12813356|P2|COMPLETED|Overall Study||10
5211343|NCT00993824|12813357|P1|COMPLETED|Overall Study||11
5211344|NCT00993824|12813356|P2|STARTED|Overall Study||10
5211345|NCT00993824|12813357|P1|STARTED|Overall Study||11
5211346|NCT00993668|12813371|P2|NOT COMPLETED|Open-Label Period||15
5211347|NCT00993668|12813372|P1|NOT COMPLETED|Open-Label Period||23
5211348|NCT00993668|12813371|P2|COMPLETED|Open-Label Period||91
5211349|NCT00993668|12813372|P1|COMPLETED|Open-Label Period||86
5211350|NCT00993668|12813371|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
5211351|NCT00993668|12813372|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
5211352|NCT00993668|12813371|P2|NOT COMPLETED|Single-Blind Period||3
5211353|NCT00993668|12813372|P1|NOT COMPLETED|Single-Blind Period||4
5211354|NCT00993668|12813371|P2|COMPLETED|Single-Blind Period||107
5211355|NCT00993668|12813372|P1|COMPLETED|Single-Blind Period||110
5211356|NCT00993668|12813371|P2|STARTED|Single-Blind Period||110
5211357|NCT00993668|12813372|P1|STARTED|Single-Blind Period||114
5211358|NCT00993655|12813400|P3|NOT COMPLETED|Overall Study||0
5211359|NCT00993655|12813401|P2|NOT COMPLETED|Overall Study||0
5211360|NCT00993655|12813402|P1|NOT COMPLETED|Overall Study||0
5211361|NCT00993655|12813400|P3|COMPLETED|Overall Study||102
5211362|NCT00993655|12813401|P2|COMPLETED|Overall Study||72
5211363|NCT00993655|12813402|P1|COMPLETED|Overall Study||101
5211364|NCT00993655|12813400|P3|STARTED|Overall Study||102
5211365|NCT00993655|12813401|P2|STARTED|Overall Study||72
5211366|NCT00993655|12813402|P1|STARTED|Overall Study||101
5211367|NCT00993616|12813416|P1|NOT COMPLETED|Overall Study||2
5211368|NCT00993616|12813416|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
5211369|NCT00993616|12813416|P1|STARTED|Overall Study||29
5211370|NCT00993499|12813434|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
5211371|NCT00993499|12813435|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
5211372|NCT00993499|12813436|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
5211373|NCT00993499|12813437|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
5211374|NCT00993499|12813438|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
5211375|NCT00993499|12813439|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
5211376|NCT00993499|12813434|P6|COMPLETED|Discontinued After Starting Course 3||0
5211377|NCT00993499|12813435|P5|COMPLETED|Discontinued After Starting Course 3||0
5211378|NCT00993499|12813436|P4|COMPLETED|Discontinued After Starting Course 3||1
5211379|NCT00993499|12813437|P3|COMPLETED|Discontinued After Starting Course 3||3
5211380|NCT00993499|12813438|P2|COMPLETED|Discontinued After Starting Course 3||4
5211381|NCT00993499|12813439|P1|COMPLETED|Discontinued After Starting Course 3||4
5211382|NCT00993499|12813434|P6|STARTED|Discontinued After Starting Course 3||3
5211383|NCT00993499|12813435|P5|STARTED|Discontinued After Starting Course 3||3
5211384|NCT00993499|12813436|P4|STARTED|Discontinued After Starting Course 3||3
5211385|NCT00993499|12813437|P3|STARTED|Discontinued After Starting Course 3||9
5211386|NCT00993499|12813438|P2|STARTED|Discontinued After Starting Course 3||9
5211387|NCT00993499|12813439|P1|STARTED|Discontinued After Starting Course 3||12
5211388|NCT00993499|12813434|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
5211389|NCT00993499|12813435|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
5211390|NCT00993499|12813436|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
5211391|NCT00993499|12813437|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
5211392|NCT00993499|12813438|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
5211393|NCT00993499|12813439|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
5211394|NCT00993499|12813434|P6|COMPLETED|Discontinued Before Starting Course 3||3
5211395|NCT00993499|12813435|P5|COMPLETED|Discontinued Before Starting Course 3||3
5211396|NCT00993499|12813436|P4|COMPLETED|Discontinued Before Starting Course 3||2
5211397|NCT00993499|12813437|P3|COMPLETED|Discontinued Before Starting Course 3||6
5211398|NCT00993499|12813438|P2|COMPLETED|Discontinued Before Starting Course 3||5
5211399|NCT00993499|12813439|P1|COMPLETED|Discontinued Before Starting Course 3||8
5211400|NCT00993499|12813434|P6|STARTED|Discontinued Before Starting Course 3||3
5211401|NCT00993499|12813435|P5|STARTED|Discontinued Before Starting Course 3||3
5211402|NCT00993499|12813436|P4|STARTED|Discontinued Before Starting Course 3||3
5211403|NCT00993499|12813437|P3|STARTED|Discontinued Before Starting Course 3||9
5211404|NCT00993499|12813438|P2|STARTED|Discontinued Before Starting Course 3||9
5211405|NCT00993499|12813439|P1|STARTED|Discontinued Before Starting Course 3||12
5211406|NCT00993499|12813434|P6|NOT COMPLETED|Run-in Period (8 Days)||0
5211407|NCT00993499|12813435|P5|NOT COMPLETED|Run-in Period (8 Days)||0
5211408|NCT00993499|12813436|P4|NOT COMPLETED|Run-in Period (8 Days)||0
5211409|NCT00993499|12813437|P3|NOT COMPLETED|Run-in Period (8 Days)||1
5211410|NCT00993499|12813438|P2|NOT COMPLETED|Run-in Period (8 Days)||3
5211411|NCT00993499|12813439|P1|NOT COMPLETED|Run-in Period (8 Days)||1
5211412|NCT00993499|12813434|P6|COMPLETED|Run-in Period (8 Days)||3
5211413|NCT00993499|12813435|P5|COMPLETED|Run-in Period (8 Days)||3
5211414|NCT00993499|12813436|P4|COMPLETED|Run-in Period (8 Days)||3
5211415|NCT00993499|12813437|P3|COMPLETED|Run-in Period (8 Days)||9
5211416|NCT00993499|12813438|P2|COMPLETED|Run-in Period (8 Days)||9
5211417|NCT00993499|12813439|P1|COMPLETED|Run-in Period (8 Days)||12
5211418|NCT00993499|12813434|P6|STARTED|Run-in Period (8 Days)||3
5211419|NCT00993499|12813435|P5|STARTED|Run-in Period (8 Days)||3
5211420|NCT00993499|12813436|P4|STARTED|Run-in Period (8 Days)||3
5211421|NCT00993499|12813437|P3|STARTED|Run-in Period (8 Days)||10
5211422|NCT00993499|12813438|P2|STARTED|Run-in Period (8 Days)||12
5211423|NCT00993499|12813439|P1|STARTED|Run-in Period (8 Days)||13
5211424|NCT00993473|12813521|P2|NOT COMPLETED|Overall Study||10
5211425|NCT00993473|12813522|P1|NOT COMPLETED|Overall Study||4
5211426|NCT00993473|12813521|P2|COMPLETED|Overall Study||54
5211427|NCT00993473|12813522|P1|COMPLETED|Overall Study||57
5211428|NCT00993473|12813521|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
5211429|NCT00993473|12813522|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
5211430|NCT00993447|12813560|P2|NOT COMPLETED|Overall Study||19
5211431|NCT00993447|12813561|P1|NOT COMPLETED|Overall Study||37
5211432|NCT00993447|12813560|P2|COMPLETED|Overall Study||180
5211433|NCT00993447|12813561|P1|COMPLETED|Overall Study||364
5211434|NCT00993447|12813560|P2|STARTED|Overall Study||199
5211435|NCT00993447|12813561|P1|STARTED|Overall Study||401
5211436|NCT00993421|12813598|P7|NOT COMPLETED|Overall Study||42
5211437|NCT00993421|12813599|P6|NOT COMPLETED|Overall Study||46
5211438|NCT00993421|12813600|P5|NOT COMPLETED|Overall Study||46
5211439|NCT00993421|12813601|P4|NOT COMPLETED|Overall Study||45
5211440|NCT00993421|12813602|P3|NOT COMPLETED|Overall Study||43
5211441|NCT00993421|12813603|P2|NOT COMPLETED|Overall Study||45
5211442|NCT00993421|12813604|P1|NOT COMPLETED|Overall Study||44
5211443|NCT00993421|12813598|P7|COMPLETED|Overall Study||4
5211444|NCT00993421|12813599|P6|COMPLETED|Overall Study||4
5211445|NCT00993421|12813600|P5|COMPLETED|Overall Study||6
5211446|NCT00993421|12813601|P4|COMPLETED|Overall Study||4
5211447|NCT00993421|12813602|P3|COMPLETED|Overall Study||5
5211448|NCT00993421|12813603|P2|COMPLETED|Overall Study||4
5211449|NCT00993421|12813604|P1|COMPLETED|Overall Study||5
5211450|NCT00993421|12813598|P7|STARTED|Overall Study||46
5211451|NCT00993421|12813599|P6|STARTED|Overall Study||50
5211452|NCT00993421|12813600|P5|STARTED|Overall Study||52
5211453|NCT00993421|12813601|P4|STARTED|Overall Study||49
5211454|NCT00993421|12813602|P3|STARTED|Overall Study||48
5211455|NCT00993421|12813603|P2|STARTED|Overall Study||49
5211456|NCT00993421|12813604|P1|STARTED|Overall Study||49
5211457|NCT00993317|12813755|P2|NOT COMPLETED|Overall Study||25
5211458|NCT00993317|12813756|P1|NOT COMPLETED|Overall Study||21
5211459|NCT00993317|12813755|P2|COMPLETED|Overall Study||60
5211460|NCT00993317|12813756|P1|COMPLETED|Overall Study||21
5211461|NCT00993317|12813755|P2|STARTED|Overall Study||85
5211462|NCT00993317|12813756|P1|STARTED|Overall Study||42
5211463|NCT00993291|12813774|P1|NOT COMPLETED|Overall Study||1
5211464|NCT00993291|12813774|P1|COMPLETED|Overall Study||19
5211465|NCT00993291|12813774|P1|STARTED|Overall Study||20
5211466|NCT00993265|12813780|P2|NOT COMPLETED|Overall Study||0
5211467|NCT00993265|12813781|P1|NOT COMPLETED|Overall Study||4
5211468|NCT00993265|12813780|P2|COMPLETED|Overall Study||19
5211469|NCT00993265|12813781|P1|COMPLETED|Overall Study||16
5211470|NCT00993265|12813780|P2|STARTED|Overall Study||19
5211471|NCT00993265|12813781|P1|STARTED|Overall Study||20
5211472|NCT00993200|12813801|P2|NOT COMPLETED|Overall Study||0
5211473|NCT00993200|12813802|P1|NOT COMPLETED|Overall Study||0
5211474|NCT00993200|12813801|P2|COMPLETED|Overall Study||13
5211475|NCT00993200|12813802|P1|COMPLETED|Overall Study||13
5211476|NCT00993200|12813801|P2|STARTED|Overall Study||13
5211477|NCT00993200|12813802|P1|STARTED|Overall Study||13
5211478|NCT00993187|12813814|P2|NOT COMPLETED|Overall Study||37
5211479|NCT00993187|12813815|P1|NOT COMPLETED|Overall Study||26
5211480|NCT00993187|12813814|P2|COMPLETED|Overall Study||108
5211481|NCT00993187|12813815|P1|COMPLETED|Overall Study||121
5211482|NCT00993187|12813814|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
5211483|NCT00993187|12813815|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
5211484|NCT00993187|12813814|P2|STARTED|Overall Study||145
5211485|NCT00993187|12813815|P1|STARTED|Overall Study||147
5211486|NCT00993148|12813833|P1|NOT COMPLETED|Overall Study||3
5211487|NCT00993148|12813833|P1|COMPLETED|Overall Study||22
5211488|NCT00993148|12813833|P1|STARTED|Overall Study||25
5211489|NCT00993044|12813845|P1|NOT COMPLETED|Irinotecan 50 mg||1
5211490|NCT00993044|12813845|P1|COMPLETED|Irinotecan 50 mg||6
5211491|NCT00993044|12813845|P1|STARTED|Irinotecan 50 mg||7
5211492|NCT00993044|12813845|P1|NOT COMPLETED|Irinotecan 30 mg||0
5211493|NCT00993044|12813845|P1|COMPLETED|Irinotecan 30 mg||6
5211494|NCT00993044|12813845|P1|STARTED|Irinotecan 30 mg||6
5211495|NCT00993031|12813852|P2|NOT COMPLETED|Overall Study||19
5211496|NCT00993031|12813853|P1|NOT COMPLETED|Overall Study||22
5211497|NCT00993031|12813852|P2|COMPLETED|Overall Study||175
5211498|NCT00993031|12813853|P1|COMPLETED|Overall Study||173
5211499|NCT00993031|12813852|P2|Delivered|Overall Study||190
5211500|NCT00993031|12813853|P1|Delivered|Overall Study||187
5211501|NCT00993031|12813852|P2|STARTED|Overall Study||194
5211502|NCT00993031|12813853|P1|STARTED|Overall Study||195
5211503|NCT00992992|12813885|P1|NOT COMPLETED|Overall Study||25
5211504|NCT00992992|12813885|P1|COMPLETED|Overall Study||0
5211505|NCT00992992|12813885|P1|STARTED|Overall Study||25
5211506|NCT00992927|12813907|P2|NOT COMPLETED|Overall Study||0
5211507|NCT00992927|12813908|P1|NOT COMPLETED|Overall Study||0
5211508|NCT00992927|12813907|P2|COMPLETED|Overall Study||22
5211509|NCT00992927|12813908|P1|COMPLETED|Overall Study||32
5211510|NCT00992927|12813907|P2|STARTED|Overall Study||22
5211511|NCT00992927|12813908|P1|STARTED|Overall Study||32
5211512|NCT00992836|12813916|P1|NOT COMPLETED|Overall Study||5
5211513|NCT00992836|12813916|P1|COMPLETED|Overall Study||150
5211514|NCT00992836|12813916|P1|Received Both Study Vaccinations|Overall Study||150
5211515|NCT00992836|12813916|P1|STARTED|Overall Study||155
5211516|NCT00992784|12813931|P3|NOT COMPLETED|Overall Study||1
5211517|NCT00992784|12813932|P2|NOT COMPLETED|Overall Study||2
5211518|NCT00992784|12813933|P1|NOT COMPLETED|Overall Study||3
5211519|NCT00992784|12813931|P3|COMPLETED|Overall Study||85
5211520|NCT00992784|12813932|P2|COMPLETED|Overall Study||102
5211521|NCT00992784|12813933|P1|COMPLETED|Overall Study||177
5211522|NCT00992784|12813931|P3|STARTED|Overall Study||86
5211523|NCT00992784|12813932|P2|STARTED|Overall Study||104
5211524|NCT00992784|12813933|P1|STARTED|Overall Study||180
5211525|NCT00992719|12814004|P3|NOT COMPLETED|Overall Study||0
5211526|NCT00992719|12814005|P2|NOT COMPLETED|Overall Study||1
5211527|NCT00992719|12814006|P1|NOT COMPLETED|Overall Study||1
5211528|NCT00992719|12814004|P3|COMPLETED|Overall Study||28
5211529|NCT00992719|12814005|P2|COMPLETED|Overall Study||27
5211530|NCT00992719|12814006|P1|COMPLETED|Overall Study||27
5211531|NCT00992719|12814004|P3|STARTED|Overall Study||28
5211532|NCT00992719|12814005|P2|STARTED|Overall Study||28
5211533|NCT00992719|12814006|P1|STARTED|Overall Study||28
5211534|NCT00992602|12814040|P1|NOT COMPLETED|Overall Study||3
5211535|NCT00992602|12814040|P1|COMPLETED|Overall Study||0
5211536|NCT00992602|12814040|P1|STARTED|Overall Study||3
5211537|NCT00992589|12814045|P4|NOT COMPLETED|Double-Blind Phase||10
5211538|NCT00992589|12814046|P3|NOT COMPLETED|Double-Blind Phase||13
5211539|NCT00992589|12814047|P2|NOT COMPLETED|Double-Blind Phase||13
5211540|NCT00992589|12814048|P1|NOT COMPLETED|Double-Blind Phase||0
5211541|NCT00992589|12814045|P4|COMPLETED|Double-Blind Phase||78
5211542|NCT00992589|12814046|P3|COMPLETED|Double-Blind Phase||77
5211543|NCT00992589|12814047|P2|COMPLETED|Double-Blind Phase||76
5211544|NCT00992589|12814048|P1|COMPLETED|Double-Blind Phase||0
5211545|NCT00992589|12814045|P4|STARTED|Double-Blind Phase||88
5211546|NCT00992589|12814046|P3|STARTED|Double-Blind Phase||90
5211547|NCT00992589|12814047|P2|STARTED|Double-Blind Phase||89
5211548|NCT00992589|12814048|P1|STARTED|Double-Blind Phase||0
5211549|NCT00992589|12814045|P4|NOT COMPLETED|Open-Label Phase||0
5211550|NCT00992589|12814046|P3|NOT COMPLETED|Open-Label Phase||0
5211551|NCT00992589|12814047|P2|NOT COMPLETED|Open-Label Phase||0
5211552|NCT00992589|12814048|P1|NOT COMPLETED|Open-Label Phase||77
5211553|NCT00992589|12814045|P4|COMPLETED|Open-Label Phase||0
5211554|NCT00992589|12814046|P3|COMPLETED|Open-Label Phase||0
5211555|NCT00992589|12814047|P2|COMPLETED|Open-Label Phase||0
5211556|NCT00992589|12814048|P1|COMPLETED|Open-Label Phase||267
5211557|NCT00992589|12814045|P4|STARTED|Open-Label Phase||0
5211558|NCT00992589|12814046|P3|STARTED|Open-Label Phase||0
5211559|NCT00992589|12814047|P2|STARTED|Open-Label Phase||0
5211560|NCT00992589|12814048|P1|STARTED|Open-Label Phase||344
5211561|NCT00992511|12814094|P4|NOT COMPLETED|Overall Study||5
5211562|NCT00992511|12814095|P3|NOT COMPLETED|Overall Study||2
5211563|NCT00992511|12814096|P2|NOT COMPLETED|Overall Study||0
5211564|NCT00992511|12814097|P1|NOT COMPLETED|Overall Study||2
5211565|NCT00992511|12814094|P4|COMPLETED|Overall Study||70
5211566|NCT00992511|12814095|P3|COMPLETED|Overall Study||74
5211567|NCT00992511|12814096|P2|COMPLETED|Overall Study||73
5211568|NCT00992511|12814097|P1|COMPLETED|Overall Study||74
5211569|NCT00992511|12814094|P4|STARTED|Overall Study||75
5211570|NCT00992511|12814095|P3|STARTED|Overall Study||76
5211571|NCT00992511|12814096|P2|STARTED|Overall Study||73
5211572|NCT00992511|12814097|P1|STARTED|Overall Study||76
5211573|NCT00992459|12814181|P2|NOT COMPLETED|Overall Study||1
5211574|NCT00992459|12814182|P1|NOT COMPLETED|Overall Study||1
5211575|NCT00992459|12814181|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
5211576|NCT00992459|12814182|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
5211577|NCT00992459|12814181|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
5211578|NCT00992459|12814182|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
5211579|NCT00992446|12814206|P1|NOT COMPLETED|Overall Study||8
5211580|NCT00992446|12814206|P1|COMPLETED|Overall Study||19
5211581|NCT00992446|12814206|P1|STARTED|Overall Study||27
5211582|NCT00992433|12814216|P2|NOT COMPLETED|Overall Study||7
5211583|NCT00992433|12814217|P1|NOT COMPLETED|Overall Study||4
5211584|NCT00992433|12814216|P2|COMPLETED|Overall Study||90
5211585|NCT00992433|12814217|P1|COMPLETED|Overall Study||91
5211586|NCT00992433|12814216|P2|STARTED|Overall Study||97
5211587|NCT00992433|12814217|P1|STARTED|Overall Study||95
5211588|NCT00992407|12814281|P2|NOT COMPLETED|Overall Study||24
5211589|NCT00992407|12814282|P1|NOT COMPLETED|Overall Study||31
5211590|NCT00992407|12814281|P2|COMPLETED|Overall Study||14
5211591|NCT00992407|12814282|P1|COMPLETED|Overall Study||6
5211592|NCT00992407|12814281|P2|Treated|Overall Study||25
5211593|NCT00992407|12814282|P1|Treated|Overall Study||20
5211594|NCT00992407|12814281|P2|STARTED|Overall Study||38
5211595|NCT00992407|12814282|P1|STARTED|Overall Study||37
5211596|NCT00992394|12814332|P2|NOT COMPLETED|Overall Study||14
5211597|NCT00992394|12814333|P1|NOT COMPLETED|Overall Study||24
5211598|NCT00992394|12814332|P2|COMPLETED|Overall Study||72
5211599|NCT00992394|12814333|P1|COMPLETED|Overall Study||64
5211600|NCT00992394|12814332|P2|mITT Population|Overall Study||84
5211601|NCT00992394|12814333|P1|mITT Population|Overall Study||86
5211602|NCT00992394|12814332|P2|Safety Population|Overall Study||84
5211603|NCT00992394|12814333|P1|Safety Population|Overall Study||87
5211604|NCT00992394|12814332|P2|STARTED|Overall Study||86
5211605|NCT00992394|12814333|P1|STARTED|Overall Study||88
5211606|NCT00992264|12814391|P16|NOT COMPLETED|Overall Study||0
5211607|NCT00992264|12814392|P15|NOT COMPLETED|Overall Study||0
5211608|NCT00992264|12814393|P14|NOT COMPLETED|Overall Study||0
5211609|NCT00992264|12814394|P13|NOT COMPLETED|Overall Study||0
5211610|NCT00992264|12814395|P12|NOT COMPLETED|Overall Study||0
5211611|NCT00992264|12814396|P11|NOT COMPLETED|Overall Study||0
5211612|NCT00992264|12814397|P10|NOT COMPLETED|Overall Study||0
5211613|NCT00992264|12814398|P9|NOT COMPLETED|Overall Study||0
5211614|NCT00992264|12814399|P8|NOT COMPLETED|Overall Study||0
5211615|NCT00992264|12814400|P7|NOT COMPLETED|Overall Study||0
5211616|NCT00992264|12814401|P6|NOT COMPLETED|Overall Study||0
5211617|NCT00992264|12814402|P5|NOT COMPLETED|Overall Study||0
5211618|NCT00992264|12814403|P4|NOT COMPLETED|Overall Study||0
5211619|NCT00992264|12814404|P3|NOT COMPLETED|Overall Study||0
5211620|NCT00992264|12814405|P2|NOT COMPLETED|Overall Study||0
5211621|NCT00992264|12814406|P1|NOT COMPLETED|Overall Study||0
5211622|NCT00992264|12814391|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211623|NCT00992264|12814392|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211624|NCT00992264|12814393|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211625|NCT00992264|12814394|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211626|NCT00992264|12814395|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211627|NCT00992264|12814396|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211628|NCT00992264|12814397|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211629|NCT00992264|12814398|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211630|NCT00992264|12814399|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211631|NCT00992264|12814400|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211632|NCT00992264|12814401|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211633|NCT00992264|12814402|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211634|NCT00992264|12814403|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211635|NCT00992264|12814404|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
5211636|NCT00992264|12814405|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211637|NCT00992264|12814406|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
5211638|NCT00992264|12814391|P16|STARTED|Overall Study||116
5211639|NCT00992264|12814392|P15|STARTED|Overall Study||117
5211640|NCT00992264|12814393|P14|STARTED|Overall Study||117
5211641|NCT00992264|12814394|P13|STARTED|Overall Study||116
5211642|NCT00992264|12814395|P12|STARTED|Overall Study||117
5211643|NCT00992264|12814396|P11|STARTED|Overall Study||117
5211644|NCT00992264|12814397|P10|STARTED|Overall Study||116
5211645|NCT00992264|12814398|P9|STARTED|Overall Study||116
5211646|NCT00992264|12814399|P8|STARTED|Overall Study||117
5211647|NCT00992264|12814400|P7|STARTED|Overall Study||116
5211648|NCT00992264|12814401|P6|STARTED|Overall Study||117
5211649|NCT00992264|12814402|P5|STARTED|Overall Study||117
5211650|NCT00992264|12814403|P4|STARTED|Overall Study||117
5211651|NCT00992264|12814404|P3|STARTED|Overall Study||117
5211652|NCT00992264|12814405|P2|STARTED|Overall Study||116
5211653|NCT00992264|12814406|P1|STARTED|Overall Study||116
5211654|NCT00992225|12814420|P1|NOT COMPLETED|Overall Study||10
5211655|NCT00992225|12814420|P1|COMPLETED|Overall Study||33
5211656|NCT00992225|12814420|P1|Received at Least One Dose of Study Drug|Overall Study||33
5211657|NCT00992225|12814420|P1|STARTED|Overall Study||43
5211658|NCT00992186|12814430|P1|NOT COMPLETED|Overall Study||46
5211659|NCT00992186|12814430|P1|COMPLETED|Overall Study||0
5211660|NCT00992186|12814430|P1|STARTED|Overall Study||46
5211661|NCT00992108|12814449|P2|NOT COMPLETED|Overall Study||1
5211662|NCT00992108|12814450|P1|NOT COMPLETED|Overall Study||0
5211663|NCT00992108|12814449|P2|COMPLETED|Overall Study||9
5211664|NCT00992108|12814450|P1|COMPLETED|Overall Study||7
5211665|NCT00992108|12814449|P2|STARTED|Overall Study||10
5211666|NCT00992108|12814450|P1|STARTED|Overall Study||7
5211667|NCT00992056|12814464|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
5211668|NCT00992056|12814465|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
5211669|NCT00992056|12814464|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
5211670|NCT00992056|12814465|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
5211671|NCT00992056|12814464|P2|STARTED|Treatment Period 2 (6 Weeks)||10
5211672|NCT00992056|12814465|P1|STARTED|Treatment Period 2 (6 Weeks)||10
5211673|NCT00992056|12814464|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
5211674|NCT00992056|12814465|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
5211675|NCT00992056|12814464|P2|COMPLETED|Washout Period (2 Weeks)||10
5211676|NCT00992056|12814465|P1|COMPLETED|Washout Period (2 Weeks)||10
5211677|NCT00992056|12814464|P2|STARTED|Washout Period (2 Weeks)||10
5211678|NCT00992056|12814465|P1|STARTED|Washout Period (2 Weeks)||11
5211679|NCT00992056|12814464|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
5211680|NCT00992056|12814465|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
5211681|NCT00992056|12814464|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
5211682|NCT00992056|12814465|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
5211683|NCT00992056|12814464|P2|STARTED|Treatment Period 1 (6 Weeks)||12
5211684|NCT00992056|12814465|P1|STARTED|Treatment Period 1 (6 Weeks)||12
5211685|NCT00992017|12814471|P1|NOT COMPLETED|Overall Study||10
5211686|NCT00992017|12814471|P1|COMPLETED|Overall Study||118
5211687|NCT00992017|12814471|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
5211688|NCT00992017|12814471|P1|Received Both Study Vaccinations|Overall Study||124
5211689|NCT00992017|12814471|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
5211690|NCT00991952|12814486|P2|NOT COMPLETED|Overall Study||1
5211691|NCT00991952|12814487|P1|NOT COMPLETED|Overall Study||0
5211692|NCT00991952|12814486|P2|COMPLETED|Overall Study||5
5211693|NCT00991952|12814487|P1|COMPLETED|Overall Study||13
5211694|NCT00991952|12814486|P2|STARTED|Overall Study||6
5211695|NCT00991952|12814487|P1|STARTED|Overall Study||13
5211696|NCT00991939|12814495|P2|NOT COMPLETED|Overall Study||2
5211697|NCT00991939|12814496|P1|NOT COMPLETED|Overall Study||5
5211698|NCT00991939|12814495|P2|COMPLETED|Overall Study||1
5211699|NCT00991939|12814496|P1|COMPLETED|Overall Study||0
5211700|NCT00991939|12814495|P2|STARTED|Overall Study||3
5211701|NCT00991939|12814496|P1|STARTED|Overall Study||5
5211702|NCT00991887|12814530|P2|NOT COMPLETED|Overall Study||1
5211703|NCT00991887|12814531|P1|NOT COMPLETED|Overall Study||2
5211704|NCT00991887|12814530|P2|COMPLETED|Overall Study||21
5211705|NCT00991887|12814531|P1|COMPLETED|Overall Study||24
5211706|NCT00991887|12814530|P2|STARTED|Overall Study||22
5211707|NCT00991887|12814531|P1|STARTED|Overall Study||26
5211708|NCT00991809|12814539|P2|NOT COMPLETED|Overall Study||6
5211709|NCT00991809|12814540|P1|NOT COMPLETED|Overall Study||4
5211710|NCT00991809|12814539|P2|COMPLETED|Overall Study||4
5211711|NCT00991809|12814540|P1|COMPLETED|Overall Study||8
5211712|NCT00991809|12814539|P2|STARTED|Overall Study||10
5211713|NCT00991809|12814540|P1|STARTED|Overall Study||12
5211714|NCT00991510|12814550|P2|NOT COMPLETED|Period III (Days 29-112)||1
5211715|NCT00991510|12814551|P1|NOT COMPLETED|Period III (Days 29-112)||1
5211716|NCT00991510|12814550|P2|COMPLETED|Period III (Days 29-112)||20
5211717|NCT00991510|12814551|P1|COMPLETED|Period III (Days 29-112)||20
5211718|NCT00991510|12814550|P2|STARTED|Period III (Days 29-112)||21
5211719|NCT00991510|12814551|P1|STARTED|Period III (Days 29-112)||21
5211720|NCT00991510|12814550|P2|NOT COMPLETED|Period II (Days 15-28)||0
5211721|NCT00991510|12814551|P1|NOT COMPLETED|Period II (Days 15-28)||0
5211722|NCT00991510|12814550|P2|COMPLETED|Period II (Days 15-28)||21
5211723|NCT00991510|12814551|P1|COMPLETED|Period II (Days 15-28)||21
5211724|NCT00991510|12814550|P2|STARTED|Period II (Days 15-28)||21
5211725|NCT00991510|12814551|P1|STARTED|Period II (Days 15-28)||21
5211726|NCT00991510|12814550|P2|NOT COMPLETED|Period I (Days 1-14)||0
5211727|NCT00991510|12814551|P1|NOT COMPLETED|Period I (Days 1-14)||1
5211728|NCT00991510|12814550|P2|COMPLETED|Period I (Days 1-14)||21
5211729|NCT00991510|12814551|P1|COMPLETED|Period I (Days 1-14)||21
5211730|NCT00991510|12814550|P2|STARTED|Period I (Days 1-14)||21
5211731|NCT00991510|12814551|P1|STARTED|Period I (Days 1-14)||22
5211732|NCT00991458|12814576|P3|NOT COMPLETED|Overall Study||25
5211733|NCT00991458|12814577|P2|NOT COMPLETED|Overall Study||28
5211734|NCT00991458|12814578|P1|NOT COMPLETED|Overall Study||20
5211735|NCT00991458|12814576|P3|COMPLETED|Overall Study||180
5211736|NCT00991458|12814577|P2|COMPLETED|Overall Study||181
5211737|NCT00991458|12814578|P1|COMPLETED|Overall Study||187
5211738|NCT00991458|12814576|P3|STARTED|Overall Study||205
5211739|NCT00991458|12814577|P2|STARTED|Overall Study||209
5211740|NCT00991458|12814578|P1|STARTED|Overall Study||207
5211741|NCT00991406|12814595|P1|NOT COMPLETED|Overall Study||1
5211742|NCT00991406|12814595|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
5211743|NCT00991406|12814595|P1|STARTED|Overall Study||9
5211744|NCT00991341|12814604|P2|NOT COMPLETED|Overall Study||179
5211745|NCT00991341|12814605|P1|NOT COMPLETED|Overall Study||204
5211746|NCT00991341|12814604|P2|COMPLETED|Overall Study||560
5211747|NCT00991341|12814605|P1|COMPLETED|Overall Study||538
5211748|NCT00991341|12814604|P2|STARTED|Overall Study||739
5211749|NCT00991341|12814605|P1|STARTED|Overall Study||742
5211750|NCT00991302|12814643|P2|NOT COMPLETED|Overall Study||13
5211751|NCT00991302|12814644|P1|NOT COMPLETED|Overall Study||14
5211752|NCT00991302|12814643|P2|COMPLETED|Overall Study||73
5211753|NCT00991302|12814644|P1|COMPLETED|Overall Study||72
5211754|NCT00991302|12814643|P2|STARTED|Overall Study||86
5211755|NCT00991302|12814644|P1|STARTED|Overall Study||86
5211756|NCT00991289|12814660|P1|NOT COMPLETED|Overall Study||12
5211757|NCT00991289|12814660|P1|COMPLETED|Overall Study|Completed study.|55
5211758|NCT00991289|12814660|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
5211759|NCT00991289|12814660|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
5211760|NCT00991276|12814680|P6|NOT COMPLETED|Third Intervention Period||1
5211761|NCT00991276|12814681|P5|NOT COMPLETED|Third Intervention Period||0
5211762|NCT00991276|12814682|P4|NOT COMPLETED|Third Intervention Period||1
5211763|NCT00991276|12814683|P3|NOT COMPLETED|Third Intervention Period||1
5211764|NCT00991276|12814684|P2|NOT COMPLETED|Third Intervention Period||0
5211765|NCT00991276|12814685|P1|NOT COMPLETED|Third Intervention Period||1
5211766|NCT00991276|12814680|P6|COMPLETED|Third Intervention Period||10
5211767|NCT00991276|12814681|P5|COMPLETED|Third Intervention Period||10
5211768|NCT00991276|12814682|P4|COMPLETED|Third Intervention Period||8
5211769|NCT00991276|12814683|P3|COMPLETED|Third Intervention Period||13
5211770|NCT00991276|12814684|P2|COMPLETED|Third Intervention Period||8
5211771|NCT00991276|12814685|P1|COMPLETED|Third Intervention Period||13
5211772|NCT00991276|12814680|P6|STARTED|Third Intervention Period||11
5211773|NCT00991276|12814681|P5|STARTED|Third Intervention Period||10
5211774|NCT00991276|12814682|P4|STARTED|Third Intervention Period||9
5211775|NCT00991276|12814683|P3|STARTED|Third Intervention Period||14
5211776|NCT00991276|12814684|P2|STARTED|Third Intervention Period||8
5211777|NCT00991276|12814685|P1|STARTED|Third Intervention Period||14
5211778|NCT00991276|12814680|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211779|NCT00991276|12814681|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211780|NCT00991276|12814682|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211781|NCT00991276|12814683|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211782|NCT00991276|12814684|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211783|NCT00991276|12814685|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211784|NCT00991276|12814680|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
5211785|NCT00991276|12814681|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
5211786|NCT00991276|12814682|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
5211787|NCT00991276|12814683|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
5211788|NCT00991276|12814684|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
5211789|NCT00991276|12814685|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
5211790|NCT00991276|12814680|P6|STARTED|Placebo Wash-out Period (7 Days)||11
5211791|NCT00991276|12814681|P5|STARTED|Placebo Wash-out Period (7 Days)||10
5211792|NCT00991276|12814682|P4|STARTED|Placebo Wash-out Period (7 Days)||9
5211793|NCT00991276|12814683|P3|STARTED|Placebo Wash-out Period (7 Days)||14
5211794|NCT00991276|12814684|P2|STARTED|Placebo Wash-out Period (7 Days)||8
5211795|NCT00991276|12814685|P1|STARTED|Placebo Wash-out Period (7 Days)||14
5211796|NCT00991276|12814680|P6|NOT COMPLETED|Second Intervention Period||1
5211797|NCT00991276|12814681|P5|NOT COMPLETED|Second Intervention Period||1
5211798|NCT00991276|12814682|P4|NOT COMPLETED|Second Intervention Period||2
5211799|NCT00991276|12814683|P3|NOT COMPLETED|Second Intervention Period||0
5211800|NCT00991276|12814684|P2|NOT COMPLETED|Second Intervention Period||2
5211801|NCT00991276|12814685|P1|NOT COMPLETED|Second Intervention Period||1
5211802|NCT00991276|12814680|P6|COMPLETED|Second Intervention Period||11
5211803|NCT00991276|12814681|P5|COMPLETED|Second Intervention Period||10
5211804|NCT00991276|12814682|P4|COMPLETED|Second Intervention Period||9
5211805|NCT00991276|12814683|P3|COMPLETED|Second Intervention Period||14
5211806|NCT00991276|12814684|P2|COMPLETED|Second Intervention Period||8
5211807|NCT00991276|12814685|P1|COMPLETED|Second Intervention Period||14
5211808|NCT00991276|12814680|P6|STARTED|Second Intervention Period||12
5211809|NCT00991276|12814681|P5|STARTED|Second Intervention Period||11
5211810|NCT00991276|12814682|P4|STARTED|Second Intervention Period||11
5211811|NCT00991276|12814683|P3|STARTED|Second Intervention Period||14
5211812|NCT00991276|12814684|P2|STARTED|Second Intervention Period||10
5211813|NCT00991276|12814685|P1|STARTED|Second Intervention Period||15
5211814|NCT00991276|12814680|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211815|NCT00991276|12814681|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211816|NCT00991276|12814682|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211817|NCT00991276|12814683|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211818|NCT00991276|12814684|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211819|NCT00991276|12814685|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
5211820|NCT00991276|12814680|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
5211821|NCT00991276|12814681|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
5211822|NCT00991276|12814682|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
5211823|NCT00991276|12814683|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
5211824|NCT00991276|12814684|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
5211825|NCT00991276|12814685|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
5211826|NCT00991276|12814680|P6|STARTED|Placebo Wash-out Period (7 Days)||12
5211827|NCT00991276|12814681|P5|STARTED|Placebo Wash-out Period (7 Days)||11
5211828|NCT00991276|12814682|P4|STARTED|Placebo Wash-out Period (7 Days)||11
5211829|NCT00991276|12814683|P3|STARTED|Placebo Wash-out Period (7 Days)||14
5211830|NCT00991276|12814684|P2|STARTED|Placebo Wash-out Period (7 Days)||10
5211831|NCT00991276|12814685|P1|STARTED|Placebo Wash-out Period (7 Days)||15
5211832|NCT00991276|12814680|P6|NOT COMPLETED|First Intervention Period||1
5211833|NCT00991276|12814681|P5|NOT COMPLETED|First Intervention Period||4
5211834|NCT00991276|12814682|P4|NOT COMPLETED|First Intervention Period||4
5211835|NCT00991276|12814683|P3|NOT COMPLETED|First Intervention Period||0
5211836|NCT00991276|12814684|P2|NOT COMPLETED|First Intervention Period||3
5211837|NCT00991276|12814685|P1|NOT COMPLETED|First Intervention Period||0
5211838|NCT00991276|12814680|P6|COMPLETED|First Intervention Period||12
5211839|NCT00991276|12814681|P5|COMPLETED|First Intervention Period||11
5211840|NCT00991276|12814682|P4|COMPLETED|First Intervention Period||11
5211841|NCT00991276|12814683|P3|COMPLETED|First Intervention Period||14
5211842|NCT00991276|12814684|P2|COMPLETED|First Intervention Period||10
5211843|NCT00991276|12814685|P1|COMPLETED|First Intervention Period||15
5211844|NCT00991276|12814680|P6|STARTED|First Intervention Period||13
5211845|NCT00991276|12814681|P5|STARTED|First Intervention Period||15
5211846|NCT00991276|12814682|P4|STARTED|First Intervention Period||15
5211847|NCT00991276|12814683|P3|STARTED|First Intervention Period||14
5211848|NCT00991276|12814684|P2|STARTED|First Intervention Period||13
5211849|NCT00991276|12814685|P1|STARTED|First Intervention Period||15
5211850|NCT00991185|12814783|P1|NOT COMPLETED|Overall Study||0
5211851|NCT00991185|12814783|P1|COMPLETED|Overall Study||8
5211852|NCT00991185|12814783|P1|STARTED|Overall Study||8
5211853|NCT00991081|12814789|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
5211854|NCT00991081|12814790|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
5211855|NCT00991081|12814791|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
5211856|NCT00991081|12814789|P3|COMPLETED|Phase II, Randomized Control Trial||15
5211857|NCT00991081|12814790|P2|COMPLETED|Phase II, Randomized Control Trial||15
5211858|NCT00991081|12814791|P1|COMPLETED|Phase II, Randomized Control Trial||0
5211859|NCT00991081|12814789|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
5211860|NCT00991081|12814790|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
5211861|NCT00991081|12814791|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
5211862|NCT00991081|12814789|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
5211863|NCT00991081|12814790|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
5211864|NCT00991081|12814791|P1|STARTED|Phase II, Randomized Control Trial||0
5211865|NCT00991081|12814789|P3|NOT COMPLETED|Phase I, Formative Research||0
5211866|NCT00991081|12814790|P2|NOT COMPLETED|Phase I, Formative Research||0
5211867|NCT00991081|12814791|P1|NOT COMPLETED|Phase I, Formative Research||0
5211868|NCT00991081|12814789|P3|COMPLETED|Phase I, Formative Research||0
5211869|NCT00991081|12814790|P2|COMPLETED|Phase I, Formative Research||0
5211870|NCT00991081|12814791|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
5211871|NCT00991081|12814789|P3|STARTED|Phase I, Formative Research||0
5211872|NCT00991081|12814790|P2|STARTED|Phase I, Formative Research||0
5211873|NCT00991081|12814791|P1|STARTED|Phase I, Formative Research||20
5211874|NCT00991029|12814825|P2|NOT COMPLETED|Overall Study||168
5211875|NCT00991029|12814826|P1|NOT COMPLETED|Overall Study||156
5211876|NCT00991029|12814825|P2|COMPLETED|Overall Study||2281
5211877|NCT00991029|12814826|P1|COMPLETED|Overall Study||2276
5211878|NCT00991029|12814825|P2|STARTED|Overall Study||2449
5211879|NCT00991029|12814826|P1|STARTED|Overall Study||2432
5211880|NCT00990964|12814856|P1|NOT COMPLETED|Overall Study||212
5211881|NCT00990964|12814856|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
5211882|NCT00990964|12814856|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
5211883|NCT00990964|12814856|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
5211884|NCT00990938|12814867|P6|NOT COMPLETED|Overall Study||0
5211885|NCT00990938|12814868|P5|NOT COMPLETED|Overall Study||0
5211886|NCT00990938|12814869|P4|NOT COMPLETED|Overall Study||0
5211887|NCT00990938|12814870|P3|NOT COMPLETED|Overall Study||0
5211888|NCT00990938|12814871|P2|NOT COMPLETED|Overall Study||0
5211889|NCT00990938|12814872|P1|NOT COMPLETED|Overall Study||0
5211890|NCT00990938|12814867|P6|COMPLETED|Overall Study||12
5211891|NCT00990938|12814868|P5|COMPLETED|Overall Study||12
5211892|NCT00990938|12814869|P4|COMPLETED|Overall Study||12
5211893|NCT00990938|12814870|P3|COMPLETED|Overall Study||12
5211894|NCT00990938|12814871|P2|COMPLETED|Overall Study||12
5211895|NCT00990938|12814872|P1|COMPLETED|Overall Study||3
5211896|NCT00990938|12814867|P6|STARTED|Overall Study||12
5211897|NCT00990938|12814868|P5|STARTED|Overall Study||12
5211898|NCT00990938|12814869|P4|STARTED|Overall Study||12
5211899|NCT00990938|12814870|P3|STARTED|Overall Study||12
5211900|NCT00990938|12814871|P2|STARTED|Overall Study||12
5211901|NCT00990938|12814872|P1|STARTED|Overall Study||3
5211902|NCT00990821|12814900|P14|NOT COMPLETED|Overall Study||1
5211903|NCT00990821|12814901|P13|NOT COMPLETED|Overall Study||2
5211904|NCT00990821|12814902|P12|NOT COMPLETED|Overall Study||5
5211905|NCT00990821|12814903|P11|NOT COMPLETED|Overall Study||3
5211906|NCT00990821|12814904|P10|NOT COMPLETED|Overall Study||1
5211907|NCT00990821|12814905|P9|NOT COMPLETED|Overall Study||0
5211908|NCT00990821|12814906|P8|NOT COMPLETED|Overall Study||0
5211909|NCT00990821|12814907|P7|NOT COMPLETED|Overall Study||1
5211910|NCT00990821|12814908|P6|NOT COMPLETED|Overall Study||3
5211911|NCT00990821|12814909|P5|NOT COMPLETED|Overall Study||3
5211912|NCT00990821|12814910|P4|NOT COMPLETED|Overall Study||0
5211913|NCT00990821|12814911|P3|NOT COMPLETED|Overall Study||0
5211914|NCT00990821|12814912|P2|NOT COMPLETED|Overall Study||2
5211915|NCT00990821|12814913|P1|NOT COMPLETED|Overall Study||0
5211916|NCT00990821|12814900|P14|COMPLETED|Overall Study||11
5211917|NCT00990821|12814901|P13|COMPLETED|Overall Study||10
5211918|NCT00990821|12814902|P12|COMPLETED|Overall Study||9
5211919|NCT00990821|12814903|P11|COMPLETED|Overall Study||9
5211920|NCT00990821|12814904|P10|COMPLETED|Overall Study||13
5211921|NCT00990821|12814905|P9|COMPLETED|Overall Study||12
5211922|NCT00990821|12814906|P8|COMPLETED|Overall Study||14
5211923|NCT00990821|12814907|P7|COMPLETED|Overall Study||11
5211924|NCT00990821|12814908|P6|COMPLETED|Overall Study||14
5211925|NCT00990821|12814909|P5|COMPLETED|Overall Study||14
5211926|NCT00990821|12814910|P4|COMPLETED|Overall Study||8
5211927|NCT00990821|12814911|P3|COMPLETED|Overall Study||14
5211928|NCT00990821|12814912|P2|COMPLETED|Overall Study||14
5211929|NCT00990821|12814913|P1|COMPLETED|Overall Study||14
5211930|NCT00990821|12814900|P14|STARTED|Overall Study||12
5211931|NCT00990821|12814901|P13|STARTED|Overall Study||12
5211932|NCT00990821|12814902|P12|STARTED|Overall Study||14
5211933|NCT00990821|12814903|P11|STARTED|Overall Study||12
5211934|NCT00990821|12814904|P10|STARTED|Overall Study||14
5211935|NCT00990821|12814905|P9|STARTED|Overall Study||12
5211936|NCT00990821|12814906|P8|STARTED|Overall Study||14
5211937|NCT00990821|12814907|P7|STARTED|Overall Study||12
5211938|NCT00990821|12814908|P6|STARTED|Overall Study||17
5211939|NCT00990821|12814909|P5|STARTED|Overall Study||17
5211940|NCT00990821|12814910|P4|STARTED|Overall Study||8
5211941|NCT00990821|12814911|P3|STARTED|Overall Study||14
5211942|NCT00990821|12814912|P2|STARTED|Overall Study||16
5211943|NCT00990821|12814913|P1|STARTED|Overall Study||14
5211944|NCT00990782|12814930|P1|NOT COMPLETED|Overall Study||5
5211945|NCT00990782|12814930|P1|COMPLETED|Overall Study||88
5211946|NCT00990782|12814930|P1|STARTED|Overall Study||93
5211947|NCT00990769|12814937|P2|NOT COMPLETED|Overall Study||0
5211948|NCT00990769|12814938|P1|NOT COMPLETED|Overall Study||0
5211949|NCT00990769|12814937|P2|COMPLETED|Overall Study||18
5211950|NCT00990769|12814938|P1|COMPLETED|Overall Study||22
5211951|NCT00990769|12814937|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
5211952|NCT00990769|12814938|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
5211953|NCT00990704|12814950|P2|NOT COMPLETED|Overall Study||2
5211954|NCT00990704|12814951|P1|NOT COMPLETED|Overall Study||1
5211955|NCT00990704|12814950|P2|COMPLETED|Overall Study||31
5211956|NCT00990704|12814951|P1|COMPLETED|Overall Study||13
5211957|NCT00990704|12814950|P2|STARTED|Overall Study||33
5211958|NCT00990704|12814951|P1|STARTED|Overall Study||14
5211959|NCT00990665|12814971|P1|NOT COMPLETED|Overall Study||48
5211960|NCT00990665|12814971|P1|COMPLETED|Overall Study||130
5211961|NCT00990665|12814971|P1|STARTED|Overall Study||178
5211962|NCT00990652|12814978|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
5211963|NCT00990652|12814978|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
5211964|NCT00990652|12814978|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
5211965|NCT00990652|12814978|P1|NOT COMPLETED|Surgical Resection||0
5211966|NCT00990652|12814978|P1|COMPLETED|Surgical Resection||9
5211967|NCT00990652|12814978|P1|STARTED|Surgical Resection||9
5211968|NCT00990652|12814978|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
5211969|NCT00990652|12814978|P1|COMPLETED|Pre-surgical Bortezomib||9
5211970|NCT00990652|12814978|P1|STARTED|Pre-surgical Bortezomib||10
5211971|NCT00990561|12814988|P4|NOT COMPLETED|Period 2||2
5211972|NCT00990561|12814989|P3|NOT COMPLETED|Period 2||0
5211973|NCT00990561|12814990|P2|NOT COMPLETED|Period 2||0
5211974|NCT00990561|12814991|P1|NOT COMPLETED|Period 2||0
5211975|NCT00990561|12814988|P4|COMPLETED|Period 2||17
5211976|NCT00990561|12814989|P3|COMPLETED|Period 2||20
5211977|NCT00990561|12814990|P2|COMPLETED|Period 2||0
5211978|NCT00990561|12814991|P1|COMPLETED|Period 2||0
5211979|NCT00990561|12814988|P4|STARTED|Period 2||19
5211980|NCT00990561|12814989|P3|STARTED|Period 2||20
5211981|NCT00990561|12814990|P2|STARTED|Period 2||0
5211982|NCT00990561|12814991|P1|STARTED|Period 2||0
5211983|NCT00990561|12814988|P4|NOT COMPLETED|Period 1||0
5211984|NCT00990561|12814989|P3|NOT COMPLETED|Period 1||0
5211985|NCT00990561|12814990|P2|NOT COMPLETED|Period 1||1
5211986|NCT00990561|12814991|P1|NOT COMPLETED|Period 1||0
5211987|NCT00990561|12814988|P4|COMPLETED|Period 1||0
5211988|NCT00990561|12814989|P3|COMPLETED|Period 1||0
5211989|NCT00990561|12814990|P2|COMPLETED|Period 1||19
5211990|NCT00990561|12814991|P1|COMPLETED|Period 1||20
5211991|NCT00990561|12814988|P4|STARTED|Period 1||0
5211992|NCT00990561|12814989|P3|STARTED|Period 1||0
5211993|NCT00990561|12814990|P2|STARTED|Period 1||20
5211994|NCT00990561|12814991|P1|STARTED|Period 1||20
5211995|NCT00990509|12814999|P2|NOT COMPLETED|Overall Study||1
5211996|NCT00990509|12815000|P1|NOT COMPLETED|Overall Study||0
5211997|NCT00990509|12814999|P2|COMPLETED|Overall Study||8
5211998|NCT00990509|12815000|P1|COMPLETED|Overall Study||5
5211999|NCT00990509|12814999|P2|STARTED|Overall Study||9
5212000|NCT00990509|12815000|P1|STARTED|Overall Study||5
5212001|NCT00990340|12815012|P2|NOT COMPLETED|Second 14-day Treatment||0
5212002|NCT00990340|12815013|P1|NOT COMPLETED|Second 14-day Treatment||0
5212003|NCT00990340|12815012|P2|COMPLETED|Second 14-day Treatment||21
5212004|NCT00990340|12815013|P1|COMPLETED|Second 14-day Treatment||21
5212005|NCT00990340|12815012|P2|STARTED|Second 14-day Treatment||21
5212006|NCT00990340|12815013|P1|STARTED|Second 14-day Treatment||21
5212007|NCT00990340|12815012|P2|NOT COMPLETED|First 14-day Treatment||4
5212008|NCT00990340|12815013|P1|NOT COMPLETED|First 14-day Treatment||6
5212009|NCT00990340|12815012|P2|COMPLETED|First 14-day Treatment||21
5212010|NCT00990340|12815013|P1|COMPLETED|First 14-day Treatment||21
5212011|NCT00990340|12815012|P2|STARTED|First 14-day Treatment||25
5212012|NCT00990340|12815013|P1|STARTED|First 14-day Treatment||27
5212013|NCT00990314|12815027|P1|NOT COMPLETED|Overall Study||12
5212014|NCT00990314|12815027|P1|COMPLETED|Overall Study||19
5212015|NCT00990314|12815027|P1|STARTED|Overall Study||31
5212016|NCT00990288|12815038|P2|NOT COMPLETED|Overall Study||0
5212017|NCT00990288|12815039|P1|NOT COMPLETED|Overall Study||0
5212018|NCT00990288|12815038|P2|COMPLETED|Overall Study||99
5212019|NCT00990288|12815039|P1|COMPLETED|Overall Study||97
5212020|NCT00990288|12815038|P2|STARTED|Overall Study||99
5212021|NCT00990288|12815039|P1|STARTED|Overall Study||97
5212022|NCT00990249|12815069|P1|NOT COMPLETED|Overall Study||13
5212023|NCT00990249|12815069|P1|COMPLETED|Overall Study||107
5212024|NCT00990249|12815069|P1|STARTED|Overall Study||120
5212025|NCT00990236|12815075|P2|NOT COMPLETED|Overall Study||0
5212026|NCT00990236|12815076|P1|NOT COMPLETED|Overall Study||0
5212027|NCT00990236|12815075|P2|COMPLETED|Overall Study||96
5212028|NCT00990236|12815076|P1|COMPLETED|Overall Study||89
5212029|NCT00990236|12815075|P2|STARTED|Overall Study||96
5212030|NCT00990236|12815076|P1|STARTED|Overall Study||89
5212031|NCT00990184|12815084|P1|NOT COMPLETED|Overall Study||1
5212032|NCT00990184|12815084|P1|COMPLETED|Overall Study||20
5212033|NCT00990184|12815084|P1|STARTED|Overall Study||21
5212034|NCT00990106|12815092|P2|NOT COMPLETED|Overall Study||12
5212035|NCT00990106|12815093|P1|NOT COMPLETED|Overall Study||9
5212036|NCT00990106|12815092|P2|COMPLETED|Overall Study||23
5212037|NCT00990106|12815093|P1|COMPLETED|Overall Study||23
5212038|NCT00990106|12815092|P2|STARTED|Overall Study||35
5212039|NCT00990106|12815093|P1|STARTED|Overall Study||32
5212040|NCT00990093|12815103|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
5212041|NCT00990093|12815104|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
5212042|NCT00990093|12815103|P2|COMPLETED|Test Period 2 (15-28 Days)||14
5212043|NCT00990093|12815104|P1|COMPLETED|Test Period 2 (15-28 Days)||13
5212044|NCT00990093|12815103|P2|STARTED|Test Period 2 (15-28 Days)||15
5212045|NCT00990093|12815104|P1|STARTED|Test Period 2 (15-28 Days)||15
5212046|NCT00990093|12815103|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
5212047|NCT00990093|12815104|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
5212048|NCT00990093|12815103|P2|COMPLETED|Test Period 1 (1-14 Days)||15
5212049|NCT00990093|12815104|P1|COMPLETED|Test Period 1 (1-14 Days)||15
5212050|NCT00990093|12815103|P2|STARTED|Test Period 1 (1-14 Days)||17
5212051|NCT00990093|12815104|P1|STARTED|Test Period 1 (1-14 Days)||19
5212052|NCT00989989|12815113|P3|NOT COMPLETED|Overall Study||23
5212053|NCT00989989|12815114|P2|NOT COMPLETED|Overall Study||10
5212054|NCT00989989|12815115|P1|NOT COMPLETED|Overall Study||18
5212055|NCT00989989|12815113|P3|COMPLETED|Overall Study||108
5212056|NCT00989989|12815114|P2|COMPLETED|Overall Study||123
5212057|NCT00989989|12815115|P1|COMPLETED|Overall Study||114
5212058|NCT00989989|12815113|P3|STARTED|Overall Study||131
5212059|NCT00989989|12815114|P2|STARTED|Overall Study||133
5212060|NCT00989989|12815115|P1|STARTED|Overall Study||132
5212061|NCT00989950|12815157|P4|NOT COMPLETED|Randomized Phase||0
5212062|NCT00989950|12815158|P3|NOT COMPLETED|Randomized Phase||0
5212063|NCT00989950|12815159|P2|NOT COMPLETED|Randomized Phase||1
5212064|NCT00989950|12815160|P1|NOT COMPLETED|Randomized Phase||1
5212065|NCT00989950|12815157|P4|COMPLETED|Randomized Phase||7
5212066|NCT00989950|12815158|P3|COMPLETED|Randomized Phase||4
5212067|NCT00989950|12815159|P2|COMPLETED|Randomized Phase||8
5212068|NCT00989950|12815160|P1|COMPLETED|Randomized Phase||5
5212069|NCT00989950|12815157|P4|STARTED|Randomized Phase||7
5212070|NCT00989950|12815158|P3|STARTED|Randomized Phase||4
5212071|NCT00989950|12815159|P2|STARTED|Randomized Phase||9
5212072|NCT00989950|12815160|P1|STARTED|Randomized Phase||6
5212073|NCT00989950|12815157|P4|NOT COMPLETED|Open Label Dose Optimization||0
5212074|NCT00989950|12815158|P3|NOT COMPLETED|Open Label Dose Optimization||0
5212075|NCT00989950|12815159|P2|NOT COMPLETED|Open Label Dose Optimization||0
5212076|NCT00989950|12815160|P1|NOT COMPLETED|Open Label Dose Optimization||0
5212077|NCT00989950|12815157|P4|COMPLETED|Open Label Dose Optimization||7
5212078|NCT00989950|12815158|P3|COMPLETED|Open Label Dose Optimization||4
5212079|NCT00989950|12815159|P2|COMPLETED|Open Label Dose Optimization||9
5212080|NCT00989950|12815160|P1|COMPLETED|Open Label Dose Optimization||6
5212081|NCT00989950|12815157|P4|STARTED|Open Label Dose Optimization||7
5212082|NCT00989950|12815158|P3|STARTED|Open Label Dose Optimization||4
5212083|NCT00989950|12815159|P2|STARTED|Open Label Dose Optimization||9
5212084|NCT00989950|12815160|P1|STARTED|Open Label Dose Optimization||6
5212085|NCT00989937|12815170|P1|NOT COMPLETED|Overall Study||0
5212086|NCT00989937|12815170|P1|COMPLETED|Overall Study||0
5212087|NCT00989937|12815170|P1|STARTED|Overall Study||0
5212088|NCT00989911|12815185|P1|NOT COMPLETED|Overall Study||3
5212089|NCT00989911|12815185|P1|COMPLETED|Overall Study||7
5212090|NCT00989911|12815185|P1|STARTED|Overall Study||10
5212091|NCT00989833|12815192|P3|NOT COMPLETED|Overall Study||2
5212092|NCT00989833|12815193|P2|NOT COMPLETED|Overall Study||3
5212093|NCT00989833|12815194|P1|NOT COMPLETED|Overall Study||2
5212094|NCT00989833|12815192|P3|COMPLETED|Overall Study||21
5212095|NCT00989833|12815193|P2|COMPLETED|Overall Study||19
5212096|NCT00989833|12815194|P1|COMPLETED|Overall Study||19
5212097|NCT00989833|12815192|P3|STARTED|Overall Study||23
5212098|NCT00989833|12815193|P2|STARTED|Overall Study||22
5212099|NCT00989833|12815194|P1|STARTED|Overall Study||21
5212100|NCT00989781|12815225|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
5212101|NCT00989781|12815226|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
5212102|NCT00989781|12815225|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
5212103|NCT00989781|12815226|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
5212104|NCT00989781|12815225|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
5212105|NCT00989781|12815226|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
5212106|NCT00989781|12815225|P2|NOT COMPLETED|Ovarian Response to hCG||2
5212107|NCT00989781|12815226|P1|NOT COMPLETED|Ovarian Response to hCG||3
5212108|NCT00989781|12815225|P2|COMPLETED|Ovarian Response to hCG||18
5212109|NCT00989781|12815226|P1|COMPLETED|Ovarian Response to hCG||18
5212110|NCT00989781|12815225|P2|STARTED|Ovarian Response to hCG||20
5212111|NCT00989781|12815226|P1|STARTED|Ovarian Response to hCG||21
5212112|NCT00989768|12815245|P1|NOT COMPLETED|Overall Study||1
5212113|NCT00989768|12815245|P1|COMPLETED|Overall Study||28
5212114|NCT00989768|12815245|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
5212115|NCT00989664|12815256|P1|NOT COMPLETED|Long-Term Follow-Up||3
5212116|NCT00989664|12815256|P1|COMPLETED|Long-Term Follow-Up||11
5212117|NCT00989664|12815256|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
5212118|NCT00989664|12815256|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
5212119|NCT00989664|12815256|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
5212120|NCT00989664|12815256|P1|STARTED|Dosimetric and Therapeutic Treatment||61
5212121|NCT00989612|12815284|P1|NOT COMPLETED|Overall Study||0
5212122|NCT00989612|12815284|P1|COMPLETED|Overall Study||100
5212123|NCT00989612|12815284|P1|STARTED|Overall Study||100
5212124|NCT00989586|12815325|P2|NOT COMPLETED|Overall Study||0
5212125|NCT00989586|12815326|P1|NOT COMPLETED|Overall Study||0
5212126|NCT00989586|12815325|P2|COMPLETED|Overall Study||17
5212127|NCT00989586|12815326|P1|COMPLETED|Overall Study||18
5212128|NCT00989586|12815325|P2|STARTED|Overall Study||17
5212129|NCT00989586|12815326|P1|STARTED|Overall Study||18
5212130|NCT00989287|12815341|P2|NOT COMPLETED|Overall Study||1
5212131|NCT00989287|12815342|P1|NOT COMPLETED|Overall Study||1
5212132|NCT00989287|12815341|P2|COMPLETED|Overall Study||65
5212133|NCT00989287|12815342|P1|COMPLETED|Overall Study||64
5212134|NCT00989287|12815341|P2|STARTED|Overall Study||66
5212135|NCT00989287|12815342|P1|STARTED|Overall Study||65
5212136|NCT00989261|12815444|P2|NOT COMPLETED|Overall Study||22
5212137|NCT00989261|12815445|P1|NOT COMPLETED|Overall Study||15
5212138|NCT00989261|12815444|P2|COMPLETED|Overall Study||154
5212139|NCT00989261|12815445|P1|COMPLETED|Overall Study||142
5212140|NCT00989261|12815444|P2|STARTED|Overall Study||176
5212141|NCT00989261|12815445|P1|STARTED|Overall Study||157
5212142|NCT00989235|12815475|P2|NOT COMPLETED|Overall Study||6
5212143|NCT00989235|12815476|P1|NOT COMPLETED|Overall Study||3
5212144|NCT00989235|12815475|P2|COMPLETED|Overall Study||44
5212145|NCT00989235|12815476|P1|COMPLETED|Overall Study||55
5212146|NCT00989235|12815475|P2|Number Completing Double-Blind Treatment|Overall Study||41
5212147|NCT00989235|12815476|P1|Number Completing Double-Blind Treatment|Overall Study||51
5212148|NCT00989235|12815475|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
5212149|NCT00989235|12815476|P1|Number Rescued to Open-Label Treatment|Overall Study||4
5212150|NCT00989235|12815475|P2|STARTED|Overall Study||50
5212151|NCT00989235|12815476|P1|STARTED|Overall Study||58
5212152|NCT00989196|12815521|P2|NOT COMPLETED|Treatment Period||0
5212153|NCT00989196|12815522|P1|NOT COMPLETED|Treatment Period||1
5212154|NCT00989196|12815521|P2|COMPLETED|Treatment Period||12
5212155|NCT00989196|12815522|P1|COMPLETED|Treatment Period||9
5212156|NCT00989196|12815521|P2|STARTED|Treatment Period||12
5212157|NCT00989196|12815522|P1|STARTED|Treatment Period||10
5212158|NCT00989196|12815521|P2|NOT COMPLETED|PK Crossover Period||0
5212159|NCT00989196|12815522|P1|NOT COMPLETED|PK Crossover Period||0
5212160|NCT00989196|12815521|P2|COMPLETED|PK Crossover Period||12
5212161|NCT00989196|12815522|P1|COMPLETED|PK Crossover Period||10
5212162|NCT00989196|12815521|P2|STARTED|PK Crossover Period||12
5212163|NCT00989196|12815522|P1|STARTED|PK Crossover Period||10
5212164|NCT00989157|12815543|P2|NOT COMPLETED|Overall Study||0
5212165|NCT00989157|12815544|P1|NOT COMPLETED|Overall Study||0
5212166|NCT00989157|12815543|P2|COMPLETED|Overall Study||10
5212167|NCT00989157|12815544|P1|COMPLETED|Overall Study||10
5212168|NCT00989157|12815543|P2|STARTED|Overall Study||10
5212169|NCT00989157|12815544|P1|STARTED|Overall Study||10
5212170|NCT00989092|12815560|P2|NOT COMPLETED|Overall Study||28
5212171|NCT00989092|12815561|P1|NOT COMPLETED|Overall Study||90
5212172|NCT00989092|12815560|P2|COMPLETED|Overall Study||31
5212173|NCT00989092|12815561|P1|COMPLETED|Overall Study||138
5212174|NCT00989092|12815560|P2|Treated With Darbepoetin Alfa|Overall Study||33
5212175|NCT00989092|12815561|P1|Treated With Darbepoetin Alfa|Overall Study||226
5212176|NCT00989092|12815560|P2|STARTED|Overall Study||59
5212177|NCT00989092|12815561|P1|STARTED|Overall Study||228
5212178|NCT00989014|12815598|P4|NOT COMPLETED|Overall Study||0
5212179|NCT00989014|12815599|P3|NOT COMPLETED|Overall Study||0
5212180|NCT00989014|12815600|P2|NOT COMPLETED|Overall Study||0
5212181|NCT00989014|12815601|P1|NOT COMPLETED|Overall Study||0
5212182|NCT00989014|12815598|P4|COMPLETED|Overall Study||32
5212183|NCT00989014|12815599|P3|COMPLETED|Overall Study||28
5212184|NCT00989014|12815600|P2|COMPLETED|Overall Study||31
5212185|NCT00989014|12815601|P1|COMPLETED|Overall Study||31
5212186|NCT00989014|12815598|P4|STARTED|Overall Study||32
5212187|NCT00989014|12815599|P3|STARTED|Overall Study||28
5212188|NCT00989014|12815600|P2|STARTED|Overall Study||31
5212189|NCT00989014|12815601|P1|STARTED|Overall Study||31
5212190|NCT00988884|12815613|P2|NOT COMPLETED|Overall Study||36
5212191|NCT00988884|12815614|P1|NOT COMPLETED|Overall Study||35
5212192|NCT00988884|12815613|P2|COMPLETED|Overall Study||584
5212193|NCT00988884|12815614|P1|COMPLETED|Overall Study||586
5212194|NCT00988884|12815613|P2|STARTED|Overall Study||620
5212195|NCT00988884|12815614|P1|STARTED|Overall Study||621
5212196|NCT00988858|12815636|P1|NOT COMPLETED|Overall Study||10
5212197|NCT00988858|12815636|P1|COMPLETED|Overall Study||45
5212198|NCT00988858|12815636|P1|STARTED|Overall Study||55
5212199|NCT00988832|12815648|P1|NOT COMPLETED|Overall Study||0
5212200|NCT00988832|12815648|P1|COMPLETED|Overall Study||380
5212201|NCT00988832|12815648|P1|STARTED|Overall Study||380
5212202|NCT00988637|12815685|P2|NOT COMPLETED|Overall Study||3
5212203|NCT00988637|12815686|P1|NOT COMPLETED|Overall Study||3
5212204|NCT00988637|12815685|P2|COMPLETED|Overall Study||65
5212205|NCT00988637|12815686|P1|COMPLETED|Overall Study||67
5212206|NCT00988637|12815685|P2|STARTED|Overall Study||68
5212207|NCT00988637|12815686|P1|STARTED|Overall Study||70
5212208|NCT00988559|12815720|P4|NOT COMPLETED|Overall Study||1
5212209|NCT00988559|12815721|P3|NOT COMPLETED|Overall Study||2
5212210|NCT00988559|12815722|P2|NOT COMPLETED|Overall Study||2
5212211|NCT00988559|12815723|P1|NOT COMPLETED|Overall Study||1
5212212|NCT00988559|12815720|P4|COMPLETED|Overall Study||6
5212213|NCT00988559|12815721|P3|COMPLETED|Overall Study||9
5212214|NCT00988559|12815722|P2|COMPLETED|Overall Study||9
5212215|NCT00988559|12815723|P1|COMPLETED|Overall Study||9
5212216|NCT00988559|12815720|P4|STARTED|Overall Study||7
5212217|NCT00988559|12815721|P3|STARTED|Overall Study||11
5212218|NCT00988559|12815722|P2|STARTED|Overall Study||11
5212219|NCT00988559|12815723|P1|STARTED|Overall Study||10
5212220|NCT00988533|12815737|P1|NOT COMPLETED|Overall Study||3
5212221|NCT00988533|12815737|P1|COMPLETED|Overall Study||27
5212222|NCT00988533|12815737|P1|STARTED|Overall Study||30
5212223|NCT00988442|12815751|P2|NOT COMPLETED|Overall Study||28
5212224|NCT00988442|12815752|P1|NOT COMPLETED|Overall Study||30
5212225|NCT00988442|12815751|P2|COMPLETED|Overall Study||1
5212226|NCT00988442|12815752|P1|COMPLETED|Overall Study||0
5212227|NCT00988442|12815751|P2|STARTED|Overall Study||29
5212228|NCT00988442|12815752|P1|STARTED|Overall Study||30
5212229|NCT00988429|12815815|P3|NOT COMPLETED|Overall Study||69
5212230|NCT00988429|12815816|P2|NOT COMPLETED|Overall Study||43
5212231|NCT00988429|12815817|P1|NOT COMPLETED|Overall Study||37
5212232|NCT00988429|12815815|P3|COMPLETED|Overall Study||142
5212233|NCT00988429|12815816|P2|COMPLETED|Overall Study||173
5212234|NCT00988429|12815817|P1|COMPLETED|Overall Study||189
5212235|NCT00988429|12815815|P3|Intention-to-treat (ITT) Population|Overall Study||205
5212236|NCT00988429|12815816|P2|Intention-to-treat (ITT) Population|Overall Study||215
5212237|NCT00988429|12815817|P1|Intention-to-treat (ITT) Population|Overall Study||220
5212238|NCT00988429|12815815|P3|Safety Population|Overall Study||210
5212239|NCT00988429|12815816|P2|Safety Population|Overall Study||216
5212240|NCT00988429|12815817|P1|Safety Population|Overall Study||224
5212241|NCT00988429|12815815|P3|STARTED|Overall Study||211
5212242|NCT00988429|12815816|P2|STARTED|Overall Study||216
5212243|NCT00988429|12815817|P1|STARTED|Overall Study||226
5212244|NCT00988351|12815830|P2|NOT COMPLETED|Overall Study||12
5212245|NCT00988351|12815831|P1|NOT COMPLETED|Overall Study||19
5212246|NCT00988351|12815830|P2|COMPLETED|Overall Study||66
5212247|NCT00988351|12815831|P1|COMPLETED|Overall Study||59
5212248|NCT00988351|12815830|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
5212249|NCT00988351|12815831|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
5212250|NCT00988351|12815830|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
5212251|NCT00988351|12815831|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
5212252|NCT00988351|12815830|P2|PAP Setup|Overall Study|APAP treatment started|78
5212253|NCT00988351|12815831|P1|PAP Setup|Overall Study|CPAP treatment started|70
5212254|NCT00988351|12815830|P2|CPAP Titration|Overall Study|no titration needed|78
5212255|NCT00988351|12815831|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
5212256|NCT00988351|12815830|P2|STARTED|Overall Study||78
5212257|NCT00988351|12815831|P1|STARTED|Overall Study||78
5212258|NCT00988325|12815848|P3|NOT COMPLETED|Overall Study||0
5212259|NCT00988325|12815849|P2|NOT COMPLETED|Overall Study||0
5212260|NCT00988325|12815850|P1|NOT COMPLETED|Overall Study||0
5212261|NCT00988325|12815848|P3|COMPLETED|Overall Study||5
5212262|NCT00988325|12815849|P2|COMPLETED|Overall Study||20
5212263|NCT00988325|12815850|P1|COMPLETED|Overall Study||40
5212264|NCT00988325|12815848|P3|STARTED|Overall Study||5
5212265|NCT00988325|12815849|P2|STARTED|Overall Study||20
5212266|NCT00988325|12815850|P1|STARTED|Overall Study||40
5212267|NCT00988247|12815908|P2|NOT COMPLETED|Overall Study||26
5212268|NCT00988247|12815909|P1|NOT COMPLETED|Overall Study||83
5212269|NCT00988247|12815908|P2|COMPLETED|Overall Study||85
5212270|NCT00988247|12815909|P1|COMPLETED|Overall Study||335
5212271|NCT00988247|12815908|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
5212272|NCT00988247|12815909|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
5212273|NCT00988247|12815908|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
5212274|NCT00988247|12815909|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
5212275|NCT00988247|12815908|P2|STARTED|Overall Study||111
5212276|NCT00988247|12815909|P1|STARTED|Overall Study||418
5212277|NCT00988221|12815928|P4|NOT COMPLETED|Part III||0
5212278|NCT00988221|12815929|P3|NOT COMPLETED|Part III||3
5212279|NCT00988221|12815930|P2|NOT COMPLETED|Part III||1
5212280|NCT00988221|12815931|P1|NOT COMPLETED|Part III||1
5212281|NCT00988221|12815928|P4|COMPLETED|Part III||0
5212282|NCT00988221|12815929|P3|COMPLETED|Part III||103
5212283|NCT00988221|12815930|P2|COMPLETED|Part III||23
5212284|NCT00988221|12815931|P1|COMPLETED|Part III||29
5212285|NCT00988221|12815928|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
5212286|NCT00988221|12815929|P3|STARTED|Part III||106
5212287|NCT00988221|12815930|P2|STARTED|Part III||24
5212288|NCT00988221|12815931|P1|STARTED|Part III||30
5212289|NCT00988221|12815928|P4|NOT COMPLETED|Part II||3
5212290|NCT00988221|12815929|P3|NOT COMPLETED|Part II||3
5212291|NCT00988221|12815930|P2|NOT COMPLETED|Part II||0
5212292|NCT00988221|12815931|P1|NOT COMPLETED|Part II||1
5212293|NCT00988221|12815928|P4|COMPLETED|Part II||81
5212294|NCT00988221|12815929|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
5212295|NCT00988221|12815930|P2|COMPLETED|Part II||11
5212296|NCT00988221|12815931|P1|COMPLETED|Part II||15
5212297|NCT00988221|12815928|P4|STARTED|Part II||84
5212298|NCT00988221|12815929|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
5212299|NCT00988221|12815930|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
5212300|NCT00988221|12815931|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
5212301|NCT00988221|12815928|P4|NOT COMPLETED|Part I||0
5212302|NCT00988221|12815929|P3|NOT COMPLETED|Part I||8
5212303|NCT00988221|12815930|P2|NOT COMPLETED|Part I||10
5212304|NCT00988221|12815931|P1|NOT COMPLETED|Part I||4
5212305|NCT00988221|12815928|P4|COMPLETED|Part I||0
5212306|NCT00988221|12815929|P3|COMPLETED|Part I||111
5212307|NCT00988221|12815930|P2|COMPLETED|Part I||24
5212308|NCT00988221|12815931|P1|COMPLETED|Part I||31
5212309|NCT00988221|12815928|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
5212310|NCT00988221|12815929|P3|STARTED|Part I||119
5212311|NCT00988221|12815930|P2|STARTED|Part I||34
5212312|NCT00988221|12815931|P1|STARTED|Part I||35
5212313|NCT00988208|12816104|P2|NOT COMPLETED|Overall Study||438
5212314|NCT00988208|12816105|P1|NOT COMPLETED|Overall Study||431
5212315|NCT00988208|12816104|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
5212316|NCT00988208|12816105|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
5212317|NCT00988208|12816104|P2|Treated|Overall Study||525
5212318|NCT00988208|12816105|P1|Treated|Overall Study||521
5212319|NCT00988208|12816104|P2|STARTED|Overall Study||533
5212320|NCT00988208|12816105|P1|STARTED|Overall Study||526
5212321|NCT00988169|12816123|P1|NOT COMPLETED|Overall Study||1
5212322|NCT00988169|12816123|P1|COMPLETED|Overall Study||5
5212323|NCT00988169|12816123|P1|STARTED|Overall Study||6
5212324|NCT00988156|12816129|P2|NOT COMPLETED|Overall Study||20
5212325|NCT00988156|12816130|P1|NOT COMPLETED|Overall Study||17
5212326|NCT00988156|12816129|P2|COMPLETED|Overall Study||135
5212327|NCT00988156|12816130|P1|COMPLETED|Overall Study||132
5212328|NCT00988156|12816129|P2|Safety Set|Overall Study||134
5212329|NCT00988156|12816130|P1|Safety Set|Overall Study||129
5212330|NCT00988156|12816129|P2|Per Protocol Set (PP)|Overall Study||97
5212331|NCT00988156|12816130|P1|Per Protocol Set (PP)|Overall Study||101
5212332|NCT00988156|12816129|P2|Intention-to-Treat Set (ITT)|Overall Study||134
5212333|NCT00988156|12816130|P1|Intention-to-Treat Set (ITT)|Overall Study||129
5212334|NCT00988156|12816129|P2|STARTED|Overall Study||155
5212335|NCT00988156|12816130|P1|STARTED|Overall Study||149
5212336|NCT00988143|12816141|P3|NOT COMPLETED|Overall Study||0
5212337|NCT00988143|12816142|P2|NOT COMPLETED|Overall Study||0
5212338|NCT00988143|12816143|P1|NOT COMPLETED|Overall Study||0
5212339|NCT00988143|12816141|P3|COMPLETED|Overall Study||190
5212340|NCT00988143|12816142|P2|COMPLETED|Overall Study||190
5212341|NCT00988143|12816143|P1|COMPLETED|Overall Study||220
5212342|NCT00988143|12816141|P3|STARTED|Overall Study||190
5212343|NCT00988143|12816142|P2|STARTED|Overall Study||190
5212344|NCT00988143|12816143|P1|STARTED|Overall Study||220
5212345|NCT00988117|12816175|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
5212346|NCT00988117|12816175|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
5212347|NCT00988117|12816175|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
5212348|NCT00988117|12816175|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
5212349|NCT00988117|12816175|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
5212350|NCT00988117|12816175|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
5212351|NCT00988091|12816184|P2|NOT COMPLETED|Open-label Period||33
5212352|NCT00988091|12816185|P1|NOT COMPLETED|Open-label Period||21
5212353|NCT00988091|12816184|P2|COMPLETED|Open-label Period||192
5212354|NCT00988091|12816185|P1|COMPLETED|Open-label Period||208
5212355|NCT00988091|12816184|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
5212356|NCT00988091|12816185|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
5212357|NCT00988091|12816184|P2|NOT COMPLETED|Double-blind Period||47
5212358|NCT00988091|12816185|P1|NOT COMPLETED|Double-blind Period||43
5212359|NCT00988091|12816184|P2|COMPLETED|Double-blind Period||251
5212360|NCT00988091|12816185|P1|COMPLETED|Double-blind Period||255
5212361|NCT00988091|12816184|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
5212362|NCT00988091|12816185|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
5212363|NCT00988091|12816184|P2|STARTED|Double-blind Period||298
5212364|NCT00988091|12816185|P1|STARTED|Double-blind Period||298
5212365|NCT00988065|12816207|P3|NOT COMPLETED|Overall Study||15
5212366|NCT00988065|12816208|P2|NOT COMPLETED|Overall Study||23
5212367|NCT00988065|12816209|P1|NOT COMPLETED|Overall Study||13
5212368|NCT00988065|12816207|P3|COMPLETED|Overall Study||135
5212369|NCT00988065|12816208|P2|COMPLETED|Overall Study||127
5212370|NCT00988065|12816209|P1|COMPLETED|Overall Study||135
5212371|NCT00988065|12816207|P3|Received Third Randomized Dose|Overall Study||135
5212372|NCT00988065|12816208|P2|Received Third Randomized Dose|Overall Study||127
5212373|NCT00988065|12816209|P1|Received Third Randomized Dose|Overall Study||135
5212374|NCT00988065|12816207|P3|Received Second Randomized Dose|Overall Study||145
5212375|NCT00988065|12816208|P2|Received Second Randomized Dose|Overall Study||135
5212376|NCT00988065|12816209|P1|Received Second Randomized Dose|Overall Study||139
5212377|NCT00988065|12816207|P3|Received First Randomized Dose|Overall Study||150
5212378|NCT00988065|12816208|P2|Received First Randomized Dose|Overall Study||150
5212379|NCT00988065|12816209|P1|Received First Randomized Dose|Overall Study||148
5212380|NCT00988065|12816207|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
5212381|NCT00988065|12816208|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
5212382|NCT00988065|12816209|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
5212383|NCT00988052|12816231|P2|NOT COMPLETED|Overall Study||416
5212384|NCT00988052|12816232|P1|NOT COMPLETED|Overall Study||423
5212385|NCT00988052|12816231|P2|COMPLETED|Overall Study||0
5212386|NCT00988052|12816232|P1|COMPLETED|Overall Study||0
5212387|NCT00988052|12816231|P2|STARTED|Overall Study||416
5212388|NCT00988052|12816232|P1|STARTED|Overall Study||423
5212389|NCT00988000|12816249|P3|NOT COMPLETED|Overall Study||0
5212390|NCT00988000|12816250|P2|NOT COMPLETED|Overall Study||0
5212391|NCT00988000|12816251|P1|NOT COMPLETED|Overall Study||0
5212392|NCT00988000|12816249|P3|COMPLETED|Overall Study||57
5212393|NCT00988000|12816250|P2|COMPLETED|Overall Study||51
5212394|NCT00988000|12816251|P1|COMPLETED|Overall Study||49
5212395|NCT00988000|12816249|P3|STARTED|Overall Study||57
5212396|NCT00988000|12816250|P2|STARTED|Overall Study||51
5212397|NCT00988000|12816251|P1|STARTED|Overall Study||49
5212398|NCT00987948|12816262|P1|NOT COMPLETED|Overall Study||3
5212399|NCT00987948|12816262|P1|COMPLETED|Overall Study||12
5212400|NCT00987948|12816262|P1|STARTED|Overall Study||15
5212401|NCT00987935|12816276|P9|NOT COMPLETED|Overall Study||32
5212402|NCT00987935|12816277|P8|NOT COMPLETED|Overall Study||62
5212403|NCT00987935|12816278|P7|NOT COMPLETED|Overall Study||15
5212404|NCT00987935|12816279|P6|NOT COMPLETED|Overall Study||3
5212405|NCT00987935|12816280|P5|NOT COMPLETED|Overall Study||7
5212406|NCT00987935|12816281|P4|NOT COMPLETED|Overall Study||3
5212407|NCT00987935|12816282|P3|NOT COMPLETED|Overall Study||3
5212408|NCT00987935|12816283|P2|NOT COMPLETED|Overall Study||3
5212409|NCT00987935|12816284|P1|NOT COMPLETED|Overall Study||4
5212410|NCT00987935|12816276|P9|COMPLETED|Overall Study||0
5212411|NCT00987935|12816277|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
5212412|NCT00987935|12816278|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
5212413|NCT00987935|12816279|P6|COMPLETED|Overall Study||0
5212414|NCT00987935|12816280|P5|COMPLETED|Overall Study||0
5212415|NCT00987935|12816281|P4|COMPLETED|Overall Study||0
5212416|NCT00987935|12816282|P3|COMPLETED|Overall Study||0
5212417|NCT00987935|12816283|P2|COMPLETED|Overall Study||0
5212418|NCT00987935|12816284|P1|COMPLETED|Overall Study||0
5212419|NCT00987935|12816276|P9|STARTED|Overall Study||32
5212420|NCT00987935|12816277|P8|STARTED|Overall Study||63
5212421|NCT00987935|12816278|P7|STARTED|Overall Study||16
5212422|NCT00987935|12816279|P6|STARTED|Overall Study||3
5212423|NCT00987935|12816280|P5|STARTED|Overall Study||7
5212424|NCT00987935|12816281|P4|STARTED|Overall Study||3
5212425|NCT00987935|12816282|P3|STARTED|Overall Study||3
5212426|NCT00987935|12816283|P2|STARTED|Overall Study||3
5212427|NCT00987935|12816284|P1|STARTED|Overall Study||4
5212428|NCT00987831|12816340|P3|NOT COMPLETED|Overall Study||0
5212429|NCT00987831|12816341|P2|NOT COMPLETED|Overall Study||3
5212430|NCT00987831|12816342|P1|NOT COMPLETED|Overall Study||1
5212431|NCT00987831|12816340|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
5212432|NCT00987831|12816341|P2|COMPLETED|Overall Study|all controls returned for two visits|52
5212433|NCT00987831|12816342|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
5212434|NCT00987831|12816340|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
5212435|NCT00987831|12816341|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
5212436|NCT00987831|12816342|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
5212437|NCT00987727|12816353|P2|NOT COMPLETED|Overall Study||7
5212438|NCT00987727|12816354|P1|NOT COMPLETED|Overall Study||5
5212439|NCT00987727|12816353|P2|COMPLETED|Overall Study||34
5212440|NCT00987727|12816354|P1|COMPLETED|Overall Study||36
5212441|NCT00987727|12816353|P2|STARTED|Overall Study||41
5212442|NCT00987727|12816354|P1|STARTED|Overall Study||41
5212443|NCT00987623|12816364|P2|NOT COMPLETED|Overall Study||3
5212444|NCT00987623|12816365|P1|NOT COMPLETED|Overall Study||5
5212445|NCT00987623|12816364|P2|COMPLETED|Overall Study||151
5212446|NCT00987623|12816365|P1|COMPLETED|Overall Study||140
5212447|NCT00987623|12816364|P2|STARTED|Overall Study||154
5212448|NCT00987623|12816365|P1|STARTED|Overall Study||145
5212449|NCT00987558|12816371|P2|NOT COMPLETED|Overall Study||5
5212450|NCT00987558|12816372|P1|NOT COMPLETED|Overall Study||1
5212451|NCT00987558|12816371|P2|COMPLETED|Overall Study||12
5212452|NCT00987558|12816372|P1|COMPLETED|Overall Study||12
5212453|NCT00987558|12816371|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
5212454|NCT00987558|12816372|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
5212455|NCT00987558|12816371|P2|Washout|Overall Study||12
5212456|NCT00987558|12816372|P1|Washout|Overall Study||13
5212457|NCT00987558|12816371|P2|Simvastatin|Overall Study||12
5212458|NCT00987558|12816372|P1|Simvastatin|Overall Study||13
5212459|NCT00987558|12816371|P2|STARTED|Overall Study||17
5212460|NCT00987558|12816372|P1|STARTED|Overall Study||13
5212461|NCT00987480|12816385|P1|NOT COMPLETED|Overall Study||0
5212462|NCT00987480|12816385|P1|COMPLETED|Overall Study||45
5212463|NCT00987480|12816385|P1|STARTED|Overall Study||45
5212464|NCT00987467|12816394|P1|NOT COMPLETED|Overall Study||2
5212465|NCT00987467|12816394|P1|COMPLETED|Overall Study||10
5212466|NCT00987467|12816394|P1|STARTED|Overall Study||12
5212467|NCT00987415|12816401|P2|NOT COMPLETED|Overall Study||9
5212468|NCT00987415|12816402|P1|NOT COMPLETED|Overall Study||9
5212469|NCT00987415|12816401|P2|COMPLETED|Overall Study||116
5212470|NCT00987415|12816402|P1|COMPLETED|Overall Study||119
5212471|NCT00987415|12816401|P2|STARTED|Overall Study||125
5212472|NCT00987415|12816402|P1|STARTED|Overall Study||128
5212473|NCT00987402|12816418|P2|NOT COMPLETED|Overall Study||98
5212474|NCT00987402|12816419|P1|NOT COMPLETED|Overall Study||86
5212475|NCT00987402|12816418|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
5212476|NCT00987402|12816419|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
5212477|NCT00987402|12816418|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
5212478|NCT00987402|12816419|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
5212479|NCT00987389|12816427|P4|NOT COMPLETED|Overall Study||3
5212480|NCT00987389|12816428|P3|NOT COMPLETED|Overall Study||8
5212481|NCT00987389|12816429|P2|NOT COMPLETED|Overall Study||8
5212482|NCT00987389|12816430|P1|NOT COMPLETED|Overall Study||9
5212483|NCT00987389|12816427|P4|COMPLETED|Overall Study||174
5212484|NCT00987389|12816428|P3|COMPLETED|Overall Study||167
5212485|NCT00987389|12816429|P2|COMPLETED|Overall Study||168
5212486|NCT00987389|12816430|P1|COMPLETED|Overall Study||167
5212487|NCT00987389|12816427|P4|STARTED|Overall Study||177
5212488|NCT00987389|12816428|P3|STARTED|Overall Study||175
5212489|NCT00987389|12816429|P2|STARTED|Overall Study||176
5212490|NCT00987389|12816430|P1|STARTED|Overall Study||176
5212491|NCT00987337|12816449|P3|NOT COMPLETED|Overall Study||51
5212492|NCT00987337|12816450|P2|NOT COMPLETED|Overall Study||55
5212493|NCT00987337|12816451|P1|NOT COMPLETED|Overall Study||57
5212494|NCT00987337|12816449|P3|COMPLETED|Overall Study||45
5212495|NCT00987337|12816450|P2|COMPLETED|Overall Study||41
5212496|NCT00987337|12816451|P1|COMPLETED|Overall Study||39
5212497|NCT00987337|12816449|P3|STARTED|Overall Study||96
5212498|NCT00987337|12816450|P2|STARTED|Overall Study||96
5212499|NCT00987337|12816451|P1|STARTED|Overall Study||96
5212500|NCT00986999|12816495|P1|NOT COMPLETED|Overall Study||1
5212501|NCT00986999|12816495|P1|COMPLETED|Overall Study||6
5212502|NCT00986999|12816495|P1|STARTED|Overall Study||7
5212503|NCT00986986|12816506|P2|NOT COMPLETED|Overall Study||1
5212504|NCT00986986|12816507|P1|NOT COMPLETED|Overall Study||0
5212505|NCT00986986|12816506|P2|COMPLETED|Overall Study||9
5212506|NCT00986986|12816507|P1|COMPLETED|Overall Study||10
5212507|NCT00986986|12816506|P2|STARTED|Overall Study||10
5212508|NCT00986986|12816507|P1|STARTED|Overall Study||10
5212509|NCT00986973|12816517|P1|NOT COMPLETED|Overall Study||1
5212510|NCT00986973|12816517|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
5212511|NCT00986973|12816517|P1|STARTED|Overall Study||6
5212512|NCT00986960|12816529|P2|NOT COMPLETED|Overall Study||0
5212513|NCT00986960|12816530|P1|NOT COMPLETED|Overall Study||0
5212514|NCT00986960|12816529|P2|COMPLETED|Overall Study||0
5212515|NCT00986960|12816530|P1|COMPLETED|Overall Study||0
5212516|NCT00986960|12816529|P2|STARTED|Overall Study||0
5212517|NCT00986960|12816530|P1|STARTED|Overall Study||0
5212518|NCT00986947|12816536|P1|NOT COMPLETED|Overall Study||20
5212519|NCT00986947|12816536|P1|COMPLETED|Overall Study||0
5212520|NCT00986947|12816536|P1|STARTED|Overall Study||20
5212521|NCT00986921|12816543|P2|NOT COMPLETED|Overall Study||0
5212522|NCT00986921|12816544|P1|NOT COMPLETED|Overall Study||1
5212523|NCT00986921|12816543|P2|COMPLETED|Overall Study||25
5212524|NCT00986921|12816544|P1|COMPLETED|Overall Study||24
5212525|NCT00986921|12816543|P2|STARTED|Overall Study||25
5212526|NCT00986921|12816544|P1|STARTED|Overall Study||25
5212527|NCT00986856|12816556|P2|NOT COMPLETED|Overall Study||0
5212528|NCT00986856|12816557|P1|NOT COMPLETED|Overall Study||0
5212529|NCT00986856|12816556|P2|COMPLETED|Overall Study||16
5212530|NCT00986856|12816557|P1|COMPLETED|Overall Study||42
5212531|NCT00986856|12816556|P2|STARTED|Overall Study||16
5212532|NCT00986856|12816557|P1|STARTED|Overall Study||42
5212533|NCT00986674|12816580|P3|NOT COMPLETED|Overall Study||48
5212534|NCT00986674|12816581|P2|NOT COMPLETED|Overall Study||45
5212535|NCT00986674|12816582|P1|NOT COMPLETED|Overall Study||47
5212536|NCT00986674|12816580|P3|COMPLETED|Overall Study||0
5212537|NCT00986674|12816581|P2|COMPLETED|Overall Study||0
5212538|NCT00986674|12816582|P1|COMPLETED|Overall Study||0
5212539|NCT00986674|12816580|P3|Eligible and Treated|Overall Study||47
5212540|NCT00986674|12816581|P2|Eligible and Treated|Overall Study||41
5212541|NCT00986674|12816582|P1|Eligible and Treated|Overall Study||39
5212542|NCT00986674|12816580|P3|Treated|Overall Study||47
5212543|NCT00986674|12816581|P2|Treated|Overall Study||42
5212544|NCT00986674|12816582|P1|Treated|Overall Study||43
5212545|NCT00986674|12816580|P3|STARTED|Overall Study||48
5212546|NCT00986674|12816581|P2|STARTED|Overall Study||45
5212547|NCT00986674|12816582|P1|STARTED|Overall Study||47
5212548|NCT00986583|12816598|P2|NOT COMPLETED|Overall Study||0
5212549|NCT00986583|12816599|P1|NOT COMPLETED|Overall Study||0
5212550|NCT00986583|12816598|P2|COMPLETED|Overall Study||32
5212551|NCT00986583|12816599|P1|COMPLETED|Overall Study||38
5212552|NCT00986583|12816598|P2|STARTED|Overall Study||32
5212553|NCT00986583|12816599|P1|STARTED|Overall Study||38
5212554|NCT00986570|12816615|P1|NOT COMPLETED|Overall Study||7
5212555|NCT00986570|12816615|P1|COMPLETED|Overall Study||114
5212556|NCT00986570|12816615|P1|STARTED|Overall Study||121
5212557|NCT00986544|12816621|P2|NOT COMPLETED|Overall Study||0
5212558|NCT00986544|12816622|P1|NOT COMPLETED|Overall Study||0
5212559|NCT00986544|12816621|P2|COMPLETED|Overall Study||53
5212560|NCT00986544|12816622|P1|COMPLETED|Overall Study||53
5212561|NCT00986544|12816621|P2|STARTED|Overall Study||53
5212562|NCT00986544|12816622|P1|STARTED|Overall Study||53
5212563|NCT00986479|12816632|P2|NOT COMPLETED|Period 2||0
5212564|NCT00986479|12816633|P1|NOT COMPLETED|Period 2||0
5212565|NCT00986479|12816632|P2|COMPLETED|Period 2||10
5212566|NCT00986479|12816633|P1|COMPLETED|Period 2||10
5212567|NCT00986479|12816632|P2|STARTED|Period 2||10
5212568|NCT00986479|12816633|P1|STARTED|Period 2||10
5212569|NCT00986479|12816632|P2|NOT COMPLETED|Period 1||0
5212570|NCT00986479|12816633|P1|NOT COMPLETED|Period 1||2
5212571|NCT00986479|12816632|P2|COMPLETED|Period 1||10
5212572|NCT00986479|12816633|P1|COMPLETED|Period 1||10
5212573|NCT00986479|12816632|P2|STARTED|Period 1||10
5212574|NCT00986479|12816633|P1|STARTED|Period 1||12
5212575|NCT00986453|12816663|P1|NOT COMPLETED|Overall Study||2
5212576|NCT00986453|12816663|P1|COMPLETED|Overall Study||43
5212577|NCT00986453|12816663|P1|STARTED|Overall Study||45
5212578|NCT00986427|12816679|P2|NOT COMPLETED|Overall Study||0
5212579|NCT00986427|12816680|P1|NOT COMPLETED|Overall Study||4
5212580|NCT00986427|12816679|P2|COMPLETED|Overall Study||12
5212581|NCT00986427|12816680|P1|COMPLETED|Overall Study||8
5212582|NCT00986427|12816679|P2|STARTED|Overall Study||12
5212583|NCT00986427|12816680|P1|STARTED|Overall Study||12
5212584|NCT00986401|12816696|P2|NOT COMPLETED|Period 2||0
5212585|NCT00986401|12816697|P1|NOT COMPLETED|Period 2||0
5212586|NCT00986401|12816696|P2|COMPLETED|Period 2||21
5212587|NCT00986401|12816697|P1|COMPLETED|Period 2||22
5212588|NCT00986401|12816696|P2|STARTED|Period 2||21
5212589|NCT00986401|12816697|P1|STARTED|Period 2||22
5212590|NCT00986401|12816696|P2|NOT COMPLETED|Period 1||1
5212591|NCT00986401|12816697|P1|NOT COMPLETED|Period 1||0
5212592|NCT00986401|12816696|P2|COMPLETED|Period 1||21
5212593|NCT00986401|12816697|P1|COMPLETED|Period 1||22
5212594|NCT00986401|12816696|P2|STARTED|Period 1||22
5212595|NCT00986401|12816697|P1|STARTED|Period 1||22
5212596|NCT00986362|12816708|P2|NOT COMPLETED|Overall Study||1
5212597|NCT00986362|12816709|P1|NOT COMPLETED|Overall Study||2
5212598|NCT00986362|12816708|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
5212599|NCT00986362|12816709|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
5212600|NCT00986362|12816708|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
5212601|NCT00986362|12816709|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
5212602|NCT00986349|12816715|P1|NOT COMPLETED|Overall Study||7
5212603|NCT00986349|12816715|P1|COMPLETED|Overall Study||16
5212604|NCT00986349|12816715|P1|Early Explant|Overall Study||4
5212605|NCT00986349|12816715|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
5212606|NCT00986349|12816715|P1|STARTED|Overall Study|attempted implant procedures|23
5212607|NCT00986310|12816730|P2|NOT COMPLETED|Overall Study||0
5212608|NCT00986310|12816731|P1|NOT COMPLETED|Overall Study||0
5212609|NCT00986310|12816730|P2|COMPLETED|Overall Study||0
5212610|NCT00986310|12816731|P1|COMPLETED|Overall Study||0
5212611|NCT00986310|12816730|P2|STARTED|Overall Study||0
5212612|NCT00986310|12816731|P1|STARTED|Overall Study||0
5212613|NCT00986258|12816739|P1|NOT COMPLETED|Maintenance Period||9
5212614|NCT00986258|12816739|P1|COMPLETED|Maintenance Period||93
5212615|NCT00986258|12816739|P1|STARTED|Maintenance Period||102
5212616|NCT00986258|12816739|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
5212617|NCT00986258|12816739|P1|COMPLETED|Titration and Optimal Dose Period||102
5212618|NCT00986258|12816739|P1|STARTED|Titration and Optimal Dose Period||125
5212619|NCT00986258|12816739|P1|NOT COMPLETED|Observation Period||11
5212620|NCT00986258|12816739|P1|COMPLETED|Observation Period||125
5212621|NCT00986258|12816739|P1|STARTED|Observation Period||136
5212622|NCT00986245|12816767|P2|NOT COMPLETED|Second Intervention||1
5212623|NCT00986245|12816768|P1|NOT COMPLETED|Second Intervention||2
5212624|NCT00986245|12816767|P2|COMPLETED|Second Intervention||32
5212625|NCT00986245|12816768|P1|COMPLETED|Second Intervention||29
5212626|NCT00986245|12816767|P2|STARTED|Second Intervention||33
5212627|NCT00986245|12816768|P1|STARTED|Second Intervention||31
5212628|NCT00986245|12816767|P2|NOT COMPLETED|First Intervention||8
5212629|NCT00986245|12816768|P1|NOT COMPLETED|First Intervention||10
5212630|NCT00986245|12816767|P2|COMPLETED|First Intervention||33
5212631|NCT00986245|12816768|P1|COMPLETED|First Intervention||31
5212632|NCT00986245|12816767|P2|STARTED|First Intervention||41
5212633|NCT00986245|12816768|P1|STARTED|First Intervention||41
5212634|NCT00986232|12816805|P4|NOT COMPLETED|Overall Study||20
5212635|NCT00986232|12816806|P3|NOT COMPLETED|Overall Study||35
5212636|NCT00986232|12816807|P2|NOT COMPLETED|Overall Study||50
5212637|NCT00986232|12816808|P1|NOT COMPLETED|Overall Study||51
5212638|NCT00986232|12816805|P4|COMPLETED|Overall Study||370
5212639|NCT00986232|12816806|P3|COMPLETED|Overall Study||346
5212640|NCT00986232|12816807|P2|COMPLETED|Overall Study||343
5212641|NCT00986232|12816808|P1|COMPLETED|Overall Study||336
5212642|NCT00986232|12816805|P4|Vaccination Visit 2|Overall Study||0
5212643|NCT00986232|12816806|P3|Vaccination Visit 2|Overall Study||360
5212644|NCT00986232|12816807|P2|Vaccination Visit 2|Overall Study||365
5212645|NCT00986232|12816808|P1|Vaccination Visit 2|Overall Study||360
5212646|NCT00986232|12816805|P4|Vaccination Visit 1|Overall Study||390
5212647|NCT00986232|12816806|P3|Vaccination Visit 1|Overall Study||381
5212648|NCT00986232|12816807|P2|Vaccination Visit 1|Overall Study||393
5212649|NCT00986232|12816808|P1|Vaccination Visit 1|Overall Study||387
5212650|NCT00986232|12816805|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
5212651|NCT00986232|12816806|P3|STARTED|Overall Study||381
5212652|NCT00986232|12816807|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
5212653|NCT00986232|12816808|P1|STARTED|Overall Study||387
5212654|NCT00986180|12816882|P2|NOT COMPLETED|Overall Study||56
5212655|NCT00986180|12816883|P1|NOT COMPLETED|Overall Study||44
5212656|NCT00986180|12816882|P2|COMPLETED|Overall Study||268
5212657|NCT00986180|12816883|P1|COMPLETED|Overall Study||277
5212658|NCT00986180|12816882|P2|STARTED|Overall Study||324
5212659|NCT00986180|12816883|P1|STARTED|Overall Study||321
5212660|NCT00986154|12816961|P2|NOT COMPLETED|Overall Study||194
5212661|NCT00986154|12816962|P1|NOT COMPLETED|Overall Study||206
5212662|NCT00986154|12816961|P2|COMPLETED|Overall Study||3955
5212663|NCT00986154|12816962|P1|COMPLETED|Overall Study||3937
5212664|NCT00986154|12816961|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
5212665|NCT00986154|12816962|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
5212666|NCT00986154|12816961|P2|STARTED|Overall Study||4149
5212667|NCT00986154|12816962|P1|STARTED|Overall Study||4143
5212668|NCT00986102|12816976|P4|NOT COMPLETED|Overall Study||1
5212669|NCT00986102|12816977|P3|NOT COMPLETED|Overall Study||0
5212670|NCT00986102|12816978|P2|NOT COMPLETED|Overall Study||2
5212671|NCT00986102|12816979|P1|NOT COMPLETED|Overall Study||1
5212672|NCT00986102|12816976|P4|COMPLETED|Overall Study||66
5212673|NCT00986102|12816977|P3|COMPLETED|Overall Study||19
5212674|NCT00986102|12816978|P2|COMPLETED|Overall Study||75
5212675|NCT00986102|12816979|P1|COMPLETED|Overall Study||52
5212676|NCT00986102|12816976|P4|STARTED|Overall Study|Number of participants who received study medication|67
5212677|NCT00986102|12816977|P3|STARTED|Overall Study|Number of participants who received study medication|19
5212678|NCT00986102|12816978|P2|STARTED|Overall Study|Number of participants who received study medication|77
5212679|NCT00986102|12816979|P1|STARTED|Overall Study|Number of participants who received study medication|53
5212680|NCT00985985|12817029|P4|NOT COMPLETED|Overall Study||13
5212681|NCT00985985|12817030|P3|NOT COMPLETED|Overall Study||11
5212682|NCT00985985|12817031|P2|NOT COMPLETED|Overall Study||24
5212683|NCT00985985|12817032|P1|NOT COMPLETED|Overall Study||24
5212684|NCT00985985|12817029|P4|COMPLETED|Overall Study||107
5212685|NCT00985985|12817030|P3|COMPLETED|Overall Study||109
5212686|NCT00985985|12817031|P2|COMPLETED|Overall Study||218
5212687|NCT00985985|12817032|P1|COMPLETED|Overall Study||217
5212688|NCT00985985|12817029|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
5212689|NCT00985985|12817030|P3|Full Analysis Set (FAS) Population|Overall Study||120
5212690|NCT00985985|12817031|P2|Full Analysis Set (FAS) Population|Overall Study||242
5212691|NCT00985985|12817032|P1|Full Analysis Set (FAS) Population|Overall Study||241
5212692|NCT00985985|12817029|P4|Safety Population|Overall Study||118
5212693|NCT00985985|12817030|P3|Safety Population|Overall Study||119
5212694|NCT00985985|12817031|P2|Safety Population|Overall Study||242
5212695|NCT00985985|12817032|P1|Safety Population|Overall Study||241
5212696|NCT00985985|12817029|P4|STARTED|Overall Study||120
5212697|NCT00985985|12817030|P3|STARTED|Overall Study||120
5212698|NCT00985985|12817031|P2|STARTED|Overall Study||242
5212699|NCT00985985|12817032|P1|STARTED|Overall Study||241
5212700|NCT00985959|12817073|P3|NOT COMPLETED|Overall Study||59
5212701|NCT00985959|12817074|P2|NOT COMPLETED|Overall Study||3
5212702|NCT00985959|12817075|P1|NOT COMPLETED|Overall Study||3
5212703|NCT00985959|12817073|P3|COMPLETED|Overall Study||28
5212704|NCT00985959|12817074|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
5212705|NCT00985959|12817075|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
5212706|NCT00985959|12817073|P3|STARTED|Overall Study|Number of participants treated|87
5212707|NCT00985959|12817074|P2|STARTED|Overall Study|Number of participants treated|6
5212708|NCT00985959|12817075|P1|STARTED|Overall Study|Number of participants treated|6
5212709|NCT00985946|12817098|P1|NOT COMPLETED|Overall Study||7
5212710|NCT00985946|12817098|P1|COMPLETED|Overall Study||8
5212711|NCT00985946|12817098|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
5212712|NCT00985907|12817106|P1|NOT COMPLETED|Overall Study||13
5212713|NCT00985907|12817106|P1|COMPLETED|Overall Study||0
5212714|NCT00985907|12817106|P1|STARTED|Overall Study||13
5212715|NCT00985829|12817116|P1|NOT COMPLETED|Overall Study||0
5212716|NCT00985829|12817116|P1|COMPLETED|Overall Study||28
5212717|NCT00985829|12817116|P1|STARTED|Overall Study||28
5212718|NCT00985790|12817127|P2|NOT COMPLETED|Overall Study||8
5212719|NCT00985790|12817128|P1|NOT COMPLETED|Overall Study||7
5212720|NCT00985790|12817127|P2|COMPLETED|Overall Study||293
5212721|NCT00985790|12817128|P1|COMPLETED|Overall Study||291
5212722|NCT00985790|12817127|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
5212723|NCT00985790|12817128|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
5212724|NCT00985751|12817169|P5|NOT COMPLETED|Overall Study||1
5212725|NCT00985751|12817170|P4|NOT COMPLETED|Overall Study||0
5212726|NCT00985751|12817171|P3|NOT COMPLETED|Overall Study||0
5212727|NCT00985751|12817172|P2|NOT COMPLETED|Overall Study||0
5212728|NCT00985751|12817173|P1|NOT COMPLETED|Overall Study||0
5212729|NCT00985751|12817169|P5|COMPLETED|Overall Study||50
5212730|NCT00985751|12817170|P4|COMPLETED|Overall Study||51
5212731|NCT00985751|12817171|P3|COMPLETED|Overall Study||52
5212732|NCT00985751|12817172|P2|COMPLETED|Overall Study||52
5212733|NCT00985751|12817173|P1|COMPLETED|Overall Study||51
5212734|NCT00985751|12817169|P5|STARTED|Overall Study||51
5212735|NCT00985751|12817170|P4|STARTED|Overall Study||51
5212736|NCT00985751|12817171|P3|STARTED|Overall Study||52
5212737|NCT00985751|12817172|P2|STARTED|Overall Study||52
5212738|NCT00985751|12817173|P1|STARTED|Overall Study||51
5212739|NCT00985738|12817236|P2|NOT COMPLETED|Overall Study||8
5212740|NCT00985738|12817237|P1|NOT COMPLETED|Overall Study||8
5212741|NCT00985738|12817236|P2|COMPLETED|Overall Study||0
5212742|NCT00985738|12817237|P1|COMPLETED|Overall Study||0
5212743|NCT00985738|12817236|P2|STARTED|Overall Study||8
5212744|NCT00985738|12817237|P1|STARTED|Overall Study||8
5212745|NCT00985725|12817245|P2|NOT COMPLETED|Overall Study||13
5212746|NCT00985725|12817246|P1|NOT COMPLETED|Overall Study||11
5212747|NCT00985725|12817245|P2|COMPLETED|Overall Study||59
5212748|NCT00985725|12817246|P1|COMPLETED|Overall Study||60
5212749|NCT00985725|12817245|P2|STARTED|Overall Study||72
5212750|NCT00985725|12817246|P1|STARTED|Overall Study||71
5212751|NCT00985712|12817282|P2|NOT COMPLETED|Overall Study||7
5212752|NCT00985712|12817283|P1|NOT COMPLETED|Overall Study||6
5212753|NCT00985712|12817282|P2|COMPLETED|Overall Study||123
5212754|NCT00985712|12817283|P1|COMPLETED|Overall Study||127
5212755|NCT00985712|12817282|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
5212843|NCT00985465|12817641|P1|STARTED|Overall Study||141
5212844|NCT00985439|12817668|P4|NOT COMPLETED|Overall Study||0
5212756|NCT00985712|12817283|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
5212757|NCT00985712|12817282|P2|Received at Least One Dose of Study Drug|Overall Study||130
5212758|NCT00985712|12817283|P1|Received at Least One Dose of Study Drug|Overall Study||131
5212759|NCT00985712|12817282|P2|STARTED|Overall Study||130
5212760|NCT00985712|12817283|P1|STARTED|Overall Study||133
5212761|NCT00985686|12817301|P4|NOT COMPLETED|Overall Study||2
5212762|NCT00985686|12817302|P3|NOT COMPLETED|Overall Study||0
5212763|NCT00985686|12817303|P2|NOT COMPLETED|Overall Study||1
5212764|NCT00985686|12817304|P1|NOT COMPLETED|Overall Study||1
5212765|NCT00985686|12817301|P4|COMPLETED|Overall Study||14
5212766|NCT00985686|12817302|P3|COMPLETED|Overall Study||13
5212767|NCT00985686|12817303|P2|COMPLETED|Overall Study||15
5212768|NCT00985686|12817304|P1|COMPLETED|Overall Study||17
5212769|NCT00985686|12817301|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
5212770|NCT00985686|12817302|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
5212771|NCT00985686|12817303|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
5212772|NCT00985686|12817304|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
5212773|NCT00985686|12817301|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
5212774|NCT00985686|12817302|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
5212775|NCT00985686|12817303|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
5212776|NCT00985686|12817304|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
5212777|NCT00985686|12817301|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
5212778|NCT00985686|12817302|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
5212779|NCT00985686|12817303|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
5212780|NCT00985686|12817304|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
5212781|NCT00985686|12817301|P4|Visit 1: Baseline Data Collection|Overall Study||16
5212782|NCT00985686|12817302|P3|Visit 1: Baseline Data Collection|Overall Study||13
5212783|NCT00985686|12817303|P2|Visit 1: Baseline Data Collection|Overall Study||15
5212784|NCT00985686|12817304|P1|Visit 1: Baseline Data Collection|Overall Study||18
5212785|NCT00985686|12817301|P4|STARTED|Overall Study||16
5212786|NCT00985686|12817302|P3|STARTED|Overall Study||13
5212787|NCT00985686|12817303|P2|STARTED|Overall Study||16
5212788|NCT00985686|12817304|P1|STARTED|Overall Study||18
5212789|NCT00985673|12817318|P6|NOT COMPLETED|Overall Study||6
5212790|NCT00985673|12817319|P5|NOT COMPLETED|Overall Study||8
5212791|NCT00985673|12817320|P4|NOT COMPLETED|Overall Study||12
5212792|NCT00985673|12817321|P3|NOT COMPLETED|Overall Study||12
5212793|NCT00985673|12817322|P2|NOT COMPLETED|Overall Study||11
5212794|NCT00985673|12817323|P1|NOT COMPLETED|Overall Study||7
5212795|NCT00985673|12817318|P6|COMPLETED|Overall Study||96
5212796|NCT00985673|12817319|P5|COMPLETED|Overall Study||93
5212797|NCT00985673|12817320|P4|COMPLETED|Overall Study||88
5212798|NCT00985673|12817321|P3|COMPLETED|Overall Study||90
5212799|NCT00985673|12817322|P2|COMPLETED|Overall Study||93
5212800|NCT00985673|12817323|P1|COMPLETED|Overall Study||95
5212801|NCT00985673|12817318|P6|STARTED|Overall Study||102
5212802|NCT00985673|12817319|P5|STARTED|Overall Study||101
5212803|NCT00985673|12817320|P4|STARTED|Overall Study||100
5212804|NCT00985673|12817321|P3|STARTED|Overall Study||102
5212805|NCT00985673|12817322|P2|STARTED|Overall Study||104
5212806|NCT00985673|12817323|P1|STARTED|Overall Study||102
5212807|NCT00985543|12817574|P1|NOT COMPLETED|Overall Study||0
5212808|NCT00985543|12817574|P1|COMPLETED|Overall Study||22
5212809|NCT00985543|12817574|P1|STARTED|Overall Study||22
5212810|NCT00985517|12817587|P4|NOT COMPLETED|Overall Study||3
5212811|NCT00985517|12817588|P3|NOT COMPLETED|Overall Study||1
5212812|NCT00985517|12817589|P2|NOT COMPLETED|Overall Study||0
5212813|NCT00985517|12817590|P1|NOT COMPLETED|Overall Study||0
5212814|NCT00985517|12817587|P4|COMPLETED|Overall Study||24
5212815|NCT00985517|12817588|P3|COMPLETED|Overall Study||23
5212816|NCT00985517|12817589|P2|COMPLETED|Overall Study||3
5212817|NCT00985517|12817590|P1|COMPLETED|Overall Study||3
5212818|NCT00985517|12817587|P4|STARTED|Overall Study||27
5212819|NCT00985517|12817588|P3|STARTED|Overall Study||24
5212820|NCT00985517|12817589|P2|STARTED|Overall Study||3
5212821|NCT00985517|12817590|P1|STARTED|Overall Study||3
5212822|NCT00985504|12817606|P2|NOT COMPLETED|Optimization Period||23
5212823|NCT00985504|12817607|P1|NOT COMPLETED|Optimization Period||26
5212824|NCT00985504|12817606|P2|COMPLETED|Optimization Period||204
5212825|NCT00985504|12817607|P1|COMPLETED|Optimization Period||203
5212826|NCT00985504|12817606|P2|STARTED|Optimization Period||227
5212827|NCT00985504|12817607|P1|STARTED|Optimization Period||229
5212828|NCT00985504|12817606|P2|NOT COMPLETED|Acute Treatment Period||12
5212829|NCT00985504|12817607|P1|NOT COMPLETED|Acute Treatment Period||15
5212830|NCT00985504|12817606|P2|COMPLETED|Acute Treatment Period||227
5212831|NCT00985504|12817607|P1|COMPLETED|Acute Treatment Period||229
5212832|NCT00985504|12817606|P2|STARTED|Acute Treatment Period||239
5212833|NCT00985504|12817607|P1|STARTED|Acute Treatment Period||244
5212834|NCT00985491|12817633|P1|NOT COMPLETED|Overall Study||19
5212835|NCT00985491|12817633|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
5212836|NCT00985491|12817633|P1|Received Device|Overall Study||43
5212837|NCT00985491|12817633|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
5212838|NCT00985465|12817640|P2|NOT COMPLETED|Overall Study||3
5212839|NCT00985465|12817641|P1|NOT COMPLETED|Overall Study||1
5212840|NCT00985465|12817640|P2|COMPLETED|Overall Study||66
5212841|NCT00985465|12817641|P1|COMPLETED|Overall Study||140
5212842|NCT00985465|12817640|P2|STARTED|Overall Study||69
5212845|NCT00985439|12817669|P3|NOT COMPLETED|Overall Study||1
5212846|NCT00985439|12817670|P2|NOT COMPLETED|Overall Study||0
5212847|NCT00985439|12817671|P1|NOT COMPLETED|Overall Study||0
5212848|NCT00985439|12817668|P4|COMPLETED|Overall Study||51
5212849|NCT00985439|12817669|P3|COMPLETED|Overall Study||50
5212850|NCT00985439|12817670|P2|COMPLETED|Overall Study||51
5212851|NCT00985439|12817671|P1|COMPLETED|Overall Study||49
5212852|NCT00985439|12817668|P4|STARTED|Overall Study||51
5212853|NCT00985439|12817669|P3|STARTED|Overall Study||51
5212854|NCT00985439|12817670|P2|STARTED|Overall Study||51
5212855|NCT00985439|12817671|P1|STARTED|Overall Study||49
5212856|NCT00985257|12817681|P1|NOT COMPLETED|Overall Study||0
5212857|NCT00985257|12817681|P1|COMPLETED|Overall Study||123
5212858|NCT00985257|12817681|P1|STARTED|Overall Study||123
5212859|NCT00985231|12817687|P2|NOT COMPLETED|Overall Study||3
5212860|NCT00985231|12817688|P1|NOT COMPLETED|Overall Study||3
5212861|NCT00985231|12817687|P2|COMPLETED|Overall Study||129
5212862|NCT00985231|12817688|P1|COMPLETED|Overall Study||130
5212863|NCT00985231|12817687|P2|STARTED|Overall Study||132
5212864|NCT00985231|12817688|P1|STARTED|Overall Study||133
5212865|NCT00985192|12817696|P1|NOT COMPLETED|Overall Study||4
5212866|NCT00985192|12817696|P1|COMPLETED|Overall Study||45
5212867|NCT00985192|12817696|P1|STARTED|Overall Study||49
5212868|NCT00985166|12817708|P3|NOT COMPLETED|Overall Study||7
5212869|NCT00985166|12817709|P2|NOT COMPLETED|Overall Study||4
5212870|NCT00985166|12817710|P1|NOT COMPLETED|Overall Study||9
5212871|NCT00985166|12817708|P3|COMPLETED|Overall Study||188
5212872|NCT00985166|12817709|P2|COMPLETED|Overall Study||201
5212873|NCT00985166|12817710|P1|COMPLETED|Overall Study||392
5212874|NCT00985166|12817708|P3|Vaccinated at Visit 1|Overall Study||195
5212875|NCT00985166|12817709|P2|Vaccinated at Visit 1|Overall Study||205
5212876|NCT00985166|12817710|P1|Vaccinated at Visit 1|Overall Study||399
5212877|NCT00985166|12817708|P3|STARTED|Overall Study||195
5212878|NCT00985166|12817709|P2|STARTED|Overall Study||205
5212879|NCT00985166|12817710|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
5212880|NCT00985153|12817730|P4|NOT COMPLETED|Overall Study||47
5212881|NCT00985153|12817731|P3|NOT COMPLETED|Overall Study||44
5212882|NCT00985153|12817732|P2|NOT COMPLETED|Overall Study||44
5212883|NCT00985153|12817733|P1|NOT COMPLETED|Overall Study||35
5212884|NCT00985153|12817730|P4|COMPLETED|Overall Study||965
5212885|NCT00985153|12817731|P3|COMPLETED|Overall Study||918
5212886|NCT00985153|12817732|P2|COMPLETED|Overall Study||924
5212887|NCT00985153|12817733|P1|COMPLETED|Overall Study||950
5212888|NCT00985153|12817730|P4|Vaccinated at Visit 1|Overall Study||1012
5212889|NCT00985153|12817731|P3|Vaccinated at Visit 1|Overall Study||962
5212890|NCT00985153|12817732|P2|Vaccinated at Visit 1|Overall Study||968
5212891|NCT00985153|12817733|P1|Vaccinated at Visit 1|Overall Study||985
5212892|NCT00985153|12817730|P4|STARTED|Overall Study||1012
5212893|NCT00985153|12817731|P3|STARTED|Overall Study||962
5212894|NCT00985153|12817732|P2|STARTED|Overall Study||968
5212895|NCT00985153|12817733|P1|STARTED|Overall Study||985
5212896|NCT00985140|12817775|P1|NOT COMPLETED|Overall Study||0
5212897|NCT00985140|12817775|P1|COMPLETED|Overall Study||15
5212898|NCT00985140|12817775|P1|STARTED|Overall Study||15
5212899|NCT00985114|12817781|P2|NOT COMPLETED|Overall Study||2
5212900|NCT00985114|12817782|P1|NOT COMPLETED|Overall Study||1
5212901|NCT00985114|12817781|P2|COMPLETED|Overall Study||37
5212902|NCT00985114|12817782|P1|COMPLETED|Overall Study||33
5212903|NCT00985114|12817781|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
5212904|NCT00985114|12817782|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
5212905|NCT00985114|12817781|P2|STARTED|Overall Study||39
5212906|NCT00985114|12817782|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
5212907|NCT00985088|12817796|P8|NOT COMPLETED|Overall Study||6
5212908|NCT00985088|12817797|P7|NOT COMPLETED|Overall Study||4
5212909|NCT00985088|12817798|P6|NOT COMPLETED|Overall Study||7
5212910|NCT00985088|12817799|P5|NOT COMPLETED|Overall Study||9
5212911|NCT00985088|12817800|P4|NOT COMPLETED|Overall Study||7
5212912|NCT00985088|12817801|P3|NOT COMPLETED|Overall Study||4
5212913|NCT00985088|12817802|P2|NOT COMPLETED|Overall Study||2
5212914|NCT00985088|12817803|P1|NOT COMPLETED|Overall Study||11
5212915|NCT00985088|12817796|P8|COMPLETED|Overall Study||216
5212916|NCT00985088|12817797|P7|COMPLETED|Overall Study||107
5212917|NCT00985088|12817798|P6|COMPLETED|Overall Study||108
5212918|NCT00985088|12817799|P5|COMPLETED|Overall Study||214
5212919|NCT00985088|12817800|P4|COMPLETED|Overall Study||214
5212920|NCT00985088|12817801|P3|COMPLETED|Overall Study||108
5212921|NCT00985088|12817802|P2|COMPLETED|Overall Study||112
5212922|NCT00985088|12817803|P1|COMPLETED|Overall Study||211
5212923|NCT00985088|12817796|P8|STARTED|Overall Study||222
5212924|NCT00985088|12817797|P7|STARTED|Overall Study||111
5212925|NCT00985088|12817798|P6|STARTED|Overall Study||115
5212926|NCT00985088|12817799|P5|STARTED|Overall Study||223
5212927|NCT00985088|12817800|P4|STARTED|Overall Study||221
5212928|NCT00985088|12817801|P3|STARTED|Overall Study||112
5212929|NCT00985088|12817802|P2|STARTED|Overall Study||114
5212930|NCT00985088|12817803|P1|STARTED|Overall Study||222
5212931|NCT00985010|12818061|P2|NOT COMPLETED|Overall Study||0
5212932|NCT00985010|12818062|P1|NOT COMPLETED|Overall Study||0
5212933|NCT00985010|12818061|P2|COMPLETED|Overall Study||5
5212934|NCT00985010|12818062|P1|COMPLETED|Overall Study||4
5212935|NCT00985010|12818061|P2|STARTED|Overall Study||5
5212936|NCT00985010|12818062|P1|STARTED|Overall Study||4
5212937|NCT00984867|12818072|P2|NOT COMPLETED|Overall Study||17
5212938|NCT00984867|12818073|P1|NOT COMPLETED|Overall Study||23
5212939|NCT00984867|12818072|P2|COMPLETED|Overall Study||208
5212940|NCT00984867|12818073|P1|COMPLETED|Overall Study||203
5212941|NCT00984867|12818072|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
5212942|NCT00984867|12818073|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
5212943|NCT00984815|12818091|P1|NOT COMPLETED|Overall Study||30
5212944|NCT00984815|12818091|P1|COMPLETED|Overall Study||56
5212945|NCT00984815|12818091|P1|STARTED|Overall Study||86
5212946|NCT00984698|12818100|P2|NOT COMPLETED|Overall Study||8
5212947|NCT00984698|12818101|P1|NOT COMPLETED|Overall Study||3
5212948|NCT00984698|12818100|P2|COMPLETED|Overall Study||14
5212949|NCT00984698|12818101|P1|COMPLETED|Overall Study||18
5212950|NCT00984698|12818100|P2|STARTED|Overall Study||22
5212951|NCT00984698|12818101|P1|STARTED|Overall Study||21
5212952|NCT00984659|12818113|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
5212953|NCT00984659|12818114|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
5212954|NCT00984659|12818115|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
5212955|NCT00984659|12818116|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
5212956|NCT00984659|12818113|P4|COMPLETED|6-week Double-blind Treatment Period||126
5212957|NCT00984659|12818114|P3|COMPLETED|6-week Double-blind Treatment Period||141
5212958|NCT00984659|12818115|P2|COMPLETED|6-week Double-blind Treatment Period||69
5212959|NCT00984659|12818116|P1|COMPLETED|6-week Double-blind Treatment Period||0
5212960|NCT00984659|12818113|P4|STARTED|6-week Double-blind Treatment Period||139
5212961|NCT00984659|12818114|P3|STARTED|6-week Double-blind Treatment Period||152
5212962|NCT00984659|12818115|P2|STARTED|6-week Double-blind Treatment Period||75
5212963|NCT00984659|12818116|P1|STARTED|6-week Double-blind Treatment Period||0
5212964|NCT00984659|12818113|P4|NOT COMPLETED|2-week Run-in Period||0
5212965|NCT00984659|12818114|P3|NOT COMPLETED|2-week Run-in Period||0
5212966|NCT00984659|12818115|P2|NOT COMPLETED|2-week Run-in Period||0
5212967|NCT00984659|12818116|P1|NOT COMPLETED|2-week Run-in Period||52
5212968|NCT00984659|12818113|P4|COMPLETED|2-week Run-in Period||0
5212969|NCT00984659|12818114|P3|COMPLETED|2-week Run-in Period||0
5212970|NCT00984659|12818115|P2|COMPLETED|2-week Run-in Period||0
5212971|NCT00984659|12818116|P1|COMPLETED|2-week Run-in Period||366
5212972|NCT00984659|12818113|P4|STARTED|2-week Run-in Period||0
5212973|NCT00984659|12818114|P3|STARTED|2-week Run-in Period||0
5212974|NCT00984659|12818115|P2|STARTED|2-week Run-in Period||0
5212975|NCT00984659|12818116|P1|STARTED|2-week Run-in Period||418
5212976|NCT00984620|12818143|P2|NOT COMPLETED|Overall Study||12
5212977|NCT00984620|12818144|P1|NOT COMPLETED|Overall Study||6
5212978|NCT00984620|12818143|P2|COMPLETED|Overall Study||67
5212979|NCT00984620|12818144|P1|COMPLETED|Overall Study||75
5212980|NCT00984620|12818143|P2|STARTED|Overall Study||79
5212981|NCT00984620|12818144|P1|STARTED|Overall Study||81
5212982|NCT00984594|12818182|P2|NOT COMPLETED|Overall Study||1
5212983|NCT00984594|12818183|P1|NOT COMPLETED|Overall Study||1
5212984|NCT00984594|12818182|P2|COMPLETED|Overall Study||1
5212985|NCT00984594|12818183|P1|COMPLETED|Overall Study||1
5212986|NCT00984594|12818182|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
5212987|NCT00984594|12818183|P1|STARTED|Overall Study||2
5212988|NCT00984568|12818199|P2|NOT COMPLETED|Overall Study||6
5212989|NCT00984568|12818200|P1|NOT COMPLETED|Overall Study||8
5212990|NCT00984568|12818199|P2|COMPLETED|Overall Study||7
5212991|NCT00984568|12818200|P1|COMPLETED|Overall Study||7
5212992|NCT00984568|12818199|P2|STARTED|Overall Study||13
5212993|NCT00984568|12818200|P1|STARTED|Overall Study||15
5212994|NCT00984542|12818208|P1|NOT COMPLETED|Overall Study||41
5212995|NCT00984542|12818208|P1|COMPLETED|Overall Study||9
5212996|NCT00984542|12818208|P1|STARTED|Overall Study||50
5212997|NCT00984490|12818216|P1|NOT COMPLETED|Overall Study||0
5212998|NCT00984490|12818216|P1|COMPLETED|Overall Study||5
5212999|NCT00984490|12818216|P1|STARTED|Overall Study||5
5213000|NCT00984334|12818226|P5|NOT COMPLETED|Overall Study||1
5213001|NCT00984334|12818227|P4|NOT COMPLETED|Overall Study||1
5213002|NCT00984334|12818228|P3|NOT COMPLETED|Overall Study||0
5213003|NCT00984334|12818229|P2|NOT COMPLETED|Overall Study||1
5213004|NCT00984334|12818230|P1|NOT COMPLETED|Overall Study||1
5213005|NCT00984334|12818226|P5|COMPLETED|Overall Study||7
5213006|NCT00984334|12818227|P4|COMPLETED|Overall Study||7
5213007|NCT00984334|12818228|P3|COMPLETED|Overall Study||8
5213008|NCT00984334|12818229|P2|COMPLETED|Overall Study||7
5213009|NCT00984334|12818230|P1|COMPLETED|Overall Study||7
5213010|NCT00984334|12818226|P5|STARTED|Overall Study||8
5213011|NCT00984334|12818227|P4|STARTED|Overall Study||8
5213012|NCT00984334|12818228|P3|STARTED|Overall Study||8
5213013|NCT00984334|12818229|P2|STARTED|Overall Study||8
5213014|NCT00984334|12818230|P1|STARTED|Overall Study||8
5213015|NCT00984308|12818244|P2|NOT COMPLETED|Overall Study||6
5213016|NCT00984308|12818245|P1|NOT COMPLETED|Overall Study||18
5213017|NCT00984308|12818244|P2|COMPLETED|Overall Study||109
5213018|NCT00984308|12818245|P1|COMPLETED|Overall Study||92
5213019|NCT00984308|12818244|P2|STARTED|Overall Study||115
5213020|NCT00984308|12818245|P1|STARTED|Overall Study||110
5213021|NCT00984295|12818258|P3|NOT COMPLETED|Overall Study||37
5213022|NCT00984295|12818259|P2|NOT COMPLETED|Overall Study||32
5213023|NCT00984295|12818260|P1|NOT COMPLETED|Overall Study||65
5213024|NCT00984295|12818258|P3|COMPLETED|Overall Study||442
5213025|NCT00984295|12818259|P2|COMPLETED|Overall Study||453
5213026|NCT00984295|12818260|P1|COMPLETED|Overall Study||884
5213027|NCT00984295|12818258|P3|Visit 2|Overall Study||453
5213028|NCT00984295|12818259|P2|Visit 2|Overall Study||468
5213029|NCT00984295|12818260|P1|Visit 2|Overall Study||909
5213030|NCT00984295|12818258|P3|Visit 1|Overall Study||479
5213031|NCT00984295|12818259|P2|Visit 1|Overall Study||485
5213032|NCT00984295|12818260|P1|Visit 1|Overall Study||949
5213033|NCT00984295|12818258|P3|STARTED|Overall Study||479
5213034|NCT00984295|12818259|P2|STARTED|Overall Study||485
5213035|NCT00984295|12818260|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
5213036|NCT00984282|12818327|P2|NOT COMPLETED|Long Term Follow-up||120
5213037|NCT00984282|12818328|P1|NOT COMPLETED|Long Term Follow-up||69
5213038|NCT00984282|12818327|P2|COMPLETED|Long Term Follow-up||4
5213039|NCT00984282|12818328|P1|COMPLETED|Long Term Follow-up||3
5213040|NCT00984282|12818327|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
5213041|NCT00984282|12818328|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
5213042|NCT00984282|12818327|P2|NOT COMPLETED|Open-label Treatment||161
5213043|NCT00984282|12818328|P1|NOT COMPLETED|Open-label Treatment||86
5213044|NCT00984282|12818327|P2|COMPLETED|Open-label Treatment||0
5213045|NCT00984282|12818328|P1|COMPLETED|Open-label Treatment||0
5213046|NCT00984282|12818327|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
5213047|NCT00984282|12818328|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
5213048|NCT00984282|12818327|P2|STARTED|Open-label Treatment||161
5213049|NCT00984282|12818328|P1|STARTED|Open-label Treatment||86
5213050|NCT00984282|12818327|P2|NOT COMPLETED|Double Blind Treatment||38
5213051|NCT00984282|12818328|P1|NOT COMPLETED|Double Blind Treatment||104
5213052|NCT00984282|12818327|P2|COMPLETED|Double Blind Treatment||172
5213053|NCT00984282|12818328|P1|COMPLETED|Double Blind Treatment||103
5213054|NCT00984282|12818327|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
5213055|NCT00984282|12818328|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
5213056|NCT00984282|12818327|P2|STARTED|Double Blind Treatment||210
5213057|NCT00984282|12818328|P1|STARTED|Double Blind Treatment||207
5213058|NCT00984256|12818351|P2|NOT COMPLETED|Overall Study||1
5213059|NCT00984256|12818352|P1|NOT COMPLETED|Overall Study||0
5213060|NCT00984256|12818351|P2|COMPLETED|Overall Study||29
5213061|NCT00984256|12818352|P1|COMPLETED|Overall Study||6
5213062|NCT00984256|12818351|P2|STARTED|Overall Study||30
5213063|NCT00984256|12818352|P1|STARTED|Overall Study||6
5213064|NCT00984204|12818372|P1|NOT COMPLETED|Overall Study||15
5213065|NCT00984204|12818372|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
5213066|NCT00984204|12818372|P1|STARTED|Overall Study||188
5213067|NCT00984165|12818382|P4|NOT COMPLETED|Overall Study||4
5213068|NCT00984165|12818383|P3|NOT COMPLETED|Overall Study||0
5213069|NCT00984165|12818384|P2|NOT COMPLETED|Overall Study||1
5213070|NCT00984165|12818385|P1|NOT COMPLETED|Overall Study||7
5213071|NCT00984165|12818382|P4|COMPLETED|Overall Study||0
5213072|NCT00984165|12818383|P3|COMPLETED|Overall Study||4
5213073|NCT00984165|12818384|P2|COMPLETED|Overall Study||0
5213074|NCT00984165|12818385|P1|COMPLETED|Overall Study||2
5213075|NCT00984165|12818382|P4|STARTED|Overall Study||4
5213076|NCT00984165|12818383|P3|STARTED|Overall Study||4
5213077|NCT00984165|12818384|P2|STARTED|Overall Study||1
5213078|NCT00984165|12818385|P1|STARTED|Overall Study||9
5213079|NCT00984139|12818398|P1|NOT COMPLETED|Overall Study||0
5213080|NCT00984139|12818398|P1|COMPLETED|Overall Study||306
5213081|NCT00984139|12818398|P1|STARTED|Overall Study||306
5213082|NCT00984126|12818414|P4|NOT COMPLETED|Overall Study||59
5213083|NCT00984126|12818415|P3|NOT COMPLETED|Overall Study||7
5213084|NCT00984126|12818416|P2|NOT COMPLETED|Overall Study||8
5213085|NCT00984126|12818417|P1|NOT COMPLETED|Overall Study||7
5213086|NCT00984126|12818414|P4|COMPLETED|Overall Study||76
5213087|NCT00984126|12818415|P3|COMPLETED|Overall Study||16
5213088|NCT00984126|12818416|P2|COMPLETED|Overall Study||20
5213089|NCT00984126|12818417|P1|COMPLETED|Overall Study||20
5213090|NCT00984126|12818414|P4|STARTED|Overall Study||135
5213091|NCT00984126|12818415|P3|STARTED|Overall Study||23
5213092|NCT00984126|12818416|P2|STARTED|Overall Study||28
5213093|NCT00984126|12818417|P1|STARTED|Overall Study||27
5213094|NCT00984061|12818442|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
5213095|NCT00984061|12818442|P1|COMPLETED|Colchicine With Clarithromycin||23
5213096|NCT00984061|12818442|P1|STARTED|Colchicine With Clarithromycin||23
5213097|NCT00984061|12818442|P1|NOT COMPLETED|Clarithromycin Alone||1
5213098|NCT00984061|12818442|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
5213099|NCT00984061|12818442|P1|STARTED|Clarithromycin Alone||24
5213100|NCT00984061|12818442|P1|NOT COMPLETED|21 Day Washout Period||0
5213101|NCT00984061|12818442|P1|COMPLETED|21 Day Washout Period||24
5213102|NCT00984061|12818442|P1|STARTED|21 Day Washout Period||24
5213103|NCT00984061|12818442|P1|NOT COMPLETED|Colchicine Alone||0
5213104|NCT00984061|12818442|P1|COMPLETED|Colchicine Alone||24
5213105|NCT00984061|12818442|P1|STARTED|Colchicine Alone||24
5213106|NCT00984022|12818455|P2|NOT COMPLETED|Overall Study||14
5213107|NCT00984022|12818456|P1|NOT COMPLETED|Overall Study||10
5213108|NCT00984022|12818455|P2|COMPLETED|Overall Study||35
5213109|NCT00984022|12818456|P1|COMPLETED|Overall Study||33
5213110|NCT00984022|12818455|P2|STARTED|Overall Study||49
5213111|NCT00984022|12818456|P1|STARTED|Overall Study||43
5213112|NCT00984009|12818466|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
5213113|NCT00984009|12818466|P1|COMPLETED|Colchicine With Grapefruit Juice||21
5213114|NCT00984009|12818466|P1|STARTED|Colchicine With Grapefruit Juice||21
5213115|NCT00984009|12818466|P1|NOT COMPLETED|Grapefruit Juice Alone||1
5213116|NCT00984009|12818466|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
5213117|NCT00984009|12818466|P1|STARTED|Grapefruit Juice Alone||22
5213118|NCT00984009|12818466|P1|NOT COMPLETED|14 Day Washout Period||0
5213119|NCT00984009|12818466|P1|COMPLETED|14 Day Washout Period||22
5213120|NCT00984009|12818466|P1|STARTED|14 Day Washout Period||22
5213121|NCT00984009|12818466|P1|NOT COMPLETED|Colchicine Alone||0
5213122|NCT00984009|12818466|P1|COMPLETED|Colchicine Alone||22
5213123|NCT00984009|12818466|P1|STARTED|Colchicine Alone||22
5213124|NCT00983983|12818480|P3|NOT COMPLETED|Overall Study||1
5213125|NCT00983983|12818481|P2|NOT COMPLETED|Overall Study||1
5213126|NCT00983983|12818482|P1|NOT COMPLETED|Overall Study||2
5213127|NCT00983983|12818480|P3|COMPLETED|Overall Study||6
5213128|NCT00983983|12818481|P2|COMPLETED|Overall Study||8
5213129|NCT00983983|12818482|P1|COMPLETED|Overall Study||6
5213130|NCT00983983|12818480|P3|STARTED|Overall Study||7
5213131|NCT00983983|12818481|P2|STARTED|Overall Study||9
5213132|NCT00983983|12818482|P1|STARTED|Overall Study||8
5213133|NCT00983957|12818499|P1|NOT COMPLETED|Overall Study||2
5213134|NCT00983957|12818499|P1|COMPLETED|Overall Study||18
5213135|NCT00983957|12818499|P1|Treatment C|Overall Study||18
5213136|NCT00983957|12818499|P1|Treatment B|Overall Study||20
5213137|NCT00983957|12818499|P1|Treatment A|Overall Study||20
5213138|NCT00983957|12818499|P1|STARTED|Overall Study||20
5213139|NCT00983931|12818533|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
5213140|NCT00983931|12818533|P1|COMPLETED|Colchicine With Cyclosporine||23
5213141|NCT00983931|12818533|P1|STARTED|Colchicine With Cyclosporine||23
5213142|NCT00983931|12818533|P1|NOT COMPLETED|14 Day Washout Period||1
5213143|NCT00983931|12818533|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
5213144|NCT00983931|12818533|P1|STARTED|14 Day Washout Period||24
5213145|NCT00983931|12818533|P1|NOT COMPLETED|Colchicine Alone||0
5213146|NCT00983931|12818533|P1|COMPLETED|Colchicine Alone||24
5213147|NCT00983931|12818533|P1|STARTED|Colchicine Alone||24
5213148|NCT00983918|12818547|P4|NOT COMPLETED|Overall Study||2
5213149|NCT00983918|12818548|P3|NOT COMPLETED|Overall Study||2
5213150|NCT00983918|12818549|P2|NOT COMPLETED|Overall Study||2
5213151|NCT00983918|12818550|P1|NOT COMPLETED|Overall Study||0
5213152|NCT00983918|12818547|P4|COMPLETED|Overall Study||18
5213153|NCT00983918|12818548|P3|COMPLETED|Overall Study||18
5213154|NCT00983918|12818549|P2|COMPLETED|Overall Study||18
5213155|NCT00983918|12818550|P1|COMPLETED|Overall Study||20
5213156|NCT00983918|12818547|P4|STARTED|Overall Study||20
5213157|NCT00983918|12818548|P3|STARTED|Overall Study||20
5213158|NCT00983918|12818549|P2|STARTED|Overall Study||20
5213159|NCT00983918|12818550|P1|STARTED|Overall Study||20
5213160|NCT00983905|12818560|P1|NOT COMPLETED|Theophylline With Colchicine||0
5213161|NCT00983905|12818560|P1|COMPLETED|Theophylline With Colchicine||27
5213162|NCT00983905|12818560|P1|STARTED|Theophylline With Colchicine||27
5213163|NCT00983905|12818560|P1|NOT COMPLETED|Colchicine Alone||2
5213164|NCT00983905|12818560|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
5213165|NCT00983905|12818560|P1|STARTED|Colchicine Alone||29
5213166|NCT00983905|12818560|P1|NOT COMPLETED|4 Day Washout Period||0
5213167|NCT00983905|12818560|P1|COMPLETED|4 Day Washout Period||29
5213168|NCT00983905|12818560|P1|STARTED|4 Day Washout Period||29
5213169|NCT00983905|12818560|P1|NOT COMPLETED|Theophylline Alone||1
5213170|NCT00983905|12818560|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
5213171|NCT00983905|12818560|P1|STARTED|Theophylline Alone||30
5213172|NCT00983892|12818573|P2|NOT COMPLETED|Overall Study||12
5213173|NCT00983892|12818574|P1|NOT COMPLETED|Overall Study||10
5213174|NCT00983892|12818573|P2|COMPLETED|Overall Study||56
5213175|NCT00983892|12818574|P1|COMPLETED|Overall Study||56
5213176|NCT00983892|12818573|P2|STARTED|Overall Study||68
5213177|NCT00983892|12818574|P1|STARTED|Overall Study||66
5213178|NCT00983853|12818586|P6|NOT COMPLETED|Overall Study||1
5213179|NCT00983853|12818587|P5|NOT COMPLETED|Overall Study||3
5213180|NCT00983853|12818588|P4|NOT COMPLETED|Overall Study||2
5213181|NCT00983853|12818589|P3|NOT COMPLETED|Overall Study||3
5213182|NCT00983853|12818590|P2|NOT COMPLETED|Overall Study||2
5213183|NCT00983853|12818591|P1|NOT COMPLETED|Overall Study||1
5213184|NCT00983853|12818586|P6|COMPLETED|Overall Study||7
5213185|NCT00983853|12818587|P5|COMPLETED|Overall Study||12
5213186|NCT00983853|12818588|P4|COMPLETED|Overall Study||6
5213187|NCT00983853|12818589|P3|COMPLETED|Overall Study||14
5213188|NCT00983853|12818590|P2|COMPLETED|Overall Study||5
5213189|NCT00983853|12818591|P1|COMPLETED|Overall Study||6
5213190|NCT00983853|12818586|P6|STARTED|Overall Study||8
5213191|NCT00983853|12818587|P5|STARTED|Overall Study||15
5213192|NCT00983853|12818588|P4|STARTED|Overall Study||8
5213193|NCT00983853|12818589|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
5213194|NCT00983853|12818590|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
5213195|NCT00983853|12818591|P1|STARTED|Overall Study||7
5213196|NCT00983827|12818619|P1|NOT COMPLETED|Overall Study||1
5213197|NCT00983827|12818619|P1|COMPLETED|Overall Study||7
5213198|NCT00983827|12818619|P1|STARTED|Overall Study||8
5213199|NCT00983801|12818623|P1|NOT COMPLETED|Overall Study||0
5213200|NCT00983801|12818623|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
5213201|NCT00983801|12818623|P1|STARTED|Overall Study|Participants who received treatment.|52
5213202|NCT00983749|12818637|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
5213203|NCT00983749|12818638|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
5213204|NCT00983749|12818637|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
5213205|NCT00983749|12818638|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
5213206|NCT00983749|12818637|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
5213207|NCT00983749|12818638|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
5213208|NCT00983749|12818637|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
5213209|NCT00983749|12818638|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
5213210|NCT00983749|12818637|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
5213211|NCT00983749|12818638|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
5213212|NCT00983749|12818637|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
5213213|NCT00983749|12818638|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
5213214|NCT00983645|12818648|P2|NOT COMPLETED|Overall Study||0
5213215|NCT00983645|12818649|P1|NOT COMPLETED|Overall Study||0
5213216|NCT00983645|12818648|P2|COMPLETED|Overall Study||7
5213217|NCT00983645|12818649|P1|COMPLETED|Overall Study||8
5213218|NCT00983645|12818648|P2|STARTED|Overall Study||7
5213219|NCT00983645|12818649|P1|STARTED|Overall Study||8
5213220|NCT00983619|12818673|P12|NOT COMPLETED|Overall Study||11
5213221|NCT00983619|12818674|P11|NOT COMPLETED|Overall Study||11
5213222|NCT00983619|12818675|P10|NOT COMPLETED|Overall Study||3
5213223|NCT00983619|12818676|P9|NOT COMPLETED|Overall Study||1
5213224|NCT00983619|12818677|P8|NOT COMPLETED|Overall Study||2
5213225|NCT00983619|12818678|P7|NOT COMPLETED|Overall Study||3
5213226|NCT00983619|12818679|P6|NOT COMPLETED|Overall Study||67
5213227|NCT00983619|12818680|P5|NOT COMPLETED|Overall Study||3
5213228|NCT00983619|12818681|P4|NOT COMPLETED|Overall Study||5
5213229|NCT00983619|12818682|P3|NOT COMPLETED|Overall Study||3
5213230|NCT00983619|12818683|P2|NOT COMPLETED|Overall Study||4
5213231|NCT00983619|12818684|P1|NOT COMPLETED|Overall Study||3
5213232|NCT00983619|12818673|P12|COMPLETED|Overall Study||3
5213233|NCT00983619|12818674|P11|COMPLETED|Overall Study||6
5213234|NCT00983619|12818675|P10|COMPLETED|Overall Study||0
5213235|NCT00983619|12818676|P9|COMPLETED|Overall Study||0
5213236|NCT00983619|12818677|P8|COMPLETED|Overall Study||1
5213237|NCT00983619|12818678|P7|COMPLETED|Overall Study||0
5213238|NCT00983619|12818679|P6|COMPLETED|Overall Study||9
5213239|NCT00983619|12818680|P5|COMPLETED|Overall Study||0
5213240|NCT00983619|12818681|P4|COMPLETED|Overall Study||1
5213241|NCT00983619|12818682|P3|COMPLETED|Overall Study||0
5213242|NCT00983619|12818683|P2|COMPLETED|Overall Study||0
5213243|NCT00983619|12818684|P1|COMPLETED|Overall Study||0
5213244|NCT00983619|12818673|P12|STARTED|Overall Study||14
5213245|NCT00983619|12818674|P11|STARTED|Overall Study||17
5213246|NCT00983619|12818675|P10|STARTED|Overall Study||3
5213247|NCT00983619|12818676|P9|STARTED|Overall Study||1
5213248|NCT00983619|12818677|P8|STARTED|Overall Study||3
5213249|NCT00983619|12818678|P7|STARTED|Overall Study||3
5213250|NCT00983619|12818679|P6|STARTED|Overall Study||76
5213251|NCT00983619|12818680|P5|STARTED|Overall Study||3
5213252|NCT00983619|12818681|P4|STARTED|Overall Study||6
5213253|NCT00983619|12818682|P3|STARTED|Overall Study||3
5213254|NCT00983619|12818683|P2|STARTED|Overall Study||4
5213255|NCT00983619|12818684|P1|STARTED|Overall Study||3
5213256|NCT00983580|12818989|P2|NOT COMPLETED|Overall Study||4
5213257|NCT00983580|12818990|P1|NOT COMPLETED|Overall Study||5
5213258|NCT00983580|12818989|P2|COMPLETED|Overall Study||49
5213259|NCT00983580|12818990|P1|COMPLETED|Overall Study||49
5213260|NCT00983580|12818989|P2|STARTED|Overall Study||53
5213261|NCT00983580|12818990|P1|STARTED|Overall Study||54
5213262|NCT00983541|12819006|P1|NOT COMPLETED|Overall Study||0
5213263|NCT00983541|12819006|P1|COMPLETED|Overall Study||1
5213264|NCT00983541|12819006|P1|STARTED|Overall Study||1
5213265|NCT00983515|12819016|P1|NOT COMPLETED|Colchicine With Ritonavir||1
5213266|NCT00983515|12819016|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
5213267|NCT00983515|12819016|P1|STARTED|Colchicine With Ritonavir||18
5213268|NCT00983515|12819016|P1|NOT COMPLETED|Ritonavir Alone||6
5213269|NCT00983515|12819016|P1|COMPLETED|Ritonavir Alone||18
5213270|NCT00983515|12819016|P1|STARTED|Ritonavir Alone||24
5213271|NCT00983515|12819016|P1|NOT COMPLETED|14 Day Washout Period||0
5213272|NCT00983515|12819016|P1|COMPLETED|14 Day Washout Period||24
5213273|NCT00983515|12819016|P1|STARTED|14 Day Washout Period||24
5213274|NCT00983515|12819016|P1|NOT COMPLETED|Colchicine Alone||0
5213275|NCT00983515|12819016|P1|COMPLETED|Colchicine Alone||24
5213276|NCT00983515|12819016|P1|STARTED|Colchicine Alone||24
5213277|NCT00983489|12819030|P3|NOT COMPLETED|Overall Study||312
5213278|NCT00983489|12819031|P2|NOT COMPLETED|Overall Study||285
5213279|NCT00983489|12819032|P1|NOT COMPLETED|Overall Study||185
5213280|NCT00983489|12819030|P3|COMPLETED|Overall Study||135
5213281|NCT00983489|12819031|P2|COMPLETED|Overall Study||168
5213282|NCT00983489|12819032|P1|COMPLETED|Overall Study||326
5213283|NCT00983489|12819030|P3|STARTED|Overall Study||447
5213284|NCT00983489|12819031|P2|STARTED|Overall Study||453
5213285|NCT00983489|12819032|P1|STARTED|Overall Study||511
5213286|NCT00983476|12819043|P3|NOT COMPLETED|Overall Study||0
5213287|NCT00983476|12819044|P2|NOT COMPLETED|Overall Study||22
5213288|NCT00983476|12819045|P1|NOT COMPLETED|Overall Study||17
5213289|NCT00983476|12819043|P3|COMPLETED|Overall Study||88
5213290|NCT00983476|12819044|P2|COMPLETED|Overall Study||71
5213291|NCT00983476|12819045|P1|COMPLETED|Overall Study||78
5213292|NCT00983476|12819043|P3|6 Month Follow up Assessment|Overall Study||74
5213293|NCT00983476|12819044|P2|6 Month Follow up Assessment|Overall Study||62
5213294|NCT00983476|12819045|P1|6 Month Follow up Assessment|Overall Study||71
5213295|NCT00983476|12819043|P3|STARTED|Overall Study||88
5213296|NCT00983476|12819044|P2|STARTED|Overall Study||93
5213297|NCT00983476|12819045|P1|STARTED|Overall Study||95
5213298|NCT00983437|12819077|P1|NOT COMPLETED|Overall Study||47
5213299|NCT00983437|12819077|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
5213300|NCT00983437|12819077|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
5213301|NCT00983437|12819077|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
5213302|NCT00983437|12819077|P1|STARTED|Overall Study||47
5213303|NCT00983385|12819096|P1|NOT COMPLETED|Maintenance Period||23
5213304|NCT00983385|12819096|P1|COMPLETED|Maintenance Period||117
5213305|NCT00983385|12819096|P1|STARTED|Maintenance Period||140
5213306|NCT00983385|12819096|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
5213307|NCT00983385|12819096|P1|COMPLETED|Titration and Optimal Dose Period||140
5213308|NCT00983385|12819096|P1|STARTED|Titration and Optimal Dose Period||176
5213309|NCT00983385|12819096|P1|NOT COMPLETED|Observation Period||32
5213310|NCT00983385|12819096|P1|COMPLETED|Observation Period||176
5213311|NCT00983385|12819096|P1|STARTED|Observation Period||208
5213312|NCT00983372|12819141|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
5213313|NCT00983372|12819141|P1|COMPLETED|Colchicine With Diltiazem ER||20
5213314|NCT00983372|12819141|P1|STARTED|Colchicine With Diltiazem ER||20
5213315|NCT00983372|12819141|P1|NOT COMPLETED|Diltiazem ER Alone||3
5213316|NCT00983372|12819141|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
5213317|NCT00983372|12819141|P1|STARTED|Diltiazem ER Alone||23
5213318|NCT00983372|12819141|P1|NOT COMPLETED|14 Day Washout Period||1
5213319|NCT00983372|12819141|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
5213320|NCT00983372|12819141|P1|STARTED|14 Day Washout Period||24
5213321|NCT00983372|12819141|P1|NOT COMPLETED|Colchicine Alone||0
5213322|NCT00983372|12819141|P1|COMPLETED|Colchicine Alone||24
5213323|NCT00983372|12819141|P1|STARTED|Colchicine Alone||24
5213324|NCT00983359|12819152|P1|NOT COMPLETED|Overall Study||1
5213325|NCT00983359|12819152|P1|COMPLETED|Overall Study||39
5213326|NCT00983359|12819152|P1|Not Eligible for Analysis|Overall Study||1
5213327|NCT00983359|12819152|P1|STARTED|Overall Study||40
5213328|NCT00983346|12819160|P1|NOT COMPLETED|Overall Study||0
5213329|NCT00983346|12819160|P1|COMPLETED|Overall Study||17
5213330|NCT00983346|12819160|P1|STARTED|Overall Study||17
5213331|NCT00983307|12819164|P1|NOT COMPLETED|Overall Study||0
5213332|NCT00983307|12819164|P1|COMPLETED|Overall Study||17
5213333|NCT00983307|12819164|P1|STARTED|Overall Study||17
5213334|NCT00983294|12819168|P1|NOT COMPLETED|Colchicine With Azithromycin||1
5213335|NCT00983294|12819168|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
5213336|NCT00983294|12819168|P1|STARTED|Colchicine With Azithromycin||22
5213337|NCT00983294|12819168|P1|NOT COMPLETED|Azithromycin Alone||0
5213338|NCT00983294|12819168|P1|COMPLETED|Azithromycin Alone||22
5213339|NCT00983294|12819168|P1|STARTED|Azithromycin Alone||22
5213340|NCT00983294|12819168|P1|NOT COMPLETED|14 Day Washout Period||2
5213341|NCT00983294|12819168|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
5213342|NCT00983294|12819168|P1|STARTED|14 Day Washout Period||24
5213343|NCT00983294|12819168|P1|NOT COMPLETED|Colchicine Alone||0
5213344|NCT00983294|12819168|P1|COMPLETED|Colchicine Alone||24
5213345|NCT00983294|12819168|P1|STARTED|Colchicine Alone||24
5213346|NCT00983281|12819181|P2|NOT COMPLETED|Overall Study||0
5213347|NCT00983281|12819182|P1|NOT COMPLETED|Overall Study||0
5213348|NCT00983281|12819181|P2|COMPLETED|Overall Study||909
5213349|NCT00983281|12819182|P1|COMPLETED|Overall Study||805
5213350|NCT00983281|12819181|P2|STARTED|Overall Study||909
5213351|NCT00983281|12819182|P1|STARTED|Overall Study||805
5213352|NCT00983242|12819188|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
5213353|NCT00983242|12819188|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
5213354|NCT00983242|12819188|P1|STARTED|Colchicine With Verapamil HCl ER||24
5213355|NCT00983242|12819188|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
5213356|NCT00983242|12819188|P1|COMPLETED|Verapamil HCl ER Alone||24
5213357|NCT00983242|12819188|P1|STARTED|Verapamil HCl ER Alone||24
5213358|NCT00983242|12819188|P1|NOT COMPLETED|14 Day Washout Period||0
5213359|NCT00983242|12819188|P1|COMPLETED|14 Day Washout Period||24
5213360|NCT00983242|12819188|P1|STARTED|14 Day Washout Period||24
5213361|NCT00983242|12819188|P1|NOT COMPLETED|Colchicine Alone||0
5213362|NCT00983242|12819188|P1|COMPLETED|Colchicine Alone||24
5213363|NCT00983242|12819188|P1|STARTED|Colchicine Alone||24
5213364|NCT00983216|12819199|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
5213365|NCT00983216|12819199|P1|COMPLETED|Colchicine With Ketoconazole||24
5213366|NCT00983216|12819199|P1|STARTED|Colchicine With Ketoconazole||24
5213367|NCT00983216|12819199|P1|NOT COMPLETED|Ketoconazole Alone||0
5213368|NCT00983216|12819199|P1|COMPLETED|Ketoconazole Alone||24
5213369|NCT00983216|12819199|P1|STARTED|Ketoconazole Alone||24
5213370|NCT00983216|12819199|P1|NOT COMPLETED|14 Day Washout Period||0
5213371|NCT00983216|12819199|P1|COMPLETED|14 Day Washout Period||24
5213372|NCT00983216|12819199|P1|STARTED|14 Day Washout Period||24
5213373|NCT00983216|12819199|P1|NOT COMPLETED|Colchicine Alone||0
5213374|NCT00983216|12819199|P1|COMPLETED|Colchicine Alone||24
5213375|NCT00983216|12819199|P1|STARTED|Colchicine Alone||24
5213376|NCT00983073|12819210|P1|NOT COMPLETED|Maintenance Period||16
5213377|NCT00983073|12819210|P1|COMPLETED|Maintenance Period||144
5213378|NCT00983073|12819210|P1|STARTED|Maintenance Period||160
5213379|NCT00983073|12819210|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
5213380|NCT00983073|12819210|P1|COMPLETED|Titration and Optimal Dose Period||160
5213381|NCT00983073|12819210|P1|STARTED|Titration and Optimal Dose Period||200
5213382|NCT00983073|12819210|P1|NOT COMPLETED|Observation Period||24
5213383|NCT00983073|12819210|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
5213384|NCT00983073|12819210|P1|STARTED|Observation Period||224
5213385|NCT00982995|12819231|P1|NOT COMPLETED|Overall Study||0
5213386|NCT00982995|12819231|P1|COMPLETED|Overall Study||3
5213387|NCT00982995|12819231|P1|STARTED|Overall Study||3
5213388|NCT00982878|12819236|P1|NOT COMPLETED|Overall Study||1
5213389|NCT00982878|12819236|P1|COMPLETED|Overall Study||12
5213390|NCT00982878|12819236|P1|STARTED|Overall Study||13
5213391|NCT00982865|12819245|P4|NOT COMPLETED|Overall Study||0
5213392|NCT00982865|12819246|P3|NOT COMPLETED|Overall Study||0
5213393|NCT00982865|12819247|P2|NOT COMPLETED|Overall Study||0
5213394|NCT00982865|12819248|P1|NOT COMPLETED|Overall Study||0
5213395|NCT00982865|12819245|P4|COMPLETED|Overall Study||34
5213396|NCT00982865|12819246|P3|COMPLETED|Overall Study||15
5213397|NCT00982865|12819247|P2|COMPLETED|Overall Study||82
5213398|NCT00982865|12819248|P1|COMPLETED|Overall Study||49
5213399|NCT00982865|12819245|P4|STARTED|Overall Study||34
5213400|NCT00982865|12819246|P3|STARTED|Overall Study||15
5213401|NCT00982865|12819247|P2|STARTED|Overall Study||82
5213402|NCT00982865|12819248|P1|STARTED|Overall Study||49
5213403|NCT00982735|12819534|P1|NOT COMPLETED|Overall Study||230
5213404|NCT00982735|12819534|P1|COMPLETED|Overall Study||757
5213405|NCT00982735|12819534|P1|STARTED|Overall Study||987
5213406|NCT00982657|12819544|P4|NOT COMPLETED|Overall Study||9
5213407|NCT00982657|12819545|P3|NOT COMPLETED|Overall Study||2
5213408|NCT00982657|12819546|P2|NOT COMPLETED|Overall Study||0
5213409|NCT00982657|12819547|P1|NOT COMPLETED|Overall Study||1
5213410|NCT00982657|12819544|P4|COMPLETED|Overall Study||7
5213411|NCT00982657|12819545|P3|COMPLETED|Overall Study||1
5213412|NCT00982657|12819546|P2|COMPLETED|Overall Study||3
5213413|NCT00982657|12819547|P1|COMPLETED|Overall Study||11
5213414|NCT00982657|12819544|P4|STARTED|Overall Study||16
5213415|NCT00982657|12819545|P3|STARTED|Overall Study||3
5213416|NCT00982657|12819546|P2|STARTED|Overall Study||3
5213417|NCT00982657|12819547|P1|STARTED|Overall Study||12
5213418|NCT00982644|12819588|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
5213419|NCT00982644|12819589|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
5213420|NCT00982644|12819588|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
5213421|NCT00982644|12819589|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
5213422|NCT00982644|12819588|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
5213423|NCT00982644|12819589|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
5213424|NCT00982644|12819588|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
5213425|NCT00982644|12819589|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
5213426|NCT00982644|12819588|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
5213427|NCT00982644|12819589|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
5213428|NCT00982644|12819588|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
5213429|NCT00982644|12819589|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
5213430|NCT00982644|12819588|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
5213431|NCT00982644|12819589|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
5213432|NCT00982644|12819588|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
5213433|NCT00982644|12819589|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
5213434|NCT00982592|12819613|P2|NOT COMPLETED|Overall Study||33
5213435|NCT00982592|12819614|P1|NOT COMPLETED|Overall Study||31
5213436|NCT00982592|12819613|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
5213437|NCT00982592|12819614|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
5213438|NCT00982592|12819613|P2|Treatment Received|Overall Study||52
5213439|NCT00982592|12819614|P1|Treatment Received|Overall Study||63
5213440|NCT00982592|12819613|P2|STARTED|Overall Study||60
5213441|NCT00982592|12819614|P1|STARTED|Overall Study||64
5213442|NCT00982553|12819628|P1|NOT COMPLETED|Phase3||0
5213443|NCT00982553|12819628|P1|COMPLETED|Phase3||14
5213444|NCT00982553|12819628|P1|STARTED|Phase3||14
5213445|NCT00982553|12819628|P1|NOT COMPLETED|Phase2||0
5213446|NCT00982553|12819628|P1|COMPLETED|Phase2||14
5213447|NCT00982553|12819628|P1|STARTED|Phase2||14
5213448|NCT00982553|12819628|P1|NOT COMPLETED|Phase1||0
5213449|NCT00982553|12819628|P1|COMPLETED|Phase1||14
5213450|NCT00982553|12819628|P1|STARTED|Phase1||14
5213451|NCT00982488|12819644|P5|NOT COMPLETED|Overall Study||1
5213452|NCT00982488|12819645|P4|NOT COMPLETED|Overall Study||3
5213453|NCT00982488|12819646|P3|NOT COMPLETED|Overall Study||34
5213454|NCT00982488|12819647|P2|NOT COMPLETED|Overall Study||14
5213455|NCT00982488|12819648|P1|NOT COMPLETED|Overall Study||185
5213456|NCT00982488|12819644|P5|COMPLETED|Overall Study|Still receiving treatment|0
5213457|NCT00982488|12819645|P4|COMPLETED|Overall Study|Still receiving treatment|0
5213458|NCT00982488|12819646|P3|COMPLETED|Overall Study|Still receiving treatment|0
5213459|NCT00982488|12819647|P2|COMPLETED|Overall Study|Still receiving treatment|0
5213460|NCT00982488|12819648|P1|COMPLETED|Overall Study|Still receiving treatment|0
5213461|NCT00982488|12819644|P5|STARTED|Overall Study|Received treatment|1
5213462|NCT00982488|12819645|P4|STARTED|Overall Study|Received treatment|3
5213463|NCT00982488|12819646|P3|STARTED|Overall Study|Received treatment|34
5213464|NCT00982488|12819647|P2|STARTED|Overall Study|Received treatment|14
5213465|NCT00982488|12819648|P1|STARTED|Overall Study|Received treatment|185
5213466|NCT00982423|12819662|P2|NOT COMPLETED|Overall Study||0
5213467|NCT00982423|12819663|P1|NOT COMPLETED|Overall Study||0
5213468|NCT00982423|12819662|P2|COMPLETED|Overall Study||19
5213469|NCT00982423|12819663|P1|COMPLETED|Overall Study||13
5213470|NCT00982423|12819662|P2|STARTED|Overall Study||19
5213471|NCT00982423|12819663|P1|STARTED|Overall Study||13
5213472|NCT00982410|12819681|P2|NOT COMPLETED|12-month Follow-up Assessment||9
5213473|NCT00982410|12819682|P1|NOT COMPLETED|12-month Follow-up Assessment||9
5213474|NCT00982410|12819681|P2|COMPLETED|12-month Follow-up Assessment||55
5213475|NCT00982410|12819682|P1|COMPLETED|12-month Follow-up Assessment||56
5213476|NCT00982410|12819681|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
5213477|NCT00982410|12819682|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
5213478|NCT00982410|12819681|P2|NOT COMPLETED|6-month Follow-up Assessment||11
5213479|NCT00982410|12819682|P1|NOT COMPLETED|6-month Follow-up Assessment||6
5213480|NCT00982410|12819681|P2|COMPLETED|6-month Follow-up Assessment||53
5213481|NCT00982410|12819682|P1|COMPLETED|6-month Follow-up Assessment||59
5213482|NCT00982410|12819681|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
5213483|NCT00982410|12819682|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
5213484|NCT00982410|12819681|P2|NOT COMPLETED|3-month Follow-up Assessment||13
5213485|NCT00982410|12819682|P1|NOT COMPLETED|3-month Follow-up Assessment||9
5213486|NCT00982410|12819681|P2|COMPLETED|3-month Follow-up Assessment||53
5213487|NCT00982410|12819682|P1|COMPLETED|3-month Follow-up Assessment||56
5213488|NCT00982410|12819681|P2|STARTED|3-month Follow-up Assessment||66
5213489|NCT00982410|12819682|P1|STARTED|3-month Follow-up Assessment||65
5213490|NCT00982397|12819706|P2|NOT COMPLETED|Phase II/Overall Study||0
5213491|NCT00982397|12819707|P1|NOT COMPLETED|Phase II/Overall Study||0
5213492|NCT00982397|12819706|P2|COMPLETED|Phase II/Overall Study||751
5213493|NCT00982397|12819707|P1|COMPLETED|Phase II/Overall Study||2019
5213494|NCT00982397|12819706|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
5213495|NCT00982397|12819707|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
5213496|NCT00982397|12819706|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
5213497|NCT00982397|12819707|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
5213498|NCT00982397|12819706|P2|STARTED|Phase II/Overall Study||751
5213499|NCT00982397|12819707|P1|STARTED|Phase II/Overall Study||2019
5213500|NCT00982397|12819706|P2|NOT COMPLETED|Phase I||0
5213501|NCT00982397|12819707|P1|NOT COMPLETED|Phase I||0
5213502|NCT00982397|12819706|P2|COMPLETED|Phase I||0
5213503|NCT00982397|12819707|P1|COMPLETED|Phase I||236
5213504|NCT00982397|12819706|P2|STARTED|Phase I||0
5213505|NCT00982397|12819707|P1|STARTED|Phase I||236
5213506|NCT00982345|12819717|P1|NOT COMPLETED|Overall Study||2
5213507|NCT00982345|12819717|P1|COMPLETED|Overall Study||18
5213508|NCT00982345|12819717|P1|STARTED|Overall Study||20
5213509|NCT00982319|12819723|P2|NOT COMPLETED|Overall Study||2
5213510|NCT00982319|12819724|P1|NOT COMPLETED|Overall Study||2
5213511|NCT00982319|12819723|P2|COMPLETED|Overall Study||15
5213512|NCT00982319|12819724|P1|COMPLETED|Overall Study||15
5213513|NCT00982319|12819723|P2|STARTED|Overall Study||17
5213514|NCT00982319|12819724|P1|STARTED|Overall Study||17
5213515|NCT00982280|12819732|P1|NOT COMPLETED|Maintenance Period||1
5213516|NCT00982280|12819732|P1|COMPLETED|Maintenance Period||54
5213517|NCT00982280|12819732|P1|STARTED|Maintenance Period||55
5213518|NCT00982280|12819732|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
5213519|NCT00982280|12819732|P1|COMPLETED|Titration and Optimal Dose Period||55
5213520|NCT00982280|12819732|P1|STARTED|Titration and Optimal Dose Period||63
5213521|NCT00982280|12819732|P1|NOT COMPLETED|Observation Period||19
5213522|NCT00982280|12819732|P1|COMPLETED|Observation Period||63
5213523|NCT00982280|12819732|P1|STARTED|Observation Period||82
5213524|NCT00982228|12819757|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
5213525|NCT00982228|12819758|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
5213526|NCT00982228|12819757|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
5213527|NCT00982228|12819758|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
5213528|NCT00982228|12819757|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
5213529|NCT00982228|12819758|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
5213530|NCT00982228|12819757|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
5213531|NCT00982228|12819758|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
5213532|NCT00982228|12819757|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
5213533|NCT00982228|12819758|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
5213534|NCT00982228|12819757|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
5213535|NCT00982228|12819758|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
5213536|NCT00982228|12819757|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
5213537|NCT00982228|12819758|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
5213538|NCT00982228|12819757|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
5213539|NCT00982228|12819758|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
5213540|NCT00982189|12819786|P4|NOT COMPLETED|Overall Study||0
5213541|NCT00982189|12819787|P3|NOT COMPLETED|Overall Study||0
5213542|NCT00982189|12819788|P2|NOT COMPLETED|Overall Study||0
5213543|NCT00982189|12819789|P1|NOT COMPLETED|Overall Study||0
5213544|NCT00982189|12819786|P4|COMPLETED|Overall Study||9
5213545|NCT00982189|12819787|P3|COMPLETED|Overall Study||9
5213546|NCT00982189|12819788|P2|COMPLETED|Overall Study||9
5213547|NCT00982189|12819789|P1|COMPLETED|Overall Study||10
5213548|NCT00982189|12819786|P4|STARTED|Overall Study||9
5213549|NCT00982189|12819787|P3|STARTED|Overall Study||9
5213550|NCT00982189|12819788|P2|STARTED|Overall Study||9
5213551|NCT00982189|12819789|P1|STARTED|Overall Study||10
5213552|NCT00982137|12819817|P4|NOT COMPLETED|Overall Study||1
5213553|NCT00982137|12819818|P3|NOT COMPLETED|Overall Study||0
5213554|NCT00982137|12819819|P2|NOT COMPLETED|Overall Study||1
5213555|NCT00982137|12819820|P1|NOT COMPLETED|Overall Study||0
5213556|NCT00982137|12819817|P4|COMPLETED|Overall Study||17
5213557|NCT00982137|12819818|P3|COMPLETED|Overall Study||18
5213558|NCT00982137|12819819|P2|COMPLETED|Overall Study||35
5213559|NCT00982137|12819820|P1|COMPLETED|Overall Study||36
5213560|NCT00982137|12819817|P4|STARTED|Overall Study||18
5213561|NCT00982137|12819818|P3|STARTED|Overall Study||18
5213562|NCT00982137|12819819|P2|STARTED|Overall Study||36
5213563|NCT00982137|12819820|P1|STARTED|Overall Study||36
5213564|NCT00982111|12819852|P2|NOT COMPLETED|Overall Study||66
5213565|NCT00982111|12819853|P1|NOT COMPLETED|Overall Study||75
5213566|NCT00982111|12819852|P2|COMPLETED|Overall Study||252
5213567|NCT00982111|12819853|P1|COMPLETED|Overall Study||240
5213568|NCT00982111|12819852|P2|On Study at Conclusion, Off Treatment|Overall Study||6
5213569|NCT00982111|12819853|P1|On Study at Conclusion, Off Treatment|Overall Study||4
5213570|NCT00982111|12819852|P2|Death Due to Any Cause|Overall Study||246
5213571|NCT00982111|12819853|P1|Death Due to Any Cause|Overall Study||236
5213572|NCT00982111|12819852|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
5213573|NCT00982111|12819853|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
5213574|NCT00982111|12819852|P2|STARTED|Overall Study||318
5213575|NCT00982111|12819853|P1|STARTED|Overall Study||315
5213576|NCT00982033|12819877|P2|NOT COMPLETED|Overall Study||0
5213577|NCT00982033|12819878|P1|NOT COMPLETED|Overall Study||0
5213578|NCT00982033|12819877|P2|COMPLETED|Overall Study||27
5213579|NCT00982033|12819878|P1|COMPLETED|Overall Study||25
5213580|NCT00982033|12819877|P2|STARTED|Overall Study||27
5213581|NCT00982033|12819878|P1|STARTED|Overall Study||25
5213582|NCT00982020|12819886|P2|NOT COMPLETED|Overall Study||64
5213583|NCT00982020|12819887|P1|NOT COMPLETED|Overall Study||57
5213584|NCT00982020|12819886|P2|COMPLETED|Overall Study||37
5213585|NCT00982020|12819887|P1|COMPLETED|Overall Study||45
5213586|NCT00982020|12819886|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
5213587|NCT00982020|12819887|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
5213588|NCT00982020|12819886|P2|STARTED|Overall Study||101
5213589|NCT00982020|12819887|P1|STARTED|Overall Study||102
5213590|NCT00982007|12819911|P4|NOT COMPLETED|Overall Study||6
5213591|NCT00982007|12819912|P3|NOT COMPLETED|Overall Study||0
5213592|NCT00982007|12819913|P2|NOT COMPLETED|Overall Study||4
5213593|NCT00982007|12819914|P1|NOT COMPLETED|Overall Study||4
5213594|NCT00982007|12819911|P4|COMPLETED|Overall Study||245
5213595|NCT00982007|12819912|P3|COMPLETED|Overall Study||253
5213596|NCT00982007|12819913|P2|COMPLETED|Overall Study||253
5213597|NCT00982007|12819914|P1|COMPLETED|Overall Study||246
5213598|NCT00982007|12819911|P4|STARTED|Overall Study||251
5213599|NCT00982007|12819912|P3|STARTED|Overall Study||253
5213600|NCT00982007|12819913|P2|STARTED|Overall Study||257
5213601|NCT00982007|12819914|P1|STARTED|Overall Study||250
5213602|NCT00981825|12819926|P2|NOT COMPLETED|Second Intervention||0
5213603|NCT00981825|12819927|P1|NOT COMPLETED|Second Intervention||0
5213604|NCT00981825|12819926|P2|COMPLETED|Second Intervention||11
5213605|NCT00981825|12819927|P1|COMPLETED|Second Intervention||11
5213606|NCT00981825|12819926|P2|STARTED|Second Intervention||11
5213607|NCT00981825|12819927|P1|STARTED|Second Intervention||11
5213608|NCT00981825|12819926|P2|NOT COMPLETED|Washout After 1st Intervention||0
5213609|NCT00981825|12819927|P1|NOT COMPLETED|Washout After 1st Intervention||0
5213610|NCT00981825|12819926|P2|COMPLETED|Washout After 1st Intervention||11
5213611|NCT00981825|12819927|P1|COMPLETED|Washout After 1st Intervention||11
5213612|NCT00981825|12819926|P2|STARTED|Washout After 1st Intervention||11
5213613|NCT00981825|12819927|P1|STARTED|Washout After 1st Intervention||11
5213614|NCT00981825|12819926|P2|NOT COMPLETED|First Intervention||0
5213615|NCT00981825|12819927|P1|NOT COMPLETED|First Intervention||0
5213616|NCT00981825|12819926|P2|COMPLETED|First Intervention||11
5213617|NCT00981825|12819927|P1|COMPLETED|First Intervention||11
5213618|NCT00981825|12819926|P2|STARTED|First Intervention||11
5213619|NCT00981825|12819927|P1|STARTED|First Intervention||11
5213620|NCT00981812|12819933|P1|NOT COMPLETED|Overall Study||0
5213621|NCT00981812|12819933|P1|COMPLETED|Overall Study||20
5213622|NCT00981812|12819933|P1|STARTED|Overall Study||20
5213623|NCT00981747|12819937|P1|NOT COMPLETED|Sildenafil and Losartan||0
5213624|NCT00981747|12819937|P1|COMPLETED|Sildenafil and Losartan||9
5213625|NCT00981747|12819937|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
5213626|NCT00981747|12819937|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
5213627|NCT00981747|12819937|P1|STARTED|Sildenafil and Losartan||9
5213628|NCT00981747|12819937|P1|NOT COMPLETED|Sildenafil||0
5213629|NCT00981747|12819937|P1|COMPLETED|Sildenafil||9
5213630|NCT00981747|12819937|P1|Completed Sildenafil|Sildenafil||9
5213631|NCT00981747|12819937|P1|Started Sildenafil|Sildenafil||9
5213632|NCT00981747|12819937|P1|STARTED|Sildenafil||9
5213633|NCT00981747|12819937|P1|NOT COMPLETED|Placebo Oral Tablet||1
5213634|NCT00981747|12819937|P1|COMPLETED|Placebo Oral Tablet||9
5213635|NCT00981747|12819937|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
5213636|NCT00981747|12819937|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
5213637|NCT00981747|12819937|P1|STARTED|Placebo Oral Tablet||10
5213638|NCT00981747|12819937|P1|NOT COMPLETED|Losartan||2
5213639|NCT00981747|12819937|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
5213640|NCT00981747|12819937|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
5213641|NCT00981747|12819937|P1|Started Losartan|Losartan||12
5213642|NCT00981747|12819937|P1|STARTED|Losartan||12
5213643|NCT00981669|12819957|P2|NOT COMPLETED|Overall Study||0
5213644|NCT00981669|12819958|P1|NOT COMPLETED|Overall Study||1
5213645|NCT00981669|12819957|P2|COMPLETED|Overall Study||40
5213646|NCT00981669|12819958|P1|COMPLETED|Overall Study||39
5213647|NCT00981669|12819957|P2|STARTED|Overall Study||40
5213648|NCT00981669|12819958|P1|STARTED|Overall Study||40
5213649|NCT00981630|12819970|P4|NOT COMPLETED|Overall Study||0
5213650|NCT00981630|12819971|P3|NOT COMPLETED|Overall Study||0
5213651|NCT00981630|12819972|P2|NOT COMPLETED|Overall Study||0
5213652|NCT00981630|12819973|P1|NOT COMPLETED|Overall Study||0
5213653|NCT00981630|12819970|P4|COMPLETED|Overall Study||32
5213654|NCT00981630|12819971|P3|COMPLETED|Overall Study||32
5213655|NCT00981630|12819972|P2|COMPLETED|Overall Study||32
5213656|NCT00981630|12819973|P1|COMPLETED|Overall Study||32
5213657|NCT00981630|12819970|P4|STARTED|Overall Study||32
5213658|NCT00981630|12819971|P3|STARTED|Overall Study||32
5213659|NCT00981630|12819972|P2|STARTED|Overall Study||32
5213660|NCT00981630|12819973|P1|STARTED|Overall Study||32
5213661|NCT00981578|12820003|P1|NOT COMPLETED|Overall Study||3
5213662|NCT00981578|12820003|P1|COMPLETED|Overall Study||14
5213663|NCT00981578|12820003|P1|STARTED|Overall Study||17
5213664|NCT00981526|12820011|P2|NOT COMPLETED|Overall Study||6
5213665|NCT00981526|12820012|P1|NOT COMPLETED|Overall Study||4
5213666|NCT00981526|12820011|P2|COMPLETED|Overall Study||22
5213667|NCT00981526|12820012|P1|COMPLETED|Overall Study||22
5213668|NCT00981526|12820011|P2|STARTED|Overall Study||28
5213669|NCT00981526|12820012|P1|STARTED|Overall Study||26
5213670|NCT00981461|12820030|P2|NOT COMPLETED|Overall Study||2
5213671|NCT00981461|12820031|P1|NOT COMPLETED|Overall Study||5
5213672|NCT00981461|12820030|P2|COMPLETED|Overall Study||22
5213673|NCT00981461|12820031|P1|COMPLETED|Overall Study||43
5213674|NCT00981461|12820030|P2|STARTED|Overall Study||24
5213675|NCT00981461|12820031|P1|STARTED|Overall Study||48
5213676|NCT00981435|12820040|P3|NOT COMPLETED|Overall Study||0
5213677|NCT00981435|12820041|P2|NOT COMPLETED|Overall Study||0
5213678|NCT00981435|12820042|P1|NOT COMPLETED|Overall Study||0
5213679|NCT00981435|12820040|P3|COMPLETED|Overall Study||37
5213680|NCT00981435|12820041|P2|COMPLETED|Overall Study||29
5213681|NCT00981435|12820042|P1|COMPLETED|Overall Study||31
5213682|NCT00981435|12820040|P3|STARTED|Overall Study||37
5213683|NCT00981435|12820041|P2|STARTED|Overall Study||29
5213684|NCT00981435|12820042|P1|STARTED|Overall Study||31
5213685|NCT00981409|12820055|P2|NOT COMPLETED|Overall Study||1
5213686|NCT00981409|12820056|P1|NOT COMPLETED|Overall Study||6
5213687|NCT00981409|12820055|P2|COMPLETED|Overall Study||10
5213688|NCT00981409|12820056|P1|COMPLETED|Overall Study||24
5213689|NCT00981409|12820055|P2|STARTED|Overall Study||11
5213690|NCT00981409|12820056|P1|STARTED|Overall Study||30
5213691|NCT00981370|12820070|P1|NOT COMPLETED|Overall Study||0
5213692|NCT00981370|12820070|P1|COMPLETED|Overall Study||0
5213693|NCT00981370|12820070|P1|STARTED|Overall Study||0
5213694|NCT00981305|12820076|P2|NOT COMPLETED|Overall Study||10
5213695|NCT00981305|12820077|P1|NOT COMPLETED|Overall Study||19
5213696|NCT00981305|12820076|P2|COMPLETED|Overall Study||57
5213697|NCT00981305|12820077|P1|COMPLETED|Overall Study||50
5213698|NCT00981305|12820076|P2|STARTED|Overall Study||67
5213699|NCT00981305|12820077|P1|STARTED|Overall Study||69
5213700|NCT00981292|12820095|P6|NOT COMPLETED|Day 3||1
5213701|NCT00981292|12820096|P5|NOT COMPLETED|Day 3||0
5213702|NCT00981292|12820097|P4|NOT COMPLETED|Day 3||0
5213703|NCT00981292|12820098|P3|NOT COMPLETED|Day 3||0
5213704|NCT00981292|12820099|P2|NOT COMPLETED|Day 3||0
5213705|NCT00981292|12820100|P1|NOT COMPLETED|Day 3||0
5213706|NCT00981292|12820095|P6|COMPLETED|Day 3||4
5213707|NCT00981292|12820096|P5|COMPLETED|Day 3||4
5213708|NCT00981292|12820097|P4|COMPLETED|Day 3||4
5213709|NCT00981292|12820098|P3|COMPLETED|Day 3||6
5213710|NCT00981292|12820099|P2|COMPLETED|Day 3||4
5213711|NCT00981292|12820100|P1|COMPLETED|Day 3||4
5213712|NCT00981292|12820095|P6|STARTED|Day 3||5
5213713|NCT00981292|12820096|P5|STARTED|Day 3||4
5213714|NCT00981292|12820097|P4|STARTED|Day 3||4
5213715|NCT00981292|12820098|P3|STARTED|Day 3||6
5213716|NCT00981292|12820099|P2|STARTED|Day 3||4
5213717|NCT00981292|12820100|P1|STARTED|Day 3||4
5213718|NCT00981292|12820095|P6|NOT COMPLETED|Day 2||0
5213719|NCT00981292|12820096|P5|NOT COMPLETED|Day 2||0
5213720|NCT00981292|12820097|P4|NOT COMPLETED|Day 2||0
5213721|NCT00981292|12820098|P3|NOT COMPLETED|Day 2||0
5213722|NCT00981292|12820099|P2|NOT COMPLETED|Day 2||0
5213723|NCT00981292|12820100|P1|NOT COMPLETED|Day 2||2
5213724|NCT00981292|12820095|P6|COMPLETED|Day 2||5
5213725|NCT00981292|12820096|P5|COMPLETED|Day 2||4
5213726|NCT00981292|12820097|P4|COMPLETED|Day 2||4
5213727|NCT00981292|12820098|P3|COMPLETED|Day 2||6
5213728|NCT00981292|12820099|P2|COMPLETED|Day 2||4
5213729|NCT00981292|12820100|P1|COMPLETED|Day 2||4
5213730|NCT00981292|12820095|P6|STARTED|Day 2||5
5213731|NCT00981292|12820096|P5|STARTED|Day 2||4
5213732|NCT00981292|12820097|P4|STARTED|Day 2||4
5213733|NCT00981292|12820098|P3|STARTED|Day 2||6
5213734|NCT00981292|12820099|P2|STARTED|Day 2||4
5213735|NCT00981292|12820100|P1|STARTED|Day 2||6
5213736|NCT00981292|12820095|P6|NOT COMPLETED|Day 1||2
5213737|NCT00981292|12820096|P5|NOT COMPLETED|Day 1||0
5213738|NCT00981292|12820097|P4|NOT COMPLETED|Day 1||0
5213739|NCT00981292|12820098|P3|NOT COMPLETED|Day 1||0
5213740|NCT00981292|12820099|P2|NOT COMPLETED|Day 1||0
5213741|NCT00981292|12820100|P1|NOT COMPLETED|Day 1||1
5213742|NCT00981292|12820095|P6|COMPLETED|Day 1||5
5213743|NCT00981292|12820096|P5|COMPLETED|Day 1||4
5213744|NCT00981292|12820097|P4|COMPLETED|Day 1||4
5213745|NCT00981292|12820098|P3|COMPLETED|Day 1||6
5213746|NCT00981292|12820099|P2|COMPLETED|Day 1||4
5213747|NCT00981292|12820100|P1|COMPLETED|Day 1||6
5213748|NCT00981292|12820095|P6|STARTED|Day 1||7
5213749|NCT00981292|12820096|P5|STARTED|Day 1||4
5213750|NCT00981292|12820097|P4|STARTED|Day 1||4
5213751|NCT00981292|12820098|P3|STARTED|Day 1||6
5213752|NCT00981292|12820099|P2|STARTED|Day 1||4
5213753|NCT00981292|12820100|P1|STARTED|Day 1||7
5213754|NCT00981253|12820119|P2|NOT COMPLETED|Overall Study||3
5213755|NCT00981253|12820120|P1|NOT COMPLETED|Overall Study||3
5213756|NCT00981253|12820119|P2|COMPLETED|Overall Study||72
5213757|NCT00981253|12820120|P1|COMPLETED|Overall Study||73
5213758|NCT00981253|12820119|P2|STARTED|Overall Study||75
5213759|NCT00981253|12820120|P1|STARTED|Overall Study||76
5213760|NCT00981227|12820144|P6|NOT COMPLETED|Overall Study||18
5213761|NCT00981227|12820145|P5|NOT COMPLETED|Overall Study||30
5213762|NCT00981227|12820146|P4|NOT COMPLETED|Overall Study||21
5213763|NCT00981227|12820147|P3|NOT COMPLETED|Overall Study||21
5213764|NCT00981227|12820148|P2|NOT COMPLETED|Overall Study||19
5213765|NCT00981227|12820149|P1|NOT COMPLETED|Overall Study||22
5213766|NCT00981227|12820144|P6|COMPLETED|Overall Study||75
5213767|NCT00981227|12820145|P5|COMPLETED|Overall Study||60
5213768|NCT00981227|12820146|P4|COMPLETED|Overall Study||73
5213769|NCT00981227|12820147|P3|COMPLETED|Overall Study||73
5213770|NCT00981227|12820148|P2|COMPLETED|Overall Study||75
5213771|NCT00981227|12820149|P1|COMPLETED|Overall Study||80
5213772|NCT00981227|12820144|P6|Per–Protocol|Overall Study||70
5213773|NCT00981227|12820145|P5|Per–Protocol|Overall Study||50
5213774|NCT00981227|12820146|P4|Per–Protocol|Overall Study||68
5213775|NCT00981227|12820147|P3|Per–Protocol|Overall Study||67
5213776|NCT00981227|12820148|P2|Per–Protocol|Overall Study||72
5213777|NCT00981227|12820149|P1|Per–Protocol|Overall Study||69
5213778|NCT00981227|12820144|P6|Safety Population|Overall Study||93
5213779|NCT00981227|12820145|P5|Safety Population|Overall Study||90
5213780|NCT00981227|12820146|P4|Safety Population|Overall Study||94
5213781|NCT00981227|12820147|P3|Safety Population|Overall Study||94
5213782|NCT00981227|12820148|P2|Safety Population|Overall Study||94
5213783|NCT00981227|12820149|P1|Safety Population|Overall Study||102
5213784|NCT00981227|12820144|P6|Randomized|Overall Study||93
5213785|NCT00981227|12820145|P5|Randomized|Overall Study||90
5213786|NCT00981227|12820146|P4|Randomized|Overall Study||94
5213787|NCT00981227|12820147|P3|Randomized|Overall Study||94
5213788|NCT00981227|12820148|P2|Randomized|Overall Study||94
5213789|NCT00981227|12820149|P1|Randomized|Overall Study||102
5213790|NCT00981227|12820144|P6|STARTED|Overall Study||93
5213791|NCT00981227|12820145|P5|STARTED|Overall Study||90
5213792|NCT00981227|12820146|P4|STARTED|Overall Study||94
5213793|NCT00981227|12820147|P3|STARTED|Overall Study||94
5213794|NCT00981227|12820148|P2|STARTED|Overall Study||94
5213795|NCT00981227|12820149|P1|STARTED|Overall Study||102
5213796|NCT00981214|12820167|P1|NOT COMPLETED|Overall Study||0
5213797|NCT00981214|12820167|P1|COMPLETED|Overall Study||19
5213798|NCT00981214|12820167|P1|STARTED|Overall Study||19
5213799|NCT00981175|12820184|P2|NOT COMPLETED|Booster Dose Vaccination||3
5213800|NCT00981175|12820185|P1|NOT COMPLETED|Booster Dose Vaccination||2
5213801|NCT00981175|12820184|P2|COMPLETED|Booster Dose Vaccination||40
5213802|NCT00981175|12820185|P1|COMPLETED|Booster Dose Vaccination||53
5213803|NCT00981175|12820184|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
5213804|NCT00981175|12820185|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
5213805|NCT00981175|12820184|P2|NOT COMPLETED|Primary Dose Vaccination||2
5213806|NCT00981175|12820185|P1|NOT COMPLETED|Primary Dose Vaccination||3
5213807|NCT00981175|12820184|P2|COMPLETED|Primary Dose Vaccination||99
5213808|NCT00981175|12820185|P1|COMPLETED|Primary Dose Vaccination||98
5213809|NCT00981175|12820184|P2|STARTED|Primary Dose Vaccination||101
5213810|NCT00981175|12820185|P1|STARTED|Primary Dose Vaccination||101
5213811|NCT00981149|12820210|P2|NOT COMPLETED|Overall Study||3
5213812|NCT00981149|12820211|P1|NOT COMPLETED|Overall Study||2
5213813|NCT00981149|12820210|P2|COMPLETED|Overall Study||9
5213814|NCT00981149|12820211|P1|COMPLETED|Overall Study||10
5213815|NCT00981149|12820210|P2|STARTED|Overall Study||12
5213816|NCT00981149|12820211|P1|STARTED|Overall Study||12
5213817|NCT00981084|12820221|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
5213818|NCT00981084|12820222|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
5213819|NCT00981084|12820221|P2|COMPLETED|Post Intervention (Data Analysis)||16
5213820|NCT00981084|12820222|P1|COMPLETED|Post Intervention (Data Analysis)||14
5213821|NCT00981084|12820221|P2|STARTED|Post Intervention (Data Analysis)||17
5213822|NCT00981084|12820222|P1|STARTED|Post Intervention (Data Analysis)||16
5213823|NCT00981084|12820221|P2|NOT COMPLETED|Second Intervention (One Day)||0
5213824|NCT00981084|12820222|P1|NOT COMPLETED|Second Intervention (One Day)||0
5213825|NCT00981084|12820221|P2|COMPLETED|Second Intervention (One Day)||17
5213826|NCT00981084|12820222|P1|COMPLETED|Second Intervention (One Day)||16
5213827|NCT00981084|12820221|P2|STARTED|Second Intervention (One Day)||17
5213828|NCT00981084|12820222|P1|STARTED|Second Intervention (One Day)||16
5213829|NCT00981084|12820221|P2|NOT COMPLETED|Washout Period (7 Days)||0
5213830|NCT00981084|12820222|P1|NOT COMPLETED|Washout Period (7 Days)||0
5213831|NCT00981084|12820221|P2|COMPLETED|Washout Period (7 Days)||17
5213832|NCT00981084|12820222|P1|COMPLETED|Washout Period (7 Days)||16
5213833|NCT00981084|12820221|P2|STARTED|Washout Period (7 Days)||17
5213834|NCT00981084|12820222|P1|STARTED|Washout Period (7 Days)||16
5213835|NCT00981084|12820221|P2|NOT COMPLETED|First Intervention (One Day)||0
5213836|NCT00981084|12820222|P1|NOT COMPLETED|First Intervention (One Day)||0
5213837|NCT00981084|12820221|P2|COMPLETED|First Intervention (One Day)||17
5213838|NCT00981084|12820222|P1|COMPLETED|First Intervention (One Day)||16
5213839|NCT00981084|12820221|P2|STARTED|First Intervention (One Day)||17
5213840|NCT00981084|12820222|P1|STARTED|First Intervention (One Day)||16
5213841|NCT00981058|12820238|P2|NOT COMPLETED|Overall Study||97
5213842|NCT00981058|12820239|P1|NOT COMPLETED|Overall Study||120
5213843|NCT00981058|12820238|P2|COMPLETED|Overall Study||451
5213844|NCT00981058|12820239|P1|COMPLETED|Overall Study||425
5213845|NCT00981058|12820238|P2|Death Due to Any Cause|Overall Study||442
5213846|NCT00981058|12820239|P1|Death Due to Any Cause|Overall Study||418
5213847|NCT00981058|12820238|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
5213848|NCT00981058|12820239|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
5213849|NCT00981058|12820238|P2|STARTED|Overall Study||548
5213850|NCT00981058|12820239|P1|STARTED|Overall Study||545
5213851|NCT00981045|12820261|P2|NOT COMPLETED|Overall Study||9
5213852|NCT00981045|12820262|P1|NOT COMPLETED|Overall Study||14
5213853|NCT00981045|12820261|P2|COMPLETED|Overall Study||1285
5213854|NCT00981045|12820262|P1|COMPLETED|Overall Study||1276
5213855|NCT00981045|12820261|P2|STARTED|Overall Study||1294
5213856|NCT00981045|12820262|P1|STARTED|Overall Study||1290
5213857|NCT00981019|12820270|P1|NOT COMPLETED|Overall Study||477
5213858|NCT00981019|12820270|P1|COMPLETED|Overall Study||301
5213859|NCT00981019|12820270|P1|STARTED|Overall Study||778
5213860|NCT00980980|12820277|P3|NOT COMPLETED|Overall Study||0
5213861|NCT00980980|12820278|P2|NOT COMPLETED|Overall Study||1
5213862|NCT00980980|12820279|P1|NOT COMPLETED|Overall Study||0
5213863|NCT00980980|12820277|P3|COMPLETED|Overall Study||13
5213864|NCT00980980|12820278|P2|COMPLETED|Overall Study||13
5213865|NCT00980980|12820279|P1|COMPLETED|Overall Study||16
5213866|NCT00980980|12820277|P3|STARTED|Overall Study||13
5213867|NCT00980980|12820278|P2|STARTED|Overall Study||14
5213868|NCT00980980|12820279|P1|STARTED|Overall Study||16
5213869|NCT00980798|12820310|P2|NOT COMPLETED|Overall Study||55
5213870|NCT00980798|12820311|P1|NOT COMPLETED|Overall Study||33
5213871|NCT00980798|12820310|P2|COMPLETED|Overall Study||84
5213872|NCT00980798|12820311|P1|COMPLETED|Overall Study||116
5213873|NCT00980798|12820310|P2|STARTED|Overall Study||139
5213874|NCT00980798|12820311|P1|STARTED|Overall Study||149
5213875|NCT00980746|12820325|P6|NOT COMPLETED|Overall Study||18
5213876|NCT00980746|12820326|P5|NOT COMPLETED|Overall Study||17
5213877|NCT00980746|12820327|P4|NOT COMPLETED|Overall Study||36
5213878|NCT00980746|12820328|P3|NOT COMPLETED|Overall Study||20
5213879|NCT00980746|12820329|P2|NOT COMPLETED|Overall Study||22
5213880|NCT00980746|12820330|P1|NOT COMPLETED|Overall Study||27
5213881|NCT00980746|12820325|P6|COMPLETED|Overall Study||78
5213882|NCT00980746|12820326|P5|COMPLETED|Overall Study||75
5213883|NCT00980746|12820327|P4|COMPLETED|Overall Study||64
5213884|NCT00980746|12820328|P3|COMPLETED|Overall Study||75
5213885|NCT00980746|12820329|P2|COMPLETED|Overall Study||67
5213886|NCT00980746|12820330|P1|COMPLETED|Overall Study||58
5213887|NCT00980746|12820325|P6|Per-protocol|Overall Study||74
5213888|NCT00980746|12820326|P5|Per-protocol|Overall Study||73
5213889|NCT00980746|12820327|P4|Per-protocol|Overall Study||62
5213890|NCT00980746|12820328|P3|Per-protocol|Overall Study||73
5213891|NCT00980746|12820329|P2|Per-protocol|Overall Study||66
5213892|NCT00980746|12820330|P1|Per-protocol|Overall Study||55
5213893|NCT00980746|12820325|P6|Safety Population|Overall Study||96
5213894|NCT00980746|12820326|P5|Safety Population|Overall Study||92
5213895|NCT00980746|12820327|P4|Safety Population|Overall Study||100
5213896|NCT00980746|12820328|P3|Safety Population|Overall Study||95
5213897|NCT00980746|12820329|P2|Safety Population|Overall Study||89
5213898|NCT00980746|12820330|P1|Safety Population|Overall Study||85
5213899|NCT00980746|12820325|P6|Randomized|Overall Study||96
5213900|NCT00980746|12820326|P5|Randomized|Overall Study||92
5213901|NCT00980746|12820327|P4|Randomized|Overall Study||100
5213902|NCT00980746|12820328|P3|Randomized|Overall Study||95
5213903|NCT00980746|12820329|P2|Randomized|Overall Study||89
5213904|NCT00980746|12820330|P1|Randomized|Overall Study||85
5213905|NCT00980746|12820325|P6|STARTED|Overall Study||96
5213906|NCT00980746|12820326|P5|STARTED|Overall Study||92
5213907|NCT00980746|12820327|P4|STARTED|Overall Study||100
5213908|NCT00980746|12820328|P3|STARTED|Overall Study||95
5213909|NCT00980746|12820329|P2|STARTED|Overall Study||89
5213910|NCT00980746|12820330|P1|STARTED|Overall Study||85
5213911|NCT00980681|12820344|P1|NOT COMPLETED|Dotarem MRA||0
5213912|NCT00980681|12820344|P1|COMPLETED|Dotarem MRA||10
5213913|NCT00980681|12820344|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
5213914|NCT00980681|12820344|P1|NOT COMPLETED|TOF MRA||0
5213915|NCT00980681|12820344|P1|COMPLETED|TOF MRA||10
5213916|NCT00980681|12820344|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
5213917|NCT00980655|12820352|P2|NOT COMPLETED|Overall Study||51
5213918|NCT00980655|12820353|P1|NOT COMPLETED|Overall Study||16
5213919|NCT00980655|12820352|P2|COMPLETED|Overall Study||139
5213920|NCT00980655|12820353|P1|COMPLETED|Overall Study||45
5213921|NCT00980655|12820352|P2|Vaccinated 23vPS Dose|Overall Study||140
5213922|NCT00980655|12820353|P1|Vaccinated 23vPS Dose|Overall Study||45
5213923|NCT00980655|12820352|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
5213924|NCT00980655|12820353|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
5213925|NCT00980655|12820352|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
5213926|NCT00980655|12820353|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
5213927|NCT00980655|12820352|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
5213928|NCT00980655|12820353|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
5213929|NCT00980655|12820352|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
5213930|NCT00980655|12820353|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
5213931|NCT00980655|12820352|P2|STARTED|Overall Study||190
5213932|NCT00980655|12820353|P1|STARTED|Overall Study||61
5213933|NCT00980642|12820401|P2|NOT COMPLETED|Overall Study||0
5213934|NCT00980642|12820402|P1|NOT COMPLETED|Overall Study||0
5213935|NCT00980642|12820401|P2|COMPLETED|Overall Study||20
5213936|NCT00980642|12820402|P1|COMPLETED|Overall Study||36
5213937|NCT00980642|12820401|P2|STARTED|Overall Study||20
5213938|NCT00980642|12820402|P1|STARTED|Overall Study||36
5213939|NCT00980590|12820414|P2|NOT COMPLETED|Overall Study||0
5213940|NCT00980590|12820415|P1|NOT COMPLETED|Overall Study||0
5213941|NCT00980590|12820414|P2|COMPLETED|Overall Study||50
5213942|NCT00980590|12820415|P1|COMPLETED|Overall Study||50
5213943|NCT00980590|12820414|P2|STARTED|Overall Study||50
5213944|NCT00980590|12820415|P1|STARTED|Overall Study||50
5213945|NCT00980395|12820427|P1|NOT COMPLETED|Overall Study||0
5213946|NCT00980395|12820427|P1|COMPLETED|Overall Study||24
5213947|NCT00980395|12820427|P1|STARTED|Overall Study||24
5213948|NCT00980343|12820436|P2|NOT COMPLETED|Overall Study||3
5213949|NCT00980343|12820437|P1|NOT COMPLETED|Overall Study||1
5213950|NCT00980343|12820436|P2|COMPLETED|Overall Study||20
5213951|NCT00980343|12820437|P1|COMPLETED|Overall Study||20
5213952|NCT00980343|12820436|P2|STARTED|Overall Study||23
5213953|NCT00980343|12820437|P1|STARTED|Overall Study||21
5213954|NCT00980330|12820461|P7|NOT COMPLETED|Overall Study||7
5213955|NCT00980330|12820462|P6|NOT COMPLETED|Overall Study||4
5213956|NCT00980330|12820463|P5|NOT COMPLETED|Overall Study||5
5213957|NCT00980330|12820464|P4|NOT COMPLETED|Overall Study||5
5213958|NCT00980330|12820465|P3|NOT COMPLETED|Overall Study||8
5213959|NCT00980330|12820466|P2|NOT COMPLETED|Overall Study||5
5213960|NCT00980330|12820467|P1|NOT COMPLETED|Overall Study||5
5213961|NCT00980330|12820461|P7|COMPLETED|Overall Study||59
5213962|NCT00980330|12820462|P6|COMPLETED|Overall Study||61
5213963|NCT00980330|12820463|P5|COMPLETED|Overall Study||63
5213964|NCT00980330|12820464|P4|COMPLETED|Overall Study||61
5213965|NCT00980330|12820465|P3|COMPLETED|Overall Study||58
5213966|NCT00980330|12820466|P2|COMPLETED|Overall Study||60
5213967|NCT00980330|12820467|P1|COMPLETED|Overall Study||61
5213968|NCT00980330|12820461|P7|STARTED|Overall Study||66
5213969|NCT00980330|12820462|P6|STARTED|Overall Study||65
5213970|NCT00980330|12820463|P5|STARTED|Overall Study||68
5213971|NCT00980330|12820464|P4|STARTED|Overall Study||66
5213972|NCT00980330|12820465|P3|STARTED|Overall Study||66
5213973|NCT00980330|12820466|P2|STARTED|Overall Study||65
5213974|NCT00980330|12820467|P1|STARTED|Overall Study||66
5213975|NCT00980278|12820567|P2|NOT COMPLETED|Overall Study||0
5213976|NCT00980278|12820568|P1|NOT COMPLETED|Overall Study||2
5213977|NCT00980278|12820567|P2|COMPLETED|Overall Study||13
5213978|NCT00980278|12820568|P1|COMPLETED|Overall Study||11
5213979|NCT00980278|12820567|P2|STARTED|Overall Study||13
5213980|NCT00980278|12820568|P1|STARTED|Overall Study||13
5213981|NCT00980200|12820582|P5|NOT COMPLETED|7-day Treatment Period 5||0
5213982|NCT00980200|12820583|P4|NOT COMPLETED|7-day Treatment Period 5||0
5213983|NCT00980200|12820584|P3|NOT COMPLETED|7-day Treatment Period 5||0
5213984|NCT00980200|12820585|P2|NOT COMPLETED|7-day Treatment Period 5||0
5213985|NCT00980200|12820586|P1|NOT COMPLETED|7-day Treatment Period 5||0
5213986|NCT00980200|12820582|P5|COMPLETED|7-day Treatment Period 5||14
5213987|NCT00980200|12820583|P4|COMPLETED|7-day Treatment Period 5||16
5213988|NCT00980200|12820584|P3|COMPLETED|7-day Treatment Period 5||15
5213989|NCT00980200|12820585|P2|COMPLETED|7-day Treatment Period 5||12
5213990|NCT00980200|12820586|P1|COMPLETED|7-day Treatment Period 5||15
5213991|NCT00980200|12820582|P5|STARTED|7-day Treatment Period 5||14
5213992|NCT00980200|12820583|P4|STARTED|7-day Treatment Period 5||16
5213993|NCT00980200|12820584|P3|STARTED|7-day Treatment Period 5||15
5213994|NCT00980200|12820585|P2|STARTED|7-day Treatment Period 5||12
5213995|NCT00980200|12820586|P1|STARTED|7-day Treatment Period 5||15
5213996|NCT00980200|12820582|P5|NOT COMPLETED|7-day Washout Period 4||0
5213997|NCT00980200|12820583|P4|NOT COMPLETED|7-day Washout Period 4||0
5213998|NCT00980200|12820584|P3|NOT COMPLETED|7-day Washout Period 4||0
5213999|NCT00980200|12820585|P2|NOT COMPLETED|7-day Washout Period 4||0
5214000|NCT00980200|12820586|P1|NOT COMPLETED|7-day Washout Period 4||0
5214001|NCT00980200|12820582|P5|COMPLETED|7-day Washout Period 4||14
5214002|NCT00980200|12820583|P4|COMPLETED|7-day Washout Period 4||16
5214003|NCT00980200|12820584|P3|COMPLETED|7-day Washout Period 4||15
5214004|NCT00980200|12820585|P2|COMPLETED|7-day Washout Period 4||12
5214005|NCT00980200|12820586|P1|COMPLETED|7-day Washout Period 4||15
5214006|NCT00980200|12820582|P5|STARTED|7-day Washout Period 4||14
5214007|NCT00980200|12820583|P4|STARTED|7-day Washout Period 4||16
5214008|NCT00980200|12820584|P3|STARTED|7-day Washout Period 4||15
5214009|NCT00980200|12820585|P2|STARTED|7-day Washout Period 4||12
5214010|NCT00980200|12820586|P1|STARTED|7-day Washout Period 4||15
5214011|NCT00980200|12820582|P5|NOT COMPLETED|7-day Treatment Period 4||0
5214012|NCT00980200|12820583|P4|NOT COMPLETED|7-day Treatment Period 4||0
5214013|NCT00980200|12820584|P3|NOT COMPLETED|7-day Treatment Period 4||0
5214014|NCT00980200|12820585|P2|NOT COMPLETED|7-day Treatment Period 4||0
5214015|NCT00980200|12820586|P1|NOT COMPLETED|7-day Treatment Period 4||0
5214016|NCT00980200|12820582|P5|COMPLETED|7-day Treatment Period 4||14
5214017|NCT00980200|12820583|P4|COMPLETED|7-day Treatment Period 4||16
5214018|NCT00980200|12820584|P3|COMPLETED|7-day Treatment Period 4||15
5214019|NCT00980200|12820585|P2|COMPLETED|7-day Treatment Period 4||12
5214020|NCT00980200|12820586|P1|COMPLETED|7-day Treatment Period 4||15
5214021|NCT00980200|12820582|P5|STARTED|7-day Treatment Period 4||14
5214022|NCT00980200|12820583|P4|STARTED|7-day Treatment Period 4||16
5214023|NCT00980200|12820584|P3|STARTED|7-day Treatment Period 4||15
5214024|NCT00980200|12820585|P2|STARTED|7-day Treatment Period 4||12
5214025|NCT00980200|12820586|P1|STARTED|7-day Treatment Period 4||15
5214026|NCT00980200|12820582|P5|NOT COMPLETED|7-day Washout Period 3||0
5214027|NCT00980200|12820583|P4|NOT COMPLETED|7-day Washout Period 3||0
5214028|NCT00980200|12820584|P3|NOT COMPLETED|7-day Washout Period 3||0
5214029|NCT00980200|12820585|P2|NOT COMPLETED|7-day Washout Period 3||0
5214030|NCT00980200|12820586|P1|NOT COMPLETED|7-day Washout Period 3||0
5214031|NCT00980200|12820582|P5|COMPLETED|7-day Washout Period 3||14
5214032|NCT00980200|12820583|P4|COMPLETED|7-day Washout Period 3||16
5214033|NCT00980200|12820584|P3|COMPLETED|7-day Washout Period 3||15
5214034|NCT00980200|12820585|P2|COMPLETED|7-day Washout Period 3||12
5214035|NCT00980200|12820586|P1|COMPLETED|7-day Washout Period 3||15
5214036|NCT00980200|12820582|P5|STARTED|7-day Washout Period 3||14
5214037|NCT00980200|12820583|P4|STARTED|7-day Washout Period 3||16
5214038|NCT00980200|12820584|P3|STARTED|7-day Washout Period 3||15
5214039|NCT00980200|12820585|P2|STARTED|7-day Washout Period 3||12
5214040|NCT00980200|12820586|P1|STARTED|7-day Washout Period 3||15
5214041|NCT00980200|12820582|P5|NOT COMPLETED|7-day Treatment Period 3||1
5214042|NCT00980200|12820583|P4|NOT COMPLETED|7-day Treatment Period 3||0
5214043|NCT00980200|12820584|P3|NOT COMPLETED|7-day Treatment Period 3||0
5214044|NCT00980200|12820585|P2|NOT COMPLETED|7-day Treatment Period 3||1
5214045|NCT00980200|12820586|P1|NOT COMPLETED|7-day Treatment Period 3||0
5214046|NCT00980200|12820582|P5|COMPLETED|7-day Treatment Period 3||14
5214047|NCT00980200|12820583|P4|COMPLETED|7-day Treatment Period 3||16
5214048|NCT00980200|12820584|P3|COMPLETED|7-day Treatment Period 3||15
5214049|NCT00980200|12820585|P2|COMPLETED|7-day Treatment Period 3||12
5214050|NCT00980200|12820586|P1|COMPLETED|7-day Treatment Period 3||15
5214051|NCT00980200|12820582|P5|STARTED|7-day Treatment Period 3||15
5214052|NCT00980200|12820583|P4|STARTED|7-day Treatment Period 3||16
5214053|NCT00980200|12820584|P3|STARTED|7-day Treatment Period 3||15
5214054|NCT00980200|12820585|P2|STARTED|7-day Treatment Period 3||13
5214055|NCT00980200|12820586|P1|STARTED|7-day Treatment Period 3||15
5214056|NCT00980200|12820582|P5|NOT COMPLETED|7-day Washout Period 2||0
5214057|NCT00980200|12820583|P4|NOT COMPLETED|7-day Washout Period 2||0
5214058|NCT00980200|12820584|P3|NOT COMPLETED|7-day Washout Period 2||0
5214059|NCT00980200|12820585|P2|NOT COMPLETED|7-day Washout Period 2||0
5214060|NCT00980200|12820586|P1|NOT COMPLETED|7-day Washout Period 2||0
5214061|NCT00980200|12820582|P5|COMPLETED|7-day Washout Period 2||15
5214062|NCT00980200|12820583|P4|COMPLETED|7-day Washout Period 2||16
5214063|NCT00980200|12820584|P3|COMPLETED|7-day Washout Period 2||15
5214064|NCT00980200|12820585|P2|COMPLETED|7-day Washout Period 2||13
5214065|NCT00980200|12820586|P1|COMPLETED|7-day Washout Period 2||15
5214066|NCT00980200|12820582|P5|STARTED|7-day Washout Period 2||15
5214067|NCT00980200|12820583|P4|STARTED|7-day Washout Period 2||16
5214068|NCT00980200|12820584|P3|STARTED|7-day Washout Period 2||15
5214069|NCT00980200|12820585|P2|STARTED|7-day Washout Period 2||13
5214070|NCT00980200|12820586|P1|STARTED|7-day Washout Period 2||15
5214071|NCT00980200|12820582|P5|NOT COMPLETED|7-day Treatment Period 2||0
5214072|NCT00980200|12820583|P4|NOT COMPLETED|7-day Treatment Period 2||0
5214073|NCT00980200|12820584|P3|NOT COMPLETED|7-day Treatment Period 2||0
5214074|NCT00980200|12820585|P2|NOT COMPLETED|7-day Treatment Period 2||0
5214075|NCT00980200|12820586|P1|NOT COMPLETED|7-day Treatment Period 2||0
5214076|NCT00980200|12820582|P5|COMPLETED|7-day Treatment Period 2||15
5214077|NCT00980200|12820583|P4|COMPLETED|7-day Treatment Period 2||16
5214078|NCT00980200|12820584|P3|COMPLETED|7-day Treatment Period 2||15
5214079|NCT00980200|12820585|P2|COMPLETED|7-day Treatment Period 2||13
5214080|NCT00980200|12820586|P1|COMPLETED|7-day Treatment Period 2||15
5214081|NCT00980200|12820582|P5|STARTED|7-day Treatment Period 2||15
5214082|NCT00980200|12820583|P4|STARTED|7-day Treatment Period 2||16
5214083|NCT00980200|12820584|P3|STARTED|7-day Treatment Period 2||15
5214084|NCT00980200|12820585|P2|STARTED|7-day Treatment Period 2||13
5214085|NCT00980200|12820586|P1|STARTED|7-day Treatment Period 2||15
5214086|NCT00980200|12820582|P5|NOT COMPLETED|7-day Washout Period 1||0
5214087|NCT00980200|12820583|P4|NOT COMPLETED|7-day Washout Period 1||0
5214088|NCT00980200|12820584|P3|NOT COMPLETED|7-day Washout Period 1||0
5214089|NCT00980200|12820585|P2|NOT COMPLETED|7-day Washout Period 1||0
5214090|NCT00980200|12820586|P1|NOT COMPLETED|7-day Washout Period 1||0
5214091|NCT00980200|12820582|P5|COMPLETED|7-day Washout Period 1||15
5214092|NCT00980200|12820583|P4|COMPLETED|7-day Washout Period 1||16
5214093|NCT00980200|12820584|P3|COMPLETED|7-day Washout Period 1||15
5214094|NCT00980200|12820585|P2|COMPLETED|7-day Washout Period 1||13
5214095|NCT00980200|12820586|P1|COMPLETED|7-day Washout Period 1||15
5214096|NCT00980200|12820582|P5|STARTED|7-day Washout Period 1||15
5214097|NCT00980200|12820583|P4|STARTED|7-day Washout Period 1||16
5214098|NCT00980200|12820584|P3|STARTED|7-day Washout Period 1||15
5214099|NCT00980200|12820585|P2|STARTED|7-day Washout Period 1||13
5214100|NCT00980200|12820586|P1|STARTED|7-day Washout Period 1||15
5214101|NCT00980200|12820582|P5|NOT COMPLETED|7-day Treatment Period 1||0
5214102|NCT00980200|12820583|P4|NOT COMPLETED|7-day Treatment Period 1||0
5214103|NCT00980200|12820584|P3|NOT COMPLETED|7-day Treatment Period 1||0
5214104|NCT00980200|12820585|P2|NOT COMPLETED|7-day Treatment Period 1||1
5214105|NCT00980200|12820586|P1|NOT COMPLETED|7-day Treatment Period 1||0
5214106|NCT00980200|12820582|P5|COMPLETED|7-day Treatment Period 1||15
5214107|NCT00980200|12820583|P4|COMPLETED|7-day Treatment Period 1||16
5214108|NCT00980200|12820584|P3|COMPLETED|7-day Treatment Period 1||15
5214109|NCT00980200|12820585|P2|COMPLETED|7-day Treatment Period 1||13
5214110|NCT00980200|12820586|P1|COMPLETED|7-day Treatment Period 1||15
5214111|NCT00980200|12820582|P5|STARTED|7-day Treatment Period 1||15
5214112|NCT00980200|12820583|P4|STARTED|7-day Treatment Period 1||16
5214113|NCT00980200|12820584|P3|STARTED|7-day Treatment Period 1||15
5214114|NCT00980200|12820585|P2|STARTED|7-day Treatment Period 1||14
5214115|NCT00980200|12820586|P1|STARTED|7-day Treatment Period 1||15
5214116|NCT00980174|12820605|P2|NOT COMPLETED|Overall Study||10
5214117|NCT00980174|12820606|P1|NOT COMPLETED|Overall Study||4
5214118|NCT00980174|12820605|P2|COMPLETED|Overall Study||111
5214119|NCT00980174|12820606|P1|COMPLETED|Overall Study||117
5214120|NCT00980174|12820605|P2|STARTED|Overall Study||121
5214121|NCT00980174|12820606|P1|STARTED|Overall Study||121
5214122|NCT00980148|12820624|P2|NOT COMPLETED|Overall Study||128
5214123|NCT00980148|12820625|P1|NOT COMPLETED|Overall Study||129
5214124|NCT00980148|12820624|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
5214125|NCT00980148|12820625|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
5214126|NCT00980148|12820624|P2|STARTED|Overall Study||283
5214127|NCT00980148|12820625|P1|STARTED|Overall Study||284
5214128|NCT00980057|12820633|P2|NOT COMPLETED|Overall Study||5
5214129|NCT00980057|12820634|P1|NOT COMPLETED|Overall Study||19
5214130|NCT00980057|12820633|P2|COMPLETED|Overall Study||155
5214131|NCT00980057|12820634|P1|COMPLETED|Overall Study||299
5214132|NCT00980057|12820633|P2|STARTED|Overall Study||160
5214133|NCT00980057|12820634|P1|STARTED|Overall Study||318
5214134|NCT00980044|12820657|P3|NOT COMPLETED|Overall Study||5
5214135|NCT00980044|12820658|P2|NOT COMPLETED|Overall Study||7
5214136|NCT00980044|12820659|P1|NOT COMPLETED|Overall Study||5
5214137|NCT00980044|12820657|P3|COMPLETED|Overall Study||12
5214138|NCT00980044|12820658|P2|COMPLETED|Overall Study||12
5214139|NCT00980044|12820659|P1|COMPLETED|Overall Study||12
5214140|NCT00980044|12820657|P3|STARTED|Overall Study||17
5214141|NCT00980044|12820658|P2|STARTED|Overall Study||19
5214142|NCT00980044|12820659|P1|STARTED|Overall Study||17
5214143|NCT00980005|12820678|P2|NOT COMPLETED|Overall Study||63
5214144|NCT00980005|12820679|P1|NOT COMPLETED|Overall Study||47
5214145|NCT00980005|12820678|P2|COMPLETED|Overall Study||998
5214146|NCT00980005|12820679|P1|COMPLETED|Overall Study||1008
5214147|NCT00980005|12820678|P2|STARTED|Overall Study||1061
5214148|NCT00980005|12820679|P1|STARTED|Overall Study||1055
5214149|NCT00979992|12820719|P1|NOT COMPLETED|Overall Study||5
5214150|NCT00979992|12820719|P1|COMPLETED|Overall Study||30
5214151|NCT00979992|12820719|P1|STARTED|Overall Study||35
5214152|NCT00979953|12820731|P4|NOT COMPLETED|Overall Study||7
5214153|NCT00979953|12820732|P3|NOT COMPLETED|Overall Study||22
5214154|NCT00979953|12820733|P2|NOT COMPLETED|Overall Study||5
5214155|NCT00979953|12820734|P1|NOT COMPLETED|Overall Study||8
5214156|NCT00979953|12820731|P4|COMPLETED|Overall Study||97
5214157|NCT00979953|12820732|P3|COMPLETED|Overall Study||82
5214158|NCT00979953|12820733|P2|COMPLETED|Overall Study||94
5214159|NCT00979953|12820734|P1|COMPLETED|Overall Study||93
5214160|NCT00979953|12820731|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
5214161|NCT00979953|12820732|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
5214162|NCT00979953|12820733|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
5214163|NCT00979953|12820734|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
5214164|NCT00979953|12820731|P4|STARTED|Overall Study||104
5214165|NCT00979953|12820732|P3|STARTED|Overall Study||104
5214166|NCT00979953|12820733|P2|STARTED|Overall Study||99
5214167|NCT00979953|12820734|P1|STARTED|Overall Study||101
5214168|NCT00979940|12820746|P2|NOT COMPLETED|Overall Study||0
5214169|NCT00979940|12820747|P1|NOT COMPLETED|Overall Study||0
5214170|NCT00979940|12820746|P2|COMPLETED|Overall Study||28
5214171|NCT00979940|12820747|P1|COMPLETED|Overall Study||32
5214172|NCT00979940|12820746|P2|STARTED|Overall Study||28
5214173|NCT00979940|12820747|P1|STARTED|Overall Study||32
5214174|NCT00979901|12820757|P4|NOT COMPLETED|Overall Study||116
5214175|NCT00979901|12820758|P3|NOT COMPLETED|Overall Study||29
5214176|NCT00979901|12820759|P2|NOT COMPLETED|Overall Study||12
5214177|NCT00979901|12820760|P1|NOT COMPLETED|Overall Study||18
5214178|NCT00979901|12820757|P4|COMPLETED|Overall Study||159
5214179|NCT00979901|12820758|P3|COMPLETED|Overall Study||573
5214180|NCT00979901|12820759|P2|COMPLETED|Overall Study||336
5214181|NCT00979901|12820760|P1|COMPLETED|Overall Study||334
5214182|NCT00979901|12820757|P4|STARTED|Overall Study||275
5214183|NCT00979901|12820758|P3|STARTED|Overall Study||602
5214184|NCT00979901|12820759|P2|STARTED|Overall Study||348
5214185|NCT00979901|12820760|P1|STARTED|Overall Study||352
5214186|NCT00979875|12820784|P6|NOT COMPLETED|Intervention 3||0
5214187|NCT00979875|12820785|P5|NOT COMPLETED|Intervention 3||0
5214188|NCT00979875|12820786|P4|NOT COMPLETED|Intervention 3||0
5214189|NCT00979875|12820787|P3|NOT COMPLETED|Intervention 3||0
5214190|NCT00979875|12820788|P2|NOT COMPLETED|Intervention 3||0
5214191|NCT00979875|12820789|P1|NOT COMPLETED|Intervention 3||0
5214192|NCT00979875|12820784|P6|COMPLETED|Intervention 3||2
5214193|NCT00979875|12820785|P5|COMPLETED|Intervention 3||3
5214194|NCT00979875|12820786|P4|COMPLETED|Intervention 3||2
5214195|NCT00979875|12820787|P3|COMPLETED|Intervention 3||3
5214196|NCT00979875|12820788|P2|COMPLETED|Intervention 3||2
5214197|NCT00979875|12820789|P1|COMPLETED|Intervention 3||2
5214198|NCT00979875|12820784|P6|STARTED|Intervention 3||2
5214199|NCT00979875|12820785|P5|STARTED|Intervention 3||3
5214200|NCT00979875|12820786|P4|STARTED|Intervention 3||2
5214201|NCT00979875|12820787|P3|STARTED|Intervention 3||3
5214202|NCT00979875|12820788|P2|STARTED|Intervention 3||2
5214203|NCT00979875|12820789|P1|STARTED|Intervention 3||2
5214204|NCT00979875|12820784|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214205|NCT00979875|12820785|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214206|NCT00979875|12820786|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214207|NCT00979875|12820787|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214208|NCT00979875|12820788|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214209|NCT00979875|12820789|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5214210|NCT00979875|12820784|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
5214211|NCT00979875|12820785|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
5214212|NCT00979875|12820786|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
5214213|NCT00979875|12820787|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
5214214|NCT00979875|12820788|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
5214215|NCT00979875|12820789|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
5214216|NCT00979875|12820784|P6|STARTED|Washout 2 (3 to 14 Days)||2
5214217|NCT00979875|12820785|P5|STARTED|Washout 2 (3 to 14 Days)||3
5214218|NCT00979875|12820786|P4|STARTED|Washout 2 (3 to 14 Days)||2
5214219|NCT00979875|12820787|P3|STARTED|Washout 2 (3 to 14 Days)||3
5214220|NCT00979875|12820788|P2|STARTED|Washout 2 (3 to 14 Days)||2
5214221|NCT00979875|12820789|P1|STARTED|Washout 2 (3 to 14 Days)||2
5214222|NCT00979875|12820784|P6|NOT COMPLETED|Intervention 2||0
5214223|NCT00979875|12820785|P5|NOT COMPLETED|Intervention 2||0
5214224|NCT00979875|12820786|P4|NOT COMPLETED|Intervention 2||0
5214225|NCT00979875|12820787|P3|NOT COMPLETED|Intervention 2||0
5214226|NCT00979875|12820788|P2|NOT COMPLETED|Intervention 2||0
5214227|NCT00979875|12820789|P1|NOT COMPLETED|Intervention 2||0
5214228|NCT00979875|12820784|P6|COMPLETED|Intervention 2||2
5214229|NCT00979875|12820785|P5|COMPLETED|Intervention 2||3
5214230|NCT00979875|12820786|P4|COMPLETED|Intervention 2||2
5214231|NCT00979875|12820787|P3|COMPLETED|Intervention 2||3
5214232|NCT00979875|12820788|P2|COMPLETED|Intervention 2||2
5214233|NCT00979875|12820789|P1|COMPLETED|Intervention 2||2
5214234|NCT00979875|12820784|P6|STARTED|Intervention 2||2
5214235|NCT00979875|12820785|P5|STARTED|Intervention 2||3
5214236|NCT00979875|12820786|P4|STARTED|Intervention 2||2
5214237|NCT00979875|12820787|P3|STARTED|Intervention 2||3
5214238|NCT00979875|12820788|P2|STARTED|Intervention 2||2
5214239|NCT00979875|12820789|P1|STARTED|Intervention 2||2
5214240|NCT00979875|12820784|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214241|NCT00979875|12820785|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214242|NCT00979875|12820786|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214243|NCT00979875|12820787|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214244|NCT00979875|12820788|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214245|NCT00979875|12820789|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5214246|NCT00979875|12820784|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
5214247|NCT00979875|12820785|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
5214248|NCT00979875|12820786|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
5214249|NCT00979875|12820787|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
5214250|NCT00979875|12820788|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
5214251|NCT00979875|12820789|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
5214252|NCT00979875|12820784|P6|STARTED|Washout 1 (3 to 14 Days)||2
5214253|NCT00979875|12820785|P5|STARTED|Washout 1 (3 to 14 Days)||3
5214254|NCT00979875|12820786|P4|STARTED|Washout 1 (3 to 14 Days)||2
5214255|NCT00979875|12820787|P3|STARTED|Washout 1 (3 to 14 Days)||3
5214256|NCT00979875|12820788|P2|STARTED|Washout 1 (3 to 14 Days)||2
5214257|NCT00979875|12820789|P1|STARTED|Washout 1 (3 to 14 Days)||2
5214258|NCT00979875|12820784|P6|NOT COMPLETED|Intervention 1||0
5214259|NCT00979875|12820785|P5|NOT COMPLETED|Intervention 1||0
5214260|NCT00979875|12820786|P4|NOT COMPLETED|Intervention 1||0
5214261|NCT00979875|12820787|P3|NOT COMPLETED|Intervention 1||0
5214262|NCT00979875|12820788|P2|NOT COMPLETED|Intervention 1||0
5214263|NCT00979875|12820789|P1|NOT COMPLETED|Intervention 1||0
5214264|NCT00979875|12820784|P6|COMPLETED|Intervention 1||2
5214265|NCT00979875|12820785|P5|COMPLETED|Intervention 1||3
5214266|NCT00979875|12820786|P4|COMPLETED|Intervention 1||2
5214267|NCT00979875|12820787|P3|COMPLETED|Intervention 1||3
5214268|NCT00979875|12820788|P2|COMPLETED|Intervention 1||2
5214269|NCT00979875|12820789|P1|COMPLETED|Intervention 1||2
5214270|NCT00979875|12820784|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
5214271|NCT00979875|12820785|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
5214272|NCT00979875|12820786|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
5214273|NCT00979875|12820787|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
5214274|NCT00979875|12820788|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
5214275|NCT00979875|12820789|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
5214276|NCT00979875|12820784|P6|STARTED|Intervention 1||2
5214277|NCT00979875|12820785|P5|STARTED|Intervention 1||3
5214278|NCT00979875|12820786|P4|STARTED|Intervention 1||2
5214279|NCT00979875|12820787|P3|STARTED|Intervention 1||3
5214280|NCT00979875|12820788|P2|STARTED|Intervention 1||2
5214281|NCT00979875|12820789|P1|STARTED|Intervention 1||2
5214282|NCT00979654|12820833|P1|NOT COMPLETED|Overall Study||36
5214283|NCT00979654|12820833|P1|COMPLETED|Overall Study||67
5214284|NCT00979654|12820833|P1|STARTED|Overall Study||103
5214285|NCT00979628|12820848|P3|NOT COMPLETED|Overall Study||6
5214286|NCT00979628|12820849|P2|NOT COMPLETED|Overall Study||9
5214287|NCT00979628|12820850|P1|NOT COMPLETED|Overall Study||9
5214288|NCT00979628|12820848|P3|COMPLETED|Overall Study||74
5214289|NCT00979628|12820849|P2|COMPLETED|Overall Study||133
5214290|NCT00979628|12820850|P1|COMPLETED|Overall Study||144
5214291|NCT00979628|12820848|P3|STARTED|Overall Study||80
5214292|NCT00979628|12820849|P2|STARTED|Overall Study||142
5214293|NCT00979628|12820850|P1|STARTED|Overall Study||153
5214294|NCT00979615|12820863|P2|NOT COMPLETED|Overall Study||8
5214295|NCT00979615|12820864|P1|NOT COMPLETED|Overall Study||6
5214296|NCT00979615|12820863|P2|COMPLETED|Overall Study||58
5214297|NCT00979615|12820864|P1|COMPLETED|Overall Study||57
5214298|NCT00979615|12820863|P2|STARTED|Overall Study||66
5214299|NCT00979615|12820864|P1|STARTED|Overall Study||63
5214300|NCT00979602|12820880|P2|NOT COMPLETED|Overall Study||133
5214301|NCT00979602|12820881|P1|NOT COMPLETED|Overall Study||145
5214302|NCT00979602|12820880|P2|COMPLETED|Overall Study||1890
5214303|NCT00979602|12820881|P1|COMPLETED|Overall Study||1880
5214304|NCT00979602|12820880|P2|STARTED|Overall Study||2023
5214305|NCT00979602|12820881|P1|STARTED|Overall Study||2025
5214306|NCT00979576|12821052|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
5214307|NCT00979576|12821053|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
5214308|NCT00979576|12821054|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
5214309|NCT00979576|12821052|P3|COMPLETED|Combination Followed by Monotherapy||0
5214310|NCT00979576|12821053|P2|COMPLETED|Combination Followed by Monotherapy||0
5214311|NCT00979576|12821054|P1|COMPLETED|Combination Followed by Monotherapy||0
5214312|NCT00979576|12821052|P3|STARTED|Combination Followed by Monotherapy||1
5214313|NCT00979576|12821053|P2|STARTED|Combination Followed by Monotherapy||2
5214314|NCT00979576|12821054|P1|STARTED|Combination Followed by Monotherapy||0
5214315|NCT00979576|12821052|P3|NOT COMPLETED|Combination Treatment Phase||9
5214316|NCT00979576|12821053|P2|NOT COMPLETED|Combination Treatment Phase||6
5214317|NCT00979576|12821054|P1|NOT COMPLETED|Combination Treatment Phase||3
5214318|NCT00979576|12821052|P3|COMPLETED|Combination Treatment Phase||0
5214319|NCT00979576|12821053|P2|COMPLETED|Combination Treatment Phase||0
5214320|NCT00979576|12821054|P1|COMPLETED|Combination Treatment Phase||0
5214321|NCT00979576|12821052|P3|STARTED|Combination Treatment Phase||9
5214322|NCT00979576|12821053|P2|STARTED|Combination Treatment Phase||6
5214323|NCT00979576|12821054|P1|STARTED|Combination Treatment Phase||3
5214324|NCT00979550|12821087|P2|NOT COMPLETED|Overall Study||0
5214325|NCT00979550|12821088|P1|NOT COMPLETED|Overall Study||0
5214326|NCT00979550|12821087|P2|COMPLETED|Overall Study||3
5214327|NCT00979550|12821088|P1|COMPLETED|Overall Study||4
5214328|NCT00979550|12821087|P2|STARTED|Overall Study||3
5214329|NCT00979550|12821088|P1|STARTED|Overall Study||4
5214330|NCT00979459|12821094|P2|NOT COMPLETED|Second Intervention||0
5214331|NCT00979459|12821095|P1|NOT COMPLETED|Second Intervention||0
5214332|NCT00979459|12821094|P2|COMPLETED|Second Intervention||6
5214333|NCT00979459|12821095|P1|COMPLETED|Second Intervention||6
5214334|NCT00979459|12821094|P2|STARTED|Second Intervention||6
5214335|NCT00979459|12821095|P1|STARTED|Second Intervention||6
5214336|NCT00979459|12821094|P2|NOT COMPLETED|7-day Washout Period||0
5214337|NCT00979459|12821095|P1|NOT COMPLETED|7-day Washout Period||0
5214338|NCT00979459|12821094|P2|COMPLETED|7-day Washout Period||6
5214339|NCT00979459|12821095|P1|COMPLETED|7-day Washout Period||6
5214340|NCT00979459|12821094|P2|STARTED|7-day Washout Period||6
5214341|NCT00979459|12821095|P1|STARTED|7-day Washout Period||6
5214342|NCT00979459|12821094|P2|NOT COMPLETED|First Intervention||0
5214343|NCT00979459|12821095|P1|NOT COMPLETED|First Intervention||0
5214344|NCT00979459|12821094|P2|COMPLETED|First Intervention||6
5214345|NCT00979459|12821095|P1|COMPLETED|First Intervention||6
5214346|NCT00979459|12821094|P2|STARTED|First Intervention||6
5214347|NCT00979459|12821095|P1|STARTED|First Intervention||6
5214348|NCT00979420|12821111|P4|NOT COMPLETED|Overall Study||2
5214349|NCT00979420|12821112|P3|NOT COMPLETED|Overall Study||1
5214350|NCT00979420|12821113|P2|NOT COMPLETED|Overall Study||0
5214351|NCT00979420|12821114|P1|NOT COMPLETED|Overall Study||7
5214352|NCT00979420|12821111|P4|COMPLETED|Overall Study||59
5214353|NCT00979420|12821112|P3|COMPLETED|Overall Study||59
5214354|NCT00979420|12821113|P2|COMPLETED|Overall Study||57
5214355|NCT00979420|12821114|P1|COMPLETED|Overall Study||171
5214356|NCT00979420|12821111|P4|STARTED|Overall Study||61
5214357|NCT00979420|12821112|P3|STARTED|Overall Study||60
5214358|NCT00979420|12821113|P2|STARTED|Overall Study||57
5214359|NCT00979420|12821114|P1|STARTED|Overall Study||178
5214360|NCT00979407|12821184|P2|NOT COMPLETED|Overall Study||7
5214361|NCT00979407|12821185|P1|NOT COMPLETED|Overall Study||6
5214362|NCT00979407|12821184|P2|COMPLETED|Overall Study||160
5214363|NCT00979407|12821185|P1|COMPLETED|Overall Study||161
5214364|NCT00979407|12821184|P2|STARTED|Overall Study||167
5214365|NCT00979407|12821185|P1|STARTED|Overall Study||167
5214366|NCT00979303|12821227|P2|NOT COMPLETED|Overall Study||0
5214367|NCT00979303|12821228|P1|NOT COMPLETED|Overall Study||0
5214368|NCT00979303|12821227|P2|COMPLETED|Overall Study||37
5214369|NCT00979303|12821228|P1|COMPLETED|Overall Study||37
5214370|NCT00979303|12821227|P2|STARTED|Overall Study||37
5214371|NCT00979303|12821228|P1|STARTED|Overall Study||37
5214372|NCT00979212|12821238|P2|NOT COMPLETED|Overall Study||8
5214373|NCT00979212|12821239|P1|NOT COMPLETED|Overall Study||2
5214374|NCT00979212|12821238|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
5214375|NCT00979212|12821239|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
5214376|NCT00979212|12821238|P2|STARTED|Overall Study||47
5214377|NCT00979212|12821239|P1|STARTED|Overall Study||24
5214378|NCT00979199|12821257|P1|NOT COMPLETED|Overall Study||222
5214379|NCT00979199|12821257|P1|COMPLETED|Overall Study||475
5214380|NCT00979199|12821257|P1|STARTED|Overall Study||697
5214381|NCT00979134|12821265|P3|NOT COMPLETED|Overall Study||40
5214382|NCT00979134|12821266|P2|NOT COMPLETED|Overall Study||6
5214383|NCT00979134|12821267|P1|NOT COMPLETED|Overall Study||33
5214384|NCT00979134|12821265|P3|COMPLETED|Overall Study|At DCO|5
5214385|NCT00979134|12821266|P2|COMPLETED|Overall Study|At DCO|0
5214386|NCT00979134|12821267|P1|COMPLETED|Overall Study|At DCO|10
5214387|NCT00979134|12821265|P3|STARTED|Overall Study||45
5214388|NCT00979134|12821266|P2|STARTED|Overall Study||6
5214389|NCT00979134|12821267|P1|STARTED|Overall Study||43
5214390|NCT00979121|12821319|P2|NOT COMPLETED|Overall Study||0
5214391|NCT00979121|12821320|P1|NOT COMPLETED|Overall Study||0
5214392|NCT00979121|12821319|P2|COMPLETED|Overall Study||366
5214393|NCT00979121|12821320|P1|COMPLETED|Overall Study||379
5214394|NCT00979121|12821319|P2|STARTED|Overall Study||366
5214395|NCT00979121|12821320|P1|STARTED|Overall Study||379
5214396|NCT00979069|12821338|P2|NOT COMPLETED|Overall Study||2
5214397|NCT00979069|12821339|P1|NOT COMPLETED|Overall Study||0
5214398|NCT00979069|12821338|P2|COMPLETED|Overall Study||8
5214399|NCT00979069|12821339|P1|COMPLETED|Overall Study||10
5214400|NCT00979069|12821338|P2|STARTED|Overall Study||10
5214401|NCT00979069|12821339|P1|STARTED|Overall Study||10
5214402|NCT00979017|12821345|P1|NOT COMPLETED|Overall Study||0
5214403|NCT00979017|12821345|P1|COMPLETED|Overall Study||41
5214404|NCT00979017|12821345|P1|STARTED|Overall Study||41
5214405|NCT00978757|12821355|P2|NOT COMPLETED|Overall Study||3
5214406|NCT00978757|12821356|P1|NOT COMPLETED|Overall Study||1
5214407|NCT00978757|12821355|P2|COMPLETED|Overall Study|June 2008|17
5214408|NCT00978757|12821356|P1|COMPLETED|Overall Study|June 2008|21
5214409|NCT00978757|12821355|P2|STARTED|Overall Study|June 2001|20
5214410|NCT00978757|12821356|P1|STARTED|Overall Study|June 2001|22
5214411|NCT00978731|12821366|P4|NOT COMPLETED|Overall Study||4
5214412|NCT00978731|12821367|P3|NOT COMPLETED|Overall Study||5
5214413|NCT00978731|12821368|P2|NOT COMPLETED|Overall Study||15
5214414|NCT00978731|12821369|P1|NOT COMPLETED|Overall Study||22
5214415|NCT00978731|12821366|P4|COMPLETED|Overall Study||0
5214416|NCT00978731|12821367|P3|COMPLETED|Overall Study||0
5214417|NCT00978731|12821368|P2|COMPLETED|Overall Study||0
5214418|NCT00978731|12821369|P1|COMPLETED|Overall Study||0
5214419|NCT00978731|12821366|P4|STARTED|Overall Study||4
5214420|NCT00978731|12821367|P3|STARTED|Overall Study||5
5214421|NCT00978731|12821368|P2|STARTED|Overall Study||15
5214422|NCT00978731|12821369|P1|STARTED|Overall Study||22
5214423|NCT00978627|12821409|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
5214424|NCT00978627|12821410|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
5214425|NCT00978627|12821409|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
5214426|NCT00978627|12821410|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
5214427|NCT00978627|12821409|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
5214428|NCT00978627|12821410|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
5214429|NCT00978627|12821409|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
5214430|NCT00978627|12821410|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
5214431|NCT00978627|12821409|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
5214432|NCT00978627|12821410|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
5214433|NCT00978627|12821409|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
5214434|NCT00978627|12821410|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
5214435|NCT00978627|12821409|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
5214436|NCT00978627|12821410|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
5214437|NCT00978562|12821432|P1|NOT COMPLETED|Overall Study||0
5214438|NCT00978562|12821432|P1|COMPLETED|Overall Study||7
5214439|NCT00978562|12821432|P1|STARTED|Overall Study||7
5214440|NCT00978445|12821437|P2|NOT COMPLETED|Overall Study||1
5214441|NCT00978445|12821438|P1|NOT COMPLETED|Overall Study||2
5214442|NCT00978445|12821437|P2|COMPLETED|Overall Study||12
5214443|NCT00978445|12821438|P1|COMPLETED|Overall Study||10
5214444|NCT00978445|12821437|P2|STARTED|Overall Study||13
5214445|NCT00978445|12821438|P1|STARTED|Overall Study||12
5214446|NCT00978432|12821448|P3|NOT COMPLETED|Overall Study||5
5214447|NCT00978432|12821449|P2|NOT COMPLETED|Overall Study||1
5214448|NCT00978432|12821450|P1|NOT COMPLETED|Overall Study||3
5214449|NCT00978432|12821448|P3|COMPLETED|Overall Study||13
5214450|NCT00978432|12821449|P2|COMPLETED|Overall Study||4
5214451|NCT00978432|12821450|P1|COMPLETED|Overall Study||7
5214452|NCT00978432|12821448|P3|STARTED|Overall Study||18
5214453|NCT00978432|12821449|P2|STARTED|Overall Study||5
5214454|NCT00978432|12821450|P1|STARTED|Overall Study||10
5214455|NCT00978419|12821472|P2|NOT COMPLETED|Overall Study||0
5214456|NCT00978419|12821473|P1|NOT COMPLETED|Overall Study||0
5214457|NCT00978419|12821472|P2|COMPLETED|Overall Study||0
5214458|NCT00978419|12821473|P1|COMPLETED|Overall Study||0
5214459|NCT00978419|12821472|P2|STARTED|Overall Study||0
5214460|NCT00978419|12821473|P1|STARTED|Overall Study||0
5214461|NCT00978380|12821501|P1|NOT COMPLETED|Overall Study||19
5214462|NCT00978380|12821501|P1|COMPLETED|Overall Study||44
5214463|NCT00978380|12821501|P1|STARTED|Overall Study||63
5214464|NCT00978341|12821507|P2|NOT COMPLETED|Second Intervention||0
5214465|NCT00978341|12821508|P1|NOT COMPLETED|Second Intervention||0
5214466|NCT00978341|12821507|P2|COMPLETED|Second Intervention||7
5214467|NCT00978341|12821508|P1|COMPLETED|Second Intervention||7
5214468|NCT00978341|12821507|P2|STARTED|Second Intervention||7
5214469|NCT00978341|12821508|P1|STARTED|Second Intervention||7
5214470|NCT00978341|12821507|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5214471|NCT00978341|12821508|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
5214472|NCT00978341|12821507|P2|COMPLETED|Washout Period of 2 Weeks||7
5214473|NCT00978341|12821508|P1|COMPLETED|Washout Period of 2 Weeks||7
5214474|NCT00978341|12821507|P2|STARTED|Washout Period of 2 Weeks||7
5214475|NCT00978341|12821508|P1|STARTED|Washout Period of 2 Weeks||8
5214476|NCT00978341|12821507|P2|NOT COMPLETED|First Intervention||0
5214477|NCT00978341|12821508|P1|NOT COMPLETED|First Intervention||0
5214478|NCT00978341|12821507|P2|COMPLETED|First Intervention||7
5214479|NCT00978341|12821508|P1|COMPLETED|First Intervention||8
5214480|NCT00978341|12821507|P2|STARTED|First Intervention||7
5214481|NCT00978341|12821508|P1|STARTED|First Intervention||8
5214482|NCT00978250|12821530|P4|NOT COMPLETED|Overall Study||1
5214483|NCT00978250|12821531|P3|NOT COMPLETED|Overall Study||0
5214484|NCT00978250|12821532|P2|NOT COMPLETED|Overall Study||1
5214485|NCT00978250|12821533|P1|NOT COMPLETED|Overall Study||0
5214486|NCT00978250|12821530|P4|COMPLETED|Overall Study||21
5214487|NCT00978250|12821531|P3|COMPLETED|Overall Study||18
5214488|NCT00978250|12821532|P2|COMPLETED|Overall Study||29
5214489|NCT00978250|12821533|P1|COMPLETED|Overall Study||25
5214490|NCT00978250|12821530|P4|STARTED|Overall Study||22
5214491|NCT00978250|12821531|P3|STARTED|Overall Study||18
5214492|NCT00978250|12821532|P2|STARTED|Overall Study||30
5214493|NCT00978250|12821533|P1|STARTED|Overall Study||25
5214494|NCT00978120|12821549|P4|NOT COMPLETED|Overall Study||2
5214495|NCT00978120|12821550|P3|NOT COMPLETED|Overall Study||3
5214496|NCT00978120|12821551|P2|NOT COMPLETED|Overall Study||0
5214497|NCT00978120|12821552|P1|NOT COMPLETED|Overall Study||2
5214498|NCT00978120|12821549|P4|COMPLETED|Overall Study||84
5214499|NCT00978120|12821550|P3|COMPLETED|Overall Study||84
5214500|NCT00978120|12821551|P2|COMPLETED|Overall Study||107
5214501|NCT00978120|12821552|P1|COMPLETED|Overall Study||108
5214502|NCT00978120|12821549|P4|STARTED|Overall Study||86
5214503|NCT00978120|12821550|P3|STARTED|Overall Study||87
5214504|NCT00978120|12821551|P2|STARTED|Overall Study||107
5214505|NCT00978120|12821552|P1|STARTED|Overall Study||110
5214506|NCT00978068|12821604|P2|NOT COMPLETED|Overall Study||9
5214507|NCT00978068|12821605|P1|NOT COMPLETED|Overall Study||4
5214508|NCT00978068|12821604|P2|COMPLETED|Overall Study||80
5214509|NCT00978068|12821605|P1|COMPLETED|Overall Study||83
5214510|NCT00978068|12821604|P2|Initiated Study Drugs|Overall Study||86
5214511|NCT00978068|12821605|P1|Initiated Study Drugs|Overall Study||84
5214512|NCT00978068|12821604|P2|STARTED|Overall Study||89
5214513|NCT00978068|12821605|P1|STARTED|Overall Study||87
5214514|NCT00978042|12821623|P2|NOT COMPLETED|Received Repeat Treatment||3
5214515|NCT00978042|12821624|P1|NOT COMPLETED|Received Repeat Treatment||43
5214516|NCT00978042|12821623|P2|COMPLETED|Received Repeat Treatment||23
5214517|NCT00978042|12821624|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
5214518|NCT00978042|12821623|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
5214519|NCT00978042|12821624|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
5214520|NCT00978042|12821623|P2|NOT COMPLETED|Initial Treatment Period||15
5214521|NCT00978042|12821624|P1|NOT COMPLETED|Initial Treatment Period||61
5214522|NCT00978042|12821623|P2|COMPLETED|Initial Treatment Period||32
5214523|NCT00978042|12821624|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
5214524|NCT00978042|12821623|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
5214525|NCT00978042|12821624|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
5214526|NCT00978042|12821623|P2|STARTED|Initial Treatment Period||47
5214527|NCT00978042|12821624|P1|STARTED|Initial Treatment Period||235
5214528|NCT00978029|12821637|P3|NOT COMPLETED|Overall Study||6
5214529|NCT00978029|12821638|P2|NOT COMPLETED|Overall Study||3
5214530|NCT00978029|12821639|P1|NOT COMPLETED|Overall Study||1
5214531|NCT00978029|12821637|P3|COMPLETED|Overall Study||59
5214532|NCT00978029|12821638|P2|COMPLETED|Overall Study||63
5214533|NCT00978029|12821639|P1|COMPLETED|Overall Study||64
5214534|NCT00978029|12821637|P3|STARTED|Overall Study||65
5214535|NCT00978029|12821638|P2|STARTED|Overall Study||66
5214536|NCT00978029|12821639|P1|STARTED|Overall Study||65
5214537|NCT00977938|12821666|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
5214538|NCT00977938|12821667|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
5214539|NCT00977938|12821668|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
5214540|NCT00977938|12821669|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
5214541|NCT00977938|12821666|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
5214542|NCT00977938|12821667|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
5214543|NCT00977938|12821668|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
5214544|NCT00977938|12821669|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
5214545|NCT00977938|12821666|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
5214546|NCT00977938|12821667|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
5214547|NCT00977938|12821668|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
5214548|NCT00977938|12821669|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
5214549|NCT00977938|12821666|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
5214550|NCT00977938|12821667|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
5214551|NCT00977938|12821668|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
5214552|NCT00977938|12821669|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
5214553|NCT00977938|12821666|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
5214554|NCT00977938|12821667|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
5214555|NCT00977938|12821668|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
5214556|NCT00977938|12821669|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
5214557|NCT00977938|12821666|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
5214558|NCT00977938|12821667|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
5214559|NCT00977938|12821668|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
5214560|NCT00977938|12821669|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
5214561|NCT00977808|12821703|P1|NOT COMPLETED|Overall Study||1
5214562|NCT00977808|12821703|P1|COMPLETED|Overall Study||11
5214563|NCT00977808|12821703|P1|Completion of Closed-Loop Admission|Overall Study||11
5214564|NCT00977808|12821703|P1|Completion of Open-Loop Admission|Overall Study||12
5214565|NCT00977808|12821703|P1|STARTED|Overall Study||12
5214566|NCT00977769|12821711|P3|NOT COMPLETED|Overall Study||0
5214567|NCT00977769|12821712|P2|NOT COMPLETED|Overall Study||0
5214568|NCT00977769|12821713|P1|NOT COMPLETED|Overall Study||0
5214569|NCT00977769|12821711|P3|COMPLETED|Overall Study||25
5214570|NCT00977769|12821712|P2|COMPLETED|Overall Study||26
5214571|NCT00977769|12821713|P1|COMPLETED|Overall Study||25
5214572|NCT00977769|12821711|P3|STARTED|Overall Study||25
5214573|NCT00977769|12821712|P2|STARTED|Overall Study||26
5214574|NCT00977769|12821713|P1|STARTED|Overall Study||25
5214575|NCT00977704|12821727|P1|NOT COMPLETED|Overall Study||0
5214576|NCT00977704|12821727|P1|COMPLETED|Overall Study||20
5214577|NCT00977704|12821727|P1|STARTED|Overall Study||20
5214578|NCT00977691|12821734|P3|NOT COMPLETED|Overall Study||0
5214579|NCT00977691|12821735|P2|NOT COMPLETED|Overall Study||1
5214580|NCT00977691|12821736|P1|NOT COMPLETED|Overall Study||0
5214581|NCT00977691|12821734|P3|COMPLETED|Overall Study||12
5214582|NCT00977691|12821735|P2|COMPLETED|Overall Study||7
5214583|NCT00977691|12821736|P1|COMPLETED|Overall Study||3
5214584|NCT00977691|12821734|P3|STARTED|Overall Study||12
5214585|NCT00977691|12821735|P2|STARTED|Overall Study||8
5214586|NCT00977691|12821736|P1|STARTED|Overall Study||3
5214587|NCT00977665|12821746|P2|NOT COMPLETED|Overall Study||15
5214588|NCT00977665|12821747|P1|NOT COMPLETED|Overall Study||21
5214589|NCT00977665|12821746|P2|COMPLETED|Overall Study||75
5214590|NCT00977665|12821747|P1|COMPLETED|Overall Study||63
5214591|NCT00977665|12821746|P2|STARTED|Overall Study||90
5214592|NCT00977665|12821747|P1|STARTED|Overall Study||84
5214593|NCT00977613|12821779|P1|NOT COMPLETED|Overall Study||16
5214594|NCT00977613|12821779|P1|COMPLETED|Overall Study||34
5214595|NCT00977613|12821779|P1|STARTED|Overall Study||50
5214596|NCT00977574|12821786|P3|NOT COMPLETED|Overall Study||4
5214597|NCT00977574|12821787|P2|NOT COMPLETED|Overall Study||2
5214598|NCT00977574|12821788|P1|NOT COMPLETED|Overall Study||4
5214599|NCT00977574|12821786|P3|COMPLETED|Overall Study||114
5214600|NCT00977574|12821787|P2|COMPLETED|Overall Study||113
5214601|NCT00977574|12821788|P1|COMPLETED|Overall Study||112
5214602|NCT00977574|12821786|P3|STARTED|Overall Study||118
5214603|NCT00977574|12821787|P2|STARTED|Overall Study||115
5214604|NCT00977574|12821788|P1|STARTED|Overall Study||116
5214605|NCT00977561|12821807|P2|NOT COMPLETED|Overall Study||4
5214606|NCT00977561|12821808|P1|NOT COMPLETED|Overall Study||5
5214607|NCT00977561|12821807|P2|COMPLETED|Overall Study||0
5214608|NCT00977561|12821808|P1|COMPLETED|Overall Study||0
5214609|NCT00977561|12821807|P2|STARTED|Overall Study||4
5214610|NCT00977561|12821808|P1|STARTED|Overall Study||5
5214611|NCT00977548|12821835|P1|NOT COMPLETED|Overall Study||13
5214612|NCT00977548|12821835|P1|COMPLETED|Overall Study||26
5214613|NCT00977548|12821835|P1|STARTED|Overall Study||39
5214614|NCT00977470|12821844|P2|NOT COMPLETED|Overall Study||38
5214615|NCT00977470|12821845|P1|NOT COMPLETED|Overall Study||38
5214616|NCT00977470|12821844|P2|COMPLETED|Overall Study||0
5214617|NCT00977470|12821845|P1|COMPLETED|Overall Study||0
5214618|NCT00977470|12821844|P2|STARTED|Overall Study||38
5214619|NCT00977470|12821845|P1|STARTED|Overall Study||38
5214620|NCT00977431|12821868|P5|NOT COMPLETED|Overall Study||13
5214621|NCT00977431|12821869|P4|NOT COMPLETED|Overall Study||3
5214622|NCT00977431|12821870|P3|NOT COMPLETED|Overall Study||7
5214623|NCT00977431|12821871|P2|NOT COMPLETED|Overall Study||6
5214624|NCT00977431|12821872|P1|NOT COMPLETED|Overall Study||7
5214625|NCT00977431|12821868|P5|COMPLETED|Overall Study||0
5214626|NCT00977431|12821869|P4|COMPLETED|Overall Study||0
5214627|NCT00977431|12821870|P3|COMPLETED|Overall Study||0
5214628|NCT00977431|12821871|P2|COMPLETED|Overall Study||0
5214629|NCT00977431|12821872|P1|COMPLETED|Overall Study||0
5214630|NCT00977431|12821868|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
5214631|NCT00977431|12821869|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
5214632|NCT00977431|12821870|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
5214633|NCT00977431|12821871|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
5214634|NCT00977431|12821872|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
5214635|NCT00977431|12821868|P5|STARTED|Overall Study||13
5214636|NCT00977431|12821869|P4|STARTED|Overall Study||3
5214637|NCT00977431|12821870|P3|STARTED|Overall Study||7
5214638|NCT00977431|12821871|P2|STARTED|Overall Study||6
5214639|NCT00977431|12821872|P1|STARTED|Overall Study||7
5214640|NCT00977379|12821905|P2|NOT COMPLETED|Overall Study||12
5214641|NCT00977379|12821906|P1|NOT COMPLETED|Overall Study||12
5214642|NCT00977379|12821905|P2|COMPLETED|Overall Study||0
5214643|NCT00977379|12821906|P1|COMPLETED|Overall Study||0
5214644|NCT00977379|12821905|P2|Treated|Overall Study||11
5214645|NCT00977379|12821906|P1|Treated|Overall Study||12
5214646|NCT00977379|12821905|P2|STARTED|Overall Study|Randomized|12
5214647|NCT00977379|12821906|P1|STARTED|Overall Study|Randomized|12
5214648|NCT00977314|12821942|P2|NOT COMPLETED|Overall Study||0
5214649|NCT00977314|12821943|P1|NOT COMPLETED|Overall Study||2
5214650|NCT00977314|12821942|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
5214651|NCT00977314|12821943|P1|COMPLETED|Overall Study||28
5214652|NCT00977314|12821942|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
5214653|NCT00977314|12821943|P1|STARTED|Overall Study||30
5214654|NCT00977197|12821951|P2|NOT COMPLETED|Overall Study||9
5214655|NCT00977197|12821952|P1|NOT COMPLETED|Overall Study||9
5214656|NCT00977197|12821951|P2|COMPLETED|Overall Study||35
5214657|NCT00977197|12821952|P1|COMPLETED|Overall Study||32
5214658|NCT00977197|12821951|P2|STARTED|Overall Study||44
5214659|NCT00977197|12821952|P1|STARTED|Overall Study||41
5214660|NCT00977184|12821982|P2|NOT COMPLETED|Overall Study||0
5214661|NCT00977184|12821983|P1|NOT COMPLETED|Overall Study||0
5214662|NCT00977184|12821982|P2|COMPLETED|Overall Study||13
5214663|NCT00977184|12821983|P1|COMPLETED|Overall Study||13
5214664|NCT00977184|12821982|P2|STARTED|Overall Study||13
5214665|NCT00977184|12821983|P1|STARTED|Overall Study||13
5214666|NCT00977171|12822009|P1|NOT COMPLETED|Overall Study||0
5214667|NCT00977171|12822009|P1|COMPLETED|Overall Study||3
5214668|NCT00977171|12822009|P1|STARTED|Overall Study||3
5214669|NCT00977106|12822015|P2|NOT COMPLETED|Overall Study||11
5214670|NCT00977106|12822016|P1|NOT COMPLETED|Overall Study||10
5214671|NCT00977106|12822015|P2|COMPLETED|Overall Study||45
5214672|NCT00977106|12822016|P1|COMPLETED|Overall Study||37
5214673|NCT00977106|12822015|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
5214674|NCT00977106|12822016|P1|STARTED|Overall Study||47
5214675|NCT00977080|12822108|P4|NOT COMPLETED|Overall Study||17
5214676|NCT00977080|12822109|P3|NOT COMPLETED|Overall Study||16
5214677|NCT00977080|12822110|P2|NOT COMPLETED|Overall Study||20
5214678|NCT00977080|12822111|P1|NOT COMPLETED|Overall Study||12
5214679|NCT00977080|12822108|P4|COMPLETED|Overall Study||53
5214680|NCT00977080|12822109|P3|COMPLETED|Overall Study||56
5214681|NCT00977080|12822110|P2|COMPLETED|Overall Study||44
5214682|NCT00977080|12822111|P1|COMPLETED|Overall Study||50
5214683|NCT00977080|12822108|P4|STARTED|Overall Study||70
5214684|NCT00977080|12822109|P3|STARTED|Overall Study||72
5214685|NCT00977080|12822110|P2|STARTED|Overall Study||64
5214686|NCT00977080|12822111|P1|STARTED|Overall Study||62
5214687|NCT00976989|12822144|P3|NOT COMPLETED|Overall Study||17
5214688|NCT00976989|12822145|P2|NOT COMPLETED|Overall Study||12
5214689|NCT00976989|12822146|P1|NOT COMPLETED|Overall Study||13
5214690|NCT00976989|12822144|P3|COMPLETED|Overall Study||60
5214691|NCT00976989|12822145|P2|COMPLETED|Overall Study||63
5214692|NCT00976989|12822146|P1|COMPLETED|Overall Study||60
5214693|NCT00976989|12822144|P3|STARTED|Overall Study||77
5214694|NCT00976989|12822145|P2|STARTED|Overall Study||75
5214695|NCT00976989|12822146|P1|STARTED|Overall Study||73
5214696|NCT00976950|12822187|P1|NOT COMPLETED|Overall Study||6
5214697|NCT00976950|12822187|P1|COMPLETED|Overall Study||36
5214698|NCT00976950|12822187|P1|STARTED|Overall Study||42
5214699|NCT00976937|12822195|P2|NOT COMPLETED|Overall Study||11
5214700|NCT00976937|12822196|P1|NOT COMPLETED|Overall Study||16
5214701|NCT00976937|12822195|P2|COMPLETED|Overall Study||150
5214702|NCT00976937|12822196|P1|COMPLETED|Overall Study||142
5214703|NCT00976937|12822195|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
5214704|NCT00976937|12822196|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
5214705|NCT00976937|12822195|P2|Treated/Safety Population|Overall Study||161
5214706|NCT00976937|12822196|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
5214707|NCT00976937|12822195|P2|STARTED|Overall Study||161
5214708|NCT00976937|12822196|P1|STARTED|Overall Study|Randomized|158
5214709|NCT00976911|12822238|P2|NOT COMPLETED|Overall Study||179
5214710|NCT00976911|12822239|P1|NOT COMPLETED|Overall Study||182
5214804|NCT00976456|12822993|P2|STARTED|Overall Study||136
5214711|NCT00976911|12822238|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
5214712|NCT00976911|12822239|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
5214713|NCT00976911|12822238|P2|STARTED|Overall Study||179
5214714|NCT00976911|12822239|P1|STARTED|Overall Study||182
5214715|NCT00976898|12822257|P1|NOT COMPLETED|Overall Study||5
5214716|NCT00976898|12822257|P1|COMPLETED|Overall Study||78
5214717|NCT00976898|12822257|P1|STARTED|Overall Study||83
5214718|NCT00976820|12822268|P4|NOT COMPLETED|Overall Study||7
5214719|NCT00976820|12822269|P3|NOT COMPLETED|Overall Study||4
5214720|NCT00976820|12822270|P2|NOT COMPLETED|Overall Study||20
5214721|NCT00976820|12822271|P1|NOT COMPLETED|Overall Study||8
5214722|NCT00976820|12822268|P4|COMPLETED|Overall Study||56
5214723|NCT00976820|12822269|P3|COMPLETED|Overall Study||60
5214724|NCT00976820|12822270|P2|COMPLETED|Overall Study||108
5214725|NCT00976820|12822271|P1|COMPLETED|Overall Study||59
5214726|NCT00976820|12822268|P4|STARTED|Overall Study||63
5214727|NCT00976820|12822269|P3|STARTED|Overall Study||64
5214728|NCT00976820|12822270|P2|STARTED|Overall Study||128
5214729|NCT00976820|12822271|P1|STARTED|Overall Study||67
5214730|NCT00976716|12822607|P1|NOT COMPLETED|Overall Study||1
5214731|NCT00976716|12822607|P1|COMPLETED|Overall Study||79
5214732|NCT00976716|12822607|P1|STARTED|Overall Study||80
5214733|NCT00976703|12822625|P2|NOT COMPLETED|Overall Study||3
5214734|NCT00976703|12822626|P1|NOT COMPLETED|Overall Study||3
5214735|NCT00976703|12822625|P2|COMPLETED|Overall Study||95
5214736|NCT00976703|12822626|P1|COMPLETED|Overall Study||96
5214737|NCT00976703|12822625|P2|STARTED|Overall Study||98
5214738|NCT00976703|12822626|P1|STARTED|Overall Study||99
5214739|NCT00976677|12822640|P2|NOT COMPLETED|Overall Study||5
5214740|NCT00976677|12822641|P1|NOT COMPLETED|Overall Study||5
5214741|NCT00976677|12822640|P2|COMPLETED|Overall Study||0
5214742|NCT00976677|12822641|P1|COMPLETED|Overall Study||0
5214743|NCT00976677|12822640|P2|STARTED|Overall Study||5
5214744|NCT00976677|12822641|P1|STARTED|Overall Study||5
5214745|NCT00976664|12822649|P2|NOT COMPLETED|Overall Study||1
5214746|NCT00976664|12822650|P1|NOT COMPLETED|Overall Study||3
5214747|NCT00976664|12822649|P2|COMPLETED|Overall Study||24
5214748|NCT00976664|12822650|P1|COMPLETED|Overall Study||22
5214749|NCT00976664|12822649|P2|STARTED|Overall Study||25
5214750|NCT00976664|12822650|P1|STARTED|Overall Study||25
5214751|NCT00976599|12822660|P2|NOT COMPLETED|Overall Study||0
5214752|NCT00976599|12822661|P1|NOT COMPLETED|Overall Study||0
5214753|NCT00976599|12822660|P2|COMPLETED|Overall Study||14
5214754|NCT00976599|12822661|P1|COMPLETED|Overall Study||15
5214755|NCT00976599|12822660|P2|STARTED|Overall Study||14
5214756|NCT00976599|12822661|P1|STARTED|Overall Study||15
5214757|NCT00976573|12822849|P2|NOT COMPLETED|Overall Study||3
5214758|NCT00976573|12822850|P1|NOT COMPLETED|Overall Study||4
5214759|NCT00976573|12822849|P2|COMPLETED|Overall Study||71
5214760|NCT00976573|12822850|P1|COMPLETED|Overall Study||71
5214761|NCT00976573|12822849|P2|STARTED|Overall Study||74
5214762|NCT00976573|12822850|P1|STARTED|Overall Study||75
5214763|NCT00976560|12822864|P2|NOT COMPLETED|Overall Study||13
5214764|NCT00976560|12822865|P1|NOT COMPLETED|Overall Study||14
5214765|NCT00976560|12822864|P2|COMPLETED|Overall Study||51
5214766|NCT00976560|12822865|P1|COMPLETED|Overall Study||50
5214767|NCT00976560|12822864|P2|STARTED|Overall Study||64
5214768|NCT00976560|12822865|P1|STARTED|Overall Study||64
5214769|NCT00976521|12822917|P4|NOT COMPLETED|Overall Study||19
5214770|NCT00976521|12822918|P3|NOT COMPLETED|Overall Study||9
5214771|NCT00976521|12822919|P2|NOT COMPLETED|Overall Study||12
5214772|NCT00976521|12822920|P1|NOT COMPLETED|Overall Study||9
5214773|NCT00976521|12822917|P4|COMPLETED|Overall Study||93
5214774|NCT00976521|12822918|P3|COMPLETED|Overall Study||102
5214775|NCT00976521|12822919|P2|COMPLETED|Overall Study||99
5214776|NCT00976521|12822920|P1|COMPLETED|Overall Study||109
5214777|NCT00976521|12822917|P4|STARTED|Overall Study||112
5214778|NCT00976521|12822918|P3|STARTED|Overall Study||111
5214779|NCT00976521|12822919|P2|STARTED|Overall Study||111
5214780|NCT00976521|12822920|P1|STARTED|Overall Study||118
5214781|NCT00976508|12822934|P2|NOT COMPLETED|Overall Study||6
5214782|NCT00976508|12822935|P1|NOT COMPLETED|Overall Study||14
5214783|NCT00976508|12822934|P2|COMPLETED|Overall Study||0
5214784|NCT00976508|12822935|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
5214785|NCT00976508|12822934|P2|STARTED|Overall Study||6
5214786|NCT00976508|12822935|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
5214787|NCT00976495|12822968|P3|NOT COMPLETED|Overall Study||0
5214788|NCT00976495|12822969|P2|NOT COMPLETED|Overall Study||1
5214789|NCT00976495|12822970|P1|NOT COMPLETED|Overall Study||0
5214790|NCT00976495|12822968|P3|COMPLETED|Overall Study||26
5214791|NCT00976495|12822969|P2|COMPLETED|Overall Study||23
5214792|NCT00976495|12822970|P1|COMPLETED|Overall Study||25
5214793|NCT00976495|12822968|P3|STARTED|Overall Study||26
5214794|NCT00976495|12822969|P2|STARTED|Overall Study||24
5214795|NCT00976495|12822970|P1|STARTED|Overall Study||25
5214796|NCT00976482|12822987|P1|NOT COMPLETED|Overall Study||259
5214797|NCT00976482|12822987|P1|COMPLETED|Overall Study||1486
5214798|NCT00976482|12822987|P1|Eligible for Last Follow up|Overall Study||1487
5214799|NCT00976482|12822987|P1|STARTED|Overall Study||1745
5214800|NCT00976456|12822993|P2|NOT COMPLETED|Overall Study||38
5214801|NCT00976456|12822994|P1|NOT COMPLETED|Overall Study||43
5214802|NCT00976456|12822993|P2|COMPLETED|Overall Study||98
5214803|NCT00976456|12822994|P1|COMPLETED|Overall Study||92
5214805|NCT00976456|12822994|P1|STARTED|Overall Study||135
5214806|NCT00976404|12823004|P2|NOT COMPLETED|Overall Study||0
5214807|NCT00976404|12823005|P1|NOT COMPLETED|Overall Study||0
5214808|NCT00976404|12823004|P2|COMPLETED|Overall Study||14
5214809|NCT00976404|12823005|P1|COMPLETED|Overall Study||14
5214810|NCT00976404|12823004|P2|STARTED|Overall Study||14
5214811|NCT00976404|12823005|P1|STARTED|Overall Study||14
5214812|NCT00976391|12823021|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
5214813|NCT00976391|12823022|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
5214814|NCT00976391|12823021|P2|COMPLETED|Follow-up Period (8 Weeks)||247
5214815|NCT00976391|12823022|P1|COMPLETED|Follow-up Period (8 Weeks)||256
5214816|NCT00976391|12823021|P2|STARTED|Follow-up Period (8 Weeks)||281
5214817|NCT00976391|12823022|P1|STARTED|Follow-up Period (8 Weeks)||285
5214818|NCT00976391|12823021|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
5214819|NCT00976391|12823022|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
5214820|NCT00976391|12823021|P2|COMPLETED|Treatment Period (52 Weeks)||242
5214821|NCT00976391|12823022|P1|COMPLETED|Treatment Period (52 Weeks)||243
5214822|NCT00976391|12823021|P2|STARTED|Treatment Period (52 Weeks)||281
5214823|NCT00976391|12823022|P1|STARTED|Treatment Period (52 Weeks)||285
5214824|NCT00976352|12823044|P2|NOT COMPLETED|Overall Study||4
5214825|NCT00976352|12823045|P1|NOT COMPLETED|Overall Study||0
5214826|NCT00976352|12823044|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
5214827|NCT00976352|12823045|P1|COMPLETED|Overall Study||3
5214828|NCT00976352|12823044|P2|STARTED|Overall Study||10
5214829|NCT00976352|12823045|P1|STARTED|Overall Study||3
5214830|NCT00976339|12823059|P2|NOT COMPLETED|Overall Study||0
5214831|NCT00976339|12823060|P1|NOT COMPLETED|Overall Study||0
5214832|NCT00976339|12823059|P2|COMPLETED|Overall Study||10
5214833|NCT00976339|12823060|P1|COMPLETED|Overall Study||10
5214834|NCT00976339|12823059|P2|STARTED|Overall Study||10
5214835|NCT00976339|12823060|P1|STARTED|Overall Study||10
5214836|NCT00976274|12823070|P2|NOT COMPLETED|Overall Study||8
5214837|NCT00976274|12823071|P1|NOT COMPLETED|Overall Study||7
5214838|NCT00976274|12823070|P2|COMPLETED|Overall Study||21
5214839|NCT00976274|12823071|P1|COMPLETED|Overall Study||24
5214840|NCT00976274|12823070|P2|STARTED|Overall Study||29
5214841|NCT00976274|12823071|P1|STARTED|Overall Study||31
5214842|NCT00976248|12823079|P1|NOT COMPLETED|Overall Study||0
5214843|NCT00976248|12823079|P1|COMPLETED|Overall Study||33
5214844|NCT00976248|12823079|P1|STARTED|Overall Study||33
5214845|NCT00976209|12823087|P2|NOT COMPLETED|Treatment Period 2||2
5214846|NCT00976209|12823088|P1|NOT COMPLETED|Treatment Period 2||0
5214847|NCT00976209|12823087|P2|COMPLETED|Treatment Period 2||161
5214848|NCT00976209|12823088|P1|COMPLETED|Treatment Period 2||158
5214849|NCT00976209|12823087|P2|STARTED|Treatment Period 2||163
5214850|NCT00976209|12823088|P1|STARTED|Treatment Period 2||158
5214851|NCT00976209|12823087|P2|NOT COMPLETED|Wash-out Period||2
5214852|NCT00976209|12823088|P1|NOT COMPLETED|Wash-out Period||4
5214853|NCT00976209|12823087|P2|COMPLETED|Wash-out Period||163
5214854|NCT00976209|12823088|P1|COMPLETED|Wash-out Period||158
5214855|NCT00976209|12823087|P2|STARTED|Wash-out Period||165
5214856|NCT00976209|12823088|P1|STARTED|Wash-out Period||162
5214857|NCT00976209|12823087|P2|NOT COMPLETED|Treatment Period 1||1
5214858|NCT00976209|12823088|P1|NOT COMPLETED|Treatment Period 1||3
5214859|NCT00976209|12823087|P2|COMPLETED|Treatment Period 1||165
5214860|NCT00976209|12823088|P1|COMPLETED|Treatment Period 1||162
5214861|NCT00976209|12823087|P2|STARTED|Treatment Period 1||166
5214862|NCT00976209|12823088|P1|STARTED|Treatment Period 1||165
5214863|NCT00976183|12823094|P1|NOT COMPLETED|Overall Study||0
5214864|NCT00976183|12823094|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
5214865|NCT00976183|12823094|P1|STARTED|Overall Study||18
5214866|NCT00976027|12823101|P2|NOT COMPLETED|Overall Study||215
5214867|NCT00976027|12823102|P1|NOT COMPLETED|Overall Study||411
5214868|NCT00976027|12823101|P2|COMPLETED|Overall Study||2835
5214869|NCT00976027|12823102|P1|COMPLETED|Overall Study||5697
5214870|NCT00976027|12823101|P2|STARTED|Overall Study||3050
5214871|NCT00976027|12823102|P1|STARTED|Overall Study||6108
5214872|NCT00975975|12823114|P1|NOT COMPLETED|Overall Study||6
5214873|NCT00975975|12823114|P1|COMPLETED|Overall Study||11
5214874|NCT00975975|12823114|P1|STARTED|Overall Study||17
5214875|NCT00975923|12823122|P2|NOT COMPLETED|Overall Study||1
5214876|NCT00975923|12823123|P1|NOT COMPLETED|Overall Study||0
5214877|NCT00975923|12823122|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
5214878|NCT00975923|12823123|P1|COMPLETED|Overall Study||30
5214879|NCT00975923|12823122|P2|STARTED|Overall Study||30
5214880|NCT00975923|12823123|P1|STARTED|Overall Study||30
5214881|NCT00975884|12823133|P2|NOT COMPLETED|Overall Study||15
5214882|NCT00975884|12823134|P1|NOT COMPLETED|Overall Study||16
5214883|NCT00975884|12823133|P2|COMPLETED|Overall Study||107
5214884|NCT00975884|12823134|P1|COMPLETED|Overall Study||168
5214885|NCT00975884|12823133|P2|STARTED|Overall Study||122
5214886|NCT00975884|12823134|P1|STARTED|Overall Study||184
5214887|NCT00975806|12823291|P3|NOT COMPLETED|Overall Study||4
5214888|NCT00975806|12823292|P2|NOT COMPLETED|Overall Study||7
5214889|NCT00975806|12823293|P1|NOT COMPLETED|Overall Study||5
5214890|NCT00975806|12823291|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
5214891|NCT00975806|12823292|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
5214892|NCT00975806|12823293|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
5214893|NCT00975806|12823291|P3|STARTED|Overall Study||4
5214894|NCT00975806|12823292|P2|STARTED|Overall Study||7
5214895|NCT00975806|12823293|P1|STARTED|Overall Study||5
5214896|NCT00975780|12823317|P2|NOT COMPLETED|Follow Up||157
5214897|NCT00975780|12823318|P1|NOT COMPLETED|Follow Up||102
5214898|NCT00975780|12823317|P2|COMPLETED|Follow Up||277
5214899|NCT00975780|12823318|P1|COMPLETED|Follow Up||298
5214900|NCT00975780|12823317|P2|STARTED|Follow Up||434
5214901|NCT00975780|12823318|P1|STARTED|Follow Up||400
5214902|NCT00975780|12823317|P2|NOT COMPLETED|Allocation||0
5214903|NCT00975780|12823318|P1|NOT COMPLETED|Allocation||0
5214904|NCT00975780|12823317|P2|COMPLETED|Allocation||434
5214905|NCT00975780|12823318|P1|COMPLETED|Allocation||400
5214906|NCT00975780|12823317|P2|STARTED|Allocation||434
5214907|NCT00975780|12823318|P1|STARTED|Allocation||400
5214908|NCT00975715|12823328|P2|NOT COMPLETED|Maintenance Period||1
5214909|NCT00975715|12823329|P1|NOT COMPLETED|Maintenance Period||2
5214910|NCT00975715|12823328|P2|COMPLETED|Maintenance Period||50
5214911|NCT00975715|12823329|P1|COMPLETED|Maintenance Period||39
5214912|NCT00975715|12823328|P2|STARTED|Maintenance Period||51
5214913|NCT00975715|12823329|P1|STARTED|Maintenance Period||41
5214914|NCT00975715|12823328|P2|NOT COMPLETED|Titration Period||0
5214915|NCT00975715|12823329|P1|NOT COMPLETED|Titration Period||7
5214916|NCT00975715|12823328|P2|COMPLETED|Titration Period||51
5214917|NCT00975715|12823329|P1|COMPLETED|Titration Period||41
5214918|NCT00975715|12823328|P2|STARTED|Titration Period||51
5214919|NCT00975715|12823329|P1|STARTED|Titration Period||48
5214920|NCT00975689|12823345|P2|NOT COMPLETED|Overall Study||3
5214921|NCT00975689|12823346|P1|NOT COMPLETED|Overall Study||2
5214922|NCT00975689|12823345|P2|COMPLETED|Overall Study||15
5214923|NCT00975689|12823346|P1|COMPLETED|Overall Study||15
5214924|NCT00975689|12823345|P2|STARTED|Overall Study||18
5214925|NCT00975689|12823346|P1|STARTED|Overall Study||17
5214926|NCT00975650|12823352|P4|NOT COMPLETED|Period 4||0
5214927|NCT00975650|12823353|P3|NOT COMPLETED|Period 4||0
5214928|NCT00975650|12823354|P2|NOT COMPLETED|Period 4||0
5214929|NCT00975650|12823355|P1|NOT COMPLETED|Period 4||0
5214930|NCT00975650|12823352|P4|COMPLETED|Period 4||14
5214931|NCT00975650|12823353|P3|COMPLETED|Period 4||14
5214932|NCT00975650|12823354|P2|COMPLETED|Period 4||14
5214933|NCT00975650|12823355|P1|COMPLETED|Period 4||12
5214934|NCT00975650|12823352|P4|STARTED|Period 4||14
5214935|NCT00975650|12823353|P3|STARTED|Period 4||14
5214936|NCT00975650|12823354|P2|STARTED|Period 4||14
5214937|NCT00975650|12823355|P1|STARTED|Period 4||12
5214938|NCT00975650|12823352|P4|NOT COMPLETED|Period 3||0
5214939|NCT00975650|12823353|P3|NOT COMPLETED|Period 3||0
5214940|NCT00975650|12823354|P2|NOT COMPLETED|Period 3||0
5214941|NCT00975650|12823355|P1|NOT COMPLETED|Period 3||0
5214942|NCT00975650|12823352|P4|COMPLETED|Period 3||14
5214943|NCT00975650|12823353|P3|COMPLETED|Period 3||14
5214944|NCT00975650|12823354|P2|COMPLETED|Period 3||14
5214945|NCT00975650|12823355|P1|COMPLETED|Period 3||12
5214946|NCT00975650|12823352|P4|STARTED|Period 3||14
5214947|NCT00975650|12823353|P3|STARTED|Period 3||14
5214948|NCT00975650|12823354|P2|STARTED|Period 3||14
5214949|NCT00975650|12823355|P1|STARTED|Period 3||12
5214950|NCT00975650|12823352|P4|NOT COMPLETED|Period 2||0
5214951|NCT00975650|12823353|P3|NOT COMPLETED|Period 2||0
5214952|NCT00975650|12823354|P2|NOT COMPLETED|Period 2||2
5214953|NCT00975650|12823355|P1|NOT COMPLETED|Period 2||1
5214954|NCT00975650|12823352|P4|COMPLETED|Period 2||14
5214955|NCT00975650|12823353|P3|COMPLETED|Period 2||14
5214956|NCT00975650|12823354|P2|COMPLETED|Period 2||14
5214957|NCT00975650|12823355|P1|COMPLETED|Period 2||12
5214958|NCT00975650|12823352|P4|STARTED|Period 2||14
5214959|NCT00975650|12823353|P3|STARTED|Period 2||14
5214960|NCT00975650|12823354|P2|STARTED|Period 2||16
5214961|NCT00975650|12823355|P1|STARTED|Period 2||13
5214962|NCT00975650|12823352|P4|NOT COMPLETED|Period 1||0
5214963|NCT00975650|12823353|P3|NOT COMPLETED|Period 1||0
5214964|NCT00975650|12823354|P2|NOT COMPLETED|Period 1||0
5214965|NCT00975650|12823355|P1|NOT COMPLETED|Period 1||0
5214966|NCT00975650|12823352|P4|COMPLETED|Period 1||14
5214967|NCT00975650|12823353|P3|COMPLETED|Period 1||14
5214968|NCT00975650|12823354|P2|COMPLETED|Period 1||16
5214969|NCT00975650|12823355|P1|COMPLETED|Period 1||13
5214970|NCT00975650|12823352|P4|STARTED|Period 1||14
5214971|NCT00975650|12823353|P3|STARTED|Period 1||14
5214972|NCT00975650|12823354|P2|STARTED|Period 1||16
5214973|NCT00975650|12823355|P1|STARTED|Period 1||13
5214974|NCT00975637|12823394|P5|NOT COMPLETED|Overall Study||2
5214975|NCT00975637|12823395|P4|NOT COMPLETED|Overall Study||6
5214976|NCT00975637|12823396|P3|NOT COMPLETED|Overall Study||2
5214977|NCT00975637|12823397|P2|NOT COMPLETED|Overall Study||1
5214978|NCT00975637|12823398|P1|NOT COMPLETED|Overall Study||3
5214979|NCT00975637|12823394|P5|COMPLETED|Overall Study||37
5214980|NCT00975637|12823395|P4|COMPLETED|Overall Study||32
5214981|NCT00975637|12823396|P3|COMPLETED|Overall Study||40
5214982|NCT00975637|12823397|P2|COMPLETED|Overall Study||38
5214983|NCT00975637|12823398|P1|COMPLETED|Overall Study||37
5214984|NCT00975637|12823394|P5|STARTED|Overall Study||39
5214985|NCT00975637|12823395|P4|STARTED|Overall Study||38
5214986|NCT00975637|12823396|P3|STARTED|Overall Study||42
5214987|NCT00975637|12823397|P2|STARTED|Overall Study||39
5214988|NCT00975637|12823398|P1|STARTED|Overall Study||40
5214989|NCT00975611|12823415|P1|NOT COMPLETED|Overall Study||17
5214990|NCT00975611|12823415|P1|COMPLETED|Overall Study||5
5214991|NCT00975611|12823415|P1|STARTED|Overall Study||22
5214992|NCT00975585|12823421|P2|NOT COMPLETED|Overall Study||12
5214993|NCT00975585|12823422|P1|NOT COMPLETED|Overall Study||7
5214994|NCT00975585|12823421|P2|COMPLETED|Overall Study||183
5214995|NCT00975585|12823422|P1|COMPLETED|Overall Study||177
5214996|NCT00975585|12823421|P2|STARTED|Overall Study||195
5214997|NCT00975585|12823422|P1|STARTED|Overall Study||184
5214998|NCT00975507|12823442|P2|NOT COMPLETED|Overall Study||4
5214999|NCT00975507|12823443|P1|NOT COMPLETED|Overall Study||20
5215000|NCT00975507|12823442|P2|COMPLETED|Overall Study||153
5215001|NCT00975507|12823443|P1|COMPLETED|Overall Study||303
5215002|NCT00975507|12823442|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
5215003|NCT00975507|12823443|P1|Vaccinated at Visit 2|Overall Study||310
5215004|NCT00975507|12823442|P2|Vaccinated at Visit 1|Overall Study||157
5215005|NCT00975507|12823443|P1|Vaccinated at Visit 1|Overall Study||323
5215006|NCT00975507|12823442|P2|STARTED|Overall Study||157
5215007|NCT00975507|12823443|P1|STARTED|Overall Study||323
5215008|NCT00975481|12823463|P6|NOT COMPLETED|Sixth Intervention Period||0
5215009|NCT00975481|12823464|P5|NOT COMPLETED|Sixth Intervention Period||0
5215010|NCT00975481|12823465|P4|NOT COMPLETED|Sixth Intervention Period||0
5215011|NCT00975481|12823466|P3|NOT COMPLETED|Sixth Intervention Period||0
5215012|NCT00975481|12823467|P2|NOT COMPLETED|Sixth Intervention Period||0
5215013|NCT00975481|12823468|P1|NOT COMPLETED|Sixth Intervention Period||0
5215014|NCT00975481|12823463|P6|COMPLETED|Sixth Intervention Period||6
5215015|NCT00975481|12823464|P5|COMPLETED|Sixth Intervention Period||5
5215016|NCT00975481|12823465|P4|COMPLETED|Sixth Intervention Period||5
5215017|NCT00975481|12823466|P3|COMPLETED|Sixth Intervention Period||4
5215018|NCT00975481|12823467|P2|COMPLETED|Sixth Intervention Period||5
5215019|NCT00975481|12823468|P1|COMPLETED|Sixth Intervention Period||4
5215020|NCT00975481|12823463|P6|STARTED|Sixth Intervention Period||6
5215021|NCT00975481|12823464|P5|STARTED|Sixth Intervention Period||5
5215022|NCT00975481|12823465|P4|STARTED|Sixth Intervention Period||5
5215023|NCT00975481|12823466|P3|STARTED|Sixth Intervention Period||4
5215024|NCT00975481|12823467|P2|STARTED|Sixth Intervention Period||5
5215025|NCT00975481|12823468|P1|STARTED|Sixth Intervention Period||4
5215026|NCT00975481|12823463|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215027|NCT00975481|12823464|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215028|NCT00975481|12823465|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215029|NCT00975481|12823466|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215030|NCT00975481|12823467|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215031|NCT00975481|12823468|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215032|NCT00975481|12823463|P6|COMPLETED|Washout Period (at Least 7 Days)||6
5215033|NCT00975481|12823464|P5|COMPLETED|Washout Period (at Least 7 Days)||5
5215034|NCT00975481|12823465|P4|COMPLETED|Washout Period (at Least 7 Days)||5
5215035|NCT00975481|12823466|P3|COMPLETED|Washout Period (at Least 7 Days)||4
5215036|NCT00975481|12823467|P2|COMPLETED|Washout Period (at Least 7 Days)||5
5215037|NCT00975481|12823468|P1|COMPLETED|Washout Period (at Least 7 Days)||4
5215038|NCT00975481|12823463|P6|STARTED|Washout Period (at Least 7 Days)||6
5215039|NCT00975481|12823464|P5|STARTED|Washout Period (at Least 7 Days)||5
5215040|NCT00975481|12823465|P4|STARTED|Washout Period (at Least 7 Days)||5
5215041|NCT00975481|12823466|P3|STARTED|Washout Period (at Least 7 Days)||4
5215042|NCT00975481|12823467|P2|STARTED|Washout Period (at Least 7 Days)||5
5215043|NCT00975481|12823468|P1|STARTED|Washout Period (at Least 7 Days)||4
5215044|NCT00975481|12823463|P6|NOT COMPLETED|Fifth Intervention Period||0
5215045|NCT00975481|12823464|P5|NOT COMPLETED|Fifth Intervention Period||1
5215046|NCT00975481|12823465|P4|NOT COMPLETED|Fifth Intervention Period||0
5215047|NCT00975481|12823466|P3|NOT COMPLETED|Fifth Intervention Period||0
5215048|NCT00975481|12823467|P2|NOT COMPLETED|Fifth Intervention Period||0
5215049|NCT00975481|12823468|P1|NOT COMPLETED|Fifth Intervention Period||0
5215050|NCT00975481|12823463|P6|COMPLETED|Fifth Intervention Period||6
5215051|NCT00975481|12823464|P5|COMPLETED|Fifth Intervention Period||5
5215052|NCT00975481|12823465|P4|COMPLETED|Fifth Intervention Period||5
5215053|NCT00975481|12823466|P3|COMPLETED|Fifth Intervention Period||4
5215054|NCT00975481|12823467|P2|COMPLETED|Fifth Intervention Period||5
5215055|NCT00975481|12823468|P1|COMPLETED|Fifth Intervention Period||4
5215056|NCT00975481|12823463|P6|STARTED|Fifth Intervention Period||6
5215057|NCT00975481|12823464|P5|STARTED|Fifth Intervention Period||6
5215058|NCT00975481|12823465|P4|STARTED|Fifth Intervention Period||5
5215059|NCT00975481|12823466|P3|STARTED|Fifth Intervention Period||4
5215060|NCT00975481|12823467|P2|STARTED|Fifth Intervention Period||5
5215061|NCT00975481|12823468|P1|STARTED|Fifth Intervention Period||4
5215062|NCT00975481|12823463|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215063|NCT00975481|12823464|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215064|NCT00975481|12823465|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215065|NCT00975481|12823466|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215066|NCT00975481|12823467|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215067|NCT00975481|12823468|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215068|NCT00975481|12823463|P6|COMPLETED|Washout Period (at Least 7 Days)||6
5215069|NCT00975481|12823464|P5|COMPLETED|Washout Period (at Least 7 Days)||6
5215070|NCT00975481|12823465|P4|COMPLETED|Washout Period (at Least 7 Days)||5
5215071|NCT00975481|12823466|P3|COMPLETED|Washout Period (at Least 7 Days)||4
5215072|NCT00975481|12823467|P2|COMPLETED|Washout Period (at Least 7 Days)||5
5215073|NCT00975481|12823468|P1|COMPLETED|Washout Period (at Least 7 Days)||4
5215074|NCT00975481|12823463|P6|STARTED|Washout Period (at Least 7 Days)||6
5215075|NCT00975481|12823464|P5|STARTED|Washout Period (at Least 7 Days)||6
5215076|NCT00975481|12823465|P4|STARTED|Washout Period (at Least 7 Days)||5
5215077|NCT00975481|12823466|P3|STARTED|Washout Period (at Least 7 Days)||4
5215078|NCT00975481|12823467|P2|STARTED|Washout Period (at Least 7 Days)||5
5215079|NCT00975481|12823468|P1|STARTED|Washout Period (at Least 7 Days)||4
5215080|NCT00975481|12823463|P6|NOT COMPLETED|Fourth Intervention Period||0
5215081|NCT00975481|12823464|P5|NOT COMPLETED|Fourth Intervention Period||0
5215082|NCT00975481|12823465|P4|NOT COMPLETED|Fourth Intervention Period||1
5215083|NCT00975481|12823466|P3|NOT COMPLETED|Fourth Intervention Period||1
5215084|NCT00975481|12823467|P2|NOT COMPLETED|Fourth Intervention Period||0
5215085|NCT00975481|12823468|P1|NOT COMPLETED|Fourth Intervention Period||0
5215086|NCT00975481|12823463|P6|COMPLETED|Fourth Intervention Period||6
5215087|NCT00975481|12823464|P5|COMPLETED|Fourth Intervention Period||6
5215088|NCT00975481|12823465|P4|COMPLETED|Fourth Intervention Period||5
5215089|NCT00975481|12823466|P3|COMPLETED|Fourth Intervention Period||4
5215090|NCT00975481|12823467|P2|COMPLETED|Fourth Intervention Period||5
5215091|NCT00975481|12823468|P1|COMPLETED|Fourth Intervention Period||4
5215092|NCT00975481|12823463|P6|STARTED|Fourth Intervention Period||6
5215093|NCT00975481|12823464|P5|STARTED|Fourth Intervention Period||6
5215094|NCT00975481|12823465|P4|STARTED|Fourth Intervention Period||6
5215095|NCT00975481|12823466|P3|STARTED|Fourth Intervention Period||5
5215096|NCT00975481|12823467|P2|STARTED|Fourth Intervention Period||5
5215097|NCT00975481|12823468|P1|STARTED|Fourth Intervention Period||4
5215098|NCT00975481|12823463|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215099|NCT00975481|12823464|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215100|NCT00975481|12823465|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215101|NCT00975481|12823466|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215102|NCT00975481|12823467|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215103|NCT00975481|12823468|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215104|NCT00975481|12823463|P6|COMPLETED|Washout Period (at Least 7 Days)||6
5215105|NCT00975481|12823464|P5|COMPLETED|Washout Period (at Least 7 Days)||6
5215106|NCT00975481|12823465|P4|COMPLETED|Washout Period (at Least 7 Days)||6
5215107|NCT00975481|12823466|P3|COMPLETED|Washout Period (at Least 7 Days)||5
5215108|NCT00975481|12823467|P2|COMPLETED|Washout Period (at Least 7 Days)||5
5215109|NCT00975481|12823468|P1|COMPLETED|Washout Period (at Least 7 Days)||4
5215110|NCT00975481|12823463|P6|STARTED|Washout Period (at Least 7 Days)||6
5215111|NCT00975481|12823464|P5|STARTED|Washout Period (at Least 7 Days)||6
5215112|NCT00975481|12823465|P4|STARTED|Washout Period (at Least 7 Days)||6
5215113|NCT00975481|12823466|P3|STARTED|Washout Period (at Least 7 Days)||5
5215114|NCT00975481|12823467|P2|STARTED|Washout Period (at Least 7 Days)||5
5215115|NCT00975481|12823468|P1|STARTED|Washout Period (at Least 7 Days)||4
5215116|NCT00975481|12823463|P6|NOT COMPLETED|Third Intervention Period||0
5215117|NCT00975481|12823464|P5|NOT COMPLETED|Third Intervention Period||0
5215118|NCT00975481|12823465|P4|NOT COMPLETED|Third Intervention Period||0
5215119|NCT00975481|12823466|P3|NOT COMPLETED|Third Intervention Period||0
5215120|NCT00975481|12823467|P2|NOT COMPLETED|Third Intervention Period||0
5215121|NCT00975481|12823468|P1|NOT COMPLETED|Third Intervention Period||0
5215122|NCT00975481|12823463|P6|COMPLETED|Third Intervention Period||6
5215123|NCT00975481|12823464|P5|COMPLETED|Third Intervention Period||6
5215124|NCT00975481|12823465|P4|COMPLETED|Third Intervention Period||6
5215125|NCT00975481|12823466|P3|COMPLETED|Third Intervention Period||5
5215126|NCT00975481|12823467|P2|COMPLETED|Third Intervention Period||5
5215127|NCT00975481|12823468|P1|COMPLETED|Third Intervention Period||4
5215128|NCT00975481|12823463|P6|STARTED|Third Intervention Period||6
5215129|NCT00975481|12823464|P5|STARTED|Third Intervention Period||6
5215130|NCT00975481|12823465|P4|STARTED|Third Intervention Period||6
5215131|NCT00975481|12823466|P3|STARTED|Third Intervention Period||5
5215132|NCT00975481|12823467|P2|STARTED|Third Intervention Period||5
5215133|NCT00975481|12823468|P1|STARTED|Third Intervention Period||4
5215134|NCT00975481|12823463|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215135|NCT00975481|12823464|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215136|NCT00975481|12823465|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215137|NCT00975481|12823466|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215138|NCT00975481|12823467|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215139|NCT00975481|12823468|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215140|NCT00975481|12823463|P6|COMPLETED|Washout Period (at Least 7 Days)||6
5215141|NCT00975481|12823464|P5|COMPLETED|Washout Period (at Least 7 Days)||6
5215142|NCT00975481|12823465|P4|COMPLETED|Washout Period (at Least 7 Days)||6
5215143|NCT00975481|12823466|P3|COMPLETED|Washout Period (at Least 7 Days)||5
5215144|NCT00975481|12823467|P2|COMPLETED|Washout Period (at Least 7 Days)||5
5215145|NCT00975481|12823468|P1|COMPLETED|Washout Period (at Least 7 Days)||4
5215146|NCT00975481|12823463|P6|STARTED|Washout Period (at Least 7 Days)||6
5215147|NCT00975481|12823464|P5|STARTED|Washout Period (at Least 7 Days)||6
5215148|NCT00975481|12823465|P4|STARTED|Washout Period (at Least 7 Days)||6
5215149|NCT00975481|12823466|P3|STARTED|Washout Period (at Least 7 Days)||5
5215150|NCT00975481|12823467|P2|STARTED|Washout Period (at Least 7 Days)||5
5215151|NCT00975481|12823468|P1|STARTED|Washout Period (at Least 7 Days)||4
5215152|NCT00975481|12823463|P6|NOT COMPLETED|Second Intervention Period||0
5215153|NCT00975481|12823464|P5|NOT COMPLETED|Second Intervention Period||0
5215154|NCT00975481|12823465|P4|NOT COMPLETED|Second Intervention Period||0
5215155|NCT00975481|12823466|P3|NOT COMPLETED|Second Intervention Period||1
5215156|NCT00975481|12823467|P2|NOT COMPLETED|Second Intervention Period||1
5215157|NCT00975481|12823468|P1|NOT COMPLETED|Second Intervention Period||2
5215158|NCT00975481|12823463|P6|COMPLETED|Second Intervention Period||6
5215159|NCT00975481|12823464|P5|COMPLETED|Second Intervention Period||6
5215160|NCT00975481|12823465|P4|COMPLETED|Second Intervention Period||6
5215161|NCT00975481|12823466|P3|COMPLETED|Second Intervention Period||5
5215162|NCT00975481|12823467|P2|COMPLETED|Second Intervention Period||5
5215163|NCT00975481|12823468|P1|COMPLETED|Second Intervention Period||4
5215164|NCT00975481|12823463|P6|STARTED|Second Intervention Period||6
5215165|NCT00975481|12823464|P5|STARTED|Second Intervention Period||6
5215166|NCT00975481|12823465|P4|STARTED|Second Intervention Period||6
5215167|NCT00975481|12823466|P3|STARTED|Second Intervention Period||6
5215168|NCT00975481|12823467|P2|STARTED|Second Intervention Period||6
5215169|NCT00975481|12823468|P1|STARTED|Second Intervention Period||6
5215170|NCT00975481|12823463|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215171|NCT00975481|12823464|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215172|NCT00975481|12823465|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215173|NCT00975481|12823466|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215174|NCT00975481|12823467|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215175|NCT00975481|12823468|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
5215176|NCT00975481|12823463|P6|COMPLETED|Washout Period (at Least 7 Days)||6
5215177|NCT00975481|12823464|P5|COMPLETED|Washout Period (at Least 7 Days)||6
5215178|NCT00975481|12823465|P4|COMPLETED|Washout Period (at Least 7 Days)||6
5215179|NCT00975481|12823466|P3|COMPLETED|Washout Period (at Least 7 Days)||6
5215180|NCT00975481|12823467|P2|COMPLETED|Washout Period (at Least 7 Days)||6
5215181|NCT00975481|12823468|P1|COMPLETED|Washout Period (at Least 7 Days)||6
5215182|NCT00975481|12823463|P6|STARTED|Washout Period (at Least 7 Days)||6
5215183|NCT00975481|12823464|P5|STARTED|Washout Period (at Least 7 Days)||6
5215184|NCT00975481|12823465|P4|STARTED|Washout Period (at Least 7 Days)||6
5215185|NCT00975481|12823466|P3|STARTED|Washout Period (at Least 7 Days)||6
5215186|NCT00975481|12823467|P2|STARTED|Washout Period (at Least 7 Days)||6
5215187|NCT00975481|12823468|P1|STARTED|Washout Period (at Least 7 Days)||6
5215188|NCT00975481|12823463|P6|NOT COMPLETED|First Intervention Period||0
5215189|NCT00975481|12823464|P5|NOT COMPLETED|First Intervention Period||0
5215190|NCT00975481|12823465|P4|NOT COMPLETED|First Intervention Period||0
5215191|NCT00975481|12823466|P3|NOT COMPLETED|First Intervention Period||0
5215192|NCT00975481|12823467|P2|NOT COMPLETED|First Intervention Period||0
5215193|NCT00975481|12823468|P1|NOT COMPLETED|First Intervention Period||0
5215194|NCT00975481|12823463|P6|COMPLETED|First Intervention Period||6
5215195|NCT00975481|12823464|P5|COMPLETED|First Intervention Period||6
5215196|NCT00975481|12823465|P4|COMPLETED|First Intervention Period||6
5215197|NCT00975481|12823466|P3|COMPLETED|First Intervention Period||6
5215198|NCT00975481|12823467|P2|COMPLETED|First Intervention Period||6
5215199|NCT00975481|12823468|P1|COMPLETED|First Intervention Period||6
5215200|NCT00975481|12823463|P6|STARTED|First Intervention Period||6
5215201|NCT00975481|12823464|P5|STARTED|First Intervention Period||6
5215202|NCT00975481|12823465|P4|STARTED|First Intervention Period||6
5215203|NCT00975481|12823466|P3|STARTED|First Intervention Period||6
5215204|NCT00975481|12823467|P2|STARTED|First Intervention Period||6
5215205|NCT00975481|12823468|P1|STARTED|First Intervention Period||6
5215206|NCT00975416|12823568|P2|NOT COMPLETED|Overall Study||5
5215207|NCT00975416|12823569|P1|NOT COMPLETED|Overall Study||3
5215208|NCT00975416|12823568|P2|COMPLETED|Overall Study||11
5215209|NCT00975416|12823569|P1|COMPLETED|Overall Study||11
5215210|NCT00975416|12823568|P2|STARTED|Overall Study||16
5215211|NCT00975416|12823569|P1|STARTED|Overall Study||14
5215212|NCT00975286|12823578|P2|NOT COMPLETED|Overall Study||29
5215213|NCT00975286|12823579|P1|NOT COMPLETED|Overall Study||12
5215214|NCT00975286|12823578|P2|COMPLETED|Overall Study||194
5215215|NCT00975286|12823579|P1|COMPLETED|Overall Study||211
5215216|NCT00975286|12823578|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
5215217|NCT00975286|12823579|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
5215218|NCT00975286|12823578|P2|Safety Population|Overall Study||223
5215219|NCT00975286|12823579|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
5215220|NCT00975286|12823578|P2|STARTED|Overall Study||223
5215221|NCT00975286|12823579|P1|STARTED|Overall Study|Randomized.|223
5215222|NCT00975221|12823611|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
5215223|NCT00975221|12823612|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
5215224|NCT00975221|12823611|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
5215225|NCT00975221|12823612|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
5215226|NCT00975221|12823611|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
5215227|NCT00975221|12823612|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
5215228|NCT00975221|12823611|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
5215229|NCT00975221|12823612|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
5215230|NCT00975221|12823611|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
5215231|NCT00975221|12823612|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
5215232|NCT00975221|12823611|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
5215233|NCT00975221|12823612|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
5215234|NCT00975221|12823611|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
5215235|NCT00975221|12823612|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
5215236|NCT00975221|12823611|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
5215237|NCT00975221|12823612|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
5215238|NCT00975221|12823611|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
5215239|NCT00975221|12823612|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
5215240|NCT00975221|12823611|P2|STARTED|Titration Phase (Weeks 1-12)||33
5215241|NCT00975221|12823612|P1|STARTED|Titration Phase (Weeks 1-12)||34
5215242|NCT00975195|12823628|P2|NOT COMPLETED|Overall Study||233
5215243|NCT00975195|12823629|P1|NOT COMPLETED|Overall Study||228
5215244|NCT00975195|12823628|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
5215245|NCT00975195|12823629|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
5215246|NCT00975195|12823628|P2|STARTED|Overall Study||1244
5215247|NCT00975195|12823629|P1|STARTED|Overall Study||1244
5215248|NCT00975156|12823689|P2|NOT COMPLETED|Overall Study||1
5215249|NCT00975156|12823690|P1|NOT COMPLETED|Overall Study||0
5215250|NCT00975156|12823689|P2|COMPLETED|Overall Study||9
5215251|NCT00975156|12823690|P1|COMPLETED|Overall Study||11
5215252|NCT00975156|12823689|P2|STARTED|Overall Study||10
5215253|NCT00975156|12823690|P1|STARTED|Overall Study||11
5215254|NCT00975143|12823702|P2|NOT COMPLETED|Overall Study||60
5215255|NCT00975143|12823703|P1|NOT COMPLETED|Overall Study||70
5215256|NCT00975143|12823702|P2|COMPLETED|Overall Study||401
5215257|NCT00975143|12823703|P1|COMPLETED|Overall Study||394
5215258|NCT00975143|12823702|P2|Completed Treatment (Week 20)|Overall Study||410
5215259|NCT00975143|12823703|P1|Completed Treatment (Week 20)|Overall Study||403
5215260|NCT00975143|12823702|P2|STARTED|Overall Study||461
5215261|NCT00975143|12823703|P1|STARTED|Overall Study||464
5215262|NCT00975130|12823713|P3|NOT COMPLETED|Study Part 2||17
5215263|NCT00975130|12823714|P2|NOT COMPLETED|Study Part 2||38
5215264|NCT00975130|12823715|P1|NOT COMPLETED|Study Part 2||0
5215265|NCT00975130|12823713|P3|COMPLETED|Study Part 2||238
5215266|NCT00975130|12823714|P2|COMPLETED|Study Part 2||212
5215267|NCT00975130|12823715|P1|COMPLETED|Study Part 2||0
5215268|NCT00975130|12823713|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
5215269|NCT00975130|12823714|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
5215270|NCT00975130|12823715|P1|STARTED|Study Part 2||0
5215271|NCT00975130|12823713|P3|NOT COMPLETED|Study Part 1||0
5215272|NCT00975130|12823714|P2|NOT COMPLETED|Study Part 1||0
5215273|NCT00975130|12823715|P1|NOT COMPLETED|Study Part 1||280
5215274|NCT00975130|12823713|P3|COMPLETED|Study Part 1||0
5215275|NCT00975130|12823714|P2|COMPLETED|Study Part 1||0
5215276|NCT00975130|12823715|P1|COMPLETED|Study Part 1||3086
5215277|NCT00975130|12823713|P3|STARTED|Study Part 1||0
5215278|NCT00975130|12823714|P2|STARTED|Study Part 1||0
5215279|NCT00975130|12823715|P1|STARTED|Study Part 1||3366
5215280|NCT00975000|12823899|P2|NOT COMPLETED|Overall Study||5
5215281|NCT00975000|12823900|P1|NOT COMPLETED|Overall Study||5
5215282|NCT00975000|12823899|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
5215283|NCT00975000|12823900|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
5215284|NCT00975000|12823899|P2|Completed Maintenance Phase|Overall Study||52
5215285|NCT00975000|12823900|P1|Completed Maintenance Phase|Overall Study||52
5215286|NCT00975000|12823899|P2|Completed Efficacy Assessment Phase|Overall Study||54
5215287|NCT00975000|12823900|P1|Completed Efficacy Assessment Phase|Overall Study||54
5215288|NCT00975000|12823899|P2|Completed Titration Phase|Overall Study||55
5215289|NCT00975000|12823900|P1|Completed Titration Phase|Overall Study||54
5215290|NCT00975000|12823899|P2|STARTED|Overall Study||57
5215291|NCT00975000|12823900|P1|STARTED|Overall Study||57
5215292|NCT00974974|12823924|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
5215293|NCT00974974|12823925|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
5215294|NCT00974974|12823924|P2|COMPLETED|Maintenance - Double Blind Treatment||182
5215295|NCT00974974|12823925|P1|COMPLETED|Maintenance - Double Blind Treatment||186
5215296|NCT00974974|12823924|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
5215297|NCT00974974|12823925|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
5215298|NCT00974974|12823924|P2|NOT COMPLETED|IPX066 Dose Conversion||0
5215299|NCT00974974|12823925|P1|NOT COMPLETED|IPX066 Dose Conversion||57
5215300|NCT00974974|12823924|P2|COMPLETED|IPX066 Dose Conversion||0
5215301|NCT00974974|12823925|P1|COMPLETED|IPX066 Dose Conversion||393
5215302|NCT00974974|12823924|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
5215303|NCT00974974|12823925|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
5215304|NCT00974974|12823924|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
5215305|NCT00974974|12823925|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
5215306|NCT00974974|12823924|P2|COMPLETED|IR CD-LD Dose Adjustment||450
5215307|NCT00974974|12823925|P1|COMPLETED|IR CD-LD Dose Adjustment||0
5215308|NCT00974974|12823924|P2|STARTED|IR CD-LD Dose Adjustment||471
5215309|NCT00974974|12823925|P1|STARTED|IR CD-LD Dose Adjustment||0
5215310|NCT00974922|12823935|P1|NOT COMPLETED|Overall Study||24
5215311|NCT00974922|12823935|P1|COMPLETED|Overall Study||16
5215312|NCT00974922|12823935|P1|STARTED|Overall Study||40
5215313|NCT00974818|12823942|P2|NOT COMPLETED|Overall Study||0
5215314|NCT00974818|12823943|P1|NOT COMPLETED|Overall Study||0
5215315|NCT00974818|12823942|P2|COMPLETED|Overall Study||25
5215316|NCT00974818|12823943|P1|COMPLETED|Overall Study||25
5215317|NCT00974818|12823942|P2|STARTED|Overall Study||25
5215318|NCT00974818|12823943|P1|STARTED|Overall Study||25
5215319|NCT00974675|12823953|P4|NOT COMPLETED|Overall Study||2
5215320|NCT00974675|12823954|P3|NOT COMPLETED|Overall Study||2
5215321|NCT00974675|12823955|P2|NOT COMPLETED|Overall Study||1
5215322|NCT00974675|12823956|P1|NOT COMPLETED|Overall Study||2
5215323|NCT00974675|12823953|P4|COMPLETED|Overall Study||2
5215324|NCT00974675|12823954|P3|COMPLETED|Overall Study||1
5215325|NCT00974675|12823955|P2|COMPLETED|Overall Study||7
5215326|NCT00974675|12823956|P1|COMPLETED|Overall Study||6
5215327|NCT00974675|12823953|P4|STARTED|Overall Study||4
5215328|NCT00974675|12823954|P3|STARTED|Overall Study||3
5215329|NCT00974675|12823955|P2|STARTED|Overall Study||8
5215330|NCT00974675|12823956|P1|STARTED|Overall Study||8
5215331|NCT00974571|12824005|P3|NOT COMPLETED|Overall Study||83
5215332|NCT00974571|12824006|P2|NOT COMPLETED|Overall Study||16
5215333|NCT00974571|12824007|P1|NOT COMPLETED|Overall Study||68
5215334|NCT00974571|12824005|P3|COMPLETED|Overall Study||530
5215335|NCT00974571|12824006|P2|COMPLETED|Overall Study||106
5215336|NCT00974571|12824007|P1|COMPLETED|Overall Study||562
5215337|NCT00974571|12824005|P3|STARTED|Overall Study||613
5215338|NCT00974571|12824006|P2|STARTED|Overall Study||122
5215339|NCT00974571|12824007|P1|STARTED|Overall Study||630
5215340|NCT00974493|12824029|P2|NOT COMPLETED|Overall Study||21
5215341|NCT00974493|12824030|P1|NOT COMPLETED|Overall Study||18
5215342|NCT00974493|12824029|P2|COMPLETED|Overall Study||506
5215343|NCT00974493|12824030|P1|COMPLETED|Overall Study||509
5215344|NCT00974493|12824029|P2|STARTED|Overall Study||527
5215345|NCT00974493|12824030|P1|STARTED|Overall Study||527
5215346|NCT00974480|12824039|P3|NOT COMPLETED|Overall Study||10
5215347|NCT00974480|12824040|P2|NOT COMPLETED|Overall Study||7
5215348|NCT00974480|12824041|P1|NOT COMPLETED|Overall Study||11
5215349|NCT00974480|12824039|P3|COMPLETED|Overall Study||30
5215350|NCT00974480|12824040|P2|COMPLETED|Overall Study||33
5215351|NCT00974480|12824041|P1|COMPLETED|Overall Study||29
5215352|NCT00974480|12824039|P3|STARTED|Overall Study||40
5215353|NCT00974480|12824040|P2|STARTED|Overall Study||40
5215354|NCT00974480|12824041|P1|STARTED|Overall Study||40
5215355|NCT00974376|12824081|P2|NOT COMPLETED|Overall Study||33
5215356|NCT00974376|12824082|P1|NOT COMPLETED|Overall Study||34
5215357|NCT00974376|12824081|P2|COMPLETED|Overall Study||42
5215358|NCT00974376|12824082|P1|COMPLETED|Overall Study||41
5215359|NCT00974376|12824081|P2|STARTED|Overall Study||75
5215360|NCT00974376|12824082|P1|STARTED|Overall Study||75
5215361|NCT00974363|12824090|P2|NOT COMPLETED|Overall Study||0
5215362|NCT00974363|12824091|P1|NOT COMPLETED|Overall Study||0
5215363|NCT00974363|12824090|P2|COMPLETED|Overall Study||168
5215364|NCT00974363|12824091|P1|COMPLETED|Overall Study||521
5215365|NCT00974363|12824090|P2|STARTED|Overall Study||168
5215366|NCT00974363|12824091|P1|STARTED|Overall Study||521
5215367|NCT00974311|12824113|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
5215368|NCT00974311|12824114|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
5215369|NCT00974311|12824113|P2|COMPLETED|OLE Phase (up to 77 Months)||0
5215370|NCT00974311|12824114|P1|COMPLETED|OLE Phase (up to 77 Months)||0
5215371|NCT00974311|12824113|P2|STARTED|OLE Phase (up to 77 Months)||50
5215372|NCT00974311|12824114|P1|STARTED|OLE Phase (up to 77 Months)||109
5215373|NCT00974311|12824113|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
5215374|NCT00974311|12824114|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
5215375|NCT00974311|12824113|P2|COMPLETED|DB Phase (up to 24 Months)||50
5215376|NCT00974311|12824114|P1|COMPLETED|DB Phase (up to 24 Months)||109
5215377|NCT00974311|12824113|P2|STARTED|DB Phase (up to 24 Months)||399
5215378|NCT00974311|12824114|P1|STARTED|DB Phase (up to 24 Months)||800
5215379|NCT00974259|12824152|P2|NOT COMPLETED|Overall Study||1
5215380|NCT00974259|12824153|P1|NOT COMPLETED|Overall Study||2
5215381|NCT00974259|12824152|P2|COMPLETED|Overall Study||62
5215382|NCT00974259|12824153|P1|COMPLETED|Overall Study||57
5215383|NCT00974259|12824152|P2|STARTED|Overall Study||63
5215384|NCT00974259|12824153|P1|STARTED|Overall Study||59
5215385|NCT00974246|12824165|P1|NOT COMPLETED|Overall Study||0
5215386|NCT00974246|12824165|P1|COMPLETED|Overall Study||27
5215387|NCT00974246|12824165|P1|STARTED|Overall Study||27
5215388|NCT00974233|12824171|P1|NOT COMPLETED|Maintenance Lenalidomide||13
5215389|NCT00974233|12824171|P1|COMPLETED|Maintenance Lenalidomide||6
5215390|NCT00974233|12824171|P1|STARTED|Maintenance Lenalidomide||19
5215391|NCT00974233|12824171|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
5215392|NCT00974233|12824171|P1|COMPLETED|Induction Chemoimmunotherapy||19
5215393|NCT00974233|12824171|P1|STARTED|Induction Chemoimmunotherapy||34
5215394|NCT00974220|12824186|P2|NOT COMPLETED|Treatment Period 2||0
5215395|NCT00974220|12824187|P1|NOT COMPLETED|Treatment Period 2||0
5215396|NCT00974220|12824186|P2|COMPLETED|Treatment Period 2||5
5215397|NCT00974220|12824187|P1|COMPLETED|Treatment Period 2||7
5215398|NCT00974220|12824186|P2|STARTED|Treatment Period 2||5
5215399|NCT00974220|12824187|P1|STARTED|Treatment Period 2||7
5215400|NCT00974220|12824186|P2|NOT COMPLETED|Treatment Period 1||2
5215401|NCT00974220|12824187|P1|NOT COMPLETED|Treatment Period 1||2
5215402|NCT00974220|12824186|P2|COMPLETED|Treatment Period 1||5
5215403|NCT00974220|12824187|P1|COMPLETED|Treatment Period 1||7
5215404|NCT00974220|12824186|P2|STARTED|Treatment Period 1||7
5215405|NCT00974220|12824187|P1|STARTED|Treatment Period 1||9
5215406|NCT00974142|12824197|P2|NOT COMPLETED|Overall Study||0
5215407|NCT00974142|12824198|P1|NOT COMPLETED|Overall Study||0
5215408|NCT00974142|12824197|P2|COMPLETED|Overall Study||9
5215409|NCT00974142|12824198|P1|COMPLETED|Overall Study||8
5215410|NCT00974142|12824197|P2|STARTED|Overall Study||9
5215411|NCT00974142|12824198|P1|STARTED|Overall Study||8
5215412|NCT00974090|12824232|P2|NOT COMPLETED|Period 2: Open-label Period||10
5215413|NCT00974090|12824233|P1|NOT COMPLETED|Period 2: Open-label Period||8
5215414|NCT00974090|12824232|P2|COMPLETED|Period 2: Open-label Period||85
5215415|NCT00974090|12824233|P1|COMPLETED|Period 2: Open-label Period||87
5215416|NCT00974090|12824232|P2|STARTED|Period 2: Open-label Period||95
5215417|NCT00974090|12824233|P1|STARTED|Period 2: Open-label Period||95
5215418|NCT00974090|12824232|P2|NOT COMPLETED|Period 1: Double Blind Period||1
5215419|NCT00974090|12824233|P1|NOT COMPLETED|Period 1: Double Blind Period||3
5215420|NCT00974090|12824232|P2|COMPLETED|Period 1: Double Blind Period||95
5215421|NCT00974090|12824233|P1|COMPLETED|Period 1: Double Blind Period||95
5215422|NCT00974090|12824232|P2|STARTED|Period 1: Double Blind Period||96
5215423|NCT00974090|12824233|P1|STARTED|Period 1: Double Blind Period||98
5215424|NCT00974051|12824247|P3|NOT COMPLETED|Overall Study||0
5215425|NCT00974051|12824248|P2|NOT COMPLETED|Overall Study||0
5215426|NCT00974051|12824249|P1|NOT COMPLETED|Overall Study||0
5215427|NCT00974051|12824247|P3|COMPLETED|Overall Study||6
5215428|NCT00974051|12824248|P2|COMPLETED|Overall Study||4
5215429|NCT00974051|12824249|P1|COMPLETED|Overall Study||6
5215430|NCT00974051|12824247|P3|STARTED|Overall Study||6
5215431|NCT00974051|12824248|P2|STARTED|Overall Study||4
5215432|NCT00974051|12824249|P1|STARTED|Overall Study||6
5215433|NCT00973973|12824269|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
5215434|NCT00973973|12824270|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
5215435|NCT00973973|12824269|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
5215436|NCT00973973|12824270|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
5215437|NCT00973973|12824269|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
5215438|NCT00973973|12824270|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
5215439|NCT00973973|12824269|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
5215440|NCT00973973|12824270|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
5215441|NCT00973973|12824269|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
5215442|NCT00973973|12824270|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
5215443|NCT00973973|12824269|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
5215444|NCT00973973|12824270|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
5215445|NCT00973973|12824269|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
5215446|NCT00973973|12824270|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
5215447|NCT00973921|12824330|P1|NOT COMPLETED|Overall Study||9
5215448|NCT00973921|12824330|P1|COMPLETED|Overall Study||31
5215449|NCT00973921|12824330|P1|STARTED|Overall Study||40
5215450|NCT00973856|12824339|P2|NOT COMPLETED|Overall Study||0
5215451|NCT00973856|12824340|P1|NOT COMPLETED|Overall Study||0
5215452|NCT00973856|12824339|P2|COMPLETED|Overall Study||2
5215453|NCT00973856|12824340|P1|COMPLETED|Overall Study||3
5215454|NCT00973856|12824339|P2|STARTED|Overall Study||2
5215455|NCT00973856|12824340|P1|STARTED|Overall Study||3
5215456|NCT00973765|12824347|P2|NOT COMPLETED|Overall Study||14
5215457|NCT00973765|12824348|P1|NOT COMPLETED|Overall Study||8
5215458|NCT00973765|12824347|P2|COMPLETED|Overall Study|102|102
5215459|NCT00973765|12824348|P1|COMPLETED|Overall Study|88|88
5215460|NCT00973765|12824347|P2|STARTED|Overall Study|116|116
5215461|NCT00973765|12824348|P1|STARTED|Overall Study|96|96
5215462|NCT00973752|12824354|P1|NOT COMPLETED|Overall Study||0
5215463|NCT00973752|12824354|P1|COMPLETED|Overall Study||30
5215464|NCT00973752|12824354|P1|STARTED|Overall Study||30
5215465|NCT00973739|12824358|P1|NOT COMPLETED|Overall Study||4
5215466|NCT00973739|12824358|P1|COMPLETED|Overall Study||17
5215467|NCT00973739|12824358|P1|STARTED|Overall Study||21
5215468|NCT00973700|12824370|P5|NOT COMPLETED|Overall Study||10
5215469|NCT00973700|12824371|P4|NOT COMPLETED|Overall Study||18
5215470|NCT00973700|12824372|P3|NOT COMPLETED|Overall Study||10
5215471|NCT00973700|12824373|P2|NOT COMPLETED|Overall Study||2
5215472|NCT00973700|12824374|P1|NOT COMPLETED|Overall Study||7
5215473|NCT00973700|12824370|P5|COMPLETED|Overall Study||158
5215474|NCT00973700|12824371|P4|COMPLETED|Overall Study||318
5215475|NCT00973700|12824372|P3|COMPLETED|Overall Study||158
5215476|NCT00973700|12824373|P2|COMPLETED|Overall Study||54
5215477|NCT00973700|12824374|P1|COMPLETED|Overall Study||49
5215478|NCT00973700|12824370|P5|STARTED|Overall Study||168
5215479|NCT00973700|12824371|P4|STARTED|Overall Study||336
5215480|NCT00973700|12824372|P3|STARTED|Overall Study||168
5215481|NCT00973700|12824373|P2|STARTED|Overall Study||56
5215482|NCT00973700|12824374|P1|STARTED|Overall Study||56
5215483|NCT00973674|12824423|P2|NOT COMPLETED|Overall Study||0
5215484|NCT00973674|12824424|P1|NOT COMPLETED|Overall Study||2
5215485|NCT00973674|12824423|P2|COMPLETED|Overall Study||26
5215486|NCT00973674|12824424|P1|COMPLETED|Overall Study||22
5215487|NCT00973674|12824423|P2|STARTED|Overall Study||26
5215488|NCT00973674|12824424|P1|STARTED|Overall Study||24
5215489|NCT00973622|12824438|P2|NOT COMPLETED|Overall Study||5
5215490|NCT00973622|12824439|P1|NOT COMPLETED|Overall Study||31
5215491|NCT00973622|12824438|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
5215492|NCT00973622|12824439|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
5215493|NCT00973622|12824438|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
5215494|NCT00973622|12824439|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
5215495|NCT00973479|12824447|P2|NOT COMPLETED|Overall Study||69
5215496|NCT00973479|12824448|P1|NOT COMPLETED|Overall Study||37
5215497|NCT00973479|12824447|P2|COMPLETED|Overall Study||326
5215498|NCT00973479|12824448|P1|COMPLETED|Overall Study||160
5215499|NCT00973479|12824447|P2|STARTED|Overall Study||395
5215500|NCT00973479|12824448|P1|STARTED|Overall Study||197
5215501|NCT00973362|12824466|P2|NOT COMPLETED|3-Year Follow-up||0
5215502|NCT00973362|12824467|P1|NOT COMPLETED|3-Year Follow-up||17
5215503|NCT00973362|12824466|P2|COMPLETED|3-Year Follow-up||0
5215504|NCT00973362|12824467|P1|COMPLETED|3-Year Follow-up||10854
5215505|NCT00973362|12824466|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
5215506|NCT00973362|12824467|P1|STARTED|3-Year Follow-up||10871
5215507|NCT00973362|12824466|P2|NOT COMPLETED|Baseline Evaluation||223
5215508|NCT00973362|12824467|P1|NOT COMPLETED|Baseline Evaluation||773
5215509|NCT00973362|12824466|P2|COMPLETED|Baseline Evaluation||1029
5215510|NCT00973362|12824467|P1|COMPLETED|Baseline Evaluation||10871
5215511|NCT00973362|12824466|P2|Conclusive Disease Status|Baseline Evaluation||939
5215512|NCT00973362|12824467|P1|Conclusive Disease Status|Baseline Evaluation||819
5215513|NCT00973362|12824466|P2|Evaluable for Analysis|Baseline Evaluation||958
5215514|NCT00973362|12824467|P1|Evaluable for Analysis|Baseline Evaluation||10871
5215515|NCT00973362|12824466|P2|STARTED|Baseline Evaluation||1252
5215516|NCT00973362|12824467|P1|STARTED|Baseline Evaluation||11644
5215517|NCT00973349|12824492|P16|NOT COMPLETED|Overall Study||2
5215518|NCT00973349|12824493|P15|NOT COMPLETED|Overall Study||2
5215519|NCT00973349|12824494|P14|NOT COMPLETED|Overall Study||0
5215520|NCT00973349|12824495|P13|NOT COMPLETED|Overall Study||1
5215521|NCT00973349|12824496|P12|NOT COMPLETED|Overall Study||2
5215522|NCT00973349|12824497|P11|NOT COMPLETED|Overall Study||0
5215523|NCT00973349|12824498|P10|NOT COMPLETED|Overall Study||6
5215524|NCT00973349|12824499|P9|NOT COMPLETED|Overall Study||4
5215525|NCT00973349|12824500|P8|NOT COMPLETED|Overall Study||3
5215526|NCT00973349|12824501|P7|NOT COMPLETED|Overall Study||2
5215527|NCT00973349|12824502|P6|NOT COMPLETED|Overall Study||4
5215528|NCT00973349|12824503|P5|NOT COMPLETED|Overall Study||5
5215529|NCT00973349|12824504|P4|NOT COMPLETED|Overall Study||5
5215530|NCT00973349|12824505|P3|NOT COMPLETED|Overall Study||5
5215531|NCT00973349|12824506|P2|NOT COMPLETED|Overall Study||3
5215532|NCT00973349|12824507|P1|NOT COMPLETED|Overall Study||4
5215533|NCT00973349|12824492|P16|COMPLETED|Overall Study||165
5215534|NCT00973349|12824493|P15|COMPLETED|Overall Study||168
5215535|NCT00973349|12824494|P14|COMPLETED|Overall Study||171
5215536|NCT00973349|12824495|P13|COMPLETED|Overall Study||168
5215537|NCT00973349|12824496|P12|COMPLETED|Overall Study||167
5215538|NCT00973349|12824497|P11|COMPLETED|Overall Study||174
5215539|NCT00973349|12824498|P10|COMPLETED|Overall Study||163
5215540|NCT00973349|12824499|P9|COMPLETED|Overall Study||167
5215541|NCT00973349|12824500|P8|COMPLETED|Overall Study||166
5215542|NCT00973349|12824501|P7|COMPLETED|Overall Study||172
5215543|NCT00973349|12824502|P6|COMPLETED|Overall Study||165
5215544|NCT00973349|12824503|P5|COMPLETED|Overall Study||165
5215545|NCT00973349|12824504|P4|COMPLETED|Overall Study||163
5215546|NCT00973349|12824505|P3|COMPLETED|Overall Study||166
5215547|NCT00973349|12824506|P2|COMPLETED|Overall Study||165
5215548|NCT00973349|12824507|P1|COMPLETED|Overall Study||166
5215549|NCT00973349|12824492|P16|STARTED|Overall Study||167
5215550|NCT00973349|12824493|P15|STARTED|Overall Study||170
5215551|NCT00973349|12824494|P14|STARTED|Overall Study||171
5215552|NCT00973349|12824495|P13|STARTED|Overall Study||169
5215553|NCT00973349|12824496|P12|STARTED|Overall Study||169
5215554|NCT00973349|12824497|P11|STARTED|Overall Study||174
5215555|NCT00973349|12824498|P10|STARTED|Overall Study||169
5215556|NCT00973349|12824499|P9|STARTED|Overall Study||171
5215557|NCT00973349|12824500|P8|STARTED|Overall Study||169
5215558|NCT00973349|12824501|P7|STARTED|Overall Study||174
5215559|NCT00973349|12824502|P6|STARTED|Overall Study||169
5215560|NCT00973349|12824503|P5|STARTED|Overall Study||170
5215561|NCT00973349|12824504|P4|STARTED|Overall Study||168
5215562|NCT00973349|12824505|P3|STARTED|Overall Study||171
5215563|NCT00973349|12824506|P2|STARTED|Overall Study||168
5215564|NCT00973349|12824507|P1|STARTED|Overall Study||170
5215565|NCT00973102|12824607|P2|NOT COMPLETED|Overall Study||1
5215566|NCT00973102|12824608|P1|NOT COMPLETED|Overall Study||1
5215567|NCT00973102|12824607|P2|COMPLETED|Overall Study||25
5215568|NCT00973102|12824608|P1|COMPLETED|Overall Study||23
5215569|NCT00973102|12824607|P2|STARTED|Overall Study||26
5215570|NCT00973102|12824608|P1|STARTED|Overall Study||24
5215571|NCT00972959|12824616|P1|NOT COMPLETED|Overall Study||0
5215572|NCT00972959|12824616|P1|COMPLETED|Overall Study||17
5215573|NCT00972959|12824616|P1|STARTED|Overall Study||17
5215574|NCT00972816|12824639|P8|NOT COMPLETED|Overall Study||9
5215575|NCT00972816|12824640|P7|NOT COMPLETED|Overall Study||10
5215576|NCT00972816|12824641|P6|NOT COMPLETED|Overall Study||11
5215577|NCT00972816|12824642|P5|NOT COMPLETED|Overall Study||12
5215578|NCT00972816|12824643|P4|NOT COMPLETED|Overall Study||8
5215579|NCT00972816|12824644|P3|NOT COMPLETED|Overall Study||9
5215580|NCT00972816|12824645|P2|NOT COMPLETED|Overall Study||11
5215581|NCT00972816|12824646|P1|NOT COMPLETED|Overall Study||17
5215582|NCT00972816|12824639|P8|COMPLETED|Overall Study||161
5215583|NCT00972816|12824640|P7|COMPLETED|Overall Study||159
5215584|NCT00972816|12824641|P6|COMPLETED|Overall Study||158
5215585|NCT00972816|12824642|P5|COMPLETED|Overall Study||157
5215586|NCT00972816|12824643|P4|COMPLETED|Overall Study||161
5215587|NCT00972816|12824644|P3|COMPLETED|Overall Study||160
5215588|NCT00972816|12824645|P2|COMPLETED|Overall Study||158
5215589|NCT00972816|12824646|P1|COMPLETED|Overall Study||156
5215590|NCT00972816|12824639|P8|STARTED|Overall Study||170
5215591|NCT00972816|12824640|P7|STARTED|Overall Study||169
5215592|NCT00972816|12824641|P6|STARTED|Overall Study||169
5215593|NCT00972816|12824642|P5|STARTED|Overall Study||169
5215594|NCT00972816|12824643|P4|STARTED|Overall Study||169
5215595|NCT00972816|12824644|P3|STARTED|Overall Study||169
5215596|NCT00972816|12824645|P2|STARTED|Overall Study||169
5215597|NCT00972816|12824646|P1|STARTED|Overall Study||173
5215598|NCT00972777|12824730|P2|NOT COMPLETED|Overall Study||14
5215599|NCT00972777|12824731|P1|NOT COMPLETED|Overall Study||14
5215600|NCT00972777|12824730|P2|COMPLETED|Overall Study||229
5215601|NCT00972777|12824731|P1|COMPLETED|Overall Study||217
5215602|NCT00972777|12824730|P2|STARTED|Overall Study||243
5215603|NCT00972777|12824731|P1|STARTED|Overall Study||231
5215604|NCT00972738|12824746|P3|NOT COMPLETED|Overall Study||29
5215605|NCT00972738|12824747|P2|NOT COMPLETED|Overall Study||6
5215606|NCT00972738|12824748|P1|NOT COMPLETED|Overall Study||21
5215607|NCT00972738|12824746|P3|COMPLETED|Overall Study||492
5215608|NCT00972738|12824747|P2|COMPLETED|Overall Study||165
5215609|NCT00972738|12824748|P1|COMPLETED|Overall Study||501
5215610|NCT00972738|12824746|P3|STARTED|Overall Study||521
5215611|NCT00972738|12824747|P2|STARTED|Overall Study||171
5215612|NCT00972738|12824748|P1|STARTED|Overall Study||522
5215613|NCT00972725|12824773|P2|NOT COMPLETED|Overall Study||0
5215614|NCT00972725|12824774|P1|NOT COMPLETED|Overall Study||0
5215615|NCT00972725|12824773|P2|COMPLETED|Overall Study||15
5215616|NCT00972725|12824774|P1|COMPLETED|Overall Study||13
5215617|NCT00972725|12824773|P2|STARTED|Overall Study||15
5215618|NCT00972725|12824774|P1|STARTED|Overall Study||13
5215619|NCT00972621|12824856|P2|NOT COMPLETED|Overall Study||1
5215620|NCT00972621|12824857|P1|NOT COMPLETED|Overall Study||0
5215621|NCT00972621|12824856|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
5215622|NCT00972621|12824857|P1|COMPLETED|Overall Study||200
5215623|NCT00972621|12824856|P2|STARTED|Overall Study||200
5215624|NCT00972621|12824857|P1|STARTED|Overall Study||200
5215625|NCT00972595|12824865|P2|NOT COMPLETED|Period 2||0
5215626|NCT00972595|12824866|P1|NOT COMPLETED|Period 2||0
5215627|NCT00972595|12824865|P2|COMPLETED|Period 2||22
5215628|NCT00972595|12824866|P1|COMPLETED|Period 2||22
5215629|NCT00972595|12824865|P2|STARTED|Period 2||22
5215630|NCT00972595|12824866|P1|STARTED|Period 2||22
5215631|NCT00972595|12824865|P2|NOT COMPLETED|Period 1||0
5215632|NCT00972595|12824866|P1|NOT COMPLETED|Period 1||1
5215633|NCT00972595|12824865|P2|COMPLETED|Period 1||22
5215634|NCT00972595|12824866|P1|COMPLETED|Period 1||22
5215635|NCT00972595|12824865|P2|STARTED|Period 1||22
5215636|NCT00972595|12824866|P1|STARTED|Period 1||23
5215637|NCT00972543|12824876|P2|NOT COMPLETED|Overall Study||1
5215638|NCT00972543|12824877|P1|NOT COMPLETED|Overall Study||5
5215639|NCT00972543|12824876|P2|COMPLETED|Overall Study||0
5215640|NCT00972543|12824877|P1|COMPLETED|Overall Study||0
5215641|NCT00972543|12824876|P2|STARTED|Overall Study||1
5215642|NCT00972543|12824877|P1|STARTED|Overall Study||5
5215643|NCT00972530|12824953|P2|NOT COMPLETED|Overall Study||0
5215644|NCT00972530|12824954|P1|NOT COMPLETED|Overall Study||0
5215645|NCT00972530|12824953|P2|COMPLETED|Overall Study||46
5215646|NCT00972530|12824954|P1|COMPLETED|Overall Study||44
5215647|NCT00972530|12824953|P2|STARTED|Overall Study||46
5215648|NCT00972530|12824954|P1|STARTED|Overall Study||44
5215649|NCT00972517|12824960|P6|NOT COMPLETED|Overall Study||0
5215650|NCT00972517|12824961|P5|NOT COMPLETED|Overall Study||1
5215651|NCT00972517|12824962|P4|NOT COMPLETED|Overall Study||3
5215652|NCT00972517|12824963|P3|NOT COMPLETED|Overall Study||0
5215653|NCT00972517|12824964|P2|NOT COMPLETED|Overall Study||1
5215654|NCT00972517|12824965|P1|NOT COMPLETED|Overall Study||0
5215655|NCT00972517|12824960|P6|COMPLETED|Overall Study||58
5215656|NCT00972517|12824961|P5|COMPLETED|Overall Study||33
5215657|NCT00972517|12824962|P4|COMPLETED|Overall Study||27
5215658|NCT00972517|12824963|P3|COMPLETED|Overall Study||60
5215659|NCT00972517|12824964|P2|COMPLETED|Overall Study||30
5215660|NCT00972517|12824965|P1|COMPLETED|Overall Study||31
5215661|NCT00972517|12824960|P6|STARTED|Overall Study||58
5215662|NCT00972517|12824961|P5|STARTED|Overall Study||34
5215663|NCT00972517|12824962|P4|STARTED|Overall Study||30
5215664|NCT00972517|12824963|P3|STARTED|Overall Study||60
5215665|NCT00972517|12824964|P2|STARTED|Overall Study||31
5215666|NCT00972517|12824965|P1|STARTED|Overall Study||31
5215667|NCT00972504|12825060|P1|NOT COMPLETED|Overall Study||3
5215668|NCT00972504|12825060|P1|COMPLETED|Overall Study||51
5215669|NCT00972504|12825060|P1|STARTED|Overall Study||54
5215670|NCT00972478|12825092|P2|NOT COMPLETED|Overall Study||38
5215671|NCT00972478|12825093|P1|NOT COMPLETED|Overall Study||7
5215672|NCT00972478|12825092|P2|COMPLETED|Overall Study||34
5215673|NCT00972478|12825093|P1|COMPLETED|Overall Study||4
5215674|NCT00972478|12825092|P2|Eligible and Began Protocol Therapy|Overall Study||63
5215675|NCT00972478|12825093|P1|Eligible and Began Protocol Therapy|Overall Study||9
5215676|NCT00972478|12825092|P2|STARTED|Overall Study||72
5215677|NCT00972478|12825093|P1|STARTED|Overall Study||11
5215678|NCT00972439|12825105|P2|NOT COMPLETED|Overall Study||0
5215679|NCT00972439|12825106|P1|NOT COMPLETED|Overall Study||0
5215680|NCT00972439|12825105|P2|COMPLETED|Overall Study||16
5215681|NCT00972439|12825106|P1|COMPLETED|Overall Study||17
5215682|NCT00972439|12825105|P2|STARTED|Overall Study||16
5215683|NCT00972439|12825106|P1|STARTED|Overall Study||17
5215684|NCT00972374|12825115|P3|NOT COMPLETED|Overall Study||1
5215685|NCT00972374|12825116|P2|NOT COMPLETED|Overall Study||0
5215686|NCT00972374|12825117|P1|NOT COMPLETED|Overall Study||2
5215687|NCT00972374|12825115|P3|COMPLETED|Overall Study||13
5215688|NCT00972374|12825116|P2|COMPLETED|Overall Study||15
5215689|NCT00972374|12825117|P1|COMPLETED|Overall Study||13
5215690|NCT00972374|12825115|P3|STARTED|Overall Study||14
5215691|NCT00972374|12825116|P2|STARTED|Overall Study||15
5215692|NCT00972374|12825117|P1|STARTED|Overall Study||15
5215693|NCT00972335|12825131|P1|NOT COMPLETED|Overall Study||17
5215694|NCT00972335|12825131|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
5215695|NCT00972335|12825131|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
5215696|NCT00972322|12825138|P2|NOT COMPLETED|Overall Study||3
5215697|NCT00972322|12825139|P1|NOT COMPLETED|Overall Study||3
5215698|NCT00972322|12825138|P2|COMPLETED|Overall Study||25
5215699|NCT00972322|12825139|P1|COMPLETED|Overall Study||25
5215700|NCT00972322|12825138|P2|STARTED|Overall Study||28
5215701|NCT00972322|12825139|P1|STARTED|Overall Study||28
5215702|NCT00972283|12825151|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
5215703|NCT00972283|12825152|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
5215704|NCT00972283|12825151|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
5215705|NCT00972283|12825152|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
5215706|NCT00972283|12825151|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
5215707|NCT00972283|12825152|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
5215708|NCT00972283|12825151|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
5215709|NCT00972283|12825152|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
5215710|NCT00972283|12825151|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
5215711|NCT00972283|12825152|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
5215712|NCT00972283|12825151|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
5215713|NCT00972283|12825152|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
5215714|NCT00972283|12825151|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
5215715|NCT00972283|12825152|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
5215716|NCT00972283|12825151|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
5215717|NCT00972283|12825152|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
5215718|NCT00972244|12825179|P5|NOT COMPLETED|Overall Study||9
5215719|NCT00972244|12825180|P4|NOT COMPLETED|Overall Study||0
5215720|NCT00972244|12825181|P3|NOT COMPLETED|Overall Study||2
5215721|NCT00972244|12825182|P2|NOT COMPLETED|Overall Study||5
5215722|NCT00972244|12825183|P1|NOT COMPLETED|Overall Study||5
5215723|NCT00972244|12825179|P5|COMPLETED|Overall Study||45
5215724|NCT00972244|12825180|P4|COMPLETED|Overall Study||52
5215725|NCT00972244|12825181|P3|COMPLETED|Overall Study||56
5215726|NCT00972244|12825182|P2|COMPLETED|Overall Study||51
5215727|NCT00972244|12825183|P1|COMPLETED|Overall Study||54
5215728|NCT00972244|12825179|P5|STARTED|Overall Study||54
5215729|NCT00972244|12825180|P4|STARTED|Overall Study||52
5215730|NCT00972244|12825181|P3|STARTED|Overall Study||58
5215731|NCT00972244|12825182|P2|STARTED|Overall Study||56
5215732|NCT00972244|12825183|P1|STARTED|Overall Study||59
5215733|NCT00972205|12825205|P1|NOT COMPLETED|Overall Study||0
5215734|NCT00972205|12825205|P1|COMPLETED|Overall Study||12
5215735|NCT00972205|12825205|P1|STARTED|Overall Study||12
5215736|NCT00972153|12825215|P3|NOT COMPLETED|Overall Study||0
5215737|NCT00972153|12825216|P2|NOT COMPLETED|Overall Study||1
5215738|NCT00972153|12825217|P1|NOT COMPLETED|Overall Study||0
5215739|NCT00972153|12825215|P3|COMPLETED|Overall Study||12
5215740|NCT00972153|12825216|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
5215741|NCT00972153|12825217|P1|COMPLETED|Overall Study||12
5215742|NCT00972153|12825215|P3|STARTED|Overall Study||12
5215743|NCT00972153|12825216|P2|STARTED|Overall Study||12
5215744|NCT00972153|12825217|P1|STARTED|Overall Study||12
5215745|NCT00972088|12825228|P1|NOT COMPLETED|Overall Study||0
5215746|NCT00972088|12825228|P1|COMPLETED|Overall Study||26
5215747|NCT00972088|12825228|P1|STARTED|Overall Study||26
5215748|NCT00972023|12825232|P1|NOT COMPLETED|Overall Study||1
5215749|NCT00972023|12825232|P1|COMPLETED|Overall Study||0
5215750|NCT00972023|12825232|P1|STARTED|Overall Study||1
5215751|NCT00971997|12825239|P1|NOT COMPLETED|Overall Study||19
5215752|NCT00971997|12825239|P1|COMPLETED|Overall Study||116
5215753|NCT00971997|12825239|P1|STARTED|Overall Study||135
5215754|NCT00971932|12825257|P1|NOT COMPLETED|Overall Study||7
5215755|NCT00971932|12825257|P1|COMPLETED|Overall Study||26
5215756|NCT00971932|12825257|P1|STARTED|Overall Study|Number of participants treated.|33
5215757|NCT00971841|12825267|P1|NOT COMPLETED|Overall Study||0
5215758|NCT00971841|12825267|P1|COMPLETED|Overall Study||1
5215759|NCT00971841|12825267|P1|STARTED|Overall Study||1
5215760|NCT00971789|12825272|P1|NOT COMPLETED|Overall Study||0
5215761|NCT00971789|12825272|P1|COMPLETED|Overall Study||18
5215762|NCT00971789|12825272|P1|STARTED|Overall Study||18
5215763|NCT00971750|12825277|P1|NOT COMPLETED|Overall Study||0
5215764|NCT00971750|12825277|P1|COMPLETED|Overall Study||253
5215765|NCT00971750|12825277|P1|STARTED|Overall Study||253
5215766|NCT00971737|12825288|P2|NOT COMPLETED|Overall Study||0
5215767|NCT00971737|12825289|P1|NOT COMPLETED|Overall Study||0
5215768|NCT00971737|12825288|P2|COMPLETED|Overall Study||30
5215769|NCT00971737|12825289|P1|COMPLETED|Overall Study||30
5215770|NCT00971737|12825288|P2|STARTED|Overall Study||30
5215771|NCT00971737|12825289|P1|STARTED|Overall Study||30
5215772|NCT00971633|12825307|P6|NOT COMPLETED|Period 3||0
5215773|NCT00971633|12825308|P5|NOT COMPLETED|Period 3||0
5215774|NCT00971633|12825309|P4|NOT COMPLETED|Period 3||0
5215775|NCT00971633|12825310|P3|NOT COMPLETED|Period 3||0
5215776|NCT00971633|12825311|P2|NOT COMPLETED|Period 3||0
5215777|NCT00971633|12825312|P1|NOT COMPLETED|Period 3||0
5215778|NCT00971633|12825307|P6|COMPLETED|Period 3||2
5215779|NCT00971633|12825308|P5|COMPLETED|Period 3||2
5215780|NCT00971633|12825309|P4|COMPLETED|Period 3||2
5215781|NCT00971633|12825310|P3|COMPLETED|Period 3||2
5215782|NCT00971633|12825311|P2|COMPLETED|Period 3||2
5215783|NCT00971633|12825312|P1|COMPLETED|Period 3||2
5215784|NCT00971633|12825307|P6|STARTED|Period 3||2
5215785|NCT00971633|12825308|P5|STARTED|Period 3||2
5215786|NCT00971633|12825309|P4|STARTED|Period 3||2
5215787|NCT00971633|12825310|P3|STARTED|Period 3||2
5215788|NCT00971633|12825311|P2|STARTED|Period 3||2
5215789|NCT00971633|12825312|P1|STARTED|Period 3||2
5215790|NCT00971633|12825307|P6|NOT COMPLETED|Period 2||0
5215791|NCT00971633|12825308|P5|NOT COMPLETED|Period 2||0
5215792|NCT00971633|12825309|P4|NOT COMPLETED|Period 2||0
5215793|NCT00971633|12825310|P3|NOT COMPLETED|Period 2||0
5215794|NCT00971633|12825311|P2|NOT COMPLETED|Period 2||0
5215795|NCT00971633|12825312|P1|NOT COMPLETED|Period 2||0
5215796|NCT00971633|12825307|P6|COMPLETED|Period 2||2
5215797|NCT00971633|12825308|P5|COMPLETED|Period 2||2
5215798|NCT00971633|12825309|P4|COMPLETED|Period 2||2
5215799|NCT00971633|12825310|P3|COMPLETED|Period 2||2
5215800|NCT00971633|12825311|P2|COMPLETED|Period 2||2
5215801|NCT00971633|12825312|P1|COMPLETED|Period 2||2
5215802|NCT00971633|12825307|P6|STARTED|Period 2||2
5215803|NCT00971633|12825308|P5|STARTED|Period 2||2
5215804|NCT00971633|12825309|P4|STARTED|Period 2||2
5215805|NCT00971633|12825310|P3|STARTED|Period 2||2
5215806|NCT00971633|12825311|P2|STARTED|Period 2||2
5215807|NCT00971633|12825312|P1|STARTED|Period 2||2
5215808|NCT00971633|12825307|P6|NOT COMPLETED|Period 1||0
5215809|NCT00971633|12825308|P5|NOT COMPLETED|Period 1||0
5215810|NCT00971633|12825309|P4|NOT COMPLETED|Period 1||0
5215811|NCT00971633|12825310|P3|NOT COMPLETED|Period 1||0
5215812|NCT00971633|12825311|P2|NOT COMPLETED|Period 1||0
5215813|NCT00971633|12825312|P1|NOT COMPLETED|Period 1||0
5215814|NCT00971633|12825307|P6|COMPLETED|Period 1||2
5215815|NCT00971633|12825308|P5|COMPLETED|Period 1||2
5215816|NCT00971633|12825309|P4|COMPLETED|Period 1||2
5215817|NCT00971633|12825310|P3|COMPLETED|Period 1||2
5215818|NCT00971633|12825311|P2|COMPLETED|Period 1||2
5215819|NCT00971633|12825312|P1|COMPLETED|Period 1||2
5215820|NCT00971633|12825307|P6|STARTED|Period 1||2
5215821|NCT00971633|12825308|P5|STARTED|Period 1||2
5215822|NCT00971633|12825309|P4|STARTED|Period 1||2
5215823|NCT00971633|12825310|P3|STARTED|Period 1||2
5215824|NCT00971633|12825311|P2|STARTED|Period 1||2
5215825|NCT00971633|12825312|P1|STARTED|Period 1||2
5215826|NCT00971620|12825325|P2|NOT COMPLETED|Overall Study||0
5215827|NCT00971620|12825326|P1|NOT COMPLETED|Overall Study||0
5215828|NCT00971620|12825325|P2|COMPLETED|Overall Study||9
5215829|NCT00971620|12825326|P1|COMPLETED|Overall Study||9
5215830|NCT00971620|12825325|P2|STARTED|Overall Study||9
5215831|NCT00971620|12825326|P1|STARTED|Overall Study||9
5215832|NCT00971425|12825358|P2|NOT COMPLETED|Overall Study||2
5215833|NCT00971425|12825359|P1|NOT COMPLETED|Overall Study||1
5215834|NCT00971425|12825358|P2|COMPLETED|Overall Study||71
5215835|NCT00971425|12825359|P1|COMPLETED|Overall Study||71
5215836|NCT00971425|12825358|P2|STARTED|Overall Study||73
5215837|NCT00971425|12825359|P1|STARTED|Overall Study||72
5215838|NCT00971321|12825395|P2|NOT COMPLETED|Up to Month 11-12||3
5215839|NCT00971321|12825396|P1|NOT COMPLETED|Up to Month 11-12||5
5215840|NCT00971321|12825395|P2|COMPLETED|Up to Month 11-12||50
5215841|NCT00971321|12825396|P1|COMPLETED|Up to Month 11-12||99
5215842|NCT00971321|12825395|P2|STARTED|Up to Month 11-12||53
5215843|NCT00971321|12825396|P1|STARTED|Up to Month 11-12||104
5215844|NCT00971321|12825395|P2|NOT COMPLETED|Up to Month 7||2
5215845|NCT00971321|12825396|P1|NOT COMPLETED|Up to Month 7||4
5215846|NCT00971321|12825395|P2|COMPLETED|Up to Month 7||51
5215847|NCT00971321|12825396|P1|COMPLETED|Up to Month 7||100
5215848|NCT00971321|12825395|P2|STARTED|Up to Month 7||53
5215849|NCT00971321|12825396|P1|STARTED|Up to Month 7||104
5215850|NCT00971321|12825395|P2|NOT COMPLETED|Up to Day 42||0
5215851|NCT00971321|12825396|P1|NOT COMPLETED|Up to Day 42||0
5215852|NCT00971321|12825395|P2|COMPLETED|Up to Day 42||53
5215853|NCT00971321|12825396|P1|COMPLETED|Up to Day 42||104
5215854|NCT00971321|12825395|P2|STARTED|Up to Day 42||53
5215855|NCT00971321|12825396|P1|STARTED|Up to Day 42||104
5215856|NCT00971295|12825446|P2|NOT COMPLETED|Overall Study||1
5215857|NCT00971295|12825447|P1|NOT COMPLETED|Overall Study||0
5215858|NCT00971295|12825446|P2|COMPLETED|Overall Study||9
5215859|NCT00971295|12825447|P1|COMPLETED|Overall Study||10
5215860|NCT00971295|12825446|P2|STARTED|Overall Study||10
5215861|NCT00971295|12825447|P1|STARTED|Overall Study||10
5215862|NCT00971282|12825457|P1|NOT COMPLETED|Overall Study||0
5215863|NCT00971282|12825457|P1|COMPLETED|Overall Study||30
5215864|NCT00971282|12825457|P1|STARTED|Overall Study||30
5215865|NCT00971243|12825476|P5|NOT COMPLETED|Open-label Period||6
5215866|NCT00971243|12825477|P4|NOT COMPLETED|Open-label Period||10
5215867|NCT00971243|12825478|P3|NOT COMPLETED|Open-label Period||5
5215868|NCT00971243|12825479|P2|NOT COMPLETED|Open-label Period||10
5215869|NCT00971243|12825480|P1|NOT COMPLETED|Open-label Period||8
5215870|NCT00971243|12825476|P5|COMPLETED|Open-label Period||64
5215871|NCT00971243|12825477|P4|COMPLETED|Open-label Period||64
5215872|NCT00971243|12825478|P3|COMPLETED|Open-label Period||66
5215873|NCT00971243|12825479|P2|COMPLETED|Open-label Period||71
5215874|NCT00971243|12825480|P1|COMPLETED|Open-label Period||60
5215875|NCT00971243|12825476|P5|STARTED|Open-label Period||70
5215876|NCT00971243|12825477|P4|STARTED|Open-label Period||74
5215877|NCT00971243|12825478|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
5215878|NCT00971243|12825479|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
5215879|NCT00971243|12825480|P1|STARTED|Open-label Period||68
5215880|NCT00971243|12825476|P5|NOT COMPLETED|Double Blind Period||18
5215881|NCT00971243|12825477|P4|NOT COMPLETED|Double Blind Period||14
5215882|NCT00971243|12825478|P3|NOT COMPLETED|Double Blind Period||19
5215883|NCT00971243|12825479|P2|NOT COMPLETED|Double Blind Period||11
5215884|NCT00971243|12825480|P1|NOT COMPLETED|Double Blind Period||19
5215885|NCT00971243|12825476|P5|COMPLETED|Double Blind Period||70
5215886|NCT00971243|12825477|P4|COMPLETED|Double Blind Period||74
5215887|NCT00971243|12825478|P3|COMPLETED|Double Blind Period||72
5215888|NCT00971243|12825479|P2|COMPLETED|Double Blind Period||82
5215889|NCT00971243|12825480|P1|COMPLETED|Double Blind Period||68
5215890|NCT00971243|12825476|P5|STARTED|Double Blind Period||88
5215891|NCT00971243|12825477|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
5215892|NCT00971243|12825478|P3|STARTED|Double Blind Period||91
5215893|NCT00971243|12825479|P2|STARTED|Double Blind Period||93
5215894|NCT00971243|12825480|P1|STARTED|Double Blind Period||87
5215895|NCT00971204|12825497|P1|NOT COMPLETED|Overall Study||24
5215896|NCT00971204|12825497|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
5215897|NCT00971204|12825497|P1|Treated|Overall Study||86
5215898|NCT00971204|12825497|P1|STARTED|Overall Study|100 enrolled participants|100
5215899|NCT00971048|12825505|P4|NOT COMPLETED|Overall Study||2
5215900|NCT00971048|12825506|P3|NOT COMPLETED|Overall Study||1
5215901|NCT00971048|12825507|P2|NOT COMPLETED|Overall Study||2
5215902|NCT00971048|12825508|P1|NOT COMPLETED|Overall Study||1
5215903|NCT00971048|12825505|P4|COMPLETED|Overall Study||11
5215904|NCT00971048|12825506|P3|COMPLETED|Overall Study||11
5215905|NCT00971048|12825507|P2|COMPLETED|Overall Study||31
5215906|NCT00971048|12825508|P1|COMPLETED|Overall Study||29
5215907|NCT00971048|12825505|P4|STARTED|Overall Study||13
5215908|NCT00971048|12825506|P3|STARTED|Overall Study||12
5215909|NCT00971048|12825507|P2|STARTED|Overall Study||33
5215910|NCT00971048|12825508|P1|STARTED|Overall Study||30
5215911|NCT00970944|12825532|P2|NOT COMPLETED|Overall Study||2
5215912|NCT00970944|12825533|P1|NOT COMPLETED|Overall Study||1
5215913|NCT00970944|12825532|P2|COMPLETED|Overall Study||95
5215914|NCT00970944|12825533|P1|COMPLETED|Overall Study||86
5215915|NCT00970944|12825532|P2|STARTED|Overall Study||97
5215916|NCT00970944|12825533|P1|STARTED|Overall Study||87
5215917|NCT00970853|12825543|P2|NOT COMPLETED|Overall Study||0
5215918|NCT00970853|12825544|P1|NOT COMPLETED|Overall Study||0
5215919|NCT00970853|12825543|P2|COMPLETED|Overall Study||98
5215920|NCT00970853|12825544|P1|COMPLETED|Overall Study||89
5215921|NCT00970853|12825543|P2|STARTED|Overall Study||98
5215922|NCT00970853|12825544|P1|STARTED|Overall Study||89
5215923|NCT00970814|12825568|P2|NOT COMPLETED|Overall Study||14
5215924|NCT00970814|12825569|P1|NOT COMPLETED|Overall Study||8
5215925|NCT00970814|12825568|P2|COMPLETED|Overall Study||50
5215926|NCT00970814|12825569|P1|COMPLETED|Overall Study||58
5215927|NCT00970814|12825568|P2|STARTED|Overall Study||64
5215928|NCT00970814|12825569|P1|STARTED|Overall Study||66
5215929|NCT00970736|12825579|P1|NOT COMPLETED|Overall Study||2
5215930|NCT00970736|12825579|P1|COMPLETED|Overall Study||18
5215931|NCT00970736|12825579|P1|STARTED|Overall Study||20
5215932|NCT00970684|12825585|P1|NOT COMPLETED|Overall Study||10
5215933|NCT00970684|12825585|P1|COMPLETED|Overall Study||3
5215934|NCT00970684|12825585|P1|STARTED|Overall Study||13
5215935|NCT00970632|12825594|P3|NOT COMPLETED|Overall Study||18
5215936|NCT00970632|12825595|P2|NOT COMPLETED|Overall Study||15
5215937|NCT00970632|12825596|P1|NOT COMPLETED|Overall Study||24
5215938|NCT00970632|12825594|P3|COMPLETED|Overall Study||150
5215939|NCT00970632|12825595|P2|COMPLETED|Overall Study||156
5215940|NCT00970632|12825596|P1|COMPLETED|Overall Study||148
5215941|NCT00970632|12825594|P3|STARTED|Overall Study||168
5215942|NCT00970632|12825595|P2|STARTED|Overall Study||171
5215943|NCT00970632|12825596|P1|STARTED|Overall Study||172
5215944|NCT00970606|12825654|P2|NOT COMPLETED|Overall Study||0
5215945|NCT00970606|12825655|P1|NOT COMPLETED|Overall Study||0
5215946|NCT00970606|12825654|P2|COMPLETED|Overall Study||3
5215947|NCT00970606|12825655|P1|COMPLETED|Overall Study||4
5215948|NCT00970606|12825654|P2|STARTED|Overall Study||3
5215949|NCT00970606|12825655|P1|STARTED|Overall Study||4
5215950|NCT00970502|12825661|P1|NOT COMPLETED|Overall Study||1
5215951|NCT00970502|12825661|P1|COMPLETED|Overall Study||14
5215952|NCT00970502|12825661|P1|STARTED|Overall Study||15
5215953|NCT00970489|12825672|P2|NOT COMPLETED|Overall Study||41
5215954|NCT00970489|12825673|P1|NOT COMPLETED|Overall Study||54
5215955|NCT00970489|12825672|P2|COMPLETED|Overall Study||717
5215956|NCT00970489|12825673|P1|COMPLETED|Overall Study||704
5215957|NCT00970489|12825672|P2|STARTED|Overall Study||758
5215958|NCT00970489|12825673|P1|STARTED|Overall Study||758
5215959|NCT00970359|12825685|P1|NOT COMPLETED|Overall Study||4
5215960|NCT00970359|12825685|P1|COMPLETED|Overall Study||20
5215961|NCT00970359|12825685|P1|STARTED|Overall Study||24
5215962|NCT00970320|12825696|P5|NOT COMPLETED|Overall Study||540
5215963|NCT00970320|12825697|P4|NOT COMPLETED|Overall Study||14
5215964|NCT00970320|12825698|P3|NOT COMPLETED|Overall Study||13
5215965|NCT00970320|12825699|P2|NOT COMPLETED|Overall Study||11
5215966|NCT00970320|12825700|P1|NOT COMPLETED|Overall Study||0
5215967|NCT00970320|12825696|P5|COMPLETED|Overall Study||1031
5215968|NCT00970320|12825697|P4|COMPLETED|Overall Study||36
5215969|NCT00970320|12825698|P3|COMPLETED|Overall Study||35
5215970|NCT00970320|12825699|P2|COMPLETED|Overall Study||13
5215971|NCT00970320|12825700|P1|COMPLETED|Overall Study||25
5215972|NCT00970320|12825696|P5|STARTED|Overall Study||1571
5215973|NCT00970320|12825697|P4|STARTED|Overall Study||50
5215974|NCT00970320|12825698|P3|STARTED|Overall Study||48
5215975|NCT00970320|12825699|P2|STARTED|Overall Study||24
5215976|NCT00970320|12825700|P1|STARTED|Overall Study||25
5215977|NCT00970307|12825715|P3|NOT COMPLETED|Overall Study||2
5215978|NCT00970307|12825716|P2|NOT COMPLETED|Overall Study||3
5215979|NCT00970307|12825717|P1|NOT COMPLETED|Overall Study||3
5215980|NCT00970307|12825715|P3|COMPLETED|Overall Study||139
5215981|NCT00970307|12825716|P2|COMPLETED|Overall Study||136
5215982|NCT00970307|12825717|P1|COMPLETED|Overall Study||138
5215983|NCT00970307|12825715|P3|STARTED|Overall Study||141
5215984|NCT00970307|12825716|P2|STARTED|Overall Study||139
5215985|NCT00970307|12825717|P1|STARTED|Overall Study||141
5215986|NCT00970294|12825791|P1|NOT COMPLETED|Overall Study||5
5215987|NCT00970294|12825791|P1|COMPLETED|Overall Study||6
5215988|NCT00970294|12825791|P1|STARTED|Overall Study||11
5215989|NCT00970281|12825799|P2|NOT COMPLETED|Overall Study||16
5215990|NCT00970281|12825800|P1|NOT COMPLETED|Overall Study||2
5215991|NCT00970281|12825799|P2|COMPLETED|Overall Study||29
5215992|NCT00970281|12825800|P1|COMPLETED|Overall Study||44
5215993|NCT00970281|12825799|P2|Full Analysis Set|Overall Study||45
5215994|NCT00970281|12825800|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
5215995|NCT00970281|12825799|P2|STARTED|Overall Study||45
5215996|NCT00970281|12825800|P1|STARTED|Overall Study||46
5215997|NCT00970268|12825818|P2|NOT COMPLETED|Overall Study||49
5215998|NCT00970268|12825819|P1|NOT COMPLETED|Overall Study||43
5215999|NCT00970268|12825818|P2|COMPLETED|Overall Study||103
5216000|NCT00970268|12825819|P1|COMPLETED|Overall Study||96
5216001|NCT00970268|12825818|P2|STARTED|Overall Study||152
5216002|NCT00970268|12825819|P1|STARTED|Overall Study||139
5216003|NCT00970216|12825833|P1|NOT COMPLETED|Overall Study||80
5216004|NCT00970216|12825833|P1|COMPLETED|Overall Study||80
5216005|NCT00970216|12825833|P1|STARTED|Overall Study||160
5216006|NCT00970203|12825839|P2|NOT COMPLETED|Overall Study||0
5216007|NCT00970203|12825840|P1|NOT COMPLETED|Overall Study||0
5216008|NCT00970203|12825839|P2|COMPLETED|Overall Study||6
5216009|NCT00970203|12825840|P1|COMPLETED|Overall Study||7
5216010|NCT00970203|12825839|P2|STARTED|Overall Study||6
5216011|NCT00970203|12825840|P1|STARTED|Overall Study||7
5216012|NCT00970073|12825853|P3|NOT COMPLETED|Overall Study||0
5216013|NCT00970073|12825854|P2|NOT COMPLETED|Overall Study||0
5216014|NCT00970073|12825855|P1|NOT COMPLETED|Overall Study||0
5216015|NCT00970073|12825853|P3|COMPLETED|Overall Study||10
5216016|NCT00970073|12825854|P2|COMPLETED|Overall Study||10
5216017|NCT00970073|12825855|P1|COMPLETED|Overall Study||10
5216018|NCT00970073|12825853|P3|STARTED|Overall Study||10
5216019|NCT00970073|12825854|P2|STARTED|Overall Study||10
5216020|NCT00970073|12825855|P1|STARTED|Overall Study||10
5216021|NCT00969878|12825874|P2|NOT COMPLETED|Overall Study||26
5216022|NCT00969878|12825875|P1|NOT COMPLETED|Overall Study||30
5216023|NCT00969878|12825874|P2|COMPLETED|Overall Study||126
5216024|NCT00969878|12825875|P1|COMPLETED|Overall Study||118
5216025|NCT00969878|12825874|P2|STARTED|Overall Study||152
5216026|NCT00969878|12825875|P1|STARTED|Overall Study||148
5216027|NCT00969761|12825895|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216028|NCT00969761|12825896|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216029|NCT00969761|12825897|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
5216030|NCT00969761|12825898|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
5216031|NCT00969761|12825899|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
5216032|NCT00969761|12825900|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216033|NCT00969761|12825901|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216034|NCT00969761|12825902|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216035|NCT00969761|12825903|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
5216036|NCT00969761|12825904|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
5216037|NCT00969761|12825905|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
5216038|NCT00969761|12825906|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
5216039|NCT00969761|12825895|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216040|NCT00969761|12825896|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216041|NCT00969761|12825897|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216042|NCT00969761|12825898|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216043|NCT00969761|12825899|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216044|NCT00969761|12825900|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216045|NCT00969761|12825901|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216046|NCT00969761|12825902|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216047|NCT00969761|12825903|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216048|NCT00969761|12825904|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216049|NCT00969761|12825905|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216050|NCT00969761|12825906|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
5216051|NCT00969761|12825895|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216052|NCT00969761|12825896|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216053|NCT00969761|12825897|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
5216054|NCT00969761|12825898|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
5216055|NCT00969761|12825899|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
5216056|NCT00969761|12825900|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216057|NCT00969761|12825901|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216058|NCT00969761|12825902|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216059|NCT00969761|12825903|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
5216060|NCT00969761|12825904|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
5216061|NCT00969761|12825905|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
5216062|NCT00969761|12825906|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
5216063|NCT00969761|12825895|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216064|NCT00969761|12825896|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216065|NCT00969761|12825897|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
5216066|NCT00969761|12825898|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
5216067|NCT00969761|12825899|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216068|NCT00969761|12825900|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216069|NCT00969761|12825901|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216070|NCT00969761|12825902|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216071|NCT00969761|12825903|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
5216072|NCT00969761|12825904|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
5216073|NCT00969761|12825905|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
5216074|NCT00969761|12825906|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
5216075|NCT00969761|12825895|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216076|NCT00969761|12825896|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216077|NCT00969761|12825897|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
5216078|NCT00969761|12825898|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
5216079|NCT00969761|12825899|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
5216080|NCT00969761|12825900|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216081|NCT00969761|12825901|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216082|NCT00969761|12825902|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216083|NCT00969761|12825903|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
5216084|NCT00969761|12825904|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
5216085|NCT00969761|12825905|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
5216086|NCT00969761|12825906|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
5216087|NCT00969761|12825895|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216088|NCT00969761|12825896|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216089|NCT00969761|12825897|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216090|NCT00969761|12825898|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
5216091|NCT00969761|12825899|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
5216092|NCT00969761|12825900|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216093|NCT00969761|12825901|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216094|NCT00969761|12825902|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216095|NCT00969761|12825903|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
5216096|NCT00969761|12825904|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
5216097|NCT00969761|12825905|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216098|NCT00969761|12825906|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
5216099|NCT00969709|12826212|P4|NOT COMPLETED|Overall Study||63
5216100|NCT00969709|12826213|P3|NOT COMPLETED|Overall Study||58
5216101|NCT00969709|12826214|P2|NOT COMPLETED|Overall Study||48
5216102|NCT00969709|12826215|P1|NOT COMPLETED|Overall Study||38
5216103|NCT00969709|12826212|P4|COMPLETED|Overall Study||117
5216104|NCT00969709|12826213|P3|COMPLETED|Overall Study||121
5216105|NCT00969709|12826214|P2|COMPLETED|Overall Study||130
5216106|NCT00969709|12826215|P1|COMPLETED|Overall Study||138
5216107|NCT00969709|12826212|P4|STARTED|Overall Study||180
5216108|NCT00969709|12826213|P3|STARTED|Overall Study||179
5216109|NCT00969709|12826214|P2|STARTED|Overall Study||178
5216110|NCT00969709|12826215|P1|STARTED|Overall Study||176
5216111|NCT00969618|12826229|P1|NOT COMPLETED|Overall Study||78
5216112|NCT00969618|12826229|P1|COMPLETED|Overall Study||133
5216113|NCT00969618|12826229|P1|STARTED|Overall Study||211
5216114|NCT00969553|12826249|P9|NOT COMPLETED|Overall Study||3
5216115|NCT00969553|12826250|P8|NOT COMPLETED|Overall Study||14
5216116|NCT00969553|12826251|P7|NOT COMPLETED|Overall Study||4
5216117|NCT00969553|12826252|P6|NOT COMPLETED|Overall Study||4
5216118|NCT00969553|12826253|P5|NOT COMPLETED|Overall Study||3
5216119|NCT00969553|12826254|P4|NOT COMPLETED|Overall Study||16
5216120|NCT00969553|12826255|P3|NOT COMPLETED|Overall Study||6
5216121|NCT00969553|12826256|P2|NOT COMPLETED|Overall Study||3
5216122|NCT00969553|12826257|P1|NOT COMPLETED|Overall Study||3
5216123|NCT00969553|12826249|P9|COMPLETED|Overall Study||0
5216124|NCT00969553|12826250|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
5216125|NCT00969553|12826251|P7|COMPLETED|Overall Study||0
5216126|NCT00969553|12826252|P6|COMPLETED|Overall Study||0
5216127|NCT00969553|12826253|P5|COMPLETED|Overall Study||0
5216128|NCT00969553|12826254|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
5216129|NCT00969553|12826255|P3|COMPLETED|Overall Study||0
5216130|NCT00969553|12826256|P2|COMPLETED|Overall Study||0
5216131|NCT00969553|12826257|P1|COMPLETED|Overall Study||0
5216132|NCT00969553|12826249|P9|STARTED|Overall Study||3
5216133|NCT00969553|12826250|P8|STARTED|Overall Study||16
5216134|NCT00969553|12826251|P7|STARTED|Overall Study||4
5216135|NCT00969553|12826252|P6|STARTED|Overall Study||4
5216136|NCT00969553|12826253|P5|STARTED|Overall Study||3
5216137|NCT00969553|12826254|P4|STARTED|Overall Study||17
5216138|NCT00969553|12826255|P3|STARTED|Overall Study||6
5216139|NCT00969553|12826256|P2|STARTED|Overall Study||3
5216140|NCT00969553|12826257|P1|STARTED|Overall Study||3
5216141|NCT00969540|12826400|P2|NOT COMPLETED|Overall Study||1
5216142|NCT00969540|12826401|P1|NOT COMPLETED|Overall Study||1
5216143|NCT00969540|12826400|P2|COMPLETED|Overall Study||3
5216144|NCT00969540|12826401|P1|COMPLETED|Overall Study||3
5216145|NCT00969540|12826400|P2|STARTED|Overall Study||4
5216146|NCT00969540|12826401|P1|STARTED|Overall Study||4
5216147|NCT00969501|12826419|P1|NOT COMPLETED|Overall Study||5
5216148|NCT00969501|12826419|P1|COMPLETED|Overall Study||27
5216149|NCT00969501|12826419|P1|STARTED|Overall Study||32
5216150|NCT00969436|12826426|P3|NOT COMPLETED|Overall Study||11
5216151|NCT00969436|12826427|P2|NOT COMPLETED|Overall Study||21
5216152|NCT00969436|12826428|P1|NOT COMPLETED|Overall Study||25
5216153|NCT00969436|12826426|P3|COMPLETED|Overall Study||79
5216154|NCT00969436|12826427|P2|COMPLETED|Overall Study||159
5216155|NCT00969436|12826428|P1|COMPLETED|Overall Study||155
5216156|NCT00969436|12826426|P3|STARTED|Overall Study||90
5216157|NCT00969436|12826427|P2|STARTED|Overall Study||180
5216158|NCT00969436|12826428|P1|STARTED|Overall Study||180
5216159|NCT00969332|12826460|P1|NOT COMPLETED|Overall Study||11
5216160|NCT00969332|12826460|P1|COMPLETED|Overall Study||51
5216161|NCT00969332|12826460|P1|STARTED|Overall Study||62
5216162|NCT00969280|12826476|P2|NOT COMPLETED|Overall Study||3
5216163|NCT00969280|12826477|P1|NOT COMPLETED|Overall Study||2
5216164|NCT00969280|12826476|P2|COMPLETED|Overall Study||18
5216165|NCT00969280|12826477|P1|COMPLETED|Overall Study||19
5216166|NCT00969280|12826476|P2|STARTED|Overall Study||21
5216167|NCT00969280|12826477|P1|STARTED|Overall Study||21
5216168|NCT00969228|12826485|P2|NOT COMPLETED|Overall Study||14
5216169|NCT00969228|12826486|P1|NOT COMPLETED|Overall Study||43
5216170|NCT00969228|12826485|P2|COMPLETED|Overall Study||162
5216171|NCT00969228|12826486|P1|COMPLETED|Overall Study||465
5216172|NCT00969228|12826485|P2|STARTED|Overall Study||176
5216173|NCT00969228|12826486|P1|STARTED|Overall Study||508
5216174|NCT00969150|12826504|P2|NOT COMPLETED|Overall Study||40
5216175|NCT00969150|12826505|P1|NOT COMPLETED|Overall Study||33
5216176|NCT00969150|12826504|P2|COMPLETED|Overall Study||135
5216177|NCT00969150|12826505|P1|COMPLETED|Overall Study||149
5216178|NCT00969150|12826504|P2|STARTED|Overall Study||175
5216179|NCT00969150|12826505|P1|STARTED|Overall Study||182
5216180|NCT00969124|12826513|P1|NOT COMPLETED|Overall Study||30
5216181|NCT00969124|12826513|P1|COMPLETED|Overall Study||298
5216182|NCT00969124|12826513|P1|STARTED|Overall Study||328
5216183|NCT00968981|12826522|P3|NOT COMPLETED|Overall Study||22
5216184|NCT00968981|12826523|P2|NOT COMPLETED|Overall Study||22
5216185|NCT00968981|12826524|P1|NOT COMPLETED|Overall Study||22
5216186|NCT00968981|12826522|P3|COMPLETED|Overall Study||0
5216187|NCT00968981|12826523|P2|COMPLETED|Overall Study||0
5216188|NCT00968981|12826524|P1|COMPLETED|Overall Study||1
5216189|NCT00968981|12826522|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
5216190|NCT00968981|12826523|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
5216191|NCT00968981|12826524|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
5216192|NCT00968981|12826522|P3|STARTED|Overall Study||22
5216193|NCT00968981|12826523|P2|STARTED|Overall Study||22
5216194|NCT00968981|12826524|P1|STARTED|Overall Study||23
5216195|NCT00968968|12826562|P2|NOT COMPLETED|Overall Study||14
5216196|NCT00968968|12826563|P1|NOT COMPLETED|Overall Study||16
5216197|NCT00968968|12826562|P2|COMPLETED|Overall Study||3
5216198|NCT00968968|12826563|P1|COMPLETED|Overall Study||4
5216199|NCT00968968|12826562|P2|STARTED|Overall Study||17
5216200|NCT00968968|12826563|P1|STARTED|Overall Study||20
5216201|NCT00968890|12826580|P2|NOT COMPLETED|Overall Study||0
5216202|NCT00968890|12826581|P1|NOT COMPLETED|Overall Study||0
5216203|NCT00968890|12826580|P2|COMPLETED|Overall Study||84
5216204|NCT00968890|12826581|P1|COMPLETED|Overall Study||84
5216205|NCT00968890|12826580|P2|STARTED|Overall Study||84
5216206|NCT00968890|12826581|P1|STARTED|Overall Study||84
5216207|NCT00968864|12826609|P1|NOT COMPLETED|Overall Study||1
5216208|NCT00968864|12826609|P1|COMPLETED|Overall Study||52
5216209|NCT00968864|12826609|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
5216210|NCT00968838|12826627|P2|NOT COMPLETED|Overall Study||0
5216211|NCT00968838|12826628|P1|NOT COMPLETED|Overall Study||0
5216212|NCT00968838|12826627|P2|COMPLETED|Overall Study||58
5216213|NCT00968838|12826628|P1|COMPLETED|Overall Study||50
5216214|NCT00968838|12826627|P2|STARTED|Overall Study||58
5216215|NCT00968838|12826628|P1|STARTED|Overall Study||50
5216216|NCT00968812|12826637|P3|NOT COMPLETED|Overall Study||168
5216217|NCT00968812|12826638|P2|NOT COMPLETED|Overall Study||162
5216218|NCT00968812|12826639|P1|NOT COMPLETED|Overall Study||140
5216219|NCT00968812|12826637|P3|COMPLETED|Overall Study||314
5216220|NCT00968812|12826638|P2|COMPLETED|Overall Study||323
5216221|NCT00968812|12826639|P1|COMPLETED|Overall Study||343
5216222|NCT00968812|12826637|P3|STARTED|Overall Study||482
5216223|NCT00968812|12826638|P2|STARTED|Overall Study||485
5216224|NCT00968812|12826639|P1|STARTED|Overall Study||483
5216225|NCT00968799|12826659|P1|NOT COMPLETED|Overall Study||2
5216226|NCT00968799|12826659|P1|COMPLETED|Overall Study||4
5216227|NCT00968799|12826659|P1|STARTED|Overall Study||6
5216228|NCT00968708|12826669|P2|NOT COMPLETED|Overall Study||298
5216229|NCT00968708|12826670|P1|NOT COMPLETED|Overall Study||318
5216230|NCT00968708|12826669|P2|COMPLETED|Overall Study||2403
5216231|NCT00968708|12826670|P1|COMPLETED|Overall Study||2361
5216232|NCT00968708|12826669|P2|Treated|Overall Study||2698
5216233|NCT00968708|12826670|P1|Treated|Overall Study||2676
5216234|NCT00968708|12826669|P2|STARTED|Overall Study||2701
5216235|NCT00968708|12826670|P1|STARTED|Overall Study||2679
5216236|NCT00968669|12826682|P4|NOT COMPLETED|Overall Study||9
5216237|NCT00968669|12826683|P3|NOT COMPLETED|Overall Study||11
5216238|NCT00968669|12826684|P2|NOT COMPLETED|Overall Study||18
5216239|NCT00968669|12826685|P1|NOT COMPLETED|Overall Study||18
5216240|NCT00968669|12826682|P4|COMPLETED|Overall Study||72
5216241|NCT00968669|12826683|P3|COMPLETED|Overall Study||72
5216242|NCT00968669|12826684|P2|COMPLETED|Overall Study||63
5216243|NCT00968669|12826685|P1|COMPLETED|Overall Study||64
5216244|NCT00968669|12826682|P4|STARTED|Overall Study||81
5216245|NCT00968669|12826683|P3|STARTED|Overall Study||83
5216246|NCT00968669|12826684|P2|STARTED|Overall Study||81
5216247|NCT00968669|12826685|P1|STARTED|Overall Study||82
5216248|NCT00968617|12826775|P1|NOT COMPLETED|Overall Study||6
5216249|NCT00968617|12826775|P1|COMPLETED|Overall Study||1
5216250|NCT00968617|12826775|P1|STARTED|Overall Study||7
5216251|NCT00968539|12826789|P2|NOT COMPLETED|Overall Study||0
5216252|NCT00968539|12826790|P1|NOT COMPLETED|Overall Study||1
5216253|NCT00968539|12826789|P2|COMPLETED|Overall Study||66
5216254|NCT00968539|12826790|P1|COMPLETED|Overall Study||63
5216255|NCT00968539|12826789|P2|STARTED|Overall Study||66
5216256|NCT00968539|12826790|P1|STARTED|Overall Study||64
5216257|NCT00968526|12826850|P2|NOT COMPLETED|Overall Study||0
5216258|NCT00968526|12826851|P1|NOT COMPLETED|Overall Study||3
5216259|NCT00968526|12826850|P2|COMPLETED|Overall Study||102
5216260|NCT00968526|12826851|P1|COMPLETED|Overall Study||135
5216261|NCT00968526|12826850|P2|STARTED|Overall Study||102
5216262|NCT00968526|12826851|P1|STARTED|Overall Study||138
5216263|NCT00968344|12826943|P2|NOT COMPLETED|Overall Study||11
5216264|NCT00968344|12826944|P1|NOT COMPLETED|Overall Study||10
5216265|NCT00968344|12826943|P2|COMPLETED|Overall Study||9
5216266|NCT00968344|12826944|P1|COMPLETED|Overall Study||10
5216267|NCT00968344|12826943|P2|STARTED|Overall Study|Includes screen fails|20
5216268|NCT00968344|12826944|P1|STARTED|Overall Study|Includes screen fails|20
5216269|NCT00968253|12826953|P3|NOT COMPLETED|Overall Study||7
5216270|NCT00968253|12826954|P2|NOT COMPLETED|Overall Study||3
5216271|NCT00968253|12826955|P1|NOT COMPLETED|Overall Study||0
5216272|NCT00968253|12826953|P3|COMPLETED|Overall Study||5
5216273|NCT00968253|12826954|P2|COMPLETED|Overall Study||6
5216274|NCT00968253|12826955|P1|COMPLETED|Overall Study||3
5216275|NCT00968253|12826953|P3|STARTED|Overall Study||12
5216276|NCT00968253|12826954|P2|STARTED|Overall Study||9
5216277|NCT00968253|12826955|P1|STARTED|Overall Study||3
5216278|NCT00968227|12826969|P1|NOT COMPLETED|Overall Study||0
5216279|NCT00968227|12826969|P1|COMPLETED|Overall Study||56
5216280|NCT00968227|12826969|P1|STARTED|Overall Study||56
5216281|NCT00968201|12826976|P3|NOT COMPLETED|Extension Study - (Period III)||280
5216282|NCT00968201|12826977|P2|NOT COMPLETED|Extension Study - (Period III)||124
5216283|NCT00968201|12826978|P1|NOT COMPLETED|Extension Study - (Period III)||0
5216284|NCT00968201|12826976|P3|COMPLETED|Extension Study - (Period III)||84
5216285|NCT00968201|12826977|P2|COMPLETED|Extension Study - (Period III)||33
5216286|NCT00968201|12826978|P1|COMPLETED|Extension Study - (Period III)||0
5216287|NCT00968201|12826976|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
5216288|NCT00968201|12826977|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
5216289|NCT00968201|12826978|P1|STARTED|Extension Study - (Period III)||0
5216290|NCT00968201|12826976|P3|NOT COMPLETED|Base Study - (Period II)||45
5216291|NCT00968201|12826977|P2|NOT COMPLETED|Base Study - (Period II)||0
5216292|NCT00968201|12826978|P1|NOT COMPLETED|Base Study - (Period II)||26
5216293|NCT00968201|12826976|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
5216294|NCT00968201|12826977|P2|COMPLETED|Base Study - (Period II)||0
5216295|NCT00968201|12826978|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
5216296|NCT00968201|12826976|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
5216297|NCT00968201|12826977|P2|STARTED|Base Study - (Period II)||0
5216298|NCT00968201|12826978|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
5216299|NCT00968149|12827039|P2|NOT COMPLETED|Overall Study||6
5216300|NCT00968149|12827040|P1|NOT COMPLETED|Overall Study||11
5216301|NCT00968149|12827039|P2|COMPLETED|Overall Study||127
5216302|NCT00968149|12827040|P1|COMPLETED|Overall Study||269
5216303|NCT00968149|12827039|P2|STARTED|Overall Study||133
5216304|NCT00968149|12827040|P1|STARTED|Overall Study||280
5216305|NCT00968071|12827060|P1|NOT COMPLETED|Overall Study||0
5216306|NCT00968071|12827060|P1|COMPLETED|Overall Study||71
5216307|NCT00968071|12827060|P1|STARTED|Overall Study||71
5216308|NCT00968032|12827064|P1|NOT COMPLETED|Overall Study||2
5216309|NCT00968032|12827064|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
5216310|NCT00968032|12827064|P1|STARTED|Overall Study||63
5216311|NCT00968019|12827068|P1|NOT COMPLETED|Overall Study||15
5216312|NCT00968019|12827068|P1|COMPLETED|Overall Study||303
5216313|NCT00968019|12827068|P1|STARTED|Overall Study||318
5216314|NCT00967993|12827089|P1|NOT COMPLETED|Overall Study||4
5216315|NCT00967993|12827089|P1|COMPLETED|Overall Study||18
5216316|NCT00967993|12827089|P1|STARTED|Overall Study||22
5216317|NCT00967941|12827096|P3|NOT COMPLETED|Overall Study||4
5216318|NCT00967941|12827097|P2|NOT COMPLETED|Overall Study||3
5216319|NCT00967941|12827098|P1|NOT COMPLETED|Overall Study||5
5216320|NCT00967941|12827096|P3|COMPLETED|Overall Study||56
5216321|NCT00967941|12827097|P2|COMPLETED|Overall Study||51
5216322|NCT00967941|12827098|P1|COMPLETED|Overall Study||62
5216323|NCT00967941|12827096|P3|STARTED|Overall Study||60
5216324|NCT00967941|12827097|P2|STARTED|Overall Study||54
5216325|NCT00967941|12827098|P1|STARTED|Overall Study||67
5216326|NCT00967798|12827108|P2|NOT COMPLETED|Overall Study||3
5216327|NCT00967798|12827109|P1|NOT COMPLETED|Overall Study||9
5216328|NCT00967798|12827108|P2|COMPLETED|Overall Study||13
5216329|NCT00967798|12827109|P1|COMPLETED|Overall Study||8
5216330|NCT00967798|12827108|P2|STARTED|Overall Study||16
5216331|NCT00967798|12827109|P1|STARTED|Overall Study||17
5216332|NCT00967694|12827123|P1|NOT COMPLETED|Overall Study||6
5216333|NCT00967694|12827123|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
5216334|NCT00967694|12827123|P1|STARTED|Overall Study||26
5216335|NCT00967668|12827130|P3|NOT COMPLETED|Overall Study||69
5216336|NCT00967668|12827131|P2|NOT COMPLETED|Overall Study||56
5216337|NCT00967668|12827132|P1|NOT COMPLETED|Overall Study||71
5216338|NCT00967668|12827130|P3|COMPLETED|Overall Study||90
5216339|NCT00967668|12827131|P2|COMPLETED|Overall Study||104
5216340|NCT00967668|12827132|P1|COMPLETED|Overall Study||91
5216341|NCT00967668|12827130|P3|18-mo Assessment|Overall Study||92
5216342|NCT00967668|12827131|P2|18-mo Assessment|Overall Study||102
5216343|NCT00967668|12827132|P1|18-mo Assessment|Overall Study||95
5216344|NCT00967668|12827130|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
5216345|NCT00967668|12827131|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
5216346|NCT00967668|12827132|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
5216347|NCT00967668|12827130|P3|3-mo Assessment|Overall Study||115
5216348|NCT00967668|12827131|P2|3-mo Assessment|Overall Study||127
5216349|NCT00967668|12827132|P1|3-mo Assessment|Overall Study||131
5216350|NCT00967668|12827130|P3|STARTED|Overall Study||159
5216351|NCT00967668|12827131|P2|STARTED|Overall Study||160
5216352|NCT00967668|12827132|P1|STARTED|Overall Study||162
5216353|NCT00967616|12827145|P2|NOT COMPLETED|Overall Study||50
5216354|NCT00967616|12827146|P1|NOT COMPLETED|Overall Study||50
5216355|NCT00967616|12827145|P2|COMPLETED|Overall Study||0
5216356|NCT00967616|12827146|P1|COMPLETED|Overall Study||0
5216357|NCT00967616|12827145|P2|STARTED|Overall Study||50
5216358|NCT00967616|12827146|P1|STARTED|Overall Study||50
5216359|NCT00967551|12827162|P2|NOT COMPLETED|Overall Study||0
5216360|NCT00967551|12827163|P1|NOT COMPLETED|Overall Study||0
5216361|NCT00967551|12827162|P2|COMPLETED|Overall Study||75
5216362|NCT00967551|12827163|P1|COMPLETED|Overall Study||68
5216363|NCT00967551|12827162|P2|STARTED|Overall Study||75
5216364|NCT00967551|12827163|P1|STARTED|Overall Study||68
5216365|NCT00967486|12827173|P2|NOT COMPLETED|Overall Study||0
5216366|NCT00967486|12827174|P1|NOT COMPLETED|Overall Study||0
5216367|NCT00967486|12827173|P2|COMPLETED|Overall Study||102
5216368|NCT00967486|12827174|P1|COMPLETED|Overall Study||98
5216369|NCT00967486|12827173|P2|STARTED|Overall Study||102
5216370|NCT00967486|12827174|P1|STARTED|Overall Study||98
5216371|NCT00967473|12827180|P1|NOT COMPLETED|Overall Study||0
5216372|NCT00967473|12827180|P1|COMPLETED|Overall Study||15
5216373|NCT00967473|12827180|P1|STARTED|Overall Study||15
5216374|NCT00967447|12827186|P1|NOT COMPLETED|Overall Study||0
5216375|NCT00967447|12827186|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
5216376|NCT00967447|12827186|P1|STARTED|Overall Study|there are no collected data in CRF|2
5216377|NCT00967369|12827195|P2|NOT COMPLETED|Overall Study||0
5216378|NCT00967369|12827196|P1|NOT COMPLETED|Overall Study||0
5216379|NCT00967369|12827195|P2|COMPLETED|Overall Study||10
5216380|NCT00967369|12827196|P1|COMPLETED|Overall Study||10
5216381|NCT00967369|12827195|P2|Refractory|Overall Study||3
5216382|NCT00967369|12827196|P1|Refractory|Overall Study||6
5216383|NCT00967369|12827195|P2|Relapsed|Overall Study||7
5216384|NCT00967369|12827196|P1|Relapsed|Overall Study||4
5216385|NCT00967369|12827195|P2|STARTED|Overall Study||10
5216386|NCT00967369|12827196|P1|STARTED|Overall Study||10
5216387|NCT00967330|12827214|P2|NOT COMPLETED|Overall Study||60
5216388|NCT00967330|12827215|P1|NOT COMPLETED|Overall Study||122
5216389|NCT00967330|12827214|P2|COMPLETED|Overall Study||0
5216390|NCT00967330|12827215|P1|COMPLETED|Overall Study||0
5216391|NCT00967330|12827214|P2|STARTED|Overall Study||60
5216392|NCT00967330|12827215|P1|STARTED|Overall Study||122
5216393|NCT00967226|12827245|P2|NOT COMPLETED|Overall Study||6
5216394|NCT00967226|12827246|P1|NOT COMPLETED|Overall Study||2
5216395|NCT00967226|12827245|P2|COMPLETED|Overall Study||2
5216396|NCT00967226|12827246|P1|COMPLETED|Overall Study||9
5216397|NCT00967226|12827245|P2|STARTED|Overall Study||8
5216398|NCT00967226|12827246|P1|STARTED|Overall Study||11
5216399|NCT00967044|12827276|P1|NOT COMPLETED|Overall Study||0
5216400|NCT00967044|12827276|P1|COMPLETED|Overall Study||30
5216401|NCT00967044|12827276|P1|STARTED|Overall Study||30
5216402|NCT00967018|12827280|P1|NOT COMPLETED|Overall Study||21
5216403|NCT00967018|12827280|P1|COMPLETED|Overall Study||56
5216404|NCT00967018|12827280|P1|STARTED|Overall Study||77
5216405|NCT00967005|12827289|P2|NOT COMPLETED|Overall Study||10
5216406|NCT00967005|12827290|P1|NOT COMPLETED|Overall Study||7
5216407|NCT00967005|12827289|P2|COMPLETED|Overall Study||5
5216408|NCT00967005|12827290|P1|COMPLETED|Overall Study||6
5216409|NCT00967005|12827289|P2|Treatment Completion|Overall Study||10
5216410|NCT00967005|12827290|P1|Treatment Completion|Overall Study||10
5216411|NCT00967005|12827289|P2|STARTED|Overall Study||15
5216412|NCT00967005|12827290|P1|STARTED|Overall Study||13
5216413|NCT00966992|12827344|P2|NOT COMPLETED|Overall Study||0
5216414|NCT00966992|12827345|P1|NOT COMPLETED|Overall Study||0
5216415|NCT00966992|12827344|P2|COMPLETED|Overall Study||0
5216416|NCT00966992|12827345|P1|COMPLETED|Overall Study||3
5216417|NCT00966992|12827344|P2|STARTED|Overall Study||0
5216418|NCT00966992|12827345|P1|STARTED|Overall Study||3
5216419|NCT00966953|12827365|P4|NOT COMPLETED|4th Intervention Order||0
5216420|NCT00966953|12827366|P3|NOT COMPLETED|4th Intervention Order||0
5216421|NCT00966953|12827367|P2|NOT COMPLETED|4th Intervention Order||0
5216422|NCT00966953|12827368|P1|NOT COMPLETED|4th Intervention Order||0
5216423|NCT00966953|12827365|P4|COMPLETED|4th Intervention Order||7
5216424|NCT00966953|12827366|P3|COMPLETED|4th Intervention Order||6
5216425|NCT00966953|12827367|P2|COMPLETED|4th Intervention Order||6
5216426|NCT00966953|12827368|P1|COMPLETED|4th Intervention Order||6
5216427|NCT00966953|12827365|P4|STARTED|4th Intervention Order||7
5216428|NCT00966953|12827366|P3|STARTED|4th Intervention Order||6
5216429|NCT00966953|12827367|P2|STARTED|4th Intervention Order||6
5216430|NCT00966953|12827368|P1|STARTED|4th Intervention Order||6
5216431|NCT00966953|12827365|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
5216432|NCT00966953|12827366|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
5216433|NCT00966953|12827367|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
5216434|NCT00966953|12827368|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
5216435|NCT00966953|12827365|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
5216436|NCT00966953|12827366|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
5216437|NCT00966953|12827367|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
5216438|NCT00966953|12827368|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
5216439|NCT00966953|12827365|P4|STARTED|1 Week Washout After 3rd Intervention||7
5216440|NCT00966953|12827366|P3|STARTED|1 Week Washout After 3rd Intervention||6
5216441|NCT00966953|12827367|P2|STARTED|1 Week Washout After 3rd Intervention||6
5216442|NCT00966953|12827368|P1|STARTED|1 Week Washout After 3rd Intervention||6
5216443|NCT00966953|12827365|P4|NOT COMPLETED|3rd Intervention Order||0
5216444|NCT00966953|12827366|P3|NOT COMPLETED|3rd Intervention Order||0
5216445|NCT00966953|12827367|P2|NOT COMPLETED|3rd Intervention Order||0
5216446|NCT00966953|12827368|P1|NOT COMPLETED|3rd Intervention Order||0
5216447|NCT00966953|12827365|P4|COMPLETED|3rd Intervention Order||7
5216448|NCT00966953|12827366|P3|COMPLETED|3rd Intervention Order||6
5216449|NCT00966953|12827367|P2|COMPLETED|3rd Intervention Order||6
5216450|NCT00966953|12827368|P1|COMPLETED|3rd Intervention Order||6
5216451|NCT00966953|12827365|P4|STARTED|3rd Intervention Order||7
5216452|NCT00966953|12827366|P3|STARTED|3rd Intervention Order||6
5216453|NCT00966953|12827367|P2|STARTED|3rd Intervention Order||6
5216454|NCT00966953|12827368|P1|STARTED|3rd Intervention Order||6
5216455|NCT00966953|12827365|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
5216456|NCT00966953|12827366|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
5216457|NCT00966953|12827367|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
5216458|NCT00966953|12827368|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
5216459|NCT00966953|12827365|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
5216460|NCT00966953|12827366|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
5216461|NCT00966953|12827367|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
5216462|NCT00966953|12827368|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
5216463|NCT00966953|12827365|P4|STARTED|1 Week Washout After 2nd Intervention||7
5216464|NCT00966953|12827366|P3|STARTED|1 Week Washout After 2nd Intervention||6
5216465|NCT00966953|12827367|P2|STARTED|1 Week Washout After 2nd Intervention||6
5216466|NCT00966953|12827368|P1|STARTED|1 Week Washout After 2nd Intervention||6
5216467|NCT00966953|12827365|P4|NOT COMPLETED|2nd Intervention||0
5216468|NCT00966953|12827366|P3|NOT COMPLETED|2nd Intervention||0
5216469|NCT00966953|12827367|P2|NOT COMPLETED|2nd Intervention||0
5216470|NCT00966953|12827368|P1|NOT COMPLETED|2nd Intervention||0
5216471|NCT00966953|12827365|P4|COMPLETED|2nd Intervention||7
5216472|NCT00966953|12827366|P3|COMPLETED|2nd Intervention||6
5216473|NCT00966953|12827367|P2|COMPLETED|2nd Intervention||6
5216474|NCT00966953|12827368|P1|COMPLETED|2nd Intervention||6
5216475|NCT00966953|12827365|P4|STARTED|2nd Intervention||7
5216476|NCT00966953|12827366|P3|STARTED|2nd Intervention||6
5216477|NCT00966953|12827367|P2|STARTED|2nd Intervention||6
5216478|NCT00966953|12827368|P1|STARTED|2nd Intervention||6
5216479|NCT00966953|12827365|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
5216480|NCT00966953|12827366|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
5216481|NCT00966953|12827367|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
5216482|NCT00966953|12827368|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
5216483|NCT00966953|12827365|P4|COMPLETED|1 Week Washout After 1st Intervention||7
5216484|NCT00966953|12827366|P3|COMPLETED|1 Week Washout After 1st Intervention||6
5216485|NCT00966953|12827367|P2|COMPLETED|1 Week Washout After 1st Intervention||6
5216486|NCT00966953|12827368|P1|COMPLETED|1 Week Washout After 1st Intervention||6
5216487|NCT00966953|12827365|P4|STARTED|1 Week Washout After 1st Intervention||7
5216488|NCT00966953|12827366|P3|STARTED|1 Week Washout After 1st Intervention||6
5216489|NCT00966953|12827367|P2|STARTED|1 Week Washout After 1st Intervention||6
5216490|NCT00966953|12827368|P1|STARTED|1 Week Washout After 1st Intervention||6
5216491|NCT00966953|12827365|P4|NOT COMPLETED|1st Intervention||0
5216492|NCT00966953|12827366|P3|NOT COMPLETED|1st Intervention||0
5216493|NCT00966953|12827367|P2|NOT COMPLETED|1st Intervention||0
5216494|NCT00966953|12827368|P1|NOT COMPLETED|1st Intervention||0
5216495|NCT00966953|12827365|P4|COMPLETED|1st Intervention||7
5216496|NCT00966953|12827366|P3|COMPLETED|1st Intervention||6
5216497|NCT00966953|12827367|P2|COMPLETED|1st Intervention||6
5216498|NCT00966953|12827368|P1|COMPLETED|1st Intervention||6
5216499|NCT00966953|12827365|P4|STARTED|1st Intervention||7
5216500|NCT00966953|12827366|P3|STARTED|1st Intervention||6
5216501|NCT00966953|12827367|P2|STARTED|1st Intervention||6
5216502|NCT00966953|12827368|P1|STARTED|1st Intervention||6
5216503|NCT00966940|12827376|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
5216504|NCT00966940|12827377|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
5216505|NCT00966940|12827376|P2|COMPLETED|Period 2, Second 6 Weeks||23
5216506|NCT00966940|12827377|P1|COMPLETED|Period 2, Second 6 Weeks||25
5216507|NCT00966940|12827376|P2|STARTED|Period 2, Second 6 Weeks||23
5216508|NCT00966940|12827377|P1|STARTED|Period 2, Second 6 Weeks||25
5216509|NCT00966940|12827376|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
5216510|NCT00966940|12827377|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
5216511|NCT00966940|12827376|P2|COMPLETED|Period 1, First 6 Weeks||23
5216512|NCT00966940|12827377|P1|COMPLETED|Period 1, First 6 Weeks||25
5216513|NCT00966940|12827376|P2|STARTED|Period 1, First 6 Weeks||23
5216514|NCT00966940|12827377|P1|STARTED|Period 1, First 6 Weeks||28
5216515|NCT00966875|12827404|P9|NOT COMPLETED|Part B||18
5216516|NCT00966875|12827405|P8|NOT COMPLETED|Part B||19
5216517|NCT00966875|12827406|P7|NOT COMPLETED|Part B||22
5216518|NCT00966875|12827407|P6|NOT COMPLETED|Part B||6
5216519|NCT00966875|12827408|P5|NOT COMPLETED|Part B||7
5216520|NCT00966875|12827409|P4|NOT COMPLETED|Part B||3
5216521|NCT00966875|12827410|P3|NOT COMPLETED|Part B||6
5216522|NCT00966875|12827411|P2|NOT COMPLETED|Part B||3
5216523|NCT00966875|12827412|P1|NOT COMPLETED|Part B||5
5216524|NCT00966875|12827404|P9|COMPLETED|Part B||32
5216525|NCT00966875|12827405|P8|COMPLETED|Part B||38
5216526|NCT00966875|12827406|P7|COMPLETED|Part B||29
5216527|NCT00966875|12827407|P6|COMPLETED|Part B||26
5216528|NCT00966875|12827408|P5|COMPLETED|Part B||44
5216529|NCT00966875|12827409|P4|COMPLETED|Part B||31
5216530|NCT00966875|12827410|P3|COMPLETED|Part B||27
5216531|NCT00966875|12827411|P2|COMPLETED|Part B||33
5216532|NCT00966875|12827412|P1|COMPLETED|Part B||41
5216533|NCT00966875|12827404|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
5216534|NCT00966875|12827405|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
5216535|NCT00966875|12827406|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
5216536|NCT00966875|12827407|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
5216537|NCT00966875|12827408|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
5216538|NCT00966875|12827409|P4|STARTED|Part B||34
5216539|NCT00966875|12827410|P3|STARTED|Part B||33
5216540|NCT00966875|12827411|P2|STARTED|Part B||36
5216541|NCT00966875|12827412|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
5216542|NCT00966875|12827404|P9|NOT COMPLETED|Part A||8
5216543|NCT00966875|12827405|P8|NOT COMPLETED|Part A||7
5216544|NCT00966875|12827406|P7|NOT COMPLETED|Part A||12
5216545|NCT00966875|12827407|P6|NOT COMPLETED|Part A||4
5216546|NCT00966875|12827408|P5|NOT COMPLETED|Part A||5
5216547|NCT00966875|12827409|P4|NOT COMPLETED|Part A||3
5216548|NCT00966875|12827410|P3|NOT COMPLETED|Part A||2
5216549|NCT00966875|12827411|P2|NOT COMPLETED|Part A||4
5216550|NCT00966875|12827412|P1|NOT COMPLETED|Part A||6
5216551|NCT00966875|12827404|P9|COMPLETED|Part A||51
5216552|NCT00966875|12827405|P8|COMPLETED|Part A||58
5216553|NCT00966875|12827406|P7|COMPLETED|Part A||52
5216554|NCT00966875|12827407|P6|COMPLETED|Part A||33
5216555|NCT00966875|12827408|P5|COMPLETED|Part A||52
5216556|NCT00966875|12827409|P4|COMPLETED|Part A||34
5216557|NCT00966875|12827410|P3|COMPLETED|Part A||33
5216558|NCT00966875|12827411|P2|COMPLETED|Part A||36
5216559|NCT00966875|12827412|P1|COMPLETED|Part A||48
5216560|NCT00966875|12827404|P9|Received ≥1 Doses of Study Drug|Part A||59
5216561|NCT00966875|12827405|P8|Received ≥1 Doses of Study Drug|Part A||65
5216562|NCT00966875|12827406|P7|Received ≥1 Doses of Study Drug|Part A||64
5216563|NCT00966875|12827407|P6|Received ≥1 Doses of Study Drug|Part A||37
5216564|NCT00966875|12827408|P5|Received ≥1 Doses of Study Drug|Part A||57
5216565|NCT00966875|12827409|P4|Received ≥1 Doses of Study Drug|Part A||37
5216566|NCT00966875|12827410|P3|Received ≥1 Doses of Study Drug|Part A||35
5216567|NCT00966875|12827411|P2|Received ≥1 Doses of Study Drug|Part A||40
5216568|NCT00966875|12827412|P1|Received ≥1 Doses of Study Drug|Part A||54
5216569|NCT00966875|12827404|P9|STARTED|Part A||59
5216570|NCT00966875|12827405|P8|STARTED|Part A||65
5216571|NCT00966875|12827406|P7|STARTED|Part A||64
5216572|NCT00966875|12827407|P6|STARTED|Part A||37
5216573|NCT00966875|12827408|P5|STARTED|Part A||57
5216574|NCT00966875|12827409|P4|STARTED|Part A||37
5216575|NCT00966875|12827410|P3|STARTED|Part A||35
5216576|NCT00966875|12827411|P2|STARTED|Part A||40
5216577|NCT00966875|12827412|P1|STARTED|Part A||54
5216578|NCT00966849|12827734|P3|NOT COMPLETED|Overall Study||1293
5216579|NCT00966849|12827735|P2|NOT COMPLETED|Overall Study||1478
5216580|NCT00966849|12827736|P1|NOT COMPLETED|Overall Study||1541
5216581|NCT00966849|12827734|P3|COMPLETED|Overall Study||1876
5216582|NCT00966849|12827735|P2|COMPLETED|Overall Study||2498
5216583|NCT00966849|12827736|P1|COMPLETED|Overall Study||2119
5216584|NCT00966849|12827734|P3|STARTED|Overall Study||3169
5216585|NCT00966849|12827735|P2|STARTED|Overall Study||3976
5216586|NCT00966849|12827736|P1|STARTED|Overall Study||3660
5216587|NCT00966823|12827753|P1|NOT COMPLETED|Overall Study||1
5216588|NCT00966823|12827753|P1|COMPLETED|Overall Study||2
5216589|NCT00966823|12827753|P1|STARTED|Overall Study||3
5216590|NCT00966719|12827763|P2|NOT COMPLETED|Overall Study||11
5216591|NCT00966719|12827764|P1|NOT COMPLETED|Overall Study||6
5216592|NCT00966719|12827763|P2|COMPLETED|Overall Study||38
5216593|NCT00966719|12827764|P1|COMPLETED|Overall Study||44
5216594|NCT00966719|12827763|P2|STARTED|Overall Study||49
5216595|NCT00966719|12827764|P1|STARTED|Overall Study||50
5216596|NCT00966654|12827784|P1|NOT COMPLETED|Overall Study||12
5216597|NCT00966654|12827784|P1|COMPLETED|Overall Study||0
5216598|NCT00966654|12827784|P1|STARTED|Overall Study||12
5216599|NCT00966641|12827792|P2|NOT COMPLETED|Second Intervention||0
5216600|NCT00966641|12827793|P1|NOT COMPLETED|Second Intervention||0
5216601|NCT00966641|12827792|P2|COMPLETED|Second Intervention||17
5216602|NCT00966641|12827793|P1|COMPLETED|Second Intervention||17
5216603|NCT00966641|12827792|P2|STARTED|Second Intervention||17
5216604|NCT00966641|12827793|P1|STARTED|Second Intervention||17
5216605|NCT00966641|12827792|P2|NOT COMPLETED|First Intervention||0
5216606|NCT00966641|12827793|P1|NOT COMPLETED|First Intervention||0
5216607|NCT00966641|12827792|P2|COMPLETED|First Intervention||17
5216608|NCT00966641|12827793|P1|COMPLETED|First Intervention||17
5216609|NCT00966641|12827792|P2|STARTED|First Intervention||17
5216610|NCT00966641|12827793|P1|STARTED|First Intervention||17
5216611|NCT00966550|12827801|P2|NOT COMPLETED|Overall Study||0
5216612|NCT00966550|12827802|P1|NOT COMPLETED|Overall Study||0
5216613|NCT00966550|12827801|P2|COMPLETED|Overall Study||12
5216614|NCT00966550|12827802|P1|COMPLETED|Overall Study||13
5216615|NCT00966550|12827801|P2|STARTED|Overall Study||12
5216616|NCT00966550|12827802|P1|STARTED|Overall Study||13
5216617|NCT00966446|12827811|P3|NOT COMPLETED|Overall Study||21
5216618|NCT00966446|12827812|P2|NOT COMPLETED|Overall Study||25
5216619|NCT00966446|12827813|P1|NOT COMPLETED|Overall Study||28
5216620|NCT00966446|12827811|P3|COMPLETED|Overall Study||52
5216621|NCT00966446|12827812|P2|COMPLETED|Overall Study||49
5216622|NCT00966446|12827813|P1|COMPLETED|Overall Study||48
5216623|NCT00966446|12827811|P3|STARTED|Overall Study||73
5216624|NCT00966446|12827812|P2|STARTED|Overall Study||74
5216625|NCT00966446|12827813|P1|STARTED|Overall Study||76
5216626|NCT00966433|12827830|P3|NOT COMPLETED|Overall Study||0
5216627|NCT00966433|12827831|P2|NOT COMPLETED|Overall Study||1
5216628|NCT00966433|12827832|P1|NOT COMPLETED|Overall Study||1
5216629|NCT00966433|12827830|P3|COMPLETED|Overall Study||11
5216630|NCT00966433|12827831|P2|COMPLETED|Overall Study||10
5216631|NCT00966433|12827832|P1|COMPLETED|Overall Study||10
5216632|NCT00966433|12827830|P3|STARTED|Overall Study||11
5216633|NCT00966433|12827831|P2|STARTED|Overall Study||11
5216634|NCT00966433|12827832|P1|STARTED|Overall Study||11
5216635|NCT00966355|12827858|P3|NOT COMPLETED|Overall Study||84
5216636|NCT00966355|12827859|P2|NOT COMPLETED|Overall Study||86
5216637|NCT00966355|12827860|P1|NOT COMPLETED|Overall Study||84
5216638|NCT00966355|12827858|P3|COMPLETED|Overall Study||261
5216639|NCT00966355|12827859|P2|COMPLETED|Overall Study||259
5216640|NCT00966355|12827860|P1|COMPLETED|Overall Study||260
5216641|NCT00966355|12827858|P3|STARTED|Overall Study||345
5216642|NCT00966355|12827859|P2|STARTED|Overall Study||345
5216643|NCT00966355|12827860|P1|STARTED|Overall Study||344
5216644|NCT00966277|12827873|P2|NOT COMPLETED|Overall Study||4
5216645|NCT00966277|12827874|P1|NOT COMPLETED|Overall Study||4
5216646|NCT00966277|12827873|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
5216647|NCT00966277|12827874|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
5216648|NCT00966277|12827873|P2|STARTED|Overall Study||37
5216649|NCT00966277|12827874|P1|STARTED|Overall Study||38
5216650|NCT00966264|12827882|P2|NOT COMPLETED|Overall Study||3
5216651|NCT00966264|12827883|P1|NOT COMPLETED|Overall Study||4
5216652|NCT00966264|12827882|P2|COMPLETED|Overall Study|5 years results|114
5216653|NCT00966264|12827883|P1|COMPLETED|Overall Study|5 years results|115
5216654|NCT00966264|12827882|P2|STARTED|Overall Study||117
5216655|NCT00966264|12827883|P1|STARTED|Overall Study||119
5216656|NCT00966238|12827895|P6|NOT COMPLETED|Overall Study||0
5216657|NCT00966238|12827896|P5|NOT COMPLETED|Overall Study||0
5216658|NCT00966238|12827897|P4|NOT COMPLETED|Overall Study||0
5216659|NCT00966238|12827898|P3|NOT COMPLETED|Overall Study||0
5216660|NCT00966238|12827899|P2|NOT COMPLETED|Overall Study||0
5216661|NCT00966238|12827900|P1|NOT COMPLETED|Overall Study||0
5216662|NCT00966238|12827895|P6|COMPLETED|Overall Study||20
5216663|NCT00966238|12827896|P5|COMPLETED|Overall Study||20
5216664|NCT00966238|12827897|P4|COMPLETED|Overall Study||20
5216665|NCT00966238|12827898|P3|COMPLETED|Overall Study||20
5216666|NCT00966238|12827899|P2|COMPLETED|Overall Study||20
5216667|NCT00966238|12827900|P1|COMPLETED|Overall Study||20
5216668|NCT00966238|12827895|P6|STARTED|Overall Study||20
5216669|NCT00966238|12827896|P5|STARTED|Overall Study||20
5216670|NCT00966238|12827897|P4|STARTED|Overall Study||20
5216671|NCT00966238|12827898|P3|STARTED|Overall Study||20
5216672|NCT00966238|12827899|P2|STARTED|Overall Study||20
5216673|NCT00966238|12827900|P1|STARTED|Overall Study||20
5216674|NCT00966186|12827922|P2|NOT COMPLETED|Overall Study||0
5216675|NCT00966186|12827923|P1|NOT COMPLETED|Overall Study||0
5216676|NCT00966186|12827922|P2|COMPLETED|Overall Study||60
5216677|NCT00966186|12827923|P1|COMPLETED|Overall Study||60
5216678|NCT00966186|12827922|P2|STARTED|Overall Study||60
5216679|NCT00966186|12827923|P1|STARTED|Overall Study||60
5216680|NCT00965848|12827929|P3|NOT COMPLETED|Overall Study||10
5216681|NCT00965848|12827930|P2|NOT COMPLETED|Overall Study||2
5216682|NCT00965848|12827931|P1|NOT COMPLETED|Overall Study||29
5216683|NCT00965848|12827929|P3|COMPLETED|Overall Study||117
5216684|NCT00965848|12827930|P2|COMPLETED|Overall Study||32
5216685|NCT00965848|12827931|P1|COMPLETED|Overall Study||78
5216686|NCT00965848|12827929|P3|STARTED|Overall Study||127
5216687|NCT00965848|12827930|P2|STARTED|Overall Study||34
5216688|NCT00965848|12827931|P1|STARTED|Overall Study||107
5216689|NCT00965757|12827950|P4|NOT COMPLETED|Extension Phase||24
5216690|NCT00965757|12827951|P3|NOT COMPLETED|Extension Phase||33
5216691|NCT00965757|12827952|P2|NOT COMPLETED|Extension Phase||0
5216692|NCT00965757|12827953|P1|NOT COMPLETED|Extension Phase||0
5216693|NCT00965757|12827950|P4|COMPLETED|Extension Phase||64
5216694|NCT00965757|12827951|P3|COMPLETED|Extension Phase||132
5216695|NCT00965757|12827952|P2|COMPLETED|Extension Phase||0
5216696|NCT00965757|12827953|P1|COMPLETED|Extension Phase||0
5216697|NCT00965757|12827950|P4|STARTED|Extension Phase||88
5216698|NCT00965757|12827951|P3|STARTED|Extension Phase||165
5216699|NCT00965757|12827952|P2|STARTED|Extension Phase||0
5216700|NCT00965757|12827953|P1|STARTED|Extension Phase||0
5216701|NCT00965757|12827950|P4|NOT COMPLETED|Double-blind Phase||0
5216702|NCT00965757|12827951|P3|NOT COMPLETED|Double-blind Phase||0
5216703|NCT00965757|12827952|P2|NOT COMPLETED|Double-blind Phase||18
5216704|NCT00965757|12827953|P1|NOT COMPLETED|Double-blind Phase||17
5216705|NCT00965757|12827950|P4|COMPLETED|Double-blind Phase||0
5216706|NCT00965757|12827951|P3|COMPLETED|Double-blind Phase||0
5216707|NCT00965757|12827952|P2|COMPLETED|Double-blind Phase||70
5216708|NCT00965757|12827953|P1|COMPLETED|Double-blind Phase||148
5216709|NCT00965757|12827950|P4|STARTED|Double-blind Phase||0
5216710|NCT00965757|12827951|P3|STARTED|Double-blind Phase||0
5216711|NCT00965757|12827952|P2|STARTED|Double-blind Phase||88
5216712|NCT00965757|12827953|P1|STARTED|Double-blind Phase||165
5216713|NCT00965731|12827987|P2|NOT COMPLETED|Overall Study||20
5216714|NCT00965731|12827988|P1|NOT COMPLETED|Overall Study||7
5216715|NCT00965731|12827987|P2|COMPLETED|Overall Study||0
5216716|NCT00965731|12827988|P1|COMPLETED|Overall Study||0
5216717|NCT00965731|12827987|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
5216718|NCT00965731|12827988|P1|STARTED|Overall Study||7
5216719|NCT00965718|12828052|P1|NOT COMPLETED|Overall Study||4
5216720|NCT00965718|12828052|P1|COMPLETED|Overall Study||16
5216721|NCT00965718|12828052|P1|STARTED|Overall Study||20
5216722|NCT00965562|12828065|P3|NOT COMPLETED|Overall Study||3
5216723|NCT00965562|12828066|P2|NOT COMPLETED|Overall Study||4
5216724|NCT00965562|12828067|P1|NOT COMPLETED|Overall Study||3
5216725|NCT00965562|12828065|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
5216726|NCT00965562|12828066|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
5216727|NCT00965562|12828067|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
5216728|NCT00965562|12828065|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
5216729|NCT00965562|12828066|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
5216730|NCT00965562|12828067|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
5216731|NCT00965562|12828065|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
5216732|NCT00965562|12828066|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
5216733|NCT00965562|12828067|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
5216734|NCT00965562|12828065|P3|STARTED|Overall Study||16
5216735|NCT00965562|12828066|P2|STARTED|Overall Study||17
5216736|NCT00965562|12828067|P1|STARTED|Overall Study||16
5216737|NCT00965523|12828105|P1|NOT COMPLETED|Study 224||6
5216738|NCT00965523|12828105|P1|COMPLETED|Study 224||0
5216739|NCT00965523|12828105|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
5216740|NCT00965523|12828105|P1|NOT COMPLETED|Study 221||7
5216741|NCT00965523|12828105|P1|COMPLETED|Study 221||74
5216742|NCT00965523|12828105|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
5216743|NCT00965497|12828110|P1|NOT COMPLETED|Overall Study||1
5216744|NCT00965497|12828110|P1|COMPLETED|Overall Study||13
5216745|NCT00965497|12828110|P1|STARTED|Overall Study||14
5216746|NCT00965484|12828115|P1|NOT COMPLETED|Overall Study||2
5216747|NCT00965484|12828115|P1|COMPLETED|Overall Study||134
5216748|NCT00965484|12828115|P1|STARTED|Overall Study||136
5216749|NCT00965458|12828124|P2|NOT COMPLETED|Overall Study||4
5216750|NCT00965458|12828125|P1|NOT COMPLETED|Overall Study||2
5216751|NCT00965458|12828124|P2|COMPLETED|Overall Study||12
5216752|NCT00965458|12828125|P1|COMPLETED|Overall Study||31
5216753|NCT00965458|12828124|P2|STARTED|Overall Study||16
5216754|NCT00965458|12828125|P1|STARTED|Overall Study||33
5216755|NCT00965419|12828141|P1|NOT COMPLETED|Follow-up Phase||62
5216756|NCT00965419|12828141|P1|COMPLETED|Follow-up Phase||18
5216757|NCT00965419|12828141|P1|STARTED|Follow-up Phase||80
5216758|NCT00965419|12828141|P1|NOT COMPLETED|Open Label Treatment for Responders||247
5216759|NCT00965419|12828141|P1|COMPLETED|Open Label Treatment for Responders||20
5216760|NCT00965419|12828141|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
5216761|NCT00965419|12828141|P1|STARTED|Open Label Treatment for Responders||267
5216762|NCT00965341|12828187|P2|NOT COMPLETED|Overall Study||8
5216763|NCT00965341|12828188|P1|NOT COMPLETED|Overall Study||6
5216764|NCT00965341|12828187|P2|COMPLETED|Overall Study||16
5216765|NCT00965341|12828188|P1|COMPLETED|Overall Study||13
5216766|NCT00965341|12828187|P2|STARTED|Overall Study||24
5216767|NCT00965341|12828188|P1|STARTED|Overall Study||19
5216768|NCT00965263|12828198|P2|NOT COMPLETED|Overall Study||3
5216769|NCT00965263|12828199|P1|NOT COMPLETED|Overall Study||2
5216770|NCT00965263|12828198|P2|COMPLETED|Overall Study||6
5216771|NCT00965263|12828199|P1|COMPLETED|Overall Study||4
5216772|NCT00965263|12828198|P2|STARTED|Overall Study||9
5216773|NCT00965263|12828199|P1|STARTED|Overall Study||6
5216774|NCT00965250|12828231|P2|NOT COMPLETED|Overall Study||0
5216775|NCT00965250|12828232|P1|NOT COMPLETED|Overall Study||0
5216776|NCT00965250|12828231|P2|COMPLETED|Overall Study||12
5216777|NCT00965250|12828232|P1|COMPLETED|Overall Study||37
5216778|NCT00965250|12828231|P2|STARTED|Overall Study||12
5216779|NCT00965250|12828232|P1|STARTED|Overall Study||37
5216780|NCT00965237|12828250|P2|NOT COMPLETED|Period 2, One Week of Wear||0
5216781|NCT00965237|12828251|P1|NOT COMPLETED|Period 2, One Week of Wear||0
5216782|NCT00965237|12828250|P2|COMPLETED|Period 2, One Week of Wear||8
5216783|NCT00965237|12828251|P1|COMPLETED|Period 2, One Week of Wear||8
5216784|NCT00965237|12828250|P2|STARTED|Period 2, One Week of Wear||8
5216785|NCT00965237|12828251|P1|STARTED|Period 2, One Week of Wear||8
5216786|NCT00965237|12828250|P2|NOT COMPLETED|Period 1, One Week of Wear||0
5216787|NCT00965237|12828251|P1|NOT COMPLETED|Period 1, One Week of Wear||0
5216788|NCT00965237|12828250|P2|COMPLETED|Period 1, One Week of Wear||8
5216789|NCT00965237|12828251|P1|COMPLETED|Period 1, One Week of Wear||8
5216790|NCT00965237|12828250|P2|STARTED|Period 1, One Week of Wear||8
5216791|NCT00965237|12828251|P1|STARTED|Period 1, One Week of Wear||8
5216792|NCT00965185|12828259|P2|NOT COMPLETED|Overall Study||1
5216793|NCT00965185|12828260|P1|NOT COMPLETED|Overall Study||2
5216794|NCT00965185|12828259|P2|COMPLETED|Overall Study||20
5216795|NCT00965185|12828260|P1|COMPLETED|Overall Study||17
5216796|NCT00965185|12828259|P2|9 Month Visit|Overall Study||21
5216797|NCT00965185|12828260|P1|9 Month Visit|Overall Study||18
5216798|NCT00965185|12828259|P2|6 Month Visit|Overall Study||21
5216799|NCT00965185|12828260|P1|6 Month Visit|Overall Study||18
5216800|NCT00965185|12828259|P2|3 Month Visit|Overall Study||21
5216801|NCT00965185|12828260|P1|3 Month Visit|Overall Study||18
5216802|NCT00965185|12828259|P2|1 Month Visit|Overall Study||21
5216803|NCT00965185|12828260|P1|1 Month Visit|Overall Study||18
5216804|NCT00965185|12828259|P2|STARTED|Overall Study||21
5216805|NCT00965185|12828260|P1|STARTED|Overall Study||19
5216806|NCT00965146|12828280|P1|NOT COMPLETED|Overall Study||210
5216807|NCT00965146|12828280|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
5216808|NCT00965146|12828280|P1|STARTED|Overall Study||210
5216809|NCT00965094|12828287|P2|NOT COMPLETED|Overall Study||1
5216810|NCT00965094|12828288|P1|NOT COMPLETED|Overall Study||5
5216811|NCT00965094|12828287|P2|COMPLETED|Overall Study||16
5216812|NCT00965094|12828288|P1|COMPLETED|Overall Study||14
5216813|NCT00965094|12828287|P2|STARTED|Overall Study||17
5216814|NCT00965094|12828288|P1|STARTED|Overall Study||19
5216815|NCT00965081|12828304|P2|NOT COMPLETED|Overall Study||43
5216816|NCT00965081|12828305|P1|NOT COMPLETED|Overall Study||34
5216817|NCT00965081|12828304|P2|COMPLETED|Overall Study||110
5216818|NCT00965081|12828305|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
5216819|NCT00965081|12828304|P2|STARTED|Overall Study||153
5216820|NCT00965081|12828305|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
5216821|NCT00965055|12828328|P1|NOT COMPLETED|Overall Study||0
5216822|NCT00965055|12828328|P1|COMPLETED|Overall Study||2
5216823|NCT00965055|12828328|P1|STARTED|Overall Study||2
5216824|NCT00964886|12828337|P4|NOT COMPLETED|Overall Study||9
5216825|NCT00964886|12828338|P3|NOT COMPLETED|Overall Study||16
5216826|NCT00964886|12828339|P2|NOT COMPLETED|Overall Study||7
5216827|NCT00964886|12828340|P1|NOT COMPLETED|Overall Study||11
5216828|NCT00964886|12828337|P4|COMPLETED|Overall Study||24
5216829|NCT00964886|12828338|P3|COMPLETED|Overall Study||21
5216830|NCT00964886|12828339|P2|COMPLETED|Overall Study||27
5216831|NCT00964886|12828340|P1|COMPLETED|Overall Study||27
5216832|NCT00964886|12828337|P4|STARTED|Overall Study||33
5216833|NCT00964886|12828338|P3|STARTED|Overall Study||37
5216834|NCT00964886|12828339|P2|STARTED|Overall Study||34
5216835|NCT00964886|12828340|P1|STARTED|Overall Study||38
5216836|NCT00964860|12828356|P2|NOT COMPLETED|Overall Study||1
5216837|NCT00964860|12828357|P1|NOT COMPLETED|Overall Study||0
5216838|NCT00964860|12828356|P2|COMPLETED|Overall Study||29
5216839|NCT00964860|12828357|P1|COMPLETED|Overall Study||30
5216840|NCT00964860|12828356|P2|STARTED|Overall Study||30
5216841|NCT00964860|12828357|P1|STARTED|Overall Study||30
5216842|NCT00964795|12828365|P1|NOT COMPLETED|Overall Study||307
5216843|NCT00964795|12828365|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
5216844|NCT00964795|12828365|P1|Number of Participants Treated|Overall Study||320
5216845|NCT00964795|12828365|P1|STARTED|Overall Study|randomized|323
5216846|NCT00964782|12828374|P2|NOT COMPLETED|Overall Study||0
5216847|NCT00964782|12828375|P1|NOT COMPLETED|Overall Study||1
5216848|NCT00964782|12828374|P2|COMPLETED|Overall Study||8
5216849|NCT00964782|12828375|P1|COMPLETED|Overall Study||7
5216850|NCT00964782|12828374|P2|STARTED|Overall Study||8
5216851|NCT00964782|12828375|P1|STARTED|Overall Study||8
5216852|NCT00964743|12828389|P1|NOT COMPLETED|Overall Study||2
5216853|NCT00964743|12828389|P1|COMPLETED|Overall Study||0
5216854|NCT00964743|12828389|P1|STARTED|Overall Study||2
5216855|NCT00964678|12828397|P1|NOT COMPLETED|Overall Study||4
5216856|NCT00964678|12828397|P1|COMPLETED|Overall Study||6
5216857|NCT00964678|12828397|P1|STARTED|Overall Study||10
5216858|NCT00964548|12828406|P2|NOT COMPLETED|Overall Study||0
5216859|NCT00964548|12828407|P1|NOT COMPLETED|Overall Study||0
5216860|NCT00964548|12828406|P2|COMPLETED|Overall Study||5
5216861|NCT00964548|12828407|P1|COMPLETED|Overall Study||5
5216862|NCT00964548|12828406|P2|STARTED|Overall Study||5
5216863|NCT00964548|12828407|P1|STARTED|Overall Study||5
5216864|NCT00964496|12828419|P2|NOT COMPLETED|Overall Study||1
5216865|NCT00964496|12828420|P1|NOT COMPLETED|Overall Study||2
5216866|NCT00964496|12828419|P2|COMPLETED|Overall Study||26
5216867|NCT00964496|12828420|P1|COMPLETED|Overall Study||26
5216868|NCT00964496|12828419|P2|STARTED|Overall Study||27
5216869|NCT00964496|12828420|P1|STARTED|Overall Study||28
5216870|NCT00964444|12828438|P1|NOT COMPLETED|Overall Study||0
5216871|NCT00964444|12828438|P1|COMPLETED|Overall Study||10
5216872|NCT00964444|12828438|P1|STARTED|Overall Study||10
5216873|NCT00964431|12828446|P4|NOT COMPLETED|Overall Study||0
5216874|NCT00964431|12828447|P3|NOT COMPLETED|Overall Study||0
5216875|NCT00964431|12828448|P2|NOT COMPLETED|Overall Study||0
5216876|NCT00964431|12828449|P1|NOT COMPLETED|Overall Study||0
5216877|NCT00964431|12828446|P4|COMPLETED|Overall Study||51
5216878|NCT00964431|12828447|P3|COMPLETED|Overall Study||51
5216879|NCT00964431|12828448|P2|COMPLETED|Overall Study||51
5216880|NCT00964431|12828449|P1|COMPLETED|Overall Study||50
5216881|NCT00964431|12828446|P4|STARTED|Overall Study||51
5216882|NCT00964431|12828447|P3|STARTED|Overall Study||51
5216883|NCT00964431|12828448|P2|STARTED|Overall Study||51
5216884|NCT00964431|12828449|P1|STARTED|Overall Study||50
5216885|NCT00964392|12828461|P2|NOT COMPLETED|Overall Study||190
5216886|NCT00964392|12828462|P1|NOT COMPLETED|Overall Study||53
5216887|NCT00964392|12828461|P2|COMPLETED|Overall Study||92
5216888|NCT00964392|12828462|P1|COMPLETED|Overall Study||72
5216889|NCT00964392|12828461|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
5216890|NCT00964392|12828462|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
5216891|NCT00964366|12828472|P2|NOT COMPLETED|Overall Study||1
5216892|NCT00964366|12828473|P1|NOT COMPLETED|Overall Study||1
5216893|NCT00964366|12828472|P2|COMPLETED|Overall Study||24
5216894|NCT00964366|12828473|P1|COMPLETED|Overall Study||27
5216895|NCT00964366|12828472|P2|STARTED|Overall Study||25
5216896|NCT00964366|12828473|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
5216897|NCT00964353|12828489|P2|NOT COMPLETED|Overall Study||0
5216898|NCT00964353|12828490|P1|NOT COMPLETED|Overall Study||0
5216899|NCT00964353|12828489|P2|COMPLETED|Overall Study||178
5216900|NCT00964353|12828490|P1|COMPLETED|Overall Study||181
5216901|NCT00964353|12828489|P2|STARTED|Overall Study||178
5216902|NCT00964353|12828490|P1|STARTED|Overall Study||181
5216903|NCT00964223|12828498|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
5216904|NCT00964223|12828498|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
5216905|NCT00964223|12828498|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
5216906|NCT00964223|12828498|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
5216907|NCT00964223|12828498|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
5216908|NCT00964223|12828498|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
5216909|NCT00964158|12828566|P3|NOT COMPLETED|Overall Study||8
5216910|NCT00964158|12828567|P2|NOT COMPLETED|Overall Study||1
5216911|NCT00964158|12828568|P1|NOT COMPLETED|Overall Study||0
5216912|NCT00964158|12828566|P3|COMPLETED|Overall Study||92
5216913|NCT00964158|12828567|P2|COMPLETED|Overall Study||56
5216914|NCT00964158|12828568|P1|COMPLETED|Overall Study||53
5216915|NCT00964158|12828566|P3|STARTED|Overall Study||100
5216916|NCT00964158|12828567|P2|STARTED|Overall Study||57
5216917|NCT00964158|12828568|P1|STARTED|Overall Study||53
5216918|NCT00964119|12828637|P1|NOT COMPLETED|Overall Study||0
5216919|NCT00964119|12828637|P1|COMPLETED|Overall Study||15
5216920|NCT00964119|12828637|P1|STARTED|Overall Study||15
5216921|NCT00964028|12828643|P2|NOT COMPLETED|Overall Study||1
5216922|NCT00964028|12828644|P1|NOT COMPLETED|Overall Study||0
5216923|NCT00964028|12828643|P2|COMPLETED|Overall Study||24
5216924|NCT00964028|12828644|P1|COMPLETED|Overall Study||25
5216925|NCT00964028|12828643|P2|STARTED|Overall Study||25
5216926|NCT00964028|12828644|P1|STARTED|Overall Study||25
5216927|NCT00963937|12828659|P3|NOT COMPLETED|Overall Study||4
5216928|NCT00963937|12828660|P2|NOT COMPLETED|Overall Study||11
5216929|NCT00963937|12828661|P1|NOT COMPLETED|Overall Study||19
5216930|NCT00963937|12828659|P3|COMPLETED|Overall Study||41
5216931|NCT00963937|12828660|P2|COMPLETED|Overall Study||33
5216932|NCT00963937|12828661|P1|COMPLETED|Overall Study||70
5216933|NCT00963937|12828659|P3|STARTED|Overall Study||45
5216934|NCT00963937|12828660|P2|STARTED|Overall Study||44
5216935|NCT00963937|12828661|P1|STARTED|Overall Study||89
5216936|NCT00963924|12828699|P2|NOT COMPLETED|Overall Study||3
5216937|NCT00963924|12828700|P1|NOT COMPLETED|Overall Study||1
5216938|NCT00963924|12828699|P2|COMPLETED|Overall Study||15
5216939|NCT00963924|12828700|P1|COMPLETED|Overall Study||17
5216940|NCT00963924|12828699|P2|STARTED|Overall Study||18
5216941|NCT00963924|12828700|P1|STARTED|Overall Study||18
5216942|NCT00963872|12828724|P2|NOT COMPLETED|Overall Study||1
5216943|NCT00963872|12828725|P1|NOT COMPLETED|Overall Study||1
5216944|NCT00963872|12828724|P2|COMPLETED|Overall Study||5
5216945|NCT00963872|12828725|P1|COMPLETED|Overall Study||24
5216946|NCT00963872|12828724|P2|STARTED|Overall Study||6
5216947|NCT00963872|12828725|P1|STARTED|Overall Study||25
5216948|NCT00963859|12828769|P1|NOT COMPLETED|Overall Study||0
5216949|NCT00963859|12828769|P1|COMPLETED|Overall Study||11
5216950|NCT00963859|12828769|P1|STARTED|Overall Study||11
5216951|NCT00963820|12828774|P12|NOT COMPLETED|Expansion Phase||4
5216952|NCT00963820|12828775|P11|NOT COMPLETED|Expansion Phase||5
5216953|NCT00963820|12828776|P10|NOT COMPLETED|Expansion Phase||9
5216954|NCT00963820|12828777|P9|NOT COMPLETED|Expansion Phase||10
5216955|NCT00963820|12828778|P8|NOT COMPLETED|Expansion Phase||0
5216956|NCT00963820|12828779|P7|NOT COMPLETED|Expansion Phase||0
5216957|NCT00963820|12828780|P6|NOT COMPLETED|Expansion Phase||0
5216958|NCT00963820|12828781|P5|NOT COMPLETED|Expansion Phase||0
5216959|NCT00963820|12828782|P4|NOT COMPLETED|Expansion Phase||0
5216960|NCT00963820|12828783|P3|NOT COMPLETED|Expansion Phase||0
5216961|NCT00963820|12828784|P2|NOT COMPLETED|Expansion Phase||0
5216962|NCT00963820|12828785|P1|NOT COMPLETED|Expansion Phase||0
5216963|NCT00963820|12828774|P12|COMPLETED|Expansion Phase||0
5216964|NCT00963820|12828775|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
5216965|NCT00963820|12828776|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
5216966|NCT00963820|12828777|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
5216967|NCT00963820|12828778|P8|COMPLETED|Expansion Phase||0
5216968|NCT00963820|12828779|P7|COMPLETED|Expansion Phase||0
5216969|NCT00963820|12828780|P6|COMPLETED|Expansion Phase||0
5216970|NCT00963820|12828781|P5|COMPLETED|Expansion Phase||0
5216971|NCT00963820|12828782|P4|COMPLETED|Expansion Phase||0
5216972|NCT00963820|12828783|P3|COMPLETED|Expansion Phase||0
5216973|NCT00963820|12828784|P2|COMPLETED|Expansion Phase||0
5216974|NCT00963820|12828785|P1|COMPLETED|Expansion Phase||0
5216975|NCT00963820|12828774|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
5216976|NCT00963820|12828775|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
5216977|NCT00963820|12828776|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
5216978|NCT00963820|12828777|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
5216979|NCT00963820|12828778|P8|STARTED|Expansion Phase||0
5216980|NCT00963820|12828779|P7|STARTED|Expansion Phase||0
5216981|NCT00963820|12828780|P6|STARTED|Expansion Phase||0
5216982|NCT00963820|12828781|P5|STARTED|Expansion Phase||0
5216983|NCT00963820|12828782|P4|STARTED|Expansion Phase||0
5216984|NCT00963820|12828783|P3|STARTED|Expansion Phase||0
5216985|NCT00963820|12828784|P2|STARTED|Expansion Phase||0
5216986|NCT00963820|12828785|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
5216987|NCT00963820|12828774|P12|NOT COMPLETED|Dose Escalation Phase||0
5216988|NCT00963820|12828775|P11|NOT COMPLETED|Dose Escalation Phase||0
5216989|NCT00963820|12828776|P10|NOT COMPLETED|Dose Escalation Phase||0
5216990|NCT00963820|12828777|P9|NOT COMPLETED|Dose Escalation Phase||0
5216991|NCT00963820|12828778|P8|NOT COMPLETED|Dose Escalation Phase||5
5216992|NCT00963820|12828779|P7|NOT COMPLETED|Dose Escalation Phase||8
5216993|NCT00963820|12828780|P6|NOT COMPLETED|Dose Escalation Phase||3
5216994|NCT00963820|12828781|P5|NOT COMPLETED|Dose Escalation Phase||4
5216995|NCT00963820|12828782|P4|NOT COMPLETED|Dose Escalation Phase||3
5216996|NCT00963820|12828783|P3|NOT COMPLETED|Dose Escalation Phase||3
5216997|NCT00963820|12828784|P2|NOT COMPLETED|Dose Escalation Phase||3
5216998|NCT00963820|12828785|P1|NOT COMPLETED|Dose Escalation Phase||3
5216999|NCT00963820|12828774|P12|COMPLETED|Dose Escalation Phase||0
5217000|NCT00963820|12828775|P11|COMPLETED|Dose Escalation Phase||0
5217001|NCT00963820|12828776|P10|COMPLETED|Dose Escalation Phase||0
5217002|NCT00963820|12828777|P9|COMPLETED|Dose Escalation Phase||0
5217003|NCT00963820|12828778|P8|COMPLETED|Dose Escalation Phase||0
5217004|NCT00963820|12828779|P7|COMPLETED|Dose Escalation Phase||0
5217005|NCT00963820|12828780|P6|COMPLETED|Dose Escalation Phase||0
5217006|NCT00963820|12828781|P5|COMPLETED|Dose Escalation Phase||0
5217007|NCT00963820|12828782|P4|COMPLETED|Dose Escalation Phase||0
5217008|NCT00963820|12828783|P3|COMPLETED|Dose Escalation Phase||0
5217009|NCT00963820|12828784|P2|COMPLETED|Dose Escalation Phase||0
5217010|NCT00963820|12828785|P1|COMPLETED|Dose Escalation Phase||0
5217011|NCT00963820|12828774|P12|STARTED|Dose Escalation Phase||0
5217012|NCT00963820|12828775|P11|STARTED|Dose Escalation Phase||0
5217013|NCT00963820|12828776|P10|STARTED|Dose Escalation Phase||0
5217014|NCT00963820|12828777|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
5217015|NCT00963820|12828778|P8|STARTED|Dose Escalation Phase||5
5217016|NCT00963820|12828779|P7|STARTED|Dose Escalation Phase||8
5217017|NCT00963820|12828780|P6|STARTED|Dose Escalation Phase||3
5217018|NCT00963820|12828781|P5|STARTED|Dose Escalation Phase||4
5217019|NCT00963820|12828782|P4|STARTED|Dose Escalation Phase||3
5217020|NCT00963820|12828783|P3|STARTED|Dose Escalation Phase||3
5217021|NCT00963820|12828784|P2|STARTED|Dose Escalation Phase||3
5217022|NCT00963820|12828785|P1|STARTED|Dose Escalation Phase||3
5217023|NCT00963807|12828921|P1|NOT COMPLETED|Overall Study||18
5217024|NCT00963807|12828921|P1|COMPLETED|Overall Study||8
5217025|NCT00963807|12828921|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
5217026|NCT00963807|12828921|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
5217027|NCT00963807|12828921|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
5217028|NCT00963807|12828921|P1|Completed Baseline Imaging|Overall Study||11
5217029|NCT00963807|12828921|P1|STARTED|Overall Study||26
5217030|NCT00963677|12828932|P2|NOT COMPLETED|Overall Study||2
5217031|NCT00963677|12828933|P1|NOT COMPLETED|Overall Study||0
5217032|NCT00963677|12828932|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
5217033|NCT00963677|12828933|P1|COMPLETED|Overall Study||35
5217034|NCT00963677|12828932|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
5217035|NCT00963677|12828933|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
5217036|NCT00963638|12828943|P2|NOT COMPLETED|Overall Study||0
5217037|NCT00963638|12828944|P1|NOT COMPLETED|Overall Study||0
5217038|NCT00963638|12828943|P2|COMPLETED|Overall Study||20
5217039|NCT00963638|12828944|P1|COMPLETED|Overall Study||20
5217040|NCT00963638|12828943|P2|STARTED|Overall Study||20
5217041|NCT00963638|12828944|P1|STARTED|Overall Study||20
5217042|NCT00963599|12828954|P4|NOT COMPLETED|Overall Study||14
5217043|NCT00963599|12828955|P3|NOT COMPLETED|Overall Study||9
5217044|NCT00963599|12828956|P2|NOT COMPLETED|Overall Study||6
5217045|NCT00963599|12828957|P1|NOT COMPLETED|Overall Study||6
5217046|NCT00963599|12828954|P4|COMPLETED|Overall Study||288
5217047|NCT00963599|12828955|P3|COMPLETED|Overall Study||292
5217048|NCT00963599|12828956|P2|COMPLETED|Overall Study||149
5217049|NCT00963599|12828957|P1|COMPLETED|Overall Study||143
5217050|NCT00963599|12828954|P4|STARTED|Overall Study||302
5217051|NCT00963599|12828955|P3|STARTED|Overall Study||301
5217052|NCT00963599|12828956|P2|STARTED|Overall Study||155
5217053|NCT00963599|12828957|P1|STARTED|Overall Study||149
5217054|NCT00963560|12829014|P3|NOT COMPLETED|Overall Study||0
5217055|NCT00963560|12829015|P2|NOT COMPLETED|Overall Study||3
5217056|NCT00963560|12829016|P1|NOT COMPLETED|Overall Study||3
5217057|NCT00963560|12829014|P3|COMPLETED|Overall Study||41
5217058|NCT00963560|12829015|P2|COMPLETED|Overall Study||41
5217059|NCT00963560|12829016|P1|COMPLETED|Overall Study||44
5217060|NCT00963560|12829014|P3|STARTED|Overall Study||41
5217061|NCT00963560|12829015|P2|STARTED|Overall Study||44
5217062|NCT00963560|12829016|P1|STARTED|Overall Study||47
5217063|NCT00963547|12829028|P7|NOT COMPLETED|Overall Study||0
5217064|NCT00963547|12829029|P6|NOT COMPLETED|Overall Study||0
5217065|NCT00963547|12829030|P5|NOT COMPLETED|Overall Study||0
5217066|NCT00963547|12829031|P4|NOT COMPLETED|Overall Study||6
5217067|NCT00963547|12829032|P3|NOT COMPLETED|Overall Study||12
5217068|NCT00963547|12829033|P2|NOT COMPLETED|Overall Study||11
5217069|NCT00963547|12829034|P1|NOT COMPLETED|Overall Study||4
5217070|NCT00963547|12829028|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
5217071|NCT00963547|12829029|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
5217072|NCT00963547|12829030|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
5217073|NCT00963547|12829031|P4|COMPLETED|Overall Study||0
5217074|NCT00963547|12829032|P3|COMPLETED|Overall Study||0
5217075|NCT00963547|12829033|P2|COMPLETED|Overall Study||0
5217076|NCT00963547|12829034|P1|COMPLETED|Overall Study||0
5217077|NCT00963547|12829028|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
5217078|NCT00963547|12829029|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
5217079|NCT00963547|12829030|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
5217080|NCT00963547|12829031|P4|Treated|Overall Study||6
5217081|NCT00963547|12829032|P3|Treated|Overall Study||11
5217082|NCT00963547|12829033|P2|Treated|Overall Study||11
5217083|NCT00963547|12829034|P1|Treated|Overall Study||3
5217084|NCT00963547|12829028|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
5217085|NCT00963547|12829029|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
5217086|NCT00963547|12829030|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
5217087|NCT00963547|12829031|P4|STARTED|Overall Study||6
5217088|NCT00963547|12829032|P3|STARTED|Overall Study||12
5217089|NCT00963547|12829033|P2|STARTED|Overall Study||11
5217090|NCT00963547|12829034|P1|STARTED|Overall Study||4
5217091|NCT00963508|12829060|P2|NOT COMPLETED|Overall Study||28
5217092|NCT00963508|12829061|P1|NOT COMPLETED|Overall Study||10
5217093|NCT00963508|12829060|P2|COMPLETED|Overall Study||169
5217094|NCT00963508|12829061|P1|COMPLETED|Overall Study||196
5217095|NCT00963508|12829060|P2|STARTED|Overall Study||197
5217096|NCT00963508|12829061|P1|STARTED|Overall Study||206
5217097|NCT00963482|12829071|P2|NOT COMPLETED|Overall Study||17
5217098|NCT00963482|12829072|P1|NOT COMPLETED|Overall Study||28
5217099|NCT00963482|12829071|P2|COMPLETED|Overall Study||33
5217100|NCT00963482|12829072|P1|COMPLETED|Overall Study||25
5217101|NCT00963482|12829071|P2|STARTED|Overall Study||50
5217102|NCT00963482|12829072|P1|STARTED|Overall Study||53
5217103|NCT00963469|12829081|P3|NOT COMPLETED|Overall Study||10
5217104|NCT00963469|12829082|P2|NOT COMPLETED|Overall Study||28
5217105|NCT00963469|12829083|P1|NOT COMPLETED|Overall Study||41
5217106|NCT00963469|12829081|P3|COMPLETED|Overall Study||170
5217107|NCT00963469|12829082|P2|COMPLETED|Overall Study||420
5217108|NCT00963469|12829083|P1|COMPLETED|Overall Study||410
5217109|NCT00963469|12829081|P3|STARTED|Overall Study||180
5217110|NCT00963469|12829082|P2|STARTED|Overall Study||448
5217111|NCT00963469|12829083|P1|STARTED|Overall Study||451
5217112|NCT00963430|12829111|P2|NOT COMPLETED|Overall Study||3
5217113|NCT00963430|12829112|P1|NOT COMPLETED|Overall Study||1
5217114|NCT00963430|12829111|P2|COMPLETED|Overall Study||57
5217115|NCT00963430|12829112|P1|COMPLETED|Overall Study||59
5217116|NCT00963430|12829111|P2|STARTED|Overall Study||60
5217117|NCT00963430|12829112|P1|STARTED|Overall Study||60
5217118|NCT00963235|12829150|P1|NOT COMPLETED|Overall Study||60
5217119|NCT00963235|12829150|P1|COMPLETED|Overall Study||271
5217120|NCT00963235|12829150|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
5217121|NCT00963235|12829150|P1|Vaccinated Dose 3|Overall Study||279
5217122|NCT00963235|12829150|P1|Vaccinated Dose 2|Overall Study||300
5217123|NCT00963235|12829150|P1|Vaccinated Dose 1|Overall Study||329
5217124|NCT00963235|12829150|P1|STARTED|Overall Study||331
5217125|NCT00963157|12829174|P5|NOT COMPLETED|Overall Study||2
5217126|NCT00963157|12829175|P4|NOT COMPLETED|Overall Study||7
5217127|NCT00963157|12829176|P3|NOT COMPLETED|Overall Study||5
5217128|NCT00963157|12829177|P2|NOT COMPLETED|Overall Study||4
5217129|NCT00963157|12829178|P1|NOT COMPLETED|Overall Study||5
5217130|NCT00963157|12829174|P5|COMPLETED|Overall Study||151
5217131|NCT00963157|12829175|P4|COMPLETED|Overall Study||150
5217132|NCT00963157|12829176|P3|COMPLETED|Overall Study||155
5217133|NCT00963157|12829177|P2|COMPLETED|Overall Study||159
5217134|NCT00963157|12829178|P1|COMPLETED|Overall Study||151
5217135|NCT00963157|12829174|P5|STARTED|Overall Study||153
5217136|NCT00963157|12829175|P4|STARTED|Overall Study||157
5217137|NCT00963157|12829176|P3|STARTED|Overall Study||160
5217138|NCT00963157|12829177|P2|STARTED|Overall Study||163
5217139|NCT00963157|12829178|P1|STARTED|Overall Study||156
5217140|NCT00963105|12829373|P3|NOT COMPLETED|Overall Study||0
5217141|NCT00963105|12829374|P2|NOT COMPLETED|Overall Study||0
5217142|NCT00963105|12829375|P1|NOT COMPLETED|Overall Study||0
5217143|NCT00963105|12829373|P3|COMPLETED|Overall Study||35
5217144|NCT00963105|12829374|P2|COMPLETED|Overall Study||35
5217145|NCT00963105|12829375|P1|COMPLETED|Overall Study||34
5217146|NCT00963105|12829373|P3|Received Treatment|Overall Study||35
5217147|NCT00963105|12829374|P2|Received Treatment|Overall Study||34
5217148|NCT00963105|12829375|P1|Received Treatment|Overall Study||34
5217149|NCT00963105|12829373|P3|STARTED|Overall Study||35
5217150|NCT00963105|12829374|P2|STARTED|Overall Study||35
5217151|NCT00963105|12829375|P1|STARTED|Overall Study||34
5217152|NCT00962949|12829406|P2|NOT COMPLETED|Overall Study||0
5217153|NCT00962949|12829407|P1|NOT COMPLETED|Overall Study||0
5217154|NCT00962949|12829406|P2|COMPLETED|Overall Study||15
5217155|NCT00962949|12829407|P1|COMPLETED|Overall Study||13
5217156|NCT00962949|12829406|P2|STARTED|Overall Study||15
5217157|NCT00962949|12829407|P1|STARTED|Overall Study||13
5217158|NCT00962871|12829423|P4|NOT COMPLETED|Overall Study||0
5217159|NCT00962871|12829424|P3|NOT COMPLETED|Overall Study||0
5217160|NCT00962871|12829425|P2|NOT COMPLETED|Overall Study||0
5217161|NCT00962871|12829426|P1|NOT COMPLETED|Overall Study||0
5217162|NCT00962871|12829423|P4|COMPLETED|Overall Study||6
5217163|NCT00962871|12829424|P3|COMPLETED|Overall Study||12
5217164|NCT00962871|12829425|P2|COMPLETED|Overall Study||6
5217165|NCT00962871|12829426|P1|COMPLETED|Overall Study||6
5217166|NCT00962871|12829423|P4|STARTED|Overall Study||6
5217167|NCT00962871|12829424|P3|STARTED|Overall Study||12
5217168|NCT00962871|12829425|P2|STARTED|Overall Study||6
5217169|NCT00962871|12829426|P1|STARTED|Overall Study||6
5217170|NCT00962780|12829442|P2|NOT COMPLETED|Overall Study||14
5217171|NCT00962780|12829443|P1|NOT COMPLETED|Overall Study||10
5217172|NCT00962780|12829442|P2|COMPLETED|Overall Study||138
5217173|NCT00962780|12829443|P1|COMPLETED|Overall Study||141
5217174|NCT00962780|12829442|P2|Vaccinated 23vPS Dose|Overall Study||139
5217175|NCT00962780|12829443|P1|Vaccinated 23vPS Dose|Overall Study||143
5217176|NCT00962780|12829442|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
5217177|NCT00962780|12829443|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
5217178|NCT00962780|12829442|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
5217179|NCT00962780|12829443|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
5217180|NCT00962780|12829442|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
5217181|NCT00962780|12829443|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
5217182|NCT00962780|12829442|P2|STARTED|Overall Study||152
5217183|NCT00962780|12829443|P1|STARTED|Overall Study||151
5217184|NCT00962754|12829507|P2|NOT COMPLETED|Overall Study||0
5217185|NCT00962754|12829508|P1|NOT COMPLETED|Overall Study||0
5217186|NCT00962754|12829507|P2|COMPLETED|Overall Study||84
5217187|NCT00962754|12829508|P1|COMPLETED|Overall Study||86
5217188|NCT00962754|12829507|P2|STARTED|Overall Study||84
5217189|NCT00962754|12829508|P1|STARTED|Overall Study||86
5217190|NCT00962741|12829518|P1|NOT COMPLETED|Overall Study||8
5217191|NCT00962741|12829518|P1|COMPLETED|Overall Study||119
5217192|NCT00962741|12829518|P1|STARTED|Overall Study||127
5217193|NCT00962650|12829609|P1|NOT COMPLETED|Overall Study||2
5217194|NCT00962650|12829609|P1|COMPLETED|Overall Study||8
5217195|NCT00962650|12829609|P1|STARTED|Overall Study||10
5217196|NCT00962598|12829615|P2|NOT COMPLETED|Overall Study||0
5217197|NCT00962598|12829616|P1|NOT COMPLETED|Overall Study||0
5217198|NCT00962598|12829615|P2|COMPLETED|Overall Study||9
5217199|NCT00962598|12829616|P1|COMPLETED|Overall Study||7
5217200|NCT00962598|12829615|P2|STARTED|Overall Study||9
5217201|NCT00962598|12829616|P1|STARTED|Overall Study||7
5217202|NCT00962585|12829628|P4|NOT COMPLETED|Overall Study||0
5217203|NCT00962585|12829629|P3|NOT COMPLETED|Overall Study||3
5217204|NCT00962585|12829630|P2|NOT COMPLETED|Overall Study||2
5217205|NCT00962585|12829631|P1|NOT COMPLETED|Overall Study||6
5217206|NCT00962585|12829628|P4|COMPLETED|Overall Study||42
5217207|NCT00962585|12829629|P3|COMPLETED|Overall Study||39
5217208|NCT00962585|12829630|P2|COMPLETED|Overall Study||40
5217209|NCT00962585|12829631|P1|COMPLETED|Overall Study||37
5217210|NCT00962585|12829628|P4|STARTED|Overall Study||42
5217211|NCT00962585|12829629|P3|STARTED|Overall Study||42
5217212|NCT00962585|12829630|P2|STARTED|Overall Study||42
5217213|NCT00962585|12829631|P1|STARTED|Overall Study||43
5217214|NCT00962390|12829693|P4|NOT COMPLETED|Overall Study||1
5217215|NCT00962390|12829694|P3|NOT COMPLETED|Overall Study||4
5217216|NCT00962390|12829695|P2|NOT COMPLETED|Overall Study||3
5217217|NCT00962390|12829696|P1|NOT COMPLETED|Overall Study||4
5217218|NCT00962390|12829693|P4|COMPLETED|Overall Study||28
5217219|NCT00962390|12829694|P3|COMPLETED|Overall Study||25
5217220|NCT00962390|12829695|P2|COMPLETED|Overall Study||26
5217221|NCT00962390|12829696|P1|COMPLETED|Overall Study||25
5217222|NCT00962390|12829693|P4|STARTED|Overall Study||29
5217223|NCT00962390|12829694|P3|STARTED|Overall Study||29
5217224|NCT00962390|12829695|P2|STARTED|Overall Study||29
5217225|NCT00962390|12829696|P1|STARTED|Overall Study||29
5217226|NCT00962247|12829758|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
5217227|NCT00962247|12829758|P1|COMPLETED|50% Reduction of Sedentary Activity||56
5217228|NCT00962247|12829758|P1|STARTED|50% Reduction of Sedentary Activity||56
5217229|NCT00962247|12829758|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
5217230|NCT00962247|12829758|P1|COMPLETED|25% Reduction of Sedentary Activity||56
5217231|NCT00962247|12829758|P1|STARTED|25% Reduction of Sedentary Activity||61
5217232|NCT00962247|12829758|P1|NOT COMPLETED|Usual Sedentary||0
5217233|NCT00962247|12829758|P1|COMPLETED|Usual Sedentary||61
5217234|NCT00962247|12829758|P1|STARTED|Usual Sedentary||61
5217235|NCT00962208|12829769|P2|NOT COMPLETED|Overall Study||10
5217236|NCT00962208|12829770|P1|NOT COMPLETED|Overall Study||14
5217237|NCT00962208|12829769|P2|COMPLETED|Overall Study||41
5217238|NCT00962208|12829770|P1|COMPLETED|Overall Study||37
5217239|NCT00962208|12829769|P2|STARTED|Overall Study||51
5217240|NCT00962208|12829770|P1|STARTED|Overall Study||51
5217241|NCT00962104|12829778|P2|NOT COMPLETED|Overall Study||25
5217242|NCT00962104|12829779|P1|NOT COMPLETED|Overall Study||40
5217243|NCT00962104|12829778|P2|COMPLETED|Overall Study||171
5217244|NCT00962104|12829779|P1|COMPLETED|Overall Study||155
5217245|NCT00962104|12829778|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
5217246|NCT00962104|12829779|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
5217247|NCT00962104|12829778|P2|STARTED|Overall Study||196
5217248|NCT00962104|12829779|P1|STARTED|Overall Study||195
5217249|NCT00962091|12829812|P7|NOT COMPLETED|Overall Study||1
5217250|NCT00962091|12829813|P6|NOT COMPLETED|Overall Study||1
5217251|NCT00962091|12829814|P5|NOT COMPLETED|Overall Study||0
5217252|NCT00962091|12829815|P4|NOT COMPLETED|Overall Study||1
5217253|NCT00962091|12829816|P3|NOT COMPLETED|Overall Study||1
5217254|NCT00962091|12829817|P2|NOT COMPLETED|Overall Study||2
5217255|NCT00962091|12829818|P1|NOT COMPLETED|Overall Study||1
5217256|NCT00962091|12829812|P7|COMPLETED|Overall Study||11
5217257|NCT00962091|12829813|P6|COMPLETED|Overall Study||11
5217258|NCT00962091|12829814|P5|COMPLETED|Overall Study||3
5217259|NCT00962091|12829815|P4|COMPLETED|Overall Study||2
5217260|NCT00962091|12829816|P3|COMPLETED|Overall Study||9
5217261|NCT00962091|12829817|P2|COMPLETED|Overall Study||7
5217262|NCT00962091|12829818|P1|COMPLETED|Overall Study||3
5217263|NCT00962091|12829812|P7|STARTED|Overall Study||12
5217264|NCT00962091|12829813|P6|STARTED|Overall Study||12
5217265|NCT00962091|12829814|P5|STARTED|Overall Study||3
5217266|NCT00962091|12829815|P4|STARTED|Overall Study||3
5217267|NCT00962091|12829816|P3|STARTED|Overall Study||10
5217268|NCT00962091|12829817|P2|STARTED|Overall Study||9
5217269|NCT00962091|12829818|P1|STARTED|Overall Study||4
5217270|NCT00962078|12829865|P2|NOT COMPLETED|Overall Study||6
5217271|NCT00962078|12829866|P1|NOT COMPLETED|Overall Study||5
5217272|NCT00962078|12829865|P2|COMPLETED|Overall Study||30
5217273|NCT00962078|12829866|P1|COMPLETED|Overall Study||30
5217274|NCT00962078|12829865|P2|STARTED|Overall Study||36
5217275|NCT00962078|12829866|P1|STARTED|Overall Study||35
5217276|NCT00962065|12829877|P3|NOT COMPLETED|Overall Study||0
5217277|NCT00962065|12829878|P2|NOT COMPLETED|Overall Study||0
5217278|NCT00962065|12829879|P1|NOT COMPLETED|Overall Study||0
5217279|NCT00962065|12829877|P3|COMPLETED|Overall Study||12
5217280|NCT00962065|12829878|P2|COMPLETED|Overall Study||12
5217281|NCT00962065|12829879|P1|COMPLETED|Overall Study||12
5217282|NCT00962065|12829877|P3|STARTED|Overall Study||12
5217283|NCT00962065|12829878|P2|STARTED|Overall Study||12
5217284|NCT00962065|12829879|P1|STARTED|Overall Study||12
5217285|NCT00962039|12829904|P2|NOT COMPLETED|Overall Study||4
5217286|NCT00962039|12829905|P1|NOT COMPLETED|Overall Study||5
5217287|NCT00962039|12829904|P2|COMPLETED|Overall Study||37
5217288|NCT00962039|12829905|P1|COMPLETED|Overall Study||35
5217289|NCT00962039|12829904|P2|STARTED|Overall Study||41
5217290|NCT00962039|12829905|P1|STARTED|Overall Study||40
5217291|NCT00962013|12829921|P1|NOT COMPLETED|Overall Study||68
5217292|NCT00962013|12829921|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
5217293|NCT00962013|12829921|P1|STARTED|Overall Study||120
5217294|NCT00962000|12829930|P2|NOT COMPLETED|Period 4 - 1 Week||0
5217295|NCT00962000|12829931|P1|NOT COMPLETED|Period 4 - 1 Week||0
5217296|NCT00962000|12829930|P2|COMPLETED|Period 4 - 1 Week||21
5217297|NCT00962000|12829931|P1|COMPLETED|Period 4 - 1 Week||21
5217298|NCT00962000|12829930|P2|STARTED|Period 4 - 1 Week||21
5217299|NCT00962000|12829931|P1|STARTED|Period 4 - 1 Week||21
5217300|NCT00962000|12829930|P2|NOT COMPLETED|Period 3 - 1 Week||0
5217301|NCT00962000|12829931|P1|NOT COMPLETED|Period 3 - 1 Week||0
5217302|NCT00962000|12829930|P2|COMPLETED|Period 3 - 1 Week||21
5217303|NCT00962000|12829931|P1|COMPLETED|Period 3 - 1 Week||21
5217304|NCT00962000|12829930|P2|STARTED|Period 3 - 1 Week||21
5217305|NCT00962000|12829931|P1|STARTED|Period 3 - 1 Week||21
5217306|NCT00962000|12829930|P2|NOT COMPLETED|Period 2 - 1 Week||0
5217307|NCT00962000|12829931|P1|NOT COMPLETED|Period 2 - 1 Week||0
5217308|NCT00962000|12829930|P2|COMPLETED|Period 2 - 1 Week||21
5217309|NCT00962000|12829931|P1|COMPLETED|Period 2 - 1 Week||21
5217310|NCT00962000|12829930|P2|STARTED|Period 2 - 1 Week||21
5217311|NCT00962000|12829931|P1|STARTED|Period 2 - 1 Week||21
5217312|NCT00962000|12829930|P2|NOT COMPLETED|Period 1 - 1 Week||0
5217313|NCT00962000|12829931|P1|NOT COMPLETED|Period 1 - 1 Week||0
5217314|NCT00962000|12829930|P2|COMPLETED|Period 1 - 1 Week||21
5217315|NCT00962000|12829931|P1|COMPLETED|Period 1 - 1 Week||21
5217316|NCT00962000|12829930|P2|STARTED|Period 1 - 1 Week||21
5217317|NCT00962000|12829931|P1|STARTED|Period 1 - 1 Week||21
5217318|NCT00961896|12829944|P3|NOT COMPLETED|Overall Study||1
5217319|NCT00961896|12829945|P2|NOT COMPLETED|Overall Study||0
5217320|NCT00961896|12829946|P1|NOT COMPLETED|Overall Study||0
5217321|NCT00961896|12829944|P3|COMPLETED|Overall Study||6
5217322|NCT00961896|12829945|P2|COMPLETED|Overall Study||3
5217323|NCT00961896|12829946|P1|COMPLETED|Overall Study||8
5217324|NCT00961896|12829944|P3|STARTED|Overall Study||7
5217325|NCT00961896|12829945|P2|STARTED|Overall Study||3
5217326|NCT00961896|12829946|P1|STARTED|Overall Study||8
5217327|NCT00961805|12829967|P2|NOT COMPLETED|Overall Study||0
5217328|NCT00961805|12829968|P1|NOT COMPLETED|Overall Study||0
5217329|NCT00961805|12829967|P2|COMPLETED|Overall Study||40
5217330|NCT00961805|12829968|P1|COMPLETED|Overall Study||40
5217331|NCT00961805|12829967|P2|STARTED|Overall Study||40
5217332|NCT00961805|12829968|P1|STARTED|Overall Study||40
5217333|NCT00961662|12829999|P3|NOT COMPLETED|Overall Study||19
5217334|NCT00961662|12830000|P2|NOT COMPLETED|Overall Study||19
5217335|NCT00961662|12830001|P1|NOT COMPLETED|Overall Study||22
5217336|NCT00961662|12829999|P3|COMPLETED|Overall Study||34
5217337|NCT00961662|12830000|P2|COMPLETED|Overall Study||32
5217338|NCT00961662|12830001|P1|COMPLETED|Overall Study||35
5217339|NCT00961662|12829999|P3|STARTED|Overall Study||53
5217340|NCT00961662|12830000|P2|STARTED|Overall Study||51
5217341|NCT00961662|12830001|P1|STARTED|Overall Study||57
5217342|NCT00961649|12830013|P4|NOT COMPLETED|Overall Study||4
5217343|NCT00961649|12830014|P3|NOT COMPLETED|Overall Study||5
5217344|NCT00961649|12830015|P2|NOT COMPLETED|Overall Study||4
5217345|NCT00961649|12830016|P1|NOT COMPLETED|Overall Study||9
5217346|NCT00961649|12830013|P4|COMPLETED|Overall Study||37
5217347|NCT00961649|12830014|P3|COMPLETED|Overall Study||39
5217348|NCT00961649|12830015|P2|COMPLETED|Overall Study||40
5217349|NCT00961649|12830016|P1|COMPLETED|Overall Study||32
5217350|NCT00961649|12830013|P4|STARTED|Overall Study||41
5217351|NCT00961649|12830014|P3|STARTED|Overall Study||44
5217352|NCT00961649|12830015|P2|STARTED|Overall Study||44
5217353|NCT00961649|12830016|P1|STARTED|Overall Study||41
5217354|NCT00961636|12830030|P3|NOT COMPLETED|Overall Study||32
5217355|NCT00961636|12830031|P2|NOT COMPLETED|Overall Study||131
5217356|NCT00961636|12830032|P1|NOT COMPLETED|Overall Study||107
5217357|NCT00961636|12830030|P3|COMPLETED|Overall Study||201
5217358|NCT00961636|12830031|P2|COMPLETED|Overall Study||325
5217359|NCT00961636|12830032|P1|COMPLETED|Overall Study||356
5217360|NCT00961636|12830030|P3|STARTED|Overall Study||233
5217361|NCT00961636|12830031|P2|STARTED|Overall Study||456
5217362|NCT00961636|12830032|P1|STARTED|Overall Study||463
5217363|NCT00961571|12830043|P1|NOT COMPLETED|Overall Study||39
5217364|NCT00961571|12830043|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
5217365|NCT00961571|12830043|P1|STARTED|Overall Study||50
5217366|NCT00961532|12830047|P1|NOT COMPLETED|Overall Study||0
5217367|NCT00961532|12830047|P1|COMPLETED|Overall Study||14
5217368|NCT00961532|12830047|P1|STARTED|Overall Study||14
5217369|NCT00961441|12830054|P2|NOT COMPLETED|Overall Study||0
5217370|NCT00961441|12830055|P1|NOT COMPLETED|Overall Study||0
5217371|NCT00961441|12830054|P2|COMPLETED|Overall Study||13
5217372|NCT00961441|12830055|P1|COMPLETED|Overall Study||12
5217373|NCT00961441|12830054|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
5217374|NCT00961441|12830055|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
5217375|NCT00961441|12830054|P2|STARTED|Overall Study||13
5217376|NCT00961441|12830055|P1|STARTED|Overall Study||12
5217377|NCT00961415|12830071|P3|NOT COMPLETED|Maintenance Treatment Phase||45
5217378|NCT00961415|12830072|P2|NOT COMPLETED|Maintenance Treatment Phase||48
5217379|NCT00961415|12830073|P1|NOT COMPLETED|Maintenance Treatment Phase||0
5217380|NCT00961415|12830071|P3|COMPLETED|Maintenance Treatment Phase||83
5217381|NCT00961415|12830072|P2|COMPLETED|Maintenance Treatment Phase||77
5217382|NCT00961415|12830073|P1|COMPLETED|Maintenance Treatment Phase||0
5217383|NCT00961415|12830071|P3|STARTED|Maintenance Treatment Phase||128
5217384|NCT00961415|12830072|P2|STARTED|Maintenance Treatment Phase||125
5217385|NCT00961415|12830073|P1|STARTED|Maintenance Treatment Phase||0
5217386|NCT00961415|12830071|P3|NOT COMPLETED|Induction Treatment Phase||0
5217387|NCT00961415|12830072|P2|NOT COMPLETED|Induction Treatment Phase||0
5217388|NCT00961415|12830073|P1|NOT COMPLETED|Induction Treatment Phase||123
5217389|NCT00961415|12830071|P3|COMPLETED|Induction Treatment Phase||0
5217390|NCT00961415|12830072|P2|COMPLETED|Induction Treatment Phase||0
5217391|NCT00961415|12830073|P1|COMPLETED|Induction Treatment Phase||253
5217392|NCT00961415|12830071|P3|STARTED|Induction Treatment Phase||0
5217393|NCT00961415|12830072|P2|STARTED|Induction Treatment Phase||0
5217394|NCT00961415|12830073|P1|STARTED|Induction Treatment Phase||376
5217395|NCT00961402|12830098|P2|NOT COMPLETED|Overall Study||5
5217396|NCT00961402|12830099|P1|NOT COMPLETED|Overall Study||1
5217397|NCT00961402|12830098|P2|COMPLETED|Overall Study||61
5217398|NCT00961402|12830099|P1|COMPLETED|Overall Study||63
5217399|NCT00961402|12830098|P2|Randomized|Overall Study||66
5217400|NCT00961402|12830099|P1|Randomized|Overall Study||64
5217401|NCT00961402|12830098|P2|STARTED|Overall Study||66
5217402|NCT00961402|12830099|P1|STARTED|Overall Study||64
5217403|NCT00961350|12830113|P2|NOT COMPLETED|Overall Study||67
5217404|NCT00961350|12830114|P1|NOT COMPLETED|Overall Study||47
5217405|NCT00961350|12830113|P2|COMPLETED|Overall Study||198
5217406|NCT00961350|12830114|P1|COMPLETED|Overall Study||218
5217407|NCT00961350|12830113|P2|Safety Population|Overall Study||265
5217408|NCT00961350|12830114|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
5217409|NCT00961350|12830113|P2|Intent-to-Treat Population (ITT)|Overall Study||265
5217410|NCT00961350|12830114|P1|Intent-to-Treat Population (ITT)|Overall Study||265
5217411|NCT00961350|12830113|P2|STARTED|Overall Study||265
5217412|NCT00961350|12830114|P1|STARTED|Overall Study||265
5217413|NCT00961311|12830128|P1|NOT COMPLETED|Overall Study||0
5217414|NCT00961311|12830128|P1|COMPLETED|Overall Study||51
5217415|NCT00961311|12830128|P1|STARTED|Overall Study||51
5217416|NCT00961298|12830135|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
5217417|NCT00961298|12830135|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
5217418|NCT00961298|12830135|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
5217419|NCT00961298|12830135|P1|NOT COMPLETED|Two Week Placebo Run in||1
5217420|NCT00961298|12830135|P1|COMPLETED|Two Week Placebo Run in||14
5217421|NCT00961298|12830135|P1|STARTED|Two Week Placebo Run in||15
5217422|NCT00961259|12830142|P3|NOT COMPLETED|Third Intervention||0
5217423|NCT00961259|12830143|P2|NOT COMPLETED|Third Intervention||0
5217424|NCT00961259|12830144|P1|NOT COMPLETED|Third Intervention||0
5217425|NCT00961259|12830142|P3|COMPLETED|Third Intervention||18
5217426|NCT00961259|12830143|P2|COMPLETED|Third Intervention||17
5217427|NCT00961259|12830144|P1|COMPLETED|Third Intervention||18
5217428|NCT00961259|12830142|P3|STARTED|Third Intervention||18
5217429|NCT00961259|12830143|P2|STARTED|Third Intervention||17
5217430|NCT00961259|12830144|P1|STARTED|Third Intervention||18
5217431|NCT00961259|12830142|P3|NOT COMPLETED|Washout Period of 7 Days||0
5217432|NCT00961259|12830143|P2|NOT COMPLETED|Washout Period of 7 Days||0
5217433|NCT00961259|12830144|P1|NOT COMPLETED|Washout Period of 7 Days||0
5217434|NCT00961259|12830142|P3|COMPLETED|Washout Period of 7 Days||18
5217435|NCT00961259|12830143|P2|COMPLETED|Washout Period of 7 Days||17
5217436|NCT00961259|12830144|P1|COMPLETED|Washout Period of 7 Days||18
5217437|NCT00961259|12830142|P3|STARTED|Washout Period of 7 Days||18
5217438|NCT00961259|12830143|P2|STARTED|Washout Period of 7 Days||17
5217439|NCT00961259|12830144|P1|STARTED|Washout Period of 7 Days||18
5217440|NCT00961259|12830142|P3|NOT COMPLETED|Second Intervention||0
5217441|NCT00961259|12830143|P2|NOT COMPLETED|Second Intervention||0
5217442|NCT00961259|12830144|P1|NOT COMPLETED|Second Intervention||0
5217443|NCT00961259|12830142|P3|COMPLETED|Second Intervention||18
5217444|NCT00961259|12830143|P2|COMPLETED|Second Intervention||17
5217445|NCT00961259|12830144|P1|COMPLETED|Second Intervention||18
5217446|NCT00961259|12830142|P3|STARTED|Second Intervention||18
5217447|NCT00961259|12830143|P2|STARTED|Second Intervention||17
5217448|NCT00961259|12830144|P1|STARTED|Second Intervention||18
5217449|NCT00961259|12830142|P3|NOT COMPLETED|Washout Period of 7 Days||0
5217450|NCT00961259|12830143|P2|NOT COMPLETED|Washout Period of 7 Days||1
5217451|NCT00961259|12830144|P1|NOT COMPLETED|Washout Period of 7 Days||0
5217452|NCT00961259|12830142|P3|COMPLETED|Washout Period of 7 Days||18
5217453|NCT00961259|12830143|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
5217454|NCT00961259|12830144|P1|COMPLETED|Washout Period of 7 Days||18
5217455|NCT00961259|12830142|P3|STARTED|Washout Period of 7 Days||18
5217456|NCT00961259|12830143|P2|STARTED|Washout Period of 7 Days||18
5217457|NCT00961259|12830144|P1|STARTED|Washout Period of 7 Days||18
5217458|NCT00961259|12830142|P3|NOT COMPLETED|First Intervention||0
5217459|NCT00961259|12830143|P2|NOT COMPLETED|First Intervention||0
5217460|NCT00961259|12830144|P1|NOT COMPLETED|First Intervention||0
5217461|NCT00961259|12830142|P3|COMPLETED|First Intervention||18
5217462|NCT00961259|12830143|P2|COMPLETED|First Intervention||18
5217463|NCT00961259|12830144|P1|COMPLETED|First Intervention||18
5217464|NCT00961259|12830142|P3|STARTED|First Intervention||18
5217465|NCT00961259|12830143|P2|STARTED|First Intervention||18
5217466|NCT00961259|12830144|P1|STARTED|First Intervention||18
5217467|NCT00961233|12830163|P2|NOT COMPLETED|Overall Study||1
5217468|NCT00961233|12830164|P1|NOT COMPLETED|Overall Study||2
5217469|NCT00961233|12830163|P2|COMPLETED|Overall Study||11
5217470|NCT00961233|12830164|P1|COMPLETED|Overall Study||11
5217471|NCT00961233|12830163|P2|STARTED|Overall Study||12
5217472|NCT00961233|12830164|P1|STARTED|Overall Study||13
5217473|NCT00961220|12830172|P1|NOT COMPLETED|Overall Study||7
5217474|NCT00961220|12830172|P1|COMPLETED|Overall Study||10
5217475|NCT00961220|12830172|P1|STARTED|Overall Study||17
5217476|NCT00961181|12830188|P1|NOT COMPLETED|Overall Study||5
5217477|NCT00961181|12830188|P1|COMPLETED|Overall Study||76
5217478|NCT00961181|12830188|P1|STARTED|Overall Study||81
5217479|NCT00961116|12830201|P2|NOT COMPLETED|Second Intervention||0
5217480|NCT00961116|12830202|P1|NOT COMPLETED|Second Intervention||0
5217481|NCT00961116|12830201|P2|COMPLETED|Second Intervention||24
5217482|NCT00961116|12830202|P1|COMPLETED|Second Intervention||25
5217483|NCT00961116|12830201|P2|STARTED|Second Intervention||24
5217484|NCT00961116|12830202|P1|STARTED|Second Intervention||25
5217485|NCT00961116|12830201|P2|NOT COMPLETED|Washout Period of 7 Days||3
5217486|NCT00961116|12830202|P1|NOT COMPLETED|Washout Period of 7 Days||2
5217487|NCT00961116|12830201|P2|COMPLETED|Washout Period of 7 Days||24
5217488|NCT00961116|12830202|P1|COMPLETED|Washout Period of 7 Days||25
5217489|NCT00961116|12830201|P2|STARTED|Washout Period of 7 Days||27
5217490|NCT00961116|12830202|P1|STARTED|Washout Period of 7 Days||27
5217491|NCT00961116|12830201|P2|NOT COMPLETED|First Intervention||0
5217492|NCT00961116|12830202|P1|NOT COMPLETED|First Intervention||0
5217493|NCT00961116|12830201|P2|COMPLETED|First Intervention||27
5217494|NCT00961116|12830202|P1|COMPLETED|First Intervention||27
5217495|NCT00961116|12830201|P2|STARTED|First Intervention||27
5217496|NCT00961116|12830202|P1|STARTED|First Intervention||27
5217497|NCT00961064|12830212|P1|NOT COMPLETED|Overall Study||0
5217498|NCT00961064|12830212|P1|COMPLETED|Overall Study||30
5217499|NCT00961064|12830212|P1|STARTED|Overall Study||30
5217500|NCT00961051|12830218|P2|NOT COMPLETED|Overall Study||14
5217501|NCT00961051|12830219|P1|NOT COMPLETED|Overall Study||12
5217502|NCT00961051|12830218|P2|COMPLETED|Overall Study||79
5217503|NCT00961051|12830219|P1|COMPLETED|Overall Study||165
5217504|NCT00961051|12830218|P2|STARTED|Overall Study||93
5217505|NCT00961051|12830219|P1|STARTED|Overall Study||177
5217506|NCT00960999|12830229|P2|NOT COMPLETED|Overall Study||2
5217507|NCT00960999|12830230|P1|NOT COMPLETED|Overall Study||8
5217508|NCT00960999|12830229|P2|COMPLETED|Overall Study||45
5217509|NCT00960999|12830230|P1|COMPLETED|Overall Study||39
5217510|NCT00960999|12830229|P2|DLCO by Best Response|Overall Study||28
5217511|NCT00960999|12830230|P1|DLCO by Best Response|Overall Study||23
5217512|NCT00960999|12830229|P2|FEV1 by Best Response|Overall Study||33
5217513|NCT00960999|12830230|P1|FEV1 by Best Response|Overall Study||26
5217514|NCT00960999|12830229|P2|Normalized SUV at 1 Year|Overall Study||7
5217515|NCT00960999|12830230|P1|Normalized SUV at 1 Year|Overall Study||4
5217516|NCT00960999|12830229|P2|Normalized SUV at 8 Weeks|Overall Study||9
5217517|NCT00960999|12830230|P1|Normalized SUV at 8 Weeks|Overall Study||3
5217518|NCT00960999|12830229|P2|Peak SUV at 1 Year|Overall Study||7
5217519|NCT00960999|12830230|P1|Peak SUV at 1 Year|Overall Study||4
5217520|NCT00960999|12830229|P2|Peak SUV at 8 Weeks|Overall Study||11
5217521|NCT00960999|12830230|P1|Peak SUV at 8 Weeks|Overall Study||3
5217522|NCT00960999|12830229|P2|Primary Endpoint Population|Overall Study||38
5217523|NCT00960999|12830230|P1|Primary Endpoint Population|Overall Study||38
5217524|NCT00960999|12830229|P2|Started Protocol Treatment|Overall Study||45
5217525|NCT00960999|12830230|P1|Started Protocol Treatment|Overall Study||39
5217526|NCT00960999|12830229|P2|Eligible|Overall Study||45
5217527|NCT00960999|12830230|P1|Eligible|Overall Study||39
5217528|NCT00960999|12830229|P2|STARTED|Overall Study||47
5217529|NCT00960999|12830230|P1|STARTED|Overall Study||47
5217530|NCT00960986|12830262|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
5217531|NCT00960986|12830263|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
5217532|NCT00960986|12830264|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
5217533|NCT00960986|12830265|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
5217534|NCT00960986|12830262|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
5217535|NCT00960986|12830263|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
5217536|NCT00960986|12830264|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
5217537|NCT00960986|12830265|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
5217538|NCT00960986|12830262|P4|STARTED|Period 3 (7-week Therapy Period)||61
5217539|NCT00960986|12830263|P3|STARTED|Period 3 (7-week Therapy Period)||59
5217540|NCT00960986|12830264|P2|STARTED|Period 3 (7-week Therapy Period)||59
5217541|NCT00960986|12830265|P1|STARTED|Period 3 (7-week Therapy Period)||56
5217542|NCT00960986|12830262|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
5217543|NCT00960986|12830263|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
5217544|NCT00960986|12830264|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
5217545|NCT00960986|12830265|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
5217546|NCT00960986|12830262|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
5217547|NCT00960986|12830263|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
5217548|NCT00960986|12830264|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
5217549|NCT00960986|12830265|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
5217550|NCT00960986|12830262|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
5217551|NCT00960986|12830263|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
5217552|NCT00960986|12830264|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
5217553|NCT00960986|12830265|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
5217554|NCT00960986|12830262|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
5217555|NCT00960986|12830263|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
5217556|NCT00960986|12830264|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
5217557|NCT00960986|12830265|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
5217558|NCT00960986|12830262|P4|COMPLETED|Period 1 (Screening and Washout)||61
5217559|NCT00960986|12830263|P3|COMPLETED|Period 1 (Screening and Washout)||59
5217560|NCT00960986|12830264|P2|COMPLETED|Period 1 (Screening and Washout)||59
5217561|NCT00960986|12830265|P1|COMPLETED|Period 1 (Screening and Washout)||56
5217562|NCT00960986|12830262|P4|STARTED|Period 1 (Screening and Washout)||64
5217563|NCT00960986|12830263|P3|STARTED|Period 1 (Screening and Washout)||63
5217564|NCT00960986|12830264|P2|STARTED|Period 1 (Screening and Washout)||63
5217565|NCT00960986|12830265|P1|STARTED|Period 1 (Screening and Washout)||59
5217566|NCT00960934|12830341|P6|NOT COMPLETED|Overall Study||64
5217567|NCT00960934|12830342|P5|NOT COMPLETED|Overall Study||64
5217568|NCT00960934|12830343|P4|NOT COMPLETED|Overall Study||64
5217569|NCT00960934|12830344|P3|NOT COMPLETED|Overall Study||64
5217570|NCT00960934|12830345|P2|NOT COMPLETED|Overall Study||63
5217571|NCT00960934|12830346|P1|NOT COMPLETED|Overall Study||64
5217572|NCT00960934|12830341|P6|COMPLETED|Overall Study||0
5217573|NCT00960934|12830342|P5|COMPLETED|Overall Study||0
5217574|NCT00960934|12830343|P4|COMPLETED|Overall Study||0
5217575|NCT00960934|12830344|P3|COMPLETED|Overall Study||0
5217576|NCT00960934|12830345|P2|COMPLETED|Overall Study||0
5217577|NCT00960934|12830346|P1|COMPLETED|Overall Study||0
5217578|NCT00960934|12830341|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
5217579|NCT00960934|12830342|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
5217580|NCT00960934|12830343|P4|Number Treated|Overall Study||64
5217581|NCT00960934|12830344|P3|Number Treated|Overall Study||64
5217582|NCT00960934|12830345|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
5217583|NCT00960934|12830346|P1|Number Treated|Overall Study||64
5217584|NCT00960934|12830341|P6|STARTED|Overall Study||64
5217585|NCT00960934|12830342|P5|STARTED|Overall Study||64
5217586|NCT00960934|12830343|P4|STARTED|Overall Study||64
5217587|NCT00960934|12830344|P3|STARTED|Overall Study||64
5217588|NCT00960934|12830345|P2|STARTED|Overall Study||63
5217589|NCT00960934|12830346|P1|STARTED|Overall Study||64
5217590|NCT00960869|12830458|P2|NOT COMPLETED|Overall Study||62
5217591|NCT00960869|12830459|P1|NOT COMPLETED|Overall Study||53
5217592|NCT00960869|12830458|P2|COMPLETED|Overall Study||198
5217593|NCT00960869|12830459|P1|COMPLETED|Overall Study||206
5217594|NCT00960869|12830458|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
5217595|NCT00960869|12830459|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
5217596|NCT00960869|12830458|P2|Intent-to-Treat Population (ITT)|Overall Study||260
5217597|NCT00960869|12830459|P1|Intent-to-Treat Population (ITT)|Overall Study||259
5217598|NCT00960869|12830458|P2|STARTED|Overall Study||260
5217599|NCT00960869|12830459|P1|STARTED|Overall Study||259
5217600|NCT00960856|12830473|P4|NOT COMPLETED|Period IV||0
5217601|NCT00960856|12830474|P3|NOT COMPLETED|Period IV||0
5217602|NCT00960856|12830475|P2|NOT COMPLETED|Period IV||0
5217603|NCT00960856|12830476|P1|NOT COMPLETED|Period IV||0
5217604|NCT00960856|12830473|P4|COMPLETED|Period IV||9
5217605|NCT00960856|12830474|P3|COMPLETED|Period IV||8
5217606|NCT00960856|12830475|P2|COMPLETED|Period IV||7
5217607|NCT00960856|12830476|P1|COMPLETED|Period IV||10
5217608|NCT00960856|12830473|P4|STARTED|Period IV||9
5217609|NCT00960856|12830474|P3|STARTED|Period IV||8
5217610|NCT00960856|12830475|P2|STARTED|Period IV||7
5217611|NCT00960856|12830476|P1|STARTED|Period IV||10
5217612|NCT00960856|12830473|P4|NOT COMPLETED|Washout Period of 7 Days||0
5217613|NCT00960856|12830474|P3|NOT COMPLETED|Washout Period of 7 Days||1
5217614|NCT00960856|12830475|P2|NOT COMPLETED|Washout Period of 7 Days||0
5217615|NCT00960856|12830476|P1|NOT COMPLETED|Washout Period of 7 Days||0
5217616|NCT00960856|12830473|P4|COMPLETED|Washout Period of 7 Days||9
5217617|NCT00960856|12830474|P3|COMPLETED|Washout Period of 7 Days||8
5217618|NCT00960856|12830475|P2|COMPLETED|Washout Period of 7 Days||7
5217619|NCT00960856|12830476|P1|COMPLETED|Washout Period of 7 Days||10
5217620|NCT00960856|12830473|P4|STARTED|Washout Period of 7 Days||9
5217621|NCT00960856|12830474|P3|STARTED|Washout Period of 7 Days||9
5217622|NCT00960856|12830475|P2|STARTED|Washout Period of 7 Days||7
5217623|NCT00960856|12830476|P1|STARTED|Washout Period of 7 Days||10
5217624|NCT00960856|12830473|P4|NOT COMPLETED|Period III||0
5217625|NCT00960856|12830474|P3|NOT COMPLETED|Period III||0
5217626|NCT00960856|12830475|P2|NOT COMPLETED|Period III||0
5217627|NCT00960856|12830476|P1|NOT COMPLETED|Period III||0
5217628|NCT00960856|12830473|P4|COMPLETED|Period III||9
5217629|NCT00960856|12830474|P3|COMPLETED|Period III||9
5217630|NCT00960856|12830475|P2|COMPLETED|Period III||7
5217631|NCT00960856|12830476|P1|COMPLETED|Period III||10
5217632|NCT00960856|12830473|P4|STARTED|Period III||9
5217633|NCT00960856|12830474|P3|STARTED|Period III||9
5217634|NCT00960856|12830475|P2|STARTED|Period III||7
5217635|NCT00960856|12830476|P1|STARTED|Period III||10
5217636|NCT00960856|12830473|P4|NOT COMPLETED|Washout Period of 7 Days||0
5217637|NCT00960856|12830474|P3|NOT COMPLETED|Washout Period of 7 Days||0
5217638|NCT00960856|12830475|P2|NOT COMPLETED|Washout Period of 7 Days||0
5217639|NCT00960856|12830476|P1|NOT COMPLETED|Washout Period of 7 Days||0
5217640|NCT00960856|12830473|P4|COMPLETED|Washout Period of 7 Days||9
5217641|NCT00960856|12830474|P3|COMPLETED|Washout Period of 7 Days||9
5217642|NCT00960856|12830475|P2|COMPLETED|Washout Period of 7 Days||7
5217643|NCT00960856|12830476|P1|COMPLETED|Washout Period of 7 Days||10
5217644|NCT00960856|12830473|P4|STARTED|Washout Period of 7 Days||9
5217645|NCT00960856|12830474|P3|STARTED|Washout Period of 7 Days||9
5217646|NCT00960856|12830475|P2|STARTED|Washout Period of 7 Days||7
5217647|NCT00960856|12830476|P1|STARTED|Washout Period of 7 Days||10
5217648|NCT00960856|12830473|P4|NOT COMPLETED|Period II||0
5217649|NCT00960856|12830474|P3|NOT COMPLETED|Period II||0
5217650|NCT00960856|12830475|P2|NOT COMPLETED|Period II||0
5217651|NCT00960856|12830476|P1|NOT COMPLETED|Period II||0
5217652|NCT00960856|12830473|P4|COMPLETED|Period II||9
5217653|NCT00960856|12830474|P3|COMPLETED|Period II||9
5217654|NCT00960856|12830475|P2|COMPLETED|Period II||7
5217655|NCT00960856|12830476|P1|COMPLETED|Period II||10
5217656|NCT00960856|12830473|P4|STARTED|Period II||9
5217657|NCT00960856|12830474|P3|STARTED|Period II||9
5217658|NCT00960856|12830475|P2|STARTED|Period II||7
5217659|NCT00960856|12830476|P1|STARTED|Period II||10
5217660|NCT00960856|12830473|P4|NOT COMPLETED|Washout Period of 7 Days||0
5217661|NCT00960856|12830474|P3|NOT COMPLETED|Washout Period of 7 Days||0
5217662|NCT00960856|12830475|P2|NOT COMPLETED|Washout Period of 7 Days||2
5217663|NCT00960856|12830476|P1|NOT COMPLETED|Washout Period of 7 Days||0
5217664|NCT00960856|12830473|P4|COMPLETED|Washout Period of 7 Days||9
5217665|NCT00960856|12830474|P3|COMPLETED|Washout Period of 7 Days||9
5217666|NCT00960856|12830475|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
5217667|NCT00960856|12830476|P1|COMPLETED|Washout Period of 7 Days||10
5217668|NCT00960856|12830473|P4|STARTED|Washout Period of 7 Days||9
5217669|NCT00960856|12830474|P3|STARTED|Washout Period of 7 Days||9
5217670|NCT00960856|12830475|P2|STARTED|Washout Period of 7 Days||9
5217671|NCT00960856|12830476|P1|STARTED|Washout Period of 7 Days||10
5217672|NCT00960856|12830473|P4|NOT COMPLETED|Period I||0
5217673|NCT00960856|12830474|P3|NOT COMPLETED|Period I||0
5217674|NCT00960856|12830475|P2|NOT COMPLETED|Period I||0
5217675|NCT00960856|12830476|P1|NOT COMPLETED|Period I||0
5217676|NCT00960856|12830473|P4|COMPLETED|Period I||9
5217677|NCT00960856|12830474|P3|COMPLETED|Period I||9
5217678|NCT00960856|12830475|P2|COMPLETED|Period I||9
5217679|NCT00960856|12830476|P1|COMPLETED|Period I||10
5217680|NCT00960856|12830473|P4|STARTED|Period I||9
5217681|NCT00960856|12830474|P3|STARTED|Period I||9
5217682|NCT00960856|12830475|P2|STARTED|Period I||9
5217683|NCT00960856|12830476|P1|STARTED|Period I||10
5217684|NCT00960843|12830496|P2|NOT COMPLETED|Overall Study||5
5217685|NCT00960843|12830497|P1|NOT COMPLETED|Overall Study||2
5217686|NCT00960843|12830496|P2|COMPLETED|Overall Study||21
5217687|NCT00960843|12830497|P1|COMPLETED|Overall Study||23
5217688|NCT00960843|12830496|P2|STARTED|Overall Study||26
5217689|NCT00960843|12830497|P1|STARTED|Overall Study||25
5217690|NCT00960778|12830509|P2|NOT COMPLETED|Overall Study||3
5217691|NCT00960778|12830510|P1|NOT COMPLETED|Overall Study||9
5217692|NCT00960778|12830509|P2|COMPLETED|Overall Study||13
5217693|NCT00960778|12830510|P1|COMPLETED|Overall Study||8
5217694|NCT00960778|12830509|P2|STARTED|Overall Study||16
5217695|NCT00960778|12830510|P1|STARTED|Overall Study||17
5217696|NCT00960687|12830518|P2|NOT COMPLETED|Second Intervention||0
5217697|NCT00960687|12830519|P1|NOT COMPLETED|Second Intervention||0
5217698|NCT00960687|12830518|P2|COMPLETED|Second Intervention||24
5217699|NCT00960687|12830519|P1|COMPLETED|Second Intervention||23
5217700|NCT00960687|12830518|P2|STARTED|Second Intervention||24
5217701|NCT00960687|12830519|P1|STARTED|Second Intervention||23
5217702|NCT00960687|12830518|P2|NOT COMPLETED|Washout Period of 7 Days||3
5217703|NCT00960687|12830519|P1|NOT COMPLETED|Washout Period of 7 Days||4
5217704|NCT00960687|12830518|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
5217705|NCT00960687|12830519|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
5217706|NCT00960687|12830518|P2|STARTED|Washout Period of 7 Days||27
5217707|NCT00960687|12830519|P1|STARTED|Washout Period of 7 Days||27
5217708|NCT00960687|12830518|P2|NOT COMPLETED|First Intervention||0
5217709|NCT00960687|12830519|P1|NOT COMPLETED|First Intervention||0
5217710|NCT00960687|12830518|P2|COMPLETED|First Intervention||27
5217711|NCT00960687|12830519|P1|COMPLETED|First Intervention||27
5217712|NCT00960687|12830518|P2|STARTED|First Intervention||27
5217713|NCT00960687|12830519|P1|STARTED|First Intervention||27
5217714|NCT00960661|12830531|P3|NOT COMPLETED|Interventional Phase||46
5217715|NCT00960661|12830532|P2|NOT COMPLETED|Interventional Phase||52
5217716|NCT00960661|12830533|P1|NOT COMPLETED|Interventional Phase||0
5217717|NCT00960661|12830531|P3|COMPLETED|Interventional Phase||275
5217718|NCT00960661|12830532|P2|COMPLETED|Interventional Phase||264
5217719|NCT00960661|12830533|P1|COMPLETED|Interventional Phase||0
5217720|NCT00960661|12830531|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
5217721|NCT00960661|12830532|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
5217722|NCT00960661|12830533|P1|Per Protocol Population|Interventional Phase||0
5217723|NCT00960661|12830531|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
5217724|NCT00960661|12830532|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
5217725|NCT00960661|12830533|P1|Intent to Treat Population|Interventional Phase||0
5217726|NCT00960661|12830531|P3|STARTED|Interventional Phase||321
5217727|NCT00960661|12830532|P2|STARTED|Interventional Phase||316
5217728|NCT00960661|12830533|P1|STARTED|Interventional Phase||0
5217729|NCT00960661|12830531|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
5217730|NCT00960661|12830532|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
5217731|NCT00960661|12830533|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
5217732|NCT00960661|12830531|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
5217733|NCT00960661|12830532|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
5217734|NCT00960661|12830533|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
5217735|NCT00960661|12830531|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
5217736|NCT00960661|12830532|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
5217737|NCT00960661|12830533|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
5217738|NCT00960622|12830565|P2|NOT COMPLETED|Overall Study||3
5217739|NCT00960622|12830566|P1|NOT COMPLETED|Overall Study||0
5217740|NCT00960622|12830565|P2|COMPLETED|Overall Study||7
5217741|NCT00960622|12830566|P1|COMPLETED|Overall Study||10
5217742|NCT00960622|12830565|P2|STARTED|Overall Study||10
5217743|NCT00960622|12830566|P1|STARTED|Overall Study||10
5217744|NCT00960570|12830572|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
5217745|NCT00960570|12830572|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
5217746|NCT00960570|12830572|P1|STARTED|Efavirenz and Fenofibric Acid||25
5217747|NCT00960570|12830572|P1|NOT COMPLETED|1 Day Period Between Dosing||3
5217748|NCT00960570|12830572|P1|COMPLETED|1 Day Period Between Dosing||25
5217749|NCT00960570|12830572|P1|STARTED|1 Day Period Between Dosing||28
5217750|NCT00960570|12830572|P1|NOT COMPLETED|Fenofibric Acid Alone||0
5217751|NCT00960570|12830572|P1|COMPLETED|Fenofibric Acid Alone||28
5217752|NCT00960570|12830572|P1|STARTED|Fenofibric Acid Alone||28
5217753|NCT00960570|12830572|P1|NOT COMPLETED|21 Day Washout Period||2
5217754|NCT00960570|12830572|P1|COMPLETED|21 Day Washout Period||28
5217755|NCT00960570|12830572|P1|STARTED|21 Day Washout Period||30
5217756|NCT00960570|12830572|P1|NOT COMPLETED|Efavirenz Alone||0
5217757|NCT00960570|12830572|P1|COMPLETED|Efavirenz Alone||30
5217758|NCT00960570|12830572|P1|STARTED|Efavirenz Alone||30
5217759|NCT00960531|12830593|P10|NOT COMPLETED|Overall Study||1
5217760|NCT00960531|12830594|P9|NOT COMPLETED|Overall Study||14
5217761|NCT00960531|12830595|P8|NOT COMPLETED|Overall Study||4
5217762|NCT00960531|12830596|P7|NOT COMPLETED|Overall Study||24
5217763|NCT00960531|12830597|P6|NOT COMPLETED|Overall Study||3
5217764|NCT00960531|12830598|P5|NOT COMPLETED|Overall Study||2
5217765|NCT00960531|12830599|P4|NOT COMPLETED|Overall Study||8
5217766|NCT00960531|12830600|P3|NOT COMPLETED|Overall Study||26
5217767|NCT00960531|12830601|P2|NOT COMPLETED|Overall Study||1
5217768|NCT00960531|12830602|P1|NOT COMPLETED|Overall Study||10
5217769|NCT00960531|12830593|P10|COMPLETED|Overall Study|Completed study|3
5217770|NCT00960531|12830594|P9|COMPLETED|Overall Study|Completed study|2
5217771|NCT00960531|12830595|P8|COMPLETED|Overall Study|Completed study|2
5217772|NCT00960531|12830596|P7|COMPLETED|Overall Study|Completed study|3
5217773|NCT00960531|12830597|P6|COMPLETED|Overall Study|Completed study|6
5217774|NCT00960531|12830598|P5|COMPLETED|Overall Study|Completed study|3
5217775|NCT00960531|12830599|P4|COMPLETED|Overall Study|Completed study|17
5217776|NCT00960531|12830600|P3|COMPLETED|Overall Study|Completed study|15
5217777|NCT00960531|12830601|P2|COMPLETED|Overall Study|Completed study|5
5217778|NCT00960531|12830602|P1|COMPLETED|Overall Study|Completed study|11
5217779|NCT00960531|12830593|P10|Completed Treatment|Overall Study||4
5217780|NCT00960531|12830594|P9|Completed Treatment|Overall Study||2
5217781|NCT00960531|12830595|P8|Completed Treatment|Overall Study||3
5217782|NCT00960531|12830596|P7|Completed Treatment|Overall Study||4
5217783|NCT00960531|12830597|P6|Completed Treatment|Overall Study||7
5217784|NCT00960531|12830598|P5|Completed Treatment|Overall Study||3
5217785|NCT00960531|12830599|P4|Completed Treatment|Overall Study||17
5217786|NCT00960531|12830600|P3|Completed Treatment|Overall Study||15
5217787|NCT00960531|12830601|P2|Completed Treatment|Overall Study||5
5217788|NCT00960531|12830602|P1|Completed Treatment|Overall Study||12
5217789|NCT00960531|12830593|P10|Treated|Overall Study||4
5217790|NCT00960531|12830594|P9|Treated|Overall Study||16
5217791|NCT00960531|12830595|P8|Treated|Overall Study||6
5217792|NCT00960531|12830596|P7|Treated|Overall Study||27
5217793|NCT00960531|12830597|P6|Treated|Overall Study||9
5217794|NCT00960531|12830598|P5|Treated|Overall Study||5
5217795|NCT00960531|12830599|P4|Treated|Overall Study||24
5217796|NCT00960531|12830600|P3|Treated|Overall Study||41
5217797|NCT00960531|12830601|P2|Treated|Overall Study||6
5217798|NCT00960531|12830602|P1|Treated|Overall Study||21
5217799|NCT00960531|12830593|P10|STARTED|Overall Study|Started=Randomized|4
5217800|NCT00960531|12830594|P9|STARTED|Overall Study|Started=Randomized|16
5217801|NCT00960531|12830595|P8|STARTED|Overall Study|Started=Randomized|6
5217802|NCT00960531|12830596|P7|STARTED|Overall Study|Started=Randomized|27
5217803|NCT00960531|12830597|P6|STARTED|Overall Study|Started=Randomized|9
5217804|NCT00960531|12830598|P5|STARTED|Overall Study|Started=Randomized|5
5217805|NCT00960531|12830599|P4|STARTED|Overall Study|Started=Randomized.|25
5217806|NCT00960531|12830600|P3|STARTED|Overall Study|Started=Randomized|41
5217807|NCT00960531|12830601|P2|STARTED|Overall Study|Started=Randomized|6
5217808|NCT00960531|12830602|P1|STARTED|Overall Study|Started=Randomized|21
5217809|NCT00960505|12830649|P3|NOT COMPLETED|Overall Study||8
5217810|NCT00960505|12830650|P2|NOT COMPLETED|Overall Study||10
5217811|NCT00960505|12830651|P1|NOT COMPLETED|Overall Study||13
5217812|NCT00960505|12830649|P3|COMPLETED|Overall Study||23
5217813|NCT00960505|12830650|P2|COMPLETED|Overall Study||25
5217814|NCT00960505|12830651|P1|COMPLETED|Overall Study||21
5217815|NCT00960505|12830649|P3|STARTED|Overall Study||31
5217816|NCT00960505|12830650|P2|STARTED|Overall Study||35
5217817|NCT00960505|12830651|P1|STARTED|Overall Study||34
5217818|NCT00960440|12830684|P4|NOT COMPLETED|Overall Study||18
5217819|NCT00960440|12830685|P3|NOT COMPLETED|Overall Study||13
5217820|NCT00960440|12830686|P2|NOT COMPLETED|Overall Study||31
5217821|NCT00960440|12830687|P1|NOT COMPLETED|Overall Study||26
5217822|NCT00960440|12830684|P4|COMPLETED|Overall Study||48
5217823|NCT00960440|12830685|P3|COMPLETED|Overall Study||53
5217824|NCT00960440|12830686|P2|COMPLETED|Overall Study||103
5217825|NCT00960440|12830687|P1|COMPLETED|Overall Study||107
5217826|NCT00960440|12830684|P4|STARTED|Overall Study||66
5217827|NCT00960440|12830685|P3|STARTED|Overall Study||66
5217828|NCT00960440|12830686|P2|STARTED|Overall Study||134
5217829|NCT00960440|12830687|P1|STARTED|Overall Study||133
5217830|NCT00960375|12830859|P2|NOT COMPLETED|Overall Study||22
5217831|NCT00960375|12830860|P1|NOT COMPLETED|Overall Study||20
5217832|NCT00960375|12830859|P2|COMPLETED|Overall Study||65
5217833|NCT00960375|12830860|P1|COMPLETED|Overall Study||72
5217834|NCT00960375|12830859|P2|STARTED|Overall Study||87
5217835|NCT00960375|12830860|P1|STARTED|Overall Study||92
5217836|NCT00960323|12830868|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
5217837|NCT00960323|12830868|P1|COMPLETED|Colchicine and Atorvastatin||23
5217838|NCT00960323|12830868|P1|STARTED|Colchicine and Atorvastatin||23
5217839|NCT00960323|12830868|P1|NOT COMPLETED|Atorvastatin Alone||1
5217840|NCT00960323|12830868|P1|COMPLETED|Atorvastatin Alone||23
5217841|NCT00960323|12830868|P1|STARTED|Atorvastatin Alone||24
5217842|NCT00960323|12830868|P1|NOT COMPLETED|14 Day Washout Period||0
5217843|NCT00960323|12830868|P1|COMPLETED|14 Day Washout Period||24
5217844|NCT00960323|12830868|P1|STARTED|14 Day Washout Period||24
5217845|NCT00960323|12830868|P1|NOT COMPLETED|Colchicine Alone||0
5217846|NCT00960323|12830868|P1|COMPLETED|Colchicine Alone||24
5217847|NCT00960323|12830868|P1|STARTED|Colchicine Alone||24
5217848|NCT00960297|12830879|P1|NOT COMPLETED|Overall Study||3
5217849|NCT00960297|12830879|P1|COMPLETED|Overall Study||1
5217850|NCT00960297|12830879|P1|STARTED|Overall Study||4
5217851|NCT00960206|12830886|P3|NOT COMPLETED|Overall Study||12
5217852|NCT00960206|12830887|P2|NOT COMPLETED|Overall Study||27
5217853|NCT00960206|12830888|P1|NOT COMPLETED|Overall Study||40
5217854|NCT00960206|12830886|P3|COMPLETED|Overall Study||77
5217855|NCT00960206|12830887|P2|COMPLETED|Overall Study||158
5217856|NCT00960206|12830888|P1|COMPLETED|Overall Study||150
5217857|NCT00960206|12830886|P3|STARTED|Overall Study||89
5217858|NCT00960206|12830887|P2|STARTED|Overall Study||185
5217859|NCT00960206|12830888|P1|STARTED|Overall Study||190
5217860|NCT00960193|12830906|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
5217861|NCT00960193|12830906|P1|COMPLETED|Colchicine With Seville Orange Juice||23
5217862|NCT00960193|12830906|P1|STARTED|Colchicine With Seville Orange Juice||23
5217863|NCT00960193|12830906|P1|NOT COMPLETED|Seville Orange Juice Alone||0
5217864|NCT00960193|12830906|P1|COMPLETED|Seville Orange Juice Alone||23
5217865|NCT00960193|12830906|P1|STARTED|Seville Orange Juice Alone||23
5217866|NCT00960193|12830906|P1|NOT COMPLETED|14 Day Washout Period||1
5217867|NCT00960193|12830906|P1|COMPLETED|14 Day Washout Period||23
5217868|NCT00960193|12830906|P1|STARTED|14 Day Washout Period||24
5217869|NCT00960193|12830906|P1|NOT COMPLETED|Colchicine Alone||0
5217870|NCT00960193|12830906|P1|COMPLETED|Colchicine Alone||24
5217871|NCT00960193|12830906|P1|STARTED|Colchicine Alone||24
5217872|NCT00960154|12830919|P2|NOT COMPLETED|Overall Study||25
5217873|NCT00960154|12830920|P1|NOT COMPLETED|Overall Study||25
5217874|NCT00960154|12830919|P2|COMPLETED|Overall Study||0
5217875|NCT00960154|12830920|P1|COMPLETED|Overall Study||0
5217876|NCT00960154|12830919|P2|STARTED|Overall Study||25
5217877|NCT00960154|12830920|P1|STARTED|Overall Study||25
5217878|NCT00960141|12830931|P3|NOT COMPLETED|Overall Study||7
5217879|NCT00960141|12830932|P2|NOT COMPLETED|Overall Study||17
5217880|NCT00960141|12830933|P1|NOT COMPLETED|Overall Study||10
5217881|NCT00960141|12830931|P3|COMPLETED|Overall Study||163
5217882|NCT00960141|12830932|P2|COMPLETED|Overall Study||309
5217883|NCT00960141|12830933|P1|COMPLETED|Overall Study||323
5217884|NCT00960141|12830931|P3|STARTED|Overall Study||170
5217885|NCT00960141|12830932|P2|STARTED|Overall Study||326
5217886|NCT00960141|12830933|P1|STARTED|Overall Study||333
5217887|NCT00960115|12830958|P2|NOT COMPLETED|Overall Study||15
5217888|NCT00960115|12830959|P1|NOT COMPLETED|Overall Study||19
5217889|NCT00960115|12830958|P2|COMPLETED|Overall Study||43
5217890|NCT00960115|12830959|P1|COMPLETED|Overall Study||95
5217891|NCT00960115|12830958|P2|STARTED|Overall Study||58
5217892|NCT00960115|12830959|P1|STARTED|Overall Study||114
5217893|NCT00960076|12830973|P2|NOT COMPLETED|Overall Study||25
5217894|NCT00960076|12830974|P1|NOT COMPLETED|Overall Study||8
5217895|NCT00960076|12830973|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
5217896|NCT00960076|12830974|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
5217897|NCT00960076|12830973|P2|STARTED|Overall Study|Randomized and treated|144
5217898|NCT00960076|12830974|P1|STARTED|Overall Study|Randomized and treated|138
5217899|NCT00960063|12830989|P3|NOT COMPLETED|Overall Study||3
5217900|NCT00960063|12830990|P2|NOT COMPLETED|Overall Study||0
5217901|NCT00960063|12830991|P1|NOT COMPLETED|Overall Study||1
5217902|NCT00960063|12830989|P3|COMPLETED|Overall Study||0
5217903|NCT00960063|12830990|P2|COMPLETED|Overall Study||0
5217904|NCT00960063|12830991|P1|COMPLETED|Overall Study||0
5217905|NCT00960063|12830989|P3|STARTED|Overall Study||3
5217906|NCT00960063|12830990|P2|STARTED|Overall Study||0
5217907|NCT00960063|12830991|P1|STARTED|Overall Study||1
5217908|NCT00960011|12831031|P2|NOT COMPLETED|Overall Study||2
5217909|NCT00960011|12831032|P1|NOT COMPLETED|Overall Study||11
5217910|NCT00960011|12831031|P2|COMPLETED|Overall Study||23
5217911|NCT00960011|12831032|P1|COMPLETED|Overall Study||22
5217912|NCT00960011|12831031|P2|STARTED|Overall Study||25
5217913|NCT00960011|12831032|P1|STARTED|Overall Study||33
5217914|NCT00959985|12831076|P4|NOT COMPLETED|Overall Study||0
5217915|NCT00959985|12831077|P3|NOT COMPLETED|Overall Study||0
5217916|NCT00959985|12831078|P2|NOT COMPLETED|Overall Study||0
5217917|NCT00959985|12831079|P1|NOT COMPLETED|Overall Study||0
5217918|NCT00959985|12831076|P4|COMPLETED|Overall Study||4
5217919|NCT00959985|12831077|P3|COMPLETED|Overall Study||4
5217920|NCT00959985|12831078|P2|COMPLETED|Overall Study||7
5217921|NCT00959985|12831079|P1|COMPLETED|Overall Study||8
5217922|NCT00959985|12831076|P4|STARTED|Overall Study||4
5217923|NCT00959985|12831077|P3|STARTED|Overall Study||4
5217924|NCT00959985|12831078|P2|STARTED|Overall Study||7
5217925|NCT00959985|12831079|P1|STARTED|Overall Study||8
5217926|NCT00959946|12831125|P8|NOT COMPLETED|Overall Study||2
5217927|NCT00959946|12831126|P7|NOT COMPLETED|Overall Study||2
5217928|NCT00959946|12831127|P6|NOT COMPLETED|Overall Study||9
5217929|NCT00959946|12831128|P5|NOT COMPLETED|Overall Study||4
5217930|NCT00959946|12831129|P4|NOT COMPLETED|Overall Study||5
5217931|NCT00959946|12831130|P3|NOT COMPLETED|Overall Study||4
5217932|NCT00959946|12831131|P2|NOT COMPLETED|Overall Study||4
5217933|NCT00959946|12831132|P1|NOT COMPLETED|Overall Study||2
5217934|NCT00959946|12831125|P8|COMPLETED|Overall Study||0
5217935|NCT00959946|12831126|P7|COMPLETED|Overall Study||0
5217936|NCT00959946|12831127|P6|COMPLETED|Overall Study||0
5217937|NCT00959946|12831128|P5|COMPLETED|Overall Study||0
5217938|NCT00959946|12831129|P4|COMPLETED|Overall Study||0
5217939|NCT00959946|12831130|P3|COMPLETED|Overall Study||0
5217940|NCT00959946|12831131|P2|COMPLETED|Overall Study||0
5217941|NCT00959946|12831132|P1|COMPLETED|Overall Study||0
5217942|NCT00959946|12831125|P8|STARTED|Overall Study||2
5217943|NCT00959946|12831126|P7|STARTED|Overall Study||2
5217944|NCT00959946|12831127|P6|STARTED|Overall Study||9
5217945|NCT00959946|12831128|P5|STARTED|Overall Study||4
5217946|NCT00959946|12831129|P4|STARTED|Overall Study||5
5217947|NCT00959946|12831130|P3|STARTED|Overall Study||4
5217948|NCT00959946|12831131|P2|STARTED|Overall Study||4
5217949|NCT00959946|12831132|P1|STARTED|Overall Study||2
5217950|NCT00959920|12831185|P2|NOT COMPLETED|Overall Study||1
5217951|NCT00959920|12831186|P1|NOT COMPLETED|Overall Study||0
5217952|NCT00959920|12831185|P2|COMPLETED|Overall Study||66
5217953|NCT00959920|12831186|P1|COMPLETED|Overall Study||72
5217954|NCT00959920|12831185|P2|STARTED|Overall Study||67
5217955|NCT00959920|12831186|P1|STARTED|Overall Study||72
5217956|NCT00959907|12831196|P2|NOT COMPLETED|Overall Study||1
5217957|NCT00959907|12831197|P1|NOT COMPLETED|Overall Study||3
5217958|NCT00959907|12831196|P2|COMPLETED|Overall Study||28
5217959|NCT00959907|12831197|P1|COMPLETED|Overall Study||27
5217960|NCT00959907|12831196|P2|STARTED|Overall Study||29
5217961|NCT00959907|12831197|P1|STARTED|Overall Study||30
5217962|NCT00959894|12831207|P1|NOT COMPLETED|Overall Study||16
5217963|NCT00959894|12831207|P1|COMPLETED|Overall Study||63
5217964|NCT00959894|12831207|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
5217965|NCT00959764|12831238|P3|NOT COMPLETED|Overall Study||36
5217966|NCT00959764|12831239|P2|NOT COMPLETED|Overall Study||57
5217967|NCT00959764|12831240|P1|NOT COMPLETED|Overall Study||95
5217968|NCT00959764|12831238|P3|COMPLETED|Overall Study||73
5217969|NCT00959764|12831239|P2|COMPLETED|Overall Study||128
5217970|NCT00959764|12831240|P1|COMPLETED|Overall Study||176
5217971|NCT00959764|12831238|P3|STARTED|Overall Study||109
5217972|NCT00959764|12831239|P2|STARTED|Overall Study||185
5217973|NCT00959764|12831240|P1|STARTED|Overall Study||271
5217974|NCT00959751|12831256|P2|NOT COMPLETED|Overall Study||12
5217975|NCT00959751|12831257|P1|NOT COMPLETED|Overall Study||9
5217976|NCT00959751|12831256|P2|COMPLETED|Overall Study||86
5217977|NCT00959751|12831257|P1|COMPLETED|Overall Study||88
5217978|NCT00959751|12831256|P2|STARTED|Overall Study||98
5217979|NCT00959751|12831257|P1|STARTED|Overall Study||97
5217980|NCT00959699|12831279|P2|NOT COMPLETED|Follow-up Period||6
5217981|NCT00959699|12831280|P1|NOT COMPLETED|Follow-up Period||6
5217982|NCT00959699|12831279|P2|COMPLETED|Follow-up Period||56
5217983|NCT00959699|12831280|P1|COMPLETED|Follow-up Period||27
5217984|NCT00959699|12831279|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
5217985|NCT00959699|12831280|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
5217986|NCT00959699|12831279|P2|NOT COMPLETED|Treatment Period||25
5217987|NCT00959699|12831280|P1|NOT COMPLETED|Treatment Period||23
5217988|NCT00959699|12831279|P2|COMPLETED|Treatment Period||40
5217989|NCT00959699|12831280|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
5217990|NCT00959699|12831279|P2|Treated|Treatment Period||64
5217991|NCT00959699|12831280|P1|Treated|Treatment Period||34
5217992|NCT00959699|12831279|P2|STARTED|Treatment Period||65
5217993|NCT00959699|12831280|P1|STARTED|Treatment Period||34
5217994|NCT00959660|12831301|P4|NOT COMPLETED|Overall Study||3
5217995|NCT00959660|12831302|P3|NOT COMPLETED|Overall Study||3
5217996|NCT00959660|12831303|P2|NOT COMPLETED|Overall Study||0
5217997|NCT00959660|12831304|P1|NOT COMPLETED|Overall Study||2
5217998|NCT00959660|12831301|P4|COMPLETED|Overall Study||22
5217999|NCT00959660|12831302|P3|COMPLETED|Overall Study||22
5218000|NCT00959660|12831303|P2|COMPLETED|Overall Study||24
5218001|NCT00959660|12831304|P1|COMPLETED|Overall Study||24
5218002|NCT00959660|12831301|P4|STARTED|Overall Study||25
5218003|NCT00959660|12831302|P3|STARTED|Overall Study||25
5218004|NCT00959660|12831303|P2|STARTED|Overall Study||24
5218005|NCT00959660|12831304|P1|STARTED|Overall Study||26
5218006|NCT00959647|12831326|P1|NOT COMPLETED|Overall Study||19
5218007|NCT00959647|12831326|P1|COMPLETED|Overall Study||0
5218008|NCT00959647|12831326|P1|STARTED|Overall Study||19
5218009|NCT00959374|12831331|P1|NOT COMPLETED|Overall Study||23
5218010|NCT00959374|12831331|P1|COMPLETED|Overall Study||218
5218011|NCT00959374|12831331|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
5218012|NCT00959192|12831345|P4|NOT COMPLETED|Overall Study||1
5218013|NCT00959192|12831346|P3|NOT COMPLETED|Overall Study||3
5218014|NCT00959192|12831347|P2|NOT COMPLETED|Overall Study||1
5218015|NCT00959192|12831348|P1|NOT COMPLETED|Overall Study||2
5218016|NCT00959192|12831345|P4|COMPLETED|Overall Study||7
5218017|NCT00959192|12831346|P3|COMPLETED|Overall Study||6
5218018|NCT00959192|12831347|P2|COMPLETED|Overall Study||8
5218019|NCT00959192|12831348|P1|COMPLETED|Overall Study||4
5218020|NCT00959192|12831345|P4|STARTED|Overall Study||8
5218021|NCT00959192|12831346|P3|STARTED|Overall Study||9
5218022|NCT00959192|12831347|P2|STARTED|Overall Study||9
5218023|NCT00959192|12831348|P1|STARTED|Overall Study||6
5218024|NCT00959166|12831392|P2|NOT COMPLETED|Overall Study||0
5218025|NCT00959166|12831393|P1|NOT COMPLETED|Overall Study||0
5218026|NCT00959166|12831392|P2|COMPLETED|Overall Study||57
5218027|NCT00959166|12831393|P1|COMPLETED|Overall Study||24
5218028|NCT00959166|12831392|P2|STARTED|Overall Study||57
5218029|NCT00959166|12831393|P1|STARTED|Overall Study||24
5218030|NCT00959049|12831407|P6|NOT COMPLETED|Overall Study||1
5218031|NCT00959049|12831408|P5|NOT COMPLETED|Overall Study||9
5218032|NCT00959049|12831409|P4|NOT COMPLETED|Overall Study||11
5218033|NCT00959049|12831410|P3|NOT COMPLETED|Overall Study||1
5218034|NCT00959049|12831411|P2|NOT COMPLETED|Overall Study||7
5218035|NCT00959049|12831412|P1|NOT COMPLETED|Overall Study||18
5218036|NCT00959049|12831407|P6|COMPLETED|Overall Study||249
5218037|NCT00959049|12831408|P5|COMPLETED|Overall Study||248
5218038|NCT00959049|12831409|P4|COMPLETED|Overall Study||217
5218039|NCT00959049|12831410|P3|COMPLETED|Overall Study||253
5218040|NCT00959049|12831411|P2|COMPLETED|Overall Study||247
5218041|NCT00959049|12831412|P1|COMPLETED|Overall Study||213
5218042|NCT00959049|12831407|P6|STARTED|Overall Study||250
5218043|NCT00959049|12831408|P5|STARTED|Overall Study||257
5218044|NCT00959049|12831409|P4|STARTED|Overall Study||228
5218045|NCT00959049|12831410|P3|STARTED|Overall Study||254
5218046|NCT00959049|12831411|P2|STARTED|Overall Study||254
5218047|NCT00959049|12831412|P1|STARTED|Overall Study||231
5218048|NCT00958919|12831462|P2|NOT COMPLETED|Second Intervention||0
5218049|NCT00958919|12831463|P1|NOT COMPLETED|Second Intervention||0
5218050|NCT00958919|12831462|P2|COMPLETED|Second Intervention||7
5218051|NCT00958919|12831463|P1|COMPLETED|Second Intervention||7
5218052|NCT00958919|12831462|P2|STARTED|Second Intervention||7
5218053|NCT00958919|12831463|P1|STARTED|Second Intervention||7
5218054|NCT00958919|12831462|P2|NOT COMPLETED|First Intervention||0
5218055|NCT00958919|12831463|P1|NOT COMPLETED|First Intervention||0
5218056|NCT00958919|12831462|P2|COMPLETED|First Intervention||7
5218057|NCT00958919|12831463|P1|COMPLETED|First Intervention||7
5218058|NCT00958919|12831462|P2|STARTED|First Intervention||7
5218059|NCT00958919|12831463|P1|STARTED|First Intervention||7
5218060|NCT00958893|12831477|P1|NOT COMPLETED|Overall Study||4
5218061|NCT00958893|12831477|P1|COMPLETED|Overall Study||0
5218062|NCT00958893|12831477|P1|STARTED|Overall Study||4
5218063|NCT00958880|12831483|P2|NOT COMPLETED|Overall Study||2
5218064|NCT00958880|12831484|P1|NOT COMPLETED|Overall Study||2
5218065|NCT00958880|12831483|P2|COMPLETED|Overall Study||18
5218066|NCT00958880|12831484|P1|COMPLETED|Overall Study||18
5218067|NCT00958880|12831483|P2|STARTED|Overall Study||20
5218068|NCT00958880|12831484|P1|STARTED|Overall Study||20
5218069|NCT00958841|12831492|P1|NOT COMPLETED|Overall Study||96
5218070|NCT00958841|12831492|P1|COMPLETED|Overall Study|Completed = Completed extension|22
5218071|NCT00958841|12831492|P1|Entered in Extension|Overall Study||63
5218072|NCT00958841|12831492|P1|Completed Month 6 (M6)|Overall Study||90
5218073|NCT00958841|12831492|P1|STARTED|Overall Study||118
5218074|NCT00958828|12831510|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
5218075|NCT00958828|12831511|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
5218076|NCT00958828|12831510|P2|COMPLETED|Period 2, 1 Week of Wear||87
5218077|NCT00958828|12831511|P1|COMPLETED|Period 2, 1 Week of Wear||89
5218078|NCT00958828|12831510|P2|STARTED|Period 2, 1 Week of Wear||88
5218079|NCT00958828|12831511|P1|STARTED|Period 2, 1 Week of Wear||89
5218080|NCT00958828|12831510|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
5218081|NCT00958828|12831511|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
5218082|NCT00958828|12831510|P2|COMPLETED|Period 1, 1 Week of Wear||88
5218083|NCT00958828|12831511|P1|COMPLETED|Period 1, 1 Week of Wear||89
5218084|NCT00958828|12831510|P2|STARTED|Period 1, 1 Week of Wear||89
5218085|NCT00958828|12831511|P1|STARTED|Period 1, 1 Week of Wear||89
5218086|NCT00958789|12831517|P1|NOT COMPLETED|Overall Study||50
5218087|NCT00958789|12831517|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
5218088|NCT00958789|12831517|P1|STARTED|Overall Study||180
5218089|NCT00958776|12831537|P2|NOT COMPLETED|Overall Study||29
5218090|NCT00958776|12831538|P1|NOT COMPLETED|Overall Study||16
5218091|NCT00958776|12831537|P2|COMPLETED|Overall Study||239
5218092|NCT00958776|12831538|P1|COMPLETED|Overall Study||121
5218093|NCT00958776|12831537|P2|STARTED|Overall Study||268
5218094|NCT00958776|12831538|P1|STARTED|Overall Study||137
5218095|NCT00958724|12831568|P1|NOT COMPLETED|Overall Study||6
5218096|NCT00958724|12831568|P1|COMPLETED|Overall Study||0
5218097|NCT00958724|12831568|P1|STARTED|Overall Study||6
5218098|NCT00958711|12831580|P2|NOT COMPLETED|Overall Study||21
5218099|NCT00958711|12831581|P1|NOT COMPLETED|Overall Study||13
5218100|NCT00958711|12831580|P2|COMPLETED|Overall Study||27
5218101|NCT00958711|12831581|P1|COMPLETED|Overall Study||29
5218102|NCT00958711|12831580|P2|STARTED|Overall Study||48
5218103|NCT00958711|12831581|P1|STARTED|Overall Study||42
5218104|NCT00958581|12831610|P3|NOT COMPLETED|Overall Study||0
5218105|NCT00958581|12831611|P2|NOT COMPLETED|Overall Study||0
5218106|NCT00958581|12831612|P1|NOT COMPLETED|Overall Study||0
5218107|NCT00958581|12831610|P3|COMPLETED|Overall Study||55
5218108|NCT00958581|12831611|P2|COMPLETED|Overall Study||61
5218109|NCT00958581|12831612|P1|COMPLETED|Overall Study||61
5218110|NCT00958581|12831610|P3|STARTED|Overall Study||55
5218111|NCT00958581|12831611|P2|STARTED|Overall Study||61
5218112|NCT00958581|12831612|P1|STARTED|Overall Study||61
5218113|NCT00958568|12831626|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
5218114|NCT00958568|12831627|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
5218115|NCT00958568|12831628|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218116|NCT00958568|12831629|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218117|NCT00958568|12831626|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
5218118|NCT00958568|12831627|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
5218119|NCT00958568|12831628|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218120|NCT00958568|12831629|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218121|NCT00958568|12831626|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
5218122|NCT00958568|12831627|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
5218123|NCT00958568|12831628|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218124|NCT00958568|12831629|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
5218125|NCT00958568|12831626|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218126|NCT00958568|12831627|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218127|NCT00958568|12831628|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
5218128|NCT00958568|12831629|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218129|NCT00958568|12831626|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218130|NCT00958568|12831627|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218131|NCT00958568|12831628|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
5218132|NCT00958568|12831629|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218133|NCT00958568|12831626|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218134|NCT00958568|12831627|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218135|NCT00958568|12831628|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
5218136|NCT00958568|12831629|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
5218137|NCT00958568|12831626|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218138|NCT00958568|12831627|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218139|NCT00958568|12831628|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218140|NCT00958568|12831629|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
5218141|NCT00958568|12831626|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218142|NCT00958568|12831627|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218143|NCT00958568|12831628|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
5218144|NCT00958568|12831629|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
5218145|NCT00958568|12831626|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
5218146|NCT00958568|12831627|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
5218147|NCT00958568|12831628|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
5218148|NCT00958568|12831629|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
5218149|NCT00958477|12831714|P4|NOT COMPLETED|Overall Study||0
5218150|NCT00958477|12831715|P3|NOT COMPLETED|Overall Study||0
5218151|NCT00958477|12831716|P2|NOT COMPLETED|Overall Study||0
5218152|NCT00958477|12831717|P1|NOT COMPLETED|Overall Study||0
5218153|NCT00958477|12831714|P4|COMPLETED|Overall Study||6
5218154|NCT00958477|12831715|P3|COMPLETED|Overall Study||6
5218155|NCT00958477|12831716|P2|COMPLETED|Overall Study||6
5218156|NCT00958477|12831717|P1|COMPLETED|Overall Study||8
5218157|NCT00958477|12831714|P4|STARTED|Overall Study||6
5218158|NCT00958477|12831715|P3|STARTED|Overall Study||6
5218159|NCT00958477|12831716|P2|STARTED|Overall Study||6
5218160|NCT00958477|12831717|P1|STARTED|Overall Study||8
5218161|NCT00958438|12831866|P3|NOT COMPLETED|Overall Study||6
5218162|NCT00958438|12831867|P2|NOT COMPLETED|Overall Study||10
5218163|NCT00958438|12831868|P1|NOT COMPLETED|Overall Study||10
5218164|NCT00958438|12831866|P3|COMPLETED|Overall Study||78
5218165|NCT00958438|12831867|P2|COMPLETED|Overall Study||72
5218166|NCT00958438|12831868|P1|COMPLETED|Overall Study||72
5218167|NCT00958438|12831866|P3|STARTED|Overall Study||84
5218168|NCT00958438|12831867|P2|STARTED|Overall Study||82
5218169|NCT00958438|12831868|P1|STARTED|Overall Study||82
5218170|NCT00958412|12831891|P1|NOT COMPLETED|Overall Study||18
5218171|NCT00958412|12831891|P1|COMPLETED|Overall Study||0
5218172|NCT00958412|12831891|P1|STARTED|Overall Study||18
5218173|NCT00958360|12831897|P2|NOT COMPLETED|Overall Study||10
5218174|NCT00958360|12831898|P1|NOT COMPLETED|Overall Study||11
5218175|NCT00958360|12831897|P2|COMPLETED|Overall Study||150
5218176|NCT00958360|12831898|P1|COMPLETED|Overall Study||152
5218177|NCT00958360|12831897|P2|STARTED|Overall Study||160
5218178|NCT00958360|12831898|P1|STARTED|Overall Study||163
5218179|NCT00958347|12831912|P1|NOT COMPLETED|Overall Study||226
5218180|NCT00958347|12831912|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
5218181|NCT00958347|12831912|P1|STARTED|Overall Study||226
5218182|NCT00958334|12831919|P3|NOT COMPLETED|Overall Study||13
5218183|NCT00958334|12831920|P2|NOT COMPLETED|Overall Study||17
5218184|NCT00958334|12831921|P1|NOT COMPLETED|Overall Study||14
5218185|NCT00958334|12831919|P3|COMPLETED|Overall Study||8
5218186|NCT00958334|12831920|P2|COMPLETED|Overall Study||5
5218187|NCT00958334|12831921|P1|COMPLETED|Overall Study||8
5218188|NCT00958334|12831919|P3|STARTED|Overall Study||21
5218189|NCT00958334|12831920|P2|STARTED|Overall Study||22
5218190|NCT00958334|12831921|P1|STARTED|Overall Study||22
5218191|NCT00958308|12831935|P3|NOT COMPLETED|Overall Study||0
5218192|NCT00958308|12831936|P2|NOT COMPLETED|Overall Study||0
5218193|NCT00958308|12831937|P1|NOT COMPLETED|Overall Study||0
5218194|NCT00958308|12831935|P3|COMPLETED|Overall Study||86
5218195|NCT00958308|12831936|P2|COMPLETED|Overall Study||85
5218196|NCT00958308|12831937|P1|COMPLETED|Overall Study||84
5218197|NCT00958308|12831935|P3|STARTED|Overall Study||86
5218198|NCT00958308|12831936|P2|STARTED|Overall Study||85
5218199|NCT00958308|12831937|P1|STARTED|Overall Study||84
5218200|NCT00958282|12831947|P2|NOT COMPLETED|Overall Study||6
5218201|NCT00958282|12831948|P1|NOT COMPLETED|Overall Study||10
5218202|NCT00958282|12831947|P2|COMPLETED|Overall Study||15
5218203|NCT00958282|12831948|P1|COMPLETED|Overall Study||12
5218204|NCT00958282|12831947|P2|STARTED|Overall Study||21
5218205|NCT00958282|12831948|P1|STARTED|Overall Study||22
5218206|NCT00958256|12831956|P1|NOT COMPLETED|Overall Study||3
5218207|NCT00958256|12831956|P1|COMPLETED|Overall Study||18
5218208|NCT00958256|12831956|P1|STARTED|Overall Study||21
5218209|NCT00958243|12831966|P6|NOT COMPLETED|Overall Study||10
5218210|NCT00958243|12831967|P5|NOT COMPLETED|Overall Study||9
5218211|NCT00958243|12831968|P4|NOT COMPLETED|Overall Study||3
5218212|NCT00958243|12831969|P3|NOT COMPLETED|Overall Study||14
5218213|NCT00958243|12831970|P2|NOT COMPLETED|Overall Study||6
5218214|NCT00958243|12831971|P1|NOT COMPLETED|Overall Study||2
5218215|NCT00958243|12831966|P6|COMPLETED|Overall Study||99
5218216|NCT00958243|12831967|P5|COMPLETED|Overall Study||100
5218217|NCT00958243|12831968|P4|COMPLETED|Overall Study||25
5218218|NCT00958243|12831969|P3|COMPLETED|Overall Study||82
5218219|NCT00958243|12831970|P2|COMPLETED|Overall Study||99
5218220|NCT00958243|12831971|P1|COMPLETED|Overall Study||24
5218221|NCT00958243|12831966|P6|STARTED|Overall Study||109
5218222|NCT00958243|12831967|P5|STARTED|Overall Study||109
5218223|NCT00958243|12831968|P4|STARTED|Overall Study||28
5218224|NCT00958243|12831969|P3|STARTED|Overall Study||96
5218225|NCT00958243|12831970|P2|STARTED|Overall Study||105
5218226|NCT00958243|12831971|P1|STARTED|Overall Study||26
5218227|NCT00958217|12832029|P2|NOT COMPLETED|Overall Study||25
5218228|NCT00958217|12832030|P1|NOT COMPLETED|Overall Study||24
5218229|NCT00958217|12832029|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
5218230|NCT00958217|12832030|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
5218231|NCT00958217|12832029|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
5218232|NCT00958217|12832030|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
5218233|NCT00958217|12832029|P2|STARTED|Overall Study||62
5218234|NCT00958217|12832030|P1|STARTED|Overall Study||61
5218235|NCT00958191|12832041|P1|NOT COMPLETED|Overall Study||111
5218236|NCT00958191|12832041|P1|COMPLETED|Overall Study||110
5218237|NCT00958191|12832041|P1|STARTED|Overall Study||221
5218238|NCT00958165|12832056|P1|NOT COMPLETED|Overall Study||14
5218239|NCT00958165|12832056|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
5218240|NCT00958165|12832056|P1|Treated|Overall Study||72
5218241|NCT00958165|12832056|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
5218242|NCT00958126|12832068|P8|NOT COMPLETED|Overall Study||0
5218243|NCT00958126|12832069|P7|NOT COMPLETED|Overall Study||1
5218244|NCT00958126|12832070|P6|NOT COMPLETED|Overall Study||1
5218245|NCT00958126|12832071|P5|NOT COMPLETED|Overall Study||0
5218246|NCT00958126|12832072|P4|NOT COMPLETED|Overall Study||11
5218247|NCT00958126|12832073|P3|NOT COMPLETED|Overall Study||10
5218248|NCT00958126|12832074|P2|NOT COMPLETED|Overall Study||9
5218249|NCT00958126|12832075|P1|NOT COMPLETED|Overall Study||1
5218250|NCT00958126|12832068|P8|COMPLETED|Overall Study||202
5218251|NCT00958126|12832069|P7|COMPLETED|Overall Study||199
5218252|NCT00958126|12832070|P6|COMPLETED|Overall Study||202
5218253|NCT00958126|12832071|P5|COMPLETED|Overall Study||50
5218254|NCT00958126|12832072|P4|COMPLETED|Overall Study||192
5218255|NCT00958126|12832073|P3|COMPLETED|Overall Study||191
5218256|NCT00958126|12832074|P2|COMPLETED|Overall Study||196
5218257|NCT00958126|12832075|P1|COMPLETED|Overall Study||48
5218258|NCT00958126|12832068|P8|STARTED|Overall Study||202
5218259|NCT00958126|12832069|P7|STARTED|Overall Study||200
5218260|NCT00958126|12832070|P6|STARTED|Overall Study||203
5218261|NCT00958126|12832071|P5|STARTED|Overall Study||50
5218262|NCT00958126|12832072|P4|STARTED|Overall Study||203
5218263|NCT00958126|12832073|P3|STARTED|Overall Study||201
5218264|NCT00958126|12832074|P2|STARTED|Overall Study||205
5218265|NCT00958126|12832075|P1|STARTED|Overall Study||49
5218266|NCT00958074|12832147|P2|NOT COMPLETED|Overall Study||1
5218267|NCT00958074|12832148|P1|NOT COMPLETED|Overall Study||0
5218268|NCT00958074|12832147|P2|COMPLETED|Overall Study||6
5218269|NCT00958074|12832148|P1|COMPLETED|Overall Study||4
5218270|NCT00958074|12832147|P2|STARTED|Overall Study||7
5218271|NCT00958074|12832148|P1|STARTED|Overall Study||4
5218272|NCT00958035|12832164|P2|NOT COMPLETED|Overall Study||4
5218273|NCT00958035|12832165|P1|NOT COMPLETED|Overall Study||3
5218274|NCT00958035|12832164|P2|COMPLETED|Overall Study||39
5218275|NCT00958035|12832165|P1|COMPLETED|Overall Study||43
5218276|NCT00958035|12832164|P2|STARTED|Overall Study||43
5218277|NCT00958035|12832165|P1|STARTED|Overall Study||46
5218278|NCT00958009|12832171|P1|NOT COMPLETED|Overall Study||2
5218279|NCT00958009|12832171|P1|COMPLETED|Overall Study||107
5218280|NCT00958009|12832171|P1|STARTED|Overall Study||109
5218281|NCT00957996|12832178|P2|NOT COMPLETED|Overall Study||28
5218282|NCT00957996|12832179|P1|NOT COMPLETED|Overall Study||26
5218283|NCT00957996|12832178|P2|COMPLETED|Overall Study||89
5218284|NCT00957996|12832179|P1|COMPLETED|Overall Study||91
5218285|NCT00957996|12832178|P2|STARTED|Overall Study||117
5218286|NCT00957996|12832179|P1|STARTED|Overall Study||117
5218287|NCT00957944|12832211|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
5218288|NCT00957944|12832212|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
5218289|NCT00957944|12832211|P2|COMPLETED|Second Intervention- 24 Hours||19
5218290|NCT00957944|12832212|P1|COMPLETED|Second Intervention- 24 Hours||20
5218291|NCT00957944|12832211|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
5218292|NCT00957944|12832212|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
5218293|NCT00957944|12832211|P2|STARTED|Second Intervention- 24 Hours||19
5218294|NCT00957944|12832212|P1|STARTED|Second Intervention- 24 Hours||20
5218295|NCT00957944|12832211|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
5218296|NCT00957944|12832212|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
5218297|NCT00957944|12832211|P2|COMPLETED|Washout Period of at Least 5 Days||19
5218298|NCT00957944|12832212|P1|COMPLETED|Washout Period of at Least 5 Days||20
5218299|NCT00957944|12832211|P2|STARTED|Washout Period of at Least 5 Days||19
5218300|NCT00957944|12832212|P1|STARTED|Washout Period of at Least 5 Days||20
5218301|NCT00957944|12832211|P2|NOT COMPLETED|First Intervention- 24 Hours||1
5218302|NCT00957944|12832212|P1|NOT COMPLETED|First Intervention- 24 Hours||0
5218303|NCT00957944|12832211|P2|COMPLETED|First Intervention- 24 Hours||19
5218304|NCT00957944|12832212|P1|COMPLETED|First Intervention- 24 Hours||20
5218305|NCT00957944|12832211|P2|STARTED|First Intervention- 24 Hours||20
5218306|NCT00957944|12832212|P1|STARTED|First Intervention- 24 Hours||20
5218307|NCT00957931|12832246|P1|NOT COMPLETED|Overall Study||4
5218308|NCT00957931|12832246|P1|COMPLETED|Overall Study||2
5218309|NCT00957931|12832246|P1|STARTED|Overall Study||6
5218310|NCT00957905|12832256|P2|NOT COMPLETED|Part B||4
5218311|NCT00957905|12832257|P1|NOT COMPLETED|Part B||0
5218312|NCT00957905|12832256|P2|COMPLETED|Part B||25
5218313|NCT00957905|12832257|P1|COMPLETED|Part B||0
5218314|NCT00957905|12832256|P2|STARTED|Part B||29
5218315|NCT00957905|12832257|P1|STARTED|Part B||0
5218316|NCT00957905|12832256|P2|NOT COMPLETED|Part A||0
5218317|NCT00957905|12832257|P1|NOT COMPLETED|Part A||0
5218318|NCT00957905|12832256|P2|COMPLETED|Part A||0
5218319|NCT00957905|12832257|P1|COMPLETED|Part A||7
5218320|NCT00957905|12832256|P2|STARTED|Part A||0
5218321|NCT00957905|12832257|P1|STARTED|Part A||7
5218322|NCT00957853|12832266|P3|NOT COMPLETED|Overall Study||0
5218323|NCT00957853|12832267|P2|NOT COMPLETED|Overall Study||0
5218324|NCT00957853|12832268|P1|NOT COMPLETED|Overall Study||1
5218325|NCT00957853|12832266|P3|COMPLETED|Overall Study||5
5218326|NCT00957853|12832267|P2|COMPLETED|Overall Study||6
5218327|NCT00957853|12832268|P1|COMPLETED|Overall Study||3
5218328|NCT00957853|12832266|P3|Neoadjuvant Tx Completion|Overall Study||5
5218329|NCT00957853|12832267|P2|Neoadjuvant Tx Completion|Overall Study||6
5218330|NCT00957853|12832268|P1|Neoadjuvant Tx Completion|Overall Study||3
5218331|NCT00957853|12832266|P3|Randomization|Overall Study||5
5218332|NCT00957853|12832267|P2|Randomization|Overall Study||6
5218333|NCT00957853|12832268|P1|Randomization|Overall Study||4
5218334|NCT00957853|12832266|P3|STARTED|Overall Study||5
5218335|NCT00957853|12832267|P2|STARTED|Overall Study||6
5218336|NCT00957853|12832268|P1|STARTED|Overall Study||4
5218337|NCT00957827|12832281|P2|NOT COMPLETED|Overall Study||0
5218338|NCT00957827|12832282|P1|NOT COMPLETED|Overall Study||0
5218339|NCT00957827|12832281|P2|COMPLETED|Overall Study||2
5218340|NCT00957827|12832282|P1|COMPLETED|Overall Study||2
5218341|NCT00957827|12832281|P2|STARTED|Overall Study||2
5218342|NCT00957827|12832282|P1|STARTED|Overall Study||2
5218343|NCT00957801|12832292|P4|NOT COMPLETED|Overall Study||1
5218344|NCT00957801|12832293|P3|NOT COMPLETED|Overall Study||0
5218345|NCT00957801|12832294|P2|NOT COMPLETED|Overall Study||0
5218346|NCT00957801|12832295|P1|NOT COMPLETED|Overall Study||0
5218347|NCT00957801|12832292|P4|COMPLETED|Overall Study||7
5218348|NCT00957801|12832293|P3|COMPLETED|Overall Study||7
5218349|NCT00957801|12832294|P2|COMPLETED|Overall Study||7
5218350|NCT00957801|12832295|P1|COMPLETED|Overall Study||7
5218351|NCT00957801|12832292|P4|STARTED|Overall Study||8
5218352|NCT00957801|12832293|P3|STARTED|Overall Study||7
5218353|NCT00957801|12832294|P2|STARTED|Overall Study||7
5218354|NCT00957801|12832295|P1|STARTED|Overall Study||7
5218355|NCT00957723|12832461|P1|NOT COMPLETED|Overall Study||113
5218356|NCT00957723|12832461|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
5218357|NCT00957723|12832461|P1|STARTED|Overall Study||411
5218358|NCT00957684|12832479|P5|NOT COMPLETED|PART II||75
5218359|NCT00957684|12832480|P4|NOT COMPLETED|PART II||0
5218360|NCT00957684|12832481|P3|NOT COMPLETED|PART II||0
5218361|NCT00957684|12832482|P2|NOT COMPLETED|PART II||0
5218362|NCT00957684|12832483|P1|NOT COMPLETED|PART II||0
5218363|NCT00957684|12832479|P5|COMPLETED|PART II||239
5218364|NCT00957684|12832480|P4|COMPLETED|PART II||0
5218365|NCT00957684|12832481|P3|COMPLETED|PART II||0
5218366|NCT00957684|12832482|P2|COMPLETED|PART II||0
5218367|NCT00957684|12832483|P1|COMPLETED|PART II||0
5218368|NCT00957684|12832479|P5|Patients Entered Part II|PART II||314
5218369|NCT00957684|12832480|P4|Patients Entered Part II|PART II||0
5218370|NCT00957684|12832481|P3|Patients Entered Part II|PART II||0
5218371|NCT00957684|12832482|P2|Patients Entered Part II|PART II||0
5218372|NCT00957684|12832483|P1|Patients Entered Part II|PART II||0
5218373|NCT00957684|12832479|P5|STARTED|PART II||314
5218374|NCT00957684|12832480|P4|STARTED|PART II||0
5218375|NCT00957684|12832481|P3|STARTED|PART II||0
5218376|NCT00957684|12832482|P2|STARTED|PART II||0
5218377|NCT00957684|12832483|P1|STARTED|PART II||0
5218378|NCT00957684|12832479|P5|NOT COMPLETED|PART I||0
5218379|NCT00957684|12832480|P4|NOT COMPLETED|PART I||18
5218380|NCT00957684|12832481|P3|NOT COMPLETED|PART I||10
5218381|NCT00957684|12832482|P2|NOT COMPLETED|PART I||13
5218382|NCT00957684|12832483|P1|NOT COMPLETED|PART I||31
5218383|NCT00957684|12832479|P5|COMPLETED|PART I||0
5218384|NCT00957684|12832480|P4|COMPLETED|PART I||84
5218385|NCT00957684|12832481|P3|COMPLETED|PART I||90
5218386|NCT00957684|12832482|P2|COMPLETED|PART I||85
5218387|NCT00957684|12832483|P1|COMPLETED|PART I||71
5218388|NCT00957684|12832479|P5|Per-protocol (PP)Population|PART I||0
5218389|NCT00957684|12832480|P4|Per-protocol (PP)Population|PART I||91
5218390|NCT00957684|12832481|P3|Per-protocol (PP)Population|PART I||94
5218391|NCT00957684|12832482|P2|Per-protocol (PP)Population|PART I||86
5218392|NCT00957684|12832483|P1|Per-protocol (PP)Population|PART I||72
5218393|NCT00957684|12832479|P5|Intention-to-treat (ITT) Population|PART I||0
5218394|NCT00957684|12832480|P4|Intention-to-treat (ITT) Population|PART I||102
5218395|NCT00957684|12832481|P3|Intention-to-treat (ITT) Population|PART I||99
5218396|NCT00957684|12832482|P2|Intention-to-treat (ITT) Population|PART I||98
5218397|NCT00957684|12832483|P1|Intention-to-treat (ITT) Population|PART I||98
5218398|NCT00957684|12832479|P5|Randomised (Safety Population)|PART I||0
5218399|NCT00957684|12832480|P4|Randomised (Safety Population)|PART I||102
5218400|NCT00957684|12832481|P3|Randomised (Safety Population)|PART I||100
5218401|NCT00957684|12832482|P2|Randomised (Safety Population)|PART I||98
5218402|NCT00957684|12832483|P1|Randomised (Safety Population)|PART I||102
5218403|NCT00957684|12832479|P5|STARTED|PART I||0
5218404|NCT00957684|12832480|P4|STARTED|PART I||102
5218405|NCT00957684|12832481|P3|STARTED|PART I||100
5218406|NCT00957684|12832482|P2|STARTED|PART I||98
5218407|NCT00957684|12832483|P1|STARTED|PART I||102
5218408|NCT00957671|12832493|P1|NOT COMPLETED|Overall Study||0
5218409|NCT00957671|12832493|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
5218410|NCT00957671|12832493|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
5218411|NCT00957658|12832550|P1|NOT COMPLETED|Overall Study||65
5218412|NCT00957658|12832550|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
5218413|NCT00957658|12832550|P1|STARTED|Overall Study||234
5218414|NCT00957593|12832565|P2|NOT COMPLETED|Overall Study||0
5218415|NCT00957593|12832566|P1|NOT COMPLETED|Overall Study||0
5218416|NCT00957593|12832565|P2|COMPLETED|Overall Study||125
5218417|NCT00957593|12832566|P1|COMPLETED|Overall Study||127
5218418|NCT00957593|12832565|P2|STARTED|Overall Study||125
5218419|NCT00957593|12832566|P1|STARTED|Overall Study||127
5218420|NCT00957580|12832577|P3|NOT COMPLETED|Overall Study||0
5218421|NCT00957580|12832578|P2|NOT COMPLETED|Overall Study||2
5218422|NCT00957580|12832579|P1|NOT COMPLETED|Overall Study||0
5218423|NCT00957580|12832577|P3|COMPLETED|Overall Study||15
5218424|NCT00957580|12832578|P2|COMPLETED|Overall Study||31
5218425|NCT00957580|12832579|P1|COMPLETED|Overall Study||33
5218426|NCT00957580|12832577|P3|Treated|Overall Study||15
5218427|NCT00957580|12832578|P2|Treated|Overall Study||32
5218428|NCT00957580|12832579|P1|Treated|Overall Study||33
5218429|NCT00957580|12832577|P3|STARTED|Overall Study||15
5218430|NCT00957580|12832578|P2|STARTED|Overall Study||33
5218431|NCT00957580|12832579|P1|STARTED|Overall Study||33
5218432|NCT00957528|12832726|P3|NOT COMPLETED|Overall Study||1
5218433|NCT00957528|12832727|P2|NOT COMPLETED|Overall Study||1
5218434|NCT00957528|12832728|P1|NOT COMPLETED|Overall Study||0
5218435|NCT00957528|12832726|P3|COMPLETED|Overall Study||8
5218436|NCT00957528|12832727|P2|COMPLETED|Overall Study||8
5218437|NCT00957528|12832728|P1|COMPLETED|Overall Study||8
5218438|NCT00957528|12832726|P3|STARTED|Overall Study||9
5218439|NCT00957528|12832727|P2|STARTED|Overall Study||9
5218440|NCT00957528|12832728|P1|STARTED|Overall Study||8
5218441|NCT00957424|12832751|P1|NOT COMPLETED|Overall Study||23
5218442|NCT00957424|12832751|P1|COMPLETED|Overall Study||44
5218443|NCT00957424|12832751|P1|Follow-up #2|Overall Study||50
5218444|NCT00957424|12832751|P1|Follow-up #1|Overall Study||59
5218445|NCT00957424|12832751|P1|STARTED|Overall Study||67
5218446|NCT00957372|12832761|P4|NOT COMPLETED|PART II||44
5218447|NCT00957372|12832762|P3|NOT COMPLETED|PART II||0
5218448|NCT00957372|12832763|P2|NOT COMPLETED|PART II||0
5218449|NCT00957372|12832764|P1|NOT COMPLETED|PART II||0
5218450|NCT00957372|12832761|P4|COMPLETED|PART II||150
5218451|NCT00957372|12832762|P3|COMPLETED|PART II||0
5218452|NCT00957372|12832763|P2|COMPLETED|PART II||0
5218453|NCT00957372|12832764|P1|COMPLETED|PART II||0
5218454|NCT00957372|12832761|P4|Per-Protocol Population|PART II||108
5218455|NCT00957372|12832762|P3|Per-Protocol Population|PART II||0
5218456|NCT00957372|12832763|P2|Per-Protocol Population|PART II||0
5218457|NCT00957372|12832764|P1|Per-Protocol Population|PART II||0
5218458|NCT00957372|12832761|P4|Intention-to-treat (ITT) Population|PART II||191
5218459|NCT00957372|12832762|P3|Intention-to-treat (ITT) Population|PART II||0
5218460|NCT00957372|12832763|P2|Intention-to-treat (ITT) Population|PART II||0
5218461|NCT00957372|12832764|P1|Intention-to-treat (ITT) Population|PART II||0
5218462|NCT00957372|12832761|P4|Safety Population|PART II||194
5218463|NCT00957372|12832762|P3|Safety Population|PART II||0
5218464|NCT00957372|12832763|P2|Safety Population|PART II||0
5218465|NCT00957372|12832764|P1|Safety Population|PART II||0
5218466|NCT00957372|12832761|P4|STARTED|PART II||194
5218467|NCT00957372|12832762|P3|STARTED|PART II||0
5218468|NCT00957372|12832763|P2|STARTED|PART II||0
5218469|NCT00957372|12832764|P1|STARTED|PART II||0
5218470|NCT00957372|12832761|P4|NOT COMPLETED|PART I||0
5218471|NCT00957372|12832762|P3|NOT COMPLETED|PART I||1
5218472|NCT00957372|12832763|P2|NOT COMPLETED|PART I||0
5218473|NCT00957372|12832764|P1|NOT COMPLETED|PART I||0
5218474|NCT00957372|12832761|P4|COMPLETED|PART I||0
5218475|NCT00957372|12832762|P3|COMPLETED|PART I||87
5218476|NCT00957372|12832763|P2|COMPLETED|PART I||85
5218477|NCT00957372|12832764|P1|COMPLETED|PART I||80
5218478|NCT00957372|12832761|P4|Randomized But Not Treated|PART I||0
5218479|NCT00957372|12832762|P3|Randomized But Not Treated|PART I||1
5218480|NCT00957372|12832763|P2|Randomized But Not Treated|PART I||0
5218481|NCT00957372|12832764|P1|Randomized But Not Treated|PART I||0
5218482|NCT00957372|12832761|P4|Per-Protocol Population|PART I||0
5218483|NCT00957372|12832762|P3|Per-Protocol Population|PART I||51
5218484|NCT00957372|12832763|P2|Per-Protocol Population|PART I||47
5218485|NCT00957372|12832764|P1|Per-Protocol Population|PART I||35
5218486|NCT00957372|12832761|P4|Intention-to-Treat Population|PART I||0
5218487|NCT00957372|12832762|P3|Intention-to-Treat Population|PART I||84
5218488|NCT00957372|12832763|P2|Intention-to-Treat Population|PART I||84
5218489|NCT00957372|12832764|P1|Intention-to-Treat Population|PART I||77
5218490|NCT00957372|12832761|P4|Safety Population|PART I||0
5218491|NCT00957372|12832762|P3|Safety Population|PART I||87
5218492|NCT00957372|12832763|P2|Safety Population|PART I||85
5218493|NCT00957372|12832764|P1|Safety Population|PART I||80
5218494|NCT00957372|12832761|P4|STARTED|PART I||0
5218495|NCT00957372|12832762|P3|STARTED|PART I||88
5218496|NCT00957372|12832763|P2|STARTED|PART I||85
5218497|NCT00957372|12832764|P1|STARTED|PART I||80
5218498|NCT00957359|12832782|P2|NOT COMPLETED|Overall Study||0
5218499|NCT00957359|12832783|P1|NOT COMPLETED|Overall Study||0
5218500|NCT00957359|12832782|P2|COMPLETED|Overall Study||15
5218501|NCT00957359|12832783|P1|COMPLETED|Overall Study||14
5218502|NCT00957359|12832782|P2|STARTED|Overall Study||15
5218503|NCT00957359|12832783|P1|STARTED|Overall Study||14
5218504|NCT00957333|12832895|P1|NOT COMPLETED|Overall Study||0
5218505|NCT00957333|12832895|P1|COMPLETED|Overall Study||44
5218506|NCT00957333|12832895|P1|STARTED|Overall Study||44
5218507|NCT00957268|12832904|P5|NOT COMPLETED|Overall Study||0
5218508|NCT00957268|12832905|P4|NOT COMPLETED|Overall Study||0
5218509|NCT00957268|12832906|P3|NOT COMPLETED|Overall Study||1
5218510|NCT00957268|12832907|P2|NOT COMPLETED|Overall Study||0
5218511|NCT00957268|12832908|P1|NOT COMPLETED|Overall Study||0
5218512|NCT00957268|12832904|P5|COMPLETED|Overall Study||22
5218513|NCT00957268|12832905|P4|COMPLETED|Overall Study||7
5218514|NCT00957268|12832906|P3|COMPLETED|Overall Study||7
5218515|NCT00957268|12832907|P2|COMPLETED|Overall Study||4
5218516|NCT00957268|12832908|P1|COMPLETED|Overall Study||5
5218517|NCT00957268|12832904|P5|STARTED|Overall Study||22
5218518|NCT00957268|12832905|P4|STARTED|Overall Study||7
5218519|NCT00957268|12832906|P3|STARTED|Overall Study||8
5218520|NCT00957268|12832907|P2|STARTED|Overall Study||4
5218521|NCT00957268|12832908|P1|STARTED|Overall Study||5
5218522|NCT00957242|12832972|P2|NOT COMPLETED|Overall Study||0
5218523|NCT00957242|12832973|P1|NOT COMPLETED|Overall Study||0
5218524|NCT00957242|12832972|P2|COMPLETED|Overall Study||72
5218525|NCT00957242|12832973|P1|COMPLETED|Overall Study||73
5218526|NCT00957242|12832972|P2|STARTED|Overall Study||72
5218527|NCT00957242|12832973|P1|STARTED|Overall Study||73
5218528|NCT00957047|12833005|P5|NOT COMPLETED|PART II||102
5218529|NCT00957047|12833006|P4|NOT COMPLETED|PART II||0
5218530|NCT00957047|12833007|P3|NOT COMPLETED|PART II||0
5218531|NCT00957047|12833008|P2|NOT COMPLETED|PART II||0
5218532|NCT00957047|12833009|P1|NOT COMPLETED|PART II||0
5218533|NCT00957047|12833005|P5|COMPLETED|PART II||223
5218534|NCT00957047|12833006|P4|COMPLETED|PART II||0
5218535|NCT00957047|12833007|P3|COMPLETED|PART II||0
5218536|NCT00957047|12833008|P2|COMPLETED|PART II||0
5218537|NCT00957047|12833009|P1|COMPLETED|PART II||0
5218538|NCT00957047|12833005|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
5218539|NCT00957047|12833006|P4|Terminated Prematurely|PART II||0
5218540|NCT00957047|12833007|P3|Terminated Prematurely|PART II||0
5218541|NCT00957047|12833008|P2|Terminated Prematurely|PART II||0
5218542|NCT00957047|12833009|P1|Terminated Prematurely|PART II||0
5218543|NCT00957047|12833005|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
5218544|NCT00957047|12833006|P4|STARTED|PART II||0
5218545|NCT00957047|12833007|P3|STARTED|PART II||0
5218546|NCT00957047|12833008|P2|STARTED|PART II||0
5218547|NCT00957047|12833009|P1|STARTED|PART II||0
5218548|NCT00957047|12833005|P5|NOT COMPLETED|PART I||0
5218549|NCT00957047|12833006|P4|NOT COMPLETED|PART I||30
5218550|NCT00957047|12833007|P3|NOT COMPLETED|PART I||21
5218551|NCT00957047|12833008|P2|NOT COMPLETED|PART I||13
5218552|NCT00957047|12833009|P1|NOT COMPLETED|PART I||6
5218553|NCT00957047|12833005|P5|COMPLETED|PART I||0
5218554|NCT00957047|12833006|P4|COMPLETED|PART I||68
5218555|NCT00957047|12833007|P3|COMPLETED|PART I||80
5218556|NCT00957047|12833008|P2|COMPLETED|PART I||83
5218557|NCT00957047|12833009|P1|COMPLETED|PART I||94
5218558|NCT00957047|12833005|P5|Per-Protocol Population|PART I||0
5218559|NCT00957047|12833006|P4|Per-Protocol Population|PART I||54
5218560|NCT00957047|12833007|P3|Per-Protocol Population|PART I||75
5218561|NCT00957047|12833008|P2|Per-Protocol Population|PART I||70
5218562|NCT00957047|12833009|P1|Per-Protocol Population|PART I||81
5218563|NCT00957047|12833005|P5|Intention-to-treat (ITT) Population|PART I||0
5218564|NCT00957047|12833006|P4|Intention-to-treat (ITT) Population|PART I||97
5218565|NCT00957047|12833007|P3|Intention-to-treat (ITT) Population|PART I||100
5218566|NCT00957047|12833008|P2|Intention-to-treat (ITT) Population|PART I||96
5218567|NCT00957047|12833009|P1|Intention-to-treat (ITT) Population|PART I||100
5218568|NCT00957047|12833005|P5|Randomized/Safety Population|PART I||0
5218569|NCT00957047|12833006|P4|Randomized/Safety Population|PART I||98
5218570|NCT00957047|12833007|P3|Randomized/Safety Population|PART I||101
5218571|NCT00957047|12833008|P2|Randomized/Safety Population|PART I||96
5218572|NCT00957047|12833009|P1|Randomized/Safety Population|PART I||100
5218573|NCT00957047|12833005|P5|STARTED|PART I||0
5218574|NCT00957047|12833006|P4|STARTED|PART I||98
5218575|NCT00957047|12833007|P3|STARTED|PART I||101
5218576|NCT00957047|12833008|P2|STARTED|PART I||96
5218577|NCT00957047|12833009|P1|STARTED|PART I||100
5218578|NCT00957034|12833030|P3|NOT COMPLETED|Overall Study||6
5218579|NCT00957034|12833031|P2|NOT COMPLETED|Overall Study||4
5218580|NCT00957034|12833032|P1|NOT COMPLETED|Overall Study||6
5218581|NCT00957034|12833030|P3|COMPLETED|Overall Study||1
5218582|NCT00957034|12833031|P2|COMPLETED|Overall Study||0
5218583|NCT00957034|12833032|P1|COMPLETED|Overall Study||0
5218584|NCT00957034|12833030|P3|STARTED|Overall Study||7
5218585|NCT00957034|12833031|P2|STARTED|Overall Study||4
5218586|NCT00957034|12833032|P1|STARTED|Overall Study||6
5218587|NCT00957021|12833055|P1|NOT COMPLETED|Overall Study||117
5218588|NCT00957021|12833055|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
5218589|NCT00957021|12833055|P1|STARTED|Overall Study||354
5218590|NCT00957008|12833068|P4|NOT COMPLETED|Overall Study||24
5218591|NCT00957008|12833069|P3|NOT COMPLETED|Overall Study||17
5218592|NCT00957008|12833070|P2|NOT COMPLETED|Overall Study||12
5218593|NCT00957008|12833071|P1|NOT COMPLETED|Overall Study||21
5218594|NCT00957008|12833068|P4|COMPLETED|Overall Study||26
5218595|NCT00957008|12833069|P3|COMPLETED|Overall Study||32
5218596|NCT00957008|12833070|P2|COMPLETED|Overall Study||37
5218597|NCT00957008|12833071|P1|COMPLETED|Overall Study||28
5218598|NCT00957008|12833068|P4|STARTED|Overall Study||50
5218599|NCT00957008|12833069|P3|STARTED|Overall Study||49
5218600|NCT00957008|12833070|P2|STARTED|Overall Study||49
5218601|NCT00957008|12833071|P1|STARTED|Overall Study||49
5218602|NCT00956943|12833099|P2|NOT COMPLETED|Overall Study||10
5218603|NCT00956943|12833100|P1|NOT COMPLETED|Overall Study||9
5218604|NCT00956943|12833099|P2|COMPLETED|Overall Study||34
5218605|NCT00956943|12833100|P1|COMPLETED|Overall Study||34
5218606|NCT00956943|12833099|P2|Baseline|Overall Study||44
5218607|NCT00956943|12833100|P1|Baseline|Overall Study||43
5218608|NCT00956943|12833099|P2|STARTED|Overall Study||44
5218609|NCT00956943|12833100|P1|STARTED|Overall Study||43
5218610|NCT00956930|12833110|P2|NOT COMPLETED|Overall Study||0
5218611|NCT00956930|12833111|P1|NOT COMPLETED|Overall Study||0
5218612|NCT00956930|12833110|P2|COMPLETED|Overall Study||21
5218613|NCT00956930|12833111|P1|COMPLETED|Overall Study||24
5218614|NCT00956930|12833110|P2|STARTED|Overall Study||21
5218615|NCT00956930|12833111|P1|STARTED|Overall Study||24
5218616|NCT00956839|12833124|P3|NOT COMPLETED|Overall Study||3
5218617|NCT00956839|12833125|P2|NOT COMPLETED|Overall Study||0
5218618|NCT00956839|12833126|P1|NOT COMPLETED|Overall Study||3
5218619|NCT00956839|12833124|P3|COMPLETED|Overall Study||10
5218620|NCT00956839|12833125|P2|COMPLETED|Overall Study||13
5218621|NCT00956839|12833126|P1|COMPLETED|Overall Study||11
5218622|NCT00956839|12833124|P3|STARTED|Overall Study||13
5218623|NCT00956839|12833125|P2|STARTED|Overall Study||13
5218624|NCT00956839|12833126|P1|STARTED|Overall Study||14
5218625|NCT00956813|12833139|P2|NOT COMPLETED|Continuation Phase||0
5218626|NCT00956813|12833140|P1|NOT COMPLETED|Continuation Phase||0
5218627|NCT00956813|12833139|P2|COMPLETED|Continuation Phase||0
5218628|NCT00956813|12833140|P1|COMPLETED|Continuation Phase||80
5218629|NCT00956813|12833139|P2|STARTED|Continuation Phase||0
5218630|NCT00956813|12833140|P1|STARTED|Continuation Phase||80
5218631|NCT00956813|12833139|P2|NOT COMPLETED|Flaxseed and Placebo||5
5218632|NCT00956813|12833140|P1|NOT COMPLETED|Flaxseed and Placebo||8
5218633|NCT00956813|12833139|P2|COMPLETED|Flaxseed and Placebo||100
5218634|NCT00956813|12833140|P1|COMPLETED|Flaxseed and Placebo||97
5218635|NCT00956813|12833139|P2|STARTED|Flaxseed and Placebo||105
5218636|NCT00956813|12833140|P1|STARTED|Flaxseed and Placebo||105
5218637|NCT00956761|12833155|P1|NOT COMPLETED|Overall Study||0
5218638|NCT00956761|12833155|P1|COMPLETED|Overall Study||63
5218639|NCT00956761|12833155|P1|STARTED|Overall Study||63
5218640|NCT00956709|12833164|P2|NOT COMPLETED|Overall Study||0
5218641|NCT00956709|12833165|P1|NOT COMPLETED|Overall Study||0
5218642|NCT00956709|12833164|P2|COMPLETED|Overall Study||19
5218643|NCT00956709|12833165|P1|COMPLETED|Overall Study||16
5218644|NCT00956709|12833164|P2|STARTED|Overall Study||19
5218645|NCT00956709|12833165|P1|STARTED|Overall Study||16
5218646|NCT00956657|12833177|P2|NOT COMPLETED|Overall Study||0
5218647|NCT00956657|12833178|P1|NOT COMPLETED|Overall Study||0
5218648|NCT00956657|12833177|P2|COMPLETED|Overall Study||13
5218649|NCT00956657|12833178|P1|COMPLETED|Overall Study||18
5218650|NCT00956657|12833177|P2|STARTED|Overall Study||13
5218651|NCT00956657|12833178|P1|STARTED|Overall Study||18
5218652|NCT00956631|12833184|P1|NOT COMPLETED|Overall Study||16
5218653|NCT00956631|12833184|P1|COMPLETED|Overall Study||62
5218654|NCT00956631|12833184|P1|STARTED|Overall Study||78
5218655|NCT00956592|12833192|P2|NOT COMPLETED|Overall Study||3
5218656|NCT00956592|12833193|P1|NOT COMPLETED|Overall Study||1
5218657|NCT00956592|12833192|P2|COMPLETED|Overall Study||147
5218658|NCT00956592|12833193|P1|COMPLETED|Overall Study||149
5218659|NCT00956592|12833192|P2|STARTED|Overall Study||150
5218660|NCT00956592|12833193|P1|STARTED|Overall Study||150
5218661|NCT00956540|12833213|P4|NOT COMPLETED|Overall Study||4
5218662|NCT00956540|12833214|P3|NOT COMPLETED|Overall Study||3
5218663|NCT00956540|12833215|P2|NOT COMPLETED|Overall Study||4
5218664|NCT00956540|12833216|P1|NOT COMPLETED|Overall Study||3
5218665|NCT00956540|12833213|P4|COMPLETED|Overall Study||41
5218666|NCT00956540|12833214|P3|COMPLETED|Overall Study||43
5218667|NCT00956540|12833215|P2|COMPLETED|Overall Study||46
5218668|NCT00956540|12833216|P1|COMPLETED|Overall Study||51
5218669|NCT00956540|12833213|P4|STARTED|Overall Study||45
5218670|NCT00956540|12833214|P3|STARTED|Overall Study||46
5218671|NCT00956540|12833215|P2|STARTED|Overall Study||50
5218672|NCT00956540|12833216|P1|STARTED|Overall Study||54
5218673|NCT00956293|12833228|P3|NOT COMPLETED|Follow-up Period||0
5218674|NCT00956293|12833229|P2|NOT COMPLETED|Follow-up Period||32
5218675|NCT00956293|12833230|P1|NOT COMPLETED|Follow-up Period||20
5218676|NCT00956293|12833228|P3|COMPLETED|Follow-up Period||0
5218677|NCT00956293|12833229|P2|COMPLETED|Follow-up Period||0
5218678|NCT00956293|12833230|P1|COMPLETED|Follow-up Period||0
5218679|NCT00956293|12833228|P3|STARTED|Follow-up Period||0
5218680|NCT00956293|12833229|P2|STARTED|Follow-up Period||32
5218681|NCT00956293|12833230|P1|STARTED|Follow-up Period||20
5218682|NCT00956293|12833228|P3|NOT COMPLETED|Main Period (Randomization)||0
5218683|NCT00956293|12833229|P2|NOT COMPLETED|Main Period (Randomization)||27
5218684|NCT00956293|12833230|P1|NOT COMPLETED|Main Period (Randomization)||1
5218685|NCT00956293|12833228|P3|COMPLETED|Main Period (Randomization)||0
5218686|NCT00956293|12833229|P2|COMPLETED|Main Period (Randomization)||26
5218687|NCT00956293|12833230|P1|COMPLETED|Main Period (Randomization)||23
5218688|NCT00956293|12833228|P3|Randomized Safety Set|Main Period (Randomization)||0
5218689|NCT00956293|12833229|P2|Randomized Safety Set|Main Period (Randomization)||51
5218690|NCT00956293|12833230|P1|Randomized Safety Set|Main Period (Randomization)||24
5218691|NCT00956293|12833228|P3|Full Analysis Set|Main Period (Randomization)||0
5218692|NCT00956293|12833229|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
5218693|NCT00956293|12833230|P1|Full Analysis Set|Main Period (Randomization)||24
5218694|NCT00956293|12833228|P3|STARTED|Main Period (Randomization)||0
5218695|NCT00956293|12833229|P2|STARTED|Main Period (Randomization)||53
5218696|NCT00956293|12833230|P1|STARTED|Main Period (Randomization)||24
5218697|NCT00956293|12833228|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
5218698|NCT00956293|12833229|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
5218699|NCT00956293|12833230|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
5218700|NCT00956293|12833228|P3|COMPLETED|Main Period (Pre-randomization)||77
5218701|NCT00956293|12833229|P2|COMPLETED|Main Period (Pre-randomization)||0
5218702|NCT00956293|12833230|P1|COMPLETED|Main Period (Pre-randomization)||0
5218703|NCT00956293|12833228|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
5218704|NCT00956293|12833229|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
5218705|NCT00956293|12833230|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
5218706|NCT00956293|12833228|P3|STARTED|Main Period (Pre-randomization)||207
5218707|NCT00956293|12833229|P2|STARTED|Main Period (Pre-randomization)||0
5218708|NCT00956293|12833230|P1|STARTED|Main Period (Pre-randomization)||0
5218709|NCT00956254|12833254|P1|NOT COMPLETED|Overall Study||0
5218710|NCT00956254|12833254|P1|COMPLETED|Overall Study||18
5218711|NCT00956254|12833254|P1|STARTED|Overall Study||18
5218712|NCT00956085|12833264|P1|NOT COMPLETED|Overall Study||0
5218713|NCT00956085|12833264|P1|COMPLETED|Overall Study||12
5218714|NCT00956085|12833264|P1|STARTED|Overall Study||12
5218715|NCT00956020|12833268|P1|NOT COMPLETED|Overall Study||0
5218716|NCT00956020|12833268|P1|COMPLETED|Overall Study||4
5218717|NCT00956020|12833268|P1|STARTED|Overall Study||4
5218718|NCT00955968|12833285|P2|NOT COMPLETED|Overall Study||126
5218719|NCT00955968|12833286|P1|NOT COMPLETED|Overall Study||137
5218720|NCT00955968|12833285|P2|COMPLETED|Overall Study||699
5218721|NCT00955968|12833286|P1|COMPLETED|Overall Study||691
5218722|NCT00955968|12833285|P2|STARTED|Overall Study||825
5218723|NCT00955968|12833286|P1|STARTED|Overall Study||828
5218724|NCT00955955|12833328|P3|NOT COMPLETED|Overall Study||0
5218725|NCT00955955|12833329|P2|NOT COMPLETED|Overall Study||0
5218726|NCT00955955|12833330|P1|NOT COMPLETED|Overall Study||2
5218727|NCT00955955|12833328|P3|COMPLETED|Overall Study||28
5218728|NCT00955955|12833329|P2|COMPLETED|Overall Study||28
5218729|NCT00955955|12833330|P1|COMPLETED|Overall Study||17
5218730|NCT00955955|12833328|P3|STARTED|Overall Study||28
5218731|NCT00955955|12833329|P2|STARTED|Overall Study||28
5218732|NCT00955955|12833330|P1|STARTED|Overall Study||19
5218733|NCT00955916|12833344|P1|NOT COMPLETED|Overall Study||0
5218734|NCT00955916|12833344|P1|COMPLETED|Overall Study||38
5218735|NCT00955916|12833344|P1|STARTED|Overall Study||38
5218736|NCT00955903|12833353|P3|NOT COMPLETED|Overall Study||7
5218737|NCT00955903|12833354|P2|NOT COMPLETED|Overall Study||3
5218738|NCT00955903|12833355|P1|NOT COMPLETED|Overall Study||6
5218739|NCT00955903|12833353|P3|COMPLETED|Overall Study||48
5218740|NCT00955903|12833354|P2|COMPLETED|Overall Study||51
5218741|NCT00955903|12833355|P1|COMPLETED|Overall Study||49
5218742|NCT00955903|12833353|P3|STARTED|Overall Study||55
5218743|NCT00955903|12833354|P2|STARTED|Overall Study||54
5218744|NCT00955903|12833355|P1|STARTED|Overall Study||55
5218745|NCT00955877|12833372|P3|NOT COMPLETED|Overall Study||0
5218746|NCT00955877|12833373|P2|NOT COMPLETED|Overall Study||0
5218747|NCT00955877|12833374|P1|NOT COMPLETED|Overall Study||0
5218748|NCT00955877|12833372|P3|COMPLETED|Overall Study||7
5218749|NCT00955877|12833373|P2|COMPLETED|Overall Study||0
5218750|NCT00955877|12833374|P1|COMPLETED|Overall Study||6
5218751|NCT00955877|12833372|P3|STARTED|Overall Study||7
5218752|NCT00955877|12833373|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
5218753|NCT00955877|12833374|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
5218754|NCT00955825|12833414|P2|NOT COMPLETED|Overall Study||17
5218755|NCT00955825|12833415|P1|NOT COMPLETED|Overall Study||26
5218756|NCT00955825|12833414|P2|COMPLETED|Overall Study||223
5218757|NCT00955825|12833415|P1|COMPLETED|Overall Study||207
5218758|NCT00955825|12833414|P2|STARTED|Overall Study||240
5218759|NCT00955825|12833415|P1|STARTED|Overall Study||233
5218760|NCT00955747|12833423|P2|NOT COMPLETED|Overall Study||69
5218761|NCT00955747|12833424|P1|NOT COMPLETED|Overall Study||69
5218762|NCT00955747|12833423|P2|COMPLETED|Overall Study||172
5218763|NCT00955747|12833424|P1|COMPLETED|Overall Study||184
5218764|NCT00955747|12833423|P2|STARTED|Overall Study||241
5218765|NCT00955747|12833424|P1|STARTED|Overall Study||253
5218766|NCT00955721|12833432|P2|NOT COMPLETED|Overall Study||0
5218767|NCT00955721|12833433|P1|NOT COMPLETED|Overall Study||3
5218768|NCT00955721|12833432|P2|COMPLETED|Overall Study||0
5218769|NCT00955721|12833433|P1|COMPLETED|Overall Study||6
5218770|NCT00955721|12833432|P2|STARTED|Overall Study||0
5218771|NCT00955721|12833433|P1|STARTED|Overall Study||9
5218772|NCT00955708|12833443|P1|NOT COMPLETED|Overall Study||1058
5218773|NCT00955708|12833443|P1|COMPLETED|Overall Study||250
5218774|NCT00955708|12833443|P1|STARTED|Overall Study||1308
5218775|NCT00955682|12833449|P2|NOT COMPLETED|Year 5 Period||0
5218776|NCT00955682|12833450|P1|NOT COMPLETED|Year 5 Period||0
5218777|NCT00955682|12833449|P2|COMPLETED|Year 5 Period||47
5218778|NCT00955682|12833450|P1|COMPLETED|Year 5 Period||239
5218779|NCT00955682|12833449|P2|STARTED|Year 5 Period||47
5218780|NCT00955682|12833450|P1|STARTED|Year 5 Period||239
5218781|NCT00955682|12833449|P2|NOT COMPLETED|Booster Period (Month 49)||1
5218782|NCT00955682|12833450|P1|NOT COMPLETED|Booster Period (Month 49)||1
5218783|NCT00955682|12833449|P2|COMPLETED|Booster Period (Month 49)||47
5218784|NCT00955682|12833450|P1|COMPLETED|Booster Period (Month 49)||244
5218785|NCT00955682|12833449|P2|STARTED|Booster Period (Month 49)||48
5218786|NCT00955682|12833450|P1|STARTED|Booster Period (Month 49)||245
5218787|NCT00955682|12833449|P2|NOT COMPLETED|Year 4 Period||0
5218788|NCT00955682|12833450|P1|NOT COMPLETED|Year 4 Period||0
5218789|NCT00955682|12833449|P2|COMPLETED|Year 4 Period||48
5218790|NCT00955682|12833450|P1|COMPLETED|Year 4 Period||246
5218791|NCT00955682|12833449|P2|STARTED|Year 4 Period||48
5218792|NCT00955682|12833450|P1|STARTED|Year 4 Period||246
5218793|NCT00955682|12833449|P2|NOT COMPLETED|Year 3 Period||0
5218794|NCT00955682|12833450|P1|NOT COMPLETED|Year 3 Period||0
5218795|NCT00955682|12833449|P2|COMPLETED|Year 3 Period||47
5218796|NCT00955682|12833450|P1|COMPLETED|Year 3 Period||273
5218797|NCT00955682|12833449|P2|STARTED|Year 3 Period||47
5218798|NCT00955682|12833450|P1|STARTED|Year 3 Period||273
5218799|NCT00955682|12833449|P2|NOT COMPLETED|Year 2 Period||0
5218800|NCT00955682|12833450|P1|NOT COMPLETED|Year 2 Period||0
5218801|NCT00955682|12833449|P2|COMPLETED|Year 2 Period||42
5218802|NCT00955682|12833450|P1|COMPLETED|Year 2 Period||253
5218803|NCT00955682|12833449|P2|STARTED|Year 2 Period||42
5218804|NCT00955682|12833450|P1|STARTED|Year 2 Period||253
5218805|NCT00955617|12833560|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
5218806|NCT00955617|12833561|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
5218807|NCT00955617|12833560|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
5218808|NCT00955617|12833561|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
5218809|NCT00955617|12833560|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
5218810|NCT00955617|12833561|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
5218811|NCT00955617|12833560|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
5218812|NCT00955617|12833561|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
5218813|NCT00955617|12833560|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
5218814|NCT00955617|12833561|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
5218815|NCT00955617|12833560|P2|STARTED|First MRA (Between Day0 and Day21)||10
5218816|NCT00955617|12833561|P1|STARTED|First MRA (Between Day0 and Day21)||10
5218817|NCT00955513|12833574|P3|NOT COMPLETED|Overall Study||3
5218818|NCT00955513|12833575|P2|NOT COMPLETED|Overall Study||2
5218819|NCT00955513|12833576|P1|NOT COMPLETED|Overall Study||1
5218820|NCT00955513|12833574|P3|COMPLETED|Overall Study||79
5218821|NCT00955513|12833575|P2|COMPLETED|Overall Study||78
5218822|NCT00955513|12833576|P1|COMPLETED|Overall Study||79
5218823|NCT00955513|12833574|P3|STARTED|Overall Study||82
5218824|NCT00955513|12833575|P2|STARTED|Overall Study||80
5218825|NCT00955513|12833576|P1|STARTED|Overall Study||80
5218826|NCT00955487|12833586|P6|NOT COMPLETED|Overall Study||0
5218827|NCT00955487|12833587|P5|NOT COMPLETED|Overall Study||0
5218828|NCT00955487|12833588|P4|NOT COMPLETED|Overall Study||0
5218829|NCT00955487|12833589|P3|NOT COMPLETED|Overall Study||0
5218830|NCT00955487|12833590|P2|NOT COMPLETED|Overall Study||0
5218831|NCT00955487|12833591|P1|NOT COMPLETED|Overall Study||0
5218832|NCT00955487|12833586|P6|COMPLETED|Overall Study||35
5218833|NCT00955487|12833587|P5|COMPLETED|Overall Study||32
5218834|NCT00955487|12833588|P4|COMPLETED|Overall Study||21
5218835|NCT00955487|12833589|P3|COMPLETED|Overall Study||17
5218836|NCT00955487|12833590|P2|COMPLETED|Overall Study||9
5218837|NCT00955487|12833591|P1|COMPLETED|Overall Study||10
5218838|NCT00955487|12833586|P6|STARTED|Overall Study||35
5218839|NCT00955487|12833587|P5|STARTED|Overall Study||32
5218840|NCT00955487|12833588|P4|STARTED|Overall Study||21
5218841|NCT00955487|12833589|P3|STARTED|Overall Study||17
5218842|NCT00955487|12833590|P2|STARTED|Overall Study||9
5218843|NCT00955487|12833591|P1|STARTED|Overall Study||10
5218844|NCT00955474|12833625|P2|NOT COMPLETED|Overall Study||5
5218845|NCT00955474|12833626|P1|NOT COMPLETED|Overall Study||7
5218846|NCT00955474|12833625|P2|COMPLETED|Overall Study||8
5218847|NCT00955474|12833626|P1|COMPLETED|Overall Study||5
5218848|NCT00955474|12833625|P2|STARTED|Overall Study||13
5218849|NCT00955474|12833626|P1|STARTED|Overall Study||12
5218850|NCT00955357|12833662|P2|NOT COMPLETED|Maintenance Phase||45
5218851|NCT00955357|12833663|P1|NOT COMPLETED|Maintenance Phase||12
5218852|NCT00955357|12833662|P2|COMPLETED|Maintenance Phase||249
5218853|NCT00955357|12833663|P1|COMPLETED|Maintenance Phase||68
5218854|NCT00955357|12833662|P2|STARTED|Maintenance Phase||294
5218855|NCT00955357|12833663|P1|STARTED|Maintenance Phase||80
5218856|NCT00955357|12833662|P2|NOT COMPLETED|Titration Phase||66
5218857|NCT00955357|12833663|P1|NOT COMPLETED|Titration Phase||16
5218858|NCT00955357|12833662|P2|COMPLETED|Titration Phase||294
5218859|NCT00955357|12833663|P1|COMPLETED|Titration Phase||80
5218860|NCT00955357|12833662|P2|STARTED|Titration Phase||360
5218861|NCT00955357|12833663|P1|STARTED|Titration Phase||96
5218862|NCT00955305|12833671|P2|NOT COMPLETED|Overall Study||87
5218863|NCT00955305|12833672|P1|NOT COMPLETED|Overall Study||88
5218864|NCT00955305|12833671|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
5218865|NCT00955305|12833672|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
5218866|NCT00955305|12833671|P2|Eligible and Treated|Overall Study||75
5218867|NCT00955305|12833672|P1|Eligible and Treated|Overall Study||78
5218868|NCT00955305|12833671|P2|Treated|Overall Study||82
5218869|NCT00955305|12833672|P1|Treated|Overall Study||83
5218870|NCT00955305|12833671|P2|STARTED|Overall Study||87
5218871|NCT00955305|12833672|P1|STARTED|Overall Study||88
5218872|NCT00955279|12833685|P3|NOT COMPLETED|Overall Study||8
5218873|NCT00955279|12833686|P2|NOT COMPLETED|Overall Study||4
5218874|NCT00955279|12833687|P1|NOT COMPLETED|Overall Study||3
5218875|NCT00955279|12833685|P3|COMPLETED|Overall Study||52
5218876|NCT00955279|12833686|P2|COMPLETED|Overall Study||51
5218877|NCT00955279|12833687|P1|COMPLETED|Overall Study||55
5218878|NCT00955279|12833685|P3|STARTED|Overall Study||60
5218879|NCT00955279|12833686|P2|STARTED|Overall Study||55
5218880|NCT00955279|12833687|P1|STARTED|Overall Study||58
5218881|NCT00955266|12833709|P2|NOT COMPLETED|Overall Study||0
5218882|NCT00955266|12833710|P1|NOT COMPLETED|Overall Study||0
5218883|NCT00955266|12833709|P2|COMPLETED|Overall Study||4
5218884|NCT00955266|12833710|P1|COMPLETED|Overall Study||4
5218885|NCT00955266|12833709|P2|STARTED|Overall Study||4
5218886|NCT00955266|12833710|P1|STARTED|Overall Study||4
5218887|NCT00955253|12833724|P2|NOT COMPLETED|Second Intervention (Day 4)||0
5218888|NCT00955253|12833725|P1|NOT COMPLETED|Second Intervention (Day 4)||0
5218889|NCT00955253|12833724|P2|COMPLETED|Second Intervention (Day 4)||6
5218890|NCT00955253|12833725|P1|COMPLETED|Second Intervention (Day 4)||7
5218891|NCT00955253|12833724|P2|STARTED|Second Intervention (Day 4)||6
5218892|NCT00955253|12833725|P1|STARTED|Second Intervention (Day 4)||7
5218893|NCT00955253|12833724|P2|NOT COMPLETED|First Intervention (Day 2)||0
5218894|NCT00955253|12833725|P1|NOT COMPLETED|First Intervention (Day 2)||0
5218895|NCT00955253|12833724|P2|COMPLETED|First Intervention (Day 2)||6
5218896|NCT00955253|12833725|P1|COMPLETED|First Intervention (Day 2)||7
5218897|NCT00955253|12833724|P2|STARTED|First Intervention (Day 2)||6
5218898|NCT00955253|12833725|P1|STARTED|First Intervention (Day 2)||7
5218899|NCT00955201|12833734|P4|NOT COMPLETED|Overall Study||4
5218900|NCT00955201|12833735|P3|NOT COMPLETED|Overall Study||1
5218901|NCT00955201|12833736|P2|NOT COMPLETED|Overall Study||0
5218902|NCT00955201|12833737|P1|NOT COMPLETED|Overall Study||4
5218903|NCT00955201|12833734|P4|COMPLETED|Overall Study||7
5218904|NCT00955201|12833735|P3|COMPLETED|Overall Study||10
5218905|NCT00955201|12833736|P2|COMPLETED|Overall Study||11
5218906|NCT00955201|12833737|P1|COMPLETED|Overall Study||8
5218907|NCT00955201|12833734|P4|STARTED|Overall Study||11
5218908|NCT00955201|12833735|P3|STARTED|Overall Study||11
5218909|NCT00955201|12833736|P2|STARTED|Overall Study||11
5218910|NCT00955201|12833737|P1|STARTED|Overall Study||12
5218911|NCT00955110|12833895|P1|NOT COMPLETED|Treatment Phase||6
5218912|NCT00955110|12833895|P1|COMPLETED|Treatment Phase||35
5218913|NCT00955110|12833895|P1|Oxycodone CR 60 mg|Treatment Phase||40
5218914|NCT00955110|12833895|P1|Oxycodone CR 30 mg|Treatment Phase||40
5218915|NCT00955110|12833895|P1|Oxymorphone ER 30 mg|Treatment Phase||38
5218916|NCT00955110|12833895|P1|Oxymorphone ER 15 mg|Treatment Phase||37
5218917|NCT00955110|12833895|P1|Placebo|Treatment Phase||38
5218918|NCT00955110|12833895|P1|STARTED|Treatment Phase||41
5218919|NCT00955110|12833895|P1|NOT COMPLETED|Qualification Phase||24
5218920|NCT00955110|12833895|P1|COMPLETED|Qualification Phase||54
5218921|NCT00955110|12833895|P1|STARTED|Qualification Phase||78
5218922|NCT00955032|12833909|P2|NOT COMPLETED|Overall Study||0
5218923|NCT00955032|12833910|P1|NOT COMPLETED|Overall Study||0
5218924|NCT00955032|12833909|P2|COMPLETED|Overall Study||8
5218925|NCT00955032|12833910|P1|COMPLETED|Overall Study||16
5218926|NCT00955032|12833909|P2|STARTED|Overall Study||8
5218927|NCT00955032|12833910|P1|STARTED|Overall Study||16
5218928|NCT00954993|12833930|P1|NOT COMPLETED|Period 2||0
5218929|NCT00954993|12833930|P1|COMPLETED|Period 2||3
5218930|NCT00954993|12833930|P1|STARTED|Period 2||3
5218931|NCT00954993|12833930|P1|NOT COMPLETED|Washout||0
5218932|NCT00954993|12833930|P1|COMPLETED|Washout||3
5218933|NCT00954993|12833930|P1|STARTED|Washout||3
5218934|NCT00954993|12833930|P1|NOT COMPLETED|Period 1||0
5218935|NCT00954993|12833930|P1|COMPLETED|Period 1||3
5218936|NCT00954993|12833930|P1|STARTED|Period 1||3
5218937|NCT00954941|12833942|P2|NOT COMPLETED|Overall Study||7
5218938|NCT00954941|12833943|P1|NOT COMPLETED|Overall Study||8
5218939|NCT00954941|12833942|P2|COMPLETED|Overall Study||41
5218940|NCT00954941|12833943|P1|COMPLETED|Overall Study||42
5218941|NCT00954941|12833942|P2|STARTED|Overall Study||48
5218942|NCT00954941|12833943|P1|STARTED|Overall Study||50
5218943|NCT00954915|12833951|P1|NOT COMPLETED|Overall Study||0
5218944|NCT00954915|12833951|P1|COMPLETED|Overall Study||1
5218945|NCT00954915|12833951|P1|STARTED|Overall Study||1
5218946|NCT00954824|12833955|P1|NOT COMPLETED|Overall Study||50
5218947|NCT00954824|12833955|P1|COMPLETED|Overall Study||50
5218948|NCT00954824|12833955|P1|STARTED|Overall Study||100
5218949|NCT00954733|12833959|P1|NOT COMPLETED|Overall Study||1
5218950|NCT00954733|12833959|P1|COMPLETED|Overall Study||39
5218951|NCT00954733|12833959|P1|STARTED|Overall Study||40
5218952|NCT00954707|12833963|P1|NOT COMPLETED|Overall Study||167
5218953|NCT00954707|12833963|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
5218954|NCT00954707|12833963|P1|STARTED|Overall Study||2509
5218955|NCT00954681|12833979|P1|NOT COMPLETED|Overall Study||5
5218956|NCT00954681|12833979|P1|COMPLETED|Overall Study||10
5218957|NCT00954681|12833979|P1|STARTED|Overall Study||15
5218958|NCT00954538|12833985|P6|NOT COMPLETED|Part III||0
5218959|NCT00954538|12833986|P5|NOT COMPLETED|Part III||1
5218960|NCT00954538|12833987|P4|NOT COMPLETED|Part III||0
5218961|NCT00954538|12833988|P3|NOT COMPLETED|Part III||0
5218962|NCT00954538|12833989|P2|NOT COMPLETED|Part III||0
5218963|NCT00954538|12833990|P1|NOT COMPLETED|Part III||0
5218964|NCT00954538|12833985|P6|COMPLETED|Part III||2
5218965|NCT00954538|12833986|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
5218966|NCT00954538|12833987|P4|COMPLETED|Part III||4
5218967|NCT00954538|12833988|P3|COMPLETED|Part III||0
5218968|NCT00954538|12833989|P2|COMPLETED|Part III||0
5218969|NCT00954538|12833990|P1|COMPLETED|Part III||0
5218970|NCT00954538|12833985|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
5218971|NCT00954538|12833986|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
5218972|NCT00954538|12833987|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
5218973|NCT00954538|12833988|P3|STARTED|Part III||0
5218974|NCT00954538|12833989|P2|STARTED|Part III||0
5218975|NCT00954538|12833990|P1|STARTED|Part III||0
5218976|NCT00954538|12833985|P6|NOT COMPLETED|Part II||0
5218977|NCT00954538|12833986|P5|NOT COMPLETED|Part II||0
5218978|NCT00954538|12833987|P4|NOT COMPLETED|Part II||0
5218979|NCT00954538|12833988|P3|NOT COMPLETED|Part II||0
5218980|NCT00954538|12833989|P2|NOT COMPLETED|Part II||0
5218981|NCT00954538|12833990|P1|NOT COMPLETED|Part II||0
5218982|NCT00954538|12833985|P6|COMPLETED|Part II||2
5218983|NCT00954538|12833986|P5|COMPLETED|Part II||0
5218984|NCT00954538|12833987|P4|COMPLETED|Part II||0
5218985|NCT00954538|12833988|P3|COMPLETED|Part II||3
5218986|NCT00954538|12833989|P2|COMPLETED|Part II||1
5218987|NCT00954538|12833990|P1|COMPLETED|Part II||0
5218988|NCT00954538|12833985|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
5218989|NCT00954538|12833986|P5|STARTED|Part II||0
5218990|NCT00954538|12833987|P4|STARTED|Part II||0
5218991|NCT00954538|12833988|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
5218992|NCT00954538|12833989|P2|STARTED|Part II|This subject did not participate in Part I or III|1
5218993|NCT00954538|12833990|P1|STARTED|Part II||0
5218994|NCT00954538|12833985|P6|NOT COMPLETED|Part I||0
5218995|NCT00954538|12833986|P5|NOT COMPLETED|Part I||0
5218996|NCT00954538|12833987|P4|NOT COMPLETED|Part I||0
5218997|NCT00954538|12833988|P3|NOT COMPLETED|Part I||0
5218998|NCT00954538|12833989|P2|NOT COMPLETED|Part I||0
5218999|NCT00954538|12833990|P1|NOT COMPLETED|Part I||0
5219000|NCT00954538|12833985|P6|COMPLETED|Part I||0
5219001|NCT00954538|12833986|P5|COMPLETED|Part I||0
5219002|NCT00954538|12833987|P4|COMPLETED|Part I||0
5219003|NCT00954538|12833988|P3|COMPLETED|Part I||0
5219004|NCT00954538|12833989|P2|COMPLETED|Part I||0
5219005|NCT00954538|12833990|P1|COMPLETED|Part I||3
5219006|NCT00954538|12833985|P6|STARTED|Part I||0
5219007|NCT00954538|12833986|P5|STARTED|Part I||0
5219008|NCT00954538|12833987|P4|STARTED|Part I||0
5219009|NCT00954538|12833988|P3|STARTED|Part I||0
5219010|NCT00954538|12833989|P2|STARTED|Part I||0
5219011|NCT00954538|12833990|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
5219012|NCT00954512|12834007|P6|NOT COMPLETED|Overall Study||4
5219013|NCT00954512|12834008|P5|NOT COMPLETED|Overall Study||4
5219014|NCT00954512|12834009|P4|NOT COMPLETED|Overall Study||2
5219015|NCT00954512|12834010|P3|NOT COMPLETED|Overall Study||0
5219016|NCT00954512|12834011|P2|NOT COMPLETED|Overall Study||3
5219017|NCT00954512|12834012|P1|NOT COMPLETED|Overall Study||2
5219018|NCT00954512|12834007|P6|COMPLETED|Overall Study||0
5219019|NCT00954512|12834008|P5|COMPLETED|Overall Study||0
5219020|NCT00954512|12834009|P4|COMPLETED|Overall Study||0
5219021|NCT00954512|12834010|P3|COMPLETED|Overall Study||0
5219022|NCT00954512|12834011|P2|COMPLETED|Overall Study||0
5219023|NCT00954512|12834012|P1|COMPLETED|Overall Study||0
5219024|NCT00954512|12834007|P6|STARTED|Overall Study||4
5219025|NCT00954512|12834008|P5|STARTED|Overall Study||4
5219026|NCT00954512|12834009|P4|STARTED|Overall Study||2
5219027|NCT00954512|12834010|P3|STARTED|Overall Study||0
5219028|NCT00954512|12834011|P2|STARTED|Overall Study||3
5219029|NCT00954512|12834012|P1|STARTED|Overall Study||2
5219030|NCT00954447|12834033|P2|NOT COMPLETED|Overall Study||88
5219031|NCT00954447|12834034|P1|NOT COMPLETED|Overall Study||110
5219032|NCT00954447|12834033|P2|COMPLETED|Overall Study||543
5219033|NCT00954447|12834034|P1|COMPLETED|Overall Study||520
5219034|NCT00954447|12834033|P2|STARTED|Overall Study||631
5219035|NCT00954447|12834034|P1|STARTED|Overall Study||630
5219036|NCT00954421|12834070|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
5219037|NCT00954421|12834070|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
5219038|NCT00954421|12834070|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
5219039|NCT00954421|12834070|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
5219040|NCT00954421|12834070|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
5219041|NCT00954421|12834070|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
5219042|NCT00954421|12834070|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
5219043|NCT00954421|12834070|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
5219044|NCT00954421|12834070|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
5219045|NCT00954421|12834070|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
5219046|NCT00954421|12834070|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
5219047|NCT00954421|12834070|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
5219048|NCT00954421|12834070|P1|NOT COMPLETED|6 Months of DBS||1
5219049|NCT00954421|12834070|P1|COMPLETED|6 Months of DBS||12
5219050|NCT00954421|12834070|P1|STARTED|6 Months of DBS||13
5219051|NCT00954421|12834070|P1|NOT COMPLETED|Baseline||0
5219052|NCT00954421|12834070|P1|COMPLETED|Baseline||13
5219053|NCT00954421|12834070|P1|STARTED|Baseline||13
5219054|NCT00954421|12834070|P1|NOT COMPLETED|Screening||3
5219055|NCT00954421|12834070|P1|COMPLETED|Screening||13
5219056|NCT00954421|12834070|P1|STARTED|Screening||16
5219057|NCT00954356|12834078|P2|NOT COMPLETED|Overall Study||0
5219058|NCT00954356|12834079|P1|NOT COMPLETED|Overall Study||0
5219059|NCT00954356|12834078|P2|COMPLETED|Overall Study||20
5219060|NCT00954356|12834079|P1|COMPLETED|Overall Study||41
5219061|NCT00954356|12834078|P2|STARTED|Overall Study||20
5219062|NCT00954356|12834079|P1|STARTED|Overall Study||41
5219063|NCT00954187|12834109|P2|NOT COMPLETED|Overall Study||0
5219064|NCT00954187|12834110|P1|NOT COMPLETED|Overall Study||0
5219065|NCT00954187|12834109|P2|COMPLETED|Overall Study||0
5219066|NCT00954187|12834110|P1|COMPLETED|Overall Study||0
5219067|NCT00954187|12834109|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
5219068|NCT00954187|12834110|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
5219069|NCT00954122|12834116|P1|NOT COMPLETED|Overall Study||7
5219070|NCT00954122|12834116|P1|COMPLETED|Overall Study||28
5219071|NCT00954122|12834116|P1|STARTED|Overall Study||35
5219072|NCT00954109|12834126|P1|NOT COMPLETED|Overall Study||0
5219073|NCT00954109|12834126|P1|COMPLETED|Overall Study||11
5219074|NCT00954109|12834126|P1|STARTED|Overall Study||11
5219075|NCT00953927|12834133|P2|NOT COMPLETED|Overall Study||95
5219076|NCT00953927|12834134|P1|NOT COMPLETED|Overall Study||105
5219077|NCT00953927|12834133|P2|COMPLETED|Overall Study||1303
5219078|NCT00953927|12834134|P1|COMPLETED|Overall Study||1294
5219079|NCT00953927|12834133|P2|STARTED|Overall Study||1398
5219080|NCT00953927|12834134|P1|STARTED|Overall Study||1399
5219081|NCT00953862|12834152|P1|NOT COMPLETED|Overall Study||6
5219082|NCT00953862|12834152|P1|COMPLETED|Overall Study||12
5219083|NCT00953862|12834152|P1|STARTED|Overall Study||18
5219084|NCT00953849|12834162|P4|NOT COMPLETED|Overall Study||0
5219085|NCT00953849|12834163|P3|NOT COMPLETED|Overall Study||0
5219086|NCT00953849|12834164|P2|NOT COMPLETED|Overall Study||0
5219087|NCT00953849|12834165|P1|NOT COMPLETED|Overall Study||0
5219088|NCT00953849|12834162|P4|COMPLETED|Overall Study||5
5219089|NCT00953849|12834163|P3|COMPLETED|Overall Study||4
5219090|NCT00953849|12834164|P2|COMPLETED|Overall Study||6
5219091|NCT00953849|12834165|P1|COMPLETED|Overall Study||6
5219092|NCT00953849|12834162|P4|STARTED|Overall Study||5
5219093|NCT00953849|12834163|P3|STARTED|Overall Study||4
5219094|NCT00953849|12834164|P2|STARTED|Overall Study||6
5219095|NCT00953849|12834165|P1|STARTED|Overall Study||6
5219096|NCT00953745|12834189|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
5219097|NCT00953745|12834190|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
5219098|NCT00953745|12834189|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
5219099|NCT00953745|12834190|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
5219100|NCT00953745|12834189|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
5219101|NCT00953745|12834190|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
5219102|NCT00953745|12834189|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
5219103|NCT00953745|12834190|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
5219104|NCT00953745|12834189|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
5219105|NCT00953745|12834190|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
5219106|NCT00953745|12834189|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
5219107|NCT00953745|12834190|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
5219108|NCT00953745|12834189|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
5219109|NCT00953745|12834190|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
5219110|NCT00953745|12834189|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
5219111|NCT00953745|12834190|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
5219112|NCT00953745|12834189|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
5219113|NCT00953745|12834190|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
5219114|NCT00953719|12834200|P2|NOT COMPLETED|Overall Study||5
5219115|NCT00953719|12834201|P1|NOT COMPLETED|Overall Study||19
5219116|NCT00953719|12834200|P2|COMPLETED|Overall Study||69
5219117|NCT00953719|12834201|P1|COMPLETED|Overall Study||150
5219118|NCT00953719|12834200|P2|STARTED|Overall Study||74
5219119|NCT00953719|12834201|P1|STARTED|Overall Study||169
5219120|NCT00953706|12834223|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
5219121|NCT00953706|12834224|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
5219122|NCT00953706|12834225|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
5219123|NCT00953706|12834226|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
5219124|NCT00953706|12834223|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
5219125|NCT00953706|12834224|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
5219126|NCT00953706|12834225|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
5219127|NCT00953706|12834226|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
5219128|NCT00953706|12834223|P4|STARTED|Part B (96-Week Open-Label Extension)||33
5219129|NCT00953706|12834224|P3|STARTED|Part B (96-Week Open-Label Extension)||5
5219130|NCT00953706|12834225|P2|STARTED|Part B (96-Week Open-Label Extension)||0
5219131|NCT00953706|12834226|P1|STARTED|Part B (96-Week Open-Label Extension)||0
5219132|NCT00953706|12834223|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
5219133|NCT00953706|12834224|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
5219134|NCT00953706|12834225|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
5219135|NCT00953706|12834226|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
5219136|NCT00953706|12834223|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
5219137|NCT00953706|12834224|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
5219138|NCT00953706|12834225|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
5219139|NCT00953706|12834226|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
5219140|NCT00953706|12834223|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
5219141|NCT00953706|12834224|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
5219142|NCT00953706|12834225|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
5219143|NCT00953706|12834226|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
5219144|NCT00953680|12834258|P2|NOT COMPLETED|Period 2||0
5219145|NCT00953680|12834259|P1|NOT COMPLETED|Period 2||0
5219146|NCT00953680|12834258|P2|COMPLETED|Period 2||38
5219147|NCT00953680|12834259|P1|COMPLETED|Period 2||38
5219148|NCT00953680|12834258|P2|STARTED|Period 2||38
5219149|NCT00953680|12834259|P1|STARTED|Period 2||38
5219150|NCT00953680|12834258|P2|NOT COMPLETED|Period 1||1
5219151|NCT00953680|12834259|P1|NOT COMPLETED|Period 1||0
5219152|NCT00953680|12834258|P2|COMPLETED|Period 1||38
5219153|NCT00953680|12834259|P1|COMPLETED|Period 1||38
5219154|NCT00953680|12834258|P2|STARTED|Period 1||39
5219155|NCT00953680|12834259|P1|STARTED|Period 1||38
5219156|NCT00953667|12834271|P1|NOT COMPLETED|Overall Study||123
5219157|NCT00953667|12834271|P1|COMPLETED|Overall Study||277
5219158|NCT00953667|12834271|P1|STARTED|Overall Study||400
5219159|NCT00953654|12834279|P3|NOT COMPLETED|Overall Study||0
5219160|NCT00953654|12834280|P2|NOT COMPLETED|Overall Study||0
5219161|NCT00953654|12834281|P1|NOT COMPLETED|Overall Study||0
5219162|NCT00953654|12834279|P3|COMPLETED|Overall Study||10
5219163|NCT00953654|12834280|P2|COMPLETED|Overall Study||10
5219164|NCT00953654|12834281|P1|COMPLETED|Overall Study||10
5219165|NCT00953654|12834279|P3|STARTED|Overall Study||10
5219166|NCT00953654|12834280|P2|STARTED|Overall Study||10
5219167|NCT00953654|12834281|P1|STARTED|Overall Study||10
5219168|NCT00953615|12834292|P1|NOT COMPLETED|Overall Study||1
5219169|NCT00953615|12834292|P1|COMPLETED|Overall Study||0
5219170|NCT00953615|12834292|P1|STARTED|Overall Study||1
5219171|NCT00953576|12834301|P2|NOT COMPLETED|Overall Study||1
5219172|NCT00953576|12834302|P1|NOT COMPLETED|Overall Study||2
5219173|NCT00953576|12834301|P2|COMPLETED|Overall Study||4
5219174|NCT00953576|12834302|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
5219175|NCT00953576|12834301|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
5219176|NCT00953576|12834302|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
5219177|NCT00953576|12834301|P2|Treated|Overall Study||5
5219178|NCT00953576|12834302|P1|Treated|Overall Study||4
5219179|NCT00953576|12834301|P2|DLT Evaluable|Overall Study||5
5219180|NCT00953576|12834302|P1|DLT Evaluable|Overall Study||3
5219181|NCT00953576|12834301|P2|STARTED|Overall Study||5
5219182|NCT00953576|12834302|P1|STARTED|Overall Study||6
5219183|NCT00953524|12834317|P4|NOT COMPLETED|Overall Study||8
5219184|NCT00953524|12834318|P3|NOT COMPLETED|Overall Study||14
5219185|NCT00953524|12834319|P2|NOT COMPLETED|Overall Study||15
5219186|NCT00953524|12834320|P1|NOT COMPLETED|Overall Study||22
5219187|NCT00953524|12834317|P4|COMPLETED|Overall Study||91
5219188|NCT00953524|12834318|P3|COMPLETED|Overall Study||233
5219189|NCT00953524|12834319|P2|COMPLETED|Overall Study||239
5219190|NCT00953524|12834320|P1|COMPLETED|Overall Study||227
5219191|NCT00953524|12834317|P4|STARTED|Overall Study||99
5219192|NCT00953524|12834318|P3|STARTED|Overall Study||247
5219193|NCT00953524|12834319|P2|STARTED|Overall Study||254
5219194|NCT00953524|12834320|P1|STARTED|Overall Study||249
5219195|NCT00953407|12834363|P5|NOT COMPLETED|Overall Study||1
5219196|NCT00953407|12834364|P4|NOT COMPLETED|Overall Study||2
5219197|NCT00953407|12834365|P3|NOT COMPLETED|Overall Study||1
5219198|NCT00953407|12834366|P2|NOT COMPLETED|Overall Study||1
5219199|NCT00953407|12834367|P1|NOT COMPLETED|Overall Study||1
5219200|NCT00953407|12834363|P5|COMPLETED|Overall Study||23
5219201|NCT00953407|12834364|P4|COMPLETED|Overall Study||23
5219202|NCT00953407|12834365|P3|COMPLETED|Overall Study||25
5219203|NCT00953407|12834366|P2|COMPLETED|Overall Study||24
5219204|NCT00953407|12834367|P1|COMPLETED|Overall Study||25
5219205|NCT00953407|12834363|P5|STARTED|Overall Study||24
5219206|NCT00953407|12834364|P4|STARTED|Overall Study||25
5219207|NCT00953407|12834365|P3|STARTED|Overall Study||26
5219208|NCT00953407|12834366|P2|STARTED|Overall Study||25
5219209|NCT00953407|12834367|P1|STARTED|Overall Study||26
5219210|NCT00953329|12834379|P1|NOT COMPLETED|Overall Study||1
5219211|NCT00953329|12834379|P1|COMPLETED|Overall Study||0
5219212|NCT00953329|12834379|P1|STARTED|Overall Study||1
5219213|NCT00953290|12834383|P1|NOT COMPLETED|Overall Study||0
5219214|NCT00953290|12834383|P1|COMPLETED|Overall Study||4
5219215|NCT00953290|12834383|P1|STARTED|Overall Study||4
5219216|NCT00953225|12834392|P2|NOT COMPLETED|Overall Study||0
5219217|NCT00953225|12834393|P1|NOT COMPLETED|Overall Study||2
5219218|NCT00953225|12834392|P2|COMPLETED|Overall Study||37
5219219|NCT00953225|12834393|P1|COMPLETED|Overall Study||44
5219220|NCT00953225|12834392|P2|STARTED|Overall Study||37
5219221|NCT00953225|12834393|P1|STARTED|Overall Study||46
5219222|NCT00953212|12834405|P4|NOT COMPLETED|Overall Study||0
5219223|NCT00953212|12834406|P3|NOT COMPLETED|Overall Study||0
5219224|NCT00953212|12834407|P2|NOT COMPLETED|Overall Study||0
5219225|NCT00953212|12834408|P1|NOT COMPLETED|Overall Study||0
5219226|NCT00953212|12834405|P4|COMPLETED|Overall Study||76
5219227|NCT00953212|12834406|P3|COMPLETED|Overall Study||78
5219228|NCT00953212|12834407|P2|COMPLETED|Overall Study||74
5219229|NCT00953212|12834408|P1|COMPLETED|Overall Study||76
5219230|NCT00953212|12834405|P4|STARTED|Overall Study||76
5219231|NCT00953212|12834406|P3|STARTED|Overall Study||78
5219232|NCT00953212|12834407|P2|STARTED|Overall Study||74
5219233|NCT00953212|12834408|P1|STARTED|Overall Study||76
5219234|NCT00953199|12834464|P2|NOT COMPLETED|Overall Study||0
5219235|NCT00953199|12834465|P1|NOT COMPLETED|Overall Study||0
5219236|NCT00953199|12834464|P2|COMPLETED|Overall Study||252
5219237|NCT00953199|12834465|P1|COMPLETED|Overall Study||254
5219238|NCT00953199|12834464|P2|STARTED|Overall Study||252
5219239|NCT00953199|12834465|P1|STARTED|Overall Study||254
5219240|NCT00953173|12834473|P1|NOT COMPLETED|Overall Study||282
5219241|NCT00953173|12834473|P1|COMPLETED|Overall Study||389
5219242|NCT00953173|12834473|P1|STARTED|Overall Study||671
5219243|NCT00953160|12834477|P1|NOT COMPLETED|Overall Study||27
5219244|NCT00953160|12834477|P1|COMPLETED|Overall Study||49
5219245|NCT00953160|12834477|P1|STARTED|Overall Study||76
5219246|NCT00953147|12834486|P3|NOT COMPLETED|Overall Study||42
5219247|NCT00953147|12834487|P2|NOT COMPLETED|Overall Study||66
5219248|NCT00953147|12834488|P1|NOT COMPLETED|Overall Study||37
5219249|NCT00953147|12834486|P3|COMPLETED|Overall Study||265
5219250|NCT00953147|12834487|P2|COMPLETED|Overall Study||439
5219251|NCT00953147|12834488|P1|COMPLETED|Overall Study||261
5219252|NCT00953147|12834486|P3|STARTED|Overall Study||307
5219253|NCT00953147|12834487|P2|STARTED|Overall Study||505
5219254|NCT00953147|12834488|P1|STARTED|Overall Study||298
5219255|NCT00953121|12834538|P3|NOT COMPLETED|Overall Study||0
5219256|NCT00953121|12834539|P2|NOT COMPLETED|Overall Study||0
5219257|NCT00953121|12834540|P1|NOT COMPLETED|Overall Study||0
5219258|NCT00953121|12834538|P3|COMPLETED|Overall Study||25
5219259|NCT00953121|12834539|P2|COMPLETED|Overall Study||39
5219260|NCT00953121|12834540|P1|COMPLETED|Overall Study||40
5219261|NCT00953121|12834538|P3|STARTED|Overall Study||25
5219262|NCT00953121|12834539|P2|STARTED|Overall Study||39
5219263|NCT00953121|12834540|P1|STARTED|Overall Study||40
5219264|NCT00953056|12834566|P6|NOT COMPLETED|Overall Study||4
5219265|NCT00953056|12834567|P5|NOT COMPLETED|Overall Study||2
5219266|NCT00953056|12834568|P4|NOT COMPLETED|Overall Study||0
5219267|NCT00953056|12834569|P3|NOT COMPLETED|Overall Study||0
5219268|NCT00953056|12834570|P2|NOT COMPLETED|Overall Study||0
5219269|NCT00953056|12834571|P1|NOT COMPLETED|Overall Study||0
5219270|NCT00953056|12834566|P6|COMPLETED|Overall Study||20
5219271|NCT00953056|12834567|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
5219272|NCT00953056|12834568|P4|COMPLETED|Overall Study||24
5219273|NCT00953056|12834569|P3|COMPLETED|Overall Study||24
5219274|NCT00953056|12834570|P2|COMPLETED|Overall Study||24
5219275|NCT00953056|12834571|P1|COMPLETED|Overall Study||24
5219276|NCT00953056|12834566|P6|STARTED|Overall Study||24
5219277|NCT00953056|12834567|P5|STARTED|Overall Study||24
5219278|NCT00953056|12834568|P4|STARTED|Overall Study||24
5219279|NCT00953056|12834569|P3|STARTED|Overall Study||24
5219280|NCT00953056|12834570|P2|STARTED|Overall Study||24
5219281|NCT00953056|12834571|P1|STARTED|Overall Study||24
5219282|NCT00953043|12834595|P2|NOT COMPLETED|Overall Study||2
5219283|NCT00953043|12834596|P1|NOT COMPLETED|Overall Study||4
5219284|NCT00953043|12834595|P2|COMPLETED|Overall Study||28
5219285|NCT00953043|12834596|P1|COMPLETED|Overall Study||26
5219286|NCT00953043|12834595|P2|STARTED|Overall Study||30
5219287|NCT00953043|12834596|P1|STARTED|Overall Study||30
5219288|NCT00953017|12834620|P4|NOT COMPLETED|Overall Study||5
5219289|NCT00953017|12834621|P3|NOT COMPLETED|Overall Study||6
5219290|NCT00953017|12834622|P2|NOT COMPLETED|Overall Study||6
5219291|NCT00953017|12834623|P1|NOT COMPLETED|Overall Study||5
5219292|NCT00953017|12834620|P4|COMPLETED|Overall Study||101
5219293|NCT00953017|12834621|P3|COMPLETED|Overall Study||100
5219294|NCT00953017|12834622|P2|COMPLETED|Overall Study||101
5219295|NCT00953017|12834623|P1|COMPLETED|Overall Study||101
5219296|NCT00953017|12834620|P4|STARTED|Overall Study||106
5219297|NCT00953017|12834621|P3|STARTED|Overall Study||106
5219298|NCT00953017|12834622|P2|STARTED|Overall Study||107
5219299|NCT00953017|12834623|P1|STARTED|Overall Study||106
5219300|NCT00952848|12834645|P1|NOT COMPLETED|Overall Study||4
5219301|NCT00952848|12834645|P1|COMPLETED|Overall Study||14
5219302|NCT00952848|12834645|P1|STARTED|Overall Study||18
5219303|NCT00952822|12834652|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
5219304|NCT00952822|12834653|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
5219305|NCT00952822|12834654|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
5219306|NCT00952822|12834655|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
5219307|NCT00952822|12834652|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
5219308|NCT00952822|12834653|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
5219309|NCT00952822|12834654|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
5219310|NCT00952822|12834655|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
5219311|NCT00952822|12834652|P4|STARTED|2nd Pharmacokinetic Evaluation||4
5219312|NCT00952822|12834653|P3|STARTED|2nd Pharmacokinetic Evaluation||11
5219313|NCT00952822|12834654|P2|STARTED|2nd Pharmacokinetic Evaluation||17
5219314|NCT00952822|12834655|P1|STARTED|2nd Pharmacokinetic Evaluation||9
5219315|NCT00952822|12834652|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
5219316|NCT00952822|12834653|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
5219317|NCT00952822|12834654|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
5219318|NCT00952822|12834655|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
5219319|NCT00952822|12834652|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
5219320|NCT00952822|12834653|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
5219321|NCT00952822|12834654|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
5219322|NCT00952822|12834655|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
5219323|NCT00952822|12834652|P4|STARTED|1st Pharmacokinetic Evaluation||4
5219324|NCT00952822|12834653|P3|STARTED|1st Pharmacokinetic Evaluation||11
5219325|NCT00952822|12834654|P2|STARTED|1st Pharmacokinetic Evaluation||18
5219326|NCT00952822|12834655|P1|STARTED|1st Pharmacokinetic Evaluation||9
5219327|NCT00952731|12834687|P2|NOT COMPLETED|Overall Study||0
5219328|NCT00952731|12834688|P1|NOT COMPLETED|Overall Study||1
5219329|NCT00952731|12834687|P2|COMPLETED|Overall Study||14
5219330|NCT00952731|12834688|P1|COMPLETED|Overall Study||12
5219331|NCT00952731|12834687|P2|Follow-up|Overall Study||14
5219332|NCT00952731|12834688|P1|Follow-up|Overall Study||12
5219333|NCT00952731|12834687|P2|Surgery|Overall Study||14
5219334|NCT00952731|12834688|P1|Surgery|Overall Study||12
5219335|NCT00952731|12834687|P2|Treatment & Pre-Surgery|Overall Study||14
5219336|NCT00952731|12834688|P1|Treatment & Pre-Surgery|Overall Study||12
5219337|NCT00952731|12834687|P2|Randomization|Overall Study||14
5219338|NCT00952731|12834688|P1|Randomization|Overall Study||13
5219339|NCT00952731|12834687|P2|STARTED|Overall Study||14
5219340|NCT00952731|12834688|P1|STARTED|Overall Study||13
5219341|NCT00952718|12834706|P2|NOT COMPLETED|Overall Study||6
5219342|NCT00952718|12834707|P1|NOT COMPLETED|Overall Study||6
5219343|NCT00952718|12834706|P2|COMPLETED|Overall Study||13
5219344|NCT00952718|12834707|P1|COMPLETED|Overall Study||13
5219345|NCT00952718|12834706|P2|STARTED|Overall Study||19
5219346|NCT00952718|12834707|P1|STARTED|Overall Study||19
5219347|NCT00952705|12834720|P3|NOT COMPLETED|Overall Study||10
5219348|NCT00952705|12834721|P2|NOT COMPLETED|Overall Study||10
5219349|NCT00952705|12834722|P1|NOT COMPLETED|Overall Study||33
5219350|NCT00952705|12834720|P3|COMPLETED|Overall Study||288
5219351|NCT00952705|12834721|P2|COMPLETED|Overall Study||290
5219352|NCT00952705|12834722|P1|COMPLETED|Overall Study||1169
5219353|NCT00952705|12834720|P3|STARTED|Overall Study||298
5219354|NCT00952705|12834721|P2|STARTED|Overall Study||300
5219355|NCT00952705|12834722|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
5219356|NCT00952653|12834784|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
5219357|NCT00952653|12834784|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
5219358|NCT00952653|12834784|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
5219359|NCT00952653|12834784|P1|NOT COMPLETED|Period 1: MDZ Alone||0
5219360|NCT00952653|12834784|P1|COMPLETED|Period 1: MDZ Alone||28
5219361|NCT00952653|12834784|P1|STARTED|Period 1: MDZ Alone||28
5219362|NCT00952614|12834809|P1|NOT COMPLETED|Overall Study||7
5219363|NCT00952614|12834809|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
5219364|NCT00952614|12834809|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
5219365|NCT00952614|12834809|P1|STARTED|Overall Study||30
5219366|NCT00952588|12834816|P2|NOT COMPLETED|Overall Study||24
5219367|NCT00952588|12834817|P1|NOT COMPLETED|Overall Study||36
5219368|NCT00952588|12834816|P2|COMPLETED|Overall Study||2
5219369|NCT00952588|12834817|P1|COMPLETED|Overall Study||12
5219370|NCT00952588|12834816|P2|STARTED|Overall Study||26
5219371|NCT00952588|12834817|P1|STARTED|Overall Study||48
5219372|NCT00952523|12834835|P1|NOT COMPLETED|Overall Study||7
5219373|NCT00952523|12834835|P1|COMPLETED|Overall Study||155
5219374|NCT00952523|12834835|P1|STARTED|Overall Study||162
5219375|NCT00952484|12834844|P3|NOT COMPLETED|Overall Study||0
5219376|NCT00952484|12834845|P2|NOT COMPLETED|Overall Study||1
5219377|NCT00952484|12834846|P1|NOT COMPLETED|Overall Study||0
5219378|NCT00952484|12834844|P3|COMPLETED|Overall Study||16
5219379|NCT00952484|12834845|P2|COMPLETED|Overall Study||6
5219380|NCT00952484|12834846|P1|COMPLETED|Overall Study||6
5219381|NCT00952484|12834844|P3|STARTED|Overall Study||16
5219382|NCT00952484|12834845|P2|STARTED|Overall Study||7
5219383|NCT00952484|12834846|P1|STARTED|Overall Study||6
5219384|NCT00952419|12834873|P3|NOT COMPLETED|Overall Study||0
5219385|NCT00952419|12834874|P2|NOT COMPLETED|Overall Study||10
5219386|NCT00952419|12834875|P1|NOT COMPLETED|Overall Study||6
5219387|NCT00952419|12834873|P3|COMPLETED|Overall Study||51
5219388|NCT00952419|12834874|P2|COMPLETED|Overall Study||198
5219389|NCT00952419|12834875|P1|COMPLETED|Overall Study||209
5219390|NCT00952419|12834873|P3|STARTED|Overall Study||51
5219391|NCT00952419|12834874|P2|STARTED|Overall Study||208
5219392|NCT00952419|12834875|P1|STARTED|Overall Study||215
5219393|NCT00952393|12834907|P1|NOT COMPLETED|Overall Study||0
5219394|NCT00952393|12834907|P1|COMPLETED|Overall Study||10
5219395|NCT00952393|12834907|P1|STARTED|Overall Study|10|10
5219396|NCT00952380|12834916|P5|NOT COMPLETED|Overall Study||6
5219397|NCT00952380|12834917|P4|NOT COMPLETED|Overall Study||3
5219398|NCT00952380|12834918|P3|NOT COMPLETED|Overall Study||2
5219399|NCT00952380|12834919|P2|NOT COMPLETED|Overall Study||1
5219400|NCT00952380|12834920|P1|NOT COMPLETED|Overall Study||0
5219401|NCT00952380|12834916|P5|COMPLETED|Overall Study||14
5219402|NCT00952380|12834917|P4|COMPLETED|Overall Study||4
5219403|NCT00952380|12834918|P3|COMPLETED|Overall Study||6
5219404|NCT00952380|12834919|P2|COMPLETED|Overall Study||1
5219405|NCT00952380|12834920|P1|COMPLETED|Overall Study||1
5219406|NCT00952380|12834916|P5|STARTED|Overall Study||20
5219407|NCT00952380|12834917|P4|STARTED|Overall Study||7
5219408|NCT00952380|12834918|P3|STARTED|Overall Study||8
5219409|NCT00952380|12834919|P2|STARTED|Overall Study||2
5219410|NCT00952380|12834920|P1|STARTED|Overall Study||1
5219411|NCT00952367|12835021|P1|NOT COMPLETED|Overall Study||6
5219412|NCT00952367|12835021|P1|COMPLETED|Overall Study||3635
5219413|NCT00952367|12835021|P1|STARTED|Overall Study||3641
5219414|NCT00952341|12835036|P2|NOT COMPLETED|Cycle 2||12
5219415|NCT00952341|12835037|P1|NOT COMPLETED|Cycle 2||9
5219416|NCT00952341|12835036|P2|COMPLETED|Cycle 2||118
5219417|NCT00952341|12835037|P1|COMPLETED|Cycle 2||101
5219418|NCT00952341|12835036|P2|STARTED|Cycle 2||130
5219419|NCT00952341|12835037|P1|STARTED|Cycle 2||110
5219420|NCT00952341|12835036|P2|NOT COMPLETED|Cycle 1||13
5219421|NCT00952341|12835037|P1|NOT COMPLETED|Cycle 1||20
5219422|NCT00952341|12835036|P2|COMPLETED|Cycle 1||199
5219423|NCT00952341|12835037|P1|COMPLETED|Cycle 1||189
5219424|NCT00952341|12835036|P2|STARTED|Cycle 1||212
5219425|NCT00952341|12835037|P1|STARTED|Cycle 1||209
5219426|NCT00952315|12835060|P3|NOT COMPLETED|Overall Study||19
5219427|NCT00952315|12835061|P2|NOT COMPLETED|Overall Study||24
5219428|NCT00952315|12835062|P1|NOT COMPLETED|Overall Study||26
5219429|NCT00952315|12835060|P3|COMPLETED|Overall Study||71
5219430|NCT00952315|12835061|P2|COMPLETED|Overall Study||66
5219431|NCT00952315|12835062|P1|COMPLETED|Overall Study||64
5219432|NCT00952315|12835060|P3|STARTED|Overall Study||90
5219433|NCT00952315|12835061|P2|STARTED|Overall Study||90
5219434|NCT00952315|12835062|P1|STARTED|Overall Study||90
5219435|NCT00952289|12835099|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
5219436|NCT00952289|12835100|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
5219437|NCT00952289|12835099|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
5219438|NCT00952289|12835100|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
5219439|NCT00952289|12835099|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
5219440|NCT00952289|12835100|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
5219441|NCT00952289|12835099|P2|NOT COMPLETED|All Participants||40
5219442|NCT00952289|12835100|P1|NOT COMPLETED|All Participants||21
5219443|NCT00952289|12835099|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
5219444|NCT00952289|12835100|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
5219445|NCT00952289|12835099|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
5219446|NCT00952289|12835100|P1|Safety Population|All Participants||155
5219447|NCT00952289|12835099|P2|STARTED|All Participants||154
5219448|NCT00952289|12835100|P1|STARTED|All Participants||155
5219449|NCT00952276|12835129|P5|NOT COMPLETED|Overall Study||0
5219450|NCT00952276|12835130|P4|NOT COMPLETED|Overall Study||1
5219451|NCT00952276|12835131|P3|NOT COMPLETED|Overall Study||0
5219452|NCT00952276|12835132|P2|NOT COMPLETED|Overall Study||0
5219453|NCT00952276|12835133|P1|NOT COMPLETED|Overall Study||1
5219454|NCT00952276|12835129|P5|COMPLETED|Overall Study||63
5219455|NCT00952276|12835130|P4|COMPLETED|Overall Study||120
5219456|NCT00952276|12835131|P3|COMPLETED|Overall Study||122
5219457|NCT00952276|12835132|P2|COMPLETED|Overall Study||115
5219458|NCT00952276|12835133|P1|COMPLETED|Overall Study||126
5219459|NCT00952276|12835129|P5|STARTED|Overall Study||63
5219460|NCT00952276|12835130|P4|STARTED|Overall Study||121
5219461|NCT00952276|12835131|P3|STARTED|Overall Study||122
5219462|NCT00952276|12835132|P2|STARTED|Overall Study||115
5219463|NCT00952276|12835133|P1|STARTED|Overall Study||127
5219464|NCT00952211|12835182|P2|NOT COMPLETED|Overall Study||0
5219465|NCT00952211|12835183|P1|NOT COMPLETED|Overall Study||0
5219466|NCT00952211|12835182|P2|COMPLETED|Overall Study||0
5219467|NCT00952211|12835183|P1|COMPLETED|Overall Study||3
5219468|NCT00952211|12835182|P2|STARTED|Overall Study||0
5219469|NCT00952211|12835183|P1|STARTED|Overall Study||3
5219470|NCT00952133|12835193|P2|NOT COMPLETED|Overall Study||0
5219471|NCT00952133|12835194|P1|NOT COMPLETED|Overall Study||0
5219472|NCT00952133|12835193|P2|COMPLETED|Overall Study||59
5219473|NCT00952133|12835194|P1|COMPLETED|Overall Study||59
5219474|NCT00952133|12835193|P2|STARTED|Overall Study||59
5219475|NCT00952133|12835194|P1|STARTED|Overall Study||59
5219476|NCT00952120|12835205|P3|NOT COMPLETED|Overall Study||0
5219477|NCT00952120|12835206|P2|NOT COMPLETED|Overall Study||0
5219478|NCT00952120|12835207|P1|NOT COMPLETED|Overall Study||0
5219479|NCT00952120|12835205|P3|COMPLETED|Overall Study||5
5219480|NCT00952120|12835206|P2|COMPLETED|Overall Study||47
5219481|NCT00952120|12835207|P1|COMPLETED|Overall Study||52
5219482|NCT00952120|12835205|P3|STARTED|Overall Study||5
5219483|NCT00952120|12835206|P2|STARTED|Overall Study||47
5219484|NCT00952120|12835207|P1|STARTED|Overall Study||52
5219485|NCT00952081|12835215|P1|NOT COMPLETED|Overall Study||0
5219486|NCT00952081|12835215|P1|COMPLETED|Overall Study||22
5219487|NCT00952081|12835215|P1|STARTED|Overall Study||22
5219488|NCT00952068|12835219|P1|NOT COMPLETED|Overall Study||7
5219489|NCT00952068|12835219|P1|COMPLETED|Overall Study||40
5219490|NCT00952068|12835219|P1|STARTED|Overall Study||47
5219491|NCT00951912|12835230|P3|NOT COMPLETED|Overall Study||2
5219492|NCT00951912|12835231|P2|NOT COMPLETED|Overall Study||5
5219493|NCT00951912|12835232|P1|NOT COMPLETED|Overall Study||7
5219494|NCT00951912|12835230|P3|COMPLETED|Overall Study||54
5219495|NCT00951912|12835231|P2|COMPLETED|Overall Study||50
5219496|NCT00951912|12835232|P1|COMPLETED|Overall Study||47
5219497|NCT00951912|12835230|P3|STARTED|Overall Study||56
5219498|NCT00951912|12835231|P2|STARTED|Overall Study||55
5219499|NCT00951912|12835232|P1|STARTED|Overall Study||54
5219500|NCT00951899|12835284|P2|NOT COMPLETED|Overall Study||0
5219501|NCT00951899|12835285|P1|NOT COMPLETED|Overall Study||0
5219502|NCT00951899|12835284|P2|COMPLETED|Overall Study||19
5219503|NCT00951899|12835285|P1|COMPLETED|Overall Study||19
5219504|NCT00951899|12835284|P2|STARTED|Overall Study||19
5219505|NCT00951899|12835285|P1|STARTED|Overall Study||19
5219506|NCT00951821|12835309|P2|NOT COMPLETED|Overall Study||0
5219507|NCT00951821|12835310|P1|NOT COMPLETED|Overall Study||0
5219508|NCT00951821|12835309|P2|COMPLETED|Overall Study||8
5219509|NCT00951821|12835310|P1|COMPLETED|Overall Study||16
5219510|NCT00951821|12835309|P2|STARTED|Overall Study||8
5219511|NCT00951821|12835310|P1|STARTED|Overall Study||16
5219512|NCT00951808|12835318|P3|NOT COMPLETED|Overall Study||4
5219513|NCT00951808|12835319|P2|NOT COMPLETED|Overall Study||0
5219514|NCT00951808|12835320|P1|NOT COMPLETED|Overall Study||0
5219515|NCT00951808|12835318|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
5219516|NCT00951808|12835319|P2|COMPLETED|Overall Study||6
5219517|NCT00951808|12835320|P1|COMPLETED|Overall Study||4
5219518|NCT00951808|12835318|P3|STARTED|Overall Study||227
5219519|NCT00951808|12835319|P2|STARTED|Overall Study||6
5219520|NCT00951808|12835320|P1|STARTED|Overall Study||4
5219521|NCT00951665|12835332|P6|NOT COMPLETED|Phase 2a||7
5219522|NCT00951665|12835333|P5|NOT COMPLETED|Phase 2a||12
5219523|NCT00951665|12835334|P4|NOT COMPLETED|Phase 2a||0
5219524|NCT00951665|12835335|P3|NOT COMPLETED|Phase 2a||0
5219525|NCT00951665|12835336|P2|NOT COMPLETED|Phase 2a||0
5219526|NCT00951665|12835337|P1|NOT COMPLETED|Phase 2a||0
5219527|NCT00951665|12835332|P6|COMPLETED|Phase 2a||15
5219528|NCT00951665|12835333|P5|COMPLETED|Phase 2a||10
5219529|NCT00951665|12835334|P4|COMPLETED|Phase 2a||0
5219530|NCT00951665|12835335|P3|COMPLETED|Phase 2a||0
5219531|NCT00951665|12835336|P2|COMPLETED|Phase 2a||0
5219532|NCT00951665|12835337|P1|COMPLETED|Phase 2a||0
5219533|NCT00951665|12835332|P6|STARTED|Phase 2a||22
5219534|NCT00951665|12835333|P5|STARTED|Phase 2a||22
5219535|NCT00951665|12835334|P4|STARTED|Phase 2a||0
5219536|NCT00951665|12835335|P3|STARTED|Phase 2a||0
5219537|NCT00951665|12835336|P2|STARTED|Phase 2a||0
5219538|NCT00951665|12835337|P1|STARTED|Phase 2a||0
5219539|NCT00951665|12835332|P6|NOT COMPLETED|Phase 1b||0
5219540|NCT00951665|12835333|P5|NOT COMPLETED|Phase 1b||0
5219541|NCT00951665|12835334|P4|NOT COMPLETED|Phase 1b||1
5219542|NCT00951665|12835335|P3|NOT COMPLETED|Phase 1b||17
5219543|NCT00951665|12835336|P2|NOT COMPLETED|Phase 1b||4
5219544|NCT00951665|12835337|P1|NOT COMPLETED|Phase 1b||22
5219545|NCT00951665|12835332|P6|COMPLETED|Phase 1b||0
5219546|NCT00951665|12835333|P5|COMPLETED|Phase 1b||0
5219547|NCT00951665|12835334|P4|COMPLETED|Phase 1b||2
5219548|NCT00951665|12835335|P3|COMPLETED|Phase 1b||4
5219549|NCT00951665|12835336|P2|COMPLETED|Phase 1b||6
5219550|NCT00951665|12835337|P1|COMPLETED|Phase 1b||7
5219551|NCT00951665|12835332|P6|Started Treatment|Phase 1b||0
5219552|NCT00951665|12835333|P5|Started Treatment|Phase 1b||0
5219553|NCT00951665|12835334|P4|Started Treatment|Phase 1b||3
5219554|NCT00951665|12835335|P3|Started Treatment|Phase 1b||21
5219555|NCT00951665|12835336|P2|Started Treatment|Phase 1b||10
5219556|NCT00951665|12835337|P1|Started Treatment|Phase 1b||26
5219557|NCT00951665|12835332|P6|STARTED|Phase 1b||0
5219558|NCT00951665|12835333|P5|STARTED|Phase 1b||0
5219559|NCT00951665|12835334|P4|STARTED|Phase 1b||3
5219560|NCT00951665|12835335|P3|STARTED|Phase 1b||21
5219561|NCT00951665|12835336|P2|STARTED|Phase 1b||10
5219562|NCT00951665|12835337|P1|STARTED|Phase 1b||29
5219563|NCT00951561|12835438|P4|NOT COMPLETED|Overall Study||1
5219564|NCT00951561|12835439|P3|NOT COMPLETED|Overall Study||3
5219565|NCT00951561|12835440|P2|NOT COMPLETED|Overall Study||0
5219566|NCT00951561|12835441|P1|NOT COMPLETED|Overall Study||0
5219567|NCT00951561|12835438|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
5219568|NCT00951561|12835439|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
5219569|NCT00951561|12835440|P2|COMPLETED|Overall Study||29
5219570|NCT00951561|12835441|P1|COMPLETED|Overall Study||25
5219571|NCT00951561|12835438|P4|STARTED|Overall Study||27
5219572|NCT00951561|12835439|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
5219573|NCT00951561|12835440|P2|STARTED|Overall Study||29
5219574|NCT00951561|12835441|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
5219575|NCT00951509|12835446|P1|NOT COMPLETED|Overall Study||2
5219576|NCT00951509|12835446|P1|COMPLETED|Overall Study||29
5219577|NCT00951509|12835446|P1|Driving Condition 5|Overall Study||30
5219578|NCT00951509|12835446|P1|Driving Condition 4|Overall Study||28
5219579|NCT00951509|12835446|P1|Driving Condition 3|Overall Study||25
5219580|NCT00951509|12835446|P1|Driving Condition 2|Overall Study||29
5219581|NCT00951509|12835446|P1|Driving Condition 1|Overall Study||29
5219582|NCT00951509|12835446|P1|STARTED|Overall Study||31
5219583|NCT00951496|12835457|P3|NOT COMPLETED|Overall Study||13
5219584|NCT00951496|12835458|P2|NOT COMPLETED|Overall Study||8
5219585|NCT00951496|12835459|P1|NOT COMPLETED|Overall Study||10
5219586|NCT00951496|12835457|P3|COMPLETED|Overall Study||508
5219587|NCT00951496|12835458|P2|COMPLETED|Overall Study||510
5219588|NCT00951496|12835459|P1|COMPLETED|Overall Study||511
5219589|NCT00951496|12835457|P3|STARTED|Overall Study||521
5219590|NCT00951496|12835458|P2|STARTED|Overall Study||518
5219591|NCT00951496|12835459|P1|STARTED|Overall Study||521
5219592|NCT00951483|12835487|P2|NOT COMPLETED|Overall Study||0
5219593|NCT00951483|12835488|P1|NOT COMPLETED|Overall Study||19
5219594|NCT00951483|12835487|P2|COMPLETED|Overall Study||44
5219595|NCT00951483|12835488|P1|COMPLETED|Overall Study||28
5219596|NCT00951483|12835487|P2|STARTED|Overall Study||44
5219597|NCT00951483|12835488|P1|STARTED|Overall Study||47
5219598|NCT00951379|12835508|P2|NOT COMPLETED|Overall Study||2
5219599|NCT00951379|12835509|P1|NOT COMPLETED|Overall Study||6
5219600|NCT00951379|12835508|P2|COMPLETED|Overall Study||23
5219601|NCT00951379|12835509|P1|COMPLETED|Overall Study||21
5219602|NCT00951379|12835508|P2|STARTED|Overall Study||25
5219603|NCT00951379|12835509|P1|STARTED|Overall Study||27
5219604|NCT00951275|12835551|P1|NOT COMPLETED|Overall Study||13
5219605|NCT00951275|12835551|P1|COMPLETED|Overall Study||92
5219606|NCT00951275|12835551|P1|STARTED|Overall Study||105
5219607|NCT00951171|12835583|P2|NOT COMPLETED|Overall Study||0
5219608|NCT00951171|12835584|P1|NOT COMPLETED|Overall Study||2
5219609|NCT00951171|12835583|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
5219610|NCT00951171|12835584|P1|COMPLETED|Overall Study||38
5219611|NCT00951171|12835583|P2|Pregnancy|Overall Study||7
5219612|NCT00951171|12835584|P1|Pregnancy|Overall Study||1
5219613|NCT00951171|12835583|P2|STARTED|Overall Study||55
5219614|NCT00951171|12835584|P1|STARTED|Overall Study||40
5219615|NCT00951093|12835590|P1|NOT COMPLETED|6 Months After GBP||0
5219616|NCT00951093|12835590|P1|COMPLETED|6 Months After GBP||53
5219617|NCT00951093|12835590|P1|STARTED|6 Months After GBP||53
5219618|NCT00951093|12835590|P1|NOT COMPLETED|Before GBP||0
5219619|NCT00951093|12835590|P1|COMPLETED|Before GBP||53
5219620|NCT00951093|12835590|P1|STARTED|Before GBP||53
5219621|NCT00951041|12835616|P2|NOT COMPLETED|Overall Study||1
5219622|NCT00951041|12835617|P1|NOT COMPLETED|Overall Study||5
5219623|NCT00951041|12835616|P2|COMPLETED|Overall Study||65
5219624|NCT00951041|12835617|P1|COMPLETED|Overall Study||59
5219625|NCT00951041|12835616|P2|STARTED|Overall Study||66
5219626|NCT00951041|12835617|P1|STARTED|Overall Study||64
5219627|NCT00951015|12835672|P5|NOT COMPLETED|Open-label Phase||50
5219628|NCT00951015|12835673|P4|NOT COMPLETED|Open-label Phase||0
5219629|NCT00951015|12835674|P3|NOT COMPLETED|Open-label Phase||0
5219630|NCT00951015|12835675|P2|NOT COMPLETED|Open-label Phase||0
5219631|NCT00951015|12835676|P1|NOT COMPLETED|Open-label Phase||0
5219632|NCT00951015|12835672|P5|COMPLETED|Open-label Phase||88
5219633|NCT00951015|12835673|P4|COMPLETED|Open-label Phase||0
5219634|NCT00951015|12835674|P3|COMPLETED|Open-label Phase||0
5219635|NCT00951015|12835675|P2|COMPLETED|Open-label Phase||0
5219636|NCT00951015|12835676|P1|COMPLETED|Open-label Phase||0
5219637|NCT00951015|12835672|P5|STARTED|Open-label Phase||138
5219638|NCT00951015|12835673|P4|STARTED|Open-label Phase||0
5219639|NCT00951015|12835674|P3|STARTED|Open-label Phase||0
5219640|NCT00951015|12835675|P2|STARTED|Open-label Phase||0
5219641|NCT00951015|12835676|P1|STARTED|Open-label Phase||0
5219642|NCT00951015|12835672|P5|NOT COMPLETED|Randomization Phase 96 Week||0
5219643|NCT00951015|12835673|P4|NOT COMPLETED|Randomization Phase 96 Week||10
5219644|NCT00951015|12835674|P3|NOT COMPLETED|Randomization Phase 96 Week||5
5219645|NCT00951015|12835675|P2|NOT COMPLETED|Randomization Phase 96 Week||7
5219646|NCT00951015|12835676|P1|NOT COMPLETED|Randomization Phase 96 Week||5
5219647|NCT00951015|12835672|P5|COMPLETED|Randomization Phase 96 Week||0
5219648|NCT00951015|12835673|P4|COMPLETED|Randomization Phase 96 Week||40
5219649|NCT00951015|12835674|P3|COMPLETED|Randomization Phase 96 Week||46
5219650|NCT00951015|12835675|P2|COMPLETED|Randomization Phase 96 Week||44
5219651|NCT00951015|12835676|P1|COMPLETED|Randomization Phase 96 Week||48
5219652|NCT00951015|12835672|P5|STARTED|Randomization Phase 96 Week||0
5219653|NCT00951015|12835673|P4|STARTED|Randomization Phase 96 Week||50
5219654|NCT00951015|12835674|P3|STARTED|Randomization Phase 96 Week||51
5219655|NCT00951015|12835675|P2|STARTED|Randomization Phase 96 Week||51
5219656|NCT00951015|12835676|P1|STARTED|Randomization Phase 96 Week||53
5219657|NCT00950963|12835773|P2|NOT COMPLETED|Overall Study||24
5219658|NCT00950963|12835774|P1|NOT COMPLETED|Overall Study||29
5219659|NCT00950963|12835773|P2|COMPLETED|Overall Study||357
5219660|NCT00950963|12835774|P1|COMPLETED|Overall Study||352
5219661|NCT00950963|12835773|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
5219662|NCT00950963|12835774|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
5219663|NCT00950950|12835790|P2|NOT COMPLETED|Overall Study||1
5219664|NCT00950950|12835791|P1|NOT COMPLETED|Overall Study||1
5219665|NCT00950950|12835790|P2|COMPLETED|Overall Study||11
5219666|NCT00950950|12835791|P1|COMPLETED|Overall Study||11
5219667|NCT00950950|12835790|P2|STARTED|Overall Study||12
5219668|NCT00950950|12835791|P1|STARTED|Overall Study||12
5219669|NCT00950937|12835854|P2|NOT COMPLETED|Overall Study||0
5219670|NCT00950937|12835855|P1|NOT COMPLETED|Overall Study||0
5219671|NCT00950937|12835854|P2|COMPLETED|Overall Study||14
5219672|NCT00950937|12835855|P1|COMPLETED|Overall Study||14
5219673|NCT00950937|12835854|P2|STARTED|Overall Study||14
5219674|NCT00950937|12835855|P1|STARTED|Overall Study||14
5219675|NCT00950911|12835873|P2|NOT COMPLETED|Overall Study||15
5219676|NCT00950911|12835874|P1|NOT COMPLETED|Overall Study||12
5219677|NCT00950911|12835873|P2|COMPLETED|Overall Study||3
5219678|NCT00950911|12835874|P1|COMPLETED|Overall Study||5
5219679|NCT00950911|12835873|P2|STARTED|Overall Study||18
5219680|NCT00950911|12835874|P1|STARTED|Overall Study||17
5219681|NCT00950872|12835880|P1|NOT COMPLETED|Overall Study||3
5219682|NCT00950872|12835880|P1|COMPLETED|Overall Study||26
5219683|NCT00950872|12835880|P1|STARTED|Overall Study||29
5219684|NCT00950859|12835889|P2|NOT COMPLETED|Overall Study||10
5219685|NCT00950859|12835890|P1|NOT COMPLETED|Overall Study||16
5219686|NCT00950859|12835889|P2|COMPLETED|Overall Study||14
5219687|NCT00950859|12835890|P1|COMPLETED|Overall Study||11
5219688|NCT00950859|12835889|P2|STARTED|Overall Study||24
5219689|NCT00950859|12835890|P1|STARTED|Overall Study||27
5219690|NCT00950833|12835933|P3|NOT COMPLETED|Overall Study||0
5219691|NCT00950833|12835934|P2|NOT COMPLETED|Overall Study||0
5219692|NCT00950833|12835935|P1|NOT COMPLETED|Overall Study||0
5219693|NCT00950833|12835933|P3|COMPLETED|Overall Study||223
5219694|NCT00950833|12835934|P2|COMPLETED|Overall Study||108
5219695|NCT00950833|12835935|P1|COMPLETED|Overall Study||112
5219696|NCT00950833|12835933|P3|STARTED|Overall Study||223
5219697|NCT00950833|12835934|P2|STARTED|Overall Study||108
5219698|NCT00950833|12835935|P1|STARTED|Overall Study||112
5219699|NCT00950807|12835989|P10|NOT COMPLETED|Treatment Period 3||1
5219700|NCT00950807|12835990|P9|NOT COMPLETED|Treatment Period 3||0
5219701|NCT00950807|12835991|P8|NOT COMPLETED|Treatment Period 3||1
5219702|NCT00950807|12835992|P7|NOT COMPLETED|Treatment Period 3||1
5219703|NCT00950807|12835993|P6|NOT COMPLETED|Treatment Period 3||0
5219704|NCT00950807|12835994|P5|NOT COMPLETED|Treatment Period 3||0
5219705|NCT00950807|12835995|P4|NOT COMPLETED|Treatment Period 3||0
5219706|NCT00950807|12835996|P3|NOT COMPLETED|Treatment Period 3||0
5219707|NCT00950807|12835997|P2|NOT COMPLETED|Treatment Period 3||0
5219708|NCT00950807|12835998|P1|NOT COMPLETED|Treatment Period 3||1
5219709|NCT00950807|12835989|P10|COMPLETED|Treatment Period 3||10
5219710|NCT00950807|12835990|P9|COMPLETED|Treatment Period 3||9
5219711|NCT00950807|12835991|P8|COMPLETED|Treatment Period 3||9
5219712|NCT00950807|12835992|P7|COMPLETED|Treatment Period 3||11
5219713|NCT00950807|12835993|P6|COMPLETED|Treatment Period 3||9
5219714|NCT00950807|12835994|P5|COMPLETED|Treatment Period 3||12
5219715|NCT00950807|12835995|P4|COMPLETED|Treatment Period 3||11
5219716|NCT00950807|12835996|P3|COMPLETED|Treatment Period 3||10
5219717|NCT00950807|12835997|P2|COMPLETED|Treatment Period 3||9
5219718|NCT00950807|12835998|P1|COMPLETED|Treatment Period 3||45
5219719|NCT00950807|12835989|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
5219720|NCT00950807|12835990|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
5219721|NCT00950807|12835991|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
5219722|NCT00950807|12835992|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
5219723|NCT00950807|12835993|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
5219724|NCT00950807|12835994|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
5219725|NCT00950807|12835995|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
5219726|NCT00950807|12835996|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
5219727|NCT00950807|12835997|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
5219728|NCT00950807|12835998|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
5219729|NCT00950807|12835989|P10|NOT COMPLETED|Washout Period 2||0
5219730|NCT00950807|12835990|P9|NOT COMPLETED|Washout Period 2||0
5219731|NCT00950807|12835991|P8|NOT COMPLETED|Washout Period 2||1
5219732|NCT00950807|12835992|P7|NOT COMPLETED|Washout Period 2||1
5219733|NCT00950807|12835993|P6|NOT COMPLETED|Washout Period 2||0
5219734|NCT00950807|12835994|P5|NOT COMPLETED|Washout Period 2||1
5219735|NCT00950807|12835995|P4|NOT COMPLETED|Washout Period 2||1
5219736|NCT00950807|12835996|P3|NOT COMPLETED|Washout Period 2||0
5219737|NCT00950807|12835997|P2|NOT COMPLETED|Washout Period 2||1
5219738|NCT00950807|12835998|P1|NOT COMPLETED|Washout Period 2||4
5219739|NCT00950807|12835989|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
5219740|NCT00950807|12835990|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
5219741|NCT00950807|12835991|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
5219742|NCT00950807|12835992|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
5219743|NCT00950807|12835993|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
5219744|NCT00950807|12835994|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
5219745|NCT00950807|12835995|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
5219746|NCT00950807|12835996|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
5219747|NCT00950807|12835997|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
5219748|NCT00950807|12835998|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
5219749|NCT00950807|12835989|P10|STARTED|Washout Period 2||11
5219750|NCT00950807|12835990|P9|STARTED|Washout Period 2||11
5219751|NCT00950807|12835991|P8|STARTED|Washout Period 2||10
5219752|NCT00950807|12835992|P7|STARTED|Washout Period 2||9
5219753|NCT00950807|12835993|P6|STARTED|Washout Period 2||9
5219754|NCT00950807|12835994|P5|STARTED|Washout Period 2||13
5219755|NCT00950807|12835995|P4|STARTED|Washout Period 2||12
5219756|NCT00950807|12835996|P3|STARTED|Washout Period 2||10
5219757|NCT00950807|12835997|P2|STARTED|Washout Period 2||12
5219758|NCT00950807|12835998|P1|STARTED|Washout Period 2||51
5219759|NCT00950807|12835989|P10|NOT COMPLETED|Treatment Period 2||0
5219760|NCT00950807|12835990|P9|NOT COMPLETED|Treatment Period 2||0
5219761|NCT00950807|12835991|P8|NOT COMPLETED|Treatment Period 2||3
5219762|NCT00950807|12835992|P7|NOT COMPLETED|Treatment Period 2||1
5219763|NCT00950807|12835993|P6|NOT COMPLETED|Treatment Period 2||1
5219764|NCT00950807|12835994|P5|NOT COMPLETED|Treatment Period 2||0
5219765|NCT00950807|12835995|P4|NOT COMPLETED|Treatment Period 2||1
5219766|NCT00950807|12835996|P3|NOT COMPLETED|Treatment Period 2||0
5219767|NCT00950807|12835997|P2|NOT COMPLETED|Treatment Period 2||1
5219768|NCT00950807|12835998|P1|NOT COMPLETED|Treatment Period 2||2
5219769|NCT00950807|12835989|P10|COMPLETED|Treatment Period 2||11
5219770|NCT00950807|12835990|P9|COMPLETED|Treatment Period 2||11
5219771|NCT00950807|12835991|P8|COMPLETED|Treatment Period 2||10
5219772|NCT00950807|12835992|P7|COMPLETED|Treatment Period 2||9
5219773|NCT00950807|12835993|P6|COMPLETED|Treatment Period 2||9
5219774|NCT00950807|12835994|P5|COMPLETED|Treatment Period 2||13
5219775|NCT00950807|12835995|P4|COMPLETED|Treatment Period 2||12
5219776|NCT00950807|12835996|P3|COMPLETED|Treatment Period 2||10
5219777|NCT00950807|12835997|P2|COMPLETED|Treatment Period 2||12
5219778|NCT00950807|12835998|P1|COMPLETED|Treatment Period 2||51
5219779|NCT00950807|12835989|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
5219780|NCT00950807|12835990|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
5219781|NCT00950807|12835991|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
5219782|NCT00950807|12835992|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
5219783|NCT00950807|12835993|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
5219784|NCT00950807|12835994|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
5219785|NCT00950807|12835995|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
5219786|NCT00950807|12835996|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
5219787|NCT00950807|12835997|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
5219788|NCT00950807|12835998|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
5219789|NCT00950807|12835989|P10|NOT COMPLETED|Washout Period 1||0
5219790|NCT00950807|12835990|P9|NOT COMPLETED|Washout Period 1||1
5219791|NCT00950807|12835991|P8|NOT COMPLETED|Washout Period 1||1
5219792|NCT00950807|12835992|P7|NOT COMPLETED|Washout Period 1||2
5219793|NCT00950807|12835993|P6|NOT COMPLETED|Washout Period 1||0
5219794|NCT00950807|12835994|P5|NOT COMPLETED|Washout Period 1||1
5219795|NCT00950807|12835995|P4|NOT COMPLETED|Washout Period 1||1
5219796|NCT00950807|12835996|P3|NOT COMPLETED|Washout Period 1||0
5219797|NCT00950807|12835997|P2|NOT COMPLETED|Washout Period 1||0
5219798|NCT00950807|12835998|P1|NOT COMPLETED|Washout Period 1||5
5219799|NCT00950807|12835989|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
5219800|NCT00950807|12835990|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
5219801|NCT00950807|12835991|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
5219802|NCT00950807|12835992|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
5219803|NCT00950807|12835993|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
5219804|NCT00950807|12835994|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
5219805|NCT00950807|12835995|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
5219806|NCT00950807|12835996|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
5219807|NCT00950807|12835997|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
5219808|NCT00950807|12835998|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
5219809|NCT00950807|12835989|P10|STARTED|Washout Period 1||13
5219810|NCT00950807|12835990|P9|STARTED|Washout Period 1||12
5219811|NCT00950807|12835991|P8|STARTED|Washout Period 1||14
5219812|NCT00950807|12835992|P7|STARTED|Washout Period 1||12
5219813|NCT00950807|12835993|P6|STARTED|Washout Period 1||11
5219814|NCT00950807|12835994|P5|STARTED|Washout Period 1||12
5219815|NCT00950807|12835995|P4|STARTED|Washout Period 1||12
5219816|NCT00950807|12835996|P3|STARTED|Washout Period 1||13
5219817|NCT00950807|12835997|P2|STARTED|Washout Period 1||13
5219818|NCT00950807|12835998|P1|STARTED|Washout Period 1||56
5219819|NCT00950807|12835989|P10|NOT COMPLETED|Treatment Period 1||0
5219820|NCT00950807|12835990|P9|NOT COMPLETED|Treatment Period 1||1
5219821|NCT00950807|12835991|P8|NOT COMPLETED|Treatment Period 1||0
5219822|NCT00950807|12835992|P7|NOT COMPLETED|Treatment Period 1||0
5219823|NCT00950807|12835993|P6|NOT COMPLETED|Treatment Period 1||2
5219824|NCT00950807|12835994|P5|NOT COMPLETED|Treatment Period 1||1
5219825|NCT00950807|12835995|P4|NOT COMPLETED|Treatment Period 1||0
5219826|NCT00950807|12835996|P3|NOT COMPLETED|Treatment Period 1||1
5219827|NCT00950807|12835997|P2|NOT COMPLETED|Treatment Period 1||0
5219828|NCT00950807|12835998|P1|NOT COMPLETED|Treatment Period 1||3
5219829|NCT00950807|12835989|P10|COMPLETED|Treatment Period 1||13
5219830|NCT00950807|12835990|P9|COMPLETED|Treatment Period 1||12
5219831|NCT00950807|12835991|P8|COMPLETED|Treatment Period 1||14
5219832|NCT00950807|12835992|P7|COMPLETED|Treatment Period 1||12
5219833|NCT00950807|12835993|P6|COMPLETED|Treatment Period 1||11
5219834|NCT00950807|12835994|P5|COMPLETED|Treatment Period 1||12
5219835|NCT00950807|12835995|P4|COMPLETED|Treatment Period 1||12
5219836|NCT00950807|12835996|P3|COMPLETED|Treatment Period 1||13
5219837|NCT00950807|12835997|P2|COMPLETED|Treatment Period 1||13
5219838|NCT00950807|12835998|P1|COMPLETED|Treatment Period 1||56
5219839|NCT00950807|12835989|P10|STARTED|Treatment Period 1||13
5219840|NCT00950807|12835990|P9|STARTED|Treatment Period 1||13
5219841|NCT00950807|12835991|P8|STARTED|Treatment Period 1||14
5219842|NCT00950807|12835992|P7|STARTED|Treatment Period 1||12
5219843|NCT00950807|12835993|P6|STARTED|Treatment Period 1||13
5219844|NCT00950807|12835994|P5|STARTED|Treatment Period 1||13
5219845|NCT00950807|12835995|P4|STARTED|Treatment Period 1||12
5219846|NCT00950807|12835996|P3|STARTED|Treatment Period 1||14
5219847|NCT00950807|12835997|P2|STARTED|Treatment Period 1||13
5219848|NCT00950807|12835998|P1|STARTED|Treatment Period 1||59
5219849|NCT00950755|12836040|P1|NOT COMPLETED|Long-Term Follow-Up||9
5219850|NCT00950755|12836040|P1|COMPLETED|Long-Term Follow-Up||9
5219851|NCT00950755|12836040|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
5219852|NCT00950755|12836040|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
5219853|NCT00950755|12836040|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
5219854|NCT00950755|12836040|P1|STARTED|Dosimetric and Therapeutic Treatment||41
5219855|NCT00950742|12836066|P2|NOT COMPLETED|Overall Study||2
5219856|NCT00950742|12836067|P1|NOT COMPLETED|Overall Study||16
5219857|NCT00950742|12836066|P2|COMPLETED|Overall Study||0
5219858|NCT00950742|12836067|P1|COMPLETED|Overall Study||0
5219859|NCT00950742|12836066|P2|STARTED|Overall Study|entered and treated|2
5219860|NCT00950742|12836067|P1|STARTED|Overall Study|entered and treated|16
5219861|NCT00950729|12836083|P1|NOT COMPLETED|Driving With Aircast||0
5219862|NCT00950729|12836083|P1|COMPLETED|Driving With Aircast||48
5219863|NCT00950729|12836083|P1|STARTED|Driving With Aircast||48
5219864|NCT00950729|12836083|P1|NOT COMPLETED|Driving With Plaster Cast||0
5219865|NCT00950729|12836083|P1|COMPLETED|Driving With Plaster Cast||48
5219866|NCT00950729|12836083|P1|STARTED|Driving With Plaster Cast||48
5219867|NCT00950729|12836083|P1|NOT COMPLETED|Driving With Running Shoes||0
5219868|NCT00950729|12836083|P1|COMPLETED|Driving With Running Shoes|June 2007|48
5219869|NCT00950729|12836083|P1|STARTED|Driving With Running Shoes|March 2007|48
5219870|NCT00950690|12836088|P1|NOT COMPLETED|Overall Study||244
5219871|NCT00950690|12836088|P1|COMPLETED|Overall Study||1105
5219872|NCT00950690|12836088|P1|STARTED|Overall Study||1349
5219873|NCT00950664|12836095|P2|NOT COMPLETED|Second Intervention||48
5219874|NCT00950664|12836096|P1|NOT COMPLETED|Second Intervention||46
5219875|NCT00950664|12836095|P2|COMPLETED|Second Intervention||0
5219876|NCT00950664|12836096|P1|COMPLETED|Second Intervention||0
5219877|NCT00950664|12836095|P2|STARTED|Second Intervention||48
5219878|NCT00950664|12836096|P1|STARTED|Second Intervention||46
5219879|NCT00950664|12836095|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
5219880|NCT00950664|12836096|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
5219881|NCT00950664|12836095|P2|COMPLETED|Washout Period of 4 Weeks||48
5219882|NCT00950664|12836096|P1|COMPLETED|Washout Period of 4 Weeks||46
5219883|NCT00950664|12836095|P2|STARTED|Washout Period of 4 Weeks||48
5219884|NCT00950664|12836096|P1|STARTED|Washout Period of 4 Weeks||46
5219885|NCT00950664|12836095|P2|NOT COMPLETED|First Intervention||5
5219886|NCT00950664|12836096|P1|NOT COMPLETED|First Intervention||3
5219887|NCT00950664|12836095|P2|COMPLETED|First Intervention||48
5219888|NCT00950664|12836096|P1|COMPLETED|First Intervention||46
5219889|NCT00950664|12836095|P2|STARTED|First Intervention||53
5219890|NCT00950664|12836096|P1|STARTED|First Intervention||49
5219891|NCT00950651|12836116|P2|NOT COMPLETED|Overall Study||35
5219892|NCT00950651|12836117|P1|NOT COMPLETED|Overall Study||31
5219893|NCT00950651|12836116|P2|COMPLETED|Overall Study||181
5219894|NCT00950651|12836117|P1|COMPLETED|Overall Study||184
5219895|NCT00950651|12836116|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
5219896|NCT00950651|12836117|P1|STARTED|Overall Study||215
5219897|NCT00950612|12836165|P2|NOT COMPLETED|Overall Study||0
5219898|NCT00950612|12836166|P1|NOT COMPLETED|Overall Study||0
5219899|NCT00950612|12836165|P2|COMPLETED|Overall Study||20
5219900|NCT00950612|12836166|P1|COMPLETED|Overall Study||40
5219901|NCT00950612|12836165|P2|STARTED|Overall Study||20
5219902|NCT00950612|12836166|P1|STARTED|Overall Study||40
5219903|NCT00950599|12836210|P10|NOT COMPLETED|Follow-Up Period||2
5219904|NCT00950599|12836211|P9|NOT COMPLETED|Follow-Up Period||13
5219905|NCT00950599|12836212|P8|NOT COMPLETED|Follow-Up Period||0
5219906|NCT00950599|12836213|P7|NOT COMPLETED|Follow-Up Period||0
5219907|NCT00950599|12836214|P6|NOT COMPLETED|Follow-Up Period||0
5219908|NCT00950599|12836215|P5|NOT COMPLETED|Follow-Up Period||0
5219909|NCT00950599|12836216|P4|NOT COMPLETED|Follow-Up Period||0
5219910|NCT00950599|12836217|P3|NOT COMPLETED|Follow-Up Period||0
5219911|NCT00950599|12836218|P2|NOT COMPLETED|Follow-Up Period||0
5219912|NCT00950599|12836219|P1|NOT COMPLETED|Follow-Up Period||0
5219913|NCT00950599|12836210|P10|COMPLETED|Follow-Up Period||78
5219914|NCT00950599|12836211|P9|COMPLETED|Follow-Up Period||296
5219915|NCT00950599|12836212|P8|COMPLETED|Follow-Up Period||0
5219916|NCT00950599|12836213|P7|COMPLETED|Follow-Up Period||0
5219917|NCT00950599|12836214|P6|COMPLETED|Follow-Up Period||0
5219918|NCT00950599|12836215|P5|COMPLETED|Follow-Up Period||0
5219919|NCT00950599|12836216|P4|COMPLETED|Follow-Up Period||0
5219920|NCT00950599|12836217|P3|COMPLETED|Follow-Up Period||0
5219921|NCT00950599|12836218|P2|COMPLETED|Follow-Up Period||0
5219922|NCT00950599|12836219|P1|COMPLETED|Follow-Up Period||0
5219923|NCT00950599|12836210|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
5219924|NCT00950599|12836211|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
5219925|NCT00950599|12836212|P8|STARTED|Follow-Up Period||0
5219926|NCT00950599|12836213|P7|STARTED|Follow-Up Period||0
5219927|NCT00950599|12836214|P6|STARTED|Follow-Up Period||0
5219928|NCT00950599|12836215|P5|STARTED|Follow-Up Period||0
5219929|NCT00950599|12836216|P4|STARTED|Follow-Up Period||0
5219930|NCT00950599|12836217|P3|STARTED|Follow-Up Period||0
5219931|NCT00950599|12836218|P2|STARTED|Follow-Up Period||0
5219932|NCT00950599|12836219|P1|STARTED|Follow-Up Period||0
5219933|NCT00950599|12836210|P10|NOT COMPLETED|Double-Blind Treatment Period||0
5219934|NCT00950599|12836211|P9|NOT COMPLETED|Double-Blind Treatment Period||0
5219935|NCT00950599|12836212|P8|NOT COMPLETED|Double-Blind Treatment Period||6
5219936|NCT00950599|12836213|P7|NOT COMPLETED|Double-Blind Treatment Period||0
5219937|NCT00950599|12836214|P6|NOT COMPLETED|Double-Blind Treatment Period||12
5219938|NCT00950599|12836215|P5|NOT COMPLETED|Double-Blind Treatment Period||7
5219939|NCT00950599|12836216|P4|NOT COMPLETED|Double-Blind Treatment Period||11
5219940|NCT00950599|12836217|P3|NOT COMPLETED|Double-Blind Treatment Period||9
5219941|NCT00950599|12836218|P2|NOT COMPLETED|Double-Blind Treatment Period||10
5219942|NCT00950599|12836219|P1|NOT COMPLETED|Double-Blind Treatment Period||7
5219943|NCT00950599|12836210|P10|COMPLETED|Double-Blind Treatment Period||0
5219944|NCT00950599|12836211|P9|COMPLETED|Double-Blind Treatment Period||0
5219945|NCT00950599|12836212|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
5219946|NCT00950599|12836213|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
5219947|NCT00950599|12836214|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
5219948|NCT00950599|12836215|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
5219949|NCT00950599|12836216|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
5219950|NCT00950599|12836217|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
5219951|NCT00950599|12836218|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
5219952|NCT00950599|12836219|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
5219953|NCT00950599|12836210|P10|STARTED|Double-Blind Treatment Period||0
5219954|NCT00950599|12836211|P9|STARTED|Double-Blind Treatment Period||0
5219955|NCT00950599|12836212|P8|STARTED|Double-Blind Treatment Period||41
5219956|NCT00950599|12836213|P7|STARTED|Double-Blind Treatment Period||44
5219957|NCT00950599|12836214|P6|STARTED|Double-Blind Treatment Period||67
5219958|NCT00950599|12836215|P5|STARTED|Double-Blind Treatment Period||52
5219959|NCT00950599|12836216|P4|STARTED|Double-Blind Treatment Period||54
5219960|NCT00950599|12836217|P3|STARTED|Double-Blind Treatment Period||63
5219961|NCT00950599|12836218|P2|STARTED|Double-Blind Treatment Period||47
5219962|NCT00950599|12836219|P1|STARTED|Double-Blind Treatment Period||55
5219963|NCT00950352|12836783|P2|NOT COMPLETED|Overall Study||11
5219964|NCT00950352|12836784|P1|NOT COMPLETED|Overall Study||42
5219965|NCT00950352|12836783|P2|COMPLETED|Overall Study||21
5219966|NCT00950352|12836784|P1|COMPLETED|Overall Study||30
5219967|NCT00950352|12836783|P2|STARTED|Overall Study||32
5219968|NCT00950352|12836784|P1|STARTED|Overall Study||72
5219969|NCT00950300|12836792|P2|NOT COMPLETED|SFU Period||78
5219970|NCT00950300|12836793|P1|NOT COMPLETED|SFU Period||78
5219971|NCT00950300|12836792|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
5219972|NCT00950300|12836793|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
5220056|NCT00949702|12837153|P1|NOT COMPLETED|Overall Study||48
5219973|NCT00950300|12836792|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
5219974|NCT00950300|12836793|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
5219975|NCT00950300|12836792|P2|NOT COMPLETED|TFFU Period||107
5219976|NCT00950300|12836793|P1|NOT COMPLETED|TFFU Period||100
5219977|NCT00950300|12836792|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
5219978|NCT00950300|12836793|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
5219979|NCT00950300|12836792|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
5219980|NCT00950300|12836793|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
5219981|NCT00950300|12836792|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
5219982|NCT00950300|12836793|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
5219983|NCT00950300|12836792|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
5219984|NCT00950300|12836793|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
5219985|NCT00950300|12836792|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
5219986|NCT00950300|12836793|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
5219987|NCT00950300|12836792|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
5219988|NCT00950300|12836793|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
5219989|NCT00950300|12836792|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
5219990|NCT00950300|12836793|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
5219991|NCT00950300|12836792|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
5219992|NCT00950300|12836793|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
5219993|NCT00950248|12836842|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
5219994|NCT00950248|12836843|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
5219995|NCT00950248|12836844|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
5219996|NCT00950248|12836842|P3|COMPLETED|Year 2&3 Treatment Randomization||33
5219997|NCT00950248|12836843|P2|COMPLETED|Year 2&3 Treatment Randomization||33
5219998|NCT00950248|12836844|P1|COMPLETED|Year 2&3 Treatment Randomization||0
5219999|NCT00950248|12836842|P3|STARTED|Year 2&3 Treatment Randomization||38
5220000|NCT00950248|12836843|P2|STARTED|Year 2&3 Treatment Randomization||39
5220001|NCT00950248|12836844|P1|STARTED|Year 2&3 Treatment Randomization||0
5220002|NCT00950248|12836842|P3|NOT COMPLETED|Year 1: Baseline||0
5220003|NCT00950248|12836843|P2|NOT COMPLETED|Year 1: Baseline||0
5220004|NCT00950248|12836844|P1|NOT COMPLETED|Year 1: Baseline||8
5220005|NCT00950248|12836842|P3|COMPLETED|Year 1: Baseline||0
5220006|NCT00950248|12836843|P2|COMPLETED|Year 1: Baseline||0
5220007|NCT00950248|12836844|P1|COMPLETED|Year 1: Baseline||77
5220008|NCT00950248|12836842|P3|STARTED|Year 1: Baseline||0
5220009|NCT00950248|12836843|P2|STARTED|Year 1: Baseline||0
5220010|NCT00950248|12836844|P1|STARTED|Year 1: Baseline||85
5220011|NCT00950235|12836865|P2|NOT COMPLETED|Overall Study||4
5220012|NCT00950235|12836866|P1|NOT COMPLETED|Overall Study||2
5220013|NCT00950235|12836865|P2|COMPLETED|Overall Study||54
5220014|NCT00950235|12836866|P1|COMPLETED|Overall Study||58
5220015|NCT00950235|12836865|P2|STARTED|Overall Study||58
5220016|NCT00950235|12836866|P1|STARTED|Overall Study||60
5220017|NCT00950183|12836876|P1|NOT COMPLETED|Overall Study||36
5220018|NCT00950183|12836876|P1|COMPLETED|Overall Study||0
5220019|NCT00950183|12836876|P1|STARTED|Overall Study||36
5220020|NCT00950170|12836884|P1|NOT COMPLETED|Overall Study||4
5220021|NCT00950170|12836884|P1|COMPLETED|Overall Study||19
5220022|NCT00950170|12836884|P1|STARTED|Overall Study||23
5220023|NCT00949988|12836935|P1|NOT COMPLETED|Overall Study||3
5220024|NCT00949988|12836935|P1|COMPLETED|Overall Study||0
5220025|NCT00949988|12836935|P1|STARTED|Overall Study||3
5220026|NCT00949975|12836950|P4|NOT COMPLETED|Overall Study||28
5220027|NCT00949975|12836951|P3|NOT COMPLETED|Overall Study||19
5220028|NCT00949975|12836952|P2|NOT COMPLETED|Overall Study||29
5220029|NCT00949975|12836953|P1|NOT COMPLETED|Overall Study||27
5220030|NCT00949975|12836950|P4|COMPLETED|Overall Study||190
5220031|NCT00949975|12836951|P3|COMPLETED|Overall Study||183
5220032|NCT00949975|12836952|P2|COMPLETED|Overall Study||177
5220033|NCT00949975|12836953|P1|COMPLETED|Overall Study||185
5220034|NCT00949975|12836950|P4|STARTED|Overall Study||218
5220035|NCT00949975|12836951|P3|STARTED|Overall Study||202
5220036|NCT00949975|12836952|P2|STARTED|Overall Study||206
5220037|NCT00949975|12836953|P1|STARTED|Overall Study||212
5220038|NCT00949910|12837071|P1|NOT COMPLETED|Overall Study||6576
5220039|NCT00949910|12837071|P1|COMPLETED|Overall Study||10
5220040|NCT00949910|12837071|P1|STARTED|Overall Study||6586
5220041|NCT00949884|12837084|P3|NOT COMPLETED|Overall Study||58
5220042|NCT00949884|12837085|P2|NOT COMPLETED|Overall Study||15
5220043|NCT00949884|12837086|P1|NOT COMPLETED|Overall Study||50
5220044|NCT00949884|12837084|P3|COMPLETED|Overall Study||411
5220045|NCT00949884|12837085|P2|COMPLETED|Overall Study||37
5220046|NCT00949884|12837086|P1|COMPLETED|Overall Study||370
5220047|NCT00949884|12837084|P3|STARTED|Overall Study||469
5220048|NCT00949884|12837085|P2|STARTED|Overall Study||52
5220049|NCT00949884|12837086|P1|STARTED|Overall Study||420
5220050|NCT00949715|12837141|P2|NOT COMPLETED|Overall Study||0
5220051|NCT00949715|12837142|P1|NOT COMPLETED|Overall Study||4
5220052|NCT00949715|12837141|P2|COMPLETED|Overall Study||33
5220053|NCT00949715|12837142|P1|COMPLETED|Overall Study||28
5220054|NCT00949715|12837141|P2|STARTED|Overall Study||33
5220055|NCT00949715|12837142|P1|STARTED|Overall Study||32
5220057|NCT00949702|12837153|P1|COMPLETED|Overall Study||84
5220058|NCT00949702|12837153|P1|STARTED|Overall Study||132
5220059|NCT00949650|12837170|P2|NOT COMPLETED|Overall Study||115
5220060|NCT00949650|12837171|P1|NOT COMPLETED|Overall Study||230
5220061|NCT00949650|12837170|P2|COMPLETED|Overall Study||0
5220062|NCT00949650|12837171|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
5220063|NCT00949650|12837170|P2|STARTED|Overall Study|Treated patients.|115
5220064|NCT00949650|12837171|P1|STARTED|Overall Study|Treated patients.|230
5220065|NCT00949533|12837209|P2|NOT COMPLETED|Overall Study||1
5220066|NCT00949533|12837210|P1|NOT COMPLETED|Overall Study||0
5220067|NCT00949533|12837209|P2|COMPLETED|Overall Study||17
5220068|NCT00949533|12837210|P1|COMPLETED|Overall Study||19
5220069|NCT00949533|12837209|P2|STARTED|Overall Study||18
5220070|NCT00949533|12837210|P1|STARTED|Overall Study||19
5220071|NCT00949403|12837222|P1|NOT COMPLETED|Overall Study||0
5220072|NCT00949403|12837222|P1|COMPLETED|Overall Study||9
5220073|NCT00949403|12837222|P1|STARTED|Overall Study||9
5220074|NCT00949325|12837226|P3|NOT COMPLETED|Overall Study||0
5220075|NCT00949325|12837227|P2|NOT COMPLETED|Overall Study||2
5220076|NCT00949325|12837228|P1|NOT COMPLETED|Overall Study||0
5220077|NCT00949325|12837226|P3|COMPLETED|Overall Study||3
5220078|NCT00949325|12837227|P2|COMPLETED|Overall Study||16
5220079|NCT00949325|12837228|P1|COMPLETED|Overall Study||3
5220080|NCT00949325|12837226|P3|STARTED|Overall Study||3
5220081|NCT00949325|12837227|P2|STARTED|Overall Study||18
5220082|NCT00949325|12837228|P1|STARTED|Overall Study||3
5220083|NCT00949234|12837246|P1|NOT COMPLETED|Overall Study||42
5220084|NCT00949234|12837246|P1|COMPLETED|Overall Study||225
5220085|NCT00949234|12837246|P1|STARTED|Overall Study||267
5220086|NCT00949117|12837252|P2|NOT COMPLETED|Overall Study||5
5220087|NCT00949117|12837253|P1|NOT COMPLETED|Overall Study||3
5220088|NCT00949117|12837252|P2|COMPLETED|Overall Study||0
5220089|NCT00949117|12837253|P1|COMPLETED|Overall Study||1
5220090|NCT00949117|12837252|P2|STARTED|Overall Study||5
5220091|NCT00949117|12837253|P1|STARTED|Overall Study||4
5220092|NCT00949078|12837269|P2|NOT COMPLETED|Overall Study||0
5220093|NCT00949078|12837270|P1|NOT COMPLETED|Overall Study||0
5220094|NCT00949078|12837269|P2|COMPLETED|Overall Study||9
5220095|NCT00949078|12837270|P1|COMPLETED|Overall Study||5
5220096|NCT00949078|12837269|P2|STARTED|Overall Study||9
5220097|NCT00949078|12837270|P1|STARTED|Overall Study||5
5220098|NCT00948974|12837294|P2|NOT COMPLETED|Overall Study||20
5220099|NCT00948974|12837295|P1|NOT COMPLETED|Overall Study||23
5220100|NCT00948974|12837294|P2|COMPLETED|Overall Study||28
5220101|NCT00948974|12837295|P1|COMPLETED|Overall Study||17
5220102|NCT00948974|12837294|P2|STARTED|Overall Study||48
5220103|NCT00948974|12837295|P1|STARTED|Overall Study||40
5220104|NCT00948935|12837305|P1|NOT COMPLETED|Overall Study||0
5220105|NCT00948935|12837305|P1|COMPLETED|Overall Study||35
5220106|NCT00948935|12837305|P1|STARTED|Overall Study||35
5220107|NCT00948922|12837313|P3|NOT COMPLETED|Overall Study||1
5220108|NCT00948922|12837314|P2|NOT COMPLETED|Overall Study||14
5220109|NCT00948922|12837315|P1|NOT COMPLETED|Overall Study||8
5220110|NCT00948922|12837313|P3|COMPLETED|Overall Study||38
5220111|NCT00948922|12837314|P2|COMPLETED|Overall Study||37
5220112|NCT00948922|12837315|P1|COMPLETED|Overall Study||26
5220113|NCT00948922|12837313|P3|STARTED|Overall Study||39
5220114|NCT00948922|12837314|P2|STARTED|Overall Study||51
5220115|NCT00948922|12837315|P1|STARTED|Overall Study||34
5220116|NCT00948896|12837338|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
5220117|NCT00948896|12837339|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
5220118|NCT00948896|12837340|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
5220119|NCT00948896|12837341|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
5220120|NCT00948896|12837342|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
5220121|NCT00948896|12837343|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
5220122|NCT00948896|12837344|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
5220123|NCT00948896|12837345|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
5220124|NCT00948896|12837338|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
5220125|NCT00948896|12837339|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
5220126|NCT00948896|12837340|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
5220127|NCT00948896|12837341|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
5220128|NCT00948896|12837342|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
5220129|NCT00948896|12837343|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
5220130|NCT00948896|12837344|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
5220131|NCT00948896|12837345|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
5220132|NCT00948896|12837338|P8|STARTED|24 Months of Age to 36 Months of Age||45
5220133|NCT00948896|12837339|P7|STARTED|24 Months of Age to 36 Months of Age||43
5220134|NCT00948896|12837340|P6|STARTED|24 Months of Age to 36 Months of Age||42
5220135|NCT00948896|12837341|P5|STARTED|24 Months of Age to 36 Months of Age||44
5220136|NCT00948896|12837342|P4|STARTED|24 Months of Age to 36 Months of Age||87
5220137|NCT00948896|12837343|P3|STARTED|24 Months of Age to 36 Months of Age||90
5220138|NCT00948896|12837344|P2|STARTED|24 Months of Age to 36 Months of Age||85
5220139|NCT00948896|12837345|P1|STARTED|24 Months of Age to 36 Months of Age||90
5220140|NCT00948896|12837338|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
5220141|NCT00948896|12837339|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
5220142|NCT00948896|12837340|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
5220143|NCT00948896|12837341|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
5220144|NCT00948896|12837342|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
5220145|NCT00948896|12837343|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
5220146|NCT00948896|12837344|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
5220147|NCT00948896|12837345|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
5220148|NCT00948896|12837338|P8|COMPLETED|Randomization to 24 Months of Age||45
5220149|NCT00948896|12837339|P7|COMPLETED|Randomization to 24 Months of Age||43
5220150|NCT00948896|12837340|P6|COMPLETED|Randomization to 24 Months of Age||42
5220151|NCT00948896|12837341|P5|COMPLETED|Randomization to 24 Months of Age||44
5220152|NCT00948896|12837342|P4|COMPLETED|Randomization to 24 Months of Age||87
5220153|NCT00948896|12837343|P3|COMPLETED|Randomization to 24 Months of Age||90
5220154|NCT00948896|12837344|P2|COMPLETED|Randomization to 24 Months of Age||85
5220155|NCT00948896|12837345|P1|COMPLETED|Randomization to 24 Months of Age||90
5220156|NCT00948896|12837338|P8|STARTED|Randomization to 24 Months of Age||47
5220157|NCT00948896|12837339|P7|STARTED|Randomization to 24 Months of Age||47
5220158|NCT00948896|12837340|P6|STARTED|Randomization to 24 Months of Age||46
5220159|NCT00948896|12837341|P5|STARTED|Randomization to 24 Months of Age||46
5220160|NCT00948896|12837342|P4|STARTED|Randomization to 24 Months of Age||98
5220161|NCT00948896|12837343|P3|STARTED|Randomization to 24 Months of Age||99
5220162|NCT00948896|12837344|P2|STARTED|Randomization to 24 Months of Age||98
5220163|NCT00948896|12837345|P1|STARTED|Randomization to 24 Months of Age||98
5220164|NCT00948857|12837381|P2|NOT COMPLETED|Overall Study||0
5220165|NCT00948857|12837382|P1|NOT COMPLETED|Overall Study||1
5220166|NCT00948857|12837381|P2|COMPLETED|Overall Study||2
5220167|NCT00948857|12837382|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
5220168|NCT00948857|12837381|P2|STARTED|Overall Study||2
5220169|NCT00948857|12837382|P1|STARTED|Overall Study||3
5220170|NCT00948818|12837390|P2|NOT COMPLETED|Overall Study||94
5220171|NCT00948818|12837391|P1|NOT COMPLETED|Overall Study||62
5220172|NCT00948818|12837390|P2|COMPLETED|Overall Study||312
5220173|NCT00948818|12837391|P1|COMPLETED|Overall Study||335
5220174|NCT00948818|12837390|P2|STARTED|Overall Study||406
5220175|NCT00948818|12837391|P1|STARTED|Overall Study||397
5220176|NCT00948792|12837426|P1|NOT COMPLETED|Overall Study||0
5220177|NCT00948792|12837426|P1|COMPLETED|Overall Study||21
5220178|NCT00948792|12837426|P1|STARTED|Overall Study||21
5220179|NCT00948766|12837438|P2|NOT COMPLETED|Extension Study||0
5220180|NCT00948766|12837439|P1|NOT COMPLETED|Extension Study||91
5220181|NCT00948766|12837438|P2|COMPLETED|Extension Study||0
5220182|NCT00948766|12837439|P1|COMPLETED|Extension Study||306
5220183|NCT00948766|12837438|P2|Exposed to Study Medication|Extension Study||0
5220184|NCT00948766|12837439|P1|Exposed to Study Medication|Extension Study||396
5220185|NCT00948766|12837438|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
5220186|NCT00948766|12837439|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
5220187|NCT00948766|12837438|P2|NOT COMPLETED|Core Study||126
5220188|NCT00948766|12837439|P1|NOT COMPLETED|Core Study||127
5220189|NCT00948766|12837438|P2|COMPLETED|Core Study||234
5220190|NCT00948766|12837439|P1|COMPLETED|Core Study||229
5220191|NCT00948766|12837438|P2|Exposed to Study Medication|Core Study||359
5220192|NCT00948766|12837439|P1|Exposed to Study Medication|Core Study||355
5220193|NCT00948766|12837438|P2|STARTED|Core Study||360
5220194|NCT00948766|12837439|P1|STARTED|Core Study||356
5220195|NCT00948688|12837455|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
5220196|NCT00948688|12837456|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
5220197|NCT00948688|12837455|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
5220198|NCT00948688|12837456|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
5220199|NCT00948688|12837455|P2|STARTED|Period 2: 100 mg Vorinostat||6
5220200|NCT00948688|12837456|P1|STARTED|Period 2: 100 mg Vorinostat||0
5220201|NCT00948688|12837455|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
5220202|NCT00948688|12837456|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
5220203|NCT00948688|12837455|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
5220204|NCT00948688|12837456|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
5220205|NCT00948688|12837455|P2|STARTED|Period 1: 200 mg Vorinostat||0
5220206|NCT00948688|12837456|P1|STARTED|Period 1: 200 mg Vorinostat||4
5220207|NCT00948675|12837470|P2|NOT COMPLETED|Overall Study||4
5220208|NCT00948675|12837471|P1|NOT COMPLETED|Overall Study||7
5220209|NCT00948675|12837470|P2|COMPLETED|Overall Study||175
5220210|NCT00948675|12837471|P1|COMPLETED|Overall Study||175
5220211|NCT00948675|12837470|P2|STARTED|Overall Study||179
5220212|NCT00948675|12837471|P1|STARTED|Overall Study||182
5220213|NCT00948610|12837487|P2|NOT COMPLETED|Overall Study||1
5220214|NCT00948610|12837488|P1|NOT COMPLETED|Overall Study||1
5220215|NCT00948610|12837487|P2|COMPLETED|Overall Study||9
5220216|NCT00948610|12837488|P1|COMPLETED|Overall Study||9
5220217|NCT00948610|12837487|P2|STARTED|Overall Study||10
5220218|NCT00948610|12837488|P1|STARTED|Overall Study||10
5220219|NCT00948506|12837498|P2|NOT COMPLETED|Overall Study||1
5220220|NCT00948506|12837499|P1|NOT COMPLETED|Overall Study||3
5220221|NCT00948506|12837498|P2|COMPLETED|Overall Study||8
5220222|NCT00948506|12837499|P1|COMPLETED|Overall Study||8
5220223|NCT00948506|12837498|P2|STARTED|Overall Study||9
5220224|NCT00948506|12837499|P1|STARTED|Overall Study||11
5220225|NCT00948441|12837510|P2|NOT COMPLETED|Overall Study||4
5220226|NCT00948441|12837511|P1|NOT COMPLETED|Overall Study||1
5220227|NCT00948441|12837510|P2|COMPLETED|Overall Study||4
5220228|NCT00948441|12837511|P1|COMPLETED|Overall Study||7
5220229|NCT00948441|12837510|P2|STARTED|Overall Study||8
5220230|NCT00948441|12837511|P1|STARTED|Overall Study||8
5220231|NCT00948389|12837524|P5|NOT COMPLETED|Overall Study||1
5220232|NCT00948389|12837525|P4|NOT COMPLETED|Overall Study||9
5220233|NCT00948389|12837526|P3|NOT COMPLETED|Overall Study||7
5220234|NCT00948389|12837527|P2|NOT COMPLETED|Overall Study||3
5220235|NCT00948389|12837528|P1|NOT COMPLETED|Overall Study||6
5220236|NCT00948389|12837524|P5|COMPLETED|Overall Study||0
5220237|NCT00948389|12837525|P4|COMPLETED|Overall Study||0
5220238|NCT00948389|12837526|P3|COMPLETED|Overall Study||0
5220239|NCT00948389|12837527|P2|COMPLETED|Overall Study||0
5220240|NCT00948389|12837528|P1|COMPLETED|Overall Study||0
5220241|NCT00948389|12837524|P5|STARTED|Overall Study||1
5220242|NCT00948389|12837525|P4|STARTED|Overall Study||9
5220243|NCT00948389|12837526|P3|STARTED|Overall Study||7
5220244|NCT00948389|12837527|P2|STARTED|Overall Study||3
5220245|NCT00948389|12837528|P1|STARTED|Overall Study||6
5220246|NCT00948298|12837567|P2|NOT COMPLETED|Overall Study||5
5220247|NCT00948298|12837568|P1|NOT COMPLETED|Overall Study||10
5220248|NCT00948298|12837567|P2|COMPLETED|Overall Study||60
5220249|NCT00948298|12837568|P1|COMPLETED|Overall Study||55
5220250|NCT00948298|12837567|P2|STARTED|Overall Study||65
5220251|NCT00948298|12837568|P1|STARTED|Overall Study||65
5220252|NCT00948246|12837576|P1|NOT COMPLETED|Overall Study||24
5220253|NCT00948246|12837576|P1|COMPLETED|Overall Study||86
5220254|NCT00948246|12837576|P1|STARTED|Overall Study||110
5220255|NCT00948155|12837585|P2|NOT COMPLETED|Second Intervention 21 Days||3
5220256|NCT00948155|12837586|P1|NOT COMPLETED|Second Intervention 21 Days||2
5220257|NCT00948155|12837585|P2|COMPLETED|Second Intervention 21 Days||8
5220258|NCT00948155|12837586|P1|COMPLETED|Second Intervention 21 Days||9
5220259|NCT00948155|12837585|P2|STARTED|Second Intervention 21 Days||11
5220260|NCT00948155|12837586|P1|STARTED|Second Intervention 21 Days||11
5220261|NCT00948155|12837585|P2|NOT COMPLETED|Washout 14 Days||2
5220262|NCT00948155|12837586|P1|NOT COMPLETED|Washout 14 Days||1
5220263|NCT00948155|12837585|P2|COMPLETED|Washout 14 Days||11
5220264|NCT00948155|12837586|P1|COMPLETED|Washout 14 Days||11
5220265|NCT00948155|12837585|P2|STARTED|Washout 14 Days||13
5220266|NCT00948155|12837586|P1|STARTED|Washout 14 Days||12
5220267|NCT00948155|12837585|P2|NOT COMPLETED|First Intervention 21 Days||2
5220268|NCT00948155|12837586|P1|NOT COMPLETED|First Intervention 21 Days||2
5220269|NCT00948155|12837585|P2|COMPLETED|First Intervention 21 Days||13
5220270|NCT00948155|12837586|P1|COMPLETED|First Intervention 21 Days||12
5220271|NCT00948155|12837585|P2|STARTED|First Intervention 21 Days||15
5220272|NCT00948155|12837586|P1|STARTED|First Intervention 21 Days||14
5220273|NCT00948090|12837608|P4|NOT COMPLETED|Overall Study||11
5220274|NCT00948090|12837609|P3|NOT COMPLETED|Overall Study||56
5220275|NCT00948090|12837610|P2|NOT COMPLETED|Overall Study||1
5220276|NCT00948090|12837611|P1|NOT COMPLETED|Overall Study||43
5220277|NCT00948090|12837608|P4|COMPLETED|Overall Study||7
5220278|NCT00948090|12837609|P3|COMPLETED|Overall Study||67
5220279|NCT00948090|12837610|P2|COMPLETED|Overall Study||0
5220280|NCT00948090|12837611|P1|COMPLETED|Overall Study||22
5220281|NCT00948090|12837608|P4|STARTED|Overall Study||18
5220282|NCT00948090|12837609|P3|STARTED|Overall Study||123
5220283|NCT00948090|12837610|P2|STARTED|Overall Study||1
5220284|NCT00948090|12837611|P1|STARTED|Overall Study||65
5220285|NCT00948064|12837633|P3|NOT COMPLETED|Phase II||1
5220286|NCT00948064|12837634|P2|NOT COMPLETED|Phase II||1
5220287|NCT00948064|12837635|P1|NOT COMPLETED|Phase II||0
5220288|NCT00948064|12837633|P3|COMPLETED|Phase II||26
5220289|NCT00948064|12837634|P2|COMPLETED|Phase II||51
5220290|NCT00948064|12837635|P1|COMPLETED|Phase II||0
5220291|NCT00948064|12837633|P3|STARTED|Phase II||27
5220292|NCT00948064|12837634|P2|STARTED|Phase II||52
5220293|NCT00948064|12837635|P1|STARTED|Phase II||0
5220294|NCT00948064|12837633|P3|NOT COMPLETED|Phase I||0
5220295|NCT00948064|12837634|P2|NOT COMPLETED|Phase I||0
5220296|NCT00948064|12837635|P1|NOT COMPLETED|Phase I||1
5220297|NCT00948064|12837633|P3|COMPLETED|Phase I||0
5220298|NCT00948064|12837634|P2|COMPLETED|Phase I||0
5220299|NCT00948064|12837635|P1|COMPLETED|Phase I||30
5220300|NCT00948064|12837633|P3|STARTED|Phase I||0
5220301|NCT00948064|12837634|P2|STARTED|Phase I||0
5220302|NCT00948064|12837635|P1|STARTED|Phase I||31
5220303|NCT00947882|12837650|P4|NOT COMPLETED|Overall Study||82
5220304|NCT00947882|12837651|P3|NOT COMPLETED|Overall Study||79
5220305|NCT00947882|12837652|P2|NOT COMPLETED|Overall Study||77
5220306|NCT00947882|12837653|P1|NOT COMPLETED|Overall Study||74
5220307|NCT00947882|12837650|P4|COMPLETED|Overall Study||20
5220308|NCT00947882|12837651|P3|COMPLETED|Overall Study||22
5220309|NCT00947882|12837652|P2|COMPLETED|Overall Study||24
5220310|NCT00947882|12837653|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
5220311|NCT00947882|12837650|P4|Visit 12, Month 6|Overall Study||95
5220312|NCT00947882|12837651|P3|Visit 12, Month 6|Overall Study||90
5220313|NCT00947882|12837652|P2|Visit 12, Month 6|Overall Study||91
5220314|NCT00947882|12837653|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
5220315|NCT00947882|12837650|P4|Safety Analysis Set|Overall Study||105
5220316|NCT00947882|12837651|P3|Safety Analysis Set|Overall Study||100
5220317|NCT00947882|12837652|P2|Safety Analysis Set|Overall Study||101
5220318|NCT00947882|12837653|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
5220319|NCT00947882|12837650|P4|Actual Treatment|Overall Study||105
5220320|NCT00947882|12837651|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
5220321|NCT00947882|12837652|P2|Actual Treatment|Overall Study||101
5220322|NCT00947882|12837653|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
5220323|NCT00947882|12837650|P4|Full Analysis Set (FAS)|Overall Study||102
5220324|NCT00947882|12837651|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
5220325|NCT00947882|12837652|P2|Full Analysis Set (FAS)|Overall Study||101
5220326|NCT00947882|12837653|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
5220327|NCT00947882|12837650|P4|STARTED|Overall Study||102
5220328|NCT00947882|12837651|P3|STARTED|Overall Study||101
5220329|NCT00947882|12837652|P2|STARTED|Overall Study||101
5220330|NCT00947882|12837653|P1|STARTED|Overall Study|Started: Randomised.|100
5220331|NCT00947856|12837681|P2|NOT COMPLETED|Follow-up Period||23
5220332|NCT00947856|12837682|P1|NOT COMPLETED|Follow-up Period||51
5220333|NCT00947856|12837681|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
5220334|NCT00947856|12837682|P1|COMPLETED|Follow-up Period||27
5220335|NCT00947856|12837681|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
5220336|NCT00947856|12837682|P1|STARTED|Follow-up Period||78
5220337|NCT00947856|12837681|P2|NOT COMPLETED|Treatment Period||32
5220338|NCT00947856|12837682|P1|NOT COMPLETED|Treatment Period||78
5220339|NCT00947856|12837681|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
5220340|NCT00947856|12837682|P1|COMPLETED|Treatment Period||0
5220341|NCT00947856|12837681|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
5220342|NCT00947856|12837682|P1|STARTED|Treatment Period||78
5220343|NCT00947791|12837711|P2|NOT COMPLETED|Overall Study||0
5220344|NCT00947791|12837712|P1|NOT COMPLETED|Overall Study||0
5220345|NCT00947791|12837711|P2|COMPLETED|Overall Study||1
5220346|NCT00947791|12837712|P1|COMPLETED|Overall Study||0
5220347|NCT00947791|12837711|P2|STARTED|Overall Study||1
5220348|NCT00947791|12837712|P1|STARTED|Overall Study||0
5220349|NCT00947765|12837730|P2|NOT COMPLETED|Overall Study||0
5220350|NCT00947765|12837731|P1|NOT COMPLETED|Overall Study||0
5220351|NCT00947765|12837730|P2|COMPLETED|Overall Study||30
5220352|NCT00947765|12837731|P1|COMPLETED|Overall Study||30
5220353|NCT00947765|12837730|P2|STARTED|Overall Study||30
5220354|NCT00947765|12837731|P1|STARTED|Overall Study||30
5220355|NCT00947752|12837753|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
5220356|NCT00947752|12837754|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
5220357|NCT00947752|12837753|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
5220358|NCT00947752|12837754|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
5220359|NCT00947752|12837753|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
5220360|NCT00947752|12837754|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
5220361|NCT00947752|12837753|P2|NOT COMPLETED|1st 14-day Treatment Period||0
5220362|NCT00947752|12837754|P1|NOT COMPLETED|1st 14-day Treatment Period||0
5220363|NCT00947752|12837753|P2|COMPLETED|1st 14-day Treatment Period||71
5220364|NCT00947752|12837754|P1|COMPLETED|1st 14-day Treatment Period||76
5220365|NCT00947752|12837753|P2|STARTED|1st 14-day Treatment Period||71
5220366|NCT00947752|12837754|P1|STARTED|1st 14-day Treatment Period||76
5220367|NCT00947752|12837753|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
5220368|NCT00947752|12837754|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
5220369|NCT00947752|12837753|P2|COMPLETED|7-Day Run-in Treatment Period||0
5220370|NCT00947752|12837754|P1|COMPLETED|7-Day Run-in Treatment Period||147
5220371|NCT00947752|12837753|P2|STARTED|7-Day Run-in Treatment Period||0
5220372|NCT00947752|12837754|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
5220373|NCT00947661|12837764|P2|NOT COMPLETED|Overall Study||15
5220374|NCT00947661|12837765|P1|NOT COMPLETED|Overall Study||13
5220375|NCT00947661|12837764|P2|COMPLETED|Overall Study||274
5220376|NCT00947661|12837765|P1|COMPLETED|Overall Study||276
5220377|NCT00947661|12837764|P2|STARTED|Overall Study||289
5220378|NCT00947661|12837765|P1|STARTED|Overall Study||289
5220379|NCT00947544|12837771|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
5220380|NCT00947544|12837772|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
5220381|NCT00947544|12837771|P2|COMPLETED|Safety-Extension Period (12 Months)||6
5220382|NCT00947544|12837772|P1|COMPLETED|Safety-Extension Period (12 Months)||10
5220383|NCT00947544|12837771|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
5220384|NCT00947544|12837772|P1|STARTED|Safety-Extension Period (12 Months)||11
5220385|NCT00947544|12837771|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
5220386|NCT00947544|12837772|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
5220387|NCT00947544|12837771|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
5220388|NCT00947544|12837772|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
5220389|NCT00947544|12837771|P2|STARTED|Switch-Over Period (2 Weeks)||0
5220390|NCT00947544|12837772|P1|STARTED|Switch-Over Period (2 Weeks)||11
5220391|NCT00947531|12837798|P2|NOT COMPLETED|Overall Study||11
5220392|NCT00947531|12837799|P1|NOT COMPLETED|Overall Study||14
5220393|NCT00947531|12837798|P2|COMPLETED|Overall Study||110
5220394|NCT00947531|12837799|P1|COMPLETED|Overall Study||107
5220395|NCT00947531|12837798|P2|STARTED|Overall Study||121
5220396|NCT00947531|12837799|P1|STARTED|Overall Study||121
5220397|NCT00947518|12837808|P3|NOT COMPLETED|Overall Study||0
5220398|NCT00947518|12837809|P2|NOT COMPLETED|Overall Study||0
5220399|NCT00947518|12837810|P1|NOT COMPLETED|Overall Study||0
5220400|NCT00947518|12837808|P3|COMPLETED|Overall Study||20
5220401|NCT00947518|12837809|P2|COMPLETED|Overall Study||20
5220402|NCT00947518|12837810|P1|COMPLETED|Overall Study||20
5220403|NCT00947518|12837808|P3|STARTED|Overall Study||20
5220404|NCT00947518|12837809|P2|STARTED|Overall Study||20
5220405|NCT00947518|12837810|P1|STARTED|Overall Study||20
5220406|NCT00947505|12837826|P2|NOT COMPLETED|Overall Study||2
5220407|NCT00947505|12837827|P1|NOT COMPLETED|Overall Study||9
5220408|NCT00947505|12837826|P2|COMPLETED|Overall Study||14
5220409|NCT00947505|12837827|P1|COMPLETED|Overall Study||24
5220410|NCT00947505|12837826|P2|STARTED|Overall Study||16
5220411|NCT00947505|12837827|P1|STARTED|Overall Study||33
5220412|NCT00947427|12837835|P2|NOT COMPLETED|Overall Study||4
5220413|NCT00947427|12837836|P1|NOT COMPLETED|Overall Study||1
5220414|NCT00947427|12837835|P2|COMPLETED|Overall Study||45
5220415|NCT00947427|12837836|P1|COMPLETED|Overall Study||21
5220416|NCT00947427|12837835|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
5220417|NCT00947427|12837836|P1|STARTED|Overall Study||22
5220418|NCT00947349|12837846|P4|NOT COMPLETED|Overall Study Standard of Care||2
5220419|NCT00947349|12837847|P3|NOT COMPLETED|Overall Study Standard of Care||2
5220420|NCT00947349|12837848|P2|NOT COMPLETED|Overall Study Standard of Care||0
5220421|NCT00947349|12837849|P1|NOT COMPLETED|Overall Study Standard of Care||0
5220422|NCT00947349|12837846|P4|COMPLETED|Overall Study Standard of Care||4
5220423|NCT00947349|12837847|P3|COMPLETED|Overall Study Standard of Care||4
5220424|NCT00947349|12837848|P2|COMPLETED|Overall Study Standard of Care||5
5220425|NCT00947349|12837849|P1|COMPLETED|Overall Study Standard of Care||4
5220426|NCT00947349|12837846|P4|STARTED|Overall Study Standard of Care||6
5220427|NCT00947349|12837847|P3|STARTED|Overall Study Standard of Care||6
5220428|NCT00947349|12837848|P2|STARTED|Overall Study Standard of Care||5
5220429|NCT00947349|12837849|P1|STARTED|Overall Study Standard of Care||4
5220430|NCT00947349|12837846|P4|NOT COMPLETED|Triple Treatment Combination Period||0
5220431|NCT00947349|12837847|P3|NOT COMPLETED|Triple Treatment Combination Period||0
5220432|NCT00947349|12837848|P2|NOT COMPLETED|Triple Treatment Combination Period||1
5220433|NCT00947349|12837849|P1|NOT COMPLETED|Triple Treatment Combination Period||0
5220434|NCT00947349|12837846|P4|COMPLETED|Triple Treatment Combination Period||6
5220435|NCT00947349|12837847|P3|COMPLETED|Triple Treatment Combination Period||6
5220436|NCT00947349|12837848|P2|COMPLETED|Triple Treatment Combination Period||5
5220437|NCT00947349|12837849|P1|COMPLETED|Triple Treatment Combination Period||4
5220438|NCT00947349|12837846|P4|STARTED|Triple Treatment Combination Period||6
5220439|NCT00947349|12837847|P3|STARTED|Triple Treatment Combination Period||6
5220440|NCT00947349|12837848|P2|STARTED|Triple Treatment Combination Period||6
5220441|NCT00947349|12837849|P1|STARTED|Triple Treatment Combination Period||4
5220442|NCT00947310|12837984|P3|NOT COMPLETED|Overall Study||0
5220443|NCT00947310|12837985|P2|NOT COMPLETED|Overall Study||0
5220444|NCT00947310|12837986|P1|NOT COMPLETED|Overall Study||0
5220445|NCT00947310|12837984|P3|COMPLETED|Overall Study||486
5220446|NCT00947310|12837985|P2|COMPLETED|Overall Study||500
5220447|NCT00947310|12837986|P1|COMPLETED|Overall Study||514
5220448|NCT00947310|12837984|P3|STARTED|Overall Study||486
5220449|NCT00947310|12837985|P2|STARTED|Overall Study||500
5220450|NCT00947310|12837986|P1|STARTED|Overall Study||514
5220451|NCT00947297|12838000|P1|NOT COMPLETED|Overall Study||7
5220452|NCT00947297|12838000|P1|COMPLETED|Overall Study||53
5220453|NCT00947297|12838000|P1|STARTED|Overall Study||60
5220454|NCT00947284|12838007|P2|NOT COMPLETED|Overall Study||3
5220455|NCT00947284|12838008|P1|NOT COMPLETED|Overall Study||0
5220456|NCT00947284|12838007|P2|COMPLETED|Overall Study||0
5220457|NCT00947284|12838008|P1|COMPLETED|Overall Study||0
5220458|NCT00947284|12838007|P2|STARTED|Overall Study||3
5220459|NCT00947284|12838008|P1|STARTED|Overall Study||0
5220460|NCT00947271|12838016|P4|NOT COMPLETED|12 Months Post Intervention||62
5220461|NCT00947271|12838017|P3|NOT COMPLETED|12 Months Post Intervention||59
5220462|NCT00947271|12838018|P2|NOT COMPLETED|12 Months Post Intervention||60
5220463|NCT00947271|12838019|P1|NOT COMPLETED|12 Months Post Intervention||71
5220464|NCT00947271|12838016|P4|COMPLETED|12 Months Post Intervention||188
5220465|NCT00947271|12838017|P3|COMPLETED|12 Months Post Intervention||195
5220466|NCT00947271|12838018|P2|COMPLETED|12 Months Post Intervention||192
5220467|NCT00947271|12838019|P1|COMPLETED|12 Months Post Intervention||183
5220468|NCT00947271|12838016|P4|STARTED|12 Months Post Intervention||250
5220469|NCT00947271|12838017|P3|STARTED|12 Months Post Intervention||254
5220470|NCT00947271|12838018|P2|STARTED|12 Months Post Intervention||252
5220471|NCT00947271|12838019|P1|STARTED|12 Months Post Intervention||254
5220472|NCT00947271|12838016|P4|NOT COMPLETED|9 Months Post Intervention||59
5220473|NCT00947271|12838017|P3|NOT COMPLETED|9 Months Post Intervention||61
5220474|NCT00947271|12838018|P2|NOT COMPLETED|9 Months Post Intervention||60
5220475|NCT00947271|12838019|P1|NOT COMPLETED|9 Months Post Intervention||70
5220476|NCT00947271|12838016|P4|COMPLETED|9 Months Post Intervention||191
5220477|NCT00947271|12838017|P3|COMPLETED|9 Months Post Intervention||193
5220478|NCT00947271|12838018|P2|COMPLETED|9 Months Post Intervention||192
5220479|NCT00947271|12838019|P1|COMPLETED|9 Months Post Intervention||184
5220480|NCT00947271|12838016|P4|STARTED|9 Months Post Intervention||250
5220481|NCT00947271|12838017|P3|STARTED|9 Months Post Intervention||254
5220482|NCT00947271|12838018|P2|STARTED|9 Months Post Intervention||252
5220483|NCT00947271|12838019|P1|STARTED|9 Months Post Intervention||254
5220484|NCT00947271|12838016|P4|NOT COMPLETED|6 Months Post Intervention||54
5220485|NCT00947271|12838017|P3|NOT COMPLETED|6 Months Post Intervention||58
5220486|NCT00947271|12838018|P2|NOT COMPLETED|6 Months Post Intervention||53
5220487|NCT00947271|12838019|P1|NOT COMPLETED|6 Months Post Intervention||55
5220488|NCT00947271|12838016|P4|COMPLETED|6 Months Post Intervention||196
5220489|NCT00947271|12838017|P3|COMPLETED|6 Months Post Intervention||196
5220490|NCT00947271|12838018|P2|COMPLETED|6 Months Post Intervention||199
5220491|NCT00947271|12838019|P1|COMPLETED|6 Months Post Intervention||199
5220492|NCT00947271|12838016|P4|STARTED|6 Months Post Intervention||250
5220493|NCT00947271|12838017|P3|STARTED|6 Months Post Intervention||254
5220494|NCT00947271|12838018|P2|STARTED|6 Months Post Intervention||252
5220495|NCT00947271|12838019|P1|STARTED|6 Months Post Intervention||254
5220496|NCT00947271|12838016|P4|NOT COMPLETED|3 Months Post Intervention||44
5220497|NCT00947271|12838017|P3|NOT COMPLETED|3 Months Post Intervention||36
5220498|NCT00947271|12838018|P2|NOT COMPLETED|3 Months Post Intervention||48
5220499|NCT00947271|12838019|P1|NOT COMPLETED|3 Months Post Intervention||52
5220500|NCT00947271|12838016|P4|COMPLETED|3 Months Post Intervention||206
5220501|NCT00947271|12838017|P3|COMPLETED|3 Months Post Intervention||218
5220502|NCT00947271|12838018|P2|COMPLETED|3 Months Post Intervention||204
5220503|NCT00947271|12838019|P1|COMPLETED|3 Months Post Intervention||202
5220504|NCT00947271|12838016|P4|STARTED|3 Months Post Intervention||250
5220505|NCT00947271|12838017|P3|STARTED|3 Months Post Intervention||254
5220506|NCT00947271|12838018|P2|STARTED|3 Months Post Intervention||252
5220507|NCT00947271|12838019|P1|STARTED|3 Months Post Intervention||254
5220508|NCT00947219|12838048|P3|NOT COMPLETED|Overall Study||4
5220509|NCT00947219|12838049|P2|NOT COMPLETED|Overall Study||4
5220510|NCT00947219|12838050|P1|NOT COMPLETED|Overall Study||6
5220511|NCT00947219|12838048|P3|COMPLETED|Overall Study||22
5220512|NCT00947219|12838049|P2|COMPLETED|Overall Study||21
5220513|NCT00947219|12838050|P1|COMPLETED|Overall Study||22
5220514|NCT00947219|12838048|P3|STARTED|Overall Study||26
5220515|NCT00947219|12838049|P2|STARTED|Overall Study||25
5220516|NCT00947219|12838050|P1|STARTED|Overall Study||28
5220517|NCT00947193|12838058|P2|NOT COMPLETED|Overall Study||0
5220518|NCT00947193|12838059|P1|NOT COMPLETED|Overall Study||3
5220519|NCT00947193|12838058|P2|COMPLETED|Overall Study||10
5220520|NCT00947193|12838059|P1|COMPLETED|Overall Study||0
5220521|NCT00947193|12838058|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
5220522|NCT00947193|12838059|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5220523|NCT00947193|12838058|P2|STARTED|Overall Study||10
5220524|NCT00947193|12838059|P1|STARTED|Overall Study||3
5220525|NCT00947167|12838069|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
5220526|NCT00947167|12838069|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
5220527|NCT00947167|12838069|P1|STARTED|Erlotinib Added to Pertuzumab||3
5220528|NCT00947167|12838069|P1|NOT COMPLETED|Pertuzumab Alone||0
5220529|NCT00947167|12838069|P1|COMPLETED|Pertuzumab Alone||4
5220530|NCT00947167|12838069|P1|STARTED|Pertuzumab Alone||4
5220531|NCT00947154|12838074|P1|NOT COMPLETED|Overall Study||1
5220532|NCT00947154|12838074|P1|COMPLETED|Overall Study||11
5220533|NCT00947154|12838074|P1|STARTED|Overall Study||12
5220534|NCT00947115|12838084|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
5220535|NCT00947115|12838085|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
5220536|NCT00947115|12838086|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
5220537|NCT00947115|12838084|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
5220538|NCT00947115|12838085|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
5220539|NCT00947115|12838086|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
5220540|NCT00947115|12838084|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
5220541|NCT00947115|12838085|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
5220542|NCT00947115|12838086|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
5220543|NCT00947115|12838084|P3|NOT COMPLETED|Year 10 (Month 120)||0
5220544|NCT00947115|12838085|P2|NOT COMPLETED|Year 10 (Month 120)||0
5220545|NCT00947115|12838086|P1|NOT COMPLETED|Year 10 (Month 120)||0
5220546|NCT00947115|12838084|P3|COMPLETED|Year 10 (Month 120)||156
5220547|NCT00947115|12838085|P2|COMPLETED|Year 10 (Month 120)||172
5220548|NCT00947115|12838086|P1|COMPLETED|Year 10 (Month 120)||142
5220549|NCT00947115|12838084|P3|STARTED|Year 10 (Month 120)||156
5220550|NCT00947115|12838085|P2|STARTED|Year 10 (Month 120)||172
5220551|NCT00947115|12838086|P1|STARTED|Year 10 (Month 120)||142
5220552|NCT00947115|12838084|P3|NOT COMPLETED|Year 9 (Month 108)||0
5220553|NCT00947115|12838085|P2|NOT COMPLETED|Year 9 (Month 108)||0
5220554|NCT00947115|12838086|P1|NOT COMPLETED|Year 9 (Month 108)||0
5220555|NCT00947115|12838084|P3|COMPLETED|Year 9 (Month 108)||157
5220556|NCT00947115|12838085|P2|COMPLETED|Year 9 (Month 108)||180
5220557|NCT00947115|12838086|P1|COMPLETED|Year 9 (Month 108)||146
5220558|NCT00947115|12838084|P3|STARTED|Year 9 (Month 108)||157
5220559|NCT00947115|12838085|P2|STARTED|Year 9 (Month 108)||180
5220560|NCT00947115|12838086|P1|STARTED|Year 9 (Month 108)||146
5220561|NCT00947115|12838084|P3|NOT COMPLETED|Year 8 (Month 96)||0
5220562|NCT00947115|12838085|P2|NOT COMPLETED|Year 8 (Month 96)||0
5220563|NCT00947115|12838086|P1|NOT COMPLETED|Year 8 (Month 96)||0
5220564|NCT00947115|12838084|P3|COMPLETED|Year 8 (Month 96)||141
5220565|NCT00947115|12838085|P2|COMPLETED|Year 8 (Month 96)||152
5220566|NCT00947115|12838086|P1|COMPLETED|Year 8 (Month 96)||137
5220567|NCT00947115|12838084|P3|STARTED|Year 8 (Month 96)||141
5220568|NCT00947115|12838085|P2|STARTED|Year 8 (Month 96)||152
5220569|NCT00947115|12838086|P1|STARTED|Year 8 (Month 96)||137
5220570|NCT00947115|12838084|P3|NOT COMPLETED|Year 7 (Month 84)||0
5220571|NCT00947115|12838085|P2|NOT COMPLETED|Year 7 (Month 84)||0
5220572|NCT00947115|12838086|P1|NOT COMPLETED|Year 7 (Month 84)||0
5220573|NCT00947115|12838084|P3|COMPLETED|Year 7 (Month 84)||160
5220574|NCT00947115|12838085|P2|COMPLETED|Year 7 (Month 84)||165
5220575|NCT00947115|12838086|P1|COMPLETED|Year 7 (Month 84)||149
5220576|NCT00947115|12838084|P3|STARTED|Year 7 (Month 84)||160
5220577|NCT00947115|12838085|P2|STARTED|Year 7 (Month 84)||165
5220578|NCT00947115|12838086|P1|STARTED|Year 7 (Month 84)||149
5220579|NCT00947115|12838084|P3|NOT COMPLETED|Year 6 (Month 72)||0
5220580|NCT00947115|12838085|P2|NOT COMPLETED|Year 6 (Month 72)||0
5220581|NCT00947115|12838086|P1|NOT COMPLETED|Year 6 (Month 72)||0
5220582|NCT00947115|12838084|P3|COMPLETED|Year 6 (Month 72)||164
5220583|NCT00947115|12838085|P2|COMPLETED|Year 6 (Month 72)||177
5220584|NCT00947115|12838086|P1|COMPLETED|Year 6 (Month 72)||147
5220585|NCT00947115|12838084|P3|STARTED|Year 6 (Month 72)||164
5220586|NCT00947115|12838085|P2|STARTED|Year 6 (Month 72)||177
5220587|NCT00947115|12838086|P1|STARTED|Year 6 (Month 72)||147
5220588|NCT00947115|12838084|P3|NOT COMPLETED|Year 5 (Month 60)||0
5220589|NCT00947115|12838085|P2|NOT COMPLETED|Year 5 (Month 60)||0
5220590|NCT00947115|12838086|P1|NOT COMPLETED|Year 5 (Month 60)||0
5220591|NCT00947115|12838084|P3|COMPLETED|Year 5 (Month 60)||170
5220592|NCT00947115|12838085|P2|COMPLETED|Year 5 (Month 60)||184
5220593|NCT00947115|12838086|P1|COMPLETED|Year 5 (Month 60)||153
5220594|NCT00947115|12838084|P3|STARTED|Year 5 (Month 60)||170
5220595|NCT00947115|12838085|P2|STARTED|Year 5 (Month 60)||184
5220596|NCT00947115|12838086|P1|STARTED|Year 5 (Month 60)||153
5220597|NCT00947011|12838148|P1|NOT COMPLETED|Overall Study||12
5220598|NCT00947011|12838148|P1|COMPLETED|Overall Study||0
5220599|NCT00947011|12838148|P1|STARTED|Overall Study||12
5220600|NCT00946998|12838158|P2|NOT COMPLETED|Overall Study||3
5220601|NCT00946998|12838159|P1|NOT COMPLETED|Overall Study||5
5220602|NCT00946998|12838158|P2|COMPLETED|Overall Study||96
5220603|NCT00946998|12838159|P1|COMPLETED|Overall Study||97
5220604|NCT00946998|12838158|P2|Received Treatment as Randomized|Overall Study||99
5220605|NCT00946998|12838159|P1|Received Treatment as Randomized|Overall Study||102
5220606|NCT00946998|12838158|P2|STARTED|Overall Study||99
5220607|NCT00946998|12838159|P1|STARTED|Overall Study||102
5220608|NCT00946985|12838173|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
5220609|NCT00946985|12838173|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
5220610|NCT00946985|12838173|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
5220611|NCT00946985|12838173|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
5220612|NCT00946985|12838173|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
5220613|NCT00946985|12838173|P1|STARTED|Stabilization Phase (25 Weeks)||162
5220614|NCT00946920|12838179|P2|NOT COMPLETED|Overall Study||44
5220615|NCT00946920|12838180|P1|NOT COMPLETED|Overall Study||110
5220616|NCT00946920|12838179|P2|COMPLETED|Overall Study||239
5220617|NCT00946920|12838180|P1|COMPLETED|Overall Study||455
5220618|NCT00946920|12838179|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
5220619|NCT00946920|12838180|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
5220620|NCT00946920|12838179|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
5220621|NCT00946920|12838180|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
5220622|NCT00946881|12838195|P1|NOT COMPLETED|Retreatment||1
5220623|NCT00946881|12838195|P1|COMPLETED|Retreatment||7
5220624|NCT00946881|12838195|P1|STARTED|Retreatment||8
5220625|NCT00946881|12838195|P1|NOT COMPLETED|First Treatment||2
5220626|NCT00946881|12838195|P1|COMPLETED|First Treatment||28
5220627|NCT00946881|12838195|P1|STARTED|First Treatment||30
5220628|NCT00946712|12838226|P2|NOT COMPLETED|Overall Study||662
5220629|NCT00946712|12838227|P1|NOT COMPLETED|Overall Study||547
5220630|NCT00946712|12838226|P2|COMPLETED|Overall Study||0
5220631|NCT00946712|12838227|P1|COMPLETED|Overall Study||124
5220632|NCT00946712|12838226|P2|STARTED|Overall Study||662
5220633|NCT00946712|12838227|P1|STARTED|Overall Study||671
5220634|NCT00946647|12838246|P5|NOT COMPLETED|Phase ll Part||42
5220635|NCT00946647|12838247|P4|NOT COMPLETED|Phase ll Part||40
5220636|NCT00946647|12838248|P3|NOT COMPLETED|Phase ll Part||0
5220637|NCT00946647|12838249|P2|NOT COMPLETED|Phase ll Part||0
5220638|NCT00946647|12838250|P1|NOT COMPLETED|Phase ll Part||0
5220639|NCT00946647|12838246|P5|COMPLETED|Phase ll Part||0
5220640|NCT00946647|12838247|P4|COMPLETED|Phase ll Part||0
5220641|NCT00946647|12838248|P3|COMPLETED|Phase ll Part||0
5220642|NCT00946647|12838249|P2|COMPLETED|Phase ll Part||0
5220643|NCT00946647|12838250|P1|COMPLETED|Phase ll Part||0
5220644|NCT00946647|12838246|P5|STARTED|Phase ll Part||42
5220645|NCT00946647|12838247|P4|STARTED|Phase ll Part||40
5220646|NCT00946647|12838248|P3|STARTED|Phase ll Part||0
5220647|NCT00946647|12838249|P2|STARTED|Phase ll Part||0
5220648|NCT00946647|12838250|P1|STARTED|Phase ll Part||0
5220649|NCT00946647|12838246|P5|NOT COMPLETED|Phase 1 Part||0
5220650|NCT00946647|12838247|P4|NOT COMPLETED|Phase 1 Part||0
5220651|NCT00946647|12838248|P3|NOT COMPLETED|Phase 1 Part||7
5220652|NCT00946647|12838249|P2|NOT COMPLETED|Phase 1 Part||18
5220653|NCT00946647|12838250|P1|NOT COMPLETED|Phase 1 Part||6
5220654|NCT00946647|12838246|P5|COMPLETED|Phase 1 Part||0
5220655|NCT00946647|12838247|P4|COMPLETED|Phase 1 Part||0
5220656|NCT00946647|12838248|P3|COMPLETED|Phase 1 Part||0
5220657|NCT00946647|12838249|P2|COMPLETED|Phase 1 Part||0
5220658|NCT00946647|12838250|P1|COMPLETED|Phase 1 Part||0
5220659|NCT00946647|12838246|P5|STARTED|Phase 1 Part||0
5220660|NCT00946647|12838247|P4|STARTED|Phase 1 Part||0
5220661|NCT00946647|12838248|P3|STARTED|Phase 1 Part||7
5220662|NCT00946647|12838249|P2|STARTED|Phase 1 Part||18
5220663|NCT00946647|12838250|P1|STARTED|Phase 1 Part||6
5220664|NCT00946530|12838284|P4|NOT COMPLETED|Overall Study||4
5220665|NCT00946530|12838285|P3|NOT COMPLETED|Overall Study||1
5220666|NCT00946530|12838286|P2|NOT COMPLETED|Overall Study||4
5220667|NCT00946530|12838287|P1|NOT COMPLETED|Overall Study||1
5220668|NCT00946530|12838284|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
5220669|NCT00946530|12838285|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
5220670|NCT00946530|12838286|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
5220671|NCT00946530|12838287|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
5220672|NCT00946530|12838284|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
5220673|NCT00946530|12838285|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
5220674|NCT00946530|12838286|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
5220675|NCT00946530|12838287|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
5220676|NCT00946478|12838303|P2|NOT COMPLETED|Overall Study||0
5220677|NCT00946478|12838304|P1|NOT COMPLETED|Overall Study||0
5220678|NCT00946478|12838303|P2|COMPLETED|Overall Study||20
5220679|NCT00946478|12838304|P1|COMPLETED|Overall Study||20
5220680|NCT00946478|12838303|P2|STARTED|Overall Study||20
5220681|NCT00946478|12838304|P1|STARTED|Overall Study||20
5220682|NCT00946348|12838312|P2|NOT COMPLETED|Overall Study||0
5220683|NCT00946348|12838313|P1|NOT COMPLETED|Overall Study||0
5220684|NCT00946348|12838312|P2|COMPLETED|Overall Study||6
5220685|NCT00946348|12838313|P1|COMPLETED|Overall Study||6
5220686|NCT00946348|12838312|P2|STARTED|Overall Study||6
5220687|NCT00946348|12838313|P1|STARTED|Overall Study||6
5220688|NCT00946322|12838319|P1|NOT COMPLETED|Post-treatment||2
5220689|NCT00946322|12838319|P1|COMPLETED|Post-treatment||9
5220690|NCT00946322|12838319|P1|STARTED|Post-treatment||11
5220691|NCT00946322|12838319|P1|NOT COMPLETED|Pre-treatment||1
5220692|NCT00946322|12838319|P1|COMPLETED|Pre-treatment||11
5220693|NCT00946322|12838319|P1|STARTED|Pre-treatment||12
5220694|NCT00946309|12838332|P2|NOT COMPLETED|Overall Study||4
5220695|NCT00946309|12838333|P1|NOT COMPLETED|Overall Study||1
5220696|NCT00946309|12838332|P2|COMPLETED|Overall Study||19
5220697|NCT00946309|12838333|P1|COMPLETED|Overall Study||21
5220698|NCT00946309|12838332|P2|STARTED|Overall Study||23
5220699|NCT00946309|12838333|P1|STARTED|Overall Study||22
5220700|NCT00946296|12838351|P2|NOT COMPLETED|Overall Study||0
5220701|NCT00946296|12838352|P1|NOT COMPLETED|Overall Study||3
5220702|NCT00946296|12838351|P2|COMPLETED|Overall Study||15
5220703|NCT00946296|12838352|P1|COMPLETED|Overall Study||18
5220704|NCT00946296|12838351|P2|STARTED|Overall Study||15
5220705|NCT00946296|12838352|P1|STARTED|Overall Study||21
5220706|NCT00946270|12838361|P3|NOT COMPLETED|Overall Study||0
5220707|NCT00946270|12838362|P2|NOT COMPLETED|Overall Study||0
5220708|NCT00946270|12838363|P1|NOT COMPLETED|Overall Study||0
5220709|NCT00946270|12838361|P3|COMPLETED|Overall Study||29
5220710|NCT00946270|12838362|P2|COMPLETED|Overall Study||20
5220711|NCT00946270|12838363|P1|COMPLETED|Overall Study||21
5220712|NCT00946270|12838361|P3|STARTED|Overall Study||29
5220713|NCT00946270|12838362|P2|STARTED|Overall Study||20
5220714|NCT00946270|12838363|P1|STARTED|Overall Study||21
5220715|NCT00946192|12838374|P3|NOT COMPLETED|Overall Study||12
5220716|NCT00946192|12838375|P2|NOT COMPLETED|Overall Study||18
5220717|NCT00946192|12838376|P1|NOT COMPLETED|Overall Study||18
5220718|NCT00946192|12838374|P3|COMPLETED|Overall Study||26
5220719|NCT00946192|12838375|P2|COMPLETED|Overall Study||22
5220720|NCT00946192|12838376|P1|COMPLETED|Overall Study||25
5220721|NCT00946192|12838374|P3|STARTED|Overall Study||38
5220722|NCT00946192|12838375|P2|STARTED|Overall Study||40
5220723|NCT00946192|12838376|P1|STARTED|Overall Study||43
5220724|NCT00946153|12838392|P5|NOT COMPLETED|Phase 2||13
5220725|NCT00946153|12838393|P4|NOT COMPLETED|Phase 2||0
5220726|NCT00946153|12838394|P3|NOT COMPLETED|Phase 2||0
5220727|NCT00946153|12838395|P2|NOT COMPLETED|Phase 2||0
5220728|NCT00946153|12838396|P1|NOT COMPLETED|Phase 2||0
5220729|NCT00946153|12838392|P5|COMPLETED|Phase 2||33
5220730|NCT00946153|12838393|P4|COMPLETED|Phase 2||0
5220731|NCT00946153|12838394|P3|COMPLETED|Phase 2||0
5220732|NCT00946153|12838395|P2|COMPLETED|Phase 2||0
5220733|NCT00946153|12838396|P1|COMPLETED|Phase 2||0
5220734|NCT00946153|12838392|P5|STARTED|Phase 2||46
5220735|NCT00946153|12838393|P4|STARTED|Phase 2||0
5220736|NCT00946153|12838394|P3|STARTED|Phase 2||0
5220737|NCT00946153|12838395|P2|STARTED|Phase 2||0
5220738|NCT00946153|12838396|P1|STARTED|Phase 2||0
5220739|NCT00946153|12838392|P5|NOT COMPLETED|Phase 1||0
5220740|NCT00946153|12838393|P4|NOT COMPLETED|Phase 1||0
5220741|NCT00946153|12838394|P3|NOT COMPLETED|Phase 1||0
5220742|NCT00946153|12838395|P2|NOT COMPLETED|Phase 1||0
5220743|NCT00946153|12838396|P1|NOT COMPLETED|Phase 1||0
5220744|NCT00946153|12838392|P5|COMPLETED|Phase 1||0
5220745|NCT00946153|12838393|P4|COMPLETED|Phase 1||5
5220746|NCT00946153|12838394|P3|COMPLETED|Phase 1||6
5220747|NCT00946153|12838395|P2|COMPLETED|Phase 1||3
5220748|NCT00946153|12838396|P1|COMPLETED|Phase 1||6
5220749|NCT00946153|12838392|P5|STARTED|Phase 1||0
5220750|NCT00946153|12838393|P4|STARTED|Phase 1||5
5220751|NCT00946153|12838394|P3|STARTED|Phase 1||6
5220752|NCT00946153|12838395|P2|STARTED|Phase 1||3
5220753|NCT00946153|12838396|P1|STARTED|Phase 1||6
5220754|NCT00946114|12838424|P2|NOT COMPLETED|Overall Study||2
5220755|NCT00946114|12838425|P1|NOT COMPLETED|Overall Study||8
5220756|NCT00946114|12838424|P2|COMPLETED|Overall Study||10
5220757|NCT00946114|12838425|P1|COMPLETED|Overall Study||12
5220758|NCT00946114|12838424|P2|STARTED|Overall Study||12
5220759|NCT00946114|12838425|P1|STARTED|Overall Study||20
5220760|NCT00946101|12838433|P2|NOT COMPLETED|Overall Study||2
5220761|NCT00946101|12838434|P1|NOT COMPLETED|Overall Study||4
5220762|NCT00946101|12838433|P2|COMPLETED|Overall Study||63
5220763|NCT00946101|12838434|P1|COMPLETED|Overall Study||257
5220764|NCT00946101|12838433|P2|Day 15 Post Dose 2|Overall Study||63
5220765|NCT00946101|12838434|P1|Day 15 Post Dose 2|Overall Study||254
5220766|NCT00946101|12838433|P2|Day 15 Post Dose 1|Overall Study||64
5220767|NCT00946101|12838434|P1|Day 15 Post Dose 1|Overall Study||260
5220768|NCT00946101|12838433|P2|STARTED|Overall Study||65
5220769|NCT00946101|12838434|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
5220770|NCT00946088|12838500|P2|NOT COMPLETED|Overall Study||1
5220771|NCT00946088|12838501|P1|NOT COMPLETED|Overall Study||0
5220772|NCT00946088|12838500|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
5220773|NCT00946088|12838501|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
5220774|NCT00946088|12838500|P2|STARTED|Overall Study||3
5220775|NCT00946088|12838501|P1|STARTED|Overall Study||4
5220776|NCT00946023|12838523|P1|NOT COMPLETED|Overall Study||0
5220777|NCT00946023|12838523|P1|COMPLETED|Overall Study||83
5220778|NCT00946023|12838523|P1|STARTED|Overall Study||83
5220779|NCT00945958|12838538|P1|NOT COMPLETED|Overall Study||12
5220780|NCT00945958|12838538|P1|COMPLETED|Overall Study||149
5220781|NCT00945958|12838538|P1|STARTED|Overall Study||161
5220782|NCT00945945|12838545|P2|NOT COMPLETED|Overall Study||55
5220783|NCT00945945|12838546|P1|NOT COMPLETED|Overall Study||36
5220784|NCT00945945|12838545|P2|COMPLETED|Overall Study||162
5220785|NCT00945945|12838546|P1|COMPLETED|Overall Study||171
5220786|NCT00945945|12838545|P2|STARTED|Overall Study||217
5220787|NCT00945945|12838546|P1|STARTED|Overall Study||207
5220788|NCT00945906|12838572|P1|NOT COMPLETED|Overall Study||7
5220789|NCT00945906|12838572|P1|COMPLETED|Overall Study||54
5220790|NCT00945906|12838572|P1|STARTED|Overall Study||61
5220791|NCT00945893|12838583|P2|NOT COMPLETED|Overall Study||10
5220792|NCT00945893|12838584|P1|NOT COMPLETED|Overall Study||3
5220793|NCT00945893|12838583|P2|COMPLETED|Overall Study||230
5220794|NCT00945893|12838584|P1|COMPLETED|Overall Study||57
5220795|NCT00945893|12838583|P2|Day 15 Post Dose 2|Overall Study||226
5220796|NCT00945893|12838584|P1|Day 15 Post Dose 2|Overall Study||54
5220797|NCT00945893|12838583|P2|Day 15 Post Dose 1|Overall Study||238
5220798|NCT00945893|12838584|P1|Day 15 Post Dose 1|Overall Study||60
5220799|NCT00945893|12838583|P2|STARTED|Overall Study||240
5220800|NCT00945893|12838584|P1|STARTED|Overall Study||60
5220801|NCT00945854|12838650|P2|NOT COMPLETED|Overall Study||4
5220802|NCT00945854|12838651|P1|NOT COMPLETED|Overall Study||2
5220803|NCT00945854|12838650|P2|COMPLETED|Overall Study||26
5220804|NCT00945854|12838651|P1|COMPLETED|Overall Study||28
5220805|NCT00945854|12838650|P2|STARTED|Overall Study||30
5220806|NCT00945854|12838651|P1|STARTED|Overall Study||30
5220807|NCT00945815|12838661|P1|NOT COMPLETED|Overall Study||8
5220808|NCT00945815|12838661|P1|COMPLETED|Overall Study||27
5220809|NCT00945815|12838661|P1|Eligible and Began Protocol Therapy|Overall Study||31
5220810|NCT00945815|12838661|P1|Eligible|Overall Study||32
5220811|NCT00945815|12838661|P1|STARTED|Overall Study||35
5220812|NCT00945750|12838672|P6|NOT COMPLETED|Period III||0
5220813|NCT00945750|12838673|P5|NOT COMPLETED|Period III||0
5220814|NCT00945750|12838674|P4|NOT COMPLETED|Period III||0
5220815|NCT00945750|12838675|P3|NOT COMPLETED|Period III||0
5220816|NCT00945750|12838676|P2|NOT COMPLETED|Period III||0
5220817|NCT00945750|12838677|P1|NOT COMPLETED|Period III||0
5220818|NCT00945750|12838672|P6|COMPLETED|Period III||5
5220819|NCT00945750|12838673|P5|COMPLETED|Period III||5
5220820|NCT00945750|12838674|P4|COMPLETED|Period III||5
5220821|NCT00945750|12838675|P3|COMPLETED|Period III||5
5220822|NCT00945750|12838676|P2|COMPLETED|Period III||5
5220823|NCT00945750|12838677|P1|COMPLETED|Period III||5
5220824|NCT00945750|12838672|P6|STARTED|Period III||5
5220825|NCT00945750|12838673|P5|STARTED|Period III||5
5220826|NCT00945750|12838674|P4|STARTED|Period III||5
5220827|NCT00945750|12838675|P3|STARTED|Period III||5
5220828|NCT00945750|12838676|P2|STARTED|Period III||5
5220829|NCT00945750|12838677|P1|STARTED|Period III||5
5220830|NCT00945750|12838672|P6|NOT COMPLETED|Period II||0
5220831|NCT00945750|12838673|P5|NOT COMPLETED|Period II||0
5220832|NCT00945750|12838674|P4|NOT COMPLETED|Period II||0
5220833|NCT00945750|12838675|P3|NOT COMPLETED|Period II||0
5220834|NCT00945750|12838676|P2|NOT COMPLETED|Period II||0
5220835|NCT00945750|12838677|P1|NOT COMPLETED|Period II||0
5220836|NCT00945750|12838672|P6|COMPLETED|Period II||5
5220837|NCT00945750|12838673|P5|COMPLETED|Period II||5
5220838|NCT00945750|12838674|P4|COMPLETED|Period II||5
5220839|NCT00945750|12838675|P3|COMPLETED|Period II||5
5220840|NCT00945750|12838676|P2|COMPLETED|Period II||5
5220841|NCT00945750|12838677|P1|COMPLETED|Period II||5
5220842|NCT00945750|12838672|P6|STARTED|Period II||5
5220843|NCT00945750|12838673|P5|STARTED|Period II||5
5220844|NCT00945750|12838674|P4|STARTED|Period II||5
5220845|NCT00945750|12838675|P3|STARTED|Period II||5
5220846|NCT00945750|12838676|P2|STARTED|Period II||5
5220847|NCT00945750|12838677|P1|STARTED|Period II||5
5220848|NCT00945750|12838672|P6|NOT COMPLETED|Period I||0
5220849|NCT00945750|12838673|P5|NOT COMPLETED|Period I||0
5220850|NCT00945750|12838674|P4|NOT COMPLETED|Period I||0
5220851|NCT00945750|12838675|P3|NOT COMPLETED|Period I||0
5220852|NCT00945750|12838676|P2|NOT COMPLETED|Period I||0
5220853|NCT00945750|12838677|P1|NOT COMPLETED|Period I||0
5220854|NCT00945750|12838672|P6|COMPLETED|Period I||5
5220855|NCT00945750|12838673|P5|COMPLETED|Period I||5
5220856|NCT00945750|12838674|P4|COMPLETED|Period I||5
5220857|NCT00945750|12838675|P3|COMPLETED|Period I||5
5220858|NCT00945750|12838676|P2|COMPLETED|Period I||5
5220859|NCT00945750|12838677|P1|COMPLETED|Period I||5
5220860|NCT00945750|12838672|P6|STARTED|Period I||5
5220861|NCT00945750|12838673|P5|STARTED|Period I||5
5220862|NCT00945750|12838674|P4|STARTED|Period I||5
5220863|NCT00945750|12838675|P3|STARTED|Period I||5
5220864|NCT00945750|12838676|P2|STARTED|Period I||5
5220865|NCT00945750|12838677|P1|STARTED|Period I||5
5220866|NCT00945659|12838693|P3|NOT COMPLETED|Overall Study||17
5220867|NCT00945659|12838694|P2|NOT COMPLETED|Overall Study||20
5220868|NCT00945659|12838695|P1|NOT COMPLETED|Overall Study||7
5220869|NCT00945659|12838693|P3|COMPLETED|Overall Study||20
5220870|NCT00945659|12838694|P2|COMPLETED|Overall Study||20
5220871|NCT00945659|12838695|P1|COMPLETED|Overall Study||32
5220872|NCT00945659|12838693|P3|12-Months|Overall Study||20
5220873|NCT00945659|12838694|P2|12-Months|Overall Study||20
5220874|NCT00945659|12838695|P1|12-Months|Overall Study||32
5220875|NCT00945659|12838693|P3|9-Months|Overall Study||20
5220876|NCT00945659|12838694|P2|9-Months|Overall Study||20
5220877|NCT00945659|12838695|P1|9-Months|Overall Study||32
5220878|NCT00945659|12838693|P3|6-Months|Overall Study||25
5220879|NCT00945659|12838694|P2|6-Months|Overall Study||29
5220880|NCT00945659|12838695|P1|6-Months|Overall Study||31
5220881|NCT00945659|12838693|P3|3-Months|Overall Study||35
5220882|NCT00945659|12838694|P2|3-Months|Overall Study||39
5220883|NCT00945659|12838695|P1|3-Months|Overall Study||38
5220884|NCT00945659|12838693|P3|Baseline|Overall Study||37
5220885|NCT00945659|12838694|P2|Baseline|Overall Study||40
5220886|NCT00945659|12838695|P1|Baseline|Overall Study||39
5220887|NCT00945659|12838693|P3|STARTED|Overall Study||37
5220888|NCT00945659|12838694|P2|STARTED|Overall Study||40
5220889|NCT00945659|12838695|P1|STARTED|Overall Study||39
5220890|NCT00945594|12838741|P2|NOT COMPLETED|Overall Study||0
5220891|NCT00945594|12838742|P1|NOT COMPLETED|Overall Study||0
5220892|NCT00945594|12838741|P2|COMPLETED|Overall Study||50
5220893|NCT00945594|12838742|P1|COMPLETED|Overall Study||50
5220894|NCT00945594|12838741|P2|STARTED|Overall Study||50
5220895|NCT00945594|12838742|P1|STARTED|Overall Study||50
5220896|NCT00945555|12838752|P1|NOT COMPLETED|Overall Study||28
5220897|NCT00945555|12838752|P1|COMPLETED|Overall Study||236
5220898|NCT00945555|12838752|P1|STARTED|Overall Study||264
5220899|NCT00945477|12838763|P1|NOT COMPLETED|Overall Study||6
5220900|NCT00945477|12838763|P1|COMPLETED|Overall Study||5
5220901|NCT00945477|12838763|P1|STARTED|Overall Study||11
5220902|NCT00945334|12838770|P2|NOT COMPLETED|Overall Study||3
5220903|NCT00945334|12838771|P1|NOT COMPLETED|Overall Study||3
5220904|NCT00945334|12838770|P2|COMPLETED|Overall Study||15
5220905|NCT00945334|12838771|P1|COMPLETED|Overall Study||16
5220906|NCT00945334|12838770|P2|STARTED|Overall Study||18
5220907|NCT00945334|12838771|P1|STARTED|Overall Study||19
5220908|NCT00945321|12838779|P6|NOT COMPLETED|Period 4||1
5220909|NCT00945321|12838780|P5|NOT COMPLETED|Period 4||0
5220910|NCT00945321|12838781|P4|NOT COMPLETED|Period 4||0
5220911|NCT00945321|12838782|P3|NOT COMPLETED|Period 4||0
5220912|NCT00945321|12838783|P2|NOT COMPLETED|Period 4||0
5220913|NCT00945321|12838784|P1|NOT COMPLETED|Period 4||0
5220914|NCT00945321|12838779|P6|COMPLETED|Period 4||6
5220915|NCT00945321|12838780|P5|COMPLETED|Period 4||6
5220916|NCT00945321|12838781|P4|COMPLETED|Period 4||7
5220917|NCT00945321|12838782|P3|COMPLETED|Period 4||7
5220918|NCT00945321|12838783|P2|COMPLETED|Period 4||7
5220919|NCT00945321|12838784|P1|COMPLETED|Period 4||7
5220920|NCT00945321|12838779|P6|STARTED|Period 4||7
5220921|NCT00945321|12838780|P5|STARTED|Period 4||6
5220922|NCT00945321|12838781|P4|STARTED|Period 4||7
5220923|NCT00945321|12838782|P3|STARTED|Period 4||7
5220924|NCT00945321|12838783|P2|STARTED|Period 4||7
5220925|NCT00945321|12838784|P1|STARTED|Period 4||7
5220926|NCT00945321|12838779|P6|NOT COMPLETED|Period 3||0
5220927|NCT00945321|12838780|P5|NOT COMPLETED|Period 3||0
5220928|NCT00945321|12838781|P4|NOT COMPLETED|Period 3||0
5220929|NCT00945321|12838782|P3|NOT COMPLETED|Period 3||0
5220930|NCT00945321|12838783|P2|NOT COMPLETED|Period 3||0
5220931|NCT00945321|12838784|P1|NOT COMPLETED|Period 3||0
5220932|NCT00945321|12838779|P6|COMPLETED|Period 3||7
5220933|NCT00945321|12838780|P5|COMPLETED|Period 3||6
5220934|NCT00945321|12838781|P4|COMPLETED|Period 3||7
5220935|NCT00945321|12838782|P3|COMPLETED|Period 3||7
5220936|NCT00945321|12838783|P2|COMPLETED|Period 3||7
5220937|NCT00945321|12838784|P1|COMPLETED|Period 3||7
5220938|NCT00945321|12838779|P6|STARTED|Period 3||7
5220939|NCT00945321|12838780|P5|STARTED|Period 3||6
5220940|NCT00945321|12838781|P4|STARTED|Period 3||7
5220941|NCT00945321|12838782|P3|STARTED|Period 3||7
5220942|NCT00945321|12838783|P2|STARTED|Period 3||7
5220943|NCT00945321|12838784|P1|STARTED|Period 3||7
5220944|NCT00945321|12838779|P6|NOT COMPLETED|Period 2||0
5220945|NCT00945321|12838780|P5|NOT COMPLETED|Period 2||0
5220946|NCT00945321|12838781|P4|NOT COMPLETED|Period 2||0
5220947|NCT00945321|12838782|P3|NOT COMPLETED|Period 2||0
5220948|NCT00945321|12838783|P2|NOT COMPLETED|Period 2||0
5220949|NCT00945321|12838784|P1|NOT COMPLETED|Period 2||0
5220950|NCT00945321|12838779|P6|COMPLETED|Period 2||7
5220951|NCT00945321|12838780|P5|COMPLETED|Period 2||6
5220952|NCT00945321|12838781|P4|COMPLETED|Period 2||7
5220953|NCT00945321|12838782|P3|COMPLETED|Period 2||7
5220954|NCT00945321|12838783|P2|COMPLETED|Period 2||7
5220955|NCT00945321|12838784|P1|COMPLETED|Period 2||7
5220956|NCT00945321|12838779|P6|STARTED|Period 2||7
5220957|NCT00945321|12838780|P5|STARTED|Period 2||6
5220958|NCT00945321|12838781|P4|STARTED|Period 2||7
5220959|NCT00945321|12838782|P3|STARTED|Period 2||7
5220960|NCT00945321|12838783|P2|STARTED|Period 2||7
5220961|NCT00945321|12838784|P1|STARTED|Period 2||7
5220962|NCT00945321|12838779|P6|NOT COMPLETED|Period 1||0
5220963|NCT00945321|12838780|P5|NOT COMPLETED|Period 1||1
5220964|NCT00945321|12838781|P4|NOT COMPLETED|Period 1||0
5220965|NCT00945321|12838782|P3|NOT COMPLETED|Period 1||0
5220966|NCT00945321|12838783|P2|NOT COMPLETED|Period 1||0
5220967|NCT00945321|12838784|P1|NOT COMPLETED|Period 1||0
5220968|NCT00945321|12838779|P6|COMPLETED|Period 1||7
5220969|NCT00945321|12838780|P5|COMPLETED|Period 1||6
5220970|NCT00945321|12838781|P4|COMPLETED|Period 1||7
5220971|NCT00945321|12838782|P3|COMPLETED|Period 1||7
5220972|NCT00945321|12838783|P2|COMPLETED|Period 1||7
5220973|NCT00945321|12838784|P1|COMPLETED|Period 1||7
5220974|NCT00945321|12838779|P6|STARTED|Period 1||7
5220975|NCT00945321|12838780|P5|STARTED|Period 1||7
5220976|NCT00945321|12838781|P4|STARTED|Period 1||7
5220977|NCT00945321|12838782|P3|STARTED|Period 1||7
5220978|NCT00945321|12838783|P2|STARTED|Period 1||7
5220979|NCT00945321|12838784|P1|STARTED|Period 1||7
5220980|NCT00945295|12838806|P2|NOT COMPLETED|Overall Study||2
5220981|NCT00945295|12838807|P1|NOT COMPLETED|Overall Study||0
5220982|NCT00945295|12838806|P2|COMPLETED|Overall Study||14
5220983|NCT00945295|12838807|P1|COMPLETED|Overall Study||15
5220984|NCT00945295|12838806|P2|STARTED|Overall Study||16
5220985|NCT00945295|12838807|P1|STARTED|Overall Study||15
5220986|NCT00945282|12838817|P2|NOT COMPLETED|Overall Study||0
5220987|NCT00945282|12838818|P1|NOT COMPLETED|Overall Study||0
5220988|NCT00945282|12838817|P2|COMPLETED|Overall Study||2
5220989|NCT00945282|12838818|P1|COMPLETED|Overall Study||6
5220990|NCT00945282|12838817|P2|STARTED|Overall Study||2
5220991|NCT00945282|12838818|P1|STARTED|Overall Study||6
5220992|NCT00945256|12838901|P5|NOT COMPLETED|Overall Study||1
5220993|NCT00945256|12838902|P4|NOT COMPLETED|Overall Study||9
5220994|NCT00945256|12838903|P3|NOT COMPLETED|Overall Study||8
5220995|NCT00945256|12838904|P2|NOT COMPLETED|Overall Study||2
5220996|NCT00945256|12838905|P1|NOT COMPLETED|Overall Study||4
5220997|NCT00945256|12838901|P5|COMPLETED|Overall Study||7
5220998|NCT00945256|12838902|P4|COMPLETED|Overall Study||7
5220999|NCT00945256|12838903|P3|COMPLETED|Overall Study||7
5221000|NCT00945256|12838904|P2|COMPLETED|Overall Study||8
5221001|NCT00945256|12838905|P1|COMPLETED|Overall Study||9
5221002|NCT00945256|12838901|P5|STARTED|Overall Study||8
5221003|NCT00945256|12838902|P4|STARTED|Overall Study||16
5221004|NCT00945256|12838903|P3|STARTED|Overall Study||15
5221005|NCT00945256|12838904|P2|STARTED|Overall Study||10
5221006|NCT00945256|12838905|P1|STARTED|Overall Study||13
5221007|NCT00945243|12838917|P1|NOT COMPLETED|Overall Study||3
5221008|NCT00945243|12838917|P1|COMPLETED|Overall Study||8
5221009|NCT00945243|12838917|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
5221010|NCT00945139|12838923|P1|NOT COMPLETED|Overall Study||0
5221011|NCT00945139|12838923|P1|COMPLETED|Overall Study||46
5221012|NCT00945139|12838923|P1|STARTED|Overall Study||46
5221013|NCT00945100|12838934|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
5221014|NCT00945100|12838935|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
5221015|NCT00945100|12838934|P2|COMPLETED|Post-10 Week Primary Outcome||56
5221016|NCT00945100|12838935|P1|COMPLETED|Post-10 Week Primary Outcome||51
5221017|NCT00945100|12838934|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
5221018|NCT00945100|12838935|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
5221019|NCT00945100|12838934|P2|NOT COMPLETED|10-week Primary Outcome||3
5221020|NCT00945100|12838935|P1|NOT COMPLETED|10-week Primary Outcome||1
5221021|NCT00945100|12838934|P2|COMPLETED|10-week Primary Outcome||83
5221022|NCT00945100|12838935|P1|COMPLETED|10-week Primary Outcome||82
5221023|NCT00945100|12838934|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
5221024|NCT00945100|12838935|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
5221025|NCT00945100|12838934|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
5221026|NCT00945100|12838935|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
5221027|NCT00945100|12838934|P2|STARTED|10-week Primary Outcome||86
5221028|NCT00945100|12838935|P1|STARTED|10-week Primary Outcome||83
5221029|NCT00945035|12838999|P2|NOT COMPLETED|Period 2||0
5221030|NCT00945035|12839000|P1|NOT COMPLETED|Period 2||0
5221031|NCT00945035|12838999|P2|COMPLETED|Period 2||18
5221032|NCT00945035|12839000|P1|COMPLETED|Period 2||18
5221033|NCT00945035|12838999|P2|STARTED|Period 2||18
5221034|NCT00945035|12839000|P1|STARTED|Period 2||18
5221035|NCT00945035|12838999|P2|NOT COMPLETED|Period 1||0
5221036|NCT00945035|12839000|P1|NOT COMPLETED|Period 1||0
5221037|NCT00945035|12838999|P2|COMPLETED|Period 1||18
5221038|NCT00945035|12839000|P1|COMPLETED|Period 1||18
5221039|NCT00945035|12838999|P2|STARTED|Period 1||18
5221040|NCT00945035|12839000|P1|STARTED|Period 1||18
5221041|NCT00945009|12839011|P3|NOT COMPLETED|Overall Study||3
5221042|NCT00945009|12839012|P2|NOT COMPLETED|Overall Study||7
5221043|NCT00945009|12839013|P1|NOT COMPLETED|Overall Study||45
5221044|NCT00945009|12839011|P3|COMPLETED|Overall Study||6
5221045|NCT00945009|12839012|P2|COMPLETED|Overall Study||32
5221046|NCT00945009|12839013|P1|COMPLETED|Overall Study||156
5221047|NCT00945009|12839011|P3|STARTED|Overall Study||9
5221048|NCT00945009|12839012|P2|STARTED|Overall Study||39
5221049|NCT00945009|12839013|P1|STARTED|Overall Study||201
5221050|NCT00944749|12839023|P1|NOT COMPLETED|Overall Study||1
5221051|NCT00944749|12839023|P1|COMPLETED|Overall Study||22
5221052|NCT00944749|12839023|P1|STARTED|Overall Study||23
5221053|NCT00944710|12839030|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
5221054|NCT00944710|12839031|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
5221055|NCT00944710|12839030|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
5221056|NCT00944710|12839031|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
5221057|NCT00944710|12839030|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
5221058|NCT00944710|12839031|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
5221059|NCT00944710|12839030|P2|STARTED|Additional Post 10-week Primary Outcome||33
5221060|NCT00944710|12839031|P1|STARTED|Additional Post 10-week Primary Outcome||40
5221061|NCT00944710|12839030|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
5221062|NCT00944710|12839031|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
5221063|NCT00944710|12839030|P2|COMPLETED|12-week Visit (Off-treatment)||33
5221064|NCT00944710|12839031|P1|COMPLETED|12-week Visit (Off-treatment)||40
5221065|NCT00944710|12839030|P2|STARTED|12-week Visit (Off-treatment)||33
5221066|NCT00944710|12839031|P1|STARTED|12-week Visit (Off-treatment)||40
5221067|NCT00944710|12839030|P2|NOT COMPLETED|10-week Primary Outcome||0
5221068|NCT00944710|12839031|P1|NOT COMPLETED|10-week Primary Outcome||0
5221069|NCT00944710|12839030|P2|COMPLETED|10-week Primary Outcome||33
5221070|NCT00944710|12839031|P1|COMPLETED|10-week Primary Outcome||40
5221071|NCT00944710|12839030|P2|STARTED|10-week Primary Outcome||33
5221072|NCT00944710|12839031|P1|STARTED|10-week Primary Outcome||40
5221073|NCT00944697|12839089|P2|NOT COMPLETED|Overall Study||5
5221074|NCT00944697|12839090|P1|NOT COMPLETED|Overall Study||2
5221075|NCT00944697|12839089|P2|COMPLETED|Overall Study||43
5221076|NCT00944697|12839090|P1|COMPLETED|Overall Study||48
5221077|NCT00944697|12839089|P2|STARTED|Overall Study||48
5221078|NCT00944697|12839090|P1|STARTED|Overall Study||50
5221079|NCT00944671|12839102|P6|NOT COMPLETED|Period III||0
5221080|NCT00944671|12839103|P5|NOT COMPLETED|Period III||0
5221081|NCT00944671|12839104|P4|NOT COMPLETED|Period III||0
5221082|NCT00944671|12839105|P3|NOT COMPLETED|Period III||0
5221083|NCT00944671|12839106|P2|NOT COMPLETED|Period III||0
5221084|NCT00944671|12839107|P1|NOT COMPLETED|Period III||0
5221085|NCT00944671|12839102|P6|COMPLETED|Period III||4
5221086|NCT00944671|12839103|P5|COMPLETED|Period III||4
5221087|NCT00944671|12839104|P4|COMPLETED|Period III||4
5221088|NCT00944671|12839105|P3|COMPLETED|Period III||4
5221089|NCT00944671|12839106|P2|COMPLETED|Period III||4
5221090|NCT00944671|12839107|P1|COMPLETED|Period III||4
5221091|NCT00944671|12839102|P6|STARTED|Period III||4
5221092|NCT00944671|12839103|P5|STARTED|Period III||4
5221093|NCT00944671|12839104|P4|STARTED|Period III||4
5221094|NCT00944671|12839105|P3|STARTED|Period III||4
5221095|NCT00944671|12839106|P2|STARTED|Period III||4
5221096|NCT00944671|12839107|P1|STARTED|Period III||4
5221097|NCT00944671|12839102|P6|NOT COMPLETED|Period II||0
5221098|NCT00944671|12839103|P5|NOT COMPLETED|Period II||0
5221099|NCT00944671|12839104|P4|NOT COMPLETED|Period II||0
5221100|NCT00944671|12839105|P3|NOT COMPLETED|Period II||0
5221101|NCT00944671|12839106|P2|NOT COMPLETED|Period II||0
5221102|NCT00944671|12839107|P1|NOT COMPLETED|Period II||0
5221103|NCT00944671|12839102|P6|COMPLETED|Period II||4
5221104|NCT00944671|12839103|P5|COMPLETED|Period II||4
5221105|NCT00944671|12839104|P4|COMPLETED|Period II||4
5221106|NCT00944671|12839105|P3|COMPLETED|Period II||4
5221107|NCT00944671|12839106|P2|COMPLETED|Period II||4
5221108|NCT00944671|12839107|P1|COMPLETED|Period II||4
5221109|NCT00944671|12839102|P6|STARTED|Period II||4
5221110|NCT00944671|12839103|P5|STARTED|Period II||4
5221111|NCT00944671|12839104|P4|STARTED|Period II||4
5221112|NCT00944671|12839105|P3|STARTED|Period II||4
5221113|NCT00944671|12839106|P2|STARTED|Period II||4
5221114|NCT00944671|12839107|P1|STARTED|Period II||4
5221115|NCT00944671|12839102|P6|NOT COMPLETED|Period I||0
5221116|NCT00944671|12839103|P5|NOT COMPLETED|Period I||0
5221117|NCT00944671|12839104|P4|NOT COMPLETED|Period I||0
5221118|NCT00944671|12839105|P3|NOT COMPLETED|Period I||0
5221119|NCT00944671|12839106|P2|NOT COMPLETED|Period I||0
5221120|NCT00944671|12839107|P1|NOT COMPLETED|Period I||0
5221121|NCT00944671|12839102|P6|COMPLETED|Period I||4
5221122|NCT00944671|12839103|P5|COMPLETED|Period I||4
5221123|NCT00944671|12839104|P4|COMPLETED|Period I||4
5221124|NCT00944671|12839105|P3|COMPLETED|Period I||4
5221125|NCT00944671|12839106|P2|COMPLETED|Period I||4
5221126|NCT00944671|12839107|P1|COMPLETED|Period I||4
5221127|NCT00944671|12839102|P6|STARTED|Period I||4
5221128|NCT00944671|12839103|P5|STARTED|Period I||4
5221129|NCT00944671|12839104|P4|STARTED|Period I||4
5221130|NCT00944671|12839105|P3|STARTED|Period I||4
5221131|NCT00944671|12839106|P2|STARTED|Period I||4
5221132|NCT00944671|12839107|P1|STARTED|Period I||4
5221133|NCT00944658|12839122|P2|NOT COMPLETED|Follow up 4 Weeks||0
5221134|NCT00944658|12839123|P1|NOT COMPLETED|Follow up 4 Weeks||0
5221135|NCT00944658|12839122|P2|COMPLETED|Follow up 4 Weeks||17
5221136|NCT00944658|12839123|P1|COMPLETED|Follow up 4 Weeks||19
5221137|NCT00944658|12839122|P2|STARTED|Follow up 4 Weeks||17
5221138|NCT00944658|12839123|P1|STARTED|Follow up 4 Weeks||19
5221139|NCT00944658|12839122|P2|NOT COMPLETED|Treatment 12 Weeks||2
5221140|NCT00944658|12839123|P1|NOT COMPLETED|Treatment 12 Weeks||0
5221141|NCT00944658|12839122|P2|COMPLETED|Treatment 12 Weeks||17
5221142|NCT00944658|12839123|P1|COMPLETED|Treatment 12 Weeks||19
5221143|NCT00944658|12839122|P2|STARTED|Treatment 12 Weeks||19
5221144|NCT00944658|12839123|P1|STARTED|Treatment 12 Weeks||19
5221145|NCT00944645|12839135|P2|NOT COMPLETED|Period 2||9
5221146|NCT00944645|12839136|P1|NOT COMPLETED|Period 2||8
5221147|NCT00944645|12839135|P2|COMPLETED|Period 2||85
5221148|NCT00944645|12839136|P1|COMPLETED|Period 2||86
5221149|NCT00944645|12839135|P2|STARTED|Period 2||94
5221150|NCT00944645|12839136|P1|STARTED|Period 2||94
5221151|NCT00944645|12839135|P2|NOT COMPLETED|Period 1||0
5221152|NCT00944645|12839136|P1|NOT COMPLETED|Period 1||0
5221153|NCT00944645|12839135|P2|COMPLETED|Period 1||94
5221154|NCT00944645|12839136|P1|COMPLETED|Period 1||94
5221155|NCT00944645|12839135|P2|STARTED|Period 1||94
5221156|NCT00944645|12839136|P1|STARTED|Period 1||94
5221157|NCT00944554|12839150|P2|NOT COMPLETED|Overall Study||29
5221158|NCT00944554|12839151|P1|NOT COMPLETED|Overall Study||28
5221159|NCT00944554|12839150|P2|COMPLETED|Overall Study||25
5221160|NCT00944554|12839151|P1|COMPLETED|Overall Study||22
5221161|NCT00944554|12839150|P2|STARTED|Overall Study||54
5221162|NCT00944554|12839151|P1|STARTED|Overall Study||50
5221163|NCT00944528|12839160|P3|NOT COMPLETED|Overall Study||0
5221164|NCT00944528|12839161|P2|NOT COMPLETED|Overall Study||2
5221165|NCT00944528|12839162|P1|NOT COMPLETED|Overall Study||1
5221166|NCT00944528|12839160|P3|COMPLETED|Overall Study||16
5221167|NCT00944528|12839161|P2|COMPLETED|Overall Study||8
5221168|NCT00944528|12839162|P1|COMPLETED|Overall Study||8
5221169|NCT00944528|12839160|P3|STARTED|Overall Study||16
5221170|NCT00944528|12839161|P2|STARTED|Overall Study||10
5221171|NCT00944528|12839162|P1|STARTED|Overall Study||9
5221172|NCT00944450|12839174|P2|NOT COMPLETED|Period 2||0
5221173|NCT00944450|12839175|P1|NOT COMPLETED|Period 2||0
5221174|NCT00944450|12839174|P2|COMPLETED|Period 2||6
5221175|NCT00944450|12839175|P1|COMPLETED|Period 2||6
5221176|NCT00944450|12839174|P2|STARTED|Period 2||6
5221177|NCT00944450|12839175|P1|STARTED|Period 2||6
5221178|NCT00944450|12839174|P2|NOT COMPLETED|Period 1||0
5221179|NCT00944450|12839175|P1|NOT COMPLETED|Period 1||0
5221180|NCT00944450|12839174|P2|COMPLETED|Period 1||6
5221181|NCT00944450|12839175|P1|COMPLETED|Period 1||6
5221182|NCT00944450|12839174|P2|STARTED|Period 1||6
5221183|NCT00944450|12839175|P1|STARTED|Period 1||6
5221184|NCT00944229|12839183|P1|NOT COMPLETED|Overall Study||25
5221185|NCT00944229|12839183|P1|COMPLETED|Overall Study||33
5221186|NCT00944229|12839183|P1|STARTED|Overall Study||58
5221187|NCT00944125|12839189|P2|NOT COMPLETED|6 Months to Study Completion||2
5221188|NCT00944125|12839190|P1|NOT COMPLETED|6 Months to Study Completion||0
5221189|NCT00944125|12839189|P2|COMPLETED|6 Months to Study Completion||18
5221190|NCT00944125|12839190|P1|COMPLETED|6 Months to Study Completion||19
5221191|NCT00944125|12839189|P2|STARTED|6 Months to Study Completion||20
5221192|NCT00944125|12839190|P1|STARTED|6 Months to Study Completion||19
5221193|NCT00944125|12839189|P2|NOT COMPLETED|3 to 6 Months||2
5221194|NCT00944125|12839190|P1|NOT COMPLETED|3 to 6 Months||0
5221195|NCT00944125|12839189|P2|COMPLETED|3 to 6 Months||20
5221196|NCT00944125|12839190|P1|COMPLETED|3 to 6 Months||19
5221197|NCT00944125|12839189|P2|STARTED|3 to 6 Months||22
5221198|NCT00944125|12839190|P1|STARTED|3 to 6 Months||19
5221199|NCT00944125|12839189|P2|NOT COMPLETED|Baseline to 3 Months||0
5221200|NCT00944125|12839190|P1|NOT COMPLETED|Baseline to 3 Months||0
5221201|NCT00944125|12839189|P2|COMPLETED|Baseline to 3 Months||22
5221202|NCT00944125|12839190|P1|COMPLETED|Baseline to 3 Months||19
5221203|NCT00944125|12839189|P2|STARTED|Baseline to 3 Months||22
5221204|NCT00944125|12839190|P1|STARTED|Baseline to 3 Months||19
5221205|NCT00944073|12839198|P2|NOT COMPLETED|Overall Study||4
5221206|NCT00944073|12839199|P1|NOT COMPLETED|Overall Study||5
5221207|NCT00944073|12839198|P2|COMPLETED|Overall Study||287
5221208|NCT00944073|12839199|P1|COMPLETED|Overall Study||287
5221209|NCT00944073|12839198|P2|STARTED|Overall Study||291
5221210|NCT00944073|12839199|P1|STARTED|Overall Study||292
5221211|NCT00944047|12839277|P1|NOT COMPLETED|Overall Study||5
5221212|NCT00944047|12839277|P1|COMPLETED|Overall Study||27
5221213|NCT00944047|12839277|P1|STARTED|Overall Study||32
5221214|NCT00944034|12839293|P12|NOT COMPLETED|Overall Study||4
5221215|NCT00944034|12839294|P11|NOT COMPLETED|Overall Study||1
5221216|NCT00944034|12839295|P10|NOT COMPLETED|Overall Study||10
5221217|NCT00944034|12839296|P9|NOT COMPLETED|Overall Study||10
5221218|NCT00944034|12839297|P8|NOT COMPLETED|Overall Study||5
5221219|NCT00944034|12839298|P7|NOT COMPLETED|Overall Study||4
5221220|NCT00944034|12839299|P6|NOT COMPLETED|Overall Study||20
5221221|NCT00944034|12839300|P5|NOT COMPLETED|Overall Study||14
5221222|NCT00944034|12839301|P4|NOT COMPLETED|Overall Study||4
5221223|NCT00944034|12839302|P3|NOT COMPLETED|Overall Study||9
5221224|NCT00944034|12839303|P2|NOT COMPLETED|Overall Study||7
5221225|NCT00944034|12839304|P1|NOT COMPLETED|Overall Study||5
5221226|NCT00944034|12839293|P12|COMPLETED|Overall Study||52
5221227|NCT00944034|12839294|P11|COMPLETED|Overall Study||50
5221228|NCT00944034|12839295|P10|COMPLETED|Overall Study||236
5221229|NCT00944034|12839296|P9|COMPLETED|Overall Study||63
5221230|NCT00944034|12839297|P8|COMPLETED|Overall Study||73
5221231|NCT00944034|12839298|P7|COMPLETED|Overall Study||102
5221232|NCT00944034|12839299|P6|COMPLETED|Overall Study||123
5221233|NCT00944034|12839300|P5|COMPLETED|Overall Study||150
5221234|NCT00944034|12839301|P4|COMPLETED|Overall Study||170
5221235|NCT00944034|12839302|P3|COMPLETED|Overall Study||143
5221236|NCT00944034|12839303|P2|COMPLETED|Overall Study||150
5221237|NCT00944034|12839304|P1|COMPLETED|Overall Study||183
5221238|NCT00944034|12839293|P12|STARTED|Overall Study||56
5221239|NCT00944034|12839294|P11|STARTED|Overall Study||51
5221240|NCT00944034|12839295|P10|STARTED|Overall Study||246
5221241|NCT00944034|12839296|P9|STARTED|Overall Study||73
5221242|NCT00944034|12839297|P8|STARTED|Overall Study||78
5221243|NCT00944034|12839298|P7|STARTED|Overall Study||106
5221244|NCT00944034|12839299|P6|STARTED|Overall Study||143
5221245|NCT00944034|12839300|P5|STARTED|Overall Study||164
5221246|NCT00944034|12839301|P4|STARTED|Overall Study||174
5221247|NCT00944034|12839302|P3|STARTED|Overall Study||152
5221248|NCT00944034|12839303|P2|STARTED|Overall Study||157
5221249|NCT00944034|12839304|P1|STARTED|Overall Study||188
5221250|NCT00944021|12839374|P5|NOT COMPLETED|Overall Study||0
5221251|NCT00944021|12839375|P4|NOT COMPLETED|Overall Study||0
5221252|NCT00944021|12839376|P3|NOT COMPLETED|Overall Study||0
5221253|NCT00944021|12839377|P2|NOT COMPLETED|Overall Study||0
5221254|NCT00944021|12839378|P1|NOT COMPLETED|Overall Study||1
5221255|NCT00944021|12839374|P5|COMPLETED|Overall Study||8
5221256|NCT00944021|12839375|P4|COMPLETED|Overall Study||16
5221257|NCT00944021|12839376|P3|COMPLETED|Overall Study||15
5221258|NCT00944021|12839377|P2|COMPLETED|Overall Study||15
5221259|NCT00944021|12839378|P1|COMPLETED|Overall Study||14
5221260|NCT00944021|12839374|P5|STARTED|Overall Study||8
5221261|NCT00944021|12839375|P4|STARTED|Overall Study||16
5221262|NCT00944021|12839376|P3|STARTED|Overall Study||15
5221263|NCT00944021|12839377|P2|STARTED|Overall Study||15
5221264|NCT00944021|12839378|P1|STARTED|Overall Study||15
5221265|NCT00943917|12839450|P15|NOT COMPLETED|Stage II Continuation||4
5221266|NCT00943917|12839451|P14|NOT COMPLETED|Stage II Continuation||3
5221267|NCT00943917|12839452|P13|NOT COMPLETED|Stage II Continuation||3
5221268|NCT00943917|12839453|P12|NOT COMPLETED|Stage II Continuation||2
5221269|NCT00943917|12839454|P11|NOT COMPLETED|Stage II Continuation||0
5221270|NCT00943917|12839455|P10|NOT COMPLETED|Stage II Continuation||1
5221271|NCT00943917|12839456|P9|NOT COMPLETED|Stage II Continuation||0
5221272|NCT00943917|12839457|P8|NOT COMPLETED|Stage II Continuation||0
5221273|NCT00943917|12839458|P7|NOT COMPLETED|Stage II Continuation||0
5221274|NCT00943917|12839459|P6|NOT COMPLETED|Stage II Continuation||0
5221275|NCT00943917|12839460|P5|NOT COMPLETED|Stage II Continuation||0
5221276|NCT00943917|12839461|P4|NOT COMPLETED|Stage II Continuation||0
5221277|NCT00943917|12839462|P3|NOT COMPLETED|Stage II Continuation||0
5221278|NCT00943917|12839463|P2|NOT COMPLETED|Stage II Continuation||0
5221279|NCT00943917|12839464|P1|NOT COMPLETED|Stage II Continuation||0
5221280|NCT00943917|12839450|P15|COMPLETED|Stage II Continuation||8
5221281|NCT00943917|12839451|P14|COMPLETED|Stage II Continuation||12
5221282|NCT00943917|12839452|P13|COMPLETED|Stage II Continuation||13
5221283|NCT00943917|12839453|P12|COMPLETED|Stage II Continuation||11
5221284|NCT00943917|12839454|P11|COMPLETED|Stage II Continuation||15
5221285|NCT00943917|12839455|P10|COMPLETED|Stage II Continuation||14
5221286|NCT00943917|12839456|P9|COMPLETED|Stage II Continuation||0
5221287|NCT00943917|12839457|P8|COMPLETED|Stage II Continuation||0
5221288|NCT00943917|12839458|P7|COMPLETED|Stage II Continuation||0
5221289|NCT00943917|12839459|P6|COMPLETED|Stage II Continuation||0
5221290|NCT00943917|12839460|P5|COMPLETED|Stage II Continuation||0
5221291|NCT00943917|12839461|P4|COMPLETED|Stage II Continuation||0
5221292|NCT00943917|12839462|P3|COMPLETED|Stage II Continuation||0
5221293|NCT00943917|12839463|P2|COMPLETED|Stage II Continuation||0
5221294|NCT00943917|12839464|P1|COMPLETED|Stage II Continuation||0
5221295|NCT00943917|12839450|P15|STARTED|Stage II Continuation||12
5221296|NCT00943917|12839451|P14|STARTED|Stage II Continuation||15
5221297|NCT00943917|12839452|P13|STARTED|Stage II Continuation||16
5221298|NCT00943917|12839453|P12|STARTED|Stage II Continuation||13
5221299|NCT00943917|12839454|P11|STARTED|Stage II Continuation||15
5221300|NCT00943917|12839455|P10|STARTED|Stage II Continuation||15
5221301|NCT00943917|12839456|P9|STARTED|Stage II Continuation||0
5221302|NCT00943917|12839457|P8|STARTED|Stage II Continuation||0
5221303|NCT00943917|12839458|P7|STARTED|Stage II Continuation||0
5221304|NCT00943917|12839459|P6|STARTED|Stage II Continuation||0
5221305|NCT00943917|12839460|P5|STARTED|Stage II Continuation||0
5221306|NCT00943917|12839461|P4|STARTED|Stage II Continuation||0
5221307|NCT00943917|12839462|P3|STARTED|Stage II Continuation||0
5221308|NCT00943917|12839463|P2|STARTED|Stage II Continuation||0
5221309|NCT00943917|12839464|P1|STARTED|Stage II Continuation||0
5221310|NCT00943917|12839450|P15|NOT COMPLETED|Stage II||0
5221311|NCT00943917|12839451|P14|NOT COMPLETED|Stage II||0
5221312|NCT00943917|12839452|P13|NOT COMPLETED|Stage II||0
5221313|NCT00943917|12839453|P12|NOT COMPLETED|Stage II||0
5221314|NCT00943917|12839454|P11|NOT COMPLETED|Stage II||0
5221315|NCT00943917|12839455|P10|NOT COMPLETED|Stage II||0
5221316|NCT00943917|12839456|P9|NOT COMPLETED|Stage II||1
5221317|NCT00943917|12839457|P8|NOT COMPLETED|Stage II||0
5221318|NCT00943917|12839458|P7|NOT COMPLETED|Stage II||3
5221319|NCT00943917|12839459|P6|NOT COMPLETED|Stage II||3
5221320|NCT00943917|12839460|P5|NOT COMPLETED|Stage II||0
5221321|NCT00943917|12839461|P4|NOT COMPLETED|Stage II||0
5221322|NCT00943917|12839462|P3|NOT COMPLETED|Stage II||0
5221323|NCT00943917|12839463|P2|NOT COMPLETED|Stage II||0
5221324|NCT00943917|12839464|P1|NOT COMPLETED|Stage II||0
5221325|NCT00943917|12839450|P15|COMPLETED|Stage II||0
5221326|NCT00943917|12839451|P14|COMPLETED|Stage II||0
5221327|NCT00943917|12839452|P13|COMPLETED|Stage II||0
5221328|NCT00943917|12839453|P12|COMPLETED|Stage II||0
5221329|NCT00943917|12839454|P11|COMPLETED|Stage II||0
5221330|NCT00943917|12839455|P10|COMPLETED|Stage II||0
5221331|NCT00943917|12839456|P9|COMPLETED|Stage II||20
5221332|NCT00943917|12839457|P8|COMPLETED|Stage II||23
5221333|NCT00943917|12839458|P7|COMPLETED|Stage II||20
5221334|NCT00943917|12839459|P6|COMPLETED|Stage II||20
5221335|NCT00943917|12839460|P5|COMPLETED|Stage II||21
5221336|NCT00943917|12839461|P4|COMPLETED|Stage II||20
5221337|NCT00943917|12839462|P3|COMPLETED|Stage II||0
5221338|NCT00943917|12839463|P2|COMPLETED|Stage II||0
5221339|NCT00943917|12839464|P1|COMPLETED|Stage II||0
5221340|NCT00943917|12839450|P15|STARTED|Stage II||0
5221341|NCT00943917|12839451|P14|STARTED|Stage II||0
5221342|NCT00943917|12839452|P13|STARTED|Stage II||0
5221343|NCT00943917|12839453|P12|STARTED|Stage II||0
5221344|NCT00943917|12839454|P11|STARTED|Stage II||0
5221345|NCT00943917|12839455|P10|STARTED|Stage II||0
5221346|NCT00943917|12839456|P9|STARTED|Stage II||21
5221347|NCT00943917|12839457|P8|STARTED|Stage II||23
5221348|NCT00943917|12839458|P7|STARTED|Stage II||23
5221349|NCT00943917|12839459|P6|STARTED|Stage II||23
5221350|NCT00943917|12839460|P5|STARTED|Stage II||21
5221351|NCT00943917|12839461|P4|STARTED|Stage II||20
5221352|NCT00943917|12839462|P3|STARTED|Stage II||0
5221353|NCT00943917|12839463|P2|STARTED|Stage II||0
5221354|NCT00943917|12839464|P1|STARTED|Stage II||0
5221355|NCT00943917|12839450|P15|NOT COMPLETED|Stage I||0
5221356|NCT00943917|12839451|P14|NOT COMPLETED|Stage I||0
5221357|NCT00943917|12839452|P13|NOT COMPLETED|Stage I||0
5221358|NCT00943917|12839453|P12|NOT COMPLETED|Stage I||0
5221359|NCT00943917|12839454|P11|NOT COMPLETED|Stage I||0
5221360|NCT00943917|12839455|P10|NOT COMPLETED|Stage I||0
5221361|NCT00943917|12839456|P9|NOT COMPLETED|Stage I||0
5221362|NCT00943917|12839457|P8|NOT COMPLETED|Stage I||0
5221363|NCT00943917|12839458|P7|NOT COMPLETED|Stage I||0
5221364|NCT00943917|12839459|P6|NOT COMPLETED|Stage I||0
5221365|NCT00943917|12839460|P5|NOT COMPLETED|Stage I||0
5221366|NCT00943917|12839461|P4|NOT COMPLETED|Stage I||0
5221367|NCT00943917|12839462|P3|NOT COMPLETED|Stage I||6
5221368|NCT00943917|12839463|P2|NOT COMPLETED|Stage I||3
5221369|NCT00943917|12839464|P1|NOT COMPLETED|Stage I||4
5221370|NCT00943917|12839450|P15|COMPLETED|Stage I||0
5221371|NCT00943917|12839451|P14|COMPLETED|Stage I||0
5221372|NCT00943917|12839452|P13|COMPLETED|Stage I||0
5221373|NCT00943917|12839453|P12|COMPLETED|Stage I||0
5221374|NCT00943917|12839454|P11|COMPLETED|Stage I||0
5221375|NCT00943917|12839455|P10|COMPLETED|Stage I||0
5221376|NCT00943917|12839456|P9|COMPLETED|Stage I||0
5221377|NCT00943917|12839457|P8|COMPLETED|Stage I||0
5221378|NCT00943917|12839458|P7|COMPLETED|Stage I||0
5221379|NCT00943917|12839459|P6|COMPLETED|Stage I||0
5221380|NCT00943917|12839460|P5|COMPLETED|Stage I||0
5221381|NCT00943917|12839461|P4|COMPLETED|Stage I||0
5221382|NCT00943917|12839462|P3|COMPLETED|Stage I||47
5221383|NCT00943917|12839463|P2|COMPLETED|Stage I||48
5221384|NCT00943917|12839464|P1|COMPLETED|Stage I||47
5221385|NCT00943917|12839450|P15|STARTED|Stage I||0
5221386|NCT00943917|12839451|P14|STARTED|Stage I||0
5221387|NCT00943917|12839452|P13|STARTED|Stage I||0
5221388|NCT00943917|12839453|P12|STARTED|Stage I||0
5221389|NCT00943917|12839454|P11|STARTED|Stage I||0
5221390|NCT00943917|12839455|P10|STARTED|Stage I||0
5221391|NCT00943917|12839456|P9|STARTED|Stage I||0
5221392|NCT00943917|12839457|P8|STARTED|Stage I||0
5221393|NCT00943917|12839458|P7|STARTED|Stage I||0
5221394|NCT00943917|12839459|P6|STARTED|Stage I||0
5221395|NCT00943917|12839460|P5|STARTED|Stage I||0
5221396|NCT00943917|12839461|P4|STARTED|Stage I||0
5221397|NCT00943917|12839462|P3|STARTED|Stage I||53
5221398|NCT00943917|12839463|P2|STARTED|Stage I||51
5221399|NCT00943917|12839464|P1|STARTED|Stage I||51
5221400|NCT00943878|12839515|P4|NOT COMPLETED|Overall Study||2
5221401|NCT00943878|12839516|P3|NOT COMPLETED|Overall Study||6
5221402|NCT00943878|12839517|P2|NOT COMPLETED|Overall Study||2
5221403|NCT00943878|12839518|P1|NOT COMPLETED|Overall Study||2
5221404|NCT00943878|12839515|P4|COMPLETED|Overall Study||198
5221405|NCT00943878|12839516|P3|COMPLETED|Overall Study||197
5221406|NCT00943878|12839517|P2|COMPLETED|Overall Study||198
5221407|NCT00943878|12839518|P1|COMPLETED|Overall Study||200
5221408|NCT00943878|12839515|P4|STARTED|Overall Study||200
5221409|NCT00943878|12839516|P3|STARTED|Overall Study||203
5221410|NCT00943878|12839517|P2|STARTED|Overall Study||200
5221411|NCT00943878|12839518|P1|STARTED|Overall Study||202
5221412|NCT00943852|12839640|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221413|NCT00943852|12839641|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221414|NCT00943852|12839642|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221415|NCT00943852|12839643|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221416|NCT00943852|12839644|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221417|NCT00943852|12839645|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221418|NCT00943852|12839646|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221419|NCT00943852|12839647|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221420|NCT00943852|12839648|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221421|NCT00943852|12839649|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
5221422|NCT00943852|12839640|P10|COMPLETED|Fifth Period of Treatment Intervention||1
5221423|NCT00943852|12839641|P9|COMPLETED|Fifth Period of Treatment Intervention||1
5221424|NCT00943852|12839642|P8|COMPLETED|Fifth Period of Treatment Intervention||0
5221425|NCT00943852|12839643|P7|COMPLETED|Fifth Period of Treatment Intervention||0
5221426|NCT00943852|12839644|P6|COMPLETED|Fifth Period of Treatment Intervention||0
5221427|NCT00943852|12839645|P5|COMPLETED|Fifth Period of Treatment Intervention||1
5221428|NCT00943852|12839646|P4|COMPLETED|Fifth Period of Treatment Intervention||0
5221429|NCT00943852|12839647|P3|COMPLETED|Fifth Period of Treatment Intervention||0
5221430|NCT00943852|12839648|P2|COMPLETED|Fifth Period of Treatment Intervention||1
5221431|NCT00943852|12839649|P1|COMPLETED|Fifth Period of Treatment Intervention||1
5221432|NCT00943852|12839640|P10|STARTED|Fifth Period of Treatment Intervention||1
5221433|NCT00943852|12839641|P9|STARTED|Fifth Period of Treatment Intervention||1
5221434|NCT00943852|12839642|P8|STARTED|Fifth Period of Treatment Intervention||0
5221435|NCT00943852|12839643|P7|STARTED|Fifth Period of Treatment Intervention||0
5221436|NCT00943852|12839644|P6|STARTED|Fifth Period of Treatment Intervention||0
5221437|NCT00943852|12839645|P5|STARTED|Fifth Period of Treatment Intervention||1
5221438|NCT00943852|12839646|P4|STARTED|Fifth Period of Treatment Intervention||0
5221439|NCT00943852|12839647|P3|STARTED|Fifth Period of Treatment Intervention||0
5221440|NCT00943852|12839648|P2|STARTED|Fifth Period of Treatment Intervention||1
5221441|NCT00943852|12839649|P1|STARTED|Fifth Period of Treatment Intervention||1
5221442|NCT00943852|12839640|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
5221443|NCT00943852|12839641|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
5221444|NCT00943852|12839642|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
5221445|NCT00943852|12839643|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
5221446|NCT00943852|12839644|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
5221447|NCT00943852|12839645|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
5221448|NCT00943852|12839646|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
5221449|NCT00943852|12839647|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
5221450|NCT00943852|12839648|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
5221451|NCT00943852|12839649|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
5221452|NCT00943852|12839640|P10|COMPLETED|Washout Period After Period 4 Treatment||1
5221453|NCT00943852|12839641|P9|COMPLETED|Washout Period After Period 4 Treatment||1
5221454|NCT00943852|12839642|P8|COMPLETED|Washout Period After Period 4 Treatment||0
5221455|NCT00943852|12839643|P7|COMPLETED|Washout Period After Period 4 Treatment||0
5221456|NCT00943852|12839644|P6|COMPLETED|Washout Period After Period 4 Treatment||0
5221457|NCT00943852|12839645|P5|COMPLETED|Washout Period After Period 4 Treatment||1
5221458|NCT00943852|12839646|P4|COMPLETED|Washout Period After Period 4 Treatment||0
5221459|NCT00943852|12839647|P3|COMPLETED|Washout Period After Period 4 Treatment||0
5221460|NCT00943852|12839648|P2|COMPLETED|Washout Period After Period 4 Treatment||1
5221461|NCT00943852|12839649|P1|COMPLETED|Washout Period After Period 4 Treatment||1
5221462|NCT00943852|12839640|P10|STARTED|Washout Period After Period 4 Treatment||1
5221463|NCT00943852|12839641|P9|STARTED|Washout Period After Period 4 Treatment||1
5221464|NCT00943852|12839642|P8|STARTED|Washout Period After Period 4 Treatment||1
5221465|NCT00943852|12839643|P7|STARTED|Washout Period After Period 4 Treatment||1
5221466|NCT00943852|12839644|P6|STARTED|Washout Period After Period 4 Treatment||0
5221467|NCT00943852|12839645|P5|STARTED|Washout Period After Period 4 Treatment||1
5221468|NCT00943852|12839646|P4|STARTED|Washout Period After Period 4 Treatment||1
5221469|NCT00943852|12839647|P3|STARTED|Washout Period After Period 4 Treatment||1
5221470|NCT00943852|12839648|P2|STARTED|Washout Period After Period 4 Treatment||1
5221471|NCT00943852|12839649|P1|STARTED|Washout Period After Period 4 Treatment||2
5221472|NCT00943852|12839640|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221473|NCT00943852|12839641|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221474|NCT00943852|12839642|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221475|NCT00943852|12839643|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221476|NCT00943852|12839644|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221477|NCT00943852|12839645|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221478|NCT00943852|12839646|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221479|NCT00943852|12839647|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221480|NCT00943852|12839648|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221481|NCT00943852|12839649|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
5221482|NCT00943852|12839640|P10|COMPLETED|Fourth Period of Treatment Intervention||1
5221483|NCT00943852|12839641|P9|COMPLETED|Fourth Period of Treatment Intervention||1
5221484|NCT00943852|12839642|P8|COMPLETED|Fourth Period of Treatment Intervention||1
5221485|NCT00943852|12839643|P7|COMPLETED|Fourth Period of Treatment Intervention||1
5221486|NCT00943852|12839644|P6|COMPLETED|Fourth Period of Treatment Intervention||0
5221487|NCT00943852|12839645|P5|COMPLETED|Fourth Period of Treatment Intervention||1
5221488|NCT00943852|12839646|P4|COMPLETED|Fourth Period of Treatment Intervention||1
5221489|NCT00943852|12839647|P3|COMPLETED|Fourth Period of Treatment Intervention||1
5221490|NCT00943852|12839648|P2|COMPLETED|Fourth Period of Treatment Intervention||1
5221491|NCT00943852|12839649|P1|COMPLETED|Fourth Period of Treatment Intervention||2
5221492|NCT00943852|12839640|P10|STARTED|Fourth Period of Treatment Intervention||1
5221493|NCT00943852|12839641|P9|STARTED|Fourth Period of Treatment Intervention||1
5221494|NCT00943852|12839642|P8|STARTED|Fourth Period of Treatment Intervention||1
5221495|NCT00943852|12839643|P7|STARTED|Fourth Period of Treatment Intervention||1
5221496|NCT00943852|12839644|P6|STARTED|Fourth Period of Treatment Intervention||0
5221497|NCT00943852|12839645|P5|STARTED|Fourth Period of Treatment Intervention||1
5221498|NCT00943852|12839646|P4|STARTED|Fourth Period of Treatment Intervention||1
5221499|NCT00943852|12839647|P3|STARTED|Fourth Period of Treatment Intervention||1
5221500|NCT00943852|12839648|P2|STARTED|Fourth Period of Treatment Intervention||1
5221501|NCT00943852|12839649|P1|STARTED|Fourth Period of Treatment Intervention||2
5221502|NCT00943852|12839640|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221503|NCT00943852|12839641|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221504|NCT00943852|12839642|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221505|NCT00943852|12839643|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
5221506|NCT00943852|12839644|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221507|NCT00943852|12839645|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221508|NCT00943852|12839646|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221509|NCT00943852|12839647|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221510|NCT00943852|12839648|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221511|NCT00943852|12839649|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
5221512|NCT00943852|12839640|P10|COMPLETED|Washout Period After Period 3 Treatment||1
5221513|NCT00943852|12839641|P9|COMPLETED|Washout Period After Period 3 Treatment||1
5221514|NCT00943852|12839642|P8|COMPLETED|Washout Period After Period 3 Treatment||1
5221515|NCT00943852|12839643|P7|COMPLETED|Washout Period After Period 3 Treatment||1
5221516|NCT00943852|12839644|P6|COMPLETED|Washout Period After Period 3 Treatment||0
5221517|NCT00943852|12839645|P5|COMPLETED|Washout Period After Period 3 Treatment||1
5221518|NCT00943852|12839646|P4|COMPLETED|Washout Period After Period 3 Treatment||1
5221519|NCT00943852|12839647|P3|COMPLETED|Washout Period After Period 3 Treatment||1
5221520|NCT00943852|12839648|P2|COMPLETED|Washout Period After Period 3 Treatment||1
5221521|NCT00943852|12839649|P1|COMPLETED|Washout Period After Period 3 Treatment||2
5221522|NCT00943852|12839640|P10|STARTED|Washout Period After Period 3 Treatment||1
5221523|NCT00943852|12839641|P9|STARTED|Washout Period After Period 3 Treatment||1
5221524|NCT00943852|12839642|P8|STARTED|Washout Period After Period 3 Treatment||1
5221525|NCT00943852|12839643|P7|STARTED|Washout Period After Period 3 Treatment||2
5221526|NCT00943852|12839644|P6|STARTED|Washout Period After Period 3 Treatment||0
5221527|NCT00943852|12839645|P5|STARTED|Washout Period After Period 3 Treatment||1
5221528|NCT00943852|12839646|P4|STARTED|Washout Period After Period 3 Treatment||1
5221529|NCT00943852|12839647|P3|STARTED|Washout Period After Period 3 Treatment||1
5221530|NCT00943852|12839648|P2|STARTED|Washout Period After Period 3 Treatment||1
5221531|NCT00943852|12839649|P1|STARTED|Washout Period After Period 3 Treatment||2
5221532|NCT00943852|12839640|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
5221533|NCT00943852|12839641|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
5221534|NCT00943852|12839642|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
5221535|NCT00943852|12839643|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
5221536|NCT00943852|12839644|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
5221537|NCT00943852|12839645|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
5221538|NCT00943852|12839646|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
5221539|NCT00943852|12839647|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
5221540|NCT00943852|12839648|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
5221541|NCT00943852|12839649|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
5221542|NCT00943852|12839640|P10|COMPLETED|Third Period of Treatment Intervention||1
5221543|NCT00943852|12839641|P9|COMPLETED|Third Period of Treatment Intervention||1
5221544|NCT00943852|12839642|P8|COMPLETED|Third Period of Treatment Intervention||1
5221545|NCT00943852|12839643|P7|COMPLETED|Third Period of Treatment Intervention||2
5221546|NCT00943852|12839644|P6|COMPLETED|Third Period of Treatment Intervention||0
5221547|NCT00943852|12839645|P5|COMPLETED|Third Period of Treatment Intervention||1
5221548|NCT00943852|12839646|P4|COMPLETED|Third Period of Treatment Intervention||1
5221549|NCT00943852|12839647|P3|COMPLETED|Third Period of Treatment Intervention||1
5221550|NCT00943852|12839648|P2|COMPLETED|Third Period of Treatment Intervention||1
5221551|NCT00943852|12839649|P1|COMPLETED|Third Period of Treatment Intervention||2
5221552|NCT00943852|12839640|P10|STARTED|Third Period of Treatment Intervention||1
5221553|NCT00943852|12839641|P9|STARTED|Third Period of Treatment Intervention||1
5221554|NCT00943852|12839642|P8|STARTED|Third Period of Treatment Intervention||1
5221555|NCT00943852|12839643|P7|STARTED|Third Period of Treatment Intervention||2
5221556|NCT00943852|12839644|P6|STARTED|Third Period of Treatment Intervention||0
5221557|NCT00943852|12839645|P5|STARTED|Third Period of Treatment Intervention||1
5221558|NCT00943852|12839646|P4|STARTED|Third Period of Treatment Intervention||1
5221559|NCT00943852|12839647|P3|STARTED|Third Period of Treatment Intervention||1
5221560|NCT00943852|12839648|P2|STARTED|Third Period of Treatment Intervention||1
5221561|NCT00943852|12839649|P1|STARTED|Third Period of Treatment Intervention||2
5221562|NCT00943852|12839640|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221563|NCT00943852|12839641|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221564|NCT00943852|12839642|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221565|NCT00943852|12839643|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221566|NCT00943852|12839644|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
5221567|NCT00943852|12839645|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221568|NCT00943852|12839646|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221569|NCT00943852|12839647|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221570|NCT00943852|12839648|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221571|NCT00943852|12839649|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
5221572|NCT00943852|12839640|P10|COMPLETED|Washout Period After Period 2 Treatment||1
5221573|NCT00943852|12839641|P9|COMPLETED|Washout Period After Period 2 Treatment||1
5221574|NCT00943852|12839642|P8|COMPLETED|Washout Period After Period 2 Treatment||1
5221575|NCT00943852|12839643|P7|COMPLETED|Washout Period After Period 2 Treatment||2
5221576|NCT00943852|12839644|P6|COMPLETED|Washout Period After Period 2 Treatment||0
5221577|NCT00943852|12839645|P5|COMPLETED|Washout Period After Period 2 Treatment||1
5221578|NCT00943852|12839646|P4|COMPLETED|Washout Period After Period 2 Treatment||1
5221579|NCT00943852|12839647|P3|COMPLETED|Washout Period After Period 2 Treatment||1
5221580|NCT00943852|12839648|P2|COMPLETED|Washout Period After Period 2 Treatment||1
5221581|NCT00943852|12839649|P1|COMPLETED|Washout Period After Period 2 Treatment||2
5221582|NCT00943852|12839640|P10|STARTED|Washout Period After Period 2 Treatment||1
5221583|NCT00943852|12839641|P9|STARTED|Washout Period After Period 2 Treatment||1
5221584|NCT00943852|12839642|P8|STARTED|Washout Period After Period 2 Treatment||1
5221585|NCT00943852|12839643|P7|STARTED|Washout Period After Period 2 Treatment||2
5221586|NCT00943852|12839644|P6|STARTED|Washout Period After Period 2 Treatment||1
5221587|NCT00943852|12839645|P5|STARTED|Washout Period After Period 2 Treatment||1
5221588|NCT00943852|12839646|P4|STARTED|Washout Period After Period 2 Treatment||1
5221589|NCT00943852|12839647|P3|STARTED|Washout Period After Period 2 Treatment||1
5221590|NCT00943852|12839648|P2|STARTED|Washout Period After Period 2 Treatment||1
5221591|NCT00943852|12839649|P1|STARTED|Washout Period After Period 2 Treatment||2
5221592|NCT00943852|12839640|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
5221593|NCT00943852|12839641|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
5221594|NCT00943852|12839642|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
5221595|NCT00943852|12839643|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
5221596|NCT00943852|12839644|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
5221597|NCT00943852|12839645|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
5221598|NCT00943852|12839646|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
5221599|NCT00943852|12839647|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
5221600|NCT00943852|12839648|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
5221601|NCT00943852|12839649|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
5221602|NCT00943852|12839640|P10|COMPLETED|Second Period of Treatment Intervention||1
5221603|NCT00943852|12839641|P9|COMPLETED|Second Period of Treatment Intervention||1
5221604|NCT00943852|12839642|P8|COMPLETED|Second Period of Treatment Intervention||1
5221605|NCT00943852|12839643|P7|COMPLETED|Second Period of Treatment Intervention||2
5221606|NCT00943852|12839644|P6|COMPLETED|Second Period of Treatment Intervention||1
5221607|NCT00943852|12839645|P5|COMPLETED|Second Period of Treatment Intervention||1
5221608|NCT00943852|12839646|P4|COMPLETED|Second Period of Treatment Intervention||1
5221609|NCT00943852|12839647|P3|COMPLETED|Second Period of Treatment Intervention||1
5221610|NCT00943852|12839648|P2|COMPLETED|Second Period of Treatment Intervention||1
5221611|NCT00943852|12839649|P1|COMPLETED|Second Period of Treatment Intervention||2
5221612|NCT00943852|12839640|P10|STARTED|Second Period of Treatment Intervention||1
5221613|NCT00943852|12839641|P9|STARTED|Second Period of Treatment Intervention||1
5221614|NCT00943852|12839642|P8|STARTED|Second Period of Treatment Intervention||1
5221615|NCT00943852|12839643|P7|STARTED|Second Period of Treatment Intervention||2
5221616|NCT00943852|12839644|P6|STARTED|Second Period of Treatment Intervention||1
5221617|NCT00943852|12839645|P5|STARTED|Second Period of Treatment Intervention||1
5221618|NCT00943852|12839646|P4|STARTED|Second Period of Treatment Intervention||1
5221619|NCT00943852|12839647|P3|STARTED|Second Period of Treatment Intervention||1
5221620|NCT00943852|12839648|P2|STARTED|Second Period of Treatment Intervention||1
5221621|NCT00943852|12839649|P1|STARTED|Second Period of Treatment Intervention||2
5221622|NCT00943852|12839640|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221623|NCT00943852|12839641|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221624|NCT00943852|12839642|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221625|NCT00943852|12839643|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221626|NCT00943852|12839644|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221627|NCT00943852|12839645|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221628|NCT00943852|12839646|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
5221629|NCT00943852|12839647|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221630|NCT00943852|12839648|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221631|NCT00943852|12839649|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
5221632|NCT00943852|12839640|P10|COMPLETED|Washout Period After Period 1 Treatment||1
5221633|NCT00943852|12839641|P9|COMPLETED|Washout Period After Period 1 Treatment||1
5221634|NCT00943852|12839642|P8|COMPLETED|Washout Period After Period 1 Treatment||1
5221635|NCT00943852|12839643|P7|COMPLETED|Washout Period After Period 1 Treatment||2
5221636|NCT00943852|12839644|P6|COMPLETED|Washout Period After Period 1 Treatment||1
5221637|NCT00943852|12839645|P5|COMPLETED|Washout Period After Period 1 Treatment||1
5221638|NCT00943852|12839646|P4|COMPLETED|Washout Period After Period 1 Treatment||1
5221639|NCT00943852|12839647|P3|COMPLETED|Washout Period After Period 1 Treatment||1
5221640|NCT00943852|12839648|P2|COMPLETED|Washout Period After Period 1 Treatment||1
5221641|NCT00943852|12839649|P1|COMPLETED|Washout Period After Period 1 Treatment||2
5221642|NCT00943852|12839640|P10|STARTED|Washout Period After Period 1 Treatment||1
5221643|NCT00943852|12839641|P9|STARTED|Washout Period After Period 1 Treatment||1
5221644|NCT00943852|12839642|P8|STARTED|Washout Period After Period 1 Treatment||1
5221645|NCT00943852|12839643|P7|STARTED|Washout Period After Period 1 Treatment||2
5221646|NCT00943852|12839644|P6|STARTED|Washout Period After Period 1 Treatment||1
5221647|NCT00943852|12839645|P5|STARTED|Washout Period After Period 1 Treatment||1
5221648|NCT00943852|12839646|P4|STARTED|Washout Period After Period 1 Treatment||2
5221649|NCT00943852|12839647|P3|STARTED|Washout Period After Period 1 Treatment||1
5221650|NCT00943852|12839648|P2|STARTED|Washout Period After Period 1 Treatment||1
5221651|NCT00943852|12839649|P1|STARTED|Washout Period After Period 1 Treatment||2
5221652|NCT00943852|12839640|P10|NOT COMPLETED|First Period of Treatment Intervention||0
5221653|NCT00943852|12839641|P9|NOT COMPLETED|First Period of Treatment Intervention||0
5221654|NCT00943852|12839642|P8|NOT COMPLETED|First Period of Treatment Intervention||0
5221655|NCT00943852|12839643|P7|NOT COMPLETED|First Period of Treatment Intervention||0
5221656|NCT00943852|12839644|P6|NOT COMPLETED|First Period of Treatment Intervention||0
5221657|NCT00943852|12839645|P5|NOT COMPLETED|First Period of Treatment Intervention||0
5221658|NCT00943852|12839646|P4|NOT COMPLETED|First Period of Treatment Intervention||0
5221659|NCT00943852|12839647|P3|NOT COMPLETED|First Period of Treatment Intervention||0
5221660|NCT00943852|12839648|P2|NOT COMPLETED|First Period of Treatment Intervention||0
5221661|NCT00943852|12839649|P1|NOT COMPLETED|First Period of Treatment Intervention||0
5221662|NCT00943852|12839640|P10|COMPLETED|First Period of Treatment Intervention||1
5221663|NCT00943852|12839641|P9|COMPLETED|First Period of Treatment Intervention||1
5221664|NCT00943852|12839642|P8|COMPLETED|First Period of Treatment Intervention||1
5221665|NCT00943852|12839643|P7|COMPLETED|First Period of Treatment Intervention||2
5221666|NCT00943852|12839644|P6|COMPLETED|First Period of Treatment Intervention||1
5221667|NCT00943852|12839645|P5|COMPLETED|First Period of Treatment Intervention||1
5221668|NCT00943852|12839646|P4|COMPLETED|First Period of Treatment Intervention||2
5221669|NCT00943852|12839647|P3|COMPLETED|First Period of Treatment Intervention||1
5221670|NCT00943852|12839648|P2|COMPLETED|First Period of Treatment Intervention||1
5221671|NCT00943852|12839649|P1|COMPLETED|First Period of Treatment Intervention||2
5221672|NCT00943852|12839640|P10|STARTED|First Period of Treatment Intervention||1
5221673|NCT00943852|12839641|P9|STARTED|First Period of Treatment Intervention||1
5221674|NCT00943852|12839642|P8|STARTED|First Period of Treatment Intervention||1
5221675|NCT00943852|12839643|P7|STARTED|First Period of Treatment Intervention||2
5221676|NCT00943852|12839644|P6|STARTED|First Period of Treatment Intervention||1
5221677|NCT00943852|12839645|P5|STARTED|First Period of Treatment Intervention||1
5221678|NCT00943852|12839646|P4|STARTED|First Period of Treatment Intervention||2
5221679|NCT00943852|12839647|P3|STARTED|First Period of Treatment Intervention||1
5221680|NCT00943852|12839648|P2|STARTED|First Period of Treatment Intervention||1
5221681|NCT00943852|12839649|P1|STARTED|First Period of Treatment Intervention||2
5221682|NCT00943826|12839662|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
5221683|NCT00943826|12839663|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
5221684|NCT00943826|12839662|P2|COMPLETED|After Primary Overall Survival Analysis||0
5221685|NCT00943826|12839663|P1|COMPLETED|After Primary Overall Survival Analysis||0
5221686|NCT00943826|12839662|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
5221687|NCT00943826|12839663|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
5221688|NCT00943826|12839662|P2|NOT COMPLETED|Monotherapy Phase||16
5221689|NCT00943826|12839663|P1|NOT COMPLETED|Monotherapy Phase||65
5221690|NCT00943826|12839662|P2|COMPLETED|Monotherapy Phase||143
5221691|NCT00943826|12839663|P1|COMPLETED|Monotherapy Phase||204
5221692|NCT00943826|12839662|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
5221693|NCT00943826|12839663|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
5221694|NCT00943826|12839662|P2|NOT COMPLETED|Maintenance Phase||39
5221695|NCT00943826|12839663|P1|NOT COMPLETED|Maintenance Phase||43
5221696|NCT00943826|12839662|P2|COMPLETED|Maintenance Phase||331
5221697|NCT00943826|12839663|P1|COMPLETED|Maintenance Phase||353
5221698|NCT00943826|12839662|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
5221699|NCT00943826|12839663|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
5221700|NCT00943826|12839662|P2|NOT COMPLETED|Concurrent Phase||42
5221701|NCT00943826|12839663|P1|NOT COMPLETED|Concurrent Phase||61
5221702|NCT00943826|12839662|P2|COMPLETED|Concurrent Phase||421
5221703|NCT00943826|12839663|P1|COMPLETED|Concurrent Phase||397
5221704|NCT00943826|12839662|P2|Treated|Concurrent Phase||459
5221705|NCT00943826|12839663|P1|Treated|Concurrent Phase||452
5221706|NCT00943826|12839662|P2|STARTED|Concurrent Phase||463
5221707|NCT00943826|12839663|P1|STARTED|Concurrent Phase||458
5221708|NCT00943787|12839681|P1|NOT COMPLETED|Overall Study||7
5221709|NCT00943787|12839681|P1|COMPLETED|Overall Study||34
5221710|NCT00943787|12839681|P1|STARTED|Overall Study||41
5221711|NCT00943761|12839688|P2|NOT COMPLETED|Overall Study||1
5221712|NCT00943761|12839689|P1|NOT COMPLETED|Overall Study||4
5221713|NCT00943761|12839688|P2|COMPLETED|Overall Study||23
5221714|NCT00943761|12839689|P1|COMPLETED|Overall Study||17
5221715|NCT00943761|12839688|P2|STARTED|Overall Study||24
5221716|NCT00943761|12839689|P1|STARTED|Overall Study||21
5221717|NCT00943735|12839701|P1|NOT COMPLETED|Overall Study||32
5221718|NCT00943735|12839701|P1|COMPLETED|Overall Study||742
5221719|NCT00943735|12839701|P1|Per Protocol Population|Overall Study||500
5221720|NCT00943735|12839701|P1|STARTED|Overall Study||774
5221721|NCT00943722|12839739|P5|NOT COMPLETED|Overall Study||22
5221722|NCT00943722|12839740|P4|NOT COMPLETED|Overall Study||22
5221723|NCT00943722|12839741|P3|NOT COMPLETED|Overall Study||13
5221724|NCT00943722|12839742|P2|NOT COMPLETED|Overall Study||22
5221725|NCT00943722|12839743|P1|NOT COMPLETED|Overall Study||25
5221726|NCT00943722|12839739|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
5221727|NCT00943722|12839740|P4|COMPLETED|Overall Study||647
5221728|NCT00943722|12839741|P3|COMPLETED|Overall Study||631
5221729|NCT00943722|12839742|P2|COMPLETED|Overall Study||621
5221730|NCT00943722|12839743|P1|COMPLETED|Overall Study||623
5221731|NCT00943722|12839739|P5|Vaccination 3|Overall Study||455
5221732|NCT00943722|12839740|P4|Vaccination 3|Overall Study||653
5221733|NCT00943722|12839741|P3|Vaccination 3|Overall Study||637
5221734|NCT00943722|12839742|P2|Vaccination 3|Overall Study||627
5221735|NCT00943722|12839743|P1|Vaccination 3|Overall Study||635
5221736|NCT00943722|12839739|P5|Vaccination 2|Overall Study||462
5221737|NCT00943722|12839740|P4|Vaccination 2|Overall Study||658
5221738|NCT00943722|12839741|P3|Vaccination 2|Overall Study||638
5221739|NCT00943722|12839742|P2|Vaccination 2|Overall Study||633
5221740|NCT00943722|12839743|P1|Vaccination 2|Overall Study||637
5221741|NCT00943722|12839739|P5|Vaccination 1|Overall Study||468
5221742|NCT00943722|12839740|P4|Vaccination 1|Overall Study||666
5221743|NCT00943722|12839741|P3|Vaccination 1|Overall Study||644
5221744|NCT00943722|12839742|P2|Vaccination 1|Overall Study||642
5221745|NCT00943722|12839743|P1|Vaccination 1|Overall Study||646
5221746|NCT00943722|12839739|P5|STARTED|Overall Study||470
5221747|NCT00943722|12839740|P4|STARTED|Overall Study||669
5221748|NCT00943722|12839741|P3|STARTED|Overall Study||644
5221749|NCT00943722|12839742|P2|STARTED|Overall Study||643
5221750|NCT00943722|12839743|P1|STARTED|Overall Study||648
5221751|NCT00943683|12839773|P2|NOT COMPLETED|Overall Study||6
5221752|NCT00943683|12839774|P1|NOT COMPLETED|Overall Study||7
5221753|NCT00943683|12839773|P2|COMPLETED|Overall Study||169
5221754|NCT00943683|12839774|P1|COMPLETED|Overall Study||74
5221755|NCT00943683|12839773|P2|STARTED|Overall Study||175
5221756|NCT00943683|12839774|P1|STARTED|Overall Study||81
5221757|NCT00943670|12839780|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
5221758|NCT00943670|12839780|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
5221759|NCT00943670|12839780|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
5221760|NCT00943670|12839780|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
5221761|NCT00943670|12839780|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
5221762|NCT00943670|12839780|P1|Treated|Single-agent Trastuzumab Emtansine||51
5221763|NCT00943670|12839780|P1|STARTED|Single-agent Trastuzumab Emtansine||51
5221764|NCT00943631|12839816|P2|NOT COMPLETED|Overall Study||2
5221765|NCT00943631|12839817|P1|NOT COMPLETED|Overall Study||4
5221766|NCT00943631|12839816|P2|COMPLETED|Overall Study||202
5221767|NCT00943631|12839817|P1|COMPLETED|Overall Study||198
5221768|NCT00943631|12839816|P2|STARTED|Overall Study||204
5221769|NCT00943631|12839817|P1|STARTED|Overall Study||202
5221770|NCT00943605|12839869|P2|NOT COMPLETED|Overall Study||30
5221771|NCT00943605|12839870|P1|NOT COMPLETED|Overall Study||30
5221772|NCT00943605|12839869|P2|COMPLETED|Overall Study||0
5221773|NCT00943605|12839870|P1|COMPLETED|Overall Study||0
5221774|NCT00943605|12839869|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
5221775|NCT00943605|12839870|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
5221776|NCT00943592|12839880|P1|NOT COMPLETED|Overall Study||3
5221777|NCT00943592|12839880|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
5221778|NCT00943592|12839880|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
5221779|NCT00943592|12839880|P1|STARTED|Overall Study||82
5221780|NCT00943579|12839893|P2|NOT COMPLETED|Overall Study||5
5221781|NCT00943579|12839894|P1|NOT COMPLETED|Overall Study||6
5221782|NCT00943579|12839893|P2|COMPLETED|Overall Study||15
5221783|NCT00943579|12839894|P1|COMPLETED|Overall Study||15
5221784|NCT00943579|12839893|P2|STARTED|Overall Study||20
5221785|NCT00943579|12839894|P1|STARTED|Overall Study||21
5221786|NCT00943488|12839915|P2|NOT COMPLETED|Overall Study||2
5221787|NCT00943488|12839916|P1|NOT COMPLETED|Overall Study||1
5221788|NCT00943488|12839915|P2|COMPLETED|Overall Study||202
5221789|NCT00943488|12839916|P1|COMPLETED|Overall Study||203
5221790|NCT00943488|12839915|P2|STARTED|Overall Study||204
5221791|NCT00943488|12839916|P1|STARTED|Overall Study||204
5221792|NCT00943436|12839972|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
5221793|NCT00943436|12839973|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
5221794|NCT00943436|12839972|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
5221795|NCT00943436|12839973|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
5221796|NCT00943436|12839972|P2|STARTED|Rest Session: 45 Minutes of Reading||10
5221797|NCT00943436|12839973|P1|STARTED|Rest Session: 45 Minutes of Reading||10
5221798|NCT00943436|12839972|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
5221799|NCT00943436|12839973|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
5221800|NCT00943436|12839972|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
5221801|NCT00943436|12839973|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
5221802|NCT00943436|12839972|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
5221803|NCT00943436|12839973|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
5221804|NCT00943397|12839995|P2|NOT COMPLETED|Overall Study||72
5221805|NCT00943397|12839996|P1|NOT COMPLETED|Overall Study||15
5221806|NCT00943397|12839995|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
5221807|NCT00943397|12839996|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
5221808|NCT00943397|12839995|P2|STARTED|Overall Study||158
5221809|NCT00943397|12839996|P1|STARTED|Overall Study||32
5221810|NCT00943384|12840002|P1|NOT COMPLETED|Overall Study||49
5221811|NCT00943384|12840002|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
5221812|NCT00943384|12840002|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
5221813|NCT00943384|12840002|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
5221814|NCT00943384|12840002|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
5221815|NCT00943319|12840016|P1|NOT COMPLETED|Overall Study||1
5221816|NCT00943319|12840016|P1|COMPLETED|Overall Study||49
5221817|NCT00943319|12840016|P1|STARTED|Overall Study||50
5221818|NCT00943306|12840022|P1|NOT COMPLETED|Overall Study||3
5221819|NCT00943306|12840022|P1|COMPLETED|Overall Study||16
5221820|NCT00943306|12840022|P1|STARTED|Overall Study||19
5221821|NCT00943202|12840083|P4|NOT COMPLETED|Overall Study||1
5221822|NCT00943202|12840084|P3|NOT COMPLETED|Overall Study||0
5221823|NCT00943202|12840085|P2|NOT COMPLETED|Overall Study||2
5221824|NCT00943202|12840086|P1|NOT COMPLETED|Overall Study||1
5221825|NCT00943202|12840083|P4|COMPLETED|Overall Study||131
5221826|NCT00943202|12840084|P3|COMPLETED|Overall Study||133
5221827|NCT00943202|12840085|P2|COMPLETED|Overall Study||131
5221828|NCT00943202|12840086|P1|COMPLETED|Overall Study||132
5221829|NCT00943202|12840083|P4|STARTED|Overall Study||132
5221830|NCT00943202|12840084|P3|STARTED|Overall Study||133
5221831|NCT00943202|12840085|P2|STARTED|Overall Study||133
5221832|NCT00943202|12840086|P1|STARTED|Overall Study||133
5221833|NCT00943150|12840302|P2|NOT COMPLETED|Overall Study||0
5221834|NCT00943150|12840303|P1|NOT COMPLETED|Overall Study||0
5221835|NCT00943150|12840302|P2|COMPLETED|Overall Study||10
5221836|NCT00943150|12840303|P1|COMPLETED|Overall Study||10
5221837|NCT00943150|12840302|P2|STARTED|Overall Study||10
5221838|NCT00943150|12840303|P1|STARTED|Overall Study||10
5221839|NCT00943124|12840324|P2|NOT COMPLETED|Period 2||0
5221840|NCT00943124|12840325|P1|NOT COMPLETED|Period 2||0
5221841|NCT00943124|12840324|P2|COMPLETED|Period 2||108
5221842|NCT00943124|12840325|P1|COMPLETED|Period 2||108
5221843|NCT00943124|12840324|P2|STARTED|Period 2||108
5221844|NCT00943124|12840325|P1|STARTED|Period 2||108
5221845|NCT00943124|12840324|P2|NOT COMPLETED|Period 1||2
5221846|NCT00943124|12840325|P1|NOT COMPLETED|Period 1||2
5221847|NCT00943124|12840324|P2|COMPLETED|Period 1||108
5221848|NCT00943124|12840325|P1|COMPLETED|Period 1||108
5221849|NCT00943124|12840324|P2|STARTED|Period 1||110
5221850|NCT00943124|12840325|P1|STARTED|Period 1||110
5221851|NCT00943111|12840347|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
5221852|NCT00943111|12840348|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
5221853|NCT00943111|12840349|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
5221854|NCT00943111|12840347|P3|COMPLETED|5 Years Long-term Treatment Period||77
5221855|NCT00943111|12840348|P2|COMPLETED|5 Years Long-term Treatment Period||0
5221856|NCT00943111|12840349|P1|COMPLETED|5 Years Long-term Treatment Period||0
5221857|NCT00943111|12840347|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
5221858|NCT00943111|12840348|P2|STARTED|5 Years Long-term Treatment Period||0
5221859|NCT00943111|12840349|P1|STARTED|5 Years Long-term Treatment Period||0
5221860|NCT00943111|12840347|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
5221861|NCT00943111|12840348|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
5221862|NCT00943111|12840349|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
5221863|NCT00943111|12840347|P3|COMPLETED|52-Weeks Primary Analysis Period||0
5221864|NCT00943111|12840348|P2|COMPLETED|52-Weeks Primary Analysis Period||52
5221865|NCT00943111|12840349|P1|COMPLETED|52-Weeks Primary Analysis Period||104
5221866|NCT00943111|12840347|P3|Treated|52-Weeks Primary Analysis Period||0
5221867|NCT00943111|12840348|P2|Treated|52-Weeks Primary Analysis Period||53
5221868|NCT00943111|12840349|P1|Treated|52-Weeks Primary Analysis Period||106
5221869|NCT00943111|12840347|P3|STARTED|52-Weeks Primary Analysis Period||0
5221870|NCT00943111|12840348|P2|STARTED|52-Weeks Primary Analysis Period||54
5221871|NCT00943111|12840349|P1|STARTED|52-Weeks Primary Analysis Period||106
5221872|NCT00943098|12840382|P2|NOT COMPLETED|Overall Study||0
5221873|NCT00943098|12840383|P1|NOT COMPLETED|Overall Study||0
5221874|NCT00943098|12840382|P2|COMPLETED|Overall Study||72
5221875|NCT00943098|12840383|P1|COMPLETED|Overall Study||70
5221876|NCT00943098|12840382|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
5221877|NCT00943098|12840383|P1|STARTED|Overall Study||70
5221878|NCT00943072|12840417|P2|NOT COMPLETED|Overall Study||14
5221879|NCT00943072|12840418|P1|NOT COMPLETED|Overall Study||5
5221880|NCT00943072|12840417|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
5221881|NCT00943072|12840418|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
5221882|NCT00943072|12840417|P2|Full Analysis Set (FAS) Population|Overall Study||73
5221883|NCT00943072|12840418|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
5221884|NCT00943072|12840417|P2|Participants Received Treatment|Overall Study||74
5221885|NCT00943072|12840418|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
5221886|NCT00943072|12840417|P2|STARTED|Overall Study||74
5221887|NCT00943072|12840418|P1|STARTED|Overall Study||115
5221888|NCT00942994|12840436|P2|NOT COMPLETED|Overall Study||19
5221889|NCT00942994|12840437|P1|NOT COMPLETED|Overall Study||16
5221890|NCT00942994|12840436|P2|COMPLETED|Overall Study||190
5221891|NCT00942994|12840437|P1|COMPLETED|Overall Study||187
5221892|NCT00942994|12840436|P2|STARTED|Overall Study||209
5221893|NCT00942994|12840437|P1|STARTED|Overall Study||203
5221894|NCT00942968|12840453|P1|NOT COMPLETED|Overall Study||229
5221895|NCT00942968|12840453|P1|COMPLETED|Overall Study||109
5221896|NCT00942968|12840453|P1|Treated|Overall Study||334
5221897|NCT00942968|12840453|P1|STARTED|Overall Study||338
5221898|NCT00942903|12840474|P1|NOT COMPLETED|Overall Study||0
5221899|NCT00942903|12840474|P1|COMPLETED|Overall Study||20
5221900|NCT00942903|12840474|P1|STARTED|Overall Study||20
5221901|NCT00942890|12840481|P2|NOT COMPLETED|Overall Study||0
5221902|NCT00942890|12840482|P1|NOT COMPLETED|Overall Study||0
5221903|NCT00942890|12840481|P2|COMPLETED|Overall Study||23
5221904|NCT00942890|12840482|P1|COMPLETED|Overall Study||21
5221905|NCT00942890|12840481|P2|STARTED|Overall Study||23
5221906|NCT00942890|12840482|P1|STARTED|Overall Study||21
5221907|NCT00942851|12840504|P2|NOT COMPLETED|Overall Study||1
5221908|NCT00942851|12840505|P1|NOT COMPLETED|Overall Study||0
5221909|NCT00942851|12840504|P2|COMPLETED|Overall Study||11
5221910|NCT00942851|12840505|P1|COMPLETED|Overall Study||12
5221911|NCT00942851|12840504|P2|STARTED|Overall Study||12
5221912|NCT00942851|12840505|P1|STARTED|Overall Study||12
5221913|NCT00942825|12840517|P2|NOT COMPLETED|Overall Study||0
5221914|NCT00942825|12840518|P1|NOT COMPLETED|Overall Study||0
5221915|NCT00942825|12840517|P2|COMPLETED|Overall Study||98
5221916|NCT00942825|12840518|P1|COMPLETED|Overall Study||97
5221917|NCT00942825|12840517|P2|STARTED|Overall Study||98
5221918|NCT00942825|12840518|P1|STARTED|Overall Study||97
5221919|NCT00942786|12840524|P1|NOT COMPLETED|Overall Study||0
5221920|NCT00942786|12840524|P1|COMPLETED|Overall Study|date of last follow-up|297
5221921|NCT00942786|12840524|P1|STARTED|Overall Study||297
5221922|NCT00942734|12840531|P1|NOT COMPLETED|Overall Study||8
5221923|NCT00942734|12840531|P1|COMPLETED|Overall Study||35
5221924|NCT00942734|12840531|P1|STARTED|Overall Study||43
5221925|NCT00942708|12840535|P1|NOT COMPLETED|Overall Study||1
5221926|NCT00942708|12840535|P1|COMPLETED|Overall Study||5
5221927|NCT00942708|12840535|P1|STARTED|Overall Study||6
5221928|NCT00942604|12840543|P2|NOT COMPLETED|Overall Study||4
5221929|NCT00942604|12840544|P1|NOT COMPLETED|Overall Study||2
5221930|NCT00942604|12840543|P2|COMPLETED|Overall Study||99
5221931|NCT00942604|12840544|P1|COMPLETED|Overall Study||98
5221932|NCT00942604|12840543|P2|STARTED|Overall Study||103
5221933|NCT00942604|12840544|P1|STARTED|Overall Study||100
5221934|NCT00942578|12840555|P3|NOT COMPLETED|Expansion Phase||0
5221935|NCT00942578|12840556|P2|NOT COMPLETED|Expansion Phase||0
5221936|NCT00942578|12840557|P1|NOT COMPLETED|Expansion Phase||0
5221937|NCT00942578|12840555|P3|COMPLETED|Expansion Phase||43
5221938|NCT00942578|12840556|P2|COMPLETED|Expansion Phase||0
5221939|NCT00942578|12840557|P1|COMPLETED|Expansion Phase||11
5221940|NCT00942578|12840555|P3|STARTED|Expansion Phase||43
5221941|NCT00942578|12840556|P2|STARTED|Expansion Phase||0
5221942|NCT00942578|12840557|P1|STARTED|Expansion Phase||11
5221943|NCT00942578|12840555|P3|NOT COMPLETED|Dose Escalation Phase||0
5221944|NCT00942578|12840556|P2|NOT COMPLETED|Dose Escalation Phase||0
5221945|NCT00942578|12840557|P1|NOT COMPLETED|Dose Escalation Phase||0
5221946|NCT00942578|12840555|P3|COMPLETED|Dose Escalation Phase||3
5221947|NCT00942578|12840556|P2|COMPLETED|Dose Escalation Phase||3
5221948|NCT00942578|12840557|P1|COMPLETED|Dose Escalation Phase||3
5221949|NCT00942578|12840555|P3|STARTED|Dose Escalation Phase||3
5221950|NCT00942578|12840556|P2|STARTED|Dose Escalation Phase||3
5221951|NCT00942578|12840557|P1|STARTED|Dose Escalation Phase||3
5221952|NCT00942448|12840587|P4|NOT COMPLETED|Overall Study||0
5221953|NCT00942448|12840588|P3|NOT COMPLETED|Overall Study||0
5221954|NCT00942448|12840589|P2|NOT COMPLETED|Overall Study||0
5221955|NCT00942448|12840590|P1|NOT COMPLETED|Overall Study||0
5221956|NCT00942448|12840587|P4|COMPLETED|Overall Study||75
5221957|NCT00942448|12840588|P3|COMPLETED|Overall Study||78
5221958|NCT00942448|12840589|P2|COMPLETED|Overall Study||76
5221959|NCT00942448|12840590|P1|COMPLETED|Overall Study||77
5221960|NCT00942448|12840587|P4|STARTED|Overall Study||75
5221961|NCT00942448|12840588|P3|STARTED|Overall Study||78
5221962|NCT00942448|12840589|P2|STARTED|Overall Study||76
5221963|NCT00942448|12840590|P1|STARTED|Overall Study||77
5221964|NCT00942422|12840652|P1|NOT COMPLETED|Overall Study||3
5221965|NCT00942422|12840652|P1|COMPLETED|Overall Study||5
5221966|NCT00942422|12840652|P1|STARTED|Overall Study||8
5221967|NCT00942409|12840656|P1|NOT COMPLETED|Overall Study||3
5221968|NCT00942409|12840656|P1|COMPLETED|Overall Study||2
5221969|NCT00942409|12840656|P1|STARTED|Overall Study||5
5221970|NCT00942357|12840662|P2|NOT COMPLETED|Overall Study||40
5221971|NCT00942357|12840663|P1|NOT COMPLETED|Overall Study||37
5221972|NCT00942357|12840662|P2|COMPLETED|Overall Study||366
5221973|NCT00942357|12840663|P1|COMPLETED|Overall Study||370
5221974|NCT00942357|12840662|P2|STARTED|Overall Study||406
5221975|NCT00942357|12840663|P1|STARTED|Overall Study||407
5221976|NCT00942331|12840679|P2|NOT COMPLETED|Overall Study||22
5221977|NCT00942331|12840680|P1|NOT COMPLETED|Overall Study||15
5221978|NCT00942331|12840679|P2|COMPLETED|Overall Study||232
5221979|NCT00942331|12840680|P1|COMPLETED|Overall Study||237
5221980|NCT00942331|12840679|P2|STARTED|Overall Study||254
5221981|NCT00942331|12840680|P1|STARTED|Overall Study||252
5221982|NCT00942266|12840690|P2|NOT COMPLETED|Overall Study||15
5221983|NCT00942266|12840691|P1|NOT COMPLETED|Overall Study||43
5221984|NCT00942266|12840690|P2|COMPLETED|Overall Study||0
5221985|NCT00942266|12840691|P1|COMPLETED|Overall Study||0
5221986|NCT00942266|12840690|P2|STARTED|Overall Study||15
5221987|NCT00942266|12840691|P1|STARTED|Overall Study||43
5221988|NCT00942188|12840713|P4|NOT COMPLETED|Overall Study||4
5221989|NCT00942188|12840714|P3|NOT COMPLETED|Overall Study||9
5221990|NCT00942188|12840715|P2|NOT COMPLETED|Overall Study||10
5221991|NCT00942188|12840716|P1|NOT COMPLETED|Overall Study||4
5221992|NCT00942188|12840713|P4|COMPLETED|Overall Study||23
5221993|NCT00942188|12840714|P3|COMPLETED|Overall Study||18
5221994|NCT00942188|12840715|P2|COMPLETED|Overall Study||16
5221995|NCT00942188|12840716|P1|COMPLETED|Overall Study||22
5221996|NCT00942188|12840713|P4|STARTED|Overall Study||27
5221997|NCT00942188|12840714|P3|STARTED|Overall Study||27
5221998|NCT00942188|12840715|P2|STARTED|Overall Study||26
5221999|NCT00942188|12840716|P1|STARTED|Overall Study||26
5222000|NCT00942175|12840755|P4|NOT COMPLETED|Overall Study||2
5222001|NCT00942175|12840756|P3|NOT COMPLETED|Overall Study||2
5222002|NCT00942175|12840757|P2|NOT COMPLETED|Overall Study||4
5222003|NCT00942175|12840758|P1|NOT COMPLETED|Overall Study||2
5222004|NCT00942175|12840755|P4|COMPLETED|Overall Study||38
5222005|NCT00942175|12840756|P3|COMPLETED|Overall Study||38
5222006|NCT00942175|12840757|P2|COMPLETED|Overall Study||36
5222007|NCT00942175|12840758|P1|COMPLETED|Overall Study||38
5222008|NCT00942175|12840755|P4|STARTED|Overall Study||40
5222009|NCT00942175|12840756|P3|STARTED|Overall Study||40
5222010|NCT00942175|12840757|P2|STARTED|Overall Study||40
5222011|NCT00942175|12840758|P1|STARTED|Overall Study||40
5222012|NCT00942162|12840811|P3|NOT COMPLETED|Overall Study||1
5222013|NCT00942162|12840812|P2|NOT COMPLETED|Overall Study||47
5222014|NCT00942162|12840813|P1|NOT COMPLETED|Overall Study||68
5222015|NCT00942162|12840811|P3|COMPLETED|Overall Study||1
5222016|NCT00942162|12840812|P2|COMPLETED|Overall Study||3
5222017|NCT00942162|12840813|P1|COMPLETED|Overall Study||3
5222018|NCT00942162|12840811|P3|STARTED|Overall Study||2
5222019|NCT00942162|12840812|P2|STARTED|Overall Study||50
5222020|NCT00942162|12840813|P1|STARTED|Overall Study||71
5222021|NCT00942149|12840878|P1|NOT COMPLETED|Overall Study||0
5222022|NCT00942149|12840878|P1|COMPLETED|Overall Study||20
5222023|NCT00942149|12840878|P1|STARTED|Overall Study||20
5222024|NCT00942084|12840882|P1|NOT COMPLETED|Overall Study||2
5222025|NCT00942084|12840882|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
5222026|NCT00942084|12840882|P1|STARTED|Overall Study||32
5222027|NCT00941993|12840891|P1|NOT COMPLETED|Overall Study||0
5222028|NCT00941993|12840891|P1|COMPLETED|Overall Study||109
5222029|NCT00941993|12840891|P1|STARTED|Overall Study||109
5222030|NCT00941928|12840899|P1|NOT COMPLETED|Overall Study||2
5222031|NCT00941928|12840899|P1|COMPLETED|Overall Study||0
5222032|NCT00941928|12840899|P1|STARTED|Overall Study||2
5222033|NCT00941889|12840905|P2|NOT COMPLETED|Overall Study||12
5222034|NCT00941889|12840906|P1|NOT COMPLETED|Overall Study||12
5222035|NCT00941889|12840905|P2|COMPLETED|Overall Study||3
5222036|NCT00941889|12840906|P1|COMPLETED|Overall Study||5
5222037|NCT00941889|12840905|P2|STARTED|Overall Study||15
5222038|NCT00941889|12840906|P1|STARTED|Overall Study||17
5222039|NCT00941863|12840917|P5|NOT COMPLETED|Continued After PCD||19
5222040|NCT00941863|12840918|P4|NOT COMPLETED|Continued After PCD||0
5222041|NCT00941863|12840919|P3|NOT COMPLETED|Continued After PCD||0
5222042|NCT00941863|12840920|P2|NOT COMPLETED|Continued After PCD||0
5222043|NCT00941863|12840921|P1|NOT COMPLETED|Continued After PCD||0
5222044|NCT00941863|12840917|P5|COMPLETED|Continued After PCD||6
5222045|NCT00941863|12840918|P4|COMPLETED|Continued After PCD||0
5222046|NCT00941863|12840919|P3|COMPLETED|Continued After PCD||0
5222047|NCT00941863|12840920|P2|COMPLETED|Continued After PCD||0
5222048|NCT00941863|12840921|P1|COMPLETED|Continued After PCD||0
5222049|NCT00941863|12840917|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
5222050|NCT00941863|12840918|P4|STARTED|Continued After PCD||0
5222051|NCT00941863|12840919|P3|STARTED|Continued After PCD||0
5222052|NCT00941863|12840920|P2|STARTED|Continued After PCD||0
5222053|NCT00941863|12840921|P1|STARTED|Continued After PCD||0
5222054|NCT00941863|12840917|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
5222055|NCT00941863|12840918|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
5222056|NCT00941863|12840919|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
5222057|NCT00941863|12840920|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
5222058|NCT00941863|12840921|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
5222059|NCT00941863|12840917|P5|COMPLETED|Until Primary Completion Date (PCD)||25
5222060|NCT00941863|12840918|P4|COMPLETED|Until Primary Completion Date (PCD)||0
5222061|NCT00941863|12840919|P3|COMPLETED|Until Primary Completion Date (PCD)||0
5222062|NCT00941863|12840920|P2|COMPLETED|Until Primary Completion Date (PCD)||0
5222063|NCT00941863|12840921|P1|COMPLETED|Until Primary Completion Date (PCD)||0
5222064|NCT00941863|12840917|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
5222065|NCT00941863|12840918|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
5222066|NCT00941863|12840919|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
5222067|NCT00941863|12840920|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
5222068|NCT00941863|12840921|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
5222069|NCT00941863|12840917|P5|STARTED|Until Primary Completion Date (PCD)||119
5222070|NCT00941863|12840918|P4|STARTED|Until Primary Completion Date (PCD)||17
5222071|NCT00941863|12840919|P3|STARTED|Until Primary Completion Date (PCD)||12
5222072|NCT00941863|12840920|P2|STARTED|Until Primary Completion Date (PCD)||3
5222073|NCT00941863|12840921|P1|STARTED|Until Primary Completion Date (PCD)||7
5222074|NCT00941798|12840948|P2|NOT COMPLETED|Overall Study||185
5222075|NCT00941798|12840949|P1|NOT COMPLETED|Overall Study||194
5222076|NCT00941798|12840948|P2|COMPLETED|Overall Study||578
5222077|NCT00941798|12840949|P1|COMPLETED|Overall Study||561
5222078|NCT00941798|12840948|P2|Full Analysis Set|Overall Study||759
5222079|NCT00941798|12840949|P1|Full Analysis Set|Overall Study||749
5222080|NCT00941798|12840948|P2|STARTED|Overall Study||763
5222081|NCT00941798|12840949|P1|STARTED|Overall Study||755
5222082|NCT00941733|12840979|P2|NOT COMPLETED|Overall Study||28
5222083|NCT00941733|12840980|P1|NOT COMPLETED|Overall Study||74
5222084|NCT00941733|12840979|P2|COMPLETED|Overall Study|1 year follow-up|91
5222085|NCT00941733|12840980|P1|COMPLETED|Overall Study|1 year follow-up|165
5222086|NCT00941733|12840979|P2|STARTED|Overall Study||119
5222087|NCT00941733|12840980|P1|STARTED|Overall Study||239
5222088|NCT00941720|12841020|P1|NOT COMPLETED|Overall Study||14
5222089|NCT00941720|12841020|P1|COMPLETED|Overall Study||57
5222090|NCT00941720|12841020|P1|STARTED|Overall Study||71
5222091|NCT00941681|12841029|P3|NOT COMPLETED|Overall Study||0
5222092|NCT00941681|12841030|P2|NOT COMPLETED|Overall Study||1
5222093|NCT00941681|12841031|P1|NOT COMPLETED|Overall Study||0
5222094|NCT00941681|12841029|P3|COMPLETED|Overall Study||12
5222095|NCT00941681|12841030|P2|COMPLETED|Overall Study||10
5222096|NCT00941681|12841031|P1|COMPLETED|Overall Study||12
5222097|NCT00941681|12841029|P3|STARTED|Overall Study||12
5222098|NCT00941681|12841030|P2|STARTED|Overall Study||11
5222099|NCT00941681|12841031|P1|STARTED|Overall Study||12
5222100|NCT00941668|12841056|P2|NOT COMPLETED|Overall Study||25
5222101|NCT00941668|12841057|P1|NOT COMPLETED|Overall Study||24
5222102|NCT00941668|12841056|P2|COMPLETED|Overall Study||0
5222103|NCT00941668|12841057|P1|COMPLETED|Overall Study||0
5222104|NCT00941668|12841056|P2|STARTED|Overall Study||25
5222105|NCT00941668|12841057|P1|STARTED|Overall Study||24
5222106|NCT00941655|12841067|P2|NOT COMPLETED|Overall Study||5
5222107|NCT00941655|12841068|P1|NOT COMPLETED|Overall Study||5
5222108|NCT00941655|12841067|P2|COMPLETED|Overall Study||2
5222109|NCT00941655|12841068|P1|COMPLETED|Overall Study||3
5222110|NCT00941655|12841067|P2|STARTED|Overall Study||7
5222111|NCT00941655|12841068|P1|STARTED|Overall Study||8
5222112|NCT00941603|12841093|P6|NOT COMPLETED|Overall Study||3
5222113|NCT00941603|12841094|P5|NOT COMPLETED|Overall Study||4
5222114|NCT00941603|12841095|P4|NOT COMPLETED|Overall Study||4
5222115|NCT00941603|12841096|P3|NOT COMPLETED|Overall Study||5
5222116|NCT00941603|12841097|P2|NOT COMPLETED|Overall Study||16
5222117|NCT00941603|12841098|P1|NOT COMPLETED|Overall Study||11
5222118|NCT00941603|12841093|P6|COMPLETED|Overall Study||94
5222119|NCT00941603|12841094|P5|COMPLETED|Overall Study||101
5222120|NCT00941603|12841095|P4|COMPLETED|Overall Study||100
5222121|NCT00941603|12841096|P3|COMPLETED|Overall Study||99
5222122|NCT00941603|12841097|P2|COMPLETED|Overall Study||89
5222123|NCT00941603|12841098|P1|COMPLETED|Overall Study||93
5222124|NCT00941603|12841093|P6|STARTED|Overall Study||97
5222125|NCT00941603|12841094|P5|STARTED|Overall Study||105
5222126|NCT00941603|12841095|P4|STARTED|Overall Study||104
5222127|NCT00941603|12841096|P3|STARTED|Overall Study||104
5222128|NCT00941603|12841097|P2|STARTED|Overall Study||105
5222129|NCT00941603|12841098|P1|STARTED|Overall Study||104
5222130|NCT00941330|12841120|P2|NOT COMPLETED|Overall Study||2
5222131|NCT00941330|12841121|P1|NOT COMPLETED|Overall Study||1
5222132|NCT00941330|12841120|P2|COMPLETED|Overall Study||9
5222133|NCT00941330|12841121|P1|COMPLETED|Overall Study||14
5222134|NCT00941330|12841120|P2|STARTED|Overall Study||11
5222135|NCT00941330|12841121|P1|STARTED|Overall Study||15
5222136|NCT00941304|12841134|P5|NOT COMPLETED|Overall Study||0
5222137|NCT00941304|12841135|P4|NOT COMPLETED|Overall Study||0
5222138|NCT00941304|12841136|P3|NOT COMPLETED|Overall Study||0
5222139|NCT00941304|12841137|P2|NOT COMPLETED|Overall Study||0
5222140|NCT00941304|12841138|P1|NOT COMPLETED|Overall Study||1
5222141|NCT00941304|12841134|P5|COMPLETED|Overall Study||31
5222142|NCT00941304|12841135|P4|COMPLETED|Overall Study||30
5222143|NCT00941304|12841136|P3|COMPLETED|Overall Study||31
5222144|NCT00941304|12841137|P2|COMPLETED|Overall Study||30
5222145|NCT00941304|12841138|P1|COMPLETED|Overall Study||30
5222146|NCT00941304|12841134|P5|STARTED|Overall Study||31
5222147|NCT00941304|12841135|P4|STARTED|Overall Study||30
5222148|NCT00941304|12841136|P3|STARTED|Overall Study||31
5222149|NCT00941304|12841137|P2|STARTED|Overall Study||30
5222150|NCT00941304|12841138|P1|STARTED|Overall Study||31
5222151|NCT00941070|12841200|P1|NOT COMPLETED|Overall Study||1
5222152|NCT00941070|12841200|P1|COMPLETED|Overall Study||25
5222153|NCT00941070|12841200|P1|STARTED|Overall Study||26
5222154|NCT00941031|12841220|P7|NOT COMPLETED|Maintenance Period||43
5222155|NCT00941031|12841221|P6|NOT COMPLETED|Maintenance Period||6
5222156|NCT00941031|12841222|P5|NOT COMPLETED|Maintenance Period||9
5222157|NCT00941031|12841223|P4|NOT COMPLETED|Maintenance Period||0
5222158|NCT00941031|12841224|P3|NOT COMPLETED|Maintenance Period||0
5222159|NCT00941031|12841225|P2|NOT COMPLETED|Maintenance Period||0
5222160|NCT00941031|12841226|P1|NOT COMPLETED|Maintenance Period||0
5222161|NCT00941031|12841220|P7|COMPLETED|Maintenance Period||204
5222162|NCT00941031|12841221|P6|COMPLETED|Maintenance Period||61
5222163|NCT00941031|12841222|P5|COMPLETED|Maintenance Period||56
5222164|NCT00941031|12841223|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
5222165|NCT00941031|12841224|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222166|NCT00941031|12841225|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222167|NCT00941031|12841226|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222168|NCT00941031|12841220|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
5222169|NCT00941031|12841221|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
5222170|NCT00941031|12841222|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
5222171|NCT00941031|12841223|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
5222172|NCT00941031|12841224|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222173|NCT00941031|12841225|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222174|NCT00941031|12841226|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
5222175|NCT00941031|12841220|P7|NOT COMPLETED|Induction Period||0
5222176|NCT00941031|12841221|P6|NOT COMPLETED|Induction Period||0
5222177|NCT00941031|12841222|P5|NOT COMPLETED|Induction Period||0
5222178|NCT00941031|12841223|P4|NOT COMPLETED|Induction Period||9
5222179|NCT00941031|12841224|P3|NOT COMPLETED|Induction Period||6
5222180|NCT00941031|12841225|P2|NOT COMPLETED|Induction Period||4
5222181|NCT00941031|12841226|P1|NOT COMPLETED|Induction Period||5
5222182|NCT00941031|12841220|P7|COMPLETED|Induction Period||0
5222183|NCT00941031|12841221|P6|COMPLETED|Induction Period||0
5222184|NCT00941031|12841222|P5|COMPLETED|Induction Period||0
5222185|NCT00941031|12841223|P4|COMPLETED|Induction Period||58
5222186|NCT00941031|12841224|P3|COMPLETED|Induction Period||127
5222187|NCT00941031|12841225|P2|COMPLETED|Induction Period||134
5222188|NCT00941031|12841226|P1|COMPLETED|Induction Period||61
5222189|NCT00941031|12841220|P7|STARTED|Induction Period||0
5222190|NCT00941031|12841221|P6|STARTED|Induction Period||0
5222191|NCT00941031|12841222|P5|STARTED|Induction Period||0
5222192|NCT00941031|12841223|P4|STARTED|Induction Period||67
5222193|NCT00941031|12841224|P3|STARTED|Induction Period||133
5222194|NCT00941031|12841225|P2|STARTED|Induction Period||138
5222195|NCT00941031|12841226|P1|STARTED|Induction Period||66
5222196|NCT00940992|12841252|P3|NOT COMPLETED|Overall Study||2
5222197|NCT00940992|12841253|P2|NOT COMPLETED|Overall Study||2
5222198|NCT00940992|12841254|P1|NOT COMPLETED|Overall Study||4
5222199|NCT00940992|12841252|P3|COMPLETED|Overall Study||28
5222200|NCT00940992|12841253|P2|COMPLETED|Overall Study||28
5222201|NCT00940992|12841254|P1|COMPLETED|Overall Study||28
5222202|NCT00940992|12841252|P3|STARTED|Overall Study||30
5222203|NCT00940992|12841253|P2|STARTED|Overall Study||30
5222204|NCT00940992|12841254|P1|STARTED|Overall Study||32
5222205|NCT00940927|12841265|P1|NOT COMPLETED|Overall Study||0
5222206|NCT00940927|12841265|P1|COMPLETED|Overall Study||81
5222207|NCT00940927|12841265|P1|STARTED|Overall Study||81
5222208|NCT00940901|12841272|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
5222209|NCT00940901|12841273|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
5222210|NCT00940901|12841272|P2|COMPLETED|Week 9-16 (Phase 2)||4
5222211|NCT00940901|12841273|P1|COMPLETED|Week 9-16 (Phase 2)||4
5222212|NCT00940901|12841272|P2|STARTED|Week 9-16 (Phase 2)||7
5222213|NCT00940901|12841273|P1|STARTED|Week 9-16 (Phase 2)||6
5222214|NCT00940901|12841272|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
5222215|NCT00940901|12841273|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
5222216|NCT00940901|12841272|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
5222217|NCT00940901|12841273|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
5222218|NCT00940901|12841272|P2|STARTED|Weeks 1-8 (Phase 1)||7
5222219|NCT00940901|12841273|P1|STARTED|Weeks 1-8 (Phase 1)||6
5222220|NCT00940888|12841283|P1|NOT COMPLETED|Overall Study||835
5222221|NCT00940888|12841283|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
5222222|NCT00940888|12841283|P1|STARTED|Overall Study|Total number of subjects consented|1701
5222223|NCT00940875|12841290|P2|NOT COMPLETED|Post-Study Treatment||3
5222224|NCT00940875|12841291|P1|NOT COMPLETED|Post-Study Treatment||0
5222225|NCT00940875|12841290|P2|COMPLETED|Post-Study Treatment||1
5222226|NCT00940875|12841291|P1|COMPLETED|Post-Study Treatment||0
5222227|NCT00940875|12841290|P2|STARTED|Post-Study Treatment||4
5222228|NCT00940875|12841291|P1|STARTED|Post-Study Treatment||0
5222229|NCT00940875|12841290|P2|NOT COMPLETED|Treatment Phase||19
5222230|NCT00940875|12841291|P1|NOT COMPLETED|Treatment Phase||26
5222231|NCT00940875|12841290|P2|COMPLETED|Treatment Phase||4
5222232|NCT00940875|12841291|P1|COMPLETED|Treatment Phase||5
5222233|NCT00940875|12841290|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
5222234|NCT00940875|12841291|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
5222235|NCT00940823|12841311|P2|NOT COMPLETED|Overall Study||32
5222236|NCT00940823|12841312|P1|NOT COMPLETED|Overall Study||35
5222237|NCT00940823|12841311|P2|COMPLETED|Overall Study||82
5222238|NCT00940823|12841312|P1|COMPLETED|Overall Study||89
5222239|NCT00940823|12841311|P2|STARTED|Overall Study||114
5222240|NCT00940823|12841312|P1|STARTED|Overall Study||124
5222241|NCT00940771|12841328|P1|NOT COMPLETED|24 Weeks||0
5222242|NCT00940771|12841328|P1|COMPLETED|24 Weeks||10
5222243|NCT00940771|12841328|P1|STARTED|24 Weeks||10
5222244|NCT00940771|12841328|P1|NOT COMPLETED|12 Weeks||0
5222245|NCT00940771|12841328|P1|COMPLETED|12 Weeks||10
5222246|NCT00940771|12841328|P1|STARTED|12 Weeks||10
5222247|NCT00940771|12841328|P1|NOT COMPLETED|4 Weeks||0
5222248|NCT00940771|12841328|P1|COMPLETED|4 Weeks||10
5222249|NCT00940771|12841328|P1|STARTED|4 Weeks||10
5222250|NCT00940771|12841328|P1|NOT COMPLETED|Pre-Entry||0
5222251|NCT00940771|12841328|P1|COMPLETED|Pre-Entry||10
5222252|NCT00940771|12841328|P1|STARTED|Pre-Entry||10
5222253|NCT00940589|12841337|P2|NOT COMPLETED|Overall Study||5
5222254|NCT00940589|12841338|P1|NOT COMPLETED|Overall Study||8
5222255|NCT00940589|12841337|P2|COMPLETED|Overall Study||29
5222256|NCT00940589|12841338|P1|COMPLETED|Overall Study||31
5222257|NCT00940589|12841337|P2|STARTED|Overall Study||34
5222258|NCT00940589|12841338|P1|STARTED|Overall Study||39
5222259|NCT00940576|12841348|P2|NOT COMPLETED|Overall Study||0
5222260|NCT00940576|12841349|P1|NOT COMPLETED|Overall Study||0
5222261|NCT00940576|12841348|P2|COMPLETED|Overall Study||9
5222262|NCT00940576|12841349|P1|COMPLETED|Overall Study||8
5222263|NCT00940576|12841348|P2|STARTED|Overall Study||9
5222264|NCT00940576|12841349|P1|STARTED|Overall Study||8
5222265|NCT00940537|12841358|P2|NOT COMPLETED|Overall Study||0
5222266|NCT00940537|12841359|P1|NOT COMPLETED|Overall Study||0
5222267|NCT00940537|12841358|P2|COMPLETED|Overall Study||9
5222268|NCT00940537|12841359|P1|COMPLETED|Overall Study||5
5222269|NCT00940537|12841358|P2|STARTED|Overall Study||9
5222270|NCT00940537|12841359|P1|STARTED|Overall Study||5
5222271|NCT00940498|12841376|P8|NOT COMPLETED|Overall Study||1
5222272|NCT00940498|12841377|P7|NOT COMPLETED|Overall Study||1
5222273|NCT00940498|12841378|P6|NOT COMPLETED|Overall Study||1
5222274|NCT00940498|12841379|P5|NOT COMPLETED|Overall Study||9
5222275|NCT00940498|12841380|P4|NOT COMPLETED|Overall Study||2
5222276|NCT00940498|12841381|P3|NOT COMPLETED|Overall Study||3
5222277|NCT00940498|12841382|P2|NOT COMPLETED|Overall Study||1
5222278|NCT00940498|12841383|P1|NOT COMPLETED|Overall Study||3
5222279|NCT00940498|12841376|P8|COMPLETED|Overall Study||3
5222280|NCT00940498|12841377|P7|COMPLETED|Overall Study||7
5222281|NCT00940498|12841378|P6|COMPLETED|Overall Study||6
5222282|NCT00940498|12841379|P5|COMPLETED|Overall Study||34
5222283|NCT00940498|12841380|P4|COMPLETED|Overall Study||2
5222284|NCT00940498|12841381|P3|COMPLETED|Overall Study||1
5222285|NCT00940498|12841382|P2|COMPLETED|Overall Study||3
5222286|NCT00940498|12841383|P1|COMPLETED|Overall Study||1
5222287|NCT00940498|12841376|P8|STARTED|Overall Study||4
5222288|NCT00940498|12841377|P7|STARTED|Overall Study||8
5222289|NCT00940498|12841378|P6|STARTED|Overall Study||7
5222290|NCT00940498|12841379|P5|STARTED|Overall Study||43
5222291|NCT00940498|12841380|P4|STARTED|Overall Study||4
5222292|NCT00940498|12841381|P3|STARTED|Overall Study||4
5222293|NCT00940498|12841382|P2|STARTED|Overall Study||4
5222294|NCT00940498|12841383|P1|STARTED|Overall Study||4
5222295|NCT00940485|12841501|P2|NOT COMPLETED|Overall Study||7
5222296|NCT00940485|12841502|P1|NOT COMPLETED|Overall Study||15
5222297|NCT00940485|12841501|P2|COMPLETED|Overall Study||93
5222298|NCT00940485|12841502|P1|COMPLETED|Overall Study||82
5222299|NCT00940485|12841501|P2|STARTED|Overall Study||100
5222300|NCT00940485|12841502|P1|STARTED|Overall Study||97
5222301|NCT00940446|12841528|P2|NOT COMPLETED|Overall Study||0
5222302|NCT00940446|12841529|P1|NOT COMPLETED|Overall Study||0
5222303|NCT00940446|12841528|P2|COMPLETED|Overall Study||30
5222304|NCT00940446|12841529|P1|COMPLETED|Overall Study||30
5222305|NCT00940446|12841528|P2|STARTED|Overall Study||30
5222306|NCT00940446|12841529|P1|STARTED|Overall Study||30
5222307|NCT00940342|12841540|P3|NOT COMPLETED|Overall Study||1
5222308|NCT00940342|12841541|P2|NOT COMPLETED|Overall Study||2
5222309|NCT00940342|12841542|P1|NOT COMPLETED|Overall Study||0
5222310|NCT00940342|12841540|P3|COMPLETED|Overall Study||39
5222311|NCT00940342|12841541|P2|COMPLETED|Overall Study||38
5222312|NCT00940342|12841542|P1|COMPLETED|Overall Study||50
5222313|NCT00940342|12841540|P3|STARTED|Overall Study||40
5222314|NCT00940342|12841541|P2|STARTED|Overall Study||40
5222315|NCT00940342|12841542|P1|STARTED|Overall Study||50
5222316|NCT00940316|12841553|P3|NOT COMPLETED|Follow up Every 3 Months||0
5222317|NCT00940316|12841554|P2|NOT COMPLETED|Follow up Every 3 Months||0
5222318|NCT00940316|12841555|P1|NOT COMPLETED|Follow up Every 3 Months||0
5222319|NCT00940316|12841553|P3|COMPLETED|Follow up Every 3 Months||2
5222320|NCT00940316|12841554|P2|COMPLETED|Follow up Every 3 Months||13
5222321|NCT00940316|12841555|P1|COMPLETED|Follow up Every 3 Months||13
5222322|NCT00940316|12841553|P3|STARTED|Follow up Every 3 Months||2
5222323|NCT00940316|12841554|P2|STARTED|Follow up Every 3 Months||13
5222324|NCT00940316|12841555|P1|STARTED|Follow up Every 3 Months||13
5222325|NCT00940316|12841553|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
5222326|NCT00940316|12841554|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
5222327|NCT00940316|12841555|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
5222328|NCT00940316|12841553|P3|COMPLETED|Crossed Over to Arm A After Progression||0
5222329|NCT00940316|12841554|P2|COMPLETED|Crossed Over to Arm A After Progression||3
5222330|NCT00940316|12841555|P1|COMPLETED|Crossed Over to Arm A After Progression||0
5222331|NCT00940316|12841553|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
5222332|NCT00940316|12841554|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
5222333|NCT00940316|12841555|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
5222334|NCT00940316|12841553|P3|STARTED|Crossed Over to Arm A After Progression||0
5222335|NCT00940316|12841554|P2|STARTED|Crossed Over to Arm A After Progression||3
5222336|NCT00940316|12841555|P1|STARTED|Crossed Over to Arm A After Progression||0
5222337|NCT00940316|12841553|P3|NOT COMPLETED|Treated After Cycle 5||1
5222338|NCT00940316|12841554|P2|NOT COMPLETED|Treated After Cycle 5||1
5222339|NCT00940316|12841555|P1|NOT COMPLETED|Treated After Cycle 5||0
5222340|NCT00940316|12841553|P3|COMPLETED|Treated After Cycle 5||1
5222341|NCT00940316|12841554|P2|COMPLETED|Treated After Cycle 5||8
5222342|NCT00940316|12841555|P1|COMPLETED|Treated After Cycle 5||8
5222343|NCT00940316|12841553|P3|STARTED|Treated After Cycle 5||2
5222344|NCT00940316|12841554|P2|STARTED|Treated After Cycle 5||9
5222345|NCT00940316|12841555|P1|STARTED|Treated After Cycle 5||8
5222346|NCT00940316|12841553|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
5222347|NCT00940316|12841554|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
5222348|NCT00940316|12841555|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
5222349|NCT00940316|12841553|P3|COMPLETED|Moved on to be Treated Cycle 5||2
5222350|NCT00940316|12841554|P2|COMPLETED|Moved on to be Treated Cycle 5||9
5222351|NCT00940316|12841555|P1|COMPLETED|Moved on to be Treated Cycle 5||8
5222352|NCT00940316|12841553|P3|STARTED|Moved on to be Treated Cycle 5||2
5222353|NCT00940316|12841554|P2|STARTED|Moved on to be Treated Cycle 5||9
5222354|NCT00940316|12841555|P1|STARTED|Moved on to be Treated Cycle 5||10
5222355|NCT00940316|12841553|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
5222356|NCT00940316|12841554|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
5222357|NCT00940316|12841555|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
5222358|NCT00940316|12841553|P3|COMPLETED|Reached First Response at 8 Weeks||2
5222359|NCT00940316|12841554|P2|COMPLETED|Reached First Response at 8 Weeks||9
5222360|NCT00940316|12841555|P1|COMPLETED|Reached First Response at 8 Weeks||10
5222361|NCT00940316|12841553|P3|STARTED|Reached First Response at 8 Weeks||2
5222362|NCT00940316|12841554|P2|STARTED|Reached First Response at 8 Weeks||13
5222363|NCT00940316|12841555|P1|STARTED|Reached First Response at 8 Weeks||13
5222364|NCT00940290|12841581|P4|NOT COMPLETED|Overall Study||0
5222365|NCT00940290|12841582|P3|NOT COMPLETED|Overall Study||0
5222366|NCT00940290|12841583|P2|NOT COMPLETED|Overall Study||0
5222367|NCT00940290|12841584|P1|NOT COMPLETED|Overall Study||0
5222368|NCT00940290|12841581|P4|COMPLETED|Overall Study||54
5222369|NCT00940290|12841582|P3|COMPLETED|Overall Study||55
5222370|NCT00940290|12841583|P2|COMPLETED|Overall Study||53
5222371|NCT00940290|12841584|P1|COMPLETED|Overall Study||54
5222372|NCT00940290|12841581|P4|STARTED|Overall Study||54
5222373|NCT00940290|12841582|P3|STARTED|Overall Study||55
5222374|NCT00940290|12841583|P2|STARTED|Overall Study||53
5222375|NCT00940290|12841584|P1|STARTED|Overall Study||54
5222376|NCT00940108|12841598|P4|NOT COMPLETED|Overall Study||5
5222377|NCT00940108|12841599|P3|NOT COMPLETED|Overall Study||3
5222378|NCT00940108|12841600|P2|NOT COMPLETED|Overall Study||9
5222379|NCT00940108|12841601|P1|NOT COMPLETED|Overall Study||5
5222380|NCT00940108|12841598|P4|COMPLETED|Overall Study||99
5222381|NCT00940108|12841599|P3|COMPLETED|Overall Study||100
5222382|NCT00940108|12841600|P2|COMPLETED|Overall Study||71
5222383|NCT00940108|12841601|P1|COMPLETED|Overall Study||77
5222384|NCT00940108|12841598|P4|STARTED|Overall Study||104
5222385|NCT00940108|12841599|P3|STARTED|Overall Study||103
5222386|NCT00940108|12841600|P2|STARTED|Overall Study||80
5222387|NCT00940108|12841601|P1|STARTED|Overall Study||82
5222388|NCT00940017|12841651|P1|NOT COMPLETED|Overall Study||4
5222389|NCT00940017|12841651|P1|COMPLETED|Overall Study||20
5222390|NCT00940017|12841651|P1|Subjects Treated|Overall Study||21
5222391|NCT00940017|12841651|P1|STARTED|Overall Study||24
5222392|NCT00939991|12841672|P2|NOT COMPLETED|Overall Study||0
5222393|NCT00939991|12841673|P1|NOT COMPLETED|Overall Study||0
5222394|NCT00939991|12841672|P2|COMPLETED|Overall Study||39
5222395|NCT00939991|12841673|P1|COMPLETED|Overall Study||9
5222396|NCT00939991|12841672|P2|STARTED|Overall Study||39
5222397|NCT00939991|12841673|P1|STARTED|Overall Study||9
5222398|NCT00939952|12841683|P1|NOT COMPLETED|Overall Study||0
5222399|NCT00939952|12841683|P1|COMPLETED|Overall Study||7
5222400|NCT00939952|12841683|P1|STARTED|Overall Study||7
5222401|NCT00939900|12841695|P2|NOT COMPLETED|Overall Study||7
5222402|NCT00939900|12841696|P1|NOT COMPLETED|Overall Study||2
5222403|NCT00939900|12841695|P2|COMPLETED|Overall Study||48
5222404|NCT00939900|12841696|P1|COMPLETED|Overall Study||53
5222405|NCT00939900|12841695|P2|STARTED|Overall Study||55
5222406|NCT00939900|12841696|P1|STARTED|Overall Study||55
5222407|NCT00939874|12841702|P1|NOT COMPLETED|Overall Study||20
5222408|NCT00939874|12841702|P1|COMPLETED|Overall Study||32
5222409|NCT00939874|12841702|P1|Completed Week 48|Overall Study||37
5222410|NCT00939874|12841702|P1|STARTED|Overall Study||52
5222411|NCT00939822|12841709|P2|NOT COMPLETED|Overall Study||3
5222412|NCT00939822|12841710|P1|NOT COMPLETED|Overall Study||2
5222413|NCT00939822|12841709|P2|COMPLETED|Overall Study||41
5222414|NCT00939822|12841710|P1|COMPLETED|Overall Study||42
5222415|NCT00939822|12841709|P2|STARTED|Overall Study||44
5222416|NCT00939822|12841710|P1|STARTED|Overall Study||44
5222417|NCT00939809|12841722|P1|NOT COMPLETED|Overall Study||3
5222418|NCT00939809|12841722|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
5222419|NCT00939809|12841722|P1|STARTED|Overall Study||31
5222420|NCT00939796|12841731|P1|NOT COMPLETED|Overall Study||0
5222421|NCT00939796|12841731|P1|COMPLETED|Overall Study||16
5222422|NCT00939796|12841731|P1|STARTED|Overall Study||16
5222423|NCT00939783|12841737|P1|NOT COMPLETED|Overall Study||649
5222424|NCT00939783|12841737|P1|COMPLETED|Overall Study||0
5222425|NCT00939783|12841737|P1|Treated|Overall Study||648
5222426|NCT00939783|12841737|P1|STARTED|Overall Study||649
5222427|NCT00939770|12841752|P8|NOT COMPLETED|Overall Study||10
5222428|NCT00939770|12841753|P7|NOT COMPLETED|Overall Study||14
5222429|NCT00939770|12841754|P6|NOT COMPLETED|Overall Study||11
5222430|NCT00939770|12841755|P5|NOT COMPLETED|Overall Study||37
5222431|NCT00939770|12841756|P4|NOT COMPLETED|Overall Study||11
5222432|NCT00939770|12841757|P3|NOT COMPLETED|Overall Study||20
5222433|NCT00939770|12841758|P2|NOT COMPLETED|Overall Study||8
5222434|NCT00939770|12841759|P1|NOT COMPLETED|Overall Study||5
5222435|NCT00939770|12841752|P8|COMPLETED|Overall Study||0
5222436|NCT00939770|12841753|P7|COMPLETED|Overall Study||0
5222437|NCT00939770|12841754|P6|COMPLETED|Overall Study||0
5222438|NCT00939770|12841755|P5|COMPLETED|Overall Study||1
5222439|NCT00939770|12841756|P4|COMPLETED|Overall Study||1
5222440|NCT00939770|12841757|P3|COMPLETED|Overall Study||3
5222441|NCT00939770|12841758|P2|COMPLETED|Overall Study||0
5222442|NCT00939770|12841759|P1|COMPLETED|Overall Study||1
5222443|NCT00939770|12841752|P8|STARTED|Overall Study||10
5222444|NCT00939770|12841753|P7|STARTED|Overall Study||14
5222445|NCT00939770|12841754|P6|STARTED|Overall Study||11
5222446|NCT00939770|12841755|P5|STARTED|Overall Study||38
5222447|NCT00939770|12841756|P4|STARTED|Overall Study||12
5222448|NCT00939770|12841757|P3|STARTED|Overall Study||23
5222449|NCT00939770|12841758|P2|STARTED|Overall Study||8
5222450|NCT00939770|12841759|P1|STARTED|Overall Study||6
5222451|NCT00939731|12841810|P2|NOT COMPLETED|Second Intervention Period||0
5222452|NCT00939731|12841811|P1|NOT COMPLETED|Second Intervention Period||0
5222453|NCT00939731|12841810|P2|COMPLETED|Second Intervention Period||12
5222454|NCT00939731|12841811|P1|COMPLETED|Second Intervention Period||12
5222455|NCT00939731|12841810|P2|STARTED|Second Intervention Period||12
5222456|NCT00939731|12841811|P1|STARTED|Second Intervention Period||12
5222457|NCT00939731|12841810|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5222458|NCT00939731|12841811|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5222459|NCT00939731|12841810|P2|COMPLETED|Washout Period (at Least 14 Days)||12
5222460|NCT00939731|12841811|P1|COMPLETED|Washout Period (at Least 14 Days)||12
5222461|NCT00939731|12841810|P2|STARTED|Washout Period (at Least 14 Days)||12
5222462|NCT00939731|12841811|P1|STARTED|Washout Period (at Least 14 Days)||12
5222463|NCT00939731|12841810|P2|NOT COMPLETED|First Intervention Period||0
5222464|NCT00939731|12841811|P1|NOT COMPLETED|First Intervention Period||0
5222465|NCT00939731|12841810|P2|COMPLETED|First Intervention Period||12
5222466|NCT00939731|12841811|P1|COMPLETED|First Intervention Period||12
5222467|NCT00939731|12841810|P2|STARTED|First Intervention Period||12
5222468|NCT00939731|12841811|P1|STARTED|First Intervention Period||12
5222469|NCT00939705|12841831|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
5222470|NCT00939705|12841832|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
5222471|NCT00939705|12841831|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
5222472|NCT00939705|12841832|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
5222473|NCT00939705|12841831|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
5222474|NCT00939705|12841832|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
5222475|NCT00939705|12841831|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
5222476|NCT00939705|12841832|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
5222477|NCT00939705|12841831|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
5222478|NCT00939705|12841832|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
5222479|NCT00939705|12841831|P2|STARTED|Period 2 - Washout Period - 21 Days||9
5222480|NCT00939705|12841832|P1|STARTED|Period 2 - Washout Period - 21 Days||9
5222481|NCT00939705|12841831|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
5222482|NCT00939705|12841832|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
5222483|NCT00939705|12841831|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
5222484|NCT00939705|12841832|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
5222485|NCT00939705|12841831|P2|STARTED|Period 1 - First Intervention - 5 Days||9
5222486|NCT00939705|12841832|P1|STARTED|Period 1 - First Intervention - 5 Days||9
5222487|NCT00939692|12841844|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
5222488|NCT00939692|12841845|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
5222489|NCT00939692|12841844|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
5222490|NCT00939692|12841845|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
5222491|NCT00939692|12841844|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
5222492|NCT00939692|12841845|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
5222493|NCT00939692|12841844|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
5222494|NCT00939692|12841845|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
5222495|NCT00939692|12841844|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
5222496|NCT00939692|12841845|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
5222497|NCT00939692|12841844|P2|STARTED|Period 1 - First Intervention - 5 Days||13
5222498|NCT00939692|12841845|P1|STARTED|Period 1 - First Intervention - 5 Days||13
5222499|NCT00939653|12841855|P1|NOT COMPLETED|Treatment Course 4||0
5222500|NCT00939653|12841855|P1|COMPLETED|Treatment Course 4||0
5222501|NCT00939653|12841855|P1|STARTED|Treatment Course 4||0
5222502|NCT00939653|12841855|P1|NOT COMPLETED|Treatment Course 3||0
5222503|NCT00939653|12841855|P1|COMPLETED|Treatment Course 3||0
5222504|NCT00939653|12841855|P1|STARTED|Treatment Course 3||0
5222505|NCT00939653|12841855|P1|NOT COMPLETED|Treatment Course 2||0
5222506|NCT00939653|12841855|P1|COMPLETED|Treatment Course 2||2
5222507|NCT00939653|12841855|P1|STARTED|Treatment Course 2||2
5222508|NCT00939653|12841855|P1|NOT COMPLETED|Treatment Course 1||0
5222509|NCT00939653|12841855|P1|COMPLETED|Treatment Course 1||6
5222510|NCT00939653|12841855|P1|STARTED|Treatment Course 1||6
5222511|NCT00939640|12841860|P1|NOT COMPLETED|Overall Study||1
5222512|NCT00939640|12841860|P1|COMPLETED|Overall Study||13
5222513|NCT00939640|12841860|P1|STARTED|Overall Study||14
5222514|NCT00939627|12841881|P3|NOT COMPLETED|Overall Study||0
5222515|NCT00939627|12841882|P2|NOT COMPLETED|Overall Study||28
5222516|NCT00939627|12841883|P1|NOT COMPLETED|Overall Study||27
5222517|NCT00939627|12841881|P3|COMPLETED|Overall Study||0
5222518|NCT00939627|12841882|P2|COMPLETED|Overall Study||0
5222519|NCT00939627|12841883|P1|COMPLETED|Overall Study||0
5222520|NCT00939627|12841881|P3|STARTED|Overall Study||0
5222521|NCT00939627|12841882|P2|STARTED|Overall Study||28
5222522|NCT00939627|12841883|P1|STARTED|Overall Study||27
5222523|NCT00939562|12841901|P2|NOT COMPLETED|Period 2||0
5222524|NCT00939562|12841902|P1|NOT COMPLETED|Period 2||0
5222525|NCT00939562|12841901|P2|COMPLETED|Period 2||12
5222526|NCT00939562|12841902|P1|COMPLETED|Period 2||12
5222527|NCT00939562|12841901|P2|STARTED|Period 2||12
5222528|NCT00939562|12841902|P1|STARTED|Period 2||12
5222529|NCT00939562|12841901|P2|NOT COMPLETED|Period 1||0
5222530|NCT00939562|12841902|P1|NOT COMPLETED|Period 1||0
5222531|NCT00939562|12841901|P2|COMPLETED|Period 1||12
5222532|NCT00939562|12841902|P1|COMPLETED|Period 1||12
5222533|NCT00939562|12841901|P2|STARTED|Period 1||12
5222534|NCT00939562|12841902|P1|STARTED|Period 1||12
5222535|NCT00939536|12841912|P2|NOT COMPLETED|Second Intervention||0
5222536|NCT00939536|12841913|P1|NOT COMPLETED|Second Intervention||0
5222537|NCT00939536|12841912|P2|COMPLETED|Second Intervention||12
5222538|NCT00939536|12841913|P1|COMPLETED|Second Intervention||12
5222539|NCT00939536|12841912|P2|STARTED|Second Intervention||12
5222540|NCT00939536|12841913|P1|STARTED|Second Intervention||12
5222541|NCT00939536|12841912|P2|NOT COMPLETED|First Intervention||0
5222542|NCT00939536|12841913|P1|NOT COMPLETED|First Intervention||0
5222543|NCT00939536|12841912|P2|COMPLETED|First Intervention||12
5222544|NCT00939536|12841913|P1|COMPLETED|First Intervention||12
5222545|NCT00939536|12841912|P2|STARTED|First Intervention||12
5222546|NCT00939536|12841913|P1|STARTED|First Intervention||12
5222547|NCT00939523|12841923|P1|NOT COMPLETED|Overall Study||3
5222548|NCT00939523|12841923|P1|COMPLETED|Overall Study||6
5222549|NCT00939523|12841923|P1|STARTED|Overall Study||9
5222550|NCT00939510|12841930|P1|NOT COMPLETED|Overall Study||1
5222551|NCT00939510|12841930|P1|COMPLETED|Overall Study||31
5222552|NCT00939510|12841930|P1|STARTED|Overall Study||32
5222553|NCT00939484|12841939|P3|NOT COMPLETED|Overall Study||3
5222554|NCT00939484|12841940|P2|NOT COMPLETED|Overall Study||20
5222555|NCT00939484|12841941|P1|NOT COMPLETED|Overall Study||8
5222556|NCT00939484|12841939|P3|COMPLETED|Overall Study||0
5222557|NCT00939484|12841940|P2|COMPLETED|Overall Study||0
5222558|NCT00939484|12841941|P1|COMPLETED|Overall Study||0
5222559|NCT00939484|12841939|P3|STARTED|Overall Study||3
5222560|NCT00939484|12841940|P2|STARTED|Overall Study||20
5222561|NCT00939484|12841941|P1|STARTED|Overall Study||8
5222562|NCT00939471|12841954|P1|NOT COMPLETED|Overall Study||11
5222563|NCT00939471|12841954|P1|COMPLETED|Overall Study||33
5222564|NCT00939471|12841954|P1|STARTED|Overall Study||44
5222565|NCT00939393|12841967|P2|NOT COMPLETED|Overall Study||0
5222566|NCT00939393|12841968|P1|NOT COMPLETED|Overall Study||4
5222567|NCT00939393|12841967|P2|COMPLETED|Overall Study||35
5222568|NCT00939393|12841968|P1|COMPLETED|Overall Study||33
5222569|NCT00939393|12841967|P2|STARTED|Overall Study||35
5222570|NCT00939393|12841968|P1|STARTED|Overall Study||37
5222571|NCT00939367|12841988|P2|NOT COMPLETED|Second Intervention||0
5222572|NCT00939367|12841989|P1|NOT COMPLETED|Second Intervention||0
5222573|NCT00939367|12841988|P2|COMPLETED|Second Intervention||15
5222574|NCT00939367|12841989|P1|COMPLETED|Second Intervention||15
5222575|NCT00939367|12841988|P2|STARTED|Second Intervention||15
5222576|NCT00939367|12841989|P1|STARTED|Second Intervention||15
5222577|NCT00939367|12841988|P2|NOT COMPLETED|First Intervention||0
5222578|NCT00939367|12841989|P1|NOT COMPLETED|First Intervention||0
5222579|NCT00939367|12841988|P2|COMPLETED|First Intervention||15
5222580|NCT00939367|12841989|P1|COMPLETED|First Intervention||15
5222581|NCT00939367|12841988|P2|STARTED|First Intervention||15
5222582|NCT00939367|12841989|P1|STARTED|First Intervention||15
5222583|NCT00939341|12841999|P1|NOT COMPLETED|Overall Study||66
5222584|NCT00939341|12841999|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
5222585|NCT00939341|12841999|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
5222586|NCT00939211|12842019|P1|NOT COMPLETED|Placebo||0
5222587|NCT00939211|12842019|P1|COMPLETED|Placebo||28
5222588|NCT00939211|12842019|P1|STARTED|Placebo||28
5222589|NCT00939211|12842019|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
5222590|NCT00939211|12842019|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
5222591|NCT00939211|12842019|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
5222592|NCT00939211|12842019|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
5222593|NCT00939211|12842019|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
5222594|NCT00939211|12842019|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
5222595|NCT00939211|12842019|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
5222596|NCT00939211|12842019|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
5222597|NCT00939211|12842019|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
5222598|NCT00939211|12842019|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
5222599|NCT00939211|12842019|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
5222600|NCT00939211|12842019|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
5222601|NCT00939198|12842081|P1|NOT COMPLETED|Overall Study||0
5222602|NCT00939198|12842081|P1|COMPLETED|Overall Study||87
5222603|NCT00939198|12842081|P1|STARTED|Overall Study||87
5222604|NCT00939185|12842086|P1|NOT COMPLETED|Overall Study||25
5222605|NCT00939185|12842086|P1|COMPLETED|Overall Study||375
5222606|NCT00939185|12842086|P1|Received Treatment|Overall Study||390
5222607|NCT00939185|12842086|P1|STARTED|Overall Study||400
5222608|NCT00939159|12842093|P1|NOT COMPLETED|Overall Study||0
5222609|NCT00939159|12842093|P1|COMPLETED|Overall Study||13
5222610|NCT00939159|12842093|P1|STARTED|Overall Study||13
5222611|NCT00939120|12842099|P2|NOT COMPLETED|Overall Study||5
5222612|NCT00939120|12842100|P1|NOT COMPLETED|Overall Study||8
5222613|NCT00939120|12842099|P2|COMPLETED|Overall Study||18
5222614|NCT00939120|12842100|P1|COMPLETED|Overall Study||15
5222615|NCT00939120|12842099|P2|STARTED|Overall Study||23
5222616|NCT00939120|12842100|P1|STARTED|Overall Study||23
5222617|NCT00939107|12842124|P2|NOT COMPLETED|Overall Study||12
5222618|NCT00939107|12842125|P1|NOT COMPLETED|Overall Study||14
5222619|NCT00939107|12842124|P2|COMPLETED|Overall Study||163
5222620|NCT00939107|12842125|P1|COMPLETED|Overall Study||161
5222621|NCT00939107|12842124|P2|12 Months Follow-up|Overall Study||163
5222622|NCT00939107|12842125|P1|12 Months Follow-up|Overall Study||161
5222623|NCT00939107|12842124|P2|STARTED|Overall Study||175
5222624|NCT00939107|12842125|P1|STARTED|Overall Study||175
5222625|NCT00939094|12842139|P2|NOT COMPLETED|Overall Study||10
5222626|NCT00939094|12842140|P1|NOT COMPLETED|Overall Study||14
5222627|NCT00939094|12842139|P2|COMPLETED|Overall Study||35
5222628|NCT00939094|12842140|P1|COMPLETED|Overall Study||28
5222629|NCT00939094|12842139|P2|STARTED|Overall Study||45
5222630|NCT00939094|12842140|P1|STARTED|Overall Study||42
5222631|NCT00939055|12842162|P2|NOT COMPLETED|Overall Study||0
5222632|NCT00939055|12842163|P1|NOT COMPLETED|Overall Study||4
5222633|NCT00939055|12842162|P2|COMPLETED|Overall Study||39
5222634|NCT00939055|12842163|P1|COMPLETED|Overall Study||69
5222635|NCT00939055|12842162|P2|STARTED|Overall Study||39
5222636|NCT00939055|12842163|P1|STARTED|Overall Study||73
5222637|NCT00939029|12842173|P2|NOT COMPLETED|Overall Study||12
5222638|NCT00939029|12842174|P1|NOT COMPLETED|Overall Study||6
5222639|NCT00939029|12842173|P2|COMPLETED|Overall Study||15
5222640|NCT00939029|12842174|P1|COMPLETED|Overall Study||19
5222641|NCT00939029|12842173|P2|STARTED|Overall Study||27
5222642|NCT00939029|12842174|P1|STARTED|Overall Study||25
5222643|NCT00939003|12842186|P2|NOT COMPLETED|Open-label Treatment Period||29
5222644|NCT00939003|12842187|P1|NOT COMPLETED|Open-label Treatment Period||29
5222645|NCT00939003|12842186|P2|COMPLETED|Open-label Treatment Period||62
5222646|NCT00939003|12842187|P1|COMPLETED|Open-label Treatment Period||66
5222647|NCT00939003|12842186|P2|STARTED|Open-label Treatment Period||91
5222648|NCT00939003|12842187|P1|STARTED|Open-label Treatment Period||95
5222649|NCT00939003|12842186|P2|NOT COMPLETED|Double-blind Treatment Period||4
5222650|NCT00939003|12842187|P1|NOT COMPLETED|Double-blind Treatment Period||2
5222651|NCT00939003|12842186|P2|COMPLETED|Double-blind Treatment Period||91
5222652|NCT00939003|12842187|P1|COMPLETED|Double-blind Treatment Period||95
5222653|NCT00939003|12842186|P2|STARTED|Double-blind Treatment Period||95
5222654|NCT00939003|12842187|P1|STARTED|Double-blind Treatment Period||97
5222655|NCT00938964|12842224|P2|NOT COMPLETED|Overall Study||28
5222656|NCT00938964|12842225|P1|NOT COMPLETED|Overall Study||30
5222657|NCT00938964|12842224|P2|COMPLETED|Overall Study||209
5222658|NCT00938964|12842225|P1|COMPLETED|Overall Study||211
5222659|NCT00938964|12842224|P2|STARTED|Overall Study||237
5222660|NCT00938964|12842225|P1|STARTED|Overall Study||241
5222661|NCT00938886|12842289|P2|NOT COMPLETED|Overall Study||10
5222662|NCT00938886|12842290|P1|NOT COMPLETED|Overall Study||7
5222663|NCT00938886|12842289|P2|COMPLETED|Overall Study||65
5222664|NCT00938886|12842290|P1|COMPLETED|Overall Study||68
5222665|NCT00938886|12842289|P2|Attended 1 Counseling Session|Overall Study||70
5222666|NCT00938886|12842290|P1|Attended 1 Counseling Session|Overall Study||70
5222667|NCT00938886|12842289|P2|STARTED|Overall Study||75
5222668|NCT00938886|12842290|P1|STARTED|Overall Study||75
5222669|NCT00938860|12842300|P2|NOT COMPLETED|Overall Study||17
5222670|NCT00938860|12842301|P1|NOT COMPLETED|Overall Study||25
5222671|NCT00938860|12842300|P2|COMPLETED|Overall Study||25
5222672|NCT00938860|12842301|P1|COMPLETED|Overall Study||25
5222673|NCT00938860|12842300|P2|Efficacy Population|Overall Study||41
5222674|NCT00938860|12842301|P1|Efficacy Population|Overall Study||40
5222675|NCT00938860|12842300|P2|STARTED|Overall Study||42
5222676|NCT00938860|12842301|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
5222677|NCT00938782|12842325|P2|NOT COMPLETED|Overall Study||0
5222678|NCT00938782|12842326|P1|NOT COMPLETED|Overall Study||0
5222679|NCT00938782|12842325|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
5222680|NCT00938782|12842326|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
5222681|NCT00938782|12842325|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
5222682|NCT00938782|12842326|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
5222683|NCT00938717|12842334|P2|NOT COMPLETED|Overall Study||108
5222684|NCT00938717|12842335|P1|NOT COMPLETED|Overall Study||98
5222685|NCT00938717|12842334|P2|COMPLETED|Overall Study||294
5222686|NCT00938717|12842335|P1|COMPLETED|Overall Study||305
5222687|NCT00938717|12842334|P2|STARTED|Overall Study||402
5222688|NCT00938717|12842335|P1|STARTED|Overall Study||403
5222689|NCT00938704|12842369|P2|NOT COMPLETED|Overall Study||0
5222690|NCT00938704|12842370|P1|NOT COMPLETED|Overall Study||0
5222691|NCT00938704|12842369|P2|COMPLETED|Overall Study||37
5222692|NCT00938704|12842370|P1|COMPLETED|Overall Study||33
5222693|NCT00938704|12842369|P2|STARTED|Overall Study||37
5222694|NCT00938704|12842370|P1|STARTED|Overall Study||33
5222695|NCT00938639|12842386|P2|NOT COMPLETED|Overall Study||4
5222696|NCT00938639|12842387|P1|NOT COMPLETED|Overall Study||3
5222697|NCT00938639|12842386|P2|COMPLETED|Overall Study||116
5222698|NCT00938639|12842387|P1|COMPLETED|Overall Study||117
5222699|NCT00938639|12842386|P2|STARTED|Overall Study||120
5222700|NCT00938639|12842387|P1|STARTED|Overall Study||120
5222701|NCT00938548|12842457|P2|NOT COMPLETED|Overall Study||0
5222702|NCT00938548|12842458|P1|NOT COMPLETED|Overall Study||0
5222703|NCT00938548|12842457|P2|COMPLETED|Overall Study||35
5222704|NCT00938548|12842458|P1|COMPLETED|Overall Study||35
5222705|NCT00938548|12842457|P2|STARTED|Overall Study||35
5222706|NCT00938548|12842458|P1|STARTED|Overall Study||35
5222707|NCT00938470|12842470|P2|NOT COMPLETED|Overall Study||3
5222708|NCT00938470|12842471|P1|NOT COMPLETED|Overall Study||7
5222709|NCT00938470|12842470|P2|COMPLETED|Overall Study||25
5222710|NCT00938470|12842471|P1|COMPLETED|Overall Study||27
5222711|NCT00938470|12842470|P2|STARTED|Overall Study||28
5222712|NCT00938470|12842471|P1|STARTED|Overall Study||34
5222713|NCT00938457|12842485|P1|NOT COMPLETED|Overall Study||0
5222714|NCT00938457|12842485|P1|COMPLETED|Overall Study||3
5222715|NCT00938457|12842485|P1|STARTED|Overall Study||3
5222716|NCT00938431|12842501|P3|NOT COMPLETED|Overall Study||8
5222717|NCT00938431|12842502|P2|NOT COMPLETED|Overall Study||9
5222718|NCT00938431|12842503|P1|NOT COMPLETED|Overall Study||6
5222719|NCT00938431|12842501|P3|COMPLETED|Overall Study||1
5222720|NCT00938431|12842502|P2|COMPLETED|Overall Study||14
5222721|NCT00938431|12842503|P1|COMPLETED|Overall Study||9
5222722|NCT00938431|12842501|P3|STARTED|Overall Study||9
5222723|NCT00938431|12842502|P2|STARTED|Overall Study||23
5222724|NCT00938431|12842503|P1|STARTED|Overall Study||15
5222725|NCT00938392|12842530|P2|NOT COMPLETED|Overall Study||4
5222726|NCT00938392|12842531|P1|NOT COMPLETED|Overall Study||2
5222727|NCT00938392|12842530|P2|COMPLETED|Overall Study||358
5222728|NCT00938392|12842531|P1|COMPLETED|Overall Study||360
5222729|NCT00938392|12842530|P2|STARTED|Overall Study||362
5222730|NCT00938392|12842531|P1|STARTED|Overall Study||362
5222731|NCT00938366|12842557|P2|NOT COMPLETED|Overall Study||0
5222732|NCT00938366|12842558|P1|NOT COMPLETED|Overall Study||1
5222733|NCT00938366|12842557|P2|COMPLETED|Overall Study||9
5222734|NCT00938366|12842558|P1|COMPLETED|Overall Study||8
5222735|NCT00938366|12842557|P2|STARTED|Overall Study||9
5222736|NCT00938366|12842558|P1|STARTED|Overall Study||9
5222737|NCT00938340|12842578|P1|NOT COMPLETED|Overall Study||5
5222738|NCT00938340|12842578|P1|COMPLETED|Overall Study||15
5222739|NCT00938340|12842578|P1|Received Walnut Oil Intervention|Overall Study||15
5222740|NCT00938340|12842578|P1|Received Walnut Skins Intervention|Overall Study||15
5222741|NCT00938340|12842578|P1|Received Walnut Nutmeat Intervention|Overall Study||19
5222742|NCT00938340|12842578|P1|Received Whole Walnut Intervention|Overall Study||16
5222743|NCT00938340|12842578|P1|STARTED|Overall Study||20
5222744|NCT00938327|12842708|P1|NOT COMPLETED|Overall Study||60
5222745|NCT00938327|12842708|P1|COMPLETED|Overall Study||272
5222746|NCT00938327|12842708|P1|STARTED|Overall Study||332
5222747|NCT00938314|12842719|P4|NOT COMPLETED|Cohort 3||1
5222748|NCT00938314|12842720|P3|NOT COMPLETED|Cohort 3||4
5222749|NCT00938314|12842721|P2|NOT COMPLETED|Cohort 3||0
5222750|NCT00938314|12842722|P1|NOT COMPLETED|Cohort 3||0
5222751|NCT00938314|12842719|P4|COMPLETED|Cohort 3||7
5222752|NCT00938314|12842720|P3|COMPLETED|Cohort 3||20
5222753|NCT00938314|12842721|P2|COMPLETED|Cohort 3||0
5222754|NCT00938314|12842722|P1|COMPLETED|Cohort 3||0
5222755|NCT00938314|12842719|P4|STARTED|Cohort 3||8
5222756|NCT00938314|12842720|P3|STARTED|Cohort 3||24
5222757|NCT00938314|12842721|P2|STARTED|Cohort 3||0
5222758|NCT00938314|12842722|P1|STARTED|Cohort 3||0
5222759|NCT00938314|12842719|P4|NOT COMPLETED|Cohort 2||2
5222760|NCT00938314|12842720|P3|NOT COMPLETED|Cohort 2||0
5222761|NCT00938314|12842721|P2|NOT COMPLETED|Cohort 2||6
5222762|NCT00938314|12842722|P1|NOT COMPLETED|Cohort 2||0
5222763|NCT00938314|12842719|P4|COMPLETED|Cohort 2||6
5222764|NCT00938314|12842720|P3|COMPLETED|Cohort 2||0
5222765|NCT00938314|12842721|P2|COMPLETED|Cohort 2||18
5222766|NCT00938314|12842722|P1|COMPLETED|Cohort 2||0
5222767|NCT00938314|12842719|P4|STARTED|Cohort 2||8
5222768|NCT00938314|12842720|P3|STARTED|Cohort 2||0
5222769|NCT00938314|12842721|P2|STARTED|Cohort 2||24
5222770|NCT00938314|12842722|P1|STARTED|Cohort 2||0
5222771|NCT00938314|12842719|P4|NOT COMPLETED|Cohort 1||2
5222772|NCT00938314|12842720|P3|NOT COMPLETED|Cohort 1||0
5222773|NCT00938314|12842721|P2|NOT COMPLETED|Cohort 1||0
5222774|NCT00938314|12842722|P1|NOT COMPLETED|Cohort 1||2
5222775|NCT00938314|12842719|P4|COMPLETED|Cohort 1||6
5222776|NCT00938314|12842720|P3|COMPLETED|Cohort 1||0
5222777|NCT00938314|12842721|P2|COMPLETED|Cohort 1||0
5222778|NCT00938314|12842722|P1|COMPLETED|Cohort 1||22
5222779|NCT00938314|12842719|P4|STARTED|Cohort 1||8
5222780|NCT00938314|12842720|P3|STARTED|Cohort 1||0
5222781|NCT00938314|12842721|P2|STARTED|Cohort 1||0
5222782|NCT00938314|12842722|P1|STARTED|Cohort 1||24
5222783|NCT00938041|12842776|P1|NOT COMPLETED|Overall Study||27
5222784|NCT00938041|12842776|P1|COMPLETED|Overall Study||5
5222785|NCT00938041|12842776|P1|STARTED|Overall Study||32
5222786|NCT00938015|12842785|P1|NOT COMPLETED|Overall Study||147
5222787|NCT00938015|12842785|P1|COMPLETED|Overall Study||156
5222788|NCT00938015|12842785|P1|STARTED|Overall Study||303
5222789|NCT00937950|12842801|P1|NOT COMPLETED|Overall Study||216
5222790|NCT00937950|12842801|P1|COMPLETED|Overall Study||1787
5222791|NCT00937950|12842801|P1|STARTED|Overall Study||2003
5222792|NCT00937937|12842817|P1|NOT COMPLETED|Overall Study||72
5222793|NCT00937937|12842817|P1|COMPLETED|Overall Study||0
5222794|NCT00937937|12842817|P1|STARTED|Overall Study||72
5222795|NCT00937833|12842826|P2|NOT COMPLETED|Overall Study||17
5222796|NCT00937833|12842827|P1|NOT COMPLETED|Overall Study||15
5222797|NCT00937833|12842826|P2|COMPLETED|Overall Study||60
5222798|NCT00937833|12842827|P1|COMPLETED|Overall Study||58
5222799|NCT00937833|12842826|P2|STARTED|Overall Study||77
5222800|NCT00937833|12842827|P1|STARTED|Overall Study||73
5222801|NCT00937794|12842833|P1|NOT COMPLETED|Overall Study||0
5222802|NCT00937794|12842833|P1|COMPLETED|Overall Study||33
5222803|NCT00937794|12842833|P1|STARTED|Overall Study||33
5222804|NCT00937768|12842840|P2|NOT COMPLETED|Overall Study||8
5222805|NCT00937768|12842841|P1|NOT COMPLETED|Overall Study||8
5222806|NCT00937768|12842840|P2|COMPLETED|Overall Study||0
5222807|NCT00937768|12842841|P1|COMPLETED|Overall Study||0
5222808|NCT00937768|12842840|P2|STARTED|Overall Study||8
5222809|NCT00937768|12842841|P1|STARTED|Overall Study||8
5222810|NCT00937560|12842861|P1|NOT COMPLETED|Maintenance Treatment||18
5222811|NCT00937560|12842861|P1|COMPLETED|Maintenance Treatment||150
5222812|NCT00937560|12842861|P1|STARTED|Maintenance Treatment||168
5222813|NCT00937560|12842861|P1|NOT COMPLETED|Initial Treatment||21
5222814|NCT00937560|12842861|P1|COMPLETED|Initial Treatment||168
5222815|NCT00937560|12842861|P1|Received Treatment|Initial Treatment||189
5222816|NCT00937560|12842861|P1|STARTED|Initial Treatment||189
5222817|NCT00937547|12842872|P3|NOT COMPLETED|Overall Study||7
5222818|NCT00937547|12842873|P2|NOT COMPLETED|Overall Study||6
5222819|NCT00937547|12842874|P1|NOT COMPLETED|Overall Study||1
5222820|NCT00937547|12842872|P3|COMPLETED|Overall Study||142
5222821|NCT00937547|12842873|P2|COMPLETED|Overall Study||78
5222822|NCT00937547|12842874|P1|COMPLETED|Overall Study||95
5222823|NCT00937547|12842872|P3|Histological Samples|Overall Study||142
5222824|NCT00937547|12842873|P2|Histological Samples|Overall Study||78
5222825|NCT00937547|12842874|P1|Histological Samples|Overall Study||95
5222826|NCT00937547|12842872|P3|STARTED|Overall Study||149
5222827|NCT00937547|12842873|P2|STARTED|Overall Study||84
5222828|NCT00937547|12842874|P1|STARTED|Overall Study||96
5222829|NCT00937521|12842911|P8|NOT COMPLETED|Booster Phase||2
5222830|NCT00937521|12842912|P7|NOT COMPLETED|Booster Phase||5
5222831|NCT00937521|12842913|P6|NOT COMPLETED|Booster Phase||5
5222832|NCT00937521|12842914|P5|NOT COMPLETED|Booster Phase||5
5222833|NCT00937521|12842915|P4|NOT COMPLETED|Booster Phase||3
5222834|NCT00937521|12842916|P3|NOT COMPLETED|Booster Phase||5
5222835|NCT00937521|12842917|P2|NOT COMPLETED|Booster Phase||2
5222836|NCT00937521|12842918|P1|NOT COMPLETED|Booster Phase||3
5222837|NCT00937521|12842911|P8|COMPLETED|Booster Phase||159
5222838|NCT00937521|12842912|P7|COMPLETED|Booster Phase||160
5222839|NCT00937521|12842913|P6|COMPLETED|Booster Phase||160
5222840|NCT00937521|12842914|P5|COMPLETED|Booster Phase||163
5222841|NCT00937521|12842915|P4|COMPLETED|Booster Phase||167
5222842|NCT00937521|12842916|P3|COMPLETED|Booster Phase||164
5222843|NCT00937521|12842917|P2|COMPLETED|Booster Phase||161
5222844|NCT00937521|12842918|P1|COMPLETED|Booster Phase||152
5222845|NCT00937521|12842911|P8|Premature Withdrawal|Booster Phase||2
5222846|NCT00937521|12842912|P7|Premature Withdrawal|Booster Phase||5
5222847|NCT00937521|12842913|P6|Premature Withdrawal|Booster Phase||5
5222848|NCT00937521|12842914|P5|Premature Withdrawal|Booster Phase||5
5222849|NCT00937521|12842915|P4|Premature Withdrawal|Booster Phase||3
5222850|NCT00937521|12842916|P3|Premature Withdrawal|Booster Phase||5
5222851|NCT00937521|12842917|P2|Premature Withdrawal|Booster Phase||2
5222852|NCT00937521|12842918|P1|Premature Withdrawal|Booster Phase||3
5222853|NCT00937521|12842911|P8|STARTED|Booster Phase||161
5222854|NCT00937521|12842912|P7|STARTED|Booster Phase||165
5222855|NCT00937521|12842913|P6|STARTED|Booster Phase||165
5222856|NCT00937521|12842914|P5|STARTED|Booster Phase||168
5222857|NCT00937521|12842915|P4|STARTED|Booster Phase||170
5222858|NCT00937521|12842916|P3|STARTED|Booster Phase||169
5222859|NCT00937521|12842917|P2|STARTED|Booster Phase||163
5222860|NCT00937521|12842918|P1|STARTED|Booster Phase||155
5222861|NCT00937521|12842911|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
5222862|NCT00937521|12842912|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
5222863|NCT00937521|12842913|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
5222864|NCT00937521|12842914|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
5222865|NCT00937521|12842915|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
5222866|NCT00937521|12842916|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
5222867|NCT00937521|12842917|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
5222868|NCT00937521|12842918|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
5222869|NCT00937521|12842911|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
5222870|NCT00937521|12842912|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
5222871|NCT00937521|12842913|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
5222872|NCT00937521|12842914|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
5222873|NCT00937521|12842915|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
5222874|NCT00937521|12842916|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
5222875|NCT00937521|12842917|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
5222876|NCT00937521|12842918|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
5222877|NCT00937521|12842911|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
5222878|NCT00937521|12842912|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
5222879|NCT00937521|12842913|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
5222880|NCT00937521|12842914|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
5222881|NCT00937521|12842915|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
5222882|NCT00937521|12842916|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
5222883|NCT00937521|12842917|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
5222884|NCT00937521|12842918|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
5222885|NCT00937521|12842911|P8|STARTED|Overall Study - Prior to Booster Dose||184
5222886|NCT00937521|12842912|P7|STARTED|Overall Study - Prior to Booster Dose||186
5222887|NCT00937521|12842913|P6|STARTED|Overall Study - Prior to Booster Dose||188
5222888|NCT00937521|12842914|P5|STARTED|Overall Study - Prior to Booster Dose||191
5222889|NCT00937521|12842915|P4|STARTED|Overall Study - Prior to Booster Dose||188
5222890|NCT00937521|12842916|P3|STARTED|Overall Study - Prior to Booster Dose||192
5222891|NCT00937521|12842917|P2|STARTED|Overall Study - Prior to Booster Dose||190
5222892|NCT00937521|12842918|P1|STARTED|Overall Study - Prior to Booster Dose||188
5222893|NCT00937495|12843024|P1|NOT COMPLETED|Overall Study||2
5222894|NCT00937495|12843024|P1|COMPLETED|Overall Study||14
5222895|NCT00937495|12843024|P1|STARTED|Overall Study||16
5222896|NCT00937404|12843030|P1|NOT COMPLETED|Overall Study||2
5222897|NCT00937404|12843030|P1|COMPLETED|Overall Study||23
5222898|NCT00937404|12843030|P1|STARTED|Overall Study||25
5222899|NCT00937391|12843039|P1|NOT COMPLETED|Stage 2||1
5222900|NCT00937391|12843039|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
5222901|NCT00937391|12843039|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
5222902|NCT00937391|12843039|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
5222903|NCT00937391|12843039|P1|NOT COMPLETED|Stage 1||0
5222904|NCT00937391|12843039|P1|COMPLETED|Stage 1||20
5222905|NCT00937391|12843039|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
5222906|NCT00937391|12843039|P1|STARTED|Stage 1||20
5222907|NCT00937326|12843095|P5|NOT COMPLETED|Overall Study||5
5222908|NCT00937326|12843096|P4|NOT COMPLETED|Overall Study||5
5222909|NCT00937326|12843097|P3|NOT COMPLETED|Overall Study||4
5222910|NCT00937326|12843098|P2|NOT COMPLETED|Overall Study||7
5222911|NCT00937326|12843099|P1|NOT COMPLETED|Overall Study||3
5222912|NCT00937326|12843095|P5|COMPLETED|Overall Study||40
5222913|NCT00937326|12843096|P4|COMPLETED|Overall Study||40
5222914|NCT00937326|12843097|P3|COMPLETED|Overall Study||42
5222915|NCT00937326|12843098|P2|COMPLETED|Overall Study||38
5222916|NCT00937326|12843099|P1|COMPLETED|Overall Study||43
5222917|NCT00937326|12843095|P5|STARTED|Overall Study||45
5222918|NCT00937326|12843096|P4|STARTED|Overall Study||45
5222919|NCT00937326|12843097|P3|STARTED|Overall Study||46
5222920|NCT00937326|12843098|P2|STARTED|Overall Study||45
5222921|NCT00937326|12843099|P1|STARTED|Overall Study||46
5222922|NCT00937235|12843327|P2|NOT COMPLETED|Overall Study||0
5222923|NCT00937235|12843328|P1|NOT COMPLETED|Overall Study||0
5222924|NCT00937235|12843327|P2|COMPLETED|Overall Study||70
5222925|NCT00937235|12843328|P1|COMPLETED|Overall Study||72
5222926|NCT00937235|12843327|P2|STARTED|Overall Study||70
5222927|NCT00937235|12843328|P1|STARTED|Overall Study||72
5222928|NCT00937157|12843348|P1|NOT COMPLETED|Overall Study||4
5222929|NCT00937157|12843348|P1|COMPLETED|Overall Study||8
5222930|NCT00937157|12843348|P1|STARTED|Overall Study||12
5222931|NCT00937118|12843352|P1|NOT COMPLETED|Overall Study||0
5222932|NCT00937118|12843352|P1|COMPLETED|Overall Study||41
5222933|NCT00937118|12843352|P1|STARTED|Overall Study||41
5222934|NCT00937105|12843361|P2|NOT COMPLETED|Overall Study||39
5222935|NCT00937105|12843362|P1|NOT COMPLETED|Overall Study||40
5222936|NCT00937105|12843361|P2|COMPLETED|Overall Study||70
5222937|NCT00937105|12843362|P1|COMPLETED|Overall Study||69
5222938|NCT00937105|12843361|P2|STARTED|Overall Study||109
5222939|NCT00937105|12843362|P1|STARTED|Overall Study||109
5222940|NCT00937040|12843379|P2|NOT COMPLETED|Overall Study||37
5222941|NCT00937040|12843380|P1|NOT COMPLETED|Overall Study||41
5222942|NCT00937040|12843379|P2|COMPLETED|Overall Study||141
5222943|NCT00937040|12843380|P1|COMPLETED|Overall Study||138
5222944|NCT00937040|12843379|P2|STARTED|Overall Study||178
5222945|NCT00937040|12843380|P1|STARTED|Overall Study||179
5222946|NCT00936975|12843422|P1|NOT COMPLETED|Overall Study||6
5222947|NCT00936975|12843422|P1|COMPLETED|Overall Study||12
5222948|NCT00936975|12843422|P1|STARTED|Overall Study||18
5222949|NCT00936910|12843431|P1|NOT COMPLETED|Overall Study||3
5222950|NCT00936910|12843431|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
5222951|NCT00936910|12843431|P1|STARTED|Overall Study||13
5222952|NCT00936897|12843440|P2|NOT COMPLETED|Overall Study||60
5222953|NCT00936897|12843441|P1|NOT COMPLETED|Overall Study||19
5222954|NCT00936897|12843440|P2|COMPLETED|Overall Study||356
5222955|NCT00936897|12843441|P1|COMPLETED|Overall Study||398
5222956|NCT00936897|12843440|P2|STARTED|Overall Study|Randomized|416
5222957|NCT00936897|12843441|P1|STARTED|Overall Study|Randomized|417
5222958|NCT00936884|12843455|P3|NOT COMPLETED|Open-label||19
5222959|NCT00936884|12843456|P2|NOT COMPLETED|Open-label||0
5222960|NCT00936884|12843457|P1|NOT COMPLETED|Open-label||0
5222961|NCT00936884|12843455|P3|COMPLETED|Open-label||12
5222962|NCT00936884|12843456|P2|COMPLETED|Open-label||0
5222963|NCT00936884|12843457|P1|COMPLETED|Open-label||0
5222964|NCT00936884|12843455|P3|STARTED|Open-label||31
5222965|NCT00936884|12843456|P2|STARTED|Open-label||0
5222966|NCT00936884|12843457|P1|STARTED|Open-label||0
5222967|NCT00936884|12843455|P3|NOT COMPLETED|Double-blind||0
5222968|NCT00936884|12843456|P2|NOT COMPLETED|Double-blind||7
5222969|NCT00936884|12843457|P1|NOT COMPLETED|Double-blind||12
5222970|NCT00936884|12843455|P3|COMPLETED|Double-blind||0
5222971|NCT00936884|12843456|P2|COMPLETED|Double-blind||18
5222972|NCT00936884|12843457|P1|COMPLETED|Double-blind||13
5222973|NCT00936884|12843455|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
5222974|NCT00936884|12843456|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
5222975|NCT00936884|12843457|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
5222976|NCT00936741|12843468|P1|NOT COMPLETED|Overall Study||9
5222977|NCT00936741|12843468|P1|COMPLETED|Overall Study||21
5222978|NCT00936741|12843468|P1|STARTED|Overall Study||30
5222979|NCT00936715|12843473|P1|NOT COMPLETED|Overall Study||6
5222980|NCT00936715|12843473|P1|COMPLETED|Overall Study||18
5222981|NCT00936715|12843473|P1|STARTED|Overall Study||24
5222982|NCT00936702|12843477|P1|NOT COMPLETED|Overall Study||46
5222983|NCT00936702|12843477|P1|COMPLETED|Overall Study||0
5222984|NCT00936702|12843477|P1|STARTED|Overall Study||46
5222985|NCT00936663|12843487|P2|NOT COMPLETED|Overall Study||0
5222986|NCT00936663|12843488|P1|NOT COMPLETED|Overall Study||0
5222987|NCT00936663|12843487|P2|COMPLETED|Overall Study||2
5222988|NCT00936663|12843488|P1|COMPLETED|Overall Study||1
5222989|NCT00936663|12843487|P2|STARTED|Overall Study||2
5222990|NCT00936663|12843488|P1|STARTED|Overall Study||1
5222991|NCT00936598|12843510|P2|NOT COMPLETED|Overall Study||0
5222992|NCT00936598|12843511|P1|NOT COMPLETED|Overall Study||2
5222993|NCT00936598|12843510|P2|COMPLETED|Overall Study||1
5222994|NCT00936598|12843511|P1|COMPLETED|Overall Study||2
5222995|NCT00936598|12843510|P2|STARTED|Overall Study||1
5222996|NCT00936598|12843511|P1|STARTED|Overall Study||4
5222997|NCT00936585|12843521|P1|NOT COMPLETED|Overall Study||0
5222998|NCT00936585|12843521|P1|COMPLETED|Overall Study||2
5222999|NCT00936585|12843521|P1|STARTED|Overall Study||2
5223000|NCT00936481|12843527|P2|NOT COMPLETED|Overall Study||0
5223001|NCT00936481|12843528|P1|NOT COMPLETED|Overall Study||0
5223002|NCT00936481|12843527|P2|COMPLETED|Overall Study||17
5223003|NCT00936481|12843528|P1|COMPLETED|Overall Study||17
5223004|NCT00936481|12843527|P2|STARTED|Overall Study||17
5223005|NCT00936481|12843528|P1|STARTED|Overall Study||17
5223006|NCT00936455|12843538|P2|NOT COMPLETED|Overall Study||0
5223007|NCT00936455|12843539|P1|NOT COMPLETED|Overall Study||0
5223008|NCT00936455|12843538|P2|COMPLETED|Overall Study||38
5223009|NCT00936455|12843539|P1|COMPLETED|Overall Study||37
5223010|NCT00936455|12843538|P2|STARTED|Overall Study||38
5223011|NCT00936455|12843539|P1|STARTED|Overall Study||37
5223012|NCT00936377|12843554|P3|NOT COMPLETED|Overall Study||0
5223013|NCT00936377|12843555|P2|NOT COMPLETED|Overall Study||0
5223014|NCT00936377|12843556|P1|NOT COMPLETED|Overall Study||0
5223015|NCT00936377|12843554|P3|COMPLETED|Overall Study||8
5223016|NCT00936377|12843555|P2|COMPLETED|Overall Study||8
5223017|NCT00936377|12843556|P1|COMPLETED|Overall Study||8
5223018|NCT00936377|12843554|P3|STARTED|Overall Study||8
5223019|NCT00936377|12843555|P2|STARTED|Overall Study||8
5223020|NCT00936377|12843556|P1|STARTED|Overall Study||8
5223021|NCT00936351|12843587|P2|NOT COMPLETED|Overall Study||2
5223022|NCT00936351|12843588|P1|NOT COMPLETED|Overall Study||3
5223023|NCT00936351|12843587|P2|COMPLETED|Overall Study||14
5223024|NCT00936351|12843588|P1|COMPLETED|Overall Study||15
5223025|NCT00936351|12843587|P2|STARTED|Overall Study||16
5223026|NCT00936351|12843588|P1|STARTED|Overall Study||18
5223027|NCT00936299|12843600|P2|NOT COMPLETED|Overall Study||12
5223028|NCT00936299|12843601|P1|NOT COMPLETED|Overall Study||13
5223029|NCT00936299|12843600|P2|COMPLETED|Overall Study||40
5223030|NCT00936299|12843601|P1|COMPLETED|Overall Study||40
5223031|NCT00936299|12843600|P2|STARTED|Overall Study||52
5223032|NCT00936299|12843601|P1|STARTED|Overall Study||53
5223033|NCT00936221|12843613|P2|NOT COMPLETED|Overall Study||1
5223034|NCT00936221|12843614|P1|NOT COMPLETED|Overall Study||1
5223035|NCT00936221|12843613|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
5223036|NCT00936221|12843614|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
5223037|NCT00936221|12843613|P2|Received Treatment|Overall Study||45
5223038|NCT00936221|12843614|P1|Received Treatment|Overall Study||44
5223039|NCT00936221|12843613|P2|STARTED|Overall Study||46
5223040|NCT00936221|12843614|P1|STARTED|Overall Study||45
5223041|NCT00936208|12843628|P2|NOT COMPLETED|Overall Study||22
5223042|NCT00936208|12843629|P1|NOT COMPLETED|Overall Study||37
5223043|NCT00936208|12843628|P2|COMPLETED|Overall Study||1574
5223044|NCT00936208|12843629|P1|COMPLETED|Overall Study||1462
5223045|NCT00936208|12843628|P2|STARTED|Overall Study||1596
5223046|NCT00936208|12843629|P1|STARTED|Overall Study||1499
5223047|NCT00936117|12843647|P1|NOT COMPLETED|Overall Study||10
5223048|NCT00936117|12843647|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
5223049|NCT00936117|12843647|P1|STARTED|Overall Study||20
5223050|NCT00936065|12843655|P3|NOT COMPLETED|Overall Study||7
5223051|NCT00936065|12843656|P2|NOT COMPLETED|Overall Study||4
5223052|NCT00936065|12843657|P1|NOT COMPLETED|Overall Study||4
5223053|NCT00936065|12843655|P3|COMPLETED|Overall Study||12
5223054|NCT00936065|12843656|P2|COMPLETED|Overall Study||16
5223055|NCT00936065|12843657|P1|COMPLETED|Overall Study||17
5223056|NCT00936065|12843655|P3|Study Assessments Performed|Overall Study||18
5223057|NCT00936065|12843656|P2|Study Assessments Performed|Overall Study||19
5223058|NCT00936065|12843657|P1|Study Assessments Performed|Overall Study||21
5223059|NCT00936065|12843655|P3|Received Treatment|Overall Study||18
5223060|NCT00936065|12843656|P2|Received Treatment|Overall Study||20
5223061|NCT00936065|12843657|P1|Received Treatment|Overall Study||21
5223062|NCT00936065|12843655|P3|STARTED|Overall Study||19
5223063|NCT00936065|12843656|P2|STARTED|Overall Study||20
5223064|NCT00936065|12843657|P1|STARTED|Overall Study||21
5223065|NCT00935883|12843763|P2|NOT COMPLETED|Follow-Up Period||0
5223066|NCT00935883|12843764|P1|NOT COMPLETED|Follow-Up Period||0
5223067|NCT00935883|12843763|P2|COMPLETED|Follow-Up Period||38
5223068|NCT00935883|12843764|P1|COMPLETED|Follow-Up Period||19
5223069|NCT00935883|12843763|P2|STARTED|Follow-Up Period||38
5223070|NCT00935883|12843764|P1|STARTED|Follow-Up Period||19
5223071|NCT00935883|12843763|P2|NOT COMPLETED|Treatment Period||2
5223072|NCT00935883|12843764|P1|NOT COMPLETED|Treatment Period||1
5223073|NCT00935883|12843763|P2|COMPLETED|Treatment Period||38
5223074|NCT00935883|12843764|P1|COMPLETED|Treatment Period||19
5223075|NCT00935883|12843763|P2|STARTED|Treatment Period||40
5223076|NCT00935883|12843764|P1|STARTED|Treatment Period||20
5223077|NCT00935857|12843778|P2|NOT COMPLETED|Overall Study||0
5223078|NCT00935857|12843779|P1|NOT COMPLETED|Overall Study||0
5223079|NCT00935857|12843778|P2|COMPLETED|Overall Study||16
5223080|NCT00935857|12843779|P1|COMPLETED|Overall Study||14
5223081|NCT00935857|12843778|P2|STARTED|Overall Study||16
5223082|NCT00935857|12843779|P1|STARTED|Overall Study||14
5223083|NCT00935818|12843791|P2|NOT COMPLETED|Overall Study||100
5223084|NCT00935818|12843792|P1|NOT COMPLETED|Overall Study||91
5223085|NCT00935818|12843791|P2|COMPLETED|Overall Study||157
5223086|NCT00935818|12843792|P1|COMPLETED|Overall Study||158
5223087|NCT00935818|12843791|P2|End of Medication Phase|Overall Study||184
5223088|NCT00935818|12843792|P1|End of Medication Phase|Overall Study||182
5223089|NCT00935818|12843791|P2|STARTED|Overall Study||257
5223090|NCT00935818|12843792|P1|STARTED|Overall Study||249
5223091|NCT00935792|12843813|P3|NOT COMPLETED|Overall Study||0
5223092|NCT00935792|12843814|P2|NOT COMPLETED|Overall Study||3
5223093|NCT00935792|12843815|P1|NOT COMPLETED|Overall Study||1
5223094|NCT00935792|12843813|P3|COMPLETED|Overall Study||12
5223095|NCT00935792|12843814|P2|COMPLETED|Overall Study||6
5223096|NCT00935792|12843815|P1|COMPLETED|Overall Study||6
5223097|NCT00935792|12843813|P3|STARTED|Overall Study||12
5223098|NCT00935792|12843814|P2|STARTED|Overall Study||9
5223099|NCT00935792|12843815|P1|STARTED|Overall Study||7
5223100|NCT00935766|12843832|P2|NOT COMPLETED|Overall Study||7
5223101|NCT00935766|12843833|P1|NOT COMPLETED|Overall Study||7
5223102|NCT00935766|12843832|P2|COMPLETED|Overall Study||27
5223103|NCT00935766|12843833|P1|COMPLETED|Overall Study||35
5223104|NCT00935766|12843832|P2|STARTED|Overall Study||34
5223105|NCT00935766|12843833|P1|STARTED|Overall Study||42
5223106|NCT00935701|12843843|P1|NOT COMPLETED|Overall Study||1
5223107|NCT00935701|12843843|P1|COMPLETED|Overall Study||9
5223108|NCT00935701|12843843|P1|Transition Acupressure to Acupuncture|Overall Study||9
5223109|NCT00935701|12843843|P1|STARTED|Overall Study||10
5223110|NCT00935649|12843850|P1|NOT COMPLETED|Overall Study||5
5223111|NCT00935649|12843850|P1|COMPLETED|Overall Study||134
5223112|NCT00935649|12843850|P1|STARTED|Overall Study||139
5223113|NCT00935584|12843860|P2|NOT COMPLETED|Overall Study||4
5223114|NCT00935584|12843861|P1|NOT COMPLETED|Overall Study||49
5223115|NCT00935584|12843860|P2|COMPLETED|Overall Study||19
5223116|NCT00935584|12843861|P1|COMPLETED|Overall Study||77
5223117|NCT00935584|12843860|P2|STARTED|Overall Study||23
5223118|NCT00935584|12843861|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
5223119|NCT00935532|12843873|P2|NOT COMPLETED|Overall Study||11
5223120|NCT00935532|12843874|P1|NOT COMPLETED|Overall Study||22
5223121|NCT00935532|12843873|P2|COMPLETED|Overall Study||201
5223122|NCT00935532|12843874|P1|COMPLETED|Overall Study||193
5223123|NCT00935532|12843873|P2|STARTED|Overall Study||212
5223124|NCT00935532|12843874|P1|STARTED|Overall Study||215
5223125|NCT00935493|12843903|P3|NOT COMPLETED|Overall Study||1
5223126|NCT00935493|12843904|P2|NOT COMPLETED|Overall Study||2
5223127|NCT00935493|12843905|P1|NOT COMPLETED|Overall Study||1
5223128|NCT00935493|12843903|P3|COMPLETED|Overall Study||40
5223129|NCT00935493|12843904|P2|COMPLETED|Overall Study||39
5223130|NCT00935493|12843905|P1|COMPLETED|Overall Study||40
5223131|NCT00935493|12843903|P3|STARTED|Overall Study||41
5223132|NCT00935493|12843904|P2|STARTED|Overall Study||41
5223133|NCT00935493|12843905|P1|STARTED|Overall Study||41
5223134|NCT00935428|12843919|P1|NOT COMPLETED|Overall Study||0
5223135|NCT00935428|12843919|P1|COMPLETED|Overall Study||231
5223136|NCT00935428|12843919|P1|STARTED|Overall Study||231
5223137|NCT00935311|12843933|P3|NOT COMPLETED|Overall Study||0
5223138|NCT00935311|12843934|P2|NOT COMPLETED|Overall Study||0
5223139|NCT00935311|12843935|P1|NOT COMPLETED|Overall Study||0
5223140|NCT00935311|12843933|P3|COMPLETED|Overall Study||40
5223141|NCT00935311|12843934|P2|COMPLETED|Overall Study||39
5223142|NCT00935311|12843935|P1|COMPLETED|Overall Study||43
5223143|NCT00935311|12843933|P3|STARTED|Overall Study||40
5223144|NCT00935311|12843934|P2|STARTED|Overall Study||39
5223145|NCT00935311|12843935|P1|STARTED|Overall Study||43
5223146|NCT00935272|12843954|P2|NOT COMPLETED|Overall Study||6
5223147|NCT00935272|12843955|P1|NOT COMPLETED|Overall Study||19
5223148|NCT00935272|12843954|P2|COMPLETED|Overall Study||39
5223149|NCT00935272|12843955|P1|COMPLETED|Overall Study||116
5223150|NCT00935272|12843954|P2|STARTED|Overall Study||45
5223151|NCT00935272|12843955|P1|STARTED|Overall Study||135
5223152|NCT00935259|12843964|P2|NOT COMPLETED|Period 2||0
5223153|NCT00935259|12843965|P1|NOT COMPLETED|Period 2||0
5223154|NCT00935259|12843964|P2|COMPLETED|Period 2||14
5223155|NCT00935259|12843965|P1|COMPLETED|Period 2||15
5223156|NCT00935259|12843964|P2|STARTED|Period 2||14
5223157|NCT00935259|12843965|P1|STARTED|Period 2||15
5223158|NCT00935259|12843964|P2|NOT COMPLETED|Period 1||1
5223159|NCT00935259|12843965|P1|NOT COMPLETED|Period 1||1
5223160|NCT00935259|12843964|P2|COMPLETED|Period 1||14
5223161|NCT00935259|12843965|P1|COMPLETED|Period 1||15
5223162|NCT00935259|12843964|P2|STARTED|Period 1||15
5223163|NCT00935259|12843965|P1|STARTED|Period 1||16
5223164|NCT00935220|12843979|P1|NOT COMPLETED|Overall Study||2
5223165|NCT00935220|12843979|P1|COMPLETED|Overall Study||39
5223166|NCT00935220|12843979|P1|STARTED|Overall Study||41
5223167|NCT00935064|12843993|P2|NOT COMPLETED|Overall Study||0
5223168|NCT00935064|12843994|P1|NOT COMPLETED|Overall Study||0
5223169|NCT00935064|12843993|P2|COMPLETED|Overall Study||30
5223170|NCT00935064|12843994|P1|COMPLETED|Overall Study||30
5223171|NCT00935064|12843993|P2|STARTED|Overall Study||30
5223172|NCT00935064|12843994|P1|STARTED|Overall Study||30
5223173|NCT00934947|12844010|P2|NOT COMPLETED|Overall Study||2
5223174|NCT00934947|12844011|P1|NOT COMPLETED|Overall Study||0
5223175|NCT00934947|12844010|P2|COMPLETED|Overall Study||20
5223176|NCT00934947|12844011|P1|COMPLETED|Overall Study||23
5223177|NCT00934947|12844010|P2|STARTED|Overall Study||22
5223178|NCT00934947|12844011|P1|STARTED|Overall Study||23
5223179|NCT00934921|12844025|P2|NOT COMPLETED|Second Intervention||0
5223180|NCT00934921|12844026|P1|NOT COMPLETED|Second Intervention||0
5223181|NCT00934921|12844025|P2|COMPLETED|Second Intervention||12
5223182|NCT00934921|12844026|P1|COMPLETED|Second Intervention||12
5223183|NCT00934921|12844025|P2|STARTED|Second Intervention||12
5223184|NCT00934921|12844026|P1|STARTED|Second Intervention||12
5223185|NCT00934921|12844025|P2|NOT COMPLETED|First Intervention||0
5223186|NCT00934921|12844026|P1|NOT COMPLETED|First Intervention||0
5223187|NCT00934921|12844025|P2|COMPLETED|First Intervention||12
5223188|NCT00934921|12844026|P1|COMPLETED|First Intervention||12
5223189|NCT00934921|12844025|P2|STARTED|First Intervention||12
5223190|NCT00934921|12844026|P1|STARTED|First Intervention||12
5223191|NCT00934856|12844040|P6|NOT COMPLETED|Extension Part||5
5223192|NCT00934856|12844041|P5|NOT COMPLETED|Extension Part||4
5223193|NCT00934856|12844042|P4|NOT COMPLETED|Extension Part||2
5223194|NCT00934856|12844043|P3|NOT COMPLETED|Extension Part||0
5223195|NCT00934856|12844044|P2|NOT COMPLETED|Extension Part||0
5223196|NCT00934856|12844045|P1|NOT COMPLETED|Extension Part||0
5223197|NCT00934856|12844040|P6|COMPLETED|Extension Part||19
5223198|NCT00934856|12844041|P5|COMPLETED|Extension Part||24
5223199|NCT00934856|12844042|P4|COMPLETED|Extension Part||2
5223200|NCT00934856|12844043|P3|COMPLETED|Extension Part||0
5223201|NCT00934856|12844044|P2|COMPLETED|Extension Part||0
5223202|NCT00934856|12844045|P1|COMPLETED|Extension Part||0
5223203|NCT00934856|12844040|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
5223204|NCT00934856|12844041|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
5223205|NCT00934856|12844042|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
5223206|NCT00934856|12844043|P3|STARTED|Extension Part||0
5223207|NCT00934856|12844044|P2|STARTED|Extension Part||0
5223208|NCT00934856|12844045|P1|STARTED|Extension Part||0
5223209|NCT00934856|12844040|P6|NOT COMPLETED|Feasibility Part||3
5223210|NCT00934856|12844041|P5|NOT COMPLETED|Feasibility Part||0
5223211|NCT00934856|12844042|P4|NOT COMPLETED|Feasibility Part||5
5223212|NCT00934856|12844043|P3|NOT COMPLETED|Feasibility Part||3
5223213|NCT00934856|12844044|P2|NOT COMPLETED|Feasibility Part||5
5223214|NCT00934856|12844045|P1|NOT COMPLETED|Feasibility Part||5
5223215|NCT00934856|12844040|P6|COMPLETED|Feasibility Part||6
5223216|NCT00934856|12844041|P5|COMPLETED|Feasibility Part||12
5223217|NCT00934856|12844042|P4|COMPLETED|Feasibility Part||1
5223218|NCT00934856|12844043|P3|COMPLETED|Feasibility Part||0
5223219|NCT00934856|12844044|P2|COMPLETED|Feasibility Part||1
5223220|NCT00934856|12844045|P1|COMPLETED|Feasibility Part||1
5223221|NCT00934856|12844040|P6|STARTED|Feasibility Part||9
5223222|NCT00934856|12844041|P5|STARTED|Feasibility Part||12
5223223|NCT00934856|12844042|P4|STARTED|Feasibility Part||6
5223224|NCT00934856|12844043|P3|STARTED|Feasibility Part||3
5223225|NCT00934856|12844044|P2|STARTED|Feasibility Part||6
5223226|NCT00934856|12844045|P1|STARTED|Feasibility Part||6
5223227|NCT00934843|12844143|P2|NOT COMPLETED|Overall Study||1
5223228|NCT00934843|12844144|P1|NOT COMPLETED|Overall Study||0
5223229|NCT00934843|12844143|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
5223230|NCT00934843|12844144|P1|COMPLETED|Overall Study||37
5223231|NCT00934843|12844143|P2|STARTED|Overall Study||40
5223232|NCT00934843|12844144|P1|STARTED|Overall Study||37
5223233|NCT00934791|12844160|P2|NOT COMPLETED|Overall Study||0
5223234|NCT00934791|12844161|P1|NOT COMPLETED|Overall Study||1
5223235|NCT00934791|12844160|P2|COMPLETED|Overall Study||0
5223236|NCT00934791|12844161|P1|COMPLETED|Overall Study||0
5223237|NCT00934791|12844160|P2|STARTED|Overall Study||0
5223238|NCT00934791|12844161|P1|STARTED|Overall Study||1
5223239|NCT00934661|12844169|P2|NOT COMPLETED|Overall Study||0
5223240|NCT00934661|12844170|P1|NOT COMPLETED|Overall Study||1
5223241|NCT00934661|12844169|P2|COMPLETED|Overall Study||20
5223242|NCT00934661|12844170|P1|COMPLETED|Overall Study||19
5223243|NCT00934661|12844169|P2|STARTED|Overall Study||20
5223244|NCT00934661|12844170|P1|STARTED|Overall Study||20
5223245|NCT00934648|12844190|P1|NOT COMPLETED|Overall Study||9
5223246|NCT00934648|12844190|P1|COMPLETED|Overall Study||6
5223247|NCT00934648|12844190|P1|STARTED|Overall Study||15
5223248|NCT00934635|12844206|P9|NOT COMPLETED|Overall Study||0
5223249|NCT00934635|12844207|P8|NOT COMPLETED|Overall Study||0
5223250|NCT00934635|12844208|P7|NOT COMPLETED|Overall Study||0
5223251|NCT00934635|12844209|P6|NOT COMPLETED|Overall Study||0
5223252|NCT00934635|12844210|P5|NOT COMPLETED|Overall Study||0
5223253|NCT00934635|12844211|P4|NOT COMPLETED|Overall Study||0
5223254|NCT00934635|12844212|P3|NOT COMPLETED|Overall Study||0
5223255|NCT00934635|12844213|P2|NOT COMPLETED|Overall Study||0
5223256|NCT00934635|12844214|P1|NOT COMPLETED|Overall Study||0
5223257|NCT00934635|12844206|P9|COMPLETED|Overall Study||1
5223258|NCT00934635|12844207|P8|COMPLETED|Overall Study||0
5223259|NCT00934635|12844208|P7|COMPLETED|Overall Study||0
5223260|NCT00934635|12844209|P6|COMPLETED|Overall Study||0
5223261|NCT00934635|12844210|P5|COMPLETED|Overall Study||0
5223262|NCT00934635|12844211|P4|COMPLETED|Overall Study||0
5223263|NCT00934635|12844212|P3|COMPLETED|Overall Study||0
5223264|NCT00934635|12844213|P2|COMPLETED|Overall Study||1
5223265|NCT00934635|12844214|P1|COMPLETED|Overall Study||0
5223266|NCT00934635|12844206|P9|STARTED|Overall Study||1
5223267|NCT00934635|12844207|P8|STARTED|Overall Study||0
5223268|NCT00934635|12844208|P7|STARTED|Overall Study||0
5223269|NCT00934635|12844209|P6|STARTED|Overall Study||0
5223270|NCT00934635|12844210|P5|STARTED|Overall Study||0
5223271|NCT00934635|12844211|P4|STARTED|Overall Study||0
5223272|NCT00934635|12844212|P3|STARTED|Overall Study||0
5223273|NCT00934635|12844213|P2|STARTED|Overall Study||1
5223274|NCT00934635|12844214|P1|STARTED|Overall Study||0
5223275|NCT00934622|12844234|P1|NOT COMPLETED|Overall Study||8
5223276|NCT00934622|12844234|P1|COMPLETED|Overall Study||68
5223277|NCT00934622|12844234|P1|STARTED|Overall Study||76
5223278|NCT00934596|12844241|P2|NOT COMPLETED|Overall Study||0
5223279|NCT00934596|12844242|P1|NOT COMPLETED|Overall Study||0
5223280|NCT00934596|12844241|P2|COMPLETED|Overall Study||10
5223281|NCT00934596|12844242|P1|COMPLETED|Overall Study||10
5223282|NCT00934596|12844241|P2|STARTED|Overall Study||10
5223283|NCT00934596|12844242|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
5223284|NCT00934544|12844272|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
5223285|NCT00934544|12844273|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
5223286|NCT00934544|12844274|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
5223287|NCT00934544|12844272|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
5223288|NCT00934544|12844273|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
5223289|NCT00934544|12844274|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
5223290|NCT00934544|12844272|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
5223291|NCT00934544|12844273|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
5223292|NCT00934544|12844274|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
5223293|NCT00934544|12844272|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
5223294|NCT00934544|12844273|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
5223295|NCT00934544|12844274|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
5223296|NCT00934544|12844272|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
5223297|NCT00934544|12844273|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
5223298|NCT00934544|12844274|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
5223299|NCT00934544|12844272|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
5223300|NCT00934544|12844273|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
5223301|NCT00934544|12844274|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
5223302|NCT00934544|12844272|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
5223303|NCT00934544|12844273|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
5223304|NCT00934544|12844274|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
5223305|NCT00934544|12844272|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
5223306|NCT00934544|12844273|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
5223307|NCT00934544|12844274|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
5223308|NCT00934544|12844272|P3|STARTED|Primary Endpoint Analysis (Interim)||0
5223309|NCT00934544|12844273|P2|STARTED|Primary Endpoint Analysis (Interim)||73
5223310|NCT00934544|12844274|P1|STARTED|Primary Endpoint Analysis (Interim)||146
5223311|NCT00934440|12844310|P1|NOT COMPLETED|Overall Study||1
5223312|NCT00934440|12844310|P1|COMPLETED|Overall Study||10
5223313|NCT00934440|12844310|P1|STARTED|Overall Study||11
5223314|NCT00934375|12844317|P2|NOT COMPLETED|Overall Study||22
5223315|NCT00934375|12844318|P1|NOT COMPLETED|Overall Study||13
5223316|NCT00934375|12844317|P2|COMPLETED|Overall Study||55
5223317|NCT00934375|12844318|P1|COMPLETED|Overall Study||55
5223318|NCT00934375|12844317|P2|STARTED|Overall Study||77
5223319|NCT00934375|12844318|P1|STARTED|Overall Study||68
5223320|NCT00934362|12844326|P2|NOT COMPLETED|Overall Study||0
5223321|NCT00934362|12844327|P1|NOT COMPLETED|Overall Study||1
5223322|NCT00934362|12844326|P2|COMPLETED|Overall Study||8
5223323|NCT00934362|12844327|P1|COMPLETED|Overall Study||7
5223324|NCT00934362|12844326|P2|STARTED|Overall Study||8
5223325|NCT00934362|12844327|P1|STARTED|Overall Study||8
5223326|NCT00934180|12844337|P2|NOT COMPLETED|Second Intervention||0
5223327|NCT00934180|12844338|P1|NOT COMPLETED|Second Intervention||0
5223328|NCT00934180|12844337|P2|COMPLETED|Second Intervention||12
5223329|NCT00934180|12844338|P1|COMPLETED|Second Intervention||12
5223330|NCT00934180|12844337|P2|STARTED|Second Intervention||12
5223331|NCT00934180|12844338|P1|STARTED|Second Intervention||12
5223332|NCT00934180|12844337|P2|NOT COMPLETED|First Intervention||0
5223333|NCT00934180|12844338|P1|NOT COMPLETED|First Intervention||0
5223334|NCT00934180|12844337|P2|COMPLETED|First Intervention||12
5223335|NCT00934180|12844338|P1|COMPLETED|First Intervention||12
5223336|NCT00934180|12844337|P2|STARTED|First Intervention||12
5223337|NCT00934180|12844338|P1|STARTED|First Intervention||12
5223338|NCT00934141|12844350|P4|NOT COMPLETED|Overall Study||3
5223339|NCT00934141|12844351|P3|NOT COMPLETED|Overall Study||0
5223340|NCT00934141|12844352|P2|NOT COMPLETED|Overall Study||3
5223341|NCT00934141|12844353|P1|NOT COMPLETED|Overall Study||4
5223342|NCT00934141|12844350|P4|COMPLETED|Overall Study||51
5223343|NCT00934141|12844351|P3|COMPLETED|Overall Study||48
5223344|NCT00934141|12844352|P2|COMPLETED|Overall Study||47
5223345|NCT00934141|12844353|P1|COMPLETED|Overall Study||45
5223346|NCT00934141|12844350|P4|STARTED|Overall Study||54
5223347|NCT00934141|12844351|P3|STARTED|Overall Study||48
5223348|NCT00934141|12844352|P2|STARTED|Overall Study||50
5223349|NCT00934141|12844353|P1|STARTED|Overall Study||49
5223350|NCT00934128|12844377|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
5223351|NCT00934128|12844378|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
5223352|NCT00934128|12844377|P2|COMPLETED|Second Intervention (2 Hours)||5
5223353|NCT00934128|12844378|P1|COMPLETED|Second Intervention (2 Hours)||3
5223354|NCT00934128|12844377|P2|STARTED|Second Intervention (2 Hours)||8
5223355|NCT00934128|12844378|P1|STARTED|Second Intervention (2 Hours)||3
5223356|NCT00934128|12844377|P2|NOT COMPLETED|Washout Period (1 Hour)||5
5223357|NCT00934128|12844378|P1|NOT COMPLETED|Washout Period (1 Hour)||7
5223358|NCT00934128|12844377|P2|COMPLETED|Washout Period (1 Hour)||8
5223359|NCT00934128|12844378|P1|COMPLETED|Washout Period (1 Hour)||3
5223360|NCT00934128|12844377|P2|STARTED|Washout Period (1 Hour)||13
5223361|NCT00934128|12844378|P1|STARTED|Washout Period (1 Hour)||10
5223362|NCT00934128|12844377|P2|NOT COMPLETED|First Intervention (2 Hours)||2
5223363|NCT00934128|12844378|P1|NOT COMPLETED|First Intervention (2 Hours)||5
5223364|NCT00934128|12844377|P2|COMPLETED|First Intervention (2 Hours)||13
5223365|NCT00934128|12844378|P1|COMPLETED|First Intervention (2 Hours)||10
5223366|NCT00934128|12844377|P2|STARTED|First Intervention (2 Hours)||15
5223367|NCT00934128|12844378|P1|STARTED|First Intervention (2 Hours)||15
5223368|NCT00934102|12844386|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
5223369|NCT00934102|12844387|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
5223370|NCT00934102|12844388|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
5223371|NCT00934102|12844386|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
5223372|NCT00934102|12844387|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
5223373|NCT00934102|12844388|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
5223374|NCT00934102|12844386|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
5223375|NCT00934102|12844387|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
5223376|NCT00934102|12844388|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
5223377|NCT00934102|12844386|P3|NOT COMPLETED|Period 1, One Night of Wear||0
5223378|NCT00934102|12844387|P2|NOT COMPLETED|Period 1, One Night of Wear||0
5223379|NCT00934102|12844388|P1|NOT COMPLETED|Period 1, One Night of Wear||1
5223380|NCT00934102|12844386|P3|COMPLETED|Period 1, One Night of Wear||15
5223381|NCT00934102|12844387|P2|COMPLETED|Period 1, One Night of Wear||15
5223382|NCT00934102|12844388|P1|COMPLETED|Period 1, One Night of Wear||15
5223383|NCT00934102|12844386|P3|STARTED|Period 1, One Night of Wear||15
5223384|NCT00934102|12844387|P2|STARTED|Period 1, One Night of Wear||15
5223385|NCT00934102|12844388|P1|STARTED|Period 1, One Night of Wear||16
5223386|NCT00934050|12844402|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
5223387|NCT00934050|12844403|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
5223388|NCT00934050|12844404|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
5223389|NCT00934050|12844405|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
5223390|NCT00934050|12844406|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
5223391|NCT00934050|12844407|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
5223392|NCT00934050|12844402|P6|COMPLETED|Enrolled After 15 Dec 2009||23
5223393|NCT00934050|12844403|P5|COMPLETED|Enrolled After 15 Dec 2009||19
5223394|NCT00934050|12844404|P4|COMPLETED|Enrolled After 15 Dec 2009||0
5223395|NCT00934050|12844405|P3|COMPLETED|Enrolled After 15 Dec 2009||0
5223396|NCT00934050|12844406|P2|COMPLETED|Enrolled After 15 Dec 2009||0
5223397|NCT00934050|12844407|P1|COMPLETED|Enrolled After 15 Dec 2009||0
5223398|NCT00934050|12844402|P6|STARTED|Enrolled After 15 Dec 2009||27
5223399|NCT00934050|12844403|P5|STARTED|Enrolled After 15 Dec 2009||26
5223400|NCT00934050|12844404|P4|STARTED|Enrolled After 15 Dec 2009||0
5223401|NCT00934050|12844405|P3|STARTED|Enrolled After 15 Dec 2009||0
5223402|NCT00934050|12844406|P2|STARTED|Enrolled After 15 Dec 2009||0
5223403|NCT00934050|12844407|P1|STARTED|Enrolled After 15 Dec 2009||0
5223404|NCT00934050|12844402|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223405|NCT00934050|12844403|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223406|NCT00934050|12844404|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
5223407|NCT00934050|12844405|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
5223408|NCT00934050|12844406|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
5223409|NCT00934050|12844407|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
5223410|NCT00934050|12844402|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223411|NCT00934050|12844403|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223412|NCT00934050|12844404|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223413|NCT00934050|12844405|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223414|NCT00934050|12844406|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223415|NCT00934050|12844407|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
5223416|NCT00934050|12844402|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
5223417|NCT00934050|12844403|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
5223418|NCT00934050|12844404|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
5223419|NCT00934050|12844405|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
5223420|NCT00934050|12844406|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
5223421|NCT00934050|12844407|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
5223422|NCT00934024|12844419|P2|NOT COMPLETED|Overall Study||5
5223423|NCT00934024|12844420|P1|NOT COMPLETED|Overall Study||0
5223424|NCT00934024|12844419|P2|COMPLETED|Overall Study||6
5223425|NCT00934024|12844420|P1|COMPLETED|Overall Study||10
5223426|NCT00934024|12844419|P2|STARTED|Overall Study||11
5223427|NCT00934024|12844420|P1|STARTED|Overall Study||10
5223428|NCT00933933|12844430|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
5223429|NCT00933933|12844431|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
5223430|NCT00933933|12844432|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
5223431|NCT00933933|12844430|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
5223432|NCT00933933|12844431|P2|COMPLETED|Pediatric From 2 to 21 Years||64
5223433|NCT00933933|12844432|P1|COMPLETED|Pediatric From 2 to 21 Years||588
5223434|NCT00933933|12844430|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
5223435|NCT00933933|12844431|P2|STARTED|Pediatric From 2 to 21 Years||64
5223436|NCT00933933|12844432|P1|STARTED|Pediatric From 2 to 21 Years||588
5223437|NCT00933933|12844430|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
5223438|NCT00933933|12844431|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
5223439|NCT00933933|12844432|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
5223440|NCT00933933|12844430|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
5223441|NCT00933933|12844431|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
5223442|NCT00933933|12844432|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
5223443|NCT00933933|12844430|P3|STARTED|Pregnant Females Between 16-44 Years||203
5223444|NCT00933933|12844431|P2|STARTED|Pregnant Females Between 16-44 Years||67
5223445|NCT00933933|12844432|P1|STARTED|Pregnant Females Between 16-44 Years||448
5223446|NCT00933933|12844430|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
5223447|NCT00933933|12844431|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
5223448|NCT00933933|12844432|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
5223449|NCT00933933|12844430|P3|COMPLETED|General Population From 16 to 89 Years||1206
5223450|NCT00933933|12844431|P2|COMPLETED|General Population From 16 to 89 Years||1267
5223451|NCT00933933|12844432|P1|COMPLETED|General Population From 16 to 89 Years||6164
5223452|NCT00933933|12844430|P3|STARTED|General Population From 16 to 89 Years||1206
5223453|NCT00933933|12844431|P2|STARTED|General Population From 16 to 89 Years||1287
5223454|NCT00933933|12844432|P1|STARTED|General Population From 16 to 89 Years||6164
5223455|NCT00933686|12844450|P2|NOT COMPLETED|Overall Study||11
5223456|NCT00933686|12844451|P1|NOT COMPLETED|Overall Study||10
5223457|NCT00933686|12844450|P2|COMPLETED|Overall Study||47
5223458|NCT00933686|12844451|P1|COMPLETED|Overall Study||45
5223459|NCT00933686|12844450|P2|STARTED|Overall Study||58
5223460|NCT00933686|12844451|P1|STARTED|Overall Study||55
5223461|NCT00933608|12844471|P2|NOT COMPLETED|Overall Study||2
5223462|NCT00933608|12844472|P1|NOT COMPLETED|Overall Study||5
5223463|NCT00933608|12844471|P2|COMPLETED|Overall Study||8
5223464|NCT00933608|12844472|P1|COMPLETED|Overall Study||2
5223465|NCT00933608|12844471|P2|STARTED|Overall Study||10
5223466|NCT00933608|12844472|P1|STARTED|Overall Study||7
5223467|NCT00933543|12844480|P2|NOT COMPLETED|Overall Study||7
5223468|NCT00933543|12844481|P1|NOT COMPLETED|Overall Study||3
5223469|NCT00933543|12844480|P2|COMPLETED|Overall Study||46
5223470|NCT00933543|12844481|P1|COMPLETED|Overall Study||51
5223471|NCT00933543|12844480|P2|STARTED|Overall Study||53
5223472|NCT00933543|12844481|P1|STARTED|Overall Study||54
5223473|NCT00933491|12844539|P2|NOT COMPLETED|Overall Study||0
5223474|NCT00933491|12844540|P1|NOT COMPLETED|Overall Study||0
5223475|NCT00933491|12844539|P2|COMPLETED|Overall Study||18
5223476|NCT00933491|12844540|P1|COMPLETED|Overall Study||14
5223477|NCT00933491|12844539|P2|STARTED|Overall Study||18
5223478|NCT00933491|12844540|P1|STARTED|Overall Study||14
5223479|NCT00933335|12844550|P2|NOT COMPLETED|Overall Study||16
5223480|NCT00933335|12844551|P1|NOT COMPLETED|Overall Study||2
5223481|NCT00933335|12844550|P2|COMPLETED|Overall Study||20
5223482|NCT00933335|12844551|P1|COMPLETED|Overall Study||0
5223483|NCT00933335|12844550|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
5223484|NCT00933335|12844551|P1|STARTED|Overall Study||2
5223485|NCT00933270|12844621|P1|NOT COMPLETED|Overall Study||87
5223486|NCT00933270|12844621|P1|COMPLETED|Overall Study||177
5223487|NCT00933270|12844621|P1|STARTED|Overall Study|ITT population|264
5223488|NCT00933244|12844715|P3|NOT COMPLETED|Overall Study||3
5223489|NCT00933244|12844716|P2|NOT COMPLETED|Overall Study||1
5223490|NCT00933244|12844717|P1|NOT COMPLETED|Overall Study||5
5223491|NCT00933244|12844715|P3|COMPLETED|Overall Study||73
5223492|NCT00933244|12844716|P2|COMPLETED|Overall Study||74
5223493|NCT00933244|12844717|P1|COMPLETED|Overall Study||74
5223494|NCT00933244|12844715|P3|STARTED|Overall Study||76
5223495|NCT00933244|12844716|P2|STARTED|Overall Study||75
5223496|NCT00933244|12844717|P1|STARTED|Overall Study||79
5223497|NCT00933166|12844734|P1|NOT COMPLETED|Overall Study||18
5223498|NCT00933166|12844734|P1|COMPLETED|Overall Study||151
5223499|NCT00933166|12844734|P1|STARTED|Overall Study||169
5223500|NCT00932893|12844740|P2|NOT COMPLETED|Overall Study||170
5223501|NCT00932893|12844741|P1|NOT COMPLETED|Overall Study||133
5223502|NCT00932893|12844740|P2|COMPLETED|Overall Study||4
5223503|NCT00932893|12844741|P1|COMPLETED|Overall Study||40
5223504|NCT00932893|12844740|P2|Treated|Overall Study||171
5223505|NCT00932893|12844741|P1|Treated|Overall Study||172
5223506|NCT00932893|12844740|P2|STARTED|Overall Study||174
5223507|NCT00932893|12844741|P1|STARTED|Overall Study||173
5223508|NCT00932828|12844772|P1|NOT COMPLETED|Overall Study||5
5223509|NCT00932828|12844772|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
5223510|NCT00932828|12844772|P1|STARTED|Overall Study||37
5223511|NCT00932698|12844789|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
5223512|NCT00932698|12844790|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
5223513|NCT00932698|12844791|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
5223514|NCT00932698|12844792|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
5223515|NCT00932698|12844793|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223516|NCT00932698|12844794|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223517|NCT00932698|12844795|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223518|NCT00932698|12844796|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223519|NCT00932698|12844797|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223520|NCT00932698|12844798|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223521|NCT00932698|12844799|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
5223522|NCT00932698|12844789|P11|COMPLETED|Part 2 (Dose Expansion)||0
5223523|NCT00932698|12844790|P10|COMPLETED|Part 2 (Dose Expansion)||0
5223524|NCT00932698|12844791|P9|COMPLETED|Part 2 (Dose Expansion)||0
5223525|NCT00932698|12844792|P8|COMPLETED|Part 2 (Dose Expansion)||0
5223526|NCT00932698|12844793|P7|COMPLETED|Part 2 (Dose Expansion)||0
5223527|NCT00932698|12844794|P6|COMPLETED|Part 2 (Dose Expansion)||0
5223528|NCT00932698|12844795|P5|COMPLETED|Part 2 (Dose Expansion)||0
5223529|NCT00932698|12844796|P4|COMPLETED|Part 2 (Dose Expansion)||0
5223530|NCT00932698|12844797|P3|COMPLETED|Part 2 (Dose Expansion)||0
5223531|NCT00932698|12844798|P2|COMPLETED|Part 2 (Dose Expansion)||0
5223532|NCT00932698|12844799|P1|COMPLETED|Part 2 (Dose Expansion)||0
5223533|NCT00932698|12844789|P11|STARTED|Part 2 (Dose Expansion)||2
5223534|NCT00932698|12844790|P10|STARTED|Part 2 (Dose Expansion)||6
5223535|NCT00932698|12844791|P9|STARTED|Part 2 (Dose Expansion)||12
5223536|NCT00932698|12844792|P8|STARTED|Part 2 (Dose Expansion)||20
5223537|NCT00932698|12844793|P7|STARTED|Part 2 (Dose Expansion)||0
5223538|NCT00932698|12844794|P6|STARTED|Part 2 (Dose Expansion)||0
5223539|NCT00932698|12844795|P5|STARTED|Part 2 (Dose Expansion)||0
5223540|NCT00932698|12844796|P4|STARTED|Part 2 (Dose Expansion)||0
5223541|NCT00932698|12844797|P3|STARTED|Part 2 (Dose Expansion)||0
5223542|NCT00932698|12844798|P2|STARTED|Part 2 (Dose Expansion)||0
5223543|NCT00932698|12844799|P1|STARTED|Part 2 (Dose Expansion)||0
5223544|NCT00932698|12844789|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
5223545|NCT00932698|12844790|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
5223546|NCT00932698|12844791|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
5223547|NCT00932698|12844792|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
5223548|NCT00932698|12844793|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
5223549|NCT00932698|12844794|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
5223550|NCT00932698|12844795|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
5223551|NCT00932698|12844796|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
5223552|NCT00932698|12844797|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
5223553|NCT00932698|12844798|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
5223554|NCT00932698|12844799|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
5223555|NCT00932698|12844789|P11|COMPLETED|Part 1 (Dose Escalation)||0
5223556|NCT00932698|12844790|P10|COMPLETED|Part 1 (Dose Escalation)||0
5223557|NCT00932698|12844791|P9|COMPLETED|Part 1 (Dose Escalation)||0
5223558|NCT00932698|12844792|P8|COMPLETED|Part 1 (Dose Escalation)||0
5223559|NCT00932698|12844793|P7|COMPLETED|Part 1 (Dose Escalation)||0
5223560|NCT00932698|12844794|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
5223561|NCT00932698|12844795|P5|COMPLETED|Part 1 (Dose Escalation)||0
5223562|NCT00932698|12844796|P4|COMPLETED|Part 1 (Dose Escalation)||0
5223563|NCT00932698|12844797|P3|COMPLETED|Part 1 (Dose Escalation)||0
5223564|NCT00932698|12844798|P2|COMPLETED|Part 1 (Dose Escalation)||0
5223565|NCT00932698|12844799|P1|COMPLETED|Part 1 (Dose Escalation)||0
5223566|NCT00932698|12844789|P11|STARTED|Part 1 (Dose Escalation)||0
5223567|NCT00932698|12844790|P10|STARTED|Part 1 (Dose Escalation)||0
5223568|NCT00932698|12844791|P9|STARTED|Part 1 (Dose Escalation)||0
5223569|NCT00932698|12844792|P8|STARTED|Part 1 (Dose Escalation)||0
5223570|NCT00932698|12844793|P7|STARTED|Part 1 (Dose Escalation)||4
5223571|NCT00932698|12844794|P6|STARTED|Part 1 (Dose Escalation)||7
5223572|NCT00932698|12844795|P5|STARTED|Part 1 (Dose Escalation)||3
5223573|NCT00932698|12844796|P4|STARTED|Part 1 (Dose Escalation)||3
5223574|NCT00932698|12844797|P3|STARTED|Part 1 (Dose Escalation)||3
5223575|NCT00932698|12844798|P2|STARTED|Part 1 (Dose Escalation)||3
5223576|NCT00932698|12844799|P1|STARTED|Part 1 (Dose Escalation)||3
5223577|NCT00932659|12844968|P1|NOT COMPLETED|Overall Study||0
5223578|NCT00932659|12844968|P1|COMPLETED|Overall Study||8
5223579|NCT00932659|12844968|P1|STARTED|Overall Study||8
5223580|NCT00932646|12844973|P4|NOT COMPLETED|Overall Study||1
5223581|NCT00932646|12844974|P3|NOT COMPLETED|Overall Study||4
5223582|NCT00932646|12844975|P2|NOT COMPLETED|Overall Study||3
5223583|NCT00932646|12844976|P1|NOT COMPLETED|Overall Study||5
5223584|NCT00932646|12844973|P4|COMPLETED|Overall Study||24
5223585|NCT00932646|12844974|P3|COMPLETED|Overall Study||21
5223586|NCT00932646|12844975|P2|COMPLETED|Overall Study||22
5223587|NCT00932646|12844976|P1|COMPLETED|Overall Study||20
5223588|NCT00932646|12844973|P4|STARTED|Overall Study||25
5223589|NCT00932646|12844974|P3|STARTED|Overall Study||25
5223590|NCT00932646|12844975|P2|STARTED|Overall Study||25
5223591|NCT00932646|12844976|P1|STARTED|Overall Study||25
5223592|NCT00932620|12845032|P2|NOT COMPLETED|Overall Study||0
5223593|NCT00932620|12845033|P1|NOT COMPLETED|Overall Study||0
5223594|NCT00932620|12845032|P2|COMPLETED|Overall Study||50
5223595|NCT00932620|12845033|P1|COMPLETED|Overall Study||50
5223596|NCT00932620|12845032|P2|STARTED|Overall Study||50
5223597|NCT00932620|12845033|P1|STARTED|Overall Study||50
5223598|NCT00932477|12845041|P6|NOT COMPLETED|Treatment 3||0
5223599|NCT00932477|12845042|P5|NOT COMPLETED|Treatment 3||0
5223600|NCT00932477|12845043|P4|NOT COMPLETED|Treatment 3||0
5223601|NCT00932477|12845044|P3|NOT COMPLETED|Treatment 3||0
5223602|NCT00932477|12845045|P2|NOT COMPLETED|Treatment 3||0
5223603|NCT00932477|12845046|P1|NOT COMPLETED|Treatment 3||0
5223604|NCT00932477|12845041|P6|COMPLETED|Treatment 3||8
5223605|NCT00932477|12845042|P5|COMPLETED|Treatment 3||8
5223606|NCT00932477|12845043|P4|COMPLETED|Treatment 3||7
5223607|NCT00932477|12845044|P3|COMPLETED|Treatment 3||9
5223608|NCT00932477|12845045|P2|COMPLETED|Treatment 3||8
5223609|NCT00932477|12845046|P1|COMPLETED|Treatment 3||7
5223610|NCT00932477|12845041|P6|STARTED|Treatment 3||8
5223611|NCT00932477|12845042|P5|STARTED|Treatment 3||8
5223612|NCT00932477|12845043|P4|STARTED|Treatment 3||7
5223613|NCT00932477|12845044|P3|STARTED|Treatment 3||9
5223614|NCT00932477|12845045|P2|STARTED|Treatment 3||8
5223615|NCT00932477|12845046|P1|STARTED|Treatment 3||7
5223616|NCT00932477|12845041|P6|NOT COMPLETED|Treatment 2||0
5223617|NCT00932477|12845042|P5|NOT COMPLETED|Treatment 2||0
5223618|NCT00932477|12845043|P4|NOT COMPLETED|Treatment 2||0
5223619|NCT00932477|12845044|P3|NOT COMPLETED|Treatment 2||0
5223620|NCT00932477|12845045|P2|NOT COMPLETED|Treatment 2||0
5223621|NCT00932477|12845046|P1|NOT COMPLETED|Treatment 2||0
5223622|NCT00932477|12845041|P6|COMPLETED|Treatment 2||8
5223623|NCT00932477|12845042|P5|COMPLETED|Treatment 2||8
5223624|NCT00932477|12845043|P4|COMPLETED|Treatment 2||7
5223625|NCT00932477|12845044|P3|COMPLETED|Treatment 2||9
5223626|NCT00932477|12845045|P2|COMPLETED|Treatment 2||8
5223627|NCT00932477|12845046|P1|COMPLETED|Treatment 2||7
5223628|NCT00932477|12845041|P6|STARTED|Treatment 2||8
5223629|NCT00932477|12845042|P5|STARTED|Treatment 2||8
5223630|NCT00932477|12845043|P4|STARTED|Treatment 2||7
5223631|NCT00932477|12845044|P3|STARTED|Treatment 2||9
5223632|NCT00932477|12845045|P2|STARTED|Treatment 2||8
5223633|NCT00932477|12845046|P1|STARTED|Treatment 2||7
5223634|NCT00932477|12845041|P6|NOT COMPLETED|Treatment 1||0
5223635|NCT00932477|12845042|P5|NOT COMPLETED|Treatment 1||0
5223636|NCT00932477|12845043|P4|NOT COMPLETED|Treatment 1||0
5223637|NCT00932477|12845044|P3|NOT COMPLETED|Treatment 1||0
5223638|NCT00932477|12845045|P2|NOT COMPLETED|Treatment 1||0
5223639|NCT00932477|12845046|P1|NOT COMPLETED|Treatment 1||0
5223640|NCT00932477|12845041|P6|COMPLETED|Treatment 1||8
5223641|NCT00932477|12845042|P5|COMPLETED|Treatment 1||8
5223642|NCT00932477|12845043|P4|COMPLETED|Treatment 1||7
5223643|NCT00932477|12845044|P3|COMPLETED|Treatment 1||9
5223644|NCT00932477|12845045|P2|COMPLETED|Treatment 1||8
5223645|NCT00932477|12845046|P1|COMPLETED|Treatment 1||7
5223646|NCT00932477|12845041|P6|STARTED|Treatment 1||8
5223647|NCT00932477|12845042|P5|STARTED|Treatment 1||8
5223648|NCT00932477|12845043|P4|STARTED|Treatment 1||7
5223649|NCT00932477|12845044|P3|STARTED|Treatment 1||9
5223650|NCT00932477|12845045|P2|STARTED|Treatment 1||8
5223651|NCT00932477|12845046|P1|STARTED|Treatment 1||7
5223652|NCT00932451|12845063|P1|NOT COMPLETED|Overall Study||822
5223653|NCT00932451|12845063|P1|COMPLETED|Overall Study||244
5223654|NCT00932451|12845063|P1|STARTED|Overall Study||1066
5223655|NCT00932425|12845087|P2|NOT COMPLETED|Overall Study||2
5223656|NCT00932425|12845088|P1|NOT COMPLETED|Overall Study||0
5223657|NCT00932425|12845087|P2|COMPLETED|Overall Study||18
5223658|NCT00932425|12845088|P1|COMPLETED|Overall Study||20
5223659|NCT00932425|12845087|P2|STARTED|Overall Study||20
5223660|NCT00932425|12845088|P1|STARTED|Overall Study||20
5223661|NCT00932399|12845103|P2|NOT COMPLETED|Overall Study||0
5223662|NCT00932399|12845104|P1|NOT COMPLETED|Overall Study||0
5223663|NCT00932399|12845103|P2|COMPLETED|Overall Study||3790
5223664|NCT00932399|12845104|P1|COMPLETED|Overall Study||759
5223665|NCT00932399|12845103|P2|STARTED|Overall Study||3790
5223666|NCT00932399|12845104|P1|STARTED|Overall Study||759
5223667|NCT00932373|12845121|P11|NOT COMPLETED|Overall Study||3
5223668|NCT00932373|12845122|P10|NOT COMPLETED|Overall Study||13
5223669|NCT00932373|12845123|P9|NOT COMPLETED|Overall Study||2
5223670|NCT00932373|12845124|P8|NOT COMPLETED|Overall Study||3
5223671|NCT00932373|12845125|P7|NOT COMPLETED|Overall Study||1
5223672|NCT00932373|12845126|P6|NOT COMPLETED|Overall Study||3
5223673|NCT00932373|12845127|P5|NOT COMPLETED|Overall Study||14
5223674|NCT00932373|12845128|P4|NOT COMPLETED|Overall Study||0
5223675|NCT00932373|12845129|P3|NOT COMPLETED|Overall Study||1
5223676|NCT00932373|12845130|P2|NOT COMPLETED|Overall Study||1
5223677|NCT00932373|12845131|P1|NOT COMPLETED|Overall Study||3
5223678|NCT00932373|12845121|P11|COMPLETED|Overall Study||0
5223679|NCT00932373|12845122|P10|COMPLETED|Overall Study||3
5223680|NCT00932373|12845123|P9|COMPLETED|Overall Study||1
5223681|NCT00932373|12845124|P8|COMPLETED|Overall Study||0
5223682|NCT00932373|12845125|P7|COMPLETED|Overall Study||2
5223683|NCT00932373|12845126|P6|COMPLETED|Overall Study||0
5223684|NCT00932373|12845127|P5|COMPLETED|Overall Study||1
5223685|NCT00932373|12845128|P4|COMPLETED|Overall Study||1
5223686|NCT00932373|12845129|P3|COMPLETED|Overall Study||0
5223687|NCT00932373|12845130|P2|COMPLETED|Overall Study||0
5223688|NCT00932373|12845131|P1|COMPLETED|Overall Study||0
5223689|NCT00932373|12845121|P11|STARTED|Overall Study||3
5223690|NCT00932373|12845122|P10|STARTED|Overall Study||16
5223691|NCT00932373|12845123|P9|STARTED|Overall Study||3
5223692|NCT00932373|12845124|P8|STARTED|Overall Study||3
5223693|NCT00932373|12845125|P7|STARTED|Overall Study||3
5223694|NCT00932373|12845126|P6|STARTED|Overall Study||3
5223695|NCT00932373|12845127|P5|STARTED|Overall Study||15
5223696|NCT00932373|12845128|P4|STARTED|Overall Study||1
5223697|NCT00932373|12845129|P3|STARTED|Overall Study||1
5223698|NCT00932373|12845130|P2|STARTED|Overall Study||1
5223699|NCT00932373|12845131|P1|STARTED|Overall Study||3
5223700|NCT00932360|12845231|P6|NOT COMPLETED|Visit 3/Week 3||0
5223701|NCT00932360|12845232|P5|NOT COMPLETED|Visit 3/Week 3||0
5223702|NCT00932360|12845233|P4|NOT COMPLETED|Visit 3/Week 3||0
5223703|NCT00932360|12845234|P3|NOT COMPLETED|Visit 3/Week 3||0
5223704|NCT00932360|12845235|P2|NOT COMPLETED|Visit 3/Week 3||0
5223705|NCT00932360|12845236|P1|NOT COMPLETED|Visit 3/Week 3||0
5223706|NCT00932360|12845231|P6|COMPLETED|Visit 3/Week 3||7
5223707|NCT00932360|12845232|P5|COMPLETED|Visit 3/Week 3||2
5223708|NCT00932360|12845233|P4|COMPLETED|Visit 3/Week 3||13
5223709|NCT00932360|12845234|P3|COMPLETED|Visit 3/Week 3||3
5223710|NCT00932360|12845235|P2|COMPLETED|Visit 3/Week 3||6
5223711|NCT00932360|12845236|P1|COMPLETED|Visit 3/Week 3||10
5223712|NCT00932360|12845231|P6|STARTED|Visit 3/Week 3||7
5223713|NCT00932360|12845232|P5|STARTED|Visit 3/Week 3||2
5223714|NCT00932360|12845233|P4|STARTED|Visit 3/Week 3||13
5223715|NCT00932360|12845234|P3|STARTED|Visit 3/Week 3||3
5223716|NCT00932360|12845235|P2|STARTED|Visit 3/Week 3||6
5223717|NCT00932360|12845236|P1|STARTED|Visit 3/Week 3||10
5223718|NCT00932360|12845231|P6|NOT COMPLETED|Washout (One Week)||0
5223719|NCT00932360|12845232|P5|NOT COMPLETED|Washout (One Week)||0
5223720|NCT00932360|12845233|P4|NOT COMPLETED|Washout (One Week)||0
5223721|NCT00932360|12845234|P3|NOT COMPLETED|Washout (One Week)||0
5223722|NCT00932360|12845235|P2|NOT COMPLETED|Washout (One Week)||0
5223723|NCT00932360|12845236|P1|NOT COMPLETED|Washout (One Week)||0
5223724|NCT00932360|12845231|P6|COMPLETED|Washout (One Week)||7
5223725|NCT00932360|12845232|P5|COMPLETED|Washout (One Week)||2
5223726|NCT00932360|12845233|P4|COMPLETED|Washout (One Week)||13
5223727|NCT00932360|12845234|P3|COMPLETED|Washout (One Week)||3
5223728|NCT00932360|12845235|P2|COMPLETED|Washout (One Week)||6
5223729|NCT00932360|12845236|P1|COMPLETED|Washout (One Week)||10
5223730|NCT00932360|12845231|P6|STARTED|Washout (One Week)||7
5223731|NCT00932360|12845232|P5|STARTED|Washout (One Week)||2
5223732|NCT00932360|12845233|P4|STARTED|Washout (One Week)||13
5223733|NCT00932360|12845234|P3|STARTED|Washout (One Week)||3
5223734|NCT00932360|12845235|P2|STARTED|Washout (One Week)||6
5223735|NCT00932360|12845236|P1|STARTED|Washout (One Week)||10
5223736|NCT00932360|12845231|P6|NOT COMPLETED|Visit 2/Week 2||0
5223737|NCT00932360|12845232|P5|NOT COMPLETED|Visit 2/Week 2||0
5223738|NCT00932360|12845233|P4|NOT COMPLETED|Visit 2/Week 2||0
5223739|NCT00932360|12845234|P3|NOT COMPLETED|Visit 2/Week 2||0
5223740|NCT00932360|12845235|P2|NOT COMPLETED|Visit 2/Week 2||0
5223741|NCT00932360|12845236|P1|NOT COMPLETED|Visit 2/Week 2||0
5223742|NCT00932360|12845231|P6|COMPLETED|Visit 2/Week 2||7
5223743|NCT00932360|12845232|P5|COMPLETED|Visit 2/Week 2||2
5223744|NCT00932360|12845233|P4|COMPLETED|Visit 2/Week 2||13
5223745|NCT00932360|12845234|P3|COMPLETED|Visit 2/Week 2||3
5223746|NCT00932360|12845235|P2|COMPLETED|Visit 2/Week 2||6
5223747|NCT00932360|12845236|P1|COMPLETED|Visit 2/Week 2||10
5223748|NCT00932360|12845231|P6|STARTED|Visit 2/Week 2||7
5223749|NCT00932360|12845232|P5|STARTED|Visit 2/Week 2||2
5223750|NCT00932360|12845233|P4|STARTED|Visit 2/Week 2||13
5223751|NCT00932360|12845234|P3|STARTED|Visit 2/Week 2||3
5223752|NCT00932360|12845235|P2|STARTED|Visit 2/Week 2||6
5223753|NCT00932360|12845236|P1|STARTED|Visit 2/Week 2||10
5223754|NCT00932360|12845231|P6|NOT COMPLETED|Washout (One Week)||0
5223755|NCT00932360|12845232|P5|NOT COMPLETED|Washout (One Week)||2
5223756|NCT00932360|12845233|P4|NOT COMPLETED|Washout (One Week)||0
5223757|NCT00932360|12845234|P3|NOT COMPLETED|Washout (One Week)||0
5223758|NCT00932360|12845235|P2|NOT COMPLETED|Washout (One Week)||0
5223759|NCT00932360|12845236|P1|NOT COMPLETED|Washout (One Week)||0
5223760|NCT00932360|12845231|P6|COMPLETED|Washout (One Week)||7
5223761|NCT00932360|12845232|P5|COMPLETED|Washout (One Week)||2
5223762|NCT00932360|12845233|P4|COMPLETED|Washout (One Week)||13
5223763|NCT00932360|12845234|P3|COMPLETED|Washout (One Week)||3
5223764|NCT00932360|12845235|P2|COMPLETED|Washout (One Week)||6
5223765|NCT00932360|12845236|P1|COMPLETED|Washout (One Week)||10
5223766|NCT00932360|12845231|P6|STARTED|Washout (One Week)||7
5223767|NCT00932360|12845232|P5|STARTED|Washout (One Week)||4
5223768|NCT00932360|12845233|P4|STARTED|Washout (One Week)||13
5223769|NCT00932360|12845234|P3|STARTED|Washout (One Week)||3
5223770|NCT00932360|12845235|P2|STARTED|Washout (One Week)||6
5223771|NCT00932360|12845236|P1|STARTED|Washout (One Week)||10
5223772|NCT00932360|12845231|P6|NOT COMPLETED|1: Visit 1/Week1||0
5223773|NCT00932360|12845232|P5|NOT COMPLETED|1: Visit 1/Week1||0
5223774|NCT00932360|12845233|P4|NOT COMPLETED|1: Visit 1/Week1||0
5223775|NCT00932360|12845234|P3|NOT COMPLETED|1: Visit 1/Week1||0
5223776|NCT00932360|12845235|P2|NOT COMPLETED|1: Visit 1/Week1||0
5223777|NCT00932360|12845236|P1|NOT COMPLETED|1: Visit 1/Week1||0
5223778|NCT00932360|12845231|P6|COMPLETED|1: Visit 1/Week1||7
5223779|NCT00932360|12845232|P5|COMPLETED|1: Visit 1/Week1||4
5223780|NCT00932360|12845233|P4|COMPLETED|1: Visit 1/Week1||13
5223781|NCT00932360|12845234|P3|COMPLETED|1: Visit 1/Week1||3
5223782|NCT00932360|12845235|P2|COMPLETED|1: Visit 1/Week1||6
5223783|NCT00932360|12845236|P1|COMPLETED|1: Visit 1/Week1||10
5223784|NCT00932360|12845231|P6|STARTED|1: Visit 1/Week1||7
5223785|NCT00932360|12845232|P5|STARTED|1: Visit 1/Week1||4
5223786|NCT00932360|12845233|P4|STARTED|1: Visit 1/Week1||13
5223787|NCT00932360|12845234|P3|STARTED|1: Visit 1/Week1||3
5223788|NCT00932360|12845235|P2|STARTED|1: Visit 1/Week1||6
5223789|NCT00932360|12845236|P1|STARTED|1: Visit 1/Week1||10
5223790|NCT00932321|12845267|P2|NOT COMPLETED|Overall Study||46
5223791|NCT00932321|12845268|P1|NOT COMPLETED|Overall Study||171
5223792|NCT00932321|12845267|P2|COMPLETED|Overall Study||141
5223793|NCT00932321|12845268|P1|COMPLETED|Overall Study||580
5223794|NCT00932321|12845267|P2|MITT Population|Overall Study||181
5223795|NCT00932321|12845268|P1|MITT Population|Overall Study||705
5223796|NCT00932321|12845267|P2|STARTED|Overall Study||187
5223797|NCT00932321|12845268|P1|STARTED|Overall Study||751
5223798|NCT00932282|12845278|P2|NOT COMPLETED|OIT Maintenance Phase||2
5223799|NCT00932282|12845279|P1|NOT COMPLETED|OIT Maintenance Phase||1
5223800|NCT00932282|12845278|P2|COMPLETED|OIT Maintenance Phase||2
5223801|NCT00932282|12845279|P1|COMPLETED|OIT Maintenance Phase||4
5223802|NCT00932282|12845278|P2|STARTED|OIT Maintenance Phase||4
5223803|NCT00932282|12845279|P1|STARTED|OIT Maintenance Phase||5
5223804|NCT00932282|12845278|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
5223805|NCT00932282|12845279|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
5223806|NCT00932282|12845278|P2|COMPLETED|Biweekly OIT Buildup Phase||4
5223807|NCT00932282|12845279|P1|COMPLETED|Biweekly OIT Buildup Phase||5
5223808|NCT00932282|12845278|P2|STARTED|Biweekly OIT Buildup Phase||5
5223809|NCT00932282|12845279|P1|STARTED|Biweekly OIT Buildup Phase||6
5223810|NCT00932282|12845278|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
5223811|NCT00932282|12845279|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
5223812|NCT00932282|12845278|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
5223813|NCT00932282|12845279|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
5223814|NCT00932282|12845278|P2|STARTED|Modified OIT Rush Desensitization Phase||5
5223815|NCT00932282|12845279|P1|STARTED|Modified OIT Rush Desensitization Phase||6
5223816|NCT00932282|12845278|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
5223817|NCT00932282|12845279|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
5223818|NCT00932282|12845278|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
5223819|NCT00932282|12845279|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
5223820|NCT00932282|12845278|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
5223821|NCT00932282|12845279|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
5223822|NCT00932165|12845293|P1|NOT COMPLETED|Overall Study||1
5223823|NCT00932165|12845293|P1|COMPLETED|Overall Study||450
5223824|NCT00932165|12845293|P1|STARTED|Overall Study||451
5223825|NCT00932152|12845306|P2|NOT COMPLETED|Overall Study||2
5223826|NCT00932152|12845307|P1|NOT COMPLETED|Overall Study||1
5223827|NCT00932152|12845306|P2|COMPLETED|Overall Study||0
5223828|NCT00932152|12845307|P1|COMPLETED|Overall Study||0
5223829|NCT00932152|12845306|P2|STARTED|Overall Study||2
5223830|NCT00932152|12845307|P1|STARTED|Overall Study||1
5223831|NCT00932126|12845317|P8|NOT COMPLETED|Overall Study||10
5223832|NCT00932126|12845318|P7|NOT COMPLETED|Overall Study||5
5223833|NCT00932126|12845319|P6|NOT COMPLETED|Overall Study||3
5223834|NCT00932126|12845320|P5|NOT COMPLETED|Overall Study||5
5223835|NCT00932126|12845321|P4|NOT COMPLETED|Overall Study||3
5223836|NCT00932126|12845322|P3|NOT COMPLETED|Overall Study||3
5223837|NCT00932126|12845323|P2|NOT COMPLETED|Overall Study||3
5223838|NCT00932126|12845324|P1|NOT COMPLETED|Overall Study||3
5223839|NCT00932126|12845317|P8|COMPLETED|Overall Study||0
5223840|NCT00932126|12845318|P7|COMPLETED|Overall Study||0
5223841|NCT00932126|12845319|P6|COMPLETED|Overall Study||0
5223842|NCT00932126|12845320|P5|COMPLETED|Overall Study||0
5223843|NCT00932126|12845321|P4|COMPLETED|Overall Study||0
5223844|NCT00932126|12845322|P3|COMPLETED|Overall Study||0
5223845|NCT00932126|12845323|P2|COMPLETED|Overall Study||0
5223846|NCT00932126|12845324|P1|COMPLETED|Overall Study||0
5223847|NCT00932126|12845317|P8|STARTED|Overall Study||10
5223848|NCT00932126|12845318|P7|STARTED|Overall Study||5
5223849|NCT00932126|12845319|P6|STARTED|Overall Study||3
5223850|NCT00932126|12845320|P5|STARTED|Overall Study||5
5223851|NCT00932126|12845321|P4|STARTED|Overall Study||3
5223852|NCT00932126|12845322|P3|STARTED|Overall Study||3
5223853|NCT00932126|12845323|P2|STARTED|Overall Study||3
5223854|NCT00932126|12845324|P1|STARTED|Overall Study||3
5223855|NCT00932113|12845362|P2|NOT COMPLETED|Overall Study||0
5223856|NCT00932113|12845363|P1|NOT COMPLETED|Overall Study||1
5223857|NCT00932113|12845362|P2|COMPLETED|Overall Study||15
5223858|NCT00932113|12845363|P1|COMPLETED|Overall Study||14
5223859|NCT00932113|12845362|P2|STARTED|Overall Study||15
5223860|NCT00932113|12845363|P1|STARTED|Overall Study||15
5223861|NCT00932035|12845381|P2|NOT COMPLETED|Overall Study||0
5223862|NCT00932035|12845382|P1|NOT COMPLETED|Overall Study||0
5223863|NCT00932035|12845381|P2|COMPLETED|Overall Study||21
5223864|NCT00932035|12845382|P1|COMPLETED|Overall Study||18
5223865|NCT00932035|12845381|P2|STARTED|Overall Study||21
5223866|NCT00932035|12845382|P1|STARTED|Overall Study||18
5223867|NCT00932022|12845394|P2|NOT COMPLETED|Overall Study||4
5223868|NCT00932022|12845395|P1|NOT COMPLETED|Overall Study||5
5223869|NCT00932022|12845394|P2|COMPLETED|Overall Study||59
5223870|NCT00932022|12845395|P1|COMPLETED|Overall Study||59
5223871|NCT00932022|12845394|P2|STARTED|Overall Study||63
5223872|NCT00932022|12845395|P1|STARTED|Overall Study||64
5223873|NCT00931996|12845409|P1|NOT COMPLETED|Overall Study||7
5223874|NCT00931996|12845409|P1|COMPLETED|Overall Study||5
5223875|NCT00931996|12845409|P1|STARTED|Overall Study||12
5223876|NCT00931918|12845415|P2|NOT COMPLETED|Overall Study||17
5223877|NCT00931918|12845416|P1|NOT COMPLETED|Overall Study||17
5223878|NCT00931918|12845415|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
5223879|NCT00931918|12845416|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
5223880|NCT00931918|12845415|P2|Safety Population: Received Study Drug|Overall Study||101
5223881|NCT00931918|12845416|P1|Safety Population: Received Study Drug|Overall Study||100
5223882|NCT00931918|12845415|P2|STARTED|Overall Study||103
5223883|NCT00931918|12845416|P1|STARTED|Overall Study||103
5223884|NCT00931879|12845442|P2|NOT COMPLETED|Overall Study||3
5223885|NCT00931879|12845443|P1|NOT COMPLETED|Overall Study||3
5223886|NCT00931879|12845442|P2|COMPLETED|Overall Study||19
5223887|NCT00931879|12845443|P1|COMPLETED|Overall Study||19
5223888|NCT00931879|12845442|P2|STARTED|Overall Study||22
5223889|NCT00931879|12845443|P1|STARTED|Overall Study||22
5223890|NCT00931801|12845468|P3|NOT COMPLETED|Overall Study||4
5223891|NCT00931801|12845469|P2|NOT COMPLETED|Overall Study||1
5223892|NCT00931801|12845470|P1|NOT COMPLETED|Overall Study||1
5223893|NCT00931801|12845468|P3|COMPLETED|Overall Study||10
5223894|NCT00931801|12845469|P2|COMPLETED|Overall Study||14
5223895|NCT00931801|12845470|P1|COMPLETED|Overall Study||13
5223896|NCT00931801|12845468|P3|STARTED|Overall Study||14
5223897|NCT00931801|12845469|P2|STARTED|Overall Study||15
5223898|NCT00931801|12845470|P1|STARTED|Overall Study||14
5223899|NCT00931723|12845493|P2|NOT COMPLETED|Overall Study||39
5223900|NCT00931723|12845494|P1|NOT COMPLETED|Overall Study||26
5223901|NCT00931723|12845493|P2|COMPLETED|Overall Study||144
5223902|NCT00931723|12845494|P1|COMPLETED|Overall Study||147
5223903|NCT00931723|12845493|P2|STARTED|Overall Study||183
5223904|NCT00931723|12845494|P1|STARTED|Overall Study||173
5223905|NCT00931710|12845542|P2|NOT COMPLETED|Overall Study||38
5223906|NCT00931710|12845543|P1|NOT COMPLETED|Overall Study||34
5223907|NCT00931710|12845542|P2|COMPLETED|Overall Study||209
5223908|NCT00931710|12845543|P1|COMPLETED|Overall Study||207
5223909|NCT00931710|12845542|P2|STARTED|Overall Study||247
5223910|NCT00931710|12845543|P1|STARTED|Overall Study||241
5223911|NCT00931632|12845561|P2|NOT COMPLETED|Overall Study||18
5223912|NCT00931632|12845562|P1|NOT COMPLETED|Overall Study||21
5223913|NCT00931632|12845561|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
5223914|NCT00931632|12845562|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
5223915|NCT00931632|12845561|P2|STARTED|Overall Study|Randomized|222
5223916|NCT00931632|12845562|P1|STARTED|Overall Study|Randomized|229
5223917|NCT00931528|12845584|P2|NOT COMPLETED|Overall Study||60
5223918|NCT00931528|12845585|P1|NOT COMPLETED|Overall Study||41
5223919|NCT00931528|12845584|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
5223920|NCT00931528|12845585|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
5223921|NCT00931528|12845584|P2|STARTED|Overall Study||121
5223922|NCT00931528|12845585|P1|STARTED|Overall Study||121
5223923|NCT00931515|12845605|P2|NOT COMPLETED|Overall Study||5
5223924|NCT00931515|12845606|P1|NOT COMPLETED|Overall Study||2
5223925|NCT00931515|12845605|P2|COMPLETED|Overall Study||10
5223926|NCT00931515|12845606|P1|COMPLETED|Overall Study||13
5223927|NCT00931515|12845605|P2|STARTED|Overall Study||15
5223928|NCT00931515|12845606|P1|STARTED|Overall Study||15
5223929|NCT00931489|12845617|P5|NOT COMPLETED|Overall Study||0
5223930|NCT00931489|12845618|P4|NOT COMPLETED|Overall Study||0
5223931|NCT00931489|12845619|P3|NOT COMPLETED|Overall Study||0
5223932|NCT00931489|12845620|P2|NOT COMPLETED|Overall Study||0
5223933|NCT00931489|12845621|P1|NOT COMPLETED|Overall Study||0
5223934|NCT00931489|12845617|P5|COMPLETED|Overall Study||7
5223935|NCT00931489|12845618|P4|COMPLETED|Overall Study||39
5223936|NCT00931489|12845619|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
5223937|NCT00931489|12845620|P2|COMPLETED|Overall Study||40
5223938|NCT00931489|12845621|P1|COMPLETED|Overall Study||40
5223939|NCT00931489|12845617|P5|STARTED|Overall Study||7
5223940|NCT00931489|12845618|P4|STARTED|Overall Study||39
5223941|NCT00931489|12845619|P3|STARTED|Overall Study||5
5223942|NCT00931489|12845620|P2|STARTED|Overall Study||40
5223943|NCT00931489|12845621|P1|STARTED|Overall Study||40
5223944|NCT00931463|12845636|P2|NOT COMPLETED|Overall Study||5
5223945|NCT00931463|12845637|P1|NOT COMPLETED|Overall Study||17
5223946|NCT00931463|12845636|P2|COMPLETED|Overall Study||265
5223947|NCT00931463|12845637|P1|COMPLETED|Overall Study||254
5223948|NCT00931463|12845636|P2|STARTED|Overall Study||270
5223949|NCT00931463|12845637|P1|STARTED|Overall Study||271
5223950|NCT00931411|12845653|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
5223951|NCT00931411|12845654|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
5223952|NCT00931411|12845653|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
5223953|NCT00931411|12845654|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
5223954|NCT00931411|12845653|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
5223955|NCT00931411|12845654|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
5223956|NCT00931411|12845653|P2|NOT COMPLETED|First Intervention - 42 Days||3
5223957|NCT00931411|12845654|P1|NOT COMPLETED|First Intervention - 42 Days||4
5223958|NCT00931411|12845653|P2|COMPLETED|First Intervention - 42 Days||35
5223959|NCT00931411|12845654|P1|COMPLETED|First Intervention - 42 Days||31
5223960|NCT00931411|12845653|P2|STARTED|First Intervention - 42 Days||38
5223961|NCT00931411|12845654|P1|STARTED|First Intervention - 42 Days||35
5223962|NCT00931385|12845675|P4|NOT COMPLETED|Overall Study||5
5223963|NCT00931385|12845676|P3|NOT COMPLETED|Overall Study||1
5223964|NCT00931385|12845677|P2|NOT COMPLETED|Overall Study||2
5223965|NCT00931385|12845678|P1|NOT COMPLETED|Overall Study||2
5223966|NCT00931385|12845675|P4|COMPLETED|Overall Study||21
5223967|NCT00931385|12845676|P3|COMPLETED|Overall Study||24
5223968|NCT00931385|12845677|P2|COMPLETED|Overall Study||21
5223969|NCT00931385|12845678|P1|COMPLETED|Overall Study||23
5223970|NCT00931385|12845675|P4|STARTED|Overall Study||26
5223971|NCT00931385|12845676|P3|STARTED|Overall Study||25
5223972|NCT00931385|12845677|P2|STARTED|Overall Study||23
5223973|NCT00931385|12845678|P1|STARTED|Overall Study||25
5223974|NCT00931359|12845734|P2|NOT COMPLETED|Overall Study||13
5223975|NCT00931359|12845735|P1|NOT COMPLETED|Overall Study||6
5223976|NCT00931359|12845734|P2|COMPLETED|Overall Study||68
5223977|NCT00931359|12845735|P1|COMPLETED|Overall Study||33
5223978|NCT00931359|12845734|P2|STARTED|Overall Study||81
5223979|NCT00931359|12845735|P1|STARTED|Overall Study||39
5223980|NCT00931307|12845747|P1|NOT COMPLETED|Overall Study||13
5223981|NCT00931307|12845747|P1|COMPLETED|Overall Study||9
5223982|NCT00931307|12845747|P1|STARTED|Overall Study||22
5223983|NCT00931268|12845751|P1|NOT COMPLETED|Overall Study||6
5223984|NCT00931268|12845751|P1|COMPLETED|Overall Study||4
5223985|NCT00931268|12845751|P1|STARTED|Overall Study||10
5223986|NCT00931255|12845763|P2|NOT COMPLETED|Overall Study||3
5223987|NCT00931255|12845764|P1|NOT COMPLETED|Overall Study||2
5223988|NCT00931255|12845763|P2|COMPLETED|Overall Study||12
5223989|NCT00931255|12845764|P1|COMPLETED|Overall Study||15
5223990|NCT00931255|12845763|P2|STARTED|Overall Study||15
5223991|NCT00931255|12845764|P1|STARTED|Overall Study||17
5223992|NCT00931242|12845788|P2|NOT COMPLETED|Overall Study||2
5223993|NCT00931242|12845789|P1|NOT COMPLETED|Overall Study||5
5223994|NCT00931242|12845788|P2|COMPLETED|Overall Study||0
5223995|NCT00931242|12845789|P1|COMPLETED|Overall Study||5
5223996|NCT00931242|12845788|P2|STARTED|Overall Study||2
5223997|NCT00931242|12845789|P1|STARTED|Overall Study||10
5223998|NCT00931164|12845795|P1|NOT COMPLETED|Overall Study||0
5223999|NCT00931164|12845795|P1|COMPLETED|Overall Study||6
5224000|NCT00931164|12845795|P1|STARTED|Overall Study||6
5224001|NCT00930982|12845801|P2|NOT COMPLETED|Overall Study||29
5224002|NCT00930982|12845802|P1|NOT COMPLETED|Overall Study||21
5224003|NCT00930982|12845801|P2|COMPLETED|Overall Study||35
5224004|NCT00930982|12845802|P1|COMPLETED|Overall Study||39
5224005|NCT00930982|12845801|P2|STARTED|Overall Study||64
5224006|NCT00930982|12845802|P1|STARTED|Overall Study||60
5224007|NCT00930969|12845836|P1|NOT COMPLETED|Overall Study||38
5224008|NCT00930969|12845836|P1|COMPLETED|Overall Study||137
5224009|NCT00930969|12845836|P1|STARTED|Overall Study||175
5224010|NCT00930930|12845846|P2|NOT COMPLETED|Overall Study||9
5224011|NCT00930930|12845847|P1|NOT COMPLETED|Overall Study||21
5224012|NCT00930930|12845846|P2|COMPLETED|Overall Study||40
5224013|NCT00930930|12845847|P1|COMPLETED|Overall Study||75
5224014|NCT00930930|12845846|P2|STARTED|Overall Study||49
5224015|NCT00930930|12845847|P1|STARTED|Overall Study||96
5224016|NCT00930813|12845861|P2|NOT COMPLETED|Overall Study||14
5224017|NCT00930813|12845862|P1|NOT COMPLETED|Overall Study||8
5224018|NCT00930813|12845861|P2|COMPLETED|Overall Study||38
5224019|NCT00930813|12845862|P1|COMPLETED|Overall Study||41
5224020|NCT00930813|12845861|P2|STARTED|Overall Study||52
5224021|NCT00930813|12845862|P1|STARTED|Overall Study||49
5224022|NCT00930787|12845872|P2|NOT COMPLETED|Overall Study||0
5224023|NCT00930787|12845873|P1|NOT COMPLETED|Overall Study||0
5224024|NCT00930787|12845872|P2|COMPLETED|Overall Study||9
5224025|NCT00930787|12845873|P1|COMPLETED|Overall Study||14
5224026|NCT00930787|12845872|P2|STARTED|Overall Study||9
5224027|NCT00930787|12845873|P1|STARTED|Overall Study||14
5224028|NCT00930774|12845883|P4|NOT COMPLETED|Overall Study||0
5224029|NCT00930774|12845884|P3|NOT COMPLETED|Overall Study||2
5224030|NCT00930774|12845885|P2|NOT COMPLETED|Overall Study||9
5224031|NCT00930774|12845886|P1|NOT COMPLETED|Overall Study||1
5224032|NCT00930774|12845883|P4|COMPLETED|Overall Study||25
5224033|NCT00930774|12845884|P3|COMPLETED|Overall Study||22
5224034|NCT00930774|12845885|P2|COMPLETED|Overall Study||16
5224035|NCT00930774|12845886|P1|COMPLETED|Overall Study||24
5224036|NCT00930774|12845883|P4|STARTED|Overall Study||25
5224037|NCT00930774|12845884|P3|STARTED|Overall Study||24
5224038|NCT00930774|12845885|P2|STARTED|Overall Study||25
5224039|NCT00930774|12845886|P1|STARTED|Overall Study||25
5224040|NCT00930761|12845926|P2|NOT COMPLETED|Overall Study||3
5224041|NCT00930761|12845927|P1|NOT COMPLETED|Overall Study||4
5224042|NCT00930761|12845926|P2|COMPLETED|Overall Study||48
5224043|NCT00930761|12845927|P1|COMPLETED|Overall Study||46
5224044|NCT00930761|12845926|P2|STARTED|Overall Study||51
5224045|NCT00930761|12845927|P1|STARTED|Overall Study||50
5224046|NCT00930722|12845939|P1|NOT COMPLETED|Overall Study||27
5224047|NCT00930722|12845939|P1|COMPLETED|Overall Study||302
5224048|NCT00930722|12845939|P1|STARTED|Overall Study||329
5224049|NCT00930644|12845954|P1|NOT COMPLETED|Overall Study||23
5224050|NCT00930644|12845954|P1|COMPLETED|Overall Study||65
5224051|NCT00930644|12845954|P1|STARTED|Overall Study||88
5224052|NCT00930553|12845967|P1|NOT COMPLETED|Overall Study||223
5224053|NCT00930553|12845967|P1|COMPLETED|Overall Study||1091
5224054|NCT00930553|12845967|P1|Participants Entered From CAMMS324|Overall Study||685
5224055|NCT00930553|12845967|P1|Participants Entered From CAMMS323|Overall Study||488
5224056|NCT00930553|12845967|P1|Participants Entered From CAMMS223|Overall Study||141
5224057|NCT00930553|12845967|P1|STARTED|Overall Study||1314
5224058|NCT00930293|12846035|P2|NOT COMPLETED|Overall Study||7
5224059|NCT00930293|12846036|P1|NOT COMPLETED|Overall Study||7
5224060|NCT00930293|12846035|P2|COMPLETED|Overall Study||19
5224061|NCT00930293|12846036|P1|COMPLETED|Overall Study||17
5224062|NCT00930293|12846035|P2|STARTED|Overall Study||26
5224063|NCT00930293|12846036|P1|STARTED|Overall Study||24
5224064|NCT00930176|12846044|P1|NOT COMPLETED|Overall Study||1
5224065|NCT00930176|12846044|P1|COMPLETED|Overall Study||15
5224066|NCT00930176|12846044|P1|STARTED|Overall Study||16
5224067|NCT00930046|12846051|P2|NOT COMPLETED|Overall Study||2
5224068|NCT00930046|12846052|P1|NOT COMPLETED|Overall Study||1
5224069|NCT00930046|12846051|P2|COMPLETED|Overall Study||5
5224070|NCT00930046|12846052|P1|COMPLETED|Overall Study||7
5224071|NCT00930046|12846051|P2|STARTED|Overall Study||7
5224072|NCT00930046|12846052|P1|STARTED|Overall Study||8
5224073|NCT00929994|12846060|P1|NOT COMPLETED|Overall Study||6
5224074|NCT00929994|12846060|P1|COMPLETED|Overall Study||14
5224075|NCT00929994|12846060|P1|STARTED|Overall Study||20
5224076|NCT00929981|12846067|P1|NOT COMPLETED|Overall Study||0
5224077|NCT00929981|12846067|P1|COMPLETED|Overall Study||80
5224078|NCT00929981|12846067|P1|STARTED|Overall Study||80
5224079|NCT00929864|12846079|P2|NOT COMPLETED|Overall Study||83
5224080|NCT00929864|12846080|P1|NOT COMPLETED|Overall Study||66
5224081|NCT00929864|12846079|P2|COMPLETED|Overall Study||245
5224082|NCT00929864|12846080|P1|COMPLETED|Overall Study||252
5224083|NCT00929864|12846079|P2|STARTED|Overall Study||328
5224084|NCT00929864|12846080|P1|STARTED|Overall Study||318
5224085|NCT00929838|12846102|P4|NOT COMPLETED|Overall Study||9
5224086|NCT00929838|12846103|P3|NOT COMPLETED|Overall Study||10
5224087|NCT00929838|12846104|P2|NOT COMPLETED|Overall Study||9
5224088|NCT00929838|12846105|P1|NOT COMPLETED|Overall Study||10
5224089|NCT00929838|12846102|P4|COMPLETED|Overall Study||55
5224090|NCT00929838|12846103|P3|COMPLETED|Overall Study||53
5224091|NCT00929838|12846104|P2|COMPLETED|Overall Study||56
5224092|NCT00929838|12846105|P1|COMPLETED|Overall Study||53
5224093|NCT00929838|12846102|P4|STARTED|Overall Study||64
5224094|NCT00929838|12846103|P3|STARTED|Overall Study||63
5224095|NCT00929838|12846104|P2|STARTED|Overall Study||65
5224096|NCT00929838|12846105|P1|STARTED|Overall Study||63
5224097|NCT00929773|12846117|P2|NOT COMPLETED|Overall Study||0
5224098|NCT00929773|12846118|P1|NOT COMPLETED|Overall Study||0
5224099|NCT00929773|12846117|P2|COMPLETED|Overall Study||50
5224100|NCT00929773|12846118|P1|COMPLETED|Overall Study||50
5224101|NCT00929773|12846117|P2|STARTED|Overall Study||50
5224102|NCT00929773|12846118|P1|STARTED|Overall Study||50
5224103|NCT00929734|12846136|P2|NOT COMPLETED|Overall Study||3
5224104|NCT00929734|12846137|P1|NOT COMPLETED|Overall Study||2
5224105|NCT00929734|12846136|P2|COMPLETED|Overall Study||47
5224106|NCT00929734|12846137|P1|COMPLETED|Overall Study||47
5224107|NCT00929734|12846136|P2|STARTED|Overall Study||50
5224108|NCT00929734|12846137|P1|STARTED|Overall Study||49
5224109|NCT00929708|12846154|P5|NOT COMPLETED|Overall Study||6
5224110|NCT00929708|12846155|P4|NOT COMPLETED|Overall Study||6
5224111|NCT00929708|12846156|P3|NOT COMPLETED|Overall Study||3
5224112|NCT00929708|12846157|P2|NOT COMPLETED|Overall Study||3
5224113|NCT00929708|12846158|P1|NOT COMPLETED|Overall Study||4
5224114|NCT00929708|12846154|P5|COMPLETED|Overall Study||57
5224115|NCT00929708|12846155|P4|COMPLETED|Overall Study||61
5224116|NCT00929708|12846156|P3|COMPLETED|Overall Study||62
5224117|NCT00929708|12846157|P2|COMPLETED|Overall Study||66
5224118|NCT00929708|12846158|P1|COMPLETED|Overall Study||61
5224119|NCT00929708|12846154|P5|STARTED|Overall Study||63
5224120|NCT00929708|12846155|P4|STARTED|Overall Study||67
5224121|NCT00929708|12846156|P3|STARTED|Overall Study||65
5224122|NCT00929708|12846157|P2|STARTED|Overall Study||69
5224123|NCT00929708|12846158|P1|STARTED|Overall Study||65
5224124|NCT00929695|12846212|P2|NOT COMPLETED|Overall Study||6
5224125|NCT00929695|12846213|P1|NOT COMPLETED|Overall Study||8
5224126|NCT00929695|12846212|P2|COMPLETED|Overall Study||77
5224127|NCT00929695|12846213|P1|COMPLETED|Overall Study||73
5224128|NCT00929695|12846212|P2|STARTED|Overall Study||83
5224129|NCT00929695|12846213|P1|STARTED|Overall Study||81
5224130|NCT00929669|12846243|P1|NOT COMPLETED|Overall Study||1
5224131|NCT00929669|12846243|P1|COMPLETED|Overall Study||1
5224132|NCT00929669|12846243|P1|STARTED|Overall Study||2
5224133|NCT00929656|12846250|P2|NOT COMPLETED|Overall Study||1
5224134|NCT00929656|12846251|P1|NOT COMPLETED|Overall Study||0
5224135|NCT00929656|12846250|P2|COMPLETED|Overall Study||8
5224136|NCT00929656|12846251|P1|COMPLETED|Overall Study||13
5224137|NCT00929656|12846250|P2|STARTED|Overall Study||9
5224138|NCT00929656|12846251|P1|STARTED|Overall Study||13
5224139|NCT00929643|12846265|P1|NOT COMPLETED|Overall Study||2
5224140|NCT00929643|12846265|P1|COMPLETED|Overall Study||201
5224141|NCT00929643|12846265|P1|STARTED|Overall Study||203
5224142|NCT00929578|12846274|P1|NOT COMPLETED|Overall Study||0
5224143|NCT00929578|12846274|P1|COMPLETED|Overall Study||15
5224144|NCT00929578|12846274|P1|STARTED|Overall Study||15
5224145|NCT00929526|12846287|P2|NOT COMPLETED|Overall Study||29
5224146|NCT00929526|12846288|P1|NOT COMPLETED|Overall Study||17
5224147|NCT00929526|12846287|P2|COMPLETED|Overall Study||348
5224148|NCT00929526|12846288|P1|COMPLETED|Overall Study||358
5224149|NCT00929526|12846287|P2|STARTED|Overall Study||377
5224150|NCT00929526|12846288|P1|STARTED|Overall Study||375
5224151|NCT00929500|12846324|P2|NOT COMPLETED|Overall Study||0
5224152|NCT00929500|12846325|P1|NOT COMPLETED|Overall Study||4
5224153|NCT00929500|12846324|P2|COMPLETED|Overall Study||4
5224154|NCT00929500|12846325|P1|COMPLETED|Overall Study||4
5224155|NCT00929500|12846324|P2|STARTED|Overall Study||4
5224156|NCT00929500|12846325|P1|STARTED|Overall Study||8
5224157|NCT00929474|12846339|P2|NOT COMPLETED|Overall Study||9
5224158|NCT00929474|12846340|P1|NOT COMPLETED|Overall Study||8
5224159|NCT00929474|12846339|P2|COMPLETED|Overall Study||0
5224160|NCT00929474|12846340|P1|COMPLETED|Overall Study||0
5224161|NCT00929474|12846339|P2|STARTED|Overall Study||9
5224162|NCT00929474|12846340|P1|STARTED|Overall Study||8
5224163|NCT00929383|12846346|P1|NOT COMPLETED|Overall Study||15
5224164|NCT00929383|12846346|P1|COMPLETED|Overall Study||67
5224165|NCT00929383|12846346|P1|STARTED|Overall Study||82
5224166|NCT00929357|12846356|P2|NOT COMPLETED|Overall Study||0
5224167|NCT00929357|12846357|P1|NOT COMPLETED|Overall Study||0
5224168|NCT00929357|12846356|P2|COMPLETED|Overall Study||64
5224169|NCT00929357|12846357|P1|COMPLETED|Overall Study||92
5224170|NCT00929357|12846356|P2|STARTED|Overall Study||64
5224171|NCT00929357|12846357|P1|STARTED|Overall Study||92
5224172|NCT00929344|12846380|P3|NOT COMPLETED|Overall Study||21
5224173|NCT00929344|12846381|P2|NOT COMPLETED|Overall Study||13
5224174|NCT00929344|12846382|P1|NOT COMPLETED|Overall Study||22
5224175|NCT00929344|12846380|P3|COMPLETED|Overall Study||29
5224176|NCT00929344|12846381|P2|COMPLETED|Overall Study||37
5224177|NCT00929344|12846382|P1|COMPLETED|Overall Study||28
5224178|NCT00929344|12846380|P3|STARTED|Overall Study||50
5224179|NCT00929344|12846381|P2|STARTED|Overall Study||50
5224180|NCT00929344|12846382|P1|STARTED|Overall Study||50
5224181|NCT00929331|12846398|P2|NOT COMPLETED|Overall Study||0
5224182|NCT00929331|12846399|P1|NOT COMPLETED|Overall Study||0
5224183|NCT00929331|12846398|P2|COMPLETED|Overall Study||55
5224184|NCT00929331|12846399|P1|COMPLETED|Overall Study||55
5224185|NCT00929331|12846398|P2|STARTED|Overall Study||55
5224186|NCT00929331|12846399|P1|STARTED|Overall Study||55
5224187|NCT00929305|12846433|P2|NOT COMPLETED|Overall Study||0
5224188|NCT00929305|12846434|P1|NOT COMPLETED|Overall Study||0
5224189|NCT00929305|12846433|P2|COMPLETED|Overall Study||43
5224190|NCT00929305|12846434|P1|COMPLETED|Overall Study||43
5224191|NCT00929305|12846433|P2|STARTED|Overall Study||43
5224192|NCT00929305|12846434|P1|STARTED|Overall Study||43
5224193|NCT00929240|12846442|P3|NOT COMPLETED|Maintenance Phase||91
5224194|NCT00929240|12846443|P2|NOT COMPLETED|Maintenance Phase||94
5224195|NCT00929240|12846444|P1|NOT COMPLETED|Maintenance Phase||0
5224196|NCT00929240|12846442|P3|COMPLETED|Maintenance Phase||0
5224197|NCT00929240|12846443|P2|COMPLETED|Maintenance Phase||0
5224198|NCT00929240|12846444|P1|COMPLETED|Maintenance Phase||0
5224199|NCT00929240|12846442|P3|STARTED|Maintenance Phase||91
5224200|NCT00929240|12846443|P2|STARTED|Maintenance Phase||94
5224201|NCT00929240|12846444|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
5224202|NCT00929240|12846442|P3|NOT COMPLETED|Initial Treatment Phase||0
5224203|NCT00929240|12846443|P2|NOT COMPLETED|Initial Treatment Phase||0
5224204|NCT00929240|12846444|P1|NOT COMPLETED|Initial Treatment Phase||99
5224205|NCT00929240|12846442|P3|COMPLETED|Initial Treatment Phase||0
5224206|NCT00929240|12846443|P2|COMPLETED|Initial Treatment Phase||0
5224207|NCT00929240|12846444|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
5224208|NCT00929240|12846442|P3|STARTED|Initial Treatment Phase||0
5224209|NCT00929240|12846443|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
5224210|NCT00929240|12846444|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
5224211|NCT00929201|12846471|P2|NOT COMPLETED|Period 2||0
5224212|NCT00929201|12846472|P1|NOT COMPLETED|Period 2||0
5224213|NCT00929201|12846471|P2|COMPLETED|Period 2||30
5224214|NCT00929201|12846472|P1|COMPLETED|Period 2||30
5224215|NCT00929201|12846471|P2|STARTED|Period 2||30
5224216|NCT00929201|12846472|P1|STARTED|Period 2||30
5224217|NCT00929201|12846471|P2|NOT COMPLETED|7-day Washout||0
5224218|NCT00929201|12846472|P1|NOT COMPLETED|7-day Washout||0
5224219|NCT00929201|12846471|P2|COMPLETED|7-day Washout||30
5224220|NCT00929201|12846472|P1|COMPLETED|7-day Washout||30
5224221|NCT00929201|12846471|P2|STARTED|7-day Washout||30
5224222|NCT00929201|12846472|P1|STARTED|7-day Washout||30
5224223|NCT00929201|12846471|P2|NOT COMPLETED|Period 1||1
5224224|NCT00929201|12846472|P1|NOT COMPLETED|Period 1||0
5224225|NCT00929201|12846471|P2|COMPLETED|Period 1||30
5224226|NCT00929201|12846472|P1|COMPLETED|Period 1||30
5224227|NCT00929201|12846471|P2|STARTED|Period 1||31
5224228|NCT00929201|12846472|P1|STARTED|Period 1||30
5224229|NCT00929162|12846482|P2|NOT COMPLETED|Overall Study||42
5224230|NCT00929162|12846483|P1|NOT COMPLETED|Overall Study||48
5224231|NCT00929162|12846482|P2|COMPLETED|Overall Study||19
5224232|NCT00929162|12846483|P1|COMPLETED|Overall Study||11
5224233|NCT00929162|12846482|P2|Patients Who Received Treatment|Overall Study||58
5224234|NCT00929162|12846483|P1|Patients Who Received Treatment|Overall Study||58
5224235|NCT00929162|12846482|P2|STARTED|Overall Study||61
5224236|NCT00929162|12846483|P1|STARTED|Overall Study||59
5224237|NCT00929110|12846496|P3|NOT COMPLETED|Overall Study||62
5224238|NCT00929110|12846497|P2|NOT COMPLETED|Overall Study||76
5224239|NCT00929110|12846498|P1|NOT COMPLETED|Overall Study||118
5224240|NCT00929110|12846496|P3|COMPLETED|Overall Study||206
5224241|NCT00929110|12846497|P2|COMPLETED|Overall Study||193
5224242|NCT00929110|12846498|P1|COMPLETED|Overall Study||411
5224243|NCT00929110|12846496|P3|STARTED|Overall Study||268
5224244|NCT00929110|12846497|P2|STARTED|Overall Study||269
5224245|NCT00929110|12846498|P1|STARTED|Overall Study||529
5224246|NCT00929071|12846563|P1|NOT COMPLETED|Overall Study||0
5224247|NCT00929071|12846563|P1|COMPLETED|Overall Study||10
5224248|NCT00929071|12846563|P1|STARTED|Overall Study||10
5224249|NCT00928954|12846570|P2|NOT COMPLETED|Overall Study||0
5224250|NCT00928954|12846571|P1|NOT COMPLETED|Overall Study||0
5224251|NCT00928954|12846570|P2|COMPLETED|Overall Study||6
5224252|NCT00928954|12846571|P1|COMPLETED|Overall Study||4
5224253|NCT00928954|12846570|P2|STARTED|Overall Study||6
5224254|NCT00928954|12846571|P1|STARTED|Overall Study||4
5224255|NCT00928889|12846581|P2|NOT COMPLETED|Overall Study||2
5224256|NCT00928889|12846582|P1|NOT COMPLETED|Overall Study||5
5224257|NCT00928889|12846581|P2|COMPLETED|Overall Study||78
5224258|NCT00928889|12846582|P1|COMPLETED|Overall Study||75
5224259|NCT00928889|12846581|P2|STARTED|Overall Study||80
5224260|NCT00928889|12846582|P1|STARTED|Overall Study||80
5224261|NCT00928772|12846609|P3|NOT COMPLETED|Overall Study||0
5224262|NCT00928772|12846610|P2|NOT COMPLETED|Overall Study||0
5224263|NCT00928772|12846611|P1|NOT COMPLETED|Overall Study||0
5224264|NCT00928772|12846609|P3|COMPLETED|Overall Study||38
5224265|NCT00928772|12846610|P2|COMPLETED|Overall Study||38
5224266|NCT00928772|12846611|P1|COMPLETED|Overall Study||39
5224267|NCT00928772|12846609|P3|STARTED|Overall Study||38
5224268|NCT00928772|12846610|P2|STARTED|Overall Study||38
5224269|NCT00928772|12846611|P1|STARTED|Overall Study||39
5224270|NCT00928746|12846628|P1|NOT COMPLETED|Overall Study||6
5224271|NCT00928746|12846628|P1|COMPLETED|Overall Study||136
5224272|NCT00928746|12846628|P1|STARTED|Overall Study||142
5224273|NCT00928720|12846651|P3|NOT COMPLETED|Overall Study||3
5224274|NCT00928720|12846652|P2|NOT COMPLETED|Overall Study||6
5224275|NCT00928720|12846653|P1|NOT COMPLETED|Overall Study||2
5224276|NCT00928720|12846651|P3|COMPLETED|Overall Study||15
5224277|NCT00928720|12846652|P2|COMPLETED|Overall Study||14
5224278|NCT00928720|12846653|P1|COMPLETED|Overall Study||17
5224279|NCT00928720|12846651|P3|STARTED|Overall Study||18
5224280|NCT00928720|12846652|P2|STARTED|Overall Study||20
5224281|NCT00928720|12846653|P1|STARTED|Overall Study||19
5224282|NCT00928707|12846678|P2|NOT COMPLETED|Overall Study||0
5224283|NCT00928707|12846679|P1|NOT COMPLETED|Overall Study||1
5224284|NCT00928707|12846678|P2|COMPLETED|Overall Study||22
5224285|NCT00928707|12846679|P1|COMPLETED|Overall Study||22
5224286|NCT00928707|12846678|P2|STARTED|Overall Study||22
5224287|NCT00928707|12846679|P1|STARTED|Overall Study||23
5224288|NCT00928694|12846691|P2|NOT COMPLETED|Second Intervention||0
5224289|NCT00928694|12846692|P1|NOT COMPLETED|Second Intervention||0
5224290|NCT00928694|12846691|P2|COMPLETED|Second Intervention||7
5224291|NCT00928694|12846692|P1|COMPLETED|Second Intervention||7
5224292|NCT00928694|12846691|P2|STARTED|Second Intervention||7
5224293|NCT00928694|12846692|P1|STARTED|Second Intervention||7
5224294|NCT00928694|12846691|P2|NOT COMPLETED|First Intervention||0
5224295|NCT00928694|12846692|P1|NOT COMPLETED|First Intervention||0
5224296|NCT00928694|12846691|P2|COMPLETED|First Intervention||7
5224297|NCT00928694|12846692|P1|COMPLETED|First Intervention||7
5224298|NCT00928694|12846691|P2|STARTED|First Intervention||7
5224299|NCT00928694|12846692|P1|STARTED|First Intervention||7
5224300|NCT00928668|12846700|P5|NOT COMPLETED|Overall Study||1
5224301|NCT00928668|12846701|P4|NOT COMPLETED|Overall Study||1
5224302|NCT00928668|12846702|P3|NOT COMPLETED|Overall Study||1
5224303|NCT00928668|12846703|P2|NOT COMPLETED|Overall Study||1
5224304|NCT00928668|12846704|P1|NOT COMPLETED|Overall Study||1
5224305|NCT00928668|12846700|P5|COMPLETED|Overall Study||5
5224306|NCT00928668|12846701|P4|COMPLETED|Overall Study||3
5224307|NCT00928668|12846702|P3|COMPLETED|Overall Study||6
5224308|NCT00928668|12846703|P2|COMPLETED|Overall Study||6
5224309|NCT00928668|12846704|P1|COMPLETED|Overall Study||6
5224310|NCT00928668|12846700|P5|STARTED|Overall Study||6
5224311|NCT00928668|12846701|P4|STARTED|Overall Study||4
5224312|NCT00928668|12846702|P3|STARTED|Overall Study||7
5224313|NCT00928668|12846703|P2|STARTED|Overall Study||7
5224314|NCT00928668|12846704|P1|STARTED|Overall Study||7
5224315|NCT00928642|12846746|P1|NOT COMPLETED|Overall Study||0
5224316|NCT00928642|12846746|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
5224317|NCT00928642|12846746|P1|STARTED|Overall Study||8
5224318|NCT00928512|12846760|P5|NOT COMPLETED|Overall Study||15
5224319|NCT00928512|12846761|P4|NOT COMPLETED|Overall Study||21
5224320|NCT00928512|12846762|P3|NOT COMPLETED|Overall Study||11
5224321|NCT00928512|12846763|P2|NOT COMPLETED|Overall Study||6
5224322|NCT00928512|12846764|P1|NOT COMPLETED|Overall Study||10
5224323|NCT00928512|12846760|P5|COMPLETED|Overall Study||35
5224324|NCT00928512|12846761|P4|COMPLETED|Overall Study||33
5224325|NCT00928512|12846762|P3|COMPLETED|Overall Study||38
5224326|NCT00928512|12846763|P2|COMPLETED|Overall Study||37
5224327|NCT00928512|12846764|P1|COMPLETED|Overall Study||31
5224328|NCT00928512|12846760|P5|Entered/Continued to Week 20 (All)|Overall Study||45
5224329|NCT00928512|12846761|P4|Entered/Continued to Week 20 (All)|Overall Study||45
5224330|NCT00928512|12846762|P3|Entered/Continued to Week 20 (All)|Overall Study||46
5224331|NCT00928512|12846763|P2|Entered/Continued to Week 20 (All)|Overall Study||43
5224332|NCT00928512|12846764|P1|Entered/Continued to Week 20 (All)|Overall Study||37
5224333|NCT00928512|12846760|P5|Completed Week 16|Overall Study||45
5224334|NCT00928512|12846761|P4|Completed Week 16|Overall Study||48
5224335|NCT00928512|12846762|P3|Completed Week 16|Overall Study||47
5224336|NCT00928512|12846763|P2|Completed Week 16|Overall Study||43
5224337|NCT00928512|12846764|P1|Completed Week 16|Overall Study||38
5224338|NCT00928512|12846760|P5|New Groups After Reassignment|Overall Study||0
5224339|NCT00928512|12846761|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
5224340|NCT00928512|12846762|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
5224341|NCT00928512|12846763|P2|New Groups After Reassignment|Overall Study||115
5224342|NCT00928512|12846764|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
5224343|NCT00928512|12846760|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
5224344|NCT00928512|12846761|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
5224345|NCT00928512|12846762|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
5224346|NCT00928512|12846763|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
5224347|NCT00928512|12846764|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
5224348|NCT00928512|12846760|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
5224349|NCT00928512|12846761|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
5224350|NCT00928512|12846762|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
5224351|NCT00928512|12846763|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
5224352|NCT00928512|12846764|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
5224353|NCT00928512|12846760|P5|Discontinued Prior to Week 16|Overall Study||5
5224354|NCT00928512|12846761|P4|Discontinued Prior to Week 16|Overall Study||6
5224355|NCT00928512|12846762|P3|Discontinued Prior to Week 16|Overall Study||2
5224356|NCT00928512|12846763|P2|Discontinued Prior to Week 16|Overall Study||0
5224357|NCT00928512|12846764|P1|Discontinued Prior to Week 16|Overall Study||3
5224358|NCT00928512|12846760|P5|STARTED|Overall Study||50
5224359|NCT00928512|12846761|P4|STARTED|Overall Study||54
5224360|NCT00928512|12846762|P3|STARTED|Overall Study||49
5224361|NCT00928512|12846763|P2|STARTED|Overall Study||43
5224362|NCT00928512|12846764|P1|STARTED|Overall Study||41
5224363|NCT00928486|12846865|P1|NOT COMPLETED|Overall Study||10
5224364|NCT00928486|12846865|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
5224365|NCT00928486|12846865|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
5224366|NCT00928486|12846865|P1|STARTED|Overall Study||25
5224367|NCT00928434|12846874|P3|NOT COMPLETED|Overall Study||44
5224368|NCT00928434|12846875|P2|NOT COMPLETED|Overall Study||14
5224369|NCT00928434|12846876|P1|NOT COMPLETED|Overall Study||44
5224370|NCT00928434|12846874|P3|COMPLETED|Overall Study||134
5224371|NCT00928434|12846875|P2|COMPLETED|Overall Study||36
5224372|NCT00928434|12846876|P1|COMPLETED|Overall Study||131
5224373|NCT00928434|12846874|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
5224374|NCT00928434|12846875|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
5224375|NCT00928434|12846876|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
5224376|NCT00928434|12846874|P3|STARTED|Overall Study|Full Analysis Set Patients|178
5224377|NCT00928434|12846875|P2|STARTED|Overall Study|Full Analysis Set Patients|50
5224378|NCT00928434|12846876|P1|STARTED|Overall Study|Full Analysis Set Patients|175
5224379|NCT00928421|12846948|P1|NOT COMPLETED|Overall Study||0
5224380|NCT00928421|12846948|P1|COMPLETED|Overall Study||16
5224381|NCT00928421|12846948|P1|Treated With Study Drug|Overall Study||16
5224382|NCT00928421|12846948|P1|STARTED|Overall Study||16
5224383|NCT00928408|12846952|P1|NOT COMPLETED|Overall Study||23
5224384|NCT00928408|12846952|P1|COMPLETED|Overall Study||282
5224385|NCT00928408|12846952|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
5224386|NCT00928408|12846952|P1|STARTED|Overall Study|Number Enrolled|305
5224387|NCT00928395|12846981|P1|NOT COMPLETED|Overall Study||21
5224388|NCT00928395|12846981|P1|COMPLETED|Overall Study||29
5224389|NCT00928395|12846981|P1|STARTED|Overall Study||50
5224390|NCT00928304|12846985|P2|NOT COMPLETED|Overall Study||0
5224391|NCT00928304|12846986|P1|NOT COMPLETED|Overall Study||0
5224392|NCT00928304|12846985|P2|COMPLETED|Overall Study||70
5224393|NCT00928304|12846986|P1|COMPLETED|Overall Study||39
5224394|NCT00928304|12846985|P2|STARTED|Overall Study||70
5224395|NCT00928304|12846986|P1|STARTED|Overall Study||39
5224396|NCT00928252|12846998|P1|NOT COMPLETED|Overall Study||3
5224397|NCT00928252|12846998|P1|COMPLETED|Overall Study||42
5224398|NCT00928252|12846998|P1|STARTED|Overall Study||45
5224399|NCT00928226|12847008|P4|NOT COMPLETED|Overall Study||0
5224400|NCT00928226|12847009|P3|NOT COMPLETED|Overall Study||0
5224401|NCT00928226|12847010|P2|NOT COMPLETED|Overall Study||0
5224402|NCT00928226|12847011|P1|NOT COMPLETED|Overall Study||0
5224403|NCT00928226|12847008|P4|COMPLETED|Overall Study||12
5224404|NCT00928226|12847009|P3|COMPLETED|Overall Study||12
5224405|NCT00928226|12847010|P2|COMPLETED|Overall Study||12
5224406|NCT00928226|12847011|P1|COMPLETED|Overall Study||20
5224407|NCT00928226|12847008|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
5224408|NCT00928226|12847009|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
5224409|NCT00928226|12847010|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
5224410|NCT00928226|12847011|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
5224411|NCT00928226|12847008|P4|Strata C: Large Tumor, Resected|Overall Study||6
5224412|NCT00928226|12847009|P3|Strata C: Large Tumor, Resected|Overall Study||6
5224413|NCT00928226|12847010|P2|Strata C: Large Tumor, Resected|Overall Study||6
5224414|NCT00928226|12847011|P1|Strata C: Large Tumor, Resected|Overall Study||8
5224415|NCT00928226|12847008|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
5224416|NCT00928226|12847009|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
5224417|NCT00928226|12847010|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
5224418|NCT00928226|12847011|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
5224419|NCT00928226|12847008|P4|Strata A: Small Tumor, Resected|Overall Study||6
5224420|NCT00928226|12847009|P3|Strata A: Small Tumor, Resected|Overall Study||6
5224421|NCT00928226|12847010|P2|Strata A: Small Tumor, Resected|Overall Study||6
5224422|NCT00928226|12847011|P1|Strata A: Small Tumor, Resected|Overall Study||6
5224423|NCT00928226|12847008|P4|STARTED|Overall Study||12
5224424|NCT00928226|12847009|P3|STARTED|Overall Study||12
5224425|NCT00928226|12847010|P2|STARTED|Overall Study||12
5224426|NCT00928226|12847011|P1|STARTED|Overall Study||20
5224427|NCT00928200|12847049|P1|NOT COMPLETED|Overall Study||0
5224428|NCT00928200|12847049|P1|COMPLETED|Overall Study||1
5224429|NCT00928200|12847049|P1|STARTED|Overall Study||1
5224430|NCT00928187|12847058|P3|NOT COMPLETED|Overall Study||5
5224431|NCT00928187|12847059|P2|NOT COMPLETED|Overall Study||6
5224432|NCT00928187|12847060|P1|NOT COMPLETED|Overall Study||2
5224433|NCT00928187|12847058|P3|COMPLETED|Overall Study||150
5224434|NCT00928187|12847059|P2|COMPLETED|Overall Study||141
5224435|NCT00928187|12847060|P1|COMPLETED|Overall Study||150
5224436|NCT00928187|12847058|P3|Analysed|Overall Study||154
5224437|NCT00928187|12847059|P2|Analysed|Overall Study||145
5224438|NCT00928187|12847060|P1|Analysed|Overall Study||152
5224439|NCT00928187|12847058|P3|STARTED|Overall Study||155
5224440|NCT00928187|12847059|P2|STARTED|Overall Study||147
5224441|NCT00928187|12847060|P1|STARTED|Overall Study||152
5224442|NCT00928174|12847104|P1|NOT COMPLETED|Overall Study||5
5224443|NCT00928174|12847104|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
5224444|NCT00928174|12847104|P1|STARTED|Overall Study||27
5224445|NCT00928083|12847111|P9|NOT COMPLETED|Overall Study||0
5224446|NCT00928083|12847112|P8|NOT COMPLETED|Overall Study||0
5224447|NCT00928083|12847113|P7|NOT COMPLETED|Overall Study||0
5224448|NCT00928083|12847114|P6|NOT COMPLETED|Overall Study||0
5224449|NCT00928083|12847115|P5|NOT COMPLETED|Overall Study||1
5224450|NCT00928083|12847116|P4|NOT COMPLETED|Overall Study||1
5224451|NCT00928083|12847117|P3|NOT COMPLETED|Overall Study||0
5224452|NCT00928083|12847118|P2|NOT COMPLETED|Overall Study||0
5224453|NCT00928083|12847119|P1|NOT COMPLETED|Overall Study||4
5224454|NCT00928083|12847111|P9|COMPLETED|Overall Study||6
5224455|NCT00928083|12847112|P8|COMPLETED|Overall Study||6
5224456|NCT00928083|12847113|P7|COMPLETED|Overall Study||6
5224457|NCT00928083|12847114|P6|COMPLETED|Overall Study||6
5224458|NCT00928083|12847115|P5|COMPLETED|Overall Study||6
5224459|NCT00928083|12847116|P4|COMPLETED|Overall Study||5
5224460|NCT00928083|12847117|P3|COMPLETED|Overall Study||8
5224461|NCT00928083|12847118|P2|COMPLETED|Overall Study||8
5224462|NCT00928083|12847119|P1|COMPLETED|Overall Study||6
5224463|NCT00928083|12847111|P9|STARTED|Overall Study||6
5224464|NCT00928083|12847112|P8|STARTED|Overall Study||6
5224465|NCT00928083|12847113|P7|STARTED|Overall Study||6
5224466|NCT00928083|12847114|P6|STARTED|Overall Study||6
5224467|NCT00928083|12847115|P5|STARTED|Overall Study||7
5224468|NCT00928083|12847116|P4|STARTED|Overall Study||6
5224469|NCT00928083|12847117|P3|STARTED|Overall Study||8
5224470|NCT00928083|12847118|P2|STARTED|Overall Study||8
5224471|NCT00928083|12847119|P1|STARTED|Overall Study||10
5224472|NCT00928070|12847230|P2|NOT COMPLETED|Overall Study||57
5224473|NCT00928070|12847231|P1|NOT COMPLETED|Overall Study||63
5224474|NCT00928070|12847230|P2|COMPLETED|Overall Study||226
5224475|NCT00928070|12847231|P1|COMPLETED|Overall Study||220
5224476|NCT00928070|12847230|P2|Treated|Overall Study||281
5224477|NCT00928070|12847231|P1|Treated|Overall Study||281
5224478|NCT00928070|12847230|P2|STARTED|Overall Study||283
5224479|NCT00928070|12847231|P1|STARTED|Overall Study||283
5224480|NCT00928057|12847289|P2|NOT COMPLETED|Overall Study||4
5224481|NCT00928057|12847290|P1|NOT COMPLETED|Overall Study||2
5224482|NCT00928057|12847289|P2|COMPLETED|Overall Study||85
5224483|NCT00928057|12847290|P1|COMPLETED|Overall Study||82
5224484|NCT00928057|12847289|P2|STARTED|Overall Study||89
5224485|NCT00928057|12847290|P1|STARTED|Overall Study||84
5224486|NCT00928018|12847315|P2|NOT COMPLETED|Overall Study||0
5224487|NCT00928018|12847316|P1|NOT COMPLETED|Overall Study||1
5224488|NCT00928018|12847315|P2|COMPLETED|Overall Study||73
5224489|NCT00928018|12847316|P1|COMPLETED|Overall Study||65
5224490|NCT00928018|12847315|P2|STARTED|Overall Study||73
5224491|NCT00928018|12847316|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
5224492|NCT00927992|12847334|P1|NOT COMPLETED|Overall Study||0
5224493|NCT00927992|12847334|P1|COMPLETED|Overall Study||11
5224494|NCT00927992|12847334|P1|STARTED|Overall Study||11
5224495|NCT00927953|12847346|P2|NOT COMPLETED|Overall Study||1
5224496|NCT00927953|12847347|P1|NOT COMPLETED|Overall Study||2
5224497|NCT00927953|12847346|P2|COMPLETED|Overall Study||6
5224498|NCT00927953|12847347|P1|COMPLETED|Overall Study||4
5224499|NCT00927953|12847346|P2|STARTED|Overall Study||7
5224500|NCT00927953|12847347|P1|STARTED|Overall Study||6
5224501|NCT00927940|12847361|P1|NOT COMPLETED|Overall Study||1
5224502|NCT00927940|12847361|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
5224503|NCT00927940|12847361|P1|STARTED|Overall Study||100
5224504|NCT00927927|12847381|P15|NOT COMPLETED|Overall Study||0
5224505|NCT00927927|12847382|P14|NOT COMPLETED|Overall Study||0
5224506|NCT00927927|12847383|P13|NOT COMPLETED|Overall Study||0
5224507|NCT00927927|12847384|P12|NOT COMPLETED|Overall Study||2
5224508|NCT00927927|12847385|P11|NOT COMPLETED|Overall Study||0
5224509|NCT00927927|12847386|P10|NOT COMPLETED|Overall Study||0
5224510|NCT00927927|12847387|P9|NOT COMPLETED|Overall Study||0
5224511|NCT00927927|12847388|P8|NOT COMPLETED|Overall Study||2
5224512|NCT00927927|12847389|P7|NOT COMPLETED|Overall Study||0
5224513|NCT00927927|12847390|P6|NOT COMPLETED|Overall Study||0
5224514|NCT00927927|12847391|P5|NOT COMPLETED|Overall Study||0
5224515|NCT00927927|12847392|P4|NOT COMPLETED|Overall Study||0
5224516|NCT00927927|12847393|P3|NOT COMPLETED|Overall Study||0
5224517|NCT00927927|12847394|P2|NOT COMPLETED|Overall Study||0
5224518|NCT00927927|12847395|P1|NOT COMPLETED|Overall Study||0
5224519|NCT00927927|12847381|P15|COMPLETED|Overall Study||9
5224520|NCT00927927|12847382|P14|COMPLETED|Overall Study||5
5224521|NCT00927927|12847383|P13|COMPLETED|Overall Study||5
5224522|NCT00927927|12847384|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
5224523|NCT00927927|12847385|P11|COMPLETED|Overall Study||5
5224524|NCT00927927|12847386|P10|COMPLETED|Overall Study||3
5224525|NCT00927927|12847387|P9|COMPLETED|Overall Study||8
5224526|NCT00927927|12847388|P8|COMPLETED|Overall Study||1
5224527|NCT00927927|12847389|P7|COMPLETED|Overall Study||3
5224528|NCT00927927|12847390|P6|COMPLETED|Overall Study||3
5224529|NCT00927927|12847391|P5|COMPLETED|Overall Study||3
5224530|NCT00927927|12847392|P4|COMPLETED|Overall Study||3
5224531|NCT00927927|12847393|P3|COMPLETED|Overall Study||3
5224532|NCT00927927|12847394|P2|COMPLETED|Overall Study||3
5224533|NCT00927927|12847395|P1|COMPLETED|Overall Study||3
5224534|NCT00927927|12847381|P15|Exposed|Overall Study||9
5224535|NCT00927927|12847382|P14|Exposed|Overall Study||5
5224536|NCT00927927|12847383|P13|Exposed|Overall Study||5
5224537|NCT00927927|12847384|P12|Exposed|Overall Study||5
5224538|NCT00927927|12847385|P11|Exposed|Overall Study||5
5224539|NCT00927927|12847386|P10|Exposed|Overall Study||3
5224540|NCT00927927|12847387|P9|Exposed|Overall Study||8
5224541|NCT00927927|12847388|P8|Exposed|Overall Study||3
5224542|NCT00927927|12847389|P7|Exposed|Overall Study||3
5224543|NCT00927927|12847390|P6|Exposed|Overall Study||3
5224544|NCT00927927|12847391|P5|Exposed|Overall Study||3
5224545|NCT00927927|12847392|P4|Exposed|Overall Study||3
5224546|NCT00927927|12847393|P3|Exposed|Overall Study||3
5224547|NCT00927927|12847394|P2|Exposed|Overall Study||3
5224548|NCT00927927|12847395|P1|Exposed|Overall Study||3
5224549|NCT00927927|12847381|P15|STARTED|Overall Study||9
5224550|NCT00927927|12847382|P14|STARTED|Overall Study||5
5224551|NCT00927927|12847383|P13|STARTED|Overall Study||5
5224552|NCT00927927|12847384|P12|STARTED|Overall Study||6
5224553|NCT00927927|12847385|P11|STARTED|Overall Study||5
5224554|NCT00927927|12847386|P10|STARTED|Overall Study||3
5224555|NCT00927927|12847387|P9|STARTED|Overall Study||8
5224556|NCT00927927|12847388|P8|STARTED|Overall Study||3
5224557|NCT00927927|12847389|P7|STARTED|Overall Study||3
5224558|NCT00927927|12847390|P6|STARTED|Overall Study||3
5224559|NCT00927927|12847391|P5|STARTED|Overall Study||3
5224560|NCT00927927|12847392|P4|STARTED|Overall Study||3
5224561|NCT00927927|12847393|P3|STARTED|Overall Study||3
5224562|NCT00927927|12847394|P2|STARTED|Overall Study||3
5224563|NCT00927927|12847395|P1|STARTED|Overall Study||3
5224564|NCT00927901|12847442|P4|NOT COMPLETED|Treatment Period 4||1
5224565|NCT00927901|12847443|P3|NOT COMPLETED|Treatment Period 4||1
5224566|NCT00927901|12847444|P2|NOT COMPLETED|Treatment Period 4||0
5224567|NCT00927901|12847445|P1|NOT COMPLETED|Treatment Period 4||0
5224568|NCT00927901|12847442|P4|COMPLETED|Treatment Period 4||8
5224569|NCT00927901|12847443|P3|COMPLETED|Treatment Period 4||5
5224570|NCT00927901|12847444|P2|COMPLETED|Treatment Period 4||7
5224571|NCT00927901|12847445|P1|COMPLETED|Treatment Period 4||7
5224572|NCT00927901|12847442|P4|STARTED|Treatment Period 4||9
5224573|NCT00927901|12847443|P3|STARTED|Treatment Period 4||6
5224574|NCT00927901|12847444|P2|STARTED|Treatment Period 4||7
5224575|NCT00927901|12847445|P1|STARTED|Treatment Period 4||7
5224576|NCT00927901|12847442|P4|NOT COMPLETED|Treatment Period 3||0
5224577|NCT00927901|12847443|P3|NOT COMPLETED|Treatment Period 3||0
5224578|NCT00927901|12847444|P2|NOT COMPLETED|Treatment Period 3||0
5224579|NCT00927901|12847445|P1|NOT COMPLETED|Treatment Period 3||0
5224580|NCT00927901|12847442|P4|COMPLETED|Treatment Period 3||9
5224581|NCT00927901|12847443|P3|COMPLETED|Treatment Period 3||6
5224582|NCT00927901|12847444|P2|COMPLETED|Treatment Period 3||7
5224583|NCT00927901|12847445|P1|COMPLETED|Treatment Period 3||7
5224584|NCT00927901|12847442|P4|STARTED|Treatment Period 3||9
5224585|NCT00927901|12847443|P3|STARTED|Treatment Period 3||6
5224586|NCT00927901|12847444|P2|STARTED|Treatment Period 3||7
5224587|NCT00927901|12847445|P1|STARTED|Treatment Period 3||7
5224588|NCT00927901|12847442|P4|NOT COMPLETED|Treatment Period 2||0
5224589|NCT00927901|12847443|P3|NOT COMPLETED|Treatment Period 2||0
5224590|NCT00927901|12847444|P2|NOT COMPLETED|Treatment Period 2||0
5224591|NCT00927901|12847445|P1|NOT COMPLETED|Treatment Period 2||0
5224592|NCT00927901|12847442|P4|COMPLETED|Treatment Period 2||9
5224593|NCT00927901|12847443|P3|COMPLETED|Treatment Period 2||6
5224594|NCT00927901|12847444|P2|COMPLETED|Treatment Period 2||7
5224595|NCT00927901|12847445|P1|COMPLETED|Treatment Period 2||7
5224596|NCT00927901|12847442|P4|STARTED|Treatment Period 2||9
5224597|NCT00927901|12847443|P3|STARTED|Treatment Period 2||6
5224598|NCT00927901|12847444|P2|STARTED|Treatment Period 2||7
5224599|NCT00927901|12847445|P1|STARTED|Treatment Period 2||7
5224600|NCT00927901|12847442|P4|NOT COMPLETED|Treatment Period 1||0
5224601|NCT00927901|12847443|P3|NOT COMPLETED|Treatment Period 1||1
5224602|NCT00927901|12847444|P2|NOT COMPLETED|Treatment Period 1||0
5224603|NCT00927901|12847445|P1|NOT COMPLETED|Treatment Period 1||0
5224604|NCT00927901|12847442|P4|COMPLETED|Treatment Period 1||9
5224605|NCT00927901|12847443|P3|COMPLETED|Treatment Period 1||6
5224606|NCT00927901|12847444|P2|COMPLETED|Treatment Period 1||7
5224607|NCT00927901|12847445|P1|COMPLETED|Treatment Period 1||7
5224608|NCT00927901|12847442|P4|STARTED|Treatment Period 1||9
5224609|NCT00927901|12847443|P3|STARTED|Treatment Period 1||7
5224610|NCT00927901|12847444|P2|STARTED|Treatment Period 1||7
5224611|NCT00927901|12847445|P1|STARTED|Treatment Period 1||7
5224612|NCT00927888|12847475|P2|NOT COMPLETED|Overall Study||0
5224613|NCT00927888|12847476|P1|NOT COMPLETED|Overall Study||0
5224614|NCT00927888|12847475|P2|COMPLETED|Overall Study||27
5224615|NCT00927888|12847476|P1|COMPLETED|Overall Study||29
5224616|NCT00927888|12847475|P2|STARTED|Overall Study||27
5224617|NCT00927888|12847476|P1|STARTED|Overall Study||29
5224618|NCT00927862|12847486|P2|NOT COMPLETED|Overall Study||45
5224619|NCT00927862|12847487|P1|NOT COMPLETED|Overall Study||27
5224620|NCT00927862|12847486|P2|COMPLETED|Overall Study||1866
5224621|NCT00927862|12847487|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
5224622|NCT00927862|12847486|P2|STARTED|Overall Study||1911
5224623|NCT00927862|12847487|P1|STARTED|Overall Study||504
5224624|NCT00927849|12847512|P3|NOT COMPLETED|Overall Study||0
5224625|NCT00927849|12847513|P2|NOT COMPLETED|Overall Study||0
5224626|NCT00927849|12847514|P1|NOT COMPLETED|Overall Study||0
5224627|NCT00927849|12847512|P3|COMPLETED|Overall Study||21
5224628|NCT00927849|12847513|P2|COMPLETED|Overall Study||21
5224629|NCT00927849|12847514|P1|COMPLETED|Overall Study||21
5224630|NCT00927849|12847512|P3|STARTED|Overall Study||21
5224631|NCT00927849|12847513|P2|STARTED|Overall Study||21
5224632|NCT00927849|12847514|P1|STARTED|Overall Study||21
5224633|NCT00927823|12847522|P4|NOT COMPLETED|Continuous Dosing Period||5
5224634|NCT00927823|12847523|P3|NOT COMPLETED|Continuous Dosing Period||26
5224635|NCT00927823|12847524|P2|NOT COMPLETED|Continuous Dosing Period||3
5224636|NCT00927823|12847525|P1|NOT COMPLETED|Continuous Dosing Period||3
5224637|NCT00927823|12847522|P4|COMPLETED|Continuous Dosing Period||0
5224638|NCT00927823|12847523|P3|COMPLETED|Continuous Dosing Period||0
5224639|NCT00927823|12847524|P2|COMPLETED|Continuous Dosing Period||0
5224640|NCT00927823|12847525|P1|COMPLETED|Continuous Dosing Period||0
5224641|NCT00927823|12847522|P4|Treated|Continuous Dosing Period||5
5224642|NCT00927823|12847523|P3|Treated|Continuous Dosing Period||23
5224643|NCT00927823|12847524|P2|Treated|Continuous Dosing Period||3
5224644|NCT00927823|12847525|P1|Treated|Continuous Dosing Period||3
5224645|NCT00927823|12847522|P4|STARTED|Continuous Dosing Period||5
5224646|NCT00927823|12847523|P3|STARTED|Continuous Dosing Period||26
5224647|NCT00927823|12847524|P2|STARTED|Continuous Dosing Period||3
5224648|NCT00927823|12847525|P1|STARTED|Continuous Dosing Period||3
5224649|NCT00927823|12847522|P4|NOT COMPLETED|Lead-In Period||0
5224650|NCT00927823|12847523|P3|NOT COMPLETED|Lead-In Period||0
5224651|NCT00927823|12847524|P2|NOT COMPLETED|Lead-In Period||0
5224652|NCT00927823|12847525|P1|NOT COMPLETED|Lead-In Period||0
5224653|NCT00927823|12847522|P4|COMPLETED|Lead-In Period||5
5224654|NCT00927823|12847523|P3|COMPLETED|Lead-In Period||26
5224655|NCT00927823|12847524|P2|COMPLETED|Lead-In Period||3
5224656|NCT00927823|12847525|P1|COMPLETED|Lead-In Period||3
5224657|NCT00927823|12847522|P4|STARTED|Lead-In Period||5
5224658|NCT00927823|12847523|P3|STARTED|Lead-In Period||26
5224659|NCT00927823|12847524|P2|STARTED|Lead-In Period||3
5224660|NCT00927823|12847525|P1|STARTED|Lead-In Period||3
5224661|NCT00927784|12847591|P2|NOT COMPLETED|Overall Study||0
5224662|NCT00927784|12847592|P1|NOT COMPLETED|Overall Study||2
5224663|NCT00927784|12847591|P2|COMPLETED|Overall Study||2
5224664|NCT00927784|12847592|P1|COMPLETED|Overall Study||6
5224665|NCT00927784|12847591|P2|STARTED|Overall Study||2
5224666|NCT00927784|12847592|P1|STARTED|Overall Study||8
5224667|NCT00927758|12847622|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224668|NCT00927758|12847623|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224669|NCT00927758|12847624|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224670|NCT00927758|12847625|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224671|NCT00927758|12847626|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224672|NCT00927758|12847627|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
5224673|NCT00927758|12847622|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
5224674|NCT00927758|12847623|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
5224675|NCT00927758|12847624|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
5224676|NCT00927758|12847625|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
5224677|NCT00927758|12847626|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
5224678|NCT00927758|12847627|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
5224679|NCT00927758|12847622|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
5224680|NCT00927758|12847623|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
5224681|NCT00927758|12847624|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
5224682|NCT00927758|12847625|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
5224683|NCT00927758|12847626|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
5224684|NCT00927758|12847627|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
5224685|NCT00927758|12847622|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
5224686|NCT00927758|12847623|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
5224687|NCT00927758|12847624|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
5224688|NCT00927758|12847625|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
5224689|NCT00927758|12847626|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
5224690|NCT00927758|12847627|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
5224691|NCT00927758|12847622|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
5224692|NCT00927758|12847623|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
5224693|NCT00927758|12847624|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
5224694|NCT00927758|12847625|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
5224695|NCT00927758|12847626|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
5224696|NCT00927758|12847627|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
5224697|NCT00927758|12847622|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
5224698|NCT00927758|12847623|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
5224699|NCT00927758|12847624|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
5224700|NCT00927758|12847625|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
5224701|NCT00927758|12847626|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
5224702|NCT00927758|12847627|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
5224703|NCT00927758|12847622|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
5224704|NCT00927758|12847623|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
5224705|NCT00927758|12847624|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
5224706|NCT00927758|12847625|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
5224707|NCT00927758|12847626|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
5224708|NCT00927758|12847627|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
5224709|NCT00927758|12847622|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
5224710|NCT00927758|12847623|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
5224711|NCT00927758|12847624|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
5224712|NCT00927758|12847625|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
5224713|NCT00927758|12847626|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
5224714|NCT00927758|12847627|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
5224715|NCT00927758|12847622|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
5224716|NCT00927758|12847623|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
5224717|NCT00927758|12847624|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
5224718|NCT00927758|12847625|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224719|NCT00927758|12847626|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224720|NCT00927758|12847627|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224721|NCT00927758|12847622|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
5224722|NCT00927758|12847623|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
5224723|NCT00927758|12847624|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
5224724|NCT00927758|12847625|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
5224725|NCT00927758|12847626|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
5224726|NCT00927758|12847627|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
5224727|NCT00927758|12847622|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224728|NCT00927758|12847623|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
5224729|NCT00927758|12847624|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
5224730|NCT00927758|12847625|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224731|NCT00927758|12847626|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
5224732|NCT00927758|12847627|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
5224733|NCT00927589|12847635|P1|NOT COMPLETED|Overall Study||16
5224734|NCT00927589|12847635|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
5224735|NCT00927589|12847635|P1|STARTED|Overall Study||59
5224736|NCT00927576|12847659|P2|NOT COMPLETED|Overall Study||0
5224737|NCT00927576|12847660|P1|NOT COMPLETED|Overall Study||0
5224738|NCT00927576|12847659|P2|COMPLETED|Overall Study||28
5224739|NCT00927576|12847660|P1|COMPLETED|Overall Study||237
5224740|NCT00927576|12847659|P2|Cognitive Testing|Overall Study||28
5224741|NCT00927576|12847660|P1|Cognitive Testing|Overall Study||237
5224742|NCT00927576|12847659|P2|STARTED|Overall Study||28
5224743|NCT00927576|12847660|P1|STARTED|Overall Study||237
5224744|NCT00927563|12847665|P1|NOT COMPLETED|Overall Study||2
5224745|NCT00927563|12847665|P1|COMPLETED|Overall Study||22
5224746|NCT00927563|12847665|P1|STARTED|Overall Study||24
5224747|NCT00927472|12847673|P2|NOT COMPLETED|Overall Study||22
5224748|NCT00927472|12847674|P1|NOT COMPLETED|Overall Study||11
5224749|NCT00927472|12847673|P2|COMPLETED|Overall Study||106
5224750|NCT00927472|12847674|P1|COMPLETED|Overall Study||115
5224751|NCT00927472|12847673|P2|STARTED|Overall Study||128
5224752|NCT00927472|12847674|P1|STARTED|Overall Study||126
5224753|NCT00927394|12847700|P2|NOT COMPLETED|Overall Study||85
5224754|NCT00927394|12847701|P1|NOT COMPLETED|Overall Study||77
5224755|NCT00927394|12847700|P2|COMPLETED|Overall Study||483
5224756|NCT00927394|12847701|P1|COMPLETED|Overall Study||498
5224757|NCT00927394|12847700|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
5224758|NCT00927394|12847701|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
5224759|NCT00927394|12847700|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
5224760|NCT00927394|12847701|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
5224761|NCT00927394|12847700|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
5224762|NCT00927394|12847701|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
5224763|NCT00927394|12847700|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
5224764|NCT00927394|12847701|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
5224765|NCT00927394|12847700|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
5224766|NCT00927394|12847701|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
5224767|NCT00927394|12847700|P2|Cohort 2 (Randomized)|Overall Study||403
5224768|NCT00927394|12847701|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
5224769|NCT00927394|12847700|P2|Cohort 1 (Randomized)|Overall Study||165
5224770|NCT00927394|12847701|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
5224771|NCT00927394|12847700|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
5224772|NCT00927394|12847701|P1|STARTED|Overall Study||575
5224773|NCT00927368|12847732|P3|NOT COMPLETED|Overall Study||5
5224774|NCT00927368|12847733|P2|NOT COMPLETED|Overall Study||5
5224775|NCT00927368|12847734|P1|NOT COMPLETED|Overall Study||6
5224776|NCT00927368|12847732|P3|COMPLETED|Overall Study||138
5224777|NCT00927368|12847733|P2|COMPLETED|Overall Study||152
5224778|NCT00927368|12847734|P1|COMPLETED|Overall Study||147
5224779|NCT00927368|12847732|P3|STARTED|Overall Study||143
5224780|NCT00927368|12847733|P2|STARTED|Overall Study||157
5224781|NCT00927368|12847734|P1|STARTED|Overall Study||153
5224782|NCT00927355|12847753|P2|NOT COMPLETED|Overall Study||1
5224783|NCT00927355|12847754|P1|NOT COMPLETED|Overall Study||1
5224784|NCT00927355|12847753|P2|COMPLETED|Overall Study||4
5224785|NCT00927355|12847754|P1|COMPLETED|Overall Study||4
5224786|NCT00927355|12847753|P2|STARTED|Overall Study||5
5224787|NCT00927355|12847754|P1|STARTED|Overall Study||5
5224788|NCT00927264|12847774|P2|NOT COMPLETED|Overall Study||25
5224789|NCT00927264|12847775|P1|NOT COMPLETED|Overall Study||56
5224790|NCT00927264|12847774|P2|COMPLETED|Overall Study||140
5224791|NCT00927264|12847775|P1|COMPLETED|Overall Study||109
5224792|NCT00927264|12847774|P2|STARTED|Overall Study||165
5224793|NCT00927264|12847775|P1|STARTED|Overall Study||165
5224794|NCT00927251|12847789|P1|NOT COMPLETED|Overall Study||8
5224795|NCT00927251|12847789|P1|COMPLETED|Overall Study||82
5224796|NCT00927251|12847789|P1|STARTED|Overall Study||90
5224797|NCT00927186|12847795|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
5224798|NCT00927186|12847796|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
5224799|NCT00927186|12847795|P2|COMPLETED|12 - 24 Months Extension Treatment||11
5224800|NCT00927186|12847796|P1|COMPLETED|12 - 24 Months Extension Treatment||10
5224801|NCT00927186|12847795|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
5224802|NCT00927186|12847796|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
5224803|NCT00927186|12847795|P2|NOT COMPLETED|12 Months Primary Study||4
5224804|NCT00927186|12847796|P1|NOT COMPLETED|12 Months Primary Study||7
5224805|NCT00927186|12847795|P2|COMPLETED|12 Months Primary Study||31
5224806|NCT00927186|12847796|P1|COMPLETED|12 Months Primary Study||27
5224807|NCT00927186|12847795|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
5224808|NCT00927186|12847796|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
5224809|NCT00927186|12847795|P2|STARTED|12 Months Primary Study||35
5224810|NCT00927186|12847796|P1|STARTED|12 Months Primary Study||34
5224811|NCT00927160|12847914|P2|NOT COMPLETED|Overall Study||0
5224812|NCT00927160|12847915|P1|NOT COMPLETED|Overall Study||0
5224813|NCT00927160|12847914|P2|COMPLETED|Overall Study||173
5224814|NCT00927160|12847915|P1|COMPLETED|Overall Study||173
5224815|NCT00927160|12847914|P2|STARTED|Overall Study||173
5224816|NCT00927160|12847915|P1|STARTED|Overall Study||173
5224817|NCT00927095|12847926|P3|NOT COMPLETED|Overall Study||2
5224818|NCT00927095|12847927|P2|NOT COMPLETED|Overall Study||4
5224819|NCT00927095|12847928|P1|NOT COMPLETED|Overall Study||6
5224820|NCT00927095|12847926|P3|COMPLETED|Overall Study||22
5224821|NCT00927095|12847927|P2|COMPLETED|Overall Study||17
5224822|NCT00927095|12847928|P1|COMPLETED|Overall Study||16
5224823|NCT00927095|12847926|P3|STARTED|Overall Study||24
5224824|NCT00927095|12847927|P2|STARTED|Overall Study||21
5224825|NCT00927095|12847928|P1|STARTED|Overall Study||22
5224826|NCT00927082|12847940|P4|NOT COMPLETED|Overall Study||19
5224827|NCT00927082|12847941|P3|NOT COMPLETED|Overall Study||22
5224828|NCT00927082|12847942|P2|NOT COMPLETED|Overall Study||10
5224829|NCT00927082|12847943|P1|NOT COMPLETED|Overall Study||12
5224830|NCT00927082|12847940|P4|COMPLETED|Overall Study||78
5224831|NCT00927082|12847941|P3|COMPLETED|Overall Study||86
5224832|NCT00927082|12847942|P2|COMPLETED|Overall Study||77
5224833|NCT00927082|12847943|P1|COMPLETED|Overall Study||79
5224834|NCT00927082|12847940|P4|STARTED|Overall Study||97
5224835|NCT00927082|12847941|P3|STARTED|Overall Study||108
5224836|NCT00927082|12847942|P2|STARTED|Overall Study||87
5224837|NCT00927082|12847943|P1|STARTED|Overall Study||91
5224838|NCT00927069|12848007|P4|NOT COMPLETED|Week 12 to Week 24||3
5224839|NCT00927069|12848008|P3|NOT COMPLETED|Week 12 to Week 24||3
5224840|NCT00927069|12848009|P2|NOT COMPLETED|Week 12 to Week 24||0
5224841|NCT00927069|12848010|P1|NOT COMPLETED|Week 12 to Week 24||2
5224842|NCT00927069|12848007|P4|COMPLETED|Week 12 to Week 24||20
5224843|NCT00927069|12848008|P3|COMPLETED|Week 12 to Week 24||28
5224844|NCT00927069|12848009|P2|COMPLETED|Week 12 to Week 24||11
5224845|NCT00927069|12848010|P1|COMPLETED|Week 12 to Week 24||16
5224846|NCT00927069|12848007|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
5224847|NCT00927069|12848008|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
5224848|NCT00927069|12848009|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
5224849|NCT00927069|12848010|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
5224850|NCT00927069|12848007|P4|NOT COMPLETED|Week 0 to Week 12||0
5224851|NCT00927069|12848008|P3|NOT COMPLETED|Week 0 to Week 12||0
5224852|NCT00927069|12848009|P2|NOT COMPLETED|Week 0 to Week 12||1
5224853|NCT00927069|12848010|P1|NOT COMPLETED|Week 0 to Week 12||1
5224854|NCT00927069|12848007|P4|COMPLETED|Week 0 to Week 12||0
5224855|NCT00927069|12848008|P3|COMPLETED|Week 0 to Week 12||0
5224856|NCT00927069|12848009|P2|COMPLETED|Week 0 to Week 12||34
5224857|NCT00927069|12848010|P1|COMPLETED|Week 0 to Week 12||49
5224858|NCT00927069|12848007|P4|STARTED|Week 0 to Week 12||0
5224859|NCT00927069|12848008|P3|STARTED|Week 0 to Week 12||0
5224860|NCT00927069|12848009|P2|STARTED|Week 0 to Week 12||35
5224861|NCT00927069|12848010|P1|STARTED|Week 0 to Week 12||50
5224862|NCT00926952|12848020|P1|NOT COMPLETED|Overall Study||0
5224863|NCT00926952|12848020|P1|COMPLETED|Overall Study||20
5224864|NCT00926952|12848020|P1|STARTED|Overall Study||20
5224865|NCT00926887|12848034|P2|NOT COMPLETED|Overall Study||0
5224866|NCT00926887|12848035|P1|NOT COMPLETED|Overall Study||0
5224867|NCT00926887|12848034|P2|COMPLETED|Overall Study||50
5224868|NCT00926887|12848035|P1|COMPLETED|Overall Study||54
5224869|NCT00926887|12848034|P2|STARTED|Overall Study||50
5224870|NCT00926887|12848035|P1|STARTED|Overall Study||54
5224871|NCT00926848|12848047|P2|NOT COMPLETED|Overall Study||0
5224872|NCT00926848|12848048|P1|NOT COMPLETED|Overall Study||0
5224873|NCT00926848|12848047|P2|COMPLETED|Overall Study||34
5224874|NCT00926848|12848048|P1|COMPLETED|Overall Study||34
5224875|NCT00926848|12848047|P2|STARTED|Overall Study||34
5224876|NCT00926848|12848048|P1|STARTED|Overall Study||34
5224877|NCT00926796|12848066|P2|NOT COMPLETED|Overall Study||106
5224878|NCT00926796|12848067|P1|NOT COMPLETED|Overall Study||107
5224879|NCT00926796|12848066|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
5224880|NCT00926796|12848067|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
5224881|NCT00926796|12848066|P2|STARTED|Overall Study|Number randomized|305
5224882|NCT00926796|12848067|P1|STARTED|Overall Study|Number randomized|309
5224883|NCT00926783|12848088|P2|NOT COMPLETED|Overall Study||3
5224884|NCT00926783|12848089|P1|NOT COMPLETED|Overall Study||3
5224885|NCT00926783|12848088|P2|COMPLETED|Overall Study||38
5224886|NCT00926783|12848089|P1|COMPLETED|Overall Study||39
5224887|NCT00926783|12848088|P2|STARTED|Overall Study||41
5224888|NCT00926783|12848089|P1|STARTED|Overall Study||42
5224889|NCT00926588|12848107|P2|NOT COMPLETED|Overall Study||4
5224890|NCT00926588|12848108|P1|NOT COMPLETED|Overall Study||8
5224891|NCT00926588|12848107|P2|COMPLETED|Overall Study||122
5224892|NCT00926588|12848108|P1|COMPLETED|Overall Study||116
5224893|NCT00926588|12848107|P2|STARTED|Overall Study||126
5224894|NCT00926588|12848108|P1|STARTED|Overall Study||124
5224895|NCT00926575|12848116|P2|NOT COMPLETED|Overall Study||17
5224896|NCT00926575|12848117|P1|NOT COMPLETED|Overall Study||16
5224897|NCT00926575|12848116|P2|COMPLETED|Overall Study||53
5224898|NCT00926575|12848117|P1|COMPLETED|Overall Study||54
5224899|NCT00926575|12848116|P2|STARTED|Overall Study||70
5224900|NCT00926575|12848117|P1|STARTED|Overall Study||70
5224901|NCT00926536|12848129|P2|NOT COMPLETED|Overall Study||2
5224902|NCT00926536|12848130|P1|NOT COMPLETED|Overall Study||1
5224903|NCT00926536|12848129|P2|COMPLETED|Overall Study||41
5224904|NCT00926536|12848130|P1|COMPLETED|Overall Study||43
5224905|NCT00926536|12848129|P2|STARTED|Overall Study||43
5224906|NCT00926536|12848130|P1|STARTED|Overall Study||44
5224907|NCT00926497|12848140|P2|NOT COMPLETED|Overall Study||0
5224908|NCT00926497|12848141|P1|NOT COMPLETED|Overall Study||0
5224909|NCT00926497|12848140|P2|COMPLETED|Overall Study||61
5224910|NCT00926497|12848141|P1|COMPLETED|Overall Study||60
5224911|NCT00926497|12848140|P2|STARTED|Overall Study||61
5224912|NCT00926497|12848141|P1|STARTED|Overall Study||60
5224913|NCT00926393|12848151|P2|NOT COMPLETED|Overall Study||3
5224914|NCT00926393|12848152|P1|NOT COMPLETED|Overall Study||2
5224915|NCT00926393|12848151|P2|COMPLETED|Overall Study||67
5224916|NCT00926393|12848152|P1|COMPLETED|Overall Study||67
5224917|NCT00926393|12848151|P2|STARTED|Overall Study||70
5224918|NCT00926393|12848152|P1|STARTED|Overall Study||69
5224919|NCT00926380|12848185|P3|NOT COMPLETED|Year 2||5
5224920|NCT00926380|12848186|P2|NOT COMPLETED|Year 2||2
5224921|NCT00926380|12848187|P1|NOT COMPLETED|Year 2||2
5224922|NCT00926380|12848185|P3|COMPLETED|Year 2||24
5224923|NCT00926380|12848186|P2|COMPLETED|Year 2||28
5224924|NCT00926380|12848187|P1|COMPLETED|Year 2||31
5224925|NCT00926380|12848185|P3|STARTED|Year 2||29
5224926|NCT00926380|12848186|P2|STARTED|Year 2||30
5224927|NCT00926380|12848187|P1|STARTED|Year 2||33
5224928|NCT00926380|12848185|P3|NOT COMPLETED|Year 1||1
5224929|NCT00926380|12848186|P2|NOT COMPLETED|Year 1||1
5224930|NCT00926380|12848187|P1|NOT COMPLETED|Year 1||0
5224931|NCT00926380|12848185|P3|COMPLETED|Year 1||29
5224932|NCT00926380|12848186|P2|COMPLETED|Year 1||30
5224933|NCT00926380|12848187|P1|COMPLETED|Year 1||33
5224934|NCT00926380|12848185|P3|STARTED|Year 1||30
5224935|NCT00926380|12848186|P2|STARTED|Year 1||31
5224936|NCT00926380|12848187|P1|STARTED|Year 1||33
5224937|NCT00926367|12848197|P2|NOT COMPLETED|Overall Study||3
5224938|NCT00926367|12848198|P1|NOT COMPLETED|Overall Study||2
5224939|NCT00926367|12848197|P2|COMPLETED|Overall Study||24
5224940|NCT00926367|12848198|P1|COMPLETED|Overall Study||23
5224941|NCT00926367|12848197|P2|STARTED|Overall Study||27
5224942|NCT00926367|12848198|P1|STARTED|Overall Study||25
5224943|NCT00926328|12848240|P2|NOT COMPLETED|Overall Study||14
5224944|NCT00926328|12848241|P1|NOT COMPLETED|Overall Study||12
5224945|NCT00926328|12848240|P2|COMPLETED|Overall Study||46
5224946|NCT00926328|12848241|P1|COMPLETED|Overall Study||48
5224947|NCT00926328|12848240|P2|STARTED|Overall Study||60
5224948|NCT00926328|12848241|P1|STARTED|Overall Study||60
5224949|NCT00926289|12848251|P2|NOT COMPLETED|Overall Study||36
5224950|NCT00926289|12848252|P1|NOT COMPLETED|Overall Study||25
5224951|NCT00926289|12848251|P2|COMPLETED|Overall Study||558
5224952|NCT00926289|12848252|P1|COMPLETED|Overall Study||269
5224953|NCT00926289|12848251|P2|STARTED|Overall Study|Number of treated patients|594
5224954|NCT00926289|12848252|P1|STARTED|Overall Study|Number of treated patients|294
5224955|NCT00926263|12848288|P2|NOT COMPLETED|Overall Study||0
5224956|NCT00926263|12848289|P1|NOT COMPLETED|Overall Study||0
5224957|NCT00926263|12848288|P2|COMPLETED|Overall Study||12
5224958|NCT00926263|12848289|P1|COMPLETED|Overall Study||16
5224959|NCT00926263|12848288|P2|STARTED|Overall Study||12
5224960|NCT00926263|12848289|P1|STARTED|Overall Study||16
5224961|NCT00926211|12848320|P1|NOT COMPLETED|Overall Study||1
5224962|NCT00926211|12848320|P1|COMPLETED|Overall Study||35
5224963|NCT00926211|12848320|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
5224964|NCT00926185|12848331|P4|NOT COMPLETED|Overall Study||10
5224965|NCT00926185|12848332|P3|NOT COMPLETED|Overall Study||10
5224966|NCT00926185|12848333|P2|NOT COMPLETED|Overall Study||6
5224967|NCT00926185|12848334|P1|NOT COMPLETED|Overall Study||3
5224968|NCT00926185|12848331|P4|COMPLETED|Overall Study||48
5224969|NCT00926185|12848332|P3|COMPLETED|Overall Study||48
5224970|NCT00926185|12848333|P2|COMPLETED|Overall Study||51
5224971|NCT00926185|12848334|P1|COMPLETED|Overall Study||54
5224972|NCT00926185|12848331|P4|STARTED|Overall Study||58
5224973|NCT00926185|12848332|P3|STARTED|Overall Study||58
5224974|NCT00926185|12848333|P2|STARTED|Overall Study||57
5224975|NCT00926185|12848334|P1|STARTED|Overall Study||57
5224976|NCT00926029|12848351|P3|NOT COMPLETED|Overall Study||1
5224977|NCT00926029|12848352|P2|NOT COMPLETED|Overall Study||1
5224978|NCT00926029|12848353|P1|NOT COMPLETED|Overall Study||2
5224979|NCT00926029|12848351|P3|COMPLETED|Overall Study||33
5224980|NCT00926029|12848352|P2|COMPLETED|Overall Study||33
5224981|NCT00926029|12848353|P1|COMPLETED|Overall Study||32
5224982|NCT00926029|12848351|P3|STARTED|Overall Study||34
5224983|NCT00926029|12848352|P2|STARTED|Overall Study||34
5224984|NCT00926029|12848353|P1|STARTED|Overall Study||34
5224985|NCT00926003|12848367|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
5224986|NCT00926003|12848368|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
5224987|NCT00926003|12848369|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
5224988|NCT00926003|12848367|P3|COMPLETED|Post-Training 3-month Follow-up||52
5224989|NCT00926003|12848368|P2|COMPLETED|Post-Training 3-month Follow-up||54
5224990|NCT00926003|12848369|P1|COMPLETED|Post-Training 3-month Follow-up||51
5224991|NCT00926003|12848367|P3|STARTED|Post-Training 3-month Follow-up||52
5224992|NCT00926003|12848368|P2|STARTED|Post-Training 3-month Follow-up||54
5224993|NCT00926003|12848369|P1|STARTED|Post-Training 3-month Follow-up||52
5224994|NCT00926003|12848367|P3|NOT COMPLETED|Post-Training Evaluation||0
5224995|NCT00926003|12848368|P2|NOT COMPLETED|Post-Training Evaluation||0
5224996|NCT00926003|12848369|P1|NOT COMPLETED|Post-Training Evaluation||1
5224997|NCT00926003|12848367|P3|COMPLETED|Post-Training Evaluation||52
5224998|NCT00926003|12848368|P2|COMPLETED|Post-Training Evaluation||54
5224999|NCT00926003|12848369|P1|COMPLETED|Post-Training Evaluation||52
5225000|NCT00926003|12848367|P3|STARTED|Post-Training Evaluation||52
5225001|NCT00926003|12848368|P2|STARTED|Post-Training Evaluation||54
5225002|NCT00926003|12848369|P1|STARTED|Post-Training Evaluation||53
5225003|NCT00926003|12848367|P3|NOT COMPLETED|Baseline||0
5225004|NCT00926003|12848368|P2|NOT COMPLETED|Baseline||0
5225005|NCT00926003|12848369|P1|NOT COMPLETED|Baseline||0
5225006|NCT00926003|12848367|P3|COMPLETED|Baseline||52
5225007|NCT00926003|12848368|P2|COMPLETED|Baseline||54
5225008|NCT00926003|12848369|P1|COMPLETED|Baseline||53
5225009|NCT00926003|12848367|P3|STARTED|Baseline||52
5225010|NCT00926003|12848368|P2|STARTED|Baseline||54
5225011|NCT00926003|12848369|P1|STARTED|Baseline||53
5225012|NCT00925990|12848382|P2|NOT COMPLETED|Overall Study||11
5225013|NCT00925990|12848383|P1|NOT COMPLETED|Overall Study||5
5225014|NCT00925990|12848382|P2|COMPLETED|Overall Study||24
5225015|NCT00925990|12848383|P1|COMPLETED|Overall Study||30
5225016|NCT00925990|12848382|P2|STARTED|Overall Study||35
5225017|NCT00925990|12848383|P1|STARTED|Overall Study||35
5225018|NCT00925938|12848394|P3|NOT COMPLETED|Overall Study||0
5225019|NCT00925938|12848395|P2|NOT COMPLETED|Overall Study||0
5225020|NCT00925938|12848396|P1|NOT COMPLETED|Overall Study||0
5225021|NCT00925938|12848394|P3|COMPLETED|Overall Study||17
5225022|NCT00925938|12848395|P2|COMPLETED|Overall Study||25
5225023|NCT00925938|12848396|P1|COMPLETED|Overall Study||9
5225024|NCT00925938|12848394|P3|STARTED|Overall Study||17
5225025|NCT00925938|12848395|P2|STARTED|Overall Study||25
5225026|NCT00925938|12848396|P1|STARTED|Overall Study||9
5225027|NCT00925899|12848418|P2|NOT COMPLETED|Part 2||12
5225028|NCT00925899|12848419|P1|NOT COMPLETED|Part 2||6
5225029|NCT00925899|12848418|P2|COMPLETED|Part 2||9
5225030|NCT00925899|12848419|P1|COMPLETED|Part 2||9
5225031|NCT00925899|12848418|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
5225032|NCT00925899|12848419|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
5225033|NCT00925899|12848418|P2|NOT COMPLETED|Part 1||11
5225034|NCT00925899|12848419|P1|NOT COMPLETED|Part 1||11
5225035|NCT00925899|12848418|P2|COMPLETED|Part 1||27
5225036|NCT00925899|12848419|P1|COMPLETED|Part 1||23
5225037|NCT00925899|12848418|P2|STARTED|Part 1||38
5225038|NCT00925899|12848419|P1|STARTED|Part 1||34
5225039|NCT00925782|12848437|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
5225040|NCT00925782|12848438|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
5225041|NCT00925782|12848437|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
5225042|NCT00925782|12848438|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
5225043|NCT00925782|12848437|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
5225044|NCT00925782|12848438|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
5225045|NCT00925782|12848437|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
5225046|NCT00925782|12848438|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
5225047|NCT00925782|12848437|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
5225048|NCT00925782|12848438|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
5225049|NCT00925782|12848437|P2|STARTED|Study Period (Day -3 to Day 0)||12
5225050|NCT00925782|12848438|P1|STARTED|Study Period (Day -3 to Day 0)||12
5225051|NCT00925782|12848437|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
5225052|NCT00925782|12848438|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
5225053|NCT00925782|12848437|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
5225054|NCT00925782|12848438|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
5225055|NCT00925782|12848437|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
5225056|NCT00925782|12848438|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
5225057|NCT00925769|12848447|P6|NOT COMPLETED|Overall Study||3
5225058|NCT00925769|12848448|P5|NOT COMPLETED|Overall Study||3
5225059|NCT00925769|12848449|P4|NOT COMPLETED|Overall Study||6
5225060|NCT00925769|12848450|P3|NOT COMPLETED|Overall Study||6
5225061|NCT00925769|12848451|P2|NOT COMPLETED|Overall Study||6
5225062|NCT00925769|12848452|P1|NOT COMPLETED|Overall Study||6
5225063|NCT00925769|12848447|P6|COMPLETED|Overall Study||0
5225064|NCT00925769|12848448|P5|COMPLETED|Overall Study||0
5225065|NCT00925769|12848449|P4|COMPLETED|Overall Study||0
5225066|NCT00925769|12848450|P3|COMPLETED|Overall Study||0
5225067|NCT00925769|12848451|P2|COMPLETED|Overall Study||0
5225068|NCT00925769|12848452|P1|COMPLETED|Overall Study||0
5225069|NCT00925769|12848447|P6|STARTED|Overall Study||3
5225070|NCT00925769|12848448|P5|STARTED|Overall Study||3
5225071|NCT00925769|12848449|P4|STARTED|Overall Study||6
5225072|NCT00925769|12848450|P3|STARTED|Overall Study||6
5225073|NCT00925769|12848451|P2|STARTED|Overall Study||6
5225074|NCT00925769|12848452|P1|STARTED|Overall Study||6
5225075|NCT00925704|12848520|P6|NOT COMPLETED|Third Intervention||1
5225076|NCT00925704|12848521|P5|NOT COMPLETED|Third Intervention||0
5225077|NCT00925704|12848522|P4|NOT COMPLETED|Third Intervention||0
5225078|NCT00925704|12848523|P3|NOT COMPLETED|Third Intervention||0
5225079|NCT00925704|12848524|P2|NOT COMPLETED|Third Intervention||0
5225080|NCT00925704|12848525|P1|NOT COMPLETED|Third Intervention||0
5225081|NCT00925704|12848520|P6|COMPLETED|Third Intervention||6
5225082|NCT00925704|12848521|P5|COMPLETED|Third Intervention||5
5225083|NCT00925704|12848522|P4|COMPLETED|Third Intervention||6
5225084|NCT00925704|12848523|P3|COMPLETED|Third Intervention||7
5225085|NCT00925704|12848524|P2|COMPLETED|Third Intervention||7
5225086|NCT00925704|12848525|P1|COMPLETED|Third Intervention||5
5225087|NCT00925704|12848520|P6|STARTED|Third Intervention||7
5225088|NCT00925704|12848521|P5|STARTED|Third Intervention||5
5225089|NCT00925704|12848522|P4|STARTED|Third Intervention||6
5225090|NCT00925704|12848523|P3|STARTED|Third Intervention||7
5225091|NCT00925704|12848524|P2|STARTED|Third Intervention||7
5225092|NCT00925704|12848525|P1|STARTED|Third Intervention||5
5225093|NCT00925704|12848520|P6|NOT COMPLETED|Washout||0
5225094|NCT00925704|12848521|P5|NOT COMPLETED|Washout||0
5225095|NCT00925704|12848522|P4|NOT COMPLETED|Washout||0
5225096|NCT00925704|12848523|P3|NOT COMPLETED|Washout||0
5225097|NCT00925704|12848524|P2|NOT COMPLETED|Washout||0
5225098|NCT00925704|12848525|P1|NOT COMPLETED|Washout||0
5225099|NCT00925704|12848520|P6|COMPLETED|Washout||7
5225100|NCT00925704|12848521|P5|COMPLETED|Washout||5
5225101|NCT00925704|12848522|P4|COMPLETED|Washout||6
5225102|NCT00925704|12848523|P3|COMPLETED|Washout||7
5225103|NCT00925704|12848524|P2|COMPLETED|Washout||7
5225104|NCT00925704|12848525|P1|COMPLETED|Washout||5
5225105|NCT00925704|12848520|P6|STARTED|Washout||7
5225106|NCT00925704|12848521|P5|STARTED|Washout||5
5225107|NCT00925704|12848522|P4|STARTED|Washout||6
5225108|NCT00925704|12848523|P3|STARTED|Washout||7
5225109|NCT00925704|12848524|P2|STARTED|Washout||7
5225110|NCT00925704|12848525|P1|STARTED|Washout||5
5225111|NCT00925704|12848520|P6|NOT COMPLETED|Second Intervention||0
5225112|NCT00925704|12848521|P5|NOT COMPLETED|Second Intervention||1
5225113|NCT00925704|12848522|P4|NOT COMPLETED|Second Intervention||0
5225114|NCT00925704|12848523|P3|NOT COMPLETED|Second Intervention||0
5225115|NCT00925704|12848524|P2|NOT COMPLETED|Second Intervention||0
5225116|NCT00925704|12848525|P1|NOT COMPLETED|Second Intervention||1
5225117|NCT00925704|12848520|P6|COMPLETED|Second Intervention||7
5225118|NCT00925704|12848521|P5|COMPLETED|Second Intervention||5
5225119|NCT00925704|12848522|P4|COMPLETED|Second Intervention||6
5225120|NCT00925704|12848523|P3|COMPLETED|Second Intervention||7
5225121|NCT00925704|12848524|P2|COMPLETED|Second Intervention||7
5225122|NCT00925704|12848525|P1|COMPLETED|Second Intervention||5
5225123|NCT00925704|12848520|P6|STARTED|Second Intervention||7
5225124|NCT00925704|12848521|P5|STARTED|Second Intervention||6
5225125|NCT00925704|12848522|P4|STARTED|Second Intervention||6
5225126|NCT00925704|12848523|P3|STARTED|Second Intervention||7
5225127|NCT00925704|12848524|P2|STARTED|Second Intervention||7
5225128|NCT00925704|12848525|P1|STARTED|Second Intervention||6
5225129|NCT00925704|12848520|P6|NOT COMPLETED|Washout||0
5225130|NCT00925704|12848521|P5|NOT COMPLETED|Washout||0
5225131|NCT00925704|12848522|P4|NOT COMPLETED|Washout||0
5225132|NCT00925704|12848523|P3|NOT COMPLETED|Washout||0
5225133|NCT00925704|12848524|P2|NOT COMPLETED|Washout||0
5225134|NCT00925704|12848525|P1|NOT COMPLETED|Washout||0
5225135|NCT00925704|12848520|P6|COMPLETED|Washout||7
5225136|NCT00925704|12848521|P5|COMPLETED|Washout||6
5225137|NCT00925704|12848522|P4|COMPLETED|Washout||6
5225138|NCT00925704|12848523|P3|COMPLETED|Washout||7
5225139|NCT00925704|12848524|P2|COMPLETED|Washout||7
5225140|NCT00925704|12848525|P1|COMPLETED|Washout||6
5225141|NCT00925704|12848520|P6|STARTED|Washout||7
5225142|NCT00925704|12848521|P5|STARTED|Washout||6
5225143|NCT00925704|12848522|P4|STARTED|Washout||6
5225144|NCT00925704|12848523|P3|STARTED|Washout||7
5225145|NCT00925704|12848524|P2|STARTED|Washout||7
5225146|NCT00925704|12848525|P1|STARTED|Washout||6
5225147|NCT00925704|12848520|P6|NOT COMPLETED|First Intervention||0
5225148|NCT00925704|12848521|P5|NOT COMPLETED|First Intervention||1
5225149|NCT00925704|12848522|P4|NOT COMPLETED|First Intervention||1
5225150|NCT00925704|12848523|P3|NOT COMPLETED|First Intervention||0
5225151|NCT00925704|12848524|P2|NOT COMPLETED|First Intervention||0
5225152|NCT00925704|12848525|P1|NOT COMPLETED|First Intervention||0
5225153|NCT00925704|12848520|P6|COMPLETED|First Intervention||7
5225154|NCT00925704|12848521|P5|COMPLETED|First Intervention||6
5225155|NCT00925704|12848522|P4|COMPLETED|First Intervention||6
5225156|NCT00925704|12848523|P3|COMPLETED|First Intervention||7
5225157|NCT00925704|12848524|P2|COMPLETED|First Intervention||7
5225158|NCT00925704|12848525|P1|COMPLETED|First Intervention||6
5225159|NCT00925704|12848520|P6|STARTED|First Intervention||7
5225160|NCT00925704|12848521|P5|STARTED|First Intervention||7
5225161|NCT00925704|12848522|P4|STARTED|First Intervention||7
5225162|NCT00925704|12848523|P3|STARTED|First Intervention||7
5225163|NCT00925704|12848524|P2|STARTED|First Intervention||7
5225164|NCT00925704|12848525|P1|STARTED|First Intervention||6
5225165|NCT00925600|12848538|P2|NOT COMPLETED|Overall Study||28
5225166|NCT00925600|12848539|P1|NOT COMPLETED|Overall Study||32
5225167|NCT00925600|12848538|P2|COMPLETED|Overall Study||355
5225168|NCT00925600|12848539|P1|COMPLETED|Overall Study||354
5225169|NCT00925600|12848538|P2|Received Treatment|Overall Study||382
5225170|NCT00925600|12848539|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
5225171|NCT00925600|12848538|P2|STARTED|Overall Study||383
5225172|NCT00925600|12848539|P1|STARTED|Overall Study||386
5225173|NCT00925587|12848561|P2|NOT COMPLETED|Overall Study||25
5225174|NCT00925587|12848562|P1|NOT COMPLETED|Overall Study||36
5225175|NCT00925587|12848561|P2|COMPLETED|Overall Study||155
5225176|NCT00925587|12848562|P1|COMPLETED|Overall Study||142
5225177|NCT00925587|12848561|P2|STARTED|Overall Study||180
5225178|NCT00925587|12848562|P1|STARTED|Overall Study||178
5225179|NCT00925548|12848676|P2|NOT COMPLETED|Overall Study||5
5225180|NCT00925548|12848677|P1|NOT COMPLETED|Overall Study||10
5225181|NCT00925548|12848676|P2|COMPLETED|Overall Study||0
5225182|NCT00925548|12848677|P1|COMPLETED|Overall Study||1
5225183|NCT00925548|12848676|P2|STARTED|Overall Study||5
5225184|NCT00925548|12848677|P1|STARTED|Overall Study||11
5225185|NCT00925522|12848703|P1|NOT COMPLETED|Overall Study||20
5225186|NCT00925522|12848703|P1|COMPLETED|Overall Study||0
5225187|NCT00925522|12848703|P1|STARTED|Overall Study||20
5225188|NCT00925353|12848707|P1|NOT COMPLETED|Overall Study||3
5225189|NCT00925353|12848707|P1|COMPLETED|Overall Study||10
5225190|NCT00925353|12848707|P1|STARTED|Overall Study||13
5225191|NCT00925301|12848713|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
5225192|NCT00925301|12848714|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
5225193|NCT00925301|12848715|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
5225194|NCT00925301|12848716|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
5225195|NCT00925301|12848713|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
5225196|NCT00925301|12848714|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
5225197|NCT00925301|12848715|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
5225198|NCT00925301|12848716|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
5225199|NCT00925301|12848713|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
5225200|NCT00925301|12848714|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
5225201|NCT00925301|12848715|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
5225202|NCT00925301|12848716|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
5225203|NCT00925301|12848713|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
5225281|NCT00925054|12848770|P5|STARTED|Overall Study||10
5225282|NCT00925054|12848771|P4|STARTED|Overall Study||1
5225204|NCT00925301|12848714|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
5225205|NCT00925301|12848715|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
5225206|NCT00925301|12848716|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
5225207|NCT00925301|12848713|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
5225208|NCT00925301|12848714|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
5225209|NCT00925301|12848715|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
5225210|NCT00925301|12848716|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
5225211|NCT00925301|12848713|P4|COMPLETED|6-Month Open-label (Stage 2)||0
5225212|NCT00925301|12848714|P3|COMPLETED|6-Month Open-label (Stage 2)||60
5225213|NCT00925301|12848715|P2|COMPLETED|6-Month Open-label (Stage 2)||0
5225214|NCT00925301|12848716|P1|COMPLETED|6-Month Open-label (Stage 2)||0
5225215|NCT00925301|12848713|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
5225216|NCT00925301|12848714|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
5225217|NCT00925301|12848715|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
5225218|NCT00925301|12848716|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
5225219|NCT00925301|12848713|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
5225220|NCT00925301|12848714|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
5225221|NCT00925301|12848715|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
5225222|NCT00925301|12848716|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
5225223|NCT00925301|12848713|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
5225224|NCT00925301|12848714|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
5225225|NCT00925301|12848715|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
5225226|NCT00925301|12848716|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
5225227|NCT00925301|12848713|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
5225228|NCT00925301|12848714|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
5225229|NCT00925301|12848715|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
5225230|NCT00925301|12848716|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
5225231|NCT00925301|12848713|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
5225232|NCT00925301|12848714|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
5225233|NCT00925301|12848715|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
5225234|NCT00925301|12848716|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
5225235|NCT00925301|12848713|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
5225236|NCT00925301|12848714|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
5225237|NCT00925301|12848715|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
5225238|NCT00925301|12848716|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
5225239|NCT00925301|12848713|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
5225240|NCT00925301|12848714|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
5225241|NCT00925301|12848715|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
5225242|NCT00925301|12848716|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
5225243|NCT00925301|12848713|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
5225244|NCT00925301|12848714|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
5225245|NCT00925301|12848715|P2|STARTED|6-Month Double-blind (Stage 1)||33
5225246|NCT00925301|12848716|P1|STARTED|6-Month Double-blind (Stage 1)||34
5225247|NCT00925288|12848732|P2|NOT COMPLETED|Overall Study||7
5225248|NCT00925288|12848733|P1|NOT COMPLETED|Overall Study||9
5225249|NCT00925288|12848732|P2|COMPLETED|Overall Study||93
5225250|NCT00925288|12848733|P1|COMPLETED|Overall Study||91
5225251|NCT00925288|12848732|P2|STARTED|Overall Study||100
5225252|NCT00925288|12848733|P1|STARTED|Overall Study||100
5225253|NCT00925132|12848745|P5|NOT COMPLETED|Overall Study||5
5225254|NCT00925132|12848746|P4|NOT COMPLETED|Overall Study||0
5225255|NCT00925132|12848747|P3|NOT COMPLETED|Overall Study||0
5225256|NCT00925132|12848748|P2|NOT COMPLETED|Overall Study||0
5225257|NCT00925132|12848749|P1|NOT COMPLETED|Overall Study||2
5225258|NCT00925132|12848745|P5|COMPLETED|Overall Study||17
5225259|NCT00925132|12848746|P4|COMPLETED|Overall Study||4
5225260|NCT00925132|12848747|P3|COMPLETED|Overall Study||4
5225261|NCT00925132|12848748|P2|COMPLETED|Overall Study||4
5225262|NCT00925132|12848749|P1|COMPLETED|Overall Study||3
5225263|NCT00925132|12848745|P5|STARTED|Overall Study||22
5225264|NCT00925132|12848746|P4|STARTED|Overall Study||4
5225265|NCT00925132|12848747|P3|STARTED|Overall Study||4
5225266|NCT00925132|12848748|P2|STARTED|Overall Study||4
5225267|NCT00925132|12848749|P1|STARTED|Overall Study||5
5225268|NCT00925119|12848755|P1|NOT COMPLETED|Overall Study||12
5225269|NCT00925119|12848755|P1|COMPLETED|Overall Study||19
5225270|NCT00925119|12848755|P1|STARTED|Overall Study||31
5225271|NCT00925054|12848770|P5|NOT COMPLETED|Overall Study||0
5225272|NCT00925054|12848771|P4|NOT COMPLETED|Overall Study||1
5225273|NCT00925054|12848772|P3|NOT COMPLETED|Overall Study||1
5225274|NCT00925054|12848773|P2|NOT COMPLETED|Overall Study||1
5225275|NCT00925054|12848774|P1|NOT COMPLETED|Overall Study||0
5225276|NCT00925054|12848770|P5|COMPLETED|Overall Study||10
5225277|NCT00925054|12848771|P4|COMPLETED|Overall Study||0
5225278|NCT00925054|12848772|P3|COMPLETED|Overall Study||12
5225279|NCT00925054|12848773|P2|COMPLETED|Overall Study||8
5225280|NCT00925054|12848774|P1|COMPLETED|Overall Study||7
5225283|NCT00925054|12848772|P3|STARTED|Overall Study||13
5225284|NCT00925054|12848773|P2|STARTED|Overall Study||9
5225285|NCT00925054|12848774|P1|STARTED|Overall Study||7
5225286|NCT00925015|12848844|P3|NOT COMPLETED|Overall Study||6
5225287|NCT00925015|12848845|P2|NOT COMPLETED|Overall Study||6
5225288|NCT00925015|12848846|P1|NOT COMPLETED|Overall Study||8
5225289|NCT00925015|12848844|P3|COMPLETED|Overall Study||0
5225290|NCT00925015|12848845|P2|COMPLETED|Overall Study||0
5225291|NCT00925015|12848846|P1|COMPLETED|Overall Study||0
5225292|NCT00925015|12848844|P3|STARTED|Overall Study||6
5225293|NCT00925015|12848845|P2|STARTED|Overall Study||6
5225294|NCT00925015|12848846|P1|STARTED|Overall Study||8
5225295|NCT00924950|12848902|P1|NOT COMPLETED|Overall Study||2
5225296|NCT00924950|12848902|P1|COMPLETED|Overall Study||28
5225297|NCT00924950|12848902|P1|STARTED|Overall Study||30
5225298|NCT00924898|12848909|P1|NOT COMPLETED|Overall Study||2
5225299|NCT00924898|12848909|P1|COMPLETED|Overall Study||90
5225300|NCT00924898|12848909|P1|STARTED|Overall Study||92
5225301|NCT00924833|12848921|P3|NOT COMPLETED|Overall Study||0
5225302|NCT00924833|12848922|P2|NOT COMPLETED|Overall Study||0
5225303|NCT00924833|12848923|P1|NOT COMPLETED|Overall Study||0
5225304|NCT00924833|12848921|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
5225305|NCT00924833|12848922|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
5225306|NCT00924833|12848923|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
5225307|NCT00924833|12848921|P3|STARTED|Overall Study||9
5225308|NCT00924833|12848922|P2|STARTED|Overall Study||9
5225309|NCT00924833|12848923|P1|STARTED|Overall Study||9
5225310|NCT00924807|12848937|P1|NOT COMPLETED|Overall Study||0
5225311|NCT00924807|12848937|P1|COMPLETED|Overall Study||4
5225312|NCT00924807|12848937|P1|STARTED|Overall Study||4
5225313|NCT00924781|12848946|P2|NOT COMPLETED|Overall Study||10
5225314|NCT00924781|12848947|P1|NOT COMPLETED|Overall Study||12
5225315|NCT00924781|12848946|P2|COMPLETED|Overall Study||9
5225316|NCT00924781|12848947|P1|COMPLETED|Overall Study||8
5225317|NCT00924781|12848946|P2|STARTED|Overall Study||19
5225318|NCT00924781|12848947|P1|STARTED|Overall Study||20
5225319|NCT00924729|12848981|P2|NOT COMPLETED|Overall Study||0
5225320|NCT00924729|12848982|P1|NOT COMPLETED|Overall Study||2
5225321|NCT00924729|12848981|P2|COMPLETED|Overall Study||25
5225322|NCT00924729|12848982|P1|COMPLETED|Overall Study||23
5225323|NCT00924729|12848981|P2|STARTED|Overall Study||25
5225324|NCT00924729|12848982|P1|STARTED|Overall Study||25
5225325|NCT00924651|12848992|P2|NOT COMPLETED|Overall Study||25
5225326|NCT00924651|12848993|P1|NOT COMPLETED|Overall Study||25
5225327|NCT00924651|12848992|P2|COMPLETED|Overall Study||312
5225328|NCT00924651|12848993|P1|COMPLETED|Overall Study||331
5225329|NCT00924651|12848992|P2|STARTED|Overall Study||337
5225330|NCT00924651|12848993|P1|STARTED|Overall Study||356
5225331|NCT00924638|12849001|P2|NOT COMPLETED|Overall Study||13
5225332|NCT00924638|12849002|P1|NOT COMPLETED|Overall Study||12
5225333|NCT00924638|12849001|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
5225334|NCT00924638|12849002|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
5225335|NCT00924638|12849001|P2|STARTED|Overall Study|Randomized to Control Arm|220
5225336|NCT00924638|12849002|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
5225337|NCT00924560|12849024|P3|NOT COMPLETED|Overall Study||83
5225338|NCT00924560|12849025|P2|NOT COMPLETED|Overall Study||208
5225339|NCT00924560|12849026|P1|NOT COMPLETED|Overall Study||211
5225340|NCT00924560|12849024|P3|COMPLETED|Overall Study||372
5225341|NCT00924560|12849025|P2|COMPLETED|Overall Study||240
5225342|NCT00924560|12849026|P1|COMPLETED|Overall Study||247
5225343|NCT00924560|12849024|P3|Received Treatment|Overall Study||0
5225344|NCT00924560|12849025|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
5225345|NCT00924560|12849026|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
5225346|NCT00924560|12849024|P3|STARTED|Overall Study||455
5225347|NCT00924560|12849025|P2|STARTED|Overall Study||448
5225348|NCT00924560|12849026|P1|STARTED|Overall Study||458
5225349|NCT00924508|12849070|P1|NOT COMPLETED|Overall Study||3
5225350|NCT00924508|12849070|P1|COMPLETED|Overall Study||20
5225351|NCT00924508|12849070|P1|STARTED|Overall Study||23
5225352|NCT00924482|12849077|P1|NOT COMPLETED|Overall Study||0
5225353|NCT00924482|12849077|P1|COMPLETED|Overall Study||261
5225354|NCT00924482|12849077|P1|STARTED|Overall Study||261
5225355|NCT00924469|12849084|P2|NOT COMPLETED|Overall Study||2
5225356|NCT00924469|12849085|P1|NOT COMPLETED|Overall Study||2
5225357|NCT00924469|12849084|P2|COMPLETED|Overall Study||26
5225358|NCT00924469|12849085|P1|COMPLETED|Overall Study||28
5225359|NCT00924469|12849084|P2|STARTED|Overall Study||28
5225360|NCT00924469|12849085|P1|STARTED|Overall Study||30
5225361|NCT00924443|12849107|P1|NOT COMPLETED|Overall Study||3
5225362|NCT00924443|12849107|P1|COMPLETED|Overall Study||66
5225363|NCT00924443|12849107|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
5225364|NCT00924443|12849107|P1|STARTED|Overall Study||69
5225365|NCT00924404|12849117|P2|NOT COMPLETED|Overall Study||4
5225366|NCT00924404|12849118|P1|NOT COMPLETED|Overall Study||6
5225367|NCT00924404|12849117|P2|COMPLETED|Overall Study||22
5225368|NCT00924404|12849118|P1|COMPLETED|Overall Study||21
5225369|NCT00924404|12849117|P2|STARTED|Overall Study||26
5225370|NCT00924404|12849118|P1|STARTED|Overall Study||27
5225371|NCT00924352|12849126|P2|NOT COMPLETED|Overall Study||0
5225372|NCT00924352|12849127|P1|NOT COMPLETED|Overall Study||0
5225373|NCT00924352|12849126|P2|COMPLETED|Overall Study||44
5225374|NCT00924352|12849127|P1|COMPLETED|Overall Study||12
5225375|NCT00924352|12849126|P2|STARTED|Overall Study||44
5225376|NCT00924352|12849127|P1|STARTED|Overall Study||12
5225377|NCT00924326|12849149|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225378|NCT00924326|12849150|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225379|NCT00924326|12849151|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225380|NCT00924326|12849152|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225381|NCT00924326|12849153|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225382|NCT00924326|12849154|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225383|NCT00924326|12849155|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225384|NCT00924326|12849156|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225385|NCT00924326|12849157|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225386|NCT00924326|12849149|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225387|NCT00924326|12849150|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225388|NCT00924326|12849151|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225389|NCT00924326|12849152|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225390|NCT00924326|12849153|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225391|NCT00924326|12849154|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225392|NCT00924326|12849155|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225393|NCT00924326|12849156|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
5225394|NCT00924326|12849157|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
5225395|NCT00924326|12849149|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225396|NCT00924326|12849150|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225397|NCT00924326|12849151|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225398|NCT00924326|12849152|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225399|NCT00924326|12849153|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225400|NCT00924326|12849154|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225401|NCT00924326|12849155|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225402|NCT00924326|12849156|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
5225403|NCT00924326|12849157|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
5225404|NCT00924326|12849149|P9|NOT COMPLETED|Dose Administration||0
5225405|NCT00924326|12849150|P8|NOT COMPLETED|Dose Administration||0
5225406|NCT00924326|12849151|P7|NOT COMPLETED|Dose Administration||0
5225407|NCT00924326|12849152|P6|NOT COMPLETED|Dose Administration||0
5225408|NCT00924326|12849153|P5|NOT COMPLETED|Dose Administration||0
5225409|NCT00924326|12849154|P4|NOT COMPLETED|Dose Administration||0
5225410|NCT00924326|12849155|P3|NOT COMPLETED|Dose Administration||0
5225411|NCT00924326|12849156|P2|NOT COMPLETED|Dose Administration||0
5225412|NCT00924326|12849157|P1|NOT COMPLETED|Dose Administration||0
5225413|NCT00924326|12849149|P9|COMPLETED|Dose Administration||2
5225414|NCT00924326|12849150|P8|COMPLETED|Dose Administration||2
5225415|NCT00924326|12849151|P7|COMPLETED|Dose Administration||1
5225416|NCT00924326|12849152|P6|COMPLETED|Dose Administration||10
5225417|NCT00924326|12849153|P5|COMPLETED|Dose Administration||7
5225418|NCT00924326|12849154|P4|COMPLETED|Dose Administration||6
5225419|NCT00924326|12849155|P3|COMPLETED|Dose Administration||5
5225420|NCT00924326|12849156|P2|COMPLETED|Dose Administration||2
5225421|NCT00924326|12849157|P1|COMPLETED|Dose Administration||8
5225422|NCT00924326|12849149|P9|STARTED|Dose Administration||2
5225423|NCT00924326|12849150|P8|STARTED|Dose Administration||2
5225424|NCT00924326|12849151|P7|STARTED|Dose Administration||1
5225425|NCT00924326|12849152|P6|STARTED|Dose Administration||10
5225426|NCT00924326|12849153|P5|STARTED|Dose Administration||7
5225427|NCT00924326|12849154|P4|STARTED|Dose Administration||6
5225428|NCT00924326|12849155|P3|STARTED|Dose Administration||5
5225429|NCT00924326|12849156|P2|STARTED|Dose Administration||2
5225430|NCT00924326|12849157|P1|STARTED|Dose Administration||8
5225431|NCT00924313|12849189|P1|NOT COMPLETED|Overall Study||1
5225432|NCT00924313|12849189|P1|COMPLETED|Overall Study||39
5225433|NCT00924313|12849189|P1|STARTED|Overall Study||40
5225434|NCT00924287|12849201|P1|NOT COMPLETED|Overall Study||1
5225435|NCT00924287|12849201|P1|COMPLETED|Overall Study||0
5225436|NCT00924287|12849201|P1|STARTED|Overall Study||1
5225437|NCT00924209|12849207|P1|NOT COMPLETED|Overall Study||0
5225438|NCT00924209|12849207|P1|COMPLETED|Overall Study||7
5225439|NCT00924209|12849207|P1|STARTED|Overall Study||7
5225440|NCT00924170|12849217|P2|NOT COMPLETED|Overall Study||8
5225441|NCT00924170|12849218|P1|NOT COMPLETED|Overall Study||7
5225442|NCT00924170|12849217|P2|COMPLETED|Overall Study||0
5225443|NCT00924170|12849218|P1|COMPLETED|Overall Study||3
5225444|NCT00924170|12849217|P2|STARTED|Overall Study||8
5225445|NCT00924170|12849218|P1|STARTED|Overall Study||10
5225446|NCT00924118|12849258|P2|NOT COMPLETED|Overall Study||0
5225447|NCT00924118|12849259|P1|NOT COMPLETED|Overall Study||0
5225448|NCT00924118|12849258|P2|COMPLETED|Overall Study||15
5225449|NCT00924118|12849259|P1|COMPLETED|Overall Study||15
5225450|NCT00924118|12849258|P2|STARTED|Overall Study||15
5225451|NCT00924118|12849259|P1|STARTED|Overall Study||15
5225452|NCT00924066|12849267|P1|NOT COMPLETED|Overall Study||0
5225453|NCT00924066|12849267|P1|COMPLETED|Overall Study||41
5225454|NCT00924066|12849267|P1|STARTED|Overall Study||41
5225455|NCT00924053|12849276|P4|NOT COMPLETED|Overall Study||0
5225456|NCT00924053|12849277|P3|NOT COMPLETED|Overall Study||0
5225457|NCT00924053|12849278|P2|NOT COMPLETED|Overall Study||0
5225458|NCT00924053|12849279|P1|NOT COMPLETED|Overall Study||0
5225459|NCT00924053|12849276|P4|COMPLETED|Overall Study||6
5225460|NCT00924053|12849277|P3|COMPLETED|Overall Study||6
5225461|NCT00924053|12849278|P2|COMPLETED|Overall Study||6
5225462|NCT00924053|12849279|P1|COMPLETED|Overall Study||6
5225463|NCT00924053|12849276|P4|STARTED|Overall Study||6
5225464|NCT00924053|12849277|P3|STARTED|Overall Study||6
5225465|NCT00924053|12849278|P2|STARTED|Overall Study||6
5225466|NCT00924053|12849279|P1|STARTED|Overall Study||6
5225467|NCT00924040|12849325|P1|NOT COMPLETED|Overall Study||0
5225468|NCT00924040|12849325|P1|COMPLETED|Overall Study||1
5225469|NCT00924040|12849325|P1|STARTED|Overall Study||1
5225470|NCT00924001|12849337|P1|NOT COMPLETED|Overall Study||0
5225471|NCT00924001|12849337|P1|COMPLETED|Overall Study||1
5225472|NCT00924001|12849337|P1|STARTED|Overall Study||1
5225473|NCT00923975|12849343|P1|NOT COMPLETED|Overall Study||1
5225474|NCT00923975|12849343|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
5225475|NCT00923975|12849343|P1|STARTED|Overall Study||51
5225476|NCT00923949|12849350|P1|NOT COMPLETED|Overall Study||0
5225477|NCT00923949|12849350|P1|COMPLETED|Overall Study||1
5225478|NCT00923949|12849350|P1|STARTED|Overall Study||1
5225479|NCT00923936|12849362|P2|NOT COMPLETED|Overall Study||3
5225480|NCT00923936|12849363|P1|NOT COMPLETED|Overall Study||8
5225481|NCT00923936|12849362|P2|COMPLETED|Overall Study||3
5225482|NCT00923936|12849363|P1|COMPLETED|Overall Study||2
5225483|NCT00923936|12849362|P2|STARTED|Overall Study||6
5225484|NCT00923936|12849363|P1|STARTED|Overall Study||10
5225485|NCT00923910|12849379|P2|NOT COMPLETED|Period 2||0
5225486|NCT00923910|12849380|P1|NOT COMPLETED|Period 2||0
5225487|NCT00923910|12849379|P2|COMPLETED|Period 2||5
5225488|NCT00923910|12849380|P1|COMPLETED|Period 2||5
5225489|NCT00923910|12849379|P2|STARTED|Period 2||5
5225490|NCT00923910|12849380|P1|STARTED|Period 2||5
5225491|NCT00923910|12849379|P2|NOT COMPLETED|Period 1||0
5225492|NCT00923910|12849380|P1|NOT COMPLETED|Period 1||0
5225493|NCT00923910|12849379|P2|COMPLETED|Period 1||5
5225494|NCT00923910|12849380|P1|COMPLETED|Period 1||5
5225495|NCT00923910|12849379|P2|STARTED|Period 1||5
5225496|NCT00923910|12849380|P1|STARTED|Period 1||5
5225497|NCT00923845|12849392|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
5225498|NCT00923845|12849393|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
5225499|NCT00923845|12849392|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
5225500|NCT00923845|12849393|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
5225501|NCT00923845|12849392|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
5225502|NCT00923845|12849393|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
5225503|NCT00923845|12849392|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
5225504|NCT00923845|12849393|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
5225505|NCT00923845|12849392|P2|STARTED|Allogeneic Stem Cell Therapy||10
5225506|NCT00923845|12849393|P1|STARTED|Allogeneic Stem Cell Therapy||0
5225507|NCT00923845|12849392|P2|NOT COMPLETED|Induction Therapy||2
5225508|NCT00923845|12849393|P1|NOT COMPLETED|Induction Therapy||0
5225509|NCT00923845|12849392|P2|COMPLETED|Induction Therapy||10
5225510|NCT00923845|12849393|P1|COMPLETED|Induction Therapy||0
5225511|NCT00923845|12849392|P2|STARTED|Induction Therapy||12
5225512|NCT00923845|12849393|P1|STARTED|Induction Therapy||0
5225513|NCT00923845|12849392|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
5225514|NCT00923845|12849393|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
5225515|NCT00923845|12849392|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
5225516|NCT00923845|12849393|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
5225517|NCT00923845|12849392|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
5225518|NCT00923845|12849393|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
5225519|NCT00923845|12849392|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
5225520|NCT00923845|12849393|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
5225521|NCT00923845|12849392|P2|COMPLETED|Donor Lymphocyte Harvest||0
5225522|NCT00923845|12849393|P1|COMPLETED|Donor Lymphocyte Harvest||13
5225523|NCT00923845|12849392|P2|STARTED|Donor Lymphocyte Harvest||0
5225524|NCT00923845|12849393|P1|STARTED|Donor Lymphocyte Harvest||13
5225525|NCT00923598|12849416|P2|NOT COMPLETED|Overall Study||5
5225526|NCT00923598|12849417|P1|NOT COMPLETED|Overall Study||4
5225527|NCT00923598|12849416|P2|COMPLETED|Overall Study||17
5225528|NCT00923598|12849417|P1|COMPLETED|Overall Study||19
5225529|NCT00923598|12849416|P2|STARTED|Overall Study||22
5225530|NCT00923598|12849417|P1|STARTED|Overall Study||23
5225531|NCT00923481|12849423|P1|NOT COMPLETED|Overall Study||0
5225532|NCT00923481|12849423|P1|COMPLETED|Overall Study||37
5225533|NCT00923481|12849423|P1|STARTED|Overall Study||37
5225534|NCT00923364|12849428|P2|NOT COMPLETED|Overall Study||0
5225535|NCT00923364|12849429|P1|NOT COMPLETED|Overall Study||4
5225536|NCT00923364|12849428|P2|COMPLETED|Overall Study||5
5225537|NCT00923364|12849429|P1|COMPLETED|Overall Study||10
5225538|NCT00923364|12849428|P2|STARTED|Overall Study||5
5225539|NCT00923364|12849429|P1|STARTED|Overall Study||14
5225540|NCT00923351|12849441|P3|NOT COMPLETED|Overall Study||12
5225541|NCT00923351|12849442|P2|NOT COMPLETED|Overall Study||0
5225542|NCT00923351|12849443|P1|NOT COMPLETED|Overall Study||0
5225543|NCT00923351|12849441|P3|COMPLETED|Overall Study||0
5225544|NCT00923351|12849442|P2|COMPLETED|Overall Study||26
5225545|NCT00923351|12849443|P1|COMPLETED|Overall Study||6
5225546|NCT00923351|12849441|P3|STARTED|Overall Study||12
5225547|NCT00923351|12849442|P2|STARTED|Overall Study||26
5225548|NCT00923351|12849443|P1|STARTED|Overall Study||6
5225549|NCT00923273|12849458|P5|NOT COMPLETED|Phase II Treatment Period||0
5225550|NCT00923273|12849459|P4|NOT COMPLETED|Phase II Treatment Period||7
5225551|NCT00923273|12849460|P3|NOT COMPLETED|Phase II Treatment Period||0
5225552|NCT00923273|12849461|P2|NOT COMPLETED|Phase II Treatment Period||0
5225553|NCT00923273|12849462|P1|NOT COMPLETED|Phase II Treatment Period||0
5225554|NCT00923273|12849458|P5|COMPLETED|Phase II Treatment Period||0
5225555|NCT00923273|12849459|P4|COMPLETED|Phase II Treatment Period||20
5225556|NCT00923273|12849460|P3|COMPLETED|Phase II Treatment Period||0
5225557|NCT00923273|12849461|P2|COMPLETED|Phase II Treatment Period||0
5225558|NCT00923273|12849462|P1|COMPLETED|Phase II Treatment Period||0
5225559|NCT00923273|12849458|P5|STARTED|Phase II Treatment Period||0
5225560|NCT00923273|12849459|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
5225561|NCT00923273|12849460|P3|STARTED|Phase II Treatment Period||0
5225562|NCT00923273|12849461|P2|STARTED|Phase II Treatment Period||0
5225563|NCT00923273|12849462|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
5225564|NCT00923273|12849458|P5|NOT COMPLETED|Phase I Treatment Period||0
5225565|NCT00923273|12849459|P4|NOT COMPLETED|Phase I Treatment Period||0
5225566|NCT00923273|12849460|P3|NOT COMPLETED|Phase I Treatment Period||0
5225567|NCT00923273|12849461|P2|NOT COMPLETED|Phase I Treatment Period||0
5225568|NCT00923273|12849462|P1|NOT COMPLETED|Phase I Treatment Period||0
5225569|NCT00923273|12849458|P5|COMPLETED|Phase I Treatment Period||5
5225570|NCT00923273|12849459|P4|COMPLETED|Phase I Treatment Period||7
5225571|NCT00923273|12849460|P3|COMPLETED|Phase I Treatment Period||3
5225572|NCT00923273|12849461|P2|COMPLETED|Phase I Treatment Period||3
5225573|NCT00923273|12849462|P1|COMPLETED|Phase I Treatment Period||4
5225574|NCT00923273|12849458|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
5225575|NCT00923273|12849459|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
5225576|NCT00923273|12849460|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
5225577|NCT00923273|12849461|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
5225578|NCT00923273|12849462|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
5225579|NCT00923260|12849487|P2|NOT COMPLETED|Overall Study||1
5225580|NCT00923260|12849488|P1|NOT COMPLETED|Overall Study||1
5225581|NCT00923260|12849487|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
5225582|NCT00923260|12849488|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
5225583|NCT00923260|12849487|P2|STARTED|Overall Study||12
5225584|NCT00923260|12849488|P1|STARTED|Overall Study||12
5225585|NCT00923247|12849622|P2|NOT COMPLETED|Overall Study||0
5225586|NCT00923247|12849623|P1|NOT COMPLETED|Overall Study||0
5225587|NCT00923247|12849622|P2|COMPLETED|Overall Study||1
5225588|NCT00923247|12849623|P1|COMPLETED|Overall Study||21
5225589|NCT00923247|12849622|P2|STARTED|Overall Study||1
5225590|NCT00923247|12849623|P1|STARTED|Overall Study||21
5225591|NCT00923195|12849651|P2|NOT COMPLETED|Overall Study||1
5225592|NCT00923195|12849652|P1|NOT COMPLETED|Overall Study||0
5225593|NCT00923195|12849651|P2|COMPLETED|Overall Study||1
5225594|NCT00923195|12849652|P1|COMPLETED|Overall Study||2
5225595|NCT00923195|12849651|P2|STARTED|Overall Study||2
5225596|NCT00923195|12849652|P1|STARTED|Overall Study||2
5225597|NCT00923156|12849663|P3|NOT COMPLETED|Overall Study||3
5225598|NCT00923156|12849664|P2|NOT COMPLETED|Overall Study||4
5225599|NCT00923156|12849665|P1|NOT COMPLETED|Overall Study||0
5225600|NCT00923156|12849663|P3|COMPLETED|Overall Study||38
5225601|NCT00923156|12849664|P2|COMPLETED|Overall Study||38
5225602|NCT00923156|12849665|P1|COMPLETED|Overall Study||40
5225603|NCT00923156|12849663|P3|STARTED|Overall Study||41
5225604|NCT00923156|12849664|P2|STARTED|Overall Study||42
5225605|NCT00923156|12849665|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
5225606|NCT00923130|12849691|P1|NOT COMPLETED|Overall Study||25
5225607|NCT00923130|12849691|P1|COMPLETED|Overall Study||5
5225608|NCT00923130|12849691|P1|STARTED|Overall Study||30
5225609|NCT00923117|12849709|P2|NOT COMPLETED|Overall Study||0
5225610|NCT00923117|12849710|P1|NOT COMPLETED|Overall Study||0
5225611|NCT00923117|12849709|P2|COMPLETED|Overall Study||43
5225612|NCT00923117|12849710|P1|COMPLETED|Overall Study||44
5225613|NCT00923117|12849709|P2|STARTED|Overall Study||43
5225614|NCT00923117|12849710|P1|STARTED|Overall Study||44
5225615|NCT00923091|12849726|P13|NOT COMPLETED|Period VI (Open-Label)||0
5225616|NCT00923091|12849727|P12|NOT COMPLETED|Period VI (Open-Label)||0
5225617|NCT00923091|12849728|P11|NOT COMPLETED|Period VI (Open-Label)||0
5225618|NCT00923091|12849729|P10|NOT COMPLETED|Period VI (Open-Label)||0
5225619|NCT00923091|12849730|P9|NOT COMPLETED|Period VI (Open-Label)||0
5225620|NCT00923091|12849731|P8|NOT COMPLETED|Period VI (Open-Label)||0
5225621|NCT00923091|12849732|P7|NOT COMPLETED|Period VI (Open-Label)||0
5225622|NCT00923091|12849733|P6|NOT COMPLETED|Period VI (Open-Label)||0
5225623|NCT00923091|12849734|P5|NOT COMPLETED|Period VI (Open-Label)||7
5225624|NCT00923091|12849735|P4|NOT COMPLETED|Period VI (Open-Label)||3
5225625|NCT00923091|12849736|P3|NOT COMPLETED|Period VI (Open-Label)||13
5225626|NCT00923091|12849737|P2|NOT COMPLETED|Period VI (Open-Label)||8
5225627|NCT00923091|12849738|P1|NOT COMPLETED|Period VI (Open-Label)||39
5225628|NCT00923091|12849726|P13|COMPLETED|Period VI (Open-Label)||0
5225629|NCT00923091|12849727|P12|COMPLETED|Period VI (Open-Label)||0
5225630|NCT00923091|12849728|P11|COMPLETED|Period VI (Open-Label)||0
5225631|NCT00923091|12849729|P10|COMPLETED|Period VI (Open-Label)||0
5225632|NCT00923091|12849730|P9|COMPLETED|Period VI (Open-Label)||0
5225633|NCT00923091|12849731|P8|COMPLETED|Period VI (Open-Label)||0
5225634|NCT00923091|12849732|P7|COMPLETED|Period VI (Open-Label)||0
5225635|NCT00923091|12849733|P6|COMPLETED|Period VI (Open-Label)||0
5225636|NCT00923091|12849734|P5|COMPLETED|Period VI (Open-Label)||157
5225637|NCT00923091|12849735|P4|COMPLETED|Period VI (Open-Label)||143
5225638|NCT00923091|12849736|P3|COMPLETED|Period VI (Open-Label)||467
5225639|NCT00923091|12849737|P2|COMPLETED|Period VI (Open-Label)||264
5225640|NCT00923091|12849738|P1|COMPLETED|Period VI (Open-Label)||1408
5225641|NCT00923091|12849726|P13|STARTED|Period VI (Open-Label)||0
5225642|NCT00923091|12849727|P12|STARTED|Period VI (Open-Label)||0
5225643|NCT00923091|12849728|P11|STARTED|Period VI (Open-Label)||0
5225644|NCT00923091|12849729|P10|STARTED|Period VI (Open-Label)||0
5225645|NCT00923091|12849730|P9|STARTED|Period VI (Open-Label)||0
5225646|NCT00923091|12849731|P8|STARTED|Period VI (Open-Label)||0
5225647|NCT00923091|12849732|P7|STARTED|Period VI (Open-Label)||0
5225648|NCT00923091|12849733|P6|STARTED|Period VI (Open-Label)||0
5225649|NCT00923091|12849734|P5|STARTED|Period VI (Open-Label)||164
5225650|NCT00923091|12849735|P4|STARTED|Period VI (Open-Label)||146
5225651|NCT00923091|12849736|P3|STARTED|Period VI (Open-Label)||480
5225652|NCT00923091|12849737|P2|STARTED|Period VI (Open-Label)||272
5225653|NCT00923091|12849738|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
5225654|NCT00923091|12849726|P13|NOT COMPLETED|Period V (Double -Blind)||2
5225655|NCT00923091|12849727|P12|NOT COMPLETED|Period V (Double -Blind)||0
5225656|NCT00923091|12849728|P11|NOT COMPLETED|Period V (Double -Blind)||1
5225657|NCT00923091|12849729|P10|NOT COMPLETED|Period V (Double -Blind)||0
5225658|NCT00923091|12849730|P9|NOT COMPLETED|Period V (Double -Blind)||1
5225659|NCT00923091|12849731|P8|NOT COMPLETED|Period V (Double -Blind)||0
5225660|NCT00923091|12849732|P7|NOT COMPLETED|Period V (Double -Blind)||0
5225661|NCT00923091|12849733|P6|NOT COMPLETED|Period V (Double -Blind)||0
5225662|NCT00923091|12849734|P5|NOT COMPLETED|Period V (Double -Blind)||0
5225663|NCT00923091|12849735|P4|NOT COMPLETED|Period V (Double -Blind)||0
5225664|NCT00923091|12849736|P3|NOT COMPLETED|Period V (Double -Blind)||0
5225665|NCT00923091|12849737|P2|NOT COMPLETED|Period V (Double -Blind)||0
5225666|NCT00923091|12849738|P1|NOT COMPLETED|Period V (Double -Blind)||0
5225667|NCT00923091|12849726|P13|COMPLETED|Period V (Double -Blind)||73
5225668|NCT00923091|12849727|P12|COMPLETED|Period V (Double -Blind)||151
5225669|NCT00923091|12849728|P11|COMPLETED|Period V (Double -Blind)||193
5225670|NCT00923091|12849729|P10|COMPLETED|Period V (Double -Blind)||119
5225671|NCT00923091|12849730|P9|COMPLETED|Period V (Double -Blind)||134
5225672|NCT00923091|12849731|P8|COMPLETED|Period V (Double -Blind)||0
5225673|NCT00923091|12849732|P7|COMPLETED|Period V (Double -Blind)||0
5225674|NCT00923091|12849733|P6|COMPLETED|Period V (Double -Blind)||0
5225675|NCT00923091|12849734|P5|COMPLETED|Period V (Double -Blind)||0
5225676|NCT00923091|12849735|P4|COMPLETED|Period V (Double -Blind)||0
5225677|NCT00923091|12849736|P3|COMPLETED|Period V (Double -Blind)||0
5225678|NCT00923091|12849737|P2|COMPLETED|Period V (Double -Blind)||0
5225679|NCT00923091|12849738|P1|COMPLETED|Period V (Double -Blind)||0
5225680|NCT00923091|12849726|P13|STARTED|Period V (Double -Blind)||75
5225681|NCT00923091|12849727|P12|STARTED|Period V (Double -Blind)||151
5225682|NCT00923091|12849728|P11|STARTED|Period V (Double -Blind)||194
5225683|NCT00923091|12849729|P10|STARTED|Period V (Double -Blind)||119
5225684|NCT00923091|12849730|P9|STARTED|Period V (Double -Blind)||135
5225685|NCT00923091|12849731|P8|STARTED|Period V (Double -Blind)||0
5225686|NCT00923091|12849732|P7|STARTED|Period V (Double -Blind)||0
5225687|NCT00923091|12849733|P6|STARTED|Period V (Double -Blind)||0
5225688|NCT00923091|12849734|P5|STARTED|Period V (Double -Blind)||0
5225689|NCT00923091|12849735|P4|STARTED|Period V (Double -Blind)||0
5225690|NCT00923091|12849736|P3|STARTED|Period V (Double -Blind)||0
5225691|NCT00923091|12849737|P2|STARTED|Period V (Double -Blind)||0
5225692|NCT00923091|12849738|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
5225693|NCT00923091|12849726|P13|NOT COMPLETED|Period IV (Double-Blind)||0
5225694|NCT00923091|12849727|P12|NOT COMPLETED|Period IV (Double-Blind)||0
5225695|NCT00923091|12849728|P11|NOT COMPLETED|Period IV (Double-Blind)||0
5225696|NCT00923091|12849729|P10|NOT COMPLETED|Period IV (Double-Blind)||0
5225697|NCT00923091|12849730|P9|NOT COMPLETED|Period IV (Double-Blind)||0
5225698|NCT00923091|12849731|P8|NOT COMPLETED|Period IV (Double-Blind)||0
5225699|NCT00923091|12849732|P7|NOT COMPLETED|Period IV (Double-Blind)||0
5225700|NCT00923091|12849733|P6|NOT COMPLETED|Period IV (Double-Blind)||0
5225701|NCT00923091|12849734|P5|NOT COMPLETED|Period IV (Double-Blind)||0
5225702|NCT00923091|12849735|P4|NOT COMPLETED|Period IV (Double-Blind)||0
5225703|NCT00923091|12849736|P3|NOT COMPLETED|Period IV (Double-Blind)||0
5225704|NCT00923091|12849737|P2|NOT COMPLETED|Period IV (Double-Blind)||2
5225705|NCT00923091|12849738|P1|NOT COMPLETED|Period IV (Double-Blind)||2
5225706|NCT00923091|12849726|P13|COMPLETED|Period IV (Double-Blind)||0
5225707|NCT00923091|12849727|P12|COMPLETED|Period IV (Double-Blind)||0
5225708|NCT00923091|12849728|P11|COMPLETED|Period IV (Double-Blind)||0
5225709|NCT00923091|12849729|P10|COMPLETED|Period IV (Double-Blind)||0
5225710|NCT00923091|12849730|P9|COMPLETED|Period IV (Double-Blind)||0
5225711|NCT00923091|12849731|P8|COMPLETED|Period IV (Double-Blind)||0
5225712|NCT00923091|12849732|P7|COMPLETED|Period IV (Double-Blind)||0
5225713|NCT00923091|12849733|P6|COMPLETED|Period IV (Double-Blind)||0
5225714|NCT00923091|12849734|P5|COMPLETED|Period IV (Double-Blind)||0
5225715|NCT00923091|12849735|P4|COMPLETED|Period IV (Double-Blind)||0
5225716|NCT00923091|12849736|P3|COMPLETED|Period IV (Double-Blind)||0
5225717|NCT00923091|12849737|P2|COMPLETED|Period IV (Double-Blind)||451
5225718|NCT00923091|12849738|P1|COMPLETED|Period IV (Double-Blind)||226
5225719|NCT00923091|12849726|P13|STARTED|Period IV (Double-Blind)||0
5225720|NCT00923091|12849727|P12|STARTED|Period IV (Double-Blind)||0
5225721|NCT00923091|12849728|P11|STARTED|Period IV (Double-Blind)||0
5225722|NCT00923091|12849729|P10|STARTED|Period IV (Double-Blind)||0
5225723|NCT00923091|12849730|P9|STARTED|Period IV (Double-Blind)||0
5225724|NCT00923091|12849731|P8|STARTED|Period IV (Double-Blind)||0
5225725|NCT00923091|12849732|P7|STARTED|Period IV (Double-Blind)||0
5225726|NCT00923091|12849733|P6|STARTED|Period IV (Double-Blind)||0
5225727|NCT00923091|12849734|P5|STARTED|Period IV (Double-Blind)||0
5225728|NCT00923091|12849735|P4|STARTED|Period IV (Double-Blind)||0
5225729|NCT00923091|12849736|P3|STARTED|Period IV (Double-Blind)||0
5225730|NCT00923091|12849737|P2|STARTED|Period IV (Double-Blind)||453
5225731|NCT00923091|12849738|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
5225732|NCT00923091|12849726|P13|NOT COMPLETED|Period III (Single-Blind)||0
5225733|NCT00923091|12849727|P12|NOT COMPLETED|Period III (Single-Blind)||0
5225734|NCT00923091|12849728|P11|NOT COMPLETED|Period III (Single-Blind)||0
5225735|NCT00923091|12849729|P10|NOT COMPLETED|Period III (Single-Blind)||0
5225736|NCT00923091|12849730|P9|NOT COMPLETED|Period III (Single-Blind)||0
5225737|NCT00923091|12849731|P8|NOT COMPLETED|Period III (Single-Blind)||0
5225738|NCT00923091|12849732|P7|NOT COMPLETED|Period III (Single-Blind)||0
5225739|NCT00923091|12849733|P6|NOT COMPLETED|Period III (Single-Blind)||0
5225740|NCT00923091|12849734|P5|NOT COMPLETED|Period III (Single-Blind)||0
5225741|NCT00923091|12849735|P4|NOT COMPLETED|Period III (Single-Blind)||0
5225742|NCT00923091|12849736|P3|NOT COMPLETED|Period III (Single-Blind)||0
5225743|NCT00923091|12849737|P2|NOT COMPLETED|Period III (Single-Blind)||0
5225744|NCT00923091|12849738|P1|NOT COMPLETED|Period III (Single-Blind)||20
5225745|NCT00923091|12849726|P13|COMPLETED|Period III (Single-Blind)||0
5225746|NCT00923091|12849727|P12|COMPLETED|Period III (Single-Blind)||0
5225747|NCT00923091|12849728|P11|COMPLETED|Period III (Single-Blind)||0
5225748|NCT00923091|12849729|P10|COMPLETED|Period III (Single-Blind)||0
5225749|NCT00923091|12849730|P9|COMPLETED|Period III (Single-Blind)||0
5225750|NCT00923091|12849731|P8|COMPLETED|Period III (Single-Blind)||0
5225751|NCT00923091|12849732|P7|COMPLETED|Period III (Single-Blind)||0
5225752|NCT00923091|12849733|P6|COMPLETED|Period III (Single-Blind)||0
5225753|NCT00923091|12849734|P5|COMPLETED|Period III (Single-Blind)||0
5225754|NCT00923091|12849735|P4|COMPLETED|Period III (Single-Blind)||0
5225755|NCT00923091|12849736|P3|COMPLETED|Period III (Single-Blind)||0
5225756|NCT00923091|12849737|P2|COMPLETED|Period III (Single-Blind)||0
5225757|NCT00923091|12849738|P1|COMPLETED|Period III (Single-Blind)||2520
5225758|NCT00923091|12849726|P13|STARTED|Period III (Single-Blind)||0
5225759|NCT00923091|12849727|P12|STARTED|Period III (Single-Blind)||0
5225760|NCT00923091|12849728|P11|STARTED|Period III (Single-Blind)||0
5225761|NCT00923091|12849729|P10|STARTED|Period III (Single-Blind)||0
5225762|NCT00923091|12849730|P9|STARTED|Period III (Single-Blind)||0
5225763|NCT00923091|12849731|P8|STARTED|Period III (Single-Blind)||0
5225764|NCT00923091|12849732|P7|STARTED|Period III (Single-Blind)||0
5225765|NCT00923091|12849733|P6|STARTED|Period III (Single-Blind)||0
5225766|NCT00923091|12849734|P5|STARTED|Period III (Single-Blind)||0
5225767|NCT00923091|12849735|P4|STARTED|Period III (Single-Blind)||0
5225768|NCT00923091|12849736|P3|STARTED|Period III (Single-Blind)||0
5225769|NCT00923091|12849737|P2|STARTED|Period III (Single-Blind)||0
5225770|NCT00923091|12849738|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
5225771|NCT00923091|12849726|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225772|NCT00923091|12849727|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225773|NCT00923091|12849728|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225774|NCT00923091|12849729|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225775|NCT00923091|12849730|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225776|NCT00923091|12849731|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
5225777|NCT00923091|12849732|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
5225778|NCT00923091|12849733|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
5225779|NCT00923091|12849734|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
5225780|NCT00923091|12849735|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
5225781|NCT00923091|12849736|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
5225782|NCT00923091|12849737|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
5225783|NCT00923091|12849738|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
5225784|NCT00923091|12849726|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225785|NCT00923091|12849727|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225786|NCT00923091|12849728|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225787|NCT00923091|12849729|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225788|NCT00923091|12849730|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
5225789|NCT00923091|12849731|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
5225790|NCT00923091|12849732|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
5225791|NCT00923091|12849733|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
5225792|NCT00923091|12849734|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
5225793|NCT00923091|12849735|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
5225794|NCT00923091|12849736|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
5225795|NCT00923091|12849737|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
5225796|NCT00923091|12849738|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
5225797|NCT00923091|12849726|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
5225798|NCT00923091|12849727|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
5225799|NCT00923091|12849728|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
5225800|NCT00923091|12849729|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
5225801|NCT00923091|12849730|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
5225802|NCT00923091|12849731|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
5225803|NCT00923091|12849732|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
5225804|NCT00923091|12849733|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
5225805|NCT00923091|12849734|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
5225806|NCT00923091|12849735|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
5225807|NCT00923091|12849736|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
5225808|NCT00923091|12849737|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
5225809|NCT00923091|12849738|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
5225810|NCT00923078|12849788|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
5225811|NCT00923078|12849789|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
5225812|NCT00923078|12849790|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
5225813|NCT00923078|12849788|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
5225814|NCT00923078|12849789|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
5225815|NCT00923078|12849790|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
5225816|NCT00923078|12849788|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
5225817|NCT00923078|12849789|P2|STARTED|Second Intervention (Weeks 5-8)||19
5225818|NCT00923078|12849790|P1|STARTED|Second Intervention (Weeks 5-8)||19
5225819|NCT00923078|12849788|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
5225820|NCT00923078|12849789|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
5225821|NCT00923078|12849790|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
5225822|NCT00923078|12849788|P3|COMPLETED|First Intervention (Weeks 1-4)||0
5225823|NCT00923078|12849789|P2|COMPLETED|First Intervention (Weeks 1-4)||19
5225824|NCT00923078|12849790|P1|COMPLETED|First Intervention (Weeks 1-4)||19
5225825|NCT00923078|12849788|P3|STARTED|First Intervention (Weeks 1-4)||20
5225826|NCT00923078|12849789|P2|STARTED|First Intervention (Weeks 1-4)||20
5225827|NCT00923078|12849790|P1|STARTED|First Intervention (Weeks 1-4)||20
5225828|NCT00922987|12849809|P1|NOT COMPLETED|Overall Study||4
5225829|NCT00922987|12849809|P1|COMPLETED|Overall Study||277
5225830|NCT00922987|12849809|P1|STARTED|Overall Study||281
5225831|NCT00922974|12849824|P2|NOT COMPLETED|Phase III Component||6
5225832|NCT00922974|12849825|P1|NOT COMPLETED|Phase III Component||8
5225833|NCT00922974|12849824|P2|COMPLETED|Phase III Component||130
5225834|NCT00922974|12849825|P1|COMPLETED|Phase III Component||209
5225835|NCT00922974|12849824|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
5225836|NCT00922974|12849825|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
5225837|NCT00922974|12849824|P2|Eligible With Adverse Event Data|Phase III Component||117
5225838|NCT00922974|12849825|P1|Eligible With Adverse Event Data|Phase III Component||202
5225839|NCT00922974|12849824|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
5225840|NCT00922974|12849825|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
5225841|NCT00922974|12849824|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
5225842|NCT00922974|12849825|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
5225843|NCT00922974|12849824|P2|Eligible|Phase III Component||130
5225844|NCT00922974|12849825|P1|Eligible|Phase III Component||209
5225845|NCT00922974|12849824|P2|STARTED|Phase III Component||136
5225846|NCT00922974|12849825|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
5225847|NCT00922974|12849824|P2|NOT COMPLETED|Phase II Component||0
5225848|NCT00922974|12849825|P1|NOT COMPLETED|Phase II Component||7
5225849|NCT00922974|12849824|P2|COMPLETED|Phase II Component||0
5225850|NCT00922974|12849825|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
5225851|NCT00922974|12849824|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
5225852|NCT00922974|12849825|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
5225853|NCT00922974|12849824|P2|Eligible and Started Treatment|Phase II Component||0
5225854|NCT00922974|12849825|P1|Eligible and Started Treatment|Phase II Component||39
5225855|NCT00922974|12849824|P2|Eligible|Phase II Component||0
5225856|NCT00922974|12849825|P1|Eligible|Phase II Component||44
5225857|NCT00922974|12849824|P2|STARTED|Phase II Component||0
5225858|NCT00922974|12849825|P1|STARTED|Phase II Component||46
5225859|NCT00922935|12849840|P3|NOT COMPLETED|Overall Study||0
5225860|NCT00922935|12849841|P2|NOT COMPLETED|Overall Study||5
5225861|NCT00922935|12849842|P1|NOT COMPLETED|Overall Study||1
5225862|NCT00922935|12849840|P3|COMPLETED|Overall Study||10
5225863|NCT00922935|12849841|P2|COMPLETED|Overall Study||11
5225864|NCT00922935|12849842|P1|COMPLETED|Overall Study||9
5225865|NCT00922935|12849840|P3|STARTED|Overall Study||10
5225866|NCT00922935|12849841|P2|STARTED|Overall Study||16
5225867|NCT00922935|12849842|P1|STARTED|Overall Study||10
5225868|NCT00922883|12849850|P1|NOT COMPLETED|Overall Study||0
5225869|NCT00922883|12849850|P1|COMPLETED|Overall Study||43
5225870|NCT00922883|12849850|P1|STARTED|Overall Study||43
5225871|NCT00922779|12849854|P1|NOT COMPLETED|Overall Study||2327
5225872|NCT00922779|12849854|P1|COMPLETED|Overall Study||4334
5225873|NCT00922779|12849854|P1|STARTED|Overall Study||6661
5225874|NCT00922766|12849861|P1|NOT COMPLETED|Overall Study||7
5225875|NCT00922766|12849861|P1|COMPLETED|Overall Study||610
5225876|NCT00922766|12849861|P1|STARTED|Overall Study||617
5225877|NCT00922701|12849870|P1|NOT COMPLETED|Overall Study||0
5225878|NCT00922701|12849870|P1|COMPLETED|Overall Study||4
5225879|NCT00922701|12849870|P1|STARTED|Overall Study||4
5225880|NCT00922636|12849879|P5|NOT COMPLETED|Overall Study||16
5225881|NCT00922636|12849880|P4|NOT COMPLETED|Overall Study||17
5225882|NCT00922636|12849881|P3|NOT COMPLETED|Overall Study||20
5225883|NCT00922636|12849882|P2|NOT COMPLETED|Overall Study||16
5225884|NCT00922636|12849883|P1|NOT COMPLETED|Overall Study||7
5225885|NCT00922636|12849879|P5|COMPLETED|Overall Study||59
5225886|NCT00922636|12849880|P4|COMPLETED|Overall Study||58
5225887|NCT00922636|12849881|P3|COMPLETED|Overall Study||56
5225888|NCT00922636|12849882|P2|COMPLETED|Overall Study||62
5225889|NCT00922636|12849883|P1|COMPLETED|Overall Study||29
5225890|NCT00922636|12849879|P5|Entered Optional Taper Phase|Overall Study||12
5225891|NCT00922636|12849880|P4|Entered Optional Taper Phase|Overall Study||7
5225892|NCT00922636|12849881|P3|Entered Optional Taper Phase|Overall Study||15
5225893|NCT00922636|12849882|P2|Entered Optional Taper Phase|Overall Study||10
5225894|NCT00922636|12849883|P1|Entered Optional Taper Phase|Overall Study||4
5225895|NCT00922636|12849879|P5|STARTED|Overall Study||75
5225896|NCT00922636|12849880|P4|STARTED|Overall Study||75
5225897|NCT00922636|12849881|P3|STARTED|Overall Study||76
5225898|NCT00922636|12849882|P2|STARTED|Overall Study||78
5225899|NCT00922636|12849883|P1|STARTED|Overall Study||36
5225900|NCT00922623|12850030|P1|NOT COMPLETED|Overall Study||5
5225901|NCT00922623|12850030|P1|COMPLETED|Overall Study||88
5225902|NCT00922623|12850030|P1|STARTED|Overall Study||93
5225903|NCT00922480|12850038|P2|NOT COMPLETED|Extension Study||3
5225904|NCT00922480|12850039|P1|NOT COMPLETED|Extension Study||5
5225905|NCT00922480|12850038|P2|COMPLETED|Extension Study||82
5225906|NCT00922480|12850039|P1|COMPLETED|Extension Study||68
5225907|NCT00922480|12850038|P2|STARTED|Extension Study||85
5225908|NCT00922480|12850039|P1|STARTED|Extension Study||73
5225909|NCT00922480|12850038|P2|NOT COMPLETED|Main Study||29
5225910|NCT00922480|12850039|P1|NOT COMPLETED|Main Study||37
5225911|NCT00922480|12850038|P2|COMPLETED|Main Study||226
5225912|NCT00922480|12850039|P1|COMPLETED|Main Study||213
5225913|NCT00922480|12850038|P2|STARTED|Main Study||255
5225914|NCT00922480|12850039|P1|STARTED|Main Study||250
5225915|NCT00922441|12850050|P3|NOT COMPLETED|Overall Study||3
5225916|NCT00922441|12850051|P2|NOT COMPLETED|Overall Study||0
5225917|NCT00922441|12850052|P1|NOT COMPLETED|Overall Study||0
5225918|NCT00922441|12850050|P3|COMPLETED|Overall Study||29
5225919|NCT00922441|12850051|P2|COMPLETED|Overall Study||30
5225920|NCT00922441|12850052|P1|COMPLETED|Overall Study||30
5225921|NCT00922441|12850050|P3|STARTED|Overall Study||32
5225922|NCT00922441|12850051|P2|STARTED|Overall Study||30
5225923|NCT00922441|12850052|P1|STARTED|Overall Study||30
5225924|NCT00922428|12850060|P1|NOT COMPLETED|Overall Study||15
5225925|NCT00922428|12850060|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
5225926|NCT00922428|12850060|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
5225927|NCT00922272|12850089|P2|NOT COMPLETED|Double-blind Phase||6
5225928|NCT00922272|12850090|P1|NOT COMPLETED|Double-blind Phase||7
5225929|NCT00922272|12850089|P2|COMPLETED|Double-blind Phase||29
5225930|NCT00922272|12850090|P1|COMPLETED|Double-blind Phase||27
5225931|NCT00922272|12850089|P2|STARTED|Double-blind Phase||35
5225932|NCT00922272|12850090|P1|STARTED|Double-blind Phase||34
5225933|NCT00922272|12850089|P2|NOT COMPLETED|Open-label Phase||0
5225934|NCT00922272|12850090|P1|NOT COMPLETED|Open-label Phase||23
5225935|NCT00922272|12850089|P2|COMPLETED|Open-label Phase||0
5225936|NCT00922272|12850090|P1|COMPLETED|Open-label Phase||69
5225937|NCT00922272|12850089|P2|STARTED|Open-label Phase||0
5225938|NCT00922272|12850090|P1|STARTED|Open-label Phase||92
5225939|NCT00922233|12850146|P1|NOT COMPLETED|Overall Study||4
5225940|NCT00922233|12850146|P1|COMPLETED|Overall Study||68
5225941|NCT00922233|12850146|P1|STARTED|Overall Study||72
5225942|NCT00922207|12850155|P3|NOT COMPLETED|Overall Study||4
5225943|NCT00922207|12850156|P2|NOT COMPLETED|Overall Study||7
5225944|NCT00922207|12850157|P1|NOT COMPLETED|Overall Study||6
5225945|NCT00922207|12850155|P3|COMPLETED|Overall Study||90
5225946|NCT00922207|12850156|P2|COMPLETED|Overall Study||88
5225947|NCT00922207|12850157|P1|COMPLETED|Overall Study||85
5225948|NCT00922207|12850155|P3|STARTED|Overall Study||94
5225949|NCT00922207|12850156|P2|STARTED|Overall Study||95
5225950|NCT00922207|12850157|P1|STARTED|Overall Study||91
5225951|NCT00922194|12850183|P1|NOT COMPLETED|Metformin for 12 Months or More||0
5225952|NCT00922194|12850183|P1|COMPLETED|Metformin for 12 Months or More||102
5225953|NCT00922194|12850183|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
5225954|NCT00922194|12850183|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
5225955|NCT00922194|12850183|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
5225956|NCT00922194|12850183|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
5225957|NCT00922116|12850193|P1|NOT COMPLETED|Overall Study||15
5225958|NCT00922116|12850193|P1|COMPLETED|Overall Study||176
5225959|NCT00922116|12850193|P1|STARTED|Overall Study||191
5225960|NCT00921947|12850204|P2|NOT COMPLETED|Day 28||0
5225961|NCT00921947|12850205|P1|NOT COMPLETED|Day 28||0
5225962|NCT00921947|12850204|P2|COMPLETED|Day 28||30
5225963|NCT00921947|12850205|P1|COMPLETED|Day 28||28
5225964|NCT00921947|12850204|P2|STARTED|Day 28||30
5225965|NCT00921947|12850205|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
5225966|NCT00921947|12850204|P2|NOT COMPLETED|Day 0||0
5225967|NCT00921947|12850205|P1|NOT COMPLETED|Day 0||0
5225968|NCT00921947|12850204|P2|COMPLETED|Day 0||30
5225969|NCT00921947|12850205|P1|COMPLETED|Day 0||30
5225970|NCT00921947|12850204|P2|STARTED|Day 0||30
5225971|NCT00921947|12850205|P1|STARTED|Day 0||30
5225972|NCT00921934|12850215|P1|NOT COMPLETED|Overall Study||0
5225973|NCT00921934|12850215|P1|COMPLETED|Overall Study||68
5225974|NCT00921934|12850215|P1|STARTED|Overall Study||68
5225975|NCT00921895|12850219|P1|NOT COMPLETED|Overall Study||0
5225976|NCT00921895|12850219|P1|COMPLETED|Overall Study||128
5225977|NCT00921895|12850219|P1|STARTED|Overall Study||128
5225978|NCT00921843|12850228|P4|NOT COMPLETED|Overall Study||0
5225979|NCT00921843|12850229|P3|NOT COMPLETED|Overall Study||0
5225980|NCT00921843|12850230|P2|NOT COMPLETED|Overall Study||0
5225981|NCT00921843|12850231|P1|NOT COMPLETED|Overall Study||0
5225982|NCT00921843|12850228|P4|COMPLETED|Overall Study||30
5225983|NCT00921843|12850229|P3|COMPLETED|Overall Study||11
5225984|NCT00921843|12850230|P2|COMPLETED|Overall Study||10
5225985|NCT00921843|12850231|P1|COMPLETED|Overall Study||10
5225986|NCT00921843|12850228|P4|STARTED|Overall Study||30
5225987|NCT00921843|12850229|P3|STARTED|Overall Study||11
5225988|NCT00921843|12850230|P2|STARTED|Overall Study||10
5225989|NCT00921843|12850231|P1|STARTED|Overall Study||10
5225990|NCT00921687|12850243|P2|NOT COMPLETED|Overall Study||0
5225991|NCT00921687|12850244|P1|NOT COMPLETED|Overall Study||0
5225992|NCT00921687|12850243|P2|COMPLETED|Overall Study||363
5225993|NCT00921687|12850244|P1|COMPLETED|Overall Study||418
5225994|NCT00921687|12850243|P2|STARTED|Overall Study||363
5225995|NCT00921687|12850244|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
5225996|NCT00921557|12850255|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
5225997|NCT00921557|12850256|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
5225998|NCT00921557|12850257|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
5225999|NCT00921557|12850255|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
5226000|NCT00921557|12850256|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
5226001|NCT00921557|12850257|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
5226002|NCT00921557|12850255|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
5226003|NCT00921557|12850256|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
5226004|NCT00921557|12850257|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
5226005|NCT00921557|12850255|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
5226006|NCT00921557|12850256|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
5226007|NCT00921557|12850257|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
5226008|NCT00921557|12850255|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
5226009|NCT00921557|12850256|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
5226010|NCT00921557|12850257|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
5226011|NCT00921557|12850255|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
5226012|NCT00921557|12850256|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
5226013|NCT00921557|12850257|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
5226014|NCT00921557|12850255|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
5226015|NCT00921557|12850256|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
5226016|NCT00921557|12850257|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
5226017|NCT00921557|12850255|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
5226018|NCT00921557|12850256|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
5226019|NCT00921557|12850257|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
5226020|NCT00921557|12850255|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
5226021|NCT00921557|12850256|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
5226022|NCT00921557|12850257|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
5226023|NCT00921518|12850317|P2|NOT COMPLETED|Overall Study||0
5226024|NCT00921518|12850318|P1|NOT COMPLETED|Overall Study||0
5226025|NCT00921518|12850317|P2|COMPLETED|Overall Study||44
5226026|NCT00921518|12850318|P1|COMPLETED|Overall Study||48
5226027|NCT00921518|12850317|P2|STARTED|Overall Study||44
5226028|NCT00921518|12850318|P1|STARTED|Overall Study||48
5226029|NCT00921310|12850326|P3|NOT COMPLETED|Overall Study||0
5226030|NCT00921310|12850327|P2|NOT COMPLETED|Overall Study||0
5226031|NCT00921310|12850328|P1|NOT COMPLETED|Overall Study||0
5226032|NCT00921310|12850326|P3|COMPLETED|Overall Study||4
5226033|NCT00921310|12850327|P2|COMPLETED|Overall Study||6
5226034|NCT00921310|12850328|P1|COMPLETED|Overall Study||2
5226035|NCT00921310|12850326|P3|STARTED|Overall Study||4
5226036|NCT00921310|12850327|P2|STARTED|Overall Study||6
5226037|NCT00921310|12850328|P1|STARTED|Overall Study||2
5226038|NCT00921115|12850353|P1|NOT COMPLETED|Overall Study||0
5226039|NCT00921115|12850353|P1|COMPLETED|Overall Study||42
5226040|NCT00921115|12850353|P1|STARTED|Overall Study||42
5226041|NCT00921024|12850359|P2|NOT COMPLETED|Overall Study||3
5226042|NCT00921024|12850360|P1|NOT COMPLETED|Overall Study||4
5226043|NCT00921024|12850359|P2|COMPLETED|Overall Study||39
5226044|NCT00921024|12850360|P1|COMPLETED|Overall Study||81
5226045|NCT00921024|12850359|P2|STARTED|Overall Study||42
5226046|NCT00921024|12850360|P1|STARTED|Overall Study||85
5226047|NCT00920907|12850370|P2|NOT COMPLETED|Maintenance Period||13
5226048|NCT00920907|12850371|P1|NOT COMPLETED|Maintenance Period||12
5226049|NCT00920907|12850370|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
5226050|NCT00920907|12850371|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
5226051|NCT00920907|12850370|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
5226052|NCT00920907|12850371|P1|STARTED|Maintenance Period||15
5226053|NCT00920907|12850370|P2|NOT COMPLETED|Induction Period||22
5226054|NCT00920907|12850371|P1|NOT COMPLETED|Induction Period||22
5226055|NCT00920907|12850370|P2|COMPLETED|Induction Period||16
5226056|NCT00920907|12850371|P1|COMPLETED|Induction Period||15
5226057|NCT00920907|12850370|P2|STARTED|Induction Period||38
5226058|NCT00920907|12850371|P1|STARTED|Induction Period||37
5226059|NCT00920855|12850412|P3|NOT COMPLETED|Overall Study||22
5226060|NCT00920855|12850413|P2|NOT COMPLETED|Overall Study||3
5226061|NCT00920855|12850414|P1|NOT COMPLETED|Overall Study||5
5226062|NCT00920855|12850412|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
5226063|NCT00920855|12850413|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
5226064|NCT00920855|12850414|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
5226065|NCT00920855|12850412|P3|Safety and Efficacy Populations|Overall Study||31
5226066|NCT00920855|12850413|P2|Safety and Efficacy Populations|Overall Study||4
5226067|NCT00920855|12850414|P1|Safety and Efficacy Populations|Overall Study||5
5226068|NCT00920855|12850412|P3|STARTED|Overall Study||31
5226069|NCT00920855|12850413|P2|STARTED|Overall Study||4
5226070|NCT00920855|12850414|P1|STARTED|Overall Study||5
5226071|NCT00920829|12850440|P4|NOT COMPLETED|Available for Analysis||11
5226072|NCT00920829|12850441|P3|NOT COMPLETED|Available for Analysis||10
5226073|NCT00920829|12850442|P2|NOT COMPLETED|Available for Analysis||11
5226074|NCT00920829|12850443|P1|NOT COMPLETED|Available for Analysis||8
5226075|NCT00920829|12850440|P4|COMPLETED|Available for Analysis||24
5226076|NCT00920829|12850441|P3|COMPLETED|Available for Analysis||28
5226077|NCT00920829|12850442|P2|COMPLETED|Available for Analysis||27
5226078|NCT00920829|12850443|P1|COMPLETED|Available for Analysis||27
5226079|NCT00920829|12850440|P4|STARTED|Available for Analysis||35
5226080|NCT00920829|12850441|P3|STARTED|Available for Analysis||38
5226081|NCT00920829|12850442|P2|STARTED|Available for Analysis||38
5226082|NCT00920829|12850443|P1|STARTED|Available for Analysis||35
5226083|NCT00920829|12850440|P4|NOT COMPLETED|Allocation||2
5226084|NCT00920829|12850441|P3|NOT COMPLETED|Allocation||0
5226085|NCT00920829|12850442|P2|NOT COMPLETED|Allocation||1
5226086|NCT00920829|12850443|P1|NOT COMPLETED|Allocation||3
5226087|NCT00920829|12850440|P4|COMPLETED|Allocation||35
5226088|NCT00920829|12850441|P3|COMPLETED|Allocation||38
5226089|NCT00920829|12850442|P2|COMPLETED|Allocation||38
5226090|NCT00920829|12850443|P1|COMPLETED|Allocation||35
5226091|NCT00920829|12850440|P4|STARTED|Allocation||37
5226092|NCT00920829|12850441|P3|STARTED|Allocation||38
5226093|NCT00920829|12850442|P2|STARTED|Allocation||39
5226094|NCT00920829|12850443|P1|STARTED|Allocation||38
5226095|NCT00920816|12850457|P4|NOT COMPLETED|Overall Study||69
5226096|NCT00920816|12850458|P3|NOT COMPLETED|Overall Study||135
5226097|NCT00920816|12850459|P2|NOT COMPLETED|Overall Study||96
5226098|NCT00920816|12850460|P1|NOT COMPLETED|Overall Study||192
5226099|NCT00920816|12850457|P4|COMPLETED|Overall Study||0
5226100|NCT00920816|12850458|P3|COMPLETED|Overall Study||0
5226101|NCT00920816|12850459|P2|COMPLETED|Overall Study||0
5226102|NCT00920816|12850460|P1|COMPLETED|Overall Study||0
5226103|NCT00920816|12850457|P4|Treated|Overall Study||69
5226104|NCT00920816|12850458|P3|Treated|Overall Study||135
5226105|NCT00920816|12850459|P2|Treated|Overall Study||96
5226106|NCT00920816|12850460|P1|Treated|Overall Study||189
5226107|NCT00920816|12850457|P4|STARTED|Overall Study||69
5226108|NCT00920816|12850458|P3|STARTED|Overall Study||135
5226109|NCT00920816|12850459|P2|STARTED|Overall Study||96
5226110|NCT00920816|12850460|P1|STARTED|Overall Study||192
5226111|NCT00920790|12850498|P1|NOT COMPLETED|Overall Study||14
5226112|NCT00920790|12850498|P1|COMPLETED|Overall Study||13
5226113|NCT00920790|12850498|P1|STARTED|Overall Study||27
5226114|NCT00920699|12850510|P3|NOT COMPLETED|Overall Study||4
5226115|NCT00920699|12850511|P2|NOT COMPLETED|Overall Study||1
5226116|NCT00920699|12850512|P1|NOT COMPLETED|Overall Study||2
5226117|NCT00920699|12850510|P3|COMPLETED|Overall Study||28
5226118|NCT00920699|12850511|P2|COMPLETED|Overall Study||29
5226119|NCT00920699|12850512|P1|COMPLETED|Overall Study||27
5226120|NCT00920699|12850510|P3|STARTED|Overall Study||32
5226121|NCT00920699|12850511|P2|STARTED|Overall Study||30
5226122|NCT00920699|12850512|P1|STARTED|Overall Study||29
5226123|NCT00920686|12850529|P3|NOT COMPLETED|Overall Study||13
5226124|NCT00920686|12850530|P2|NOT COMPLETED|Overall Study||22
5226125|NCT00920686|12850531|P1|NOT COMPLETED|Overall Study||19
5226126|NCT00920686|12850529|P3|COMPLETED|Overall Study||62
5226127|NCT00920686|12850530|P2|COMPLETED|Overall Study||60
5226128|NCT00920686|12850531|P1|COMPLETED|Overall Study||63
5226129|NCT00920686|12850529|P3|STARTED|Overall Study||75
5226130|NCT00920686|12850530|P2|STARTED|Overall Study||82
5226131|NCT00920686|12850531|P1|STARTED|Overall Study||82
5226132|NCT00920647|12850555|P4|NOT COMPLETED|Overall Study||0
5226133|NCT00920647|12850556|P3|NOT COMPLETED|Overall Study||0
5226134|NCT00920647|12850557|P2|NOT COMPLETED|Overall Study||0
5226135|NCT00920647|12850558|P1|NOT COMPLETED|Overall Study||0
5226136|NCT00920647|12850555|P4|COMPLETED|Overall Study||4
5226137|NCT00920647|12850556|P3|COMPLETED|Overall Study||4
5226138|NCT00920647|12850557|P2|COMPLETED|Overall Study||4
5226139|NCT00920647|12850558|P1|COMPLETED|Overall Study||4
5226140|NCT00920647|12850555|P4|STARTED|Overall Study||4
5226141|NCT00920647|12850556|P3|STARTED|Overall Study||4
5226142|NCT00920647|12850557|P2|STARTED|Overall Study||4
5226143|NCT00920647|12850558|P1|STARTED|Overall Study||4
5226144|NCT00920621|12850610|P4|NOT COMPLETED|Overall Study||35
5226145|NCT00920621|12850611|P3|NOT COMPLETED|Overall Study||35
5226146|NCT00920621|12850612|P2|NOT COMPLETED|Overall Study||45
5226147|NCT00920621|12850613|P1|NOT COMPLETED|Overall Study||54
5226148|NCT00920621|12850610|P4|COMPLETED|Overall Study||401
5226149|NCT00920621|12850611|P3|COMPLETED|Overall Study||405
5226150|NCT00920621|12850612|P2|COMPLETED|Overall Study||391
5226151|NCT00920621|12850613|P1|COMPLETED|Overall Study||386
5226152|NCT00920621|12850610|P4|STARTED|Overall Study||436
5226153|NCT00920621|12850611|P3|STARTED|Overall Study||440
5226154|NCT00920621|12850612|P2|STARTED|Overall Study||436
5226155|NCT00920621|12850613|P1|STARTED|Overall Study||440
5226156|NCT00920556|12850643|P1|NOT COMPLETED|Overall Study||24
5226157|NCT00920556|12850643|P1|COMPLETED|Overall Study||0
5226158|NCT00920556|12850643|P1|STARTED|Overall Study||24
5226159|NCT00920439|12850682|P1|NOT COMPLETED|Overall Study||0
5226160|NCT00920439|12850682|P1|COMPLETED|Overall Study||25
5226161|NCT00920439|12850682|P1|STARTED|Overall Study||25
5226162|NCT00920426|12850692|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226163|NCT00920426|12850693|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226164|NCT00920426|12850694|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226165|NCT00920426|12850695|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226166|NCT00920426|12850692|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
5226167|NCT00920426|12850693|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226168|NCT00920426|12850694|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226169|NCT00920426|12850695|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
5226170|NCT00920426|12850692|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
5226171|NCT00920426|12850693|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
5226172|NCT00920426|12850694|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
5226173|NCT00920426|12850695|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
5226174|NCT00920426|12850692|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
5226175|NCT00920426|12850693|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
5226176|NCT00920426|12850694|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
5226177|NCT00920426|12850695|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
5226178|NCT00920426|12850692|P4|COMPLETED|ITZ112929: Randomized Regimen||0
5226179|NCT00920426|12850693|P3|COMPLETED|ITZ112929: Randomized Regimen||2
5226180|NCT00920426|12850694|P2|COMPLETED|ITZ112929: Randomized Regimen||7
5226181|NCT00920426|12850695|P1|COMPLETED|ITZ112929: Randomized Regimen||0
5226182|NCT00920426|12850692|P4|STARTED|ITZ112929: Randomized Regimen||0
5226183|NCT00920426|12850693|P3|STARTED|ITZ112929: Randomized Regimen||2
5226184|NCT00920426|12850694|P2|STARTED|ITZ112929: Randomized Regimen||7
5226185|NCT00920426|12850695|P1|STARTED|ITZ112929: Randomized Regimen||0
5226186|NCT00920426|12850692|P4|NOT COMPLETED|ITZ111451||0
5226187|NCT00920426|12850693|P3|NOT COMPLETED|ITZ111451||0
5226188|NCT00920426|12850694|P2|NOT COMPLETED|ITZ111451||0
5226189|NCT00920426|12850695|P1|NOT COMPLETED|ITZ111451||1
5226190|NCT00920426|12850692|P4|COMPLETED|ITZ111451||0
5226191|NCT00920426|12850693|P3|COMPLETED|ITZ111451||0
5226192|NCT00920426|12850694|P2|COMPLETED|ITZ111451||0
5226193|NCT00920426|12850695|P1|COMPLETED|ITZ111451||7
5226194|NCT00920426|12850692|P4|STARTED|ITZ111451||0
5226195|NCT00920426|12850693|P3|STARTED|ITZ111451||0
5226196|NCT00920426|12850694|P2|STARTED|ITZ111451||0
5226197|NCT00920426|12850695|P1|STARTED|ITZ111451||8
5226198|NCT00920374|12850764|P2|NOT COMPLETED|Overall Study||0
5226199|NCT00920374|12850765|P1|NOT COMPLETED|Overall Study||0
5226200|NCT00920374|12850764|P2|COMPLETED|Overall Study||57
5226201|NCT00920374|12850765|P1|COMPLETED|Overall Study||61
5226202|NCT00920374|12850764|P2|STARTED|Overall Study||57
5226203|NCT00920374|12850765|P1|STARTED|Overall Study||61
5226204|NCT00920309|12850791|P2|NOT COMPLETED|Overall Study||0
5226205|NCT00920309|12850792|P1|NOT COMPLETED|Overall Study||0
5226206|NCT00920309|12850791|P2|COMPLETED|Overall Study||7
5226207|NCT00920309|12850792|P1|COMPLETED|Overall Study||14
5226208|NCT00920309|12850791|P2|STARTED|Overall Study||7
5226209|NCT00920309|12850792|P1|STARTED|Overall Study||14
5226210|NCT00920231|12850802|P2|NOT COMPLETED|Overall Study||0
5226211|NCT00920231|12850803|P1|NOT COMPLETED|Overall Study||0
5226212|NCT00920231|12850802|P2|COMPLETED|Overall Study||8
5226213|NCT00920231|12850803|P1|COMPLETED|Overall Study||8
5226214|NCT00920231|12850802|P2|STARTED|Overall Study||8
5226215|NCT00920231|12850803|P1|STARTED|Overall Study||8
5226216|NCT00920218|12850815|P4|NOT COMPLETED|Overall Study||7
5226217|NCT00920218|12850816|P3|NOT COMPLETED|Overall Study||8
5226218|NCT00920218|12850817|P2|NOT COMPLETED|Overall Study||5
5226219|NCT00920218|12850818|P1|NOT COMPLETED|Overall Study||2
5226220|NCT00920218|12850815|P4|COMPLETED|Overall Study||23
5226221|NCT00920218|12850816|P3|COMPLETED|Overall Study||23
5226222|NCT00920218|12850817|P2|COMPLETED|Overall Study||24
5226223|NCT00920218|12850818|P1|COMPLETED|Overall Study||28
5226224|NCT00920218|12850815|P4|STARTED|Overall Study||30
5226225|NCT00920218|12850816|P3|STARTED|Overall Study||31
5226226|NCT00920218|12850817|P2|STARTED|Overall Study||29
5226227|NCT00920218|12850818|P1|STARTED|Overall Study||30
5226228|NCT00920140|12850921|P5|NOT COMPLETED|Phase 2||11
5226229|NCT00920140|12850922|P4|NOT COMPLETED|Phase 2||22
5226230|NCT00920140|12850923|P3|NOT COMPLETED|Phase 2||50
5226231|NCT00920140|12850924|P2|NOT COMPLETED|Phase 2||0
5226232|NCT00920140|12850925|P1|NOT COMPLETED|Phase 2||0
5226233|NCT00920140|12850921|P5|COMPLETED|Phase 2||0
5226234|NCT00920140|12850922|P4|COMPLETED|Phase 2||0
5226235|NCT00920140|12850923|P3|COMPLETED|Phase 2||0
5226236|NCT00920140|12850924|P2|COMPLETED|Phase 2||0
5226237|NCT00920140|12850925|P1|COMPLETED|Phase 2||0
5226238|NCT00920140|12850921|P5|STARTED|Phase 2||11
5226239|NCT00920140|12850922|P4|STARTED|Phase 2||22
5226240|NCT00920140|12850923|P3|STARTED|Phase 2||50
5226241|NCT00920140|12850924|P2|STARTED|Phase 2||0
5226242|NCT00920140|12850925|P1|STARTED|Phase 2||0
5226243|NCT00920140|12850921|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
5226244|NCT00920140|12850922|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
5226245|NCT00920140|12850923|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
5226246|NCT00920140|12850924|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
5226247|NCT00920140|12850925|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
5226248|NCT00920140|12850921|P5|COMPLETED|Phase 1 (Dose Escalation)||0
5226249|NCT00920140|12850922|P4|COMPLETED|Phase 1 (Dose Escalation)||0
5226250|NCT00920140|12850923|P3|COMPLETED|Phase 1 (Dose Escalation)||0
5226251|NCT00920140|12850924|P2|COMPLETED|Phase 1 (Dose Escalation)||0
5226252|NCT00920140|12850925|P1|COMPLETED|Phase 1 (Dose Escalation)||0
5226253|NCT00920140|12850921|P5|STARTED|Phase 1 (Dose Escalation)||0
5226254|NCT00920140|12850922|P4|STARTED|Phase 1 (Dose Escalation)||0
5226255|NCT00920140|12850923|P3|STARTED|Phase 1 (Dose Escalation)||0
5226256|NCT00920140|12850924|P2|STARTED|Phase 1 (Dose Escalation)||9
5226257|NCT00920140|12850925|P1|STARTED|Phase 1 (Dose Escalation)||5
5226258|NCT00920075|12850963|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
5226259|NCT00920075|12850963|P1|COMPLETED|Post Study, 11 Pts Responded||11
5226260|NCT00920075|12850963|P1|STARTED|Post Study, 11 Pts Responded||11
5226261|NCT00920075|12850963|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
5226262|NCT00920075|12850963|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
5226263|NCT00920075|12850963|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
5226264|NCT00920023|12850969|P1|NOT COMPLETED|Overall Study||0
5226265|NCT00920023|12850969|P1|COMPLETED|Overall Study||15
5226266|NCT00920023|12850969|P1|STARTED|Overall Study||15
5226267|NCT00919932|12850976|P2|NOT COMPLETED|Overall Study||0
5226268|NCT00919932|12850977|P1|NOT COMPLETED|Overall Study||0
5226269|NCT00919932|12850976|P2|COMPLETED|Overall Study||5
5226270|NCT00919932|12850977|P1|COMPLETED|Overall Study||4
5226271|NCT00919932|12850976|P2|STARTED|Overall Study||5
5226272|NCT00919932|12850977|P1|STARTED|Overall Study||4
5226273|NCT00919893|12850987|P2|NOT COMPLETED|Overall Study||9
5226274|NCT00919893|12850988|P1|NOT COMPLETED|Overall Study||19
5226275|NCT00919893|12850987|P2|COMPLETED|Overall Study||60
5226276|NCT00919893|12850988|P1|COMPLETED|Overall Study||51
5226277|NCT00919893|12850987|P2|STARTED|Overall Study||69
5226278|NCT00919893|12850988|P1|STARTED|Overall Study||70
5226279|NCT00919867|12851000|P6|NOT COMPLETED|Third Intervention||0
5226280|NCT00919867|12851001|P5|NOT COMPLETED|Third Intervention||0
5226281|NCT00919867|12851002|P4|NOT COMPLETED|Third Intervention||0
5226282|NCT00919867|12851003|P3|NOT COMPLETED|Third Intervention||0
5226283|NCT00919867|12851004|P2|NOT COMPLETED|Third Intervention||0
5226284|NCT00919867|12851005|P1|NOT COMPLETED|Third Intervention||0
5226285|NCT00919867|12851000|P6|COMPLETED|Third Intervention||6
5226286|NCT00919867|12851001|P5|COMPLETED|Third Intervention||7
5226287|NCT00919867|12851002|P4|COMPLETED|Third Intervention||7
5226288|NCT00919867|12851003|P3|COMPLETED|Third Intervention||6
5226289|NCT00919867|12851004|P2|COMPLETED|Third Intervention||7
5226290|NCT00919867|12851005|P1|COMPLETED|Third Intervention||7
5226291|NCT00919867|12851000|P6|STARTED|Third Intervention||6
5226292|NCT00919867|12851001|P5|STARTED|Third Intervention||7
5226293|NCT00919867|12851002|P4|STARTED|Third Intervention||7
5226294|NCT00919867|12851003|P3|STARTED|Third Intervention||6
5226295|NCT00919867|12851004|P2|STARTED|Third Intervention||7
5226296|NCT00919867|12851005|P1|STARTED|Third Intervention||7
5226297|NCT00919867|12851000|P6|NOT COMPLETED|Washout||0
5226298|NCT00919867|12851001|P5|NOT COMPLETED|Washout||0
5226299|NCT00919867|12851002|P4|NOT COMPLETED|Washout||0
5226300|NCT00919867|12851003|P3|NOT COMPLETED|Washout||0
5226301|NCT00919867|12851004|P2|NOT COMPLETED|Washout||0
5226302|NCT00919867|12851005|P1|NOT COMPLETED|Washout||0
5226303|NCT00919867|12851000|P6|COMPLETED|Washout||6
5226304|NCT00919867|12851001|P5|COMPLETED|Washout||7
5226305|NCT00919867|12851002|P4|COMPLETED|Washout||7
5226306|NCT00919867|12851003|P3|COMPLETED|Washout||6
5226307|NCT00919867|12851004|P2|COMPLETED|Washout||7
5226308|NCT00919867|12851005|P1|COMPLETED|Washout||7
5226309|NCT00919867|12851000|P6|STARTED|Washout||6
5226310|NCT00919867|12851001|P5|STARTED|Washout||7
5226311|NCT00919867|12851002|P4|STARTED|Washout||7
5226312|NCT00919867|12851003|P3|STARTED|Washout||6
5226313|NCT00919867|12851004|P2|STARTED|Washout||7
5226314|NCT00919867|12851005|P1|STARTED|Washout||7
5226315|NCT00919867|12851000|P6|NOT COMPLETED|Second Intervention||0
5226316|NCT00919867|12851001|P5|NOT COMPLETED|Second Intervention||0
5226317|NCT00919867|12851002|P4|NOT COMPLETED|Second Intervention||0
5226318|NCT00919867|12851003|P3|NOT COMPLETED|Second Intervention||0
5226319|NCT00919867|12851004|P2|NOT COMPLETED|Second Intervention||0
5226320|NCT00919867|12851005|P1|NOT COMPLETED|Second Intervention||0
5226321|NCT00919867|12851000|P6|COMPLETED|Second Intervention||6
5226322|NCT00919867|12851001|P5|COMPLETED|Second Intervention||7
5226323|NCT00919867|12851002|P4|COMPLETED|Second Intervention||7
5226324|NCT00919867|12851003|P3|COMPLETED|Second Intervention||6
5226325|NCT00919867|12851004|P2|COMPLETED|Second Intervention||7
5226326|NCT00919867|12851005|P1|COMPLETED|Second Intervention||7
5226327|NCT00919867|12851000|P6|STARTED|Second Intervention||6
5226328|NCT00919867|12851001|P5|STARTED|Second Intervention||7
5226329|NCT00919867|12851002|P4|STARTED|Second Intervention||7
5226330|NCT00919867|12851003|P3|STARTED|Second Intervention||6
5226331|NCT00919867|12851004|P2|STARTED|Second Intervention||7
5226332|NCT00919867|12851005|P1|STARTED|Second Intervention||7
5226333|NCT00919867|12851000|P6|NOT COMPLETED|Washout||0
5226334|NCT00919867|12851001|P5|NOT COMPLETED|Washout||0
5226335|NCT00919867|12851002|P4|NOT COMPLETED|Washout||0
5226336|NCT00919867|12851003|P3|NOT COMPLETED|Washout||0
5226337|NCT00919867|12851004|P2|NOT COMPLETED|Washout||0
5226338|NCT00919867|12851005|P1|NOT COMPLETED|Washout||0
5226339|NCT00919867|12851000|P6|COMPLETED|Washout||6
5226340|NCT00919867|12851001|P5|COMPLETED|Washout||7
5226341|NCT00919867|12851002|P4|COMPLETED|Washout||7
5226342|NCT00919867|12851003|P3|COMPLETED|Washout||6
5226343|NCT00919867|12851004|P2|COMPLETED|Washout||7
5226344|NCT00919867|12851005|P1|COMPLETED|Washout||7
5226345|NCT00919867|12851000|P6|STARTED|Washout||6
5226346|NCT00919867|12851001|P5|STARTED|Washout||7
5226347|NCT00919867|12851002|P4|STARTED|Washout||7
5226348|NCT00919867|12851003|P3|STARTED|Washout||6
5226349|NCT00919867|12851004|P2|STARTED|Washout||7
5226350|NCT00919867|12851005|P1|STARTED|Washout||7
5226351|NCT00919867|12851000|P6|NOT COMPLETED|First Intervention||1
5226352|NCT00919867|12851001|P5|NOT COMPLETED|First Intervention||0
5226353|NCT00919867|12851002|P4|NOT COMPLETED|First Intervention||0
5226354|NCT00919867|12851003|P3|NOT COMPLETED|First Intervention||1
5226355|NCT00919867|12851004|P2|NOT COMPLETED|First Intervention||0
5226356|NCT00919867|12851005|P1|NOT COMPLETED|First Intervention||0
5226357|NCT00919867|12851000|P6|COMPLETED|First Intervention||6
5226358|NCT00919867|12851001|P5|COMPLETED|First Intervention||7
5226359|NCT00919867|12851002|P4|COMPLETED|First Intervention||7
5226360|NCT00919867|12851003|P3|COMPLETED|First Intervention||6
5226361|NCT00919867|12851004|P2|COMPLETED|First Intervention||7
5226362|NCT00919867|12851005|P1|COMPLETED|First Intervention||7
5226363|NCT00919867|12851000|P6|STARTED|First Intervention||7
5226364|NCT00919867|12851001|P5|STARTED|First Intervention||7
5226365|NCT00919867|12851002|P4|STARTED|First Intervention||7
5226366|NCT00919867|12851003|P3|STARTED|First Intervention||7
5226367|NCT00919867|12851004|P2|STARTED|First Intervention||7
5226368|NCT00919867|12851005|P1|STARTED|First Intervention||7
5226369|NCT00919854|12851026|P1|NOT COMPLETED|Overall Study||1
5226370|NCT00919854|12851026|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
5226371|NCT00919854|12851026|P1|STARTED|Overall Study||21
5226372|NCT00919802|12851035|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
5226373|NCT00919802|12851036|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
5226374|NCT00919802|12851035|P2|COMPLETED|Second Intervention - (24 Hours)||13
5226375|NCT00919802|12851036|P1|COMPLETED|Second Intervention - (24 Hours)||12
5226376|NCT00919802|12851035|P2|STARTED|Second Intervention - (24 Hours)||13
5226377|NCT00919802|12851036|P1|STARTED|Second Intervention - (24 Hours)||12
5226378|NCT00919802|12851035|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
5226379|NCT00919802|12851036|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
5226380|NCT00919802|12851035|P2|COMPLETED|First Intervention - (24 Hours)||13
5226381|NCT00919802|12851036|P1|COMPLETED|First Intervention - (24 Hours)||12
5226382|NCT00919802|12851035|P2|STARTED|First Intervention - (24 Hours)||13
5226383|NCT00919802|12851036|P1|STARTED|First Intervention - (24 Hours)||12
5226384|NCT00919763|12851046|P2|NOT COMPLETED|Overall Study||4
5226385|NCT00919763|12851047|P1|NOT COMPLETED|Overall Study||12
5226386|NCT00919763|12851046|P2|COMPLETED|Overall Study||45
5226387|NCT00919763|12851047|P1|COMPLETED|Overall Study||41
5226388|NCT00919763|12851046|P2|STARTED|Overall Study||49
5226389|NCT00919763|12851047|P1|STARTED|Overall Study||53
5226390|NCT00919724|12851055|P2|NOT COMPLETED|Overall Study||0
5226391|NCT00919724|12851056|P1|NOT COMPLETED|Overall Study||0
5226392|NCT00919724|12851055|P2|COMPLETED|Overall Study||44
5226393|NCT00919724|12851056|P1|COMPLETED|Overall Study||45
5226394|NCT00919724|12851055|P2|STARTED|Overall Study||44
5226395|NCT00919724|12851056|P1|STARTED|Overall Study||45
5226396|NCT00919711|12851064|P2|NOT COMPLETED|Overall Study||13
5226397|NCT00919711|12851065|P1|NOT COMPLETED|Overall Study||33
5226398|NCT00919711|12851064|P2|COMPLETED|Overall Study||422
5226399|NCT00919711|12851065|P1|COMPLETED|Overall Study||402
5226400|NCT00919711|12851064|P2|STARTED|Overall Study||435
5226401|NCT00919711|12851065|P1|STARTED|Overall Study||435
5226402|NCT00919633|12851081|P4|NOT COMPLETED|Overall Study||21
5226403|NCT00919633|12851082|P3|NOT COMPLETED|Overall Study||23
5226404|NCT00919633|12851083|P2|NOT COMPLETED|Overall Study||15
5226405|NCT00919633|12851084|P1|NOT COMPLETED|Overall Study||22
5226406|NCT00919633|12851081|P4|COMPLETED|Overall Study||5
5226407|NCT00919633|12851082|P3|COMPLETED|Overall Study||4
5226408|NCT00919633|12851083|P2|COMPLETED|Overall Study||10
5226409|NCT00919633|12851084|P1|COMPLETED|Overall Study||6
5226410|NCT00919633|12851081|P4|STARTED|Overall Study||26
5226411|NCT00919633|12851082|P3|STARTED|Overall Study||27
5226412|NCT00919633|12851083|P2|STARTED|Overall Study||25
5226413|NCT00919633|12851084|P1|STARTED|Overall Study||28
5226414|NCT00919191|12851102|P1|NOT COMPLETED|Overall Study||0
5226415|NCT00919191|12851102|P1|COMPLETED|Overall Study||26
5226416|NCT00919191|12851102|P1|STARTED|Overall Study||26
5226417|NCT00919126|12851112|P3|NOT COMPLETED|Overall Study||1
5226418|NCT00919126|12851113|P2|NOT COMPLETED|Overall Study||5
5226419|NCT00919126|12851114|P1|NOT COMPLETED|Overall Study||1
5226420|NCT00919126|12851112|P3|COMPLETED|Overall Study||32
5226421|NCT00919126|12851113|P2|COMPLETED|Overall Study||32
5226422|NCT00919126|12851114|P1|COMPLETED|Overall Study||31
5226423|NCT00919126|12851112|P3|STARTED|Overall Study||33
5226424|NCT00919126|12851113|P2|STARTED|Overall Study||37
5226425|NCT00919126|12851114|P1|STARTED|Overall Study||32
5226426|NCT00919113|12851160|P2|NOT COMPLETED|Overall Study||8
5226427|NCT00919113|12851161|P1|NOT COMPLETED|Overall Study||9
5226428|NCT00919113|12851160|P2|COMPLETED|Overall Study||40
5226429|NCT00919113|12851161|P1|COMPLETED|Overall Study||41
5226430|NCT00919113|12851160|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
5226431|NCT00919113|12851161|P1|Received Placebo|Overall Study||0
5226432|NCT00919113|12851160|P2|Received Uracyst|Overall Study||0
5226433|NCT00919113|12851161|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
5226434|NCT00919113|12851160|P2|STARTED|Overall Study||48
5226435|NCT00919113|12851161|P1|STARTED|Overall Study||50
5226436|NCT00919100|12851171|P2|NOT COMPLETED|Overall Study||0
5226437|NCT00919100|12851172|P1|NOT COMPLETED|Overall Study||0
5226438|NCT00919100|12851171|P2|COMPLETED|Overall Study||41
5226439|NCT00919100|12851172|P1|COMPLETED|Overall Study||40
5226440|NCT00919100|12851171|P2|STARTED|Overall Study||41
5226441|NCT00919100|12851172|P1|STARTED|Overall Study||40
5226442|NCT00919061|12851182|P1|NOT COMPLETED|Overall Study||2
5226443|NCT00919061|12851182|P1|COMPLETED|Overall Study||37
5226444|NCT00919061|12851182|P1|STARTED|Overall Study||39
5226445|NCT00919035|12851187|P1|NOT COMPLETED|Overall Study||0
5226446|NCT00919035|12851187|P1|COMPLETED|Overall Study||21
5226447|NCT00919035|12851187|P1|STARTED|Overall Study||21
5226448|NCT00918957|12851195|P2|NOT COMPLETED|Overall Study||0
5226449|NCT00918957|12851196|P1|NOT COMPLETED|Overall Study||3
5226450|NCT00918957|12851195|P2|COMPLETED|Overall Study||30
5226451|NCT00918957|12851196|P1|COMPLETED|Overall Study||29
5226452|NCT00918957|12851195|P2|STARTED|Overall Study||30
5226453|NCT00918957|12851196|P1|STARTED|Overall Study||32
5226454|NCT00918931|12851223|P1|NOT COMPLETED|Overall Study||0
5226455|NCT00918931|12851223|P1|COMPLETED|Overall Study||3
5226456|NCT00918931|12851223|P1|STARTED|Overall Study||3
5226457|NCT00918879|12851229|P2|NOT COMPLETED|Overall Study||6
5226458|NCT00918879|12851230|P1|NOT COMPLETED|Overall Study||6
5226459|NCT00918879|12851229|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
5226460|NCT00918879|12851230|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
5226461|NCT00918879|12851229|P2|STARTED|Overall Study|Randomized and treated|106
5226462|NCT00918879|12851230|P1|STARTED|Overall Study|Randomized and treated|107
5226463|NCT00918866|12851244|P2|NOT COMPLETED|Overall Study||0
5226464|NCT00918866|12851245|P1|NOT COMPLETED|Overall Study||0
5226465|NCT00918866|12851244|P2|COMPLETED|Overall Study||16
5226466|NCT00918866|12851245|P1|COMPLETED|Overall Study||16
5226467|NCT00918866|12851244|P2|STARTED|Overall Study||16
5226468|NCT00918866|12851245|P1|STARTED|Overall Study||16
5226469|NCT00918749|12851262|P3|NOT COMPLETED|Overall Study||7
5226470|NCT00918749|12851263|P2|NOT COMPLETED|Overall Study||3
5226471|NCT00918749|12851264|P1|NOT COMPLETED|Overall Study||7
5226472|NCT00918749|12851262|P3|COMPLETED|Overall Study||62
5226473|NCT00918749|12851263|P2|COMPLETED|Overall Study||63
5226474|NCT00918749|12851264|P1|COMPLETED|Overall Study||63
5226475|NCT00918749|12851262|P3|ITT (Intent to Treat) Population|Overall Study||69
5226476|NCT00918749|12851263|P2|ITT (Intent to Treat) Population|Overall Study||66
5226477|NCT00918749|12851264|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
5226478|NCT00918749|12851262|P3|STARTED|Overall Study||69
5226479|NCT00918749|12851263|P2|STARTED|Overall Study||66
5226480|NCT00918749|12851264|P1|STARTED|Overall Study||70
5226481|NCT00918736|12851296|P1|NOT COMPLETED|Overall Study||4
5226482|NCT00918736|12851296|P1|COMPLETED|Overall Study|October, 2008|46
5226483|NCT00918736|12851296|P1|STARTED|Overall Study|October, 2007|50
5226484|NCT00918723|12851300|P1|NOT COMPLETED|Overall Study||0
5226485|NCT00918723|12851300|P1|COMPLETED|Overall Study||40
5226486|NCT00918723|12851300|P1|STARTED|Overall Study||40
5226487|NCT00918684|12851309|P1|NOT COMPLETED|Treatment Phase||25
5226488|NCT00918684|12851309|P1|COMPLETED|Treatment Phase||65
5226489|NCT00918684|12851309|P1|STARTED|Treatment Phase||90
5226490|NCT00918684|12851309|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
5226491|NCT00918684|12851309|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
5226492|NCT00918684|12851309|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
5226493|NCT00918671|12851315|P1|NOT COMPLETED|Overall Study||0
5226494|NCT00918671|12851315|P1|COMPLETED|Overall Study||60
5226495|NCT00918671|12851315|P1|STARTED|Overall Study||60
5226496|NCT00918645|12851320|P1|NOT COMPLETED|Overall Study||1
5226497|NCT00918645|12851320|P1|COMPLETED|Overall Study||12
5226498|NCT00918645|12851320|P1|STARTED|Overall Study||13
5226499|NCT00918580|12851326|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
5226500|NCT00918580|12851326|P1|COMPLETED|After 6-month FU to 1-year FU||87
5226501|NCT00918580|12851326|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
5226502|NCT00918580|12851326|P1|STARTED|After 6-month FU to 1-year FU||147
5226503|NCT00918580|12851326|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
5226504|NCT00918580|12851326|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
5226505|NCT00918580|12851326|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
5226506|NCT00918580|12851326|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
5226507|NCT00918580|12851326|P1|STARTED|Up to 6-month Follow-up(FU)||158
5226508|NCT00918567|12851346|P2|NOT COMPLETED|Overall Study||2
5226509|NCT00918567|12851347|P1|NOT COMPLETED|Overall Study||5
5226510|NCT00918567|12851346|P2|COMPLETED|Overall Study||25
5226511|NCT00918567|12851347|P1|COMPLETED|Overall Study||24
5226512|NCT00918567|12851346|P2|STARTED|Overall Study||27
5226513|NCT00918567|12851347|P1|STARTED|Overall Study||29
5226514|NCT00918463|12851373|P1|NOT COMPLETED|Overall Study||2
5226515|NCT00918463|12851373|P1|COMPLETED|Overall Study||0
5226516|NCT00918463|12851373|P1|STARTED|Overall Study||2
5226517|NCT00918385|12851381|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
5226518|NCT00918385|12851382|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
5226519|NCT00918385|12851381|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
5226520|NCT00918385|12851382|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
5226521|NCT00918385|12851381|P2|STARTED|Combination Nilutamide and Dasatinib||11
5226522|NCT00918385|12851382|P1|STARTED|Combination Nilutamide and Dasatinib||12
5226523|NCT00918385|12851381|P2|NOT COMPLETED|Monotherapy||6
5226524|NCT00918385|12851382|P1|NOT COMPLETED|Monotherapy||2
5226525|NCT00918385|12851381|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
5226526|NCT00918385|12851382|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
5226527|NCT00918385|12851381|P2|STARTED|Monotherapy||17
5226528|NCT00918385|12851382|P1|STARTED|Monotherapy||14
5226529|NCT00918346|12851391|P2|NOT COMPLETED|Post Study Period||0
5226530|NCT00918346|12851392|P1|NOT COMPLETED|Post Study Period||0
5226531|NCT00918346|12851391|P2|COMPLETED|Post Study Period||21
5226532|NCT00918346|12851392|P1|COMPLETED|Post Study Period||21
5226533|NCT00918346|12851391|P2|STARTED|Post Study Period||21
5226534|NCT00918346|12851392|P1|STARTED|Post Study Period||21
5226535|NCT00918346|12851391|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
5226536|NCT00918346|12851392|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
5226537|NCT00918346|12851391|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
5226538|NCT00918346|12851392|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
5226539|NCT00918346|12851391|P2|STARTED|Second Treatment Period (4 Weeks)||21
5226540|NCT00918346|12851392|P1|STARTED|Second Treatment Period (4 Weeks)||21
5226541|NCT00918346|12851391|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
5226542|NCT00918346|12851392|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
5226543|NCT00918346|12851391|P2|COMPLETED|Washout (at Least 4 Weeks)||21
5226544|NCT00918346|12851392|P1|COMPLETED|Washout (at Least 4 Weeks)||21
5226545|NCT00918346|12851391|P2|STARTED|Washout (at Least 4 Weeks)||21
5226546|NCT00918346|12851392|P1|STARTED|Washout (at Least 4 Weeks)||21
5226547|NCT00918346|12851391|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
5226548|NCT00918346|12851392|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
5226549|NCT00918346|12851391|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
5226550|NCT00918346|12851392|P1|COMPLETED|First Treatment Period (4 Weeks)||21
5226551|NCT00918346|12851391|P2|STARTED|First Treatment Period (4 Weeks)||22
5226552|NCT00918346|12851392|P1|STARTED|First Treatment Period (4 Weeks)||21
5226553|NCT00918333|12851408|P2|NOT COMPLETED|Overall Study||5
5226554|NCT00918333|12851409|P1|NOT COMPLETED|Overall Study||3
5226555|NCT00918333|12851408|P2|COMPLETED|Overall Study||93
5226556|NCT00918333|12851409|P1|COMPLETED|Overall Study||23
5226557|NCT00918333|12851408|P2|STARTED|Overall Study||98
5226558|NCT00918333|12851409|P1|STARTED|Overall Study||26
5226559|NCT00918281|12851429|P1|NOT COMPLETED|Overall Study||29
5226560|NCT00918281|12851429|P1|COMPLETED|Overall Study||41
5226561|NCT00918281|12851429|P1|STARTED|Overall Study||70
5226562|NCT00918255|12851439|P3|NOT COMPLETED|Overall Study||5
5226563|NCT00918255|12851440|P2|NOT COMPLETED|Overall Study||0
5226564|NCT00918255|12851441|P1|NOT COMPLETED|Overall Study||6
5226565|NCT00918255|12851439|P3|COMPLETED|Overall Study||46
5226566|NCT00918255|12851440|P2|COMPLETED|Overall Study||52
5226567|NCT00918255|12851441|P1|COMPLETED|Overall Study||45
5226568|NCT00918255|12851439|P3|STARTED|Overall Study||51
5226569|NCT00918255|12851440|P2|STARTED|Overall Study||52
5226570|NCT00918255|12851441|P1|STARTED|Overall Study||51
5226571|NCT00918229|12851467|P1|NOT COMPLETED|Overall Study||0
5226572|NCT00918229|12851467|P1|COMPLETED|Overall Study||24
5226573|NCT00918229|12851467|P1|STARTED|Overall Study||24
5226574|NCT00918203|12851474|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
5226575|NCT00918203|12851475|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
5226576|NCT00918203|12851476|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
5226577|NCT00918203|12851474|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
5226578|NCT00918203|12851475|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
5226579|NCT00918203|12851476|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
5226580|NCT00918203|12851474|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
5226581|NCT00918203|12851475|P2|STARTED|Crossover to Olaratumab Monotherapy||0
5226582|NCT00918203|12851476|P1|STARTED|Crossover to Olaratumab Monotherapy||0
5226583|NCT00918203|12851474|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
5226584|NCT00918203|12851475|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
5226585|NCT00918203|12851476|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
5226586|NCT00918203|12851474|P3|COMPLETED|Treatment With or Without Olaratumab||0
5226587|NCT00918203|12851475|P2|COMPLETED|Treatment With or Without Olaratumab||57
5226588|NCT00918203|12851476|P1|COMPLETED|Treatment With or Without Olaratumab||64
5226589|NCT00918203|12851474|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
5226590|NCT00918203|12851475|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
5226591|NCT00918203|12851476|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
5226592|NCT00918203|12851474|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
5226593|NCT00918203|12851475|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
5226594|NCT00918203|12851476|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
5226595|NCT00918203|12851474|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
5226596|NCT00918203|12851475|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
5226597|NCT00918203|12851476|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
5226598|NCT00918203|12851474|P3|STARTED|Treatment With or Without Olaratumab||0
5226599|NCT00918203|12851475|P2|STARTED|Treatment With or Without Olaratumab||67
5226600|NCT00918203|12851476|P1|STARTED|Treatment With or Without Olaratumab||70
5226601|NCT00918138|12851507|P2|NOT COMPLETED|Overall Study||1
5226602|NCT00918138|12851508|P1|NOT COMPLETED|Overall Study||2
5226603|NCT00918138|12851507|P2|COMPLETED|Overall Study||46
5226604|NCT00918138|12851508|P1|COMPLETED|Overall Study||44
5226605|NCT00918138|12851507|P2|STARTED|Overall Study||47
5226606|NCT00918138|12851508|P1|STARTED|Overall Study||46
5226607|NCT00918125|12851524|P2|NOT COMPLETED|Overall Study||0
5226608|NCT00918125|12851525|P1|NOT COMPLETED|Overall Study||0
5226609|NCT00918125|12851524|P2|COMPLETED|Overall Study||39
5226610|NCT00918125|12851525|P1|COMPLETED|Overall Study||20
5226611|NCT00918125|12851524|P2|STARTED|Overall Study||39
5226612|NCT00918125|12851525|P1|STARTED|Overall Study||20
5226613|NCT00917865|12851536|P1|NOT COMPLETED|Overall Study||0
5226614|NCT00917865|12851536|P1|COMPLETED|Overall Study||11
5226615|NCT00917865|12851536|P1|STARTED|Overall Study||11
5226616|NCT00917852|12851547|P1|NOT COMPLETED|Overall Study||6
5226617|NCT00917852|12851547|P1|COMPLETED|Overall Study||45
5226618|NCT00917852|12851547|P1|STARTED|Overall Study||51
5226619|NCT00917735|12851554|P2|NOT COMPLETED|Overall Study||63
5226620|NCT00917735|12851555|P1|NOT COMPLETED|Overall Study||75
5226621|NCT00917735|12851554|P2|COMPLETED|Overall Study||474
5226622|NCT00917735|12851555|P1|COMPLETED|Overall Study||463
5226623|NCT00917735|12851554|P2|STARTED|Overall Study||537
5226624|NCT00917735|12851555|P1|STARTED|Overall Study||538
5226625|NCT00917644|12851565|P2|NOT COMPLETED|Period 2: Second Intervention||0
5226626|NCT00917644|12851566|P1|NOT COMPLETED|Period 2: Second Intervention||1
5226627|NCT00917644|12851565|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
5226628|NCT00917644|12851566|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
5226629|NCT00917644|12851565|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
5226630|NCT00917644|12851566|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
5226631|NCT00917644|12851565|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
5226632|NCT00917644|12851566|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
5226633|NCT00917644|12851565|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
5226634|NCT00917644|12851566|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
5226635|NCT00917644|12851565|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
5226636|NCT00917644|12851566|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
5226637|NCT00917644|12851565|P2|NOT COMPLETED|Period 1: First Intervention||0
5226638|NCT00917644|12851566|P1|NOT COMPLETED|Period 1: First Intervention||0
5226639|NCT00917644|12851565|P2|COMPLETED|Period 1: First Intervention||37
5226640|NCT00917644|12851566|P1|COMPLETED|Period 1: First Intervention||39
5226641|NCT00917644|12851565|P2|STARTED|Period 1: First Intervention||37
5226642|NCT00917644|12851566|P1|STARTED|Period 1: First Intervention||39
5226643|NCT00917579|12851580|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
5226644|NCT00917579|12851581|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
5226645|NCT00917579|12851580|P2|COMPLETED|Period 2: 2nd Intervention||37
5226646|NCT00917579|12851581|P1|COMPLETED|Period 2: 2nd Intervention||37
5226647|NCT00917579|12851580|P2|STARTED|Period 2: 2nd Intervention||37
5226648|NCT00917579|12851581|P1|STARTED|Period 2: 2nd Intervention||37
5226649|NCT00917579|12851580|P2|NOT COMPLETED|Washout >= 2 Weeks||0
5226650|NCT00917579|12851581|P1|NOT COMPLETED|Washout >= 2 Weeks||2
5226651|NCT00917579|12851580|P2|COMPLETED|Washout >= 2 Weeks||37
5226652|NCT00917579|12851581|P1|COMPLETED|Washout >= 2 Weeks||37
5226653|NCT00917579|12851580|P2|STARTED|Washout >= 2 Weeks||37
5226654|NCT00917579|12851581|P1|STARTED|Washout >= 2 Weeks||39
5226655|NCT00917579|12851580|P2|NOT COMPLETED|Period 1: 1st Intervention||0
5226656|NCT00917579|12851581|P1|NOT COMPLETED|Period 1: 1st Intervention||0
5226657|NCT00917579|12851580|P2|COMPLETED|Period 1: 1st Intervention||37
5226658|NCT00917579|12851581|P1|COMPLETED|Period 1: 1st Intervention||39
5226659|NCT00917579|12851580|P2|STARTED|Period 1: 1st Intervention||37
5226660|NCT00917579|12851581|P1|STARTED|Period 1: 1st Intervention||39
5226661|NCT00917553|12851597|P2|NOT COMPLETED|Overall Study||1
5226662|NCT00917553|12851598|P1|NOT COMPLETED|Overall Study||2
5226663|NCT00917553|12851597|P2|COMPLETED|Overall Study||15
5226664|NCT00917553|12851598|P1|COMPLETED|Overall Study||15
5226665|NCT00917553|12851597|P2|STARTED|Overall Study||16
5226666|NCT00917553|12851598|P1|STARTED|Overall Study||17
5226667|NCT00917501|12851614|P2|NOT COMPLETED|Overall Study||5
5226668|NCT00917501|12851615|P1|NOT COMPLETED|Overall Study||8
5226669|NCT00917501|12851614|P2|COMPLETED|Overall Study||21
5226670|NCT00917501|12851615|P1|COMPLETED|Overall Study||21
5226671|NCT00917501|12851614|P2|STARTED|Overall Study||26
5226672|NCT00917501|12851615|P1|STARTED|Overall Study||29
5226673|NCT00917462|12851621|P1|NOT COMPLETED|Overall Study||1
5226674|NCT00917462|12851621|P1|COMPLETED|Overall Study||34
5226675|NCT00917462|12851621|P1|STARTED|Overall Study||35
5226676|NCT00917384|12851631|P2|NOT COMPLETED|Overall Study||4
5226677|NCT00917384|12851632|P1|NOT COMPLETED|Overall Study||14
5226678|NCT00917384|12851631|P2|COMPLETED|Overall Study||113
5226679|NCT00917384|12851632|P1|COMPLETED|Overall Study||224
5226680|NCT00917384|12851631|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
5226681|NCT00917384|12851632|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
5226682|NCT00917384|12851631|P2|STARTED|Overall Study||117
5226683|NCT00917384|12851632|P1|STARTED|Overall Study||238
5226684|NCT00917267|12851656|P2|NOT COMPLETED|Overall Study||79
5226685|NCT00917267|12851657|P1|NOT COMPLETED|Overall Study||39
5226686|NCT00917267|12851656|P2|COMPLETED|Overall Study||266
5226687|NCT00917267|12851657|P1|COMPLETED|Overall Study||307
5226688|NCT00917267|12851656|P2|Intent to Treat (ITT)|Overall Study||338
5226689|NCT00917267|12851657|P1|Intent to Treat (ITT)|Overall Study||340
5226690|NCT00917267|12851656|P2|STARTED|Overall Study||345
5226691|NCT00917267|12851657|P1|STARTED|Overall Study||346
5226692|NCT00917124|12851685|P2|NOT COMPLETED|Overall Study||6
5226693|NCT00917124|12851686|P1|NOT COMPLETED|Overall Study||4
5226694|NCT00917124|12851685|P2|COMPLETED|Overall Study||94
5226695|NCT00917124|12851686|P1|COMPLETED|Overall Study||96
5226696|NCT00917124|12851685|P2|STARTED|Overall Study||100
5226697|NCT00917124|12851686|P1|STARTED|Overall Study||100
5226698|NCT00916929|12851696|P2|NOT COMPLETED|Overall Study||29
5226699|NCT00916929|12851697|P1|NOT COMPLETED|Overall Study||10
5226700|NCT00916929|12851696|P2|COMPLETED|Overall Study||53
5226701|NCT00916929|12851697|P1|COMPLETED|Overall Study||70
5226702|NCT00916929|12851696|P2|STARTED|Overall Study||82
5226703|NCT00916929|12851697|P1|STARTED|Overall Study||80
5226704|NCT00916721|12851707|P2|NOT COMPLETED|Overall Study||10
5226705|NCT00916721|12851708|P1|NOT COMPLETED|Overall Study||10
5226706|NCT00916721|12851707|P2|COMPLETED|Overall Study||29
5226707|NCT00916721|12851708|P1|COMPLETED|Overall Study||25
5226708|NCT00916721|12851707|P2|STARTED|Overall Study||39
5226709|NCT00916721|12851708|P1|STARTED|Overall Study||35
5226710|NCT00916643|12851720|P1|NOT COMPLETED|Overall Study||0
5226711|NCT00916643|12851720|P1|COMPLETED|Overall Study||113
5226712|NCT00916643|12851720|P1|STARTED|Overall Study||113
5226713|NCT00916617|12851731|P4|NOT COMPLETED|Overall Study||7
5226714|NCT00916617|12851732|P3|NOT COMPLETED|Overall Study||10
5226715|NCT00916617|12851733|P2|NOT COMPLETED|Overall Study||21
5226716|NCT00916617|12851734|P1|NOT COMPLETED|Overall Study||23
5226717|NCT00916617|12851731|P4|COMPLETED|Overall Study||0
5226718|NCT00916617|12851732|P3|COMPLETED|Overall Study||0
5226719|NCT00916617|12851733|P2|COMPLETED|Overall Study||0
5226720|NCT00916617|12851734|P1|COMPLETED|Overall Study||1
5226721|NCT00916617|12851731|P4|STARTED|Overall Study||7
5226722|NCT00916617|12851732|P3|STARTED|Overall Study||10
5226723|NCT00916617|12851733|P2|STARTED|Overall Study||21
5226724|NCT00916617|12851734|P1|STARTED|Overall Study||24
5226725|NCT00916578|12851748|P1|NOT COMPLETED|Overall Study||7
5226726|NCT00916578|12851748|P1|COMPLETED|Overall Study||26
5226727|NCT00916578|12851748|P1|STARTED|Overall Study||33
5226728|NCT00916539|12851754|P2|NOT COMPLETED|Overall Study||0
5226729|NCT00916539|12851755|P1|NOT COMPLETED|Overall Study||0
5226730|NCT00916539|12851754|P2|COMPLETED|Overall Study||31
5226731|NCT00916539|12851755|P1|COMPLETED|Overall Study||31
5226732|NCT00916539|12851754|P2|STARTED|Overall Study||31
5226733|NCT00916539|12851755|P1|STARTED|Overall Study||31
5226734|NCT00916383|12851777|P1|NOT COMPLETED|Overall Study||3
5226735|NCT00916383|12851777|P1|COMPLETED|Overall Study||46
5226736|NCT00916383|12851777|P1|STARTED|Overall Study||49
5226737|NCT00916370|12851805|P2|NOT COMPLETED|Overall Study||2
5226738|NCT00916370|12851806|P1|NOT COMPLETED|Overall Study||5
5226739|NCT00916370|12851805|P2|COMPLETED|Overall Study||102
5226740|NCT00916370|12851806|P1|COMPLETED|Overall Study||396
5226741|NCT00916370|12851805|P2|STARTED|Overall Study||104
5226742|NCT00916370|12851806|P1|STARTED|Overall Study||401
5226743|NCT00916357|12851980|P6|NOT COMPLETED|Period 3||0
5226744|NCT00916357|12851981|P5|NOT COMPLETED|Period 3||0
5226745|NCT00916357|12851982|P4|NOT COMPLETED|Period 3||0
5226746|NCT00916357|12851983|P3|NOT COMPLETED|Period 3||0
5226747|NCT00916357|12851984|P2|NOT COMPLETED|Period 3||0
5226748|NCT00916357|12851985|P1|NOT COMPLETED|Period 3||0
5226749|NCT00916357|12851980|P6|COMPLETED|Period 3||4
5226750|NCT00916357|12851981|P5|COMPLETED|Period 3||3
5226751|NCT00916357|12851982|P4|COMPLETED|Period 3||3
5226752|NCT00916357|12851983|P3|COMPLETED|Period 3||4
5226753|NCT00916357|12851984|P2|COMPLETED|Period 3||4
5226754|NCT00916357|12851985|P1|COMPLETED|Period 3||3
5226755|NCT00916357|12851980|P6|STARTED|Period 3||4
5226756|NCT00916357|12851981|P5|STARTED|Period 3||3
5226757|NCT00916357|12851982|P4|STARTED|Period 3||3
5226758|NCT00916357|12851983|P3|STARTED|Period 3||4
5226759|NCT00916357|12851984|P2|STARTED|Period 3||4
5226760|NCT00916357|12851985|P1|STARTED|Period 3||3
5226761|NCT00916357|12851980|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
5226762|NCT00916357|12851981|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
5226763|NCT00916357|12851982|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
5226764|NCT00916357|12851983|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
5226765|NCT00916357|12851984|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
5226766|NCT00916357|12851985|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
5226767|NCT00916357|12851980|P6|COMPLETED|Washout (3 to 14 Days)||4
5226768|NCT00916357|12851981|P5|COMPLETED|Washout (3 to 14 Days)||3
5226769|NCT00916357|12851982|P4|COMPLETED|Washout (3 to 14 Days)||3
5226770|NCT00916357|12851983|P3|COMPLETED|Washout (3 to 14 Days)||4
5226771|NCT00916357|12851984|P2|COMPLETED|Washout (3 to 14 Days)||4
5226772|NCT00916357|12851985|P1|COMPLETED|Washout (3 to 14 Days)||3
5226773|NCT00916357|12851980|P6|STARTED|Washout (3 to 14 Days)||4
5226774|NCT00916357|12851981|P5|STARTED|Washout (3 to 14 Days)||3
5226775|NCT00916357|12851982|P4|STARTED|Washout (3 to 14 Days)||3
5226776|NCT00916357|12851983|P3|STARTED|Washout (3 to 14 Days)||4
5226777|NCT00916357|12851984|P2|STARTED|Washout (3 to 14 Days)||4
5226778|NCT00916357|12851985|P1|STARTED|Washout (3 to 14 Days)||3
5226779|NCT00916357|12851980|P6|NOT COMPLETED|Period 2||0
5226780|NCT00916357|12851981|P5|NOT COMPLETED|Period 2||0
5226781|NCT00916357|12851982|P4|NOT COMPLETED|Period 2||1
5226782|NCT00916357|12851983|P3|NOT COMPLETED|Period 2||0
5226783|NCT00916357|12851984|P2|NOT COMPLETED|Period 2||0
5226784|NCT00916357|12851985|P1|NOT COMPLETED|Period 2||0
5226785|NCT00916357|12851980|P6|COMPLETED|Period 2||4
5226786|NCT00916357|12851981|P5|COMPLETED|Period 2||3
5226787|NCT00916357|12851982|P4|COMPLETED|Period 2||3
5226788|NCT00916357|12851983|P3|COMPLETED|Period 2||4
5226789|NCT00916357|12851984|P2|COMPLETED|Period 2||4
5226790|NCT00916357|12851985|P1|COMPLETED|Period 2||3
5226791|NCT00916357|12851980|P6|STARTED|Period 2||4
5226792|NCT00916357|12851981|P5|STARTED|Period 2||3
5226793|NCT00916357|12851982|P4|STARTED|Period 2||4
5226794|NCT00916357|12851983|P3|STARTED|Period 2||4
5226795|NCT00916357|12851984|P2|STARTED|Period 2||4
5226796|NCT00916357|12851985|P1|STARTED|Period 2||3
5226797|NCT00916357|12851980|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
5226798|NCT00916357|12851981|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
5226799|NCT00916357|12851982|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
5226800|NCT00916357|12851983|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
5226801|NCT00916357|12851984|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
5226802|NCT00916357|12851985|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
5226803|NCT00916357|12851980|P6|COMPLETED|Washout (3 to 14 Days)||4
5226804|NCT00916357|12851981|P5|COMPLETED|Washout (3 to 14 Days)||3
5226805|NCT00916357|12851982|P4|COMPLETED|Washout (3 to 14 Days)||4
5226806|NCT00916357|12851983|P3|COMPLETED|Washout (3 to 14 Days)||4
5226807|NCT00916357|12851984|P2|COMPLETED|Washout (3 to 14 Days)||4
5226808|NCT00916357|12851985|P1|COMPLETED|Washout (3 to 14 Days)||3
5226809|NCT00916357|12851980|P6|STARTED|Washout (3 to 14 Days)||4
5226810|NCT00916357|12851981|P5|STARTED|Washout (3 to 14 Days)||3
5226811|NCT00916357|12851982|P4|STARTED|Washout (3 to 14 Days)||4
5226812|NCT00916357|12851983|P3|STARTED|Washout (3 to 14 Days)||4
5226813|NCT00916357|12851984|P2|STARTED|Washout (3 to 14 Days)||4
5226814|NCT00916357|12851985|P1|STARTED|Washout (3 to 14 Days)||3
5226815|NCT00916357|12851980|P6|NOT COMPLETED|Period 1||0
5226816|NCT00916357|12851981|P5|NOT COMPLETED|Period 1||0
5226817|NCT00916357|12851982|P4|NOT COMPLETED|Period 1||0
5226818|NCT00916357|12851983|P3|NOT COMPLETED|Period 1||0
5226819|NCT00916357|12851984|P2|NOT COMPLETED|Period 1||0
5226820|NCT00916357|12851985|P1|NOT COMPLETED|Period 1||1
5226821|NCT00916357|12851980|P6|COMPLETED|Period 1||4
5226822|NCT00916357|12851981|P5|COMPLETED|Period 1||3
5226823|NCT00916357|12851982|P4|COMPLETED|Period 1||4
5226824|NCT00916357|12851983|P3|COMPLETED|Period 1||4
5226825|NCT00916357|12851984|P2|COMPLETED|Period 1||4
5226826|NCT00916357|12851985|P1|COMPLETED|Period 1||3
5226827|NCT00916357|12851980|P6|Received at Least 1 Dose of Study Drug|Period 1||4
5226828|NCT00916357|12851981|P5|Received at Least 1 Dose of Study Drug|Period 1||3
5226829|NCT00916357|12851982|P4|Received at Least 1 Dose of Study Drug|Period 1||4
5226830|NCT00916357|12851983|P3|Received at Least 1 Dose of Study Drug|Period 1||4
5226831|NCT00916357|12851984|P2|Received at Least 1 Dose of Study Drug|Period 1||4
5226832|NCT00916357|12851985|P1|Received at Least 1 Dose of Study Drug|Period 1||4
5226833|NCT00916357|12851980|P6|STARTED|Period 1||4
5226834|NCT00916357|12851981|P5|STARTED|Period 1||3
5226835|NCT00916357|12851982|P4|STARTED|Period 1||4
5226836|NCT00916357|12851983|P3|STARTED|Period 1||4
5226837|NCT00916357|12851984|P2|STARTED|Period 1||4
5226838|NCT00916357|12851985|P1|STARTED|Period 1||4
5226839|NCT00916344|12852023|P1|NOT COMPLETED|Overall Study||8
5226840|NCT00916344|12852023|P1|COMPLETED|Overall Study||167
5226841|NCT00916344|12852023|P1|STARTED|Overall Study||175
5226842|NCT00916305|12852030|P2|NOT COMPLETED|Overall Study||28
5226843|NCT00916305|12852031|P1|NOT COMPLETED|Overall Study||21
5226844|NCT00916305|12852030|P2|COMPLETED|Overall Study||9
5226845|NCT00916305|12852031|P1|COMPLETED|Overall Study||7
5226846|NCT00916305|12852030|P2|STARTED|Overall Study||37
5226847|NCT00916305|12852031|P1|STARTED|Overall Study||28
5226848|NCT00916279|12852039|P1|NOT COMPLETED|Overall Study||4
5226849|NCT00916279|12852039|P1|COMPLETED|Overall Study||37
5226850|NCT00916279|12852039|P1|24 Months|Overall Study||37
5226851|NCT00916279|12852039|P1|6 Months|Overall Study||41
5226852|NCT00916279|12852039|P1|30 Days|Overall Study||41
5226853|NCT00916279|12852039|P1|STARTED|Overall Study||41
5226854|NCT00916149|12852050|P3|NOT COMPLETED|Overall Study||0
5226855|NCT00916149|12852051|P2|NOT COMPLETED|Overall Study||2
5226856|NCT00916149|12852052|P1|NOT COMPLETED|Overall Study||4
5226857|NCT00916149|12852050|P3|COMPLETED|Overall Study||5
5226858|NCT00916149|12852051|P2|COMPLETED|Overall Study||8
5226859|NCT00916149|12852052|P1|COMPLETED|Overall Study||12
5226860|NCT00916149|12852050|P3|STARTED|Overall Study||5
5226861|NCT00916149|12852051|P2|STARTED|Overall Study||10
5226862|NCT00916149|12852052|P1|STARTED|Overall Study||16
5226863|NCT00916136|12852123|P2|NOT COMPLETED|Overall Study||0
5226864|NCT00916136|12852124|P1|NOT COMPLETED|Overall Study||0
5226865|NCT00916136|12852123|P2|COMPLETED|Overall Study||29
5226866|NCT00916136|12852124|P1|COMPLETED|Overall Study||37
5226867|NCT00916136|12852123|P2|STARTED|Overall Study||29
5226868|NCT00916136|12852124|P1|STARTED|Overall Study||37
5226869|NCT00916058|12852139|P7|NOT COMPLETED|Phase 2||3
5226870|NCT00916058|12852140|P6|NOT COMPLETED|Phase 2||0
5226871|NCT00916058|12852141|P5|NOT COMPLETED|Phase 2||0
5226872|NCT00916058|12852142|P4|NOT COMPLETED|Phase 2||0
5226873|NCT00916058|12852143|P3|NOT COMPLETED|Phase 2||0
5226874|NCT00916058|12852144|P2|NOT COMPLETED|Phase 2||0
5226875|NCT00916058|12852145|P1|NOT COMPLETED|Phase 2||0
5226876|NCT00916058|12852139|P7|COMPLETED|Phase 2||28
5226877|NCT00916058|12852140|P6|COMPLETED|Phase 2||0
5226878|NCT00916058|12852141|P5|COMPLETED|Phase 2||0
5226879|NCT00916058|12852142|P4|COMPLETED|Phase 2||0
5226880|NCT00916058|12852143|P3|COMPLETED|Phase 2||0
5226881|NCT00916058|12852144|P2|COMPLETED|Phase 2||0
5226882|NCT00916058|12852145|P1|COMPLETED|Phase 2||0
5226883|NCT00916058|12852139|P7|STARTED|Phase 2||31
5226884|NCT00916058|12852140|P6|STARTED|Phase 2||0
5226885|NCT00916058|12852141|P5|STARTED|Phase 2||0
5226886|NCT00916058|12852142|P4|STARTED|Phase 2||0
5226887|NCT00916058|12852143|P3|STARTED|Phase 2||0
5226888|NCT00916058|12852144|P2|STARTED|Phase 2||0
5226889|NCT00916058|12852145|P1|STARTED|Phase 2||0
5226890|NCT00916058|12852139|P7|NOT COMPLETED|Phase 1||0
5226891|NCT00916058|12852140|P6|NOT COMPLETED|Phase 1||1
5226892|NCT00916058|12852141|P5|NOT COMPLETED|Phase 1||0
5226893|NCT00916058|12852142|P4|NOT COMPLETED|Phase 1||0
5226894|NCT00916058|12852143|P3|NOT COMPLETED|Phase 1||0
5226895|NCT00916058|12852144|P2|NOT COMPLETED|Phase 1||0
5226896|NCT00916058|12852145|P1|NOT COMPLETED|Phase 1||0
5226897|NCT00916058|12852139|P7|COMPLETED|Phase 1||0
5226898|NCT00916058|12852140|P6|COMPLETED|Phase 1||7
5226899|NCT00916058|12852141|P5|COMPLETED|Phase 1||3
5226900|NCT00916058|12852142|P4|COMPLETED|Phase 1||3
5226901|NCT00916058|12852143|P3|COMPLETED|Phase 1||3
5226902|NCT00916058|12852144|P2|COMPLETED|Phase 1||6
5226903|NCT00916058|12852145|P1|COMPLETED|Phase 1||3
5226904|NCT00916058|12852139|P7|STARTED|Phase 1||0
5226905|NCT00916058|12852140|P6|STARTED|Phase 1||8
5226906|NCT00916058|12852141|P5|STARTED|Phase 1||3
5226907|NCT00916058|12852142|P4|STARTED|Phase 1||3
5226908|NCT00916058|12852143|P3|STARTED|Phase 1||3
5226909|NCT00916058|12852144|P2|STARTED|Phase 1||6
5226910|NCT00916058|12852145|P1|STARTED|Phase 1||3
5226911|NCT00916032|12852165|P2|NOT COMPLETED|Overall Study||0
5226912|NCT00916032|12852166|P1|NOT COMPLETED|Overall Study||0
5226913|NCT00916032|12852165|P2|COMPLETED|Overall Study||11
5226914|NCT00916032|12852166|P1|COMPLETED|Overall Study||12
5226915|NCT00916032|12852165|P2|STARTED|Overall Study||11
5226916|NCT00916032|12852166|P1|STARTED|Overall Study||12
5226917|NCT00916006|12852208|P2|NOT COMPLETED|Overall Study||7
5226918|NCT00916006|12852209|P1|NOT COMPLETED|Overall Study||3
5226919|NCT00916006|12852208|P2|COMPLETED|Overall Study||127
5226920|NCT00916006|12852209|P1|COMPLETED|Overall Study||132
5226921|NCT00916006|12852208|P2|STARTED|Overall Study||134
5226922|NCT00916006|12852209|P1|STARTED|Overall Study||135
5226923|NCT00915967|12852219|P2|NOT COMPLETED|Overall Study||2
5226924|NCT00915967|12852220|P1|NOT COMPLETED|Overall Study||1
5226925|NCT00915967|12852219|P2|COMPLETED|Overall Study||98
5226926|NCT00915967|12852220|P1|COMPLETED|Overall Study||97
5226927|NCT00915967|12852219|P2|STARTED|Overall Study||100
5226928|NCT00915967|12852220|P1|STARTED|Overall Study||98
5226929|NCT00915954|12852229|P3|NOT COMPLETED|Overall Study||0
5226930|NCT00915954|12852230|P2|NOT COMPLETED|Overall Study||0
5226931|NCT00915954|12852231|P1|NOT COMPLETED|Overall Study||0
5226932|NCT00915954|12852229|P3|COMPLETED|Overall Study||10
5226933|NCT00915954|12852230|P2|COMPLETED|Overall Study||8
5226934|NCT00915954|12852231|P1|COMPLETED|Overall Study||10
5226935|NCT00915954|12852229|P3|STARTED|Overall Study||10
5226936|NCT00915954|12852230|P2|STARTED|Overall Study||8
5226937|NCT00915954|12852231|P1|STARTED|Overall Study||10
5226938|NCT00915902|12852250|P2|NOT COMPLETED|2nd Treatment Period||1
5226939|NCT00915902|12852251|P1|NOT COMPLETED|2nd Treatment Period||0
5226940|NCT00915902|12852250|P2|COMPLETED|2nd Treatment Period||20
5226941|NCT00915902|12852251|P1|COMPLETED|2nd Treatment Period||19
5226942|NCT00915902|12852250|P2|STARTED|2nd Treatment Period||21
5226943|NCT00915902|12852251|P1|STARTED|2nd Treatment Period||19
5226944|NCT00915902|12852250|P2|NOT COMPLETED|Washout (4 Weeks)||1
5226945|NCT00915902|12852251|P1|NOT COMPLETED|Washout (4 Weeks)||0
5226946|NCT00915902|12852250|P2|COMPLETED|Washout (4 Weeks)||21
5226947|NCT00915902|12852251|P1|COMPLETED|Washout (4 Weeks)||19
5226948|NCT00915902|12852250|P2|STARTED|Washout (4 Weeks)||22
5226949|NCT00915902|12852251|P1|STARTED|Washout (4 Weeks)||19
5226950|NCT00915902|12852250|P2|NOT COMPLETED|1st Treatment Period||0
5226951|NCT00915902|12852251|P1|NOT COMPLETED|1st Treatment Period||1
5226952|NCT00915902|12852250|P2|COMPLETED|1st Treatment Period||22
5226953|NCT00915902|12852251|P1|COMPLETED|1st Treatment Period||19
5226954|NCT00915902|12852250|P2|STARTED|1st Treatment Period||22
5226955|NCT00915902|12852251|P1|STARTED|1st Treatment Period||20
5226956|NCT00915876|12852261|P2|NOT COMPLETED|Overall Study||1
5226957|NCT00915876|12852262|P1|NOT COMPLETED|Overall Study||0
5226958|NCT00915876|12852261|P2|COMPLETED|Overall Study||20
5226959|NCT00915876|12852262|P1|COMPLETED|Overall Study||20
5226960|NCT00915876|12852261|P2|Moving Beyond First Dose|Overall Study||20
5226961|NCT00915876|12852262|P1|Moving Beyond First Dose|Overall Study||20
5226962|NCT00915876|12852261|P2|STARTED|Overall Study||21
5226963|NCT00915876|12852262|P1|STARTED|Overall Study||20
5226964|NCT00915798|12852272|P4|NOT COMPLETED|Overall Study||0
5226965|NCT00915798|12852273|P3|NOT COMPLETED|Overall Study||0
5226966|NCT00915798|12852274|P2|NOT COMPLETED|Overall Study||0
5226967|NCT00915798|12852275|P1|NOT COMPLETED|Overall Study||0
5226968|NCT00915798|12852272|P4|COMPLETED|Overall Study||26
5226969|NCT00915798|12852273|P3|COMPLETED|Overall Study||23
5226970|NCT00915798|12852274|P2|COMPLETED|Overall Study||21
5226971|NCT00915798|12852275|P1|COMPLETED|Overall Study||19
5226972|NCT00915798|12852272|P4|STARTED|Overall Study||26
5226973|NCT00915798|12852273|P3|STARTED|Overall Study||23
5226974|NCT00915798|12852274|P2|STARTED|Overall Study||21
5226975|NCT00915798|12852275|P1|STARTED|Overall Study||19
5226976|NCT00915772|12852298|P3|NOT COMPLETED|Overall Study||29
5226977|NCT00915772|12852299|P2|NOT COMPLETED|Overall Study||46
5226978|NCT00915772|12852300|P1|NOT COMPLETED|Overall Study||36
5226979|NCT00915772|12852298|P3|COMPLETED|Overall Study||142
5226980|NCT00915772|12852299|P2|COMPLETED|Overall Study||179
5226981|NCT00915772|12852300|P1|COMPLETED|Overall Study||134
5226982|NCT00915772|12852298|P3|STARTED|Overall Study||171
5226983|NCT00915772|12852299|P2|STARTED|Overall Study||225
5226984|NCT00915772|12852300|P1|STARTED|Overall Study||170
5226985|NCT00915759|12852345|P1|NOT COMPLETED|Overall Study||0
5226986|NCT00915759|12852345|P1|COMPLETED|Overall Study|number of participants|40
5226987|NCT00915759|12852345|P1|STARTED|Overall Study|number of participants|40
5226988|NCT00915655|12852355|P1|NOT COMPLETED|Overall Study||0
5226989|NCT00915655|12852355|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
5226990|NCT00915655|12852355|P1|STARTED|Overall Study||12
5226991|NCT00915603|12852362|P2|NOT COMPLETED|Overall Study||55
5226992|NCT00915603|12852363|P1|NOT COMPLETED|Overall Study||56
5226993|NCT00915603|12852362|P2|COMPLETED|Overall Study||0
5226994|NCT00915603|12852363|P1|COMPLETED|Overall Study||0
5226995|NCT00915603|12852362|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
5226996|NCT00915603|12852363|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
5226997|NCT00915590|12852379|P2|NOT COMPLETED|Overall Study||1
5226998|NCT00915590|12852380|P1|NOT COMPLETED|Overall Study||2
5226999|NCT00915590|12852379|P2|COMPLETED|Overall Study||4
5227000|NCT00915590|12852380|P1|COMPLETED|Overall Study||3
5227001|NCT00915590|12852379|P2|STARTED|Overall Study||5
5227002|NCT00915590|12852380|P1|STARTED|Overall Study||5
5227003|NCT00915551|12852399|P2|NOT COMPLETED|Overall Study||1
5227004|NCT00915551|12852400|P1|NOT COMPLETED|Overall Study||0
5227005|NCT00915551|12852399|P2|COMPLETED|Overall Study||135
5227006|NCT00915551|12852400|P1|COMPLETED|Overall Study||142
5227007|NCT00915551|12852399|P2|STARTED|Overall Study||136
5227008|NCT00915551|12852400|P1|STARTED|Overall Study||142
5227009|NCT00915525|12852410|P2|NOT COMPLETED|Overall Study||135
5227010|NCT00915525|12852411|P1|NOT COMPLETED|Overall Study||265
5227011|NCT00915525|12852410|P2|COMPLETED|Overall Study||151
5227012|NCT00915525|12852411|P1|COMPLETED|Overall Study||278
5227013|NCT00915525|12852410|P2|STARTED|Overall Study||286
5227014|NCT00915525|12852411|P1|STARTED|Overall Study||543
5227015|NCT00915499|12852514|P2|NOT COMPLETED|Overall Study||2
5227016|NCT00915499|12852515|P1|NOT COMPLETED|Overall Study||4
5227017|NCT00915499|12852514|P2|COMPLETED|Overall Study||31
5227018|NCT00915499|12852515|P1|COMPLETED|Overall Study||29
5227019|NCT00915499|12852514|P2|STARTED|Overall Study||33
5227020|NCT00915499|12852515|P1|STARTED|Overall Study||33
5227021|NCT00915473|12852525|P2|NOT COMPLETED|4-week Follow Up||5
5227022|NCT00915473|12852526|P1|NOT COMPLETED|4-week Follow Up||1
5227023|NCT00915473|12852525|P2|COMPLETED|4-week Follow Up||30
5227024|NCT00915473|12852526|P1|COMPLETED|4-week Follow Up||33
5227025|NCT00915473|12852525|P2|STARTED|4-week Follow Up||35
5227026|NCT00915473|12852526|P1|STARTED|4-week Follow Up||34
5227027|NCT00915473|12852525|P2|NOT COMPLETED|Injection||0
5227028|NCT00915473|12852526|P1|NOT COMPLETED|Injection||0
5227029|NCT00915473|12852525|P2|COMPLETED|Injection||35
5227030|NCT00915473|12852526|P1|COMPLETED|Injection||34
5227031|NCT00915473|12852525|P2|STARTED|Injection||35
5227032|NCT00915473|12852526|P1|STARTED|Injection||34
5227033|NCT00915473|12852525|P2|NOT COMPLETED|Screening||0
5227034|NCT00915473|12852526|P1|NOT COMPLETED|Screening||1
5227035|NCT00915473|12852525|P2|COMPLETED|Screening||35
5227036|NCT00915473|12852526|P1|COMPLETED|Screening||34
5227037|NCT00915473|12852525|P2|STARTED|Screening||35
5227038|NCT00915473|12852526|P1|STARTED|Screening||35
5227039|NCT00915356|12852543|P5|NOT COMPLETED|Overall Study||0
5227040|NCT00915356|12852544|P4|NOT COMPLETED|Overall Study||0
5227041|NCT00915356|12852545|P3|NOT COMPLETED|Overall Study||0
5227042|NCT00915356|12852546|P2|NOT COMPLETED|Overall Study||0
5227043|NCT00915356|12852547|P1|NOT COMPLETED|Overall Study||1
5227044|NCT00915356|12852543|P5|COMPLETED|Overall Study||43
5227045|NCT00915356|12852544|P4|COMPLETED|Overall Study||12
5227046|NCT00915356|12852545|P3|COMPLETED|Overall Study||45
5227047|NCT00915356|12852546|P2|COMPLETED|Overall Study||45
5227048|NCT00915356|12852547|P1|COMPLETED|Overall Study||25
5227049|NCT00915356|12852543|P5|STARTED|Overall Study||43
5227050|NCT00915356|12852544|P4|STARTED|Overall Study||12
5227051|NCT00915356|12852545|P3|STARTED|Overall Study||45
5227052|NCT00915356|12852546|P2|STARTED|Overall Study||45
5227053|NCT00915356|12852547|P1|STARTED|Overall Study||26
5227054|NCT00915343|12852609|P3|NOT COMPLETED|Part B - Open Label Period||2
5227055|NCT00915343|12852610|P2|NOT COMPLETED|Part B - Open Label Period||0
5227056|NCT00915343|12852611|P1|NOT COMPLETED|Part B - Open Label Period||0
5227057|NCT00915343|12852609|P3|COMPLETED|Part B - Open Label Period||57
5227058|NCT00915343|12852610|P2|COMPLETED|Part B - Open Label Period||0
5227059|NCT00915343|12852611|P1|COMPLETED|Part B - Open Label Period||0
5227060|NCT00915343|12852609|P3|STARTED|Part B - Open Label Period||59
5227061|NCT00915343|12852610|P2|STARTED|Part B - Open Label Period||0
5227062|NCT00915343|12852611|P1|STARTED|Part B - Open Label Period||0
5227063|NCT00915343|12852609|P3|NOT COMPLETED|Part A - Second Intervention Period||0
5227064|NCT00915343|12852610|P2|NOT COMPLETED|Part A - Second Intervention Period||0
5227065|NCT00915343|12852611|P1|NOT COMPLETED|Part A - Second Intervention Period||0
5227066|NCT00915343|12852609|P3|COMPLETED|Part A - Second Intervention Period||0
5227067|NCT00915343|12852610|P2|COMPLETED|Part A - Second Intervention Period||32
5227068|NCT00915343|12852611|P1|COMPLETED|Part A - Second Intervention Period||32
5227069|NCT00915343|12852609|P3|STARTED|Part A - Second Intervention Period||0
5227070|NCT00915343|12852610|P2|STARTED|Part A - Second Intervention Period||32
5227071|NCT00915343|12852611|P1|STARTED|Part A - Second Intervention Period||32
5227072|NCT00915343|12852609|P3|NOT COMPLETED|Part A - First Intervention Period||0
5227073|NCT00915343|12852610|P2|NOT COMPLETED|Part A - First Intervention Period||0
5227074|NCT00915343|12852611|P1|NOT COMPLETED|Part A - First Intervention Period||0
5227075|NCT00915343|12852609|P3|COMPLETED|Part A - First Intervention Period||0
5227076|NCT00915343|12852610|P2|COMPLETED|Part A - First Intervention Period||32
5227077|NCT00915343|12852611|P1|COMPLETED|Part A - First Intervention Period||32
5227078|NCT00915343|12852609|P3|STARTED|Part A - First Intervention Period||0
5227079|NCT00915343|12852610|P2|STARTED|Part A - First Intervention Period||32
5227080|NCT00915343|12852611|P1|STARTED|Part A - First Intervention Period||32
5227081|NCT00915278|12852696|P6|NOT COMPLETED|Overall Study||8
5227082|NCT00915278|12852697|P5|NOT COMPLETED|Overall Study||2
5227083|NCT00915278|12852698|P4|NOT COMPLETED|Overall Study||3
5227084|NCT00915278|12852699|P3|NOT COMPLETED|Overall Study||1
5227085|NCT00915278|12852700|P2|NOT COMPLETED|Overall Study||3
5227086|NCT00915278|12852701|P1|NOT COMPLETED|Overall Study||5
5227087|NCT00915278|12852696|P6|COMPLETED|Overall Study||1
5227088|NCT00915278|12852697|P5|COMPLETED|Overall Study||1
5227089|NCT00915278|12852698|P4|COMPLETED|Overall Study||2
5227090|NCT00915278|12852699|P3|COMPLETED|Overall Study||2
5227091|NCT00915278|12852700|P2|COMPLETED|Overall Study||2
5227092|NCT00915278|12852701|P1|COMPLETED|Overall Study||3
5227093|NCT00915278|12852696|P6|STARTED|Overall Study||9
5227094|NCT00915278|12852697|P5|STARTED|Overall Study||3
5227095|NCT00915278|12852698|P4|STARTED|Overall Study||5
5227096|NCT00915278|12852699|P3|STARTED|Overall Study||3
5227097|NCT00915278|12852700|P2|STARTED|Overall Study||5
5227098|NCT00915278|12852701|P1|STARTED|Overall Study||8
5227099|NCT00915148|12852847|P1|NOT COMPLETED|Overall Study||0
5227100|NCT00915148|12852847|P1|COMPLETED|Overall Study|August 2010|110
5227101|NCT00915148|12852847|P1|STARTED|Overall Study|October 2009|110
5227102|NCT00915031|12852854|P2|NOT COMPLETED|Overall Study||0
5227103|NCT00915031|12852855|P1|NOT COMPLETED|Overall Study||0
5227104|NCT00915031|12852854|P2|COMPLETED|Overall Study||24
5227105|NCT00915031|12852855|P1|COMPLETED|Overall Study||714
5227106|NCT00915031|12852854|P2|STARTED|Overall Study||24
5227107|NCT00915031|12852855|P1|STARTED|Overall Study||714
5227108|NCT00915018|12852862|P2|NOT COMPLETED|Overall Study||207
5227109|NCT00915018|12852863|P1|NOT COMPLETED|Overall Study||215
5227110|NCT00915018|12852862|P2|COMPLETED|Overall Study||30
5227111|NCT00915018|12852863|P1|COMPLETED|Overall Study||27
5227112|NCT00915018|12852862|P2|Received Treatment|Overall Study||234
5227113|NCT00915018|12852863|P1|Received Treatment|Overall Study||240
5227114|NCT00915018|12852862|P2|STARTED|Overall Study||237
5227115|NCT00915018|12852863|P1|STARTED|Overall Study||242
5227116|NCT00915005|12852879|P2|NOT COMPLETED|Overall Study||19
5227117|NCT00915005|12852880|P1|NOT COMPLETED|Overall Study||13
5227118|NCT00915005|12852879|P2|COMPLETED|Overall Study||57
5227119|NCT00915005|12852880|P1|COMPLETED|Overall Study||92
5227120|NCT00915005|12852879|P2|STARTED|Overall Study||76
5227121|NCT00915005|12852880|P1|STARTED|Overall Study||105
5227122|NCT00914966|12852888|P1|NOT COMPLETED|Step 3: 2500 Units||0
5227123|NCT00914966|12852888|P1|COMPLETED|Step 3: 2500 Units||12
5227124|NCT00914966|12852888|P1|STARTED|Step 3: 2500 Units||12
5227125|NCT00914966|12852888|P1|NOT COMPLETED|Step 2: 2000 Units||1
5227126|NCT00914966|12852888|P1|COMPLETED|Step 2: 2000 Units||12
5227127|NCT00914966|12852888|P1|STARTED|Step 2: 2000 Units||13
5227128|NCT00914966|12852888|P1|NOT COMPLETED|Step 1: 1500 Units||2
5227129|NCT00914966|12852888|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
5227130|NCT00914966|12852888|P1|STARTED|Step 1: 1500 Units||20
5227131|NCT00914927|12852907|P7|NOT COMPLETED|Overall Study||0
5227132|NCT00914927|12852908|P6|NOT COMPLETED|Overall Study||0
5227133|NCT00914927|12852909|P5|NOT COMPLETED|Overall Study||2
5227134|NCT00914927|12852910|P4|NOT COMPLETED|Overall Study||2
5227135|NCT00914927|12852911|P3|NOT COMPLETED|Overall Study||0
5227136|NCT00914927|12852912|P2|NOT COMPLETED|Overall Study||2
5227137|NCT00914927|12852913|P1|NOT COMPLETED|Overall Study||2
5227138|NCT00914927|12852907|P7|COMPLETED|Overall Study||21
5227139|NCT00914927|12852908|P6|COMPLETED|Overall Study||21
5227140|NCT00914927|12852909|P5|COMPLETED|Overall Study||19
5227141|NCT00914927|12852910|P4|COMPLETED|Overall Study||14
5227142|NCT00914927|12852911|P3|COMPLETED|Overall Study||17
5227143|NCT00914927|12852912|P2|COMPLETED|Overall Study||14
5227144|NCT00914927|12852913|P1|COMPLETED|Overall Study||16
5227145|NCT00914927|12852907|P7|STARTED|Overall Study||21
5227146|NCT00914927|12852908|P6|STARTED|Overall Study||21
5227147|NCT00914927|12852909|P5|STARTED|Overall Study||21
5227148|NCT00914927|12852910|P4|STARTED|Overall Study||16
5227149|NCT00914927|12852911|P3|STARTED|Overall Study||17
5227150|NCT00914927|12852912|P2|STARTED|Overall Study||16
5227151|NCT00914927|12852913|P1|STARTED|Overall Study||18
5227152|NCT00914862|12852962|P5|NOT COMPLETED|Overall Study||0
5227153|NCT00914862|12852963|P4|NOT COMPLETED|Overall Study||0
5227154|NCT00914862|12852964|P3|NOT COMPLETED|Overall Study||0
5227155|NCT00914862|12852965|P2|NOT COMPLETED|Overall Study||0
5227156|NCT00914862|12852966|P1|NOT COMPLETED|Overall Study||0
5227157|NCT00914862|12852962|P5|COMPLETED|Overall Study||28
5227158|NCT00914862|12852963|P4|COMPLETED|Overall Study||8
5227159|NCT00914862|12852964|P3|COMPLETED|Overall Study||8
5227160|NCT00914862|12852965|P2|COMPLETED|Overall Study||6
5227161|NCT00914862|12852966|P1|COMPLETED|Overall Study||6
5227162|NCT00914862|12852962|P5|STARTED|Overall Study||28
5227163|NCT00914862|12852963|P4|STARTED|Overall Study||8
5227164|NCT00914862|12852964|P3|STARTED|Overall Study||8
5227165|NCT00914862|12852965|P2|STARTED|Overall Study||6
5227166|NCT00914862|12852966|P1|STARTED|Overall Study||6
5227167|NCT00914849|12853040|P2|NOT COMPLETED|Overall Study||1
5227168|NCT00914849|12853041|P1|NOT COMPLETED|Overall Study||1
5227169|NCT00914849|12853040|P2|COMPLETED|Overall Study||33
5227170|NCT00914849|12853041|P1|COMPLETED|Overall Study||33
5227171|NCT00914849|12853040|P2|STARTED|Overall Study||34
5227172|NCT00914849|12853041|P1|STARTED|Overall Study||34
5227173|NCT00914810|12853075|P2|NOT COMPLETED|Overall Study||1
5227174|NCT00914810|12853076|P1|NOT COMPLETED|Overall Study||2
5227175|NCT00914810|12853075|P2|COMPLETED|Overall Study||18
5227176|NCT00914810|12853076|P1|COMPLETED|Overall Study||18
5227177|NCT00914810|12853075|P2|STARTED|Overall Study||19
5227178|NCT00914810|12853076|P1|STARTED|Overall Study||20
5227179|NCT00914589|12853087|P3|NOT COMPLETED|Overall Study||12
5227180|NCT00914589|12853088|P2|NOT COMPLETED|Overall Study||16
5227181|NCT00914589|12853089|P1|NOT COMPLETED|Overall Study||25
5227182|NCT00914589|12853087|P3|COMPLETED|Overall Study||126
5227183|NCT00914589|12853088|P2|COMPLETED|Overall Study||127
5227184|NCT00914589|12853089|P1|COMPLETED|Overall Study||103
5227185|NCT00914589|12853087|P3|STARTED|Overall Study||138
5227186|NCT00914589|12853088|P2|STARTED|Overall Study||143
5227187|NCT00914589|12853089|P1|STARTED|Overall Study||128
5227188|NCT00914485|12853109|P1|NOT COMPLETED|Overall Study||0
5227189|NCT00914485|12853109|P1|COMPLETED|Overall Study||369
5227190|NCT00914485|12853109|P1|STARTED|Overall Study||369
5227191|NCT00914459|12853115|P2|NOT COMPLETED|Overall Study||1
5227192|NCT00914459|12853116|P1|NOT COMPLETED|Overall Study||1
5227193|NCT00914459|12853115|P2|COMPLETED|Overall Study||18
5227194|NCT00914459|12853116|P1|COMPLETED|Overall Study||17
5227195|NCT00914459|12853115|P2|STARTED|Overall Study||19
5227196|NCT00914459|12853116|P1|STARTED|Overall Study||18
5227197|NCT00914316|12853146|P4|NOT COMPLETED|Phase 2||0
5227198|NCT00914316|12853147|P3|NOT COMPLETED|Phase 2||1
5227199|NCT00914316|12853148|P2|NOT COMPLETED|Phase 2||0
5227200|NCT00914316|12853149|P1|NOT COMPLETED|Phase 2||1
5227201|NCT00914316|12853146|P4|COMPLETED|Phase 2||6
5227202|NCT00914316|12853147|P3|COMPLETED|Phase 2||2
5227203|NCT00914316|12853148|P2|COMPLETED|Phase 2||4
5227204|NCT00914316|12853149|P1|COMPLETED|Phase 2||1
5227205|NCT00914316|12853146|P4|STARTED|Phase 2||6
5227206|NCT00914316|12853147|P3|STARTED|Phase 2||3
5227207|NCT00914316|12853148|P2|STARTED|Phase 2||4
5227208|NCT00914316|12853149|P1|STARTED|Phase 2||2
5227209|NCT00914316|12853146|P4|NOT COMPLETED|Phase 1||2
5227210|NCT00914316|12853147|P3|NOT COMPLETED|Phase 1||5
5227211|NCT00914316|12853148|P2|NOT COMPLETED|Phase 1||2
5227212|NCT00914316|12853149|P1|NOT COMPLETED|Phase 1||5
5227213|NCT00914316|12853146|P4|COMPLETED|Phase 1||6
5227214|NCT00914316|12853147|P3|COMPLETED|Phase 1||3
5227215|NCT00914316|12853148|P2|COMPLETED|Phase 1||4
5227216|NCT00914316|12853149|P1|COMPLETED|Phase 1||2
5227217|NCT00914316|12853146|P4|STARTED|Phase 1||8
5227218|NCT00914316|12853147|P3|STARTED|Phase 1||8
5227219|NCT00914316|12853148|P2|STARTED|Phase 1||6
5227220|NCT00914316|12853149|P1|STARTED|Phase 1||7
5227221|NCT00914186|12853167|P4|NOT COMPLETED|Overall Study||10
5227222|NCT00914186|12853168|P3|NOT COMPLETED|Overall Study||2
5227223|NCT00914186|12853169|P2|NOT COMPLETED|Overall Study||2
5227224|NCT00914186|12853170|P1|NOT COMPLETED|Overall Study||3
5227225|NCT00914186|12853167|P4|COMPLETED|Overall Study||20
5227226|NCT00914186|12853168|P3|COMPLETED|Overall Study||29
5227227|NCT00914186|12853169|P2|COMPLETED|Overall Study||28
5227228|NCT00914186|12853170|P1|COMPLETED|Overall Study||28
5227229|NCT00914186|12853167|P4|STARTED|Overall Study||30
5227230|NCT00914186|12853168|P3|STARTED|Overall Study||31
5227231|NCT00914186|12853169|P2|STARTED|Overall Study||30
5227232|NCT00914186|12853170|P1|STARTED|Overall Study||31
5227233|NCT00914069|12853204|P2|NOT COMPLETED|Overall Study||0
5227234|NCT00914069|12853205|P1|NOT COMPLETED|Overall Study||0
5227235|NCT00914069|12853204|P2|COMPLETED|Overall Study||88
5227236|NCT00914069|12853205|P1|COMPLETED|Overall Study||84
5227237|NCT00914069|12853204|P2|STARTED|Overall Study||88
5227238|NCT00914069|12853205|P1|STARTED|Overall Study||84
5227239|NCT00913978|12853221|P2|NOT COMPLETED|Overall Study||3
5227240|NCT00913978|12853222|P1|NOT COMPLETED|Overall Study||1
5227241|NCT00913978|12853221|P2|COMPLETED|Overall Study||21
5227242|NCT00913978|12853222|P1|COMPLETED|Overall Study||25
5227243|NCT00913978|12853221|P2|STARTED|Overall Study||24
5227244|NCT00913978|12853222|P1|STARTED|Overall Study||26
5227245|NCT00913913|12853230|P1|NOT COMPLETED|Overall Study||8
5227246|NCT00913913|12853230|P1|COMPLETED|Overall Study||0
5227247|NCT00913913|12853230|P1|STARTED|Overall Study||8
5227248|NCT00913835|12853239|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
5227249|NCT00913835|12853240|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
5227250|NCT00913835|12853239|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
5227251|NCT00913835|12853240|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
5227252|NCT00913835|12853239|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
5227253|NCT00913835|12853240|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
5227254|NCT00913835|12853239|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
5227255|NCT00913835|12853240|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
5227256|NCT00913835|12853239|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
5227257|NCT00913835|12853240|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
5227258|NCT00913835|12853239|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
5227259|NCT00913835|12853240|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
5227260|NCT00913835|12853239|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
5227261|NCT00913835|12853240|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
5227262|NCT00913835|12853239|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
5227263|NCT00913835|12853240|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
5227264|NCT00913770|12853279|P3|NOT COMPLETED|Overall Study||21
5227265|NCT00913770|12853280|P2|NOT COMPLETED|Overall Study||29
5227266|NCT00913770|12853281|P1|NOT COMPLETED|Overall Study||35
5227267|NCT00913770|12853279|P3|COMPLETED|Overall Study||93
5227268|NCT00913770|12853280|P2|COMPLETED|Overall Study||82
5227269|NCT00913770|12853281|P1|COMPLETED|Overall Study||69
5227270|NCT00913770|12853279|P3|STARTED|Overall Study||114
5227271|NCT00913770|12853280|P2|STARTED|Overall Study||111
5227272|NCT00913770|12853281|P1|STARTED|Overall Study||104
5227273|NCT00913744|12853294|P2|NOT COMPLETED|Overall Study||1
5227274|NCT00913744|12853295|P1|NOT COMPLETED|Overall Study||5
5227275|NCT00913744|12853294|P2|COMPLETED|Overall Study||24
5227276|NCT00913744|12853295|P1|COMPLETED|Overall Study||70
5227277|NCT00913744|12853294|P2|STARTED|Overall Study||25
5227278|NCT00913744|12853295|P1|STARTED|Overall Study||75
5227279|NCT00913692|12853301|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
5227280|NCT00913692|12853301|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
5227281|NCT00913692|12853301|P1|STARTED|Treatment Phase 2 (5 Months)||1
5227282|NCT00913692|12853301|P1|NOT COMPLETED|Washout (2 Weeks)||0
5227283|NCT00913692|12853301|P1|COMPLETED|Washout (2 Weeks)||1
5227284|NCT00913692|12853301|P1|STARTED|Washout (2 Weeks)||1
5227285|NCT00913692|12853301|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
5227286|NCT00913692|12853301|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
5227287|NCT00913692|12853301|P1|STARTED|Treatment Phase 1 (5 Months)||2
5227288|NCT00913692|12853301|P1|NOT COMPLETED|Screening (4 Months)||9
5227289|NCT00913692|12853301|P1|COMPLETED|Screening (4 Months)||2
5227290|NCT00913692|12853301|P1|STARTED|Screening (4 Months)||11
5227291|NCT00913627|12853315|P4|NOT COMPLETED|Overall Study||0
5227292|NCT00913627|12853316|P3|NOT COMPLETED|Overall Study||0
5227293|NCT00913627|12853317|P2|NOT COMPLETED|Overall Study||0
5227294|NCT00913627|12853318|P1|NOT COMPLETED|Overall Study||0
5227295|NCT00913627|12853315|P4|COMPLETED|Overall Study||58
5227296|NCT00913627|12853316|P3|COMPLETED|Overall Study||56
5227297|NCT00913627|12853317|P2|COMPLETED|Overall Study||53
5227298|NCT00913627|12853318|P1|COMPLETED|Overall Study||29
5227299|NCT00913627|12853315|P4|STARTED|Overall Study||58
5227300|NCT00913627|12853316|P3|STARTED|Overall Study||56
5227301|NCT00913627|12853317|P2|STARTED|Overall Study||53
5227302|NCT00913627|12853318|P1|STARTED|Overall Study||29
5227303|NCT00913523|12853395|P3|NOT COMPLETED|Overall Study||14
5227304|NCT00913523|12853396|P2|NOT COMPLETED|Overall Study||16
5227305|NCT00913523|12853397|P1|NOT COMPLETED|Overall Study||18
5227306|NCT00913523|12853395|P3|COMPLETED|Overall Study||147
5227307|NCT00913523|12853396|P2|COMPLETED|Overall Study||143
5227308|NCT00913523|12853397|P1|COMPLETED|Overall Study||144
5227309|NCT00913523|12853395|P3|STARTED|Overall Study||161
5227310|NCT00913523|12853396|P2|STARTED|Overall Study||159
5227311|NCT00913523|12853397|P1|STARTED|Overall Study||162
5227312|NCT00913510|12853422|P2|NOT COMPLETED|Overall Study||4
5227313|NCT00913510|12853423|P1|NOT COMPLETED|Overall Study||8
5227314|NCT00913510|12853422|P2|COMPLETED|Overall Study||3
5227315|NCT00913510|12853423|P1|COMPLETED|Overall Study||5
5227316|NCT00913510|12853422|P2|STARTED|Overall Study||7
5227317|NCT00913510|12853423|P1|STARTED|Overall Study||13
5227318|NCT00913458|12853429|P7|NOT COMPLETED|Phase 3||8
5227319|NCT00913458|12853430|P6|NOT COMPLETED|Phase 3||18
5227320|NCT00913458|12853431|P5|NOT COMPLETED|Phase 3||22
5227321|NCT00913458|12853432|P4|NOT COMPLETED|Phase 3||0
5227322|NCT00913458|12853433|P3|NOT COMPLETED|Phase 3||0
5227323|NCT00913458|12853434|P2|NOT COMPLETED|Phase 3||0
5227324|NCT00913458|12853435|P1|NOT COMPLETED|Phase 3||0
5227325|NCT00913458|12853429|P7|COMPLETED|Phase 3||24
5227326|NCT00913458|12853430|P6|COMPLETED|Phase 3||28
5227327|NCT00913458|12853431|P5|COMPLETED|Phase 3||31
5227328|NCT00913458|12853432|P4|COMPLETED|Phase 3||0
5227329|NCT00913458|12853433|P3|COMPLETED|Phase 3||0
5227330|NCT00913458|12853434|P2|COMPLETED|Phase 3||0
5227331|NCT00913458|12853435|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
5227332|NCT00913458|12853429|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
5227333|NCT00913458|12853430|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
5227334|NCT00913458|12853431|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
5227335|NCT00913458|12853432|P4|STARTED|Phase 3||0
5227336|NCT00913458|12853433|P3|STARTED|Phase 3||0
5227337|NCT00913458|12853434|P2|STARTED|Phase 3||0
5227424|NCT00913003|12853581|P2|STARTED|Overall Study||11
5227338|NCT00913458|12853435|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
5227339|NCT00913458|12853429|P7|NOT COMPLETED|Phase 2||0
5227340|NCT00913458|12853430|P6|NOT COMPLETED|Phase 2||0
5227341|NCT00913458|12853431|P5|NOT COMPLETED|Phase 2||0
5227342|NCT00913458|12853432|P4|NOT COMPLETED|Phase 2||33
5227343|NCT00913458|12853433|P3|NOT COMPLETED|Phase 2||19
5227344|NCT00913458|12853434|P2|NOT COMPLETED|Phase 2||10
5227345|NCT00913458|12853435|P1|NOT COMPLETED|Phase 2||0
5227346|NCT00913458|12853429|P7|COMPLETED|Phase 2||0
5227347|NCT00913458|12853430|P6|COMPLETED|Phase 2||0
5227348|NCT00913458|12853431|P5|COMPLETED|Phase 2||0
5227349|NCT00913458|12853432|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
5227350|NCT00913458|12853433|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
5227351|NCT00913458|12853434|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
5227352|NCT00913458|12853435|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
5227353|NCT00913458|12853429|P7|STARTED|Phase 2||0
5227354|NCT00913458|12853430|P6|STARTED|Phase 2||0
5227355|NCT00913458|12853431|P5|STARTED|Phase 2||0
5227356|NCT00913458|12853432|P4|STARTED|Phase 2||65
5227357|NCT00913458|12853433|P3|STARTED|Phase 2||65
5227358|NCT00913458|12853434|P2|STARTED|Phase 2||63
5227359|NCT00913458|12853435|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
5227360|NCT00913458|12853429|P7|NOT COMPLETED|Phase 1||0
5227361|NCT00913458|12853430|P6|NOT COMPLETED|Phase 1||0
5227362|NCT00913458|12853431|P5|NOT COMPLETED|Phase 1||0
5227363|NCT00913458|12853432|P4|NOT COMPLETED|Phase 1||0
5227364|NCT00913458|12853433|P3|NOT COMPLETED|Phase 1||0
5227365|NCT00913458|12853434|P2|NOT COMPLETED|Phase 1||0
5227366|NCT00913458|12853435|P1|NOT COMPLETED|Phase 1||112
5227367|NCT00913458|12853429|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
5227368|NCT00913458|12853430|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
5227369|NCT00913458|12853431|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
5227370|NCT00913458|12853432|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
5227371|NCT00913458|12853433|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
5227372|NCT00913458|12853434|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
5227373|NCT00913458|12853435|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
5227374|NCT00913458|12853429|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
5227375|NCT00913458|12853430|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
5227376|NCT00913458|12853431|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
5227377|NCT00913458|12853432|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
5227378|NCT00913458|12853433|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
5227379|NCT00913458|12853434|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
5227380|NCT00913458|12853435|P1|STARTED|Phase 1||306
5227381|NCT00913380|12853528|P2|NOT COMPLETED|Clinical Outcomes||6
5227382|NCT00913380|12853529|P1|NOT COMPLETED|Clinical Outcomes||6
5227383|NCT00913380|12853528|P2|COMPLETED|Clinical Outcomes||441
5227384|NCT00913380|12853529|P1|COMPLETED|Clinical Outcomes||438
5227385|NCT00913380|12853528|P2|STARTED|Clinical Outcomes||447
5227386|NCT00913380|12853529|P1|STARTED|Clinical Outcomes||444
5227387|NCT00913380|12853528|P2|NOT COMPLETED|CT Examination||0
5227388|NCT00913380|12853529|P1|NOT COMPLETED|CT Examination||0
5227389|NCT00913380|12853528|P2|COMPLETED|CT Examination||447
5227390|NCT00913380|12853529|P1|COMPLETED|CT Examination||444
5227391|NCT00913380|12853528|P2|STARTED|CT Examination||447
5227392|NCT00913380|12853529|P1|STARTED|CT Examination||444
5227393|NCT00913263|12853555|P1|NOT COMPLETED|Overall Study||0
5227394|NCT00913263|12853555|P1|COMPLETED|Overall Study||24
5227395|NCT00913263|12853555|P1|STARTED|Overall Study||24
5227396|NCT00913133|12853564|P1|NOT COMPLETED|Overall Study||0
5227397|NCT00913133|12853564|P1|COMPLETED|Overall Study||516
5227398|NCT00913133|12853564|P1|STARTED|Overall Study||516
5227399|NCT00913081|12853569|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
5227400|NCT00913081|12853569|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
5227401|NCT00913081|12853569|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
5227402|NCT00913081|12853569|P1|NOT COMPLETED|Washout #3 (7days)||0
5227403|NCT00913081|12853569|P1|COMPLETED|Washout #3 (7days)||17
5227404|NCT00913081|12853569|P1|STARTED|Washout #3 (7days)||17
5227405|NCT00913081|12853569|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
5227406|NCT00913081|12853569|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
5227407|NCT00913081|12853569|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
5227408|NCT00913081|12853569|P1|NOT COMPLETED|Washout #2 (7 Days)||0
5227409|NCT00913081|12853569|P1|COMPLETED|Washout #2 (7 Days)||17
5227410|NCT00913081|12853569|P1|STARTED|Washout #2 (7 Days)||17
5227411|NCT00913081|12853569|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
5227412|NCT00913081|12853569|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
5227413|NCT00913081|12853569|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
5227414|NCT00913081|12853569|P1|NOT COMPLETED|Washout #1 (7 Days)||0
5227415|NCT00913081|12853569|P1|COMPLETED|Washout #1 (7 Days)||17
5227416|NCT00913081|12853569|P1|STARTED|Washout #1 (7 Days)||17
5227417|NCT00913081|12853569|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
5227418|NCT00913081|12853569|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
5227419|NCT00913081|12853569|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
5227420|NCT00913003|12853581|P2|NOT COMPLETED|Overall Study||0
5227421|NCT00913003|12853582|P1|NOT COMPLETED|Overall Study||0
5227422|NCT00913003|12853581|P2|COMPLETED|Overall Study||11
5227423|NCT00913003|12853582|P1|COMPLETED|Overall Study||11
5227425|NCT00913003|12853582|P1|STARTED|Overall Study||11
5227426|NCT00912964|12853595|P3|NOT COMPLETED|Overall Study||54
5227427|NCT00912964|12853596|P2|NOT COMPLETED|Overall Study||46
5227428|NCT00912964|12853597|P1|NOT COMPLETED|Overall Study||66
5227429|NCT00912964|12853595|P3|COMPLETED|Overall Study||386
5227430|NCT00912964|12853596|P2|COMPLETED|Overall Study||387
5227431|NCT00912964|12853597|P1|COMPLETED|Overall Study||367
5227432|NCT00912964|12853595|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
5227433|NCT00912964|12853596|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
5227434|NCT00912964|12853597|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
5227435|NCT00912964|12853595|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
5227436|NCT00912964|12853596|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
5227437|NCT00912964|12853597|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
5227438|NCT00912964|12853595|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
5227439|NCT00912964|12853596|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
5227440|NCT00912964|12853597|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
5227441|NCT00912964|12853595|P3|STARTED|Overall Study||440
5227442|NCT00912964|12853596|P2|STARTED|Overall Study||433
5227443|NCT00912964|12853597|P1|STARTED|Overall Study||433
5227444|NCT00912925|12853721|P2|NOT COMPLETED|Overall Study||0
5227445|NCT00912925|12853722|P1|NOT COMPLETED|Overall Study||0
5227446|NCT00912925|12853721|P2|COMPLETED|Overall Study||22
5227447|NCT00912925|12853722|P1|COMPLETED|Overall Study||23
5227448|NCT00912925|12853721|P2|STARTED|Overall Study||22
5227449|NCT00912925|12853722|P1|STARTED|Overall Study||23
5227450|NCT00912912|12853740|P1|NOT COMPLETED|Overall Study||4
5227451|NCT00912912|12853740|P1|COMPLETED|Overall Study||1
5227452|NCT00912912|12853740|P1|STARTED|Overall Study||5
5227453|NCT00912808|12853746|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
5227454|NCT00912808|12853747|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
5227455|NCT00912808|12853746|P2|COMPLETED|Second Intervention (6 Weeks)||9
5227456|NCT00912808|12853747|P1|COMPLETED|Second Intervention (6 Weeks)||8
5227457|NCT00912808|12853746|P2|Received Intervention|Second Intervention (6 Weeks)||10
5227458|NCT00912808|12853747|P1|Received Intervention|Second Intervention (6 Weeks)||9
5227459|NCT00912808|12853746|P2|STARTED|Second Intervention (6 Weeks)||10
5227460|NCT00912808|12853747|P1|STARTED|Second Intervention (6 Weeks)||9
5227461|NCT00912808|12853746|P2|NOT COMPLETED|Washout||1
5227462|NCT00912808|12853747|P1|NOT COMPLETED|Washout||0
5227463|NCT00912808|12853746|P2|COMPLETED|Washout||10
5227464|NCT00912808|12853747|P1|COMPLETED|Washout||9
5227465|NCT00912808|12853746|P2|STARTED|Washout||11
5227466|NCT00912808|12853747|P1|STARTED|Washout||9
5227467|NCT00912808|12853746|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
5227468|NCT00912808|12853747|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
5227469|NCT00912808|12853746|P2|COMPLETED|First Intervention (6 Weeks)||11
5227470|NCT00912808|12853747|P1|COMPLETED|First Intervention (6 Weeks)||9
5227471|NCT00912808|12853746|P2|Received Intervention|First Intervention (6 Weeks)||12
5227472|NCT00912808|12853747|P1|Received Intervention|First Intervention (6 Weeks)||11
5227473|NCT00912808|12853746|P2|STARTED|First Intervention (6 Weeks)||12
5227474|NCT00912808|12853747|P1|STARTED|First Intervention (6 Weeks)||11
5227475|NCT00912795|12853757|P2|NOT COMPLETED|Overall Study||58
5227476|NCT00912795|12853758|P1|NOT COMPLETED|Overall Study||47
5227477|NCT00912795|12853757|P2|COMPLETED|Overall Study||17
5227478|NCT00912795|12853758|P1|COMPLETED|Overall Study||29
5227479|NCT00912795|12853757|P2|STARTED|Overall Study||75
5227480|NCT00912795|12853758|P1|STARTED|Overall Study||76
5227481|NCT00912782|12853772|P2|NOT COMPLETED|Overall Study||5
5227482|NCT00912782|12853773|P1|NOT COMPLETED|Overall Study||3
5227483|NCT00912782|12853772|P2|COMPLETED|Overall Study||20
5227484|NCT00912782|12853773|P1|COMPLETED|Overall Study||24
5227485|NCT00912782|12853772|P2|STARTED|Overall Study||25
5227486|NCT00912782|12853773|P1|STARTED|Overall Study||27
5227487|NCT00912743|12853783|P2|NOT COMPLETED|Overall Study||20
5227488|NCT00912743|12853784|P1|NOT COMPLETED|Overall Study||13
5227489|NCT00912743|12853783|P2|COMPLETED|Overall Study||0
5227490|NCT00912743|12853784|P1|COMPLETED|Overall Study||0
5227491|NCT00912743|12853783|P2|STARTED|Overall Study||20
5227492|NCT00912743|12853784|P1|STARTED|Overall Study||13
5227493|NCT00912509|12853796|P2|NOT COMPLETED|Overall Study||3
5227494|NCT00912509|12853797|P1|NOT COMPLETED|Overall Study||5
5227495|NCT00912509|12853796|P2|COMPLETED|Overall Study||7
5227496|NCT00912509|12853797|P1|COMPLETED|Overall Study||15
5227497|NCT00912509|12853796|P2|STARTED|Overall Study||10
5227498|NCT00912509|12853797|P1|STARTED|Overall Study||20
5227499|NCT00912405|12853805|P1|NOT COMPLETED|Overall Study||5
5227500|NCT00912405|12853805|P1|COMPLETED|Overall Study||45
5227501|NCT00912405|12853805|P1|STARTED|Overall Study||50
5227502|NCT00912340|12853815|P3|NOT COMPLETED|Overall Study||4
5227503|NCT00912340|12853816|P2|NOT COMPLETED|Overall Study||4
5227504|NCT00912340|12853817|P1|NOT COMPLETED|Overall Study||2
5227505|NCT00912340|12853815|P3|COMPLETED|Overall Study||0
5227506|NCT00912340|12853816|P2|COMPLETED|Overall Study||26
5227507|NCT00912340|12853817|P1|COMPLETED|Overall Study||22
5227508|NCT00912340|12853815|P3|STARTED|Overall Study||4
5227509|NCT00912340|12853816|P2|STARTED|Overall Study||30
5227510|NCT00912340|12853817|P1|STARTED|Overall Study||24
5227511|NCT00912301|12853831|P3|NOT COMPLETED|Overall Study||0
5227512|NCT00912301|12853832|P2|NOT COMPLETED|Overall Study||0
5227513|NCT00912301|12853833|P1|NOT COMPLETED|Overall Study||0
5227514|NCT00912301|12853831|P3|COMPLETED|Overall Study||13
5227515|NCT00912301|12853832|P2|COMPLETED|Overall Study||12
5227516|NCT00912301|12853833|P1|COMPLETED|Overall Study||11
5227517|NCT00912301|12853831|P3|STARTED|Overall Study||13
5227518|NCT00912301|12853832|P2|STARTED|Overall Study||12
5227519|NCT00912301|12853833|P1|STARTED|Overall Study||11
5227520|NCT00912288|12853855|P2|NOT COMPLETED|Overall Study||40
5227521|NCT00912288|12853856|P1|NOT COMPLETED|Overall Study||41
5227522|NCT00912288|12853855|P2|COMPLETED|Overall Study||2
5227523|NCT00912288|12853856|P1|COMPLETED|Overall Study||3
5227524|NCT00912288|12853855|P2|STARTED|Overall Study||42
5227525|NCT00912288|12853856|P1|STARTED|Overall Study||44
5227526|NCT00912223|12853878|P1|NOT COMPLETED|Overall Study||3
5227527|NCT00912223|12853878|P1|COMPLETED|Overall Study||62
5227528|NCT00912223|12853878|P1|STARTED|Overall Study||65
5227529|NCT00912158|12853897|P3|NOT COMPLETED|Overall Study||0
5227530|NCT00912158|12853898|P2|NOT COMPLETED|Overall Study||0
5227531|NCT00912158|12853899|P1|NOT COMPLETED|Overall Study||0
5227532|NCT00912158|12853897|P3|COMPLETED|Overall Study||41
5227533|NCT00912158|12853898|P2|COMPLETED|Overall Study||44
5227534|NCT00912158|12853899|P1|COMPLETED|Overall Study||44
5227535|NCT00912158|12853897|P3|STARTED|Overall Study||41
5227536|NCT00912158|12853898|P2|STARTED|Overall Study||44
5227537|NCT00912158|12853899|P1|STARTED|Overall Study||44
5227538|NCT00912093|12853909|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
5227539|NCT00912093|12853910|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
5227540|NCT00912093|12853911|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
5227541|NCT00912093|12853912|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
5227542|NCT00912093|12853913|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
5227543|NCT00912093|12853909|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
5227544|NCT00912093|12853910|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
5227545|NCT00912093|12853911|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
5227546|NCT00912093|12853912|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
5227547|NCT00912093|12853913|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
5227548|NCT00912093|12853909|P5|STARTED|The Open Label Extension (OLE) Phase||4
5227549|NCT00912093|12853910|P4|STARTED|The Open Label Extension (OLE) Phase||2
5227550|NCT00912093|12853911|P3|STARTED|The Open Label Extension (OLE) Phase||3
5227551|NCT00912093|12853912|P2|STARTED|The Open Label Extension (OLE) Phase||35
5227552|NCT00912093|12853913|P1|STARTED|The Open Label Extension (OLE) Phase||38
5227553|NCT00912093|12853909|P5|NOT COMPLETED|The Controlled Phase||1
5227554|NCT00912093|12853910|P4|NOT COMPLETED|The Controlled Phase||0
5227555|NCT00912093|12853911|P3|NOT COMPLETED|The Controlled Phase||0
5227556|NCT00912093|12853912|P2|NOT COMPLETED|The Controlled Phase||2
5227557|NCT00912093|12853913|P1|NOT COMPLETED|The Controlled Phase||0
5227558|NCT00912093|12853909|P5|COMPLETED|The Controlled Phase||4
5227559|NCT00912093|12853910|P4|COMPLETED|The Controlled Phase||2
5227560|NCT00912093|12853911|P3|COMPLETED|The Controlled Phase||3
5227561|NCT00912093|12853912|P2|COMPLETED|The Controlled Phase||43
5227562|NCT00912093|12853913|P1|COMPLETED|The Controlled Phase||43
5227563|NCT00912093|12853909|P5|STARTED|The Controlled Phase||5
5227564|NCT00912093|12853910|P4|STARTED|The Controlled Phase||2
5227565|NCT00912093|12853911|P3|STARTED|The Controlled Phase||3
5227566|NCT00912093|12853912|P2|STARTED|The Controlled Phase||45
5227567|NCT00912093|12853913|P1|STARTED|The Controlled Phase||43
5227568|NCT00912028|12853932|P5|NOT COMPLETED|Overall Study||3
5227569|NCT00912028|12853933|P4|NOT COMPLETED|Overall Study||1
5227570|NCT00912028|12853934|P3|NOT COMPLETED|Overall Study||0
5227571|NCT00912028|12853935|P2|NOT COMPLETED|Overall Study||3
5227572|NCT00912028|12853936|P1|NOT COMPLETED|Overall Study||5
5227573|NCT00912028|12853932|P5|COMPLETED|Overall Study||0
5227574|NCT00912028|12853933|P4|COMPLETED|Overall Study||16
5227575|NCT00912028|12853934|P3|COMPLETED|Overall Study||13
5227576|NCT00912028|12853935|P2|COMPLETED|Overall Study||0
5227577|NCT00912028|12853936|P1|COMPLETED|Overall Study||30
5227578|NCT00912028|12853932|P5|STARTED|Overall Study||3
5227579|NCT00912028|12853933|P4|STARTED|Overall Study||17
5227580|NCT00912028|12853934|P3|STARTED|Overall Study||13
5227581|NCT00912028|12853935|P2|STARTED|Overall Study||3
5227582|NCT00912028|12853936|P1|STARTED|Overall Study||35
5227583|NCT00912015|12853965|P4|NOT COMPLETED|Overall Study||2
5227584|NCT00912015|12853966|P3|NOT COMPLETED|Overall Study||3
5227585|NCT00912015|12853967|P2|NOT COMPLETED|Overall Study||8
5227586|NCT00912015|12853968|P1|NOT COMPLETED|Overall Study||16
5227587|NCT00912015|12853965|P4|COMPLETED|Overall Study||0
5227588|NCT00912015|12853966|P3|COMPLETED|Overall Study||22
5227589|NCT00912015|12853967|P2|COMPLETED|Overall Study||62
5227590|NCT00912015|12853968|P1|COMPLETED|Overall Study||125
5227591|NCT00912015|12853965|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
5227592|NCT00912015|12853966|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
5227593|NCT00912015|12853967|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
5227594|NCT00912015|12853968|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
5227595|NCT00912002|12853978|P1|NOT COMPLETED|Overall Study||0
5227596|NCT00912002|12853978|P1|COMPLETED|Overall Study||6
5227597|NCT00912002|12853978|P1|STARTED|Overall Study||6
5227598|NCT00911989|12853984|P1|NOT COMPLETED|Overall Study||1
5227599|NCT00911989|12853984|P1|COMPLETED|Overall Study||3
5227600|NCT00911989|12853984|P1|STARTED|Overall Study||4
5227601|NCT00911937|12853990|P2|NOT COMPLETED|Overall Study||95
5227602|NCT00911937|12853991|P1|NOT COMPLETED|Overall Study||87
5227603|NCT00911937|12853990|P2|COMPLETED|Overall Study||381
5227604|NCT00911937|12853991|P1|COMPLETED|Overall Study||400
5227605|NCT00911937|12853990|P2|Treated|Overall Study||463
5227606|NCT00911937|12853991|P1|Treated|Overall Study||474
5227607|NCT00911937|12853990|P2|STARTED|Overall Study||476
5227608|NCT00911937|12853991|P1|STARTED|Overall Study||487
5227609|NCT00911898|12854051|P1|NOT COMPLETED|Overall Study||0
5227610|NCT00911898|12854051|P1|COMPLETED|Overall Study||20
5227611|NCT00911898|12854051|P1|STARTED|Overall Study||20
5227612|NCT00911859|12854058|P3|NOT COMPLETED|Follow-up Period||41
5227613|NCT00911859|12854059|P2|NOT COMPLETED|Follow-up Period||46
5227614|NCT00911859|12854060|P1|NOT COMPLETED|Follow-up Period||11
5227615|NCT00911859|12854058|P3|COMPLETED|Follow-up Period||11
5227616|NCT00911859|12854059|P2|COMPLETED|Follow-up Period||7
5227617|NCT00911859|12854060|P1|COMPLETED|Follow-up Period||1
5227618|NCT00911859|12854058|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
5227619|NCT00911859|12854059|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
5227620|NCT00911859|12854060|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
5227621|NCT00911859|12854058|P3|NOT COMPLETED|Maintainance Period||21
5227622|NCT00911859|12854059|P2|NOT COMPLETED|Maintainance Period||0
5227623|NCT00911859|12854060|P1|NOT COMPLETED|Maintainance Period||0
5227624|NCT00911859|12854058|P3|COMPLETED|Maintainance Period||0
5227625|NCT00911859|12854059|P2|COMPLETED|Maintainance Period||0
5227626|NCT00911859|12854060|P1|COMPLETED|Maintainance Period||0
5227627|NCT00911859|12854058|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
5227628|NCT00911859|12854059|P2|STARTED|Maintainance Period||0
5227629|NCT00911859|12854060|P1|STARTED|Maintainance Period||0
5227630|NCT00911859|12854058|P3|NOT COMPLETED|Treatment Period||25
5227631|NCT00911859|12854059|P2|NOT COMPLETED|Treatment Period||21
5227632|NCT00911859|12854060|P1|NOT COMPLETED|Treatment Period||8
5227633|NCT00911859|12854058|P3|COMPLETED|Treatment Period||27
5227634|NCT00911859|12854059|P2|COMPLETED|Treatment Period||33
5227635|NCT00911859|12854060|P1|COMPLETED|Treatment Period||4
5227636|NCT00911859|12854058|P3|Received Treatment|Treatment Period||52
5227637|NCT00911859|12854059|P2|Received Treatment|Treatment Period||53
5227638|NCT00911859|12854060|P1|Received Treatment|Treatment Period||12
5227639|NCT00911859|12854058|P3|STARTED|Treatment Period||52
5227640|NCT00911859|12854059|P2|STARTED|Treatment Period||54
5227641|NCT00911859|12854060|P1|STARTED|Treatment Period||12
5227642|NCT00911820|12854086|P2|NOT COMPLETED|Overall Study||43
5227643|NCT00911820|12854087|P1|NOT COMPLETED|Overall Study||45
5227644|NCT00911820|12854086|P2|COMPLETED|Overall Study||0
5227645|NCT00911820|12854087|P1|COMPLETED|Overall Study||0
5227646|NCT00911820|12854086|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
5227647|NCT00911820|12854087|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
5227648|NCT00911820|12854086|P2|STARTED|Overall Study||43
5227649|NCT00911820|12854087|P1|STARTED|Overall Study||45
5227650|NCT00911807|12854104|P3|NOT COMPLETED|Overall Study||23
5227651|NCT00911807|12854105|P2|NOT COMPLETED|Overall Study||18
5227652|NCT00911807|12854106|P1|NOT COMPLETED|Overall Study||17
5227653|NCT00911807|12854104|P3|COMPLETED|Overall Study||52
5227654|NCT00911807|12854105|P2|COMPLETED|Overall Study||52
5227655|NCT00911807|12854106|P1|COMPLETED|Overall Study||55
5227656|NCT00911807|12854104|P3|STARTED|Overall Study||75
5227657|NCT00911807|12854105|P2|STARTED|Overall Study||70
5227658|NCT00911807|12854106|P1|STARTED|Overall Study||72
5227659|NCT00911768|12854116|P2|NOT COMPLETED|Overall Study||4
5227660|NCT00911768|12854117|P1|NOT COMPLETED|Overall Study||6
5227661|NCT00911768|12854116|P2|COMPLETED|Overall Study||46
5227662|NCT00911768|12854117|P1|COMPLETED|Overall Study||44
5227663|NCT00911768|12854116|P2|STARTED|Overall Study||50
5227664|NCT00911768|12854117|P1|STARTED|Overall Study||50
5227665|NCT00911742|12854129|P2|NOT COMPLETED|Treatment Phase II||0
5227666|NCT00911742|12854130|P1|NOT COMPLETED|Treatment Phase II||0
5227667|NCT00911742|12854129|P2|COMPLETED|Treatment Phase II||13
5227668|NCT00911742|12854130|P1|COMPLETED|Treatment Phase II||13
5227669|NCT00911742|12854129|P2|STARTED|Treatment Phase II||13
5227670|NCT00911742|12854130|P1|STARTED|Treatment Phase II||13
5227671|NCT00911742|12854129|P2|NOT COMPLETED|Treatment Phase I||0
5227672|NCT00911742|12854130|P1|NOT COMPLETED|Treatment Phase I||0
5227673|NCT00911742|12854129|P2|COMPLETED|Treatment Phase I||13
5227674|NCT00911742|12854130|P1|COMPLETED|Treatment Phase I||13
5227675|NCT00911742|12854129|P2|STARTED|Treatment Phase I||13
5227676|NCT00911742|12854130|P1|STARTED|Treatment Phase I||13
5227677|NCT00911625|12854146|P2|NOT COMPLETED|Overall Study||0
5227678|NCT00911625|12854147|P1|NOT COMPLETED|Overall Study||7
5227679|NCT00911625|12854146|P2|COMPLETED|Overall Study||57
5227680|NCT00911625|12854147|P1|COMPLETED|Overall Study||50
5227681|NCT00911625|12854146|P2|STARTED|Overall Study||57
5227682|NCT00911625|12854147|P1|STARTED|Overall Study||57
5227683|NCT00911612|12854157|P2|NOT COMPLETED|Overall Study||0
5227684|NCT00911612|12854158|P1|NOT COMPLETED|Overall Study||0
5227685|NCT00911612|12854157|P2|COMPLETED|Overall Study||12
5227686|NCT00911612|12854158|P1|COMPLETED|Overall Study||12
5227687|NCT00911612|12854157|P2|STARTED|Overall Study||12
5227688|NCT00911612|12854158|P1|STARTED|Overall Study||12
5227689|NCT00911547|12854176|P4|NOT COMPLETED|Overall Study||16
5227690|NCT00911547|12854177|P3|NOT COMPLETED|Overall Study||22
5227691|NCT00911547|12854178|P2|NOT COMPLETED|Overall Study||42
5227692|NCT00911547|12854179|P1|NOT COMPLETED|Overall Study||11
5227693|NCT00911547|12854176|P4|COMPLETED|Overall Study||177
5227694|NCT00911547|12854177|P3|COMPLETED|Overall Study||178
5227695|NCT00911547|12854178|P2|COMPLETED|Overall Study||159
5227696|NCT00911547|12854179|P1|COMPLETED|Overall Study||37
5227697|NCT00911547|12854176|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
5227698|NCT00911547|12854177|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
5227699|NCT00911547|12854178|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
5227700|NCT00911547|12854179|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
5227701|NCT00911534|12854207|P2|NOT COMPLETED|Overall Study||16
5227702|NCT00911534|12854208|P1|NOT COMPLETED|Overall Study||15
5227703|NCT00911534|12854207|P2|COMPLETED|Overall Study||137
5227704|NCT00911534|12854208|P1|COMPLETED|Overall Study||132
5227705|NCT00911534|12854207|P2|STARTED|Overall Study|Randomized (treated)|153
5227706|NCT00911534|12854208|P1|STARTED|Overall Study|Randomized (treated)|147
5227707|NCT00911508|12854222|P2|NOT COMPLETED|Overall Study||130
5227708|NCT00911508|12854223|P1|NOT COMPLETED|Overall Study||106
5227709|NCT00911508|12854222|P2|COMPLETED|Overall Study||966
5227710|NCT00911508|12854223|P1|COMPLETED|Overall Study||1002
5227711|NCT00911508|12854222|P2|STARTED|Overall Study||1096
5227712|NCT00911508|12854223|P1|STARTED|Overall Study||1108
5227713|NCT00911495|12854255|P1|NOT COMPLETED|Overall Study||1
5227714|NCT00911495|12854255|P1|COMPLETED|Overall Study||14
5227715|NCT00911495|12854255|P1|STARTED|Overall Study||15
5227716|NCT00911443|12854268|P5|NOT COMPLETED|Overall Study||0
5227717|NCT00911443|12854269|P4|NOT COMPLETED|Overall Study||0
5227718|NCT00911443|12854270|P3|NOT COMPLETED|Overall Study||0
5227719|NCT00911443|12854271|P2|NOT COMPLETED|Overall Study||0
5227720|NCT00911443|12854272|P1|NOT COMPLETED|Overall Study||0
5227721|NCT00911443|12854268|P5|COMPLETED|Overall Study||97
5227722|NCT00911443|12854269|P4|COMPLETED|Overall Study||99
5227723|NCT00911443|12854270|P3|COMPLETED|Overall Study||98
5227724|NCT00911443|12854271|P2|COMPLETED|Overall Study||97
5227725|NCT00911443|12854272|P1|COMPLETED|Overall Study||97
5227726|NCT00911443|12854268|P5|STARTED|Overall Study||97
5227727|NCT00911443|12854269|P4|STARTED|Overall Study||99
5227728|NCT00911443|12854270|P3|STARTED|Overall Study||98
5227729|NCT00911443|12854271|P2|STARTED|Overall Study||97
5227730|NCT00911443|12854272|P1|STARTED|Overall Study||97
5227731|NCT00911326|12854289|P1|NOT COMPLETED|Overall Study||16
5227732|NCT00911326|12854289|P1|COMPLETED|Overall Study||85
5227733|NCT00911326|12854289|P1|STARTED|Overall Study||101
5227734|NCT00911300|12854298|P2|NOT COMPLETED|Overall Study||43
5227735|NCT00911300|12854299|P1|NOT COMPLETED|Overall Study||35
5227736|NCT00911300|12854298|P2|COMPLETED|Overall Study||131
5227737|NCT00911300|12854299|P1|COMPLETED|Overall Study||140
5227738|NCT00911300|12854298|P2|STARTED|Overall Study||174
5227739|NCT00911300|12854299|P1|STARTED|Overall Study||175
5227740|NCT00911274|12854325|P2|NOT COMPLETED|Period 2||0
5227741|NCT00911274|12854326|P1|NOT COMPLETED|Period 2||0
5227742|NCT00911274|12854325|P2|COMPLETED|Period 2||26
5227743|NCT00911274|12854326|P1|COMPLETED|Period 2||27
5227744|NCT00911274|12854325|P2|STARTED|Period 2||26
5227745|NCT00911274|12854326|P1|STARTED|Period 2||27
5227746|NCT00911274|12854325|P2|NOT COMPLETED|Period 1||0
5227747|NCT00911274|12854326|P1|NOT COMPLETED|Period 1||0
5227748|NCT00911274|12854325|P2|COMPLETED|Period 1||26
5227749|NCT00911274|12854326|P1|COMPLETED|Period 1||27
5227750|NCT00911274|12854325|P2|STARTED|Period 1||26
5227751|NCT00911274|12854326|P1|STARTED|Period 1||27
5227752|NCT00911170|12854336|P2|NOT COMPLETED|Long Term Follow-Up||422
5227753|NCT00911170|12854337|P1|NOT COMPLETED|Long Term Follow-Up||423
5227754|NCT00911170|12854336|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
5227755|NCT00911170|12854337|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
5227756|NCT00911170|12854336|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
5227757|NCT00911170|12854337|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
5227758|NCT00911170|12854336|P2|NOT COMPLETED|Treatment Period||37
5227759|NCT00911170|12854337|P1|NOT COMPLETED|Treatment Period||27
5227760|NCT00911170|12854336|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
5227761|NCT00911170|12854337|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
5227762|NCT00911170|12854336|P2|Received Investigational Product|Treatment Period||419
5227763|NCT00911170|12854337|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
5227764|NCT00911170|12854336|P2|Received Bevacizumab|Treatment Period||420
5227765|NCT00911170|12854337|P1|Received Bevacizumab|Treatment Period||423
5227766|NCT00911170|12854336|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
5227767|NCT00911170|12854337|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
5227768|NCT00911170|12854336|P2|STARTED|Treatment Period||423
5227769|NCT00911170|12854337|P1|STARTED|Treatment Period||424
5227770|NCT00911157|12854361|P2|NOT COMPLETED|Overall Study||2
5227771|NCT00911157|12854362|P1|NOT COMPLETED|Overall Study||7
5227772|NCT00911157|12854361|P2|COMPLETED|Overall Study||8
5227773|NCT00911157|12854362|P1|COMPLETED|Overall Study||22
5227774|NCT00911157|12854361|P2|STARTED|Overall Study||10
5227775|NCT00911157|12854362|P1|STARTED|Overall Study||29
5227776|NCT00911144|12854378|P2|NOT COMPLETED|Overall Study||5
5227777|NCT00911144|12854379|P1|NOT COMPLETED|Overall Study||16
5227778|NCT00911144|12854378|P2|COMPLETED|Overall Study||108
5227779|NCT00911144|12854379|P1|COMPLETED|Overall Study||319
5227780|NCT00911144|12854378|P2|STARTED|Overall Study||113
5227781|NCT00911144|12854379|P1|STARTED|Overall Study||335
5227782|NCT00911053|12854408|P5|NOT COMPLETED|Overall Study||0
5227783|NCT00911053|12854409|P4|NOT COMPLETED|Overall Study||0
5227784|NCT00911053|12854410|P3|NOT COMPLETED|Overall Study||0
5227785|NCT00911053|12854411|P2|NOT COMPLETED|Overall Study||0
5227786|NCT00911053|12854412|P1|NOT COMPLETED|Overall Study||0
5227787|NCT00911053|12854408|P5|COMPLETED|Overall Study||0
5227788|NCT00911053|12854409|P4|COMPLETED|Overall Study||0
5227789|NCT00911053|12854410|P3|COMPLETED|Overall Study||0
5227790|NCT00911053|12854411|P2|COMPLETED|Overall Study||0
5227791|NCT00911053|12854412|P1|COMPLETED|Overall Study||0
5227792|NCT00911053|12854408|P5|STARTED|Overall Study||0
5227793|NCT00911053|12854409|P4|STARTED|Overall Study||0
5227794|NCT00911053|12854410|P3|STARTED|Overall Study||0
5227795|NCT00911053|12854411|P2|STARTED|Overall Study||0
5227796|NCT00911053|12854412|P1|STARTED|Overall Study||0
5227797|NCT00910988|12854433|P4|NOT COMPLETED|Overall Study||0
5227798|NCT00910988|12854434|P3|NOT COMPLETED|Overall Study||3
5227799|NCT00910988|12854435|P2|NOT COMPLETED|Overall Study||4
5227800|NCT00910988|12854436|P1|NOT COMPLETED|Overall Study||2
5227801|NCT00910988|12854433|P4|COMPLETED|Overall Study||6
5227802|NCT00910988|12854434|P3|COMPLETED|Overall Study||5
5227803|NCT00910988|12854435|P2|COMPLETED|Overall Study||12
5227804|NCT00910988|12854436|P1|COMPLETED|Overall Study||14
5227805|NCT00910988|12854433|P4|STARTED|Overall Study||6
5227806|NCT00910988|12854434|P3|STARTED|Overall Study||8
5227807|NCT00910988|12854435|P2|STARTED|Overall Study||16
5227808|NCT00910988|12854436|P1|STARTED|Overall Study||16
5227809|NCT00910962|12854481|P3|NOT COMPLETED|Overall Study||76
5227810|NCT00910962|12854482|P2|NOT COMPLETED|Overall Study||78
5227811|NCT00910962|12854483|P1|NOT COMPLETED|Overall Study||43
5227812|NCT00910962|12854481|P3|COMPLETED|Overall Study||116
5227813|NCT00910962|12854482|P2|COMPLETED|Overall Study||121
5227814|NCT00910962|12854483|P1|COMPLETED|Overall Study||92
5227815|NCT00910962|12854481|P3|STARTED|Overall Study||192
5227816|NCT00910962|12854482|P2|STARTED|Overall Study||199
5227817|NCT00910962|12854483|P1|STARTED|Overall Study||135
5227818|NCT00910910|12854575|P2|NOT COMPLETED|Overall Study||224
5227819|NCT00910910|12854576|P1|NOT COMPLETED|Overall Study||225
5227820|NCT00910910|12854575|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
5227821|NCT00910910|12854576|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
5227822|NCT00910910|12854575|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
5227823|NCT00910910|12854576|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
5227824|NCT00910910|12854575|P2|STARTED|Overall Study||225
5227825|NCT00910910|12854576|P1|STARTED|Overall Study||225
5227826|NCT00910871|12854612|P1|NOT COMPLETED|Overall Study||54
5227827|NCT00910871|12854612|P1|COMPLETED|Overall Study||179
5227828|NCT00910871|12854612|P1|STARTED|Overall Study||233
5227829|NCT00910858|12854620|P3|NOT COMPLETED|Combined Treatment Phase||4
5227830|NCT00910858|12854621|P2|NOT COMPLETED|Combined Treatment Phase||10
5227831|NCT00910858|12854622|P1|NOT COMPLETED|Combined Treatment Phase||9
5227832|NCT00910858|12854620|P3|COMPLETED|Combined Treatment Phase||0
5227833|NCT00910858|12854621|P2|COMPLETED|Combined Treatment Phase||0
5227834|NCT00910858|12854622|P1|COMPLETED|Combined Treatment Phase||0
5227835|NCT00910858|12854620|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
5227836|NCT00910858|12854621|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
5227837|NCT00910858|12854622|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
5227838|NCT00910858|12854620|P3|NOT COMPLETED|Monotherapy Phase||7
5227839|NCT00910858|12854621|P2|NOT COMPLETED|Monotherapy Phase||15
5227840|NCT00910858|12854622|P1|NOT COMPLETED|Monotherapy Phase||17
5227841|NCT00910858|12854620|P3|COMPLETED|Monotherapy Phase||0
5227842|NCT00910858|12854621|P2|COMPLETED|Monotherapy Phase||0
5227843|NCT00910858|12854622|P1|COMPLETED|Monotherapy Phase||0
5227844|NCT00910858|12854620|P3|Pharmacokinetic Population|Monotherapy Phase||7
5227845|NCT00910858|12854621|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
5227846|NCT00910858|12854622|P1|Pharmacokinetic Population|Monotherapy Phase||17
5227847|NCT00910858|12854620|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
5227848|NCT00910858|12854621|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
5227849|NCT00910858|12854622|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
5227850|NCT00910858|12854620|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
5227936|NCT00910689|12854815|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
5227851|NCT00910858|12854621|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
5227852|NCT00910858|12854622|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
5227853|NCT00910858|12854620|P3|NOT COMPLETED|Pharmacokinetic Phase||0
5227854|NCT00910858|12854621|P2|NOT COMPLETED|Pharmacokinetic Phase||0
5227855|NCT00910858|12854622|P1|NOT COMPLETED|Pharmacokinetic Phase||1
5227856|NCT00910858|12854620|P3|COMPLETED|Pharmacokinetic Phase||3
5227857|NCT00910858|12854621|P2|COMPLETED|Pharmacokinetic Phase||0
5227858|NCT00910858|12854622|P1|COMPLETED|Pharmacokinetic Phase||8
5227859|NCT00910858|12854620|P3|STARTED|Pharmacokinetic Phase||3
5227860|NCT00910858|12854621|P2|STARTED|Pharmacokinetic Phase||0
5227861|NCT00910858|12854622|P1|STARTED|Pharmacokinetic Phase||9
5227862|NCT00910845|12854647|P2|NOT COMPLETED|Treatment Cycle 2||9
5227863|NCT00910845|12854648|P1|NOT COMPLETED|Treatment Cycle 2||5
5227864|NCT00910845|12854647|P2|COMPLETED|Treatment Cycle 2||203
5227865|NCT00910845|12854648|P1|COMPLETED|Treatment Cycle 2||136
5227866|NCT00910845|12854647|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
5227867|NCT00910845|12854648|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
5227868|NCT00910845|12854647|P2|NOT COMPLETED|Treatment Cycle 1||34
5227869|NCT00910845|12854648|P1|NOT COMPLETED|Treatment Cycle 1||31
5227870|NCT00910845|12854647|P2|COMPLETED|Treatment Cycle 1||243
5227871|NCT00910845|12854648|P1|COMPLETED|Treatment Cycle 1||249
5227872|NCT00910845|12854647|P2|STARTED|Treatment Cycle 1||277
5227873|NCT00910845|12854648|P1|STARTED|Treatment Cycle 1||280
5227874|NCT00910728|12854667|P9|NOT COMPLETED|Overall Study||3
5227875|NCT00910728|12854668|P8|NOT COMPLETED|Overall Study||3
5227876|NCT00910728|12854669|P7|NOT COMPLETED|Overall Study||6
5227877|NCT00910728|12854670|P6|NOT COMPLETED|Overall Study||1
5227878|NCT00910728|12854671|P5|NOT COMPLETED|Overall Study||5
5227879|NCT00910728|12854672|P4|NOT COMPLETED|Overall Study||3
5227880|NCT00910728|12854673|P3|NOT COMPLETED|Overall Study||3
5227881|NCT00910728|12854674|P2|NOT COMPLETED|Overall Study||3
5227882|NCT00910728|12854675|P1|NOT COMPLETED|Overall Study||6
5227883|NCT00910728|12854667|P9|COMPLETED|Overall Study||0
5227884|NCT00910728|12854668|P8|COMPLETED|Overall Study||1
5227885|NCT00910728|12854669|P7|COMPLETED|Overall Study||0
5227886|NCT00910728|12854670|P6|COMPLETED|Overall Study||0
5227887|NCT00910728|12854671|P5|COMPLETED|Overall Study||1
5227888|NCT00910728|12854672|P4|COMPLETED|Overall Study||0
5227889|NCT00910728|12854673|P3|COMPLETED|Overall Study||0
5227890|NCT00910728|12854674|P2|COMPLETED|Overall Study||0
5227891|NCT00910728|12854675|P1|COMPLETED|Overall Study||0
5227892|NCT00910728|12854667|P9|STARTED|Overall Study||3
5227893|NCT00910728|12854668|P8|STARTED|Overall Study||4
5227894|NCT00910728|12854669|P7|STARTED|Overall Study||6
5227895|NCT00910728|12854670|P6|STARTED|Overall Study||1
5227896|NCT00910728|12854671|P5|STARTED|Overall Study||6
5227897|NCT00910728|12854672|P4|STARTED|Overall Study||3
5227898|NCT00910728|12854673|P3|STARTED|Overall Study||3
5227899|NCT00910728|12854674|P2|STARTED|Overall Study||3
5227900|NCT00910728|12854675|P1|STARTED|Overall Study||6
5227901|NCT00910715|12854797|P3|NOT COMPLETED|Overall Study||0
5227902|NCT00910715|12854798|P2|NOT COMPLETED|Overall Study||26
5227903|NCT00910715|12854799|P1|NOT COMPLETED|Overall Study||22
5227904|NCT00910715|12854797|P3|COMPLETED|Overall Study||81
5227905|NCT00910715|12854798|P2|COMPLETED|Overall Study||91
5227906|NCT00910715|12854799|P1|COMPLETED|Overall Study||86
5227907|NCT00910715|12854797|P3|STARTED|Overall Study||81
5227908|NCT00910715|12854798|P2|STARTED|Overall Study||117
5227909|NCT00910715|12854799|P1|STARTED|Overall Study||108
5227910|NCT00910689|12854813|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
5227911|NCT00910689|12854814|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
5227912|NCT00910689|12854815|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
5227913|NCT00910689|12854816|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
5227914|NCT00910689|12854813|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
5227915|NCT00910689|12854814|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
5227916|NCT00910689|12854815|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
5227917|NCT00910689|12854816|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
5227918|NCT00910689|12854813|P4|STARTED|Months 11- 16: Evaluation Period II||41
5227919|NCT00910689|12854814|P3|STARTED|Months 11- 16: Evaluation Period II||35
5227920|NCT00910689|12854815|P2|STARTED|Months 11- 16: Evaluation Period II||35
5227921|NCT00910689|12854816|P1|STARTED|Months 11- 16: Evaluation Period II||40
5227922|NCT00910689|12854813|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
5227923|NCT00910689|12854814|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
5227924|NCT00910689|12854815|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
5227925|NCT00910689|12854816|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
5227926|NCT00910689|12854813|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
5227927|NCT00910689|12854814|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
5227928|NCT00910689|12854815|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
5227929|NCT00910689|12854816|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
5227930|NCT00910689|12854813|P4|STARTED|Months 5 - 10: Evaluation Period I||48
5227931|NCT00910689|12854814|P3|STARTED|Months 5 - 10: Evaluation Period I||42
5227932|NCT00910689|12854815|P2|STARTED|Months 5 - 10: Evaluation Period I||42
5227933|NCT00910689|12854816|P1|STARTED|Months 5 - 10: Evaluation Period I||44
5227934|NCT00910689|12854813|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
5227935|NCT00910689|12854814|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
5227937|NCT00910689|12854816|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
5227938|NCT00910689|12854813|P4|COMPLETED|Month 2- 4: Treatment Period||48
5227939|NCT00910689|12854814|P3|COMPLETED|Month 2- 4: Treatment Period||42
5227940|NCT00910689|12854815|P2|COMPLETED|Month 2- 4: Treatment Period||42
5227941|NCT00910689|12854816|P1|COMPLETED|Month 2- 4: Treatment Period||44
5227942|NCT00910689|12854813|P4|STARTED|Month 2- 4: Treatment Period||59
5227943|NCT00910689|12854814|P3|STARTED|Month 2- 4: Treatment Period||50
5227944|NCT00910689|12854815|P2|STARTED|Month 2- 4: Treatment Period||52
5227945|NCT00910689|12854816|P1|STARTED|Month 2- 4: Treatment Period||53
5227946|NCT00910689|12854813|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
5227947|NCT00910689|12854814|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
5227948|NCT00910689|12854815|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
5227949|NCT00910689|12854816|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
5227950|NCT00910689|12854813|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
5227951|NCT00910689|12854814|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
5227952|NCT00910689|12854815|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
5227953|NCT00910689|12854816|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
5227954|NCT00910689|12854813|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
5227955|NCT00910689|12854814|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
5227956|NCT00910689|12854815|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
5227957|NCT00910689|12854816|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
5227958|NCT00910663|12854848|P2|NOT COMPLETED|Period 2||0
5227959|NCT00910663|12854849|P1|NOT COMPLETED|Period 2||0
5227960|NCT00910663|12854848|P2|COMPLETED|Period 2||29
5227961|NCT00910663|12854849|P1|COMPLETED|Period 2||30
5227962|NCT00910663|12854848|P2|STARTED|Period 2||29
5227963|NCT00910663|12854849|P1|STARTED|Period 2||30
5227964|NCT00910663|12854848|P2|NOT COMPLETED|Period 1||1
5227965|NCT00910663|12854849|P1|NOT COMPLETED|Period 1||0
5227966|NCT00910663|12854848|P2|COMPLETED|Period 1||29
5227967|NCT00910663|12854849|P1|COMPLETED|Period 1||30
5227968|NCT00910663|12854848|P2|STARTED|Period 1||30
5227969|NCT00910663|12854849|P1|STARTED|Period 1||30
5227970|NCT00910624|12854863|P4|NOT COMPLETED|Follow-Up Phase||0
5227971|NCT00910624|12854864|P3|NOT COMPLETED|Follow-Up Phase||4
5227972|NCT00910624|12854865|P2|NOT COMPLETED|Follow-Up Phase||4
5227973|NCT00910624|12854866|P1|NOT COMPLETED|Follow-Up Phase||6
5227974|NCT00910624|12854863|P4|COMPLETED|Follow-Up Phase||2
5227975|NCT00910624|12854864|P3|COMPLETED|Follow-Up Phase||25
5227976|NCT00910624|12854865|P2|COMPLETED|Follow-Up Phase||76
5227977|NCT00910624|12854866|P1|COMPLETED|Follow-Up Phase||42
5227978|NCT00910624|12854863|P4|STARTED|Follow-Up Phase||2
5227979|NCT00910624|12854864|P3|STARTED|Follow-Up Phase||29
5227980|NCT00910624|12854865|P2|STARTED|Follow-Up Phase||80
5227981|NCT00910624|12854866|P1|STARTED|Follow-Up Phase||48
5227982|NCT00910624|12854863|P4|NOT COMPLETED|Treatment Phase||0
5227983|NCT00910624|12854864|P3|NOT COMPLETED|Treatment Phase||9
5227984|NCT00910624|12854865|P2|NOT COMPLETED|Treatment Phase||21
5227985|NCT00910624|12854866|P1|NOT COMPLETED|Treatment Phase||30
5227986|NCT00910624|12854863|P4|COMPLETED|Treatment Phase||2
5227987|NCT00910624|12854864|P3|COMPLETED|Treatment Phase||20
5227988|NCT00910624|12854865|P2|COMPLETED|Treatment Phase||64
5227989|NCT00910624|12854866|P1|COMPLETED|Treatment Phase||22
5227990|NCT00910624|12854863|P4|STARTED|Treatment Phase||2
5227991|NCT00910624|12854864|P3|STARTED|Treatment Phase||29
5227992|NCT00910624|12854865|P2|STARTED|Treatment Phase||85
5227993|NCT00910624|12854866|P1|STARTED|Treatment Phase||52
5227994|NCT00910520|12854880|P2|NOT COMPLETED|Treatment Cycle 2||8
5227995|NCT00910520|12854881|P1|NOT COMPLETED|Treatment Cycle 2||7
5227996|NCT00910520|12854880|P2|COMPLETED|Treatment Cycle 2||215
5227997|NCT00910520|12854881|P1|COMPLETED|Treatment Cycle 2||156
5227998|NCT00910520|12854880|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
5227999|NCT00910520|12854881|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
5228000|NCT00910520|12854880|P2|NOT COMPLETED|Treatment Cycle 1||24
5228001|NCT00910520|12854881|P1|NOT COMPLETED|Treatment Cycle 1||20
5228002|NCT00910520|12854880|P2|COMPLETED|Treatment Cycle 1||247
5228003|NCT00910520|12854881|P1|COMPLETED|Treatment Cycle 1||257
5228004|NCT00910520|12854880|P2|STARTED|Treatment Cycle 1||271
5228005|NCT00910520|12854881|P1|STARTED|Treatment Cycle 1||277
5228006|NCT00910299|12854893|P2|NOT COMPLETED|Overall Study||74
5228007|NCT00910299|12854894|P1|NOT COMPLETED|Overall Study||76
5228008|NCT00910299|12854893|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
5228009|NCT00910299|12854894|P1|COMPLETED|Overall Study||136
5228010|NCT00910299|12854893|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
5228011|NCT00910299|12854894|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
5228012|NCT00910299|12854893|P2|STARTED|Overall Study||211
5228013|NCT00910299|12854894|P1|STARTED|Overall Study||212
5228014|NCT00910273|12854906|P2|NOT COMPLETED|Overall Study||13
5228015|NCT00910273|12854907|P1|NOT COMPLETED|Overall Study||18
5228016|NCT00910273|12854906|P2|COMPLETED|Overall Study||3
5228017|NCT00910273|12854907|P1|COMPLETED|Overall Study||0
5228018|NCT00910273|12854906|P2|STARTED|Overall Study||16
5228019|NCT00910273|12854907|P1|STARTED|Overall Study||18
5228020|NCT00910247|12854957|P1|NOT COMPLETED|Overall Study||69
5228021|NCT00910247|12854957|P1|COMPLETED|Overall Study||205
5228022|NCT00910247|12854957|P1|STARTED|Overall Study||274
5228023|NCT00910208|12854980|P3|NOT COMPLETED|Overall Study||1
5228024|NCT00910208|12854981|P2|NOT COMPLETED|Overall Study||2
5228025|NCT00910208|12854982|P1|NOT COMPLETED|Overall Study||2
5228026|NCT00910208|12854980|P3|COMPLETED|Overall Study||69
5228027|NCT00910208|12854981|P2|COMPLETED|Overall Study||70
5228028|NCT00910208|12854982|P1|COMPLETED|Overall Study||67
5228029|NCT00910208|12854980|P3|STARTED|Overall Study||70
5228030|NCT00910208|12854981|P2|STARTED|Overall Study||72
5228031|NCT00910208|12854982|P1|STARTED|Overall Study||69
5228032|NCT00910091|12855007|P2|NOT COMPLETED|Treatment and Survival||4
5228033|NCT00910091|12855008|P1|NOT COMPLETED|Treatment and Survival||4
5228034|NCT00910091|12855007|P2|COMPLETED|Treatment and Survival||31
5228035|NCT00910091|12855008|P1|COMPLETED|Treatment and Survival||32
5228036|NCT00910091|12855007|P2|STARTED|Treatment and Survival||35
5228037|NCT00910091|12855008|P1|STARTED|Treatment and Survival||36
5228038|NCT00910091|12855007|P2|NOT COMPLETED|Pre-assignment||2
5228039|NCT00910091|12855008|P1|NOT COMPLETED|Pre-assignment||0
5228040|NCT00910091|12855007|P2|COMPLETED|Pre-assignment||35
5228041|NCT00910091|12855008|P1|COMPLETED|Pre-assignment||36
5228042|NCT00910091|12855007|P2|STARTED|Pre-assignment||37
5228043|NCT00910091|12855008|P1|STARTED|Pre-assignment||36
5228044|NCT00910039|12855036|P1|NOT COMPLETED|Overall Study||1
5228045|NCT00910039|12855036|P1|COMPLETED|Overall Study||13
5228046|NCT00910039|12855036|P1|STARTED|Overall Study||14
5228047|NCT00910000|12855053|P6|NOT COMPLETED|Overall Study||1
5228048|NCT00910000|12855054|P5|NOT COMPLETED|Overall Study||1
5228049|NCT00910000|12855055|P4|NOT COMPLETED|Overall Study||2
5228050|NCT00910000|12855056|P3|NOT COMPLETED|Overall Study||3
5228051|NCT00910000|12855057|P2|NOT COMPLETED|Overall Study||3
5228052|NCT00910000|12855058|P1|NOT COMPLETED|Overall Study||0
5228053|NCT00910000|12855053|P6|COMPLETED|Overall Study||0
5228054|NCT00910000|12855054|P5|COMPLETED|Overall Study||2
5228055|NCT00910000|12855055|P4|COMPLETED|Overall Study||0
5228056|NCT00910000|12855056|P3|COMPLETED|Overall Study||0
5228057|NCT00910000|12855057|P2|COMPLETED|Overall Study||0
5228058|NCT00910000|12855058|P1|COMPLETED|Overall Study||3
5228059|NCT00910000|12855053|P6|STARTED|Overall Study||1
5228060|NCT00910000|12855054|P5|STARTED|Overall Study||3
5228061|NCT00910000|12855055|P4|STARTED|Overall Study||2
5228062|NCT00910000|12855056|P3|STARTED|Overall Study||3
5228063|NCT00910000|12855057|P2|STARTED|Overall Study||3
5228064|NCT00910000|12855058|P1|STARTED|Overall Study||3
5228065|NCT00909870|12855076|P2|NOT COMPLETED|Overall Study||27
5228066|NCT00909870|12855077|P1|NOT COMPLETED|Overall Study||23
5228067|NCT00909870|12855076|P2|COMPLETED|Overall Study||236
5228068|NCT00909870|12855077|P1|COMPLETED|Overall Study||251
5228069|NCT00909870|12855076|P2|STARTED|Overall Study||263
5228070|NCT00909870|12855077|P1|STARTED|Overall Study||274
5228071|NCT00909857|12855089|P2|NOT COMPLETED|Overall Study||45
5228072|NCT00909857|12855090|P1|NOT COMPLETED|Overall Study||36
5228073|NCT00909857|12855089|P2|COMPLETED|Overall Study||209
5228074|NCT00909857|12855090|P1|COMPLETED|Overall Study||217
5228075|NCT00909857|12855089|P2|Treated|Overall Study||230
5228076|NCT00909857|12855090|P1|Treated|Overall Study||234
5228077|NCT00909857|12855089|P2|STARTED|Overall Study||254
5228078|NCT00909857|12855090|P1|STARTED|Overall Study||253
5228079|NCT00909844|12855230|P1|NOT COMPLETED|Overall Study||4
5228080|NCT00909844|12855230|P1|COMPLETED|Overall Study||31
5228081|NCT00909844|12855230|P1|STARTED|Overall Study||35
5228082|NCT00909792|12855248|P2|NOT COMPLETED|Period 2||1
5228083|NCT00909792|12855249|P1|NOT COMPLETED|Period 2||1
5228084|NCT00909792|12855248|P2|COMPLETED|Period 2||124
5228085|NCT00909792|12855249|P1|COMPLETED|Period 2||128
5228086|NCT00909792|12855248|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
5228087|NCT00909792|12855249|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
5228088|NCT00909792|12855248|P2|NOT COMPLETED|Period 1||1
5228089|NCT00909792|12855249|P1|NOT COMPLETED|Period 1||0
5228090|NCT00909792|12855248|P2|COMPLETED|Period 1||127
5228091|NCT00909792|12855249|P1|COMPLETED|Period 1||130
5228092|NCT00909792|12855248|P2|STARTED|Period 1||128
5228093|NCT00909792|12855249|P1|STARTED|Period 1||130
5228094|NCT00909779|12855257|P2|NOT COMPLETED|Overall Study||165
5228095|NCT00909779|12855258|P1|NOT COMPLETED|Overall Study||210
5228096|NCT00909779|12855257|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
5228097|NCT00909779|12855258|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
5228098|NCT00909779|12855257|P2|STARTED|Overall Study||420
5228099|NCT00909779|12855258|P1|STARTED|Overall Study||421
5228100|NCT00909753|12855282|P2|NOT COMPLETED|Period: Second Intervention||0
5228101|NCT00909753|12855283|P1|NOT COMPLETED|Period: Second Intervention||1
5228102|NCT00909753|12855282|P2|COMPLETED|Period: Second Intervention||43
5228103|NCT00909753|12855283|P1|COMPLETED|Period: Second Intervention||43
5228104|NCT00909753|12855282|P2|STARTED|Period: Second Intervention||43
5228105|NCT00909753|12855283|P1|STARTED|Period: Second Intervention||44
5228106|NCT00909753|12855282|P2|NOT COMPLETED|Period: Washout of 28 Days||3
5228107|NCT00909753|12855283|P1|NOT COMPLETED|Period: Washout of 28 Days||2
5228108|NCT00909753|12855282|P2|COMPLETED|Period: Washout of 28 Days||43
5228109|NCT00909753|12855283|P1|COMPLETED|Period: Washout of 28 Days||44
5228110|NCT00909753|12855282|P2|STARTED|Period: Washout of 28 Days||46
5228111|NCT00909753|12855283|P1|STARTED|Period: Washout of 28 Days||46
5228112|NCT00909753|12855282|P2|NOT COMPLETED|Period: First Intervention||0
5228113|NCT00909753|12855283|P1|NOT COMPLETED|Period: First Intervention||0
5228114|NCT00909753|12855282|P2|COMPLETED|Period: First Intervention||46
5228115|NCT00909753|12855283|P1|COMPLETED|Period: First Intervention||46
5228116|NCT00909753|12855282|P2|STARTED|Period: First Intervention||46
5228117|NCT00909753|12855283|P1|STARTED|Period: First Intervention||46
5228118|NCT00909727|12855303|P2|NOT COMPLETED|Overall Study||0
5228119|NCT00909727|12855304|P1|NOT COMPLETED|Overall Study||4
5228120|NCT00909727|12855303|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
5228121|NCT00909727|12855304|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
5228122|NCT00909727|12855303|P2|Completed Treatment Period, Week 24|Overall Study||26
5228123|NCT00909727|12855304|P1|Completed Treatment Period, Week 24|Overall Study||23
5228124|NCT00909727|12855303|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
5228125|NCT00909727|12855304|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
5228126|NCT00909649|12855320|P2|NOT COMPLETED|Overall Study||0
5228127|NCT00909649|12855321|P1|NOT COMPLETED|Overall Study||0
5228128|NCT00909649|12855320|P2|COMPLETED|Overall Study||25
5228129|NCT00909649|12855321|P1|COMPLETED|Overall Study||25
5228130|NCT00909649|12855320|P2|STARTED|Overall Study||25
5228131|NCT00909649|12855321|P1|STARTED|Overall Study||25
5228132|NCT00909610|12855327|P2|NOT COMPLETED|Period: Second Intervention||0
5228133|NCT00909610|12855328|P1|NOT COMPLETED|Period: Second Intervention||1
5228134|NCT00909610|12855327|P2|COMPLETED|Period: Second Intervention||33
5228135|NCT00909610|12855328|P1|COMPLETED|Period: Second Intervention||36
5228136|NCT00909610|12855327|P2|STARTED|Period: Second Intervention||33
5228137|NCT00909610|12855328|P1|STARTED|Period: Second Intervention||37
5228138|NCT00909610|12855327|P2|NOT COMPLETED|Period: Washout of 28 Days||6
5228139|NCT00909610|12855328|P1|NOT COMPLETED|Period: Washout of 28 Days||3
5228140|NCT00909610|12855327|P2|COMPLETED|Period: Washout of 28 Days||33
5228141|NCT00909610|12855328|P1|COMPLETED|Period: Washout of 28 Days||37
5228142|NCT00909610|12855327|P2|STARTED|Period: Washout of 28 Days||39
5228143|NCT00909610|12855328|P1|STARTED|Period: Washout of 28 Days||40
5228144|NCT00909610|12855327|P2|NOT COMPLETED|Period: First Intervention||1
5228145|NCT00909610|12855328|P1|NOT COMPLETED|Period: First Intervention||0
5228146|NCT00909610|12855327|P2|COMPLETED|Period: First Intervention||39
5228147|NCT00909610|12855328|P1|COMPLETED|Period: First Intervention||40
5228148|NCT00909610|12855327|P2|STARTED|Period: First Intervention||40
5228149|NCT00909610|12855328|P1|STARTED|Period: First Intervention||40
5228150|NCT00909545|12855350|P4|NOT COMPLETED|Overall Study||5
5228151|NCT00909545|12855351|P3|NOT COMPLETED|Overall Study||1
5228152|NCT00909545|12855352|P2|NOT COMPLETED|Overall Study||1
5228153|NCT00909545|12855353|P1|NOT COMPLETED|Overall Study||1
5228154|NCT00909545|12855350|P4|COMPLETED|Overall Study||19
5228155|NCT00909545|12855351|P3|COMPLETED|Overall Study||25
5228156|NCT00909545|12855352|P2|COMPLETED|Overall Study||22
5228157|NCT00909545|12855353|P1|COMPLETED|Overall Study||25
5228158|NCT00909545|12855350|P4|STARTED|Overall Study||24
5228159|NCT00909545|12855351|P3|STARTED|Overall Study||26
5228160|NCT00909545|12855352|P2|STARTED|Overall Study||23
5228161|NCT00909545|12855353|P1|STARTED|Overall Study||26
5228162|NCT00909532|12855489|P2|NOT COMPLETED|Overall Study||6
5228163|NCT00909532|12855490|P1|NOT COMPLETED|Overall Study||10
5228164|NCT00909532|12855489|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
5228165|NCT00909532|12855490|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
5228166|NCT00909532|12855489|P2|Completed Treatment Period, Week 24|Overall Study||80
5228167|NCT00909532|12855490|P1|Completed Treatment Period, Week 24|Overall Study||71
5228168|NCT00909532|12855489|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
5228169|NCT00909532|12855490|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
5228170|NCT00909480|12855508|P2|NOT COMPLETED|Overall Study||41
5228171|NCT00909480|12855509|P1|NOT COMPLETED|Overall Study||38
5228172|NCT00909480|12855508|P2|COMPLETED|Overall Study||188
5228173|NCT00909480|12855509|P1|COMPLETED|Overall Study||190
5228174|NCT00909480|12855508|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
5228175|NCT00909480|12855509|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
5228176|NCT00909480|12855508|P2|STARTED|Overall Study||229
5228177|NCT00909480|12855509|P1|STARTED|Overall Study||228
5228178|NCT00909428|12855544|P3|NOT COMPLETED|Overall Study||9
5228179|NCT00909428|12855545|P2|NOT COMPLETED|Overall Study||10
5228180|NCT00909428|12855546|P1|NOT COMPLETED|Overall Study||13
5228181|NCT00909428|12855544|P3|COMPLETED|Overall Study||0
5228182|NCT00909428|12855545|P2|COMPLETED|Overall Study||5
5228183|NCT00909428|12855546|P1|COMPLETED|Overall Study||5
5228184|NCT00909428|12855544|P3|STARTED|Overall Study||9
5228185|NCT00909428|12855545|P2|STARTED|Overall Study||15
5228186|NCT00909428|12855546|P1|STARTED|Overall Study||18
5228187|NCT00909389|12855553|P1|NOT COMPLETED|Overall Study||133
5228188|NCT00909389|12855553|P1|COMPLETED|Overall Study||4615
5228189|NCT00909389|12855553|P1|STARTED|Overall Study||4748
5228190|NCT00909363|12855560|P3|NOT COMPLETED|Overall Study||0
5228191|NCT00909363|12855561|P2|NOT COMPLETED|Overall Study||0
5228192|NCT00909363|12855562|P1|NOT COMPLETED|Overall Study||2
5228193|NCT00909363|12855560|P3|COMPLETED|Overall Study||5
5228194|NCT00909363|12855561|P2|COMPLETED|Overall Study||8
5228195|NCT00909363|12855562|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
5228196|NCT00909363|12855560|P3|STARTED|Overall Study||5
5228197|NCT00909363|12855561|P2|STARTED|Overall Study||8
5228198|NCT00909363|12855562|P1|STARTED|Overall Study||11
5228199|NCT00909324|12855581|P2|NOT COMPLETED|Overall Study||0
5228200|NCT00909324|12855582|P1|NOT COMPLETED|Overall Study||0
5228201|NCT00909324|12855581|P2|COMPLETED|Overall Study||90
5228202|NCT00909324|12855582|P1|COMPLETED|Overall Study||72
5228203|NCT00909324|12855581|P2|STARTED|Overall Study||90
5228204|NCT00909324|12855582|P1|STARTED|Overall Study||72
5228205|NCT00909220|12855594|P2|NOT COMPLETED|Overall Study||0
5228206|NCT00909220|12855595|P1|NOT COMPLETED|Overall Study||0
5228207|NCT00909220|12855594|P2|COMPLETED|Overall Study||36
5228208|NCT00909220|12855595|P1|COMPLETED|Overall Study||41
5228209|NCT00909220|12855594|P2|Submission for Publication|Overall Study||36
5228210|NCT00909220|12855595|P1|Submission for Publication|Overall Study||41
5228211|NCT00909220|12855594|P2|Data Analyses|Overall Study||36
5228212|NCT00909220|12855595|P1|Data Analyses|Overall Study||41
5228213|NCT00909220|12855594|P2|Data Entry|Overall Study||36
5228214|NCT00909220|12855595|P1|Data Entry|Overall Study||41
5228215|NCT00909220|12855594|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
5228216|NCT00909220|12855595|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
5228217|NCT00909181|12855609|P3|NOT COMPLETED|Overall Study||33
5228218|NCT00909181|12855610|P2|NOT COMPLETED|Overall Study||18
5228219|NCT00909181|12855611|P1|NOT COMPLETED|Overall Study||39
5228220|NCT00909181|12855609|P3|COMPLETED|Overall Study||169
5228221|NCT00909181|12855610|P2|COMPLETED|Overall Study||196
5228222|NCT00909181|12855611|P1|COMPLETED|Overall Study||171
5228223|NCT00909181|12855609|P3|STARTED|Overall Study||202
5228224|NCT00909181|12855610|P2|STARTED|Overall Study||214
5228225|NCT00909181|12855611|P1|STARTED|Overall Study||210
5228226|NCT00909155|12855622|P3|NOT COMPLETED|Overall Study||7
5228227|NCT00909155|12855623|P2|NOT COMPLETED|Overall Study||5
5228228|NCT00909155|12855624|P1|NOT COMPLETED|Overall Study||3
5228229|NCT00909155|12855622|P3|COMPLETED|Overall Study||14
5228230|NCT00909155|12855623|P2|COMPLETED|Overall Study||9
5228231|NCT00909155|12855624|P1|COMPLETED|Overall Study||12
5228232|NCT00909155|12855622|P3|STARTED|Overall Study||21
5228233|NCT00909155|12855623|P2|STARTED|Overall Study||14
5228234|NCT00909155|12855624|P1|STARTED|Overall Study||15
5228235|NCT00909090|12855637|P2|NOT COMPLETED|Overall Study||17
5228236|NCT00909090|12855638|P1|NOT COMPLETED|Overall Study||17
5228237|NCT00909090|12855637|P2|COMPLETED|Overall Study||39
5228238|NCT00909090|12855638|P1|COMPLETED|Overall Study||36
5228239|NCT00909090|12855637|P2|STARTED|Overall Study||56
5228240|NCT00909090|12855638|P1|STARTED|Overall Study||53
5228241|NCT00909064|12855650|P1|NOT COMPLETED|Overall Study||0
5228242|NCT00909064|12855650|P1|COMPLETED|Overall Study||114
5228243|NCT00909064|12855650|P1|STARTED|Overall Study||114
5228244|NCT00909038|12855656|P1|NOT COMPLETED|Overall Study||417
5228245|NCT00909038|12855656|P1|COMPLETED|Overall Study||1994
5228246|NCT00909038|12855656|P1|STARTED|Overall Study||2411
5228247|NCT00908960|12855668|P3|NOT COMPLETED|Overall Study||2
5228248|NCT00908960|12855669|P2|NOT COMPLETED|Overall Study||1
5228249|NCT00908960|12855670|P1|NOT COMPLETED|Overall Study||1
5228250|NCT00908960|12855668|P3|COMPLETED|Overall Study||32
5228251|NCT00908960|12855669|P2|COMPLETED|Overall Study||11
5228252|NCT00908960|12855670|P1|COMPLETED|Overall Study||23
5228253|NCT00908960|12855668|P3|Evaluable|Overall Study||32
5228254|NCT00908960|12855669|P2|Evaluable|Overall Study||11
5228255|NCT00908960|12855670|P1|Evaluable|Overall Study||23
5228256|NCT00908960|12855668|P3|STARTED|Overall Study||34
5228257|NCT00908960|12855669|P2|STARTED|Overall Study||12
5228258|NCT00908960|12855670|P1|STARTED|Overall Study||24
5228259|NCT00908947|12855684|P1|NOT COMPLETED|Overall Study||90
5228260|NCT00908947|12855684|P1|COMPLETED|Overall Study||83
5228261|NCT00908947|12855684|P1|STARTED|Overall Study||173
5228262|NCT00908908|12855706|P1|NOT COMPLETED|Overall Study||0
5228263|NCT00908908|12855706|P1|COMPLETED|Overall Study||6
5228264|NCT00908908|12855706|P1|Physician Decision|Overall Study||0
5228265|NCT00908908|12855706|P1|Administrative/Other|Overall Study||0
5228266|NCT00908908|12855706|P1|Withdrawl by Subject|Overall Study||0
5228267|NCT00908908|12855706|P1|Adverse Event|Overall Study||0
5228268|NCT00908908|12855706|P1|STARTED|Overall Study||6
5228269|NCT00908895|12855714|P2|NOT COMPLETED|Overall Study||6
5228270|NCT00908895|12855715|P1|NOT COMPLETED|Overall Study||4
5228271|NCT00908895|12855714|P2|COMPLETED|Overall Study||57
5228272|NCT00908895|12855715|P1|COMPLETED|Overall Study||53
5228273|NCT00908895|12855714|P2|STARTED|Overall Study||63
5228274|NCT00908895|12855715|P1|STARTED|Overall Study||57
5228275|NCT00908882|12855725|P2|NOT COMPLETED|Overall Study||30
5228276|NCT00908882|12855726|P1|NOT COMPLETED|Overall Study||28
5228277|NCT00908882|12855725|P2|COMPLETED|Overall Study||59
5228278|NCT00908882|12855726|P1|COMPLETED|Overall Study||61
5228279|NCT00908882|12855725|P2|STARTED|Overall Study||89
5228280|NCT00908882|12855726|P1|STARTED|Overall Study||89
5228281|NCT00908830|12855752|P2|NOT COMPLETED|Overall Study||0
5228282|NCT00908830|12855753|P1|NOT COMPLETED|Overall Study||0
5228283|NCT00908830|12855752|P2|COMPLETED|Overall Study||5
5228284|NCT00908830|12855753|P1|COMPLETED|Overall Study||5
5228285|NCT00908830|12855752|P2|STARTED|Overall Study||5
5228286|NCT00908830|12855753|P1|STARTED|Overall Study||5
5228287|NCT00908791|12855761|P1|NOT COMPLETED|Overall Study||0
5228288|NCT00908791|12855761|P1|COMPLETED|Overall Study||24
5228289|NCT00908791|12855761|P1|STARTED|Overall Study||24
5228290|NCT00908687|12855784|P6|NOT COMPLETED|Overall Study||6
5228291|NCT00908687|12855785|P5|NOT COMPLETED|Overall Study||4
5228292|NCT00908687|12855786|P4|NOT COMPLETED|Overall Study||3
5228293|NCT00908687|12855787|P3|NOT COMPLETED|Overall Study||3
5228294|NCT00908687|12855788|P2|NOT COMPLETED|Overall Study||1
5228295|NCT00908687|12855789|P1|NOT COMPLETED|Overall Study||1
5228296|NCT00908687|12855784|P6|COMPLETED|Overall Study||94
5228297|NCT00908687|12855785|P5|COMPLETED|Overall Study||94
5228298|NCT00908687|12855786|P4|COMPLETED|Overall Study||47
5228299|NCT00908687|12855787|P3|COMPLETED|Overall Study||99
5228300|NCT00908687|12855788|P2|COMPLETED|Overall Study||99
5228301|NCT00908687|12855789|P1|COMPLETED|Overall Study||49
5228302|NCT00908687|12855784|P6|STARTED|Overall Study||100
5228303|NCT00908687|12855785|P5|STARTED|Overall Study||98
5228304|NCT00908687|12855786|P4|STARTED|Overall Study||50
5228305|NCT00908687|12855787|P3|STARTED|Overall Study||102
5228306|NCT00908687|12855788|P2|STARTED|Overall Study||100
5228307|NCT00908687|12855789|P1|STARTED|Overall Study||50
5228308|NCT00908648|12855805|P2|NOT COMPLETED|Overall Study||0
5228309|NCT00908648|12855806|P1|NOT COMPLETED|Overall Study||0
5228310|NCT00908648|12855805|P2|COMPLETED|Overall Study||103
5228311|NCT00908648|12855806|P1|COMPLETED|Overall Study||108
5228312|NCT00908648|12855805|P2|STARTED|Overall Study||103
5228313|NCT00908648|12855806|P1|STARTED|Overall Study||108
5228314|NCT00908596|12855816|P4|NOT COMPLETED|Overall Study||37
5228315|NCT00908596|12855817|P3|NOT COMPLETED|Overall Study||74
5228316|NCT00908596|12855818|P2|NOT COMPLETED|Overall Study||13
5228317|NCT00908596|12855819|P1|NOT COMPLETED|Overall Study||47
5228318|NCT00908596|12855816|P4|COMPLETED|Overall Study||48
5228319|NCT00908596|12855817|P3|COMPLETED|Overall Study||119
5228320|NCT00908596|12855818|P2|COMPLETED|Overall Study||19
5228321|NCT00908596|12855819|P1|COMPLETED|Overall Study||0
5228322|NCT00908596|12855816|P4|STARTED|Overall Study||85
5228323|NCT00908596|12855817|P3|STARTED|Overall Study||193
5228324|NCT00908596|12855818|P2|STARTED|Overall Study||32
5228325|NCT00908596|12855819|P1|STARTED|Overall Study||47
5228326|NCT00908583|12855849|P1|NOT COMPLETED|Phase 5||3
5228327|NCT00908583|12855849|P1|COMPLETED|Phase 5||2
5228328|NCT00908583|12855849|P1|STARTED|Phase 5||5
5228329|NCT00908583|12855849|P1|NOT COMPLETED|Phase 4||2
5228330|NCT00908583|12855849|P1|COMPLETED|Phase 4||3
5228331|NCT00908583|12855849|P1|STARTED|Phase 4||5
5228332|NCT00908583|12855849|P1|NOT COMPLETED|Phase 3||2
5228333|NCT00908583|12855849|P1|COMPLETED|Phase 3||8
5228334|NCT00908583|12855849|P1|STARTED|Phase 3||10
5228335|NCT00908583|12855849|P1|NOT COMPLETED|Phase 2||2
5228336|NCT00908583|12855849|P1|COMPLETED|Phase 2||10
5228337|NCT00908583|12855849|P1|STARTED|Phase 2||12
5228338|NCT00908583|12855849|P1|NOT COMPLETED|Phase 1||5
5228339|NCT00908583|12855849|P1|COMPLETED|Phase 1||15
5228340|NCT00908583|12855849|P1|STARTED|Phase 1||20
5228341|NCT00908544|12855869|P2|NOT COMPLETED|Overall Study||6
5228342|NCT00908544|12855870|P1|NOT COMPLETED|Overall Study||5
5228343|NCT00908544|12855869|P2|COMPLETED|Overall Study||16
5228344|NCT00908544|12855870|P1|COMPLETED|Overall Study||15
5228345|NCT00908544|12855869|P2|STARTED|Overall Study||22
5228346|NCT00908544|12855870|P1|STARTED|Overall Study||20
5228347|NCT00908466|12855912|P2|NOT COMPLETED|Overall Study||1
5228348|NCT00908466|12855913|P1|NOT COMPLETED|Overall Study||1
5228349|NCT00908466|12855912|P2|COMPLETED|Overall Study||14
5228350|NCT00908466|12855913|P1|COMPLETED|Overall Study||14
5228351|NCT00908466|12855912|P2|STARTED|Overall Study||15
5228352|NCT00908466|12855913|P1|STARTED|Overall Study||15
5228353|NCT00908388|12855919|P1|NOT COMPLETED|Overall Study||10
5228354|NCT00908388|12855919|P1|COMPLETED|Overall Study||40
5228355|NCT00908388|12855919|P1|STARTED|Overall Study||50
5228356|NCT00908375|12855929|P2|NOT COMPLETED|Overall Study||10
5228357|NCT00908375|12855930|P1|NOT COMPLETED|Overall Study||10
5228358|NCT00908375|12855929|P2|COMPLETED|Overall Study||9
5228359|NCT00908375|12855930|P1|COMPLETED|Overall Study||10
5228360|NCT00908375|12855929|P2|STARTED|Overall Study||19
5228361|NCT00908375|12855930|P1|STARTED|Overall Study||20
5228362|NCT00908349|12855940|P1|NOT COMPLETED|Overall Study||35
5228363|NCT00908349|12855940|P1|COMPLETED|Overall Study||179
5228364|NCT00908349|12855940|P1|STARTED|Overall Study||214
5228365|NCT00908310|12855944|P1|NOT COMPLETED|Overall Study||60
5228366|NCT00908310|12855944|P1|COMPLETED|Overall Study||153
5228367|NCT00908310|12855944|P1|STARTED|Overall Study||213
5228368|NCT00908232|12855948|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
5228369|NCT00908232|12855949|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
5228370|NCT00908232|12855950|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
5228371|NCT00908232|12855951|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
5228372|NCT00908232|12855948|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
5228373|NCT00908232|12855949|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
5228374|NCT00908232|12855950|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
5228375|NCT00908232|12855951|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
5228376|NCT00908232|12855948|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
5228377|NCT00908232|12855949|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
5228378|NCT00908232|12855950|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
5228379|NCT00908232|12855951|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
5228380|NCT00908232|12855948|P4|NOT COMPLETED|Cycle 1 to 4||0
5228381|NCT00908232|12855949|P3|NOT COMPLETED|Cycle 1 to 4||0
5228382|NCT00908232|12855950|P2|NOT COMPLETED|Cycle 1 to 4||0
5228383|NCT00908232|12855951|P1|NOT COMPLETED|Cycle 1 to 4||28
5228384|NCT00908232|12855948|P4|COMPLETED|Cycle 1 to 4||0
5228385|NCT00908232|12855949|P3|COMPLETED|Cycle 1 to 4||0
5228386|NCT00908232|12855950|P2|COMPLETED|Cycle 1 to 4||0
5228387|NCT00908232|12855951|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
5228388|NCT00908232|12855948|P4|STARTED|Cycle 1 to 4||0
5228389|NCT00908232|12855949|P3|STARTED|Cycle 1 to 4||0
5228390|NCT00908232|12855950|P2|STARTED|Cycle 1 to 4||0
5228391|NCT00908232|12855951|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
5228392|NCT00908141|12855969|P2|NOT COMPLETED|Overall Study||1
5228393|NCT00908141|12855970|P1|NOT COMPLETED|Overall Study||0
5228394|NCT00908141|12855969|P2|COMPLETED|Overall Study||8
5228395|NCT00908141|12855970|P1|COMPLETED|Overall Study||8
5228396|NCT00908141|12855969|P2|STARTED|Overall Study||9
5228397|NCT00908141|12855970|P1|STARTED|Overall Study||8
5228398|NCT00908128|12855978|P2|NOT COMPLETED|Period 4||0
5228399|NCT00908128|12855979|P1|NOT COMPLETED|Period 4||0
5228400|NCT00908128|12855978|P2|COMPLETED|Period 4||19
5228401|NCT00908128|12855979|P1|COMPLETED|Period 4||20
5228402|NCT00908128|12855978|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
5228403|NCT00908128|12855979|P1|STARTED|Period 4||20
5228404|NCT00908128|12855978|P2|NOT COMPLETED|Period 3||0
5228405|NCT00908128|12855979|P1|NOT COMPLETED|Period 3||0
5228406|NCT00908128|12855978|P2|COMPLETED|Period 3||20
5228407|NCT00908128|12855979|P1|COMPLETED|Period 3||20
5228408|NCT00908128|12855978|P2|STARTED|Period 3||20
5228409|NCT00908128|12855979|P1|STARTED|Period 3||20
5228410|NCT00908128|12855978|P2|NOT COMPLETED|Period 2||0
5228411|NCT00908128|12855979|P1|NOT COMPLETED|Period 2||0
5228412|NCT00908128|12855978|P2|COMPLETED|Period 2||20
5228413|NCT00908128|12855979|P1|COMPLETED|Period 2||20
5228414|NCT00908128|12855978|P2|STARTED|Period 2||20
5228415|NCT00908128|12855979|P1|STARTED|Period 2||20
5228416|NCT00908128|12855978|P2|NOT COMPLETED|Period 1||0
5228417|NCT00908128|12855979|P1|NOT COMPLETED|Period 1||0
5228418|NCT00908128|12855978|P2|COMPLETED|Period 1||20
5228419|NCT00908128|12855979|P1|COMPLETED|Period 1||20
5228420|NCT00908128|12855978|P2|STARTED|Period 1||20
5228421|NCT00908128|12855979|P1|STARTED|Period 1||20
5228422|NCT00908115|12855987|P1|NOT COMPLETED|Overall Study||14
5228423|NCT00908115|12855987|P1|COMPLETED|Overall Study||1244
5228424|NCT00908115|12855987|P1|STARTED|Overall Study||1258
5228425|NCT00908076|12855995|P2|NOT COMPLETED|Overall Study||1
5228426|NCT00908076|12855996|P1|NOT COMPLETED|Overall Study||1
5228427|NCT00908076|12855995|P2|COMPLETED|Overall Study||26
5228428|NCT00908076|12855996|P1|COMPLETED|Overall Study||26
5228429|NCT00908076|12855995|P2|STARTED|Overall Study||27
5228430|NCT00908076|12855996|P1|STARTED|Overall Study||27
5228431|NCT00908037|12856009|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
5228432|NCT00908037|12856010|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
5228433|NCT00908037|12856011|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
5228434|NCT00908037|12856012|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228435|NCT00908037|12856013|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228436|NCT00908037|12856014|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228437|NCT00908037|12856015|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228438|NCT00908037|12856016|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228439|NCT00908037|12856017|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228440|NCT00908037|12856018|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228441|NCT00908037|12856019|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228442|NCT00908037|12856020|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228443|NCT00908037|12856009|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
5228444|NCT00908037|12856010|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
5228445|NCT00908037|12856011|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
5228446|NCT00908037|12856012|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228447|NCT00908037|12856013|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228448|NCT00908037|12856014|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228449|NCT00908037|12856015|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228450|NCT00908037|12856016|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228451|NCT00908037|12856017|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228452|NCT00908037|12856018|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228453|NCT00908037|12856019|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228454|NCT00908037|12856020|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
5228455|NCT00908037|12856009|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
5228456|NCT00908037|12856010|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
5228457|NCT00908037|12856011|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
5228458|NCT00908037|12856012|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228459|NCT00908037|12856013|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228460|NCT00908037|12856014|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228461|NCT00908037|12856015|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228462|NCT00908037|12856016|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228463|NCT00908037|12856017|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228464|NCT00908037|12856018|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228465|NCT00908037|12856019|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228466|NCT00908037|12856020|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
5228467|NCT00908037|12856009|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228468|NCT00908037|12856010|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228469|NCT00908037|12856011|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228470|NCT00908037|12856012|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
5228471|NCT00908037|12856013|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228472|NCT00908037|12856014|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
5228473|NCT00908037|12856015|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228474|NCT00908037|12856016|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
5228475|NCT00908037|12856017|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
5228476|NCT00908037|12856018|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228477|NCT00908037|12856019|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228478|NCT00908037|12856020|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
5228479|NCT00908037|12856009|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228480|NCT00908037|12856010|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228481|NCT00908037|12856011|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228482|NCT00908037|12856012|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
5228483|NCT00908037|12856013|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
5228484|NCT00908037|12856014|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
5228485|NCT00908037|12856015|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
5228486|NCT00908037|12856016|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
5228487|NCT00908037|12856017|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
5228488|NCT00908037|12856018|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228489|NCT00908037|12856019|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228490|NCT00908037|12856020|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
5228491|NCT00908037|12856009|P12|STARTED|Part 2 (7 Week Randomized Period)||0
5228492|NCT00908037|12856010|P11|STARTED|Part 2 (7 Week Randomized Period)||0
5228493|NCT00908037|12856011|P10|STARTED|Part 2 (7 Week Randomized Period)||0
5228494|NCT00908037|12856012|P9|STARTED|Part 2 (7 Week Randomized Period)||10
5228495|NCT00908037|12856013|P8|STARTED|Part 2 (7 Week Randomized Period)||5
5228496|NCT00908037|12856014|P7|STARTED|Part 2 (7 Week Randomized Period)||19
5228497|NCT00908037|12856015|P6|STARTED|Part 2 (7 Week Randomized Period)||9
5228498|NCT00908037|12856016|P5|STARTED|Part 2 (7 Week Randomized Period)||16
5228499|NCT00908037|12856017|P4|STARTED|Part 2 (7 Week Randomized Period)||8
5228500|NCT00908037|12856018|P3|STARTED|Part 2 (7 Week Randomized Period)||0
5228501|NCT00908037|12856019|P2|STARTED|Part 2 (7 Week Randomized Period)||0
5228502|NCT00908037|12856020|P1|STARTED|Part 2 (7 Week Randomized Period)||0
5228503|NCT00908037|12856009|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228504|NCT00908037|12856010|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228505|NCT00908037|12856011|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228506|NCT00908037|12856012|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228507|NCT00908037|12856013|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228508|NCT00908037|12856014|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228509|NCT00908037|12856015|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228510|NCT00908037|12856016|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228511|NCT00908037|12856017|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228512|NCT00908037|12856018|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228513|NCT00908037|12856019|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228514|NCT00908037|12856020|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228515|NCT00908037|12856009|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228516|NCT00908037|12856010|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228517|NCT00908037|12856011|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228518|NCT00908037|12856012|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228519|NCT00908037|12856013|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228520|NCT00908037|12856014|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228521|NCT00908037|12856015|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228522|NCT00908037|12856016|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228523|NCT00908037|12856017|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
5228524|NCT00908037|12856018|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
5228525|NCT00908037|12856019|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
5228526|NCT00908037|12856020|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
5228527|NCT00908037|12856009|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228528|NCT00908037|12856010|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228529|NCT00908037|12856011|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228530|NCT00908037|12856012|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228531|NCT00908037|12856013|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228532|NCT00908037|12856014|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228533|NCT00908037|12856015|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228534|NCT00908037|12856016|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228535|NCT00908037|12856017|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
5228536|NCT00908037|12856018|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
5228537|NCT00908037|12856019|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
5228538|NCT00908037|12856020|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
5228539|NCT00908011|12856169|P2|NOT COMPLETED|Overall Study||2
5228540|NCT00908011|12856170|P1|NOT COMPLETED|Overall Study||2
5228541|NCT00908011|12856169|P2|COMPLETED|Overall Study||18
5228542|NCT00908011|12856170|P1|COMPLETED|Overall Study||21
5228543|NCT00908011|12856169|P2|STARTED|Overall Study||20
5228544|NCT00908011|12856170|P1|STARTED|Overall Study||23
5228545|NCT00907907|12856178|P2|NOT COMPLETED|Period 4||0
5228546|NCT00907907|12856179|P1|NOT COMPLETED|Period 4||0
5228547|NCT00907907|12856178|P2|COMPLETED|Period 4||18
5228548|NCT00907907|12856179|P1|COMPLETED|Period 4||19
5228549|NCT00907907|12856178|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
5228550|NCT00907907|12856179|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
5228551|NCT00907907|12856178|P2|NOT COMPLETED|Period 3||0
5228552|NCT00907907|12856179|P1|NOT COMPLETED|Period 3||0
5228553|NCT00907907|12856178|P2|COMPLETED|Period 3||20
5228554|NCT00907907|12856179|P1|COMPLETED|Period 3||20
5228555|NCT00907907|12856178|P2|STARTED|Period 3||20
5228556|NCT00907907|12856179|P1|STARTED|Period 3||20
5228557|NCT00907907|12856178|P2|NOT COMPLETED|Period 2||0
5228558|NCT00907907|12856179|P1|NOT COMPLETED|Period 2||0
5228559|NCT00907907|12856178|P2|COMPLETED|Period 2||20
5228560|NCT00907907|12856179|P1|COMPLETED|Period 2||20
5228561|NCT00907907|12856178|P2|STARTED|Period 2||20
5228562|NCT00907907|12856179|P1|STARTED|Period 2||20
5228563|NCT00907907|12856178|P2|NOT COMPLETED|Period 1||0
5228564|NCT00907907|12856179|P1|NOT COMPLETED|Period 1||0
5228565|NCT00907907|12856178|P2|COMPLETED|Period 1||20
5228566|NCT00907907|12856179|P1|COMPLETED|Period 1||20
5228567|NCT00907907|12856178|P2|STARTED|Period 1||20
5228568|NCT00907907|12856179|P1|STARTED|Period 1||20
5228569|NCT00907881|12856187|P1|NOT COMPLETED|Overall Study||85
5228570|NCT00907881|12856187|P1|COMPLETED|Overall Study||984
5228571|NCT00907881|12856187|P1|STARTED|Overall Study||1069
5228572|NCT00907803|12856197|P3|NOT COMPLETED|Overall Study||0
5228573|NCT00907803|12856198|P2|NOT COMPLETED|Overall Study||3
5228574|NCT00907803|12856199|P1|NOT COMPLETED|Overall Study||3
5228575|NCT00907803|12856197|P3|COMPLETED|Overall Study||16
5228576|NCT00907803|12856198|P2|COMPLETED|Overall Study||43
5228577|NCT00907803|12856199|P1|COMPLETED|Overall Study||42
5228578|NCT00907803|12856197|P3|STARTED|Overall Study||16
5228579|NCT00907803|12856198|P2|STARTED|Overall Study||46
5228580|NCT00907803|12856199|P1|STARTED|Overall Study||45
5228581|NCT00907777|12856230|P2|NOT COMPLETED|Overall Study||1
5228582|NCT00907777|12856231|P1|NOT COMPLETED|Overall Study||0
5228583|NCT00907777|12856230|P2|COMPLETED|Overall Study||26
5228584|NCT00907777|12856231|P1|COMPLETED|Overall Study||25
5228585|NCT00907777|12856230|P2|STARTED|Overall Study||27
5228586|NCT00907777|12856231|P1|STARTED|Overall Study||25
5228587|NCT00907738|12856258|P5|NOT COMPLETED|Overall Study||2
5228588|NCT00907738|12856259|P4|NOT COMPLETED|Overall Study||4
5228589|NCT00907738|12856260|P3|NOT COMPLETED|Overall Study||7
5228590|NCT00907738|12856261|P2|NOT COMPLETED|Overall Study||1
5228591|NCT00907738|12856262|P1|NOT COMPLETED|Overall Study||13
5228592|NCT00907738|12856258|P5|COMPLETED|Overall Study||0
5228593|NCT00907738|12856259|P4|COMPLETED|Overall Study||0
5228594|NCT00907738|12856260|P3|COMPLETED|Overall Study||0
5228595|NCT00907738|12856261|P2|COMPLETED|Overall Study||0
5228596|NCT00907738|12856262|P1|COMPLETED|Overall Study||0
5228597|NCT00907738|12856258|P5|STARTED|Overall Study||2
5228598|NCT00907738|12856259|P4|STARTED|Overall Study||4
5228599|NCT00907738|12856260|P3|STARTED|Overall Study||7
5228600|NCT00907738|12856261|P2|STARTED|Overall Study||1
5228601|NCT00907738|12856262|P1|STARTED|Overall Study||13
5228602|NCT00907621|12856280|P2|NOT COMPLETED|Overall Study||4
5228603|NCT00907621|12856281|P1|NOT COMPLETED|Overall Study||7
5228604|NCT00907621|12856280|P2|COMPLETED|Overall Study||41
5228605|NCT00907621|12856281|P1|COMPLETED|Overall Study||38
5228606|NCT00907621|12856280|P2|STARTED|Overall Study||45
5228607|NCT00907621|12856281|P1|STARTED|Overall Study||45
5228608|NCT00907517|12856294|P5|NOT COMPLETED|Overall Study||5
5228609|NCT00907517|12856295|P4|NOT COMPLETED|Overall Study||4
5228610|NCT00907517|12856296|P3|NOT COMPLETED|Overall Study||4
5228611|NCT00907517|12856297|P2|NOT COMPLETED|Overall Study||3
5228612|NCT00907517|12856298|P1|NOT COMPLETED|Overall Study||3
5228613|NCT00907517|12856294|P5|COMPLETED|Overall Study||1
5228614|NCT00907517|12856295|P4|COMPLETED|Overall Study||2
5228615|NCT00907517|12856296|P3|COMPLETED|Overall Study||2
5228616|NCT00907517|12856297|P2|COMPLETED|Overall Study||0
5228617|NCT00907517|12856298|P1|COMPLETED|Overall Study||0
5228618|NCT00907517|12856294|P5|STARTED|Overall Study||6
5228619|NCT00907517|12856295|P4|STARTED|Overall Study||6
5228620|NCT00907517|12856296|P3|STARTED|Overall Study||6
5228621|NCT00907517|12856297|P2|STARTED|Overall Study||3
5228622|NCT00907517|12856298|P1|STARTED|Overall Study||3
5228623|NCT00907478|12856323|P3|NOT COMPLETED|Overall Study||22
5228624|NCT00907478|12856324|P2|NOT COMPLETED|Overall Study||17
5228625|NCT00907478|12856325|P1|NOT COMPLETED|Overall Study||27
5228626|NCT00907478|12856323|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
5228627|NCT00907478|12856324|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
5228628|NCT00907478|12856325|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
5228629|NCT00907478|12856323|P3|STARTED|Overall Study||69
5228630|NCT00907478|12856324|P2|STARTED|Overall Study||50
5228631|NCT00907478|12856325|P1|STARTED|Overall Study||50
5228632|NCT00907426|12856356|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
5228633|NCT00907426|12856357|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
5228634|NCT00907426|12856358|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
5228635|NCT00907426|12856356|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
5228636|NCT00907426|12856357|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
5228637|NCT00907426|12856358|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
5228638|NCT00907426|12856356|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
5228639|NCT00907426|12856357|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
5228640|NCT00907426|12856358|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
5228641|NCT00907426|12856356|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
5228642|NCT00907426|12856357|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
5228643|NCT00907426|12856358|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
5228644|NCT00907426|12856356|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
5228645|NCT00907426|12856357|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
5228646|NCT00907426|12856358|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
5228647|NCT00907426|12856356|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
5228648|NCT00907426|12856357|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
5228649|NCT00907426|12856358|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
5228650|NCT00907374|12856375|P2|NOT COMPLETED|Overall Study||2
5228651|NCT00907374|12856376|P1|NOT COMPLETED|Overall Study||2
5228652|NCT00907374|12856375|P2|COMPLETED|Overall Study||11
5228653|NCT00907374|12856376|P1|COMPLETED|Overall Study||12
5228654|NCT00907374|12856375|P2|STARTED|Overall Study||13
5228655|NCT00907374|12856376|P1|STARTED|Overall Study||14
5228656|NCT00907335|12856390|P2|NOT COMPLETED|Overall Study||1
5228657|NCT00907335|12856391|P1|NOT COMPLETED|Overall Study||8
5228658|NCT00907335|12856390|P2|COMPLETED|Overall Study||54
5228659|NCT00907335|12856391|P1|COMPLETED|Overall Study||47
5228660|NCT00907335|12856390|P2|STARTED|Overall Study||55
5228661|NCT00907335|12856391|P1|STARTED|Overall Study||55
5228662|NCT00907296|12856417|P10|NOT COMPLETED|Overall Study||7
5228663|NCT00907296|12856418|P9|NOT COMPLETED|Overall Study||4
5228664|NCT00907296|12856419|P8|NOT COMPLETED|Overall Study||7
5228665|NCT00907296|12856420|P7|NOT COMPLETED|Overall Study||6
5228666|NCT00907296|12856421|P6|NOT COMPLETED|Overall Study||9
5228667|NCT00907296|12856422|P5|NOT COMPLETED|Overall Study||1
5228668|NCT00907296|12856423|P4|NOT COMPLETED|Overall Study||4
5228669|NCT00907296|12856424|P3|NOT COMPLETED|Overall Study||2
5228670|NCT00907296|12856425|P2|NOT COMPLETED|Overall Study||5
5228671|NCT00907296|12856426|P1|NOT COMPLETED|Overall Study||20
5228672|NCT00907296|12856417|P10|COMPLETED|Overall Study||28
5228673|NCT00907296|12856418|P9|COMPLETED|Overall Study||27
5228674|NCT00907296|12856419|P8|COMPLETED|Overall Study||26
5228675|NCT00907296|12856420|P7|COMPLETED|Overall Study||27
5228676|NCT00907296|12856421|P6|COMPLETED|Overall Study||24
5228677|NCT00907296|12856422|P5|COMPLETED|Overall Study||32
5228678|NCT00907296|12856423|P4|COMPLETED|Overall Study||29
5228679|NCT00907296|12856424|P3|COMPLETED|Overall Study||32
5228680|NCT00907296|12856425|P2|COMPLETED|Overall Study||29
5228681|NCT00907296|12856426|P1|COMPLETED|Overall Study||83
5228682|NCT00907296|12856417|P10|Received Treatment|Overall Study||35
5228683|NCT00907296|12856418|P9|Received Treatment|Overall Study||30
5228684|NCT00907296|12856419|P8|Received Treatment|Overall Study||32
5228685|NCT00907296|12856420|P7|Received Treatment|Overall Study||31
5228686|NCT00907296|12856421|P6|Received Treatment|Overall Study||32
5228687|NCT00907296|12856422|P5|Received Treatment|Overall Study||33
5228688|NCT00907296|12856423|P4|Received Treatment|Overall Study||32
5228689|NCT00907296|12856424|P3|Received Treatment|Overall Study||34
5228690|NCT00907296|12856425|P2|Received Treatment|Overall Study||34
5228691|NCT00907296|12856426|P1|Received Treatment|Overall Study||100
5228692|NCT00907296|12856417|P10|STARTED|Overall Study||35
5228693|NCT00907296|12856418|P9|STARTED|Overall Study||31
5228694|NCT00907296|12856419|P8|STARTED|Overall Study||33
5228695|NCT00907296|12856420|P7|STARTED|Overall Study||33
5228696|NCT00907296|12856421|P6|STARTED|Overall Study||33
5228697|NCT00907296|12856422|P5|STARTED|Overall Study||33
5228698|NCT00907296|12856423|P4|STARTED|Overall Study||33
5228699|NCT00907296|12856424|P3|STARTED|Overall Study||34
5228700|NCT00907296|12856425|P2|STARTED|Overall Study||34
5228701|NCT00907296|12856426|P1|STARTED|Overall Study||103
5228702|NCT00907257|12856480|P2|NOT COMPLETED|Overall Study||12
5228703|NCT00907257|12856481|P1|NOT COMPLETED|Overall Study||13
5228704|NCT00907257|12856480|P2|COMPLETED|Overall Study||112
5228705|NCT00907257|12856481|P1|COMPLETED|Overall Study||110
5228706|NCT00907257|12856480|P2|STARTED|Overall Study||124
5228707|NCT00907257|12856481|P1|STARTED|Overall Study||123
5228708|NCT00907218|12856491|P1|NOT COMPLETED|Overall Study||0
5228709|NCT00907218|12856491|P1|COMPLETED|Overall Study||2
5228710|NCT00907218|12856491|P1|STARTED|Overall Study||2
5228711|NCT00907153|12856503|P2|NOT COMPLETED|Overall Study||4
5228712|NCT00907153|12856504|P1|NOT COMPLETED|Overall Study||2
5228713|NCT00907153|12856503|P2|COMPLETED|Overall Study||11
5228714|NCT00907153|12856504|P1|COMPLETED|Overall Study||11
5228715|NCT00907153|12856503|P2|STARTED|Overall Study||15
5228716|NCT00907153|12856504|P1|STARTED|Overall Study||13
5228717|NCT00907101|12856546|P1|NOT COMPLETED|Overall Study||0
5228718|NCT00907101|12856546|P1|COMPLETED|Overall Study||30
5228719|NCT00907101|12856546|P1|STARTED|Overall Study||30
5228720|NCT00907088|12856556|P2|NOT COMPLETED|Overall Study||30
5228721|NCT00907088|12856557|P1|NOT COMPLETED|Overall Study||20
5228722|NCT00907088|12856556|P2|COMPLETED|Overall Study||99
5228723|NCT00907088|12856557|P1|COMPLETED|Overall Study||102
5228724|NCT00907088|12856556|P2|STARTED|Overall Study||129
5228725|NCT00907088|12856557|P1|STARTED|Overall Study||122
5228726|NCT00906971|12856565|P2|NOT COMPLETED|Overall Study||3
5228727|NCT00906971|12856566|P1|NOT COMPLETED|Overall Study||8
5228728|NCT00906971|12856565|P2|COMPLETED|Overall Study||33
5228729|NCT00906971|12856566|P1|COMPLETED|Overall Study||28
5228730|NCT00906971|12856565|P2|STARTED|Overall Study||36
5228731|NCT00906971|12856566|P1|STARTED|Overall Study||36
5228732|NCT00906945|12856579|P6|NOT COMPLETED|Overall Study||2
5228733|NCT00906945|12856580|P5|NOT COMPLETED|Overall Study||1
5228734|NCT00906945|12856581|P4|NOT COMPLETED|Overall Study||1
5228735|NCT00906945|12856582|P3|NOT COMPLETED|Overall Study||0
5228736|NCT00906945|12856583|P2|NOT COMPLETED|Overall Study||0
5228737|NCT00906945|12856584|P1|NOT COMPLETED|Overall Study||0
5228738|NCT00906945|12856579|P6|COMPLETED|Overall Study||14
5228739|NCT00906945|12856580|P5|COMPLETED|Overall Study||6
5228740|NCT00906945|12856581|P4|COMPLETED|Overall Study||6
5228741|NCT00906945|12856582|P3|COMPLETED|Overall Study||3
5228742|NCT00906945|12856583|P2|COMPLETED|Overall Study||3
5228743|NCT00906945|12856584|P1|COMPLETED|Overall Study||3
5228744|NCT00906945|12856579|P6|STARTED|Overall Study||16
5228745|NCT00906945|12856580|P5|STARTED|Overall Study||7
5228746|NCT00906945|12856581|P4|STARTED|Overall Study||7
5228747|NCT00906945|12856582|P3|STARTED|Overall Study||3
5228748|NCT00906945|12856583|P2|STARTED|Overall Study||3
5228749|NCT00906945|12856584|P1|STARTED|Overall Study||3
5228750|NCT00906789|12856611|P1|NOT COMPLETED|Overall Study||0
5228751|NCT00906789|12856611|P1|COMPLETED|Overall Study||15
5228752|NCT00906789|12856611|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
5228753|NCT00906776|12856621|P2|NOT COMPLETED|Overall Study||0
5228754|NCT00906776|12856622|P1|NOT COMPLETED|Overall Study||0
5228755|NCT00906776|12856621|P2|COMPLETED|Overall Study||8
5228756|NCT00906776|12856622|P1|COMPLETED|Overall Study||11
5228757|NCT00906776|12856621|P2|STARTED|Overall Study||8
5228758|NCT00906776|12856622|P1|STARTED|Overall Study||11
5228759|NCT00906698|12856644|P6|NOT COMPLETED|Overall Study||5
5228760|NCT00906698|12856645|P5|NOT COMPLETED|Overall Study||18
5228761|NCT00906698|12856646|P4|NOT COMPLETED|Overall Study||4
5228762|NCT00906698|12856647|P3|NOT COMPLETED|Overall Study||6
5228763|NCT00906698|12856648|P2|NOT COMPLETED|Overall Study||19
5228764|NCT00906698|12856649|P1|NOT COMPLETED|Overall Study||3
5228765|NCT00906698|12856644|P6|COMPLETED|Overall Study||0
5228766|NCT00906698|12856645|P5|COMPLETED|Overall Study||0
5228767|NCT00906698|12856646|P4|COMPLETED|Overall Study||0
5228768|NCT00906698|12856647|P3|COMPLETED|Overall Study||0
5228769|NCT00906698|12856648|P2|COMPLETED|Overall Study||0
5228770|NCT00906698|12856649|P1|COMPLETED|Overall Study||0
5228771|NCT00906698|12856644|P6|STARTED|Overall Study||5
5228772|NCT00906698|12856645|P5|STARTED|Overall Study||18
5228773|NCT00906698|12856646|P4|STARTED|Overall Study||4
5228774|NCT00906698|12856647|P3|STARTED|Overall Study||6
5228775|NCT00906698|12856648|P2|STARTED|Overall Study||19
5228776|NCT00906698|12856649|P1|STARTED|Overall Study||3
5228777|NCT00906503|12856731|P1|NOT COMPLETED|Overall Study||0
5228778|NCT00906503|12856731|P1|COMPLETED|Overall Study||9
5228779|NCT00906503|12856731|P1|STARTED|Overall Study||9
5228780|NCT00906425|12856737|P2|NOT COMPLETED|Overall Study||72
5228781|NCT00906425|12856738|P1|NOT COMPLETED|Overall Study||73
5228782|NCT00906425|12856737|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
5228783|NCT00906425|12856738|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
5228784|NCT00906425|12856737|P2|2 Year|Overall Study|ITT population|58
5228785|NCT00906425|12856738|P1|2 Year|Overall Study|ITT population|62
5228786|NCT00906425|12856737|P2|1 Year|Overall Study|ITT population|60
5228787|NCT00906425|12856738|P1|1 Year|Overall Study|ITT population|67
5228788|NCT00906425|12856737|P2|6 Months|Overall Study|ITT population|64
5228789|NCT00906425|12856738|P1|6 Months|Overall Study|ITT population|69
5228790|NCT00906425|12856737|P2|STARTED|Overall Study||72
5228791|NCT00906425|12856738|P1|STARTED|Overall Study||73
5228792|NCT00906399|12856751|P7|NOT COMPLETED|Year 2||29
5228793|NCT00906399|12856752|P6|NOT COMPLETED|Year 2||47
5228794|NCT00906399|12856753|P5|NOT COMPLETED|Year 2||35
5228795|NCT00906399|12856754|P4|NOT COMPLETED|Year 2||30
5228796|NCT00906399|12856755|P3|NOT COMPLETED|Year 2||0
5228797|NCT00906399|12856756|P2|NOT COMPLETED|Year 2||0
5228798|NCT00906399|12856757|P1|NOT COMPLETED|Year 2||0
5228799|NCT00906399|12856751|P7|COMPLETED|Year 2||409
5228800|NCT00906399|12856752|P6|COMPLETED|Year 2||391
5228801|NCT00906399|12856753|P5|COMPLETED|Year 2||193
5228802|NCT00906399|12856754|P4|COMPLETED|Year 2||198
5228803|NCT00906399|12856755|P3|COMPLETED|Year 2||0
5228804|NCT00906399|12856756|P2|COMPLETED|Year 2||0
5228805|NCT00906399|12856757|P1|COMPLETED|Year 2||0
5228806|NCT00906399|12856751|P7|Completed Year 2 Study Treatment|Year 2||411
5228807|NCT00906399|12856752|P6|Completed Year 2 Study Treatment|Year 2||391
5228808|NCT00906399|12856753|P5|Completed Year 2 Study Treatment|Year 2||196
5228809|NCT00906399|12856754|P4|Completed Year 2 Study Treatment|Year 2||200
5228810|NCT00906399|12856755|P3|Completed Year 2 Study Treatment|Year 2||0
5228811|NCT00906399|12856756|P2|Completed Year 2 Study Treatment|Year 2||0
5228812|NCT00906399|12856757|P1|Completed Year 2 Study Treatment|Year 2||0
5228813|NCT00906399|12856751|P7|STARTED|Year 2||438
5228814|NCT00906399|12856752|P6|STARTED|Year 2||438
5228815|NCT00906399|12856753|P5|STARTED|Year 2||228
5228816|NCT00906399|12856754|P4|STARTED|Year 2||228
5228817|NCT00906399|12856755|P3|STARTED|Year 2||0
5228818|NCT00906399|12856756|P2|STARTED|Year 2||0
5228819|NCT00906399|12856757|P1|STARTED|Year 2||0
5228820|NCT00906399|12856751|P7|NOT COMPLETED|Year 1||0
5228821|NCT00906399|12856752|P6|NOT COMPLETED|Year 1||0
5228822|NCT00906399|12856753|P5|NOT COMPLETED|Year 1||0
5228823|NCT00906399|12856754|P4|NOT COMPLETED|Year 1||0
5228824|NCT00906399|12856755|P3|NOT COMPLETED|Year 1||76
5228825|NCT00906399|12856756|P2|NOT COMPLETED|Year 1||63
5228826|NCT00906399|12856757|P1|NOT COMPLETED|Year 1||44
5228827|NCT00906399|12856751|P7|COMPLETED|Year 1||0
5228828|NCT00906399|12856752|P6|COMPLETED|Year 1||0
5228829|NCT00906399|12856753|P5|COMPLETED|Year 1||0
5228830|NCT00906399|12856754|P4|COMPLETED|Year 1||0
5228831|NCT00906399|12856755|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
5228832|NCT00906399|12856756|P2|COMPLETED|Year 1||438
5228833|NCT00906399|12856757|P1|COMPLETED|Year 1||456
5228834|NCT00906399|12856751|P7|Completed Year 1 Study Treatment|Year 1||0
5228835|NCT00906399|12856752|P6|Completed Year 1 Study Treatment|Year 1||0
5228836|NCT00906399|12856753|P5|Completed Year 1 Study Treatment|Year 1||0
5228837|NCT00906399|12856754|P4|Completed Year 1 Study Treatment|Year 1||0
5228838|NCT00906399|12856755|P3|Completed Year 1 Study Treatment|Year 1||438
5228839|NCT00906399|12856756|P2|Completed Year 1 Study Treatment|Year 1||438
5228840|NCT00906399|12856757|P1|Completed Year 1 Study Treatment|Year 1||456
5228841|NCT00906399|12856751|P7|STARTED|Year 1||0
5228842|NCT00906399|12856752|P6|STARTED|Year 1||0
5228843|NCT00906399|12856753|P5|STARTED|Year 1||0
5228844|NCT00906399|12856754|P4|STARTED|Year 1||0
5228845|NCT00906399|12856755|P3|STARTED|Year 1||515
5228846|NCT00906399|12856756|P2|STARTED|Year 1||501
5228847|NCT00906399|12856757|P1|STARTED|Year 1||500
5228848|NCT00906373|12856780|P2|NOT COMPLETED|Overall Study||8
5228849|NCT00906373|12856781|P1|NOT COMPLETED|Overall Study||0
5228850|NCT00906373|12856780|P2|COMPLETED|Overall Study||33
5228851|NCT00906373|12856781|P1|COMPLETED|Overall Study||6
5228852|NCT00906373|12856780|P2|Received Any Amount of Study Drug|Overall Study||41
5228853|NCT00906373|12856781|P1|Received Any Amount of Study Drug|Overall Study||6
5228854|NCT00906373|12856780|P2|STARTED|Overall Study||41
5228855|NCT00906373|12856781|P1|STARTED|Overall Study||6
5228856|NCT00906347|12856820|P2|NOT COMPLETED|Received Study Drug||31
5228857|NCT00906347|12856821|P1|NOT COMPLETED|Received Study Drug||40
5228858|NCT00906347|12856820|P2|COMPLETED|Received Study Drug||143
5228859|NCT00906347|12856821|P1|COMPLETED|Received Study Drug||136
5228860|NCT00906347|12856820|P2|STARTED|Received Study Drug||174
5228861|NCT00906347|12856821|P1|STARTED|Received Study Drug||176
5228862|NCT00906347|12856820|P2|NOT COMPLETED|Randomized||0
5228863|NCT00906347|12856821|P1|NOT COMPLETED|Randomized||0
5228864|NCT00906347|12856820|P2|COMPLETED|Randomized||174
5228865|NCT00906347|12856821|P1|COMPLETED|Randomized||176
5228866|NCT00906347|12856820|P2|STARTED|Randomized||174
5228867|NCT00906347|12856821|P1|STARTED|Randomized||176
5228868|NCT00906282|12856841|P1|NOT COMPLETED|Surgical Resection||0
5228869|NCT00906282|12856841|P1|COMPLETED|Surgical Resection||27
5228870|NCT00906282|12856841|P1|STARTED|Surgical Resection||27
5228871|NCT00906282|12856841|P1|NOT COMPLETED|Preoperative Chemotherapy||19
5228872|NCT00906282|12856841|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
5228873|NCT00906282|12856841|P1|STARTED|Preoperative Chemotherapy||46
5228874|NCT00906243|12856849|P1|NOT COMPLETED|Overall Study||0
5228875|NCT00906243|12856849|P1|COMPLETED|Overall Study||6
5228876|NCT00906243|12856849|P1|STARTED|Overall Study||6
5228877|NCT00906204|12856855|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
5228878|NCT00906204|12856856|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
5228879|NCT00906204|12856855|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
5228880|NCT00906204|12856856|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
5228881|NCT00906204|12856855|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
5228882|NCT00906204|12856856|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
5228883|NCT00906204|12856855|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
5228884|NCT00906204|12856856|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
5228885|NCT00906204|12856855|P2|COMPLETED|Primary Endpoint (Early Safety)||51
5228886|NCT00906204|12856856|P1|COMPLETED|Primary Endpoint (Early Safety)||43
5228887|NCT00906204|12856855|P2|STARTED|Primary Endpoint (Early Safety)||52
5228888|NCT00906204|12856856|P1|STARTED|Primary Endpoint (Early Safety)||45
5228889|NCT00906178|12856874|P2|NOT COMPLETED|Overall Study||16
5228890|NCT00906178|12856875|P1|NOT COMPLETED|Overall Study||15
5228891|NCT00906178|12856874|P2|COMPLETED|Overall Study||167
5228892|NCT00906178|12856875|P1|COMPLETED|Overall Study||168
5228893|NCT00906178|12856874|P2|STARTED|Overall Study||183
5228894|NCT00906178|12856875|P1|STARTED|Overall Study||183
5228895|NCT00906165|12856889|P2|NOT COMPLETED|Overall Study||0
5228896|NCT00906165|12856890|P1|NOT COMPLETED|Overall Study||4
5228897|NCT00906165|12856889|P2|COMPLETED|Overall Study||14
5228898|NCT00906165|12856890|P1|COMPLETED|Overall Study||10
5228899|NCT00906165|12856889|P2|STARTED|Overall Study||14
5228900|NCT00906165|12856890|P1|STARTED|Overall Study||14
5228901|NCT00906087|12856910|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
5228902|NCT00906087|12856910|P1|COMPLETED|Final Washout Period 4 Weeks||12
5228903|NCT00906087|12856910|P1|STARTED|Final Washout Period 4 Weeks||12
5228904|NCT00906087|12856910|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
5228905|NCT00906087|12856910|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
5228906|NCT00906087|12856910|P1|STARTED|Cosopt Treatment 6 Weeks||12
5228907|NCT00906087|12856910|P1|NOT COMPLETED|Initial Washout||2
5228908|NCT00906087|12856910|P1|COMPLETED|Initial Washout||12
5228909|NCT00906087|12856910|P1|Completed Washout and Continue Protocol|Initial Washout||12
5228910|NCT00906087|12856910|P1|Begin Washout|Initial Washout||13
5228911|NCT00906087|12856910|P1|Completed Screening|Initial Washout||14
5228912|NCT00906087|12856910|P1|STARTED|Initial Washout||14
5228913|NCT00906074|12856919|P2|NOT COMPLETED|Overall Study||0
5228914|NCT00906074|12856920|P1|NOT COMPLETED|Overall Study||0
5228915|NCT00906074|12856919|P2|COMPLETED|Overall Study||90
5228916|NCT00906074|12856920|P1|COMPLETED|Overall Study||90
5228917|NCT00906074|12856919|P2|STARTED|Overall Study||90
5228918|NCT00906074|12856920|P1|STARTED|Overall Study||90
5228919|NCT00906035|12856947|P3|NOT COMPLETED|Overall Study||0
5228920|NCT00906035|12856948|P2|NOT COMPLETED|Overall Study||3
5228921|NCT00906035|12856949|P1|NOT COMPLETED|Overall Study||2
5228922|NCT00906035|12856947|P3|COMPLETED|Overall Study||8
5228923|NCT00906035|12856948|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
5228924|NCT00906035|12856949|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
5228925|NCT00906035|12856947|P3|STARTED|Overall Study||8
5228926|NCT00906035|12856948|P2|STARTED|Overall Study||9
5228927|NCT00906035|12856949|P1|STARTED|Overall Study||8
5228928|NCT00905840|12856963|P1|NOT COMPLETED|Overall Study||16
5228929|NCT00905840|12856963|P1|COMPLETED|Overall Study||75
5228930|NCT00905840|12856963|P1|STARTED|Overall Study||91
5228931|NCT00905827|12856975|P3|NOT COMPLETED|Overall Study||0
5228932|NCT00905827|12856976|P2|NOT COMPLETED|Overall Study||0
5228933|NCT00905827|12856977|P1|NOT COMPLETED|Overall Study||0
5228934|NCT00905827|12856975|P3|COMPLETED|Overall Study||73
5228935|NCT00905827|12856976|P2|COMPLETED|Overall Study||69
5228936|NCT00905827|12856977|P1|COMPLETED|Overall Study||70
5228937|NCT00905827|12856975|P3|STARTED|Overall Study||73
5228938|NCT00905827|12856976|P2|STARTED|Overall Study||69
5228939|NCT00905827|12856977|P1|STARTED|Overall Study||70
5228940|NCT00905632|12856994|P7|NOT COMPLETED|Overall Study||4
5228941|NCT00905632|12856995|P6|NOT COMPLETED|Overall Study||1
5228942|NCT00905632|12856996|P5|NOT COMPLETED|Overall Study||0
5228943|NCT00905632|12856997|P4|NOT COMPLETED|Overall Study||0
5228944|NCT00905632|12856998|P3|NOT COMPLETED|Overall Study||0
5228945|NCT00905632|12856999|P2|NOT COMPLETED|Overall Study||0
5228946|NCT00905632|12857000|P1|NOT COMPLETED|Overall Study||0
5228947|NCT00905632|12856994|P7|COMPLETED|Overall Study||7
5228948|NCT00905632|12856995|P6|COMPLETED|Overall Study||8
5228949|NCT00905632|12856996|P5|COMPLETED|Overall Study||10
5228950|NCT00905632|12856997|P4|COMPLETED|Overall Study||6
5228951|NCT00905632|12856998|P3|COMPLETED|Overall Study||7
5228952|NCT00905632|12856999|P2|COMPLETED|Overall Study||6
5228953|NCT00905632|12857000|P1|COMPLETED|Overall Study||8
5228954|NCT00905632|12856994|P7|STARTED|Overall Study||11
5228955|NCT00905632|12856995|P6|STARTED|Overall Study||9
5228956|NCT00905632|12856996|P5|STARTED|Overall Study||10
5228957|NCT00905632|12856997|P4|STARTED|Overall Study||6
5228958|NCT00905632|12856998|P3|STARTED|Overall Study||7
5228959|NCT00905632|12856999|P2|STARTED|Overall Study||6
5228960|NCT00905632|12857000|P1|STARTED|Overall Study||8
5228961|NCT00905606|12857138|P2|NOT COMPLETED|Period 2||0
5228962|NCT00905606|12857139|P1|NOT COMPLETED|Period 2||0
5228963|NCT00905606|12857138|P2|COMPLETED|Period 2||14
5228964|NCT00905606|12857139|P1|COMPLETED|Period 2||14
5228965|NCT00905606|12857138|P2|STARTED|Period 2||14
5228966|NCT00905606|12857139|P1|STARTED|Period 2||14
5228967|NCT00905606|12857138|P2|NOT COMPLETED|Washout||0
5228968|NCT00905606|12857139|P1|NOT COMPLETED|Washout||1
5228969|NCT00905606|12857138|P2|COMPLETED|Washout||14
5228970|NCT00905606|12857139|P1|COMPLETED|Washout||14
5228971|NCT00905606|12857138|P2|STARTED|Washout||14
5228972|NCT00905606|12857139|P1|STARTED|Washout||15
5228973|NCT00905606|12857138|P2|NOT COMPLETED|Period 1||1
5228974|NCT00905606|12857139|P1|NOT COMPLETED|Period 1||0
5228975|NCT00905606|12857138|P2|COMPLETED|Period 1||14
5228976|NCT00905606|12857139|P1|COMPLETED|Period 1||15
5228977|NCT00905606|12857138|P2|STARTED|Period 1||15
5228978|NCT00905606|12857139|P1|STARTED|Period 1||15
5228979|NCT00905580|12857149|P2|NOT COMPLETED|Overall Study||3
5228980|NCT00905580|12857150|P1|NOT COMPLETED|Overall Study||2
5228981|NCT00905580|12857149|P2|COMPLETED|Overall Study||47
5228982|NCT00905580|12857150|P1|COMPLETED|Overall Study||47
5228983|NCT00905580|12857149|P2|STARTED|Overall Study||50
5228984|NCT00905580|12857150|P1|STARTED|Overall Study||49
5228985|NCT00905567|12857164|P2|NOT COMPLETED|Period 2||0
5228986|NCT00905567|12857165|P1|NOT COMPLETED|Period 2||0
5228987|NCT00905567|12857164|P2|COMPLETED|Period 2||11
5228988|NCT00905567|12857165|P1|COMPLETED|Period 2||12
5228989|NCT00905567|12857164|P2|STARTED|Period 2||11
5228990|NCT00905567|12857165|P1|STARTED|Period 2||12
5228991|NCT00905567|12857164|P2|NOT COMPLETED|Washout||1
5228992|NCT00905567|12857165|P1|NOT COMPLETED|Washout||0
5228993|NCT00905567|12857164|P2|COMPLETED|Washout||11
5228994|NCT00905567|12857165|P1|COMPLETED|Washout||12
5228995|NCT00905567|12857164|P2|STARTED|Washout||12
5228996|NCT00905567|12857165|P1|STARTED|Washout||12
5228997|NCT00905567|12857164|P2|NOT COMPLETED|Period 1||0
5228998|NCT00905567|12857165|P1|NOT COMPLETED|Period 1||0
5228999|NCT00905567|12857164|P2|COMPLETED|Period 1||12
5229000|NCT00905567|12857165|P1|COMPLETED|Period 1||12
5229001|NCT00905567|12857164|P2|STARTED|Period 1||12
5229002|NCT00905567|12857165|P1|STARTED|Period 1||12
5229003|NCT00905554|12857175|P2|NOT COMPLETED|Overall Study||0
5229004|NCT00905554|12857176|P1|NOT COMPLETED|Overall Study||0
5229005|NCT00905554|12857175|P2|COMPLETED|Overall Study||114
5229006|NCT00905554|12857176|P1|COMPLETED|Overall Study||116
5229007|NCT00905554|12857175|P2|STARTED|Overall Study||114
5229008|NCT00905554|12857176|P1|STARTED|Overall Study||116
5229009|NCT00905515|12857187|P3|NOT COMPLETED|Overall Study||2
5229010|NCT00905515|12857188|P2|NOT COMPLETED|Overall Study||0
5229011|NCT00905515|12857189|P1|NOT COMPLETED|Overall Study||2
5229012|NCT00905515|12857187|P3|COMPLETED|Overall Study||20
5229013|NCT00905515|12857188|P2|COMPLETED|Overall Study||20
5229014|NCT00905515|12857189|P1|COMPLETED|Overall Study||19
5229015|NCT00905515|12857187|P3|STARTED|Overall Study||22
5229016|NCT00905515|12857188|P2|STARTED|Overall Study||20
5229017|NCT00905515|12857189|P1|STARTED|Overall Study||21
5229018|NCT00905489|12857197|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
5229019|NCT00905489|12857197|P1|COMPLETED|Optional Extension Phase (OEP)||39
5229020|NCT00905489|12857197|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
5229021|NCT00905489|12857197|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
5229022|NCT00905489|12857197|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
5229023|NCT00905489|12857197|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
5229024|NCT00905437|12857246|P2|NOT COMPLETED|Overall Study||10
5229025|NCT00905437|12857247|P1|NOT COMPLETED|Overall Study||8
5229026|NCT00905437|12857246|P2|COMPLETED|Overall Study||27
5229027|NCT00905437|12857247|P1|COMPLETED|Overall Study||27
5229028|NCT00905437|12857246|P2|STARTED|Overall Study||37
5229029|NCT00905437|12857247|P1|STARTED|Overall Study||35
5229030|NCT00905424|12857267|P2|NOT COMPLETED|Overall Study||9
5229031|NCT00905424|12857268|P1|NOT COMPLETED|Overall Study||11
5229032|NCT00905424|12857267|P2|COMPLETED|Overall Study||79
5229033|NCT00905424|12857268|P1|COMPLETED|Overall Study||78
5229034|NCT00905424|12857267|P2|STARTED|Overall Study||88
5229035|NCT00905424|12857268|P1|STARTED|Overall Study||89
5229036|NCT00905359|12857310|P2|NOT COMPLETED|Overall Study||16
5229037|NCT00905359|12857311|P1|NOT COMPLETED|Overall Study||24
5229038|NCT00905359|12857310|P2|COMPLETED|Overall Study||65
5229039|NCT00905359|12857311|P1|COMPLETED|Overall Study||58
5229040|NCT00905359|12857310|P2|24 Months Follow up|Overall Study||65
5229041|NCT00905359|12857311|P1|24 Months Follow up|Overall Study||58
5229042|NCT00905359|12857310|P2|12 Months Follow up|Overall Study||72
5229043|NCT00905359|12857311|P1|12 Months Follow up|Overall Study||68
5229044|NCT00905359|12857310|P2|STARTED|Overall Study||81
5229045|NCT00905359|12857311|P1|STARTED|Overall Study||82
5229046|NCT00905346|12857347|P2|NOT COMPLETED|Period 2||0
5229047|NCT00905346|12857348|P1|NOT COMPLETED|Period 2||0
5229048|NCT00905346|12857347|P2|COMPLETED|Period 2||11
5229049|NCT00905346|12857348|P1|COMPLETED|Period 2||10
5229050|NCT00905346|12857347|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
5229051|NCT00905346|12857348|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
5229052|NCT00905346|12857347|P2|NOT COMPLETED|Period 1||0
5229053|NCT00905346|12857348|P1|NOT COMPLETED|Period 1||1
5229054|NCT00905346|12857347|P2|COMPLETED|Period 1||12
5229055|NCT00905346|12857348|P1|COMPLETED|Period 1||11
5229056|NCT00905346|12857347|P2|STARTED|Period 1||12
5229057|NCT00905346|12857348|P1|STARTED|Period 1||12
5229058|NCT00905307|12857362|P6|NOT COMPLETED|Overall Study||42
5229059|NCT00905307|12857363|P5|NOT COMPLETED|Overall Study||16
5229060|NCT00905307|12857364|P4|NOT COMPLETED|Overall Study||37
5229061|NCT00905307|12857365|P3|NOT COMPLETED|Overall Study||37
5229062|NCT00905307|12857366|P2|NOT COMPLETED|Overall Study||37
5229063|NCT00905307|12857367|P1|NOT COMPLETED|Overall Study||22
5229064|NCT00905307|12857362|P6|COMPLETED|Overall Study||53
5229065|NCT00905307|12857363|P5|COMPLETED|Overall Study||34
5229066|NCT00905307|12857364|P4|COMPLETED|Overall Study||56
5229067|NCT00905307|12857365|P3|COMPLETED|Overall Study||53
5229068|NCT00905307|12857366|P2|COMPLETED|Overall Study||52
5229069|NCT00905307|12857367|P1|COMPLETED|Overall Study||20
5229070|NCT00905307|12857362|P6|STARTED|Overall Study||95
5229071|NCT00905307|12857363|P5|STARTED|Overall Study||50
5229072|NCT00905307|12857364|P4|STARTED|Overall Study||93
5229073|NCT00905307|12857365|P3|STARTED|Overall Study||90
5229074|NCT00905307|12857366|P2|STARTED|Overall Study||89
5229075|NCT00905307|12857367|P1|STARTED|Overall Study||42
5229076|NCT00905268|12857427|P4|NOT COMPLETED|Overall Study||2
5229077|NCT00905268|12857428|P3|NOT COMPLETED|Overall Study||0
5229078|NCT00905268|12857429|P2|NOT COMPLETED|Overall Study||1
5229079|NCT00905268|12857430|P1|NOT COMPLETED|Overall Study||4
5229080|NCT00905268|12857427|P4|COMPLETED|Overall Study||57
5229081|NCT00905268|12857428|P3|COMPLETED|Overall Study||59
5229082|NCT00905268|12857429|P2|COMPLETED|Overall Study||56
5229083|NCT00905268|12857430|P1|COMPLETED|Overall Study||53
5229084|NCT00905268|12857427|P4|STARTED|Overall Study||59
5229085|NCT00905268|12857428|P3|STARTED|Overall Study||59
5229086|NCT00905268|12857429|P2|STARTED|Overall Study||57
5229087|NCT00905268|12857430|P1|STARTED|Overall Study||57
5229088|NCT00905255|12857462|P2|NOT COMPLETED|Overall Study||9
5229089|NCT00905255|12857463|P1|NOT COMPLETED|Overall Study||13
5229090|NCT00905255|12857462|P2|COMPLETED|Overall Study||27
5229091|NCT00905255|12857463|P1|COMPLETED|Overall Study||20
5229092|NCT00905255|12857462|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
5229093|NCT00905255|12857463|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
5229094|NCT00905255|12857462|P2|Safety Population|Overall Study||36
5229095|NCT00905255|12857463|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
5229096|NCT00905255|12857462|P2|STARTED|Overall Study||36
5229097|NCT00905255|12857463|P1|STARTED|Overall Study|Randomized.|33
5229098|NCT00905164|12857481|P2|NOT COMPLETED|Period 2||0
5229099|NCT00905164|12857482|P1|NOT COMPLETED|Period 2||0
5229100|NCT00905164|12857481|P2|COMPLETED|Period 2||11
5229101|NCT00905164|12857482|P1|COMPLETED|Period 2||12
5229102|NCT00905164|12857481|P2|STARTED|Period 2||11
5229103|NCT00905164|12857482|P1|STARTED|Period 2||12
5229104|NCT00905164|12857481|P2|NOT COMPLETED|Period 1||1
5229105|NCT00905164|12857482|P1|NOT COMPLETED|Period 1||0
5229106|NCT00905164|12857481|P2|COMPLETED|Period 1||11
5229107|NCT00905164|12857482|P1|COMPLETED|Period 1||12
5229108|NCT00905164|12857481|P2|STARTED|Period 1||12
5229109|NCT00905164|12857482|P1|STARTED|Period 1||12
5229110|NCT00905151|12857490|P1|NOT COMPLETED|Overall Study||6
5229111|NCT00905151|12857490|P1|COMPLETED|Overall Study||200
5229112|NCT00905151|12857490|P1|STARTED|Overall Study||206
5229113|NCT00905125|12857496|P2|NOT COMPLETED|Overall Study||3
5229114|NCT00905125|12857497|P1|NOT COMPLETED|Overall Study||4
5229115|NCT00905125|12857496|P2|COMPLETED|Overall Study||53
5229116|NCT00905125|12857497|P1|COMPLETED|Overall Study||42
5229117|NCT00905125|12857496|P2|STARTED|Overall Study||56
5229118|NCT00905125|12857497|P1|STARTED|Overall Study||46
5229119|NCT00905034|12857529|P1|NOT COMPLETED|Overall Study||1
5229120|NCT00905034|12857529|P1|COMPLETED|Overall Study||36
5229121|NCT00905034|12857529|P1|STARTED|Overall Study||37
5229122|NCT00905021|12857533|P1|NOT COMPLETED|Overall Study||2
5229123|NCT00905021|12857533|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
5229124|NCT00905021|12857533|P1|STARTED|Overall Study||4
5229125|NCT00904995|12857542|P2|NOT COMPLETED|Overall Study||0
5229126|NCT00904995|12857543|P1|NOT COMPLETED|Overall Study||0
5229127|NCT00904995|12857542|P2|COMPLETED|Overall Study||11
5229128|NCT00904995|12857543|P1|COMPLETED|Overall Study||10
5229129|NCT00904995|12857542|P2|STARTED|Overall Study||11
5229130|NCT00904995|12857543|P1|STARTED|Overall Study||10
5229131|NCT00904982|12857553|P4|NOT COMPLETED|Overall Study||0
5229132|NCT00904982|12857554|P3|NOT COMPLETED|Overall Study||0
5229133|NCT00904982|12857555|P2|NOT COMPLETED|Overall Study||0
5229134|NCT00904982|12857556|P1|NOT COMPLETED|Overall Study||2
5229135|NCT00904982|12857553|P4|COMPLETED|Overall Study||68
5229136|NCT00904982|12857554|P3|COMPLETED|Overall Study||67
5229137|NCT00904982|12857555|P2|COMPLETED|Overall Study||67
5229138|NCT00904982|12857556|P1|COMPLETED|Overall Study||66
5229139|NCT00904982|12857553|P4|STARTED|Overall Study||68
5229140|NCT00904982|12857554|P3|STARTED|Overall Study||67
5229141|NCT00904982|12857555|P2|STARTED|Overall Study||67
5229142|NCT00904982|12857556|P1|STARTED|Overall Study||68
5229143|NCT00904969|12857566|P1|NOT COMPLETED|Overall Study||19
5229144|NCT00904969|12857566|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
5229145|NCT00904969|12857566|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
5229146|NCT00904943|12857618|P2|NOT COMPLETED|Period 2||0
5229147|NCT00904943|12857619|P1|NOT COMPLETED|Period 2||0
5229148|NCT00904943|12857618|P2|COMPLETED|Period 2||8
5229149|NCT00904943|12857619|P1|COMPLETED|Period 2||9
5229150|NCT00904943|12857618|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
5229151|NCT00904943|12857619|P1|STARTED|Period 2||9
5229152|NCT00904943|12857618|P2|NOT COMPLETED|Period 1||0
5229153|NCT00904943|12857619|P1|NOT COMPLETED|Period 1||0
5229154|NCT00904943|12857618|P2|COMPLETED|Period 1||9
5229155|NCT00904943|12857619|P1|COMPLETED|Period 1||9
5229156|NCT00904943|12857618|P2|STARTED|Period 1||9
5229157|NCT00904943|12857619|P1|STARTED|Period 1||9
5229158|NCT00904917|12857631|P4|NOT COMPLETED|Overall Study||2
5229159|NCT00904917|12857632|P3|NOT COMPLETED|Overall Study||2
5229160|NCT00904917|12857633|P2|NOT COMPLETED|Overall Study||2
5229161|NCT00904917|12857634|P1|NOT COMPLETED|Overall Study||2
5229162|NCT00904917|12857631|P4|COMPLETED|Overall Study||6
5229163|NCT00904917|12857632|P3|COMPLETED|Overall Study||6
5229164|NCT00904917|12857633|P2|COMPLETED|Overall Study||9
5229165|NCT00904917|12857634|P1|COMPLETED|Overall Study||5
5229166|NCT00904917|12857631|P4|STARTED|Overall Study||8
5229167|NCT00904917|12857632|P3|STARTED|Overall Study||8
5229168|NCT00904917|12857633|P2|STARTED|Overall Study||11
5229169|NCT00904917|12857634|P1|STARTED|Overall Study||7
5229170|NCT00904839|12857652|P3|NOT COMPLETED|Overall Study||15
5229171|NCT00904839|12857653|P2|NOT COMPLETED|Overall Study||18
5229172|NCT00904839|12857654|P1|NOT COMPLETED|Overall Study||1
5229173|NCT00904839|12857652|P3|COMPLETED|Overall Study||27
5229174|NCT00904839|12857653|P2|COMPLETED|Overall Study||64
5229175|NCT00904839|12857654|P1|COMPLETED|Overall Study||3
5229176|NCT00904839|12857652|P3|STARTED|Overall Study|Randomised|42
5229177|NCT00904839|12857653|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
5229178|NCT00904839|12857654|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
5229179|NCT00904826|12857688|P1|NOT COMPLETED|Overall Study||0
5229180|NCT00904826|12857688|P1|COMPLETED|Overall Study||14
5229181|NCT00904826|12857688|P1|STARTED|Overall Study||14
5229182|NCT00904748|12857700|P6|NOT COMPLETED|Overall Study||0
5229183|NCT00904748|12857701|P5|NOT COMPLETED|Overall Study||1
5229184|NCT00904748|12857702|P4|NOT COMPLETED|Overall Study||2
5229185|NCT00904748|12857703|P3|NOT COMPLETED|Overall Study||1
5229186|NCT00904748|12857704|P2|NOT COMPLETED|Overall Study||1
5229187|NCT00904748|12857705|P1|NOT COMPLETED|Overall Study||1
5229188|NCT00904748|12857700|P6|COMPLETED|Overall Study||8
5229189|NCT00904748|12857701|P5|COMPLETED|Overall Study||7
5229190|NCT00904748|12857702|P4|COMPLETED|Overall Study||6
5229191|NCT00904748|12857703|P3|COMPLETED|Overall Study||7
5229192|NCT00904748|12857704|P2|COMPLETED|Overall Study||7
5229193|NCT00904748|12857705|P1|COMPLETED|Overall Study||7
5229194|NCT00904748|12857700|P6|Received Treatment|Overall Study||8
5229195|NCT00904748|12857701|P5|Received Treatment|Overall Study||7
5229196|NCT00904748|12857702|P4|Received Treatment|Overall Study||8
5229197|NCT00904748|12857703|P3|Received Treatment|Overall Study||8
5229198|NCT00904748|12857704|P2|Received Treatment|Overall Study||8
5229199|NCT00904748|12857705|P1|Received Treatment|Overall Study||8
5229200|NCT00904748|12857700|P6|STARTED|Overall Study||8
5229201|NCT00904748|12857701|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
5229202|NCT00904748|12857702|P4|STARTED|Overall Study||8
5229203|NCT00904748|12857703|P3|STARTED|Overall Study||8
5229204|NCT00904748|12857704|P2|STARTED|Overall Study||8
5229205|NCT00904748|12857705|P1|STARTED|Overall Study||8
5229206|NCT00904722|12857729|P1|NOT COMPLETED|Overall Study||1
5229207|NCT00904722|12857729|P1|COMPLETED|Overall Study||29
5229208|NCT00904722|12857729|P1|STARTED|Overall Study||30
5229209|NCT00904670|12857734|P2|NOT COMPLETED|Second Intervention Period||0
5229210|NCT00904670|12857735|P1|NOT COMPLETED|Second Intervention Period||0
5229211|NCT00904670|12857734|P2|COMPLETED|Second Intervention Period||22
5229212|NCT00904670|12857735|P1|COMPLETED|Second Intervention Period||17
5229213|NCT00904670|12857734|P2|STARTED|Second Intervention Period||22
5229214|NCT00904670|12857735|P1|STARTED|Second Intervention Period||17
5229215|NCT00904670|12857734|P2|NOT COMPLETED|First Intervention Period||0
5229216|NCT00904670|12857735|P1|NOT COMPLETED|First Intervention Period||0
5229217|NCT00904670|12857734|P2|COMPLETED|First Intervention Period||22
5229218|NCT00904670|12857735|P1|COMPLETED|First Intervention Period||17
5229219|NCT00904670|12857734|P2|STARTED|First Intervention Period||22
5229220|NCT00904670|12857735|P1|STARTED|First Intervention Period||17
5229221|NCT00904670|12857734|P2|NOT COMPLETED|Open Label Phase||0
5229222|NCT00904670|12857735|P1|NOT COMPLETED|Open Label Phase||6
5229223|NCT00904670|12857734|P2|COMPLETED|Open Label Phase||22
5229224|NCT00904670|12857735|P1|COMPLETED|Open Label Phase||17
5229225|NCT00904670|12857734|P2|STARTED|Open Label Phase||22
5229226|NCT00904670|12857735|P1|STARTED|Open Label Phase||23
5229227|NCT00904618|12857756|P1|NOT COMPLETED|Overall Study||0
5229228|NCT00904618|12857756|P1|COMPLETED|Overall Study||48
5229229|NCT00904618|12857756|P1|STARTED|Overall Study||48
5229230|NCT00904488|12857766|P2|NOT COMPLETED|Overall Study||0
5229231|NCT00904488|12857767|P1|NOT COMPLETED|Overall Study||0
5229232|NCT00904488|12857766|P2|COMPLETED|Overall Study||6
5229233|NCT00904488|12857767|P1|COMPLETED|Overall Study||5
5229234|NCT00904488|12857766|P2|STARTED|Overall Study||6
5229235|NCT00904488|12857767|P1|STARTED|Overall Study||5
5229236|NCT00904423|12857797|P1|NOT COMPLETED|Overall Study||0
5229237|NCT00904423|12857797|P1|COMPLETED|Overall Study||8
5229238|NCT00904423|12857797|P1|STARTED|Overall Study||8
5229239|NCT00904371|12857805|P1|NOT COMPLETED|Overall Study||9
5229240|NCT00904371|12857805|P1|COMPLETED|Overall Study||202
5229241|NCT00904371|12857805|P1|STARTED|Overall Study||211
5229242|NCT00904215|12857819|P1|NOT COMPLETED|Overall Study||135
5229243|NCT00904215|12857819|P1|COMPLETED|Overall Study||960
5229244|NCT00904215|12857819|P1|STARTED|Overall Study||1095
5229245|NCT00904189|12857826|P1|NOT COMPLETED|Overall Study||0
5229246|NCT00904189|12857826|P1|COMPLETED|Overall Study||2
5229247|NCT00904189|12857826|P1|STARTED|Overall Study||2
5229248|NCT00904150|12857833|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
5229249|NCT00904150|12857834|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
5229250|NCT00904150|12857833|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
5229251|NCT00904150|12857834|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
5229252|NCT00904150|12857833|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
5229253|NCT00904150|12857834|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
5229254|NCT00904150|12857833|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
5229255|NCT00904150|12857834|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
5229256|NCT00904150|12857833|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
5229257|NCT00904150|12857834|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
5229258|NCT00904150|12857833|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
5229259|NCT00904150|12857834|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
5229260|NCT00904150|12857833|P2|NOT COMPLETED|Saliva Samples (DNA)||145
5229261|NCT00904150|12857834|P1|NOT COMPLETED|Saliva Samples (DNA)||3
5229262|NCT00904150|12857833|P2|COMPLETED|Saliva Samples (DNA)||155
5229263|NCT00904150|12857834|P1|COMPLETED|Saliva Samples (DNA)||282
5229264|NCT00904150|12857833|P2|STARTED|Saliva Samples (DNA)||300
5229265|NCT00904150|12857834|P1|STARTED|Saliva Samples (DNA)||285
5229266|NCT00904033|12857856|P4|NOT COMPLETED|Overall Study||2
5229267|NCT00904033|12857857|P3|NOT COMPLETED|Overall Study||1
5229268|NCT00904033|12857858|P2|NOT COMPLETED|Overall Study||1
5229269|NCT00904033|12857859|P1|NOT COMPLETED|Overall Study||1
5229270|NCT00904033|12857856|P4|COMPLETED|Overall Study||9
5229271|NCT00904033|12857857|P3|COMPLETED|Overall Study||9
5229272|NCT00904033|12857858|P2|COMPLETED|Overall Study||9
5229273|NCT00904033|12857859|P1|COMPLETED|Overall Study||9
5229274|NCT00904033|12857856|P4|STARTED|Overall Study||11
5229275|NCT00904033|12857857|P3|STARTED|Overall Study||10
5229276|NCT00904033|12857858|P2|STARTED|Overall Study||10
5229277|NCT00904033|12857859|P1|STARTED|Overall Study||10
5229278|NCT00904007|12857883|P2|NOT COMPLETED|Overall Study||0
5229279|NCT00904007|12857884|P1|NOT COMPLETED|Overall Study||0
5229280|NCT00904007|12857883|P2|COMPLETED|Overall Study||56
5229281|NCT00904007|12857884|P1|COMPLETED|Overall Study||55
5229282|NCT00904007|12857883|P2|STARTED|Overall Study||56
5229283|NCT00904007|12857884|P1|STARTED|Overall Study||55
5229284|NCT00903968|12857924|P8|NOT COMPLETED|Overall Study||33
5229285|NCT00903968|12857925|P7|NOT COMPLETED|Overall Study||3
5229286|NCT00903968|12857926|P6|NOT COMPLETED|Overall Study||6
5229287|NCT00903968|12857927|P5|NOT COMPLETED|Overall Study||4
5229288|NCT00903968|12857928|P4|NOT COMPLETED|Overall Study||3
5229289|NCT00903968|12857929|P3|NOT COMPLETED|Overall Study||3
5229290|NCT00903968|12857930|P2|NOT COMPLETED|Overall Study||3
5229291|NCT00903968|12857931|P1|NOT COMPLETED|Overall Study||3
5229292|NCT00903968|12857924|P8|COMPLETED|Overall Study||0
5229293|NCT00903968|12857925|P7|COMPLETED|Overall Study||0
5229294|NCT00903968|12857926|P6|COMPLETED|Overall Study||0
5229295|NCT00903968|12857927|P5|COMPLETED|Overall Study||0
5229296|NCT00903968|12857928|P4|COMPLETED|Overall Study||0
5229297|NCT00903968|12857929|P3|COMPLETED|Overall Study||0
5229298|NCT00903968|12857930|P2|COMPLETED|Overall Study||0
5229299|NCT00903968|12857931|P1|COMPLETED|Overall Study||0
5229300|NCT00903968|12857924|P8|STARTED|Overall Study||33
5229301|NCT00903968|12857925|P7|STARTED|Overall Study||3
5229302|NCT00903968|12857926|P6|STARTED|Overall Study||6
5229303|NCT00903968|12857927|P5|STARTED|Overall Study||4
5229304|NCT00903968|12857928|P4|STARTED|Overall Study||3
5229305|NCT00903968|12857929|P3|STARTED|Overall Study||3
5229306|NCT00903968|12857930|P2|STARTED|Overall Study||3
5229307|NCT00903968|12857931|P1|STARTED|Overall Study||3
5229308|NCT00903929|12857961|P4|NOT COMPLETED|Overall Study||3
5229309|NCT00903929|12857962|P3|NOT COMPLETED|Overall Study||1
5229310|NCT00903929|12857963|P2|NOT COMPLETED|Overall Study||0
5229311|NCT00903929|12857964|P1|NOT COMPLETED|Overall Study||0
5229312|NCT00903929|12857961|P4|COMPLETED|Overall Study||6
5229313|NCT00903929|12857962|P3|COMPLETED|Overall Study||3
5229314|NCT00903929|12857963|P2|COMPLETED|Overall Study||3
5229315|NCT00903929|12857964|P1|COMPLETED|Overall Study||3
5229316|NCT00903929|12857961|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
5229317|NCT00903929|12857962|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
5229318|NCT00903929|12857963|P2|STARTED|Overall Study||3
5229319|NCT00903929|12857964|P1|STARTED|Overall Study||3
5229320|NCT00903877|12857970|P1|NOT COMPLETED|Overall Study||43
5229321|NCT00903877|12857970|P1|COMPLETED|Overall Study||8
5229322|NCT00903877|12857970|P1|STARTED|Overall Study||51
5229323|NCT00903786|12857974|P1|NOT COMPLETED|Overall Study||15
5229324|NCT00903786|12857974|P1|COMPLETED|Overall Study||6
5229325|NCT00903786|12857974|P1|STARTED|Overall Study||21
5229326|NCT00903760|12857984|P2|NOT COMPLETED|Overall Study||16
5229327|NCT00903760|12857985|P1|NOT COMPLETED|Overall Study||19
5229328|NCT00903760|12857984|P2|COMPLETED|Overall Study|Completed all 24 courses|2
5229329|NCT00903760|12857985|P1|COMPLETED|Overall Study|Completed all 24 courses|0
5229330|NCT00903760|12857984|P2|STARTED|Overall Study||18
5229331|NCT00903760|12857985|P1|STARTED|Overall Study||19
5229332|NCT00903695|12857995|P2|NOT COMPLETED|Overall Study||0
5229333|NCT00903695|12857996|P1|NOT COMPLETED|Overall Study||2
5229334|NCT00903695|12857995|P2|COMPLETED|Overall Study||2
5229335|NCT00903695|12857996|P1|COMPLETED|Overall Study||6
5229336|NCT00903695|12857995|P2|STARTED|Overall Study||2
5229337|NCT00903695|12857996|P1|STARTED|Overall Study||8
5229338|NCT00903682|12858018|P2|NOT COMPLETED|Overall Study||15
5229339|NCT00903682|12858019|P1|NOT COMPLETED|Overall Study||16
5229340|NCT00903682|12858018|P2|COMPLETED|Overall Study||63
5229341|NCT00903682|12858019|P1|COMPLETED|Overall Study||63
5229342|NCT00903682|12858018|P2|STARTED|Overall Study||78
5229343|NCT00903682|12858019|P1|STARTED|Overall Study||79
5229344|NCT00903630|12858040|P3|NOT COMPLETED|Phase 2||1
5229345|NCT00903630|12858041|P2|NOT COMPLETED|Phase 2||0
5229346|NCT00903630|12858042|P1|NOT COMPLETED|Phase 2||0
5229347|NCT00903630|12858040|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
5229348|NCT00903630|12858041|P2|COMPLETED|Phase 2||0
5229349|NCT00903630|12858042|P1|COMPLETED|Phase 2||6
5229350|NCT00903630|12858040|P3|STARTED|Phase 2||4
5229351|NCT00903630|12858041|P2|STARTED|Phase 2||0
5229352|NCT00903630|12858042|P1|STARTED|Phase 2||6
5229353|NCT00903630|12858040|P3|NOT COMPLETED|Phase l||0
5229354|NCT00903630|12858041|P2|NOT COMPLETED|Phase l||0
5229355|NCT00903630|12858042|P1|NOT COMPLETED|Phase l||0
5229356|NCT00903630|12858040|P3|COMPLETED|Phase l||0
5229357|NCT00903630|12858041|P2|COMPLETED|Phase l||5
5229358|NCT00903630|12858042|P1|COMPLETED|Phase l||6
5229359|NCT00903630|12858040|P3|STARTED|Phase l||0
5229360|NCT00903630|12858041|P2|STARTED|Phase l||5
5229361|NCT00903630|12858042|P1|STARTED|Phase l||6
5229362|NCT00903617|12858060|P4|NOT COMPLETED|Overall Study||1
5229363|NCT00903617|12858061|P3|NOT COMPLETED|Overall Study||5
5229364|NCT00903617|12858062|P2|NOT COMPLETED|Overall Study||5
5229365|NCT00903617|12858063|P1|NOT COMPLETED|Overall Study||3
5229366|NCT00903617|12858060|P4|COMPLETED|Overall Study||20
5229367|NCT00903617|12858061|P3|COMPLETED|Overall Study||15
5229368|NCT00903617|12858062|P2|COMPLETED|Overall Study||15
5229369|NCT00903617|12858063|P1|COMPLETED|Overall Study||16
5229370|NCT00903617|12858060|P4|STARTED|Overall Study||21
5229371|NCT00903617|12858061|P3|STARTED|Overall Study||20
5229372|NCT00903617|12858062|P2|STARTED|Overall Study||20
5229373|NCT00903617|12858063|P1|STARTED|Overall Study||19
5229374|NCT00903448|12858157|P2|NOT COMPLETED|Period 3: 5 Days||0
5229375|NCT00903448|12858158|P1|NOT COMPLETED|Period 3: 5 Days||0
5229376|NCT00903448|12858157|P2|COMPLETED|Period 3: 5 Days||20
5229377|NCT00903448|12858158|P1|COMPLETED|Period 3: 5 Days||20
5229378|NCT00903448|12858157|P2|STARTED|Period 3: 5 Days||20
5229379|NCT00903448|12858158|P1|STARTED|Period 3: 5 Days||20
5229380|NCT00903448|12858157|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
5229381|NCT00903448|12858158|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
5229382|NCT00903448|12858157|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
5229383|NCT00903448|12858158|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
5229384|NCT00903448|12858157|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
5229385|NCT00903448|12858158|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
5229386|NCT00903448|12858157|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
5229387|NCT00903448|12858158|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
5229388|NCT00903448|12858157|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
5229389|NCT00903448|12858158|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
5229390|NCT00903448|12858157|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
5229391|NCT00903448|12858158|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
5229392|NCT00903409|12858166|P2|NOT COMPLETED|Overall Study||27
5229393|NCT00903409|12858167|P1|NOT COMPLETED|Overall Study||26
5229394|NCT00903409|12858166|P2|COMPLETED|Overall Study||73
5229395|NCT00903409|12858167|P1|COMPLETED|Overall Study||62
5229396|NCT00903409|12858166|P2|STARTED|Overall Study||100
5229397|NCT00903409|12858167|P1|STARTED|Overall Study||88
5229398|NCT00903396|12858185|P4|NOT COMPLETED|Overall Study||0
5229399|NCT00903396|12858186|P3|NOT COMPLETED|Overall Study||0
5229400|NCT00903396|12858187|P2|NOT COMPLETED|Overall Study||0
5229401|NCT00903396|12858188|P1|NOT COMPLETED|Overall Study||0
5229402|NCT00903396|12858185|P4|COMPLETED|Overall Study||1
5229403|NCT00903396|12858186|P3|COMPLETED|Overall Study||3
5229404|NCT00903396|12858187|P2|COMPLETED|Overall Study||1
5229405|NCT00903396|12858188|P1|COMPLETED|Overall Study||2
5229406|NCT00903396|12858185|P4|STARTED|Overall Study||1
5229407|NCT00903396|12858186|P3|STARTED|Overall Study||3
5229408|NCT00903396|12858187|P2|STARTED|Overall Study||1
5229409|NCT00903396|12858188|P1|STARTED|Overall Study||2
5229410|NCT00903383|12858218|P4|NOT COMPLETED|Overall Study||5
5229411|NCT00903383|12858219|P3|NOT COMPLETED|Overall Study||3
5229412|NCT00903383|12858220|P2|NOT COMPLETED|Overall Study||6
5229413|NCT00903383|12858221|P1|NOT COMPLETED|Overall Study||7
5229414|NCT00903383|12858218|P4|COMPLETED|Overall Study||44
5229415|NCT00903383|12858219|P3|COMPLETED|Overall Study||47
5229416|NCT00903383|12858220|P2|COMPLETED|Overall Study||48
5229417|NCT00903383|12858221|P1|COMPLETED|Overall Study||48
5229418|NCT00903383|12858218|P4|STARTED|Overall Study||49
5229419|NCT00903383|12858219|P3|STARTED|Overall Study||50
5229420|NCT00903383|12858220|P2|STARTED|Overall Study||54
5229421|NCT00903383|12858221|P1|STARTED|Overall Study||55
5229422|NCT00903370|12858253|P2|NOT COMPLETED|Overall Study||24
5229423|NCT00903370|12858254|P1|NOT COMPLETED|Overall Study||28
5229424|NCT00903370|12858253|P2|COMPLETED|Overall Study||109
5229425|NCT00903370|12858254|P1|COMPLETED|Overall Study||99
5229426|NCT00903370|12858253|P2|STARTED|Overall Study||133
5229427|NCT00903370|12858254|P1|STARTED|Overall Study||127
5229428|NCT00903357|12858262|P2|NOT COMPLETED|Second Intervention||0
5229429|NCT00903357|12858263|P1|NOT COMPLETED|Second Intervention||1
5229430|NCT00903357|12858262|P2|COMPLETED|Second Intervention||22
5229431|NCT00903357|12858263|P1|COMPLETED|Second Intervention||21
5229432|NCT00903357|12858262|P2|STARTED|Second Intervention||22
5229433|NCT00903357|12858263|P1|STARTED|Second Intervention||22
5229434|NCT00903357|12858262|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
5229435|NCT00903357|12858263|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
5229436|NCT00903357|12858262|P2|COMPLETED|Wash Out Period of 2 Weeks||22
5229437|NCT00903357|12858263|P1|COMPLETED|Wash Out Period of 2 Weeks||22
5229438|NCT00903357|12858262|P2|STARTED|Wash Out Period of 2 Weeks||23
5229439|NCT00903357|12858263|P1|STARTED|Wash Out Period of 2 Weeks||22
5229440|NCT00903357|12858262|P2|NOT COMPLETED|First Intervention||4
5229441|NCT00903357|12858263|P1|NOT COMPLETED|First Intervention||5
5229442|NCT00903357|12858262|P2|COMPLETED|First Intervention||23
5229443|NCT00903357|12858263|P1|COMPLETED|First Intervention||22
5229444|NCT00903357|12858262|P2|STARTED|First Intervention||27
5229445|NCT00903357|12858263|P1|STARTED|First Intervention||27
5229446|NCT00903344|12858275|P2|NOT COMPLETED|Overall Study||3
5229447|NCT00903344|12858276|P1|NOT COMPLETED|Overall Study||5
5229448|NCT00903344|12858275|P2|COMPLETED|Overall Study||7
5229449|NCT00903344|12858276|P1|COMPLETED|Overall Study||7
5229450|NCT00903344|12858275|P2|6 Month Visit|Overall Study||10
5229451|NCT00903344|12858276|P1|6 Month Visit|Overall Study||9
5229452|NCT00903344|12858275|P2|3 Month Visit|Overall Study||10
5229453|NCT00903344|12858276|P1|3 Month Visit|Overall Study||10
5229454|NCT00903344|12858275|P2|STARTED|Overall Study||10
5229455|NCT00903344|12858276|P1|STARTED|Overall Study||12
5229456|NCT00903331|12858294|P2|NOT COMPLETED|Overall Study||18
5229457|NCT00903331|12858295|P1|NOT COMPLETED|Overall Study||5
5229458|NCT00903331|12858294|P2|COMPLETED|Overall Study||101
5229459|NCT00903331|12858295|P1|COMPLETED|Overall Study||54
5229460|NCT00903331|12858294|P2|STARTED|Overall Study||119
5229461|NCT00903331|12858295|P1|STARTED|Overall Study||59
5229462|NCT00903201|12858306|P3|NOT COMPLETED|Overall Study||2
5229463|NCT00903201|12858307|P2|NOT COMPLETED|Overall Study||6
5229464|NCT00903201|12858308|P1|NOT COMPLETED|Overall Study||5
5229465|NCT00903201|12858306|P3|COMPLETED|Overall Study||39
5229466|NCT00903201|12858307|P2|COMPLETED|Overall Study||38
5229467|NCT00903201|12858308|P1|COMPLETED|Overall Study||56
5229468|NCT00903201|12858306|P3|STARTED|Overall Study||41
5229469|NCT00903201|12858307|P2|STARTED|Overall Study||44
5229470|NCT00903201|12858308|P1|STARTED|Overall Study||61
5229471|NCT00903175|12858366|P2|NOT COMPLETED|Period 2 - Second Line||36
5229472|NCT00903175|12858367|P1|NOT COMPLETED|Period 2 - Second Line||49
5229473|NCT00903175|12858366|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
5229474|NCT00903175|12858367|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
5229475|NCT00903175|12858366|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
5229476|NCT00903175|12858367|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
5229477|NCT00903175|12858366|P2|NOT COMPLETED|Period 1 - First Line||89
5229478|NCT00903175|12858367|P1|NOT COMPLETED|Period 1 - First Line||77
5229479|NCT00903175|12858366|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
5229480|NCT00903175|12858367|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
5229481|NCT00903175|12858366|P2|STARTED|Period 1 - First Line||231
5229482|NCT00903175|12858367|P1|STARTED|Period 1 - First Line||238
5229483|NCT00903162|12858397|P1|NOT COMPLETED|Overall Study||4
5229484|NCT00903162|12858397|P1|COMPLETED|Overall Study||12
5229485|NCT00903162|12858397|P1|STARTED|Overall Study||16
5229486|NCT00903032|12858405|P2|NOT COMPLETED|Overall Study||5
5229487|NCT00903032|12858406|P1|NOT COMPLETED|Overall Study||7
5229488|NCT00903032|12858405|P2|COMPLETED|Overall Study||119
5229489|NCT00903032|12858406|P1|COMPLETED|Overall Study||122
5229490|NCT00903032|12858405|P2|STARTED|Overall Study||124
5229491|NCT00903032|12858406|P1|STARTED|Overall Study||129
5229492|NCT00903006|12858416|P4|NOT COMPLETED|Overall Study||0
5229493|NCT00903006|12858417|P3|NOT COMPLETED|Overall Study||1
5229494|NCT00903006|12858418|P2|NOT COMPLETED|Overall Study||3
5229495|NCT00903006|12858419|P1|NOT COMPLETED|Overall Study||2
5229496|NCT00903006|12858416|P4|COMPLETED|Overall Study||0
5229497|NCT00903006|12858417|P3|COMPLETED|Overall Study||0
5229498|NCT00903006|12858418|P2|COMPLETED|Overall Study||0
5229499|NCT00903006|12858419|P1|COMPLETED|Overall Study||0
5229500|NCT00903006|12858416|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
5229501|NCT00903006|12858417|P3|STARTED|Overall Study||1
5229502|NCT00903006|12858418|P2|STARTED|Overall Study||3
5229503|NCT00903006|12858419|P1|STARTED|Overall Study||2
5229504|NCT00902850|12858431|P2|NOT COMPLETED|Overall Study||2
5229505|NCT00902850|12858432|P1|NOT COMPLETED|Overall Study||2
5229506|NCT00902850|12858431|P2|COMPLETED|Overall Study||12
5229507|NCT00902850|12858432|P1|COMPLETED|Overall Study||12
5229508|NCT00902850|12858431|P2|STARTED|Overall Study||14
5229509|NCT00902850|12858432|P1|STARTED|Overall Study||14
5229510|NCT00902746|12858438|P1|NOT COMPLETED|Overall Study||36
5229511|NCT00902746|12858438|P1|COMPLETED|Overall Study||113
5229512|NCT00902746|12858438|P1|Transfer to Step 2|Overall Study||133
5229513|NCT00902746|12858438|P1|Initiation of Study Drug Administration|Overall Study||148
5229514|NCT00902746|12858438|P1|STARTED|Overall Study||149
5229515|NCT00902668|12858443|P1|NOT COMPLETED|Overall Study||3
5229516|NCT00902668|12858443|P1|COMPLETED|Overall Study||0
5229517|NCT00902668|12858443|P1|STARTED|Overall Study||3
5229518|NCT00902577|12858447|P1|NOT COMPLETED|Overall Study||8
5229519|NCT00902577|12858447|P1|COMPLETED|Overall Study||42
5229520|NCT00902577|12858447|P1|DWI MRI|Overall Study||39
5229521|NCT00902577|12858447|P1|DSE MRI|Overall Study||37
5229522|NCT00902577|12858447|P1|DCE MRI|Overall Study||31
5229523|NCT00902577|12858447|P1|FMISO/PET|Overall Study||38
5229524|NCT00902577|12858447|P1|STARTED|Overall Study||50
5229525|NCT00902564|12858476|P1|NOT COMPLETED|Overall Study||2
5229526|NCT00902564|12858476|P1|COMPLETED|Overall Study||28
5229527|NCT00902564|12858476|P1|STARTED|Overall Study||30
5229528|NCT00902538|12858491|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
5229529|NCT00902538|12858492|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
5229530|NCT00902538|12858493|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
5229531|NCT00902538|12858494|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229532|NCT00902538|12858495|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229533|NCT00902538|12858496|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229534|NCT00902538|12858491|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
5229535|NCT00902538|12858492|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
5229536|NCT00902538|12858493|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
5229537|NCT00902538|12858494|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229538|NCT00902538|12858495|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229539|NCT00902538|12858496|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
5229540|NCT00902538|12858491|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
5229541|NCT00902538|12858492|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
5229542|NCT00902538|12858493|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
5229543|NCT00902538|12858494|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
5229544|NCT00902538|12858495|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
5229545|NCT00902538|12858496|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
5229546|NCT00902538|12858491|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
5229547|NCT00902538|12858492|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
5229548|NCT00902538|12858493|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
5229549|NCT00902538|12858494|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
5229550|NCT00902538|12858495|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
5229551|NCT00902538|12858496|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
5229552|NCT00902538|12858491|P6|COMPLETED|3-Single-blind, Single Treatment||0
5229553|NCT00902538|12858492|P5|COMPLETED|3-Single-blind, Single Treatment||0
5229554|NCT00902538|12858493|P4|COMPLETED|3-Single-blind, Single Treatment||0
5229555|NCT00902538|12858494|P3|COMPLETED|3-Single-blind, Single Treatment||0
5229556|NCT00902538|12858495|P2|COMPLETED|3-Single-blind, Single Treatment||767
5229557|NCT00902538|12858496|P1|COMPLETED|3-Single-blind, Single Treatment||0
5229558|NCT00902538|12858491|P6|STARTED|3-Single-blind, Single Treatment||0
5229559|NCT00902538|12858492|P5|STARTED|3-Single-blind, Single Treatment||0
5229560|NCT00902538|12858493|P4|STARTED|3-Single-blind, Single Treatment||0
5229561|NCT00902538|12858494|P3|STARTED|3-Single-blind, Single Treatment||0
5229562|NCT00902538|12858495|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
5229563|NCT00902538|12858496|P1|STARTED|3-Single-blind, Single Treatment||0
5229564|NCT00902538|12858491|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229565|NCT00902538|12858492|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229566|NCT00902538|12858493|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229567|NCT00902538|12858494|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
5229568|NCT00902538|12858495|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
5229569|NCT00902538|12858496|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
5229570|NCT00902538|12858491|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229571|NCT00902538|12858492|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229572|NCT00902538|12858493|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
5229573|NCT00902538|12858494|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
5229574|NCT00902538|12858495|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
5229575|NCT00902538|12858496|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
5229576|NCT00902538|12858491|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
5229577|NCT00902538|12858492|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
5229578|NCT00902538|12858493|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
5229579|NCT00902538|12858494|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
5229580|NCT00902538|12858495|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
5229581|NCT00902538|12858496|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
5229582|NCT00902538|12858491|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229583|NCT00902538|12858492|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229584|NCT00902538|12858493|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229585|NCT00902538|12858494|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229586|NCT00902538|12858495|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229587|NCT00902538|12858496|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
5229588|NCT00902538|12858491|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229589|NCT00902538|12858492|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229590|NCT00902538|12858493|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229591|NCT00902538|12858494|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229592|NCT00902538|12858495|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
5229593|NCT00902538|12858496|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
5229594|NCT00902538|12858491|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
5229595|NCT00902538|12858492|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
5229596|NCT00902538|12858493|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
5229597|NCT00902538|12858494|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
5229598|NCT00902538|12858495|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
5229599|NCT00902538|12858496|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
5229600|NCT00902486|12858530|P6|NOT COMPLETED|Follow-up (After Week 24)||0
5229601|NCT00902486|12858531|P5|NOT COMPLETED|Follow-up (After Week 24)||0
5229602|NCT00902486|12858532|P4|NOT COMPLETED|Follow-up (After Week 24)||1
5229603|NCT00902486|12858533|P3|NOT COMPLETED|Follow-up (After Week 24)||0
5229604|NCT00902486|12858534|P2|NOT COMPLETED|Follow-up (After Week 24)||0
5229605|NCT00902486|12858535|P1|NOT COMPLETED|Follow-up (After Week 24)||0
5229606|NCT00902486|12858530|P6|COMPLETED|Follow-up (After Week 24)||24
5229607|NCT00902486|12858531|P5|COMPLETED|Follow-up (After Week 24)||29
5229608|NCT00902486|12858532|P4|COMPLETED|Follow-up (After Week 24)||26
5229609|NCT00902486|12858533|P3|COMPLETED|Follow-up (After Week 24)||13
5229610|NCT00902486|12858534|P2|COMPLETED|Follow-up (After Week 24)||14
5229611|NCT00902486|12858535|P1|COMPLETED|Follow-up (After Week 24)||0
5229612|NCT00902486|12858530|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
5229613|NCT00902486|12858531|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
5229614|NCT00902486|12858532|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
5229615|NCT00902486|12858533|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
5229616|NCT00902486|12858534|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
5229617|NCT00902486|12858535|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
5229618|NCT00902486|12858530|P6|STARTED|Follow-up (After Week 24)||24
5229619|NCT00902486|12858531|P5|STARTED|Follow-up (After Week 24)||29
5229620|NCT00902486|12858532|P4|STARTED|Follow-up (After Week 24)||27
5229621|NCT00902486|12858533|P3|STARTED|Follow-up (After Week 24)||13
5229622|NCT00902486|12858534|P2|STARTED|Follow-up (After Week 24)||14
5229623|NCT00902486|12858535|P1|STARTED|Follow-up (After Week 24)||0
5229624|NCT00902486|12858530|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
5229625|NCT00902486|12858531|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
5229626|NCT00902486|12858532|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
5229627|NCT00902486|12858533|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
5229628|NCT00902486|12858534|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
5229629|NCT00902486|12858535|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
5229630|NCT00902486|12858530|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
5229631|NCT00902486|12858531|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
5229632|NCT00902486|12858532|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
5229633|NCT00902486|12858533|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
5229634|NCT00902486|12858534|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
5229635|NCT00902486|12858535|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
5229636|NCT00902486|12858530|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
5229637|NCT00902486|12858531|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
5229638|NCT00902486|12858532|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
5229639|NCT00902486|12858533|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
5229640|NCT00902486|12858534|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
5229641|NCT00902486|12858535|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
5229642|NCT00902486|12858530|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
5229643|NCT00902486|12858531|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
5229644|NCT00902486|12858532|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
5229645|NCT00902486|12858533|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
5229646|NCT00902486|12858534|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
5229647|NCT00902486|12858535|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
5229648|NCT00902486|12858530|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
5229649|NCT00902486|12858531|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
5229650|NCT00902486|12858532|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
5229651|NCT00902486|12858533|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
5229652|NCT00902486|12858534|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
5229653|NCT00902486|12858535|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
5229654|NCT00902486|12858530|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
5229655|NCT00902486|12858531|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
5229656|NCT00902486|12858532|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
5229657|NCT00902486|12858533|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
5229658|NCT00902486|12858534|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
5229659|NCT00902486|12858535|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
5229660|NCT00902486|12858530|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
5229661|NCT00902486|12858531|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
5229662|NCT00902486|12858532|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
5229663|NCT00902486|12858533|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
5229664|NCT00902486|12858534|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
5229665|NCT00902486|12858535|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
5229666|NCT00902486|12858530|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
5229667|NCT00902486|12858531|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
5229668|NCT00902486|12858532|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
5229669|NCT00902486|12858533|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
5229670|NCT00902486|12858534|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
5229671|NCT00902486|12858535|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
5229672|NCT00902330|12858673|P2|NOT COMPLETED|Overall Study||5
5229673|NCT00902330|12858674|P1|NOT COMPLETED|Overall Study||4
5229674|NCT00902330|12858673|P2|COMPLETED|Overall Study||75
5229675|NCT00902330|12858674|P1|COMPLETED|Overall Study||77
5229676|NCT00902330|12858673|P2|STARTED|Overall Study||80
5229677|NCT00902330|12858674|P1|STARTED|Overall Study||81
5229678|NCT00902304|12858711|P3|NOT COMPLETED|Overall Study||110
5229679|NCT00902304|12858712|P2|NOT COMPLETED|Overall Study||71
5229680|NCT00902304|12858713|P1|NOT COMPLETED|Overall Study||58
5229681|NCT00902304|12858711|P3|COMPLETED|Overall Study||568
5229682|NCT00902304|12858712|P2|COMPLETED|Overall Study||289
5229683|NCT00902304|12858713|P1|COMPLETED|Overall Study||466
5229684|NCT00902304|12858711|P3|STARTED|Overall Study||678
5229685|NCT00902304|12858712|P2|STARTED|Overall Study||360
5229686|NCT00902304|12858713|P1|STARTED|Overall Study||524
5229687|NCT00902278|12858763|P5|NOT COMPLETED|Overall Study||2
5229688|NCT00902278|12858764|P4|NOT COMPLETED|Overall Study||0
5229689|NCT00902278|12858765|P3|NOT COMPLETED|Overall Study||5
5229690|NCT00902278|12858766|P2|NOT COMPLETED|Overall Study||2
5229691|NCT00902278|12858767|P1|NOT COMPLETED|Overall Study||4
5229692|NCT00902278|12858763|P5|COMPLETED|Overall Study||35
5229693|NCT00902278|12858764|P4|COMPLETED|Overall Study||12
5229694|NCT00902278|12858765|P3|COMPLETED|Overall Study||49
5229695|NCT00902278|12858766|P2|COMPLETED|Overall Study||34
5229696|NCT00902278|12858767|P1|COMPLETED|Overall Study||50
5229697|NCT00902278|12858763|P5|STARTED|Overall Study||37
5229698|NCT00902278|12858764|P4|STARTED|Overall Study||12
5229699|NCT00902278|12858765|P3|STARTED|Overall Study||54
5229700|NCT00902278|12858766|P2|STARTED|Overall Study||36
5229701|NCT00902278|12858767|P1|STARTED|Overall Study||54
5229702|NCT00902265|12858784|P1|NOT COMPLETED|Overall Study||6
5229703|NCT00902265|12858784|P1|COMPLETED|Overall Study||132
5229704|NCT00902265|12858784|P1|Participants Who Received Treatment|Overall Study||137
5229705|NCT00902265|12858784|P1|STARTED|Overall Study||138
5229706|NCT00902226|12858796|P1|NOT COMPLETED|Overall Study||0
5229707|NCT00902226|12858796|P1|COMPLETED|Overall Study||30
5229708|NCT00902226|12858796|P1|STARTED|Overall Study||30
5229709|NCT00902174|12858808|P2|NOT COMPLETED|Overall Study||18
5229710|NCT00902174|12858809|P1|NOT COMPLETED|Overall Study||34
5229711|NCT00902174|12858808|P2|COMPLETED|Overall Study||81
5229712|NCT00902174|12858809|P1|COMPLETED|Overall Study||69
5229713|NCT00902174|12858808|P2|STARTED|Overall Study||99
5229714|NCT00902174|12858809|P1|STARTED|Overall Study||103
5229715|NCT00902161|12858847|P3|NOT COMPLETED|Period 2||0
5229716|NCT00902161|12858848|P2|NOT COMPLETED|Period 2||0
5229717|NCT00902161|12858849|P1|NOT COMPLETED|Period 2||0
5229718|NCT00902161|12858847|P3|COMPLETED|Period 2||0
5229719|NCT00902161|12858848|P2|COMPLETED|Period 2||9
5229720|NCT00902161|12858849|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
5229721|NCT00902161|12858847|P3|STARTED|Period 2||0
5229722|NCT00902161|12858848|P2|STARTED|Period 2||9
5229723|NCT00902161|12858849|P1|STARTED|Period 2||8
5229724|NCT00902161|12858847|P3|NOT COMPLETED|Post-clamp Washout||0
5229725|NCT00902161|12858848|P2|NOT COMPLETED|Post-clamp Washout||0
5229726|NCT00902161|12858849|P1|NOT COMPLETED|Post-clamp Washout||0
5229727|NCT00902161|12858847|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
5229728|NCT00902161|12858848|P2|COMPLETED|Post-clamp Washout||0
5229729|NCT00902161|12858849|P1|COMPLETED|Post-clamp Washout||0
5229730|NCT00902161|12858847|P3|STARTED|Post-clamp Washout||22
5229731|NCT00902161|12858848|P2|STARTED|Post-clamp Washout||0
5229732|NCT00902161|12858849|P1|STARTED|Post-clamp Washout||0
5229733|NCT00902161|12858847|P3|NOT COMPLETED|Period 1||0
5229734|NCT00902161|12858848|P2|NOT COMPLETED|Period 1||0
5229735|NCT00902161|12858849|P1|NOT COMPLETED|Period 1||0
5229736|NCT00902161|12858847|P3|COMPLETED|Period 1||0
5229737|NCT00902161|12858848|P2|COMPLETED|Period 1||10
5229738|NCT00902161|12858849|P1|COMPLETED|Period 1||12
5229739|NCT00902161|12858847|P3|STARTED|Period 1||0
5229740|NCT00902161|12858848|P2|STARTED|Period 1||10
5229741|NCT00902161|12858849|P1|STARTED|Period 1||12
5229742|NCT00902161|12858847|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
5229743|NCT00902161|12858848|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
5229744|NCT00902161|12858849|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
5229745|NCT00902161|12858847|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
5229746|NCT00902161|12858848|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
5229747|NCT00902161|12858849|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
5229748|NCT00902161|12858847|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
5229749|NCT00902161|12858848|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
5229750|NCT00902161|12858849|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
5229751|NCT00902018|12858867|P3|NOT COMPLETED|Overall Study||0
5229752|NCT00902018|12858868|P2|NOT COMPLETED|Overall Study||0
5229753|NCT00902018|12858869|P1|NOT COMPLETED|Overall Study||0
5229754|NCT00902018|12858867|P3|COMPLETED|Overall Study||10
5229755|NCT00902018|12858868|P2|COMPLETED|Overall Study||3
5229756|NCT00902018|12858869|P1|COMPLETED|Overall Study||7
5229757|NCT00902018|12858867|P3|STARTED|Overall Study||10
5229758|NCT00902018|12858868|P2|STARTED|Overall Study||3
5229759|NCT00902018|12858869|P1|STARTED|Overall Study||7
5229760|NCT00901927|12858884|P1|NOT COMPLETED|Overall Study||6
5229761|NCT00901927|12858884|P1|COMPLETED|Overall Study||8
5229762|NCT00901927|12858884|P1|STARTED|Overall Study||14
5229763|NCT00901901|12858892|P2|NOT COMPLETED|Follow-up Period||341
5229764|NCT00901901|12858893|P1|NOT COMPLETED|Follow-up Period||340
5229765|NCT00901901|12858892|P2|COMPLETED|Follow-up Period||0
5229766|NCT00901901|12858893|P1|COMPLETED|Follow-up Period||0
5229767|NCT00901901|12858892|P2|STARTED|Follow-up Period||341
5229768|NCT00901901|12858893|P1|STARTED|Follow-up Period||340
5229769|NCT00901901|12858892|P2|NOT COMPLETED|Treatment Period||177
5229770|NCT00901901|12858893|P1|NOT COMPLETED|Treatment Period||169
5229771|NCT00901901|12858892|P2|COMPLETED|Treatment Period||181
5229772|NCT00901901|12858893|P1|COMPLETED|Treatment Period||193
5229773|NCT00901901|12858892|P2|Participants Received Treatment|Treatment Period||355
5229774|NCT00901901|12858893|P1|Participants Received Treatment|Treatment Period||362
5229775|NCT00901901|12858892|P2|STARTED|Treatment Period||358
5229776|NCT00901901|12858893|P1|STARTED|Treatment Period||362
5229777|NCT00901628|12858915|P2|NOT COMPLETED|Overall Study||10
5229778|NCT00901628|12858916|P1|NOT COMPLETED|Overall Study||4
5229779|NCT00901628|12858915|P2|COMPLETED|Overall Study||42
5229780|NCT00901628|12858916|P1|COMPLETED|Overall Study||45
5229781|NCT00901628|12858915|P2|STARTED|Overall Study||52
5229782|NCT00901628|12858916|P1|STARTED|Overall Study||49
5229783|NCT00901576|12858938|P6|NOT COMPLETED|Third Intervention||0
5229784|NCT00901576|12858939|P5|NOT COMPLETED|Third Intervention||0
5229785|NCT00901576|12858940|P4|NOT COMPLETED|Third Intervention||0
5229786|NCT00901576|12858941|P3|NOT COMPLETED|Third Intervention||0
5229787|NCT00901576|12858942|P2|NOT COMPLETED|Third Intervention||0
5229788|NCT00901576|12858943|P1|NOT COMPLETED|Third Intervention||0
5229789|NCT00901576|12858938|P6|COMPLETED|Third Intervention||5
5229790|NCT00901576|12858939|P5|COMPLETED|Third Intervention||6
5229791|NCT00901576|12858940|P4|COMPLETED|Third Intervention||5
5229792|NCT00901576|12858941|P3|COMPLETED|Third Intervention||7
5229793|NCT00901576|12858942|P2|COMPLETED|Third Intervention||7
5229794|NCT00901576|12858943|P1|COMPLETED|Third Intervention||5
5229795|NCT00901576|12858938|P6|STARTED|Third Intervention||5
5229796|NCT00901576|12858939|P5|STARTED|Third Intervention||6
5229797|NCT00901576|12858940|P4|STARTED|Third Intervention||5
5229798|NCT00901576|12858941|P3|STARTED|Third Intervention||7
5229799|NCT00901576|12858942|P2|STARTED|Third Intervention||7
5229800|NCT00901576|12858943|P1|STARTED|Third Intervention||5
5229801|NCT00901576|12858938|P6|NOT COMPLETED|Washout||0
5229802|NCT00901576|12858939|P5|NOT COMPLETED|Washout||0
5229803|NCT00901576|12858940|P4|NOT COMPLETED|Washout||0
5229804|NCT00901576|12858941|P3|NOT COMPLETED|Washout||0
5229805|NCT00901576|12858942|P2|NOT COMPLETED|Washout||0
5229806|NCT00901576|12858943|P1|NOT COMPLETED|Washout||0
5229807|NCT00901576|12858938|P6|COMPLETED|Washout||5
5229808|NCT00901576|12858939|P5|COMPLETED|Washout||6
5229809|NCT00901576|12858940|P4|COMPLETED|Washout||5
5229810|NCT00901576|12858941|P3|COMPLETED|Washout||7
5229811|NCT00901576|12858942|P2|COMPLETED|Washout||7
5229812|NCT00901576|12858943|P1|COMPLETED|Washout||5
5229813|NCT00901576|12858938|P6|STARTED|Washout||5
5229814|NCT00901576|12858939|P5|STARTED|Washout||6
5229815|NCT00901576|12858940|P4|STARTED|Washout||5
5229816|NCT00901576|12858941|P3|STARTED|Washout||7
5229817|NCT00901576|12858942|P2|STARTED|Washout||7
5229818|NCT00901576|12858943|P1|STARTED|Washout||5
5229819|NCT00901576|12858938|P6|NOT COMPLETED|Second Intervention||1
5229820|NCT00901576|12858939|P5|NOT COMPLETED|Second Intervention||0
5229821|NCT00901576|12858940|P4|NOT COMPLETED|Second Intervention||1
5229822|NCT00901576|12858941|P3|NOT COMPLETED|Second Intervention||0
5229823|NCT00901576|12858942|P2|NOT COMPLETED|Second Intervention||0
5229824|NCT00901576|12858943|P1|NOT COMPLETED|Second Intervention||1
5229825|NCT00901576|12858938|P6|COMPLETED|Second Intervention||5
5229826|NCT00901576|12858939|P5|COMPLETED|Second Intervention||6
5229827|NCT00901576|12858940|P4|COMPLETED|Second Intervention||5
5229828|NCT00901576|12858941|P3|COMPLETED|Second Intervention||7
5229829|NCT00901576|12858942|P2|COMPLETED|Second Intervention||7
5229830|NCT00901576|12858943|P1|COMPLETED|Second Intervention||5
5229831|NCT00901576|12858938|P6|STARTED|Second Intervention||6
5229832|NCT00901576|12858939|P5|STARTED|Second Intervention||6
5229833|NCT00901576|12858940|P4|STARTED|Second Intervention||6
5229834|NCT00901576|12858941|P3|STARTED|Second Intervention||7
5229835|NCT00901576|12858942|P2|STARTED|Second Intervention||7
5229836|NCT00901576|12858943|P1|STARTED|Second Intervention||6
5229837|NCT00901576|12858938|P6|NOT COMPLETED|Washout||0
5229838|NCT00901576|12858939|P5|NOT COMPLETED|Washout||0
5229839|NCT00901576|12858940|P4|NOT COMPLETED|Washout||0
5229840|NCT00901576|12858941|P3|NOT COMPLETED|Washout||0
5229841|NCT00901576|12858942|P2|NOT COMPLETED|Washout||0
5229842|NCT00901576|12858943|P1|NOT COMPLETED|Washout||0
5229843|NCT00901576|12858938|P6|COMPLETED|Washout||6
5229844|NCT00901576|12858939|P5|COMPLETED|Washout||6
5229845|NCT00901576|12858940|P4|COMPLETED|Washout||6
5229846|NCT00901576|12858941|P3|COMPLETED|Washout||7
5229847|NCT00901576|12858942|P2|COMPLETED|Washout||7
5229848|NCT00901576|12858943|P1|COMPLETED|Washout||6
5229849|NCT00901576|12858938|P6|STARTED|Washout||6
5229850|NCT00901576|12858939|P5|STARTED|Washout||6
5229851|NCT00901576|12858940|P4|STARTED|Washout||6
5229852|NCT00901576|12858941|P3|STARTED|Washout||7
5229853|NCT00901576|12858942|P2|STARTED|Washout||7
5229854|NCT00901576|12858943|P1|STARTED|Washout||6
5229855|NCT00901576|12858938|P6|NOT COMPLETED|First Intervention||0
5229856|NCT00901576|12858939|P5|NOT COMPLETED|First Intervention||0
5229857|NCT00901576|12858940|P4|NOT COMPLETED|First Intervention||0
5229858|NCT00901576|12858941|P3|NOT COMPLETED|First Intervention||0
5229859|NCT00901576|12858942|P2|NOT COMPLETED|First Intervention||0
5229860|NCT00901576|12858943|P1|NOT COMPLETED|First Intervention||0
5229861|NCT00901576|12858938|P6|COMPLETED|First Intervention||6
5229862|NCT00901576|12858939|P5|COMPLETED|First Intervention||6
5229863|NCT00901576|12858940|P4|COMPLETED|First Intervention||6
5229864|NCT00901576|12858941|P3|COMPLETED|First Intervention||7
5229865|NCT00901576|12858942|P2|COMPLETED|First Intervention||7
5229866|NCT00901576|12858943|P1|COMPLETED|First Intervention||6
5229867|NCT00901576|12858938|P6|STARTED|First Intervention||6
5229868|NCT00901576|12858939|P5|STARTED|First Intervention||6
5229869|NCT00901576|12858940|P4|STARTED|First Intervention||6
5229870|NCT00901576|12858941|P3|STARTED|First Intervention||7
5229871|NCT00901576|12858942|P2|STARTED|First Intervention||7
5229872|NCT00901576|12858943|P1|STARTED|First Intervention||6
5229873|NCT00901459|12858964|P1|NOT COMPLETED|Overall Study||6
5229874|NCT00901459|12858964|P1|COMPLETED|Overall Study||15
5229875|NCT00901459|12858964|P1|STARTED|Overall Study||21
5229876|NCT00901342|12858975|P1|NOT COMPLETED|Overall Study||15
5229877|NCT00901342|12858975|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
5229878|NCT00901342|12858975|P1|Received at Least 1 Infusion|Overall Study||98
5229879|NCT00901342|12858975|P1|STARTED|Overall Study||104
5229880|NCT00901316|12858981|P2|NOT COMPLETED|Overall Study||0
5229881|NCT00901316|12858982|P1|NOT COMPLETED|Overall Study||0
5229882|NCT00901316|12858981|P2|COMPLETED|Overall Study||495
5229883|NCT00901316|12858982|P1|COMPLETED|Overall Study||492
5229884|NCT00901316|12858981|P2|STARTED|Overall Study||495
5229885|NCT00901316|12858982|P1|STARTED|Overall Study||492
5229886|NCT00901303|12858990|P2|NOT COMPLETED|Overall Study||0
5229887|NCT00901303|12858991|P1|NOT COMPLETED|Overall Study||0
5229888|NCT00901303|12858990|P2|COMPLETED|Overall Study||1
5229889|NCT00901303|12858991|P1|COMPLETED|Overall Study||5
5229890|NCT00901303|12858990|P2|STARTED|Overall Study||1
5229891|NCT00901303|12858991|P1|STARTED|Overall Study||5
5229892|NCT00901225|12858997|P1|NOT COMPLETED|Overall Study||1
5229893|NCT00901225|12858997|P1|COMPLETED|Overall Study||20
5229894|NCT00901225|12858997|P1|STARTED|Overall Study||21
5229895|NCT00901186|12859008|P2|NOT COMPLETED|Overall Study||11
5229896|NCT00901186|12859009|P1|NOT COMPLETED|Overall Study||9
5229897|NCT00901186|12859008|P2|COMPLETED|Overall Study||32
5229898|NCT00901186|12859009|P1|COMPLETED|Overall Study||31
5229899|NCT00901186|12859008|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
5229900|NCT00901186|12859009|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
5229901|NCT00901186|12859008|P2|Safety Set|Overall Study||43
5229902|NCT00901186|12859009|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
5229903|NCT00901186|12859008|P2|STARTED|Overall Study||43
5229904|NCT00901186|12859009|P1|STARTED|Overall Study||40
5229905|NCT00901017|12859025|P1|NOT COMPLETED|Overall Study||0
5229906|NCT00901017|12859025|P1|COMPLETED|Overall Study||14
5229907|NCT00901017|12859025|P1|STARTED|Overall Study||14
5229908|NCT00900822|12859039|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
5229909|NCT00900822|12859039|P1|COMPLETED|12 Months Clinical Evaluation||11
5229910|NCT00900822|12859039|P1|STARTED|12 Months Clinical Evaluation||11
5229911|NCT00900822|12859039|P1|NOT COMPLETED|9 Months Histological Evaluation||0
5229912|NCT00900822|12859039|P1|COMPLETED|9 Months Histological Evaluation||11
5229913|NCT00900822|12859039|P1|STARTED|9 Months Histological Evaluation||11
5229914|NCT00900796|12859049|P1|NOT COMPLETED|Phase 2||5
5229915|NCT00900796|12859049|P1|COMPLETED|Phase 2||6
5229916|NCT00900796|12859049|P1|STARTED|Phase 2||11
5229917|NCT00900796|12859049|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
5229918|NCT00900796|12859049|P1|COMPLETED|Between Phase 1 and Phase 2||11
5229919|NCT00900796|12859049|P1|STARTED|Between Phase 1 and Phase 2||121
5229920|NCT00900796|12859049|P1|NOT COMPLETED|Phase 1||11
5229921|NCT00900796|12859049|P1|COMPLETED|Phase 1||121
5229922|NCT00900796|12859049|P1|STARTED|Phase 1||132
5229923|NCT00900757|12859059|P1|NOT COMPLETED|Overall Study||19
5229924|NCT00900757|12859059|P1|COMPLETED|Overall Study||38
5229925|NCT00900757|12859059|P1|STARTED|Overall Study||57
5229926|NCT00900731|12859069|P2|NOT COMPLETED|Overall Study||61
5229927|NCT00900731|12859070|P1|NOT COMPLETED|Overall Study||60
5229928|NCT00900731|12859069|P2|COMPLETED|Overall Study||740
5229929|NCT00900731|12859070|P1|COMPLETED|Overall Study||737
5229930|NCT00900731|12859069|P2|Safety Set: Received Study Drug|Overall Study||799
5229931|NCT00900731|12859070|P1|Safety Set: Received Study Drug|Overall Study||794
5229932|NCT00900731|12859069|P2|STARTED|Overall Study||801
5229933|NCT00900731|12859070|P1|STARTED|Overall Study|Randomized participants|797
5229934|NCT00900666|12859092|P2|NOT COMPLETED|Overall Study||0
5229935|NCT00900666|12859093|P1|NOT COMPLETED|Overall Study||0
5229936|NCT00900666|12859092|P2|COMPLETED|Overall Study||9
5229937|NCT00900666|12859093|P1|COMPLETED|Overall Study||10
5229938|NCT00900666|12859092|P2|STARTED|Overall Study||9
5229939|NCT00900666|12859093|P1|STARTED|Overall Study||10
5229940|NCT00900627|12859107|P6|NOT COMPLETED|Overall Study||26
5229941|NCT00900627|12859108|P5|NOT COMPLETED|Overall Study||29
5229942|NCT00900627|12859109|P4|NOT COMPLETED|Overall Study||6
5229943|NCT00900627|12859110|P3|NOT COMPLETED|Overall Study||6
5229944|NCT00900627|12859111|P2|NOT COMPLETED|Overall Study||2
5229945|NCT00900627|12859112|P1|NOT COMPLETED|Overall Study||6
5229946|NCT00900627|12859107|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
5229947|NCT00900627|12859108|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
5229948|NCT00900627|12859109|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
5229949|NCT00900627|12859110|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
5229950|NCT00900627|12859111|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
5229951|NCT00900627|12859112|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
5229952|NCT00900627|12859107|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
5229953|NCT00900627|12859108|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
5229954|NCT00900627|12859109|P4|STARTED|Overall Study||6
5229955|NCT00900627|12859110|P3|STARTED|Overall Study||6
5229956|NCT00900627|12859111|P2|STARTED|Overall Study||2
5229957|NCT00900627|12859112|P1|STARTED|Overall Study||6
5229958|NCT00900601|12859130|P1|NOT COMPLETED|Overall Study||1
5229959|NCT00900601|12859130|P1|COMPLETED|Overall Study||8
5229960|NCT00900601|12859130|P1|STARTED|Overall Study||9
5229961|NCT00900237|12859138|P2|NOT COMPLETED|Overall Study||0
5229962|NCT00900237|12859139|P1|NOT COMPLETED|Overall Study||0
5229963|NCT00900237|12859138|P2|COMPLETED|Overall Study||7
5229964|NCT00900237|12859139|P1|COMPLETED|Overall Study||7
5229965|NCT00900237|12859138|P2|STARTED|Overall Study||7
5229966|NCT00900237|12859139|P1|STARTED|Overall Study||7
5229967|NCT00900159|12859149|P2|NOT COMPLETED|Second Intervention||0
5229968|NCT00900159|12859150|P1|NOT COMPLETED|Second Intervention||1
5229969|NCT00900159|12859149|P2|COMPLETED|Second Intervention||13
5229970|NCT00900159|12859150|P1|COMPLETED|Second Intervention||10
5229971|NCT00900159|12859149|P2|STARTED|Second Intervention||13
5229972|NCT00900159|12859150|P1|STARTED|Second Intervention||11
5229973|NCT00900159|12859149|P2|NOT COMPLETED|Washout||0
5229974|NCT00900159|12859150|P1|NOT COMPLETED|Washout||0
5229975|NCT00900159|12859149|P2|COMPLETED|Washout||13
5229976|NCT00900159|12859150|P1|COMPLETED|Washout||11
5229977|NCT00900159|12859149|P2|STARTED|Washout||13
5229978|NCT00900159|12859150|P1|STARTED|Washout||11
5229979|NCT00900159|12859149|P2|NOT COMPLETED|First Intervention||0
5229980|NCT00900159|12859150|P1|NOT COMPLETED|First Intervention||0
5229981|NCT00900159|12859149|P2|COMPLETED|First Intervention||13
5229982|NCT00900159|12859150|P1|COMPLETED|First Intervention||11
5229983|NCT00900159|12859149|P2|STARTED|First Intervention||13
5229984|NCT00900159|12859150|P1|STARTED|First Intervention||11
5229985|NCT00900146|12859169|P5|NOT COMPLETED|Intermediate: Period III||167
5229986|NCT00900146|12859170|P4|NOT COMPLETED|Intermediate: Period III||90
5229987|NCT00900146|12859171|P3|NOT COMPLETED|Intermediate: Period III||84
5229988|NCT00900146|12859172|P2|NOT COMPLETED|Intermediate: Period III||93
5229989|NCT00900146|12859173|P1|NOT COMPLETED|Intermediate: Period III||87
5229990|NCT00900146|12859169|P5|COMPLETED|Intermediate: Period III||0
5229991|NCT00900146|12859170|P4|COMPLETED|Intermediate: Period III||0
5229992|NCT00900146|12859171|P3|COMPLETED|Intermediate: Period III||0
5229993|NCT00900146|12859172|P2|COMPLETED|Intermediate: Period III||0
5229994|NCT00900146|12859173|P1|COMPLETED|Intermediate: Period III||0
5229995|NCT00900146|12859169|P5|Safety Set|Intermediate: Period III||166
5229996|NCT00900146|12859170|P4|Safety Set|Intermediate: Period III||90
5229997|NCT00900146|12859171|P3|Safety Set|Intermediate: Period III||84
5229998|NCT00900146|12859172|P2|Safety Set|Intermediate: Period III||92
5229999|NCT00900146|12859173|P1|Safety Set|Intermediate: Period III||86
5230000|NCT00900146|12859169|P5|STARTED|Intermediate: Period III||167
5230001|NCT00900146|12859170|P4|STARTED|Intermediate: Period III||90
5230002|NCT00900146|12859171|P3|STARTED|Intermediate: Period III||84
5230003|NCT00900146|12859172|P2|STARTED|Intermediate: Period III||93
5230004|NCT00900146|12859173|P1|STARTED|Intermediate: Period III||87
5230005|NCT00900146|12859169|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
5230006|NCT00900146|12859170|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
5230007|NCT00900146|12859171|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
5230008|NCT00900146|12859172|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
5230009|NCT00900146|12859173|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
5230010|NCT00900146|12859169|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
5230011|NCT00900146|12859170|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
5230012|NCT00900146|12859171|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
5230013|NCT00900146|12859172|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
5230014|NCT00900146|12859173|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
5230015|NCT00900146|12859169|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
5230016|NCT00900146|12859170|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
5230017|NCT00900146|12859171|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
5230018|NCT00900146|12859172|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
5230019|NCT00900146|12859173|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
5230020|NCT00900146|12859169|P5|STARTED|Dose Finding: Period II (4 Months)||179
5230021|NCT00900146|12859170|P4|STARTED|Dose Finding: Period II (4 Months)||92
5230022|NCT00900146|12859171|P3|STARTED|Dose Finding: Period II (4 Months)||92
5230023|NCT00900146|12859172|P2|STARTED|Dose Finding: Period II (4 Months)||95
5230024|NCT00900146|12859173|P1|STARTED|Dose Finding: Period II (4 Months)||93
5230025|NCT00900029|12859290|P5|NOT COMPLETED|Overall Study||6
5230026|NCT00900029|12859291|P4|NOT COMPLETED|Overall Study||7
5230027|NCT00900029|12859292|P3|NOT COMPLETED|Overall Study||3
5230028|NCT00900029|12859293|P2|NOT COMPLETED|Overall Study||4
5230029|NCT00900029|12859294|P1|NOT COMPLETED|Overall Study||3
5230030|NCT00900029|12859290|P5|COMPLETED|Overall Study||38
5230031|NCT00900029|12859291|P4|COMPLETED|Overall Study||35
5230032|NCT00900029|12859292|P3|COMPLETED|Overall Study||38
5230033|NCT00900029|12859293|P2|COMPLETED|Overall Study||37
5230034|NCT00900029|12859294|P1|COMPLETED|Overall Study||35
5230035|NCT00900029|12859290|P5|STARTED|Overall Study||44
5230036|NCT00900029|12859291|P4|STARTED|Overall Study||42
5230037|NCT00900029|12859292|P3|STARTED|Overall Study||41
5230038|NCT00900029|12859293|P2|STARTED|Overall Study||41
5230039|NCT00900029|12859294|P1|STARTED|Overall Study||38
5230040|NCT00899847|12859311|P1|NOT COMPLETED|Overall Study||2
5230041|NCT00899847|12859311|P1|COMPLETED|Overall Study||7
5230042|NCT00899847|12859311|P1|STARTED|Overall Study||9
5230043|NCT00899717|12859324|P2|NOT COMPLETED|Overall Study||0
5230044|NCT00899717|12859325|P1|NOT COMPLETED|Overall Study||0
5230045|NCT00899717|12859324|P2|COMPLETED|Overall Study||11
5230046|NCT00899717|12859325|P1|COMPLETED|Overall Study||10
5230047|NCT00899717|12859324|P2|STARTED|Overall Study||11
5230048|NCT00899717|12859325|P1|STARTED|Overall Study||10
5230049|NCT00899678|12859342|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
5230050|NCT00899678|12859343|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
5230051|NCT00899678|12859344|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
5230052|NCT00899678|12859342|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
5230053|NCT00899678|12859343|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
5230054|NCT00899678|12859344|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
5230055|NCT00899678|12859342|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
5230056|NCT00899678|12859343|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
5230057|NCT00899678|12859344|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
5230058|NCT00899678|12859342|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
5230059|NCT00899678|12859343|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
5230060|NCT00899678|12859344|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
5230061|NCT00899678|12859342|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
5230062|NCT00899678|12859343|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
5230063|NCT00899678|12859344|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
5230064|NCT00899678|12859342|P3|STARTED|Induction Period (Weeks 0 to 6)||35
5230065|NCT00899678|12859343|P2|STARTED|Induction Period (Weeks 0 to 6)||37
5230066|NCT00899678|12859344|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
5230067|NCT00899600|12859374|P2|NOT COMPLETED|Overall Study||0
5230068|NCT00899600|12859375|P1|NOT COMPLETED|Overall Study||0
5230069|NCT00899600|12859374|P2|COMPLETED|Overall Study||52
5230070|NCT00899600|12859375|P1|COMPLETED|Overall Study||50
5230071|NCT00899600|12859374|P2|STARTED|Overall Study||52
5230072|NCT00899600|12859375|P1|STARTED|Overall Study||50
5230073|NCT00899574|12859389|P1|NOT COMPLETED|Overall Study||0
5230074|NCT00899574|12859389|P1|COMPLETED|Overall Study||10
5230075|NCT00899574|12859389|P1|STARTED|Overall Study||10
5230076|NCT00899548|12859394|P1|NOT COMPLETED|Overall Study||3
5230077|NCT00899548|12859394|P1|COMPLETED|Overall Study||179
5230078|NCT00899548|12859394|P1|STARTED|Overall Study||182
5230079|NCT00899470|12859406|P4|NOT COMPLETED|Fourth Therapy||0
5230080|NCT00899470|12859407|P3|NOT COMPLETED|Fourth Therapy||0
5230081|NCT00899470|12859408|P2|NOT COMPLETED|Fourth Therapy||0
5230082|NCT00899470|12859409|P1|NOT COMPLETED|Fourth Therapy||0
5230083|NCT00899470|12859406|P4|COMPLETED|Fourth Therapy||6
5230084|NCT00899470|12859407|P3|COMPLETED|Fourth Therapy||6
5230085|NCT00899470|12859408|P2|COMPLETED|Fourth Therapy||6
5230086|NCT00899470|12859409|P1|COMPLETED|Fourth Therapy||6
5230087|NCT00899470|12859406|P4|STARTED|Fourth Therapy||6
5230088|NCT00899470|12859407|P3|STARTED|Fourth Therapy||6
5230089|NCT00899470|12859408|P2|STARTED|Fourth Therapy||6
5230090|NCT00899470|12859409|P1|STARTED|Fourth Therapy||6
5230091|NCT00899470|12859406|P4|NOT COMPLETED|Third Washout||0
5230092|NCT00899470|12859407|P3|NOT COMPLETED|Third Washout||0
5230093|NCT00899470|12859408|P2|NOT COMPLETED|Third Washout||0
5230094|NCT00899470|12859409|P1|NOT COMPLETED|Third Washout||0
5230095|NCT00899470|12859406|P4|COMPLETED|Third Washout||6
5230096|NCT00899470|12859407|P3|COMPLETED|Third Washout||6
5230097|NCT00899470|12859408|P2|COMPLETED|Third Washout||6
5230098|NCT00899470|12859409|P1|COMPLETED|Third Washout||6
5230099|NCT00899470|12859406|P4|STARTED|Third Washout||6
5230100|NCT00899470|12859407|P3|STARTED|Third Washout||6
5230101|NCT00899470|12859408|P2|STARTED|Third Washout||6
5230102|NCT00899470|12859409|P1|STARTED|Third Washout||6
5230103|NCT00899470|12859406|P4|NOT COMPLETED|Third Therapy||0
5230104|NCT00899470|12859407|P3|NOT COMPLETED|Third Therapy||0
5230105|NCT00899470|12859408|P2|NOT COMPLETED|Third Therapy||0
5230106|NCT00899470|12859409|P1|NOT COMPLETED|Third Therapy||0
5230107|NCT00899470|12859406|P4|COMPLETED|Third Therapy||6
5230108|NCT00899470|12859407|P3|COMPLETED|Third Therapy||6
5230109|NCT00899470|12859408|P2|COMPLETED|Third Therapy||6
5230110|NCT00899470|12859409|P1|COMPLETED|Third Therapy||6
5230111|NCT00899470|12859406|P4|STARTED|Third Therapy||6
5230112|NCT00899470|12859407|P3|STARTED|Third Therapy||6
5230113|NCT00899470|12859408|P2|STARTED|Third Therapy||6
5230114|NCT00899470|12859409|P1|STARTED|Third Therapy||6
5230115|NCT00899470|12859406|P4|NOT COMPLETED|Second Washout||0
5230116|NCT00899470|12859407|P3|NOT COMPLETED|Second Washout||0
5230117|NCT00899470|12859408|P2|NOT COMPLETED|Second Washout||0
5230118|NCT00899470|12859409|P1|NOT COMPLETED|Second Washout||0
5230119|NCT00899470|12859406|P4|COMPLETED|Second Washout||6
5230120|NCT00899470|12859407|P3|COMPLETED|Second Washout||6
5230121|NCT00899470|12859408|P2|COMPLETED|Second Washout||6
5230122|NCT00899470|12859409|P1|COMPLETED|Second Washout||6
5230123|NCT00899470|12859406|P4|STARTED|Second Washout||6
5230124|NCT00899470|12859407|P3|STARTED|Second Washout||6
5230125|NCT00899470|12859408|P2|STARTED|Second Washout||6
5230126|NCT00899470|12859409|P1|STARTED|Second Washout||6
5230127|NCT00899470|12859406|P4|NOT COMPLETED|Second Therapy||0
5230128|NCT00899470|12859407|P3|NOT COMPLETED|Second Therapy||0
5230129|NCT00899470|12859408|P2|NOT COMPLETED|Second Therapy||0
5230130|NCT00899470|12859409|P1|NOT COMPLETED|Second Therapy||0
5230131|NCT00899470|12859406|P4|COMPLETED|Second Therapy||6
5230132|NCT00899470|12859407|P3|COMPLETED|Second Therapy||6
5230133|NCT00899470|12859408|P2|COMPLETED|Second Therapy||6
5230134|NCT00899470|12859409|P1|COMPLETED|Second Therapy||6
5230135|NCT00899470|12859406|P4|STARTED|Second Therapy||6
5230136|NCT00899470|12859407|P3|STARTED|Second Therapy||6
5230137|NCT00899470|12859408|P2|STARTED|Second Therapy||6
5230138|NCT00899470|12859409|P1|STARTED|Second Therapy||6
5230139|NCT00899470|12859406|P4|NOT COMPLETED|First Washout Period||0
5230140|NCT00899470|12859407|P3|NOT COMPLETED|First Washout Period||0
5230141|NCT00899470|12859408|P2|NOT COMPLETED|First Washout Period||0
5230142|NCT00899470|12859409|P1|NOT COMPLETED|First Washout Period||0
5230143|NCT00899470|12859406|P4|COMPLETED|First Washout Period||6
5230144|NCT00899470|12859407|P3|COMPLETED|First Washout Period||6
5230145|NCT00899470|12859408|P2|COMPLETED|First Washout Period||6
5230146|NCT00899470|12859409|P1|COMPLETED|First Washout Period||6
5230147|NCT00899470|12859406|P4|STARTED|First Washout Period||6
5230148|NCT00899470|12859407|P3|STARTED|First Washout Period||6
5230149|NCT00899470|12859408|P2|STARTED|First Washout Period||6
5230150|NCT00899470|12859409|P1|STARTED|First Washout Period||6
5230151|NCT00899470|12859406|P4|NOT COMPLETED|First Therapy||0
5230152|NCT00899470|12859407|P3|NOT COMPLETED|First Therapy||0
5230153|NCT00899470|12859408|P2|NOT COMPLETED|First Therapy||0
5230154|NCT00899470|12859409|P1|NOT COMPLETED|First Therapy||0
5230155|NCT00899470|12859406|P4|COMPLETED|First Therapy||6
5230156|NCT00899470|12859407|P3|COMPLETED|First Therapy||6
5230157|NCT00899470|12859408|P2|COMPLETED|First Therapy||6
5230158|NCT00899470|12859409|P1|COMPLETED|First Therapy||6
5230159|NCT00899470|12859406|P4|STARTED|First Therapy||6
5230160|NCT00899470|12859407|P3|STARTED|First Therapy||6
5230161|NCT00899470|12859408|P2|STARTED|First Therapy||6
5230162|NCT00899470|12859409|P1|STARTED|First Therapy||6
5230163|NCT00899431|12859488|P3|NOT COMPLETED|Overall Study||0
5230164|NCT00899431|12859489|P2|NOT COMPLETED|Overall Study||0
5230165|NCT00899431|12859490|P1|NOT COMPLETED|Overall Study||1
5230166|NCT00899431|12859488|P3|COMPLETED|Overall Study||9
5230167|NCT00899431|12859489|P2|COMPLETED|Overall Study||8
5230168|NCT00899431|12859490|P1|COMPLETED|Overall Study||21
5230169|NCT00899431|12859488|P3|STARTED|Overall Study||9
5230170|NCT00899431|12859489|P2|STARTED|Overall Study||8
5230171|NCT00899431|12859490|P1|STARTED|Overall Study||22
5230172|NCT00899392|12859503|P2|NOT COMPLETED|Overall Study||24
5230173|NCT00899392|12859504|P1|NOT COMPLETED|Overall Study||21
5230174|NCT00899392|12859503|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
5230175|NCT00899392|12859504|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
5230176|NCT00899392|12859503|P2|STARTED|Overall Study||74
5230177|NCT00899392|12859504|P1|STARTED|Overall Study||68
5230178|NCT00899379|12859521|P5|NOT COMPLETED|Overall Study||31
5230179|NCT00899379|12859522|P4|NOT COMPLETED|Overall Study||37
5230180|NCT00899379|12859523|P3|NOT COMPLETED|Overall Study||29
5230181|NCT00899379|12859524|P2|NOT COMPLETED|Overall Study||29
5230182|NCT00899379|12859525|P1|NOT COMPLETED|Overall Study||34
5230183|NCT00899379|12859521|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
5230184|NCT00899379|12859522|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
5230185|NCT00899379|12859523|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
5230186|NCT00899379|12859524|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
5230187|NCT00899379|12859525|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
5230188|NCT00899379|12859521|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
5230189|NCT00899379|12859522|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
5230190|NCT00899379|12859523|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
5230191|NCT00899379|12859524|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
5230192|NCT00899379|12859525|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
5230193|NCT00899379|12859521|P5|Patients Treated|Overall Study|Patients who took study drug|81
5230194|NCT00899379|12859522|P4|Patients Treated|Overall Study|Patients who took study drug|77
5230195|NCT00899379|12859523|P3|Patients Treated|Overall Study|Patients who took study drug|84
5230196|NCT00899379|12859524|P2|Patients Treated|Overall Study|Patients who took study drug|82
5230197|NCT00899379|12859525|P1|Patients Treated|Overall Study|Patients who took study drug|83
5230198|NCT00899379|12859521|P5|STARTED|Overall Study|Patients who were allocated study drug|94
5230199|NCT00899379|12859522|P4|STARTED|Overall Study|Patients who were allocated study drug|94
5230200|NCT00899379|12859523|P3|STARTED|Overall Study|Patients who were allocated study drug|95
5230201|NCT00899379|12859524|P2|STARTED|Overall Study|Patients who were allocated study drug|95
5230202|NCT00899379|12859525|P1|STARTED|Overall Study|Patients who were allocated study drug|95
5230203|NCT00899353|12859537|P1|NOT COMPLETED|Overall Study||5
5230204|NCT00899353|12859537|P1|COMPLETED|Overall Study||11
5230205|NCT00899353|12859537|P1|STARTED|Overall Study||16
5230206|NCT00898937|12859561|P3|NOT COMPLETED|Overall Study||0
5230207|NCT00898937|12859562|P2|NOT COMPLETED|Overall Study||0
5230208|NCT00898937|12859563|P1|NOT COMPLETED|Overall Study||0
5230209|NCT00898937|12859561|P3|COMPLETED|Overall Study||9
5230210|NCT00898937|12859562|P2|COMPLETED|Overall Study||21
5230211|NCT00898937|12859563|P1|COMPLETED|Overall Study||25
5230212|NCT00898937|12859561|P3|STARTED|Overall Study||9
5230213|NCT00898937|12859562|P2|STARTED|Overall Study||21
5230214|NCT00898937|12859563|P1|STARTED|Overall Study||25
5230215|NCT00898807|12859573|P2|NOT COMPLETED|Overall Study||9
5230216|NCT00898807|12859574|P1|NOT COMPLETED|Overall Study||8
5230217|NCT00898807|12859573|P2|COMPLETED|Overall Study||83
5230218|NCT00898807|12859574|P1|COMPLETED|Overall Study||86
5230219|NCT00898807|12859573|P2|STARTED|Overall Study||92
5230220|NCT00898807|12859574|P1|STARTED|Overall Study||94
5230221|NCT00898677|12859590|P4|NOT COMPLETED|Overall Study||19
5230222|NCT00898677|12859591|P3|NOT COMPLETED|Overall Study||72
5230223|NCT00898677|12859592|P2|NOT COMPLETED|Overall Study||69
5230224|NCT00898677|12859593|P1|NOT COMPLETED|Overall Study||17
5230225|NCT00898677|12859590|P4|COMPLETED|Overall Study||159
5230226|NCT00898677|12859591|P3|COMPLETED|Overall Study||383
5230227|NCT00898677|12859592|P2|COMPLETED|Overall Study||386
5230228|NCT00898677|12859593|P1|COMPLETED|Overall Study||163
5230229|NCT00898677|12859590|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
5230230|NCT00898677|12859591|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
5230231|NCT00898677|12859592|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
5230232|NCT00898677|12859593|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
5230233|NCT00898677|12859590|P4|STARTED|Overall Study||178
5230234|NCT00898677|12859591|P3|STARTED|Overall Study||455
5230235|NCT00898677|12859592|P2|STARTED|Overall Study||455
5230236|NCT00898677|12859593|P1|STARTED|Overall Study||180
5230237|NCT00898560|12859619|P1|NOT COMPLETED|Overall Study||1
5230238|NCT00898560|12859619|P1|COMPLETED|Overall Study||19
5230239|NCT00898560|12859619|P1|STARTED|Overall Study||20
5230240|NCT00898443|12859631|P2|NOT COMPLETED|Overall Study||0
5230241|NCT00898443|12859632|P1|NOT COMPLETED|Overall Study||1
5230242|NCT00898443|12859631|P2|COMPLETED|Overall Study||8
5230243|NCT00898443|12859632|P1|COMPLETED|Overall Study||9
5230244|NCT00898443|12859631|P2|STARTED|Overall Study||8
5230245|NCT00898443|12859632|P1|STARTED|Overall Study||10
5230246|NCT00898222|12859640|P1|NOT COMPLETED|Overall Study||0
5230247|NCT00898222|12859640|P1|COMPLETED|Overall Study||4
5230248|NCT00898222|12859640|P1|STARTED|Overall Study||4
5230249|NCT00897949|12859647|P3|NOT COMPLETED|Overall Study||69
5230250|NCT00897949|12859648|P2|NOT COMPLETED|Overall Study||103
5230251|NCT00897949|12859649|P1|NOT COMPLETED|Overall Study||104
5230252|NCT00897949|12859647|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
5230253|NCT00897949|12859648|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
5230254|NCT00897949|12859649|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
5230255|NCT00897949|12859647|P3|Patients Treated|Overall Study|Patients who took study drug|304
5230256|NCT00897949|12859648|P2|Patients Treated|Overall Study|Patients who took study drug|456
5230257|NCT00897949|12859649|P1|Patients Treated|Overall Study|Patients who took study drug|458
5230258|NCT00897949|12859647|P3|STARTED|Overall Study|Patients who were allocated study drug|370
5230259|NCT00897949|12859648|P2|STARTED|Overall Study|Patients who were allocated study drug|549
5230260|NCT00897949|12859649|P1|STARTED|Overall Study|Patients who were allocated study drug|554
5230261|NCT00897910|12859672|P1|NOT COMPLETED|Overall Study||0
5230262|NCT00897910|12859672|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
5230263|NCT00897910|12859672|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
5230264|NCT00897897|12859676|P1|NOT COMPLETED|Overall Study||0
5230265|NCT00897897|12859676|P1|COMPLETED|Overall Study||33
5230266|NCT00897897|12859676|P1|STARTED|Overall Study||33
5230267|NCT00897715|12859683|P2|NOT COMPLETED|Overall Study||1
5230268|NCT00897715|12859684|P1|NOT COMPLETED|Overall Study||2
5230269|NCT00897715|12859683|P2|COMPLETED|Overall Study||6
5230270|NCT00897715|12859684|P1|COMPLETED|Overall Study||6
5230271|NCT00897715|12859683|P2|STARTED|Overall Study||7
5230272|NCT00897715|12859684|P1|STARTED|Overall Study||8
5230273|NCT00897676|12859692|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
5230274|NCT00897676|12859693|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
5230275|NCT00897676|12859692|P2|COMPLETED|Intervention 2(6 Hours)||7
5230276|NCT00897676|12859693|P1|COMPLETED|Intervention 2(6 Hours)||9
5230277|NCT00897676|12859692|P2|STARTED|Intervention 2(6 Hours)||7
5230278|NCT00897676|12859693|P1|STARTED|Intervention 2(6 Hours)||9
5230279|NCT00897676|12859692|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
5230280|NCT00897676|12859693|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
5230281|NCT00897676|12859692|P2|COMPLETED|Intervention 1(6 Hours)||7
5230282|NCT00897676|12859693|P1|COMPLETED|Intervention 1(6 Hours)||9
5230283|NCT00897676|12859692|P2|STARTED|Intervention 1(6 Hours)||7
5230284|NCT00897676|12859693|P1|STARTED|Intervention 1(6 Hours)||9
5230285|NCT00897390|12859709|P1|NOT COMPLETED|Overall Study||6
5230286|NCT00897390|12859709|P1|COMPLETED|Overall Study||18
5230287|NCT00897390|12859709|P1|STARTED|Overall Study||24
5230288|NCT00897104|12859799|P3|NOT COMPLETED|Overall Study||8
5230289|NCT00897104|12859800|P2|NOT COMPLETED|Overall Study||71
5230290|NCT00897104|12859801|P1|NOT COMPLETED|Overall Study||64
5230291|NCT00897104|12859799|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
5230292|NCT00897104|12859800|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
5230293|NCT00897104|12859801|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
5230294|NCT00897104|12859799|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
5230295|NCT00897104|12859800|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
5230296|NCT00897104|12859801|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
5230297|NCT00897104|12859799|P3|Participants Treated|Overall Study|Participants who took study drug|80
5230298|NCT00897104|12859800|P2|Participants Treated|Overall Study|Participants who took study drug|357
5230299|NCT00897104|12859801|P1|Participants Treated|Overall Study|Participants who took study drug|355
5230300|NCT00897104|12859799|P3|STARTED|Overall Study|Participants who were allocated study drug|87
5230301|NCT00897104|12859800|P2|STARTED|Overall Study|Participants who were allocated study drug|428
5230302|NCT00897104|12859801|P1|STARTED|Overall Study|Participants who were allocated study drug|418
5230303|NCT00896779|12859829|P2|NOT COMPLETED|Overall Study||1
5230304|NCT00896779|12859830|P1|NOT COMPLETED|Overall Study||0
5230305|NCT00896779|12859829|P2|COMPLETED|Overall Study||11
5230306|NCT00896779|12859830|P1|COMPLETED|Overall Study||8
5230307|NCT00896779|12859829|P2|STARTED|Overall Study||12
5230308|NCT00896779|12859830|P1|STARTED|Overall Study||8
5230309|NCT00896649|12859836|P1|NOT COMPLETED|Overall Study||5
5230310|NCT00896649|12859836|P1|COMPLETED|Overall Study||188
5230311|NCT00896649|12859836|P1|STARTED|Overall Study||193
5230312|NCT00896532|12859849|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230313|NCT00896532|12859850|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
5230314|NCT00896532|12859851|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230315|NCT00896532|12859852|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230316|NCT00896532|12859853|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
5230317|NCT00896532|12859854|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230318|NCT00896532|12859855|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230319|NCT00896532|12859856|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230320|NCT00896532|12859857|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230321|NCT00896532|12859858|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230322|NCT00896532|12859859|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230323|NCT00896532|12859860|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230324|NCT00896532|12859861|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230325|NCT00896532|12859862|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230326|NCT00896532|12859863|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230327|NCT00896532|12859864|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230328|NCT00896532|12859865|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230329|NCT00896532|12859866|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230330|NCT00896532|12859867|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230331|NCT00896532|12859868|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230332|NCT00896532|12859869|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230333|NCT00896532|12859870|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230334|NCT00896532|12859871|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
5230335|NCT00896532|12859849|P23|COMPLETED|Months 48-72: Follow-on Phase||8
5230336|NCT00896532|12859850|P22|COMPLETED|Months 48-72: Follow-on Phase||57
5230337|NCT00896532|12859851|P21|COMPLETED|Months 48-72: Follow-on Phase||12
5230338|NCT00896532|12859852|P20|COMPLETED|Months 48-72: Follow-on Phase||11
5230339|NCT00896532|12859853|P19|COMPLETED|Months 48-72: Follow-on Phase||50
5230340|NCT00896532|12859854|P18|COMPLETED|Months 48-72: Follow-on Phase||0
5230341|NCT00896532|12859855|P17|COMPLETED|Months 48-72: Follow-on Phase||0
5230342|NCT00896532|12859856|P16|COMPLETED|Months 48-72: Follow-on Phase||0
5230343|NCT00896532|12859857|P15|COMPLETED|Months 48-72: Follow-on Phase||0
5230344|NCT00896532|12859858|P14|COMPLETED|Months 48-72: Follow-on Phase||0
5230345|NCT00896532|12859859|P13|COMPLETED|Months 48-72: Follow-on Phase||0
5230346|NCT00896532|12859860|P12|COMPLETED|Months 48-72: Follow-on Phase||0
5230347|NCT00896532|12859861|P11|COMPLETED|Months 48-72: Follow-on Phase||0
5230348|NCT00896532|12859862|P10|COMPLETED|Months 48-72: Follow-on Phase||0
5230349|NCT00896532|12859863|P9|COMPLETED|Months 48-72: Follow-on Phase||0
5230350|NCT00896532|12859864|P8|COMPLETED|Months 48-72: Follow-on Phase||0
5230351|NCT00896532|12859865|P7|COMPLETED|Months 48-72: Follow-on Phase||0
5230352|NCT00896532|12859866|P6|COMPLETED|Months 48-72: Follow-on Phase||0
5230353|NCT00896532|12859867|P5|COMPLETED|Months 48-72: Follow-on Phase||0
5230354|NCT00896532|12859868|P4|COMPLETED|Months 48-72: Follow-on Phase||0
5230355|NCT00896532|12859869|P3|COMPLETED|Months 48-72: Follow-on Phase||0
5230356|NCT00896532|12859870|P2|COMPLETED|Months 48-72: Follow-on Phase||0
5230357|NCT00896532|12859871|P1|COMPLETED|Months 48-72: Follow-on Phase||0
5230358|NCT00896532|12859849|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
5230359|NCT00896532|12859850|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
5230360|NCT00896532|12859851|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
5230361|NCT00896532|12859852|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
5230362|NCT00896532|12859853|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230363|NCT00896532|12859854|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230364|NCT00896532|12859855|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230365|NCT00896532|12859856|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230366|NCT00896532|12859857|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230367|NCT00896532|12859858|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230368|NCT00896532|12859859|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230369|NCT00896532|12859860|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230370|NCT00896532|12859861|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230371|NCT00896532|12859862|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230372|NCT00896532|12859863|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230373|NCT00896532|12859864|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230374|NCT00896532|12859865|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230375|NCT00896532|12859866|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230376|NCT00896532|12859867|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230377|NCT00896532|12859868|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230378|NCT00896532|12859869|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230379|NCT00896532|12859870|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230380|NCT00896532|12859871|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
5230381|NCT00896532|12859849|P23|STARTED|Months 48-72: Follow-on Phase||8
5230382|NCT00896532|12859850|P22|STARTED|Months 48-72: Follow-on Phase||59
5230383|NCT00896532|12859851|P21|STARTED|Months 48-72: Follow-on Phase||12
5230384|NCT00896532|12859852|P20|STARTED|Months 48-72: Follow-on Phase||11
5230385|NCT00896532|12859853|P19|STARTED|Months 48-72: Follow-on Phase||51
5230386|NCT00896532|12859854|P18|STARTED|Months 48-72: Follow-on Phase||0
5230387|NCT00896532|12859855|P17|STARTED|Months 48-72: Follow-on Phase||0
5230388|NCT00896532|12859856|P16|STARTED|Months 48-72: Follow-on Phase||0
5230389|NCT00896532|12859857|P15|STARTED|Months 48-72: Follow-on Phase||0
5230390|NCT00896532|12859858|P14|STARTED|Months 48-72: Follow-on Phase||0
5230391|NCT00896532|12859859|P13|STARTED|Months 48-72: Follow-on Phase||0
5230392|NCT00896532|12859860|P12|STARTED|Months 48-72: Follow-on Phase||0
5230393|NCT00896532|12859861|P11|STARTED|Months 48-72: Follow-on Phase||0
5230394|NCT00896532|12859862|P10|STARTED|Months 48-72: Follow-on Phase||0
5230395|NCT00896532|12859863|P9|STARTED|Months 48-72: Follow-on Phase||0
5230396|NCT00896532|12859864|P8|STARTED|Months 48-72: Follow-on Phase||0
5230397|NCT00896532|12859865|P7|STARTED|Months 48-72: Follow-on Phase||0
5230398|NCT00896532|12859866|P6|STARTED|Months 48-72: Follow-on Phase||0
5230399|NCT00896532|12859867|P5|STARTED|Months 48-72: Follow-on Phase||0
5230400|NCT00896532|12859868|P4|STARTED|Months 48-72: Follow-on Phase||0
5230401|NCT00896532|12859869|P3|STARTED|Months 48-72: Follow-on Phase||0
5230402|NCT00896532|12859870|P2|STARTED|Months 48-72: Follow-on Phase||0
5230403|NCT00896532|12859871|P1|STARTED|Months 48-72: Follow-on Phase||0
5230404|NCT00896532|12859849|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230405|NCT00896532|12859850|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230406|NCT00896532|12859851|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230407|NCT00896532|12859852|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230408|NCT00896532|12859853|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230409|NCT00896532|12859854|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
5230410|NCT00896532|12859855|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
5230411|NCT00896532|12859856|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
5230412|NCT00896532|12859857|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230413|NCT00896532|12859858|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230414|NCT00896532|12859859|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230415|NCT00896532|12859860|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230416|NCT00896532|12859861|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230417|NCT00896532|12859862|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230418|NCT00896532|12859863|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230419|NCT00896532|12859864|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230420|NCT00896532|12859865|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230421|NCT00896532|12859866|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230422|NCT00896532|12859867|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230423|NCT00896532|12859868|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230424|NCT00896532|12859869|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230425|NCT00896532|12859870|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230426|NCT00896532|12859871|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230427|NCT00896532|12859849|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230428|NCT00896532|12859850|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230429|NCT00896532|12859851|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230430|NCT00896532|12859852|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230431|NCT00896532|12859853|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230432|NCT00896532|12859854|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
5230433|NCT00896532|12859855|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
5230434|NCT00896532|12859856|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
5230435|NCT00896532|12859857|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
5230436|NCT00896532|12859858|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230437|NCT00896532|12859859|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230438|NCT00896532|12859860|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230439|NCT00896532|12859861|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230440|NCT00896532|12859862|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230441|NCT00896532|12859863|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230442|NCT00896532|12859864|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230443|NCT00896532|12859865|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230444|NCT00896532|12859866|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230445|NCT00896532|12859867|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230446|NCT00896532|12859868|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230447|NCT00896532|12859869|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230448|NCT00896532|12859870|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230449|NCT00896532|12859871|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
5230450|NCT00896532|12859849|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230451|NCT00896532|12859850|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230452|NCT00896532|12859851|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230453|NCT00896532|12859852|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230454|NCT00896532|12859853|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230455|NCT00896532|12859854|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
5230456|NCT00896532|12859855|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
5230457|NCT00896532|12859856|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
5230458|NCT00896532|12859857|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
5230459|NCT00896532|12859858|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230460|NCT00896532|12859859|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230461|NCT00896532|12859860|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230462|NCT00896532|12859861|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230463|NCT00896532|12859862|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230464|NCT00896532|12859863|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230465|NCT00896532|12859864|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230466|NCT00896532|12859865|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230467|NCT00896532|12859866|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230468|NCT00896532|12859867|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230469|NCT00896532|12859868|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230470|NCT00896532|12859869|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230471|NCT00896532|12859870|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230472|NCT00896532|12859871|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
5230473|NCT00896532|12859849|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
5230474|NCT00896532|12859850|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
5230475|NCT00896532|12859851|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
5230476|NCT00896532|12859852|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
5230477|NCT00896532|12859853|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
5230478|NCT00896532|12859854|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
5230479|NCT00896532|12859855|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
5230480|NCT00896532|12859856|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
5230481|NCT00896532|12859857|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
5230482|NCT00896532|12859858|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
5230483|NCT00896532|12859859|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
5230484|NCT00896532|12859860|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
5230485|NCT00896532|12859861|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
5230486|NCT00896532|12859862|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
5230487|NCT00896532|12859863|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
5230488|NCT00896532|12859864|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
5230489|NCT00896532|12859865|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
5230490|NCT00896532|12859866|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
5230491|NCT00896532|12859867|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
5230492|NCT00896532|12859868|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
5230493|NCT00896532|12859869|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
5230494|NCT00896532|12859870|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
5230495|NCT00896532|12859871|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
5230496|NCT00896532|12859849|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230497|NCT00896532|12859850|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230498|NCT00896532|12859851|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230499|NCT00896532|12859852|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230500|NCT00896532|12859853|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230501|NCT00896532|12859854|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230502|NCT00896532|12859855|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230503|NCT00896532|12859856|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230504|NCT00896532|12859857|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230505|NCT00896532|12859858|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
5230506|NCT00896532|12859859|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
5230507|NCT00896532|12859860|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
5230508|NCT00896532|12859861|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
5230509|NCT00896532|12859862|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230510|NCT00896532|12859863|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
5230511|NCT00896532|12859864|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230512|NCT00896532|12859865|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230513|NCT00896532|12859866|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230514|NCT00896532|12859867|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230515|NCT00896532|12859868|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230516|NCT00896532|12859869|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230517|NCT00896532|12859870|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230518|NCT00896532|12859871|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230519|NCT00896532|12859849|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230520|NCT00896532|12859850|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230521|NCT00896532|12859851|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230522|NCT00896532|12859852|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230523|NCT00896532|12859853|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230524|NCT00896532|12859854|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230525|NCT00896532|12859855|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230526|NCT00896532|12859856|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230527|NCT00896532|12859857|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230528|NCT00896532|12859858|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
5230529|NCT00896532|12859859|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
5230530|NCT00896532|12859860|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
5230531|NCT00896532|12859861|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
5230532|NCT00896532|12859862|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
5230533|NCT00896532|12859863|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
5230534|NCT00896532|12859864|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230535|NCT00896532|12859865|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230536|NCT00896532|12859866|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230537|NCT00896532|12859867|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230538|NCT00896532|12859868|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230539|NCT00896532|12859869|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230540|NCT00896532|12859870|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230541|NCT00896532|12859871|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
5230542|NCT00896532|12859849|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230543|NCT00896532|12859850|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230544|NCT00896532|12859851|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230545|NCT00896532|12859852|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230546|NCT00896532|12859853|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230547|NCT00896532|12859854|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230548|NCT00896532|12859855|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230549|NCT00896532|12859856|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230550|NCT00896532|12859857|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230551|NCT00896532|12859858|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
5230552|NCT00896532|12859859|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
5230553|NCT00896532|12859860|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
5230554|NCT00896532|12859861|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
5230555|NCT00896532|12859862|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
5230556|NCT00896532|12859863|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
5230557|NCT00896532|12859864|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230558|NCT00896532|12859865|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230559|NCT00896532|12859866|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230560|NCT00896532|12859867|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230561|NCT00896532|12859868|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230562|NCT00896532|12859869|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230563|NCT00896532|12859870|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230564|NCT00896532|12859871|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
5230565|NCT00896532|12859849|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
5230566|NCT00896532|12859850|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
5230567|NCT00896532|12859851|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
5230568|NCT00896532|12859852|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
5230569|NCT00896532|12859853|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
5230570|NCT00896532|12859854|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
5230571|NCT00896532|12859855|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
5230572|NCT00896532|12859856|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
5230573|NCT00896532|12859857|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
5230574|NCT00896532|12859858|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
5230575|NCT00896532|12859859|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
5230576|NCT00896532|12859860|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
5230577|NCT00896532|12859861|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
5230578|NCT00896532|12859862|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
5230579|NCT00896532|12859863|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
5230580|NCT00896532|12859864|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
5230581|NCT00896532|12859865|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
5230582|NCT00896532|12859866|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
5230583|NCT00896532|12859867|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
5230584|NCT00896532|12859868|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
5230585|NCT00896532|12859869|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
5230586|NCT00896532|12859870|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
5230587|NCT00896532|12859871|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
5230588|NCT00896532|12859849|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230589|NCT00896532|12859850|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230590|NCT00896532|12859851|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230591|NCT00896532|12859852|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230592|NCT00896532|12859853|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230593|NCT00896532|12859854|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230594|NCT00896532|12859855|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230595|NCT00896532|12859856|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230596|NCT00896532|12859857|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230597|NCT00896532|12859858|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230598|NCT00896532|12859859|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230599|NCT00896532|12859860|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230600|NCT00896532|12859861|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230601|NCT00896532|12859862|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230602|NCT00896532|12859863|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230603|NCT00896532|12859864|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
5230604|NCT00896532|12859865|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
5230605|NCT00896532|12859866|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
5230606|NCT00896532|12859867|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
5230607|NCT00896532|12859868|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
5230608|NCT00896532|12859869|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
5230609|NCT00896532|12859870|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
5230610|NCT00896532|12859871|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
5230611|NCT00896532|12859849|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230612|NCT00896532|12859850|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230613|NCT00896532|12859851|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230614|NCT00896532|12859852|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230615|NCT00896532|12859853|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230616|NCT00896532|12859854|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230617|NCT00896532|12859855|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230618|NCT00896532|12859856|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230619|NCT00896532|12859857|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230620|NCT00896532|12859858|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230621|NCT00896532|12859859|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230622|NCT00896532|12859860|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230623|NCT00896532|12859861|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230624|NCT00896532|12859862|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230625|NCT00896532|12859863|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
5230626|NCT00896532|12859864|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
5230627|NCT00896532|12859865|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
5230628|NCT00896532|12859866|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
5230629|NCT00896532|12859867|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
5230630|NCT00896532|12859868|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
5230631|NCT00896532|12859869|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
5230632|NCT00896532|12859870|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
5230633|NCT00896532|12859871|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
5230634|NCT00896532|12859849|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230635|NCT00896532|12859850|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230636|NCT00896532|12859851|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230637|NCT00896532|12859852|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230638|NCT00896532|12859853|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230639|NCT00896532|12859854|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230640|NCT00896532|12859855|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230641|NCT00896532|12859856|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230642|NCT00896532|12859857|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230643|NCT00896532|12859858|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230644|NCT00896532|12859859|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230645|NCT00896532|12859860|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230646|NCT00896532|12859861|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230647|NCT00896532|12859862|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230648|NCT00896532|12859863|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
5230649|NCT00896532|12859864|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
5230650|NCT00896532|12859865|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
5230651|NCT00896532|12859866|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
5230652|NCT00896532|12859867|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
5230653|NCT00896532|12859868|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
5230654|NCT00896532|12859869|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
5230655|NCT00896532|12859870|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
5230656|NCT00896532|12859871|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
5230657|NCT00896532|12859849|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230658|NCT00896532|12859850|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230659|NCT00896532|12859851|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230660|NCT00896532|12859852|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230661|NCT00896532|12859853|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230662|NCT00896532|12859854|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230663|NCT00896532|12859855|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230664|NCT00896532|12859856|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230665|NCT00896532|12859857|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230666|NCT00896532|12859858|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230667|NCT00896532|12859859|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230668|NCT00896532|12859860|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230669|NCT00896532|12859861|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230670|NCT00896532|12859862|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230671|NCT00896532|12859863|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
5230672|NCT00896532|12859864|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
5230673|NCT00896532|12859865|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
5230674|NCT00896532|12859866|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
5230675|NCT00896532|12859867|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
5230676|NCT00896532|12859868|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
5230677|NCT00896532|12859869|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
5230678|NCT00896532|12859870|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
5230767|NCT00896038|12860339|P2|STARTED|Overall Study||28
5230768|NCT00896038|12860340|P1|STARTED|Overall Study||30
5230679|NCT00896532|12859871|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
5230680|NCT00896532|12859849|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230681|NCT00896532|12859850|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230682|NCT00896532|12859851|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230683|NCT00896532|12859852|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230684|NCT00896532|12859853|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230685|NCT00896532|12859854|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230686|NCT00896532|12859855|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230687|NCT00896532|12859856|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230688|NCT00896532|12859857|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230689|NCT00896532|12859858|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230690|NCT00896532|12859859|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230691|NCT00896532|12859860|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230692|NCT00896532|12859861|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230693|NCT00896532|12859862|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230694|NCT00896532|12859863|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
5230695|NCT00896532|12859864|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
5230696|NCT00896532|12859865|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
5230697|NCT00896532|12859866|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
5230698|NCT00896532|12859867|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
5230699|NCT00896532|12859868|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
5230700|NCT00896532|12859869|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
5230701|NCT00896532|12859870|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
5230702|NCT00896532|12859871|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
5230703|NCT00896480|12859998|P1|NOT COMPLETED|Overall Study||21
5230704|NCT00896480|12859998|P1|COMPLETED|Overall Study||3
5230705|NCT00896480|12859998|P1|STARTED|Overall Study||24
5230706|NCT00896454|12860046|P1|NOT COMPLETED|Overall Study||33
5230707|NCT00896454|12860046|P1|COMPLETED|Overall Study||0
5230708|NCT00896454|12860046|P1|STARTED|Overall Study||33
5230709|NCT00896441|12860060|P2|NOT COMPLETED|Overall Study||0
5230710|NCT00896441|12860061|P1|NOT COMPLETED|Overall Study||2
5230711|NCT00896441|12860060|P2|COMPLETED|Overall Study||9
5230712|NCT00896441|12860061|P1|COMPLETED|Overall Study||15
5230713|NCT00896441|12860060|P2|STARTED|Overall Study||9
5230714|NCT00896441|12860061|P1|STARTED|Overall Study||17
5230715|NCT00896389|12860068|P1|NOT COMPLETED|HCTZ High Dose||0
5230716|NCT00896389|12860068|P1|COMPLETED|HCTZ High Dose||25
5230717|NCT00896389|12860068|P1|STARTED|HCTZ High Dose||25
5230718|NCT00896389|12860068|P1|NOT COMPLETED|HCTZ Low Dose||0
5230719|NCT00896389|12860068|P1|COMPLETED|HCTZ Low Dose||28
5230720|NCT00896389|12860068|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
5230721|NCT00896389|12860068|P1|NOT COMPLETED|Salt Loading||0
5230722|NCT00896389|12860068|P1|COMPLETED|Salt Loading||124
5230723|NCT00896389|12860068|P1|STARTED|Salt Loading||124
5230724|NCT00896363|12860085|P3|NOT COMPLETED|Overall Study||8
5230725|NCT00896363|12860086|P2|NOT COMPLETED|Overall Study||11
5230726|NCT00896363|12860087|P1|NOT COMPLETED|Overall Study||6
5230727|NCT00896363|12860085|P3|COMPLETED|Overall Study||24
5230728|NCT00896363|12860086|P2|COMPLETED|Overall Study||25
5230729|NCT00896363|12860087|P1|COMPLETED|Overall Study||25
5230730|NCT00896363|12860085|P3|STARTED|Overall Study||32
5230731|NCT00896363|12860086|P2|STARTED|Overall Study||36
5230732|NCT00896363|12860087|P1|STARTED|Overall Study||31
5230733|NCT00896337|12860139|P1|NOT COMPLETED|Overall Study||25
5230734|NCT00896337|12860139|P1|COMPLETED|Overall Study||100
5230735|NCT00896337|12860139|P1|STARTED|Overall Study||125
5230736|NCT00896298|12860208|P2|NOT COMPLETED|Overall Study||3
5230737|NCT00896298|12860209|P1|NOT COMPLETED|Overall Study||3
5230738|NCT00896298|12860208|P2|COMPLETED|Overall Study||9
5230739|NCT00896298|12860209|P1|COMPLETED|Overall Study||10
5230740|NCT00896298|12860208|P2|STARTED|Overall Study||12
5230741|NCT00896298|12860209|P1|STARTED|Overall Study||13
5230742|NCT00896233|12860221|P1|NOT COMPLETED|Overall Study||1
5230743|NCT00896233|12860221|P1|COMPLETED|Overall Study||9
5230744|NCT00896233|12860221|P1|STARTED|Overall Study||10
5230745|NCT00896168|12860234|P2|NOT COMPLETED|Overall Study||19
5230746|NCT00896168|12860235|P1|NOT COMPLETED|Overall Study||14
5230747|NCT00896168|12860234|P2|COMPLETED|Overall Study||111
5230748|NCT00896168|12860235|P1|COMPLETED|Overall Study||90
5230749|NCT00896168|12860234|P2|STARTED|Overall Study||130
5230750|NCT00896168|12860235|P1|STARTED|Overall Study||104
5230751|NCT00896064|12860265|P2|NOT COMPLETED|Overall Study||0
5230752|NCT00896064|12860266|P1|NOT COMPLETED|Overall Study||0
5230753|NCT00896064|12860265|P2|COMPLETED|Overall Study||21
5230754|NCT00896064|12860266|P1|COMPLETED|Overall Study||22
5230755|NCT00896064|12860265|P2|STARTED|Overall Study||21
5230756|NCT00896064|12860266|P1|STARTED|Overall Study||22
5230757|NCT00896051|12860296|P2|NOT COMPLETED|Overall Study||9
5230758|NCT00896051|12860297|P1|NOT COMPLETED|Overall Study||10
5230759|NCT00896051|12860296|P2|COMPLETED|Overall Study||16
5230760|NCT00896051|12860297|P1|COMPLETED|Overall Study||15
5230761|NCT00896051|12860296|P2|STARTED|Overall Study||25
5230762|NCT00896051|12860297|P1|STARTED|Overall Study||25
5230763|NCT00896038|12860339|P2|NOT COMPLETED|Overall Study||1
5230764|NCT00896038|12860340|P1|NOT COMPLETED|Overall Study||4
5230765|NCT00896038|12860339|P2|COMPLETED|Overall Study||27
5230766|NCT00896038|12860340|P1|COMPLETED|Overall Study||26
5230769|NCT00896025|12860378|P1|NOT COMPLETED|Overall Study||0
5230770|NCT00896025|12860378|P1|COMPLETED|Overall Study||8
5230771|NCT00896025|12860378|P1|STARTED|Overall Study||8
5230772|NCT00895947|12860392|P2|NOT COMPLETED|Overall Study||10
5230773|NCT00895947|12860393|P1|NOT COMPLETED|Overall Study||12
5230774|NCT00895947|12860392|P2|COMPLETED|Overall Study||90
5230775|NCT00895947|12860393|P1|COMPLETED|Overall Study||88
5230776|NCT00895947|12860392|P2|STARTED|Overall Study||100
5230777|NCT00895947|12860393|P1|STARTED|Overall Study||100
5230778|NCT00895934|12860411|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
5230779|NCT00895934|12860412|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
5230780|NCT00895934|12860413|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
5230781|NCT00895934|12860414|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
5230782|NCT00895934|12860411|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
5230783|NCT00895934|12860412|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
5230784|NCT00895934|12860413|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
5230785|NCT00895934|12860414|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
5230786|NCT00895934|12860411|P4|STARTED|Efficacy of Most Tolerated Dose||37
5230787|NCT00895934|12860412|P3|STARTED|Efficacy of Most Tolerated Dose||0
5230788|NCT00895934|12860413|P2|STARTED|Efficacy of Most Tolerated Dose||0
5230789|NCT00895934|12860414|P1|STARTED|Efficacy of Most Tolerated Dose||0
5230790|NCT00895934|12860411|P4|NOT COMPLETED|Dose Escalation||0
5230791|NCT00895934|12860412|P3|NOT COMPLETED|Dose Escalation||0
5230792|NCT00895934|12860413|P2|NOT COMPLETED|Dose Escalation||0
5230793|NCT00895934|12860414|P1|NOT COMPLETED|Dose Escalation||0
5230794|NCT00895934|12860411|P4|COMPLETED|Dose Escalation||6
5230795|NCT00895934|12860412|P3|COMPLETED|Dose Escalation||3
5230796|NCT00895934|12860413|P2|COMPLETED|Dose Escalation||3
5230797|NCT00895934|12860414|P1|COMPLETED|Dose Escalation||3
5230798|NCT00895934|12860411|P4|STARTED|Dose Escalation||6
5230799|NCT00895934|12860412|P3|STARTED|Dose Escalation||3
5230800|NCT00895934|12860413|P2|STARTED|Dose Escalation||3
5230801|NCT00895934|12860414|P1|STARTED|Dose Escalation||3
5230802|NCT00895895|12860431|P5|NOT COMPLETED|Period 2||49
5230803|NCT00895895|12860432|P4|NOT COMPLETED|Period 2||54
5230804|NCT00895895|12860433|P3|NOT COMPLETED|Period 2||49
5230805|NCT00895895|12860434|P2|NOT COMPLETED|Period 2||53
5230806|NCT00895895|12860435|P1|NOT COMPLETED|Period 2||56
5230807|NCT00895895|12860431|P5|COMPLETED|Period 2||35
5230808|NCT00895895|12860432|P4|COMPLETED|Period 2||37
5230809|NCT00895895|12860433|P3|COMPLETED|Period 2||33
5230810|NCT00895895|12860434|P2|COMPLETED|Period 2||31
5230811|NCT00895895|12860435|P1|COMPLETED|Period 2||30
5230812|NCT00895895|12860431|P5|STARTED|Period 2||84
5230813|NCT00895895|12860432|P4|STARTED|Period 2||91
5230814|NCT00895895|12860433|P3|STARTED|Period 2||82
5230815|NCT00895895|12860434|P2|STARTED|Period 2||84
5230816|NCT00895895|12860435|P1|STARTED|Period 2||86
5230817|NCT00895895|12860431|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
5230818|NCT00895895|12860432|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
5230819|NCT00895895|12860433|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
5230820|NCT00895895|12860434|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
5230821|NCT00895895|12860435|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
5230822|NCT00895895|12860431|P5|COMPLETED|After Period 1, Prior to Period 2||84
5230823|NCT00895895|12860432|P4|COMPLETED|After Period 1, Prior to Period 2||91
5230824|NCT00895895|12860433|P3|COMPLETED|After Period 1, Prior to Period 2||82
5230825|NCT00895895|12860434|P2|COMPLETED|After Period 1, Prior to Period 2||84
5230826|NCT00895895|12860435|P1|COMPLETED|After Period 1, Prior to Period 2||86
5230827|NCT00895895|12860431|P5|STARTED|After Period 1, Prior to Period 2||86
5230828|NCT00895895|12860432|P4|STARTED|After Period 1, Prior to Period 2||91
5230829|NCT00895895|12860433|P3|STARTED|After Period 1, Prior to Period 2||84
5230830|NCT00895895|12860434|P2|STARTED|After Period 1, Prior to Period 2||84
5230831|NCT00895895|12860435|P1|STARTED|After Period 1, Prior to Period 2||86
5230832|NCT00895895|12860431|P5|NOT COMPLETED|Period 1||20
5230833|NCT00895895|12860432|P4|NOT COMPLETED|Period 1||13
5230834|NCT00895895|12860433|P3|NOT COMPLETED|Period 1||20
5230835|NCT00895895|12860434|P2|NOT COMPLETED|Period 1||21
5230836|NCT00895895|12860435|P1|NOT COMPLETED|Period 1||21
5230837|NCT00895895|12860431|P5|COMPLETED|Period 1||86
5230838|NCT00895895|12860432|P4|COMPLETED|Period 1||91
5230839|NCT00895895|12860433|P3|COMPLETED|Period 1||84
5230840|NCT00895895|12860434|P2|COMPLETED|Period 1||84
5230841|NCT00895895|12860435|P1|COMPLETED|Period 1||86
5230842|NCT00895895|12860431|P5|Randomized But Not Treated|Period 1||2
5230843|NCT00895895|12860432|P4|Randomized But Not Treated|Period 1||1
5230844|NCT00895895|12860433|P3|Randomized But Not Treated|Period 1||1
5230845|NCT00895895|12860434|P2|Randomized But Not Treated|Period 1||3
5230846|NCT00895895|12860435|P1|Randomized But Not Treated|Period 1||1
5230847|NCT00895895|12860431|P5|STARTED|Period 1||106
5230848|NCT00895895|12860432|P4|STARTED|Period 1||104
5230849|NCT00895895|12860433|P3|STARTED|Period 1||104
5230850|NCT00895895|12860434|P2|STARTED|Period 1||105
5230851|NCT00895895|12860435|P1|STARTED|Period 1||107
5230852|NCT00895843|12860549|P2|NOT COMPLETED|Overall Study||12
5230853|NCT00895843|12860550|P1|NOT COMPLETED|Overall Study||12
5230854|NCT00895843|12860549|P2|COMPLETED|Overall Study||50
5230855|NCT00895843|12860550|P1|COMPLETED|Overall Study||48
5230856|NCT00895843|12860549|P2|STARTED|Overall Study||62
5230857|NCT00895843|12860550|P1|STARTED|Overall Study||60
5230858|NCT00895830|12860561|P5|NOT COMPLETED|Overall Study||0
5230859|NCT00895830|12860562|P4|NOT COMPLETED|Overall Study||0
5230860|NCT00895830|12860563|P3|NOT COMPLETED|Overall Study||0
5230861|NCT00895830|12860564|P2|NOT COMPLETED|Overall Study||0
5230862|NCT00895830|12860565|P1|NOT COMPLETED|Overall Study||0
5230863|NCT00895830|12860561|P5|COMPLETED|Overall Study||55
5230864|NCT00895830|12860562|P4|COMPLETED|Overall Study||52
5230865|NCT00895830|12860563|P3|COMPLETED|Overall Study||49
5230866|NCT00895830|12860564|P2|COMPLETED|Overall Study||50
5230867|NCT00895830|12860565|P1|COMPLETED|Overall Study||51
5230868|NCT00895830|12860561|P5|STARTED|Overall Study||55
5230869|NCT00895830|12860562|P4|STARTED|Overall Study||52
5230870|NCT00895830|12860563|P3|STARTED|Overall Study||49
5230871|NCT00895830|12860564|P2|STARTED|Overall Study||50
5230872|NCT00895830|12860565|P1|STARTED|Overall Study||51
5230873|NCT00895817|12860579|P2|NOT COMPLETED|Overall Study||0
5230874|NCT00895817|12860580|P1|NOT COMPLETED|Overall Study||0
5230875|NCT00895817|12860579|P2|COMPLETED|Overall Study||21
5230876|NCT00895817|12860580|P1|COMPLETED|Overall Study||21
5230877|NCT00895817|12860579|P2|STARTED|Overall Study||21
5230878|NCT00895817|12860580|P1|STARTED|Overall Study||21
5230879|NCT00895752|12860586|P1|NOT COMPLETED|Overall Study||0
5230880|NCT00895752|12860586|P1|COMPLETED|Overall Study||6
5230881|NCT00895752|12860586|P1|STARTED|Overall Study||6
5230882|NCT00895661|12860597|P1|NOT COMPLETED|Overall Study||3
5230883|NCT00895661|12860597|P1|COMPLETED|Overall Study||37
5230884|NCT00895661|12860597|P1|STARTED|Overall Study||40
5230885|NCT00895622|12860607|P3|NOT COMPLETED|Overall Study||4
5230886|NCT00895622|12860608|P2|NOT COMPLETED|Overall Study||4
5230887|NCT00895622|12860609|P1|NOT COMPLETED|Overall Study||5
5230888|NCT00895622|12860607|P3|COMPLETED|Overall Study||53
5230889|NCT00895622|12860608|P2|COMPLETED|Overall Study||52
5230890|NCT00895622|12860609|P1|COMPLETED|Overall Study||60
5230891|NCT00895622|12860607|P3|STARTED|Overall Study||57
5230892|NCT00895622|12860608|P2|STARTED|Overall Study||56
5230893|NCT00895622|12860609|P1|STARTED|Overall Study||65
5230894|NCT00895583|12860636|P2|NOT COMPLETED|Overall Study||12
5230895|NCT00895583|12860637|P1|NOT COMPLETED|Overall Study||44
5230896|NCT00895583|12860636|P2|COMPLETED|Overall Study||111
5230897|NCT00895583|12860637|P1|COMPLETED|Overall Study||87
5230898|NCT00895583|12860636|P2|STARTED|Overall Study||123
5230899|NCT00895583|12860637|P1|STARTED|Overall Study||131
5230900|NCT00895531|12860717|P2|NOT COMPLETED|Overall Study||0
5230901|NCT00895531|12860718|P1|NOT COMPLETED|Overall Study||0
5230902|NCT00895531|12860717|P2|COMPLETED|Overall Study||37
5230903|NCT00895531|12860718|P1|COMPLETED|Overall Study||38
5230904|NCT00895531|12860717|P2|STARTED|Overall Study||37
5230905|NCT00895531|12860718|P1|STARTED|Overall Study||38
5230906|NCT00895453|12860727|P3|NOT COMPLETED|Overall Study||23
5230907|NCT00895453|12860728|P2|NOT COMPLETED|Overall Study||25
5230908|NCT00895453|12860729|P1|NOT COMPLETED|Overall Study||25
5230909|NCT00895453|12860727|P3|COMPLETED|Overall Study||23
5230910|NCT00895453|12860728|P2|COMPLETED|Overall Study||25
5230911|NCT00895453|12860729|P1|COMPLETED|Overall Study||23
5230912|NCT00895453|12860727|P3|STARTED|Overall Study||46
5230913|NCT00895453|12860728|P2|STARTED|Overall Study||50
5230914|NCT00895453|12860729|P1|STARTED|Overall Study||48
5230915|NCT00895414|12860737|P2|NOT COMPLETED|Second Intervention (14 Days)||0
5230916|NCT00895414|12860738|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5230917|NCT00895414|12860737|P2|COMPLETED|Second Intervention (14 Days)||9
5230918|NCT00895414|12860738|P1|COMPLETED|Second Intervention (14 Days)||8
5230919|NCT00895414|12860737|P2|STARTED|Second Intervention (14 Days)||9
5230920|NCT00895414|12860738|P1|STARTED|Second Intervention (14 Days)||8
5230921|NCT00895414|12860737|P2|NOT COMPLETED|First Intervention (14 Days)||1
5230922|NCT00895414|12860738|P1|NOT COMPLETED|First Intervention (14 Days)||1
5230923|NCT00895414|12860737|P2|COMPLETED|First Intervention (14 Days)||9
5230924|NCT00895414|12860738|P1|COMPLETED|First Intervention (14 Days)||8
5230925|NCT00895414|12860737|P2|STARTED|First Intervention (14 Days)||10
5230926|NCT00895414|12860738|P1|STARTED|First Intervention (14 Days)||9
5230927|NCT00895310|12860748|P1|NOT COMPLETED|Overall Study||1
5230928|NCT00895310|12860748|P1|COMPLETED|Overall Study||29
5230929|NCT00895310|12860748|P1|STARTED|Overall Study||30
5230930|NCT00895284|12860757|P2|NOT COMPLETED|Overall Study||0
5230931|NCT00895284|12860758|P1|NOT COMPLETED|Overall Study||0
5230932|NCT00895284|12860757|P2|COMPLETED|Overall Study||0
5230933|NCT00895284|12860758|P1|COMPLETED|Overall Study||3
5230934|NCT00895284|12860757|P2|STARTED|Overall Study||0
5230935|NCT00895284|12860758|P1|STARTED|Overall Study||3
5230936|NCT00895245|12860764|P1|NOT COMPLETED|Overall Study||6
5230937|NCT00895245|12860764|P1|COMPLETED|Overall Study||0
5230938|NCT00895245|12860764|P1|STARTED|Overall Study||6
5230939|NCT00895232|12860774|P3|NOT COMPLETED|Overall Study||5
5230940|NCT00895232|12860775|P2|NOT COMPLETED|Overall Study||4
5230941|NCT00895232|12860776|P1|NOT COMPLETED|Overall Study||3
5230942|NCT00895232|12860774|P3|COMPLETED|Overall Study||3
5230943|NCT00895232|12860775|P2|COMPLETED|Overall Study||2
5230944|NCT00895232|12860776|P1|COMPLETED|Overall Study||4
5230945|NCT00895232|12860774|P3|STARTED|Overall Study||8
5230946|NCT00895232|12860775|P2|STARTED|Overall Study||6
5230947|NCT00895232|12860776|P1|STARTED|Overall Study||7
5230948|NCT00895193|12860794|P4|NOT COMPLETED|Overall Study||0
5230949|NCT00895193|12860795|P3|NOT COMPLETED|Overall Study||0
5230950|NCT00895193|12860796|P2|NOT COMPLETED|Overall Study||0
5230951|NCT00895193|12860797|P1|NOT COMPLETED|Overall Study||0
5230952|NCT00895193|12860794|P4|COMPLETED|Overall Study||25
5230953|NCT00895193|12860795|P3|COMPLETED|Overall Study||25
5230954|NCT00895193|12860796|P2|COMPLETED|Overall Study||25
5230955|NCT00895193|12860797|P1|COMPLETED|Overall Study||25
5230956|NCT00895193|12860794|P4|STARTED|Overall Study||25
5230957|NCT00895193|12860795|P3|STARTED|Overall Study||25
5230958|NCT00895193|12860796|P2|STARTED|Overall Study||25
5230959|NCT00895193|12860797|P1|STARTED|Overall Study||25
5230960|NCT00895180|12860821|P2|NOT COMPLETED|Overall Study||0
5230961|NCT00895180|12860822|P1|NOT COMPLETED|Overall Study||0
5230962|NCT00895180|12860821|P2|COMPLETED|Overall Study||40
5230963|NCT00895180|12860822|P1|COMPLETED|Overall Study||40
5230964|NCT00895180|12860821|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
5230965|NCT00895180|12860822|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
5230966|NCT00895180|12860821|P2|STARTED|Overall Study||40
5230967|NCT00895180|12860822|P1|STARTED|Overall Study||40
5230968|NCT00895154|12860842|P2|NOT COMPLETED|Overall Study||2
5230969|NCT00895154|12860843|P1|NOT COMPLETED|Overall Study||1
5230970|NCT00895154|12860842|P2|COMPLETED|Overall Study||8
5230971|NCT00895154|12860843|P1|COMPLETED|Overall Study||7
5230972|NCT00895154|12860842|P2|Follow Up|Overall Study||8
5230973|NCT00895154|12860843|P1|Follow Up|Overall Study||7
5230974|NCT00895154|12860842|P2|STARTED|Overall Study||10
5230975|NCT00895154|12860843|P1|STARTED|Overall Study||8
5230976|NCT00895037|12860878|P3|NOT COMPLETED|Overall Study||1
5230977|NCT00895037|12860879|P2|NOT COMPLETED|Overall Study||2
5230978|NCT00895037|12860880|P1|NOT COMPLETED|Overall Study||0
5230979|NCT00895037|12860878|P3|COMPLETED|Overall Study||1
5230980|NCT00895037|12860879|P2|COMPLETED|Overall Study||75
5230981|NCT00895037|12860880|P1|COMPLETED|Overall Study||22
5230982|NCT00895037|12860878|P3|STARTED|Overall Study||2
5230983|NCT00895037|12860879|P2|STARTED|Overall Study||77
5230984|NCT00895037|12860880|P1|STARTED|Overall Study||22
5230985|NCT00895011|12860911|P3|NOT COMPLETED|Overall Study||8
5230986|NCT00895011|12860912|P2|NOT COMPLETED|Overall Study||14
5230987|NCT00895011|12860913|P1|NOT COMPLETED|Overall Study||24
5230988|NCT00895011|12860911|P3|COMPLETED|Overall Study||91
5230989|NCT00895011|12860912|P2|COMPLETED|Overall Study||85
5230990|NCT00895011|12860913|P1|COMPLETED|Overall Study||76
5230991|NCT00895011|12860911|P3|STARTED|Overall Study||99
5230992|NCT00895011|12860912|P2|STARTED|Overall Study||99
5230993|NCT00895011|12860913|P1|STARTED|Overall Study||100
5230994|NCT00894933|12860927|P1|NOT COMPLETED|Overall Study||4
5230995|NCT00894933|12860927|P1|COMPLETED|Overall Study||29
5230996|NCT00894933|12860927|P1|STARTED|Overall Study||33
5230997|NCT00894803|12860945|P2|NOT COMPLETED|Overall Study||5
5230998|NCT00894803|12860946|P1|NOT COMPLETED|Overall Study||20
5230999|NCT00894803|12860945|P2|COMPLETED|Overall Study||20
5231000|NCT00894803|12860946|P1|COMPLETED|Overall Study||81
5231001|NCT00894803|12860945|P2|STARTED|Overall Study||25
5231002|NCT00894803|12860946|P1|STARTED|Overall Study||101
5231003|NCT00894790|12860982|P2|NOT COMPLETED|Overall Study||2
5231004|NCT00894790|12860983|P1|NOT COMPLETED|Overall Study||1
5231005|NCT00894790|12860982|P2|COMPLETED|Overall Study||2
5231006|NCT00894790|12860983|P1|COMPLETED|Overall Study||3
5231007|NCT00894790|12860982|P2|STARTED|Overall Study||4
5231008|NCT00894790|12860983|P1|STARTED|Overall Study||4
5231009|NCT00894738|12861007|P2|NOT COMPLETED|Overall Study||0
5231010|NCT00894738|12861008|P1|NOT COMPLETED|Overall Study||0
5231011|NCT00894738|12861007|P2|COMPLETED|Overall Study||19
5231012|NCT00894738|12861008|P1|COMPLETED|Overall Study||25
5231013|NCT00894738|12861007|P2|STARTED|Overall Study||19
5231014|NCT00894738|12861008|P1|STARTED|Overall Study||25
5231015|NCT00894699|12861018|P2|NOT COMPLETED|Overall Study||0
5231016|NCT00894699|12861019|P1|NOT COMPLETED|Overall Study||0
5231017|NCT00894699|12861018|P2|COMPLETED|Overall Study||19
5231018|NCT00894699|12861019|P1|COMPLETED|Overall Study||21
5231019|NCT00894699|12861018|P2|STARTED|Overall Study||19
5231020|NCT00894699|12861019|P1|STARTED|Overall Study||21
5231021|NCT00894686|12861025|P1|NOT COMPLETED|Overall Study||56
5231022|NCT00894686|12861025|P1|COMPLETED|Overall Study||123
5231023|NCT00894686|12861025|P1|STARTED|Overall Study||179
5231024|NCT00894647|12861049|P2|NOT COMPLETED|Overall Study||14
5231025|NCT00894647|12861050|P1|NOT COMPLETED|Overall Study||10
5231026|NCT00894647|12861049|P2|COMPLETED|Overall Study||112
5231027|NCT00894647|12861050|P1|COMPLETED|Overall Study||111
5231028|NCT00894647|12861049|P2|STARTED|Overall Study||126
5231029|NCT00894647|12861050|P1|STARTED|Overall Study||121
5231030|NCT00894556|12861063|P4|NOT COMPLETED|Treatment Phase||0
5231031|NCT00894556|12861064|P3|NOT COMPLETED|Treatment Phase||1
5231032|NCT00894556|12861065|P2|NOT COMPLETED|Treatment Phase||4
5231033|NCT00894556|12861066|P1|NOT COMPLETED|Treatment Phase||4
5231034|NCT00894556|12861063|P4|COMPLETED|Treatment Phase||0
5231035|NCT00894556|12861064|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
5231036|NCT00894556|12861065|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
5231037|NCT00894556|12861066|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
5231038|NCT00894556|12861063|P4|STARTED|Treatment Phase||0
5231039|NCT00894556|12861064|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
5231040|NCT00894556|12861065|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
5231041|NCT00894556|12861066|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
5231042|NCT00894556|12861063|P4|NOT COMPLETED|Baseline Phase||85
5231043|NCT00894556|12861064|P3|NOT COMPLETED|Baseline Phase||0
5231044|NCT00894556|12861065|P2|NOT COMPLETED|Baseline Phase||0
5231045|NCT00894556|12861066|P1|NOT COMPLETED|Baseline Phase||0
5231046|NCT00894556|12861063|P4|COMPLETED|Baseline Phase||109
5231047|NCT00894556|12861064|P3|COMPLETED|Baseline Phase||0
5231048|NCT00894556|12861065|P2|COMPLETED|Baseline Phase||0
5231049|NCT00894556|12861066|P1|COMPLETED|Baseline Phase||0
5231050|NCT00894556|12861063|P4|STARTED|Baseline Phase||194
5231051|NCT00894556|12861064|P3|STARTED|Baseline Phase||0
5231052|NCT00894556|12861065|P2|STARTED|Baseline Phase||0
5231053|NCT00894556|12861066|P1|STARTED|Baseline Phase||0
5231054|NCT00894543|12861077|P2|NOT COMPLETED|Week 4 to Week 8||2
5231055|NCT00894543|12861078|P1|NOT COMPLETED|Week 4 to Week 8||4
5231056|NCT00894543|12861077|P2|COMPLETED|Week 4 to Week 8||97
5231057|NCT00894543|12861078|P1|COMPLETED|Week 4 to Week 8||97
5231058|NCT00894543|12861077|P2|STARTED|Week 4 to Week 8||99
5231059|NCT00894543|12861078|P1|STARTED|Week 4 to Week 8||101
5231060|NCT00894543|12861077|P2|NOT COMPLETED|Baseline to Week 4||2
5231061|NCT00894543|12861078|P1|NOT COMPLETED|Baseline to Week 4||3
5231062|NCT00894543|12861077|P2|COMPLETED|Baseline to Week 4||99
5231063|NCT00894543|12861078|P1|COMPLETED|Baseline to Week 4||101
5231064|NCT00894543|12861077|P2|STARTED|Baseline to Week 4||101
5231065|NCT00894543|12861078|P1|STARTED|Baseline to Week 4||104
5231066|NCT00894543|12861077|P2|NOT COMPLETED|Baseline||0
5231067|NCT00894543|12861078|P1|NOT COMPLETED|Baseline||0
5231068|NCT00894543|12861077|P2|COMPLETED|Baseline||101
5231069|NCT00894543|12861078|P1|COMPLETED|Baseline||104
5231070|NCT00894543|12861077|P2|STARTED|Baseline||101
5231071|NCT00894543|12861078|P1|STARTED|Baseline||104
5231072|NCT00894517|12861102|P2|NOT COMPLETED|Overall Study||5
5231073|NCT00894517|12861103|P1|NOT COMPLETED|Overall Study||2
5231074|NCT00894517|12861102|P2|COMPLETED|Overall Study||26
5231075|NCT00894517|12861103|P1|COMPLETED|Overall Study||28
5231076|NCT00894517|12861102|P2|STARTED|Overall Study||31
5231077|NCT00894517|12861103|P1|STARTED|Overall Study||30
5231078|NCT00894504|12861117|P1|NOT COMPLETED|Overall Study||71
5231079|NCT00894504|12861117|P1|COMPLETED|Overall Study||0
5231080|NCT00894504|12861117|P1|STARTED|Overall Study||71
5231081|NCT00894465|12861133|P2|NOT COMPLETED|Overall Study||0
5231082|NCT00894465|12861134|P1|NOT COMPLETED|Overall Study||0
5231083|NCT00894465|12861133|P2|COMPLETED|Overall Study||22
5231084|NCT00894465|12861134|P1|COMPLETED|Overall Study||22
5231085|NCT00894465|12861133|P2|STARTED|Overall Study||22
5231086|NCT00894465|12861134|P1|STARTED|Overall Study||22
5231087|NCT00894413|12861144|P2|NOT COMPLETED|Overall Study||8
5231088|NCT00894413|12861145|P1|NOT COMPLETED|Overall Study||0
5231089|NCT00894413|12861144|P2|COMPLETED|Overall Study||17
5231090|NCT00894413|12861145|P1|COMPLETED|Overall Study||15
5231091|NCT00894413|12861144|P2|STARTED|Overall Study||25
5231092|NCT00894413|12861145|P1|STARTED|Overall Study||15
5231093|NCT00894387|12861153|P2|NOT COMPLETED|Overall Study||175
5231094|NCT00894387|12861154|P1|NOT COMPLETED|Overall Study||175
5231095|NCT00894387|12861153|P2|COMPLETED|Overall Study||643
5231096|NCT00894387|12861154|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
5231097|NCT00894387|12861153|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
5231098|NCT00894387|12861154|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
5231099|NCT00894387|12861153|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
5231100|NCT00894387|12861154|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
5231101|NCT00894387|12861153|P2|Full Analysis Set|Overall Study||807
5231102|NCT00894387|12861154|P1|Full Analysis Set|Overall Study||808
5231103|NCT00894387|12861153|P2|Safety Set|Overall Study||810
5231104|NCT00894387|12861154|P1|Safety Set|Overall Study||808
5231105|NCT00894387|12861153|P2|STARTED|Overall Study||818
5231106|NCT00894387|12861154|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
5231107|NCT00894361|12861174|P2|NOT COMPLETED|Overall Study||64
5231108|NCT00894361|12861175|P1|NOT COMPLETED|Overall Study||24
5231109|NCT00894361|12861174|P2|COMPLETED|Overall Study||136
5231110|NCT00894361|12861175|P1|COMPLETED|Overall Study||176
5231111|NCT00894361|12861174|P2|STARTED|Overall Study||200
5231112|NCT00894361|12861175|P1|STARTED|Overall Study||200
5231113|NCT00894322|12861184|P3|NOT COMPLETED|Overall Study||0
5231114|NCT00894322|12861185|P2|NOT COMPLETED|Overall Study||0
5231115|NCT00894322|12861186|P1|NOT COMPLETED|Overall Study||1
5231116|NCT00894322|12861184|P3|COMPLETED|Overall Study||12
5231117|NCT00894322|12861185|P2|COMPLETED|Overall Study||23
5231118|NCT00894322|12861186|P1|COMPLETED|Overall Study||29
5231119|NCT00894322|12861184|P3|STARTED|Overall Study||12
5231120|NCT00894322|12861185|P2|STARTED|Overall Study||23
5231121|NCT00894322|12861186|P1|STARTED|Overall Study||30
5231122|NCT00894244|12861225|P1|NOT COMPLETED|Overall Study||1
5231123|NCT00894244|12861225|P1|COMPLETED|Overall Study||24
5231124|NCT00894244|12861225|P1|STARTED|Overall Study||25
5231125|NCT00894166|12861237|P8|NOT COMPLETED|Overall Study||34
5231126|NCT00894166|12861238|P7|NOT COMPLETED|Overall Study||16
5231127|NCT00894166|12861239|P6|NOT COMPLETED|Overall Study||16
5231128|NCT00894166|12861240|P5|NOT COMPLETED|Overall Study||24
5231129|NCT00894166|12861241|P4|NOT COMPLETED|Overall Study||69
5231130|NCT00894166|12861242|P3|NOT COMPLETED|Overall Study||62
5231131|NCT00894166|12861243|P2|NOT COMPLETED|Overall Study||63
5231132|NCT00894166|12861244|P1|NOT COMPLETED|Overall Study||61
5231133|NCT00894166|12861237|P8|COMPLETED|Overall Study||0
5231134|NCT00894166|12861238|P7|COMPLETED|Overall Study||19
5231135|NCT00894166|12861239|P6|COMPLETED|Overall Study||20
5231136|NCT00894166|12861240|P5|COMPLETED|Overall Study||10
5231137|NCT00894166|12861241|P4|COMPLETED|Overall Study||45
5231138|NCT00894166|12861242|P3|COMPLETED|Overall Study||50
5231139|NCT00894166|12861243|P2|COMPLETED|Overall Study||46
5231140|NCT00894166|12861244|P1|COMPLETED|Overall Study||71
5231141|NCT00894166|12861237|P8|STARTED|Overall Study||34
5231142|NCT00894166|12861238|P7|STARTED|Overall Study||35
5231143|NCT00894166|12861239|P6|STARTED|Overall Study||36
5231144|NCT00894166|12861240|P5|STARTED|Overall Study||34
5231145|NCT00894166|12861241|P4|STARTED|Overall Study||114
5231146|NCT00894166|12861242|P3|STARTED|Overall Study||112
5231147|NCT00894166|12861243|P2|STARTED|Overall Study||109
5231148|NCT00894166|12861244|P1|STARTED|Overall Study||132
5231149|NCT00894127|12861274|P1|NOT COMPLETED|Overall Study||0
5231150|NCT00894127|12861274|P1|COMPLETED|Overall Study||128
5231151|NCT00894127|12861274|P1|STARTED|Overall Study||128
5231152|NCT00893997|12861278|P1|NOT COMPLETED|Overall Study||0
5231153|NCT00893997|12861278|P1|COMPLETED|Overall Study||10
5231154|NCT00893997|12861278|P1|STARTED|Overall Study||10
5231155|NCT00893984|12861283|P1|NOT COMPLETED|Overall Study||6
5231156|NCT00893984|12861283|P1|COMPLETED|Overall Study||0
5231157|NCT00893984|12861283|P1|STARTED|Overall Study||6
5231158|NCT00893971|12861290|P1|NOT COMPLETED|Overall Study||3
5231159|NCT00893971|12861290|P1|COMPLETED|Overall Study||13
5231160|NCT00893971|12861290|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
5231161|NCT00893971|12861290|P1|Placebo + FF MDI (PT005)|Overall Study||13
5231162|NCT00893971|12861290|P1|Placebo + GFF MDI (PT003)|Overall Study||15
5231163|NCT00893971|12861290|P1|Placebo + GP MDI (PT001)|Overall Study||15
5231164|NCT00893971|12861290|P1|STARTED|Overall Study||16
5231165|NCT00893789|12861408|P4|NOT COMPLETED|Overall Study||13
5231166|NCT00893789|12861409|P3|NOT COMPLETED|Overall Study||7
5231167|NCT00893789|12861410|P2|NOT COMPLETED|Overall Study||4
5231168|NCT00893789|12861411|P1|NOT COMPLETED|Overall Study||6
5231169|NCT00893789|12861408|P4|COMPLETED|Overall Study||16
5231170|NCT00893789|12861409|P3|COMPLETED|Overall Study||22
5231171|NCT00893789|12861410|P2|COMPLETED|Overall Study||26
5231172|NCT00893789|12861411|P1|COMPLETED|Overall Study||23
5231173|NCT00893789|12861408|P4|Full Analysis Set (FAS)|Overall Study||27
5231174|NCT00893789|12861409|P3|Full Analysis Set (FAS)|Overall Study||28
5231175|NCT00893789|12861410|P2|Full Analysis Set (FAS)|Overall Study||29
5231176|NCT00893789|12861411|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
5231177|NCT00893789|12861408|P4|Safety Analysis Set (SAS)|Overall Study||29
5231178|NCT00893789|12861409|P3|Safety Analysis Set (SAS)|Overall Study||29
5231179|NCT00893789|12861410|P2|Safety Analysis Set (SAS)|Overall Study||30
5231180|NCT00893789|12861411|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
5231181|NCT00893789|12861408|P4|STARTED|Overall Study||29
5231182|NCT00893789|12861409|P3|STARTED|Overall Study||29
5231183|NCT00893789|12861410|P2|STARTED|Overall Study||30
5231184|NCT00893789|12861411|P1|STARTED|Overall Study||29
5231185|NCT00893763|12861495|P2|NOT COMPLETED|Overall Study||110
5231186|NCT00893763|12861496|P1|NOT COMPLETED|Overall Study||110
5231187|NCT00893763|12861495|P2|COMPLETED|Overall Study||47
5231188|NCT00893763|12861496|P1|COMPLETED|Overall Study||47
5231189|NCT00893763|12861495|P2|STARTED|Overall Study||157
5231190|NCT00893763|12861496|P1|STARTED|Overall Study||157
5231191|NCT00893737|12861504|P1|NOT COMPLETED|Overall Study||12
5231192|NCT00893737|12861504|P1|COMPLETED|Overall Study||135
5231193|NCT00893737|12861504|P1|STARTED|Overall Study||147
5231194|NCT00893464|12861518|P8|NOT COMPLETED|Overall Study||2
5231195|NCT00893464|12861519|P7|NOT COMPLETED|Overall Study||2
5231196|NCT00893464|12861520|P6|NOT COMPLETED|Overall Study||0
5231197|NCT00893464|12861521|P5|NOT COMPLETED|Overall Study||0
5231198|NCT00893464|12861522|P4|NOT COMPLETED|Overall Study||0
5231199|NCT00893464|12861523|P3|NOT COMPLETED|Overall Study||0
5231200|NCT00893464|12861524|P2|NOT COMPLETED|Overall Study||0
5231201|NCT00893464|12861525|P1|NOT COMPLETED|Overall Study||0
5231202|NCT00893464|12861518|P8|COMPLETED|Overall Study||3
5231203|NCT00893464|12861519|P7|COMPLETED|Overall Study||8
5231204|NCT00893464|12861520|P6|COMPLETED|Overall Study||7
5231205|NCT00893464|12861521|P5|COMPLETED|Overall Study||4
5231206|NCT00893464|12861522|P4|COMPLETED|Overall Study||1
5231207|NCT00893464|12861523|P3|COMPLETED|Overall Study||1
5231208|NCT00893464|12861524|P2|COMPLETED|Overall Study||1
5231209|NCT00893464|12861525|P1|COMPLETED|Overall Study||1
5231210|NCT00893464|12861518|P8|STARTED|Overall Study||5
5231211|NCT00893464|12861519|P7|STARTED|Overall Study||10
5231212|NCT00893464|12861520|P6|STARTED|Overall Study||7
5231213|NCT00893464|12861521|P5|STARTED|Overall Study||4
5231214|NCT00893464|12861522|P4|STARTED|Overall Study||1
5231215|NCT00893464|12861523|P3|STARTED|Overall Study||1
5231216|NCT00893464|12861524|P2|STARTED|Overall Study||1
5231217|NCT00893464|12861525|P1|STARTED|Overall Study||1
5231218|NCT00893152|12861643|P2|NOT COMPLETED|Overall Study||0
5231219|NCT00893152|12861644|P1|NOT COMPLETED|Overall Study||0
5231220|NCT00893152|12861643|P2|COMPLETED|Overall Study||36
5231221|NCT00893152|12861644|P1|COMPLETED|Overall Study||47
5231222|NCT00893152|12861643|P2|STARTED|Overall Study||36
5231223|NCT00893152|12861644|P1|STARTED|Overall Study||47
5231224|NCT00893113|12861652|P2|NOT COMPLETED|Overall Study||16
5231225|NCT00893113|12861653|P1|NOT COMPLETED|Overall Study||13
5231226|NCT00893113|12861652|P2|COMPLETED|Overall Study||22
5231227|NCT00893113|12861653|P1|COMPLETED|Overall Study||23
5231228|NCT00893113|12861652|P2|STARTED|Overall Study||38
5231229|NCT00893113|12861653|P1|STARTED|Overall Study||36
5231230|NCT00893074|12861663|P1|NOT COMPLETED|Overall Study||11
5231231|NCT00893074|12861663|P1|COMPLETED|Overall Study||13
5231232|NCT00893074|12861663|P1|STARTED|Overall Study||24
5231233|NCT00892957|12861683|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
5231234|NCT00892957|12861684|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
5231235|NCT00892957|12861683|P2|COMPLETED|Postoperative Day 30 Assessment||66
5231236|NCT00892957|12861684|P1|COMPLETED|Postoperative Day 30 Assessment||70
5231237|NCT00892957|12861683|P2|STARTED|Postoperative Day 30 Assessment||66
5231238|NCT00892957|12861684|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
5231239|NCT00892957|12861683|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
5231240|NCT00892957|12861684|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
5231241|NCT00892957|12861683|P2|COMPLETED|Postoperative Day 14 Assessment||66
5231242|NCT00892957|12861684|P1|COMPLETED|Postoperative Day 14 Assessment||68
5231243|NCT00892957|12861683|P2|STARTED|Postoperative Day 14 Assessment||66
5231244|NCT00892957|12861684|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
5231245|NCT00892957|12861683|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
5231246|NCT00892957|12861684|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
5231247|NCT00892957|12861683|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
5231248|NCT00892957|12861684|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
5231249|NCT00892957|12861683|P2|STARTED|Between Postoperative Day 1 and Day 14||70
5231250|NCT00892957|12861684|P1|STARTED|Between Postoperative Day 1 and Day 14||70
5231251|NCT00892957|12861683|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
5231252|NCT00892957|12861684|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
5231253|NCT00892957|12861683|P2|COMPLETED|Postoperative Day 1 Assessment||70
5231254|NCT00892957|12861684|P1|COMPLETED|Postoperative Day 1 Assessment||70
5231255|NCT00892957|12861683|P2|STARTED|Postoperative Day 1 Assessment||70
5231256|NCT00892957|12861684|P1|STARTED|Postoperative Day 1 Assessment||70
5231257|NCT00892957|12861683|P2|NOT COMPLETED|Intraoperative Day 0||0
5231258|NCT00892957|12861684|P1|NOT COMPLETED|Intraoperative Day 0||0
5231259|NCT00892957|12861683|P2|COMPLETED|Intraoperative Day 0||70
5231260|NCT00892957|12861684|P1|COMPLETED|Intraoperative Day 0||70
5231261|NCT00892957|12861683|P2|STARTED|Intraoperative Day 0||70
5231262|NCT00892957|12861684|P1|STARTED|Intraoperative Day 0||70
5231263|NCT00892775|12861772|P2|NOT COMPLETED|Overall Study||1
5231264|NCT00892775|12861773|P1|NOT COMPLETED|Overall Study||5
5231265|NCT00892775|12861772|P2|COMPLETED|Overall Study||165
5231266|NCT00892775|12861773|P1|COMPLETED|Overall Study||327
5231267|NCT00892775|12861772|P2|STARTED|Overall Study||166
5231268|NCT00892775|12861773|P1|STARTED|Overall Study||332
5231269|NCT00892723|12861800|P3|NOT COMPLETED|Overall Study||2
5231270|NCT00892723|12861801|P2|NOT COMPLETED|Overall Study||4
5231271|NCT00892723|12861802|P1|NOT COMPLETED|Overall Study||2
5231272|NCT00892723|12861800|P3|COMPLETED|Overall Study||17
5231273|NCT00892723|12861801|P2|COMPLETED|Overall Study||15
5231274|NCT00892723|12861802|P1|COMPLETED|Overall Study||19
5231275|NCT00892723|12861800|P3|STARTED|Overall Study||19
5231276|NCT00892723|12861801|P2|STARTED|Overall Study||19
5231277|NCT00892723|12861802|P1|STARTED|Overall Study||21
5231278|NCT00892710|12861846|P3|NOT COMPLETED|Overall Study||55
5231279|NCT00892710|12861847|P2|NOT COMPLETED|Overall Study||59
5231280|NCT00892710|12861848|P1|NOT COMPLETED|Overall Study||48
5231281|NCT00892710|12861846|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
5231282|NCT00892710|12861847|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
5231283|NCT00892710|12861848|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
5231284|NCT00892710|12861846|P3|STARTED|Overall Study||55
5231285|NCT00892710|12861847|P2|STARTED|Overall Study||59
5231286|NCT00892710|12861848|P1|STARTED|Overall Study||48
5231287|NCT00892697|12861871|P1|NOT COMPLETED|Overall Study||0
5231288|NCT00892697|12861871|P1|COMPLETED|Overall Study||15
5231289|NCT00892697|12861871|P1|STARTED|Overall Study||15
5231290|NCT00892606|12861878|P2|NOT COMPLETED|Overall Study||4
5231291|NCT00892606|12861879|P1|NOT COMPLETED|Overall Study||5
5231292|NCT00892606|12861878|P2|COMPLETED|Overall Study||33
5231293|NCT00892606|12861879|P1|COMPLETED|Overall Study||33
5231294|NCT00892606|12861878|P2|STARTED|Overall Study||37
5231295|NCT00892606|12861879|P1|STARTED|Overall Study||38
5231296|NCT00892437|12861891|P2|NOT COMPLETED|Open-Label Extension Phase||4
5231297|NCT00892437|12861892|P1|NOT COMPLETED|Open-Label Extension Phase||12
5231298|NCT00892437|12861891|P2|COMPLETED|Open-Label Extension Phase||15
5231299|NCT00892437|12861892|P1|COMPLETED|Open-Label Extension Phase||32
5231300|NCT00892437|12861891|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
5231301|NCT00892437|12861892|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
5231302|NCT00892437|12861891|P2|NOT COMPLETED|Randomized Phase||5
5231303|NCT00892437|12861892|P1|NOT COMPLETED|Randomized Phase||11
5231304|NCT00892437|12861891|P2|COMPLETED|Randomized Phase||24
5231305|NCT00892437|12861892|P1|COMPLETED|Randomized Phase||45
5231306|NCT00892437|12861891|P2|Randomized and Treated|Randomized Phase||29
5231307|NCT00892437|12861892|P1|Randomized and Treated|Randomized Phase||50
5231308|NCT00892437|12861891|P2|STARTED|Randomized Phase||29
5231309|NCT00892437|12861892|P1|STARTED|Randomized Phase||56
5231310|NCT00892281|12861911|P2|NOT COMPLETED|Overall Study||37
5231311|NCT00892281|12861912|P1|NOT COMPLETED|Overall Study||267
5231312|NCT00892281|12861911|P2|COMPLETED|Overall Study||187
5231313|NCT00892281|12861912|P1|COMPLETED|Overall Study||930
5231314|NCT00892281|12861911|P2|STARTED|Overall Study||224
5231315|NCT00892281|12861912|P1|STARTED|Overall Study||1197
5231316|NCT00892177|12861925|P6|NOT COMPLETED|Phase II||2
5231317|NCT00892177|12861926|P5|NOT COMPLETED|Phase II||5
5231318|NCT00892177|12861927|P4|NOT COMPLETED|Phase II||0
5231319|NCT00892177|12861928|P3|NOT COMPLETED|Phase II||0
5231320|NCT00892177|12861929|P2|NOT COMPLETED|Phase II||0
5231321|NCT00892177|12861930|P1|NOT COMPLETED|Phase II||0
5231322|NCT00892177|12861925|P6|COMPLETED|Phase II||38
5231323|NCT00892177|12861926|P5|COMPLETED|Phase II||83
5231324|NCT00892177|12861927|P4|COMPLETED|Phase II||0
5231325|NCT00892177|12861928|P3|COMPLETED|Phase II||0
5231326|NCT00892177|12861929|P2|COMPLETED|Phase II||0
5231327|NCT00892177|12861930|P1|COMPLETED|Phase II||0
5231328|NCT00892177|12861925|P6|STARTED|Phase II||40
5231329|NCT00892177|12861926|P5|STARTED|Phase II||88
5231330|NCT00892177|12861927|P4|STARTED|Phase II||0
5231331|NCT00892177|12861928|P3|STARTED|Phase II||0
5231332|NCT00892177|12861929|P2|STARTED|Phase II||0
5231333|NCT00892177|12861930|P1|STARTED|Phase II||0
5231334|NCT00892177|12861925|P6|NOT COMPLETED|Phase I: Dose Level 3||0
5231335|NCT00892177|12861926|P5|NOT COMPLETED|Phase I: Dose Level 3||0
5231336|NCT00892177|12861927|P4|NOT COMPLETED|Phase I: Dose Level 3||0
5231337|NCT00892177|12861928|P3|NOT COMPLETED|Phase I: Dose Level 3||0
5231338|NCT00892177|12861929|P2|NOT COMPLETED|Phase I: Dose Level 3||0
5231339|NCT00892177|12861930|P1|NOT COMPLETED|Phase I: Dose Level 3||0
5231340|NCT00892177|12861925|P6|COMPLETED|Phase I: Dose Level 3||0
5231341|NCT00892177|12861926|P5|COMPLETED|Phase I: Dose Level 3||0
5231342|NCT00892177|12861927|P4|COMPLETED|Phase I: Dose Level 3||6
5231343|NCT00892177|12861928|P3|COMPLETED|Phase I: Dose Level 3||0
5231344|NCT00892177|12861929|P2|COMPLETED|Phase I: Dose Level 3||0
5231345|NCT00892177|12861930|P1|COMPLETED|Phase I: Dose Level 3||0
5231346|NCT00892177|12861925|P6|STARTED|Phase I: Dose Level 3||0
5231347|NCT00892177|12861926|P5|STARTED|Phase I: Dose Level 3||0
5231348|NCT00892177|12861927|P4|STARTED|Phase I: Dose Level 3||6
5231349|NCT00892177|12861928|P3|STARTED|Phase I: Dose Level 3||0
5231350|NCT00892177|12861929|P2|STARTED|Phase I: Dose Level 3||0
5231351|NCT00892177|12861930|P1|STARTED|Phase I: Dose Level 3||0
5231352|NCT00892177|12861925|P6|NOT COMPLETED|Phase I: Dose Level 2||0
5231353|NCT00892177|12861926|P5|NOT COMPLETED|Phase I: Dose Level 2||0
5231354|NCT00892177|12861927|P4|NOT COMPLETED|Phase I: Dose Level 2||0
5231355|NCT00892177|12861928|P3|NOT COMPLETED|Phase I: Dose Level 2||0
5231356|NCT00892177|12861929|P2|NOT COMPLETED|Phase I: Dose Level 2||0
5231357|NCT00892177|12861930|P1|NOT COMPLETED|Phase I: Dose Level 2||0
5231358|NCT00892177|12861925|P6|COMPLETED|Phase I: Dose Level 2||0
5231359|NCT00892177|12861926|P5|COMPLETED|Phase I: Dose Level 2||0
5231360|NCT00892177|12861927|P4|COMPLETED|Phase I: Dose Level 2||0
5231361|NCT00892177|12861928|P3|COMPLETED|Phase I: Dose Level 2||3
5231362|NCT00892177|12861929|P2|COMPLETED|Phase I: Dose Level 2||0
5231363|NCT00892177|12861930|P1|COMPLETED|Phase I: Dose Level 2||0
5231364|NCT00892177|12861925|P6|STARTED|Phase I: Dose Level 2||0
5231365|NCT00892177|12861926|P5|STARTED|Phase I: Dose Level 2||0
5231366|NCT00892177|12861927|P4|STARTED|Phase I: Dose Level 2||0
5231367|NCT00892177|12861928|P3|STARTED|Phase I: Dose Level 2||3
5231368|NCT00892177|12861929|P2|STARTED|Phase I: Dose Level 2||0
5231369|NCT00892177|12861930|P1|STARTED|Phase I: Dose Level 2||0
5231370|NCT00892177|12861925|P6|NOT COMPLETED|Phase I: Dose Level 1||0
5231371|NCT00892177|12861926|P5|NOT COMPLETED|Phase I: Dose Level 1||0
5231372|NCT00892177|12861927|P4|NOT COMPLETED|Phase I: Dose Level 1||0
5231373|NCT00892177|12861928|P3|NOT COMPLETED|Phase I: Dose Level 1||0
5231374|NCT00892177|12861929|P2|NOT COMPLETED|Phase I: Dose Level 1||0
5231375|NCT00892177|12861930|P1|NOT COMPLETED|Phase I: Dose Level 1||0
5231376|NCT00892177|12861925|P6|COMPLETED|Phase I: Dose Level 1||0
5231377|NCT00892177|12861926|P5|COMPLETED|Phase I: Dose Level 1||0
5231378|NCT00892177|12861927|P4|COMPLETED|Phase I: Dose Level 1||0
5231379|NCT00892177|12861928|P3|COMPLETED|Phase I: Dose Level 1||0
5231380|NCT00892177|12861929|P2|COMPLETED|Phase I: Dose Level 1||4
5231381|NCT00892177|12861930|P1|COMPLETED|Phase I: Dose Level 1||0
5231382|NCT00892177|12861925|P6|STARTED|Phase I: Dose Level 1||0
5231383|NCT00892177|12861926|P5|STARTED|Phase I: Dose Level 1||0
5231384|NCT00892177|12861927|P4|STARTED|Phase I: Dose Level 1||0
5231385|NCT00892177|12861928|P3|STARTED|Phase I: Dose Level 1||0
5231386|NCT00892177|12861929|P2|STARTED|Phase I: Dose Level 1||4
5231387|NCT00892177|12861930|P1|STARTED|Phase I: Dose Level 1||0
5231388|NCT00892177|12861925|P6|NOT COMPLETED|Phase I: Dose Level 0||0
5231389|NCT00892177|12861926|P5|NOT COMPLETED|Phase I: Dose Level 0||0
5231390|NCT00892177|12861927|P4|NOT COMPLETED|Phase I: Dose Level 0||0
5231391|NCT00892177|12861928|P3|NOT COMPLETED|Phase I: Dose Level 0||0
5231392|NCT00892177|12861929|P2|NOT COMPLETED|Phase I: Dose Level 0||0
5231393|NCT00892177|12861930|P1|NOT COMPLETED|Phase I: Dose Level 0||0
5231394|NCT00892177|12861925|P6|COMPLETED|Phase I: Dose Level 0||0
5231395|NCT00892177|12861926|P5|COMPLETED|Phase I: Dose Level 0||0
5231396|NCT00892177|12861927|P4|COMPLETED|Phase I: Dose Level 0||0
5231397|NCT00892177|12861928|P3|COMPLETED|Phase I: Dose Level 0||0
5231398|NCT00892177|12861929|P2|COMPLETED|Phase I: Dose Level 0||0
5231399|NCT00892177|12861930|P1|COMPLETED|Phase I: Dose Level 0||3
5231400|NCT00892177|12861925|P6|STARTED|Phase I: Dose Level 0||0
5231401|NCT00892177|12861926|P5|STARTED|Phase I: Dose Level 0||0
5231402|NCT00892177|12861927|P4|STARTED|Phase I: Dose Level 0||0
5231403|NCT00892177|12861928|P3|STARTED|Phase I: Dose Level 0||0
5231404|NCT00892177|12861929|P2|STARTED|Phase I: Dose Level 0||0
5231405|NCT00892177|12861930|P1|STARTED|Phase I: Dose Level 0||3
5231406|NCT00892151|12861955|P1|NOT COMPLETED|Overall Study||1
5231407|NCT00892151|12861955|P1|COMPLETED|Overall Study||50
5231408|NCT00892151|12861955|P1|STARTED|Overall Study||51
5231409|NCT00892099|12861964|P3|NOT COMPLETED|Overall Study||7
5231410|NCT00892099|12861965|P2|NOT COMPLETED|Overall Study||1
5231411|NCT00892099|12861966|P1|NOT COMPLETED|Overall Study||5
5231412|NCT00892099|12861964|P3|COMPLETED|Overall Study||29
5231413|NCT00892099|12861965|P2|COMPLETED|Overall Study||32
5231414|NCT00892099|12861966|P1|COMPLETED|Overall Study||31
5231415|NCT00892099|12861964|P3|STARTED|Overall Study||36
5231416|NCT00892099|12861965|P2|STARTED|Overall Study||33
5231417|NCT00892099|12861966|P1|STARTED|Overall Study||36
5231418|NCT00892047|12861991|P2|NOT COMPLETED|Overall Study||7
5231419|NCT00892047|12861992|P1|NOT COMPLETED|Overall Study||4
5231420|NCT00892047|12861991|P2|COMPLETED|Overall Study||83
5231421|NCT00892047|12861992|P1|COMPLETED|Overall Study||87
5231422|NCT00892047|12861991|P2|STARTED|Overall Study||90
5231423|NCT00892047|12861992|P1|STARTED|Overall Study||91
5231424|NCT00892008|12862008|P1|NOT COMPLETED|Overall Study||565
5231425|NCT00892008|12862008|P1|COMPLETED|Overall Study||1713
5231426|NCT00892008|12862008|P1|STARTED|Overall Study||2278
5231427|NCT00891995|12862024|P2|NOT COMPLETED|Overall Study||0
5231428|NCT00891995|12862025|P1|NOT COMPLETED|Overall Study||0
5231429|NCT00891995|12862024|P2|COMPLETED|Overall Study||21
5231430|NCT00891995|12862025|P1|COMPLETED|Overall Study||50
5231431|NCT00891995|12862024|P2|STARTED|Overall Study||21
5231432|NCT00891995|12862025|P1|STARTED|Overall Study||50
5231433|NCT00891982|12862049|P2|NOT COMPLETED|Overall Study||1
5231434|NCT00891982|12862050|P1|NOT COMPLETED|Overall Study||2
5231435|NCT00891982|12862049|P2|COMPLETED|Overall Study||30
5231436|NCT00891982|12862050|P1|COMPLETED|Overall Study||28
5231437|NCT00891982|12862049|P2|STARTED|Overall Study||31
5231438|NCT00891982|12862050|P1|STARTED|Overall Study||30
5231439|NCT00891930|12862094|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
5231440|NCT00891930|12862094|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
5231441|NCT00891930|12862094|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
5231442|NCT00891930|12862094|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
5231443|NCT00891930|12862094|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
5231444|NCT00891930|12862094|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
5231445|NCT00891930|12862094|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
5231446|NCT00891904|12862115|P1|NOT COMPLETED|Overall Study||2
5231447|NCT00891904|12862115|P1|COMPLETED|Overall Study||0
5231448|NCT00891904|12862115|P1|STARTED|Overall Study||2
5231449|NCT00891878|12862124|P2|NOT COMPLETED|Overall Study||0
5231450|NCT00891878|12862125|P1|NOT COMPLETED|Overall Study||0
5231451|NCT00891878|12862124|P2|COMPLETED|Overall Study||6
5231452|NCT00891878|12862125|P1|COMPLETED|Overall Study||6
5231453|NCT00891878|12862124|P2|STARTED|Overall Study||6
5231454|NCT00891878|12862125|P1|STARTED|Overall Study||6
5231455|NCT00891839|12862141|P1|NOT COMPLETED|Overall Study||7
5231456|NCT00891839|12862141|P1|COMPLETED|Overall Study|completed treatment|38
5231457|NCT00891839|12862141|P1|STARTED|Overall Study||45
5231458|NCT00891813|12862150|P1|NOT COMPLETED|Overall Study||12
5231459|NCT00891813|12862150|P1|COMPLETED|Overall Study||88
5231460|NCT00891813|12862150|P1|STARTED|Overall Study||100
5231461|NCT00891774|12862156|P1|NOT COMPLETED|Overall Study||14
5231462|NCT00891774|12862156|P1|COMPLETED|Overall Study||158
5231463|NCT00891774|12862156|P1|STARTED|Overall Study||172
5231464|NCT00891735|12862167|P4|NOT COMPLETED|Overall Study||15
5231465|NCT00891735|12862168|P3|NOT COMPLETED|Overall Study||12
5231466|NCT00891735|12862169|P2|NOT COMPLETED|Overall Study||16
5231467|NCT00891735|12862170|P1|NOT COMPLETED|Overall Study||17
5231468|NCT00891735|12862167|P4|COMPLETED|Overall Study||258
5231469|NCT00891735|12862168|P3|COMPLETED|Overall Study||263
5231470|NCT00891735|12862169|P2|COMPLETED|Overall Study||258
5231471|NCT00891735|12862170|P1|COMPLETED|Overall Study||258
5231472|NCT00891735|12862167|P4|STARTED|Overall Study||273
5231473|NCT00891735|12862168|P3|STARTED|Overall Study||275
5231474|NCT00891735|12862169|P2|STARTED|Overall Study||274
5231475|NCT00891735|12862170|P1|STARTED|Overall Study||275
5231476|NCT00891657|12862210|P2|NOT COMPLETED|Overall Study||1
5231477|NCT00891657|12862211|P1|NOT COMPLETED|Overall Study||1
5231478|NCT00891657|12862210|P2|COMPLETED|Overall Study||5
5231479|NCT00891657|12862211|P1|COMPLETED|Overall Study||8
5231480|NCT00891657|12862210|P2|STARTED|Overall Study||6
5231481|NCT00891657|12862211|P1|STARTED|Overall Study||9
5231482|NCT00891618|12862223|P1|NOT COMPLETED|Overall Study||1
5231483|NCT00891618|12862223|P1|COMPLETED|Overall Study||20
5231484|NCT00891618|12862223|P1|STARTED|Overall Study||21
5231485|NCT00891527|12862227|P1|NOT COMPLETED|Overall Study||2
5231486|NCT00891527|12862227|P1|COMPLETED|Overall Study||48
5231487|NCT00891527|12862227|P1|STARTED|Overall Study||50
5231488|NCT00891462|12862236|P3|NOT COMPLETED|Overall Study||24
5231489|NCT00891462|12862237|P2|NOT COMPLETED|Overall Study||33
5231490|NCT00891462|12862238|P1|NOT COMPLETED|Overall Study||37
5231491|NCT00891462|12862236|P3|COMPLETED|Overall Study||166
5231492|NCT00891462|12862237|P2|COMPLETED|Overall Study||152
5231493|NCT00891462|12862238|P1|COMPLETED|Overall Study||149
5231494|NCT00891462|12862236|P3|STARTED|Overall Study||190
5231495|NCT00891462|12862237|P2|STARTED|Overall Study||185
5231496|NCT00891462|12862238|P1|STARTED|Overall Study||186
5231497|NCT00891436|12862251|P2|NOT COMPLETED|Overall Study||0
5231498|NCT00891436|12862252|P1|NOT COMPLETED|Overall Study||0
5231499|NCT00891436|12862251|P2|COMPLETED|Overall Study||10
5231500|NCT00891436|12862252|P1|COMPLETED|Overall Study||10
5231501|NCT00891436|12862251|P2|STARTED|Overall Study||10
5231502|NCT00891436|12862252|P1|STARTED|Overall Study||10
5231503|NCT00891371|12862260|P1|NOT COMPLETED|Treatment||9
5231504|NCT00891371|12862260|P1|COMPLETED|Treatment||27
5231505|NCT00891371|12862260|P1|STARTED|Treatment||36
5231506|NCT00891371|12862260|P1|NOT COMPLETED|Pre-assignment||6
5231507|NCT00891371|12862260|P1|COMPLETED|Pre-assignment||36
5231508|NCT00891371|12862260|P1|STARTED|Pre-assignment||42
5231509|NCT00891319|12862271|P2|NOT COMPLETED|Overall Study||0
5231510|NCT00891319|12862272|P1|NOT COMPLETED|Overall Study||8
5231511|NCT00891319|12862271|P2|COMPLETED|Overall Study||40
5231512|NCT00891319|12862272|P1|COMPLETED|Overall Study||32
5231513|NCT00891319|12862271|P2|STARTED|Overall Study||40
5231514|NCT00891319|12862272|P1|STARTED|Overall Study||40
5231515|NCT00891293|12862282|P1|NOT COMPLETED|Overall Study||84
5231516|NCT00891293|12862282|P1|COMPLETED|Overall Study||9
5231517|NCT00891293|12862282|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
5231518|NCT00891228|12862297|P3|NOT COMPLETED|Overall Study||15
5231519|NCT00891228|12862298|P2|NOT COMPLETED|Overall Study||13
5231520|NCT00891228|12862299|P1|NOT COMPLETED|Overall Study||11
5231521|NCT00891228|12862297|P3|COMPLETED|Overall Study||19
5231522|NCT00891228|12862298|P2|COMPLETED|Overall Study||20
5231523|NCT00891228|12862299|P1|COMPLETED|Overall Study||21
5231524|NCT00891228|12862297|P3|STARTED|Overall Study||34
5231525|NCT00891228|12862298|P2|STARTED|Overall Study||33
5231526|NCT00891228|12862299|P1|STARTED|Overall Study||32
5231527|NCT00891202|12862321|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
5231528|NCT00891202|12862322|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
5231529|NCT00891202|12862323|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
5231530|NCT00891202|12862324|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
5231531|NCT00891202|12862321|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
5231532|NCT00891202|12862322|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
5231533|NCT00891202|12862323|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
5231534|NCT00891202|12862324|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
5231535|NCT00891202|12862321|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
5231536|NCT00891202|12862322|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
5231537|NCT00891202|12862323|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
5231538|NCT00891202|12862324|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
5231539|NCT00891202|12862321|P4|NOT COMPLETED|PAP (Up To Week 39)||0
5231540|NCT00891202|12862322|P3|NOT COMPLETED|PAP (Up To Week 39)||0
5231541|NCT00891202|12862323|P2|NOT COMPLETED|PAP (Up To Week 39)||0
5231542|NCT00891202|12862324|P1|NOT COMPLETED|PAP (Up To Week 39)||1
5231543|NCT00891202|12862321|P4|COMPLETED|PAP (Up To Week 39)||0
5231544|NCT00891202|12862322|P3|COMPLETED|PAP (Up To Week 39)||0
5231545|NCT00891202|12862323|P2|COMPLETED|PAP (Up To Week 39)||20
5231546|NCT00891202|12862324|P1|COMPLETED|PAP (Up To Week 39)||19
5231547|NCT00891202|12862321|P4|STARTED|PAP (Up To Week 39)||0
5231548|NCT00891202|12862322|P3|STARTED|PAP (Up To Week 39)||0
5231549|NCT00891202|12862323|P2|STARTED|PAP (Up To Week 39)||20
5231550|NCT00891202|12862324|P1|STARTED|PAP (Up To Week 39)||20
5231551|NCT00891176|12862350|P4|NOT COMPLETED|At 6 Years of Age||0
5231552|NCT00891176|12862351|P3|NOT COMPLETED|At 6 Years of Age||0
5231553|NCT00891176|12862352|P2|NOT COMPLETED|At 6 Years of Age||0
5231554|NCT00891176|12862353|P1|NOT COMPLETED|At 6 Years of Age||0
5231555|NCT00891176|12862350|P4|COMPLETED|At 6 Years of Age||135
5231556|NCT00891176|12862351|P3|COMPLETED|At 6 Years of Age||135
5231557|NCT00891176|12862352|P2|COMPLETED|At 6 Years of Age||138
5231558|NCT00891176|12862353|P1|COMPLETED|At 6 Years of Age||131
5231559|NCT00891176|12862350|P4|STARTED|At 6 Years of Age||135
5231560|NCT00891176|12862351|P3|STARTED|At 6 Years of Age||135
5231561|NCT00891176|12862352|P2|STARTED|At 6 Years of Age||138
5231562|NCT00891176|12862353|P1|STARTED|At 6 Years of Age||131
5231563|NCT00891176|12862350|P4|NOT COMPLETED|At 4 Years of Age||0
5231564|NCT00891176|12862351|P3|NOT COMPLETED|At 4 Years of Age||0
5231565|NCT00891176|12862352|P2|NOT COMPLETED|At 4 Years of Age||0
5231566|NCT00891176|12862353|P1|NOT COMPLETED|At 4 Years of Age||0
5231567|NCT00891176|12862350|P4|COMPLETED|At 4 Years of Age||137
5231568|NCT00891176|12862351|P3|COMPLETED|At 4 Years of Age||142
5231569|NCT00891176|12862352|P2|COMPLETED|At 4 Years of Age||142
5231570|NCT00891176|12862353|P1|COMPLETED|At 4 Years of Age||140
5231571|NCT00891176|12862350|P4|STARTED|At 4 Years of Age||137
5231572|NCT00891176|12862351|P3|STARTED|At 4 Years of Age||142
5231573|NCT00891176|12862352|P2|STARTED|At 4 Years of Age||142
5231574|NCT00891176|12862353|P1|STARTED|At 4 Years of Age||140
5231575|NCT00891176|12862350|P4|NOT COMPLETED|At 3 Years of Age||0
5231576|NCT00891176|12862351|P3|NOT COMPLETED|At 3 Years of Age||0
5231577|NCT00891176|12862352|P2|NOT COMPLETED|At 3 Years of Age||0
5231578|NCT00891176|12862353|P1|NOT COMPLETED|At 3 Years of Age||0
5231579|NCT00891176|12862350|P4|COMPLETED|At 3 Years of Age||141
5231580|NCT00891176|12862351|P3|COMPLETED|At 3 Years of Age||149
5231581|NCT00891176|12862352|P2|COMPLETED|At 3 Years of Age||147
5231582|NCT00891176|12862353|P1|COMPLETED|At 3 Years of Age||144
5231583|NCT00891176|12862350|P4|STARTED|At 3 Years of Age||141
5231584|NCT00891176|12862351|P3|STARTED|At 3 Years of Age||149
5231585|NCT00891176|12862352|P2|STARTED|At 3 Years of Age||147
5231586|NCT00891176|12862353|P1|STARTED|At 3 Years of Age||144
5231587|NCT00891046|12862500|P5|NOT COMPLETED|Overall Study||39
5231588|NCT00891046|12862501|P4|NOT COMPLETED|Overall Study||3
5231589|NCT00891046|12862502|P3|NOT COMPLETED|Overall Study||23
5231590|NCT00891046|12862503|P2|NOT COMPLETED|Overall Study||9
5231591|NCT00891046|12862504|P1|NOT COMPLETED|Overall Study||12
5231592|NCT00891046|12862500|P5|COMPLETED|Overall Study||84
5231593|NCT00891046|12862501|P4|COMPLETED|Overall Study||8
5231594|NCT00891046|12862502|P3|COMPLETED|Overall Study||17
5231595|NCT00891046|12862503|P2|COMPLETED|Overall Study||54
5231596|NCT00891046|12862504|P1|COMPLETED|Overall Study||21
5231597|NCT00891046|12862500|P5|STARTED|Overall Study||123
5231598|NCT00891046|12862501|P4|STARTED|Overall Study||11
5231599|NCT00891046|12862502|P3|STARTED|Overall Study||40
5231600|NCT00891046|12862503|P2|STARTED|Overall Study||63
5231601|NCT00891046|12862504|P1|STARTED|Overall Study||33
5231602|NCT00891020|12862580|P3|NOT COMPLETED|Long-term Extension Period||23
5231603|NCT00891020|12862581|P2|NOT COMPLETED|Long-term Extension Period||24
5231604|NCT00891020|12862582|P1|NOT COMPLETED|Long-term Extension Period||6
5231605|NCT00891020|12862580|P3|COMPLETED|Long-term Extension Period||170
5231606|NCT00891020|12862581|P2|COMPLETED|Long-term Extension Period||172
5231607|NCT00891020|12862582|P1|COMPLETED|Long-term Extension Period||49
5231608|NCT00891020|12862580|P3|STARTED|Long-term Extension Period||193
5231609|NCT00891020|12862581|P2|STARTED|Long-term Extension Period||196
5231610|NCT00891020|12862582|P1|STARTED|Long-term Extension Period||55
5231611|NCT00891020|12862580|P3|NOT COMPLETED|24 Week Treatment Period||58
5231612|NCT00891020|12862581|P2|NOT COMPLETED|24 Week Treatment Period||60
5231613|NCT00891020|12862582|P1|NOT COMPLETED|24 Week Treatment Period||37
5231614|NCT00891020|12862580|P3|COMPLETED|24 Week Treatment Period||302
5231615|NCT00891020|12862581|P2|COMPLETED|24 Week Treatment Period||303
5231616|NCT00891020|12862582|P1|COMPLETED|24 Week Treatment Period||126
5231617|NCT00891020|12862580|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
5231618|NCT00891020|12862581|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
5231619|NCT00891020|12862582|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
5231620|NCT00891020|12862580|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
5231621|NCT00891020|12862581|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
5231622|NCT00891020|12862582|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
5231623|NCT00891020|12862580|P3|STARTED|24 Week Treatment Period||360
5231624|NCT00891020|12862581|P2|STARTED|24 Week Treatment Period||363
5231625|NCT00891020|12862582|P1|STARTED|24 Week Treatment Period||163
5231626|NCT00890981|12862615|P2|NOT COMPLETED|Overall Study||0
5231627|NCT00890981|12862616|P1|NOT COMPLETED|Overall Study||0
5231628|NCT00890981|12862615|P2|COMPLETED|Overall Study||40
5231629|NCT00890981|12862616|P1|COMPLETED|Overall Study||39
5231630|NCT00890981|12862615|P2|STARTED|Overall Study||40
5231631|NCT00890981|12862616|P1|STARTED|Overall Study||39
5231632|NCT00890929|12862646|P1|NOT COMPLETED|Overall Study||6
5231633|NCT00890929|12862646|P1|COMPLETED|Overall Study||39
5231634|NCT00890929|12862646|P1|Initiated Treatment|Overall Study||43
5231635|NCT00890929|12862646|P1|Consented & Enrolled|Overall Study||45
5231636|NCT00890929|12862646|P1|STARTED|Overall Study||45
5231637|NCT00890916|12862658|P1|NOT COMPLETED|"Rehab - NP Off"||0
5231638|NCT00890916|12862658|P1|COMPLETED|"Rehab - NP Off"||10
5231639|NCT00890916|12862658|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
5231640|NCT00890916|12862658|P1|STARTED|"Rehab - NP Off"||10
5231641|NCT00890916|12862658|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
5231642|NCT00890916|12862658|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
5231643|NCT00890916|12862658|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
5231644|NCT00890916|12862658|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
5231645|NCT00890825|12862664|P2|NOT COMPLETED|Overall Study||14
5231646|NCT00890825|12862665|P1|NOT COMPLETED|Overall Study||14
5231647|NCT00890825|12862664|P2|COMPLETED|Overall Study||29
5231648|NCT00890825|12862665|P1|COMPLETED|Overall Study||30
5231649|NCT00890825|12862664|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
5231650|NCT00890825|12862665|P1|STARTED|Overall Study||44
5231651|NCT00890721|12862685|P2|NOT COMPLETED|Overall Study||1
5231652|NCT00890721|12862686|P1|NOT COMPLETED|Overall Study||1
5231653|NCT00890721|12862685|P2|COMPLETED|Overall Study||93
5231654|NCT00890721|12862686|P1|COMPLETED|Overall Study||94
5231655|NCT00890721|12862685|P2|STARTED|Overall Study||94
5231656|NCT00890721|12862686|P1|STARTED|Overall Study||95
5231657|NCT00890695|12862694|P2|NOT COMPLETED|Overall Study||0
5231658|NCT00890695|12862695|P1|NOT COMPLETED|Overall Study||1
5231659|NCT00890695|12862694|P2|COMPLETED|Overall Study||33
5231660|NCT00890695|12862695|P1|COMPLETED|Overall Study||31
5231661|NCT00890695|12862694|P2|STARTED|Overall Study||33
5231662|NCT00890695|12862695|P1|STARTED|Overall Study||32
5231663|NCT00890682|12862713|P2|NOT COMPLETED|Overall Study||2
5231664|NCT00890682|12862714|P1|NOT COMPLETED|Overall Study||4
5231665|NCT00890682|12862713|P2|COMPLETED|Overall Study||94
5231666|NCT00890682|12862714|P1|COMPLETED|Overall Study||93
5231667|NCT00890682|12862713|P2|STARTED|Overall Study||96
5231668|NCT00890682|12862714|P1|STARTED|Overall Study||97
5231669|NCT00890656|12862720|P1|NOT COMPLETED|Overall Study||0
5231670|NCT00890656|12862720|P1|COMPLETED|Overall Study||90
5231671|NCT00890656|12862720|P1|STARTED|Overall Study||90
5231672|NCT00890617|12862724|P1|NOT COMPLETED|Overall Study||0
5231673|NCT00890617|12862724|P1|COMPLETED|Overall Study||9
5231674|NCT00890617|12862724|P1|STARTED|Overall Study||9
5231675|NCT00890591|12862729|P1|NOT COMPLETED|Overall Study||20
5231676|NCT00890591|12862729|P1|COMPLETED|Overall Study||124
5231677|NCT00890591|12862729|P1|STARTED|Overall Study||144
5231678|NCT00890552|12862735|P1|NOT COMPLETED|On-treatment||10
5231679|NCT00890552|12862735|P1|COMPLETED|On-treatment||14
5231680|NCT00890552|12862735|P1|STARTED|On-treatment||24
5231681|NCT00890552|12862735|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
5231682|NCT00890552|12862735|P1|COMPLETED|Enrollment and Pre-treatment||24
5231683|NCT00890552|12862735|P1|STARTED|Enrollment and Pre-treatment||25
5231684|NCT00890409|12862744|P2|NOT COMPLETED|Overall Study||21
5231685|NCT00890409|12862745|P1|NOT COMPLETED|Overall Study||20
5231686|NCT00890409|12862744|P2|COMPLETED|Overall Study||119
5231687|NCT00890409|12862745|P1|COMPLETED|Overall Study||96
5231688|NCT00890409|12862744|P2|STARTED|Overall Study||140
5231689|NCT00890409|12862745|P1|STARTED|Overall Study||116
5231690|NCT00890201|12862755|P2|NOT COMPLETED|Overall Study||56
5231691|NCT00890201|12862756|P1|NOT COMPLETED|Overall Study||5
5231692|NCT00890201|12862755|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
5231693|NCT00890201|12862756|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
5231694|NCT00890201|12862755|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
5231695|NCT00890201|12862756|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
5231696|NCT00890162|12862764|P2|NOT COMPLETED|Overall Study||1
5231697|NCT00890162|12862765|P1|NOT COMPLETED|Overall Study||2
5231698|NCT00890162|12862764|P2|COMPLETED|Overall Study||7
5231699|NCT00890162|12862765|P1|COMPLETED|Overall Study||6
5231700|NCT00890162|12862764|P2|STARTED|Overall Study||8
5231701|NCT00890162|12862765|P1|STARTED|Overall Study||8
5231702|NCT00890097|12862774|P3|NOT COMPLETED|Overall Study||77
5231703|NCT00890097|12862775|P2|NOT COMPLETED|Overall Study||86
5231704|NCT00890097|12862776|P1|NOT COMPLETED|Overall Study||68
5231705|NCT00890097|12862774|P3|COMPLETED|Overall Study||184
5231706|NCT00890097|12862775|P2|COMPLETED|Overall Study||173
5231707|NCT00890097|12862776|P1|COMPLETED|Overall Study||184
5231708|NCT00890097|12862774|P3|STARTED|Overall Study||261
5231709|NCT00890097|12862775|P2|STARTED|Overall Study||259
5231710|NCT00890097|12862776|P1|STARTED|Overall Study||252
5231711|NCT00890084|12862784|P1|NOT COMPLETED|Overall Study||142
5231712|NCT00890084|12862784|P1|COMPLETED|Overall Study||2771
5231713|NCT00890084|12862784|P1|STARTED|Overall Study||2913
5231714|NCT00889928|12862795|P1|NOT COMPLETED|Overall Study||0
5231715|NCT00889928|12862795|P1|COMPLETED|Overall Study||7
5231716|NCT00889928|12862795|P1|STARTED|Overall Study||7
5231717|NCT00889915|12862803|P4|NOT COMPLETED|Overall Study||8
5231718|NCT00889915|12862804|P3|NOT COMPLETED|Overall Study||13
5231719|NCT00889915|12862805|P2|NOT COMPLETED|Overall Study||5
5231720|NCT00889915|12862806|P1|NOT COMPLETED|Overall Study||2
5231721|NCT00889915|12862803|P4|COMPLETED|Overall Study||40
5231722|NCT00889915|12862804|P3|COMPLETED|Overall Study||54
5231723|NCT00889915|12862805|P2|COMPLETED|Overall Study||71
5231724|NCT00889915|12862806|P1|COMPLETED|Overall Study||35
5231725|NCT00889915|12862803|P4|STARTED|Overall Study||48
5231726|NCT00889915|12862804|P3|STARTED|Overall Study||67
5231727|NCT00889915|12862805|P2|STARTED|Overall Study||76
5231728|NCT00889915|12862806|P1|STARTED|Overall Study||37
5231729|NCT00889863|12862824|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
5231730|NCT00889863|12862825|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
5231731|NCT00889863|12862824|P2|COMPLETED|Part II: Randomized Double Blind||24
5231732|NCT00889863|12862825|P1|COMPLETED|Part II: Randomized Double Blind||39
5231733|NCT00889863|12862824|P2|STARTED|Part II: Randomized Double Blind||50
5231734|NCT00889863|12862825|P1|STARTED|Part II: Randomized Double Blind||50
5231735|NCT00889863|12862824|P2|NOT COMPLETED|Part I: Open Label||0
5231736|NCT00889863|12862825|P1|NOT COMPLETED|Part I: Open Label||77
5231737|NCT00889863|12862824|P2|COMPLETED|Part I: Open Label||0
5231738|NCT00889863|12862825|P1|COMPLETED|Part I: Open Label||100
5231739|NCT00889863|12862824|P2|Entered Part 1d|Part I: Open Label||0
5231740|NCT00889863|12862825|P1|Entered Part 1d|Part I: Open Label||103
5231741|NCT00889863|12862824|P2|Entered Part Ic|Part I: Open Label||0
5231742|NCT00889863|12862825|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
5231743|NCT00889863|12862824|P2|Entered Part Ib|Part I: Open Label||0
5231744|NCT00889863|12862825|P1|Entered Part Ib|Part I: Open Label||142
5231745|NCT00889863|12862824|P2|Entered Part Ia|Part I: Open Label||0
5231746|NCT00889863|12862825|P1|Entered Part Ia|Part I: Open Label||145
5231747|NCT00889863|12862824|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
5231748|NCT00889863|12862825|P1|STARTED|Part I: Open Label||177
5231749|NCT00889824|12862847|P1|NOT COMPLETED|Overall Study||0
5231750|NCT00889824|12862847|P1|COMPLETED|Overall Study||5
5231751|NCT00889824|12862847|P1|STARTED|Overall Study||5
5231752|NCT00889720|12862851|P1|NOT COMPLETED|Overall Study||8
5231753|NCT00889720|12862851|P1|COMPLETED|Overall Study||8
5231754|NCT00889720|12862851|P1|Surgical Population|Overall Study||12
5231755|NCT00889720|12862851|P1|STARTED|Overall Study||16
5231756|NCT00889707|12862878|P2|NOT COMPLETED|Overall Study||10
5231757|NCT00889707|12862879|P1|NOT COMPLETED|Overall Study||7
5231758|NCT00889707|12862878|P2|COMPLETED|Overall Study||21
5231759|NCT00889707|12862879|P1|COMPLETED|Overall Study||54
5231760|NCT00889707|12862878|P2|STARTED|Overall Study||31
5231761|NCT00889707|12862879|P1|STARTED|Overall Study||61
5231762|NCT00889681|12862887|P1|NOT COMPLETED|Overall Study||3
5231763|NCT00889681|12862887|P1|COMPLETED|Overall Study||78
5231764|NCT00889681|12862887|P1|Received Treatment|Overall Study||78
5231765|NCT00889681|12862887|P1|STARTED|Overall Study||81
5231766|NCT00889603|12862894|P1|NOT COMPLETED|Overall Study||37
5231767|NCT00889603|12862894|P1|COMPLETED|Overall Study||333
5231768|NCT00889603|12862894|P1|STARTED|Overall Study||370
5231769|NCT00889512|12862909|P2|NOT COMPLETED|Overall Study||0
5231770|NCT00889512|12862910|P1|NOT COMPLETED|Overall Study||0
5231771|NCT00889512|12862909|P2|COMPLETED|Overall Study||9
5231772|NCT00889512|12862910|P1|COMPLETED|Overall Study||5
5231773|NCT00889512|12862909|P2|STARTED|Overall Study||9
5231774|NCT00889512|12862910|P1|STARTED|Overall Study||5
5231775|NCT00889421|12862916|P1|NOT COMPLETED|Overall Study||3
5231776|NCT00889421|12862916|P1|COMPLETED|Overall Study||0
5231777|NCT00889421|12862916|P1|STARTED|Overall Study||3
5231778|NCT00889330|12862926|P2|NOT COMPLETED|Overall Study||0
5231779|NCT00889330|12862927|P1|NOT COMPLETED|Overall Study||0
5231780|NCT00889330|12862926|P2|COMPLETED|Overall Study||30
5231781|NCT00889330|12862927|P1|COMPLETED|Overall Study||30
5231782|NCT00889330|12862926|P2|STARTED|Overall Study||30
5231783|NCT00889330|12862927|P1|STARTED|Overall Study||30
5231784|NCT00889265|12862957|P1|NOT COMPLETED|Overall Study||7
5231785|NCT00889265|12862957|P1|COMPLETED|Overall Study||44
5231786|NCT00889265|12862957|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
5231787|NCT00889252|12862964|P2|NOT COMPLETED|Overall Study||4
5231788|NCT00889252|12862965|P1|NOT COMPLETED|Overall Study||7
5231789|NCT00889252|12862964|P2|COMPLETED|Overall Study||78
5231790|NCT00889252|12862965|P1|COMPLETED|Overall Study||161
5231791|NCT00889252|12862964|P2|STARTED|Overall Study||82
5231792|NCT00889252|12862965|P1|STARTED|Overall Study||168
5231793|NCT00889226|12863009|P2|NOT COMPLETED|Overall Study||35
5231794|NCT00889226|12863010|P1|NOT COMPLETED|Overall Study||25
5231795|NCT00889226|12863009|P2|COMPLETED|Overall Study||43
5231796|NCT00889226|12863010|P1|COMPLETED|Overall Study||58
5231797|NCT00889226|12863009|P2|STARTED|Overall Study||78
5231798|NCT00889226|12863010|P1|STARTED|Overall Study||83
5231799|NCT00889200|12863018|P1|NOT COMPLETED|Overall Study||0
5231800|NCT00889200|12863018|P1|COMPLETED|Overall Study||12
5231801|NCT00889200|12863018|P1|STARTED|Overall Study||12
5231802|NCT00889187|12863022|P4|NOT COMPLETED|Overall Study||0
5231803|NCT00889187|12863023|P3|NOT COMPLETED|Overall Study||0
5231804|NCT00889187|12863024|P2|NOT COMPLETED|Overall Study||0
5231805|NCT00889187|12863025|P1|NOT COMPLETED|Overall Study||0
5231806|NCT00889187|12863022|P4|COMPLETED|Overall Study||0
5231807|NCT00889187|12863023|P3|COMPLETED|Overall Study||4
5231808|NCT00889187|12863024|P2|COMPLETED|Overall Study||3
5231809|NCT00889187|12863025|P1|COMPLETED|Overall Study||3
5231810|NCT00889187|12863022|P4|STARTED|Overall Study||0
5231811|NCT00889187|12863023|P3|STARTED|Overall Study||4
5231812|NCT00889187|12863024|P2|STARTED|Overall Study||3
5231813|NCT00889187|12863025|P1|STARTED|Overall Study||3
5231814|NCT00889005|12863042|P2|NOT COMPLETED|Overall Study||2
5231815|NCT00889005|12863043|P1|NOT COMPLETED|Overall Study||8
5231816|NCT00889005|12863042|P2|COMPLETED|Overall Study||72
5231817|NCT00889005|12863043|P1|COMPLETED|Overall Study||57
5231818|NCT00889005|12863042|P2|STARTED|Overall Study||74
5231819|NCT00889005|12863043|P1|STARTED|Overall Study||65
5231820|NCT00888979|12863049|P1|NOT COMPLETED|Overall Study||4
5231821|NCT00888979|12863049|P1|COMPLETED|Overall Study||6
5231822|NCT00888979|12863049|P1|Received the Inhaler/Counseling|Overall Study||8
5231823|NCT00888979|12863049|P1|STARTED|Overall Study||10
5231824|NCT00888940|12863057|P2|NOT COMPLETED|Overall Study||21
5231825|NCT00888940|12863058|P1|NOT COMPLETED|Overall Study||28
5231826|NCT00888940|12863057|P2|COMPLETED|Overall Study||101
5231827|NCT00888940|12863058|P1|COMPLETED|Overall Study||92
5231828|NCT00888940|12863057|P2|Completed Therapy|Overall Study||106
5231829|NCT00888940|12863058|P1|Completed Therapy|Overall Study||107
5231830|NCT00888940|12863057|P2|STARTED|Overall Study||122
5231831|NCT00888940|12863058|P1|STARTED|Overall Study||120
5231832|NCT00888849|12863068|P2|NOT COMPLETED|Overall Study||9
5231833|NCT00888849|12863069|P1|NOT COMPLETED|Overall Study||5
5231834|NCT00888849|12863068|P2|COMPLETED|Overall Study||129
5231835|NCT00888849|12863069|P1|COMPLETED|Overall Study||137
5231836|NCT00888849|12863068|P2|STARTED|Overall Study||138
5231837|NCT00888849|12863069|P1|STARTED|Overall Study||142
5231838|NCT00888654|12863079|P1|NOT COMPLETED|Overall Study||10
5231839|NCT00888654|12863079|P1|COMPLETED|Overall Study||31
5231840|NCT00888654|12863079|P1|STARTED|Overall Study||41
5231841|NCT00888628|12863085|P1|NOT COMPLETED|Overall Study||3
5231842|NCT00888628|12863085|P1|COMPLETED|Overall Study||4
5231843|NCT00888628|12863085|P1|Transplanted|Overall Study||4
5231844|NCT00888628|12863085|P1|Withdrawn|Overall Study||1
5231845|NCT00888628|12863085|P1|Screen Failure|Overall Study||2
5231846|NCT00888628|12863085|P1|Enrolled|Overall Study||7
5231847|NCT00888628|12863085|P1|STARTED|Overall Study||7
5231848|NCT00888615|12863097|P1|NOT COMPLETED|Overall Study||2
5231849|NCT00888615|12863097|P1|COMPLETED|Overall Study||56
5231850|NCT00888615|12863097|P1|STARTED|Overall Study||58
5231851|NCT00888459|12863108|P2|NOT COMPLETED|Overall Study||0
5231852|NCT00888459|12863109|P1|NOT COMPLETED|Overall Study||0
5231853|NCT00888459|12863108|P2|COMPLETED|Overall Study||30
5231854|NCT00888459|12863109|P1|COMPLETED|Overall Study||30
5231855|NCT00888459|12863108|P2|STARTED|Overall Study||30
5231856|NCT00888459|12863109|P1|STARTED|Overall Study||30
5231857|NCT00888433|12863117|P2|NOT COMPLETED|Overall Study||3
5231858|NCT00888433|12863118|P1|NOT COMPLETED|Overall Study||3
5231859|NCT00888433|12863117|P2|COMPLETED|Overall Study||51
5231860|NCT00888433|12863118|P1|COMPLETED|Overall Study||49
5231861|NCT00888433|12863117|P2|STARTED|Overall Study||54
5231862|NCT00888433|12863118|P1|STARTED|Overall Study||52
5231863|NCT00888381|12863126|P2|NOT COMPLETED|Overall Study||1
5231864|NCT00888381|12863127|P1|NOT COMPLETED|Overall Study||0
5231865|NCT00888381|12863126|P2|COMPLETED|Overall Study||59
5231866|NCT00888381|12863127|P1|COMPLETED|Overall Study||60
5231867|NCT00888381|12863126|P2|STARTED|Overall Study||60
5231868|NCT00888381|12863127|P1|STARTED|Overall Study||60
5231869|NCT00888355|12863147|P4|NOT COMPLETED|Overall Study||10
5231870|NCT00888355|12863148|P3|NOT COMPLETED|Overall Study||12
5231871|NCT00888355|12863149|P2|NOT COMPLETED|Overall Study||9
5231872|NCT00888355|12863150|P1|NOT COMPLETED|Overall Study||22
5231873|NCT00888355|12863147|P4|COMPLETED|Overall Study||96
5231874|NCT00888355|12863148|P3|COMPLETED|Overall Study||94
5231875|NCT00888355|12863149|P2|COMPLETED|Overall Study||99
5231876|NCT00888355|12863150|P1|COMPLETED|Overall Study||86
5231877|NCT00888355|12863147|P4|STARTED|Overall Study||106
5231878|NCT00888355|12863148|P3|STARTED|Overall Study||106
5231879|NCT00888355|12863149|P2|STARTED|Overall Study||108
5231880|NCT00888355|12863150|P1|STARTED|Overall Study||108
5231881|NCT00888329|12863206|P2|NOT COMPLETED|Overall Study||9
5231882|NCT00888329|12863207|P1|NOT COMPLETED|Overall Study||6
5231883|NCT00888329|12863206|P2|COMPLETED|Overall Study||122
5231884|NCT00888329|12863207|P1|COMPLETED|Overall Study||119
5231885|NCT00888329|12863206|P2|STARTED|Overall Study||131
5231886|NCT00888329|12863207|P1|STARTED|Overall Study||125
5231887|NCT00888238|12863213|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
5231888|NCT00888238|12863214|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
5231889|NCT00888238|12863215|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
5231890|NCT00888238|12863213|P3|COMPLETED|Third Period of Treatment Intervention||3
5231891|NCT00888238|12863214|P2|COMPLETED|Third Period of Treatment Intervention||4
5231892|NCT00888238|12863215|P1|COMPLETED|Third Period of Treatment Intervention||4
5231893|NCT00888238|12863213|P3|STARTED|Third Period of Treatment Intervention||3
5231894|NCT00888238|12863214|P2|STARTED|Third Period of Treatment Intervention||4
5231895|NCT00888238|12863215|P1|STARTED|Third Period of Treatment Intervention||4
5231896|NCT00888238|12863213|P3|NOT COMPLETED|Washout Period After Period 2||1
5231897|NCT00888238|12863214|P2|NOT COMPLETED|Washout Period After Period 2||0
5231898|NCT00888238|12863215|P1|NOT COMPLETED|Washout Period After Period 2||0
5231899|NCT00888238|12863213|P3|COMPLETED|Washout Period After Period 2||3
5231900|NCT00888238|12863214|P2|COMPLETED|Washout Period After Period 2||4
5231901|NCT00888238|12863215|P1|COMPLETED|Washout Period After Period 2||4
5231902|NCT00888238|12863213|P3|STARTED|Washout Period After Period 2||4
5231903|NCT00888238|12863214|P2|STARTED|Washout Period After Period 2||4
5231904|NCT00888238|12863215|P1|STARTED|Washout Period After Period 2||4
5231905|NCT00888238|12863213|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
5231906|NCT00888238|12863214|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
5231907|NCT00888238|12863215|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
5231908|NCT00888238|12863213|P3|COMPLETED|Second Period of Treatment Intervention||4
5231909|NCT00888238|12863214|P2|COMPLETED|Second Period of Treatment Intervention||4
5231910|NCT00888238|12863215|P1|COMPLETED|Second Period of Treatment Intervention||4
5231911|NCT00888238|12863213|P3|STARTED|Second Period of Treatment Intervention||4
5231912|NCT00888238|12863214|P2|STARTED|Second Period of Treatment Intervention||4
5231913|NCT00888238|12863215|P1|STARTED|Second Period of Treatment Intervention||4
5231914|NCT00888238|12863213|P3|NOT COMPLETED|Washout Period After Period 1||0
5231915|NCT00888238|12863214|P2|NOT COMPLETED|Washout Period After Period 1||0
5231916|NCT00888238|12863215|P1|NOT COMPLETED|Washout Period After Period 1||0
5231917|NCT00888238|12863213|P3|COMPLETED|Washout Period After Period 1||4
5231918|NCT00888238|12863214|P2|COMPLETED|Washout Period After Period 1||4
5231919|NCT00888238|12863215|P1|COMPLETED|Washout Period After Period 1||4
5231920|NCT00888238|12863213|P3|STARTED|Washout Period After Period 1||4
5231921|NCT00888238|12863214|P2|STARTED|Washout Period After Period 1||4
5231922|NCT00888238|12863215|P1|STARTED|Washout Period After Period 1||4
5231923|NCT00888238|12863213|P3|NOT COMPLETED|First Period of Treatment Intervention||0
5231924|NCT00888238|12863214|P2|NOT COMPLETED|First Period of Treatment Intervention||0
5231925|NCT00888238|12863215|P1|NOT COMPLETED|First Period of Treatment Intervention||0
5231926|NCT00888238|12863213|P3|COMPLETED|First Period of Treatment Intervention||4
5231927|NCT00888238|12863214|P2|COMPLETED|First Period of Treatment Intervention||4
5231928|NCT00888238|12863215|P1|COMPLETED|First Period of Treatment Intervention||4
5231929|NCT00888238|12863213|P3|STARTED|First Period of Treatment Intervention||4
5231930|NCT00888238|12863214|P2|STARTED|First Period of Treatment Intervention||4
5231931|NCT00888238|12863215|P1|STARTED|First Period of Treatment Intervention||4
5231932|NCT00888173|12863223|P1|NOT COMPLETED|Overall Study||2
5231933|NCT00888173|12863223|P1|COMPLETED|Overall Study||43
5231934|NCT00888173|12863223|P1|STARTED|Overall Study||45
5231935|NCT00888134|12863231|P1|NOT COMPLETED|Follow-up||1
5231936|NCT00888134|12863231|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
5231937|NCT00888134|12863231|P1|STARTED|Follow-up||27
5231938|NCT00888134|12863231|P1|NOT COMPLETED|Treatment With Study Drug||1
5231939|NCT00888134|12863231|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
5231940|NCT00888134|12863231|P1|STARTED|Treatment With Study Drug||28
5231941|NCT00887978|12863241|P2|NOT COMPLETED|Overall Study||15
5231942|NCT00887978|12863242|P1|NOT COMPLETED|Overall Study||25
5231943|NCT00887978|12863241|P2|COMPLETED|Overall Study||138
5231944|NCT00887978|12863242|P1|COMPLETED|Overall Study||132
5231945|NCT00887978|12863241|P2|STARTED|Overall Study||153
5231946|NCT00887978|12863242|P1|STARTED|Overall Study||157
5231947|NCT00887965|12863278|P1|NOT COMPLETED|Overall Study||0
5231948|NCT00887965|12863278|P1|COMPLETED|Overall Study||15
5231949|NCT00887965|12863278|P1|STARTED|Overall Study||15
5231950|NCT00887926|12863312|P4|NOT COMPLETED|Overall Study||0
5231951|NCT00887926|12863313|P3|NOT COMPLETED|Overall Study||0
5231952|NCT00887926|12863314|P2|NOT COMPLETED|Overall Study||1
5231953|NCT00887926|12863315|P1|NOT COMPLETED|Overall Study||0
5231954|NCT00887926|12863312|P4|COMPLETED|Overall Study||5
5231955|NCT00887926|12863313|P3|COMPLETED|Overall Study||3
5231956|NCT00887926|12863314|P2|COMPLETED|Overall Study||13
5231957|NCT00887926|12863315|P1|COMPLETED|Overall Study||3
5231958|NCT00887926|12863312|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
5231959|NCT00887926|12863313|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5231960|NCT00887926|12863314|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
5231961|NCT00887926|12863315|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5231962|NCT00887926|12863312|P4|STARTED|Overall Study||5
5231963|NCT00887926|12863313|P3|STARTED|Overall Study||3
5231964|NCT00887926|12863314|P2|STARTED|Overall Study||14
5231965|NCT00887926|12863315|P1|STARTED|Overall Study||3
5231966|NCT00887913|12863350|P1|NOT COMPLETED|Overall Study||6
5231967|NCT00887913|12863350|P1|COMPLETED|Overall Study||63
5231968|NCT00887913|12863350|P1|STARTED|Overall Study||69
5231969|NCT00887822|12863358|P2|NOT COMPLETED|Overall Study||102
5231970|NCT00887822|12863359|P1|NOT COMPLETED|Overall Study||97
5231971|NCT00887822|12863358|P2|COMPLETED|Overall Study||0
5231972|NCT00887822|12863359|P1|COMPLETED|Overall Study||3
5231973|NCT00887822|12863358|P2|Treated (Safety Population)|Overall Study||101
5231974|NCT00887822|12863359|P1|Treated (Safety Population)|Overall Study||100
5231975|NCT00887822|12863358|P2|STARTED|Overall Study||102
5231976|NCT00887822|12863359|P1|STARTED|Overall Study||100
5231977|NCT00887809|12863391|P2|NOT COMPLETED|Overall Study||0
5231978|NCT00887809|12863392|P1|NOT COMPLETED|Overall Study||4
5231979|NCT00887809|12863391|P2|COMPLETED|Overall Study||10
5231980|NCT00887809|12863392|P1|COMPLETED|Overall Study||33
5231981|NCT00887809|12863391|P2|STARTED|Overall Study||10
5231982|NCT00887809|12863392|P1|STARTED|Overall Study||37
5231983|NCT00887744|12863398|P1|NOT COMPLETED|Overall Study||34
5231984|NCT00887744|12863398|P1|COMPLETED|Overall Study||128
5231985|NCT00887744|12863398|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
5231986|NCT00887679|12863407|P1|NOT COMPLETED|Overall Study||10
5231987|NCT00887679|12863407|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
5231988|NCT00887679|12863407|P1|STARTED|Overall Study||30
5231989|NCT00887653|12863416|P1|NOT COMPLETED|Overall Study||0
5231990|NCT00887653|12863416|P1|COMPLETED|Overall Study||20
5231991|NCT00887653|12863416|P1|STARTED|Overall Study||20
5231992|NCT00887640|12863422|P1|NOT COMPLETED|Overall Study||0
5231993|NCT00887640|12863422|P1|COMPLETED|Overall Study||11
5231994|NCT00887640|12863422|P1|STARTED|Overall Study||11
5231995|NCT00887588|12863437|P2|NOT COMPLETED|Extension Period||5
5231996|NCT00887588|12863438|P1|NOT COMPLETED|Extension Period||6
5231997|NCT00887588|12863437|P2|COMPLETED|Extension Period||120
5231998|NCT00887588|12863438|P1|COMPLETED|Extension Period||121
5231999|NCT00887588|12863437|P2|Arterial Stiffness Set|Extension Period||94
5232000|NCT00887588|12863438|P1|Arterial Stiffness Set|Extension Period||86
5232001|NCT00887588|12863437|P2|STARTED|Extension Period||125
5232002|NCT00887588|12863438|P1|STARTED|Extension Period||127
5232003|NCT00887588|12863437|P2|NOT COMPLETED|Core Period||21
5232004|NCT00887588|12863438|P1|NOT COMPLETED|Core Period||19
5232005|NCT00887588|12863437|P2|COMPLETED|Core Period||131
5232006|NCT00887588|12863438|P1|COMPLETED|Core Period||130
5232007|NCT00887588|12863437|P2|Arterial Stiffness Set|Core Period||94
5232008|NCT00887588|12863438|P1|Arterial Stiffness Set|Core Period||86
5232009|NCT00887588|12863437|P2|Full Analysis Set|Core Period||146
5232010|NCT00887588|12863438|P1|Full Analysis Set|Core Period||148
5232011|NCT00887588|12863437|P2|Extension Efficacy Set|Core Period||125
5232012|NCT00887588|12863438|P1|Extension Efficacy Set|Core Period||127
5232013|NCT00887588|12863437|P2|STARTED|Core Period||152
5232014|NCT00887588|12863438|P1|STARTED|Core Period||149
5232015|NCT00887575|12863490|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
5232016|NCT00887575|12863491|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
5232017|NCT00887575|12863492|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
5232018|NCT00887575|12863490|P3|COMPLETED|Phase II - Maintenance Therapy||0
5232019|NCT00887575|12863491|P2|COMPLETED|Phase II - Maintenance Therapy||0
5232020|NCT00887575|12863492|P1|COMPLETED|Phase II - Maintenance Therapy||6
5232021|NCT00887575|12863490|P3|STARTED|Phase II - Maintenance Therapy||0
5232022|NCT00887575|12863491|P2|STARTED|Phase II - Maintenance Therapy||0
5232023|NCT00887575|12863492|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
5232024|NCT00887575|12863490|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
5232025|NCT00887575|12863491|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
5232026|NCT00887575|12863492|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
5232027|NCT00887575|12863490|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
5232028|NCT00887575|12863491|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
5232029|NCT00887575|12863492|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
5232030|NCT00887575|12863490|P3|STARTED|Phase II - Neoadjuvant Therapy||0
5232031|NCT00887575|12863491|P2|STARTED|Phase II - Neoadjuvant Therapy||0
5232032|NCT00887575|12863492|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
5232033|NCT00887575|12863490|P3|NOT COMPLETED|Phase I||3
5232034|NCT00887575|12863491|P2|NOT COMPLETED|Phase I||6
5232035|NCT00887575|12863492|P1|NOT COMPLETED|Phase I||0
5232036|NCT00887575|12863490|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5232037|NCT00887575|12863491|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5232038|NCT00887575|12863492|P1|COMPLETED|Phase I||6
5232039|NCT00887575|12863490|P3|STARTED|Phase I||3
5232040|NCT00887575|12863491|P2|STARTED|Phase I||6
5232041|NCT00887575|12863492|P1|STARTED|Phase I||6
5232042|NCT00887562|12863503|P3|NOT COMPLETED|Overall Study||1
5232043|NCT00887562|12863504|P2|NOT COMPLETED|Overall Study||2
5232044|NCT00887562|12863505|P1|NOT COMPLETED|Overall Study||3
5232045|NCT00887562|12863503|P3|COMPLETED|Overall Study||7
5232046|NCT00887562|12863504|P2|COMPLETED|Overall Study||7
5232047|NCT00887562|12863505|P1|COMPLETED|Overall Study||7
5232048|NCT00887562|12863503|P3|STARTED|Overall Study||8
5232049|NCT00887562|12863504|P2|STARTED|Overall Study||9
5232050|NCT00887562|12863505|P1|STARTED|Overall Study||10
5232051|NCT00887549|12863519|P1|NOT COMPLETED|Maintenance Therapy||43
5232052|NCT00887549|12863519|P1|COMPLETED|Maintenance Therapy||0
5232053|NCT00887549|12863519|P1|STARTED|Maintenance Therapy||43
5232054|NCT00887549|12863519|P1|NOT COMPLETED|Induction Therapy||27
5232055|NCT00887549|12863519|P1|COMPLETED|Induction Therapy||43
5232056|NCT00887549|12863519|P1|STARTED|Induction Therapy||70
5232057|NCT00887510|12863528|P2|NOT COMPLETED|Overall Study||0
5232058|NCT00887510|12863529|P1|NOT COMPLETED|Overall Study||0
5232059|NCT00887510|12863528|P2|COMPLETED|Overall Study||12
5232060|NCT00887510|12863529|P1|COMPLETED|Overall Study||12
5232061|NCT00887510|12863528|P2|STARTED|Overall Study||12
5232062|NCT00887510|12863529|P1|STARTED|Overall Study||12
5232063|NCT00887484|12863537|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
5232064|NCT00887484|12863537|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
5232065|NCT00887484|12863537|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
5232066|NCT00887484|12863537|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
5232067|NCT00887484|12863537|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
5232068|NCT00887484|12863537|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
5232069|NCT00887471|12863603|P2|NOT COMPLETED|Overall Study||0
5232070|NCT00887471|12863604|P1|NOT COMPLETED|Overall Study||0
5232071|NCT00887471|12863603|P2|COMPLETED|Overall Study||15
5232072|NCT00887471|12863604|P1|COMPLETED|Overall Study||15
5232073|NCT00887471|12863603|P2|STARTED|Overall Study||15
5232074|NCT00887471|12863604|P1|STARTED|Overall Study||15
5232075|NCT00887458|12863614|P2|NOT COMPLETED|Overall Study||4
5232076|NCT00887458|12863615|P1|NOT COMPLETED|Overall Study||0
5232077|NCT00887458|12863614|P2|COMPLETED|Overall Study||25
5232078|NCT00887458|12863615|P1|COMPLETED|Overall Study||17
5232079|NCT00887458|12863614|P2|STARTED|Overall Study||29
5232080|NCT00887458|12863615|P1|STARTED|Overall Study||17
5232081|NCT00887354|12863625|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
5232082|NCT00887354|12863626|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
5232083|NCT00887354|12863625|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
5232084|NCT00887354|12863626|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
5232085|NCT00887354|12863625|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
5232086|NCT00887354|12863626|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
5232087|NCT00887354|12863625|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
5232088|NCT00887354|12863626|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
5232089|NCT00887354|12863625|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
5232090|NCT00887354|12863626|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
5232091|NCT00887354|12863625|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
5232092|NCT00887354|12863626|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
5232093|NCT00887354|12863625|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
5232094|NCT00887354|12863626|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
5232095|NCT00887354|12863625|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
5232096|NCT00887354|12863626|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
5232097|NCT00887341|12863646|P2|NOT COMPLETED|Overall Study||3
5232098|NCT00887341|12863647|P1|NOT COMPLETED|Overall Study||2
5232099|NCT00887341|12863646|P2|COMPLETED|Overall Study||36
5232100|NCT00887341|12863647|P1|COMPLETED|Overall Study||35
5232101|NCT00887341|12863646|P2|STARTED|Overall Study||39
5232102|NCT00887341|12863647|P1|STARTED|Overall Study||37
5232103|NCT00887315|12863683|P2|NOT COMPLETED|Overall Study||4
5232104|NCT00887315|12863684|P1|NOT COMPLETED|Overall Study||7
5232105|NCT00887315|12863683|P2|COMPLETED|Overall Study||0
5232106|NCT00887315|12863684|P1|COMPLETED|Overall Study||0
5232107|NCT00887315|12863683|P2|STARTED|Overall Study||4
5232108|NCT00887315|12863684|P1|STARTED|Overall Study||7
5232109|NCT00887289|12863692|P1|NOT COMPLETED|Overall Study||95
5232110|NCT00887289|12863692|P1|COMPLETED|Overall Study||1409
5232111|NCT00887289|12863692|P1|STARTED|Overall Study||1504
5232112|NCT00887250|12863704|P3|NOT COMPLETED|Overall Study||13
5232113|NCT00887250|12863705|P2|NOT COMPLETED|Overall Study||12
5232114|NCT00887250|12863706|P1|NOT COMPLETED|Overall Study||18
5232115|NCT00887250|12863704|P3|COMPLETED|Overall Study||110
5232116|NCT00887250|12863705|P2|COMPLETED|Overall Study||115
5232117|NCT00887250|12863706|P1|COMPLETED|Overall Study||98
5232118|NCT00887250|12863704|P3|STARTED|Overall Study||123
5232119|NCT00887250|12863705|P2|STARTED|Overall Study||127
5232120|NCT00887250|12863706|P1|STARTED|Overall Study||116
5232121|NCT00887224|12863729|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
5232122|NCT00887224|12863730|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
5232123|NCT00887224|12863731|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
5232124|NCT00887224|12863729|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
5232125|NCT00887224|12863730|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
5232126|NCT00887224|12863731|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
5232127|NCT00887224|12863729|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
5232128|NCT00887224|12863730|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
5232129|NCT00887224|12863731|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
5232130|NCT00887224|12863729|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
5232131|NCT00887224|12863730|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
5232132|NCT00887224|12863731|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
5232133|NCT00887224|12863729|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
5232134|NCT00887224|12863730|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
5232135|NCT00887224|12863731|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
5232136|NCT00887224|12863729|P3|NOT COMPLETED|Double-blind (DB) Phase||62
5232137|NCT00887224|12863730|P2|NOT COMPLETED|Double-blind (DB) Phase||100
5232138|NCT00887224|12863731|P1|NOT COMPLETED|Double-blind (DB) Phase||0
5232139|NCT00887224|12863729|P3|COMPLETED|Double-blind (DB) Phase||210
5232140|NCT00887224|12863730|P2|COMPLETED|Double-blind (DB) Phase||176
5232141|NCT00887224|12863731|P1|COMPLETED|Double-blind (DB) Phase||0
5232142|NCT00887224|12863729|P3|STARTED|Double-blind (DB) Phase||272
5232143|NCT00887224|12863730|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
5232144|NCT00887224|12863731|P1|STARTED|Double-blind (DB) Phase||0
5232145|NCT00887224|12863729|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
5232146|NCT00887224|12863730|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
5232147|NCT00887224|12863731|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
5232148|NCT00887224|12863729|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
5232149|NCT00887224|12863730|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
5232150|NCT00887224|12863731|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
5232151|NCT00887224|12863729|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
5232152|NCT00887224|12863730|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
5232153|NCT00887224|12863731|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
5232154|NCT00887224|12863729|P3|STARTED|OL Taper Phase / OL Follow Up||0
5232155|NCT00887224|12863730|P2|STARTED|OL Taper Phase / OL Follow Up||0
5232156|NCT00887224|12863731|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
5232157|NCT00887224|12863729|P3|NOT COMPLETED|Between OLS and DB Phases||0
5232158|NCT00887224|12863730|P2|NOT COMPLETED|Between OLS and DB Phases||0
5232159|NCT00887224|12863731|P1|NOT COMPLETED|Between OLS and DB Phases||28
5232160|NCT00887224|12863729|P3|COMPLETED|Between OLS and DB Phases||0
5232161|NCT00887224|12863730|P2|COMPLETED|Between OLS and DB Phases||0
5232162|NCT00887224|12863731|P1|COMPLETED|Between OLS and DB Phases||548
5232163|NCT00887224|12863729|P3|STARTED|Between OLS and DB Phases||0
5232164|NCT00887224|12863730|P2|STARTED|Between OLS and DB Phases||0
5232165|NCT00887224|12863731|P1|STARTED|Between OLS and DB Phases||576
5232166|NCT00887224|12863729|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
5232167|NCT00887224|12863730|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
5232168|NCT00887224|12863731|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
5232169|NCT00887224|12863729|P3|COMPLETED|Open-label Stability (OLS) Phase||0
5232170|NCT00887224|12863730|P2|COMPLETED|Open-label Stability (OLS) Phase||0
5232171|NCT00887224|12863731|P1|COMPLETED|Open-label Stability (OLS) Phase||576
5232172|NCT00887224|12863729|P3|STARTED|Open-label Stability (OLS) Phase||0
5232173|NCT00887224|12863730|P2|STARTED|Open-label Stability (OLS) Phase||0
5232174|NCT00887224|12863731|P1|STARTED|Open-label Stability (OLS) Phase||659
5232175|NCT00887224|12863729|P3|NOT COMPLETED|Between OLR and OLS Phases||0
5232176|NCT00887224|12863730|P2|NOT COMPLETED|Between OLR and OLS Phases||0
5232177|NCT00887224|12863731|P1|NOT COMPLETED|Between OLR and OLS Phases||93
5232178|NCT00887224|12863729|P3|COMPLETED|Between OLR and OLS Phases||0
5232179|NCT00887224|12863730|P2|COMPLETED|Between OLR and OLS Phases||0
5232180|NCT00887224|12863731|P1|COMPLETED|Between OLR and OLS Phases||659
5232181|NCT00887224|12863729|P3|STARTED|Between OLR and OLS Phases||0
5232182|NCT00887224|12863730|P2|STARTED|Between OLR and OLS Phases||0
5232183|NCT00887224|12863731|P1|STARTED|Between OLR and OLS Phases||752
5232184|NCT00887224|12863729|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
5232185|NCT00887224|12863730|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
5232186|NCT00887224|12863731|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
5232187|NCT00887224|12863729|P3|COMPLETED|Open-label Response (OLR) Phase||0
5232188|NCT00887224|12863730|P2|COMPLETED|Open-label Response (OLR) Phase||0
5232189|NCT00887224|12863731|P1|COMPLETED|Open-label Response (OLR) Phase||752
5232190|NCT00887224|12863729|P3|STARTED|Open-label Response (OLR) Phase||0
5232191|NCT00887224|12863730|P2|STARTED|Open-label Response (OLR) Phase||0
5232192|NCT00887224|12863731|P1|STARTED|Open-label Response (OLR) Phase||874
5232193|NCT00887198|12863758|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
5232194|NCT00887198|12863759|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
5232195|NCT00887198|12863760|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
5232196|NCT00887198|12863758|P3|COMPLETED|Cross Over (Placebo to AA)||0
5232197|NCT00887198|12863759|P2|COMPLETED|Cross Over (Placebo to AA)||0
5232198|NCT00887198|12863760|P1|COMPLETED|Cross Over (Placebo to AA)||0
5232199|NCT00887198|12863758|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
5232200|NCT00887198|12863759|P2|STARTED|Cross Over (Placebo to AA)||0
5232201|NCT00887198|12863760|P1|STARTED|Cross Over (Placebo to AA)||0
5232202|NCT00887198|12863758|P3|NOT COMPLETED|Randomized Period||0
5232203|NCT00887198|12863759|P2|NOT COMPLETED|Randomized Period||542
5232204|NCT00887198|12863760|P1|NOT COMPLETED|Randomized Period||546
5232205|NCT00887198|12863758|P3|COMPLETED|Randomized Period||0
5232206|NCT00887198|12863759|P2|COMPLETED|Randomized Period||0
5232207|NCT00887198|12863760|P1|COMPLETED|Randomized Period||0
5232208|NCT00887198|12863758|P3|Treated|Randomized Period||0
5232209|NCT00887198|12863759|P2|Treated|Randomized Period||540
5232210|NCT00887198|12863760|P1|Treated|Randomized Period||542
5232211|NCT00887198|12863758|P3|STARTED|Randomized Period||0
5232212|NCT00887198|12863759|P2|STARTED|Randomized Period||542
5232213|NCT00887198|12863760|P1|STARTED|Randomized Period||546
5232214|NCT00887159|12863791|P3|NOT COMPLETED|Overall Study||56
5232215|NCT00887159|12863792|P2|NOT COMPLETED|Overall Study||56
5232216|NCT00887159|12863793|P1|NOT COMPLETED|Overall Study||29
5232217|NCT00887159|12863791|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
5232218|NCT00887159|12863792|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
5232219|NCT00887159|12863793|P1|COMPLETED|Overall Study||27
5232220|NCT00887159|12863791|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
5232221|NCT00887159|12863792|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
5232222|NCT00887159|12863793|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
5232223|NCT00887159|12863791|P3|Eligible and Treated Patients|Overall Study||52
5232224|NCT00887159|12863792|P2|Eligible and Treated Patients|Overall Study||52
5232225|NCT00887159|12863793|P1|Eligible and Treated Patients|Overall Study||48
5232226|NCT00887159|12863791|P3|Patients Who Started Assigned Treatment|Overall Study||52
5232227|NCT00887159|12863792|P2|Patients Who Started Assigned Treatment|Overall Study||53
5232228|NCT00887159|12863793|P1|Patients Who Started Assigned Treatment|Overall Study||53
5232229|NCT00887159|12863791|P3|STARTED|Overall Study||56
5232230|NCT00887159|12863792|P2|STARTED|Overall Study||56
5232231|NCT00887159|12863793|P1|STARTED|Overall Study||56
5232232|NCT00887068|12863811|P2|NOT COMPLETED|Overall Study||0
5232233|NCT00887068|12863812|P1|NOT COMPLETED|Overall Study||6
5232234|NCT00887068|12863811|P2|COMPLETED|Overall Study||94
5232235|NCT00887068|12863812|P1|COMPLETED|Overall Study||87
5232236|NCT00887068|12863811|P2|STARTED|Overall Study||94
5232237|NCT00887068|12863812|P1|STARTED|Overall Study||93
5232238|NCT00886938|12863820|P1|NOT COMPLETED|Overall Study||2
5232239|NCT00886938|12863820|P1|COMPLETED|Overall Study||10
5232240|NCT00886938|12863820|P1|STARTED|Overall Study||12
5232241|NCT00886899|12863824|P1|NOT COMPLETED|Overall Study||0
5232242|NCT00886899|12863824|P1|COMPLETED|Overall Study||147
5232243|NCT00886899|12863824|P1|STARTED|Overall Study||147
5232244|NCT00886834|12863833|P2|NOT COMPLETED|Overall Study||3
5232245|NCT00886834|12863834|P1|NOT COMPLETED|Overall Study||0
5232246|NCT00886834|12863833|P2|COMPLETED|Overall Study||51
5232247|NCT00886834|12863834|P1|COMPLETED|Overall Study||54
5232248|NCT00886834|12863833|P2|STARTED|Overall Study||54
5232249|NCT00886834|12863834|P1|STARTED|Overall Study||54
5232250|NCT00886821|12863856|P14|NOT COMPLETED|Stage 2||1
5232251|NCT00886821|12863857|P13|NOT COMPLETED|Stage 2||5
5232252|NCT00886821|12863858|P12|NOT COMPLETED|Stage 2||1
5232253|NCT00886821|12863859|P11|NOT COMPLETED|Stage 2||0
5232254|NCT00886821|12863860|P10|NOT COMPLETED|Stage 2||0
5232255|NCT00886821|12863861|P9|NOT COMPLETED|Stage 2||0
5232256|NCT00886821|12863862|P8|NOT COMPLETED|Stage 2||0
5232257|NCT00886821|12863863|P7|NOT COMPLETED|Stage 2||0
5232258|NCT00886821|12863864|P6|NOT COMPLETED|Stage 2||0
5232259|NCT00886821|12863865|P5|NOT COMPLETED|Stage 2||0
5232260|NCT00886821|12863866|P4|NOT COMPLETED|Stage 2||0
5232261|NCT00886821|12863867|P3|NOT COMPLETED|Stage 2||0
5232262|NCT00886821|12863868|P2|NOT COMPLETED|Stage 2||0
5232263|NCT00886821|12863869|P1|NOT COMPLETED|Stage 2||0
5232264|NCT00886821|12863856|P14|COMPLETED|Stage 2||8
5232265|NCT00886821|12863857|P13|COMPLETED|Stage 2||8
5232266|NCT00886821|12863858|P12|COMPLETED|Stage 2||8
5232267|NCT00886821|12863859|P11|COMPLETED|Stage 2||9
5232268|NCT00886821|12863860|P10|COMPLETED|Stage 2||0
5232269|NCT00886821|12863861|P9|COMPLETED|Stage 2||0
5232270|NCT00886821|12863862|P8|COMPLETED|Stage 2||0
5232271|NCT00886821|12863863|P7|COMPLETED|Stage 2||0
5232272|NCT00886821|12863864|P6|COMPLETED|Stage 2||0
5232273|NCT00886821|12863865|P5|COMPLETED|Stage 2||0
5232274|NCT00886821|12863866|P4|COMPLETED|Stage 2||0
5232275|NCT00886821|12863867|P3|COMPLETED|Stage 2||0
5232276|NCT00886821|12863868|P2|COMPLETED|Stage 2||0
5232277|NCT00886821|12863869|P1|COMPLETED|Stage 2||0
5232278|NCT00886821|12863856|P14|STARTED|Stage 2||9
5232279|NCT00886821|12863857|P13|STARTED|Stage 2||13
5232280|NCT00886821|12863858|P12|STARTED|Stage 2||9
5232281|NCT00886821|12863859|P11|STARTED|Stage 2||9
5232282|NCT00886821|12863860|P10|STARTED|Stage 2||0
5232283|NCT00886821|12863861|P9|STARTED|Stage 2||0
5232284|NCT00886821|12863862|P8|STARTED|Stage 2||0
5232285|NCT00886821|12863863|P7|STARTED|Stage 2||0
5232286|NCT00886821|12863864|P6|STARTED|Stage 2||0
5232287|NCT00886821|12863865|P5|STARTED|Stage 2||0
5232288|NCT00886821|12863866|P4|STARTED|Stage 2||0
5232289|NCT00886821|12863867|P3|STARTED|Stage 2||0
5232290|NCT00886821|12863868|P2|STARTED|Stage 2||0
5232291|NCT00886821|12863869|P1|STARTED|Stage 2||0
5232292|NCT00886821|12863856|P14|NOT COMPLETED|Stage 1||0
5232293|NCT00886821|12863857|P13|NOT COMPLETED|Stage 1||0
5232294|NCT00886821|12863858|P12|NOT COMPLETED|Stage 1||0
5232295|NCT00886821|12863859|P11|NOT COMPLETED|Stage 1||0
5232296|NCT00886821|12863860|P10|NOT COMPLETED|Stage 1||0
5232297|NCT00886821|12863861|P9|NOT COMPLETED|Stage 1||0
5232298|NCT00886821|12863862|P8|NOT COMPLETED|Stage 1||0
5232299|NCT00886821|12863863|P7|NOT COMPLETED|Stage 1||0
5232300|NCT00886821|12863864|P6|NOT COMPLETED|Stage 1||0
5232301|NCT00886821|12863865|P5|NOT COMPLETED|Stage 1||0
5232302|NCT00886821|12863866|P4|NOT COMPLETED|Stage 1||0
5232303|NCT00886821|12863867|P3|NOT COMPLETED|Stage 1||0
5232304|NCT00886821|12863868|P2|NOT COMPLETED|Stage 1||0
5232305|NCT00886821|12863869|P1|NOT COMPLETED|Stage 1||0
5232306|NCT00886821|12863856|P14|COMPLETED|Stage 1||0
5232307|NCT00886821|12863857|P13|COMPLETED|Stage 1||0
5232308|NCT00886821|12863858|P12|COMPLETED|Stage 1||0
5232309|NCT00886821|12863859|P11|COMPLETED|Stage 1||0
5232310|NCT00886821|12863860|P10|COMPLETED|Stage 1||18
5232311|NCT00886821|12863861|P9|COMPLETED|Stage 1||6
5232312|NCT00886821|12863862|P8|COMPLETED|Stage 1||6
5232313|NCT00886821|12863863|P7|COMPLETED|Stage 1||6
5232314|NCT00886821|12863864|P6|COMPLETED|Stage 1||6
5232315|NCT00886821|12863865|P5|COMPLETED|Stage 1||6
5232316|NCT00886821|12863866|P4|COMPLETED|Stage 1||7
5232317|NCT00886821|12863867|P3|COMPLETED|Stage 1||6
5232318|NCT00886821|12863868|P2|COMPLETED|Stage 1||6
5232319|NCT00886821|12863869|P1|COMPLETED|Stage 1||7
5232320|NCT00886821|12863856|P14|STARTED|Stage 1||0
5232321|NCT00886821|12863857|P13|STARTED|Stage 1||0
5232322|NCT00886821|12863858|P12|STARTED|Stage 1||0
5232323|NCT00886821|12863859|P11|STARTED|Stage 1||0
5232324|NCT00886821|12863860|P10|STARTED|Stage 1||18
5232325|NCT00886821|12863861|P9|STARTED|Stage 1||6
5232326|NCT00886821|12863862|P8|STARTED|Stage 1||6
5232327|NCT00886821|12863863|P7|STARTED|Stage 1||6
5232328|NCT00886821|12863864|P6|STARTED|Stage 1||6
5232329|NCT00886821|12863865|P5|STARTED|Stage 1||6
5232330|NCT00886821|12863866|P4|STARTED|Stage 1||7
5232331|NCT00886821|12863867|P3|STARTED|Stage 1||6
5232332|NCT00886821|12863868|P2|STARTED|Stage 1||6
5232333|NCT00886821|12863869|P1|STARTED|Stage 1||7
5232334|NCT00886795|12864094|P1|NOT COMPLETED|Overall Study||1
5232335|NCT00886795|12864094|P1|COMPLETED|Overall Study||3
5232336|NCT00886795|12864094|P1|STARTED|Overall Study||4
5232337|NCT00886769|12864101|P2|NOT COMPLETED|Overall Study||37
5232338|NCT00886769|12864102|P1|NOT COMPLETED|Overall Study||6
5232339|NCT00886769|12864101|P2|COMPLETED|Overall Study||4
5232340|NCT00886769|12864102|P1|COMPLETED|Overall Study||37
5232341|NCT00886769|12864101|P2|STARTED|Overall Study||41
5232342|NCT00886769|12864102|P1|STARTED|Overall Study||43
5232343|NCT00886743|12864126|P1|NOT COMPLETED|Overall Study||4
5232344|NCT00886743|12864126|P1|COMPLETED|Overall Study||15
5232345|NCT00886743|12864126|P1|STARTED|Overall Study|Received treatment|19
5232346|NCT00886704|12864136|P2|NOT COMPLETED|Overall Study||0
5232347|NCT00886704|12864137|P1|NOT COMPLETED|Overall Study||0
5232348|NCT00886704|12864136|P2|COMPLETED|Overall Study||10
5232349|NCT00886704|12864137|P1|COMPLETED|Overall Study||40
5232350|NCT00886704|12864136|P2|STARTED|Overall Study||10
5232351|NCT00886704|12864137|P1|STARTED|Overall Study||40
5232352|NCT00886691|12864147|P2|NOT COMPLETED|Overall Study||0
5232353|NCT00886691|12864148|P1|NOT COMPLETED|Overall Study||0
5232354|NCT00886691|12864147|P2|COMPLETED|Overall Study||75
5232355|NCT00886691|12864148|P1|COMPLETED|Overall Study||75
5232356|NCT00886691|12864147|P2|STARTED|Overall Study||75
5232357|NCT00886691|12864148|P1|STARTED|Overall Study||75
5232358|NCT00886639|12864164|P1|NOT COMPLETED|Overall Study||16
5232359|NCT00886639|12864164|P1|COMPLETED|Overall Study||111
5232360|NCT00886639|12864164|P1|STARTED|Overall Study||127
5232361|NCT00886626|12864168|P2|NOT COMPLETED|Period 2 (90 Days)||0
5232362|NCT00886626|12864169|P1|NOT COMPLETED|Period 2 (90 Days)||0
5232363|NCT00886626|12864168|P2|COMPLETED|Period 2 (90 Days)||6
5232364|NCT00886626|12864169|P1|COMPLETED|Period 2 (90 Days)||5
5232365|NCT00886626|12864168|P2|STARTED|Period 2 (90 Days)||6
5232366|NCT00886626|12864169|P1|STARTED|Period 2 (90 Days)||5
5232367|NCT00886626|12864168|P2|NOT COMPLETED|Period 1 (90 Days)||0
5232368|NCT00886626|12864169|P1|NOT COMPLETED|Period 1 (90 Days)||1
5232369|NCT00886626|12864168|P2|COMPLETED|Period 1 (90 Days)||6
5232370|NCT00886626|12864169|P1|COMPLETED|Period 1 (90 Days)||5
5232371|NCT00886626|12864168|P2|STARTED|Period 1 (90 Days)||6
5232372|NCT00886626|12864169|P1|STARTED|Period 1 (90 Days)||6
5232373|NCT00886613|12864178|P3|NOT COMPLETED|Overall Study||3
5232374|NCT00886613|12864179|P2|NOT COMPLETED|Overall Study||0
5232375|NCT00886613|12864180|P1|NOT COMPLETED|Overall Study||2
5232376|NCT00886613|12864178|P3|COMPLETED|Overall Study||37
5232377|NCT00886613|12864179|P2|COMPLETED|Overall Study||39
5232378|NCT00886613|12864180|P1|COMPLETED|Overall Study||39
5232379|NCT00886613|12864178|P3|STARTED|Overall Study||40
5232380|NCT00886613|12864179|P2|STARTED|Overall Study||39
5232381|NCT00886613|12864180|P1|STARTED|Overall Study||41
5232382|NCT00886600|12864202|P4|NOT COMPLETED|Combination Therapy Period||0
5232383|NCT00886600|12864203|P3|NOT COMPLETED|Combination Therapy Period||2
5232384|NCT00886600|12864204|P2|NOT COMPLETED|Combination Therapy Period||0
5232385|NCT00886600|12864205|P1|NOT COMPLETED|Combination Therapy Period||0
5232386|NCT00886600|12864202|P4|COMPLETED|Combination Therapy Period||23
5232387|NCT00886600|12864203|P3|COMPLETED|Combination Therapy Period||19
5232388|NCT00886600|12864204|P2|COMPLETED|Combination Therapy Period||21
5232389|NCT00886600|12864205|P1|COMPLETED|Combination Therapy Period||28
5232390|NCT00886600|12864202|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
5232391|NCT00886600|12864203|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
5232392|NCT00886600|12864204|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
5232393|NCT00886600|12864205|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
5232394|NCT00886600|12864202|P4|NOT COMPLETED|Double-blind Monotherapy||2
5232395|NCT00886600|12864203|P3|NOT COMPLETED|Double-blind Monotherapy||1
5232396|NCT00886600|12864204|P2|NOT COMPLETED|Double-blind Monotherapy||1
5232397|NCT00886600|12864205|P1|NOT COMPLETED|Double-blind Monotherapy||2
5232398|NCT00886600|12864202|P4|COMPLETED|Double-blind Monotherapy||29
5232399|NCT00886600|12864203|P3|COMPLETED|Double-blind Monotherapy||29
5232400|NCT00886600|12864204|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
5232401|NCT00886600|12864205|P1|COMPLETED|Double-blind Monotherapy||30
5232402|NCT00886600|12864202|P4|STARTED|Double-blind Monotherapy||31
5232403|NCT00886600|12864203|P3|STARTED|Double-blind Monotherapy||30
5232404|NCT00886600|12864204|P2|STARTED|Double-blind Monotherapy||29
5232405|NCT00886600|12864205|P1|STARTED|Double-blind Monotherapy||32
5232406|NCT00886587|12864229|P2|NOT COMPLETED|Overall Study||2
5232407|NCT00886587|12864230|P1|NOT COMPLETED|Overall Study||4
5232408|NCT00886587|12864229|P2|COMPLETED|Overall Study||39
5232409|NCT00886587|12864230|P1|COMPLETED|Overall Study||37
5232410|NCT00886587|12864229|P2|STARTED|Overall Study||41
5232411|NCT00886587|12864230|P1|STARTED|Overall Study||41
5232412|NCT00886483|12864244|P2|NOT COMPLETED|Overall Study||3
5232413|NCT00886483|12864245|P1|NOT COMPLETED|Overall Study||2
5232414|NCT00886483|12864244|P2|COMPLETED|Overall Study||10
5232415|NCT00886483|12864245|P1|COMPLETED|Overall Study||24
5232416|NCT00886483|12864244|P2|Completed 20 Treatments|Overall Study||11
5232417|NCT00886483|12864245|P1|Completed 20 Treatments|Overall Study||25
5232418|NCT00886483|12864244|P2|STARTED|Overall Study||13
5232419|NCT00886483|12864245|P1|STARTED|Overall Study||26
5232420|NCT00886340|12864263|P2|NOT COMPLETED|Overall Study||7
5232421|NCT00886340|12864264|P1|NOT COMPLETED|Overall Study||0
5232422|NCT00886340|12864263|P2|COMPLETED|Overall Study||24
5232423|NCT00886340|12864264|P1|COMPLETED|Overall Study||27
5232424|NCT00886340|12864263|P2|STARTED|Overall Study||31
5232425|NCT00886340|12864264|P1|STARTED|Overall Study||27
5232426|NCT00886288|12864272|P2|NOT COMPLETED|Overall Study||227
5232427|NCT00886288|12864273|P1|NOT COMPLETED|Overall Study||743
5232428|NCT00886288|12864272|P2|COMPLETED|Overall Study||457
5232429|NCT00886288|12864273|P1|COMPLETED|Overall Study||1284
5232430|NCT00886288|12864272|P2|STARTED|Overall Study|Baseline Population|684
5232431|NCT00886288|12864273|P1|STARTED|Overall Study|Baseline Population|2027
5232432|NCT00886262|12864291|P2|NOT COMPLETED|Overall Study||3
5232433|NCT00886262|12864292|P1|NOT COMPLETED|Overall Study||0
5232434|NCT00886262|12864291|P2|COMPLETED|Overall Study||7
5232435|NCT00886262|12864292|P1|COMPLETED|Overall Study||8
5232436|NCT00886262|12864291|P2|STARTED|Overall Study||10
5232437|NCT00886262|12864292|P1|STARTED|Overall Study||8
5232438|NCT00886236|12864307|P3|NOT COMPLETED|Overall Study||4
5232439|NCT00886236|12864308|P2|NOT COMPLETED|Overall Study||4
5232440|NCT00886236|12864309|P1|NOT COMPLETED|Overall Study||2
5232441|NCT00886236|12864307|P3|COMPLETED|Overall Study||17
5232442|NCT00886236|12864308|P2|COMPLETED|Overall Study||17
5232443|NCT00886236|12864309|P1|COMPLETED|Overall Study||18
5232444|NCT00886236|12864307|P3|STARTED|Overall Study||21
5232445|NCT00886236|12864308|P2|STARTED|Overall Study||21
5232446|NCT00886236|12864309|P1|STARTED|Overall Study||20
5232447|NCT00886145|12864323|P1|NOT COMPLETED|Overall Study||0
5232448|NCT00886145|12864323|P1|COMPLETED|Overall Study||1
5232449|NCT00886145|12864323|P1|STARTED|Overall Study||1
5232450|NCT00886119|12864329|P2|NOT COMPLETED|Period 2||0
5232451|NCT00886119|12864330|P1|NOT COMPLETED|Period 2||0
5232452|NCT00886119|12864329|P2|COMPLETED|Period 2||22
5232453|NCT00886119|12864330|P1|COMPLETED|Period 2||23
5232454|NCT00886119|12864329|P2|STARTED|Period 2||22
5232455|NCT00886119|12864330|P1|STARTED|Period 2||23
5232456|NCT00886119|12864329|P2|NOT COMPLETED|Period 1||0
5232457|NCT00886119|12864330|P1|NOT COMPLETED|Period 1||1
5232458|NCT00886119|12864329|P2|COMPLETED|Period 1||22
5232459|NCT00886119|12864330|P1|COMPLETED|Period 1||23
5232460|NCT00886119|12864329|P2|STARTED|Period 1||22
5232461|NCT00886119|12864330|P1|STARTED|Period 1||24
5232462|NCT00886015|12864338|P2|NOT COMPLETED|Overall Study||2
5232463|NCT00886015|12864339|P1|NOT COMPLETED|Overall Study||0
5232464|NCT00886015|12864338|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
5232465|NCT00886015|12864339|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
5232466|NCT00886015|12864338|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
5232467|NCT00886015|12864339|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
5232468|NCT00885846|12864358|P3|NOT COMPLETED|Overall Study||2
5232469|NCT00885846|12864359|P2|NOT COMPLETED|Overall Study||5
5232470|NCT00885846|12864360|P1|NOT COMPLETED|Overall Study||2
5232471|NCT00885846|12864358|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
5232472|NCT00885846|12864359|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
5232473|NCT00885846|12864360|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
5232474|NCT00885846|12864358|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
5232475|NCT00885846|12864359|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
5232476|NCT00885846|12864360|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
5232477|NCT00885768|12864368|P1|NOT COMPLETED|Overall Study||0
5232478|NCT00885768|12864368|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
5232479|NCT00885768|12864368|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
5232480|NCT00885755|12864375|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
5232481|NCT00885755|12864376|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
5232482|NCT00885755|12864377|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
5232483|NCT00885755|12864375|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
5232484|NCT00885755|12864376|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
5232485|NCT00885755|12864377|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
5232486|NCT00885755|12864375|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
5232487|NCT00885755|12864376|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
5232488|NCT00885755|12864377|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
5232489|NCT00885755|12864375|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
5232490|NCT00885755|12864376|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
5232491|NCT00885755|12864377|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
5232492|NCT00885755|12864375|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
5232493|NCT00885755|12864376|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
5232494|NCT00885755|12864377|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
5232495|NCT00885755|12864375|P3|STARTED|Part I: Trastuzumab+Taxane||1
5232496|NCT00885755|12864376|P2|STARTED|Part I: Trastuzumab+Taxane||1
5232497|NCT00885755|12864377|P1|STARTED|Part I: Trastuzumab+Taxane||31
5232498|NCT00885742|12864402|P1|NOT COMPLETED|Overall Study||0
5232499|NCT00885742|12864402|P1|COMPLETED|Overall Study||41
5232500|NCT00885742|12864402|P1|STARTED|Overall Study||41
5232501|NCT00885703|12864420|P7|NOT COMPLETED|Overall Study||6
5232502|NCT00885703|12864421|P6|NOT COMPLETED|Overall Study||13
5232503|NCT00885703|12864422|P5|NOT COMPLETED|Overall Study||12
5232504|NCT00885703|12864423|P4|NOT COMPLETED|Overall Study||9
5232505|NCT00885703|12864424|P3|NOT COMPLETED|Overall Study||11
5232506|NCT00885703|12864425|P2|NOT COMPLETED|Overall Study||10
5232507|NCT00885703|12864426|P1|NOT COMPLETED|Overall Study||10
5232508|NCT00885703|12864420|P7|COMPLETED|Overall Study||18
5232509|NCT00885703|12864421|P6|COMPLETED|Overall Study||11
5232510|NCT00885703|12864422|P5|COMPLETED|Overall Study||12
5232511|NCT00885703|12864423|P4|COMPLETED|Overall Study||15
5232512|NCT00885703|12864424|P3|COMPLETED|Overall Study||13
5232513|NCT00885703|12864425|P2|COMPLETED|Overall Study||16
5232514|NCT00885703|12864426|P1|COMPLETED|Overall Study||12
5232515|NCT00885703|12864420|P7|STARTED|Overall Study||24
5232516|NCT00885703|12864421|P6|STARTED|Overall Study||24
5232517|NCT00885703|12864422|P5|STARTED|Overall Study||24
5232518|NCT00885703|12864423|P4|STARTED|Overall Study||24
5232519|NCT00885703|12864424|P3|STARTED|Overall Study||24
5232520|NCT00885703|12864425|P2|STARTED|Overall Study||26
5232521|NCT00885703|12864426|P1|STARTED|Overall Study||22
5232522|NCT00885677|12864484|P2|NOT COMPLETED|Overall Study||178
5232523|NCT00885677|12864485|P1|NOT COMPLETED|Overall Study||183
5232524|NCT00885677|12864484|P2|COMPLETED|Overall Study||277
5232525|NCT00885677|12864485|P1|COMPLETED|Overall Study||279
5232526|NCT00885677|12864484|P2|Intention To Treat|Overall Study||428
5232527|NCT00885677|12864485|P1|Intention To Treat|Overall Study||437
5232528|NCT00885677|12864484|P2|STARTED|Overall Study||455
5232529|NCT00885677|12864485|P1|STARTED|Overall Study||462
5232530|NCT00885638|12864493|P2|NOT COMPLETED|Overall Study||0
5232531|NCT00885638|12864494|P1|NOT COMPLETED|Overall Study||0
5232532|NCT00885638|12864493|P2|COMPLETED|Overall Study||6
5232533|NCT00885638|12864494|P1|COMPLETED|Overall Study||6
5232534|NCT00885638|12864493|P2|STARTED|Overall Study||6
5232535|NCT00885638|12864494|P1|STARTED|Overall Study||6
5232536|NCT00885534|12864501|P1|NOT COMPLETED|Overall Study||1
5232537|NCT00885534|12864501|P1|COMPLETED|Overall Study||6
5232538|NCT00885534|12864501|P1|STARTED|Overall Study||7
5232539|NCT00885482|12864505|P1|NOT COMPLETED|Overall Study||4
5232540|NCT00885482|12864505|P1|COMPLETED|Overall Study||36
5232541|NCT00885482|12864505|P1|STARTED|Overall Study||40
5232542|NCT00885378|12864511|P2|NOT COMPLETED|Overall Study||8
5232543|NCT00885378|12864512|P1|NOT COMPLETED|Overall Study||8
5232544|NCT00885378|12864511|P2|COMPLETED|Overall Study||78
5232545|NCT00885378|12864512|P1|COMPLETED|Overall Study||66
5232546|NCT00885378|12864511|P2|STARTED|Overall Study|Number randomized.|86
5232547|NCT00885378|12864512|P1|STARTED|Overall Study|Number randomized.|74
5232548|NCT00885365|12864542|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
5232549|NCT00885365|12864543|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
5232550|NCT00885365|12864542|P2|COMPLETED|4 Weeks OFF Treatment||159
5232551|NCT00885365|12864543|P1|COMPLETED|4 Weeks OFF Treatment||155
5232552|NCT00885365|12864542|P2|STARTED|4 Weeks OFF Treatment||159
5232553|NCT00885365|12864543|P1|STARTED|4 Weeks OFF Treatment||155
5232554|NCT00885365|12864542|P2|NOT COMPLETED|4 Weeks ON Treatment||6
5232555|NCT00885365|12864543|P1|NOT COMPLETED|4 Weeks ON Treatment||4
5232556|NCT00885365|12864542|P2|COMPLETED|4 Weeks ON Treatment||159
5232557|NCT00885365|12864543|P1|COMPLETED|4 Weeks ON Treatment||155
5232558|NCT00885365|12864542|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
5232559|NCT00885365|12864543|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
5232560|NCT00885365|12864542|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
5232561|NCT00885365|12864543|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
5232562|NCT00885365|12864542|P2|STARTED|4 Weeks ON Treatment||165
5232563|NCT00885365|12864543|P1|STARTED|4 Weeks ON Treatment||159
5232564|NCT00885352|12864579|P2|NOT COMPLETED|Overall Study||20
5232565|NCT00885352|12864580|P1|NOT COMPLETED|Overall Study||8
5232566|NCT00885352|12864579|P2|COMPLETED|Overall Study||136
5232567|NCT00885352|12864580|P1|COMPLETED|Overall Study||149
5232568|NCT00885352|12864579|P2|STARTED|Overall Study||156
5232569|NCT00885352|12864580|P1|STARTED|Overall Study||157
5232570|NCT00885170|12864592|P2|NOT COMPLETED|Overall Study||23
5232571|NCT00885170|12864593|P1|NOT COMPLETED|Overall Study||38
5232572|NCT00885170|12864592|P2|COMPLETED|Overall Study||99
5232573|NCT00885170|12864593|P1|COMPLETED|Overall Study||86
5232574|NCT00885170|12864592|P2|Treated|Overall Study||121
5232575|NCT00885170|12864593|P1|Treated|Overall Study||122
5232576|NCT00885170|12864592|P2|STARTED|Overall Study||122
5232577|NCT00885170|12864593|P1|STARTED|Overall Study||124
5232578|NCT00885118|12864652|P5|NOT COMPLETED|Overall Study||1
5232579|NCT00885118|12864653|P4|NOT COMPLETED|Overall Study||0
5232580|NCT00885118|12864654|P3|NOT COMPLETED|Overall Study||1
5232581|NCT00885118|12864655|P2|NOT COMPLETED|Overall Study||0
5232582|NCT00885118|12864656|P1|NOT COMPLETED|Overall Study||1
5232583|NCT00885118|12864652|P5|COMPLETED|Overall Study||18
5232584|NCT00885118|12864653|P4|COMPLETED|Overall Study||20
5232585|NCT00885118|12864654|P3|COMPLETED|Overall Study||20
5232586|NCT00885118|12864655|P2|COMPLETED|Overall Study||19
5232587|NCT00885118|12864656|P1|COMPLETED|Overall Study||20
5232588|NCT00885118|12864652|P5|STARTED|Overall Study||19
5232589|NCT00885118|12864653|P4|STARTED|Overall Study||20
5232590|NCT00885118|12864654|P3|STARTED|Overall Study||21
5232591|NCT00885118|12864655|P2|STARTED|Overall Study||19
5232592|NCT00885118|12864656|P1|STARTED|Overall Study||21
5232593|NCT00885105|12864795|P2|NOT COMPLETED|Overall Study||10
5232594|NCT00885105|12864796|P1|NOT COMPLETED|Overall Study||1
5232595|NCT00885105|12864795|P2|COMPLETED|Overall Study||120
5232596|NCT00885105|12864796|P1|COMPLETED|Overall Study||111
5232597|NCT00885105|12864795|P2|STARTED|Overall Study||130
5232598|NCT00885105|12864796|P1|STARTED|Overall Study||112
5232599|NCT00885092|12864814|P2|NOT COMPLETED|Period 2, 7 Days||0
5232600|NCT00885092|12864815|P1|NOT COMPLETED|Period 2, 7 Days||0
5232601|NCT00885092|12864814|P2|COMPLETED|Period 2, 7 Days||20
5232602|NCT00885092|12864815|P1|COMPLETED|Period 2, 7 Days||20
5232603|NCT00885092|12864814|P2|STARTED|Period 2, 7 Days||20
5232604|NCT00885092|12864815|P1|STARTED|Period 2, 7 Days||20
5232605|NCT00885092|12864814|P2|NOT COMPLETED|Period 1, 7 Days||0
5232606|NCT00885092|12864815|P1|NOT COMPLETED|Period 1, 7 Days||0
5232607|NCT00885092|12864814|P2|COMPLETED|Period 1, 7 Days||20
5232608|NCT00885092|12864815|P1|COMPLETED|Period 1, 7 Days||20
5232609|NCT00885092|12864814|P2|STARTED|Period 1, 7 Days||20
5232610|NCT00885092|12864815|P1|STARTED|Period 1, 7 Days||20
5232611|NCT00885079|12864827|P2|NOT COMPLETED|Overall Study||4
5232612|NCT00885079|12864828|P1|NOT COMPLETED|Overall Study||2
5232613|NCT00885079|12864827|P2|COMPLETED|Overall Study||91
5232614|NCT00885079|12864828|P1|COMPLETED|Overall Study||91
5232615|NCT00885079|12864827|P2|STARTED|Overall Study||95
5232616|NCT00885079|12864828|P1|STARTED|Overall Study||93
5232617|NCT00884949|12864836|P1|NOT COMPLETED|Continuation Period||0
5232618|NCT00884949|12864836|P1|COMPLETED|Continuation Period||18
5232619|NCT00884949|12864836|P1|STARTED|Continuation Period||18
5232620|NCT00884949|12864836|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
5232621|NCT00884949|12864836|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
5232622|NCT00884949|12864836|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
5232623|NCT00884949|12864836|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
5232624|NCT00884949|12864836|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
5232625|NCT00884949|12864836|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
5232626|NCT00884949|12864836|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
5232627|NCT00884949|12864836|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
5232628|NCT00884949|12864836|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
5232629|NCT00884910|12864853|P1|NOT COMPLETED|Overall Study||1
5232630|NCT00884910|12864853|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
5232631|NCT00884910|12864853|P1|STARTED|Overall Study||33
5232632|NCT00884897|12864860|P2|NOT COMPLETED|Overall Study||0
5232633|NCT00884897|12864861|P1|NOT COMPLETED|Overall Study||0
5232634|NCT00884897|12864860|P2|COMPLETED|Overall Study||15
5232635|NCT00884897|12864861|P1|COMPLETED|Overall Study||13
5232636|NCT00884897|12864860|P2|STARTED|Overall Study||15
5232637|NCT00884897|12864861|P1|STARTED|Overall Study||13
5232638|NCT00884832|12864871|P2|NOT COMPLETED|Overall Study||1
5232639|NCT00884832|12864872|P1|NOT COMPLETED|Overall Study||0
5232640|NCT00884832|12864871|P2|COMPLETED|Overall Study||21
5232641|NCT00884832|12864872|P1|COMPLETED|Overall Study||22
5232642|NCT00884832|12864871|P2|STARTED|Overall Study||22
5232643|NCT00884832|12864872|P1|STARTED|Overall Study||22
5232644|NCT00884806|12864902|P1|NOT COMPLETED|Overall Study||0
5232645|NCT00884806|12864902|P1|COMPLETED|Overall Study||110
5232646|NCT00884806|12864902|P1|STARTED|Overall Study||110
5232647|NCT00884793|12864907|P1|NOT COMPLETED|Overall Study||1
5232648|NCT00884793|12864907|P1|COMPLETED|Overall Study||7
5232649|NCT00884793|12864907|P1|STARTED|Overall Study||8
5232650|NCT00884754|12864916|P2|NOT COMPLETED|Overall Study||0
5232651|NCT00884754|12864917|P1|NOT COMPLETED|Overall Study||0
5232652|NCT00884754|12864916|P2|COMPLETED|Overall Study||30
5232653|NCT00884754|12864917|P1|COMPLETED|Overall Study||30
5232654|NCT00884754|12864916|P2|STARTED|Overall Study||30
5232655|NCT00884754|12864917|P1|STARTED|Overall Study||30
5232656|NCT00884741|12864926|P4|NOT COMPLETED|Randomization||8
5232657|NCT00884741|12864927|P3|NOT COMPLETED|Randomization||8
5232658|NCT00884741|12864928|P2|NOT COMPLETED|Randomization||0
5232659|NCT00884741|12864929|P1|NOT COMPLETED|Randomization||0
5232660|NCT00884741|12864926|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
5232661|NCT00884741|12864927|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
5232662|NCT00884741|12864928|P2|COMPLETED|Randomization||0
5232663|NCT00884741|12864929|P1|COMPLETED|Randomization||0
5232664|NCT00884741|12864926|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
5232665|NCT00884741|12864927|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
5232666|NCT00884741|12864928|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
5232667|NCT00884741|12864929|P1|STARTED|Randomization||0
5232668|NCT00884741|12864926|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
5232669|NCT00884741|12864927|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
5232670|NCT00884741|12864928|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
5232671|NCT00884741|12864929|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
5232672|NCT00884741|12864926|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
5232673|NCT00884741|12864927|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
5232674|NCT00884741|12864928|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
5232675|NCT00884741|12864929|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
5232676|NCT00884741|12864926|P4|STARTED|Step 2 Registration: Tissue Analysis||0
5232677|NCT00884741|12864927|P3|STARTED|Step 2 Registration: Tissue Analysis||0
5232678|NCT00884741|12864928|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
5232679|NCT00884741|12864929|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
5232680|NCT00884741|12864926|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
5232681|NCT00884741|12864927|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
5232682|NCT00884741|12864928|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
5232683|NCT00884741|12864929|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
5232684|NCT00884741|12864926|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
5232685|NCT00884741|12864927|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
5232686|NCT00884741|12864928|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
5232687|NCT00884741|12864929|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
5232688|NCT00884741|12864926|P4|STARTED|Step 1 Registration: Tissue Screening||0
5232689|NCT00884741|12864927|P3|STARTED|Step 1 Registration: Tissue Screening||0
5232690|NCT00884741|12864928|P2|STARTED|Step 1 Registration: Tissue Screening||0
5232691|NCT00884741|12864929|P1|STARTED|Step 1 Registration: Tissue Screening||978
5232692|NCT00884611|12864940|P1|NOT COMPLETED|Overall Study||1
5232693|NCT00884611|12864940|P1|COMPLETED|Overall Study||19
5232694|NCT00884611|12864940|P1|Enrolled, Not Treated|Overall Study||1
5232695|NCT00884611|12864940|P1|STARTED|Overall Study||20
5232696|NCT00884585|12864964|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
5232697|NCT00884585|12864965|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
5232698|NCT00884585|12864964|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
5232699|NCT00884585|12864965|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
5232700|NCT00884585|12864964|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
5232701|NCT00884585|12864965|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
5232702|NCT00884585|12864964|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
5232703|NCT00884585|12864965|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
5232704|NCT00884585|12864964|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
5232705|NCT00884585|12864965|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
5232706|NCT00884585|12864964|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
5232707|NCT00884585|12864965|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
5232708|NCT00884585|12864964|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
5232709|NCT00884585|12864965|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
5232710|NCT00884585|12864964|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
5232711|NCT00884585|12864965|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
5232712|NCT00884585|12864964|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
5232713|NCT00884585|12864965|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
5232714|NCT00884390|12864979|P2|NOT COMPLETED|Overall Study||8
5232715|NCT00884390|12864980|P1|NOT COMPLETED|Overall Study||23
5232716|NCT00884390|12864979|P2|COMPLETED|Overall Study||54
5232717|NCT00884390|12864980|P1|COMPLETED|Overall Study||123
5232718|NCT00884390|12864979|P2|STARTED|Overall Study||62
5232719|NCT00884390|12864980|P1|STARTED|Overall Study||146
5232720|NCT00884377|12864998|P2|NOT COMPLETED|Overall Study||1
5232721|NCT00884377|12864999|P1|NOT COMPLETED|Overall Study||2
5232722|NCT00884377|12864998|P2|COMPLETED|Overall Study||27
5232723|NCT00884377|12864999|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
5232724|NCT00884377|12864998|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
5232725|NCT00884377|12864999|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
5232726|NCT00884325|12865021|P2|NOT COMPLETED|Overall Study||4
5232727|NCT00884325|12865022|P1|NOT COMPLETED|Overall Study||3
5232728|NCT00884325|12865021|P2|COMPLETED|Overall Study||16
5232729|NCT00884325|12865022|P1|COMPLETED|Overall Study||17
5232730|NCT00884325|12865021|P2|STARTED|Overall Study||20
5232731|NCT00884325|12865022|P1|STARTED|Overall Study||20
5232732|NCT00884312|12865032|P2|NOT COMPLETED|Overall Study||25
5232733|NCT00884312|12865033|P1|NOT COMPLETED|Overall Study||2
5232734|NCT00884312|12865032|P2|COMPLETED|Overall Study||67
5232735|NCT00884312|12865033|P1|COMPLETED|Overall Study||7
5232736|NCT00884312|12865032|P2|Received Treatment|Overall Study||91
5232737|NCT00884312|12865033|P1|Received Treatment|Overall Study||9
5232738|NCT00884312|12865032|P2|STARTED|Overall Study||92
5232739|NCT00884312|12865033|P1|STARTED|Overall Study||9
5232740|NCT00884286|12865049|P2|NOT COMPLETED|Overall Study||33
5232741|NCT00884286|12865050|P1|NOT COMPLETED|Overall Study||32
5232742|NCT00884286|12865049|P2|COMPLETED|Overall Study||0
5232743|NCT00884286|12865050|P1|COMPLETED|Overall Study||2
5232744|NCT00884286|12865049|P2|STARTED|Overall Study||33
5232745|NCT00884286|12865050|P1|STARTED|Overall Study||34
5232746|NCT00884273|12865064|P2|NOT COMPLETED|Overall Study||5
5232747|NCT00884273|12865065|P1|NOT COMPLETED|Overall Study||2
5232748|NCT00884273|12865064|P2|COMPLETED|Overall Study||93
5232749|NCT00884273|12865065|P1|COMPLETED|Overall Study||82
5232750|NCT00884273|12865064|P2|Safety Analysis Set|Overall Study||98
5232751|NCT00884273|12865065|P1|Safety Analysis Set|Overall Study||84
5232752|NCT00884273|12865064|P2|Per Protocol (PP) Analysis Set|Overall Study||92
5232753|NCT00884273|12865065|P1|Per Protocol (PP) Analysis Set|Overall Study||81
5232754|NCT00884273|12865064|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
5232755|NCT00884273|12865065|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
5232756|NCT00884273|12865064|P2|STARTED|Overall Study|ITT population.|98
5232757|NCT00884273|12865065|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
5232758|NCT00884221|12865091|P2|NOT COMPLETED|Overall Study||32
5232759|NCT00884221|12865092|P1|NOT COMPLETED|Overall Study||34
5232760|NCT00884221|12865091|P2|COMPLETED|Overall Study||343
5232761|NCT00884221|12865092|P1|COMPLETED|Overall Study||340
5232762|NCT00884221|12865091|P2|STARTED|Overall Study||375
5232763|NCT00884221|12865092|P1|STARTED|Overall Study||374
5232764|NCT00884117|12865128|P1|NOT COMPLETED|Overall Study||249
5232765|NCT00884117|12865128|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
5232766|NCT00884117|12865128|P1|STARTED|Overall Study||4561
5232767|NCT00884065|12865172|P2|NOT COMPLETED|Overall Study||0
5232768|NCT00884065|12865173|P1|NOT COMPLETED|Overall Study||0
5232769|NCT00884065|12865172|P2|COMPLETED|Overall Study||25
5232770|NCT00884065|12865173|P1|COMPLETED|Overall Study||25
5232771|NCT00884065|12865172|P2|STARTED|Overall Study||25
5232772|NCT00884065|12865173|P1|STARTED|Overall Study||25
5232773|NCT00884052|12865189|P2|NOT COMPLETED|Overall Study||0
5232774|NCT00884052|12865190|P1|NOT COMPLETED|Overall Study||0
5232775|NCT00884052|12865189|P2|COMPLETED|Overall Study||12
5232776|NCT00884052|12865190|P1|COMPLETED|Overall Study||6
5232777|NCT00884052|12865189|P2|STARTED|Overall Study||12
5232778|NCT00884052|12865190|P1|STARTED|Overall Study||6
5232779|NCT00884039|12865199|P2|NOT COMPLETED|Overall Study||1
5232780|NCT00884039|12865200|P1|NOT COMPLETED|Overall Study||2
5232781|NCT00884039|12865199|P2|COMPLETED|Overall Study||1
5232782|NCT00884039|12865200|P1|COMPLETED|Overall Study||3
5232783|NCT00884039|12865199|P2|STARTED|Overall Study||2
5232784|NCT00884039|12865200|P1|STARTED|Overall Study||5
5232785|NCT00883779|12865208|P2|NOT COMPLETED|Off-study Phase||202
5232786|NCT00883779|12865209|P1|NOT COMPLETED|Off-study Phase||209
5232787|NCT00883779|12865208|P2|COMPLETED|Off-study Phase||0
5232788|NCT00883779|12865209|P1|COMPLETED|Off-study Phase||0
5232789|NCT00883779|12865208|P2|STARTED|Off-study Phase||202
5232790|NCT00883779|12865209|P1|STARTED|Off-study Phase||209
5232791|NCT00883779|12865208|P2|NOT COMPLETED|Post-Study Treatment Phase||135
5232792|NCT00883779|12865209|P1|NOT COMPLETED|Post-Study Treatment Phase||112
5232793|NCT00883779|12865208|P2|COMPLETED|Post-Study Treatment Phase||0
5232794|NCT00883779|12865209|P1|COMPLETED|Post-Study Treatment Phase||0
5232795|NCT00883779|12865208|P2|STARTED|Post-Study Treatment Phase||135
5232796|NCT00883779|12865209|P1|STARTED|Post-Study Treatment Phase||112
5232797|NCT00883779|12865208|P2|NOT COMPLETED|Primary Study Treatment Phase||86
5232798|NCT00883779|12865209|P1|NOT COMPLETED|Primary Study Treatment Phase||105
5232799|NCT00883779|12865208|P2|COMPLETED|Primary Study Treatment Phase||140
5232800|NCT00883779|12865209|P1|COMPLETED|Primary Study Treatment Phase||120
5232801|NCT00883779|12865208|P2|STARTED|Primary Study Treatment Phase||226
5232802|NCT00883779|12865209|P1|STARTED|Primary Study Treatment Phase||225
5232803|NCT00883753|12865245|P1|NOT COMPLETED|Overall Study||107
5232804|NCT00883753|12865245|P1|COMPLETED|Overall Study||827
5232805|NCT00883753|12865245|P1|STARTED|Overall Study||934
5232806|NCT00883740|12865285|P2|NOT COMPLETED|Second Intervention||1
5232807|NCT00883740|12865286|P1|NOT COMPLETED|Second Intervention||1
5232808|NCT00883740|12865285|P2|COMPLETED|Second Intervention||50
5232809|NCT00883740|12865286|P1|COMPLETED|Second Intervention||52
5232810|NCT00883740|12865285|P2|STARTED|Second Intervention||51
5232811|NCT00883740|12865286|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
5232812|NCT00883740|12865285|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
5232813|NCT00883740|12865286|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
5232814|NCT00883740|12865285|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
5232815|NCT00883740|12865286|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
5232816|NCT00883740|12865285|P2|STARTED|Taper and Washout Period (2 Weeks)||51
5232817|NCT00883740|12865286|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
5232818|NCT00883740|12865285|P2|NOT COMPLETED|First Intervention||8
5232819|NCT00883740|12865286|P1|NOT COMPLETED|First Intervention||7
5232820|NCT00883740|12865285|P2|COMPLETED|First Intervention||51
5232821|NCT00883740|12865286|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
5232822|NCT00883740|12865285|P2|STARTED|First Intervention||59
5232823|NCT00883740|12865286|P1|STARTED|First Intervention||60
5232824|NCT00883675|12865326|P1|NOT COMPLETED|Overall Study||0
5232825|NCT00883675|12865326|P1|COMPLETED|Overall Study||133
5232826|NCT00883675|12865326|P1|STARTED|Overall Study||133
5232827|NCT00883558|12865330|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
5232828|NCT00883558|12865331|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
5232829|NCT00883558|12865332|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
5232830|NCT00883558|12865330|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
5232831|NCT00883558|12865331|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
5232832|NCT00883558|12865332|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
5232833|NCT00883558|12865330|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
5232834|NCT00883558|12865331|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
5232835|NCT00883558|12865332|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
5232836|NCT00883558|12865330|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
5232837|NCT00883558|12865331|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
5232838|NCT00883558|12865332|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
5232839|NCT00883558|12865330|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
5232840|NCT00883558|12865331|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
5232841|NCT00883558|12865332|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
5232842|NCT00883558|12865330|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
5232843|NCT00883558|12865331|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
5232844|NCT00883558|12865332|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
5232845|NCT00883558|12865330|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
5232846|NCT00883558|12865331|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
5232847|NCT00883558|12865332|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
5232848|NCT00883558|12865330|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
5232849|NCT00883558|12865331|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
5232850|NCT00883558|12865332|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
5232851|NCT00883558|12865330|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
5232852|NCT00883558|12865331|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
5232853|NCT00883558|12865332|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
5232854|NCT00883558|12865330|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
5232855|NCT00883558|12865331|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
5232856|NCT00883558|12865332|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
5232857|NCT00883558|12865330|P3|STARTED|Titration Period (Weeks 0 to 4)||0
5232858|NCT00883558|12865331|P2|STARTED|Titration Period (Weeks 0 to 4)||0
5232859|NCT00883558|12865332|P1|STARTED|Titration Period (Weeks 0 to 4)||48
5232860|NCT00883493|12865344|P2|NOT COMPLETED|Overall Study||50
5232861|NCT00883493|12865345|P1|NOT COMPLETED|Overall Study||46
5232862|NCT00883493|12865344|P2|COMPLETED|Overall Study||159
5232863|NCT00883493|12865345|P1|COMPLETED|Overall Study||166
5232864|NCT00883493|12865344|P2|Per Protocol Analysis Population|Overall Study||155
5232865|NCT00883493|12865345|P1|Per Protocol Analysis Population|Overall Study||162
5232866|NCT00883493|12865344|P2|Intention To Treat Analysis Population|Overall Study||195
5232867|NCT00883493|12865345|P1|Intention To Treat Analysis Population|Overall Study||204
5232868|NCT00883493|12865344|P2|STARTED|Overall Study||209
5232869|NCT00883493|12865345|P1|STARTED|Overall Study||212
5232870|NCT00883415|12865369|P1|NOT COMPLETED|Overall Study||2
5232871|NCT00883415|12865369|P1|COMPLETED|Overall Study||18
5232872|NCT00883415|12865369|P1|STARTED|Overall Study||20
5232873|NCT00883389|12865373|P1|NOT COMPLETED|Overall Study||0
5232874|NCT00883389|12865373|P1|COMPLETED|Overall Study||26
5232875|NCT00883389|12865373|P1|STARTED|Overall Study||26
5232876|NCT00883337|12865380|P3|NOT COMPLETED|Extension Treatment Period||19
5232877|NCT00883337|12865381|P2|NOT COMPLETED|Extension Treatment Period||23
5232878|NCT00883337|12865382|P1|NOT COMPLETED|Extension Treatment Period||28
5232879|NCT00883337|12865380|P3|COMPLETED|Extension Treatment Period||40
5232880|NCT00883337|12865381|P2|COMPLETED|Extension Treatment Period||66
5232881|NCT00883337|12865382|P1|COMPLETED|Extension Treatment Period||61
5232882|NCT00883337|12865380|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
5232883|NCT00883337|12865381|P2|STARTED|Extension Treatment Period||89
5232884|NCT00883337|12865382|P1|STARTED|Extension Treatment Period||89
5232885|NCT00883337|12865380|P3|NOT COMPLETED|Core Treatment Period||33
5232886|NCT00883337|12865381|P2|NOT COMPLETED|Core Treatment Period||22
5232887|NCT00883337|12865382|P1|NOT COMPLETED|Core Treatment Period||20
5232888|NCT00883337|12865380|P3|COMPLETED|Core Treatment Period||71
5232889|NCT00883337|12865381|P2|COMPLETED|Core Treatment Period||89
5232890|NCT00883337|12865382|P1|COMPLETED|Core Treatment Period||89
5232891|NCT00883337|12865380|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
5232892|NCT00883337|12865381|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
5232893|NCT00883337|12865382|P1|Treated|Core Treatment Period||109
5232894|NCT00883337|12865380|P3|STARTED|Core Treatment Period||104
5232895|NCT00883337|12865381|P2|STARTED|Core Treatment Period||111
5232896|NCT00883337|12865382|P1|STARTED|Core Treatment Period||109
5232897|NCT00883246|12865414|P1|NOT COMPLETED|Overall Study||173
5232898|NCT00883246|12865414|P1|COMPLETED|Overall Study||626
5232899|NCT00883246|12865414|P1|STARTED|Overall Study||799
5232900|NCT00883233|12865436|P4|NOT COMPLETED|Overall Study||5
5232901|NCT00883233|12865437|P3|NOT COMPLETED|Overall Study||4
5232902|NCT00883233|12865438|P2|NOT COMPLETED|Overall Study||4
5232903|NCT00883233|12865439|P1|NOT COMPLETED|Overall Study||5
5232904|NCT00883233|12865436|P4|COMPLETED|Overall Study||25
5232905|NCT00883233|12865437|P3|COMPLETED|Overall Study||25
5232906|NCT00883233|12865438|P2|COMPLETED|Overall Study||28
5232907|NCT00883233|12865439|P1|COMPLETED|Overall Study||27
5232908|NCT00883233|12865436|P4|STARTED|Overall Study||30
5232909|NCT00883233|12865437|P3|STARTED|Overall Study||29
5232910|NCT00883233|12865438|P2|STARTED|Overall Study||32
5232911|NCT00883233|12865439|P1|STARTED|Overall Study||32
5232912|NCT00883181|12865449|P1|NOT COMPLETED|Overall Study||278
5232913|NCT00883181|12865449|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
5232914|NCT00883181|12865449|P1|STARTED|Overall Study|Full analysis set|1347
5232915|NCT00883168|12865662|P4|NOT COMPLETED|Overall Study||15
5232916|NCT00883168|12865663|P3|NOT COMPLETED|Overall Study||19
5232917|NCT00883168|12865664|P2|NOT COMPLETED|Overall Study||15
5232918|NCT00883168|12865665|P1|NOT COMPLETED|Overall Study||14
5232919|NCT00883168|12865662|P4|COMPLETED|Overall Study||433
5232920|NCT00883168|12865663|P3|COMPLETED|Overall Study||431
5232921|NCT00883168|12865664|P2|COMPLETED|Overall Study||430
5232922|NCT00883168|12865665|P1|COMPLETED|Overall Study||434
5232923|NCT00883168|12865662|P4|STARTED|Overall Study||448
5232924|NCT00883168|12865663|P3|STARTED|Overall Study||450
5232925|NCT00883168|12865664|P2|STARTED|Overall Study||445
5232926|NCT00883168|12865665|P1|STARTED|Overall Study||448
5232927|NCT00883129|12865685|P2|NOT COMPLETED|Overall Study||36
5232928|NCT00883129|12865686|P1|NOT COMPLETED|Overall Study||20
5232929|NCT00883129|12865685|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
5232930|NCT00883129|12865686|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
5232931|NCT00883129|12865685|P2|STARTED|Overall Study||73
5232932|NCT00883129|12865686|P1|STARTED|Overall Study||69
5232933|NCT00883116|12865710|P2|NOT COMPLETED|Overall Study||219
5232934|NCT00883116|12865711|P1|NOT COMPLETED|Overall Study||209
5232935|NCT00883116|12865710|P2|COMPLETED|Overall Study||29
5232936|NCT00883116|12865711|P1|COMPLETED|Overall Study||39
5232937|NCT00883116|12865710|P2|Received Treatment|Overall Study||239
5232938|NCT00883116|12865711|P1|Received Treatment|Overall Study||248
5232939|NCT00883116|12865710|P2|STARTED|Overall Study||248
5232940|NCT00883116|12865711|P1|STARTED|Overall Study||248
5232941|NCT00883103|12865726|P2|NOT COMPLETED|Overall Study||0
5232942|NCT00883103|12865727|P1|NOT COMPLETED|Overall Study||0
5232943|NCT00883103|12865726|P2|COMPLETED|Overall Study||68
5232944|NCT00883103|12865727|P1|COMPLETED|Overall Study||69
5232945|NCT00883103|12865726|P2|STARTED|Overall Study||68
5232946|NCT00883103|12865727|P1|STARTED|Overall Study||69
5232947|NCT00883090|12865733|P1|NOT COMPLETED|Overall Study||2
5232948|NCT00883090|12865733|P1|COMPLETED|Overall Study||13
5232949|NCT00883090|12865733|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
5232950|NCT00883051|12865753|P5|NOT COMPLETED|Overall Study||18
5232951|NCT00883051|12865754|P4|NOT COMPLETED|Overall Study||29
5232952|NCT00883051|12865755|P3|NOT COMPLETED|Overall Study||29
5232953|NCT00883051|12865756|P2|NOT COMPLETED|Overall Study||22
5232954|NCT00883051|12865757|P1|NOT COMPLETED|Overall Study||24
5232955|NCT00883051|12865753|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
5232956|NCT00883051|12865754|P4|COMPLETED|Overall Study||70
5232957|NCT00883051|12865755|P3|COMPLETED|Overall Study||71
5232958|NCT00883051|12865756|P2|COMPLETED|Overall Study||82
5232959|NCT00883051|12865757|P1|COMPLETED|Overall Study||82
5232960|NCT00883051|12865753|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
5232961|NCT00883051|12865754|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
5232962|NCT00883051|12865755|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
5232963|NCT00883051|12865756|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
5232964|NCT00883051|12865757|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
5232965|NCT00883051|12865753|P5|No Study Medication Used|Overall Study||17
5232966|NCT00883051|12865754|P4|No Study Medication Used|Overall Study||29
5232967|NCT00883051|12865755|P3|No Study Medication Used|Overall Study||29
5232968|NCT00883051|12865756|P2|No Study Medication Used|Overall Study||22
5232969|NCT00883051|12865757|P1|No Study Medication Used|Overall Study||24
5232970|NCT00883051|12865753|P5|STARTED|Overall Study||103
5232971|NCT00883051|12865754|P4|STARTED|Overall Study||99
5232972|NCT00883051|12865755|P3|STARTED|Overall Study||100
5232973|NCT00883051|12865756|P2|STARTED|Overall Study||104
5232974|NCT00883051|12865757|P1|STARTED|Overall Study||106
5232975|NCT00882999|12865861|P7|NOT COMPLETED|Overall Study||8
5232976|NCT00882999|12865862|P6|NOT COMPLETED|Overall Study||7
5232977|NCT00882999|12865863|P5|NOT COMPLETED|Overall Study||8
5232978|NCT00882999|12865864|P4|NOT COMPLETED|Overall Study||5
5232979|NCT00882999|12865865|P3|NOT COMPLETED|Overall Study||4
5232980|NCT00882999|12865866|P2|NOT COMPLETED|Overall Study||8
5232981|NCT00882999|12865867|P1|NOT COMPLETED|Overall Study||8
5232982|NCT00882999|12865861|P7|COMPLETED|Overall Study||27
5232983|NCT00882999|12865862|P6|COMPLETED|Overall Study||28
5232984|NCT00882999|12865863|P5|COMPLETED|Overall Study||28
5232985|NCT00882999|12865864|P4|COMPLETED|Overall Study||31
5232986|NCT00882999|12865865|P3|COMPLETED|Overall Study||30
5232987|NCT00882999|12865866|P2|COMPLETED|Overall Study||26
5232988|NCT00882999|12865867|P1|COMPLETED|Overall Study||27
5232989|NCT00882999|12865861|P7|Completed Study Treatment|Overall Study||31
5232990|NCT00882999|12865862|P6|Completed Study Treatment|Overall Study||30
5232991|NCT00882999|12865863|P5|Completed Study Treatment|Overall Study||29
5232992|NCT00882999|12865864|P4|Completed Study Treatment|Overall Study||33
5232993|NCT00882999|12865865|P3|Completed Study Treatment|Overall Study||31
5232994|NCT00882999|12865866|P2|Completed Study Treatment|Overall Study||29
5232995|NCT00882999|12865867|P1|Completed Study Treatment|Overall Study||29
5232996|NCT00882999|12865861|P7|Received Any Amount of Study Drug|Overall Study||35
5232997|NCT00882999|12865862|P6|Received Any Amount of Study Drug|Overall Study||35
5232998|NCT00882999|12865863|P5|Received Any Amount of Study Drug|Overall Study||36
5232999|NCT00882999|12865864|P4|Received Any Amount of Study Drug|Overall Study||36
5233000|NCT00882999|12865865|P3|Received Any Amount of Study Drug|Overall Study||34
5233001|NCT00882999|12865866|P2|Received Any Amount of Study Drug|Overall Study||34
5233002|NCT00882999|12865867|P1|Received Any Amount of Study Drug|Overall Study||35
5233003|NCT00882999|12865861|P7|STARTED|Overall Study||35
5233004|NCT00882999|12865862|P6|STARTED|Overall Study||35
5233005|NCT00882999|12865863|P5|STARTED|Overall Study||36
5233006|NCT00882999|12865864|P4|STARTED|Overall Study||36
5233007|NCT00882999|12865865|P3|STARTED|Overall Study||34
5233008|NCT00882999|12865866|P2|STARTED|Overall Study||34
5233009|NCT00882999|12865867|P1|STARTED|Overall Study||35
5233010|NCT00882921|12865994|P1|NOT COMPLETED|Overall Study||11
5233011|NCT00882921|12865994|P1|COMPLETED|Overall Study||15
5233012|NCT00882921|12865994|P1|STARTED|Overall Study||26
5233013|NCT00882908|12866004|P5|NOT COMPLETED|Overall Study||6
5233014|NCT00882908|12866005|P4|NOT COMPLETED|Overall Study||7
5233015|NCT00882908|12866006|P3|NOT COMPLETED|Overall Study||7
5233016|NCT00882908|12866007|P2|NOT COMPLETED|Overall Study||6
5233017|NCT00882908|12866008|P1|NOT COMPLETED|Overall Study||3
5233018|NCT00882908|12866004|P5|COMPLETED|Overall Study||71
5233019|NCT00882908|12866005|P4|COMPLETED|Overall Study||72
5233020|NCT00882908|12866006|P3|COMPLETED|Overall Study||70
5233021|NCT00882908|12866007|P2|COMPLETED|Overall Study||69
5233022|NCT00882908|12866008|P1|COMPLETED|Overall Study||75
5233023|NCT00882908|12866004|P5|STARTED|Overall Study||77
5233024|NCT00882908|12866005|P4|STARTED|Overall Study||79
5233025|NCT00882908|12866006|P3|STARTED|Overall Study||77
5233026|NCT00882908|12866007|P2|STARTED|Overall Study||75
5233027|NCT00882908|12866008|P1|STARTED|Overall Study||78
5233028|NCT00882778|12866083|P1|NOT COMPLETED|Overall Study||0
5233029|NCT00882778|12866083|P1|COMPLETED|Overall Study||86
5233030|NCT00882778|12866083|P1|STARTED|Overall Study||86
5233031|NCT00882713|12866114|P1|NOT COMPLETED|Overall Study||22
5233032|NCT00882713|12866114|P1|COMPLETED|Overall Study||172
5233033|NCT00882713|12866114|P1|STARTED|Overall Study||194
5233034|NCT00882687|12866140|P4|NOT COMPLETED|Overall Study||2
5233035|NCT00882687|12866141|P3|NOT COMPLETED|Overall Study||3
5233036|NCT00882687|12866142|P2|NOT COMPLETED|Overall Study||2
5233037|NCT00882687|12866143|P1|NOT COMPLETED|Overall Study||2
5233038|NCT00882687|12866140|P4|COMPLETED|Overall Study||13
5233039|NCT00882687|12866141|P3|COMPLETED|Overall Study||12
5233040|NCT00882687|12866142|P2|COMPLETED|Overall Study||13
5233041|NCT00882687|12866143|P1|COMPLETED|Overall Study||13
5233042|NCT00882687|12866140|P4|STARTED|Overall Study||15
5233043|NCT00882687|12866141|P3|STARTED|Overall Study||15
5233044|NCT00882687|12866142|P2|STARTED|Overall Study||15
5233045|NCT00882687|12866143|P1|STARTED|Overall Study||15
5233046|NCT00882661|12866176|P2|NOT COMPLETED|Treatment||26
5233047|NCT00882661|12866177|P1|NOT COMPLETED|Treatment||10
5233048|NCT00882661|12866176|P2|COMPLETED|Treatment||114
5233049|NCT00882661|12866177|P1|COMPLETED|Treatment||141
5233050|NCT00882661|12866176|P2|STARTED|Treatment||140
5233051|NCT00882661|12866177|P1|STARTED|Treatment||151
5233052|NCT00882661|12866176|P2|NOT COMPLETED|Investigational Training||0
5233053|NCT00882661|12866177|P1|NOT COMPLETED|Investigational Training||10
5233054|NCT00882661|12866176|P2|COMPLETED|Investigational Training||0
5233055|NCT00882661|12866177|P1|COMPLETED|Investigational Training||79
5233056|NCT00882661|12866176|P2|STARTED|Investigational Training||0
5233057|NCT00882661|12866177|P1|STARTED|Investigational Training||89
5233058|NCT00882583|12866207|P2|NOT COMPLETED|Overall Study||1
5233059|NCT00882583|12866208|P1|NOT COMPLETED|Overall Study||1
5233060|NCT00882583|12866207|P2|COMPLETED|Overall Study||11
5233061|NCT00882583|12866208|P1|COMPLETED|Overall Study||6
5233062|NCT00882583|12866207|P2|STARTED|Overall Study||12
5233063|NCT00882583|12866208|P1|STARTED|Overall Study||7
5233064|NCT00882557|12866216|P2|NOT COMPLETED|Overall Study||1
5233065|NCT00882557|12866217|P1|NOT COMPLETED|Overall Study||2
5233066|NCT00882557|12866216|P2|COMPLETED|Overall Study||7
5233067|NCT00882557|12866217|P1|COMPLETED|Overall Study||6
5233068|NCT00882557|12866216|P2|Completed Dose 2|Overall Study||7
5233069|NCT00882557|12866217|P1|Completed Dose 2|Overall Study||6
5233070|NCT00882557|12866216|P2|Completed Dose 1|Overall Study||7
5233071|NCT00882557|12866217|P1|Completed Dose 1|Overall Study||8
5233072|NCT00882557|12866216|P2|STARTED|Overall Study||8
5233073|NCT00882557|12866217|P1|STARTED|Overall Study||8
5233074|NCT00882518|12866237|P2|NOT COMPLETED|Overall Study||44
5233075|NCT00882518|12866238|P1|NOT COMPLETED|Overall Study||38
5233076|NCT00882518|12866237|P2|COMPLETED|Overall Study||148
5233077|NCT00882518|12866238|P1|COMPLETED|Overall Study||158
5233078|NCT00882518|12866237|P2|STARTED|Overall Study||192
5233079|NCT00882518|12866238|P1|STARTED|Overall Study||196
5233080|NCT00882440|12866267|P7|NOT COMPLETED|Overall Study||4
5233081|NCT00882440|12866268|P6|NOT COMPLETED|Overall Study||7
5233082|NCT00882440|12866269|P5|NOT COMPLETED|Overall Study||10
5233083|NCT00882440|12866270|P4|NOT COMPLETED|Overall Study||3
5233084|NCT00882440|12866271|P3|NOT COMPLETED|Overall Study||7
5233085|NCT00882440|12866272|P2|NOT COMPLETED|Overall Study||8
5233086|NCT00882440|12866273|P1|NOT COMPLETED|Overall Study||11
5233087|NCT00882440|12866267|P7|COMPLETED|Overall Study||79
5233088|NCT00882440|12866268|P6|COMPLETED|Overall Study||77
5233089|NCT00882440|12866269|P5|COMPLETED|Overall Study||80
5233090|NCT00882440|12866270|P4|COMPLETED|Overall Study||76
5233091|NCT00882440|12866271|P3|COMPLETED|Overall Study||75
5233092|NCT00882440|12866272|P2|COMPLETED|Overall Study||72
5233093|NCT00882440|12866273|P1|COMPLETED|Overall Study||67
5233094|NCT00882440|12866267|P7|STARTED|Overall Study||83
5233095|NCT00882440|12866268|P6|STARTED|Overall Study||84
5233096|NCT00882440|12866269|P5|STARTED|Overall Study||90
5233097|NCT00882440|12866270|P4|STARTED|Overall Study||79
5233098|NCT00882440|12866271|P3|STARTED|Overall Study||82
5233099|NCT00882440|12866272|P2|STARTED|Overall Study||80
5233100|NCT00882440|12866273|P1|STARTED|Overall Study||78
5233101|NCT00882362|12866298|P2|NOT COMPLETED|Overall Study||23
5233102|NCT00882362|12866299|P1|NOT COMPLETED|Overall Study||49
5233103|NCT00882362|12866298|P2|COMPLETED|Overall Study||10
5233104|NCT00882362|12866299|P1|COMPLETED|Overall Study||73
5233105|NCT00882362|12866298|P2|STARTED|Overall Study||33
5233106|NCT00882362|12866299|P1|STARTED|Overall Study||122
5233107|NCT00882310|12866305|P1|NOT COMPLETED|Overall Study||22
5233108|NCT00882310|12866305|P1|COMPLETED|Overall Study||15
5233109|NCT00882310|12866305|P1|STARTED|Overall Study||37
5233110|NCT00882206|12866311|P1|NOT COMPLETED|Overall Study||0
5233111|NCT00882206|12866311|P1|COMPLETED|Overall Study||13
5233112|NCT00882206|12866311|P1|STARTED|Overall Study||13
5233113|NCT00882115|12866318|P1|NOT COMPLETED|Overall Study||9
5233114|NCT00882115|12866318|P1|COMPLETED|Overall Study||29
5233115|NCT00882115|12866318|P1|STARTED|Overall Study||38
5233116|NCT00882102|12866322|P1|NOT COMPLETED|Overall Study||0
5233117|NCT00882102|12866322|P1|COMPLETED|Overall Study||40
5233118|NCT00882102|12866322|P1|STARTED|Overall Study||40
5233119|NCT00881959|12866328|P2|NOT COMPLETED|Overall Study||4
5233120|NCT00881959|12866329|P1|NOT COMPLETED|Overall Study||2
5233121|NCT00881959|12866328|P2|COMPLETED|Overall Study||38
5233122|NCT00881959|12866329|P1|COMPLETED|Overall Study||36
5233123|NCT00881959|12866328|P2|STARTED|Overall Study||42
5233124|NCT00881959|12866329|P1|STARTED|Overall Study||38
5233125|NCT00881894|12866337|P2|NOT COMPLETED|Overall Study||3
5233126|NCT00881894|12866338|P1|NOT COMPLETED|Overall Study||1
5233127|NCT00881894|12866337|P2|COMPLETED|Overall Study||23
5233128|NCT00881894|12866338|P1|COMPLETED|Overall Study||25
5233129|NCT00881894|12866337|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
5233130|NCT00881894|12866338|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
5233131|NCT00881894|12866337|P2|STARTED|Overall Study||26
5233132|NCT00881894|12866338|P1|STARTED|Overall Study||26
5233133|NCT00881868|12866370|P2|NOT COMPLETED|Overall Study||2
5233134|NCT00881868|12866371|P1|NOT COMPLETED|Overall Study||8
5233135|NCT00881868|12866370|P2|COMPLETED|Overall Study||38
5233136|NCT00881868|12866371|P1|COMPLETED|Overall Study||33
5233137|NCT00881868|12866370|P2|STARTED|Overall Study||40
5233138|NCT00881868|12866371|P1|STARTED|Overall Study||41
5233139|NCT00881751|12866385|P2|NOT COMPLETED|Overall Study||5
5233140|NCT00881751|12866386|P1|NOT COMPLETED|Overall Study||0
5233141|NCT00881751|12866385|P2|COMPLETED|Overall Study||43
5233142|NCT00881751|12866386|P1|COMPLETED|Overall Study||47
5233143|NCT00881751|12866385|P2|STARTED|Overall Study||48
5233144|NCT00881751|12866386|P1|STARTED|Overall Study||47
5233145|NCT00881712|12866401|P3|NOT COMPLETED|Overall Study||0
5233146|NCT00881712|12866402|P2|NOT COMPLETED|Overall Study||0
5233147|NCT00881712|12866403|P1|NOT COMPLETED|Overall Study||2
5233148|NCT00881712|12866401|P3|COMPLETED|Overall Study||0
5233149|NCT00881712|12866402|P2|COMPLETED|Overall Study||0
5233150|NCT00881712|12866403|P1|COMPLETED|Overall Study||13
5233151|NCT00881712|12866401|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
5233152|NCT00881712|12866402|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
5233153|NCT00881712|12866403|P1|STARTED|Overall Study||15
5233154|NCT00881647|12866425|P2|NOT COMPLETED|Overall Study||1
5233155|NCT00881647|12866426|P1|NOT COMPLETED|Overall Study||2
5233156|NCT00881647|12866425|P2|COMPLETED|Overall Study||15
5233157|NCT00881647|12866426|P1|COMPLETED|Overall Study||27
5233158|NCT00881647|12866425|P2|STARTED|Overall Study||16
5233159|NCT00881647|12866426|P1|STARTED|Overall Study||29
5233160|NCT00881621|12866436|P1|NOT COMPLETED|Overall Study||34
5233161|NCT00881621|12866436|P1|COMPLETED|Overall Study||17
5233162|NCT00881621|12866436|P1|STARTED|Overall Study||51
5233163|NCT00881608|12866448|P1|NOT COMPLETED|Overall Study||11
5233164|NCT00881608|12866448|P1|COMPLETED|Overall Study||0
5233165|NCT00881608|12866448|P1|STARTED|Overall Study||11
5233166|NCT00881530|12866471|P6|NOT COMPLETED|Overall Study||5
5233167|NCT00881530|12866472|P5|NOT COMPLETED|Overall Study||14
5233168|NCT00881530|12866473|P4|NOT COMPLETED|Overall Study||9
5233169|NCT00881530|12866474|P3|NOT COMPLETED|Overall Study||5
5233170|NCT00881530|12866475|P2|NOT COMPLETED|Overall Study||5
5233171|NCT00881530|12866476|P1|NOT COMPLETED|Overall Study||14
5233172|NCT00881530|12866471|P6|COMPLETED|Overall Study||51
5233173|NCT00881530|12866472|P5|COMPLETED|Overall Study||152
5233174|NCT00881530|12866473|P4|COMPLETED|Overall Study||157
5233175|NCT00881530|12866474|P3|COMPLETED|Overall Study||51
5233176|NCT00881530|12866475|P2|COMPLETED|Overall Study||104
5233177|NCT00881530|12866476|P1|COMPLETED|Overall Study||92
5233178|NCT00881530|12866471|P6|STARTED|Overall Study||56
5233179|NCT00881530|12866472|P5|STARTED|Overall Study||166
5233180|NCT00881530|12866473|P4|STARTED|Overall Study||166
5233181|NCT00881530|12866474|P3|STARTED|Overall Study||56
5233182|NCT00881530|12866475|P2|STARTED|Overall Study||109
5233183|NCT00881530|12866476|P1|STARTED|Overall Study||106
5233184|NCT00881504|12866532|P1|NOT COMPLETED|Overall Study||1
5233185|NCT00881504|12866532|P1|COMPLETED|Overall Study||8
5233186|NCT00881504|12866532|P1|STARTED|Overall Study||9
5233187|NCT00881465|12866539|P2|NOT COMPLETED|Overall Study||0
5233188|NCT00881465|12866540|P1|NOT COMPLETED|Overall Study||2
5233189|NCT00881465|12866539|P2|COMPLETED|Overall Study||15
5233190|NCT00881465|12866540|P1|COMPLETED|Overall Study||14
5233191|NCT00881465|12866539|P2|STARTED|Overall Study||15
5233192|NCT00881465|12866540|P1|STARTED|Overall Study||16
5233193|NCT00881361|12866552|P3|NOT COMPLETED|Overall Study||2
5233194|NCT00881361|12866553|P2|NOT COMPLETED|Overall Study||9
5233195|NCT00881361|12866554|P1|NOT COMPLETED|Overall Study||44
5233196|NCT00881361|12866552|P3|COMPLETED|Overall Study||0
5233197|NCT00881361|12866553|P2|COMPLETED|Overall Study||38
5233198|NCT00881361|12866554|P1|COMPLETED|Overall Study||663
5233199|NCT00881361|12866552|P3|STARTED|Overall Study||2
5233200|NCT00881361|12866553|P2|STARTED|Overall Study||47
5233201|NCT00881361|12866554|P1|STARTED|Overall Study||707
5233202|NCT00881335|12866569|P2|NOT COMPLETED|Overall Study||2
5233203|NCT00881335|12866570|P1|NOT COMPLETED|Overall Study||3
5233204|NCT00881335|12866569|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
5233205|NCT00881335|12866570|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
5233206|NCT00881335|12866569|P2|STARTED|Overall Study||30
5233207|NCT00881335|12866570|P1|STARTED|Overall Study||30
5233208|NCT00881205|12866590|P2|NOT COMPLETED|Overall Study||7
5233209|NCT00881205|12866591|P1|NOT COMPLETED|Overall Study||11
5233210|NCT00881205|12866590|P2|COMPLETED|Overall Study||34
5233211|NCT00881205|12866591|P1|COMPLETED|Overall Study||34
5233212|NCT00881205|12866590|P2|STARTED|Overall Study||41
5233213|NCT00881205|12866591|P1|STARTED|Overall Study||45
5233214|NCT00880997|12866601|P3|NOT COMPLETED|Overall Study||8
5233215|NCT00880997|12866602|P2|NOT COMPLETED|Overall Study||2
5233216|NCT00880997|12866603|P1|NOT COMPLETED|Overall Study||3
5233217|NCT00880997|12866601|P3|COMPLETED|Overall Study||5
5233218|NCT00880997|12866602|P2|COMPLETED|Overall Study||6
5233219|NCT00880997|12866603|P1|COMPLETED|Overall Study||6
5233220|NCT00880997|12866601|P3|STARTED|Overall Study||13
5233221|NCT00880997|12866602|P2|STARTED|Overall Study||8
5233222|NCT00880997|12866603|P1|STARTED|Overall Study||9
5233223|NCT00880919|12866623|P3|NOT COMPLETED|Overall Study||6
5233224|NCT00880919|12866624|P2|NOT COMPLETED|Overall Study||14
5233225|NCT00880919|12866625|P1|NOT COMPLETED|Overall Study||15
5233226|NCT00880919|12866623|P3|COMPLETED|Overall Study||23
5233227|NCT00880919|12866624|P2|COMPLETED|Overall Study||19
5233228|NCT00880919|12866625|P1|COMPLETED|Overall Study||18
5233229|NCT00880919|12866623|P3|STARTED|Overall Study||29
5233230|NCT00880919|12866624|P2|STARTED|Overall Study||33
5233231|NCT00880919|12866625|P1|STARTED|Overall Study||33
5233232|NCT00880906|12866659|P2|NOT COMPLETED|Overall Study||7
5233233|NCT00880906|12866660|P1|NOT COMPLETED|Overall Study||12
5233234|NCT00880906|12866659|P2|COMPLETED|Overall Study||14
5233235|NCT00880906|12866660|P1|COMPLETED|Overall Study||17
5233236|NCT00880906|12866659|P2|STARTED|Overall Study||21
5233237|NCT00880906|12866660|P1|STARTED|Overall Study||29
5233238|NCT00880893|12866670|P2|NOT COMPLETED|Overall Study||45
5233239|NCT00880893|12866671|P1|NOT COMPLETED|Overall Study||107
5233240|NCT00880893|12866670|P2|COMPLETED|Overall Study||255
5233241|NCT00880893|12866671|P1|COMPLETED|Overall Study||791
5233242|NCT00880893|12866670|P2|STARTED|Overall Study||300
5233243|NCT00880893|12866671|P1|STARTED|Overall Study||898
5233244|NCT00880763|12866723|P4|NOT COMPLETED|Extension Period (Part 2)||3
5233245|NCT00880763|12866724|P3|NOT COMPLETED|Extension Period (Part 2)||3
5233246|NCT00880763|12866725|P2|NOT COMPLETED|Extension Period (Part 2)||3
5233247|NCT00880763|12866726|P1|NOT COMPLETED|Extension Period (Part 2)||0
5233248|NCT00880763|12866723|P4|COMPLETED|Extension Period (Part 2)||19
5233249|NCT00880763|12866724|P3|COMPLETED|Extension Period (Part 2)||20
5233250|NCT00880763|12866725|P2|COMPLETED|Extension Period (Part 2)||19
5233251|NCT00880763|12866726|P1|COMPLETED|Extension Period (Part 2)||23
5233252|NCT00880763|12866723|P4|STARTED|Extension Period (Part 2)||22
5233253|NCT00880763|12866724|P3|STARTED|Extension Period (Part 2)||23
5233254|NCT00880763|12866725|P2|STARTED|Extension Period (Part 2)||22
5233255|NCT00880763|12866726|P1|STARTED|Extension Period (Part 2)||23
5233256|NCT00880763|12866723|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
5233257|NCT00880763|12866724|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
5233258|NCT00880763|12866725|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
5233259|NCT00880763|12866726|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
5233260|NCT00880763|12866723|P4|COMPLETED|Initial Treatment Period (Part 1)||22
5233261|NCT00880763|12866724|P3|COMPLETED|Initial Treatment Period (Part 1)||23
5233262|NCT00880763|12866725|P2|COMPLETED|Initial Treatment Period (Part 1)||22
5233263|NCT00880763|12866726|P1|COMPLETED|Initial Treatment Period (Part 1)||23
5233264|NCT00880763|12866723|P4|STARTED|Initial Treatment Period (Part 1)||22
5233265|NCT00880763|12866724|P3|STARTED|Initial Treatment Period (Part 1)||23
5233266|NCT00880763|12866725|P2|STARTED|Initial Treatment Period (Part 1)||22
5233267|NCT00880763|12866726|P1|STARTED|Initial Treatment Period (Part 1)||23
5233268|NCT00880750|12866758|P2|NOT COMPLETED|Second Intervention||2
5233269|NCT00880750|12866759|P1|NOT COMPLETED|Second Intervention||4
5233270|NCT00880750|12866758|P2|COMPLETED|Second Intervention||30
5233271|NCT00880750|12866759|P1|COMPLETED|Second Intervention||26
5233272|NCT00880750|12866758|P2|STARTED|Second Intervention||32
5233273|NCT00880750|12866759|P1|STARTED|Second Intervention||30
5233274|NCT00880750|12866758|P2|NOT COMPLETED|Washout Period||0
5233275|NCT00880750|12866759|P1|NOT COMPLETED|Washout Period||0
5233276|NCT00880750|12866758|P2|COMPLETED|Washout Period||32
5233277|NCT00880750|12866759|P1|COMPLETED|Washout Period||30
5233278|NCT00880750|12866758|P2|STARTED|Washout Period||32
5233279|NCT00880750|12866759|P1|STARTED|Washout Period||30
5233280|NCT00880750|12866758|P2|NOT COMPLETED|First Intervention||1
5233281|NCT00880750|12866759|P1|NOT COMPLETED|First Intervention||9
5233282|NCT00880750|12866758|P2|COMPLETED|First Intervention||32
5233283|NCT00880750|12866759|P1|COMPLETED|First Intervention||30
5233284|NCT00880750|12866758|P2|STARTED|First Intervention||33
5233285|NCT00880750|12866759|P1|STARTED|First Intervention||39
5233286|NCT00880698|12866777|P4|NOT COMPLETED|Overall Study||3
5233287|NCT00880698|12866778|P3|NOT COMPLETED|Overall Study||1
5233288|NCT00880698|12866779|P2|NOT COMPLETED|Overall Study||3
5233289|NCT00880698|12866780|P1|NOT COMPLETED|Overall Study||1
5233290|NCT00880698|12866777|P4|COMPLETED|Overall Study||36
5233291|NCT00880698|12866778|P3|COMPLETED|Overall Study||36
5233292|NCT00880698|12866779|P2|COMPLETED|Overall Study||61
5233293|NCT00880698|12866780|P1|COMPLETED|Overall Study||61
5233294|NCT00880698|12866777|P4|STARTED|Overall Study||39
5233295|NCT00880698|12866778|P3|STARTED|Overall Study||37
5233296|NCT00880698|12866779|P2|STARTED|Overall Study||64
5233297|NCT00880698|12866780|P1|STARTED|Overall Study||62
5233298|NCT00880685|12866806|P1|NOT COMPLETED|Memantine 30mg||0
5233299|NCT00880685|12866806|P1|COMPLETED|Memantine 30mg||9
5233300|NCT00880685|12866806|P1|STARTED|Memantine 30mg||9
5233301|NCT00880685|12866806|P1|NOT COMPLETED|Memantine 20mg||1
5233302|NCT00880685|12866806|P1|COMPLETED|Memantine 20mg||9
5233303|NCT00880685|12866806|P1|STARTED|Memantine 20mg||10
5233304|NCT00880685|12866806|P1|NOT COMPLETED|Memantine 10mg||2
5233305|NCT00880685|12866806|P1|COMPLETED|Memantine 10mg||10
5233306|NCT00880685|12866806|P1|STARTED|Memantine 10mg||12
5233307|NCT00880620|12866818|P4|NOT COMPLETED|Overall Study||24
5233308|NCT00880620|12866819|P3|NOT COMPLETED|Overall Study||21
5233309|NCT00880620|12866820|P2|NOT COMPLETED|Overall Study||15
5233310|NCT00880620|12866821|P1|NOT COMPLETED|Overall Study||21
5233311|NCT00880620|12866818|P4|COMPLETED|Overall Study||74
5233312|NCT00880620|12866819|P3|COMPLETED|Overall Study||83
5233313|NCT00880620|12866820|P2|COMPLETED|Overall Study||72
5233314|NCT00880620|12866821|P1|COMPLETED|Overall Study||71
5233315|NCT00880620|12866818|P4|Week 23|Overall Study||74
5233316|NCT00880620|12866819|P3|Week 23|Overall Study||85
5233317|NCT00880620|12866820|P2|Week 23|Overall Study||72
5233318|NCT00880620|12866821|P1|Week 23|Overall Study||71
5233319|NCT00880620|12866818|P4|Week 16|Overall Study||74
5233320|NCT00880620|12866819|P3|Week 16|Overall Study||87
5233321|NCT00880620|12866820|P2|Week 16|Overall Study||73
5233322|NCT00880620|12866821|P1|Week 16|Overall Study||74
5233323|NCT00880620|12866818|P4|Week 9|Overall Study||78
5233324|NCT00880620|12866819|P3|Week 9|Overall Study||88
5233325|NCT00880620|12866820|P2|Week 9|Overall Study||73
5233326|NCT00880620|12866821|P1|Week 9|Overall Study||80
5233327|NCT00880620|12866818|P4|Week 4|Overall Study||86
5233328|NCT00880620|12866819|P3|Week 4|Overall Study||94
5233329|NCT00880620|12866820|P2|Week 4|Overall Study||79
5233330|NCT00880620|12866821|P1|Week 4|Overall Study||88
5233331|NCT00880620|12866818|P4|STARTED|Overall Study||98
5233332|NCT00880620|12866819|P3|STARTED|Overall Study||104
5233333|NCT00880620|12866820|P2|STARTED|Overall Study||87
5233334|NCT00880620|12866821|P1|STARTED|Overall Study||92
5233335|NCT00880607|12866837|P2|NOT COMPLETED|Overall Study||3
5233336|NCT00880607|12866838|P1|NOT COMPLETED|Overall Study||7
5233337|NCT00880607|12866837|P2|COMPLETED|Overall Study||34
5233338|NCT00880607|12866838|P1|COMPLETED|Overall Study||37
5233339|NCT00880607|12866837|P2|Observation After Receiving Medication|Overall Study||35
5233340|NCT00880607|12866838|P1|Observation After Receiving Medication|Overall Study||42
5233341|NCT00880607|12866837|P2|STARTED|Overall Study||37
5233342|NCT00880607|12866838|P1|STARTED|Overall Study||44
5233343|NCT00880581|12866856|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
5233344|NCT00880581|12866856|P1|COMPLETED|Cycle 2 Re-treatment||24
5233345|NCT00880581|12866856|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
5233346|NCT00880581|12866856|P1|NOT COMPLETED|Cycle 1||0
5233347|NCT00880581|12866856|P1|COMPLETED|Cycle 1||30
5233348|NCT00880581|12866856|P1|STARTED|Cycle 1||30
5233349|NCT00880568|12866870|P9|NOT COMPLETED|Overall Study||3
5233350|NCT00880568|12866871|P8|NOT COMPLETED|Overall Study||2
5233351|NCT00880568|12866872|P7|NOT COMPLETED|Overall Study||6
5233352|NCT00880568|12866873|P6|NOT COMPLETED|Overall Study||3
5233353|NCT00880568|12866874|P5|NOT COMPLETED|Overall Study||3
5233354|NCT00880568|12866875|P4|NOT COMPLETED|Overall Study||1
5233355|NCT00880568|12866876|P3|NOT COMPLETED|Overall Study||3
5233356|NCT00880568|12866877|P2|NOT COMPLETED|Overall Study||3
5233357|NCT00880568|12866878|P1|NOT COMPLETED|Overall Study||3
5233358|NCT00880568|12866870|P9|COMPLETED|Overall Study||0
5233359|NCT00880568|12866871|P8|COMPLETED|Overall Study||0
5233360|NCT00880568|12866872|P7|COMPLETED|Overall Study||0
5233361|NCT00880568|12866873|P6|COMPLETED|Overall Study||0
5233362|NCT00880568|12866874|P5|COMPLETED|Overall Study||0
5233363|NCT00880568|12866875|P4|COMPLETED|Overall Study||0
5233364|NCT00880568|12866876|P3|COMPLETED|Overall Study||0
5233365|NCT00880568|12866877|P2|COMPLETED|Overall Study||0
5233366|NCT00880568|12866878|P1|COMPLETED|Overall Study||0
5233367|NCT00880568|12866870|P9|STARTED|Overall Study||3
5233368|NCT00880568|12866871|P8|STARTED|Overall Study||2
5233369|NCT00880568|12866872|P7|STARTED|Overall Study||6
5233370|NCT00880568|12866873|P6|STARTED|Overall Study||3
5233371|NCT00880568|12866874|P5|STARTED|Overall Study||3
5233372|NCT00880568|12866875|P4|STARTED|Overall Study||1
5233373|NCT00880568|12866876|P3|STARTED|Overall Study||3
5233374|NCT00880568|12866877|P2|STARTED|Overall Study||3
5233375|NCT00880568|12866878|P1|STARTED|Overall Study||3
5233376|NCT00880555|12866924|P6|NOT COMPLETED|Overall Study||1
5233377|NCT00880555|12866925|P5|NOT COMPLETED|Overall Study||1
5233378|NCT00880555|12866926|P4|NOT COMPLETED|Overall Study||2
5233379|NCT00880555|12866927|P3|NOT COMPLETED|Overall Study||5
5233380|NCT00880555|12866928|P2|NOT COMPLETED|Overall Study||17
5233381|NCT00880555|12866929|P1|NOT COMPLETED|Overall Study||10
5233382|NCT00880555|12866924|P6|COMPLETED|Overall Study||0
5233383|NCT00880555|12866925|P5|COMPLETED|Overall Study||0
5233384|NCT00880555|12866926|P4|COMPLETED|Overall Study||0
5233385|NCT00880555|12866927|P3|COMPLETED|Overall Study||6
5233386|NCT00880555|12866928|P2|COMPLETED|Overall Study||23
5233387|NCT00880555|12866929|P1|COMPLETED|Overall Study||13
5233388|NCT00880555|12866924|P6|STARTED|Overall Study||1
5233389|NCT00880555|12866925|P5|STARTED|Overall Study||1
5233390|NCT00880555|12866926|P4|STARTED|Overall Study||2
5233391|NCT00880555|12866927|P3|STARTED|Overall Study||11
5233392|NCT00880555|12866928|P2|STARTED|Overall Study||40
5233393|NCT00880555|12866929|P1|STARTED|Overall Study||23
5233394|NCT00880542|12866940|P1|NOT COMPLETED|Follow-up Period||0
5233395|NCT00880542|12866940|P1|COMPLETED|Follow-up Period||7
5233396|NCT00880542|12866940|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
5233397|NCT00880542|12866940|P1|NOT COMPLETED|Continued Treatment Period||0
5233398|NCT00880542|12866940|P1|COMPLETED|Continued Treatment Period||0
5233399|NCT00880542|12866940|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
5233400|NCT00880542|12866940|P1|NOT COMPLETED|Post Surgical Evaluation||0
5233401|NCT00880542|12866940|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
5233402|NCT00880542|12866940|P1|STARTED|Post Surgical Evaluation||3
5233403|NCT00880542|12866940|P1|NOT COMPLETED|REP: Surgical Resection||1
5233404|NCT00880542|12866940|P1|COMPLETED|REP: Surgical Resection||3
5233405|NCT00880542|12866940|P1|STARTED|REP: Surgical Resection||4
5233406|NCT00880542|12866940|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
5233407|NCT00880542|12866940|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
5233408|NCT00880542|12866940|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
5233409|NCT00880542|12866940|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
5233410|NCT00880542|12866940|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
5233411|NCT00880542|12866940|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
5233412|NCT00880425|12866945|P2|NOT COMPLETED|Overall Study||0
5233413|NCT00880425|12866946|P1|NOT COMPLETED|Overall Study||0
5233414|NCT00880425|12866945|P2|COMPLETED|Overall Study||27
5233415|NCT00880425|12866946|P1|COMPLETED|Overall Study||18
5233416|NCT00880425|12866945|P2|STARTED|Overall Study||27
5233417|NCT00880425|12866946|P1|STARTED|Overall Study||18
5233418|NCT00880399|12866957|P3|NOT COMPLETED|Overall Study||26
5233419|NCT00880399|12866958|P2|NOT COMPLETED|Overall Study||29
5233420|NCT00880399|12866959|P1|NOT COMPLETED|Overall Study||31
5233421|NCT00880399|12866957|P3|COMPLETED|Overall Study||81
5233422|NCT00880399|12866958|P2|COMPLETED|Overall Study||84
5233423|NCT00880399|12866959|P1|COMPLETED|Overall Study||77
5233424|NCT00880399|12866957|P3|STARTED|Overall Study||107
5233425|NCT00880399|12866958|P2|STARTED|Overall Study||113
5233426|NCT00880399|12866959|P1|STARTED|Overall Study||108
5233427|NCT00880360|12867015|P1|NOT COMPLETED|Overall Study||0
5233428|NCT00880360|12867015|P1|COMPLETED|Overall Study||19
5233429|NCT00880360|12867015|P1|STARTED|Overall Study||19
5233430|NCT00880334|12867022|P2|NOT COMPLETED|Crossover Phase||0
5233431|NCT00880334|12867023|P1|NOT COMPLETED|Crossover Phase||0
5233432|NCT00880334|12867022|P2|COMPLETED|Crossover Phase||37
5233433|NCT00880334|12867023|P1|COMPLETED|Crossover Phase||0
5233434|NCT00880334|12867022|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
5233435|NCT00880334|12867023|P1|STARTED|Crossover Phase||0
5233436|NCT00880334|12867022|P2|NOT COMPLETED|Randomized Phase||40
5233437|NCT00880334|12867023|P1|NOT COMPLETED|Randomized Phase||4
5233438|NCT00880334|12867022|P2|COMPLETED|Randomized Phase||35
5233439|NCT00880334|12867023|P1|COMPLETED|Randomized Phase||70
5233440|NCT00880334|12867022|P2|Eligible & Treated|Randomized Phase||72
5233441|NCT00880334|12867023|P1|Eligible & Treated|Randomized Phase||70
5233442|NCT00880334|12867022|P2|STARTED|Randomized Phase||75
5233443|NCT00880334|12867023|P1|STARTED|Randomized Phase||74
5233444|NCT00880269|12867040|P2|NOT COMPLETED|Overall Study||27
5233445|NCT00880269|12867041|P1|NOT COMPLETED|Overall Study||32
5233446|NCT00880269|12867040|P2|COMPLETED|Overall Study||0
5233447|NCT00880269|12867041|P1|COMPLETED|Overall Study||0
5233448|NCT00880269|12867040|P2|Discontinued Treatment|Overall Study||27
5233449|NCT00880269|12867041|P1|Discontinued Treatment|Overall Study||32
5233450|NCT00880269|12867040|P2|STARTED|Overall Study||27
5233451|NCT00880269|12867041|P1|STARTED|Overall Study||32
5233452|NCT00880256|12867057|P1|NOT COMPLETED|Overall Study||28
5233453|NCT00880256|12867057|P1|COMPLETED|Overall Study||65
5233454|NCT00880256|12867057|P1|STARTED|Overall Study||93
5233455|NCT00880230|12867062|P1|NOT COMPLETED|Overall Study||7
5233456|NCT00880230|12867062|P1|COMPLETED|Overall Study||134
5233457|NCT00880230|12867062|P1|STARTED|Overall Study||141
5233458|NCT00880191|12867084|P2|NOT COMPLETED|Overall Study||8
5233459|NCT00880191|12867085|P1|NOT COMPLETED|Overall Study||13
5233460|NCT00880191|12867084|P2|COMPLETED|Overall Study||198
5233461|NCT00880191|12867085|P1|COMPLETED|Overall Study||194
5233462|NCT00880191|12867084|P2|Available for Primary Endpoint Analysis|Overall Study||206
5233463|NCT00880191|12867085|P1|Available for Primary Endpoint Analysis|Overall Study||207
5233464|NCT00880191|12867084|P2|STARTED|Overall Study||206
5233465|NCT00880191|12867085|P1|STARTED|Overall Study||207
5233466|NCT00880165|12867105|P2|NOT COMPLETED|Overall Study||50
5233467|NCT00880165|12867106|P1|NOT COMPLETED|Overall Study||62
5233468|NCT00880165|12867105|P2|COMPLETED|Overall Study||98
5233469|NCT00880165|12867106|P1|COMPLETED|Overall Study||86
5233470|NCT00880165|12867105|P2|STARTED|Overall Study||148
5233471|NCT00880165|12867106|P1|STARTED|Overall Study||148
5233472|NCT00880100|12867116|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
5233473|NCT00880100|12867116|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
5233474|NCT00880100|12867116|P1|STARTED|Treatment Phase With Ultrase® MT12||48
5233475|NCT00880100|12867116|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
5233476|NCT00880100|12867116|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
5233477|NCT00880100|12867116|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
5233478|NCT00880087|12867129|P2|NOT COMPLETED|Overall Study||2
5233479|NCT00880087|12867130|P1|NOT COMPLETED|Overall Study||0
5233480|NCT00880087|12867129|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
5233481|NCT00880087|12867130|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
5233482|NCT00880087|12867129|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
5233483|NCT00880087|12867130|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
5233484|NCT00880048|12867145|P3|NOT COMPLETED|Overall Study||35
5233485|NCT00880048|12867146|P2|NOT COMPLETED|Overall Study||33
5233486|NCT00880048|12867147|P1|NOT COMPLETED|Overall Study||28
5233487|NCT00880048|12867145|P3|COMPLETED|Overall Study||77
5233488|NCT00880048|12867146|P2|COMPLETED|Overall Study||82
5233489|NCT00880048|12867147|P1|COMPLETED|Overall Study||88
5233490|NCT00880048|12867145|P3|STARTED|Overall Study||112
5233491|NCT00880048|12867146|P2|STARTED|Overall Study||115
5233492|NCT00880048|12867147|P1|STARTED|Overall Study||116
5233493|NCT00880022|12867205|P2|NOT COMPLETED|Overall Study||3
5233494|NCT00880022|12867206|P1|NOT COMPLETED|Overall Study||2
5233495|NCT00880022|12867205|P2|COMPLETED|Overall Study||21
5233496|NCT00880022|12867206|P1|COMPLETED|Overall Study||21
5233497|NCT00880022|12867205|P2|STARTED|Overall Study||24
5233498|NCT00880022|12867206|P1|STARTED|Overall Study||23
5233499|NCT00880009|12867214|P1|NOT COMPLETED|Overall Study||16
5233500|NCT00880009|12867214|P1|COMPLETED|Overall Study||0
5233501|NCT00880009|12867214|P1|STARTED|Overall Study||16
5233502|NCT00879996|12867238|P2|NOT COMPLETED|Overall Study||13
5233503|NCT00879996|12867239|P1|NOT COMPLETED|Overall Study||15
5233504|NCT00879996|12867238|P2|COMPLETED|Overall Study||13
5233505|NCT00879996|12867239|P1|COMPLETED|Overall Study||13
5233506|NCT00879996|12867238|P2|STARTED|Overall Study||26
5233507|NCT00879996|12867239|P1|STARTED|Overall Study||28
5233508|NCT00879970|12867254|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
5233509|NCT00879970|12867255|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
5233510|NCT00879970|12867256|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
5233511|NCT00879970|12867257|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
5233512|NCT00879970|12867258|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
5233513|NCT00879970|12867254|P5|COMPLETED|Period 2 Vitamin D Randomization||600
5233514|NCT00879970|12867255|P4|COMPLETED|Period 2 Vitamin D Randomization||610
5233515|NCT00879970|12867256|P3|COMPLETED|Period 2 Vitamin D Randomization||0
5233516|NCT00879970|12867257|P2|COMPLETED|Period 2 Vitamin D Randomization||0
5233517|NCT00879970|12867258|P1|COMPLETED|Period 2 Vitamin D Randomization||0
5233518|NCT00879970|12867254|P5|STARTED|Period 2 Vitamin D Randomization||607
5233519|NCT00879970|12867255|P4|STARTED|Period 2 Vitamin D Randomization||614
5233520|NCT00879970|12867256|P3|STARTED|Period 2 Vitamin D Randomization||0
5233521|NCT00879970|12867257|P2|STARTED|Period 2 Vitamin D Randomization||0
5233522|NCT00879970|12867258|P1|STARTED|Period 2 Vitamin D Randomization||0
5233523|NCT00879970|12867254|P5|NOT COMPLETED|Period 1 TZD Randomization||0
5233524|NCT00879970|12867255|P4|NOT COMPLETED|Period 1 TZD Randomization||0
5233525|NCT00879970|12867256|P3|NOT COMPLETED|Period 1 TZD Randomization||6
5233526|NCT00879970|12867257|P2|NOT COMPLETED|Period 1 TZD Randomization||4
5233527|NCT00879970|12867258|P1|NOT COMPLETED|Period 1 TZD Randomization||8
5233528|NCT00879970|12867254|P5|COMPLETED|Period 1 TZD Randomization||0
5233529|NCT00879970|12867255|P4|COMPLETED|Period 1 TZD Randomization||0
5233530|NCT00879970|12867256|P3|COMPLETED|Period 1 TZD Randomization||393
5233531|NCT00879970|12867257|P2|COMPLETED|Period 1 TZD Randomization||388
5233532|NCT00879970|12867258|P1|COMPLETED|Period 1 TZD Randomization||533
5233533|NCT00879970|12867254|P5|STARTED|Period 1 TZD Randomization||0
5233534|NCT00879970|12867255|P4|STARTED|Period 1 TZD Randomization||0
5233535|NCT00879970|12867256|P3|STARTED|Period 1 TZD Randomization||399
5233536|NCT00879970|12867257|P2|STARTED|Period 1 TZD Randomization||392
5233537|NCT00879970|12867258|P1|STARTED|Period 1 TZD Randomization||541
5233538|NCT00879879|12867340|P1|NOT COMPLETED|Overall Study||3
5233539|NCT00879879|12867340|P1|COMPLETED|Overall Study||17
5233540|NCT00879879|12867340|P1|STARTED|Overall Study||20
5233541|NCT00879814|12867348|P4|NOT COMPLETED|Overall Study||5
5233542|NCT00879814|12867349|P3|NOT COMPLETED|Overall Study||3
5233543|NCT00879814|12867350|P2|NOT COMPLETED|Overall Study||2
5233544|NCT00879814|12867351|P1|NOT COMPLETED|Overall Study||4
5233545|NCT00879814|12867348|P4|COMPLETED|Overall Study||7
5233546|NCT00879814|12867349|P3|COMPLETED|Overall Study||9
5233547|NCT00879814|12867350|P2|COMPLETED|Overall Study||10
5233548|NCT00879814|12867351|P1|COMPLETED|Overall Study||8
5233549|NCT00879814|12867348|P4|STARTED|Overall Study||12
5233550|NCT00879814|12867349|P3|STARTED|Overall Study||12
5233551|NCT00879814|12867350|P2|STARTED|Overall Study||12
5233552|NCT00879814|12867351|P1|STARTED|Overall Study||12
5233553|NCT00879775|12867459|P2|NOT COMPLETED|Overall Study||1
5233554|NCT00879775|12867460|P1|NOT COMPLETED|Overall Study||2
5233555|NCT00879775|12867459|P2|COMPLETED|Overall Study||20
5233556|NCT00879775|12867460|P1|COMPLETED|Overall Study||18
5233557|NCT00879775|12867459|P2|STARTED|Overall Study||21
5233558|NCT00879775|12867460|P1|STARTED|Overall Study||20
5233559|NCT00879710|12867476|P4|NOT COMPLETED|Phase 2 6 Weeks||0
5233560|NCT00879710|12867477|P3|NOT COMPLETED|Phase 2 6 Weeks||0
5233561|NCT00879710|12867478|P2|NOT COMPLETED|Phase 2 6 Weeks||0
5233562|NCT00879710|12867479|P1|NOT COMPLETED|Phase 2 6 Weeks||0
5233563|NCT00879710|12867476|P4|COMPLETED|Phase 2 6 Weeks||13
5233564|NCT00879710|12867477|P3|COMPLETED|Phase 2 6 Weeks||10
5233565|NCT00879710|12867478|P2|COMPLETED|Phase 2 6 Weeks||14
5233566|NCT00879710|12867479|P1|COMPLETED|Phase 2 6 Weeks||10
5233567|NCT00879710|12867476|P4|STARTED|Phase 2 6 Weeks||13
5233568|NCT00879710|12867477|P3|STARTED|Phase 2 6 Weeks||10
5233569|NCT00879710|12867478|P2|STARTED|Phase 2 6 Weeks||14
5233570|NCT00879710|12867479|P1|STARTED|Phase 2 6 Weeks||10
5233571|NCT00879710|12867476|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
5233572|NCT00879710|12867477|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
5233573|NCT00879710|12867478|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
5233574|NCT00879710|12867479|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
5233575|NCT00879710|12867476|P4|COMPLETED|Wash Out Period of 4 Weeks||13
5233576|NCT00879710|12867477|P3|COMPLETED|Wash Out Period of 4 Weeks||10
5233577|NCT00879710|12867478|P2|COMPLETED|Wash Out Period of 4 Weeks||14
5233578|NCT00879710|12867479|P1|COMPLETED|Wash Out Period of 4 Weeks||10
5233579|NCT00879710|12867476|P4|STARTED|Wash Out Period of 4 Weeks||13
5233580|NCT00879710|12867477|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
5233581|NCT00879710|12867478|P2|STARTED|Wash Out Period of 4 Weeks||14
5233582|NCT00879710|12867479|P1|STARTED|Wash Out Period of 4 Weeks||10
5233583|NCT00879710|12867476|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
5233584|NCT00879710|12867477|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
5233585|NCT00879710|12867478|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
5233586|NCT00879710|12867479|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
5233587|NCT00879710|12867476|P4|COMPLETED|Phase 1 - 6 Weeks||13
5233588|NCT00879710|12867477|P3|COMPLETED|Phase 1 - 6 Weeks||9
5233589|NCT00879710|12867478|P2|COMPLETED|Phase 1 - 6 Weeks||14
5233590|NCT00879710|12867479|P1|COMPLETED|Phase 1 - 6 Weeks||10
5233591|NCT00879710|12867476|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
5233592|NCT00879710|12867477|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
5233593|NCT00879710|12867478|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
5233594|NCT00879710|12867479|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
5233595|NCT00879697|12867489|P2|NOT COMPLETED|Overall Study||2
5233596|NCT00879697|12867490|P1|NOT COMPLETED|Overall Study||2
5233597|NCT00879697|12867489|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
5233598|NCT00879697|12867490|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
5233599|NCT00879697|12867489|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
5233600|NCT00879697|12867490|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
5233601|NCT00879684|12867496|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
5233602|NCT00879684|12867497|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233603|NCT00879684|12867498|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233604|NCT00879684|12867499|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233605|NCT00879684|12867500|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233606|NCT00879684|12867501|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233607|NCT00879684|12867502|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
5233608|NCT00879684|12867496|P7|COMPLETED|Stage 2: Expanded Cohort||0
5233609|NCT00879684|12867497|P6|COMPLETED|Stage 2: Expanded Cohort||0
5233610|NCT00879684|12867498|P5|COMPLETED|Stage 2: Expanded Cohort||0
5233611|NCT00879684|12867499|P4|COMPLETED|Stage 2: Expanded Cohort||0
5233612|NCT00879684|12867500|P3|COMPLETED|Stage 2: Expanded Cohort||0
5233613|NCT00879684|12867501|P2|COMPLETED|Stage 2: Expanded Cohort||0
5233614|NCT00879684|12867502|P1|COMPLETED|Stage 2: Expanded Cohort||0
5233615|NCT00879684|12867496|P7|STARTED|Stage 2: Expanded Cohort||13
5233616|NCT00879684|12867497|P6|STARTED|Stage 2: Expanded Cohort||0
5233617|NCT00879684|12867498|P5|STARTED|Stage 2: Expanded Cohort||0
5233618|NCT00879684|12867499|P4|STARTED|Stage 2: Expanded Cohort||0
5233619|NCT00879684|12867500|P3|STARTED|Stage 2: Expanded Cohort||0
5233620|NCT00879684|12867501|P2|STARTED|Stage 2: Expanded Cohort||0
5233621|NCT00879684|12867502|P1|STARTED|Stage 2: Expanded Cohort||0
5233622|NCT00879684|12867496|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
5233623|NCT00879684|12867497|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
5233624|NCT00879684|12867498|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
5233625|NCT00879684|12867499|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
5233626|NCT00879684|12867500|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
5233627|NCT00879684|12867501|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
5233628|NCT00879684|12867502|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
5233629|NCT00879684|12867496|P7|COMPLETED|Stage 1: Dose Escalation||0
5233630|NCT00879684|12867497|P6|COMPLETED|Stage 1: Dose Escalation||0
5233631|NCT00879684|12867498|P5|COMPLETED|Stage 1: Dose Escalation||0
5233632|NCT00879684|12867499|P4|COMPLETED|Stage 1: Dose Escalation||0
5233633|NCT00879684|12867500|P3|COMPLETED|Stage 1: Dose Escalation||0
5233634|NCT00879684|12867501|P2|COMPLETED|Stage 1: Dose Escalation||0
5233635|NCT00879684|12867502|P1|COMPLETED|Stage 1: Dose Escalation||0
5233636|NCT00879684|12867496|P7|STARTED|Stage 1: Dose Escalation||0
5233637|NCT00879684|12867497|P6|STARTED|Stage 1: Dose Escalation||3
5233638|NCT00879684|12867498|P5|STARTED|Stage 1: Dose Escalation||3
5233639|NCT00879684|12867499|P4|STARTED|Stage 1: Dose Escalation||6
5233640|NCT00879684|12867500|P3|STARTED|Stage 1: Dose Escalation||3
5233641|NCT00879684|12867501|P2|STARTED|Stage 1: Dose Escalation||3
5233642|NCT00879684|12867502|P1|STARTED|Stage 1: Dose Escalation||3
5233643|NCT00879658|12867571|P7|NOT COMPLETED|Overall Study||0
5233644|NCT00879658|12867572|P6|NOT COMPLETED|Overall Study||1
5233645|NCT00879658|12867573|P5|NOT COMPLETED|Overall Study||2
5233646|NCT00879658|12867574|P4|NOT COMPLETED|Overall Study||4
5233647|NCT00879658|12867575|P3|NOT COMPLETED|Overall Study||7
5233648|NCT00879658|12867576|P2|NOT COMPLETED|Overall Study||5
5233649|NCT00879658|12867577|P1|NOT COMPLETED|Overall Study||15
5233650|NCT00879658|12867571|P7|COMPLETED|Overall Study||16
5233651|NCT00879658|12867572|P6|COMPLETED|Overall Study||50
5233652|NCT00879658|12867573|P5|COMPLETED|Overall Study||40
5233653|NCT00879658|12867574|P4|COMPLETED|Overall Study||42
5233654|NCT00879658|12867575|P3|COMPLETED|Overall Study||36
5233655|NCT00879658|12867576|P2|COMPLETED|Overall Study||44
5233656|NCT00879658|12867577|P1|COMPLETED|Overall Study||35
5233657|NCT00879658|12867571|P7|STARTED|Overall Study||16
5233658|NCT00879658|12867572|P6|STARTED|Overall Study||51
5233659|NCT00879658|12867573|P5|STARTED|Overall Study||42
5233660|NCT00879658|12867574|P4|STARTED|Overall Study||46
5233661|NCT00879658|12867575|P3|STARTED|Overall Study||43
5233662|NCT00879658|12867576|P2|STARTED|Overall Study||49
5233663|NCT00879658|12867577|P1|STARTED|Overall Study||50
5233664|NCT00879645|12867663|P4|NOT COMPLETED|Overall Study||0
5233665|NCT00879645|12867664|P3|NOT COMPLETED|Overall Study||0
5233666|NCT00879645|12867665|P2|NOT COMPLETED|Overall Study||0
5233667|NCT00879645|12867666|P1|NOT COMPLETED|Overall Study||1
5233668|NCT00879645|12867663|P4|COMPLETED|Overall Study||7
5233669|NCT00879645|12867664|P3|COMPLETED|Overall Study||6
5233670|NCT00879645|12867665|P2|COMPLETED|Overall Study||6
5233671|NCT00879645|12867666|P1|COMPLETED|Overall Study||8
5233672|NCT00879645|12867663|P4|STARTED|Overall Study||7
5233673|NCT00879645|12867664|P3|STARTED|Overall Study||6
5233674|NCT00879645|12867665|P2|STARTED|Overall Study||6
5233675|NCT00879645|12867666|P1|STARTED|Overall Study||9
5233676|NCT00879619|12867684|P1|NOT COMPLETED|Overall Study||0
5233677|NCT00879619|12867684|P1|COMPLETED|Overall Study||4
5233678|NCT00879619|12867684|P1|STARTED|Overall Study||4
5233679|NCT00879411|12867693|P1|NOT COMPLETED|Overall Study||162
5233680|NCT00879411|12867693|P1|COMPLETED|Overall Study||539
5233681|NCT00879411|12867693|P1|STARTED|Overall Study||701
5233682|NCT00879398|12867699|P1|NOT COMPLETED|Overall Study||675
5233683|NCT00879398|12867699|P1|COMPLETED|Overall Study||2434
5233684|NCT00879398|12867699|P1|STARTED|Overall Study||3109
5233685|NCT00879359|12867709|P1|NOT COMPLETED|Overall Study||0
5233686|NCT00879359|12867709|P1|COMPLETED|Overall Study||15
5233687|NCT00879359|12867709|P1|STARTED|Overall Study||15
5233688|NCT00879333|12867717|P2|NOT COMPLETED|Overall Study||217
5233689|NCT00879333|12867718|P1|NOT COMPLETED|Overall Study||428
5233690|NCT00879333|12867717|P2|COMPLETED|Overall Study||0
5233691|NCT00879333|12867718|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
5233692|NCT00879333|12867717|P2|Discontinued Study Treatment|Overall Study||217
5233693|NCT00879333|12867718|P1|Discontinued Study Treatment|Overall Study||428
5233694|NCT00879333|12867717|P2|STARTED|Overall Study||217
5233695|NCT00879333|12867718|P1|STARTED|Overall Study||439
5233696|NCT00879255|12867738|P2|NOT COMPLETED|Overall Study||19
5233697|NCT00879255|12867739|P1|NOT COMPLETED|Overall Study||16
5233698|NCT00879255|12867738|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
5233699|NCT00879255|12867739|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
5233700|NCT00879255|12867738|P2|Completed 3-mo Follow-up|Overall Study||49
5233701|NCT00879255|12867739|P1|Completed 3-mo Follow-up|Overall Study||48
5233702|NCT00879255|12867738|P2|Completed Posttreatment Follow-up|Overall Study||55
5233703|NCT00879255|12867739|P1|Completed Posttreatment Follow-up|Overall Study||50
5233704|NCT00879255|12867738|P2|Received Allocated Intervention:|Overall Study||56
5233705|NCT00879255|12867739|P1|Received Allocated Intervention:|Overall Study||51
5233706|NCT00879255|12867738|P2|STARTED|Overall Study||64
5233707|NCT00879255|12867739|P1|STARTED|Overall Study||61
5233708|NCT00879229|12867751|P2|NOT COMPLETED|Overall Study||14
5233709|NCT00879229|12867752|P1|NOT COMPLETED|Overall Study||22
5233710|NCT00879229|12867751|P2|COMPLETED|Overall Study||1
5233711|NCT00879229|12867752|P1|COMPLETED|Overall Study||3
5233712|NCT00879229|12867751|P2|STARTED|Overall Study||15
5233713|NCT00879229|12867752|P1|STARTED|Overall Study||25
5233714|NCT00879190|12867778|P2|NOT COMPLETED|Overall Study||0
5233715|NCT00879190|12867779|P1|NOT COMPLETED|Overall Study||0
5233716|NCT00879190|12867778|P2|COMPLETED|Overall Study||49
5233717|NCT00879190|12867779|P1|COMPLETED|Overall Study||43
5233718|NCT00879190|12867778|P2|STARTED|Overall Study||49
5233719|NCT00879190|12867779|P1|STARTED|Overall Study||43
5233720|NCT00879034|12867789|P1|NOT COMPLETED|Overall Study||0
5233721|NCT00879034|12867789|P1|COMPLETED|Overall Study||5
5233722|NCT00879034|12867789|P1|Received Treatment|Overall Study||4
5233723|NCT00879034|12867789|P1|STARTED|Overall Study||5
5233724|NCT00878995|12867800|P2|NOT COMPLETED|Midpoint Study - Post Study||0
5233725|NCT00878995|12867801|P1|NOT COMPLETED|Midpoint Study - Post Study||0
5233726|NCT00878995|12867800|P2|COMPLETED|Midpoint Study - Post Study||10
5233727|NCT00878995|12867801|P1|COMPLETED|Midpoint Study - Post Study||12
5233728|NCT00878995|12867800|P2|STARTED|Midpoint Study - Post Study||10
5233729|NCT00878995|12867801|P1|STARTED|Midpoint Study - Post Study||12
5233730|NCT00878995|12867800|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
5233731|NCT00878995|12867801|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
5233732|NCT00878995|12867800|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
5233733|NCT00878995|12867801|P1|COMPLETED|Baseline Study - Midpoint Study||12
5233734|NCT00878995|12867800|P2|Baseline Study|Baseline Study - Midpoint Study||12
5233735|NCT00878995|12867801|P1|Baseline Study|Baseline Study - Midpoint Study||12
5233736|NCT00878995|12867800|P2|STARTED|Baseline Study - Midpoint Study||12
5233737|NCT00878995|12867801|P1|STARTED|Baseline Study - Midpoint Study||12
5233738|NCT00878969|12867902|P3|NOT COMPLETED|Overall Study||11
5233739|NCT00878969|12867903|P2|NOT COMPLETED|Overall Study||15
5233740|NCT00878969|12867904|P1|NOT COMPLETED|Overall Study||15
5233741|NCT00878969|12867902|P3|COMPLETED|Overall Study||15
5233742|NCT00878969|12867903|P2|COMPLETED|Overall Study||12
5233743|NCT00878969|12867904|P1|COMPLETED|Overall Study||10
5233744|NCT00878969|12867902|P3|STARTED|Overall Study||26
5233745|NCT00878969|12867903|P2|STARTED|Overall Study||27
5233746|NCT00878969|12867904|P1|STARTED|Overall Study||25
5233747|NCT00878878|12867914|P2|NOT COMPLETED|Overall Study||0
5233748|NCT00878878|12867915|P1|NOT COMPLETED|Overall Study||0
5233749|NCT00878878|12867914|P2|COMPLETED|Overall Study||15
5233750|NCT00878878|12867915|P1|COMPLETED|Overall Study||15
5233751|NCT00878878|12867914|P2|STARTED|Overall Study||15
5233752|NCT00878878|12867915|P1|STARTED|Overall Study||15
5233753|NCT00878826|12867928|P3|NOT COMPLETED|Overall Study||0
5233754|NCT00878826|12867929|P2|NOT COMPLETED|Overall Study||0
5233755|NCT00878826|12867930|P1|NOT COMPLETED|Overall Study||0
5233756|NCT00878826|12867928|P3|COMPLETED|Overall Study||2
5233757|NCT00878826|12867929|P2|COMPLETED|Overall Study||6
5233758|NCT00878826|12867930|P1|COMPLETED|Overall Study||3
5233759|NCT00878826|12867928|P3|STARTED|Overall Study||2
5233760|NCT00878826|12867929|P2|STARTED|Overall Study||6
5233761|NCT00878826|12867930|P1|STARTED|Overall Study||3
5233762|NCT00878800|12867952|P5|NOT COMPLETED|Overall Study||16
5233763|NCT00878800|12867953|P4|NOT COMPLETED|Overall Study||6
5233764|NCT00878800|12867954|P3|NOT COMPLETED|Overall Study||9
5233765|NCT00878800|12867955|P2|NOT COMPLETED|Overall Study||7
5233766|NCT00878800|12867956|P1|NOT COMPLETED|Overall Study||3
5233767|NCT00878800|12867952|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
5233768|NCT00878800|12867953|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
5233769|NCT00878800|12867954|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
5233770|NCT00878800|12867955|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
5233771|NCT00878800|12867956|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
5233772|NCT00878800|12867952|P5|STARTED|Overall Study||16
5233773|NCT00878800|12867953|P4|STARTED|Overall Study||6
5233774|NCT00878800|12867954|P3|STARTED|Overall Study||9
5233775|NCT00878800|12867955|P2|STARTED|Overall Study||7
5233776|NCT00878800|12867956|P1|STARTED|Overall Study||3
5233777|NCT00878722|12867991|P8|NOT COMPLETED|Overall Study||7
5233778|NCT00878722|12867992|P7|NOT COMPLETED|Overall Study||6
5233779|NCT00878722|12867993|P6|NOT COMPLETED|Overall Study||2
5233780|NCT00878722|12867994|P5|NOT COMPLETED|Overall Study||7
5233781|NCT00878722|12867995|P4|NOT COMPLETED|Overall Study||9
5233782|NCT00878722|12867996|P3|NOT COMPLETED|Overall Study||3
5233783|NCT00878722|12867997|P2|NOT COMPLETED|Overall Study||3
5233784|NCT00878722|12867998|P1|NOT COMPLETED|Overall Study||3
5233785|NCT00878722|12867991|P8|COMPLETED|Overall Study||0
5233786|NCT00878722|12867992|P7|COMPLETED|Overall Study||0
5233787|NCT00878722|12867993|P6|COMPLETED|Overall Study||1
5233788|NCT00878722|12867994|P5|COMPLETED|Overall Study||0
5233789|NCT00878722|12867995|P4|COMPLETED|Overall Study||0
5233790|NCT00878722|12867996|P3|COMPLETED|Overall Study||0
5233791|NCT00878722|12867997|P2|COMPLETED|Overall Study||0
5233792|NCT00878722|12867998|P1|COMPLETED|Overall Study||0
5233793|NCT00878722|12867991|P8|STARTED|Overall Study||7
5233794|NCT00878722|12867992|P7|STARTED|Overall Study||6
5233795|NCT00878722|12867993|P6|STARTED|Overall Study||3
5233796|NCT00878722|12867994|P5|STARTED|Overall Study||7
5233797|NCT00878722|12867995|P4|STARTED|Overall Study||9
5233798|NCT00878722|12867996|P3|STARTED|Overall Study||3
5233799|NCT00878722|12867997|P2|STARTED|Overall Study||3
5233800|NCT00878722|12867998|P1|STARTED|Overall Study||3
5233801|NCT00878709|12868083|P2|NOT COMPLETED|Overall Study||237
5233802|NCT00878709|12868084|P1|NOT COMPLETED|Overall Study||325
5233803|NCT00878709|12868083|P2|COMPLETED|Overall Study||1183
5233804|NCT00878709|12868084|P1|COMPLETED|Overall Study||1095
5233805|NCT00878709|12868083|P2|STARTED|Overall Study||1420
5233806|NCT00878709|12868084|P1|STARTED|Overall Study||1420
5233807|NCT00878644|12868110|P2|NOT COMPLETED|Overall Study||4
5233808|NCT00878644|12868111|P1|NOT COMPLETED|Overall Study||4
5233809|NCT00878644|12868110|P2|COMPLETED|Overall Study||136
5233810|NCT00878644|12868111|P1|COMPLETED|Overall Study||151
5233811|NCT00878644|12868110|P2|STARTED|Overall Study||140
5233812|NCT00878644|12868111|P1|STARTED|Overall Study||155
5233813|NCT00878605|12868127|P4|NOT COMPLETED|Overall Study||3
5233814|NCT00878605|12868128|P3|NOT COMPLETED|Overall Study||1
5233815|NCT00878605|12868129|P2|NOT COMPLETED|Overall Study||3
5233816|NCT00878605|12868130|P1|NOT COMPLETED|Overall Study||3
5233817|NCT00878605|12868127|P4|COMPLETED|Overall Study||6
5233818|NCT00878605|12868128|P3|COMPLETED|Overall Study||8
5233819|NCT00878605|12868129|P2|COMPLETED|Overall Study||7
5233820|NCT00878605|12868130|P1|COMPLETED|Overall Study||7
5233821|NCT00878605|12868127|P4|STARTED|Overall Study||9
5233822|NCT00878605|12868128|P3|STARTED|Overall Study||9
5233823|NCT00878605|12868129|P2|STARTED|Overall Study||10
5233824|NCT00878605|12868130|P1|STARTED|Overall Study||10
5233825|NCT00878553|12868144|P5|NOT COMPLETED|PK Study||0
5233826|NCT00878553|12868145|P4|NOT COMPLETED|PK Study||1
5233827|NCT00878553|12868146|P3|NOT COMPLETED|PK Study||0
5233828|NCT00878553|12868147|P2|NOT COMPLETED|PK Study||0
5233829|NCT00878553|12868148|P1|NOT COMPLETED|PK Study||0
5233830|NCT00878553|12868144|P5|COMPLETED|PK Study||15
5233831|NCT00878553|12868145|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
5233832|NCT00878553|12868146|P3|COMPLETED|PK Study||17
5233833|NCT00878553|12868147|P2|COMPLETED|PK Study||16
5233834|NCT00878553|12868148|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
5233835|NCT00878553|12868144|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
5233836|NCT00878553|12868145|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
5233837|NCT00878553|12868146|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
5233838|NCT00878553|12868147|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
5233839|NCT00878553|12868148|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
5233840|NCT00878553|12868144|P5|NOT COMPLETED|Sleep Study||0
5233841|NCT00878553|12868145|P4|NOT COMPLETED|Sleep Study||0
5233842|NCT00878553|12868146|P3|NOT COMPLETED|Sleep Study||0
5233843|NCT00878553|12868147|P2|NOT COMPLETED|Sleep Study||0
5233844|NCT00878553|12868148|P1|NOT COMPLETED|Sleep Study||5
5233845|NCT00878553|12868144|P5|COMPLETED|Sleep Study||0
5233846|NCT00878553|12868145|P4|COMPLETED|Sleep Study||0
5233847|NCT00878553|12868146|P3|COMPLETED|Sleep Study||0
5233848|NCT00878553|12868147|P2|COMPLETED|Sleep Study||0
5233849|NCT00878553|12868148|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
5233850|NCT00878553|12868144|P5|Number of Patients Receiving 20mg|Sleep Study||0
5233851|NCT00878553|12868145|P4|Number of Patients Receiving 20mg|Sleep Study||0
5233852|NCT00878553|12868146|P3|Number of Patients Receiving 20mg|Sleep Study||0
5233853|NCT00878553|12868147|P2|Number of Patients Receiving 20mg|Sleep Study||0
5233854|NCT00878553|12868148|P1|Number of Patients Receiving 20mg|Sleep Study||65
5233855|NCT00878553|12868144|P5|Number of Patients Receiving 15mg|Sleep Study||0
5233856|NCT00878553|12868145|P4|Number of Patients Receiving 15mg|Sleep Study||0
5233857|NCT00878553|12868146|P3|Number of Patients Receiving 15mg|Sleep Study||0
5233858|NCT00878553|12868147|P2|Number of Patients Receiving 15mg|Sleep Study||0
5233859|NCT00878553|12868148|P1|Number of Patients Receiving 15mg|Sleep Study||65
5233860|NCT00878553|12868144|P5|Number of Patients Receiving 10mg|Sleep Study||0
5233861|NCT00878553|12868145|P4|Number of Patients Receiving 10mg|Sleep Study||0
5233862|NCT00878553|12868146|P3|Number of Patients Receiving 10mg|Sleep Study||0
5233863|NCT00878553|12868147|P2|Number of Patients Receiving 10mg|Sleep Study||0
5233864|NCT00878553|12868148|P1|Number of Patients Receiving 10mg|Sleep Study||65
5233865|NCT00878553|12868144|P5|Number of Patients Receiving Placebo|Sleep Study||0
5233866|NCT00878553|12868145|P4|Number of Patients Receiving Placebo|Sleep Study||0
5233867|NCT00878553|12868146|P3|Number of Patients Receiving Placebo|Sleep Study||0
5233868|NCT00878553|12868147|P2|Number of Patients Receiving Placebo|Sleep Study||0
5233869|NCT00878553|12868148|P1|Number of Patients Receiving Placebo|Sleep Study||66
5233870|NCT00878553|12868144|P5|STARTED|Sleep Study||0
5233871|NCT00878553|12868145|P4|STARTED|Sleep Study||0
5233872|NCT00878553|12868146|P3|STARTED|Sleep Study||0
5233873|NCT00878553|12868147|P2|STARTED|Sleep Study||0
5233874|NCT00878553|12868148|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
5233875|NCT00878501|12868207|P3|NOT COMPLETED|Overall Study||8
5233876|NCT00878501|12868208|P2|NOT COMPLETED|Overall Study||7
5233877|NCT00878501|12868209|P1|NOT COMPLETED|Overall Study||17
5233878|NCT00878501|12868207|P3|COMPLETED|Overall Study||85
5233879|NCT00878501|12868208|P2|COMPLETED|Overall Study||37
5233880|NCT00878501|12868209|P1|COMPLETED|Overall Study||87
5233881|NCT00878501|12868207|P3|Interim Analysis|Overall Study||81
5233882|NCT00878501|12868208|P2|Interim Analysis|Overall Study||37
5233883|NCT00878501|12868209|P1|Interim Analysis|Overall Study||83
5233884|NCT00878501|12868207|P3|STARTED|Overall Study||93
5233885|NCT00878501|12868208|P2|STARTED|Overall Study||44
5233886|NCT00878501|12868209|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
5233887|NCT00878436|12868228|P2|NOT COMPLETED|Overall Study||24
5233888|NCT00878436|12868229|P1|NOT COMPLETED|Overall Study||23
5233889|NCT00878436|12868228|P2|COMPLETED|Overall Study||0
5233890|NCT00878436|12868229|P1|COMPLETED|Overall Study||5
5233891|NCT00878436|12868228|P2|6 Months|Overall Study||0
5233892|NCT00878436|12868229|P1|6 Months|Overall Study||8
5233893|NCT00878436|12868228|P2|Completed 2 Cycles|Overall Study||20
5233894|NCT00878436|12868229|P1|Completed 2 Cycles|Overall Study||21
5233895|NCT00878436|12868228|P2|STARTED|Overall Study||24
5233896|NCT00878436|12868229|P1|STARTED|Overall Study||28
5233897|NCT00878228|12868243|P2|NOT COMPLETED|Overall Study||12
5233898|NCT00878228|12868244|P1|NOT COMPLETED|Overall Study||10
5233899|NCT00878228|12868243|P2|COMPLETED|Overall Study||37
5233900|NCT00878228|12868244|P1|COMPLETED|Overall Study||39
5233901|NCT00878228|12868243|P2|STARTED|Overall Study||49
5233902|NCT00878228|12868244|P1|STARTED|Overall Study||49
5233903|NCT00878215|12868258|P4|NOT COMPLETED|Overall Study||0
5233904|NCT00878215|12868259|P3|NOT COMPLETED|Overall Study||0
5233905|NCT00878215|12868260|P2|NOT COMPLETED|Overall Study||10
5233906|NCT00878215|12868261|P1|NOT COMPLETED|Overall Study||0
5233907|NCT00878215|12868258|P4|COMPLETED|Overall Study||0
5233908|NCT00878215|12868259|P3|COMPLETED|Overall Study||0
5233909|NCT00878215|12868260|P2|COMPLETED|Overall Study||9
5233910|NCT00878215|12868261|P1|COMPLETED|Overall Study||21
5233911|NCT00878215|12868258|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
5233912|NCT00878215|12868259|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
5233913|NCT00878215|12868260|P2|STARTED|Overall Study||19
5233914|NCT00878215|12868261|P1|STARTED|Overall Study||21
5233915|NCT00878189|12868273|P9|NOT COMPLETED|Overall Study||8
5233916|NCT00878189|12868274|P8|NOT COMPLETED|Overall Study||3
5233917|NCT00878189|12868275|P7|NOT COMPLETED|Overall Study||16
5233918|NCT00878189|12868276|P6|NOT COMPLETED|Overall Study||23
5233919|NCT00878189|12868277|P5|NOT COMPLETED|Overall Study||4
5233920|NCT00878189|12868278|P4|NOT COMPLETED|Overall Study||8
5233921|NCT00878189|12868279|P3|NOT COMPLETED|Overall Study||4
5233922|NCT00878189|12868280|P2|NOT COMPLETED|Overall Study||3
5233923|NCT00878189|12868281|P1|NOT COMPLETED|Overall Study||3
5233924|NCT00878189|12868273|P9|COMPLETED|Overall Study||0
5233925|NCT00878189|12868274|P8|COMPLETED|Overall Study||0
5233926|NCT00878189|12868275|P7|COMPLETED|Overall Study||0
5233927|NCT00878189|12868276|P6|COMPLETED|Overall Study||0
5233928|NCT00878189|12868277|P5|COMPLETED|Overall Study||0
5233929|NCT00878189|12868278|P4|COMPLETED|Overall Study||0
5233930|NCT00878189|12868279|P3|COMPLETED|Overall Study||0
5233931|NCT00878189|12868280|P2|COMPLETED|Overall Study||0
5233932|NCT00878189|12868281|P1|COMPLETED|Overall Study||0
5233933|NCT00878189|12868273|P9|STARTED|Overall Study||8
5233934|NCT00878189|12868274|P8|STARTED|Overall Study||3
5233935|NCT00878189|12868275|P7|STARTED|Overall Study||16
5233936|NCT00878189|12868276|P6|STARTED|Overall Study||23
5233937|NCT00878189|12868277|P5|STARTED|Overall Study||4
5233938|NCT00878189|12868278|P4|STARTED|Overall Study||8
5233939|NCT00878189|12868279|P3|STARTED|Overall Study||4
5233940|NCT00878189|12868280|P2|STARTED|Overall Study||3
5233941|NCT00878189|12868281|P1|STARTED|Overall Study||3
5233942|NCT00877929|12868549|P2|NOT COMPLETED|Overall Study||35
5233943|NCT00877929|12868550|P1|NOT COMPLETED|Overall Study||20
5233944|NCT00877929|12868549|P2|COMPLETED|Overall Study||319
5233945|NCT00877929|12868550|P1|COMPLETED|Overall Study||332
5233946|NCT00877929|12868549|P2|STARTED|Overall Study||354
5233947|NCT00877929|12868550|P1|STARTED|Overall Study||352
5233948|NCT00877890|12868638|P2|NOT COMPLETED|Overall Study||30
5233949|NCT00877890|12868639|P1|NOT COMPLETED|Overall Study||20
5233950|NCT00877890|12868638|P2|COMPLETED|Overall Study||95
5233951|NCT00877890|12868639|P1|COMPLETED|Overall Study||109
5233952|NCT00877890|12868638|P2|Intent to Treat (ITT)|Overall Study||123
5233953|NCT00877890|12868639|P1|Intent to Treat (ITT)|Overall Study||129
5233954|NCT00877890|12868638|P2|STARTED|Overall Study||125
5233955|NCT00877890|12868639|P1|STARTED|Overall Study||129
5233956|NCT00877877|12868673|P1|NOT COMPLETED|Year 10||0
5233957|NCT00877877|12868673|P1|COMPLETED|Year 10||495
5233958|NCT00877877|12868673|P1|STARTED|Year 10||495
5233959|NCT00877877|12868673|P1|NOT COMPLETED|Year 9||0
5233960|NCT00877877|12868673|P1|COMPLETED|Year 9||507
5233961|NCT00877877|12868673|P1|STARTED|Year 9||507
5233962|NCT00877877|12868673|P1|NOT COMPLETED|Year 8||0
5233963|NCT00877877|12868673|P1|COMPLETED|Year 8||522
5233964|NCT00877877|12868673|P1|STARTED|Year 8||522
5233965|NCT00877877|12868673|P1|NOT COMPLETED|Year 7||0
5233966|NCT00877877|12868673|P1|COMPLETED|Year 7||523
5233967|NCT00877877|12868673|P1|STARTED|Year 7||523
5233968|NCT00877877|12868673|P1|NOT COMPLETED|Year 6||0
5233969|NCT00877877|12868673|P1|COMPLETED|Year 6||529
5233970|NCT00877877|12868673|P1|STARTED|Year 6||529
5233971|NCT00877877|12868673|P1|NOT COMPLETED|Year 5||0
5233972|NCT00877877|12868673|P1|COMPLETED|Year 5||397
5233973|NCT00877877|12868673|P1|STARTED|Year 5||397
5233974|NCT00877799|12868704|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
5233975|NCT00877799|12868705|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
5233976|NCT00877799|12868706|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233977|NCT00877799|12868707|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233978|NCT00877799|12868708|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233979|NCT00877799|12868704|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
5233980|NCT00877799|12868705|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
5233981|NCT00877799|12868706|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233982|NCT00877799|12868707|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233983|NCT00877799|12868708|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
5233984|NCT00877799|12868704|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
5233985|NCT00877799|12868705|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
5233986|NCT00877799|12868706|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
5233987|NCT00877799|12868707|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
5233988|NCT00877799|12868708|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
5233989|NCT00877799|12868704|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5233990|NCT00877799|12868705|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5233991|NCT00877799|12868706|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
5233992|NCT00877799|12868707|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
5233993|NCT00877799|12868708|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
5233994|NCT00877799|12868704|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5233995|NCT00877799|12868705|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5233996|NCT00877799|12868706|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
5233997|NCT00877799|12868707|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
5233998|NCT00877799|12868708|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
5233999|NCT00877799|12868704|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5234000|NCT00877799|12868705|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
5234001|NCT00877799|12868706|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
5234002|NCT00877799|12868707|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
5234003|NCT00877799|12868708|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
5234004|NCT00877773|12868723|P1|NOT COMPLETED|Overall Study||44
5234005|NCT00877773|12868723|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
5234006|NCT00877773|12868723|P1|STARTED|Overall Study||44
5234007|NCT00877604|12868729|P2|NOT COMPLETED|Overall Study||3
5234008|NCT00877604|12868730|P1|NOT COMPLETED|Overall Study||2
5234009|NCT00877604|12868729|P2|COMPLETED|Overall Study||14
5234010|NCT00877604|12868730|P1|COMPLETED|Overall Study||15
5234011|NCT00877604|12868729|P2|STARTED|Overall Study||17
5234012|NCT00877604|12868730|P1|STARTED|Overall Study||17
5234013|NCT00877487|12868736|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
5234014|NCT00877487|12868737|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
5234015|NCT00877487|12868736|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
5234016|NCT00877487|12868737|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
5234017|NCT00877487|12868736|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
5234018|NCT00877487|12868737|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
5234019|NCT00877487|12868736|P2|NOT COMPLETED|Open-label Treatment Phase||0
5234020|NCT00877487|12868737|P1|NOT COMPLETED|Open-label Treatment Phase||7
5234021|NCT00877487|12868736|P2|COMPLETED|Open-label Treatment Phase||0
5234022|NCT00877487|12868737|P1|COMPLETED|Open-label Treatment Phase||116
5234023|NCT00877487|12868736|P2|STARTED|Open-label Treatment Phase||0
5234024|NCT00877487|12868737|P1|STARTED|Open-label Treatment Phase||123
5234025|NCT00877448|12868754|P7|NOT COMPLETED|Overall Study||0
5234026|NCT00877448|12868755|P6|NOT COMPLETED|Overall Study||1
5234027|NCT00877448|12868756|P5|NOT COMPLETED|Overall Study||0
5234028|NCT00877448|12868757|P4|NOT COMPLETED|Overall Study||1
5234029|NCT00877448|12868758|P3|NOT COMPLETED|Overall Study||0
5234030|NCT00877448|12868759|P2|NOT COMPLETED|Overall Study||1
5234031|NCT00877448|12868760|P1|NOT COMPLETED|Overall Study||0
5234032|NCT00877448|12868754|P7|COMPLETED|Overall Study||3
5234033|NCT00877448|12868755|P6|COMPLETED|Overall Study||9
5234034|NCT00877448|12868756|P5|COMPLETED|Overall Study||10
5234035|NCT00877448|12868757|P4|COMPLETED|Overall Study||9
5234036|NCT00877448|12868758|P3|COMPLETED|Overall Study||10
5234037|NCT00877448|12868759|P2|COMPLETED|Overall Study||9
5234038|NCT00877448|12868760|P1|COMPLETED|Overall Study||10
5234039|NCT00877448|12868754|P7|STARTED|Overall Study||3
5234040|NCT00877448|12868755|P6|STARTED|Overall Study||10
5234041|NCT00877448|12868756|P5|STARTED|Overall Study||10
5234042|NCT00877448|12868757|P4|STARTED|Overall Study||10
5234043|NCT00877448|12868758|P3|STARTED|Overall Study||10
5234044|NCT00877448|12868759|P2|STARTED|Overall Study||10
5234045|NCT00877448|12868760|P1|STARTED|Overall Study||10
5234046|NCT00877383|12868785|P2|NOT COMPLETED|Overall Study||37
5234047|NCT00877383|12868786|P1|NOT COMPLETED|Overall Study||29
5234048|NCT00877383|12868785|P2|COMPLETED|Overall Study||533
5234049|NCT00877383|12868786|P1|COMPLETED|Overall Study||543
5234050|NCT00877383|12868785|P2|STARTED|Overall Study||570
5234051|NCT00877383|12868786|P1|STARTED|Overall Study||572
5234052|NCT00877370|12868802|P1|NOT COMPLETED|Overall Study||0
5234053|NCT00877370|12868802|P1|COMPLETED|Overall Study||8
5234054|NCT00877370|12868802|P1|STARTED|Overall Study||8
5234055|NCT00877071|12868806|P1|NOT COMPLETED|Overall Study||2
5234056|NCT00877071|12868806|P1|COMPLETED|Overall Study||0
5234057|NCT00877071|12868806|P1|STARTED|Overall Study||2
5234058|NCT00877058|12868816|P3|NOT COMPLETED|Overall Study||39
5234059|NCT00877058|12868817|P2|NOT COMPLETED|Overall Study||40
5234060|NCT00877058|12868818|P1|NOT COMPLETED|Overall Study||37
5234061|NCT00877058|12868816|P3|COMPLETED|Overall Study||75
5234062|NCT00877058|12868817|P2|COMPLETED|Overall Study||131
5234063|NCT00877058|12868818|P1|COMPLETED|Overall Study||137
5234064|NCT00877058|12868816|P3|STARTED|Overall Study||114
5234065|NCT00877058|12868817|P2|STARTED|Overall Study||171
5234066|NCT00877058|12868818|P1|STARTED|Overall Study||174
5234067|NCT00877032|12868839|P7|NOT COMPLETED|Overall Study||2
5234068|NCT00877032|12868840|P6|NOT COMPLETED|Overall Study||0
5234069|NCT00877032|12868841|P5|NOT COMPLETED|Overall Study||0
5234070|NCT00877032|12868842|P4|NOT COMPLETED|Overall Study||1
5234071|NCT00877032|12868843|P3|NOT COMPLETED|Overall Study||0
5234072|NCT00877032|12868844|P2|NOT COMPLETED|Overall Study||0
5234073|NCT00877032|12868845|P1|NOT COMPLETED|Overall Study||0
5234074|NCT00877032|12868839|P7|COMPLETED|Overall Study||18
5234075|NCT00877032|12868840|P6|COMPLETED|Overall Study||6
5234076|NCT00877032|12868841|P5|COMPLETED|Overall Study||6
5234077|NCT00877032|12868842|P4|COMPLETED|Overall Study||6
5234078|NCT00877032|12868843|P3|COMPLETED|Overall Study||6
5234079|NCT00877032|12868844|P2|COMPLETED|Overall Study||6
5234080|NCT00877032|12868845|P1|COMPLETED|Overall Study||6
5234081|NCT00877032|12868839|P7|Treated|Overall Study||18
5234082|NCT00877032|12868840|P6|Treated|Overall Study||6
5234083|NCT00877032|12868841|P5|Treated|Overall Study||6
5234084|NCT00877032|12868842|P4|Treated|Overall Study||6
5234085|NCT00877032|12868843|P3|Treated|Overall Study||6
5234086|NCT00877032|12868844|P2|Treated|Overall Study||6
5234087|NCT00877032|12868845|P1|Treated|Overall Study||6
5234088|NCT00877032|12868839|P7|STARTED|Overall Study||20
5234089|NCT00877032|12868840|P6|STARTED|Overall Study||6
5234090|NCT00877032|12868841|P5|STARTED|Overall Study||6
5234091|NCT00877032|12868842|P4|STARTED|Overall Study||7
5234092|NCT00877032|12868843|P3|STARTED|Overall Study||6
5234093|NCT00877032|12868844|P2|STARTED|Overall Study||6
5234094|NCT00877032|12868845|P1|STARTED|Overall Study||6
5234095|NCT00877006|12868946|P2|NOT COMPLETED|Long-Term Follow-up Period||55
5234096|NCT00877006|12868947|P1|NOT COMPLETED|Long-Term Follow-up Period||53
5234097|NCT00877006|12868946|P2|COMPLETED|Long-Term Follow-up Period||154
5234098|NCT00877006|12868947|P1|COMPLETED|Long-Term Follow-up Period||157
5234099|NCT00877006|12868946|P2|STARTED|Long-Term Follow-up Period||209
5234100|NCT00877006|12868947|P1|STARTED|Long-Term Follow-up Period||210
5234101|NCT00877006|12868946|P2|NOT COMPLETED|Treatment Period||27
5234102|NCT00877006|12868947|P1|NOT COMPLETED|Treatment Period||25
5234103|NCT00877006|12868946|P2|COMPLETED|Treatment Period||196
5234104|NCT00877006|12868947|P1|COMPLETED|Treatment Period||199
5234105|NCT00877006|12868946|P2|STARTED|Treatment Period||223
5234106|NCT00877006|12868947|P1|STARTED|Treatment Period||224
5234107|NCT00876993|12868990|P5|NOT COMPLETED|Overall Study||2
5234108|NCT00876993|12868991|P4|NOT COMPLETED|Overall Study||0
5234109|NCT00876993|12868992|P3|NOT COMPLETED|Overall Study||2
5234110|NCT00876993|12868993|P2|NOT COMPLETED|Overall Study||0
5234111|NCT00876993|12868994|P1|NOT COMPLETED|Overall Study||1
5234112|NCT00876993|12868990|P5|COMPLETED|Overall Study||3
5234113|NCT00876993|12868991|P4|COMPLETED|Overall Study||5
5234114|NCT00876993|12868992|P3|COMPLETED|Overall Study||3
5234115|NCT00876993|12868993|P2|COMPLETED|Overall Study||6
5234116|NCT00876993|12868994|P1|COMPLETED|Overall Study||4
5234117|NCT00876993|12868990|P5|STARTED|Overall Study||5
5234118|NCT00876993|12868991|P4|STARTED|Overall Study||5
5234119|NCT00876993|12868992|P3|STARTED|Overall Study||5
5234120|NCT00876993|12868993|P2|STARTED|Overall Study||6
5234121|NCT00876993|12868994|P1|STARTED|Overall Study||5
5234122|NCT00876928|12869023|P2|NOT COMPLETED|Overall Study||5
5234123|NCT00876928|12869024|P1|NOT COMPLETED|Overall Study||3
5234124|NCT00876928|12869023|P2|COMPLETED|Overall Study||56
5234125|NCT00876928|12869024|P1|COMPLETED|Overall Study||53
5234126|NCT00876928|12869023|P2|STARTED|Overall Study||61
5234127|NCT00876928|12869024|P1|STARTED|Overall Study||56
5234128|NCT00876915|12869035|P3|NOT COMPLETED|Overall Study||0
5234129|NCT00876915|12869036|P2|NOT COMPLETED|Overall Study||14
5234130|NCT00876915|12869037|P1|NOT COMPLETED|Overall Study||19
5234131|NCT00876915|12869035|P3|COMPLETED|Overall Study||101
5234132|NCT00876915|12869036|P2|COMPLETED|Overall Study||34
5234133|NCT00876915|12869037|P1|COMPLETED|Overall Study||31
5234134|NCT00876915|12869035|P3|Week 8|Overall Study||0
5234135|NCT00876915|12869036|P2|Week 8|Overall Study||36
5234136|NCT00876915|12869037|P1|Week 8|Overall Study||33
5234137|NCT00876915|12869035|P3|Week 4|Overall Study||0
5234138|NCT00876915|12869036|P2|Week 4|Overall Study||45
5234139|NCT00876915|12869037|P1|Week 4|Overall Study||38
5234140|NCT00876915|12869035|P3|STARTED|Overall Study||101
5234141|NCT00876915|12869036|P2|STARTED|Overall Study||48
5234142|NCT00876915|12869037|P1|STARTED|Overall Study||50
5234143|NCT00876733|12869061|P4|NOT COMPLETED|Overall Study||7
5234144|NCT00876733|12869062|P3|NOT COMPLETED|Overall Study||30
5234145|NCT00876733|12869063|P2|NOT COMPLETED|Overall Study||42
5234146|NCT00876733|12869064|P1|NOT COMPLETED|Overall Study||91
5234147|NCT00876733|12869061|P4|COMPLETED|Overall Study||14
5234148|NCT00876733|12869062|P3|COMPLETED|Overall Study||63
5234149|NCT00876733|12869063|P2|COMPLETED|Overall Study||161
5234150|NCT00876733|12869064|P1|COMPLETED|Overall Study||197
5234151|NCT00876733|12869061|P4|STARTED|Overall Study||21
5234152|NCT00876733|12869062|P3|STARTED|Overall Study||93
5234153|NCT00876733|12869063|P2|STARTED|Overall Study||203
5234154|NCT00876733|12869064|P1|STARTED|Overall Study||288
5234155|NCT00876694|12869172|P2|NOT COMPLETED|Overall Study||12
5234156|NCT00876694|12869173|P1|NOT COMPLETED|Overall Study||21
5234157|NCT00876694|12869172|P2|COMPLETED|Overall Study||49
5234158|NCT00876694|12869173|P1|COMPLETED|Overall Study||104
5234159|NCT00876694|12869172|P2|STARTED|Overall Study||61
5234160|NCT00876694|12869173|P1|STARTED|Overall Study||125
5234161|NCT00876460|12869199|P8|NOT COMPLETED|Mono Therapy Phase||3
5234162|NCT00876460|12869200|P7|NOT COMPLETED|Mono Therapy Phase||1
5234163|NCT00876460|12869201|P6|NOT COMPLETED|Mono Therapy Phase||0
5234164|NCT00876460|12869202|P5|NOT COMPLETED|Mono Therapy Phase||2
5234165|NCT00876460|12869203|P4|NOT COMPLETED|Mono Therapy Phase||1
5234166|NCT00876460|12869204|P3|NOT COMPLETED|Mono Therapy Phase||0
5234167|NCT00876460|12869205|P2|NOT COMPLETED|Mono Therapy Phase||1
5234168|NCT00876460|12869206|P1|NOT COMPLETED|Mono Therapy Phase||0
5234169|NCT00876460|12869199|P8|COMPLETED|Mono Therapy Phase||0
5234170|NCT00876460|12869200|P7|COMPLETED|Mono Therapy Phase||0
5234171|NCT00876460|12869201|P6|COMPLETED|Mono Therapy Phase||0
5234172|NCT00876460|12869202|P5|COMPLETED|Mono Therapy Phase||0
5234173|NCT00876460|12869203|P4|COMPLETED|Mono Therapy Phase||0
5234174|NCT00876460|12869204|P3|COMPLETED|Mono Therapy Phase||0
5234175|NCT00876460|12869205|P2|COMPLETED|Mono Therapy Phase||0
5234176|NCT00876460|12869206|P1|COMPLETED|Mono Therapy Phase||0
5234177|NCT00876460|12869199|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
5234178|NCT00876460|12869200|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
5234179|NCT00876460|12869201|P6|STARTED|Mono Therapy Phase||0
5234180|NCT00876460|12869202|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
5234181|NCT00876460|12869203|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
5234182|NCT00876460|12869204|P3|STARTED|Mono Therapy Phase||0
5234183|NCT00876460|12869205|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
5234184|NCT00876460|12869206|P1|STARTED|Mono Therapy Phase||0
5234185|NCT00876460|12869199|P8|NOT COMPLETED|Combination Therapy Phase||6
5234186|NCT00876460|12869200|P7|NOT COMPLETED|Combination Therapy Phase||8
5234187|NCT00876460|12869201|P6|NOT COMPLETED|Combination Therapy Phase||3
5234188|NCT00876460|12869202|P5|NOT COMPLETED|Combination Therapy Phase||7
5234189|NCT00876460|12869203|P4|NOT COMPLETED|Combination Therapy Phase||6
5234190|NCT00876460|12869204|P3|NOT COMPLETED|Combination Therapy Phase||3
5234191|NCT00876460|12869205|P2|NOT COMPLETED|Combination Therapy Phase||7
5234192|NCT00876460|12869206|P1|NOT COMPLETED|Combination Therapy Phase||3
5234193|NCT00876460|12869199|P8|COMPLETED|Combination Therapy Phase||0
5234194|NCT00876460|12869200|P7|COMPLETED|Combination Therapy Phase||0
5234195|NCT00876460|12869201|P6|COMPLETED|Combination Therapy Phase||0
5234196|NCT00876460|12869202|P5|COMPLETED|Combination Therapy Phase||0
5234197|NCT00876460|12869203|P4|COMPLETED|Combination Therapy Phase||0
5234198|NCT00876460|12869204|P3|COMPLETED|Combination Therapy Phase||0
5234199|NCT00876460|12869205|P2|COMPLETED|Combination Therapy Phase||0
5234200|NCT00876460|12869206|P1|COMPLETED|Combination Therapy Phase||0
5234201|NCT00876460|12869199|P8|STARTED|Combination Therapy Phase||6
5234202|NCT00876460|12869200|P7|STARTED|Combination Therapy Phase||8
5234203|NCT00876460|12869201|P6|STARTED|Combination Therapy Phase||3
5234204|NCT00876460|12869202|P5|STARTED|Combination Therapy Phase||7
5234205|NCT00876460|12869203|P4|STARTED|Combination Therapy Phase||6
5234206|NCT00876460|12869204|P3|STARTED|Combination Therapy Phase||3
5234207|NCT00876460|12869205|P2|STARTED|Combination Therapy Phase||7
5234208|NCT00876460|12869206|P1|STARTED|Combination Therapy Phase||3
5234209|NCT00876447|12869278|P2|NOT COMPLETED|Overall Study||81
5234210|NCT00876447|12869279|P1|NOT COMPLETED|Overall Study||80
5234211|NCT00876447|12869278|P2|COMPLETED|Overall Study||122
5234212|NCT00876447|12869279|P1|COMPLETED|Overall Study||105
5234213|NCT00876447|12869278|P2|STARTED|Overall Study||203
5234214|NCT00876447|12869279|P1|STARTED|Overall Study||185
5234215|NCT00876395|12869339|P2|NOT COMPLETED|Overall Study||239
5234216|NCT00876395|12869340|P1|NOT COMPLETED|Overall Study||480
5234217|NCT00876395|12869339|P2|COMPLETED|Overall Study||0
5234218|NCT00876395|12869340|P1|COMPLETED|Overall Study||0
5234219|NCT00876395|12869339|P2|Untreated|Overall Study||1
5234220|NCT00876395|12869340|P1|Untreated|Overall Study||8
5234221|NCT00876395|12869339|P2|STARTED|Overall Study||239
5234222|NCT00876395|12869340|P1|STARTED|Overall Study||480
5234223|NCT00876343|12869381|P3|NOT COMPLETED|Overall Study||12
5234224|NCT00876343|12869382|P2|NOT COMPLETED|Overall Study||17
5234225|NCT00876343|12869383|P1|NOT COMPLETED|Overall Study||17
5234226|NCT00876343|12869381|P3|COMPLETED|Overall Study||183
5234227|NCT00876343|12869382|P2|COMPLETED|Overall Study||180
5234228|NCT00876343|12869383|P1|COMPLETED|Overall Study||177
5234229|NCT00876343|12869381|P3|STARTED|Overall Study||195
5234230|NCT00876343|12869382|P2|STARTED|Overall Study||197
5234231|NCT00876343|12869383|P1|STARTED|Overall Study||194
5234232|NCT00876265|12869397|P1|NOT COMPLETED|Overall Study||12
5234233|NCT00876265|12869397|P1|COMPLETED|Overall Study||106
5234234|NCT00876265|12869397|P1|STARTED|Overall Study||118
5234235|NCT00876200|12869405|P2|NOT COMPLETED|Overall Study||3
5234236|NCT00876200|12869406|P1|NOT COMPLETED|Overall Study||1
5234237|NCT00876200|12869405|P2|COMPLETED|Overall Study||9
5234238|NCT00876200|12869406|P1|COMPLETED|Overall Study||8
5234239|NCT00876200|12869405|P2|STARTED|Overall Study||12
5234240|NCT00876200|12869406|P1|STARTED|Overall Study||9
5234241|NCT00876018|12869415|P3|NOT COMPLETED|Overall Study||3
5234242|NCT00876018|12869416|P2|NOT COMPLETED|Overall Study||5
5234243|NCT00876018|12869417|P1|NOT COMPLETED|Overall Study||5
5234244|NCT00876018|12869415|P3|COMPLETED|Overall Study||97
5234245|NCT00876018|12869416|P2|COMPLETED|Overall Study||95
5234246|NCT00876018|12869417|P1|COMPLETED|Overall Study||95
5234247|NCT00876018|12869415|P3|STARTED|Overall Study||100
5234248|NCT00876018|12869416|P2|STARTED|Overall Study||100
5234249|NCT00876018|12869417|P1|STARTED|Overall Study||100
5234250|NCT00875979|12869472|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
5234251|NCT00875979|12869473|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
5234252|NCT00875979|12869472|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
5234253|NCT00875979|12869473|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
5234254|NCT00875979|12869472|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
5234255|NCT00875979|12869473|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
5234256|NCT00875979|12869472|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
5234257|NCT00875979|12869473|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
5234258|NCT00875979|12869472|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
5234259|NCT00875979|12869473|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
5234260|NCT00875979|12869472|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
5234261|NCT00875979|12869473|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
5234262|NCT00875979|12869472|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
5234263|NCT00875979|12869473|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
5234264|NCT00875979|12869472|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
5234265|NCT00875979|12869473|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
5234266|NCT00875979|12869472|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
5234267|NCT00875979|12869473|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
5234268|NCT00875836|12869485|P2|NOT COMPLETED|Overall Study||40
5234269|NCT00875836|12869486|P1|NOT COMPLETED|Overall Study||43
5234270|NCT00875836|12869485|P2|COMPLETED|Overall Study||47
5234271|NCT00875836|12869486|P1|COMPLETED|Overall Study||45
5234272|NCT00875836|12869485|P2|STARTED|Overall Study||87
5234273|NCT00875836|12869486|P1|STARTED|Overall Study||88
5234274|NCT00875810|12869496|P1|NOT COMPLETED|Overall Study||46
5234275|NCT00875810|12869496|P1|COMPLETED|Overall Study||148
5234276|NCT00875810|12869496|P1|24 Months Follow up|Overall Study||148
5234277|NCT00875810|12869496|P1|12 Months Follow up|Overall Study||112
5234278|NCT00875810|12869496|P1|6 Months Follow up|Overall Study||80
5234279|NCT00875810|12869496|P1|3 Months Follow up|Overall Study||175
5234280|NCT00875810|12869496|P1|Discharged|Overall Study||177
5234281|NCT00875810|12869496|P1|Implanted|Overall Study||190
5234282|NCT00875810|12869496|P1|STARTED|Overall Study||194
5234283|NCT00875797|12869505|P2|NOT COMPLETED|Overall Study||3
5234284|NCT00875797|12869506|P1|NOT COMPLETED|Overall Study||6
5234285|NCT00875797|12869505|P2|COMPLETED|Overall Study||42
5234286|NCT00875797|12869506|P1|COMPLETED|Overall Study||39
5234287|NCT00875797|12869505|P2|STARTED|Overall Study||45
5234288|NCT00875797|12869506|P1|STARTED|Overall Study||45
5234289|NCT00875706|12869519|P3|NOT COMPLETED|Overall Study||0
5234290|NCT00875706|12869520|P2|NOT COMPLETED|Overall Study||0
5234291|NCT00875706|12869521|P1|NOT COMPLETED|Overall Study||1
5234292|NCT00875706|12869519|P3|COMPLETED|Overall Study||13
5234293|NCT00875706|12869520|P2|COMPLETED|Overall Study||24
5234294|NCT00875706|12869521|P1|COMPLETED|Overall Study||7
5234295|NCT00875706|12869519|P3|STARTED|Overall Study||13
5234296|NCT00875706|12869520|P2|STARTED|Overall Study||24
5234297|NCT00875706|12869521|P1|STARTED|Overall Study||8
5234298|NCT00875667|12869540|P2|NOT COMPLETED|Overall Study||73
5234299|NCT00875667|12869541|P1|NOT COMPLETED|Overall Study||170
5234300|NCT00875667|12869540|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
5234301|NCT00875667|12869541|P1|COMPLETED|Overall Study||0
5234302|NCT00875667|12869540|P2|Participants Treated|Overall Study||83
5234303|NCT00875667|12869541|P1|Participants Treated|Overall Study||167
5234304|NCT00875667|12869540|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
5234305|NCT00875667|12869541|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
5234306|NCT00875667|12869540|P2|STARTED|Overall Study||84
5234307|NCT00875667|12869541|P1|STARTED|Overall Study||170
5234308|NCT00875641|12869642|P3|NOT COMPLETED|Overall Study||0
5234309|NCT00875641|12869643|P2|NOT COMPLETED|Overall Study||0
5234310|NCT00875641|12869644|P1|NOT COMPLETED|Overall Study||0
5234311|NCT00875641|12869642|P3|COMPLETED|Overall Study||159344
5234312|NCT00875641|12869643|P2|COMPLETED|Overall Study||173384
5234313|NCT00875641|12869644|P1|COMPLETED|Overall Study||57931
5234314|NCT00875641|12869642|P3|STARTED|Overall Study||159344
5234315|NCT00875641|12869643|P2|STARTED|Overall Study||173384
5234316|NCT00875641|12869644|P1|STARTED|Overall Study||57931
5234317|NCT00875615|12869676|P1|NOT COMPLETED|Overall Study||1
5234318|NCT00875615|12869676|P1|COMPLETED|Overall Study||10
5234319|NCT00875615|12869676|P1|STARTED|Overall Study||11
5234320|NCT00875589|12869683|P2|NOT COMPLETED|Overall Study||0
5234321|NCT00875589|12869684|P1|NOT COMPLETED|Overall Study||0
5234322|NCT00875589|12869683|P2|COMPLETED|Overall Study||11
5234323|NCT00875589|12869684|P1|COMPLETED|Overall Study||15
5234324|NCT00875589|12869683|P2|STARTED|Overall Study||11
5234325|NCT00875589|12869684|P1|STARTED|Overall Study||15
5234326|NCT00875563|12869690|P1|NOT COMPLETED|Overall Study||24
5234327|NCT00875563|12869690|P1|COMPLETED|Overall Study||18
5234328|NCT00875563|12869690|P1|STARTED|Overall Study||42
5234329|NCT00875550|12869696|P2|NOT COMPLETED|Overall Study||10
5234330|NCT00875550|12869697|P1|NOT COMPLETED|Overall Study||12
5234331|NCT00875550|12869696|P2|COMPLETED|Overall Study||76
5234332|NCT00875550|12869697|P1|COMPLETED|Overall Study||77
5234333|NCT00875550|12869696|P2|STARTED|Overall Study||86
5234334|NCT00875550|12869697|P1|STARTED|Overall Study||89
5234335|NCT00875524|12869715|P2|NOT COMPLETED|Overall Study||6
5234336|NCT00875524|12869716|P1|NOT COMPLETED|Overall Study||8
5234337|NCT00875524|12869715|P2|COMPLETED|Overall Study||54
5234338|NCT00875524|12869716|P1|COMPLETED|Overall Study||112
5234339|NCT00875524|12869715|P2|Received Vaccination 3|Overall Study||58
5234340|NCT00875524|12869716|P1|Received Vaccination 3|Overall Study||114
5234341|NCT00875524|12869715|P2|Received Vaccination 2|Overall Study||58
5234342|NCT00875524|12869716|P1|Received Vaccination 2|Overall Study||116
5234343|NCT00875524|12869715|P2|Received Vaccination 1|Overall Study||60
5234344|NCT00875524|12869716|P1|Received Vaccination 1|Overall Study||120
5234345|NCT00875524|12869715|P2|STARTED|Overall Study||60
5234346|NCT00875524|12869716|P1|STARTED|Overall Study||120
5234347|NCT00875485|12869734|P2|NOT COMPLETED|Challenge Dose Epoch||0
5234348|NCT00875485|12869735|P1|NOT COMPLETED|Challenge Dose Epoch||1
5234349|NCT00875485|12869734|P2|COMPLETED|Challenge Dose Epoch||11
5234350|NCT00875485|12869735|P1|COMPLETED|Challenge Dose Epoch||7
5234351|NCT00875485|12869734|P2|STARTED|Challenge Dose Epoch||11
5234352|NCT00875485|12869735|P1|STARTED|Challenge Dose Epoch||8
5234353|NCT00875485|12869734|P2|NOT COMPLETED|Year 15||0
5234354|NCT00875485|12869735|P1|NOT COMPLETED|Year 15||0
5234355|NCT00875485|12869734|P2|COMPLETED|Year 15||111
5234356|NCT00875485|12869735|P1|COMPLETED|Year 15||98
5234357|NCT00875485|12869734|P2|STARTED|Year 15||111
5234358|NCT00875485|12869735|P1|STARTED|Year 15||98
5234359|NCT00875485|12869734|P2|NOT COMPLETED|Year 14||0
5234360|NCT00875485|12869735|P1|NOT COMPLETED|Year 14||0
5234361|NCT00875485|12869734|P2|COMPLETED|Year 14||113
5234362|NCT00875485|12869735|P1|COMPLETED|Year 14||100
5234363|NCT00875485|12869734|P2|STARTED|Year 14||113
5234364|NCT00875485|12869735|P1|STARTED|Year 14||100
5234365|NCT00875485|12869734|P2|NOT COMPLETED|Year 13||0
5234366|NCT00875485|12869735|P1|NOT COMPLETED|Year 13||0
5234367|NCT00875485|12869734|P2|COMPLETED|Year 13||113
5234368|NCT00875485|12869735|P1|COMPLETED|Year 13||102
5234369|NCT00875485|12869734|P2|STARTED|Year 13||113
5234370|NCT00875485|12869735|P1|STARTED|Year 13||102
5234371|NCT00875485|12869734|P2|NOT COMPLETED|Year 12||0
5234372|NCT00875485|12869735|P1|NOT COMPLETED|Year 12||0
5234373|NCT00875485|12869734|P2|COMPLETED|Year 12||109
5234374|NCT00875485|12869735|P1|COMPLETED|Year 12||101
5234375|NCT00875485|12869734|P2|STARTED|Year 12||109
5234376|NCT00875485|12869735|P1|STARTED|Year 12||101
5234377|NCT00875485|12869734|P2|NOT COMPLETED|Year 11||0
5234378|NCT00875485|12869735|P1|NOT COMPLETED|Year 11||0
5234379|NCT00875485|12869734|P2|COMPLETED|Year 11||111
5234380|NCT00875485|12869735|P1|COMPLETED|Year 11||99
5234381|NCT00875485|12869734|P2|STARTED|Year 11||111
5234382|NCT00875485|12869735|P1|STARTED|Year 11||99
5234383|NCT00875433|12869775|P1|NOT COMPLETED|Overall Study||60
5234384|NCT00875433|12869775|P1|COMPLETED|Overall Study||0
5234385|NCT00875433|12869775|P1|STARTED|Overall Study|Treated|60
5234386|NCT00875420|12869805|P5|NOT COMPLETED|Overall Study||2
5234387|NCT00875420|12869806|P4|NOT COMPLETED|Overall Study||2
5234388|NCT00875420|12869807|P3|NOT COMPLETED|Overall Study||3
5234389|NCT00875420|12869808|P2|NOT COMPLETED|Overall Study||2
5234390|NCT00875420|12869809|P1|NOT COMPLETED|Overall Study||2
5234391|NCT00875420|12869805|P5|COMPLETED|Overall Study||17
5234392|NCT00875420|12869806|P4|COMPLETED|Overall Study||16
5234393|NCT00875420|12869807|P3|COMPLETED|Overall Study||18
5234394|NCT00875420|12869808|P2|COMPLETED|Overall Study||18
5234395|NCT00875420|12869809|P1|COMPLETED|Overall Study||20
5234396|NCT00875420|12869805|P5|STARTED|Overall Study||19
5234397|NCT00875420|12869806|P4|STARTED|Overall Study||18
5234398|NCT00875420|12869807|P3|STARTED|Overall Study||21
5234399|NCT00875420|12869808|P2|STARTED|Overall Study||20
5234400|NCT00875420|12869809|P1|STARTED|Overall Study||22
5234401|NCT00875394|12869839|P3|NOT COMPLETED|Overall Study||0
5234402|NCT00875394|12869840|P2|NOT COMPLETED|Overall Study||0
5234403|NCT00875394|12869841|P1|NOT COMPLETED|Overall Study||0
5234404|NCT00875394|12869839|P3|COMPLETED|Overall Study||9
5234405|NCT00875394|12869840|P2|COMPLETED|Overall Study||23
5234406|NCT00875394|12869841|P1|COMPLETED|Overall Study||36
5234407|NCT00875394|12869839|P3|STARTED|Overall Study||9
5234408|NCT00875394|12869840|P2|STARTED|Overall Study||23
5234409|NCT00875394|12869841|P1|STARTED|Overall Study||36
5234410|NCT00875329|12869849|P1|NOT COMPLETED|Overall Study||0
5234411|NCT00875329|12869849|P1|COMPLETED|Overall Study||97
5234412|NCT00875329|12869849|P1|STARTED|Overall Study||97
5234413|NCT00875277|12869853|P1|NOT COMPLETED|Overall Study||0
5234414|NCT00875277|12869853|P1|COMPLETED|Overall Study||24
5234415|NCT00875277|12869853|P1|STARTED|Overall Study||24
5234416|NCT00875212|12869934|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
5234417|NCT00875212|12869934|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
5234418|NCT00875212|12869934|P1|STARTED|CaGP and Fluoride Dentifrice||12
5234419|NCT00875212|12869934|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
5234420|NCT00875212|12869934|P1|COMPLETED|Fluoride Only Dentifrice||12
5234421|NCT00875212|12869934|P1|STARTED|Fluoride Only Dentifrice||12
5234422|NCT00875212|12869934|P1|NOT COMPLETED|CaGP Only Dentifrice||0
5234423|NCT00875212|12869934|P1|COMPLETED|CaGP Only Dentifrice||12
5234424|NCT00875212|12869934|P1|STARTED|CaGP Only Dentifrice||12
5234425|NCT00875212|12869934|P1|NOT COMPLETED|Placebo Dentifrice||0
5234426|NCT00875212|12869934|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
5234427|NCT00875212|12869934|P1|STARTED|Placebo Dentifrice||12
5234428|NCT00875017|12869951|P6|NOT COMPLETED|Fourth Intervention||1
5234429|NCT00875017|12869952|P5|NOT COMPLETED|Fourth Intervention||0
5234430|NCT00875017|12869953|P4|NOT COMPLETED|Fourth Intervention||0
5234431|NCT00875017|12869954|P3|NOT COMPLETED|Fourth Intervention||0
5234432|NCT00875017|12869955|P2|NOT COMPLETED|Fourth Intervention||0
5234433|NCT00875017|12869956|P1|NOT COMPLETED|Fourth Intervention||0
5234434|NCT00875017|12869951|P6|COMPLETED|Fourth Intervention||4
5234435|NCT00875017|12869952|P5|COMPLETED|Fourth Intervention||3
5234436|NCT00875017|12869953|P4|COMPLETED|Fourth Intervention||4
5234437|NCT00875017|12869954|P3|COMPLETED|Fourth Intervention||2
5234438|NCT00875017|12869955|P2|COMPLETED|Fourth Intervention||3
5234439|NCT00875017|12869956|P1|COMPLETED|Fourth Intervention||3
5234440|NCT00875017|12869951|P6|STARTED|Fourth Intervention||5
5234441|NCT00875017|12869952|P5|STARTED|Fourth Intervention||3
5234442|NCT00875017|12869953|P4|STARTED|Fourth Intervention||4
5234443|NCT00875017|12869954|P3|STARTED|Fourth Intervention||2
5234444|NCT00875017|12869955|P2|STARTED|Fourth Intervention||3
5234445|NCT00875017|12869956|P1|STARTED|Fourth Intervention||3
5234446|NCT00875017|12869951|P6|NOT COMPLETED|Washout||0
5234447|NCT00875017|12869952|P5|NOT COMPLETED|Washout||1
5234448|NCT00875017|12869953|P4|NOT COMPLETED|Washout||0
5234449|NCT00875017|12869954|P3|NOT COMPLETED|Washout||0
5234450|NCT00875017|12869955|P2|NOT COMPLETED|Washout||0
5234451|NCT00875017|12869956|P1|NOT COMPLETED|Washout||0
5234452|NCT00875017|12869951|P6|COMPLETED|Washout||5
5234453|NCT00875017|12869952|P5|COMPLETED|Washout||3
5234454|NCT00875017|12869953|P4|COMPLETED|Washout||4
5234455|NCT00875017|12869954|P3|COMPLETED|Washout||2
5234456|NCT00875017|12869955|P2|COMPLETED|Washout||3
5234457|NCT00875017|12869956|P1|COMPLETED|Washout||3
5234458|NCT00875017|12869951|P6|STARTED|Washout||5
5234459|NCT00875017|12869952|P5|STARTED|Washout||4
5234460|NCT00875017|12869953|P4|STARTED|Washout||4
5234461|NCT00875017|12869954|P3|STARTED|Washout||2
5234462|NCT00875017|12869955|P2|STARTED|Washout||3
5234463|NCT00875017|12869956|P1|STARTED|Washout||3
5234464|NCT00875017|12869951|P6|NOT COMPLETED|Third Intervention||0
5234465|NCT00875017|12869952|P5|NOT COMPLETED|Third Intervention||0
5234466|NCT00875017|12869953|P4|NOT COMPLETED|Third Intervention||0
5234467|NCT00875017|12869954|P3|NOT COMPLETED|Third Intervention||1
5234468|NCT00875017|12869955|P2|NOT COMPLETED|Third Intervention||1
5234469|NCT00875017|12869956|P1|NOT COMPLETED|Third Intervention||0
5234470|NCT00875017|12869951|P6|COMPLETED|Third Intervention||5
5234471|NCT00875017|12869952|P5|COMPLETED|Third Intervention||4
5234472|NCT00875017|12869953|P4|COMPLETED|Third Intervention||4
5234473|NCT00875017|12869954|P3|COMPLETED|Third Intervention||2
5234474|NCT00875017|12869955|P2|COMPLETED|Third Intervention||3
5234475|NCT00875017|12869956|P1|COMPLETED|Third Intervention||3
5234476|NCT00875017|12869951|P6|STARTED|Third Intervention||5
5234477|NCT00875017|12869952|P5|STARTED|Third Intervention||4
5234478|NCT00875017|12869953|P4|STARTED|Third Intervention||4
5234479|NCT00875017|12869954|P3|STARTED|Third Intervention||3
5234480|NCT00875017|12869955|P2|STARTED|Third Intervention||4
5234481|NCT00875017|12869956|P1|STARTED|Third Intervention||3
5234482|NCT00875017|12869951|P6|NOT COMPLETED|Washout||0
5234483|NCT00875017|12869952|P5|NOT COMPLETED|Washout||0
5234484|NCT00875017|12869953|P4|NOT COMPLETED|Washout||0
5234485|NCT00875017|12869954|P3|NOT COMPLETED|Washout||0
5234486|NCT00875017|12869955|P2|NOT COMPLETED|Washout||1
5234487|NCT00875017|12869956|P1|NOT COMPLETED|Washout||0
5234488|NCT00875017|12869951|P6|COMPLETED|Washout||5
5234489|NCT00875017|12869952|P5|COMPLETED|Washout||4
5234490|NCT00875017|12869953|P4|COMPLETED|Washout||4
5234491|NCT00875017|12869954|P3|COMPLETED|Washout||3
5234492|NCT00875017|12869955|P2|COMPLETED|Washout||4
5234493|NCT00875017|12869956|P1|COMPLETED|Washout||3
5234494|NCT00875017|12869951|P6|STARTED|Washout||5
5234495|NCT00875017|12869952|P5|STARTED|Washout||4
5234496|NCT00875017|12869953|P4|STARTED|Washout||4
5234497|NCT00875017|12869954|P3|STARTED|Washout||3
5234498|NCT00875017|12869955|P2|STARTED|Washout||5
5234499|NCT00875017|12869956|P1|STARTED|Washout||3
5234500|NCT00875017|12869951|P6|NOT COMPLETED|Second Intervention||0
5234501|NCT00875017|12869952|P5|NOT COMPLETED|Second Intervention||0
5234502|NCT00875017|12869953|P4|NOT COMPLETED|Second Intervention||1
5234503|NCT00875017|12869954|P3|NOT COMPLETED|Second Intervention||0
5234504|NCT00875017|12869955|P2|NOT COMPLETED|Second Intervention||0
5234505|NCT00875017|12869956|P1|NOT COMPLETED|Second Intervention||0
5234506|NCT00875017|12869951|P6|COMPLETED|Second Intervention||5
5234507|NCT00875017|12869952|P5|COMPLETED|Second Intervention||4
5234508|NCT00875017|12869953|P4|COMPLETED|Second Intervention||4
5234509|NCT00875017|12869954|P3|COMPLETED|Second Intervention||3
5234510|NCT00875017|12869955|P2|COMPLETED|Second Intervention||5
5234511|NCT00875017|12869956|P1|COMPLETED|Second Intervention||3
5234512|NCT00875017|12869951|P6|STARTED|Second Intervention||5
5234513|NCT00875017|12869952|P5|STARTED|Second Intervention||4
5234514|NCT00875017|12869953|P4|STARTED|Second Intervention||5
5234515|NCT00875017|12869954|P3|STARTED|Second Intervention||3
5234516|NCT00875017|12869955|P2|STARTED|Second Intervention||5
5234517|NCT00875017|12869956|P1|STARTED|Second Intervention||3
5234518|NCT00875017|12869951|P6|NOT COMPLETED|Washout||0
5234519|NCT00875017|12869952|P5|NOT COMPLETED|Washout||0
5234520|NCT00875017|12869953|P4|NOT COMPLETED|Washout||0
5234521|NCT00875017|12869954|P3|NOT COMPLETED|Washout||1
5234522|NCT00875017|12869955|P2|NOT COMPLETED|Washout||0
5234523|NCT00875017|12869956|P1|NOT COMPLETED|Washout||0
5234524|NCT00875017|12869951|P6|COMPLETED|Washout||5
5234525|NCT00875017|12869952|P5|COMPLETED|Washout||4
5234526|NCT00875017|12869953|P4|COMPLETED|Washout||5
5234527|NCT00875017|12869954|P3|COMPLETED|Washout||3
5234528|NCT00875017|12869955|P2|COMPLETED|Washout||5
5234529|NCT00875017|12869956|P1|COMPLETED|Washout||3
5234530|NCT00875017|12869951|P6|STARTED|Washout||5
5234531|NCT00875017|12869952|P5|STARTED|Washout||4
5234532|NCT00875017|12869953|P4|STARTED|Washout||5
5234533|NCT00875017|12869954|P3|STARTED|Washout||4
5234534|NCT00875017|12869955|P2|STARTED|Washout||5
5234535|NCT00875017|12869956|P1|STARTED|Washout||3
5234536|NCT00875017|12869951|P6|NOT COMPLETED|First Intervention||0
5234537|NCT00875017|12869952|P5|NOT COMPLETED|First Intervention||1
5234538|NCT00875017|12869953|P4|NOT COMPLETED|First Intervention||1
5234539|NCT00875017|12869954|P3|NOT COMPLETED|First Intervention||1
5234540|NCT00875017|12869955|P2|NOT COMPLETED|First Intervention||0
5234541|NCT00875017|12869956|P1|NOT COMPLETED|First Intervention||2
5234542|NCT00875017|12869951|P6|COMPLETED|First Intervention||5
5234543|NCT00875017|12869952|P5|COMPLETED|First Intervention||4
5234544|NCT00875017|12869953|P4|COMPLETED|First Intervention||5
5234545|NCT00875017|12869954|P3|COMPLETED|First Intervention||4
5234546|NCT00875017|12869955|P2|COMPLETED|First Intervention||5
5234547|NCT00875017|12869956|P1|COMPLETED|First Intervention||3
5234548|NCT00875017|12869951|P6|STARTED|First Intervention||5
5234549|NCT00875017|12869952|P5|STARTED|First Intervention||5
5234550|NCT00875017|12869953|P4|STARTED|First Intervention||6
5234551|NCT00875017|12869954|P3|STARTED|First Intervention||5
5234552|NCT00875017|12869955|P2|STARTED|First Intervention||5
5234553|NCT00875017|12869956|P1|STARTED|First Intervention||5
5234554|NCT00874939|12869970|P1|NOT COMPLETED|Overall Study||4
5234555|NCT00874939|12869970|P1|COMPLETED|Overall Study||0
5234556|NCT00874939|12869970|P1|Treated|Overall Study||0
5234557|NCT00874939|12869970|P1|STARTED|Overall Study||4
5234558|NCT00874887|12869986|P2|NOT COMPLETED|Overall Study||0
5234559|NCT00874887|12869987|P1|NOT COMPLETED|Overall Study||0
5234560|NCT00874887|12869986|P2|COMPLETED|Overall Study||34
5234561|NCT00874887|12869987|P1|COMPLETED|Overall Study||32
5234562|NCT00874887|12869986|P2|STARTED|Overall Study||34
5234563|NCT00874887|12869987|P1|STARTED|Overall Study||32
5234564|NCT00874848|12870003|P2|NOT COMPLETED|Overall Study||28
5234565|NCT00874848|12870004|P1|NOT COMPLETED|Overall Study||59
5234566|NCT00874848|12870003|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
5234567|NCT00874848|12870004|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
5234568|NCT00874848|12870003|P2|Discontinued|Overall Study||28
5234569|NCT00874848|12870004|P1|Discontinued|Overall Study||59
5234570|NCT00874848|12870003|P2|STARTED|Overall Study||29
5234571|NCT00874848|12870004|P1|STARTED|Overall Study||59
5234572|NCT00874822|12870020|P1|NOT COMPLETED|Overall Study||8
5234573|NCT00874822|12870020|P1|COMPLETED|Overall Study||208
5234574|NCT00874822|12870020|P1|STARTED|Overall Study||216
5234575|NCT00874770|12870028|P4|NOT COMPLETED|Overall Study||5
5234576|NCT00874770|12870029|P3|NOT COMPLETED|Overall Study||4
5234577|NCT00874770|12870030|P2|NOT COMPLETED|Overall Study||1
5234578|NCT00874770|12870031|P1|NOT COMPLETED|Overall Study||5
5234579|NCT00874770|12870028|P4|COMPLETED|Overall Study||7
5234580|NCT00874770|12870029|P3|COMPLETED|Overall Study||8
5234581|NCT00874770|12870030|P2|COMPLETED|Overall Study||11
5234582|NCT00874770|12870031|P1|COMPLETED|Overall Study||7
5234583|NCT00874770|12870028|P4|STARTED|Overall Study||12
5234584|NCT00874770|12870029|P3|STARTED|Overall Study||12
5234585|NCT00874770|12870030|P2|STARTED|Overall Study||12
5234586|NCT00874770|12870031|P1|STARTED|Overall Study||12
5234587|NCT00874731|12870065|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
5234588|NCT00874731|12870066|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
5234589|NCT00874731|12870067|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
5234590|NCT00874731|12870065|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
5234591|NCT00874731|12870066|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
5234592|NCT00874731|12870067|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
5234593|NCT00874731|12870065|P3|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, started this period in “Pt 2. Ridaforolimus 40 mg” arm.|22
5234594|NCT00874731|12870066|P2|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, enter into the “Pt 2. Ridaforolimus 40 mg” arm.|0
5234595|NCT00874731|12870067|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
5234596|NCT00874731|12870065|P3|NOT COMPLETED|Washout Period||0
5234597|NCT00874731|12870066|P2|NOT COMPLETED|Washout Period||0
5234598|NCT00874731|12870067|P1|NOT COMPLETED|Washout Period||0
5234599|NCT00874731|12870065|P3|COMPLETED|Washout Period||0
5234600|NCT00874731|12870066|P2|COMPLETED|Washout Period||22
5234601|NCT00874731|12870067|P1|COMPLETED|Washout Period||0
5234602|NCT00874731|12870065|P3|STARTED|Washout Period||0
5234603|NCT00874731|12870066|P2|STARTED|Washout Period||22
5234604|NCT00874731|12870067|P1|STARTED|Washout Period||0
5234605|NCT00874731|12870065|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234606|NCT00874731|12870066|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234607|NCT00874731|12870067|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234608|NCT00874731|12870065|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234609|NCT00874731|12870066|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
5234610|NCT00874731|12870067|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234611|NCT00874731|12870065|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
5234612|NCT00874731|12870066|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, started this period in “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|22
5234613|NCT00874731|12870067|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, enter into the “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|0
5234614|NCT00874731|12870065|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
5234615|NCT00874731|12870066|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
5234616|NCT00874731|12870067|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
5234617|NCT00874731|12870065|P3|COMPLETED|Part 1, Day 1: Placebo||0
5234618|NCT00874731|12870066|P2|COMPLETED|Part 1, Day 1: Placebo||0
5234619|NCT00874731|12870067|P1|COMPLETED|Part 1, Day 1: Placebo||22
5234620|NCT00874731|12870065|P3|STARTED|Part 1, Day 1: Placebo||0
5234621|NCT00874731|12870066|P2|STARTED|Part 1, Day 1: Placebo||0
5234622|NCT00874731|12870067|P1|STARTED|Part 1, Day 1: Placebo||23
5234623|NCT00874614|12870096|P1|NOT COMPLETED|Overall Study||58
5234624|NCT00874614|12870096|P1|COMPLETED|Overall Study|As of December 2017|16
5234625|NCT00874614|12870096|P1|Received Two Therapeutic Doses|Overall Study||50
5234626|NCT00874614|12870096|P1|Received at Least One Therapeutic Dose|Overall Study||68
5234627|NCT00874614|12870096|P1|STARTED|Overall Study||74
5234628|NCT00874549|12870108|P4|NOT COMPLETED|Overall Study||2
5234629|NCT00874549|12870109|P3|NOT COMPLETED|Overall Study||4
5234630|NCT00874549|12870110|P2|NOT COMPLETED|Overall Study||1
5234631|NCT00874549|12870111|P1|NOT COMPLETED|Overall Study||1
5234632|NCT00874549|12870108|P4|COMPLETED|Overall Study||56
5234633|NCT00874549|12870109|P3|COMPLETED|Overall Study||47
5234634|NCT00874549|12870110|P2|COMPLETED|Overall Study||55
5234635|NCT00874549|12870111|P1|COMPLETED|Overall Study||50
5234636|NCT00874549|12870108|P4|STARTED|Overall Study||58
5234637|NCT00874549|12870109|P3|STARTED|Overall Study||51
5234638|NCT00874549|12870110|P2|STARTED|Overall Study||56
5234639|NCT00874549|12870111|P1|STARTED|Overall Study||51
5234640|NCT00874510|12870179|P2|NOT COMPLETED|Year 2||0
5234641|NCT00874510|12870180|P1|NOT COMPLETED|Year 2||0
5234642|NCT00874510|12870179|P2|COMPLETED|Year 2||87
5234643|NCT00874510|12870180|P1|COMPLETED|Year 2||92
5234644|NCT00874510|12870179|P2|STARTED|Year 2||87
5234645|NCT00874510|12870180|P1|STARTED|Year 2||92
5234646|NCT00874510|12870179|P2|NOT COMPLETED|Year 1||0
5234647|NCT00874510|12870180|P1|NOT COMPLETED|Year 1||0
5234648|NCT00874510|12870179|P2|COMPLETED|Year 1||85
5234649|NCT00874510|12870180|P1|COMPLETED|Year 1||88
5234650|NCT00874510|12870179|P2|STARTED|Year 1||85
5234651|NCT00874510|12870180|P1|STARTED|Year 1||88
5234652|NCT00874497|12870188|P2|NOT COMPLETED|Overall Study||18
5234653|NCT00874497|12870189|P1|NOT COMPLETED|Overall Study||28
5234654|NCT00874497|12870188|P2|COMPLETED|Overall Study||15
5234655|NCT00874497|12870189|P1|COMPLETED|Overall Study||23
5234656|NCT00874497|12870188|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
5234657|NCT00874497|12870189|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
5234658|NCT00874276|12870229|P2|NOT COMPLETED|Overall Study||1
5234659|NCT00874276|12870230|P1|NOT COMPLETED|Overall Study||1
5234660|NCT00874276|12870229|P2|COMPLETED|Overall Study||7
5234661|NCT00874276|12870230|P1|COMPLETED|Overall Study||5
5234662|NCT00874276|12870229|P2|STARTED|Overall Study||8
5234663|NCT00874276|12870230|P1|STARTED|Overall Study||6
5234664|NCT00874250|12870238|P1|NOT COMPLETED|Overall Study||51
5234665|NCT00874250|12870238|P1|COMPLETED|Overall Study||0
5234666|NCT00874250|12870238|P1|STARTED|Overall Study||51
5234667|NCT00874237|12870250|P6|NOT COMPLETED|Overall Study||0
5234668|NCT00874237|12870251|P5|NOT COMPLETED|Overall Study||0
5234669|NCT00874237|12870252|P4|NOT COMPLETED|Overall Study||0
5234670|NCT00874237|12870253|P3|NOT COMPLETED|Overall Study||1
5234671|NCT00874237|12870254|P2|NOT COMPLETED|Overall Study||1
5234672|NCT00874237|12870255|P1|NOT COMPLETED|Overall Study||0
5234673|NCT00874237|12870250|P6|COMPLETED|Overall Study||8
5234674|NCT00874237|12870251|P5|COMPLETED|Overall Study||8
5234675|NCT00874237|12870252|P4|COMPLETED|Overall Study||8
5234676|NCT00874237|12870253|P3|COMPLETED|Overall Study||7
5234677|NCT00874237|12870254|P2|COMPLETED|Overall Study||7
5234678|NCT00874237|12870255|P1|COMPLETED|Overall Study||8
5234679|NCT00874237|12870250|P6|STARTED|Overall Study||8
5234680|NCT00874237|12870251|P5|STARTED|Overall Study||8
5234681|NCT00874237|12870252|P4|STARTED|Overall Study||8
5234682|NCT00874237|12870253|P3|STARTED|Overall Study||8
5234683|NCT00874237|12870254|P2|STARTED|Overall Study||8
5234684|NCT00874237|12870255|P1|STARTED|Overall Study||8
5234685|NCT00874120|12870273|P2|NOT COMPLETED|Second Intervention||0
5234686|NCT00874120|12870274|P1|NOT COMPLETED|Second Intervention||2
5234687|NCT00874120|12870273|P2|COMPLETED|Second Intervention||56
5234688|NCT00874120|12870274|P1|COMPLETED|Second Intervention||50
5234689|NCT00874120|12870273|P2|STARTED|Second Intervention||56
5234690|NCT00874120|12870274|P1|STARTED|Second Intervention||52
5234691|NCT00874120|12870273|P2|NOT COMPLETED|Wash-out Period||0
5234692|NCT00874120|12870274|P1|NOT COMPLETED|Wash-out Period||0
5234693|NCT00874120|12870273|P2|COMPLETED|Wash-out Period||56
5234694|NCT00874120|12870274|P1|COMPLETED|Wash-out Period||52
5234695|NCT00874120|12870273|P2|STARTED|Wash-out Period||56
5234696|NCT00874120|12870274|P1|STARTED|Wash-out Period||52
5234697|NCT00874120|12870273|P2|NOT COMPLETED|First Intervention||2
5234698|NCT00874120|12870274|P1|NOT COMPLETED|First Intervention||6
5234699|NCT00874120|12870273|P2|COMPLETED|First Intervention||56
5234700|NCT00874120|12870274|P1|COMPLETED|First Intervention||52
5234701|NCT00874120|12870273|P2|STARTED|First Intervention||58
5234702|NCT00874120|12870274|P1|STARTED|First Intervention||58
5234703|NCT00874094|12870280|P1|NOT COMPLETED|Overall Study||0
5234704|NCT00874094|12870280|P1|COMPLETED|Overall Study||15
5234705|NCT00874094|12870280|P1|STARTED|Overall Study||15
5234706|NCT00874029|12870287|P1|NOT COMPLETED|Overall Study||21
5234707|NCT00874029|12870287|P1|COMPLETED|Overall Study||116
5234708|NCT00874029|12870287|P1|STARTED|Overall Study||137
5234709|NCT00873912|12870303|P2|NOT COMPLETED|Overall Study||0
5234710|NCT00873912|12870304|P1|NOT COMPLETED|Overall Study||3
5234711|NCT00873912|12870303|P2|COMPLETED|Overall Study||60
5234712|NCT00873912|12870304|P1|COMPLETED|Overall Study||237
5234713|NCT00873912|12870303|P2|STARTED|Overall Study||60
5234714|NCT00873912|12870304|P1|STARTED|Overall Study||240
5234715|NCT00873873|12870322|P4|NOT COMPLETED|Overall Study||0
5234716|NCT00873873|12870323|P3|NOT COMPLETED|Overall Study||0
5234717|NCT00873873|12870324|P2|NOT COMPLETED|Overall Study||0
5234718|NCT00873873|12870325|P1|NOT COMPLETED|Overall Study||0
5234719|NCT00873873|12870322|P4|COMPLETED|Overall Study||18
5234720|NCT00873873|12870323|P3|COMPLETED|Overall Study||9
5234721|NCT00873873|12870324|P2|COMPLETED|Overall Study||8
5234722|NCT00873873|12870325|P1|COMPLETED|Overall Study||20
5234723|NCT00873873|12870322|P4|STARTED|Overall Study||18
5234724|NCT00873873|12870323|P3|STARTED|Overall Study||9
5234725|NCT00873873|12870324|P2|STARTED|Overall Study||8
5234726|NCT00873873|12870325|P1|STARTED|Overall Study||20
5234727|NCT00873860|12870343|P4|NOT COMPLETED|Overall Study||1
5234728|NCT00873860|12870344|P3|NOT COMPLETED|Overall Study||3
5234729|NCT00873860|12870345|P2|NOT COMPLETED|Overall Study||0
5234730|NCT00873860|12870346|P1|NOT COMPLETED|Overall Study||4
5234731|NCT00873860|12870343|P4|COMPLETED|Overall Study||47
5234732|NCT00873860|12870344|P3|COMPLETED|Overall Study||48
5234733|NCT00873860|12870345|P2|COMPLETED|Overall Study||47
5234734|NCT00873860|12870346|P1|COMPLETED|Overall Study||44
5234735|NCT00873860|12870343|P4|Treated|Overall Study||48
5234736|NCT00873860|12870344|P3|Treated|Overall Study||51
5234737|NCT00873860|12870345|P2|Treated|Overall Study||47
5234738|NCT00873860|12870346|P1|Treated|Overall Study||47
5234739|NCT00873860|12870343|P4|STARTED|Overall Study||48
5234740|NCT00873860|12870344|P3|STARTED|Overall Study||51
5234741|NCT00873860|12870345|P2|STARTED|Overall Study||47
5234742|NCT00873860|12870346|P1|STARTED|Overall Study||48
5234743|NCT00873821|12870417|P2|NOT COMPLETED|Overall Study||0
5234744|NCT00873821|12870418|P1|NOT COMPLETED|Overall Study||0
5234745|NCT00873821|12870417|P2|COMPLETED|Overall Study||22
5234746|NCT00873821|12870418|P1|COMPLETED|Overall Study||22
5234747|NCT00873821|12870417|P2|STARTED|Overall Study||22
5234748|NCT00873821|12870418|P1|STARTED|Overall Study||22
5234749|NCT00873782|12870428|P1|NOT COMPLETED|Overall Study||0
5234750|NCT00873782|12870428|P1|COMPLETED|Overall Study||16
5234751|NCT00873782|12870428|P1|STARTED|Overall Study||16
5234752|NCT00873730|12870434|P2|NOT COMPLETED|Overall Study||5
5234753|NCT00873730|12870435|P1|NOT COMPLETED|Overall Study||6
5234754|NCT00873730|12870434|P2|COMPLETED|Overall Study||49
5234755|NCT00873730|12870435|P1|COMPLETED|Overall Study||48
5234756|NCT00873730|12870434|P2|STARTED|Overall Study||54
5234757|NCT00873730|12870435|P1|STARTED|Overall Study||54
5234758|NCT00873457|12870471|P1|NOT COMPLETED|Overall Study||0
5234759|NCT00873457|12870471|P1|COMPLETED|Overall Study||16
5234760|NCT00873457|12870471|P1|STARTED|Overall Study||16
5234761|NCT00873366|12870478|P1|NOT COMPLETED|Overall Study||6
5234762|NCT00873366|12870478|P1|COMPLETED|Overall Study||71
5234763|NCT00873366|12870478|P1|STARTED|Overall Study||77
5234764|NCT00873327|12870497|P1|NOT COMPLETED|Overall Study||0
5234765|NCT00873327|12870497|P1|COMPLETED|Overall Study||32
5234766|NCT00873327|12870497|P1|STARTED|Overall Study||32
5234767|NCT00873119|12870503|P2|NOT COMPLETED|Overall Study||26
5234768|NCT00873119|12870504|P1|NOT COMPLETED|Overall Study||44
5234769|NCT00873119|12870503|P2|COMPLETED|Overall Study||19
5234770|NCT00873119|12870504|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
5234771|NCT00873119|12870503|P2|STARTED|Overall Study||45
5234772|NCT00873119|12870504|P1|STARTED|Overall Study||44
5234773|NCT00873093|12870525|P5|NOT COMPLETED|Overall Study||2
5234774|NCT00873093|12870526|P4|NOT COMPLETED|Overall Study||11
5234775|NCT00873093|12870527|P3|NOT COMPLETED|Overall Study||16
5234776|NCT00873093|12870528|P2|NOT COMPLETED|Overall Study||27
5234777|NCT00873093|12870529|P1|NOT COMPLETED|Overall Study||1
5234778|NCT00873093|12870525|P5|COMPLETED|Overall Study||8
5234779|NCT00873093|12870526|P4|COMPLETED|Overall Study||12
5234780|NCT00873093|12870527|P3|COMPLETED|Overall Study||33
5234781|NCT00873093|12870528|P2|COMPLETED|Overall Study||35
5234782|NCT00873093|12870529|P1|COMPLETED|Overall Study||3
5234783|NCT00873093|12870525|P5|STARTED|Overall Study||10
5234784|NCT00873093|12870526|P4|STARTED|Overall Study||23
5234785|NCT00873093|12870527|P3|STARTED|Overall Study||49
5234786|NCT00873093|12870528|P2|STARTED|Overall Study||62
5234787|NCT00873093|12870529|P1|STARTED|Overall Study||4
5234788|NCT00873041|12870586|P3|NOT COMPLETED|Extension Study||2
5234789|NCT00873041|12870587|P2|NOT COMPLETED|Extension Study||0
5234790|NCT00873041|12870588|P1|NOT COMPLETED|Extension Study||1
5234791|NCT00873041|12870586|P3|COMPLETED|Extension Study||46
5234792|NCT00873041|12870587|P2|COMPLETED|Extension Study||44
5234793|NCT00873041|12870588|P1|COMPLETED|Extension Study||40
5234794|NCT00873041|12870586|P3|STARTED|Extension Study||48
5234795|NCT00873041|12870587|P2|STARTED|Extension Study||44
5234796|NCT00873041|12870588|P1|STARTED|Extension Study||41
5234797|NCT00873041|12870586|P3|NOT COMPLETED|Core Study||5
5234798|NCT00873041|12870587|P2|NOT COMPLETED|Core Study||6
5234799|NCT00873041|12870588|P1|NOT COMPLETED|Core Study||7
5234800|NCT00873041|12870586|P3|COMPLETED|Core Study||51
5234801|NCT00873041|12870587|P2|COMPLETED|Core Study||49
5234802|NCT00873041|12870588|P1|COMPLETED|Core Study||48
5234803|NCT00873041|12870586|P3|STARTED|Core Study||56
5234804|NCT00873041|12870587|P2|STARTED|Core Study||55
5234805|NCT00873041|12870588|P1|STARTED|Core Study||55
5234806|NCT00873015|12870646|P4|NOT COMPLETED|Overall Study||0
5234807|NCT00873015|12870647|P3|NOT COMPLETED|Overall Study||0
5234808|NCT00873015|12870648|P2|NOT COMPLETED|Overall Study||1
5234809|NCT00873015|12870649|P1|NOT COMPLETED|Overall Study||0
5234810|NCT00873015|12870646|P4|COMPLETED|Overall Study||3
5234811|NCT00873015|12870647|P3|COMPLETED|Overall Study||3
5234812|NCT00873015|12870648|P2|COMPLETED|Overall Study||3
5234813|NCT00873015|12870649|P1|COMPLETED|Overall Study||9
5234814|NCT00873015|12870646|P4|STARTED|Overall Study||3
5234815|NCT00873015|12870647|P3|STARTED|Overall Study||3
5234816|NCT00873015|12870648|P2|STARTED|Overall Study||4
5234817|NCT00873015|12870649|P1|STARTED|Overall Study||9
5234818|NCT00872989|12870666|P2|NOT COMPLETED|Overall Study||63
5234819|NCT00872989|12870667|P1|NOT COMPLETED|Overall Study||65
5234820|NCT00872989|12870666|P2|COMPLETED|Overall Study||0
5234821|NCT00872989|12870667|P1|COMPLETED|Overall Study||1
5234822|NCT00872989|12870666|P2|STARTED|Overall Study||63
5234823|NCT00872989|12870667|P1|STARTED|Overall Study||66
5234824|NCT00872898|12870686|P2|NOT COMPLETED|Part Two - Double Blind||6
5234825|NCT00872898|12870687|P1|NOT COMPLETED|Part Two - Double Blind||11
5234826|NCT00872898|12870686|P2|COMPLETED|Part Two - Double Blind||54
5234827|NCT00872898|12870687|P1|COMPLETED|Part Two - Double Blind||50
5234828|NCT00872898|12870686|P2|STARTED|Part Two - Double Blind||60
5234829|NCT00872898|12870687|P1|STARTED|Part Two - Double Blind||61
5234830|NCT00872898|12870686|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
5234831|NCT00872898|12870687|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
5234832|NCT00872898|12870686|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
5234833|NCT00872898|12870687|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
5234834|NCT00872898|12870686|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
5234835|NCT00872898|12870687|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
5234836|NCT00872833|12870721|P2|NOT COMPLETED|Overall Study||0
5234837|NCT00872833|12870722|P1|NOT COMPLETED|Overall Study||0
5234838|NCT00872833|12870721|P2|COMPLETED|Overall Study||17
5234839|NCT00872833|12870722|P1|COMPLETED|Overall Study||15
5234840|NCT00872833|12870721|P2|STARTED|Overall Study||17
5234841|NCT00872833|12870722|P1|STARTED|Overall Study||15
5234842|NCT00872729|12870731|P1|NOT COMPLETED|Overall Study||0
5234843|NCT00872729|12870731|P1|COMPLETED|Overall Study||9
5234844|NCT00872729|12870731|P1|STARTED|Overall Study||9
5234845|NCT00872599|12870761|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
5234846|NCT00872599|12870762|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
5234847|NCT00872599|12870761|P2|COMPLETED|Second Drug During High Salt Intake||16
5234848|NCT00872599|12870762|P1|COMPLETED|Second Drug During High Salt Intake||15
5234849|NCT00872599|12870761|P2|STARTED|Second Drug During High Salt Intake||16
5234850|NCT00872599|12870762|P1|STARTED|Second Drug During High Salt Intake||15
5234851|NCT00872599|12870761|P2|NOT COMPLETED|Second Washout Period||1
5234852|NCT00872599|12870762|P1|NOT COMPLETED|Second Washout Period||1
5234853|NCT00872599|12870761|P2|COMPLETED|Second Washout Period||16
5234854|NCT00872599|12870762|P1|COMPLETED|Second Washout Period||15
5234855|NCT00872599|12870761|P2|STARTED|Second Washout Period||17
5234856|NCT00872599|12870762|P1|STARTED|Second Washout Period||16
5234857|NCT00872599|12870761|P2|NOT COMPLETED|First Drug During High Salt Intake||0
5234858|NCT00872599|12870762|P1|NOT COMPLETED|First Drug During High Salt Intake||0
5234859|NCT00872599|12870761|P2|COMPLETED|First Drug During High Salt Intake||17
5234860|NCT00872599|12870762|P1|COMPLETED|First Drug During High Salt Intake||16
5234861|NCT00872599|12870761|P2|STARTED|First Drug During High Salt Intake||17
5234862|NCT00872599|12870762|P1|STARTED|First Drug During High Salt Intake||16
5234863|NCT00872599|12870761|P2|NOT COMPLETED|First Washout Period After Low Salt||0
5234864|NCT00872599|12870762|P1|NOT COMPLETED|First Washout Period After Low Salt||0
5234865|NCT00872599|12870761|P2|COMPLETED|First Washout Period After Low Salt||17
5234866|NCT00872599|12870762|P1|COMPLETED|First Washout Period After Low Salt||16
5234867|NCT00872599|12870761|P2|STARTED|First Washout Period After Low Salt||17
5234868|NCT00872599|12870762|P1|STARTED|First Washout Period After Low Salt||16
5234869|NCT00872534|12870772|P2|NOT COMPLETED|Overall Study||3
5234870|NCT00872534|12870773|P1|NOT COMPLETED|Overall Study||3
5234871|NCT00872534|12870772|P2|COMPLETED|Overall Study||101
5234872|NCT00872534|12870773|P1|COMPLETED|Overall Study||97
5234873|NCT00872534|12870772|P2|STARTED|Overall Study||104
5234874|NCT00872534|12870773|P1|STARTED|Overall Study||100
5234875|NCT00872521|12870782|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
5234876|NCT00872521|12870783|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
5234877|NCT00872521|12870784|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
5234878|NCT00872521|12870782|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
5234879|NCT00872521|12870783|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
5234880|NCT00872521|12870784|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
5234881|NCT00872521|12870782|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
5234882|NCT00872521|12870783|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
5234883|NCT00872521|12870784|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
5234884|NCT00872521|12870782|P3|NOT COMPLETED|Completed 3-month Follow up||0
5234885|NCT00872521|12870783|P2|NOT COMPLETED|Completed 3-month Follow up||3
5234886|NCT00872521|12870784|P1|NOT COMPLETED|Completed 3-month Follow up||0
5234887|NCT00872521|12870782|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
5234888|NCT00872521|12870783|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
5234889|NCT00872521|12870784|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
5234890|NCT00872521|12870782|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
5234891|NCT00872521|12870783|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
5234892|NCT00872521|12870784|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
5234893|NCT00872521|12870782|P3|NOT COMPLETED|Primary Endpoint Analysis||1
5234894|NCT00872521|12870783|P2|NOT COMPLETED|Primary Endpoint Analysis||5
5234895|NCT00872521|12870784|P1|NOT COMPLETED|Primary Endpoint Analysis||1
5234896|NCT00872521|12870782|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
5234897|NCT00872521|12870783|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
5234898|NCT00872521|12870784|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
5234899|NCT00872521|12870782|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
5234900|NCT00872521|12870783|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
5234901|NCT00872521|12870784|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
5234902|NCT00872521|12870782|P3|NOT COMPLETED|Completed PAD Induction||0
5234903|NCT00872521|12870783|P2|NOT COMPLETED|Completed PAD Induction||4
5234904|NCT00872521|12870784|P1|NOT COMPLETED|Completed PAD Induction||5
5234905|NCT00872521|12870782|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
5234906|NCT00872521|12870783|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
5234907|NCT00872521|12870784|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
5234908|NCT00872521|12870782|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
5234909|NCT00872521|12870783|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
5234910|NCT00872521|12870784|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
5234911|NCT00872430|12870832|P2|NOT COMPLETED|Second Intervention||0
5234912|NCT00872430|12870833|P1|NOT COMPLETED|Second Intervention||0
5234913|NCT00872430|12870832|P2|COMPLETED|Second Intervention||10
5234914|NCT00872430|12870833|P1|COMPLETED|Second Intervention||10
5234915|NCT00872430|12870832|P2|STARTED|Second Intervention||10
5234916|NCT00872430|12870833|P1|STARTED|Second Intervention||10
5234917|NCT00872430|12870832|P2|NOT COMPLETED|Washout Period||0
5234918|NCT00872430|12870833|P1|NOT COMPLETED|Washout Period||0
5234919|NCT00872430|12870832|P2|COMPLETED|Washout Period||10
5234920|NCT00872430|12870833|P1|COMPLETED|Washout Period||10
5234921|NCT00872430|12870832|P2|STARTED|Washout Period||10
5234922|NCT00872430|12870833|P1|STARTED|Washout Period||10
5234923|NCT00872430|12870832|P2|NOT COMPLETED|First Intervention||0
5234924|NCT00872430|12870833|P1|NOT COMPLETED|First Intervention||0
5234925|NCT00872430|12870832|P2|COMPLETED|First Intervention||10
5234926|NCT00872430|12870833|P1|COMPLETED|First Intervention||10
5234927|NCT00872430|12870832|P2|STARTED|First Intervention||10
5234928|NCT00872430|12870833|P1|STARTED|First Intervention||10
5234929|NCT00872339|12870842|P3|NOT COMPLETED|Overall Study||0
5234930|NCT00872339|12870843|P2|NOT COMPLETED|Overall Study||0
5234931|NCT00872339|12870844|P1|NOT COMPLETED|Overall Study||0
5234932|NCT00872339|12870842|P3|COMPLETED|Overall Study||37
5234933|NCT00872339|12870843|P2|COMPLETED|Overall Study||14
5234934|NCT00872339|12870844|P1|COMPLETED|Overall Study||201
5234935|NCT00872339|12870842|P3|STARTED|Overall Study||37
5234936|NCT00872339|12870843|P2|STARTED|Overall Study||14
5234937|NCT00872339|12870844|P1|STARTED|Overall Study||201
5234938|NCT00872170|12870855|P2|NOT COMPLETED|Overall Study||0
5234939|NCT00872170|12870856|P1|NOT COMPLETED|Overall Study||1
5234940|NCT00872170|12870855|P2|COMPLETED|Overall Study||13
5234941|NCT00872170|12870856|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
5234942|NCT00872170|12870855|P2|STARTED|Overall Study||13
5234943|NCT00872170|12870856|P1|STARTED|Overall Study||14
5234944|NCT00872079|12870871|P1|NOT COMPLETED|Overall Study||0
5234945|NCT00872079|12870871|P1|COMPLETED|Overall Study||175
5234946|NCT00872079|12870871|P1|STARTED|Overall Study||175
5234947|NCT00872027|12870877|P2|NOT COMPLETED|Overall Study||0
5234948|NCT00872027|12870878|P1|NOT COMPLETED|Overall Study||0
5234949|NCT00872027|12870877|P2|COMPLETED|Overall Study||8
5234950|NCT00872027|12870878|P1|COMPLETED|Overall Study||7
5234951|NCT00872027|12870877|P2|STARTED|Overall Study||8
5234952|NCT00872027|12870878|P1|STARTED|Overall Study||7
5234953|NCT00872001|12870886|P2|NOT COMPLETED|Overall Study||131
5234954|NCT00872001|12870887|P1|NOT COMPLETED|Overall Study||136
5234955|NCT00872001|12870886|P2|COMPLETED|Overall Study||1413
5234956|NCT00872001|12870887|P1|COMPLETED|Overall Study||1400
5234957|NCT00872001|12870886|P2|STARTED|Overall Study||1544
5234958|NCT00872001|12870887|P1|STARTED|Overall Study||1536
5234959|NCT00871975|12870895|P1|NOT COMPLETED|Overall Study||22
5234960|NCT00871975|12870895|P1|COMPLETED|Overall Study||133
5234961|NCT00871975|12870895|P1|STARTED|Overall Study||155
5234962|NCT00871871|12870901|P4|NOT COMPLETED|Part II||4
5234963|NCT00871871|12870902|P3|NOT COMPLETED|Part II||4
5234964|NCT00871871|12870903|P2|NOT COMPLETED|Part II||0
5234965|NCT00871871|12870904|P1|NOT COMPLETED|Part II||0
5234966|NCT00871871|12870901|P4|COMPLETED|Part II||11
5234967|NCT00871871|12870902|P3|COMPLETED|Part II||9
5234968|NCT00871871|12870903|P2|COMPLETED|Part II||0
5234969|NCT00871871|12870904|P1|COMPLETED|Part II||0
5234970|NCT00871871|12870901|P4|STARTED|Part II||15
5234971|NCT00871871|12870902|P3|STARTED|Part II||13
5234972|NCT00871871|12870903|P2|STARTED|Part II||0
5234973|NCT00871871|12870904|P1|STARTED|Part II||0
5234974|NCT00871871|12870901|P4|NOT COMPLETED|Part I||0
5234975|NCT00871871|12870902|P3|NOT COMPLETED|Part I||0
5234976|NCT00871871|12870903|P2|NOT COMPLETED|Part I||3
5234977|NCT00871871|12870904|P1|NOT COMPLETED|Part I||3
5234978|NCT00871871|12870901|P4|COMPLETED|Part I||0
5234979|NCT00871871|12870902|P3|COMPLETED|Part I||0
5234980|NCT00871871|12870903|P2|COMPLETED|Part I||15
5234981|NCT00871871|12870904|P1|COMPLETED|Part I||15
5234982|NCT00871871|12870901|P4|STARTED|Part I||0
5234983|NCT00871871|12870902|P3|STARTED|Part I||0
5234984|NCT00871871|12870903|P2|STARTED|Part I||18
5234985|NCT00871871|12870904|P1|STARTED|Part I||18
5234986|NCT00871845|12870926|P2|NOT COMPLETED|Overall Study||0
5234987|NCT00871845|12870927|P1|NOT COMPLETED|Overall Study||0
5234988|NCT00871845|12870926|P2|COMPLETED|Overall Study||25
5234989|NCT00871845|12870927|P1|COMPLETED|Overall Study||11
5234990|NCT00871845|12870926|P2|STARTED|Overall Study||25
5234991|NCT00871845|12870927|P1|STARTED|Overall Study||11
5234992|NCT00871819|12870937|P1|NOT COMPLETED|Overall Study||0
5234993|NCT00871819|12870937|P1|COMPLETED|Overall Study||20
5234994|NCT00871819|12870937|P1|STARTED|Overall Study||20
5234995|NCT00871780|12870941|P1|NOT COMPLETED|Overall Study||27
5234996|NCT00871780|12870941|P1|COMPLETED|Overall Study||197
5234997|NCT00871780|12870941|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
5234998|NCT00871780|12870941|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
5234999|NCT00871780|12870941|P1|STARTED|Overall Study|number enrolled|224
5235000|NCT00871741|12870961|P2|NOT COMPLETED|Overall Study||7
5235001|NCT00871741|12870962|P1|NOT COMPLETED|Overall Study||9
5235002|NCT00871741|12870961|P2|COMPLETED|Overall Study||0
5235003|NCT00871741|12870962|P1|COMPLETED|Overall Study||0
5235004|NCT00871741|12870961|P2|STARTED|Overall Study||7
5235005|NCT00871741|12870962|P1|STARTED|Overall Study||9
5235006|NCT00871728|12870976|P1|NOT COMPLETED|Overall Study||20
5235007|NCT00871728|12870976|P1|COMPLETED|Overall Study||112
5235008|NCT00871728|12870976|P1|Treated|Overall Study||130
5235009|NCT00871728|12870976|P1|STARTED|Overall Study||132
5235010|NCT00871715|12870989|P3|NOT COMPLETED|Overall Study||26
5235011|NCT00871715|12870990|P2|NOT COMPLETED|Overall Study||16
5235012|NCT00871715|12870991|P1|NOT COMPLETED|Overall Study||15
5235013|NCT00871715|12870989|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
5235014|NCT00871715|12870990|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
5235015|NCT00871715|12870991|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
5235016|NCT00871715|12870989|P3|6-mo Follow-up|Overall Study||112
5235017|NCT00871715|12870990|P2|6-mo Follow-up|Overall Study||113
5235018|NCT00871715|12870991|P1|6-mo Follow-up|Overall Study||110
5235019|NCT00871715|12870989|P3|Post-Intervention|Overall Study||115
5235020|NCT00871715|12870990|P2|Post-Intervention|Overall Study||115
5235021|NCT00871715|12870991|P1|Post-Intervention|Overall Study||112
5235022|NCT00871715|12870989|P3|STARTED|Overall Study||122
5235023|NCT00871715|12870990|P2|STARTED|Overall Study||120
5235024|NCT00871715|12870991|P1|STARTED|Overall Study||119
5235025|NCT00871689|12871042|P1|NOT COMPLETED|Overall Study||0
5235026|NCT00871689|12871042|P1|COMPLETED|Overall Study||2
5235027|NCT00871689|12871042|P1|STARTED|Overall Study||2
5235028|NCT00871624|12871055|P2|NOT COMPLETED|Overall Study||1
5235029|NCT00871624|12871056|P1|NOT COMPLETED|Overall Study||2
5235030|NCT00871624|12871055|P2|COMPLETED|Overall Study||17
5235031|NCT00871624|12871056|P1|COMPLETED|Overall Study||16
5235032|NCT00871624|12871055|P2|STARTED|Overall Study||18
5235033|NCT00871624|12871056|P1|STARTED|Overall Study||18
5235034|NCT00871572|12871068|P4|NOT COMPLETED|Overall Study||7
5235035|NCT00871572|12871069|P3|NOT COMPLETED|Overall Study||4
5235036|NCT00871572|12871070|P2|NOT COMPLETED|Overall Study||6
5235037|NCT00871572|12871071|P1|NOT COMPLETED|Overall Study||2
5235038|NCT00871572|12871068|P4|COMPLETED|Overall Study||19
5235039|NCT00871572|12871069|P3|COMPLETED|Overall Study||30
5235040|NCT00871572|12871070|P2|COMPLETED|Overall Study||11
5235041|NCT00871572|12871071|P1|COMPLETED|Overall Study||8
5235042|NCT00871572|12871068|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
5235043|NCT00871572|12871069|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
5235044|NCT00871572|12871070|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
5235045|NCT00871572|12871071|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
5235046|NCT00871572|12871068|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
5235047|NCT00871572|12871069|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
5235048|NCT00871572|12871070|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
5235049|NCT00871572|12871071|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
5235050|NCT00871572|12871068|P4|STARTED|Overall Study||26
5235051|NCT00871572|12871069|P3|STARTED|Overall Study||34
5235052|NCT00871572|12871070|P2|STARTED|Overall Study||17
5235053|NCT00871572|12871071|P1|STARTED|Overall Study||10
5235054|NCT00871494|12871141|P1|NOT COMPLETED|Overall Study||14
5235055|NCT00871494|12871141|P1|COMPLETED|Overall Study||62
5235056|NCT00871494|12871141|P1|STARTED|Overall Study||76
5235057|NCT00871429|12871148|P1|NOT COMPLETED|Overall Study||24
5235058|NCT00871429|12871148|P1|COMPLETED|Overall Study||75
5235059|NCT00871429|12871148|P1|STARTED|Overall Study||99
5235060|NCT00871403|12871159|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
5235061|NCT00871403|12871160|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
5235062|NCT00871403|12871161|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
5235063|NCT00871403|12871159|P3|COMPLETED|Monotherapy Treatment Phase||0
5235064|NCT00871403|12871160|P2|COMPLETED|Monotherapy Treatment Phase||0
5235065|NCT00871403|12871161|P1|COMPLETED|Monotherapy Treatment Phase||0
5235066|NCT00871403|12871159|P3|STARTED|Monotherapy Treatment Phase||1
5235067|NCT00871403|12871160|P2|STARTED|Monotherapy Treatment Phase||13
5235068|NCT00871403|12871161|P1|STARTED|Monotherapy Treatment Phase||0
5235069|NCT00871403|12871159|P3|NOT COMPLETED|Combination Treatment Phase||12
5235070|NCT00871403|12871160|P2|NOT COMPLETED|Combination Treatment Phase||49
5235071|NCT00871403|12871161|P1|NOT COMPLETED|Combination Treatment Phase||9
5235072|NCT00871403|12871159|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
5235073|NCT00871403|12871160|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
5235074|NCT00871403|12871161|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
5235075|NCT00871403|12871159|P3|STARTED|Combination Treatment Phase||35
5235076|NCT00871403|12871160|P2|STARTED|Combination Treatment Phase||62
5235077|NCT00871403|12871161|P1|STARTED|Combination Treatment Phase||9
5235078|NCT00871377|12871174|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
5235079|NCT00871377|12871175|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
5235080|NCT00871377|12871176|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
5235081|NCT00871377|12871177|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
5235082|NCT00871377|12871178|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
5235083|NCT00871377|12871179|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
5235084|NCT00871377|12871174|P6|COMPLETED|Third Intervention (10 Weeks)||3
5235085|NCT00871377|12871175|P5|COMPLETED|Third Intervention (10 Weeks)||4
5235086|NCT00871377|12871176|P4|COMPLETED|Third Intervention (10 Weeks)||3
5235087|NCT00871377|12871177|P3|COMPLETED|Third Intervention (10 Weeks)||3
5235088|NCT00871377|12871178|P2|COMPLETED|Third Intervention (10 Weeks)||4
5235089|NCT00871377|12871179|P1|COMPLETED|Third Intervention (10 Weeks)||2
5235090|NCT00871377|12871174|P6|STARTED|Third Intervention (10 Weeks)||3
5235091|NCT00871377|12871175|P5|STARTED|Third Intervention (10 Weeks)||4
5235092|NCT00871377|12871176|P4|STARTED|Third Intervention (10 Weeks)||4
5235093|NCT00871377|12871177|P3|STARTED|Third Intervention (10 Weeks)||3
5235094|NCT00871377|12871178|P2|STARTED|Third Intervention (10 Weeks)||4
5235095|NCT00871377|12871179|P1|STARTED|Third Intervention (10 Weeks)||2
5235096|NCT00871377|12871174|P6|NOT COMPLETED|Washout (6 Weeks)||1
5235097|NCT00871377|12871175|P5|NOT COMPLETED|Washout (6 Weeks)||0
5235098|NCT00871377|12871176|P4|NOT COMPLETED|Washout (6 Weeks)||0
5235099|NCT00871377|12871177|P3|NOT COMPLETED|Washout (6 Weeks)||0
5235100|NCT00871377|12871178|P2|NOT COMPLETED|Washout (6 Weeks)||0
5235101|NCT00871377|12871179|P1|NOT COMPLETED|Washout (6 Weeks)||0
5235102|NCT00871377|12871174|P6|COMPLETED|Washout (6 Weeks)||3
5235103|NCT00871377|12871175|P5|COMPLETED|Washout (6 Weeks)||4
5235104|NCT00871377|12871176|P4|COMPLETED|Washout (6 Weeks)||4
5235105|NCT00871377|12871177|P3|COMPLETED|Washout (6 Weeks)||3
5235106|NCT00871377|12871178|P2|COMPLETED|Washout (6 Weeks)||4
5235107|NCT00871377|12871179|P1|COMPLETED|Washout (6 Weeks)||2
5235108|NCT00871377|12871174|P6|STARTED|Washout (6 Weeks)||4
5235109|NCT00871377|12871175|P5|STARTED|Washout (6 Weeks)||4
5235110|NCT00871377|12871176|P4|STARTED|Washout (6 Weeks)||4
5235111|NCT00871377|12871177|P3|STARTED|Washout (6 Weeks)||3
5235112|NCT00871377|12871178|P2|STARTED|Washout (6 Weeks)||4
5235113|NCT00871377|12871179|P1|STARTED|Washout (6 Weeks)||2
5235114|NCT00871377|12871174|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235115|NCT00871377|12871175|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235116|NCT00871377|12871176|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235117|NCT00871377|12871177|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235118|NCT00871377|12871178|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235119|NCT00871377|12871179|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
5235120|NCT00871377|12871174|P6|COMPLETED|Second Intervention (10 Weeks)||4
5235121|NCT00871377|12871175|P5|COMPLETED|Second Intervention (10 Weeks)||4
5235122|NCT00871377|12871176|P4|COMPLETED|Second Intervention (10 Weeks)||4
5235123|NCT00871377|12871177|P3|COMPLETED|Second Intervention (10 Weeks)||3
5235124|NCT00871377|12871178|P2|COMPLETED|Second Intervention (10 Weeks)||4
5235125|NCT00871377|12871179|P1|COMPLETED|Second Intervention (10 Weeks)||2
5235126|NCT00871377|12871174|P6|STARTED|Second Intervention (10 Weeks)||4
5235127|NCT00871377|12871175|P5|STARTED|Second Intervention (10 Weeks)||4
5235128|NCT00871377|12871176|P4|STARTED|Second Intervention (10 Weeks)||4
5235129|NCT00871377|12871177|P3|STARTED|Second Intervention (10 Weeks)||3
5235130|NCT00871377|12871178|P2|STARTED|Second Intervention (10 Weeks)||4
5235131|NCT00871377|12871179|P1|STARTED|Second Intervention (10 Weeks)||2
5235132|NCT00871377|12871174|P6|NOT COMPLETED|Washout (6 Weeks)||0
5235133|NCT00871377|12871175|P5|NOT COMPLETED|Washout (6 Weeks)||0
5235134|NCT00871377|12871176|P4|NOT COMPLETED|Washout (6 Weeks)||0
5235135|NCT00871377|12871177|P3|NOT COMPLETED|Washout (6 Weeks)||0
5235136|NCT00871377|12871178|P2|NOT COMPLETED|Washout (6 Weeks)||0
5235137|NCT00871377|12871179|P1|NOT COMPLETED|Washout (6 Weeks)||1
5235138|NCT00871377|12871174|P6|COMPLETED|Washout (6 Weeks)||4
5235139|NCT00871377|12871175|P5|COMPLETED|Washout (6 Weeks)||4
5235140|NCT00871377|12871176|P4|COMPLETED|Washout (6 Weeks)||4
5235141|NCT00871377|12871177|P3|COMPLETED|Washout (6 Weeks)||3
5235142|NCT00871377|12871178|P2|COMPLETED|Washout (6 Weeks)||4
5235143|NCT00871377|12871179|P1|COMPLETED|Washout (6 Weeks)||2
5235144|NCT00871377|12871174|P6|STARTED|Washout (6 Weeks)||4
5235145|NCT00871377|12871175|P5|STARTED|Washout (6 Weeks)||4
5235146|NCT00871377|12871176|P4|STARTED|Washout (6 Weeks)||4
5235147|NCT00871377|12871177|P3|STARTED|Washout (6 Weeks)||3
5235148|NCT00871377|12871178|P2|STARTED|Washout (6 Weeks)||4
5235149|NCT00871377|12871179|P1|STARTED|Washout (6 Weeks)||3
5235150|NCT00871377|12871174|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
5235151|NCT00871377|12871175|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
5235152|NCT00871377|12871176|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
5235153|NCT00871377|12871177|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
5235154|NCT00871377|12871178|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
5235155|NCT00871377|12871179|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
5235156|NCT00871377|12871174|P6|COMPLETED|First Intervention (10 Weeks)||4
5235157|NCT00871377|12871175|P5|COMPLETED|First Intervention (10 Weeks)||4
5235158|NCT00871377|12871176|P4|COMPLETED|First Intervention (10 Weeks)||4
5235159|NCT00871377|12871177|P3|COMPLETED|First Intervention (10 Weeks)||3
5235160|NCT00871377|12871178|P2|COMPLETED|First Intervention (10 Weeks)||4
5235161|NCT00871377|12871179|P1|COMPLETED|First Intervention (10 Weeks)||3
5235162|NCT00871377|12871174|P6|STARTED|First Intervention (10 Weeks)||5
5235163|NCT00871377|12871175|P5|STARTED|First Intervention (10 Weeks)||4
5235164|NCT00871377|12871176|P4|STARTED|First Intervention (10 Weeks)||4
5235165|NCT00871377|12871177|P3|STARTED|First Intervention (10 Weeks)||4
5235166|NCT00871377|12871178|P2|STARTED|First Intervention (10 Weeks)||4
5235167|NCT00871377|12871179|P1|STARTED|First Intervention (10 Weeks)||3
5235168|NCT00871351|12871190|P3|NOT COMPLETED|Overall Study||0
5235169|NCT00871351|12871191|P2|NOT COMPLETED|Overall Study||1
5235170|NCT00871351|12871192|P1|NOT COMPLETED|Overall Study||4
5235171|NCT00871351|12871190|P3|COMPLETED|Overall Study||32
5235172|NCT00871351|12871191|P2|COMPLETED|Overall Study||45
5235173|NCT00871351|12871192|P1|COMPLETED|Overall Study||43
5235174|NCT00871351|12871190|P3|STARTED|Overall Study||32
5235175|NCT00871351|12871191|P2|STARTED|Overall Study||46
5235176|NCT00871351|12871192|P1|STARTED|Overall Study||47
5235177|NCT00871338|12871214|P2|NOT COMPLETED|After Booster||0
5235178|NCT00871338|12871215|P1|NOT COMPLETED|After Booster||0
5235179|NCT00871338|12871214|P2|COMPLETED|After Booster||135
5235180|NCT00871338|12871215|P1|COMPLETED|After Booster||139
5235181|NCT00871338|12871214|P2|STARTED|After Booster||135
5235182|NCT00871338|12871215|P1|STARTED|After Booster||139
5235183|NCT00871338|12871214|P2|NOT COMPLETED|Prior to Booster||3
5235184|NCT00871338|12871215|P1|NOT COMPLETED|Prior to Booster||2
5235185|NCT00871338|12871214|P2|COMPLETED|Prior to Booster||139
5235186|NCT00871338|12871215|P1|COMPLETED|Prior to Booster||140
5235187|NCT00871338|12871214|P2|STARTED|Prior to Booster||142
5235188|NCT00871338|12871215|P1|STARTED|Prior to Booster||142
5235189|NCT00871286|12871295|P2|NOT COMPLETED|Overall Study||6
5235190|NCT00871286|12871296|P1|NOT COMPLETED|Overall Study||0
5235191|NCT00871286|12871295|P2|COMPLETED|Overall Study||14
5235192|NCT00871286|12871296|P1|COMPLETED|Overall Study||20
5235193|NCT00871286|12871295|P2|STARTED|Overall Study||20
5235194|NCT00871286|12871296|P1|STARTED|Overall Study||20
5235195|NCT00871234|12871304|P1|NOT COMPLETED|Overall Study||5
5235196|NCT00871234|12871304|P1|COMPLETED|Overall Study||23
5235197|NCT00871234|12871304|P1|STARTED|Overall Study||28
5235198|NCT00871169|12871308|P1|NOT COMPLETED|Overall Study||3
5235199|NCT00871169|12871308|P1|COMPLETED|Overall Study||58
5235200|NCT00871169|12871308|P1|STARTED|Overall Study||61
5235201|NCT00871143|12871315|P2|NOT COMPLETED|Overall Study||0
5235202|NCT00871143|12871316|P1|NOT COMPLETED|Overall Study||0
5235203|NCT00871143|12871315|P2|COMPLETED|Overall Study||25
5235204|NCT00871143|12871316|P1|COMPLETED|Overall Study||21
5235205|NCT00871143|12871315|P2|STARTED|Overall Study||25
5235206|NCT00871143|12871316|P1|STARTED|Overall Study||21
5235207|NCT00871117|12871336|P2|NOT COMPLETED|Overall Study||10
5235208|NCT00871117|12871337|P1|NOT COMPLETED|Overall Study||5
5235209|NCT00871117|12871336|P2|COMPLETED|Overall Study||227
5235210|NCT00871117|12871337|P1|COMPLETED|Overall Study||234
5235211|NCT00871117|12871336|P2|STARTED|Overall Study||237
5235212|NCT00871117|12871337|P1|STARTED|Overall Study||239
5235213|NCT00871000|12871371|P2|NOT COMPLETED|Overall Study||0
5235214|NCT00871000|12871372|P1|NOT COMPLETED|Overall Study||1
5235215|NCT00871000|12871371|P2|COMPLETED|Overall Study||152
5235216|NCT00871000|12871372|P1|COMPLETED|Overall Study||150
5235217|NCT00871000|12871371|P2|STARTED|Overall Study||152
5235218|NCT00871000|12871372|P1|STARTED|Overall Study||151
5235219|NCT00870896|12871414|P1|NOT COMPLETED|Overall Study||0
5235220|NCT00870896|12871414|P1|COMPLETED|Overall Study||5
5235221|NCT00870896|12871414|P1|STARTED|Overall Study||5
5235222|NCT00870870|12871424|P4|NOT COMPLETED|Overall Study||5
5235223|NCT00870870|12871425|P3|NOT COMPLETED|Overall Study||3
5235224|NCT00870870|12871426|P2|NOT COMPLETED|Overall Study||1
5235225|NCT00870870|12871427|P1|NOT COMPLETED|Overall Study||0
5235226|NCT00870870|12871424|P4|COMPLETED|Overall Study||20
5235227|NCT00870870|12871425|P3|COMPLETED|Overall Study||26
5235228|NCT00870870|12871426|P2|COMPLETED|Overall Study||5
5235229|NCT00870870|12871427|P1|COMPLETED|Overall Study||4
5235230|NCT00870870|12871424|P4|STARTED|Overall Study||25
5235231|NCT00870870|12871425|P3|STARTED|Overall Study||29
5235232|NCT00870870|12871426|P2|STARTED|Overall Study||6
5235233|NCT00870870|12871427|P1|STARTED|Overall Study||4
5235234|NCT00870740|12871471|P6|NOT COMPLETED|Overall Study||17
5235235|NCT00870740|12871472|P5|NOT COMPLETED|Overall Study||11
5235236|NCT00870740|12871473|P4|NOT COMPLETED|Overall Study||12
5235237|NCT00870740|12871474|P3|NOT COMPLETED|Overall Study||10
5235238|NCT00870740|12871475|P2|NOT COMPLETED|Overall Study||9
5235239|NCT00870740|12871476|P1|NOT COMPLETED|Overall Study||12
5235240|NCT00870740|12871471|P6|COMPLETED|Overall Study||70
5235241|NCT00870740|12871472|P5|COMPLETED|Overall Study||77
5235242|NCT00870740|12871473|P4|COMPLETED|Overall Study||74
5235243|NCT00870740|12871474|P3|COMPLETED|Overall Study||76
5235244|NCT00870740|12871475|P2|COMPLETED|Overall Study||75
5235245|NCT00870740|12871476|P1|COMPLETED|Overall Study||74
5235246|NCT00870740|12871471|P6|STARTED|Overall Study|number randomized and dosed|87
5235247|NCT00870740|12871472|P5|STARTED|Overall Study|number randomized and dosed|88
5235248|NCT00870740|12871473|P4|STARTED|Overall Study|number randomized and dosed|86
5235249|NCT00870740|12871474|P3|STARTED|Overall Study|number randomized and dosed|86
5235250|NCT00870740|12871475|P2|STARTED|Overall Study|number randomized and dosed|84
5235251|NCT00870740|12871476|P1|STARTED|Overall Study|number randomized and dosed|86
5235252|NCT00870727|12871552|P2|NOT COMPLETED|Overall Study||5
5235253|NCT00870727|12871553|P1|NOT COMPLETED|Overall Study||1
5235254|NCT00870727|12871552|P2|COMPLETED|Overall Study||11
5235255|NCT00870727|12871553|P1|COMPLETED|Overall Study||16
5235256|NCT00870727|12871552|P2|STARTED|Overall Study||16
5235257|NCT00870727|12871553|P1|STARTED|Overall Study||17
5235258|NCT00870688|12871569|P1|NOT COMPLETED|Overall Study||4
5235259|NCT00870688|12871569|P1|COMPLETED|Overall Study||78
5235260|NCT00870688|12871569|P1|STARTED|Overall Study||82
5235261|NCT00870584|12871574|P2|NOT COMPLETED|Overall Study||13
5235262|NCT00870584|12871575|P1|NOT COMPLETED|Overall Study||16
5235263|NCT00870584|12871574|P2|COMPLETED|Overall Study||122
5235264|NCT00870584|12871575|P1|COMPLETED|Overall Study||120
5235265|NCT00870584|12871574|P2|STARTED|Overall Study||135
5235266|NCT00870584|12871575|P1|STARTED|Overall Study||136
5235267|NCT00870545|12871583|P1|NOT COMPLETED|Overall Study||17
5235268|NCT00870545|12871583|P1|COMPLETED|Overall Study||69
5235269|NCT00870545|12871583|P1|STARTED|Overall Study||86
5235270|NCT00870467|12871594|P6|NOT COMPLETED|Open-label||3
5235271|NCT00870467|12871595|P5|NOT COMPLETED|Open-label||5
5235272|NCT00870467|12871596|P4|NOT COMPLETED|Open-label||7
5235273|NCT00870467|12871597|P3|NOT COMPLETED|Open-label||13
5235274|NCT00870467|12871598|P2|NOT COMPLETED|Open-label||0
5235275|NCT00870467|12871599|P1|NOT COMPLETED|Open-label||0
5235276|NCT00870467|12871594|P6|COMPLETED|Open-label||21
5235277|NCT00870467|12871595|P5|COMPLETED|Open-label||5
5235278|NCT00870467|12871596|P4|COMPLETED|Open-label||120
5235279|NCT00870467|12871597|P3|COMPLETED|Open-label||132
5235280|NCT00870467|12871598|P2|COMPLETED|Open-label||0
5235281|NCT00870467|12871599|P1|COMPLETED|Open-label||0
5235282|NCT00870467|12871594|P6|STARTED|Open-label||24
5235283|NCT00870467|12871595|P5|STARTED|Open-label||10
5235284|NCT00870467|12871596|P4|STARTED|Open-label||127
5235285|NCT00870467|12871597|P3|STARTED|Open-label||145
5235286|NCT00870467|12871598|P2|STARTED|Open-label||0
5235287|NCT00870467|12871599|P1|STARTED|Open-label||0
5235288|NCT00870467|12871594|P6|NOT COMPLETED|Double-blind||0
5235289|NCT00870467|12871595|P5|NOT COMPLETED|Double-blind||0
5235290|NCT00870467|12871596|P4|NOT COMPLETED|Double-blind||0
5235291|NCT00870467|12871597|P3|NOT COMPLETED|Double-blind||0
5235292|NCT00870467|12871598|P2|NOT COMPLETED|Double-blind||12
5235293|NCT00870467|12871599|P1|NOT COMPLETED|Double-blind||16
5235294|NCT00870467|12871594|P6|COMPLETED|Double-blind||0
5235295|NCT00870467|12871595|P5|COMPLETED|Double-blind||0
5235296|NCT00870467|12871596|P4|COMPLETED|Double-blind||0
5235297|NCT00870467|12871597|P3|COMPLETED|Double-blind||0
5235298|NCT00870467|12871598|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
5235299|NCT00870467|12871599|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
5235300|NCT00870467|12871594|P6|STARTED|Double-blind||0
5235301|NCT00870467|12871595|P5|STARTED|Double-blind||0
5235302|NCT00870467|12871596|P4|STARTED|Double-blind||0
5235303|NCT00870467|12871597|P3|STARTED|Double-blind||0
5235304|NCT00870467|12871598|P2|STARTED|Double-blind||163
5235305|NCT00870467|12871599|P1|STARTED|Double-blind||171
5235306|NCT00870363|12871647|P4|NOT COMPLETED|Overall Study||0
5235307|NCT00870363|12871648|P3|NOT COMPLETED|Overall Study||3
5235308|NCT00870363|12871649|P2|NOT COMPLETED|Overall Study||3
5235309|NCT00870363|12871650|P1|NOT COMPLETED|Overall Study||0
5235310|NCT00870363|12871647|P4|COMPLETED|Overall Study||12
5235311|NCT00870363|12871648|P3|COMPLETED|Overall Study||8
5235312|NCT00870363|12871649|P2|COMPLETED|Overall Study||8
5235313|NCT00870363|12871650|P1|COMPLETED|Overall Study||10
5235314|NCT00870363|12871647|P4|STARTED|Overall Study||12
5235315|NCT00870363|12871648|P3|STARTED|Overall Study||11
5235316|NCT00870363|12871649|P2|STARTED|Overall Study||11
5235317|NCT00870363|12871650|P1|STARTED|Overall Study||10
5235318|NCT00870233|12871684|P1|NOT COMPLETED|Overall Study||24
5235319|NCT00870233|12871684|P1|COMPLETED|Overall Study||96
5235320|NCT00870233|12871684|P1|STARTED|Overall Study||120
5235321|NCT00870194|12871693|P2|NOT COMPLETED|Overall Study||14
5235322|NCT00870194|12871694|P1|NOT COMPLETED|Overall Study||26
5235323|NCT00870194|12871693|P2|COMPLETED|Overall Study||114
5235324|NCT00870194|12871694|P1|COMPLETED|Overall Study||101
5235325|NCT00870194|12871693|P2|Per Protocol Set|Overall Study||111
5235326|NCT00870194|12871694|P1|Per Protocol Set|Overall Study||97
5235327|NCT00870194|12871693|P2|STARTED|Overall Study||128
5235328|NCT00870194|12871694|P1|STARTED|Overall Study||127
5235329|NCT00870103|12871732|P1|NOT COMPLETED|Overall Study||4
5235330|NCT00870103|12871732|P1|COMPLETED|Overall Study||60
5235331|NCT00870103|12871732|P1|STARTED|Overall Study||64
5235332|NCT00869999|12871737|P1|NOT COMPLETED|Overall Study||2
5235333|NCT00869999|12871737|P1|COMPLETED|Overall Study||24
5235334|NCT00869999|12871737|P1|STARTED|Overall Study||26
5235335|NCT00869960|12871743|P1|NOT COMPLETED|Overall Study||2
5235336|NCT00869960|12871743|P1|COMPLETED|Overall Study||22
5235337|NCT00869960|12871743|P1|STARTED|Overall Study||24
5235338|NCT00869947|12871756|P2|NOT COMPLETED|Overall Study||0
5235339|NCT00869947|12871757|P1|NOT COMPLETED|Overall Study||0
5235340|NCT00869947|12871756|P2|COMPLETED|Overall Study||8
5235341|NCT00869947|12871757|P1|COMPLETED|Overall Study||8
5235342|NCT00869947|12871756|P2|STARTED|Overall Study||8
5235343|NCT00869947|12871757|P1|STARTED|Overall Study||8
5235344|NCT00869791|12871770|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
5235345|NCT00869791|12871771|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
5235346|NCT00869791|12871770|P2|COMPLETED|Period 2 Treatment for 7 Days||13
5235347|NCT00869791|12871771|P1|COMPLETED|Period 2 Treatment for 7 Days||14
5235348|NCT00869791|12871770|P2|STARTED|Period 2 Treatment for 7 Days||13
5235349|NCT00869791|12871771|P1|STARTED|Period 2 Treatment for 7 Days||14
5235350|NCT00869791|12871770|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
5235351|NCT00869791|12871771|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
5235352|NCT00869791|12871770|P2|COMPLETED|Period 1 Treatment for 7 Days||13
5235353|NCT00869791|12871771|P1|COMPLETED|Period 1 Treatment for 7 Days||14
5235354|NCT00869791|12871770|P2|STARTED|Period 1 Treatment for 7 Days||13
5235355|NCT00869791|12871771|P1|STARTED|Period 1 Treatment for 7 Days||14
5235356|NCT00869778|12871792|P3|NOT COMPLETED|Overall Study||10
5235357|NCT00869778|12871793|P2|NOT COMPLETED|Overall Study||7
5235358|NCT00869778|12871794|P1|NOT COMPLETED|Overall Study||12
5235359|NCT00869778|12871792|P3|COMPLETED|Overall Study||110
5235360|NCT00869778|12871793|P2|COMPLETED|Overall Study||113
5235361|NCT00869778|12871794|P1|COMPLETED|Overall Study||108
5235362|NCT00869778|12871792|P3|STARTED|Overall Study||120
5235363|NCT00869778|12871793|P2|STARTED|Overall Study||120
5235364|NCT00869778|12871794|P1|STARTED|Overall Study||120
5235365|NCT00869622|12871831|P2|NOT COMPLETED|Overall Study||14
5235366|NCT00869622|12871832|P1|NOT COMPLETED|Overall Study||13
5235367|NCT00869622|12871831|P2|COMPLETED|Overall Study||26
5235368|NCT00869622|12871832|P1|COMPLETED|Overall Study||27
5235369|NCT00869622|12871831|P2|STARTED|Overall Study||40
5235370|NCT00869622|12871832|P1|STARTED|Overall Study||40
5235371|NCT00869609|12871842|P2|NOT COMPLETED|Overall Study||3
5235372|NCT00869609|12871843|P1|NOT COMPLETED|Overall Study||6
5235373|NCT00869609|12871842|P2|COMPLETED|Overall Study||26
5235374|NCT00869609|12871843|P1|COMPLETED|Overall Study||25
5235375|NCT00869609|12871842|P2|STARTED|Overall Study||29
5235376|NCT00869609|12871843|P1|STARTED|Overall Study||31
5235377|NCT00869557|12871869|P2|NOT COMPLETED|Extension Phase||3
5235378|NCT00869557|12871870|P1|NOT COMPLETED|Extension Phase||10
5235379|NCT00869557|12871869|P2|COMPLETED|Extension Phase||11
5235380|NCT00869557|12871870|P1|COMPLETED|Extension Phase||35
5235381|NCT00869557|12871869|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
5235382|NCT00869557|12871870|P1|STARTED|Extension Phase||45
5235383|NCT00869557|12871869|P2|NOT COMPLETED|Randomized Phase||2
5235384|NCT00869557|12871870|P1|NOT COMPLETED|Randomized Phase||3
5235385|NCT00869557|12871869|P2|COMPLETED|Randomized Phase||21
5235386|NCT00869557|12871870|P1|COMPLETED|Randomized Phase||45
5235387|NCT00869557|12871869|P2|STARTED|Randomized Phase||23
5235388|NCT00869557|12871870|P1|STARTED|Randomized Phase||48
5235389|NCT00869518|12871889|P2|NOT COMPLETED|Overall Study||1
5235390|NCT00869518|12871890|P1|NOT COMPLETED|Overall Study||1
5235391|NCT00869518|12871889|P2|COMPLETED|Overall Study||5
5235392|NCT00869518|12871890|P1|COMPLETED|Overall Study||5
5235393|NCT00869518|12871889|P2|STARTED|Overall Study||6
5235394|NCT00869518|12871890|P1|STARTED|Overall Study||6
5235395|NCT00869440|12871906|P4|NOT COMPLETED|Overall Study||0
5235396|NCT00869440|12871907|P3|NOT COMPLETED|Overall Study||0
5235397|NCT00869440|12871908|P2|NOT COMPLETED|Overall Study||1
5235398|NCT00869440|12871909|P1|NOT COMPLETED|Overall Study||2
5235399|NCT00869440|12871906|P4|COMPLETED|Overall Study||25
5235400|NCT00869440|12871907|P3|COMPLETED|Overall Study||25
5235401|NCT00869440|12871908|P2|COMPLETED|Overall Study||24
5235402|NCT00869440|12871909|P1|COMPLETED|Overall Study||23
5235403|NCT00869440|12871906|P4|STARTED|Overall Study||25
5235404|NCT00869440|12871907|P3|STARTED|Overall Study||25
5235405|NCT00869440|12871908|P2|STARTED|Overall Study||25
5235406|NCT00869440|12871909|P1|STARTED|Overall Study||25
5235407|NCT00869414|12871927|P3|NOT COMPLETED|Overall Study||0
5235408|NCT00869414|12871928|P2|NOT COMPLETED|Overall Study||0
5235409|NCT00869414|12871929|P1|NOT COMPLETED|Overall Study||0
5235410|NCT00869414|12871927|P3|COMPLETED|Overall Study||0
5235411|NCT00869414|12871928|P2|COMPLETED|Overall Study||0
5235412|NCT00869414|12871929|P1|COMPLETED|Overall Study||0
5235413|NCT00869414|12871927|P3|STARTED|Overall Study||0
5235414|NCT00869414|12871928|P2|STARTED|Overall Study||0
5235415|NCT00869414|12871929|P1|STARTED|Overall Study||0
5235416|NCT00869401|12871943|P5|NOT COMPLETED|Overall Study||3
5235417|NCT00869401|12871944|P4|NOT COMPLETED|Overall Study||5
5235418|NCT00869401|12871945|P3|NOT COMPLETED|Overall Study||0
5235419|NCT00869401|12871946|P2|NOT COMPLETED|Overall Study||0
5235420|NCT00869401|12871947|P1|NOT COMPLETED|Overall Study||0
5235421|NCT00869401|12871943|P5|COMPLETED|Overall Study||63
5235422|NCT00869401|12871944|P4|COMPLETED|Overall Study||133
5235423|NCT00869401|12871945|P3|COMPLETED|Overall Study||7
5235424|NCT00869401|12871946|P2|COMPLETED|Overall Study||3
5235425|NCT00869401|12871947|P1|COMPLETED|Overall Study||3
5235426|NCT00869401|12871943|P5|STARTED|Overall Study||66
5235427|NCT00869401|12871944|P4|STARTED|Overall Study||138
5235428|NCT00869401|12871945|P3|STARTED|Overall Study||7
5235429|NCT00869401|12871946|P2|STARTED|Overall Study||3
5235430|NCT00869401|12871947|P1|STARTED|Overall Study||3
5235431|NCT00869375|12871965|P2|NOT COMPLETED|Overall Study||0
5235432|NCT00869375|12871966|P1|NOT COMPLETED|Overall Study||0
5235433|NCT00869375|12871965|P2|COMPLETED|Overall Study||3
5235434|NCT00869375|12871966|P1|COMPLETED|Overall Study||3
5235435|NCT00869375|12871965|P2|STARTED|Overall Study||3
5235436|NCT00869375|12871966|P1|STARTED|Overall Study||3
5235437|NCT00869362|12871976|P2|NOT COMPLETED|Overall Study||5
5235438|NCT00869362|12871977|P1|NOT COMPLETED|Overall Study||1
5235439|NCT00869362|12871976|P2|COMPLETED|Overall Study||11
5235440|NCT00869362|12871977|P1|COMPLETED|Overall Study||14
5235441|NCT00869362|12871976|P2|STARTED|Overall Study||16
5235442|NCT00869362|12871977|P1|STARTED|Overall Study||15
5235443|NCT00869349|12871987|P2|NOT COMPLETED|Overall Study||4
5235444|NCT00869349|12871988|P1|NOT COMPLETED|Overall Study||7
5235445|NCT00869349|12871987|P2|COMPLETED|Overall Study||36
5235446|NCT00869349|12871988|P1|COMPLETED|Overall Study||32
5235447|NCT00869349|12871987|P2|STARTED|Overall Study||40
5235448|NCT00869349|12871988|P1|STARTED|Overall Study||39
5235449|NCT00869323|12871998|P1|NOT COMPLETED|Maintenance Therapy||1
5235450|NCT00869323|12871998|P1|COMPLETED|Maintenance Therapy||1
5235451|NCT00869323|12871998|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
5235452|NCT00869323|12871998|P1|NOT COMPLETED|Induction Therapy||0
5235453|NCT00869323|12871998|P1|COMPLETED|Induction Therapy||3
5235454|NCT00869323|12871998|P1|STARTED|Induction Therapy||3
5235455|NCT00869258|12872006|P1|NOT COMPLETED|Overall Study||1
5235456|NCT00869258|12872006|P1|COMPLETED|Overall Study||31
5235457|NCT00869258|12872006|P1|STARTED|Overall Study||32
5235458|NCT00869206|12872012|P2|NOT COMPLETED|Overall Study||27
5235459|NCT00869206|12872013|P1|NOT COMPLETED|Overall Study||29
5235460|NCT00869206|12872012|P2|COMPLETED|Overall Study||884
5235461|NCT00869206|12872013|P1|COMPLETED|Overall Study||882
5235462|NCT00869206|12872012|P2|STARTED|Overall Study||911
5235463|NCT00869206|12872013|P1|STARTED|Overall Study||911
5235464|NCT00869167|12872043|P2|NOT COMPLETED|Overall Study||1
5235465|NCT00869167|12872044|P1|NOT COMPLETED|Overall Study||0
5235466|NCT00869167|12872043|P2|COMPLETED|Overall Study||0
5235467|NCT00869167|12872044|P1|COMPLETED|Overall Study||2
5235468|NCT00869167|12872043|P2|STARTED|Overall Study||1
5235469|NCT00869167|12872044|P1|STARTED|Overall Study||2
5235470|NCT00869141|12872060|P2|NOT COMPLETED|Overall Study||0
5235471|NCT00869141|12872061|P1|NOT COMPLETED|Overall Study||0
5235472|NCT00869141|12872060|P2|COMPLETED|Overall Study||26
5235473|NCT00869141|12872061|P1|COMPLETED|Overall Study||26
5235474|NCT00869141|12872060|P2|STARTED|Overall Study||26
5235475|NCT00869141|12872061|P1|STARTED|Overall Study||26
5235476|NCT00869128|12872071|P2|NOT COMPLETED|Overall Study||6
5235477|NCT00869128|12872072|P1|NOT COMPLETED|Overall Study||6
5235478|NCT00869128|12872071|P2|COMPLETED|Overall Study||12
5235479|NCT00869128|12872072|P1|COMPLETED|Overall Study||12
5235480|NCT00869128|12872071|P2|STARTED|Overall Study||18
5235481|NCT00869128|12872072|P1|STARTED|Overall Study||18
5235482|NCT00869089|12872076|P1|NOT COMPLETED|Overall Study||3
5235483|NCT00869089|12872076|P1|COMPLETED|Overall Study||2
5235484|NCT00869089|12872076|P1|STARTED|Overall Study||5
5235485|NCT00869050|12872080|P1|NOT COMPLETED|Overall Study||3
5235486|NCT00869050|12872080|P1|COMPLETED|Overall Study||38
5235487|NCT00869050|12872080|P1|STARTED|Overall Study||41
5235488|NCT00869024|12872087|P2|NOT COMPLETED|Overall Study||5
5235489|NCT00869024|12872088|P1|NOT COMPLETED|Overall Study||2
5235490|NCT00869024|12872087|P2|COMPLETED|Overall Study||4
5235491|NCT00869024|12872088|P1|COMPLETED|Overall Study||14
5235492|NCT00869024|12872087|P2|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
5235493|NCT00869024|12872088|P1|STARTED|Overall Study||16
5235494|NCT00868998|12872104|P1|NOT COMPLETED|Overall Study||5
5235495|NCT00868998|12872104|P1|COMPLETED|Overall Study||0
5235496|NCT00868998|12872104|P1|STARTED|Overall Study||5
5235497|NCT00868959|12872109|P1|NOT COMPLETED|Overall Study||258
5235498|NCT00868959|12872109|P1|COMPLETED|Overall Study||559
5235499|NCT00868959|12872109|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
5235500|NCT00868790|12872115|P14|NOT COMPLETED|Post-study||0
5235501|NCT00868790|12872116|P13|NOT COMPLETED|Post-study||0
5235502|NCT00868790|12872117|P12|NOT COMPLETED|Post-study||0
5235503|NCT00868790|12872118|P11|NOT COMPLETED|Post-study||0
5235504|NCT00868790|12872119|P10|NOT COMPLETED|Post-study||1
5235505|NCT00868790|12872120|P9|NOT COMPLETED|Post-study||0
5235506|NCT00868790|12872121|P8|NOT COMPLETED|Post-study||2
5235507|NCT00868790|12872122|P7|NOT COMPLETED|Post-study||0
5235508|NCT00868790|12872123|P6|NOT COMPLETED|Post-study||0
5235509|NCT00868790|12872124|P5|NOT COMPLETED|Post-study||1
5235510|NCT00868790|12872125|P4|NOT COMPLETED|Post-study||0
5235511|NCT00868790|12872126|P3|NOT COMPLETED|Post-study||0
5235512|NCT00868790|12872127|P2|NOT COMPLETED|Post-study||0
5235513|NCT00868790|12872128|P1|NOT COMPLETED|Post-study||0
5235514|NCT00868790|12872115|P14|COMPLETED|Post-study||7
5235515|NCT00868790|12872116|P13|COMPLETED|Post-study||6
5235516|NCT00868790|12872117|P12|COMPLETED|Post-study||3
5235517|NCT00868790|12872118|P11|COMPLETED|Post-study||5
5235518|NCT00868790|12872119|P10|COMPLETED|Post-study||1
5235519|NCT00868790|12872120|P9|COMPLETED|Post-study||6
5235520|NCT00868790|12872121|P8|COMPLETED|Post-study||12
5235521|NCT00868790|12872122|P7|COMPLETED|Post-study||4
5235522|NCT00868790|12872123|P6|COMPLETED|Post-study||1
5235523|NCT00868790|12872124|P5|COMPLETED|Post-study||17
5235524|NCT00868790|12872125|P4|COMPLETED|Post-study||3
5235525|NCT00868790|12872126|P3|COMPLETED|Post-study||3
5235526|NCT00868790|12872127|P2|COMPLETED|Post-study||6
5235527|NCT00868790|12872128|P1|COMPLETED|Post-study||7
5235528|NCT00868790|12872115|P14|STARTED|Post-study||7
5235529|NCT00868790|12872116|P13|STARTED|Post-study||6
5235530|NCT00868790|12872117|P12|STARTED|Post-study||3
5235531|NCT00868790|12872118|P11|STARTED|Post-study||5
5235532|NCT00868790|12872119|P10|STARTED|Post-study||2
5235533|NCT00868790|12872120|P9|STARTED|Post-study||6
5235534|NCT00868790|12872121|P8|STARTED|Post-study||14
5235535|NCT00868790|12872122|P7|STARTED|Post-study||4
5235536|NCT00868790|12872123|P6|STARTED|Post-study||1
5235537|NCT00868790|12872124|P5|STARTED|Post-study||18
5235538|NCT00868790|12872125|P4|STARTED|Post-study||3
5235539|NCT00868790|12872126|P3|STARTED|Post-study||3
5235540|NCT00868790|12872127|P2|STARTED|Post-study||6
5235541|NCT00868790|12872128|P1|STARTED|Post-study||7
5235542|NCT00868790|12872115|P14|NOT COMPLETED|Period 4||1
5235543|NCT00868790|12872116|P13|NOT COMPLETED|Period 4||1
5235544|NCT00868790|12872117|P12|NOT COMPLETED|Period 4||1
5235545|NCT00868790|12872118|P11|NOT COMPLETED|Period 4||3
5235546|NCT00868790|12872119|P10|NOT COMPLETED|Period 4||0
5235547|NCT00868790|12872120|P9|NOT COMPLETED|Period 4||2
5235548|NCT00868790|12872121|P8|NOT COMPLETED|Period 4||3
5235549|NCT00868790|12872122|P7|NOT COMPLETED|Period 4||0
5235550|NCT00868790|12872123|P6|NOT COMPLETED|Period 4||0
5235551|NCT00868790|12872124|P5|NOT COMPLETED|Period 4||0
5235552|NCT00868790|12872125|P4|NOT COMPLETED|Period 4||0
5235553|NCT00868790|12872126|P3|NOT COMPLETED|Period 4||1
5235554|NCT00868790|12872127|P2|NOT COMPLETED|Period 4||0
5235555|NCT00868790|12872128|P1|NOT COMPLETED|Period 4||2
5235556|NCT00868790|12872115|P14|COMPLETED|Period 4||7
5235557|NCT00868790|12872116|P13|COMPLETED|Period 4||6
5235558|NCT00868790|12872117|P12|COMPLETED|Period 4||3
5235559|NCT00868790|12872118|P11|COMPLETED|Period 4||5
5235560|NCT00868790|12872119|P10|COMPLETED|Period 4||2
5235561|NCT00868790|12872120|P9|COMPLETED|Period 4||6
5235562|NCT00868790|12872121|P8|COMPLETED|Period 4||14
5235563|NCT00868790|12872122|P7|COMPLETED|Period 4||4
5235564|NCT00868790|12872123|P6|COMPLETED|Period 4||1
5235565|NCT00868790|12872124|P5|COMPLETED|Period 4||18
5235566|NCT00868790|12872125|P4|COMPLETED|Period 4||3
5235567|NCT00868790|12872126|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
5235568|NCT00868790|12872127|P2|COMPLETED|Period 4||6
5235569|NCT00868790|12872128|P1|COMPLETED|Period 4||7
5235570|NCT00868790|12872115|P14|STARTED|Period 4||8
5235571|NCT00868790|12872116|P13|STARTED|Period 4||7
5235572|NCT00868790|12872117|P12|STARTED|Period 4||4
5235573|NCT00868790|12872118|P11|STARTED|Period 4||8
5235574|NCT00868790|12872119|P10|STARTED|Period 4||2
5235575|NCT00868790|12872120|P9|STARTED|Period 4||8
5235576|NCT00868790|12872121|P8|STARTED|Period 4||17
5235577|NCT00868790|12872122|P7|STARTED|Period 4||4
5235578|NCT00868790|12872123|P6|STARTED|Period 4||1
5235579|NCT00868790|12872124|P5|STARTED|Period 4||18
5235580|NCT00868790|12872125|P4|STARTED|Period 4||3
5235581|NCT00868790|12872126|P3|STARTED|Period 4||4
5235582|NCT00868790|12872127|P2|STARTED|Period 4||6
5235583|NCT00868790|12872128|P1|STARTED|Period 4||9
5235584|NCT00868790|12872115|P14|NOT COMPLETED|Period 3||0
5235585|NCT00868790|12872116|P13|NOT COMPLETED|Period 3||0
5235586|NCT00868790|12872117|P12|NOT COMPLETED|Period 3||0
5235587|NCT00868790|12872118|P11|NOT COMPLETED|Period 3||1
5235588|NCT00868790|12872119|P10|NOT COMPLETED|Period 3||1
5235589|NCT00868790|12872120|P9|NOT COMPLETED|Period 3||0
5235590|NCT00868790|12872121|P8|NOT COMPLETED|Period 3||0
5235591|NCT00868790|12872122|P7|NOT COMPLETED|Period 3||0
5235592|NCT00868790|12872123|P6|NOT COMPLETED|Period 3||0
5235593|NCT00868790|12872124|P5|NOT COMPLETED|Period 3||0
5235594|NCT00868790|12872125|P4|NOT COMPLETED|Period 3||1
5235595|NCT00868790|12872126|P3|NOT COMPLETED|Period 3||0
5235596|NCT00868790|12872127|P2|NOT COMPLETED|Period 3||0
5235597|NCT00868790|12872128|P1|NOT COMPLETED|Period 3||0
5235598|NCT00868790|12872115|P14|COMPLETED|Period 3||8
5235599|NCT00868790|12872116|P13|COMPLETED|Period 3||7
5235600|NCT00868790|12872117|P12|COMPLETED|Period 3||4
5235601|NCT00868790|12872118|P11|COMPLETED|Period 3||8
5235602|NCT00868790|12872119|P10|COMPLETED|Period 3||2
5235603|NCT00868790|12872120|P9|COMPLETED|Period 3||8
5235604|NCT00868790|12872121|P8|COMPLETED|Period 3||17
5235605|NCT00868790|12872122|P7|COMPLETED|Period 3||4
5235606|NCT00868790|12872123|P6|COMPLETED|Period 3||1
5235607|NCT00868790|12872124|P5|COMPLETED|Period 3||18
5235608|NCT00868790|12872125|P4|COMPLETED|Period 3||3
5235609|NCT00868790|12872126|P3|COMPLETED|Period 3||4
5235610|NCT00868790|12872127|P2|COMPLETED|Period 3||6
5235611|NCT00868790|12872128|P1|COMPLETED|Period 3||9
5235612|NCT00868790|12872115|P14|STARTED|Period 3||8
5235613|NCT00868790|12872116|P13|STARTED|Period 3||7
5235614|NCT00868790|12872117|P12|STARTED|Period 3||4
5235615|NCT00868790|12872118|P11|STARTED|Period 3||9
5235616|NCT00868790|12872119|P10|STARTED|Period 3||3
5235617|NCT00868790|12872120|P9|STARTED|Period 3||8
5235618|NCT00868790|12872121|P8|STARTED|Period 3||17
5235619|NCT00868790|12872122|P7|STARTED|Period 3||4
5235620|NCT00868790|12872123|P6|STARTED|Period 3||1
5235621|NCT00868790|12872124|P5|STARTED|Period 3||18
5235622|NCT00868790|12872125|P4|STARTED|Period 3||4
5235623|NCT00868790|12872126|P3|STARTED|Period 3||4
5235624|NCT00868790|12872127|P2|STARTED|Period 3||6
5235625|NCT00868790|12872128|P1|STARTED|Period 3||9
5235626|NCT00868790|12872115|P14|NOT COMPLETED|Period 2||1
5235627|NCT00868790|12872116|P13|NOT COMPLETED|Period 2||0
5235628|NCT00868790|12872117|P12|NOT COMPLETED|Period 2||0
5235629|NCT00868790|12872118|P11|NOT COMPLETED|Period 2||0
5235630|NCT00868790|12872119|P10|NOT COMPLETED|Period 2||0
5235631|NCT00868790|12872120|P9|NOT COMPLETED|Period 2||2
5235632|NCT00868790|12872121|P8|NOT COMPLETED|Period 2||0
5235633|NCT00868790|12872122|P7|NOT COMPLETED|Period 2||0
5235634|NCT00868790|12872123|P6|NOT COMPLETED|Period 2||1
5235635|NCT00868790|12872124|P5|NOT COMPLETED|Period 2||0
5235636|NCT00868790|12872125|P4|NOT COMPLETED|Period 2||0
5235637|NCT00868790|12872126|P3|NOT COMPLETED|Period 2||0
5235638|NCT00868790|12872127|P2|NOT COMPLETED|Period 2||1
5235639|NCT00868790|12872128|P1|NOT COMPLETED|Period 2||0
5235640|NCT00868790|12872115|P14|COMPLETED|Period 2||8
5235641|NCT00868790|12872116|P13|COMPLETED|Period 2||7
5235642|NCT00868790|12872117|P12|COMPLETED|Period 2||4
5235643|NCT00868790|12872118|P11|COMPLETED|Period 2||9
5235644|NCT00868790|12872119|P10|COMPLETED|Period 2||3
5235645|NCT00868790|12872120|P9|COMPLETED|Period 2||8
5235646|NCT00868790|12872121|P8|COMPLETED|Period 2||17
5235647|NCT00868790|12872122|P7|COMPLETED|Period 2||4
5235648|NCT00868790|12872123|P6|COMPLETED|Period 2||1
5235649|NCT00868790|12872124|P5|COMPLETED|Period 2||18
5235650|NCT00868790|12872125|P4|COMPLETED|Period 2||4
5235651|NCT00868790|12872126|P3|COMPLETED|Period 2||4
5235652|NCT00868790|12872127|P2|COMPLETED|Period 2||6
5235653|NCT00868790|12872128|P1|COMPLETED|Period 2||9
5235654|NCT00868790|12872115|P14|STARTED|Period 2||9
5235655|NCT00868790|12872116|P13|STARTED|Period 2||7
5235656|NCT00868790|12872117|P12|STARTED|Period 2||4
5235657|NCT00868790|12872118|P11|STARTED|Period 2||9
5235658|NCT00868790|12872119|P10|STARTED|Period 2||3
5235659|NCT00868790|12872120|P9|STARTED|Period 2||10
5235660|NCT00868790|12872121|P8|STARTED|Period 2||17
5235661|NCT00868790|12872122|P7|STARTED|Period 2||4
5235662|NCT00868790|12872123|P6|STARTED|Period 2||2
5235663|NCT00868790|12872124|P5|STARTED|Period 2||18
5235664|NCT00868790|12872125|P4|STARTED|Period 2||4
5235665|NCT00868790|12872126|P3|STARTED|Period 2||4
5235666|NCT00868790|12872127|P2|STARTED|Period 2||7
5235667|NCT00868790|12872128|P1|STARTED|Period 2||9
5235668|NCT00868790|12872115|P14|NOT COMPLETED|Period 1||2
5235669|NCT00868790|12872116|P13|NOT COMPLETED|Period 1||0
5235670|NCT00868790|12872117|P12|NOT COMPLETED|Period 1||0
5235671|NCT00868790|12872118|P11|NOT COMPLETED|Period 1||0
5235672|NCT00868790|12872119|P10|NOT COMPLETED|Period 1||0
5235673|NCT00868790|12872120|P9|NOT COMPLETED|Period 1||1
5235674|NCT00868790|12872121|P8|NOT COMPLETED|Period 1||3
5235675|NCT00868790|12872122|P7|NOT COMPLETED|Period 1||0
5235676|NCT00868790|12872123|P6|NOT COMPLETED|Period 1||1
5235677|NCT00868790|12872124|P5|NOT COMPLETED|Period 1||1
5235678|NCT00868790|12872125|P4|NOT COMPLETED|Period 1||0
5235679|NCT00868790|12872126|P3|NOT COMPLETED|Period 1||0
5235680|NCT00868790|12872127|P2|NOT COMPLETED|Period 1||1
5235681|NCT00868790|12872128|P1|NOT COMPLETED|Period 1||2
5235682|NCT00868790|12872115|P14|COMPLETED|Period 1||9
5235683|NCT00868790|12872116|P13|COMPLETED|Period 1||7
5235684|NCT00868790|12872117|P12|COMPLETED|Period 1||4
5235685|NCT00868790|12872118|P11|COMPLETED|Period 1||9
5235686|NCT00868790|12872119|P10|COMPLETED|Period 1||3
5235687|NCT00868790|12872120|P9|COMPLETED|Period 1||10
5235688|NCT00868790|12872121|P8|COMPLETED|Period 1||17
5235689|NCT00868790|12872122|P7|COMPLETED|Period 1||4
5235690|NCT00868790|12872123|P6|COMPLETED|Period 1||2
5235691|NCT00868790|12872124|P5|COMPLETED|Period 1||18
5235692|NCT00868790|12872125|P4|COMPLETED|Period 1||4
5235693|NCT00868790|12872126|P3|COMPLETED|Period 1||4
5235694|NCT00868790|12872127|P2|COMPLETED|Period 1||7
5235695|NCT00868790|12872128|P1|COMPLETED|Period 1||9
5235696|NCT00868790|12872115|P14|STARTED|Period 1||11
5235697|NCT00868790|12872116|P13|STARTED|Period 1||7
5235698|NCT00868790|12872117|P12|STARTED|Period 1||4
5235699|NCT00868790|12872118|P11|STARTED|Period 1||9
5235700|NCT00868790|12872119|P10|STARTED|Period 1||3
5235701|NCT00868790|12872120|P9|STARTED|Period 1||11
5235702|NCT00868790|12872121|P8|STARTED|Period 1||20
5235703|NCT00868790|12872122|P7|STARTED|Period 1||4
5235704|NCT00868790|12872123|P6|STARTED|Period 1||3
5235705|NCT00868790|12872124|P5|STARTED|Period 1||19
5235706|NCT00868790|12872125|P4|STARTED|Period 1||4
5235707|NCT00868790|12872126|P3|STARTED|Period 1||4
5235708|NCT00868790|12872127|P2|STARTED|Period 1||8
5235709|NCT00868790|12872128|P1|STARTED|Period 1||11
5235710|NCT00868751|12872165|P1|NOT COMPLETED|Overall Study||1
5235711|NCT00868751|12872165|P1|COMPLETED|Overall Study||0
5235712|NCT00868751|12872165|P1|STARTED|Overall Study||1
5235713|NCT00868712|12872176|P3|NOT COMPLETED|Overall Study||0
5235714|NCT00868712|12872177|P2|NOT COMPLETED|Overall Study||0
5235715|NCT00868712|12872178|P1|NOT COMPLETED|Overall Study||0
5235716|NCT00868712|12872176|P3|COMPLETED|Overall Study||28
5235717|NCT00868712|12872177|P2|COMPLETED|Overall Study||11
5235718|NCT00868712|12872178|P1|COMPLETED|Overall Study||31
5235719|NCT00868712|12872176|P3|STARTED|Overall Study||28
5235720|NCT00868712|12872177|P2|STARTED|Overall Study||11
5235721|NCT00868712|12872178|P1|STARTED|Overall Study||31
5235722|NCT00868699|12872192|P3|NOT COMPLETED|Overall Study||43
5235723|NCT00868699|12872193|P2|NOT COMPLETED|Overall Study||45
5235724|NCT00868699|12872194|P1|NOT COMPLETED|Overall Study||43
5235725|NCT00868699|12872192|P3|COMPLETED|Overall Study||123
5235726|NCT00868699|12872193|P2|COMPLETED|Overall Study||124
5235727|NCT00868699|12872194|P1|COMPLETED|Overall Study||127
5235728|NCT00868699|12872192|P3|Safety Population|Overall Study||164
5235729|NCT00868699|12872193|P2|Safety Population|Overall Study||167
5235730|NCT00868699|12872194|P1|Safety Population|Overall Study||168
5235731|NCT00868699|12872192|P3|Intent-to-Treat Population|Overall Study||161
5235732|NCT00868699|12872193|P2|Intent-to-Treat Population|Overall Study||162
5235733|NCT00868699|12872194|P1|Intent-to-Treat Population|Overall Study||162
5235734|NCT00868699|12872192|P3|STARTED|Overall Study||166
5235735|NCT00868699|12872193|P2|STARTED|Overall Study||169
5235736|NCT00868699|12872194|P1|STARTED|Overall Study||170
5235737|NCT00868608|12872211|P3|NOT COMPLETED|Overall Study||5
5235738|NCT00868608|12872212|P2|NOT COMPLETED|Overall Study||3
5235739|NCT00868608|12872213|P1|NOT COMPLETED|Overall Study||23
5235740|NCT00868608|12872211|P3|COMPLETED|Overall Study||0
5235741|NCT00868608|12872212|P2|COMPLETED|Overall Study||1
5235742|NCT00868608|12872213|P1|COMPLETED|Overall Study||49
5235743|NCT00868608|12872211|P3|STARTED|Overall Study||5
5235744|NCT00868608|12872212|P2|STARTED|Overall Study||4
5235745|NCT00868608|12872213|P1|STARTED|Overall Study||72
5235746|NCT00868530|12872237|P1|NOT COMPLETED|Overall Study||4
5235747|NCT00868530|12872237|P1|COMPLETED|Overall Study||49
5235748|NCT00868530|12872237|P1|STARTED|Overall Study||53
5235749|NCT00868517|12872252|P3|NOT COMPLETED|Overall Study||2
5235750|NCT00868517|12872253|P2|NOT COMPLETED|Overall Study||4
5235751|NCT00868517|12872254|P1|NOT COMPLETED|Overall Study||4
5235752|NCT00868517|12872252|P3|COMPLETED|Overall Study||9
5235753|NCT00868517|12872253|P2|COMPLETED|Overall Study||8
5235754|NCT00868517|12872254|P1|COMPLETED|Overall Study||8
5235755|NCT00868517|12872252|P3|STARTED|Overall Study||11
5235756|NCT00868517|12872253|P2|STARTED|Overall Study||12
5235757|NCT00868517|12872254|P1|STARTED|Overall Study||12
5235758|NCT00868452|12872279|P2|NOT COMPLETED|Overall Study||29
5235759|NCT00868452|12872280|P1|NOT COMPLETED|Overall Study||40
5235760|NCT00868452|12872279|P2|COMPLETED|Overall Study||136
5235761|NCT00868452|12872280|P1|COMPLETED|Overall Study||143
5235762|NCT00868452|12872279|P2|STARTED|Overall Study||165
5235763|NCT00868452|12872280|P1|STARTED|Overall Study||183
5235764|NCT00868439|12872292|P2|NOT COMPLETED|Overall Study||9
5235765|NCT00868439|12872293|P1|NOT COMPLETED|Overall Study||8
5235766|NCT00868439|12872292|P2|COMPLETED|Overall Study||40
5235767|NCT00868439|12872293|P1|COMPLETED|Overall Study||48
5235768|NCT00868439|12872292|P2|STARTED|Overall Study||49
5235769|NCT00868439|12872293|P1|STARTED|Overall Study||56
5235770|NCT00868374|12872311|P2|NOT COMPLETED|Overall Study||7
5235771|NCT00868374|12872312|P1|NOT COMPLETED|Overall Study||7
5235772|NCT00868374|12872311|P2|COMPLETED|Overall Study||4
5235773|NCT00868374|12872312|P1|COMPLETED|Overall Study||5
5235774|NCT00868374|12872311|P2|STARTED|Overall Study||11
5235775|NCT00868374|12872312|P1|STARTED|Overall Study||12
5235776|NCT00868348|12872320|P2|NOT COMPLETED|Overall Study||0
5235777|NCT00868348|12872321|P1|NOT COMPLETED|Overall Study||0
5235778|NCT00868348|12872320|P2|COMPLETED|Overall Study||30
5235779|NCT00868348|12872321|P1|COMPLETED|Overall Study||30
5235780|NCT00868348|12872320|P2|STARTED|Overall Study||30
5235781|NCT00868348|12872321|P1|STARTED|Overall Study||30
5235782|NCT00868309|12872339|P2|NOT COMPLETED|Overall Study||0
5235783|NCT00868309|12872340|P1|NOT COMPLETED|Overall Study||0
5235784|NCT00868309|12872339|P2|COMPLETED|Overall Study||6
5235785|NCT00868309|12872340|P1|COMPLETED|Overall Study||6
5235786|NCT00868309|12872339|P2|STARTED|Overall Study||6
5235787|NCT00868309|12872340|P1|STARTED|Overall Study||6
5235788|NCT00868296|12872350|P2|NOT COMPLETED|Overall Study||3
5235789|NCT00868296|12872351|P1|NOT COMPLETED|Overall Study||0
5235790|NCT00868296|12872350|P2|COMPLETED|Overall Study||43
5235791|NCT00868296|12872351|P1|COMPLETED|Overall Study||12
5235792|NCT00868296|12872350|P2|STARTED|Overall Study||46
5235793|NCT00868296|12872351|P1|STARTED|Overall Study||12
5235794|NCT00868231|12872359|P6|NOT COMPLETED|Treatment Period 3||0
5235795|NCT00868231|12872360|P5|NOT COMPLETED|Treatment Period 3||0
5235796|NCT00868231|12872361|P4|NOT COMPLETED|Treatment Period 3||0
5235797|NCT00868231|12872362|P3|NOT COMPLETED|Treatment Period 3||1
5235798|NCT00868231|12872363|P2|NOT COMPLETED|Treatment Period 3||0
5235799|NCT00868231|12872364|P1|NOT COMPLETED|Treatment Period 3||0
5235800|NCT00868231|12872359|P6|COMPLETED|Treatment Period 3||5
5235801|NCT00868231|12872360|P5|COMPLETED|Treatment Period 3||4
5235802|NCT00868231|12872361|P4|COMPLETED|Treatment Period 3||5
5235803|NCT00868231|12872362|P3|COMPLETED|Treatment Period 3||4
5235804|NCT00868231|12872363|P2|COMPLETED|Treatment Period 3||5
5235805|NCT00868231|12872364|P1|COMPLETED|Treatment Period 3||4
5235806|NCT00868231|12872359|P6|STARTED|Treatment Period 3||5
5235807|NCT00868231|12872360|P5|STARTED|Treatment Period 3||4
5235808|NCT00868231|12872361|P4|STARTED|Treatment Period 3||5
5235809|NCT00868231|12872362|P3|STARTED|Treatment Period 3||5
5235810|NCT00868231|12872363|P2|STARTED|Treatment Period 3||5
5235811|NCT00868231|12872364|P1|STARTED|Treatment Period 3||4
5235812|NCT00868231|12872359|P6|NOT COMPLETED|Treatment Period 2||0
5235813|NCT00868231|12872360|P5|NOT COMPLETED|Treatment Period 2||0
5235814|NCT00868231|12872361|P4|NOT COMPLETED|Treatment Period 2||0
5235815|NCT00868231|12872362|P3|NOT COMPLETED|Treatment Period 2||0
5235816|NCT00868231|12872363|P2|NOT COMPLETED|Treatment Period 2||0
5235817|NCT00868231|12872364|P1|NOT COMPLETED|Treatment Period 2||1
5235818|NCT00868231|12872359|P6|COMPLETED|Treatment Period 2||5
5235819|NCT00868231|12872360|P5|COMPLETED|Treatment Period 2||4
5235820|NCT00868231|12872361|P4|COMPLETED|Treatment Period 2||5
5235821|NCT00868231|12872362|P3|COMPLETED|Treatment Period 2||5
5235822|NCT00868231|12872363|P2|COMPLETED|Treatment Period 2||5
5235823|NCT00868231|12872364|P1|COMPLETED|Treatment Period 2||4
5235824|NCT00868231|12872359|P6|STARTED|Treatment Period 2||5
5235825|NCT00868231|12872360|P5|STARTED|Treatment Period 2||4
5235826|NCT00868231|12872361|P4|STARTED|Treatment Period 2||5
5235827|NCT00868231|12872362|P3|STARTED|Treatment Period 2||5
5235828|NCT00868231|12872363|P2|STARTED|Treatment Period 2||5
5235829|NCT00868231|12872364|P1|STARTED|Treatment Period 2||5
5235830|NCT00868231|12872359|P6|NOT COMPLETED|Treatment Period 1||0
5235831|NCT00868231|12872360|P5|NOT COMPLETED|Treatment Period 1||1
5235832|NCT00868231|12872361|P4|NOT COMPLETED|Treatment Period 1||0
5235833|NCT00868231|12872362|P3|NOT COMPLETED|Treatment Period 1||0
5235834|NCT00868231|12872363|P2|NOT COMPLETED|Treatment Period 1||0
5235835|NCT00868231|12872364|P1|NOT COMPLETED|Treatment Period 1||0
5235836|NCT00868231|12872359|P6|COMPLETED|Treatment Period 1||5
5235837|NCT00868231|12872360|P5|COMPLETED|Treatment Period 1||4
5235838|NCT00868231|12872361|P4|COMPLETED|Treatment Period 1||5
5235839|NCT00868231|12872362|P3|COMPLETED|Treatment Period 1||5
5235840|NCT00868231|12872363|P2|COMPLETED|Treatment Period 1||5
5235841|NCT00868231|12872364|P1|COMPLETED|Treatment Period 1||5
5235842|NCT00868231|12872359|P6|STARTED|Treatment Period 1||5
5235843|NCT00868231|12872360|P5|STARTED|Treatment Period 1||5
5235844|NCT00868231|12872361|P4|STARTED|Treatment Period 1||5
5235845|NCT00868231|12872362|P3|STARTED|Treatment Period 1||5
5235846|NCT00868231|12872363|P2|STARTED|Treatment Period 1||5
5235847|NCT00868231|12872364|P1|STARTED|Treatment Period 1||5
5235848|NCT00868218|12872409|P4|NOT COMPLETED|Overall Study||0
5235849|NCT00868218|12872410|P3|NOT COMPLETED|Overall Study||0
5235850|NCT00868218|12872411|P2|NOT COMPLETED|Overall Study||0
5235851|NCT00868218|12872412|P1|NOT COMPLETED|Overall Study||0
5235852|NCT00868218|12872409|P4|COMPLETED|Overall Study||15
5235853|NCT00868218|12872410|P3|COMPLETED|Overall Study||15
5235854|NCT00868218|12872411|P2|COMPLETED|Overall Study||15
5235855|NCT00868218|12872412|P1|COMPLETED|Overall Study||15
5235856|NCT00868218|12872409|P4|STARTED|Overall Study||15
5235857|NCT00868218|12872410|P3|STARTED|Overall Study||15
5235858|NCT00868218|12872411|P2|STARTED|Overall Study||15
5235859|NCT00868218|12872412|P1|STARTED|Overall Study||15
5235860|NCT00868192|12872430|P1|NOT COMPLETED|Overall Study||4
5235861|NCT00868192|12872430|P1|COMPLETED|Overall Study||34
5235862|NCT00868192|12872430|P1|STARTED|Overall Study||38
5235863|NCT00868166|12872447|P2|NOT COMPLETED|Overall Study||114
5235864|NCT00868166|12872448|P1|NOT COMPLETED|Overall Study||112
5235865|NCT00868166|12872447|P2|COMPLETED|Overall Study||139
5235866|NCT00868166|12872448|P1|COMPLETED|Overall Study||147
5235867|NCT00868166|12872447|P2|STARTED|Overall Study||253
5235868|NCT00868166|12872448|P1|STARTED|Overall Study||259
5235869|NCT00868140|12872470|P2|NOT COMPLETED|Overall Study||0
5235870|NCT00868140|12872471|P1|NOT COMPLETED|Overall Study||0
5235871|NCT00868140|12872470|P2|COMPLETED|Overall Study||25
5235872|NCT00868140|12872471|P1|COMPLETED|Overall Study||26
5235873|NCT00868140|12872470|P2|STARTED|Overall Study||25
5235874|NCT00868140|12872471|P1|STARTED|Overall Study||26
5235875|NCT00868101|12872489|P2|NOT COMPLETED|Overall Study||0
5235876|NCT00868101|12872490|P1|NOT COMPLETED|Overall Study||0
5235877|NCT00868101|12872489|P2|COMPLETED|Overall Study||10
5235878|NCT00868101|12872490|P1|COMPLETED|Overall Study||12
5235879|NCT00868101|12872489|P2|STARTED|Overall Study||10
5235880|NCT00868101|12872490|P1|STARTED|Overall Study||12
5235881|NCT00867932|12872502|P1|NOT COMPLETED|Overall Study||0
5235882|NCT00867932|12872502|P1|COMPLETED|Overall Study||7
5235883|NCT00867932|12872502|P1|Intent-to-Treat (ITT) Population|Overall Study||7
5235884|NCT00867932|12872502|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
5235885|NCT00867932|12872502|P1|Maintenance Phase|Overall Study||7
5235886|NCT00867932|12872502|P1|Induction Phase|Overall Study||7
5235887|NCT00867932|12872502|P1|STARTED|Overall Study||7
5235888|NCT00867815|12872510|P1|NOT COMPLETED|Overall Study||1
5235889|NCT00867815|12872510|P1|COMPLETED|Overall Study||9
5235890|NCT00867815|12872510|P1|STARTED|Overall Study||10
5235891|NCT00867659|12872516|P1|NOT COMPLETED|Overall Study||0
5235892|NCT00867659|12872516|P1|COMPLETED|Overall Study|January 2010|20
5235893|NCT00867659|12872516|P1|STARTED|Overall Study|October 2009|20
5235894|NCT00867568|12872521|P1|NOT COMPLETED|Overall Study||15
5235895|NCT00867568|12872521|P1|COMPLETED|Overall Study||3
5235896|NCT00867568|12872521|P1|STARTED|Overall Study||18
5235897|NCT00867529|12872530|P1|NOT COMPLETED|Overall Study||0
5235898|NCT00867529|12872530|P1|COMPLETED|Overall Study||63
5235899|NCT00867529|12872530|P1|STARTED|Overall Study||63
5235900|NCT00867503|12872538|P1|NOT COMPLETED|Overall Study||1
5235901|NCT00867503|12872538|P1|COMPLETED|Overall Study||9
5235902|NCT00867503|12872538|P1|STARTED|Overall Study||10
5235903|NCT00867490|12872544|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
5235904|NCT00867490|12872544|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
5235905|NCT00867490|12872544|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
5235906|NCT00867490|12872544|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
5235907|NCT00867490|12872544|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
5235908|NCT00867490|12872544|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
5235909|NCT00867490|12872544|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
5235910|NCT00867490|12872544|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
5235911|NCT00867490|12872544|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
5235912|NCT00867451|12872563|P2|NOT COMPLETED|Overall Study||0
5235913|NCT00867451|12872564|P1|NOT COMPLETED|Overall Study||0
5235914|NCT00867451|12872563|P2|COMPLETED|Overall Study||4
5235915|NCT00867451|12872564|P1|COMPLETED|Overall Study||4
5235916|NCT00867451|12872563|P2|STARTED|Overall Study||4
5235917|NCT00867451|12872564|P1|STARTED|Overall Study||4
5235918|NCT00867360|12872586|P2|NOT COMPLETED|Overall Study||1
5235919|NCT00867360|12872587|P1|NOT COMPLETED|Overall Study||1
5235920|NCT00867360|12872586|P2|COMPLETED|Overall Study||5
5235921|NCT00867360|12872587|P1|COMPLETED|Overall Study||3
5235922|NCT00867360|12872586|P2|STARTED|Overall Study||6
5235923|NCT00867360|12872587|P1|STARTED|Overall Study||4
5235924|NCT00867334|12872599|P2|NOT COMPLETED|Overall Study||1
5235925|NCT00867334|12872600|P1|NOT COMPLETED|Overall Study||2
5235926|NCT00867334|12872599|P2|COMPLETED|Overall Study||0
5235927|NCT00867334|12872600|P1|COMPLETED|Overall Study||4
5235928|NCT00867334|12872599|P2|STARTED|Overall Study||1
5235929|NCT00867334|12872600|P1|STARTED|Overall Study||6
5235930|NCT00867321|12872611|P6|NOT COMPLETED|Overall Study||0
5235931|NCT00867321|12872612|P5|NOT COMPLETED|Overall Study||0
5235932|NCT00867321|12872613|P4|NOT COMPLETED|Overall Study||0
5235933|NCT00867321|12872614|P3|NOT COMPLETED|Overall Study||0
5235934|NCT00867321|12872615|P2|NOT COMPLETED|Overall Study||1
5235935|NCT00867321|12872616|P1|NOT COMPLETED|Overall Study||0
5235936|NCT00867321|12872611|P6|COMPLETED|Overall Study||3
5235937|NCT00867321|12872612|P5|COMPLETED|Overall Study||5
5235938|NCT00867321|12872613|P4|COMPLETED|Overall Study||6
5235939|NCT00867321|12872614|P3|COMPLETED|Overall Study||3
5235940|NCT00867321|12872615|P2|COMPLETED|Overall Study||2
5235941|NCT00867321|12872616|P1|COMPLETED|Overall Study||4
5235942|NCT00867321|12872611|P6|STARTED|Overall Study||3
5235943|NCT00867321|12872612|P5|STARTED|Overall Study||5
5235944|NCT00867321|12872613|P4|STARTED|Overall Study||6
5235945|NCT00867321|12872614|P3|STARTED|Overall Study||3
5235946|NCT00867321|12872615|P2|STARTED|Overall Study||3
5235947|NCT00867321|12872616|P1|STARTED|Overall Study||4
5235948|NCT00867308|12872636|P2|NOT COMPLETED|Overall Study||18
5235949|NCT00867308|12872637|P1|NOT COMPLETED|Overall Study||9
5235950|NCT00867308|12872636|P2|COMPLETED|Overall Study||0
5235951|NCT00867308|12872637|P1|COMPLETED|Overall Study||0
5235952|NCT00867308|12872636|P2|STARTED|Overall Study||18
5235953|NCT00867308|12872637|P1|STARTED|Overall Study||9
5235954|NCT00867217|12872647|P2|NOT COMPLETED|Overall Study||10
5235955|NCT00867217|12872648|P1|NOT COMPLETED|Overall Study||3
5235956|NCT00867217|12872647|P2|COMPLETED|Overall Study||70
5235957|NCT00867217|12872648|P1|COMPLETED|Overall Study||77
5235958|NCT00867217|12872647|P2|STARTED|Overall Study||80
5235959|NCT00867217|12872648|P1|STARTED|Overall Study||80
5235960|NCT00867165|12872656|P2|NOT COMPLETED|Overall Study||0
5235961|NCT00867165|12872657|P1|NOT COMPLETED|Overall Study||4
5235962|NCT00867165|12872656|P2|COMPLETED|Overall Study||45
5235963|NCT00867165|12872657|P1|COMPLETED|Overall Study||89
5235964|NCT00867165|12872656|P2|STARTED|Overall Study||45
5235965|NCT00867165|12872657|P1|STARTED|Overall Study||93
5235966|NCT00867139|12872762|P3|NOT COMPLETED|Overall Study||1
5235967|NCT00867139|12872763|P2|NOT COMPLETED|Overall Study||0
5235968|NCT00867139|12872764|P1|NOT COMPLETED|Overall Study||0
5235969|NCT00867139|12872762|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
5235970|NCT00867139|12872763|P2|COMPLETED|Overall Study||1
5235971|NCT00867139|12872764|P1|COMPLETED|Overall Study||2
5235972|NCT00867139|12872762|P3|STARTED|Overall Study||4
5235973|NCT00867139|12872763|P2|STARTED|Overall Study||1
5235974|NCT00867139|12872764|P1|STARTED|Overall Study||2
5235975|NCT00867113|12872805|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
5235976|NCT00867113|12872805|P1|COMPLETED|Post Treatment After Survival Follow-up||57
5235977|NCT00867113|12872805|P1|STARTED|Post Treatment After Survival Follow-up||68
5235978|NCT00867113|12872805|P1|NOT COMPLETED|Treatment Period||45
5235979|NCT00867113|12872805|P1|COMPLETED|Treatment Period||46
5235980|NCT00867113|12872805|P1|Full Analysis Set (FAS)|Treatment Period||91
5235981|NCT00867113|12872805|P1|Safety Set|Treatment Period||91
5235982|NCT00867113|12872805|P1|STARTED|Treatment Period||91
5235983|NCT00867100|12872825|P13|NOT COMPLETED|Overall Study||0
5235984|NCT00867100|12872826|P12|NOT COMPLETED|Overall Study||0
5235985|NCT00867100|12872827|P11|NOT COMPLETED|Overall Study||1
5235986|NCT00867100|12872828|P10|NOT COMPLETED|Overall Study||0
5235987|NCT00867100|12872829|P9|NOT COMPLETED|Overall Study||0
5235988|NCT00867100|12872830|P8|NOT COMPLETED|Overall Study||0
5235989|NCT00867100|12872831|P7|NOT COMPLETED|Overall Study||1
5235990|NCT00867100|12872832|P6|NOT COMPLETED|Overall Study||0
5235991|NCT00867100|12872833|P5|NOT COMPLETED|Overall Study||0
5235992|NCT00867100|12872834|P4|NOT COMPLETED|Overall Study||0
5235993|NCT00867100|12872835|P3|NOT COMPLETED|Overall Study||0
5235994|NCT00867100|12872836|P2|NOT COMPLETED|Overall Study||1
5235995|NCT00867100|12872837|P1|NOT COMPLETED|Overall Study||0
5235996|NCT00867100|12872825|P13|COMPLETED|Overall Study||6
5235997|NCT00867100|12872826|P12|COMPLETED|Overall Study||6
5235998|NCT00867100|12872827|P11|COMPLETED|Overall Study||3
5235999|NCT00867100|12872828|P10|COMPLETED|Overall Study||6
5236000|NCT00867100|12872829|P9|COMPLETED|Overall Study||6
5236001|NCT00867100|12872830|P8|COMPLETED|Overall Study||3
5236002|NCT00867100|12872831|P7|COMPLETED|Overall Study||6
5236003|NCT00867100|12872832|P6|COMPLETED|Overall Study||6
5236004|NCT00867100|12872833|P5|COMPLETED|Overall Study||14
5236005|NCT00867100|12872834|P4|COMPLETED|Overall Study||8
5236006|NCT00867100|12872835|P3|COMPLETED|Overall Study||8
5236007|NCT00867100|12872836|P2|COMPLETED|Overall Study||4
5236008|NCT00867100|12872837|P1|COMPLETED|Overall Study||5
5236009|NCT00867100|12872825|P13|STARTED|Overall Study||6
5236010|NCT00867100|12872826|P12|STARTED|Overall Study||6
5236011|NCT00867100|12872827|P11|STARTED|Overall Study||4
5236012|NCT00867100|12872828|P10|STARTED|Overall Study||6
5236013|NCT00867100|12872829|P9|STARTED|Overall Study||6
5236014|NCT00867100|12872830|P8|STARTED|Overall Study||3
5236015|NCT00867100|12872831|P7|STARTED|Overall Study||7
5236016|NCT00867100|12872832|P6|STARTED|Overall Study||6
5236017|NCT00867100|12872833|P5|STARTED|Overall Study||14
5236018|NCT00867100|12872834|P4|STARTED|Overall Study||8
5236019|NCT00867100|12872835|P3|STARTED|Overall Study||8
5236020|NCT00867100|12872836|P2|STARTED|Overall Study||5
5236021|NCT00867100|12872837|P1|STARTED|Overall Study||5
5236022|NCT00867087|12872869|P1|NOT COMPLETED|Overall Study||42
5236023|NCT00867087|12872869|P1|COMPLETED|Overall Study||21
5236024|NCT00867087|12872869|P1|STARTED|Overall Study||63
5236025|NCT00867035|12872885|P2|NOT COMPLETED|Baseline to 1 Week||0
5236026|NCT00867035|12872886|P1|NOT COMPLETED|Baseline to 1 Week||1
5236027|NCT00867035|12872885|P2|COMPLETED|Baseline to 1 Week||8
5236028|NCT00867035|12872886|P1|COMPLETED|Baseline to 1 Week||11
5236029|NCT00867035|12872885|P2|STARTED|Baseline to 1 Week||8
5236030|NCT00867035|12872886|P1|STARTED|Baseline to 1 Week||12
5236031|NCT00867035|12872885|P2|NOT COMPLETED|Baseline to 4 Hours||0
5236032|NCT00867035|12872886|P1|NOT COMPLETED|Baseline to 4 Hours||0
5236033|NCT00867035|12872885|P2|COMPLETED|Baseline to 4 Hours||8
5236034|NCT00867035|12872886|P1|COMPLETED|Baseline to 4 Hours||12
5236035|NCT00867035|12872885|P2|STARTED|Baseline to 4 Hours||8
5236036|NCT00867035|12872886|P1|STARTED|Baseline to 4 Hours||12
5236037|NCT00867035|12872885|P2|NOT COMPLETED|Baseline to 2 Hours||0
5236038|NCT00867035|12872886|P1|NOT COMPLETED|Baseline to 2 Hours||0
5236039|NCT00867035|12872885|P2|COMPLETED|Baseline to 2 Hours||8
5236040|NCT00867035|12872886|P1|COMPLETED|Baseline to 2 Hours||12
5236041|NCT00867035|12872885|P2|STARTED|Baseline to 2 Hours||8
5236042|NCT00867035|12872886|P1|STARTED|Baseline to 2 Hours||12
5236043|NCT00867035|12872885|P2|NOT COMPLETED|Baseline to 1 Hour||1
5236044|NCT00867035|12872886|P1|NOT COMPLETED|Baseline to 1 Hour||1
5236045|NCT00867035|12872885|P2|COMPLETED|Baseline to 1 Hour||8
5236046|NCT00867035|12872886|P1|COMPLETED|Baseline to 1 Hour||12
5236047|NCT00867035|12872885|P2|STARTED|Baseline to 1 Hour||9
5236048|NCT00867035|12872886|P1|STARTED|Baseline to 1 Hour||13
5236049|NCT00867009|12872912|P1|NOT COMPLETED|Maintenance Period||4
5236050|NCT00867009|12872912|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
5236051|NCT00867009|12872912|P1|STARTED|Maintenance Period||51
5236052|NCT00867009|12872912|P1|NOT COMPLETED|Induction Period||62
5236053|NCT00867009|12872912|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
5236054|NCT00867009|12872912|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
5236055|NCT00867009|12872912|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
5236056|NCT00867009|12872912|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
5236057|NCT00866918|12872921|P2|NOT COMPLETED|Overall Study||12
5236058|NCT00866918|12872922|P1|NOT COMPLETED|Overall Study||16
5236059|NCT00866918|12872921|P2|COMPLETED|Overall Study||27
5236060|NCT00866918|12872922|P1|COMPLETED|Overall Study||53
5236061|NCT00866918|12872921|P2|STARTED|Overall Study||39
5236062|NCT00866918|12872922|P1|STARTED|Overall Study||69
5236063|NCT00866905|12872934|P1|NOT COMPLETED|Overall Study||33
5236064|NCT00866905|12872934|P1|COMPLETED|Overall Study||135
5236065|NCT00866905|12872934|P1|STARTED|Overall Study||168
5236066|NCT00866879|12872941|P2|NOT COMPLETED|Overall Study||0
5236067|NCT00866879|12872942|P1|NOT COMPLETED|Overall Study||0
5236068|NCT00866879|12872941|P2|COMPLETED|Overall Study||185
5236069|NCT00866879|12872942|P1|COMPLETED|Overall Study||90
5236070|NCT00866879|12872941|P2|STARTED|Overall Study||185
5236071|NCT00866879|12872942|P1|STARTED|Overall Study||90
5236072|NCT00866814|12872956|P1|NOT COMPLETED|Overall Study||20
5236073|NCT00866814|12872956|P1|COMPLETED|Overall Study||99
5236074|NCT00866814|12872956|P1|STARTED|Overall Study||119
5236075|NCT00866788|12872969|P4|NOT COMPLETED|Overall Study||5
5236076|NCT00866788|12872970|P3|NOT COMPLETED|Overall Study||2
5236077|NCT00866788|12872971|P2|NOT COMPLETED|Overall Study||6
5236078|NCT00866788|12872972|P1|NOT COMPLETED|Overall Study||6
5236079|NCT00866788|12872969|P4|COMPLETED|Overall Study||16
5236080|NCT00866788|12872970|P3|COMPLETED|Overall Study||23
5236081|NCT00866788|12872971|P2|COMPLETED|Overall Study||17
5236082|NCT00866788|12872972|P1|COMPLETED|Overall Study||15
5236083|NCT00866788|12872969|P4|STARTED|Overall Study||21
5236084|NCT00866788|12872970|P3|STARTED|Overall Study||25
5236085|NCT00866788|12872971|P2|STARTED|Overall Study||23
5236086|NCT00866788|12872972|P1|STARTED|Overall Study||21
5236087|NCT00866775|12873020|P2|NOT COMPLETED|Overall Study||52
5236088|NCT00866775|12873021|P1|NOT COMPLETED|Overall Study||36
5236089|NCT00866775|12873020|P2|COMPLETED|Overall Study||76
5236090|NCT00866775|12873021|P1|COMPLETED|Overall Study||29
5236091|NCT00866775|12873020|P2|STARTED|Overall Study||128
5236092|NCT00866775|12873021|P1|STARTED|Overall Study||65
5236093|NCT00866749|12873057|P1|NOT COMPLETED|Overall Study||0
5236094|NCT00866749|12873057|P1|COMPLETED|Overall Study||120
5236095|NCT00866749|12873057|P1|STARTED|Overall Study||120
5236096|NCT00866723|12873064|P1|NOT COMPLETED|Overall Study||5
5236097|NCT00866723|12873064|P1|COMPLETED|Overall Study||0
5236098|NCT00866723|12873064|P1|STARTED|Overall Study||5
5236099|NCT00866697|12873071|P2|NOT COMPLETED|Overall Study||228
5236100|NCT00866697|12873072|P1|NOT COMPLETED|Overall Study||214
5236101|NCT00866697|12873071|P2|COMPLETED|Overall Study||244
5236102|NCT00866697|12873072|P1|COMPLETED|Overall Study||254
5236103|NCT00866697|12873071|P2|STARTED|Overall Study||472
5236104|NCT00866697|12873072|P1|STARTED|Overall Study||468
5236105|NCT00866658|12873114|P2|NOT COMPLETED|Overall Study||21
5236106|NCT00866658|12873115|P1|NOT COMPLETED|Overall Study||13
5236107|NCT00866658|12873114|P2|COMPLETED|Overall Study||133
5236108|NCT00866658|12873115|P1|COMPLETED|Overall Study||144
5236109|NCT00866658|12873114|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
5236110|NCT00866658|12873115|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
5236111|NCT00866658|12873114|P2|Safety Population|Overall Study||154
5236112|NCT00866658|12873115|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
5236113|NCT00866658|12873114|P2|STARTED|Overall Study||154
5236114|NCT00866658|12873115|P1|STARTED|Overall Study|Randomized.|157
5236115|NCT00866619|12873147|P4|NOT COMPLETED|Overall Study||630
5236116|NCT00866619|12873148|P3|NOT COMPLETED|Overall Study||889
5236117|NCT00866619|12873149|P2|NOT COMPLETED|Overall Study||1270
5236118|NCT00866619|12873150|P1|NOT COMPLETED|Overall Study||1846
5236119|NCT00866619|12873147|P4|COMPLETED|Overall Study||1549
5236120|NCT00866619|12873148|P3|COMPLETED|Overall Study||2085
5236121|NCT00866619|12873149|P2|COMPLETED|Overall Study||3088
5236122|NCT00866619|12873150|P1|COMPLETED|Overall Study||4102
5236123|NCT00866619|12873147|P4|STARTED|Overall Study||2179
5236124|NCT00866619|12873148|P3|STARTED|Overall Study||2974
5236125|NCT00866619|12873149|P2|STARTED|Overall Study||4358
5236126|NCT00866619|12873150|P1|STARTED|Overall Study||5948
5236127|NCT00866606|12873470|P1|NOT COMPLETED|Overall Study||4
5236128|NCT00866606|12873470|P1|COMPLETED|Overall Study||31
5236129|NCT00866606|12873470|P1|STARTED|Overall Study||35
5236130|NCT00866359|12873484|P4|NOT COMPLETED|Observational Follow-Up Phase||0
5236131|NCT00866359|12873485|P3|NOT COMPLETED|Observational Follow-Up Phase||0
5236132|NCT00866359|12873486|P2|NOT COMPLETED|Observational Follow-Up Phase||0
5236133|NCT00866359|12873487|P1|NOT COMPLETED|Observational Follow-Up Phase||0
5236134|NCT00866359|12873484|P4|COMPLETED|Observational Follow-Up Phase||54
5236135|NCT00866359|12873485|P3|COMPLETED|Observational Follow-Up Phase||54
5236136|NCT00866359|12873486|P2|COMPLETED|Observational Follow-Up Phase||0
5236137|NCT00866359|12873487|P1|COMPLETED|Observational Follow-Up Phase||0
5236138|NCT00866359|12873484|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
5236139|NCT00866359|12873485|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
5236140|NCT00866359|12873486|P2|STARTED|Observational Follow-Up Phase||0
5236141|NCT00866359|12873487|P1|STARTED|Observational Follow-Up Phase||0
5236142|NCT00866359|12873484|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
5236143|NCT00866359|12873485|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
5236144|NCT00866359|12873486|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
5236145|NCT00866359|12873487|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
5236146|NCT00866359|12873484|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
5236147|NCT00866359|12873485|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
5236148|NCT00866359|12873486|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
5236149|NCT00866359|12873487|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
5236150|NCT00866359|12873484|P4|STARTED|Extension Phase (Day 86 to 169)||50
5236151|NCT00866359|12873485|P3|STARTED|Extension Phase (Day 86 to 169)||45
5236152|NCT00866359|12873486|P2|STARTED|Extension Phase (Day 86 to 169)||0
5236153|NCT00866359|12873487|P1|STARTED|Extension Phase (Day 86 to 169)||0
5236154|NCT00866359|12873484|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
5236155|NCT00866359|12873485|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
5236156|NCT00866359|12873486|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
5236157|NCT00866359|12873487|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
5236158|NCT00866359|12873484|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
5236159|NCT00866359|12873485|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
5236160|NCT00866359|12873486|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
5236161|NCT00866359|12873487|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
5236162|NCT00866359|12873484|P4|STARTED|Treatment Phase (Days 1 to 85)||0
5236163|NCT00866359|12873485|P3|STARTED|Treatment Phase (Days 1 to 85)||0
5236164|NCT00866359|12873486|P2|STARTED|Treatment Phase (Days 1 to 85)||55
5236165|NCT00866359|12873487|P1|STARTED|Treatment Phase (Days 1 to 85)||56
5236166|NCT00866333|12873543|P3|NOT COMPLETED|Overall Study||12
5236167|NCT00866333|12873544|P2|NOT COMPLETED|Overall Study||7
5236168|NCT00866333|12873545|P1|NOT COMPLETED|Overall Study||5
5236169|NCT00866333|12873543|P3|COMPLETED|Overall Study||4
5236170|NCT00866333|12873544|P2|COMPLETED|Overall Study||10
5236171|NCT00866333|12873545|P1|COMPLETED|Overall Study||11
5236172|NCT00866333|12873543|P3|STARTED|Overall Study||16
5236173|NCT00866333|12873544|P2|STARTED|Overall Study||17
5236174|NCT00866333|12873545|P1|STARTED|Overall Study||16
5236175|NCT00866320|12873562|P1|NOT COMPLETED|Overall Study||6
5236176|NCT00866320|12873562|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
5236177|NCT00866320|12873562|P1|STARTED|Overall Study||49
5236178|NCT00866307|12873569|P3|NOT COMPLETED|Consolidation/Maintenance||16
5236179|NCT00866307|12873570|P2|NOT COMPLETED|Consolidation/Maintenance||9
5236180|NCT00866307|12873571|P1|NOT COMPLETED|Consolidation/Maintenance||0
5236181|NCT00866307|12873569|P3|COMPLETED|Consolidation/Maintenance||14
5236182|NCT00866307|12873570|P2|COMPLETED|Consolidation/Maintenance||45
5236183|NCT00866307|12873571|P1|COMPLETED|Consolidation/Maintenance||0
5236184|NCT00866307|12873569|P3|STARTED|Consolidation/Maintenance||30
5236185|NCT00866307|12873570|P2|STARTED|Consolidation/Maintenance||54
5236186|NCT00866307|12873571|P1|STARTED|Consolidation/Maintenance||0
5236187|NCT00866307|12873569|P3|NOT COMPLETED|Induction||0
5236188|NCT00866307|12873570|P2|NOT COMPLETED|Induction||0
5236189|NCT00866307|12873571|P1|NOT COMPLETED|Induction||20
5236190|NCT00866307|12873569|P3|COMPLETED|Induction||0
5236191|NCT00866307|12873570|P2|COMPLETED|Induction||0
5236192|NCT00866307|12873571|P1|COMPLETED|Induction||84
5236193|NCT00866307|12873569|P3|STARTED|Induction||0
5236194|NCT00866307|12873570|P2|STARTED|Induction||0
5236195|NCT00866307|12873571|P1|STARTED|Induction||104
5236196|NCT00866294|12873581|P3|NOT COMPLETED|Overall Study||11
5236197|NCT00866294|12873582|P2|NOT COMPLETED|Overall Study||20
5236198|NCT00866294|12873583|P1|NOT COMPLETED|Overall Study||33
5236199|NCT00866294|12873581|P3|COMPLETED|Overall Study||72
5236200|NCT00866294|12873582|P2|COMPLETED|Overall Study||141
5236201|NCT00866294|12873583|P1|COMPLETED|Overall Study||139
5236202|NCT00866294|12873581|P3|STARTED|Overall Study||83
5236203|NCT00866294|12873582|P2|STARTED|Overall Study||161
5236204|NCT00866294|12873583|P1|STARTED|Overall Study||172
5236205|NCT00866281|12873612|P2|NOT COMPLETED|Overall Study||15
5236206|NCT00866281|12873613|P1|NOT COMPLETED|Overall Study||7
5236207|NCT00866281|12873612|P2|COMPLETED|Overall Study||0
5236208|NCT00866281|12873613|P1|COMPLETED|Overall Study||0
5236209|NCT00866281|12873612|P2|STARTED|Overall Study||15
5236210|NCT00866281|12873613|P1|STARTED|Overall Study||7
5236211|NCT00866177|12873629|P1|NOT COMPLETED|Overall Study||152
5236212|NCT00866177|12873629|P1|COMPLETED|Overall Study||15
5236213|NCT00866177|12873629|P1|STARTED|Overall Study||167
5236214|NCT00866047|12873633|P1|NOT COMPLETED|Follow-up Period||5
5236215|NCT00866047|12873633|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
5236216|NCT00866047|12873633|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
5236217|NCT00866047|12873633|P1|NOT COMPLETED|Treatment Period||48
5236218|NCT00866047|12873633|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
5236219|NCT00866047|12873633|P1|STARTED|Treatment Period||58
5236220|NCT00866034|12873651|P2|NOT COMPLETED|Overall Study||8
5236221|NCT00866034|12873652|P1|NOT COMPLETED|Overall Study||16
5236222|NCT00866034|12873651|P2|COMPLETED|Overall Study||301
5236223|NCT00866034|12873652|P1|COMPLETED|Overall Study||292
5236224|NCT00866034|12873651|P2|STARTED|Overall Study||309
5236225|NCT00866034|12873652|P1|STARTED|Overall Study||308
5236226|NCT00865904|12873665|P5|NOT COMPLETED|Overall Study||1
5236227|NCT00865904|12873666|P4|NOT COMPLETED|Overall Study||1
5236228|NCT00865904|12873667|P3|NOT COMPLETED|Overall Study||0
5236229|NCT00865904|12873668|P2|NOT COMPLETED|Overall Study||0
5236230|NCT00865904|12873669|P1|NOT COMPLETED|Overall Study||2
5236231|NCT00865904|12873665|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
5236232|NCT00865904|12873666|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
5236233|NCT00865904|12873667|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
5236234|NCT00865904|12873668|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
5236235|NCT00865904|12873669|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
5236236|NCT00865904|12873665|P5|STARTED|Overall Study|Randomized.|20
5236237|NCT00865904|12873666|P4|STARTED|Overall Study|Randomized.|18
5236238|NCT00865904|12873667|P3|STARTED|Overall Study|Randomized.|18
5236239|NCT00865904|12873668|P2|STARTED|Overall Study|Randomized.|18
5236240|NCT00865904|12873669|P1|STARTED|Overall Study|Randomized.|19
5236241|NCT00865709|12873726|P2|NOT COMPLETED|Long Term Follow-up||49
5236242|NCT00865709|12873727|P1|NOT COMPLETED|Long Term Follow-up||46
5236243|NCT00865709|12873726|P2|COMPLETED|Long Term Follow-up||33
5236244|NCT00865709|12873727|P1|COMPLETED|Long Term Follow-up||24
5236245|NCT00865709|12873726|P2|STARTED|Long Term Follow-up||82
5236246|NCT00865709|12873727|P1|STARTED|Long Term Follow-up||70
5236247|NCT00865709|12873726|P2|NOT COMPLETED|Active Follow-up||1
5236248|NCT00865709|12873727|P1|NOT COMPLETED|Active Follow-up||8
5236249|NCT00865709|12873726|P2|COMPLETED|Active Follow-up||15
5236250|NCT00865709|12873727|P1|COMPLETED|Active Follow-up||17
5236251|NCT00865709|12873726|P2|STARTED|Active Follow-up||16
5236252|NCT00865709|12873727|P1|STARTED|Active Follow-up||25
5236253|NCT00865709|12873726|P2|NOT COMPLETED|Treatment||18
5236254|NCT00865709|12873727|P1|NOT COMPLETED|Treatment||30
5236255|NCT00865709|12873726|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
5236256|NCT00865709|12873727|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
5236257|NCT00865709|12873726|P2|Received Treatment|Treatment|Safety population|101
5236258|NCT00865709|12873727|P1|Received Treatment|Treatment|Safety population|97
5236259|NCT00865709|12873726|P2|STARTED|Treatment||101
5236260|NCT00865709|12873727|P1|STARTED|Treatment||97
5236261|NCT00865566|12873745|P2|NOT COMPLETED|Overall Study||687
5236262|NCT00865566|12873746|P1|NOT COMPLETED|Overall Study||624
5236263|NCT00865566|12873745|P2|COMPLETED|Overall Study||564
5236264|NCT00865566|12873746|P1|COMPLETED|Overall Study||629
5236265|NCT00865566|12873745|P2|Modified Intent-to-Treat Population|Overall Study||1245
5236266|NCT00865566|12873746|P1|Modified Intent-to-Treat Population|Overall Study||1251
5236267|NCT00865566|12873745|P2|STARTED|Overall Study||1251
5236268|NCT00865566|12873746|P1|STARTED|Overall Study||1253
5236269|NCT00865514|12873766|P1|NOT COMPLETED|Overall Study||2
5236270|NCT00865514|12873766|P1|COMPLETED|Overall Study||0
5236271|NCT00865514|12873766|P1|STARTED|Overall Study||2
5236272|NCT00865345|12873771|P1|NOT COMPLETED|Overall Study||2
5236273|NCT00865345|12873771|P1|COMPLETED|Overall Study||61
5236274|NCT00865345|12873771|P1|STARTED|Overall Study||63
5236275|NCT00865306|12873778|P2|NOT COMPLETED|One-Year Follow-Up||0
5236276|NCT00865306|12873779|P1|NOT COMPLETED|One-Year Follow-Up||0
5236277|NCT00865306|12873778|P2|COMPLETED|One-Year Follow-Up||15
5236278|NCT00865306|12873779|P1|COMPLETED|One-Year Follow-Up||29
5236279|NCT00865306|12873778|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
5236280|NCT00865306|12873779|P1|STARTED|One-Year Follow-Up||29
5236281|NCT00865306|12873778|P2|NOT COMPLETED|Controlled Trial||2
5236282|NCT00865306|12873779|P1|NOT COMPLETED|Controlled Trial||5
5236283|NCT00865306|12873778|P2|COMPLETED|Controlled Trial||28
5236284|NCT00865306|12873779|P1|COMPLETED|Controlled Trial||29
5236285|NCT00865306|12873778|P2|STARTED|Controlled Trial||30
5236286|NCT00865306|12873779|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
5236287|NCT00865202|12873791|P2|NOT COMPLETED|Overall Study||0
5236288|NCT00865202|12873792|P1|NOT COMPLETED|Overall Study||0
5236289|NCT00865202|12873791|P2|COMPLETED|Overall Study||149
5236290|NCT00865202|12873792|P1|COMPLETED|Overall Study||152
5236291|NCT00865202|12873791|P2|STARTED|Overall Study||149
5236292|NCT00865202|12873792|P1|STARTED|Overall Study||152
5236293|NCT00865189|12873808|P2|NOT COMPLETED|Overall Study||19
5236294|NCT00865189|12873809|P1|NOT COMPLETED|Overall Study||12
5236295|NCT00865189|12873808|P2|COMPLETED|Overall Study||26
5236296|NCT00865189|12873809|P1|COMPLETED|Overall Study||34
5236297|NCT00865189|12873808|P2|STARTED|Overall Study||45
5236298|NCT00865189|12873809|P1|STARTED|Overall Study||46
5236299|NCT00865124|12873837|P3|NOT COMPLETED|Overall Study||0
5236300|NCT00865124|12873838|P2|NOT COMPLETED|Overall Study||1
5236301|NCT00865124|12873839|P1|NOT COMPLETED|Overall Study||4
5236302|NCT00865124|12873837|P3|COMPLETED|Overall Study||17
5236303|NCT00865124|12873838|P2|COMPLETED|Overall Study||24
5236304|NCT00865124|12873839|P1|COMPLETED|Overall Study||23
5236305|NCT00865124|12873837|P3|STARTED|Overall Study||17
5236306|NCT00865124|12873838|P2|STARTED|Overall Study||25
5236307|NCT00865124|12873839|P1|STARTED|Overall Study||27
5236308|NCT00865098|12873856|P1|NOT COMPLETED|Overall Study||1
5236309|NCT00865098|12873856|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
5236310|NCT00865098|12873856|P1|STARTED|Overall Study||22
5236311|NCT00865046|12873868|P3|NOT COMPLETED|Overall Study||1
5236312|NCT00865046|12873869|P2|NOT COMPLETED|Overall Study||5
5236313|NCT00865046|12873870|P1|NOT COMPLETED|Overall Study||6
5236314|NCT00865046|12873868|P3|COMPLETED|Overall Study||62
5236315|NCT00865046|12873869|P2|COMPLETED|Overall Study||59
5236316|NCT00865046|12873870|P1|COMPLETED|Overall Study||57
5236317|NCT00865046|12873868|P3|STARTED|Overall Study||63
5236318|NCT00865046|12873869|P2|STARTED|Overall Study||64
5236319|NCT00865046|12873870|P1|STARTED|Overall Study||63
5236320|NCT00865020|12873880|P2|NOT COMPLETED|Overall Study||51
5236321|NCT00865020|12873881|P1|NOT COMPLETED|Overall Study||49
5236322|NCT00865020|12873880|P2|COMPLETED|Overall Study||357
5236323|NCT00865020|12873881|P1|COMPLETED|Overall Study||365
5236324|NCT00865020|12873880|P2|STARTED|Overall Study||408
5236325|NCT00865020|12873881|P1|STARTED|Overall Study||414
5236326|NCT00864916|12873897|P2|NOT COMPLETED|Overall Study||4
5236327|NCT00864916|12873898|P1|NOT COMPLETED|Overall Study||6
5236328|NCT00864916|12873897|P2|COMPLETED|Overall Study||5
5236329|NCT00864916|12873898|P1|COMPLETED|Overall Study||4
5236330|NCT00864916|12873897|P2|STARTED|Overall Study||9
5236331|NCT00864916|12873898|P1|STARTED|Overall Study||10
5236332|NCT00864851|12873907|P3|NOT COMPLETED|Overall Study||0
5236333|NCT00864851|12873908|P2|NOT COMPLETED|Overall Study||1
5236334|NCT00864851|12873909|P1|NOT COMPLETED|Overall Study||3
5236335|NCT00864851|12873907|P3|COMPLETED|Overall Study||5
5236336|NCT00864851|12873908|P2|COMPLETED|Overall Study||18
5236337|NCT00864851|12873909|P1|COMPLETED|Overall Study||17
5236338|NCT00864851|12873907|P3|STARTED|Overall Study||5
5236339|NCT00864851|12873908|P2|STARTED|Overall Study||19
5236340|NCT00864851|12873909|P1|STARTED|Overall Study||20
5236341|NCT00864721|12873943|P1|NOT COMPLETED|Overall Study||34
5236342|NCT00864721|12873943|P1|COMPLETED|Overall Study||29
5236343|NCT00864721|12873943|P1|STARTED|Overall Study||63
5236344|NCT00864708|12873951|P1|NOT COMPLETED|Overall Study||0
5236345|NCT00864708|12873951|P1|COMPLETED|Overall Study||1
5236346|NCT00864708|12873951|P1|STARTED|Overall Study||1
5236347|NCT00864682|12873963|P3|NOT COMPLETED|Overall Study||2
5236348|NCT00864682|12873964|P2|NOT COMPLETED|Overall Study||1
5236349|NCT00864682|12873965|P1|NOT COMPLETED|Overall Study||2
5236350|NCT00864682|12873963|P3|COMPLETED|Overall Study||51
5236351|NCT00864682|12873964|P2|COMPLETED|Overall Study||50
5236352|NCT00864682|12873965|P1|COMPLETED|Overall Study||50
5236353|NCT00864682|12873963|P3|STARTED|Overall Study||53
5236354|NCT00864682|12873964|P2|STARTED|Overall Study||51
5236355|NCT00864682|12873965|P1|STARTED|Overall Study||52
5236356|NCT00864539|12873985|P6|NOT COMPLETED|Overall Study||14
5236357|NCT00864539|12873986|P5|NOT COMPLETED|Overall Study||22
5236358|NCT00864539|12873987|P4|NOT COMPLETED|Overall Study||7
5236359|NCT00864539|12873988|P3|NOT COMPLETED|Overall Study||10
5236360|NCT00864539|12873989|P2|NOT COMPLETED|Overall Study||23
5236361|NCT00864539|12873990|P1|NOT COMPLETED|Overall Study||9
5236362|NCT00864539|12873985|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
5236363|NCT00864539|12873986|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
5236364|NCT00864539|12873987|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
5236365|NCT00864539|12873988|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
5236366|NCT00864539|12873989|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
5236367|NCT00864539|12873990|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
5236368|NCT00864539|12873985|P6|STARTED|Overall Study||85
5236369|NCT00864539|12873986|P5|STARTED|Overall Study||103
5236370|NCT00864539|12873987|P4|STARTED|Overall Study||96
5236371|NCT00864539|12873988|P3|STARTED|Overall Study||102
5236372|NCT00864539|12873989|P2|STARTED|Overall Study||95
5236373|NCT00864539|12873990|P1|STARTED|Overall Study||104
5236374|NCT00864513|12874004|P1|NOT COMPLETED|Overall Study||3
5236375|NCT00864513|12874004|P1|COMPLETED|Overall Study||12
5236376|NCT00864513|12874004|P1|STARTED|Overall Study||15
5236377|NCT00864474|12874011|P1|NOT COMPLETED|Overall Study||0
5236378|NCT00864474|12874011|P1|COMPLETED|Overall Study||68
5236379|NCT00864474|12874011|P1|STARTED|Overall Study||68
5236380|NCT00864383|12874052|P3|NOT COMPLETED|Modified Intent to Treat||85
5236381|NCT00864383|12874053|P2|NOT COMPLETED|Modified Intent to Treat||87
5236382|NCT00864383|12874054|P1|NOT COMPLETED|Modified Intent to Treat||85
5236383|NCT00864383|12874052|P3|COMPLETED|Modified Intent to Treat||551
5236384|NCT00864383|12874053|P2|COMPLETED|Modified Intent to Treat||568
5236385|NCT00864383|12874054|P1|COMPLETED|Modified Intent to Treat||555
5236386|NCT00864383|12874052|P3|STARTED|Modified Intent to Treat||636
5236387|NCT00864383|12874053|P2|STARTED|Modified Intent to Treat||655
5236388|NCT00864383|12874054|P1|STARTED|Modified Intent to Treat||640
5236389|NCT00864383|12874052|P3|NOT COMPLETED|Per- Protocol||112
5236390|NCT00864383|12874053|P2|NOT COMPLETED|Per- Protocol||141
5236391|NCT00864383|12874054|P1|NOT COMPLETED|Per- Protocol||130
5236392|NCT00864383|12874052|P3|COMPLETED|Per- Protocol||524
5236393|NCT00864383|12874053|P2|COMPLETED|Per- Protocol||514
5236394|NCT00864383|12874054|P1|COMPLETED|Per- Protocol||510
5236395|NCT00864383|12874052|P3|STARTED|Per- Protocol||636
5236396|NCT00864383|12874053|P2|STARTED|Per- Protocol||655
5236397|NCT00864383|12874054|P1|STARTED|Per- Protocol||640
5236398|NCT00864253|12874088|P2|NOT COMPLETED|Overall Study||58
5236399|NCT00864253|12874089|P1|NOT COMPLETED|Overall Study||99
5236400|NCT00864253|12874088|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
5236401|NCT00864253|12874089|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
5236402|NCT00864253|12874088|P2|Treated|Overall Study||258
5236403|NCT00864253|12874089|P1|Treated|Overall Study||257
5236404|NCT00864253|12874088|P2|STARTED|Overall Study||265
5236405|NCT00864253|12874089|P1|STARTED|Overall Study||264
5236406|NCT00864227|12874119|P1|NOT COMPLETED|Overall Study||4
5236407|NCT00864227|12874119|P1|COMPLETED|Overall Study||50
5236408|NCT00864227|12874119|P1|STARTED|Overall Study||54
5236409|NCT00864123|12874136|P2|NOT COMPLETED|Overall Study||0
5236410|NCT00864123|12874137|P1|NOT COMPLETED|Overall Study||0
5236411|NCT00864123|12874136|P2|COMPLETED|Overall Study||15
5236412|NCT00864123|12874137|P1|COMPLETED|Overall Study||15
5236413|NCT00864123|12874136|P2|STARTED|Overall Study||15
5236414|NCT00864123|12874137|P1|STARTED|Overall Study||15
5236415|NCT00864084|12874147|P1|NOT COMPLETED|Overall Study||3
5236416|NCT00864084|12874147|P1|COMPLETED|Overall Study||11
5236417|NCT00864084|12874147|P1|STARTED|Overall Study||14
5236418|NCT00864032|12874170|P3|NOT COMPLETED|Overall Study||0
5236419|NCT00864032|12874171|P2|NOT COMPLETED|Overall Study||0
5236420|NCT00864032|12874172|P1|NOT COMPLETED|Overall Study||0
5236421|NCT00864032|12874170|P3|COMPLETED|Overall Study||0
5236422|NCT00864032|12874171|P2|COMPLETED|Overall Study||5
5236423|NCT00864032|12874172|P1|COMPLETED|Overall Study||3
5236424|NCT00864032|12874170|P3|STARTED|Overall Study||0
5236425|NCT00864032|12874171|P2|STARTED|Overall Study||5
5236426|NCT00864032|12874172|P1|STARTED|Overall Study||3
5236427|NCT00863928|12874180|P2|NOT COMPLETED|Overall Study||0
5236428|NCT00863928|12874181|P1|NOT COMPLETED|Overall Study||36
5236429|NCT00863928|12874180|P2|COMPLETED|Overall Study||41
5236430|NCT00863928|12874181|P1|COMPLETED|Overall Study||58
5236431|NCT00863928|12874180|P2|STARTED|Overall Study||41
5236432|NCT00863928|12874181|P1|STARTED|Overall Study||94
5236433|NCT00863798|12874190|P3|NOT COMPLETED|Overall Study||25
5236434|NCT00863798|12874191|P2|NOT COMPLETED|Overall Study||30
5236435|NCT00863798|12874192|P1|NOT COMPLETED|Overall Study||32
5236436|NCT00863798|12874190|P3|COMPLETED|Overall Study||202
5236437|NCT00863798|12874191|P2|COMPLETED|Overall Study||198
5236438|NCT00863798|12874192|P1|COMPLETED|Overall Study||195
5236439|NCT00863798|12874190|P3|Treated|Overall Study||224
5236440|NCT00863798|12874191|P2|Treated|Overall Study||226
5236441|NCT00863798|12874192|P1|Treated|Overall Study||223
5236442|NCT00863798|12874190|P3|STARTED|Overall Study||227
5236443|NCT00863798|12874191|P2|STARTED|Overall Study||228
5236444|NCT00863798|12874192|P1|STARTED|Overall Study||227
5236445|NCT00863746|12874244|P2|NOT COMPLETED|Survival Follow up||280
5236446|NCT00863746|12874245|P1|NOT COMPLETED|Survival Follow up||253
5236447|NCT00863746|12874244|P2|COMPLETED|Survival Follow up||51
5236448|NCT00863746|12874245|P1|COMPLETED|Survival Follow up||45
5236449|NCT00863746|12874244|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
5236450|NCT00863746|12874245|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
5236451|NCT00863746|12874244|P2|NOT COMPLETED|Treatment||35
5236452|NCT00863746|12874245|P1|NOT COMPLETED|Treatment||71
5236453|NCT00863746|12874244|P2|COMPLETED|Treatment||318
5236454|NCT00863746|12874245|P1|COMPLETED|Treatment||279
5236455|NCT00863746|12874244|P2|Participants Received Treatment|Treatment|Safety population|351
5236456|NCT00863746|12874245|P1|Participants Received Treatment|Treatment|Safety population|346
5236457|NCT00863746|12874244|P2|STARTED|Treatment||353
5236458|NCT00863746|12874245|P1|STARTED|Treatment||350
5236459|NCT00863707|12874271|P2|NOT COMPLETED|Overall Study||3
5236460|NCT00863707|12874272|P1|NOT COMPLETED|Overall Study||4
5236461|NCT00863707|12874271|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
5236462|NCT00863707|12874272|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
5236463|NCT00863707|12874271|P2|STARTED|Overall Study||337
5236464|NCT00863707|12874272|P1|STARTED|Overall Study||174
5236465|NCT00863655|12874280|P2|NOT COMPLETED|Overall Study||239
5236466|NCT00863655|12874281|P1|NOT COMPLETED|Overall Study||485
5236467|NCT00863655|12874280|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
5236468|NCT00863655|12874281|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
5236469|NCT00863655|12874280|P2|STARTED|Overall Study||239
5236470|NCT00863655|12874281|P1|STARTED|Overall Study||485
5236471|NCT00863551|12874308|P1|NOT COMPLETED|Overall Study||0
5236472|NCT00863551|12874308|P1|COMPLETED|Overall Study||12
5236473|NCT00863551|12874308|P1|STARTED|Overall Study||12
5236474|NCT00863512|12874318|P2|NOT COMPLETED|Overall Study||0
5236475|NCT00863512|12874319|P1|NOT COMPLETED|Overall Study||14
5236476|NCT00863512|12874318|P2|COMPLETED|Overall Study||17
5236477|NCT00863512|12874319|P1|COMPLETED|Overall Study||3
5236478|NCT00863512|12874318|P2|STARTED|Overall Study||17
5236479|NCT00863512|12874319|P1|STARTED|Overall Study||17
5236480|NCT00863434|12874325|P1|NOT COMPLETED|Overall Study||0
5236481|NCT00863434|12874325|P1|COMPLETED|Overall Study||2
5236482|NCT00863434|12874325|P1|STARTED|Overall Study||2
5236483|NCT00863356|12874331|P1|NOT COMPLETED|Overall Study||0
5236484|NCT00863356|12874331|P1|COMPLETED|Overall Study||20
5236485|NCT00863356|12874331|P1|STARTED|Overall Study||20
5236486|NCT00863343|12874337|P2|NOT COMPLETED|Overall Study||0
5236487|NCT00863343|12874338|P1|NOT COMPLETED|Overall Study||0
5236488|NCT00863343|12874337|P2|COMPLETED|Overall Study||374
5236489|NCT00863343|12874338|P1|COMPLETED|Overall Study||17
5236490|NCT00863343|12874337|P2|STARTED|Overall Study||374
5236491|NCT00863343|12874338|P1|STARTED|Overall Study||17
5236492|NCT00863330|12874350|P1|NOT COMPLETED|Overall Study||6
5236493|NCT00863330|12874350|P1|COMPLETED|Overall Study||0
5236494|NCT00863330|12874350|P1|STARTED|Overall Study||6
5236495|NCT00863317|12874356|P2|NOT COMPLETED|Overall Study||9
5236496|NCT00863317|12874357|P1|NOT COMPLETED|Overall Study||8
5236497|NCT00863317|12874356|P2|COMPLETED|Overall Study||64
5236498|NCT00863317|12874357|P1|COMPLETED|Overall Study||60
5236499|NCT00863317|12874356|P2|STARTED|Overall Study||73
5236500|NCT00863317|12874357|P1|STARTED|Overall Study||68
5236501|NCT00863265|12874363|P6|NOT COMPLETED|Overall Study||0
5236502|NCT00863265|12874364|P5|NOT COMPLETED|Overall Study||1
5236503|NCT00863265|12874365|P4|NOT COMPLETED|Overall Study||0
5236504|NCT00863265|12874366|P3|NOT COMPLETED|Overall Study||0
5236505|NCT00863265|12874367|P2|NOT COMPLETED|Overall Study||0
5236506|NCT00863265|12874368|P1|NOT COMPLETED|Overall Study||0
5236507|NCT00863265|12874363|P6|COMPLETED|Overall Study||3
5236508|NCT00863265|12874364|P5|COMPLETED|Overall Study||3
5236509|NCT00863265|12874365|P4|COMPLETED|Overall Study||4
5236510|NCT00863265|12874366|P3|COMPLETED|Overall Study||4
5236511|NCT00863265|12874367|P2|COMPLETED|Overall Study||3
5236512|NCT00863265|12874368|P1|COMPLETED|Overall Study||4
5236513|NCT00863265|12874363|P6|STARTED|Overall Study||3
5236514|NCT00863265|12874364|P5|STARTED|Overall Study||4
5236515|NCT00863265|12874365|P4|STARTED|Overall Study||4
5236516|NCT00863265|12874366|P3|STARTED|Overall Study||4
5236517|NCT00863265|12874367|P2|STARTED|Overall Study||3
5236518|NCT00863265|12874368|P1|STARTED|Overall Study||4
5236519|NCT00863122|12874384|P2|NOT COMPLETED|Overall Study||0
5236520|NCT00863122|12874385|P1|NOT COMPLETED|Overall Study||0
5236521|NCT00863122|12874384|P2|COMPLETED|Overall Study||7
5236522|NCT00863122|12874385|P1|COMPLETED|Overall Study||19
5236523|NCT00863122|12874384|P2|STARTED|Overall Study||7
5236524|NCT00863122|12874385|P1|STARTED|Overall Study||19
5236525|NCT00863109|12874396|P1|NOT COMPLETED|Follow-up Period||11
5236526|NCT00863109|12874396|P1|COMPLETED|Follow-up Period||48
5236527|NCT00863109|12874396|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
5236528|NCT00863109|12874396|P1|NOT COMPLETED|Treatment Period||77
5236529|NCT00863109|12874396|P1|COMPLETED|Treatment Period||53
5236530|NCT00863109|12874396|P1|STARTED|Treatment Period||130
5236531|NCT00863057|12874413|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
5236532|NCT00863057|12874414|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
5236533|NCT00863057|12874415|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
5236534|NCT00863057|12874416|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
5236535|NCT00863057|12874413|P4|COMPLETED|Period 4 (Weeks 16-20)||2
5236536|NCT00863057|12874414|P3|COMPLETED|Period 4 (Weeks 16-20)||2
5236537|NCT00863057|12874415|P2|COMPLETED|Period 4 (Weeks 16-20)||1
5236538|NCT00863057|12874416|P1|COMPLETED|Period 4 (Weeks 16-20)||3
5236539|NCT00863057|12874413|P4|STARTED|Period 4 (Weeks 16-20)||2
5236540|NCT00863057|12874414|P3|STARTED|Period 4 (Weeks 16-20)||2
5236541|NCT00863057|12874415|P2|STARTED|Period 4 (Weeks 16-20)||1
5236542|NCT00863057|12874416|P1|STARTED|Period 4 (Weeks 16-20)||3
5236543|NCT00863057|12874413|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
5236544|NCT00863057|12874414|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
5236545|NCT00863057|12874415|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
5236546|NCT00863057|12874416|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
5236547|NCT00863057|12874413|P4|COMPLETED|Period 3 (Weeks 11-15)||2
5236548|NCT00863057|12874414|P3|COMPLETED|Period 3 (Weeks 11-15)||2
5236549|NCT00863057|12874415|P2|COMPLETED|Period 3 (Weeks 11-15)||1
5236550|NCT00863057|12874416|P1|COMPLETED|Period 3 (Weeks 11-15)||3
5236551|NCT00863057|12874413|P4|STARTED|Period 3 (Weeks 11-15)||2
5236552|NCT00863057|12874414|P3|STARTED|Period 3 (Weeks 11-15)||2
5236553|NCT00863057|12874415|P2|STARTED|Period 3 (Weeks 11-15)||1
5236554|NCT00863057|12874416|P1|STARTED|Period 3 (Weeks 11-15)||3
5236555|NCT00863057|12874413|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
5236556|NCT00863057|12874414|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
5236557|NCT00863057|12874415|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
5236558|NCT00863057|12874416|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
5236559|NCT00863057|12874413|P4|COMPLETED|Period 2 (Weeks 6-10)||2
5236560|NCT00863057|12874414|P3|COMPLETED|Period 2 (Weeks 6-10)||2
5236561|NCT00863057|12874415|P2|COMPLETED|Period 2 (Weeks 6-10)||1
5236562|NCT00863057|12874416|P1|COMPLETED|Period 2 (Weeks 6-10)||3
5236563|NCT00863057|12874413|P4|STARTED|Period 2 (Weeks 6-10)||3
5236564|NCT00863057|12874414|P3|STARTED|Period 2 (Weeks 6-10)||3
5236565|NCT00863057|12874415|P2|STARTED|Period 2 (Weeks 6-10)||2
5236566|NCT00863057|12874416|P1|STARTED|Period 2 (Weeks 6-10)||3
5236567|NCT00863057|12874413|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
5236568|NCT00863057|12874414|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
5236569|NCT00863057|12874415|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
5236570|NCT00863057|12874416|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
5236571|NCT00863057|12874413|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
5236572|NCT00863057|12874414|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
5236573|NCT00863057|12874415|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
5236574|NCT00863057|12874416|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
5236575|NCT00863057|12874413|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
5236576|NCT00863057|12874414|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
5236577|NCT00863057|12874415|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
5236578|NCT00863057|12874416|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
5236579|NCT00862979|12874474|P2|NOT COMPLETED|Overall Study||7
5236580|NCT00862979|12874475|P1|NOT COMPLETED|Overall Study||8
5236581|NCT00862979|12874474|P2|COMPLETED|Overall Study||71
5236582|NCT00862979|12874475|P1|COMPLETED|Overall Study||76
5236583|NCT00862979|12874474|P2|Full Analysis Set (FAS)|Overall Study||71
5236584|NCT00862979|12874475|P1|Full Analysis Set (FAS)|Overall Study||74
5236585|NCT00862979|12874474|P2|STARTED|Overall Study||78
5236586|NCT00862979|12874475|P1|STARTED|Overall Study||84
5236587|NCT00862940|12874493|P2|NOT COMPLETED|Overall Study||30
5236588|NCT00862940|12874494|P1|NOT COMPLETED|Overall Study||30
5236589|NCT00862940|12874493|P2|COMPLETED|Overall Study||114
5236590|NCT00862940|12874494|P1|COMPLETED|Overall Study||103
5236591|NCT00862940|12874493|P2|STARTED|Overall Study||144
5236592|NCT00862940|12874494|P1|STARTED|Overall Study||133
5236593|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 6||0
5236594|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 6||0
5236595|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 6||0
5236596|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 6||0
5236597|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 6||0
5236598|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 6||0
5236599|NCT00862849|12874506|P6|COMPLETED|Intervention 6||3
5236600|NCT00862849|12874507|P5|COMPLETED|Intervention 6||4
5236601|NCT00862849|12874508|P4|COMPLETED|Intervention 6||4
5236602|NCT00862849|12874509|P3|COMPLETED|Intervention 6||3
5236603|NCT00862849|12874510|P2|COMPLETED|Intervention 6||3
5236604|NCT00862849|12874511|P1|COMPLETED|Intervention 6||3
5236605|NCT00862849|12874506|P6|STARTED|Intervention 6||3
5236606|NCT00862849|12874507|P5|STARTED|Intervention 6||4
5236607|NCT00862849|12874508|P4|STARTED|Intervention 6||4
5236608|NCT00862849|12874509|P3|STARTED|Intervention 6||3
5236609|NCT00862849|12874510|P2|STARTED|Intervention 6||3
5236610|NCT00862849|12874511|P1|STARTED|Intervention 6||3
5236611|NCT00862849|12874506|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236612|NCT00862849|12874507|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236613|NCT00862849|12874508|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236614|NCT00862849|12874509|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236615|NCT00862849|12874510|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236616|NCT00862849|12874511|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
5236617|NCT00862849|12874506|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
5236618|NCT00862849|12874507|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
5236619|NCT00862849|12874508|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
5236620|NCT00862849|12874509|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
5236621|NCT00862849|12874510|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
5236622|NCT00862849|12874511|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
5236623|NCT00862849|12874506|P6|STARTED|Washout 5 (3 to 14 Days)||3
5236624|NCT00862849|12874507|P5|STARTED|Washout 5 (3 to 14 Days)||4
5236625|NCT00862849|12874508|P4|STARTED|Washout 5 (3 to 14 Days)||4
5236626|NCT00862849|12874509|P3|STARTED|Washout 5 (3 to 14 Days)||3
5236627|NCT00862849|12874510|P2|STARTED|Washout 5 (3 to 14 Days)||3
5236628|NCT00862849|12874511|P1|STARTED|Washout 5 (3 to 14 Days)||3
5236629|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 5||0
5236630|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 5||0
5236631|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 5||0
5236632|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 5||0
5236633|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 5||0
5236634|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 5||0
5236635|NCT00862849|12874506|P6|COMPLETED|Intervention 5||3
5236636|NCT00862849|12874507|P5|COMPLETED|Intervention 5||4
5236637|NCT00862849|12874508|P4|COMPLETED|Intervention 5||4
5236638|NCT00862849|12874509|P3|COMPLETED|Intervention 5||3
5236639|NCT00862849|12874510|P2|COMPLETED|Intervention 5||3
5236640|NCT00862849|12874511|P1|COMPLETED|Intervention 5||3
5236641|NCT00862849|12874506|P6|STARTED|Intervention 5||3
5236642|NCT00862849|12874507|P5|STARTED|Intervention 5||4
5236643|NCT00862849|12874508|P4|STARTED|Intervention 5||4
5236644|NCT00862849|12874509|P3|STARTED|Intervention 5||3
5236645|NCT00862849|12874510|P2|STARTED|Intervention 5||3
5236646|NCT00862849|12874511|P1|STARTED|Intervention 5||3
5236647|NCT00862849|12874506|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236648|NCT00862849|12874507|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236649|NCT00862849|12874508|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236650|NCT00862849|12874509|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236651|NCT00862849|12874510|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236652|NCT00862849|12874511|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
5236653|NCT00862849|12874506|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
5236654|NCT00862849|12874507|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
5236655|NCT00862849|12874508|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
5236656|NCT00862849|12874509|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
5236657|NCT00862849|12874510|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
5236658|NCT00862849|12874511|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
5236659|NCT00862849|12874506|P6|STARTED|Washout 4 (3 to 14 Days)||3
5236660|NCT00862849|12874507|P5|STARTED|Washout 4 (3 to 14 Days)||4
5236661|NCT00862849|12874508|P4|STARTED|Washout 4 (3 to 14 Days)||4
5236662|NCT00862849|12874509|P3|STARTED|Washout 4 (3 to 14 Days)||3
5236663|NCT00862849|12874510|P2|STARTED|Washout 4 (3 to 14 Days)||3
5236664|NCT00862849|12874511|P1|STARTED|Washout 4 (3 to 14 Days)||3
5236665|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 4||0
5236666|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 4||0
5236667|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 4||0
5236668|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 4||0
5236669|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 4||0
5236670|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 4||0
5236671|NCT00862849|12874506|P6|COMPLETED|Intervention 4||3
5236672|NCT00862849|12874507|P5|COMPLETED|Intervention 4||4
5236673|NCT00862849|12874508|P4|COMPLETED|Intervention 4||4
5236674|NCT00862849|12874509|P3|COMPLETED|Intervention 4||3
5236675|NCT00862849|12874510|P2|COMPLETED|Intervention 4||3
5236676|NCT00862849|12874511|P1|COMPLETED|Intervention 4||3
5236677|NCT00862849|12874506|P6|STARTED|Intervention 4||3
5236678|NCT00862849|12874507|P5|STARTED|Intervention 4||4
5236679|NCT00862849|12874508|P4|STARTED|Intervention 4||4
5236680|NCT00862849|12874509|P3|STARTED|Intervention 4||3
5236681|NCT00862849|12874510|P2|STARTED|Intervention 4||3
5236682|NCT00862849|12874511|P1|STARTED|Intervention 4||3
5236683|NCT00862849|12874506|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236684|NCT00862849|12874507|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236685|NCT00862849|12874508|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236686|NCT00862849|12874509|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236687|NCT00862849|12874510|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236688|NCT00862849|12874511|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
5236689|NCT00862849|12874506|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
5236690|NCT00862849|12874507|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
5236691|NCT00862849|12874508|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
5236692|NCT00862849|12874509|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
5236693|NCT00862849|12874510|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
5236694|NCT00862849|12874511|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
5236695|NCT00862849|12874506|P6|STARTED|Washout 3 (3 to 14 Days)||3
5236696|NCT00862849|12874507|P5|STARTED|Washout 3 (3 to 14 Days)||4
5236697|NCT00862849|12874508|P4|STARTED|Washout 3 (3 to 14 Days)||4
5236698|NCT00862849|12874509|P3|STARTED|Washout 3 (3 to 14 Days)||3
5236699|NCT00862849|12874510|P2|STARTED|Washout 3 (3 to 14 Days)||3
5236700|NCT00862849|12874511|P1|STARTED|Washout 3 (3 to 14 Days)||3
5236701|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 3||0
5236702|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 3||0
5236703|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 3||0
5236704|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 3||0
5236705|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 3||0
5236706|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 3||0
5236707|NCT00862849|12874506|P6|COMPLETED|Intervention 3||3
5236708|NCT00862849|12874507|P5|COMPLETED|Intervention 3||4
5236709|NCT00862849|12874508|P4|COMPLETED|Intervention 3||4
5236710|NCT00862849|12874509|P3|COMPLETED|Intervention 3||3
5236711|NCT00862849|12874510|P2|COMPLETED|Intervention 3||3
5236712|NCT00862849|12874511|P1|COMPLETED|Intervention 3||3
5236713|NCT00862849|12874506|P6|STARTED|Intervention 3||3
5236714|NCT00862849|12874507|P5|STARTED|Intervention 3||4
5236715|NCT00862849|12874508|P4|STARTED|Intervention 3||4
5236716|NCT00862849|12874509|P3|STARTED|Intervention 3||3
5236717|NCT00862849|12874510|P2|STARTED|Intervention 3||3
5236718|NCT00862849|12874511|P1|STARTED|Intervention 3||3
5236719|NCT00862849|12874506|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5236720|NCT00862849|12874507|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5236721|NCT00862849|12874508|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5236722|NCT00862849|12874509|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5236723|NCT00862849|12874510|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
5236724|NCT00862849|12874511|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
5236725|NCT00862849|12874506|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
5236726|NCT00862849|12874507|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
5236727|NCT00862849|12874508|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
5236728|NCT00862849|12874509|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
5236729|NCT00862849|12874510|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
5236730|NCT00862849|12874511|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
5236731|NCT00862849|12874506|P6|STARTED|Washout 2 (3 to 14 Days)||3
5236732|NCT00862849|12874507|P5|STARTED|Washout 2 (3 to 14 Days)||4
5236733|NCT00862849|12874508|P4|STARTED|Washout 2 (3 to 14 Days)||4
5236734|NCT00862849|12874509|P3|STARTED|Washout 2 (3 to 14 Days)||3
5236735|NCT00862849|12874510|P2|STARTED|Washout 2 (3 to 14 Days)||4
5236736|NCT00862849|12874511|P1|STARTED|Washout 2 (3 to 14 Days)||3
5236737|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 2||0
5236738|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 2||0
5236739|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 2||0
5236740|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 2||0
5236741|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 2||0
5236742|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 2||0
5236743|NCT00862849|12874506|P6|COMPLETED|Intervention 2||3
5236744|NCT00862849|12874507|P5|COMPLETED|Intervention 2||4
5236745|NCT00862849|12874508|P4|COMPLETED|Intervention 2||4
5236746|NCT00862849|12874509|P3|COMPLETED|Intervention 2||3
5236747|NCT00862849|12874510|P2|COMPLETED|Intervention 2||4
5236748|NCT00862849|12874511|P1|COMPLETED|Intervention 2||3
5236749|NCT00862849|12874506|P6|STARTED|Intervention 2||3
5236750|NCT00862849|12874507|P5|STARTED|Intervention 2||4
5236751|NCT00862849|12874508|P4|STARTED|Intervention 2||4
5236752|NCT00862849|12874509|P3|STARTED|Intervention 2||3
5236753|NCT00862849|12874510|P2|STARTED|Intervention 2||4
5236754|NCT00862849|12874511|P1|STARTED|Intervention 2||3
5236755|NCT00862849|12874506|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5236756|NCT00862849|12874507|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5236757|NCT00862849|12874508|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5236758|NCT00862849|12874509|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5236759|NCT00862849|12874510|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
5236760|NCT00862849|12874511|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
5236761|NCT00862849|12874506|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
5236762|NCT00862849|12874507|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
5236763|NCT00862849|12874508|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
5236764|NCT00862849|12874509|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
5236765|NCT00862849|12874510|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
5236766|NCT00862849|12874511|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
5236767|NCT00862849|12874506|P6|STARTED|Washout 1 (3 to 14 Days)||3
5236768|NCT00862849|12874507|P5|STARTED|Washout 1 (3 to 14 Days)||4
5236769|NCT00862849|12874508|P4|STARTED|Washout 1 (3 to 14 Days)||4
5236770|NCT00862849|12874509|P3|STARTED|Washout 1 (3 to 14 Days)||3
5236771|NCT00862849|12874510|P2|STARTED|Washout 1 (3 to 14 Days)||5
5236772|NCT00862849|12874511|P1|STARTED|Washout 1 (3 to 14 Days)||3
5236773|NCT00862849|12874506|P6|NOT COMPLETED|Intervention 1||0
5236774|NCT00862849|12874507|P5|NOT COMPLETED|Intervention 1||0
5236775|NCT00862849|12874508|P4|NOT COMPLETED|Intervention 1||0
5236776|NCT00862849|12874509|P3|NOT COMPLETED|Intervention 1||0
5236777|NCT00862849|12874510|P2|NOT COMPLETED|Intervention 1||0
5236778|NCT00862849|12874511|P1|NOT COMPLETED|Intervention 1||0
5236779|NCT00862849|12874506|P6|COMPLETED|Intervention 1||3
5236780|NCT00862849|12874507|P5|COMPLETED|Intervention 1||4
5236781|NCT00862849|12874508|P4|COMPLETED|Intervention 1||4
5236782|NCT00862849|12874509|P3|COMPLETED|Intervention 1||3
5236783|NCT00862849|12874510|P2|COMPLETED|Intervention 1||5
5236784|NCT00862849|12874511|P1|COMPLETED|Intervention 1||3
5236785|NCT00862849|12874506|P6|Received at Least One Dose of Study Drug|Intervention 1||3
5236786|NCT00862849|12874507|P5|Received at Least One Dose of Study Drug|Intervention 1||4
5236787|NCT00862849|12874508|P4|Received at Least One Dose of Study Drug|Intervention 1||4
5236788|NCT00862849|12874509|P3|Received at Least One Dose of Study Drug|Intervention 1||3
5236789|NCT00862849|12874510|P2|Received at Least One Dose of Study Drug|Intervention 1||5
5236790|NCT00862849|12874511|P1|Received at Least One Dose of Study Drug|Intervention 1||3
5236791|NCT00862849|12874506|P6|STARTED|Intervention 1||3
5236792|NCT00862849|12874507|P5|STARTED|Intervention 1||4
5236793|NCT00862849|12874508|P4|STARTED|Intervention 1||4
5236794|NCT00862849|12874509|P3|STARTED|Intervention 1||3
5236795|NCT00862849|12874510|P2|STARTED|Intervention 1||5
5236796|NCT00862849|12874511|P1|STARTED|Intervention 1||3
5236797|NCT00862836|12874534|P1|NOT COMPLETED|Overall Study||1
5236798|NCT00862836|12874534|P1|COMPLETED|Overall Study||14
5236799|NCT00862836|12874534|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
5236800|NCT00862836|12874534|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
5236801|NCT00862836|12874534|P1|STARTED|Overall Study||15
5236802|NCT00862823|12874545|P2|NOT COMPLETED|Second Intervention||0
5236803|NCT00862823|12874546|P1|NOT COMPLETED|Second Intervention||0
5236804|NCT00862823|12874545|P2|COMPLETED|Second Intervention||9
5236805|NCT00862823|12874546|P1|COMPLETED|Second Intervention||5
5236806|NCT00862823|12874545|P2|STARTED|Second Intervention||9
5236807|NCT00862823|12874546|P1|STARTED|Second Intervention||5
5236808|NCT00862823|12874545|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5236809|NCT00862823|12874546|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5236810|NCT00862823|12874545|P2|COMPLETED|Washout Period of 2 Weeks||9
5236811|NCT00862823|12874546|P1|COMPLETED|Washout Period of 2 Weeks||5
5236812|NCT00862823|12874545|P2|STARTED|Washout Period of 2 Weeks||9
5236813|NCT00862823|12874546|P1|STARTED|Washout Period of 2 Weeks||5
5236814|NCT00862823|12874545|P2|NOT COMPLETED|First Intervention||1
5236815|NCT00862823|12874546|P1|NOT COMPLETED|First Intervention||1
5236816|NCT00862823|12874545|P2|COMPLETED|First Intervention||9
5236817|NCT00862823|12874546|P1|COMPLETED|First Intervention||5
5236818|NCT00862823|12874545|P2|STARTED|First Intervention||10
5236819|NCT00862823|12874546|P1|STARTED|First Intervention||6
5236820|NCT00862810|12874555|P2|NOT COMPLETED|Overall Study||4
5236821|NCT00862810|12874556|P1|NOT COMPLETED|Overall Study||4
5236822|NCT00862810|12874555|P2|COMPLETED|Overall Study||35
5236823|NCT00862810|12874556|P1|COMPLETED|Overall Study||29
5236824|NCT00862810|12874555|P2|STARTED|Overall Study||39
5236825|NCT00862810|12874556|P1|STARTED|Overall Study||33
5236826|NCT00862784|12874562|P1|NOT COMPLETED|Overall Study||0
5236827|NCT00862784|12874562|P1|COMPLETED|Overall Study||48
5236828|NCT00862784|12874562|P1|Received Any Amount of Study Drug|Overall Study||48
5236829|NCT00862784|12874562|P1|STARTED|Overall Study||48
5236830|NCT00862745|12874584|P2|NOT COMPLETED|Open-label Follow-up||49
5236831|NCT00862745|12874585|P1|NOT COMPLETED|Open-label Follow-up||39
5236832|NCT00862745|12874584|P2|COMPLETED|Open-label Follow-up||225
5236833|NCT00862745|12874585|P1|COMPLETED|Open-label Follow-up||229
5236834|NCT00862745|12874584|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
5236835|NCT00862745|12874585|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
5236836|NCT00862745|12874584|P2|NOT COMPLETED|Randomized Control Trial||39
5236837|NCT00862745|12874585|P1|NOT COMPLETED|Randomized Control Trial||38
5236838|NCT00862745|12874584|P2|COMPLETED|Randomized Control Trial||284
5236839|NCT00862745|12874585|P1|COMPLETED|Randomized Control Trial||284
5236840|NCT00862745|12874584|P2|STARTED|Randomized Control Trial||323
5236841|NCT00862745|12874585|P1|STARTED|Randomized Control Trial||322
5236842|NCT00862719|12874595|P4|NOT COMPLETED|Overall Study||1
5236843|NCT00862719|12874596|P3|NOT COMPLETED|Overall Study||4
5236844|NCT00862719|12874597|P2|NOT COMPLETED|Overall Study||6
5236845|NCT00862719|12874598|P1|NOT COMPLETED|Overall Study||10
5236846|NCT00862719|12874595|P4|COMPLETED|Overall Study||0
5236847|NCT00862719|12874596|P3|COMPLETED|Overall Study||0
5236848|NCT00862719|12874597|P2|COMPLETED|Overall Study||1
5236849|NCT00862719|12874598|P1|COMPLETED|Overall Study||7
5236850|NCT00862719|12874595|P4|STARTED|Overall Study||1
5236851|NCT00862719|12874596|P3|STARTED|Overall Study||4
5236852|NCT00862719|12874597|P2|STARTED|Overall Study||7
5236853|NCT00862719|12874598|P1|STARTED|Overall Study||17
5236854|NCT00862654|12874621|P4|NOT COMPLETED|Overall Study||6
5236855|NCT00862654|12874622|P3|NOT COMPLETED|Overall Study||6
5236856|NCT00862654|12874623|P2|NOT COMPLETED|Overall Study||8
5236857|NCT00862654|12874624|P1|NOT COMPLETED|Overall Study||6
5236858|NCT00862654|12874621|P4|COMPLETED|Overall Study||74
5236859|NCT00862654|12874622|P3|COMPLETED|Overall Study||76
5236860|NCT00862654|12874623|P2|COMPLETED|Overall Study||74
5236861|NCT00862654|12874624|P1|COMPLETED|Overall Study||76
5236862|NCT00862654|12874621|P4|STARTED|Overall Study||80
5236863|NCT00862654|12874622|P3|STARTED|Overall Study||82
5236864|NCT00862654|12874623|P2|STARTED|Overall Study||82
5236865|NCT00862654|12874624|P1|STARTED|Overall Study||82
5236866|NCT00862641|12874638|P4|NOT COMPLETED|Overall Study||4
5236867|NCT00862641|12874639|P3|NOT COMPLETED|Overall Study||1
5236868|NCT00862641|12874640|P2|NOT COMPLETED|Overall Study||4
5236869|NCT00862641|12874641|P1|NOT COMPLETED|Overall Study||1
5236870|NCT00862641|12874638|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
5236871|NCT00862641|12874639|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
5236872|NCT00862641|12874640|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
5236873|NCT00862641|12874641|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
5236874|NCT00862641|12874638|P4|STARTED|Overall Study||320
5236875|NCT00862641|12874639|P3|STARTED|Overall Study||152
5236876|NCT00862641|12874640|P2|STARTED|Overall Study||360
5236877|NCT00862641|12874641|P1|STARTED|Overall Study||177
5236878|NCT00862563|12874687|P4|NOT COMPLETED|Overall Study||5
5236879|NCT00862563|12874688|P3|NOT COMPLETED|Overall Study||6
5236880|NCT00862563|12874689|P2|NOT COMPLETED|Overall Study||4
5236881|NCT00862563|12874690|P1|NOT COMPLETED|Overall Study||4
5236882|NCT00862563|12874687|P4|COMPLETED|Overall Study||19
5236883|NCT00862563|12874688|P3|COMPLETED|Overall Study||15
5236884|NCT00862563|12874689|P2|COMPLETED|Overall Study||17
5236885|NCT00862563|12874690|P1|COMPLETED|Overall Study||15
5236886|NCT00862563|12874687|P4|STARTED|Overall Study||24
5236887|NCT00862563|12874688|P3|STARTED|Overall Study||21
5236888|NCT00862563|12874689|P2|STARTED|Overall Study||21
5236889|NCT00862563|12874690|P1|STARTED|Overall Study||19
5236890|NCT00862537|12874728|P1|NOT COMPLETED|Overall Study||7
5236891|NCT00862537|12874728|P1|COMPLETED|Overall Study||11
5236892|NCT00862537|12874728|P1|STARTED|Overall Study||18
5236893|NCT00862459|12874735|P3|NOT COMPLETED|Overall Study||6
5236894|NCT00862459|12874736|P2|NOT COMPLETED|Overall Study||8
5236895|NCT00862459|12874737|P1|NOT COMPLETED|Overall Study||6
5236896|NCT00862459|12874735|P3|COMPLETED|Overall Study||66
5236897|NCT00862459|12874736|P2|COMPLETED|Overall Study||85
5236898|NCT00862459|12874737|P1|COMPLETED|Overall Study||66
5236899|NCT00862459|12874735|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
5236900|NCT00862459|12874736|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
5236901|NCT00862459|12874737|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
5236902|NCT00862459|12874735|P3|STARTED|Overall Study||72
5236903|NCT00862459|12874736|P2|STARTED|Overall Study||93
5236904|NCT00862459|12874737|P1|STARTED|Overall Study||72
5236905|NCT00862277|12874884|P3|NOT COMPLETED|Overall Study||5
5236906|NCT00862277|12874885|P2|NOT COMPLETED|Overall Study||2
5236907|NCT00862277|12874886|P1|NOT COMPLETED|Overall Study||1
5236908|NCT00862277|12874884|P3|COMPLETED|Overall Study||100
5236909|NCT00862277|12874885|P2|COMPLETED|Overall Study||94
5236910|NCT00862277|12874886|P1|COMPLETED|Overall Study||560
5236911|NCT00862277|12874884|P3|STARTED|Overall Study||105
5236912|NCT00862277|12874885|P2|STARTED|Overall Study||96
5236913|NCT00862277|12874886|P1|STARTED|Overall Study||561
5236914|NCT00862251|12874900|P3|NOT COMPLETED|Overall Study||9
5236915|NCT00862251|12874901|P2|NOT COMPLETED|Overall Study||5
5236916|NCT00862251|12874902|P1|NOT COMPLETED|Overall Study||19
5236917|NCT00862251|12874900|P3|COMPLETED|Overall Study||315
5236918|NCT00862251|12874901|P2|COMPLETED|Overall Study||157
5236919|NCT00862251|12874902|P1|COMPLETED|Overall Study||303
5236920|NCT00862251|12874900|P3|STARTED|Overall Study||324
5236921|NCT00862251|12874901|P2|STARTED|Overall Study||162
5236922|NCT00862251|12874902|P1|STARTED|Overall Study||322
5236923|NCT00862186|12874955|P1|NOT COMPLETED|Overall Study||0
5236924|NCT00862186|12874955|P1|COMPLETED|Overall Study||15
5236925|NCT00862186|12874955|P1|STARTED|Overall Study||15
5236926|NCT00862134|12874962|P2|NOT COMPLETED|Overall Study||12
5236927|NCT00862134|12874963|P1|NOT COMPLETED|Overall Study||11
5236928|NCT00862134|12874962|P2|COMPLETED|Overall Study||11
5236929|NCT00862134|12874963|P1|COMPLETED|Overall Study||8
5236930|NCT00862134|12874962|P2|STARTED|Overall Study||23
5236931|NCT00862134|12874963|P1|STARTED|Overall Study||19
5236932|NCT00862121|12874975|P2|NOT COMPLETED|Overall Study||8
5236933|NCT00862121|12874976|P1|NOT COMPLETED|Overall Study||1
5236934|NCT00862121|12874975|P2|COMPLETED|Overall Study||4
5236935|NCT00862121|12874976|P1|COMPLETED|Overall Study||7
5236936|NCT00862121|12874975|P2|Safety Analysis Set|Overall Study||11
5236937|NCT00862121|12874976|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
5236938|NCT00862121|12874975|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
5236939|NCT00862121|12874976|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
5236940|NCT00862121|12874975|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
5236941|NCT00862121|12874976|P1|STARTED|Overall Study||8
5236942|NCT00862082|12874994|P2|NOT COMPLETED|Overall Study||1
5236943|NCT00862082|12874995|P1|NOT COMPLETED|Overall Study||5
5236944|NCT00862082|12874994|P2|COMPLETED|Overall Study||5
5236945|NCT00862082|12874995|P1|COMPLETED|Overall Study||3
5236946|NCT00862082|12874994|P2|STARTED|Overall Study||6
5236947|NCT00862082|12874995|P1|STARTED|Overall Study||8
5236948|NCT00861913|12875038|P1|NOT COMPLETED|Overall Study||0
5236949|NCT00861913|12875038|P1|COMPLETED|Overall Study||13
5236950|NCT00861913|12875038|P1|STARTED|Overall Study||13
5236951|NCT00861757|12875050|P4|NOT COMPLETED|Overall Study||9
5236952|NCT00861757|12875051|P3|NOT COMPLETED|Overall Study||18
5236953|NCT00861757|12875052|P2|NOT COMPLETED|Overall Study||15
5236954|NCT00861757|12875053|P1|NOT COMPLETED|Overall Study||9
5236955|NCT00861757|12875050|P4|COMPLETED|Overall Study||143
5236956|NCT00861757|12875051|P3|COMPLETED|Overall Study||137
5236957|NCT00861757|12875052|P2|COMPLETED|Overall Study||136
5236958|NCT00861757|12875053|P1|COMPLETED|Overall Study||145
5236959|NCT00861757|12875050|P4|STARTED|Overall Study||152
5236960|NCT00861757|12875051|P3|STARTED|Overall Study||155
5236961|NCT00861757|12875052|P2|STARTED|Overall Study||151
5236962|NCT00861757|12875053|P1|STARTED|Overall Study||154
5236963|NCT00861744|12875111|P4|NOT COMPLETED|Overall Study||33
5236964|NCT00861744|12875112|P3|NOT COMPLETED|Overall Study||24
5236965|NCT00861744|12875113|P2|NOT COMPLETED|Overall Study||29
5236966|NCT00861744|12875114|P1|NOT COMPLETED|Overall Study||17
5236967|NCT00861744|12875111|P4|COMPLETED|Overall Study||275
5236968|NCT00861744|12875112|P3|COMPLETED|Overall Study||280
5236969|NCT00861744|12875113|P2|COMPLETED|Overall Study||275
5236970|NCT00861744|12875114|P1|COMPLETED|Overall Study||287
5236971|NCT00861744|12875111|P4|STARTED|Overall Study||308
5236972|NCT00861744|12875112|P3|STARTED|Overall Study||304
5236973|NCT00861744|12875113|P2|STARTED|Overall Study||304
5236974|NCT00861744|12875114|P1|STARTED|Overall Study||304
5236975|NCT00861705|12875296|P4|NOT COMPLETED|Overall Study||1
5236976|NCT00861705|12875297|P3|NOT COMPLETED|Overall Study||0
5236977|NCT00861705|12875298|P2|NOT COMPLETED|Overall Study||3
5236978|NCT00861705|12875299|P1|NOT COMPLETED|Overall Study||7
5236979|NCT00861705|12875296|P4|COMPLETED|Overall Study||112
5236980|NCT00861705|12875297|P3|COMPLETED|Overall Study||113
5236981|NCT00861705|12875298|P2|COMPLETED|Overall Study||110
5236982|NCT00861705|12875299|P1|COMPLETED|Overall Study||108
5236983|NCT00861705|12875296|P4|STARTED|Overall Study||113
5236984|NCT00861705|12875297|P3|STARTED|Overall Study||113
5236985|NCT00861705|12875298|P2|STARTED|Overall Study||113
5236986|NCT00861705|12875299|P1|STARTED|Overall Study||115
5236987|NCT00861692|12875339|P1|NOT COMPLETED|Overall Study||6
5236988|NCT00861692|12875339|P1|COMPLETED|Overall Study||14
5236989|NCT00861692|12875339|P1|STARTED|Overall Study||20
5236990|NCT00861614|12875351|P2|NOT COMPLETED|Overall Study||368
5236991|NCT00861614|12875352|P1|NOT COMPLETED|Overall Study||371
5236992|NCT00861614|12875351|P2|COMPLETED|Overall Study||28
5236993|NCT00861614|12875352|P1|COMPLETED|Overall Study||22
5236994|NCT00861614|12875351|P2|STARTED|Overall Study||396
5236995|NCT00861614|12875352|P1|STARTED|Overall Study||393
5236996|NCT00861601|12875385|P3|NOT COMPLETED|Overall Study||0
5236997|NCT00861601|12875386|P2|NOT COMPLETED|Overall Study||0
5236998|NCT00861601|12875387|P1|NOT COMPLETED|Overall Study||0
5236999|NCT00861601|12875385|P3|COMPLETED|Overall Study||12
5237000|NCT00861601|12875386|P2|COMPLETED|Overall Study||14
5237001|NCT00861601|12875387|P1|COMPLETED|Overall Study||12
5237002|NCT00861601|12875385|P3|STARTED|Overall Study||12
5237003|NCT00861601|12875386|P2|STARTED|Overall Study||14
5237004|NCT00861601|12875387|P1|STARTED|Overall Study||12
5237005|NCT00861471|12875437|P1|NOT COMPLETED|Overall Study||9
5237006|NCT00861471|12875437|P1|COMPLETED|Overall Study||3
5237007|NCT00861471|12875437|P1|STARTED|Overall Study||12
5237008|NCT00861341|12875445|P1|NOT COMPLETED|Overall Study||2
5237009|NCT00861341|12875445|P1|COMPLETED|Overall Study||38
5237010|NCT00861341|12875445|P1|STARTED|Overall Study||40
5237011|NCT00861263|12875450|P1|NOT COMPLETED|Overall Study||0
5237012|NCT00861263|12875450|P1|COMPLETED|Overall Study||193
5237013|NCT00861263|12875450|P1|STARTED|Overall Study||193
5237014|NCT00861198|12875454|P1|NOT COMPLETED|Overall Study||5
5237015|NCT00861198|12875454|P1|COMPLETED|Overall Study||70
5237016|NCT00861198|12875454|P1|STARTED|Overall Study||75
5237017|NCT00861146|12875460|P2|NOT COMPLETED|Overall Study||8
5237018|NCT00861146|12875461|P1|NOT COMPLETED|Overall Study||20
5237019|NCT00861146|12875460|P2|COMPLETED|Overall Study||38
5237020|NCT00861146|12875461|P1|COMPLETED|Overall Study||85
5237021|NCT00861146|12875460|P2|Week 13 Assessment|Overall Study||38
5237022|NCT00861146|12875461|P1|Week 13 Assessment|Overall Study||85
5237023|NCT00861146|12875460|P2|Week 2 Assessment|Overall Study||45
5237024|NCT00861146|12875461|P1|Week 2 Assessment|Overall Study||97
5237025|NCT00861146|12875460|P2|STARTED|Overall Study||46
5237026|NCT00861146|12875461|P1|STARTED|Overall Study||105
5237027|NCT00860951|12875471|P1|NOT COMPLETED|Overall Study||7
5237028|NCT00860951|12875471|P1|COMPLETED|Overall Study||22
5237029|NCT00860951|12875471|P1|STARTED|Overall Study||29
5237030|NCT00860938|12875479|P2|NOT COMPLETED|Overall Study||8
5237031|NCT00860938|12875480|P1|NOT COMPLETED|Overall Study||14
5237032|NCT00860938|12875479|P2|COMPLETED|Overall Study||37
5237033|NCT00860938|12875480|P1|COMPLETED|Overall Study||31
5237034|NCT00860938|12875479|P2|STARTED|Overall Study||45
5237035|NCT00860938|12875480|P1|STARTED|Overall Study||45
5237036|NCT00860847|12875494|P2|NOT COMPLETED|Overall Study||5
5237037|NCT00860847|12875495|P1|NOT COMPLETED|Overall Study||4
5237038|NCT00860847|12875494|P2|COMPLETED|Overall Study||28
5237039|NCT00860847|12875495|P1|COMPLETED|Overall Study||28
5237040|NCT00860847|12875494|P2|STARTED|Overall Study||33
5237041|NCT00860847|12875495|P1|STARTED|Overall Study||32
5237042|NCT00860795|12875503|P2|NOT COMPLETED|Overall Study||0
5237043|NCT00860795|12875504|P1|NOT COMPLETED|Overall Study||0
5237044|NCT00860795|12875503|P2|COMPLETED|Overall Study||10
5237045|NCT00860795|12875504|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
5237046|NCT00860795|12875503|P2|Number to Complete Study Medication|Overall Study||10
5237047|NCT00860795|12875504|P1|Number to Complete Study Medication|Overall Study||9
5237048|NCT00860795|12875503|P2|STARTED|Overall Study||10
5237049|NCT00860795|12875504|P1|STARTED|Overall Study||10
5237050|NCT00860743|12875528|P2|NOT COMPLETED|Overall Study||0
5237051|NCT00860743|12875529|P1|NOT COMPLETED|Overall Study||3
5237052|NCT00860743|12875528|P2|COMPLETED|Overall Study||23
5237053|NCT00860743|12875529|P1|COMPLETED|Overall Study||37
5237054|NCT00860743|12875528|P2|STARTED|Overall Study||23
5237055|NCT00860743|12875529|P1|STARTED|Overall Study||40
5237056|NCT00860535|12875535|P1|NOT COMPLETED|Overall Study||1
5237057|NCT00860535|12875535|P1|COMPLETED|Overall Study||8
5237058|NCT00860535|12875535|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
5237059|NCT00860535|12875535|P1|STARTED|Overall Study||9
5237060|NCT00860470|12875542|P2|NOT COMPLETED|Overall Study||59
5237061|NCT00860470|12875543|P1|NOT COMPLETED|Overall Study||48
5237062|NCT00860470|12875542|P2|COMPLETED|Overall Study||22346
5237063|NCT00860470|12875543|P1|COMPLETED|Overall Study||22114
5237064|NCT00860470|12875542|P2|STARTED|Overall Study||22405
5237065|NCT00860470|12875543|P1|STARTED|Overall Study||22162
5237066|NCT00860457|12875567|P1|NOT COMPLETED|Overall Study||11
5237067|NCT00860457|12875567|P1|COMPLETED|Overall Study||11
5237068|NCT00860457|12875567|P1|STARTED|Overall Study||22
5237069|NCT00860405|12875573|P2|NOT COMPLETED|Overall Study||4
5237070|NCT00860405|12875574|P1|NOT COMPLETED|Overall Study||5
5237071|NCT00860405|12875573|P2|COMPLETED|Overall Study||26
5237072|NCT00860405|12875574|P1|COMPLETED|Overall Study|completed overall study|26
5237073|NCT00860405|12875573|P2|Day 28 Follow-up Performed|Overall Study||29
5237074|NCT00860405|12875574|P1|Day 28 Follow-up Performed|Overall Study||31
5237075|NCT00860405|12875573|P2|Completed Treatment|Overall Study||29
5237076|NCT00860405|12875574|P1|Completed Treatment|Overall Study||31
5237077|NCT00860405|12875573|P2|STARTED|Overall Study||30
5237078|NCT00860405|12875574|P1|STARTED|Overall Study||31
5237079|NCT00860314|12875598|P2|NOT COMPLETED|Overall Study||0
5237080|NCT00860314|12875599|P1|NOT COMPLETED|Overall Study||0
5237081|NCT00860314|12875598|P2|COMPLETED|Overall Study||48
5237082|NCT00860314|12875599|P1|COMPLETED|Overall Study||48
5237083|NCT00860314|12875598|P2|STARTED|Overall Study||48
5237084|NCT00860314|12875599|P1|STARTED|Overall Study||48
5237085|NCT00860262|12875614|P3|NOT COMPLETED|Overall Study||18
5237086|NCT00860262|12875615|P2|NOT COMPLETED|Overall Study||22
5237087|NCT00860262|12875616|P1|NOT COMPLETED|Overall Study||20
5237088|NCT00860262|12875614|P3|COMPLETED|Overall Study||202
5237089|NCT00860262|12875615|P2|COMPLETED|Overall Study||195
5237090|NCT00860262|12875616|P1|COMPLETED|Overall Study||401
5237091|NCT00860262|12875614|P3|STARTED|Overall Study||220
5237092|NCT00860262|12875615|P2|STARTED|Overall Study||217
5237093|NCT00860262|12875616|P1|STARTED|Overall Study||421
5237094|NCT00860249|12875729|P3|NOT COMPLETED|Overall Study||21
5237095|NCT00860249|12875730|P2|NOT COMPLETED|Overall Study||18
5237096|NCT00860249|12875731|P1|NOT COMPLETED|Overall Study||21
5237097|NCT00860249|12875729|P3|COMPLETED|Overall Study||0
5237098|NCT00860249|12875730|P2|COMPLETED|Overall Study||0
5237099|NCT00860249|12875731|P1|COMPLETED|Overall Study||0
5237100|NCT00860249|12875729|P3|STARTED|Overall Study||21
5237101|NCT00860249|12875730|P2|STARTED|Overall Study||18
5237102|NCT00860249|12875731|P1|STARTED|Overall Study||21
5237103|NCT00860171|12875742|P1|NOT COMPLETED|Overall Study||0
5237104|NCT00860171|12875742|P1|COMPLETED|Overall Study||16
5237105|NCT00860171|12875742|P1|STARTED|Overall Study||16
5237106|NCT00860158|12875751|P1|NOT COMPLETED|Overall Study||1
5237107|NCT00860158|12875751|P1|COMPLETED|Overall Study||0
5237108|NCT00860158|12875751|P1|STARTED|Overall Study||1
5237109|NCT00860067|12875763|P3|NOT COMPLETED|Overall Study||9
5237110|NCT00860067|12875764|P2|NOT COMPLETED|Overall Study||9
5237111|NCT00860067|12875765|P1|NOT COMPLETED|Overall Study||51
5237112|NCT00860067|12875763|P3|COMPLETED|Overall Study||292
5237113|NCT00860067|12875764|P2|COMPLETED|Overall Study||290
5237114|NCT00860067|12875765|P1|COMPLETED|Overall Study||1149
5237115|NCT00860067|12875763|P3|STARTED|Overall Study||301
5237116|NCT00860067|12875764|P2|STARTED|Overall Study||299
5237117|NCT00860067|12875765|P1|STARTED|Overall Study||1200
5237118|NCT00860028|12875825|P2|NOT COMPLETED|Smoking Cessation Phase||2
5237119|NCT00860028|12875826|P1|NOT COMPLETED|Smoking Cessation Phase||0
5237120|NCT00860028|12875825|P2|COMPLETED|Smoking Cessation Phase||12
5237121|NCT00860028|12875826|P1|COMPLETED|Smoking Cessation Phase||13
5237122|NCT00860028|12875825|P2|STARTED|Smoking Cessation Phase||14
5237123|NCT00860028|12875826|P1|STARTED|Smoking Cessation Phase||13
5237124|NCT00860028|12875825|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
5237125|NCT00860028|12875826|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
5237126|NCT00860028|12875825|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
5237127|NCT00860028|12875826|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
5237128|NCT00860028|12875825|P2|STARTED|Placebo Controlled Pretreatment Period||15
5237129|NCT00860028|12875826|P1|STARTED|Placebo Controlled Pretreatment Period||15
5237130|NCT00859976|12875838|P2|NOT COMPLETED|Overall Study||18
5237131|NCT00859976|12875839|P1|NOT COMPLETED|Overall Study||16
5237132|NCT00859976|12875838|P2|COMPLETED|Overall Study||67
5237133|NCT00859976|12875839|P1|COMPLETED|Overall Study||66
5237134|NCT00859976|12875838|P2|STARTED|Overall Study||85
5237135|NCT00859976|12875839|P1|STARTED|Overall Study||82
5237136|NCT00859950|12875855|P2|NOT COMPLETED|Overall Study||0
5237137|NCT00859950|12875856|P1|NOT COMPLETED|Overall Study||0
5237138|NCT00859950|12875855|P2|COMPLETED|Overall Study||21
5237139|NCT00859950|12875856|P1|COMPLETED|Overall Study||49
5237140|NCT00859950|12875855|P2|STARTED|Overall Study||21
5237141|NCT00859950|12875856|P1|STARTED|Overall Study||49
5237142|NCT00859937|12875864|P2|NOT COMPLETED|Overall Study||0
5237143|NCT00859937|12875865|P1|NOT COMPLETED|Overall Study||1
5237144|NCT00859937|12875864|P2|COMPLETED|Overall Study||14
5237145|NCT00859937|12875865|P1|COMPLETED|Overall Study||40
5237146|NCT00859937|12875864|P2|STARTED|Overall Study||14
5237147|NCT00859937|12875865|P1|STARTED|Overall Study||41
5237148|NCT00859898|12875880|P3|NOT COMPLETED|Overall Study||27
5237149|NCT00859898|12875881|P2|NOT COMPLETED|Overall Study||31
5237150|NCT00859898|12875882|P1|NOT COMPLETED|Overall Study||28
5237151|NCT00859898|12875880|P3|COMPLETED|Overall Study||181
5237152|NCT00859898|12875881|P2|COMPLETED|Overall Study||188
5237153|NCT00859898|12875882|P1|COMPLETED|Overall Study||183
5237154|NCT00859898|12875880|P3|STARTED|Overall Study||208
5237155|NCT00859898|12875881|P2|STARTED|Overall Study||219
5237156|NCT00859898|12875882|P1|STARTED|Overall Study||211
5237157|NCT00859833|12875923|P1|NOT COMPLETED|Overall Study||0
5237158|NCT00859833|12875923|P1|COMPLETED|Overall Study||30
5237159|NCT00859833|12875923|P1|STARTED|Overall Study||30
5237160|NCT00859651|12875930|P2|NOT COMPLETED|Overall Study||0
5237161|NCT00859651|12875931|P1|NOT COMPLETED|Overall Study||0
5237162|NCT00859651|12875930|P2|COMPLETED|Overall Study||22
5237163|NCT00859651|12875931|P1|COMPLETED|Overall Study||18
5237164|NCT00859651|12875930|P2|STARTED|Overall Study||22
5237165|NCT00859651|12875931|P1|STARTED|Overall Study||18
5237166|NCT00859638|12875941|P2|NOT COMPLETED|Overall Study||4
5237167|NCT00859638|12875942|P1|NOT COMPLETED|Overall Study||10
5237168|NCT00859638|12875941|P2|COMPLETED|Overall Study||55
5237169|NCT00859638|12875942|P1|COMPLETED|Overall Study||55
5237170|NCT00859638|12875941|P2|STARTED|Overall Study||59
5237171|NCT00859638|12875942|P1|STARTED|Overall Study||65
5237172|NCT00859586|12875948|P1|NOT COMPLETED|Overall Study||4
5237173|NCT00859586|12875948|P1|COMPLETED|Overall Study||4
5237174|NCT00859586|12875948|P1|STARTED|Overall Study||8
5237175|NCT00859573|12875954|P2|NOT COMPLETED|Overall Study||2
5237176|NCT00859573|12875955|P1|NOT COMPLETED|Overall Study||5
5237177|NCT00859573|12875954|P2|COMPLETED|Overall Study||1
5237178|NCT00859573|12875955|P1|COMPLETED|Overall Study||1
5237179|NCT00859573|12875954|P2|STARTED|Overall Study||3
5237180|NCT00859573|12875955|P1|STARTED|Overall Study||6
5237181|NCT00859547|12875961|P1|NOT COMPLETED|Overall Study||2
5237182|NCT00859547|12875961|P1|COMPLETED|Overall Study||28
5237183|NCT00859547|12875961|P1|STARTED|Overall Study||30
5237184|NCT00859521|12875974|P2|NOT COMPLETED|Second Intervention||0
5237185|NCT00859521|12875975|P1|NOT COMPLETED|Second Intervention||0
5237186|NCT00859521|12875974|P2|COMPLETED|Second Intervention||14
5237187|NCT00859521|12875975|P1|COMPLETED|Second Intervention||15
5237188|NCT00859521|12875974|P2|STARTED|Second Intervention||14
5237189|NCT00859521|12875975|P1|STARTED|Second Intervention||15
5237190|NCT00859521|12875974|P2|NOT COMPLETED|Washout||1
5237191|NCT00859521|12875975|P1|NOT COMPLETED|Washout||0
5237192|NCT00859521|12875974|P2|COMPLETED|Washout||14
5237193|NCT00859521|12875975|P1|COMPLETED|Washout||15
5237194|NCT00859521|12875974|P2|STARTED|Washout||15
5237195|NCT00859521|12875975|P1|STARTED|Washout||15
5237196|NCT00859521|12875974|P2|NOT COMPLETED|First Intervention||0
5237197|NCT00859521|12875975|P1|NOT COMPLETED|First Intervention||0
5237198|NCT00859521|12875974|P2|COMPLETED|First Intervention||15
5237199|NCT00859521|12875975|P1|COMPLETED|First Intervention||15
5237200|NCT00859521|12875974|P2|STARTED|First Intervention||15
5237201|NCT00859521|12875975|P1|STARTED|First Intervention||15
5237202|NCT00859508|12875985|P2|NOT COMPLETED|Overall Study||0
5237203|NCT00859508|12875986|P1|NOT COMPLETED|Overall Study||6
5237204|NCT00859508|12875985|P2|COMPLETED|Overall Study||37
5237205|NCT00859508|12875986|P1|COMPLETED|Overall Study||62
5237206|NCT00859508|12875985|P2|STARTED|Overall Study||37
5237207|NCT00859508|12875986|P1|STARTED|Overall Study||68
5237208|NCT00859469|12875992|P1|NOT COMPLETED|Overall Study||28
5237209|NCT00859469|12875992|P1|COMPLETED|Overall Study||1
5237210|NCT00859469|12875992|P1|6 Cycles|Overall Study||16
5237211|NCT00859469|12875992|P1|STARTED|Overall Study||29
5237212|NCT00859456|12875998|P1|NOT COMPLETED|Overall Study||8
5237213|NCT00859456|12875998|P1|COMPLETED|Overall Study||1
5237214|NCT00859456|12875998|P1|STARTED|Overall Study||9
5237215|NCT00859430|12876004|P2|NOT COMPLETED|Second Intervention||0
5237216|NCT00859430|12876005|P1|NOT COMPLETED|Second Intervention||0
5237217|NCT00859430|12876004|P2|COMPLETED|Second Intervention||10
5237218|NCT00859430|12876005|P1|COMPLETED|Second Intervention||11
5237219|NCT00859430|12876004|P2|STARTED|Second Intervention||10
5237220|NCT00859430|12876005|P1|STARTED|Second Intervention||11
5237221|NCT00859430|12876004|P2|NOT COMPLETED|First Intervention||1
5237222|NCT00859430|12876005|P1|NOT COMPLETED|First Intervention||0
5237223|NCT00859430|12876004|P2|COMPLETED|First Intervention||10
5237224|NCT00859430|12876005|P1|COMPLETED|First Intervention||11
5237225|NCT00859430|12876004|P2|STARTED|First Intervention||11
5237226|NCT00859430|12876005|P1|STARTED|First Intervention||11
5237227|NCT00859339|12876013|P1|NOT COMPLETED|Overall Study||0
5237228|NCT00859339|12876013|P1|COMPLETED|Overall Study||9
5237229|NCT00859339|12876013|P1|STARTED|Overall Study||9
5237230|NCT00859313|12876021|P1|NOT COMPLETED|Overall Study||4
5237231|NCT00859313|12876021|P1|COMPLETED|Overall Study||26
5237232|NCT00859313|12876021|P1|STARTED|Overall Study||30
5237233|NCT00859222|12876028|P5|NOT COMPLETED|Overall Study||15
5237234|NCT00859222|12876029|P4|NOT COMPLETED|Overall Study||24
5237235|NCT00859222|12876030|P3|NOT COMPLETED|Overall Study||6
5237236|NCT00859222|12876031|P2|NOT COMPLETED|Overall Study||3
5237237|NCT00859222|12876032|P1|NOT COMPLETED|Overall Study||3
5237238|NCT00859222|12876028|P5|COMPLETED|Overall Study||0
5237239|NCT00859222|12876029|P4|COMPLETED|Overall Study||0
5237240|NCT00859222|12876030|P3|COMPLETED|Overall Study||0
5237241|NCT00859222|12876031|P2|COMPLETED|Overall Study||0
5237242|NCT00859222|12876032|P1|COMPLETED|Overall Study||0
5237243|NCT00859222|12876028|P5|STARTED|Overall Study||15
5237244|NCT00859222|12876029|P4|STARTED|Overall Study||24
5237245|NCT00859222|12876030|P3|STARTED|Overall Study||6
5237246|NCT00859222|12876031|P2|STARTED|Overall Study||3
5237247|NCT00859222|12876032|P1|STARTED|Overall Study||3
5237248|NCT00859131|12876059|P2|NOT COMPLETED|Overall Study||0
5237249|NCT00859131|12876060|P1|NOT COMPLETED|Overall Study||0
5237250|NCT00859131|12876059|P2|COMPLETED|Overall Study||98
5237251|NCT00859131|12876060|P1|COMPLETED|Overall Study||102
5237252|NCT00859131|12876059|P2|STARTED|Overall Study||98
5237253|NCT00859131|12876060|P1|STARTED|Overall Study||102
5237254|NCT00859053|12876082|P4|NOT COMPLETED|Overall Study||0
5237255|NCT00859053|12876083|P3|NOT COMPLETED|Overall Study||0
5237256|NCT00859053|12876084|P2|NOT COMPLETED|Overall Study||0
5237257|NCT00859053|12876085|P1|NOT COMPLETED|Overall Study||0
5237258|NCT00859053|12876082|P4|COMPLETED|Overall Study||12
5237259|NCT00859053|12876083|P3|COMPLETED|Overall Study||6
5237260|NCT00859053|12876084|P2|COMPLETED|Overall Study||6
5237261|NCT00859053|12876085|P1|COMPLETED|Overall Study||6
5237262|NCT00859053|12876082|P4|STARTED|Overall Study||12
5237263|NCT00859053|12876083|P3|STARTED|Overall Study||6
5237264|NCT00859053|12876084|P2|STARTED|Overall Study||6
5237265|NCT00859053|12876085|P1|STARTED|Overall Study||6
5237266|NCT00859040|12876129|P2|NOT COMPLETED|Overall Study||0
5237267|NCT00859040|12876130|P1|NOT COMPLETED|Overall Study||0
5237268|NCT00859040|12876129|P2|COMPLETED|Overall Study||16
5237269|NCT00859040|12876130|P1|COMPLETED|Overall Study||18
5237270|NCT00859040|12876129|P2|STARTED|Overall Study||16
5237271|NCT00859040|12876130|P1|STARTED|Overall Study||18
5237272|NCT00859027|12876145|P2|NOT COMPLETED|Overall Study||5
5237273|NCT00859027|12876146|P1|NOT COMPLETED|Overall Study||5
5237274|NCT00859027|12876145|P2|COMPLETED|Overall Study||20
5237275|NCT00859027|12876146|P1|COMPLETED|Overall Study||20
5237276|NCT00859027|12876145|P2|STARTED|Overall Study||25
5237277|NCT00859027|12876146|P1|STARTED|Overall Study||25
5237278|NCT00859014|12876154|P1|NOT COMPLETED|Overall Study||5
5237279|NCT00859014|12876154|P1|COMPLETED|Overall Study||20
5237280|NCT00859014|12876154|P1|STARTED|Overall Study||25
5237281|NCT00858988|12876161|P2|NOT COMPLETED|Analysis||1
5237282|NCT00858988|12876162|P1|NOT COMPLETED|Analysis||2
5237283|NCT00858988|12876161|P2|COMPLETED|Analysis||72
5237284|NCT00858988|12876162|P1|COMPLETED|Analysis||72
5237285|NCT00858988|12876161|P2|STARTED|Analysis||73
5237286|NCT00858988|12876162|P1|STARTED|Analysis||74
5237287|NCT00858988|12876161|P2|NOT COMPLETED|Randomized and Allocation||0
5237288|NCT00858988|12876162|P1|NOT COMPLETED|Randomized and Allocation||0
5237289|NCT00858988|12876161|P2|COMPLETED|Randomized and Allocation||73
5237290|NCT00858988|12876162|P1|COMPLETED|Randomized and Allocation||74
5237291|NCT00858988|12876161|P2|STARTED|Randomized and Allocation||73
5237292|NCT00858988|12876162|P1|STARTED|Randomized and Allocation||74
5237293|NCT00858962|12876168|P1|NOT COMPLETED|Overall Study||0
5237294|NCT00858962|12876168|P1|COMPLETED|Overall Study||12
5237295|NCT00858962|12876168|P1|STARTED|Overall Study||12
5237296|NCT00858858|12876172|P1|NOT COMPLETED|Overall Study||18
5237297|NCT00858858|12876172|P1|COMPLETED|Overall Study||42
5237298|NCT00858858|12876172|P1|STARTED|Overall Study||60
5237299|NCT00858845|12876178|P2|NOT COMPLETED|Overall Study||1
5237300|NCT00858845|12876179|P1|NOT COMPLETED|Overall Study||0
5237301|NCT00858845|12876178|P2|COMPLETED|Overall Study||5
5237302|NCT00858845|12876179|P1|COMPLETED|Overall Study||5
5237303|NCT00858845|12876178|P2|STARTED|Overall Study||6
5237304|NCT00858845|12876179|P1|STARTED|Overall Study||5
5237305|NCT00858832|12876191|P2|NOT COMPLETED|Overall Study||1
5237306|NCT00858832|12876192|P1|NOT COMPLETED|Overall Study||1
5237307|NCT00858832|12876191|P2|COMPLETED|Overall Study||22
5237308|NCT00858832|12876192|P1|COMPLETED|Overall Study||20
5237309|NCT00858832|12876191|P2|STARTED|Overall Study||23
5237310|NCT00858832|12876192|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
5237311|NCT00858780|12876198|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
5237312|NCT00858780|12876199|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237313|NCT00858780|12876200|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237314|NCT00858780|12876201|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237315|NCT00858780|12876202|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237316|NCT00858780|12876198|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
5237317|NCT00858780|12876199|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237318|NCT00858780|12876200|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237319|NCT00858780|12876201|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237320|NCT00858780|12876202|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
5237321|NCT00858780|12876198|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
5237322|NCT00858780|12876199|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
5237323|NCT00858780|12876200|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
5237324|NCT00858780|12876201|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
5237325|NCT00858780|12876202|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
5237326|NCT00858780|12876198|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
5237327|NCT00858780|12876199|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
5237328|NCT00858780|12876200|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
5237329|NCT00858780|12876201|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
5237330|NCT00858780|12876202|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
5237331|NCT00858780|12876198|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
5237332|NCT00858780|12876199|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
5237333|NCT00858780|12876200|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
5237334|NCT00858780|12876201|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
5237335|NCT00858780|12876202|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
5237336|NCT00858780|12876198|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
5237337|NCT00858780|12876199|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
5237338|NCT00858780|12876200|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
5237339|NCT00858780|12876201|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
5237340|NCT00858780|12876202|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
5237341|NCT00858780|12876198|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237342|NCT00858780|12876199|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237343|NCT00858780|12876200|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237344|NCT00858780|12876201|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237345|NCT00858780|12876202|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
5237346|NCT00858780|12876198|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237347|NCT00858780|12876199|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237348|NCT00858780|12876200|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237349|NCT00858780|12876201|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237350|NCT00858780|12876202|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
5237351|NCT00858780|12876198|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237352|NCT00858780|12876199|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237353|NCT00858780|12876200|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237354|NCT00858780|12876201|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
5237355|NCT00858780|12876202|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
5237356|NCT00858702|12876277|P2|NOT COMPLETED|Overall Study||2
5237357|NCT00858702|12876278|P1|NOT COMPLETED|Overall Study||5
5237358|NCT00858702|12876277|P2|COMPLETED|Overall Study||50
5237359|NCT00858702|12876278|P1|COMPLETED|Overall Study||48
5237360|NCT00858702|12876277|P2|STARTED|Overall Study||52
5237361|NCT00858702|12876278|P1|STARTED|Overall Study||53
5237362|NCT00858689|12876286|P1|NOT COMPLETED|Overall Study||1
5237363|NCT00858689|12876286|P1|COMPLETED|Overall Study||19
5237364|NCT00858689|12876286|P1|STARTED|Overall Study||20
5237365|NCT00858637|12876293|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
5237366|NCT00858637|12876294|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
5237367|NCT00858637|12876295|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
5237368|NCT00858637|12876296|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
5237369|NCT00858637|12876297|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
5237370|NCT00858637|12876298|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
5237371|NCT00858637|12876293|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
5237372|NCT00858637|12876294|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
5237373|NCT00858637|12876295|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
5237374|NCT00858637|12876296|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
5237375|NCT00858637|12876297|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
5237376|NCT00858637|12876298|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
5237377|NCT00858637|12876293|P6|STARTED|Placebo-controlled Withdrawal Phase||59
5237378|NCT00858637|12876294|P5|STARTED|Placebo-controlled Withdrawal Phase||56
5237379|NCT00858637|12876295|P4|STARTED|Placebo-controlled Withdrawal Phase||0
5237380|NCT00858637|12876296|P3|STARTED|Placebo-controlled Withdrawal Phase||54
5237381|NCT00858637|12876297|P2|STARTED|Placebo-controlled Withdrawal Phase||49
5237382|NCT00858637|12876298|P1|STARTED|Placebo-controlled Withdrawal Phase||0
5237383|NCT00858637|12876293|P6|NOT COMPLETED|Active Comparison Phase||0
5237384|NCT00858637|12876294|P5|NOT COMPLETED|Active Comparison Phase||0
5237385|NCT00858637|12876295|P4|NOT COMPLETED|Active Comparison Phase||18
5237386|NCT00858637|12876296|P3|NOT COMPLETED|Active Comparison Phase||0
5237387|NCT00858637|12876297|P2|NOT COMPLETED|Active Comparison Phase||0
5237388|NCT00858637|12876298|P1|NOT COMPLETED|Active Comparison Phase||24
5237389|NCT00858637|12876293|P6|COMPLETED|Active Comparison Phase||0
5237390|NCT00858637|12876294|P5|COMPLETED|Active Comparison Phase||0
5237391|NCT00858637|12876295|P4|COMPLETED|Active Comparison Phase||115
5237392|NCT00858637|12876296|P3|COMPLETED|Active Comparison Phase||0
5237393|NCT00858637|12876297|P2|COMPLETED|Active Comparison Phase||0
5237394|NCT00858637|12876298|P1|COMPLETED|Active Comparison Phase||103
5237395|NCT00858637|12876293|P6|STARTED|Active Comparison Phase||0
5237396|NCT00858637|12876294|P5|STARTED|Active Comparison Phase||0
5237397|NCT00858637|12876295|P4|STARTED|Active Comparison Phase||133
5237398|NCT00858637|12876296|P3|STARTED|Active Comparison Phase||0
5237399|NCT00858637|12876297|P2|STARTED|Active Comparison Phase||0
5237400|NCT00858637|12876298|P1|STARTED|Active Comparison Phase||127
5237401|NCT00858507|12876310|P2|NOT COMPLETED|Overall Study||15
5237402|NCT00858507|12876311|P1|NOT COMPLETED|Overall Study||22
5237403|NCT00858507|12876310|P2|COMPLETED|Overall Study||101
5237404|NCT00858507|12876311|P1|COMPLETED|Overall Study||83
5237405|NCT00858507|12876310|P2|STARTED|Overall Study||116
5237406|NCT00858507|12876311|P1|STARTED|Overall Study||105
5237407|NCT00858494|12876317|P1|NOT COMPLETED|Overall Study||4
5237408|NCT00858494|12876317|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
5237409|NCT00858494|12876317|P1|STARTED|Overall Study||49
5237410|NCT00858468|12876324|P2|NOT COMPLETED|Overall Study||0
5237411|NCT00858468|12876325|P1|NOT COMPLETED|Overall Study||0
5237412|NCT00858468|12876324|P2|COMPLETED|Overall Study||192
5237413|NCT00858468|12876325|P1|COMPLETED|Overall Study||201
5237414|NCT00858468|12876324|P2|STARTED|Overall Study||192
5237415|NCT00858468|12876325|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
5237416|NCT00858442|12876339|P2|NOT COMPLETED|Compression:Start to Finish||3
5237417|NCT00858442|12876340|P1|NOT COMPLETED|Compression:Start to Finish||1
5237418|NCT00858442|12876339|P2|COMPLETED|Compression:Start to Finish||20
5237419|NCT00858442|12876340|P1|COMPLETED|Compression:Start to Finish||20
5237420|NCT00858442|12876339|P2|STARTED|Compression:Start to Finish||23
5237421|NCT00858442|12876340|P1|STARTED|Compression:Start to Finish||21
5237422|NCT00858442|12876339|P2|NOT COMPLETED|From Surgery to Start Compression;||0
5237423|NCT00858442|12876340|P1|NOT COMPLETED|From Surgery to Start Compression;||0
5237424|NCT00858442|12876339|P2|COMPLETED|From Surgery to Start Compression;||23
5237425|NCT00858442|12876340|P1|COMPLETED|From Surgery to Start Compression;||21
5237426|NCT00858442|12876339|P2|STARTED|From Surgery to Start Compression;||23
5237427|NCT00858442|12876340|P1|STARTED|From Surgery to Start Compression;||21
5237428|NCT00858403|12876350|P1|NOT COMPLETED|Overall Study||5
5237429|NCT00858403|12876350|P1|COMPLETED|Overall Study||2
5237430|NCT00858403|12876350|P1|STARTED|Overall Study||7
5237431|NCT00858390|12876362|P2|NOT COMPLETED|Overall Study||0
5237432|NCT00858390|12876363|P1|NOT COMPLETED|Overall Study||0
5237433|NCT00858390|12876362|P2|COMPLETED|Overall Study||18
5237434|NCT00858390|12876363|P1|COMPLETED|Overall Study||18
5237435|NCT00858390|12876362|P2|STARTED|Overall Study||18
5237436|NCT00858390|12876363|P1|STARTED|Overall Study||18
5237437|NCT00858364|12876371|P2|NOT COMPLETED|Overall Study||457
5237438|NCT00858364|12876372|P1|NOT COMPLETED|Overall Study||204
5237439|NCT00858364|12876371|P2|COMPLETED|Overall Study||1246
5237440|NCT00858364|12876372|P1|COMPLETED|Overall Study||642
5237441|NCT00858364|12876371|P2|Received Study Drug|Overall Study||1681
5237442|NCT00858364|12876372|P1|Received Study Drug|Overall Study||837
5237443|NCT00858364|12876371|P2|STARTED|Overall Study||1703
5237444|NCT00858364|12876372|P1|STARTED|Overall Study||846
5237445|NCT00858247|12876394|P2|NOT COMPLETED|Week 12 Follow-up||1
5237446|NCT00858247|12876395|P1|NOT COMPLETED|Week 12 Follow-up||0
5237447|NCT00858247|12876394|P2|COMPLETED|Week 12 Follow-up||23
5237448|NCT00858247|12876395|P1|COMPLETED|Week 12 Follow-up||23
5237449|NCT00858247|12876394|P2|STARTED|Week 12 Follow-up||24
5237450|NCT00858247|12876395|P1|STARTED|Week 12 Follow-up||23
5237451|NCT00858247|12876394|P2|NOT COMPLETED|Baseline Assessment||2
5237452|NCT00858247|12876395|P1|NOT COMPLETED|Baseline Assessment||2
5237453|NCT00858247|12876394|P2|COMPLETED|Baseline Assessment||24
5237454|NCT00858247|12876395|P1|COMPLETED|Baseline Assessment||23
5237455|NCT00858247|12876394|P2|STARTED|Baseline Assessment||26
5237456|NCT00858247|12876395|P1|STARTED|Baseline Assessment||25
5237457|NCT00858208|12876411|P1|NOT COMPLETED|Overall Study||79
5237458|NCT00858208|12876411|P1|COMPLETED|Overall Study||6
5237459|NCT00858208|12876411|P1|STARTED|Overall Study||85
5237460|NCT00858143|12876428|P1|NOT COMPLETED|Overall Study||50
5237461|NCT00858143|12876428|P1|COMPLETED|Overall Study||261
5237462|NCT00858143|12876428|P1|STARTED|Overall Study|Baseline|311
5237463|NCT00858130|12876477|P1|NOT COMPLETED|Overall Study||0
5237464|NCT00858130|12876477|P1|COMPLETED|Overall Study||12
5237465|NCT00858130|12876477|P1|STARTED|Overall Study||12
5237466|NCT00858013|12876487|P2|NOT COMPLETED|Overall Study||19
5237467|NCT00858013|12876488|P1|NOT COMPLETED|Overall Study||22
5237468|NCT00858013|12876487|P2|COMPLETED|Overall Study||23
5237469|NCT00858013|12876488|P1|COMPLETED|Overall Study||24
5237470|NCT00858013|12876487|P2|STARTED|Overall Study||42
5237471|NCT00858013|12876488|P1|STARTED|Overall Study||46
5237472|NCT00857961|12876502|P1|NOT COMPLETED|Overall Study||0
5237473|NCT00857961|12876502|P1|COMPLETED|Overall Study||21
5237474|NCT00857961|12876502|P1|STARTED|Overall Study||21
5237475|NCT00857948|12876540|P4|NOT COMPLETED|Overall Study||0
5237476|NCT00857948|12876541|P3|NOT COMPLETED|Overall Study||1
5237477|NCT00857948|12876542|P2|NOT COMPLETED|Overall Study||0
5237478|NCT00857948|12876543|P1|NOT COMPLETED|Overall Study||3
5237479|NCT00857948|12876540|P4|COMPLETED|Overall Study||23
5237480|NCT00857948|12876541|P3|COMPLETED|Overall Study||18
5237481|NCT00857948|12876542|P2|COMPLETED|Overall Study||18
5237482|NCT00857948|12876543|P1|COMPLETED|Overall Study||15
5237483|NCT00857948|12876540|P4|STARTED|Overall Study||23
5237484|NCT00857948|12876541|P3|STARTED|Overall Study||19
5237485|NCT00857948|12876542|P2|STARTED|Overall Study||18
5237486|NCT00857948|12876543|P1|STARTED|Overall Study||18
5237487|NCT00857896|12876565|P1|NOT COMPLETED|Week 5 to Week 8||0
5237488|NCT00857896|12876565|P1|COMPLETED|Week 5 to Week 8||20
5237489|NCT00857896|12876565|P1|STARTED|Week 5 to Week 8||20
5237490|NCT00857896|12876565|P1|NOT COMPLETED|Baseline to Week 4||1
5237491|NCT00857896|12876565|P1|COMPLETED|Baseline to Week 4||20
5237492|NCT00857896|12876565|P1|STARTED|Baseline to Week 4||21
5237493|NCT00857857|12876577|P1|NOT COMPLETED|Overall Study||0
5237494|NCT00857857|12876577|P1|COMPLETED|Overall Study||24
5237495|NCT00857857|12876577|P1|STARTED|Overall Study||24
5237496|NCT00857818|12876721|P2|NOT COMPLETED|Overall Study||8
5237497|NCT00857818|12876722|P1|NOT COMPLETED|Overall Study||11
5237498|NCT00857818|12876721|P2|COMPLETED|Overall Study||6
5237499|NCT00857818|12876722|P1|COMPLETED|Overall Study||3
5237500|NCT00857818|12876721|P2|Received Treatment|Overall Study||12
5237501|NCT00857818|12876722|P1|Received Treatment|Overall Study||14
5237502|NCT00857818|12876721|P2|STARTED|Overall Study||14
5237503|NCT00857818|12876722|P1|STARTED|Overall Study||14
5237504|NCT00857792|12876750|P1|NOT COMPLETED|Overall Study||12
5237505|NCT00857792|12876750|P1|COMPLETED|Overall Study||108
5237506|NCT00857792|12876750|P1|STARTED|Overall Study||120
5237507|NCT00857766|12876756|P2|NOT COMPLETED|Overall Study||30
5237508|NCT00857766|12876757|P1|NOT COMPLETED|Overall Study||31
5237509|NCT00857766|12876756|P2|COMPLETED|Overall Study||96
5237510|NCT00857766|12876757|P1|COMPLETED|Overall Study||92
5237511|NCT00857766|12876756|P2|STARTED|Overall Study||126
5237512|NCT00857766|12876757|P1|STARTED|Overall Study||123
5237513|NCT00857727|12876769|P2|NOT COMPLETED|Overall Study||0
5237514|NCT00857727|12876770|P1|NOT COMPLETED|Overall Study||0
5237515|NCT00857727|12876769|P2|COMPLETED|Overall Study||14
5237516|NCT00857727|12876770|P1|COMPLETED|Overall Study||14
5237517|NCT00857727|12876769|P2|STARTED|Overall Study||14
5237518|NCT00857727|12876770|P1|STARTED|Overall Study||14
5237519|NCT00857714|12876792|P1|NOT COMPLETED|Overall Study||0
5237520|NCT00857714|12876792|P1|COMPLETED|Overall Study||1
5237521|NCT00857714|12876792|P1|STARTED|Overall Study||1
5237522|NCT00857649|12876799|P2|NOT COMPLETED|Overall Study||32
5237523|NCT00857649|12876800|P1|NOT COMPLETED|Overall Study||31
5237524|NCT00857649|12876799|P2|COMPLETED|Overall Study||155
5237525|NCT00857649|12876800|P1|COMPLETED|Overall Study||151
5237526|NCT00857649|12876799|P2|STARTED|Overall Study||187
5237527|NCT00857649|12876800|P1|STARTED|Overall Study||182
5237528|NCT00857623|12876816|P2|NOT COMPLETED|Overall Study||10
5237529|NCT00857623|12876817|P1|NOT COMPLETED|Overall Study||14
5237530|NCT00857623|12876816|P2|COMPLETED|Overall Study||55
5237531|NCT00857623|12876817|P1|COMPLETED|Overall Study||48
5237532|NCT00857623|12876816|P2|STARTED|Overall Study||65
5237533|NCT00857623|12876817|P1|STARTED|Overall Study||62
5237534|NCT00857584|12876841|P2|NOT COMPLETED|Overall Study||5
5237535|NCT00857584|12876842|P1|NOT COMPLETED|Overall Study||4
5237536|NCT00857584|12876841|P2|COMPLETED|Overall Study||8
5237537|NCT00857584|12876842|P1|COMPLETED|Overall Study||10
5237538|NCT00857584|12876841|P2|Week 8|Overall Study||8
5237539|NCT00857584|12876842|P1|Week 8|Overall Study||10
5237540|NCT00857584|12876841|P2|Week 4|Overall Study||9
5237541|NCT00857584|12876842|P1|Week 4|Overall Study||11
5237542|NCT00857584|12876841|P2|Week 2|Overall Study||11
5237543|NCT00857584|12876842|P1|Week 2|Overall Study||14
5237544|NCT00857584|12876841|P2|Week 1|Overall Study||13
5237545|NCT00857584|12876842|P1|Week 1|Overall Study||14
5237546|NCT00857584|12876841|P2|STARTED|Overall Study||13
5237547|NCT00857584|12876842|P1|STARTED|Overall Study||14
5237548|NCT00857545|12876884|P2|NOT COMPLETED|Overall Study||0
5237549|NCT00857545|12876885|P1|NOT COMPLETED|Overall Study||0
5237550|NCT00857545|12876884|P2|COMPLETED|Overall Study||85
5237551|NCT00857545|12876885|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
5237552|NCT00857545|12876884|P2|STARTED|Overall Study||85
5237553|NCT00857545|12876885|P1|STARTED|Overall Study||86
5237554|NCT00857532|12876895|P1|NOT COMPLETED|Overall Study||0
5237555|NCT00857532|12876895|P1|COMPLETED|Overall Study||31
5237556|NCT00857532|12876895|P1|STARTED|Overall Study||31
5237557|NCT00857506|12876906|P3|NOT COMPLETED|Overall Study||18
5237558|NCT00857506|12876907|P2|NOT COMPLETED|Overall Study||15
5237559|NCT00857506|12876908|P1|NOT COMPLETED|Overall Study||15
5237560|NCT00857506|12876906|P3|COMPLETED|Overall Study||51
5237561|NCT00857506|12876907|P2|COMPLETED|Overall Study||37
5237562|NCT00857506|12876908|P1|COMPLETED|Overall Study||16
5237563|NCT00857506|12876906|P3|STARTED|Overall Study||69
5237564|NCT00857506|12876907|P2|STARTED|Overall Study||52
5237565|NCT00857506|12876908|P1|STARTED|Overall Study||31
5237566|NCT00857493|12876936|P2|NOT COMPLETED|Overall Study||0
5237567|NCT00857493|12876937|P1|NOT COMPLETED|Overall Study||3
5237568|NCT00857493|12876936|P2|COMPLETED|Overall Study||58
5237569|NCT00857493|12876937|P1|COMPLETED|Overall Study||59
5237570|NCT00857493|12876936|P2|STARTED|Overall Study||58
5237571|NCT00857493|12876937|P1|STARTED|Overall Study||62
5237572|NCT00857454|12876969|P1|NOT COMPLETED|Overall Study||20
5237573|NCT00857454|12876969|P1|COMPLETED|Overall Study||51
5237574|NCT00857454|12876969|P1|STARTED|Overall Study||71
5237575|NCT00857415|12876982|P2|NOT COMPLETED|Overall Study||0
5237576|NCT00857415|12876983|P1|NOT COMPLETED|Overall Study||117
5237577|NCT00857415|12876982|P2|COMPLETED|Overall Study||74
5237578|NCT00857415|12876983|P1|COMPLETED|Overall Study||35
5237579|NCT00857415|12876982|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
5237580|NCT00857415|12876983|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
5237581|NCT00857415|12876982|P2|STARTED|Overall Study||74
5237582|NCT00857415|12876983|P1|STARTED|Overall Study||152
5237583|NCT00857389|12876990|P1|NOT COMPLETED|Overall Study||2
5237584|NCT00857389|12876990|P1|COMPLETED|Overall Study||58
5237585|NCT00857389|12876990|P1|STARTED|Overall Study||60
5237586|NCT00857311|12877004|P4|NOT COMPLETED|Overall Study||0
5237587|NCT00857311|12877005|P3|NOT COMPLETED|Overall Study||0
5237588|NCT00857311|12877006|P2|NOT COMPLETED|Overall Study||0
5237589|NCT00857311|12877007|P1|NOT COMPLETED|Overall Study||1
5237590|NCT00857311|12877004|P4|COMPLETED|Overall Study||0
5237591|NCT00857311|12877005|P3|COMPLETED|Overall Study||8
5237592|NCT00857311|12877006|P2|COMPLETED|Overall Study||0
5237593|NCT00857311|12877007|P1|COMPLETED|Overall Study||8
5237594|NCT00857311|12877004|P4|STARTED|Overall Study||0
5237595|NCT00857311|12877005|P3|STARTED|Overall Study||8
5237596|NCT00857311|12877006|P2|STARTED|Overall Study||0
5237597|NCT00857311|12877007|P1|STARTED|Overall Study||9
5237598|NCT00857285|12877019|P2|NOT COMPLETED|Overall Study||6
5237599|NCT00857285|12877020|P1|NOT COMPLETED|Overall Study||12
5237600|NCT00857285|12877019|P2|COMPLETED|Overall Study||59
5237601|NCT00857285|12877020|P1|COMPLETED|Overall Study||53
5237602|NCT00857285|12877019|P2|STARTED|Overall Study||65
5237603|NCT00857285|12877020|P1|STARTED|Overall Study||65
5237604|NCT00857272|12877026|P2|NOT COMPLETED|Overall Study||9
5237605|NCT00857272|12877027|P1|NOT COMPLETED|Overall Study||9
5237606|NCT00857272|12877026|P2|COMPLETED|Overall Study||145
5237607|NCT00857272|12877027|P1|COMPLETED|Overall Study||145
5237608|NCT00857272|12877026|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
5237609|NCT00857272|12877027|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
5237610|NCT00857259|12877036|P3|NOT COMPLETED|Overall Study||1
5237611|NCT00857259|12877037|P2|NOT COMPLETED|Overall Study||0
5237612|NCT00857259|12877038|P1|NOT COMPLETED|Overall Study||1
5237613|NCT00857259|12877036|P3|COMPLETED|Overall Study||6
5237614|NCT00857259|12877037|P2|COMPLETED|Overall Study||1
5237615|NCT00857259|12877038|P1|COMPLETED|Overall Study||7
5237616|NCT00857259|12877036|P3|STARTED|Overall Study||7
5237617|NCT00857259|12877037|P2|STARTED|Overall Study||1
5237618|NCT00857259|12877038|P1|STARTED|Overall Study||8
5237619|NCT00857246|12877048|P1|NOT COMPLETED|ChemoRT||3
5237620|NCT00857246|12877048|P1|COMPLETED|ChemoRT||12
5237621|NCT00857246|12877048|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
5237622|NCT00857246|12877048|P1|NOT COMPLETED|Surgery (Curative)||6
5237623|NCT00857246|12877048|P1|COMPLETED|Surgery (Curative)||21
5237624|NCT00857246|12877048|P1|STARTED|Surgery (Curative)||27
5237625|NCT00857246|12877048|P1|NOT COMPLETED|Induction Regimen||3
5237626|NCT00857246|12877048|P1|COMPLETED|Induction Regimen||27
5237627|NCT00857246|12877048|P1|STARTED|Induction Regimen||30
5237628|NCT00857233|12877058|P1|NOT COMPLETED|Overall Study||55
5237629|NCT00857233|12877058|P1|COMPLETED|Overall Study||242
5237630|NCT00857233|12877058|P1|STARTED|Overall Study||297
5237631|NCT00857220|12877067|P1|NOT COMPLETED|Overall Study||183
5237632|NCT00857220|12877067|P1|COMPLETED|Overall Study||121
5237633|NCT00857220|12877067|P1|STARTED|Overall Study||304
5237634|NCT00856999|12877084|P1|NOT COMPLETED|Overall Study||5
5237635|NCT00856999|12877084|P1|COMPLETED|Overall Study||45
5237636|NCT00856999|12877084|P1|STARTED|Overall Study||50
5237637|NCT00856986|12877094|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
5237638|NCT00856986|12877095|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
5237639|NCT00856986|12877096|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
5237640|NCT00856986|12877097|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
5237641|NCT00856986|12877098|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
5237642|NCT00856986|12877094|P5|COMPLETED|Extension Period, Weeks 26-52||0
5237643|NCT00856986|12877095|P4|COMPLETED|Extension Period, Weeks 26-52||0
5237644|NCT00856986|12877096|P3|COMPLETED|Extension Period, Weeks 26-52||432
5237645|NCT00856986|12877097|P2|COMPLETED|Extension Period, Weeks 26-52||130
5237646|NCT00856986|12877098|P1|COMPLETED|Extension Period, Weeks 26-52||108
5237647|NCT00856986|12877094|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
5237648|NCT00856986|12877095|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
5237649|NCT00856986|12877096|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
5237650|NCT00856986|12877097|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
5237651|NCT00856986|12877098|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
5237652|NCT00856986|12877094|P5|STARTED|Extension Period, Weeks 26-52||0
5237653|NCT00856986|12877095|P4|STARTED|Extension Period, Weeks 26-52||0
5237654|NCT00856986|12877096|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
5237655|NCT00856986|12877097|P2|STARTED|Extension Period, Weeks 26-52||144
5237656|NCT00856986|12877098|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
5237657|NCT00856986|12877094|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
5237658|NCT00856986|12877095|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
5237659|NCT00856986|12877096|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
5237660|NCT00856986|12877097|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
5237661|NCT00856986|12877098|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
5237662|NCT00856986|12877094|P5|COMPLETED|Main Period, Weeks 0-26||0
5237663|NCT00856986|12877095|P4|COMPLETED|Main Period, Weeks 0-26||0
5237664|NCT00856986|12877096|P3|COMPLETED|Main Period, Weeks 0-26||470
5237665|NCT00856986|12877097|P2|COMPLETED|Main Period, Weeks 0-26||144
5237666|NCT00856986|12877098|P1|COMPLETED|Main Period, Weeks 0-26||127
5237667|NCT00856986|12877094|P5|STARTED|Main Period, Weeks 0-26||0
5237668|NCT00856986|12877095|P4|STARTED|Main Period, Weeks 0-26||0
5237669|NCT00856986|12877096|P3|STARTED|Main Period, Weeks 0-26||498
5237670|NCT00856986|12877097|P2|STARTED|Main Period, Weeks 0-26||162
5237671|NCT00856986|12877098|P1|STARTED|Main Period, Weeks 0-26||161
5237672|NCT00856986|12877094|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
5237673|NCT00856986|12877095|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
5237674|NCT00856986|12877096|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
5237675|NCT00856986|12877097|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
5237676|NCT00856986|12877098|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
5237677|NCT00856986|12877094|P5|COMPLETED|Run-in Period, Weeks -12-0||0
5237678|NCT00856986|12877095|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
5237679|NCT00856986|12877096|P3|COMPLETED|Run-in Period, Weeks -12-0||498
5237680|NCT00856986|12877097|P2|COMPLETED|Run-in Period, Weeks -12-0||162
5237681|NCT00856986|12877098|P1|COMPLETED|Run-in Period, Weeks -12-0||161
5237682|NCT00856986|12877094|P5|STARTED|Run-in Period, Weeks -12-0||0
5237683|NCT00856986|12877095|P4|STARTED|Run-in Period, Weeks -12-0||167
5237684|NCT00856986|12877096|P3|STARTED|Run-in Period, Weeks -12-0||498
5237685|NCT00856986|12877097|P2|STARTED|Run-in Period, Weeks -12-0||162
5237686|NCT00856986|12877098|P1|STARTED|Run-in Period, Weeks -12-0||161
5237687|NCT00856973|12877268|P3|NOT COMPLETED|Overall Study||38
5237688|NCT00856973|12877269|P2|NOT COMPLETED|Overall Study||41
5237689|NCT00856973|12877270|P1|NOT COMPLETED|Overall Study||36
5237690|NCT00856973|12877268|P3|COMPLETED|Overall Study||123
5237691|NCT00856973|12877269|P2|COMPLETED|Overall Study||122
5237692|NCT00856973|12877270|P1|COMPLETED|Overall Study||126
5237693|NCT00856973|12877268|P3|STARTED|Overall Study||161
5237694|NCT00856973|12877269|P2|STARTED|Overall Study||163
5237695|NCT00856973|12877270|P1|STARTED|Overall Study||162
5237696|NCT00856934|12877338|P3|NOT COMPLETED|Overall Study||0
5237697|NCT00856934|12877339|P2|NOT COMPLETED|Overall Study||0
5237698|NCT00856934|12877340|P1|NOT COMPLETED|Overall Study||0
5237699|NCT00856934|12877338|P3|COMPLETED|Overall Study||15
5237700|NCT00856934|12877339|P2|COMPLETED|Overall Study||15
5237701|NCT00856934|12877340|P1|COMPLETED|Overall Study||15
5237702|NCT00856934|12877338|P3|STARTED|Overall Study||15
5237703|NCT00856934|12877339|P2|STARTED|Overall Study||15
5237704|NCT00856934|12877340|P1|STARTED|Overall Study||15
5237705|NCT00856908|12877350|P2|NOT COMPLETED|Overall Study||0
5237706|NCT00856908|12877351|P1|NOT COMPLETED|Overall Study||1
5237707|NCT00856908|12877350|P2|COMPLETED|Overall Study||5
5237708|NCT00856908|12877351|P1|COMPLETED|Overall Study||14
5237709|NCT00856908|12877350|P2|STARTED|Overall Study||5
5237710|NCT00856908|12877351|P1|STARTED|Overall Study||15
5237711|NCT00856856|12877376|P1|NOT COMPLETED|5-year Clinical Follow-up||0
5237712|NCT00856856|12877376|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
5237713|NCT00856856|12877376|P1|STARTED|5-year Clinical Follow-up||100
5237714|NCT00856856|12877376|P1|NOT COMPLETED|4-year Clinical Follow-up||1
5237715|NCT00856856|12877376|P1|COMPLETED|4-year Clinical Follow-up||99
5237716|NCT00856856|12877376|P1|STARTED|4-year Clinical Follow-up||100
5237717|NCT00856856|12877376|P1|NOT COMPLETED|3-year Clinical Follow-up||0
5237718|NCT00856856|12877376|P1|COMPLETED|3-year Clinical Follow-up||100
5237719|NCT00856856|12877376|P1|STARTED|3-year Clinical Follow-up||100
5237720|NCT00856856|12877376|P1|NOT COMPLETED|2-year Clinical Follow-up||1
5237721|NCT00856856|12877376|P1|COMPLETED|2-year Clinical Follow-up||100
5237722|NCT00856856|12877376|P1|STARTED|2-year Clinical Follow-up||101
5237723|NCT00856856|12877376|P1|NOT COMPLETED|1-year Clinical Follow-up||0
5237724|NCT00856856|12877376|P1|COMPLETED|1-year Clinical Follow-up||101
5237725|NCT00856856|12877376|P1|STARTED|1-year Clinical Follow-up||101
5237726|NCT00856856|12877376|P1|NOT COMPLETED|270-day Clinical Follow-up||0
5237727|NCT00856856|12877376|P1|COMPLETED|270-day Clinical Follow-up||101
5237728|NCT00856856|12877376|P1|STARTED|270-day Clinical Follow-up||101
5237729|NCT00856856|12877376|P1|NOT COMPLETED|180-day Clinical Follow-up||0
5237730|NCT00856856|12877376|P1|COMPLETED|180-day Clinical Follow-up||101
5237731|NCT00856856|12877376|P1|STARTED|180-day Clinical Follow-up||101
5237732|NCT00856856|12877376|P1|NOT COMPLETED|30-day Clinical Follow-up||0
5237733|NCT00856856|12877376|P1|COMPLETED|30-day Clinical Follow-up||101
5237734|NCT00856856|12877376|P1|STARTED|30-day Clinical Follow-up||101
5237735|NCT00856856|12877376|P1|NOT COMPLETED|Baseline||0
5237736|NCT00856856|12877376|P1|COMPLETED|Baseline||101
5237737|NCT00856856|12877376|P1|STARTED|Baseline||101
5237738|NCT00856843|12877575|P2|NOT COMPLETED|Overall Study||5
5237739|NCT00856843|12877576|P1|NOT COMPLETED|Overall Study||2
5237740|NCT00856843|12877575|P2|COMPLETED|Overall Study||63
5237741|NCT00856843|12877576|P1|COMPLETED|Overall Study||66
5237742|NCT00856843|12877575|P2|STARTED|Overall Study||68
5237743|NCT00856843|12877576|P1|STARTED|Overall Study||68
5237744|NCT00856830|12877612|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
5237745|NCT00856830|12877613|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
5237746|NCT00856830|12877614|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
5237747|NCT00856830|12877615|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
5237748|NCT00856830|12877612|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
5237749|NCT00856830|12877613|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
5237750|NCT00856830|12877614|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
5237751|NCT00856830|12877615|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
5237752|NCT00856830|12877612|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
5237753|NCT00856830|12877613|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
5237754|NCT00856830|12877614|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
5237755|NCT00856830|12877615|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
5237756|NCT00856830|12877612|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
5237757|NCT00856830|12877613|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
5237758|NCT00856830|12877614|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
5237759|NCT00856830|12877615|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
5237760|NCT00856830|12877612|P4|COMPLETED|Irinotecan & Bendamustine||12
5237761|NCT00856830|12877613|P3|COMPLETED|Irinotecan & Bendamustine||6
5237762|NCT00856830|12877614|P2|COMPLETED|Irinotecan & Bendamustine||6
5237763|NCT00856830|12877615|P1|COMPLETED|Irinotecan & Bendamustine||3
5237764|NCT00856830|12877612|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
5237765|NCT00856830|12877613|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
5237766|NCT00856830|12877614|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
5237767|NCT00856830|12877615|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
5237768|NCT00856830|12877612|P4|STARTED|Irinotecan & Bendamustine||15
5237769|NCT00856830|12877613|P3|STARTED|Irinotecan & Bendamustine||6
5237770|NCT00856830|12877614|P2|STARTED|Irinotecan & Bendamustine||6
5237771|NCT00856830|12877615|P1|STARTED|Irinotecan & Bendamustine||3
5237772|NCT00856791|12877621|P1|NOT COMPLETED|Overall Study||0
5237773|NCT00856791|12877621|P1|COMPLETED|Overall Study||1
5237774|NCT00856791|12877621|P1|STARTED|Overall Study||1
5237775|NCT00856778|12877626|P1|NOT COMPLETED|Overall Study||24
5237776|NCT00856778|12877626|P1|COMPLETED|Overall Study||74
5237777|NCT00856778|12877626|P1|STARTED|Overall Study||98
5237778|NCT00856739|12877645|P3|NOT COMPLETED|Overall Study||0
5237779|NCT00856739|12877646|P2|NOT COMPLETED|Overall Study||0
5237780|NCT00856739|12877647|P1|NOT COMPLETED|Overall Study||0
5237781|NCT00856739|12877645|P3|COMPLETED|Overall Study||55
5237782|NCT00856739|12877646|P2|COMPLETED|Overall Study||52
5237783|NCT00856739|12877647|P1|COMPLETED|Overall Study||70
5237784|NCT00856739|12877645|P3|STARTED|Overall Study||55
5237785|NCT00856739|12877646|P2|STARTED|Overall Study||52
5237786|NCT00856739|12877647|P1|STARTED|Overall Study||70
5237787|NCT00856726|12877658|P1|NOT COMPLETED|Overall Study||0
5237788|NCT00856726|12877658|P1|COMPLETED|Overall Study||26
5237789|NCT00856726|12877658|P1|STARTED|Overall Study||26
5237790|NCT00856661|12877669|P2|NOT COMPLETED|Overall Study||29
5237791|NCT00856661|12877670|P1|NOT COMPLETED|Overall Study||27
5237792|NCT00856661|12877669|P2|COMPLETED|Overall Study||106
5237793|NCT00856661|12877670|P1|COMPLETED|Overall Study||108
5237794|NCT00856661|12877669|P2|Randomized Not Treated|Overall Study||4
5237795|NCT00856661|12877670|P1|Randomized Not Treated|Overall Study||9
5237796|NCT00856661|12877669|P2|Treated|Overall Study||131
5237797|NCT00856661|12877670|P1|Treated|Overall Study||126
5237798|NCT00856661|12877669|P2|STARTED|Overall Study|Randomised|135
5237799|NCT00856661|12877670|P1|STARTED|Overall Study|Randomised|135
5237800|NCT00856635|12877684|P2|NOT COMPLETED|Overall Study||8
5237801|NCT00856635|12877685|P1|NOT COMPLETED|Overall Study||10
5237802|NCT00856635|12877684|P2|COMPLETED|Overall Study||14
5237803|NCT00856635|12877685|P1|COMPLETED|Overall Study||12
5237804|NCT00856635|12877684|P2|Received Study Drug|Overall Study||20
5237805|NCT00856635|12877685|P1|Received Study Drug|Overall Study||20
5237806|NCT00856635|12877684|P2|STARTED|Overall Study||22
5237807|NCT00856635|12877685|P1|STARTED|Overall Study||22
5237808|NCT00856609|12877695|P2|NOT COMPLETED|Overall Study||0
5237809|NCT00856609|12877696|P1|NOT COMPLETED|Overall Study||1
5237810|NCT00856609|12877695|P2|COMPLETED|Overall Study||39
5237811|NCT00856609|12877696|P1|COMPLETED|Overall Study||40
5237812|NCT00856609|12877695|P2|STARTED|Overall Study||39
5237813|NCT00856609|12877696|P1|STARTED|Overall Study||41
5237814|NCT00856583|12877708|P2|NOT COMPLETED|Overall Study||2597
5237815|NCT00856583|12877709|P1|NOT COMPLETED|Overall Study||3137
5237816|NCT00856583|12877708|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
5237817|NCT00856583|12877709|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
5237818|NCT00856583|12877708|P2|STARTED|Overall Study|Patients treated|4904
5237819|NCT00856583|12877709|P1|STARTED|Overall Study|Patients treated|4905
5237820|NCT00856557|12877739|P2|NOT COMPLETED|Overall Study||16
5237821|NCT00856557|12877740|P1|NOT COMPLETED|Overall Study||12
5237822|NCT00856557|12877739|P2|COMPLETED|Overall Study||60
5237823|NCT00856557|12877740|P1|COMPLETED|Overall Study||50
5237824|NCT00856557|12877739|P2|With Patients With Contextual Flags|Overall Study||60
5237825|NCT00856557|12877740|P1|With Patients With Contextual Flags|Overall Study||50
5237826|NCT00856557|12877739|P2|Tested With Standardized Patients|Overall Study||76
5237827|NCT00856557|12877740|P1|Tested With Standardized Patients|Overall Study||62
5237828|NCT00856557|12877739|P2|Received Intervention/Control|Overall Study||76
5237829|NCT00856557|12877740|P1|Received Intervention/Control|Overall Study||62
5237830|NCT00856557|12877739|P2|STARTED|Overall Study||76
5237831|NCT00856557|12877740|P1|STARTED|Overall Study||62
5237832|NCT00856544|12877754|P4|NOT COMPLETED|Overall Study||13
5237833|NCT00856544|12877755|P3|NOT COMPLETED|Overall Study||8
5237834|NCT00856544|12877756|P2|NOT COMPLETED|Overall Study||66
5237835|NCT00856544|12877757|P1|NOT COMPLETED|Overall Study||57
5237836|NCT00856544|12877754|P4|COMPLETED|Overall Study||67
5237837|NCT00856544|12877755|P3|COMPLETED|Overall Study||71
5237838|NCT00856544|12877756|P2|COMPLETED|Overall Study||252
5237839|NCT00856544|12877757|P1|COMPLETED|Overall Study||261
5237840|NCT00856544|12877754|P4|Treated|Overall Study||80
5237841|NCT00856544|12877755|P3|Treated|Overall Study||79
5237842|NCT00856544|12877756|P2|Treated|Overall Study||318
5237843|NCT00856544|12877757|P1|Treated|Overall Study||315
5237844|NCT00856544|12877754|P4|STARTED|Overall Study||80
5237845|NCT00856544|12877755|P3|STARTED|Overall Study||79
5237846|NCT00856544|12877756|P2|STARTED|Overall Study||318
5237847|NCT00856544|12877757|P1|STARTED|Overall Study||318
5237848|NCT00856518|12877936|P2|NOT COMPLETED|Overall Study||2
5237849|NCT00856518|12877937|P1|NOT COMPLETED|Overall Study||4
5237850|NCT00856518|12877936|P2|COMPLETED|Overall Study||16
5237851|NCT00856518|12877937|P1|COMPLETED|Overall Study||20
5237852|NCT00856518|12877936|P2|STARTED|Overall Study||18
5237853|NCT00856518|12877937|P1|STARTED|Overall Study||24
5237854|NCT00856492|12877950|P3|NOT COMPLETED|Overall Study||2
5237855|NCT00856492|12877951|P2|NOT COMPLETED|Overall Study||1
5237856|NCT00856492|12877952|P1|NOT COMPLETED|Overall Study||1
5237857|NCT00856492|12877950|P3|COMPLETED|Overall Study||51
5237858|NCT00856492|12877951|P2|COMPLETED|Overall Study||62
5237859|NCT00856492|12877952|P1|COMPLETED|Overall Study||98
5237860|NCT00856492|12877950|P3|Toxicity Eval|Overall Study||51
5237861|NCT00856492|12877951|P2|Toxicity Eval|Overall Study||60
5237862|NCT00856492|12877952|P1|Toxicity Eval|Overall Study||96
5237863|NCT00856492|12877950|P3|STARTED|Overall Study||53
5237864|NCT00856492|12877951|P2|STARTED|Overall Study||63
5237865|NCT00856492|12877952|P1|STARTED|Overall Study||99
5237866|NCT00856414|12877966|P1|NOT COMPLETED|Overall Study||0
5237867|NCT00856414|12877966|P1|COMPLETED|Overall Study||45
5237868|NCT00856414|12877966|P1|STARTED|Overall Study||45
5237869|NCT00856388|12877974|P1|NOT COMPLETED|Overall Study||1
5237870|NCT00856388|12877974|P1|COMPLETED|Overall Study||61
5237871|NCT00856388|12877974|P1|STARTED|Overall Study||62
5237872|NCT00856349|12877985|P1|NOT COMPLETED|Overall Study||1021
5237873|NCT00856349|12877985|P1|COMPLETED|Overall Study||3111
5237874|NCT00856349|12877985|P1|24 Month Follow-up|Overall Study||1698
5237875|NCT00856349|12877985|P1|18 Month Follow-up|Overall Study||2467
5237876|NCT00856349|12877985|P1|12 Month Follow-up|Overall Study||3228
5237877|NCT00856349|12877985|P1|STARTED|Overall Study||4132
5237878|NCT00856323|12877994|P1|NOT COMPLETED|Overall Study||2
5237879|NCT00856323|12877994|P1|COMPLETED|Overall Study||51
5237880|NCT00856323|12877994|P1|STARTED|Overall Study||53
5237881|NCT00856297|12878006|P5|NOT COMPLETED|Overall Study||0
5237882|NCT00856297|12878007|P4|NOT COMPLETED|Overall Study||0
5237883|NCT00856297|12878008|P3|NOT COMPLETED|Overall Study||0
5237884|NCT00856297|12878009|P2|NOT COMPLETED|Overall Study||0
5237885|NCT00856297|12878010|P1|NOT COMPLETED|Overall Study||2
5237886|NCT00856297|12878006|P5|COMPLETED|Overall Study||31
5237887|NCT00856297|12878007|P4|COMPLETED|Overall Study||44
5237888|NCT00856297|12878008|P3|COMPLETED|Overall Study||107
5237889|NCT00856297|12878009|P2|COMPLETED|Overall Study||76
5237890|NCT00856297|12878010|P1|COMPLETED|Overall Study||129
5237891|NCT00856297|12878006|P5|STARTED|Overall Study||31
5237892|NCT00856297|12878007|P4|STARTED|Overall Study||44
5237893|NCT00856297|12878008|P3|STARTED|Overall Study||107
5237894|NCT00856297|12878009|P2|STARTED|Overall Study||76
5237895|NCT00856297|12878010|P1|STARTED|Overall Study||131
5237896|NCT00856284|12878043|P3|NOT COMPLETED|Overall Study||447
5237897|NCT00856284|12878044|P2|NOT COMPLETED|Overall Study||392
5237898|NCT00856284|12878045|P1|NOT COMPLETED|Overall Study||408
5237899|NCT00856284|12878043|P3|COMPLETED|Overall Study||427
5237900|NCT00856284|12878044|P2|COMPLETED|Overall Study||493
5237901|NCT00856284|12878045|P1|COMPLETED|Overall Study||472
5237902|NCT00856284|12878043|P3|Received Study Drug|Overall Study||869
5237903|NCT00856284|12878044|P2|Received Study Drug|Overall Study||878
5237904|NCT00856284|12878045|P1|Received Study Drug|Overall Study||873
5237905|NCT00856284|12878043|P3|STARTED|Overall Study||874
5237906|NCT00856284|12878044|P2|STARTED|Overall Study||885
5237907|NCT00856284|12878045|P1|STARTED|Overall Study||880
5237908|NCT00856245|12878071|P1|NOT COMPLETED|Overall Study||5
5237909|NCT00856245|12878071|P1|COMPLETED|Overall Study||14
5237910|NCT00856245|12878071|P1|STARTED|Overall Study||19
5237911|NCT00856232|12878079|P3|NOT COMPLETED|Overall Study||0
5237912|NCT00856232|12878080|P2|NOT COMPLETED|Overall Study||0
5237913|NCT00856232|12878081|P1|NOT COMPLETED|Overall Study||0
5237914|NCT00856232|12878079|P3|COMPLETED|Overall Study||36
5237915|NCT00856232|12878080|P2|COMPLETED|Overall Study||29
5237916|NCT00856232|12878081|P1|COMPLETED|Overall Study||26
5237917|NCT00856232|12878079|P3|STARTED|Overall Study||36
5237918|NCT00856232|12878080|P2|STARTED|Overall Study||29
5237919|NCT00856232|12878081|P1|STARTED|Overall Study||26
5237920|NCT00856206|12878094|P2|NOT COMPLETED|Overall Study||161
5237921|NCT00856206|12878095|P1|NOT COMPLETED|Overall Study||54
5237922|NCT00856206|12878094|P2|COMPLETED|Overall Study||824
5237923|NCT00856206|12878095|P1|COMPLETED|Overall Study||276
5237924|NCT00856206|12878094|P2|STARTED|Overall Study||985
5237925|NCT00856206|12878095|P1|STARTED|Overall Study||330
5237926|NCT00856193|12878109|P2|NOT COMPLETED|Period 2||2
5237927|NCT00856193|12878110|P1|NOT COMPLETED|Period 2||0
5237928|NCT00856193|12878109|P2|COMPLETED|Period 2||15
5237929|NCT00856193|12878110|P1|COMPLETED|Period 2||16
5237930|NCT00856193|12878109|P2|STARTED|Period 2||17
5237931|NCT00856193|12878110|P1|STARTED|Period 2||16
5237932|NCT00856193|12878109|P2|NOT COMPLETED|Period 1||0
5237933|NCT00856193|12878110|P1|NOT COMPLETED|Period 1||0
5237934|NCT00856193|12878109|P2|COMPLETED|Period 1||17
5237935|NCT00856193|12878110|P1|COMPLETED|Period 1||16
5237936|NCT00856193|12878109|P2|STARTED|Period 1||17
5237937|NCT00856193|12878110|P1|STARTED|Period 1||16
5237938|NCT00856180|12878122|P1|NOT COMPLETED|Overall Study||20
5237939|NCT00856180|12878122|P1|COMPLETED|Overall Study||0
5237940|NCT00856180|12878122|P1|STARTED|Overall Study||20
5237941|NCT00856050|12878131|P1|NOT COMPLETED|Overall Study||0
5237942|NCT00856050|12878131|P1|COMPLETED|Overall Study||26
5237943|NCT00856050|12878131|P1|STARTED|Overall Study||26
5237944|NCT00856024|12878135|P1|NOT COMPLETED|Overall Study||0
5237945|NCT00856024|12878135|P1|COMPLETED|Overall Study||902
5237946|NCT00856024|12878135|P1|STARTED|Overall Study||902
5237947|NCT00855959|12878147|P1|NOT COMPLETED|Overall Study||9
5237948|NCT00855959|12878147|P1|COMPLETED|Overall Study||99
5237949|NCT00855959|12878147|P1|Patients Who Received Pulmicort Respules|Overall Study||105
5237950|NCT00855959|12878147|P1|STARTED|Overall Study||108
5237951|NCT00855933|12878164|P2|NOT COMPLETED|Overall Study||1
5237952|NCT00855933|12878165|P1|NOT COMPLETED|Overall Study||0
5237953|NCT00855933|12878164|P2|COMPLETED|Overall Study||29
5237954|NCT00855933|12878165|P1|COMPLETED|Overall Study||30
5237955|NCT00855933|12878164|P2|STARTED|Overall Study||30
5237956|NCT00855933|12878165|P1|STARTED|Overall Study||30
5237957|NCT00855920|12878174|P3|NOT COMPLETED|Overall Study||11
5237958|NCT00855920|12878175|P2|NOT COMPLETED|Overall Study||9
5237959|NCT00855920|12878176|P1|NOT COMPLETED|Overall Study||8
5237960|NCT00855920|12878174|P3|COMPLETED|Overall Study||64
5237961|NCT00855920|12878175|P2|COMPLETED|Overall Study||65
5237962|NCT00855920|12878176|P1|COMPLETED|Overall Study||68
5237963|NCT00855920|12878174|P3|Safety Population|Overall Study||75
5237964|NCT00855920|12878175|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
5237965|NCT00855920|12878176|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
5237966|NCT00855920|12878174|P3|STARTED|Overall Study||75
5237967|NCT00855920|12878175|P2|STARTED|Overall Study||74
5237968|NCT00855920|12878176|P1|STARTED|Overall Study||76
5237969|NCT00855894|12878193|P1|NOT COMPLETED|Overall Study||33
5237970|NCT00855894|12878193|P1|COMPLETED|Overall Study||8
5237971|NCT00855894|12878193|P1|STARTED|Overall Study||41
5237972|NCT00855868|12878203|P2|NOT COMPLETED|Overall Study||1
5237973|NCT00855868|12878204|P1|NOT COMPLETED|Overall Study||1
5237974|NCT00855868|12878203|P2|COMPLETED|Overall Study||14
5237975|NCT00855868|12878204|P1|COMPLETED|Overall Study||12
5237976|NCT00855868|12878203|P2|STARTED|Overall Study||15
5237977|NCT00855868|12878204|P1|STARTED|Overall Study||13
5237978|NCT00855842|12878210|P1|NOT COMPLETED|Overall Study||0
5237979|NCT00855842|12878210|P1|COMPLETED|Overall Study||4
5237980|NCT00855842|12878210|P1|STARTED|Overall Study||4
5237981|NCT00855816|12878216|P2|NOT COMPLETED|Overall Study||21
5237982|NCT00855816|12878217|P1|NOT COMPLETED|Overall Study||26
5237983|NCT00855816|12878216|P2|COMPLETED|Overall Study||12
5237984|NCT00855816|12878217|P1|COMPLETED|Overall Study||21
5237985|NCT00855816|12878216|P2|STARTED|Overall Study||33
5237986|NCT00855816|12878217|P1|STARTED|Overall Study||47
5237987|NCT00855738|12878223|P1|NOT COMPLETED|Overall Study||5
5237988|NCT00855738|12878223|P1|COMPLETED|Overall Study||106
5237989|NCT00855738|12878223|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
5237990|NCT00855738|12878223|P1|STARTED|Overall Study||111
5237991|NCT00855595|12878251|P2|NOT COMPLETED|Overall Study||7
5237992|NCT00855595|12878252|P1|NOT COMPLETED|Overall Study||6
5237993|NCT00855595|12878251|P2|COMPLETED|Overall Study||94
5237994|NCT00855595|12878252|P1|COMPLETED|Overall Study||100
5237995|NCT00855595|12878251|P2|STARTED|Overall Study||101
5237996|NCT00855595|12878252|P1|STARTED|Overall Study||106
5237997|NCT00855582|12878291|P3|NOT COMPLETED|Overall Study||30
5237998|NCT00855582|12878292|P2|NOT COMPLETED|Overall Study||24
5237999|NCT00855582|12878293|P1|NOT COMPLETED|Overall Study||26
5238000|NCT00855582|12878291|P3|COMPLETED|Overall Study||170
5238001|NCT00855582|12878292|P2|COMPLETED|Overall Study||184
5238002|NCT00855582|12878293|P1|COMPLETED|Overall Study||172
5238003|NCT00855582|12878291|P3|STARTED|Overall Study||200
5238004|NCT00855582|12878292|P2|STARTED|Overall Study||208
5238005|NCT00855582|12878293|P1|STARTED|Overall Study||198
5238006|NCT00855465|12878382|P2|NOT COMPLETED|Follow-up Period (FUP)||2
5238007|NCT00855465|12878383|P1|NOT COMPLETED|Follow-up Period (FUP)||8
5238008|NCT00855465|12878382|P2|COMPLETED|Follow-up Period (FUP)||2
5238009|NCT00855465|12878383|P1|COMPLETED|Follow-up Period (FUP)||9
5238010|NCT00855465|12878382|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
5238011|NCT00855465|12878383|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
5238012|NCT00855465|12878382|P2|NOT COMPLETED|Treatment Period||5
5238013|NCT00855465|12878383|P1|NOT COMPLETED|Treatment Period||14
5238014|NCT00855465|12878382|P2|COMPLETED|Treatment Period||83
5238015|NCT00855465|12878383|P1|COMPLETED|Treatment Period||160
5238016|NCT00855465|12878382|P2|Participants Received Treatment|Treatment Period||88
5238017|NCT00855465|12878383|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
5238018|NCT00855465|12878382|P2|STARTED|Treatment Period||88
5238019|NCT00855465|12878383|P1|STARTED|Treatment Period||174
5238020|NCT00855439|12878473|P2|NOT COMPLETED|Overall Study||0
5238021|NCT00855439|12878474|P1|NOT COMPLETED|Overall Study||3
5238022|NCT00855439|12878473|P2|COMPLETED|Overall Study||24
5238023|NCT00855439|12878474|P1|COMPLETED|Overall Study||19
5238024|NCT00855439|12878473|P2|STARTED|Overall Study||24
5238025|NCT00855439|12878474|P1|STARTED|Overall Study||22
5238026|NCT00855413|12878486|P1|NOT COMPLETED|Overall Study||0
5238027|NCT00855413|12878486|P1|COMPLETED|Overall Study||15
5238028|NCT00855413|12878486|P1|STARTED|Overall Study||15
5238029|NCT00855335|12878532|P5|NOT COMPLETED|Overall Study||1
5238030|NCT00855335|12878533|P4|NOT COMPLETED|Overall Study||7
5238031|NCT00855335|12878534|P3|NOT COMPLETED|Overall Study||5
5238032|NCT00855335|12878535|P2|NOT COMPLETED|Overall Study||2
5238033|NCT00855335|12878536|P1|NOT COMPLETED|Overall Study||5
5238034|NCT00855335|12878532|P5|COMPLETED|Overall Study||6
5238035|NCT00855335|12878533|P4|COMPLETED|Overall Study||12
5238036|NCT00855335|12878534|P3|COMPLETED|Overall Study||10
5238037|NCT00855335|12878535|P2|COMPLETED|Overall Study||16
5238038|NCT00855335|12878536|P1|COMPLETED|Overall Study||13
5238039|NCT00855335|12878532|P5|STARTED|Overall Study||7
5238040|NCT00855335|12878533|P4|STARTED|Overall Study||19
5238041|NCT00855335|12878534|P3|STARTED|Overall Study||15
5238042|NCT00855335|12878535|P2|STARTED|Overall Study||18
5238043|NCT00855335|12878536|P1|STARTED|Overall Study||18
5238044|NCT00855309|12878623|P2|NOT COMPLETED|Overall Study||0
5238045|NCT00855309|12878624|P1|NOT COMPLETED|Overall Study||1
5238046|NCT00855309|12878623|P2|COMPLETED|Overall Study||55
5238047|NCT00855309|12878624|P1|COMPLETED|Overall Study||56
5238048|NCT00855309|12878623|P2|STARTED|Overall Study||55
5238049|NCT00855309|12878624|P1|STARTED|Overall Study||57
5238050|NCT00855218|12878632|P2|NOT COMPLETED|Overall Study||153
5238051|NCT00855218|12878633|P1|NOT COMPLETED|Overall Study||154
5238052|NCT00855218|12878632|P2|COMPLETED|Overall Study||0
5238053|NCT00855218|12878633|P1|COMPLETED|Overall Study||0
5238054|NCT00855218|12878632|P2|Participants Received Treatment|Overall Study||151
5238055|NCT00855218|12878633|P1|Participants Received Treatment|Overall Study||153
5238056|NCT00855218|12878632|P2|STARTED|Overall Study||153
5238057|NCT00855218|12878633|P1|STARTED|Overall Study||154
5238058|NCT00855166|12878651|P2|NOT COMPLETED|Overall Study||8
5238059|NCT00855166|12878652|P1|NOT COMPLETED|Overall Study||5
5238060|NCT00855166|12878651|P2|COMPLETED|Overall Study||83
5238061|NCT00855166|12878652|P1|COMPLETED|Overall Study||86
5238062|NCT00855166|12878651|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
5238063|NCT00855166|12878652|P1|STARTED|Overall Study||91
5238064|NCT00855062|12878672|P2|NOT COMPLETED|Step2||6
5238065|NCT00855062|12878673|P1|NOT COMPLETED|Step2||6
5238066|NCT00855062|12878672|P2|COMPLETED|Step2||15
5238067|NCT00855062|12878673|P1|COMPLETED|Step2||13
5238068|NCT00855062|12878672|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
5238069|NCT00855062|12878673|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
5238070|NCT00855062|12878672|P2|NOT COMPLETED|Step1||11
5238071|NCT00855062|12878673|P1|NOT COMPLETED|Step1||10
5238072|NCT00855062|12878672|P2|COMPLETED|Step1||26
5238073|NCT00855062|12878673|P1|COMPLETED|Step1||26
5238074|NCT00855062|12878672|P2|STARTED|Step1||37
5238075|NCT00855062|12878673|P1|STARTED|Step1||36
5238076|NCT00855010|12878699|P2|NOT COMPLETED|Overall Study||1
5238077|NCT00855010|12878700|P1|NOT COMPLETED|Overall Study||4
5238078|NCT00855010|12878699|P2|COMPLETED|Overall Study||18
5238079|NCT00855010|12878700|P1|COMPLETED|Overall Study||19
5238080|NCT00855010|12878699|P2|STARTED|Overall Study||19
5238081|NCT00855010|12878700|P1|STARTED|Overall Study||23
5238082|NCT00854906|12878722|P1|NOT COMPLETED|Overall Study||1
5238083|NCT00854906|12878722|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
5238084|NCT00854906|12878722|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
5238085|NCT00854724|12878731|P2|NOT COMPLETED|Second Intervention||1
5238086|NCT00854724|12878732|P1|NOT COMPLETED|Second Intervention||1
5238087|NCT00854724|12878731|P2|COMPLETED|Second Intervention||5
5238088|NCT00854724|12878732|P1|COMPLETED|Second Intervention||5
5238089|NCT00854724|12878731|P2|STARTED|Second Intervention||6
5238090|NCT00854724|12878732|P1|STARTED|Second Intervention||6
5238091|NCT00854724|12878731|P2|NOT COMPLETED|Washout||1
5238092|NCT00854724|12878732|P1|NOT COMPLETED|Washout||1
5238093|NCT00854724|12878731|P2|COMPLETED|Washout||6
5238094|NCT00854724|12878732|P1|COMPLETED|Washout||6
5238095|NCT00854724|12878731|P2|STARTED|Washout||7
5238096|NCT00854724|12878732|P1|STARTED|Washout||7
5238097|NCT00854724|12878731|P2|NOT COMPLETED|First Intervention||1
5238098|NCT00854724|12878732|P1|NOT COMPLETED|First Intervention||1
5238099|NCT00854724|12878731|P2|COMPLETED|First Intervention||7
5238100|NCT00854724|12878732|P1|COMPLETED|First Intervention||7
5238101|NCT00854724|12878731|P2|STARTED|First Intervention||8
5238102|NCT00854724|12878732|P1|STARTED|First Intervention||8
5238103|NCT00854620|12878738|P1|NOT COMPLETED|Overall Study||1
5238104|NCT00854620|12878738|P1|COMPLETED|Overall Study||8
5238105|NCT00854620|12878738|P1|STARTED|Overall Study||9
5238106|NCT00854607|12878742|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
5238107|NCT00854607|12878742|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
5238108|NCT00854607|12878742|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
5238109|NCT00854607|12878742|P1|NOT COMPLETED|Enrollment||0
5238110|NCT00854607|12878742|P1|COMPLETED|Enrollment||116
5238111|NCT00854607|12878742|P1|STARTED|Enrollment||116
5238112|NCT00854594|12878777|P2|NOT COMPLETED|Overall Study||0
5238113|NCT00854594|12878778|P1|NOT COMPLETED|Overall Study||0
5238114|NCT00854594|12878777|P2|COMPLETED|Overall Study||69
5238115|NCT00854594|12878778|P1|COMPLETED|Overall Study||48
5238116|NCT00854594|12878777|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
5238117|NCT00854594|12878778|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
5238118|NCT00854581|12878790|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
5238119|NCT00854581|12878790|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
5238120|NCT00854581|12878790|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
5238121|NCT00854581|12878790|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
5238122|NCT00854581|12878790|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
5238123|NCT00854581|12878790|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
5238124|NCT00854581|12878790|P1|NOT COMPLETED|Induction (Up to Day 21)||6
5238125|NCT00854581|12878790|P1|COMPLETED|Induction (Up to Day 21)||7
5238126|NCT00854581|12878790|P1|STARTED|Induction (Up to Day 21)||13
5238127|NCT00854373|12878805|P2|NOT COMPLETED|Overall Study||4
5238128|NCT00854373|12878806|P1|NOT COMPLETED|Overall Study||2
5238129|NCT00854373|12878805|P2|COMPLETED|Overall Study||89
5238130|NCT00854373|12878806|P1|COMPLETED|Overall Study||93
5238131|NCT00854373|12878805|P2|STARTED|Overall Study||93
5238132|NCT00854373|12878806|P1|STARTED|Overall Study||95
5238133|NCT00854360|12878820|P4|NOT COMPLETED|Overall Study||10
5238134|NCT00854360|12878821|P3|NOT COMPLETED|Overall Study||2
5238135|NCT00854360|12878822|P2|NOT COMPLETED|Overall Study||3
5238136|NCT00854360|12878823|P1|NOT COMPLETED|Overall Study||2
5238137|NCT00854360|12878820|P4|COMPLETED|Overall Study||114
5238138|NCT00854360|12878821|P3|COMPLETED|Overall Study||120
5238139|NCT00854360|12878822|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
5238140|NCT00854360|12878823|P1|COMPLETED|Overall Study||116
5238141|NCT00854360|12878820|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
5238142|NCT00854360|12878821|P3|Intent to Treat / Safety Population|Overall Study||122
5238143|NCT00854360|12878822|P2|Intent to Treat / Safety Population|Overall Study||123
5238144|NCT00854360|12878823|P1|Intent to Treat / Safety Population|Overall Study||118
5238145|NCT00854360|12878820|P4|STARTED|Overall Study||124
5238146|NCT00854360|12878821|P3|STARTED|Overall Study||122
5238147|NCT00854360|12878822|P2|STARTED|Overall Study||123
5238148|NCT00854360|12878823|P1|STARTED|Overall Study||118
5238149|NCT00854308|12878855|P2|NOT COMPLETED|Overall Study||67
5238150|NCT00854308|12878856|P1|NOT COMPLETED|Overall Study||62
5238151|NCT00854308|12878855|P2|COMPLETED|Overall Study||1
5238152|NCT00854308|12878856|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
5238153|NCT00854308|12878855|P2|Received Study Drug|Overall Study||67
5238154|NCT00854308|12878856|P1|Received Study Drug|Overall Study||69
5238155|NCT00854308|12878855|P2|STARTED|Overall Study||68
5238156|NCT00854308|12878856|P1|STARTED|Overall Study||69
5238157|NCT00854113|12878881|P11|NOT COMPLETED|Overall Study||0
5238158|NCT00854113|12878882|P10|NOT COMPLETED|Overall Study||0
5238159|NCT00854113|12878883|P9|NOT COMPLETED|Overall Study||1
5238160|NCT00854113|12878884|P8|NOT COMPLETED|Overall Study||3
5238161|NCT00854113|12878885|P7|NOT COMPLETED|Overall Study||0
5238162|NCT00854113|12878886|P6|NOT COMPLETED|Overall Study||0
5238163|NCT00854113|12878887|P5|NOT COMPLETED|Overall Study||0
5238164|NCT00854113|12878888|P4|NOT COMPLETED|Overall Study||0
5238165|NCT00854113|12878889|P3|NOT COMPLETED|Overall Study||0
5238166|NCT00854113|12878890|P2|NOT COMPLETED|Overall Study||0
5238167|NCT00854113|12878891|P1|NOT COMPLETED|Overall Study||0
5238168|NCT00854113|12878881|P11|COMPLETED|Overall Study||6
5238169|NCT00854113|12878882|P10|COMPLETED|Overall Study||8
5238170|NCT00854113|12878883|P9|COMPLETED|Overall Study||7
5238171|NCT00854113|12878884|P8|COMPLETED|Overall Study||5
5238172|NCT00854113|12878885|P7|COMPLETED|Overall Study||12
5238173|NCT00854113|12878886|P6|COMPLETED|Overall Study||6
5238174|NCT00854113|12878887|P5|COMPLETED|Overall Study||6
5238175|NCT00854113|12878888|P4|COMPLETED|Overall Study||6
5238176|NCT00854113|12878889|P3|COMPLETED|Overall Study||6
5238177|NCT00854113|12878890|P2|COMPLETED|Overall Study||6
5238178|NCT00854113|12878891|P1|COMPLETED|Overall Study||6
5238179|NCT00854113|12878881|P11|STARTED|Overall Study||6
5238180|NCT00854113|12878882|P10|STARTED|Overall Study||8
5238181|NCT00854113|12878883|P9|STARTED|Overall Study||8
5238182|NCT00854113|12878884|P8|STARTED|Overall Study||8
5238183|NCT00854113|12878885|P7|STARTED|Overall Study||12
5238184|NCT00854113|12878886|P6|STARTED|Overall Study||6
5238185|NCT00854113|12878887|P5|STARTED|Overall Study||6
5238186|NCT00854113|12878888|P4|STARTED|Overall Study||6
5238187|NCT00854113|12878889|P3|STARTED|Overall Study||6
5238188|NCT00854113|12878890|P2|STARTED|Overall Study||6
5238189|NCT00854113|12878891|P1|STARTED|Overall Study||6
5238190|NCT00854100|12878995|P3|NOT COMPLETED|Overall Study||11
5238191|NCT00854100|12878996|P2|NOT COMPLETED|Overall Study||6
5238192|NCT00854100|12878997|P1|NOT COMPLETED|Overall Study||9
5238193|NCT00854100|12878995|P3|COMPLETED|Overall Study||63
5238194|NCT00854100|12878996|P2|COMPLETED|Overall Study||70
5238195|NCT00854100|12878997|P1|COMPLETED|Overall Study||72
5238196|NCT00854100|12878995|P3|STARTED|Overall Study||74
5238197|NCT00854100|12878996|P2|STARTED|Overall Study||76
5238198|NCT00854100|12878997|P1|STARTED|Overall Study||81
5238199|NCT00854087|12879011|P2|NOT COMPLETED|Overall Study||19
5238200|NCT00854087|12879012|P1|NOT COMPLETED|Overall Study||19
5238201|NCT00854087|12879011|P2|COMPLETED|Overall Study||40
5238202|NCT00854087|12879012|P1|COMPLETED|Overall Study||40
5238203|NCT00854087|12879011|P2|STARTED|Overall Study||59
5238204|NCT00854087|12879012|P1|STARTED|Overall Study||59
5238205|NCT00853996|12879018|P1|NOT COMPLETED|Overall Study||0
5238206|NCT00853996|12879018|P1|COMPLETED|Overall Study||25
5238207|NCT00853996|12879018|P1|STARTED|Overall Study||25
5238208|NCT00853970|12879030|P2|NOT COMPLETED|Overall Study||3
5238209|NCT00853970|12879031|P1|NOT COMPLETED|Overall Study||6
5238210|NCT00853970|12879030|P2|COMPLETED|Overall Study||144
5238211|NCT00853970|12879031|P1|COMPLETED|Overall Study||146
5238212|NCT00853970|12879030|P2|STARTED|Overall Study||147
5238213|NCT00853970|12879031|P1|STARTED|Overall Study||152
5238214|NCT00853957|12879041|P2|NOT COMPLETED|Overall Study||19
5238215|NCT00853957|12879042|P1|NOT COMPLETED|Overall Study||14
5238216|NCT00853957|12879041|P2|COMPLETED|Overall Study||204
5238217|NCT00853957|12879042|P1|COMPLETED|Overall Study||206
5238218|NCT00853957|12879041|P2|STARTED|Overall Study||223
5238219|NCT00853957|12879042|P1|STARTED|Overall Study||220
5238220|NCT00853905|12879060|P2|NOT COMPLETED|Overall Study||4
5238221|NCT00853905|12879061|P1|NOT COMPLETED|Overall Study||2
5238222|NCT00853905|12879060|P2|COMPLETED|Overall Study||36
5238223|NCT00853905|12879061|P1|COMPLETED|Overall Study||35
5238224|NCT00853905|12879060|P2|STARTED|Overall Study||40
5238225|NCT00853905|12879061|P1|STARTED|Overall Study||37
5238226|NCT00853840|12879075|P2|NOT COMPLETED|Period 2||0
5238227|NCT00853840|12879076|P1|NOT COMPLETED|Period 2||0
5238228|NCT00853840|12879075|P2|COMPLETED|Period 2||9
5238229|NCT00853840|12879076|P1|COMPLETED|Period 2||9
5238230|NCT00853840|12879075|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
5238231|NCT00853840|12879076|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
5238232|NCT00853840|12879075|P2|Maraviroc (Days 1 - 3)|Period 2||9
5238233|NCT00853840|12879076|P1|Maraviroc (Days 1 - 3)|Period 2||9
5238234|NCT00853840|12879075|P2|STARTED|Period 2||9
5238235|NCT00853840|12879076|P1|STARTED|Period 2||9
5238236|NCT00853840|12879075|P2|NOT COMPLETED|Period 1||0
5238237|NCT00853840|12879076|P1|NOT COMPLETED|Period 1||0
5238238|NCT00853840|12879075|P2|COMPLETED|Period 1||9
5238239|NCT00853840|12879076|P1|COMPLETED|Period 1||9
5238240|NCT00853840|12879075|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
5238241|NCT00853840|12879076|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
5238242|NCT00853840|12879075|P2|Maraviroc (Days 1 - 4)|Period 1||9
5238243|NCT00853840|12879076|P1|Maraviroc (Days 1 - 4)|Period 1||9
5238244|NCT00853840|12879075|P2|STARTED|Period 1||9
5238245|NCT00853840|12879076|P1|STARTED|Period 1||9
5238246|NCT00853827|12879093|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
5238247|NCT00853827|12879094|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
5238248|NCT00853827|12879093|P2|COMPLETED|Double Blind Period (103 Weeks)||199
5238249|NCT00853827|12879094|P1|COMPLETED|Double Blind Period (103 Weeks)||201
5238250|NCT00853827|12879093|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
5238251|NCT00853827|12879094|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
5238252|NCT00853827|12879093|P2|STARTED|Double Blind Period (103 Weeks)||308
5238253|NCT00853827|12879094|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
5238254|NCT00853827|12879093|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
5238255|NCT00853827|12879094|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
5238256|NCT00853827|12879093|P2|COMPLETED|Single Blind Period (1 Week)||0
5238257|NCT00853827|12879094|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
5238258|NCT00853827|12879093|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
5238259|NCT00853827|12879094|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
5238260|NCT00853762|12879110|P4|NOT COMPLETED|Overall Study||22
5238261|NCT00853762|12879111|P3|NOT COMPLETED|Overall Study||17
5238262|NCT00853762|12879112|P2|NOT COMPLETED|Overall Study||19
5238263|NCT00853762|12879113|P1|NOT COMPLETED|Overall Study||16
5238264|NCT00853762|12879110|P4|COMPLETED|Overall Study||0
5238265|NCT00853762|12879111|P3|COMPLETED|Overall Study||0
5238266|NCT00853762|12879112|P2|COMPLETED|Overall Study||0
5238267|NCT00853762|12879113|P1|COMPLETED|Overall Study||0
5238268|NCT00853762|12879110|P4|STARTED|Overall Study||22
5238269|NCT00853762|12879111|P3|STARTED|Overall Study||17
5238270|NCT00853762|12879112|P2|STARTED|Overall Study||19
5238271|NCT00853762|12879113|P1|STARTED|Overall Study||16
5238272|NCT00853749|12879181|P2|NOT COMPLETED|Overall Study||1
5238273|NCT00853749|12879182|P1|NOT COMPLETED|Overall Study||0
5238274|NCT00853749|12879181|P2|COMPLETED|Overall Study||38
5238275|NCT00853749|12879182|P1|COMPLETED|Overall Study||50
5238276|NCT00853749|12879181|P2|Vaccinated|Overall Study||39
5238277|NCT00853749|12879182|P1|Vaccinated|Overall Study||50
5238278|NCT00853749|12879181|P2|STARTED|Overall Study||39
5238279|NCT00853749|12879182|P1|STARTED|Overall Study||50
5238280|NCT00853723|12879203|P3|NOT COMPLETED|Overall Study||2
5238281|NCT00853723|12879204|P2|NOT COMPLETED|Overall Study||7
5238282|NCT00853723|12879205|P1|NOT COMPLETED|Overall Study||6
5238283|NCT00853723|12879203|P3|COMPLETED|Overall Study||33
5238284|NCT00853723|12879204|P2|COMPLETED|Overall Study||28
5238285|NCT00853723|12879205|P1|COMPLETED|Overall Study||29
5238286|NCT00853723|12879203|P3|STARTED|Overall Study||35
5238287|NCT00853723|12879204|P2|STARTED|Overall Study||35
5238288|NCT00853723|12879205|P1|STARTED|Overall Study||35
5238289|NCT00853671|12879249|P1|NOT COMPLETED|Overall Study||0
5238290|NCT00853671|12879249|P1|COMPLETED|Overall Study||50
5238291|NCT00853671|12879249|P1|STARTED|Overall Study||50
5238292|NCT00853658|12879259|P3|NOT COMPLETED|Overall Study||815
5238293|NCT00853658|12879260|P2|NOT COMPLETED|Overall Study||832
5238294|NCT00853658|12879261|P1|NOT COMPLETED|Overall Study||787
5238295|NCT00853658|12879259|P3|COMPLETED|Overall Study||1539
5238296|NCT00853658|12879260|P2|COMPLETED|Overall Study||1524
5238297|NCT00853658|12879261|P1|COMPLETED|Overall Study||1567
5238298|NCT00853658|12879259|P3|Safety Set|Overall Study||2345
5238299|NCT00853658|12879260|P2|Safety Set|Overall Study||2348
5238300|NCT00853658|12879261|P1|Safety Set|Overall Study||2347
5238301|NCT00853658|12879259|P3|Full Analysis Set (FAS)|Overall Study||2336
5238302|NCT00853658|12879260|P2|Full Analysis Set (FAS)|Overall Study||2340
5238303|NCT00853658|12879261|P1|Full Analysis Set (FAS)|Overall Study||2340
5238304|NCT00853658|12879259|P3|STARTED|Overall Study||2354
5238305|NCT00853658|12879260|P2|STARTED|Overall Study||2356
5238306|NCT00853658|12879261|P1|STARTED|Overall Study||2354
5238307|NCT00853606|12879275|P1|NOT COMPLETED|Overall Study||220
5238308|NCT00853606|12879275|P1|COMPLETED|Overall Study||492
5238309|NCT00853606|12879275|P1|STARTED|Overall Study||712
5238310|NCT00853593|12879281|P1|NOT COMPLETED|Overall Study||45
5238311|NCT00853593|12879281|P1|COMPLETED|Overall Study||152
5238312|NCT00853593|12879281|P1|Model 4396 Lead Attempted|Overall Study||164
5238313|NCT00853593|12879281|P1|Implant Attempted|Overall Study||193
5238314|NCT00853593|12879281|P1|STARTED|Overall Study||197
5238315|NCT00853580|12879308|P2|NOT COMPLETED|Overall Study||16
5238316|NCT00853580|12879309|P1|NOT COMPLETED|Overall Study||7
5238317|NCT00853580|12879308|P2|COMPLETED|Overall Study||56
5238318|NCT00853580|12879309|P1|COMPLETED|Overall Study||67
5238319|NCT00853580|12879308|P2|STARTED|Overall Study||72
5238320|NCT00853580|12879309|P1|STARTED|Overall Study||74
5238321|NCT00853567|12879356|P1|NOT COMPLETED|Overall Study||71
5238322|NCT00853567|12879356|P1|COMPLETED|Overall Study||0
5238323|NCT00853567|12879356|P1|STARTED|Overall Study||71
5238324|NCT00853489|12879366|P2|NOT COMPLETED|Overall Study||2
5238325|NCT00853489|12879367|P1|NOT COMPLETED|Overall Study||5
5238326|NCT00853489|12879366|P2|COMPLETED|Overall Study||12
5238327|NCT00853489|12879367|P1|COMPLETED|Overall Study||11
5238328|NCT00853489|12879366|P2|STARTED|Overall Study||14
5238329|NCT00853489|12879367|P1|STARTED|Overall Study||16
5238330|NCT00853385|12879382|P5|NOT COMPLETED|Overall Study||42
5238331|NCT00853385|12879383|P4|NOT COMPLETED|Overall Study||13
5238332|NCT00853385|12879384|P3|NOT COMPLETED|Overall Study||9
5238333|NCT00853385|12879385|P2|NOT COMPLETED|Overall Study||43
5238334|NCT00853385|12879386|P1|NOT COMPLETED|Overall Study||54
5238335|NCT00853385|12879382|P5|COMPLETED|Overall Study||162
5238336|NCT00853385|12879383|P4|COMPLETED|Overall Study||39
5238337|NCT00853385|12879384|P3|COMPLETED|Overall Study||47
5238338|NCT00853385|12879385|P2|COMPLETED|Overall Study||158
5238339|NCT00853385|12879386|P1|COMPLETED|Overall Study||150
5238340|NCT00853385|12879382|P5|STARTED|Overall Study||204
5238341|NCT00853385|12879383|P4|STARTED|Overall Study||52
5238342|NCT00853385|12879384|P3|STARTED|Overall Study||56
5238343|NCT00853385|12879385|P2|STARTED|Overall Study||201
5238344|NCT00853385|12879386|P1|STARTED|Overall Study||204
5238345|NCT00853372|12879601|P2|NOT COMPLETED|Overall Study||29
5238346|NCT00853372|12879602|P1|NOT COMPLETED|Overall Study||32
5238347|NCT00853372|12879601|P2|COMPLETED|Overall Study||13
5238348|NCT00853372|12879602|P1|COMPLETED|Overall Study||11
5238349|NCT00853372|12879601|P2|STARTED|Overall Study||42
5238350|NCT00853372|12879602|P1|STARTED|Overall Study||43
5238351|NCT00853333|12879639|P3|NOT COMPLETED|Overall Study||0
5238352|NCT00853333|12879640|P2|NOT COMPLETED|Overall Study||0
5238353|NCT00853333|12879641|P1|NOT COMPLETED|Overall Study||0
5238354|NCT00853333|12879639|P3|COMPLETED|Overall Study||31
5238355|NCT00853333|12879640|P2|COMPLETED|Overall Study||27
5238356|NCT00853333|12879641|P1|COMPLETED|Overall Study||28
5238357|NCT00853333|12879639|P3|STARTED|Overall Study||31
5238358|NCT00853333|12879640|P2|STARTED|Overall Study||27
5238359|NCT00853333|12879641|P1|STARTED|Overall Study||28
5238360|NCT00853307|12879651|P2|NOT COMPLETED|Overall Study||5
5238361|NCT00853307|12879652|P1|NOT COMPLETED|Overall Study||2
5238362|NCT00853307|12879651|P2|COMPLETED|Overall Study||20
5238363|NCT00853307|12879652|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
5238364|NCT00853307|12879651|P2|STARTED|Overall Study||25
5238365|NCT00853307|12879652|P1|STARTED|Overall Study||6
5238366|NCT00853242|12879679|P7|NOT COMPLETED|Overall Study||5
5238367|NCT00853242|12879680|P6|NOT COMPLETED|Overall Study||2
5238368|NCT00853242|12879681|P5|NOT COMPLETED|Overall Study||4
5238369|NCT00853242|12879682|P4|NOT COMPLETED|Overall Study||4
5238370|NCT00853242|12879683|P3|NOT COMPLETED|Overall Study||3
5238371|NCT00853242|12879684|P2|NOT COMPLETED|Overall Study||3
5238372|NCT00853242|12879685|P1|NOT COMPLETED|Overall Study||3
5238373|NCT00853242|12879679|P7|COMPLETED|Overall Study||44
5238374|NCT00853242|12879680|P6|COMPLETED|Overall Study||49
5238375|NCT00853242|12879681|P5|COMPLETED|Overall Study||46
5238376|NCT00853242|12879682|P4|COMPLETED|Overall Study||46
5238377|NCT00853242|12879683|P3|COMPLETED|Overall Study||46
5238378|NCT00853242|12879684|P2|COMPLETED|Overall Study||47
5238379|NCT00853242|12879685|P1|COMPLETED|Overall Study||47
5238380|NCT00853242|12879679|P7|Treated|Overall Study||48
5238381|NCT00853242|12879680|P6|Treated|Overall Study||51
5238382|NCT00853242|12879681|P5|Treated|Overall Study||50
5238383|NCT00853242|12879682|P4|Treated|Overall Study||50
5238384|NCT00853242|12879683|P3|Treated|Overall Study||48
5238385|NCT00853242|12879684|P2|Treated|Overall Study||49
5238386|NCT00853242|12879685|P1|Treated|Overall Study||50
5238387|NCT00853242|12879679|P7|STARTED|Overall Study||49
5238388|NCT00853242|12879680|P6|STARTED|Overall Study||51
5238389|NCT00853242|12879681|P5|STARTED|Overall Study||50
5238390|NCT00853242|12879682|P4|STARTED|Overall Study||50
5238391|NCT00853242|12879683|P3|STARTED|Overall Study||49
5238392|NCT00853242|12879684|P2|STARTED|Overall Study||50
5238393|NCT00853242|12879685|P1|STARTED|Overall Study||50
5238394|NCT00853229|12879727|P2|NOT COMPLETED|Phase 2: Cross Over||0
5238395|NCT00853229|12879728|P1|NOT COMPLETED|Phase 2: Cross Over||0
5238396|NCT00853229|12879727|P2|COMPLETED|Phase 2: Cross Over||0
5238397|NCT00853229|12879728|P1|COMPLETED|Phase 2: Cross Over||0
5238398|NCT00853229|12879727|P2|STARTED|Phase 2: Cross Over||0
5238399|NCT00853229|12879728|P1|STARTED|Phase 2: Cross Over||0
5238400|NCT00853229|12879727|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
5238401|NCT00853229|12879728|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
5238402|NCT00853229|12879727|P2|COMPLETED|Phase 1: Initial Intervention||0
5238403|NCT00853229|12879728|P1|COMPLETED|Phase 1: Initial Intervention||0
5238404|NCT00853229|12879727|P2|STARTED|Phase 1: Initial Intervention||8
5238405|NCT00853229|12879728|P1|STARTED|Phase 1: Initial Intervention||8
5238406|NCT00853151|12879738|P4|NOT COMPLETED|Overall Study||3
5238407|NCT00853151|12879739|P3|NOT COMPLETED|Overall Study||8
5238408|NCT00853151|12879740|P2|NOT COMPLETED|Overall Study||13
5238409|NCT00853151|12879741|P1|NOT COMPLETED|Overall Study||10
5238410|NCT00853151|12879738|P4|COMPLETED|Overall Study||15
5238411|NCT00853151|12879739|P3|COMPLETED|Overall Study||30
5238412|NCT00853151|12879740|P2|COMPLETED|Overall Study||24
5238413|NCT00853151|12879741|P1|COMPLETED|Overall Study||28
5238414|NCT00853151|12879738|P4|STARTED|Overall Study||18
5238415|NCT00853151|12879739|P3|STARTED|Overall Study||38
5238416|NCT00853151|12879740|P2|STARTED|Overall Study||37
5238417|NCT00853151|12879741|P1|STARTED|Overall Study||38
5238418|NCT00853125|12879883|P1|NOT COMPLETED|Overall Study||1
5238419|NCT00853125|12879883|P1|COMPLETED|Overall Study||9
5238420|NCT00853125|12879883|P1|STARTED|Overall Study||10
5238421|NCT00853112|12879895|P7|NOT COMPLETED|Overall Study||1
5238422|NCT00853112|12879896|P6|NOT COMPLETED|Overall Study||0
5238423|NCT00853112|12879897|P5|NOT COMPLETED|Overall Study||0
5238424|NCT00853112|12879898|P4|NOT COMPLETED|Overall Study||2
5238425|NCT00853112|12879899|P3|NOT COMPLETED|Overall Study||0
5238426|NCT00853112|12879900|P2|NOT COMPLETED|Overall Study||1
5238427|NCT00853112|12879901|P1|NOT COMPLETED|Overall Study||0
5238428|NCT00853112|12879895|P7|COMPLETED|Overall Study||6
5238429|NCT00853112|12879896|P6|COMPLETED|Overall Study||7
5238430|NCT00853112|12879897|P5|COMPLETED|Overall Study||6
5238431|NCT00853112|12879898|P4|COMPLETED|Overall Study||6
5238432|NCT00853112|12879899|P3|COMPLETED|Overall Study||7
5238433|NCT00853112|12879900|P2|COMPLETED|Overall Study||6
5238434|NCT00853112|12879901|P1|COMPLETED|Overall Study||6
5238435|NCT00853112|12879895|P7|Treated|Overall Study||6
5238436|NCT00853112|12879896|P6|Treated|Overall Study||7
5238437|NCT00853112|12879897|P5|Treated|Overall Study||6
5238438|NCT00853112|12879898|P4|Treated|Overall Study||6
5238439|NCT00853112|12879899|P3|Treated|Overall Study||7
5238440|NCT00853112|12879900|P2|Treated|Overall Study||6
5238441|NCT00853112|12879901|P1|Treated|Overall Study||6
5238442|NCT00853112|12879895|P7|STARTED|Overall Study||7
5238443|NCT00853112|12879896|P6|STARTED|Overall Study||7
5238444|NCT00853112|12879897|P5|STARTED|Overall Study||6
5238445|NCT00853112|12879898|P4|STARTED|Overall Study||8
5238446|NCT00853112|12879899|P3|STARTED|Overall Study||7
5238447|NCT00853112|12879900|P2|STARTED|Overall Study||7
5238448|NCT00853112|12879901|P1|STARTED|Overall Study||6
5238449|NCT00853099|12880011|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
5238450|NCT00853099|12880012|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
5238451|NCT00853099|12880013|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
5238452|NCT00853099|12880014|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
5238453|NCT00853099|12880011|P4|COMPLETED|Double-blind + Open-label Periods||119
5238454|NCT00853099|12880012|P3|COMPLETED|Double-blind + Open-label Periods||0
5238455|NCT00853099|12880013|P2|COMPLETED|Double-blind + Open-label Periods||0
5238456|NCT00853099|12880014|P1|COMPLETED|Double-blind + Open-label Periods||0
5238457|NCT00853099|12880011|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
5238458|NCT00853099|12880012|P3|STARTED|Double-blind + Open-label Periods||0
5238459|NCT00853099|12880013|P2|STARTED|Double-blind + Open-label Periods||0
5238460|NCT00853099|12880014|P1|STARTED|Double-blind + Open-label Periods||0
5238461|NCT00853099|12880011|P4|NOT COMPLETED|Double-blind Period||0
5238462|NCT00853099|12880012|P3|NOT COMPLETED|Double-blind Period||31
5238463|NCT00853099|12880013|P2|NOT COMPLETED|Double-blind Period||29
5238464|NCT00853099|12880014|P1|NOT COMPLETED|Double-blind Period||23
5238465|NCT00853099|12880011|P4|COMPLETED|Double-blind Period||0
5238466|NCT00853099|12880012|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
5238467|NCT00853099|12880013|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
5238468|NCT00853099|12880014|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
5238469|NCT00853099|12880011|P4|Completed Week 8|Double-blind Period||0
5238470|NCT00853099|12880012|P3|Completed Week 8|Double-blind Period||86
5238471|NCT00853099|12880013|P2|Completed Week 8|Double-blind Period||85
5238472|NCT00853099|12880014|P1|Completed Week 8|Double-blind Period||92
5238473|NCT00853099|12880011|P4|Treated|Double-blind Period||0
5238474|NCT00853099|12880012|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
5238475|NCT00853099|12880013|P2|Treated|Double-blind Period||87
5238476|NCT00853099|12880014|P1|Treated|Double-blind Period||96
5238477|NCT00853099|12880011|P4|STARTED|Double-blind Period||0
5238478|NCT00853099|12880012|P3|STARTED|Double-blind Period||91
5238479|NCT00853099|12880013|P2|STARTED|Double-blind Period||87
5238480|NCT00853099|12880014|P1|STARTED|Double-blind Period||96
5238481|NCT00853073|12880056|P2|NOT COMPLETED|Overall Study||2
5238482|NCT00853073|12880057|P1|NOT COMPLETED|Overall Study||3
5238483|NCT00853073|12880056|P2|COMPLETED|Overall Study||29
5238484|NCT00853073|12880057|P1|COMPLETED|Overall Study||29
5238485|NCT00853073|12880056|P2|STARTED|Overall Study||31
5238486|NCT00853073|12880057|P1|STARTED|Overall Study||32
5238487|NCT00853047|12880070|P6|NOT COMPLETED|Open-Label Extension Phase||17
5238488|NCT00853047|12880071|P5|NOT COMPLETED|Open-Label Extension Phase||0
5238489|NCT00853047|12880072|P4|NOT COMPLETED|Open-Label Extension Phase||0
5238490|NCT00853047|12880073|P3|NOT COMPLETED|Open-Label Extension Phase||0
5238491|NCT00853047|12880074|P2|NOT COMPLETED|Open-Label Extension Phase||0
5238492|NCT00853047|12880075|P1|NOT COMPLETED|Open-Label Extension Phase||0
5238493|NCT00853047|12880070|P6|COMPLETED|Open-Label Extension Phase||2
5238494|NCT00853047|12880071|P5|COMPLETED|Open-Label Extension Phase||0
5238495|NCT00853047|12880072|P4|COMPLETED|Open-Label Extension Phase||0
5238496|NCT00853047|12880073|P3|COMPLETED|Open-Label Extension Phase||0
5238497|NCT00853047|12880074|P2|COMPLETED|Open-Label Extension Phase||0
5238498|NCT00853047|12880075|P1|COMPLETED|Open-Label Extension Phase||0
5238499|NCT00853047|12880070|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
5238500|NCT00853047|12880071|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
5238501|NCT00853047|12880072|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
5238502|NCT00853047|12880073|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
5238503|NCT00853047|12880074|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
5238504|NCT00853047|12880075|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
5238505|NCT00853047|12880070|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
5238506|NCT00853047|12880071|P5|STARTED|Open-Label Extension Phase||0
5238507|NCT00853047|12880072|P4|STARTED|Open-Label Extension Phase||0
5238508|NCT00853047|12880073|P3|STARTED|Open-Label Extension Phase||0
5238509|NCT00853047|12880074|P2|STARTED|Open-Label Extension Phase||0
5238510|NCT00853047|12880075|P1|STARTED|Open-Label Extension Phase||0
5238511|NCT00853047|12880070|P6|NOT COMPLETED|Core Phase||0
5238512|NCT00853047|12880071|P5|NOT COMPLETED|Core Phase||0
5238513|NCT00853047|12880072|P4|NOT COMPLETED|Core Phase||1
5238514|NCT00853047|12880073|P3|NOT COMPLETED|Core Phase||0
5238515|NCT00853047|12880074|P2|NOT COMPLETED|Core Phase||0
5238516|NCT00853047|12880075|P1|NOT COMPLETED|Core Phase||0
5238517|NCT00853047|12880070|P6|COMPLETED|Core Phase||0
5238518|NCT00853047|12880071|P5|COMPLETED|Core Phase||9
5238519|NCT00853047|12880072|P4|COMPLETED|Core Phase||2
5238520|NCT00853047|12880073|P3|COMPLETED|Core Phase||3
5238521|NCT00853047|12880074|P2|COMPLETED|Core Phase||3
5238522|NCT00853047|12880075|P1|COMPLETED|Core Phase||5
5238523|NCT00853047|12880070|P6|STARTED|Core Phase||0
5238524|NCT00853047|12880071|P5|STARTED|Core Phase||9
5238525|NCT00853047|12880072|P4|STARTED|Core Phase||3
5238526|NCT00853047|12880073|P3|STARTED|Core Phase||3
5238527|NCT00853047|12880074|P2|STARTED|Core Phase||3
5238528|NCT00853047|12880075|P1|STARTED|Core Phase||5
5238529|NCT00853021|12880141|P1|NOT COMPLETED|Overall Study||5
5238530|NCT00853021|12880141|P1|COMPLETED|Overall Study||21
5238531|NCT00853021|12880141|P1|STARTED|Overall Study||26
5238532|NCT00852995|12880153|P5|NOT COMPLETED|Overall Study||4
5238533|NCT00852995|12880154|P4|NOT COMPLETED|Overall Study||5
5238534|NCT00852995|12880155|P3|NOT COMPLETED|Overall Study||5
5238535|NCT00852995|12880156|P2|NOT COMPLETED|Overall Study||1
5238536|NCT00852995|12880157|P1|NOT COMPLETED|Overall Study||8
5238537|NCT00852995|12880153|P5|COMPLETED|Overall Study||46
5238538|NCT00852995|12880154|P4|COMPLETED|Overall Study||40
5238539|NCT00852995|12880155|P3|COMPLETED|Overall Study||39
5238540|NCT00852995|12880156|P2|COMPLETED|Overall Study||42
5238541|NCT00852995|12880157|P1|COMPLETED|Overall Study||38
5238542|NCT00852995|12880153|P5|STARTED|Overall Study||50
5238543|NCT00852995|12880154|P4|STARTED|Overall Study||45
5238544|NCT00852995|12880155|P3|STARTED|Overall Study||44
5238545|NCT00852995|12880156|P2|STARTED|Overall Study||43
5238546|NCT00852995|12880157|P1|STARTED|Overall Study||46
5238547|NCT00852969|12880201|P2|NOT COMPLETED|Overall Study||2
5238548|NCT00852969|12880202|P1|NOT COMPLETED|Overall Study||0
5238549|NCT00852969|12880201|P2|COMPLETED|Overall Study||13
5238550|NCT00852969|12880202|P1|COMPLETED|Overall Study||15
5238551|NCT00852969|12880201|P2|STARTED|Overall Study||15
5238552|NCT00852969|12880202|P1|STARTED|Overall Study||15
5238553|NCT00852930|12880213|P3|NOT COMPLETED|Overall Study||2
5238554|NCT00852930|12880214|P2|NOT COMPLETED|Overall Study||1
5238555|NCT00852930|12880215|P1|NOT COMPLETED|Overall Study||1
5238556|NCT00852930|12880213|P3|COMPLETED|Overall Study||15
5238557|NCT00852930|12880214|P2|COMPLETED|Overall Study||16
5238558|NCT00852930|12880215|P1|COMPLETED|Overall Study||15
5238559|NCT00852930|12880213|P3|STARTED|Overall Study||17
5238560|NCT00852930|12880214|P2|STARTED|Overall Study||17
5238561|NCT00852930|12880215|P1|STARTED|Overall Study||16
5238562|NCT00852917|12880236|P4|NOT COMPLETED|Overall Study||93
5238563|NCT00852917|12880237|P3|NOT COMPLETED|Overall Study||58
5238564|NCT00852917|12880238|P2|NOT COMPLETED|Overall Study||46
5238565|NCT00852917|12880239|P1|NOT COMPLETED|Overall Study||44
5238566|NCT00852917|12880236|P4|COMPLETED|Overall Study||134
5238567|NCT00852917|12880237|P3|COMPLETED|Overall Study||50
5238568|NCT00852917|12880238|P2|COMPLETED|Overall Study||65
5238569|NCT00852917|12880239|P1|COMPLETED|Overall Study||62
5238570|NCT00852917|12880236|P4|STARTED|Overall Study||227
5238571|NCT00852917|12880237|P3|STARTED|Overall Study||108
5238572|NCT00852917|12880238|P2|STARTED|Overall Study||111
5238573|NCT00852917|12880239|P1|STARTED|Overall Study||106
5238574|NCT00852761|12880279|P2|NOT COMPLETED|Overall Study||0
5238575|NCT00852761|12880280|P1|NOT COMPLETED|Overall Study||0
5238576|NCT00852761|12880279|P2|COMPLETED|Overall Study||17
5238577|NCT00852761|12880280|P1|COMPLETED|Overall Study||17
5238578|NCT00852761|12880279|P2|STARTED|Overall Study||17
5238579|NCT00852761|12880280|P1|STARTED|Overall Study||17
5238580|NCT00852644|12880322|P6|NOT COMPLETED|Overall Study||0
5238581|NCT00852644|12880323|P5|NOT COMPLETED|Overall Study||0
5238582|NCT00852644|12880324|P4|NOT COMPLETED|Overall Study||0
5238583|NCT00852644|12880325|P3|NOT COMPLETED|Overall Study||0
5238584|NCT00852644|12880326|P2|NOT COMPLETED|Overall Study||0
5238585|NCT00852644|12880327|P1|NOT COMPLETED|Overall Study||0
5238586|NCT00852644|12880322|P6|COMPLETED|Overall Study||0
5238587|NCT00852644|12880323|P5|COMPLETED|Overall Study||0
5238588|NCT00852644|12880324|P4|COMPLETED|Overall Study||3
5238589|NCT00852644|12880325|P3|COMPLETED|Overall Study||0
5238590|NCT00852644|12880326|P2|COMPLETED|Overall Study||3
5238591|NCT00852644|12880327|P1|COMPLETED|Overall Study||3
5238592|NCT00852644|12880322|P6|STARTED|Overall Study||0
5238593|NCT00852644|12880323|P5|STARTED|Overall Study||0
5238594|NCT00852644|12880324|P4|STARTED|Overall Study||3
5238595|NCT00852644|12880325|P3|STARTED|Overall Study||0
5238596|NCT00852644|12880326|P2|STARTED|Overall Study||3
5238597|NCT00852644|12880327|P1|STARTED|Overall Study||3
5238598|NCT00852631|12880348|P1|NOT COMPLETED|Overall Study||11
5238599|NCT00852631|12880348|P1|COMPLETED|Overall Study||17
5238600|NCT00852631|12880348|P1|STARTED|Overall Study||28
5238601|NCT00852592|12880356|P2|NOT COMPLETED|Overall Study||4
5238602|NCT00852592|12880357|P1|NOT COMPLETED|Overall Study||3
5238603|NCT00852592|12880356|P2|COMPLETED|Overall Study||19
5238604|NCT00852592|12880357|P1|COMPLETED|Overall Study||20
5238605|NCT00852592|12880356|P2|STARTED|Overall Study||23
5238606|NCT00852592|12880357|P1|STARTED|Overall Study||23
5238607|NCT00852540|12880367|P2|NOT COMPLETED|Overall Study||18
5238608|NCT00852540|12880368|P1|NOT COMPLETED|Overall Study||36
5238609|NCT00852540|12880367|P2|COMPLETED|Overall Study||122
5238610|NCT00852540|12880368|P1|COMPLETED|Overall Study||234
5238611|NCT00852540|12880367|P2|STARTED|Overall Study||140
5238612|NCT00852540|12880368|P1|STARTED|Overall Study||270
5238613|NCT00852527|12880394|P2|NOT COMPLETED|Overall Study||0
5238614|NCT00852527|12880395|P1|NOT COMPLETED|Overall Study||0
5238615|NCT00852527|12880394|P2|COMPLETED|Overall Study||242
5238616|NCT00852527|12880395|P1|COMPLETED|Overall Study||196
5238617|NCT00852527|12880394|P2|STARTED|Overall Study||242
5238618|NCT00852527|12880395|P1|STARTED|Overall Study||196
5238619|NCT00852475|12880402|P2|NOT COMPLETED|Overall Study||4
5238620|NCT00852475|12880403|P1|NOT COMPLETED|Overall Study||3
5238621|NCT00852475|12880402|P2|COMPLETED|Overall Study||16
5238622|NCT00852475|12880403|P1|COMPLETED|Overall Study||23
5238623|NCT00852475|12880402|P2|STARTED|Overall Study||20
5238624|NCT00852475|12880403|P1|STARTED|Overall Study||26
5238625|NCT00852397|12880414|P3|NOT COMPLETED|Overall Study||14
5238626|NCT00852397|12880415|P2|NOT COMPLETED|Overall Study||8
5238627|NCT00852397|12880416|P1|NOT COMPLETED|Overall Study||11
5238628|NCT00852397|12880414|P3|COMPLETED|Overall Study||36
5238629|NCT00852397|12880415|P2|COMPLETED|Overall Study||41
5238630|NCT00852397|12880416|P1|COMPLETED|Overall Study||41
5238631|NCT00852397|12880414|P3|Treated Participants|Overall Study||49
5238632|NCT00852397|12880415|P2|Treated Participants|Overall Study||49
5238633|NCT00852397|12880416|P1|Treated Participants|Overall Study||51
5238634|NCT00852397|12880414|P3|STARTED|Overall Study||50
5238635|NCT00852397|12880415|P2|STARTED|Overall Study||49
5238636|NCT00852397|12880416|P1|STARTED|Overall Study||52
5238637|NCT00852241|12880445|P1|NOT COMPLETED|Overall Study||18
5238638|NCT00852241|12880445|P1|COMPLETED|Overall Study||0
5238639|NCT00852241|12880445|P1|STARTED|Overall Study||18
5238640|NCT00852202|12880452|P3|NOT COMPLETED|Overall Study||26
5238641|NCT00852202|12880453|P2|NOT COMPLETED|Overall Study||12
5238642|NCT00852202|12880454|P1|NOT COMPLETED|Overall Study||17
5238643|NCT00852202|12880452|P3|COMPLETED|Overall Study||49
5238644|NCT00852202|12880453|P2|COMPLETED|Overall Study||63
5238645|NCT00852202|12880454|P1|COMPLETED|Overall Study||60
5238646|NCT00852202|12880452|P3|STARTED|Overall Study||75
5238647|NCT00852202|12880453|P2|STARTED|Overall Study||75
5238648|NCT00852202|12880454|P1|STARTED|Overall Study||77
5238649|NCT00852137|12880467|P2|NOT COMPLETED|Overall Study||0
5238650|NCT00852137|12880468|P1|NOT COMPLETED|Overall Study||0
5238651|NCT00852137|12880467|P2|COMPLETED|Overall Study||3
5238652|NCT00852137|12880468|P1|COMPLETED|Overall Study||13
5238653|NCT00852137|12880467|P2|STARTED|Overall Study||3
5238654|NCT00852137|12880468|P1|STARTED|Overall Study||13
5238655|NCT00852124|12880490|P2|NOT COMPLETED|Overall Study||0
5238656|NCT00852124|12880491|P1|NOT COMPLETED|Overall Study||0
5238657|NCT00852124|12880490|P2|COMPLETED|Overall Study||0
5238658|NCT00852124|12880491|P1|COMPLETED|Overall Study||3
5238659|NCT00852124|12880490|P2|STARTED|Overall Study||0
5238660|NCT00852124|12880491|P1|STARTED|Overall Study||3
5238661|NCT00851903|12880496|P1|NOT COMPLETED|Overall Study||2
5238662|NCT00851903|12880496|P1|COMPLETED|Overall Study||110
5238663|NCT00851903|12880496|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
5238664|NCT00851903|12880496|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
5238665|NCT00851903|12880496|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
5238666|NCT00851903|12880496|P1|STARTED|Overall Study||112
5238667|NCT00851890|12880510|P4|NOT COMPLETED|Overall Study||1
5238668|NCT00851890|12880511|P3|NOT COMPLETED|Overall Study||0
5238669|NCT00851890|12880512|P2|NOT COMPLETED|Overall Study||1
5238670|NCT00851890|12880513|P1|NOT COMPLETED|Overall Study||0
5238671|NCT00851890|12880510|P4|COMPLETED|Overall Study||5
5238672|NCT00851890|12880511|P3|COMPLETED|Overall Study||8
5238673|NCT00851890|12880512|P2|COMPLETED|Overall Study||7
5238674|NCT00851890|12880513|P1|COMPLETED|Overall Study||8
5238675|NCT00851890|12880510|P4|STARTED|Overall Study||6
5238676|NCT00851890|12880511|P3|STARTED|Overall Study||8
5238677|NCT00851890|12880512|P2|STARTED|Overall Study||8
5238678|NCT00851890|12880513|P1|STARTED|Overall Study||8
5238679|NCT00851877|12880570|P3|NOT COMPLETED|Phase II||3
5238680|NCT00851877|12880571|P2|NOT COMPLETED|Phase II||0
5238681|NCT00851877|12880572|P1|NOT COMPLETED|Phase II||0
5238682|NCT00851877|12880570|P3|COMPLETED|Phase II||22
5238683|NCT00851877|12880571|P2|COMPLETED|Phase II||0
5238684|NCT00851877|12880572|P1|COMPLETED|Phase II||0
5238685|NCT00851877|12880570|P3|STARTED|Phase II||25
5238686|NCT00851877|12880571|P2|STARTED|Phase II||0
5238687|NCT00851877|12880572|P1|STARTED|Phase II||0
5238688|NCT00851877|12880570|P3|NOT COMPLETED|Phase I-2||0
5238689|NCT00851877|12880571|P2|NOT COMPLETED|Phase I-2||0
5238690|NCT00851877|12880572|P1|NOT COMPLETED|Phase I-2||0
5238691|NCT00851877|12880570|P3|COMPLETED|Phase I-2||0
5238692|NCT00851877|12880571|P2|COMPLETED|Phase I-2||5
5238693|NCT00851877|12880572|P1|COMPLETED|Phase I-2||0
5238694|NCT00851877|12880570|P3|STARTED|Phase I-2||0
5238695|NCT00851877|12880571|P2|STARTED|Phase I-2||5
5238696|NCT00851877|12880572|P1|STARTED|Phase I-2||0
5238697|NCT00851877|12880570|P3|NOT COMPLETED|Phase I-1||0
5238698|NCT00851877|12880571|P2|NOT COMPLETED|Phase I-1||0
5238699|NCT00851877|12880572|P1|NOT COMPLETED|Phase I-1||1
5238700|NCT00851877|12880570|P3|COMPLETED|Phase I-1||0
5238701|NCT00851877|12880571|P2|COMPLETED|Phase I-1||0
5238702|NCT00851877|12880572|P1|COMPLETED|Phase I-1||6
5238703|NCT00851877|12880570|P3|STARTED|Phase I-1||0
5238704|NCT00851877|12880571|P2|STARTED|Phase I-1||0
5238705|NCT00851877|12880572|P1|STARTED|Phase I-1||7
5238706|NCT00851799|12880582|P3|NOT COMPLETED|Overall Study||24
5238707|NCT00851799|12880583|P2|NOT COMPLETED|Overall Study||13
5238708|NCT00851799|12880584|P1|NOT COMPLETED|Overall Study||16
5238709|NCT00851799|12880582|P3|COMPLETED|Overall Study||89
5238710|NCT00851799|12880583|P2|COMPLETED|Overall Study||93
5238711|NCT00851799|12880584|P1|COMPLETED|Overall Study||93
5238712|NCT00851799|12880582|P3|STARTED|Overall Study||113
5238713|NCT00851799|12880583|P2|STARTED|Overall Study||106
5238714|NCT00851799|12880584|P1|STARTED|Overall Study||109
5238715|NCT00851786|12880672|P2|NOT COMPLETED|Overall Study||2
5238716|NCT00851786|12880673|P1|NOT COMPLETED|Overall Study||5
5238717|NCT00851786|12880672|P2|COMPLETED|Overall Study||97
5238718|NCT00851786|12880673|P1|COMPLETED|Overall Study||291
5238719|NCT00851786|12880672|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
5238720|NCT00851786|12880673|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
5238721|NCT00851747|12880686|P3|NOT COMPLETED|Overall Study||6
5238722|NCT00851747|12880687|P2|NOT COMPLETED|Overall Study||6
5238723|NCT00851747|12880688|P1|NOT COMPLETED|Overall Study||6
5238724|NCT00851747|12880686|P3|COMPLETED|Overall Study||0
5238725|NCT00851747|12880687|P2|COMPLETED|Overall Study||0
5238726|NCT00851747|12880688|P1|COMPLETED|Overall Study||0
5238727|NCT00851747|12880686|P3|STARTED|Overall Study||6
5238728|NCT00851747|12880687|P2|STARTED|Overall Study||6
5238729|NCT00851747|12880688|P1|STARTED|Overall Study||6
5238730|NCT00851721|12880697|P2|NOT COMPLETED|Overall Study||1
5238731|NCT00851721|12880698|P1|NOT COMPLETED|Overall Study||2
5238732|NCT00851721|12880697|P2|COMPLETED|Overall Study||16
5238733|NCT00851721|12880698|P1|COMPLETED|Overall Study||17
5238734|NCT00851721|12880697|P2|STARTED|Overall Study||17
5238735|NCT00851721|12880698|P1|STARTED|Overall Study||19
5238736|NCT00851682|12880788|P2|NOT COMPLETED|Overall Study||0
5238737|NCT00851682|12880789|P1|NOT COMPLETED|Overall Study||5
5238738|NCT00851682|12880788|P2|COMPLETED|Overall Study||5
5238739|NCT00851682|12880789|P1|COMPLETED|Overall Study||55
5238740|NCT00851682|12880788|P2|STARTED|Overall Study||5
5238741|NCT00851682|12880789|P1|STARTED|Overall Study||60
5238742|NCT00851643|12880803|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
5238743|NCT00851643|12880804|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
5238744|NCT00851643|12880805|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
5238745|NCT00851643|12880806|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
5238746|NCT00851643|12880807|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
5238747|NCT00851643|12880808|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
5238748|NCT00851643|12880803|P6|COMPLETED|Extension Study (Up to 36 Months)||14
5238749|NCT00851643|12880804|P5|COMPLETED|Extension Study (Up to 36 Months)||19
5238750|NCT00851643|12880805|P4|COMPLETED|Extension Study (Up to 36 Months)||5
5238751|NCT00851643|12880806|P3|COMPLETED|Extension Study (Up to 36 Months)||14
5238752|NCT00851643|12880807|P2|COMPLETED|Extension Study (Up to 36 Months)||15
5238753|NCT00851643|12880808|P1|COMPLETED|Extension Study (Up to 36 Months)||6
5238754|NCT00851643|12880803|P6|STARTED|Extension Study (Up to 36 Months)||15
5238755|NCT00851643|12880804|P5|STARTED|Extension Study (Up to 36 Months)||21
5238756|NCT00851643|12880805|P4|STARTED|Extension Study (Up to 36 Months)||7
5238757|NCT00851643|12880806|P3|STARTED|Extension Study (Up to 36 Months)||19
5238758|NCT00851643|12880807|P2|STARTED|Extension Study (Up to 36 Months)||19
5238759|NCT00851643|12880808|P1|STARTED|Extension Study (Up to 36 Months)||10
5238760|NCT00851643|12880803|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
5238761|NCT00851643|12880804|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
5238762|NCT00851643|12880805|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
5238763|NCT00851643|12880806|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
5238764|NCT00851643|12880807|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
5238765|NCT00851643|12880808|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
5238766|NCT00851643|12880803|P6|COMPLETED|Base Study (Up to 12 Months)||29
5238767|NCT00851643|12880804|P5|COMPLETED|Base Study (Up to 12 Months)||30
5238768|NCT00851643|12880805|P4|COMPLETED|Base Study (Up to 12 Months)||15
5238769|NCT00851643|12880806|P3|COMPLETED|Base Study (Up to 12 Months)||30
5238770|NCT00851643|12880807|P2|COMPLETED|Base Study (Up to 12 Months)||30
5238771|NCT00851643|12880808|P1|COMPLETED|Base Study (Up to 12 Months)||14
5238772|NCT00851643|12880803|P6|STARTED|Base Study (Up to 12 Months)||30
5238773|NCT00851643|12880804|P5|STARTED|Base Study (Up to 12 Months)||30
5238774|NCT00851643|12880805|P4|STARTED|Base Study (Up to 12 Months)||15
5238775|NCT00851643|12880806|P3|STARTED|Base Study (Up to 12 Months)||30
5238776|NCT00851643|12880807|P2|STARTED|Base Study (Up to 12 Months)||30
5238777|NCT00851643|12880808|P1|STARTED|Base Study (Up to 12 Months)||15
5238778|NCT00851630|12880829|P2|NOT COMPLETED|Overall Study||2
5238779|NCT00851630|12880830|P1|NOT COMPLETED|Overall Study||2
5238780|NCT00851630|12880829|P2|COMPLETED|Overall Study||33
5238781|NCT00851630|12880830|P1|COMPLETED|Overall Study||33
5238782|NCT00851630|12880829|P2|STARTED|Overall Study||35
5238783|NCT00851630|12880830|P1|STARTED|Overall Study||35
5238784|NCT00851591|12880844|P2|NOT COMPLETED|Overall Study||0
5238785|NCT00851591|12880845|P1|NOT COMPLETED|Overall Study||2
5238786|NCT00851591|12880844|P2|COMPLETED|Overall Study||1
5238787|NCT00851591|12880845|P1|COMPLETED|Overall Study||0
5238788|NCT00851591|12880844|P2|STARTED|Overall Study|One received treatment.|1
5238789|NCT00851591|12880845|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
5238790|NCT00851552|12880851|P1|NOT COMPLETED|Overall Study||7
5238791|NCT00851552|12880851|P1|COMPLETED|Overall Study||2
5238792|NCT00851552|12880851|P1|STARTED|Overall Study||9
5238793|NCT00851409|12880856|P1|NOT COMPLETED|Overall Study||0
5238794|NCT00851409|12880856|P1|COMPLETED|Overall Study||25
5238795|NCT00851409|12880856|P1|STARTED|Overall Study||25
5238796|NCT00851357|12880864|P3|NOT COMPLETED|Overall Study||0
5238797|NCT00851357|12880865|P2|NOT COMPLETED|Overall Study||0
5238798|NCT00851357|12880866|P1|NOT COMPLETED|Overall Study||0
5238799|NCT00851357|12880864|P3|COMPLETED|Overall Study||1799
5238800|NCT00851357|12880865|P2|COMPLETED|Overall Study||1201
5238801|NCT00851357|12880866|P1|COMPLETED|Overall Study||1200
5238802|NCT00851357|12880864|P3|STARTED|Overall Study||1799
5238803|NCT00851357|12880865|P2|STARTED|Overall Study||1201
5238804|NCT00851357|12880866|P1|STARTED|Overall Study||1200
5238805|NCT00851318|12880881|P4|NOT COMPLETED|Overall Study||19
5238806|NCT00851318|12880882|P3|NOT COMPLETED|Overall Study||21
5238807|NCT00851318|12880883|P2|NOT COMPLETED|Overall Study||5
5238808|NCT00851318|12880884|P1|NOT COMPLETED|Overall Study||30
5238809|NCT00851318|12880881|P4|COMPLETED|Overall Study||73
5238810|NCT00851318|12880882|P3|COMPLETED|Overall Study||72
5238811|NCT00851318|12880883|P2|COMPLETED|Overall Study||14
5238812|NCT00851318|12880884|P1|COMPLETED|Overall Study||51
5238813|NCT00851318|12880881|P4|Completed Week 52|Overall Study||85
5238814|NCT00851318|12880882|P3|Completed Week 52|Overall Study||87
5238815|NCT00851318|12880883|P2|Completed Week 52|Overall Study||16
5238816|NCT00851318|12880884|P1|Completed Week 52|Overall Study||64
5238817|NCT00851318|12880881|P4|Completed Week 24|Overall Study||87
5238818|NCT00851318|12880882|P3|Completed Week 24|Overall Study||90
5238819|NCT00851318|12880883|P2|Completed Week 24|Overall Study||17
5238820|NCT00851318|12880884|P1|Completed Week 24|Overall Study||69
5238821|NCT00851318|12880881|P4|STARTED|Overall Study||92
5238822|NCT00851318|12880882|P3|STARTED|Overall Study||93
5238823|NCT00851318|12880883|P2|STARTED|Overall Study||19
5238824|NCT00851318|12880884|P1|STARTED|Overall Study||81
5238825|NCT00851279|12880914|P1|NOT COMPLETED|Overall Study||0
5238826|NCT00851279|12880914|P1|COMPLETED|Overall Study||53
5238827|NCT00851279|12880914|P1|STARTED|Overall Study||53
5238828|NCT00851253|12880920|P2|NOT COMPLETED|Overall Study||0
5238829|NCT00851253|12880921|P1|NOT COMPLETED|Overall Study||1
5238830|NCT00851253|12880920|P2|COMPLETED|Overall Study||10
5238831|NCT00851253|12880921|P1|COMPLETED|Overall Study||1
5238832|NCT00851253|12880920|P2|STARTED|Overall Study||10
5238833|NCT00851253|12880921|P1|STARTED|Overall Study||2
5238834|NCT00851084|12880931|P2|NOT COMPLETED|Overall Study||119
5238835|NCT00851084|12880932|P1|NOT COMPLETED|Overall Study||117
5238836|NCT00851084|12880931|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
5238837|NCT00851084|12880932|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
5238838|NCT00851084|12880931|P2|STARTED|Overall Study||119
5238839|NCT00851084|12880932|P1|STARTED|Overall Study||117
5238840|NCT00851006|12880948|P2|NOT COMPLETED|Overall Study||0
5238841|NCT00851006|12880949|P1|NOT COMPLETED|Overall Study||0
5238842|NCT00851006|12880948|P2|COMPLETED|Overall Study||6
5238843|NCT00851006|12880949|P1|COMPLETED|Overall Study||7
5238844|NCT00851006|12880948|P2|STARTED|Overall Study||6
5238845|NCT00851006|12880949|P1|STARTED|Overall Study||7
5238846|NCT00850993|12880960|P4|NOT COMPLETED|Overall Study||1
5238847|NCT00850993|12880961|P3|NOT COMPLETED|Overall Study||0
5238848|NCT00850993|12880962|P2|NOT COMPLETED|Overall Study||0
5238849|NCT00850993|12880963|P1|NOT COMPLETED|Overall Study||1
5238850|NCT00850993|12880960|P4|COMPLETED|Overall Study||14
5238851|NCT00850993|12880961|P3|COMPLETED|Overall Study||8
5238852|NCT00850993|12880962|P2|COMPLETED|Overall Study||18
5238853|NCT00850993|12880963|P1|COMPLETED|Overall Study||16
5238854|NCT00850993|12880960|P4|Per Protocol|Overall Study||13
5238855|NCT00850993|12880961|P3|Per Protocol|Overall Study||5
5238856|NCT00850993|12880962|P2|Per Protocol|Overall Study||13
5238857|NCT00850993|12880963|P1|Per Protocol|Overall Study||10
5238858|NCT00850993|12880960|P4|Received Phototherapy|Overall Study||8
5238859|NCT00850993|12880961|P3|Received Phototherapy|Overall Study||2
5238860|NCT00850993|12880962|P2|Received Phototherapy|Overall Study||6
5238861|NCT00850993|12880963|P1|Received Phototherapy|Overall Study||3
5238862|NCT00850993|12880960|P4|Intent-to-treat|Overall Study||15
5238863|NCT00850993|12880961|P3|Intent-to-treat|Overall Study||8
5238864|NCT00850993|12880962|P2|Intent-to-treat|Overall Study||18
5238865|NCT00850993|12880963|P1|Intent-to-treat|Overall Study||17
5238866|NCT00850993|12880960|P4|Safety|Overall Study||15
5238867|NCT00850993|12880961|P3|Safety|Overall Study||8
5238868|NCT00850993|12880962|P2|Safety|Overall Study||18
5238869|NCT00850993|12880963|P1|Safety|Overall Study||17
5238870|NCT00850993|12880960|P4|STARTED|Overall Study||15
5238871|NCT00850993|12880961|P3|STARTED|Overall Study||8
5238872|NCT00850993|12880962|P2|STARTED|Overall Study||18
5238873|NCT00850993|12880963|P1|STARTED|Overall Study||17
5238874|NCT00850889|12880977|P1|NOT COMPLETED|Overall Study||0
5238875|NCT00850889|12880977|P1|COMPLETED|Overall Study||32
5238876|NCT00850889|12880977|P1|STARTED|Overall Study||32
5238877|NCT00850759|12880992|P4|NOT COMPLETED|Overall Study||3
5238878|NCT00850759|12880993|P3|NOT COMPLETED|Overall Study||5
5238879|NCT00850759|12880994|P2|NOT COMPLETED|Overall Study||5
5238880|NCT00850759|12880995|P1|NOT COMPLETED|Overall Study||7
5238881|NCT00850759|12880992|P4|COMPLETED|Overall Study||55
5238882|NCT00850759|12880993|P3|COMPLETED|Overall Study||52
5238883|NCT00850759|12880994|P2|COMPLETED|Overall Study||52
5238884|NCT00850759|12880995|P1|COMPLETED|Overall Study||52
5238885|NCT00850759|12880992|P4|STARTED|Overall Study||58
5238886|NCT00850759|12880993|P3|STARTED|Overall Study||57
5238887|NCT00850759|12880994|P2|STARTED|Overall Study||57
5238888|NCT00850759|12880995|P1|STARTED|Overall Study||59
5238889|NCT00850720|12881005|P1|NOT COMPLETED|Overall Study||0
5238890|NCT00850720|12881005|P1|COMPLETED|Overall Study||0
5238891|NCT00850720|12881005|P1|STARTED|Overall Study||0
5238892|NCT00850642|12881011|P2|NOT COMPLETED|Overall Study||0
5238893|NCT00850642|12881012|P1|NOT COMPLETED|Overall Study||0
5238894|NCT00850642|12881011|P2|COMPLETED|Overall Study||4
5238895|NCT00850642|12881012|P1|COMPLETED|Overall Study||3
5238896|NCT00850642|12881011|P2|STARTED|Overall Study||4
5238897|NCT00850642|12881012|P1|STARTED|Overall Study||3
5238898|NCT00850603|12881050|P5|NOT COMPLETED|Overall Study||0
5238899|NCT00850603|12881051|P4|NOT COMPLETED|Overall Study||0
5238900|NCT00850603|12881052|P3|NOT COMPLETED|Overall Study||0
5238901|NCT00850603|12881053|P2|NOT COMPLETED|Overall Study||0
5238902|NCT00850603|12881054|P1|NOT COMPLETED|Overall Study||0
5238903|NCT00850603|12881050|P5|COMPLETED|Overall Study||34
5238904|NCT00850603|12881051|P4|COMPLETED|Overall Study||34
5238905|NCT00850603|12881052|P3|COMPLETED|Overall Study||34
5238906|NCT00850603|12881053|P2|COMPLETED|Overall Study||34
5238907|NCT00850603|12881054|P1|COMPLETED|Overall Study||34
5238908|NCT00850603|12881050|P5|STARTED|Overall Study||34
5238909|NCT00850603|12881051|P4|STARTED|Overall Study||34
5238910|NCT00850603|12881052|P3|STARTED|Overall Study||34
5238911|NCT00850603|12881053|P2|STARTED|Overall Study||34
5238912|NCT00850603|12881054|P1|STARTED|Overall Study||34
5238913|NCT00850564|12881076|P1|NOT COMPLETED|Overall Study||2
5238914|NCT00850564|12881076|P1|COMPLETED|Overall Study||13
5238915|NCT00850564|12881076|P1|STARTED|Overall Study||15
5238916|NCT00850538|12881081|P1|NOT COMPLETED|Overall Study||41
5238917|NCT00850538|12881081|P1|COMPLETED|Overall Study||60
5238918|NCT00850538|12881081|P1|STARTED|Overall Study||101
5238919|NCT00850499|12881087|P2|NOT COMPLETED|Overall Study||2
5238920|NCT00850499|12881088|P1|NOT COMPLETED|Overall Study||3
5238921|NCT00850499|12881087|P2|COMPLETED|Overall Study||6
5238922|NCT00850499|12881088|P1|COMPLETED|Overall Study||1
5238923|NCT00850499|12881087|P2|STARTED|Overall Study||8
5238924|NCT00850499|12881088|P1|STARTED|Overall Study||4
5238925|NCT00850473|12881096|P1|NOT COMPLETED|Overall Study||0
5238926|NCT00850473|12881096|P1|COMPLETED|Overall Study||3
5238927|NCT00850473|12881096|P1|STARTED|Overall Study||3
5238928|NCT00850460|12881102|P2|NOT COMPLETED|Overall Study||4
5238929|NCT00850460|12881103|P1|NOT COMPLETED|Overall Study||4
5238930|NCT00850460|12881102|P2|COMPLETED|Overall Study||3
5238931|NCT00850460|12881103|P1|COMPLETED|Overall Study||3
5238932|NCT00850460|12881102|P2|Completion - Week 8|Overall Study||3
5238933|NCT00850460|12881103|P1|Completion - Week 8|Overall Study||3
5238934|NCT00850460|12881102|P2|Started - Week 0|Overall Study||7
5238935|NCT00850460|12881103|P1|Started - Week 0|Overall Study||7
5238936|NCT00850460|12881102|P2|STARTED|Overall Study||7
5238937|NCT00850460|12881103|P1|STARTED|Overall Study||7
5238938|NCT00850421|12881111|P1|NOT COMPLETED|Overall Study||17
5238939|NCT00850421|12881111|P1|COMPLETED|Overall Study||18
5238940|NCT00850421|12881111|P1|STARTED|Overall Study||35
5238941|NCT00850395|12881117|P1|NOT COMPLETED|Overall Study||10
5238942|NCT00850395|12881117|P1|COMPLETED|Overall Study||69
5238943|NCT00850395|12881117|P1|STARTED|Overall Study||79
5238944|NCT00850343|12881137|P4|NOT COMPLETED|Overall Study||13
5238945|NCT00850343|12881138|P3|NOT COMPLETED|Overall Study||14
5238946|NCT00850343|12881139|P2|NOT COMPLETED|Overall Study||3
5238947|NCT00850343|12881140|P1|NOT COMPLETED|Overall Study||46
5238948|NCT00850343|12881137|P4|COMPLETED|Overall Study||30
5238949|NCT00850343|12881138|P3|COMPLETED|Overall Study||29
5238950|NCT00850343|12881139|P2|COMPLETED|Overall Study||9
5238951|NCT00850343|12881140|P1|COMPLETED|Overall Study||64
5238952|NCT00850343|12881137|P4|Completed Week 52|Overall Study||37
5238953|NCT00850343|12881138|P3|Completed Week 52|Overall Study||37
5238954|NCT00850343|12881139|P2|Completed Week 52|Overall Study||11
5238955|NCT00850343|12881140|P1|Completed Week 52|Overall Study||88
5238956|NCT00850343|12881137|P4|Completed Week 24|Overall Study||39
5238957|NCT00850343|12881138|P3|Completed Week 24|Overall Study||39
5238958|NCT00850343|12881139|P2|Completed Week 24|Overall Study||12
5238959|NCT00850343|12881140|P1|Completed Week 24|Overall Study||94
5238960|NCT00850343|12881137|P4|STARTED|Overall Study||43
5238961|NCT00850343|12881138|P3|STARTED|Overall Study||43
5238962|NCT00850343|12881139|P2|STARTED|Overall Study||12
5238963|NCT00850343|12881140|P1|STARTED|Overall Study||110
5238964|NCT00850200|12881170|P1|NOT COMPLETED|Overall Study||5
5238965|NCT00850200|12881170|P1|COMPLETED|Overall Study||15
5238966|NCT00850200|12881170|P1|STARTED|Overall Study||20
5238967|NCT00850174|12881180|P2|NOT COMPLETED|Second Intervention||0
5238968|NCT00850174|12881181|P1|NOT COMPLETED|Second Intervention||1
5238969|NCT00850174|12881180|P2|COMPLETED|Second Intervention||28
5238970|NCT00850174|12881181|P1|COMPLETED|Second Intervention||29
5238971|NCT00850174|12881180|P2|STARTED|Second Intervention||28
5238972|NCT00850174|12881181|P1|STARTED|Second Intervention||30
5238973|NCT00850174|12881180|P2|NOT COMPLETED|Washout: One Week||2
5238974|NCT00850174|12881181|P1|NOT COMPLETED|Washout: One Week||0
5238975|NCT00850174|12881180|P2|COMPLETED|Washout: One Week||28
5238976|NCT00850174|12881181|P1|COMPLETED|Washout: One Week||30
5238977|NCT00850174|12881180|P2|STARTED|Washout: One Week||30
5238978|NCT00850174|12881181|P1|STARTED|Washout: One Week||30
5238979|NCT00850174|12881180|P2|NOT COMPLETED|First Intervention||0
5238980|NCT00850174|12881181|P1|NOT COMPLETED|First Intervention||0
5238981|NCT00850174|12881180|P2|COMPLETED|First Intervention||30
5238982|NCT00850174|12881181|P1|COMPLETED|First Intervention||30
5238983|NCT00850174|12881180|P2|STARTED|First Intervention||30
5238984|NCT00850174|12881181|P1|STARTED|First Intervention||30
5238985|NCT00850135|12881195|P1|NOT COMPLETED|Overall Study||1
5238986|NCT00850135|12881195|P1|COMPLETED|Overall Study||56
5238987|NCT00850135|12881195|P1|STARTED|Overall Study||57
5238988|NCT00850096|12881203|P2|NOT COMPLETED|Overall Study||2
5238989|NCT00850096|12881204|P1|NOT COMPLETED|Overall Study||3
5238990|NCT00850096|12881203|P2|COMPLETED|Overall Study||45
5238991|NCT00850096|12881204|P1|COMPLETED|Overall Study||44
5238992|NCT00850096|12881203|P2|STARTED|Overall Study||47
5238993|NCT00850096|12881204|P1|STARTED|Overall Study||47
5238994|NCT00850070|12881214|P2|NOT COMPLETED|Overall Study||1
5238995|NCT00850070|12881215|P1|NOT COMPLETED|Overall Study||3
5238996|NCT00850070|12881214|P2|COMPLETED|Overall Study||22
5238997|NCT00850070|12881215|P1|COMPLETED|Overall Study||20
5238998|NCT00850070|12881214|P2|STARTED|Overall Study||23
5238999|NCT00850070|12881215|P1|STARTED|Overall Study||23
5239000|NCT00850031|12881239|P1|NOT COMPLETED|Overall Study||17
5239001|NCT00850031|12881239|P1|COMPLETED|Overall Study||101
5239002|NCT00850031|12881239|P1|STARTED|Overall Study||118
5239003|NCT00849940|12881244|P1|NOT COMPLETED|Overall Study||4
5239004|NCT00849940|12881244|P1|COMPLETED|Overall Study||68
5239005|NCT00849940|12881244|P1|STARTED|Overall Study||72
5239006|NCT00849901|12881255|P3|NOT COMPLETED|Extension Phase||17
5239007|NCT00849901|12881256|P2|NOT COMPLETED|Extension Phase||26
5239008|NCT00849901|12881257|P1|NOT COMPLETED|Extension Phase||27
5239009|NCT00849901|12881255|P3|COMPLETED|Extension Phase||69
5239010|NCT00849901|12881256|P2|COMPLETED|Extension Phase||65
5239011|NCT00849901|12881257|P1|COMPLETED|Extension Phase||56
5239012|NCT00849901|12881255|P3|STARTED|Extension Phase||86
5239013|NCT00849901|12881256|P2|STARTED|Extension Phase||91
5239014|NCT00849901|12881257|P1|STARTED|Extension Phase||83
5239015|NCT00849901|12881255|P3|NOT COMPLETED|Acute Treatment Phase||16
5239016|NCT00849901|12881256|P2|NOT COMPLETED|Acute Treatment Phase||26
5239017|NCT00849901|12881257|P1|NOT COMPLETED|Acute Treatment Phase||30
5239018|NCT00849901|12881255|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
5239019|NCT00849901|12881256|P2|COMPLETED|Acute Treatment Phase||91
5239020|NCT00849901|12881257|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
5239021|NCT00849901|12881255|P3|STARTED|Acute Treatment Phase||103
5239022|NCT00849901|12881256|P2|STARTED|Acute Treatment Phase||117
5239023|NCT00849901|12881257|P1|STARTED|Acute Treatment Phase||117
5239024|NCT00849875|12881304|P1|NOT COMPLETED|Overall Study||47
5239025|NCT00849875|12881304|P1|COMPLETED|Overall Study||1
5239026|NCT00849875|12881304|P1|STARTED|Overall Study||48
5239027|NCT00849862|12881386|P2|NOT COMPLETED|Second Intervention||0
5239028|NCT00849862|12881387|P1|NOT COMPLETED|Second Intervention||0
5239029|NCT00849862|12881386|P2|COMPLETED|Second Intervention||11
5239030|NCT00849862|12881387|P1|COMPLETED|Second Intervention||11
5239031|NCT00849862|12881386|P2|STARTED|Second Intervention||11
5239032|NCT00849862|12881387|P1|STARTED|Second Intervention||11
5239033|NCT00849862|12881386|P2|NOT COMPLETED|Washout: 7 Days||0
5239034|NCT00849862|12881387|P1|NOT COMPLETED|Washout: 7 Days||0
5239035|NCT00849862|12881386|P2|COMPLETED|Washout: 7 Days||11
5239036|NCT00849862|12881387|P1|COMPLETED|Washout: 7 Days||11
5239037|NCT00849862|12881386|P2|STARTED|Washout: 7 Days||11
5239038|NCT00849862|12881387|P1|STARTED|Washout: 7 Days||11
5239039|NCT00849862|12881386|P2|NOT COMPLETED|First Intervention||0
5239040|NCT00849862|12881387|P1|NOT COMPLETED|First Intervention||0
5239041|NCT00849862|12881386|P2|COMPLETED|First Intervention||11
5239042|NCT00849862|12881387|P1|COMPLETED|First Intervention||11
5239043|NCT00849862|12881386|P2|STARTED|First Intervention||11
5239044|NCT00849862|12881387|P1|STARTED|First Intervention||11
5239045|NCT00849810|12881395|P1|NOT COMPLETED|Overall Study||0
5239046|NCT00849810|12881395|P1|COMPLETED|Overall Study||1
5239047|NCT00849810|12881395|P1|STARTED|Overall Study||1
5239048|NCT00849797|12881401|P2|NOT COMPLETED|Second Intervention||0
5239049|NCT00849797|12881402|P1|NOT COMPLETED|Second Intervention||0
5239050|NCT00849797|12881401|P2|COMPLETED|Second Intervention||57
5239051|NCT00849797|12881402|P1|COMPLETED|Second Intervention||59
5239052|NCT00849797|12881401|P2|STARTED|Second Intervention||57
5239053|NCT00849797|12881402|P1|STARTED|Second Intervention||59
5239054|NCT00849797|12881401|P2|NOT COMPLETED|Washout: One Week||2
5239055|NCT00849797|12881402|P1|NOT COMPLETED|Washout: One Week||0
5239056|NCT00849797|12881401|P2|COMPLETED|Washout: One Week||57
5239057|NCT00849797|12881402|P1|COMPLETED|Washout: One Week||59
5239058|NCT00849797|12881401|P2|STARTED|Washout: One Week||59
5239059|NCT00849797|12881402|P1|STARTED|Washout: One Week||59
5239060|NCT00849797|12881401|P2|NOT COMPLETED|First Intervention||1
5239061|NCT00849797|12881402|P1|NOT COMPLETED|First Intervention||1
5239062|NCT00849797|12881401|P2|COMPLETED|First Intervention||59
5239063|NCT00849797|12881402|P1|COMPLETED|First Intervention||59
5239064|NCT00849797|12881401|P2|STARTED|First Intervention||60
5239065|NCT00849797|12881402|P1|STARTED|First Intervention||60
5239066|NCT00849693|12881420|P4|NOT COMPLETED|Extension Phase||38
5239067|NCT00849693|12881421|P3|NOT COMPLETED|Extension Phase||35
5239068|NCT00849693|12881422|P2|NOT COMPLETED|Extension Phase||30
5239069|NCT00849693|12881423|P1|NOT COMPLETED|Extension Phase||30
5239070|NCT00849693|12881420|P4|COMPLETED|Extension Phase||44
5239071|NCT00849693|12881421|P3|COMPLETED|Extension Phase||49
5239072|NCT00849693|12881422|P2|COMPLETED|Extension Phase||50
5239073|NCT00849693|12881423|P1|COMPLETED|Extension Phase||43
5239074|NCT00849693|12881420|P4|STARTED|Extension Phase||82
5239075|NCT00849693|12881421|P3|STARTED|Extension Phase||84
5239076|NCT00849693|12881422|P2|STARTED|Extension Phase||80
5239077|NCT00849693|12881423|P1|STARTED|Extension Phase||73
5239078|NCT00849693|12881420|P4|NOT COMPLETED|Acute Treatment Phase||37
5239079|NCT00849693|12881421|P3|NOT COMPLETED|Acute Treatment Phase||33
5239080|NCT00849693|12881422|P2|NOT COMPLETED|Acute Treatment Phase||35
5239081|NCT00849693|12881423|P1|NOT COMPLETED|Acute Treatment Phase||33
5239082|NCT00849693|12881420|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
5239083|NCT00849693|12881421|P3|COMPLETED|Acute Treatment Phase||84
5239084|NCT00849693|12881422|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
5239085|NCT00849693|12881423|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
5239086|NCT00849693|12881420|P4|STARTED|Acute Treatment Phase||122
5239087|NCT00849693|12881421|P3|STARTED|Acute Treatment Phase||117
5239088|NCT00849693|12881422|P2|STARTED|Acute Treatment Phase||116
5239089|NCT00849693|12881423|P1|STARTED|Acute Treatment Phase||108
5239090|NCT00849680|12881490|P8|NOT COMPLETED|Overall Study||8
5239091|NCT00849680|12881491|P7|NOT COMPLETED|Overall Study||17
5239092|NCT00849680|12881492|P6|NOT COMPLETED|Overall Study||15
5239093|NCT00849680|12881493|P5|NOT COMPLETED|Overall Study||10
5239094|NCT00849680|12881494|P4|NOT COMPLETED|Overall Study||14
5239095|NCT00849680|12881495|P3|NOT COMPLETED|Overall Study||15
5239096|NCT00849680|12881496|P2|NOT COMPLETED|Overall Study||3
5239097|NCT00849680|12881497|P1|NOT COMPLETED|Overall Study||11
5239098|NCT00849680|12881490|P8|COMPLETED|Overall Study||23
5239099|NCT00849680|12881491|P7|COMPLETED|Overall Study||61
5239100|NCT00849680|12881492|P6|COMPLETED|Overall Study||27
5239101|NCT00849680|12881493|P5|COMPLETED|Overall Study||32
5239102|NCT00849680|12881494|P4|COMPLETED|Overall Study||28
5239103|NCT00849680|12881495|P3|COMPLETED|Overall Study||27
5239104|NCT00849680|12881496|P2|COMPLETED|Overall Study||10
5239105|NCT00849680|12881497|P1|COMPLETED|Overall Study||16
5239106|NCT00849680|12881490|P8|STARTED|Overall Study||31
5239107|NCT00849680|12881491|P7|STARTED|Overall Study||78
5239108|NCT00849680|12881492|P6|STARTED|Overall Study||42
5239109|NCT00849680|12881493|P5|STARTED|Overall Study||42
5239110|NCT00849680|12881494|P4|STARTED|Overall Study||42
5239111|NCT00849680|12881495|P3|STARTED|Overall Study||42
5239112|NCT00849680|12881496|P2|STARTED|Overall Study||13
5239113|NCT00849680|12881497|P1|STARTED|Overall Study||27
5239114|NCT00849524|12881539|P1|NOT COMPLETED|Overall Study||3
5239115|NCT00849524|12881539|P1|COMPLETED|Overall Study||3
5239116|NCT00849524|12881539|P1|STARTED|Overall Study||6
5239117|NCT00849485|12881547|P2|NOT COMPLETED|Second Intervention||0
5239118|NCT00849485|12881548|P1|NOT COMPLETED|Second Intervention||0
5239119|NCT00849485|12881547|P2|COMPLETED|Second Intervention||11
5239120|NCT00849485|12881548|P1|COMPLETED|Second Intervention||11
5239121|NCT00849485|12881547|P2|STARTED|Second Intervention||11
5239122|NCT00849485|12881548|P1|STARTED|Second Intervention||11
5239123|NCT00849485|12881547|P2|NOT COMPLETED|Washout: 7 Days||0
5239124|NCT00849485|12881548|P1|NOT COMPLETED|Washout: 7 Days||0
5239125|NCT00849485|12881547|P2|COMPLETED|Washout: 7 Days||11
5239126|NCT00849485|12881548|P1|COMPLETED|Washout: 7 Days||11
5239127|NCT00849485|12881547|P2|STARTED|Washout: 7 Days||11
5239128|NCT00849485|12881548|P1|STARTED|Washout: 7 Days||11
5239129|NCT00849485|12881547|P2|NOT COMPLETED|First Intervention||0
5239130|NCT00849485|12881548|P1|NOT COMPLETED|First Intervention||0
5239131|NCT00849485|12881547|P2|COMPLETED|First Intervention||11
5239132|NCT00849485|12881548|P1|COMPLETED|First Intervention||11
5239133|NCT00849485|12881547|P2|STARTED|First Intervention||11
5239134|NCT00849485|12881548|P1|STARTED|First Intervention||11
5239135|NCT00849472|12881556|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
5239136|NCT00849472|12881556|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
5239137|NCT00849472|12881556|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
5239138|NCT00849472|12881556|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
5239139|NCT00849472|12881556|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
5239140|NCT00849472|12881556|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
5239141|NCT00849472|12881556|P1|NOT COMPLETED|Weekly Paclitaxel||16
5239142|NCT00849472|12881556|P1|COMPLETED|Weekly Paclitaxel||78
5239143|NCT00849472|12881556|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
5239144|NCT00849472|12881556|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
5239145|NCT00849472|12881556|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
5239146|NCT00849472|12881556|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
5239147|NCT00849381|12881570|P1|NOT COMPLETED|Overall Study||145
5239148|NCT00849381|12881570|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
5239149|NCT00849381|12881570|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
5239150|NCT00849290|12881576|P1|NOT COMPLETED|Overall Study||55
5239151|NCT00849290|12881576|P1|COMPLETED|Overall Study||58
5239152|NCT00849290|12881576|P1|STARTED|Overall Study||113
5239153|NCT00849251|12881580|P2|NOT COMPLETED|Overall Study||1
5239154|NCT00849251|12881581|P1|NOT COMPLETED|Overall Study||1
5239155|NCT00849251|12881580|P2|COMPLETED|Overall Study||24
5239156|NCT00849251|12881581|P1|COMPLETED|Overall Study||5
5239157|NCT00849251|12881580|P2|STARTED|Overall Study||25
5239158|NCT00849251|12881581|P1|STARTED|Overall Study||6
5239159|NCT00849212|12881587|P1|NOT COMPLETED|Overall Study||7
5239160|NCT00849212|12881587|P1|COMPLETED|Overall Study||23
5239161|NCT00849212|12881587|P1|STARTED|Overall Study||30
5239162|NCT00849186|12881592|P1|NOT COMPLETED|Overall Study||10
5239163|NCT00849186|12881592|P1|COMPLETED|Overall Study||16
5239164|NCT00849186|12881592|P1|STARTED|Overall Study||26
5239165|NCT00849147|12881598|P1|NOT COMPLETED|Overall Study||5
5239166|NCT00849147|12881598|P1|COMPLETED|Overall Study||50
5239167|NCT00849147|12881598|P1|STARTED|Overall Study||55
5239168|NCT00849121|12881615|P2|NOT COMPLETED|Overall Study||0
5239169|NCT00849121|12881616|P1|NOT COMPLETED|Overall Study||0
5239170|NCT00849121|12881615|P2|COMPLETED|Overall Study||9
5239171|NCT00849121|12881616|P1|COMPLETED|Overall Study||8
5239172|NCT00849121|12881615|P2|STARTED|Overall Study||9
5239173|NCT00849121|12881616|P1|STARTED|Overall Study||8
5239174|NCT00849108|12881631|P2|NOT COMPLETED|Cohort 2 Efficacy||10
5239175|NCT00849108|12881632|P1|NOT COMPLETED|Cohort 2 Efficacy||0
5239176|NCT00849108|12881631|P2|COMPLETED|Cohort 2 Efficacy||133
5239177|NCT00849108|12881632|P1|COMPLETED|Cohort 2 Efficacy||0
5239178|NCT00849108|12881631|P2|STARTED|Cohort 2 Efficacy||143
5239179|NCT00849108|12881632|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
5239180|NCT00849108|12881631|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
5239181|NCT00849108|12881632|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
5239182|NCT00849108|12881631|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
5239183|NCT00849108|12881632|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
5239184|NCT00849108|12881631|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
5239185|NCT00849108|12881632|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
5239186|NCT00849056|12881642|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
5239187|NCT00849056|12881643|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
5239188|NCT00849056|12881642|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
5239189|NCT00849056|12881643|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
5239190|NCT00849056|12881642|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
5239191|NCT00849056|12881643|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
5239192|NCT00849056|12881642|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
5239193|NCT00849056|12881643|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
5239194|NCT00849056|12881642|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
5239195|NCT00849056|12881643|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
5239196|NCT00849056|12881642|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
5239197|NCT00849056|12881643|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
5239198|NCT00849017|12881668|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
5239199|NCT00849017|12881669|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
5239200|NCT00849017|12881670|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
5239201|NCT00849017|12881668|P3|COMPLETED|Follow-up Period (8 Weeks)||74
5239202|NCT00849017|12881669|P2|COMPLETED|Follow-up Period (8 Weeks)||83
5239203|NCT00849017|12881670|P1|COMPLETED|Follow-up Period (8 Weeks)||76
5239204|NCT00849017|12881668|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
5239205|NCT00849017|12881669|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
5239206|NCT00849017|12881670|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
5239207|NCT00849017|12881668|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
5239208|NCT00849017|12881669|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
5239209|NCT00849017|12881670|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
5239210|NCT00849017|12881668|P3|COMPLETED|Treatment Period (156 Weeks)||57
5239211|NCT00849017|12881669|P2|COMPLETED|Treatment Period (156 Weeks)||68
5239212|NCT00849017|12881670|P1|COMPLETED|Treatment Period (156 Weeks)||58
5239213|NCT00849017|12881668|P3|STARTED|Treatment Period (156 Weeks)||99
5239214|NCT00849017|12881669|P2|STARTED|Treatment Period (156 Weeks)||101
5239215|NCT00849017|12881670|P1|STARTED|Treatment Period (156 Weeks)||101
5239216|NCT00848965|12881713|P1|NOT COMPLETED|Overall Study||2
5239217|NCT00848965|12881713|P1|COMPLETED|Overall Study||57
5239218|NCT00848965|12881713|P1|STARTED|Overall Study||59
5239219|NCT00848926|12881755|P1|NOT COMPLETED|Follow-up Period||12
5239220|NCT00848926|12881755|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
5239221|NCT00848926|12881755|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
5239222|NCT00848926|12881755|P1|NOT COMPLETED|Treatment Period||84
5239223|NCT00848926|12881755|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
5239224|NCT00848926|12881755|P1|STARTED|Treatment Period||102
5239225|NCT00848783|12881774|P3|NOT COMPLETED|Overall Study||0
5239226|NCT00848783|12881775|P2|NOT COMPLETED|Overall Study||2
5239227|NCT00848783|12881776|P1|NOT COMPLETED|Overall Study||3
5239228|NCT00848783|12881774|P3|COMPLETED|Overall Study||1
5239229|NCT00848783|12881775|P2|COMPLETED|Overall Study||1
5239230|NCT00848783|12881776|P1|COMPLETED|Overall Study||1
5239231|NCT00848783|12881774|P3|STARTED|Overall Study||1
5239232|NCT00848783|12881775|P2|STARTED|Overall Study||3
5239233|NCT00848783|12881776|P1|STARTED|Overall Study||4
5239234|NCT00848744|12881785|P1|NOT COMPLETED|Overall Study||0
5239235|NCT00848744|12881785|P1|COMPLETED|Overall Study||10
5239236|NCT00848744|12881785|P1|STARTED|Overall Study||10
5239237|NCT00848718|12881805|P13|NOT COMPLETED|Overall Study||8
5239238|NCT00848718|12881806|P12|NOT COMPLETED|Overall Study||6
5239239|NCT00848718|12881807|P11|NOT COMPLETED|Overall Study||4
5239240|NCT00848718|12881808|P10|NOT COMPLETED|Overall Study||9
5239241|NCT00848718|12881809|P9|NOT COMPLETED|Overall Study||4
5239242|NCT00848718|12881810|P8|NOT COMPLETED|Overall Study||5
5239243|NCT00848718|12881811|P7|NOT COMPLETED|Overall Study||3
5239244|NCT00848718|12881812|P6|NOT COMPLETED|Overall Study||5
5239245|NCT00848718|12881813|P5|NOT COMPLETED|Overall Study||6
5239246|NCT00848718|12881814|P4|NOT COMPLETED|Overall Study||5
5239247|NCT00848718|12881815|P3|NOT COMPLETED|Overall Study||6
5239248|NCT00848718|12881816|P2|NOT COMPLETED|Overall Study||9
5239249|NCT00848718|12881817|P1|NOT COMPLETED|Overall Study||7
5239250|NCT00848718|12881805|P13|COMPLETED|Overall Study||0
5239251|NCT00848718|12881806|P12|COMPLETED|Overall Study||0
5239252|NCT00848718|12881807|P11|COMPLETED|Overall Study||0
5239253|NCT00848718|12881808|P10|COMPLETED|Overall Study||0
5239254|NCT00848718|12881809|P9|COMPLETED|Overall Study||0
5239255|NCT00848718|12881810|P8|COMPLETED|Overall Study||0
5239256|NCT00848718|12881811|P7|COMPLETED|Overall Study||0
5239257|NCT00848718|12881812|P6|COMPLETED|Overall Study||0
5239258|NCT00848718|12881813|P5|COMPLETED|Overall Study||0
5239259|NCT00848718|12881814|P4|COMPLETED|Overall Study||0
5239260|NCT00848718|12881815|P3|COMPLETED|Overall Study||0
5239261|NCT00848718|12881816|P2|COMPLETED|Overall Study||0
5239262|NCT00848718|12881817|P1|COMPLETED|Overall Study||0
5239263|NCT00848718|12881805|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
5239264|NCT00848718|12881806|P12|Treated|Overall Study||6
5239265|NCT00848718|12881807|P11|Treated|Overall Study||4
5239266|NCT00848718|12881808|P10|Treated|Overall Study||9
5239267|NCT00848718|12881809|P9|Treated|Overall Study||4
5239268|NCT00848718|12881810|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
5239269|NCT00848718|12881811|P7|Treated|Overall Study||3
5239270|NCT00848718|12881812|P6|Treated|Overall Study||5
5239271|NCT00848718|12881813|P5|Treated|Overall Study||6
5239272|NCT00848718|12881814|P4|Treated|Overall Study||5
5239273|NCT00848718|12881815|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
5239274|NCT00848718|12881816|P2|Treated|Overall Study||9
5239275|NCT00848718|12881817|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
5239276|NCT00848718|12881805|P13|STARTED|Overall Study||8
5239277|NCT00848718|12881806|P12|STARTED|Overall Study||6
5239278|NCT00848718|12881807|P11|STARTED|Overall Study||4
5239279|NCT00848718|12881808|P10|STARTED|Overall Study||9
5239280|NCT00848718|12881809|P9|STARTED|Overall Study||4
5239281|NCT00848718|12881810|P8|STARTED|Overall Study||5
5239282|NCT00848718|12881811|P7|STARTED|Overall Study||3
5239283|NCT00848718|12881812|P6|STARTED|Overall Study||5
5239284|NCT00848718|12881813|P5|STARTED|Overall Study||6
5239285|NCT00848718|12881814|P4|STARTED|Overall Study||5
5239286|NCT00848718|12881815|P3|STARTED|Overall Study||6
5239287|NCT00848718|12881816|P2|STARTED|Overall Study||9
5239288|NCT00848718|12881817|P1|STARTED|Overall Study||7
5239289|NCT00848549|12881918|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
5239290|NCT00848549|12881919|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
5239291|NCT00848549|12881918|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
5239292|NCT00848549|12881919|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
5239293|NCT00848549|12881918|P2|STARTED|E2090-E044-314 (Extension Study)||158
5239294|NCT00848549|12881919|P1|STARTED|E2090-E044-314 (Extension Study)||137
5239295|NCT00848549|12881918|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
5239296|NCT00848549|12881919|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
5239297|NCT00848549|12881918|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
5239298|NCT00848549|12881919|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
5239299|NCT00848549|12881918|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
5239300|NCT00848549|12881919|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
5239301|NCT00848549|12881918|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
5239302|NCT00848549|12881919|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
5239303|NCT00848549|12881918|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
5239304|NCT00848549|12881919|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
5239305|NCT00848549|12881918|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
5239306|NCT00848549|12881919|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
5239307|NCT00848536|12881937|P2|NOT COMPLETED|Overall Study||7
5239308|NCT00848536|12881938|P1|NOT COMPLETED|Overall Study||4
5239309|NCT00848536|12881937|P2|COMPLETED|Overall Study||179
5239310|NCT00848536|12881938|P1|COMPLETED|Overall Study||181
5239311|NCT00848536|12881937|P2|STARTED|Overall Study||186
5239312|NCT00848536|12881938|P1|STARTED|Overall Study||185
5239313|NCT00848510|12881952|P4|NOT COMPLETED|Overall Study||0
5239314|NCT00848510|12881953|P3|NOT COMPLETED|Overall Study||0
5239315|NCT00848510|12881954|P2|NOT COMPLETED|Overall Study||0
5239316|NCT00848510|12881955|P1|NOT COMPLETED|Overall Study||0
5239317|NCT00848510|12881952|P4|COMPLETED|Overall Study||10
5239318|NCT00848510|12881953|P3|COMPLETED|Overall Study||8
5239319|NCT00848510|12881954|P2|COMPLETED|Overall Study||13
5239320|NCT00848510|12881955|P1|COMPLETED|Overall Study||10
5239321|NCT00848510|12881952|P4|STARTED|Overall Study||10
5239322|NCT00848510|12881953|P3|STARTED|Overall Study||8
5239323|NCT00848510|12881954|P2|STARTED|Overall Study||13
5239324|NCT00848510|12881955|P1|STARTED|Overall Study||10
5239325|NCT00848497|12882003|P2|NOT COMPLETED|Overall Study||1
5239326|NCT00848497|12882004|P1|NOT COMPLETED|Overall Study||2
5239327|NCT00848497|12882003|P2|COMPLETED|Overall Study||0
5239328|NCT00848497|12882004|P1|COMPLETED|Overall Study||0
5239329|NCT00848497|12882003|P2|STARTED|Overall Study|Completed Visit 4|1
5239330|NCT00848497|12882004|P1|STARTED|Overall Study||2
5239331|NCT00848484|12882018|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
5239332|NCT00848484|12882019|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
5239333|NCT00848484|12882018|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
5239334|NCT00848484|12882019|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
5239335|NCT00848484|12882018|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
5239336|NCT00848484|12882019|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
5239337|NCT00848484|12882018|P2|STARTED|Second Intervention (Treatment Period 2)||21
5239338|NCT00848484|12882019|P1|STARTED|Second Intervention (Treatment Period 2)||25
5239339|NCT00848484|12882018|P2|NOT COMPLETED|Washout Period of Two Weeks||3
5239340|NCT00848484|12882019|P1|NOT COMPLETED|Washout Period of Two Weeks||0
5239341|NCT00848484|12882018|P2|COMPLETED|Washout Period of Two Weeks||21
5239342|NCT00848484|12882019|P1|COMPLETED|Washout Period of Two Weeks||25
5239343|NCT00848484|12882018|P2|STARTED|Washout Period of Two Weeks||24
5239344|NCT00848484|12882019|P1|STARTED|Washout Period of Two Weeks||25
5239345|NCT00848484|12882018|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
5239346|NCT00848484|12882019|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
5239347|NCT00848484|12882018|P2|COMPLETED|First Intervention (Treatment Period 1)||24
5239348|NCT00848484|12882019|P1|COMPLETED|First Intervention (Treatment Period 1)||25
5239349|NCT00848484|12882018|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
5239350|NCT00848484|12882019|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
5239351|NCT00848484|12882018|P2|STARTED|First Intervention (Treatment Period 1)||27
5239352|NCT00848484|12882019|P1|STARTED|First Intervention (Treatment Period 1)||27
5239353|NCT00848393|12882038|P3|NOT COMPLETED|Overall Study||3
5239354|NCT00848393|12882039|P2|NOT COMPLETED|Overall Study||0
5239355|NCT00848393|12882040|P1|NOT COMPLETED|Overall Study||0
5239356|NCT00848393|12882038|P3|COMPLETED|Overall Study||15
5239357|NCT00848393|12882039|P2|COMPLETED|Overall Study||16
5239358|NCT00848393|12882040|P1|COMPLETED|Overall Study||17
5239359|NCT00848393|12882038|P3|STARTED|Overall Study||18
5239360|NCT00848393|12882039|P2|STARTED|Overall Study||16
5239361|NCT00848393|12882040|P1|STARTED|Overall Study||17
5239362|NCT00848367|12882068|P2|NOT COMPLETED|Overall Study||9
5239363|NCT00848367|12882069|P1|NOT COMPLETED|Overall Study||9
5239364|NCT00848367|12882068|P2|COMPLETED|Overall Study||41
5239365|NCT00848367|12882069|P1|COMPLETED|Overall Study||43
5239366|NCT00848367|12882068|P2|STARTED|Overall Study||50
5239367|NCT00848367|12882069|P1|STARTED|Overall Study||52
5239368|NCT00848354|12882079|P2|NOT COMPLETED|Phase 2 Year 2||7
5239369|NCT00848354|12882080|P1|NOT COMPLETED|Phase 2 Year 2||23
5239370|NCT00848354|12882079|P2|COMPLETED|Phase 2 Year 2||113
5239371|NCT00848354|12882080|P1|COMPLETED|Phase 2 Year 2||218
5239372|NCT00848354|12882079|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
5239373|NCT00848354|12882080|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
5239374|NCT00848354|12882079|P2|NOT COMPLETED|Phase 2 Year 1||6
5239375|NCT00848354|12882080|P1|NOT COMPLETED|Phase 2 Year 1||18
5239376|NCT00848354|12882079|P2|COMPLETED|Phase 2 Year 1||120
5239377|NCT00848354|12882080|P1|COMPLETED|Phase 2 Year 1||242
5239378|NCT00848354|12882079|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
5239379|NCT00848354|12882080|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
5239380|NCT00848354|12882079|P2|NOT COMPLETED|Phase 1||14
5239381|NCT00848354|12882080|P1|NOT COMPLETED|Phase 1||12
5239382|NCT00848354|12882079|P2|COMPLETED|Phase 1||129
5239383|NCT00848354|12882080|P1|COMPLETED|Phase 1||269
5239384|NCT00848354|12882079|P2|STARTED|Phase 1||143
5239385|NCT00848354|12882080|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
5239386|NCT00848250|12882232|P2|NOT COMPLETED|Overall Study||1
5239387|NCT00848250|12882233|P1|NOT COMPLETED|Overall Study||0
5239388|NCT00848250|12882232|P2|COMPLETED|Overall Study||9
5239389|NCT00848250|12882233|P1|COMPLETED|Overall Study||11
5239390|NCT00848250|12882232|P2|STARTED|Overall Study||10
5239391|NCT00848250|12882233|P1|STARTED|Overall Study||11
5239392|NCT00848237|12882251|P1|NOT COMPLETED|Overall Study||539
5239393|NCT00848237|12882251|P1|COMPLETED|Overall Study||4982
5239394|NCT00848237|12882251|P1|STARTED|Overall Study||5521
5239395|NCT00848211|12882264|P4|NOT COMPLETED|Overall Study||0
5239396|NCT00848211|12882265|P3|NOT COMPLETED|Overall Study||1
5239397|NCT00848211|12882266|P2|NOT COMPLETED|Overall Study||1
5239398|NCT00848211|12882267|P1|NOT COMPLETED|Overall Study||0
5239399|NCT00848211|12882264|P4|COMPLETED|Overall Study||5
5239400|NCT00848211|12882265|P3|COMPLETED|Overall Study||5
5239401|NCT00848211|12882266|P2|COMPLETED|Overall Study||6
5239402|NCT00848211|12882267|P1|COMPLETED|Overall Study||6
5239403|NCT00848211|12882264|P4|STARTED|Overall Study||5
5239404|NCT00848211|12882265|P3|STARTED|Overall Study||6
5239405|NCT00848211|12882266|P2|STARTED|Overall Study||7
5239406|NCT00848211|12882267|P1|STARTED|Overall Study||6
5239407|NCT00848198|12882285|P1|NOT COMPLETED|Overall Study||15
5239408|NCT00848198|12882285|P1|COMPLETED|Overall Study||299
5239409|NCT00848198|12882285|P1|STARTED|Overall Study||314
5239410|NCT00848185|12882326|P3|NOT COMPLETED|Overall Study||0
5239411|NCT00848185|12882327|P2|NOT COMPLETED|Overall Study||0
5239412|NCT00848185|12882328|P1|NOT COMPLETED|Overall Study||0
5239413|NCT00848185|12882326|P3|COMPLETED|Overall Study||32
5239414|NCT00848185|12882327|P2|COMPLETED|Overall Study||32
5239415|NCT00848185|12882328|P1|COMPLETED|Overall Study||32
5239416|NCT00848185|12882326|P3|STARTED|Overall Study||32
5239417|NCT00848185|12882327|P2|STARTED|Overall Study||32
5239418|NCT00848185|12882328|P1|STARTED|Overall Study||32
5239419|NCT00848172|12882338|P2|NOT COMPLETED|Visit 3 - Follow Up||0
5239420|NCT00848172|12882339|P1|NOT COMPLETED|Visit 3 - Follow Up||0
5239421|NCT00848172|12882338|P2|COMPLETED|Visit 3 - Follow Up||8
5239422|NCT00848172|12882339|P1|COMPLETED|Visit 3 - Follow Up||10
5239423|NCT00848172|12882338|P2|STARTED|Visit 3 - Follow Up||8
5239424|NCT00848172|12882339|P1|STARTED|Visit 3 - Follow Up||10
5239425|NCT00848172|12882338|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
5239426|NCT00848172|12882339|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
5239427|NCT00848172|12882338|P2|COMPLETED|Visit 2 - Drug Administration||8
5239428|NCT00848172|12882339|P1|COMPLETED|Visit 2 - Drug Administration||10
5239429|NCT00848172|12882338|P2|STARTED|Visit 2 - Drug Administration||9
5239430|NCT00848172|12882339|P1|STARTED|Visit 2 - Drug Administration||10
5239431|NCT00848120|12882350|P1|NOT COMPLETED|Overall Study||1
5239432|NCT00848120|12882350|P1|COMPLETED|Overall Study||28
5239433|NCT00848120|12882350|P1|STARTED|Overall Study||29
5239434|NCT00848107|12882362|P1|NOT COMPLETED|Overall Study||21
5239435|NCT00848107|12882362|P1|COMPLETED|Overall Study||94
5239436|NCT00848107|12882362|P1|STARTED|Overall Study||115
5239437|NCT00848081|12882372|P2|NOT COMPLETED|Overall Study||18
5239438|NCT00848081|12882373|P1|NOT COMPLETED|Overall Study||20
5239439|NCT00848081|12882372|P2|COMPLETED|Overall Study||140
5239440|NCT00848081|12882373|P1|COMPLETED|Overall Study||140
5239441|NCT00848081|12882372|P2|STARTED|Overall Study||158
5239442|NCT00848081|12882373|P1|STARTED|Overall Study||160
5239443|NCT00848042|12882390|P3|NOT COMPLETED|Overall Study||0
5239444|NCT00848042|12882391|P2|NOT COMPLETED|Overall Study||2
5239445|NCT00848042|12882392|P1|NOT COMPLETED|Overall Study||4
5239446|NCT00848042|12882390|P3|COMPLETED|Overall Study||1
5239447|NCT00848042|12882391|P2|COMPLETED|Overall Study||3
5239448|NCT00848042|12882392|P1|COMPLETED|Overall Study||1
5239449|NCT00848042|12882390|P3|Month 6|Overall Study||1
5239450|NCT00848042|12882391|P2|Month 6|Overall Study||3
5239451|NCT00848042|12882392|P1|Month 6|Overall Study||1
5239452|NCT00848042|12882390|P3|Month 5|Overall Study||1
5239453|NCT00848042|12882391|P2|Month 5|Overall Study||3
5239454|NCT00848042|12882392|P1|Month 5|Overall Study||1
5239455|NCT00848042|12882390|P3|Month 4|Overall Study||1
5239456|NCT00848042|12882391|P2|Month 4|Overall Study||4
5239457|NCT00848042|12882392|P1|Month 4|Overall Study||1
5239458|NCT00848042|12882390|P3|Month 3|Overall Study||1
5239459|NCT00848042|12882391|P2|Month 3|Overall Study||4
5239460|NCT00848042|12882392|P1|Month 3|Overall Study||1
5239461|NCT00848042|12882390|P3|Month 2|Overall Study||1
5239462|NCT00848042|12882391|P2|Month 2|Overall Study||5
5239463|NCT00848042|12882392|P1|Month 2|Overall Study||1
5239464|NCT00848042|12882390|P3|Month 1|Overall Study||1
5239465|NCT00848042|12882391|P2|Month 1|Overall Study||5
5239466|NCT00848042|12882392|P1|Month 1|Overall Study||4
5239467|NCT00848042|12882390|P3|Day 15|Overall Study||1
5239468|NCT00848042|12882391|P2|Day 15|Overall Study||5
5239469|NCT00848042|12882392|P1|Day 15|Overall Study||4
5239470|NCT00848042|12882390|P3|Day 8|Overall Study||1
5239471|NCT00848042|12882391|P2|Day 8|Overall Study||5
5239472|NCT00848042|12882392|P1|Day 8|Overall Study||5
5239473|NCT00848042|12882390|P3|Day 3|Overall Study||1
5239474|NCT00848042|12882391|P2|Day 3|Overall Study||5
5239475|NCT00848042|12882392|P1|Day 3|Overall Study||5
5239476|NCT00848042|12882390|P3|Day 2|Overall Study||1
5239477|NCT00848042|12882391|P2|Day 2|Overall Study||5
5239478|NCT00848042|12882392|P1|Day 2|Overall Study||5
5239479|NCT00848042|12882390|P3|Day 1|Overall Study||1
5239480|NCT00848042|12882391|P2|Day 1|Overall Study||5
5239481|NCT00848042|12882392|P1|Day 1|Overall Study||5
5239482|NCT00848042|12882390|P3|STARTED|Overall Study||1
5239483|NCT00848042|12882391|P2|STARTED|Overall Study||5
5239484|NCT00848042|12882392|P1|STARTED|Overall Study||5
5239485|NCT00848016|12882403|P1|NOT COMPLETED|Overall Study||0
5239486|NCT00848016|12882403|P1|COMPLETED|Overall Study||29
5239487|NCT00848016|12882403|P1|STARTED|Overall Study||29
5239488|NCT00847938|12882413|P4|NOT COMPLETED|Overall Study||0
5239489|NCT00847938|12882414|P3|NOT COMPLETED|Overall Study||1
5239490|NCT00847938|12882415|P2|NOT COMPLETED|Overall Study||1
5239491|NCT00847938|12882416|P1|NOT COMPLETED|Overall Study||0
5239492|NCT00847938|12882413|P4|COMPLETED|Overall Study||15
5239493|NCT00847938|12882414|P3|COMPLETED|Overall Study||15
5239494|NCT00847938|12882415|P2|COMPLETED|Overall Study||14
5239495|NCT00847938|12882416|P1|COMPLETED|Overall Study||16
5239496|NCT00847938|12882413|P4|STARTED|Overall Study||15
5239497|NCT00847938|12882414|P3|STARTED|Overall Study||16
5239498|NCT00847938|12882415|P2|STARTED|Overall Study||15
5239499|NCT00847938|12882416|P1|STARTED|Overall Study||16
5239500|NCT00847912|12882428|P2|NOT COMPLETED|Overall Study||13
5239501|NCT00847912|12882429|P1|NOT COMPLETED|Overall Study||9
5239502|NCT00847912|12882428|P2|COMPLETED|Overall Study||464
5239503|NCT00847912|12882429|P1|COMPLETED|Overall Study||468
5239504|NCT00847912|12882428|P2|STARTED|Overall Study||477
5239505|NCT00847912|12882429|P1|STARTED|Overall Study||477
5239506|NCT00847886|12882439|P2|NOT COMPLETED|Overall Study||1
5239507|NCT00847886|12882440|P1|NOT COMPLETED|Overall Study||0
5239508|NCT00847886|12882439|P2|COMPLETED|Overall Study||3
5239509|NCT00847886|12882440|P1|COMPLETED|Overall Study||12
5239510|NCT00847886|12882439|P2|STARTED|Overall Study||4
5239511|NCT00847886|12882440|P1|STARTED|Overall Study||12
5239512|NCT00847808|12882466|P1|NOT COMPLETED|Overall Study||15
5239513|NCT00847808|12882466|P1|COMPLETED|Overall Study||163
5239514|NCT00847808|12882466|P1|STARTED|Overall Study||178
5239515|NCT00847730|12882483|P1|NOT COMPLETED|Overall Study||8
5239516|NCT00847730|12882483|P1|COMPLETED|Overall Study||25
5239517|NCT00847730|12882483|P1|STARTED|Overall Study||33
5239518|NCT00847704|12882487|P1|NOT COMPLETED|Overall Study||1
5239519|NCT00847704|12882487|P1|COMPLETED|Overall Study||2
5239520|NCT00847704|12882487|P1|STARTED|Overall Study||3
5239521|NCT00847665|12882498|P2|NOT COMPLETED|Overall Study||0
5239522|NCT00847665|12882499|P1|NOT COMPLETED|Overall Study||1
5239523|NCT00847665|12882498|P2|COMPLETED|Overall Study||165
5239524|NCT00847665|12882499|P1|COMPLETED|Overall Study||164
5239525|NCT00847665|12882498|P2|STARTED|Overall Study||165
5239526|NCT00847665|12882499|P1|STARTED|Overall Study||165
5239527|NCT00847626|12882522|P11|NOT COMPLETED|Overall Study||20
5239528|NCT00847626|12882523|P10|NOT COMPLETED|Overall Study||14
5239529|NCT00847626|12882524|P9|NOT COMPLETED|Overall Study||14
5239530|NCT00847626|12882525|P8|NOT COMPLETED|Overall Study||19
5239531|NCT00847626|12882526|P7|NOT COMPLETED|Overall Study||22
5239532|NCT00847626|12882527|P6|NOT COMPLETED|Overall Study||37
5239533|NCT00847626|12882528|P5|NOT COMPLETED|Overall Study||28
5239534|NCT00847626|12882529|P4|NOT COMPLETED|Overall Study||31
5239535|NCT00847626|12882530|P3|NOT COMPLETED|Overall Study||16
5239536|NCT00847626|12882531|P2|NOT COMPLETED|Overall Study||23
5239537|NCT00847626|12882532|P1|NOT COMPLETED|Overall Study||21
5239538|NCT00847626|12882522|P11|COMPLETED|Overall Study||142
5239539|NCT00847626|12882523|P10|COMPLETED|Overall Study||139
5239540|NCT00847626|12882524|P9|COMPLETED|Overall Study||141
5239541|NCT00847626|12882525|P8|COMPLETED|Overall Study||141
5239542|NCT00847626|12882526|P7|COMPLETED|Overall Study||135
5239543|NCT00847626|12882527|P6|COMPLETED|Overall Study||125
5239544|NCT00847626|12882528|P5|COMPLETED|Overall Study||125
5239545|NCT00847626|12882529|P4|COMPLETED|Overall Study||125
5239546|NCT00847626|12882530|P3|COMPLETED|Overall Study||131
5239547|NCT00847626|12882531|P2|COMPLETED|Overall Study||131
5239548|NCT00847626|12882532|P1|COMPLETED|Overall Study||135
5239549|NCT00847626|12882522|P11|STARTED|Overall Study||162
5239550|NCT00847626|12882523|P10|STARTED|Overall Study||153
5239551|NCT00847626|12882524|P9|STARTED|Overall Study||155
5239552|NCT00847626|12882525|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
5239553|NCT00847626|12882526|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
5239554|NCT00847626|12882527|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
5239555|NCT00847626|12882528|P5|STARTED|Overall Study||153
5239556|NCT00847626|12882529|P4|STARTED|Overall Study||156
5239557|NCT00847626|12882530|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
5239558|NCT00847626|12882531|P2|STARTED|Overall Study||154
5239559|NCT00847626|12882532|P1|STARTED|Overall Study||156
5239560|NCT00847613|12882731|P4|NOT COMPLETED|Overall Study||79
5239561|NCT00847613|12882732|P3|NOT COMPLETED|Overall Study||81
5239562|NCT00847613|12882733|P2|NOT COMPLETED|Overall Study||319
5239563|NCT00847613|12882734|P1|NOT COMPLETED|Overall Study||321
5239564|NCT00847613|12882731|P4|COMPLETED|Overall Study||0
5239565|NCT00847613|12882732|P3|COMPLETED|Overall Study||0
5239566|NCT00847613|12882733|P2|COMPLETED|Overall Study||0
5239567|NCT00847613|12882734|P1|COMPLETED|Overall Study||0
5239568|NCT00847613|12882731|P4|Treated|Overall Study||79
5239569|NCT00847613|12882732|P3|Treated|Overall Study||81
5239570|NCT00847613|12882733|P2|Treated|Overall Study||316
5239571|NCT00847613|12882734|P1|Treated|Overall Study||321
5239572|NCT00847613|12882731|P4|STARTED|Overall Study||79
5239573|NCT00847613|12882732|P3|STARTED|Overall Study||81
5239574|NCT00847613|12882733|P2|STARTED|Overall Study||319
5239575|NCT00847613|12882734|P1|STARTED|Overall Study||321
5239576|NCT00847587|12882974|P2|NOT COMPLETED|Overall Study||0
5239577|NCT00847587|12882975|P1|NOT COMPLETED|Overall Study||1
5239578|NCT00847587|12882974|P2|COMPLETED|Overall Study||34
5239579|NCT00847587|12882975|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
5239580|NCT00847587|12882974|P2|STARTED|Overall Study||34
5239581|NCT00847587|12882975|P1|STARTED|Overall Study||35
5239582|NCT00847561|12882985|P2|NOT COMPLETED|Overall Study||4
5239583|NCT00847561|12882986|P1|NOT COMPLETED|Overall Study||13
5239584|NCT00847561|12882985|P2|COMPLETED|Overall Study||62
5239585|NCT00847561|12882986|P1|COMPLETED|Overall Study||57
5239586|NCT00847561|12882985|P2|STARTED|Overall Study||66
5239587|NCT00847561|12882986|P1|STARTED|Overall Study||70
5239588|NCT00847535|12882992|P3|NOT COMPLETED|Overall Study||1
5239589|NCT00847535|12882993|P2|NOT COMPLETED|Overall Study||2
5239590|NCT00847535|12882994|P1|NOT COMPLETED|Overall Study||2
5239591|NCT00847535|12882992|P3|COMPLETED|Overall Study||15
5239592|NCT00847535|12882993|P2|COMPLETED|Overall Study||22
5239593|NCT00847535|12882994|P1|COMPLETED|Overall Study||22
5239594|NCT00847535|12882992|P3|200 Million AMDC|Overall Study||8
5239595|NCT00847535|12882993|P2|200 Million AMDC|Overall Study||0
5239596|NCT00847535|12882994|P1|200 Million AMDC|Overall Study||0
5239597|NCT00847535|12882992|P3|100 Million AMDC|Overall Study||8
5239598|NCT00847535|12882993|P2|100 Million AMDC|Overall Study||8
5239599|NCT00847535|12882994|P1|100 Million AMDC|Overall Study||8
5239600|NCT00847535|12882992|P3|50 Million AMDC|Overall Study||0
5239601|NCT00847535|12882993|P2|50 Million AMDC|Overall Study||8
5239602|NCT00847535|12882994|P1|50 Million AMDC|Overall Study||8
5239603|NCT00847535|12882992|P3|10 Million AMDC|Overall Study||0
5239604|NCT00847535|12882993|P2|10 Million AMDC|Overall Study||8
5239605|NCT00847535|12882994|P1|10 Million AMDC|Overall Study||8
5239606|NCT00847535|12882992|P3|STARTED|Overall Study||16
5239607|NCT00847535|12882993|P2|STARTED|Overall Study||24
5239608|NCT00847535|12882994|P1|STARTED|Overall Study||24
5239609|NCT00847522|12883002|P1|NOT COMPLETED|Overall Study||0
5239610|NCT00847522|12883002|P1|COMPLETED|Overall Study||90
5239611|NCT00847522|12883002|P1|Phase II|Overall Study||80
5239612|NCT00847522|12883002|P1|Phase I|Overall Study||10
5239613|NCT00847522|12883002|P1|STARTED|Overall Study||90
5239614|NCT00847509|12883007|P1|NOT COMPLETED|Overall Study||11
5239615|NCT00847509|12883007|P1|COMPLETED|Overall Study||38
5239616|NCT00847509|12883007|P1|STARTED|Overall Study||49
5239617|NCT00847405|12883013|P2|NOT COMPLETED|Second Intervention||0
5239618|NCT00847405|12883014|P1|NOT COMPLETED|Second Intervention||0
5239619|NCT00847405|12883013|P2|COMPLETED|Second Intervention||13
5239620|NCT00847405|12883014|P1|COMPLETED|Second Intervention||13
5239621|NCT00847405|12883013|P2|STARTED|Second Intervention||13
5239622|NCT00847405|12883014|P1|STARTED|Second Intervention||13
5239623|NCT00847405|12883013|P2|NOT COMPLETED|Washout of 7 Days||0
5239624|NCT00847405|12883014|P1|NOT COMPLETED|Washout of 7 Days||1
5239625|NCT00847405|12883013|P2|COMPLETED|Washout of 7 Days||13
5239626|NCT00847405|12883014|P1|COMPLETED|Washout of 7 Days||13
5239627|NCT00847405|12883013|P2|STARTED|Washout of 7 Days||13
5239628|NCT00847405|12883014|P1|STARTED|Washout of 7 Days||14
5239629|NCT00847405|12883013|P2|NOT COMPLETED|First Intervention||1
5239630|NCT00847405|12883014|P1|NOT COMPLETED|First Intervention||0
5239631|NCT00847405|12883013|P2|COMPLETED|First Intervention||13
5239632|NCT00847405|12883014|P1|COMPLETED|First Intervention||14
5239633|NCT00847405|12883013|P2|STARTED|First Intervention||14
5239634|NCT00847405|12883014|P1|STARTED|First Intervention||14
5239635|NCT00847379|12883025|P3|NOT COMPLETED|Overall Study||57
5239636|NCT00847379|12883026|P2|NOT COMPLETED|Overall Study||57
5239637|NCT00847379|12883027|P1|NOT COMPLETED|Overall Study||59
5239638|NCT00847379|12883025|P3|COMPLETED|Overall Study||0
5239639|NCT00847379|12883026|P2|COMPLETED|Overall Study||0
5239640|NCT00847379|12883027|P1|COMPLETED|Overall Study||0
5239641|NCT00847379|12883025|P3|As-treated Population|Overall Study||57
5239642|NCT00847379|12883026|P2|As-treated Population|Overall Study||57
5239643|NCT00847379|12883027|P1|As-treated Population|Overall Study||59
5239644|NCT00847379|12883025|P3|STARTED|Overall Study||57
5239645|NCT00847379|12883026|P2|STARTED|Overall Study||57
5239646|NCT00847379|12883027|P1|STARTED|Overall Study||59
5239647|NCT00847301|12883125|P1|NOT COMPLETED|Overall Study||54
5239648|NCT00847301|12883125|P1|COMPLETED|Overall Study||374
5239649|NCT00847301|12883125|P1|STARTED|Overall Study||428
5239650|NCT00847288|12883135|P2|NOT COMPLETED|Overall Study||47
5239651|NCT00847288|12883136|P1|NOT COMPLETED|Overall Study||30
5239652|NCT00847288|12883135|P2|COMPLETED|Overall Study||780
5239653|NCT00847288|12883136|P1|COMPLETED|Overall Study||811
5239654|NCT00847288|12883135|P2|STARTED|Overall Study||827
5239655|NCT00847288|12883136|P1|STARTED|Overall Study||841
5239656|NCT00847210|12883150|P2|NOT COMPLETED|Overall Study||0
5239657|NCT00847210|12883151|P1|NOT COMPLETED|Overall Study||0
5239658|NCT00847210|12883150|P2|COMPLETED|Overall Study||18
5239659|NCT00847210|12883151|P1|COMPLETED|Overall Study||18
5239660|NCT00847210|12883150|P2|STARTED|Overall Study||18
5239661|NCT00847210|12883151|P1|STARTED|Overall Study||18
5239662|NCT00847197|12883173|P2|NOT COMPLETED|Overall Study||5
5239663|NCT00847197|12883174|P1|NOT COMPLETED|Overall Study||24
5239664|NCT00847197|12883173|P2|COMPLETED|Overall Study||70
5239665|NCT00847197|12883174|P1|COMPLETED|Overall Study||92
5239666|NCT00847197|12883173|P2|STARTED|Overall Study||75
5239667|NCT00847197|12883174|P1|STARTED|Overall Study||116
5239668|NCT00847171|12883184|P1|NOT COMPLETED|Overall Study||0
5239669|NCT00847171|12883184|P1|COMPLETED|Overall Study||20
5239670|NCT00847171|12883184|P1|STARTED|Overall Study||20
5239671|NCT00847145|12883198|P8|NOT COMPLETED|Overall Study||4
5239672|NCT00847145|12883199|P7|NOT COMPLETED|Overall Study||9
5239673|NCT00847145|12883200|P6|NOT COMPLETED|Overall Study||4
5239674|NCT00847145|12883201|P5|NOT COMPLETED|Overall Study||6
5239675|NCT00847145|12883202|P4|NOT COMPLETED|Overall Study||1
5239676|NCT00847145|12883203|P3|NOT COMPLETED|Overall Study||11
5239677|NCT00847145|12883204|P2|NOT COMPLETED|Overall Study||6
5239678|NCT00847145|12883205|P1|NOT COMPLETED|Overall Study||6
5239679|NCT00847145|12883198|P8|COMPLETED|Overall Study||136
5239680|NCT00847145|12883199|P7|COMPLETED|Overall Study||143
5239681|NCT00847145|12883200|P6|COMPLETED|Overall Study||152
5239682|NCT00847145|12883201|P5|COMPLETED|Overall Study||131
5239683|NCT00847145|12883202|P4|COMPLETED|Overall Study||116
5239684|NCT00847145|12883203|P3|COMPLETED|Overall Study||274
5239685|NCT00847145|12883204|P2|COMPLETED|Overall Study||627
5239686|NCT00847145|12883205|P1|COMPLETED|Overall Study||623
5239687|NCT00847145|12883198|P8|STARTED|Overall Study||140
5239688|NCT00847145|12883199|P7|STARTED|Overall Study||152
5239689|NCT00847145|12883200|P6|STARTED|Overall Study||156
5239690|NCT00847145|12883201|P5|STARTED|Overall Study||137
5239691|NCT00847145|12883202|P4|STARTED|Overall Study||117
5239692|NCT00847145|12883203|P3|STARTED|Overall Study||285
5239693|NCT00847145|12883204|P2|STARTED|Overall Study||633
5239694|NCT00847145|12883205|P1|STARTED|Overall Study||629
5239695|NCT00847132|12883255|P2|NOT COMPLETED|Overall Study||1
5239696|NCT00847132|12883256|P1|NOT COMPLETED|Overall Study||1
5239697|NCT00847132|12883255|P2|COMPLETED|Overall Study||84
5239698|NCT00847132|12883256|P1|COMPLETED|Overall Study||89
5239699|NCT00847132|12883255|P2|STARTED|Overall Study||85
5239700|NCT00847132|12883256|P1|STARTED|Overall Study||90
5239701|NCT00847015|12883264|P1|NOT COMPLETED|Overall Study||3
5239702|NCT00847015|12883264|P1|COMPLETED|Overall Study||15
5239703|NCT00847015|12883264|P1|STARTED|Overall Study||18
5239704|NCT00847002|12883272|P2|NOT COMPLETED|Overall Study||0
5239705|NCT00847002|12883273|P1|NOT COMPLETED|Overall Study||0
5239706|NCT00847002|12883272|P2|COMPLETED|Overall Study||4
5239707|NCT00847002|12883273|P1|COMPLETED|Overall Study||4
5239708|NCT00847002|12883272|P2|STARTED|Overall Study||4
5239709|NCT00847002|12883273|P1|STARTED|Overall Study||4
5239710|NCT00846885|12883283|P2|NOT COMPLETED|Second Intervention||0
5239711|NCT00846885|12883284|P1|NOT COMPLETED|Second Intervention||0
5239712|NCT00846885|12883283|P2|COMPLETED|Second Intervention||14
5239713|NCT00846885|12883284|P1|COMPLETED|Second Intervention||14
5239714|NCT00846885|12883283|P2|STARTED|Second Intervention||14
5239715|NCT00846885|12883284|P1|STARTED|Second Intervention||14
5239716|NCT00846885|12883283|P2|NOT COMPLETED|Washout of 7 Days||0
5239717|NCT00846885|12883284|P1|NOT COMPLETED|Washout of 7 Days||0
5239718|NCT00846885|12883283|P2|COMPLETED|Washout of 7 Days||14
5239719|NCT00846885|12883284|P1|COMPLETED|Washout of 7 Days||14
5239720|NCT00846885|12883283|P2|STARTED|Washout of 7 Days||14
5239721|NCT00846885|12883284|P1|STARTED|Washout of 7 Days||14
5239722|NCT00846885|12883283|P2|NOT COMPLETED|First Intervention||0
5239723|NCT00846885|12883284|P1|NOT COMPLETED|First Intervention||0
5239724|NCT00846885|12883283|P2|COMPLETED|First Intervention||14
5239725|NCT00846885|12883284|P1|COMPLETED|First Intervention||14
5239726|NCT00846885|12883283|P2|STARTED|First Intervention||14
5239727|NCT00846885|12883284|P1|STARTED|First Intervention||14
5239728|NCT00846846|12883292|P1|NOT COMPLETED|Overall Study||75
5239729|NCT00846846|12883292|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
5239730|NCT00846846|12883292|P1|STARTED|Overall Study||1018
5239731|NCT00846807|12883297|P1|NOT COMPLETED|Overall Study||632
5239732|NCT00846807|12883297|P1|COMPLETED|Overall Study|Completed treatment.|4660
5239733|NCT00846807|12883297|P1|STARTED|Overall Study|Entered and treated.|5292
5239734|NCT00846768|12883305|P4|NOT COMPLETED|Overall Study||0
5239735|NCT00846768|12883306|P3|NOT COMPLETED|Overall Study||0
5239736|NCT00846768|12883307|P2|NOT COMPLETED|Overall Study||1
5239737|NCT00846768|12883308|P1|NOT COMPLETED|Overall Study||0
5239738|NCT00846768|12883305|P4|COMPLETED|Overall Study||12
5239739|NCT00846768|12883306|P3|COMPLETED|Overall Study||12
5239740|NCT00846768|12883307|P2|COMPLETED|Overall Study||11
5239741|NCT00846768|12883308|P1|COMPLETED|Overall Study||11
5239742|NCT00846768|12883305|P4|STARTED|Overall Study||12
5239743|NCT00846768|12883306|P3|STARTED|Overall Study||12
5239744|NCT00846768|12883307|P2|STARTED|Overall Study||12
5239745|NCT00846768|12883308|P1|STARTED|Overall Study||11
5239746|NCT00846742|12883378|P1|NOT COMPLETED|Overall Study||1
5239747|NCT00846742|12883378|P1|COMPLETED|Overall Study||84
5239748|NCT00846742|12883378|P1|Without Radiation Therapy (RT)|Overall Study||68
5239749|NCT00846742|12883378|P1|With Radiation Therapy (RT)|Overall Study||17
5239750|NCT00846742|12883378|P1|STARTED|Overall Study||85
5239751|NCT00846651|12883386|P2|NOT COMPLETED|Overall Study||4
5239752|NCT00846651|12883387|P1|NOT COMPLETED|Overall Study||4
5239753|NCT00846651|12883386|P2|COMPLETED|Overall Study||37
5239754|NCT00846651|12883387|P1|COMPLETED|Overall Study||37
5239755|NCT00846651|12883386|P2|STARTED|Overall Study||41
5239756|NCT00846651|12883387|P1|STARTED|Overall Study||41
5239757|NCT00846586|12883405|P2|NOT COMPLETED|Overall Study||35
5239758|NCT00846586|12883406|P1|NOT COMPLETED|Overall Study||39
5239759|NCT00846586|12883405|P2|COMPLETED|Overall Study||529
5239760|NCT00846586|12883406|P1|COMPLETED|Overall Study||531
5239761|NCT00846586|12883405|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
5239762|NCT00846586|12883406|P1|Received Study Drug|Overall Study||570
5239763|NCT00846586|12883405|P2|STARTED|Overall Study||564
5239764|NCT00846586|12883406|P1|STARTED|Overall Study||570
5239765|NCT00846573|12883425|P4|NOT COMPLETED|Overall Study||0
5239766|NCT00846573|12883426|P3|NOT COMPLETED|Overall Study||0
5239767|NCT00846573|12883427|P2|NOT COMPLETED|Overall Study||0
5239768|NCT00846573|12883428|P1|NOT COMPLETED|Overall Study||0
5239769|NCT00846573|12883425|P4|COMPLETED|Overall Study||0
5239770|NCT00846573|12883426|P3|COMPLETED|Overall Study||7
5239771|NCT00846573|12883427|P2|COMPLETED|Overall Study||2
5239772|NCT00846573|12883428|P1|COMPLETED|Overall Study||5
5239773|NCT00846573|12883425|P4|STARTED|Overall Study||0
5239774|NCT00846573|12883426|P3|STARTED|Overall Study||7
5239775|NCT00846573|12883427|P2|STARTED|Overall Study||2
5239776|NCT00846573|12883428|P1|STARTED|Overall Study||5
5239777|NCT00846547|12883436|P1|NOT COMPLETED|Overall Study||7
5239778|NCT00846547|12883436|P1|COMPLETED|Overall Study||25
5239779|NCT00846547|12883436|P1|STARTED|Overall Study||32
5239780|NCT00846521|12883440|P1|NOT COMPLETED|Overall Study||11
5239781|NCT00846521|12883440|P1|COMPLETED|Overall Study||12
5239782|NCT00846521|12883440|P1|STARTED|Overall Study||23
5239783|NCT00846495|12883447|P2|NOT COMPLETED|Overall Study||3
5239784|NCT00846495|12883448|P1|NOT COMPLETED|Overall Study||8
5239785|NCT00846495|12883447|P2|COMPLETED|Overall Study||24
5239786|NCT00846495|12883448|P1|COMPLETED|Overall Study||20
5239787|NCT00846495|12883447|P2|STARTED|Overall Study||27
5239788|NCT00846495|12883448|P1|STARTED|Overall Study||28
5239789|NCT00846391|12883471|P3|NOT COMPLETED|Overall Study||3
5239790|NCT00846391|12883472|P2|NOT COMPLETED|Overall Study||2
5239791|NCT00846391|12883473|P1|NOT COMPLETED|Overall Study||1
5239792|NCT00846391|12883471|P3|COMPLETED|Overall Study||3
5239793|NCT00846391|12883472|P2|COMPLETED|Overall Study||2
5239794|NCT00846391|12883473|P1|COMPLETED|Overall Study||3
5239795|NCT00846391|12883471|P3|STARTED|Overall Study||6
5239796|NCT00846391|12883472|P2|STARTED|Overall Study||4
5239797|NCT00846391|12883473|P1|STARTED|Overall Study||4
5239798|NCT00846365|12883484|P3|NOT COMPLETED|Overall Study||33
5239799|NCT00846365|12883485|P2|NOT COMPLETED|Overall Study||49
5239800|NCT00846365|12883486|P1|NOT COMPLETED|Overall Study||55
5239801|NCT00846365|12883484|P3|COMPLETED|Overall Study||323
5239802|NCT00846365|12883485|P2|COMPLETED|Overall Study||308
5239803|NCT00846365|12883486|P1|COMPLETED|Overall Study||317
5239804|NCT00846365|12883484|P3|STARTED|Overall Study||356
5239805|NCT00846365|12883485|P2|STARTED|Overall Study||357
5239806|NCT00846365|12883486|P1|STARTED|Overall Study||372
5239807|NCT00846287|12883541|P2|NOT COMPLETED|Overall Study||5
5239808|NCT00846287|12883542|P1|NOT COMPLETED|Overall Study||10
5239809|NCT00846287|12883541|P2|COMPLETED|Overall Study||10
5239810|NCT00846287|12883542|P1|COMPLETED|Overall Study||6
5239811|NCT00846287|12883541|P2|STARTED|Overall Study||15
5239812|NCT00846287|12883542|P1|STARTED|Overall Study||16
5239813|NCT00846066|12883552|P2|NOT COMPLETED|Overall Study||0
5239814|NCT00846066|12883553|P1|NOT COMPLETED|Overall Study||0
5239815|NCT00846066|12883552|P2|COMPLETED|Overall Study||29
5239816|NCT00846066|12883553|P1|COMPLETED|Overall Study||27
5239817|NCT00846066|12883552|P2|STARTED|Overall Study||29
5239818|NCT00846066|12883553|P1|STARTED|Overall Study||27
5239819|NCT00846053|12883567|P2|NOT COMPLETED|Overall Study||0
5239820|NCT00846053|12883568|P1|NOT COMPLETED|Overall Study||3
5239821|NCT00846053|12883567|P2|COMPLETED|Overall Study||8
5239822|NCT00846053|12883568|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
5239823|NCT00846053|12883567|P2|STARTED|Overall Study||8
5239824|NCT00846053|12883568|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
5239825|NCT00846027|12883576|P1|NOT COMPLETED|Overall Study||90
5239826|NCT00846027|12883576|P1|COMPLETED|Overall Study||0
5239827|NCT00846027|12883576|P1|Received Treatment|Overall Study||83
5239828|NCT00846027|12883576|P1|STARTED|Overall Study||90
5239829|NCT00845975|12883585|P2|NOT COMPLETED|Overall Study||0
5239830|NCT00845975|12883586|P1|NOT COMPLETED|Overall Study||0
5239831|NCT00845975|12883585|P2|COMPLETED|Overall Study||9
5239832|NCT00845975|12883586|P1|COMPLETED|Overall Study||9
5239833|NCT00845975|12883585|P2|STARTED|Overall Study||9
5239834|NCT00845975|12883586|P1|STARTED|Overall Study||9
5239835|NCT00845897|12883599|P3|NOT COMPLETED|Overall Study||3
5239836|NCT00845897|12883600|P2|NOT COMPLETED|Overall Study||5
5239837|NCT00845897|12883601|P1|NOT COMPLETED|Overall Study||2
5239838|NCT00845897|12883599|P3|COMPLETED|Overall Study||2
5239839|NCT00845897|12883600|P2|COMPLETED|Overall Study||2
5239840|NCT00845897|12883601|P1|COMPLETED|Overall Study||3
5239841|NCT00845897|12883599|P3|STARTED|Overall Study||5
5239842|NCT00845897|12883600|P2|STARTED|Overall Study||7
5239843|NCT00845897|12883601|P1|STARTED|Overall Study||5
5239844|NCT00845858|12883615|P3|NOT COMPLETED|Overall Study||8
5239845|NCT00845858|12883616|P2|NOT COMPLETED|Overall Study||12
5239846|NCT00845858|12883617|P1|NOT COMPLETED|Overall Study||8
5239847|NCT00845858|12883615|P3|COMPLETED|Overall Study||87
5239848|NCT00845858|12883616|P2|COMPLETED|Overall Study||84
5239849|NCT00845858|12883617|P1|COMPLETED|Overall Study||88
5239850|NCT00845858|12883615|P3|STARTED|Overall Study||95
5239851|NCT00845858|12883616|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
5239939|NCT00845507|12883830|P1|COMPLETED|Overall Study||22
5239852|NCT00845858|12883617|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
5239853|NCT00845845|12883630|P2|NOT COMPLETED|Overall Study||4
5239854|NCT00845845|12883631|P1|NOT COMPLETED|Overall Study||0
5239855|NCT00845845|12883630|P2|COMPLETED|Overall Study||2
5239856|NCT00845845|12883631|P1|COMPLETED|Overall Study||3
5239857|NCT00845845|12883630|P2|STARTED|Overall Study||6
5239858|NCT00845845|12883631|P1|STARTED|Overall Study||3
5239859|NCT00845832|12883642|P3|NOT COMPLETED|Extended Safety Follow-Up||7
5239860|NCT00845832|12883643|P2|NOT COMPLETED|Extended Safety Follow-Up||0
5239861|NCT00845832|12883644|P1|NOT COMPLETED|Extended Safety Follow-Up||0
5239862|NCT00845832|12883642|P3|COMPLETED|Extended Safety Follow-Up||0
5239863|NCT00845832|12883643|P2|COMPLETED|Extended Safety Follow-Up||5
5239864|NCT00845832|12883644|P1|COMPLETED|Extended Safety Follow-Up||2
5239865|NCT00845832|12883642|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
5239866|NCT00845832|12883643|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
5239867|NCT00845832|12883644|P1|STARTED|Extended Safety Follow-Up||2
5239868|NCT00845832|12883642|P3|NOT COMPLETED|Safety Follow-Up||0
5239869|NCT00845832|12883643|P2|NOT COMPLETED|Safety Follow-Up||0
5239870|NCT00845832|12883644|P1|NOT COMPLETED|Safety Follow-Up||1
5239871|NCT00845832|12883642|P3|COMPLETED|Safety Follow-Up||12
5239872|NCT00845832|12883643|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
5239873|NCT00845832|12883644|P1|COMPLETED|Safety Follow-Up||2
5239874|NCT00845832|12883642|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
5239875|NCT00845832|12883643|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
5239876|NCT00845832|12883644|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
5239877|NCT00845832|12883642|P3|NOT COMPLETED|Treatment Period||0
5239878|NCT00845832|12883643|P2|NOT COMPLETED|Treatment Period||3
5239879|NCT00845832|12883644|P1|NOT COMPLETED|Treatment Period||1
5239880|NCT00845832|12883642|P3|COMPLETED|Treatment Period||10
5239881|NCT00845832|12883643|P2|COMPLETED|Treatment Period||7
5239882|NCT00845832|12883644|P1|COMPLETED|Treatment Period||3
5239883|NCT00845832|12883642|P3|STARTED|Treatment Period||10
5239884|NCT00845832|12883643|P2|STARTED|Treatment Period||10
5239885|NCT00845832|12883644|P1|STARTED|Treatment Period||4
5239886|NCT00845728|12883690|P2|NOT COMPLETED|Overall Study||342
5239887|NCT00845728|12883691|P1|NOT COMPLETED|Overall Study||386
5239888|NCT00845728|12883690|P2|COMPLETED|Overall Study||1379
5239889|NCT00845728|12883691|P1|COMPLETED|Overall Study||1337
5239890|NCT00845728|12883690|P2|Exposed|Overall Study||1718
5239891|NCT00845728|12883691|P1|Exposed|Overall Study||1721
5239892|NCT00845728|12883690|P2|STARTED|Overall Study||1721
5239893|NCT00845728|12883691|P1|STARTED|Overall Study||1723
5239894|NCT00845702|12883699|P1|NOT COMPLETED|Dotarem MRA||0
5239895|NCT00845702|12883699|P1|COMPLETED|Dotarem MRA||32
5239896|NCT00845702|12883699|P1|STARTED|Dotarem MRA||32
5239897|NCT00845702|12883699|P1|NOT COMPLETED|TOF MRA||1
5239898|NCT00845702|12883699|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
5239899|NCT00845702|12883699|P1|STARTED|TOF MRA||33
5239900|NCT00845676|12883705|P1|NOT COMPLETED|Overall Study||2
5239901|NCT00845676|12883705|P1|COMPLETED|Overall Study||19
5239902|NCT00845676|12883705|P1|STARTED|Overall Study||21
5239903|NCT00845663|12883713|P2|NOT COMPLETED|Overall Study||0
5239904|NCT00845663|12883714|P1|NOT COMPLETED|Overall Study||0
5239905|NCT00845663|12883713|P2|COMPLETED|Overall Study||49
5239906|NCT00845663|12883714|P1|COMPLETED|Overall Study||49
5239907|NCT00845663|12883713|P2|STARTED|Overall Study||49
5239908|NCT00845663|12883714|P1|STARTED|Overall Study||49
5239909|NCT00845650|12883768|P6|NOT COMPLETED|Overall Study||2
5239910|NCT00845650|12883769|P5|NOT COMPLETED|Overall Study||3
5239911|NCT00845650|12883770|P4|NOT COMPLETED|Overall Study||1
5239912|NCT00845650|12883771|P3|NOT COMPLETED|Overall Study||3
5239913|NCT00845650|12883772|P2|NOT COMPLETED|Overall Study||0
5239914|NCT00845650|12883773|P1|NOT COMPLETED|Overall Study||1
5239915|NCT00845650|12883768|P6|COMPLETED|Overall Study||15
5239916|NCT00845650|12883769|P5|COMPLETED|Overall Study||28
5239917|NCT00845650|12883770|P4|COMPLETED|Overall Study||13
5239918|NCT00845650|12883771|P3|COMPLETED|Overall Study||28
5239919|NCT00845650|12883772|P2|COMPLETED|Overall Study||5
5239920|NCT00845650|12883773|P1|COMPLETED|Overall Study||30
5239921|NCT00845650|12883768|P6|STARTED|Overall Study|1 subject not dosed|17
5239922|NCT00845650|12883769|P5|STARTED|Overall Study|2 subjects not dosed|31
5239923|NCT00845650|12883770|P4|STARTED|Overall Study||14
5239924|NCT00845650|12883771|P3|STARTED|Overall Study||31
5239925|NCT00845650|12883772|P2|STARTED|Overall Study||5
5239926|NCT00845650|12883773|P1|STARTED|Overall Study|1 subject not dosed|31
5239927|NCT00845520|12883811|P3|NOT COMPLETED|Overall Study||1
5239928|NCT00845520|12883812|P2|NOT COMPLETED|Overall Study||2
5239929|NCT00845520|12883813|P1|NOT COMPLETED|Overall Study||2
5239930|NCT00845520|12883811|P3|COMPLETED|Overall Study||23
5239931|NCT00845520|12883812|P2|COMPLETED|Overall Study||23
5239932|NCT00845520|12883813|P1|COMPLETED|Overall Study||23
5239933|NCT00845520|12883811|P3|STARTED|Overall Study||24
5239934|NCT00845520|12883812|P2|STARTED|Overall Study||25
5239935|NCT00845520|12883813|P1|STARTED|Overall Study||25
5239936|NCT00845507|12883829|P2|NOT COMPLETED|Overall Study||1
5239937|NCT00845507|12883830|P1|NOT COMPLETED|Overall Study||2
5239938|NCT00845507|12883829|P2|COMPLETED|Overall Study||29
5239940|NCT00845507|12883829|P2|STARTED|Overall Study||30
5239941|NCT00845507|12883830|P1|STARTED|Overall Study||24
5239942|NCT00845481|12883838|P1|NOT COMPLETED|Overall Study||0
5239943|NCT00845481|12883838|P1|COMPLETED|Overall Study||24
5239944|NCT00845481|12883838|P1|STARTED|Overall Study||24
5239945|NCT00845429|12883850|P3|NOT COMPLETED|Overall Study||20
5239946|NCT00845429|12883851|P2|NOT COMPLETED|Overall Study||15
5239947|NCT00845429|12883852|P1|NOT COMPLETED|Overall Study||14
5239948|NCT00845429|12883850|P3|COMPLETED|Overall Study||224
5239949|NCT00845429|12883851|P2|COMPLETED|Overall Study||226
5239950|NCT00845429|12883852|P1|COMPLETED|Overall Study||230
5239951|NCT00845429|12883850|P3|STARTED|Overall Study||244
5239952|NCT00845429|12883851|P2|STARTED|Overall Study||241
5239953|NCT00845429|12883852|P1|STARTED|Overall Study||244
5239954|NCT00845195|12883871|P2|NOT COMPLETED|Overall Study||0
5239955|NCT00845195|12883872|P1|NOT COMPLETED|Overall Study||0
5239956|NCT00845195|12883871|P2|COMPLETED|Overall Study||75
5239957|NCT00845195|12883872|P1|COMPLETED|Overall Study||75
5239958|NCT00845195|12883871|P2|STARTED|Overall Study||75
5239959|NCT00845195|12883872|P1|STARTED|Overall Study||75
5239960|NCT00845182|12883887|P3|NOT COMPLETED|Overall Study||6
5239961|NCT00845182|12883888|P2|NOT COMPLETED|Overall Study||4
5239962|NCT00845182|12883889|P1|NOT COMPLETED|Overall Study||3
5239963|NCT00845182|12883887|P3|COMPLETED|Overall Study||9
5239964|NCT00845182|12883888|P2|COMPLETED|Overall Study||11
5239965|NCT00845182|12883889|P1|COMPLETED|Overall Study||10
5239966|NCT00845182|12883887|P3|STARTED|Overall Study||15
5239967|NCT00845182|12883888|P2|STARTED|Overall Study||15
5239968|NCT00845182|12883889|P1|STARTED|Overall Study||13
5239969|NCT00845130|12883903|P2|NOT COMPLETED|Overall Study||3
5239970|NCT00845130|12883904|P1|NOT COMPLETED|Overall Study||4
5239971|NCT00845130|12883903|P2|COMPLETED|Overall Study||19
5239972|NCT00845130|12883904|P1|COMPLETED|Overall Study||16
5239973|NCT00845130|12883903|P2|STARTED|Overall Study||22
5239974|NCT00845130|12883904|P1|STARTED|Overall Study||20
5239975|NCT00845065|12883914|P2|NOT COMPLETED|Overall Study||55
5239976|NCT00845065|12883915|P1|NOT COMPLETED|Overall Study||47
5239977|NCT00845065|12883914|P2|COMPLETED|Overall Study||79
5239978|NCT00845065|12883915|P1|COMPLETED|Overall Study||20
5239979|NCT00845065|12883914|P2|STARTED|Overall Study||134
5239980|NCT00845065|12883915|P1|STARTED|Overall Study||67
5239981|NCT00845039|12883931|P2|NOT COMPLETED|Overall Study||0
5239982|NCT00845039|12883932|P1|NOT COMPLETED|Overall Study||0
5239983|NCT00845039|12883931|P2|COMPLETED|Overall Study||2
5239984|NCT00845039|12883932|P1|COMPLETED|Overall Study||2
5239985|NCT00845039|12883931|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
5239986|NCT00845039|12883932|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
5239987|NCT00845039|12883931|P2|STARTED|Overall Study||2
5239988|NCT00845039|12883932|P1|STARTED|Overall Study||2
5239989|NCT00845000|12883959|P6|NOT COMPLETED|Period 3||0
5239990|NCT00845000|12883960|P5|NOT COMPLETED|Period 3||0
5239991|NCT00845000|12883961|P4|NOT COMPLETED|Period 3||0
5239992|NCT00845000|12883962|P3|NOT COMPLETED|Period 3||0
5239993|NCT00845000|12883963|P2|NOT COMPLETED|Period 3||0
5239994|NCT00845000|12883964|P1|NOT COMPLETED|Period 3||0
5239995|NCT00845000|12883959|P6|COMPLETED|Period 3||2
5239996|NCT00845000|12883960|P5|COMPLETED|Period 3||2
5239997|NCT00845000|12883961|P4|COMPLETED|Period 3||2
5239998|NCT00845000|12883962|P3|COMPLETED|Period 3||2
5239999|NCT00845000|12883963|P2|COMPLETED|Period 3||2
5240000|NCT00845000|12883964|P1|COMPLETED|Period 3||2
5240001|NCT00845000|12883959|P6|STARTED|Period 3||2
5240002|NCT00845000|12883960|P5|STARTED|Period 3||2
5240003|NCT00845000|12883961|P4|STARTED|Period 3||2
5240004|NCT00845000|12883962|P3|STARTED|Period 3||2
5240005|NCT00845000|12883963|P2|STARTED|Period 3||2
5240006|NCT00845000|12883964|P1|STARTED|Period 3||2
5240007|NCT00845000|12883959|P6|NOT COMPLETED|Period 2||0
5240008|NCT00845000|12883960|P5|NOT COMPLETED|Period 2||0
5240009|NCT00845000|12883961|P4|NOT COMPLETED|Period 2||0
5240010|NCT00845000|12883962|P3|NOT COMPLETED|Period 2||0
5240011|NCT00845000|12883963|P2|NOT COMPLETED|Period 2||0
5240012|NCT00845000|12883964|P1|NOT COMPLETED|Period 2||0
5240013|NCT00845000|12883959|P6|COMPLETED|Period 2||2
5240014|NCT00845000|12883960|P5|COMPLETED|Period 2||2
5240015|NCT00845000|12883961|P4|COMPLETED|Period 2||2
5240016|NCT00845000|12883962|P3|COMPLETED|Period 2||2
5240017|NCT00845000|12883963|P2|COMPLETED|Period 2||2
5240018|NCT00845000|12883964|P1|COMPLETED|Period 2||2
5240019|NCT00845000|12883959|P6|STARTED|Period 2||2
5240020|NCT00845000|12883960|P5|STARTED|Period 2||2
5240021|NCT00845000|12883961|P4|STARTED|Period 2||2
5240022|NCT00845000|12883962|P3|STARTED|Period 2||2
5240023|NCT00845000|12883963|P2|STARTED|Period 2||2
5240024|NCT00845000|12883964|P1|STARTED|Period 2||2
5240025|NCT00845000|12883959|P6|NOT COMPLETED|Period 1||0
5240026|NCT00845000|12883960|P5|NOT COMPLETED|Period 1||0
5240027|NCT00845000|12883961|P4|NOT COMPLETED|Period 1||0
5240028|NCT00845000|12883962|P3|NOT COMPLETED|Period 1||0
5240029|NCT00845000|12883963|P2|NOT COMPLETED|Period 1||0
5240030|NCT00845000|12883964|P1|NOT COMPLETED|Period 1||0
5240031|NCT00845000|12883959|P6|COMPLETED|Period 1||2
5240032|NCT00845000|12883960|P5|COMPLETED|Period 1||2
5240033|NCT00845000|12883961|P4|COMPLETED|Period 1||2
5240034|NCT00845000|12883962|P3|COMPLETED|Period 1||2
5240035|NCT00845000|12883963|P2|COMPLETED|Period 1||2
5240036|NCT00845000|12883964|P1|COMPLETED|Period 1||2
5240037|NCT00845000|12883959|P6|STARTED|Period 1||2
5240038|NCT00845000|12883960|P5|STARTED|Period 1||2
5240039|NCT00845000|12883961|P4|STARTED|Period 1||2
5240040|NCT00845000|12883962|P3|STARTED|Period 1||2
5240041|NCT00845000|12883963|P2|STARTED|Period 1||2
5240042|NCT00845000|12883964|P1|STARTED|Period 1||2
5240043|NCT00844896|12883983|P2|NOT COMPLETED|Overall Study||17
5240044|NCT00844896|12883984|P1|NOT COMPLETED|Overall Study||12
5240045|NCT00844896|12883983|P2|COMPLETED|Overall Study||11
5240046|NCT00844896|12883984|P1|COMPLETED|Overall Study||17
5240047|NCT00844896|12883983|P2|STARTED|Overall Study||28
5240048|NCT00844896|12883984|P1|STARTED|Overall Study||29
5240049|NCT00844883|12884006|P1|NOT COMPLETED|Overall Study||4
5240050|NCT00844883|12884006|P1|COMPLETED|Overall Study||46
5240051|NCT00844883|12884006|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
5240052|NCT00844883|12884006|P1|STARTED|Overall Study||50
5240053|NCT00844857|12884018|P2|NOT COMPLETED|Overall Study||37
5240054|NCT00844857|12884019|P1|NOT COMPLETED|Overall Study||78
5240055|NCT00844857|12884018|P2|COMPLETED|Overall Study||60
5240056|NCT00844857|12884019|P1|COMPLETED|Overall Study||116
5240057|NCT00844857|12884018|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
5240058|NCT00844857|12884019|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
5240059|NCT00844857|12884018|P2|STARTED|Overall Study||97
5240060|NCT00844857|12884019|P1|STARTED|Overall Study||194
5240061|NCT00844844|12884063|P1|NOT COMPLETED|Post Treatment Period||1
5240062|NCT00844844|12884063|P1|COMPLETED|Post Treatment Period||5
5240063|NCT00844844|12884063|P1|STARTED|Post Treatment Period||6
5240064|NCT00844844|12884063|P1|NOT COMPLETED|Extension Treatment Period||2
5240065|NCT00844844|12884063|P1|COMPLETED|Extension Treatment Period||11
5240066|NCT00844844|12884063|P1|STARTED|Extension Treatment Period||13
5240067|NCT00844844|12884063|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
5240068|NCT00844844|12884063|P1|COMPLETED|Treatment Period (26 Weeks)||15
5240069|NCT00844844|12884063|P1|STARTED|Treatment Period (26 Weeks)||17
5240070|NCT00844844|12884063|P1|NOT COMPLETED|Screening Period||0
5240071|NCT00844844|12884063|P1|COMPLETED|Screening Period||17
5240072|NCT00844844|12884063|P1|STARTED|Screening Period||17
5240073|NCT00844831|12884077|P1|NOT COMPLETED|Overall Study||6
5240074|NCT00844831|12884077|P1|COMPLETED|Overall Study||19
5240075|NCT00844831|12884077|P1|STARTED|Overall Study||25
5240076|NCT00844805|12884087|P4|NOT COMPLETED|Follow-Up Phase||9
5240077|NCT00844805|12884088|P3|NOT COMPLETED|Follow-Up Phase||9
5240078|NCT00844805|12884089|P2|NOT COMPLETED|Follow-Up Phase||0
5240079|NCT00844805|12884090|P1|NOT COMPLETED|Follow-Up Phase||0
5240080|NCT00844805|12884087|P4|COMPLETED|Follow-Up Phase||32
5240081|NCT00844805|12884088|P3|COMPLETED|Follow-Up Phase||32
5240082|NCT00844805|12884089|P2|COMPLETED|Follow-Up Phase||0
5240083|NCT00844805|12884090|P1|COMPLETED|Follow-Up Phase||0
5240084|NCT00844805|12884087|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
5240085|NCT00844805|12884088|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
5240086|NCT00844805|12884089|P2|STARTED|Follow-Up Phase||0
5240087|NCT00844805|12884090|P1|STARTED|Follow-Up Phase||0
5240088|NCT00844805|12884087|P4|NOT COMPLETED|Treatment Phase||0
5240089|NCT00844805|12884088|P3|NOT COMPLETED|Treatment Phase||0
5240090|NCT00844805|12884089|P2|NOT COMPLETED|Treatment Phase||7
5240091|NCT00844805|12884090|P1|NOT COMPLETED|Treatment Phase||10
5240092|NCT00844805|12884087|P4|COMPLETED|Treatment Phase||0
5240093|NCT00844805|12884088|P3|COMPLETED|Treatment Phase||0
5240094|NCT00844805|12884089|P2|COMPLETED|Treatment Phase||45
5240095|NCT00844805|12884090|P1|COMPLETED|Treatment Phase||96
5240096|NCT00844805|12884087|P4|STARTED|Treatment Phase||0
5240097|NCT00844805|12884088|P3|STARTED|Treatment Phase||0
5240098|NCT00844805|12884089|P2|STARTED|Treatment Phase||52
5240099|NCT00844805|12884090|P1|STARTED|Treatment Phase||106
5240100|NCT00844753|12884134|P4|NOT COMPLETED|Overall Study||11
5240101|NCT00844753|12884135|P3|NOT COMPLETED|Overall Study||7
5240102|NCT00844753|12884136|P2|NOT COMPLETED|Overall Study||3
5240103|NCT00844753|12884137|P1|NOT COMPLETED|Overall Study||8
5240104|NCT00844753|12884134|P4|COMPLETED|Overall Study||21
5240105|NCT00844753|12884135|P3|COMPLETED|Overall Study||25
5240106|NCT00844753|12884136|P2|COMPLETED|Overall Study||29
5240107|NCT00844753|12884137|P1|COMPLETED|Overall Study||24
5240108|NCT00844753|12884134|P4|STARTED|Overall Study||32
5240109|NCT00844753|12884135|P3|STARTED|Overall Study||32
5240110|NCT00844753|12884136|P2|STARTED|Overall Study||32
5240111|NCT00844753|12884137|P1|STARTED|Overall Study||32
5240112|NCT00844714|12884149|P1|NOT COMPLETED|Overall Study||0
5240113|NCT00844714|12884149|P1|COMPLETED|Overall Study||20
5240114|NCT00844714|12884149|P1|STARTED|Overall Study||20
5240115|NCT00844649|12884155|P2|NOT COMPLETED|Overall Study||418
5240116|NCT00844649|12884156|P1|NOT COMPLETED|Overall Study||405
5240117|NCT00844649|12884155|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
5240118|NCT00844649|12884156|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
5240119|NCT00844649|12884155|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
5240120|NCT00844649|12884156|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
5240121|NCT00844649|12884155|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
5240297|NCT00843492|12884784|P1|NOT COMPLETED|Overall Study||8
5240122|NCT00844649|12884156|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
5240123|NCT00844597|12884180|P6|NOT COMPLETED|Overall Study||0
5240124|NCT00844597|12884181|P5|NOT COMPLETED|Overall Study||0
5240125|NCT00844597|12884182|P4|NOT COMPLETED|Overall Study||1
5240126|NCT00844597|12884183|P3|NOT COMPLETED|Overall Study||0
5240127|NCT00844597|12884184|P2|NOT COMPLETED|Overall Study||0
5240128|NCT00844597|12884185|P1|NOT COMPLETED|Overall Study||0
5240129|NCT00844597|12884180|P6|COMPLETED|Overall Study||4
5240130|NCT00844597|12884181|P5|COMPLETED|Overall Study||4
5240131|NCT00844597|12884182|P4|COMPLETED|Overall Study||2
5240132|NCT00844597|12884183|P3|COMPLETED|Overall Study||2
5240133|NCT00844597|12884184|P2|COMPLETED|Overall Study||2
5240134|NCT00844597|12884185|P1|COMPLETED|Overall Study||4
5240135|NCT00844597|12884180|P6|STARTED|Overall Study||4
5240136|NCT00844597|12884181|P5|STARTED|Overall Study||4
5240137|NCT00844597|12884182|P4|STARTED|Overall Study||3
5240138|NCT00844597|12884183|P3|STARTED|Overall Study||2
5240139|NCT00844597|12884184|P2|STARTED|Overall Study||2
5240140|NCT00844597|12884185|P1|STARTED|Overall Study||4
5240141|NCT00844558|12884205|P2|NOT COMPLETED|Overall Study||4
5240142|NCT00844558|12884206|P1|NOT COMPLETED|Overall Study||12
5240143|NCT00844558|12884205|P2|COMPLETED|Overall Study||18
5240144|NCT00844558|12884206|P1|COMPLETED|Overall Study||24
5240145|NCT00844558|12884205|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
5240146|NCT00844558|12884206|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
5240147|NCT00844558|12884205|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
5240148|NCT00844558|12884206|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
5240149|NCT00844558|12884205|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
5240150|NCT00844558|12884206|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
5240151|NCT00844558|12884205|P2|Received Allocated Intervention|Overall Study||21
5240152|NCT00844558|12884206|P1|Received Allocated Intervention|Overall Study||33
5240153|NCT00844558|12884205|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
5240154|NCT00844558|12884206|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
5240155|NCT00844545|12884222|P1|NOT COMPLETED|Post Treatment Period||1
5240156|NCT00844545|12884222|P1|COMPLETED|Post Treatment Period||5
5240157|NCT00844545|12884222|P1|STARTED|Post Treatment Period||6
5240158|NCT00844545|12884222|P1|NOT COMPLETED|Extension Treatment Period||2
5240159|NCT00844545|12884222|P1|COMPLETED|Extension Treatment Period||11
5240160|NCT00844545|12884222|P1|STARTED|Extension Treatment Period||13
5240161|NCT00844545|12884222|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
5240162|NCT00844545|12884222|P1|COMPLETED|Treatment Period (26 Weeks)||15
5240163|NCT00844545|12884222|P1|STARTED|Treatment Period (26 Weeks)||17
5240164|NCT00844545|12884222|P1|NOT COMPLETED|Screening Period||0
5240165|NCT00844545|12884222|P1|COMPLETED|Screening Period||17
5240166|NCT00844545|12884222|P1|STARTED|Screening Period||17
5240167|NCT00844532|12884236|P1|NOT COMPLETED|Overall Study||39
5240168|NCT00844532|12884236|P1|COMPLETED|Overall Study||112
5240169|NCT00844532|12884236|P1|STARTED|Overall Study||151
5240170|NCT00844519|12884322|P2|NOT COMPLETED|Overall Study||1
5240171|NCT00844519|12884323|P1|NOT COMPLETED|Overall Study||2
5240172|NCT00844519|12884322|P2|COMPLETED|Overall Study||25
5240173|NCT00844519|12884323|P1|COMPLETED|Overall Study||24
5240174|NCT00844519|12884322|P2|STARTED|Overall Study||26
5240175|NCT00844519|12884323|P1|STARTED|Overall Study||26
5240176|NCT00844480|12884331|P2|NOT COMPLETED|Overall Study||3
5240177|NCT00844480|12884332|P1|NOT COMPLETED|Overall Study||2
5240178|NCT00844480|12884331|P2|COMPLETED|Overall Study||6
5240179|NCT00844480|12884332|P1|COMPLETED|Overall Study||6
5240180|NCT00844480|12884331|P2|STARTED|Overall Study||9
5240181|NCT00844480|12884332|P1|STARTED|Overall Study||8
5240182|NCT00844428|12884340|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
5240183|NCT00844428|12884340|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
5240184|NCT00844428|12884340|P1|STARTED|Post Treatment Period (Patients Who Disc||5
5240185|NCT00844428|12884340|P1|NOT COMPLETED|Extension Treatment Period||1
5240186|NCT00844428|12884340|P1|COMPLETED|Extension Treatment Period||18
5240187|NCT00844428|12884340|P1|STARTED|Extension Treatment Period||19
5240188|NCT00844428|12884340|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
5240189|NCT00844428|12884340|P1|COMPLETED|Treatment Period (26 Weeks)||20
5240190|NCT00844428|12884340|P1|STARTED|Treatment Period (26 Weeks)||20
5240191|NCT00844428|12884340|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
5240192|NCT00844428|12884340|P1|COMPLETED|Observation Period (8 Weeks)||20
5240193|NCT00844428|12884340|P1|STARTED|Observation Period (8 Weeks)||20
5240194|NCT00844428|12884340|P1|NOT COMPLETED|Screening Period||3
5240195|NCT00844428|12884340|P1|COMPLETED|Screening Period||20
5240196|NCT00844428|12884340|P1|STARTED|Screening Period||23
5240197|NCT00844415|12884356|P1|NOT COMPLETED|Overall Study||1
5240198|NCT00844415|12884356|P1|COMPLETED|Overall Study|Completed.|8
5240199|NCT00844415|12884356|P1|Pat. Received Single Dose 75mg|Overall Study||1
5240200|NCT00844415|12884356|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
5240201|NCT00844415|12884356|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
5240202|NCT00844415|12884356|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
5240203|NCT00844415|12884356|P1|STARTED|Overall Study|Entered and treated.|9
5240204|NCT00844376|12884370|P2|NOT COMPLETED|Period 2: Second Intervention||0
5240205|NCT00844376|12884371|P1|NOT COMPLETED|Period 2: Second Intervention||0
5240206|NCT00844376|12884370|P2|COMPLETED|Period 2: Second Intervention||6
5240207|NCT00844376|12884371|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
5240208|NCT00844376|12884370|P2|STARTED|Period 2: Second Intervention||6
5240209|NCT00844376|12884371|P1|STARTED|Period 2: Second Intervention||5
5240210|NCT00844376|12884370|P2|NOT COMPLETED|Period 1: First Intervention||0
5240211|NCT00844376|12884371|P1|NOT COMPLETED|Period 1: First Intervention||1
5240212|NCT00844376|12884370|P2|COMPLETED|Period 1: First Intervention||6
5240213|NCT00844376|12884371|P1|COMPLETED|Period 1: First Intervention||5
5240214|NCT00844376|12884370|P2|STARTED|Period 1: First Intervention||6
5240215|NCT00844376|12884371|P1|STARTED|Period 1: First Intervention||6
5240216|NCT00844298|12884389|P1|NOT COMPLETED|Overall Study||0
5240217|NCT00844298|12884389|P1|COMPLETED|Overall Study||91
5240218|NCT00844298|12884389|P1|STARTED|Overall Study||91
5240219|NCT00844194|12884395|P2|NOT COMPLETED|Overall Study||8
5240220|NCT00844194|12884396|P1|NOT COMPLETED|Overall Study||25
5240221|NCT00844194|12884395|P2|COMPLETED|Overall Study||22
5240222|NCT00844194|12884396|P1|COMPLETED|Overall Study||53
5240223|NCT00844194|12884395|P2|STARTED|Overall Study||30
5240224|NCT00844194|12884396|P1|STARTED|Overall Study||78
5240225|NCT00844090|12884602|P2|NOT COMPLETED|Overall Study||8
5240226|NCT00844090|12884603|P1|NOT COMPLETED|Overall Study||6
5240227|NCT00844090|12884602|P2|COMPLETED|Overall Study||46
5240228|NCT00844090|12884603|P1|COMPLETED|Overall Study||46
5240229|NCT00844090|12884602|P2|STARTED|Overall Study||54
5240230|NCT00844090|12884603|P1|STARTED|Overall Study||52
5240231|NCT00844051|12884611|P2|NOT COMPLETED|Overall Study||0
5240232|NCT00844051|12884612|P1|NOT COMPLETED|Overall Study||0
5240233|NCT00844051|12884611|P2|COMPLETED|Overall Study||2368
5240234|NCT00844051|12884612|P1|COMPLETED|Overall Study||2087
5240235|NCT00844051|12884611|P2|STARTED|Overall Study||2368
5240236|NCT00844051|12884612|P1|STARTED|Overall Study||2087
5240237|NCT00843986|12884622|P2|NOT COMPLETED|Overall Study||1
5240238|NCT00843986|12884623|P1|NOT COMPLETED|Overall Study||1
5240239|NCT00843986|12884622|P2|COMPLETED|Overall Study||5
5240240|NCT00843986|12884623|P1|COMPLETED|Overall Study||2
5240241|NCT00843986|12884622|P2|Completed Treatment (Infusion)|Overall Study||6
5240242|NCT00843986|12884623|P1|Completed Treatment (Infusion)|Overall Study||2
5240243|NCT00843986|12884622|P2|STARTED|Overall Study||6
5240244|NCT00843986|12884623|P1|STARTED|Overall Study||3
5240245|NCT00843856|12884651|P2|NOT COMPLETED|Overall Study||2
5240246|NCT00843856|12884652|P1|NOT COMPLETED|Overall Study||1
5240247|NCT00843856|12884651|P2|COMPLETED|Overall Study||18
5240248|NCT00843856|12884652|P1|COMPLETED|Overall Study||19
5240249|NCT00843856|12884651|P2|STARTED|Overall Study||20
5240250|NCT00843856|12884652|P1|STARTED|Overall Study||20
5240251|NCT00843843|12884662|P2|NOT COMPLETED|Overall Study||2
5240252|NCT00843843|12884663|P1|NOT COMPLETED|Overall Study||2
5240253|NCT00843843|12884662|P2|COMPLETED|Overall Study||6
5240254|NCT00843843|12884663|P1|COMPLETED|Overall Study||6
5240255|NCT00843843|12884662|P2|STARTED|Overall Study||8
5240256|NCT00843843|12884663|P1|STARTED|Overall Study||8
5240257|NCT00843830|12884671|P1|NOT COMPLETED|Overall Study||0
5240258|NCT00843830|12884671|P1|COMPLETED|Overall Study||4
5240259|NCT00843830|12884671|P1|STARTED|Overall Study||4
5240260|NCT00843778|12884676|P1|NOT COMPLETED|Overall Study||35
5240261|NCT00843778|12884676|P1|COMPLETED|Overall Study||96
5240262|NCT00843778|12884676|P1|STARTED|Overall Study||131
5240263|NCT00843713|12884711|P2|NOT COMPLETED|Overall Study||0
5240264|NCT00843713|12884712|P1|NOT COMPLETED|Overall Study||0
5240265|NCT00843713|12884711|P2|COMPLETED|Overall Study||26
5240266|NCT00843713|12884712|P1|COMPLETED|Overall Study||30
5240267|NCT00843713|12884711|P2|STARTED|Overall Study||26
5240268|NCT00843713|12884712|P1|STARTED|Overall Study||30
5240269|NCT00843635|12884721|P3|NOT COMPLETED|Overall Study||0
5240270|NCT00843635|12884722|P2|NOT COMPLETED|Overall Study||2
5240271|NCT00843635|12884723|P1|NOT COMPLETED|Overall Study||2
5240272|NCT00843635|12884721|P3|COMPLETED|Overall Study||5
5240273|NCT00843635|12884722|P2|COMPLETED|Overall Study||13
5240274|NCT00843635|12884723|P1|COMPLETED|Overall Study||13
5240275|NCT00843635|12884721|P3|STARTED|Overall Study||5
5240276|NCT00843635|12884722|P2|STARTED|Overall Study||15
5240277|NCT00843635|12884723|P1|STARTED|Overall Study||15
5240278|NCT00843622|12884743|P2|NOT COMPLETED|Overall Study||55
5240279|NCT00843622|12884744|P1|NOT COMPLETED|Overall Study||43
5240280|NCT00843622|12884743|P2|COMPLETED|Overall Study||70
5240281|NCT00843622|12884744|P1|COMPLETED|Overall Study||82
5240282|NCT00843622|12884743|P2|STARTED|Overall Study||125
5240283|NCT00843622|12884744|P1|STARTED|Overall Study||125
5240284|NCT00843518|12884752|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
5240285|NCT00843518|12884753|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
5240286|NCT00843518|12884752|P2|COMPLETED|Period 3 (Single-blind Washout)||49
5240287|NCT00843518|12884753|P1|COMPLETED|Period 3 (Single-blind Washout)||42
5240288|NCT00843518|12884752|P2|STARTED|Period 3 (Single-blind Washout)||49
5240289|NCT00843518|12884753|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
5240290|NCT00843518|12884752|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
5240291|NCT00843518|12884753|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
5240292|NCT00843518|12884752|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
5240293|NCT00843518|12884753|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
5240294|NCT00843518|12884752|P2|STARTED|Period 2 (Double-blind Treatment)||69
5240295|NCT00843518|12884753|P1|STARTED|Period 2 (Double-blind Treatment)||63
5240296|NCT00843492|12884783|P2|NOT COMPLETED|Overall Study||14
5240298|NCT00843492|12884783|P2|COMPLETED|Overall Study||607
5240299|NCT00843492|12884784|P1|COMPLETED|Overall Study||614
5240300|NCT00843492|12884783|P2|STARTED|Overall Study||621
5240301|NCT00843492|12884784|P1|STARTED|Overall Study||622
5240302|NCT00843479|12884804|P2|NOT COMPLETED|Overall Study||0
5240303|NCT00843479|12884805|P1|NOT COMPLETED|Overall Study||0
5240304|NCT00843479|12884804|P2|COMPLETED|Overall Study||12
5240305|NCT00843479|12884805|P1|COMPLETED|Overall Study||12
5240306|NCT00843479|12884804|P2|STARTED|Overall Study||12
5240307|NCT00843479|12884805|P1|STARTED|Overall Study||12
5240308|NCT00843466|12884823|P2|NOT COMPLETED|Overall Study||0
5240309|NCT00843466|12884824|P1|NOT COMPLETED|Overall Study||0
5240310|NCT00843466|12884823|P2|COMPLETED|Overall Study||18
5240311|NCT00843466|12884824|P1|COMPLETED|Overall Study||24
5240312|NCT00843466|12884823|P2|STARTED|Overall Study||18
5240313|NCT00843466|12884824|P1|STARTED|Overall Study||24
5240314|NCT00843349|12884834|P4|NOT COMPLETED|Overall Study||1
5240315|NCT00843349|12884835|P3|NOT COMPLETED|Overall Study||0
5240316|NCT00843349|12884836|P2|NOT COMPLETED|Overall Study||0
5240317|NCT00843349|12884837|P1|NOT COMPLETED|Overall Study||3
5240318|NCT00843349|12884834|P4|COMPLETED|Overall Study||10
5240319|NCT00843349|12884835|P3|COMPLETED|Overall Study||10
5240320|NCT00843349|12884836|P2|COMPLETED|Overall Study||11
5240321|NCT00843349|12884837|P1|COMPLETED|Overall Study||8
5240322|NCT00843349|12884834|P4|STARTED|Overall Study||11
5240323|NCT00843349|12884835|P3|STARTED|Overall Study||10
5240324|NCT00843349|12884836|P2|STARTED|Overall Study||11
5240325|NCT00843349|12884837|P1|STARTED|Overall Study||11
5240326|NCT00843310|12884851|P1|NOT COMPLETED|Overall Study||7
5240327|NCT00843310|12884851|P1|COMPLETED|Overall Study||1
5240328|NCT00843310|12884851|P1|STARTED|Overall Study||8
5240329|NCT00843284|12884855|P1|NOT COMPLETED|Overall Study||72
5240330|NCT00843284|12884855|P1|COMPLETED|Overall Study||619
5240331|NCT00843284|12884855|P1|STARTED|Overall Study||691
5240332|NCT00843193|12884865|P2|NOT COMPLETED|Overall Study||11
5240333|NCT00843193|12884866|P1|NOT COMPLETED|Overall Study||8
5240334|NCT00843193|12884865|P2|COMPLETED|Overall Study||88
5240335|NCT00843193|12884866|P1|COMPLETED|Overall Study||91
5240336|NCT00843193|12884865|P2|STARTED|Overall Study||99
5240337|NCT00843193|12884866|P1|STARTED|Overall Study||99
5240338|NCT00843180|12884902|P2|NOT COMPLETED|Overall Study||0
5240339|NCT00843180|12884903|P1|NOT COMPLETED|Overall Study||0
5240340|NCT00843180|12884902|P2|COMPLETED|Overall Study||7
5240341|NCT00843180|12884903|P1|COMPLETED|Overall Study||16
5240342|NCT00843180|12884902|P2|STARTED|Overall Study||7
5240343|NCT00843180|12884903|P1|STARTED|Overall Study||16
5240344|NCT00843167|12884917|P2|NOT COMPLETED|Follow-up||0
5240345|NCT00843167|12884918|P1|NOT COMPLETED|Follow-up||0
5240346|NCT00843167|12884917|P2|COMPLETED|Follow-up||24
5240347|NCT00843167|12884918|P1|COMPLETED|Follow-up||24
5240348|NCT00843167|12884917|P2|Completed Final Visit|Follow-up||24
5240349|NCT00843167|12884918|P1|Completed Final Visit|Follow-up||24
5240350|NCT00843167|12884917|P2|STARTED|Follow-up||24
5240351|NCT00843167|12884918|P1|STARTED|Follow-up||24
5240352|NCT00843167|12884917|P2|NOT COMPLETED|Treatment Period||8
5240353|NCT00843167|12884918|P1|NOT COMPLETED|Treatment Period||3
5240354|NCT00843167|12884917|P2|COMPLETED|Treatment Period||19
5240355|NCT00843167|12884918|P1|COMPLETED|Treatment Period||24
5240356|NCT00843167|12884917|P2|STARTED|Treatment Period||27
5240357|NCT00843167|12884918|P1|STARTED|Treatment Period||27
5240358|NCT00843115|12884931|P1|NOT COMPLETED|Overall Study||66
5240359|NCT00843115|12884931|P1|COMPLETED|Overall Study||304
5240360|NCT00843115|12884931|P1|STARTED|Overall Study||370
5240361|NCT00843050|12884977|P1|NOT COMPLETED|Overall Study||13
5240362|NCT00843050|12884977|P1|COMPLETED|Overall Study||0
5240363|NCT00843050|12884977|P1|STARTED|Overall Study||13
5240364|NCT00843024|12884987|P6|NOT COMPLETED|Double-blind Treatment Phase||25
5240365|NCT00843024|12884988|P5|NOT COMPLETED|Double-blind Treatment Phase||20
5240366|NCT00843024|12884989|P4|NOT COMPLETED|Double-blind Treatment Phase||23
5240367|NCT00843024|12884990|P3|NOT COMPLETED|Double-blind Treatment Phase||31
5240368|NCT00843024|12884991|P2|NOT COMPLETED|Double-blind Treatment Phase||0
5240369|NCT00843024|12884992|P1|NOT COMPLETED|Double-blind Treatment Phase||0
5240370|NCT00843024|12884987|P6|COMPLETED|Double-blind Treatment Phase||152
5240371|NCT00843024|12884988|P5|COMPLETED|Double-blind Treatment Phase||97
5240372|NCT00843024|12884989|P4|COMPLETED|Double-blind Treatment Phase||96
5240373|NCT00843024|12884990|P3|COMPLETED|Double-blind Treatment Phase||145
5240374|NCT00843024|12884991|P2|COMPLETED|Double-blind Treatment Phase||0
5240375|NCT00843024|12884992|P1|COMPLETED|Double-blind Treatment Phase||0
5240376|NCT00843024|12884987|P6|STARTED|Double-blind Treatment Phase||177
5240377|NCT00843024|12884988|P5|STARTED|Double-blind Treatment Phase||117
5240378|NCT00843024|12884989|P4|STARTED|Double-blind Treatment Phase||119
5240379|NCT00843024|12884990|P3|STARTED|Double-blind Treatment Phase||176
5240380|NCT00843024|12884991|P2|STARTED|Double-blind Treatment Phase||0
5240381|NCT00843024|12884992|P1|STARTED|Double-blind Treatment Phase||0
5240382|NCT00843024|12884987|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
5240383|NCT00843024|12884988|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
5240384|NCT00843024|12884989|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
5240385|NCT00843024|12884990|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
5240386|NCT00843024|12884991|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
5240387|NCT00843024|12884992|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
5240388|NCT00843024|12884987|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
5240389|NCT00843024|12884988|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
5240390|NCT00843024|12884989|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
5240391|NCT00843024|12884990|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
5240392|NCT00843024|12884991|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
5240393|NCT00843024|12884992|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
5240394|NCT00843024|12884987|P6|STARTED|Single-blind Placebo Run-In Phase||0
5240395|NCT00843024|12884988|P5|STARTED|Single-blind Placebo Run-In Phase||0
5240396|NCT00843024|12884989|P4|STARTED|Single-blind Placebo Run-In Phase||0
5240397|NCT00843024|12884990|P3|STARTED|Single-blind Placebo Run-In Phase||0
5240398|NCT00843024|12884991|P2|STARTED|Single-blind Placebo Run-In Phase||457
5240399|NCT00843024|12884992|P1|STARTED|Single-blind Placebo Run-In Phase||408
5240400|NCT00842985|12885057|P1|NOT COMPLETED|Fourth Intervention||0
5240401|NCT00842985|12885057|P1|COMPLETED|Fourth Intervention||15
5240402|NCT00842985|12885057|P1|STARTED|Fourth Intervention||15
5240403|NCT00842985|12885057|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
5240404|NCT00842985|12885057|P1|COMPLETED|Washout Period of GE 4 Days||15
5240405|NCT00842985|12885057|P1|STARTED|Washout Period of GE 4 Days||15
5240406|NCT00842985|12885057|P1|NOT COMPLETED|Third Intervention||0
5240407|NCT00842985|12885057|P1|COMPLETED|Third Intervention||15
5240408|NCT00842985|12885057|P1|STARTED|Third Intervention||15
5240409|NCT00842985|12885057|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
5240410|NCT00842985|12885057|P1|COMPLETED|Washout Period of GE 4 Days||15
5240411|NCT00842985|12885057|P1|STARTED|Washout Period of GE 4 Days||17
5240412|NCT00842985|12885057|P1|NOT COMPLETED|Second Intervention||1
5240413|NCT00842985|12885057|P1|COMPLETED|Second Intervention||17
5240414|NCT00842985|12885057|P1|STARTED|Second Intervention||18
5240415|NCT00842985|12885057|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
5240416|NCT00842985|12885057|P1|COMPLETED|Washout Period of GE 4 Days||18
5240417|NCT00842985|12885057|P1|STARTED|Washout Period of GE 4 Days||20
5240418|NCT00842985|12885057|P1|NOT COMPLETED|First Intervention||6
5240419|NCT00842985|12885057|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
5240420|NCT00842985|12885057|P1|STARTED|First Intervention|Signed Consent|26
5240421|NCT00842985|12885057|P1|NOT COMPLETED|Screening||27
5240422|NCT00842985|12885057|P1|COMPLETED|Screening||26
5240423|NCT00842985|12885057|P1|STARTED|Screening||53
5240424|NCT00842946|12885066|P2|NOT COMPLETED|Overall Study||5
5240425|NCT00842946|12885067|P1|NOT COMPLETED|Overall Study||5
5240426|NCT00842946|12885066|P2|COMPLETED|Overall Study||19
5240427|NCT00842946|12885067|P1|COMPLETED|Overall Study||16
5240428|NCT00842946|12885066|P2|STARTED|Overall Study||24
5240429|NCT00842946|12885067|P1|STARTED|Overall Study||21
5240430|NCT00842829|12885075|P3|NOT COMPLETED|Continuation Period||61
5240431|NCT00842829|12885076|P2|NOT COMPLETED|Continuation Period||0
5240432|NCT00842829|12885077|P1|NOT COMPLETED|Continuation Period||0
5240433|NCT00842829|12885075|P3|COMPLETED|Continuation Period||27
5240434|NCT00842829|12885076|P2|COMPLETED|Continuation Period||0
5240435|NCT00842829|12885077|P1|COMPLETED|Continuation Period||0
5240436|NCT00842829|12885075|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
5240437|NCT00842829|12885076|P2|Continuation Safety Analysis Set|Continuation Period||0
5240438|NCT00842829|12885077|P1|Continuation Safety Analysis Set|Continuation Period||0
5240439|NCT00842829|12885075|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
5240440|NCT00842829|12885076|P2|STARTED|Continuation Period||0
5240441|NCT00842829|12885077|P1|STARTED|Continuation Period||0
5240442|NCT00842829|12885075|P3|NOT COMPLETED|Treatment Period||63
5240443|NCT00842829|12885076|P2|NOT COMPLETED|Treatment Period||0
5240444|NCT00842829|12885077|P1|NOT COMPLETED|Treatment Period||0
5240445|NCT00842829|12885075|P3|COMPLETED|Treatment Period||218
5240446|NCT00842829|12885076|P2|COMPLETED|Treatment Period||0
5240447|NCT00842829|12885077|P1|COMPLETED|Treatment Period||0
5240448|NCT00842829|12885075|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
5240449|NCT00842829|12885076|P2|Safety Analysis Set|Treatment Period||0
5240450|NCT00842829|12885077|P1|Safety Analysis Set|Treatment Period||0
5240451|NCT00842829|12885075|P3|STARTED|Treatment Period||281
5240452|NCT00842829|12885076|P2|STARTED|Treatment Period||0
5240453|NCT00842829|12885077|P1|STARTED|Treatment Period||0
5240454|NCT00842829|12885075|P3|NOT COMPLETED|Dose Titration Period||0
5240455|NCT00842829|12885076|P2|NOT COMPLETED|Dose Titration Period||23
5240456|NCT00842829|12885077|P1|NOT COMPLETED|Dose Titration Period||26
5240457|NCT00842829|12885075|P3|COMPLETED|Dose Titration Period||0
5240458|NCT00842829|12885076|P2|COMPLETED|Dose Titration Period||151
5240459|NCT00842829|12885077|P1|COMPLETED|Dose Titration Period||130
5240460|NCT00842829|12885075|P3|Titration Safety Analysis Set|Dose Titration Period||0
5240461|NCT00842829|12885076|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
5240462|NCT00842829|12885077|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
5240463|NCT00842829|12885075|P3|STARTED|Dose Titration Period||0
5240464|NCT00842829|12885076|P2|STARTED|Dose Titration Period||174
5240465|NCT00842829|12885077|P1|STARTED|Dose Titration Period||156
5240466|NCT00842764|12885111|P1|NOT COMPLETED|Overall Study||2
5240467|NCT00842764|12885111|P1|COMPLETED|Overall Study||5
5240468|NCT00842764|12885111|P1|STARTED|Overall Study||7
5240469|NCT00842751|12885115|P1|NOT COMPLETED|Overall Study||0
5240470|NCT00842751|12885115|P1|COMPLETED|Overall Study||11
5240471|NCT00842751|12885115|P1|STARTED|Overall Study||11
5240472|NCT00842712|12885136|P7|NOT COMPLETED|Randomized Part||6
5240473|NCT00842712|12885137|P6|NOT COMPLETED|Randomized Part||1
5240474|NCT00842712|12885138|P5|NOT COMPLETED|Randomized Part||0
5240475|NCT00842712|12885139|P4|NOT COMPLETED|Randomized Part||0
5240476|NCT00842712|12885140|P3|NOT COMPLETED|Randomized Part||0
5240477|NCT00842712|12885141|P2|NOT COMPLETED|Randomized Part||0
5240478|NCT00842712|12885142|P1|NOT COMPLETED|Randomized Part||0
5240479|NCT00842712|12885136|P7|COMPLETED|Randomized Part||78
5240480|NCT00842712|12885137|P6|COMPLETED|Randomized Part||50
5240481|NCT00842712|12885138|P5|COMPLETED|Randomized Part||85
5240482|NCT00842712|12885139|P4|COMPLETED|Randomized Part||0
5240483|NCT00842712|12885140|P3|COMPLETED|Randomized Part||0
5240484|NCT00842712|12885141|P2|COMPLETED|Randomized Part||0
5240485|NCT00842712|12885142|P1|COMPLETED|Randomized Part||0
5240486|NCT00842712|12885136|P7|Treated|Randomized Part||80
5240487|NCT00842712|12885137|P6|Treated|Randomized Part||50
5240488|NCT00842712|12885138|P5|Treated|Randomized Part||85
5240489|NCT00842712|12885139|P4|Treated|Randomized Part||0
5240490|NCT00842712|12885140|P3|Treated|Randomized Part||0
5240491|NCT00842712|12885141|P2|Treated|Randomized Part||0
5240492|NCT00842712|12885142|P1|Treated|Randomized Part||0
5240493|NCT00842712|12885136|P7|STARTED|Randomized Part||84
5240494|NCT00842712|12885137|P6|STARTED|Randomized Part||51
5240495|NCT00842712|12885138|P5|STARTED|Randomized Part||85
5240496|NCT00842712|12885139|P4|STARTED|Randomized Part||0
5240497|NCT00842712|12885140|P3|STARTED|Randomized Part||0
5240498|NCT00842712|12885141|P2|STARTED|Randomized Part||0
5240499|NCT00842712|12885142|P1|STARTED|Randomized Part||0
5240500|NCT00842712|12885136|P7|NOT COMPLETED|Safety Run-in Part||0
5240501|NCT00842712|12885137|P6|NOT COMPLETED|Safety Run-in Part||0
5240502|NCT00842712|12885138|P5|NOT COMPLETED|Safety Run-in Part||0
5240503|NCT00842712|12885139|P4|NOT COMPLETED|Safety Run-in Part||1
5240504|NCT00842712|12885140|P3|NOT COMPLETED|Safety Run-in Part||0
5240505|NCT00842712|12885141|P2|NOT COMPLETED|Safety Run-in Part||2
5240506|NCT00842712|12885142|P1|NOT COMPLETED|Safety Run-in Part||3
5240507|NCT00842712|12885136|P7|COMPLETED|Safety Run-in Part||0
5240508|NCT00842712|12885137|P6|COMPLETED|Safety Run-in Part||0
5240509|NCT00842712|12885138|P5|COMPLETED|Safety Run-in Part||0
5240510|NCT00842712|12885139|P4|COMPLETED|Safety Run-in Part||2
5240511|NCT00842712|12885140|P3|COMPLETED|Safety Run-in Part||3
5240512|NCT00842712|12885141|P2|COMPLETED|Safety Run-in Part||1
5240513|NCT00842712|12885142|P1|COMPLETED|Safety Run-in Part||0
5240514|NCT00842712|12885136|P7|STARTED|Safety Run-in Part||0
5240515|NCT00842712|12885137|P6|STARTED|Safety Run-in Part||0
5240516|NCT00842712|12885138|P5|STARTED|Safety Run-in Part||0
5240517|NCT00842712|12885139|P4|STARTED|Safety Run-in Part||3
5240518|NCT00842712|12885140|P3|STARTED|Safety Run-in Part||3
5240519|NCT00842712|12885141|P2|STARTED|Safety Run-in Part||3
5240520|NCT00842712|12885142|P1|STARTED|Safety Run-in Part||3
5240521|NCT00842608|12885174|P4|NOT COMPLETED|Overall Study||1
5240522|NCT00842608|12885175|P3|NOT COMPLETED|Overall Study||0
5240523|NCT00842608|12885176|P2|NOT COMPLETED|Overall Study||1
5240524|NCT00842608|12885177|P1|NOT COMPLETED|Overall Study||4
5240525|NCT00842608|12885174|P4|COMPLETED|Overall Study||100
5240526|NCT00842608|12885175|P3|COMPLETED|Overall Study||99
5240527|NCT00842608|12885176|P2|COMPLETED|Overall Study||176
5240528|NCT00842608|12885177|P1|COMPLETED|Overall Study||170
5240529|NCT00842608|12885174|P4|STARTED|Overall Study||101
5240530|NCT00842608|12885175|P3|STARTED|Overall Study||99
5240531|NCT00842608|12885176|P2|STARTED|Overall Study||177
5240532|NCT00842608|12885177|P1|STARTED|Overall Study||174
5240533|NCT00842543|12885199|P4|NOT COMPLETED|Overall Study||4
5240534|NCT00842543|12885200|P3|NOT COMPLETED|Overall Study||3
5240535|NCT00842543|12885201|P2|NOT COMPLETED|Overall Study||0
5240536|NCT00842543|12885202|P1|NOT COMPLETED|Overall Study||2
5240537|NCT00842543|12885199|P4|COMPLETED|Overall Study||4
5240538|NCT00842543|12885200|P3|COMPLETED|Overall Study||10
5240539|NCT00842543|12885201|P2|COMPLETED|Overall Study||5
5240540|NCT00842543|12885202|P1|COMPLETED|Overall Study||11
5240541|NCT00842543|12885199|P4|STARTED|Overall Study||8
5240542|NCT00842543|12885200|P3|STARTED|Overall Study||13
5240543|NCT00842543|12885201|P2|STARTED|Overall Study||5
5240544|NCT00842543|12885202|P1|STARTED|Overall Study||13
5240545|NCT00842530|12885216|P2|NOT COMPLETED|Overall Study||57
5240546|NCT00842530|12885217|P1|NOT COMPLETED|Overall Study||117
5240547|NCT00842530|12885216|P2|COMPLETED|Overall Study||1276
5240548|NCT00842530|12885217|P1|COMPLETED|Overall Study||2552
5240549|NCT00842530|12885216|P2|Received Vaccination 3|Overall Study||1282
5240550|NCT00842530|12885217|P1|Received Vaccination 3|Overall Study||2557
5240551|NCT00842530|12885216|P2|Received Vaccination 2|Overall Study||1300
5240552|NCT00842530|12885217|P1|Received Vaccination 2|Overall Study||2584
5240553|NCT00842530|12885216|P2|Received Vaccination 1|Overall Study||1331
5240554|NCT00842530|12885217|P1|Received Vaccination 1|Overall Study||2666
5240555|NCT00842530|12885216|P2|STARTED|Overall Study||1333
5240556|NCT00842530|12885217|P1|STARTED|Overall Study||2669
5240557|NCT00842361|12885247|P2|NOT COMPLETED|Overall Study||2
5240558|NCT00842361|12885248|P1|NOT COMPLETED|Overall Study||1
5240559|NCT00842361|12885247|P2|COMPLETED|Overall Study||31
5240560|NCT00842361|12885248|P1|COMPLETED|Overall Study||32
5240561|NCT00842361|12885247|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
5240562|NCT00842361|12885248|P1|Exposed|Overall Study||33
5240563|NCT00842361|12885247|P2|STARTED|Overall Study||33
5240564|NCT00842361|12885248|P1|STARTED|Overall Study||33
5240565|NCT00842348|12885268|P2|NOT COMPLETED|Study 729||38
5240566|NCT00842348|12885269|P1|NOT COMPLETED|Study 729||26
5240567|NCT00842348|12885268|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
5240568|NCT00842348|12885269|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
5240569|NCT00842348|12885268|P2|STARTED|Study 729||47
5240570|NCT00842348|12885269|P1|STARTED|Study 729||42
5240571|NCT00842348|12885268|P2|NOT COMPLETED|Patients Randomised in Study 726||56
5240572|NCT00842348|12885269|P1|NOT COMPLETED|Patients Randomised in Study 726||59
5240573|NCT00842348|12885268|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
5240574|NCT00842348|12885269|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
5240575|NCT00842348|12885268|P2|STARTED|Patients Randomised in Study 726||103
5240576|NCT00842348|12885269|P1|STARTED|Patients Randomised in Study 726||101
5240577|NCT00842335|12885279|P1|NOT COMPLETED|Overall Study||0
5240578|NCT00842335|12885279|P1|COMPLETED|Overall Study||18
5240579|NCT00842335|12885279|P1|STARTED|Overall Study||18
5240580|NCT00842309|12885288|P2|NOT COMPLETED|Overall Study||1
5240581|NCT00842309|12885289|P1|NOT COMPLETED|Overall Study||3
5240582|NCT00842309|12885288|P2|COMPLETED|Overall Study||13
5240583|NCT00842309|12885289|P1|COMPLETED|Overall Study||11
5240584|NCT00842309|12885288|P2|STARTED|Overall Study||14
5240585|NCT00842309|12885289|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
5240586|NCT00842296|12885297|P1|NOT COMPLETED|Overall Study||0
5240587|NCT00842296|12885297|P1|COMPLETED|Overall Study||326
5240588|NCT00842296|12885297|P1|STARTED|Overall Study||326
5240589|NCT00842257|12885323|P1|NOT COMPLETED|Overall Study||1
5240590|NCT00842257|12885323|P1|COMPLETED|Overall Study||19
5240591|NCT00842257|12885323|P1|STARTED|Overall Study||20
5240592|NCT00842244|12885330|P1|NOT COMPLETED|Overall Study||21
5240593|NCT00842244|12885330|P1|COMPLETED|Overall Study||1
5240594|NCT00842244|12885330|P1|STARTED|Overall Study||22
5240595|NCT00842231|12885349|P1|NOT COMPLETED|Overall Study||0
5240596|NCT00842231|12885349|P1|COMPLETED|Overall Study||40
5240597|NCT00842231|12885349|P1|STARTED|Overall Study||40
5240598|NCT00842153|12885357|P2|NOT COMPLETED|Overall Study||3
5240599|NCT00842153|12885358|P1|NOT COMPLETED|Overall Study||1
5240600|NCT00842153|12885357|P2|COMPLETED|Overall Study||27
5240601|NCT00842153|12885358|P1|COMPLETED|Overall Study||27
5240602|NCT00842153|12885357|P2|STARTED|Overall Study||30
5240603|NCT00842153|12885358|P1|STARTED|Overall Study||28
5240604|NCT00842075|12885398|P2|NOT COMPLETED|Overall Study||0
5240605|NCT00842075|12885399|P1|NOT COMPLETED|Overall Study||0
5240606|NCT00842075|12885398|P2|COMPLETED|Overall Study||5
5240607|NCT00842075|12885399|P1|COMPLETED|Overall Study||5
5240608|NCT00842075|12885398|P2|STARTED|Overall Study||5
5240609|NCT00842075|12885399|P1|STARTED|Overall Study||5
5240610|NCT00842023|12885409|P2|NOT COMPLETED|Overall Study||0
5240611|NCT00842023|12885410|P1|NOT COMPLETED|Overall Study||0
5240612|NCT00842023|12885409|P2|COMPLETED|Overall Study||44
5240613|NCT00842023|12885410|P1|COMPLETED|Overall Study||45
5240614|NCT00842023|12885409|P2|STARTED|Overall Study||44
5240615|NCT00842023|12885410|P1|STARTED|Overall Study||45
5240616|NCT00841971|12885422|P2|NOT COMPLETED|Overall Study||1
5240617|NCT00841971|12885423|P1|NOT COMPLETED|Overall Study||2
5240618|NCT00841971|12885422|P2|COMPLETED|Overall Study||99
5240619|NCT00841971|12885423|P1|COMPLETED|Overall Study||98
5240620|NCT00841971|12885422|P2|STARTED|Overall Study||100
5240621|NCT00841971|12885423|P1|STARTED|Overall Study||100
5240622|NCT00841906|12885433|P2|NOT COMPLETED|Overall Study||0
5240623|NCT00841906|12885434|P1|NOT COMPLETED|Overall Study||2
5240624|NCT00841906|12885433|P2|COMPLETED|Overall Study||14
5240625|NCT00841906|12885434|P1|COMPLETED|Overall Study||16
5240626|NCT00841906|12885433|P2|STARTED|Overall Study||14
5240627|NCT00841906|12885434|P1|STARTED|Overall Study||18
5240628|NCT00841828|12885448|P2|NOT COMPLETED|Overall Study||2
5240629|NCT00841828|12885449|P1|NOT COMPLETED|Overall Study||10
5240630|NCT00841828|12885448|P2|COMPLETED|Overall Study||48
5240631|NCT00841828|12885449|P1|COMPLETED|Overall Study||42
5240632|NCT00841828|12885448|P2|STARTED|Overall Study||50
5240633|NCT00841828|12885449|P1|STARTED|Overall Study||52
5240634|NCT00841815|12885459|P2|NOT COMPLETED|Period 2||0
5240635|NCT00841815|12885460|P1|NOT COMPLETED|Period 2||0
5240636|NCT00841815|12885459|P2|COMPLETED|Period 2||13
5240637|NCT00841815|12885460|P1|COMPLETED|Period 2||14
5240638|NCT00841815|12885459|P2|STARTED|Period 2||13
5240639|NCT00841815|12885460|P1|STARTED|Period 2||14
5240640|NCT00841815|12885459|P2|NOT COMPLETED|Washout||1
5240641|NCT00841815|12885460|P1|NOT COMPLETED|Washout||0
5240642|NCT00841815|12885459|P2|COMPLETED|Washout||13
5240643|NCT00841815|12885460|P1|COMPLETED|Washout||14
5240644|NCT00841815|12885459|P2|STARTED|Washout||14
5240645|NCT00841815|12885460|P1|STARTED|Washout||14
5240646|NCT00841815|12885459|P2|NOT COMPLETED|Period 1||0
5240647|NCT00841815|12885460|P1|NOT COMPLETED|Period 1||0
5240648|NCT00841815|12885459|P2|COMPLETED|Period 1||14
5240649|NCT00841815|12885460|P1|COMPLETED|Period 1||14
5240650|NCT00841815|12885459|P2|STARTED|Period 1||14
5240651|NCT00841815|12885460|P1|STARTED|Period 1||14
5240652|NCT00841776|12885470|P2|NOT COMPLETED|Overall Study||3
5240653|NCT00841776|12885471|P1|NOT COMPLETED|Overall Study||2
5240654|NCT00841776|12885470|P2|COMPLETED|Overall Study||24
5240655|NCT00841776|12885471|P1|COMPLETED|Overall Study||25
5240656|NCT00841776|12885470|P2|STARTED|Overall Study||27
5240657|NCT00841776|12885471|P1|STARTED|Overall Study||27
5240658|NCT00841763|12885489|P4|NOT COMPLETED|Overall Study||3
5240659|NCT00841763|12885490|P3|NOT COMPLETED|Overall Study||8
5240660|NCT00841763|12885491|P2|NOT COMPLETED|Overall Study||57
5240661|NCT00841763|12885492|P1|NOT COMPLETED|Overall Study||162
5240662|NCT00841763|12885489|P4|COMPLETED|Overall Study||53
5240663|NCT00841763|12885490|P3|COMPLETED|Overall Study||211
5240664|NCT00841763|12885491|P2|COMPLETED|Overall Study||624
5240665|NCT00841763|12885492|P1|COMPLETED|Overall Study||2529
5240666|NCT00841763|12885489|P4|STARTED|Overall Study||56
5240667|NCT00841763|12885490|P3|STARTED|Overall Study||219
5240668|NCT00841763|12885491|P2|STARTED|Overall Study||681
5240669|NCT00841763|12885492|P1|STARTED|Overall Study||2691
5240670|NCT00841698|12885554|P2|NOT COMPLETED|Second Intervention||0
5240671|NCT00841698|12885555|P1|NOT COMPLETED|Second Intervention||0
5240672|NCT00841698|12885554|P2|COMPLETED|Second Intervention||25
5240673|NCT00841698|12885555|P1|COMPLETED|Second Intervention||24
5240674|NCT00841698|12885554|P2|STARTED|Second Intervention||25
5240675|NCT00841698|12885555|P1|STARTED|Second Intervention||24
5240676|NCT00841698|12885554|P2|NOT COMPLETED|Washout: 2 Weeks||0
5240677|NCT00841698|12885555|P1|NOT COMPLETED|Washout: 2 Weeks||0
5240678|NCT00841698|12885554|P2|COMPLETED|Washout: 2 Weeks||25
5240679|NCT00841698|12885555|P1|COMPLETED|Washout: 2 Weeks||24
5240680|NCT00841698|12885554|P2|STARTED|Washout: 2 Weeks||25
5240681|NCT00841698|12885555|P1|STARTED|Washout: 2 Weeks||24
5240682|NCT00841698|12885554|P2|NOT COMPLETED|First Intervention||0
5240683|NCT00841698|12885555|P1|NOT COMPLETED|First Intervention||1
5240684|NCT00841698|12885554|P2|COMPLETED|First Intervention||25
5240685|NCT00841698|12885555|P1|COMPLETED|First Intervention||24
5240686|NCT00841698|12885554|P2|STARTED|First Intervention||25
5240687|NCT00841698|12885555|P1|STARTED|First Intervention||25
5240688|NCT00841672|12885565|P2|NOT COMPLETED|Overall Study||32
5240689|NCT00841672|12885566|P1|NOT COMPLETED|Overall Study||20
5240690|NCT00841672|12885565|P2|COMPLETED|Overall Study||209
5240691|NCT00841672|12885566|P1|COMPLETED|Overall Study||224
5240692|NCT00841672|12885565|P2|STARTED|Overall Study||241
5240693|NCT00841672|12885566|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
5240694|NCT00841659|12885582|P2|NOT COMPLETED|Second Intervention||0
5240695|NCT00841659|12885583|P1|NOT COMPLETED|Second Intervention||0
5240696|NCT00841659|12885582|P2|COMPLETED|Second Intervention||12
5240697|NCT00841659|12885583|P1|COMPLETED|Second Intervention||11
5240698|NCT00841659|12885582|P2|STARTED|Second Intervention||12
5240699|NCT00841659|12885583|P1|STARTED|Second Intervention||11
5240700|NCT00841659|12885582|P2|NOT COMPLETED|Washout: 2 Weeks||0
5240701|NCT00841659|12885583|P1|NOT COMPLETED|Washout: 2 Weeks||1
5240702|NCT00841659|12885582|P2|COMPLETED|Washout: 2 Weeks||12
5240703|NCT00841659|12885583|P1|COMPLETED|Washout: 2 Weeks||11
5240704|NCT00841659|12885582|P2|STARTED|Washout: 2 Weeks||12
5240705|NCT00841659|12885583|P1|STARTED|Washout: 2 Weeks||12
5240706|NCT00841659|12885582|P2|NOT COMPLETED|First Intervention||0
5240707|NCT00841659|12885583|P1|NOT COMPLETED|First Intervention||0
5240708|NCT00841659|12885582|P2|COMPLETED|First Intervention||12
5240709|NCT00841659|12885583|P1|COMPLETED|First Intervention||12
5240710|NCT00841659|12885582|P2|STARTED|First Intervention||12
5240711|NCT00841659|12885583|P1|STARTED|First Intervention||12
5240712|NCT00841568|12885591|P1|NOT COMPLETED|Overall Study||5
5240713|NCT00841568|12885591|P1|COMPLETED|Overall Study||12
5240714|NCT00841568|12885591|P1|STARTED|Overall Study||17
5240715|NCT00841555|12885607|P3|NOT COMPLETED|Overall Study||0
5240716|NCT00841555|12885608|P2|NOT COMPLETED|Overall Study||0
5240717|NCT00841555|12885609|P1|NOT COMPLETED|Overall Study||0
5240718|NCT00841555|12885607|P3|COMPLETED|Overall Study||3
5240719|NCT00841555|12885608|P2|COMPLETED|Overall Study||3
5240720|NCT00841555|12885609|P1|COMPLETED|Overall Study||3
5240721|NCT00841555|12885607|P3|STARTED|Overall Study||3
5240722|NCT00841555|12885608|P2|STARTED|Overall Study||3
5240723|NCT00841555|12885609|P1|STARTED|Overall Study||3
5240724|NCT00841542|12885619|P2|NOT COMPLETED|Period 2||0
5240725|NCT00841542|12885620|P1|NOT COMPLETED|Period 2||0
5240726|NCT00841542|12885619|P2|COMPLETED|Period 2||14
5240727|NCT00841542|12885620|P1|COMPLETED|Period 2||13
5240728|NCT00841542|12885619|P2|STARTED|Period 2||14
5240729|NCT00841542|12885620|P1|STARTED|Period 2||13
5240730|NCT00841542|12885619|P2|NOT COMPLETED|Period 1||0
5240731|NCT00841542|12885620|P1|NOT COMPLETED|Period 1||1
5240732|NCT00841542|12885619|P2|COMPLETED|Period 1||14
5240733|NCT00841542|12885620|P1|COMPLETED|Period 1||13
5240734|NCT00841542|12885619|P2|STARTED|Period 1||14
5240735|NCT00841542|12885620|P1|STARTED|Period 1||14
5240736|NCT00841412|12885628|P2|NOT COMPLETED|Overall Study||30
5240737|NCT00841412|12885629|P1|NOT COMPLETED|Overall Study||40
5240738|NCT00841412|12885628|P2|COMPLETED|Overall Study||50
5240739|NCT00841412|12885629|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
5240740|NCT00841412|12885628|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
5240741|NCT00841412|12885629|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
5240742|NCT00841321|12885635|P2|NOT COMPLETED|Overall Study||3
5240743|NCT00841321|12885636|P1|NOT COMPLETED|Overall Study||1
5240744|NCT00841321|12885635|P2|COMPLETED|Overall Study||58
5240745|NCT00841321|12885636|P1|COMPLETED|Overall Study||58
5240746|NCT00841321|12885635|P2|STARTED|Overall Study||61
5240747|NCT00841321|12885636|P1|STARTED|Overall Study||59
5240748|NCT00841269|12885650|P2|NOT COMPLETED|Overall Study||9
5240749|NCT00841269|12885651|P1|NOT COMPLETED|Overall Study||8
5240750|NCT00841269|12885650|P2|COMPLETED|Overall Study||13
5240751|NCT00841269|12885651|P1|COMPLETED|Overall Study||12
5240752|NCT00841269|12885650|P2|STARTED|Overall Study||22
5240753|NCT00841269|12885651|P1|STARTED|Overall Study||20
5240754|NCT00841204|12885662|P2|NOT COMPLETED|Overall Study||0
5240755|NCT00841204|12885663|P1|NOT COMPLETED|Overall Study||0
5240756|NCT00841204|12885662|P2|COMPLETED|Overall Study||25
5240757|NCT00841204|12885663|P1|COMPLETED|Overall Study||25
5240758|NCT00841204|12885662|P2|STARTED|Overall Study||25
5240759|NCT00841204|12885663|P1|STARTED|Overall Study||25
5240760|NCT00841100|12885683|P1|NOT COMPLETED|Phase 3 (28 Days)||0
5240761|NCT00841100|12885683|P1|COMPLETED|Phase 3 (28 Days)||4
5240762|NCT00841100|12885683|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
5240763|NCT00841100|12885683|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
5240764|NCT00841100|12885683|P1|COMPLETED|Phase 2 (2 Weeks)||5
5240765|NCT00841100|12885683|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
5240766|NCT00841100|12885683|P1|NOT COMPLETED|Phase 1 (28 Days)||3
5240767|NCT00841100|12885683|P1|COMPLETED|Phase 1 (28 Days)||15
5240768|NCT00841100|12885683|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
5240769|NCT00841100|12885683|P1|NOT COMPLETED|Acute Component (24 Hours)||0
5240770|NCT00841100|12885683|P1|COMPLETED|Acute Component (24 Hours)||21
5240771|NCT00841100|12885683|P1|STARTED|Acute Component (24 Hours)||21
5240772|NCT00841087|12885689|P2|NOT COMPLETED|Overall Study||0
5240773|NCT00841087|12885690|P1|NOT COMPLETED|Overall Study||0
5240774|NCT00841087|12885689|P2|COMPLETED|Overall Study||32
5240775|NCT00841087|12885690|P1|COMPLETED|Overall Study||33
5240776|NCT00841087|12885689|P2|STARTED|Overall Study||32
5240777|NCT00841087|12885690|P1|STARTED|Overall Study||33
5240778|NCT00841035|12885708|P1|NOT COMPLETED|Phase 2 of Overall Study||0
5240779|NCT00841035|12885708|P1|COMPLETED|Phase 2 of Overall Study||6
5240780|NCT00841035|12885708|P1|STARTED|Phase 2 of Overall Study||6
5240781|NCT00841035|12885708|P1|NOT COMPLETED|Phase 1 Overall Study||13
5240782|NCT00841035|12885708|P1|COMPLETED|Phase 1 Overall Study||6
5240783|NCT00841035|12885708|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
5240784|NCT00840996|12885715|P2|NOT COMPLETED|Overall Study||0
5240785|NCT00840996|12885716|P1|NOT COMPLETED|Overall Study||1
5240786|NCT00840996|12885715|P2|COMPLETED|Overall Study||58
5240787|NCT00840996|12885716|P1|COMPLETED|Overall Study||57
5240788|NCT00840996|12885715|P2|STARTED|Overall Study||58
5240789|NCT00840996|12885716|P1|STARTED|Overall Study||58
5240790|NCT00840879|12885736|P2|NOT COMPLETED|Second Intervention||0
5240791|NCT00840879|12885737|P1|NOT COMPLETED|Second Intervention||1
5240792|NCT00840879|12885736|P2|COMPLETED|Second Intervention||14
5240793|NCT00840879|12885737|P1|COMPLETED|Second Intervention||13
5240794|NCT00840879|12885736|P2|STARTED|Second Intervention||14
5240795|NCT00840879|12885737|P1|STARTED|Second Intervention||14
5240796|NCT00840879|12885736|P2|NOT COMPLETED|Washout: 14 Days||0
5240797|NCT00840879|12885737|P1|NOT COMPLETED|Washout: 14 Days||0
5240798|NCT00840879|12885736|P2|COMPLETED|Washout: 14 Days||14
5240799|NCT00840879|12885737|P1|COMPLETED|Washout: 14 Days||14
5240800|NCT00840879|12885736|P2|STARTED|Washout: 14 Days||14
5240801|NCT00840879|12885737|P1|STARTED|Washout: 14 Days||14
5240802|NCT00840879|12885736|P2|NOT COMPLETED|First Intervention||0
5240803|NCT00840879|12885737|P1|NOT COMPLETED|First Intervention||0
5240804|NCT00840879|12885736|P2|COMPLETED|First Intervention||14
5240805|NCT00840879|12885737|P1|COMPLETED|First Intervention||14
5240806|NCT00840879|12885736|P2|STARTED|First Intervention||14
5240807|NCT00840879|12885737|P1|STARTED|First Intervention||14
5240808|NCT00840866|12885747|P2|NOT COMPLETED|Second Intervention||0
5240809|NCT00840866|12885748|P1|NOT COMPLETED|Second Intervention||0
5240810|NCT00840866|12885747|P2|COMPLETED|Second Intervention||19
5240811|NCT00840866|12885748|P1|COMPLETED|Second Intervention||20
5240812|NCT00840866|12885747|P2|STARTED|Second Intervention||19
5240813|NCT00840866|12885748|P1|STARTED|Second Intervention||20
5240814|NCT00840866|12885747|P2|NOT COMPLETED|Washout of 7 Days||0
5240815|NCT00840866|12885748|P1|NOT COMPLETED|Washout of 7 Days||0
5240816|NCT00840866|12885747|P2|COMPLETED|Washout of 7 Days||19
5240817|NCT00840866|12885748|P1|COMPLETED|Washout of 7 Days||20
5240818|NCT00840866|12885747|P2|STARTED|Washout of 7 Days||19
5240819|NCT00840866|12885748|P1|STARTED|Washout of 7 Days||20
5240820|NCT00840866|12885747|P2|NOT COMPLETED|First Intervention||0
5240821|NCT00840866|12885748|P1|NOT COMPLETED|First Intervention||0
5240822|NCT00840866|12885747|P2|COMPLETED|First Intervention||19
5240823|NCT00840866|12885748|P1|COMPLETED|First Intervention||20
5240824|NCT00840866|12885747|P2|STARTED|First Intervention||19
5240825|NCT00840866|12885748|P1|STARTED|First Intervention||20
5240826|NCT00840840|12885758|P2|NOT COMPLETED|Period 2||0
5240827|NCT00840840|12885759|P1|NOT COMPLETED|Period 2||0
5240828|NCT00840840|12885758|P2|COMPLETED|Period 2||24
5240829|NCT00840840|12885759|P1|COMPLETED|Period 2||23
5240830|NCT00840840|12885758|P2|STARTED|Period 2||24
5240831|NCT00840840|12885759|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
5240832|NCT00840840|12885758|P2|NOT COMPLETED|Period 1||0
5240833|NCT00840840|12885759|P1|NOT COMPLETED|Period 1||0
5240834|NCT00840840|12885758|P2|COMPLETED|Period 1||24
5240835|NCT00840840|12885759|P1|COMPLETED|Period 1||24
5240836|NCT00840840|12885758|P2|STARTED|Period 1||24
5240837|NCT00840840|12885759|P1|STARTED|Period 1||24
5240838|NCT00840827|12885773|P1|NOT COMPLETED|Overall Study||6
5240839|NCT00840827|12885773|P1|COMPLETED|Overall Study||0
5240840|NCT00840827|12885773|P1|STARTED|Overall Study||6
5240841|NCT00840749|12885788|P2|NOT COMPLETED|Overall Study||27
5240842|NCT00840749|12885789|P1|NOT COMPLETED|Overall Study||31
5240843|NCT00840749|12885788|P2|COMPLETED|Overall Study||0
5240844|NCT00840749|12885789|P1|COMPLETED|Overall Study||0
5240845|NCT00840749|12885788|P2|36 Months Post tx|Overall Study||0
5240846|NCT00840749|12885789|P1|36 Months Post tx|Overall Study||1
5240847|NCT00840749|12885788|P2|24 Months Post tx|Overall Study||3
5240848|NCT00840749|12885789|P1|24 Months Post tx|Overall Study||9
5240849|NCT00840749|12885788|P2|18 Months Post tx|Overall Study||6
5240850|NCT00840749|12885789|P1|18 Months Post tx|Overall Study||12
5240851|NCT00840749|12885788|P2|12 Months Post tx|Overall Study||7
5240852|NCT00840749|12885789|P1|12 Months Post tx|Overall Study||14
5240853|NCT00840749|12885788|P2|6 Months Post tx|Overall Study||10
5240854|NCT00840749|12885789|P1|6 Months Post tx|Overall Study||16
5240855|NCT00840749|12885788|P2|1 Month Post tx|Overall Study||15
5240856|NCT00840749|12885789|P1|1 Month Post tx|Overall Study||19
5240857|NCT00840749|12885788|P2|Treatment|Overall Study||16
5240858|NCT00840749|12885789|P1|Treatment|Overall Study||20
5240859|NCT00840749|12885788|P2|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
5240860|NCT00840749|12885789|P1|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
5240861|NCT00840658|12885801|P4|NOT COMPLETED|Overall Study||4
5240862|NCT00840658|12885802|P3|NOT COMPLETED|Overall Study||5
5240863|NCT00840658|12885803|P2|NOT COMPLETED|Overall Study||3
5240864|NCT00840658|12885804|P1|NOT COMPLETED|Overall Study||5
5240865|NCT00840658|12885801|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
5240866|NCT00840658|12885802|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
5240867|NCT00840658|12885803|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
5240868|NCT00840658|12885804|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
5240869|NCT00840658|12885801|P4|STARTED|Overall Study||146
5240870|NCT00840658|12885802|P3|STARTED|Overall Study||148
5240871|NCT00840658|12885803|P2|STARTED|Overall Study||146
5240872|NCT00840658|12885804|P1|STARTED|Overall Study||144
5240873|NCT00840632|12885822|P2|NOT COMPLETED|Second Intervention||0
5240874|NCT00840632|12885823|P1|NOT COMPLETED|Second Intervention||0
5240875|NCT00840632|12885822|P2|COMPLETED|Second Intervention||18
5240876|NCT00840632|12885823|P1|COMPLETED|Second Intervention||19
5240877|NCT00840632|12885822|P2|STARTED|Second Intervention||18
5240878|NCT00840632|12885823|P1|STARTED|Second Intervention||19
5240879|NCT00840632|12885822|P2|NOT COMPLETED|Washout||1
5240880|NCT00840632|12885823|P1|NOT COMPLETED|Washout||1
5240881|NCT00840632|12885822|P2|COMPLETED|Washout||18
5240882|NCT00840632|12885823|P1|COMPLETED|Washout||19
5240883|NCT00840632|12885822|P2|STARTED|Washout||19
5240884|NCT00840632|12885823|P1|STARTED|Washout||20
5240885|NCT00840632|12885822|P2|NOT COMPLETED|First Intervention||1
5240886|NCT00840632|12885823|P1|NOT COMPLETED|First Intervention||0
5240887|NCT00840632|12885822|P2|COMPLETED|First Intervention||19
5240888|NCT00840632|12885823|P1|COMPLETED|First Intervention||20
5240889|NCT00840632|12885822|P2|STARTED|First Intervention||20
5240890|NCT00840632|12885823|P1|STARTED|First Intervention||20
5240891|NCT00840476|12885839|P2|NOT COMPLETED|Second Intervention||0
5240892|NCT00840476|12885840|P1|NOT COMPLETED|Second Intervention||0
5240893|NCT00840476|12885839|P2|COMPLETED|Second Intervention||14
5240894|NCT00840476|12885840|P1|COMPLETED|Second Intervention||14
5240895|NCT00840476|12885839|P2|STARTED|Second Intervention||14
5240896|NCT00840476|12885840|P1|STARTED|Second Intervention||14
5240897|NCT00840476|12885839|P2|NOT COMPLETED|Washout: 14 Days||0
5240898|NCT00840476|12885840|P1|NOT COMPLETED|Washout: 14 Days||0
5240899|NCT00840476|12885839|P2|COMPLETED|Washout: 14 Days||14
5240900|NCT00840476|12885840|P1|COMPLETED|Washout: 14 Days||14
5240901|NCT00840476|12885839|P2|STARTED|Washout: 14 Days||14
5240902|NCT00840476|12885840|P1|STARTED|Washout: 14 Days||14
5240903|NCT00840476|12885839|P2|NOT COMPLETED|First Intervention||0
5240904|NCT00840476|12885840|P1|NOT COMPLETED|First Intervention||0
5240905|NCT00840476|12885839|P2|COMPLETED|First Intervention||14
5240906|NCT00840476|12885840|P1|COMPLETED|First Intervention||14
5240907|NCT00840476|12885839|P2|STARTED|First Intervention||14
5240908|NCT00840476|12885840|P1|STARTED|First Intervention||14
5240909|NCT00840463|12885850|P2|NOT COMPLETED|Overall Study||0
5240910|NCT00840463|12885851|P1|NOT COMPLETED|Overall Study||1
5240911|NCT00840463|12885850|P2|COMPLETED|Overall Study||1
5240912|NCT00840463|12885851|P1|COMPLETED|Overall Study||2
5240913|NCT00840463|12885850|P2|STARTED|Overall Study||1
5240914|NCT00840463|12885851|P1|STARTED|Overall Study||3
5240915|NCT00840450|12885865|P1|NOT COMPLETED|Overall Study||3
5240916|NCT00840450|12885865|P1|COMPLETED|Overall Study||9
5240917|NCT00840450|12885865|P1|STARTED|Overall Study||12
5240918|NCT00840411|12885873|P2|NOT COMPLETED|Second Intervention||0
5240919|NCT00840411|12885874|P1|NOT COMPLETED|Second Intervention||0
5240920|NCT00840411|12885873|P2|COMPLETED|Second Intervention||33
5240921|NCT00840411|12885874|P1|COMPLETED|Second Intervention||31
5240922|NCT00840411|12885873|P2|STARTED|Second Intervention||33
5240923|NCT00840411|12885874|P1|STARTED|Second Intervention||31
5240924|NCT00840411|12885873|P2|NOT COMPLETED|Washout||0
5240925|NCT00840411|12885874|P1|NOT COMPLETED|Washout||1
5240926|NCT00840411|12885873|P2|COMPLETED|Washout||33
5240927|NCT00840411|12885874|P1|COMPLETED|Washout||31
5240928|NCT00840411|12885873|P2|STARTED|Washout||33
5240929|NCT00840411|12885874|P1|STARTED|Washout||32
5240930|NCT00840411|12885873|P2|NOT COMPLETED|First Intervention||0
5240931|NCT00840411|12885874|P1|NOT COMPLETED|First Intervention||1
5240932|NCT00840411|12885873|P2|COMPLETED|First Intervention||33
5240933|NCT00840411|12885874|P1|COMPLETED|First Intervention||32
5240934|NCT00840411|12885873|P2|STARTED|First Intervention||33
5240935|NCT00840411|12885874|P1|STARTED|First Intervention||33
5240936|NCT00840307|12885882|P1|NOT COMPLETED|Overall Study||4
5240937|NCT00840307|12885882|P1|COMPLETED|Overall Study||16
5240938|NCT00840307|12885882|P1|STARTED|Overall Study||20
5240939|NCT00840294|12885888|P2|NOT COMPLETED|Overall Study||5
5240940|NCT00840294|12885889|P1|NOT COMPLETED|Overall Study||3
5240941|NCT00840294|12885888|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
5240942|NCT00840294|12885889|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
5240943|NCT00840294|12885888|P2|STARTED|Overall Study||43
5240944|NCT00840294|12885889|P1|STARTED|Overall Study||42
5240945|NCT00840281|12885899|P2|NOT COMPLETED|Second Intervention||0
5240946|NCT00840281|12885900|P1|NOT COMPLETED|Second Intervention||0
5240947|NCT00840281|12885899|P2|COMPLETED|Second Intervention||19
5240948|NCT00840281|12885900|P1|COMPLETED|Second Intervention||19
5240949|NCT00840281|12885899|P2|STARTED|Second Intervention||19
5240950|NCT00840281|12885900|P1|STARTED|Second Intervention||19
5240951|NCT00840281|12885899|P2|NOT COMPLETED|Washout of 7 Days||0
5240952|NCT00840281|12885900|P1|NOT COMPLETED|Washout of 7 Days||0
5240953|NCT00840281|12885899|P2|COMPLETED|Washout of 7 Days||19
5240954|NCT00840281|12885900|P1|COMPLETED|Washout of 7 Days||19
5240955|NCT00840281|12885899|P2|STARTED|Washout of 7 Days||19
5240956|NCT00840281|12885900|P1|STARTED|Washout of 7 Days||19
5240957|NCT00840281|12885899|P2|NOT COMPLETED|First Intervention||0
5240958|NCT00840281|12885900|P1|NOT COMPLETED|First Intervention||0
5240959|NCT00840281|12885899|P2|COMPLETED|First Intervention||19
5240960|NCT00840281|12885900|P1|COMPLETED|First Intervention||19
5240961|NCT00840281|12885899|P2|STARTED|First Intervention||19
5240962|NCT00840281|12885900|P1|STARTED|First Intervention||19
5240963|NCT00840216|12885910|P2|NOT COMPLETED|Second Intervention||0
5240964|NCT00840216|12885911|P1|NOT COMPLETED|Second Intervention||0
5240965|NCT00840216|12885910|P2|COMPLETED|Second Intervention||11
5240966|NCT00840216|12885911|P1|COMPLETED|Second Intervention||10
5240967|NCT00840216|12885910|P2|STARTED|Second Intervention||11
5240968|NCT00840216|12885911|P1|STARTED|Second Intervention||10
5240969|NCT00840216|12885910|P2|NOT COMPLETED|Washout: 7 Days||0
5240970|NCT00840216|12885911|P1|NOT COMPLETED|Washout: 7 Days||1
5240971|NCT00840216|12885910|P2|COMPLETED|Washout: 7 Days||11
5240972|NCT00840216|12885911|P1|COMPLETED|Washout: 7 Days||10
5240973|NCT00840216|12885910|P2|STARTED|Washout: 7 Days||11
5240974|NCT00840216|12885911|P1|STARTED|Washout: 7 Days||11
5240975|NCT00840216|12885910|P2|NOT COMPLETED|First Intervention||0
5240976|NCT00840216|12885911|P1|NOT COMPLETED|First Intervention||0
5240977|NCT00840216|12885910|P2|COMPLETED|First Intervention||11
5240978|NCT00840216|12885911|P1|COMPLETED|First Intervention||11
5240979|NCT00840216|12885910|P2|STARTED|First Intervention||11
5240980|NCT00840216|12885911|P1|STARTED|First Intervention||11
5240981|NCT00840203|12885921|P2|NOT COMPLETED|Second Intervention||0
5240982|NCT00840203|12885922|P1|NOT COMPLETED|Second Intervention||0
5240983|NCT00840203|12885921|P2|COMPLETED|Second Intervention||34
5240984|NCT00840203|12885922|P1|COMPLETED|Second Intervention||35
5240985|NCT00840203|12885921|P2|STARTED|Second Intervention||34
5240986|NCT00840203|12885922|P1|STARTED|Second Intervention||35
5240987|NCT00840203|12885921|P2|NOT COMPLETED|Washout||0
5240988|NCT00840203|12885922|P1|NOT COMPLETED|Washout||1
5240989|NCT00840203|12885921|P2|COMPLETED|Washout||34
5240990|NCT00840203|12885922|P1|COMPLETED|Washout||35
5240991|NCT00840203|12885921|P2|STARTED|Washout||34
5240992|NCT00840203|12885922|P1|STARTED|Washout||36
5240993|NCT00840203|12885921|P2|NOT COMPLETED|First Intervention||1
5240994|NCT00840203|12885922|P1|NOT COMPLETED|First Intervention||1
5240995|NCT00840203|12885921|P2|COMPLETED|First Intervention||34
5240996|NCT00840203|12885922|P1|COMPLETED|First Intervention||36
5240997|NCT00840203|12885921|P2|STARTED|First Intervention||35
5240998|NCT00840203|12885922|P1|STARTED|First Intervention||37
5240999|NCT00840177|12885939|P3|NOT COMPLETED|Overall Study||11
5241000|NCT00840177|12885940|P2|NOT COMPLETED|Overall Study||9
5241001|NCT00840177|12885941|P1|NOT COMPLETED|Overall Study||18
5241002|NCT00840177|12885939|P3|COMPLETED|Overall Study||39
5241003|NCT00840177|12885940|P2|COMPLETED|Overall Study||20
5241004|NCT00840177|12885941|P1|COMPLETED|Overall Study||18
5241005|NCT00840177|12885939|P3|Assessed for AEs|Overall Study||46
5241006|NCT00840177|12885940|P2|Assessed for AEs|Overall Study||29
5241007|NCT00840177|12885941|P1|Assessed for AEs|Overall Study||35
5241008|NCT00840177|12885939|P3|Treated|Overall Study||46
5241009|NCT00840177|12885940|P2|Treated|Overall Study||29
5241010|NCT00840177|12885941|P1|Treated|Overall Study||36
5241011|NCT00840177|12885939|P3|STARTED|Overall Study||50
5241012|NCT00840177|12885940|P2|STARTED|Overall Study||29
5241013|NCT00840177|12885941|P1|STARTED|Overall Study||36
5241014|NCT00840099|12885960|P2|NOT COMPLETED|Period 2||0
5241015|NCT00840099|12885961|P1|NOT COMPLETED|Period 2||0
5241016|NCT00840099|12885960|P2|COMPLETED|Period 2||24
5241017|NCT00840099|12885961|P1|COMPLETED|Period 2||21
5241018|NCT00840099|12885960|P2|STARTED|Period 2||24
5241019|NCT00840099|12885961|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
5241020|NCT00840099|12885960|P2|NOT COMPLETED|Period 1||0
5241021|NCT00840099|12885961|P1|NOT COMPLETED|Period 1||0
5241022|NCT00840099|12885960|P2|COMPLETED|Period 1||24
5241023|NCT00840099|12885961|P1|COMPLETED|Period 1||24
5241024|NCT00840099|12885960|P2|STARTED|Period 1||24
5241025|NCT00840099|12885961|P1|STARTED|Period 1||24
5241026|NCT00840086|12885975|P1|NOT COMPLETED|Overall Study||4
5241027|NCT00840086|12885975|P1|COMPLETED|Overall Study||146
5241028|NCT00840086|12885975|P1|STARTED|Overall Study||150
5241029|NCT00840073|12885984|P2|NOT COMPLETED|Second Intervention||1
5241030|NCT00840073|12885985|P1|NOT COMPLETED|Second Intervention||1
5241031|NCT00840073|12885984|P2|COMPLETED|Second Intervention||24
5241032|NCT00840073|12885985|P1|COMPLETED|Second Intervention||24
5241033|NCT00840073|12885984|P2|STARTED|Second Intervention||25
5241034|NCT00840073|12885985|P1|STARTED|Second Intervention||25
5241035|NCT00840073|12885984|P2|NOT COMPLETED|First Intervention||0
5241036|NCT00840073|12885985|P1|NOT COMPLETED|First Intervention||0
5241037|NCT00840073|12885984|P2|COMPLETED|First Intervention||25
5241038|NCT00840073|12885985|P1|COMPLETED|First Intervention||25
5241039|NCT00840073|12885984|P2|STARTED|First Intervention||25
5241040|NCT00840073|12885985|P1|STARTED|First Intervention||25
5241041|NCT00840060|12885999|P2|NOT COMPLETED|Overall Study||1
5241042|NCT00840060|12886000|P1|NOT COMPLETED|Overall Study||1
5241043|NCT00840060|12885999|P2|COMPLETED|Overall Study||19
5241044|NCT00840060|12886000|P1|COMPLETED|Overall Study||19
5241045|NCT00840060|12885999|P2|STARTED|Overall Study||20
5241046|NCT00840060|12886000|P1|STARTED|Overall Study||20
5241047|NCT00840034|12886010|P2|NOT COMPLETED|Taper Phase||2
5241048|NCT00840034|12886011|P1|NOT COMPLETED|Taper Phase||3
5241049|NCT00840034|12886010|P2|COMPLETED|Taper Phase||80
5241050|NCT00840034|12886011|P1|COMPLETED|Taper Phase||87
5241051|NCT00840034|12886010|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
5241052|NCT00840034|12886011|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
5241053|NCT00840034|12886010|P2|NOT COMPLETED|Acute Treatment Phase||36
5241054|NCT00840034|12886011|P1|NOT COMPLETED|Acute Treatment Phase||21
5241055|NCT00840034|12886010|P2|COMPLETED|Acute Treatment Phase||80
5241056|NCT00840034|12886011|P1|COMPLETED|Acute Treatment Phase||90
5241057|NCT00840034|12886010|P2|STARTED|Acute Treatment Phase||116
5241058|NCT00840034|12886011|P1|STARTED|Acute Treatment Phase||111
5241059|NCT00839982|12886047|P4|NOT COMPLETED|Overall Study||0
5241060|NCT00839982|12886048|P3|NOT COMPLETED|Overall Study||0
5241061|NCT00839982|12886049|P2|NOT COMPLETED|Overall Study||0
5241062|NCT00839982|12886050|P1|NOT COMPLETED|Overall Study||0
5241063|NCT00839982|12886047|P4|COMPLETED|Overall Study||3
5241064|NCT00839982|12886048|P3|COMPLETED|Overall Study||2
5241065|NCT00839982|12886049|P2|COMPLETED|Overall Study||26
5241066|NCT00839982|12886050|P1|COMPLETED|Overall Study||4
5241067|NCT00839982|12886047|P4|STARTED|Overall Study||3
5241068|NCT00839982|12886048|P3|STARTED|Overall Study||2
5241069|NCT00839982|12886049|P2|STARTED|Overall Study||26
5241070|NCT00839982|12886050|P1|STARTED|Overall Study||4
5241071|NCT00839956|12886064|P1|NOT COMPLETED|Overall Study||12
5241072|NCT00839956|12886064|P1|COMPLETED|Overall Study||19
5241073|NCT00839956|12886064|P1|STARTED|Overall Study||31
5241074|NCT00839930|12886073|P2|NOT COMPLETED|Second Intervention||0
5241075|NCT00839930|12886074|P1|NOT COMPLETED|Second Intervention||0
5241076|NCT00839930|12886073|P2|COMPLETED|Second Intervention||15
5241077|NCT00839930|12886074|P1|COMPLETED|Second Intervention||15
5241078|NCT00839930|12886073|P2|STARTED|Second Intervention||15
5241079|NCT00839930|12886074|P1|STARTED|Second Intervention||15
5241080|NCT00839930|12886073|P2|NOT COMPLETED|Washout: 7 Days||0
5241081|NCT00839930|12886074|P1|NOT COMPLETED|Washout: 7 Days||0
5241082|NCT00839930|12886073|P2|COMPLETED|Washout: 7 Days||15
5241083|NCT00839930|12886074|P1|COMPLETED|Washout: 7 Days||15
5241084|NCT00839930|12886073|P2|STARTED|Washout: 7 Days||15
5241085|NCT00839930|12886074|P1|STARTED|Washout: 7 Days||15
5241086|NCT00839930|12886073|P2|NOT COMPLETED|First Intervention||0
5241087|NCT00839930|12886074|P1|NOT COMPLETED|First Intervention||0
5241088|NCT00839930|12886073|P2|COMPLETED|First Intervention||15
5241089|NCT00839930|12886074|P1|COMPLETED|First Intervention||15
5241090|NCT00839930|12886073|P2|STARTED|First Intervention||15
5241091|NCT00839930|12886074|P1|STARTED|First Intervention||15
5241092|NCT00839917|12886084|P2|NOT COMPLETED|Overall Study||1
5241093|NCT00839917|12886085|P1|NOT COMPLETED|Overall Study||1
5241094|NCT00839917|12886084|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
5241095|NCT00839917|12886085|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
5241096|NCT00839917|12886084|P2|STARTED|Overall Study||17
5241097|NCT00839917|12886085|P1|STARTED|Overall Study||13
5241098|NCT00839852|12886121|P1|NOT COMPLETED|Overall Study||47
5241099|NCT00839852|12886121|P1|COMPLETED|Overall Study||46
5241100|NCT00839852|12886121|P1|STARTED|Overall Study||93
5241101|NCT00839800|12886128|P2|NOT COMPLETED|Overall Study||110
5241102|NCT00839800|12886129|P1|NOT COMPLETED|Overall Study||93
5241103|NCT00839800|12886128|P2|COMPLETED|Overall Study||932
5241104|NCT00839800|12886129|P1|COMPLETED|Overall Study||956
5241105|NCT00839800|12886128|P2|STARTED|Overall Study||1042
5241106|NCT00839800|12886129|P1|STARTED|Overall Study||1049
5241107|NCT00839540|12886162|P3|NOT COMPLETED|Overall Study||0
5241108|NCT00839540|12886163|P2|NOT COMPLETED|Overall Study||0
5241109|NCT00839540|12886164|P1|NOT COMPLETED|Overall Study||0
5241110|NCT00839540|12886162|P3|COMPLETED|Overall Study||5
5241111|NCT00839540|12886163|P2|COMPLETED|Overall Study||8
5241112|NCT00839540|12886164|P1|COMPLETED|Overall Study||8
5241113|NCT00839540|12886162|P3|STARTED|Overall Study||5
5241114|NCT00839540|12886163|P2|STARTED|Overall Study||8
5241115|NCT00839540|12886164|P1|STARTED|Overall Study||8
5241116|NCT00839527|12886175|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
5241117|NCT00839527|12886176|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
5241118|NCT00839527|12886177|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
5241119|NCT00839527|12886175|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
5241120|NCT00839527|12886176|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
5241121|NCT00839527|12886177|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
5241122|NCT00839527|12886175|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
5241123|NCT00839527|12886176|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
5241124|NCT00839527|12886177|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
5241125|NCT00839527|12886175|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
5241126|NCT00839527|12886176|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
5241127|NCT00839527|12886177|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
5241128|NCT00839527|12886175|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
5241129|NCT00839527|12886176|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
5241130|NCT00839527|12886177|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
5241131|NCT00839527|12886175|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
5241132|NCT00839527|12886176|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
5241133|NCT00839527|12886177|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
5241134|NCT00839436|12886212|P3|NOT COMPLETED|Overall Study||1
5241135|NCT00839436|12886213|P2|NOT COMPLETED|Overall Study||1
5241136|NCT00839436|12886214|P1|NOT COMPLETED|Overall Study||1
5241137|NCT00839436|12886212|P3|COMPLETED|Overall Study||0
5241138|NCT00839436|12886213|P2|COMPLETED|Overall Study||4
5241139|NCT00839436|12886214|P1|COMPLETED|Overall Study||2
5241140|NCT00839436|12886212|P3|STARTED|Overall Study||1
5241141|NCT00839436|12886213|P2|STARTED|Overall Study||5
5241142|NCT00839436|12886214|P1|STARTED|Overall Study||3
5241143|NCT00839423|12886226|P4|NOT COMPLETED|Overall Study||20
5241144|NCT00839423|12886227|P3|NOT COMPLETED|Overall Study||18
5241145|NCT00839423|12886228|P2|NOT COMPLETED|Overall Study||10
5241146|NCT00839423|12886229|P1|NOT COMPLETED|Overall Study||18
5241147|NCT00839423|12886226|P4|COMPLETED|Overall Study||93
5241148|NCT00839423|12886227|P3|COMPLETED|Overall Study||82
5241149|NCT00839423|12886228|P2|COMPLETED|Overall Study||98
5241150|NCT00839423|12886229|P1|COMPLETED|Overall Study||87
5241151|NCT00839423|12886226|P4|STARTED|Overall Study||113
5241152|NCT00839423|12886227|P3|STARTED|Overall Study||100
5241153|NCT00839423|12886228|P2|STARTED|Overall Study||108
5241154|NCT00839423|12886229|P1|STARTED|Overall Study||105
5241155|NCT00839332|12886270|P3|NOT COMPLETED|Phase 2||39
5241156|NCT00839332|12886271|P2|NOT COMPLETED|Phase 2||68
5241157|NCT00839332|12886272|P1|NOT COMPLETED|Phase 2||0
5241158|NCT00839332|12886270|P3|COMPLETED|Phase 2||0
5241159|NCT00839332|12886271|P2|COMPLETED|Phase 2||0
5241160|NCT00839332|12886272|P1|COMPLETED|Phase 2||0
5241161|NCT00839332|12886270|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
5241162|NCT00839332|12886271|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
5241163|NCT00839332|12886272|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
5241164|NCT00839332|12886270|P3|STARTED|Phase 2||39
5241165|NCT00839332|12886271|P2|STARTED|Phase 2||68
5241166|NCT00839332|12886272|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
5241167|NCT00839332|12886270|P3|NOT COMPLETED|Phase 1||0
5241168|NCT00839332|12886271|P2|NOT COMPLETED|Phase 1||0
5241169|NCT00839332|12886272|P1|NOT COMPLETED|Phase 1||50
5241170|NCT00839332|12886270|P3|COMPLETED|Phase 1||0
5241171|NCT00839332|12886271|P2|COMPLETED|Phase 1||0
5241172|NCT00839332|12886272|P1|COMPLETED|Phase 1||0
5241173|NCT00839332|12886270|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
5241174|NCT00839332|12886271|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
5241175|NCT00839332|12886272|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
5241176|NCT00839332|12886270|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
5241177|NCT00839332|12886271|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
5241178|NCT00839332|12886272|P1|STARTED|Phase 1||50
5241179|NCT00839319|12886300|P5|NOT COMPLETED|Overall Study||0
5241180|NCT00839319|12886301|P4|NOT COMPLETED|Overall Study||3
5241181|NCT00839319|12886302|P3|NOT COMPLETED|Overall Study||3
5241182|NCT00839319|12886303|P2|NOT COMPLETED|Overall Study||1
5241183|NCT00839319|12886304|P1|NOT COMPLETED|Overall Study||2
5241184|NCT00839319|12886300|P5|COMPLETED|Overall Study||8
5241185|NCT00839319|12886301|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
5241186|NCT00839319|12886302|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
5241187|NCT00839319|12886303|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
5241188|NCT00839319|12886304|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
5241189|NCT00839319|12886300|P5|STARTED|Overall Study||8
5241190|NCT00839319|12886301|P4|STARTED|Overall Study||8
5241191|NCT00839319|12886302|P3|STARTED|Overall Study||8
5241192|NCT00839319|12886303|P2|STARTED|Overall Study||8
5241193|NCT00839319|12886304|P1|STARTED|Overall Study||8
5241194|NCT00839306|12886333|P2|NOT COMPLETED|Overall Study||43
5241195|NCT00839306|12886334|P1|NOT COMPLETED|Overall Study||25
5241196|NCT00839306|12886333|P2|COMPLETED|Overall Study||134
5241197|NCT00839306|12886334|P1|COMPLETED|Overall Study||35
5241198|NCT00839306|12886333|P2|STARTED|Overall Study|Treated|177
5241199|NCT00839306|12886334|P1|STARTED|Overall Study|Treated|60
5241200|NCT00839254|12886350|P8|NOT COMPLETED|Overall Study||15
5241201|NCT00839254|12886351|P7|NOT COMPLETED|Overall Study||28
5241202|NCT00839254|12886352|P6|NOT COMPLETED|Overall Study||26
5241203|NCT00839254|12886353|P5|NOT COMPLETED|Overall Study||37
5241204|NCT00839254|12886354|P4|NOT COMPLETED|Overall Study||62
5241205|NCT00839254|12886355|P3|NOT COMPLETED|Overall Study||90
5241206|NCT00839254|12886356|P2|NOT COMPLETED|Overall Study||92
5241207|NCT00839254|12886357|P1|NOT COMPLETED|Overall Study||153
5241208|NCT00839254|12886350|P8|COMPLETED|Overall Study||256
5241209|NCT00839254|12886351|P7|COMPLETED|Overall Study||340
5241210|NCT00839254|12886352|P6|COMPLETED|Overall Study||178
5241211|NCT00839254|12886353|P5|COMPLETED|Overall Study||204
5241212|NCT00839254|12886354|P4|COMPLETED|Overall Study||797
5241213|NCT00839254|12886355|P3|COMPLETED|Overall Study||979
5241214|NCT00839254|12886356|P2|COMPLETED|Overall Study||1224
5241215|NCT00839254|12886357|P1|COMPLETED|Overall Study||1696
5241216|NCT00839254|12886350|P8|STARTED|Overall Study||271
5241217|NCT00839254|12886351|P7|STARTED|Overall Study||368
5241218|NCT00839254|12886352|P6|STARTED|Overall Study||204
5241219|NCT00839254|12886353|P5|STARTED|Overall Study||241
5241220|NCT00839254|12886354|P4|STARTED|Overall Study||859
5241221|NCT00839254|12886355|P3|STARTED|Overall Study||1069
5241222|NCT00839254|12886356|P2|STARTED|Overall Study||1316
5241223|NCT00839254|12886357|P1|STARTED|Overall Study||1849
5241224|NCT00839241|12886581|P2|NOT COMPLETED|Overall Study||17
5241225|NCT00839241|12886582|P1|NOT COMPLETED|Overall Study||5
5241226|NCT00839241|12886581|P2|COMPLETED|Overall Study||8
5241227|NCT00839241|12886582|P1|COMPLETED|Overall Study||15
5241228|NCT00839241|12886581|P2|STARTED|Overall Study||25
5241229|NCT00839241|12886582|P1|STARTED|Overall Study||20
5241230|NCT00839098|12886669|P3|NOT COMPLETED|Overall Study||7
5241231|NCT00839098|12886670|P2|NOT COMPLETED|Overall Study||1
5241232|NCT00839098|12886671|P1|NOT COMPLETED|Overall Study||2
5241233|NCT00839098|12886669|P3|COMPLETED|Overall Study||6
5241234|NCT00839098|12886670|P2|COMPLETED|Overall Study||11
5241235|NCT00839098|12886671|P1|COMPLETED|Overall Study||1
5241236|NCT00839098|12886669|P3|STARTED|Overall Study||13
5241237|NCT00839098|12886670|P2|STARTED|Overall Study||12
5241238|NCT00839098|12886671|P1|STARTED|Overall Study||3
5241239|NCT00839072|12886697|P2|NOT COMPLETED|Second Intervention Period||0
5241240|NCT00839072|12886698|P1|NOT COMPLETED|Second Intervention Period||1
5241241|NCT00839072|12886697|P2|COMPLETED|Second Intervention Period||11
5241242|NCT00839072|12886698|P1|COMPLETED|Second Intervention Period||9
5241243|NCT00839072|12886697|P2|STARTED|Second Intervention Period||11
5241244|NCT00839072|12886698|P1|STARTED|Second Intervention Period||10
5241245|NCT00839072|12886697|P2|NOT COMPLETED|Washout Period of 7 Days||0
5241246|NCT00839072|12886698|P1|NOT COMPLETED|Washout Period of 7 Days||0
5241247|NCT00839072|12886697|P2|COMPLETED|Washout Period of 7 Days||11
5241248|NCT00839072|12886698|P1|COMPLETED|Washout Period of 7 Days||10
5241249|NCT00839072|12886697|P2|STARTED|Washout Period of 7 Days||11
5241250|NCT00839072|12886698|P1|STARTED|Washout Period of 7 Days||10
5241251|NCT00839072|12886697|P2|NOT COMPLETED|First Intervention Period||1
5241252|NCT00839072|12886698|P1|NOT COMPLETED|First Intervention Period||2
5241253|NCT00839072|12886697|P2|COMPLETED|First Intervention Period||11
5241254|NCT00839072|12886698|P1|COMPLETED|First Intervention Period||10
5241255|NCT00839072|12886697|P2|STARTED|First Intervention Period||12
5241256|NCT00839072|12886698|P1|STARTED|First Intervention Period||12
5241257|NCT00838981|12886718|P4|NOT COMPLETED|Day 4 to Week 11||7
5241258|NCT00838981|12886719|P3|NOT COMPLETED|Day 4 to Week 11||11
5241259|NCT00838981|12886720|P2|NOT COMPLETED|Day 4 to Week 11||8
5241260|NCT00838981|12886721|P1|NOT COMPLETED|Day 4 to Week 11||7
5241261|NCT00838981|12886718|P4|COMPLETED|Day 4 to Week 11||12
5241262|NCT00838981|12886719|P3|COMPLETED|Day 4 to Week 11||16
5241263|NCT00838981|12886720|P2|COMPLETED|Day 4 to Week 11||11
5241264|NCT00838981|12886721|P1|COMPLETED|Day 4 to Week 11||19
5241265|NCT00838981|12886718|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
5241266|NCT00838981|12886719|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
5241267|NCT00838981|12886720|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
5241268|NCT00838981|12886721|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
5241269|NCT00838981|12886718|P4|STARTED|Day 4 to Week 11||19
5241270|NCT00838981|12886719|P3|STARTED|Day 4 to Week 11||27
5241271|NCT00838981|12886720|P2|STARTED|Day 4 to Week 11||19
5241272|NCT00838981|12886721|P1|STARTED|Day 4 to Week 11||26
5241273|NCT00838981|12886718|P4|NOT COMPLETED|Week 1 Days 1-3||0
5241274|NCT00838981|12886719|P3|NOT COMPLETED|Week 1 Days 1-3||0
5241275|NCT00838981|12886720|P2|NOT COMPLETED|Week 1 Days 1-3||0
5241276|NCT00838981|12886721|P1|NOT COMPLETED|Week 1 Days 1-3||0
5241277|NCT00838981|12886718|P4|COMPLETED|Week 1 Days 1-3||19
5241278|NCT00838981|12886719|P3|COMPLETED|Week 1 Days 1-3||27
5241279|NCT00838981|12886720|P2|COMPLETED|Week 1 Days 1-3||19
5241280|NCT00838981|12886721|P1|COMPLETED|Week 1 Days 1-3||26
5241281|NCT00838981|12886718|P4|STARTED|Week 1 Days 1-3||19
5241282|NCT00838981|12886719|P3|STARTED|Week 1 Days 1-3||27
5241283|NCT00838981|12886720|P2|STARTED|Week 1 Days 1-3||19
5241284|NCT00838981|12886721|P1|STARTED|Week 1 Days 1-3||26
5241285|NCT00838929|12886742|P3|NOT COMPLETED|Overall Study||1
5241286|NCT00838929|12886743|P2|NOT COMPLETED|Overall Study||3
5241287|NCT00838929|12886744|P1|NOT COMPLETED|Overall Study||0
5241288|NCT00838929|12886742|P3|COMPLETED|Overall Study||5
5241289|NCT00838929|12886743|P2|COMPLETED|Overall Study||5
5241290|NCT00838929|12886744|P1|COMPLETED|Overall Study||3
5241291|NCT00838929|12886742|P3|STARTED|Overall Study||6
5241292|NCT00838929|12886743|P2|STARTED|Overall Study||8
5241293|NCT00838929|12886744|P1|STARTED|Overall Study||3
5241294|NCT00838916|12886752|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
5241295|NCT00838916|12886753|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
5241296|NCT00838916|12886752|P2|COMPLETED|Follow-up Period (8 Weeks)||190
5241297|NCT00838916|12886753|P1|COMPLETED|Follow-up Period (8 Weeks)||408
5241298|NCT00838916|12886752|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
5241299|NCT00838916|12886753|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
5241300|NCT00838916|12886752|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
5241301|NCT00838916|12886753|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
5241302|NCT00838916|12886752|P2|COMPLETED|Treatment Period (156 Weeks)||164
5241303|NCT00838916|12886753|P1|COMPLETED|Treatment Period (156 Weeks)||308
5241304|NCT00838916|12886752|P2|STARTED|Treatment Period (156 Weeks)||241
5241305|NCT00838916|12886753|P1|STARTED|Treatment Period (156 Weeks)||504
5241306|NCT00838903|12886782|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
5241307|NCT00838903|12886783|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
5241308|NCT00838903|12886784|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
5241309|NCT00838903|12886785|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
5241310|NCT00838903|12886782|P4|COMPLETED|Follow-up Period (8 Weeks)||244
5241311|NCT00838903|12886783|P3|COMPLETED|Follow-up Period (8 Weeks)||243
5241312|NCT00838903|12886784|P2|COMPLETED|Follow-up Period (8 Weeks)||237
5241313|NCT00838903|12886785|P1|COMPLETED|Follow-up Period (8 Weeks)||75
5241314|NCT00838903|12886782|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
5241315|NCT00838903|12886783|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
5241316|NCT00838903|12886784|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
5241317|NCT00838903|12886785|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
5241318|NCT00838903|12886782|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
5241319|NCT00838903|12886783|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
5241320|NCT00838903|12886784|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
5241321|NCT00838903|12886785|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
5241322|NCT00838903|12886782|P4|COMPLETED|Treatment Period (156 Weeks)||192
5241323|NCT00838903|12886783|P3|COMPLETED|Treatment Period (156 Weeks)||191
5241324|NCT00838903|12886784|P2|COMPLETED|Treatment Period (156 Weeks)||190
5241325|NCT00838903|12886785|P1|COMPLETED|Treatment Period (156 Weeks)||55
5241326|NCT00838903|12886782|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
5241327|NCT00838903|12886783|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
5241328|NCT00838903|12886784|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
5241329|NCT00838903|12886785|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
5241330|NCT00838903|12886782|P4|STARTED|Treatment Period (156 Weeks)||302
5241331|NCT00838903|12886783|P3|STARTED|Treatment Period (156 Weeks)||307
5241332|NCT00838903|12886784|P2|STARTED|Treatment Period (156 Weeks)||302
5241333|NCT00838903|12886785|P1|STARTED|Treatment Period (156 Weeks)||101
5241334|NCT00838695|12886829|P2|NOT COMPLETED|Overall Study||0
5241335|NCT00838695|12886830|P1|NOT COMPLETED|Overall Study||0
5241336|NCT00838695|12886829|P2|COMPLETED|Overall Study||64
5241337|NCT00838695|12886830|P1|COMPLETED|Overall Study||42
5241338|NCT00838695|12886829|P2|STARTED|Overall Study||64
5241339|NCT00838695|12886830|P1|STARTED|Overall Study||42
5241340|NCT00838682|12886840|P2|NOT COMPLETED|Overall Study||19
5241341|NCT00838682|12886841|P1|NOT COMPLETED|Overall Study||25
5241342|NCT00838682|12886840|P2|COMPLETED|Overall Study||33
5241343|NCT00838682|12886841|P1|COMPLETED|Overall Study||29
5241344|NCT00838682|12886840|P2|STARTED|Overall Study||52
5241345|NCT00838682|12886841|P1|STARTED|Overall Study||54
5241346|NCT00838630|12886859|P2|NOT COMPLETED|Second Intervention||0
5241347|NCT00838630|12886860|P1|NOT COMPLETED|Second Intervention||0
5241348|NCT00838630|12886859|P2|COMPLETED|Second Intervention||18
5241349|NCT00838630|12886860|P1|COMPLETED|Second Intervention||16
5241350|NCT00838630|12886859|P2|STARTED|Second Intervention||18
5241351|NCT00838630|12886860|P1|STARTED|Second Intervention||16
5241352|NCT00838630|12886859|P2|NOT COMPLETED|Washout: 7 Days||0
5241353|NCT00838630|12886860|P1|NOT COMPLETED|Washout: 7 Days||1
5241354|NCT00838630|12886859|P2|COMPLETED|Washout: 7 Days||18
5241355|NCT00838630|12886860|P1|COMPLETED|Washout: 7 Days||16
5241356|NCT00838630|12886859|P2|STARTED|Washout: 7 Days||18
5241357|NCT00838630|12886860|P1|STARTED|Washout: 7 Days||17
5241358|NCT00838630|12886859|P2|NOT COMPLETED|First Intervention||0
5241359|NCT00838630|12886860|P1|NOT COMPLETED|First Intervention||1
5241360|NCT00838630|12886859|P2|COMPLETED|First Intervention||18
5241361|NCT00838630|12886860|P1|COMPLETED|First Intervention||17
5241362|NCT00838630|12886859|P2|STARTED|First Intervention||18
5241363|NCT00838630|12886860|P1|STARTED|First Intervention||18
5241364|NCT00838578|12886868|P1|NOT COMPLETED|Overall Study||2
5241365|NCT00838578|12886868|P1|COMPLETED|Overall Study||63
5241366|NCT00838578|12886868|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
5241367|NCT00838565|12886882|P6|NOT COMPLETED|Overall Study||2
5241368|NCT00838565|12886883|P5|NOT COMPLETED|Overall Study||0
5241369|NCT00838565|12886884|P4|NOT COMPLETED|Overall Study||0
5241370|NCT00838565|12886885|P3|NOT COMPLETED|Overall Study||1
5241371|NCT00838565|12886886|P2|NOT COMPLETED|Overall Study||3
5241372|NCT00838565|12886887|P1|NOT COMPLETED|Overall Study||0
5241373|NCT00838565|12886882|P6|COMPLETED|Overall Study||5
5241374|NCT00838565|12886883|P5|COMPLETED|Overall Study||6
5241375|NCT00838565|12886884|P4|COMPLETED|Overall Study||6
5241376|NCT00838565|12886885|P3|COMPLETED|Overall Study||5
5241377|NCT00838565|12886886|P2|COMPLETED|Overall Study||4
5241378|NCT00838565|12886887|P1|COMPLETED|Overall Study||9
5241379|NCT00838565|12886882|P6|Treated|Overall Study||7
5241380|NCT00838565|12886883|P5|Treated|Overall Study||6
5241381|NCT00838565|12886884|P4|Treated|Overall Study||6
5241382|NCT00838565|12886885|P3|Treated|Overall Study||6
5241383|NCT00838565|12886886|P2|Treated|Overall Study||6
5241384|NCT00838565|12886887|P1|Treated|Overall Study||9
5241385|NCT00838565|12886882|P6|STARTED|Overall Study||7
5241386|NCT00838565|12886883|P5|STARTED|Overall Study||6
5241387|NCT00838565|12886884|P4|STARTED|Overall Study||6
5241388|NCT00838565|12886885|P3|STARTED|Overall Study||6
5241389|NCT00838565|12886886|P2|STARTED|Overall Study||7
5241390|NCT00838565|12886887|P1|STARTED|Overall Study||9
5241391|NCT00838539|12886992|P12|NOT COMPLETED|Overall Study||4
5241392|NCT00838539|12886993|P11|NOT COMPLETED|Overall Study||5
5241393|NCT00838539|12886994|P10|NOT COMPLETED|Overall Study||8
5241394|NCT00838539|12886995|P9|NOT COMPLETED|Overall Study||5
5241395|NCT00838539|12886996|P8|NOT COMPLETED|Overall Study||6
5241396|NCT00838539|12886997|P7|NOT COMPLETED|Overall Study||5
5241397|NCT00838539|12886998|P6|NOT COMPLETED|Overall Study||4
5241398|NCT00838539|12886999|P5|NOT COMPLETED|Overall Study||6
5241399|NCT00838539|12887000|P4|NOT COMPLETED|Overall Study||4
5241400|NCT00838539|12887001|P3|NOT COMPLETED|Overall Study||5
5241401|NCT00838539|12887002|P2|NOT COMPLETED|Overall Study||6
5241402|NCT00838539|12887003|P1|NOT COMPLETED|Overall Study||3
5241403|NCT00838539|12886992|P12|COMPLETED|Overall Study||0
5241404|NCT00838539|12886993|P11|COMPLETED|Overall Study||0
5241405|NCT00838539|12886994|P10|COMPLETED|Overall Study||0
5241406|NCT00838539|12886995|P9|COMPLETED|Overall Study||0
5241407|NCT00838539|12886996|P8|COMPLETED|Overall Study||0
5241408|NCT00838539|12886997|P7|COMPLETED|Overall Study||2
5241409|NCT00838539|12886998|P6|COMPLETED|Overall Study||0
5241410|NCT00838539|12886999|P5|COMPLETED|Overall Study||0
5241411|NCT00838539|12887000|P4|COMPLETED|Overall Study||0
5241412|NCT00838539|12887001|P3|COMPLETED|Overall Study||0
5241413|NCT00838539|12887002|P2|COMPLETED|Overall Study||0
5241414|NCT00838539|12887003|P1|COMPLETED|Overall Study||0
5241415|NCT00838539|12886992|P12|Received Treatment|Overall Study||4
5241416|NCT00838539|12886993|P11|Received Treatment|Overall Study||5
5241417|NCT00838539|12886994|P10|Received Treatment|Overall Study||8
5241418|NCT00838539|12886995|P9|Received Treatment|Overall Study||5
5241419|NCT00838539|12886996|P8|Received Treatment|Overall Study||6
5241420|NCT00838539|12886997|P7|Received Treatment|Overall Study||7
5241421|NCT00838539|12886998|P6|Received Treatment|Overall Study||4
5241422|NCT00838539|12886999|P5|Received Treatment|Overall Study||4
5241423|NCT00838539|12887000|P4|Received Treatment|Overall Study||4
5241424|NCT00838539|12887001|P3|Received Treatment|Overall Study||5
5241425|NCT00838539|12887002|P2|Received Treatment|Overall Study||5
5241426|NCT00838539|12887003|P1|Received Treatment|Overall Study||3
5241427|NCT00838539|12886992|P12|STARTED|Overall Study||4
5241428|NCT00838539|12886993|P11|STARTED|Overall Study||5
5241429|NCT00838539|12886994|P10|STARTED|Overall Study||8
5241430|NCT00838539|12886995|P9|STARTED|Overall Study||5
5241431|NCT00838539|12886996|P8|STARTED|Overall Study||6
5241432|NCT00838539|12886997|P7|STARTED|Overall Study||7
5241433|NCT00838539|12886998|P6|STARTED|Overall Study||4
5241434|NCT00838539|12886999|P5|STARTED|Overall Study||6
5241435|NCT00838539|12887000|P4|STARTED|Overall Study||4
5241436|NCT00838539|12887001|P3|STARTED|Overall Study||5
5241437|NCT00838539|12887002|P2|STARTED|Overall Study||6
5241438|NCT00838539|12887003|P1|STARTED|Overall Study||3
5241439|NCT00838526|12887053|P2|NOT COMPLETED|Overall Study||39
5241440|NCT00838526|12887054|P1|NOT COMPLETED|Overall Study||24
5241441|NCT00838526|12887053|P2|COMPLETED|Overall Study||137
5241442|NCT00838526|12887054|P1|COMPLETED|Overall Study||35
5241443|NCT00838526|12887053|P2|STARTED|Overall Study|Treated|176
5241444|NCT00838526|12887054|P1|STARTED|Overall Study|Treated|59
5241445|NCT00838513|12887062|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
5241446|NCT00838513|12887062|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
5241447|NCT00838513|12887062|P1|STARTED|Post Treatment Period (Patients Who Disc||5
5241448|NCT00838513|12887062|P1|NOT COMPLETED|Extension Treatment Period||1
5241449|NCT00838513|12887062|P1|COMPLETED|Extension Treatment Period||18
5241450|NCT00838513|12887062|P1|STARTED|Extension Treatment Period||19
5241451|NCT00838513|12887062|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
5241452|NCT00838513|12887062|P1|COMPLETED|Treatment Period (26 Weeks)||20
5241453|NCT00838513|12887062|P1|STARTED|Treatment Period (26 Weeks)||20
5241454|NCT00838513|12887062|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
5241455|NCT00838513|12887062|P1|COMPLETED|Observation Period (8 Weeks)||20
5241456|NCT00838513|12887062|P1|STARTED|Observation Period (8 Weeks)||20
5241457|NCT00838513|12887062|P1|NOT COMPLETED|Screening Period||3
5241458|NCT00838513|12887062|P1|COMPLETED|Screening Period||20
5241459|NCT00838513|12887062|P1|STARTED|Screening Period||23
5241460|NCT00838331|12887078|P1|NOT COMPLETED|Aged Blood Transfusion||9
5241461|NCT00838331|12887078|P1|COMPLETED|Aged Blood Transfusion||8
5241462|NCT00838331|12887078|P1|STARTED|Aged Blood Transfusion||17
5241463|NCT00838331|12887078|P1|NOT COMPLETED|Fresh Blood Transfusion||0
5241464|NCT00838331|12887078|P1|COMPLETED|Fresh Blood Transfusion||17
5241465|NCT00838331|12887078|P1|STARTED|Fresh Blood Transfusion||17
5241466|NCT00838279|12887084|P2|NOT COMPLETED|Second Intervention||0
5241467|NCT00838279|12887085|P1|NOT COMPLETED|Second Intervention||0
5241468|NCT00838279|12887084|P2|COMPLETED|Second Intervention||15
5241469|NCT00838279|12887085|P1|COMPLETED|Second Intervention||15
5241470|NCT00838279|12887084|P2|STARTED|Second Intervention||15
5241471|NCT00838279|12887085|P1|STARTED|Second Intervention||15
5241472|NCT00838279|12887084|P2|NOT COMPLETED|Washout||1
5241473|NCT00838279|12887085|P1|NOT COMPLETED|Washout||1
5241474|NCT00838279|12887084|P2|COMPLETED|Washout||15
5241475|NCT00838279|12887085|P1|COMPLETED|Washout||15
5241476|NCT00838279|12887084|P2|STARTED|Washout||16
5241477|NCT00838279|12887085|P1|STARTED|Washout||16
5241478|NCT00838279|12887084|P2|NOT COMPLETED|First Intervention||0
5241479|NCT00838279|12887085|P1|NOT COMPLETED|First Intervention||0
5241480|NCT00838279|12887084|P2|COMPLETED|First Intervention||16
5241481|NCT00838279|12887085|P1|COMPLETED|First Intervention||16
5241482|NCT00838279|12887084|P2|STARTED|First Intervention||16
5241483|NCT00838279|12887085|P1|STARTED|First Intervention||16
5241484|NCT00838201|12887095|P2|NOT COMPLETED|Overall Study||53
5241485|NCT00838201|12887096|P1|NOT COMPLETED|Overall Study||42
5241486|NCT00838201|12887095|P2|COMPLETED|Overall Study||145
5241487|NCT00838201|12887096|P1|COMPLETED|Overall Study||144
5241488|NCT00838201|12887095|P2|STARTED|Overall Study||198
5241489|NCT00838201|12887096|P1|STARTED|Overall Study||186
5241490|NCT00838162|12887106|P4|NOT COMPLETED|Overall Study||0
5241491|NCT00838162|12887107|P3|NOT COMPLETED|Overall Study||0
5241492|NCT00838162|12887108|P2|NOT COMPLETED|Overall Study||0
5241493|NCT00838162|12887109|P1|NOT COMPLETED|Overall Study||0
5241494|NCT00838162|12887106|P4|COMPLETED|Overall Study||8
5241495|NCT00838162|12887107|P3|COMPLETED|Overall Study||8
5241496|NCT00838162|12887108|P2|COMPLETED|Overall Study||8
5241497|NCT00838162|12887109|P1|COMPLETED|Overall Study||9
5241498|NCT00838162|12887106|P4|STARTED|Overall Study||8
5241499|NCT00838162|12887107|P3|STARTED|Overall Study||8
5241500|NCT00838162|12887108|P2|STARTED|Overall Study||8
5241501|NCT00838162|12887109|P1|STARTED|Overall Study||9
5241502|NCT00838136|12887153|P2|NOT COMPLETED|Second Intervention||1
5241503|NCT00838136|12887154|P1|NOT COMPLETED|Second Intervention||0
5241504|NCT00838136|12887153|P2|COMPLETED|Second Intervention||15
5241505|NCT00838136|12887154|P1|COMPLETED|Second Intervention||16
5241506|NCT00838136|12887153|P2|STARTED|Second Intervention||16
5241507|NCT00838136|12887154|P1|STARTED|Second Intervention||16
5241508|NCT00838136|12887153|P2|NOT COMPLETED|First Intervention||0
5241509|NCT00838136|12887154|P1|NOT COMPLETED|First Intervention||0
5241510|NCT00838136|12887153|P2|COMPLETED|First Intervention||16
5241511|NCT00838136|12887154|P1|COMPLETED|First Intervention||16
5241512|NCT00838136|12887153|P2|STARTED|First Intervention||16
5241513|NCT00838136|12887154|P1|STARTED|First Intervention||16
5241514|NCT00838110|12887164|P4|NOT COMPLETED|Overall Study||18
5241515|NCT00838110|12887165|P3|NOT COMPLETED|Overall Study||17
5241516|NCT00838110|12887166|P2|NOT COMPLETED|Overall Study||22
5241517|NCT00838110|12887167|P1|NOT COMPLETED|Overall Study||22
5241518|NCT00838110|12887164|P4|COMPLETED|Overall Study||226
5241519|NCT00838110|12887165|P3|COMPLETED|Overall Study||226
5241520|NCT00838110|12887166|P2|COMPLETED|Overall Study||106
5241521|NCT00838110|12887167|P1|COMPLETED|Overall Study||105
5241522|NCT00838110|12887164|P4|Treated|Overall Study||244
5241523|NCT00838110|12887165|P3|Treated|Overall Study||243
5241524|NCT00838110|12887166|P2|Treated|Overall Study||127
5241525|NCT00838110|12887167|P1|Treated|Overall Study||127
5241526|NCT00838110|12887164|P4|STARTED|Overall Study||244
5241527|NCT00838110|12887165|P3|STARTED|Overall Study||243
5241528|NCT00838110|12887166|P2|STARTED|Overall Study||128
5241529|NCT00838110|12887167|P1|STARTED|Overall Study||127
5241530|NCT00838097|12887187|P1|NOT COMPLETED|Overall Study||176
5241531|NCT00838097|12887187|P1|COMPLETED|Overall Study||145
5241532|NCT00838097|12887187|P1|Received Darbepoetin Alfa|Overall Study||319
5241533|NCT00838097|12887187|P1|STARTED|Overall Study||321
5241534|NCT00838006|12887198|P3|NOT COMPLETED|Overall Study||48
5241535|NCT00838006|12887199|P2|NOT COMPLETED|Overall Study||26
5241536|NCT00838006|12887200|P1|NOT COMPLETED|Overall Study||34
5241537|NCT00838006|12887198|P3|COMPLETED|Overall Study||94
5241538|NCT00838006|12887199|P2|COMPLETED|Overall Study||72
5241539|NCT00838006|12887200|P1|COMPLETED|Overall Study||68
5241540|NCT00838006|12887198|P3|3-month Post-deployment Follow-up|Overall Study||135
5241541|NCT00838006|12887199|P2|3-month Post-deployment Follow-up|Overall Study||80
5241542|NCT00838006|12887200|P1|3-month Post-deployment Follow-up|Overall Study||92
5241543|NCT00838006|12887198|P3|STARTED|Overall Study||142
5241544|NCT00838006|12887199|P2|STARTED|Overall Study||98
5241545|NCT00838006|12887200|P1|STARTED|Overall Study||102
5241546|NCT00837967|12887211|P2|NOT COMPLETED|Second Intervention||0
5241547|NCT00837967|12887212|P1|NOT COMPLETED|Second Intervention||0
5241548|NCT00837967|12887211|P2|COMPLETED|Second Intervention||12
5241549|NCT00837967|12887212|P1|COMPLETED|Second Intervention||11
5241550|NCT00837967|12887211|P2|STARTED|Second Intervention||12
5241551|NCT00837967|12887212|P1|STARTED|Second Intervention||11
5241552|NCT00837967|12887211|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
5241553|NCT00837967|12887212|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
5241554|NCT00837967|12887211|P2|COMPLETED|Washout Period of 7 - 14 Days||12
5241555|NCT00837967|12887212|P1|COMPLETED|Washout Period of 7 - 14 Days||11
5241556|NCT00837967|12887211|P2|STARTED|Washout Period of 7 - 14 Days||12
5241557|NCT00837967|12887212|P1|STARTED|Washout Period of 7 - 14 Days||13
5241558|NCT00837967|12887211|P2|NOT COMPLETED|First Intervention||0
5241559|NCT00837967|12887212|P1|NOT COMPLETED|First Intervention||0
5241560|NCT00837967|12887211|P2|COMPLETED|First Intervention||12
5241561|NCT00837967|12887212|P1|COMPLETED|First Intervention||13
5241562|NCT00837967|12887211|P2|STARTED|First Intervention||12
5241563|NCT00837967|12887212|P1|STARTED|First Intervention||13
5241564|NCT00837902|12887230|P2|NOT COMPLETED|Overall Study||0
5241565|NCT00837902|12887231|P1|NOT COMPLETED|Overall Study||0
5241566|NCT00837902|12887230|P2|COMPLETED|Overall Study||69
5241567|NCT00837902|12887231|P1|COMPLETED|Overall Study||85
5241568|NCT00837902|12887230|P2|STARTED|Overall Study||69
5241569|NCT00837902|12887231|P1|STARTED|Overall Study||85
5241570|NCT00837876|12887238|P1|NOT COMPLETED|Overall Study||37
5241571|NCT00837876|12887238|P1|COMPLETED|Overall Study||0
5241572|NCT00837876|12887238|P1|STARTED|Overall Study||37
5241573|NCT00837824|12887247|P2|NOT COMPLETED|Overall Study||0
5241574|NCT00837824|12887248|P1|NOT COMPLETED|Overall Study||0
5241575|NCT00837824|12887247|P2|COMPLETED|Overall Study||9
5241576|NCT00837824|12887248|P1|COMPLETED|Overall Study||11
5241577|NCT00837824|12887247|P2|STARTED|Overall Study||9
5241578|NCT00837824|12887248|P1|STARTED|Overall Study||11
5241579|NCT00837811|12887260|P3|NOT COMPLETED|Overall Study||1
5241580|NCT00837811|12887261|P2|NOT COMPLETED|Overall Study||34
5241581|NCT00837811|12887262|P1|NOT COMPLETED|Overall Study||7
5241582|NCT00837811|12887260|P3|COMPLETED|Overall Study||0
5241583|NCT00837811|12887261|P2|COMPLETED|Overall Study||87
5241584|NCT00837811|12887262|P1|COMPLETED|Overall Study||53
5241585|NCT00837811|12887260|P3|Included in Efficacy Analyses|Overall Study||1
5241586|NCT00837811|12887261|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
5241587|NCT00837811|12887262|P1|Included in Efficacy Analyses|Overall Study||59
5241588|NCT00837811|12887260|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
5241589|NCT00837811|12887261|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
5241590|NCT00837811|12887262|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
5241591|NCT00837811|12887260|P3|Received Any Amount of Study Drug|Overall Study||1
5241592|NCT00837811|12887261|P2|Received Any Amount of Study Drug|Overall Study||121
5241593|NCT00837811|12887262|P1|Received Any Amount of Study Drug|Overall Study||60
5241594|NCT00837811|12887260|P3|STARTED|Overall Study||1
5241595|NCT00837811|12887261|P2|STARTED|Overall Study||121
5241596|NCT00837811|12887262|P1|STARTED|Overall Study||60
5241597|NCT00837759|12887347|P1|NOT COMPLETED|Overall Study||4
5241598|NCT00837759|12887347|P1|COMPLETED|Overall Study||3
5241599|NCT00837759|12887347|P1|STARTED|Overall Study||7
5241600|NCT00837694|12887362|P6|NOT COMPLETED|Overall Study||1
5241601|NCT00837694|12887363|P5|NOT COMPLETED|Overall Study||1
5241602|NCT00837694|12887364|P4|NOT COMPLETED|Overall Study||1
5241603|NCT00837694|12887365|P3|NOT COMPLETED|Overall Study||2
5241604|NCT00837694|12887366|P2|NOT COMPLETED|Overall Study||0
5241605|NCT00837694|12887367|P1|NOT COMPLETED|Overall Study||2
5241606|NCT00837694|12887362|P6|COMPLETED|Overall Study||10
5241607|NCT00837694|12887363|P5|COMPLETED|Overall Study||11
5241608|NCT00837694|12887364|P4|COMPLETED|Overall Study||10
5241609|NCT00837694|12887365|P3|COMPLETED|Overall Study||8
5241610|NCT00837694|12887366|P2|COMPLETED|Overall Study||11
5241611|NCT00837694|12887367|P1|COMPLETED|Overall Study||8
5241612|NCT00837694|12887362|P6|STARTED|Overall Study||11
5241613|NCT00837694|12887363|P5|STARTED|Overall Study||12
5241614|NCT00837694|12887364|P4|STARTED|Overall Study||11
5241615|NCT00837694|12887365|P3|STARTED|Overall Study||10
5241616|NCT00837694|12887366|P2|STARTED|Overall Study||11
5241617|NCT00837694|12887367|P1|STARTED|Overall Study||10
5241618|NCT00837616|12887383|P2|NOT COMPLETED|Overall Study||1
5241619|NCT00837616|12887384|P1|NOT COMPLETED|Overall Study||0
5241620|NCT00837616|12887383|P2|COMPLETED|Overall Study||20
5241621|NCT00837616|12887384|P1|COMPLETED|Overall Study||20
5241622|NCT00837616|12887383|P2|STARTED|Overall Study||21
5241623|NCT00837616|12887384|P1|STARTED|Overall Study||20
5241624|NCT00837590|12887411|P3|NOT COMPLETED|Overall Study||1
5241625|NCT00837590|12887412|P2|NOT COMPLETED|Overall Study||1
5241626|NCT00837590|12887413|P1|NOT COMPLETED|Overall Study||0
5241627|NCT00837590|12887411|P3|COMPLETED|Overall Study||4
5241628|NCT00837590|12887412|P2|COMPLETED|Overall Study||4
5241629|NCT00837590|12887413|P1|COMPLETED|Overall Study||6
5241630|NCT00837590|12887411|P3|STARTED|Overall Study||5
5241631|NCT00837590|12887412|P2|STARTED|Overall Study||5
5241632|NCT00837590|12887413|P1|STARTED|Overall Study||6
5241633|NCT00837577|12887423|P2|NOT COMPLETED|Open-label Period||9
5241634|NCT00837577|12887424|P1|NOT COMPLETED|Open-label Period||8
5241635|NCT00837577|12887423|P2|COMPLETED|Open-label Period||54
5241636|NCT00837577|12887424|P1|COMPLETED|Open-label Period||60
5241637|NCT00837577|12887423|P2|STARTED|Open-label Period||63
5241638|NCT00837577|12887424|P1|STARTED|Open-label Period||68
5241639|NCT00837577|12887423|P2|NOT COMPLETED|Double-blind Period||0
5241640|NCT00837577|12887424|P1|NOT COMPLETED|Double-blind Period||2
5241641|NCT00837577|12887423|P2|COMPLETED|Double-blind Period||63
5241642|NCT00837577|12887424|P1|COMPLETED|Double-blind Period||68
5241643|NCT00837577|12887423|P2|STARTED|Double-blind Period||63
5241644|NCT00837577|12887424|P1|STARTED|Double-blind Period||70
5241645|NCT00837512|12887435|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
5241646|NCT00837512|12887436|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
5241647|NCT00837512|12887435|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
5241648|NCT00837512|12887436|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
5241649|NCT00837512|12887435|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
5241650|NCT00837512|12887436|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
5241651|NCT00837512|12887435|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
5241652|NCT00837512|12887436|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
5241653|NCT00837512|12887435|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
5241654|NCT00837512|12887436|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
5241655|NCT00837512|12887435|P2|STARTED|Both Arms: Washout (7-28 Days)||8
5241656|NCT00837512|12887436|P1|STARTED|Both Arms: Washout (7-28 Days)||8
5241657|NCT00837512|12887435|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
5241658|NCT00837512|12887436|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
5241659|NCT00837512|12887435|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
5241660|NCT00837512|12887436|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
5241661|NCT00837512|12887435|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
5241662|NCT00837512|12887436|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
5241663|NCT00837486|12887444|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
5241664|NCT00837486|12887445|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
5241665|NCT00837486|12887444|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
5241666|NCT00837486|12887445|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
5241667|NCT00837486|12887444|P2|STARTED|Long-term Follow-up Phase - Open Label||0
5241668|NCT00837486|12887445|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
5241669|NCT00837486|12887444|P2|NOT COMPLETED|Blinded-treatment Phase||0
5241670|NCT00837486|12887445|P1|NOT COMPLETED|Blinded-treatment Phase||1
5241671|NCT00837486|12887444|P2|COMPLETED|Blinded-treatment Phase||14
5241672|NCT00837486|12887445|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
5241673|NCT00837486|12887444|P2|STARTED|Blinded-treatment Phase||14
5241674|NCT00837486|12887445|P1|STARTED|Blinded-treatment Phase||16
5241675|NCT00837473|12887457|P1|NOT COMPLETED|Overall Study||3
5241676|NCT00837473|12887457|P1|COMPLETED|Overall Study||12
5241677|NCT00837473|12887457|P1|STARTED|Overall Study||15
5241678|NCT00837447|12887470|P1|NOT COMPLETED|Overall Study||0
5241679|NCT00837447|12887470|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
5241680|NCT00837447|12887470|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
5241681|NCT00837434|12887477|P2|NOT COMPLETED|Overall Study||1
5241682|NCT00837434|12887478|P1|NOT COMPLETED|Overall Study||9
5241683|NCT00837434|12887477|P2|COMPLETED|Overall Study||19
5241684|NCT00837434|12887478|P1|COMPLETED|Overall Study||34
5241685|NCT00837434|12887477|P2|STARTED|Overall Study||20
5241686|NCT00837434|12887478|P1|STARTED|Overall Study||43
5241687|NCT00837330|12887498|P2|NOT COMPLETED|Overall Study||3
5241688|NCT00837330|12887499|P1|NOT COMPLETED|Overall Study||1
5241689|NCT00837330|12887498|P2|COMPLETED|Overall Study||7
5241690|NCT00837330|12887499|P1|COMPLETED|Overall Study||9
5241691|NCT00837330|12887498|P2|STARTED|Overall Study||10
5241692|NCT00837330|12887499|P1|STARTED|Overall Study||10
5241693|NCT00837252|12887505|P1|NOT COMPLETED|Overall Study||0
5241694|NCT00837252|12887505|P1|COMPLETED|Overall Study||5
5241695|NCT00837252|12887505|P1|STARTED|Overall Study||5
5241696|NCT00837213|12887522|P2|NOT COMPLETED|Overall Study||5
5241697|NCT00837213|12887523|P1|NOT COMPLETED|Overall Study||6
5241698|NCT00837213|12887522|P2|COMPLETED|Overall Study||12
5241699|NCT00837213|12887523|P1|COMPLETED|Overall Study||10
5241700|NCT00837213|12887522|P2|STARTED|Overall Study||17
5241701|NCT00837213|12887523|P1|STARTED|Overall Study||16
5241702|NCT00837200|12887543|P1|NOT COMPLETED|Overall Study||0
5241703|NCT00837200|12887543|P1|COMPLETED|Overall Study||13
5241704|NCT00837200|12887543|P1|STARTED|Overall Study||13
5241705|NCT00837161|12887549|P1|NOT COMPLETED|Overall Study||2
5241706|NCT00837161|12887549|P1|COMPLETED|Overall Study||9
5241707|NCT00837161|12887549|P1|STARTED|Overall Study||11
5241708|NCT00837148|12887557|P1|NOT COMPLETED|Overall Study||2
5241709|NCT00837148|12887557|P1|COMPLETED|Overall Study||35
5241710|NCT00837148|12887557|P1|STARTED|Overall Study||37
5241711|NCT00837096|12887563|P2|NOT COMPLETED|Overall Study||9
5241712|NCT00837096|12887564|P1|NOT COMPLETED|Overall Study||10
5241713|NCT00837096|12887563|P2|COMPLETED|Overall Study||0
5241714|NCT00837096|12887564|P1|COMPLETED|Overall Study||0
5241715|NCT00837096|12887563|P2|STARTED|Overall Study||9
5241716|NCT00837096|12887564|P1|STARTED|Overall Study||10
5241717|NCT00837031|12887570|P1|NOT COMPLETED|Overall Study||0
5241718|NCT00837031|12887570|P1|COMPLETED|Overall Study||72
5241719|NCT00837031|12887570|P1|STARTED|Overall Study||72
5241720|NCT00836953|12887576|P1|NOT COMPLETED|Overall Study||2
5241721|NCT00836953|12887576|P1|COMPLETED|Overall Study||31
5241722|NCT00836953|12887576|P1|STARTED|Overall Study||33
5241723|NCT00836927|12887587|P5|NOT COMPLETED|Overall Study||1
5241724|NCT00836927|12887588|P4|NOT COMPLETED|Overall Study||1
5241725|NCT00836927|12887589|P3|NOT COMPLETED|Overall Study||0
5241726|NCT00836927|12887590|P2|NOT COMPLETED|Overall Study||0
5241727|NCT00836927|12887591|P1|NOT COMPLETED|Overall Study||3
5241728|NCT00836927|12887587|P5|COMPLETED|Overall Study||0
5241729|NCT00836927|12887588|P4|COMPLETED|Overall Study||0
5241730|NCT00836927|12887589|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
5241731|NCT00836927|12887590|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
5241732|NCT00836927|12887591|P1|COMPLETED|Overall Study||0
5241733|NCT00836927|12887587|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
5241734|NCT00836927|12887588|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
5241735|NCT00836927|12887589|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
5241736|NCT00836927|12887590|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
5241737|NCT00836927|12887591|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
5241738|NCT00836927|12887587|P5|STARTED|Overall Study||1
5241739|NCT00836927|12887588|P4|STARTED|Overall Study||1
5241740|NCT00836927|12887589|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
5241741|NCT00836927|12887590|P2|STARTED|Overall Study||1
5241742|NCT00836927|12887591|P1|STARTED|Overall Study||3
5241743|NCT00836901|12887627|P2|NOT COMPLETED|Second Intervention||0
5241744|NCT00836901|12887628|P1|NOT COMPLETED|Second Intervention||0
5241745|NCT00836901|12887627|P2|COMPLETED|Second Intervention||28
5241746|NCT00836901|12887628|P1|COMPLETED|Second Intervention||23
5241747|NCT00836901|12887627|P2|STARTED|Second Intervention||28
5241748|NCT00836901|12887628|P1|STARTED|Second Intervention||23
5241749|NCT00836901|12887627|P2|NOT COMPLETED|First Intervention||0
5241750|NCT00836901|12887628|P1|NOT COMPLETED|First Intervention||1
5241751|NCT00836901|12887627|P2|COMPLETED|First Intervention||28
5241752|NCT00836901|12887628|P1|COMPLETED|First Intervention||23
5241753|NCT00836901|12887627|P2|STARTED|First Intervention||28
5241754|NCT00836901|12887628|P1|STARTED|First Intervention||24
5241755|NCT00836875|12887644|P2|NOT COMPLETED|Overall Study||3
5241756|NCT00836875|12887645|P1|NOT COMPLETED|Overall Study||3
5241757|NCT00836875|12887644|P2|COMPLETED|Overall Study||17
5241758|NCT00836875|12887645|P1|COMPLETED|Overall Study||8
5241759|NCT00836875|12887644|P2|STARTED|Overall Study||20
5241760|NCT00836875|12887645|P1|STARTED|Overall Study||11
5241761|NCT00836810|12887661|P2|NOT COMPLETED|Overall Study||0
5241762|NCT00836810|12887662|P1|NOT COMPLETED|Overall Study||1
5241763|NCT00836810|12887661|P2|COMPLETED|Overall Study||6
5241764|NCT00836810|12887662|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
5241765|NCT00836810|12887661|P2|STARTED|Overall Study||6
5241766|NCT00836810|12887662|P1|STARTED|Overall Study||5
5241767|NCT00836758|12887678|P1|NOT COMPLETED|Overall Study||0
5241768|NCT00836758|12887678|P1|COMPLETED|Overall Study||115
5241769|NCT00836758|12887678|P1|STARTED|Overall Study||115
5241770|NCT00836745|12887684|P1|NOT COMPLETED|Overall Study||21
5241771|NCT00836745|12887684|P1|COMPLETED|Overall Study||15
5241772|NCT00836745|12887684|P1|STARTED|Overall Study||36
5241773|NCT00836719|12887691|P1|NOT COMPLETED|Overall Study||0
5241774|NCT00836719|12887691|P1|COMPLETED|Overall Study||10
5241775|NCT00836719|12887691|P1|STARTED|Overall Study||10
5241776|NCT00836706|12887698|P2|NOT COMPLETED|Second Intervention||0
5241777|NCT00836706|12887699|P1|NOT COMPLETED|Second Intervention||0
5241778|NCT00836706|12887698|P2|COMPLETED|Second Intervention||11
5241779|NCT00836706|12887699|P1|COMPLETED|Second Intervention||11
5241780|NCT00836706|12887698|P2|STARTED|Second Intervention||11
5241781|NCT00836706|12887699|P1|STARTED|Second Intervention||11
5241782|NCT00836706|12887698|P2|NOT COMPLETED|Washout: 7 Days||1
5241783|NCT00836706|12887699|P1|NOT COMPLETED|Washout: 7 Days||0
5241784|NCT00836706|12887698|P2|COMPLETED|Washout: 7 Days||11
5241785|NCT00836706|12887699|P1|COMPLETED|Washout: 7 Days||11
5241786|NCT00836706|12887698|P2|STARTED|Washout: 7 Days||12
5241787|NCT00836706|12887699|P1|STARTED|Washout: 7 Days||11
5241788|NCT00836706|12887698|P2|NOT COMPLETED|First Intervention||0
5241789|NCT00836706|12887699|P1|NOT COMPLETED|First Intervention||0
5241790|NCT00836706|12887698|P2|COMPLETED|First Intervention||12
5241791|NCT00836706|12887699|P1|COMPLETED|First Intervention||11
5241792|NCT00836706|12887698|P2|STARTED|First Intervention||12
5241793|NCT00836706|12887699|P1|STARTED|First Intervention||11
5241794|NCT00836693|12887709|P2|NOT COMPLETED|Overall Study||6
5241795|NCT00836693|12887710|P1|NOT COMPLETED|Overall Study||17
5241796|NCT00836693|12887709|P2|COMPLETED|Overall Study||64
5241797|NCT00836693|12887710|P1|COMPLETED|Overall Study||130
5241798|NCT00836693|12887709|P2|STARTED|Overall Study||70
5241799|NCT00836693|12887710|P1|STARTED|Overall Study||147
5241800|NCT00836641|12887752|P2|NOT COMPLETED|Overall Study||0
5241801|NCT00836641|12887753|P1|NOT COMPLETED|Overall Study||0
5241802|NCT00836641|12887752|P2|COMPLETED|Overall Study||34
5241803|NCT00836641|12887753|P1|COMPLETED|Overall Study||36
5241804|NCT00836641|12887752|P2|STARTED|Overall Study||34
5241805|NCT00836641|12887753|P1|STARTED|Overall Study||36
5241806|NCT00836589|12887760|P1|NOT COMPLETED|Overall Study||1266
5241807|NCT00836589|12887760|P1|COMPLETED|Overall Study||731
5241808|NCT00836589|12887760|P1|STARTED|Overall Study||1997
5241809|NCT00836498|12887793|P2|NOT COMPLETED|Overall Study||1
5241810|NCT00836498|12887794|P1|NOT COMPLETED|Overall Study||4
5241811|NCT00836498|12887793|P2|COMPLETED|Overall Study||21
5241812|NCT00836498|12887794|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
5241813|NCT00836498|12887793|P2|STARTED|Overall Study||22
5241814|NCT00836498|12887794|P1|STARTED|Overall Study||44
5241815|NCT00836472|12887826|P2|NOT COMPLETED|Second Intervention||0
5241816|NCT00836472|12887827|P1|NOT COMPLETED|Second Intervention||0
5241817|NCT00836472|12887826|P2|COMPLETED|Second Intervention||27
5241818|NCT00836472|12887827|P1|COMPLETED|Second Intervention||28
5241819|NCT00836472|12887826|P2|STARTED|Second Intervention||27
5241820|NCT00836472|12887827|P1|STARTED|Second Intervention||28
5241821|NCT00836472|12887826|P2|NOT COMPLETED|Washout||3
5241822|NCT00836472|12887827|P1|NOT COMPLETED|Washout||2
5241823|NCT00836472|12887826|P2|COMPLETED|Washout||27
5241824|NCT00836472|12887827|P1|COMPLETED|Washout||28
5241825|NCT00836472|12887826|P2|STARTED|Washout||30
5241826|NCT00836472|12887827|P1|STARTED|Washout||30
5241827|NCT00836472|12887826|P2|NOT COMPLETED|First Intervention||0
5241828|NCT00836472|12887827|P1|NOT COMPLETED|First Intervention||0
5241829|NCT00836472|12887826|P2|COMPLETED|First Intervention||30
5241830|NCT00836472|12887827|P1|COMPLETED|First Intervention||30
5241831|NCT00836472|12887826|P2|STARTED|First Intervention||30
5241832|NCT00836472|12887827|P1|STARTED|First Intervention||30
5241833|NCT00836433|12887843|P2|NOT COMPLETED|Overall Study||7
5241834|NCT00836433|12887844|P1|NOT COMPLETED|Overall Study||12
5241835|NCT00836433|12887843|P2|COMPLETED|Overall Study||321
5241836|NCT00836433|12887844|P1|COMPLETED|Overall Study||349
5241837|NCT00836433|12887843|P2|STARTED|Overall Study||328
5241838|NCT00836433|12887844|P1|STARTED|Overall Study||361
5241839|NCT00836407|12887854|P2|NOT COMPLETED|Overall Study||8
5241840|NCT00836407|12887855|P1|NOT COMPLETED|Overall Study||11
5241841|NCT00836407|12887854|P2|COMPLETED|Overall Study||7
5241842|NCT00836407|12887855|P1|COMPLETED|Overall Study||4
5241843|NCT00836407|12887854|P2|STARTED|Overall Study||15
5241844|NCT00836407|12887855|P1|STARTED|Overall Study||15
5241845|NCT00836355|12887867|P4|NOT COMPLETED|Overall Study||0
5241846|NCT00836355|12887868|P3|NOT COMPLETED|Overall Study||0
5241847|NCT00836355|12887869|P2|NOT COMPLETED|Overall Study||0
5241848|NCT00836355|12887870|P1|NOT COMPLETED|Overall Study||0
5241849|NCT00836355|12887867|P4|COMPLETED|Overall Study||2
5241850|NCT00836355|12887868|P3|COMPLETED|Overall Study||0
5241851|NCT00836355|12887869|P2|COMPLETED|Overall Study||4
5241852|NCT00836355|12887870|P1|COMPLETED|Overall Study||0
5241853|NCT00836355|12887867|P4|STARTED|Overall Study||2
5241854|NCT00836355|12887868|P3|STARTED|Overall Study||0
5241855|NCT00836355|12887869|P2|STARTED|Overall Study||4
5241856|NCT00836355|12887870|P1|STARTED|Overall Study||0
5241857|NCT00836342|12887891|P3|NOT COMPLETED|Overall Study||0
5241858|NCT00836342|12887892|P2|NOT COMPLETED|Overall Study||0
5241859|NCT00836342|12887893|P1|NOT COMPLETED|Overall Study||0
5241860|NCT00836342|12887891|P3|COMPLETED|Overall Study||36
5241861|NCT00836342|12887892|P2|COMPLETED|Overall Study||23
5241862|NCT00836342|12887893|P1|COMPLETED|Overall Study||22
5241863|NCT00836342|12887891|P3|STARTED|Overall Study||36
5241864|NCT00836342|12887892|P2|STARTED|Overall Study||23
5241865|NCT00836342|12887893|P1|STARTED|Overall Study||22
5241866|NCT00836277|12887904|P1|NOT COMPLETED|Overall Study||6
5241867|NCT00836277|12887904|P1|COMPLETED|Overall Study||18
5241868|NCT00836277|12887904|P1|STARTED|Overall Study||24
5241869|NCT00836095|12887914|P2|NOT COMPLETED|Overall Study||3
5241870|NCT00836095|12887915|P1|NOT COMPLETED|Overall Study||0
5241871|NCT00836095|12887914|P2|COMPLETED|Overall Study||27
5241872|NCT00836095|12887915|P1|COMPLETED|Overall Study||22
5241873|NCT00836095|12887914|P2|STARTED|Overall Study||30
5241874|NCT00836095|12887915|P1|STARTED|Overall Study||22
5241875|NCT00836056|12887925|P2|NOT COMPLETED|Second Intervention||0
5241876|NCT00836056|12887926|P1|NOT COMPLETED|Second Intervention||0
5241877|NCT00836056|12887925|P2|COMPLETED|Second Intervention||12
5241878|NCT00836056|12887926|P1|COMPLETED|Second Intervention||11
5241879|NCT00836056|12887925|P2|STARTED|Second Intervention||12
5241880|NCT00836056|12887926|P1|STARTED|Second Intervention||11
5241881|NCT00836056|12887925|P2|NOT COMPLETED|Washout: 7 Days||0
5241882|NCT00836056|12887926|P1|NOT COMPLETED|Washout: 7 Days||0
5241883|NCT00836056|12887925|P2|COMPLETED|Washout: 7 Days||12
5241884|NCT00836056|12887926|P1|COMPLETED|Washout: 7 Days||11
5241885|NCT00836056|12887925|P2|STARTED|Washout: 7 Days||12
5241886|NCT00836056|12887926|P1|STARTED|Washout: 7 Days||11
5241887|NCT00836056|12887925|P2|NOT COMPLETED|First Intervention||0
5241888|NCT00836056|12887926|P1|NOT COMPLETED|First Intervention||1
5241889|NCT00836056|12887925|P2|COMPLETED|First Intervention||12
5241890|NCT00836056|12887926|P1|COMPLETED|First Intervention||11
5241891|NCT00836056|12887925|P2|STARTED|First Intervention||12
5241892|NCT00836056|12887926|P1|STARTED|First Intervention||12
5241893|NCT00836017|12887934|P1|NOT COMPLETED|Overall Study||544
5241894|NCT00836017|12887934|P1|COMPLETED|Overall Study||502
5241895|NCT00836017|12887934|P1|STARTED|Overall Study||1046
5241896|NCT00836004|12887944|P2|NOT COMPLETED|Second Intervention||0
5241897|NCT00836004|12887945|P1|NOT COMPLETED|Second Intervention||0
5241898|NCT00836004|12887944|P2|COMPLETED|Second Intervention||12
5241899|NCT00836004|12887945|P1|COMPLETED|Second Intervention||12
5241900|NCT00836004|12887944|P2|STARTED|Second Intervention||12
5241901|NCT00836004|12887945|P1|STARTED|Second Intervention||12
5241902|NCT00836004|12887944|P2|NOT COMPLETED|Washout: 7 Days||0
5241903|NCT00836004|12887945|P1|NOT COMPLETED|Washout: 7 Days||0
5241904|NCT00836004|12887944|P2|COMPLETED|Washout: 7 Days||12
5241905|NCT00836004|12887945|P1|COMPLETED|Washout: 7 Days||12
5241906|NCT00836004|12887944|P2|STARTED|Washout: 7 Days||12
5241907|NCT00836004|12887945|P1|STARTED|Washout: 7 Days||12
5241908|NCT00836004|12887944|P2|NOT COMPLETED|First Intervention||0
5241909|NCT00836004|12887945|P1|NOT COMPLETED|First Intervention||0
5241910|NCT00836004|12887944|P2|COMPLETED|First Intervention||12
5241911|NCT00836004|12887945|P1|COMPLETED|First Intervention||12
5241912|NCT00836004|12887944|P2|STARTED|First Intervention||12
5241913|NCT00836004|12887945|P1|STARTED|First Intervention||12
5241914|NCT00835991|12887955|P2|NOT COMPLETED|Second Intervention||0
5241915|NCT00835991|12887956|P1|NOT COMPLETED|Second Intervention||0
5241916|NCT00835991|12887955|P2|COMPLETED|Second Intervention||26
5241917|NCT00835991|12887956|P1|COMPLETED|Second Intervention||27
5241918|NCT00835991|12887955|P2|STARTED|Second Intervention||26
5241919|NCT00835991|12887956|P1|STARTED|Second Intervention||27
5241920|NCT00835991|12887955|P2|NOT COMPLETED|Washout||3
5241921|NCT00835991|12887956|P1|NOT COMPLETED|Washout||3
5241922|NCT00835991|12887955|P2|COMPLETED|Washout||26
5241923|NCT00835991|12887956|P1|COMPLETED|Washout||27
5241924|NCT00835991|12887955|P2|STARTED|Washout||29
5241925|NCT00835991|12887956|P1|STARTED|Washout||30
5241926|NCT00835991|12887955|P2|NOT COMPLETED|First Intervention||1
5241927|NCT00835991|12887956|P1|NOT COMPLETED|First Intervention||0
5241928|NCT00835991|12887955|P2|COMPLETED|First Intervention||29
5241929|NCT00835991|12887956|P1|COMPLETED|First Intervention||30
5241930|NCT00835991|12887955|P2|STARTED|First Intervention||30
5241931|NCT00835991|12887956|P1|STARTED|First Intervention||30
5241932|NCT00835978|12887974|P4|NOT COMPLETED|Overall Study||10
5241933|NCT00835978|12887975|P3|NOT COMPLETED|Overall Study||91
5241934|NCT00835978|12887976|P2|NOT COMPLETED|Overall Study||56
5241935|NCT00835978|12887977|P1|NOT COMPLETED|Overall Study||56
5241936|NCT00835978|12887974|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
5241937|NCT00835978|12887975|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
5241938|NCT00835978|12887976|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
5241939|NCT00835978|12887977|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
5241940|NCT00835978|12887974|P4|Treated|Overall Study||10
5241941|NCT00835978|12887975|P3|Treated|Overall Study||91
5241942|NCT00835978|12887976|P2|Treated|Overall Study||56
5241943|NCT00835978|12887977|P1|Treated|Overall Study||56
5241944|NCT00835978|12887974|P4|STARTED|Overall Study||10
5241945|NCT00835978|12887975|P3|STARTED|Overall Study||91
5241946|NCT00835978|12887976|P2|STARTED|Overall Study||56
5241947|NCT00835978|12887977|P1|STARTED|Overall Study||56
5241948|NCT00835926|12888037|P2|NOT COMPLETED|Overall Study||0
5241949|NCT00835926|12888038|P1|NOT COMPLETED|Overall Study||0
5241950|NCT00835926|12888037|P2|COMPLETED|Overall Study||60
5241951|NCT00835926|12888038|P1|COMPLETED|Overall Study||61
5241952|NCT00835926|12888037|P2|STARTED|Overall Study||60
5241953|NCT00835926|12888038|P1|STARTED|Overall Study||61
5241954|NCT00835900|12888052|P2|NOT COMPLETED|Overall Study||6
5241955|NCT00835900|12888053|P1|NOT COMPLETED|Overall Study||5
5241956|NCT00835900|12888052|P2|COMPLETED|Overall Study||22
5241957|NCT00835900|12888053|P1|COMPLETED|Overall Study||27
5241958|NCT00835900|12888052|P2|STARTED|Overall Study||28
5241959|NCT00835900|12888053|P1|STARTED|Overall Study||32
5241960|NCT00835861|12888063|P2|NOT COMPLETED|Overall Study||2
5241961|NCT00835861|12888064|P1|NOT COMPLETED|Overall Study||1
5241962|NCT00835861|12888063|P2|COMPLETED|Overall Study||14
5241963|NCT00835861|12888064|P1|COMPLETED|Overall Study||14
5241964|NCT00835861|12888063|P2|STARTED|Overall Study||16
5241965|NCT00835861|12888064|P1|STARTED|Overall Study||15
5241966|NCT00835796|12888088|P2|NOT COMPLETED|Second Intervention||0
5241967|NCT00835796|12888089|P1|NOT COMPLETED|Second Intervention||0
5241968|NCT00835796|12888088|P2|COMPLETED|Second Intervention||9
5241969|NCT00835796|12888089|P1|COMPLETED|Second Intervention||10
5241970|NCT00835796|12888088|P2|STARTED|Second Intervention||9
5241971|NCT00835796|12888089|P1|STARTED|Second Intervention||10
5241972|NCT00835796|12888088|P2|NOT COMPLETED|Washout||0
5241973|NCT00835796|12888089|P1|NOT COMPLETED|Washout||0
5241974|NCT00835796|12888088|P2|COMPLETED|Washout||9
5241975|NCT00835796|12888089|P1|COMPLETED|Washout||10
5241976|NCT00835796|12888088|P2|STARTED|Washout||9
5241977|NCT00835796|12888089|P1|STARTED|Washout||10
5241978|NCT00835796|12888088|P2|NOT COMPLETED|First Intervention||1
5241979|NCT00835796|12888089|P1|NOT COMPLETED|First Intervention||0
5241980|NCT00835796|12888088|P2|COMPLETED|First Intervention||9
5241981|NCT00835796|12888089|P1|COMPLETED|First Intervention||10
5241982|NCT00835796|12888088|P2|STARTED|First Intervention||10
5241983|NCT00835796|12888089|P1|STARTED|First Intervention||10
5241984|NCT00835731|12888099|P2|NOT COMPLETED|Overall Study||1
5241985|NCT00835731|12888100|P1|NOT COMPLETED|Overall Study||2
5241986|NCT00835731|12888099|P2|COMPLETED|Overall Study||60
5241987|NCT00835731|12888100|P1|COMPLETED|Overall Study||62
5241988|NCT00835731|12888099|P2|STARTED|Overall Study||61
5241989|NCT00835731|12888100|P1|STARTED|Overall Study||64
5241990|NCT00835705|12888120|P2|NOT COMPLETED|Second Intervention||0
5241991|NCT00835705|12888121|P1|NOT COMPLETED|Second Intervention||1
5241992|NCT00835705|12888120|P2|COMPLETED|Second Intervention||28
5241993|NCT00835705|12888121|P1|COMPLETED|Second Intervention||22
5241994|NCT00835705|12888120|P2|STARTED|Second Intervention||28
5241995|NCT00835705|12888121|P1|STARTED|Second Intervention||23
5241996|NCT00835705|12888120|P2|NOT COMPLETED|First Intervention||0
5241997|NCT00835705|12888121|P1|NOT COMPLETED|First Intervention||1
5241998|NCT00835705|12888120|P2|COMPLETED|First Intervention||28
5241999|NCT00835705|12888121|P1|COMPLETED|First Intervention||23
5242000|NCT00835705|12888120|P2|STARTED|First Intervention||28
5242001|NCT00835705|12888121|P1|STARTED|First Intervention||24
5242002|NCT00835692|12888137|P2|NOT COMPLETED|Second Intervention||0
5242003|NCT00835692|12888138|P1|NOT COMPLETED|Second Intervention||0
5242004|NCT00835692|12888137|P2|COMPLETED|Second Intervention||28
5242005|NCT00835692|12888138|P1|COMPLETED|Second Intervention||27
5242006|NCT00835692|12888137|P2|STARTED|Second Intervention||28
5242007|NCT00835692|12888138|P1|STARTED|Second Intervention||27
5242008|NCT00835692|12888137|P2|NOT COMPLETED|Washout||0
5242009|NCT00835692|12888138|P1|NOT COMPLETED|Washout||0
5242010|NCT00835692|12888137|P2|COMPLETED|Washout||28
5242011|NCT00835692|12888138|P1|COMPLETED|Washout||27
5242012|NCT00835692|12888137|P2|STARTED|Washout||28
5242013|NCT00835692|12888138|P1|STARTED|Washout||27
5242014|NCT00835692|12888137|P2|NOT COMPLETED|First Intervention||0
5242015|NCT00835692|12888138|P1|NOT COMPLETED|First Intervention||1
5242016|NCT00835692|12888137|P2|COMPLETED|First Intervention||28
5242017|NCT00835692|12888138|P1|COMPLETED|First Intervention||27
5242018|NCT00835692|12888137|P2|STARTED|First Intervention||28
5242019|NCT00835692|12888138|P1|STARTED|First Intervention||28
5242020|NCT00835679|12888150|P4|NOT COMPLETED|Overall Study||0
5242021|NCT00835679|12888151|P3|NOT COMPLETED|Overall Study||0
5242022|NCT00835679|12888152|P2|NOT COMPLETED|Overall Study||0
5242023|NCT00835679|12888153|P1|NOT COMPLETED|Overall Study||1
5242024|NCT00835679|12888150|P4|COMPLETED|Overall Study||0
5242025|NCT00835679|12888151|P3|COMPLETED|Overall Study||0
5242026|NCT00835679|12888152|P2|COMPLETED|Overall Study||0
5242027|NCT00835679|12888153|P1|COMPLETED|Overall Study||8
5242028|NCT00835679|12888150|P4|STARTED|Overall Study||0
5242029|NCT00835679|12888151|P3|STARTED|Overall Study||0
5242030|NCT00835679|12888152|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
5242031|NCT00835679|12888153|P1|STARTED|Overall Study||9
5242032|NCT00835666|12888177|P2|NOT COMPLETED|Second Intervention||0
5242033|NCT00835666|12888178|P1|NOT COMPLETED|Second Intervention||0
5242034|NCT00835666|12888177|P2|COMPLETED|Second Intervention||16
5242035|NCT00835666|12888178|P1|COMPLETED|Second Intervention||14
5242036|NCT00835666|12888177|P2|STARTED|Second Intervention||16
5242037|NCT00835666|12888178|P1|STARTED|Second Intervention||14
5242038|NCT00835666|12888177|P2|NOT COMPLETED|Washout||0
5242039|NCT00835666|12888178|P1|NOT COMPLETED|Washout||2
5242040|NCT00835666|12888177|P2|COMPLETED|Washout||16
5242041|NCT00835666|12888178|P1|COMPLETED|Washout||14
5242042|NCT00835666|12888177|P2|STARTED|Washout||16
5242043|NCT00835666|12888178|P1|STARTED|Washout||16
5242044|NCT00835666|12888177|P2|NOT COMPLETED|First Intervention||0
5242045|NCT00835666|12888178|P1|NOT COMPLETED|First Intervention||0
5242046|NCT00835666|12888177|P2|COMPLETED|First Intervention||16
5242047|NCT00835666|12888178|P1|COMPLETED|First Intervention||16
5242048|NCT00835666|12888177|P2|STARTED|First Intervention||16
5242049|NCT00835666|12888178|P1|STARTED|First Intervention||16
5242050|NCT00835640|12888188|P2|NOT COMPLETED|Second Intervention||0
5242051|NCT00835640|12888189|P1|NOT COMPLETED|Second Intervention||1
5242052|NCT00835640|12888188|P2|COMPLETED|Second Intervention||12
5242053|NCT00835640|12888189|P1|COMPLETED|Second Intervention||11
5242054|NCT00835640|12888188|P2|STARTED|Second Intervention||12
5242055|NCT00835640|12888189|P1|STARTED|Second Intervention||12
5242056|NCT00835640|12888188|P2|NOT COMPLETED|Washout of 7 Days||0
5242057|NCT00835640|12888189|P1|NOT COMPLETED|Washout of 7 Days||0
5242058|NCT00835640|12888188|P2|COMPLETED|Washout of 7 Days||12
5242059|NCT00835640|12888189|P1|COMPLETED|Washout of 7 Days||12
5242060|NCT00835640|12888188|P2|STARTED|Washout of 7 Days||12
5242061|NCT00835640|12888189|P1|STARTED|Washout of 7 Days||12
5242062|NCT00835640|12888188|P2|NOT COMPLETED|First Intervention||0
5242063|NCT00835640|12888189|P1|NOT COMPLETED|First Intervention||0
5242064|NCT00835640|12888188|P2|COMPLETED|First Intervention||12
5242065|NCT00835640|12888189|P1|COMPLETED|First Intervention||12
5242066|NCT00835640|12888188|P2|STARTED|First Intervention||12
5242067|NCT00835640|12888189|P1|STARTED|First Intervention||12
5242068|NCT00835614|12888199|P2|NOT COMPLETED|Second Intervention||0
5242069|NCT00835614|12888200|P1|NOT COMPLETED|Second Intervention||0
5242070|NCT00835614|12888199|P2|COMPLETED|Second Intervention||13
5242071|NCT00835614|12888200|P1|COMPLETED|Second Intervention||13
5242072|NCT00835614|12888199|P2|STARTED|Second Intervention||13
5242073|NCT00835614|12888200|P1|STARTED|Second Intervention||13
5242074|NCT00835614|12888199|P2|NOT COMPLETED|Washout of 7 Days||0
5242075|NCT00835614|12888200|P1|NOT COMPLETED|Washout of 7 Days||0
5242076|NCT00835614|12888199|P2|COMPLETED|Washout of 7 Days||13
5242077|NCT00835614|12888200|P1|COMPLETED|Washout of 7 Days||13
5242078|NCT00835614|12888199|P2|STARTED|Washout of 7 Days||13
5242079|NCT00835614|12888200|P1|STARTED|Washout of 7 Days||13
5242080|NCT00835614|12888199|P2|NOT COMPLETED|First Intervention||0
5242081|NCT00835614|12888200|P1|NOT COMPLETED|First Intervention||0
5242082|NCT00835614|12888199|P2|COMPLETED|First Intervention||13
5242083|NCT00835614|12888200|P1|COMPLETED|First Intervention||13
5242084|NCT00835614|12888199|P2|STARTED|First Intervention||13
5242085|NCT00835614|12888200|P1|STARTED|First Intervention||13
5242086|NCT00835588|12888210|P2|NOT COMPLETED|Second Intervention||0
5242087|NCT00835588|12888211|P1|NOT COMPLETED|Second Intervention||0
5242088|NCT00835588|12888210|P2|COMPLETED|Second Intervention||50
5242089|NCT00835588|12888211|P1|COMPLETED|Second Intervention||50
5242090|NCT00835588|12888210|P2|STARTED|Second Intervention||50
5242091|NCT00835588|12888211|P1|STARTED|Second Intervention||50
5242092|NCT00835588|12888210|P2|NOT COMPLETED|Washout: 5 Days||0
5242093|NCT00835588|12888211|P1|NOT COMPLETED|Washout: 5 Days||0
5242094|NCT00835588|12888210|P2|COMPLETED|Washout: 5 Days||50
5242095|NCT00835588|12888211|P1|COMPLETED|Washout: 5 Days||50
5242096|NCT00835588|12888210|P2|STARTED|Washout: 5 Days||50
5242097|NCT00835588|12888211|P1|STARTED|Washout: 5 Days||50
5242098|NCT00835588|12888210|P2|NOT COMPLETED|First Intervention||0
5242099|NCT00835588|12888211|P1|NOT COMPLETED|First Intervention||0
5242100|NCT00835588|12888210|P2|COMPLETED|First Intervention||50
5242101|NCT00835588|12888211|P1|COMPLETED|First Intervention||50
5242102|NCT00835588|12888210|P2|STARTED|First Intervention||50
5242103|NCT00835588|12888211|P1|STARTED|First Intervention||50
5242104|NCT00835575|12888221|P2|NOT COMPLETED|Second Intervention||0
5242105|NCT00835575|12888222|P1|NOT COMPLETED|Second Intervention||0
5242106|NCT00835575|12888221|P2|COMPLETED|Second Intervention||16
5242107|NCT00835575|12888222|P1|COMPLETED|Second Intervention||15
5242108|NCT00835575|12888221|P2|STARTED|Second Intervention||16
5242109|NCT00835575|12888222|P1|STARTED|Second Intervention||15
5242110|NCT00835575|12888221|P2|NOT COMPLETED|Washout of 14 Days||0
5242111|NCT00835575|12888222|P1|NOT COMPLETED|Washout of 14 Days||1
5242112|NCT00835575|12888221|P2|COMPLETED|Washout of 14 Days||16
5242113|NCT00835575|12888222|P1|COMPLETED|Washout of 14 Days||15
5242114|NCT00835575|12888221|P2|STARTED|Washout of 14 Days||16
5242115|NCT00835575|12888222|P1|STARTED|Washout of 14 Days||16
5242116|NCT00835575|12888221|P2|NOT COMPLETED|First Intervention||0
5242117|NCT00835575|12888222|P1|NOT COMPLETED|First Intervention||0
5242118|NCT00835575|12888221|P2|COMPLETED|First Intervention||16
5242119|NCT00835575|12888222|P1|COMPLETED|First Intervention||16
5242120|NCT00835575|12888221|P2|STARTED|First Intervention||16
5242121|NCT00835575|12888222|P1|STARTED|First Intervention||16
5242122|NCT00835549|12888232|P2|NOT COMPLETED|Second Intervention||0
5242123|NCT00835549|12888233|P1|NOT COMPLETED|Second Intervention||0
5242124|NCT00835549|12888232|P2|COMPLETED|Second Intervention||16
5242125|NCT00835549|12888233|P1|COMPLETED|Second Intervention||14
5242126|NCT00835549|12888232|P2|STARTED|Second Intervention||16
5242127|NCT00835549|12888233|P1|STARTED|Second Intervention||14
5242128|NCT00835549|12888232|P2|NOT COMPLETED|Washout of 7 Days||0
5242129|NCT00835549|12888233|P1|NOT COMPLETED|Washout of 7 Days||2
5242130|NCT00835549|12888232|P2|COMPLETED|Washout of 7 Days||16
5242131|NCT00835549|12888233|P1|COMPLETED|Washout of 7 Days||14
5242132|NCT00835549|12888232|P2|STARTED|Washout of 7 Days||16
5242133|NCT00835549|12888233|P1|STARTED|Washout of 7 Days||16
5242134|NCT00835549|12888232|P2|NOT COMPLETED|First Intervention||0
5242135|NCT00835549|12888233|P1|NOT COMPLETED|First Intervention||0
5242136|NCT00835549|12888232|P2|COMPLETED|First Intervention||16
5242137|NCT00835549|12888233|P1|COMPLETED|First Intervention||16
5242138|NCT00835549|12888232|P2|STARTED|First Intervention||16
5242139|NCT00835549|12888233|P1|STARTED|First Intervention||16
5242140|NCT00835536|12888243|P2|NOT COMPLETED|Second Intervention||0
5242141|NCT00835536|12888244|P1|NOT COMPLETED|Second Intervention||0
5242142|NCT00835536|12888243|P2|COMPLETED|Second Intervention||14
5242143|NCT00835536|12888244|P1|COMPLETED|Second Intervention||12
5242144|NCT00835536|12888243|P2|STARTED|Second Intervention||14
5242145|NCT00835536|12888244|P1|STARTED|Second Intervention||12
5242146|NCT00835536|12888243|P2|NOT COMPLETED|Washout of 5 Weeks||0
5242147|NCT00835536|12888244|P1|NOT COMPLETED|Washout of 5 Weeks||1
5242148|NCT00835536|12888243|P2|COMPLETED|Washout of 5 Weeks||14
5242149|NCT00835536|12888244|P1|COMPLETED|Washout of 5 Weeks||12
5242150|NCT00835536|12888243|P2|STARTED|Washout of 5 Weeks||14
5242151|NCT00835536|12888244|P1|STARTED|Washout of 5 Weeks||13
5242152|NCT00835536|12888243|P2|NOT COMPLETED|First Intervention||0
5242153|NCT00835536|12888244|P1|NOT COMPLETED|First Intervention||0
5242154|NCT00835536|12888243|P2|COMPLETED|First Intervention||14
5242155|NCT00835536|12888244|P1|COMPLETED|First Intervention||13
5242156|NCT00835536|12888243|P2|STARTED|First Intervention||14
5242157|NCT00835536|12888244|P1|STARTED|First Intervention||13
5242158|NCT00835510|12888253|P3|NOT COMPLETED|Overall Study||38
5242159|NCT00835510|12888254|P2|NOT COMPLETED|Overall Study||69
5242160|NCT00835510|12888255|P1|NOT COMPLETED|Overall Study||76
5242161|NCT00835510|12888253|P3|COMPLETED|Overall Study||70
5242162|NCT00835510|12888254|P2|COMPLETED|Overall Study||152
5242163|NCT00835510|12888255|P1|COMPLETED|Overall Study||143
5242164|NCT00835510|12888253|P3|Positive Fungal Culture|Overall Study||71
5242165|NCT00835510|12888254|P2|Positive Fungal Culture|Overall Study||155
5242166|NCT00835510|12888255|P1|Positive Fungal Culture|Overall Study||149
5242167|NCT00835510|12888253|P3|STARTED|Overall Study||108
5242168|NCT00835510|12888254|P2|STARTED|Overall Study||221
5242169|NCT00835510|12888255|P1|STARTED|Overall Study||219
5242170|NCT00835497|12888277|P2|NOT COMPLETED|Second Intervention||0
5242171|NCT00835497|12888278|P1|NOT COMPLETED|Second Intervention||0
5242172|NCT00835497|12888277|P2|COMPLETED|Second Intervention||20
5242173|NCT00835497|12888278|P1|COMPLETED|Second Intervention||20
5242174|NCT00835497|12888277|P2|STARTED|Second Intervention||20
5242175|NCT00835497|12888278|P1|STARTED|Second Intervention||20
5242176|NCT00835497|12888277|P2|NOT COMPLETED|Washout: 7 Days||0
5242177|NCT00835497|12888278|P1|NOT COMPLETED|Washout: 7 Days||0
5242178|NCT00835497|12888277|P2|COMPLETED|Washout: 7 Days||20
5242179|NCT00835497|12888278|P1|COMPLETED|Washout: 7 Days||20
5242180|NCT00835497|12888277|P2|STARTED|Washout: 7 Days||20
5242181|NCT00835497|12888278|P1|STARTED|Washout: 7 Days||20
5242182|NCT00835497|12888277|P2|NOT COMPLETED|First Intervention||0
5242183|NCT00835497|12888278|P1|NOT COMPLETED|First Intervention||0
5242184|NCT00835497|12888277|P2|COMPLETED|First Intervention||20
5242185|NCT00835497|12888278|P1|COMPLETED|First Intervention||20
5242186|NCT00835497|12888277|P2|STARTED|First Intervention||20
5242187|NCT00835497|12888278|P1|STARTED|First Intervention||20
5242188|NCT00835484|12888294|P2|NOT COMPLETED|Second Intervention||0
5242189|NCT00835484|12888295|P1|NOT COMPLETED|Second Intervention||0
5242190|NCT00835484|12888294|P2|COMPLETED|Second Intervention||16
5242191|NCT00835484|12888295|P1|COMPLETED|Second Intervention||16
5242192|NCT00835484|12888294|P2|STARTED|Second Intervention||16
5242193|NCT00835484|12888295|P1|STARTED|Second Intervention||16
5242194|NCT00835484|12888294|P2|NOT COMPLETED|Washout of 7 Days||0
5242195|NCT00835484|12888295|P1|NOT COMPLETED|Washout of 7 Days||0
5242196|NCT00835484|12888294|P2|COMPLETED|Washout of 7 Days||16
5242197|NCT00835484|12888295|P1|COMPLETED|Washout of 7 Days||16
5242198|NCT00835484|12888294|P2|STARTED|Washout of 7 Days||16
5242199|NCT00835484|12888295|P1|STARTED|Washout of 7 Days||16
5242200|NCT00835484|12888294|P2|NOT COMPLETED|First Intervention||0
5242201|NCT00835484|12888295|P1|NOT COMPLETED|First Intervention||0
5242202|NCT00835484|12888294|P2|COMPLETED|First Intervention||16
5242203|NCT00835484|12888295|P1|COMPLETED|First Intervention||16
5242204|NCT00835484|12888294|P2|STARTED|First Intervention||16
5242205|NCT00835484|12888295|P1|STARTED|First Intervention||16
5242206|NCT00835406|12888305|P2|NOT COMPLETED|Period: Second Intervention||0
5242207|NCT00835406|12888306|P1|NOT COMPLETED|Period: Second Intervention||0
5242208|NCT00835406|12888305|P2|COMPLETED|Period: Second Intervention||67
5242209|NCT00835406|12888306|P1|COMPLETED|Period: Second Intervention||68
5242210|NCT00835406|12888305|P2|STARTED|Period: Second Intervention||67
5242211|NCT00835406|12888306|P1|STARTED|Period: Second Intervention||68
5242212|NCT00835406|12888305|P2|NOT COMPLETED|Period: Washout of 7 Days||2
5242213|NCT00835406|12888306|P1|NOT COMPLETED|Period: Washout of 7 Days||0
5242214|NCT00835406|12888305|P2|COMPLETED|Period: Washout of 7 Days||67
5242215|NCT00835406|12888306|P1|COMPLETED|Period: Washout of 7 Days||68
5242216|NCT00835406|12888305|P2|STARTED|Period: Washout of 7 Days||69
5242217|NCT00835406|12888306|P1|STARTED|Period: Washout of 7 Days||68
5242218|NCT00835406|12888305|P2|NOT COMPLETED|Period: First Intervention||1
5242219|NCT00835406|12888306|P1|NOT COMPLETED|Period: First Intervention||2
5242220|NCT00835406|12888305|P2|COMPLETED|Period: First Intervention||69
5242221|NCT00835406|12888306|P1|COMPLETED|Period: First Intervention||68
5242222|NCT00835406|12888305|P2|STARTED|Period: First Intervention||70
5242223|NCT00835406|12888306|P1|STARTED|Period: First Intervention||70
5242224|NCT00835380|12888312|P1|NOT COMPLETED|Overall Study||2
5242225|NCT00835380|12888312|P1|COMPLETED|Overall Study||78
5242226|NCT00835380|12888312|P1|STARTED|Overall Study||80
5242227|NCT00835367|12888319|P2|NOT COMPLETED|Second Intervention||1
5242228|NCT00835367|12888320|P1|NOT COMPLETED|Second Intervention||1
5242229|NCT00835367|12888319|P2|COMPLETED|Second Intervention||33
5242230|NCT00835367|12888320|P1|COMPLETED|Second Intervention||30
5242231|NCT00835367|12888319|P2|STARTED|Second Intervention||34
5242232|NCT00835367|12888320|P1|STARTED|Second Intervention||31
5242233|NCT00835367|12888319|P2|NOT COMPLETED|Washout||0
5242234|NCT00835367|12888320|P1|NOT COMPLETED|Washout||3
5242235|NCT00835367|12888319|P2|COMPLETED|Washout||34
5242236|NCT00835367|12888320|P1|COMPLETED|Washout||31
5242237|NCT00835367|12888319|P2|STARTED|Washout||34
5242238|NCT00835367|12888320|P1|STARTED|Washout||34
5242239|NCT00835367|12888319|P2|NOT COMPLETED|First Intervention||0
5242240|NCT00835367|12888320|P1|NOT COMPLETED|First Intervention||0
5242241|NCT00835367|12888319|P2|COMPLETED|First Intervention||34
5242242|NCT00835367|12888320|P1|COMPLETED|First Intervention||34
5242243|NCT00835367|12888319|P2|STARTED|First Intervention||34
5242244|NCT00835367|12888320|P1|STARTED|First Intervention||34
5242245|NCT00835354|12888342|P2|NOT COMPLETED|Second Intervention||0
5242246|NCT00835354|12888343|P1|NOT COMPLETED|Second Intervention||0
5242247|NCT00835354|12888342|P2|COMPLETED|Second Intervention||12
5242248|NCT00835354|12888343|P1|COMPLETED|Second Intervention||13
5242249|NCT00835354|12888342|P2|STARTED|Second Intervention||12
5242250|NCT00835354|12888343|P1|STARTED|Second Intervention||13
5242251|NCT00835354|12888342|P2|NOT COMPLETED|Washout of 7 Days||0
5242252|NCT00835354|12888343|P1|NOT COMPLETED|Washout of 7 Days||0
5242253|NCT00835354|12888342|P2|COMPLETED|Washout of 7 Days||12
5242254|NCT00835354|12888343|P1|COMPLETED|Washout of 7 Days||13
5242255|NCT00835354|12888342|P2|STARTED|Washout of 7 Days||12
5242256|NCT00835354|12888343|P1|STARTED|Washout of 7 Days||13
5242257|NCT00835354|12888342|P2|NOT COMPLETED|First Intervention||1
5242258|NCT00835354|12888343|P1|NOT COMPLETED|First Intervention||0
5242259|NCT00835354|12888342|P2|COMPLETED|First Intervention||12
5242260|NCT00835354|12888343|P1|COMPLETED|First Intervention||13
5242261|NCT00835354|12888342|P2|STARTED|First Intervention||13
5242262|NCT00835354|12888343|P1|STARTED|First Intervention||13
5242263|NCT00835341|12888353|P2|NOT COMPLETED|Overall Study||12
5242264|NCT00835341|12888354|P1|NOT COMPLETED|Overall Study||3
5242265|NCT00835341|12888353|P2|COMPLETED|Overall Study||46
5242266|NCT00835341|12888354|P1|COMPLETED|Overall Study||32
5242267|NCT00835341|12888353|P2|STARTED|Overall Study||58
5242268|NCT00835341|12888354|P1|STARTED|Overall Study||35
5242269|NCT00835328|12888364|P4|NOT COMPLETED|Cohort 4: Dose Level 4||0
5242270|NCT00835328|12888365|P3|NOT COMPLETED|Cohort 4: Dose Level 4||0
5242271|NCT00835328|12888366|P2|NOT COMPLETED|Cohort 4: Dose Level 4||0
5242272|NCT00835328|12888367|P1|NOT COMPLETED|Cohort 4: Dose Level 4||0
5242273|NCT00835328|12888364|P4|COMPLETED|Cohort 4: Dose Level 4||4
5242274|NCT00835328|12888365|P3|COMPLETED|Cohort 4: Dose Level 4||0
5242275|NCT00835328|12888366|P2|COMPLETED|Cohort 4: Dose Level 4||0
5242276|NCT00835328|12888367|P1|COMPLETED|Cohort 4: Dose Level 4||0
5242277|NCT00835328|12888364|P4|STARTED|Cohort 4: Dose Level 4||4
5242278|NCT00835328|12888365|P3|STARTED|Cohort 4: Dose Level 4||0
5242279|NCT00835328|12888366|P2|STARTED|Cohort 4: Dose Level 4||0
5242280|NCT00835328|12888367|P1|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
5242281|NCT00835328|12888364|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
5242282|NCT00835328|12888365|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
5242283|NCT00835328|12888366|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
5242284|NCT00835328|12888367|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
5242285|NCT00835328|12888364|P4|COMPLETED|Cohort 3: Dose Level 3||0
5242286|NCT00835328|12888365|P3|COMPLETED|Cohort 3: Dose Level 3||2
5242287|NCT00835328|12888366|P2|COMPLETED|Cohort 3: Dose Level 3||0
5242288|NCT00835328|12888367|P1|COMPLETED|Cohort 3: Dose Level 3||0
5242289|NCT00835328|12888364|P4|STARTED|Cohort 3: Dose Level 3||0
5242290|NCT00835328|12888365|P3|STARTED|Cohort 3: Dose Level 3||2
5242291|NCT00835328|12888366|P2|STARTED|Cohort 3: Dose Level 3||0
5242292|NCT00835328|12888367|P1|STARTED|Cohort 3: Dose Level 3||0
5242293|NCT00835328|12888364|P4|NOT COMPLETED|Cohort 2: Dose Level 2||0
5242294|NCT00835328|12888365|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
5242295|NCT00835328|12888366|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
5242296|NCT00835328|12888367|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
5242297|NCT00835328|12888364|P4|COMPLETED|Cohort 2: Dose Level 2||0
5242298|NCT00835328|12888365|P3|COMPLETED|Cohort 2: Dose Level 2||0
5242299|NCT00835328|12888366|P2|COMPLETED|Cohort 2: Dose Level 2||2
5242300|NCT00835328|12888367|P1|COMPLETED|Cohort 2: Dose Level 2||0
5242301|NCT00835328|12888364|P4|STARTED|Cohort 2: Dose Level 2||0
5242302|NCT00835328|12888365|P3|STARTED|Cohort 2: Dose Level 2||0
5242303|NCT00835328|12888366|P2|STARTED|Cohort 2: Dose Level 2||2
5242304|NCT00835328|12888367|P1|STARTED|Cohort 2: Dose Level 2||0
5242305|NCT00835328|12888364|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
5242306|NCT00835328|12888365|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
5242307|NCT00835328|12888366|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
5242308|NCT00835328|12888367|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
5242309|NCT00835328|12888364|P4|COMPLETED|Cohort 1: Dose Level 1||0
5242310|NCT00835328|12888365|P3|COMPLETED|Cohort 1: Dose Level 1||0
5242311|NCT00835328|12888366|P2|COMPLETED|Cohort 1: Dose Level 1||0
5242312|NCT00835328|12888367|P1|COMPLETED|Cohort 1: Dose Level 1||5
5242313|NCT00835328|12888364|P4|STARTED|Cohort 1: Dose Level 1||0
5242314|NCT00835328|12888365|P3|STARTED|Cohort 1: Dose Level 1||0
5242315|NCT00835328|12888366|P2|STARTED|Cohort 1: Dose Level 1||0
5242316|NCT00835328|12888367|P1|STARTED|Cohort 1: Dose Level 1||5
5242317|NCT00835276|12888406|P2|NOT COMPLETED|Second Intervention||0
5242318|NCT00835276|12888407|P1|NOT COMPLETED|Second Intervention||0
5242319|NCT00835276|12888406|P2|COMPLETED|Second Intervention||24
5242320|NCT00835276|12888407|P1|COMPLETED|Second Intervention||24
5242321|NCT00835276|12888406|P2|STARTED|Second Intervention||24
5242322|NCT00835276|12888407|P1|STARTED|Second Intervention||24
5242323|NCT00835276|12888406|P2|NOT COMPLETED|Washout of 7 Days||0
5242324|NCT00835276|12888407|P1|NOT COMPLETED|Washout of 7 Days||0
5242325|NCT00835276|12888406|P2|COMPLETED|Washout of 7 Days||24
5242326|NCT00835276|12888407|P1|COMPLETED|Washout of 7 Days||24
5242327|NCT00835276|12888406|P2|STARTED|Washout of 7 Days||24
5242328|NCT00835276|12888407|P1|STARTED|Washout of 7 Days||24
5242329|NCT00835276|12888406|P2|NOT COMPLETED|First Intervention||0
5242330|NCT00835276|12888407|P1|NOT COMPLETED|First Intervention||0
5242331|NCT00835276|12888406|P2|COMPLETED|First Intervention||24
5242332|NCT00835276|12888407|P1|COMPLETED|First Intervention||24
5242333|NCT00835276|12888406|P2|STARTED|First Intervention||24
5242334|NCT00835276|12888407|P1|STARTED|First Intervention||24
5242335|NCT00835263|12888417|P2|NOT COMPLETED|Second Intervention||0
5242336|NCT00835263|12888418|P1|NOT COMPLETED|Second Intervention||1
5242337|NCT00835263|12888417|P2|COMPLETED|Second Intervention||16
5242338|NCT00835263|12888418|P1|COMPLETED|Second Intervention||15
5242339|NCT00835263|12888417|P2|STARTED|Second Intervention||16
5242340|NCT00835263|12888418|P1|STARTED|Second Intervention||16
5242341|NCT00835263|12888417|P2|NOT COMPLETED|First Intervention||0
5242342|NCT00835263|12888418|P1|NOT COMPLETED|First Intervention||0
5242343|NCT00835263|12888417|P2|COMPLETED|First Intervention||16
5242344|NCT00835263|12888418|P1|COMPLETED|First Intervention||16
5242345|NCT00835263|12888417|P2|STARTED|First Intervention||16
5242346|NCT00835263|12888418|P1|STARTED|First Intervention||16
5242347|NCT00835237|12888428|P2|NOT COMPLETED|Overall Study||0
5242348|NCT00835237|12888429|P1|NOT COMPLETED|Overall Study||6
5242349|NCT00835237|12888428|P2|COMPLETED|Overall Study||445
5242350|NCT00835237|12888429|P1|COMPLETED|Overall Study||881
5242351|NCT00835237|12888428|P2|STARTED|Overall Study||445
5242352|NCT00835237|12888429|P1|STARTED|Overall Study||887
5242353|NCT00835224|12888453|P1|NOT COMPLETED|Overall Study||10
5242354|NCT00835224|12888453|P1|COMPLETED|Overall Study||24
5242355|NCT00835224|12888453|P1|STARTED|Overall Study||34
5242356|NCT00835211|12888469|P2|NOT COMPLETED|Second Intervention||0
5242357|NCT00835211|12888470|P1|NOT COMPLETED|Second Intervention||0
5242358|NCT00835211|12888469|P2|COMPLETED|Second Intervention||22
5242359|NCT00835211|12888470|P1|COMPLETED|Second Intervention||21
5242360|NCT00835211|12888469|P2|STARTED|Second Intervention||22
5242361|NCT00835211|12888470|P1|STARTED|Second Intervention||21
5242362|NCT00835211|12888469|P2|NOT COMPLETED|Washout: 7 Days||1
5242363|NCT00835211|12888470|P1|NOT COMPLETED|Washout: 7 Days||3
5242364|NCT00835211|12888469|P2|COMPLETED|Washout: 7 Days||22
5242365|NCT00835211|12888470|P1|COMPLETED|Washout: 7 Days||21
5242366|NCT00835211|12888469|P2|STARTED|Washout: 7 Days||23
5242367|NCT00835211|12888470|P1|STARTED|Washout: 7 Days||24
5242368|NCT00835211|12888469|P2|NOT COMPLETED|First Intervention||1
5242369|NCT00835211|12888470|P1|NOT COMPLETED|First Intervention||0
5242370|NCT00835211|12888469|P2|COMPLETED|First Intervention||23
5242371|NCT00835211|12888470|P1|COMPLETED|First Intervention||24
5242372|NCT00835211|12888469|P2|STARTED|First Intervention||24
5242373|NCT00835211|12888470|P1|STARTED|First Intervention||24
5242374|NCT00835198|12888480|P2|NOT COMPLETED|Overall Study||7
5242375|NCT00835198|12888481|P1|NOT COMPLETED|Overall Study||8
5242376|NCT00835198|12888480|P2|COMPLETED|Overall Study||74
5242377|NCT00835198|12888481|P1|COMPLETED|Overall Study||74
5242378|NCT00835198|12888480|P2|STARTED|Overall Study||81
5242379|NCT00835198|12888481|P1|STARTED|Overall Study||82
5242380|NCT00835185|12888493|P1|NOT COMPLETED|Overall Study||0
5242381|NCT00835185|12888493|P1|COMPLETED|Overall Study||44
5242382|NCT00835185|12888493|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
5242383|NCT00835185|12888493|P1|STARTED|Overall Study||44
5242384|NCT00835172|12888516|P2|NOT COMPLETED|Second Intervention||0
5242385|NCT00835172|12888517|P1|NOT COMPLETED|Second Intervention||0
5242386|NCT00835172|12888516|P2|COMPLETED|Second Intervention||15
5242387|NCT00835172|12888517|P1|COMPLETED|Second Intervention||16
5242388|NCT00835172|12888516|P2|STARTED|Second Intervention||15
5242389|NCT00835172|12888517|P1|STARTED|Second Intervention||16
5242390|NCT00835172|12888516|P2|NOT COMPLETED|Washout||1
5242391|NCT00835172|12888517|P1|NOT COMPLETED|Washout||0
5242392|NCT00835172|12888516|P2|COMPLETED|Washout||15
5242393|NCT00835172|12888517|P1|COMPLETED|Washout||16
5242394|NCT00835172|12888516|P2|STARTED|Washout||16
5242395|NCT00835172|12888517|P1|STARTED|Washout||16
5242396|NCT00835172|12888516|P2|NOT COMPLETED|First Intervention||0
5242397|NCT00835172|12888517|P1|NOT COMPLETED|First Intervention||0
5242398|NCT00835172|12888516|P2|COMPLETED|First Intervention||16
5242399|NCT00835172|12888517|P1|COMPLETED|First Intervention||16
5242400|NCT00835172|12888516|P2|STARTED|First Intervention||16
5242401|NCT00835172|12888517|P1|STARTED|First Intervention||16
5242402|NCT00835159|12888527|P2|NOT COMPLETED|Overall Study||0
5242403|NCT00835159|12888528|P1|NOT COMPLETED|Overall Study||0
5242404|NCT00835159|12888527|P2|COMPLETED|Overall Study||17
5242405|NCT00835159|12888528|P1|COMPLETED|Overall Study||11
5242406|NCT00835159|12888527|P2|STARTED|Overall Study||17
5242407|NCT00835159|12888528|P1|STARTED|Overall Study||11
5242408|NCT00835146|12888536|P2|NOT COMPLETED|Second Intervention||0
5242409|NCT00835146|12888537|P1|NOT COMPLETED|Second Intervention||0
5242410|NCT00835146|12888536|P2|COMPLETED|Second Intervention||14
5242411|NCT00835146|12888537|P1|COMPLETED|Second Intervention||14
5242412|NCT00835146|12888536|P2|STARTED|Second Intervention||14
5242413|NCT00835146|12888537|P1|STARTED|Second Intervention||14
5242414|NCT00835146|12888536|P2|NOT COMPLETED|Washout of 5 Weeks||0
5242415|NCT00835146|12888537|P1|NOT COMPLETED|Washout of 5 Weeks||0
5242416|NCT00835146|12888536|P2|COMPLETED|Washout of 5 Weeks||14
5242417|NCT00835146|12888537|P1|COMPLETED|Washout of 5 Weeks||14
5242418|NCT00835146|12888536|P2|STARTED|Washout of 5 Weeks||14
5242419|NCT00835146|12888537|P1|STARTED|Washout of 5 Weeks||14
5242420|NCT00835146|12888536|P2|NOT COMPLETED|First Intervention||0
5242421|NCT00835146|12888537|P1|NOT COMPLETED|First Intervention||0
5242422|NCT00835146|12888536|P2|COMPLETED|First Intervention||14
5242423|NCT00835146|12888537|P1|COMPLETED|First Intervention||14
5242424|NCT00835146|12888536|P2|STARTED|First Intervention||14
5242425|NCT00835146|12888537|P1|STARTED|First Intervention||14
5242426|NCT00835120|12888543|P1|NOT COMPLETED|Overall Study||8
5242427|NCT00835120|12888543|P1|COMPLETED|Overall Study||26
5242428|NCT00835120|12888543|P1|STARTED|Overall Study||34
5242429|NCT00835081|12888553|P2|NOT COMPLETED|Second Intervention||0
5242430|NCT00835081|12888554|P1|NOT COMPLETED|Second Intervention||0
5242431|NCT00835081|12888553|P2|COMPLETED|Second Intervention||13
5242432|NCT00835081|12888554|P1|COMPLETED|Second Intervention||12
5242433|NCT00835081|12888553|P2|STARTED|Second Intervention||13
5242434|NCT00835081|12888554|P1|STARTED|Second Intervention||12
5242435|NCT00835081|12888553|P2|NOT COMPLETED|Washout of 7 Days||0
5242436|NCT00835081|12888554|P1|NOT COMPLETED|Washout of 7 Days||1
5242437|NCT00835081|12888553|P2|COMPLETED|Washout of 7 Days||13
5242438|NCT00835081|12888554|P1|COMPLETED|Washout of 7 Days||12
5242439|NCT00835081|12888553|P2|STARTED|Washout of 7 Days||13
5242440|NCT00835081|12888554|P1|STARTED|Washout of 7 Days||13
5242441|NCT00835081|12888553|P2|NOT COMPLETED|First Intervention||0
5242442|NCT00835081|12888554|P1|NOT COMPLETED|First Intervention||0
5242443|NCT00835081|12888553|P2|COMPLETED|First Intervention||13
5242444|NCT00835081|12888554|P1|COMPLETED|First Intervention||13
5242445|NCT00835081|12888553|P2|STARTED|First Intervention||13
5242446|NCT00835081|12888554|P1|STARTED|First Intervention||13
5242447|NCT00835068|12888564|P2|NOT COMPLETED|Overall Study||1
5242448|NCT00835068|12888565|P1|NOT COMPLETED|Overall Study||10
5242449|NCT00835068|12888564|P2|COMPLETED|Overall Study||0
5242450|NCT00835068|12888565|P1|COMPLETED|Overall Study||47
5242451|NCT00835068|12888564|P2|STARTED|Overall Study||1
5242452|NCT00835068|12888565|P1|STARTED|Overall Study||57
5242453|NCT00835042|12888585|P2|NOT COMPLETED|Second Intervention||0
5242454|NCT00835042|12888586|P1|NOT COMPLETED|Second Intervention||0
5242455|NCT00835042|12888585|P2|COMPLETED|Second Intervention||24
5242456|NCT00835042|12888586|P1|COMPLETED|Second Intervention||26
5242457|NCT00835042|12888585|P2|STARTED|Second Intervention||24
5242458|NCT00835042|12888586|P1|STARTED|Second Intervention||26
5242459|NCT00835042|12888585|P2|NOT COMPLETED|Washout of 21 Days||2
5242460|NCT00835042|12888586|P1|NOT COMPLETED|Washout of 21 Days||0
5242461|NCT00835042|12888585|P2|COMPLETED|Washout of 21 Days||24
5242462|NCT00835042|12888586|P1|COMPLETED|Washout of 21 Days||26
5242463|NCT00835042|12888585|P2|STARTED|Washout of 21 Days||26
5242464|NCT00835042|12888586|P1|STARTED|Washout of 21 Days||26
5242465|NCT00835042|12888585|P2|NOT COMPLETED|First Intervention||2
5242466|NCT00835042|12888586|P1|NOT COMPLETED|First Intervention||4
5242467|NCT00835042|12888585|P2|COMPLETED|First Intervention||26
5242468|NCT00835042|12888586|P1|COMPLETED|First Intervention||26
5242469|NCT00835042|12888585|P2|STARTED|First Intervention||28
5242470|NCT00835042|12888586|P1|STARTED|First Intervention||30
5242471|NCT00835003|12888608|P2|NOT COMPLETED|Overall Study||0
5242472|NCT00835003|12888609|P1|NOT COMPLETED|Overall Study||0
5242473|NCT00835003|12888608|P2|COMPLETED|Overall Study||638
5242474|NCT00835003|12888609|P1|COMPLETED|Overall Study||636
5242475|NCT00835003|12888608|P2|STARTED|Overall Study||638
5242476|NCT00835003|12888609|P1|STARTED|Overall Study||636
5242477|NCT00834990|12888617|P2|NOT COMPLETED|Second Intervention||0
5242478|NCT00834990|12888618|P1|NOT COMPLETED|Second Intervention||0
5242479|NCT00834990|12888617|P2|COMPLETED|Second Intervention||11
5242480|NCT00834990|12888618|P1|COMPLETED|Second Intervention||12
5242481|NCT00834990|12888617|P2|STARTED|Second Intervention||11
5242482|NCT00834990|12888618|P1|STARTED|Second Intervention||12
5242483|NCT00834990|12888617|P2|NOT COMPLETED|Washout of 7 Days||0
5242484|NCT00834990|12888618|P1|NOT COMPLETED|Washout of 7 Days||0
5242485|NCT00834990|12888617|P2|COMPLETED|Washout of 7 Days||11
5242486|NCT00834990|12888618|P1|COMPLETED|Washout of 7 Days||12
5242487|NCT00834990|12888617|P2|STARTED|Washout of 7 Days||11
5242488|NCT00834990|12888618|P1|STARTED|Washout of 7 Days||12
5242489|NCT00834990|12888617|P2|NOT COMPLETED|First Intervention||0
5242490|NCT00834990|12888618|P1|NOT COMPLETED|First Intervention||0
5242491|NCT00834990|12888617|P2|COMPLETED|First Intervention||11
5242492|NCT00834990|12888618|P1|COMPLETED|First Intervention||12
5242493|NCT00834990|12888617|P2|STARTED|First Intervention||11
5242494|NCT00834990|12888618|P1|STARTED|First Intervention||12
5242495|NCT00834977|12888628|P2|NOT COMPLETED|Second Intervention||0
5242496|NCT00834977|12888629|P1|NOT COMPLETED|Second Intervention||0
5242497|NCT00834977|12888628|P2|COMPLETED|Second Intervention||24
5242498|NCT00834977|12888629|P1|COMPLETED|Second Intervention||24
5242499|NCT00834977|12888628|P2|STARTED|Second Intervention||24
5242500|NCT00834977|12888629|P1|STARTED|Second Intervention||24
5242501|NCT00834977|12888628|P2|NOT COMPLETED|First Intervention||0
5242502|NCT00834977|12888629|P1|NOT COMPLETED|First Intervention||0
5242503|NCT00834977|12888628|P2|COMPLETED|First Intervention||24
5242504|NCT00834977|12888629|P1|COMPLETED|First Intervention||24
5242505|NCT00834977|12888628|P2|STARTED|First Intervention||24
5242506|NCT00834977|12888629|P1|STARTED|First Intervention||24
5242507|NCT00834964|12888651|P2|NOT COMPLETED|Second Intervention||0
5242508|NCT00834964|12888652|P1|NOT COMPLETED|Second Intervention||0
5242509|NCT00834964|12888651|P2|COMPLETED|Second Intervention||15
5242510|NCT00834964|12888652|P1|COMPLETED|Second Intervention||15
5242511|NCT00834964|12888651|P2|STARTED|Second Intervention||15
5242512|NCT00834964|12888652|P1|STARTED|Second Intervention||15
5242513|NCT00834964|12888651|P2|NOT COMPLETED|Washout: 7 Days||0
5242514|NCT00834964|12888652|P1|NOT COMPLETED|Washout: 7 Days||0
5242515|NCT00834964|12888651|P2|COMPLETED|Washout: 7 Days||15
5242516|NCT00834964|12888652|P1|COMPLETED|Washout: 7 Days||15
5242517|NCT00834964|12888651|P2|STARTED|Washout: 7 Days||15
5242518|NCT00834964|12888652|P1|STARTED|Washout: 7 Days||15
5242519|NCT00834964|12888651|P2|NOT COMPLETED|First Intervention||0
5242520|NCT00834964|12888652|P1|NOT COMPLETED|First Intervention||0
5242521|NCT00834964|12888651|P2|COMPLETED|First Intervention||15
5242522|NCT00834964|12888652|P1|COMPLETED|First Intervention||15
5242523|NCT00834964|12888651|P2|STARTED|First Intervention||15
5242524|NCT00834964|12888652|P1|STARTED|First Intervention||15
5242525|NCT00834912|12888672|P6|NOT COMPLETED|Treatment Period 3||0
5242526|NCT00834912|12888673|P5|NOT COMPLETED|Treatment Period 3||0
5242527|NCT00834912|12888674|P4|NOT COMPLETED|Treatment Period 3||0
5242528|NCT00834912|12888675|P3|NOT COMPLETED|Treatment Period 3||0
5242529|NCT00834912|12888676|P2|NOT COMPLETED|Treatment Period 3||0
5242530|NCT00834912|12888677|P1|NOT COMPLETED|Treatment Period 3||0
5242531|NCT00834912|12888672|P6|COMPLETED|Treatment Period 3||6
5242532|NCT00834912|12888673|P5|COMPLETED|Treatment Period 3||5
5242533|NCT00834912|12888674|P4|COMPLETED|Treatment Period 3||5
5242534|NCT00834912|12888675|P3|COMPLETED|Treatment Period 3||5
5242535|NCT00834912|12888676|P2|COMPLETED|Treatment Period 3||5
5242536|NCT00834912|12888677|P1|COMPLETED|Treatment Period 3||6
5242537|NCT00834912|12888672|P6|STARTED|Treatment Period 3||6
5242538|NCT00834912|12888673|P5|STARTED|Treatment Period 3||5
5242539|NCT00834912|12888674|P4|STARTED|Treatment Period 3||5
5242540|NCT00834912|12888675|P3|STARTED|Treatment Period 3||5
5242541|NCT00834912|12888676|P2|STARTED|Treatment Period 3||5
5242542|NCT00834912|12888677|P1|STARTED|Treatment Period 3||6
5242543|NCT00834912|12888672|P6|NOT COMPLETED|Treatment Period 2||0
5242544|NCT00834912|12888673|P5|NOT COMPLETED|Treatment Period 2||1
5242545|NCT00834912|12888674|P4|NOT COMPLETED|Treatment Period 2||0
5242546|NCT00834912|12888675|P3|NOT COMPLETED|Treatment Period 2||1
5242547|NCT00834912|12888676|P2|NOT COMPLETED|Treatment Period 2||0
5242548|NCT00834912|12888677|P1|NOT COMPLETED|Treatment Period 2||0
5242549|NCT00834912|12888672|P6|COMPLETED|Treatment Period 2||6
5242550|NCT00834912|12888673|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
5242551|NCT00834912|12888674|P4|COMPLETED|Treatment Period 2||5
5242552|NCT00834912|12888675|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
5242553|NCT00834912|12888676|P2|COMPLETED|Treatment Period 2||5
5242554|NCT00834912|12888677|P1|COMPLETED|Treatment Period 2||6
5242555|NCT00834912|12888672|P6|STARTED|Treatment Period 2||6
5242556|NCT00834912|12888673|P5|STARTED|Treatment Period 2||6
5242557|NCT00834912|12888674|P4|STARTED|Treatment Period 2||5
5242558|NCT00834912|12888675|P3|STARTED|Treatment Period 2||6
5242559|NCT00834912|12888676|P2|STARTED|Treatment Period 2||5
5242560|NCT00834912|12888677|P1|STARTED|Treatment Period 2||6
5242561|NCT00834912|12888672|P6|NOT COMPLETED|Treatment Period 1||0
5242562|NCT00834912|12888673|P5|NOT COMPLETED|Treatment Period 1||0
5242563|NCT00834912|12888674|P4|NOT COMPLETED|Treatment Period 1||1
5242564|NCT00834912|12888675|P3|NOT COMPLETED|Treatment Period 1||0
5242565|NCT00834912|12888676|P2|NOT COMPLETED|Treatment Period 1||1
5242566|NCT00834912|12888677|P1|NOT COMPLETED|Treatment Period 1||0
5242567|NCT00834912|12888672|P6|COMPLETED|Treatment Period 1||6
5242568|NCT00834912|12888673|P5|COMPLETED|Treatment Period 1||6
5242569|NCT00834912|12888674|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
5242570|NCT00834912|12888675|P3|COMPLETED|Treatment Period 1||6
5242571|NCT00834912|12888676|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
5242572|NCT00834912|12888677|P1|COMPLETED|Treatment Period 1||6
5242573|NCT00834912|12888672|P6|STARTED|Treatment Period 1||6
5242574|NCT00834912|12888673|P5|STARTED|Treatment Period 1||6
5242575|NCT00834912|12888674|P4|STARTED|Treatment Period 1||6
5242576|NCT00834912|12888675|P3|STARTED|Treatment Period 1||6
5242577|NCT00834912|12888676|P2|STARTED|Treatment Period 1||6
5242578|NCT00834912|12888677|P1|STARTED|Treatment Period 1||6
5242579|NCT00834899|12888699|P2|NOT COMPLETED|Overall Study||1
5242580|NCT00834899|12888700|P1|NOT COMPLETED|Overall Study||1
5242581|NCT00834899|12888699|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
5242582|NCT00834899|12888700|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
5242583|NCT00834899|12888699|P2|STARTED|Overall Study||4
5242584|NCT00834899|12888700|P1|STARTED|Overall Study||9
5242585|NCT00834886|12888716|P4|NOT COMPLETED|Overall Study||0
5242586|NCT00834886|12888717|P3|NOT COMPLETED|Overall Study||1
5242587|NCT00834886|12888718|P2|NOT COMPLETED|Overall Study||1
5242588|NCT00834886|12888719|P1|NOT COMPLETED|Overall Study||0
5242589|NCT00834886|12888716|P4|COMPLETED|Overall Study||10
5242590|NCT00834886|12888717|P3|COMPLETED|Overall Study||9
5242591|NCT00834886|12888718|P2|COMPLETED|Overall Study||9
5242592|NCT00834886|12888719|P1|COMPLETED|Overall Study||10
5242593|NCT00834886|12888716|P4|STARTED|Overall Study||10
5242594|NCT00834886|12888717|P3|STARTED|Overall Study||10
5242595|NCT00834886|12888718|P2|STARTED|Overall Study||10
5242596|NCT00834886|12888719|P1|STARTED|Overall Study||10
5242597|NCT00834873|12888739|P2|NOT COMPLETED|Second Intervention||0
5242598|NCT00834873|12888740|P1|NOT COMPLETED|Second Intervention||0
5242599|NCT00834873|12888739|P2|COMPLETED|Second Intervention||11
5242600|NCT00834873|12888740|P1|COMPLETED|Second Intervention||12
5242601|NCT00834873|12888739|P2|STARTED|Second Intervention||11
5242602|NCT00834873|12888740|P1|STARTED|Second Intervention||12
5242603|NCT00834873|12888739|P2|NOT COMPLETED|Washout: 7 Days||0
5242604|NCT00834873|12888740|P1|NOT COMPLETED|Washout: 7 Days||0
5242605|NCT00834873|12888739|P2|COMPLETED|Washout: 7 Days||11
5242606|NCT00834873|12888740|P1|COMPLETED|Washout: 7 Days||12
5242607|NCT00834873|12888739|P2|STARTED|Washout: 7 Days||11
5242608|NCT00834873|12888740|P1|STARTED|Washout: 7 Days||12
5242609|NCT00834873|12888739|P2|NOT COMPLETED|First Intervention||1
5242610|NCT00834873|12888740|P1|NOT COMPLETED|First Intervention||0
5242611|NCT00834873|12888739|P2|COMPLETED|First Intervention||11
5242612|NCT00834873|12888740|P1|COMPLETED|First Intervention||12
5242613|NCT00834873|12888739|P2|STARTED|First Intervention||12
5242614|NCT00834873|12888740|P1|STARTED|First Intervention||12
5242615|NCT00834834|12888750|P2|NOT COMPLETED|Overall Study||3
5242616|NCT00834834|12888751|P1|NOT COMPLETED|Overall Study||4
5242617|NCT00834834|12888750|P2|COMPLETED|Overall Study||39
5242618|NCT00834834|12888751|P1|COMPLETED|Overall Study||38
5242619|NCT00834834|12888750|P2|STARTED|Overall Study||42
5242620|NCT00834834|12888751|P1|STARTED|Overall Study||42
5242621|NCT00834808|12888762|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
5242622|NCT00834808|12888763|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
5242623|NCT00834808|12888764|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
5242624|NCT00834808|12888762|P3|COMPLETED|Treatment Period 3 (Day 15)||9
5242625|NCT00834808|12888763|P2|COMPLETED|Treatment Period 3 (Day 15)||9
5242626|NCT00834808|12888764|P1|COMPLETED|Treatment Period 3 (Day 15)||9
5242627|NCT00834808|12888762|P3|STARTED|Treatment Period 3 (Day 15)||9
5242628|NCT00834808|12888763|P2|STARTED|Treatment Period 3 (Day 15)||9
5242629|NCT00834808|12888764|P1|STARTED|Treatment Period 3 (Day 15)||9
5242630|NCT00834808|12888762|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
5242631|NCT00834808|12888763|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
5242632|NCT00834808|12888764|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
5242633|NCT00834808|12888762|P3|COMPLETED|Treatment Period 2 (Day 8)||9
5242634|NCT00834808|12888763|P2|COMPLETED|Treatment Period 2 (Day 8)||9
5242635|NCT00834808|12888764|P1|COMPLETED|Treatment Period 2 (Day 8)||9
5242636|NCT00834808|12888762|P3|STARTED|Treatment Period 2 (Day 8)||9
5242637|NCT00834808|12888763|P2|STARTED|Treatment Period 2 (Day 8)||9
5242638|NCT00834808|12888764|P1|STARTED|Treatment Period 2 (Day 8)||9
5242639|NCT00834808|12888762|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
5242640|NCT00834808|12888763|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
5242641|NCT00834808|12888764|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
5242642|NCT00834808|12888762|P3|COMPLETED|Treatment Period 1 (Day 1)||9
5242643|NCT00834808|12888763|P2|COMPLETED|Treatment Period 1 (Day 1)||9
5242644|NCT00834808|12888764|P1|COMPLETED|Treatment Period 1 (Day 1)||9
5242645|NCT00834808|12888762|P3|STARTED|Treatment Period 1 (Day 1)||9
5242646|NCT00834808|12888763|P2|STARTED|Treatment Period 1 (Day 1)||9
5242647|NCT00834808|12888764|P1|STARTED|Treatment Period 1 (Day 1)||9
5242648|NCT00834795|12888786|P2|NOT COMPLETED|Second Intervention||0
5242649|NCT00834795|12888787|P1|NOT COMPLETED|Second Intervention||1
5242650|NCT00834795|12888786|P2|COMPLETED|Second Intervention||17
5242651|NCT00834795|12888787|P1|COMPLETED|Second Intervention||17
5242652|NCT00834795|12888786|P2|STARTED|Second Intervention||17
5242653|NCT00834795|12888787|P1|STARTED|Second Intervention||18
5242654|NCT00834795|12888786|P2|NOT COMPLETED|Washout: 7 Days||1
5242655|NCT00834795|12888787|P1|NOT COMPLETED|Washout: 7 Days||0
5242656|NCT00834795|12888786|P2|COMPLETED|Washout: 7 Days||17
5242657|NCT00834795|12888787|P1|COMPLETED|Washout: 7 Days||18
5242658|NCT00834795|12888786|P2|STARTED|Washout: 7 Days||18
5242659|NCT00834795|12888787|P1|STARTED|Washout: 7 Days||18
5242660|NCT00834795|12888786|P2|NOT COMPLETED|First Intervention||0
5242661|NCT00834795|12888787|P1|NOT COMPLETED|First Intervention||0
5242662|NCT00834795|12888786|P2|COMPLETED|First Intervention||18
5242663|NCT00834795|12888787|P1|COMPLETED|First Intervention||18
5242664|NCT00834795|12888786|P2|STARTED|First Intervention||18
5242665|NCT00834795|12888787|P1|STARTED|First Intervention||18
5242666|NCT00834756|12888797|P2|NOT COMPLETED|Second Intervention||0
5242667|NCT00834756|12888798|P1|NOT COMPLETED|Second Intervention||0
5242668|NCT00834756|12888797|P2|COMPLETED|Second Intervention||18
5242669|NCT00834756|12888798|P1|COMPLETED|Second Intervention||16
5242670|NCT00834756|12888797|P2|STARTED|Second Intervention||18
5242671|NCT00834756|12888798|P1|STARTED|Second Intervention||16
5242672|NCT00834756|12888797|P2|NOT COMPLETED|Washout: 21 Days||0
5242673|NCT00834756|12888798|P1|NOT COMPLETED|Washout: 21 Days||1
5242674|NCT00834756|12888797|P2|COMPLETED|Washout: 21 Days||18
5242675|NCT00834756|12888798|P1|COMPLETED|Washout: 21 Days||16
5242676|NCT00834756|12888797|P2|STARTED|Washout: 21 Days||18
5242677|NCT00834756|12888798|P1|STARTED|Washout: 21 Days||17
5242678|NCT00834756|12888797|P2|NOT COMPLETED|First Intervention||0
5242679|NCT00834756|12888798|P1|NOT COMPLETED|First Intervention||1
5242680|NCT00834756|12888797|P2|COMPLETED|First Intervention||18
5242681|NCT00834756|12888798|P1|COMPLETED|First Intervention||17
5242682|NCT00834756|12888797|P2|STARTED|First Intervention||18
5242683|NCT00834756|12888798|P1|STARTED|First Intervention||18
5242684|NCT00834743|12888808|P2|NOT COMPLETED|Second Intervention||0
5242685|NCT00834743|12888809|P1|NOT COMPLETED|Second Intervention||1
5242686|NCT00834743|12888808|P2|COMPLETED|Second Intervention||16
5242687|NCT00834743|12888809|P1|COMPLETED|Second Intervention||15
5242688|NCT00834743|12888808|P2|STARTED|Second Intervention||16
5242689|NCT00834743|12888809|P1|STARTED|Second Intervention||16
5242690|NCT00834743|12888808|P2|NOT COMPLETED|Washout of 7 Days||0
5242691|NCT00834743|12888809|P1|NOT COMPLETED|Washout of 7 Days||0
5242692|NCT00834743|12888808|P2|COMPLETED|Washout of 7 Days||16
5242693|NCT00834743|12888809|P1|COMPLETED|Washout of 7 Days||16
5242694|NCT00834743|12888808|P2|STARTED|Washout of 7 Days||16
5242695|NCT00834743|12888809|P1|STARTED|Washout of 7 Days||16
5242696|NCT00834743|12888808|P2|NOT COMPLETED|First Intervention||0
5242697|NCT00834743|12888809|P1|NOT COMPLETED|First Intervention||0
5242698|NCT00834743|12888808|P2|COMPLETED|First Intervention||16
5242699|NCT00834743|12888809|P1|COMPLETED|First Intervention||16
5242700|NCT00834743|12888808|P2|STARTED|First Intervention||16
5242701|NCT00834743|12888809|P1|STARTED|First Intervention||16
5242702|NCT00834717|12888819|P2|NOT COMPLETED|Second Intervention||0
5242703|NCT00834717|12888820|P1|NOT COMPLETED|Second Intervention||0
5242704|NCT00834717|12888819|P2|COMPLETED|Second Intervention||19
5242705|NCT00834717|12888820|P1|COMPLETED|Second Intervention||19
5242706|NCT00834717|12888819|P2|STARTED|Second Intervention||19
5242707|NCT00834717|12888820|P1|STARTED|Second Intervention||19
5242708|NCT00834717|12888819|P2|NOT COMPLETED|First Intervention||1
5242709|NCT00834717|12888820|P1|NOT COMPLETED|First Intervention||1
5242710|NCT00834717|12888819|P2|COMPLETED|First Intervention||19
5242711|NCT00834717|12888820|P1|COMPLETED|First Intervention||19
5242712|NCT00834717|12888819|P2|STARTED|First Intervention||20
5242713|NCT00834717|12888820|P1|STARTED|First Intervention||20
5242714|NCT00834678|12888828|P1|NOT COMPLETED|Overall Study||0
5242715|NCT00834678|12888828|P1|COMPLETED|Overall Study||11
5242716|NCT00834678|12888828|P1|STARTED|Overall Study||11
5242717|NCT00834652|12888842|P2|NOT COMPLETED|Overall Study||40
5242718|NCT00834652|12888843|P1|NOT COMPLETED|Overall Study||38
5242719|NCT00834652|12888842|P2|COMPLETED|Overall Study||62
5242720|NCT00834652|12888843|P1|COMPLETED|Overall Study||66
5242721|NCT00834652|12888842|P2|STARTED|Overall Study||102
5242722|NCT00834652|12888843|P1|STARTED|Overall Study||104
5242723|NCT00834639|12888851|P2|NOT COMPLETED|Second Intervention||2
5242724|NCT00834639|12888852|P1|NOT COMPLETED|Second Intervention||0
5242725|NCT00834639|12888851|P2|COMPLETED|Second Intervention||10
5242726|NCT00834639|12888852|P1|COMPLETED|Second Intervention||12
5242727|NCT00834639|12888851|P2|STARTED|Second Intervention||12
5242728|NCT00834639|12888852|P1|STARTED|Second Intervention||12
5242729|NCT00834639|12888851|P2|NOT COMPLETED|Washout of 7 Days||0
5242730|NCT00834639|12888852|P1|NOT COMPLETED|Washout of 7 Days||0
5242731|NCT00834639|12888851|P2|COMPLETED|Washout of 7 Days||12
5242732|NCT00834639|12888852|P1|COMPLETED|Washout of 7 Days||12
5242733|NCT00834639|12888851|P2|STARTED|Washout of 7 Days||12
5242734|NCT00834639|12888852|P1|STARTED|Washout of 7 Days||12
5242735|NCT00834639|12888851|P2|NOT COMPLETED|First Intervention||0
5242736|NCT00834639|12888852|P1|NOT COMPLETED|First Intervention||0
5242737|NCT00834639|12888851|P2|COMPLETED|First Intervention||12
5242738|NCT00834639|12888852|P1|COMPLETED|First Intervention||12
5242739|NCT00834639|12888851|P2|STARTED|First Intervention||12
5242740|NCT00834639|12888852|P1|STARTED|First Intervention||12
5242741|NCT00834626|12888860|P1|NOT COMPLETED|Overall Study||0
5242742|NCT00834626|12888860|P1|COMPLETED|Overall Study||30
5242743|NCT00834626|12888860|P1|1 Year Follow-up|Overall Study||30
5242744|NCT00834626|12888860|P1|STARTED|Overall Study||30
5242745|NCT00834613|12888869|P2|NOT COMPLETED|Second Intervention||0
5242746|NCT00834613|12888870|P1|NOT COMPLETED|Second Intervention||0
5242747|NCT00834613|12888869|P2|COMPLETED|Second Intervention||16
5242748|NCT00834613|12888870|P1|COMPLETED|Second Intervention||15
5242749|NCT00834613|12888869|P2|STARTED|Second Intervention||16
5242750|NCT00834613|12888870|P1|STARTED|Second Intervention||15
5242751|NCT00834613|12888869|P2|NOT COMPLETED|Washout of 7 Days||0
5242752|NCT00834613|12888870|P1|NOT COMPLETED|Washout of 7 Days||0
5242753|NCT00834613|12888869|P2|COMPLETED|Washout of 7 Days||16
5242754|NCT00834613|12888870|P1|COMPLETED|Washout of 7 Days||15
5242755|NCT00834613|12888869|P2|STARTED|Washout of 7 Days||16
5242756|NCT00834613|12888870|P1|STARTED|Washout of 7 Days||15
5242757|NCT00834613|12888869|P2|NOT COMPLETED|First Intervention||0
5242758|NCT00834613|12888870|P1|NOT COMPLETED|First Intervention||1
5242759|NCT00834613|12888869|P2|COMPLETED|First Intervention||16
5242760|NCT00834613|12888870|P1|COMPLETED|First Intervention||15
5242761|NCT00834613|12888869|P2|STARTED|First Intervention||16
5242762|NCT00834613|12888870|P1|STARTED|First Intervention||16
5242763|NCT00834587|12888880|P2|NOT COMPLETED|Second Intervention||0
5242764|NCT00834587|12888881|P1|NOT COMPLETED|Second Intervention||0
5242765|NCT00834587|12888880|P2|COMPLETED|Second Intervention||20
5242766|NCT00834587|12888881|P1|COMPLETED|Second Intervention||19
5242767|NCT00834587|12888880|P2|STARTED|Second Intervention||20
5242768|NCT00834587|12888881|P1|STARTED|Second Intervention||19
5242769|NCT00834587|12888880|P2|NOT COMPLETED|Washout: 7 Days||0
5242770|NCT00834587|12888881|P1|NOT COMPLETED|Washout: 7 Days||1
5242771|NCT00834587|12888880|P2|COMPLETED|Washout: 7 Days||20
5242772|NCT00834587|12888881|P1|COMPLETED|Washout: 7 Days||19
5242773|NCT00834587|12888880|P2|STARTED|Washout: 7 Days||20
5242774|NCT00834587|12888881|P1|STARTED|Washout: 7 Days||20
5242775|NCT00834587|12888880|P2|NOT COMPLETED|First Intervention||0
5242776|NCT00834587|12888881|P1|NOT COMPLETED|First Intervention||0
5242777|NCT00834587|12888880|P2|COMPLETED|First Intervention||20
5242778|NCT00834587|12888881|P1|COMPLETED|First Intervention||20
5242779|NCT00834587|12888880|P2|STARTED|First Intervention||20
5242780|NCT00834587|12888881|P1|STARTED|First Intervention||20
5242781|NCT00834574|12888897|P2|NOT COMPLETED|Second Intervention||0
5242782|NCT00834574|12888898|P1|NOT COMPLETED|Second Intervention||0
5242783|NCT00834574|12888897|P2|COMPLETED|Second Intervention||16
5242784|NCT00834574|12888898|P1|COMPLETED|Second Intervention||16
5242785|NCT00834574|12888897|P2|STARTED|Second Intervention||16
5242786|NCT00834574|12888898|P1|STARTED|Second Intervention||16
5242787|NCT00834574|12888897|P2|NOT COMPLETED|Washout of 7 Days||0
5242788|NCT00834574|12888898|P1|NOT COMPLETED|Washout of 7 Days||0
5242789|NCT00834574|12888897|P2|COMPLETED|Washout of 7 Days||16
5242790|NCT00834574|12888898|P1|COMPLETED|Washout of 7 Days||16
5242791|NCT00834574|12888897|P2|STARTED|Washout of 7 Days||16
5242792|NCT00834574|12888898|P1|STARTED|Washout of 7 Days||16
5242793|NCT00834574|12888897|P2|NOT COMPLETED|First Intervention||0
5242794|NCT00834574|12888898|P1|NOT COMPLETED|First Intervention||0
5242795|NCT00834574|12888897|P2|COMPLETED|First Intervention||16
5242796|NCT00834574|12888898|P1|COMPLETED|First Intervention||16
5242797|NCT00834574|12888897|P2|STARTED|First Intervention||16
5242798|NCT00834574|12888898|P1|STARTED|First Intervention||16
5242799|NCT00834561|12888908|P2|NOT COMPLETED|Second Intervention||0
5242800|NCT00834561|12888909|P1|NOT COMPLETED|Second Intervention||0
5242801|NCT00834561|12888908|P2|COMPLETED|Second Intervention||16
5242802|NCT00834561|12888909|P1|COMPLETED|Second Intervention||16
5242803|NCT00834561|12888908|P2|STARTED|Second Intervention||16
5242804|NCT00834561|12888909|P1|STARTED|Second Intervention||16
5242805|NCT00834561|12888908|P2|NOT COMPLETED|First Intervention||0
5242806|NCT00834561|12888909|P1|NOT COMPLETED|First Intervention||0
5242807|NCT00834561|12888908|P2|COMPLETED|First Intervention||16
5242808|NCT00834561|12888909|P1|COMPLETED|First Intervention||16
5242809|NCT00834561|12888908|P2|STARTED|First Intervention||16
5242810|NCT00834561|12888909|P1|STARTED|First Intervention||16
5242811|NCT00834535|12888919|P2|NOT COMPLETED|Second Intervention||0
5242812|NCT00834535|12888920|P1|NOT COMPLETED|Second Intervention||0
5242813|NCT00834535|12888919|P2|COMPLETED|Second Intervention||16
5242814|NCT00834535|12888920|P1|COMPLETED|Second Intervention||16
5242815|NCT00834535|12888919|P2|STARTED|Second Intervention||16
5242816|NCT00834535|12888920|P1|STARTED|Second Intervention||16
5242817|NCT00834535|12888919|P2|NOT COMPLETED|Washout of 7 Days||0
5242818|NCT00834535|12888920|P1|NOT COMPLETED|Washout of 7 Days||0
5242819|NCT00834535|12888919|P2|COMPLETED|Washout of 7 Days||16
5242820|NCT00834535|12888920|P1|COMPLETED|Washout of 7 Days||16
5242821|NCT00834535|12888919|P2|STARTED|Washout of 7 Days||16
5242822|NCT00834535|12888920|P1|STARTED|Washout of 7 Days||16
5242823|NCT00834535|12888919|P2|NOT COMPLETED|First Intervention||0
5242824|NCT00834535|12888920|P1|NOT COMPLETED|First Intervention||0
5242825|NCT00834535|12888919|P2|COMPLETED|First Intervention||16
5242826|NCT00834535|12888920|P1|COMPLETED|First Intervention||16
5242827|NCT00834535|12888919|P2|STARTED|First Intervention||16
5242828|NCT00834535|12888920|P1|STARTED|First Intervention||16
5242829|NCT00834522|12888930|P2|NOT COMPLETED|Second Intervention||0
5242830|NCT00834522|12888931|P1|NOT COMPLETED|Second Intervention||0
5242831|NCT00834522|12888930|P2|COMPLETED|Second Intervention||39
5242832|NCT00834522|12888931|P1|COMPLETED|Second Intervention||37
5242833|NCT00834522|12888930|P2|STARTED|Second Intervention||39
5242834|NCT00834522|12888931|P1|STARTED|Second Intervention||37
5242835|NCT00834522|12888930|P2|NOT COMPLETED|Washout||1
5242836|NCT00834522|12888931|P1|NOT COMPLETED|Washout||3
5242837|NCT00834522|12888930|P2|COMPLETED|Washout||39
5242838|NCT00834522|12888931|P1|COMPLETED|Washout||37
5242839|NCT00834522|12888930|P2|STARTED|Washout||40
5242840|NCT00834522|12888931|P1|STARTED|Washout||40
5242841|NCT00834522|12888930|P2|NOT COMPLETED|First Intervention||0
5242842|NCT00834522|12888931|P1|NOT COMPLETED|First Intervention||0
5242843|NCT00834522|12888930|P2|COMPLETED|First Intervention||40
5242844|NCT00834522|12888931|P1|COMPLETED|First Intervention||40
5242845|NCT00834522|12888930|P2|STARTED|First Intervention||40
5242846|NCT00834522|12888931|P1|STARTED|First Intervention||40
5242847|NCT00834483|12888941|P2|NOT COMPLETED|Overall Study||0
5242848|NCT00834483|12888942|P1|NOT COMPLETED|Overall Study||0
5242849|NCT00834483|12888941|P2|COMPLETED|Overall Study||29
5242850|NCT00834483|12888942|P1|COMPLETED|Overall Study||31
5242851|NCT00834483|12888941|P2|STARTED|Overall Study||29
5242852|NCT00834483|12888942|P1|STARTED|Overall Study||31
5242853|NCT00834444|12888954|P2|NOT COMPLETED|Second Intervention||0
5242854|NCT00834444|12888955|P1|NOT COMPLETED|Second Intervention||1
5242855|NCT00834444|12888954|P2|COMPLETED|Second Intervention||16
5242856|NCT00834444|12888955|P1|COMPLETED|Second Intervention||16
5242857|NCT00834444|12888954|P2|STARTED|Second Intervention||16
5242858|NCT00834444|12888955|P1|STARTED|Second Intervention||17
5242859|NCT00834444|12888954|P2|NOT COMPLETED|Washout of 7 Days||1
5242860|NCT00834444|12888955|P1|NOT COMPLETED|Washout of 7 Days||0
5242861|NCT00834444|12888954|P2|COMPLETED|Washout of 7 Days||16
5242862|NCT00834444|12888955|P1|COMPLETED|Washout of 7 Days||17
5242863|NCT00834444|12888954|P2|STARTED|Washout of 7 Days||17
5242864|NCT00834444|12888955|P1|STARTED|Washout of 7 Days||17
5242865|NCT00834444|12888954|P2|NOT COMPLETED|First Intervention||1
5242866|NCT00834444|12888955|P1|NOT COMPLETED|First Intervention||1
5242867|NCT00834444|12888954|P2|COMPLETED|First Intervention||17
5242868|NCT00834444|12888955|P1|COMPLETED|First Intervention||17
5242869|NCT00834444|12888954|P2|STARTED|First Intervention||18
5242870|NCT00834444|12888955|P1|STARTED|First Intervention||18
5242871|NCT00834431|12888965|P2|NOT COMPLETED|Second Intervention||0
5242872|NCT00834431|12888966|P1|NOT COMPLETED|Second Intervention||0
5242873|NCT00834431|12888965|P2|COMPLETED|Second Intervention||16
5242874|NCT00834431|12888966|P1|COMPLETED|Second Intervention||18
5242875|NCT00834431|12888965|P2|STARTED|Second Intervention||16
5242876|NCT00834431|12888966|P1|STARTED|Second Intervention||18
5242877|NCT00834431|12888965|P2|NOT COMPLETED|Washout of 7 Days||1
5242878|NCT00834431|12888966|P1|NOT COMPLETED|Washout of 7 Days||0
5242879|NCT00834431|12888965|P2|COMPLETED|Washout of 7 Days||16
5242880|NCT00834431|12888966|P1|COMPLETED|Washout of 7 Days||18
5242881|NCT00834431|12888965|P2|STARTED|Washout of 7 Days||17
5242882|NCT00834431|12888966|P1|STARTED|Washout of 7 Days||18
5242883|NCT00834431|12888965|P2|NOT COMPLETED|First Intervention||1
5242884|NCT00834431|12888966|P1|NOT COMPLETED|First Intervention||0
5242885|NCT00834431|12888965|P2|COMPLETED|First Intervention||17
5242886|NCT00834431|12888966|P1|COMPLETED|First Intervention||18
5242887|NCT00834431|12888965|P2|STARTED|First Intervention||18
5242888|NCT00834431|12888966|P1|STARTED|First Intervention||18
5242889|NCT00834418|12888976|P2|NOT COMPLETED|Overall Study||2
5242890|NCT00834418|12888977|P1|NOT COMPLETED|Overall Study||0
5242891|NCT00834418|12888976|P2|COMPLETED|Overall Study||40
5242892|NCT00834418|12888977|P1|COMPLETED|Overall Study||42
5242893|NCT00834418|12888976|P2|STARTED|Overall Study||42
5242894|NCT00834418|12888977|P1|STARTED|Overall Study||42
5242895|NCT00834405|12888985|P2|NOT COMPLETED|Overall Study||0
5242896|NCT00834405|12888986|P1|NOT COMPLETED|Overall Study||0
5242897|NCT00834405|12888985|P2|COMPLETED|Overall Study||17
5242898|NCT00834405|12888986|P1|COMPLETED|Overall Study||20
5242899|NCT00834405|12888985|P2|STARTED|Overall Study||17
5242900|NCT00834405|12888986|P1|STARTED|Overall Study||20
5242901|NCT00834366|12888994|P2|NOT COMPLETED|Treatment Period 2||0
5242902|NCT00834366|12888995|P1|NOT COMPLETED|Treatment Period 2||0
5242903|NCT00834366|12888994|P2|COMPLETED|Treatment Period 2||12
5242904|NCT00834366|12888995|P1|COMPLETED|Treatment Period 2||12
5242905|NCT00834366|12888994|P2|STARTED|Treatment Period 2||12
5242906|NCT00834366|12888995|P1|STARTED|Treatment Period 2||12
5242907|NCT00834366|12888994|P2|NOT COMPLETED|Treatment Period 1||1
5242908|NCT00834366|12888995|P1|NOT COMPLETED|Treatment Period 1||1
5242909|NCT00834366|12888994|P2|COMPLETED|Treatment Period 1||12
5242910|NCT00834366|12888995|P1|COMPLETED|Treatment Period 1||12
5242911|NCT00834366|12888994|P2|STARTED|Treatment Period 1||13
5242912|NCT00834366|12888995|P1|STARTED|Treatment Period 1||13
5242913|NCT00834340|12889011|P2|NOT COMPLETED|Second Intervention||0
5242914|NCT00834340|12889012|P1|NOT COMPLETED|Second Intervention||0
5242915|NCT00834340|12889011|P2|COMPLETED|Second Intervention||16
5242916|NCT00834340|12889012|P1|COMPLETED|Second Intervention||14
5242917|NCT00834340|12889011|P2|STARTED|Second Intervention||16
5242918|NCT00834340|12889012|P1|STARTED|Second Intervention||14
5242919|NCT00834340|12889011|P2|NOT COMPLETED|Washout||0
5242920|NCT00834340|12889012|P1|NOT COMPLETED|Washout||2
5242921|NCT00834340|12889011|P2|COMPLETED|Washout||16
5242922|NCT00834340|12889012|P1|COMPLETED|Washout||14
5242923|NCT00834340|12889011|P2|STARTED|Washout||16
5242924|NCT00834340|12889012|P1|STARTED|Washout||16
5242925|NCT00834340|12889011|P2|NOT COMPLETED|First Intervention||0
5242926|NCT00834340|12889012|P1|NOT COMPLETED|First Intervention||0
5242927|NCT00834340|12889011|P2|COMPLETED|First Intervention||16
5242928|NCT00834340|12889012|P1|COMPLETED|First Intervention||16
5242929|NCT00834340|12889011|P2|STARTED|First Intervention||16
5242930|NCT00834340|12889012|P1|STARTED|First Intervention||16
5242931|NCT00834288|12889022|P2|NOT COMPLETED|Treatment Phase II||0
5242932|NCT00834288|12889023|P1|NOT COMPLETED|Treatment Phase II||0
5242933|NCT00834288|12889022|P2|COMPLETED|Treatment Phase II||13
5242934|NCT00834288|12889023|P1|COMPLETED|Treatment Phase II||13
5242935|NCT00834288|12889022|P2|STARTED|Treatment Phase II||13
5242936|NCT00834288|12889023|P1|STARTED|Treatment Phase II||13
5242937|NCT00834288|12889022|P2|NOT COMPLETED|Treatment Phase I||0
5242938|NCT00834288|12889023|P1|NOT COMPLETED|Treatment Phase I||0
5242939|NCT00834288|12889022|P2|COMPLETED|Treatment Phase I||13
5242940|NCT00834288|12889023|P1|COMPLETED|Treatment Phase I||13
5242941|NCT00834288|12889022|P2|STARTED|Treatment Phase I||13
5242942|NCT00834288|12889023|P1|STARTED|Treatment Phase I||13
5242943|NCT00834275|12889045|P2|NOT COMPLETED|Second Intervention||0
5242944|NCT00834275|12889046|P1|NOT COMPLETED|Second Intervention||0
5242945|NCT00834275|12889045|P2|COMPLETED|Second Intervention||13
5242946|NCT00834275|12889046|P1|COMPLETED|Second Intervention||13
5242947|NCT00834275|12889045|P2|STARTED|Second Intervention||13
5242948|NCT00834275|12889046|P1|STARTED|Second Intervention||13
5242949|NCT00834275|12889045|P2|NOT COMPLETED|Washout of 7 Days||0
5242950|NCT00834275|12889046|P1|NOT COMPLETED|Washout of 7 Days||0
5242951|NCT00834275|12889045|P2|COMPLETED|Washout of 7 Days||13
5242952|NCT00834275|12889046|P1|COMPLETED|Washout of 7 Days||13
5242953|NCT00834275|12889045|P2|STARTED|Washout of 7 Days||13
5242954|NCT00834275|12889046|P1|STARTED|Washout of 7 Days||13
5242955|NCT00834275|12889045|P2|NOT COMPLETED|First Intervention||0
5242956|NCT00834275|12889046|P1|NOT COMPLETED|First Intervention||0
5242957|NCT00834275|12889045|P2|COMPLETED|First Intervention||13
5242958|NCT00834275|12889046|P1|COMPLETED|First Intervention||13
5242959|NCT00834275|12889045|P2|STARTED|First Intervention||13
5242960|NCT00834275|12889046|P1|STARTED|First Intervention||13
5242961|NCT00834249|12889056|P2|NOT COMPLETED|Second Intervention||0
5242962|NCT00834249|12889057|P1|NOT COMPLETED|Second Intervention||1
5242963|NCT00834249|12889056|P2|COMPLETED|Second Intervention||8
5242964|NCT00834249|12889057|P1|COMPLETED|Second Intervention||7
5242965|NCT00834249|12889056|P2|STARTED|Second Intervention||8
5242966|NCT00834249|12889057|P1|STARTED|Second Intervention||8
5242967|NCT00834249|12889056|P2|NOT COMPLETED|Washout: 7 Days||1
5242968|NCT00834249|12889057|P1|NOT COMPLETED|Washout: 7 Days||1
5242969|NCT00834249|12889056|P2|COMPLETED|Washout: 7 Days||8
5242970|NCT00834249|12889057|P1|COMPLETED|Washout: 7 Days||8
5242971|NCT00834249|12889056|P2|STARTED|Washout: 7 Days||9
5242972|NCT00834249|12889057|P1|STARTED|Washout: 7 Days||9
5242973|NCT00834249|12889056|P2|NOT COMPLETED|First Intervention||0
5242974|NCT00834249|12889057|P1|NOT COMPLETED|First Intervention||0
5242975|NCT00834249|12889056|P2|COMPLETED|First Intervention||9
5242976|NCT00834249|12889057|P1|COMPLETED|First Intervention||9
5242977|NCT00834249|12889056|P2|STARTED|First Intervention||9
5242978|NCT00834249|12889057|P1|STARTED|First Intervention||9
5242979|NCT00834236|12889073|P2|NOT COMPLETED|Overall Study||0
5242980|NCT00834236|12889074|P1|NOT COMPLETED|Overall Study||0
5242981|NCT00834236|12889073|P2|COMPLETED|Overall Study||47
5242982|NCT00834236|12889074|P1|COMPLETED|Overall Study||29
5242983|NCT00834236|12889073|P2|STARTED|Overall Study||47
5242984|NCT00834236|12889074|P1|STARTED|Overall Study||29
5242985|NCT00834210|12889082|P2|NOT COMPLETED|Overall Study||8
5242986|NCT00834210|12889083|P1|NOT COMPLETED|Overall Study||3
5242987|NCT00834210|12889082|P2|COMPLETED|Overall Study||77
5242988|NCT00834210|12889083|P1|COMPLETED|Overall Study||83
5242989|NCT00834210|12889082|P2|STARTED|Overall Study||85
5242990|NCT00834210|12889083|P1|STARTED|Overall Study||86
5242991|NCT00834197|12889097|P2|NOT COMPLETED|Second Intervention||0
5242992|NCT00834197|12889098|P1|NOT COMPLETED|Second Intervention||0
5242993|NCT00834197|12889097|P2|COMPLETED|Second Intervention||16
5242994|NCT00834197|12889098|P1|COMPLETED|Second Intervention||16
5242995|NCT00834197|12889097|P2|STARTED|Second Intervention||16
5242996|NCT00834197|12889098|P1|STARTED|Second Intervention||16
5242997|NCT00834197|12889097|P2|NOT COMPLETED|Washout of 14 Days||0
5242998|NCT00834197|12889098|P1|NOT COMPLETED|Washout of 14 Days||0
5242999|NCT00834197|12889097|P2|COMPLETED|Washout of 14 Days||16
5243000|NCT00834197|12889098|P1|COMPLETED|Washout of 14 Days||16
5243001|NCT00834197|12889097|P2|STARTED|Washout of 14 Days||16
5243002|NCT00834197|12889098|P1|STARTED|Washout of 14 Days||16
5243003|NCT00834197|12889097|P2|NOT COMPLETED|First Intervention||0
5243004|NCT00834197|12889098|P1|NOT COMPLETED|First Intervention||0
5243005|NCT00834197|12889097|P2|COMPLETED|First Intervention||16
5243006|NCT00834197|12889098|P1|COMPLETED|First Intervention||16
5243007|NCT00834197|12889097|P2|STARTED|First Intervention||16
5243008|NCT00834197|12889098|P1|STARTED|First Intervention||16
5243009|NCT00834171|12889108|P2|NOT COMPLETED|Overall Study||0
5243010|NCT00834171|12889109|P1|NOT COMPLETED|Overall Study||0
5243011|NCT00834171|12889108|P2|COMPLETED|Overall Study||7
5243012|NCT00834171|12889109|P1|COMPLETED|Overall Study||43
5243013|NCT00834171|12889108|P2|STARTED|Overall Study||7
5243014|NCT00834171|12889109|P1|STARTED|Overall Study||43
5243015|NCT00834132|12889117|P2|NOT COMPLETED|Second Intervention||0
5243016|NCT00834132|12889118|P1|NOT COMPLETED|Second Intervention||0
5243017|NCT00834132|12889117|P2|COMPLETED|Second Intervention||12
5243018|NCT00834132|12889118|P1|COMPLETED|Second Intervention||12
5243019|NCT00834132|12889117|P2|STARTED|Second Intervention||12
5243020|NCT00834132|12889118|P1|STARTED|Second Intervention||12
5243021|NCT00834132|12889117|P2|NOT COMPLETED|Washout: 21 Days||0
5243022|NCT00834132|12889118|P1|NOT COMPLETED|Washout: 21 Days||0
5243023|NCT00834132|12889117|P2|COMPLETED|Washout: 21 Days||12
5243024|NCT00834132|12889118|P1|COMPLETED|Washout: 21 Days||12
5243025|NCT00834132|12889117|P2|STARTED|Washout: 21 Days||12
5243026|NCT00834132|12889118|P1|STARTED|Washout: 21 Days||12
5243027|NCT00834132|12889117|P2|NOT COMPLETED|First Intervention||0
5243028|NCT00834132|12889118|P1|NOT COMPLETED|First Intervention||0
5243029|NCT00834132|12889117|P2|COMPLETED|First Intervention||12
5243030|NCT00834132|12889118|P1|COMPLETED|First Intervention||12
5243031|NCT00834132|12889117|P2|STARTED|First Intervention||12
5243032|NCT00834132|12889118|P1|STARTED|First Intervention||12
5243033|NCT00834106|12889128|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
5243034|NCT00834106|12889129|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
5243035|NCT00834106|12889128|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
5243036|NCT00834106|12889129|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
5243037|NCT00834106|12889128|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
5243038|NCT00834106|12889129|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
5243039|NCT00834106|12889128|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
5243040|NCT00834106|12889129|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
5243041|NCT00834106|12889128|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
5243042|NCT00834106|12889129|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
5243043|NCT00834106|12889128|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
5243044|NCT00834106|12889129|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
5243045|NCT00834106|12889128|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
5243046|NCT00834106|12889129|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
5243047|NCT00834106|12889128|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
5243048|NCT00834106|12889129|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
5243049|NCT00834080|12889153|P1|NOT COMPLETED|Overall Study||23
5243050|NCT00834080|12889153|P1|COMPLETED|Overall Study||15
5243051|NCT00834080|12889153|P1|STARTED|Overall Study||38
5243052|NCT00834067|12889159|P2|NOT COMPLETED|Second Intervention||0
5243053|NCT00834067|12889160|P1|NOT COMPLETED|Second Intervention||0
5243054|NCT00834067|12889159|P2|COMPLETED|Second Intervention||29
5243055|NCT00834067|12889160|P1|COMPLETED|Second Intervention||30
5243056|NCT00834067|12889159|P2|STARTED|Second Intervention||29
5243057|NCT00834067|12889160|P1|STARTED|Second Intervention||30
5243058|NCT00834067|12889159|P2|NOT COMPLETED|Washout of 21 Days||1
5243059|NCT00834067|12889160|P1|NOT COMPLETED|Washout of 21 Days||0
5243060|NCT00834067|12889159|P2|COMPLETED|Washout of 21 Days||29
5243061|NCT00834067|12889160|P1|COMPLETED|Washout of 21 Days||30
5243062|NCT00834067|12889159|P2|STARTED|Washout of 21 Days||30
5243063|NCT00834067|12889160|P1|STARTED|Washout of 21 Days||30
5243064|NCT00834067|12889159|P2|NOT COMPLETED|First Intervention||0
5243065|NCT00834067|12889160|P1|NOT COMPLETED|First Intervention||0
5243066|NCT00834067|12889159|P2|COMPLETED|First Intervention||30
5243067|NCT00834067|12889160|P1|COMPLETED|First Intervention||30
5243068|NCT00834067|12889159|P2|STARTED|First Intervention||30
5243069|NCT00834067|12889160|P1|STARTED|First Intervention||30
5243070|NCT00834041|12889182|P2|NOT COMPLETED|Overall Study||1
5243071|NCT00834041|12889183|P1|NOT COMPLETED|Overall Study||1
5243072|NCT00834041|12889182|P2|COMPLETED|Overall Study||19
5243073|NCT00834041|12889183|P1|COMPLETED|Overall Study||18
5243074|NCT00834041|12889182|P2|STARTED|Overall Study||20
5243075|NCT00834041|12889183|P1|STARTED|Overall Study||19
5243076|NCT00833989|12889201|P4|NOT COMPLETED|Overall Study||2
5243077|NCT00833989|12889202|P3|NOT COMPLETED|Overall Study||1
5243078|NCT00833989|12889203|P2|NOT COMPLETED|Overall Study||0
5243079|NCT00833989|12889204|P1|NOT COMPLETED|Overall Study||3
5243080|NCT00833989|12889201|P4|COMPLETED|Overall Study||6
5243081|NCT00833989|12889202|P3|COMPLETED|Overall Study||8
5243082|NCT00833989|12889203|P2|COMPLETED|Overall Study||8
5243083|NCT00833989|12889204|P1|COMPLETED|Overall Study||14
5243084|NCT00833989|12889201|P4|STARTED|Overall Study||8
5243085|NCT00833989|12889202|P3|STARTED|Overall Study||9
5243086|NCT00833989|12889203|P2|STARTED|Overall Study||8
5243087|NCT00833989|12889204|P1|STARTED|Overall Study||17
5243088|NCT00833976|12889308|P1|NOT COMPLETED|Overall Study||51
5243089|NCT00833976|12889308|P1|COMPLETED|Overall Study||14
5243090|NCT00833976|12889308|P1|STARTED|Overall Study||65
5243091|NCT00833937|12889316|P2|NOT COMPLETED|Second Intervention||0
5243092|NCT00833937|12889317|P1|NOT COMPLETED|Second Intervention||0
5243093|NCT00833937|12889316|P2|COMPLETED|Second Intervention||12
5243094|NCT00833937|12889317|P1|COMPLETED|Second Intervention||11
5243095|NCT00833937|12889316|P2|STARTED|Second Intervention||12
5243096|NCT00833937|12889317|P1|STARTED|Second Intervention||11
5243097|NCT00833937|12889316|P2|NOT COMPLETED|Washout||0
5243098|NCT00833937|12889317|P1|NOT COMPLETED|Washout||1
5243099|NCT00833937|12889316|P2|COMPLETED|Washout||12
5243100|NCT00833937|12889317|P1|COMPLETED|Washout||11
5243101|NCT00833937|12889316|P2|STARTED|Washout||12
5243102|NCT00833937|12889317|P1|STARTED|Washout||12
5243103|NCT00833937|12889316|P2|NOT COMPLETED|First Intervention||0
5243104|NCT00833937|12889317|P1|NOT COMPLETED|First Intervention||0
5243105|NCT00833937|12889316|P2|COMPLETED|First Intervention||12
5243106|NCT00833937|12889317|P1|COMPLETED|First Intervention||12
5243107|NCT00833937|12889316|P2|STARTED|First Intervention||12
5243108|NCT00833937|12889317|P1|STARTED|First Intervention||12
5243109|NCT00833924|12889325|P1|NOT COMPLETED|Overall Study||109
5243110|NCT00833924|12889325|P1|COMPLETED|Overall Study||11
5243111|NCT00833924|12889325|P1|12-month|Overall Study||113
5243112|NCT00833924|12889325|P1|30-day|Overall Study||120
5243113|NCT00833924|12889325|P1|STARTED|Overall Study||120
5243114|NCT00833911|12889330|P1|NOT COMPLETED|Maintenance Phase II||10
5243115|NCT00833911|12889330|P1|COMPLETED|Maintenance Phase II||166
5243116|NCT00833911|12889330|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
5243117|NCT00833911|12889330|P1|NOT COMPLETED|Maintenance Phase I||98
5243118|NCT00833911|12889330|P1|COMPLETED|Maintenance Phase I||273
5243119|NCT00833911|12889330|P1|STARTED|Maintenance Phase I||371
5243120|NCT00833911|12889330|P1|NOT COMPLETED|Titration||21
5243121|NCT00833911|12889330|P1|COMPLETED|Titration||371
5243122|NCT00833911|12889330|P1|STARTED|Titration||392
5243123|NCT00833898|12889340|P2|NOT COMPLETED|Overall Study||36
5243124|NCT00833898|12889341|P1|NOT COMPLETED|Overall Study||40
5243125|NCT00833898|12889340|P2|COMPLETED|Overall Study||38
5243126|NCT00833898|12889341|P1|COMPLETED|Overall Study||34
5243127|NCT00833898|12889340|P2|Month 12 (Post Transplantation)|Overall Study||50
5243128|NCT00833898|12889341|P1|Month 12 (Post Transplantation)|Overall Study||50
5243129|NCT00833898|12889340|P2|Month 6 (Post Transplantation)|Overall Study||54
5243130|NCT00833898|12889341|P1|Month 6 (Post Transplantation)|Overall Study||59
5243131|NCT00833898|12889340|P2|Month 3 (Post Transplantation)|Overall Study||64
5243132|NCT00833898|12889341|P1|Month 3 (Post Transplantation)|Overall Study||66
5243133|NCT00833898|12889340|P2|Month 1 (Post Transplantation)|Overall Study||74
5243134|NCT00833898|12889341|P1|Month 1 (Post Transplantation)|Overall Study||72
5243135|NCT00833898|12889340|P2|STARTED|Overall Study||74
5243136|NCT00833898|12889341|P1|STARTED|Overall Study||74
5243137|NCT00833859|12889387|P1|NOT COMPLETED|Overall Study||0
5243138|NCT00833859|12889387|P1|COMPLETED|Overall Study||2
5243139|NCT00833859|12889387|P1|STARTED|Overall Study||2
5243140|NCT00833833|12889400|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
5243141|NCT00833833|12889401|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
5243142|NCT00833833|12889402|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
5243143|NCT00833833|12889403|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
5243144|NCT00833833|12889404|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
5243145|NCT00833833|12889405|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
5243146|NCT00833833|12889400|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
5243147|NCT00833833|12889401|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
5243148|NCT00833833|12889402|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
5243149|NCT00833833|12889403|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
5243150|NCT00833833|12889404|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
5243151|NCT00833833|12889405|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
5243152|NCT00833833|12889400|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
5243153|NCT00833833|12889401|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
5243154|NCT00833833|12889402|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
5243155|NCT00833833|12889403|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
5243156|NCT00833833|12889404|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
5243157|NCT00833833|12889405|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
5243158|NCT00833833|12889400|P6|STARTED|Phase 2 (as of 01 April 2011)||108
5243159|NCT00833833|12889401|P5|STARTED|Phase 2 (as of 01 April 2011)||113
5243160|NCT00833833|12889402|P4|STARTED|Phase 2 (as of 01 April 2011)||0
5243161|NCT00833833|12889403|P3|STARTED|Phase 2 (as of 01 April 2011)||0
5243162|NCT00833833|12889404|P2|STARTED|Phase 2 (as of 01 April 2011)||0
5243163|NCT00833833|12889405|P1|STARTED|Phase 2 (as of 01 April 2011)||0
5243164|NCT00833833|12889400|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
5243165|NCT00833833|12889401|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
5243166|NCT00833833|12889402|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
5243167|NCT00833833|12889403|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
5243168|NCT00833833|12889404|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
5243169|NCT00833833|12889405|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
5243170|NCT00833833|12889400|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
5243171|NCT00833833|12889401|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
5243172|NCT00833833|12889402|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
5243173|NCT00833833|12889403|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
5243174|NCT00833833|12889404|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
5243175|NCT00833833|12889405|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
5243176|NCT00833833|12889400|P6|STARTED|Phase 1 (as of 01 April 2011)||0
5243177|NCT00833833|12889401|P5|STARTED|Phase 1 (as of 01 April 2011)||0
5243178|NCT00833833|12889402|P4|STARTED|Phase 1 (as of 01 April 2011)||10
5243179|NCT00833833|12889403|P3|STARTED|Phase 1 (as of 01 April 2011)||14
5243180|NCT00833833|12889404|P2|STARTED|Phase 1 (as of 01 April 2011)||8
5243181|NCT00833833|12889405|P1|STARTED|Phase 1 (as of 01 April 2011)||6
5243182|NCT00833794|12889445|P2|NOT COMPLETED|Double-blind Phase||49
5243183|NCT00833794|12889446|P1|NOT COMPLETED|Double-blind Phase||106
5243184|NCT00833794|12889445|P2|COMPLETED|Double-blind Phase||165
5243185|NCT00833794|12889446|P1|COMPLETED|Double-blind Phase||326
5243186|NCT00833794|12889445|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
5243187|NCT00833794|12889446|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
5243188|NCT00833794|12889445|P2|NOT COMPLETED|Open-label Phase||0
5243189|NCT00833794|12889446|P1|NOT COMPLETED|Open-label Phase||382
5243190|NCT00833794|12889445|P2|COMPLETED|Open-label Phase||0
5243191|NCT00833794|12889446|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
5243192|NCT00833794|12889445|P2|Received Open-Label Treatment|Open-label Phase||0
5243193|NCT00833794|12889446|P1|Received Open-Label Treatment|Open-label Phase||1023
5243194|NCT00833794|12889445|P2|Entered run-in Period|Open-label Phase||0
5243195|NCT00833794|12889446|P1|Entered run-in Period|Open-label Phase||1027
5243196|NCT00833794|12889445|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
5243197|NCT00833794|12889446|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
5243198|NCT00833781|12889474|P2|NOT COMPLETED|Overall Study||0
5243199|NCT00833781|12889475|P1|NOT COMPLETED|Overall Study||0
5243200|NCT00833781|12889474|P2|COMPLETED|Overall Study||5
5243201|NCT00833781|12889475|P1|COMPLETED|Overall Study||10
5243202|NCT00833781|12889474|P2|STARTED|Overall Study||5
5243203|NCT00833781|12889475|P1|STARTED|Overall Study||10
5243204|NCT00833755|12889490|P4|NOT COMPLETED|Overall Study||6
5243205|NCT00833755|12889491|P3|NOT COMPLETED|Overall Study||2
5243206|NCT00833755|12889492|P2|NOT COMPLETED|Overall Study||5
5243207|NCT00833755|12889493|P1|NOT COMPLETED|Overall Study||4
5243208|NCT00833755|12889490|P4|COMPLETED|Overall Study||17
5243209|NCT00833755|12889491|P3|COMPLETED|Overall Study||20
5243210|NCT00833755|12889492|P2|COMPLETED|Overall Study||13
5243211|NCT00833755|12889493|P1|COMPLETED|Overall Study||12
5243212|NCT00833755|12889490|P4|STARTED|Overall Study||23
5243213|NCT00833755|12889491|P3|STARTED|Overall Study||22
5243214|NCT00833755|12889492|P2|STARTED|Overall Study||18
5243215|NCT00833755|12889493|P1|STARTED|Overall Study||16
5243216|NCT00833703|12889513|P2|NOT COMPLETED|Overall Study||1
5243217|NCT00833703|12889514|P1|NOT COMPLETED|Overall Study||0
5243218|NCT00833703|12889513|P2|COMPLETED|Overall Study|Completed follow-up|25
5243219|NCT00833703|12889514|P1|COMPLETED|Overall Study|Completed follow-up|23
5243220|NCT00833703|12889513|P2|Completed Treatment|Overall Study||24
5243221|NCT00833703|12889514|P1|Completed Treatment|Overall Study||22
5243222|NCT00833703|12889513|P2|Treated|Overall Study||26
5243223|NCT00833703|12889514|P1|Treated|Overall Study||23
5243224|NCT00833703|12889513|P2|STARTED|Overall Study|Included|26
5243225|NCT00833703|12889514|P1|STARTED|Overall Study|Included|23
5243226|NCT00833690|12889527|P3|NOT COMPLETED|Overall Study||0
5243227|NCT00833690|12889528|P2|NOT COMPLETED|Overall Study||2
5243228|NCT00833690|12889529|P1|NOT COMPLETED|Overall Study||4
5243229|NCT00833690|12889527|P3|COMPLETED|Overall Study||26
5243230|NCT00833690|12889528|P2|COMPLETED|Overall Study||22
5243231|NCT00833690|12889529|P1|COMPLETED|Overall Study||21
5243232|NCT00833690|12889527|P3|STARTED|Overall Study||26
5243233|NCT00833690|12889528|P2|STARTED|Overall Study||24
5243234|NCT00833690|12889529|P1|STARTED|Overall Study||25
5243235|NCT00833664|12889653|P2|NOT COMPLETED|Second Intervention||0
5243236|NCT00833664|12889654|P1|NOT COMPLETED|Second Intervention||0
5243237|NCT00833664|12889653|P2|COMPLETED|Second Intervention||11
5243238|NCT00833664|12889654|P1|COMPLETED|Second Intervention||10
5243239|NCT00833664|12889653|P2|STARTED|Second Intervention||11
5243240|NCT00833664|12889654|P1|STARTED|Second Intervention||10
5243241|NCT00833664|12889653|P2|NOT COMPLETED|Washout: 14 Days||0
5243242|NCT00833664|12889654|P1|NOT COMPLETED|Washout: 14 Days||1
5243243|NCT00833664|12889653|P2|COMPLETED|Washout: 14 Days||11
5243244|NCT00833664|12889654|P1|COMPLETED|Washout: 14 Days||10
5243245|NCT00833664|12889653|P2|STARTED|Washout: 14 Days||11
5243246|NCT00833664|12889654|P1|STARTED|Washout: 14 Days||11
5243247|NCT00833664|12889653|P2|NOT COMPLETED|First Intervention||0
5243248|NCT00833664|12889654|P1|NOT COMPLETED|First Intervention||0
5243249|NCT00833664|12889653|P2|COMPLETED|First Intervention||11
5243250|NCT00833664|12889654|P1|COMPLETED|First Intervention||11
5243251|NCT00833664|12889653|P2|STARTED|First Intervention||11
5243252|NCT00833664|12889654|P1|STARTED|First Intervention||11
5243253|NCT00833638|12889665|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
5243254|NCT00833638|12889666|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
5243255|NCT00833638|12889667|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
5243256|NCT00833638|12889665|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
5243257|NCT00833638|12889666|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
5243258|NCT00833638|12889667|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
5243259|NCT00833638|12889665|P3|STARTED|Phase 3: Open-label Extension Phase||124
5243260|NCT00833638|12889666|P2|STARTED|Phase 3: Open-label Extension Phase||108
5243261|NCT00833638|12889667|P1|STARTED|Phase 3: Open-label Extension Phase||111
5243262|NCT00833638|12889665|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
5243263|NCT00833638|12889666|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
5243264|NCT00833638|12889667|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
5243265|NCT00833638|12889665|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
5243266|NCT00833638|12889666|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
5243267|NCT00833638|12889667|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
5243268|NCT00833638|12889665|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
5243269|NCT00833638|12889666|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
5243270|NCT00833638|12889667|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
5243271|NCT00833586|12889709|P2|NOT COMPLETED|Second Intervention||0
5243272|NCT00833586|12889710|P1|NOT COMPLETED|Second Intervention||0
5243273|NCT00833586|12889709|P2|COMPLETED|Second Intervention||14
5243274|NCT00833586|12889710|P1|COMPLETED|Second Intervention||14
5243275|NCT00833586|12889709|P2|STARTED|Second Intervention||14
5243276|NCT00833586|12889710|P1|STARTED|Second Intervention||14
5243277|NCT00833586|12889709|P2|NOT COMPLETED|Washout: 14 Days||0
5243278|NCT00833586|12889710|P1|NOT COMPLETED|Washout: 14 Days||0
5243279|NCT00833586|12889709|P2|COMPLETED|Washout: 14 Days||14
5243280|NCT00833586|12889710|P1|COMPLETED|Washout: 14 Days||14
5243281|NCT00833586|12889709|P2|STARTED|Washout: 14 Days||14
5243282|NCT00833586|12889710|P1|STARTED|Washout: 14 Days||14
5243283|NCT00833586|12889709|P2|NOT COMPLETED|First Intervention||0
5243284|NCT00833586|12889710|P1|NOT COMPLETED|First Intervention||0
5243285|NCT00833586|12889709|P2|COMPLETED|First Intervention||14
5243286|NCT00833586|12889710|P1|COMPLETED|First Intervention||14
5243287|NCT00833586|12889709|P2|STARTED|First Intervention||14
5243288|NCT00833586|12889710|P1|STARTED|First Intervention||14
5243289|NCT00833560|12889718|P1|NOT COMPLETED|Overall Study||42
5243290|NCT00833560|12889718|P1|COMPLETED|Overall Study||353
5243291|NCT00833560|12889718|P1|STARTED|Overall Study||395
5243292|NCT00833547|12889727|P2|NOT COMPLETED|Overall Study||2
5243293|NCT00833547|12889728|P1|NOT COMPLETED|Overall Study||2
5243294|NCT00833547|12889727|P2|COMPLETED|Overall Study||10
5243295|NCT00833547|12889728|P1|COMPLETED|Overall Study||11
5243296|NCT00833547|12889727|P2|STARTED|Overall Study||12
5243297|NCT00833547|12889728|P1|STARTED|Overall Study||13
5243298|NCT00833521|12889738|P2|NOT COMPLETED|Second Intervention||0
5243299|NCT00833521|12889739|P1|NOT COMPLETED|Second Intervention||0
5243300|NCT00833521|12889738|P2|COMPLETED|Second Intervention||19
5243301|NCT00833521|12889739|P1|COMPLETED|Second Intervention||19
5243302|NCT00833521|12889738|P2|STARTED|Second Intervention||19
5243303|NCT00833521|12889739|P1|STARTED|Second Intervention||19
5243304|NCT00833521|12889738|P2|NOT COMPLETED|First Intervention||0
5243305|NCT00833521|12889739|P1|NOT COMPLETED|First Intervention||0
5243306|NCT00833521|12889738|P2|COMPLETED|First Intervention||19
5243307|NCT00833521|12889739|P1|COMPLETED|First Intervention||19
5243308|NCT00833521|12889738|P2|STARTED|First Intervention||19
5243309|NCT00833521|12889739|P1|STARTED|First Intervention||19
5243310|NCT00833482|12889749|P6|NOT COMPLETED|Days 21-30||0
5243311|NCT00833482|12889750|P5|NOT COMPLETED|Days 21-30||1
5243312|NCT00833482|12889751|P4|NOT COMPLETED|Days 21-30||0
5243313|NCT00833482|12889752|P3|NOT COMPLETED|Days 21-30||1
5243314|NCT00833482|12889753|P2|NOT COMPLETED|Days 21-30||0
5243315|NCT00833482|12889754|P1|NOT COMPLETED|Days 21-30||0
5243316|NCT00833482|12889749|P6|COMPLETED|Days 21-30||0
5243317|NCT00833482|12889750|P5|COMPLETED|Days 21-30||7
5243318|NCT00833482|12889751|P4|COMPLETED|Days 21-30||0
5243319|NCT00833482|12889752|P3|COMPLETED|Days 21-30||20
5243320|NCT00833482|12889753|P2|COMPLETED|Days 21-30||0
5243321|NCT00833482|12889754|P1|COMPLETED|Days 21-30||0
5243322|NCT00833482|12889749|P6|STARTED|Days 21-30||0
5243323|NCT00833482|12889750|P5|STARTED|Days 21-30||8
5243324|NCT00833482|12889751|P4|STARTED|Days 21-30||0
5243325|NCT00833482|12889752|P3|STARTED|Days 21-30||21
5243326|NCT00833482|12889753|P2|STARTED|Days 21-30||0
5243327|NCT00833482|12889754|P1|STARTED|Days 21-30||0
5243328|NCT00833482|12889749|P6|NOT COMPLETED|Days 11-20||0
5243329|NCT00833482|12889750|P5|NOT COMPLETED|Days 11-20||0
5243330|NCT00833482|12889751|P4|NOT COMPLETED|Days 11-20||0
5243331|NCT00833482|12889752|P3|NOT COMPLETED|Days 11-20||0
5243332|NCT00833482|12889753|P2|NOT COMPLETED|Days 11-20||3
5243333|NCT00833482|12889754|P1|NOT COMPLETED|Days 11-20||0
5243334|NCT00833482|12889749|P6|COMPLETED|Days 11-20||8
5243335|NCT00833482|12889750|P5|COMPLETED|Days 11-20||0
5243336|NCT00833482|12889751|P4|COMPLETED|Days 11-20||0
5243337|NCT00833482|12889752|P3|COMPLETED|Days 11-20||0
5243338|NCT00833482|12889753|P2|COMPLETED|Days 11-20||21
5243339|NCT00833482|12889754|P1|COMPLETED|Days 11-20||0
5243340|NCT00833482|12889749|P6|STARTED|Days 11-20|Participants who received treatment.|8
5243341|NCT00833482|12889750|P5|STARTED|Days 11-20||0
5243342|NCT00833482|12889751|P4|STARTED|Days 11-20||0
5243343|NCT00833482|12889752|P3|STARTED|Days 11-20||0
5243344|NCT00833482|12889753|P2|STARTED|Days 11-20|Participants who received treatment.|24
5243345|NCT00833482|12889754|P1|STARTED|Days 11-20||0
5243346|NCT00833482|12889749|P6|NOT COMPLETED|Days 1-3||0
5243347|NCT00833482|12889750|P5|NOT COMPLETED|Days 1-3||0
5243348|NCT00833482|12889751|P4|NOT COMPLETED|Days 1-3||0
5243349|NCT00833482|12889752|P3|NOT COMPLETED|Days 1-3||0
5243350|NCT00833482|12889753|P2|NOT COMPLETED|Days 1-3||0
5243351|NCT00833482|12889754|P1|NOT COMPLETED|Days 1-3||0
5243352|NCT00833482|12889749|P6|COMPLETED|Days 1-3||0
5243353|NCT00833482|12889750|P5|COMPLETED|Days 1-3||0
5243354|NCT00833482|12889751|P4|COMPLETED|Days 1-3||8
5243355|NCT00833482|12889752|P3|COMPLETED|Days 1-3||0
5243356|NCT00833482|12889753|P2|COMPLETED|Days 1-3||0
5243357|NCT00833482|12889754|P1|COMPLETED|Days 1-3||24
5243358|NCT00833482|12889749|P6|STARTED|Days 1-3||0
5243359|NCT00833482|12889750|P5|STARTED|Days 1-3||0
5243360|NCT00833482|12889751|P4|STARTED|Days 1-3||8
5243361|NCT00833482|12889752|P3|STARTED|Days 1-3||0
5243362|NCT00833482|12889753|P2|STARTED|Days 1-3|Participants who received treatment|0
5243363|NCT00833482|12889754|P1|STARTED|Days 1-3|Participants who received treatment|24
5243364|NCT00833469|12889810|P1|NOT COMPLETED|Overall Study||2
5243365|NCT00833469|12889810|P1|COMPLETED|Overall Study||3
5243366|NCT00833469|12889810|P1|STARTED|Overall Study||5
5243367|NCT00833443|12889818|P2|NOT COMPLETED|Overall Study||28
5243368|NCT00833443|12889819|P1|NOT COMPLETED|Overall Study||20
5243369|NCT00833443|12889818|P2|COMPLETED|Overall Study||15
5243370|NCT00833443|12889819|P1|COMPLETED|Overall Study||21
5243371|NCT00833443|12889818|P2|STARTED|Overall Study||43
5243372|NCT00833443|12889819|P1|STARTED|Overall Study||41
5243373|NCT00833417|12889833|P2|NOT COMPLETED|Overall Study||71
5243374|NCT00833417|12889834|P1|NOT COMPLETED|Overall Study||33
5243375|NCT00833417|12889833|P2|COMPLETED|Overall Study||0
5243376|NCT00833417|12889834|P1|COMPLETED|Overall Study||0
5243377|NCT00833417|12889833|P2|STARTED|Overall Study||71
5243378|NCT00833417|12889834|P1|STARTED|Overall Study||33
5243379|NCT00833365|12889849|P2|NOT COMPLETED|Overall Study||0
5243380|NCT00833365|12889850|P1|NOT COMPLETED|Overall Study||0
5243381|NCT00833365|12889849|P2|COMPLETED|Overall Study||6
5243382|NCT00833365|12889850|P1|COMPLETED|Overall Study||9
5243383|NCT00833365|12889849|P2|STARTED|Overall Study||6
5243384|NCT00833365|12889850|P1|STARTED|Overall Study||9
5243385|NCT00833261|12889858|P1|NOT COMPLETED|Overall Study||4
5243386|NCT00833261|12889858|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
5243387|NCT00833261|12889858|P1|STARTED|Overall Study||37
5243388|NCT00833248|12889865|P2|NOT COMPLETED|Overall Study||3
5243389|NCT00833248|12889866|P1|NOT COMPLETED|Overall Study||4
5243390|NCT00833248|12889865|P2|COMPLETED|Overall Study||62
5243391|NCT00833248|12889866|P1|COMPLETED|Overall Study||177
5243392|NCT00833248|12889865|P2|Safety Analysis Set|Overall Study||64
5243393|NCT00833248|12889866|P1|Safety Analysis Set|Overall Study||181
5243394|NCT00833248|12889865|P2|Per Protocol (PP) Analysis Set|Overall Study||57
5243395|NCT00833248|12889866|P1|Per Protocol (PP) Analysis Set|Overall Study||164
5243396|NCT00833248|12889865|P2|Full Analysis Set (FAS)|Overall Study||64
5243397|NCT00833248|12889866|P1|Full Analysis Set (FAS)|Overall Study||180
5243398|NCT00833248|12889865|P2|STARTED|Overall Study||65
5243399|NCT00833248|12889866|P1|STARTED|Overall Study||181
5243400|NCT00833105|12889888|P1|NOT COMPLETED|Overall Study||3
5243401|NCT00833105|12889888|P1|COMPLETED|Overall Study||10
5243402|NCT00833105|12889888|P1|STARTED|Overall Study||13
5243403|NCT00833092|12889906|P2|NOT COMPLETED|Overall Study||7
5243404|NCT00833092|12889907|P1|NOT COMPLETED|Overall Study||4
5243405|NCT00833092|12889906|P2|COMPLETED|Overall Study||50
5243406|NCT00833092|12889907|P1|COMPLETED|Overall Study||50
5243407|NCT00833092|12889906|P2|STARTED|Overall Study||57
5243408|NCT00833092|12889907|P1|STARTED|Overall Study||54
5243409|NCT00833053|12889915|P2|NOT COMPLETED|Overall Study||3
5243410|NCT00833053|12889916|P1|NOT COMPLETED|Overall Study||9
5243411|NCT00833053|12889915|P2|COMPLETED|Overall Study||17
5243412|NCT00833053|12889916|P1|COMPLETED|Overall Study||10
5243413|NCT00833053|12889915|P2|STARTED|Overall Study||20
5243414|NCT00833053|12889916|P1|STARTED|Overall Study||19
5243415|NCT00833040|12889934|P6|NOT COMPLETED|Overall Study||1
5243416|NCT00833040|12889935|P5|NOT COMPLETED|Overall Study||0
5243417|NCT00833040|12889936|P4|NOT COMPLETED|Overall Study||0
5243418|NCT00833040|12889937|P3|NOT COMPLETED|Overall Study||0
5243419|NCT00833040|12889938|P2|NOT COMPLETED|Overall Study||0
5243420|NCT00833040|12889939|P1|NOT COMPLETED|Overall Study||0
5243421|NCT00833040|12889934|P6|COMPLETED|Overall Study||4
5243422|NCT00833040|12889935|P5|COMPLETED|Overall Study||5
5243423|NCT00833040|12889936|P4|COMPLETED|Overall Study||6
5243424|NCT00833040|12889937|P3|COMPLETED|Overall Study||6
5243425|NCT00833040|12889938|P2|COMPLETED|Overall Study||6
5243426|NCT00833040|12889939|P1|COMPLETED|Overall Study||6
5243427|NCT00833040|12889934|P6|STARTED|Overall Study||5
5243428|NCT00833040|12889935|P5|STARTED|Overall Study||5
5243429|NCT00833040|12889936|P4|STARTED|Overall Study||6
5243430|NCT00833040|12889937|P3|STARTED|Overall Study||6
5243431|NCT00833040|12889938|P2|STARTED|Overall Study||6
5243432|NCT00833040|12889939|P1|STARTED|Overall Study||6
5243433|NCT00833027|12889944|P1|NOT COMPLETED|Overall Study||211
5243434|NCT00833027|12889944|P1|COMPLETED|Overall Study||397
5243435|NCT00833027|12889944|P1|STARTED|Overall Study||608
5243436|NCT00832975|12889949|P1|NOT COMPLETED|Overall Study||39
5243437|NCT00832975|12889949|P1|COMPLETED|Overall Study||118
5243438|NCT00832975|12889949|P1|STARTED|Overall Study||157
5243439|NCT00832871|12889954|P1|NOT COMPLETED|Overall Study||0
5243440|NCT00832871|12889954|P1|COMPLETED|Overall Study||4
5243441|NCT00832871|12889954|P1|STARTED|Overall Study||4
5243442|NCT00832819|12889963|P3|NOT COMPLETED|Overall Study||1
5243443|NCT00832819|12889964|P2|NOT COMPLETED|Overall Study||1
5243444|NCT00832819|12889965|P1|NOT COMPLETED|Overall Study||0
5243445|NCT00832819|12889963|P3|COMPLETED|Overall Study||15
5243446|NCT00832819|12889964|P2|COMPLETED|Overall Study||5
5243447|NCT00832819|12889965|P1|COMPLETED|Overall Study||6
5243448|NCT00832819|12889963|P3|STARTED|Overall Study||16
5243449|NCT00832819|12889964|P2|STARTED|Overall Study||6
5243450|NCT00832819|12889965|P1|STARTED|Overall Study||6
5243451|NCT00832780|12889971|P1|NOT COMPLETED|Overall Study||25
5243452|NCT00832780|12889971|P1|COMPLETED|Overall Study||19
5243453|NCT00832780|12889971|P1|STARTED|Overall Study||44
5243454|NCT00832767|12889981|P2|NOT COMPLETED|Overall Study||18
5243455|NCT00832767|12889982|P1|NOT COMPLETED|Overall Study||22
5243456|NCT00832767|12889981|P2|COMPLETED|Overall Study||63
5243457|NCT00832767|12889982|P1|COMPLETED|Overall Study||99
5243458|NCT00832767|12889981|P2|STARTED|Overall Study||81
5243459|NCT00832767|12889982|P1|STARTED|Overall Study||121
5243460|NCT00832650|12890013|P3|NOT COMPLETED|Overall Study||1
5243461|NCT00832650|12890014|P2|NOT COMPLETED|Overall Study||0
5243462|NCT00832650|12890015|P1|NOT COMPLETED|Overall Study||0
5243463|NCT00832650|12890013|P3|COMPLETED|Overall Study||22
5243464|NCT00832650|12890014|P2|COMPLETED|Overall Study||12
5243465|NCT00832650|12890015|P1|COMPLETED|Overall Study||25
5243466|NCT00832650|12890013|P3|Treated|Overall Study||22
5243467|NCT00832650|12890014|P2|Treated|Overall Study||12
5243468|NCT00832650|12890015|P1|Treated|Overall Study||25
5243469|NCT00832650|12890013|P3|STARTED|Overall Study||23
5243470|NCT00832650|12890014|P2|STARTED|Overall Study||12
5243471|NCT00832650|12890015|P1|STARTED|Overall Study||25
5243472|NCT00832637|12890047|P1|NOT COMPLETED|Overall Study||0
5243473|NCT00832637|12890047|P1|COMPLETED|Overall Study||33
5243474|NCT00832637|12890047|P1|STARTED|Overall Study||33
5243475|NCT00832624|12890055|P1|NOT COMPLETED|Overall Study||10
5243476|NCT00832624|12890055|P1|COMPLETED|Overall Study||0
5243477|NCT00832624|12890055|P1|STARTED|Overall Study||10
5243478|NCT00832598|12890059|P1|NOT COMPLETED|Overall Study||0
5243479|NCT00832598|12890059|P1|COMPLETED|Overall Study||13
5243480|NCT00832598|12890059|P1|STARTED|Overall Study||13
5243481|NCT00832585|12890065|P1|NOT COMPLETED|Overall Study||2
5243482|NCT00832585|12890065|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
5243483|NCT00832585|12890065|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
5243484|NCT00832572|12890072|P2|NOT COMPLETED|Period 2||0
5243485|NCT00832572|12890073|P1|NOT COMPLETED|Period 2||0
5243486|NCT00832572|12890072|P2|COMPLETED|Period 2||2
5243487|NCT00832572|12890073|P1|COMPLETED|Period 2||3
5243488|NCT00832572|12890072|P2|STARTED|Period 2||2
5243489|NCT00832572|12890073|P1|STARTED|Period 2||3
5243490|NCT00832572|12890072|P2|NOT COMPLETED|Period 1||0
5243491|NCT00832572|12890073|P1|NOT COMPLETED|Period 1||0
5243492|NCT00832572|12890072|P2|COMPLETED|Period 1||2
5243493|NCT00832572|12890073|P1|COMPLETED|Period 1||3
5243494|NCT00832572|12890072|P2|STARTED|Period 1||2
5243495|NCT00832572|12890073|P1|STARTED|Period 1||3
5243496|NCT00832520|12890085|P1|NOT COMPLETED|Overall Study||0
5243497|NCT00832520|12890085|P1|COMPLETED|Overall Study||13
5243498|NCT00832520|12890085|P1|STARTED|Overall Study||13
5243499|NCT00832455|12890090|P1|NOT COMPLETED|Overall Study||72
5243500|NCT00832455|12890090|P1|COMPLETED|Overall Study||373
5243501|NCT00832455|12890090|P1|Week 12|Overall Study||373
5243502|NCT00832455|12890090|P1|Week 8 (Optional)|Overall Study||247
5243503|NCT00832455|12890090|P1|Week 4|Overall Study||411
5243504|NCT00832455|12890090|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
5243505|NCT00832455|12890090|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
5243506|NCT00832416|12890114|P4|NOT COMPLETED|Overall Study||83
5243507|NCT00832416|12890115|P3|NOT COMPLETED|Overall Study||61
5243508|NCT00832416|12890116|P2|NOT COMPLETED|Overall Study||53
5243509|NCT00832416|12890117|P1|NOT COMPLETED|Overall Study||46
5243510|NCT00832416|12890114|P4|COMPLETED|Overall Study||144
5243511|NCT00832416|12890115|P3|COMPLETED|Overall Study||54
5243512|NCT00832416|12890116|P2|COMPLETED|Overall Study||60
5243513|NCT00832416|12890117|P1|COMPLETED|Overall Study||64
5243514|NCT00832416|12890114|P4|STARTED|Overall Study||227
5243515|NCT00832416|12890115|P3|STARTED|Overall Study||115
5243516|NCT00832416|12890116|P2|STARTED|Overall Study||113
5243517|NCT00832416|12890117|P1|STARTED|Overall Study||110
5243518|NCT00832390|12890158|P3|NOT COMPLETED|Overall Study||0
5243519|NCT00832390|12890159|P2|NOT COMPLETED|Overall Study||0
5243520|NCT00832390|12890160|P1|NOT COMPLETED|Overall Study||0
5243521|NCT00832390|12890158|P3|COMPLETED|Overall Study||1
5243522|NCT00832390|12890159|P2|COMPLETED|Overall Study||16
5243523|NCT00832390|12890160|P1|COMPLETED|Overall Study||12
5243524|NCT00832390|12890158|P3|STARTED|Overall Study||1
5243525|NCT00832390|12890159|P2|STARTED|Overall Study||16
5243526|NCT00832390|12890160|P1|STARTED|Overall Study||12
5243527|NCT00832377|12890168|P1|NOT COMPLETED|Overall Study||1
5243528|NCT00832377|12890168|P1|COMPLETED|Overall Study||36
5243529|NCT00832377|12890168|P1|STARTED|Overall Study||37
5243530|NCT00832338|12890175|P1|NOT COMPLETED|Overall Study||0
5243531|NCT00832338|12890175|P1|COMPLETED|Overall Study||23
5243532|NCT00832338|12890175|P1|STARTED|Overall Study||23
5243533|NCT00832299|12890179|P1|NOT COMPLETED|Overall Study||0
5243534|NCT00832299|12890179|P1|COMPLETED|Overall Study||2
5243535|NCT00832299|12890179|P1|STARTED|Overall Study||2
5243536|NCT00832260|12890184|P1|NOT COMPLETED|Overall Study||0
5243537|NCT00832260|12890184|P1|COMPLETED|Overall Study||70
5243538|NCT00832260|12890184|P1|STARTED|Overall Study||70
5243539|NCT00832130|12890191|P2|NOT COMPLETED|Overall Study||0
5243540|NCT00832130|12890192|P1|NOT COMPLETED|Overall Study||0
5243541|NCT00832130|12890191|P2|COMPLETED|Overall Study||70
5243542|NCT00832130|12890192|P1|COMPLETED|Overall Study||69
5243543|NCT00832130|12890191|P2|STARTED|Overall Study||70
5243544|NCT00832130|12890192|P1|STARTED|Overall Study||69
5243545|NCT00832117|12890214|P1|NOT COMPLETED|Overall Study||12
5243546|NCT00832117|12890214|P1|COMPLETED|Overall Study||17
5243547|NCT00832117|12890214|P1|STARTED|Overall Study||29
5243548|NCT00832091|12890233|P2|NOT COMPLETED|Overall Study||2
5243549|NCT00832091|12890234|P1|NOT COMPLETED|Overall Study||5
5243550|NCT00832091|12890233|P2|COMPLETED|Overall Study||53
5243551|NCT00832091|12890234|P1|COMPLETED|Overall Study||12
5243552|NCT00832091|12890233|P2|STARTED|Overall Study||55
5243553|NCT00832091|12890234|P1|STARTED|Overall Study||17
5243554|NCT00832078|12890242|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
5243555|NCT00832078|12890243|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
5243556|NCT00832078|12890242|P2|COMPLETED|Test Day 2 - 2 Period||10
5243557|NCT00832078|12890243|P1|COMPLETED|Test Day 2 - 2 Period||12
5243558|NCT00832078|12890242|P2|STARTED|Test Day 2 - 2 Period||10
5243559|NCT00832078|12890243|P1|STARTED|Test Day 2 - 2 Period||13
5243560|NCT00832078|12890242|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
5243561|NCT00832078|12890243|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
5243562|NCT00832078|12890242|P2|COMPLETED|Test Day 2 - 1 Period||10
5243563|NCT00832078|12890243|P1|COMPLETED|Test Day 2 - 1 Period||13
5243564|NCT00832078|12890242|P2|STARTED|Test Day 2 - 1 Period||10
5243565|NCT00832078|12890243|P1|STARTED|Test Day 2 - 1 Period||13
5243566|NCT00832078|12890242|P2|NOT COMPLETED|Test Day 1-2 Period||2
5243567|NCT00832078|12890243|P1|NOT COMPLETED|Test Day 1-2 Period||0
5243568|NCT00832078|12890242|P2|COMPLETED|Test Day 1-2 Period||10
5243569|NCT00832078|12890243|P1|COMPLETED|Test Day 1-2 Period||13
5243570|NCT00832078|12890242|P2|STARTED|Test Day 1-2 Period||12
5243571|NCT00832078|12890243|P1|STARTED|Test Day 1-2 Period||13
5243572|NCT00832078|12890242|P2|NOT COMPLETED|Test Day 1- 1 Period||0
5243573|NCT00832078|12890243|P1|NOT COMPLETED|Test Day 1- 1 Period||0
5243574|NCT00832078|12890242|P2|COMPLETED|Test Day 1- 1 Period||12
5243575|NCT00832078|12890243|P1|COMPLETED|Test Day 1- 1 Period||13
5243576|NCT00832078|12890242|P2|STARTED|Test Day 1- 1 Period||12
5243577|NCT00832078|12890243|P1|STARTED|Test Day 1- 1 Period||13
5243578|NCT00832000|12890249|P2|NOT COMPLETED|Overall Study||1
5243579|NCT00832000|12890250|P1|NOT COMPLETED|Overall Study||6
5243580|NCT00832000|12890249|P2|COMPLETED|Overall Study||29
5243581|NCT00832000|12890250|P1|COMPLETED|Overall Study||23
5243582|NCT00832000|12890249|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
5243583|NCT00832000|12890250|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
5243584|NCT00832000|12890249|P2|STARTED|Overall Study|Placebo|30
5243585|NCT00832000|12890250|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
5243586|NCT00831987|12890288|P2|NOT COMPLETED|Overall Study||0
5243587|NCT00831987|12890289|P1|NOT COMPLETED|Overall Study||0
5243588|NCT00831987|12890288|P2|COMPLETED|Overall Study||60
5243589|NCT00831987|12890289|P1|COMPLETED|Overall Study||60
5243590|NCT00831987|12890288|P2|STARTED|Overall Study||60
5243591|NCT00831987|12890289|P1|STARTED|Overall Study||60
5243592|NCT00831844|12890311|P10|NOT COMPLETED|Overall Study||0
5243593|NCT00831844|12890312|P9|NOT COMPLETED|Overall Study||9
5243594|NCT00831844|12890313|P8|NOT COMPLETED|Overall Study||10
5243595|NCT00831844|12890314|P7|NOT COMPLETED|Overall Study||10
5243596|NCT00831844|12890315|P6|NOT COMPLETED|Overall Study||19
5243597|NCT00831844|12890316|P5|NOT COMPLETED|Overall Study||14
5243598|NCT00831844|12890317|P4|NOT COMPLETED|Overall Study||10
5243599|NCT00831844|12890318|P3|NOT COMPLETED|Overall Study||20
5243600|NCT00831844|12890319|P2|NOT COMPLETED|Overall Study||12
5243601|NCT00831844|12890320|P1|NOT COMPLETED|Overall Study||10
5243602|NCT00831844|12890311|P10|COMPLETED|Overall Study||0
5243603|NCT00831844|12890312|P9|COMPLETED|Overall Study||0
5243604|NCT00831844|12890313|P8|COMPLETED|Overall Study||0
5243605|NCT00831844|12890314|P7|COMPLETED|Overall Study||0
5243606|NCT00831844|12890315|P6|COMPLETED|Overall Study||1
5243607|NCT00831844|12890316|P5|COMPLETED|Overall Study||0
5243608|NCT00831844|12890317|P4|COMPLETED|Overall Study||0
5243609|NCT00831844|12890318|P3|COMPLETED|Overall Study||1
5243610|NCT00831844|12890319|P2|COMPLETED|Overall Study||0
5243611|NCT00831844|12890320|P1|COMPLETED|Overall Study||0
5243612|NCT00831844|12890311|P10|STARTED|Overall Study||0
5243613|NCT00831844|12890312|P9|STARTED|Overall Study||9
5243614|NCT00831844|12890313|P8|STARTED|Overall Study||10
5243615|NCT00831844|12890314|P7|STARTED|Overall Study||10
5243616|NCT00831844|12890315|P6|STARTED|Overall Study||20
5243617|NCT00831844|12890316|P5|STARTED|Overall Study||14
5243618|NCT00831844|12890317|P4|STARTED|Overall Study||10
5243619|NCT00831844|12890318|P3|STARTED|Overall Study||21
5243620|NCT00831844|12890319|P2|STARTED|Overall Study||12
5243621|NCT00831844|12890320|P1|STARTED|Overall Study||10
5243622|NCT00831792|12890342|P1|NOT COMPLETED|Overall Study||6
5243623|NCT00831792|12890342|P1|COMPLETED|Overall Study||40
5243624|NCT00831792|12890342|P1|STARTED|Overall Study||46
5243625|NCT00831779|12890348|P2|NOT COMPLETED|Overall Study||1
5243626|NCT00831779|12890349|P1|NOT COMPLETED|Overall Study||1
5243627|NCT00831779|12890348|P2|COMPLETED|Overall Study||22
5243628|NCT00831779|12890349|P1|COMPLETED|Overall Study||20
5243629|NCT00831779|12890348|P2|STARTED|Overall Study||23
5243630|NCT00831779|12890349|P1|STARTED|Overall Study||21
5243631|NCT00831766|12890359|P2|NOT COMPLETED|Overall Study||0
5243632|NCT00831766|12890360|P1|NOT COMPLETED|Overall Study||0
5243633|NCT00831766|12890359|P2|COMPLETED|Overall Study||28
5243634|NCT00831766|12890360|P1|COMPLETED|Overall Study||23
5243635|NCT00831766|12890359|P2|STARTED|Overall Study||28
5243636|NCT00831766|12890360|P1|STARTED|Overall Study||23
5243637|NCT00831753|12890371|P2|NOT COMPLETED|Overall Study||0
5243638|NCT00831753|12890372|P1|NOT COMPLETED|Overall Study||0
5243639|NCT00831753|12890371|P2|COMPLETED|Overall Study||131
5243640|NCT00831753|12890372|P1|COMPLETED|Overall Study||132
5243641|NCT00831753|12890371|P2|STARTED|Overall Study||131
5243642|NCT00831753|12890372|P1|STARTED|Overall Study||132
5243643|NCT00831701|12890386|P2|NOT COMPLETED|Overall Study||5
5243644|NCT00831701|12890387|P1|NOT COMPLETED|Overall Study||5
5243645|NCT00831701|12890386|P2|COMPLETED|Overall Study||45
5243646|NCT00831701|12890387|P1|COMPLETED|Overall Study||45
5243647|NCT00831701|12890386|P2|STARTED|Overall Study||50
5243648|NCT00831701|12890387|P1|STARTED|Overall Study||50
5243649|NCT00831675|12890403|P2|NOT COMPLETED|Overall Study||0
5243650|NCT00831675|12890404|P1|NOT COMPLETED|Overall Study||0
5243651|NCT00831675|12890403|P2|COMPLETED|Overall Study||18
5243652|NCT00831675|12890404|P1|COMPLETED|Overall Study||12
5243653|NCT00831675|12890403|P2|STARTED|Overall Study||18
5243654|NCT00831675|12890404|P1|STARTED|Overall Study||12
5243655|NCT00831493|12890416|P1|NOT COMPLETED|Overall Study||1
5243656|NCT00831493|12890416|P1|COMPLETED|Overall Study||2
5243657|NCT00831493|12890416|P1|STARTED|Overall Study||3
5243658|NCT00831480|12890420|P1|NOT COMPLETED|Overall Study||2
5243659|NCT00831480|12890420|P1|COMPLETED|Overall Study||7
5243660|NCT00831480|12890420|P1|STARTED|Overall Study||9
5243661|NCT00831441|12890426|P2|NOT COMPLETED|Follow Up (30 Days)||174
5243662|NCT00831441|12890427|P1|NOT COMPLETED|Follow Up (30 Days)||133
5243663|NCT00831441|12890426|P2|COMPLETED|Follow Up (30 Days)||3355
5243664|NCT00831441|12890427|P1|COMPLETED|Follow Up (30 Days)||3375
5243665|NCT00831441|12890426|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
5243666|NCT00831441|12890427|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
5243667|NCT00831441|12890426|P2|NOT COMPLETED|Randomized||3705
5243668|NCT00831441|12890427|P1|NOT COMPLETED|Randomized||3687
5243669|NCT00831441|12890426|P2|COMPLETED|Randomized||0
5243670|NCT00831441|12890427|P1|COMPLETED|Randomized||0
5243671|NCT00831441|12890426|P2|Treated|Randomized||3672
5243672|NCT00831441|12890427|P1|Treated|Randomized||3643
5243673|NCT00831441|12890426|P2|STARTED|Randomized||3705
5243674|NCT00831441|12890427|P1|STARTED|Randomized||3687
5243675|NCT00831428|12890455|P1|NOT COMPLETED|Overall Study||0
5243676|NCT00831428|12890455|P1|COMPLETED|Overall Study||97
5243677|NCT00831428|12890455|P1|STARTED|Overall Study||97
5243678|NCT00831415|12890459|P1|NOT COMPLETED|Overall Study||75
5243679|NCT00831415|12890459|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
5243680|NCT00831415|12890459|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
5243681|NCT00831415|12890459|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
5243682|NCT00831415|12890459|P1|STARTED|Overall Study||304
5243683|NCT00831389|12890468|P2|NOT COMPLETED|Overall Study||1
5243684|NCT00831389|12890469|P1|NOT COMPLETED|Overall Study||0
5243685|NCT00831389|12890468|P2|COMPLETED|Overall Study||6
5243686|NCT00831389|12890469|P1|COMPLETED|Overall Study||6
5243687|NCT00831389|12890468|P2|STARTED|Overall Study||7
5243688|NCT00831389|12890469|P1|STARTED|Overall Study||6
5243689|NCT00831311|12890495|P2|NOT COMPLETED|Overall Study||8
5243690|NCT00831311|12890496|P1|NOT COMPLETED|Overall Study||12
5243691|NCT00831311|12890495|P2|COMPLETED|Overall Study||304
5243692|NCT00831311|12890496|P1|COMPLETED|Overall Study||300
5243693|NCT00831311|12890495|P2|STARTED|Overall Study||312
5243694|NCT00831311|12890496|P1|STARTED|Overall Study||312
5243695|NCT00831272|12890518|P4|NOT COMPLETED|Overall Study||10
5243696|NCT00831272|12890519|P3|NOT COMPLETED|Overall Study||10
5243697|NCT00831272|12890520|P2|NOT COMPLETED|Overall Study||7
5243698|NCT00831272|12890521|P1|NOT COMPLETED|Overall Study||8
5243699|NCT00831272|12890518|P4|COMPLETED|Overall Study||56
5243700|NCT00831272|12890519|P3|COMPLETED|Overall Study||63
5243701|NCT00831272|12890520|P2|COMPLETED|Overall Study||37
5243702|NCT00831272|12890521|P1|COMPLETED|Overall Study||30
5243703|NCT00831272|12890518|P4|STARTED|Overall Study||66
5243704|NCT00831272|12890519|P3|STARTED|Overall Study||73
5243705|NCT00831272|12890520|P2|STARTED|Overall Study||44
5243706|NCT00831272|12890521|P1|STARTED|Overall Study||38
5243707|NCT00831233|12890533|P2|NOT COMPLETED|Overall Study||1
5243708|NCT00831233|12890534|P1|NOT COMPLETED|Overall Study||3
5243709|NCT00831233|12890533|P2|COMPLETED|Overall Study||12
5243710|NCT00831233|12890534|P1|COMPLETED|Overall Study||26
5243711|NCT00831233|12890533|P2|Per Protocol (PP) Analysis Set|Overall Study||11
5243712|NCT00831233|12890534|P1|Per Protocol (PP) Analysis Set|Overall Study||26
5243713|NCT00831233|12890533|P2|Full Analysis Set (FAS)|Overall Study||13
5243714|NCT00831233|12890534|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
5243715|NCT00831233|12890533|P2|STARTED|Overall Study|ITT population.|13
5243716|NCT00831233|12890534|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
5243717|NCT00831181|12890558|P1|NOT COMPLETED|Overall Study||12
5243718|NCT00831181|12890558|P1|COMPLETED|Overall Study||15
5243719|NCT00831181|12890558|P1|STARTED|Overall Study||27
5243720|NCT00831129|12890571|P2|NOT COMPLETED|Overall Study||10
5243721|NCT00831129|12890572|P1|NOT COMPLETED|Overall Study||0
5243722|NCT00831129|12890571|P2|COMPLETED|Overall Study||23
5243723|NCT00831129|12890572|P1|COMPLETED|Overall Study||20
5243724|NCT00831129|12890571|P2|STARTED|Overall Study||33
5243725|NCT00831129|12890572|P1|STARTED|Overall Study||20
5243726|NCT00830960|12890614|P6|NOT COMPLETED|Overall Study||37
5243727|NCT00830960|12890615|P5|NOT COMPLETED|Overall Study||32
5243728|NCT00830960|12890616|P4|NOT COMPLETED|Overall Study||32
5243729|NCT00830960|12890617|P3|NOT COMPLETED|Overall Study||29
5243730|NCT00830960|12890618|P2|NOT COMPLETED|Overall Study||28
5243731|NCT00830960|12890619|P1|NOT COMPLETED|Overall Study||33
5243732|NCT00830960|12890614|P6|COMPLETED|Overall Study||63
5243733|NCT00830960|12890615|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
5243734|NCT00830960|12890616|P4|COMPLETED|Overall Study||106
5243735|NCT00830960|12890617|P3|COMPLETED|Overall Study||108
5243736|NCT00830960|12890618|P2|COMPLETED|Overall Study||96
5243737|NCT00830960|12890619|P1|COMPLETED|Overall Study||91
5243738|NCT00830960|12890614|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
5243739|NCT00830960|12890615|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
5243740|NCT00830960|12890616|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
5243741|NCT00830960|12890617|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
5243742|NCT00830960|12890618|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
5243743|NCT00830960|12890619|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
5243744|NCT00830960|12890614|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
5243745|NCT00830960|12890615|P5|STARTED|Overall Study||96
5243746|NCT00830960|12890616|P4|STARTED|Overall Study||138
5243747|NCT00830960|12890617|P3|STARTED|Overall Study||137
5243748|NCT00830960|12890618|P2|STARTED|Overall Study||124
5243749|NCT00830960|12890619|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
5243750|NCT00830947|12890735|P2|NOT COMPLETED|Overall Study||4
5243751|NCT00830947|12890736|P1|NOT COMPLETED|Overall Study||4
5243752|NCT00830947|12890735|P2|COMPLETED|Overall Study||18
5243753|NCT00830947|12890736|P1|COMPLETED|Overall Study||19
5243754|NCT00830947|12890735|P2|STARTED|Overall Study||22
5243755|NCT00830947|12890736|P1|STARTED|Overall Study||23
5243756|NCT00830869|12890754|P12|NOT COMPLETED|Period 2: Part 2||20
5243757|NCT00830869|12890755|P11|NOT COMPLETED|Period 2: Part 2||11
5243758|NCT00830869|12890756|P10|NOT COMPLETED|Period 2: Part 2||20
5243759|NCT00830869|12890757|P9|NOT COMPLETED|Period 2: Part 2||22
5243760|NCT00830869|12890758|P8|NOT COMPLETED|Period 2: Part 2||20
5243761|NCT00830869|12890759|P7|NOT COMPLETED|Period 2: Part 2||0
5243762|NCT00830869|12890760|P6|NOT COMPLETED|Period 2: Part 2||0
5243763|NCT00830869|12890761|P5|NOT COMPLETED|Period 2: Part 2||0
5243764|NCT00830869|12890762|P4|NOT COMPLETED|Period 2: Part 2||0
5243765|NCT00830869|12890763|P3|NOT COMPLETED|Period 2: Part 2||0
5243766|NCT00830869|12890764|P2|NOT COMPLETED|Period 2: Part 2||0
5243767|NCT00830869|12890765|P1|NOT COMPLETED|Period 2: Part 2||0
5243768|NCT00830869|12890754|P12|COMPLETED|Period 2: Part 2||0
5243769|NCT00830869|12890755|P11|COMPLETED|Period 2: Part 2||0
5243770|NCT00830869|12890756|P10|COMPLETED|Period 2: Part 2||0
5243771|NCT00830869|12890757|P9|COMPLETED|Period 2: Part 2||0
5243772|NCT00830869|12890758|P8|COMPLETED|Period 2: Part 2||0
5243773|NCT00830869|12890759|P7|COMPLETED|Period 2: Part 2||0
5243774|NCT00830869|12890760|P6|COMPLETED|Period 2: Part 2||0
5243775|NCT00830869|12890761|P5|COMPLETED|Period 2: Part 2||0
5243776|NCT00830869|12890762|P4|COMPLETED|Period 2: Part 2||0
5243777|NCT00830869|12890763|P3|COMPLETED|Period 2: Part 2||0
5243778|NCT00830869|12890764|P2|COMPLETED|Period 2: Part 2||0
5243779|NCT00830869|12890765|P1|COMPLETED|Period 2: Part 2||0
5243780|NCT00830869|12890754|P12|STARTED|Period 2: Part 2||20
5243781|NCT00830869|12890755|P11|STARTED|Period 2: Part 2||11
5243782|NCT00830869|12890756|P10|STARTED|Period 2: Part 2||20
5243783|NCT00830869|12890757|P9|STARTED|Period 2: Part 2||22
5243784|NCT00830869|12890758|P8|STARTED|Period 2: Part 2||20
5243785|NCT00830869|12890759|P7|STARTED|Period 2: Part 2||0
5243786|NCT00830869|12890760|P6|STARTED|Period 2: Part 2||0
5243787|NCT00830869|12890761|P5|STARTED|Period 2: Part 2||0
5243788|NCT00830869|12890762|P4|STARTED|Period 2: Part 2||0
5243789|NCT00830869|12890763|P3|STARTED|Period 2: Part 2||0
5243790|NCT00830869|12890764|P2|STARTED|Period 2: Part 2||0
5243791|NCT00830869|12890765|P1|STARTED|Period 2: Part 2||0
5243792|NCT00830869|12890754|P12|NOT COMPLETED|Period 1: Part 1||0
5243793|NCT00830869|12890755|P11|NOT COMPLETED|Period 1: Part 1||0
5243794|NCT00830869|12890756|P10|NOT COMPLETED|Period 1: Part 1||0
5243795|NCT00830869|12890757|P9|NOT COMPLETED|Period 1: Part 1||0
5243796|NCT00830869|12890758|P8|NOT COMPLETED|Period 1: Part 1||0
5243797|NCT00830869|12890759|P7|NOT COMPLETED|Period 1: Part 1||3
5243798|NCT00830869|12890760|P6|NOT COMPLETED|Period 1: Part 1||6
5243799|NCT00830869|12890761|P5|NOT COMPLETED|Period 1: Part 1||4
5243800|NCT00830869|12890762|P4|NOT COMPLETED|Period 1: Part 1||7
5243801|NCT00830869|12890763|P3|NOT COMPLETED|Period 1: Part 1||1
5243802|NCT00830869|12890764|P2|NOT COMPLETED|Period 1: Part 1||1
5243803|NCT00830869|12890765|P1|NOT COMPLETED|Period 1: Part 1||1
5243804|NCT00830869|12890754|P12|COMPLETED|Period 1: Part 1||0
5243805|NCT00830869|12890755|P11|COMPLETED|Period 1: Part 1||0
5243806|NCT00830869|12890756|P10|COMPLETED|Period 1: Part 1||0
5243807|NCT00830869|12890757|P9|COMPLETED|Period 1: Part 1||0
5243808|NCT00830869|12890758|P8|COMPLETED|Period 1: Part 1||0
5243809|NCT00830869|12890759|P7|COMPLETED|Period 1: Part 1||0
5243810|NCT00830869|12890760|P6|COMPLETED|Period 1: Part 1||0
5243811|NCT00830869|12890761|P5|COMPLETED|Period 1: Part 1||0
5243812|NCT00830869|12890762|P4|COMPLETED|Period 1: Part 1||0
5243813|NCT00830869|12890763|P3|COMPLETED|Period 1: Part 1||0
5243814|NCT00830869|12890764|P2|COMPLETED|Period 1: Part 1||0
5243815|NCT00830869|12890765|P1|COMPLETED|Period 1: Part 1||0
5243816|NCT00830869|12890754|P12|STARTED|Period 1: Part 1||0
5243817|NCT00830869|12890755|P11|STARTED|Period 1: Part 1||0
5243818|NCT00830869|12890756|P10|STARTED|Period 1: Part 1||0
5243819|NCT00830869|12890757|P9|STARTED|Period 1: Part 1||0
5243820|NCT00830869|12890758|P8|STARTED|Period 1: Part 1||0
5243821|NCT00830869|12890759|P7|STARTED|Period 1: Part 1||3
5243822|NCT00830869|12890760|P6|STARTED|Period 1: Part 1||6
5243823|NCT00830869|12890761|P5|STARTED|Period 1: Part 1||4
5243824|NCT00830869|12890762|P4|STARTED|Period 1: Part 1||7
5243825|NCT00830869|12890763|P3|STARTED|Period 1: Part 1||1
5243826|NCT00830869|12890764|P2|STARTED|Period 1: Part 1||1
5243827|NCT00830869|12890765|P1|STARTED|Period 1: Part 1||1
5243828|NCT00830804|12890901|P1|NOT COMPLETED|Overall Study||15
5243829|NCT00830804|12890901|P1|COMPLETED|Overall Study||97
5243830|NCT00830804|12890901|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
5243831|NCT00830791|12890927|P6|NOT COMPLETED|Overall Study||0
5243832|NCT00830791|12890928|P5|NOT COMPLETED|Overall Study||0
5243833|NCT00830791|12890929|P4|NOT COMPLETED|Overall Study||0
5243834|NCT00830791|12890930|P3|NOT COMPLETED|Overall Study||0
5243835|NCT00830791|12890931|P2|NOT COMPLETED|Overall Study||0
5243836|NCT00830791|12890932|P1|NOT COMPLETED|Overall Study||0
5243837|NCT00830791|12890927|P6|COMPLETED|Overall Study||0
5243838|NCT00830791|12890928|P5|COMPLETED|Overall Study||0
5243839|NCT00830791|12890929|P4|COMPLETED|Overall Study||8
5243840|NCT00830791|12890930|P3|COMPLETED|Overall Study||8
5243841|NCT00830791|12890931|P2|COMPLETED|Overall Study||8
5243842|NCT00830791|12890932|P1|COMPLETED|Overall Study||8
5243843|NCT00830791|12890927|P6|STARTED|Overall Study||0
5243844|NCT00830791|12890928|P5|STARTED|Overall Study||0
5243845|NCT00830791|12890929|P4|STARTED|Overall Study||8
5243846|NCT00830791|12890930|P3|STARTED|Overall Study||8
5243847|NCT00830791|12890931|P2|STARTED|Overall Study||8
5243848|NCT00830791|12890932|P1|STARTED|Overall Study||8
5243849|NCT00830765|12890981|P2|NOT COMPLETED|Overall Study||2
5243850|NCT00830765|12890982|P1|NOT COMPLETED|Overall Study||3
5243851|NCT00830765|12890981|P2|COMPLETED|Overall Study||69
5243852|NCT00830765|12890982|P1|COMPLETED|Overall Study||70
5243853|NCT00830765|12890981|P2|STARTED|Overall Study||71
5243854|NCT00830765|12890982|P1|STARTED|Overall Study||73
5243855|NCT00830596|12890991|P3|NOT COMPLETED|Overall Study||6
5243856|NCT00830596|12890992|P2|NOT COMPLETED|Overall Study||2
5243857|NCT00830596|12890993|P1|NOT COMPLETED|Overall Study||2
5243858|NCT00830596|12890991|P3|COMPLETED|Overall Study||67
5243859|NCT00830596|12890992|P2|COMPLETED|Overall Study||72
5243860|NCT00830596|12890993|P1|COMPLETED|Overall Study||72
5243861|NCT00830596|12890991|P3|STARTED|Overall Study||73
5243862|NCT00830596|12890992|P2|STARTED|Overall Study||74
5243863|NCT00830596|12890993|P1|STARTED|Overall Study||74
5243864|NCT00830518|12891015|P2|NOT COMPLETED|Overall Study||11
5243865|NCT00830518|12891016|P1|NOT COMPLETED|Overall Study||46
5243866|NCT00830518|12891015|P2|COMPLETED|Overall Study||0
5243867|NCT00830518|12891016|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
5243868|NCT00830518|12891015|P2|STARTED|Overall Study||11
5243869|NCT00830518|12891016|P1|STARTED|Overall Study||46
5243870|NCT00830440|12891035|P2|NOT COMPLETED|Overall Study||0
5243871|NCT00830440|12891036|P1|NOT COMPLETED|Overall Study||8
5243872|NCT00830440|12891035|P2|COMPLETED|Overall Study||11
5243873|NCT00830440|12891036|P1|COMPLETED|Overall Study||24
5243874|NCT00830440|12891035|P2|Completed 24 Week Follow up|Overall Study||0
5243875|NCT00830440|12891036|P1|Completed 24 Week Follow up|Overall Study||3
5243876|NCT00830440|12891035|P2|Completed 16 Week Follow up|Overall Study||0
5243877|NCT00830440|12891036|P1|Completed 16 Week Follow up|Overall Study||4
5243878|NCT00830440|12891035|P2|Completed 12 Week Follow up|Overall Study||11
5243879|NCT00830440|12891036|P1|Completed 12 Week Follow up|Overall Study||24
5243880|NCT00830440|12891035|P2|Received Device|Overall Study||0
5243881|NCT00830440|12891036|P1|Received Device|Overall Study||26
5243882|NCT00830440|12891035|P2|STARTED|Overall Study||11
5243883|NCT00830440|12891036|P1|STARTED|Overall Study||32
5243884|NCT00830388|12891046|P1|NOT COMPLETED|Overall Study||0
5243885|NCT00830388|12891046|P1|COMPLETED|Overall Study||11
5243886|NCT00830388|12891046|P1|STARTED|Overall Study||11
5243887|NCT00830375|12891051|P1|NOT COMPLETED|Overall Study||1
5243888|NCT00830375|12891051|P1|COMPLETED|Overall Study||9
5243889|NCT00830375|12891051|P1|STARTED|Overall Study||10
5243890|NCT00830362|12891057|P2|NOT COMPLETED|Overall Study||4
5243891|NCT00830362|12891058|P1|NOT COMPLETED|Overall Study||4
5243892|NCT00830362|12891057|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
5243893|NCT00830362|12891058|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
5243894|NCT00830362|12891057|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
5243895|NCT00830362|12891058|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
5243896|NCT00830362|12891057|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
5243897|NCT00830362|12891058|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
5243898|NCT00830336|12891066|P2|NOT COMPLETED|Second Intervention||0
5243899|NCT00830336|12891067|P1|NOT COMPLETED|Second Intervention||0
5243900|NCT00830336|12891066|P2|COMPLETED|Second Intervention||40
5243901|NCT00830336|12891067|P1|COMPLETED|Second Intervention||39
5243902|NCT00830336|12891066|P2|STARTED|Second Intervention||40
5243903|NCT00830336|12891067|P1|STARTED|Second Intervention||39
5243904|NCT00830336|12891066|P2|NOT COMPLETED|Washout: 21 Days||0
5243905|NCT00830336|12891067|P1|NOT COMPLETED|Washout: 21 Days||1
5243906|NCT00830336|12891066|P2|COMPLETED|Washout: 21 Days||40
5243907|NCT00830336|12891067|P1|COMPLETED|Washout: 21 Days||39
5243908|NCT00830336|12891066|P2|STARTED|Washout: 21 Days||40
5243909|NCT00830336|12891067|P1|STARTED|Washout: 21 Days||40
5243910|NCT00830336|12891066|P2|NOT COMPLETED|First Intervention||0
5243911|NCT00830336|12891067|P1|NOT COMPLETED|First Intervention||0
5243912|NCT00830336|12891066|P2|COMPLETED|First Intervention||40
5243913|NCT00830336|12891067|P1|COMPLETED|First Intervention||40
5243914|NCT00830336|12891066|P2|STARTED|First Intervention||40
5243915|NCT00830336|12891067|P1|STARTED|First Intervention||40
5243916|NCT00830310|12891075|P1|NOT COMPLETED|Overall Study||13
5243917|NCT00830310|12891075|P1|COMPLETED|Overall Study||30
5243918|NCT00830310|12891075|P1|STARTED|Overall Study||43
5243919|NCT00830284|12891087|P1|NOT COMPLETED|Overall Study||2
5243920|NCT00830284|12891087|P1|COMPLETED|Overall Study||10
5243921|NCT00830284|12891087|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
5243922|NCT00830258|12891094|P2|NOT COMPLETED|Second Intervention||0
5243923|NCT00830258|12891095|P1|NOT COMPLETED|Second Intervention||0
5243924|NCT00830258|12891094|P2|COMPLETED|Second Intervention||30
5243925|NCT00830258|12891095|P1|COMPLETED|Second Intervention||28
5243926|NCT00830258|12891094|P2|STARTED|Second Intervention||30
5243927|NCT00830258|12891095|P1|STARTED|Second Intervention||28
5243928|NCT00830258|12891094|P2|NOT COMPLETED|Washout: 7 Days||0
5243929|NCT00830258|12891095|P1|NOT COMPLETED|Washout: 7 Days||1
5243930|NCT00830258|12891094|P2|COMPLETED|Washout: 7 Days||30
5243931|NCT00830258|12891095|P1|COMPLETED|Washout: 7 Days||28
5243932|NCT00830258|12891094|P2|STARTED|Washout: 7 Days||30
5243933|NCT00830258|12891095|P1|STARTED|Washout: 7 Days||29
5243934|NCT00830258|12891094|P2|NOT COMPLETED|First Intervention||0
5243935|NCT00830258|12891095|P1|NOT COMPLETED|First Intervention||1
5243936|NCT00830258|12891094|P2|COMPLETED|First Intervention||30
5243937|NCT00830258|12891095|P1|COMPLETED|First Intervention||29
5243938|NCT00830258|12891094|P2|STARTED|First Intervention||30
5243939|NCT00830258|12891095|P1|STARTED|First Intervention||30
5243940|NCT00830232|12891105|P2|NOT COMPLETED|Overall Study||0
5243941|NCT00830232|12891106|P1|NOT COMPLETED|Overall Study||0
5243942|NCT00830232|12891105|P2|COMPLETED|Overall Study||20
5243943|NCT00830232|12891106|P1|COMPLETED|Overall Study||20
5243944|NCT00830232|12891105|P2|STARTED|Overall Study||20
5243945|NCT00830232|12891106|P1|STARTED|Overall Study||20
5243946|NCT00830219|12891114|P2|NOT COMPLETED|Second Intervention||0
5243947|NCT00830219|12891115|P1|NOT COMPLETED|Second Intervention||0
5243948|NCT00830219|12891114|P2|COMPLETED|Second Intervention||22
5243949|NCT00830219|12891115|P1|COMPLETED|Second Intervention||22
5243950|NCT00830219|12891114|P2|STARTED|Second Intervention||22
5243951|NCT00830219|12891115|P1|STARTED|Second Intervention||22
5243952|NCT00830219|12891114|P2|NOT COMPLETED|Washout of 7 Days||1
5243953|NCT00830219|12891115|P1|NOT COMPLETED|Washout of 7 Days||1
5243954|NCT00830219|12891114|P2|COMPLETED|Washout of 7 Days||22
5243955|NCT00830219|12891115|P1|COMPLETED|Washout of 7 Days||22
5243956|NCT00830219|12891114|P2|STARTED|Washout of 7 Days||23
5243957|NCT00830219|12891115|P1|STARTED|Washout of 7 Days||23
5243958|NCT00830219|12891114|P2|NOT COMPLETED|First Intervention||0
5243959|NCT00830219|12891115|P1|NOT COMPLETED|First Intervention||0
5243960|NCT00830219|12891114|P2|COMPLETED|First Intervention||23
5243961|NCT00830219|12891115|P1|COMPLETED|First Intervention||23
5243962|NCT00830219|12891114|P2|STARTED|First Intervention||23
5243963|NCT00830219|12891115|P1|STARTED|First Intervention||23
5243964|NCT00830206|12891125|P2|NOT COMPLETED|Second Intervention||0
5243965|NCT00830206|12891126|P1|NOT COMPLETED|Second Intervention||0
5243966|NCT00830206|12891125|P2|COMPLETED|Second Intervention||39
5243967|NCT00830206|12891126|P1|COMPLETED|Second Intervention||39
5243968|NCT00830206|12891125|P2|STARTED|Second Intervention||39
5243969|NCT00830206|12891126|P1|STARTED|Second Intervention||39
5243970|NCT00830206|12891125|P2|NOT COMPLETED|Washout: 21 Days||1
5243971|NCT00830206|12891126|P1|NOT COMPLETED|Washout: 21 Days||1
5243972|NCT00830206|12891125|P2|COMPLETED|Washout: 21 Days||39
5243973|NCT00830206|12891126|P1|COMPLETED|Washout: 21 Days||39
5243974|NCT00830206|12891125|P2|STARTED|Washout: 21 Days||40
5243975|NCT00830206|12891126|P1|STARTED|Washout: 21 Days||40
5243976|NCT00830206|12891125|P2|NOT COMPLETED|First Intervention||0
5243977|NCT00830206|12891126|P1|NOT COMPLETED|First Intervention||0
5243978|NCT00830206|12891125|P2|COMPLETED|First Intervention||40
5243979|NCT00830206|12891126|P1|COMPLETED|First Intervention||40
5243980|NCT00830206|12891125|P2|STARTED|First Intervention||40
5243981|NCT00830206|12891126|P1|STARTED|First Intervention||40
5243982|NCT00830167|12891136|P2|NOT COMPLETED|Overall Study||43
5243983|NCT00830167|12891137|P1|NOT COMPLETED|Overall Study||40
5243984|NCT00830167|12891136|P2|COMPLETED|Overall Study||207
5243985|NCT00830167|12891137|P1|COMPLETED|Overall Study||208
5243986|NCT00830167|12891136|P2|STARTED|Overall Study|Treated|250
5243987|NCT00830167|12891137|P1|STARTED|Overall Study|Treated|248
5243988|NCT00830128|12891207|P1|NOT COMPLETED|Overall Study||19
5243989|NCT00830128|12891207|P1|COMPLETED|Overall Study||87
5243990|NCT00830128|12891207|P1|STARTED|Overall Study||106
5243991|NCT00830115|12891222|P1|NOT COMPLETED|Overall Study||3
5243992|NCT00830115|12891222|P1|COMPLETED|Overall Study||1042
5243993|NCT00830115|12891222|P1|STARTED|Overall Study||1045
5243994|NCT00830076|12891238|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
5243995|NCT00830076|12891238|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
5243996|NCT00830076|12891238|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
5243997|NCT00830076|12891238|P1|NOT COMPLETED|7-day Washout||0
5243998|NCT00830076|12891238|P1|COMPLETED|7-day Washout||18
5243999|NCT00830076|12891238|P1|STARTED|7-day Washout||18
5244000|NCT00830076|12891238|P1|NOT COMPLETED|Sitagliptin + Metformin||0
5244001|NCT00830076|12891238|P1|COMPLETED|Sitagliptin + Metformin||18
5244002|NCT00830076|12891238|P1|STARTED|Sitagliptin + Metformin||18
5244003|NCT00830076|12891238|P1|NOT COMPLETED|7-day Washout||0
5244004|NCT00830076|12891238|P1|COMPLETED|7-day Washout||18
5244005|NCT00830076|12891238|P1|STARTED|7-day Washout||18
5244006|NCT00830076|12891238|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
5244007|NCT00830076|12891238|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
5244008|NCT00830076|12891238|P1|STARTED|Metformin + Placebo Sitagliptin||18
5244009|NCT00830076|12891238|P1|NOT COMPLETED|7-day Washout||0
5244010|NCT00830076|12891238|P1|COMPLETED|7-day Washout||18
5244011|NCT00830076|12891238|P1|STARTED|7-day Washout||18
5244012|NCT00830076|12891238|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
5244013|NCT00830076|12891238|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
5244014|NCT00830076|12891238|P1|STARTED|Sitagliptin + Placebo Metformin||18
5244015|NCT00830037|12891249|P2|NOT COMPLETED|Overall Study||19
5244016|NCT00830037|12891250|P1|NOT COMPLETED|Overall Study||18
5244017|NCT00830037|12891249|P2|COMPLETED|Overall Study||50
5244018|NCT00830037|12891250|P1|COMPLETED|Overall Study||49
5244019|NCT00830037|12891249|P2|STARTED|Overall Study||69
5244020|NCT00830037|12891250|P1|STARTED|Overall Study||67
5244021|NCT00830024|12891260|P2|NOT COMPLETED|Second Intervention||0
5244022|NCT00830024|12891261|P1|NOT COMPLETED|Second Intervention||0
5244023|NCT00830024|12891260|P2|COMPLETED|Second Intervention||18
5244024|NCT00830024|12891261|P1|COMPLETED|Second Intervention||17
5244025|NCT00830024|12891260|P2|STARTED|Second Intervention||18
5244026|NCT00830024|12891261|P1|STARTED|Second Intervention||17
5244027|NCT00830024|12891260|P2|NOT COMPLETED|Washout: 7 Days||0
5244028|NCT00830024|12891261|P1|NOT COMPLETED|Washout: 7 Days||1
5244029|NCT00830024|12891260|P2|COMPLETED|Washout: 7 Days||18
5244030|NCT00830024|12891261|P1|COMPLETED|Washout: 7 Days||17
5244031|NCT00830024|12891260|P2|STARTED|Washout: 7 Days||18
5244032|NCT00830024|12891261|P1|STARTED|Washout: 7 Days||18
5244033|NCT00830024|12891260|P2|NOT COMPLETED|First Intervention||0
5244034|NCT00830024|12891261|P1|NOT COMPLETED|First Intervention||0
5244035|NCT00830024|12891260|P2|COMPLETED|First Intervention||18
5244036|NCT00830024|12891261|P1|COMPLETED|First Intervention||18
5244037|NCT00830024|12891260|P2|STARTED|First Intervention||18
5244038|NCT00830024|12891261|P1|STARTED|First Intervention||18
5244039|NCT00829998|12891271|P2|NOT COMPLETED|Second Intervention||0
5244040|NCT00829998|12891272|P1|NOT COMPLETED|Second Intervention||0
5244041|NCT00829998|12891271|P2|COMPLETED|Second Intervention||19
5244042|NCT00829998|12891272|P1|COMPLETED|Second Intervention||21
5244043|NCT00829998|12891271|P2|STARTED|Second Intervention||19
5244044|NCT00829998|12891272|P1|STARTED|Second Intervention||21
5244045|NCT00829998|12891271|P2|NOT COMPLETED|Washout||1
5244046|NCT00829998|12891272|P1|NOT COMPLETED|Washout||0
5244047|NCT00829998|12891271|P2|COMPLETED|Washout||19
5244048|NCT00829998|12891272|P1|COMPLETED|Washout||21
5244049|NCT00829998|12891271|P2|STARTED|Washout||20
5244050|NCT00829998|12891272|P1|STARTED|Washout||21
5244051|NCT00829998|12891271|P2|NOT COMPLETED|First Intervention||0
5244052|NCT00829998|12891272|P1|NOT COMPLETED|First Intervention||0
5244053|NCT00829998|12891271|P2|COMPLETED|First Intervention||20
5244054|NCT00829998|12891272|P1|COMPLETED|First Intervention||21
5244055|NCT00829998|12891271|P2|STARTED|First Intervention||20
5244056|NCT00829998|12891272|P1|STARTED|First Intervention||21
5244057|NCT00829985|12891282|P2|NOT COMPLETED|Overall Study||4
5244058|NCT00829985|12891283|P1|NOT COMPLETED|Overall Study||9
5244059|NCT00829985|12891282|P2|COMPLETED|Overall Study||22
5244060|NCT00829985|12891283|P1|COMPLETED|Overall Study||19
5244061|NCT00829985|12891282|P2|STARTED|Overall Study||26
5244062|NCT00829985|12891283|P1|STARTED|Overall Study||28
5244063|NCT00829933|12891301|P4|NOT COMPLETED|Overall Study||14
5244064|NCT00829933|12891302|P3|NOT COMPLETED|Overall Study||13
5244065|NCT00829933|12891303|P2|NOT COMPLETED|Overall Study||13
5244066|NCT00829933|12891304|P1|NOT COMPLETED|Overall Study||14
5244067|NCT00829933|12891301|P4|COMPLETED|Overall Study||120
5244068|NCT00829933|12891302|P3|COMPLETED|Overall Study||119
5244069|NCT00829933|12891303|P2|COMPLETED|Overall Study||122
5244070|NCT00829933|12891304|P1|COMPLETED|Overall Study||121
5244071|NCT00829933|12891301|P4|Baseline Analysis Population|Overall Study||129
5244072|NCT00829933|12891302|P3|Baseline Analysis Population|Overall Study||131
5244073|NCT00829933|12891303|P2|Baseline Analysis Population|Overall Study||134
5244074|NCT00829933|12891304|P1|Baseline Analysis Population|Overall Study||131
5244075|NCT00829933|12891301|P4|STARTED|Overall Study||134
5244076|NCT00829933|12891302|P3|STARTED|Overall Study||132
5244077|NCT00829933|12891303|P2|STARTED|Overall Study||135
5244078|NCT00829933|12891304|P1|STARTED|Overall Study||135
5244079|NCT00829868|12891316|P2|NOT COMPLETED|Second Intervention||0
5244080|NCT00829868|12891317|P1|NOT COMPLETED|Second Intervention||0
5244081|NCT00829868|12891316|P2|COMPLETED|Second Intervention||21
5244082|NCT00829868|12891317|P1|COMPLETED|Second Intervention||20
5244083|NCT00829868|12891316|P2|STARTED|Second Intervention||21
5244084|NCT00829868|12891317|P1|STARTED|Second Intervention||20
5244085|NCT00829868|12891316|P2|NOT COMPLETED|Washout||0
5244086|NCT00829868|12891317|P1|NOT COMPLETED|Washout||1
5244087|NCT00829868|12891316|P2|COMPLETED|Washout||21
5244088|NCT00829868|12891317|P1|COMPLETED|Washout||20
5244089|NCT00829868|12891316|P2|STARTED|Washout||21
5244090|NCT00829868|12891317|P1|STARTED|Washout||21
5244091|NCT00829868|12891316|P2|NOT COMPLETED|First Intervention||0
5244092|NCT00829868|12891317|P1|NOT COMPLETED|First Intervention||0
5244093|NCT00829868|12891316|P2|COMPLETED|First Intervention||21
5244094|NCT00829868|12891317|P1|COMPLETED|First Intervention||21
5244095|NCT00829868|12891316|P2|STARTED|First Intervention||21
5244096|NCT00829868|12891317|P1|STARTED|First Intervention||21
5244097|NCT00829829|12891328|P3|NOT COMPLETED|Overall Study||11
5244098|NCT00829829|12891329|P2|NOT COMPLETED|Overall Study||16
5244099|NCT00829829|12891330|P1|NOT COMPLETED|Overall Study||22
5244100|NCT00829829|12891328|P3|COMPLETED|Overall Study||70
5244101|NCT00829829|12891329|P2|COMPLETED|Overall Study||64
5244102|NCT00829829|12891330|P1|COMPLETED|Overall Study||58
5244103|NCT00829829|12891328|P3|Treated|Overall Study||81
5244104|NCT00829829|12891329|P2|Treated|Overall Study||80
5244105|NCT00829829|12891330|P1|Treated|Overall Study||79
5244106|NCT00829829|12891328|P3|STARTED|Overall Study||81
5244107|NCT00829829|12891329|P2|STARTED|Overall Study||80
5244108|NCT00829829|12891330|P1|STARTED|Overall Study||80
5244109|NCT00829790|12891355|P2|NOT COMPLETED|Second Intervention||0
5244110|NCT00829790|12891356|P1|NOT COMPLETED|Second Intervention||0
5244111|NCT00829790|12891355|P2|COMPLETED|Second Intervention||14
5244112|NCT00829790|12891356|P1|COMPLETED|Second Intervention||15
5244113|NCT00829790|12891355|P2|STARTED|Second Intervention||14
5244114|NCT00829790|12891356|P1|STARTED|Second Intervention||15
5244115|NCT00829790|12891355|P2|NOT COMPLETED|Washout of 14 Days||1
5244116|NCT00829790|12891356|P1|NOT COMPLETED|Washout of 14 Days||0
5244117|NCT00829790|12891355|P2|COMPLETED|Washout of 14 Days||14
5244118|NCT00829790|12891356|P1|COMPLETED|Washout of 14 Days||15
5244119|NCT00829790|12891355|P2|STARTED|Washout of 14 Days||15
5244120|NCT00829790|12891356|P1|STARTED|Washout of 14 Days||15
5244121|NCT00829790|12891355|P2|NOT COMPLETED|First Intervention||0
5244122|NCT00829790|12891356|P1|NOT COMPLETED|First Intervention||0
5244123|NCT00829790|12891355|P2|COMPLETED|First Intervention||15
5244124|NCT00829790|12891356|P1|COMPLETED|First Intervention||15
5244125|NCT00829790|12891355|P2|STARTED|First Intervention||15
5244126|NCT00829790|12891356|P1|STARTED|First Intervention||15
5244127|NCT00829764|12891366|P2|NOT COMPLETED|Second Intervention||0
5244128|NCT00829764|12891367|P1|NOT COMPLETED|Second Intervention||0
5244129|NCT00829764|12891366|P2|COMPLETED|Second Intervention||14
5244130|NCT00829764|12891367|P1|COMPLETED|Second Intervention||13
5244131|NCT00829764|12891366|P2|STARTED|Second Intervention||14
5244132|NCT00829764|12891367|P1|STARTED|Second Intervention||13
5244133|NCT00829764|12891366|P2|NOT COMPLETED|Washout of 14 Days||0
5244134|NCT00829764|12891367|P1|NOT COMPLETED|Washout of 14 Days||0
5244135|NCT00829764|12891366|P2|COMPLETED|Washout of 14 Days||14
5244136|NCT00829764|12891367|P1|COMPLETED|Washout of 14 Days||13
5244137|NCT00829764|12891366|P2|STARTED|Washout of 14 Days||14
5244138|NCT00829764|12891367|P1|STARTED|Washout of 14 Days||13
5244139|NCT00829764|12891366|P2|NOT COMPLETED|First Intervention||1
5244140|NCT00829764|12891367|P1|NOT COMPLETED|First Intervention||2
5244141|NCT00829764|12891366|P2|COMPLETED|First Intervention||14
5244142|NCT00829764|12891367|P1|COMPLETED|First Intervention||13
5244143|NCT00829764|12891366|P2|STARTED|First Intervention||15
5244144|NCT00829764|12891367|P1|STARTED|First Intervention||15
5244145|NCT00829738|12891375|P1|NOT COMPLETED|Overall Study||8
5244146|NCT00829738|12891375|P1|COMPLETED|Overall Study||4180
5244147|NCT00829738|12891375|P1|STARTED|Overall Study||4188
5244148|NCT00829712|12891393|P2|NOT COMPLETED|Second Intervention||0
5244149|NCT00829712|12891394|P1|NOT COMPLETED|Second Intervention||0
5244150|NCT00829712|12891393|P2|COMPLETED|Second Intervention||11
5244151|NCT00829712|12891394|P1|COMPLETED|Second Intervention||12
5244152|NCT00829712|12891393|P2|STARTED|Second Intervention||11
5244153|NCT00829712|12891394|P1|STARTED|Second Intervention||12
5244154|NCT00829712|12891393|P2|NOT COMPLETED|Washout of 7 Days||1
5244155|NCT00829712|12891394|P1|NOT COMPLETED|Washout of 7 Days||0
5244156|NCT00829712|12891393|P2|COMPLETED|Washout of 7 Days||11
5244157|NCT00829712|12891394|P1|COMPLETED|Washout of 7 Days||12
5244158|NCT00829712|12891393|P2|STARTED|Washout of 7 Days||12
5244159|NCT00829712|12891394|P1|STARTED|Washout of 7 Days||12
5244160|NCT00829712|12891393|P2|NOT COMPLETED|First Intervention||0
5244161|NCT00829712|12891394|P1|NOT COMPLETED|First Intervention||0
5244162|NCT00829712|12891393|P2|COMPLETED|First Intervention||12
5244163|NCT00829712|12891394|P1|COMPLETED|First Intervention||12
5244164|NCT00829712|12891393|P2|STARTED|First Intervention||12
5244165|NCT00829712|12891394|P1|STARTED|First Intervention||12
5244166|NCT00829686|12891404|P2|NOT COMPLETED|Overall Study||0
5244167|NCT00829686|12891405|P1|NOT COMPLETED|Overall Study||0
5244168|NCT00829686|12891404|P2|COMPLETED|Overall Study||18
5244169|NCT00829686|12891405|P1|COMPLETED|Overall Study||13
5244170|NCT00829686|12891404|P2|STARTED|Overall Study||18
5244171|NCT00829686|12891405|P1|STARTED|Overall Study||13
5244172|NCT00829673|12891413|P2|NOT COMPLETED|Second Intervention||0
5244173|NCT00829673|12891414|P1|NOT COMPLETED|Second Intervention||0
5244174|NCT00829673|12891413|P2|COMPLETED|Second Intervention||12
5244175|NCT00829673|12891414|P1|COMPLETED|Second Intervention||11
5244176|NCT00829673|12891413|P2|STARTED|Second Intervention||12
5244177|NCT00829673|12891414|P1|STARTED|Second Intervention||11
5244178|NCT00829673|12891413|P2|NOT COMPLETED|Washout of 7 Days||0
5244179|NCT00829673|12891414|P1|NOT COMPLETED|Washout of 7 Days||1
5244180|NCT00829673|12891413|P2|COMPLETED|Washout of 7 Days||12
5244181|NCT00829673|12891414|P1|COMPLETED|Washout of 7 Days||11
5244182|NCT00829673|12891413|P2|STARTED|Washout of 7 Days||12
5244183|NCT00829673|12891414|P1|STARTED|Washout of 7 Days||12
5244184|NCT00829673|12891413|P2|NOT COMPLETED|First Intervention||0
5244185|NCT00829673|12891414|P1|NOT COMPLETED|First Intervention||0
5244186|NCT00829673|12891413|P2|COMPLETED|First Intervention||12
5244187|NCT00829673|12891414|P1|COMPLETED|First Intervention||12
5244188|NCT00829673|12891413|P2|STARTED|First Intervention||12
5244189|NCT00829673|12891414|P1|STARTED|First Intervention||12
5244190|NCT00829621|12891424|P2|NOT COMPLETED|Overall Study||4
5244191|NCT00829621|12891425|P1|NOT COMPLETED|Overall Study||4
5244192|NCT00829621|12891424|P2|COMPLETED|Overall Study||8
5244193|NCT00829621|12891425|P1|COMPLETED|Overall Study||4
5244194|NCT00829621|12891424|P2|STARTED|Overall Study||12
5244195|NCT00829621|12891425|P1|STARTED|Overall Study||8
5244196|NCT00829530|12891433|P2|NOT COMPLETED|Second Intervention||0
5244197|NCT00829530|12891434|P1|NOT COMPLETED|Second Intervention||1
5244198|NCT00829530|12891433|P2|COMPLETED|Second Intervention||18
5244199|NCT00829530|12891434|P1|COMPLETED|Second Intervention||19
5244200|NCT00829530|12891433|P2|STARTED|Second Intervention||18
5244201|NCT00829530|12891434|P1|STARTED|Second Intervention||20
5244202|NCT00829530|12891433|P2|NOT COMPLETED|Washout of 42 Days||0
5244203|NCT00829530|12891434|P1|NOT COMPLETED|Washout of 42 Days||0
5244204|NCT00829530|12891433|P2|COMPLETED|Washout of 42 Days||18
5244205|NCT00829530|12891434|P1|COMPLETED|Washout of 42 Days||20
5244206|NCT00829530|12891433|P2|STARTED|Washout of 42 Days||18
5244207|NCT00829530|12891434|P1|STARTED|Washout of 42 Days||20
5244208|NCT00829530|12891433|P2|NOT COMPLETED|First Intervention||2
5244209|NCT00829530|12891434|P1|NOT COMPLETED|First Intervention||0
5244210|NCT00829530|12891433|P2|COMPLETED|First Intervention||18
5244211|NCT00829530|12891434|P1|COMPLETED|First Intervention||20
5244212|NCT00829530|12891433|P2|STARTED|First Intervention||20
5244213|NCT00829530|12891434|P1|STARTED|First Intervention||20
5244214|NCT00829504|12891448|P2|NOT COMPLETED|Second Intervention||0
5244215|NCT00829504|12891449|P1|NOT COMPLETED|Second Intervention||1
5244216|NCT00829504|12891448|P2|COMPLETED|Second Intervention||22
5244217|NCT00829504|12891449|P1|COMPLETED|Second Intervention||19
5244218|NCT00829504|12891448|P2|STARTED|Second Intervention||22
5244219|NCT00829504|12891449|P1|STARTED|Second Intervention||20
5244220|NCT00829504|12891448|P2|NOT COMPLETED|Washout of 7 Days||0
5244221|NCT00829504|12891449|P1|NOT COMPLETED|Washout of 7 Days||1
5244222|NCT00829504|12891448|P2|COMPLETED|Washout of 7 Days||22
5244223|NCT00829504|12891449|P1|COMPLETED|Washout of 7 Days||20
5244224|NCT00829504|12891448|P2|STARTED|Washout of 7 Days||22
5244225|NCT00829504|12891449|P1|STARTED|Washout of 7 Days||21
5244226|NCT00829504|12891448|P2|NOT COMPLETED|First Intervention||0
5244227|NCT00829504|12891449|P1|NOT COMPLETED|First Intervention||1
5244228|NCT00829504|12891448|P2|COMPLETED|First Intervention||22
5244229|NCT00829504|12891449|P1|COMPLETED|First Intervention||21
5244230|NCT00829504|12891448|P2|STARTED|First Intervention||22
5244231|NCT00829504|12891449|P1|STARTED|First Intervention||22
5244232|NCT00829452|12891459|P2|NOT COMPLETED|Second Intervention||1
5244233|NCT00829452|12891460|P1|NOT COMPLETED|Second Intervention||0
5244234|NCT00829452|12891459|P2|COMPLETED|Second Intervention||17
5244235|NCT00829452|12891460|P1|COMPLETED|Second Intervention||20
5244236|NCT00829452|12891459|P2|STARTED|Second Intervention||18
5244237|NCT00829452|12891460|P1|STARTED|Second Intervention||20
5244238|NCT00829452|12891459|P2|NOT COMPLETED|Washout of 42 Days||1
5244239|NCT00829452|12891460|P1|NOT COMPLETED|Washout of 42 Days||0
5244240|NCT00829452|12891459|P2|COMPLETED|Washout of 42 Days||18
5244241|NCT00829452|12891460|P1|COMPLETED|Washout of 42 Days||20
5244242|NCT00829452|12891459|P2|STARTED|Washout of 42 Days||19
5244243|NCT00829452|12891460|P1|STARTED|Washout of 42 Days||20
5244244|NCT00829452|12891459|P2|NOT COMPLETED|First Intervention||1
5244245|NCT00829452|12891460|P1|NOT COMPLETED|First Intervention||0
5244246|NCT00829452|12891459|P2|COMPLETED|First Intervention||19
5244247|NCT00829452|12891460|P1|COMPLETED|First Intervention||20
5244248|NCT00829452|12891459|P2|STARTED|First Intervention||20
5244249|NCT00829452|12891460|P1|STARTED|First Intervention||20
5244250|NCT00829439|12891472|P4|NOT COMPLETED|Overall Study||0
5244251|NCT00829439|12891473|P3|NOT COMPLETED|Overall Study||1
5244252|NCT00829439|12891474|P2|NOT COMPLETED|Overall Study||0
5244253|NCT00829439|12891475|P1|NOT COMPLETED|Overall Study||0
5244254|NCT00829439|12891472|P4|COMPLETED|Overall Study||4
5244255|NCT00829439|12891473|P3|COMPLETED|Overall Study||5
5244256|NCT00829439|12891474|P2|COMPLETED|Overall Study||3
5244257|NCT00829439|12891475|P1|COMPLETED|Overall Study||3
5244258|NCT00829439|12891472|P4|STARTED|Overall Study||4
5244259|NCT00829439|12891473|P3|STARTED|Overall Study||6
5244260|NCT00829439|12891474|P2|STARTED|Overall Study||3
5244261|NCT00829439|12891475|P1|STARTED|Overall Study||3
5244262|NCT00829426|12891481|P2|NOT COMPLETED|Second Intervention||0
5244263|NCT00829426|12891482|P1|NOT COMPLETED|Second Intervention||0
5244264|NCT00829426|12891481|P2|COMPLETED|Second Intervention||16
5244265|NCT00829426|12891482|P1|COMPLETED|Second Intervention||15
5244266|NCT00829426|12891481|P2|STARTED|Second Intervention||16
5244267|NCT00829426|12891482|P1|STARTED|Second Intervention||15
5244268|NCT00829426|12891481|P2|NOT COMPLETED|Washout: 7 Days||0
5244269|NCT00829426|12891482|P1|NOT COMPLETED|Washout: 7 Days||1
5244270|NCT00829426|12891481|P2|COMPLETED|Washout: 7 Days||16
5244271|NCT00829426|12891482|P1|COMPLETED|Washout: 7 Days||15
5244272|NCT00829426|12891481|P2|STARTED|Washout: 7 Days||16
5244273|NCT00829426|12891482|P1|STARTED|Washout: 7 Days||16
5244274|NCT00829426|12891481|P2|NOT COMPLETED|First Intervention||0
5244275|NCT00829426|12891482|P1|NOT COMPLETED|First Intervention||0
5244276|NCT00829426|12891481|P2|COMPLETED|First Intervention||16
5244277|NCT00829426|12891482|P1|COMPLETED|First Intervention||16
5244278|NCT00829426|12891481|P2|STARTED|First Intervention||16
5244279|NCT00829426|12891482|P1|STARTED|First Intervention||16
5244280|NCT00829413|12891490|P1|NOT COMPLETED|Overall Study||94
5244281|NCT00829413|12891490|P1|COMPLETED|Overall Study||259
5244282|NCT00829413|12891490|P1|STARTED|Overall Study||353
5244283|NCT00829387|12891539|P2|NOT COMPLETED|Overall Study||3
5244284|NCT00829387|12891540|P1|NOT COMPLETED|Overall Study||3
5244285|NCT00829387|12891539|P2|COMPLETED|Overall Study||21
5244286|NCT00829387|12891540|P1|COMPLETED|Overall Study||20
5244287|NCT00829387|12891539|P2|STARTED|Overall Study||24
5244288|NCT00829387|12891540|P1|STARTED|Overall Study||23
5244289|NCT00829309|12891558|P2|NOT COMPLETED|Second Intervention||0
5244290|NCT00829309|12891559|P1|NOT COMPLETED|Second Intervention||0
5244291|NCT00829309|12891558|P2|COMPLETED|Second Intervention||8
5244292|NCT00829309|12891559|P1|COMPLETED|Second Intervention||7
5244293|NCT00829309|12891558|P2|STARTED|Second Intervention||8
5244294|NCT00829309|12891559|P1|STARTED|Second Intervention||7
5244295|NCT00829309|12891558|P2|NOT COMPLETED|Washout: 7 Days||0
5244296|NCT00829309|12891559|P1|NOT COMPLETED|Washout: 7 Days||1
5244297|NCT00829309|12891558|P2|COMPLETED|Washout: 7 Days||8
5244298|NCT00829309|12891559|P1|COMPLETED|Washout: 7 Days||7
5244299|NCT00829309|12891558|P2|STARTED|Washout: 7 Days||8
5244300|NCT00829309|12891559|P1|STARTED|Washout: 7 Days||8
5244301|NCT00829309|12891558|P2|NOT COMPLETED|First Intervention||0
5244302|NCT00829309|12891559|P1|NOT COMPLETED|First Intervention||0
5244303|NCT00829309|12891558|P2|COMPLETED|First Intervention||8
5244304|NCT00829309|12891559|P1|COMPLETED|First Intervention||8
5244305|NCT00829309|12891558|P2|STARTED|First Intervention||8
5244306|NCT00829309|12891559|P1|STARTED|First Intervention||8
5244307|NCT00829296|12891569|P2|NOT COMPLETED|Overall Study||4
5244308|NCT00829296|12891570|P1|NOT COMPLETED|Overall Study||5
5244309|NCT00829296|12891569|P2|COMPLETED|Overall Study||32
5244310|NCT00829296|12891570|P1|COMPLETED|Overall Study||29
5244311|NCT00829296|12891569|P2|STARTED|Overall Study||36
5244312|NCT00829296|12891570|P1|STARTED|Overall Study||34
5244313|NCT00829283|12891584|P2|NOT COMPLETED|Overall Study||25
5244314|NCT00829283|12891585|P1|NOT COMPLETED|Overall Study||7
5244315|NCT00829283|12891584|P2|COMPLETED|Overall Study||127
5244316|NCT00829283|12891585|P1|COMPLETED|Overall Study||32
5244317|NCT00829283|12891584|P2|STARTED|Overall Study||152
5244318|NCT00829283|12891585|P1|STARTED|Overall Study||39
5244319|NCT00829244|12891595|P2|NOT COMPLETED|Overall Study||21
5244320|NCT00829244|12891596|P1|NOT COMPLETED|Overall Study||14
5244321|NCT00829244|12891595|P2|COMPLETED|Overall Study||83
5244322|NCT00829244|12891596|P1|COMPLETED|Overall Study||82
5244323|NCT00829244|12891595|P2|STARTED|Overall Study||104
5244324|NCT00829244|12891596|P1|STARTED|Overall Study||96
5244325|NCT00829179|12891626|P1|NOT COMPLETED|Overall Study||1
5244326|NCT00829179|12891626|P1|COMPLETED|Overall Study||19
5244327|NCT00829179|12891626|P1|STARTED|Overall Study||20
5244328|NCT00829166|12891632|P2|NOT COMPLETED|Overall Study||496
5244329|NCT00829166|12891633|P1|NOT COMPLETED|Overall Study||495
5244330|NCT00829166|12891632|P2|COMPLETED|Overall Study||0
5244331|NCT00829166|12891633|P1|COMPLETED|Overall Study||0
5244332|NCT00829166|12891632|P2|Treated|Overall Study||488
5244333|NCT00829166|12891633|P1|Treated|Overall Study||490
5244334|NCT00829166|12891632|P2|STARTED|Overall Study||496
5244335|NCT00829166|12891633|P1|STARTED|Overall Study||495
5244336|NCT00829049|12891674|P2|NOT COMPLETED|Overall Study||20
5244337|NCT00829049|12891675|P1|NOT COMPLETED|Overall Study||17
5244338|NCT00829049|12891674|P2|COMPLETED|Overall Study||68
5244339|NCT00829049|12891675|P1|COMPLETED|Overall Study||60
5244340|NCT00829049|12891674|P2|STARTED|Overall Study||88
5244341|NCT00829049|12891675|P1|STARTED|Overall Study||77
5244342|NCT00829036|12891687|P1|NOT COMPLETED|Overall Study||0
5244343|NCT00829036|12891687|P1|COMPLETED|Overall Study||24
5244344|NCT00829036|12891687|P1|STARTED|Overall Study||24
5244345|NCT00829010|12891696|P5|NOT COMPLETED|Overall Study||2
5244346|NCT00829010|12891697|P4|NOT COMPLETED|Overall Study||8
5244347|NCT00829010|12891698|P3|NOT COMPLETED|Overall Study||3
5244348|NCT00829010|12891699|P2|NOT COMPLETED|Overall Study||9
5244349|NCT00829010|12891700|P1|NOT COMPLETED|Overall Study||10
5244350|NCT00829010|12891696|P5|COMPLETED|Overall Study||98
5244351|NCT00829010|12891697|P4|COMPLETED|Overall Study||92
5244352|NCT00829010|12891698|P3|COMPLETED|Overall Study||97
5244353|NCT00829010|12891699|P2|COMPLETED|Overall Study||92
5244354|NCT00829010|12891700|P1|COMPLETED|Overall Study||73
5244355|NCT00829010|12891696|P5|STARTED|Overall Study||100
5244356|NCT00829010|12891697|P4|STARTED|Overall Study||100
5244357|NCT00829010|12891698|P3|STARTED|Overall Study||100
5244358|NCT00829010|12891699|P2|STARTED|Overall Study||101
5244359|NCT00829010|12891700|P1|STARTED|Overall Study||83
5244360|NCT00828984|12891865|P3|NOT COMPLETED|Overall Study||9
5244361|NCT00828984|12891866|P2|NOT COMPLETED|Overall Study||16
5244362|NCT00828984|12891867|P1|NOT COMPLETED|Overall Study||14
5244363|NCT00828984|12891865|P3|COMPLETED|Overall Study||19
5244364|NCT00828984|12891866|P2|COMPLETED|Overall Study||15
5244365|NCT00828984|12891867|P1|COMPLETED|Overall Study||14
5244366|NCT00828984|12891865|P3|Post Intervention Follow-Up|Overall Study||19
5244367|NCT00828984|12891866|P2|Post Intervention Follow-Up|Overall Study||16
5244368|NCT00828984|12891867|P1|Post Intervention Follow-Up|Overall Study||15
5244369|NCT00828984|12891865|P3|Flexible Sigmoidoscopy|Overall Study||19
5244370|NCT00828984|12891866|P2|Flexible Sigmoidoscopy|Overall Study||19
5244371|NCT00828984|12891867|P1|Flexible Sigmoidoscopy|Overall Study||20
5244372|NCT00828984|12891865|P3|Treatment|Overall Study||24
5244373|NCT00828984|12891866|P2|Treatment|Overall Study||26
5244374|NCT00828984|12891867|P1|Treatment|Overall Study||24
5244375|NCT00828984|12891865|P3|Randomization|Overall Study||28
5244376|NCT00828984|12891866|P2|Randomization|Overall Study||31
5244377|NCT00828984|12891867|P1|Randomization|Overall Study||28
5244378|NCT00828984|12891865|P3|STARTED|Overall Study||28
5244379|NCT00828984|12891866|P2|STARTED|Overall Study||31
5244380|NCT00828984|12891867|P1|STARTED|Overall Study||28
5244381|NCT00828945|12891890|P1|NOT COMPLETED|Overall Study||41
5244382|NCT00828945|12891890|P1|COMPLETED|Overall Study||216
5244383|NCT00828945|12891890|P1|STARTED|Overall Study||257
5244384|NCT00828841|12891907|P3|NOT COMPLETED|Overall Study||4
5244385|NCT00828841|12891908|P2|NOT COMPLETED|Overall Study||4
5244386|NCT00828841|12891909|P1|NOT COMPLETED|Overall Study||4
5244387|NCT00828841|12891907|P3|COMPLETED|Overall Study||126
5244388|NCT00828841|12891908|P2|COMPLETED|Overall Study||232
5244389|NCT00828841|12891909|P1|COMPLETED|Overall Study||231
5244390|NCT00828841|12891907|P3|STARTED|Overall Study||130
5244391|NCT00828841|12891908|P2|STARTED|Overall Study||236
5244392|NCT00828841|12891909|P1|STARTED|Overall Study||235
5244393|NCT00828750|12891922|P1|NOT COMPLETED|Overall Study||4
5244394|NCT00828750|12891922|P1|COMPLETED|Overall Study||15
5244395|NCT00828750|12891922|P1|STARTED|Overall Study||19
5244396|NCT00828711|12891936|P3|NOT COMPLETED|Overall Study||0
5244397|NCT00828711|12891937|P2|NOT COMPLETED|Overall Study||0
5244398|NCT00828711|12891938|P1|NOT COMPLETED|Overall Study||1
5244399|NCT00828711|12891936|P3|COMPLETED|Overall Study||131
5244400|NCT00828711|12891937|P2|COMPLETED|Overall Study||125
5244401|NCT00828711|12891938|P1|COMPLETED|Overall Study||117
5244402|NCT00828711|12891936|P3|STARTED|Overall Study||131
5244403|NCT00828711|12891937|P2|STARTED|Overall Study||125
5244404|NCT00828711|12891938|P1|STARTED|Overall Study||118
5244405|NCT00828672|12891969|P2|NOT COMPLETED|Follow-up||0
5244406|NCT00828672|12891970|P1|NOT COMPLETED|Follow-up||0
5244407|NCT00828672|12891969|P2|COMPLETED|Follow-up||41
5244408|NCT00828672|12891970|P1|COMPLETED|Follow-up||42
5244409|NCT00828672|12891969|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
5244410|NCT00828672|12891970|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
5244411|NCT00828672|12891969|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
5244412|NCT00828672|12891970|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
5244413|NCT00828672|12891969|P2|COMPLETED|Post-surgery (<30 Days)||38
5244414|NCT00828672|12891970|P1|COMPLETED|Post-surgery (<30 Days)||41
5244415|NCT00828672|12891969|P2|STARTED|Post-surgery (<30 Days)||39
5244416|NCT00828672|12891970|P1|STARTED|Post-surgery (<30 Days)||41
5244417|NCT00828672|12891969|P2|NOT COMPLETED|Study Treatment||2
5244418|NCT00828672|12891970|P1|NOT COMPLETED|Study Treatment||2
5244419|NCT00828672|12891969|P2|COMPLETED|Study Treatment||39
5244420|NCT00828672|12891970|P1|COMPLETED|Study Treatment||41
5244421|NCT00828672|12891969|P2|STARTED|Study Treatment||41
5244422|NCT00828672|12891970|P1|STARTED|Study Treatment||43
5244423|NCT00828672|12891969|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
5244424|NCT00828672|12891970|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
5244425|NCT00828672|12891969|P2|COMPLETED|Pre-treatment (Baseline)||41
5244426|NCT00828672|12891970|P1|COMPLETED|Pre-treatment (Baseline)||43
5244427|NCT00828672|12891969|P2|STARTED|Pre-treatment (Baseline)||41
5244428|NCT00828672|12891970|P1|STARTED|Pre-treatment (Baseline)||43
5244429|NCT00828568|12891991|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
5244430|NCT00828568|12891992|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
5244431|NCT00828568|12891993|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
5244432|NCT00828568|12891991|P3|COMPLETED|Treated - Received at Least One Dose||55
5244433|NCT00828568|12891992|P2|COMPLETED|Treated - Received at Least One Dose||150
5244434|NCT00828568|12891993|P1|COMPLETED|Treated - Received at Least One Dose||153
5244435|NCT00828568|12891991|P3|STARTED|Treated - Received at Least One Dose||60
5244436|NCT00828568|12891992|P2|STARTED|Treated - Received at Least One Dose||179
5244437|NCT00828568|12891993|P1|STARTED|Treated - Received at Least One Dose||183
5244438|NCT00828568|12891991|P3|NOT COMPLETED|Randomized||2
5244439|NCT00828568|12891992|P2|NOT COMPLETED|Randomized||0
5244440|NCT00828568|12891993|P1|NOT COMPLETED|Randomized||1
5244441|NCT00828568|12891991|P3|COMPLETED|Randomized||60
5244442|NCT00828568|12891992|P2|COMPLETED|Randomized||179
5244443|NCT00828568|12891993|P1|COMPLETED|Randomized||183
5244444|NCT00828568|12891991|P3|STARTED|Randomized||62
5244445|NCT00828568|12891992|P2|STARTED|Randomized||179
5244446|NCT00828568|12891993|P1|STARTED|Randomized||184
5244447|NCT00828542|12892008|P2|NOT COMPLETED|Overall Study||3
5244448|NCT00828542|12892009|P1|NOT COMPLETED|Overall Study||3
5244449|NCT00828542|12892008|P2|COMPLETED|Overall Study||20
5244450|NCT00828542|12892009|P1|COMPLETED|Overall Study||20
5244451|NCT00828542|12892008|P2|STARTED|Overall Study||23
5244452|NCT00828542|12892009|P1|STARTED|Overall Study||23
5244453|NCT00828516|12892015|P1|NOT COMPLETED|Clinical Phase: Series 2||0
5244454|NCT00828516|12892015|P1|COMPLETED|Clinical Phase: Series 2||30
5244455|NCT00828516|12892015|P1|STARTED|Clinical Phase: Series 2||30
5244456|NCT00828516|12892015|P1|NOT COMPLETED|Clinical Phase: Series 1||2
5244457|NCT00828516|12892015|P1|COMPLETED|Clinical Phase: Series 1||33
5244458|NCT00828516|12892015|P1|STARTED|Clinical Phase: Series 1||35
5244459|NCT00828464|12892020|P1|NOT COMPLETED|Overall Study||1
5244460|NCT00828464|12892020|P1|COMPLETED|Overall Study||29
5244461|NCT00828464|12892020|P1|STARTED|Overall Study||30
5244462|NCT00828451|12892037|P1|NOT COMPLETED|Overall Study||11
5244463|NCT00828451|12892037|P1|COMPLETED|Overall Study||18
5244464|NCT00828451|12892037|P1|STARTED|Overall Study||29
5244465|NCT00828412|12892045|P2|NOT COMPLETED|Overall Study||2
5244466|NCT00828412|12892046|P1|NOT COMPLETED|Overall Study||9
5244467|NCT00828412|12892045|P2|COMPLETED|Overall Study||48
5244468|NCT00828412|12892046|P1|COMPLETED|Overall Study||41
5244469|NCT00828412|12892045|P2|STARTED|Overall Study||50
5244470|NCT00828412|12892046|P1|STARTED|Overall Study||50
5244471|NCT00828347|12892054|P2|NOT COMPLETED|Overall Study||0
5244472|NCT00828347|12892055|P1|NOT COMPLETED|Overall Study||0
5244473|NCT00828347|12892054|P2|COMPLETED|Overall Study||11
5244474|NCT00828347|12892055|P1|COMPLETED|Overall Study||12
5244475|NCT00828347|12892054|P2|STARTED|Overall Study||11
5244476|NCT00828347|12892055|P1|STARTED|Overall Study||12
5244477|NCT00828321|12892063|P2|NOT COMPLETED|Second Intervention||1
5244478|NCT00828321|12892064|P1|NOT COMPLETED|Second Intervention||0
5244479|NCT00828321|12892063|P2|COMPLETED|Second Intervention||19
5244480|NCT00828321|12892064|P1|COMPLETED|Second Intervention||18
5244481|NCT00828321|12892063|P2|STARTED|Second Intervention||20
5244482|NCT00828321|12892064|P1|STARTED|Second Intervention||18
5244483|NCT00828321|12892063|P2|NOT COMPLETED|Washout of 42 Days||0
5244484|NCT00828321|12892064|P1|NOT COMPLETED|Washout of 42 Days||2
5244485|NCT00828321|12892063|P2|COMPLETED|Washout of 42 Days||20
5244486|NCT00828321|12892064|P1|COMPLETED|Washout of 42 Days||18
5244487|NCT00828321|12892063|P2|STARTED|Washout of 42 Days||20
5244488|NCT00828321|12892064|P1|STARTED|Washout of 42 Days||20
5244489|NCT00828321|12892063|P2|NOT COMPLETED|First Intervention||0
5244490|NCT00828321|12892064|P1|NOT COMPLETED|First Intervention||0
5244491|NCT00828321|12892063|P2|COMPLETED|First Intervention||20
5244492|NCT00828321|12892064|P1|COMPLETED|First Intervention||20
5244493|NCT00828321|12892063|P2|STARTED|First Intervention||20
5244494|NCT00828321|12892064|P1|STARTED|First Intervention||20
5244495|NCT00828308|12892076|P1|NOT COMPLETED|Overall Study||0
5244496|NCT00828308|12892076|P1|COMPLETED|Overall Study||16
5244497|NCT00828308|12892076|P1|STARTED|Overall Study||16
5244498|NCT00828295|12892082|P2|NOT COMPLETED|Overall Study||0
5244499|NCT00828295|12892083|P1|NOT COMPLETED|Overall Study||0
5244500|NCT00828295|12892082|P2|COMPLETED|Overall Study||75
5244501|NCT00828295|12892083|P1|COMPLETED|Overall Study||75
5244502|NCT00828295|12892082|P2|STARTED|Overall Study||75
5244503|NCT00828295|12892083|P1|STARTED|Overall Study||75
5244504|NCT00828204|12892093|P2|NOT COMPLETED|Extension Study||3
5244505|NCT00828204|12892094|P1|NOT COMPLETED|Extension Study||0
5244506|NCT00828204|12892093|P2|COMPLETED|Extension Study||61
5244507|NCT00828204|12892094|P1|COMPLETED|Extension Study||0
5244508|NCT00828204|12892093|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
5244509|NCT00828204|12892094|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
5244510|NCT00828204|12892093|P2|NOT COMPLETED|Main Study: After Study Restart||3
5244511|NCT00828204|12892094|P1|NOT COMPLETED|Main Study: After Study Restart||0
5244512|NCT00828204|12892093|P2|COMPLETED|Main Study: After Study Restart||71
5244513|NCT00828204|12892094|P1|COMPLETED|Main Study: After Study Restart||0
5244514|NCT00828204|12892093|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
5244515|NCT00828204|12892094|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
5244516|NCT00828204|12892093|P2|Completed Manual Injection|Main Study: After Study Restart||74
5244517|NCT00828204|12892094|P1|Completed Manual Injection|Main Study: After Study Restart||0
5244518|NCT00828204|12892093|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
5244519|NCT00828204|12892094|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
5244520|NCT00828204|12892093|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
5244521|NCT00828204|12892094|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
5244522|NCT00828204|12892093|P2|COMPLETED|Main Study: Prior to Study Suspension||0
5244523|NCT00828204|12892094|P1|COMPLETED|Main Study: Prior to Study Suspension||7
5244524|NCT00828204|12892093|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
5244525|NCT00828204|12892094|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
5244526|NCT00828204|12892093|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
5244527|NCT00828204|12892094|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
5244528|NCT00828204|12892093|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
5244529|NCT00828204|12892094|P1|STARTED|Main Study: Prior to Study Suspension||21
5244530|NCT00828191|12892113|P2|NOT COMPLETED|Overall Study||10
5244531|NCT00828191|12892114|P1|NOT COMPLETED|Overall Study||8
5244532|NCT00828191|12892113|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
5244533|NCT00828191|12892114|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
5244534|NCT00828191|12892113|P2|STARTED|Overall Study|Randomized patients|400
5244535|NCT00828191|12892114|P1|STARTED|Overall Study|Randomized patients|400
5244536|NCT00828178|12892126|P2|NOT COMPLETED|Overall Study||2
5244537|NCT00828178|12892127|P1|NOT COMPLETED|Overall Study||0
5244538|NCT00828178|12892126|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
5244539|NCT00828178|12892127|P1|COMPLETED|Overall Study||42
5244540|NCT00828178|12892126|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
5244541|NCT00828178|12892127|P1|STARTED|Overall Study||42
5244542|NCT00828139|12892141|P4|NOT COMPLETED|Overall Study||51
5244543|NCT00828139|12892142|P3|NOT COMPLETED|Overall Study||55
5244544|NCT00828139|12892143|P2|NOT COMPLETED|Overall Study||41
5244545|NCT00828139|12892144|P1|NOT COMPLETED|Overall Study||41
5244546|NCT00828139|12892141|P4|COMPLETED|Overall Study||0
5244547|NCT00828139|12892142|P3|COMPLETED|Overall Study||0
5244548|NCT00828139|12892143|P2|COMPLETED|Overall Study||0
5244549|NCT00828139|12892144|P1|COMPLETED|Overall Study||1
5244550|NCT00828139|12892141|P4|STARTED|Overall Study||51
5244551|NCT00828139|12892142|P3|STARTED|Overall Study||55
5244552|NCT00828139|12892143|P2|STARTED|Overall Study||41
5244553|NCT00828139|12892144|P1|STARTED|Overall Study||42
5244554|NCT00828113|12892164|P2|NOT COMPLETED|Overall Study||31
5244555|NCT00828113|12892165|P1|NOT COMPLETED|Overall Study||30
5244556|NCT00828113|12892164|P2|COMPLETED|Overall Study||20
5244557|NCT00828113|12892165|P1|COMPLETED|Overall Study||20
5244558|NCT00828113|12892164|P2|STARTED|Overall Study||51
5244559|NCT00828113|12892165|P1|STARTED|Overall Study||50
5244560|NCT00828074|12892173|P3|NOT COMPLETED|Overall Study||0
5244561|NCT00828074|12892174|P2|NOT COMPLETED|Overall Study||0
5244562|NCT00828074|12892175|P1|NOT COMPLETED|Overall Study||0
5244563|NCT00828074|12892173|P3|COMPLETED|Overall Study||35
5244564|NCT00828074|12892174|P2|COMPLETED|Overall Study||5
5244565|NCT00828074|12892175|P1|COMPLETED|Overall Study||6
5244566|NCT00828074|12892173|P3|STARTED|Overall Study||35
5244567|NCT00828074|12892174|P2|STARTED|Overall Study||5
5244568|NCT00828074|12892175|P1|STARTED|Overall Study||6
5244569|NCT00828061|12892187|P6|NOT COMPLETED|Period 3||0
5244570|NCT00828061|12892188|P5|NOT COMPLETED|Period 3||0
5244571|NCT00828061|12892189|P4|NOT COMPLETED|Period 3||0
5244572|NCT00828061|12892190|P3|NOT COMPLETED|Period 3||0
5244573|NCT00828061|12892191|P2|NOT COMPLETED|Period 3||0
5244574|NCT00828061|12892192|P1|NOT COMPLETED|Period 3||0
5244575|NCT00828061|12892187|P6|COMPLETED|Period 3||3
5244576|NCT00828061|12892188|P5|COMPLETED|Period 3||3
5244577|NCT00828061|12892189|P4|COMPLETED|Period 3||3
5244578|NCT00828061|12892190|P3|COMPLETED|Period 3||3
5244579|NCT00828061|12892191|P2|COMPLETED|Period 3||3
5244580|NCT00828061|12892192|P1|COMPLETED|Period 3||4
5244581|NCT00828061|12892187|P6|STARTED|Period 3||3
5244582|NCT00828061|12892188|P5|STARTED|Period 3||3
5244583|NCT00828061|12892189|P4|STARTED|Period 3||3
5244584|NCT00828061|12892190|P3|STARTED|Period 3||3
5244585|NCT00828061|12892191|P2|STARTED|Period 3||3
5244586|NCT00828061|12892192|P1|STARTED|Period 3||4
5244587|NCT00828061|12892187|P6|NOT COMPLETED|Period 2||0
5244588|NCT00828061|12892188|P5|NOT COMPLETED|Period 2||0
5244589|NCT00828061|12892189|P4|NOT COMPLETED|Period 2||0
5244590|NCT00828061|12892190|P3|NOT COMPLETED|Period 2||0
5244591|NCT00828061|12892191|P2|NOT COMPLETED|Period 2||0
5244592|NCT00828061|12892192|P1|NOT COMPLETED|Period 2||0
5244593|NCT00828061|12892187|P6|COMPLETED|Period 2||3
5244594|NCT00828061|12892188|P5|COMPLETED|Period 2||3
5244595|NCT00828061|12892189|P4|COMPLETED|Period 2||3
5244596|NCT00828061|12892190|P3|COMPLETED|Period 2||3
5244597|NCT00828061|12892191|P2|COMPLETED|Period 2||3
5244598|NCT00828061|12892192|P1|COMPLETED|Period 2||4
5244599|NCT00828061|12892187|P6|STARTED|Period 2||3
5244600|NCT00828061|12892188|P5|STARTED|Period 2||3
5244601|NCT00828061|12892189|P4|STARTED|Period 2||3
5244602|NCT00828061|12892190|P3|STARTED|Period 2||3
5244603|NCT00828061|12892191|P2|STARTED|Period 2||3
5244604|NCT00828061|12892192|P1|STARTED|Period 2||4
5244605|NCT00828061|12892187|P6|NOT COMPLETED|Period 1||0
5244606|NCT00828061|12892188|P5|NOT COMPLETED|Period 1||0
5244607|NCT00828061|12892189|P4|NOT COMPLETED|Period 1||0
5244608|NCT00828061|12892190|P3|NOT COMPLETED|Period 1||0
5244609|NCT00828061|12892191|P2|NOT COMPLETED|Period 1||0
5244610|NCT00828061|12892192|P1|NOT COMPLETED|Period 1||0
5244611|NCT00828061|12892187|P6|COMPLETED|Period 1||3
5244612|NCT00828061|12892188|P5|COMPLETED|Period 1||3
5244613|NCT00828061|12892189|P4|COMPLETED|Period 1||3
5244614|NCT00828061|12892190|P3|COMPLETED|Period 1||3
5244615|NCT00828061|12892191|P2|COMPLETED|Period 1||3
5244616|NCT00828061|12892192|P1|COMPLETED|Period 1||4
5244617|NCT00828061|12892187|P6|STARTED|Period 1||3
5244618|NCT00828061|12892188|P5|STARTED|Period 1||3
5244619|NCT00828061|12892189|P4|STARTED|Period 1||3
5244620|NCT00828061|12892190|P3|STARTED|Period 1||3
5244621|NCT00828061|12892191|P2|STARTED|Period 1||3
5244622|NCT00828061|12892192|P1|STARTED|Period 1||4
5244623|NCT00828009|12892203|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
5244624|NCT00828009|12892203|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
5244625|NCT00828009|12892203|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
5244626|NCT00828009|12892203|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
5244627|NCT00828009|12892203|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
5244628|NCT00828009|12892203|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
5244629|NCT00827983|12892212|P2|NOT COMPLETED|Overall Study||16
5244630|NCT00827983|12892213|P1|NOT COMPLETED|Overall Study||18
5244631|NCT00827983|12892212|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
5244632|NCT00827983|12892213|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
5244633|NCT00827983|12892212|P2|STARTED|Overall Study|all randomised patients|344
5244634|NCT00827983|12892213|P1|STARTED|Overall Study|All randomised patients|339
5244635|NCT00827944|12892225|P2|NOT COMPLETED|Overall Study||59
5244636|NCT00827944|12892226|P1|NOT COMPLETED|Overall Study||63
5244637|NCT00827944|12892225|P2|COMPLETED|Overall Study||240
5244638|NCT00827944|12892226|P1|COMPLETED|Overall Study||241
5244639|NCT00827944|12892225|P2|STARTED|Overall Study||299
5244640|NCT00827944|12892226|P1|STARTED|Overall Study||304
5244641|NCT00827931|12892246|P2|NOT COMPLETED|Overall Study||6
5244642|NCT00827931|12892247|P1|NOT COMPLETED|Overall Study||6
5244643|NCT00827931|12892246|P2|COMPLETED|Overall Study||39
5244644|NCT00827931|12892247|P1|COMPLETED|Overall Study||43
5244645|NCT00827931|12892246|P2|STARTED|Overall Study||45
5244646|NCT00827931|12892247|P1|STARTED|Overall Study||49
5244647|NCT00827918|12892268|P3|NOT COMPLETED|Overall Study||21
5244648|NCT00827918|12892269|P2|NOT COMPLETED|Overall Study||9
5244649|NCT00827918|12892270|P1|NOT COMPLETED|Overall Study||28
5244650|NCT00827918|12892268|P3|COMPLETED|Overall Study||62
5244651|NCT00827918|12892269|P2|COMPLETED|Overall Study||38
5244652|NCT00827918|12892270|P1|COMPLETED|Overall Study||58
5244653|NCT00827918|12892268|P3|STARTED|Overall Study||83
5244654|NCT00827918|12892269|P2|STARTED|Overall Study||47
5244655|NCT00827918|12892270|P1|STARTED|Overall Study||86
5244656|NCT00827827|12892298|P2|NOT COMPLETED|Overall Study||0
5244657|NCT00827827|12892299|P1|NOT COMPLETED|Overall Study||8
5244658|NCT00827827|12892298|P2|COMPLETED|Overall Study||16
5244659|NCT00827827|12892299|P1|COMPLETED|Overall Study||14
5244660|NCT00827827|12892298|P2|STARTED|Overall Study||16
5244661|NCT00827827|12892299|P1|STARTED|Overall Study||22
5244662|NCT00827632|12892343|P2|NOT COMPLETED|Overall Study||23
5244663|NCT00827632|12892344|P1|NOT COMPLETED|Overall Study||22
5244664|NCT00827632|12892343|P2|COMPLETED|Overall Study||75
5244665|NCT00827632|12892344|P1|COMPLETED|Overall Study||106
5244666|NCT00827632|12892343|P2|STARTED|Overall Study||98
5244667|NCT00827632|12892344|P1|STARTED|Overall Study||128
5244668|NCT00827606|12892356|P2|NOT COMPLETED|Overall Study||38
5244669|NCT00827606|12892357|P1|NOT COMPLETED|Overall Study||27
5244670|NCT00827606|12892356|P2|COMPLETED|Overall Study||94
5244671|NCT00827606|12892357|P1|COMPLETED|Overall Study||112
5244672|NCT00827606|12892356|P2|STARTED|Overall Study||132
5244673|NCT00827606|12892357|P1|STARTED|Overall Study||139
5244674|NCT00827567|12892418|P1|NOT COMPLETED|Overall Study||4
5244675|NCT00827567|12892418|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
5244676|NCT00827567|12892418|P1|STARTED|Overall Study||4
5244677|NCT00827541|12892424|P2|NOT COMPLETED|Overall Study||11
5244678|NCT00827541|12892425|P1|NOT COMPLETED|Overall Study||4
5244679|NCT00827541|12892424|P2|COMPLETED|Overall Study||85
5244680|NCT00827541|12892425|P1|COMPLETED|Overall Study||15
5244681|NCT00827541|12892424|P2|STARTED|Overall Study||96
5244682|NCT00827541|12892425|P1|STARTED|Overall Study||19
5244683|NCT00827502|12892437|P1|NOT COMPLETED|Overall Study||21
5244684|NCT00827502|12892437|P1|COMPLETED|Overall Study||400
5244685|NCT00827502|12892437|P1|Received Treatment (Number Treated)|Overall Study||410
5244686|NCT00827502|12892437|P1|STARTED|Overall Study||421
5244687|NCT00827372|12892443|P1|NOT COMPLETED|Overall Study||8
5244688|NCT00827372|12892443|P1|COMPLETED|Overall Study||2
5244689|NCT00827372|12892443|P1|STARTED|Overall Study||10
5244690|NCT00827255|12892451|P1|NOT COMPLETED|Overall Study||0
5244691|NCT00827255|12892451|P1|COMPLETED|Overall Study||35
5244692|NCT00827255|12892451|P1|STARTED|Overall Study||35
5244693|NCT00827242|12892458|P2|NOT COMPLETED|Overall Study||12
5244694|NCT00827242|12892459|P1|NOT COMPLETED|Overall Study||13
5244695|NCT00827242|12892458|P2|COMPLETED|Overall Study||152
5244696|NCT00827242|12892459|P1|COMPLETED|Overall Study||148
5244697|NCT00827242|12892458|P2|STARTED|Overall Study||164
5244698|NCT00827242|12892459|P1|STARTED|Overall Study||161
5244699|NCT00827112|12892497|P2|NOT COMPLETED|Overall Study||12
5244700|NCT00827112|12892498|P1|NOT COMPLETED|Overall Study||15
5244701|NCT00827112|12892497|P2|COMPLETED|Overall Study||52
5244702|NCT00827112|12892498|P1|COMPLETED|Overall Study||50
5244703|NCT00827112|12892497|P2|Treated|Overall Study||61
5244704|NCT00827112|12892498|P1|Treated|Overall Study||60
5244705|NCT00827112|12892497|P2|STARTED|Overall Study||64
5244706|NCT00827112|12892498|P1|STARTED|Overall Study||65
5244707|NCT00827099|12892531|P1|NOT COMPLETED|Overall Study||0
5244708|NCT00827099|12892531|P1|COMPLETED|Overall Study||5
5244709|NCT00827099|12892531|P1|STARTED|Overall Study||5
5244710|NCT00827073|12892542|P2|NOT COMPLETED|Overall Study||0
5244711|NCT00827073|12892543|P1|NOT COMPLETED|Overall Study||0
5244712|NCT00827073|12892542|P2|COMPLETED|Overall Study||20
5244713|NCT00827073|12892543|P1|COMPLETED|Overall Study||20
5244714|NCT00827073|12892542|P2|STARTED|Overall Study||20
5244715|NCT00827073|12892543|P1|STARTED|Overall Study||20
5244716|NCT00826943|12892551|P6|NOT COMPLETED|Overall Study||0
5244717|NCT00826943|12892552|P5|NOT COMPLETED|Overall Study||1
5244718|NCT00826943|12892553|P4|NOT COMPLETED|Overall Study||0
5244719|NCT00826943|12892554|P3|NOT COMPLETED|Overall Study||0
5244720|NCT00826943|12892555|P2|NOT COMPLETED|Overall Study||0
5244721|NCT00826943|12892556|P1|NOT COMPLETED|Overall Study||0
5244722|NCT00826943|12892551|P6|COMPLETED|Overall Study||2
5244723|NCT00826943|12892552|P5|COMPLETED|Overall Study||6
5244724|NCT00826943|12892553|P4|COMPLETED|Overall Study||5
5244725|NCT00826943|12892554|P3|COMPLETED|Overall Study||4
5244726|NCT00826943|12892555|P2|COMPLETED|Overall Study||6
5244727|NCT00826943|12892556|P1|COMPLETED|Overall Study||6
5244728|NCT00826943|12892551|P6|STARTED|Overall Study||2
5244729|NCT00826943|12892552|P5|STARTED|Overall Study||7
5244730|NCT00826943|12892553|P4|STARTED|Overall Study||5
5244731|NCT00826943|12892554|P3|STARTED|Overall Study||4
5244732|NCT00826943|12892555|P2|STARTED|Overall Study||6
5244733|NCT00826943|12892556|P1|STARTED|Overall Study||6
5244734|NCT00826800|12892570|P1|NOT COMPLETED|Overall Study||0
5244735|NCT00826800|12892570|P1|COMPLETED|Overall Study||2
5244736|NCT00826800|12892570|P1|STARTED|Overall Study||2
5244737|NCT00826748|12892577|P3|NOT COMPLETED|Overall Study||4
5244738|NCT00826748|12892578|P2|NOT COMPLETED|Overall Study||0
5244739|NCT00826748|12892579|P1|NOT COMPLETED|Overall Study||0
5244740|NCT00826748|12892577|P3|COMPLETED|Overall Study||8
5244741|NCT00826748|12892578|P2|COMPLETED|Overall Study||4
5244742|NCT00826748|12892579|P1|COMPLETED|Overall Study||6
5244743|NCT00826748|12892577|P3|STARTED|Overall Study||12
5244744|NCT00826748|12892578|P2|STARTED|Overall Study||4
5244745|NCT00826748|12892579|P1|STARTED|Overall Study||6
5244746|NCT00826618|12892587|P1|NOT COMPLETED|Overall Study||1
5244747|NCT00826618|12892587|P1|COMPLETED|Overall Study||5
5244748|NCT00826618|12892587|P1|STARTED|Overall Study||6
5244749|NCT00826540|12892591|P1|NOT COMPLETED|Overall Study||4
5244750|NCT00826540|12892591|P1|COMPLETED|Overall Study||79
5244751|NCT00826540|12892591|P1|STARTED|Overall Study||83
5244752|NCT00826449|12892597|P1|NOT COMPLETED|Overall Study||5
5244753|NCT00826449|12892597|P1|COMPLETED|Overall Study||42
5244754|NCT00826449|12892597|P1|Phase II|Overall Study||35
5244755|NCT00826449|12892597|P1|Phase I|Overall Study||12
5244756|NCT00826449|12892597|P1|STARTED|Overall Study||47
5244757|NCT00826280|12892606|P3|NOT COMPLETED|Overall Study||46
5244758|NCT00826280|12892607|P2|NOT COMPLETED|Overall Study||46
5244759|NCT00826280|12892608|P1|NOT COMPLETED|Overall Study||48
5244760|NCT00826280|12892606|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
5244761|NCT00826280|12892607|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
5244762|NCT00826280|12892608|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
5244763|NCT00826280|12892606|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
5244764|NCT00826280|12892607|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
5244765|NCT00826280|12892608|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
5244766|NCT00826280|12892606|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
5244767|NCT00826280|12892607|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
5244768|NCT00826280|12892608|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
5244769|NCT00826280|12892606|P3|STARTED|Overall Study||117
5244770|NCT00826280|12892607|P2|STARTED|Overall Study||116
5244771|NCT00826280|12892608|P1|STARTED|Overall Study||114
5244772|NCT00826267|12892637|P3|NOT COMPLETED|Overall Study||0
5244773|NCT00826267|12892638|P2|NOT COMPLETED|Overall Study||0
5244774|NCT00826267|12892639|P1|NOT COMPLETED|Overall Study||1
5244775|NCT00826267|12892637|P3|COMPLETED|Overall Study||11
5244776|NCT00826267|12892638|P2|COMPLETED|Overall Study||8
5244777|NCT00826267|12892639|P1|COMPLETED|Overall Study||9
5244778|NCT00826267|12892637|P3|STARTED|Overall Study||11
5244779|NCT00826267|12892638|P2|STARTED|Overall Study||8
5244780|NCT00826267|12892639|P1|STARTED|Overall Study||10
5244781|NCT00826241|12892657|P1|NOT COMPLETED|Overall Study||27
5244782|NCT00826241|12892657|P1|COMPLETED|Overall Study||31
5244783|NCT00826241|12892657|P1|STARTED|Overall Study||58
5244784|NCT00826228|12892663|P1|NOT COMPLETED|Overall Study||1
5244785|NCT00826228|12892663|P1|COMPLETED|Overall Study||11
5244786|NCT00826228|12892663|P1|STARTED|Overall Study||12
5244787|NCT00826202|12892670|P2|NOT COMPLETED|Overall Study||13
5244788|NCT00826202|12892671|P1|NOT COMPLETED|Overall Study||10
5244789|NCT00826202|12892670|P2|COMPLETED|Overall Study||11
5244790|NCT00826202|12892671|P1|COMPLETED|Overall Study||10
5244791|NCT00826202|12892670|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
5244792|NCT00826202|12892671|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
5244793|NCT00826202|12892670|P2|STARTED|Overall Study||24
5244794|NCT00826202|12892671|P1|STARTED|Overall Study||20
5244795|NCT00826176|12892685|P2|NOT COMPLETED|Overall Study||0
5244796|NCT00826176|12892686|P1|NOT COMPLETED|Overall Study||13
5244797|NCT00826176|12892685|P2|COMPLETED|Overall Study|treated and completed|36
5244798|NCT00826176|12892686|P1|COMPLETED|Overall Study|treated and completed|115
5244799|NCT00826176|12892685|P2|STARTED|Overall Study|enrolled|36
5244800|NCT00826176|12892686|P1|STARTED|Overall Study|enrolled|128
5244801|NCT00826150|12892699|P3|NOT COMPLETED|Overall Study||3
5244802|NCT00826150|12892700|P2|NOT COMPLETED|Overall Study||2
5244803|NCT00826150|12892701|P1|NOT COMPLETED|Overall Study||6
5244804|NCT00826150|12892699|P3|COMPLETED|Overall Study||0
5244805|NCT00826150|12892700|P2|COMPLETED|Overall Study||1
5244806|NCT00826150|12892701|P1|COMPLETED|Overall Study||2
5244807|NCT00826150|12892699|P3|STARTED|Overall Study||3
5244808|NCT00826150|12892700|P2|STARTED|Overall Study||3
5244809|NCT00826150|12892701|P1|STARTED|Overall Study||8
5244810|NCT00826111|12892735|P2|NOT COMPLETED|Overall Study||2
5244811|NCT00826111|12892736|P1|NOT COMPLETED|Overall Study||7
5244812|NCT00826111|12892735|P2|COMPLETED|Overall Study||3
5244813|NCT00826111|12892736|P1|COMPLETED|Overall Study||7
5244814|NCT00826111|12892735|P2|STARTED|Overall Study||5
5244815|NCT00826111|12892736|P1|STARTED|Overall Study||14
5244816|NCT00826020|12892758|P1|NOT COMPLETED|Overall Study||0
5244817|NCT00826020|12892758|P1|COMPLETED|Overall Study||72
5244818|NCT00826020|12892758|P1|STARTED|Overall Study||72
5244819|NCT00826007|12892765|P2|NOT COMPLETED|Overall Study||0
5244820|NCT00826007|12892766|P1|NOT COMPLETED|Overall Study||0
5244821|NCT00826007|12892765|P2|COMPLETED|Overall Study||279
5244822|NCT00826007|12892766|P1|COMPLETED|Overall Study|Retrospective review|308
5244823|NCT00826007|12892765|P2|STARTED|Overall Study||279
5244824|NCT00826007|12892766|P1|STARTED|Overall Study|Retrospective review|308
5244825|NCT00825994|12892771|P1|NOT COMPLETED|Overall Study||5
5244826|NCT00825994|12892771|P1|COMPLETED|Overall Study||19
5244827|NCT00825994|12892771|P1|STARTED|Overall Study||24
5244828|NCT00825916|12892779|P3|NOT COMPLETED|Overall Study||1
5244829|NCT00825916|12892780|P2|NOT COMPLETED|Overall Study||2
5244830|NCT00825916|12892781|P1|NOT COMPLETED|Overall Study||4
5244831|NCT00825916|12892779|P3|COMPLETED|Overall Study||19
5244832|NCT00825916|12892780|P2|COMPLETED|Overall Study||18
5244833|NCT00825916|12892781|P1|COMPLETED|Overall Study||15
5244834|NCT00825916|12892779|P3|STARTED|Overall Study||20
5244835|NCT00825916|12892780|P2|STARTED|Overall Study||20
5244836|NCT00825916|12892781|P1|STARTED|Overall Study||19
5244837|NCT00825825|12892822|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
5244838|NCT00825825|12892823|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
5244839|NCT00825825|12892824|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
5244840|NCT00825825|12892825|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
5244841|NCT00825825|12892826|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
5244842|NCT00825825|12892827|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
5244843|NCT00825825|12892822|P6|COMPLETED|Third Medication Period (14 Days)||1
5244844|NCT00825825|12892823|P5|COMPLETED|Third Medication Period (14 Days)||3
5244845|NCT00825825|12892824|P4|COMPLETED|Third Medication Period (14 Days)||3
5244846|NCT00825825|12892825|P3|COMPLETED|Third Medication Period (14 Days)||2
5244847|NCT00825825|12892826|P2|COMPLETED|Third Medication Period (14 Days)||2
5244848|NCT00825825|12892827|P1|COMPLETED|Third Medication Period (14 Days)||1
5244849|NCT00825825|12892822|P6|STARTED|Third Medication Period (14 Days)||3
5244850|NCT00825825|12892823|P5|STARTED|Third Medication Period (14 Days)||3
5244851|NCT00825825|12892824|P4|STARTED|Third Medication Period (14 Days)||3
5244852|NCT00825825|12892825|P3|STARTED|Third Medication Period (14 Days)||2
5244853|NCT00825825|12892826|P2|STARTED|Third Medication Period (14 Days)||4
5244854|NCT00825825|12892827|P1|STARTED|Third Medication Period (14 Days)||1
5244855|NCT00825825|12892822|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
5244856|NCT00825825|12892823|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
5244857|NCT00825825|12892824|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
5244858|NCT00825825|12892825|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
5244859|NCT00825825|12892826|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
5244860|NCT00825825|12892827|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
5244861|NCT00825825|12892822|P6|COMPLETED|Second Washout Period (14 Days)||3
5244862|NCT00825825|12892823|P5|COMPLETED|Second Washout Period (14 Days)||3
5244863|NCT00825825|12892824|P4|COMPLETED|Second Washout Period (14 Days)||3
5244864|NCT00825825|12892825|P3|COMPLETED|Second Washout Period (14 Days)||2
5244865|NCT00825825|12892826|P2|COMPLETED|Second Washout Period (14 Days)||4
5244866|NCT00825825|12892827|P1|COMPLETED|Second Washout Period (14 Days)||1
5244867|NCT00825825|12892822|P6|STARTED|Second Washout Period (14 Days)||3
5244868|NCT00825825|12892823|P5|STARTED|Second Washout Period (14 Days)||3
5244869|NCT00825825|12892824|P4|STARTED|Second Washout Period (14 Days)||3
5244870|NCT00825825|12892825|P3|STARTED|Second Washout Period (14 Days)||2
5244871|NCT00825825|12892826|P2|STARTED|Second Washout Period (14 Days)||4
5244872|NCT00825825|12892827|P1|STARTED|Second Washout Period (14 Days)||1
5244873|NCT00825825|12892822|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
5244874|NCT00825825|12892823|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
5244875|NCT00825825|12892824|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
5244876|NCT00825825|12892825|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
5244877|NCT00825825|12892826|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
5244878|NCT00825825|12892827|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
5244879|NCT00825825|12892822|P6|COMPLETED|Second Medication Period (14 Days)||3
5244880|NCT00825825|12892823|P5|COMPLETED|Second Medication Period (14 Days)||3
5244881|NCT00825825|12892824|P4|COMPLETED|Second Medication Period (14 Days)||3
5244882|NCT00825825|12892825|P3|COMPLETED|Second Medication Period (14 Days)||2
5244883|NCT00825825|12892826|P2|COMPLETED|Second Medication Period (14 Days)||4
5244884|NCT00825825|12892827|P1|COMPLETED|Second Medication Period (14 Days)||1
5244885|NCT00825825|12892822|P6|STARTED|Second Medication Period (14 Days)||3
5244886|NCT00825825|12892823|P5|STARTED|Second Medication Period (14 Days)||4
5244887|NCT00825825|12892824|P4|STARTED|Second Medication Period (14 Days)||5
5244888|NCT00825825|12892825|P3|STARTED|Second Medication Period (14 Days)||2
5244889|NCT00825825|12892826|P2|STARTED|Second Medication Period (14 Days)||4
5244890|NCT00825825|12892827|P1|STARTED|Second Medication Period (14 Days)||3
5244891|NCT00825825|12892822|P6|NOT COMPLETED|First Washout Period (14 Days)||0
5244892|NCT00825825|12892823|P5|NOT COMPLETED|First Washout Period (14 Days)||0
5244893|NCT00825825|12892824|P4|NOT COMPLETED|First Washout Period (14 Days)||0
5244894|NCT00825825|12892825|P3|NOT COMPLETED|First Washout Period (14 Days)||0
5244895|NCT00825825|12892826|P2|NOT COMPLETED|First Washout Period (14 Days)||0
5244896|NCT00825825|12892827|P1|NOT COMPLETED|First Washout Period (14 Days)||0
5244897|NCT00825825|12892822|P6|COMPLETED|First Washout Period (14 Days)||3
5244898|NCT00825825|12892823|P5|COMPLETED|First Washout Period (14 Days)||4
5244899|NCT00825825|12892824|P4|COMPLETED|First Washout Period (14 Days)||5
5244900|NCT00825825|12892825|P3|COMPLETED|First Washout Period (14 Days)||2
5244901|NCT00825825|12892826|P2|COMPLETED|First Washout Period (14 Days)||4
5244902|NCT00825825|12892827|P1|COMPLETED|First Washout Period (14 Days)||3
5244903|NCT00825825|12892822|P6|STARTED|First Washout Period (14 Days)||3
5244904|NCT00825825|12892823|P5|STARTED|First Washout Period (14 Days)||4
5244905|NCT00825825|12892824|P4|STARTED|First Washout Period (14 Days)||5
5244906|NCT00825825|12892825|P3|STARTED|First Washout Period (14 Days)||2
5244907|NCT00825825|12892826|P2|STARTED|First Washout Period (14 Days)||4
5244908|NCT00825825|12892827|P1|STARTED|First Washout Period (14 Days)||3
5244909|NCT00825825|12892822|P6|NOT COMPLETED|First Medication Period (14 Days)||2
5244910|NCT00825825|12892823|P5|NOT COMPLETED|First Medication Period (14 Days)||0
5244911|NCT00825825|12892824|P4|NOT COMPLETED|First Medication Period (14 Days)||0
5244912|NCT00825825|12892825|P3|NOT COMPLETED|First Medication Period (14 Days)||1
5244913|NCT00825825|12892826|P2|NOT COMPLETED|First Medication Period (14 Days)||0
5244914|NCT00825825|12892827|P1|NOT COMPLETED|First Medication Period (14 Days)||3
5244915|NCT00825825|12892822|P6|COMPLETED|First Medication Period (14 Days)||3
5244916|NCT00825825|12892823|P5|COMPLETED|First Medication Period (14 Days)||4
5244917|NCT00825825|12892824|P4|COMPLETED|First Medication Period (14 Days)||5
5244918|NCT00825825|12892825|P3|COMPLETED|First Medication Period (14 Days)||2
5244919|NCT00825825|12892826|P2|COMPLETED|First Medication Period (14 Days)||4
5244920|NCT00825825|12892827|P1|COMPLETED|First Medication Period (14 Days)||3
5244921|NCT00825825|12892822|P6|STARTED|First Medication Period (14 Days)||5
5244922|NCT00825825|12892823|P5|STARTED|First Medication Period (14 Days)||4
5244923|NCT00825825|12892824|P4|STARTED|First Medication Period (14 Days)||5
5244924|NCT00825825|12892825|P3|STARTED|First Medication Period (14 Days)||3
5244925|NCT00825825|12892826|P2|STARTED|First Medication Period (14 Days)||4
5244926|NCT00825825|12892827|P1|STARTED|First Medication Period (14 Days)||6
5244927|NCT00825812|12892843|P4|NOT COMPLETED|Overall Study||10
5244928|NCT00825812|12892844|P3|NOT COMPLETED|Overall Study||6
5244929|NCT00825812|12892845|P2|NOT COMPLETED|Overall Study||1
5244930|NCT00825812|12892846|P1|NOT COMPLETED|Overall Study||0
5244931|NCT00825812|12892843|P4|COMPLETED|Overall Study||111
5244932|NCT00825812|12892844|P3|COMPLETED|Overall Study||120
5244933|NCT00825812|12892845|P2|COMPLETED|Overall Study||31
5244934|NCT00825812|12892846|P1|COMPLETED|Overall Study||29
5244935|NCT00825812|12892843|P4|TREATED|Overall Study||111
5244936|NCT00825812|12892844|P3|TREATED|Overall Study||120
5244937|NCT00825812|12892845|P2|TREATED|Overall Study||31
5244938|NCT00825812|12892846|P1|TREATED|Overall Study||29
5244939|NCT00825812|12892843|P4|STARTED|Overall Study||121
5244940|NCT00825812|12892844|P3|STARTED|Overall Study||126
5244941|NCT00825812|12892845|P2|STARTED|Overall Study||32
5244942|NCT00825812|12892846|P1|STARTED|Overall Study||29
5244943|NCT00825786|12892862|P2|NOT COMPLETED|Overall Study||0
5244944|NCT00825786|12892863|P1|NOT COMPLETED|Overall Study||0
5244945|NCT00825786|12892862|P2|COMPLETED|Overall Study||51
5244946|NCT00825786|12892863|P1|COMPLETED|Overall Study||52
5244947|NCT00825786|12892862|P2|STARTED|Overall Study||51
5244948|NCT00825786|12892863|P1|STARTED|Overall Study||52
5244949|NCT00825734|12892881|P3|NOT COMPLETED|Phase II||76
5244950|NCT00825734|12892882|P2|NOT COMPLETED|Phase II||0
5244951|NCT00825734|12892883|P1|NOT COMPLETED|Phase II||0
5244952|NCT00825734|12892881|P3|COMPLETED|Phase II||0
5244953|NCT00825734|12892882|P2|COMPLETED|Phase II||0
5244954|NCT00825734|12892883|P1|COMPLETED|Phase II||0
5244955|NCT00825734|12892881|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
5244956|NCT00825734|12892882|P2|STARTED|Phase II||0
5244957|NCT00825734|12892883|P1|STARTED|Phase II||0
5244958|NCT00825734|12892881|P3|NOT COMPLETED|Phase I||0
5244959|NCT00825734|12892882|P2|NOT COMPLETED|Phase I||3
5244960|NCT00825734|12892883|P1|NOT COMPLETED|Phase I||4
5244961|NCT00825734|12892881|P3|COMPLETED|Phase I||3
5244962|NCT00825734|12892882|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5244963|NCT00825734|12892883|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
5244964|NCT00825734|12892881|P3|STARTED|Phase I||3
5244965|NCT00825734|12892882|P2|STARTED|Phase I||3
5244966|NCT00825734|12892883|P1|STARTED|Phase I||4
5244967|NCT00825682|12892893|P2|NOT COMPLETED|Overall Study||5
5244968|NCT00825682|12892894|P1|NOT COMPLETED|Overall Study||13
5244969|NCT00825682|12892893|P2|COMPLETED|Overall Study||20
5244970|NCT00825682|12892894|P1|COMPLETED|Overall Study||34
5244971|NCT00825682|12892893|P2|STARTED|Overall Study||25
5244972|NCT00825682|12892894|P1|STARTED|Overall Study||47
5244973|NCT00825630|12892908|P4|NOT COMPLETED|Overall Study||0
5244974|NCT00825630|12892909|P3|NOT COMPLETED|Overall Study||0
5244975|NCT00825630|12892910|P2|NOT COMPLETED|Overall Study||0
5244976|NCT00825630|12892911|P1|NOT COMPLETED|Overall Study||0
5244977|NCT00825630|12892908|P4|COMPLETED|Overall Study||13
5244978|NCT00825630|12892909|P3|COMPLETED|Overall Study||19
5244979|NCT00825630|12892910|P2|COMPLETED|Overall Study||62
5244980|NCT00825630|12892911|P1|COMPLETED|Overall Study||29
5244981|NCT00825630|12892908|P4|STARTED|Overall Study||13
5244982|NCT00825630|12892909|P3|STARTED|Overall Study||19
5244983|NCT00825630|12892910|P2|STARTED|Overall Study||62
5244984|NCT00825630|12892911|P1|STARTED|Overall Study||29
5244985|NCT00825565|12892921|P1|NOT COMPLETED|Overall Study||0
5244986|NCT00825565|12892921|P1|COMPLETED|Overall Study||8
5244987|NCT00825565|12892921|P1|STARTED|Overall Study||8
5244988|NCT00825500|12892934|P3|NOT COMPLETED|Overall Study||0
5244989|NCT00825500|12892935|P2|NOT COMPLETED|Overall Study||0
5244990|NCT00825500|12892936|P1|NOT COMPLETED|Overall Study||0
5244991|NCT00825500|12892934|P3|COMPLETED|Overall Study||120
5244992|NCT00825500|12892935|P2|COMPLETED|Overall Study||121
5244993|NCT00825500|12892936|P1|COMPLETED|Overall Study||125
5244994|NCT00825500|12892934|P3|STARTED|Overall Study||120
5244995|NCT00825500|12892935|P2|STARTED|Overall Study||121
5244996|NCT00825500|12892936|P1|STARTED|Overall Study||125
5244997|NCT00825370|12892949|P2|NOT COMPLETED|Overall Study||0
5244998|NCT00825370|12892950|P1|NOT COMPLETED|Overall Study||0
5244999|NCT00825370|12892949|P2|COMPLETED|Overall Study||175
5245000|NCT00825370|12892950|P1|COMPLETED|Overall Study||175
5245001|NCT00825370|12892949|P2|STARTED|Overall Study||175
5245002|NCT00825370|12892950|P1|STARTED|Overall Study||175
5245003|NCT00825344|12892964|P2|NOT COMPLETED|Overall Study||1
5245004|NCT00825344|12892965|P1|NOT COMPLETED|Overall Study||1
5245005|NCT00825344|12892964|P2|COMPLETED|Overall Study||42
5245006|NCT00825344|12892965|P1|COMPLETED|Overall Study||33
5245007|NCT00825344|12892964|P2|STARTED|Overall Study||43
5245008|NCT00825344|12892965|P1|STARTED|Overall Study||34
5245009|NCT00825318|12892975|P1|NOT COMPLETED|Overall Study||1
5245010|NCT00825318|12892975|P1|COMPLETED|Overall Study||12
5245011|NCT00825318|12892975|P1|STARTED|Overall Study||13
5245012|NCT00825305|12892985|P2|NOT COMPLETED|Overall Study||23
5245013|NCT00825305|12892986|P1|NOT COMPLETED|Overall Study||17
5245014|NCT00825305|12892985|P2|COMPLETED|Overall Study||252
5245015|NCT00825305|12892986|P1|COMPLETED|Overall Study||533
5245016|NCT00825305|12892985|P2|STARTED|Overall Study||275
5245017|NCT00825305|12892986|P1|STARTED|Overall Study||550
5245018|NCT00825266|12893000|P2|NOT COMPLETED|Overall Study||0
5245019|NCT00825266|12893001|P1|NOT COMPLETED|Overall Study||0
5245020|NCT00825266|12893000|P2|COMPLETED|Overall Study||1
5245021|NCT00825266|12893001|P1|COMPLETED|Overall Study||1
5245022|NCT00825266|12893000|P2|STARTED|Overall Study||1
5245023|NCT00825266|12893001|P1|STARTED|Overall Study||1
5245024|NCT00825227|12893013|P2|NOT COMPLETED|Overall Study||0
5245025|NCT00825227|12893014|P1|NOT COMPLETED|Overall Study||0
5245026|NCT00825227|12893013|P2|COMPLETED|Overall Study||4
5245027|NCT00825227|12893014|P1|COMPLETED|Overall Study||6
5245028|NCT00825227|12893013|P2|STARTED|Overall Study||4
5245029|NCT00825227|12893014|P1|STARTED|Overall Study||6
5245030|NCT00825175|12893026|P2|NOT COMPLETED|Overall Study||5
5245031|NCT00825175|12893027|P1|NOT COMPLETED|Overall Study||0
5245032|NCT00825175|12893026|P2|COMPLETED|Overall Study||7
5245033|NCT00825175|12893027|P1|COMPLETED|Overall Study||10
5245034|NCT00825175|12893026|P2|STARTED|Overall Study||12
5245035|NCT00825175|12893027|P1|STARTED|Overall Study||10
5245036|NCT00825162|12893036|P3|NOT COMPLETED|Overall Study||6
5245037|NCT00825162|12893037|P2|NOT COMPLETED|Overall Study||21
5245038|NCT00825162|12893038|P1|NOT COMPLETED|Overall Study||28
5245039|NCT00825162|12893036|P3|COMPLETED|Overall Study||396
5245040|NCT00825162|12893037|P2|COMPLETED|Overall Study||859
5245041|NCT00825162|12893038|P1|COMPLETED|Overall Study||682
5245042|NCT00825162|12893036|P3|STARTED|Overall Study||402
5245043|NCT00825162|12893037|P2|STARTED|Overall Study||880
5245044|NCT00825162|12893038|P1|STARTED|Overall Study||710
5245045|NCT00824993|12893064|P2|NOT COMPLETED|Overall Study||17
5245046|NCT00824993|12893065|P1|NOT COMPLETED|Overall Study||14
5245047|NCT00824993|12893064|P2|COMPLETED|Overall Study||22
5245048|NCT00824993|12893065|P1|COMPLETED|Overall Study||25
5245049|NCT00824993|12893064|P2|6 Month Follow up|Overall Study||27
5245050|NCT00824993|12893065|P1|6 Month Follow up|Overall Study||33
5245051|NCT00824993|12893064|P2|STARTED|Overall Study||39
5245052|NCT00824993|12893065|P1|STARTED|Overall Study||39
5245053|NCT00824850|12893073|P2|NOT COMPLETED|Overall Study||1
5245054|NCT00824850|12893074|P1|NOT COMPLETED|Overall Study||0
5245055|NCT00824850|12893073|P2|COMPLETED|Overall Study||36
5245056|NCT00824850|12893074|P1|COMPLETED|Overall Study||38
5245057|NCT00824850|12893073|P2|Received Vaccination 13vPnC|Overall Study||36
5245058|NCT00824850|12893074|P1|Received Vaccination 13vPnC|Overall Study||38
5245059|NCT00824850|12893073|P2|STARTED|Overall Study||37
5245060|NCT00824850|12893074|P1|STARTED|Overall Study||38
5245061|NCT00824824|12893120|P2|NOT COMPLETED|Overall Study||0
5245062|NCT00824824|12893121|P1|NOT COMPLETED|Overall Study||0
5245063|NCT00824824|12893120|P2|COMPLETED|Overall Study||3
5245064|NCT00824824|12893121|P1|COMPLETED|Overall Study||4
5245065|NCT00824824|12893120|P2|STARTED|Overall Study||3
5245066|NCT00824824|12893121|P1|STARTED|Overall Study||4
5245067|NCT00824772|12893127|P1|NOT COMPLETED|Overall Study||8
5245068|NCT00824772|12893127|P1|COMPLETED|Overall Study||196
5245069|NCT00824772|12893127|P1|STARTED|Overall Study||204
5245070|NCT00824746|12893132|P1|NOT COMPLETED|Overall Study||0
5245071|NCT00824746|12893132|P1|COMPLETED|Overall Study||23
5245072|NCT00824746|12893132|P1|STARTED|Overall Study||23
5245073|NCT00824733|12893138|P1|NOT COMPLETED|Overall Study||0
5245074|NCT00824733|12893138|P1|COMPLETED|Overall Study||6
5245075|NCT00824733|12893138|P1|STARTED|Overall Study||6
5245076|NCT00824720|12893147|P3|NOT COMPLETED|Overall Study||1
5245077|NCT00824720|12893148|P2|NOT COMPLETED|Overall Study||1
5245078|NCT00824720|12893149|P1|NOT COMPLETED|Overall Study||3
5245079|NCT00824720|12893147|P3|COMPLETED|Overall Study||19
5245080|NCT00824720|12893148|P2|COMPLETED|Overall Study||15
5245081|NCT00824720|12893149|P1|COMPLETED|Overall Study||16
5245082|NCT00824720|12893147|P3|STARTED|Overall Study||20
5245083|NCT00824720|12893148|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
5245084|NCT00824720|12893149|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
5245085|NCT00824655|12893165|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
5245086|NCT00824655|12893166|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
5245087|NCT00824655|12893165|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
5245088|NCT00824655|12893166|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
5245089|NCT00824655|12893165|P2|STARTED|Toddler Dose (12 Months of Age)||116
5245090|NCT00824655|12893166|P1|STARTED|Toddler Dose (12 Months of Age)||118
5245091|NCT00824655|12893165|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
5245092|NCT00824655|12893166|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
5245093|NCT00824655|12893165|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
5245094|NCT00824655|12893166|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
5245095|NCT00824655|12893165|P2|STARTED|After Infant Dose (6 Months of Age)||0
5245096|NCT00824655|12893166|P1|STARTED|After Infant Dose (6 Months of Age)||118
5245097|NCT00824655|12893165|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
5245098|NCT00824655|12893166|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
5245099|NCT00824655|12893165|P2|COMPLETED|Infant Series (5 Months of Age)||0
5245100|NCT00824655|12893166|P1|COMPLETED|Infant Series (5 Months of Age)||118
5245101|NCT00824655|12893165|P2|STARTED|Infant Series (5 Months of Age)||0
5245102|NCT00824655|12893166|P1|STARTED|Infant Series (5 Months of Age)||118
5245103|NCT00824616|12893186|P2|NOT COMPLETED|Overall Study||7
5245104|NCT00824616|12893187|P1|NOT COMPLETED|Overall Study||6
5245105|NCT00824616|12893186|P2|COMPLETED|Overall Study||27
5245106|NCT00824616|12893187|P1|COMPLETED|Overall Study||28
5245107|NCT00824616|12893186|P2|STARTED|Overall Study||34
5245108|NCT00824616|12893187|P1|STARTED|Overall Study||34
5245109|NCT00824564|12893197|P2|NOT COMPLETED|Overall Study||10
5245110|NCT00824564|12893198|P1|NOT COMPLETED|Overall Study||8
5245111|NCT00824564|12893197|P2|COMPLETED|Overall Study||30
5245112|NCT00824564|12893198|P1|COMPLETED|Overall Study||34
5245113|NCT00824564|12893197|P2|Treated|Overall Study||40
5245114|NCT00824564|12893198|P1|Treated|Overall Study||41
5245115|NCT00824564|12893197|P2|STARTED|Overall Study||40
5245116|NCT00824564|12893198|P1|STARTED|Overall Study||42
5245117|NCT00824538|12893216|P1|NOT COMPLETED|Overall Study||2
5245118|NCT00824538|12893216|P1|COMPLETED|Overall Study||11
5245119|NCT00824538|12893216|P1|STARTED|Overall Study|13 patients entered the study|13
5245120|NCT00824512|12893226|P2|NOT COMPLETED|Overall Study||0
5245121|NCT00824512|12893227|P1|NOT COMPLETED|Overall Study||0
5245122|NCT00824512|12893226|P2|COMPLETED|Overall Study||11
5245123|NCT00824512|12893227|P1|COMPLETED|Overall Study||11
5245124|NCT00824512|12893226|P2|STARTED|Overall Study||11
5245125|NCT00824512|12893227|P1|STARTED|Overall Study||11
5245126|NCT00824473|12893277|P2|NOT COMPLETED|Overall Study||13
5245127|NCT00824473|12893278|P1|NOT COMPLETED|Overall Study||15
5245128|NCT00824473|12893277|P2|COMPLETED|Overall Study||238
5245129|NCT00824473|12893278|P1|COMPLETED|Overall Study||240
5245130|NCT00824473|12893277|P2|STARTED|Overall Study||251
5245131|NCT00824473|12893278|P1|STARTED|Overall Study|1 subject was randomized in error|255
5245132|NCT00824460|12893300|P6|NOT COMPLETED|Overall Study||8
5245133|NCT00824460|12893301|P5|NOT COMPLETED|Overall Study||9
5245134|NCT00824460|12893302|P4|NOT COMPLETED|Overall Study||12
5245135|NCT00824460|12893303|P3|NOT COMPLETED|Overall Study||5
5245136|NCT00824460|12893304|P2|NOT COMPLETED|Overall Study||9
5245137|NCT00824460|12893305|P1|NOT COMPLETED|Overall Study||8
5245138|NCT00824460|12893300|P6|COMPLETED|Overall Study||18
5245139|NCT00824460|12893301|P5|COMPLETED|Overall Study||15
5245140|NCT00824460|12893302|P4|COMPLETED|Overall Study||15
5245141|NCT00824460|12893303|P3|COMPLETED|Overall Study||20
5245142|NCT00824460|12893304|P2|COMPLETED|Overall Study||17
5245143|NCT00824460|12893305|P1|COMPLETED|Overall Study||18
5245144|NCT00824460|12893300|P6|STARTED|Overall Study||26
5245145|NCT00824460|12893301|P5|STARTED|Overall Study||24
5245146|NCT00824460|12893302|P4|STARTED|Overall Study||27
5245147|NCT00824460|12893303|P3|STARTED|Overall Study||25
5245148|NCT00824460|12893304|P2|STARTED|Overall Study||26
5245149|NCT00824460|12893305|P1|STARTED|Overall Study||26
5245150|NCT00824434|12893337|P1|NOT COMPLETED|Overall Study||0
5245151|NCT00824434|12893337|P1|COMPLETED|Overall Study||100
5245152|NCT00824434|12893337|P1|STARTED|Overall Study||100
5245153|NCT00824421|12893359|P3|NOT COMPLETED|Overall Study||14
5245154|NCT00824421|12893360|P2|NOT COMPLETED|Overall Study||22
5245155|NCT00824421|12893361|P1|NOT COMPLETED|Overall Study||17
5245156|NCT00824421|12893359|P3|COMPLETED|Overall Study||49
5245157|NCT00824421|12893360|P2|COMPLETED|Overall Study||44
5245158|NCT00824421|12893361|P1|COMPLETED|Overall Study||49
5245159|NCT00824421|12893359|P3|Treated|Overall Study||63
5245160|NCT00824421|12893360|P2|Treated|Overall Study||65
5245161|NCT00824421|12893361|P1|Treated|Overall Study||65
5245162|NCT00824421|12893359|P3|STARTED|Overall Study||63
5245163|NCT00824421|12893360|P2|STARTED|Overall Study||66
5245164|NCT00824421|12893361|P1|STARTED|Overall Study||66
5245165|NCT00824408|12893412|P5|NOT COMPLETED|Randomized Phase||46
5245166|NCT00824408|12893413|P4|NOT COMPLETED|Randomized Phase||46
5245167|NCT00824408|12893414|P3|NOT COMPLETED|Randomized Phase||36
5245168|NCT00824408|12893415|P2|NOT COMPLETED|Randomized Phase||0
5245169|NCT00824408|12893416|P1|NOT COMPLETED|Randomized Phase||0
5245170|NCT00824408|12893412|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
5245171|NCT00824408|12893413|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
5245172|NCT00824408|12893414|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
5245173|NCT00824408|12893415|P2|COMPLETED|Randomized Phase||0
5245174|NCT00824408|12893416|P1|COMPLETED|Randomized Phase||0
5245175|NCT00824408|12893412|P5|STARTED|Randomized Phase||47
5245176|NCT00824408|12893413|P4|STARTED|Randomized Phase||47
5245177|NCT00824408|12893414|P3|STARTED|Randomized Phase||37
5245178|NCT00824408|12893415|P2|STARTED|Randomized Phase||0
5245179|NCT00824408|12893416|P1|STARTED|Randomized Phase||0
5245180|NCT00824408|12893412|P5|NOT COMPLETED|Run-in Phase||0
5245181|NCT00824408|12893413|P4|NOT COMPLETED|Run-in Phase||0
5245182|NCT00824408|12893414|P3|NOT COMPLETED|Run-in Phase||0
5245183|NCT00824408|12893415|P2|NOT COMPLETED|Run-in Phase||6
5245184|NCT00824408|12893416|P1|NOT COMPLETED|Run-in Phase||6
5245185|NCT00824408|12893412|P5|COMPLETED|Run-in Phase||0
5245186|NCT00824408|12893413|P4|COMPLETED|Run-in Phase||0
5245187|NCT00824408|12893414|P3|COMPLETED|Run-in Phase||0
5245188|NCT00824408|12893415|P2|COMPLETED|Run-in Phase||0
5245189|NCT00824408|12893416|P1|COMPLETED|Run-in Phase||0
5245190|NCT00824408|12893412|P5|STARTED|Run-in Phase||0
5245191|NCT00824408|12893413|P4|STARTED|Run-in Phase||0
5245192|NCT00824408|12893414|P3|STARTED|Run-in Phase||0
5245193|NCT00824408|12893415|P2|STARTED|Run-in Phase||6
5245194|NCT00824408|12893416|P1|STARTED|Run-in Phase||6
5245195|NCT00824382|12893468|P4|NOT COMPLETED|Overall Study||5
5245196|NCT00824382|12893469|P3|NOT COMPLETED|Overall Study||3
5245197|NCT00824382|12893470|P2|NOT COMPLETED|Overall Study||2
5245198|NCT00824382|12893471|P1|NOT COMPLETED|Overall Study||5
5245199|NCT00824382|12893468|P4|COMPLETED|Overall Study||81
5245200|NCT00824382|12893469|P3|COMPLETED|Overall Study||76
5245201|NCT00824382|12893470|P2|COMPLETED|Overall Study||82
5245202|NCT00824382|12893471|P1|COMPLETED|Overall Study||74
5245203|NCT00824382|12893468|P4|STARTED|Overall Study||86
5245204|NCT00824382|12893469|P3|STARTED|Overall Study||79
5245205|NCT00824382|12893470|P2|STARTED|Overall Study||84
5245206|NCT00824382|12893471|P1|STARTED|Overall Study||79
5245207|NCT00824369|12893547|P6|NOT COMPLETED|Overall Study||1
5245208|NCT00824369|12893548|P5|NOT COMPLETED|Overall Study||1
5245209|NCT00824369|12893549|P4|NOT COMPLETED|Overall Study||2
5245210|NCT00824369|12893550|P3|NOT COMPLETED|Overall Study||1
5245211|NCT00824369|12893551|P2|NOT COMPLETED|Overall Study||0
5245212|NCT00824369|12893552|P1|NOT COMPLETED|Overall Study||1
5245213|NCT00824369|12893547|P6|COMPLETED|Overall Study||16
5245214|NCT00824369|12893548|P5|COMPLETED|Overall Study||11
5245215|NCT00824369|12893549|P4|COMPLETED|Overall Study||9
5245216|NCT00824369|12893550|P3|COMPLETED|Overall Study||2
5245217|NCT00824369|12893551|P2|COMPLETED|Overall Study||4
5245218|NCT00824369|12893552|P1|COMPLETED|Overall Study||4
5245219|NCT00824369|12893547|P6|STARTED|Overall Study||17
5245220|NCT00824369|12893548|P5|STARTED|Overall Study||12
5245221|NCT00824369|12893549|P4|STARTED|Overall Study||11
5245222|NCT00824369|12893550|P3|STARTED|Overall Study||3
5245223|NCT00824369|12893551|P2|STARTED|Overall Study||4
5245224|NCT00824369|12893552|P1|STARTED|Overall Study||5
5245225|NCT00824291|12893592|P2|NOT COMPLETED|Overall Study||35
5245226|NCT00824291|12893593|P1|NOT COMPLETED|Overall Study||54
5245227|NCT00824291|12893592|P2|COMPLETED|Overall Study||107
5245228|NCT00824291|12893593|P1|COMPLETED|Overall Study||231
5245229|NCT00824291|12893592|P2|STARTED|Overall Study||142
5245230|NCT00824291|12893593|P1|STARTED|Overall Study||285
5245231|NCT00824265|12893615|P2|NOT COMPLETED|Survival Follow-up Phase||16
5245232|NCT00824265|12893616|P1|NOT COMPLETED|Survival Follow-up Phase||9
5245233|NCT00824265|12893615|P2|COMPLETED|Survival Follow-up Phase||73
5245234|NCT00824265|12893616|P1|COMPLETED|Survival Follow-up Phase||87
5245235|NCT00824265|12893615|P2|STARTED|Survival Follow-up Phase||89
5245236|NCT00824265|12893616|P1|STARTED|Survival Follow-up Phase||96
5245237|NCT00824265|12893615|P2|NOT COMPLETED|Follow-up Phase||31
5245238|NCT00824265|12893616|P1|NOT COMPLETED|Follow-up Phase||18
5245239|NCT00824265|12893615|P2|COMPLETED|Follow-up Phase||129
5245240|NCT00824265|12893616|P1|COMPLETED|Follow-up Phase||154
5245241|NCT00824265|12893615|P2|STARTED|Follow-up Phase||160
5245242|NCT00824265|12893616|P1|STARTED|Follow-up Phase||172
5245243|NCT00824265|12893615|P2|NOT COMPLETED|Treatment Phase||80
5245244|NCT00824265|12893616|P1|NOT COMPLETED|Treatment Phase||64
5245245|NCT00824265|12893615|P2|COMPLETED|Treatment Phase||102
5245246|NCT00824265|12893616|P1|COMPLETED|Treatment Phase||119
5245247|NCT00824265|12893615|P2|STARTED|Treatment Phase||182
5245248|NCT00824265|12893616|P1|STARTED|Treatment Phase||183
5245249|NCT00824161|12893677|P1|NOT COMPLETED|Overall Study||2
5245250|NCT00824161|12893677|P1|COMPLETED|Overall Study||26
5245251|NCT00824161|12893677|P1|STARTED|Overall Study||28
5245252|NCT00824070|12893686|P3|NOT COMPLETED|Overall Study||0
5245253|NCT00824070|12893687|P2|NOT COMPLETED|Overall Study||0
5245254|NCT00824070|12893688|P1|NOT COMPLETED|Overall Study||0
5245255|NCT00824070|12893686|P3|COMPLETED|Overall Study||36
5245256|NCT00824070|12893687|P2|COMPLETED|Overall Study||35
5245257|NCT00824070|12893688|P1|COMPLETED|Overall Study||34
5245258|NCT00824070|12893686|P3|STARTED|Overall Study||36
5245259|NCT00824070|12893687|P2|STARTED|Overall Study||35
5245260|NCT00824070|12893688|P1|STARTED|Overall Study||34
5245261|NCT00824044|12893698|P2|NOT COMPLETED|Overall Study||6
5245262|NCT00824044|12893699|P1|NOT COMPLETED|Overall Study||9
5245263|NCT00824044|12893698|P2|COMPLETED|Overall Study||10
5245264|NCT00824044|12893699|P1|COMPLETED|Overall Study||14
5245265|NCT00824044|12893698|P2|STARTED|Overall Study||16
5245266|NCT00824044|12893699|P1|STARTED|Overall Study||23
5245267|NCT00824005|12893743|P2|NOT COMPLETED|Overall Study||2
5245268|NCT00824005|12893744|P1|NOT COMPLETED|Overall Study||0
5245269|NCT00824005|12893743|P2|COMPLETED|Overall Study||59
5245270|NCT00824005|12893744|P1|COMPLETED|Overall Study||31
5245271|NCT00824005|12893743|P2|STARTED|Overall Study||61
5245272|NCT00824005|12893744|P1|STARTED|Overall Study||31
5245273|NCT00823979|12893779|P3|NOT COMPLETED|Overall Study||24
5245274|NCT00823979|12893780|P2|NOT COMPLETED|Overall Study||32
5245275|NCT00823979|12893781|P1|NOT COMPLETED|Overall Study||29
5245276|NCT00823979|12893779|P3|COMPLETED|Overall Study||11
5245277|NCT00823979|12893780|P2|COMPLETED|Overall Study||3
5245278|NCT00823979|12893781|P1|COMPLETED|Overall Study||6
5245279|NCT00823979|12893779|P3|Treated|Overall Study||34
5245280|NCT00823979|12893780|P2|Treated|Overall Study||32
5245281|NCT00823979|12893781|P1|Treated|Overall Study||31
5245282|NCT00823979|12893779|P3|STARTED|Overall Study||35
5245283|NCT00823979|12893780|P2|STARTED|Overall Study||35
5245284|NCT00823979|12893781|P1|STARTED|Overall Study||35
5245285|NCT00823966|12893819|P1|NOT COMPLETED|Overall Study||0
5245286|NCT00823966|12893819|P1|COMPLETED|Overall Study||3
5245287|NCT00823966|12893819|P1|STARTED|Overall Study||3
5245288|NCT00823901|12893826|P2|NOT COMPLETED|Overall Study||2
5245289|NCT00823901|12893827|P1|NOT COMPLETED|Overall Study||4
5245290|NCT00823901|12893826|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
5245291|NCT00823901|12893827|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
5245292|NCT00823901|12893826|P2|STARTED|Overall Study|Randomized to placebo gel|40
5245293|NCT00823901|12893827|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
5245294|NCT00823836|12893835|P2|NOT COMPLETED|Long-term Phase||5
5245295|NCT00823836|12893836|P1|NOT COMPLETED|Long-term Phase||5
5245296|NCT00823836|12893835|P2|COMPLETED|Long-term Phase||79
5245297|NCT00823836|12893836|P1|COMPLETED|Long-term Phase||68
5245298|NCT00823836|12893835|P2|STARTED|Long-term Phase||84
5245299|NCT00823836|12893836|P1|STARTED|Long-term Phase||73
5245300|NCT00823836|12893835|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
5245301|NCT00823836|12893836|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
5245302|NCT00823836|12893835|P2|COMPLETED|NV and PR/XR Switching Phases||117
5245303|NCT00823836|12893836|P1|COMPLETED|NV and PR/XR Switching Phases||124
5245304|NCT00823836|12893835|P2|STARTED|NV and PR/XR Switching Phases||146
5245305|NCT00823836|12893836|P1|STARTED|NV and PR/XR Switching Phases||156
5245306|NCT00823823|12893942|P2|NOT COMPLETED|Overall Study||6
5245307|NCT00823823|12893943|P1|NOT COMPLETED|Overall Study||8
5245308|NCT00823823|12893942|P2|COMPLETED|Overall Study||101
5245309|NCT00823823|12893943|P1|COMPLETED|Overall Study||101
5245310|NCT00823823|12893942|P2|STARTED|Overall Study||107
5245311|NCT00823823|12893943|P1|STARTED|Overall Study||109
5245312|NCT00823797|12893953|P2|NOT COMPLETED|Overall Study||0
5245313|NCT00823797|12893954|P1|NOT COMPLETED|Overall Study||0
5245314|NCT00823797|12893953|P2|COMPLETED|Overall Study||16
5245315|NCT00823797|12893954|P1|COMPLETED|Overall Study||29
5245316|NCT00823797|12893953|P2|STARTED|Overall Study||16
5245317|NCT00823797|12893954|P1|STARTED|Overall Study||29
5245318|NCT00823719|12893967|P2|NOT COMPLETED|Overall Study||11
5245319|NCT00823719|12893968|P1|NOT COMPLETED|Overall Study||6
5245320|NCT00823719|12893967|P2|COMPLETED|Overall Study||24
5245321|NCT00823719|12893968|P1|COMPLETED|Overall Study||20
5245322|NCT00823719|12893967|P2|STARTED|Overall Study||35
5245323|NCT00823719|12893968|P1|STARTED|Overall Study||26
5245324|NCT00823615|12894021|P2|NOT COMPLETED|Period 2||2
5245325|NCT00823615|12894022|P1|NOT COMPLETED|Period 2||3
5245326|NCT00823615|12894021|P2|COMPLETED|Period 2||17
5245327|NCT00823615|12894022|P1|COMPLETED|Period 2||16
5245328|NCT00823615|12894021|P2|STARTED|Period 2||19
5245329|NCT00823615|12894022|P1|STARTED|Period 2||19
5245330|NCT00823615|12894021|P2|NOT COMPLETED|Period 1||0
5245331|NCT00823615|12894022|P1|NOT COMPLETED|Period 1||0
5245332|NCT00823615|12894021|P2|COMPLETED|Period 1||19
5245333|NCT00823615|12894022|P1|COMPLETED|Period 1||19
5245334|NCT00823615|12894021|P2|STARTED|Period 1||19
5245335|NCT00823615|12894022|P1|STARTED|Period 1||19
5245336|NCT00823472|12894032|P2|NOT COMPLETED|Overall Study||28
5245337|NCT00823472|12894033|P1|NOT COMPLETED|Overall Study||24
5245338|NCT00823472|12894032|P2|COMPLETED|Overall Study||39
5245339|NCT00823472|12894033|P1|COMPLETED|Overall Study||56
5245340|NCT00823472|12894032|P2|STARTED|Overall Study||67
5245341|NCT00823472|12894033|P1|STARTED|Overall Study||80
5245342|NCT00823459|12894041|P1|NOT COMPLETED|Overall Study||0
5245343|NCT00823459|12894041|P1|COMPLETED|Overall Study||58
5245344|NCT00823459|12894041|P1|STARTED|Overall Study||58
5245345|NCT00823303|12894051|P2|NOT COMPLETED|Overall Study||11
5245346|NCT00823303|12894052|P1|NOT COMPLETED|Overall Study||9
5245347|NCT00823303|12894051|P2|COMPLETED|Overall Study||45
5245348|NCT00823303|12894052|P1|COMPLETED|Overall Study||45
5245349|NCT00823303|12894051|P2|STARTED|Overall Study||56
5245350|NCT00823303|12894052|P1|STARTED|Overall Study||54
5245351|NCT00823264|12894060|P2|NOT COMPLETED|Overall Study||0
5245352|NCT00823264|12894061|P1|NOT COMPLETED|Overall Study||2
5245353|NCT00823264|12894060|P2|COMPLETED|Overall Study||7
5245354|NCT00823264|12894061|P1|COMPLETED|Overall Study||8
5245355|NCT00823264|12894060|P2|STARTED|Overall Study||7
5245356|NCT00823264|12894061|P1|STARTED|Overall Study||10
5245357|NCT00823212|12894069|P2|NOT COMPLETED|Overall Study||33
5245358|NCT00823212|12894070|P1|NOT COMPLETED|Overall Study||35
5245359|NCT00823212|12894069|P2|COMPLETED|Overall Study|12-month follow-up|735
5245360|NCT00823212|12894070|P1|COMPLETED|Overall Study|12-month follow-up|727
5245361|NCT00823212|12894069|P2|STARTED|Overall Study||768
5245362|NCT00823212|12894070|P1|STARTED|Overall Study||762
5245363|NCT00823199|12894152|P1|NOT COMPLETED|Overall Study||2
5245364|NCT00823199|12894152|P1|COMPLETED|Overall Study||8
5245365|NCT00823199|12894152|P1|STARTED|Overall Study||10
5245366|NCT00823134|12894158|P1|NOT COMPLETED|Overall Study||1
5245367|NCT00823134|12894158|P1|COMPLETED|Overall Study||22
5245368|NCT00823134|12894158|P1|STARTED|Overall Study||23
5245369|NCT00823095|12894168|P1|NOT COMPLETED|Overall Study||0
5245370|NCT00823095|12894168|P1|COMPLETED|Overall Study||7
5245371|NCT00823095|12894168|P1|STARTED|Overall Study||7
5245372|NCT00823082|12894175|P2|NOT COMPLETED|Overall Study||1
5245373|NCT00823082|12894176|P1|NOT COMPLETED|Overall Study||0
5245374|NCT00823082|12894175|P2|COMPLETED|Overall Study||99
5245375|NCT00823082|12894176|P1|COMPLETED|Overall Study||100
5245376|NCT00823082|12894175|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
5245377|NCT00823082|12894176|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
5245378|NCT00823082|12894175|P2|Safety Population|Overall Study||99
5245379|NCT00823082|12894176|P1|Safety Population|Overall Study||100
5245380|NCT00823082|12894175|P2|STARTED|Overall Study||100
5245381|NCT00823082|12894176|P1|STARTED|Overall Study||100
5245382|NCT00823069|12894210|P1|NOT COMPLETED|Overall Study||0
5245383|NCT00823069|12894210|P1|COMPLETED|Overall Study||60
5245384|NCT00823069|12894210|P1|STARTED|Overall Study||60
5245385|NCT00823043|12894217|P2|NOT COMPLETED|Overall Study||0
5245386|NCT00823043|12894218|P1|NOT COMPLETED|Overall Study||0
5245387|NCT00823043|12894217|P2|COMPLETED|Overall Study||39
5245388|NCT00823043|12894218|P1|COMPLETED|Overall Study||64
5245389|NCT00823043|12894217|P2|STARTED|Overall Study||39
5245390|NCT00823043|12894218|P1|STARTED|Overall Study||64
5245391|NCT00822926|12894231|P2|NOT COMPLETED|Second Injection Visit||1
5245392|NCT00822926|12894232|P1|NOT COMPLETED|Second Injection Visit||1
5245393|NCT00822926|12894231|P2|COMPLETED|Second Injection Visit||2
5245394|NCT00822926|12894232|P1|COMPLETED|Second Injection Visit||1
5245395|NCT00822926|12894231|P2|STARTED|Second Injection Visit||3
5245396|NCT00822926|12894232|P1|STARTED|Second Injection Visit||2
5245397|NCT00822926|12894231|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
5245398|NCT00822926|12894232|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
5245399|NCT00822926|12894231|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
5245400|NCT00822926|12894232|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
5245401|NCT00822926|12894231|P2|STARTED|Washout (Varies Based on Scheduling)||3
5245402|NCT00822926|12894232|P1|STARTED|Washout (Varies Based on Scheduling)||2
5245403|NCT00822926|12894231|P2|NOT COMPLETED|First Injection Visit||0
5245404|NCT00822926|12894232|P1|NOT COMPLETED|First Injection Visit||0
5245405|NCT00822926|12894231|P2|COMPLETED|First Injection Visit||3
5245406|NCT00822926|12894232|P1|COMPLETED|First Injection Visit||2
5245407|NCT00822926|12894231|P2|STARTED|First Injection Visit||3
5245408|NCT00822926|12894232|P1|STARTED|First Injection Visit||2
5245409|NCT00822900|12894246|P2|NOT COMPLETED|Overall Study||93
5245410|NCT00822900|12894247|P1|NOT COMPLETED|Overall Study||108
5245411|NCT00822900|12894246|P2|COMPLETED|Overall Study||347
5245412|NCT00822900|12894247|P1|COMPLETED|Overall Study||334
5245413|NCT00822900|12894246|P2|STARTED|Overall Study||440
5245414|NCT00822900|12894247|P1|STARTED|Overall Study||442
5245415|NCT00822770|12894275|P1|NOT COMPLETED|Overall Study||0
5245416|NCT00822770|12894275|P1|COMPLETED|Overall Study||47
5245417|NCT00822770|12894275|P1|STARTED|Overall Study||47
5245418|NCT00822757|12894281|P2|NOT COMPLETED|Overall Study||0
5245419|NCT00822757|12894282|P1|NOT COMPLETED|Overall Study||0
5245420|NCT00822757|12894281|P2|COMPLETED|Overall Study||10
5245421|NCT00822757|12894282|P1|COMPLETED|Overall Study||41
5245422|NCT00822757|12894281|P2|STARTED|Overall Study||10
5245423|NCT00822757|12894282|P1|STARTED|Overall Study||41
5245424|NCT00822692|12894294|P2|NOT COMPLETED|Overall Study||25
5245425|NCT00822692|12894295|P1|NOT COMPLETED|Overall Study||17
5245426|NCT00822692|12894294|P2|COMPLETED|Overall Study|June 1 , 2009|51
5245427|NCT00822692|12894295|P1|COMPLETED|Overall Study|June 1, 2009|46
5245428|NCT00822692|12894294|P2|STARTED|Overall Study|July 1, 2008|76
5245429|NCT00822692|12894295|P1|STARTED|Overall Study|July 1, 2008|63
5245430|NCT00822679|12894303|P2|NOT COMPLETED|Overall Study||0
5245431|NCT00822679|12894304|P1|NOT COMPLETED|Overall Study||0
5245432|NCT00822679|12894303|P2|COMPLETED|Overall Study||0
5245433|NCT00822679|12894304|P1|COMPLETED|Overall Study||0
5245434|NCT00822679|12894303|P2|STARTED|Overall Study||0
5245435|NCT00822679|12894304|P1|STARTED|Overall Study||0
5245436|NCT00822588|12894312|P2|NOT COMPLETED|Overall Study||4
5245437|NCT00822588|12894313|P1|NOT COMPLETED|Overall Study||7
5245438|NCT00822588|12894312|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
5245439|NCT00822588|12894313|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
5245440|NCT00822588|12894312|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
5245441|NCT00822588|12894313|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
5245442|NCT00822523|12894322|P3|NOT COMPLETED|Overall Study||0
5245443|NCT00822523|12894323|P2|NOT COMPLETED|Overall Study||0
5245444|NCT00822523|12894324|P1|NOT COMPLETED|Overall Study||0
5245445|NCT00822523|12894322|P3|COMPLETED|Overall Study||4
5245446|NCT00822523|12894323|P2|COMPLETED|Overall Study||4
5245447|NCT00822523|12894324|P1|COMPLETED|Overall Study||5
5245448|NCT00822523|12894322|P3|STARTED|Overall Study||4
5245449|NCT00822523|12894323|P2|STARTED|Overall Study||4
5245450|NCT00822523|12894324|P1|STARTED|Overall Study||5
5245451|NCT00822510|12894370|P2|NOT COMPLETED|Overall Study||5
5245452|NCT00822510|12894371|P1|NOT COMPLETED|Overall Study||3
5245453|NCT00822510|12894370|P2|COMPLETED|Overall Study||36
5245454|NCT00822510|12894371|P1|COMPLETED|Overall Study||35
5245455|NCT00822510|12894370|P2|STARTED|Overall Study||41
5245456|NCT00822510|12894371|P1|STARTED|Overall Study||38
5245457|NCT00822354|12894391|P2|NOT COMPLETED|Second Intervention (28 Days)||0
5245458|NCT00822354|12894392|P1|NOT COMPLETED|Second Intervention (28 Days)||1
5245459|NCT00822354|12894391|P2|COMPLETED|Second Intervention (28 Days)||5
5245460|NCT00822354|12894392|P1|COMPLETED|Second Intervention (28 Days)||3
5245461|NCT00822354|12894391|P2|STARTED|Second Intervention (28 Days)||5
5245462|NCT00822354|12894392|P1|STARTED|Second Intervention (28 Days)||4
5245463|NCT00822354|12894391|P2|NOT COMPLETED|Washout (7 Days)||0
5245464|NCT00822354|12894392|P1|NOT COMPLETED|Washout (7 Days)||0
5245465|NCT00822354|12894391|P2|COMPLETED|Washout (7 Days)||5
5245466|NCT00822354|12894392|P1|COMPLETED|Washout (7 Days)||4
5245467|NCT00822354|12894391|P2|STARTED|Washout (7 Days)||5
5245468|NCT00822354|12894392|P1|STARTED|Washout (7 Days)||4
5245469|NCT00822354|12894391|P2|NOT COMPLETED|First Intervention (28 Days)||0
5245470|NCT00822354|12894392|P1|NOT COMPLETED|First Intervention (28 Days)||1
5245471|NCT00822354|12894391|P2|COMPLETED|First Intervention (28 Days)||5
5245472|NCT00822354|12894392|P1|COMPLETED|First Intervention (28 Days)||4
5245473|NCT00822354|12894391|P2|STARTED|First Intervention (28 Days)||5
5245474|NCT00822354|12894392|P1|STARTED|First Intervention (28 Days)||5
5245475|NCT00822328|12894422|P2|NOT COMPLETED|Overall Study||0
5245476|NCT00822328|12894423|P1|NOT COMPLETED|Overall Study||0
5245477|NCT00822328|12894422|P2|COMPLETED|Overall Study||12
5245478|NCT00822328|12894423|P1|COMPLETED|Overall Study||12
5245479|NCT00822328|12894422|P2|STARTED|Overall Study||12
5245480|NCT00822328|12894423|P1|STARTED|Overall Study||12
5245481|NCT00822237|12894433|P2|NOT COMPLETED|Dose 2 Vaccination||11
5245482|NCT00822237|12894434|P1|NOT COMPLETED|Dose 2 Vaccination||4
5245483|NCT00822237|12894433|P2|COMPLETED|Dose 2 Vaccination||262
5245484|NCT00822237|12894434|P1|COMPLETED|Dose 2 Vaccination||270
5245485|NCT00822237|12894433|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
5245486|NCT00822237|12894434|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
5245487|NCT00822237|12894433|P2|NOT COMPLETED|Dose 1 Vaccination||26
5245488|NCT00822237|12894434|P1|NOT COMPLETED|Dose 1 Vaccination||25
5245489|NCT00822237|12894433|P2|COMPLETED|Dose 1 Vaccination||273
5245490|NCT00822237|12894434|P1|COMPLETED|Dose 1 Vaccination||274
5245491|NCT00822237|12894433|P2|STARTED|Dose 1 Vaccination|Number randomized|299
5245492|NCT00822237|12894434|P1|STARTED|Dose 1 Vaccination|Number randomized|299
5245493|NCT00822185|12894444|P5|NOT COMPLETED|Overall Study||0
5245494|NCT00822185|12894445|P4|NOT COMPLETED|Overall Study||0
5245495|NCT00822185|12894446|P3|NOT COMPLETED|Overall Study||0
5245496|NCT00822185|12894447|P2|NOT COMPLETED|Overall Study||0
5245497|NCT00822185|12894448|P1|NOT COMPLETED|Overall Study||0
5245498|NCT00822185|12894444|P5|COMPLETED|Overall Study||8
5245499|NCT00822185|12894445|P4|COMPLETED|Overall Study||6
5245500|NCT00822185|12894446|P3|COMPLETED|Overall Study||6
5245501|NCT00822185|12894447|P2|COMPLETED|Overall Study||6
5245502|NCT00822185|12894448|P1|COMPLETED|Overall Study||6
5245503|NCT00822185|12894444|P5|STARTED|Overall Study||8
5245504|NCT00822185|12894445|P4|STARTED|Overall Study||6
5245505|NCT00822185|12894446|P3|STARTED|Overall Study||6
5245506|NCT00822185|12894447|P2|STARTED|Overall Study||6
5245507|NCT00822185|12894448|P1|STARTED|Overall Study||6
5245508|NCT00822172|12894515|P2|NOT COMPLETED|Overall Study||19
5245509|NCT00822172|12894516|P1|NOT COMPLETED|Overall Study||15
5245510|NCT00822172|12894515|P2|COMPLETED|Overall Study||64
5245511|NCT00822172|12894516|P1|COMPLETED|Overall Study||65
5245512|NCT00822172|12894515|P2|STARTED|Overall Study||83
5245513|NCT00822172|12894516|P1|STARTED|Overall Study||80
5245514|NCT00822120|12894536|P6|NOT COMPLETED|PET-directed Therapy||0
5245515|NCT00822120|12894537|P5|NOT COMPLETED|PET-directed Therapy||0
5245516|NCT00822120|12894538|P4|NOT COMPLETED|PET-directed Therapy||10
5245517|NCT00822120|12894539|P3|NOT COMPLETED|PET-directed Therapy||0
5245518|NCT00822120|12894540|P2|NOT COMPLETED|PET-directed Therapy||0
5245519|NCT00822120|12894541|P1|NOT COMPLETED|PET-directed Therapy||0
5245520|NCT00822120|12894536|P6|COMPLETED|PET-directed Therapy||1
5245521|NCT00822120|12894537|P5|COMPLETED|PET-directed Therapy||10
5245522|NCT00822120|12894538|P4|COMPLETED|PET-directed Therapy||45
5245523|NCT00822120|12894539|P3|COMPLETED|PET-directed Therapy||270
5245524|NCT00822120|12894540|P2|COMPLETED|PET-directed Therapy||0
5245525|NCT00822120|12894541|P1|COMPLETED|PET-directed Therapy||0
5245526|NCT00822120|12894536|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
5245527|NCT00822120|12894537|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
5245528|NCT00822120|12894538|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
5245529|NCT00822120|12894539|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
5245530|NCT00822120|12894540|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
5245531|NCT00822120|12894541|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
5245532|NCT00822120|12894536|P6|STARTED|PET-directed Therapy||1
5245533|NCT00822120|12894537|P5|STARTED|PET-directed Therapy||10
5245534|NCT00822120|12894538|P4|STARTED|PET-directed Therapy||55
5245535|NCT00822120|12894539|P3|STARTED|PET-directed Therapy||270
5245536|NCT00822120|12894540|P2|STARTED|PET-directed Therapy||0
5245537|NCT00822120|12894541|P1|STARTED|PET-directed Therapy||0
5245538|NCT00822120|12894536|P6|NOT COMPLETED|Initial Registration||0
5245539|NCT00822120|12894537|P5|NOT COMPLETED|Initial Registration||0
5245540|NCT00822120|12894538|P4|NOT COMPLETED|Initial Registration||0
5245541|NCT00822120|12894539|P3|NOT COMPLETED|Initial Registration||0
5245542|NCT00822120|12894540|P2|NOT COMPLETED|Initial Registration||1
5245543|NCT00822120|12894541|P1|NOT COMPLETED|Initial Registration||26
5245544|NCT00822120|12894536|P6|COMPLETED|Initial Registration||0
5245545|NCT00822120|12894537|P5|COMPLETED|Initial Registration||0
5245546|NCT00822120|12894538|P4|COMPLETED|Initial Registration||0
5245547|NCT00822120|12894539|P3|COMPLETED|Initial Registration||0
5245548|NCT00822120|12894540|P2|COMPLETED|Initial Registration||12
5245549|NCT00822120|12894541|P1|COMPLETED|Initial Registration||332
5245550|NCT00822120|12894536|P6|Eligible and Evaluable Patients|Initial Registration||0
5245551|NCT00822120|12894537|P5|Eligible and Evaluable Patients|Initial Registration||0
5245552|NCT00822120|12894538|P4|Eligible and Evaluable Patients|Initial Registration||0
5245553|NCT00822120|12894539|P3|Eligible and Evaluable Patients|Initial Registration||0
5245554|NCT00822120|12894540|P2|Eligible and Evaluable Patients|Initial Registration||12
5245555|NCT00822120|12894541|P1|Eligible and Evaluable Patients|Initial Registration||336
5245556|NCT00822120|12894536|P6|STARTED|Initial Registration||0
5245557|NCT00822120|12894537|P5|STARTED|Initial Registration||0
5245558|NCT00822120|12894538|P4|STARTED|Initial Registration||0
5245559|NCT00822120|12894539|P3|STARTED|Initial Registration||0
5245560|NCT00822120|12894540|P2|STARTED|Initial Registration||13
5245561|NCT00822120|12894541|P1|STARTED|Initial Registration||358
5245562|NCT00822107|12894564|P1|NOT COMPLETED|Overall Study||0
5245563|NCT00822107|12894564|P1|COMPLETED|Overall Study||5
5245564|NCT00822107|12894564|P1|STARTED|Overall Study||5
5245565|NCT00822094|12894570|P2|NOT COMPLETED|Overall Study||25
5245566|NCT00822094|12894571|P1|NOT COMPLETED|Overall Study||44
5245567|NCT00822094|12894570|P2|COMPLETED|Overall Study||20
5245568|NCT00822094|12894571|P1|COMPLETED|Overall Study||37
5245569|NCT00822094|12894570|P2|STARTED|Overall Study||45
5245570|NCT00822094|12894571|P1|STARTED|Overall Study||81
5245571|NCT00821964|12894587|P1|NOT COMPLETED|Overall Study||6
5245572|NCT00821964|12894587|P1|COMPLETED|Overall Study||9
5245573|NCT00821964|12894587|P1|Evaluable for Pathologic Response|Overall Study||7
5245574|NCT00821964|12894587|P1|Evaluable for Clinical Response|Overall Study||14
5245575|NCT00821964|12894587|P1|STARTED|Overall Study||15
5245576|NCT00821951|12894596|P1|NOT COMPLETED|Overall Study||5
5245577|NCT00821951|12894596|P1|COMPLETED|Overall Study||12
5245578|NCT00821951|12894596|P1|STARTED|Overall Study||17
5245579|NCT00821886|12894600|P1|NOT COMPLETED|Overall Study||9
5245580|NCT00821886|12894600|P1|COMPLETED|Overall Study||49
5245581|NCT00821886|12894600|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
5245582|NCT00821873|12894607|P1|NOT COMPLETED|Overall Study||4
5245583|NCT00821873|12894607|P1|COMPLETED|Overall Study||5
5245584|NCT00821873|12894607|P1|STARTED|Overall Study||9
5245585|NCT00821821|12894614|P3|NOT COMPLETED|Overall Study||0
5245586|NCT00821821|12894615|P2|NOT COMPLETED|Overall Study||0
5245587|NCT00821821|12894616|P1|NOT COMPLETED|Overall Study||0
5245588|NCT00821821|12894614|P3|COMPLETED|Overall Study||11
5245589|NCT00821821|12894615|P2|COMPLETED|Overall Study||13
5245590|NCT00821821|12894616|P1|COMPLETED|Overall Study||12
5245591|NCT00821821|12894614|P3|STARTED|Overall Study||11
5245592|NCT00821821|12894615|P2|STARTED|Overall Study||13
5245593|NCT00821821|12894616|P1|STARTED|Overall Study||12
5245594|NCT00821795|12894628|P2|NOT COMPLETED|Overall Study||4
5245595|NCT00821795|12894629|P1|NOT COMPLETED|Overall Study||6
5245596|NCT00821795|12894628|P2|COMPLETED|Overall Study||60
5245597|NCT00821795|12894629|P1|COMPLETED|Overall Study||44
5245598|NCT00821795|12894628|P2|STARTED|Overall Study||64
5245599|NCT00821795|12894629|P1|STARTED|Overall Study||50
5245600|NCT00821678|12894637|P2|NOT COMPLETED|Overall Study||14
5245601|NCT00821678|12894638|P1|NOT COMPLETED|Overall Study||21
5245602|NCT00821678|12894637|P2|COMPLETED|Overall Study||118
5245603|NCT00821678|12894638|P1|COMPLETED|Overall Study||112
5245604|NCT00821678|12894637|P2|STARTED|Overall Study||132
5245605|NCT00821678|12894638|P1|STARTED|Overall Study||133
5245606|NCT00821626|12894660|P2|NOT COMPLETED|Overall Study||0
5245607|NCT00821626|12894661|P1|NOT COMPLETED|Overall Study||0
5245608|NCT00821626|12894660|P2|COMPLETED|Overall Study||33
5245609|NCT00821626|12894661|P1|COMPLETED|Overall Study||60
5245610|NCT00821626|12894660|P2|STARTED|Overall Study||33
5245611|NCT00821626|12894661|P1|STARTED|Overall Study||60
5245612|NCT00821587|12894673|P2|NOT COMPLETED|Overall Study||1
5245613|NCT00821587|12894674|P1|NOT COMPLETED|Overall Study||0
5245614|NCT00821587|12894673|P2|COMPLETED|Overall Study||18
5245615|NCT00821587|12894674|P1|COMPLETED|Overall Study||20
5245616|NCT00821587|12894673|P2|STARTED|Overall Study||19
5245617|NCT00821587|12894674|P1|STARTED|Overall Study||20
5245618|NCT00821509|12894683|P3|NOT COMPLETED|Overall Study||34
5245619|NCT00821509|12894684|P2|NOT COMPLETED|Overall Study||11
5245620|NCT00821509|12894685|P1|NOT COMPLETED|Overall Study||12
5245621|NCT00821509|12894683|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
5245622|NCT00821509|12894684|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
5245623|NCT00821509|12894685|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
5245624|NCT00821509|12894683|P3|STARTED|Overall Study||224
5245625|NCT00821509|12894684|P2|STARTED|Overall Study||202
5245626|NCT00821509|12894685|P1|STARTED|Overall Study||257
5245627|NCT00821431|12894698|P2|NOT COMPLETED|Overall Study||5
5245628|NCT00821431|12894699|P1|NOT COMPLETED|Overall Study||15
5245629|NCT00821431|12894698|P2|COMPLETED|Overall Study||47
5245630|NCT00821431|12894699|P1|COMPLETED|Overall Study||23
5245631|NCT00821431|12894698|P2|STARTED|Overall Study||52
5245632|NCT00821431|12894699|P1|STARTED|Overall Study||38
5245633|NCT00821327|12894707|P1|NOT COMPLETED|Overall Study||35
5245634|NCT00821327|12894707|P1|COMPLETED|Overall Study||1
5245635|NCT00821327|12894707|P1|STARTED|Overall Study||36
5245636|NCT00821236|12894716|P1|NOT COMPLETED|Overall Study||3
5245637|NCT00821236|12894716|P1|COMPLETED|Overall Study||37
5245638|NCT00821236|12894716|P1|STARTED|Overall Study||40
5245639|NCT00821184|12894732|P2|NOT COMPLETED|Overall Study||0
5245640|NCT00821184|12894733|P1|NOT COMPLETED|Overall Study||0
5245641|NCT00821184|12894732|P2|COMPLETED|Overall Study||6
5245642|NCT00821184|12894733|P1|COMPLETED|Overall Study||6
5245643|NCT00821184|12894732|P2|STARTED|Overall Study||6
5245644|NCT00821184|12894733|P1|STARTED|Overall Study||6
5245645|NCT00821119|12894743|P2|NOT COMPLETED|Overall Study||0
5245646|NCT00821119|12894744|P1|NOT COMPLETED|Overall Study||0
5245647|NCT00821119|12894743|P2|COMPLETED|Overall Study||100
5245648|NCT00821119|12894744|P1|COMPLETED|Overall Study||100
5245649|NCT00821119|12894743|P2|STARTED|Overall Study||100
5245650|NCT00821119|12894744|P1|STARTED|Overall Study||100
5245651|NCT00821093|12894756|P2|NOT COMPLETED|Overall Study||40
5245652|NCT00821093|12894757|P1|NOT COMPLETED|Overall Study||49
5245653|NCT00821093|12894756|P2|COMPLETED|Overall Study||523
5245654|NCT00821093|12894757|P1|COMPLETED|Overall Study||511
5245655|NCT00821093|12894756|P2|Exposed to Drug|Overall Study||562
5245656|NCT00821093|12894757|P1|Exposed to Drug|Overall Study||559
5245657|NCT00821093|12894756|P2|STARTED|Overall Study||563
5245658|NCT00821093|12894757|P1|STARTED|Overall Study||560
5245659|NCT00821041|12894767|P2|NOT COMPLETED|Overall Study||0
5245660|NCT00821041|12894768|P1|NOT COMPLETED|Overall Study||0
5245661|NCT00821041|12894767|P2|COMPLETED|Overall Study||59
5245662|NCT00821041|12894768|P1|COMPLETED|Overall Study||59
5245663|NCT00821041|12894767|P2|STARTED|Overall Study||59
5245664|NCT00821041|12894768|P1|STARTED|Overall Study||59
5245665|NCT00821015|12894776|P1|NOT COMPLETED|Overall Study||12
5245666|NCT00821015|12894776|P1|COMPLETED|Overall Study||15
5245667|NCT00821015|12894776|P1|STARTED|Overall Study||27
5245668|NCT00820898|12894787|P1|NOT COMPLETED|Overall Study||1
5245669|NCT00820898|12894787|P1|COMPLETED|Overall Study||23
5245670|NCT00820898|12894787|P1|STARTED|Overall Study||24
5245671|NCT00820872|12894797|P1|NOT COMPLETED|Overall Study||0
5245672|NCT00820872|12894797|P1|COMPLETED|Overall Study||30
5245673|NCT00820872|12894797|P1|STARTED|Overall Study||30
5245674|NCT00820755|12894801|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
5245675|NCT00820755|12894802|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
5245676|NCT00820755|12894803|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
5245677|NCT00820755|12894801|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
5245678|NCT00820755|12894802|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
5245679|NCT00820755|12894803|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
5245680|NCT00820755|12894801|P3|STARTED|Period 2: Maintenance Therapy Phase||154
5245681|NCT00820755|12894802|P2|STARTED|Period 2: Maintenance Therapy Phase||157
5245682|NCT00820755|12894803|P1|STARTED|Period 2: Maintenance Therapy Phase||0
5245683|NCT00820755|12894801|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
5245684|NCT00820755|12894802|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
5245685|NCT00820755|12894803|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
5245686|NCT00820755|12894801|P3|COMPLETED|Period 1: Combination Therapy Phase||0
5245687|NCT00820755|12894802|P2|COMPLETED|Period 1: Combination Therapy Phase||0
5245688|NCT00820755|12894803|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
5245689|NCT00820755|12894801|P3|STARTED|Period 1: Combination Therapy Phase||0
5245690|NCT00820755|12894802|P2|STARTED|Period 1: Combination Therapy Phase||0
5245691|NCT00820755|12894803|P1|STARTED|Period 1: Combination Therapy Phase||583
5245692|NCT00820664|12894827|P3|NOT COMPLETED|Overall Study||0
5245693|NCT00820664|12894828|P2|NOT COMPLETED|Overall Study||0
5245694|NCT00820664|12894829|P1|NOT COMPLETED|Overall Study||0
5245695|NCT00820664|12894827|P3|COMPLETED|Overall Study||9
5245696|NCT00820664|12894828|P2|COMPLETED|Overall Study||11
5245697|NCT00820664|12894829|P1|COMPLETED|Overall Study||9
5245698|NCT00820664|12894827|P3|STARTED|Overall Study||9
5245699|NCT00820664|12894828|P2|STARTED|Overall Study||11
5245700|NCT00820664|12894829|P1|STARTED|Overall Study||9
5245701|NCT00820612|12894839|P2|NOT COMPLETED|Overall Study||0
5245702|NCT00820612|12894840|P1|NOT COMPLETED|Overall Study||0
5245703|NCT00820612|12894839|P2|COMPLETED|Overall Study||295
5245704|NCT00820612|12894840|P1|COMPLETED|Overall Study||307
5245705|NCT00820612|12894839|P2|STARTED|Overall Study||295
5245706|NCT00820612|12894840|P1|STARTED|Overall Study||307
5245707|NCT00820573|12894850|P4|NOT COMPLETED|Overall Study||0
5245708|NCT00820573|12894851|P3|NOT COMPLETED|Overall Study||0
5245709|NCT00820573|12894852|P2|NOT COMPLETED|Overall Study||0
5245710|NCT00820573|12894853|P1|NOT COMPLETED|Overall Study||0
5245711|NCT00820573|12894850|P4|COMPLETED|Overall Study||4
5245712|NCT00820573|12894851|P3|COMPLETED|Overall Study||4
5245713|NCT00820573|12894852|P2|COMPLETED|Overall Study||4
5245714|NCT00820573|12894853|P1|COMPLETED|Overall Study||4
5245715|NCT00820573|12894850|P4|STARTED|Overall Study||4
5245716|NCT00820573|12894851|P3|STARTED|Overall Study||4
5245717|NCT00820573|12894852|P2|STARTED|Overall Study||4
5245718|NCT00820573|12894853|P1|STARTED|Overall Study||4
5245719|NCT00820534|12894877|P2|NOT COMPLETED|Overall Study||0
5245720|NCT00820534|12894878|P1|NOT COMPLETED|Overall Study||0
5245721|NCT00820534|12894877|P2|COMPLETED|Overall Study||62
5245722|NCT00820534|12894878|P1|COMPLETED|Overall Study||64
5245723|NCT00820534|12894877|P2|STARTED|Overall Study||62
5245724|NCT00820534|12894878|P1|STARTED|Overall Study||64
5245725|NCT00820443|12894886|P1|NOT COMPLETED|24 Month||43
5245726|NCT00820443|12894886|P1|COMPLETED|24 Month||202
5245727|NCT00820443|12894886|P1|STARTED|24 Month||245
5245728|NCT00820443|12894886|P1|NOT COMPLETED|12 Month||24
5245729|NCT00820443|12894886|P1|COMPLETED|12 Month||226
5245730|NCT00820443|12894886|P1|STARTED|12 Month||250
5245731|NCT00820443|12894886|P1|NOT COMPLETED|6 Month||20
5245732|NCT00820443|12894886|P1|COMPLETED|6 Month||233
5245733|NCT00820443|12894886|P1|STARTED|6 Month||253
5245734|NCT00820443|12894886|P1|NOT COMPLETED|3 Month||9
5245735|NCT00820443|12894886|P1|COMPLETED|3 Month||244
5245736|NCT00820443|12894886|P1|STARTED|3 Month||253
5245737|NCT00820443|12894886|P1|NOT COMPLETED|Immediately||5
5245738|NCT00820443|12894886|P1|COMPLETED|Immediately||248
5245739|NCT00820443|12894886|P1|STARTED|Immediately||253
5245740|NCT00820443|12894886|P1|NOT COMPLETED|Op||0
5245741|NCT00820443|12894886|P1|COMPLETED|Op||253
5245742|NCT00820443|12894886|P1|STARTED|Op||253
5245743|NCT00820443|12894886|P1|NOT COMPLETED|Pre-Op||0
5245744|NCT00820443|12894886|P1|COMPLETED|Pre-Op||253
5245745|NCT00820443|12894886|P1|STARTED|Pre-Op||253
5245746|NCT00820248|12894896|P2|NOT COMPLETED|Overall Study||1
5245747|NCT00820248|12894897|P1|NOT COMPLETED|Overall Study||4
5245748|NCT00820248|12894896|P2|COMPLETED|Overall Study||159
5245749|NCT00820248|12894897|P1|COMPLETED|Overall Study||156
5245750|NCT00820248|12894896|P2|Received Protocol Treatment|Overall Study||159
5245751|NCT00820248|12894897|P1|Received Protocol Treatment|Overall Study||156
5245752|NCT00820248|12894896|P2|STARTED|Overall Study||160
5245753|NCT00820248|12894897|P1|STARTED|Overall Study||160
5245754|NCT00820235|12894908|P3|NOT COMPLETED|Overall Study||17
5245755|NCT00820235|12894909|P2|NOT COMPLETED|Overall Study||21
5245756|NCT00820235|12894910|P1|NOT COMPLETED|Overall Study||15
5245757|NCT00820235|12894908|P3|COMPLETED|Overall Study||27
5245758|NCT00820235|12894909|P2|COMPLETED|Overall Study||28
5245759|NCT00820235|12894910|P1|COMPLETED|Overall Study||33
5245760|NCT00820235|12894908|P3|STARTED|Overall Study||44
5245761|NCT00820235|12894909|P2|STARTED|Overall Study||49
5245762|NCT00820235|12894910|P1|STARTED|Overall Study||48
5245763|NCT00820222|12894929|P2|NOT COMPLETED|Overall Study||190
5245764|NCT00820222|12894930|P1|NOT COMPLETED|Overall Study||176
5245765|NCT00820222|12894929|P2|COMPLETED|Overall Study||79
5245766|NCT00820222|12894930|P1|COMPLETED|Overall Study||95
5245767|NCT00820222|12894929|P2|STARTED|Overall Study||269
5245768|NCT00820222|12894930|P1|STARTED|Overall Study||271
5245769|NCT00820170|12894961|P5|NOT COMPLETED|Overall Study||4
5245770|NCT00820170|12894962|P4|NOT COMPLETED|Overall Study||0
5245771|NCT00820170|12894963|P3|NOT COMPLETED|Overall Study||0
5245772|NCT00820170|12894964|P2|NOT COMPLETED|Overall Study||0
5245773|NCT00820170|12894965|P1|NOT COMPLETED|Overall Study||0
5245774|NCT00820170|12894961|P5|COMPLETED|Overall Study||0
5245775|NCT00820170|12894962|P4|COMPLETED|Overall Study||40
5245776|NCT00820170|12894963|P3|COMPLETED|Overall Study||3
5245777|NCT00820170|12894964|P2|COMPLETED|Overall Study||5
5245778|NCT00820170|12894965|P1|COMPLETED|Overall Study||3
5245779|NCT00820170|12894961|P5|STARTED|Overall Study||4
5245780|NCT00820170|12894962|P4|STARTED|Overall Study||40
5245781|NCT00820170|12894963|P3|STARTED|Overall Study||3
5245782|NCT00820170|12894964|P2|STARTED|Overall Study||5
5245783|NCT00820170|12894965|P1|STARTED|Overall Study||3
5245784|NCT00820027|12895017|P4|NOT COMPLETED|Overall Study||13
5245785|NCT00820027|12895018|P3|NOT COMPLETED|Overall Study||21
5245786|NCT00820027|12895019|P2|NOT COMPLETED|Overall Study||14
5245787|NCT00820027|12895020|P1|NOT COMPLETED|Overall Study||26
5245788|NCT00820027|12895017|P4|COMPLETED|Overall Study||85
5245789|NCT00820027|12895018|P3|COMPLETED|Overall Study||203
5245790|NCT00820027|12895019|P2|COMPLETED|Overall Study||216
5245791|NCT00820027|12895020|P1|COMPLETED|Overall Study||198
5245792|NCT00820027|12895017|P4|STARTED|Overall Study||98
5245793|NCT00820027|12895018|P3|STARTED|Overall Study||224
5245794|NCT00820027|12895019|P2|STARTED|Overall Study||230
5245795|NCT00820027|12895020|P1|STARTED|Overall Study||224
5245796|NCT00819910|12895062|P4|NOT COMPLETED|Overall Study||1
5245797|NCT00819910|12895063|P3|NOT COMPLETED|Overall Study||3
5245798|NCT00819910|12895064|P2|NOT COMPLETED|Overall Study||1
5245799|NCT00819910|12895065|P1|NOT COMPLETED|Overall Study||2
5245800|NCT00819910|12895062|P4|COMPLETED|Overall Study||10
5245801|NCT00819910|12895063|P3|COMPLETED|Overall Study||7
5245802|NCT00819910|12895064|P2|COMPLETED|Overall Study||9
5245803|NCT00819910|12895065|P1|COMPLETED|Overall Study||8
5245804|NCT00819910|12895062|P4|STARTED|Overall Study||11
5245805|NCT00819910|12895063|P3|STARTED|Overall Study||10
5245806|NCT00819910|12895064|P2|STARTED|Overall Study||10
5245807|NCT00819910|12895065|P1|STARTED|Overall Study||10
5245808|NCT00819832|12895097|P6|NOT COMPLETED|Overall Study||0
5245809|NCT00819832|12895098|P5|NOT COMPLETED|Overall Study||0
5245810|NCT00819832|12895099|P4|NOT COMPLETED|Overall Study||0
5245811|NCT00819832|12895100|P3|NOT COMPLETED|Overall Study||0
5245812|NCT00819832|12895101|P2|NOT COMPLETED|Overall Study||0
5245813|NCT00819832|12895102|P1|NOT COMPLETED|Overall Study||3
5245814|NCT00819832|12895097|P6|COMPLETED|Overall Study||0
5245815|NCT00819832|12895098|P5|COMPLETED|Overall Study||0
5245816|NCT00819832|12895099|P4|COMPLETED|Overall Study||0
5245817|NCT00819832|12895100|P3|COMPLETED|Overall Study||0
5245818|NCT00819832|12895101|P2|COMPLETED|Overall Study||0
5245819|NCT00819832|12895102|P1|COMPLETED|Overall Study||0
5245820|NCT00819832|12895097|P6|STARTED|Overall Study||0
5245821|NCT00819832|12895098|P5|STARTED|Overall Study||0
5245822|NCT00819832|12895099|P4|STARTED|Overall Study||0
5245823|NCT00819832|12895100|P3|STARTED|Overall Study||0
5245824|NCT00819832|12895101|P2|STARTED|Overall Study||0
5245825|NCT00819832|12895102|P1|STARTED|Overall Study|No patient data analysis.|3
5245826|NCT00819793|12895116|P1|NOT COMPLETED|Overall Study||0
5245827|NCT00819793|12895116|P1|COMPLETED|Overall Study||32
5245828|NCT00819793|12895116|P1|STARTED|Overall Study||32
5245829|NCT00819780|12895123|P2|NOT COMPLETED|Overall Study||21
5245830|NCT00819780|12895124|P1|NOT COMPLETED|Overall Study||28
5245831|NCT00819780|12895123|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
5245832|NCT00819780|12895124|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
5245833|NCT00819780|12895123|P2|Received Study Treatment|Overall Study||139
5245834|NCT00819780|12895124|P1|Received Study Treatment|Overall Study||139
5245835|NCT00819780|12895123|P2|STARTED|Overall Study||143
5245836|NCT00819780|12895124|P1|STARTED|Overall Study||142
5245837|NCT00819767|12895158|P2|NOT COMPLETED|Overall Study||2
5245838|NCT00819767|12895159|P1|NOT COMPLETED|Overall Study||1
5245839|NCT00819767|12895158|P2|COMPLETED|Overall Study||33
5245840|NCT00819767|12895159|P1|COMPLETED|Overall Study||32
5245841|NCT00819767|12895158|P2|STARTED|Overall Study||35
5245842|NCT00819767|12895159|P1|STARTED|Overall Study||33
5245843|NCT00819741|12895171|P2|NOT COMPLETED|Overall Study||14
5245844|NCT00819741|12895172|P1|NOT COMPLETED|Overall Study||22
5245845|NCT00819741|12895171|P2|COMPLETED|Overall Study||201
5245846|NCT00819741|12895172|P1|COMPLETED|Overall Study||196
5245847|NCT00819741|12895171|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
5245848|NCT00819741|12895172|P1|Exposed to Drug|Overall Study||218
5245849|NCT00819741|12895171|P2|STARTED|Overall Study||215
5245850|NCT00819741|12895172|P1|STARTED|Overall Study||218
5245851|NCT00819637|12895209|P3|NOT COMPLETED|Overall Study||0
5245852|NCT00819637|12895210|P2|NOT COMPLETED|Overall Study||0
5245853|NCT00819637|12895211|P1|NOT COMPLETED|Overall Study||0
5245854|NCT00819637|12895209|P3|COMPLETED|Overall Study||0
5245855|NCT00819637|12895210|P2|COMPLETED|Overall Study||0
5245856|NCT00819637|12895211|P1|COMPLETED|Overall Study||2
5245857|NCT00819637|12895209|P3|STARTED|Overall Study||0
5245858|NCT00819637|12895210|P2|STARTED|Overall Study||0
5245859|NCT00819637|12895211|P1|STARTED|Overall Study||2
5245860|NCT00819585|12895226|P11|NOT COMPLETED|Extension Study||2
5245861|NCT00819585|12895227|P10|NOT COMPLETED|Extension Study||1
5245862|NCT00819585|12895228|P9|NOT COMPLETED|Extension Study||8
5245863|NCT00819585|12895229|P8|NOT COMPLETED|Extension Study||0
5245864|NCT00819585|12895230|P7|NOT COMPLETED|Extension Study||0
5245865|NCT00819585|12895231|P6|NOT COMPLETED|Extension Study||0
5245866|NCT00819585|12895232|P5|NOT COMPLETED|Extension Study||0
5245867|NCT00819585|12895233|P4|NOT COMPLETED|Extension Study||0
5245868|NCT00819585|12895234|P3|NOT COMPLETED|Extension Study||0
5245869|NCT00819585|12895235|P2|NOT COMPLETED|Extension Study||0
5245870|NCT00819585|12895236|P1|NOT COMPLETED|Extension Study||0
5245871|NCT00819585|12895226|P11|COMPLETED|Extension Study||58
5245872|NCT00819585|12895227|P10|COMPLETED|Extension Study||24
5245873|NCT00819585|12895228|P9|COMPLETED|Extension Study||173
5245874|NCT00819585|12895229|P8|COMPLETED|Extension Study||75
5245875|NCT00819585|12895230|P7|COMPLETED|Extension Study||0
5245876|NCT00819585|12895231|P6|COMPLETED|Extension Study||0
5245877|NCT00819585|12895232|P5|COMPLETED|Extension Study||0
5245878|NCT00819585|12895233|P4|COMPLETED|Extension Study||0
5245879|NCT00819585|12895234|P3|COMPLETED|Extension Study||0
5245880|NCT00819585|12895235|P2|COMPLETED|Extension Study||0
5245881|NCT00819585|12895236|P1|COMPLETED|Extension Study||0
5245882|NCT00819585|12895226|P11|STARTED|Extension Study||60
5245883|NCT00819585|12895227|P10|STARTED|Extension Study||25
5245884|NCT00819585|12895228|P9|STARTED|Extension Study||181
5245885|NCT00819585|12895229|P8|STARTED|Extension Study||75
5245886|NCT00819585|12895230|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245887|NCT00819585|12895231|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245888|NCT00819585|12895232|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245889|NCT00819585|12895233|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245890|NCT00819585|12895234|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245891|NCT00819585|12895235|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245892|NCT00819585|12895236|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
5245893|NCT00819585|12895226|P11|NOT COMPLETED|Core Study||0
5245894|NCT00819585|12895227|P10|NOT COMPLETED|Core Study||0
5245895|NCT00819585|12895228|P9|NOT COMPLETED|Core Study||0
5245896|NCT00819585|12895229|P8|NOT COMPLETED|Core Study||0
5245897|NCT00819585|12895230|P7|NOT COMPLETED|Core Study||13
5245898|NCT00819585|12895231|P6|NOT COMPLETED|Core Study||2
5245899|NCT00819585|12895232|P5|NOT COMPLETED|Core Study||3
5245900|NCT00819585|12895233|P4|NOT COMPLETED|Core Study||5
5245901|NCT00819585|12895234|P3|NOT COMPLETED|Core Study||6
5245902|NCT00819585|12895235|P2|NOT COMPLETED|Core Study||6
5245903|NCT00819585|12895236|P1|NOT COMPLETED|Core Study||6
5245904|NCT00819585|12895226|P11|COMPLETED|Core Study||0
5245905|NCT00819585|12895227|P10|COMPLETED|Core Study||0
5245906|NCT00819585|12895228|P9|COMPLETED|Core Study||0
5245907|NCT00819585|12895229|P8|COMPLETED|Core Study||0
5245908|NCT00819585|12895230|P7|COMPLETED|Core Study||95
5245909|NCT00819585|12895231|P6|COMPLETED|Core Study||52
5245910|NCT00819585|12895232|P5|COMPLETED|Core Study||50
5245911|NCT00819585|12895233|P4|COMPLETED|Core Study||49
5245912|NCT00819585|12895234|P3|COMPLETED|Core Study||48
5245913|NCT00819585|12895235|P2|COMPLETED|Core Study||48
5245914|NCT00819585|12895236|P1|COMPLETED|Core Study||49
5245915|NCT00819585|12895226|P11|Received Study Medication|Core Study||0
5245916|NCT00819585|12895227|P10|Received Study Medication|Core Study||0
5245917|NCT00819585|12895228|P9|Received Study Medication|Core Study||0
5245918|NCT00819585|12895229|P8|Received Study Medication|Core Study||0
5245919|NCT00819585|12895230|P7|Received Study Medication|Core Study||108
5245920|NCT00819585|12895231|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
5245921|NCT00819585|12895232|P5|Received Study Medication|Core Study||53
5245922|NCT00819585|12895233|P4|Received Study Medication|Core Study||54
5245923|NCT00819585|12895234|P3|Received Study Medication|Core Study||54
5245924|NCT00819585|12895235|P2|Received Study Medication|Core Study||54
5245925|NCT00819585|12895236|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
5245926|NCT00819585|12895226|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
5245927|NCT00819585|12895227|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
5245928|NCT00819585|12895228|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
5245929|NCT00819585|12895229|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
5245930|NCT00819585|12895230|P7|STARTED|Core Study||108
5245931|NCT00819585|12895231|P6|STARTED|Core Study||54
5245932|NCT00819585|12895232|P5|STARTED|Core Study||53
5245933|NCT00819585|12895233|P4|STARTED|Core Study||54
5245934|NCT00819585|12895234|P3|STARTED|Core Study||54
5245935|NCT00819585|12895235|P2|STARTED|Core Study||54
5245936|NCT00819585|12895236|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
5245937|NCT00819507|12895307|P1|NOT COMPLETED|Overall Study||0
5245938|NCT00819507|12895307|P1|COMPLETED|Overall Study||25
5245939|NCT00819507|12895307|P1|STARTED|Overall Study||25
5245940|NCT00819403|12895314|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5245941|NCT00819403|12895315|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5245942|NCT00819403|12895314|P2|COMPLETED|Second Intervention (6 Weeks)||8
5245943|NCT00819403|12895315|P1|COMPLETED|Second Intervention (6 Weeks)||7
5245944|NCT00819403|12895314|P2|STARTED|Second Intervention (6 Weeks)||8
5245945|NCT00819403|12895315|P1|STARTED|Second Intervention (6 Weeks)||7
5245946|NCT00819403|12895314|P2|NOT COMPLETED|Washout (14 Days)||0
5245947|NCT00819403|12895315|P1|NOT COMPLETED|Washout (14 Days)||0
5245948|NCT00819403|12895314|P2|COMPLETED|Washout (14 Days)||8
5245949|NCT00819403|12895315|P1|COMPLETED|Washout (14 Days)||7
5245950|NCT00819403|12895314|P2|STARTED|Washout (14 Days)||8
5245951|NCT00819403|12895315|P1|STARTED|Washout (14 Days)||7
5245952|NCT00819403|12895314|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
5245953|NCT00819403|12895315|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5245954|NCT00819403|12895314|P2|COMPLETED|First Intervention (6 Weeks)||8
5245955|NCT00819403|12895315|P1|COMPLETED|First Intervention (6 Weeks)||7
5245956|NCT00819403|12895314|P2|STARTED|First Intervention (6 Weeks)||8
5245957|NCT00819403|12895315|P1|STARTED|First Intervention (6 Weeks)||7
5245958|NCT00819390|12895327|P4|NOT COMPLETED|Overall Study||0
5245959|NCT00819390|12895328|P3|NOT COMPLETED|Overall Study||1
5245960|NCT00819390|12895329|P2|NOT COMPLETED|Overall Study||1
5245961|NCT00819390|12895330|P1|NOT COMPLETED|Overall Study||3
5245962|NCT00819390|12895327|P4|COMPLETED|Overall Study||19
5245963|NCT00819390|12895328|P3|COMPLETED|Overall Study||17
5245964|NCT00819390|12895329|P2|COMPLETED|Overall Study||16
5245965|NCT00819390|12895330|P1|COMPLETED|Overall Study||13
5245966|NCT00819390|12895327|P4|STARTED|Overall Study||19
5245967|NCT00819390|12895328|P3|STARTED|Overall Study||18
5245968|NCT00819390|12895329|P2|STARTED|Overall Study||17
5245969|NCT00819390|12895330|P1|STARTED|Overall Study||16
5245970|NCT00819286|12895442|P2|NOT COMPLETED|Overall Study||25
5245971|NCT00819286|12895443|P1|NOT COMPLETED|Overall Study||14
5245972|NCT00819286|12895442|P2|COMPLETED|Overall Study||45
5245973|NCT00819286|12895443|P1|COMPLETED|Overall Study||56
5245974|NCT00819286|12895442|P2|STARTED|Overall Study||70
5245975|NCT00819286|12895443|P1|STARTED|Overall Study||70
5245976|NCT00819260|12895451|P1|NOT COMPLETED|Overall Study||0
5245977|NCT00819260|12895451|P1|COMPLETED|Overall Study||31
5245978|NCT00819260|12895451|P1|STARTED|Overall Study||31
5245979|NCT00819247|12895466|P3|NOT COMPLETED|Overall Study||14
5245980|NCT00819247|12895467|P2|NOT COMPLETED|Overall Study||16
5245981|NCT00819247|12895468|P1|NOT COMPLETED|Overall Study||11
5245982|NCT00819247|12895466|P3|COMPLETED|Overall Study||26
5245983|NCT00819247|12895467|P2|COMPLETED|Overall Study||30
5245984|NCT00819247|12895468|P1|COMPLETED|Overall Study||32
5245985|NCT00819247|12895466|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
5245986|NCT00819247|12895467|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
5245987|NCT00819247|12895468|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
5245988|NCT00819247|12895466|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
5245989|NCT00819247|12895467|P2|Intent-to-treat Population|Overall Study||46
5245990|NCT00819247|12895468|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
5245991|NCT00819247|12895466|P3|Randomized|Overall Study||40
5245992|NCT00819247|12895467|P2|Randomized|Overall Study||46
5245993|NCT00819247|12895468|P1|Randomized|Overall Study||43
5245994|NCT00819247|12895466|P3|STARTED|Overall Study||40
5245995|NCT00819247|12895467|P2|STARTED|Overall Study||46
5245996|NCT00819247|12895468|P1|STARTED|Overall Study||43
5245997|NCT00819234|12895494|P10|NOT COMPLETED|Overall Study||7
5245998|NCT00819234|12895495|P9|NOT COMPLETED|Overall Study||6
5245999|NCT00819234|12895496|P8|NOT COMPLETED|Overall Study||9
5246000|NCT00819234|12895497|P7|NOT COMPLETED|Overall Study||5
5246001|NCT00819234|12895498|P6|NOT COMPLETED|Overall Study||7
5246002|NCT00819234|12895499|P5|NOT COMPLETED|Overall Study||1
5246003|NCT00819234|12895500|P4|NOT COMPLETED|Overall Study||6
5246004|NCT00819234|12895501|P3|NOT COMPLETED|Overall Study||8
5246005|NCT00819234|12895502|P2|NOT COMPLETED|Overall Study||15
5246006|NCT00819234|12895503|P1|NOT COMPLETED|Overall Study||10
5246007|NCT00819234|12895494|P10|COMPLETED|Overall Study||30
5246008|NCT00819234|12895495|P9|COMPLETED|Overall Study||31
5246009|NCT00819234|12895496|P8|COMPLETED|Overall Study||20
5246010|NCT00819234|12895497|P7|COMPLETED|Overall Study||8
5246011|NCT00819234|12895498|P6|COMPLETED|Overall Study||7
5246012|NCT00819234|12895499|P5|COMPLETED|Overall Study||12
5246013|NCT00819234|12895500|P4|COMPLETED|Overall Study||22
5246014|NCT00819234|12895501|P3|COMPLETED|Overall Study||28
5246015|NCT00819234|12895502|P2|COMPLETED|Overall Study||20
5246016|NCT00819234|12895503|P1|COMPLETED|Overall Study||21
5246017|NCT00819234|12895494|P10|STARTED|Overall Study||37
5246018|NCT00819234|12895495|P9|STARTED|Overall Study||37
5246019|NCT00819234|12895496|P8|STARTED|Overall Study||29
5246020|NCT00819234|12895497|P7|STARTED|Overall Study||13
5246021|NCT00819234|12895498|P6|STARTED|Overall Study||14
5246022|NCT00819234|12895499|P5|STARTED|Overall Study||13
5246023|NCT00819234|12895500|P4|STARTED|Overall Study||28
5246024|NCT00819234|12895501|P3|STARTED|Overall Study||36
5246025|NCT00819234|12895502|P2|STARTED|Overall Study||35
5246026|NCT00819234|12895503|P1|STARTED|Overall Study||31
5246027|NCT00819182|12895664|P3|NOT COMPLETED|Overall Study||1
5246028|NCT00819182|12895665|P2|NOT COMPLETED|Overall Study||8
5246029|NCT00819182|12895666|P1|NOT COMPLETED|Overall Study||13
5246030|NCT00819182|12895664|P3|COMPLETED|Overall Study||43
5246031|NCT00819182|12895665|P2|COMPLETED|Overall Study||78
5246032|NCT00819182|12895666|P1|COMPLETED|Overall Study||75
5246033|NCT00819182|12895664|P3|Week 16 Visit|Overall Study||43
5246034|NCT00819182|12895665|P2|Week 16 Visit|Overall Study||78
5246035|NCT00819182|12895666|P1|Week 16 Visit|Overall Study||75
5246036|NCT00819182|12895664|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
5246037|NCT00819182|12895665|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
5246038|NCT00819182|12895666|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
5246039|NCT00819156|12895702|P6|NOT COMPLETED|Overall Study||8
5246040|NCT00819156|12895703|P5|NOT COMPLETED|Overall Study||6
5246041|NCT00819156|12895704|P4|NOT COMPLETED|Overall Study||2
5246042|NCT00819156|12895705|P3|NOT COMPLETED|Overall Study||6
5246043|NCT00819156|12895706|P2|NOT COMPLETED|Overall Study||10
5246044|NCT00819156|12895707|P1|NOT COMPLETED|Overall Study||10
5246045|NCT00819156|12895702|P6|COMPLETED|Overall Study||23
5246046|NCT00819156|12895703|P5|COMPLETED|Overall Study||27
5246047|NCT00819156|12895704|P4|COMPLETED|Overall Study||28
5246048|NCT00819156|12895705|P3|COMPLETED|Overall Study||26
5246049|NCT00819156|12895706|P2|COMPLETED|Overall Study||23
5246050|NCT00819156|12895707|P1|COMPLETED|Overall Study||20
5246051|NCT00819156|12895702|P6|Randomised and Treated (ITT Population)|Overall Study||30
5246052|NCT00819156|12895703|P5|Randomised and Treated (ITT Population)|Overall Study||33
5246053|NCT00819156|12895704|P4|Randomised and Treated (ITT Population)|Overall Study||30
5246054|NCT00819156|12895705|P3|Randomised and Treated (ITT Population)|Overall Study||32
5246055|NCT00819156|12895706|P2|Randomised and Treated (ITT Population)|Overall Study||32
5246056|NCT00819156|12895707|P1|Randomised and Treated (ITT Population)|Overall Study||30
5246057|NCT00819156|12895702|P6|STARTED|Overall Study||31
5246058|NCT00819156|12895703|P5|STARTED|Overall Study||33
5246059|NCT00819156|12895704|P4|STARTED|Overall Study||30
5246060|NCT00819156|12895705|P3|STARTED|Overall Study||32
5246061|NCT00819156|12895706|P2|STARTED|Overall Study||33
5246062|NCT00819156|12895707|P1|STARTED|Overall Study||30
5246063|NCT00819091|12895797|P2|NOT COMPLETED|Overall Study||10
5246064|NCT00819091|12895798|P1|NOT COMPLETED|Overall Study||7
5246065|NCT00819091|12895797|P2|COMPLETED|Overall Study||151
5246066|NCT00819091|12895798|P1|COMPLETED|Overall Study||77
5246067|NCT00819091|12895797|P2|STARTED|Overall Study||161
5246068|NCT00819091|12895798|P1|STARTED|Overall Study||84
5246069|NCT00819052|12895824|P2|NOT COMPLETED|Overall Study||14
5246070|NCT00819052|12895825|P1|NOT COMPLETED|Overall Study||6
5246071|NCT00819052|12895824|P2|COMPLETED|Overall Study||281
5246072|NCT00819052|12895825|P1|COMPLETED|Overall Study||142
5246073|NCT00819052|12895824|P2|STARTED|Overall Study||295
5246074|NCT00819052|12895825|P1|STARTED|Overall Study||148
5246075|NCT00819039|12895940|P3|NOT COMPLETED|Overall Study||1
5246076|NCT00819039|12895941|P2|NOT COMPLETED|Overall Study||0
5246077|NCT00819039|12895942|P1|NOT COMPLETED|Overall Study||2
5246078|NCT00819039|12895940|P3|COMPLETED|Overall Study||24
5246079|NCT00819039|12895941|P2|COMPLETED|Overall Study||27
5246080|NCT00819039|12895942|P1|COMPLETED|Overall Study||44
5246081|NCT00819039|12895940|P3|STARTED|Overall Study||25
5246082|NCT00819039|12895941|P2|STARTED|Overall Study||27
5246083|NCT00819039|12895942|P1|STARTED|Overall Study||46
5246084|NCT00819013|12895972|P4|NOT COMPLETED|Overall Study||4
5246085|NCT00819013|12895973|P3|NOT COMPLETED|Overall Study||5
5246086|NCT00819013|12895974|P2|NOT COMPLETED|Overall Study||1
5246087|NCT00819013|12895975|P1|NOT COMPLETED|Overall Study||3
5246088|NCT00819013|12895972|P4|COMPLETED|Overall Study||17
5246089|NCT00819013|12895973|P3|COMPLETED|Overall Study||16
5246090|NCT00819013|12895974|P2|COMPLETED|Overall Study||22
5246091|NCT00819013|12895975|P1|COMPLETED|Overall Study||19
5246092|NCT00819013|12895972|P4|STARTED|Overall Study||21
5246093|NCT00819013|12895973|P3|STARTED|Overall Study||21
5246094|NCT00819013|12895974|P2|STARTED|Overall Study||23
5246095|NCT00819013|12895975|P1|STARTED|Overall Study||22
5246096|NCT00818961|12896025|P1|NOT COMPLETED|Overall Study||0
5246097|NCT00818961|12896025|P1|COMPLETED|Overall Study||36
5246098|NCT00818961|12896025|P1|STARTED|Overall Study||36
5246099|NCT00818883|12896041|P2|NOT COMPLETED|Overall Study||46
5246100|NCT00818883|12896042|P1|NOT COMPLETED|Overall Study||51
5246101|NCT00818883|12896041|P2|COMPLETED|Overall Study||260
5246102|NCT00818883|12896042|P1|COMPLETED|Overall Study||252
5246103|NCT00818883|12896041|P2|STARTED|Overall Study||306
5246104|NCT00818883|12896042|P1|STARTED|Overall Study||303
5246105|NCT00818805|12896076|P2|NOT COMPLETED|Second Intervention||0
5246106|NCT00818805|12896077|P1|NOT COMPLETED|Second Intervention||0
5246107|NCT00818805|12896076|P2|COMPLETED|Second Intervention||25
5246108|NCT00818805|12896077|P1|COMPLETED|Second Intervention||25
5246109|NCT00818805|12896076|P2|STARTED|Second Intervention||25
5246110|NCT00818805|12896077|P1|STARTED|Second Intervention||25
5246111|NCT00818805|12896076|P2|NOT COMPLETED|First Intervention||0
5246112|NCT00818805|12896077|P1|NOT COMPLETED|First Intervention||0
5246113|NCT00818805|12896076|P2|COMPLETED|First Intervention||25
5246114|NCT00818805|12896077|P1|COMPLETED|First Intervention||25
5246115|NCT00818805|12896076|P2|STARTED|First Intervention||25
5246116|NCT00818805|12896077|P1|STARTED|First Intervention||25
5246117|NCT00818779|12896089|P2|NOT COMPLETED|Overall Study||1
5246118|NCT00818779|12896090|P1|NOT COMPLETED|Overall Study||6
5246119|NCT00818779|12896089|P2|COMPLETED|Overall Study||15
5246120|NCT00818779|12896090|P1|COMPLETED|Overall Study||16
5246121|NCT00818779|12896089|P2|STARTED|Overall Study||16
5246122|NCT00818779|12896090|P1|STARTED|Overall Study||22
5246123|NCT00818766|12896106|P2|NOT COMPLETED|Overall Study||10
5246124|NCT00818766|12896107|P1|NOT COMPLETED|Overall Study||15
5246125|NCT00818766|12896106|P2|COMPLETED|Overall Study||116
5246126|NCT00818766|12896107|P1|COMPLETED|Overall Study||110
5246127|NCT00818766|12896106|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
5246128|NCT00818766|12896107|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
5246129|NCT00818766|12896106|P2|Received Allocated Intervention|Overall Study||126
5246130|NCT00818766|12896107|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
5246131|NCT00818766|12896106|P2|STARTED|Overall Study||126
5246132|NCT00818766|12896107|P1|STARTED|Overall Study||125
5246133|NCT00818753|12896136|P3|NOT COMPLETED|Overall Study||1
5246134|NCT00818753|12896137|P2|NOT COMPLETED|Overall Study||0
5246135|NCT00818753|12896138|P1|NOT COMPLETED|Overall Study||3
5246136|NCT00818753|12896136|P3|COMPLETED|Overall Study||9
5246137|NCT00818753|12896137|P2|COMPLETED|Overall Study||21
5246138|NCT00818753|12896138|P1|COMPLETED|Overall Study||19
5246139|NCT00818753|12896136|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
5246140|NCT00818753|12896137|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
5246141|NCT00818753|12896138|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
5246142|NCT00818662|12896162|P4|NOT COMPLETED|Overall Study||16
5246143|NCT00818662|12896163|P3|NOT COMPLETED|Overall Study||9
5246144|NCT00818662|12896164|P2|NOT COMPLETED|Overall Study||33
5246145|NCT00818662|12896165|P1|NOT COMPLETED|Overall Study||23
5246146|NCT00818662|12896162|P4|COMPLETED|Overall Study||47
5246147|NCT00818662|12896163|P3|COMPLETED|Overall Study||49
5246148|NCT00818662|12896164|P2|COMPLETED|Overall Study||102
5246149|NCT00818662|12896165|P1|COMPLETED|Overall Study||104
5246150|NCT00818662|12896162|P4|STARTED|Overall Study||63
5246151|NCT00818662|12896163|P3|STARTED|Overall Study||58
5246152|NCT00818662|12896164|P2|STARTED|Overall Study||135
5246153|NCT00818662|12896165|P1|STARTED|Overall Study||127
5246154|NCT00818649|12896251|P1|NOT COMPLETED|Overall Study||4
5246155|NCT00818649|12896251|P1|COMPLETED|Overall Study||12
5246156|NCT00818649|12896251|P1|STARTED|Overall Study||16
5246157|NCT00818623|12896265|P8|NOT COMPLETED|Overall Study||1
5246158|NCT00818623|12896266|P7|NOT COMPLETED|Overall Study||4
5246159|NCT00818623|12896267|P6|NOT COMPLETED|Overall Study||3
5246160|NCT00818623|12896268|P5|NOT COMPLETED|Overall Study||4
5246161|NCT00818623|12896269|P4|NOT COMPLETED|Overall Study||5
5246162|NCT00818623|12896270|P3|NOT COMPLETED|Overall Study||4
5246163|NCT00818623|12896271|P2|NOT COMPLETED|Overall Study||4
5246164|NCT00818623|12896272|P1|NOT COMPLETED|Overall Study||2
5246165|NCT00818623|12896265|P8|COMPLETED|Overall Study||26
5246166|NCT00818623|12896266|P7|COMPLETED|Overall Study||23
5246167|NCT00818623|12896267|P6|COMPLETED|Overall Study||21
5246168|NCT00818623|12896268|P5|COMPLETED|Overall Study||23
5246169|NCT00818623|12896269|P4|COMPLETED|Overall Study||19
5246170|NCT00818623|12896270|P3|COMPLETED|Overall Study||9
5246171|NCT00818623|12896271|P2|COMPLETED|Overall Study||8
5246172|NCT00818623|12896272|P1|COMPLETED|Overall Study||24
5246173|NCT00818623|12896265|P8|Intent-to-treat (ITT) Population|Overall Study||27
5246174|NCT00818623|12896266|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
5246175|NCT00818623|12896267|P6|Intent-to-treat (ITT) Population|Overall Study||24
5246176|NCT00818623|12896268|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
5246177|NCT00818623|12896269|P4|Intent-to-treat (ITT) Population|Overall Study||24
5246178|NCT00818623|12896270|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
5246179|NCT00818623|12896271|P2|Intent-to-treat (ITT) Population|Overall Study||12
5246180|NCT00818623|12896272|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
5246181|NCT00818623|12896265|P8|STARTED|Overall Study||27
5246182|NCT00818623|12896266|P7|STARTED|Overall Study||27
5246183|NCT00818623|12896267|P6|STARTED|Overall Study||24
5246184|NCT00818623|12896268|P5|STARTED|Overall Study||27
5246185|NCT00818623|12896269|P4|STARTED|Overall Study||24
5246186|NCT00818623|12896270|P3|STARTED|Overall Study||13
5246187|NCT00818623|12896271|P2|STARTED|Overall Study||12
5246188|NCT00818623|12896272|P1|STARTED|Overall Study||26
5246189|NCT00818519|12896348|P2|NOT COMPLETED|Overall Study||19
5246190|NCT00818519|12896349|P1|NOT COMPLETED|Overall Study||14
5246191|NCT00818519|12896348|P2|COMPLETED|Overall Study||71
5246192|NCT00818519|12896349|P1|COMPLETED|Overall Study||75
5246193|NCT00818519|12896348|P2|Participants Received Treatment|Overall Study|= Baseline|86
5246194|NCT00818519|12896349|P1|Participants Received Treatment|Overall Study|= Baseline|87
5246195|NCT00818519|12896348|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
5246196|NCT00818519|12896349|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
5246197|NCT00818454|12896379|P4|NOT COMPLETED|Treatment Period 3||1
5246198|NCT00818454|12896380|P3|NOT COMPLETED|Treatment Period 3||0
5246199|NCT00818454|12896381|P2|NOT COMPLETED|Treatment Period 3||0
5246200|NCT00818454|12896382|P1|NOT COMPLETED|Treatment Period 3||0
5246201|NCT00818454|12896379|P4|COMPLETED|Treatment Period 3||138
5246202|NCT00818454|12896380|P3|COMPLETED|Treatment Period 3||26
5246203|NCT00818454|12896381|P2|COMPLETED|Treatment Period 3||0
5246204|NCT00818454|12896382|P1|COMPLETED|Treatment Period 3||0
5246205|NCT00818454|12896379|P4|STARTED|Treatment Period 3||139
5246206|NCT00818454|12896380|P3|STARTED|Treatment Period 3||26
5246207|NCT00818454|12896381|P2|STARTED|Treatment Period 3||0
5246208|NCT00818454|12896382|P1|STARTED|Treatment Period 3||0
5246209|NCT00818454|12896379|P4|NOT COMPLETED|Treatment Period 2||0
5246210|NCT00818454|12896380|P3|NOT COMPLETED|Treatment Period 2||0
5246211|NCT00818454|12896381|P2|NOT COMPLETED|Treatment Period 2||1
5246212|NCT00818454|12896382|P1|NOT COMPLETED|Treatment Period 2||2
5246213|NCT00818454|12896379|P4|COMPLETED|Treatment Period 2||0
5246214|NCT00818454|12896380|P3|COMPLETED|Treatment Period 2||0
5246215|NCT00818454|12896381|P2|COMPLETED|Treatment Period 2||106
5246216|NCT00818454|12896382|P1|COMPLETED|Treatment Period 2||106
5246217|NCT00818454|12896379|P4|STARTED|Treatment Period 2||0
5246218|NCT00818454|12896380|P3|STARTED|Treatment Period 2||0
5246219|NCT00818454|12896381|P2|STARTED|Treatment Period 2||107
5246220|NCT00818454|12896382|P1|STARTED|Treatment Period 2||108
5246221|NCT00818454|12896379|P4|NOT COMPLETED|Washout Period of 1 Week||0
5246222|NCT00818454|12896380|P3|NOT COMPLETED|Washout Period of 1 Week||0
5246223|NCT00818454|12896381|P2|NOT COMPLETED|Washout Period of 1 Week||3
5246224|NCT00818454|12896382|P1|NOT COMPLETED|Washout Period of 1 Week||4
5246225|NCT00818454|12896379|P4|COMPLETED|Washout Period of 1 Week||0
5246226|NCT00818454|12896380|P3|COMPLETED|Washout Period of 1 Week||0
5246227|NCT00818454|12896381|P2|COMPLETED|Washout Period of 1 Week||107
5246228|NCT00818454|12896382|P1|COMPLETED|Washout Period of 1 Week||108
5246229|NCT00818454|12896379|P4|STARTED|Washout Period of 1 Week||0
5246230|NCT00818454|12896380|P3|STARTED|Washout Period of 1 Week||0
5246231|NCT00818454|12896381|P2|STARTED|Washout Period of 1 Week||110
5246232|NCT00818454|12896382|P1|STARTED|Washout Period of 1 Week||112
5246233|NCT00818454|12896379|P4|NOT COMPLETED|Treatment Period 1||0
5246234|NCT00818454|12896380|P3|NOT COMPLETED|Treatment Period 1||0
5246235|NCT00818454|12896381|P2|NOT COMPLETED|Treatment Period 1||1
5246236|NCT00818454|12896382|P1|NOT COMPLETED|Treatment Period 1||3
5246237|NCT00818454|12896379|P4|COMPLETED|Treatment Period 1||0
5246238|NCT00818454|12896380|P3|COMPLETED|Treatment Period 1||0
5246239|NCT00818454|12896381|P2|COMPLETED|Treatment Period 1||110
5246240|NCT00818454|12896382|P1|COMPLETED|Treatment Period 1||112
5246241|NCT00818454|12896379|P4|STARTED|Treatment Period 1||0
5246242|NCT00818454|12896380|P3|STARTED|Treatment Period 1||0
5246243|NCT00818454|12896381|P2|STARTED|Treatment Period 1||111
5246244|NCT00818454|12896382|P1|STARTED|Treatment Period 1||115
5246245|NCT00818441|12896410|P2|NOT COMPLETED|Overall Study||30
5246246|NCT00818441|12896411|P1|NOT COMPLETED|Overall Study||89
5246247|NCT00818441|12896410|P2|COMPLETED|Overall Study||0
5246248|NCT00818441|12896411|P1|COMPLETED|Overall Study||0
5246249|NCT00818441|12896410|P2|STARTED|Overall Study||30
5246250|NCT00818441|12896411|P1|STARTED|Overall Study||89
5246251|NCT00818389|12896433|P2|NOT COMPLETED|Overall Study||6
5246252|NCT00818389|12896434|P1|NOT COMPLETED|Overall Study||4
5246253|NCT00818389|12896433|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
5246254|NCT00818389|12896434|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
5246255|NCT00818389|12896433|P2|STARTED|Overall Study||44
5246256|NCT00818389|12896434|P1|STARTED|Overall Study||40
5246257|NCT00818337|12896444|P1|NOT COMPLETED|Overall Study||0
5246258|NCT00818337|12896444|P1|COMPLETED|Overall Study||36
5246259|NCT00818337|12896444|P1|STARTED|Overall Study||36
5246260|NCT00818324|12896449|P1|NOT COMPLETED|Overall Study||27
5246261|NCT00818324|12896449|P1|COMPLETED|Overall Study||127
5246262|NCT00818324|12896449|P1|STARTED|Overall Study||154
5246263|NCT00818272|12896454|P1|NOT COMPLETED|Overall Study||74
5246264|NCT00818272|12896454|P1|COMPLETED|Overall Study||74
5246265|NCT00818272|12896454|P1|STARTED|Overall Study||148
5246266|NCT00818259|12896469|P9|NOT COMPLETED|Part V||0
5246267|NCT00818259|12896470|P8|NOT COMPLETED|Part V||1
5246268|NCT00818259|12896471|P7|NOT COMPLETED|Part V||0
5246269|NCT00818259|12896472|P6|NOT COMPLETED|Part V||0
5246270|NCT00818259|12896473|P5|NOT COMPLETED|Part V||0
5246271|NCT00818259|12896474|P4|NOT COMPLETED|Part V||0
5246272|NCT00818259|12896475|P3|NOT COMPLETED|Part V||0
5246273|NCT00818259|12896476|P2|NOT COMPLETED|Part V||0
5246274|NCT00818259|12896477|P1|NOT COMPLETED|Part V||0
5246275|NCT00818259|12896469|P9|COMPLETED|Part V||6
5246276|NCT00818259|12896470|P8|COMPLETED|Part V||16
5246277|NCT00818259|12896471|P7|COMPLETED|Part V||0
5246278|NCT00818259|12896472|P6|COMPLETED|Part V||0
5246279|NCT00818259|12896473|P5|COMPLETED|Part V||0
5246280|NCT00818259|12896474|P4|COMPLETED|Part V||0
5246281|NCT00818259|12896475|P3|COMPLETED|Part V||0
5246282|NCT00818259|12896476|P2|COMPLETED|Part V||0
5246283|NCT00818259|12896477|P1|COMPLETED|Part V||0
5246284|NCT00818259|12896469|P9|STARTED|Part V|Newly enrolled participants|6
5246285|NCT00818259|12896470|P8|STARTED|Part V|Participants continuing from Part IV|17
5246286|NCT00818259|12896471|P7|STARTED|Part V||0
5246287|NCT00818259|12896472|P6|STARTED|Part V||0
5246288|NCT00818259|12896473|P5|STARTED|Part V||0
5246289|NCT00818259|12896474|P4|STARTED|Part V||0
5246290|NCT00818259|12896475|P3|STARTED|Part V||0
5246291|NCT00818259|12896476|P2|STARTED|Part V||0
5246292|NCT00818259|12896477|P1|STARTED|Part V||0
5246293|NCT00818259|12896469|P9|NOT COMPLETED|Part IV||0
5246294|NCT00818259|12896470|P8|NOT COMPLETED|Part IV||0
5246295|NCT00818259|12896471|P7|NOT COMPLETED|Part IV||0
5246296|NCT00818259|12896472|P6|NOT COMPLETED|Part IV||1
5246297|NCT00818259|12896473|P5|NOT COMPLETED|Part IV||0
5246298|NCT00818259|12896474|P4|NOT COMPLETED|Part IV||0
5246299|NCT00818259|12896475|P3|NOT COMPLETED|Part IV||0
5246300|NCT00818259|12896476|P2|NOT COMPLETED|Part IV||0
5246301|NCT00818259|12896477|P1|NOT COMPLETED|Part IV||0
5246302|NCT00818259|12896469|P9|COMPLETED|Part IV||0
5246303|NCT00818259|12896470|P8|COMPLETED|Part IV||0
5246304|NCT00818259|12896471|P7|COMPLETED|Part IV||5
5246305|NCT00818259|12896472|P6|COMPLETED|Part IV||14
5246306|NCT00818259|12896473|P5|COMPLETED|Part IV||0
5246307|NCT00818259|12896474|P4|COMPLETED|Part IV||0
5246308|NCT00818259|12896475|P3|COMPLETED|Part IV||0
5246309|NCT00818259|12896476|P2|COMPLETED|Part IV||0
5246310|NCT00818259|12896477|P1|COMPLETED|Part IV||0
5246311|NCT00818259|12896469|P9|STARTED|Part IV||0
5246312|NCT00818259|12896470|P8|STARTED|Part IV||0
5246313|NCT00818259|12896471|P7|STARTED|Part IV|Newly enrolled participants|5
5246314|NCT00818259|12896472|P6|STARTED|Part IV|Participants continuing from Part III|15
5246315|NCT00818259|12896473|P5|STARTED|Part IV||0
5246316|NCT00818259|12896474|P4|STARTED|Part IV||0
5246317|NCT00818259|12896475|P3|STARTED|Part IV||0
5246318|NCT00818259|12896476|P2|STARTED|Part IV||0
5246319|NCT00818259|12896477|P1|STARTED|Part IV||0
5246320|NCT00818259|12896469|P9|NOT COMPLETED|Part III||0
5246321|NCT00818259|12896470|P8|NOT COMPLETED|Part III||0
5246322|NCT00818259|12896471|P7|NOT COMPLETED|Part III||0
5246323|NCT00818259|12896472|P6|NOT COMPLETED|Part III||0
5246324|NCT00818259|12896473|P5|NOT COMPLETED|Part III||0
5246325|NCT00818259|12896474|P4|NOT COMPLETED|Part III||0
5246326|NCT00818259|12896475|P3|NOT COMPLETED|Part III||0
5246327|NCT00818259|12896476|P2|NOT COMPLETED|Part III||0
5246328|NCT00818259|12896477|P1|NOT COMPLETED|Part III||0
5246329|NCT00818259|12896469|P9|COMPLETED|Part III||0
5246330|NCT00818259|12896470|P8|COMPLETED|Part III||0
5246331|NCT00818259|12896471|P7|COMPLETED|Part III||0
5246332|NCT00818259|12896472|P6|COMPLETED|Part III||0
5246333|NCT00818259|12896473|P5|COMPLETED|Part III||19
5246334|NCT00818259|12896474|P4|COMPLETED|Part III||0
5246335|NCT00818259|12896475|P3|COMPLETED|Part III||0
5246336|NCT00818259|12896476|P2|COMPLETED|Part III||0
5246337|NCT00818259|12896477|P1|COMPLETED|Part III||0
5246338|NCT00818259|12896469|P9|STARTED|Part III||0
5246339|NCT00818259|12896470|P8|STARTED|Part III||0
5246340|NCT00818259|12896471|P7|STARTED|Part III||0
5246341|NCT00818259|12896472|P6|STARTED|Part III||0
5246342|NCT00818259|12896473|P5|STARTED|Part III|Newly enrolled participants|19
5246343|NCT00818259|12896474|P4|STARTED|Part III||0
5246344|NCT00818259|12896475|P3|STARTED|Part III||0
5246345|NCT00818259|12896476|P2|STARTED|Part III||0
5246346|NCT00818259|12896477|P1|STARTED|Part III||0
5246347|NCT00818259|12896469|P9|NOT COMPLETED|Part II||0
5246348|NCT00818259|12896470|P8|NOT COMPLETED|Part II||0
5246349|NCT00818259|12896471|P7|NOT COMPLETED|Part II||0
5246350|NCT00818259|12896472|P6|NOT COMPLETED|Part II||0
5246351|NCT00818259|12896473|P5|NOT COMPLETED|Part II||0
5246352|NCT00818259|12896474|P4|NOT COMPLETED|Part II||2
5246353|NCT00818259|12896475|P3|NOT COMPLETED|Part II||1
5246354|NCT00818259|12896476|P2|NOT COMPLETED|Part II||0
5246355|NCT00818259|12896477|P1|NOT COMPLETED|Part II||0
5246356|NCT00818259|12896469|P9|COMPLETED|Part II||0
5246357|NCT00818259|12896470|P8|COMPLETED|Part II||0
5246358|NCT00818259|12896471|P7|COMPLETED|Part II||0
5246359|NCT00818259|12896472|P6|COMPLETED|Part II||0
5246360|NCT00818259|12896473|P5|COMPLETED|Part II||0
5246361|NCT00818259|12896474|P4|COMPLETED|Part II||18
5246362|NCT00818259|12896475|P3|COMPLETED|Part II||18
5246363|NCT00818259|12896476|P2|COMPLETED|Part II||0
5246364|NCT00818259|12896477|P1|COMPLETED|Part II||0
5246365|NCT00818259|12896469|P9|Treated|Part II||0
5246366|NCT00818259|12896470|P8|Treated|Part II||0
5246367|NCT00818259|12896471|P7|Treated|Part II||0
5246368|NCT00818259|12896472|P6|Treated|Part II||0
5246369|NCT00818259|12896473|P5|Treated|Part II||0
5246370|NCT00818259|12896474|P4|Treated|Part II||19
5246371|NCT00818259|12896475|P3|Treated|Part II||19
5246372|NCT00818259|12896476|P2|Treated|Part II||0
5246373|NCT00818259|12896477|P1|Treated|Part II||0
5246374|NCT00818259|12896469|P9|STARTED|Part II||0
5246375|NCT00818259|12896470|P8|STARTED|Part II||0
5246376|NCT00818259|12896471|P7|STARTED|Part II||0
5246377|NCT00818259|12896472|P6|STARTED|Part II||0
5246378|NCT00818259|12896473|P5|STARTED|Part II||0
5246379|NCT00818259|12896474|P4|STARTED|Part II|Newly enrolled participants|20
5246380|NCT00818259|12896475|P3|STARTED|Part II|Newly enrolled participants|19
5246381|NCT00818259|12896476|P2|STARTED|Part II||0
5246382|NCT00818259|12896477|P1|STARTED|Part II||0
5246383|NCT00818259|12896469|P9|NOT COMPLETED|Part I||0
5246384|NCT00818259|12896470|P8|NOT COMPLETED|Part I||0
5246385|NCT00818259|12896471|P7|NOT COMPLETED|Part I||0
5246386|NCT00818259|12896472|P6|NOT COMPLETED|Part I||0
5246387|NCT00818259|12896473|P5|NOT COMPLETED|Part I||0
5246388|NCT00818259|12896474|P4|NOT COMPLETED|Part I||0
5246389|NCT00818259|12896475|P3|NOT COMPLETED|Part I||0
5246390|NCT00818259|12896476|P2|NOT COMPLETED|Part I||0
5246391|NCT00818259|12896477|P1|NOT COMPLETED|Part I||1
5246392|NCT00818259|12896469|P9|COMPLETED|Part I||0
5246393|NCT00818259|12896470|P8|COMPLETED|Part I||0
5246394|NCT00818259|12896471|P7|COMPLETED|Part I||0
5246395|NCT00818259|12896472|P6|COMPLETED|Part I||0
5246396|NCT00818259|12896473|P5|COMPLETED|Part I||0
5246397|NCT00818259|12896474|P4|COMPLETED|Part I||0
5246398|NCT00818259|12896475|P3|COMPLETED|Part I||0
5246399|NCT00818259|12896476|P2|COMPLETED|Part I||11
5246400|NCT00818259|12896477|P1|COMPLETED|Part I||11
5246401|NCT00818259|12896469|P9|STARTED|Part I||0
5246402|NCT00818259|12896470|P8|STARTED|Part I||0
5246403|NCT00818259|12896471|P7|STARTED|Part I||0
5246404|NCT00818259|12896472|P6|STARTED|Part I||0
5246405|NCT00818259|12896473|P5|STARTED|Part I||0
5246406|NCT00818259|12896474|P4|STARTED|Part I||0
5246407|NCT00818259|12896475|P3|STARTED|Part I||0
5246408|NCT00818259|12896476|P2|STARTED|Part I|Newly enrolled participants|11
5246409|NCT00818259|12896477|P1|STARTED|Part I|Newly enrolled participants|12
5246410|NCT00818259|12896469|P9|NOT COMPLETED|Randomization||0
5246411|NCT00818259|12896470|P8|NOT COMPLETED|Randomization||0
5246412|NCT00818259|12896471|P7|NOT COMPLETED|Randomization||0
5246413|NCT00818259|12896472|P6|NOT COMPLETED|Randomization||0
5246414|NCT00818259|12896473|P5|NOT COMPLETED|Randomization||0
5246415|NCT00818259|12896474|P4|NOT COMPLETED|Randomization||0
5246416|NCT00818259|12896475|P3|NOT COMPLETED|Randomization||0
5246417|NCT00818259|12896476|P2|NOT COMPLETED|Randomization||0
5246418|NCT00818259|12896477|P1|NOT COMPLETED|Randomization||0
5246419|NCT00818259|12896469|P9|COMPLETED|Randomization||6
5246420|NCT00818259|12896470|P8|COMPLETED|Randomization||0
5246421|NCT00818259|12896471|P7|COMPLETED|Randomization||5
5246422|NCT00818259|12896472|P6|COMPLETED|Randomization||0
5246423|NCT00818259|12896473|P5|COMPLETED|Randomization||19
5246424|NCT00818259|12896474|P4|COMPLETED|Randomization||20
5246425|NCT00818259|12896475|P3|COMPLETED|Randomization||19
5246426|NCT00818259|12896476|P2|COMPLETED|Randomization||11
5246427|NCT00818259|12896477|P1|COMPLETED|Randomization||12
5246428|NCT00818259|12896469|P9|STARTED|Randomization||6
5246429|NCT00818259|12896470|P8|STARTED|Randomization||0
5246430|NCT00818259|12896471|P7|STARTED|Randomization||5
5246431|NCT00818259|12896472|P6|STARTED|Randomization||0
5246432|NCT00818259|12896473|P5|STARTED|Randomization||19
5246433|NCT00818259|12896474|P4|STARTED|Randomization||20
5246434|NCT00818259|12896475|P3|STARTED|Randomization||19
5246435|NCT00818259|12896476|P2|STARTED|Randomization||11
5246436|NCT00818259|12896477|P1|STARTED|Randomization||12
5246437|NCT00818246|12896549|P1|NOT COMPLETED|Overall Study||5
5246438|NCT00818246|12896549|P1|COMPLETED|Overall Study|split-face study|35
5246439|NCT00818246|12896549|P1|STARTED|Overall Study||40
5246440|NCT00818207|12896558|P2|NOT COMPLETED|Overall Study||267
5246441|NCT00818207|12896559|P1|NOT COMPLETED|Overall Study||222
5246442|NCT00818207|12896558|P2|COMPLETED|Overall Study||417
5246443|NCT00818207|12896559|P1|COMPLETED|Overall Study||474
5246444|NCT00818207|12896558|P2|STARTED|Overall Study||684
5246445|NCT00818207|12896559|P1|STARTED|Overall Study||696
5246446|NCT00818168|12896573|P1|NOT COMPLETED|Overall Study||70
5246447|NCT00818168|12896573|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
5246448|NCT00818168|12896573|P1|STARTED|Overall Study||320
5246449|NCT00818116|12896581|P1|NOT COMPLETED|Overall Study||0
5246450|NCT00818116|12896581|P1|COMPLETED|Overall Study||34
5246451|NCT00818116|12896581|P1|STARTED|Overall Study||34
5246452|NCT00817999|12896587|P2|NOT COMPLETED|No Grapefruit Juice||0
5246453|NCT00817999|12896588|P1|NOT COMPLETED|No Grapefruit Juice||0
5246454|NCT00817999|12896587|P2|COMPLETED|No Grapefruit Juice||17
5246455|NCT00817999|12896588|P1|COMPLETED|No Grapefruit Juice||15
5246456|NCT00817999|12896587|P2|STARTED|No Grapefruit Juice||17
5246457|NCT00817999|12896588|P1|STARTED|No Grapefruit Juice||15
5246458|NCT00817999|12896587|P2|NOT COMPLETED|Grapefruit Juice||0
5246459|NCT00817999|12896588|P1|NOT COMPLETED|Grapefruit Juice||0
5246460|NCT00817999|12896587|P2|COMPLETED|Grapefruit Juice||17
5246461|NCT00817999|12896588|P1|COMPLETED|Grapefruit Juice||15
5246462|NCT00817999|12896587|P2|STARTED|Grapefruit Juice||17
5246463|NCT00817999|12896588|P1|STARTED|Grapefruit Juice||15
5246464|NCT00817843|12896596|P2|NOT COMPLETED|Second Period (6 Weeks)||1
5246465|NCT00817843|12896597|P1|NOT COMPLETED|Second Period (6 Weeks)||0
5246466|NCT00817843|12896596|P2|COMPLETED|Second Period (6 Weeks)||44
5246467|NCT00817843|12896597|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
5246468|NCT00817843|12896596|P2|STARTED|Second Period (6 Weeks)||45
5246469|NCT00817843|12896597|P1|STARTED|Second Period (6 Weeks)||41
5246470|NCT00817843|12896596|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
5246471|NCT00817843|12896597|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
5246472|NCT00817843|12896596|P2|COMPLETED|Washout Period (6 Weeks)||45
5246473|NCT00817843|12896597|P1|COMPLETED|Washout Period (6 Weeks)||41
5246474|NCT00817843|12896596|P2|STARTED|Washout Period (6 Weeks)||46
5246475|NCT00817843|12896597|P1|STARTED|Washout Period (6 Weeks)||42
5246476|NCT00817843|12896596|P2|NOT COMPLETED|First Period (6 Weeks)||4
5246477|NCT00817843|12896597|P1|NOT COMPLETED|First Period (6 Weeks)||8
5246478|NCT00817843|12896596|P2|COMPLETED|First Period (6 Weeks)||46
5246479|NCT00817843|12896597|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
5246480|NCT00817843|12896596|P2|STARTED|First Period (6 Weeks)||50
5246481|NCT00817843|12896597|P1|STARTED|First Period (6 Weeks)||50
5246482|NCT00817804|12896604|P2|NOT COMPLETED|Overall Study||0
5246483|NCT00817804|12896605|P1|NOT COMPLETED|Overall Study||0
5246484|NCT00817804|12896604|P2|COMPLETED|Overall Study||2
5246485|NCT00817804|12896605|P1|COMPLETED|Overall Study||1
5246486|NCT00817804|12896604|P2|STARTED|Overall Study||2
5246487|NCT00817804|12896605|P1|STARTED|Overall Study||1
5246488|NCT00817778|12896613|P2|NOT COMPLETED|Overall Study||3
5246489|NCT00817778|12896614|P1|NOT COMPLETED|Overall Study||3
5246490|NCT00817778|12896613|P2|COMPLETED|Overall Study||5
5246491|NCT00817778|12896614|P1|COMPLETED|Overall Study||16
5246492|NCT00817778|12896613|P2|STARTED|Overall Study||8
5246493|NCT00817778|12896614|P1|STARTED|Overall Study||19
5246494|NCT00817596|12896639|P1|NOT COMPLETED|Overall Study||48
5246495|NCT00817596|12896639|P1|COMPLETED|Overall Study||62
5246496|NCT00817596|12896639|P1|STARTED|Overall Study||110
5246497|NCT00817531|12896643|P1|NOT COMPLETED|Overall Study||2
5246498|NCT00817531|12896643|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
5246499|NCT00817531|12896643|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
5246500|NCT00817479|12896649|P2|NOT COMPLETED|Overall Study||1
5246501|NCT00817479|12896650|P1|NOT COMPLETED|Overall Study||1
5246502|NCT00817479|12896649|P2|COMPLETED|Overall Study||13
5246503|NCT00817479|12896650|P1|COMPLETED|Overall Study||5
5246504|NCT00817479|12896649|P2|STARTED|Overall Study||14
5246505|NCT00817479|12896650|P1|STARTED|Overall Study||6
5246506|NCT00817336|12896660|P2|NOT COMPLETED|Overall Study||1
5246507|NCT00817336|12896661|P1|NOT COMPLETED|Overall Study||1
5246508|NCT00817336|12896660|P2|COMPLETED|Overall Study||7
5246509|NCT00817336|12896661|P1|COMPLETED|Overall Study||7
5246510|NCT00817336|12896660|P2|STARTED|Overall Study||8
5246511|NCT00817336|12896661|P1|STARTED|Overall Study||8
5246512|NCT00817219|12896672|P1|NOT COMPLETED|Overall Study||0
5246513|NCT00817219|12896672|P1|COMPLETED|Overall Study||33
5246514|NCT00817219|12896672|P1|STARTED|Overall Study||33
5246515|NCT00817206|12896687|P2|NOT COMPLETED|Overall Study||9
5246516|NCT00817206|12896688|P1|NOT COMPLETED|Overall Study||21
5246517|NCT00817206|12896687|P2|COMPLETED|Overall Study||154
5246518|NCT00817206|12896688|P1|COMPLETED|Overall Study||142
5246519|NCT00817206|12896687|P2|STARTED|Overall Study||163
5246520|NCT00817206|12896688|P1|STARTED|Overall Study||163
5246521|NCT00817089|12896698|P4|NOT COMPLETED|Second Alcohol Challenge||0
5246522|NCT00817089|12896699|P3|NOT COMPLETED|Second Alcohol Challenge||0
5246523|NCT00817089|12896700|P2|NOT COMPLETED|Second Alcohol Challenge||1
5246524|NCT00817089|12896701|P1|NOT COMPLETED|Second Alcohol Challenge||0
5246525|NCT00817089|12896698|P4|COMPLETED|Second Alcohol Challenge||5
5246526|NCT00817089|12896699|P3|COMPLETED|Second Alcohol Challenge||4
5246527|NCT00817089|12896700|P2|COMPLETED|Second Alcohol Challenge||7
5246528|NCT00817089|12896701|P1|COMPLETED|Second Alcohol Challenge||6
5246529|NCT00817089|12896698|P4|STARTED|Second Alcohol Challenge||5
5246530|NCT00817089|12896699|P3|STARTED|Second Alcohol Challenge||4
5246531|NCT00817089|12896700|P2|STARTED|Second Alcohol Challenge||8
5246532|NCT00817089|12896701|P1|STARTED|Second Alcohol Challenge||6
5246533|NCT00817089|12896698|P4|NOT COMPLETED|First Alcohol Challenge||1
5246534|NCT00817089|12896699|P3|NOT COMPLETED|First Alcohol Challenge||0
5246535|NCT00817089|12896700|P2|NOT COMPLETED|First Alcohol Challenge||0
5246536|NCT00817089|12896701|P1|NOT COMPLETED|First Alcohol Challenge||0
5246537|NCT00817089|12896698|P4|COMPLETED|First Alcohol Challenge||5
5246538|NCT00817089|12896699|P3|COMPLETED|First Alcohol Challenge||4
5246539|NCT00817089|12896700|P2|COMPLETED|First Alcohol Challenge||8
5246540|NCT00817089|12896701|P1|COMPLETED|First Alcohol Challenge||6
5246541|NCT00817089|12896698|P4|STARTED|First Alcohol Challenge||6
5246542|NCT00817089|12896699|P3|STARTED|First Alcohol Challenge||4
5246543|NCT00817089|12896700|P2|STARTED|First Alcohol Challenge||8
5246544|NCT00817089|12896701|P1|STARTED|First Alcohol Challenge||6
5246545|NCT00817063|12896717|P2|NOT COMPLETED|Overall Study||170
5246546|NCT00817063|12896718|P1|NOT COMPLETED|Overall Study||137
5246547|NCT00817063|12896717|P2|COMPLETED|Overall Study||128
5246548|NCT00817063|12896718|P1|COMPLETED|Overall Study||161
5246549|NCT00817063|12896717|P2|STARTED|Overall Study||298
5246550|NCT00817063|12896718|P1|STARTED|Overall Study||298
5246551|NCT00816907|12896762|P2|NOT COMPLETED|Overall Study||17
5246552|NCT00816907|12896763|P1|NOT COMPLETED|Overall Study||13
5246553|NCT00816907|12896762|P2|COMPLETED|Overall Study||58
5246554|NCT00816907|12896763|P1|COMPLETED|Overall Study||58
5246555|NCT00816907|12896762|P2|STARTED|Overall Study||75
5246556|NCT00816907|12896763|P1|STARTED|Overall Study||71
5246557|NCT00816829|12896785|P2|NOT COMPLETED|Overall Study||0
5246558|NCT00816829|12896786|P1|NOT COMPLETED|Overall Study||0
5246559|NCT00816829|12896785|P2|COMPLETED|Overall Study||18
5246560|NCT00816829|12896786|P1|COMPLETED|Overall Study||16
5246561|NCT00816829|12896785|P2|STARTED|Overall Study||18
5246562|NCT00816829|12896786|P1|STARTED|Overall Study||16
5246563|NCT00816777|12896812|P2|NOT COMPLETED|Overall Study||0
5246564|NCT00816777|12896813|P1|NOT COMPLETED|Overall Study||0
5246565|NCT00816777|12896812|P2|COMPLETED|Overall Study||2
5246566|NCT00816777|12896813|P1|COMPLETED|Overall Study||2
5246567|NCT00816777|12896812|P2|STARTED|Overall Study||2
5246568|NCT00816777|12896813|P1|STARTED|Overall Study||2
5246569|NCT00816751|12896835|P2|NOT COMPLETED|Overall Study||0
5246570|NCT00816751|12896836|P1|NOT COMPLETED|Overall Study||0
5246571|NCT00816751|12896835|P2|COMPLETED|Overall Study||44
5246572|NCT00816751|12896836|P1|COMPLETED|Overall Study||45
5246573|NCT00816751|12896835|P2|STARTED|Overall Study||44
5246574|NCT00816751|12896836|P1|STARTED|Overall Study||45
5246575|NCT00816595|12896846|P2|NOT COMPLETED|Overall Study||0
5246576|NCT00816595|12896847|P1|NOT COMPLETED|Overall Study||2
5246577|NCT00816595|12896846|P2|COMPLETED|Overall Study||33
5246578|NCT00816595|12896847|P1|COMPLETED|Overall Study||33
5246579|NCT00816595|12896846|P2|STARTED|Overall Study||33
5246580|NCT00816595|12896847|P1|STARTED|Overall Study||35
5246581|NCT00816556|12896860|P3|NOT COMPLETED|Overall Study||3
5246582|NCT00816556|12896861|P2|NOT COMPLETED|Overall Study||2
5246583|NCT00816556|12896862|P1|NOT COMPLETED|Overall Study||2
5246584|NCT00816556|12896860|P3|COMPLETED|Overall Study||19
5246585|NCT00816556|12896861|P2|COMPLETED|Overall Study||19
5246586|NCT00816556|12896862|P1|COMPLETED|Overall Study||18
5246587|NCT00816556|12896860|P3|STARTED|Overall Study||22
5246588|NCT00816556|12896861|P2|STARTED|Overall Study||21
5246589|NCT00816556|12896862|P1|STARTED|Overall Study||20
5246590|NCT00816400|12896885|P9|NOT COMPLETED|Overall Study||6
5246591|NCT00816400|12896886|P8|NOT COMPLETED|Overall Study||5
5246592|NCT00816400|12896887|P7|NOT COMPLETED|Overall Study||2
5246593|NCT00816400|12896888|P6|NOT COMPLETED|Overall Study||3
5246594|NCT00816400|12896889|P5|NOT COMPLETED|Overall Study||2
5246595|NCT00816400|12896890|P4|NOT COMPLETED|Overall Study||3
5246596|NCT00816400|12896891|P3|NOT COMPLETED|Overall Study||5
5246597|NCT00816400|12896892|P2|NOT COMPLETED|Overall Study||3
5246598|NCT00816400|12896893|P1|NOT COMPLETED|Overall Study||2
5246599|NCT00816400|12896885|P9|COMPLETED|Overall Study||0
5246600|NCT00816400|12896886|P8|COMPLETED|Overall Study||1
5246601|NCT00816400|12896887|P7|COMPLETED|Overall Study||1
5246602|NCT00816400|12896888|P6|COMPLETED|Overall Study||0
5246603|NCT00816400|12896889|P5|COMPLETED|Overall Study||1
5246604|NCT00816400|12896890|P4|COMPLETED|Overall Study||0
5246605|NCT00816400|12896891|P3|COMPLETED|Overall Study||0
5246606|NCT00816400|12896892|P2|COMPLETED|Overall Study||0
5246607|NCT00816400|12896893|P1|COMPLETED|Overall Study||1
5246608|NCT00816400|12896885|P9|STARTED|Overall Study||6
5246609|NCT00816400|12896886|P8|STARTED|Overall Study||6
5246610|NCT00816400|12896887|P7|STARTED|Overall Study||3
5246611|NCT00816400|12896888|P6|STARTED|Overall Study||3
5246612|NCT00816400|12896889|P5|STARTED|Overall Study||3
5246613|NCT00816400|12896890|P4|STARTED|Overall Study||3
5246614|NCT00816400|12896891|P3|STARTED|Overall Study||5
5246615|NCT00816400|12896892|P2|STARTED|Overall Study||3
5246616|NCT00816400|12896893|P1|STARTED|Overall Study||3
5246617|NCT00816361|12897084|P9|NOT COMPLETED|Overall Study||10
5246618|NCT00816361|12897085|P8|NOT COMPLETED|Overall Study||9
5246619|NCT00816361|12897086|P7|NOT COMPLETED|Overall Study||3
5246620|NCT00816361|12897087|P6|NOT COMPLETED|Overall Study||3
5246621|NCT00816361|12897088|P5|NOT COMPLETED|Overall Study||2
5246622|NCT00816361|12897089|P4|NOT COMPLETED|Overall Study||3
5246623|NCT00816361|12897090|P3|NOT COMPLETED|Overall Study||3
5246624|NCT00816361|12897091|P2|NOT COMPLETED|Overall Study||3
5246625|NCT00816361|12897092|P1|NOT COMPLETED|Overall Study||4
5246626|NCT00816361|12897084|P9|COMPLETED|Overall Study||0
5246627|NCT00816361|12897085|P8|COMPLETED|Overall Study||1
5246628|NCT00816361|12897086|P7|COMPLETED|Overall Study||0
5246629|NCT00816361|12897087|P6|COMPLETED|Overall Study||0
5246630|NCT00816361|12897088|P5|COMPLETED|Overall Study||1
5246631|NCT00816361|12897089|P4|COMPLETED|Overall Study||0
5246632|NCT00816361|12897090|P3|COMPLETED|Overall Study||1
5246633|NCT00816361|12897091|P2|COMPLETED|Overall Study||0
5246634|NCT00816361|12897092|P1|COMPLETED|Overall Study||0
5246635|NCT00816361|12897084|P9|STARTED|Overall Study||10
5246636|NCT00816361|12897085|P8|STARTED|Overall Study||10
5246637|NCT00816361|12897086|P7|STARTED|Overall Study||3
5246638|NCT00816361|12897087|P6|STARTED|Overall Study||3
5246639|NCT00816361|12897088|P5|STARTED|Overall Study||3
5246640|NCT00816361|12897089|P4|STARTED|Overall Study||3
5246641|NCT00816361|12897090|P3|STARTED|Overall Study||4
5246642|NCT00816361|12897091|P2|STARTED|Overall Study||3
5246643|NCT00816361|12897092|P1|STARTED|Overall Study||4
5246644|NCT00816348|12897245|P1|NOT COMPLETED|Overall Study||0
5246645|NCT00816348|12897245|P1|COMPLETED|Overall Study||15
5246646|NCT00816348|12897245|P1|STARTED|Overall Study||15
5246647|NCT00816166|12897251|P2|NOT COMPLETED|Overall Study||12
5246648|NCT00816166|12897252|P1|NOT COMPLETED|Overall Study||10
5246649|NCT00816166|12897251|P2|COMPLETED|Overall Study||41
5246650|NCT00816166|12897252|P1|COMPLETED|Overall Study||49
5246651|NCT00816166|12897251|P2|ITT Population (Met Eligibility)|Overall Study||53
5246652|NCT00816166|12897252|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
5246653|NCT00816166|12897251|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
5246654|NCT00816166|12897252|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
5246655|NCT00816101|12897261|P3|NOT COMPLETED|Overall Study||0
5246656|NCT00816101|12897262|P2|NOT COMPLETED|Overall Study||0
5246657|NCT00816101|12897263|P1|NOT COMPLETED|Overall Study||0
5246658|NCT00816101|12897261|P3|COMPLETED|Overall Study||5
5246659|NCT00816101|12897262|P2|COMPLETED|Overall Study||8
5246660|NCT00816101|12897263|P1|COMPLETED|Overall Study||13
5246661|NCT00816101|12897261|P3|STARTED|Overall Study||5
5246662|NCT00816101|12897262|P2|STARTED|Overall Study||8
5246663|NCT00816101|12897263|P1|STARTED|Overall Study||13
5246664|NCT00816062|12897277|P1|NOT COMPLETED|Overall Study||127
5246665|NCT00816062|12897277|P1|COMPLETED|Overall Study||133
5246666|NCT00816062|12897277|P1|STARTED|Overall Study||260
5246667|NCT00816036|12897284|P2|NOT COMPLETED|Overall Study||108
5246668|NCT00816036|12897285|P1|NOT COMPLETED|Overall Study||176
5246669|NCT00816036|12897284|P2|COMPLETED|Overall Study||287
5246670|NCT00816036|12897285|P1|COMPLETED|Overall Study||327
5246671|NCT00816036|12897284|P2|STARTED|Overall Study||395
5246672|NCT00816036|12897285|P1|STARTED|Overall Study||503
5246673|NCT00816023|12897299|P4|NOT COMPLETED|Overall Study||12
5246674|NCT00816023|12897300|P3|NOT COMPLETED|Overall Study||9
5246675|NCT00816023|12897301|P2|NOT COMPLETED|Overall Study||6
5246676|NCT00816023|12897302|P1|NOT COMPLETED|Overall Study||9
5246677|NCT00816023|12897299|P4|COMPLETED|Overall Study||62
5246678|NCT00816023|12897300|P3|COMPLETED|Overall Study||60
5246679|NCT00816023|12897301|P2|COMPLETED|Overall Study||56
5246680|NCT00816023|12897302|P1|COMPLETED|Overall Study||62
5246681|NCT00816023|12897299|P4|Completed Therapy|Overall Study||63
5246682|NCT00816023|12897300|P3|Completed Therapy|Overall Study||61
5246683|NCT00816023|12897301|P2|Completed Therapy|Overall Study||59
5246684|NCT00816023|12897302|P1|Completed Therapy|Overall Study||65
5246685|NCT00816023|12897299|P4|STARTED|Overall Study||74
5246686|NCT00816023|12897300|P3|STARTED|Overall Study||69
5246687|NCT00816023|12897301|P2|STARTED|Overall Study||62
5246688|NCT00816023|12897302|P1|STARTED|Overall Study||71
5246689|NCT00815997|12897318|P2|NOT COMPLETED|Overall Study||0
5246690|NCT00815997|12897319|P1|NOT COMPLETED|Overall Study||0
5246691|NCT00815997|12897318|P2|COMPLETED|Overall Study||80
5246692|NCT00815997|12897319|P1|COMPLETED|Overall Study||80
5246693|NCT00815997|12897318|P2|STARTED|Overall Study||80
5246694|NCT00815997|12897319|P1|STARTED|Overall Study||80
5246695|NCT00815919|12897339|P1|NOT COMPLETED|Overall Study||4
5246696|NCT00815919|12897339|P1|COMPLETED|Overall Study||18
5246697|NCT00815919|12897339|P1|STARTED|Overall Study||22
5246698|NCT00815776|12897350|P3|NOT COMPLETED|Overall Study||6
5246699|NCT00815776|12897351|P2|NOT COMPLETED|Overall Study||8
5246700|NCT00815776|12897352|P1|NOT COMPLETED|Overall Study||8
5246701|NCT00815776|12897350|P3|COMPLETED|Overall Study||22
5246702|NCT00815776|12897351|P2|COMPLETED|Overall Study||56
5246703|NCT00815776|12897352|P1|COMPLETED|Overall Study||52
5246704|NCT00815776|12897350|P3|STARTED|Overall Study||28
5246705|NCT00815776|12897351|P2|STARTED|Overall Study||64
5246706|NCT00815776|12897352|P1|STARTED|Overall Study||60
5246707|NCT00815698|12897368|P2|NOT COMPLETED|Overall Study||0
5246708|NCT00815698|12897369|P1|NOT COMPLETED|Overall Study||0
5246709|NCT00815698|12897368|P2|COMPLETED|Overall Study||171
5246710|NCT00815698|12897369|P1|COMPLETED|Overall Study||163
5246711|NCT00815698|12897368|P2|STARTED|Overall Study||171
5246712|NCT00815698|12897369|P1|STARTED|Overall Study||163
5246713|NCT00815685|12897377|P1|NOT COMPLETED|Overall Study||22
5246714|NCT00815685|12897377|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
5246715|NCT00815685|12897377|P1|STARTED|Overall Study||36
5246716|NCT00815659|12897382|P1|NOT COMPLETED|Overall Study||23
5246717|NCT00815659|12897382|P1|COMPLETED|Overall Study||74
5246718|NCT00815659|12897382|P1|STARTED|Overall Study||97
5246719|NCT00815633|12897425|P1|NOT COMPLETED|Overall Study||1
5246720|NCT00815633|12897425|P1|COMPLETED|Overall Study||0
5246721|NCT00815633|12897425|P1|STARTED|Overall Study||1
5246722|NCT00815516|12897432|P2|NOT COMPLETED|Overall Study||1
5246723|NCT00815516|12897433|P1|NOT COMPLETED|Overall Study||4
5246724|NCT00815516|12897432|P2|COMPLETED|Overall Study||9
5246725|NCT00815516|12897433|P1|COMPLETED|Overall Study||16
5246726|NCT00815516|12897432|P2|STARTED|Overall Study||10
5246727|NCT00815516|12897433|P1|STARTED|Overall Study||20
5246728|NCT00815490|12897464|P2|NOT COMPLETED|Overall Study||0
5246729|NCT00815490|12897465|P1|NOT COMPLETED|Overall Study||0
5246730|NCT00815490|12897464|P2|COMPLETED|Overall Study||9
5246731|NCT00815490|12897465|P1|COMPLETED|Overall Study||9
5246732|NCT00815490|12897464|P2|STARTED|Overall Study||9
5246733|NCT00815490|12897465|P1|STARTED|Overall Study||9
5246734|NCT00815360|12897473|P2|NOT COMPLETED|Overall Study||0
5246735|NCT00815360|12897474|P1|NOT COMPLETED|Overall Study||0
5246736|NCT00815360|12897473|P2|COMPLETED|Overall Study||11
5246737|NCT00815360|12897474|P1|COMPLETED|Overall Study||11
5246738|NCT00815360|12897473|P2|STARTED|Overall Study||11
5246739|NCT00815360|12897474|P1|STARTED|Overall Study||11
5246740|NCT00815347|12897482|P1|NOT COMPLETED|Overall Study||4
5246741|NCT00815347|12897482|P1|COMPLETED|Overall Study||7
5246742|NCT00815347|12897482|P1|STARTED|Overall Study||11
5246743|NCT00815308|12897498|P1|NOT COMPLETED|Overall Study||10
5246744|NCT00815308|12897498|P1|COMPLETED|Overall Study||45
5246745|NCT00815308|12897498|P1|STARTED|Overall Study||55
5246746|NCT00815295|12897507|P3|NOT COMPLETED|Overall Study||3
5246747|NCT00815295|12897508|P2|NOT COMPLETED|Overall Study||1
5246748|NCT00815295|12897509|P1|NOT COMPLETED|Overall Study||0
5246749|NCT00815295|12897507|P3|COMPLETED|Overall Study||9
5246750|NCT00815295|12897508|P2|COMPLETED|Overall Study||7
5246751|NCT00815295|12897509|P1|COMPLETED|Overall Study||8
5246752|NCT00815295|12897507|P3|STARTED|Overall Study||12
5246753|NCT00815295|12897508|P2|STARTED|Overall Study||8
5246754|NCT00815295|12897509|P1|STARTED|Overall Study||8
5246755|NCT00815191|12897521|P2|NOT COMPLETED|Overall Study||1
5246756|NCT00815191|12897522|P1|NOT COMPLETED|Overall Study||1
5246757|NCT00815191|12897521|P2|COMPLETED|Overall Study||34
5246758|NCT00815191|12897522|P1|COMPLETED|Overall Study||37
5246759|NCT00815191|12897521|P2|STARTED|Overall Study||35
5246760|NCT00815191|12897522|P1|STARTED|Overall Study||38
5246761|NCT00815087|12897530|P2|NOT COMPLETED|Overall Study||0
5246762|NCT00815087|12897531|P1|NOT COMPLETED|Overall Study||0
5246763|NCT00815087|12897530|P2|COMPLETED|Overall Study||10
5246764|NCT00815087|12897531|P1|COMPLETED|Overall Study||10
5246765|NCT00815087|12897530|P2|STARTED|Overall Study||10
5246766|NCT00815087|12897531|P1|STARTED|Overall Study||10
5246767|NCT00815035|12897539|P3|NOT COMPLETED|Open Label Extension Phase||6
5246768|NCT00815035|12897540|P2|NOT COMPLETED|Open Label Extension Phase||0
5246769|NCT00815035|12897541|P1|NOT COMPLETED|Open Label Extension Phase||0
5246770|NCT00815035|12897539|P3|COMPLETED|Open Label Extension Phase||9
5246771|NCT00815035|12897540|P2|COMPLETED|Open Label Extension Phase||0
5246772|NCT00815035|12897541|P1|COMPLETED|Open Label Extension Phase||0
5246773|NCT00815035|12897539|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
5246774|NCT00815035|12897540|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
5246775|NCT00815035|12897541|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
5246776|NCT00815035|12897539|P3|NOT COMPLETED|Blinded Phase||0
5246777|NCT00815035|12897540|P2|NOT COMPLETED|Blinded Phase||0
5246778|NCT00815035|12897541|P1|NOT COMPLETED|Blinded Phase||1
5246779|NCT00815035|12897539|P3|COMPLETED|Blinded Phase||0
5246780|NCT00815035|12897540|P2|COMPLETED|Blinded Phase||6
5246781|NCT00815035|12897541|P1|COMPLETED|Blinded Phase||9
5246782|NCT00815035|12897539|P3|STARTED|Blinded Phase||0
5246783|NCT00815035|12897540|P2|STARTED|Blinded Phase||6
5246784|NCT00815035|12897541|P1|STARTED|Blinded Phase||10
5246785|NCT00814983|12897559|P2|NOT COMPLETED|Overall Study||0
5246786|NCT00814983|12897560|P1|NOT COMPLETED|Overall Study||3
5246787|NCT00814983|12897559|P2|COMPLETED|Overall Study||0
5246788|NCT00814983|12897560|P1|COMPLETED|Overall Study||12
5246789|NCT00814983|12897559|P2|STARTED|Overall Study||0
5246790|NCT00814983|12897560|P1|STARTED|Overall Study||15
5246791|NCT00814970|12897570|P1|NOT COMPLETED|Overall Study||50
5246792|NCT00814970|12897570|P1|COMPLETED|Overall Study||146
5246793|NCT00814970|12897570|P1|STARTED|Overall Study||196
5246794|NCT00814892|12897591|P1|NOT COMPLETED|Overall Study||2
5246795|NCT00814892|12897591|P1|COMPLETED|Overall Study||0
5246796|NCT00814892|12897591|P1|STARTED|Overall Study||2
5246797|NCT00814879|12897603|P2|NOT COMPLETED|By Week 48||3
5246798|NCT00814879|12897604|P1|NOT COMPLETED|By Week 48||2
5246799|NCT00814879|12897603|P2|COMPLETED|By Week 48||26
5246800|NCT00814879|12897604|P1|COMPLETED|By Week 48||25
5246801|NCT00814879|12897603|P2|STARTED|By Week 48||29
5246802|NCT00814879|12897604|P1|STARTED|By Week 48||27
5246803|NCT00814879|12897603|P2|NOT COMPLETED|By Week 24||1
5246804|NCT00814879|12897604|P1|NOT COMPLETED|By Week 24||1
5246805|NCT00814879|12897603|P2|COMPLETED|By Week 24||29
5246806|NCT00814879|12897604|P1|COMPLETED|By Week 24||27
5246807|NCT00814879|12897603|P2|STARTED|By Week 24||30
5246808|NCT00814879|12897604|P1|STARTED|By Week 24||28
5246809|NCT00814801|12897623|P3|NOT COMPLETED|Overall Study||43
5246810|NCT00814801|12897624|P2|NOT COMPLETED|Overall Study||38
5246811|NCT00814801|12897625|P1|NOT COMPLETED|Overall Study||34
5246812|NCT00814801|12897623|P3|COMPLETED|Overall Study||151
5246813|NCT00814801|12897624|P2|COMPLETED|Overall Study||154
5246814|NCT00814801|12897625|P1|COMPLETED|Overall Study||160
5246815|NCT00814801|12897623|P3|STARTED|Overall Study||194
5246816|NCT00814801|12897624|P2|STARTED|Overall Study||192
5246817|NCT00814801|12897625|P1|STARTED|Overall Study||194
5246818|NCT00814788|12897645|P1|NOT COMPLETED|Overall Study||0
5246819|NCT00814788|12897645|P1|COMPLETED|Overall Study||24
5246820|NCT00814788|12897645|P1|STARTED|Overall Study||24
5246821|NCT00814775|12897653|P2|NOT COMPLETED|Overall Study||0
5246822|NCT00814775|12897654|P1|NOT COMPLETED|Overall Study||0
5246823|NCT00814775|12897653|P2|COMPLETED|Overall Study||20
5246824|NCT00814775|12897654|P1|COMPLETED|Overall Study||23
5246825|NCT00814775|12897653|P2|STARTED|Overall Study||20
5246826|NCT00814775|12897654|P1|STARTED|Overall Study||23
5246827|NCT00814710|12897664|P2|NOT COMPLETED|Overall Study||3
5246828|NCT00814710|12897665|P1|NOT COMPLETED|Overall Study||8
5246829|NCT00814710|12897664|P2|COMPLETED|Overall Study||117
5246830|NCT00814710|12897665|P1|COMPLETED|Overall Study||232
5246831|NCT00814710|12897664|P2|STARTED|Overall Study||120
5246832|NCT00814710|12897665|P1|STARTED|Overall Study||240
5246833|NCT00814697|12897703|P1|NOT COMPLETED|Overall Study||0
5246834|NCT00814697|12897703|P1|COMPLETED|Overall Study||12
5246835|NCT00814697|12897703|P1|STARTED|Overall Study||12
5246836|NCT00814671|12897710|P3|NOT COMPLETED|Overall Study||2
5246837|NCT00814671|12897711|P2|NOT COMPLETED|Overall Study||4
5246838|NCT00814671|12897712|P1|NOT COMPLETED|Overall Study||7
5246839|NCT00814671|12897710|P3|COMPLETED|Overall Study||49
5246840|NCT00814671|12897711|P2|COMPLETED|Overall Study||44
5246841|NCT00814671|12897712|P1|COMPLETED|Overall Study||47
5246842|NCT00814671|12897710|P3|STARTED|Overall Study||51
5246843|NCT00814671|12897711|P2|STARTED|Overall Study||48
5246844|NCT00814671|12897712|P1|STARTED|Overall Study||54
5246845|NCT00814658|12897733|P2|NOT COMPLETED|Overall Study||4
5246846|NCT00814658|12897734|P1|NOT COMPLETED|Overall Study||4
5246847|NCT00814658|12897733|P2|COMPLETED|Overall Study||8
5246848|NCT00814658|12897734|P1|COMPLETED|Overall Study||5
5246849|NCT00814658|12897733|P2|STARTED|Overall Study||12
5246850|NCT00814658|12897734|P1|STARTED|Overall Study||9
5246851|NCT00814632|12897800|P1|NOT COMPLETED|Overall Study||2
5246852|NCT00814632|12897800|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
5246853|NCT00814632|12897800|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
5246854|NCT00814580|12897806|P2|NOT COMPLETED|Overall Study||47
5246855|NCT00814580|12897807|P1|NOT COMPLETED|Overall Study||31
5246856|NCT00814580|12897806|P2|COMPLETED|Overall Study||141
5246857|NCT00814580|12897807|P1|COMPLETED|Overall Study||163
5246858|NCT00814580|12897806|P2|STARTED|Overall Study||188
5246859|NCT00814580|12897807|P1|STARTED|Overall Study||194
5246860|NCT00814502|12897937|P2|NOT COMPLETED|Overall Study||2
5246861|NCT00814502|12897938|P1|NOT COMPLETED|Overall Study||1
5246862|NCT00814502|12897937|P2|COMPLETED|Overall Study||7
5246863|NCT00814502|12897938|P1|COMPLETED|Overall Study||7
5246864|NCT00814502|12897937|P2|STARTED|Overall Study||9
5246865|NCT00814502|12897938|P1|STARTED|Overall Study||8
5246866|NCT00814489|12897951|P3|NOT COMPLETED|Overall Study||1
5246867|NCT00814489|12897952|P2|NOT COMPLETED|Overall Study||0
5246868|NCT00814489|12897953|P1|NOT COMPLETED|Overall Study||2
5246869|NCT00814489|12897951|P3|COMPLETED|Overall Study||7
5246870|NCT00814489|12897952|P2|COMPLETED|Overall Study||17
5246871|NCT00814489|12897953|P1|COMPLETED|Overall Study||13
5246872|NCT00814489|12897951|P3|STARTED|Overall Study||8
5246873|NCT00814489|12897952|P2|STARTED|Overall Study||17
5246874|NCT00814489|12897953|P1|STARTED|Overall Study||15
5246875|NCT00814463|12897985|P1|NOT COMPLETED|Overall Study||1
5246876|NCT00814463|12897985|P1|COMPLETED|Overall Study||0
5246877|NCT00814463|12897985|P1|STARTED|Overall Study||1
5246878|NCT00814346|12897998|P2|NOT COMPLETED|Open Phase (17 Months)||0
5246879|NCT00814346|12897999|P1|NOT COMPLETED|Open Phase (17 Months)||10
5246880|NCT00814346|12897998|P2|COMPLETED|Open Phase (17 Months)||0
5246881|NCT00814346|12897999|P1|COMPLETED|Open Phase (17 Months)||31
5246882|NCT00814346|12897998|P2|AD|Open Phase (17 Months)||0
5246883|NCT00814346|12897999|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
5246884|NCT00814346|12897998|P2|MC|Open Phase (17 Months)||0
5246885|NCT00814346|12897999|P1|MC|Open Phase (17 Months)||20
5246886|NCT00814346|12897998|P2|CNE|Open Phase (17 Months)||0
5246887|NCT00814346|12897999|P1|CNE|Open Phase (17 Months)||21
5246888|NCT00814346|12897998|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
5246889|NCT00814346|12897999|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
5246890|NCT00814346|12897998|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
5246891|NCT00814346|12897999|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
5246892|NCT00814346|12897998|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
5246893|NCT00814346|12897999|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
5246894|NCT00814346|12897998|P2|AD|Double-blind Phase (4 Weeks)||2
5246895|NCT00814346|12897999|P1|AD|Double-blind Phase (4 Weeks)||3
5246896|NCT00814346|12897998|P2|MC|Double-blind Phase (4 Weeks)||11
5246897|NCT00814346|12897999|P1|MC|Double-blind Phase (4 Weeks)||10
5246898|NCT00814346|12897998|P2|CNE|Double-blind Phase (4 Weeks)||13
5246899|NCT00814346|12897999|P1|CNE|Double-blind Phase (4 Weeks)||10
5246900|NCT00814346|12897998|P2|STARTED|Double-blind Phase (4 Weeks)||26
5246901|NCT00814346|12897999|P1|STARTED|Double-blind Phase (4 Weeks)||23
5246902|NCT00814333|12898065|P2|NOT COMPLETED|Treatment Period||0
5246903|NCT00814333|12898066|P1|NOT COMPLETED|Treatment Period||0
5246904|NCT00814333|12898065|P2|COMPLETED|Treatment Period||0
5246905|NCT00814333|12898066|P1|COMPLETED|Treatment Period||0
5246906|NCT00814333|12898065|P2|STARTED|Treatment Period||0
5246907|NCT00814333|12898066|P1|STARTED|Treatment Period||0
5246908|NCT00814333|12898065|P2|NOT COMPLETED|Enrollment||0
5246909|NCT00814333|12898066|P1|NOT COMPLETED|Enrollment||1
5246910|NCT00814333|12898065|P2|COMPLETED|Enrollment||0
5246911|NCT00814333|12898066|P1|COMPLETED|Enrollment||0
5246912|NCT00814333|12898065|P2|STARTED|Enrollment||0
5246913|NCT00814333|12898066|P1|STARTED|Enrollment||1
5246914|NCT00814320|12898074|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
5246915|NCT00814320|12898075|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
5246916|NCT00814320|12898074|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
5246917|NCT00814320|12898075|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
5246918|NCT00814320|12898074|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
5246919|NCT00814320|12898075|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
5246920|NCT00814320|12898074|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
5246921|NCT00814320|12898075|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
5246922|NCT00814320|12898074|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
5246923|NCT00814320|12898075|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
5246924|NCT00814320|12898074|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
5246925|NCT00814320|12898075|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
5246926|NCT00814320|12898074|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
5246927|NCT00814320|12898075|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
5246928|NCT00814320|12898074|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
5246929|NCT00814320|12898075|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
5246930|NCT00814320|12898074|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
5246931|NCT00814320|12898075|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
5246932|NCT00814320|12898074|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
5246933|NCT00814320|12898075|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
5246934|NCT00814320|12898074|P2|COMPLETED|Epoch 1 (IV Treatment)||71
5246935|NCT00814320|12898075|P1|COMPLETED|Epoch 1 (IV Treatment)||13
5246936|NCT00814320|12898074|P2|STARTED|Epoch 1 (IV Treatment)||73
5246937|NCT00814320|12898075|P1|STARTED|Epoch 1 (IV Treatment)||14
5246938|NCT00814307|12898207|P4|NOT COMPLETED|Overall Study||10
5246939|NCT00814307|12898208|P3|NOT COMPLETED|Overall Study||7
5246940|NCT00814307|12898209|P2|NOT COMPLETED|Overall Study||27
5246941|NCT00814307|12898210|P1|NOT COMPLETED|Overall Study||12
5246942|NCT00814307|12898207|P4|COMPLETED|Overall Study||51
5246943|NCT00814307|12898208|P3|COMPLETED|Overall Study||54
5246944|NCT00814307|12898209|P2|COMPLETED|Overall Study||218
5246945|NCT00814307|12898210|P1|COMPLETED|Overall Study||232
5246946|NCT00814307|12898207|P4|Treated|Overall Study||61
5246947|NCT00814307|12898208|P3|Treated|Overall Study||61
5246948|NCT00814307|12898209|P2|Treated|Overall Study||245
5246949|NCT00814307|12898210|P1|Treated|Overall Study||243
5246950|NCT00814307|12898207|P4|STARTED|Overall Study||61
5246951|NCT00814307|12898208|P3|STARTED|Overall Study||61
5246952|NCT00814307|12898209|P2|STARTED|Overall Study||245
5246953|NCT00814307|12898210|P1|STARTED|Overall Study||244
5246954|NCT00814255|12898375|P3|NOT COMPLETED|Overall Study||1
5246955|NCT00814255|12898376|P2|NOT COMPLETED|Overall Study||0
5246956|NCT00814255|12898377|P1|NOT COMPLETED|Overall Study||1
5246957|NCT00814255|12898375|P3|COMPLETED|Overall Study||7
5246958|NCT00814255|12898376|P2|COMPLETED|Overall Study||7
5246959|NCT00814255|12898377|P1|COMPLETED|Overall Study||7
5246960|NCT00814255|12898375|P3|STARTED|Overall Study||8
5246961|NCT00814255|12898376|P2|STARTED|Overall Study||7
5246962|NCT00814255|12898377|P1|STARTED|Overall Study||8
5246963|NCT00814177|12898399|P2|NOT COMPLETED|Overall Study||0
5246964|NCT00814177|12898400|P1|NOT COMPLETED|Overall Study||0
5246965|NCT00814177|12898399|P2|COMPLETED|Overall Study||80
5246966|NCT00814177|12898400|P1|COMPLETED|Overall Study||80
5246967|NCT00814177|12898399|P2|STARTED|Overall Study||80
5246968|NCT00814177|12898400|P1|STARTED|Overall Study||80
5246969|NCT00814164|12898406|P1|NOT COMPLETED|Overall Study||19
5246970|NCT00814164|12898406|P1|COMPLETED|Overall Study||2
5246971|NCT00814164|12898406|P1|STARTED|Overall Study||21
5246972|NCT00814138|12898419|P2|NOT COMPLETED|Overall Study||7
5246973|NCT00814138|12898420|P1|NOT COMPLETED|Overall Study||1
5246974|NCT00814138|12898419|P2|COMPLETED|Overall Study||18
5246975|NCT00814138|12898420|P1|COMPLETED|Overall Study||24
5246976|NCT00814138|12898419|P2|STARTED|Overall Study||25
5246977|NCT00814138|12898420|P1|STARTED|Overall Study||25
5246978|NCT00813995|12898440|P2|NOT COMPLETED|Overall Study||16
5246979|NCT00813995|12898441|P1|NOT COMPLETED|Overall Study||23
5246980|NCT00813995|12898440|P2|COMPLETED|Overall Study||182
5246981|NCT00813995|12898441|P1|COMPLETED|Overall Study||174
5246982|NCT00813995|12898440|P2|STARTED|Overall Study||198
5246983|NCT00813995|12898441|P1|STARTED|Overall Study||197
5246984|NCT00813982|12898455|P1|NOT COMPLETED|Overall Study||0
5246985|NCT00813982|12898455|P1|COMPLETED|Overall Study||59
5246986|NCT00813982|12898455|P1|STARTED|Overall Study||59
5246987|NCT00813943|12898464|P3|NOT COMPLETED|Overall Study||3
5246988|NCT00813943|12898465|P2|NOT COMPLETED|Overall Study||5
5246989|NCT00813943|12898466|P1|NOT COMPLETED|Overall Study||5
5246990|NCT00813943|12898464|P3|COMPLETED|Overall Study||86
5246991|NCT00813943|12898465|P2|COMPLETED|Overall Study||83
5246992|NCT00813943|12898466|P1|COMPLETED|Overall Study||83
5246993|NCT00813943|12898464|P3|STARTED|Overall Study||89
5246994|NCT00813943|12898465|P2|STARTED|Overall Study||88
5246995|NCT00813943|12898466|P1|STARTED|Overall Study||88
5246996|NCT00813917|12898496|P2|NOT COMPLETED|Overall Study||6
5246997|NCT00813917|12898497|P1|NOT COMPLETED|Overall Study||6
5246998|NCT00813917|12898496|P2|COMPLETED|Overall Study||32
5246999|NCT00813917|12898497|P1|COMPLETED|Overall Study||32
5247000|NCT00813917|12898496|P2|STARTED|Overall Study||38
5247001|NCT00813917|12898497|P1|STARTED|Overall Study||38
5247002|NCT00813904|12898503|P1|NOT COMPLETED|Overall Study||1
5247003|NCT00813904|12898503|P1|COMPLETED|Overall Study||30
5247004|NCT00813904|12898503|P1|STARTED|Overall Study||31
5247005|NCT00813865|12898509|P1|NOT COMPLETED|Overall Study||7
5247006|NCT00813865|12898509|P1|COMPLETED|Overall Study||1
5247007|NCT00813865|12898509|P1|Pharmacodynamic (PD) Population|Overall Study||8
5247008|NCT00813865|12898509|P1|Safety Population|Overall Study||8
5247009|NCT00813865|12898509|P1|STARTED|Overall Study||8
5247010|NCT00813813|12898517|P2|NOT COMPLETED|Overall Study||9
5247011|NCT00813813|12898518|P1|NOT COMPLETED|Overall Study||3
5247012|NCT00813813|12898517|P2|COMPLETED|Overall Study||16
5247013|NCT00813813|12898518|P1|COMPLETED|Overall Study||4
5247014|NCT00813813|12898517|P2|STARTED|Overall Study||25
5247015|NCT00813813|12898518|P1|STARTED|Overall Study||7
5247016|NCT00813800|12898534|P1|NOT COMPLETED|Overall Study||6
5247017|NCT00813800|12898534|P1|COMPLETED|Overall Study||5
5247018|NCT00813800|12898534|P1|STARTED|Overall Study||11
5247019|NCT00813761|12898542|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
5247020|NCT00813761|12898543|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
5247021|NCT00813761|12898544|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
5247022|NCT00813761|12898545|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
5247023|NCT00813761|12898542|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
5247024|NCT00813761|12898543|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
5247025|NCT00813761|12898544|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
5247026|NCT00813761|12898545|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
5247027|NCT00813761|12898542|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
5247028|NCT00813761|12898543|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
5247029|NCT00813761|12898544|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
5247030|NCT00813761|12898545|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
5247031|NCT00813761|12898542|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
5247032|NCT00813761|12898543|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
5247033|NCT00813761|12898544|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
5247034|NCT00813761|12898545|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
5247035|NCT00813761|12898542|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
5247036|NCT00813761|12898543|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
5247037|NCT00813761|12898544|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
5247038|NCT00813761|12898545|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
5247039|NCT00813761|12898542|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
5247040|NCT00813761|12898543|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
5247041|NCT00813761|12898544|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
5247042|NCT00813761|12898545|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
5247043|NCT00813748|12898595|P2|NOT COMPLETED|Skin Test Substudy||1
5247044|NCT00813748|12898596|P1|NOT COMPLETED|Skin Test Substudy||0
5247045|NCT00813748|12898595|P2|COMPLETED|Skin Test Substudy||7
5247046|NCT00813748|12898596|P1|COMPLETED|Skin Test Substudy||3
5247047|NCT00813748|12898595|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
5247048|NCT00813748|12898596|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
5247049|NCT00813748|12898595|P2|NOT COMPLETED|Main Observational Study||0
5247050|NCT00813748|12898596|P1|NOT COMPLETED|Main Observational Study||0
5247051|NCT00813748|12898595|P2|COMPLETED|Main Observational Study||88
5247052|NCT00813748|12898596|P1|COMPLETED|Main Observational Study||30
5247053|NCT00813748|12898595|P2|STARTED|Main Observational Study||88
5247054|NCT00813748|12898596|P1|STARTED|Main Observational Study||30
5247055|NCT00813709|12898625|P6|NOT COMPLETED|Open Label Period||11
5247056|NCT00813709|12898626|P5|NOT COMPLETED|Open Label Period||10
5247057|NCT00813709|12898627|P4|NOT COMPLETED|Open Label Period||20
5247058|NCT00813709|12898628|P3|NOT COMPLETED|Open Label Period||0
5247059|NCT00813709|12898629|P2|NOT COMPLETED|Open Label Period||0
5247060|NCT00813709|12898630|P1|NOT COMPLETED|Open Label Period||0
5247061|NCT00813709|12898625|P6|COMPLETED|Open Label Period||35
5247062|NCT00813709|12898626|P5|COMPLETED|Open Label Period||41
5247063|NCT00813709|12898627|P4|COMPLETED|Open Label Period||38
5247064|NCT00813709|12898628|P3|COMPLETED|Open Label Period||0
5247065|NCT00813709|12898629|P2|COMPLETED|Open Label Period||0
5247066|NCT00813709|12898630|P1|COMPLETED|Open Label Period||0
5247067|NCT00813709|12898625|P6|Treated|Open Label Period||45
5247068|NCT00813709|12898626|P5|Treated|Open Label Period||51
5247069|NCT00813709|12898627|P4|Treated|Open Label Period||57
5247070|NCT00813709|12898628|P3|Treated|Open Label Period||0
5247071|NCT00813709|12898629|P2|Treated|Open Label Period||0
5247072|NCT00813709|12898630|P1|Treated|Open Label Period||0
5247073|NCT00813709|12898625|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
5247074|NCT00813709|12898626|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
5247075|NCT00813709|12898627|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
5247076|NCT00813709|12898628|P3|STARTED|Open Label Period||0
5247077|NCT00813709|12898629|P2|STARTED|Open Label Period||0
5247078|NCT00813709|12898630|P1|STARTED|Open Label Period||0
5247079|NCT00813709|12898625|P6|NOT COMPLETED|Double Blind Period||0
5247080|NCT00813709|12898626|P5|NOT COMPLETED|Double Blind Period||0
5247081|NCT00813709|12898627|P4|NOT COMPLETED|Double Blind Period||0
5247082|NCT00813709|12898628|P3|NOT COMPLETED|Double Blind Period||31
5247083|NCT00813709|12898629|P2|NOT COMPLETED|Double Blind Period||41
5247084|NCT00813709|12898630|P1|NOT COMPLETED|Double Blind Period||31
5247085|NCT00813709|12898625|P6|COMPLETED|Double Blind Period||0
5247086|NCT00813709|12898626|P5|COMPLETED|Double Blind Period||0
5247087|NCT00813709|12898627|P4|COMPLETED|Double Blind Period||0
5247088|NCT00813709|12898628|P3|COMPLETED|Double Blind Period||68
5247089|NCT00813709|12898629|P2|COMPLETED|Double Blind Period||76
5247090|NCT00813709|12898630|P1|COMPLETED|Double Blind Period||53
5247091|NCT00813709|12898625|P6|Treated|Double Blind Period||0
5247092|NCT00813709|12898626|P5|Treated|Double Blind Period||0
5247093|NCT00813709|12898627|P4|Treated|Double Blind Period||0
5247094|NCT00813709|12898628|P3|Treated|Double Blind Period||98
5247095|NCT00813709|12898629|P2|Treated|Double Blind Period||114
5247096|NCT00813709|12898630|P1|Treated|Double Blind Period||83
5247097|NCT00813709|12898625|P6|STARTED|Double Blind Period||0
5247098|NCT00813709|12898626|P5|STARTED|Double Blind Period||0
5247099|NCT00813709|12898627|P4|STARTED|Double Blind Period||0
5247100|NCT00813709|12898628|P3|STARTED|Double Blind Period||99
5247101|NCT00813709|12898629|P2|STARTED|Double Blind Period||117
5247102|NCT00813709|12898630|P1|STARTED|Double Blind Period||84
5247103|NCT00813592|12898710|P1|NOT COMPLETED|Overall Study||2
5247104|NCT00813592|12898710|P1|COMPLETED|Overall Study||0
5247105|NCT00813592|12898710|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
5247106|NCT00813592|12898710|P1|Treated|Overall Study|Two patients were treated.|2
5247107|NCT00813592|12898710|P1|STARTED|Overall Study||2
5247108|NCT00813488|12898719|P2|NOT COMPLETED|Open-label Extension||7
5247109|NCT00813488|12898720|P1|NOT COMPLETED|Open-label Extension||12
5247110|NCT00813488|12898719|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
5247111|NCT00813488|12898720|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
5247112|NCT00813488|12898719|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
5247113|NCT00813488|12898720|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
5247114|NCT00813488|12898719|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
5247115|NCT00813488|12898720|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
5247116|NCT00813488|12898719|P2|COMPLETED|Double-blind Treatment Period 2||65
5247117|NCT00813488|12898720|P1|COMPLETED|Double-blind Treatment Period 2||66
5247118|NCT00813488|12898719|P2|STARTED|Double-blind Treatment Period 2||66
5247119|NCT00813488|12898720|P1|STARTED|Double-blind Treatment Period 2||71
5247120|NCT00813488|12898719|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
5247121|NCT00813488|12898720|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
5247122|NCT00813488|12898719|P2|COMPLETED|Double-blind Treatment Period 1||66
5247123|NCT00813488|12898720|P1|COMPLETED|Double-blind Treatment Period 1||71
5247124|NCT00813488|12898719|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
5247125|NCT00813488|12898720|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
5247126|NCT00813488|12898719|P2|NOT COMPLETED|Titration Period 2||10
5247127|NCT00813488|12898720|P1|NOT COMPLETED|Titration Period 2||16
5247128|NCT00813488|12898719|P2|COMPLETED|Titration Period 2||79
5247129|NCT00813488|12898720|P1|COMPLETED|Titration Period 2||64
5247130|NCT00813488|12898719|P2|STARTED|Titration Period 2||89
5247131|NCT00813488|12898720|P1|STARTED|Titration Period 2||80
5247132|NCT00813488|12898719|P2|NOT COMPLETED|Titration Period 1||17
5247133|NCT00813488|12898720|P1|NOT COMPLETED|Titration Period 1||27
5247134|NCT00813488|12898719|P2|COMPLETED|Titration Period 1||89
5247135|NCT00813488|12898720|P1|COMPLETED|Titration Period 1||80
5247136|NCT00813488|12898719|P2|STARTED|Titration Period 1||106
5247137|NCT00813488|12898720|P1|STARTED|Titration Period 1||107
5247138|NCT00813319|12898818|P2|NOT COMPLETED|Overall Study||0
5247139|NCT00813319|12898819|P1|NOT COMPLETED|Overall Study||0
5247140|NCT00813319|12898818|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
5247141|NCT00813319|12898819|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
5247142|NCT00813319|12898818|P2|STARTED|Overall Study||108
5247143|NCT00813319|12898819|P1|STARTED|Overall Study||108
5247144|NCT00813293|12898831|P2|NOT COMPLETED|Overall Study||1
5247145|NCT00813293|12898832|P1|NOT COMPLETED|Overall Study||1
5247146|NCT00813293|12898831|P2|COMPLETED|Overall Study||9
5247147|NCT00813293|12898832|P1|COMPLETED|Overall Study||9
5247148|NCT00813293|12898831|P2|Evaluable RFA|Overall Study||8
5247149|NCT00813293|12898832|P1|Evaluable RFA|Overall Study||7
5247150|NCT00813293|12898831|P2|Started Treatment|Overall Study||10
5247151|NCT00813293|12898832|P1|Started Treatment|Overall Study||9
5247152|NCT00813293|12898831|P2|STARTED|Overall Study||10
5247153|NCT00813293|12898832|P1|STARTED|Overall Study||10
5247154|NCT00813176|12898852|P2|NOT COMPLETED|Overall Study||0
5247155|NCT00813176|12898853|P1|NOT COMPLETED|Overall Study||0
5247156|NCT00813176|12898852|P2|COMPLETED|Overall Study||25
5247157|NCT00813176|12898853|P1|COMPLETED|Overall Study||25
5247158|NCT00813176|12898852|P2|STARTED|Overall Study||25
5247159|NCT00813176|12898853|P1|STARTED|Overall Study||25
5247160|NCT00813150|12898871|P2|NOT COMPLETED|Long Term Follow-up||31
5247161|NCT00813150|12898872|P1|NOT COMPLETED|Long Term Follow-up||24
5247162|NCT00813150|12898871|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
5247163|NCT00813150|12898872|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
5247164|NCT00813150|12898871|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
5247165|NCT00813150|12898872|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
5247166|NCT00813150|12898871|P2|NOT COMPLETED|Treatment Period||32
5247167|NCT00813150|12898872|P1|NOT COMPLETED|Treatment Period||32
5247168|NCT00813150|12898871|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
5247169|NCT00813150|12898872|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
5247170|NCT00813150|12898871|P2|Intent-to-treat Participants|Treatment Period||47
5247171|NCT00813150|12898872|P1|Intent-to-treat Participants|Treatment Period||43
5247172|NCT00813150|12898871|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
5247173|NCT00813150|12898872|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
5247174|NCT00813111|12898886|P2|NOT COMPLETED|Overall Study||0
5247175|NCT00813111|12898887|P1|NOT COMPLETED|Overall Study||2
5247176|NCT00813111|12898886|P2|COMPLETED|Overall Study||70
5247177|NCT00813111|12898887|P1|COMPLETED|Overall Study||64
5247178|NCT00813111|12898886|P2|STARTED|Overall Study||70
5247179|NCT00813111|12898887|P1|STARTED|Overall Study||66
5247180|NCT00813098|12898896|P3|NOT COMPLETED|Overall Study||2
5247181|NCT00813098|12898897|P2|NOT COMPLETED|Overall Study||8
5247182|NCT00813098|12898898|P1|NOT COMPLETED|Overall Study||3
5247183|NCT00813098|12898896|P3|COMPLETED|Overall Study||50
5247184|NCT00813098|12898897|P2|COMPLETED|Overall Study||46
5247185|NCT00813098|12898898|P1|COMPLETED|Overall Study||46
5247186|NCT00813098|12898896|P3|STARTED|Overall Study||52
5247187|NCT00813098|12898897|P2|STARTED|Overall Study||54
5247188|NCT00813098|12898898|P1|STARTED|Overall Study||49
5247189|NCT00812981|12898923|P2|NOT COMPLETED|Overall Study||1
5247190|NCT00812981|12898924|P1|NOT COMPLETED|Overall Study||0
5247191|NCT00812981|12898923|P2|COMPLETED|Overall Study||159
5247192|NCT00812981|12898924|P1|COMPLETED|Overall Study||160
5247193|NCT00812981|12898923|P2|STARTED|Overall Study||160
5247194|NCT00812981|12898924|P1|STARTED|Overall Study||160
5247195|NCT00812968|12898962|P1|NOT COMPLETED|Overall Study||11
5247196|NCT00812968|12898962|P1|COMPLETED|Overall Study||0
5247197|NCT00812968|12898962|P1|STARTED|Overall Study||11
5247198|NCT00812955|12898997|P4|NOT COMPLETED|Overall Study||8
5247199|NCT00812955|12898998|P3|NOT COMPLETED|Overall Study||6
5247200|NCT00812955|12898999|P2|NOT COMPLETED|Overall Study||7
5247201|NCT00812955|12899000|P1|NOT COMPLETED|Overall Study||10
5247202|NCT00812955|12898997|P4|COMPLETED|Overall Study||110
5247203|NCT00812955|12898998|P3|COMPLETED|Overall Study||113
5247204|NCT00812955|12898999|P2|COMPLETED|Overall Study||111
5247205|NCT00812955|12899000|P1|COMPLETED|Overall Study||109
5247206|NCT00812955|12898997|P4|STARTED|Overall Study||118
5247207|NCT00812955|12898998|P3|STARTED|Overall Study||119
5247208|NCT00812955|12898999|P2|STARTED|Overall Study||118
5247209|NCT00812955|12899000|P1|STARTED|Overall Study||119
5247210|NCT00812929|12899020|P10|NOT COMPLETED|Treatment Period 5||0
5247211|NCT00812929|12899021|P9|NOT COMPLETED|Treatment Period 5||0
5247212|NCT00812929|12899022|P8|NOT COMPLETED|Treatment Period 5||0
5247213|NCT00812929|12899023|P7|NOT COMPLETED|Treatment Period 5||0
5247214|NCT00812929|12899024|P6|NOT COMPLETED|Treatment Period 5||0
5247215|NCT00812929|12899025|P5|NOT COMPLETED|Treatment Period 5||0
5247216|NCT00812929|12899026|P4|NOT COMPLETED|Treatment Period 5||0
5247217|NCT00812929|12899027|P3|NOT COMPLETED|Treatment Period 5||0
5247218|NCT00812929|12899028|P2|NOT COMPLETED|Treatment Period 5||0
5247219|NCT00812929|12899029|P1|NOT COMPLETED|Treatment Period 5||0
5247220|NCT00812929|12899020|P10|COMPLETED|Treatment Period 5||4
5247221|NCT00812929|12899021|P9|COMPLETED|Treatment Period 5||4
5247222|NCT00812929|12899022|P8|COMPLETED|Treatment Period 5||5
5247223|NCT00812929|12899023|P7|COMPLETED|Treatment Period 5||5
5247224|NCT00812929|12899024|P6|COMPLETED|Treatment Period 5||4
5247225|NCT00812929|12899025|P5|COMPLETED|Treatment Period 5||5
5247226|NCT00812929|12899026|P4|COMPLETED|Treatment Period 5||4
5247227|NCT00812929|12899027|P3|COMPLETED|Treatment Period 5||4
5247228|NCT00812929|12899028|P2|COMPLETED|Treatment Period 5||4
5247229|NCT00812929|12899029|P1|COMPLETED|Treatment Period 5||5
5247230|NCT00812929|12899020|P10|STARTED|Treatment Period 5||4
5247231|NCT00812929|12899021|P9|STARTED|Treatment Period 5||4
5247232|NCT00812929|12899022|P8|STARTED|Treatment Period 5||5
5247233|NCT00812929|12899023|P7|STARTED|Treatment Period 5||5
5247234|NCT00812929|12899024|P6|STARTED|Treatment Period 5||4
5247235|NCT00812929|12899025|P5|STARTED|Treatment Period 5||5
5247236|NCT00812929|12899026|P4|STARTED|Treatment Period 5||4
5247237|NCT00812929|12899027|P3|STARTED|Treatment Period 5||4
5247238|NCT00812929|12899028|P2|STARTED|Treatment Period 5||4
5247239|NCT00812929|12899029|P1|STARTED|Treatment Period 5||5
5247240|NCT00812929|12899020|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247241|NCT00812929|12899021|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247242|NCT00812929|12899022|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247243|NCT00812929|12899023|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247244|NCT00812929|12899024|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247245|NCT00812929|12899025|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247246|NCT00812929|12899026|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247247|NCT00812929|12899027|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247248|NCT00812929|12899028|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247249|NCT00812929|12899029|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
5247250|NCT00812929|12899020|P10|COMPLETED|Washout Period 4 (7 Days)||4
5247251|NCT00812929|12899021|P9|COMPLETED|Washout Period 4 (7 Days)||4
5247252|NCT00812929|12899022|P8|COMPLETED|Washout Period 4 (7 Days)||5
5247253|NCT00812929|12899023|P7|COMPLETED|Washout Period 4 (7 Days)||5
5247254|NCT00812929|12899024|P6|COMPLETED|Washout Period 4 (7 Days)||4
5247255|NCT00812929|12899025|P5|COMPLETED|Washout Period 4 (7 Days)||5
5247256|NCT00812929|12899026|P4|COMPLETED|Washout Period 4 (7 Days)||4
5247257|NCT00812929|12899027|P3|COMPLETED|Washout Period 4 (7 Days)||4
5247258|NCT00812929|12899028|P2|COMPLETED|Washout Period 4 (7 Days)||4
5247259|NCT00812929|12899029|P1|COMPLETED|Washout Period 4 (7 Days)||5
5247260|NCT00812929|12899020|P10|STARTED|Washout Period 4 (7 Days)||4
5247261|NCT00812929|12899021|P9|STARTED|Washout Period 4 (7 Days)||4
5247262|NCT00812929|12899022|P8|STARTED|Washout Period 4 (7 Days)||5
5247263|NCT00812929|12899023|P7|STARTED|Washout Period 4 (7 Days)||5
5247264|NCT00812929|12899024|P6|STARTED|Washout Period 4 (7 Days)||4
5247265|NCT00812929|12899025|P5|STARTED|Washout Period 4 (7 Days)||5
5247266|NCT00812929|12899026|P4|STARTED|Washout Period 4 (7 Days)||4
5247267|NCT00812929|12899027|P3|STARTED|Washout Period 4 (7 Days)||4
5247268|NCT00812929|12899028|P2|STARTED|Washout Period 4 (7 Days)||4
5247269|NCT00812929|12899029|P1|STARTED|Washout Period 4 (7 Days)||5
5247270|NCT00812929|12899020|P10|NOT COMPLETED|Treatment Period 4||0
5247271|NCT00812929|12899021|P9|NOT COMPLETED|Treatment Period 4||0
5247272|NCT00812929|12899022|P8|NOT COMPLETED|Treatment Period 4||0
5247273|NCT00812929|12899023|P7|NOT COMPLETED|Treatment Period 4||0
5247274|NCT00812929|12899024|P6|NOT COMPLETED|Treatment Period 4||0
5247275|NCT00812929|12899025|P5|NOT COMPLETED|Treatment Period 4||0
5247276|NCT00812929|12899026|P4|NOT COMPLETED|Treatment Period 4||0
5247277|NCT00812929|12899027|P3|NOT COMPLETED|Treatment Period 4||0
5247278|NCT00812929|12899028|P2|NOT COMPLETED|Treatment Period 4||0
5247279|NCT00812929|12899029|P1|NOT COMPLETED|Treatment Period 4||0
5247280|NCT00812929|12899020|P10|COMPLETED|Treatment Period 4||4
5247281|NCT00812929|12899021|P9|COMPLETED|Treatment Period 4||4
5247282|NCT00812929|12899022|P8|COMPLETED|Treatment Period 4||5
5247283|NCT00812929|12899023|P7|COMPLETED|Treatment Period 4||5
5247284|NCT00812929|12899024|P6|COMPLETED|Treatment Period 4||4
5247285|NCT00812929|12899025|P5|COMPLETED|Treatment Period 4||5
5247286|NCT00812929|12899026|P4|COMPLETED|Treatment Period 4||4
5247287|NCT00812929|12899027|P3|COMPLETED|Treatment Period 4||4
5247288|NCT00812929|12899028|P2|COMPLETED|Treatment Period 4||4
5247289|NCT00812929|12899029|P1|COMPLETED|Treatment Period 4||5
5247290|NCT00812929|12899020|P10|STARTED|Treatment Period 4||4
5247291|NCT00812929|12899021|P9|STARTED|Treatment Period 4||4
5247292|NCT00812929|12899022|P8|STARTED|Treatment Period 4||5
5247293|NCT00812929|12899023|P7|STARTED|Treatment Period 4||5
5247294|NCT00812929|12899024|P6|STARTED|Treatment Period 4||4
5247295|NCT00812929|12899025|P5|STARTED|Treatment Period 4||5
5247296|NCT00812929|12899026|P4|STARTED|Treatment Period 4||4
5247297|NCT00812929|12899027|P3|STARTED|Treatment Period 4||4
5247298|NCT00812929|12899028|P2|STARTED|Treatment Period 4||4
5247299|NCT00812929|12899029|P1|STARTED|Treatment Period 4||5
5247300|NCT00812929|12899020|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247301|NCT00812929|12899021|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247302|NCT00812929|12899022|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247303|NCT00812929|12899023|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247304|NCT00812929|12899024|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
5247305|NCT00812929|12899025|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247306|NCT00812929|12899026|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247307|NCT00812929|12899027|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247308|NCT00812929|12899028|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247309|NCT00812929|12899029|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
5247310|NCT00812929|12899020|P10|COMPLETED|Washout Period 3 (7 Days)||4
5247311|NCT00812929|12899021|P9|COMPLETED|Washout Period 3 (7 Days)||4
5247312|NCT00812929|12899022|P8|COMPLETED|Washout Period 3 (7 Days)||5
5247313|NCT00812929|12899023|P7|COMPLETED|Washout Period 3 (7 Days)||5
5247314|NCT00812929|12899024|P6|COMPLETED|Washout Period 3 (7 Days)||4
5247315|NCT00812929|12899025|P5|COMPLETED|Washout Period 3 (7 Days)||5
5247316|NCT00812929|12899026|P4|COMPLETED|Washout Period 3 (7 Days)||4
5247317|NCT00812929|12899027|P3|COMPLETED|Washout Period 3 (7 Days)||4
5247318|NCT00812929|12899028|P2|COMPLETED|Washout Period 3 (7 Days)||4
5247319|NCT00812929|12899029|P1|COMPLETED|Washout Period 3 (7 Days)||5
5247320|NCT00812929|12899020|P10|STARTED|Washout Period 3 (7 Days)||4
5247321|NCT00812929|12899021|P9|STARTED|Washout Period 3 (7 Days)||4
5247322|NCT00812929|12899022|P8|STARTED|Washout Period 3 (7 Days)||5
5247323|NCT00812929|12899023|P7|STARTED|Washout Period 3 (7 Days)||5
5247324|NCT00812929|12899024|P6|STARTED|Washout Period 3 (7 Days)||5
5247325|NCT00812929|12899025|P5|STARTED|Washout Period 3 (7 Days)||5
5247326|NCT00812929|12899026|P4|STARTED|Washout Period 3 (7 Days)||4
5247327|NCT00812929|12899027|P3|STARTED|Washout Period 3 (7 Days)||4
5247328|NCT00812929|12899028|P2|STARTED|Washout Period 3 (7 Days)||4
5247329|NCT00812929|12899029|P1|STARTED|Washout Period 3 (7 Days)||5
5247330|NCT00812929|12899020|P10|NOT COMPLETED|Treatment Period 3||0
5247331|NCT00812929|12899021|P9|NOT COMPLETED|Treatment Period 3||0
5247332|NCT00812929|12899022|P8|NOT COMPLETED|Treatment Period 3||0
5247333|NCT00812929|12899023|P7|NOT COMPLETED|Treatment Period 3||0
5247334|NCT00812929|12899024|P6|NOT COMPLETED|Treatment Period 3||0
5247335|NCT00812929|12899025|P5|NOT COMPLETED|Treatment Period 3||0
5247336|NCT00812929|12899026|P4|NOT COMPLETED|Treatment Period 3||0
5247337|NCT00812929|12899027|P3|NOT COMPLETED|Treatment Period 3||0
5247338|NCT00812929|12899028|P2|NOT COMPLETED|Treatment Period 3||0
5247339|NCT00812929|12899029|P1|NOT COMPLETED|Treatment Period 3||0
5247340|NCT00812929|12899020|P10|COMPLETED|Treatment Period 3||4
5247341|NCT00812929|12899021|P9|COMPLETED|Treatment Period 3||4
5247342|NCT00812929|12899022|P8|COMPLETED|Treatment Period 3||5
5247343|NCT00812929|12899023|P7|COMPLETED|Treatment Period 3||5
5247344|NCT00812929|12899024|P6|COMPLETED|Treatment Period 3||5
5247345|NCT00812929|12899025|P5|COMPLETED|Treatment Period 3||5
5247346|NCT00812929|12899026|P4|COMPLETED|Treatment Period 3||4
5247347|NCT00812929|12899027|P3|COMPLETED|Treatment Period 3||4
5247348|NCT00812929|12899028|P2|COMPLETED|Treatment Period 3||4
5247349|NCT00812929|12899029|P1|COMPLETED|Treatment Period 3||5
5247350|NCT00812929|12899020|P10|STARTED|Treatment Period 3||4
5247351|NCT00812929|12899021|P9|STARTED|Treatment Period 3||4
5247352|NCT00812929|12899022|P8|STARTED|Treatment Period 3||5
5247353|NCT00812929|12899023|P7|STARTED|Treatment Period 3||5
5247354|NCT00812929|12899024|P6|STARTED|Treatment Period 3||5
5247355|NCT00812929|12899025|P5|STARTED|Treatment Period 3||5
5247356|NCT00812929|12899026|P4|STARTED|Treatment Period 3||4
5247357|NCT00812929|12899027|P3|STARTED|Treatment Period 3||4
5247358|NCT00812929|12899028|P2|STARTED|Treatment Period 3||4
5247359|NCT00812929|12899029|P1|STARTED|Treatment Period 3||5
5247360|NCT00812929|12899020|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
5247361|NCT00812929|12899021|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247362|NCT00812929|12899022|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247363|NCT00812929|12899023|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247364|NCT00812929|12899024|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247365|NCT00812929|12899025|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247366|NCT00812929|12899026|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247367|NCT00812929|12899027|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247368|NCT00812929|12899028|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247369|NCT00812929|12899029|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5247370|NCT00812929|12899020|P10|COMPLETED|Washout Period 2 (7 Days)||4
5247371|NCT00812929|12899021|P9|COMPLETED|Washout Period 2 (7 Days)||4
5247372|NCT00812929|12899022|P8|COMPLETED|Washout Period 2 (7 Days)||5
5247373|NCT00812929|12899023|P7|COMPLETED|Washout Period 2 (7 Days)||5
5247374|NCT00812929|12899024|P6|COMPLETED|Washout Period 2 (7 Days)||5
5247375|NCT00812929|12899025|P5|COMPLETED|Washout Period 2 (7 Days)||5
5247376|NCT00812929|12899026|P4|COMPLETED|Washout Period 2 (7 Days)||4
5247377|NCT00812929|12899027|P3|COMPLETED|Washout Period 2 (7 Days)||4
5247378|NCT00812929|12899028|P2|COMPLETED|Washout Period 2 (7 Days)||4
5247379|NCT00812929|12899029|P1|COMPLETED|Washout Period 2 (7 Days)||5
5247380|NCT00812929|12899020|P10|STARTED|Washout Period 2 (7 Days)||5
5247381|NCT00812929|12899021|P9|STARTED|Washout Period 2 (7 Days)||4
5247382|NCT00812929|12899022|P8|STARTED|Washout Period 2 (7 Days)||5
5247383|NCT00812929|12899023|P7|STARTED|Washout Period 2 (7 Days)||5
5247384|NCT00812929|12899024|P6|STARTED|Washout Period 2 (7 Days)||5
5247385|NCT00812929|12899025|P5|STARTED|Washout Period 2 (7 Days)||5
5247386|NCT00812929|12899026|P4|STARTED|Washout Period 2 (7 Days)||4
5247387|NCT00812929|12899027|P3|STARTED|Washout Period 2 (7 Days)||4
5247388|NCT00812929|12899028|P2|STARTED|Washout Period 2 (7 Days)||4
5247389|NCT00812929|12899029|P1|STARTED|Washout Period 2 (7 Days)||5
5247390|NCT00812929|12899020|P10|NOT COMPLETED|Treatment Period 2||0
5247391|NCT00812929|12899021|P9|NOT COMPLETED|Treatment Period 2||0
5247392|NCT00812929|12899022|P8|NOT COMPLETED|Treatment Period 2||0
5247393|NCT00812929|12899023|P7|NOT COMPLETED|Treatment Period 2||0
5247394|NCT00812929|12899024|P6|NOT COMPLETED|Treatment Period 2||0
5247395|NCT00812929|12899025|P5|NOT COMPLETED|Treatment Period 2||0
5247396|NCT00812929|12899026|P4|NOT COMPLETED|Treatment Period 2||0
5247397|NCT00812929|12899027|P3|NOT COMPLETED|Treatment Period 2||0
5247398|NCT00812929|12899028|P2|NOT COMPLETED|Treatment Period 2||0
5247399|NCT00812929|12899029|P1|NOT COMPLETED|Treatment Period 2||0
5247400|NCT00812929|12899020|P10|COMPLETED|Treatment Period 2||5
5247401|NCT00812929|12899021|P9|COMPLETED|Treatment Period 2||4
5247402|NCT00812929|12899022|P8|COMPLETED|Treatment Period 2||5
5247403|NCT00812929|12899023|P7|COMPLETED|Treatment Period 2||5
5247404|NCT00812929|12899024|P6|COMPLETED|Treatment Period 2||5
5247405|NCT00812929|12899025|P5|COMPLETED|Treatment Period 2||5
5247406|NCT00812929|12899026|P4|COMPLETED|Treatment Period 2||4
5247407|NCT00812929|12899027|P3|COMPLETED|Treatment Period 2||4
5247408|NCT00812929|12899028|P2|COMPLETED|Treatment Period 2||4
5247409|NCT00812929|12899029|P1|COMPLETED|Treatment Period 2||5
5247410|NCT00812929|12899020|P10|STARTED|Treatment Period 2||5
5247411|NCT00812929|12899021|P9|STARTED|Treatment Period 2||4
5247412|NCT00812929|12899022|P8|STARTED|Treatment Period 2||5
5247413|NCT00812929|12899023|P7|STARTED|Treatment Period 2||5
5247414|NCT00812929|12899024|P6|STARTED|Treatment Period 2||5
5247415|NCT00812929|12899025|P5|STARTED|Treatment Period 2||5
5247416|NCT00812929|12899026|P4|STARTED|Treatment Period 2||4
5247417|NCT00812929|12899027|P3|STARTED|Treatment Period 2||4
5247418|NCT00812929|12899028|P2|STARTED|Treatment Period 2||4
5247419|NCT00812929|12899029|P1|STARTED|Treatment Period 2||5
5247420|NCT00812929|12899020|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247421|NCT00812929|12899021|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247422|NCT00812929|12899022|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247423|NCT00812929|12899023|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247424|NCT00812929|12899024|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247425|NCT00812929|12899025|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247426|NCT00812929|12899026|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247427|NCT00812929|12899027|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
5247428|NCT00812929|12899028|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247429|NCT00812929|12899029|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5247430|NCT00812929|12899020|P10|COMPLETED|Washout Period 1 (7 Days)||5
5247431|NCT00812929|12899021|P9|COMPLETED|Washout Period 1 (7 Days)||4
5247432|NCT00812929|12899022|P8|COMPLETED|Washout Period 1 (7 Days)||5
5247433|NCT00812929|12899023|P7|COMPLETED|Washout Period 1 (7 Days)||5
5247434|NCT00812929|12899024|P6|COMPLETED|Washout Period 1 (7 Days)||5
5247435|NCT00812929|12899025|P5|COMPLETED|Washout Period 1 (7 Days)||5
5247436|NCT00812929|12899026|P4|COMPLETED|Washout Period 1 (7 Days)||4
5247437|NCT00812929|12899027|P3|COMPLETED|Washout Period 1 (7 Days)||4
5247438|NCT00812929|12899028|P2|COMPLETED|Washout Period 1 (7 Days)||4
5247439|NCT00812929|12899029|P1|COMPLETED|Washout Period 1 (7 Days)||5
5247440|NCT00812929|12899020|P10|STARTED|Washout Period 1 (7 Days)||5
5247441|NCT00812929|12899021|P9|STARTED|Washout Period 1 (7 Days)||4
5247442|NCT00812929|12899022|P8|STARTED|Washout Period 1 (7 Days)||5
5247443|NCT00812929|12899023|P7|STARTED|Washout Period 1 (7 Days)||5
5247444|NCT00812929|12899024|P6|STARTED|Washout Period 1 (7 Days)||5
5247445|NCT00812929|12899025|P5|STARTED|Washout Period 1 (7 Days)||5
5247446|NCT00812929|12899026|P4|STARTED|Washout Period 1 (7 Days)||4
5247447|NCT00812929|12899027|P3|STARTED|Washout Period 1 (7 Days)||5
5247448|NCT00812929|12899028|P2|STARTED|Washout Period 1 (7 Days)||4
5247449|NCT00812929|12899029|P1|STARTED|Washout Period 1 (7 Days)||5
5247450|NCT00812929|12899020|P10|NOT COMPLETED|Treatment Period 1||0
5247451|NCT00812929|12899021|P9|NOT COMPLETED|Treatment Period 1||0
5247452|NCT00812929|12899022|P8|NOT COMPLETED|Treatment Period 1||0
5247453|NCT00812929|12899023|P7|NOT COMPLETED|Treatment Period 1||0
5247454|NCT00812929|12899024|P6|NOT COMPLETED|Treatment Period 1||0
5247455|NCT00812929|12899025|P5|NOT COMPLETED|Treatment Period 1||0
5247456|NCT00812929|12899026|P4|NOT COMPLETED|Treatment Period 1||0
5247457|NCT00812929|12899027|P3|NOT COMPLETED|Treatment Period 1||0
5247458|NCT00812929|12899028|P2|NOT COMPLETED|Treatment Period 1||0
5247459|NCT00812929|12899029|P1|NOT COMPLETED|Treatment Period 1||0
5247460|NCT00812929|12899020|P10|COMPLETED|Treatment Period 1||5
5247461|NCT00812929|12899021|P9|COMPLETED|Treatment Period 1||4
5247462|NCT00812929|12899022|P8|COMPLETED|Treatment Period 1||5
5247463|NCT00812929|12899023|P7|COMPLETED|Treatment Period 1||5
5247464|NCT00812929|12899024|P6|COMPLETED|Treatment Period 1||5
5247465|NCT00812929|12899025|P5|COMPLETED|Treatment Period 1||5
5247466|NCT00812929|12899026|P4|COMPLETED|Treatment Period 1||4
5247467|NCT00812929|12899027|P3|COMPLETED|Treatment Period 1||5
5247468|NCT00812929|12899028|P2|COMPLETED|Treatment Period 1||4
5247469|NCT00812929|12899029|P1|COMPLETED|Treatment Period 1||5
5247470|NCT00812929|12899020|P10|STARTED|Treatment Period 1||5
5247471|NCT00812929|12899021|P9|STARTED|Treatment Period 1||4
5247472|NCT00812929|12899022|P8|STARTED|Treatment Period 1||5
5247473|NCT00812929|12899023|P7|STARTED|Treatment Period 1||5
5247474|NCT00812929|12899024|P6|STARTED|Treatment Period 1||5
5247475|NCT00812929|12899025|P5|STARTED|Treatment Period 1||5
5247476|NCT00812929|12899026|P4|STARTED|Treatment Period 1||4
5247477|NCT00812929|12899027|P3|STARTED|Treatment Period 1||5
5247478|NCT00812929|12899028|P2|STARTED|Treatment Period 1||4
5247479|NCT00812929|12899029|P1|STARTED|Treatment Period 1||5
5247480|NCT00812916|12899145|P1|NOT COMPLETED|Overall Study||3
5247481|NCT00812916|12899145|P1|COMPLETED|Overall Study||203
5247482|NCT00812916|12899145|P1|CFAE - Guided Ablation|Overall Study||203
5247483|NCT00812916|12899145|P1|Data Available|Overall Study||205
5247484|NCT00812916|12899145|P1|STARTED|Overall Study|206 enrolled (consented)|206
5247485|NCT00812877|12899156|P2|NOT COMPLETED|Overall Study||51
5247486|NCT00812877|12899157|P1|NOT COMPLETED|Overall Study||37
5247487|NCT00812877|12899156|P2|COMPLETED|Overall Study||130
5247488|NCT00812877|12899157|P1|COMPLETED|Overall Study||158
5247489|NCT00812877|12899156|P2|STARTED|Overall Study||181
5247490|NCT00812877|12899157|P1|STARTED|Overall Study||195
5247491|NCT00812838|12899167|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
5247492|NCT00812838|12899168|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
5247493|NCT00812838|12899167|P2|COMPLETED|Optional Crossover of 16 Weeks||4
5247494|NCT00812838|12899168|P1|COMPLETED|Optional Crossover of 16 Weeks||0
5247495|NCT00812838|12899167|P2|STARTED|Optional Crossover of 16 Weeks||4
5247496|NCT00812838|12899168|P1|STARTED|Optional Crossover of 16 Weeks||0
5247497|NCT00812838|12899167|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
5247498|NCT00812838|12899168|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
5247499|NCT00812838|12899167|P2|COMPLETED|Treatment Period of 16 Weeks||6
5247500|NCT00812838|12899168|P1|COMPLETED|Treatment Period of 16 Weeks||6
5247501|NCT00812838|12899167|P2|STARTED|Treatment Period of 16 Weeks||6
5247502|NCT00812838|12899168|P1|STARTED|Treatment Period of 16 Weeks||6
5247503|NCT00812812|12899184|P2|NOT COMPLETED|Overall Study||4
5247504|NCT00812812|12899185|P1|NOT COMPLETED|Overall Study||3
5247505|NCT00812812|12899184|P2|COMPLETED|Overall Study||25
5247506|NCT00812812|12899185|P1|COMPLETED|Overall Study||24
5247507|NCT00812812|12899184|P2|STARTED|Overall Study||29
5247508|NCT00812812|12899185|P1|STARTED|Overall Study||27
5247509|NCT00812708|12899198|P1|NOT COMPLETED|Overall Study||8
5247510|NCT00812708|12899198|P1|COMPLETED|Overall Study||64
5247603|NCT00812006|12899545|P3|STARTED|Overall Study||36
5247604|NCT00812006|12899546|P2|STARTED|Overall Study||36
5247511|NCT00812708|12899198|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
5247512|NCT00812708|12899198|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
5247513|NCT00812604|12899209|P2|NOT COMPLETED|Overall Study||5
5247514|NCT00812604|12899210|P1|NOT COMPLETED|Overall Study||5
5247515|NCT00812604|12899209|P2|COMPLETED|Overall Study||22
5247516|NCT00812604|12899210|P1|COMPLETED|Overall Study||23
5247517|NCT00812604|12899209|P2|STARTED|Overall Study||27
5247518|NCT00812604|12899210|P1|STARTED|Overall Study||28
5247519|NCT00812565|12899226|P8|NOT COMPLETED|Overall Study||1
5247520|NCT00812565|12899227|P7|NOT COMPLETED|Overall Study||0
5247521|NCT00812565|12899228|P6|NOT COMPLETED|Overall Study||1
5247522|NCT00812565|12899229|P5|NOT COMPLETED|Overall Study||1
5247523|NCT00812565|12899230|P4|NOT COMPLETED|Overall Study||2
5247524|NCT00812565|12899231|P3|NOT COMPLETED|Overall Study||0
5247525|NCT00812565|12899232|P2|NOT COMPLETED|Overall Study||1
5247526|NCT00812565|12899233|P1|NOT COMPLETED|Overall Study||3
5247527|NCT00812565|12899226|P8|COMPLETED|Overall Study||6
5247528|NCT00812565|12899227|P7|COMPLETED|Overall Study||8
5247529|NCT00812565|12899228|P6|COMPLETED|Overall Study||6
5247530|NCT00812565|12899229|P5|COMPLETED|Overall Study||6
5247531|NCT00812565|12899230|P4|COMPLETED|Overall Study||5
5247532|NCT00812565|12899231|P3|COMPLETED|Overall Study||7
5247533|NCT00812565|12899232|P2|COMPLETED|Overall Study||6
5247534|NCT00812565|12899233|P1|COMPLETED|Overall Study||5
5247535|NCT00812565|12899226|P8|STARTED|Overall Study||7
5247536|NCT00812565|12899227|P7|STARTED|Overall Study||8
5247537|NCT00812565|12899228|P6|STARTED|Overall Study||7
5247538|NCT00812565|12899229|P5|STARTED|Overall Study||7
5247539|NCT00812565|12899230|P4|STARTED|Overall Study||7
5247540|NCT00812565|12899231|P3|STARTED|Overall Study||7
5247541|NCT00812565|12899232|P2|STARTED|Overall Study||7
5247542|NCT00812565|12899233|P1|STARTED|Overall Study||8
5247543|NCT00812487|12899357|P2|NOT COMPLETED|Overall Study||3
5247544|NCT00812487|12899358|P1|NOT COMPLETED|Overall Study||6
5247545|NCT00812487|12899357|P2|COMPLETED|Overall Study||39
5247546|NCT00812487|12899358|P1|COMPLETED|Overall Study||26
5247547|NCT00812487|12899357|P2|STARTED|Overall Study||42
5247548|NCT00812487|12899358|P1|STARTED|Overall Study||32
5247549|NCT00812461|12899384|P2|NOT COMPLETED|All Treated Patients||147
5247550|NCT00812461|12899385|P1|NOT COMPLETED|All Treated Patients||132
5247551|NCT00812461|12899384|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
5247552|NCT00812461|12899385|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
5247553|NCT00812461|12899384|P2|STARTED|All Treated Patients||341
5247554|NCT00812461|12899385|P1|STARTED|All Treated Patients||337
5247555|NCT00812461|12899384|P2|NOT COMPLETED|All Randomised Patients||17
5247556|NCT00812461|12899385|P1|NOT COMPLETED|All Randomised Patients||23
5247557|NCT00812461|12899384|P2|COMPLETED|All Randomised Patients||341
5247558|NCT00812461|12899385|P1|COMPLETED|All Randomised Patients||337
5247559|NCT00812461|12899384|P2|STARTED|All Randomised Patients||358
5247560|NCT00812461|12899385|P1|STARTED|All Randomised Patients||360
5247561|NCT00812331|12899408|P5|NOT COMPLETED|Overall Study||0
5247562|NCT00812331|12899409|P4|NOT COMPLETED|Overall Study||0
5247563|NCT00812331|12899410|P3|NOT COMPLETED|Overall Study||0
5247564|NCT00812331|12899411|P2|NOT COMPLETED|Overall Study||0
5247565|NCT00812331|12899412|P1|NOT COMPLETED|Overall Study||1
5247566|NCT00812331|12899408|P5|COMPLETED|Overall Study||8
5247567|NCT00812331|12899409|P4|COMPLETED|Overall Study||7
5247568|NCT00812331|12899410|P3|COMPLETED|Overall Study||8
5247569|NCT00812331|12899411|P2|COMPLETED|Overall Study||8
5247570|NCT00812331|12899412|P1|COMPLETED|Overall Study||5
5247571|NCT00812331|12899408|P5|STARTED|Overall Study||8
5247572|NCT00812331|12899409|P4|STARTED|Overall Study||7
5247573|NCT00812331|12899410|P3|STARTED|Overall Study||8
5247574|NCT00812331|12899411|P2|STARTED|Overall Study||8
5247575|NCT00812331|12899412|P1|STARTED|Overall Study||6
5247576|NCT00812253|12899487|P2|NOT COMPLETED|Overall Study||3
5247577|NCT00812253|12899488|P1|NOT COMPLETED|Overall Study||6
5247578|NCT00812253|12899487|P2|COMPLETED|Overall Study||39
5247579|NCT00812253|12899488|P1|COMPLETED|Overall Study||26
5247580|NCT00812253|12899487|P2|STARTED|Overall Study||42
5247581|NCT00812253|12899488|P1|STARTED|Overall Study||32
5247582|NCT00812110|12899504|P1|NOT COMPLETED|Overall Study||0
5247583|NCT00812110|12899504|P1|COMPLETED|Overall Study||292
5247584|NCT00812110|12899504|P1|STARTED|Overall Study||292
5247585|NCT00812097|12899513|P4|NOT COMPLETED|Overall Study||35
5247586|NCT00812097|12899514|P3|NOT COMPLETED|Overall Study||57
5247587|NCT00812097|12899515|P2|NOT COMPLETED|Overall Study||89
5247588|NCT00812097|12899516|P1|NOT COMPLETED|Overall Study||245
5247589|NCT00812097|12899513|P4|COMPLETED|Overall Study||34
5247590|NCT00812097|12899514|P3|COMPLETED|Overall Study||67
5247591|NCT00812097|12899515|P2|COMPLETED|Overall Study||101
5247592|NCT00812097|12899516|P1|COMPLETED|Overall Study||327
5247593|NCT00812097|12899513|P4|STARTED|Overall Study||69
5247594|NCT00812097|12899514|P3|STARTED|Overall Study||124
5247595|NCT00812097|12899515|P2|STARTED|Overall Study||190
5247596|NCT00812097|12899516|P1|STARTED|Overall Study||572
5247597|NCT00812006|12899545|P3|NOT COMPLETED|Overall Study||6
5247598|NCT00812006|12899546|P2|NOT COMPLETED|Overall Study||3
5247599|NCT00812006|12899547|P1|NOT COMPLETED|Overall Study||6
5247600|NCT00812006|12899545|P3|COMPLETED|Overall Study||30
5247601|NCT00812006|12899546|P2|COMPLETED|Overall Study||33
5247602|NCT00812006|12899547|P1|COMPLETED|Overall Study||30
5247605|NCT00812006|12899547|P1|STARTED|Overall Study||36
5247606|NCT00811954|12899564|P3|NOT COMPLETED|Overall Study||101
5247607|NCT00811954|12899565|P2|NOT COMPLETED|Overall Study||72
5247608|NCT00811954|12899566|P1|NOT COMPLETED|Overall Study||89
5247609|NCT00811954|12899564|P3|COMPLETED|Overall Study||500
5247610|NCT00811954|12899565|P2|COMPLETED|Overall Study||531
5247611|NCT00811954|12899566|P1|COMPLETED|Overall Study||516
5247612|NCT00811954|12899564|P3|STARTED|Overall Study||601
5247613|NCT00811954|12899565|P2|STARTED|Overall Study||603
5247614|NCT00811954|12899566|P1|STARTED|Overall Study||605
5247615|NCT00811941|12899630|P2|NOT COMPLETED|All Treated Patients||191
5247616|NCT00811941|12899631|P1|NOT COMPLETED|All Treated Patients||52
5247617|NCT00811941|12899630|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
5247618|NCT00811941|12899631|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
5247619|NCT00811941|12899630|P2|STARTED|All Treated Patients||501
5247620|NCT00811941|12899631|P1|STARTED|All Treated Patients||164
5247621|NCT00811941|12899630|P2|NOT COMPLETED|All Randomised Patients||8
5247622|NCT00811941|12899631|P1|NOT COMPLETED|All Randomised Patients||2
5247623|NCT00811941|12899630|P2|COMPLETED|All Randomised Patients||501
5247624|NCT00811941|12899631|P1|COMPLETED|All Randomised Patients||164
5247625|NCT00811941|12899630|P2|STARTED|All Randomised Patients||509
5247626|NCT00811941|12899631|P1|STARTED|All Randomised Patients||166
5247627|NCT00811928|12899669|P2|NOT COMPLETED|Overall Study||33
5247628|NCT00811928|12899670|P1|NOT COMPLETED|Overall Study||39
5247629|NCT00811928|12899669|P2|COMPLETED|Overall Study||90
5247630|NCT00811928|12899670|P1|COMPLETED|Overall Study||90
5247631|NCT00811928|12899669|P2|STARTED|Overall Study||123
5247632|NCT00811928|12899670|P1|STARTED|Overall Study||129
5247633|NCT00811850|12899688|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
5247634|NCT00811850|12899688|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
5247635|NCT00811850|12899688|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
5247636|NCT00811850|12899688|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
5247637|NCT00811850|12899688|P1|COMPLETED|Treatment Period 2: Wash Out||15
5247638|NCT00811850|12899688|P1|STARTED|Treatment Period 2: Wash Out||15
5247639|NCT00811850|12899688|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
5247640|NCT00811850|12899688|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
5247641|NCT00811850|12899688|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
5247642|NCT00811798|12899708|P1|NOT COMPLETED|Overall Study||0
5247643|NCT00811798|12899708|P1|COMPLETED|Overall Study||92
5247644|NCT00811798|12899708|P1|STARTED|Overall Study||92
5247645|NCT00811733|12899714|P2|NOT COMPLETED|Overall Study||10
5247646|NCT00811733|12899715|P1|NOT COMPLETED|Overall Study||11
5247647|NCT00811733|12899714|P2|COMPLETED|Overall Study||12
5247648|NCT00811733|12899715|P1|COMPLETED|Overall Study||4
5247649|NCT00811733|12899714|P2|STARTED|Overall Study||22
5247650|NCT00811733|12899715|P1|STARTED|Overall Study||15
5247651|NCT00811720|12899763|P2|NOT COMPLETED|All Treated Patients||164
5247652|NCT00811720|12899764|P1|NOT COMPLETED|All Treated Patients||96
5247653|NCT00811720|12899763|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
5247654|NCT00811720|12899764|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
5247655|NCT00811720|12899763|P2|STARTED|All Treated Patients||302
5247656|NCT00811720|12899764|P1|STARTED|All Treated Patients||296
5247657|NCT00811720|12899763|P2|NOT COMPLETED|All Randomised Patients||4
5247658|NCT00811720|12899764|P1|NOT COMPLETED|All Randomised Patients||2
5247659|NCT00811720|12899763|P2|COMPLETED|All Randomised Patients||302
5247660|NCT00811720|12899764|P1|COMPLETED|All Randomised Patients||296
5247661|NCT00811720|12899763|P2|STARTED|All Randomised Patients||306
5247662|NCT00811720|12899764|P1|STARTED|All Randomised Patients||298
5247663|NCT00811655|12899782|P1|NOT COMPLETED|Overall Study||1
5247664|NCT00811655|12899782|P1|COMPLETED|Overall Study||5
5247665|NCT00811655|12899782|P1|STARTED|Overall Study||6
5247666|NCT00811642|12899794|P1|NOT COMPLETED|Overall Study||15
5247667|NCT00811642|12899794|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
5247668|NCT00811642|12899794|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
5247669|NCT00811590|12899804|P1|NOT COMPLETED|Overall Study||0
5247670|NCT00811590|12899804|P1|COMPLETED|Overall Study||3
5247671|NCT00811590|12899804|P1|STARTED|Overall Study||3
5247672|NCT00811577|12899810|P2|NOT COMPLETED|Overall Study||1
5247673|NCT00811577|12899811|P1|NOT COMPLETED|Overall Study||10
5247674|NCT00811577|12899810|P2|COMPLETED|Overall Study||23
5247675|NCT00811577|12899811|P1|COMPLETED|Overall Study||116
5247676|NCT00811577|12899810|P2|STARTED|Overall Study||24
5247677|NCT00811577|12899811|P1|STARTED|Overall Study||126
5247678|NCT00811564|12899862|P2|NOT COMPLETED|Overall Study||2
5247679|NCT00811564|12899863|P1|NOT COMPLETED|Overall Study||9
5247680|NCT00811564|12899862|P2|COMPLETED|Overall Study||73
5247681|NCT00811564|12899863|P1|COMPLETED|Overall Study||64
5247682|NCT00811564|12899862|P2|STARTED|Overall Study||75
5247683|NCT00811564|12899863|P1|STARTED|Overall Study||73
5247684|NCT00811473|12899871|P2|NOT COMPLETED|Overall Study||26
5247685|NCT00811473|12899872|P1|NOT COMPLETED|Overall Study||23
5247686|NCT00811473|12899871|P2|COMPLETED|Overall Study||74
5247687|NCT00811473|12899872|P1|COMPLETED|Overall Study||70
5247688|NCT00811473|12899871|P2|STARTED|Overall Study||100
5247689|NCT00811473|12899872|P1|STARTED|Overall Study||93
5247690|NCT00811434|12899888|P2|NOT COMPLETED|Second Intervention||0
5247691|NCT00811434|12899889|P1|NOT COMPLETED|Second Intervention||0
5247692|NCT00811434|12899888|P2|COMPLETED|Second Intervention||5
5247693|NCT00811434|12899889|P1|COMPLETED|Second Intervention||4
5247694|NCT00811434|12899888|P2|STARTED|Second Intervention||5
5247695|NCT00811434|12899889|P1|STARTED|Second Intervention||4
5247696|NCT00811434|12899888|P2|NOT COMPLETED|Washout (1 Month)||0
5247697|NCT00811434|12899889|P1|NOT COMPLETED|Washout (1 Month)||0
5247698|NCT00811434|12899888|P2|COMPLETED|Washout (1 Month)||5
5247699|NCT00811434|12899889|P1|COMPLETED|Washout (1 Month)||4
5247700|NCT00811434|12899888|P2|STARTED|Washout (1 Month)||5
5247701|NCT00811434|12899889|P1|STARTED|Washout (1 Month)||4
5247702|NCT00811434|12899888|P2|NOT COMPLETED|First Intervention||0
5247703|NCT00811434|12899889|P1|NOT COMPLETED|First Intervention||3
5247704|NCT00811434|12899888|P2|COMPLETED|First Intervention||5
5247705|NCT00811434|12899889|P1|COMPLETED|First Intervention||4
5247706|NCT00811434|12899888|P2|STARTED|First Intervention||5
5247707|NCT00811434|12899889|P1|STARTED|First Intervention||7
5247708|NCT00811395|12899903|P6|NOT COMPLETED|Extension Treatment||2
5247709|NCT00811395|12899904|P5|NOT COMPLETED|Extension Treatment||0
5247710|NCT00811395|12899905|P4|NOT COMPLETED|Extension Treatment||3
5247711|NCT00811395|12899906|P3|NOT COMPLETED|Extension Treatment||3
5247712|NCT00811395|12899907|P2|NOT COMPLETED|Extension Treatment||6
5247713|NCT00811395|12899908|P1|NOT COMPLETED|Extension Treatment||2
5247714|NCT00811395|12899903|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
5247715|NCT00811395|12899904|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
5247716|NCT00811395|12899905|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
5247717|NCT00811395|12899906|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
5247718|NCT00811395|12899907|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
5247719|NCT00811395|12899908|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
5247720|NCT00811395|12899903|P6|STARTED|Extension Treatment|continued initial treatment|29
5247721|NCT00811395|12899904|P5|STARTED|Extension Treatment|continued initial treatment|30
5247722|NCT00811395|12899905|P4|STARTED|Extension Treatment|continued initial treatment|37
5247723|NCT00811395|12899906|P3|STARTED|Extension Treatment|continued initial treatment|27
5247724|NCT00811395|12899907|P2|STARTED|Extension Treatment|continued initial treatment|28
5247725|NCT00811395|12899908|P1|STARTED|Extension Treatment|continued initial treatment|31
5247726|NCT00811395|12899903|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
5247727|NCT00811395|12899904|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
5247728|NCT00811395|12899905|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
5247729|NCT00811395|12899906|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
5247730|NCT00811395|12899907|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
5247731|NCT00811395|12899908|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
5247732|NCT00811395|12899903|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
5247733|NCT00811395|12899904|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
5247734|NCT00811395|12899905|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
5247735|NCT00811395|12899906|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
5247736|NCT00811395|12899907|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
5247737|NCT00811395|12899908|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
5247738|NCT00811395|12899903|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
5247739|NCT00811395|12899904|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
5247740|NCT00811395|12899905|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
5247741|NCT00811395|12899906|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
5247742|NCT00811395|12899907|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
5247743|NCT00811395|12899908|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
5247744|NCT00811382|12899972|P2|NOT COMPLETED|Overall Study||0
5247745|NCT00811382|12899973|P1|NOT COMPLETED|Overall Study||0
5247746|NCT00811382|12899972|P2|COMPLETED|Overall Study||75
5247747|NCT00811382|12899973|P1|COMPLETED|Overall Study||88
5247748|NCT00811382|12899972|P2|STARTED|Overall Study||75
5247749|NCT00811382|12899973|P1|STARTED|Overall Study||88
5247750|NCT00811317|12899985|P1|NOT COMPLETED|Overall Study||0
5247751|NCT00811317|12899985|P1|COMPLETED|Overall Study||11
5247752|NCT00811317|12899985|P1|STARTED|Overall Study||11
5247753|NCT00811252|12900014|P3|NOT COMPLETED|Overall Study||23
5247754|NCT00811252|12900015|P2|NOT COMPLETED|Overall Study||20
5247755|NCT00811252|12900016|P1|NOT COMPLETED|Overall Study||17
5247756|NCT00811252|12900014|P3|COMPLETED|Overall Study||128
5247757|NCT00811252|12900015|P2|COMPLETED|Overall Study||136
5247758|NCT00811252|12900016|P1|COMPLETED|Overall Study||128
5247759|NCT00811252|12900014|P3|STARTED|Overall Study||151
5247760|NCT00811252|12900015|P2|STARTED|Overall Study||156
5247761|NCT00811252|12900016|P1|STARTED|Overall Study||145
5247762|NCT00811187|12900062|P2|NOT COMPLETED|Overall Study||3
5247763|NCT00811187|12900063|P1|NOT COMPLETED|Overall Study||3
5247764|NCT00811187|12900062|P2|COMPLETED|Overall Study||37
5247765|NCT00811187|12900063|P1|COMPLETED|Overall Study||37
5247766|NCT00811187|12900062|P2|STARTED|Overall Study||40
5247767|NCT00811187|12900063|P1|STARTED|Overall Study||40
5247768|NCT00811174|12900069|P1|NOT COMPLETED|Overall Study||3
5247769|NCT00811174|12900069|P1|COMPLETED|Overall Study||2
5247770|NCT00811174|12900069|P1|STARTED|Overall Study||5
5247771|NCT00811135|12900080|P1|NOT COMPLETED|Overall Study||88
5247772|NCT00811135|12900080|P1|COMPLETED|Overall Study||0
5247773|NCT00811135|12900080|P1|STARTED|Overall Study||88
5247774|NCT00811070|12900098|P6|NOT COMPLETED|Overall Study||1
5247775|NCT00811070|12900099|P5|NOT COMPLETED|Overall Study||5
5247776|NCT00811070|12900100|P4|NOT COMPLETED|Overall Study||2
5247777|NCT00811070|12900101|P3|NOT COMPLETED|Overall Study||0
5247778|NCT00811070|12900102|P2|NOT COMPLETED|Overall Study||1
5247779|NCT00811070|12900103|P1|NOT COMPLETED|Overall Study||1
5247780|NCT00811070|12900098|P6|COMPLETED|Overall Study||10
5247781|NCT00811070|12900099|P5|COMPLETED|Overall Study||2
5247782|NCT00811070|12900100|P4|COMPLETED|Overall Study||26
5247783|NCT00811070|12900101|P3|COMPLETED|Overall Study||3
5247784|NCT00811070|12900102|P2|COMPLETED|Overall Study||6
5247785|NCT00811070|12900103|P1|COMPLETED|Overall Study||6
5247786|NCT00811070|12900098|P6|STARTED|Overall Study||11
5247787|NCT00811070|12900099|P5|STARTED|Overall Study||7
5247788|NCT00811070|12900100|P4|STARTED|Overall Study||28
5247789|NCT00811070|12900101|P3|STARTED|Overall Study||3
5247790|NCT00811070|12900102|P2|STARTED|Overall Study||7
5247791|NCT00811070|12900103|P1|STARTED|Overall Study||7
5247792|NCT00811057|12900163|P3|NOT COMPLETED|Overall Study||10
5247793|NCT00811057|12900164|P2|NOT COMPLETED|Overall Study||10
5247794|NCT00811057|12900165|P1|NOT COMPLETED|Overall Study||5
5247795|NCT00811057|12900163|P3|COMPLETED|Overall Study||87
5247796|NCT00811057|12900164|P2|COMPLETED|Overall Study||104
5247797|NCT00811057|12900165|P1|COMPLETED|Overall Study||85
5247798|NCT00811057|12900163|P3|STARTED|Overall Study||97
5247799|NCT00811057|12900164|P2|STARTED|Overall Study||114
5247800|NCT00811057|12900165|P1|STARTED|Overall Study||90
5247801|NCT00811018|12900176|P1|NOT COMPLETED|Overall Study||968
5247802|NCT00811018|12900176|P1|COMPLETED|Overall Study||224
5247803|NCT00811018|12900176|P1|STARTED|Overall Study||1192
5247804|NCT00810901|12900194|P2|NOT COMPLETED|Overall Study||58
5247805|NCT00810901|12900195|P1|NOT COMPLETED|Overall Study||88
5247806|NCT00810901|12900194|P2|COMPLETED|Overall Study||118
5247807|NCT00810901|12900195|P1|COMPLETED|Overall Study||165
5247808|NCT00810901|12900194|P2|6-month Follow-up|Overall Study||122
5247809|NCT00810901|12900195|P1|6-month Follow-up|Overall Study||181
5247810|NCT00810901|12900194|P2|1-month Follow up|Overall Study||146
5247811|NCT00810901|12900195|P1|1-month Follow up|Overall Study||242
5247812|NCT00810901|12900194|P2|STARTED|Overall Study||176
5247813|NCT00810901|12900195|P1|STARTED|Overall Study||253
5247814|NCT00810888|12900206|P3|NOT COMPLETED|Overall Study||0
5247815|NCT00810888|12900207|P2|NOT COMPLETED|Overall Study||0
5247816|NCT00810888|12900208|P1|NOT COMPLETED|Overall Study||0
5247817|NCT00810888|12900206|P3|COMPLETED|Overall Study||73
5247818|NCT00810888|12900207|P2|COMPLETED|Overall Study||9
5247819|NCT00810888|12900208|P1|COMPLETED|Overall Study||10
5247820|NCT00810888|12900206|P3|STARTED|Overall Study||73
5247821|NCT00810888|12900207|P2|STARTED|Overall Study||9
5247822|NCT00810888|12900208|P1|STARTED|Overall Study||10
5247823|NCT00810810|12900241|P4|NOT COMPLETED|Overall Study||13
5247824|NCT00810810|12900242|P3|NOT COMPLETED|Overall Study||11
5247825|NCT00810810|12900243|P2|NOT COMPLETED|Overall Study||11
5247826|NCT00810810|12900244|P1|NOT COMPLETED|Overall Study||0
5247827|NCT00810810|12900241|P4|COMPLETED|Overall Study||38
5247828|NCT00810810|12900242|P3|COMPLETED|Overall Study||45
5247829|NCT00810810|12900243|P2|COMPLETED|Overall Study||38
5247830|NCT00810810|12900244|P1|COMPLETED|Overall Study||124
5247831|NCT00810810|12900241|P4|STARTED|Overall Study||51
5247832|NCT00810810|12900242|P3|STARTED|Overall Study||56
5247833|NCT00810810|12900243|P2|STARTED|Overall Study||49
5247834|NCT00810810|12900244|P1|STARTED|Overall Study||124
5247835|NCT00810771|12900261|P3|NOT COMPLETED|Overall Study||0
5247836|NCT00810771|12900262|P2|NOT COMPLETED|Overall Study||0
5247837|NCT00810771|12900263|P1|NOT COMPLETED|Overall Study||0
5247838|NCT00810771|12900261|P3|COMPLETED|Overall Study||84
5247839|NCT00810771|12900262|P2|COMPLETED|Overall Study||234
5247840|NCT00810771|12900263|P1|COMPLETED|Overall Study||232
5247841|NCT00810771|12900261|P3|STARTED|Overall Study||84
5247842|NCT00810771|12900262|P2|STARTED|Overall Study||234
5247843|NCT00810771|12900263|P1|STARTED|Overall Study||232
5247844|NCT00810719|12900283|P1|NOT COMPLETED|Overall Study||0
5247845|NCT00810719|12900283|P1|COMPLETED|Overall Study||30
5247846|NCT00810719|12900283|P1|STARTED|Overall Study||30
5247847|NCT00810693|12900292|P3|NOT COMPLETED|Follow-up Period (FUP)||4
5247848|NCT00810693|12900293|P2|NOT COMPLETED|Follow-up Period (FUP)||3
5247849|NCT00810693|12900294|P1|NOT COMPLETED|Follow-up Period (FUP)||8
5247850|NCT00810693|12900292|P3|COMPLETED|Follow-up Period (FUP)||12
5247851|NCT00810693|12900293|P2|COMPLETED|Follow-up Period (FUP)||4
5247852|NCT00810693|12900294|P1|COMPLETED|Follow-up Period (FUP)||15
5247853|NCT00810693|12900292|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
5247854|NCT00810693|12900293|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
5247855|NCT00810693|12900294|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
5247856|NCT00810693|12900292|P3|NOT COMPLETED|Treatment Period||16
5247857|NCT00810693|12900293|P2|NOT COMPLETED|Treatment Period||7
5247858|NCT00810693|12900294|P1|NOT COMPLETED|Treatment Period||17
5247859|NCT00810693|12900292|P3|COMPLETED|Treatment Period||111
5247860|NCT00810693|12900293|P2|COMPLETED|Treatment Period||57
5247861|NCT00810693|12900294|P1|COMPLETED|Treatment Period||237
5247862|NCT00810693|12900292|P3|Participants Received Treatment|Treatment Period||126
5247863|NCT00810693|12900293|P2|Participants Received Treatment|Treatment Period||63
5247864|NCT00810693|12900294|P1|Participants Received Treatment|Treatment Period||254
5247865|NCT00810693|12900292|P3|STARTED|Treatment Period|1 randomized but not treated|127
5247866|NCT00810693|12900293|P2|STARTED|Treatment Period|1 randomized but not treated|64
5247867|NCT00810693|12900294|P1|STARTED|Treatment Period||254
5247868|NCT00810641|12900326|P3|NOT COMPLETED|Overall Study||2
5247869|NCT00810641|12900327|P2|NOT COMPLETED|Overall Study||1
5247870|NCT00810641|12900328|P1|NOT COMPLETED|Overall Study||0
5247871|NCT00810641|12900326|P3|COMPLETED|Overall Study||49
5247872|NCT00810641|12900327|P2|COMPLETED|Overall Study||53
5247873|NCT00810641|12900328|P1|COMPLETED|Overall Study||52
5247874|NCT00810641|12900326|P3|STARTED|Overall Study||51
5247875|NCT00810641|12900327|P2|STARTED|Overall Study||54
5247876|NCT00810641|12900328|P1|STARTED|Overall Study||52
5247877|NCT00810615|12900338|P2|NOT COMPLETED|Overall Study||1
5247878|NCT00810615|12900339|P1|NOT COMPLETED|Overall Study||1
5247879|NCT00810615|12900338|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
5247880|NCT00810615|12900339|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
5247881|NCT00810615|12900338|P2|STARTED|Overall Study||25
5247882|NCT00810615|12900339|P1|STARTED|Overall Study||25
5247883|NCT00810602|12900389|P2|NOT COMPLETED|Overall Study||3
5247884|NCT00810602|12900390|P1|NOT COMPLETED|Overall Study||8
5247885|NCT00810602|12900389|P2|COMPLETED|Overall Study||31
5247886|NCT00810602|12900390|P1|COMPLETED|Overall Study||19
5247887|NCT00810602|12900389|P2|STARTED|Overall Study||34
5247888|NCT00810602|12900390|P1|STARTED|Overall Study||27
5247889|NCT00810576|12900397|P1|NOT COMPLETED|Overall Study||0
5247890|NCT00810576|12900397|P1|COMPLETED|Overall Study||1
5247891|NCT00810576|12900397|P1|STARTED|Overall Study||1
5247892|NCT00810511|12900403|P2|NOT COMPLETED|Overall Study||4
5247893|NCT00810511|12900404|P1|NOT COMPLETED|Overall Study||10
5247894|NCT00810511|12900403|P2|COMPLETED|Overall Study||102
5247895|NCT00810511|12900404|P1|COMPLETED|Overall Study||97
5247896|NCT00810511|12900403|P2|STARTED|Overall Study||106
5247897|NCT00810511|12900404|P1|STARTED|Overall Study||107
5247898|NCT00810446|12900410|P1|NOT COMPLETED|Overall Study||0
5247899|NCT00810446|12900410|P1|COMPLETED|Overall Study||72
5247900|NCT00810446|12900410|P1|STARTED|Overall Study||72
5247901|NCT00810407|12900422|P1|NOT COMPLETED|Overall Study||6
5247902|NCT00810407|12900422|P1|COMPLETED|Overall Study||588
5247903|NCT00810407|12900422|P1|STARTED|Overall Study||594
5247904|NCT00810394|12900434|P1|NOT COMPLETED|Overall Study||3
5247905|NCT00810394|12900434|P1|COMPLETED|Overall Study||47
5247906|NCT00810394|12900434|P1|Cycle 3 400mg Twice Daily|Overall Study||5
5247907|NCT00810394|12900434|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
5247908|NCT00810394|12900434|P1|Cycle 2 400mg Once Daily|Overall Study||22
5247909|NCT00810394|12900434|P1|Cycle 2 600mg Twice Daily|Overall Study||13
5247910|NCT00810394|12900434|P1|STARTED|Overall Study||50
5247911|NCT00810368|12900442|P2|NOT COMPLETED|Overall Study||2
5247912|NCT00810368|12900443|P1|NOT COMPLETED|Overall Study||6
5247913|NCT00810368|12900442|P2|COMPLETED|Overall Study||13
5247914|NCT00810368|12900443|P1|COMPLETED|Overall Study||12
5247915|NCT00810368|12900442|P2|STARTED|Overall Study||15
5247916|NCT00810368|12900443|P1|STARTED|Overall Study||18
5247917|NCT00810355|12900464|P3|NOT COMPLETED|Overall Study||11
5247918|NCT00810355|12900465|P2|NOT COMPLETED|Overall Study||17
5247919|NCT00810355|12900466|P1|NOT COMPLETED|Overall Study||14
5247920|NCT00810355|12900464|P3|COMPLETED|Overall Study||14
5247921|NCT00810355|12900465|P2|COMPLETED|Overall Study||8
5247922|NCT00810355|12900466|P1|COMPLETED|Overall Study||11
5247923|NCT00810355|12900464|P3|STARTED|Overall Study||25
5247924|NCT00810355|12900465|P2|STARTED|Overall Study||25
5247925|NCT00810355|12900466|P1|STARTED|Overall Study||25
5247926|NCT00810342|12900482|P2|NOT COMPLETED|12-month Followup||11
5247927|NCT00810342|12900483|P1|NOT COMPLETED|12-month Followup||12
5247928|NCT00810342|12900482|P2|COMPLETED|12-month Followup||136
5247929|NCT00810342|12900483|P1|COMPLETED|12-month Followup||113
5247930|NCT00810342|12900482|P2|STARTED|12-month Followup||147
5247931|NCT00810342|12900483|P1|STARTED|12-month Followup||125
5247932|NCT00810342|12900482|P2|NOT COMPLETED|6-month Follow-up||8
5247933|NCT00810342|12900483|P1|NOT COMPLETED|6-month Follow-up||24
5247934|NCT00810342|12900482|P2|COMPLETED|6-month Follow-up||147
5247935|NCT00810342|12900483|P1|COMPLETED|6-month Follow-up||125
5247936|NCT00810342|12900482|P2|STARTED|6-month Follow-up||155
5247937|NCT00810342|12900483|P1|STARTED|6-month Follow-up||149
5247938|NCT00810342|12900482|P2|NOT COMPLETED|Month 1 Follow-up||2
5247939|NCT00810342|12900483|P1|NOT COMPLETED|Month 1 Follow-up||5
5247940|NCT00810342|12900482|P2|COMPLETED|Month 1 Follow-up||155
5247941|NCT00810342|12900483|P1|COMPLETED|Month 1 Follow-up||149
5247942|NCT00810342|12900482|P2|STARTED|Month 1 Follow-up||157
5247943|NCT00810342|12900483|P1|STARTED|Month 1 Follow-up||154
5247944|NCT00810303|12900491|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
5247945|NCT00810303|12900491|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
5247946|NCT00810303|12900491|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
5247947|NCT00810303|12900491|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
5247948|NCT00810303|12900491|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
5247949|NCT00810303|12900491|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
5247950|NCT00810303|12900491|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
5247951|NCT00810303|12900491|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
5247952|NCT00810303|12900491|P1|STARTED|Ezetimibe Alone - Day 6-15||12
5247953|NCT00810303|12900491|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
5247954|NCT00810303|12900491|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
5247955|NCT00810303|12900491|P1|STARTED|Efavirenz Alone - Day 1-5||12
5247956|NCT00810277|12900516|P1|NOT COMPLETED|Overall Study||1
5247957|NCT00810277|12900516|P1|COMPLETED|Overall Study||13
5247958|NCT00810277|12900516|P1|STARTED|Overall Study||14
5247959|NCT00810264|12900529|P1|NOT COMPLETED|Overall Study||1553
5247960|NCT00810264|12900529|P1|COMPLETED|Overall Study||946
5247961|NCT00810264|12900529|P1|STARTED|Overall Study||2499
5247962|NCT00810199|12900556|P2|NOT COMPLETED|Overall Study||82
5247963|NCT00810199|12900557|P1|NOT COMPLETED|Overall Study||59
5247964|NCT00810199|12900556|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
5247965|NCT00810199|12900557|P1|COMPLETED|Overall Study||220
5247966|NCT00810199|12900556|P2|Completed Week 104|Overall Study||201
5247967|NCT00810199|12900557|P1|Completed Week 104|Overall Study||222
5247968|NCT00810199|12900556|P2|Completed Week 52|Overall Study||229
5247969|NCT00810199|12900557|P1|Completed Week 52|Overall Study||243
5247970|NCT00810199|12900556|P2|Completed Week 24|Overall Study||250
5247971|NCT00810199|12900557|P1|Completed Week 24|Overall Study||259
5247972|NCT00810199|12900556|P2|Received Study Drug|Overall Study||276
5247973|NCT00810199|12900557|P1|Received Study Drug|Overall Study||277
5247974|NCT00810199|12900556|P2|STARTED|Overall Study||277
5247975|NCT00810199|12900557|P1|STARTED|Overall Study||279
5247976|NCT00810108|12900635|P2|NOT COMPLETED|Overall Study||0
5247977|NCT00810108|12900636|P1|NOT COMPLETED|Overall Study||1
5247978|NCT00810108|12900635|P2|COMPLETED|Overall Study||7
5247979|NCT00810108|12900636|P1|COMPLETED|Overall Study||5
5247980|NCT00810108|12900635|P2|STARTED|Overall Study||7
5247981|NCT00810108|12900636|P1|STARTED|Overall Study||6
5247982|NCT00810095|12900641|P1|NOT COMPLETED|Overall Study||0
5247983|NCT00810095|12900641|P1|COMPLETED|Overall Study||40
5247984|NCT00810095|12900641|P1|STARTED|Overall Study||40
5247985|NCT00810082|12900650|P2|NOT COMPLETED|Overall Study||4
5247986|NCT00810082|12900651|P1|NOT COMPLETED|Overall Study||0
5247987|NCT00810082|12900650|P2|COMPLETED|Overall Study||27
5247988|NCT00810082|12900651|P1|COMPLETED|Overall Study||34
5247989|NCT00810082|12900650|P2|STARTED|Overall Study||31
5247990|NCT00810082|12900651|P1|STARTED|Overall Study||34
5247991|NCT00810069|12900659|P3|NOT COMPLETED|Double-Blind Period II||72
5247992|NCT00810069|12900660|P2|NOT COMPLETED|Double-Blind Period II||56
5247993|NCT00810069|12900661|P1|NOT COMPLETED|Double-Blind Period II||0
5247994|NCT00810069|12900659|P3|COMPLETED|Double-Blind Period II||212
5247995|NCT00810069|12900660|P2|COMPLETED|Double-Blind Period II||226
5247996|NCT00810069|12900661|P1|COMPLETED|Double-Blind Period II||0
5247997|NCT00810069|12900659|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
5247998|NCT00810069|12900660|P2|STARTED|Double-Blind Period II||282
5247999|NCT00810069|12900661|P1|STARTED|Double-Blind Period II||0
5248000|NCT00810069|12900659|P3|NOT COMPLETED|Lead-in Period I||0
5248001|NCT00810069|12900660|P2|NOT COMPLETED|Lead-in Period I||0
5248002|NCT00810069|12900661|P1|NOT COMPLETED|Lead-in Period I||274
5248003|NCT00810069|12900659|P3|COMPLETED|Lead-in Period I||0
5248004|NCT00810069|12900660|P2|COMPLETED|Lead-in Period I||0
5248005|NCT00810069|12900661|P1|COMPLETED|Lead-in Period I||566
5248006|NCT00810069|12900659|P3|STARTED|Lead-in Period I||0
5248007|NCT00810069|12900660|P2|STARTED|Lead-in Period I||0
5248008|NCT00810069|12900661|P1|STARTED|Lead-in Period I||840
5248009|NCT00810043|12900706|P3|NOT COMPLETED|Overall Study||8
5248010|NCT00810043|12900707|P2|NOT COMPLETED|Overall Study||1
5248011|NCT00810043|12900708|P1|NOT COMPLETED|Overall Study||4
5248012|NCT00810043|12900706|P3|COMPLETED|Overall Study||0
5248013|NCT00810043|12900707|P2|COMPLETED|Overall Study||54
5248014|NCT00810043|12900708|P1|COMPLETED|Overall Study||53
5248015|NCT00810043|12900706|P3|STARTED|Overall Study||8
5248016|NCT00810043|12900707|P2|STARTED|Overall Study||55
5248017|NCT00810043|12900708|P1|STARTED|Overall Study||57
5248018|NCT00809965|12900730|P3|NOT COMPLETED|Overall Study||844
5248019|NCT00809965|12900731|P2|NOT COMPLETED|Overall Study||775
5248020|NCT00809965|12900732|P1|NOT COMPLETED|Overall Study||783
5248021|NCT00809965|12900730|P3|COMPLETED|Overall Study||4332
5248022|NCT00809965|12900731|P2|COMPLETED|Overall Study||4399
5248023|NCT00809965|12900732|P1|COMPLETED|Overall Study||4393
5248024|NCT00809965|12900730|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
5248025|NCT00809965|12900731|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
5248026|NCT00809965|12900732|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
5248027|NCT00809965|12900730|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
5248028|NCT00809965|12900731|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
5248029|NCT00809965|12900732|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
5248030|NCT00809965|12900730|P3|STARTED|Overall Study||5176
5248031|NCT00809965|12900731|P2|STARTED|Overall Study||5174
5248032|NCT00809965|12900732|P1|STARTED|Overall Study||5176
5248033|NCT00809926|12900754|P2|NOT COMPLETED|Overall Study||23
5248034|NCT00809926|12900755|P1|NOT COMPLETED|Overall Study||31
5248035|NCT00809926|12900754|P2|COMPLETED|Overall Study||196
5248036|NCT00809926|12900755|P1|COMPLETED|Overall Study||201
5248037|NCT00809926|12900754|P2|STARTED|Overall Study||219
5248038|NCT00809926|12900755|P1|STARTED|Overall Study||232
5248039|NCT00809848|12900784|P5|NOT COMPLETED|Overall Study||3
5248040|NCT00809848|12900785|P4|NOT COMPLETED|Overall Study||1
5248041|NCT00809848|12900786|P3|NOT COMPLETED|Overall Study||0
5248042|NCT00809848|12900787|P2|NOT COMPLETED|Overall Study||0
5248043|NCT00809848|12900788|P1|NOT COMPLETED|Overall Study||0
5248044|NCT00809848|12900784|P5|COMPLETED|Overall Study||34
5248045|NCT00809848|12900785|P4|COMPLETED|Overall Study||30
5248046|NCT00809848|12900786|P3|COMPLETED|Overall Study||34
5248047|NCT00809848|12900787|P2|COMPLETED|Overall Study||34
5248048|NCT00809848|12900788|P1|COMPLETED|Overall Study||36
5248049|NCT00809848|12900784|P5|STARTED|Overall Study||37
5248050|NCT00809848|12900785|P4|STARTED|Overall Study||31
5248051|NCT00809848|12900786|P3|STARTED|Overall Study||34
5248052|NCT00809848|12900787|P2|STARTED|Overall Study||34
5248053|NCT00809848|12900788|P1|STARTED|Overall Study||36
5248054|NCT00809835|12900809|P4|NOT COMPLETED|Overall Study||2
5248055|NCT00809835|12900810|P3|NOT COMPLETED|Overall Study||11
5248056|NCT00809835|12900811|P2|NOT COMPLETED|Overall Study||7
5248057|NCT00809835|12900812|P1|NOT COMPLETED|Overall Study||8
5248058|NCT00809835|12900809|P4|COMPLETED|Overall Study||25
5248059|NCT00809835|12900810|P3|COMPLETED|Overall Study||27
5248060|NCT00809835|12900811|P2|COMPLETED|Overall Study||20
5248061|NCT00809835|12900812|P1|COMPLETED|Overall Study||20
5248062|NCT00809835|12900809|P4|STARTED|Overall Study||27
5248063|NCT00809835|12900810|P3|STARTED|Overall Study||38
5248064|NCT00809835|12900811|P2|STARTED|Overall Study||27
5248065|NCT00809835|12900812|P1|STARTED|Overall Study||28
5248066|NCT00809809|12900832|P2|NOT COMPLETED|Overall Study||2
5248067|NCT00809809|12900833|P1|NOT COMPLETED|Overall Study||3
5248068|NCT00809809|12900832|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
5248069|NCT00809809|12900833|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
5248070|NCT00809809|12900832|P2|STARTED|Overall Study||79
5248071|NCT00809809|12900833|P1|STARTED|Overall Study||78
5248072|NCT00809757|12900842|P3|NOT COMPLETED|Overall Study||11
5248073|NCT00809757|12900843|P2|NOT COMPLETED|Overall Study||5
5248074|NCT00809757|12900844|P1|NOT COMPLETED|Overall Study||6
5248075|NCT00809757|12900842|P3|COMPLETED|Overall Study||53
5248076|NCT00809757|12900843|P2|COMPLETED|Overall Study||60
5248077|NCT00809757|12900844|P1|COMPLETED|Overall Study||62
5248078|NCT00809757|12900842|P3|STARTED|Overall Study||64
5248079|NCT00809757|12900843|P2|STARTED|Overall Study||65
5248080|NCT00809757|12900844|P1|STARTED|Overall Study||68
5248081|NCT00809614|12900929|P2|NOT COMPLETED|Overall Study||4
5248082|NCT00809614|12900930|P1|NOT COMPLETED|Overall Study||3
5248083|NCT00809614|12900929|P2|COMPLETED|Overall Study||10
5248084|NCT00809614|12900930|P1|COMPLETED|Overall Study||25
5248085|NCT00809614|12900929|P2|Pharmacodynamic (PD) Set|Overall Study||13
5248086|NCT00809614|12900930|P1|Pharmacodynamic (PD) Set|Overall Study||24
5248087|NCT00809614|12900929|P2|Pharmacokinetic Safety Set|Overall Study||14
5248088|NCT00809614|12900930|P1|Pharmacokinetic Safety Set|Overall Study||27
5248089|NCT00809614|12900929|P2|STARTED|Overall Study||14
5248090|NCT00809614|12900930|P1|STARTED|Overall Study||28
5248091|NCT00809523|12900960|P2|NOT COMPLETED|Overall Study||4
5248092|NCT00809523|12900961|P1|NOT COMPLETED|Overall Study||7
5248093|NCT00809523|12900960|P2|COMPLETED|Overall Study||48
5248094|NCT00809523|12900961|P1|COMPLETED|Overall Study||47
5248095|NCT00809523|12900960|P2|STARTED|Overall Study||52
5248096|NCT00809523|12900961|P1|STARTED|Overall Study||54
5248097|NCT00809471|12900974|P3|NOT COMPLETED|Overall Study||17
5248098|NCT00809471|12900975|P2|NOT COMPLETED|Overall Study||20
5248099|NCT00809471|12900976|P1|NOT COMPLETED|Overall Study||20
5248100|NCT00809471|12900974|P3|COMPLETED|Overall Study||114
5248101|NCT00809471|12900975|P2|COMPLETED|Overall Study||109
5248102|NCT00809471|12900976|P1|COMPLETED|Overall Study||110
5248103|NCT00809471|12900974|P3|STARTED|Overall Study||131
5248104|NCT00809471|12900975|P2|STARTED|Overall Study||129
5248105|NCT00809471|12900976|P1|STARTED|Overall Study||130
5248106|NCT00809458|12900992|P2|NOT COMPLETED|Overall Study||1
5248107|NCT00809458|12900993|P1|NOT COMPLETED|Overall Study||1
5248108|NCT00809458|12900992|P2|COMPLETED|Overall Study||5
5248109|NCT00809458|12900993|P1|COMPLETED|Overall Study||8
5248110|NCT00809458|12900992|P2|STARTED|Overall Study||6
5248111|NCT00809458|12900993|P1|STARTED|Overall Study||9
5248112|NCT00809445|12901006|P3|NOT COMPLETED|6 Month Follow-up||24
5248113|NCT00809445|12901007|P2|NOT COMPLETED|6 Month Follow-up||23
5248114|NCT00809445|12901008|P1|NOT COMPLETED|6 Month Follow-up||24
5248115|NCT00809445|12901006|P3|COMPLETED|6 Month Follow-up||395
5248116|NCT00809445|12901007|P2|COMPLETED|6 Month Follow-up||410
5248117|NCT00809445|12901008|P1|COMPLETED|6 Month Follow-up||405
5248118|NCT00809445|12901006|P3|STARTED|6 Month Follow-up||419
5248119|NCT00809445|12901007|P2|STARTED|6 Month Follow-up||433
5248120|NCT00809445|12901008|P1|STARTED|6 Month Follow-up||429
5248121|NCT00809445|12901006|P3|NOT COMPLETED|1 Month Follow-up||4
5248122|NCT00809445|12901007|P2|NOT COMPLETED|1 Month Follow-up||4
5248123|NCT00809445|12901008|P1|NOT COMPLETED|1 Month Follow-up||2
5248124|NCT00809445|12901006|P3|COMPLETED|1 Month Follow-up||415
5248125|NCT00809445|12901007|P2|COMPLETED|1 Month Follow-up||429
5248126|NCT00809445|12901008|P1|COMPLETED|1 Month Follow-up||427
5248127|NCT00809445|12901006|P3|STARTED|1 Month Follow-up||419
5248128|NCT00809445|12901007|P2|STARTED|1 Month Follow-up||433
5248129|NCT00809445|12901008|P1|STARTED|1 Month Follow-up||429
5248130|NCT00809341|12901027|P2|NOT COMPLETED|Overall Study||1
5248131|NCT00809341|12901028|P1|NOT COMPLETED|Overall Study||0
5248132|NCT00809341|12901027|P2|COMPLETED|Overall Study||4
5248133|NCT00809341|12901028|P1|COMPLETED|Overall Study||20
5248134|NCT00809341|12901027|P2|STARTED|Overall Study||5
5248135|NCT00809341|12901028|P1|STARTED|Overall Study||20
5248136|NCT00809328|12901036|P1|NOT COMPLETED|Overall Study||29
5248137|NCT00809328|12901036|P1|COMPLETED|Overall Study||73
5248138|NCT00809328|12901036|P1|STARTED|Overall Study||102
5248139|NCT00809276|12901044|P1|NOT COMPLETED|Overall Study||0
5248140|NCT00809276|12901044|P1|COMPLETED|Overall Study||92
5248141|NCT00809276|12901044|P1|STARTED|Overall Study||92
5248142|NCT00809185|12901048|P1|NOT COMPLETED|Overall Study||0
5248143|NCT00809185|12901048|P1|COMPLETED|Overall Study||7
5248144|NCT00809185|12901048|P1|STARTED|Overall Study||7
5248145|NCT00809159|12901058|P6|NOT COMPLETED|Part 1 and 2||3
5248146|NCT00809159|12901059|P5|NOT COMPLETED|Part 1 and 2||6
5248147|NCT00809159|12901060|P4|NOT COMPLETED|Part 1 and 2||5
5248148|NCT00809159|12901061|P3|NOT COMPLETED|Part 1 and 2||10
5248149|NCT00809159|12901062|P2|NOT COMPLETED|Part 1 and 2||0
5248150|NCT00809159|12901063|P1|NOT COMPLETED|Part 1 and 2||0
5248151|NCT00809159|12901058|P6|COMPLETED|Part 1 and 2||3
5248152|NCT00809159|12901059|P5|COMPLETED|Part 1 and 2||6
5248153|NCT00809159|12901060|P4|COMPLETED|Part 1 and 2||7
5248154|NCT00809159|12901061|P3|COMPLETED|Part 1 and 2||20
5248155|NCT00809159|12901062|P2|COMPLETED|Part 1 and 2||0
5248156|NCT00809159|12901063|P1|COMPLETED|Part 1 and 2||0
5248157|NCT00809159|12901058|P6|PD Analysis Set|Part 1 and 2||6
5248158|NCT00809159|12901059|P5|PD Analysis Set|Part 1 and 2||12
5248159|NCT00809159|12901060|P4|PD Analysis Set|Part 1 and 2||12
5248160|NCT00809159|12901061|P3|PD Analysis Set|Part 1 and 2||28
5248161|NCT00809159|12901062|P2|PD Analysis Set|Part 1 and 2||0
5248162|NCT00809159|12901063|P1|PD Analysis Set|Part 1 and 2||0
5248163|NCT00809159|12901058|P6|PK Analysis Set|Part 1 and 2||6
5248164|NCT00809159|12901059|P5|PK Analysis Set|Part 1 and 2||12
5248165|NCT00809159|12901060|P4|PK Analysis Set|Part 1 and 2||12
5248166|NCT00809159|12901061|P3|PK Analysis Set|Part 1 and 2||30
5248167|NCT00809159|12901062|P2|PK Analysis Set|Part 1 and 2||0
5248168|NCT00809159|12901063|P1|PK Analysis Set|Part 1 and 2||0
5248169|NCT00809159|12901058|P6|STARTED|Part 1 and 2||6
5248170|NCT00809159|12901059|P5|STARTED|Part 1 and 2||12
5248171|NCT00809159|12901060|P4|STARTED|Part 1 and 2||12
5248172|NCT00809159|12901061|P3|STARTED|Part 1 and 2||30
5248173|NCT00809159|12901062|P2|STARTED|Part 1 and 2||0
5248174|NCT00809159|12901063|P1|STARTED|Part 1 and 2||0
5248175|NCT00809159|12901058|P6|NOT COMPLETED|Part 1||0
5248176|NCT00809159|12901059|P5|NOT COMPLETED|Part 1||0
5248177|NCT00809159|12901060|P4|NOT COMPLETED|Part 1||0
5248178|NCT00809159|12901061|P3|NOT COMPLETED|Part 1||0
5248179|NCT00809159|12901062|P2|NOT COMPLETED|Part 1||3
5248180|NCT00809159|12901063|P1|NOT COMPLETED|Part 1||8
5248181|NCT00809159|12901058|P6|COMPLETED|Part 1||0
5248182|NCT00809159|12901059|P5|COMPLETED|Part 1||0
5248183|NCT00809159|12901060|P4|COMPLETED|Part 1||0
5248184|NCT00809159|12901061|P3|COMPLETED|Part 1||0
5248185|NCT00809159|12901062|P2|COMPLETED|Part 1||3
5248186|NCT00809159|12901063|P1|COMPLETED|Part 1||16
5248187|NCT00809159|12901058|P6|PD Analysis Set|Part 1||0
5248188|NCT00809159|12901059|P5|PD Analysis Set|Part 1||0
5248189|NCT00809159|12901060|P4|PD Analysis Set|Part 1||0
5248190|NCT00809159|12901061|P3|PD Analysis Set|Part 1||0
5248191|NCT00809159|12901062|P2|PD Analysis Set|Part 1||6
5248192|NCT00809159|12901063|P1|PD Analysis Set|Part 1||23
5248193|NCT00809159|12901058|P6|PK Analysis Set|Part 1||0
5248194|NCT00809159|12901059|P5|PK Analysis Set|Part 1||0
5248195|NCT00809159|12901060|P4|PK Analysis Set|Part 1||0
5248196|NCT00809159|12901061|P3|PK Analysis Set|Part 1||0
5248197|NCT00809159|12901062|P2|PK Analysis Set|Part 1||6
5248198|NCT00809159|12901063|P1|PK Analysis Set|Part 1||24
5248199|NCT00809159|12901058|P6|STARTED|Part 1||0
5248200|NCT00809159|12901059|P5|STARTED|Part 1||0
5248201|NCT00809159|12901060|P4|STARTED|Part 1||0
5248202|NCT00809159|12901061|P3|STARTED|Part 1||0
5248203|NCT00809159|12901062|P2|STARTED|Part 1||6
5248204|NCT00809159|12901063|P1|STARTED|Part 1||24
5248205|NCT00809146|12901129|P2|NOT COMPLETED|Overall Study||0
5248206|NCT00809146|12901130|P1|NOT COMPLETED|Overall Study||0
5248207|NCT00809146|12901129|P2|COMPLETED|Overall Study||445
5248208|NCT00809146|12901130|P1|COMPLETED|Overall Study||448
5248209|NCT00809146|12901129|P2|STARTED|Overall Study||445
5248210|NCT00809146|12901130|P1|STARTED|Overall Study||448
5248211|NCT00809133|12901168|P14|NOT COMPLETED|Overall Study||7
5248212|NCT00809133|12901169|P13|NOT COMPLETED|Overall Study||5
5248213|NCT00809133|12901170|P12|NOT COMPLETED|Overall Study||8
5248214|NCT00809133|12901171|P11|NOT COMPLETED|Overall Study||6
5248215|NCT00809133|12901172|P10|NOT COMPLETED|Overall Study||9
5248216|NCT00809133|12901173|P9|NOT COMPLETED|Overall Study||3
5248217|NCT00809133|12901174|P8|NOT COMPLETED|Overall Study||8
5248218|NCT00809133|12901175|P7|NOT COMPLETED|Overall Study||6
5248219|NCT00809133|12901176|P6|NOT COMPLETED|Overall Study||7
5248220|NCT00809133|12901177|P5|NOT COMPLETED|Overall Study||5
5248221|NCT00809133|12901178|P4|NOT COMPLETED|Overall Study||3
5248222|NCT00809133|12901179|P3|NOT COMPLETED|Overall Study||6
5248223|NCT00809133|12901180|P2|NOT COMPLETED|Overall Study||7
5248224|NCT00809133|12901181|P1|NOT COMPLETED|Overall Study||3
5248225|NCT00809133|12901168|P14|COMPLETED|Overall Study||0
5248226|NCT00809133|12901169|P13|COMPLETED|Overall Study||0
5248227|NCT00809133|12901170|P12|COMPLETED|Overall Study||0
5248228|NCT00809133|12901171|P11|COMPLETED|Overall Study||0
5248229|NCT00809133|12901172|P10|COMPLETED|Overall Study||0
5248230|NCT00809133|12901173|P9|COMPLETED|Overall Study||0
5248231|NCT00809133|12901174|P8|COMPLETED|Overall Study||0
5248232|NCT00809133|12901175|P7|COMPLETED|Overall Study||0
5248233|NCT00809133|12901176|P6|COMPLETED|Overall Study||0
5248234|NCT00809133|12901177|P5|COMPLETED|Overall Study||0
5248235|NCT00809133|12901178|P4|COMPLETED|Overall Study||0
5248236|NCT00809133|12901179|P3|COMPLETED|Overall Study||0
5248237|NCT00809133|12901180|P2|COMPLETED|Overall Study||0
5248238|NCT00809133|12901181|P1|COMPLETED|Overall Study||0
5248239|NCT00809133|12901168|P14|STARTED|Overall Study||7
5248240|NCT00809133|12901169|P13|STARTED|Overall Study||5
5248241|NCT00809133|12901170|P12|STARTED|Overall Study||8
5248242|NCT00809133|12901171|P11|STARTED|Overall Study||6
5248243|NCT00809133|12901172|P10|STARTED|Overall Study||9
5248244|NCT00809133|12901173|P9|STARTED|Overall Study||3
5248245|NCT00809133|12901174|P8|STARTED|Overall Study||8
5248246|NCT00809133|12901175|P7|STARTED|Overall Study||6
5248247|NCT00809133|12901176|P6|STARTED|Overall Study||7
5248248|NCT00809133|12901177|P5|STARTED|Overall Study||5
5248249|NCT00809133|12901178|P4|STARTED|Overall Study||3
5248250|NCT00809133|12901179|P3|STARTED|Overall Study||6
5248251|NCT00809133|12901180|P2|STARTED|Overall Study||7
5248252|NCT00809133|12901181|P1|STARTED|Overall Study||3
5248253|NCT00809094|12901335|P2|NOT COMPLETED|Overall Study||1
5248254|NCT00809094|12901336|P1|NOT COMPLETED|Overall Study||0
5248255|NCT00809094|12901335|P2|COMPLETED|Overall Study||33
5248256|NCT00809094|12901336|P1|COMPLETED|Overall Study||36
5248257|NCT00809094|12901335|P2|STARTED|Overall Study||34
5248258|NCT00809094|12901336|P1|STARTED|Overall Study||36
5248259|NCT00809055|12901356|P2|NOT COMPLETED|Overall Study||7
5248260|NCT00809055|12901357|P1|NOT COMPLETED|Overall Study||9
5248261|NCT00809055|12901356|P2|COMPLETED|Overall Study||30
5248262|NCT00809055|12901357|P1|COMPLETED|Overall Study||28
5248263|NCT00809055|12901356|P2|STARTED|Overall Study||37
5248264|NCT00809055|12901357|P1|STARTED|Overall Study||37
5248265|NCT00808899|12901381|P1|NOT COMPLETED|Overall Study||4
5248266|NCT00808899|12901381|P1|COMPLETED|Overall Study||0
5248267|NCT00808899|12901381|P1|STARTED|Overall Study||4
5248268|NCT00808834|12901385|P2|NOT COMPLETED|Period 2||0
5248269|NCT00808834|12901386|P1|NOT COMPLETED|Period 2||0
5248270|NCT00808834|12901385|P2|COMPLETED|Period 2||99
5248271|NCT00808834|12901386|P1|COMPLETED|Period 2||97
5248272|NCT00808834|12901385|P2|STARTED|Period 2||99
5248273|NCT00808834|12901386|P1|STARTED|Period 2||97
5248274|NCT00808834|12901385|P2|NOT COMPLETED|Period 1||0
5248275|NCT00808834|12901386|P1|NOT COMPLETED|Period 1||0
5248276|NCT00808834|12901385|P2|COMPLETED|Period 1||99
5248277|NCT00808834|12901386|P1|COMPLETED|Period 1||97
5248278|NCT00808834|12901385|P2|STARTED|Period 1||99
5248279|NCT00808834|12901386|P1|STARTED|Period 1||97
5248280|NCT00808808|12901395|P3|NOT COMPLETED|Overall Study||2557
5248281|NCT00808808|12901396|P2|NOT COMPLETED|Overall Study||2437
5248282|NCT00808808|12901397|P1|NOT COMPLETED|Overall Study||2817
5248283|NCT00808808|12901395|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
5248284|NCT00808808|12901396|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
5248285|NCT00808808|12901397|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
5248286|NCT00808808|12901395|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
5248287|NCT00808808|12901396|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
5248288|NCT00808808|12901397|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
5248289|NCT00808808|12901395|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
5248290|NCT00808808|12901396|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
5248291|NCT00808808|12901397|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
5248292|NCT00808769|12901423|P2|NOT COMPLETED|Second Intervention||0
5248293|NCT00808769|12901424|P1|NOT COMPLETED|Second Intervention||0
5248294|NCT00808769|12901423|P2|COMPLETED|Second Intervention||15
5248295|NCT00808769|12901424|P1|COMPLETED|Second Intervention||15
5248296|NCT00808769|12901423|P2|STARTED|Second Intervention||15
5248297|NCT00808769|12901424|P1|STARTED|Second Intervention||15
5248298|NCT00808769|12901423|P2|NOT COMPLETED|First Intervention||0
5248299|NCT00808769|12901424|P1|NOT COMPLETED|First Intervention||0
5248300|NCT00808769|12901423|P2|COMPLETED|First Intervention||15
5248301|NCT00808769|12901424|P1|COMPLETED|First Intervention||15
5248302|NCT00808769|12901423|P2|STARTED|First Intervention||15
5248303|NCT00808769|12901424|P1|STARTED|First Intervention||15
5248304|NCT00808665|12901432|P2|NOT COMPLETED|Overall Study||3
5248305|NCT00808665|12901433|P1|NOT COMPLETED|Overall Study||6
5248306|NCT00808665|12901432|P2|COMPLETED|Overall Study||29
5248307|NCT00808665|12901433|P1|COMPLETED|Overall Study||25
5248308|NCT00808665|12901432|P2|Completed Post Operative Doses|Overall Study||29
5248309|NCT00808665|12901433|P1|Completed Post Operative Doses|Overall Study||25
5248310|NCT00808665|12901432|P2|Completed Intra-operative Dose|Overall Study||32
5248311|NCT00808665|12901433|P1|Completed Intra-operative Dose|Overall Study||26
5248312|NCT00808665|12901432|P2|Medication Started|Overall Study||32
5248313|NCT00808665|12901433|P1|Medication Started|Overall Study||30
5248314|NCT00808665|12901432|P2|STARTED|Overall Study||32
5248315|NCT00808665|12901433|P1|STARTED|Overall Study||31
5248316|NCT00808639|12901439|P1|NOT COMPLETED|Overall Study||1
5248317|NCT00808639|12901439|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
5248318|NCT00808639|12901439|P1|STARTED|Overall Study||39
5248319|NCT00808509|12901447|P2|NOT COMPLETED|Observation Phase||0
5248320|NCT00808509|12901448|P1|NOT COMPLETED|Observation Phase||0
5248321|NCT00808509|12901447|P2|COMPLETED|Observation Phase||15
5248322|NCT00808509|12901448|P1|COMPLETED|Observation Phase||16
5248323|NCT00808509|12901447|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
5248324|NCT00808509|12901448|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
5248325|NCT00808509|12901447|P2|NOT COMPLETED|Randomized Phase||5
5248326|NCT00808509|12901448|P1|NOT COMPLETED|Randomized Phase||2
5248327|NCT00808509|12901447|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
5248328|NCT00808509|12901448|P1|COMPLETED|Randomized Phase||15
5248329|NCT00808509|12901447|P2|Received Rescue Therapy|Randomized Phase||9
5248330|NCT00808509|12901448|P1|Received Rescue Therapy|Randomized Phase||0
5248331|NCT00808509|12901447|P2|STARTED|Randomized Phase||16
5248332|NCT00808509|12901448|P1|STARTED|Randomized Phase||17
5248333|NCT00808483|12901546|P2|NOT COMPLETED|From 5 Months to 12 Months||0
5248334|NCT00808483|12901547|P1|NOT COMPLETED|From 5 Months to 12 Months||1
5248335|NCT00808483|12901546|P2|COMPLETED|From 5 Months to 12 Months||32
5248336|NCT00808483|12901547|P1|COMPLETED|From 5 Months to 12 Months||32
5248337|NCT00808483|12901546|P2|STARTED|From 5 Months to 12 Months||32
5248338|NCT00808483|12901547|P1|STARTED|From 5 Months to 12 Months||33
5248339|NCT00808483|12901546|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
5248340|NCT00808483|12901547|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
5248341|NCT00808483|12901546|P2|COMPLETED|From 3 to 5 Months After Surgery||32
5248342|NCT00808483|12901547|P1|COMPLETED|From 3 to 5 Months After Surgery||33
5248343|NCT00808483|12901546|P2|STARTED|From 3 to 5 Months After Surgery||33
5248344|NCT00808483|12901547|P1|STARTED|From 3 to 5 Months After Surgery||35
5248345|NCT00808470|12901569|P2|NOT COMPLETED|Overall Study||0
5248346|NCT00808470|12901570|P1|NOT COMPLETED|Overall Study||2
5248347|NCT00808470|12901569|P2|COMPLETED|Overall Study||35
5248348|NCT00808470|12901570|P1|COMPLETED|Overall Study||35
5248349|NCT00808470|12901569|P2|STARTED|Overall Study||35
5248350|NCT00808470|12901570|P1|STARTED|Overall Study||37
5248351|NCT00808444|12901584|P2|NOT COMPLETED|Overall Study||1
5248352|NCT00808444|12901585|P1|NOT COMPLETED|Overall Study||1
5248353|NCT00808444|12901584|P2|COMPLETED|Overall Study||232
5248354|NCT00808444|12901585|P1|COMPLETED|Overall Study||232
5248355|NCT00808444|12901584|P2|STARTED|Overall Study||233
5248356|NCT00808444|12901585|P1|STARTED|Overall Study||233
5248357|NCT00808405|12901625|P2|NOT COMPLETED|Overall Study||0
5248358|NCT00808405|12901626|P1|NOT COMPLETED|Overall Study||0
5248359|NCT00808405|12901625|P2|COMPLETED|Overall Study||27
5248360|NCT00808405|12901626|P1|COMPLETED|Overall Study||61
5248361|NCT00808405|12901625|P2|STARTED|Overall Study||27
5248362|NCT00808405|12901626|P1|STARTED|Overall Study||61
5248363|NCT00808340|12901634|P6|NOT COMPLETED|Third Intervention||0
5248364|NCT00808340|12901635|P5|NOT COMPLETED|Third Intervention||0
5248365|NCT00808340|12901636|P4|NOT COMPLETED|Third Intervention||0
5248366|NCT00808340|12901637|P3|NOT COMPLETED|Third Intervention||0
5248367|NCT00808340|12901638|P2|NOT COMPLETED|Third Intervention||0
5248368|NCT00808340|12901639|P1|NOT COMPLETED|Third Intervention||0
5248369|NCT00808340|12901634|P6|COMPLETED|Third Intervention||6
5248370|NCT00808340|12901635|P5|COMPLETED|Third Intervention||5
5248371|NCT00808340|12901636|P4|COMPLETED|Third Intervention||3
5248372|NCT00808340|12901637|P3|COMPLETED|Third Intervention||7
5248373|NCT00808340|12901638|P2|COMPLETED|Third Intervention||9
5248374|NCT00808340|12901639|P1|COMPLETED|Third Intervention||4
5248375|NCT00808340|12901634|P6|STARTED|Third Intervention||6
5248376|NCT00808340|12901635|P5|STARTED|Third Intervention||5
5248377|NCT00808340|12901636|P4|STARTED|Third Intervention||3
5248378|NCT00808340|12901637|P3|STARTED|Third Intervention||7
5248379|NCT00808340|12901638|P2|STARTED|Third Intervention||9
5248380|NCT00808340|12901639|P1|STARTED|Third Intervention||4
5248381|NCT00808340|12901634|P6|NOT COMPLETED|Second Intervention||0
5248382|NCT00808340|12901635|P5|NOT COMPLETED|Second Intervention||0
5248383|NCT00808340|12901636|P4|NOT COMPLETED|Second Intervention||0
5248384|NCT00808340|12901637|P3|NOT COMPLETED|Second Intervention||0
5248385|NCT00808340|12901638|P2|NOT COMPLETED|Second Intervention||0
5248386|NCT00808340|12901639|P1|NOT COMPLETED|Second Intervention||0
5248387|NCT00808340|12901634|P6|COMPLETED|Second Intervention||6
5248388|NCT00808340|12901635|P5|COMPLETED|Second Intervention||5
5248389|NCT00808340|12901636|P4|COMPLETED|Second Intervention||3
5248390|NCT00808340|12901637|P3|COMPLETED|Second Intervention||7
5248391|NCT00808340|12901638|P2|COMPLETED|Second Intervention||9
5248392|NCT00808340|12901639|P1|COMPLETED|Second Intervention||4
5248393|NCT00808340|12901634|P6|STARTED|Second Intervention||6
5248394|NCT00808340|12901635|P5|STARTED|Second Intervention||5
5248395|NCT00808340|12901636|P4|STARTED|Second Intervention||3
5248396|NCT00808340|12901637|P3|STARTED|Second Intervention||7
5248397|NCT00808340|12901638|P2|STARTED|Second Intervention||9
5248398|NCT00808340|12901639|P1|STARTED|Second Intervention||4
5248399|NCT00808340|12901634|P6|NOT COMPLETED|First Intervention||0
5248400|NCT00808340|12901635|P5|NOT COMPLETED|First Intervention||0
5248401|NCT00808340|12901636|P4|NOT COMPLETED|First Intervention||0
5248402|NCT00808340|12901637|P3|NOT COMPLETED|First Intervention||0
5248403|NCT00808340|12901638|P2|NOT COMPLETED|First Intervention||0
5248404|NCT00808340|12901639|P1|NOT COMPLETED|First Intervention||0
5248405|NCT00808340|12901634|P6|COMPLETED|First Intervention||6
5248406|NCT00808340|12901635|P5|COMPLETED|First Intervention||5
5248407|NCT00808340|12901636|P4|COMPLETED|First Intervention||3
5248408|NCT00808340|12901637|P3|COMPLETED|First Intervention||7
5248409|NCT00808340|12901638|P2|COMPLETED|First Intervention||9
5248410|NCT00808340|12901639|P1|COMPLETED|First Intervention||4
5248411|NCT00808340|12901634|P6|STARTED|First Intervention||6
5248412|NCT00808340|12901635|P5|STARTED|First Intervention||5
5248413|NCT00808340|12901636|P4|STARTED|First Intervention||3
5248414|NCT00808340|12901637|P3|STARTED|First Intervention||7
5248415|NCT00808340|12901638|P2|STARTED|First Intervention||9
5248416|NCT00808340|12901639|P1|STARTED|First Intervention||4
5248417|NCT00808249|12901660|P4|NOT COMPLETED|Overall Study||16
5248418|NCT00808249|12901661|P3|NOT COMPLETED|Overall Study||22
5248419|NCT00808249|12901662|P2|NOT COMPLETED|Overall Study||15
5248420|NCT00808249|12901663|P1|NOT COMPLETED|Overall Study||17
5248421|NCT00808249|12901660|P4|COMPLETED|Overall Study||90
5248422|NCT00808249|12901661|P3|COMPLETED|Overall Study||83
5248423|NCT00808249|12901662|P2|COMPLETED|Overall Study||91
5248424|NCT00808249|12901663|P1|COMPLETED|Overall Study||90
5248425|NCT00808249|12901660|P4|STARTED|Overall Study||106
5248426|NCT00808249|12901661|P3|STARTED|Overall Study||105
5248427|NCT00808249|12901662|P2|STARTED|Overall Study||106
5248428|NCT00808249|12901663|P1|STARTED|Overall Study||107
5248429|NCT00808236|12901691|P2|NOT COMPLETED|Overall Study||91
5248430|NCT00808236|12901692|P1|NOT COMPLETED|Overall Study||82
5248431|NCT00808236|12901691|P2|COMPLETED|Overall Study||13
5248432|NCT00808236|12901692|P1|COMPLETED|Overall Study||14
5248433|NCT00808236|12901691|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
5248434|NCT00808236|12901692|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
5248435|NCT00808236|12901691|P2|Achieved ROSC|Overall Study||43
5248436|NCT00808236|12901692|P1|Achieved ROSC|Overall Study||33
5248437|NCT00808236|12901691|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
5248438|NCT00808236|12901692|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
5248439|NCT00808236|12901691|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
5248440|NCT00808236|12901692|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
5248441|NCT00808236|12901691|P2|STARTED|Overall Study||104
5248442|NCT00808236|12901692|P1|STARTED|Overall Study||96
5248443|NCT00808132|12901725|P5|NOT COMPLETED|Overall Study||100
5248444|NCT00808132|12901726|P4|NOT COMPLETED|Overall Study||69
5248445|NCT00808132|12901727|P3|NOT COMPLETED|Overall Study||54
5248446|NCT00808132|12901728|P2|NOT COMPLETED|Overall Study||88
5248447|NCT00808132|12901729|P1|NOT COMPLETED|Overall Study||98
5248448|NCT00808132|12901725|P5|COMPLETED|Overall Study||383
5248449|NCT00808132|12901726|P4|COMPLETED|Overall Study||159
5248450|NCT00808132|12901727|P3|COMPLETED|Overall Study||185
5248451|NCT00808132|12901728|P2|COMPLETED|Overall Study||393
5248452|NCT00808132|12901729|P1|COMPLETED|Overall Study||357
5248453|NCT00808132|12901725|P5|Treated|Overall Study||474
5248454|NCT00808132|12901726|P4|Treated|Overall Study||220
5248455|NCT00808132|12901727|P3|Treated|Overall Study||230
5248456|NCT00808132|12901728|P2|Treated|Overall Study||474
5248457|NCT00808132|12901729|P1|Treated|Overall Study||445
5248458|NCT00808132|12901725|P5|STARTED|Overall Study||483
5248459|NCT00808132|12901726|P4|STARTED|Overall Study||228
5248460|NCT00808132|12901727|P3|STARTED|Overall Study||239
5248461|NCT00808132|12901728|P2|STARTED|Overall Study||481
5248462|NCT00808132|12901729|P1|STARTED|Overall Study||455
5248463|NCT00808080|12901801|P1|NOT COMPLETED|Overall Study||6
5248464|NCT00808080|12901801|P1|COMPLETED|Overall Study||0
5248465|NCT00808080|12901801|P1|STARTED|Overall Study||6
5248466|NCT00808067|12901808|P2|NOT COMPLETED|Overall Study||518
5248467|NCT00808067|12901809|P1|NOT COMPLETED|Overall Study||481
5248468|NCT00808067|12901808|P2|COMPLETED|Overall Study||2438
5248469|NCT00808067|12901809|P1|COMPLETED|Overall Study||2446
5248470|NCT00808067|12901808|P2|STARTED|Overall Study|Number of patients which are treated.|2956
5248471|NCT00808067|12901809|P1|STARTED|Overall Study|Number of patients which are treated.|2927
5248472|NCT00808028|12901845|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
5248473|NCT00808028|12901846|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
5248474|NCT00808028|12901847|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
5248475|NCT00808028|12901848|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
5248476|NCT00808028|12901845|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
5248477|NCT00808028|12901846|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
5248478|NCT00808028|12901847|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
5248479|NCT00808028|12901848|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
5248480|NCT00808028|12901845|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
5248481|NCT00808028|12901846|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
5248482|NCT00808028|12901847|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
5248483|NCT00808028|12901848|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
5248484|NCT00808028|12901845|P4|NOT COMPLETED|Stage 1 (6 Months)||15
5248485|NCT00808028|12901846|P3|NOT COMPLETED|Stage 1 (6 Months)||7
5248486|NCT00808028|12901847|P2|NOT COMPLETED|Stage 1 (6 Months)||1
5248487|NCT00808028|12901848|P1|NOT COMPLETED|Stage 1 (6 Months)||5
5248488|NCT00808028|12901845|P4|COMPLETED|Stage 1 (6 Months)||183
5248489|NCT00808028|12901846|P3|COMPLETED|Stage 1 (6 Months)||191
5248490|NCT00808028|12901847|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
5248491|NCT00808028|12901848|P1|COMPLETED|Stage 1 (6 Months)||116
5248492|NCT00808028|12901845|P4|STARTED|Stage 1 (6 Months)||198
5248493|NCT00808028|12901846|P3|STARTED|Stage 1 (6 Months)||198
5248494|NCT00808028|12901847|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
5248495|NCT00808028|12901848|P1|STARTED|Stage 1 (6 Months)||121
5248496|NCT00808015|12901884|P1|NOT COMPLETED|Overall Study||344
5248497|NCT00808015|12901884|P1|COMPLETED|Overall Study||1033
5248498|NCT00808015|12901884|P1|Treated|Overall Study||1373
5248499|NCT00808015|12901884|P1|STARTED|Overall Study||1377
5248500|NCT00807989|12901898|P2|NOT COMPLETED|Overall Study||2
5248501|NCT00807989|12901899|P1|NOT COMPLETED|Overall Study||3
5248502|NCT00807989|12901898|P2|COMPLETED|Overall Study||98
5248503|NCT00807989|12901899|P1|COMPLETED|Overall Study||104
5248504|NCT00807989|12901898|P2|STARTED|Overall Study||100
5248505|NCT00807989|12901899|P1|STARTED|Overall Study||107
5248506|NCT00807937|12901913|P4|NOT COMPLETED|Overall Study||15
5248507|NCT00807937|12901914|P3|NOT COMPLETED|Overall Study||14
5248508|NCT00807937|12901915|P2|NOT COMPLETED|Overall Study||25
5248509|NCT00807937|12901916|P1|NOT COMPLETED|Overall Study||27
5248510|NCT00807937|12901913|P4|COMPLETED|Overall Study||77
5248511|NCT00807937|12901914|P3|COMPLETED|Overall Study||78
5248512|NCT00807937|12901915|P2|COMPLETED|Overall Study||67
5248513|NCT00807937|12901916|P1|COMPLETED|Overall Study||66
5248514|NCT00807937|12901913|P4|STARTED|Overall Study||92
5248515|NCT00807937|12901914|P3|STARTED|Overall Study||92
5248516|NCT00807937|12901915|P2|STARTED|Overall Study||92
5248517|NCT00807937|12901916|P1|STARTED|Overall Study||93
5248518|NCT00807885|12901951|P9|NOT COMPLETED|Overall Study||0
5248519|NCT00807885|12901952|P8|NOT COMPLETED|Overall Study||0
5248520|NCT00807885|12901953|P7|NOT COMPLETED|Overall Study||0
5248521|NCT00807885|12901954|P6|NOT COMPLETED|Overall Study||1
5248522|NCT00807885|12901955|P5|NOT COMPLETED|Overall Study||0
5248523|NCT00807885|12901956|P4|NOT COMPLETED|Overall Study||0
5248524|NCT00807885|12901957|P3|NOT COMPLETED|Overall Study||0
5248525|NCT00807885|12901958|P2|NOT COMPLETED|Overall Study||0
5248526|NCT00807885|12901959|P1|NOT COMPLETED|Overall Study||0
5248527|NCT00807885|12901951|P9|COMPLETED|Overall Study||11
5248528|NCT00807885|12901952|P8|COMPLETED|Overall Study||11
5248529|NCT00807885|12901953|P7|COMPLETED|Overall Study||12
5248530|NCT00807885|12901954|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
5248531|NCT00807885|12901955|P5|COMPLETED|Overall Study||12
5248532|NCT00807885|12901956|P4|COMPLETED|Overall Study||10
5248533|NCT00807885|12901957|P3|COMPLETED|Overall Study||11
5248534|NCT00807885|12901958|P2|COMPLETED|Overall Study||11
5248535|NCT00807885|12901959|P1|COMPLETED|Overall Study||10
5248536|NCT00807885|12901951|P9|STARTED|Overall Study||11
5248537|NCT00807885|12901952|P8|STARTED|Overall Study||11
5248538|NCT00807885|12901953|P7|STARTED|Overall Study||12
5248539|NCT00807885|12901954|P6|STARTED|Overall Study||12
5248540|NCT00807885|12901955|P5|STARTED|Overall Study||12
5248541|NCT00807885|12901956|P4|STARTED|Overall Study||10
5248542|NCT00807885|12901957|P3|STARTED|Overall Study||11
5248543|NCT00807885|12901958|P2|STARTED|Overall Study||11
5248544|NCT00807885|12901959|P1|STARTED|Overall Study||10
5248545|NCT00807846|12902008|P2|NOT COMPLETED|Overall Study||4
5248546|NCT00807846|12902009|P1|NOT COMPLETED|Overall Study||12
5248547|NCT00807846|12902008|P2|COMPLETED|Overall Study||94
5248548|NCT00807846|12902009|P1|COMPLETED|Overall Study||88
5248549|NCT00807846|12902008|P2|STARTED|Overall Study||98
5248550|NCT00807846|12902009|P1|STARTED|Overall Study||100
5248551|NCT00807768|12902043|P2|NOT COMPLETED|Overall Study||0
5248552|NCT00807768|12902044|P1|NOT COMPLETED|Overall Study||0
5248553|NCT00807768|12902043|P2|COMPLETED|Overall Study||300
5248554|NCT00807768|12902044|P1|COMPLETED|Overall Study||301
5248555|NCT00807768|12902043|P2|STARTED|Overall Study||300
5248556|NCT00807768|12902044|P1|STARTED|Overall Study||301
5248557|NCT00807742|12902062|P2|NOT COMPLETED|Overall Study||54
5248558|NCT00807742|12902063|P1|NOT COMPLETED|Overall Study||46
5248559|NCT00807742|12902062|P2|COMPLETED|Overall Study||114
5248560|NCT00807742|12902063|P1|COMPLETED|Overall Study||126
5248561|NCT00807742|12902062|P2|STARTED|Overall Study||168
5248562|NCT00807742|12902063|P1|STARTED|Overall Study||172
5248563|NCT00807664|12902109|P2|NOT COMPLETED|Overall Study||19
5248564|NCT00807664|12902110|P1|NOT COMPLETED|Overall Study||11
5248565|NCT00807664|12902109|P2|COMPLETED|Overall Study||75
5248566|NCT00807664|12902110|P1|COMPLETED|Overall Study||77
5248567|NCT00807664|12902109|P2|STARTED|Overall Study||94
5248568|NCT00807664|12902110|P1|STARTED|Overall Study||88
5248569|NCT00807599|12902122|P3|NOT COMPLETED|Overall Study||17
5248570|NCT00807599|12902123|P2|NOT COMPLETED|Overall Study||0
5248571|NCT00807599|12902124|P1|NOT COMPLETED|Overall Study||0
5248572|NCT00807599|12902122|P3|COMPLETED|Overall Study||0
5248573|NCT00807599|12902123|P2|COMPLETED|Overall Study||24
5248574|NCT00807599|12902124|P1|COMPLETED|Overall Study||26
5248575|NCT00807599|12902122|P3|STARTED|Overall Study||17
5248576|NCT00807599|12902123|P2|STARTED|Overall Study||24
5248577|NCT00807599|12902124|P1|STARTED|Overall Study||26
5248578|NCT00807586|12902138|P2|NOT COMPLETED|Overall Study||1
5248579|NCT00807586|12902139|P1|NOT COMPLETED|Overall Study||6
5248580|NCT00807586|12902138|P2|COMPLETED|Overall Study||58
5248581|NCT00807586|12902139|P1|COMPLETED|Overall Study||54
5248582|NCT00807586|12902138|P2|STARTED|Overall Study||59
5248583|NCT00807586|12902139|P1|STARTED|Overall Study||60
5248584|NCT00807573|12902151|P1|NOT COMPLETED|Overall Study||2
5248585|NCT00807573|12902151|P1|COMPLETED|Overall Study||42
5248586|NCT00807573|12902151|P1|STARTED|Overall Study||44
5248587|NCT00807560|12902157|P2|NOT COMPLETED|Overall Study||0
5248588|NCT00807560|12902158|P1|NOT COMPLETED|Overall Study||0
5248589|NCT00807560|12902157|P2|COMPLETED|Overall Study||39
5248590|NCT00807560|12902158|P1|COMPLETED|Overall Study||38
5248591|NCT00807560|12902157|P2|STARTED|Overall Study||39
5248592|NCT00807560|12902158|P1|STARTED|Overall Study||38
5248593|NCT00807495|12902197|P5|NOT COMPLETED|Overall Study||5
5248594|NCT00807495|12902198|P4|NOT COMPLETED|Overall Study||1
5248595|NCT00807495|12902199|P3|NOT COMPLETED|Overall Study||4
5248596|NCT00807495|12902200|P2|NOT COMPLETED|Overall Study||6
5248597|NCT00807495|12902201|P1|NOT COMPLETED|Overall Study||8
5248598|NCT00807495|12902197|P5|COMPLETED|Overall Study||2
5248599|NCT00807495|12902198|P4|COMPLETED|Overall Study||0
5248600|NCT00807495|12902199|P3|COMPLETED|Overall Study||1
5248601|NCT00807495|12902200|P2|COMPLETED|Overall Study||7
5248602|NCT00807495|12902201|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
5248603|NCT00807495|12902197|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
5248604|NCT00807495|12902198|P4|STARTED|Overall Study||1
5248605|NCT00807495|12902199|P3|STARTED|Overall Study||5
5248606|NCT00807495|12902200|P2|STARTED|Overall Study||13
5248607|NCT00807495|12902201|P1|STARTED|Overall Study||22
5248608|NCT00807456|12902243|P1|NOT COMPLETED|Overall Study||0
5248609|NCT00807456|12902243|P1|COMPLETED|Overall Study||65
5248610|NCT00807456|12902243|P1|STARTED|Overall Study||65
5248611|NCT00807365|12902247|P1|NOT COMPLETED|Overall Study||5
5248612|NCT00807365|12902247|P1|COMPLETED|Overall Study||0
5248613|NCT00807365|12902247|P1|STARTED|Overall Study||5
5248614|NCT00807248|12902255|P4|NOT COMPLETED|Overall Study||14
5248615|NCT00807248|12902256|P3|NOT COMPLETED|Overall Study||18
5248616|NCT00807248|12902257|P2|NOT COMPLETED|Overall Study||12
5248617|NCT00807248|12902258|P1|NOT COMPLETED|Overall Study||21
5248618|NCT00807248|12902255|P4|COMPLETED|Overall Study||126
5248619|NCT00807248|12902256|P3|COMPLETED|Overall Study||121
5248620|NCT00807248|12902257|P2|COMPLETED|Overall Study||128
5248621|NCT00807248|12902258|P1|COMPLETED|Overall Study||50
5248622|NCT00807248|12902255|P4|STARTED|Overall Study||140
5248623|NCT00807248|12902256|P3|STARTED|Overall Study||139
5248624|NCT00807248|12902257|P2|STARTED|Overall Study||140
5248625|NCT00807248|12902258|P1|STARTED|Overall Study||71
5248626|NCT00807235|12902302|P2|NOT COMPLETED|Overall Study||0
5248627|NCT00807235|12902303|P1|NOT COMPLETED|Overall Study||1
5248628|NCT00807235|12902302|P2|COMPLETED|Overall Study||6
5248629|NCT00807235|12902303|P1|COMPLETED|Overall Study||10
5248630|NCT00807235|12902302|P2|STARTED|Overall Study||6
5248631|NCT00807235|12902303|P1|STARTED|Overall Study||11
5248632|NCT00807209|12902336|P3|NOT COMPLETED|Overall Study||0
5248633|NCT00807209|12902337|P2|NOT COMPLETED|Overall Study||0
5248634|NCT00807209|12902338|P1|NOT COMPLETED|Overall Study||0
5248635|NCT00807209|12902336|P3|COMPLETED|Overall Study||1
5248636|NCT00807209|12902337|P2|COMPLETED|Overall Study||1
5248637|NCT00807209|12902338|P1|COMPLETED|Overall Study||1
5248638|NCT00807209|12902336|P3|STARTED|Overall Study||1
5248639|NCT00807209|12902337|P2|STARTED|Overall Study||1
5248640|NCT00807209|12902338|P1|STARTED|Overall Study||1
5248641|NCT00807092|12902348|P2|NOT COMPLETED|Overall Study||4
5248642|NCT00807092|12902349|P1|NOT COMPLETED|Overall Study||1
5248643|NCT00807092|12902348|P2|COMPLETED|Overall Study||69
5248644|NCT00807092|12902349|P1|COMPLETED|Overall Study||71
5248645|NCT00807092|12902348|P2|Exposed to Drug|Overall Study||73
5248646|NCT00807092|12902349|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
5248647|NCT00807092|12902348|P2|STARTED|Overall Study||73
5248648|NCT00807092|12902349|P1|STARTED|Overall Study||72
5248649|NCT00807040|12902379|P2|NOT COMPLETED|Overall Study||41
5248650|NCT00807040|12902380|P1|NOT COMPLETED|Overall Study||36
5248651|NCT00807040|12902379|P2|COMPLETED|Overall Study||84
5248652|NCT00807040|12902380|P1|COMPLETED|Overall Study||90
5248653|NCT00807040|12902379|P2|STARTED|Overall Study||125
5248654|NCT00807040|12902380|P1|STARTED|Overall Study||126
5248655|NCT00807014|12902390|P2|NOT COMPLETED|Overall Study||27
5248656|NCT00807014|12902391|P1|NOT COMPLETED|Overall Study||27
5248657|NCT00807014|12902390|P2|COMPLETED|Overall Study||58
5248658|NCT00807014|12902391|P1|COMPLETED|Overall Study||56
5248659|NCT00807014|12902390|P2|STARTED|Overall Study||85
5248660|NCT00807014|12902391|P1|STARTED|Overall Study||83
5248661|NCT00807001|12902422|P5|NOT COMPLETED|Overall Study||0
5248662|NCT00807001|12902423|P4|NOT COMPLETED|Overall Study||0
5248663|NCT00807001|12902424|P3|NOT COMPLETED|Overall Study||0
5248664|NCT00807001|12902425|P2|NOT COMPLETED|Overall Study||1
5248665|NCT00807001|12902426|P1|NOT COMPLETED|Overall Study||0
5248666|NCT00807001|12902422|P5|COMPLETED|Overall Study||9
5248667|NCT00807001|12902423|P4|COMPLETED|Overall Study||8
5248668|NCT00807001|12902424|P3|COMPLETED|Overall Study||8
5248669|NCT00807001|12902425|P2|COMPLETED|Overall Study||7
5248670|NCT00807001|12902426|P1|COMPLETED|Overall Study||8
5248671|NCT00807001|12902422|P5|STARTED|Overall Study||9
5248672|NCT00807001|12902423|P4|STARTED|Overall Study||8
5248673|NCT00807001|12902424|P3|STARTED|Overall Study||8
5248674|NCT00807001|12902425|P2|STARTED|Overall Study||8
5248675|NCT00807001|12902426|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
5248676|NCT00806988|12902445|P2|NOT COMPLETED|Overall Study||43
5248677|NCT00806988|12902446|P1|NOT COMPLETED|Overall Study||27
5248678|NCT00806988|12902445|P2|COMPLETED|Overall Study||108
5248679|NCT00806988|12902446|P1|COMPLETED|Overall Study||123
5248680|NCT00806988|12902445|P2|STARTED|Overall Study||151
5248681|NCT00806988|12902446|P1|STARTED|Overall Study||150
5248682|NCT00806819|12902456|P2|NOT COMPLETED|Overall Study||358
5248683|NCT00806819|12902457|P1|NOT COMPLETED|Overall Study||346
5248684|NCT00806819|12902456|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
5248685|NCT00806819|12902457|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
5248686|NCT00806819|12902456|P2|STARTED|Overall Study|randomised patients|360
5248687|NCT00806819|12902457|P1|STARTED|Overall Study|randomised patients|353
5248688|NCT00806676|12902492|P3|NOT COMPLETED|Overall Study||6
5248689|NCT00806676|12902493|P2|NOT COMPLETED|Overall Study||0
5248690|NCT00806676|12902494|P1|NOT COMPLETED|Overall Study||4
5248691|NCT00806676|12902492|P3|COMPLETED|Overall Study||23
5248692|NCT00806676|12902493|P2|COMPLETED|Overall Study||9
5248693|NCT00806676|12902494|P1|COMPLETED|Overall Study||25
5248694|NCT00806676|12902492|P3|STARTED|Overall Study||29
5248695|NCT00806676|12902493|P2|STARTED|Overall Study||9
5248696|NCT00806676|12902494|P1|STARTED|Overall Study||29
5248697|NCT00806624|12902526|P3|NOT COMPLETED|Overall Study||6
5248698|NCT00806624|12902527|P2|NOT COMPLETED|Overall Study||12
5248699|NCT00806624|12902528|P1|NOT COMPLETED|Overall Study||9
5248700|NCT00806624|12902526|P3|COMPLETED|Overall Study||69
5248701|NCT00806624|12902527|P2|COMPLETED|Overall Study||68
5248702|NCT00806624|12902528|P1|COMPLETED|Overall Study||70
5248703|NCT00806624|12902526|P3|STARTED|Overall Study||75
5248704|NCT00806624|12902527|P2|STARTED|Overall Study||80
5248705|NCT00806624|12902528|P1|STARTED|Overall Study||79
5248706|NCT00806598|12902536|P1|NOT COMPLETED|Overall Study||0
5248707|NCT00806598|12902536|P1|COMPLETED|Overall Study||48
5248708|NCT00806598|12902536|P1|STARTED|Overall Study||48
5248709|NCT00806585|12902545|P5|NOT COMPLETED|Overall Study||31
5248710|NCT00806585|12902546|P4|NOT COMPLETED|Overall Study||15
5248711|NCT00806585|12902547|P3|NOT COMPLETED|Overall Study||32
5248712|NCT00806585|12902548|P2|NOT COMPLETED|Overall Study||31
5248713|NCT00806585|12902549|P1|NOT COMPLETED|Overall Study||32
5248714|NCT00806585|12902545|P5|COMPLETED|Overall Study||106
5248715|NCT00806585|12902546|P4|COMPLETED|Overall Study||56
5248716|NCT00806585|12902547|P3|COMPLETED|Overall Study||109
5248717|NCT00806585|12902548|P2|COMPLETED|Overall Study||103
5248718|NCT00806585|12902549|P1|COMPLETED|Overall Study||105
5248719|NCT00806585|12902545|P5|STARTED|Overall Study||137
5248720|NCT00806585|12902546|P4|STARTED|Overall Study||71
5248721|NCT00806585|12902547|P3|STARTED|Overall Study||141
5248722|NCT00806585|12902548|P2|STARTED|Overall Study||134
5248723|NCT00806585|12902549|P1|STARTED|Overall Study||137
5248724|NCT00806546|12902581|P1|NOT COMPLETED|Overall Study||307
5248725|NCT00806546|12902581|P1|COMPLETED|Overall Study||207
5248726|NCT00806546|12902581|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
5248727|NCT00806494|12902585|P1|NOT COMPLETED|Overall Study||80
5248728|NCT00806494|12902585|P1|COMPLETED|Overall Study||251
5248729|NCT00806494|12902585|P1|STARTED|Overall Study||331
5248730|NCT00806442|12902609|P2|NOT COMPLETED|Overall Study||7
5248731|NCT00806442|12902610|P1|NOT COMPLETED|Overall Study||4
5248732|NCT00806442|12902609|P2|COMPLETED|Overall Study||14
5248733|NCT00806442|12902610|P1|COMPLETED|Overall Study||14
5248734|NCT00806442|12902609|P2|Second Intervention (3 Wks)|Overall Study||14
5248735|NCT00806442|12902610|P1|Second Intervention (3 Wks)|Overall Study||15
5248736|NCT00806442|12902609|P2|Washout (3 Wks)|Overall Study||14
5248737|NCT00806442|12902610|P1|Washout (3 Wks)|Overall Study||15
5248738|NCT00806442|12902609|P2|First Intervention (3 Wks)|Overall Study||21
5248739|NCT00806442|12902610|P1|First Intervention (3 Wks)|Overall Study||18
5248740|NCT00806442|12902609|P2|STARTED|Overall Study||21
5248741|NCT00806442|12902610|P1|STARTED|Overall Study||18
5248742|NCT00806416|12902632|P4|NOT COMPLETED|Period 2 - Part II||0
5248743|NCT00806416|12902633|P3|NOT COMPLETED|Period 2 - Part II||0
5248744|NCT00806416|12902634|P2|NOT COMPLETED|Period 2 - Part II||0
5248745|NCT00806416|12902635|P1|NOT COMPLETED|Period 2 - Part II||0
5248746|NCT00806416|12902632|P4|COMPLETED|Period 2 - Part II||14
5248747|NCT00806416|12902633|P3|COMPLETED|Period 2 - Part II||14
5248748|NCT00806416|12902634|P2|COMPLETED|Period 2 - Part II||0
5248749|NCT00806416|12902635|P1|COMPLETED|Period 2 - Part II||0
5248750|NCT00806416|12902632|P4|STARTED|Period 2 - Part II||14
5248751|NCT00806416|12902633|P3|STARTED|Period 2 - Part II||14
5248752|NCT00806416|12902634|P2|STARTED|Period 2 - Part II||0
5248753|NCT00806416|12902635|P1|STARTED|Period 2 - Part II||0
5248754|NCT00806416|12902632|P4|NOT COMPLETED|Period 1 - Part II||2
5248755|NCT00806416|12902633|P3|NOT COMPLETED|Period 1 - Part II||0
5248756|NCT00806416|12902634|P2|NOT COMPLETED|Period 1 - Part II||0
5248757|NCT00806416|12902635|P1|NOT COMPLETED|Period 1 - Part II||0
5248758|NCT00806416|12902632|P4|COMPLETED|Period 1 - Part II||14
5248759|NCT00806416|12902633|P3|COMPLETED|Period 1 - Part II||14
5248760|NCT00806416|12902634|P2|COMPLETED|Period 1 - Part II||0
5248761|NCT00806416|12902635|P1|COMPLETED|Period 1 - Part II||0
5248762|NCT00806416|12902632|P4|STARTED|Period 1 - Part II||16
5248763|NCT00806416|12902633|P3|STARTED|Period 1 - Part II||14
5248764|NCT00806416|12902634|P2|STARTED|Period 1 - Part II||0
5248765|NCT00806416|12902635|P1|STARTED|Period 1 - Part II||0
5248766|NCT00806416|12902632|P4|NOT COMPLETED|Period 2 - Part I||0
5248767|NCT00806416|12902633|P3|NOT COMPLETED|Period 2 - Part I||0
5248768|NCT00806416|12902634|P2|NOT COMPLETED|Period 2 - Part I||0
5248769|NCT00806416|12902635|P1|NOT COMPLETED|Period 2 - Part I||0
5248770|NCT00806416|12902632|P4|COMPLETED|Period 2 - Part I||0
5248771|NCT00806416|12902633|P3|COMPLETED|Period 2 - Part I||0
5248772|NCT00806416|12902634|P2|COMPLETED|Period 2 - Part I||103
5248773|NCT00806416|12902635|P1|COMPLETED|Period 2 - Part I||104
5248774|NCT00806416|12902632|P4|STARTED|Period 2 - Part I||0
5248775|NCT00806416|12902633|P3|STARTED|Period 2 - Part I||0
5248776|NCT00806416|12902634|P2|STARTED|Period 2 - Part I||103
5248777|NCT00806416|12902635|P1|STARTED|Period 2 - Part I||104
5248778|NCT00806416|12902632|P4|NOT COMPLETED|Period 1 - Part I||0
5248779|NCT00806416|12902633|P3|NOT COMPLETED|Period 1 - Part I||0
5248780|NCT00806416|12902634|P2|NOT COMPLETED|Period 1 - Part I||4
5248781|NCT00806416|12902635|P1|NOT COMPLETED|Period 1 - Part I||3
5248782|NCT00806416|12902632|P4|COMPLETED|Period 1 - Part I||0
5248783|NCT00806416|12902633|P3|COMPLETED|Period 1 - Part I||0
5248784|NCT00806416|12902634|P2|COMPLETED|Period 1 - Part I||103
5248785|NCT00806416|12902635|P1|COMPLETED|Period 1 - Part I||104
5248786|NCT00806416|12902632|P4|STARTED|Period 1 - Part I||0
5248787|NCT00806416|12902633|P3|STARTED|Period 1 - Part I||0
5248788|NCT00806416|12902634|P2|STARTED|Period 1 - Part I||107
5248789|NCT00806416|12902635|P1|STARTED|Period 1 - Part I||107
5248790|NCT00806403|12902648|P2|NOT COMPLETED|Overall Study||3
5248791|NCT00806403|12902649|P1|NOT COMPLETED|Overall Study||4
5248792|NCT00806403|12902648|P2|COMPLETED|Overall Study||98
5248793|NCT00806403|12902649|P1|COMPLETED|Overall Study||100
5248794|NCT00806403|12902648|P2|STARTED|Overall Study||101
5248795|NCT00806403|12902649|P1|STARTED|Overall Study||104
5248796|NCT00806390|12902663|P2|NOT COMPLETED|Overall Study||0
5248797|NCT00806390|12902664|P1|NOT COMPLETED|Overall Study||0
5248798|NCT00806390|12902663|P2|COMPLETED|Overall Study||8
5248799|NCT00806390|12902664|P1|COMPLETED|Overall Study||7
5248800|NCT00806390|12902663|P2|STARTED|Overall Study||8
5248801|NCT00806390|12902664|P1|STARTED|Overall Study||7
5248802|NCT00806351|12902672|P2|NOT COMPLETED|Overall Study||4
5248803|NCT00806351|12902673|P1|NOT COMPLETED|Overall Study||5
5248804|NCT00806351|12902672|P2|COMPLETED|Overall Study||2
5248805|NCT00806351|12902673|P1|COMPLETED|Overall Study||10
5248806|NCT00806351|12902672|P2|STARTED|Overall Study||6
5248807|NCT00806351|12902673|P1|STARTED|Overall Study||15
5248808|NCT00806286|12902707|P3|NOT COMPLETED|Overall Study||3
5248809|NCT00806286|12902708|P2|NOT COMPLETED|Overall Study||54
5248810|NCT00806286|12902709|P1|NOT COMPLETED|Overall Study||54
5248811|NCT00806286|12902707|P3|COMPLETED|Overall Study||0
5248812|NCT00806286|12902708|P2|COMPLETED|Overall Study||0
5248813|NCT00806286|12902709|P1|COMPLETED|Overall Study||0
5248814|NCT00806286|12902707|P3|STARTED|Overall Study||3
5248815|NCT00806286|12902708|P2|STARTED|Overall Study||54
5248816|NCT00806286|12902709|P1|STARTED|Overall Study||54
5248817|NCT00806260|12902731|P6|NOT COMPLETED|Period 3||0
5248818|NCT00806260|12902732|P5|NOT COMPLETED|Period 3||0
5248819|NCT00806260|12902733|P4|NOT COMPLETED|Period 3||0
5248820|NCT00806260|12902734|P3|NOT COMPLETED|Period 3||1
5248821|NCT00806260|12902735|P2|NOT COMPLETED|Period 3||1
5248822|NCT00806260|12902736|P1|NOT COMPLETED|Period 3||1
5248823|NCT00806260|12902731|P6|COMPLETED|Period 3||0
5248824|NCT00806260|12902732|P5|COMPLETED|Period 3||0
5248825|NCT00806260|12902733|P4|COMPLETED|Period 3||12
5248826|NCT00806260|12902734|P3|COMPLETED|Period 3||5
5248827|NCT00806260|12902735|P2|COMPLETED|Period 3||7
5248828|NCT00806260|12902736|P1|COMPLETED|Period 3||12
5248829|NCT00806260|12902731|P6|STARTED|Period 3||0
5248830|NCT00806260|12902732|P5|STARTED|Period 3||0
5248831|NCT00806260|12902733|P4|STARTED|Period 3||12
5248832|NCT00806260|12902734|P3|STARTED|Period 3||6
5248833|NCT00806260|12902735|P2|STARTED|Period 3||8
5248834|NCT00806260|12902736|P1|STARTED|Period 3||13
5248835|NCT00806260|12902731|P6|NOT COMPLETED|Period 2||0
5248836|NCT00806260|12902732|P5|NOT COMPLETED|Period 2||0
5248837|NCT00806260|12902733|P4|NOT COMPLETED|Period 2||2
5248838|NCT00806260|12902734|P3|NOT COMPLETED|Period 2||2
5248839|NCT00806260|12902735|P2|NOT COMPLETED|Period 2||0
5248840|NCT00806260|12902736|P1|NOT COMPLETED|Period 2||2
5248841|NCT00806260|12902731|P6|COMPLETED|Period 2||0
5248842|NCT00806260|12902732|P5|COMPLETED|Period 2||0
5248843|NCT00806260|12902733|P4|COMPLETED|Period 2||12
5248844|NCT00806260|12902734|P3|COMPLETED|Period 2||6
5248845|NCT00806260|12902735|P2|COMPLETED|Period 2||8
5248846|NCT00806260|12902736|P1|COMPLETED|Period 2||13
5248847|NCT00806260|12902731|P6|STARTED|Period 2||0
5248848|NCT00806260|12902732|P5|STARTED|Period 2||0
5248849|NCT00806260|12902733|P4|STARTED|Period 2||14
5248850|NCT00806260|12902734|P3|STARTED|Period 2||8
5248851|NCT00806260|12902735|P2|STARTED|Period 2||8
5248852|NCT00806260|12902736|P1|STARTED|Period 2||15
5248853|NCT00806260|12902731|P6|NOT COMPLETED|Period 1 (1 Day)||0
5248854|NCT00806260|12902732|P5|NOT COMPLETED|Period 1 (1 Day)||3
5248855|NCT00806260|12902733|P4|NOT COMPLETED|Period 1 (1 Day)||0
5248856|NCT00806260|12902734|P3|NOT COMPLETED|Period 1 (1 Day)||0
5248857|NCT00806260|12902735|P2|NOT COMPLETED|Period 1 (1 Day)||0
5248858|NCT00806260|12902736|P1|NOT COMPLETED|Period 1 (1 Day)||0
5248859|NCT00806260|12902731|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
5248860|NCT00806260|12902732|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
5248861|NCT00806260|12902733|P4|COMPLETED|Period 1 (1 Day)||14
5248862|NCT00806260|12902734|P3|COMPLETED|Period 1 (1 Day)||8
5248863|NCT00806260|12902735|P2|COMPLETED|Period 1 (1 Day)||8
5248864|NCT00806260|12902736|P1|COMPLETED|Period 1 (1 Day)||15
5248865|NCT00806260|12902731|P6|STARTED|Period 1 (1 Day)||17
5248866|NCT00806260|12902732|P5|STARTED|Period 1 (1 Day)||18
5248867|NCT00806260|12902733|P4|STARTED|Period 1 (1 Day)||14
5248868|NCT00806260|12902734|P3|STARTED|Period 1 (1 Day)||8
5248869|NCT00806260|12902735|P2|STARTED|Period 1 (1 Day)||8
5248870|NCT00806260|12902736|P1|STARTED|Period 1 (1 Day)||15
5248871|NCT00806234|12902751|P3|NOT COMPLETED|Overall Study||12
5248872|NCT00806234|12902752|P2|NOT COMPLETED|Overall Study||12
5248873|NCT00806234|12902753|P1|NOT COMPLETED|Overall Study||13
5248874|NCT00806234|12902751|P3|COMPLETED|Overall Study||37
5248875|NCT00806234|12902752|P2|COMPLETED|Overall Study||19
5248876|NCT00806234|12902753|P1|COMPLETED|Overall Study||34
5248877|NCT00806234|12902751|P3|STARTED|Overall Study||49
5248878|NCT00806234|12902752|P2|STARTED|Overall Study||31
5248879|NCT00806234|12902753|P1|STARTED|Overall Study||47
5248880|NCT00806221|12902770|P1|NOT COMPLETED|Overall Study||2
5248881|NCT00806221|12902770|P1|COMPLETED|Overall Study||20
5248882|NCT00806221|12902770|P1|STARTED|Overall Study||22
5248883|NCT00806195|12902781|P4|NOT COMPLETED|Overall Study||106
5248884|NCT00806195|12902782|P3|NOT COMPLETED|Overall Study||270
5248885|NCT00806195|12902783|P2|NOT COMPLETED|Overall Study||162
5248886|NCT00806195|12902784|P1|NOT COMPLETED|Overall Study||514
5248887|NCT00806195|12902781|P4|COMPLETED|Overall Study||383
5248888|NCT00806195|12902782|P3|COMPLETED|Overall Study||1139
5248889|NCT00806195|12902783|P2|COMPLETED|Overall Study||1321
5248890|NCT00806195|12902784|P1|COMPLETED|Overall Study||3849
5248891|NCT00806195|12902781|P4|STARTED|Overall Study||489
5248892|NCT00806195|12902782|P3|STARTED|Overall Study||1409
5248893|NCT00806195|12902783|P2|STARTED|Overall Study||1483
5248894|NCT00806195|12902784|P1|STARTED|Overall Study||4363
5248895|NCT00806078|12902798|P2|NOT COMPLETED|Second Intervention||0
5248896|NCT00806078|12902799|P1|NOT COMPLETED|Second Intervention||0
5248897|NCT00806078|12902798|P2|COMPLETED|Second Intervention||9
5248898|NCT00806078|12902799|P1|COMPLETED|Second Intervention||9
5248899|NCT00806078|12902798|P2|STARTED|Second Intervention||9
5248900|NCT00806078|12902799|P1|STARTED|Second Intervention||9
5248901|NCT00806078|12902798|P2|NOT COMPLETED|7 Day Washout Period||0
5248902|NCT00806078|12902799|P1|NOT COMPLETED|7 Day Washout Period||0
5248903|NCT00806078|12902798|P2|COMPLETED|7 Day Washout Period||9
5248904|NCT00806078|12902799|P1|COMPLETED|7 Day Washout Period||9
5248905|NCT00806078|12902798|P2|STARTED|7 Day Washout Period||9
5248906|NCT00806078|12902799|P1|STARTED|7 Day Washout Period||9
5248907|NCT00806078|12902798|P2|NOT COMPLETED|First Intervention||0
5248908|NCT00806078|12902799|P1|NOT COMPLETED|First Intervention||0
5248909|NCT00806078|12902798|P2|COMPLETED|First Intervention||9
5248910|NCT00806078|12902799|P1|COMPLETED|First Intervention||9
5248911|NCT00806078|12902798|P2|STARTED|First Intervention||9
5248912|NCT00806078|12902799|P1|STARTED|First Intervention||9
5248913|NCT00806026|12902815|P6|NOT COMPLETED|Overall Study||32
5248914|NCT00806026|12902816|P5|NOT COMPLETED|Overall Study||30
5248915|NCT00806026|12902817|P4|NOT COMPLETED|Overall Study||29
5248916|NCT00806026|12902818|P3|NOT COMPLETED|Overall Study||93
5248917|NCT00806026|12902819|P2|NOT COMPLETED|Overall Study||101
5248918|NCT00806026|12902820|P1|NOT COMPLETED|Overall Study||92
5248919|NCT00806026|12902815|P6|COMPLETED|Overall Study||29
5248920|NCT00806026|12902816|P5|COMPLETED|Overall Study||29
5248921|NCT00806026|12902817|P4|COMPLETED|Overall Study||32
5248922|NCT00806026|12902818|P3|COMPLETED|Overall Study||89
5248923|NCT00806026|12902819|P2|COMPLETED|Overall Study||82
5248924|NCT00806026|12902820|P1|COMPLETED|Overall Study||93
5248925|NCT00806026|12902815|P6|Treated|Overall Study||61
5248926|NCT00806026|12902816|P5|Treated|Overall Study||59
5248927|NCT00806026|12902817|P4|Treated|Overall Study||59
5248928|NCT00806026|12902818|P3|Treated|Overall Study||180
5248929|NCT00806026|12902819|P2|Treated|Overall Study||178
5248930|NCT00806026|12902820|P1|Treated|Overall Study||182
5248931|NCT00806026|12902815|P6|STARTED|Overall Study||61
5248932|NCT00806026|12902816|P5|STARTED|Overall Study||59
5248933|NCT00806026|12902817|P4|STARTED|Overall Study||61
5248934|NCT00806026|12902818|P3|STARTED|Overall Study||182
5248935|NCT00806026|12902819|P2|STARTED|Overall Study||183
5248936|NCT00806026|12902820|P1|STARTED|Overall Study||185
5248937|NCT00805961|12902915|P1|NOT COMPLETED|Maintenance Treatment||34
5248938|NCT00805961|12902915|P1|COMPLETED|Maintenance Treatment||23
5248939|NCT00805961|12902915|P1|STARTED|Maintenance Treatment||57
5248940|NCT00805961|12902915|P1|NOT COMPLETED|Treatment-Free Interval||7
5248941|NCT00805961|12902915|P1|COMPLETED|Treatment-Free Interval||57
5248942|NCT00805961|12902915|P1|STARTED|Treatment-Free Interval||64
5248943|NCT00805961|12902915|P1|NOT COMPLETED|Modality Therapy||4
5248944|NCT00805961|12902915|P1|COMPLETED|Modality Therapy||64
5248945|NCT00805961|12902915|P1|STARTED|Modality Therapy||68
5248946|NCT00805948|12902923|P2|NOT COMPLETED|Overall Study||96
5248947|NCT00805948|12902924|P1|NOT COMPLETED|Overall Study||68
5248948|NCT00805948|12902923|P2|COMPLETED|Overall Study||99
5248949|NCT00805948|12902924|P1|COMPLETED|Overall Study||86
5248950|NCT00805948|12902923|P2|STARTED|Overall Study||195
5248951|NCT00805948|12902924|P1|STARTED|Overall Study||154
5248952|NCT00805935|12902939|P4|NOT COMPLETED|Overall Study||11
5248953|NCT00805935|12902940|P3|NOT COMPLETED|Overall Study||15
5248954|NCT00805935|12902941|P2|NOT COMPLETED|Overall Study||19
5248955|NCT00805935|12902942|P1|NOT COMPLETED|Overall Study||13
5248956|NCT00805935|12902939|P4|COMPLETED|Overall Study||19
5248957|NCT00805935|12902940|P3|COMPLETED|Overall Study||13
5248958|NCT00805935|12902941|P2|COMPLETED|Overall Study||8
5248959|NCT00805935|12902942|P1|COMPLETED|Overall Study||12
5248960|NCT00805935|12902939|P4|STARTED|Overall Study||30
5248961|NCT00805935|12902940|P3|STARTED|Overall Study||28
5248962|NCT00805935|12902941|P2|STARTED|Overall Study||27
5248963|NCT00805935|12902942|P1|STARTED|Overall Study||25
5248964|NCT00805870|12902996|P2|NOT COMPLETED|Overall Study||0
5248965|NCT00805870|12902997|P1|NOT COMPLETED|Overall Study||0
5248966|NCT00805870|12902996|P2|COMPLETED|Overall Study||10
5248967|NCT00805870|12902997|P1|COMPLETED|Overall Study||10
5248968|NCT00805870|12902996|P2|STARTED|Overall Study||10
5248969|NCT00805870|12902997|P1|STARTED|Overall Study||10
5248970|NCT00805792|12903009|P1|NOT COMPLETED|Overall Study||5
5248971|NCT00805792|12903009|P1|COMPLETED|Overall Study||28
5248972|NCT00805792|12903009|P1|STARTED|Overall Study||33
5248973|NCT00805766|12903017|P1|NOT COMPLETED|Increased Dose Period||13
5248974|NCT00805766|12903017|P1|COMPLETED|Increased Dose Period||26
5248975|NCT00805766|12903017|P1|STARTED|Increased Dose Period||39
5248976|NCT00805766|12903017|P1|NOT COMPLETED|Screening Period||6
5248977|NCT00805766|12903017|P1|COMPLETED|Screening Period||39
5248978|NCT00805766|12903017|P1|STARTED|Screening Period||45
5248979|NCT00805740|12903031|P2|NOT COMPLETED|Overall Study||4
5248980|NCT00805740|12903032|P1|NOT COMPLETED|Overall Study||11
5248981|NCT00805740|12903031|P2|COMPLETED|Overall Study||9
5248982|NCT00805740|12903032|P1|COMPLETED|Overall Study||17
5248983|NCT00805740|12903031|P2|Treated|Overall Study||13
5248984|NCT00805740|12903032|P1|Treated|Overall Study||26
5248985|NCT00805740|12903031|P2|STARTED|Overall Study||13
5248986|NCT00805740|12903032|P1|STARTED|Overall Study||28
5248987|NCT00805675|12903057|P3|NOT COMPLETED|Overall Study||1
5248988|NCT00805675|12903058|P2|NOT COMPLETED|Overall Study||0
5248989|NCT00805675|12903059|P1|NOT COMPLETED|Overall Study||0
5248990|NCT00805675|12903057|P3|COMPLETED|Overall Study||15
5248991|NCT00805675|12903058|P2|COMPLETED|Overall Study||14
5248992|NCT00805675|12903059|P1|COMPLETED|Overall Study||16
5248993|NCT00805675|12903057|P3|STARTED|Overall Study||16
5248994|NCT00805675|12903058|P2|STARTED|Overall Study||14
5248995|NCT00805675|12903059|P1|STARTED|Overall Study||16
5248996|NCT00805545|12903093|P2|NOT COMPLETED|Overall Study||3
5248997|NCT00805545|12903094|P1|NOT COMPLETED|Overall Study||6
5248998|NCT00805545|12903093|P2|COMPLETED|Overall Study||197
5248999|NCT00805545|12903094|P1|COMPLETED|Overall Study||194
5249000|NCT00805545|12903093|P2|STARTED|Overall Study||200
5249001|NCT00805545|12903094|P1|STARTED|Overall Study||200
5249002|NCT00805532|12903102|P2|NOT COMPLETED|Overall Study||1
5249003|NCT00805532|12903103|P1|NOT COMPLETED|Overall Study||0
5249004|NCT00805532|12903102|P2|COMPLETED|Overall Study||38
5249005|NCT00805532|12903103|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
5249006|NCT00805532|12903102|P2|STARTED|Overall Study||39
5249007|NCT00805532|12903103|P1|STARTED|Overall Study||42
5249008|NCT00805493|12903120|P3|NOT COMPLETED|Overall Study||1
5249009|NCT00805493|12903121|P2|NOT COMPLETED|Overall Study||0
5249010|NCT00805493|12903122|P1|NOT COMPLETED|Overall Study||2
5249011|NCT00805493|12903120|P3|COMPLETED|Overall Study||0
5249012|NCT00805493|12903121|P2|COMPLETED|Overall Study||2
5249013|NCT00805493|12903122|P1|COMPLETED|Overall Study||1
5249014|NCT00805493|12903120|P3|STARTED|Overall Study||1
5249015|NCT00805493|12903121|P2|STARTED|Overall Study||2
5249016|NCT00805493|12903122|P1|STARTED|Overall Study||3
5249017|NCT00805480|12903137|P4|NOT COMPLETED|Overall Study||5
5249018|NCT00805480|12903138|P3|NOT COMPLETED|Overall Study||12
5249019|NCT00805480|12903139|P2|NOT COMPLETED|Overall Study||7
5249020|NCT00805480|12903140|P1|NOT COMPLETED|Overall Study||14
5249021|NCT00805480|12903137|P4|COMPLETED|Overall Study||5
5249022|NCT00805480|12903138|P3|COMPLETED|Overall Study||19
5249023|NCT00805480|12903139|P2|COMPLETED|Overall Study||22
5249024|NCT00805480|12903140|P1|COMPLETED|Overall Study||16
5249025|NCT00805480|12903137|P4|Pharmacodynamic Analysis Set|Overall Study||10
5249026|NCT00805480|12903138|P3|Pharmacodynamic Analysis Set|Overall Study||29
5249027|NCT00805480|12903139|P2|Pharmacodynamic Analysis Set|Overall Study||25
5249028|NCT00805480|12903140|P1|Pharmacodynamic Analysis Set|Overall Study||30
5249029|NCT00805480|12903137|P4|STARTED|Overall Study||10
5249030|NCT00805480|12903138|P3|STARTED|Overall Study||31
5249031|NCT00805480|12903139|P2|STARTED|Overall Study||29
5249032|NCT00805480|12903140|P1|STARTED|Overall Study||30
5249033|NCT00805467|12903169|P4|NOT COMPLETED|Overall Study||237
5249034|NCT00805467|12903170|P3|NOT COMPLETED|Overall Study||103
5249035|NCT00805467|12903171|P2|NOT COMPLETED|Overall Study||34
5249036|NCT00805467|12903172|P1|NOT COMPLETED|Overall Study||0
5249037|NCT00805467|12903169|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
5249038|NCT00805467|12903170|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
5249039|NCT00805467|12903171|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
5249040|NCT00805467|12903172|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
5249041|NCT00805467|12903169|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
5249042|NCT00805467|12903170|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
5249043|NCT00805467|12903171|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
5249044|NCT00805467|12903172|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
5249045|NCT00805467|12903169|P4|STARTED|Overall Study|Patients who received treatment|381
5249046|NCT00805467|12903170|P3|STARTED|Overall Study|Patients who received treatment|183
5249047|NCT00805467|12903171|P2|STARTED|Overall Study|Patients who received treatment|59
5249048|NCT00805467|12903172|P1|STARTED|Overall Study|Patients who received treatment|1
5249049|NCT00805441|12903192|P2|NOT COMPLETED|Overall Study||36
5249050|NCT00805441|12903193|P1|NOT COMPLETED|Overall Study||34
5249051|NCT00805441|12903192|P2|COMPLETED|Overall Study||60
5249052|NCT00805441|12903193|P1|COMPLETED|Overall Study||60
5249053|NCT00805441|12903192|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
5249054|NCT00805441|12903193|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
5249055|NCT00805441|12903192|P2|STARTED|Overall Study||96
5249056|NCT00805441|12903193|P1|STARTED|Overall Study||94
5249057|NCT00805389|12903228|P5|NOT COMPLETED|Overall Study||13
5249058|NCT00805389|12903229|P4|NOT COMPLETED|Overall Study||17
5249059|NCT00805389|12903230|P3|NOT COMPLETED|Overall Study||12
5249060|NCT00805389|12903231|P2|NOT COMPLETED|Overall Study||5
5249061|NCT00805389|12903232|P1|NOT COMPLETED|Overall Study||7
5249062|NCT00805389|12903228|P5|COMPLETED|Overall Study||129
5249063|NCT00805389|12903229|P4|COMPLETED|Overall Study||128
5249064|NCT00805389|12903230|P3|COMPLETED|Overall Study||129
5249065|NCT00805389|12903231|P2|COMPLETED|Overall Study||137
5249066|NCT00805389|12903232|P1|COMPLETED|Overall Study||136
5249067|NCT00805389|12903228|P5|STARTED|Overall Study||142
5249068|NCT00805389|12903229|P4|STARTED|Overall Study||145
5249069|NCT00805389|12903230|P3|STARTED|Overall Study||141
5249070|NCT00805389|12903231|P2|STARTED|Overall Study||142
5249071|NCT00805389|12903232|P1|STARTED|Overall Study||143
5249072|NCT00805285|12903479|P1|NOT COMPLETED|Overall Study||1
5249073|NCT00805285|12903479|P1|COMPLETED|Overall Study||0
5249074|NCT00805285|12903479|P1|STARTED|Overall Study||1
5249075|NCT00805207|12903496|P9|NOT COMPLETED|Overall Study||0
5249076|NCT00805207|12903497|P8|NOT COMPLETED|Overall Study||0
5249077|NCT00805207|12903498|P7|NOT COMPLETED|Overall Study||0
5249078|NCT00805207|12903499|P6|NOT COMPLETED|Overall Study||3
5249079|NCT00805207|12903500|P5|NOT COMPLETED|Overall Study||1
5249080|NCT00805207|12903501|P4|NOT COMPLETED|Overall Study||0
5249081|NCT00805207|12903502|P3|NOT COMPLETED|Overall Study||1
5249082|NCT00805207|12903503|P2|NOT COMPLETED|Overall Study||2
5249083|NCT00805207|12903504|P1|NOT COMPLETED|Overall Study||0
5249084|NCT00805207|12903496|P9|COMPLETED|Overall Study||6
5249085|NCT00805207|12903497|P8|COMPLETED|Overall Study||6
5249086|NCT00805207|12903498|P7|COMPLETED|Overall Study||6
5249087|NCT00805207|12903499|P6|COMPLETED|Overall Study||9
5249088|NCT00805207|12903500|P5|COMPLETED|Overall Study||2
5249089|NCT00805207|12903501|P4|COMPLETED|Overall Study||6
5249090|NCT00805207|12903502|P3|COMPLETED|Overall Study||11
5249091|NCT00805207|12903503|P2|COMPLETED|Overall Study||7
5249092|NCT00805207|12903504|P1|COMPLETED|Overall Study||1
5249093|NCT00805207|12903496|P9|STARTED|Overall Study||6
5249094|NCT00805207|12903497|P8|STARTED|Overall Study||6
5249095|NCT00805207|12903498|P7|STARTED|Overall Study||6
5249096|NCT00805207|12903499|P6|STARTED|Overall Study||12
5249097|NCT00805207|12903500|P5|STARTED|Overall Study||3
5249098|NCT00805207|12903501|P4|STARTED|Overall Study||6
5249099|NCT00805207|12903502|P3|STARTED|Overall Study||12
5249100|NCT00805207|12903503|P2|STARTED|Overall Study||9
5249101|NCT00805207|12903504|P1|STARTED|Overall Study||1
5249102|NCT00805194|12903562|P2|NOT COMPLETED|Overall Study||654
5249103|NCT00805194|12903563|P1|NOT COMPLETED|Overall Study||649
5249104|NCT00805194|12903562|P2|COMPLETED|Overall Study||5
5249105|NCT00805194|12903563|P1|COMPLETED|Overall Study||6
5249106|NCT00805194|12903562|P2|STARTED|Overall Study|randomised patients|659
5249107|NCT00805194|12903563|P1|STARTED|Overall Study|randomised patients|655
5249108|NCT00805142|12903597|P2|NOT COMPLETED|Maintenance Period||2
5249109|NCT00805142|12903598|P1|NOT COMPLETED|Maintenance Period||0
5249110|NCT00805142|12903597|P2|COMPLETED|Maintenance Period||30
5249111|NCT00805142|12903598|P1|COMPLETED|Maintenance Period||30
5249112|NCT00805142|12903597|P2|STARTED|Maintenance Period||32
5249113|NCT00805142|12903598|P1|STARTED|Maintenance Period||30
5249114|NCT00805142|12903597|P2|NOT COMPLETED|Titration Period||10
5249115|NCT00805142|12903598|P1|NOT COMPLETED|Titration Period||6
5249116|NCT00805142|12903597|P2|COMPLETED|Titration Period||32
5249117|NCT00805142|12903598|P1|COMPLETED|Titration Period||30
5249118|NCT00805142|12903597|P2|STARTED|Titration Period||42
5249119|NCT00805142|12903598|P1|STARTED|Titration Period||36
5249120|NCT00805038|12903624|P2|NOT COMPLETED|Overall Study||0
5249121|NCT00805038|12903625|P1|NOT COMPLETED|Overall Study||0
5249122|NCT00805038|12903624|P2|COMPLETED|Overall Study||92
5249123|NCT00805038|12903625|P1|COMPLETED|Overall Study||75
5249124|NCT00805038|12903624|P2|STARTED|Overall Study||92
5249125|NCT00805038|12903625|P1|STARTED|Overall Study||75
5249126|NCT00805025|12903631|P1|NOT COMPLETED|Overall Study||49
5249127|NCT00805025|12903631|P1|COMPLETED|Overall Study||82
5249128|NCT00805025|12903631|P1|Enrolled and Treated|Overall Study||89
5249129|NCT00805025|12903631|P1|STARTED|Overall Study||131
5249130|NCT00804999|12903641|P4|NOT COMPLETED|Overall Study||0
5249131|NCT00804999|12903642|P3|NOT COMPLETED|Overall Study||0
5249132|NCT00804999|12903643|P2|NOT COMPLETED|Overall Study||0
5249133|NCT00804999|12903644|P1|NOT COMPLETED|Overall Study||0
5249134|NCT00804999|12903641|P4|COMPLETED|Overall Study||10
5249135|NCT00804999|12903642|P3|COMPLETED|Overall Study||14
5249136|NCT00804999|12903643|P2|COMPLETED|Overall Study||12
5249137|NCT00804999|12903644|P1|COMPLETED|Overall Study||15
5249138|NCT00804999|12903641|P4|STARTED|Overall Study||10
5249139|NCT00804999|12903642|P3|STARTED|Overall Study||14
5249140|NCT00804999|12903643|P2|STARTED|Overall Study||12
5249141|NCT00804999|12903644|P1|STARTED|Overall Study||15
5249142|NCT00804986|12903660|P6|NOT COMPLETED|Overall Study||10
5249143|NCT00804986|12903661|P5|NOT COMPLETED|Overall Study||9
5249144|NCT00804986|12903662|P4|NOT COMPLETED|Overall Study||8
5249145|NCT00804986|12903663|P3|NOT COMPLETED|Overall Study||2
5249146|NCT00804986|12903664|P2|NOT COMPLETED|Overall Study||8
5249147|NCT00804986|12903665|P1|NOT COMPLETED|Overall Study||1
5249148|NCT00804986|12903660|P6|COMPLETED|Overall Study||31
5249149|NCT00804986|12903661|P5|COMPLETED|Overall Study||34
5249150|NCT00804986|12903662|P4|COMPLETED|Overall Study||34
5249151|NCT00804986|12903663|P3|COMPLETED|Overall Study||40
5249152|NCT00804986|12903664|P2|COMPLETED|Overall Study||35
5249153|NCT00804986|12903665|P1|COMPLETED|Overall Study||35
5249154|NCT00804986|12903660|P6|STARTED|Overall Study||41
5249155|NCT00804986|12903661|P5|STARTED|Overall Study||43
5249156|NCT00804986|12903662|P4|STARTED|Overall Study||42
5249157|NCT00804986|12903663|P3|STARTED|Overall Study||42
5249158|NCT00804986|12903664|P2|STARTED|Overall Study||43
5249159|NCT00804986|12903665|P1|STARTED|Overall Study||36
5249160|NCT00804973|12903760|P3|NOT COMPLETED|Overall Study||0
5249161|NCT00804973|12903761|P2|NOT COMPLETED|Overall Study||0
5249162|NCT00804973|12903762|P1|NOT COMPLETED|Overall Study||0
5249163|NCT00804973|12903760|P3|COMPLETED|Overall Study||40
5249164|NCT00804973|12903761|P2|COMPLETED|Overall Study||40
5249165|NCT00804973|12903762|P1|COMPLETED|Overall Study||40
5249166|NCT00804973|12903760|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
5249167|NCT00804973|12903761|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
5249168|NCT00804973|12903762|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
5249169|NCT00804973|12903760|P3|STARTED|Overall Study||40
5249170|NCT00804973|12903761|P2|STARTED|Overall Study||40
5249171|NCT00804973|12903762|P1|STARTED|Overall Study||40
5249172|NCT00804908|12903800|P3|NOT COMPLETED|Overall Study||114
5249173|NCT00804908|12903801|P2|NOT COMPLETED|Overall Study||116
5249174|NCT00804908|12903802|P1|NOT COMPLETED|Overall Study||115
5249175|NCT00804908|12903800|P3|COMPLETED|Overall Study||1
5249176|NCT00804908|12903801|P2|COMPLETED|Overall Study||0
5249177|NCT00804908|12903802|P1|COMPLETED|Overall Study||0
5249178|NCT00804908|12903800|P3|STARTED|Overall Study||115
5249179|NCT00804908|12903801|P2|STARTED|Overall Study||116
5249180|NCT00804908|12903802|P1|STARTED|Overall Study||115
5249181|NCT00804843|12903833|P2|NOT COMPLETED|Overall Study||7
5249182|NCT00804843|12903834|P1|NOT COMPLETED|Overall Study||10
5249183|NCT00804843|12903833|P2|COMPLETED|Overall Study||43
5249184|NCT00804843|12903834|P1|COMPLETED|Overall Study||40
5249185|NCT00804843|12903833|P2|STARTED|Overall Study||50
5249186|NCT00804843|12903834|P1|STARTED|Overall Study||50
5249187|NCT00804713|12903844|P1|NOT COMPLETED|Overall Study||0
5249188|NCT00804713|12903844|P1|COMPLETED|Overall Study||1978
5249189|NCT00804713|12903844|P1|STARTED|Overall Study||1978
5249190|NCT00804687|12903852|P6|NOT COMPLETED|Period 5: Treatment Period||0
5249191|NCT00804687|12903853|P5|NOT COMPLETED|Period 5: Treatment Period||1
5249192|NCT00804687|12903854|P4|NOT COMPLETED|Period 5: Treatment Period||0
5249193|NCT00804687|12903855|P3|NOT COMPLETED|Period 5: Treatment Period||1
5249194|NCT00804687|12903856|P2|NOT COMPLETED|Period 5: Treatment Period||0
5249195|NCT00804687|12903857|P1|NOT COMPLETED|Period 5: Treatment Period||1
5249196|NCT00804687|12903852|P6|COMPLETED|Period 5: Treatment Period||8
5249197|NCT00804687|12903853|P5|COMPLETED|Period 5: Treatment Period||8
5249198|NCT00804687|12903854|P4|COMPLETED|Period 5: Treatment Period||8
5249199|NCT00804687|12903855|P3|COMPLETED|Period 5: Treatment Period||8
5249200|NCT00804687|12903856|P2|COMPLETED|Period 5: Treatment Period||9
5249201|NCT00804687|12903857|P1|COMPLETED|Period 5: Treatment Period||8
5249202|NCT00804687|12903852|P6|STARTED|Period 5: Treatment Period||8
5249203|NCT00804687|12903853|P5|STARTED|Period 5: Treatment Period||9
5249204|NCT00804687|12903854|P4|STARTED|Period 5: Treatment Period||8
5249205|NCT00804687|12903855|P3|STARTED|Period 5: Treatment Period||9
5249206|NCT00804687|12903856|P2|STARTED|Period 5: Treatment Period||9
5249207|NCT00804687|12903857|P1|STARTED|Period 5: Treatment Period||9
5249208|NCT00804687|12903852|P6|NOT COMPLETED|Period 4: Washout Period||0
5249209|NCT00804687|12903853|P5|NOT COMPLETED|Period 4: Washout Period||0
5249210|NCT00804687|12903854|P4|NOT COMPLETED|Period 4: Washout Period||0
5249211|NCT00804687|12903855|P3|NOT COMPLETED|Period 4: Washout Period||0
5249212|NCT00804687|12903856|P2|NOT COMPLETED|Period 4: Washout Period||0
5249213|NCT00804687|12903857|P1|NOT COMPLETED|Period 4: Washout Period||0
5249214|NCT00804687|12903852|P6|COMPLETED|Period 4: Washout Period||8
5249215|NCT00804687|12903853|P5|COMPLETED|Period 4: Washout Period||9
5249216|NCT00804687|12903854|P4|COMPLETED|Period 4: Washout Period||8
5249217|NCT00804687|12903855|P3|COMPLETED|Period 4: Washout Period||9
5249218|NCT00804687|12903856|P2|COMPLETED|Period 4: Washout Period||9
5249219|NCT00804687|12903857|P1|COMPLETED|Period 4: Washout Period||9
5249220|NCT00804687|12903852|P6|STARTED|Period 4: Washout Period||8
5249221|NCT00804687|12903853|P5|STARTED|Period 4: Washout Period||9
5249222|NCT00804687|12903854|P4|STARTED|Period 4: Washout Period||8
5249223|NCT00804687|12903855|P3|STARTED|Period 4: Washout Period||9
5249224|NCT00804687|12903856|P2|STARTED|Period 4: Washout Period||9
5249225|NCT00804687|12903857|P1|STARTED|Period 4: Washout Period||9
5249226|NCT00804687|12903852|P6|NOT COMPLETED|Period 3: Treatment Period||0
5249227|NCT00804687|12903853|P5|NOT COMPLETED|Period 3: Treatment Period||0
5249228|NCT00804687|12903854|P4|NOT COMPLETED|Period 3: Treatment Period||1
5249229|NCT00804687|12903855|P3|NOT COMPLETED|Period 3: Treatment Period||0
5249230|NCT00804687|12903856|P2|NOT COMPLETED|Period 3: Treatment Period||0
5249231|NCT00804687|12903857|P1|NOT COMPLETED|Period 3: Treatment Period||0
5249232|NCT00804687|12903852|P6|COMPLETED|Period 3: Treatment Period||8
5249233|NCT00804687|12903853|P5|COMPLETED|Period 3: Treatment Period||9
5249234|NCT00804687|12903854|P4|COMPLETED|Period 3: Treatment Period||8
5249235|NCT00804687|12903855|P3|COMPLETED|Period 3: Treatment Period||9
5249236|NCT00804687|12903856|P2|COMPLETED|Period 3: Treatment Period||9
5249237|NCT00804687|12903857|P1|COMPLETED|Period 3: Treatment Period||9
5249238|NCT00804687|12903852|P6|STARTED|Period 3: Treatment Period||8
5249239|NCT00804687|12903853|P5|STARTED|Period 3: Treatment Period||9
5249240|NCT00804687|12903854|P4|STARTED|Period 3: Treatment Period||9
5249241|NCT00804687|12903855|P3|STARTED|Period 3: Treatment Period||9
5249242|NCT00804687|12903856|P2|STARTED|Period 3: Treatment Period||9
5249243|NCT00804687|12903857|P1|STARTED|Period 3: Treatment Period||9
5249244|NCT00804687|12903852|P6|NOT COMPLETED|Period 2: Washout Period||0
5249245|NCT00804687|12903853|P5|NOT COMPLETED|Period 2: Washout Period||0
5249246|NCT00804687|12903854|P4|NOT COMPLETED|Period 2: Washout Period||0
5249247|NCT00804687|12903855|P3|NOT COMPLETED|Period 2: Washout Period||0
5249248|NCT00804687|12903856|P2|NOT COMPLETED|Period 2: Washout Period||0
5249249|NCT00804687|12903857|P1|NOT COMPLETED|Period 2: Washout Period||0
5249250|NCT00804687|12903852|P6|COMPLETED|Period 2: Washout Period||8
5249251|NCT00804687|12903853|P5|COMPLETED|Period 2: Washout Period||9
5249252|NCT00804687|12903854|P4|COMPLETED|Period 2: Washout Period||9
5249253|NCT00804687|12903855|P3|COMPLETED|Period 2: Washout Period||9
5249254|NCT00804687|12903856|P2|COMPLETED|Period 2: Washout Period||9
5249255|NCT00804687|12903857|P1|COMPLETED|Period 2: Washout Period||9
5249256|NCT00804687|12903852|P6|STARTED|Period 2: Washout Period||8
5249257|NCT00804687|12903853|P5|STARTED|Period 2: Washout Period||9
5249258|NCT00804687|12903854|P4|STARTED|Period 2: Washout Period||9
5249259|NCT00804687|12903855|P3|STARTED|Period 2: Washout Period||9
5249260|NCT00804687|12903856|P2|STARTED|Period 2: Washout Period||9
5249261|NCT00804687|12903857|P1|STARTED|Period 2: Washout Period||9
5249262|NCT00804687|12903852|P6|NOT COMPLETED|Period 1: Treatment Period||0
5249263|NCT00804687|12903853|P5|NOT COMPLETED|Period 1: Treatment Period||0
5249264|NCT00804687|12903854|P4|NOT COMPLETED|Period 1: Treatment Period||0
5249265|NCT00804687|12903855|P3|NOT COMPLETED|Period 1: Treatment Period||0
5249266|NCT00804687|12903856|P2|NOT COMPLETED|Period 1: Treatment Period||0
5249267|NCT00804687|12903857|P1|NOT COMPLETED|Period 1: Treatment Period||0
5249268|NCT00804687|12903852|P6|COMPLETED|Period 1: Treatment Period||8
5249269|NCT00804687|12903853|P5|COMPLETED|Period 1: Treatment Period||9
5249270|NCT00804687|12903854|P4|COMPLETED|Period 1: Treatment Period||9
5249271|NCT00804687|12903855|P3|COMPLETED|Period 1: Treatment Period||9
5249272|NCT00804687|12903856|P2|COMPLETED|Period 1: Treatment Period||9
5249273|NCT00804687|12903857|P1|COMPLETED|Period 1: Treatment Period||9
5249274|NCT00804687|12903852|P6|STARTED|Period 1: Treatment Period||8
5249275|NCT00804687|12903853|P5|STARTED|Period 1: Treatment Period||9
5249276|NCT00804687|12903854|P4|STARTED|Period 1: Treatment Period||9
5249277|NCT00804687|12903855|P3|STARTED|Period 1: Treatment Period||9
5249278|NCT00804687|12903856|P2|STARTED|Period 1: Treatment Period||9
5249279|NCT00804687|12903857|P1|STARTED|Period 1: Treatment Period||9
5249280|NCT00804648|12903874|P6|NOT COMPLETED|Third Invervention||0
5249281|NCT00804648|12903875|P5|NOT COMPLETED|Third Invervention||0
5249282|NCT00804648|12903876|P4|NOT COMPLETED|Third Invervention||0
5249283|NCT00804648|12903877|P3|NOT COMPLETED|Third Invervention||0
5249284|NCT00804648|12903878|P2|NOT COMPLETED|Third Invervention||0
5249285|NCT00804648|12903879|P1|NOT COMPLETED|Third Invervention||0
5249286|NCT00804648|12903874|P6|COMPLETED|Third Invervention||8
5249287|NCT00804648|12903875|P5|COMPLETED|Third Invervention||4
5249288|NCT00804648|12903876|P4|COMPLETED|Third Invervention||4
5249289|NCT00804648|12903877|P3|COMPLETED|Third Invervention||6
5249290|NCT00804648|12903878|P2|COMPLETED|Third Invervention||5
5249291|NCT00804648|12903879|P1|COMPLETED|Third Invervention||3
5249292|NCT00804648|12903874|P6|STARTED|Third Invervention||8
5249293|NCT00804648|12903875|P5|STARTED|Third Invervention||4
5249294|NCT00804648|12903876|P4|STARTED|Third Invervention||4
5249295|NCT00804648|12903877|P3|STARTED|Third Invervention||6
5249296|NCT00804648|12903878|P2|STARTED|Third Invervention||5
5249297|NCT00804648|12903879|P1|STARTED|Third Invervention||3
5249298|NCT00804648|12903874|P6|NOT COMPLETED|Second Intervention||0
5249299|NCT00804648|12903875|P5|NOT COMPLETED|Second Intervention||0
5249300|NCT00804648|12903876|P4|NOT COMPLETED|Second Intervention||0
5249301|NCT00804648|12903877|P3|NOT COMPLETED|Second Intervention||0
5249302|NCT00804648|12903878|P2|NOT COMPLETED|Second Intervention||0
5249303|NCT00804648|12903879|P1|NOT COMPLETED|Second Intervention||0
5249304|NCT00804648|12903874|P6|COMPLETED|Second Intervention||8
5249305|NCT00804648|12903875|P5|COMPLETED|Second Intervention||4
5249306|NCT00804648|12903876|P4|COMPLETED|Second Intervention||4
5249307|NCT00804648|12903877|P3|COMPLETED|Second Intervention||6
5249308|NCT00804648|12903878|P2|COMPLETED|Second Intervention||5
5249309|NCT00804648|12903879|P1|COMPLETED|Second Intervention||3
5249310|NCT00804648|12903874|P6|STARTED|Second Intervention||8
5249311|NCT00804648|12903875|P5|STARTED|Second Intervention||4
5249312|NCT00804648|12903876|P4|STARTED|Second Intervention||4
5249313|NCT00804648|12903877|P3|STARTED|Second Intervention||6
5249314|NCT00804648|12903878|P2|STARTED|Second Intervention||5
5249315|NCT00804648|12903879|P1|STARTED|Second Intervention||3
5249316|NCT00804648|12903874|P6|NOT COMPLETED|First Intervention||0
5249317|NCT00804648|12903875|P5|NOT COMPLETED|First Intervention||0
5249318|NCT00804648|12903876|P4|NOT COMPLETED|First Intervention||0
5249319|NCT00804648|12903877|P3|NOT COMPLETED|First Intervention||0
5249320|NCT00804648|12903878|P2|NOT COMPLETED|First Intervention||0
5249321|NCT00804648|12903879|P1|NOT COMPLETED|First Intervention||0
5249322|NCT00804648|12903874|P6|COMPLETED|First Intervention||8
5249323|NCT00804648|12903875|P5|COMPLETED|First Intervention||4
5249324|NCT00804648|12903876|P4|COMPLETED|First Intervention||4
5249325|NCT00804648|12903877|P3|COMPLETED|First Intervention||6
5249326|NCT00804648|12903878|P2|COMPLETED|First Intervention||5
5249327|NCT00804648|12903879|P1|COMPLETED|First Intervention||3
5249328|NCT00804648|12903874|P6|STARTED|First Intervention||8
5249329|NCT00804648|12903875|P5|STARTED|First Intervention||4
5249330|NCT00804648|12903876|P4|STARTED|First Intervention||4
5249331|NCT00804648|12903877|P3|STARTED|First Intervention||6
5249332|NCT00804648|12903878|P2|STARTED|First Intervention||5
5249333|NCT00804648|12903879|P1|STARTED|First Intervention||3
5249334|NCT00804609|12903922|P2|NOT COMPLETED|Overall Study||1
5249335|NCT00804609|12903923|P1|NOT COMPLETED|Overall Study||0
5249336|NCT00804609|12903922|P2|COMPLETED|Overall Study||14
5249337|NCT00804609|12903923|P1|COMPLETED|Overall Study||15
5249338|NCT00804609|12903922|P2|STARTED|Overall Study||15
5249339|NCT00804609|12903923|P1|STARTED|Overall Study||15
5249340|NCT00804596|12903929|P1|NOT COMPLETED|Overall Study||0
5249341|NCT00804596|12903929|P1|COMPLETED|Overall Study||74
5249342|NCT00804596|12903929|P1|STARTED|Overall Study||74
5249343|NCT00804570|12903936|P2|NOT COMPLETED|Overall Study||94
5249344|NCT00804570|12903937|P1|NOT COMPLETED|Overall Study||72
5249345|NCT00804570|12903936|P2|COMPLETED|Overall Study||94
5249346|NCT00804570|12903937|P1|COMPLETED|Overall Study||115
5249347|NCT00804570|12903936|P2|STARTED|Overall Study||188
5249348|NCT00804570|12903937|P1|STARTED|Overall Study||187
5249349|NCT00804349|12903995|P2|NOT COMPLETED|Overall Study||0
5249350|NCT00804349|12903996|P1|NOT COMPLETED|Overall Study||0
5249351|NCT00804349|12903995|P2|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
5249352|NCT00804349|12903996|P1|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
5249353|NCT00804349|12903995|P2|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
5249354|NCT00804349|12903996|P1|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
5249355|NCT00804193|12904011|P3|NOT COMPLETED|Overall Study||32
5249356|NCT00804193|12904012|P2|NOT COMPLETED|Overall Study||44
5249357|NCT00804193|12904013|P1|NOT COMPLETED|Overall Study||39
5249358|NCT00804193|12904011|P3|COMPLETED|Overall Study||77
5249359|NCT00804193|12904012|P2|COMPLETED|Overall Study||180
5249360|NCT00804193|12904013|P1|COMPLETED|Overall Study||181
5249361|NCT00804193|12904011|P3|STARTED|Overall Study||109
5249362|NCT00804193|12904012|P2|STARTED|Overall Study||224
5249363|NCT00804193|12904013|P1|STARTED|Overall Study||220
5249364|NCT00804141|12904027|P1|NOT COMPLETED|Overall Study||563
5249365|NCT00804141|12904027|P1|COMPLETED|Overall Study||477
5249366|NCT00804141|12904027|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
5249367|NCT00804141|12904027|P1|STARTED|Overall Study||1040
5249368|NCT00803959|12904034|P2|NOT COMPLETED|Overall Study||51
5249369|NCT00803959|12904035|P1|NOT COMPLETED|Overall Study||56
5249370|NCT00803959|12904034|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
5249371|NCT00803959|12904035|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
5249372|NCT00803959|12904034|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
5249373|NCT00803959|12904035|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
5249374|NCT00803959|12904034|P2|STARTED|Overall Study||315
5249375|NCT00803959|12904035|P1|STARTED|Overall Study||315
5249376|NCT00803790|12904067|P4|NOT COMPLETED|Period 2||1
5249377|NCT00803790|12904068|P3|NOT COMPLETED|Period 2||1
5249378|NCT00803790|12904069|P2|NOT COMPLETED|Period 2||0
5249379|NCT00803790|12904070|P1|NOT COMPLETED|Period 2||2
5249380|NCT00803790|12904067|P4|COMPLETED|Period 2||30
5249381|NCT00803790|12904068|P3|COMPLETED|Period 2||30
5249382|NCT00803790|12904069|P2|COMPLETED|Period 2||114
5249383|NCT00803790|12904070|P1|COMPLETED|Period 2||114
5249384|NCT00803790|12904067|P4|STARTED|Period 2||31
5249385|NCT00803790|12904068|P3|STARTED|Period 2||31
5249386|NCT00803790|12904069|P2|STARTED|Period 2||114
5249387|NCT00803790|12904070|P1|STARTED|Period 2||116
5249388|NCT00803790|12904067|P4|NOT COMPLETED|Period 1||4
5249389|NCT00803790|12904068|P3|NOT COMPLETED|Period 1||1
5249390|NCT00803790|12904069|P2|NOT COMPLETED|Period 1||12
5249391|NCT00803790|12904070|P1|NOT COMPLETED|Period 1||9
5249392|NCT00803790|12904067|P4|COMPLETED|Period 1||31
5249393|NCT00803790|12904068|P3|COMPLETED|Period 1||31
5249394|NCT00803790|12904069|P2|COMPLETED|Period 1||114
5249395|NCT00803790|12904070|P1|COMPLETED|Period 1||116
5249396|NCT00803790|12904067|P4|STARTED|Period 1||35
5249397|NCT00803790|12904068|P3|STARTED|Period 1||32
5249398|NCT00803790|12904069|P2|STARTED|Period 1||126
5249399|NCT00803790|12904070|P1|STARTED|Period 1||125
5249400|NCT00803777|12904081|P1|NOT COMPLETED|Overall Study||0
5249401|NCT00803777|12904081|P1|COMPLETED|Overall Study||147
5249402|NCT00803777|12904081|P1|STARTED|Overall Study||147
5249403|NCT00803751|12904091|P2|NOT COMPLETED|Overall Study||0
5249404|NCT00803751|12904092|P1|NOT COMPLETED|Overall Study||0
5249405|NCT00803751|12904091|P2|COMPLETED|Overall Study||23
5249406|NCT00803751|12904092|P1|COMPLETED|Overall Study||26
5249407|NCT00803751|12904091|P2|STARTED|Overall Study||23
5249408|NCT00803751|12904092|P1|STARTED|Overall Study||26
5249409|NCT00803738|12904110|P2|NOT COMPLETED|Overall Study||110
5249410|NCT00803738|12904111|P1|NOT COMPLETED|Overall Study||94
5249411|NCT00803738|12904110|P2|COMPLETED|Overall Study||176
5249412|NCT00803738|12904111|P1|COMPLETED|Overall Study||192
5249413|NCT00803738|12904110|P2|STARTED|Overall Study||286
5249414|NCT00803738|12904111|P1|STARTED|Overall Study||286
5249415|NCT00803712|12904123|P2|NOT COMPLETED|Overall Study||27
5249416|NCT00803712|12904124|P1|NOT COMPLETED|Overall Study||36
5249417|NCT00803712|12904123|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
5249418|NCT00803712|12904124|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
5249419|NCT00803712|12904123|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
5249420|NCT00803712|12904124|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
5249421|NCT00803712|12904123|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
5249422|NCT00803712|12904124|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
5249423|NCT00803712|12904123|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
5249424|NCT00803712|12904124|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
5249425|NCT00803686|12904192|P4|NOT COMPLETED|Part 2, Period 3||0
5249426|NCT00803686|12904193|P3|NOT COMPLETED|Part 2, Period 3||0
5249427|NCT00803686|12904194|P2|NOT COMPLETED|Part 2, Period 3||0
5249428|NCT00803686|12904195|P1|NOT COMPLETED|Part 2, Period 3||0
5249429|NCT00803686|12904192|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
5249430|NCT00803686|12904193|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
5249431|NCT00803686|12904194|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
5249432|NCT00803686|12904195|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
5249433|NCT00803686|12904192|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
5249434|NCT00803686|12904193|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
5249435|NCT00803686|12904194|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
5249436|NCT00803686|12904195|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
5249437|NCT00803686|12904192|P4|NOT COMPLETED|Part 1, Period 2||0
5249438|NCT00803686|12904193|P3|NOT COMPLETED|Part 1, Period 2||0
5249439|NCT00803686|12904194|P2|NOT COMPLETED|Part 1, Period 2||0
5249440|NCT00803686|12904195|P1|NOT COMPLETED|Part 1, Period 2||0
5249441|NCT00803686|12904192|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
5249442|NCT00803686|12904193|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
5249443|NCT00803686|12904194|P2|COMPLETED|Part 1, Period 2||6
5249444|NCT00803686|12904195|P1|COMPLETED|Part 1, Period 2||6
5249445|NCT00803686|12904192|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
5249446|NCT00803686|12904193|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
5249447|NCT00803686|12904194|P2|STARTED|Part 1, Period 2||6
5249448|NCT00803686|12904195|P1|STARTED|Part 1, Period 2||6
5249449|NCT00803686|12904192|P4|NOT COMPLETED|Part 1, Period 1||0
5249450|NCT00803686|12904193|P3|NOT COMPLETED|Part 1, Period 1||0
5249451|NCT00803686|12904194|P2|NOT COMPLETED|Part 1, Period 1||0
5249452|NCT00803686|12904195|P1|NOT COMPLETED|Part 1, Period 1||0
5249453|NCT00803686|12904192|P4|COMPLETED|Part 1, Period 1||0
5249454|NCT00803686|12904193|P3|COMPLETED|Part 1, Period 1||0
5249455|NCT00803686|12904194|P2|COMPLETED|Part 1, Period 1||6
5249456|NCT00803686|12904195|P1|COMPLETED|Part 1, Period 1||6
5249457|NCT00803686|12904192|P4|STARTED|Part 1, Period 1||0
5249458|NCT00803686|12904193|P3|STARTED|Part 1, Period 1||0
5249459|NCT00803686|12904194|P2|STARTED|Part 1, Period 1||6
5249460|NCT00803686|12904195|P1|STARTED|Part 1, Period 1||6
5249461|NCT00803647|12904213|P1|NOT COMPLETED|Overall Study||0
5249462|NCT00803647|12904213|P1|COMPLETED|Overall Study||20
5249463|NCT00803647|12904213|P1|STARTED|Overall Study||20
5249464|NCT00803634|12904223|P2|NOT COMPLETED|Overall Study||5
5249465|NCT00803634|12904224|P1|NOT COMPLETED|Overall Study||6
5249466|NCT00803634|12904223|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
5249467|NCT00803634|12904224|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
5249468|NCT00803634|12904223|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
5249469|NCT00803634|12904224|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
5249470|NCT00803634|12904223|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
5249471|NCT00803634|12904224|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
5249472|NCT00803595|12904253|P3|NOT COMPLETED|Overall Study||16
5249473|NCT00803595|12904254|P2|NOT COMPLETED|Overall Study||8
5249474|NCT00803595|12904255|P1|NOT COMPLETED|Overall Study||15
5249475|NCT00803595|12904253|P3|COMPLETED|Overall Study||322
5249476|NCT00803595|12904254|P2|COMPLETED|Overall Study||319
5249477|NCT00803595|12904255|P1|COMPLETED|Overall Study||322
5249478|NCT00803595|12904253|P3|STARTED|Overall Study||338
5249479|NCT00803595|12904254|P2|STARTED|Overall Study||327
5249480|NCT00803595|12904255|P1|STARTED|Overall Study||337
5249481|NCT00803569|12904266|P1|NOT COMPLETED|Overall Study||4
5249482|NCT00803569|12904266|P1|COMPLETED|Overall Study||9
5249483|NCT00803569|12904266|P1|STARTED|Overall Study||13
5249484|NCT00803543|12904276|P2|NOT COMPLETED|Overall Study||12
5249485|NCT00803543|12904277|P1|NOT COMPLETED|Overall Study||24
5249486|NCT00803543|12904276|P2|COMPLETED|Overall Study||22
5249487|NCT00803543|12904277|P1|COMPLETED|Overall Study||45
5249488|NCT00803543|12904276|P2|STARTED|Overall Study||34
5249489|NCT00803543|12904277|P1|STARTED|Overall Study||69
5249490|NCT00803517|12904291|P2|NOT COMPLETED|Overall Study||0
5249491|NCT00803517|12904292|P1|NOT COMPLETED|Overall Study||0
5249492|NCT00803517|12904291|P2|COMPLETED|Overall Study||12
5249493|NCT00803517|12904292|P1|COMPLETED|Overall Study||12
5249494|NCT00803517|12904291|P2|STARTED|Overall Study||12
5249495|NCT00803517|12904292|P1|STARTED|Overall Study||12
5249496|NCT00803452|12904300|P2|NOT COMPLETED|Overall Study||5
5249497|NCT00803452|12904301|P1|NOT COMPLETED|Overall Study||0
5249498|NCT00803452|12904300|P2|COMPLETED|Overall Study||17
5249499|NCT00803452|12904301|P1|COMPLETED|Overall Study||9
5249500|NCT00803452|12904300|P2|STARTED|Overall Study||22
5249501|NCT00803452|12904301|P1|STARTED|Overall Study||9
5249502|NCT00803413|12904311|P4|NOT COMPLETED|Overall Period||0
5249503|NCT00803413|12904312|P3|NOT COMPLETED|Overall Period||0
5249504|NCT00803413|12904313|P2|NOT COMPLETED|Overall Period||0
5249505|NCT00803413|12904314|P1|NOT COMPLETED|Overall Period||0
5249506|NCT00803413|12904311|P4|COMPLETED|Overall Period||30
5249507|NCT00803413|12904312|P3|COMPLETED|Overall Period||29
5249508|NCT00803413|12904313|P2|COMPLETED|Overall Period||32
5249509|NCT00803413|12904314|P1|COMPLETED|Overall Period||28
5249510|NCT00803413|12904311|P4|STARTED|Overall Period||30
5249511|NCT00803413|12904312|P3|STARTED|Overall Period||29
5249512|NCT00803413|12904313|P2|STARTED|Overall Period||32
5249513|NCT00803413|12904314|P1|STARTED|Overall Period||28
5249514|NCT00803400|12904326|P2|NOT COMPLETED|Overall Study||24
5249515|NCT00803400|12904327|P1|NOT COMPLETED|Overall Study||20
5249516|NCT00803400|12904326|P2|COMPLETED|Overall Study||51
5249517|NCT00803400|12904327|P1|COMPLETED|Overall Study||55
5249518|NCT00803400|12904326|P2|STARTED|Overall Study||75
5249519|NCT00803400|12904327|P1|STARTED|Overall Study||75
5249520|NCT00803361|12904339|P2|NOT COMPLETED|Overall Study||28
5249521|NCT00803361|12904340|P1|NOT COMPLETED|Overall Study||26
5249522|NCT00803361|12904339|P2|COMPLETED|Overall Study||74
5249523|NCT00803361|12904340|P1|COMPLETED|Overall Study||82
5249524|NCT00803361|12904339|P2|STARTED|Overall Study||102
5249525|NCT00803361|12904340|P1|STARTED|Overall Study||108
5249526|NCT00803283|12904360|P2|NOT COMPLETED|Overall Study||0
5249527|NCT00803283|12904361|P1|NOT COMPLETED|Overall Study||0
5249528|NCT00803283|12904360|P2|COMPLETED|Overall Study||1
5249529|NCT00803283|12904361|P1|COMPLETED|Overall Study||1
5249530|NCT00803283|12904360|P2|STARTED|Overall Study||1
5249531|NCT00803283|12904361|P1|STARTED|Overall Study||1
5249532|NCT00803270|12904387|P2|NOT COMPLETED|Overall Study||2
5249533|NCT00803270|12904388|P1|NOT COMPLETED|Overall Study||1
5249534|NCT00803270|12904387|P2|COMPLETED|Overall Study||12
5249535|NCT00803270|12904388|P1|COMPLETED|Overall Study||12
5249536|NCT00803270|12904387|P2|STARTED|Overall Study||14
5249537|NCT00803270|12904388|P1|STARTED|Overall Study||13
5249538|NCT00803244|12904398|P2|NOT COMPLETED|Overall Study||15
5249539|NCT00803244|12904399|P1|NOT COMPLETED|Overall Study||7
5249540|NCT00803244|12904398|P2|COMPLETED|Overall Study||178
5249541|NCT00803244|12904399|P1|COMPLETED|Overall Study||181
5249542|NCT00803244|12904398|P2|STARTED|Overall Study||193
5249543|NCT00803244|12904399|P1|STARTED|Overall Study||188
5249544|NCT00803205|12904409|P2|NOT COMPLETED|Overall Study||14
5249545|NCT00803205|12904410|P1|NOT COMPLETED|Overall Study||20
5249546|NCT00803205|12904409|P2|COMPLETED|Overall Study||104
5249547|NCT00803205|12904410|P1|COMPLETED|Overall Study||100
5249548|NCT00803205|12904409|P2|Per Protocol Population|Overall Study||103
5249549|NCT00803205|12904410|P1|Per Protocol Population|Overall Study||100
5249550|NCT00803205|12904409|P2|ITT Population|Overall Study||116
5249551|NCT00803205|12904410|P1|ITT Population|Overall Study||116
5249552|NCT00803205|12904409|P2|As-Treated Population*|Overall Study||118
5249553|NCT00803205|12904410|P1|As-Treated Population*|Overall Study||120
5249554|NCT00803205|12904409|P2|Completed Week 24|Overall Study||110
5249555|NCT00803205|12904410|P1|Completed Week 24|Overall Study||103
5249556|NCT00803205|12904409|P2|Completed Week 16|Overall Study||113
5249557|NCT00803205|12904410|P1|Completed Week 16|Overall Study||107
5249558|NCT00803205|12904409|P2|STARTED|Overall Study||118
5249559|NCT00803205|12904410|P1|STARTED|Overall Study||120
5249560|NCT00803179|12904453|P1|NOT COMPLETED|Overall Study||3
5249561|NCT00803179|12904453|P1|COMPLETED|Overall Study||2
5249562|NCT00803179|12904453|P1|STARTED|Overall Study||5
5249563|NCT00803114|12904459|P2|NOT COMPLETED|Overall Study||0
5249564|NCT00803114|12904460|P1|NOT COMPLETED|Overall Study||0
5249565|NCT00803114|12904459|P2|COMPLETED|Overall Study||115
5249566|NCT00803114|12904460|P1|COMPLETED|Overall Study||113
5249567|NCT00803114|12904459|P2|STARTED|Overall Study||115
5249568|NCT00803114|12904460|P1|STARTED|Overall Study||113
5249569|NCT00803101|12904472|P2|NOT COMPLETED|Overall Study||22
5249570|NCT00803101|12904473|P1|NOT COMPLETED|Overall Study||18
5249571|NCT00803101|12904472|P2|COMPLETED|Overall Study||66
5249572|NCT00803101|12904473|P1|COMPLETED|Overall Study||70
5249573|NCT00803101|12904472|P2|STARTED|Overall Study||88
5249574|NCT00803101|12904473|P1|STARTED|Overall Study||88
5249575|NCT00803062|12904495|P4|NOT COMPLETED|Overall Study||0
5249576|NCT00803062|12904496|P3|NOT COMPLETED|Overall Study||0
5249577|NCT00803062|12904497|P2|NOT COMPLETED|Overall Study||0
5249578|NCT00803062|12904498|P1|NOT COMPLETED|Overall Study||0
5249579|NCT00803062|12904495|P4|COMPLETED|Overall Study||112
5249580|NCT00803062|12904496|P3|COMPLETED|Overall Study||111
5249581|NCT00803062|12904497|P2|COMPLETED|Overall Study||115
5249582|NCT00803062|12904498|P1|COMPLETED|Overall Study||114
5249583|NCT00803062|12904495|P4|STARTED|Overall Study||112
5249584|NCT00803062|12904496|P3|STARTED|Overall Study||111
5249585|NCT00803062|12904497|P2|STARTED|Overall Study||115
5249586|NCT00803062|12904498|P1|STARTED|Overall Study||114
5249587|NCT00803049|12904524|P4|NOT COMPLETED|Overall Study||102
5249588|NCT00803049|12904525|P3|NOT COMPLETED|Overall Study||44
5249589|NCT00803049|12904526|P2|NOT COMPLETED|Overall Study||118
5249590|NCT00803049|12904527|P1|NOT COMPLETED|Overall Study||61
5249591|NCT00803049|12904524|P4|COMPLETED|Overall Study||151
5249592|NCT00803049|12904525|P3|COMPLETED|Overall Study||64
5249593|NCT00803049|12904526|P2|COMPLETED|Overall Study||134
5249594|NCT00803049|12904527|P1|COMPLETED|Overall Study||68
5249595|NCT00803049|12904524|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
5249596|NCT00803049|12904525|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
5249597|NCT00803049|12904526|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
5249598|NCT00803049|12904527|P1|Safety Population|Overall Study||129
5249599|NCT00803049|12904524|P4|Treated|Overall Study||251
5249600|NCT00803049|12904525|P3|Treated|Overall Study||108
5249601|NCT00803049|12904526|P2|Treated|Overall Study||252
5249602|NCT00803049|12904527|P1|Treated|Overall Study||129
5249603|NCT00803049|12904524|P4|STARTED|Overall Study|Randomized in extension study|253
5249604|NCT00803049|12904525|P3|STARTED|Overall Study|Randomized in extension study|108
5249605|NCT00803049|12904526|P2|STARTED|Overall Study|Randomized in extension study|252
5249606|NCT00803049|12904527|P1|STARTED|Overall Study|Randomized in extension study|129
5249607|NCT00803023|12904561|P4|NOT COMPLETED|Overall Study||8
5249608|NCT00803023|12904562|P3|NOT COMPLETED|Overall Study||11
5249609|NCT00803023|12904563|P2|NOT COMPLETED|Overall Study||8
5249610|NCT00803023|12904564|P1|NOT COMPLETED|Overall Study||5
5249611|NCT00803023|12904561|P4|COMPLETED|Overall Study||25
5249612|NCT00803023|12904562|P3|COMPLETED|Overall Study||20
5249613|NCT00803023|12904563|P2|COMPLETED|Overall Study||25
5249614|NCT00803023|12904564|P1|COMPLETED|Overall Study||27
5249615|NCT00803023|12904561|P4|STARTED|Overall Study||33
5249616|NCT00803023|12904562|P3|STARTED|Overall Study||31
5249617|NCT00803023|12904563|P2|STARTED|Overall Study||33
5249618|NCT00803023|12904564|P1|STARTED|Overall Study||32
5249619|NCT00803010|12904576|P2|NOT COMPLETED|Overall Study||0
5249620|NCT00803010|12904577|P1|NOT COMPLETED|Overall Study||0
5249621|NCT00803010|12904576|P2|COMPLETED|Overall Study||37
5249622|NCT00803010|12904577|P1|COMPLETED|Overall Study||37
5249623|NCT00803010|12904576|P2|STARTED|Overall Study||37
5249624|NCT00803010|12904577|P1|STARTED|Overall Study||37
5249625|NCT00802997|12904589|P2|NOT COMPLETED|6 Month to 9 Months||0
5249626|NCT00802997|12904590|P1|NOT COMPLETED|6 Month to 9 Months||2
5249627|NCT00802997|12904589|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
5249628|NCT00802997|12904590|P1|COMPLETED|6 Month to 9 Months||25
5249629|NCT00802997|12904589|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
5249630|NCT00802997|12904590|P1|STARTED|6 Month to 9 Months||27
5249631|NCT00802997|12904589|P2|NOT COMPLETED|3 Months to 6 Months||0
5249632|NCT00802997|12904590|P1|NOT COMPLETED|3 Months to 6 Months||7
5249633|NCT00802997|12904589|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
5249634|NCT00802997|12904590|P1|COMPLETED|3 Months to 6 Months||27
5249635|NCT00802997|12904589|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
5249636|NCT00802997|12904590|P1|STARTED|3 Months to 6 Months||34
5249637|NCT00802997|12904589|P2|NOT COMPLETED|Baseline to 3 Months||0
5249638|NCT00802997|12904590|P1|NOT COMPLETED|Baseline to 3 Months||0
5249639|NCT00802997|12904589|P2|COMPLETED|Baseline to 3 Months||17
5249640|NCT00802997|12904590|P1|COMPLETED|Baseline to 3 Months||34
5249641|NCT00802997|12904589|P2|STARTED|Baseline to 3 Months||17
5249642|NCT00802997|12904590|P1|STARTED|Baseline to 3 Months||34
5249643|NCT00802945|12904602|P2|NOT COMPLETED|Overall Study||35
5249644|NCT00802945|12904603|P1|NOT COMPLETED|Overall Study||35
5249645|NCT00802945|12904602|P2|COMPLETED|Overall Study||0
5249646|NCT00802945|12904603|P1|COMPLETED|Overall Study||0
5249647|NCT00802945|12904602|P2|STARTED|Overall Study||35
5249648|NCT00802945|12904603|P1|STARTED|Overall Study||35
5249649|NCT00802919|12904621|P2|NOT COMPLETED|Overall Study||1
5249650|NCT00802919|12904622|P1|NOT COMPLETED|Overall Study||3
5249651|NCT00802919|12904621|P2|COMPLETED|Overall Study||45
5249652|NCT00802919|12904622|P1|COMPLETED|Overall Study||42
5249653|NCT00802919|12904621|P2|STARTED|Overall Study||46
5249654|NCT00802919|12904622|P1|STARTED|Overall Study||45
5249655|NCT00802893|12904634|P1|NOT COMPLETED|Overall Study||3
5249656|NCT00802893|12904634|P1|COMPLETED|Overall Study||0
5249657|NCT00802893|12904634|P1|STARTED|Overall Study||3
5249658|NCT00802880|12904639|P1|NOT COMPLETED|Overall Study||0
5249659|NCT00802880|12904639|P1|COMPLETED|Overall Study||80
5249660|NCT00802880|12904639|P1|STARTED|Overall Study||80
5249661|NCT00802867|12904658|P1|NOT COMPLETED|Overall Study||13
5249662|NCT00802867|12904658|P1|COMPLETED|Overall Study||976
5249663|NCT00802867|12904658|P1|STARTED|Overall Study||989
5249664|NCT00802854|12904666|P1|NOT COMPLETED|Overall Study||0
5249665|NCT00802854|12904666|P1|COMPLETED|Overall Study||244
5249666|NCT00802854|12904666|P1|STARTED|Overall Study||244
5249667|NCT00802841|12904681|P2|NOT COMPLETED|Overall Study||95
5249668|NCT00802841|12904682|P1|NOT COMPLETED|Overall Study||96
5249669|NCT00802841|12904681|P2|COMPLETED|Overall Study||0
5249670|NCT00802841|12904682|P1|COMPLETED|Overall Study||0
5249671|NCT00802841|12904681|P2|Cross-over Set|Overall Study||56
5249672|NCT00802841|12904682|P1|Cross-over Set|Overall Study||13
5249673|NCT00802841|12904681|P2|Safety Set|Overall Study||93
5249674|NCT00802841|12904682|P1|Safety Set|Overall Study||96
5249675|NCT00802841|12904681|P2|Full Analysis Set|Overall Study||95
5249676|NCT00802841|12904682|P1|Full Analysis Set|Overall Study||96
5249677|NCT00802841|12904681|P2|STARTED|Overall Study||95
5249678|NCT00802841|12904682|P1|STARTED|Overall Study||96
5249679|NCT00802737|12904707|P3|NOT COMPLETED|Overall Study||1
5249680|NCT00802737|12904708|P2|NOT COMPLETED|Overall Study||11
5249681|NCT00802737|12904709|P1|NOT COMPLETED|Overall Study||17
5249682|NCT00802737|12904707|P3|COMPLETED|Overall Study||0
5249683|NCT00802737|12904708|P2|COMPLETED|Overall Study||0
5249684|NCT00802737|12904709|P1|COMPLETED|Overall Study||0
5249685|NCT00802737|12904707|P3|STARTED|Overall Study||1
5249686|NCT00802737|12904708|P2|STARTED|Overall Study||11
5249687|NCT00802737|12904709|P1|STARTED|Overall Study||17
5249688|NCT00802685|12904757|P2|NOT COMPLETED|Overall Study||0
5249689|NCT00802685|12904758|P1|NOT COMPLETED|Overall Study||0
5249690|NCT00802685|12904757|P2|COMPLETED|Overall Study||51
5249691|NCT00802685|12904758|P1|COMPLETED|Overall Study||54
5249692|NCT00802685|12904757|P2|STARTED|Overall Study||51
5249693|NCT00802685|12904758|P1|STARTED|Overall Study||54
5249694|NCT00802672|12904769|P3|NOT COMPLETED|Overall Study||34
5249695|NCT00802672|12904770|P2|NOT COMPLETED|Overall Study||52
5249696|NCT00802672|12904771|P1|NOT COMPLETED|Overall Study||68
5249697|NCT00802672|12904769|P3|COMPLETED|Overall Study||77
5249698|NCT00802672|12904770|P2|COMPLETED|Overall Study||174
5249699|NCT00802672|12904771|P1|COMPLETED|Overall Study||156
5249700|NCT00802672|12904769|P3|STARTED|Overall Study||111
5249701|NCT00802672|12904770|P2|STARTED|Overall Study||226
5249702|NCT00802672|12904771|P1|STARTED|Overall Study||224
5249703|NCT00802659|12904789|P4|NOT COMPLETED|Overall Study||0
5249704|NCT00802659|12904790|P3|NOT COMPLETED|Overall Study||0
5249705|NCT00802659|12904791|P2|NOT COMPLETED|Overall Study||1
5249706|NCT00802659|12904792|P1|NOT COMPLETED|Overall Study||0
5249707|NCT00802659|12904789|P4|COMPLETED|Overall Study||0
5249708|NCT00802659|12904790|P3|COMPLETED|Overall Study||0
5249709|NCT00802659|12904791|P2|COMPLETED|Overall Study||1
5249710|NCT00802659|12904792|P1|COMPLETED|Overall Study||0
5249711|NCT00802659|12904789|P4|STARTED|Overall Study||0
5249712|NCT00802659|12904790|P3|STARTED|Overall Study||0
5249713|NCT00802659|12904791|P2|STARTED|Overall Study||2
5249714|NCT00802659|12904792|P1|STARTED|Overall Study||0
5249715|NCT00802633|12904820|P2|NOT COMPLETED|Overall Study||0
5249716|NCT00802633|12904821|P1|NOT COMPLETED|Overall Study||0
5249717|NCT00802633|12904820|P2|COMPLETED|Overall Study||40
5249718|NCT00802633|12904821|P1|COMPLETED|Overall Study||40
5249719|NCT00802633|12904820|P2|STARTED|Overall Study||40
5249720|NCT00802633|12904821|P1|STARTED|Overall Study||40
5249721|NCT00802529|12904831|P2|NOT COMPLETED|Overall Study||1
5249722|NCT00802529|12904832|P1|NOT COMPLETED|Overall Study||0
5249723|NCT00802529|12904831|P2|COMPLETED|Overall Study||29
5249724|NCT00802529|12904832|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
5249725|NCT00802529|12904831|P2|STARTED|Overall Study||30
5249726|NCT00802529|12904832|P1|STARTED|Overall Study||30
5249727|NCT00802503|12904844|P2|NOT COMPLETED|Overall Study||20
5249728|NCT00802503|12904845|P1|NOT COMPLETED|Overall Study||10
5249729|NCT00802503|12904844|P2|COMPLETED|Overall Study||133
5249730|NCT00802503|12904845|P1|COMPLETED|Overall Study||142
5249731|NCT00802503|12904844|P2|STARTED|Overall Study||153
5249732|NCT00802503|12904845|P1|STARTED|Overall Study||152
5249733|NCT00802464|12904871|P4|NOT COMPLETED|Month 8 - Month 14||0
5249734|NCT00802464|12904872|P3|NOT COMPLETED|Month 8 - Month 14||1
5249735|NCT00802464|12904873|P2|NOT COMPLETED|Month 8 - Month 14||2
5249736|NCT00802464|12904874|P1|NOT COMPLETED|Month 8 - Month 14||1
5249737|NCT00802464|12904871|P4|COMPLETED|Month 8 - Month 14||126
5249738|NCT00802464|12904872|P3|COMPLETED|Month 8 - Month 14||129
5249739|NCT00802464|12904873|P2|COMPLETED|Month 8 - Month 14||63
5249740|NCT00802464|12904874|P1|COMPLETED|Month 8 - Month 14||33
5249741|NCT00802464|12904871|P4|STARTED|Month 8 - Month 14||126
5249742|NCT00802464|12904872|P3|STARTED|Month 8 - Month 14||130
5249743|NCT00802464|12904873|P2|STARTED|Month 8 - Month 14||65
5249744|NCT00802464|12904874|P1|STARTED|Month 8 - Month 14||34
5249745|NCT00802464|12904871|P4|NOT COMPLETED|Month 0 - Month 8||9
5249746|NCT00802464|12904872|P3|NOT COMPLETED|Month 0 - Month 8||7
5249747|NCT00802464|12904873|P2|NOT COMPLETED|Month 0 - Month 8||3
5249748|NCT00802464|12904874|P1|NOT COMPLETED|Month 0 - Month 8||0
5249749|NCT00802464|12904871|P4|COMPLETED|Month 0 - Month 8||141
5249750|NCT00802464|12904872|P3|COMPLETED|Month 0 - Month 8||142
5249751|NCT00802464|12904873|P2|COMPLETED|Month 0 - Month 8||70
5249752|NCT00802464|12904874|P1|COMPLETED|Month 0 - Month 8||38
5249753|NCT00802464|12904871|P4|STARTED|Month 0 - Month 8||150
5249754|NCT00802464|12904872|P3|STARTED|Month 0 - Month 8||149
5249755|NCT00802464|12904873|P2|STARTED|Month 0 - Month 8||73
5249756|NCT00802464|12904874|P1|STARTED|Month 0 - Month 8||38
5249757|NCT00802438|12904960|P1|NOT COMPLETED|Overall Study||28
5249758|NCT00802438|12904960|P1|COMPLETED|Overall Study||10
5249759|NCT00802438|12904960|P1|STARTED|Overall Study||38
5249760|NCT00802412|12904967|P2|NOT COMPLETED|Overall Study||1
5249761|NCT00802412|12904968|P1|NOT COMPLETED|Overall Study||2
5249762|NCT00802412|12904967|P2|COMPLETED|Overall Study||66
5249763|NCT00802412|12904968|P1|COMPLETED|Overall Study||63
5249764|NCT00802412|12904967|P2|STARTED|Overall Study||67
5249765|NCT00802412|12904968|P1|STARTED|Overall Study||65
5249766|NCT00802360|12904980|P4|NOT COMPLETED|Overall Study||22
5249767|NCT00802360|12904981|P3|NOT COMPLETED|Overall Study||25
5249768|NCT00802360|12904982|P2|NOT COMPLETED|Overall Study||26
5249769|NCT00802360|12904983|P1|NOT COMPLETED|Overall Study||24
5249770|NCT00802360|12904980|P4|COMPLETED|Overall Study||17
5249771|NCT00802360|12904981|P3|COMPLETED|Overall Study||17
5249772|NCT00802360|12904982|P2|COMPLETED|Overall Study||16
5249773|NCT00802360|12904983|P1|COMPLETED|Overall Study||18
5249774|NCT00802360|12904980|P4|STARTED|Overall Study||39
5249775|NCT00802360|12904981|P3|STARTED|Overall Study||42
5249776|NCT00802360|12904982|P2|STARTED|Overall Study||42
5249777|NCT00802360|12904983|P1|STARTED|Overall Study||42
5249778|NCT00802204|12905025|P2|NOT COMPLETED|Overall Study||1
5249779|NCT00802204|12905026|P1|NOT COMPLETED|Overall Study||1
5249780|NCT00802204|12905025|P2|COMPLETED|Overall Study||18
5249781|NCT00802204|12905026|P1|COMPLETED|Overall Study||8
5249782|NCT00802204|12905025|P2|STARTED|Overall Study||19
5249783|NCT00802204|12905026|P1|STARTED|Overall Study||9
5249784|NCT00802178|12905050|P1|NOT COMPLETED|Overall Study||113
5249785|NCT00802178|12905050|P1|COMPLETED|Overall Study||2335
5249786|NCT00802178|12905050|P1|STARTED|Overall Study||2448
5249787|NCT00802113|12905059|P2|NOT COMPLETED|Overall Study||0
5249788|NCT00802113|12905060|P1|NOT COMPLETED|Overall Study||0
5249789|NCT00802113|12905059|P2|COMPLETED|Overall Study||17
5249790|NCT00802113|12905060|P1|COMPLETED|Overall Study||6
5249791|NCT00802113|12905059|P2|STARTED|Overall Study||17
5249792|NCT00802113|12905060|P1|STARTED|Overall Study||6
5249793|NCT00802100|12905081|P3|NOT COMPLETED|Overall Study||4
5249794|NCT00802100|12905082|P2|NOT COMPLETED|Overall Study||7
5249795|NCT00802100|12905083|P1|NOT COMPLETED|Overall Study||6
5249796|NCT00802100|12905081|P3|COMPLETED|Overall Study||2
5249797|NCT00802100|12905082|P2|COMPLETED|Overall Study||2
5249798|NCT00802100|12905083|P1|COMPLETED|Overall Study||0
5249799|NCT00802100|12905081|P3|STARTED|Overall Study||6
5249800|NCT00802100|12905082|P2|STARTED|Overall Study||9
5249801|NCT00802100|12905083|P1|STARTED|Overall Study||6
5249802|NCT00802074|12905098|P6|NOT COMPLETED|Overall Study||0
5249803|NCT00802074|12905099|P5|NOT COMPLETED|Overall Study||0
5249804|NCT00802074|12905100|P4|NOT COMPLETED|Overall Study||0
5249805|NCT00802074|12905101|P3|NOT COMPLETED|Overall Study||1
5249806|NCT00802074|12905102|P2|NOT COMPLETED|Overall Study||1
5249807|NCT00802074|12905103|P1|NOT COMPLETED|Overall Study||2
5249808|NCT00802074|12905098|P6|COMPLETED|Overall Study||7
5249809|NCT00802074|12905099|P5|COMPLETED|Overall Study||7
5249810|NCT00802074|12905100|P4|COMPLETED|Overall Study||7
5249811|NCT00802074|12905101|P3|COMPLETED|Overall Study||6
5249812|NCT00802074|12905102|P2|COMPLETED|Overall Study||7
5249813|NCT00802074|12905103|P1|COMPLETED|Overall Study||7
5249814|NCT00802074|12905098|P6|STARTED|Overall Study||7
5249815|NCT00802074|12905099|P5|STARTED|Overall Study||7
5249816|NCT00802074|12905100|P4|STARTED|Overall Study||7
5249817|NCT00802074|12905101|P3|STARTED|Overall Study||7
5249818|NCT00802074|12905102|P2|STARTED|Overall Study||8
5249819|NCT00802074|12905103|P1|STARTED|Overall Study||9
5249820|NCT00801983|12905137|P2|NOT COMPLETED|Period 2||1
5249821|NCT00801983|12905138|P1|NOT COMPLETED|Period 2||2
5249822|NCT00801983|12905137|P2|COMPLETED|Period 2||32
5249823|NCT00801983|12905138|P1|COMPLETED|Period 2||38
5249824|NCT00801983|12905137|P2|STARTED|Period 2||33
5249825|NCT00801983|12905138|P1|STARTED|Period 2||40
5249826|NCT00801983|12905137|P2|NOT COMPLETED|Period 1||8
5249827|NCT00801983|12905138|P1|NOT COMPLETED|Period 1||4
5249828|NCT00801983|12905137|P2|COMPLETED|Period 1||33
5249829|NCT00801983|12905138|P1|COMPLETED|Period 1||40
5249830|NCT00801983|12905137|P2|STARTED|Period 1||41
5249831|NCT00801983|12905138|P1|STARTED|Period 1||44
5249832|NCT00801931|12905144|P1|NOT COMPLETED|Overall Study||0
5249833|NCT00801931|12905144|P1|COMPLETED|Overall Study||1
5249834|NCT00801931|12905144|P1|STARTED|Overall Study||1
5249835|NCT00801892|12905153|P2|NOT COMPLETED|Sham Crossover Period||2
5249836|NCT00801892|12905154|P1|NOT COMPLETED|Sham Crossover Period||0
5249837|NCT00801892|12905153|P2|COMPLETED|Sham Crossover Period||5
5249838|NCT00801892|12905154|P1|COMPLETED|Sham Crossover Period||0
5249839|NCT00801892|12905153|P2|STARTED|Sham Crossover Period||7
5249840|NCT00801892|12905154|P1|STARTED|Sham Crossover Period||0
5249841|NCT00801892|12905153|P2|NOT COMPLETED|Main Study Period||1
5249842|NCT00801892|12905154|P1|NOT COMPLETED|Main Study Period||0
5249843|NCT00801892|12905153|P2|COMPLETED|Main Study Period||10
5249844|NCT00801892|12905154|P1|COMPLETED|Main Study Period||12
5249845|NCT00801892|12905153|P2|STARTED|Main Study Period||11
5249846|NCT00801892|12905154|P1|STARTED|Main Study Period||12
5249847|NCT00801827|12905170|P1|NOT COMPLETED|Overall Study||0
5249848|NCT00801827|12905170|P1|COMPLETED|Overall Study||5
5249849|NCT00801827|12905170|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
5249850|NCT00801801|12905174|P1|NOT COMPLETED|Overall Study||0
5249851|NCT00801801|12905174|P1|COMPLETED|Overall Study||5
5249852|NCT00801801|12905174|P1|STARTED|Overall Study||5
5249853|NCT00801684|12905179|P1|NOT COMPLETED|Overall Study||0
5249854|NCT00801684|12905179|P1|COMPLETED|Overall Study||24
5249855|NCT00801684|12905179|P1|STARTED|Overall Study||24
5249856|NCT00801632|12905201|P1|NOT COMPLETED|Overall Study||1
5249857|NCT00801632|12905201|P1|COMPLETED|Overall Study||4
5249858|NCT00801632|12905201|P1|STARTED|Overall Study||5
5249859|NCT00801398|12905218|P6|NOT COMPLETED|Overall Study||3
5249860|NCT00801398|12905219|P5|NOT COMPLETED|Overall Study||7
5249861|NCT00801398|12905220|P4|NOT COMPLETED|Overall Study||6
5249862|NCT00801398|12905221|P3|NOT COMPLETED|Overall Study||7
5249863|NCT00801398|12905222|P2|NOT COMPLETED|Overall Study||9
5249864|NCT00801398|12905223|P1|NOT COMPLETED|Overall Study||6
5249865|NCT00801398|12905218|P6|COMPLETED|Overall Study||5
5249866|NCT00801398|12905219|P5|COMPLETED|Overall Study||1
5249867|NCT00801398|12905220|P4|COMPLETED|Overall Study||3
5249868|NCT00801398|12905221|P3|COMPLETED|Overall Study||4
5249869|NCT00801398|12905222|P2|COMPLETED|Overall Study||0
5249870|NCT00801398|12905223|P1|COMPLETED|Overall Study||7
5249871|NCT00801398|12905218|P6|STARTED|Overall Study||8
5249872|NCT00801398|12905219|P5|STARTED|Overall Study||8
5249873|NCT00801398|12905220|P4|STARTED|Overall Study||9
5249874|NCT00801398|12905221|P3|STARTED|Overall Study||11
5249875|NCT00801398|12905222|P2|STARTED|Overall Study||9
5249876|NCT00801398|12905223|P1|STARTED|Overall Study||13
5249877|NCT00801242|12905279|P1|NOT COMPLETED|Overall Study||52
5249878|NCT00801242|12905279|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
5249879|NCT00801242|12905279|P1|Started Cycle 3|Overall Study||2
5249880|NCT00801242|12905279|P1|Started Cycle 2|Overall Study||35
5249881|NCT00801242|12905279|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
5249882|NCT00801242|12905279|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
5249883|NCT00801242|12905279|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
5249884|NCT00801242|12905279|P1|STARTED|Overall Study|Randomized participants.|220
5249885|NCT00801229|12905292|P2|NOT COMPLETED|Received Study Drug/Placebo||4
5249886|NCT00801229|12905293|P1|NOT COMPLETED|Received Study Drug/Placebo||4
5249887|NCT00801229|12905292|P2|COMPLETED|Received Study Drug/Placebo||30
5249888|NCT00801229|12905293|P1|COMPLETED|Received Study Drug/Placebo||31
5249889|NCT00801229|12905292|P2|STARTED|Received Study Drug/Placebo||34
5249890|NCT00801229|12905293|P1|STARTED|Received Study Drug/Placebo||35
5249891|NCT00801229|12905292|P2|NOT COMPLETED|Signed Consent||3
5249892|NCT00801229|12905293|P1|NOT COMPLETED|Signed Consent||3
5249893|NCT00801229|12905292|P2|COMPLETED|Signed Consent||34
5249894|NCT00801229|12905293|P1|COMPLETED|Signed Consent||35
5249895|NCT00801229|12905292|P2|STARTED|Signed Consent||37
5249896|NCT00801229|12905293|P1|STARTED|Signed Consent||38
5249897|NCT00801138|12905303|P4|NOT COMPLETED|Overall Study||0
5249898|NCT00801138|12905304|P3|NOT COMPLETED|Overall Study||0
5249899|NCT00801138|12905305|P2|NOT COMPLETED|Overall Study||0
5249900|NCT00801138|12905306|P1|NOT COMPLETED|Overall Study||0
5249901|NCT00801138|12905303|P4|COMPLETED|Overall Study||54
5249902|NCT00801138|12905304|P3|COMPLETED|Overall Study||54
5249903|NCT00801138|12905305|P2|COMPLETED|Overall Study||56
5249904|NCT00801138|12905306|P1|COMPLETED|Overall Study||54
5249905|NCT00801138|12905303|P4|STARTED|Overall Study||54
5249906|NCT00801138|12905304|P3|STARTED|Overall Study||54
5249907|NCT00801138|12905305|P2|STARTED|Overall Study||56
5249908|NCT00801138|12905306|P1|STARTED|Overall Study||54
5249909|NCT00801099|12905328|P1|NOT COMPLETED|Overall Study||101
5249910|NCT00801099|12905328|P1|COMPLETED|Overall Study||175
5249911|NCT00801099|12905328|P1|STARTED|Overall Study||276
5249912|NCT00800982|12905334|P2|NOT COMPLETED|Overall Study||3
5249913|NCT00800982|12905335|P1|NOT COMPLETED|Overall Study||2
5249914|NCT00800982|12905334|P2|COMPLETED|Overall Study||12
5249915|NCT00800982|12905335|P1|COMPLETED|Overall Study||13
5249916|NCT00800982|12905334|P2|STARTED|Overall Study||15
5249917|NCT00800982|12905335|P1|STARTED|Overall Study||15
5249918|NCT00800865|12905343|P2|NOT COMPLETED|Overall Study||0
5249919|NCT00800865|12905344|P1|NOT COMPLETED|Overall Study||0
5249920|NCT00800865|12905343|P2|COMPLETED|Overall Study||16
5249921|NCT00800865|12905344|P1|COMPLETED|Overall Study||15
5249922|NCT00800865|12905343|P2|STARTED|Overall Study||16
5249923|NCT00800865|12905344|P1|STARTED|Overall Study||15
5249924|NCT00800839|12905352|P1|NOT COMPLETED|Overall Study||7
5249925|NCT00800839|12905352|P1|COMPLETED|Overall Study||49
5249926|NCT00800839|12905352|P1|STARTED|Overall Study||56
5249927|NCT00800735|12905361|P1|NOT COMPLETED|Overall Study||14
5249928|NCT00800735|12905361|P1|COMPLETED|Overall Study||16
5249929|NCT00800735|12905361|P1|STARTED|Overall Study||30
5249930|NCT00800683|12905367|P2|NOT COMPLETED|Overall Study||19
5249931|NCT00800683|12905368|P1|NOT COMPLETED|Overall Study||17
5249932|NCT00800683|12905367|P2|COMPLETED|Overall Study|Number who completed treatment|49
5249933|NCT00800683|12905368|P1|COMPLETED|Overall Study|Number who completed treatment|48
5249934|NCT00800683|12905367|P2|STARTED|Overall Study|Number who started treatment|68
5249935|NCT00800683|12905368|P1|STARTED|Overall Study|Number who started treatment|65
5249936|NCT00800540|12905414|P2|NOT COMPLETED|Period 2: 6 Weeks||1
5249937|NCT00800540|12905415|P1|NOT COMPLETED|Period 2: 6 Weeks||0
5249938|NCT00800540|12905414|P2|COMPLETED|Period 2: 6 Weeks||16
5249939|NCT00800540|12905415|P1|COMPLETED|Period 2: 6 Weeks||16
5249940|NCT00800540|12905414|P2|STARTED|Period 2: 6 Weeks||17
5249941|NCT00800540|12905415|P1|STARTED|Period 2: 6 Weeks||16
5249942|NCT00800540|12905414|P2|NOT COMPLETED|Washout: 4 Weeks||0
5249943|NCT00800540|12905415|P1|NOT COMPLETED|Washout: 4 Weeks||0
5249944|NCT00800540|12905414|P2|COMPLETED|Washout: 4 Weeks||17
5249945|NCT00800540|12905415|P1|COMPLETED|Washout: 4 Weeks||16
5249946|NCT00800540|12905414|P2|STARTED|Washout: 4 Weeks||17
5249947|NCT00800540|12905415|P1|STARTED|Washout: 4 Weeks||16
5249948|NCT00800540|12905414|P2|NOT COMPLETED|Period One: 6 Weeks||1
5249949|NCT00800540|12905415|P1|NOT COMPLETED|Period One: 6 Weeks||1
5249950|NCT00800540|12905414|P2|COMPLETED|Period One: 6 Weeks||17
5249951|NCT00800540|12905415|P1|COMPLETED|Period One: 6 Weeks||16
5249952|NCT00800540|12905414|P2|STARTED|Period One: 6 Weeks||18
5249953|NCT00800540|12905415|P1|STARTED|Period One: 6 Weeks||17
5249954|NCT00800436|12905450|P7|NOT COMPLETED|Overall Study||0
5249955|NCT00800436|12905451|P6|NOT COMPLETED|Overall Study||0
5249956|NCT00800436|12905452|P5|NOT COMPLETED|Overall Study||0
5249957|NCT00800436|12905453|P4|NOT COMPLETED|Overall Study||1
5249958|NCT00800436|12905454|P3|NOT COMPLETED|Overall Study||1
5249959|NCT00800436|12905455|P2|NOT COMPLETED|Overall Study||0
5249960|NCT00800436|12905456|P1|NOT COMPLETED|Overall Study||0
5249961|NCT00800436|12905450|P7|COMPLETED|Overall Study||20
5249962|NCT00800436|12905451|P6|COMPLETED|Overall Study||20
5249963|NCT00800436|12905452|P5|COMPLETED|Overall Study||6
5249964|NCT00800436|12905453|P4|COMPLETED|Overall Study||5
5249965|NCT00800436|12905454|P3|COMPLETED|Overall Study||5
5249966|NCT00800436|12905455|P2|COMPLETED|Overall Study||6
5249967|NCT00800436|12905456|P1|COMPLETED|Overall Study||6
5249968|NCT00800436|12905450|P7|STARTED|Overall Study||20
5249969|NCT00800436|12905451|P6|STARTED|Overall Study||20
5249970|NCT00800436|12905452|P5|STARTED|Overall Study||6
5249971|NCT00800436|12905453|P4|STARTED|Overall Study||6
5249972|NCT00800436|12905454|P3|STARTED|Overall Study||6
5249973|NCT00800436|12905455|P2|STARTED|Overall Study||6
5249974|NCT00800436|12905456|P1|STARTED|Overall Study||6
5249975|NCT00800384|12905502|P2|NOT COMPLETED|Overall Study||43
5249976|NCT00800384|12905503|P1|NOT COMPLETED|Overall Study||41
5249977|NCT00800384|12905502|P2|COMPLETED|Overall Study||1210
5249978|NCT00800384|12905503|P1|COMPLETED|Overall Study||1206
5249979|NCT00800384|12905502|P2|STARTED|Overall Study||1253
5249980|NCT00800384|12905503|P1|STARTED|Overall Study||1247
5249981|NCT00800345|12905511|P1|NOT COMPLETED|Overall Study||0
5249982|NCT00800345|12905511|P1|COMPLETED|Overall Study||33
5249983|NCT00800345|12905511|P1|STARTED|Overall Study||33
5249984|NCT00800254|12905518|P2|NOT COMPLETED|Overall Study||6
5249985|NCT00800254|12905519|P1|NOT COMPLETED|Overall Study||5
5249986|NCT00800254|12905518|P2|COMPLETED|Overall Study||25
5249987|NCT00800254|12905519|P1|COMPLETED|Overall Study||30
5249988|NCT00800254|12905518|P2|3.5 Weeks Post-operatively|Overall Study||31
5249989|NCT00800254|12905519|P1|3.5 Weeks Post-operatively|Overall Study||31
5249990|NCT00800254|12905518|P2|STARTED|Overall Study||31
5249991|NCT00800254|12905519|P1|STARTED|Overall Study||35
5249992|NCT00800202|12905541|P2|NOT COMPLETED|Overall Study||24
5249993|NCT00800202|12905542|P1|NOT COMPLETED|Overall Study||67
5249994|NCT00800202|12905541|P2|COMPLETED|Overall Study||0
5249995|NCT00800202|12905542|P1|COMPLETED|Overall Study||0
5249996|NCT00800202|12905541|P2|STARTED|Overall Study||24
5249997|NCT00800202|12905542|P1|STARTED|Overall Study||67
5249998|NCT00799903|12905562|P2|NOT COMPLETED|Overall Study||278
5249999|NCT00799903|12905563|P1|NOT COMPLETED|Overall Study||273
5250000|NCT00799903|12905562|P2|COMPLETED|Overall Study||7646
5250001|NCT00799903|12905563|P1|COMPLETED|Overall Study||7631
5250002|NCT00799903|12905562|P2|STARTED|Overall Study||7924
5250003|NCT00799903|12905563|P1|STARTED|Overall Study||7904
5250004|NCT00799825|12905583|P1|NOT COMPLETED|Overall Study||48
5250005|NCT00799825|12905583|P1|COMPLETED|Overall Study||296
5250006|NCT00799825|12905583|P1|STARTED|Overall Study||344
5250007|NCT00799773|12905591|P2|NOT COMPLETED|Overall Study||0
5250008|NCT00799773|12905592|P1|NOT COMPLETED|Overall Study||0
5250009|NCT00799773|12905591|P2|COMPLETED|Overall Study||1
5250010|NCT00799773|12905592|P1|COMPLETED|Overall Study||2
5250011|NCT00799773|12905591|P2|STARTED|Overall Study||1
5250012|NCT00799773|12905592|P1|STARTED|Overall Study||2
5250013|NCT00799708|12905623|P3|NOT COMPLETED|Overall Study||0
5250014|NCT00799708|12905624|P2|NOT COMPLETED|Overall Study||0
5250015|NCT00799708|12905625|P1|NOT COMPLETED|Overall Study||1
5250016|NCT00799708|12905623|P3|COMPLETED|Overall Study||11
5250017|NCT00799708|12905624|P2|COMPLETED|Overall Study||6
5250018|NCT00799708|12905625|P1|COMPLETED|Overall Study||9
5250019|NCT00799708|12905623|P3|STARTED|Overall Study||11
5250020|NCT00799708|12905624|P2|STARTED|Overall Study||6
5250021|NCT00799708|12905625|P1|STARTED|Overall Study||10
5250022|NCT00799643|12905637|P2|NOT COMPLETED|Overall Study||27
5250023|NCT00799643|12905638|P1|NOT COMPLETED|Overall Study||25
5250024|NCT00799643|12905637|P2|COMPLETED|Overall Study||119
5250025|NCT00799643|12905638|P1|COMPLETED|Overall Study||115
5250026|NCT00799643|12905637|P2|STARTED|Overall Study||146
5250027|NCT00799643|12905638|P1|STARTED|Overall Study||140
5250028|NCT00799617|12905648|P2|NOT COMPLETED|Anemia Trial||3
5250029|NCT00799617|12905649|P1|NOT COMPLETED|Anemia Trial||3
5250030|NCT00799617|12905648|P2|COMPLETED|Anemia Trial||32
5250031|NCT00799617|12905649|P1|COMPLETED|Anemia Trial||24
5250032|NCT00799617|12905648|P2|STARTED|Anemia Trial||35
5250033|NCT00799617|12905649|P1|STARTED|Anemia Trial||27
5250034|NCT00799617|12905648|P2|NOT COMPLETED|Cognitive Function Trial||1
5250035|NCT00799617|12905649|P1|NOT COMPLETED|Cognitive Function Trial||0
5250036|NCT00799617|12905648|P2|COMPLETED|Cognitive Function Trial||245
5250037|NCT00799617|12905649|P1|COMPLETED|Cognitive Function Trial||247
5250038|NCT00799617|12905648|P2|STARTED|Cognitive Function Trial||246
5250039|NCT00799617|12905649|P1|STARTED|Cognitive Function Trial||247
5250040|NCT00799617|12905648|P2|NOT COMPLETED|Bone Trial||16
5250041|NCT00799617|12905649|P1|NOT COMPLETED|Bone Trial||6
5250042|NCT00799617|12905648|P2|COMPLETED|Bone Trial||85
5250043|NCT00799617|12905649|P1|COMPLETED|Bone Trial||104
5250044|NCT00799617|12905648|P2|STARTED|Bone Trial||101
5250045|NCT00799617|12905649|P1|STARTED|Bone Trial||110
5250046|NCT00799617|12905648|P2|NOT COMPLETED|Cardiovascular Trial||17
5250047|NCT00799617|12905649|P1|NOT COMPLETED|Cardiovascular Trial||15
5250048|NCT00799617|12905648|P2|COMPLETED|Cardiovascular Trial||65
5250049|NCT00799617|12905649|P1|COMPLETED|Cardiovascular Trial||73
5250050|NCT00799617|12905648|P2|STARTED|Cardiovascular Trial||82
5250051|NCT00799617|12905649|P1|STARTED|Cardiovascular Trial||88
5250052|NCT00799617|12905648|P2|NOT COMPLETED|Vitality Trial||22
5250053|NCT00799617|12905649|P1|NOT COMPLETED|Vitality Trial||7
5250054|NCT00799617|12905648|P2|COMPLETED|Vitality Trial||216
5250055|NCT00799617|12905649|P1|COMPLETED|Vitality Trial||229
5250056|NCT00799617|12905648|P2|STARTED|Vitality Trial||238
5250057|NCT00799617|12905649|P1|STARTED|Vitality Trial||236
5250058|NCT00799617|12905648|P2|NOT COMPLETED|Physical Function Trial||11
5250059|NCT00799617|12905649|P1|NOT COMPLETED|Physical Function Trial||6
5250060|NCT00799617|12905648|P2|COMPLETED|Physical Function Trial||185
5250061|NCT00799617|12905649|P1|COMPLETED|Physical Function Trial||185
5250062|NCT00799617|12905648|P2|STARTED|Physical Function Trial||196
5250063|NCT00799617|12905649|P1|STARTED|Physical Function Trial||191
5250064|NCT00799617|12905648|P2|NOT COMPLETED|Sexual Funtion Trial||21
5250065|NCT00799617|12905649|P1|NOT COMPLETED|Sexual Funtion Trial||16
5250066|NCT00799617|12905648|P2|COMPLETED|Sexual Funtion Trial||215
5250067|NCT00799617|12905649|P1|COMPLETED|Sexual Funtion Trial||218
5250068|NCT00799617|12905648|P2|STARTED|Sexual Funtion Trial||236
5250069|NCT00799617|12905649|P1|STARTED|Sexual Funtion Trial||234
5250070|NCT00799617|12905648|P2|NOT COMPLETED|Main Testosterone Trial||21
5250071|NCT00799617|12905649|P1|NOT COMPLETED|Main Testosterone Trial||19
5250072|NCT00799617|12905648|P2|COMPLETED|Main Testosterone Trial||374
5250073|NCT00799617|12905649|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
5250074|NCT00799617|12905648|P2|STARTED|Main Testosterone Trial||395
5250075|NCT00799617|12905649|P1|STARTED|Main Testosterone Trial||395
5250076|NCT00799604|12905730|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
5250077|NCT00799604|12905731|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
5250078|NCT00799604|12905732|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
5250079|NCT00799604|12905730|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
5250080|NCT00799604|12905731|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
5250081|NCT00799604|12905732|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
5250082|NCT00799604|12905730|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
5250083|NCT00799604|12905731|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
5250084|NCT00799604|12905732|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
5250085|NCT00799604|12905730|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
5250086|NCT00799604|12905731|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
5250087|NCT00799604|12905732|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
5250088|NCT00799604|12905730|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
5250089|NCT00799604|12905731|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
5250090|NCT00799604|12905732|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
5250091|NCT00799604|12905730|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
5250092|NCT00799604|12905731|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
5250093|NCT00799604|12905732|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
5250094|NCT00799591|12905756|P1|NOT COMPLETED|Overall Study||66
5250095|NCT00799591|12905756|P1|COMPLETED|Overall Study||90
5250096|NCT00799591|12905756|P1|STARTED|Overall Study||156
5250097|NCT00799578|12905767|P1|NOT COMPLETED|Overall Study||2
5250098|NCT00799578|12905767|P1|COMPLETED|Overall Study||11
5250099|NCT00799578|12905767|P1|STARTED|Overall Study||13
5250100|NCT00799487|12905774|P3|NOT COMPLETED|Double-Blind Assessment Period||2
5250101|NCT00799487|12905775|P2|NOT COMPLETED|Double-Blind Assessment Period||1
5250102|NCT00799487|12905776|P1|NOT COMPLETED|Double-Blind Assessment Period||0
5250103|NCT00799487|12905774|P3|COMPLETED|Double-Blind Assessment Period||32
5250104|NCT00799487|12905775|P2|COMPLETED|Double-Blind Assessment Period||33
5250105|NCT00799487|12905776|P1|COMPLETED|Double-Blind Assessment Period||0
5250106|NCT00799487|12905774|P3|STARTED|Double-Blind Assessment Period||34
5250107|NCT00799487|12905775|P2|STARTED|Double-Blind Assessment Period||34
5250108|NCT00799487|12905776|P1|STARTED|Double-Blind Assessment Period||0
5250109|NCT00799487|12905774|P3|NOT COMPLETED|Dose Adjustment Period||0
5250110|NCT00799487|12905775|P2|NOT COMPLETED|Dose Adjustment Period||0
5250111|NCT00799487|12905776|P1|NOT COMPLETED|Dose Adjustment Period||21
5250112|NCT00799487|12905774|P3|COMPLETED|Dose Adjustment Period||34
5250113|NCT00799487|12905775|P2|COMPLETED|Dose Adjustment Period||34
5250114|NCT00799487|12905776|P1|COMPLETED|Dose Adjustment Period||0
5250115|NCT00799487|12905774|P3|STARTED|Dose Adjustment Period||34
5250116|NCT00799487|12905775|P2|STARTED|Dose Adjustment Period||34
5250117|NCT00799487|12905776|P1|STARTED|Dose Adjustment Period||21
5250118|NCT00799474|12905856|P1|NOT COMPLETED|Overall Study||0
5250119|NCT00799474|12905856|P1|COMPLETED|Overall Study||609
5250120|NCT00799474|12905856|P1|STARTED|Overall Study||609
5250121|NCT00799435|12905864|P2|NOT COMPLETED|Overall Study||0
5250122|NCT00799435|12905865|P1|NOT COMPLETED|Overall Study||0
5250123|NCT00799435|12905864|P2|COMPLETED|Overall Study||1
5250124|NCT00799435|12905865|P1|COMPLETED|Overall Study||1
5250125|NCT00799435|12905864|P2|STARTED|Overall Study||1
5250126|NCT00799435|12905865|P1|STARTED|Overall Study||1
5250127|NCT00799422|12905871|P6|NOT COMPLETED|Third Week of Wear||0
5250128|NCT00799422|12905872|P5|NOT COMPLETED|Third Week of Wear||0
5250129|NCT00799422|12905873|P4|NOT COMPLETED|Third Week of Wear||0
5250130|NCT00799422|12905874|P3|NOT COMPLETED|Third Week of Wear||0
5250131|NCT00799422|12905875|P2|NOT COMPLETED|Third Week of Wear||0
5250132|NCT00799422|12905876|P1|NOT COMPLETED|Third Week of Wear||0
5250133|NCT00799422|12905871|P6|COMPLETED|Third Week of Wear||4
5250134|NCT00799422|12905872|P5|COMPLETED|Third Week of Wear||4
5250135|NCT00799422|12905873|P4|COMPLETED|Third Week of Wear||3
5250136|NCT00799422|12905874|P3|COMPLETED|Third Week of Wear||3
5250137|NCT00799422|12905875|P2|COMPLETED|Third Week of Wear||4
5250138|NCT00799422|12905876|P1|COMPLETED|Third Week of Wear||4
5250139|NCT00799422|12905871|P6|STARTED|Third Week of Wear||4
5250140|NCT00799422|12905872|P5|STARTED|Third Week of Wear||4
5250141|NCT00799422|12905873|P4|STARTED|Third Week of Wear||3
5250142|NCT00799422|12905874|P3|STARTED|Third Week of Wear||3
5250143|NCT00799422|12905875|P2|STARTED|Third Week of Wear||4
5250144|NCT00799422|12905876|P1|STARTED|Third Week of Wear||4
5250145|NCT00799422|12905871|P6|NOT COMPLETED|Second Week of Wear||0
5250146|NCT00799422|12905872|P5|NOT COMPLETED|Second Week of Wear||0
5250147|NCT00799422|12905873|P4|NOT COMPLETED|Second Week of Wear||0
5250148|NCT00799422|12905874|P3|NOT COMPLETED|Second Week of Wear||0
5250149|NCT00799422|12905875|P2|NOT COMPLETED|Second Week of Wear||0
5250150|NCT00799422|12905876|P1|NOT COMPLETED|Second Week of Wear||0
5250151|NCT00799422|12905871|P6|COMPLETED|Second Week of Wear||4
5250152|NCT00799422|12905872|P5|COMPLETED|Second Week of Wear||4
5250153|NCT00799422|12905873|P4|COMPLETED|Second Week of Wear||3
5250154|NCT00799422|12905874|P3|COMPLETED|Second Week of Wear||3
5250155|NCT00799422|12905875|P2|COMPLETED|Second Week of Wear||4
5250156|NCT00799422|12905876|P1|COMPLETED|Second Week of Wear||4
5250157|NCT00799422|12905871|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
5250158|NCT00799422|12905872|P5|STARTED|Second Week of Wear||4
5250159|NCT00799422|12905873|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
5250160|NCT00799422|12905874|P3|STARTED|Second Week of Wear||3
5250161|NCT00799422|12905875|P2|STARTED|Second Week of Wear||4
5250162|NCT00799422|12905876|P1|STARTED|Second Week of Wear||4
5250163|NCT00799422|12905871|P6|NOT COMPLETED|First Week of Wear||0
5250164|NCT00799422|12905872|P5|NOT COMPLETED|First Week of Wear||0
5250165|NCT00799422|12905873|P4|NOT COMPLETED|First Week of Wear||1
5250166|NCT00799422|12905874|P3|NOT COMPLETED|First Week of Wear||1
5250167|NCT00799422|12905875|P2|NOT COMPLETED|First Week of Wear||0
5250168|NCT00799422|12905876|P1|NOT COMPLETED|First Week of Wear||0
5250169|NCT00799422|12905871|P6|COMPLETED|First Week of Wear||5
5250170|NCT00799422|12905872|P5|COMPLETED|First Week of Wear||4
5250171|NCT00799422|12905873|P4|COMPLETED|First Week of Wear||4
5250172|NCT00799422|12905874|P3|COMPLETED|First Week of Wear||3
5250173|NCT00799422|12905875|P2|COMPLETED|First Week of Wear||4
5250174|NCT00799422|12905876|P1|COMPLETED|First Week of Wear||4
5250175|NCT00799422|12905871|P6|STARTED|First Week of Wear||5
5250176|NCT00799422|12905872|P5|STARTED|First Week of Wear||4
5250177|NCT00799422|12905873|P4|STARTED|First Week of Wear||5
5250178|NCT00799422|12905874|P3|STARTED|First Week of Wear||4
5250179|NCT00799422|12905875|P2|STARTED|First Week of Wear||4
5250180|NCT00799422|12905876|P1|STARTED|First Week of Wear||4
5250181|NCT00799409|12905893|P3|NOT COMPLETED|Overall Study||0
5250182|NCT00799409|12905894|P2|NOT COMPLETED|Overall Study||0
5250183|NCT00799409|12905895|P1|NOT COMPLETED|Overall Study||7
5250184|NCT00799409|12905893|P3|COMPLETED|Overall Study||35
5250185|NCT00799409|12905894|P2|COMPLETED|Overall Study||36
5250186|NCT00799409|12905895|P1|COMPLETED|Overall Study||0
5250187|NCT00799409|12905893|P3|STARTED|Overall Study||35
5250188|NCT00799409|12905894|P2|STARTED|Overall Study||36
5250189|NCT00799409|12905895|P1|STARTED|Overall Study||7
5250190|NCT00799396|12905975|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
5250191|NCT00799396|12905975|P1|COMPLETED|Clopidogrel Plus Aspirin||663
5250192|NCT00799396|12905975|P1|STARTED|Clopidogrel Plus Aspirin||669
5250193|NCT00799396|12905975|P1|NOT COMPLETED|Clopidogrel Treatment||13
5250194|NCT00799396|12905975|P1|COMPLETED|Clopidogrel Treatment||669
5250195|NCT00799396|12905975|P1|STARTED|Clopidogrel Treatment||682
5250196|NCT00799383|12905982|P2|NOT COMPLETED|Overall Study||6
5250197|NCT00799383|12905983|P1|NOT COMPLETED|Overall Study||3
5250198|NCT00799383|12905982|P2|COMPLETED|Overall Study||18
5250199|NCT00799383|12905983|P1|COMPLETED|Overall Study||20
5250200|NCT00799383|12905982|P2|STARTED|Overall Study||24
5250201|NCT00799383|12905983|P1|STARTED|Overall Study||23
5250202|NCT00799292|12906005|P2|NOT COMPLETED|Overall Study||0
5250203|NCT00799292|12906006|P1|NOT COMPLETED|Overall Study||0
5250204|NCT00799292|12906005|P2|COMPLETED|Overall Study||29
5250205|NCT00799292|12906006|P1|COMPLETED|Overall Study||29
5250206|NCT00799292|12906005|P2|STARTED|Overall Study||29
5250207|NCT00799292|12906006|P1|STARTED|Overall Study||29
5250208|NCT00799266|12906012|P2|NOT COMPLETED|Overall Study||1
5250209|NCT00799266|12906013|P1|NOT COMPLETED|Overall Study||3
5250210|NCT00799266|12906012|P2|COMPLETED|Overall Study||15
5250211|NCT00799266|12906013|P1|COMPLETED|Overall Study||15
5250212|NCT00799266|12906012|P2|Safety Set|Overall Study||16
5250213|NCT00799266|12906013|P1|Safety Set|Overall Study||18
5250214|NCT00799266|12906012|P2|Modified Intention-to-treat (MITT)|Overall Study||16
5250215|NCT00799266|12906013|P1|Modified Intention-to-treat (MITT)|Overall Study||17
5250216|NCT00799266|12906012|P2|STARTED|Overall Study||16
5250217|NCT00799266|12906013|P1|STARTED|Overall Study||18
5250218|NCT00799227|12906044|P1|NOT COMPLETED|Overall Study||3
5250219|NCT00799227|12906044|P1|COMPLETED|Overall Study||53
5250220|NCT00799227|12906044|P1|STARTED|Overall Study||56
5250221|NCT00798967|12906053|P2|NOT COMPLETED|Overall Study||4
5250222|NCT00798967|12906054|P1|NOT COMPLETED|Overall Study||4
5250223|NCT00798967|12906053|P2|COMPLETED|Overall Study||39
5250224|NCT00798967|12906054|P1|COMPLETED|Overall Study||39
5250225|NCT00798967|12906053|P2|Discontinued During Dosing Period|Overall Study||4
5250226|NCT00798967|12906054|P1|Discontinued During Dosing Period|Overall Study||4
5250227|NCT00798967|12906053|P2|STARTED|Overall Study||43
5250228|NCT00798967|12906054|P1|STARTED|Overall Study||43
5250229|NCT00798889|12906062|P1|NOT COMPLETED|Overall Study||314
5250230|NCT00798889|12906062|P1|COMPLETED|Overall Study||0
5250231|NCT00798889|12906062|P1|Treated|Overall Study||311
5250232|NCT00798889|12906062|P1|STARTED|Overall Study||314
5250233|NCT00798759|12906068|P2|NOT COMPLETED|Overall Study||13
5250234|NCT00798759|12906069|P1|NOT COMPLETED|Overall Study||8
5250235|NCT00798759|12906068|P2|COMPLETED|Overall Study||106
5250236|NCT00798759|12906069|P1|COMPLETED|Overall Study||109
5250237|NCT00798759|12906068|P2|STARTED|Overall Study||119
5250238|NCT00798759|12906069|P1|STARTED|Overall Study||117
5250239|NCT00798720|12906077|P1|NOT COMPLETED|Overall Study||0
5250240|NCT00798720|12906077|P1|COMPLETED|Overall Study||18
5250241|NCT00798720|12906077|P1|STARTED|Overall Study||18
5250242|NCT00798707|12906087|P3|NOT COMPLETED|Overall Study||22
5250243|NCT00798707|12906088|P2|NOT COMPLETED|Overall Study||33
5250244|NCT00798707|12906089|P1|NOT COMPLETED|Overall Study||26
5250245|NCT00798707|12906087|P3|COMPLETED|Overall Study||215
5250246|NCT00798707|12906088|P2|COMPLETED|Overall Study||204
5250247|NCT00798707|12906089|P1|COMPLETED|Overall Study||209
5250248|NCT00798707|12906087|P3|Treated|Overall Study||236
5250249|NCT00798707|12906088|P2|Treated|Overall Study||232
5250250|NCT00798707|12906089|P1|Treated|Overall Study||231
5250251|NCT00798707|12906087|P3|STARTED|Overall Study||237
5250252|NCT00798707|12906088|P2|STARTED|Overall Study||237
5250253|NCT00798707|12906089|P1|STARTED|Overall Study||235
5250254|NCT00798694|12906141|P2|NOT COMPLETED|Overall Study||1
5250255|NCT00798694|12906142|P1|NOT COMPLETED|Overall Study||2
5250256|NCT00798694|12906141|P2|COMPLETED|Overall Study||27
5250257|NCT00798694|12906142|P1|COMPLETED|Overall Study||28
5250258|NCT00798694|12906141|P2|STARTED|Overall Study||28
5250259|NCT00798694|12906142|P1|STARTED|Overall Study||30
5250260|NCT00798655|12906166|P1|NOT COMPLETED|Overall Study||2
5250261|NCT00798655|12906166|P1|COMPLETED|Overall Study||44
5250262|NCT00798655|12906166|P1|STARTED|Overall Study||46
5250263|NCT00798603|12906171|P1|NOT COMPLETED|Overall Study||35
5250264|NCT00798603|12906171|P1|COMPLETED|Overall Study||27
5250265|NCT00798603|12906171|P1|STARTED|Overall Study||62
5250266|NCT00798590|12906193|P2|NOT COMPLETED|Overall Study||8
5250267|NCT00798590|12906194|P1|NOT COMPLETED|Overall Study||11
5250268|NCT00798590|12906193|P2|COMPLETED|Overall Study||0
5250269|NCT00798590|12906194|P1|COMPLETED|Overall Study||0
5250270|NCT00798590|12906193|P2|STARTED|Overall Study||8
5250271|NCT00798590|12906194|P1|STARTED|Overall Study||11
5250272|NCT00798577|12906204|P2|NOT COMPLETED|Overall Study||0
5250273|NCT00798577|12906205|P1|NOT COMPLETED|Overall Study||0
5250274|NCT00798577|12906204|P2|COMPLETED|Overall Study||7
5250275|NCT00798577|12906205|P1|COMPLETED|Overall Study||17
5250276|NCT00798577|12906204|P2|STARTED|Overall Study||7
5250277|NCT00798577|12906205|P1|STARTED|Overall Study||17
5250278|NCT00798486|12906219|P1|NOT COMPLETED|Overall Study||0
5250279|NCT00798486|12906219|P1|COMPLETED|Overall Study||110
5250280|NCT00798486|12906219|P1|STARTED|Overall Study||110
5250281|NCT00798434|12906228|P2|NOT COMPLETED|Open-Label||32
5250282|NCT00798434|12906229|P1|NOT COMPLETED|Open-Label||42
5250283|NCT00798434|12906228|P2|COMPLETED|Open-Label||282
5250284|NCT00798434|12906229|P1|COMPLETED|Open-Label||299
5250285|NCT00798434|12906228|P2|Received Treatment|Open-Label||313
5250286|NCT00798434|12906229|P1|Received Treatment|Open-Label||341
5250287|NCT00798434|12906228|P2|STARTED|Open-Label||314
5250288|NCT00798434|12906229|P1|STARTED|Open-Label||341
5250289|NCT00798434|12906228|P2|NOT COMPLETED|Double-Blind||84
5250290|NCT00798434|12906229|P1|NOT COMPLETED|Double-Blind||55
5250291|NCT00798434|12906228|P2|COMPLETED|Double-Blind||314
5250292|NCT00798434|12906229|P1|COMPLETED|Double-Blind||341
5250293|NCT00798434|12906228|P2|Received Treatment|Double-Blind||392
5250294|NCT00798434|12906229|P1|Received Treatment|Double-Blind||393
5250295|NCT00798434|12906228|P2|STARTED|Double-Blind||398
5250296|NCT00798434|12906229|P1|STARTED|Double-Blind||396
5250297|NCT00798369|12906315|P6|NOT COMPLETED|Overall Study||3
5250298|NCT00798369|12906316|P5|NOT COMPLETED|Overall Study||1
5250299|NCT00798369|12906317|P4|NOT COMPLETED|Overall Study||1
5250300|NCT00798369|12906318|P3|NOT COMPLETED|Overall Study||2
5250301|NCT00798369|12906319|P2|NOT COMPLETED|Overall Study||1
5250302|NCT00798369|12906320|P1|NOT COMPLETED|Overall Study||1
5250303|NCT00798369|12906315|P6|COMPLETED|Overall Study||54
5250304|NCT00798369|12906316|P5|COMPLETED|Overall Study||27
5250305|NCT00798369|12906317|P4|COMPLETED|Overall Study||28
5250306|NCT00798369|12906318|P3|COMPLETED|Overall Study||27
5250307|NCT00798369|12906319|P2|COMPLETED|Overall Study||28
5250308|NCT00798369|12906320|P1|COMPLETED|Overall Study||27
5250309|NCT00798369|12906315|P6|STARTED|Overall Study||57
5250310|NCT00798369|12906316|P5|STARTED|Overall Study||28
5250311|NCT00798369|12906317|P4|STARTED|Overall Study||29
5250312|NCT00798369|12906318|P3|STARTED|Overall Study||29
5250313|NCT00798369|12906319|P2|STARTED|Overall Study||29
5250314|NCT00798369|12906320|P1|STARTED|Overall Study||28
5250315|NCT00798317|12906367|P2|NOT COMPLETED|Overall Study||7
5250316|NCT00798317|12906368|P1|NOT COMPLETED|Overall Study||10
5250317|NCT00798317|12906367|P2|COMPLETED|Overall Study||74
5250318|NCT00798317|12906368|P1|COMPLETED|Overall Study||235
5250319|NCT00798317|12906367|P2|STARTED|Overall Study||81
5250320|NCT00798317|12906368|P1|STARTED|Overall Study||245
5250321|NCT00798304|12906379|P3|NOT COMPLETED|Overall Study||10
5250322|NCT00798304|12906380|P2|NOT COMPLETED|Overall Study||22
5250323|NCT00798304|12906381|P1|NOT COMPLETED|Overall Study||14
5250324|NCT00798304|12906379|P3|COMPLETED|Overall Study||0
5250325|NCT00798304|12906380|P2|COMPLETED|Overall Study||0
5250326|NCT00798304|12906381|P1|COMPLETED|Overall Study||0
5250327|NCT00798304|12906379|P3|STARTED|Overall Study||10
5250328|NCT00798304|12906380|P2|STARTED|Overall Study||22
5250329|NCT00798304|12906381|P1|STARTED|Overall Study||14
5250330|NCT00798174|12906407|P2|NOT COMPLETED|Overall Study||3
5250331|NCT00798174|12906408|P1|NOT COMPLETED|Overall Study||4
5250332|NCT00798174|12906407|P2|COMPLETED|Overall Study||13
5250333|NCT00798174|12906408|P1|COMPLETED|Overall Study||12
5250334|NCT00798174|12906407|P2|STARTED|Overall Study||16
5250335|NCT00798174|12906408|P1|STARTED|Overall Study||16
5250336|NCT00798161|12906419|P7|NOT COMPLETED|Overall Study||10
5250337|NCT00798161|12906420|P6|NOT COMPLETED|Overall Study||11
5250338|NCT00798161|12906421|P5|NOT COMPLETED|Overall Study||16
5250339|NCT00798161|12906422|P4|NOT COMPLETED|Overall Study||21
5250340|NCT00798161|12906423|P3|NOT COMPLETED|Overall Study||21
5250341|NCT00798161|12906424|P2|NOT COMPLETED|Overall Study||17
5250342|NCT00798161|12906425|P1|NOT COMPLETED|Overall Study||18
5250343|NCT00798161|12906419|P7|COMPLETED|Overall Study||56
5250344|NCT00798161|12906420|P6|COMPLETED|Overall Study||132
5250345|NCT00798161|12906421|P5|COMPLETED|Overall Study||127
5250346|NCT00798161|12906422|P4|COMPLETED|Overall Study||121
5250347|NCT00798161|12906423|P3|COMPLETED|Overall Study||126
5250348|NCT00798161|12906424|P2|COMPLETED|Overall Study||127
5250349|NCT00798161|12906425|P1|COMPLETED|Overall Study||54
5250350|NCT00798161|12906419|P7|STARTED|Overall Study||66
5250351|NCT00798161|12906420|P6|STARTED|Overall Study||143
5250352|NCT00798161|12906421|P5|STARTED|Overall Study||143
5250353|NCT00798161|12906422|P4|STARTED|Overall Study||142
5250354|NCT00798161|12906423|P3|STARTED|Overall Study||147
5250355|NCT00798161|12906424|P2|STARTED|Overall Study||144
5250356|NCT00798161|12906425|P1|STARTED|Overall Study||72
5250357|NCT00798135|12906532|P1|NOT COMPLETED|Overall Study||13
5250358|NCT00798135|12906532|P1|COMPLETED|Overall Study||0
5250359|NCT00798135|12906532|P1|STARTED|Overall Study||13
5250360|NCT00798096|12906538|P1|NOT COMPLETED|Overall Study||2
5250361|NCT00798096|12906538|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
5250362|NCT00798096|12906538|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
5250363|NCT00798018|12906549|P4|NOT COMPLETED|Overall Study||0
5250364|NCT00798018|12906550|P3|NOT COMPLETED|Overall Study||0
5250365|NCT00798018|12906551|P2|NOT COMPLETED|Overall Study||0
5250366|NCT00798018|12906552|P1|NOT COMPLETED|Overall Study||0
5250367|NCT00798018|12906549|P4|COMPLETED|Overall Study||25
5250368|NCT00798018|12906550|P3|COMPLETED|Overall Study||25
5250369|NCT00798018|12906551|P2|COMPLETED|Overall Study||25
5250370|NCT00798018|12906552|P1|COMPLETED|Overall Study||25
5250371|NCT00798018|12906549|P4|STARTED|Overall Study||25
5250372|NCT00798018|12906550|P3|STARTED|Overall Study||25
5250373|NCT00798018|12906551|P2|STARTED|Overall Study||25
5250374|NCT00798018|12906552|P1|STARTED|Overall Study||25
5250375|NCT00797966|12906566|P6|NOT COMPLETED|Phase A+||28
5250376|NCT00797966|12906567|P5|NOT COMPLETED|Phase A+||0
5250377|NCT00797966|12906568|P4|NOT COMPLETED|Phase A+||0
5250378|NCT00797966|12906569|P3|NOT COMPLETED|Phase A+||0
5250379|NCT00797966|12906570|P2|NOT COMPLETED|Phase A+||0
5250380|NCT00797966|12906571|P1|NOT COMPLETED|Phase A+||0
5250381|NCT00797966|12906566|P6|COMPLETED|Phase A+||207
5250382|NCT00797966|12906567|P5|COMPLETED|Phase A+||0
5250383|NCT00797966|12906568|P4|COMPLETED|Phase A+||0
5250384|NCT00797966|12906569|P3|COMPLETED|Phase A+||0
5250385|NCT00797966|12906570|P2|COMPLETED|Phase A+||0
5250386|NCT00797966|12906571|P1|COMPLETED|Phase A+||0
5250387|NCT00797966|12906566|P6|STARTED|Phase A+||235
5250388|NCT00797966|12906567|P5|STARTED|Phase A+||0
5250389|NCT00797966|12906568|P4|STARTED|Phase A+||0
5250390|NCT00797966|12906569|P3|STARTED|Phase A+||0
5250391|NCT00797966|12906570|P2|STARTED|Phase A+||0
5250392|NCT00797966|12906571|P1|STARTED|Phase A+||0
5250393|NCT00797966|12906566|P6|NOT COMPLETED|Phase B||0
5250394|NCT00797966|12906567|P5|NOT COMPLETED|Phase B||0
5250395|NCT00797966|12906568|P4|NOT COMPLETED|Phase B||16
5250396|NCT00797966|12906569|P3|NOT COMPLETED|Phase B||21
5250397|NCT00797966|12906570|P2|NOT COMPLETED|Phase B||18
5250398|NCT00797966|12906571|P1|NOT COMPLETED|Phase B||11
5250399|NCT00797966|12906566|P6|COMPLETED|Phase B||0
5250400|NCT00797966|12906567|P5|COMPLETED|Phase B||0
5250401|NCT00797966|12906568|P4|COMPLETED|Phase B||110
5250402|NCT00797966|12906569|P3|COMPLETED|Phase B||100
5250403|NCT00797966|12906570|P2|COMPLETED|Phase B||102
5250404|NCT00797966|12906571|P1|COMPLETED|Phase B||51
5250405|NCT00797966|12906566|P6|STARTED|Phase B||0
5250406|NCT00797966|12906567|P5|STARTED|Phase B||0
5250407|NCT00797966|12906568|P4|STARTED|Phase B|Randomized participants.|126
5250408|NCT00797966|12906569|P3|STARTED|Phase B|Randomized participants.|121
5250409|NCT00797966|12906570|P2|STARTED|Phase B|Randomized participants.|120
5250410|NCT00797966|12906571|P1|STARTED|Phase B|Randomized participants.|62
5250411|NCT00797966|12906566|P6|NOT COMPLETED|Phase A||0
5250412|NCT00797966|12906567|P5|NOT COMPLETED|Phase A||185
5250413|NCT00797966|12906568|P4|NOT COMPLETED|Phase A||0
5250414|NCT00797966|12906569|P3|NOT COMPLETED|Phase A||0
5250415|NCT00797966|12906570|P2|NOT COMPLETED|Phase A||0
5250416|NCT00797966|12906571|P1|NOT COMPLETED|Phase A||0
5250417|NCT00797966|12906566|P6|COMPLETED|Phase A||0
5250418|NCT00797966|12906567|P5|COMPLETED|Phase A||664
5250419|NCT00797966|12906568|P4|COMPLETED|Phase A||0
5250420|NCT00797966|12906569|P3|COMPLETED|Phase A||0
5250421|NCT00797966|12906570|P2|COMPLETED|Phase A||0
5250422|NCT00797966|12906571|P1|COMPLETED|Phase A||0
5250423|NCT00797966|12906566|P6|STARTED|Phase A||0
5250424|NCT00797966|12906567|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
5250425|NCT00797966|12906568|P4|STARTED|Phase A||0
5250426|NCT00797966|12906569|P3|STARTED|Phase A||0
5250427|NCT00797966|12906570|P2|STARTED|Phase A||0
5250428|NCT00797966|12906571|P1|STARTED|Phase A||0
5250429|NCT00797862|12906636|P3|NOT COMPLETED|Overall Study||86
5250430|NCT00797862|12906637|P2|NOT COMPLETED|Overall Study||68
5250431|NCT00797862|12906638|P1|NOT COMPLETED|Overall Study||124
5250432|NCT00797862|12906636|P3|COMPLETED|Overall Study||230
5250433|NCT00797862|12906637|P2|COMPLETED|Overall Study||250
5250434|NCT00797862|12906638|P1|COMPLETED|Overall Study||496
5250435|NCT00797862|12906636|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
5250436|NCT00797862|12906637|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
5250437|NCT00797862|12906638|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
5250438|NCT00797862|12906636|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
5250439|NCT00797862|12906637|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
5250440|NCT00797862|12906638|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
5250441|NCT00797823|12906667|P3|NOT COMPLETED|Second Period (Crossover)||0
5250442|NCT00797823|12906668|P2|NOT COMPLETED|Second Period (Crossover)||0
5250443|NCT00797823|12906669|P1|NOT COMPLETED|Second Period (Crossover)||0
5250444|NCT00797823|12906667|P3|COMPLETED|Second Period (Crossover)||0
5250445|NCT00797823|12906668|P2|COMPLETED|Second Period (Crossover)||4
5250446|NCT00797823|12906669|P1|COMPLETED|Second Period (Crossover)||3
5250447|NCT00797823|12906667|P3|STARTED|Second Period (Crossover)||0
5250448|NCT00797823|12906668|P2|STARTED|Second Period (Crossover)||4
5250449|NCT00797823|12906669|P1|STARTED|Second Period (Crossover)||3
5250450|NCT00797823|12906667|P3|NOT COMPLETED|First Period (Initial Randomization)||0
5250451|NCT00797823|12906668|P2|NOT COMPLETED|First Period (Initial Randomization)||0
5250452|NCT00797823|12906669|P1|NOT COMPLETED|First Period (Initial Randomization)||1
5250453|NCT00797823|12906667|P3|COMPLETED|First Period (Initial Randomization)||0
5250454|NCT00797823|12906668|P2|COMPLETED|First Period (Initial Randomization)||4
5250455|NCT00797823|12906669|P1|COMPLETED|First Period (Initial Randomization)||3
5250456|NCT00797823|12906667|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
5250457|NCT00797823|12906668|P2|STARTED|First Period (Initial Randomization)||4
5250458|NCT00797823|12906669|P1|STARTED|First Period (Initial Randomization)||4
5250459|NCT00797823|12906667|P3|NOT COMPLETED|Pilot Studies||0
5250460|NCT00797823|12906668|P2|NOT COMPLETED|Pilot Studies||0
5250461|NCT00797823|12906669|P1|NOT COMPLETED|Pilot Studies||0
5250462|NCT00797823|12906667|P3|COMPLETED|Pilot Studies||6
5250463|NCT00797823|12906668|P2|COMPLETED|Pilot Studies||0
5250464|NCT00797823|12906669|P1|COMPLETED|Pilot Studies||0
5250465|NCT00797823|12906667|P3|STARTED|Pilot Studies||6
5250466|NCT00797823|12906668|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
5250467|NCT00797823|12906669|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
5250468|NCT00797797|12906680|P2|NOT COMPLETED|Overall Study||43
5250469|NCT00797797|12906681|P1|NOT COMPLETED|Overall Study||55
5250470|NCT00797797|12906680|P2|COMPLETED|Overall Study||141
5250471|NCT00797797|12906681|P1|COMPLETED|Overall Study||123
5250472|NCT00797797|12906680|P2|STARTED|Overall Study||184
5250473|NCT00797797|12906681|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
5250474|NCT00797732|12906691|P3|NOT COMPLETED|Overall Study||154
5250475|NCT00797732|12906692|P2|NOT COMPLETED|Overall Study||3
5250476|NCT00797732|12906693|P1|NOT COMPLETED|Overall Study||5
5250477|NCT00797732|12906691|P3|COMPLETED|Overall Study||0
5250478|NCT00797732|12906692|P2|COMPLETED|Overall Study||18
5250479|NCT00797732|12906693|P1|COMPLETED|Overall Study||16
5250480|NCT00797732|12906691|P3|Evaluable at 12 Months|Overall Study||0
5250481|NCT00797732|12906692|P2|Evaluable at 12 Months|Overall Study||18
5250482|NCT00797732|12906693|P1|Evaluable at 12 Months|Overall Study||17
5250483|NCT00797732|12906691|P3|Evaluable at 20 Weeks|Overall Study||0
5250484|NCT00797732|12906692|P2|Evaluable at 20 Weeks|Overall Study||18
5250485|NCT00797732|12906693|P1|Evaluable at 20 Weeks|Overall Study||17
5250486|NCT00797732|12906691|P3|Evaluable at Baseline|Overall Study||0
5250487|NCT00797732|12906692|P2|Evaluable at Baseline|Overall Study||18
5250488|NCT00797732|12906693|P1|Evaluable at Baseline|Overall Study||18
5250489|NCT00797732|12906691|P3|STARTED|Overall Study||154
5250490|NCT00797732|12906692|P2|STARTED|Overall Study||21
5250491|NCT00797732|12906693|P1|STARTED|Overall Study||21
5250492|NCT00797667|12906708|P3|NOT COMPLETED|Overall Study||127
5250493|NCT00797667|12906709|P2|NOT COMPLETED|Overall Study||259
5250494|NCT00797667|12906710|P1|NOT COMPLETED|Overall Study||260
5250495|NCT00797667|12906708|P3|COMPLETED|Overall Study||4
5250496|NCT00797667|12906709|P2|COMPLETED|Overall Study||5
5250497|NCT00797667|12906710|P1|COMPLETED|Overall Study||5
5250498|NCT00797667|12906708|P3|Treated|Overall Study||130
5250499|NCT00797667|12906709|P2|Treated|Overall Study||263
5250500|NCT00797667|12906710|P1|Treated|Overall Study||263
5250501|NCT00797667|12906708|P3|STARTED|Overall Study||131
5250502|NCT00797667|12906709|P2|STARTED|Overall Study||264
5250503|NCT00797667|12906710|P1|STARTED|Overall Study||265
5250504|NCT00797563|12906736|P1|NOT COMPLETED|Overall Study||1
5250505|NCT00797563|12906736|P1|COMPLETED|Overall Study||101
5250506|NCT00797563|12906736|P1|STARTED|Overall Study|number of subjects|102
5250507|NCT00797511|12906742|P1|NOT COMPLETED|Overall Study||1
5250508|NCT00797511|12906742|P1|COMPLETED|Overall Study||131
5250509|NCT00797511|12906742|P1|STARTED|Overall Study||132
5250510|NCT00797459|12906750|P1|NOT COMPLETED|Overall Study||0
5250511|NCT00797459|12906750|P1|COMPLETED|Overall Study||60
5250512|NCT00797459|12906750|P1|STARTED|Overall Study||60
5250513|NCT00797316|12906760|P2|NOT COMPLETED|Overall Study||32
5250514|NCT00797316|12906761|P1|NOT COMPLETED|Overall Study||23
5250515|NCT00797316|12906760|P2|COMPLETED|Overall Study||233
5250516|NCT00797316|12906761|P1|COMPLETED|Overall Study||244
5250517|NCT00797316|12906760|P2|STARTED|Overall Study||265
5250518|NCT00797316|12906761|P1|STARTED|Overall Study||267
5250519|NCT00797277|12906777|P2|NOT COMPLETED|Overall Study||0
5250520|NCT00797277|12906778|P1|NOT COMPLETED|Overall Study||0
5250521|NCT00797277|12906777|P2|COMPLETED|Overall Study||30
5250522|NCT00797277|12906778|P1|COMPLETED|Overall Study||37
5250523|NCT00797277|12906777|P2|STARTED|Overall Study||30
5250524|NCT00797277|12906778|P1|STARTED|Overall Study||37
5250525|NCT00797225|12906790|P8|NOT COMPLETED|Weeks 13 to 24||0
5250526|NCT00797225|12906791|P7|NOT COMPLETED|Weeks 13 to 24||2
5250527|NCT00797225|12906792|P6|NOT COMPLETED|Weeks 13 to 24||0
5250528|NCT00797225|12906793|P5|NOT COMPLETED|Weeks 13 to 24||1
5250529|NCT00797225|12906794|P4|NOT COMPLETED|Weeks 13 to 24||0
5250530|NCT00797225|12906795|P3|NOT COMPLETED|Weeks 13 to 24||2
5250531|NCT00797225|12906796|P2|NOT COMPLETED|Weeks 13 to 24||4
5250532|NCT00797225|12906797|P1|NOT COMPLETED|Weeks 13 to 24||0
5250533|NCT00797225|12906790|P8|COMPLETED|Weeks 13 to 24||22
5250534|NCT00797225|12906791|P7|COMPLETED|Weeks 13 to 24||20
5250535|NCT00797225|12906792|P6|COMPLETED|Weeks 13 to 24||21
5250536|NCT00797225|12906793|P5|COMPLETED|Weeks 13 to 24||19
5250537|NCT00797225|12906794|P4|COMPLETED|Weeks 13 to 24||0
5250538|NCT00797225|12906795|P3|COMPLETED|Weeks 13 to 24||41
5250539|NCT00797225|12906796|P2|COMPLETED|Weeks 13 to 24||38
5250540|NCT00797225|12906797|P1|COMPLETED|Weeks 13 to 24||0
5250541|NCT00797225|12906790|P8|STARTED|Weeks 13 to 24||22
5250542|NCT00797225|12906791|P7|STARTED|Weeks 13 to 24||22
5250543|NCT00797225|12906792|P6|STARTED|Weeks 13 to 24||21
5250544|NCT00797225|12906793|P5|STARTED|Weeks 13 to 24||20
5250545|NCT00797225|12906794|P4|STARTED|Weeks 13 to 24||0
5250546|NCT00797225|12906795|P3|STARTED|Weeks 13 to 24||43
5250547|NCT00797225|12906796|P2|STARTED|Weeks 13 to 24||42
5250548|NCT00797225|12906797|P1|STARTED|Weeks 13 to 24||0
5250549|NCT00797225|12906790|P8|NOT COMPLETED|Weeks 1 to 12||0
5250550|NCT00797225|12906791|P7|NOT COMPLETED|Weeks 1 to 12||0
5250551|NCT00797225|12906792|P6|NOT COMPLETED|Weeks 1 to 12||0
5250552|NCT00797225|12906793|P5|NOT COMPLETED|Weeks 1 to 12||0
5250553|NCT00797225|12906794|P4|NOT COMPLETED|Weeks 1 to 12||0
5250554|NCT00797225|12906795|P3|NOT COMPLETED|Weeks 1 to 12||1
5250555|NCT00797225|12906796|P2|NOT COMPLETED|Weeks 1 to 12||1
5250556|NCT00797225|12906797|P1|NOT COMPLETED|Weeks 1 to 12||2
5250557|NCT00797225|12906790|P8|COMPLETED|Weeks 1 to 12||0
5250558|NCT00797225|12906791|P7|COMPLETED|Weeks 1 to 12||0
5250559|NCT00797225|12906792|P6|COMPLETED|Weeks 1 to 12||0
5250560|NCT00797225|12906793|P5|COMPLETED|Weeks 1 to 12||0
5250561|NCT00797225|12906794|P4|COMPLETED|Weeks 1 to 12||44
5250562|NCT00797225|12906795|P3|COMPLETED|Weeks 1 to 12||43
5250563|NCT00797225|12906796|P2|COMPLETED|Weeks 1 to 12||42
5250564|NCT00797225|12906797|P1|COMPLETED|Weeks 1 to 12||41
5250565|NCT00797225|12906790|P8|Received Study Drug|Weeks 1 to 12||0
5250566|NCT00797225|12906791|P7|Received Study Drug|Weeks 1 to 12||0
5250567|NCT00797225|12906792|P6|Received Study Drug|Weeks 1 to 12||0
5250568|NCT00797225|12906793|P5|Received Study Drug|Weeks 1 to 12||0
5250569|NCT00797225|12906794|P4|Received Study Drug|Weeks 1 to 12||44
5250570|NCT00797225|12906795|P3|Received Study Drug|Weeks 1 to 12||44
5250571|NCT00797225|12906796|P2|Received Study Drug|Weeks 1 to 12||43
5250572|NCT00797225|12906797|P1|Received Study Drug|Weeks 1 to 12||43
5250573|NCT00797225|12906790|P8|STARTED|Weeks 1 to 12||0
5250574|NCT00797225|12906791|P7|STARTED|Weeks 1 to 12||0
5250575|NCT00797225|12906792|P6|STARTED|Weeks 1 to 12||0
5250576|NCT00797225|12906793|P5|STARTED|Weeks 1 to 12||0
5250577|NCT00797225|12906794|P4|STARTED|Weeks 1 to 12||44
5250578|NCT00797225|12906795|P3|STARTED|Weeks 1 to 12||44
5250579|NCT00797225|12906796|P2|STARTED|Weeks 1 to 12||43
5250580|NCT00797225|12906797|P1|STARTED|Weeks 1 to 12||43
5250581|NCT00797212|12906905|P1|NOT COMPLETED|Overall Study||0
5250582|NCT00797212|12906905|P1|COMPLETED|Overall Study||50
5250583|NCT00797212|12906905|P1|STARTED|Overall Study||50
5250584|NCT00797108|12906914|P3|NOT COMPLETED|Overall Study||6
5250585|NCT00797108|12906915|P2|NOT COMPLETED|Overall Study||2
5250586|NCT00797108|12906916|P1|NOT COMPLETED|Overall Study||4
5250587|NCT00797108|12906914|P3|COMPLETED|Overall Study||6
5250588|NCT00797108|12906915|P2|COMPLETED|Overall Study||9
5250589|NCT00797108|12906916|P1|COMPLETED|Overall Study||8
5250590|NCT00797108|12906914|P3|Treated|Overall Study||12
5250591|NCT00797108|12906915|P2|Treated|Overall Study||11
5250592|NCT00797108|12906916|P1|Treated|Overall Study||10
5250593|NCT00797108|12906914|P3|STARTED|Overall Study||12
5250594|NCT00797108|12906915|P2|STARTED|Overall Study||11
5250595|NCT00797108|12906916|P1|STARTED|Overall Study||12
5250596|NCT00796991|12906951|P3|NOT COMPLETED|Overall Study||14
5250597|NCT00796991|12906952|P2|NOT COMPLETED|Overall Study||12
5250598|NCT00796991|12906953|P1|NOT COMPLETED|Overall Study||15
5250599|NCT00796991|12906951|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
5250600|NCT00796991|12906952|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
5250601|NCT00796991|12906953|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
5250602|NCT00796991|12906951|P3|STARTED|Overall Study||20
5250603|NCT00796991|12906952|P2|STARTED|Overall Study||19
5250604|NCT00796991|12906953|P1|STARTED|Overall Study||20
5250605|NCT00796926|12907053|P2|NOT COMPLETED|Overall Study||0
5250606|NCT00796926|12907054|P1|NOT COMPLETED|Overall Study||1
5250607|NCT00796926|12907053|P2|COMPLETED|Overall Study||15
5250608|NCT00796926|12907054|P1|COMPLETED|Overall Study||14
5250609|NCT00796926|12907053|P2|STARTED|Overall Study||15
5250610|NCT00796926|12907054|P1|STARTED|Overall Study||15
5250611|NCT00796861|12907060|P1|NOT COMPLETED|Overall Study||4
5250612|NCT00796861|12907060|P1|COMPLETED|Overall Study||0
5250613|NCT00796861|12907060|P1|STARTED|Overall Study||4
5250614|NCT00796822|12907066|P2|NOT COMPLETED|Overall Study||0
5250615|NCT00796822|12907067|P1|NOT COMPLETED|Overall Study||3
5250616|NCT00796822|12907066|P2|COMPLETED|Overall Study||13
5250617|NCT00796822|12907067|P1|COMPLETED|Overall Study||10
5250618|NCT00796822|12907066|P2|STARTED|Overall Study||13
5250619|NCT00796822|12907067|P1|STARTED|Overall Study||13
5250620|NCT00796757|12907075|P1|NOT COMPLETED|Overall Study||86
5250621|NCT00796757|12907075|P1|COMPLETED|Overall Study||60
5250622|NCT00796757|12907075|P1|STARTED|Overall Study||146
5250623|NCT00796744|12907090|P3|NOT COMPLETED|Overall Study||1
5250624|NCT00796744|12907091|P2|NOT COMPLETED|Overall Study||0
5250625|NCT00796744|12907092|P1|NOT COMPLETED|Overall Study||0
5250626|NCT00796744|12907090|P3|COMPLETED|Overall Study||27
5250627|NCT00796744|12907091|P2|COMPLETED|Overall Study||26
5250628|NCT00796744|12907092|P1|COMPLETED|Overall Study||24
5250629|NCT00796744|12907090|P3|STARTED|Overall Study||28
5250630|NCT00796744|12907091|P2|STARTED|Overall Study||26
5250631|NCT00796744|12907092|P1|STARTED|Overall Study||24
5250632|NCT00796718|12907109|P1|NOT COMPLETED|Overall Study||9
5250633|NCT00796718|12907109|P1|COMPLETED|Overall Study||53
5250634|NCT00796718|12907109|P1|STARTED|Overall Study||62
5250635|NCT00796705|12907120|P4|NOT COMPLETED|Overall Study||0
5250636|NCT00796705|12907121|P3|NOT COMPLETED|Overall Study||0
5250637|NCT00796705|12907122|P2|NOT COMPLETED|Overall Study||0
5250638|NCT00796705|12907123|P1|NOT COMPLETED|Overall Study||0
5250639|NCT00796705|12907120|P4|COMPLETED|Overall Study||2
5250640|NCT00796705|12907121|P3|COMPLETED|Overall Study||4
5250641|NCT00796705|12907122|P2|COMPLETED|Overall Study||4
5250642|NCT00796705|12907123|P1|COMPLETED|Overall Study||3
5250643|NCT00796705|12907120|P4|STARTED|Overall Study||2
5250644|NCT00796705|12907121|P3|STARTED|Overall Study||4
5250645|NCT00796705|12907122|P2|STARTED|Overall Study||4
5250646|NCT00796705|12907123|P1|STARTED|Overall Study||3
5250647|NCT00796666|12907161|P2|NOT COMPLETED|Overall Study||64
5250648|NCT00796666|12907162|P1|NOT COMPLETED|Overall Study||67
5250649|NCT00796666|12907161|P2|COMPLETED|Overall Study||0
5250650|NCT00796666|12907162|P1|COMPLETED|Overall Study||0
5250651|NCT00796666|12907161|P2|Randomized and Not Treated|Overall Study||0
5250652|NCT00796666|12907162|P1|Randomized and Not Treated|Overall Study||1
5250653|NCT00796666|12907161|P2|Treated|Overall Study||64
5250654|NCT00796666|12907162|P1|Treated|Overall Study||66
5250655|NCT00796666|12907161|P2|STARTED|Overall Study||64
5250656|NCT00796666|12907162|P1|STARTED|Overall Study||67
5250657|NCT00796653|12907196|P4|NOT COMPLETED|Overall Study||40
5250658|NCT00796653|12907197|P3|NOT COMPLETED|Overall Study||36
5250659|NCT00796653|12907198|P2|NOT COMPLETED|Overall Study||37
5250660|NCT00796653|12907199|P1|NOT COMPLETED|Overall Study||51
5250661|NCT00796653|12907196|P4|COMPLETED|Overall Study||193
5250662|NCT00796653|12907197|P3|COMPLETED|Overall Study||198
5250663|NCT00796653|12907198|P2|COMPLETED|Overall Study||195
5250664|NCT00796653|12907199|P1|COMPLETED|Overall Study||184
5250665|NCT00796653|12907196|P4|STARTED|Overall Study||233
5250666|NCT00796653|12907197|P3|STARTED|Overall Study||234
5250667|NCT00796653|12907198|P2|STARTED|Overall Study||232
5250668|NCT00796653|12907199|P1|STARTED|Overall Study||235
5250669|NCT00796627|12907467|P2|NOT COMPLETED|Overall Study||0
5250670|NCT00796627|12907468|P1|NOT COMPLETED|Overall Study||0
5250671|NCT00796627|12907467|P2|COMPLETED|Overall Study||31
5250672|NCT00796627|12907468|P1|COMPLETED|Overall Study||10
5250673|NCT00796627|12907467|P2|STARTED|Overall Study||31
5250674|NCT00796627|12907468|P1|STARTED|Overall Study||10
5250675|NCT00796614|12907484|P4|NOT COMPLETED|Overall Study||1
5250676|NCT00796614|12907485|P3|NOT COMPLETED|Overall Study||3
5250677|NCT00796614|12907486|P2|NOT COMPLETED|Overall Study||4
5250678|NCT00796614|12907487|P1|NOT COMPLETED|Overall Study||5
5250679|NCT00796614|12907484|P4|COMPLETED|Overall Study||40
5250680|NCT00796614|12907485|P3|COMPLETED|Overall Study||36
5250681|NCT00796614|12907486|P2|COMPLETED|Overall Study||36
5250682|NCT00796614|12907487|P1|COMPLETED|Overall Study||36
5250683|NCT00796614|12907484|P4|Not Treated|Overall Study||0
5250684|NCT00796614|12907485|P3|Not Treated|Overall Study||1
5250685|NCT00796614|12907486|P2|Not Treated|Overall Study||0
5250686|NCT00796614|12907487|P1|Not Treated|Overall Study||0
5250687|NCT00796614|12907484|P4|STARTED|Overall Study||41
5250688|NCT00796614|12907485|P3|STARTED|Overall Study||39
5250689|NCT00796614|12907486|P2|STARTED|Overall Study||40
5250690|NCT00796614|12907487|P1|STARTED|Overall Study||41
5250691|NCT00796562|12907529|P1|NOT COMPLETED|Overall Study||49
5250692|NCT00796562|12907529|P1|COMPLETED|Overall Study||47
5250693|NCT00796562|12907529|P1|STARTED|Overall Study||96
5250694|NCT00796549|12907538|P1|NOT COMPLETED|Overall Study||218
5250695|NCT00796549|12907538|P1|COMPLETED|Overall Study||0
5250696|NCT00796549|12907538|P1|Entered|Overall Study|entered and treated|69
5250697|NCT00796549|12907538|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
5250698|NCT00796523|12907555|P2|NOT COMPLETED|Overall Study||7
5250699|NCT00796523|12907556|P1|NOT COMPLETED|Overall Study||9
5250700|NCT00796523|12907555|P2|COMPLETED|Overall Study||17
5250701|NCT00796523|12907556|P1|COMPLETED|Overall Study||18
5250702|NCT00796523|12907555|P2|STARTED|Overall Study||24
5250703|NCT00796523|12907556|P1|STARTED|Overall Study||27
5250704|NCT00796510|12907566|P2|NOT COMPLETED|Overall Study||0
5250705|NCT00796510|12907567|P1|NOT COMPLETED|Overall Study||3
5250706|NCT00796510|12907566|P2|COMPLETED|Overall Study||0
5250707|NCT00796510|12907567|P1|COMPLETED|Overall Study||0
5250708|NCT00796510|12907566|P2|STARTED|Overall Study||0
5250709|NCT00796510|12907567|P1|STARTED|Overall Study||3
5250710|NCT00796445|12907579|P2|NOT COMPLETED|Overall Study||292
5250711|NCT00796445|12907580|P1|NOT COMPLETED|Overall Study||584
5250712|NCT00796445|12907579|P2|COMPLETED|Overall Study||158
5250713|NCT00796445|12907580|P1|COMPLETED|Overall Study||310
5250714|NCT00796445|12907579|P2|STARTED|Overall Study||450
5250715|NCT00796445|12907580|P1|STARTED|Overall Study||894
5250716|NCT00796419|12907632|P2|NOT COMPLETED|Overall Study||1
5250717|NCT00796419|12907633|P1|NOT COMPLETED|Overall Study||0
5250718|NCT00796419|12907632|P2|COMPLETED|Overall Study||13
5250719|NCT00796419|12907633|P1|COMPLETED|Overall Study||13
5250720|NCT00796419|12907632|P2|STARTED|Overall Study||14
5250721|NCT00796419|12907633|P1|STARTED|Overall Study||13
5250722|NCT00796367|12907646|P3|NOT COMPLETED|Overall Study||47
5250723|NCT00796367|12907647|P2|NOT COMPLETED|Overall Study||25
5250724|NCT00796367|12907648|P1|NOT COMPLETED|Overall Study||30
5250725|NCT00796367|12907646|P3|COMPLETED|Overall Study||248
5250726|NCT00796367|12907647|P2|COMPLETED|Overall Study||129
5250727|NCT00796367|12907648|P1|COMPLETED|Overall Study||197
5250728|NCT00796367|12907646|P3|STARTED|Overall Study||295
5250729|NCT00796367|12907647|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
5250730|NCT00796367|12907648|P1|STARTED|Overall Study||227
5250731|NCT00796328|12907659|P1|NOT COMPLETED|Overall Study||6
5250732|NCT00796328|12907659|P1|COMPLETED|Overall Study||40
5250733|NCT00796328|12907659|P1|STARTED|Overall Study||46
5250734|NCT00796315|12907663|P3|NOT COMPLETED|Overall Study||0
5250735|NCT00796315|12907664|P2|NOT COMPLETED|Overall Study||1
5250736|NCT00796315|12907665|P1|NOT COMPLETED|Overall Study||0
5250737|NCT00796315|12907663|P3|COMPLETED|Overall Study||15
5250738|NCT00796315|12907664|P2|COMPLETED|Overall Study||16
5250739|NCT00796315|12907665|P1|COMPLETED|Overall Study||9
5250740|NCT00796315|12907663|P3|STARTED|Overall Study||15
5250741|NCT00796315|12907664|P2|STARTED|Overall Study||17
5250742|NCT00796315|12907665|P1|STARTED|Overall Study||9
5250743|NCT00796302|12907678|P2|NOT COMPLETED|Overall Study||18
5250744|NCT00796302|12907679|P1|NOT COMPLETED|Overall Study||13
5250745|NCT00796302|12907678|P2|COMPLETED|Overall Study||66
5250746|NCT00796302|12907679|P1|COMPLETED|Overall Study||71
5250747|NCT00796302|12907678|P2|STARTED|Overall Study||84
5250748|NCT00796302|12907679|P1|STARTED|Overall Study||84
5250749|NCT00796224|12907693|P2|NOT COMPLETED|Overall Study||1
5250750|NCT00796224|12907694|P1|NOT COMPLETED|Overall Study||1
5250751|NCT00796224|12907693|P2|COMPLETED|Overall Study||18
5250752|NCT00796224|12907694|P1|COMPLETED|Overall Study||18
5250753|NCT00796224|12907693|P2|STARTED|Overall Study||19
5250754|NCT00796224|12907694|P1|STARTED|Overall Study||19
5250755|NCT00796120|12907714|P2|NOT COMPLETED|Overall Study||60
5250756|NCT00796120|12907715|P1|NOT COMPLETED|Overall Study||61
5250757|NCT00796120|12907714|P2|COMPLETED|Overall Study||0
5250758|NCT00796120|12907715|P1|COMPLETED|Overall Study||0
5250759|NCT00796120|12907714|P2|Treated|Overall Study||57
5250760|NCT00796120|12907715|P1|Treated|Overall Study||61
5250761|NCT00796120|12907714|P2|STARTED|Overall Study||60
5250762|NCT00796120|12907715|P1|STARTED|Overall Study||61
5250763|NCT00796003|12907731|P2|NOT COMPLETED|Overall Study||29
5250764|NCT00796003|12907732|P1|NOT COMPLETED|Overall Study||3
5250765|NCT00796003|12907731|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
5250766|NCT00796003|12907732|P1|COMPLETED|Overall Study||0
5250767|NCT00796003|12907731|P2|Treated|Overall Study|Number of participants treated|34
5250768|NCT00796003|12907732|P1|Treated|Overall Study|Number of participants treated|3
5250769|NCT00796003|12907731|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
5250770|NCT00796003|12907732|P1|STARTED|Overall Study|Number of participants enrolled|3
5250771|NCT00795951|12907753|P1|NOT COMPLETED|Overall Study||2
5250772|NCT00795951|12907753|P1|COMPLETED|Overall Study||100
5250773|NCT00795951|12907753|P1|STARTED|Overall Study||102
5250774|NCT00795886|12907846|P1|NOT COMPLETED|Overall Study||10
5250775|NCT00795886|12907846|P1|COMPLETED|Overall Study||53
5250776|NCT00795886|12907846|P1|STARTED|Overall Study||63
5250777|NCT00795821|12907854|P2|NOT COMPLETED|Taper Phase||0
5250778|NCT00795821|12907855|P1|NOT COMPLETED|Taper Phase||9
5250779|NCT00795821|12907854|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
5250780|NCT00795821|12907855|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
5250781|NCT00795821|12907854|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
5250782|NCT00795821|12907855|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
5250783|NCT00795821|12907854|P2|NOT COMPLETED|Long-term Extension Phase||92
5250784|NCT00795821|12907855|P1|NOT COMPLETED|Long-term Extension Phase||90
5250785|NCT00795821|12907854|P2|COMPLETED|Long-term Extension Phase||115
5250786|NCT00795821|12907855|P1|COMPLETED|Long-term Extension Phase||100
5250787|NCT00795821|12907854|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
5250788|NCT00795821|12907855|P1|STARTED|Long-term Extension Phase||190
5250789|NCT00795821|12907854|P2|NOT COMPLETED|Acute Treatment Phase||31
5250790|NCT00795821|12907855|P1|NOT COMPLETED|Acute Treatment Phase||56
5250791|NCT00795821|12907854|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
5250792|NCT00795821|12907855|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
5250793|NCT00795821|12907854|P2|STARTED|Acute Treatment Phase||245
5250794|NCT00795821|12907855|P1|STARTED|Acute Treatment Phase||250
5250795|NCT00795769|12907924|P1|NOT COMPLETED|Overall Study||0
5250796|NCT00795769|12907924|P1|COMPLETED|Overall Study||49
5250797|NCT00795769|12907924|P1|STARTED|Overall Study||49
5250798|NCT00795717|12907930|P2|NOT COMPLETED|Phase II||1
5250799|NCT00795717|12907931|P1|NOT COMPLETED|Phase II||0
5250800|NCT00795717|12907930|P2|COMPLETED|Phase II||18
5250801|NCT00795717|12907931|P1|COMPLETED|Phase II||18
5250802|NCT00795717|12907930|P2|STARTED|Phase II||19
5250803|NCT00795717|12907931|P1|STARTED|Phase II||18
5250804|NCT00795717|12907930|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
5250805|NCT00795717|12907931|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
5250806|NCT00795717|12907930|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
5250807|NCT00795717|12907931|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
5250808|NCT00795717|12907930|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
5250809|NCT00795717|12907931|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
5250810|NCT00795704|12907943|P2|NOT COMPLETED|Overall Study||3
5250811|NCT00795704|12907944|P1|NOT COMPLETED|Overall Study||4
5250812|NCT00795704|12907943|P2|COMPLETED|Overall Study||9
5250813|NCT00795704|12907944|P1|COMPLETED|Overall Study||8
5250814|NCT00795704|12907943|P2|STARTED|Overall Study||12
5250815|NCT00795704|12907944|P1|STARTED|Overall Study||12
5250816|NCT00795665|12907954|P1|NOT COMPLETED|Overall Study||0
5250817|NCT00795665|12907954|P1|COMPLETED|Overall Study||7
5250818|NCT00795665|12907954|P1|STARTED|Overall Study||7
5250819|NCT00795639|12907964|P2|NOT COMPLETED|Overall Study||26
5250820|NCT00795639|12907965|P1|NOT COMPLETED|Overall Study||21
5250821|NCT00795639|12907964|P2|COMPLETED|Overall Study||66
5250822|NCT00795639|12907965|P1|COMPLETED|Overall Study||70
5250823|NCT00795639|12907964|P2|Randomized and Not Treated|Overall Study||1
5250824|NCT00795639|12907965|P1|Randomized and Not Treated|Overall Study||0
5250825|NCT00795639|12907964|P2|STARTED|Overall Study||92
5250826|NCT00795639|12907965|P1|STARTED|Overall Study||91
5250827|NCT00795600|12907977|P2|NOT COMPLETED|Overall Study||4
5250828|NCT00795600|12907978|P1|NOT COMPLETED|Overall Study||4
5250829|NCT00795600|12907977|P2|COMPLETED|Overall Study||31
5250830|NCT00795600|12907978|P1|COMPLETED|Overall Study||21
5250831|NCT00795600|12907977|P2|Exposed to Drug|Overall Study||35
5250832|NCT00795600|12907978|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
5250833|NCT00795600|12907977|P2|STARTED|Overall Study||35
5250834|NCT00795600|12907978|P1|STARTED|Overall Study||25
5250835|NCT00795535|12908098|P1|NOT COMPLETED|Overall Study||20
5250836|NCT00795535|12908098|P1|COMPLETED|Overall Study||75
5250837|NCT00795535|12908098|P1|STARTED|Overall Study||95
5250838|NCT00795509|12908105|P1|NOT COMPLETED|Overall Study||31
5250839|NCT00795509|12908105|P1|COMPLETED|Overall Study||343
5250840|NCT00795509|12908105|P1|STARTED|Overall Study||374
5250841|NCT00795366|12908112|P2|NOT COMPLETED|Overall Study||0
5250842|NCT00795366|12908113|P1|NOT COMPLETED|Overall Study||0
5250843|NCT00795366|12908112|P2|COMPLETED|Overall Study||54
5250844|NCT00795366|12908113|P1|COMPLETED|Overall Study||42
5250845|NCT00795366|12908112|P2|STARTED|Overall Study||54
5250846|NCT00795366|12908113|P1|STARTED|Overall Study||42
5250847|NCT00795340|12908121|P2|NOT COMPLETED|Overall Study||0
5250848|NCT00795340|12908122|P1|NOT COMPLETED|Overall Study||7
5250849|NCT00795340|12908121|P2|COMPLETED|Overall Study||153
5250850|NCT00795340|12908122|P1|COMPLETED|Overall Study||146
5250851|NCT00795340|12908121|P2|STARTED|Overall Study||153
5250852|NCT00795340|12908122|P1|STARTED|Overall Study||153
5250853|NCT00795288|12908134|P2|NOT COMPLETED|Overall Study||0
5250854|NCT00795288|12908135|P1|NOT COMPLETED|Overall Study||0
5250855|NCT00795288|12908134|P2|COMPLETED|Overall Study||21
5250856|NCT00795288|12908135|P1|COMPLETED|Overall Study||21
5250857|NCT00795288|12908134|P2|STARTED|Overall Study||21
5250858|NCT00795288|12908135|P1|STARTED|Overall Study||21
5250859|NCT00795236|12908147|P2|NOT COMPLETED|Overall Study||0
5250860|NCT00795236|12908148|P1|NOT COMPLETED|Overall Study||0
5250861|NCT00795236|12908147|P2|COMPLETED|Overall Study||0
5250862|NCT00795236|12908148|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
5250863|NCT00795236|12908147|P2|STARTED|Overall Study||0
5250864|NCT00795236|12908148|P1|STARTED|Overall Study||0
5250865|NCT00795210|12908161|P3|NOT COMPLETED|Overall Study||2
5250866|NCT00795210|12908162|P2|NOT COMPLETED|Overall Study||1
5250867|NCT00795210|12908163|P1|NOT COMPLETED|Overall Study||0
5250868|NCT00795210|12908161|P3|COMPLETED|Overall Study||3
5250869|NCT00795210|12908162|P2|COMPLETED|Overall Study||11
5250870|NCT00795210|12908163|P1|COMPLETED|Overall Study||8
5250871|NCT00795210|12908161|P3|STARTED|Overall Study||5
5250872|NCT00795210|12908162|P2|STARTED|Overall Study||12
5250873|NCT00795210|12908163|P1|STARTED|Overall Study||8
5250874|NCT00795184|12908174|P2|NOT COMPLETED|Overall Study||13
5250875|NCT00795184|12908175|P1|NOT COMPLETED|Overall Study||8
5250876|NCT00795184|12908174|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
5250877|NCT00795184|12908175|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
5250878|NCT00795184|12908174|P2|STARTED|Overall Study||57
5250879|NCT00795184|12908175|P1|STARTED|Overall Study||65
5250880|NCT00795145|12908186|P7|NOT COMPLETED|Cohort 2||0
5250881|NCT00795145|12908187|P6|NOT COMPLETED|Cohort 2||0
5250882|NCT00795145|12908188|P5|NOT COMPLETED|Cohort 2||0
5250883|NCT00795145|12908189|P4|NOT COMPLETED|Cohort 2||0
5250884|NCT00795145|12908190|P3|NOT COMPLETED|Cohort 2||0
5250885|NCT00795145|12908191|P2|NOT COMPLETED|Cohort 2||0
5250886|NCT00795145|12908192|P1|NOT COMPLETED|Cohort 2||0
5250887|NCT00795145|12908186|P7|COMPLETED|Cohort 2||10
5250888|NCT00795145|12908187|P6|COMPLETED|Cohort 2||10
5250889|NCT00795145|12908188|P5|COMPLETED|Cohort 2||10
5250890|NCT00795145|12908189|P4|COMPLETED|Cohort 2||10
5250891|NCT00795145|12908190|P3|COMPLETED|Cohort 2||0
5250892|NCT00795145|12908191|P2|COMPLETED|Cohort 2||0
5250893|NCT00795145|12908192|P1|COMPLETED|Cohort 2||0
5250894|NCT00795145|12908186|P7|STARTED|Cohort 2||10
5250895|NCT00795145|12908187|P6|STARTED|Cohort 2||10
5250896|NCT00795145|12908188|P5|STARTED|Cohort 2||10
5250897|NCT00795145|12908189|P4|STARTED|Cohort 2||10
5250898|NCT00795145|12908190|P3|STARTED|Cohort 2||0
5250899|NCT00795145|12908191|P2|STARTED|Cohort 2||0
5250900|NCT00795145|12908192|P1|STARTED|Cohort 2||0
5250901|NCT00795145|12908186|P7|NOT COMPLETED|Cohort 1||0
5250902|NCT00795145|12908187|P6|NOT COMPLETED|Cohort 1||0
5250903|NCT00795145|12908188|P5|NOT COMPLETED|Cohort 1||0
5250904|NCT00795145|12908189|P4|NOT COMPLETED|Cohort 1||0
5250905|NCT00795145|12908190|P3|NOT COMPLETED|Cohort 1||0
5250906|NCT00795145|12908191|P2|NOT COMPLETED|Cohort 1||0
5250907|NCT00795145|12908192|P1|NOT COMPLETED|Cohort 1||0
5250908|NCT00795145|12908186|P7|COMPLETED|Cohort 1||0
5250909|NCT00795145|12908187|P6|COMPLETED|Cohort 1||0
5250910|NCT00795145|12908188|P5|COMPLETED|Cohort 1||0
5250911|NCT00795145|12908189|P4|COMPLETED|Cohort 1||0
5250912|NCT00795145|12908190|P3|COMPLETED|Cohort 1||3
5250913|NCT00795145|12908191|P2|COMPLETED|Cohort 1||3
5250914|NCT00795145|12908192|P1|COMPLETED|Cohort 1||3
5250915|NCT00795145|12908186|P7|STARTED|Cohort 1||0
5250916|NCT00795145|12908187|P6|STARTED|Cohort 1||0
5250917|NCT00795145|12908188|P5|STARTED|Cohort 1||0
5250918|NCT00795145|12908189|P4|STARTED|Cohort 1||0
5250919|NCT00795145|12908190|P3|STARTED|Cohort 1||3
5250920|NCT00795145|12908191|P2|STARTED|Cohort 1||3
5250921|NCT00795145|12908192|P1|STARTED|Cohort 1||3
5250922|NCT00795132|12908236|P1|NOT COMPLETED|Overall Study||3
5250923|NCT00795132|12908236|P1|COMPLETED|Overall Study||44
5250924|NCT00795132|12908236|P1|STARTED|Overall Study||47
5250925|NCT00795002|12908250|P2|NOT COMPLETED|Overall Study||0
5250926|NCT00795002|12908251|P1|NOT COMPLETED|Overall Study||0
5250927|NCT00795002|12908250|P2|COMPLETED|Overall Study||37
5250928|NCT00795002|12908251|P1|COMPLETED|Overall Study||37
5250929|NCT00795002|12908250|P2|STARTED|Overall Study||37
5250930|NCT00795002|12908251|P1|STARTED|Overall Study||37
5250931|NCT00794963|12908263|P2|NOT COMPLETED|Overall Study||4
5250932|NCT00794963|12908264|P1|NOT COMPLETED|Overall Study||1
5250933|NCT00794963|12908263|P2|COMPLETED|Overall Study||0
5250934|NCT00794963|12908264|P1|COMPLETED|Overall Study||3
5250935|NCT00794963|12908263|P2|STARTED|Overall Study||4
5250936|NCT00794963|12908264|P1|STARTED|Overall Study||4
5250937|NCT00794950|12908270|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
5250938|NCT00794950|12908270|P1|COMPLETED|Beginning Sunitinib Treatment||24
5250939|NCT00794950|12908270|P1|STARTED|Beginning Sunitinib Treatment||36
5250940|NCT00794950|12908270|P1|NOT COMPLETED|BCG Induction||7
5250941|NCT00794950|12908270|P1|COMPLETED|BCG Induction||36
5250942|NCT00794950|12908270|P1|STARTED|BCG Induction||43
5250943|NCT00794924|12908279|P2|NOT COMPLETED|Overall Study||70
5250944|NCT00794924|12908280|P1|NOT COMPLETED|Overall Study||60
5250945|NCT00794924|12908279|P2|COMPLETED|Overall Study||101
5250946|NCT00794924|12908280|P1|COMPLETED|Overall Study||114
5250947|NCT00794924|12908279|P2|STARTED|Overall Study|14 patients refused to start the study|171
5250948|NCT00794924|12908280|P1|STARTED|Overall Study|14 patients refused to start the study|174
5250949|NCT00794820|12908284|P1|NOT COMPLETED|Overall Study||16
5250950|NCT00794820|12908284|P1|COMPLETED|Overall Study||50
5250951|NCT00794820|12908284|P1|STARTED|Overall Study||66
5250952|NCT00794677|12908292|P2|NOT COMPLETED|Second Intervention||0
5250953|NCT00794677|12908293|P1|NOT COMPLETED|Second Intervention||0
5250954|NCT00794677|12908292|P2|COMPLETED|Second Intervention||13
5250955|NCT00794677|12908293|P1|COMPLETED|Second Intervention||11
5250956|NCT00794677|12908292|P2|STARTED|Second Intervention||13
5250957|NCT00794677|12908293|P1|STARTED|Second Intervention||11
5250958|NCT00794677|12908292|P2|NOT COMPLETED|First Intervention||0
5250959|NCT00794677|12908293|P1|NOT COMPLETED|First Intervention||2
5250960|NCT00794677|12908292|P2|COMPLETED|First Intervention||13
5250961|NCT00794677|12908293|P1|COMPLETED|First Intervention||11
5250962|NCT00794677|12908292|P2|STARTED|First Intervention||13
5250963|NCT00794677|12908293|P1|STARTED|First Intervention||13
5250964|NCT00794664|12908315|P2|NOT COMPLETED|Follow-up Period||5
5250965|NCT00794664|12908316|P1|NOT COMPLETED|Follow-up Period||1
5250966|NCT00794664|12908315|P2|COMPLETED|Follow-up Period||28
5250967|NCT00794664|12908316|P1|COMPLETED|Follow-up Period||15
5250968|NCT00794664|12908315|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
5250969|NCT00794664|12908316|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
5250970|NCT00794664|12908315|P2|NOT COMPLETED|Treatment Period||12
5250971|NCT00794664|12908316|P1|NOT COMPLETED|Treatment Period||1
5250972|NCT00794664|12908315|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
5250973|NCT00794664|12908316|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
5250974|NCT00794664|12908315|P2|STARTED|Treatment Period||39
5250975|NCT00794664|12908316|P1|STARTED|Treatment Period||19
5250976|NCT00794573|12908362|P2|NOT COMPLETED|Overall Study||45
5250977|NCT00794573|12908363|P1|NOT COMPLETED|Overall Study||38
5250978|NCT00794573|12908362|P2|COMPLETED|Overall Study||106
5250979|NCT00794573|12908363|P1|COMPLETED|Overall Study||113
5250980|NCT00794573|12908362|P2|STARTED|Overall Study||151
5250981|NCT00794573|12908363|P1|STARTED|Overall Study||151
5250982|NCT00794560|12908395|P4|NOT COMPLETED|Overall Study||4
5250983|NCT00794560|12908396|P3|NOT COMPLETED|Overall Study||4
5250984|NCT00794560|12908397|P2|NOT COMPLETED|Overall Study||4
5250985|NCT00794560|12908398|P1|NOT COMPLETED|Overall Study||3
5250986|NCT00794560|12908395|P4|COMPLETED|Overall Study||34
5250987|NCT00794560|12908396|P3|COMPLETED|Overall Study||40
5250988|NCT00794560|12908397|P2|COMPLETED|Overall Study||32
5250989|NCT00794560|12908398|P1|COMPLETED|Overall Study||33
5250990|NCT00794560|12908395|P4|STARTED|Overall Study||38
5250991|NCT00794560|12908396|P3|STARTED|Overall Study||44
5250992|NCT00794560|12908397|P2|STARTED|Overall Study||36
5250993|NCT00794560|12908398|P1|STARTED|Overall Study||36
5250994|NCT00794547|12908412|P2|NOT COMPLETED|Overall Study||0
5250995|NCT00794547|12908413|P1|NOT COMPLETED|Overall Study||0
5250996|NCT00794547|12908412|P2|COMPLETED|Overall Study||16
5250997|NCT00794547|12908413|P1|COMPLETED|Overall Study||18
5250998|NCT00794547|12908412|P2|STARTED|Overall Study||16
5250999|NCT00794547|12908413|P1|STARTED|Overall Study||18
5251000|NCT00794508|12908421|P1|NOT COMPLETED|Overall Study||0
5251001|NCT00794508|12908421|P1|COMPLETED|Overall Study||10
5251002|NCT00794508|12908421|P1|STARTED|Overall Study||10
5251003|NCT00794469|12908427|P1|NOT COMPLETED|Overall Study||0
5251004|NCT00794469|12908427|P1|COMPLETED|Overall Study||21
5251005|NCT00794469|12908427|P1|STARTED|Overall Study||21
5251006|NCT00794365|12908432|P1|NOT COMPLETED|Overall Study||79
5251007|NCT00794365|12908432|P1|COMPLETED|Overall Study||251
5251008|NCT00794365|12908432|P1|STARTED|Overall Study||330
5251009|NCT00794313|12908438|P3|NOT COMPLETED|Overall Study||0
5251010|NCT00794313|12908439|P2|NOT COMPLETED|Overall Study||0
5251011|NCT00794313|12908440|P1|NOT COMPLETED|Overall Study||0
5251012|NCT00794313|12908438|P3|COMPLETED|Overall Study||1
5251013|NCT00794313|12908439|P2|COMPLETED|Overall Study||1
5251014|NCT00794313|12908440|P1|COMPLETED|Overall Study||1
5251015|NCT00794313|12908438|P3|STARTED|Overall Study||1
5251016|NCT00794313|12908439|P2|STARTED|Overall Study||1
5251017|NCT00794313|12908440|P1|STARTED|Overall Study||1
5251018|NCT00794196|12908453|P2|NOT COMPLETED|Overall Study||23
5251019|NCT00794196|12908454|P1|NOT COMPLETED|Overall Study||5
5251020|NCT00794196|12908453|P2|COMPLETED|Overall Study||64
5251021|NCT00794196|12908454|P1|COMPLETED|Overall Study||87
5251022|NCT00794196|12908453|P2|STARTED|Overall Study||87
5251023|NCT00794196|12908454|P1|STARTED|Overall Study||92
5251024|NCT00794170|12908464|P2|NOT COMPLETED|Overall Study||3
5251025|NCT00794170|12908465|P1|NOT COMPLETED|Overall Study||7
5251026|NCT00794170|12908464|P2|COMPLETED|Overall Study||152
5251027|NCT00794170|12908465|P1|COMPLETED|Overall Study||150
5251028|NCT00794170|12908464|P2|STARTED|Overall Study||155
5251029|NCT00794170|12908465|P1|STARTED|Overall Study||157
5251030|NCT00794157|12908474|P3|NOT COMPLETED|Overall Study||19
5251031|NCT00794157|12908475|P2|NOT COMPLETED|Overall Study||10
5251032|NCT00794157|12908476|P1|NOT COMPLETED|Overall Study||10
5251033|NCT00794157|12908474|P3|COMPLETED|Overall Study||98
5251034|NCT00794157|12908475|P2|COMPLETED|Overall Study||106
5251035|NCT00794157|12908476|P1|COMPLETED|Overall Study||104
5251036|NCT00794157|12908474|P3|STARTED|Overall Study||117
5251037|NCT00794157|12908475|P2|STARTED|Overall Study||116
5251038|NCT00794157|12908476|P1|STARTED|Overall Study||114
5251039|NCT00794144|12908498|P2|NOT COMPLETED|Overall Study||3
5251040|NCT00794144|12908499|P1|NOT COMPLETED|Overall Study||3
5251041|NCT00794144|12908498|P2|COMPLETED|Overall Study||63
5251042|NCT00794144|12908499|P1|COMPLETED|Overall Study||63
5251043|NCT00794144|12908498|P2|STARTED|Overall Study||66
5251044|NCT00794144|12908499|P1|STARTED|Overall Study||66
5251045|NCT00794118|12908505|P1|NOT COMPLETED|Overall Study||27
5251046|NCT00794118|12908505|P1|COMPLETED|Overall Study||272
5251047|NCT00794118|12908505|P1|STARTED|Overall Study||299
5251048|NCT00794040|12908565|P2|NOT COMPLETED|Overall Study||5
5251049|NCT00794040|12908566|P1|NOT COMPLETED|Overall Study||3
5251050|NCT00794040|12908565|P2|COMPLETED|Overall Study||23
5251051|NCT00794040|12908566|P1|COMPLETED|Overall Study||22
5251052|NCT00794040|12908565|P2|STARTED|Overall Study||28
5251053|NCT00794040|12908566|P1|STARTED|Overall Study||25
5251054|NCT00793910|12908582|P2|NOT COMPLETED|Overall Study||7
5251055|NCT00793910|12908583|P1|NOT COMPLETED|Overall Study||5
5251056|NCT00793910|12908582|P2|COMPLETED|Overall Study||46
5251057|NCT00793910|12908583|P1|COMPLETED|Overall Study||48
5251058|NCT00793910|12908582|P2|STARTED|Overall Study||53
5251059|NCT00793910|12908583|P1|STARTED|Overall Study||53
5251060|NCT00793871|12908597|P1|NOT COMPLETED|Overall Study||60
5251061|NCT00793871|12908597|P1|COMPLETED|Overall Study||0
5251062|NCT00793871|12908597|P1|Received Treatment|Overall Study||59
5251063|NCT00793871|12908597|P1|STARTED|Overall Study||60
5251064|NCT00793819|12908611|P2|NOT COMPLETED|Overall Study||9
5251065|NCT00793819|12908612|P1|NOT COMPLETED|Overall Study||14
5251066|NCT00793819|12908611|P2|COMPLETED|Overall Study||89
5251067|NCT00793819|12908612|P1|COMPLETED|Overall Study||97
5251068|NCT00793819|12908611|P2|STARTED|Overall Study||98
5251069|NCT00793819|12908612|P1|STARTED|Overall Study||111
5251070|NCT00793793|12908630|P12|NOT COMPLETED|Overall Study||6
5251071|NCT00793793|12908631|P11|NOT COMPLETED|Overall Study||3
5251072|NCT00793793|12908632|P10|NOT COMPLETED|Overall Study||9
5251073|NCT00793793|12908633|P9|NOT COMPLETED|Overall Study||9
5251074|NCT00793793|12908634|P8|NOT COMPLETED|Overall Study||0
5251075|NCT00793793|12908635|P7|NOT COMPLETED|Overall Study||4
5251076|NCT00793793|12908636|P6|NOT COMPLETED|Overall Study||2
5251077|NCT00793793|12908637|P5|NOT COMPLETED|Overall Study||2
5251078|NCT00793793|12908638|P4|NOT COMPLETED|Overall Study||3
5251079|NCT00793793|12908639|P3|NOT COMPLETED|Overall Study||2
5251080|NCT00793793|12908640|P2|NOT COMPLETED|Overall Study||1
5251081|NCT00793793|12908641|P1|NOT COMPLETED|Overall Study||0
5251082|NCT00793793|12908630|P12|COMPLETED|Overall Study||1
5251083|NCT00793793|12908631|P11|COMPLETED|Overall Study||3
5251084|NCT00793793|12908632|P10|COMPLETED|Overall Study||6
5251085|NCT00793793|12908633|P9|COMPLETED|Overall Study||6
5251086|NCT00793793|12908634|P8|COMPLETED|Overall Study||6
5251087|NCT00793793|12908635|P7|COMPLETED|Overall Study||3
5251088|NCT00793793|12908636|P6|COMPLETED|Overall Study||4
5251089|NCT00793793|12908637|P5|COMPLETED|Overall Study||4
5251090|NCT00793793|12908638|P4|COMPLETED|Overall Study||4
5251091|NCT00793793|12908639|P3|COMPLETED|Overall Study||5
5251092|NCT00793793|12908640|P2|COMPLETED|Overall Study||5
5251093|NCT00793793|12908641|P1|COMPLETED|Overall Study||8
5251094|NCT00793793|12908630|P12|STARTED|Overall Study||7
5251095|NCT00793793|12908631|P11|STARTED|Overall Study||6
5251096|NCT00793793|12908632|P10|STARTED|Overall Study||15
5251097|NCT00793793|12908633|P9|STARTED|Overall Study||15
5251098|NCT00793793|12908634|P8|STARTED|Overall Study||6
5251099|NCT00793793|12908635|P7|STARTED|Overall Study||7
5251100|NCT00793793|12908636|P6|STARTED|Overall Study||6
5251101|NCT00793793|12908637|P5|STARTED|Overall Study||6
5251102|NCT00793793|12908638|P4|STARTED|Overall Study||7
5251103|NCT00793793|12908639|P3|STARTED|Overall Study||7
5251104|NCT00793793|12908640|P2|STARTED|Overall Study||6
5251105|NCT00793793|12908641|P1|STARTED|Overall Study||8
5251106|NCT00793780|12909016|P2|NOT COMPLETED|Overall Study||1
5251107|NCT00793780|12909017|P1|NOT COMPLETED|Overall Study||2
5251108|NCT00793780|12909016|P2|COMPLETED|Overall Study||11
5251109|NCT00793780|12909017|P1|COMPLETED|Overall Study||10
5251110|NCT00793780|12909016|P2|Collected Baseline Data|Overall Study||12
5251111|NCT00793780|12909017|P1|Collected Baseline Data|Overall Study||11
5251112|NCT00793780|12909016|P2|Randomization|Overall Study||12
5251113|NCT00793780|12909017|P1|Randomization|Overall Study||12
5251114|NCT00793780|12909016|P2|STARTED|Overall Study||12
5251115|NCT00793780|12909017|P1|STARTED|Overall Study||12
5251116|NCT00793650|12909035|P2|NOT COMPLETED|Overall Study||0
5251117|NCT00793650|12909036|P1|NOT COMPLETED|Overall Study||0
5251118|NCT00793650|12909035|P2|COMPLETED|Overall Study||20
5251119|NCT00793650|12909036|P1|COMPLETED|Overall Study||19
5251120|NCT00793650|12909035|P2|STARTED|Overall Study||20
5251121|NCT00793650|12909036|P1|STARTED|Overall Study||19
5251122|NCT00793624|12909048|P4|NOT COMPLETED|Overall Study||43
5251123|NCT00793624|12909049|P3|NOT COMPLETED|Overall Study||39
5251124|NCT00793624|12909050|P2|NOT COMPLETED|Overall Study||36
5251125|NCT00793624|12909051|P1|NOT COMPLETED|Overall Study||57
5251126|NCT00793624|12909048|P4|COMPLETED|Overall Study||184
5251127|NCT00793624|12909049|P3|COMPLETED|Overall Study||186
5251128|NCT00793624|12909050|P2|COMPLETED|Overall Study||191
5251129|NCT00793624|12909051|P1|COMPLETED|Overall Study||168
5251130|NCT00793624|12909048|P4|STARTED|Overall Study||227
5251131|NCT00793624|12909049|P3|STARTED|Overall Study||225
5251132|NCT00793624|12909050|P2|STARTED|Overall Study||227
5251133|NCT00793624|12909051|P1|STARTED|Overall Study||225
5251134|NCT00793611|12909319|P2|NOT COMPLETED|Overall Study||0
5251135|NCT00793611|12909320|P1|NOT COMPLETED|Overall Study||0
5251136|NCT00793611|12909319|P2|COMPLETED|Overall Study||10
5251137|NCT00793611|12909320|P1|COMPLETED|Overall Study||10
5251138|NCT00793611|12909319|P2|STARTED|Overall Study||10
5251139|NCT00793611|12909320|P1|STARTED|Overall Study||10
5251140|NCT00793585|12909332|P2|NOT COMPLETED|Overall Study||3
5251141|NCT00793585|12909333|P1|NOT COMPLETED|Overall Study||2
5251142|NCT00793585|12909332|P2|COMPLETED|Overall Study||18
5251143|NCT00793585|12909333|P1|COMPLETED|Overall Study||17
5251144|NCT00793585|12909332|P2|STARTED|Overall Study||21
5251145|NCT00793585|12909333|P1|STARTED|Overall Study||19
5251146|NCT00793572|12909341|P1|NOT COMPLETED|Overall Study||0
5251147|NCT00793572|12909341|P1|COMPLETED|Overall Study||32
5251148|NCT00793572|12909341|P1|STARTED|Overall Study||32
5251149|NCT00793546|12909352|P2|NOT COMPLETED|Overall Study||28
5251150|NCT00793546|12909353|P1|NOT COMPLETED|Overall Study||14
5251151|NCT00793546|12909352|P2|COMPLETED|Overall Study||0
5251152|NCT00793546|12909353|P1|COMPLETED|Overall Study||0
5251153|NCT00793546|12909352|P2|STARTED|Overall Study||28
5251154|NCT00793546|12909353|P1|STARTED|Overall Study||14
5251155|NCT00793520|12909383|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
5251156|NCT00793520|12909384|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
5251157|NCT00793520|12909383|P2|COMPLETED|Placebo Crossover to Milnacipran||0
5251158|NCT00793520|12909384|P1|COMPLETED|Placebo Crossover to Milnacipran||0
5251159|NCT00793520|12909383|P2|STARTED|Placebo Crossover to Milnacipran||1
5251160|NCT00793520|12909384|P1|STARTED|Placebo Crossover to Milnacipran||0
5251161|NCT00793520|12909383|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
5251162|NCT00793520|12909384|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
5251163|NCT00793520|12909383|P2|COMPLETED|Milnacipran Crossover to Placebo||0
5251164|NCT00793520|12909384|P1|COMPLETED|Milnacipran Crossover to Placebo||0
5251165|NCT00793520|12909383|P2|STARTED|Milnacipran Crossover to Placebo||0
5251166|NCT00793520|12909384|P1|STARTED|Milnacipran Crossover to Placebo||1
5251167|NCT00793455|12909394|P2|NOT COMPLETED|Overall Study||0
5251168|NCT00793455|12909395|P1|NOT COMPLETED|Overall Study||0
5251169|NCT00793455|12909394|P2|COMPLETED|Overall Study||314
5251170|NCT00793455|12909395|P1|COMPLETED|Overall Study||314
5251171|NCT00793455|12909394|P2|STARTED|Overall Study||314
5251172|NCT00793455|12909395|P1|STARTED|Overall Study||314
5251173|NCT00793403|12909403|P1|NOT COMPLETED|Overall Study||73
5251174|NCT00793403|12909403|P1|COMPLETED|Overall Study||220
5251175|NCT00793403|12909403|P1|STARTED|Overall Study||293
5251176|NCT00793325|12909450|P1|NOT COMPLETED|Overall Study||19
5251177|NCT00793325|12909450|P1|COMPLETED|Overall Study||890
5251178|NCT00793325|12909450|P1|STARTED|Overall Study||909
5251179|NCT00793182|12909476|P2|NOT COMPLETED|Overall Study||1
5251180|NCT00793182|12909477|P1|NOT COMPLETED|Overall Study||0
5251181|NCT00793182|12909476|P2|COMPLETED|Overall Study||3
5251182|NCT00793182|12909477|P1|COMPLETED|Overall Study||2
5251183|NCT00793182|12909476|P2|STARTED|Overall Study||4
5251184|NCT00793182|12909477|P1|STARTED|Overall Study||2
5251185|NCT00793169|12909483|P1|NOT COMPLETED|Overall Study||0
5251186|NCT00793169|12909483|P1|COMPLETED|Overall Study||19
5251187|NCT00793169|12909483|P1|STARTED|Overall Study||19
5251188|NCT00793104|12909487|P1|NOT COMPLETED|Overall Study||1
5251189|NCT00793104|12909487|P1|COMPLETED|Overall Study||9
5251190|NCT00793104|12909487|P1|STARTED|Overall Study||10
5251191|NCT00792948|12909495|P1|NOT COMPLETED|Overall Study||28
5251192|NCT00792948|12909495|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
5251193|NCT00792948|12909495|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
5251194|NCT00792935|12909506|P2|NOT COMPLETED|Overall Study||3
5251195|NCT00792935|12909507|P1|NOT COMPLETED|Overall Study||4
5251196|NCT00792935|12909506|P2|COMPLETED|Overall Study||68
5251197|NCT00792935|12909507|P1|COMPLETED|Overall Study||68
5251198|NCT00792935|12909506|P2|STARTED|Overall Study||71
5251199|NCT00792935|12909507|P1|STARTED|Overall Study||72
5251200|NCT00792922|12909519|P4|NOT COMPLETED|At 3 Years||0
5251201|NCT00792922|12909520|P3|NOT COMPLETED|At 3 Years||0
5251202|NCT00792922|12909521|P2|NOT COMPLETED|At 3 Years||0
5251203|NCT00792922|12909522|P1|NOT COMPLETED|At 3 Years||0
5251204|NCT00792922|12909519|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251205|NCT00792922|12909520|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251206|NCT00792922|12909521|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251207|NCT00792922|12909522|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251208|NCT00792922|12909519|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251209|NCT00792922|12909520|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251210|NCT00792922|12909521|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251211|NCT00792922|12909522|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251212|NCT00792922|12909519|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251213|NCT00792922|12909520|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251214|NCT00792922|12909521|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251215|NCT00792922|12909522|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251216|NCT00792922|12909519|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251217|NCT00792922|12909520|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251218|NCT00792922|12909521|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251219|NCT00792922|12909522|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
5251220|NCT00792922|12909519|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
5251221|NCT00792922|12909520|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
5251222|NCT00792922|12909521|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
5251223|NCT00792922|12909522|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
5251224|NCT00792922|12909519|P4|NOT COMPLETED|At Baseline||0
5251225|NCT00792922|12909520|P3|NOT COMPLETED|At Baseline||0
5251226|NCT00792922|12909521|P2|NOT COMPLETED|At Baseline||0
5251227|NCT00792922|12909522|P1|NOT COMPLETED|At Baseline||0
5251228|NCT00792922|12909519|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251229|NCT00792922|12909520|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251230|NCT00792922|12909521|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251231|NCT00792922|12909522|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251232|NCT00792922|12909519|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251233|NCT00792922|12909520|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251234|NCT00792922|12909521|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251235|NCT00792922|12909522|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251236|NCT00792922|12909519|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251237|NCT00792922|12909520|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251238|NCT00792922|12909521|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251239|NCT00792922|12909522|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251240|NCT00792922|12909519|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251241|NCT00792922|12909520|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251242|NCT00792922|12909521|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251243|NCT00792922|12909522|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251244|NCT00792922|12909519|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251245|NCT00792922|12909520|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251246|NCT00792922|12909521|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251247|NCT00792922|12909522|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
5251248|NCT00792909|12909539|P3|NOT COMPLETED|Overall Study||0
5251249|NCT00792909|12909540|P2|NOT COMPLETED|Overall Study||1
5251250|NCT00792909|12909541|P1|NOT COMPLETED|Overall Study||0
5251251|NCT00792909|12909539|P3|COMPLETED|Overall Study||62
5251252|NCT00792909|12909540|P2|COMPLETED|Overall Study||58
5251253|NCT00792909|12909541|P1|COMPLETED|Overall Study||51
5251254|NCT00792909|12909539|P3|STARTED|Overall Study||62
5251255|NCT00792909|12909540|P2|STARTED|Overall Study||59
5251256|NCT00792909|12909541|P1|STARTED|Overall Study||51
5251257|NCT00792805|12909597|P3|NOT COMPLETED|Overall Study||33
5251258|NCT00792805|12909598|P2|NOT COMPLETED|Overall Study||26
5251259|NCT00792805|12909599|P1|NOT COMPLETED|Overall Study||22
5251260|NCT00792805|12909597|P3|COMPLETED|Overall Study||154
5251261|NCT00792805|12909598|P2|COMPLETED|Overall Study||162
5251262|NCT00792805|12909599|P1|COMPLETED|Overall Study||166
5251263|NCT00792805|12909597|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
5251264|NCT00792805|12909598|P2|Exposed to Study Medication or Placebo|Overall Study||188
5251265|NCT00792805|12909599|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
5251266|NCT00792805|12909597|P3|STARTED|Overall Study||187
5251267|NCT00792805|12909598|P2|STARTED|Overall Study||188
5251268|NCT00792805|12909599|P1|STARTED|Overall Study||188
5251269|NCT00792701|12909609|P2|NOT COMPLETED|Overall Study||44
5251270|NCT00792701|12909610|P1|NOT COMPLETED|Overall Study||19
5251271|NCT00792701|12909609|P2|COMPLETED|Overall Study||22
5251272|NCT00792701|12909610|P1|COMPLETED|Overall Study||0
5251273|NCT00792701|12909609|P2|Eligible and Analyzable|Overall Study||44
5251274|NCT00792701|12909610|P1|Eligible and Analyzable|Overall Study||17
5251275|NCT00792701|12909609|P2|Eligible|Overall Study||63
5251276|NCT00792701|12909610|P1|Eligible|Overall Study||18
5251277|NCT00792701|12909609|P2|STARTED|Overall Study||66
5251278|NCT00792701|12909610|P1|STARTED|Overall Study||19
5251279|NCT00792688|12909624|P3|NOT COMPLETED|Overall Study||0
5251280|NCT00792688|12909625|P2|NOT COMPLETED|Overall Study||0
5251281|NCT00792688|12909626|P1|NOT COMPLETED|Overall Study||0
5251282|NCT00792688|12909624|P3|COMPLETED|Overall Study||9
5251283|NCT00792688|12909625|P2|COMPLETED|Overall Study||8
5251284|NCT00792688|12909626|P1|COMPLETED|Overall Study||9
5251285|NCT00792688|12909624|P3|STARTED|Overall Study||9
5251286|NCT00792688|12909625|P2|STARTED|Overall Study||8
5251287|NCT00792688|12909626|P1|STARTED|Overall Study||9
5251288|NCT00792636|12909640|P3|NOT COMPLETED|Overall Study||81
5251289|NCT00792636|12909641|P2|NOT COMPLETED|Overall Study||81
5251290|NCT00792636|12909642|P1|NOT COMPLETED|Overall Study||68
5251291|NCT00792636|12909640|P3|COMPLETED|Overall Study||55
5251292|NCT00792636|12909641|P2|COMPLETED|Overall Study||55
5251293|NCT00792636|12909642|P1|COMPLETED|Overall Study||67
5251294|NCT00792636|12909640|P3|STARTED|Overall Study||136
5251295|NCT00792636|12909641|P2|STARTED|Overall Study||136
5251296|NCT00792636|12909642|P1|STARTED|Overall Study||135
5251297|NCT00792623|12909679|P1|NOT COMPLETED|Overall Study||7
5251298|NCT00792623|12909679|P1|COMPLETED|Overall Study||22
5251299|NCT00792623|12909679|P1|STARTED|Overall Study||29
5251300|NCT00792610|12909692|P1|NOT COMPLETED|Overall Study||0
5251301|NCT00792610|12909692|P1|COMPLETED|Overall Study||127
5251302|NCT00792610|12909692|P1|Youths|Overall Study||127
5251303|NCT00792610|12909692|P1|STARTED|Overall Study||127
5251304|NCT00792571|12909696|P1|NOT COMPLETED|Overall Study||10
5251305|NCT00792571|12909696|P1|COMPLETED|Overall Study||8
5251306|NCT00792571|12909696|P1|STARTED|Overall Study||18
5251307|NCT00792428|12909707|P2|NOT COMPLETED|Overall Study||0
5251308|NCT00792428|12909708|P1|NOT COMPLETED|Overall Study||0
5251309|NCT00792428|12909707|P2|COMPLETED|Overall Study||10
5251310|NCT00792428|12909708|P1|COMPLETED|Overall Study||10
5251311|NCT00792428|12909707|P2|STARTED|Overall Study||10
5251312|NCT00792428|12909708|P1|STARTED|Overall Study||10
5251313|NCT00792298|12909716|P8|NOT COMPLETED|Treatment Period 2||2
5251314|NCT00792298|12909717|P7|NOT COMPLETED|Treatment Period 2||1
5251315|NCT00792298|12909718|P6|NOT COMPLETED|Treatment Period 2||0
5251316|NCT00792298|12909719|P5|NOT COMPLETED|Treatment Period 2||2
5251317|NCT00792298|12909720|P4|NOT COMPLETED|Treatment Period 2||2
5251318|NCT00792298|12909721|P3|NOT COMPLETED|Treatment Period 2||1
5251319|NCT00792298|12909722|P2|NOT COMPLETED|Treatment Period 2||1
5251320|NCT00792298|12909723|P1|NOT COMPLETED|Treatment Period 2||1
5251321|NCT00792298|12909716|P8|COMPLETED|Treatment Period 2||28
5251322|NCT00792298|12909717|P7|COMPLETED|Treatment Period 2||28
5251323|NCT00792298|12909718|P6|COMPLETED|Treatment Period 2||27
5251324|NCT00792298|12909719|P5|COMPLETED|Treatment Period 2||30
5251325|NCT00792298|12909720|P4|COMPLETED|Treatment Period 2||26
5251326|NCT00792298|12909721|P3|COMPLETED|Treatment Period 2||30
5251327|NCT00792298|12909722|P2|COMPLETED|Treatment Period 2||30
5251328|NCT00792298|12909723|P1|COMPLETED|Treatment Period 2||29
5251329|NCT00792298|12909716|P8|STARTED|Treatment Period 2||30
5251330|NCT00792298|12909717|P7|STARTED|Treatment Period 2||29
5251331|NCT00792298|12909718|P6|STARTED|Treatment Period 2||27
5251332|NCT00792298|12909719|P5|STARTED|Treatment Period 2||32
5251333|NCT00792298|12909720|P4|STARTED|Treatment Period 2||28
5251334|NCT00792298|12909721|P3|STARTED|Treatment Period 2||31
5251335|NCT00792298|12909722|P2|STARTED|Treatment Period 2||31
5251336|NCT00792298|12909723|P1|STARTED|Treatment Period 2||30
5251337|NCT00792298|12909716|P8|NOT COMPLETED|Washout||0
5251338|NCT00792298|12909717|P7|NOT COMPLETED|Washout||0
5251339|NCT00792298|12909718|P6|NOT COMPLETED|Washout||2
5251340|NCT00792298|12909719|P5|NOT COMPLETED|Washout||0
5251341|NCT00792298|12909720|P4|NOT COMPLETED|Washout||0
5251342|NCT00792298|12909721|P3|NOT COMPLETED|Washout||1
5251343|NCT00792298|12909722|P2|NOT COMPLETED|Washout||0
5251344|NCT00792298|12909723|P1|NOT COMPLETED|Washout||0
5251345|NCT00792298|12909716|P8|COMPLETED|Washout||30
5251346|NCT00792298|12909717|P7|COMPLETED|Washout||29
5251347|NCT00792298|12909718|P6|COMPLETED|Washout||27
5251348|NCT00792298|12909719|P5|COMPLETED|Washout||32
5251349|NCT00792298|12909720|P4|COMPLETED|Washout||28
5251350|NCT00792298|12909721|P3|COMPLETED|Washout||31
5251351|NCT00792298|12909722|P2|COMPLETED|Washout||31
5251352|NCT00792298|12909723|P1|COMPLETED|Washout||30
5251353|NCT00792298|12909716|P8|STARTED|Washout||30
5251354|NCT00792298|12909717|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
5251355|NCT00792298|12909718|P6|STARTED|Washout||29
5251356|NCT00792298|12909719|P5|STARTED|Washout||32
5251357|NCT00792298|12909720|P4|STARTED|Washout||28
5251358|NCT00792298|12909721|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
5251359|NCT00792298|12909722|P2|STARTED|Washout||31
5251360|NCT00792298|12909723|P1|STARTED|Washout||30
5251361|NCT00792298|12909716|P8|NOT COMPLETED|Treatment Period 1||1
5251362|NCT00792298|12909717|P7|NOT COMPLETED|Treatment Period 1||4
5251363|NCT00792298|12909718|P6|NOT COMPLETED|Treatment Period 1||3
5251364|NCT00792298|12909719|P5|NOT COMPLETED|Treatment Period 1||0
5251365|NCT00792298|12909720|P4|NOT COMPLETED|Treatment Period 1||4
5251366|NCT00792298|12909721|P3|NOT COMPLETED|Treatment Period 1||2
5251367|NCT00792298|12909722|P2|NOT COMPLETED|Treatment Period 1||1
5251368|NCT00792298|12909723|P1|NOT COMPLETED|Treatment Period 1||1
5251369|NCT00792298|12909716|P8|COMPLETED|Treatment Period 1||30
5251370|NCT00792298|12909717|P7|COMPLETED|Treatment Period 1||27
5251371|NCT00792298|12909718|P6|COMPLETED|Treatment Period 1||29
5251372|NCT00792298|12909719|P5|COMPLETED|Treatment Period 1||32
5251373|NCT00792298|12909720|P4|COMPLETED|Treatment Period 1||28
5251374|NCT00792298|12909721|P3|COMPLETED|Treatment Period 1||31
5251375|NCT00792298|12909722|P2|COMPLETED|Treatment Period 1||31
5251376|NCT00792298|12909723|P1|COMPLETED|Treatment Period 1||30
5251377|NCT00792298|12909716|P8|STARTED|Treatment Period 1||31
5251378|NCT00792298|12909717|P7|STARTED|Treatment Period 1||31
5251379|NCT00792298|12909718|P6|STARTED|Treatment Period 1||32
5251380|NCT00792298|12909719|P5|STARTED|Treatment Period 1||32
5251381|NCT00792298|12909720|P4|STARTED|Treatment Period 1||32
5251382|NCT00792298|12909721|P3|STARTED|Treatment Period 1||33
5251383|NCT00792298|12909722|P2|STARTED|Treatment Period 1||32
5251384|NCT00792298|12909723|P1|STARTED|Treatment Period 1||31
5251385|NCT00792259|12909753|P3|NOT COMPLETED|Overall Study||0
5251386|NCT00792259|12909754|P2|NOT COMPLETED|Overall Study||0
5251387|NCT00792259|12909755|P1|NOT COMPLETED|Overall Study||1
5251388|NCT00792259|12909753|P3|COMPLETED|Overall Study||13
5251389|NCT00792259|12909754|P2|COMPLETED|Overall Study||20
5251390|NCT00792259|12909755|P1|COMPLETED|Overall Study||14
5251391|NCT00792259|12909753|P3|STARTED|Overall Study||13
5251392|NCT00792259|12909754|P2|STARTED|Overall Study||20
5251393|NCT00792259|12909755|P1|STARTED|Overall Study||15
5251394|NCT00792116|12909765|P2|NOT COMPLETED|Overall Study||1
5251395|NCT00792116|12909766|P1|NOT COMPLETED|Overall Study||1
5251396|NCT00792116|12909765|P2|COMPLETED|Overall Study||54
5251397|NCT00792116|12909766|P1|COMPLETED|Overall Study||52
5251398|NCT00792116|12909765|P2|STARTED|Overall Study||55
5251399|NCT00792116|12909766|P1|STARTED|Overall Study||53
5251400|NCT00792103|12909776|P1|NOT COMPLETED|Overall Study||133
5251401|NCT00792103|12909776|P1|COMPLETED|Overall Study||65
5251402|NCT00792103|12909776|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
5251403|NCT00791999|12909788|P4|NOT COMPLETED|Overall Study||52
5251404|NCT00791999|12909789|P3|NOT COMPLETED|Overall Study||20
5251405|NCT00791999|12909790|P2|NOT COMPLETED|Overall Study||16
5251406|NCT00791999|12909791|P1|NOT COMPLETED|Overall Study||21
5251407|NCT00791999|12909788|P4|COMPLETED|Overall Study||25
5251408|NCT00791999|12909789|P3|COMPLETED|Overall Study||65
5251409|NCT00791999|12909790|P2|COMPLETED|Overall Study||66
5251410|NCT00791999|12909791|P1|COMPLETED|Overall Study||51
5251411|NCT00791999|12909788|P4|STARTED|Overall Study||77
5251412|NCT00791999|12909789|P3|STARTED|Overall Study||85
5251413|NCT00791999|12909790|P2|STARTED|Overall Study||82
5251414|NCT00791999|12909791|P1|STARTED|Overall Study||72
5251415|NCT00791973|12909807|P2|NOT COMPLETED|Second Intervention (1 Week)||0
5251416|NCT00791973|12909808|P1|NOT COMPLETED|Second Intervention (1 Week)||0
5251417|NCT00791973|12909807|P2|COMPLETED|Second Intervention (1 Week)||7
5251418|NCT00791973|12909808|P1|COMPLETED|Second Intervention (1 Week)||8
5251419|NCT00791973|12909807|P2|STARTED|Second Intervention (1 Week)||7
5251420|NCT00791973|12909808|P1|STARTED|Second Intervention (1 Week)||8
5251421|NCT00791973|12909807|P2|NOT COMPLETED|Washout (1 Week)||0
5251422|NCT00791973|12909808|P1|NOT COMPLETED|Washout (1 Week)||0
5251423|NCT00791973|12909807|P2|COMPLETED|Washout (1 Week)||7
5251424|NCT00791973|12909808|P1|COMPLETED|Washout (1 Week)||8
5251425|NCT00791973|12909807|P2|STARTED|Washout (1 Week)||7
5251426|NCT00791973|12909808|P1|STARTED|Washout (1 Week)||8
5251427|NCT00791973|12909807|P2|NOT COMPLETED|First Intervention (1 Week)||0
5251428|NCT00791973|12909808|P1|NOT COMPLETED|First Intervention (1 Week)||0
5251429|NCT00791973|12909807|P2|COMPLETED|First Intervention (1 Week)||7
5251430|NCT00791973|12909808|P1|COMPLETED|First Intervention (1 Week)||8
5251431|NCT00791973|12909807|P2|STARTED|First Intervention (1 Week)||7
5251432|NCT00791973|12909808|P1|STARTED|First Intervention (1 Week)||8
5251433|NCT00791934|12909816|P1|NOT COMPLETED|Overall Study||15
5251434|NCT00791934|12909816|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
5251435|NCT00791934|12909816|P1|STARTED|Overall Study||63
5251436|NCT00791921|12909826|P2|NOT COMPLETED|Overall Study||96
5251437|NCT00791921|12909827|P1|NOT COMPLETED|Overall Study||34
5251438|NCT00791921|12909826|P2|COMPLETED|Overall Study||18
5251439|NCT00791921|12909827|P1|COMPLETED|Overall Study||82
5251440|NCT00791921|12909826|P2|STARTED|Overall Study||114
5251441|NCT00791921|12909827|P1|STARTED|Overall Study||116
5251442|NCT00791908|12909835|P1|NOT COMPLETED|Overall Study||0
5251443|NCT00791908|12909835|P1|COMPLETED|Overall Study||15
5251444|NCT00791908|12909835|P1|STARTED|Overall Study||15
5251445|NCT00791843|12909843|P1|NOT COMPLETED|Overall Study||0
5251446|NCT00791843|12909843|P1|COMPLETED|Overall Study|Data unavailable for the study|0
5251447|NCT00791843|12909843|P1|STARTED|Overall Study|Data unavailable for the study|0
5251448|NCT00791817|12909849|P2|NOT COMPLETED|2: Single Dose||0
5251449|NCT00791817|12909850|P1|NOT COMPLETED|2: Single Dose||0
5251450|NCT00791817|12909849|P2|COMPLETED|2: Single Dose||5
5251451|NCT00791817|12909850|P1|COMPLETED|2: Single Dose||5
5251452|NCT00791817|12909849|P2|STARTED|2: Single Dose||5
5251453|NCT00791817|12909850|P1|STARTED|2: Single Dose||5
5251454|NCT00791817|12909849|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
5251455|NCT00791817|12909850|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
5251456|NCT00791817|12909849|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
5251457|NCT00791817|12909850|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
5251458|NCT00791817|12909849|P2|STARTED|1: Single Dose Followed by Week Washout||5
5251459|NCT00791817|12909850|P1|STARTED|1: Single Dose Followed by Week Washout||5
5251460|NCT00791778|12909858|P2|NOT COMPLETED|Follow-up||1
5251461|NCT00791778|12909859|P1|NOT COMPLETED|Follow-up||5
5251462|NCT00791778|12909858|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
5251463|NCT00791778|12909859|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
5251464|NCT00791778|12909858|P2|STARTED|Follow-up||91
5251465|NCT00791778|12909859|P1|STARTED|Follow-up||100
5251466|NCT00791778|12909858|P2|NOT COMPLETED|Double-blind Treatment||48
5251467|NCT00791778|12909859|P1|NOT COMPLETED|Double-blind Treatment||77
5251468|NCT00791778|12909858|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
5251469|NCT00791778|12909859|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
5251470|NCT00791778|12909858|P2|STARTED|Double-blind Treatment||123
5251471|NCT00791778|12909859|P1|STARTED|Double-blind Treatment||123
5251472|NCT00791765|12909913|P2|NOT COMPLETED|Weeks 13 to 24||8
5251473|NCT00791765|12909914|P1|NOT COMPLETED|Weeks 13 to 24||5
5251474|NCT00791765|12909913|P2|COMPLETED|Weeks 13 to 24||49
5251475|NCT00791765|12909914|P1|COMPLETED|Weeks 13 to 24||49
5251476|NCT00791765|12909913|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
5251477|NCT00791765|12909914|P1|STARTED|Weeks 13 to 24||54
5251478|NCT00791765|12909913|P2|NOT COMPLETED|Weeks 1 to 12||4
5251479|NCT00791765|12909914|P1|NOT COMPLETED|Weeks 1 to 12||8
5251480|NCT00791765|12909913|P2|COMPLETED|Weeks 1 to 12||58
5251481|NCT00791765|12909914|P1|COMPLETED|Weeks 1 to 12||54
5251482|NCT00791765|12909913|P2|Treated|Weeks 1 to 12||59
5251483|NCT00791765|12909914|P1|Treated|Weeks 1 to 12||62
5251484|NCT00791765|12909913|P2|STARTED|Weeks 1 to 12||62
5251485|NCT00791765|12909914|P1|STARTED|Weeks 1 to 12||62
5251486|NCT00791700|12909929|P4|NOT COMPLETED|Overall Study||30
5251487|NCT00791700|12909930|P3|NOT COMPLETED|Overall Study||6
5251488|NCT00791700|12909931|P2|NOT COMPLETED|Overall Study||11
5251489|NCT00791700|12909932|P1|NOT COMPLETED|Overall Study||6
5251490|NCT00791700|12909929|P4|COMPLETED|Overall Study||13
5251491|NCT00791700|12909930|P3|COMPLETED|Overall Study||7
5251492|NCT00791700|12909931|P2|COMPLETED|Overall Study||20
5251493|NCT00791700|12909932|P1|COMPLETED|Overall Study||10
5251494|NCT00791700|12909929|P4|STARTED|Overall Study||43
5251495|NCT00791700|12909930|P3|STARTED|Overall Study||13
5251496|NCT00791700|12909931|P2|STARTED|Overall Study||31
5251497|NCT00791700|12909932|P1|STARTED|Overall Study||16
5251498|NCT00791661|12910020|P3|NOT COMPLETED|Period 3||0
5251499|NCT00791661|12910021|P2|NOT COMPLETED|Period 3||0
5251500|NCT00791661|12910022|P1|NOT COMPLETED|Period 3||0
5251501|NCT00791661|12910020|P3|COMPLETED|Period 3||6
5251502|NCT00791661|12910021|P2|COMPLETED|Period 3||8
5251503|NCT00791661|12910022|P1|COMPLETED|Period 3||8
5251504|NCT00791661|12910020|P3|Received Matching Placebo to MK-1006|Period 3||1
5251505|NCT00791661|12910021|P2|Received Matching Placebo to MK-1006|Period 3||2
5251506|NCT00791661|12910022|P1|Received Matching Placebo to MK-1006|Period 3||2
5251507|NCT00791661|12910020|P3|Received MK-1006|Period 3||5
5251508|NCT00791661|12910021|P2|Received MK-1006|Period 3||6
5251509|NCT00791661|12910022|P1|Received MK-1006|Period 3||6
5251510|NCT00791661|12910020|P3|STARTED|Period 3||6
5251511|NCT00791661|12910021|P2|STARTED|Period 3||8
5251512|NCT00791661|12910022|P1|STARTED|Period 3||8
5251513|NCT00791661|12910020|P3|NOT COMPLETED|7 Day Wash-out||0
5251514|NCT00791661|12910021|P2|NOT COMPLETED|7 Day Wash-out||0
5251515|NCT00791661|12910022|P1|NOT COMPLETED|7 Day Wash-out||0
5251516|NCT00791661|12910020|P3|COMPLETED|7 Day Wash-out||6
5251517|NCT00791661|12910021|P2|COMPLETED|7 Day Wash-out||8
5251518|NCT00791661|12910022|P1|COMPLETED|7 Day Wash-out||8
5251519|NCT00791661|12910020|P3|STARTED|7 Day Wash-out||6
5251520|NCT00791661|12910021|P2|STARTED|7 Day Wash-out||8
5251521|NCT00791661|12910022|P1|STARTED|7 Day Wash-out||8
5251522|NCT00791661|12910020|P3|NOT COMPLETED|Period 2||0
5251523|NCT00791661|12910021|P2|NOT COMPLETED|Period 2||0
5251524|NCT00791661|12910022|P1|NOT COMPLETED|Period 2||0
5251525|NCT00791661|12910020|P3|COMPLETED|Period 2||6
5251526|NCT00791661|12910021|P2|COMPLETED|Period 2||8
5251527|NCT00791661|12910022|P1|COMPLETED|Period 2||8
5251528|NCT00791661|12910020|P3|Received Matching Placebo to MK-1006|Period 2||2
5251529|NCT00791661|12910021|P2|Received Matching Placebo to MK-1006|Period 2||2
5251530|NCT00791661|12910022|P1|Received Matching Placebo to MK-1006|Period 2||2
5251531|NCT00791661|12910020|P3|Received MK-1006|Period 2||4
5251532|NCT00791661|12910021|P2|Received MK-1006|Period 2||6
5251533|NCT00791661|12910022|P1|Received MK-1006|Period 2||6
5251534|NCT00791661|12910020|P3|STARTED|Period 2||6
5251535|NCT00791661|12910021|P2|STARTED|Period 2||8
5251536|NCT00791661|12910022|P1|STARTED|Period 2||8
5251537|NCT00791661|12910020|P3|NOT COMPLETED|7 Day Wash-out||2
5251538|NCT00791661|12910021|P2|NOT COMPLETED|7 Day Wash-out||0
5251539|NCT00791661|12910022|P1|NOT COMPLETED|7 Day Wash-out||0
5251540|NCT00791661|12910020|P3|COMPLETED|7 Day Wash-out||6
5251541|NCT00791661|12910021|P2|COMPLETED|7 Day Wash-out||8
5251542|NCT00791661|12910022|P1|COMPLETED|7 Day Wash-out||8
5251543|NCT00791661|12910020|P3|STARTED|7 Day Wash-out||8
5251544|NCT00791661|12910021|P2|STARTED|7 Day Wash-out||8
5251545|NCT00791661|12910022|P1|STARTED|7 Day Wash-out||8
5251546|NCT00791661|12910020|P3|NOT COMPLETED|Period 1||0
5251547|NCT00791661|12910021|P2|NOT COMPLETED|Period 1||0
5251548|NCT00791661|12910022|P1|NOT COMPLETED|Period 1||0
5251549|NCT00791661|12910020|P3|COMPLETED|Period 1||8
5251550|NCT00791661|12910021|P2|COMPLETED|Period 1||8
5251551|NCT00791661|12910022|P1|COMPLETED|Period 1||8
5251552|NCT00791661|12910020|P3|Received Matching Placebo to MK-1006|Period 1||2
5251553|NCT00791661|12910021|P2|Received Matching Placebo to MK-1006|Period 1||2
5251554|NCT00791661|12910022|P1|Received Matching Placebo to MK-1006|Period 1||2
5251555|NCT00791661|12910020|P3|Received MK-1006|Period 1||6
5251556|NCT00791661|12910021|P2|Received MK-1006|Period 1||6
5251557|NCT00791661|12910022|P1|Received MK-1006|Period 1||6
5251558|NCT00791661|12910020|P3|STARTED|Period 1||8
5251559|NCT00791661|12910021|P2|STARTED|Period 1||8
5251560|NCT00791661|12910022|P1|STARTED|Period 1||8
5251561|NCT00791648|12910115|P2|NOT COMPLETED|Overall Study||2
5251562|NCT00791648|12910116|P1|NOT COMPLETED|Overall Study||0
5251563|NCT00791648|12910115|P2|COMPLETED|Overall Study||307
5251564|NCT00791648|12910116|P1|COMPLETED|Overall Study||308
5251565|NCT00791648|12910115|P2|STARTED|Overall Study||309
5251566|NCT00791648|12910116|P1|STARTED|Overall Study||308
5251567|NCT00791557|12910152|P1|NOT COMPLETED|Overall Study||1
5251568|NCT00791557|12910152|P1|COMPLETED|Overall Study||1
5251569|NCT00791557|12910152|P1|STARTED|Overall Study||2
5251570|NCT00791518|12910156|P1|NOT COMPLETED|Overall Study||93
5251571|NCT00791518|12910156|P1|COMPLETED|Overall Study||991
5251572|NCT00791518|12910156|P1|STARTED|Overall Study||1084
5251573|NCT00791492|12910184|P2|NOT COMPLETED|Overall Study||3
5251574|NCT00791492|12910185|P1|NOT COMPLETED|Overall Study||6
5251575|NCT00791492|12910184|P2|COMPLETED|Overall Study||38
5251576|NCT00791492|12910185|P1|COMPLETED|Overall Study||39
5251577|NCT00791492|12910184|P2|TREATED|Overall Study||41
5251578|NCT00791492|12910185|P1|TREATED|Overall Study||44
5251579|NCT00791492|12910184|P2|STARTED|Overall Study||41
5251580|NCT00791492|12910185|P1|STARTED|Overall Study||45
5251581|NCT00791479|12910233|P6|NOT COMPLETED|Overall Study||3
5251582|NCT00791479|12910234|P5|NOT COMPLETED|Overall Study||3
5251583|NCT00791479|12910235|P4|NOT COMPLETED|Overall Study||4
5251584|NCT00791479|12910236|P3|NOT COMPLETED|Overall Study||0
5251585|NCT00791479|12910237|P2|NOT COMPLETED|Overall Study||3
5251586|NCT00791479|12910238|P1|NOT COMPLETED|Overall Study||2
5251587|NCT00791479|12910233|P6|COMPLETED|Overall Study||29
5251588|NCT00791479|12910234|P5|COMPLETED|Overall Study||0
5251589|NCT00791479|12910235|P4|COMPLETED|Overall Study||25
5251590|NCT00791479|12910236|P3|COMPLETED|Overall Study||34
5251591|NCT00791479|12910237|P2|COMPLETED|Overall Study||31
5251592|NCT00791479|12910238|P1|COMPLETED|Overall Study||33
5251593|NCT00791479|12910233|P6|Received at Least One Dose of Study Drug|Overall Study||32
5251594|NCT00791479|12910234|P5|Received at Least One Dose of Study Drug|Overall Study||3
5251595|NCT00791479|12910235|P4|Received at Least One Dose of Study Drug|Overall Study||29
5251596|NCT00791479|12910236|P3|Received at Least One Dose of Study Drug|Overall Study||34
5251597|NCT00791479|12910237|P2|Received at Least One Dose of Study Drug|Overall Study||34
5251598|NCT00791479|12910238|P1|Received at Least One Dose of Study Drug|Overall Study||35
5251599|NCT00791479|12910233|P6|STARTED|Overall Study||32
5251600|NCT00791479|12910234|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
5251601|NCT00791479|12910235|P4|STARTED|Overall Study||29
5251602|NCT00791479|12910236|P3|STARTED|Overall Study||34
5251603|NCT00791479|12910237|P2|STARTED|Overall Study||34
5251604|NCT00791479|12910238|P1|STARTED|Overall Study||35
5251605|NCT00791388|12910337|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
5251606|NCT00791388|12910338|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
5251607|NCT00791388|12910339|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
5251608|NCT00791388|12910340|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
5251609|NCT00791388|12910341|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
5251610|NCT00791388|12910337|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
5251611|NCT00791388|12910338|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
5251612|NCT00791388|12910339|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
5251613|NCT00791388|12910340|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
5251614|NCT00791388|12910341|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
5251615|NCT00791388|12910337|P5|STARTED|Period 4 - 400 mg Dose Group||8
5251616|NCT00791388|12910338|P4|STARTED|Period 4 - 400 mg Dose Group||0
5251617|NCT00791388|12910339|P3|STARTED|Period 4 - 400 mg Dose Group||0
5251618|NCT00791388|12910340|P2|STARTED|Period 4 - 400 mg Dose Group||0
5251619|NCT00791388|12910341|P1|STARTED|Period 4 - 400 mg Dose Group||4
5251620|NCT00791388|12910337|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
5251621|NCT00791388|12910338|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
5251622|NCT00791388|12910339|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
5251623|NCT00791388|12910340|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
5251624|NCT00791388|12910341|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
5251625|NCT00791388|12910337|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
5251626|NCT00791388|12910338|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
5251627|NCT00791388|12910339|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
5251628|NCT00791388|12910340|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
5251629|NCT00791388|12910341|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
5251630|NCT00791388|12910337|P5|STARTED|Period 3 - 200 mg Dose Group||0
5251631|NCT00791388|12910338|P4|STARTED|Period 3 - 200 mg Dose Group||8
5251632|NCT00791388|12910339|P3|STARTED|Period 3 - 200 mg Dose Group||0
5251633|NCT00791388|12910340|P2|STARTED|Period 3 - 200 mg Dose Group||0
5251634|NCT00791388|12910341|P1|STARTED|Period 3 - 200 mg Dose Group||3
5251635|NCT00791388|12910337|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
5251636|NCT00791388|12910338|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
5251637|NCT00791388|12910339|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
5251638|NCT00791388|12910340|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
5251639|NCT00791388|12910341|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
5251640|NCT00791388|12910337|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
5251641|NCT00791388|12910338|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
5251642|NCT00791388|12910339|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
5251643|NCT00791388|12910340|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
5251644|NCT00791388|12910341|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
5251645|NCT00791388|12910337|P5|STARTED|Period 2 - 100 mg Dose Group||0
5251646|NCT00791388|12910338|P4|STARTED|Period 2 - 100 mg Dose Group||0
5251647|NCT00791388|12910339|P3|STARTED|Period 2 - 100 mg Dose Group||8
5251648|NCT00791388|12910340|P2|STARTED|Period 2 - 100 mg Dose Group||0
5251649|NCT00791388|12910341|P1|STARTED|Period 2 - 100 mg Dose Group||3
5251650|NCT00791388|12910337|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
5251651|NCT00791388|12910338|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
5251652|NCT00791388|12910339|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
5251653|NCT00791388|12910340|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
5251654|NCT00791388|12910341|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
5251655|NCT00791388|12910337|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
5251656|NCT00791388|12910338|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
5251657|NCT00791388|12910339|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
5251658|NCT00791388|12910340|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
5251659|NCT00791388|12910341|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
5251660|NCT00791388|12910337|P5|STARTED|Period 1 - 50 mg Dose Group||0
5251661|NCT00791388|12910338|P4|STARTED|Period 1 - 50 mg Dose Group||0
5251662|NCT00791388|12910339|P3|STARTED|Period 1 - 50 mg Dose Group||0
5251663|NCT00791388|12910340|P2|STARTED|Period 1 - 50 mg Dose Group||8
5251664|NCT00791388|12910341|P1|STARTED|Period 1 - 50 mg Dose Group||3
5251665|NCT00791336|12910368|P1|NOT COMPLETED|Overall Study||0
5251666|NCT00791336|12910368|P1|COMPLETED|Overall Study||1
5251667|NCT00791336|12910368|P1|STARTED|Overall Study||1
5251668|NCT00791323|12910376|P2|NOT COMPLETED|Overall Study||0
5251669|NCT00791323|12910377|P1|NOT COMPLETED|Overall Study||0
5251670|NCT00791323|12910376|P2|COMPLETED|Overall Study||3
5251671|NCT00791323|12910377|P1|COMPLETED|Overall Study||6
5251672|NCT00791323|12910376|P2|STARTED|Overall Study||3
5251673|NCT00791323|12910377|P1|STARTED|Overall Study||6
5251674|NCT00791258|12910383|P1|NOT COMPLETED|Overall Study||263
5251675|NCT00791258|12910383|P1|COMPLETED|Overall Study||736
5251676|NCT00791258|12910383|P1|STARTED|Overall Study||999
5251677|NCT00791128|12910445|P1|NOT COMPLETED|Overall Study||9
5251678|NCT00791128|12910445|P1|COMPLETED|Overall Study||13
5251679|NCT00791128|12910445|P1|STARTED|Overall Study||22
5251680|NCT00791102|12910450|P2|NOT COMPLETED|Period 2||0
5251681|NCT00791102|12910451|P1|NOT COMPLETED|Period 2||0
5251682|NCT00791102|12910450|P2|COMPLETED|Period 2||10
5251683|NCT00791102|12910451|P1|COMPLETED|Period 2||10
5251684|NCT00791102|12910450|P2|STARTED|Period 2||10
5251685|NCT00791102|12910451|P1|STARTED|Period 2||10
5251686|NCT00791102|12910450|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5251687|NCT00791102|12910451|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5251688|NCT00791102|12910450|P2|COMPLETED|Washout Period of 2 Weeks||10
5251689|NCT00791102|12910451|P1|COMPLETED|Washout Period of 2 Weeks||10
5251690|NCT00791102|12910450|P2|STARTED|Washout Period of 2 Weeks||10
5251691|NCT00791102|12910451|P1|STARTED|Washout Period of 2 Weeks||10
5251692|NCT00791102|12910450|P2|NOT COMPLETED|Period 1||0
5251693|NCT00791102|12910451|P1|NOT COMPLETED|Period 1||0
5251694|NCT00791102|12910450|P2|COMPLETED|Period 1||10
5251695|NCT00791102|12910451|P1|COMPLETED|Period 1||10
5251696|NCT00791102|12910450|P2|STARTED|Period 1||10
5251697|NCT00791102|12910451|P1|STARTED|Period 1||10
5251698|NCT00791089|12910469|P2|NOT COMPLETED|Overall Study||6
5251699|NCT00791089|12910470|P1|NOT COMPLETED|Overall Study||6
5251700|NCT00791089|12910469|P2|COMPLETED|Overall Study||0
5251701|NCT00791089|12910470|P1|COMPLETED|Overall Study||0
5251702|NCT00791089|12910469|P2|Six-month Data Collected|Overall Study||5
5251703|NCT00791089|12910470|P1|Six-month Data Collected|Overall Study||6
5251704|NCT00791089|12910469|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
5251705|NCT00791089|12910470|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
5251706|NCT00791089|12910469|P2|STARTED|Overall Study||6
5251707|NCT00791089|12910470|P1|STARTED|Overall Study||6
5251708|NCT00791076|12910476|P1|NOT COMPLETED|Overall Study||8
5251709|NCT00791076|12910476|P1|COMPLETED|Overall Study||0
5251710|NCT00791076|12910476|P1|STARTED|Overall Study||8
5251711|NCT00791037|12910484|P1|NOT COMPLETED|Overall Study||0
5251712|NCT00791037|12910484|P1|COMPLETED|Overall Study||23
5251713|NCT00791037|12910484|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
5251714|NCT00791037|12910484|P1|Primary Outcome|Overall Study||19
5251715|NCT00791037|12910484|P1|STARTED|Overall Study||23
5251716|NCT00790933|12910496|P5|NOT COMPLETED|Overall Study||276
5251717|NCT00790933|12910497|P4|NOT COMPLETED|Overall Study||14
5251718|NCT00790933|12910498|P3|NOT COMPLETED|Overall Study||269
5251719|NCT00790933|12910499|P2|NOT COMPLETED|Overall Study||480
5251720|NCT00790933|12910500|P1|NOT COMPLETED|Overall Study||438
5251721|NCT00790933|12910496|P5|COMPLETED|Overall Study||145
5251722|NCT00790933|12910497|P4|COMPLETED|Overall Study||23
5251723|NCT00790933|12910498|P3|COMPLETED|Overall Study||115
5251724|NCT00790933|12910499|P2|COMPLETED|Overall Study||246
5251725|NCT00790933|12910500|P1|COMPLETED|Overall Study||237
5251726|NCT00790933|12910496|P5|STARTED|Overall Study||421
5251727|NCT00790933|12910497|P4|STARTED|Overall Study||37
5251728|NCT00790933|12910498|P3|STARTED|Overall Study||384
5251729|NCT00790933|12910499|P2|STARTED|Overall Study||726
5251730|NCT00790933|12910500|P1|STARTED|Overall Study||675
5251731|NCT00790907|12911031|P3|NOT COMPLETED|Overall Study||339
5251732|NCT00790907|12911032|P2|NOT COMPLETED|Overall Study||340
5251733|NCT00790907|12911033|P1|NOT COMPLETED|Overall Study||455
5251734|NCT00790907|12911031|P3|COMPLETED|Overall Study||663
5251735|NCT00790907|12911032|P2|COMPLETED|Overall Study||684
5251736|NCT00790907|12911033|P1|COMPLETED|Overall Study||754
5251737|NCT00790907|12911031|P3|STARTED|Overall Study||1002
5251738|NCT00790907|12911032|P2|STARTED|Overall Study||1024
5251739|NCT00790907|12911033|P1|STARTED|Overall Study||1209
5251740|NCT00790868|12911056|P2|NOT COMPLETED|Overall Study||17
5251741|NCT00790868|12911057|P1|NOT COMPLETED|Overall Study||6
5251742|NCT00790868|12911056|P2|COMPLETED|Overall Study||75
5251743|NCT00790868|12911057|P1|COMPLETED|Overall Study||82
5251744|NCT00790868|12911056|P2|STARTED|Overall Study||92
5251745|NCT00790868|12911057|P1|STARTED|Overall Study||88
5251746|NCT00790855|12911071|P1|NOT COMPLETED|Overall Study||0
5251747|NCT00790855|12911071|P1|COMPLETED|Overall Study||25
5251748|NCT00790855|12911071|P1|STARTED|Overall Study||25
5251749|NCT00790842|12911079|P11|NOT COMPLETED|Expansion Cohort||0
5251750|NCT00790842|12911080|P10|NOT COMPLETED|Expansion Cohort||0
5251751|NCT00790842|12911081|P9|NOT COMPLETED|Expansion Cohort||0
5251752|NCT00790842|12911082|P8|NOT COMPLETED|Expansion Cohort||0
5251753|NCT00790842|12911083|P7|NOT COMPLETED|Expansion Cohort||1
5251754|NCT00790842|12911084|P6|NOT COMPLETED|Expansion Cohort||0
5251755|NCT00790842|12911085|P5|NOT COMPLETED|Expansion Cohort||0
5251756|NCT00790842|12911086|P4|NOT COMPLETED|Expansion Cohort||0
5251757|NCT00790842|12911087|P3|NOT COMPLETED|Expansion Cohort||7
5251758|NCT00790842|12911088|P2|NOT COMPLETED|Expansion Cohort||0
5251759|NCT00790842|12911089|P1|NOT COMPLETED|Expansion Cohort||0
5251760|NCT00790842|12911079|P11|COMPLETED|Expansion Cohort||0
5251761|NCT00790842|12911080|P10|COMPLETED|Expansion Cohort||0
5251762|NCT00790842|12911081|P9|COMPLETED|Expansion Cohort||0
5251763|NCT00790842|12911082|P8|COMPLETED|Expansion Cohort||0
5251764|NCT00790842|12911083|P7|COMPLETED|Expansion Cohort||1
5251765|NCT00790842|12911084|P6|COMPLETED|Expansion Cohort||0
5251766|NCT00790842|12911085|P5|COMPLETED|Expansion Cohort||0
5251767|NCT00790842|12911086|P4|COMPLETED|Expansion Cohort||0
5251768|NCT00790842|12911087|P3|COMPLETED|Expansion Cohort||7
5251769|NCT00790842|12911088|P2|COMPLETED|Expansion Cohort||0
5251770|NCT00790842|12911089|P1|COMPLETED|Expansion Cohort||0
5251771|NCT00790842|12911079|P11|Began Treatment|Expansion Cohort||0
5251772|NCT00790842|12911080|P10|Began Treatment|Expansion Cohort||0
5251773|NCT00790842|12911081|P9|Began Treatment|Expansion Cohort||0
5251774|NCT00790842|12911082|P8|Began Treatment|Expansion Cohort||0
5251775|NCT00790842|12911083|P7|Began Treatment|Expansion Cohort||2
5251776|NCT00790842|12911084|P6|Began Treatment|Expansion Cohort||0
5251777|NCT00790842|12911085|P5|Began Treatment|Expansion Cohort||0
5251778|NCT00790842|12911086|P4|Began Treatment|Expansion Cohort||0
5251779|NCT00790842|12911087|P3|Began Treatment|Expansion Cohort||14
5251780|NCT00790842|12911088|P2|Began Treatment|Expansion Cohort||0
5251781|NCT00790842|12911089|P1|Began Treatment|Expansion Cohort||0
5251782|NCT00790842|12911079|P11|STARTED|Expansion Cohort||0
5251783|NCT00790842|12911080|P10|STARTED|Expansion Cohort||0
5251784|NCT00790842|12911081|P9|STARTED|Expansion Cohort||0
5251785|NCT00790842|12911082|P8|STARTED|Expansion Cohort||0
5251786|NCT00790842|12911083|P7|STARTED|Expansion Cohort||2
5251787|NCT00790842|12911084|P6|STARTED|Expansion Cohort||0
5251788|NCT00790842|12911085|P5|STARTED|Expansion Cohort||0
5251789|NCT00790842|12911086|P4|STARTED|Expansion Cohort||0
5251790|NCT00790842|12911087|P3|STARTED|Expansion Cohort||14
5251791|NCT00790842|12911088|P2|STARTED|Expansion Cohort||0
5251792|NCT00790842|12911089|P1|STARTED|Expansion Cohort||0
5251793|NCT00790842|12911079|P11|NOT COMPLETED|Dose Level 4||2
5251794|NCT00790842|12911080|P10|NOT COMPLETED|Dose Level 4||0
5251795|NCT00790842|12911081|P9|NOT COMPLETED|Dose Level 4||0
5251796|NCT00790842|12911082|P8|NOT COMPLETED|Dose Level 4||0
5251797|NCT00790842|12911083|P7|NOT COMPLETED|Dose Level 4||2
5251798|NCT00790842|12911084|P6|NOT COMPLETED|Dose Level 4||0
5251799|NCT00790842|12911085|P5|NOT COMPLETED|Dose Level 4||0
5251800|NCT00790842|12911086|P4|NOT COMPLETED|Dose Level 4||0
5251801|NCT00790842|12911087|P3|NOT COMPLETED|Dose Level 4||0
5251802|NCT00790842|12911088|P2|NOT COMPLETED|Dose Level 4||0
5251803|NCT00790842|12911089|P1|NOT COMPLETED|Dose Level 4||0
5251804|NCT00790842|12911079|P11|COMPLETED|Dose Level 4||3
5251805|NCT00790842|12911080|P10|COMPLETED|Dose Level 4||0
5251806|NCT00790842|12911081|P9|COMPLETED|Dose Level 4||0
5251807|NCT00790842|12911082|P8|COMPLETED|Dose Level 4||0
5251808|NCT00790842|12911083|P7|COMPLETED|Dose Level 4||6
5251809|NCT00790842|12911084|P6|COMPLETED|Dose Level 4||0
5251810|NCT00790842|12911085|P5|COMPLETED|Dose Level 4||0
5251811|NCT00790842|12911086|P4|COMPLETED|Dose Level 4||0
5251812|NCT00790842|12911087|P3|COMPLETED|Dose Level 4||0
5251813|NCT00790842|12911088|P2|COMPLETED|Dose Level 4||0
5251814|NCT00790842|12911089|P1|COMPLETED|Dose Level 4||0
5251815|NCT00790842|12911079|P11|Began Treatment|Dose Level 4||5
5251816|NCT00790842|12911080|P10|Began Treatment|Dose Level 4||0
5251817|NCT00790842|12911081|P9|Began Treatment|Dose Level 4||0
5251818|NCT00790842|12911082|P8|Began Treatment|Dose Level 4||0
5251819|NCT00790842|12911083|P7|Began Treatment|Dose Level 4||8
5251820|NCT00790842|12911084|P6|Began Treatment|Dose Level 4||0
5251821|NCT00790842|12911085|P5|Began Treatment|Dose Level 4||0
5251822|NCT00790842|12911086|P4|Began Treatment|Dose Level 4||0
5251823|NCT00790842|12911087|P3|Began Treatment|Dose Level 4||0
5251824|NCT00790842|12911088|P2|Began Treatment|Dose Level 4||0
5251825|NCT00790842|12911089|P1|Began Treatment|Dose Level 4||0
5251826|NCT00790842|12911079|P11|STARTED|Dose Level 4||5
5251827|NCT00790842|12911080|P10|STARTED|Dose Level 4||0
5251828|NCT00790842|12911081|P9|STARTED|Dose Level 4||0
5251829|NCT00790842|12911082|P8|STARTED|Dose Level 4||0
5251830|NCT00790842|12911083|P7|STARTED|Dose Level 4||8
5251831|NCT00790842|12911084|P6|STARTED|Dose Level 4||0
5251832|NCT00790842|12911085|P5|STARTED|Dose Level 4||0
5251833|NCT00790842|12911086|P4|STARTED|Dose Level 4||0
5251834|NCT00790842|12911087|P3|STARTED|Dose Level 4||0
5251835|NCT00790842|12911088|P2|STARTED|Dose Level 4||0
5251836|NCT00790842|12911089|P1|STARTED|Dose Level 4||0
5251837|NCT00790842|12911079|P11|NOT COMPLETED|Dose Level 3||0
5251838|NCT00790842|12911080|P10|NOT COMPLETED|Dose Level 3||2
5251839|NCT00790842|12911081|P9|NOT COMPLETED|Dose Level 3||0
5251840|NCT00790842|12911082|P8|NOT COMPLETED|Dose Level 3||0
5251841|NCT00790842|12911083|P7|NOT COMPLETED|Dose Level 3||0
5251842|NCT00790842|12911084|P6|NOT COMPLETED|Dose Level 3||1
5251843|NCT00790842|12911085|P5|NOT COMPLETED|Dose Level 3||0
5251844|NCT00790842|12911086|P4|NOT COMPLETED|Dose Level 3||0
5251845|NCT00790842|12911087|P3|NOT COMPLETED|Dose Level 3||5
5251846|NCT00790842|12911088|P2|NOT COMPLETED|Dose Level 3||0
5251847|NCT00790842|12911089|P1|NOT COMPLETED|Dose Level 3||0
5251848|NCT00790842|12911079|P11|COMPLETED|Dose Level 3||0
5251849|NCT00790842|12911080|P10|COMPLETED|Dose Level 3||1
5251850|NCT00790842|12911081|P9|COMPLETED|Dose Level 3||0
5251851|NCT00790842|12911082|P8|COMPLETED|Dose Level 3||0
5251852|NCT00790842|12911083|P7|COMPLETED|Dose Level 3||0
5251853|NCT00790842|12911084|P6|COMPLETED|Dose Level 3||2
5251854|NCT00790842|12911085|P5|COMPLETED|Dose Level 3||0
5251855|NCT00790842|12911086|P4|COMPLETED|Dose Level 3||0
5251856|NCT00790842|12911087|P3|COMPLETED|Dose Level 3||2
5251857|NCT00790842|12911088|P2|COMPLETED|Dose Level 3||0
5251858|NCT00790842|12911089|P1|COMPLETED|Dose Level 3||0
5251859|NCT00790842|12911079|P11|Began Treatment|Dose Level 3||0
5251860|NCT00790842|12911080|P10|Began Treatment|Dose Level 3||3
5251861|NCT00790842|12911081|P9|Began Treatment|Dose Level 3||0
5251862|NCT00790842|12911082|P8|Began Treatment|Dose Level 3||0
5251863|NCT00790842|12911083|P7|Began Treatment|Dose Level 3||0
5251864|NCT00790842|12911084|P6|Began Treatment|Dose Level 3||3
5251865|NCT00790842|12911085|P5|Began Treatment|Dose Level 3||0
5251866|NCT00790842|12911086|P4|Began Treatment|Dose Level 3||0
5251867|NCT00790842|12911087|P3|Began Treatment|Dose Level 3||6
5251868|NCT00790842|12911088|P2|Began Treatment|Dose Level 3||0
5251869|NCT00790842|12911089|P1|Began Treatment|Dose Level 3||0
5251870|NCT00790842|12911079|P11|STARTED|Dose Level 3||0
5251871|NCT00790842|12911080|P10|STARTED|Dose Level 3||3
5251872|NCT00790842|12911081|P9|STARTED|Dose Level 3||0
5251873|NCT00790842|12911082|P8|STARTED|Dose Level 3||0
5251874|NCT00790842|12911083|P7|STARTED|Dose Level 3||0
5251875|NCT00790842|12911084|P6|STARTED|Dose Level 3||3
5251876|NCT00790842|12911085|P5|STARTED|Dose Level 3||0
5251877|NCT00790842|12911086|P4|STARTED|Dose Level 3||0
5251878|NCT00790842|12911087|P3|STARTED|Dose Level 3||7
5251879|NCT00790842|12911088|P2|STARTED|Dose Level 3||0
5251880|NCT00790842|12911089|P1|STARTED|Dose Level 3||0
5251881|NCT00790842|12911079|P11|NOT COMPLETED|Dose Level 2||0
5251882|NCT00790842|12911080|P10|NOT COMPLETED|Dose Level 2||0
5251883|NCT00790842|12911081|P9|NOT COMPLETED|Dose Level 2||2
5251884|NCT00790842|12911082|P8|NOT COMPLETED|Dose Level 2||0
5251885|NCT00790842|12911083|P7|NOT COMPLETED|Dose Level 2||0
5251886|NCT00790842|12911084|P6|NOT COMPLETED|Dose Level 2||0
5251887|NCT00790842|12911085|P5|NOT COMPLETED|Dose Level 2||1
5251888|NCT00790842|12911086|P4|NOT COMPLETED|Dose Level 2||0
5251889|NCT00790842|12911087|P3|NOT COMPLETED|Dose Level 2||0
5251890|NCT00790842|12911088|P2|NOT COMPLETED|Dose Level 2||3
5251891|NCT00790842|12911089|P1|NOT COMPLETED|Dose Level 2||0
5251892|NCT00790842|12911079|P11|COMPLETED|Dose Level 2||0
5251893|NCT00790842|12911080|P10|COMPLETED|Dose Level 2||0
5251894|NCT00790842|12911081|P9|COMPLETED|Dose Level 2||1
5251895|NCT00790842|12911082|P8|COMPLETED|Dose Level 2||0
5251896|NCT00790842|12911083|P7|COMPLETED|Dose Level 2||0
5251897|NCT00790842|12911084|P6|COMPLETED|Dose Level 2||0
5251898|NCT00790842|12911085|P5|COMPLETED|Dose Level 2||2
5251899|NCT00790842|12911086|P4|COMPLETED|Dose Level 2||0
5251900|NCT00790842|12911087|P3|COMPLETED|Dose Level 2||0
5251901|NCT00790842|12911088|P2|COMPLETED|Dose Level 2||0
5251902|NCT00790842|12911089|P1|COMPLETED|Dose Level 2||0
5251903|NCT00790842|12911079|P11|Began Treatment|Dose Level 2||0
5251904|NCT00790842|12911080|P10|Began Treatment|Dose Level 2||0
5251905|NCT00790842|12911081|P9|Began Treatment|Dose Level 2||3
5251906|NCT00790842|12911082|P8|Began Treatment|Dose Level 2||0
5251907|NCT00790842|12911083|P7|Began Treatment|Dose Level 2||0
5251908|NCT00790842|12911084|P6|Began Treatment|Dose Level 2||0
5251909|NCT00790842|12911085|P5|Began Treatment|Dose Level 2||3
5251910|NCT00790842|12911086|P4|Began Treatment|Dose Level 2||0
5251911|NCT00790842|12911087|P3|Began Treatment|Dose Level 2||0
5251912|NCT00790842|12911088|P2|Began Treatment|Dose Level 2||3
5251913|NCT00790842|12911089|P1|Began Treatment|Dose Level 2||0
5251914|NCT00790842|12911079|P11|STARTED|Dose Level 2||0
5251915|NCT00790842|12911080|P10|STARTED|Dose Level 2||0
5251916|NCT00790842|12911081|P9|STARTED|Dose Level 2||3
5251917|NCT00790842|12911082|P8|STARTED|Dose Level 2||0
5251918|NCT00790842|12911083|P7|STARTED|Dose Level 2||0
5251919|NCT00790842|12911084|P6|STARTED|Dose Level 2||0
5251920|NCT00790842|12911085|P5|STARTED|Dose Level 2||3
5251921|NCT00790842|12911086|P4|STARTED|Dose Level 2||0
5251922|NCT00790842|12911087|P3|STARTED|Dose Level 2||0
5251923|NCT00790842|12911088|P2|STARTED|Dose Level 2||3
5251924|NCT00790842|12911089|P1|STARTED|Dose Level 2||0
5251925|NCT00790842|12911079|P11|NOT COMPLETED|Dose Level 1||0
5251926|NCT00790842|12911080|P10|NOT COMPLETED|Dose Level 1||0
5251927|NCT00790842|12911081|P9|NOT COMPLETED|Dose Level 1||0
5251928|NCT00790842|12911082|P8|NOT COMPLETED|Dose Level 1||2
5251929|NCT00790842|12911083|P7|NOT COMPLETED|Dose Level 1||0
5251930|NCT00790842|12911084|P6|NOT COMPLETED|Dose Level 1||0
5251931|NCT00790842|12911085|P5|NOT COMPLETED|Dose Level 1||0
5251932|NCT00790842|12911086|P4|NOT COMPLETED|Dose Level 1||2
5251933|NCT00790842|12911087|P3|NOT COMPLETED|Dose Level 1||0
5251934|NCT00790842|12911088|P2|NOT COMPLETED|Dose Level 1||0
5251935|NCT00790842|12911089|P1|NOT COMPLETED|Dose Level 1||3
5251936|NCT00790842|12911079|P11|COMPLETED|Dose Level 1||0
5251937|NCT00790842|12911080|P10|COMPLETED|Dose Level 1||0
5251938|NCT00790842|12911081|P9|COMPLETED|Dose Level 1||0
5251939|NCT00790842|12911082|P8|COMPLETED|Dose Level 1||1
5251940|NCT00790842|12911083|P7|COMPLETED|Dose Level 1||0
5251941|NCT00790842|12911084|P6|COMPLETED|Dose Level 1||0
5251942|NCT00790842|12911085|P5|COMPLETED|Dose Level 1||0
5251943|NCT00790842|12911086|P4|COMPLETED|Dose Level 1||1
5251944|NCT00790842|12911087|P3|COMPLETED|Dose Level 1||0
5251945|NCT00790842|12911088|P2|COMPLETED|Dose Level 1||0
5251946|NCT00790842|12911089|P1|COMPLETED|Dose Level 1||3
5251947|NCT00790842|12911079|P11|Began Treatment|Dose Level 1||0
5251948|NCT00790842|12911080|P10|Began Treatment|Dose Level 1||0
5251949|NCT00790842|12911081|P9|Began Treatment|Dose Level 1||0
5251950|NCT00790842|12911082|P8|Began Treatment|Dose Level 1||3
5251951|NCT00790842|12911083|P7|Began Treatment|Dose Level 1||0
5251952|NCT00790842|12911084|P6|Began Treatment|Dose Level 1||0
5251953|NCT00790842|12911085|P5|Began Treatment|Dose Level 1||0
5251954|NCT00790842|12911086|P4|Began Treatment|Dose Level 1||3
5251955|NCT00790842|12911087|P3|Began Treatment|Dose Level 1||0
5251956|NCT00790842|12911088|P2|Began Treatment|Dose Level 1||0
5251957|NCT00790842|12911089|P1|Began Treatment|Dose Level 1||6
5251958|NCT00790842|12911079|P11|STARTED|Dose Level 1||0
5251959|NCT00790842|12911080|P10|STARTED|Dose Level 1||0
5251960|NCT00790842|12911081|P9|STARTED|Dose Level 1||0
5251961|NCT00790842|12911082|P8|STARTED|Dose Level 1||3
5251962|NCT00790842|12911083|P7|STARTED|Dose Level 1||0
5251963|NCT00790842|12911084|P6|STARTED|Dose Level 1||0
5251964|NCT00790842|12911085|P5|STARTED|Dose Level 1||0
5251965|NCT00790842|12911086|P4|STARTED|Dose Level 1||3
5251966|NCT00790842|12911087|P3|STARTED|Dose Level 1||0
5251967|NCT00790842|12911088|P2|STARTED|Dose Level 1||0
5251968|NCT00790842|12911089|P1|STARTED|Dose Level 1||6
5251969|NCT00790803|12911146|P1|NOT COMPLETED|Overall Study||0
5251970|NCT00790803|12911146|P1|COMPLETED|Overall Study||5
5251971|NCT00790803|12911146|P1|STARTED|Overall Study||5
5251972|NCT00790790|12911157|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
5251973|NCT00790790|12911158|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
5251974|NCT00790790|12911159|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
5251975|NCT00790790|12911157|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
5251976|NCT00790790|12911158|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
5251977|NCT00790790|12911159|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
5251978|NCT00790790|12911157|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
5251979|NCT00790790|12911158|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
5251980|NCT00790790|12911159|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
5251981|NCT00790790|12911157|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
5251982|NCT00790790|12911158|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
5251983|NCT00790790|12911159|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
5251984|NCT00790790|12911157|P3|COMPLETED|Study Period 2: Therapy Phase||27
5251985|NCT00790790|12911158|P2|COMPLETED|Study Period 2: Therapy Phase||32
5251986|NCT00790790|12911159|P1|COMPLETED|Study Period 2: Therapy Phase||37
5251987|NCT00790790|12911157|P3|STARTED|Study Period 2: Therapy Phase||48
5251988|NCT00790790|12911158|P2|STARTED|Study Period 2: Therapy Phase||50
5251989|NCT00790790|12911159|P1|STARTED|Study Period 2: Therapy Phase||49
5251990|NCT00790751|12911236|P4|NOT COMPLETED|Overall Study||21
5251991|NCT00790751|12911237|P3|NOT COMPLETED|Overall Study||20
5251992|NCT00790751|12911238|P2|NOT COMPLETED|Overall Study||30
5251993|NCT00790751|12911239|P1|NOT COMPLETED|Overall Study||25
5251994|NCT00790751|12911236|P4|COMPLETED|Overall Study||141
5251995|NCT00790751|12911237|P3|COMPLETED|Overall Study||141
5251996|NCT00790751|12911238|P2|COMPLETED|Overall Study||131
5251997|NCT00790751|12911239|P1|COMPLETED|Overall Study||137
5251998|NCT00790751|12911236|P4|STARTED|Overall Study||162
5251999|NCT00790751|12911237|P3|STARTED|Overall Study||161
5252000|NCT00790751|12911238|P2|STARTED|Overall Study||161
5252001|NCT00790751|12911239|P1|STARTED|Overall Study||162
5252002|NCT00790738|12911259|P2|NOT COMPLETED|Overall Study||3
5252003|NCT00790738|12911260|P1|NOT COMPLETED|Overall Study||2
5252004|NCT00790738|12911259|P2|COMPLETED|Overall Study||3
5252005|NCT00790738|12911260|P1|COMPLETED|Overall Study||3
5252006|NCT00790738|12911259|P2|STARTED|Overall Study||6
5252007|NCT00790738|12911260|P1|STARTED|Overall Study||5
5252008|NCT00790673|12911274|P4|NOT COMPLETED|Overall Study||0
5252009|NCT00790673|12911275|P3|NOT COMPLETED|Overall Study||0
5252010|NCT00790673|12911276|P2|NOT COMPLETED|Overall Study||0
5252011|NCT00790673|12911277|P1|NOT COMPLETED|Overall Study||0
5252012|NCT00790673|12911274|P4|COMPLETED|Overall Study||8
5252013|NCT00790673|12911275|P3|COMPLETED|Overall Study||12
5252014|NCT00790673|12911276|P2|COMPLETED|Overall Study||6
5252015|NCT00790673|12911277|P1|COMPLETED|Overall Study||6
5252016|NCT00790673|12911274|P4|STARTED|Overall Study||8
5252017|NCT00790673|12911275|P3|STARTED|Overall Study||12
5252018|NCT00790673|12911276|P2|STARTED|Overall Study||6
5252019|NCT00790673|12911277|P1|STARTED|Overall Study||6
5252020|NCT00790647|12911287|P1|NOT COMPLETED|Overall Study||1
5252021|NCT00790647|12911287|P1|COMPLETED|Overall Study||9
5252022|NCT00790647|12911287|P1|STARTED|Overall Study||10
5252023|NCT00790569|12911297|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
5252024|NCT00790569|12911298|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
5252025|NCT00790569|12911299|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
5252026|NCT00790569|12911297|P3|COMPLETED|End of Study (12 Month Interview)||83
5252027|NCT00790569|12911298|P2|COMPLETED|End of Study (12 Month Interview)||26
5252028|NCT00790569|12911299|P1|COMPLETED|End of Study (12 Month Interview)||71
5252029|NCT00790569|12911297|P3|STARTED|End of Study (12 Month Interview)||133
5252030|NCT00790569|12911298|P2|STARTED|End of Study (12 Month Interview)||45
5252031|NCT00790569|12911299|P1|STARTED|End of Study (12 Month Interview)||137
5252032|NCT00790569|12911297|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
5252033|NCT00790569|12911298|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
5252034|NCT00790569|12911299|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
5252035|NCT00790569|12911297|P3|COMPLETED|End of Treatment (6 Month Interview)||107
5252036|NCT00790569|12911298|P2|COMPLETED|End of Treatment (6 Month Interview)||35
5252037|NCT00790569|12911299|P1|COMPLETED|End of Treatment (6 Month Interview)||115
5252038|NCT00790569|12911297|P3|STARTED|End of Treatment (6 Month Interview)||133
5252039|NCT00790569|12911298|P2|STARTED|End of Treatment (6 Month Interview)||45
5252040|NCT00790569|12911299|P1|STARTED|End of Treatment (6 Month Interview)||137
5252041|NCT00790556|12911340|P2|NOT COMPLETED|Treatment Period 2||0
5252042|NCT00790556|12911341|P1|NOT COMPLETED|Treatment Period 2||0
5252043|NCT00790556|12911340|P2|COMPLETED|Treatment Period 2||6
5252044|NCT00790556|12911341|P1|COMPLETED|Treatment Period 2||6
5252045|NCT00790556|12911340|P2|STARTED|Treatment Period 2||6
5252046|NCT00790556|12911341|P1|STARTED|Treatment Period 2||6
5252047|NCT00790556|12911340|P2|NOT COMPLETED|Washout After Period 1||0
5252048|NCT00790556|12911341|P1|NOT COMPLETED|Washout After Period 1||0
5252049|NCT00790556|12911340|P2|COMPLETED|Washout After Period 1||6
5252050|NCT00790556|12911341|P1|COMPLETED|Washout After Period 1||6
5252051|NCT00790556|12911340|P2|STARTED|Washout After Period 1||6
5252052|NCT00790556|12911341|P1|STARTED|Washout After Period 1||6
5252053|NCT00790556|12911340|P2|NOT COMPLETED|Treatment Period 1||0
5252054|NCT00790556|12911341|P1|NOT COMPLETED|Treatment Period 1||2
5252055|NCT00790556|12911340|P2|COMPLETED|Treatment Period 1||6
5252056|NCT00790556|12911341|P1|COMPLETED|Treatment Period 1||6
5252057|NCT00790556|12911340|P2|STARTED|Treatment Period 1||6
5252058|NCT00790556|12911341|P1|STARTED|Treatment Period 1||8
5252059|NCT00790452|12911353|P2|NOT COMPLETED|Overall Study||0
5252060|NCT00790452|12911354|P1|NOT COMPLETED|Overall Study||1
5252061|NCT00790452|12911353|P2|COMPLETED|Overall Study||0
5252062|NCT00790452|12911354|P1|COMPLETED|Overall Study||0
5252063|NCT00790452|12911353|P2|STARTED|Overall Study||0
5252064|NCT00790452|12911354|P1|STARTED|Overall Study||1
5252065|NCT00790400|12911362|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
5252066|NCT00790400|12911363|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
5252067|NCT00790400|12911362|P2|COMPLETED|Everolimus Period (Core or Extension)||0
5252068|NCT00790400|12911363|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
5252069|NCT00790400|12911362|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
5252070|NCT00790400|12911363|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
5252071|NCT00790400|12911362|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
5252072|NCT00790400|12911363|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
5252073|NCT00790400|12911362|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
5252074|NCT00790400|12911363|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
5252075|NCT00790400|12911362|P2|STARTED|Double-blind Period (Core Phase)||39
5252076|NCT00790400|12911363|P1|STARTED|Double-blind Period (Core Phase)||79
5252077|NCT00790335|12911392|P2|NOT COMPLETED|Overall Study||112
5252078|NCT00790335|12911393|P1|NOT COMPLETED|Overall Study||80
5252079|NCT00790335|12911392|P2|COMPLETED|Overall Study||243
5252080|NCT00790335|12911393|P1|COMPLETED|Overall Study||257
5252081|NCT00790335|12911392|P2|STARTED|Overall Study||355
5252082|NCT00790335|12911393|P1|STARTED|Overall Study||337
5252083|NCT00790296|12911453|P2|NOT COMPLETED|Overall Study||2
5252084|NCT00790296|12911454|P1|NOT COMPLETED|Overall Study||1
5252085|NCT00790296|12911453|P2|COMPLETED|Overall Study||4
5252086|NCT00790296|12911454|P1|COMPLETED|Overall Study||4
5252087|NCT00790296|12911453|P2|STARTED|Overall Study||6
5252088|NCT00790296|12911454|P1|STARTED|Overall Study||5
5252089|NCT00790270|12911463|P3|NOT COMPLETED|Overall Study||0
5252090|NCT00790270|12911464|P2|NOT COMPLETED|Overall Study||0
5252091|NCT00790270|12911465|P1|NOT COMPLETED|Overall Study||0
5252092|NCT00790270|12911463|P3|COMPLETED|Overall Study||20
5252093|NCT00790270|12911464|P2|COMPLETED|Overall Study||20
5252094|NCT00790270|12911465|P1|COMPLETED|Overall Study||21
5252095|NCT00790270|12911463|P3|STARTED|Overall Study||20
5252096|NCT00790270|12911464|P2|STARTED|Overall Study||20
5252097|NCT00790270|12911465|P1|STARTED|Overall Study||21
5252098|NCT00790218|12911476|P3|NOT COMPLETED|Overall Study||0
5252099|NCT00790218|12911477|P2|NOT COMPLETED|Overall Study||0
5252100|NCT00790218|12911478|P1|NOT COMPLETED|Overall Study||1
5252101|NCT00790218|12911476|P3|COMPLETED|Overall Study||7
5252102|NCT00790218|12911477|P2|COMPLETED|Overall Study||6
5252103|NCT00790218|12911478|P1|COMPLETED|Overall Study||5
5252104|NCT00790218|12911476|P3|STARTED|Overall Study||7
5252105|NCT00790218|12911477|P2|STARTED|Overall Study||6
5252106|NCT00790218|12911478|P1|STARTED|Overall Study||6
5252107|NCT00790205|12911488|P2|NOT COMPLETED|Overall Study||434
5252108|NCT00790205|12911489|P1|NOT COMPLETED|Overall Study||360
5252109|NCT00790205|12911488|P2|COMPLETED|Overall Study||6905
5252110|NCT00790205|12911489|P1|COMPLETED|Overall Study||6972
5252111|NCT00790205|12911488|P2|Treated|Overall Study||7274
5252112|NCT00790205|12911489|P1|Treated|Overall Study||7266
5252113|NCT00790205|12911488|P2|STARTED|Overall Study||7339
5252114|NCT00790205|12911489|P1|STARTED|Overall Study||7332
5252115|NCT00790192|12911533|P4|NOT COMPLETED|Overall Study||48
5252116|NCT00790192|12911534|P3|NOT COMPLETED|Overall Study||23
5252117|NCT00790192|12911535|P2|NOT COMPLETED|Overall Study||28
5252118|NCT00790192|12911536|P1|NOT COMPLETED|Overall Study||36
5252119|NCT00790192|12911533|P4|COMPLETED|Overall Study||74
5252120|NCT00790192|12911534|P3|COMPLETED|Overall Study||97
5252121|NCT00790192|12911535|P2|COMPLETED|Overall Study||93
5252122|NCT00790192|12911536|P1|COMPLETED|Overall Study||89
5252123|NCT00790192|12911533|P4|STARTED|Overall Study||122
5252124|NCT00790192|12911534|P3|STARTED|Overall Study||120
5252125|NCT00790192|12911535|P2|STARTED|Overall Study||121
5252126|NCT00790192|12911536|P1|STARTED|Overall Study||125
5252127|NCT00790088|12911550|P1|NOT COMPLETED|Overall Study||39
5252128|NCT00790088|12911550|P1|COMPLETED|Overall Study||235
5252129|NCT00790088|12911550|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
5252130|NCT00790088|12911550|P1|STARTED|Overall Study||274
5252131|NCT00790062|12911563|P3|NOT COMPLETED|Overall Study||0
5252132|NCT00790062|12911564|P2|NOT COMPLETED|Overall Study||0
5252133|NCT00790062|12911565|P1|NOT COMPLETED|Overall Study||0
5252134|NCT00790062|12911563|P3|COMPLETED|Overall Study||658
5252135|NCT00790062|12911564|P2|COMPLETED|Overall Study||481
5252136|NCT00790062|12911565|P1|COMPLETED|Overall Study||659
5252137|NCT00790062|12911563|P3|STARTED|Overall Study||658
5252138|NCT00790062|12911564|P2|STARTED|Overall Study||481
5252139|NCT00790062|12911565|P1|STARTED|Overall Study||659
5252140|NCT00790036|12911596|P2|NOT COMPLETED|Overall Study||121
5252141|NCT00790036|12911597|P1|NOT COMPLETED|Overall Study||195
5252142|NCT00790036|12911596|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
5252143|NCT00790036|12911597|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
5252144|NCT00790036|12911596|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
5252145|NCT00790036|12911597|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
5252146|NCT00790036|12911596|P2|STARTED|Overall Study||370
5252147|NCT00790036|12911597|P1|STARTED|Overall Study||372
5252148|NCT00790023|12911611|P3|NOT COMPLETED|Overall Study||21
5252149|NCT00790023|12911612|P2|NOT COMPLETED|Overall Study||10
5252150|NCT00790023|12911613|P1|NOT COMPLETED|Overall Study||11
5252151|NCT00790023|12911611|P3|COMPLETED|Overall Study||214
5252152|NCT00790023|12911612|P2|COMPLETED|Overall Study||225
5252153|NCT00790023|12911613|P1|COMPLETED|Overall Study||226
5252154|NCT00790023|12911611|P3|STARTED|Overall Study||235
5252155|NCT00790023|12911612|P2|STARTED|Overall Study||235
5252156|NCT00790023|12911613|P1|STARTED|Overall Study||237
5252157|NCT00789997|12911703|P2|NOT COMPLETED|Overall Study||2
5252158|NCT00789997|12911704|P1|NOT COMPLETED|Overall Study||1
5252159|NCT00789997|12911703|P2|COMPLETED|Overall Study||38
5252160|NCT00789997|12911704|P1|COMPLETED|Overall Study||40
5252161|NCT00789997|12911703|P2|STARTED|Overall Study||40
5252162|NCT00789997|12911704|P1|STARTED|Overall Study||41
5252163|NCT00789958|12911712|P1|NOT COMPLETED|Overall Study||37
5252164|NCT00789958|12911712|P1|COMPLETED|Overall Study||68
5252165|NCT00789958|12911712|P1|Eligible and Analyzable|Overall Study||79
5252166|NCT00789958|12911712|P1|STARTED|Overall Study||105
5252167|NCT00789880|12911731|P6|NOT COMPLETED|Overall Study||0
5252168|NCT00789880|12911732|P5|NOT COMPLETED|Overall Study||3
5252169|NCT00789880|12911733|P4|NOT COMPLETED|Overall Study||1
5252170|NCT00789880|12911734|P3|NOT COMPLETED|Overall Study||0
5252171|NCT00789880|12911735|P2|NOT COMPLETED|Overall Study||1
5252172|NCT00789880|12911736|P1|NOT COMPLETED|Overall Study||1
5252173|NCT00789880|12911731|P6|COMPLETED|Overall Study||8
5252174|NCT00789880|12911732|P5|COMPLETED|Overall Study||15
5252175|NCT00789880|12911733|P4|COMPLETED|Overall Study||15
5252176|NCT00789880|12911734|P3|COMPLETED|Overall Study||8
5252177|NCT00789880|12911735|P2|COMPLETED|Overall Study||15
5252178|NCT00789880|12911736|P1|COMPLETED|Overall Study||15
5252179|NCT00789880|12911731|P6|STARTED|Overall Study||8
5252180|NCT00789880|12911732|P5|STARTED|Overall Study||18
5252181|NCT00789880|12911733|P4|STARTED|Overall Study||16
5252182|NCT00789880|12911734|P3|STARTED|Overall Study||8
5252183|NCT00789880|12911735|P2|STARTED|Overall Study||16
5252184|NCT00789880|12911736|P1|STARTED|Overall Study||16
5252185|NCT00789867|12911765|P3|NOT COMPLETED|Overall Study||0
5252186|NCT00789867|12911766|P2|NOT COMPLETED|Overall Study||0
5252187|NCT00789867|12911767|P1|NOT COMPLETED|Overall Study||0
5252188|NCT00789867|12911765|P3|COMPLETED|Overall Study||8
5252189|NCT00789867|12911766|P2|COMPLETED|Overall Study||10
5252190|NCT00789867|12911767|P1|COMPLETED|Overall Study||17
5252191|NCT00789867|12911765|P3|STARTED|Overall Study||8
5252192|NCT00789867|12911766|P2|STARTED|Overall Study||10
5252193|NCT00789867|12911767|P1|STARTED|Overall Study||17
5252194|NCT00789854|12911793|P3|NOT COMPLETED|Overall Study||47
5252195|NCT00789854|12911794|P2|NOT COMPLETED|Overall Study||35
5252196|NCT00789854|12911795|P1|NOT COMPLETED|Overall Study||49
5252197|NCT00789854|12911793|P3|COMPLETED|Overall Study||182
5252198|NCT00789854|12911794|P2|COMPLETED|Overall Study||196
5252199|NCT00789854|12911795|P1|COMPLETED|Overall Study||179
5252200|NCT00789854|12911793|P3|STARTED|Overall Study||229
5252201|NCT00789854|12911794|P2|STARTED|Overall Study||231
5252202|NCT00789854|12911795|P1|STARTED|Overall Study||228
5252203|NCT00789828|12911892|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
5252204|NCT00789828|12911893|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
5252205|NCT00789828|12911892|P2|COMPLETED|Open-label Extension Period (4 Years)||0
5252206|NCT00789828|12911893|P1|COMPLETED|Open-label Extension Period (4 Years)||82
5252207|NCT00789828|12911892|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
5252208|NCT00789828|12911893|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
5252209|NCT00789828|12911892|P2|NOT COMPLETED|Core Period (48 Weeks)||6
5252210|NCT00789828|12911893|P1|NOT COMPLETED|Core Period (48 Weeks)||0
5252211|NCT00789828|12911892|P2|COMPLETED|Core Period (48 Weeks)||33
5252212|NCT00789828|12911893|P1|COMPLETED|Core Period (48 Weeks)||78
5252213|NCT00789828|12911892|P2|STARTED|Core Period (48 Weeks)||39
5252214|NCT00789828|12911893|P1|STARTED|Core Period (48 Weeks)||78
5252215|NCT00789815|12911927|P2|NOT COMPLETED|Overall Study||1
5252216|NCT00789815|12911928|P1|NOT COMPLETED|Overall Study||7
5252217|NCT00789815|12911927|P2|COMPLETED|Overall Study||249
5252218|NCT00789815|12911928|P1|COMPLETED|Overall Study||243
5252219|NCT00789815|12911927|P2|STARTED|Overall Study||250
5252220|NCT00789815|12911928|P1|STARTED|Overall Study||250
5252221|NCT00789802|12911951|P3|NOT COMPLETED|Overall Study||6
5252222|NCT00789802|12911952|P2|NOT COMPLETED|Overall Study||7
5252223|NCT00789802|12911953|P1|NOT COMPLETED|Overall Study||10
5252224|NCT00789802|12911951|P3|COMPLETED|Overall Study||37
5252225|NCT00789802|12911952|P2|COMPLETED|Overall Study||35
5252226|NCT00789802|12911953|P1|COMPLETED|Overall Study||34
5252227|NCT00789802|12911951|P3|STARTED|Overall Study||43
5252228|NCT00789802|12911952|P2|STARTED|Overall Study||42
5252229|NCT00789802|12911953|P1|STARTED|Overall Study||44
5252230|NCT00789776|12911972|P2|NOT COMPLETED|Overall Study||1
5252231|NCT00789776|12911973|P1|NOT COMPLETED|Overall Study||0
5252232|NCT00789776|12911972|P2|COMPLETED|Overall Study||35
5252233|NCT00789776|12911973|P1|COMPLETED|Overall Study||5
5252234|NCT00789776|12911972|P2|STARTED|Overall Study||36
5252235|NCT00789776|12911973|P1|STARTED|Overall Study||5
5252236|NCT00789750|12911993|P2|NOT COMPLETED|Overall Study||60
5252237|NCT00789750|12911994|P1|NOT COMPLETED|Overall Study||59
5252238|NCT00789750|12911993|P2|COMPLETED|Overall Study||222
5252239|NCT00789750|12911994|P1|COMPLETED|Overall Study||221
5252240|NCT00789750|12911993|P2|Intent to Treat Set|Overall Study||276
5252241|NCT00789750|12911994|P1|Intent to Treat Set|Overall Study||271
5252242|NCT00789750|12911993|P2|Safety Set|Overall Study||277
5252243|NCT00789750|12911994|P1|Safety Set|Overall Study||274
5252244|NCT00789750|12911993|P2|Dropped During run-in Period|Overall Study||5
5252245|NCT00789750|12911994|P1|Dropped During run-in Period|Overall Study||6
5252246|NCT00789750|12911993|P2|STARTED|Overall Study||282
5252247|NCT00789750|12911994|P1|STARTED|Overall Study||280
5252248|NCT00789737|12912038|P2|NOT COMPLETED|Overall Study||55
5252249|NCT00789737|12912039|P1|NOT COMPLETED|Overall Study||48
5252250|NCT00789737|12912038|P2|COMPLETED|Overall Study||126
5252251|NCT00789737|12912039|P1|COMPLETED|Overall Study||128
5252252|NCT00789737|12912038|P2|STARTED|Overall Study||181
5252253|NCT00789737|12912039|P1|STARTED|Overall Study||176
5252254|NCT00789724|12912071|P2|NOT COMPLETED|Overall Study||0
5252255|NCT00789724|12912072|P1|NOT COMPLETED|Overall Study||0
5252256|NCT00789724|12912071|P2|COMPLETED|Overall Study||5
5252257|NCT00789724|12912072|P1|COMPLETED|Overall Study||5
5252258|NCT00789724|12912071|P2|STARTED|Overall Study||5
5252259|NCT00789724|12912072|P1|STARTED|Overall Study||5
5252260|NCT00789698|12912082|P4|NOT COMPLETED|Overall Study||52
5252261|NCT00789698|12912083|P3|NOT COMPLETED|Overall Study||27
5252262|NCT00789698|12912084|P2|NOT COMPLETED|Overall Study||33
5252263|NCT00789698|12912085|P1|NOT COMPLETED|Overall Study||40
5252264|NCT00789698|12912082|P4|COMPLETED|Overall Study||33
5252265|NCT00789698|12912083|P3|COMPLETED|Overall Study||29
5252266|NCT00789698|12912084|P2|COMPLETED|Overall Study||46
5252267|NCT00789698|12912085|P1|COMPLETED|Overall Study||32
5252268|NCT00789698|12912082|P4|STARTED|Overall Study||85
5252269|NCT00789698|12912083|P3|STARTED|Overall Study||56
5252270|NCT00789698|12912084|P2|STARTED|Overall Study||79
5252271|NCT00789698|12912085|P1|STARTED|Overall Study||72
5252272|NCT00789685|12912099|P1|NOT COMPLETED|Overall Study||12
5252273|NCT00789685|12912099|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
5252274|NCT00789685|12912099|P1|STARTED|Overall Study||37
5252275|NCT00789672|12912107|P2|NOT COMPLETED|Overall Study||0
5252276|NCT00789672|12912108|P1|NOT COMPLETED|Overall Study||0
5252277|NCT00789672|12912107|P2|COMPLETED|Overall Study||17
5252278|NCT00789672|12912108|P1|COMPLETED|Overall Study||16
5252279|NCT00789672|12912107|P2|STARTED|Overall Study||17
5252280|NCT00789672|12912108|P1|STARTED|Overall Study||16
5252281|NCT00789581|12912140|P2|NOT COMPLETED|Adjuvant Therapy||57
5252282|NCT00789581|12912141|P1|NOT COMPLETED|Adjuvant Therapy||40
5252283|NCT00789581|12912140|P2|COMPLETED|Adjuvant Therapy||234
5252284|NCT00789581|12912141|P1|COMPLETED|Adjuvant Therapy||255
5252285|NCT00789581|12912140|P2|STARTED|Adjuvant Therapy||291
5252286|NCT00789581|12912141|P1|STARTED|Adjuvant Therapy||295
5252287|NCT00789581|12912140|P2|NOT COMPLETED|AC Therapy||17
5252288|NCT00789581|12912141|P1|NOT COMPLETED|AC Therapy||11
5252289|NCT00789581|12912140|P2|COMPLETED|AC Therapy||291
5252290|NCT00789581|12912141|P1|COMPLETED|AC Therapy||295
5252291|NCT00789581|12912140|P2|STARTED|AC Therapy||308
5252292|NCT00789581|12912141|P1|STARTED|AC Therapy||306
5252293|NCT00789555|12912152|P3|NOT COMPLETED|Overall Study||159
5252294|NCT00789555|12912153|P2|NOT COMPLETED|Overall Study||139
5252295|NCT00789555|12912154|P1|NOT COMPLETED|Overall Study||159
5252296|NCT00789555|12912152|P3|COMPLETED|Overall Study||263
5252297|NCT00789555|12912153|P2|COMPLETED|Overall Study||278
5252298|NCT00789555|12912154|P1|COMPLETED|Overall Study||262
5252299|NCT00789555|12912152|P3|STARTED|Overall Study||422
5252300|NCT00789555|12912153|P2|STARTED|Overall Study||417
5252301|NCT00789555|12912154|P1|STARTED|Overall Study||421
5252302|NCT00789529|12912179|P2|NOT COMPLETED|Overall Study||1
5252303|NCT00789529|12912180|P1|NOT COMPLETED|Overall Study||1
5252304|NCT00789529|12912179|P2|COMPLETED|Overall Study||15
5252305|NCT00789529|12912180|P1|COMPLETED|Overall Study||15
5252306|NCT00789529|12912179|P2|STARTED|Overall Study||16
5252307|NCT00789529|12912180|P1|STARTED|Overall Study||16
5252308|NCT00789477|12912193|P5|NOT COMPLETED|Overall Study||7
5252309|NCT00789477|12912194|P4|NOT COMPLETED|Overall Study||10
5252310|NCT00789477|12912195|P3|NOT COMPLETED|Overall Study||11
5252311|NCT00789477|12912196|P2|NOT COMPLETED|Overall Study||6
5252312|NCT00789477|12912197|P1|NOT COMPLETED|Overall Study||11
5252313|NCT00789477|12912193|P5|COMPLETED|Overall Study||38
5252314|NCT00789477|12912194|P4|COMPLETED|Overall Study||34
5252315|NCT00789477|12912195|P3|COMPLETED|Overall Study||33
5252316|NCT00789477|12912196|P2|COMPLETED|Overall Study||38
5252317|NCT00789477|12912197|P1|COMPLETED|Overall Study||33
5252318|NCT00789477|12912193|P5|Participants Received Treatment|Overall Study|SAF|45
5252319|NCT00789477|12912194|P4|Participants Received Treatment|Overall Study|SAF|42
5252320|NCT00789477|12912195|P3|Participants Received Treatment|Overall Study|SAF|44
5252321|NCT00789477|12912196|P2|Participants Received Treatment|Overall Study|SAF|44
5252322|NCT00789477|12912197|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
5252323|NCT00789477|12912193|P5|STARTED|Overall Study|randomized|45
5252324|NCT00789477|12912194|P4|STARTED|Overall Study|randomized|44
5252325|NCT00789477|12912195|P3|STARTED|Overall Study|randomized|44
5252326|NCT00789477|12912196|P2|STARTED|Overall Study|randomized|44
5252327|NCT00789477|12912197|P1|STARTED|Overall Study|randomized|44
5252328|NCT00789438|12912232|P3|NOT COMPLETED|Overall Study||0
5252329|NCT00789438|12912233|P2|NOT COMPLETED|Overall Study||0
5252330|NCT00789438|12912234|P1|NOT COMPLETED|Overall Study||0
5252331|NCT00789438|12912232|P3|COMPLETED|Overall Study||28
5252332|NCT00789438|12912233|P2|COMPLETED|Overall Study||20
5252333|NCT00789438|12912234|P1|COMPLETED|Overall Study||21
5252334|NCT00789438|12912232|P3|STARTED|Overall Study||28
5252335|NCT00789438|12912233|P2|STARTED|Overall Study||20
5252336|NCT00789438|12912234|P1|STARTED|Overall Study||21
5252337|NCT00789373|12912242|P3|NOT COMPLETED|Maintenance||180
5252338|NCT00789373|12912243|P2|NOT COMPLETED|Maintenance||359
5252339|NCT00789373|12912244|P1|NOT COMPLETED|Maintenance||0
5252340|NCT00789373|12912242|P3|COMPLETED|Maintenance||0
5252341|NCT00789373|12912243|P2|COMPLETED|Maintenance||0
5252342|NCT00789373|12912244|P1|COMPLETED|Maintenance||0
5252343|NCT00789373|12912242|P3|STARTED|Maintenance||180
5252344|NCT00789373|12912243|P2|STARTED|Maintenance||359
5252345|NCT00789373|12912244|P1|STARTED|Maintenance||0
5252346|NCT00789373|12912242|P3|NOT COMPLETED|Induction||0
5252347|NCT00789373|12912243|P2|NOT COMPLETED|Induction||0
5252348|NCT00789373|12912244|P1|NOT COMPLETED|Induction||399
5252349|NCT00789373|12912242|P3|COMPLETED|Induction||0
5252350|NCT00789373|12912243|P2|COMPLETED|Induction||0
5252351|NCT00789373|12912244|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
5252352|NCT00789373|12912242|P3|STARTED|Induction||0
5252353|NCT00789373|12912243|P2|STARTED|Induction||0
5252354|NCT00789373|12912244|P1|STARTED|Induction||939
5252355|NCT00789360|12912271|P2|NOT COMPLETED|Overall Study||1
5252356|NCT00789360|12912272|P1|NOT COMPLETED|Overall Study||3
5252357|NCT00789360|12912271|P2|COMPLETED|Overall Study||14
5252358|NCT00789360|12912272|P1|COMPLETED|Overall Study||12
5252359|NCT00789360|12912271|P2|STARTED|Overall Study||15
5252360|NCT00789360|12912272|P1|STARTED|Overall Study||15
5252361|NCT00789321|12912282|P2|NOT COMPLETED|Overall Study||1
5252362|NCT00789321|12912283|P1|NOT COMPLETED|Overall Study||0
5252363|NCT00789321|12912282|P2|COMPLETED|Overall Study||22
5252364|NCT00789321|12912283|P1|COMPLETED|Overall Study||24
5252365|NCT00789321|12912282|P2|STARTED|Overall Study||23
5252366|NCT00789321|12912283|P1|STARTED|Overall Study||24
5252367|NCT00789256|12912293|P2|NOT COMPLETED|Overall Study||0
5252368|NCT00789256|12912294|P1|NOT COMPLETED|Overall Study||0
5252369|NCT00789256|12912293|P2|COMPLETED|Overall Study||12
5252370|NCT00789256|12912294|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
5252371|NCT00789256|12912293|P2|STARTED|Overall Study||12
5252372|NCT00789256|12912294|P1|STARTED|Overall Study||14
5252373|NCT00789191|12912305|P2|NOT COMPLETED|Overall Study||19
5252374|NCT00789191|12912306|P1|NOT COMPLETED|Overall Study||14
5252375|NCT00789191|12912305|P2|COMPLETED|Overall Study||92
5252376|NCT00789191|12912306|P1|COMPLETED|Overall Study||97
5252377|NCT00789191|12912305|P2|Exposed|Overall Study|1 non-compliance|110
5252378|NCT00789191|12912306|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
5252379|NCT00789191|12912305|P2|STARTED|Overall Study||111
5252380|NCT00789191|12912306|P1|STARTED|Overall Study||111
5252381|NCT00789113|12912334|P1|NOT COMPLETED|Overall Study||0
5252382|NCT00789113|12912334|P1|COMPLETED|Overall Study||12
5252383|NCT00789113|12912334|P1|STARTED|Overall Study||12
5252384|NCT00789074|12912341|P2|NOT COMPLETED|Overall Study||13
5252385|NCT00789074|12912342|P1|NOT COMPLETED|Overall Study||11
5252386|NCT00789074|12912341|P2|COMPLETED|Overall Study||35
5252387|NCT00789074|12912342|P1|COMPLETED|Overall Study||42
5252388|NCT00789074|12912341|P2|STARTED|Overall Study||48
5252389|NCT00789074|12912342|P1|STARTED|Overall Study||53
5252390|NCT00789035|12912363|P5|NOT COMPLETED|Overall Study||6
5252391|NCT00789035|12912364|P4|NOT COMPLETED|Overall Study||1
5252392|NCT00789035|12912365|P3|NOT COMPLETED|Overall Study||1
5252393|NCT00789035|12912366|P2|NOT COMPLETED|Overall Study||7
5252394|NCT00789035|12912367|P1|NOT COMPLETED|Overall Study||6
5252395|NCT00789035|12912363|P5|COMPLETED|Overall Study||74
5252396|NCT00789035|12912364|P4|COMPLETED|Overall Study||81
5252397|NCT00789035|12912365|P3|COMPLETED|Overall Study||80
5252398|NCT00789035|12912366|P2|COMPLETED|Overall Study||74
5252399|NCT00789035|12912367|P1|COMPLETED|Overall Study||76
5252400|NCT00789035|12912363|P5|STARTED|Overall Study||80
5252401|NCT00789035|12912364|P4|STARTED|Overall Study||82
5252402|NCT00789035|12912365|P3|STARTED|Overall Study||81
5252403|NCT00789035|12912366|P2|STARTED|Overall Study||81
5252404|NCT00789035|12912367|P1|STARTED|Overall Study||82
5252405|NCT00788957|12912426|P6|NOT COMPLETED|Part 3||11
5252406|NCT00788957|12912427|P5|NOT COMPLETED|Part 3||9
5252407|NCT00788957|12912428|P4|NOT COMPLETED|Part 3||0
5252408|NCT00788957|12912429|P3|NOT COMPLETED|Part 3||0
5252409|NCT00788957|12912430|P2|NOT COMPLETED|Part 3||0
5252410|NCT00788957|12912431|P1|NOT COMPLETED|Part 3||0
5252411|NCT00788957|12912426|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
5252412|NCT00788957|12912427|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
5252413|NCT00788957|12912428|P4|COMPLETED|Part 3||0
5252414|NCT00788957|12912429|P3|COMPLETED|Part 3||0
5252415|NCT00788957|12912430|P2|COMPLETED|Part 3||0
5252416|NCT00788957|12912431|P1|COMPLETED|Part 3||0
5252417|NCT00788957|12912426|P6|STARTED|Part 3||12
5252418|NCT00788957|12912427|P5|STARTED|Part 3||13
5252419|NCT00788957|12912428|P4|STARTED|Part 3||0
5252420|NCT00788957|12912429|P3|STARTED|Part 3||0
5252421|NCT00788957|12912430|P2|STARTED|Part 3||0
5252422|NCT00788957|12912431|P1|STARTED|Part 3||0
5252423|NCT00788957|12912426|P6|NOT COMPLETED|Part 2||0
5252424|NCT00788957|12912427|P5|NOT COMPLETED|Part 2||0
5252425|NCT00788957|12912428|P4|NOT COMPLETED|Part 2||41
5252426|NCT00788957|12912429|P3|NOT COMPLETED|Part 2||44
5252427|NCT00788957|12912430|P2|NOT COMPLETED|Part 2||42
5252428|NCT00788957|12912431|P1|NOT COMPLETED|Part 2||0
5252429|NCT00788957|12912426|P6|COMPLETED|Part 2||0
5252430|NCT00788957|12912427|P5|COMPLETED|Part 2||0
5252431|NCT00788957|12912428|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
5252432|NCT00788957|12912429|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
5252433|NCT00788957|12912430|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
5252434|NCT00788957|12912431|P1|COMPLETED|Part 2||0
5252435|NCT00788957|12912426|P6|STARTED|Part 2||0
5252436|NCT00788957|12912427|P5|STARTED|Part 2||0
5252437|NCT00788957|12912428|P4|STARTED|Part 2||46
5252438|NCT00788957|12912429|P3|STARTED|Part 2||48
5252439|NCT00788957|12912430|P2|STARTED|Part 2||48
5252440|NCT00788957|12912431|P1|STARTED|Part 2||0
5252441|NCT00788957|12912426|P6|NOT COMPLETED|Part 1||0
5252442|NCT00788957|12912427|P5|NOT COMPLETED|Part 1||0
5252443|NCT00788957|12912428|P4|NOT COMPLETED|Part 1||0
5252444|NCT00788957|12912429|P3|NOT COMPLETED|Part 1||0
5252445|NCT00788957|12912430|P2|NOT COMPLETED|Part 1||0
5252446|NCT00788957|12912431|P1|NOT COMPLETED|Part 1||9
5252447|NCT00788957|12912426|P6|COMPLETED|Part 1||0
5252448|NCT00788957|12912427|P5|COMPLETED|Part 1||0
5252449|NCT00788957|12912428|P4|COMPLETED|Part 1||0
5252450|NCT00788957|12912429|P3|COMPLETED|Part 1||0
5252451|NCT00788957|12912430|P2|COMPLETED|Part 1||0
5252452|NCT00788957|12912431|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
5252453|NCT00788957|12912426|P6|STARTED|Part 1||0
5252454|NCT00788957|12912427|P5|STARTED|Part 1||0
5252455|NCT00788957|12912428|P4|STARTED|Part 1||0
5252456|NCT00788957|12912429|P3|STARTED|Part 1||0
5252457|NCT00788957|12912430|P2|STARTED|Part 1||0
5252458|NCT00788957|12912431|P1|STARTED|Part 1||11
5252459|NCT00788892|12912487|P2|NOT COMPLETED|Overall Study||23
5252460|NCT00788892|12912488|P1|NOT COMPLETED|Overall Study||49
5252461|NCT00788892|12912487|P2|COMPLETED|Overall Study||18
5252462|NCT00788892|12912488|P1|COMPLETED|Overall Study||36
5252463|NCT00788892|12912487|P2|STARTED|Overall Study||41
5252464|NCT00788892|12912488|P1|STARTED|Overall Study||85
5252465|NCT00788827|12912504|P1|NOT COMPLETED|Overall Study||2
5252466|NCT00788827|12912504|P1|COMPLETED|Overall Study||5
5252467|NCT00788827|12912504|P1|STARTED|Overall Study||7
5252468|NCT00788775|12912518|P2|NOT COMPLETED|Overall Study||8
5252469|NCT00788775|12912519|P1|NOT COMPLETED|Overall Study||10
5252470|NCT00788775|12912518|P2|COMPLETED|Overall Study||1
5252471|NCT00788775|12912519|P1|COMPLETED|Overall Study||1
5252472|NCT00788775|12912518|P2|Treated|Overall Study||8
5252473|NCT00788775|12912519|P1|Treated|Overall Study||11
5252474|NCT00788775|12912518|P2|STARTED|Overall Study||9
5252475|NCT00788775|12912519|P1|STARTED|Overall Study||11
5252476|NCT00788710|12912534|P3|NOT COMPLETED|Overall Study||6
5252477|NCT00788710|12912535|P2|NOT COMPLETED|Overall Study||8
5252478|NCT00788710|12912536|P1|NOT COMPLETED|Overall Study||5
5252479|NCT00788710|12912534|P3|COMPLETED|Overall Study||138
5252480|NCT00788710|12912535|P2|COMPLETED|Overall Study||134
5252481|NCT00788710|12912536|P1|COMPLETED|Overall Study||139
5252482|NCT00788710|12912534|P3|STARTED|Overall Study||144
5252483|NCT00788710|12912535|P2|STARTED|Overall Study||142
5252484|NCT00788710|12912536|P1|STARTED|Overall Study||144
5252485|NCT00788697|12912550|P1|NOT COMPLETED|Overall Study||109
5252486|NCT00788697|12912550|P1|COMPLETED|Overall Study||240
5252487|NCT00788697|12912550|P1|STARTED|Overall Study||349
5252488|NCT00788593|12912597|P3|NOT COMPLETED|Second Intervention Period||1
5252489|NCT00788593|12912598|P2|NOT COMPLETED|Second Intervention Period||1
5252490|NCT00788593|12912599|P1|NOT COMPLETED|Second Intervention Period||0
5252491|NCT00788593|12912597|P3|COMPLETED|Second Intervention Period||36
5252492|NCT00788593|12912598|P2|COMPLETED|Second Intervention Period||37
5252493|NCT00788593|12912599|P1|COMPLETED|Second Intervention Period||0
5252494|NCT00788593|12912597|P3|STARTED|Second Intervention Period||37
5252495|NCT00788593|12912598|P2|STARTED|Second Intervention Period||38
5252496|NCT00788593|12912599|P1|STARTED|Second Intervention Period||0
5252497|NCT00788593|12912597|P3|NOT COMPLETED|First Intervention Period||0
5252498|NCT00788593|12912598|P2|NOT COMPLETED|First Intervention Period||1
5252499|NCT00788593|12912599|P1|NOT COMPLETED|First Intervention Period||0
5252500|NCT00788593|12912597|P3|COMPLETED|First Intervention Period||37
5252501|NCT00788593|12912598|P2|COMPLETED|First Intervention Period||38
5252502|NCT00788593|12912599|P1|COMPLETED|First Intervention Period||0
5252503|NCT00788593|12912597|P3|STARTED|First Intervention Period||37
5252504|NCT00788593|12912598|P2|STARTED|First Intervention Period||39
5252505|NCT00788593|12912599|P1|STARTED|First Intervention Period||0
5252506|NCT00788593|12912597|P3|NOT COMPLETED|Placebo Run-in Phase||0
5252507|NCT00788593|12912598|P2|NOT COMPLETED|Placebo Run-in Phase||0
5252508|NCT00788593|12912599|P1|NOT COMPLETED|Placebo Run-in Phase||6
5252509|NCT00788593|12912597|P3|COMPLETED|Placebo Run-in Phase||0
5252510|NCT00788593|12912598|P2|COMPLETED|Placebo Run-in Phase||0
5252511|NCT00788593|12912599|P1|COMPLETED|Placebo Run-in Phase||76
5252512|NCT00788593|12912597|P3|STARTED|Placebo Run-in Phase||0
5252513|NCT00788593|12912598|P2|STARTED|Placebo Run-in Phase||0
5252514|NCT00788593|12912599|P1|STARTED|Placebo Run-in Phase||82
5252515|NCT00788372|12912616|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
5252516|NCT00788372|12912616|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
5252517|NCT00788372|12912616|P1|STARTED|Period 2 (Week 4 to Week 52)||111
5252518|NCT00788372|12912616|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
5252519|NCT00788372|12912616|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
5252520|NCT00788372|12912616|P1|STARTED|Period 1 (up to 4 Weeks)||142
5252521|NCT00788255|12912630|P1|NOT COMPLETED|Overall Study||0
5252522|NCT00788255|12912630|P1|COMPLETED|Overall Study||25
5252523|NCT00788255|12912630|P1|Oxytocin: 0 μU/mL|Overall Study||25
5252524|NCT00788255|12912630|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
5252525|NCT00788255|12912630|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
5252526|NCT00788255|12912630|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
5252527|NCT00788255|12912630|P1|STARTED|Overall Study||25
5252528|NCT00788151|12912645|P2|NOT COMPLETED|Overall Study||10
5252529|NCT00788151|12912646|P1|NOT COMPLETED|Overall Study||14
5252530|NCT00788151|12912645|P2|COMPLETED|Overall Study||90
5252531|NCT00788151|12912646|P1|COMPLETED|Overall Study||186
5252532|NCT00788151|12912645|P2|Received Vaccination 3|Overall Study||90
5252533|NCT00788151|12912646|P1|Received Vaccination 3|Overall Study||186
5252534|NCT00788151|12912645|P2|Received Vaccination 2|Overall Study||92
5252535|NCT00788151|12912646|P1|Received Vaccination 2|Overall Study||188
5252536|NCT00788151|12912645|P2|Received Vaccination 1|Overall Study||99
5252537|NCT00788151|12912646|P1|Received Vaccination 1|Overall Study||199
5252538|NCT00788151|12912645|P2|STARTED|Overall Study||100
5252539|NCT00788151|12912646|P1|STARTED|Overall Study||200
5252540|NCT00788073|12912690|P2|NOT COMPLETED|Placebo Then STX209||1
5252541|NCT00788073|12912691|P1|NOT COMPLETED|Placebo Then STX209||2
5252542|NCT00788073|12912690|P2|COMPLETED|Placebo Then STX209||29
5252543|NCT00788073|12912691|P1|COMPLETED|Placebo Then STX209||27
5252544|NCT00788073|12912690|P2|STARTED|Placebo Then STX209||30
5252545|NCT00788073|12912691|P1|STARTED|Placebo Then STX209||29
5252546|NCT00788073|12912690|P2|NOT COMPLETED|STX209 Then Placebo||3
5252547|NCT00788073|12912691|P1|NOT COMPLETED|STX209 Then Placebo||1
5252548|NCT00788073|12912690|P2|COMPLETED|STX209 Then Placebo||30
5252549|NCT00788073|12912691|P1|COMPLETED|STX209 Then Placebo||29
5252550|NCT00788073|12912690|P2|STARTED|STX209 Then Placebo||33
5252551|NCT00788073|12912691|P1|STARTED|STX209 Then Placebo||30
5252552|NCT00788008|12912701|P2|NOT COMPLETED|Overall Study||0
5252553|NCT00788008|12912702|P1|NOT COMPLETED|Overall Study||0
5252554|NCT00788008|12912701|P2|COMPLETED|Overall Study||101
5252555|NCT00788008|12912702|P1|COMPLETED|Overall Study||98
5252556|NCT00788008|12912701|P2|STARTED|Overall Study||101
5252557|NCT00788008|12912702|P1|STARTED|Overall Study||98
5252558|NCT00787943|12912708|P1|NOT COMPLETED|Overall Study||0
5252559|NCT00787943|12912708|P1|COMPLETED|Overall Study||10
5252560|NCT00787943|12912708|P1|STARTED|Overall Study||10
5252561|NCT00787930|12912716|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
5252562|NCT00787930|12912716|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
5252563|NCT00787930|12912716|P1|STARTED|Continuation Treatment -- up to 12 Month||19
5252564|NCT00787930|12912716|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
5252565|NCT00787930|12912716|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
5252566|NCT00787930|12912716|P1|STARTED|Acute Treatment -- 3 Weeks||19
5252567|NCT00787917|12912731|P2|NOT COMPLETED|Open Label||0
5252568|NCT00787917|12912732|P1|NOT COMPLETED|Open Label||4
5252569|NCT00787917|12912731|P2|COMPLETED|Open Label||0
5252570|NCT00787917|12912732|P1|COMPLETED|Open Label||3
5252571|NCT00787917|12912731|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
5252572|NCT00787917|12912732|P1|STARTED|Open Label||7
5252573|NCT00787917|12912731|P2|NOT COMPLETED|Blinded Treatment||2
5252574|NCT00787917|12912732|P1|NOT COMPLETED|Blinded Treatment||5
5252575|NCT00787917|12912731|P2|COMPLETED|Blinded Treatment||3
5252576|NCT00787917|12912732|P1|COMPLETED|Blinded Treatment||4
5252577|NCT00787917|12912731|P2|STARTED|Blinded Treatment||5
5252578|NCT00787917|12912732|P1|STARTED|Blinded Treatment||9
5252579|NCT00787904|12912751|P2|NOT COMPLETED|Overall Study||0
5252580|NCT00787904|12912752|P1|NOT COMPLETED|Overall Study||0
5252581|NCT00787904|12912751|P2|COMPLETED|Overall Study||13
5252582|NCT00787904|12912752|P1|COMPLETED|Overall Study||6
5252583|NCT00787904|12912751|P2|STARTED|Overall Study||13
5252584|NCT00787904|12912752|P1|STARTED|Overall Study||6
5252585|NCT00787891|12912762|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
5252586|NCT00787891|12912763|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
5252587|NCT00787891|12912762|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
5252588|NCT00787891|12912763|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
5252589|NCT00787891|12912762|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
5252590|NCT00787891|12912763|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
5252591|NCT00787891|12912762|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
5252592|NCT00787891|12912763|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
5252593|NCT00787891|12912762|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
5252594|NCT00787891|12912763|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
5252595|NCT00787891|12912762|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
5252596|NCT00787891|12912763|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
5252597|NCT00787852|12912783|P2|NOT COMPLETED|Overall Study||0
5252598|NCT00787852|12912784|P1|NOT COMPLETED|Overall Study||1
5252599|NCT00787852|12912783|P2|COMPLETED|Overall Study||5
5252600|NCT00787852|12912784|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
5252601|NCT00787852|12912783|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
5252602|NCT00787852|12912784|P1|STARTED|Overall Study||6
5252603|NCT00787839|12912790|P1|NOT COMPLETED|Overall Study||404
5252604|NCT00787839|12912790|P1|COMPLETED|Overall Study||1535
5252605|NCT00787839|12912790|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
5252606|NCT00787839|12912790|P1|Completed GCT Screening|Overall Study||1876
5252607|NCT00787839|12912790|P1|Consented|Overall Study|consented|1939
5252608|NCT00787839|12912790|P1|STARTED|Overall Study||1939
5252609|NCT00787800|12912813|P2|NOT COMPLETED|Overall Study||7
5252610|NCT00787800|12912814|P1|NOT COMPLETED|Overall Study||3
5252611|NCT00787800|12912813|P2|COMPLETED|Overall Study||43
5252612|NCT00787800|12912814|P1|COMPLETED|Overall Study||47
5252613|NCT00787800|12912813|P2|STARTED|Overall Study||50
5252614|NCT00787800|12912814|P1|STARTED|Overall Study||50
5252615|NCT00787787|12912830|P1|NOT COMPLETED|Overall Study||7
5252616|NCT00787787|12912830|P1|COMPLETED|Overall Study||0
5252617|NCT00787787|12912830|P1|STARTED|Overall Study||7
5252618|NCT00787761|12912836|P1|NOT COMPLETED|Overall Study||0
5252619|NCT00787761|12912836|P1|COMPLETED|Overall Study||24
5252620|NCT00787761|12912836|P1|STARTED|Overall Study||24
5252621|NCT00787722|12912847|P1|NOT COMPLETED|Overall Study||1
5252622|NCT00787722|12912847|P1|COMPLETED|Overall Study||12
5252623|NCT00787722|12912847|P1|STARTED|Overall Study||13
5252624|NCT00787644|12912858|P2|NOT COMPLETED|Overall Study||2
5252625|NCT00787644|12912859|P1|NOT COMPLETED|Overall Study||2
5252626|NCT00787644|12912858|P2|COMPLETED|Overall Study||9
5252627|NCT00787644|12912859|P1|COMPLETED|Overall Study||10
5252628|NCT00787644|12912858|P2|STARTED|Overall Study||11
5252629|NCT00787644|12912859|P1|STARTED|Overall Study||12
5252630|NCT00787618|12912868|P3|NOT COMPLETED|Overall Study||0
5252631|NCT00787618|12912869|P2|NOT COMPLETED|Overall Study||0
5252632|NCT00787618|12912870|P1|NOT COMPLETED|Overall Study||0
5252633|NCT00787618|12912868|P3|COMPLETED|Overall Study||3
5252634|NCT00787618|12912869|P2|COMPLETED|Overall Study||0
5252635|NCT00787618|12912870|P1|COMPLETED|Overall Study||3
5252636|NCT00787618|12912868|P3|STARTED|Overall Study||3
5252637|NCT00787618|12912869|P2|STARTED|Overall Study||0
5252638|NCT00787618|12912870|P1|STARTED|Overall Study||3
5252639|NCT00787605|12912880|P2|NOT COMPLETED|Overall Study||56
5252640|NCT00787605|12912881|P1|NOT COMPLETED|Overall Study||46
5252641|NCT00787605|12912880|P2|COMPLETED|Overall Study||376
5252642|NCT00787605|12912881|P1|COMPLETED|Overall Study||382
5252643|NCT00787605|12912880|P2|STARTED|Overall Study||432
5252644|NCT00787605|12912881|P1|STARTED|Overall Study||428
5252645|NCT00787566|12912900|P3|NOT COMPLETED|Overall Study||0
5252646|NCT00787566|12912901|P2|NOT COMPLETED|Overall Study||1
5252647|NCT00787566|12912902|P1|NOT COMPLETED|Overall Study||0
5252648|NCT00787566|12912900|P3|COMPLETED|Overall Study||22
5252649|NCT00787566|12912901|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
5252650|NCT00787566|12912902|P1|COMPLETED|Overall Study||21
5252651|NCT00787566|12912900|P3|STARTED|Overall Study||22
5252652|NCT00787566|12912901|P2|STARTED|Overall Study||25
5252653|NCT00787566|12912902|P1|STARTED|Overall Study||21
5252654|NCT00787527|12912910|P1|NOT COMPLETED|Overall Study||3
5252655|NCT00787527|12912910|P1|COMPLETED|Overall Study||11
5252656|NCT00787527|12912910|P1|STARTED|Overall Study||14
5252657|NCT00787332|12912920|P2|NOT COMPLETED|Overall Study||0
5252658|NCT00787332|12912921|P1|NOT COMPLETED|Overall Study||0
5252659|NCT00787332|12912920|P2|COMPLETED|Overall Study||8
5252660|NCT00787332|12912921|P1|COMPLETED|Overall Study||8
5252661|NCT00787332|12912920|P2|STARTED|Overall Study||8
5252662|NCT00787332|12912921|P1|STARTED|Overall Study||8
5252663|NCT00787319|12912927|P1|NOT COMPLETED|Overall Study||63
5252664|NCT00787319|12912927|P1|COMPLETED|Overall Study||45
5252665|NCT00787319|12912927|P1|STARTED|Overall Study||108
5252666|NCT00787267|12912939|P1|NOT COMPLETED|Overall Study||12
5252667|NCT00787267|12912939|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
5252668|NCT00787267|12912939|P1|STARTED|Overall Study|Signed a consent form|37
5252669|NCT00787254|12912949|P2|NOT COMPLETED|Overall Study||82
5252670|NCT00787254|12912950|P1|NOT COMPLETED|Overall Study||76
5252671|NCT00787254|12912949|P2|COMPLETED|Overall Study||99
5252672|NCT00787254|12912950|P1|COMPLETED|Overall Study||109
5252673|NCT00787254|12912949|P2|STARTED|Overall Study||181
5252674|NCT00787254|12912950|P1|STARTED|Overall Study||185
5252675|NCT00787241|12913053|P3|NOT COMPLETED|Overall Study||0
5252676|NCT00787241|12913054|P2|NOT COMPLETED|Overall Study||0
5252677|NCT00787241|12913055|P1|NOT COMPLETED|Overall Study||0
5252678|NCT00787241|12913053|P3|COMPLETED|Overall Study||41
5252679|NCT00787241|12913054|P2|COMPLETED|Overall Study||143
5252680|NCT00787241|12913055|P1|COMPLETED|Overall Study||261
5252681|NCT00787241|12913053|P3|STARTED|Overall Study||41
5252682|NCT00787241|12913054|P2|STARTED|Overall Study||143
5252683|NCT00787241|12913055|P1|STARTED|Overall Study||261
5252684|NCT00787202|12913074|P5|NOT COMPLETED|Overall Study||4
5252685|NCT00787202|12913075|P4|NOT COMPLETED|Overall Study||2
5252686|NCT00787202|12913076|P3|NOT COMPLETED|Overall Study||7
5252687|NCT00787202|12913077|P2|NOT COMPLETED|Overall Study||11
5252688|NCT00787202|12913078|P1|NOT COMPLETED|Overall Study||14
5252689|NCT00787202|12913074|P5|COMPLETED|Overall Study||45
5252690|NCT00787202|12913075|P4|COMPLETED|Overall Study||31
5252691|NCT00787202|12913076|P3|COMPLETED|Overall Study||26
5252692|NCT00787202|12913077|P2|COMPLETED|Overall Study||20
5252693|NCT00787202|12913078|P1|COMPLETED|Overall Study||35
5252694|NCT00787202|12913074|P5|Treated|Overall Study||49
5252695|NCT00787202|12913075|P4|Treated|Overall Study||33
5252696|NCT00787202|12913076|P3|Treated|Overall Study||33
5252697|NCT00787202|12913077|P2|Treated|Overall Study||31
5252698|NCT00787202|12913078|P1|Treated|Overall Study||48
5252699|NCT00787202|12913074|P5|STARTED|Overall Study||49
5252700|NCT00787202|12913075|P4|STARTED|Overall Study||33
5252701|NCT00787202|12913076|P3|STARTED|Overall Study||33
5252702|NCT00787202|12913077|P2|STARTED|Overall Study||31
5252703|NCT00787202|12913078|P1|STARTED|Overall Study||49
5252704|NCT00787189|12913131|P2|NOT COMPLETED|Overall Study||2
5252705|NCT00787189|12913132|P1|NOT COMPLETED|Overall Study||2
5252706|NCT00787189|12913131|P2|COMPLETED|Overall Study|To study end point.|30
5252707|NCT00787189|12913132|P1|COMPLETED|Overall Study|To study end point.|30
5252708|NCT00787189|12913131|P2|STARTED|Overall Study||32
5252709|NCT00787189|12913132|P1|STARTED|Overall Study||32
5252710|NCT00787150|12913141|P3|NOT COMPLETED|Overall Study||5
5252711|NCT00787150|12913142|P2|NOT COMPLETED|Overall Study||7
5252712|NCT00787150|12913143|P1|NOT COMPLETED|Overall Study||9
5252713|NCT00787150|12913141|P3|COMPLETED|Overall Study||66
5252714|NCT00787150|12913142|P2|COMPLETED|Overall Study||65
5252715|NCT00787150|12913143|P1|COMPLETED|Overall Study||66
5252716|NCT00787150|12913141|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
5252717|NCT00787150|12913142|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
5252718|NCT00787150|12913143|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
5252719|NCT00787137|12913188|P3|NOT COMPLETED|Overall Study||1
5252720|NCT00787137|12913189|P2|NOT COMPLETED|Overall Study||0
5252721|NCT00787137|12913190|P1|NOT COMPLETED|Overall Study||0
5252722|NCT00787137|12913188|P3|COMPLETED|Overall Study||4
5252723|NCT00787137|12913189|P2|COMPLETED|Overall Study||6
5252724|NCT00787137|12913190|P1|COMPLETED|Overall Study||6
5252725|NCT00787137|12913188|P3|STARTED|Overall Study||5
5252726|NCT00787137|12913189|P2|STARTED|Overall Study||6
5252727|NCT00787137|12913190|P1|STARTED|Overall Study||6
5252728|NCT00787124|12913212|P2|NOT COMPLETED|Overall Study||0
5252729|NCT00787124|12913213|P1|NOT COMPLETED|Overall Study||0
5252730|NCT00787124|12913212|P2|COMPLETED|Overall Study||4
5252731|NCT00787124|12913213|P1|COMPLETED|Overall Study||4
5252732|NCT00787124|12913212|P2|STARTED|Overall Study||4
5252733|NCT00787124|12913213|P1|STARTED|Overall Study||4
5252734|NCT00787020|12913223|P2|NOT COMPLETED|Overall Study||0
5252735|NCT00787020|12913224|P1|NOT COMPLETED|Overall Study||0
5252736|NCT00787020|12913223|P2|COMPLETED|Overall Study||13
5252737|NCT00787020|12913224|P1|COMPLETED|Overall Study||24
5252738|NCT00787020|12913223|P2|STARTED|Overall Study||13
5252739|NCT00787020|12913224|P1|STARTED|Overall Study||24
5252740|NCT00786994|12913238|P4|NOT COMPLETED|Overall Study||6
5252741|NCT00786994|12913239|P3|NOT COMPLETED|Overall Study||2
5252742|NCT00786994|12913240|P2|NOT COMPLETED|Overall Study||15
5252743|NCT00786994|12913241|P1|NOT COMPLETED|Overall Study||10
5252744|NCT00786994|12913238|P4|COMPLETED|Overall Study||22
5252745|NCT00786994|12913239|P3|COMPLETED|Overall Study||24
5252746|NCT00786994|12913240|P2|COMPLETED|Overall Study||39
5252747|NCT00786994|12913241|P1|COMPLETED|Overall Study||47
5252748|NCT00786994|12913238|P4|ITT|Overall Study||28
5252749|NCT00786994|12913239|P3|ITT|Overall Study||25
5252750|NCT00786994|12913240|P2|ITT|Overall Study||51
5252751|NCT00786994|12913241|P1|ITT|Overall Study||53
5252752|NCT00786994|12913238|P4|STARTED|Overall Study||28
5252753|NCT00786994|12913239|P3|STARTED|Overall Study||26
5252754|NCT00786994|12913240|P2|STARTED|Overall Study||54
5252755|NCT00786994|12913241|P1|STARTED|Overall Study||57
5252756|NCT00786916|12913253|P3|NOT COMPLETED|Overall Study||0
5252757|NCT00786916|12913254|P2|NOT COMPLETED|Overall Study||0
5252758|NCT00786916|12913255|P1|NOT COMPLETED|Overall Study||0
5252759|NCT00786916|12913253|P3|COMPLETED|Overall Study||34
5252760|NCT00786916|12913254|P2|COMPLETED|Overall Study||36
5252761|NCT00786916|12913255|P1|COMPLETED|Overall Study||39
5252762|NCT00786916|12913253|P3|STARTED|Overall Study||34
5252763|NCT00786916|12913254|P2|STARTED|Overall Study||36
5252764|NCT00786916|12913255|P1|STARTED|Overall Study||39
5252765|NCT00786864|12913265|P2|NOT COMPLETED|Overall Study||1
5252766|NCT00786864|12913266|P1|NOT COMPLETED|Overall Study||1
5252767|NCT00786864|12913265|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
5252768|NCT00786864|12913266|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
5252769|NCT00786864|12913265|P2|STARTED|Overall Study||33
5252770|NCT00786864|12913266|P1|STARTED|Overall Study||39
5252771|NCT00786838|12913278|P1|NOT COMPLETED|Overall Study||49
5252772|NCT00786838|12913278|P1|COMPLETED|Overall Study||26
5252773|NCT00786838|12913278|P1|STARTED|Overall Study||75
5252774|NCT00786825|12913305|P2|NOT COMPLETED|Overall Study||0
5252775|NCT00786825|12913306|P1|NOT COMPLETED|Overall Study||0
5252776|NCT00786825|12913305|P2|COMPLETED|Overall Study||5
5252777|NCT00786825|12913306|P1|COMPLETED|Overall Study||5
5252778|NCT00786825|12913305|P2|STARTED|Overall Study||5
5252779|NCT00786825|12913306|P1|STARTED|Overall Study||5
5252780|NCT00786799|12913314|P2|NOT COMPLETED|Overall Study||1
5252781|NCT00786799|12913315|P1|NOT COMPLETED|Overall Study||1
5252782|NCT00786799|12913314|P2|COMPLETED|Overall Study||12
5252783|NCT00786799|12913315|P1|COMPLETED|Overall Study||13
5252784|NCT00786799|12913314|P2|STARTED|Overall Study||13
5252785|NCT00786799|12913315|P1|STARTED|Overall Study||14
5252786|NCT00786682|12913326|P1|NOT COMPLETED|Overall Study||0
5252787|NCT00786682|12913326|P1|COMPLETED|Overall Study||11
5252788|NCT00786682|12913326|P1|STARTED|Overall Study||11
5252789|NCT00786643|12913334|P2|NOT COMPLETED|Overall Study||0
5252790|NCT00786643|12913335|P1|NOT COMPLETED|Overall Study||0
5252791|NCT00786643|12913334|P2|COMPLETED|Overall Study||28
5252792|NCT00786643|12913335|P1|COMPLETED|Overall Study||20
5252793|NCT00786643|12913334|P2|STARTED|Overall Study||28
5252794|NCT00786643|12913335|P1|STARTED|Overall Study||20
5252795|NCT00786565|12913345|P1|NOT COMPLETED|Post Surgery||2
5252796|NCT00786565|12913345|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
5252797|NCT00786565|12913345|P1|STARTED|Post Surgery||69
5252798|NCT00786565|12913345|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
5252799|NCT00786565|12913345|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
5252800|NCT00786565|12913345|P1|STARTED|Enrollment Prior to Surgery||75
5252801|NCT00786487|12913387|P4|NOT COMPLETED|Overall Study||0
5252802|NCT00786487|12913388|P3|NOT COMPLETED|Overall Study||0
5252803|NCT00786487|12913389|P2|NOT COMPLETED|Overall Study||0
5252804|NCT00786487|12913390|P1|NOT COMPLETED|Overall Study||0
5252805|NCT00786487|12913387|P4|COMPLETED|Overall Study||7
5252806|NCT00786487|12913388|P3|COMPLETED|Overall Study||9
5252807|NCT00786487|12913389|P2|COMPLETED|Overall Study||7
5252808|NCT00786487|12913390|P1|COMPLETED|Overall Study||10
5252809|NCT00786487|12913387|P4|STARTED|Overall Study||7
5252810|NCT00786487|12913388|P3|STARTED|Overall Study||9
5252811|NCT00786487|12913389|P2|STARTED|Overall Study||7
5252812|NCT00786487|12913390|P1|STARTED|Overall Study||10
5252813|NCT00786474|12913402|P2|NOT COMPLETED|Overall Study||43
5252814|NCT00786474|12913403|P1|NOT COMPLETED|Overall Study||37
5252815|NCT00786474|12913402|P2|COMPLETED|Overall Study||891
5252816|NCT00786474|12913403|P1|COMPLETED|Overall Study||913
5252817|NCT00786474|12913402|P2|STARTED|Overall Study||934
5252818|NCT00786474|12913403|P1|STARTED|Overall Study||950
5252819|NCT00786422|12913415|P1|NOT COMPLETED|Follow-up Period||3
5252820|NCT00786422|12913415|P1|COMPLETED|Follow-up Period||17
5252821|NCT00786422|12913415|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
5252822|NCT00786422|12913415|P1|NOT COMPLETED|Rivaroxaban Treatment||11
5252823|NCT00786422|12913415|P1|COMPLETED|Rivaroxaban Treatment||14
5252824|NCT00786422|12913415|P1|STARTED|Rivaroxaban Treatment||25
5252825|NCT00786409|12913431|P1|NOT COMPLETED|Overall Study||7
5252826|NCT00786409|12913431|P1|COMPLETED|Overall Study||20
5252827|NCT00786409|12913431|P1|STARTED|Overall Study||27
5252828|NCT00786188|12913448|P2|NOT COMPLETED|Overall Study||1
5252829|NCT00786188|12913449|P1|NOT COMPLETED|Overall Study||5
5252830|NCT00786188|12913448|P2|COMPLETED|Overall Study||51
5252831|NCT00786188|12913449|P1|COMPLETED|Overall Study||45
5252832|NCT00786188|12913448|P2|STARTED|Overall Study||52
5252833|NCT00786188|12913449|P1|STARTED|Overall Study||50
5252834|NCT00786032|12913475|P1|NOT COMPLETED|Overall Study||24
5252835|NCT00786032|12913475|P1|COMPLETED|Overall Study||3
5252836|NCT00786032|12913475|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
5252837|NCT00786032|12913475|P1|STARTED|Overall Study||27
5252838|NCT00786019|12913487|P2|NOT COMPLETED|Overall Study||10
5252839|NCT00786019|12913488|P1|NOT COMPLETED|Overall Study||5
5252840|NCT00786019|12913487|P2|COMPLETED|Overall Study||17
5252841|NCT00786019|12913488|P1|COMPLETED|Overall Study||15
5252842|NCT00786019|12913487|P2|STARTED|Overall Study||27
5252843|NCT00786019|12913488|P1|STARTED|Overall Study||20
5252844|NCT00785980|12913496|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
5252845|NCT00785980|12913496|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
5252846|NCT00785980|12913496|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
5252847|NCT00785980|12913496|P1|NOT COMPLETED|Ciprofloxacin Alone||0
5252848|NCT00785980|12913496|P1|COMPLETED|Ciprofloxacin Alone||21
5252849|NCT00785980|12913496|P1|STARTED|Ciprofloxacin Alone||21
5252850|NCT00785980|12913496|P1|NOT COMPLETED|7 Day Washout Period||3
5252851|NCT00785980|12913496|P1|COMPLETED|7 Day Washout Period||21
5252852|NCT00785980|12913496|P1|STARTED|7 Day Washout Period||24
5252853|NCT00785980|12913496|P1|NOT COMPLETED|Quinine Sulfate Alone||0
5252854|NCT00785980|12913496|P1|COMPLETED|Quinine Sulfate Alone||24
5252855|NCT00785980|12913496|P1|STARTED|Quinine Sulfate Alone||24
5252856|NCT00785928|12913514|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
5252857|NCT00785928|12913515|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
5252858|NCT00785928|12913516|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
5252859|NCT00785928|12913517|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
5252860|NCT00785928|12913518|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
5252861|NCT00785928|12913519|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
5252862|NCT00785928|12913520|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
5252863|NCT00785928|12913514|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
5252864|NCT00785928|12913515|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
5252865|NCT00785928|12913516|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
5252866|NCT00785928|12913517|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
5252867|NCT00785928|12913518|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
5252868|NCT00785928|12913519|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
5252869|NCT00785928|12913520|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
5252870|NCT00785928|12913514|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
5252871|NCT00785928|12913515|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
5252872|NCT00785928|12913516|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
5252873|NCT00785928|12913517|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
5252874|NCT00785928|12913518|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
5252875|NCT00785928|12913519|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
5252876|NCT00785928|12913520|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
5252877|NCT00785928|12913514|P7|NOT COMPLETED|Treatment Phase||3
5252878|NCT00785928|12913515|P6|NOT COMPLETED|Treatment Phase||0
5252879|NCT00785928|12913516|P5|NOT COMPLETED|Treatment Phase||2
5252880|NCT00785928|12913517|P4|NOT COMPLETED|Treatment Phase||0
5252881|NCT00785928|12913518|P3|NOT COMPLETED|Treatment Phase||3
5252882|NCT00785928|12913519|P2|NOT COMPLETED|Treatment Phase||5
5252883|NCT00785928|12913520|P1|NOT COMPLETED|Treatment Phase||3
5252884|NCT00785928|12913514|P7|COMPLETED|Treatment Phase||23
5252885|NCT00785928|12913515|P6|COMPLETED|Treatment Phase||13
5252886|NCT00785928|12913516|P5|COMPLETED|Treatment Phase||16
5252887|NCT00785928|12913517|P4|COMPLETED|Treatment Phase||15
5252888|NCT00785928|12913518|P3|COMPLETED|Treatment Phase||17
5252889|NCT00785928|12913519|P2|COMPLETED|Treatment Phase||25
5252890|NCT00785928|12913520|P1|COMPLETED|Treatment Phase||33
5252891|NCT00785928|12913514|P7|STARTED|Treatment Phase||26
5252892|NCT00785928|12913515|P6|STARTED|Treatment Phase||13
5252893|NCT00785928|12913516|P5|STARTED|Treatment Phase||18
5252894|NCT00785928|12913517|P4|STARTED|Treatment Phase||15
5252895|NCT00785928|12913518|P3|STARTED|Treatment Phase||20
5252896|NCT00785928|12913519|P2|STARTED|Treatment Phase||30
5252897|NCT00785928|12913520|P1|STARTED|Treatment Phase||36
5252898|NCT00785798|12913660|P1|NOT COMPLETED|Overall Study||1
5252899|NCT00785798|12913660|P1|COMPLETED|Overall Study||16
5252900|NCT00785798|12913660|P1|STARTED|Overall Study||17
5252901|NCT00785785|12913667|P2|NOT COMPLETED|Optional Extension Phase||125
5252902|NCT00785785|12913668|P1|NOT COMPLETED|Optional Extension Phase||39
5252903|NCT00785785|12913667|P2|COMPLETED|Optional Extension Phase||0
5252904|NCT00785785|12913668|P1|COMPLETED|Optional Extension Phase||0
5252905|NCT00785785|12913667|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
5252906|NCT00785785|12913668|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
5252907|NCT00785785|12913667|P2|NOT COMPLETED|Core Phase up to 36 Months||320
5252908|NCT00785785|12913668|P1|NOT COMPLETED|Core Phase up to 36 Months||324
5252909|NCT00785785|12913667|P2|COMPLETED|Core Phase up to 36 Months||0
5252910|NCT00785785|12913668|P1|COMPLETED|Core Phase up to 36 Months||0
5252911|NCT00785785|12913667|P2|STARTED|Core Phase up to 36 Months||320
5252912|NCT00785785|12913668|P1|STARTED|Core Phase up to 36 Months||324
5252913|NCT00785772|12913676|P1|NOT COMPLETED|Overall Study||0
5252914|NCT00785772|12913676|P1|COMPLETED|Overall Study||1
5252915|NCT00785772|12913676|P1|STARTED|Overall Study||1
5252916|NCT00785707|12913682|P1|NOT COMPLETED|Overall Study||7
5252917|NCT00785707|12913682|P1|COMPLETED|Overall Study||24
5252918|NCT00785707|12913682|P1|STARTED|Overall Study||31
5252919|NCT00785629|12913691|P4|NOT COMPLETED|Overall Study||16
5252920|NCT00785629|12913692|P3|NOT COMPLETED|Overall Study||10
5252921|NCT00785629|12913693|P2|NOT COMPLETED|Overall Study||5
5252922|NCT00785629|12913694|P1|NOT COMPLETED|Overall Study||8
5252923|NCT00785629|12913691|P4|COMPLETED|Overall Study|16 not completed|41
5252924|NCT00785629|12913692|P3|COMPLETED|Overall Study|10 not completed|18
5252925|NCT00785629|12913693|P2|COMPLETED|Overall Study|5 not completed|25
5252926|NCT00785629|12913694|P1|COMPLETED|Overall Study|8 not completed|22
5252927|NCT00785629|12913691|P4|STARTED|Overall Study||57
5252928|NCT00785629|12913692|P3|STARTED|Overall Study||28
5252929|NCT00785629|12913693|P2|STARTED|Overall Study||30
5252930|NCT00785629|12913694|P1|STARTED|Overall Study||30
5252931|NCT00785577|12913707|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
5252932|NCT00785577|12913708|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
5252933|NCT00785577|12913709|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
5252934|NCT00785577|12913710|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
5252935|NCT00785577|12913711|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
5252936|NCT00785577|12913707|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
5252937|NCT00785577|12913708|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
5252938|NCT00785577|12913709|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
5252939|NCT00785577|12913710|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
5252940|NCT00785577|12913711|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
5252941|NCT00785577|12913707|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
5252942|NCT00785577|12913708|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
5252943|NCT00785577|12913709|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
5252944|NCT00785577|12913710|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
5252945|NCT00785577|12913711|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
5252946|NCT00785577|12913707|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
5252947|NCT00785577|12913708|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
5252948|NCT00785577|12913709|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
5252949|NCT00785577|12913710|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
5252950|NCT00785577|12913711|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
5252951|NCT00785577|12913707|P5|COMPLETED|Study Period 2: Therapy Phase||27
5252952|NCT00785577|12913708|P4|COMPLETED|Study Period 2: Therapy Phase||36
5252953|NCT00785577|12913709|P3|COMPLETED|Study Period 2: Therapy Phase||25
5252954|NCT00785577|12913710|P2|COMPLETED|Study Period 2: Therapy Phase||36
5252955|NCT00785577|12913711|P1|COMPLETED|Study Period 2: Therapy Phase||78
5252956|NCT00785577|12913707|P5|STARTED|Study Period 2: Therapy Phase||47
5252957|NCT00785577|12913708|P4|STARTED|Study Period 2: Therapy Phase||49
5252958|NCT00785577|12913709|P3|STARTED|Study Period 2: Therapy Phase||43
5252959|NCT00785577|12913710|P2|STARTED|Study Period 2: Therapy Phase||45
5252960|NCT00785577|12913711|P1|STARTED|Study Period 2: Therapy Phase||89
5252961|NCT00785538|12913851|P4|NOT COMPLETED|Treatment Period||1
5252962|NCT00785538|12913852|P3|NOT COMPLETED|Treatment Period||2
5252963|NCT00785538|12913853|P2|NOT COMPLETED|Treatment Period||2
5252964|NCT00785538|12913854|P1|NOT COMPLETED|Treatment Period||1
5252965|NCT00785538|12913851|P4|COMPLETED|Treatment Period||1
5252966|NCT00785538|12913852|P3|COMPLETED|Treatment Period||4
5252967|NCT00785538|12913853|P2|COMPLETED|Treatment Period||7
5252968|NCT00785538|12913854|P1|COMPLETED|Treatment Period||6
5252969|NCT00785538|12913851|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
5252970|NCT00785538|12913852|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
5252971|NCT00785538|12913853|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
5252972|NCT00785538|12913854|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
5252973|NCT00785538|12913851|P4|STARTED|Treatment Period||2
5252974|NCT00785538|12913852|P3|STARTED|Treatment Period||6
5252975|NCT00785538|12913853|P2|STARTED|Treatment Period||9
5252976|NCT00785538|12913854|P1|STARTED|Treatment Period||7
5252977|NCT00785538|12913851|P4|NOT COMPLETED|PK Period||0
5252978|NCT00785538|12913852|P3|NOT COMPLETED|PK Period||0
5252979|NCT00785538|12913853|P2|NOT COMPLETED|PK Period||0
5252980|NCT00785538|12913854|P1|NOT COMPLETED|PK Period||0
5252981|NCT00785538|12913851|P4|COMPLETED|PK Period||0
5252982|NCT00785538|12913852|P3|COMPLETED|PK Period||1
5252983|NCT00785538|12913853|P2|COMPLETED|PK Period||1
5252984|NCT00785538|12913854|P1|COMPLETED|PK Period||7
5252985|NCT00785538|12913851|P4|STARTED|PK Period||0
5252986|NCT00785538|12913852|P3|STARTED|PK Period||1
5252987|NCT00785538|12913853|P2|STARTED|PK Period||1
5252988|NCT00785538|12913854|P1|STARTED|PK Period||7
5252989|NCT00785512|12913902|P2|NOT COMPLETED|Overall Study||4
5252990|NCT00785512|12913903|P1|NOT COMPLETED|Overall Study||3
5252991|NCT00785512|12913902|P2|COMPLETED|Overall Study||101
5252992|NCT00785512|12913903|P1|COMPLETED|Overall Study||99
5252993|NCT00785512|12913902|P2|STARTED|Overall Study||105
5252994|NCT00785512|12913903|P1|STARTED|Overall Study||102
5252995|NCT00785486|12913912|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
5252996|NCT00785486|12913912|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
5252997|NCT00785486|12913912|P1|STARTED|Midazolam With Qualaquin at Steady State||23
5252998|NCT00785486|12913912|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
5252999|NCT00785486|12913912|P1|COMPLETED|Qualaquin Alone at Steady State||23
5253000|NCT00785486|12913912|P1|STARTED|Qualaquin Alone at Steady State||23
5253001|NCT00785486|12913912|P1|NOT COMPLETED|3 Day Washout||0
5253002|NCT00785486|12913912|P1|COMPLETED|3 Day Washout||23
5253003|NCT00785486|12913912|P1|STARTED|3 Day Washout||23
5253004|NCT00785486|12913912|P1|NOT COMPLETED|Midazolam Alone||1
5253005|NCT00785486|12913912|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
5253006|NCT00785486|12913912|P1|STARTED|Midazolam Alone||24
5253007|NCT00785356|12913936|P1|NOT COMPLETED|Overall Study||8
5253008|NCT00785356|12913936|P1|COMPLETED|Overall Study||0
5253009|NCT00785356|12913936|P1|STARTED|Overall Study||8
5253010|NCT00785291|12913947|P3|NOT COMPLETED|Overall Study||106
5253011|NCT00785291|12913948|P2|NOT COMPLETED|Overall Study||149
5253012|NCT00785291|12913949|P1|NOT COMPLETED|Overall Study||136
5253013|NCT00785291|12913947|P3|COMPLETED|Overall Study||139
5253014|NCT00785291|12913948|P2|COMPLETED|Overall Study||122
5253015|NCT00785291|12913949|P1|COMPLETED|Overall Study||147
5253016|NCT00785291|12913947|P3|STARTED|Overall Study||245
5253017|NCT00785291|12913948|P2|STARTED|Overall Study||271
5253018|NCT00785291|12913949|P1|STARTED|Overall Study||283
5253019|NCT00785213|12913969|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
5253020|NCT00785213|12913969|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
5253021|NCT00785213|12913969|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
5253022|NCT00785213|12913969|P1|NOT COMPLETED|Quinine Sulfate Alone||4
5253023|NCT00785213|12913969|P1|COMPLETED|Quinine Sulfate Alone||19
5253024|NCT00785213|12913969|P1|STARTED|Quinine Sulfate Alone||23
5253025|NCT00785213|12913969|P1|NOT COMPLETED|2 Day Washout Period||0
5253026|NCT00785213|12913969|P1|COMPLETED|2 Day Washout Period||23
5253027|NCT00785213|12913969|P1|STARTED|2 Day Washout Period||23
5253028|NCT00785213|12913969|P1|NOT COMPLETED|Rosiglitazone Alone||0
5253029|NCT00785213|12913969|P1|COMPLETED|Rosiglitazone Alone||23
5253030|NCT00785213|12913969|P1|STARTED|Rosiglitazone Alone||23
5253031|NCT00785044|12913980|P1|NOT COMPLETED|Overall Study||496
5253032|NCT00785044|12913980|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
5253033|NCT00785044|12913980|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
5253034|NCT00785044|12913980|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
5253035|NCT00784979|12913985|P1|NOT COMPLETED|Overall Study||6
5253036|NCT00784979|12913985|P1|COMPLETED|Overall Study||20
5253037|NCT00784979|12913985|P1|STARTED|Overall Study||26
5253038|NCT00784927|12913989|P1|NOT COMPLETED|Overall Study||3
5253039|NCT00784927|12913989|P1|COMPLETED|Overall Study||33
5253040|NCT00784927|12913989|P1|STARTED|Overall Study||36
5253041|NCT00784875|12914001|P4|NOT COMPLETED|Period D||1
5253042|NCT00784875|12914002|P3|NOT COMPLETED|Period D||6
5253043|NCT00784875|12914003|P2|NOT COMPLETED|Period D||4
5253044|NCT00784875|12914004|P1|NOT COMPLETED|Period D||5
5253045|NCT00784875|12914001|P4|COMPLETED|Period D||87
5253046|NCT00784875|12914002|P3|COMPLETED|Period D||88
5253047|NCT00784875|12914003|P2|COMPLETED|Period D||85
5253048|NCT00784875|12914004|P1|COMPLETED|Period D||86
5253049|NCT00784875|12914001|P4|STARTED|Period D||88
5253050|NCT00784875|12914002|P3|STARTED|Period D||94
5253051|NCT00784875|12914003|P2|STARTED|Period D||89
5253052|NCT00784875|12914004|P1|STARTED|Period D||91
5253053|NCT00784875|12914001|P4|NOT COMPLETED|Period C||7
5253054|NCT00784875|12914002|P3|NOT COMPLETED|Period C||13
5253055|NCT00784875|12914003|P2|NOT COMPLETED|Period C||6
5253056|NCT00784875|12914004|P1|NOT COMPLETED|Period C||7
5253057|NCT00784875|12914001|P4|COMPLETED|Period C||91
5253058|NCT00784875|12914002|P3|COMPLETED|Period C||84
5253059|NCT00784875|12914003|P2|COMPLETED|Period C||91
5253060|NCT00784875|12914004|P1|COMPLETED|Period C||96
5253061|NCT00784875|12914001|P4|STARTED|Period C||98
5253062|NCT00784875|12914002|P3|STARTED|Period C||97
5253063|NCT00784875|12914003|P2|STARTED|Period C||97
5253064|NCT00784875|12914004|P1|STARTED|Period C||103
5253065|NCT00784875|12914001|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
5253066|NCT00784875|12914002|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
5253067|NCT00784875|12914003|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
5253068|NCT00784875|12914004|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
5253069|NCT00784875|12914001|P4|COMPLETED|Period B - Efficacy Endpoint||98
5253070|NCT00784875|12914002|P3|COMPLETED|Period B - Efficacy Endpoint||96
5253071|NCT00784875|12914003|P2|COMPLETED|Period B - Efficacy Endpoint||101
5253072|NCT00784875|12914004|P1|COMPLETED|Period B - Efficacy Endpoint||100
5253073|NCT00784875|12914001|P4|Cohort 2|Period B - Efficacy Endpoint||101
5253074|NCT00784875|12914002|P3|Cohort 2|Period B - Efficacy Endpoint||102
5253075|NCT00784875|12914003|P2|Cohort 2|Period B - Efficacy Endpoint||102
5253076|NCT00784875|12914004|P1|Cohort 2|Period B - Efficacy Endpoint||102
5253077|NCT00784875|12914001|P4|STARTED|Period B - Efficacy Endpoint||117
5253078|NCT00784875|12914002|P3|STARTED|Period B - Efficacy Endpoint||117
5253079|NCT00784875|12914003|P2|STARTED|Period B - Efficacy Endpoint||113
5253080|NCT00784875|12914004|P1|STARTED|Period B - Efficacy Endpoint||114
5253081|NCT00784875|12914001|P4|NOT COMPLETED|Period A - Baseline||182
5253082|NCT00784875|12914002|P3|NOT COMPLETED|Period A - Baseline||0
5253083|NCT00784875|12914003|P2|NOT COMPLETED|Period A - Baseline||0
5253084|NCT00784875|12914004|P1|NOT COMPLETED|Period A - Baseline||0
5253085|NCT00784875|12914001|P4|COMPLETED|Period A - Baseline||461
5253086|NCT00784875|12914002|P3|COMPLETED|Period A - Baseline||0
5253087|NCT00784875|12914003|P2|COMPLETED|Period A - Baseline||0
5253088|NCT00784875|12914004|P1|COMPLETED|Period A - Baseline||0
5253089|NCT00784875|12914001|P4|STARTED|Period A - Baseline||643
5253090|NCT00784875|12914002|P3|STARTED|Period A - Baseline||0
5253091|NCT00784875|12914003|P2|STARTED|Period A - Baseline||0
5253092|NCT00784875|12914004|P1|STARTED|Period A - Baseline||0
5253093|NCT00784849|12914118|P1|NOT COMPLETED|Overall Study||0
5253094|NCT00784849|12914118|P1|COMPLETED|Overall Study||62
5253095|NCT00784849|12914118|P1|STARTED|Overall Study||62
5253096|NCT00784836|12914124|P1|NOT COMPLETED|Overall Study||3
5253097|NCT00784836|12914124|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
5253098|NCT00784836|12914124|P1|STARTED|Overall Study||3
5253099|NCT00784810|12914131|P2|NOT COMPLETED|Overall Study||49
5253100|NCT00784810|12914132|P1|NOT COMPLETED|Overall Study||63
5253101|NCT00784810|12914131|P2|COMPLETED|Overall Study||74
5253102|NCT00784810|12914132|P1|COMPLETED|Overall Study||61
5253103|NCT00784810|12914131|P2|STARTED|Overall Study||123
5253104|NCT00784810|12914132|P1|STARTED|Overall Study||124
5253105|NCT00784784|12914142|P2|NOT COMPLETED|Overall Study||2
5253106|NCT00784784|12914143|P1|NOT COMPLETED|Overall Study||2
5253107|NCT00784784|12914142|P2|COMPLETED|Overall Study||40
5253108|NCT00784784|12914143|P1|COMPLETED|Overall Study||20
5253109|NCT00784784|12914142|P2|STARTED|Overall Study||42
5253110|NCT00784784|12914143|P1|STARTED|Overall Study||22
5253111|NCT00784758|12914153|P2|NOT COMPLETED|Overall Study||0
5253112|NCT00784758|12914154|P1|NOT COMPLETED|Overall Study||4
5253113|NCT00784758|12914153|P2|COMPLETED|Overall Study||39
5253114|NCT00784758|12914154|P1|COMPLETED|Overall Study||38
5253115|NCT00784758|12914153|P2|Completed Treatment|Overall Study||39
5253116|NCT00784758|12914154|P1|Completed Treatment|Overall Study||40
5253117|NCT00784758|12914153|P2|Began Treatment|Overall Study||39
5253118|NCT00784758|12914154|P1|Began Treatment|Overall Study||41
5253119|NCT00784758|12914153|P2|STARTED|Overall Study||39
5253120|NCT00784758|12914154|P1|STARTED|Overall Study||42
5253121|NCT00784719|12914203|P7|NOT COMPLETED|Overall Study||5
5253122|NCT00784719|12914204|P6|NOT COMPLETED|Overall Study||3
5253123|NCT00784719|12914205|P5|NOT COMPLETED|Overall Study||6
5253124|NCT00784719|12914206|P4|NOT COMPLETED|Overall Study||0
5253125|NCT00784719|12914207|P3|NOT COMPLETED|Overall Study||1
5253126|NCT00784719|12914208|P2|NOT COMPLETED|Overall Study||3
5253127|NCT00784719|12914209|P1|NOT COMPLETED|Overall Study||3
5253128|NCT00784719|12914203|P7|COMPLETED|Overall Study||42
5253129|NCT00784719|12914204|P6|COMPLETED|Overall Study||41
5253130|NCT00784719|12914205|P5|COMPLETED|Overall Study||42
5253131|NCT00784719|12914206|P4|COMPLETED|Overall Study||48
5253132|NCT00784719|12914207|P3|COMPLETED|Overall Study||46
5253133|NCT00784719|12914208|P2|COMPLETED|Overall Study||43
5253134|NCT00784719|12914209|P1|COMPLETED|Overall Study||44
5253135|NCT00784719|12914203|P7|STARTED|Overall Study||47
5253136|NCT00784719|12914204|P6|STARTED|Overall Study||44
5253137|NCT00784719|12914205|P5|STARTED|Overall Study||48
5253138|NCT00784719|12914206|P4|STARTED|Overall Study||48
5253139|NCT00784719|12914207|P3|STARTED|Overall Study||47
5253140|NCT00784719|12914208|P2|STARTED|Overall Study||46
5253141|NCT00784719|12914209|P1|STARTED|Overall Study||47
5253142|NCT00784654|12914379|P3|NOT COMPLETED|Randomized Withdrawal Period||63
5253143|NCT00784654|12914380|P2|NOT COMPLETED|Randomized Withdrawal Period||18
5253144|NCT00784654|12914381|P1|NOT COMPLETED|Randomized Withdrawal Period||0
5253145|NCT00784654|12914379|P3|COMPLETED|Randomized Withdrawal Period||16
5253146|NCT00784654|12914380|P2|COMPLETED|Randomized Withdrawal Period||60
5253147|NCT00784654|12914381|P1|COMPLETED|Randomized Withdrawal Period||0
5253148|NCT00784654|12914379|P3|STARTED|Randomized Withdrawal Period||79
5253149|NCT00784654|12914380|P2|STARTED|Randomized Withdrawal Period||78
5253150|NCT00784654|12914381|P1|STARTED|Randomized Withdrawal Period||0
5253151|NCT00784654|12914379|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
5253152|NCT00784654|12914380|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
5253153|NCT00784654|12914381|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
5253154|NCT00784654|12914379|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
5253155|NCT00784654|12914380|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
5253156|NCT00784654|12914381|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
5253157|NCT00784654|12914379|P3|STARTED|Open-Label Period (Non-Randomized)||0
5253158|NCT00784654|12914380|P2|STARTED|Open-Label Period (Non-Randomized)||0
5253159|NCT00784654|12914381|P1|STARTED|Open-Label Period (Non-Randomized)||276
5253160|NCT00784563|12914416|P3|NOT COMPLETED|Year 3||3
5253161|NCT00784563|12914417|P2|NOT COMPLETED|Year 3||0
5253162|NCT00784563|12914418|P1|NOT COMPLETED|Year 3||0
5253163|NCT00784563|12914416|P3|COMPLETED|Year 3||14
5253164|NCT00784563|12914417|P2|COMPLETED|Year 3||0
5253165|NCT00784563|12914418|P1|COMPLETED|Year 3||0
5253166|NCT00784563|12914416|P3|STARTED|Year 3||17
5253167|NCT00784563|12914417|P2|STARTED|Year 3||0
5253168|NCT00784563|12914418|P1|STARTED|Year 3||0
5253169|NCT00784563|12914416|P3|NOT COMPLETED|Years 1 & 2||0
5253170|NCT00784563|12914417|P2|NOT COMPLETED|Years 1 & 2||5
5253171|NCT00784563|12914418|P1|NOT COMPLETED|Years 1 & 2||3
5253172|NCT00784563|12914416|P3|COMPLETED|Years 1 & 2||0
5253173|NCT00784563|12914417|P2|COMPLETED|Years 1 & 2||17
5253174|NCT00784563|12914418|P1|COMPLETED|Years 1 & 2||18
5253175|NCT00784563|12914416|P3|STARTED|Years 1 & 2||0
5253176|NCT00784563|12914417|P2|STARTED|Years 1 & 2||22
5253177|NCT00784563|12914418|P1|STARTED|Years 1 & 2||21
5253178|NCT00784550|12914436|P2|NOT COMPLETED|Overall Study||42
5253179|NCT00784550|12914437|P1|NOT COMPLETED|Overall Study||36
5253180|NCT00784550|12914436|P2|COMPLETED|Overall Study||127
5253181|NCT00784550|12914437|P1|COMPLETED|Overall Study||137
5253182|NCT00784550|12914436|P2|STARTED|Overall Study||169
5253183|NCT00784550|12914437|P1|STARTED|Overall Study||173
5253184|NCT00784524|12914453|P1|NOT COMPLETED|Overall Study||0
5253185|NCT00784524|12914453|P1|COMPLETED|Overall Study||14
5253186|NCT00784524|12914453|P1|STARTED|Overall Study||14
5253187|NCT00784459|12914463|P2|NOT COMPLETED|Overall Study||2
5253188|NCT00784459|12914464|P1|NOT COMPLETED|Overall Study||0
5253189|NCT00784459|12914463|P2|COMPLETED|Overall Study||11
5253190|NCT00784459|12914464|P1|COMPLETED|Overall Study||11
5253191|NCT00784459|12914463|P2|STARTED|Overall Study||13
5253192|NCT00784459|12914464|P1|STARTED|Overall Study||11
5253193|NCT00784368|12914475|P3|NOT COMPLETED|Overall Study||11
5253194|NCT00784368|12914476|P2|NOT COMPLETED|Overall Study||11
5253195|NCT00784368|12914477|P1|NOT COMPLETED|Overall Study||8
5253196|NCT00784368|12914475|P3|COMPLETED|Overall Study||12
5253197|NCT00784368|12914476|P2|COMPLETED|Overall Study||5
5253198|NCT00784368|12914477|P1|COMPLETED|Overall Study||8
5253199|NCT00784368|12914475|P3|STARTED|Overall Study||23
5253200|NCT00784368|12914476|P2|STARTED|Overall Study||16
5253201|NCT00784368|12914477|P1|STARTED|Overall Study||16
5253202|NCT00784303|12914513|P2|NOT COMPLETED|Overall Study||0
5253203|NCT00784303|12914514|P1|NOT COMPLETED|Overall Study||0
5253204|NCT00784303|12914513|P2|COMPLETED|Overall Study||59
5253205|NCT00784303|12914514|P1|COMPLETED|Overall Study||58
5253206|NCT00784303|12914513|P2|STARTED|Overall Study||59
5253207|NCT00784303|12914514|P1|STARTED|Overall Study||58
5253208|NCT00784277|12914553|P7|NOT COMPLETED|ER Treatment||15
5253209|NCT00784277|12914554|P6|NOT COMPLETED|ER Treatment||24
5253210|NCT00784277|12914555|P5|NOT COMPLETED|ER Treatment||9
5253211|NCT00784277|12914556|P4|NOT COMPLETED|ER Treatment||0
5253212|NCT00784277|12914557|P3|NOT COMPLETED|ER Treatment||0
5253213|NCT00784277|12914558|P2|NOT COMPLETED|ER Treatment||0
5253214|NCT00784277|12914559|P1|NOT COMPLETED|ER Treatment||0
5253215|NCT00784277|12914553|P7|COMPLETED|ER Treatment||76
5253216|NCT00784277|12914554|P6|COMPLETED|ER Treatment||226
5253217|NCT00784277|12914555|P5|COMPLETED|ER Treatment||113
5253218|NCT00784277|12914556|P4|COMPLETED|ER Treatment||0
5253219|NCT00784277|12914557|P3|COMPLETED|ER Treatment||0
5253220|NCT00784277|12914558|P2|COMPLETED|ER Treatment||0
5253221|NCT00784277|12914559|P1|COMPLETED|ER Treatment||0
5253222|NCT00784277|12914553|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
5253223|NCT00784277|12914554|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
5253224|NCT00784277|12914555|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
5253225|NCT00784277|12914556|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
5253226|NCT00784277|12914557|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
5253227|NCT00784277|12914558|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
5253228|NCT00784277|12914559|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
5253229|NCT00784277|12914553|P7|NOT COMPLETED|IR Treatment||0
5253230|NCT00784277|12914554|P6|NOT COMPLETED|IR Treatment||0
5253231|NCT00784277|12914555|P5|NOT COMPLETED|IR Treatment||0
5253232|NCT00784277|12914556|P4|NOT COMPLETED|IR Treatment||43
5253233|NCT00784277|12914557|P3|NOT COMPLETED|IR Treatment||28
5253234|NCT00784277|12914558|P2|NOT COMPLETED|IR Treatment||17
5253235|NCT00784277|12914559|P1|NOT COMPLETED|IR Treatment||16
5253236|NCT00784277|12914553|P7|COMPLETED|IR Treatment||0
5253237|NCT00784277|12914554|P6|COMPLETED|IR Treatment||0
5253238|NCT00784277|12914555|P5|COMPLETED|IR Treatment||0
5253239|NCT00784277|12914556|P4|COMPLETED|IR Treatment||100
5253240|NCT00784277|12914557|P3|COMPLETED|IR Treatment||126
5253241|NCT00784277|12914558|P2|COMPLETED|IR Treatment||134
5253242|NCT00784277|12914559|P1|COMPLETED|IR Treatment||132
5253243|NCT00784277|12914553|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
5253244|NCT00784277|12914554|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
5253245|NCT00784277|12914555|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
5253246|NCT00784277|12914556|P4|STARTED|IR Treatment||143
5253247|NCT00784277|12914557|P3|STARTED|IR Treatment||154
5253248|NCT00784277|12914558|P2|STARTED|IR Treatment||151
5253249|NCT00784277|12914559|P1|STARTED|IR Treatment||148
5253250|NCT00784238|12914576|P1|NOT COMPLETED|Overall Study||119
5253251|NCT00784238|12914576|P1|COMPLETED|Overall Study||170
5253252|NCT00784238|12914576|P1|STARTED|Overall Study||289
5253253|NCT00784225|12914621|P4|NOT COMPLETED|Overall Study||0
5253254|NCT00784225|12914622|P3|NOT COMPLETED|Overall Study||0
5253255|NCT00784225|12914623|P2|NOT COMPLETED|Overall Study||0
5253256|NCT00784225|12914624|P1|NOT COMPLETED|Overall Study||0
5253257|NCT00784225|12914621|P4|COMPLETED|Overall Study||3374
5253258|NCT00784225|12914622|P3|COMPLETED|Overall Study||3369
5253259|NCT00784225|12914623|P2|COMPLETED|Overall Study||3357
5253260|NCT00784225|12914624|P1|COMPLETED|Overall Study||3375
5253261|NCT00784225|12914621|P4|STARTED|Overall Study||3374
5253262|NCT00784225|12914622|P3|STARTED|Overall Study||3369
5253263|NCT00784225|12914623|P2|STARTED|Overall Study||3357
5253264|NCT00784225|12914624|P1|STARTED|Overall Study||3375
5253265|NCT00784147|12914648|P2|NOT COMPLETED|Overall Study||9
5253266|NCT00784147|12914649|P1|NOT COMPLETED|Overall Study||8
5253267|NCT00784147|12914648|P2|COMPLETED|Overall Study||45
5253268|NCT00784147|12914649|P1|COMPLETED|Overall Study||51
5253269|NCT00784147|12914648|P2|STARTED|Overall Study||54
5253270|NCT00784147|12914649|P1|STARTED|Overall Study||59
5253271|NCT00784134|12914669|P2|NOT COMPLETED|Overall Study||6
5253272|NCT00784134|12914670|P1|NOT COMPLETED|Overall Study||3
5253273|NCT00784134|12914669|P2|COMPLETED|Overall Study||245
5253274|NCT00784134|12914670|P1|COMPLETED|Overall Study||246
5253275|NCT00784134|12914669|P2|STARTED|Overall Study||251
5253276|NCT00784134|12914670|P1|STARTED|Overall Study||249
5253277|NCT00784095|12914769|P3|NOT COMPLETED|Overall Study||1
5253278|NCT00784095|12914770|P2|NOT COMPLETED|Overall Study||1
5253279|NCT00784095|12914771|P1|NOT COMPLETED|Overall Study||0
5253280|NCT00784095|12914769|P3|COMPLETED|Overall Study||11
5253281|NCT00784095|12914770|P2|COMPLETED|Overall Study||11
5253282|NCT00784095|12914771|P1|COMPLETED|Overall Study||12
5253283|NCT00784095|12914769|P3|STARTED|Overall Study||12
5253284|NCT00784095|12914770|P2|STARTED|Overall Study||12
5253285|NCT00784095|12914771|P1|STARTED|Overall Study||12
5253286|NCT00784043|12914793|P2|NOT COMPLETED|Overall Study||6
5253287|NCT00784043|12914794|P1|NOT COMPLETED|Overall Study||31
5253288|NCT00784043|12914793|P2|COMPLETED|Overall Study||0
5253289|NCT00784043|12914794|P1|COMPLETED|Overall Study||0
5253290|NCT00784043|12914793|P2|STARTED|Overall Study||6
5253291|NCT00784043|12914794|P1|STARTED|Overall Study||31
5253292|NCT00784030|12914806|P2|NOT COMPLETED|Overall Study||0
5253293|NCT00784030|12914807|P1|NOT COMPLETED|Overall Study||0
5253294|NCT00784030|12914806|P2|COMPLETED|Overall Study||10
5253295|NCT00784030|12914807|P1|COMPLETED|Overall Study||13
5253296|NCT00784030|12914806|P2|STARTED|Overall Study||10
5253297|NCT00784030|12914807|P1|STARTED|Overall Study||13
5253298|NCT00783965|12914815|P2|NOT COMPLETED|Second Intervention (24 Months)||9
5253299|NCT00783965|12914816|P1|NOT COMPLETED|Second Intervention (24 Months)||0
5253300|NCT00783965|12914815|P2|COMPLETED|Second Intervention (24 Months)||16
5253301|NCT00783965|12914816|P1|COMPLETED|Second Intervention (24 Months)||2
5253302|NCT00783965|12914815|P2|STARTED|Second Intervention (24 Months)||25
5253303|NCT00783965|12914816|P1|STARTED|Second Intervention (24 Months)||2
5253304|NCT00783965|12914815|P2|NOT COMPLETED|First Intervention (12 Months)||4
5253305|NCT00783965|12914816|P1|NOT COMPLETED|First Intervention (12 Months)||3
5253306|NCT00783965|12914815|P2|COMPLETED|First Intervention (12 Months)||25
5253307|NCT00783965|12914816|P1|COMPLETED|First Intervention (12 Months)||2
5253308|NCT00783965|12914815|P2|STARTED|First Intervention (12 Months)||29
5253309|NCT00783965|12914816|P1|STARTED|First Intervention (12 Months)||5
5253310|NCT00783952|12914824|P1|NOT COMPLETED|Overall Study||0
5253311|NCT00783952|12914824|P1|COMPLETED|Overall Study||8
5253312|NCT00783952|12914824|P1|STARTED|Overall Study||8
5253313|NCT00783835|12914829|P1|NOT COMPLETED|Overall Study||10
5253314|NCT00783835|12914829|P1|COMPLETED|Overall Study||50
5253315|NCT00783835|12914829|P1|STARTED|Overall Study||60
5253316|NCT00783796|12914841|P1|NOT COMPLETED|Overall Study||6
5253317|NCT00783796|12914841|P1|COMPLETED|Overall Study||144
5253318|NCT00783796|12914841|P1|STARTED|Overall Study||150
5253319|NCT00783718|12914946|P7|NOT COMPLETED|Maintenance Phase||195
5253320|NCT00783718|12914947|P6|NOT COMPLETED|Maintenance Phase||41
5253321|NCT00783718|12914948|P5|NOT COMPLETED|Maintenance Phase||45
5253322|NCT00783718|12914949|P4|NOT COMPLETED|Maintenance Phase||78
5253323|NCT00783718|12914950|P3|NOT COMPLETED|Maintenance Phase||0
5253324|NCT00783718|12914951|P2|NOT COMPLETED|Maintenance Phase||0
5253325|NCT00783718|12914952|P1|NOT COMPLETED|Maintenance Phase||105
5253326|NCT00783718|12914946|P7|COMPLETED|Maintenance Phase||135
5253327|NCT00783718|12914947|P6|COMPLETED|Maintenance Phase||84
5253328|NCT00783718|12914948|P5|COMPLETED|Maintenance Phase||77
5253329|NCT00783718|12914949|P4|COMPLETED|Maintenance Phase||48
5253330|NCT00783718|12914950|P3|COMPLETED|Maintenance Phase||0
5253331|NCT00783718|12914951|P2|COMPLETED|Maintenance Phase||0
5253332|NCT00783718|12914952|P1|COMPLETED|Maintenance Phase||30
5253333|NCT00783718|12914946|P7|STARTED|Maintenance Phase||330
5253334|NCT00783718|12914947|P6|STARTED|Maintenance Phase||125
5253335|NCT00783718|12914948|P5|STARTED|Maintenance Phase||122
5253336|NCT00783718|12914949|P4|STARTED|Maintenance Phase||126
5253337|NCT00783718|12914950|P3|STARTED|Maintenance Phase||0
5253338|NCT00783718|12914951|P2|STARTED|Maintenance Phase||0
5253339|NCT00783718|12914952|P1|STARTED|Maintenance Phase||135
5253340|NCT00783718|12914946|P7|NOT COMPLETED|Induction Phase||0
5253341|NCT00783718|12914947|P6|NOT COMPLETED|Induction Phase||0
5253342|NCT00783718|12914948|P5|NOT COMPLETED|Induction Phase||0
5253343|NCT00783718|12914949|P4|NOT COMPLETED|Induction Phase||0
5253344|NCT00783718|12914950|P3|NOT COMPLETED|Induction Phase||36
5253345|NCT00783718|12914951|P2|NOT COMPLETED|Induction Phase||7
5253346|NCT00783718|12914952|P1|NOT COMPLETED|Induction Phase||14
5253347|NCT00783718|12914946|P7|COMPLETED|Induction Phase||0
5253348|NCT00783718|12914947|P6|COMPLETED|Induction Phase||0
5253349|NCT00783718|12914948|P5|COMPLETED|Induction Phase||0
5253350|NCT00783718|12914949|P4|COMPLETED|Induction Phase||0
5253351|NCT00783718|12914950|P3|COMPLETED|Induction Phase||485
5253352|NCT00783718|12914951|P2|COMPLETED|Induction Phase||218
5253353|NCT00783718|12914952|P1|COMPLETED|Induction Phase||135
5253354|NCT00783718|12914946|P7|STARTED|Induction Phase||0
5253355|NCT00783718|12914947|P6|STARTED|Induction Phase||0
5253356|NCT00783718|12914948|P5|STARTED|Induction Phase||0
5253357|NCT00783718|12914949|P4|STARTED|Induction Phase||0
5253358|NCT00783718|12914950|P3|STARTED|Induction Phase||521
5253359|NCT00783718|12914951|P2|STARTED|Induction Phase||225
5253360|NCT00783718|12914952|P1|STARTED|Induction Phase||149
5253361|NCT00783705|12914980|P2|NOT COMPLETED|Overall Study||5
5253362|NCT00783705|12914981|P1|NOT COMPLETED|Overall Study||6
5253363|NCT00783705|12914980|P2|COMPLETED|Overall Study||36
5253364|NCT00783705|12914981|P1|COMPLETED|Overall Study||38
5253365|NCT00783705|12914980|P2|STARTED|Overall Study||41
5253366|NCT00783705|12914981|P1|STARTED|Overall Study||44
5253367|NCT00783692|12915028|P7|NOT COMPLETED|Maintenance Phase||249
5253368|NCT00783692|12915029|P6|NOT COMPLETED|Maintenance Phase||72
5253369|NCT00783692|12915030|P5|NOT COMPLETED|Maintenance Phase||81
5253370|NCT00783692|12915031|P4|NOT COMPLETED|Maintenance Phase||89
5253371|NCT00783692|12915032|P3|NOT COMPLETED|Maintenance Phase||0
5253372|NCT00783692|12915033|P2|NOT COMPLETED|Maintenance Phase||0
5253373|NCT00783692|12915034|P1|NOT COMPLETED|Maintenance Phase||95
5253374|NCT00783692|12915028|P7|COMPLETED|Maintenance Phase||163
5253375|NCT00783692|12915029|P6|COMPLETED|Maintenance Phase||82
5253376|NCT00783692|12915030|P5|COMPLETED|Maintenance Phase||73
5253377|NCT00783692|12915031|P4|COMPLETED|Maintenance Phase||64
5253378|NCT00783692|12915032|P3|COMPLETED|Maintenance Phase||0
5253379|NCT00783692|12915033|P2|COMPLETED|Maintenance Phase||0
5253380|NCT00783692|12915034|P1|COMPLETED|Maintenance Phase||42
5253381|NCT00783692|12915028|P7|STARTED|Maintenance Phase||412
5253382|NCT00783692|12915029|P6|STARTED|Maintenance Phase||154
5253383|NCT00783692|12915030|P5|STARTED|Maintenance Phase||154
5253384|NCT00783692|12915031|P4|STARTED|Maintenance Phase||153
5253385|NCT00783692|12915032|P3|STARTED|Maintenance Phase||0
5253386|NCT00783692|12915033|P2|STARTED|Maintenance Phase||0
5253387|NCT00783692|12915034|P1|STARTED|Maintenance Phase||137
5253388|NCT00783692|12915028|P7|NOT COMPLETED|Induction Phase||0
5253389|NCT00783692|12915029|P6|NOT COMPLETED|Induction Phase||0
5253390|NCT00783692|12915030|P5|NOT COMPLETED|Induction Phase||0
5253391|NCT00783692|12915031|P4|NOT COMPLETED|Induction Phase||0
5253392|NCT00783692|12915032|P3|NOT COMPLETED|Induction Phase||74
5253393|NCT00783692|12915033|P2|NOT COMPLETED|Induction Phase||21
5253394|NCT00783692|12915034|P1|NOT COMPLETED|Induction Phase||11
5253395|NCT00783692|12915028|P7|COMPLETED|Induction Phase||0
5253396|NCT00783692|12915029|P6|COMPLETED|Induction Phase||0
5253397|NCT00783692|12915030|P5|COMPLETED|Induction Phase||0
5253398|NCT00783692|12915031|P4|COMPLETED|Induction Phase||0
5253399|NCT00783692|12915032|P3|COMPLETED|Induction Phase||674
5253400|NCT00783692|12915033|P2|COMPLETED|Induction Phase||199
5253401|NCT00783692|12915034|P1|COMPLETED|Induction Phase||137
5253402|NCT00783692|12915028|P7|Treated|Induction Phase||0
5253403|NCT00783692|12915029|P6|Treated|Induction Phase||0
5253404|NCT00783692|12915030|P5|Treated|Induction Phase||0
5253405|NCT00783692|12915031|P4|Treated|Induction Phase||0
5253406|NCT00783692|12915032|P3|Treated|Induction Phase||747
5253407|NCT00783692|12915033|P2|Treated|Induction Phase||220
5253408|NCT00783692|12915034|P1|Treated|Induction Phase||148
5253409|NCT00783692|12915028|P7|STARTED|Induction Phase||0
5253410|NCT00783692|12915029|P6|STARTED|Induction Phase||0
5253411|NCT00783692|12915030|P5|STARTED|Induction Phase||0
5253412|NCT00783692|12915031|P4|STARTED|Induction Phase||0
5253413|NCT00783692|12915032|P3|STARTED|Induction Phase||748
5253414|NCT00783692|12915033|P2|STARTED|Induction Phase||220
5253415|NCT00783692|12915034|P1|STARTED|Induction Phase||148
5253416|NCT00783614|12915061|P4|NOT COMPLETED|Overall Study||0
5253417|NCT00783614|12915062|P3|NOT COMPLETED|Overall Study||0
5253418|NCT00783614|12915063|P2|NOT COMPLETED|Overall Study||0
5253419|NCT00783614|12915064|P1|NOT COMPLETED|Overall Study||0
5253420|NCT00783614|12915061|P4|COMPLETED|Overall Study||5
5253421|NCT00783614|12915062|P3|COMPLETED|Overall Study||5
5253422|NCT00783614|12915063|P2|COMPLETED|Overall Study||6
5253423|NCT00783614|12915064|P1|COMPLETED|Overall Study||6
5253424|NCT00783614|12915061|P4|STARTED|Overall Study||5
5253425|NCT00783614|12915062|P3|STARTED|Overall Study||5
5253426|NCT00783614|12915063|P2|STARTED|Overall Study||6
5253427|NCT00783614|12915064|P1|STARTED|Overall Study||6
5253428|NCT00783432|12915080|P2|NOT COMPLETED|Overall Study||78
5253429|NCT00783432|12915081|P1|NOT COMPLETED|Overall Study||85
5253430|NCT00783432|12915080|P2|COMPLETED|Overall Study||354
5253431|NCT00783432|12915081|P1|COMPLETED|Overall Study||345
5253432|NCT00783432|12915080|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
5253433|NCT00783432|12915081|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
5253434|NCT00783302|12915091|P1|NOT COMPLETED|Overall Study||35
5253435|NCT00783302|12915091|P1|COMPLETED|Overall Study||850
5253436|NCT00783302|12915091|P1|STARTED|Overall Study||885
5253437|NCT00783289|12915113|P4|NOT COMPLETED|Overall Study||0
5253438|NCT00783289|12915114|P3|NOT COMPLETED|Overall Study||0
5253439|NCT00783289|12915115|P2|NOT COMPLETED|Overall Study||1
5253440|NCT00783289|12915116|P1|NOT COMPLETED|Overall Study||0
5253441|NCT00783289|12915113|P4|COMPLETED|Overall Study||6
5253442|NCT00783289|12915114|P3|COMPLETED|Overall Study||6
5253443|NCT00783289|12915115|P2|COMPLETED|Overall Study||6
5253444|NCT00783289|12915116|P1|COMPLETED|Overall Study||6
5253445|NCT00783289|12915113|P4|STARTED|Overall Study||6
5253446|NCT00783289|12915114|P3|STARTED|Overall Study||6
5253447|NCT00783289|12915115|P2|STARTED|Overall Study||7
5253448|NCT00783289|12915116|P1|STARTED|Overall Study||6
5253449|NCT00783263|12915146|P4|NOT COMPLETED|Overall Study||3
5253450|NCT00783263|12915147|P3|NOT COMPLETED|Overall Study||3
5253451|NCT00783263|12915148|P2|NOT COMPLETED|Overall Study||2
5253452|NCT00783263|12915149|P1|NOT COMPLETED|Overall Study||4
5253453|NCT00783263|12915146|P4|COMPLETED|Overall Study||118
5253454|NCT00783263|12915147|P3|COMPLETED|Overall Study||119
5253455|NCT00783263|12915148|P2|COMPLETED|Overall Study||96
5253456|NCT00783263|12915149|P1|COMPLETED|Overall Study||95
5253457|NCT00783263|12915146|P4|STARTED|Overall Study||121
5253458|NCT00783263|12915147|P3|STARTED|Overall Study||122
5253459|NCT00783263|12915148|P2|STARTED|Overall Study||98
5253460|NCT00783263|12915149|P1|STARTED|Overall Study||99
5253461|NCT00783224|12915179|P4|NOT COMPLETED|Overall Study||2
5253462|NCT00783224|12915180|P3|NOT COMPLETED|Overall Study||1
5253463|NCT00783224|12915181|P2|NOT COMPLETED|Overall Study||0
5253464|NCT00783224|12915182|P1|NOT COMPLETED|Overall Study||0
5253465|NCT00783224|12915179|P4|COMPLETED|Overall Study||140
5253466|NCT00783224|12915180|P3|COMPLETED|Overall Study||142
5253467|NCT00783224|12915181|P2|COMPLETED|Overall Study||34
5253468|NCT00783224|12915182|P1|COMPLETED|Overall Study||32
5253469|NCT00783224|12915179|P4|STARTED|Overall Study||142
5253470|NCT00783224|12915180|P3|STARTED|Overall Study||143
5253471|NCT00783224|12915181|P2|STARTED|Overall Study||34
5253472|NCT00783224|12915182|P1|STARTED|Overall Study||32
5253473|NCT00783198|12915194|P3|NOT COMPLETED|Overall Study||42
5253474|NCT00783198|12915195|P2|NOT COMPLETED|Overall Study||43
5253475|NCT00783198|12915196|P1|NOT COMPLETED|Overall Study||57
5253476|NCT00783198|12915194|P3|COMPLETED|Overall Study||146
5253477|NCT00783198|12915195|P2|COMPLETED|Overall Study||144
5253478|NCT00783198|12915196|P1|COMPLETED|Overall Study||133
5253479|NCT00783198|12915194|P3|STARTED|Overall Study||188
5253480|NCT00783198|12915195|P2|STARTED|Overall Study||187
5253481|NCT00783198|12915196|P1|STARTED|Overall Study||190
5253482|NCT00783094|12915219|P3|NOT COMPLETED|Open-Label Extension Period||30
5253483|NCT00783094|12915220|P2|NOT COMPLETED|Open-Label Extension Period||19
5253484|NCT00783094|12915221|P1|NOT COMPLETED|Open-Label Extension Period||22
5253485|NCT00783094|12915219|P3|COMPLETED|Open-Label Extension Period||101
5253486|NCT00783094|12915220|P2|COMPLETED|Open-Label Extension Period||109
5253487|NCT00783094|12915221|P1|COMPLETED|Open-Label Extension Period||113
5253488|NCT00783094|12915219|P3|STARTED|Open-Label Extension Period||131
5253489|NCT00783094|12915220|P2|STARTED|Open-Label Extension Period||128
5253490|NCT00783094|12915221|P1|STARTED|Open-Label Extension Period||135
5253491|NCT00783094|12915219|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
5253492|NCT00783094|12915220|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
5253493|NCT00783094|12915221|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
5253494|NCT00783094|12915219|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
5253495|NCT00783094|12915220|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
5253496|NCT00783094|12915221|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
5253497|NCT00783094|12915219|P3|STARTED|Randomized Double-Blind Treatment Period||140
5253498|NCT00783094|12915220|P2|STARTED|Randomized Double-Blind Treatment Period||140
5253499|NCT00783094|12915221|P1|STARTED|Randomized Double-Blind Treatment Period||142
5253500|NCT00782834|12915297|P1|NOT COMPLETED|Treatment Phase||1
5253501|NCT00782834|12915297|P1|COMPLETED|Treatment Phase||13
5253502|NCT00782834|12915297|P1|STARTED|Treatment Phase||14
5253503|NCT00782834|12915297|P1|NOT COMPLETED|Screened Patients||1
5253504|NCT00782834|12915297|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
5253505|NCT00782834|12915297|P1|STARTED|Screened Patients||15
5253506|NCT00782821|12915306|P4|NOT COMPLETED|Overall Study||2
5253507|NCT00782821|12915307|P3|NOT COMPLETED|Overall Study||1
5253508|NCT00782821|12915308|P2|NOT COMPLETED|Overall Study||0
5253509|NCT00782821|12915309|P1|NOT COMPLETED|Overall Study||0
5253510|NCT00782821|12915306|P4|COMPLETED|Overall Study||8
5253511|NCT00782821|12915307|P3|COMPLETED|Overall Study||9
5253512|NCT00782821|12915308|P2|COMPLETED|Overall Study||10
5253513|NCT00782821|12915309|P1|COMPLETED|Overall Study||10
5253514|NCT00782821|12915306|P4|STARTED|Overall Study||10
5253515|NCT00782821|12915307|P3|STARTED|Overall Study||10
5253516|NCT00782821|12915308|P2|STARTED|Overall Study||10
5253517|NCT00782821|12915309|P1|STARTED|Overall Study||10
5253518|NCT00782795|12915337|P2|NOT COMPLETED|Overall Study||2
5253519|NCT00782795|12915338|P1|NOT COMPLETED|Overall Study||1
5253520|NCT00782795|12915337|P2|COMPLETED|Overall Study||6
5253521|NCT00782795|12915338|P1|COMPLETED|Overall Study||16
5253522|NCT00782795|12915337|P2|24 Week Appointment|Overall Study||7
5253523|NCT00782795|12915338|P1|24 Week Appointment|Overall Study||16
5253524|NCT00782795|12915337|P2|6 Weeks (1st Apptment)|Overall Study||7
5253525|NCT00782795|12915338|P1|6 Weeks (1st Apptment)|Overall Study||16
5253526|NCT00782795|12915337|P2|STARTED|Overall Study||8
5253527|NCT00782795|12915338|P1|STARTED|Overall Study||17
5253528|NCT00782756|12915370|P1|NOT COMPLETED|Overall Study||0
5253529|NCT00782756|12915370|P1|COMPLETED|Overall Study||40
5253530|NCT00782756|12915370|P1|STARTED|Overall Study||40
5253531|NCT00782717|12915378|P2|NOT COMPLETED|Overall Study||28
5253532|NCT00782717|12915379|P1|NOT COMPLETED|Overall Study||15
5253533|NCT00782717|12915378|P2|COMPLETED|Overall Study||102
5253534|NCT00782717|12915379|P1|COMPLETED|Overall Study||118
5253535|NCT00782717|12915378|P2|STARTED|Overall Study||130
5253536|NCT00782717|12915379|P1|STARTED|Overall Study||133
5253537|NCT00782639|12915389|P2|NOT COMPLETED|Overall Study||0
5253538|NCT00782639|12915390|P1|NOT COMPLETED|Overall Study||0
5253539|NCT00782639|12915389|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
5253540|NCT00782639|12915390|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
5253541|NCT00782639|12915389|P2|STARTED|Overall Study||11
5253542|NCT00782639|12915390|P1|STARTED|Overall Study||12
5253543|NCT00782626|12915406|P1|NOT COMPLETED|Overall Study||7
5253544|NCT00782626|12915406|P1|COMPLETED|Overall Study||16
5253545|NCT00782626|12915406|P1|STARTED|Overall Study||23
5253546|NCT00782509|12915413|P3|NOT COMPLETED|Overall Study||36
5253547|NCT00782509|12915414|P2|NOT COMPLETED|Overall Study||24
5253548|NCT00782509|12915415|P1|NOT COMPLETED|Overall Study||41
5253549|NCT00782509|12915413|P3|COMPLETED|Overall Study||181
5253550|NCT00782509|12915414|P2|COMPLETED|Overall Study||185
5253551|NCT00782509|12915415|P1|COMPLETED|Overall Study||175
5253552|NCT00782509|12915413|P3|STARTED|Overall Study||217
5253553|NCT00782509|12915414|P2|STARTED|Overall Study||209
5253554|NCT00782509|12915415|P1|STARTED|Overall Study||216
5253555|NCT00782496|12915608|P2|NOT COMPLETED|Overall Study||15
5253556|NCT00782496|12915609|P1|NOT COMPLETED|Overall Study||14
5253557|NCT00782496|12915608|P2|COMPLETED|Overall Study||90
5253558|NCT00782496|12915609|P1|COMPLETED|Overall Study||92
5253559|NCT00782496|12915608|P2|STARTED|Overall Study||105
5253560|NCT00782496|12915609|P1|STARTED|Overall Study||106
5253561|NCT00782483|12915616|P1|NOT COMPLETED|Overall Study||6
5253562|NCT00782483|12915616|P1|COMPLETED|Overall Study||0
5253563|NCT00782483|12915616|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
5253564|NCT00782418|12915620|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253565|NCT00782418|12915621|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253566|NCT00782418|12915622|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253567|NCT00782418|12915623|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253568|NCT00782418|12915624|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253569|NCT00782418|12915625|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253570|NCT00782418|12915626|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
5253571|NCT00782418|12915620|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
5253572|NCT00782418|12915621|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
5253573|NCT00782418|12915622|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
5253574|NCT00782418|12915623|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
5253575|NCT00782418|12915624|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
5253576|NCT00782418|12915625|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
5253577|NCT00782418|12915626|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
5253578|NCT00782418|12915620|P7|STARTED|Period 2 Procedure/Treatment Groups||4
5253579|NCT00782418|12915621|P6|STARTED|Period 2 Procedure/Treatment Groups||4
5253580|NCT00782418|12915622|P5|STARTED|Period 2 Procedure/Treatment Groups||3
5253581|NCT00782418|12915623|P4|STARTED|Period 2 Procedure/Treatment Groups||1
5253582|NCT00782418|12915624|P3|STARTED|Period 2 Procedure/Treatment Groups||4
5253583|NCT00782418|12915625|P2|STARTED|Period 2 Procedure/Treatment Groups||4
5253584|NCT00782418|12915626|P1|STARTED|Period 2 Procedure/Treatment Groups||3
5253585|NCT00782418|12915620|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
5253586|NCT00782418|12915621|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
5253587|NCT00782418|12915622|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
5253588|NCT00782418|12915623|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
5253589|NCT00782418|12915624|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
5253590|NCT00782418|12915625|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
5253591|NCT00782418|12915626|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
5253592|NCT00782418|12915620|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
5253593|NCT00782418|12915621|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
5253594|NCT00782418|12915622|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
5253595|NCT00782418|12915623|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
5253596|NCT00782418|12915624|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
5253597|NCT00782418|12915625|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
5253598|NCT00782418|12915626|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
5253599|NCT00782418|12915620|P7|STARTED|Period 1 Procedure/Treatment Groups||4
5253600|NCT00782418|12915621|P6|STARTED|Period 1 Procedure/Treatment Groups||5
5253601|NCT00782418|12915622|P5|STARTED|Period 1 Procedure/Treatment Groups||5
5253602|NCT00782418|12915623|P4|STARTED|Period 1 Procedure/Treatment Groups||2
5253603|NCT00782418|12915624|P3|STARTED|Period 1 Procedure/Treatment Groups||4
5253604|NCT00782418|12915625|P2|STARTED|Period 1 Procedure/Treatment Groups||4
5253605|NCT00782418|12915626|P1|STARTED|Period 1 Procedure/Treatment Groups||3
5253606|NCT00782379|12915646|P1|NOT COMPLETED|Overall Study||0
5253607|NCT00782379|12915646|P1|COMPLETED|Overall Study||20
5253608|NCT00782379|12915646|P1|STARTED|Overall Study||20
5253609|NCT00782340|12915663|P3|NOT COMPLETED|Randomized Double Blind||0
5253610|NCT00782340|12915664|P2|NOT COMPLETED|Randomized Double Blind||0
5253611|NCT00782340|12915665|P1|NOT COMPLETED|Randomized Double Blind||0
5253612|NCT00782340|12915663|P3|COMPLETED|Randomized Double Blind||80
5253613|NCT00782340|12915664|P2|COMPLETED|Randomized Double Blind||82
5253614|NCT00782340|12915665|P1|COMPLETED|Randomized Double Blind||0
5253615|NCT00782340|12915663|P3|STARTED|Randomized Double Blind||80
5253616|NCT00782340|12915664|P2|STARTED|Randomized Double Blind||82
5253617|NCT00782340|12915665|P1|STARTED|Randomized Double Blind||0
5253618|NCT00782340|12915663|P3|NOT COMPLETED|Open Label Titration||0
5253619|NCT00782340|12915664|P2|NOT COMPLETED|Open Label Titration||0
5253620|NCT00782340|12915665|P1|NOT COMPLETED|Open Label Titration||101
5253621|NCT00782340|12915663|P3|COMPLETED|Open Label Titration||0
5253622|NCT00782340|12915664|P2|COMPLETED|Open Label Titration||0
5253623|NCT00782340|12915665|P1|COMPLETED|Open Label Titration||162
5253624|NCT00782340|12915663|P3|STARTED|Open Label Titration||0
5253625|NCT00782340|12915664|P2|STARTED|Open Label Titration||0
5253626|NCT00782340|12915665|P1|STARTED|Open Label Titration||263
5253627|NCT00782288|12915691|P3|NOT COMPLETED|Overall Study||0
5253628|NCT00782288|12915692|P2|NOT COMPLETED|Overall Study||0
5253629|NCT00782288|12915693|P1|NOT COMPLETED|Overall Study||0
5253630|NCT00782288|12915691|P3|COMPLETED|Overall Study||8
5253631|NCT00782288|12915692|P2|COMPLETED|Overall Study||8
5253632|NCT00782288|12915693|P1|COMPLETED|Overall Study||8
5253633|NCT00782288|12915691|P3|STARTED|Overall Study||8
5253634|NCT00782288|12915692|P2|STARTED|Overall Study||8
5253635|NCT00782288|12915693|P1|STARTED|Overall Study||8
5253636|NCT00782275|12915735|P1|NOT COMPLETED|Overall Study||41
5253637|NCT00782275|12915735|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
5253638|NCT00782275|12915735|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
5253639|NCT00782275|12915735|P1|Treated|Overall Study||40
5253640|NCT00782275|12915735|P1|STARTED|Overall Study||41
5253641|NCT00782210|12915744|P3|NOT COMPLETED|Overall Study||35
5253642|NCT00782210|12915745|P2|NOT COMPLETED|Overall Study||35
5253643|NCT00782210|12915746|P1|NOT COMPLETED|Overall Study||50
5253644|NCT00782210|12915744|P3|COMPLETED|Overall Study||172
5253645|NCT00782210|12915745|P2|COMPLETED|Overall Study||173
5253646|NCT00782210|12915746|P1|COMPLETED|Overall Study||159
5253647|NCT00782210|12915744|P3|STARTED|Overall Study||207
5253648|NCT00782210|12915745|P2|STARTED|Overall Study||208
5253649|NCT00782210|12915746|P1|STARTED|Overall Study||209
5253650|NCT00782184|12915939|P2|NOT COMPLETED|Overall Study||5
5253651|NCT00782184|12915940|P1|NOT COMPLETED|Overall Study||4
5253652|NCT00782184|12915939|P2|COMPLETED|Overall Study||125
5253653|NCT00782184|12915940|P1|COMPLETED|Overall Study||116
5253654|NCT00782184|12915939|P2|STARTED|Overall Study||130
5253655|NCT00782184|12915940|P1|STARTED|Overall Study||120
5253656|NCT00782171|12915977|P2|NOT COMPLETED|Overall Study||19
5253657|NCT00782171|12915978|P1|NOT COMPLETED|Overall Study||22
5253658|NCT00782171|12915977|P2|COMPLETED|Overall Study||115
5253659|NCT00782171|12915978|P1|COMPLETED|Overall Study||124
5253660|NCT00782171|12915977|P2|Surgery (Baseline)|Overall Study||128
5253661|NCT00782171|12915978|P1|Surgery (Baseline)|Overall Study||138
5253662|NCT00782171|12915977|P2|1 Year|Overall Study||120
5253663|NCT00782171|12915978|P1|1 Year|Overall Study||131
5253664|NCT00782171|12915977|P2|20-23 Weeks|Overall Study||124
5253665|NCT00782171|12915978|P1|20-23 Weeks|Overall Study||135
5253666|NCT00782171|12915977|P2|STARTED|Overall Study||134
5253667|NCT00782171|12915978|P1|STARTED|Overall Study||146
5253668|NCT00782067|12916010|P1|NOT COMPLETED|Overall Study||116
5253669|NCT00782067|12916010|P1|COMPLETED|Overall Study||0
5253670|NCT00782067|12916010|P1|Primary Efficacy Population (PEP)|Overall Study||89
5253671|NCT00782067|12916010|P1|Safety Set (SS)|Overall Study||116
5253672|NCT00782067|12916010|P1|STARTED|Overall Study||116
5253673|NCT00781963|12916022|P2|NOT COMPLETED|Overall Study||2
5253674|NCT00781963|12916023|P1|NOT COMPLETED|Overall Study||17
5253675|NCT00781963|12916022|P2|COMPLETED|Overall Study||51
5253676|NCT00781963|12916023|P1|COMPLETED|Overall Study||89
5253677|NCT00781963|12916022|P2|STARTED|Overall Study||53
5253678|NCT00781963|12916023|P1|STARTED|Overall Study||106
5253679|NCT00781950|12916041|P2|NOT COMPLETED|Overall Study||13
5253680|NCT00781950|12916042|P1|NOT COMPLETED|Overall Study||11
5253681|NCT00781950|12916041|P2|COMPLETED|Overall Study||45
5253682|NCT00781950|12916042|P1|COMPLETED|Overall Study||41
5253683|NCT00781950|12916041|P2|STARTED|Overall Study||58
5253684|NCT00781950|12916042|P1|STARTED|Overall Study||52
5253685|NCT00781937|12916052|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
5253686|NCT00781937|12916053|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
5253687|NCT00781937|12916052|P2|COMPLETED|Follow up Period (Week 56-68)||141
5253688|NCT00781937|12916053|P1|COMPLETED|Follow up Period (Week 56-68)||153
5253689|NCT00781937|12916052|P2|STARTED|Follow up Period (Week 56-68)||146
5253690|NCT00781937|12916053|P1|STARTED|Follow up Period (Week 56-68)||159
5253691|NCT00781937|12916052|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
5253692|NCT00781937|12916053|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
5253693|NCT00781937|12916052|P2|COMPLETED|Main Trial Period Through Week 56||146
5253694|NCT00781937|12916053|P1|COMPLETED|Main Trial Period Through Week 56||159
5253695|NCT00781937|12916052|P2|STARTED|Main Trial Period Through Week 56||210
5253696|NCT00781937|12916053|P1|STARTED|Main Trial Period Through Week 56||212
5253697|NCT00781911|12916111|P2|NOT COMPLETED|Overall Study||8
5253698|NCT00781911|12916112|P1|NOT COMPLETED|Overall Study||6
5253699|NCT00781911|12916111|P2|COMPLETED|Overall Study||4
5253700|NCT00781911|12916112|P1|COMPLETED|Overall Study||25
5253701|NCT00781911|12916111|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
5253702|NCT00781911|12916112|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
5253703|NCT00781911|12916111|P2|STARTED|Overall Study||12
5253704|NCT00781911|12916112|P1|STARTED|Overall Study||31
5253705|NCT00781898|12916140|P2|NOT COMPLETED|Overall Study||29
5253706|NCT00781898|12916141|P1|NOT COMPLETED|Overall Study||34
5253707|NCT00781898|12916140|P2|COMPLETED|Overall Study||126
5253708|NCT00781898|12916141|P1|COMPLETED|Overall Study||119
5253709|NCT00781898|12916140|P2|STARTED|Overall Study||155
5253710|NCT00781898|12916141|P1|STARTED|Overall Study||153
5253711|NCT00781885|12916147|P1|NOT COMPLETED|Overall Study||1
5253712|NCT00781885|12916147|P1|COMPLETED|Overall Study||18
5253713|NCT00781885|12916147|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
5253714|NCT00781885|12916147|P1|STARTED|Overall Study||19
5253715|NCT00781859|12916164|P2|NOT COMPLETED|Overall Study||9
5253716|NCT00781859|12916165|P1|NOT COMPLETED|Overall Study||19
5253717|NCT00781859|12916164|P2|COMPLETED|Overall Study||98
5253718|NCT00781859|12916165|P1|COMPLETED|Overall Study||200
5253719|NCT00781859|12916164|P2|STARTED|Overall Study||107
5253720|NCT00781859|12916165|P1|STARTED|Overall Study||219
5253721|NCT00781768|12916175|P2|NOT COMPLETED|Overall Study||2
5253722|NCT00781768|12916176|P1|NOT COMPLETED|Overall Study||0
5253723|NCT00781768|12916175|P2|COMPLETED|Overall Study||90
5253724|NCT00781768|12916176|P1|COMPLETED|Overall Study||89
5253725|NCT00781768|12916175|P2|STARTED|Overall Study||92
5253726|NCT00781768|12916176|P1|STARTED|Overall Study||89
5253727|NCT00781599|12916184|P2|NOT COMPLETED|Overall Study||4
5253728|NCT00781599|12916185|P1|NOT COMPLETED|Overall Study||7
5253729|NCT00781599|12916184|P2|COMPLETED|Overall Study||32
5253730|NCT00781599|12916185|P1|COMPLETED|Overall Study||29
5253731|NCT00781599|12916184|P2|STARTED|Overall Study||36
5253732|NCT00781599|12916185|P1|STARTED|Overall Study||36
5253733|NCT00781508|12916199|P2|NOT COMPLETED|Overall Study||0
5253734|NCT00781508|12916200|P1|NOT COMPLETED|Overall Study||0
5253735|NCT00781508|12916199|P2|COMPLETED|Overall Study||5
5253736|NCT00781508|12916200|P1|COMPLETED|Overall Study||5
5253737|NCT00781508|12916199|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
5253738|NCT00781508|12916200|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
5253739|NCT00781456|12916210|P2|NOT COMPLETED|Overall Study||16
5253740|NCT00781456|12916211|P1|NOT COMPLETED|Overall Study||21
5253741|NCT00781456|12916210|P2|COMPLETED|Overall Study||35
5253742|NCT00781456|12916211|P1|COMPLETED|Overall Study||37
5253743|NCT00781456|12916210|P2|Received Study Drug|Overall Study||49
5253744|NCT00781456|12916211|P1|Received Study Drug|Overall Study||57
5253745|NCT00781456|12916210|P2|STARTED|Overall Study||51
5253746|NCT00781456|12916211|P1|STARTED|Overall Study||58
5253747|NCT00781391|12916234|P3|NOT COMPLETED|Overall Study||784
5253748|NCT00781391|12916235|P2|NOT COMPLETED|Overall Study||807
5253749|NCT00781391|12916236|P1|NOT COMPLETED|Overall Study||879
5253750|NCT00781391|12916234|P3|COMPLETED|Overall Study||6250
5253751|NCT00781391|12916235|P2|COMPLETED|Overall Study||6228
5253752|NCT00781391|12916236|P1|COMPLETED|Overall Study||6157
5253753|NCT00781391|12916234|P3|Per Protocol Analysis Set|Overall Study||6982
5253754|NCT00781391|12916235|P2|Per Protocol Analysis Set|Overall Study||6995
5253755|NCT00781391|12916236|P1|Per Protocol Analysis Set|Overall Study||6993
5253756|NCT00781391|12916234|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
5253757|NCT00781391|12916235|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
5253758|NCT00781391|12916236|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
5253759|NCT00781391|12916234|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
5253760|NCT00781391|12916235|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
5253761|NCT00781391|12916236|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
5253762|NCT00781391|12916234|P3|STARTED|Overall Study||7034
5253763|NCT00781391|12916235|P2|STARTED|Overall Study||7035
5253764|NCT00781391|12916236|P1|STARTED|Overall Study||7036
5253765|NCT00781365|12916270|P2|NOT COMPLETED|Overall Study||36
5253766|NCT00781365|12916271|P1|NOT COMPLETED|Overall Study||34
5253767|NCT00781365|12916270|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
5253768|NCT00781365|12916271|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
5253769|NCT00781365|12916270|P2|STARTED|Overall Study||222
5253770|NCT00781365|12916271|P1|STARTED|Overall Study||228
5253771|NCT00781326|12916281|P1|NOT COMPLETED|Phase 2||0
5253772|NCT00781326|12916281|P1|COMPLETED|Phase 2||0
5253773|NCT00781326|12916281|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
5253774|NCT00781326|12916281|P1|NOT COMPLETED|Phase I||4
5253775|NCT00781326|12916281|P1|COMPLETED|Phase I||2
5253776|NCT00781326|12916281|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
5253777|NCT00781274|12916285|P1|NOT COMPLETED|Overall Study||2
5253778|NCT00781274|12916285|P1|COMPLETED|Overall Study||30
5253779|NCT00781274|12916285|P1|STARTED|Overall Study||32
5253780|NCT00781079|12916291|P2|NOT COMPLETED|Overall Study||17
5253781|NCT00781079|12916292|P1|NOT COMPLETED|Overall Study||27
5253782|NCT00781079|12916291|P2|COMPLETED|Overall Study||116
5253783|NCT00781079|12916292|P1|COMPLETED|Overall Study||122
5253784|NCT00781079|12916291|P2|STARTED|Overall Study||133
5253785|NCT00781079|12916292|P1|STARTED|Overall Study||149
5253786|NCT00780962|12916310|P2|NOT COMPLETED|Overall Study||27
5253787|NCT00780962|12916311|P1|NOT COMPLETED|Overall Study||15
5253788|NCT00780962|12916310|P2|COMPLETED|Overall Study||172
5253789|NCT00780962|12916311|P1|COMPLETED|Overall Study||185
5253790|NCT00780962|12916310|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
5253791|NCT00780962|12916311|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
5253792|NCT00780962|12916310|P2|STARTED|Overall Study||199
5253793|NCT00780962|12916311|P1|STARTED|Overall Study||200
5253794|NCT00780910|12916317|P1|NOT COMPLETED|Overall Study||2
5253795|NCT00780910|12916317|P1|COMPLETED|Overall Study||107
5253796|NCT00780910|12916317|P1|STARTED|Overall Study||109
5253797|NCT00780741|12916323|P2|NOT COMPLETED|Overall Study||10
5253798|NCT00780741|12916324|P1|NOT COMPLETED|Overall Study||7
5253799|NCT00780741|12916323|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
5253800|NCT00780741|12916324|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
5253801|NCT00780741|12916323|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
5253802|NCT00780741|12916324|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
5253803|NCT00780741|12916323|P2|STARTED|Overall Study|randomized|81
5253804|NCT00780741|12916324|P1|STARTED|Overall Study|randomized|82
5253805|NCT00780715|12916340|P4|NOT COMPLETED|Overall Study||0
5253806|NCT00780715|12916341|P3|NOT COMPLETED|Overall Study||0
5253807|NCT00780715|12916342|P2|NOT COMPLETED|Overall Study||0
5253808|NCT00780715|12916343|P1|NOT COMPLETED|Overall Study||0
5253809|NCT00780715|12916340|P4|COMPLETED|Overall Study||11
5253810|NCT00780715|12916341|P3|COMPLETED|Overall Study||6
5253811|NCT00780715|12916342|P2|COMPLETED|Overall Study||6
5253812|NCT00780715|12916343|P1|COMPLETED|Overall Study||6
5253813|NCT00780715|12916340|P4|STARTED|Overall Study||11
5253814|NCT00780715|12916341|P3|STARTED|Overall Study||6
5253815|NCT00780715|12916342|P2|STARTED|Overall Study||6
5253816|NCT00780715|12916343|P1|STARTED|Overall Study||6
5253817|NCT00780676|12916358|P5|NOT COMPLETED|Overall Study||0
5253818|NCT00780676|12916359|P4|NOT COMPLETED|Overall Study||0
5253819|NCT00780676|12916360|P3|NOT COMPLETED|Overall Study||0
5253820|NCT00780676|12916361|P2|NOT COMPLETED|Overall Study||0
5253821|NCT00780676|12916362|P1|NOT COMPLETED|Overall Study||0
5253822|NCT00780676|12916358|P5|COMPLETED|Overall Study||0
5253823|NCT00780676|12916359|P4|COMPLETED|Overall Study||0
5253824|NCT00780676|12916360|P3|COMPLETED|Overall Study||13
5253825|NCT00780676|12916361|P2|COMPLETED|Overall Study||8
5253826|NCT00780676|12916362|P1|COMPLETED|Overall Study||9
5253827|NCT00780676|12916358|P5|STARTED|Overall Study||0
5253828|NCT00780676|12916359|P4|STARTED|Overall Study||0
5253829|NCT00780676|12916360|P3|STARTED|Overall Study||13
5253830|NCT00780676|12916361|P2|STARTED|Overall Study||8
5253831|NCT00780676|12916362|P1|STARTED|Overall Study||9
5253832|NCT00780572|12916370|P2|NOT COMPLETED|Overall Study||0
5253833|NCT00780572|12916371|P1|NOT COMPLETED|Overall Study||0
5253834|NCT00780572|12916370|P2|COMPLETED|Overall Study||298
5253835|NCT00780572|12916371|P1|COMPLETED|Overall Study||297
5253836|NCT00780572|12916370|P2|STARTED|Overall Study||298
5253837|NCT00780572|12916371|P1|STARTED|Overall Study||297
5253838|NCT00780559|12916379|P2|NOT COMPLETED|Overall Study||7
5253839|NCT00780559|12916380|P1|NOT COMPLETED|Overall Study||3
5253840|NCT00780559|12916379|P2|COMPLETED|Overall Study||33
5253841|NCT00780559|12916380|P1|COMPLETED|Overall Study||29
5253842|NCT00780559|12916379|P2|STARTED|Overall Study||40
5253843|NCT00780559|12916380|P1|STARTED|Overall Study||32
5253844|NCT00780494|12916394|P1|NOT COMPLETED|Overall Study||0
5253845|NCT00780494|12916394|P1|COMPLETED|Overall Study||35
5253846|NCT00780494|12916394|P1|STARTED|Overall Study||35
5253847|NCT00780481|12916403|P1|NOT COMPLETED|Overall Study||0
5253848|NCT00780481|12916403|P1|COMPLETED|Overall Study||13
5253849|NCT00780481|12916403|P1|STARTED|Overall Study||13
5253850|NCT00780455|12916412|P2|NOT COMPLETED|Overall Study||0
5253851|NCT00780455|12916413|P1|NOT COMPLETED|Overall Study||0
5253852|NCT00780455|12916412|P2|COMPLETED|Overall Study||2
5253853|NCT00780455|12916413|P1|COMPLETED|Overall Study||2
5253854|NCT00780455|12916412|P2|STARTED|Overall Study||2
5253855|NCT00780455|12916413|P1|STARTED|Overall Study||2
5253856|NCT00780442|12916439|P2|NOT COMPLETED|Overall Study||0
5253857|NCT00780442|12916440|P1|NOT COMPLETED|Overall Study||0
5253858|NCT00780442|12916439|P2|COMPLETED|Overall Study||15
5253859|NCT00780442|12916440|P1|COMPLETED|Overall Study||12
5253860|NCT00780442|12916439|P2|STARTED|Overall Study||15
5253861|NCT00780442|12916440|P1|STARTED|Overall Study||12
5253862|NCT00780416|12916448|P2|NOT COMPLETED|Overall Study||9
5253863|NCT00780416|12916449|P1|NOT COMPLETED|Overall Study||12
5253864|NCT00780416|12916448|P2|COMPLETED|Overall Study||54
5253865|NCT00780416|12916449|P1|COMPLETED|Overall Study||114
5253866|NCT00780416|12916448|P2|STARTED|Overall Study||63
5253867|NCT00780416|12916449|P1|STARTED|Overall Study||126
5253868|NCT00780403|12916455|P2|NOT COMPLETED|Second Intervention||0
5253869|NCT00780403|12916456|P1|NOT COMPLETED|Second Intervention||0
5253870|NCT00780403|12916455|P2|COMPLETED|Second Intervention||111
5253871|NCT00780403|12916456|P1|COMPLETED|Second Intervention||109
5253872|NCT00780403|12916455|P2|STARTED|Second Intervention||111
5253873|NCT00780403|12916456|P1|STARTED|Second Intervention||109
5253874|NCT00780403|12916455|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
5253875|NCT00780403|12916456|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
5253876|NCT00780403|12916455|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
5253877|NCT00780403|12916456|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
5253878|NCT00780403|12916455|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
5253879|NCT00780403|12916456|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
5253880|NCT00780403|12916455|P2|NOT COMPLETED|First Intervention||0
5253881|NCT00780403|12916456|P1|NOT COMPLETED|First Intervention||0
5253882|NCT00780403|12916455|P2|COMPLETED|First Intervention||111
5253883|NCT00780403|12916456|P1|COMPLETED|First Intervention||109
5253884|NCT00780403|12916455|P2|STARTED|First Intervention||111
5253885|NCT00780403|12916456|P1|STARTED|First Intervention||109
5253886|NCT00780338|12916465|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
5253887|NCT00780338|12916466|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
5253888|NCT00780338|12916465|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
5253889|NCT00780338|12916466|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
5253890|NCT00780338|12916465|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
5253891|NCT00780338|12916466|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
5253892|NCT00780338|12916465|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
5253893|NCT00780338|12916466|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
5253894|NCT00780338|12916465|P2|COMPLETED|Baseline to Mid (1 Year)||164
5253895|NCT00780338|12916466|P1|COMPLETED|Baseline to Mid (1 Year)||169
5253896|NCT00780338|12916465|P2|STARTED|Baseline to Mid (1 Year)||202
5253897|NCT00780338|12916466|P1|STARTED|Baseline to Mid (1 Year)||174
5253898|NCT00780273|12916494|P1|NOT COMPLETED|Overall Study||2
5253899|NCT00780273|12916494|P1|COMPLETED|Overall Study||17
5253900|NCT00780273|12916494|P1|STARTED|Overall Study||19
5253901|NCT00780234|12916505|P2|NOT COMPLETED|Overall Study||8
5253902|NCT00780234|12916506|P1|NOT COMPLETED|Overall Study||8
5253903|NCT00780234|12916505|P2|COMPLETED|Overall Study||37
5253904|NCT00780234|12916506|P1|COMPLETED|Overall Study||39
5253905|NCT00780234|12916505|P2|STARTED|Overall Study||45
5253906|NCT00780234|12916506|P1|STARTED|Overall Study||47
5253907|NCT00780208|12916512|P1|NOT COMPLETED|Overall Study||6
5253908|NCT00780208|12916512|P1|COMPLETED|Overall Study||8
5253909|NCT00780208|12916512|P1|STARTED|Overall Study||14
5253910|NCT00780143|12916517|P1|NOT COMPLETED|Overall Study||3
5253911|NCT00780143|12916517|P1|COMPLETED|Overall Study||0
5253912|NCT00780143|12916517|P1|STARTED|Overall Study||3
5253913|NCT00780026|12916525|P2|NOT COMPLETED|Overall Study||0
5253914|NCT00780026|12916526|P1|NOT COMPLETED|Overall Study||0
5253915|NCT00780026|12916525|P2|COMPLETED|Overall Study||50
5253916|NCT00780026|12916526|P1|COMPLETED|Overall Study||50
5253917|NCT00780026|12916525|P2|STARTED|Overall Study||50
5253918|NCT00780026|12916526|P1|STARTED|Overall Study||50
5253919|NCT00779909|12916548|P4|NOT COMPLETED|Overall Study||1
5253920|NCT00779909|12916549|P3|NOT COMPLETED|Overall Study||0
5253921|NCT00779909|12916550|P2|NOT COMPLETED|Overall Study||1
5253922|NCT00779909|12916551|P1|NOT COMPLETED|Overall Study||1
5253923|NCT00779909|12916548|P4|COMPLETED|Overall Study||7
5253924|NCT00779909|12916549|P3|COMPLETED|Overall Study||8
5253925|NCT00779909|12916550|P2|COMPLETED|Overall Study||8
5253926|NCT00779909|12916551|P1|COMPLETED|Overall Study||9
5253927|NCT00779909|12916548|P4|STARTED|Overall Study||8
5253928|NCT00779909|12916549|P3|STARTED|Overall Study||8
5253929|NCT00779909|12916550|P2|STARTED|Overall Study||9
5253930|NCT00779909|12916551|P1|STARTED|Overall Study||10
5253931|NCT00779870|12916596|P3|NOT COMPLETED|Overall Study||0
5253932|NCT00779870|12916597|P2|NOT COMPLETED|Overall Study||0
5253933|NCT00779870|12916598|P1|NOT COMPLETED|Overall Study||0
5253934|NCT00779870|12916596|P3|COMPLETED|Overall Study||7
5253935|NCT00779870|12916597|P2|COMPLETED|Overall Study||6
5253936|NCT00779870|12916598|P1|COMPLETED|Overall Study||5
5253937|NCT00779870|12916596|P3|STARTED|Overall Study||7
5253938|NCT00779870|12916597|P2|STARTED|Overall Study||6
5253939|NCT00779870|12916598|P1|STARTED|Overall Study||5
5253940|NCT00779857|12916615|P1|NOT COMPLETED|Overall Study||6
5253941|NCT00779857|12916615|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
5253942|NCT00779857|12916615|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
5253943|NCT00779857|12916615|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
5253944|NCT00779857|12916615|P1|STARTED|Overall Study|70 patients treated|70
5253945|NCT00779779|12916620|P1|NOT COMPLETED|Overall Study||24
5253946|NCT00779779|12916620|P1|COMPLETED|Overall Study||498
5253947|NCT00779779|12916620|P1|STARTED|Overall Study||522
5253948|NCT00779766|12916629|P2|NOT COMPLETED|Month 72||189
5253949|NCT00779766|12916630|P1|NOT COMPLETED|Month 72||185
5253950|NCT00779766|12916629|P2|COMPLETED|Month 72||2158
5253951|NCT00779766|12916630|P1|COMPLETED|Month 72||2134
5253952|NCT00779766|12916629|P2|STARTED|Month 72||2347
5253953|NCT00779766|12916630|P1|STARTED|Month 72||2319
5253954|NCT00779766|12916629|P2|NOT COMPLETED|Month 48||168
5253955|NCT00779766|12916630|P1|NOT COMPLETED|Month 48||174
5253956|NCT00779766|12916629|P2|COMPLETED|Month 48||2559
5253957|NCT00779766|12916630|P1|COMPLETED|Month 48||2529
5253958|NCT00779766|12916629|P2|STARTED|Month 48||2727
5253959|NCT00779766|12916630|P1|STARTED|Month 48||2703
5253960|NCT00779766|12916629|P2|NOT COMPLETED|Month 24||332
5253961|NCT00779766|12916630|P1|NOT COMPLETED|Month 24||332
5253962|NCT00779766|12916629|P2|COMPLETED|Month 24||2693
5253963|NCT00779766|12916630|P1|COMPLETED|Month 24||2694
5253964|NCT00779766|12916629|P2|STARTED|Month 24||3025
5253965|NCT00779766|12916630|P1|STARTED|Month 24||3026
5253966|NCT00779701|12916714|P1|NOT COMPLETED|Overall Study||0
5253967|NCT00779701|12916714|P1|COMPLETED|Overall Study||27
5253968|NCT00779701|12916714|P1|STARTED|Overall Study||27
5253969|NCT00779675|12916718|P1|NOT COMPLETED|Extended Treatment Period||46
5253970|NCT00779675|12916718|P1|COMPLETED|Extended Treatment Period||147
5253971|NCT00779675|12916718|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
5253972|NCT00779675|12916718|P1|NOT COMPLETED|Treatment Period||332
5253973|NCT00779675|12916718|P1|COMPLETED|Treatment Period||328
5253974|NCT00779675|12916718|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
5253975|NCT00779584|12916746|P9|NOT COMPLETED|Overall Study||2
5253976|NCT00779584|12916747|P8|NOT COMPLETED|Overall Study||3
5253977|NCT00779584|12916748|P7|NOT COMPLETED|Overall Study||8
5253978|NCT00779584|12916749|P6|NOT COMPLETED|Overall Study||6
5253979|NCT00779584|12916750|P5|NOT COMPLETED|Overall Study||7
5253980|NCT00779584|12916751|P4|NOT COMPLETED|Overall Study||6
5253981|NCT00779584|12916752|P3|NOT COMPLETED|Overall Study||7
5253982|NCT00779584|12916753|P2|NOT COMPLETED|Overall Study||3
5253983|NCT00779584|12916754|P1|NOT COMPLETED|Overall Study||3
5253984|NCT00779584|12916746|P9|COMPLETED|Overall Study||0
5253985|NCT00779584|12916747|P8|COMPLETED|Overall Study||0
5253986|NCT00779584|12916748|P7|COMPLETED|Overall Study||0
5253987|NCT00779584|12916749|P6|COMPLETED|Overall Study||0
5253988|NCT00779584|12916750|P5|COMPLETED|Overall Study||0
5253989|NCT00779584|12916751|P4|COMPLETED|Overall Study||0
5253990|NCT00779584|12916752|P3|COMPLETED|Overall Study||0
5253991|NCT00779584|12916753|P2|COMPLETED|Overall Study||0
5253992|NCT00779584|12916754|P1|COMPLETED|Overall Study||0
5253993|NCT00779584|12916746|P9|Treated|Overall Study||2
5253994|NCT00779584|12916747|P8|Treated|Overall Study||3
5253995|NCT00779584|12916748|P7|Treated|Overall Study||8
5253996|NCT00779584|12916749|P6|Treated|Overall Study||4
5253997|NCT00779584|12916750|P5|Treated|Overall Study||7
5253998|NCT00779584|12916751|P4|Treated|Overall Study||6
5253999|NCT00779584|12916752|P3|Treated|Overall Study||7
5254000|NCT00779584|12916753|P2|Treated|Overall Study||3
5254001|NCT00779584|12916754|P1|Treated|Overall Study||3
5254002|NCT00779584|12916746|P9|STARTED|Overall Study||2
5254003|NCT00779584|12916747|P8|STARTED|Overall Study||3
5254004|NCT00779584|12916748|P7|STARTED|Overall Study||8
5254005|NCT00779584|12916749|P6|STARTED|Overall Study||6
5254006|NCT00779584|12916750|P5|STARTED|Overall Study||7
5254007|NCT00779584|12916751|P4|STARTED|Overall Study||6
5254008|NCT00779584|12916752|P3|STARTED|Overall Study||7
5254009|NCT00779584|12916753|P2|STARTED|Overall Study||3
5254010|NCT00779584|12916754|P1|STARTED|Overall Study||3
5254011|NCT00779558|12916830|P2|NOT COMPLETED|Overall Study||7
5254012|NCT00779558|12916831|P1|NOT COMPLETED|Overall Study||4
5254013|NCT00779558|12916830|P2|COMPLETED|Overall Study||37
5254014|NCT00779558|12916831|P1|COMPLETED|Overall Study||53
5254015|NCT00779558|12916830|P2|STARTED|Overall Study||44
5254016|NCT00779558|12916831|P1|STARTED|Overall Study||57
5254017|NCT00779506|12916845|P1|NOT COMPLETED|Overall Study||29
5254018|NCT00779506|12916845|P1|COMPLETED|Overall Study||67
5254019|NCT00779506|12916845|P1|Withdrawal Treatment|Overall Study||27
5254020|NCT00779506|12916845|P1|Treatment Complete|Overall Study||67
5254021|NCT00779506|12916845|P1|MITT|Overall Study||89
5254022|NCT00779506|12916845|P1|Assigned|Overall Study||94
5254023|NCT00779506|12916845|P1|Screen Failed|Overall Study||2
5254024|NCT00779506|12916845|P1|Enrolled|Overall Study||96
5254025|NCT00779506|12916845|P1|STARTED|Overall Study||96
5254026|NCT00779467|12916859|P4|NOT COMPLETED|Overall Study||19
5254027|NCT00779467|12916860|P3|NOT COMPLETED|Overall Study||10
5254028|NCT00779467|12916861|P2|NOT COMPLETED|Overall Study||5
5254029|NCT00779467|12916862|P1|NOT COMPLETED|Overall Study||15
5254030|NCT00779467|12916859|P4|COMPLETED|Overall Study||35
5254031|NCT00779467|12916860|P3|COMPLETED|Overall Study||38
5254032|NCT00779467|12916861|P2|COMPLETED|Overall Study||40
5254033|NCT00779467|12916862|P1|COMPLETED|Overall Study||38
5254034|NCT00779467|12916859|P4|STARTED|Overall Study||54
5254035|NCT00779467|12916860|P3|STARTED|Overall Study||48
5254036|NCT00779467|12916861|P2|STARTED|Overall Study||45
5254037|NCT00779467|12916862|P1|STARTED|Overall Study||53
5254038|NCT00779402|12916902|P2|NOT COMPLETED|Long-term Follow-up||6
5254039|NCT00779402|12916903|P1|NOT COMPLETED|Long-term Follow-up||21
5254040|NCT00779402|12916902|P2|COMPLETED|Long-term Follow-up||7
5254041|NCT00779402|12916903|P1|COMPLETED|Long-term Follow-up||20
5254042|NCT00779402|12916902|P2|STARTED|Long-term Follow-up||13
5254043|NCT00779402|12916903|P1|STARTED|Long-term Follow-up||41
5254044|NCT00779402|12916902|P2|NOT COMPLETED|Surveillance Phase||31
5254045|NCT00779402|12916903|P1|NOT COMPLETED|Surveillance Phase||43
5254046|NCT00779402|12916902|P2|COMPLETED|Surveillance Phase||13
5254047|NCT00779402|12916903|P1|COMPLETED|Surveillance Phase||41
5254048|NCT00779402|12916902|P2|STARTED|Surveillance Phase||44
5254049|NCT00779402|12916903|P1|STARTED|Surveillance Phase||84
5254050|NCT00779402|12916902|P2|NOT COMPLETED|Treatment Phase 1||15
5254051|NCT00779402|12916903|P1|NOT COMPLETED|Treatment Phase 1||33
5254052|NCT00779402|12916902|P2|COMPLETED|Treatment Phase 1||44
5254053|NCT00779402|12916903|P1|COMPLETED|Treatment Phase 1||84
5254054|NCT00779402|12916902|P2|Received Booster Infusion|Treatment Phase 1||30
5254055|NCT00779402|12916903|P1|Received Booster Infusion|Treatment Phase 1||50
5254056|NCT00779402|12916902|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
5254057|NCT00779402|12916903|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
5254058|NCT00779402|12916902|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
5254059|NCT00779402|12916903|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
5254060|NCT00779402|12916902|P2|STARTED|Treatment Phase 1||59
5254061|NCT00779402|12916903|P1|STARTED|Treatment Phase 1||117
5254062|NCT00779311|12916916|P5|NOT COMPLETED|Overall Study||0
5254063|NCT00779311|12916917|P4|NOT COMPLETED|Overall Study||0
5254064|NCT00779311|12916918|P3|NOT COMPLETED|Overall Study||0
5254065|NCT00779311|12916919|P2|NOT COMPLETED|Overall Study||0
5254066|NCT00779311|12916920|P1|NOT COMPLETED|Overall Study||0
5254067|NCT00779311|12916916|P5|COMPLETED|Overall Study||0
5254068|NCT00779311|12916917|P4|COMPLETED|Overall Study||0
5254069|NCT00779311|12916918|P3|COMPLETED|Overall Study||0
5254070|NCT00779311|12916919|P2|COMPLETED|Overall Study||0
5254071|NCT00779311|12916920|P1|COMPLETED|Overall Study||8
5254072|NCT00779311|12916916|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
5254073|NCT00779311|12916917|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
5254074|NCT00779311|12916918|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
5254075|NCT00779311|12916919|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
5254076|NCT00779311|12916920|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
5254077|NCT00779311|12916916|P5|STARTED|Overall Study||0
5254078|NCT00779311|12916917|P4|STARTED|Overall Study||0
5254079|NCT00779311|12916918|P3|STARTED|Overall Study||0
5254080|NCT00779311|12916919|P2|STARTED|Overall Study||0
5254173|NCT00778830|12917097|P1|NOT COMPLETED|Overall Study||0
5254081|NCT00779311|12916920|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
5254082|NCT00779285|12916942|P1|NOT COMPLETED|Overall Study||0
5254083|NCT00779285|12916942|P1|COMPLETED|Overall Study||1
5254084|NCT00779285|12916942|P1|STARTED|Overall Study||1
5254085|NCT00779259|12916946|P1|NOT COMPLETED|Theophylline With Quinine||0
5254086|NCT00779259|12916946|P1|COMPLETED|Theophylline With Quinine||22
5254087|NCT00779259|12916946|P1|STARTED|Theophylline With Quinine||22
5254088|NCT00779259|12916946|P1|NOT COMPLETED|Quinine Alone||2
5254089|NCT00779259|12916946|P1|COMPLETED|Quinine Alone||22
5254090|NCT00779259|12916946|P1|STARTED|Quinine Alone||24
5254091|NCT00779259|12916946|P1|NOT COMPLETED|4 Day Washout Period||0
5254092|NCT00779259|12916946|P1|COMPLETED|4 Day Washout Period||24
5254093|NCT00779259|12916946|P1|STARTED|4 Day Washout Period||24
5254094|NCT00779259|12916946|P1|NOT COMPLETED|Theophylline Alone||0
5254095|NCT00779259|12916946|P1|COMPLETED|Theophylline Alone||24
5254096|NCT00779259|12916946|P1|STARTED|Theophylline Alone||24
5254097|NCT00779246|12916967|P2|NOT COMPLETED|Overall Study||53
5254098|NCT00779246|12916968|P1|NOT COMPLETED|Overall Study||33
5254099|NCT00779246|12916967|P2|COMPLETED|Overall Study||715
5254100|NCT00779246|12916968|P1|COMPLETED|Overall Study||717
5254101|NCT00779246|12916967|P2|STARTED|Overall Study||768
5254102|NCT00779246|12916968|P1|STARTED|Overall Study||750
5254103|NCT00779155|12916980|P2|NOT COMPLETED|Overall Study||0
5254104|NCT00779155|12916981|P1|NOT COMPLETED|Overall Study||0
5254105|NCT00779155|12916980|P2|COMPLETED|Overall Study||6
5254106|NCT00779155|12916981|P1|COMPLETED|Overall Study||6
5254107|NCT00779155|12916980|P2|STARTED|Overall Study||6
5254108|NCT00779155|12916981|P1|STARTED|Overall Study||6
5254109|NCT00779142|12916987|P1|NOT COMPLETED|Overall Study||3
5254110|NCT00779142|12916987|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
5254111|NCT00779142|12916987|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
5254112|NCT00779116|12916993|P2|NOT COMPLETED|Second Intervention||0
5254113|NCT00779116|12916994|P1|NOT COMPLETED|Second Intervention||0
5254114|NCT00779116|12916993|P2|COMPLETED|Second Intervention||108
5254115|NCT00779116|12916994|P1|COMPLETED|Second Intervention||109
5254116|NCT00779116|12916993|P2|STARTED|Second Intervention||108
5254117|NCT00779116|12916994|P1|STARTED|Second Intervention||109
5254118|NCT00779116|12916993|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
5254119|NCT00779116|12916994|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
5254120|NCT00779116|12916993|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
5254121|NCT00779116|12916994|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
5254122|NCT00779116|12916993|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
5254123|NCT00779116|12916994|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
5254124|NCT00779116|12916993|P2|NOT COMPLETED|First Intervention||0
5254125|NCT00779116|12916994|P1|NOT COMPLETED|First Intervention||0
5254126|NCT00779116|12916993|P2|COMPLETED|First Intervention||108
5254127|NCT00779116|12916994|P1|COMPLETED|First Intervention||109
5254128|NCT00779116|12916993|P2|STARTED|First Intervention||108
5254129|NCT00779116|12916994|P1|STARTED|First Intervention||109
5254130|NCT00779038|12917001|P1|NOT COMPLETED|Overall Study||13
5254131|NCT00779038|12917001|P1|COMPLETED|Overall Study||0
5254132|NCT00779038|12917001|P1|STARTED|Overall Study||13
5254133|NCT00779025|12917010|P1|NOT COMPLETED|Overall Study||1
5254134|NCT00779025|12917010|P1|COMPLETED|Overall Study||81
5254135|NCT00779025|12917010|P1|STARTED|Overall Study||82
5254136|NCT00778999|12917021|P2|NOT COMPLETED|Overall Study||34
5254137|NCT00778999|12917022|P1|NOT COMPLETED|Overall Study||28
5254138|NCT00778999|12917021|P2|COMPLETED|Overall Study||185
5254139|NCT00778999|12917022|P1|COMPLETED|Overall Study||195
5254140|NCT00778999|12917021|P2|STARTED|Overall Study||219
5254141|NCT00778999|12917022|P1|STARTED|Overall Study||223
5254142|NCT00778921|12917031|P3|NOT COMPLETED|Overall Study||28
5254143|NCT00778921|12917032|P2|NOT COMPLETED|Overall Study||19
5254144|NCT00778921|12917033|P1|NOT COMPLETED|Overall Study||18
5254145|NCT00778921|12917031|P3|COMPLETED|Overall Study||255
5254146|NCT00778921|12917032|P2|COMPLETED|Overall Study||266
5254147|NCT00778921|12917033|P1|COMPLETED|Overall Study||261
5254148|NCT00778921|12917031|P3|STARTED|Overall Study||283
5254149|NCT00778921|12917032|P2|STARTED|Overall Study||285
5254150|NCT00778921|12917033|P1|STARTED|Overall Study||279
5254151|NCT00778895|12917050|P3|NOT COMPLETED|ESFU Phase||2
5254152|NCT00778895|12917051|P2|NOT COMPLETED|ESFU Phase||12
5254153|NCT00778895|12917052|P1|NOT COMPLETED|ESFU Phase||11
5254154|NCT00778895|12917050|P3|COMPLETED|ESFU Phase||41
5254155|NCT00778895|12917051|P2|COMPLETED|ESFU Phase||155
5254156|NCT00778895|12917052|P1|COMPLETED|ESFU Phase||153
5254157|NCT00778895|12917050|P3|STARTED|ESFU Phase||43
5254158|NCT00778895|12917051|P2|STARTED|ESFU Phase||167
5254159|NCT00778895|12917052|P1|STARTED|ESFU Phase||164
5254160|NCT00778895|12917050|P3|NOT COMPLETED|Active Phase||0
5254161|NCT00778895|12917051|P2|NOT COMPLETED|Active Phase||6
5254162|NCT00778895|12917052|P1|NOT COMPLETED|Active Phase||7
5254163|NCT00778895|12917050|P3|COMPLETED|Active Phase||43
5254164|NCT00778895|12917051|P2|COMPLETED|Active Phase||161
5254165|NCT00778895|12917052|P1|COMPLETED|Active Phase||157
5254166|NCT00778895|12917050|P3|STARTED|Active Phase||43
5254167|NCT00778895|12917051|P2|STARTED|Active Phase||167
5254168|NCT00778895|12917052|P1|STARTED|Active Phase||164
5254169|NCT00778869|12917090|P1|NOT COMPLETED|Overall Study||0
5254170|NCT00778869|12917090|P1|COMPLETED|Overall Study||10
5254171|NCT00778869|12917090|P1|STARTED|Overall Study||10
5254172|NCT00778830|12917096|P2|NOT COMPLETED|Overall Study||1
5254174|NCT00778830|12917096|P2|COMPLETED|Overall Study||187
5254175|NCT00778830|12917097|P1|COMPLETED|Overall Study||101
5254176|NCT00778830|12917096|P2|STARTED|Overall Study||188
5254177|NCT00778830|12917097|P1|STARTED|Overall Study||101
5254178|NCT00778817|12917109|P1|NOT COMPLETED|Overall Study||4
5254179|NCT00778817|12917109|P1|COMPLETED|Overall Study||16
5254180|NCT00778817|12917109|P1|STARTED|Overall Study||20
5254181|NCT00778648|12917126|P2|NOT COMPLETED|Overall Study||5
5254182|NCT00778648|12917127|P1|NOT COMPLETED|Overall Study||9
5254183|NCT00778648|12917126|P2|COMPLETED|Overall Study||266
5254184|NCT00778648|12917127|P1|COMPLETED|Overall Study||263
5254185|NCT00778648|12917126|P2|STARTED|Overall Study||271
5254186|NCT00778648|12917127|P1|STARTED|Overall Study||272
5254187|NCT00778622|12917136|P3|NOT COMPLETED|Overall Study||15
5254188|NCT00778622|12917137|P2|NOT COMPLETED|Overall Study||15
5254189|NCT00778622|12917138|P1|NOT COMPLETED|Overall Study||16
5254190|NCT00778622|12917136|P3|COMPLETED|Overall Study||109
5254191|NCT00778622|12917137|P2|COMPLETED|Overall Study||107
5254192|NCT00778622|12917138|P1|COMPLETED|Overall Study||109
5254193|NCT00778622|12917136|P3|STARTED|Overall Study||124
5254194|NCT00778622|12917137|P2|STARTED|Overall Study||122
5254195|NCT00778622|12917138|P1|STARTED|Overall Study||125
5254196|NCT00778375|12917191|P1|NOT COMPLETED|Overall Study||3
5254197|NCT00778375|12917191|P1|COMPLETED|Overall Study||119
5254198|NCT00778375|12917191|P1|STARTED|Overall Study||122
5254199|NCT00778336|12917205|P4|NOT COMPLETED|3 Month Follow Up||0
5254200|NCT00778336|12917206|P3|NOT COMPLETED|3 Month Follow Up||5
5254201|NCT00778336|12917207|P2|NOT COMPLETED|3 Month Follow Up||23
5254202|NCT00778336|12917208|P1|NOT COMPLETED|3 Month Follow Up||23
5254203|NCT00778336|12917205|P4|COMPLETED|3 Month Follow Up||12
5254204|NCT00778336|12917206|P3|COMPLETED|3 Month Follow Up||65
5254205|NCT00778336|12917207|P2|COMPLETED|3 Month Follow Up||144
5254206|NCT00778336|12917208|P1|COMPLETED|3 Month Follow Up||169
5254207|NCT00778336|12917205|P4|STARTED|3 Month Follow Up||12
5254208|NCT00778336|12917206|P3|STARTED|3 Month Follow Up||70
5254209|NCT00778336|12917207|P2|STARTED|3 Month Follow Up||167
5254210|NCT00778336|12917208|P1|STARTED|3 Month Follow Up||192
5254211|NCT00778336|12917205|P4|NOT COMPLETED|Index Procedure-Discharge||0
5254212|NCT00778336|12917206|P3|NOT COMPLETED|Index Procedure-Discharge||2
5254213|NCT00778336|12917207|P2|NOT COMPLETED|Index Procedure-Discharge||3
5254214|NCT00778336|12917208|P1|NOT COMPLETED|Index Procedure-Discharge||6
5254215|NCT00778336|12917205|P4|COMPLETED|Index Procedure-Discharge||12
5254216|NCT00778336|12917206|P3|COMPLETED|Index Procedure-Discharge||70
5254217|NCT00778336|12917207|P2|COMPLETED|Index Procedure-Discharge||167
5254218|NCT00778336|12917208|P1|COMPLETED|Index Procedure-Discharge||192
5254219|NCT00778336|12917205|P4|STARTED|Index Procedure-Discharge||12
5254220|NCT00778336|12917206|P3|STARTED|Index Procedure-Discharge||72
5254221|NCT00778336|12917207|P2|STARTED|Index Procedure-Discharge||170
5254222|NCT00778336|12917208|P1|STARTED|Index Procedure-Discharge||198
5254223|NCT00778310|12917228|P2|NOT COMPLETED|Overall Study||0
5254224|NCT00778310|12917229|P1|NOT COMPLETED|Overall Study||0
5254225|NCT00778310|12917228|P2|COMPLETED|Overall Study||26
5254226|NCT00778310|12917229|P1|COMPLETED|Overall Study||17
5254227|NCT00778310|12917228|P2|Usable Data|Overall Study||21
5254228|NCT00778310|12917229|P1|Usable Data|Overall Study||14
5254229|NCT00778310|12917228|P2|STARTED|Overall Study||26
5254230|NCT00778310|12917229|P1|STARTED|Overall Study||17
5254231|NCT00778258|12917246|P9|NOT COMPLETED|Overall Study||4
5254232|NCT00778258|12917247|P8|NOT COMPLETED|Overall Study||15
5254233|NCT00778258|12917248|P7|NOT COMPLETED|Overall Study||15
5254234|NCT00778258|12917249|P6|NOT COMPLETED|Overall Study||10
5254235|NCT00778258|12917250|P5|NOT COMPLETED|Overall Study||0
5254236|NCT00778258|12917251|P4|NOT COMPLETED|Overall Study||3
5254237|NCT00778258|12917252|P3|NOT COMPLETED|Overall Study||10
5254238|NCT00778258|12917253|P2|NOT COMPLETED|Overall Study||2
5254239|NCT00778258|12917254|P1|NOT COMPLETED|Overall Study||7
5254240|NCT00778258|12917246|P9|COMPLETED|Overall Study||6
5254241|NCT00778258|12917247|P8|COMPLETED|Overall Study||26
5254242|NCT00778258|12917248|P7|COMPLETED|Overall Study||19
5254243|NCT00778258|12917249|P6|COMPLETED|Overall Study||13
5254244|NCT00778258|12917250|P5|COMPLETED|Overall Study||6
5254245|NCT00778258|12917251|P4|COMPLETED|Overall Study||12
5254246|NCT00778258|12917252|P3|COMPLETED|Overall Study||10
5254247|NCT00778258|12917253|P2|COMPLETED|Overall Study||3
5254248|NCT00778258|12917254|P1|COMPLETED|Overall Study||9
5254249|NCT00778258|12917246|P9|STARTED|Overall Study||10
5254250|NCT00778258|12917247|P8|STARTED|Overall Study||41
5254251|NCT00778258|12917248|P7|STARTED|Overall Study||34
5254252|NCT00778258|12917249|P6|STARTED|Overall Study||23
5254253|NCT00778258|12917250|P5|STARTED|Overall Study||6
5254254|NCT00778258|12917251|P4|STARTED|Overall Study||15
5254255|NCT00778258|12917252|P3|STARTED|Overall Study||20
5254256|NCT00778258|12917253|P2|STARTED|Overall Study||5
5254257|NCT00778258|12917254|P1|STARTED|Overall Study||16
5254258|NCT00778167|12917309|P3|NOT COMPLETED|Overall Study||0
5254259|NCT00778167|12917310|P2|NOT COMPLETED|Overall Study||0
5254260|NCT00778167|12917311|P1|NOT COMPLETED|Overall Study||0
5254261|NCT00778167|12917309|P3|COMPLETED|Overall Study||4
5254262|NCT00778167|12917310|P2|COMPLETED|Overall Study||8
5254263|NCT00778167|12917311|P1|COMPLETED|Overall Study||6
5254264|NCT00778167|12917309|P3|STARTED|Overall Study||4
5254265|NCT00778167|12917310|P2|STARTED|Overall Study||8
5254266|NCT00778167|12917311|P1|STARTED|Overall Study||6
5254267|NCT00778102|12917321|P2|NOT COMPLETED|Overall Study||22
5254268|NCT00778102|12917322|P1|NOT COMPLETED|Overall Study||21
5254269|NCT00778102|12917321|P2|COMPLETED|Overall Study||19
5254270|NCT00778102|12917322|P1|COMPLETED|Overall Study||18
5254271|NCT00778102|12917321|P2|STARTED|Overall Study||41
5254272|NCT00778102|12917322|P1|STARTED|Overall Study||39
5254273|NCT00777946|12917357|P3|NOT COMPLETED|Overall Study||16
5254274|NCT00777946|12917358|P2|NOT COMPLETED|Overall Study||6
5254275|NCT00777946|12917359|P1|NOT COMPLETED|Overall Study||21
5254276|NCT00777946|12917357|P3|COMPLETED|Overall Study||244
5254277|NCT00777946|12917358|P2|COMPLETED|Overall Study||271
5254278|NCT00777946|12917359|P1|COMPLETED|Overall Study||262
5254279|NCT00777946|12917357|P3|Safety & Full Analysis Sets|Overall Study||260
5254280|NCT00777946|12917358|P2|Safety & Full Analysis Sets|Overall Study||276
5254281|NCT00777946|12917359|P1|Safety & Full Analysis Sets|Overall Study||282
5254282|NCT00777946|12917357|P3|STARTED|Overall Study||260
5254283|NCT00777946|12917358|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
5254284|NCT00777946|12917359|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
5254285|NCT00777855|12917382|P2|NOT COMPLETED|Second Intervention||0
5254286|NCT00777855|12917383|P1|NOT COMPLETED|Second Intervention||0
5254287|NCT00777855|12917382|P2|COMPLETED|Second Intervention||5
5254288|NCT00777855|12917383|P1|COMPLETED|Second Intervention||5
5254289|NCT00777855|12917382|P2|STARTED|Second Intervention||5
5254290|NCT00777855|12917383|P1|STARTED|Second Intervention||5
5254291|NCT00777855|12917382|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
5254292|NCT00777855|12917383|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
5254293|NCT00777855|12917382|P2|COMPLETED|Washout Period (>= 14 Days)||5
5254294|NCT00777855|12917383|P1|COMPLETED|Washout Period (>= 14 Days)||5
5254295|NCT00777855|12917382|P2|STARTED|Washout Period (>= 14 Days)||5
5254296|NCT00777855|12917383|P1|STARTED|Washout Period (>= 14 Days)||5
5254297|NCT00777855|12917382|P2|NOT COMPLETED|First Intervention||0
5254298|NCT00777855|12917383|P1|NOT COMPLETED|First Intervention||0
5254299|NCT00777855|12917382|P2|COMPLETED|First Intervention||5
5254300|NCT00777855|12917383|P1|COMPLETED|First Intervention||5
5254301|NCT00777855|12917382|P2|STARTED|First Intervention||5
5254302|NCT00777855|12917383|P1|STARTED|First Intervention||5
5254303|NCT00777803|12917394|P2|NOT COMPLETED|Overall Study||7
5254304|NCT00777803|12917395|P1|NOT COMPLETED|Overall Study||15
5254305|NCT00777803|12917394|P2|COMPLETED|Overall Study||90
5254306|NCT00777803|12917395|P1|COMPLETED|Overall Study||269
5254307|NCT00777803|12917394|P2|STARTED|Overall Study||97
5254308|NCT00777803|12917395|P1|STARTED|Overall Study||284
5254309|NCT00777790|12917430|P3|NOT COMPLETED|Overall Study||0
5254310|NCT00777790|12917431|P2|NOT COMPLETED|Overall Study||0
5254311|NCT00777790|12917432|P1|NOT COMPLETED|Overall Study||0
5254312|NCT00777790|12917430|P3|COMPLETED|Overall Study||88
5254313|NCT00777790|12917431|P2|COMPLETED|Overall Study||77
5254314|NCT00777790|12917432|P1|COMPLETED|Overall Study||76
5254315|NCT00777790|12917430|P3|STARTED|Overall Study||88
5254316|NCT00777790|12917431|P2|STARTED|Overall Study||77
5254317|NCT00777790|12917432|P1|STARTED|Overall Study||76
5254318|NCT00777764|12917442|P2|NOT COMPLETED|Overall Study||1
5254319|NCT00777764|12917443|P1|NOT COMPLETED|Overall Study||0
5254320|NCT00777764|12917442|P2|COMPLETED|Overall Study||29
5254321|NCT00777764|12917443|P1|COMPLETED|Overall Study||30
5254322|NCT00777764|12917442|P2|STARTED|Overall Study||30
5254323|NCT00777764|12917443|P1|STARTED|Overall Study||30
5254324|NCT00777634|12917455|P2|NOT COMPLETED|Overall Study||1
5254325|NCT00777634|12917456|P1|NOT COMPLETED|Overall Study||5
5254326|NCT00777634|12917455|P2|COMPLETED|Overall Study||133
5254327|NCT00777634|12917456|P1|COMPLETED|Overall Study||129
5254328|NCT00777634|12917455|P2|STARTED|Overall Study||134
5254329|NCT00777634|12917456|P1|STARTED|Overall Study||134
5254330|NCT00777608|12917474|P2|NOT COMPLETED|Overall Study||6
5254331|NCT00777608|12917475|P1|NOT COMPLETED|Overall Study||4
5254332|NCT00777608|12917474|P2|COMPLETED|Overall Study||47
5254333|NCT00777608|12917475|P1|COMPLETED|Overall Study||49
5254334|NCT00777608|12917474|P2|STARTED|Overall Study||53
5254335|NCT00777608|12917475|P1|STARTED|Overall Study||53
5254336|NCT00777556|12917485|P1|NOT COMPLETED|Overall Study||66
5254337|NCT00777556|12917485|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
5254338|NCT00777556|12917485|P1|Used Product|Overall Study||297
5254339|NCT00777556|12917485|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
5254340|NCT00777556|12917485|P1|Dispensed Product|Overall Study||307
5254341|NCT00777556|12917485|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
5254342|NCT00777491|12917494|P2|NOT COMPLETED|Overall Study||2
5254343|NCT00777491|12917495|P1|NOT COMPLETED|Overall Study||2
5254344|NCT00777491|12917494|P2|COMPLETED|Overall Study||33
5254345|NCT00777491|12917495|P1|COMPLETED|Overall Study||33
5254346|NCT00777491|12917494|P2|Has 3 Year AUASI Data|Overall Study||6
5254347|NCT00777491|12917495|P1|Has 3 Year AUASI Data|Overall Study||6
5254348|NCT00777491|12917494|P2|Has Adverse Event Data (Late)|Overall Study||31
5254349|NCT00777491|12917495|P1|Has Adverse Event Data (Late)|Overall Study||32
5254350|NCT00777491|12917494|P2|Has Adverse Event Data (Treatment)|Overall Study||33
5254351|NCT00777491|12917495|P1|Has Adverse Event Data (Treatment)|Overall Study||33
5254352|NCT00777491|12917494|P2|Started Adjuvant Therapy|Overall Study||31
5254353|NCT00777491|12917495|P1|Started Adjuvant Therapy|Overall Study||32
5254354|NCT00777491|12917494|P2|Started Consolidation Therapy|Overall Study||25
5254355|NCT00777491|12917495|P1|Started Consolidation Therapy|Overall Study||29
5254356|NCT00777491|12917494|P2|Started Induction Therapy|Overall Study||33
5254357|NCT00777491|12917495|P1|Started Induction Therapy|Overall Study||33
5254358|NCT00777491|12917494|P2|Has 3-year Efficacy Data|Overall Study||25
5254359|NCT00777491|12917495|P1|Has 3-year Efficacy Data|Overall Study||27
5254360|NCT00777491|12917494|P2|Eligible|Overall Study||33
5254361|NCT00777491|12917495|P1|Eligible|Overall Study||33
5254362|NCT00777491|12917494|P2|STARTED|Overall Study||35
5254363|NCT00777491|12917495|P1|STARTED|Overall Study||35
5254364|NCT00777335|12917515|P2|NOT COMPLETED|Overall Study||0
5254365|NCT00777335|12917516|P1|NOT COMPLETED|Overall Study||0
5254366|NCT00777335|12917515|P2|COMPLETED|Overall Study||2
5254367|NCT00777335|12917516|P1|COMPLETED|Overall Study||2
5254368|NCT00777335|12917515|P2|STARTED|Overall Study||2
5254369|NCT00777335|12917516|P1|STARTED|Overall Study||2
5254370|NCT00777296|12917528|P4|NOT COMPLETED|Overall Study||1
5254371|NCT00777296|12917529|P3|NOT COMPLETED|Overall Study||2
5254372|NCT00777296|12917530|P2|NOT COMPLETED|Overall Study||1
5254373|NCT00777296|12917531|P1|NOT COMPLETED|Overall Study||1
5254374|NCT00777296|12917528|P4|COMPLETED|Overall Study||10
5254375|NCT00777296|12917529|P3|COMPLETED|Overall Study||21
5254376|NCT00777296|12917530|P2|COMPLETED|Overall Study||10
5254377|NCT00777296|12917531|P1|COMPLETED|Overall Study||20
5254378|NCT00777296|12917528|P4|STARTED|Overall Study||11
5254379|NCT00777296|12917529|P3|STARTED|Overall Study||23
5254380|NCT00777296|12917530|P2|STARTED|Overall Study||11
5254381|NCT00777296|12917531|P1|STARTED|Overall Study||21
5254382|NCT00777257|12917573|P3|NOT COMPLETED|Overall Study||9
5254383|NCT00777257|12917574|P2|NOT COMPLETED|Overall Study||12
5254384|NCT00777257|12917575|P1|NOT COMPLETED|Overall Study||11
5254385|NCT00777257|12917573|P3|COMPLETED|Overall Study||442
5254386|NCT00777257|12917574|P2|COMPLETED|Overall Study||438
5254387|NCT00777257|12917575|P1|COMPLETED|Overall Study||433
5254388|NCT00777257|12917573|P3|STARTED|Overall Study||451
5254389|NCT00777257|12917574|P2|STARTED|Overall Study||450
5254390|NCT00777257|12917575|P1|STARTED|Overall Study||444
5254391|NCT00777205|12917594|P2|NOT COMPLETED|Overall Study||71
5254392|NCT00777205|12917595|P1|NOT COMPLETED|Overall Study||31
5254393|NCT00777205|12917594|P2|COMPLETED|Overall Study||129
5254394|NCT00777205|12917595|P1|COMPLETED|Overall Study||212
5254395|NCT00777205|12917594|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
5254396|NCT00777205|12917595|P1|Intervention Interruption|Overall Study||0
5254397|NCT00777205|12917594|P2|STARTED|Overall Study||200
5254398|NCT00777205|12917595|P1|STARTED|Overall Study||243
5254399|NCT00777179|12917611|P2|NOT COMPLETED|Overall Study||0
5254400|NCT00777179|12917612|P1|NOT COMPLETED|Overall Study||0
5254401|NCT00777179|12917611|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
5254402|NCT00777179|12917612|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
5254403|NCT00777179|12917611|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
5254404|NCT00777179|12917612|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
5254405|NCT00777153|12917629|P3|NOT COMPLETED|Overall Study||37
5254406|NCT00777153|12917630|P2|NOT COMPLETED|Overall Study||83
5254407|NCT00777153|12917631|P1|NOT COMPLETED|Overall Study||90
5254408|NCT00777153|12917629|P3|COMPLETED|Overall Study||28
5254409|NCT00777153|12917630|P2|COMPLETED|Overall Study||46
5254410|NCT00777153|12917631|P1|COMPLETED|Overall Study||41
5254411|NCT00777153|12917629|P3|STARTED|Overall Study||65
5254412|NCT00777153|12917630|P2|STARTED|Overall Study||129
5254413|NCT00777153|12917631|P1|STARTED|Overall Study||131
5254414|NCT00777101|12917656|P2|NOT COMPLETED|Overall Study||51
5254415|NCT00777101|12917657|P1|NOT COMPLETED|Overall Study||62
5254416|NCT00777101|12917656|P2|COMPLETED|Overall Study||65
5254417|NCT00777101|12917657|P1|COMPLETED|Overall Study||55
5254418|NCT00777101|12917656|P2|Treated|Overall Study||115
5254419|NCT00777101|12917657|P1|Treated|Overall Study||116
5254420|NCT00777101|12917656|P2|STARTED|Overall Study||116
5254421|NCT00777101|12917657|P1|STARTED|Overall Study||117
5254422|NCT00777088|12917675|P1|NOT COMPLETED|Overall Study||1
5254423|NCT00777088|12917675|P1|COMPLETED|Overall Study||107
5254424|NCT00777088|12917675|P1|STARTED|Overall Study||108
5254425|NCT00777062|12917689|P2|NOT COMPLETED|Overall Study||5
5254426|NCT00777062|12917690|P1|NOT COMPLETED|Overall Study||3
5254427|NCT00777062|12917689|P2|COMPLETED|Overall Study||36
5254428|NCT00777062|12917690|P1|COMPLETED|Overall Study||36
5254429|NCT00777062|12917689|P2|STARTED|Overall Study||41
5254430|NCT00777062|12917690|P1|STARTED|Overall Study||39
5254431|NCT00777049|12917700|P2|NOT COMPLETED|Overall Study||1
5254432|NCT00777049|12917701|P1|NOT COMPLETED|Overall Study||1
5254433|NCT00777049|12917700|P2|COMPLETED|Overall Study||20
5254434|NCT00777049|12917701|P1|COMPLETED|Overall Study||32
5254435|NCT00777049|12917700|P2|STARTED|Overall Study||21
5254436|NCT00777049|12917701|P1|STARTED|Overall Study||33
5254437|NCT00777036|12917710|P3|NOT COMPLETED|Follow-Up||4
5254438|NCT00777036|12917711|P2|NOT COMPLETED|Follow-Up||8
5254439|NCT00777036|12917712|P1|NOT COMPLETED|Follow-Up||5
5254440|NCT00777036|12917710|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
5254441|NCT00777036|12917711|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
5254442|NCT00777036|12917712|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
5254443|NCT00777036|12917710|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
5254444|NCT00777036|12917711|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
5254534|NCT00776009|12918073|P5|COMPLETED|Period 3: Third Intervention||26
5254445|NCT00777036|12917712|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
5254446|NCT00777036|12917710|P3|NOT COMPLETED|On Treatment||23
5254447|NCT00777036|12917711|P2|NOT COMPLETED|On Treatment||16
5254448|NCT00777036|12917712|P1|NOT COMPLETED|On Treatment||15
5254449|NCT00777036|12917710|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
5254450|NCT00777036|12917711|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
5254451|NCT00777036|12917712|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
5254452|NCT00777036|12917710|P3|STARTED|On Treatment||84
5254453|NCT00777036|12917711|P2|STARTED|On Treatment||17
5254454|NCT00777036|12917712|P1|STARTED|On Treatment||29
5254455|NCT00777023|12917808|P3|NOT COMPLETED|Overall Study||37
5254456|NCT00777023|12917809|P2|NOT COMPLETED|Overall Study||41
5254457|NCT00777023|12917810|P1|NOT COMPLETED|Overall Study||35
5254458|NCT00777023|12917808|P3|COMPLETED|Overall Study||146
5254459|NCT00777023|12917809|P2|COMPLETED|Overall Study||149
5254460|NCT00777023|12917810|P1|COMPLETED|Overall Study||151
5254461|NCT00777023|12917808|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
5254462|NCT00777023|12917809|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
5254463|NCT00777023|12917810|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
5254464|NCT00776997|12917827|P1|NOT COMPLETED|Overall Study||2
5254465|NCT00776997|12917827|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
5254466|NCT00776997|12917827|P1|STARTED|Overall Study||100
5254467|NCT00776984|12917836|P2|NOT COMPLETED|Overall Study||21
5254468|NCT00776984|12917837|P1|NOT COMPLETED|Overall Study||31
5254469|NCT00776984|12917836|P2|COMPLETED|Overall Study||198
5254470|NCT00776984|12917837|P1|COMPLETED|Overall Study||203
5254471|NCT00776984|12917836|P2|STARTED|Overall Study||219
5254472|NCT00776984|12917837|P1|STARTED|Overall Study||234
5254473|NCT00776919|12917911|P4|NOT COMPLETED|Overall Study||39
5254474|NCT00776919|12917912|P3|NOT COMPLETED|Overall Study||32
5254475|NCT00776919|12917913|P2|NOT COMPLETED|Overall Study||33
5254476|NCT00776919|12917914|P1|NOT COMPLETED|Overall Study||27
5254477|NCT00776919|12917911|P4|COMPLETED|Overall Study||293
5254478|NCT00776919|12917912|P3|COMPLETED|Overall Study||296
5254479|NCT00776919|12917913|P2|COMPLETED|Overall Study||295
5254480|NCT00776919|12917914|P1|COMPLETED|Overall Study||300
5254481|NCT00776919|12917911|P4|STARTED|Overall Study||332
5254482|NCT00776919|12917912|P3|STARTED|Overall Study||328
5254483|NCT00776919|12917913|P2|STARTED|Overall Study||328
5254484|NCT00776919|12917914|P1|STARTED|Overall Study||327
5254485|NCT00776789|12917978|P2|NOT COMPLETED|Overall Study||3
5254486|NCT00776789|12917979|P1|NOT COMPLETED|Overall Study||3
5254487|NCT00776789|12917978|P2|COMPLETED|Overall Study||18
5254488|NCT00776789|12917979|P1|COMPLETED|Overall Study||17
5254489|NCT00776789|12917978|P2|STARTED|Overall Study||21
5254490|NCT00776789|12917979|P1|STARTED|Overall Study||20
5254491|NCT00776659|12917991|P1|NOT COMPLETED|Overall Study||26
5254492|NCT00776659|12917991|P1|COMPLETED|Overall Study||13
5254493|NCT00776659|12917991|P1|STARTED|Overall Study||39
5254494|NCT00776594|12918003|P2|NOT COMPLETED|Overall Study||2
5254495|NCT00776594|12918004|P1|NOT COMPLETED|Overall Study||4
5254496|NCT00776594|12918003|P2|COMPLETED|Overall Study||34
5254497|NCT00776594|12918004|P1|COMPLETED|Overall Study||62
5254498|NCT00776594|12918003|P2|STARTED|Overall Study||36
5254499|NCT00776594|12918004|P1|STARTED|Overall Study||66
5254500|NCT00776555|12918018|P2|NOT COMPLETED|Overall Study||0
5254501|NCT00776555|12918019|P1|NOT COMPLETED|Overall Study||3
5254502|NCT00776555|12918018|P2|COMPLETED|Overall Study||0
5254503|NCT00776555|12918019|P1|COMPLETED|Overall Study||0
5254504|NCT00776555|12918018|P2|STARTED|Overall Study||0
5254505|NCT00776555|12918019|P1|STARTED|Overall Study||3
5254506|NCT00776295|12918029|P1|NOT COMPLETED|Overall Study||0
5254507|NCT00776295|12918029|P1|COMPLETED|Overall Study||2
5254508|NCT00776295|12918029|P1|STARTED|Overall Study||2
5254509|NCT00776230|12918037|P3|NOT COMPLETED|Overall Study||5
5254510|NCT00776230|12918038|P2|NOT COMPLETED|Overall Study||3
5254511|NCT00776230|12918039|P1|NOT COMPLETED|Overall Study||3
5254512|NCT00776230|12918037|P3|COMPLETED|Overall Study||97
5254513|NCT00776230|12918038|P2|COMPLETED|Overall Study||100
5254514|NCT00776230|12918039|P1|COMPLETED|Overall Study||96
5254515|NCT00776230|12918037|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
5254516|NCT00776230|12918038|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
5254517|NCT00776230|12918039|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
5254518|NCT00776230|12918037|P3|STARTED|Overall Study||102
5254519|NCT00776230|12918038|P2|STARTED|Overall Study||103
5254520|NCT00776230|12918039|P1|STARTED|Overall Study||99
5254521|NCT00776100|12918049|P2|NOT COMPLETED|Overall Study||0
5254522|NCT00776100|12918050|P1|NOT COMPLETED|Overall Study||1
5254523|NCT00776100|12918049|P2|COMPLETED|Overall Study||1
5254524|NCT00776100|12918050|P1|COMPLETED|Overall Study||0
5254525|NCT00776100|12918049|P2|STARTED|Overall Study||1
5254526|NCT00776100|12918050|P1|STARTED|Overall Study||1
5254527|NCT00776009|12918072|P6|NOT COMPLETED|Period 3: Third Intervention||0
5254528|NCT00776009|12918073|P5|NOT COMPLETED|Period 3: Third Intervention||0
5254529|NCT00776009|12918074|P4|NOT COMPLETED|Period 3: Third Intervention||0
5254530|NCT00776009|12918075|P3|NOT COMPLETED|Period 3: Third Intervention||0
5254531|NCT00776009|12918076|P2|NOT COMPLETED|Period 3: Third Intervention||0
5254532|NCT00776009|12918077|P1|NOT COMPLETED|Period 3: Third Intervention||1
5254533|NCT00776009|12918072|P6|COMPLETED|Period 3: Third Intervention||26
5254535|NCT00776009|12918074|P4|COMPLETED|Period 3: Third Intervention||27
5254536|NCT00776009|12918075|P3|COMPLETED|Period 3: Third Intervention||27
5254537|NCT00776009|12918076|P2|COMPLETED|Period 3: Third Intervention||27
5254538|NCT00776009|12918077|P1|COMPLETED|Period 3: Third Intervention||24
5254539|NCT00776009|12918072|P6|STARTED|Period 3: Third Intervention||26
5254540|NCT00776009|12918073|P5|STARTED|Period 3: Third Intervention||26
5254541|NCT00776009|12918074|P4|STARTED|Period 3: Third Intervention||27
5254542|NCT00776009|12918075|P3|STARTED|Period 3: Third Intervention||27
5254543|NCT00776009|12918076|P2|STARTED|Period 3: Third Intervention||27
5254544|NCT00776009|12918077|P1|STARTED|Period 3: Third Intervention||25
5254545|NCT00776009|12918072|P6|NOT COMPLETED|Period 2: Second Intervention||1
5254546|NCT00776009|12918073|P5|NOT COMPLETED|Period 2: Second Intervention||0
5254547|NCT00776009|12918074|P4|NOT COMPLETED|Period 2: Second Intervention||0
5254548|NCT00776009|12918075|P3|NOT COMPLETED|Period 2: Second Intervention||1
5254549|NCT00776009|12918076|P2|NOT COMPLETED|Period 2: Second Intervention||0
5254550|NCT00776009|12918077|P1|NOT COMPLETED|Period 2: Second Intervention||1
5254551|NCT00776009|12918072|P6|COMPLETED|Period 2: Second Intervention||26
5254552|NCT00776009|12918073|P5|COMPLETED|Period 2: Second Intervention||26
5254553|NCT00776009|12918074|P4|COMPLETED|Period 2: Second Intervention||27
5254554|NCT00776009|12918075|P3|COMPLETED|Period 2: Second Intervention||27
5254555|NCT00776009|12918076|P2|COMPLETED|Period 2: Second Intervention||27
5254556|NCT00776009|12918077|P1|COMPLETED|Period 2: Second Intervention||25
5254557|NCT00776009|12918072|P6|STARTED|Period 2: Second Intervention||27
5254558|NCT00776009|12918073|P5|STARTED|Period 2: Second Intervention||26
5254559|NCT00776009|12918074|P4|STARTED|Period 2: Second Intervention||27
5254560|NCT00776009|12918075|P3|STARTED|Period 2: Second Intervention||28
5254561|NCT00776009|12918076|P2|STARTED|Period 2: Second Intervention||27
5254562|NCT00776009|12918077|P1|STARTED|Period 2: Second Intervention||26
5254563|NCT00776009|12918072|P6|NOT COMPLETED|Period 1: First Intervention||0
5254564|NCT00776009|12918073|P5|NOT COMPLETED|Period 1: First Intervention||2
5254565|NCT00776009|12918074|P4|NOT COMPLETED|Period 1: First Intervention||0
5254566|NCT00776009|12918075|P3|NOT COMPLETED|Period 1: First Intervention||1
5254567|NCT00776009|12918076|P2|NOT COMPLETED|Period 1: First Intervention||1
5254568|NCT00776009|12918077|P1|NOT COMPLETED|Period 1: First Intervention||0
5254569|NCT00776009|12918072|P6|COMPLETED|Period 1: First Intervention||27
5254570|NCT00776009|12918073|P5|COMPLETED|Period 1: First Intervention||26
5254571|NCT00776009|12918074|P4|COMPLETED|Period 1: First Intervention||27
5254572|NCT00776009|12918075|P3|COMPLETED|Period 1: First Intervention||28
5254573|NCT00776009|12918076|P2|COMPLETED|Period 1: First Intervention||27
5254574|NCT00776009|12918077|P1|COMPLETED|Period 1: First Intervention||26
5254575|NCT00776009|12918072|P6|STARTED|Period 1: First Intervention||27
5254576|NCT00776009|12918073|P5|STARTED|Period 1: First Intervention||28
5254577|NCT00776009|12918074|P4|STARTED|Period 1: First Intervention||27
5254578|NCT00776009|12918075|P3|STARTED|Period 1: First Intervention||29
5254579|NCT00776009|12918076|P2|STARTED|Period 1: First Intervention||28
5254580|NCT00776009|12918077|P1|STARTED|Period 1: First Intervention||26
5254581|NCT00775983|12918099|P2|NOT COMPLETED|Overall Study||2
5254582|NCT00775983|12918100|P1|NOT COMPLETED|Overall Study||1
5254583|NCT00775983|12918099|P2|COMPLETED|Overall Study||34
5254584|NCT00775983|12918100|P1|COMPLETED|Overall Study||35
5254585|NCT00775983|12918099|P2|STARTED|Overall Study||36
5254586|NCT00775983|12918100|P1|STARTED|Overall Study||36
5254587|NCT00775944|12918112|P4|NOT COMPLETED|Overall Study||16
5254588|NCT00775944|12918113|P3|NOT COMPLETED|Overall Study||16
5254589|NCT00775944|12918114|P2|NOT COMPLETED|Overall Study||9
5254590|NCT00775944|12918115|P1|NOT COMPLETED|Overall Study||15
5254591|NCT00775944|12918112|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
5254592|NCT00775944|12918113|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
5254593|NCT00775944|12918114|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
5254594|NCT00775944|12918115|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
5254595|NCT00775944|12918112|P4|STARTED|Overall Study||648
5254596|NCT00775944|12918113|P3|STARTED|Overall Study||648
5254597|NCT00775944|12918114|P2|STARTED|Overall Study||647
5254598|NCT00775944|12918115|P1|STARTED|Overall Study||648
5254599|NCT00775931|12918143|P2|NOT COMPLETED|Overall Study||0
5254600|NCT00775931|12918144|P1|NOT COMPLETED|Overall Study||0
5254601|NCT00775931|12918143|P2|COMPLETED|Overall Study||1
5254602|NCT00775931|12918144|P1|COMPLETED|Overall Study||6
5254603|NCT00775931|12918143|P2|STARTED|Overall Study||1
5254604|NCT00775931|12918144|P1|STARTED|Overall Study||6
5254605|NCT00775684|12918159|P3|NOT COMPLETED|Overall Study||3
5254606|NCT00775684|12918160|P2|NOT COMPLETED|Overall Study||1
5254607|NCT00775684|12918161|P1|NOT COMPLETED|Overall Study||3
5254608|NCT00775684|12918159|P3|COMPLETED|Overall Study||14
5254609|NCT00775684|12918160|P2|COMPLETED|Overall Study||12
5254610|NCT00775684|12918161|P1|COMPLETED|Overall Study||14
5254611|NCT00775684|12918159|P3|STARTED|Overall Study||17
5254612|NCT00775684|12918160|P2|STARTED|Overall Study||13
5254613|NCT00775684|12918161|P1|STARTED|Overall Study||17
5254614|NCT00775671|12918183|P2|NOT COMPLETED|Overall Study||0
5254615|NCT00775671|12918184|P1|NOT COMPLETED|Overall Study||0
5254616|NCT00775671|12918183|P2|COMPLETED|Overall Study||23
5254617|NCT00775671|12918184|P1|COMPLETED|Overall Study||23
5254618|NCT00775671|12918183|P2|STARTED|Overall Study||23
5254619|NCT00775671|12918184|P1|STARTED|Overall Study||23
5254620|NCT00775658|12918192|P2|NOT COMPLETED|Second Intervention||0
5254621|NCT00775658|12918193|P1|NOT COMPLETED|Second Intervention||0
5254622|NCT00775658|12918192|P2|COMPLETED|Second Intervention||11
5254623|NCT00775658|12918193|P1|COMPLETED|Second Intervention||10
5254624|NCT00775658|12918192|P2|STARTED|Second Intervention||11
5254625|NCT00775658|12918193|P1|STARTED|Second Intervention||10
5254626|NCT00775658|12918192|P2|NOT COMPLETED|First Intervention||0
5254627|NCT00775658|12918193|P1|NOT COMPLETED|First Intervention||0
5254628|NCT00775658|12918192|P2|COMPLETED|First Intervention||11
5254629|NCT00775658|12918193|P1|COMPLETED|First Intervention||10
5254630|NCT00775658|12918192|P2|STARTED|First Intervention||11
5254631|NCT00775658|12918193|P1|STARTED|First Intervention||10
5254632|NCT00775645|12918203|P2|NOT COMPLETED|Overall Study||20
5254633|NCT00775645|12918204|P1|NOT COMPLETED|Overall Study||17
5254634|NCT00775645|12918203|P2|COMPLETED|Overall Study||181
5254635|NCT00775645|12918204|P1|COMPLETED|Overall Study||191
5254636|NCT00775645|12918203|P2|STARTED|Overall Study||201
5254637|NCT00775645|12918204|P1|STARTED|Overall Study||208
5254638|NCT00775606|12918226|P2|NOT COMPLETED|Overall Study||0
5254639|NCT00775606|12918227|P1|NOT COMPLETED|Overall Study||3
5254640|NCT00775606|12918226|P2|COMPLETED|Overall Study||5
5254641|NCT00775606|12918227|P1|COMPLETED|Overall Study||5
5254642|NCT00775606|12918226|P2|STARTED|Overall Study||5
5254643|NCT00775606|12918227|P1|STARTED|Overall Study||8
5254644|NCT00775593|12918237|P1|NOT COMPLETED|Overall Study||7
5254645|NCT00775593|12918237|P1|COMPLETED|Overall Study||53
5254646|NCT00775593|12918237|P1|STARTED|Overall Study||60
5254647|NCT00775528|12918244|P1|NOT COMPLETED|Overall Study||1
5254648|NCT00775528|12918244|P1|COMPLETED|Overall Study||18
5254649|NCT00775528|12918244|P1|STARTED|Overall Study|Started means number of patients who consented|19
5254650|NCT00775463|12918253|P2|NOT COMPLETED|Overall Study||13
5254651|NCT00775463|12918254|P1|NOT COMPLETED|Overall Study||11
5254652|NCT00775463|12918253|P2|COMPLETED|Overall Study||59
5254653|NCT00775463|12918254|P1|COMPLETED|Overall Study||65
5254654|NCT00775463|12918253|P2|STARTED|Overall Study||72
5254655|NCT00775463|12918254|P1|STARTED|Overall Study||76
5254656|NCT00775450|12918291|P5|NOT COMPLETED|Overall Study||2
5254657|NCT00775450|12918292|P4|NOT COMPLETED|Overall Study||0
5254658|NCT00775450|12918293|P3|NOT COMPLETED|Overall Study||0
5254659|NCT00775450|12918294|P2|NOT COMPLETED|Overall Study||0
5254660|NCT00775450|12918295|P1|NOT COMPLETED|Overall Study||3
5254661|NCT00775450|12918291|P5|COMPLETED|Overall Study||199
5254662|NCT00775450|12918292|P4|COMPLETED|Overall Study||108
5254663|NCT00775450|12918293|P3|COMPLETED|Overall Study||105
5254664|NCT00775450|12918294|P2|COMPLETED|Overall Study||98
5254665|NCT00775450|12918295|P1|COMPLETED|Overall Study||292
5254666|NCT00775450|12918291|P5|STARTED|Overall Study||201
5254667|NCT00775450|12918292|P4|STARTED|Overall Study||108
5254668|NCT00775450|12918293|P3|STARTED|Overall Study||105
5254669|NCT00775450|12918294|P2|STARTED|Overall Study||98
5254670|NCT00775450|12918295|P1|STARTED|Overall Study||295
5254671|NCT00775437|12918322|P1|NOT COMPLETED|Overall Study||6
5254672|NCT00775437|12918322|P1|COMPLETED|Overall Study||26
5254673|NCT00775437|12918322|P1|STARTED|Overall Study||32
5254674|NCT00775411|12918372|P1|NOT COMPLETED|Overall Study||1
5254675|NCT00775411|12918372|P1|COMPLETED|Overall Study||43
5254676|NCT00775411|12918372|P1|STARTED|Overall Study||44
5254677|NCT00775346|12918378|P1|NOT COMPLETED|Overall Study||0
5254678|NCT00775346|12918378|P1|COMPLETED|Overall Study||92
5254679|NCT00775346|12918378|P1|STARTED|Overall Study||92
5254680|NCT00775229|12918384|P2|NOT COMPLETED|Overall Study||2
5254681|NCT00775229|12918385|P1|NOT COMPLETED|Overall Study||5
5254682|NCT00775229|12918384|P2|COMPLETED|Overall Study||24
5254683|NCT00775229|12918385|P1|COMPLETED|Overall Study||20
5254684|NCT00775229|12918384|P2|STARTED|Overall Study||26
5254685|NCT00775229|12918385|P1|STARTED|Overall Study||25
5254686|NCT00775203|12918397|P2|NOT COMPLETED|Overall Study||43
5254687|NCT00775203|12918398|P1|NOT COMPLETED|Overall Study||62
5254688|NCT00775203|12918397|P2|COMPLETED|Overall Study||163
5254689|NCT00775203|12918398|P1|COMPLETED|Overall Study||144
5254690|NCT00775203|12918397|P2|Received Study Medication|Overall Study||204
5254691|NCT00775203|12918398|P1|Received Study Medication|Overall Study||202
5254692|NCT00775203|12918397|P2|STARTED|Overall Study||206
5254693|NCT00775203|12918398|P1|STARTED|Overall Study||206
5254694|NCT00775190|12918432|P2|NOT COMPLETED|Overall Study||5
5254695|NCT00775190|12918433|P1|NOT COMPLETED|Overall Study||4
5254696|NCT00775190|12918432|P2|COMPLETED|Overall Study||0
5254697|NCT00775190|12918433|P1|COMPLETED|Overall Study||3
5254698|NCT00775190|12918432|P2|STARTED|Overall Study||5
5254699|NCT00775190|12918433|P1|STARTED|Overall Study||7
5254700|NCT00775138|12918459|P4|NOT COMPLETED|Overall Study||2
5254701|NCT00775138|12918460|P3|NOT COMPLETED|Overall Study||3
5254702|NCT00775138|12918461|P2|NOT COMPLETED|Overall Study||0
5254703|NCT00775138|12918462|P1|NOT COMPLETED|Overall Study||0
5254704|NCT00775138|12918459|P4|COMPLETED|Overall Study||8
5254705|NCT00775138|12918460|P3|COMPLETED|Overall Study||17
5254706|NCT00775138|12918461|P2|COMPLETED|Overall Study||10
5254707|NCT00775138|12918462|P1|COMPLETED|Overall Study||24
5254708|NCT00775138|12918459|P4|STARTED|Overall Study||10
5254709|NCT00775138|12918460|P3|STARTED|Overall Study||20
5254710|NCT00775138|12918461|P2|STARTED|Overall Study||10
5254711|NCT00775138|12918462|P1|STARTED|Overall Study||24
5254712|NCT00775021|12918508|P2|NOT COMPLETED|Second Intervention||1
5254713|NCT00775021|12918509|P1|NOT COMPLETED|Second Intervention||0
5254714|NCT00775021|12918508|P2|COMPLETED|Second Intervention||59
5254715|NCT00775021|12918509|P1|COMPLETED|Second Intervention||62
5254716|NCT00775021|12918508|P2|STARTED|Second Intervention||60
5254717|NCT00775021|12918509|P1|STARTED|Second Intervention||62
5254718|NCT00775021|12918508|P2|NOT COMPLETED|First Intervention||0
5254719|NCT00775021|12918509|P1|NOT COMPLETED|First Intervention||1
5254720|NCT00775021|12918508|P2|COMPLETED|First Intervention||60
5254721|NCT00775021|12918509|P1|COMPLETED|First Intervention||62
5254722|NCT00775021|12918508|P2|STARTED|First Intervention||60
5254723|NCT00775021|12918509|P1|STARTED|First Intervention||63
5254724|NCT00774995|12918527|P4|NOT COMPLETED|Overall Study||0
5254725|NCT00774995|12918528|P3|NOT COMPLETED|Overall Study||1
5254726|NCT00774995|12918529|P2|NOT COMPLETED|Overall Study||0
5254727|NCT00774995|12918530|P1|NOT COMPLETED|Overall Study||0
5254728|NCT00774995|12918527|P4|COMPLETED|Overall Study||16
5254729|NCT00774995|12918528|P3|COMPLETED|Overall Study||7
5254730|NCT00774995|12918529|P2|COMPLETED|Overall Study||16
5254731|NCT00774995|12918530|P1|COMPLETED|Overall Study||9
5254732|NCT00774995|12918527|P4|STARTED|Overall Study||16
5254733|NCT00774995|12918528|P3|STARTED|Overall Study||8
5254734|NCT00774995|12918529|P2|STARTED|Overall Study||16
5254735|NCT00774995|12918530|P1|STARTED|Overall Study||9
5254736|NCT00774930|12918570|P2|NOT COMPLETED|LTOLE Phase||17
5254737|NCT00774930|12918571|P1|NOT COMPLETED|LTOLE Phase||15
5254738|NCT00774930|12918570|P2|COMPLETED|LTOLE Phase||8
5254739|NCT00774930|12918571|P1|COMPLETED|LTOLE Phase||17
5254740|NCT00774930|12918570|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
5254741|NCT00774930|12918571|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
5254742|NCT00774930|12918570|P2|NOT COMPLETED|IOL Phase||9
5254743|NCT00774930|12918571|P1|NOT COMPLETED|IOL Phase||13
5254744|NCT00774930|12918570|P2|COMPLETED|IOL Phase||37
5254745|NCT00774930|12918571|P1|COMPLETED|IOL Phase||43
5254746|NCT00774930|12918570|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
5254747|NCT00774930|12918571|P1|STARTED|IOL Phase||56
5254748|NCT00774930|12918570|P2|NOT COMPLETED|DB Phase||22
5254749|NCT00774930|12918571|P1|NOT COMPLETED|DB Phase||14
5254750|NCT00774930|12918570|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
5254751|NCT00774930|12918571|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
5254752|NCT00774930|12918570|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
5254753|NCT00774930|12918571|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
5254754|NCT00774852|12918599|P2|NOT COMPLETED|Overall Study||41
5254755|NCT00774852|12918600|P1|NOT COMPLETED|Overall Study||45
5254756|NCT00774852|12918599|P2|COMPLETED|Overall Study||27
5254757|NCT00774852|12918600|P1|COMPLETED|Overall Study||24
5254758|NCT00774852|12918599|P2|STARTED|Overall Study||68
5254759|NCT00774852|12918600|P1|STARTED|Overall Study||69
5254760|NCT00774800|12918648|P1|NOT COMPLETED|Intervention 4||1
5254761|NCT00774800|12918648|P1|COMPLETED|Intervention 4||21
5254762|NCT00774800|12918648|P1|Received at Least One Dose of Study Drug|Intervention 4||21
5254763|NCT00774800|12918648|P1|STARTED|Intervention 4||22
5254764|NCT00774800|12918648|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
5254765|NCT00774800|12918648|P1|COMPLETED|Washout (3 to 10 Days)||22
5254766|NCT00774800|12918648|P1|STARTED|Washout (3 to 10 Days)||22
5254767|NCT00774800|12918648|P1|NOT COMPLETED|Intervention 3||0
5254768|NCT00774800|12918648|P1|COMPLETED|Intervention 3||22
5254769|NCT00774800|12918648|P1|Received at Least One Dose of Study Drug|Intervention 3||22
5254770|NCT00774800|12918648|P1|STARTED|Intervention 3||22
5254771|NCT00774800|12918648|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
5254772|NCT00774800|12918648|P1|COMPLETED|Washout (3 to 10 Days)||22
5254773|NCT00774800|12918648|P1|STARTED|Washout (3 to 10 Days)||22
5254774|NCT00774800|12918648|P1|NOT COMPLETED|Intervention 2||0
5254775|NCT00774800|12918648|P1|COMPLETED|Intervention 2||22
5254776|NCT00774800|12918648|P1|Received at Least One Dose of Study Drug|Intervention 2||22
5254777|NCT00774800|12918648|P1|STARTED|Intervention 2||22
5254778|NCT00774800|12918648|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
5254779|NCT00774800|12918648|P1|COMPLETED|Washout (3 to 10 Days)||22
5254780|NCT00774800|12918648|P1|STARTED|Washout (3 to 10 Days)||22
5254781|NCT00774800|12918648|P1|NOT COMPLETED|Intervention 1||0
5254782|NCT00774800|12918648|P1|COMPLETED|Intervention 1||22
5254783|NCT00774800|12918648|P1|Received at Least One Dose of Study Drug|Intervention 1||22
5254784|NCT00774800|12918648|P1|STARTED|Intervention 1||22
5254785|NCT00774787|12918670|P1|NOT COMPLETED|Overall Study||1
5254786|NCT00774787|12918670|P1|COMPLETED|Overall Study||26
5254787|NCT00774787|12918670|P1|STARTED|Overall Study||27
5254788|NCT00774748|12918677|P1|NOT COMPLETED|Overall Study||3
5254789|NCT00774748|12918677|P1|COMPLETED|Overall Study||18
5254790|NCT00774748|12918677|P1|STARTED|Overall Study||21
5254791|NCT00774579|12918687|P2|NOT COMPLETED|Overall Study||0
5254792|NCT00774579|12918688|P1|NOT COMPLETED|Overall Study||0
5254793|NCT00774579|12918687|P2|COMPLETED|Overall Study||9
5254794|NCT00774579|12918688|P1|COMPLETED|Overall Study||9
5254795|NCT00774579|12918687|P2|STARTED|Overall Study||9
5254796|NCT00774579|12918688|P1|STARTED|Overall Study||9
5254797|NCT00774397|12918703|P7|NOT COMPLETED|Overall Study||30
5254798|NCT00774397|12918704|P6|NOT COMPLETED|Overall Study||22
5254799|NCT00774397|12918705|P5|NOT COMPLETED|Overall Study||46
5254800|NCT00774397|12918706|P4|NOT COMPLETED|Overall Study||17
5254801|NCT00774397|12918707|P3|NOT COMPLETED|Overall Study||30
5254802|NCT00774397|12918708|P2|NOT COMPLETED|Overall Study||13
5254803|NCT00774397|12918709|P1|NOT COMPLETED|Overall Study||14
5254804|NCT00774397|12918703|P7|COMPLETED|Overall Study||41
5254805|NCT00774397|12918704|P6|COMPLETED|Overall Study||54
5254806|NCT00774397|12918705|P5|COMPLETED|Overall Study||97
5254807|NCT00774397|12918706|P4|COMPLETED|Overall Study||129
5254808|NCT00774397|12918707|P3|COMPLETED|Overall Study||113
5254809|NCT00774397|12918708|P2|COMPLETED|Overall Study||56
5254810|NCT00774397|12918709|P1|COMPLETED|Overall Study||57
5254811|NCT00774397|12918703|P7|STARTED|Overall Study||71
5254812|NCT00774397|12918704|P6|STARTED|Overall Study||76
5254813|NCT00774397|12918705|P5|STARTED|Overall Study||143
5254814|NCT00774397|12918706|P4|STARTED|Overall Study||146
5254815|NCT00774397|12918707|P3|STARTED|Overall Study||143
5254816|NCT00774397|12918708|P2|STARTED|Overall Study||69
5254817|NCT00774397|12918709|P1|STARTED|Overall Study||71
5254818|NCT00774306|12918945|P4|NOT COMPLETED|Overall Study||5
5254819|NCT00774306|12918946|P3|NOT COMPLETED|Overall Study||8
5254820|NCT00774306|12918947|P2|NOT COMPLETED|Overall Study||2
5254821|NCT00774306|12918948|P1|NOT COMPLETED|Overall Study||18
5254822|NCT00774306|12918945|P4|COMPLETED|Overall Study||2
5254823|NCT00774306|12918946|P3|COMPLETED|Overall Study||8
5254824|NCT00774306|12918947|P2|COMPLETED|Overall Study||3
5254825|NCT00774306|12918948|P1|COMPLETED|Overall Study||6
5254826|NCT00774306|12918945|P4|STARTED|Overall Study||7
5254827|NCT00774306|12918946|P3|STARTED|Overall Study||16
5254828|NCT00774306|12918947|P2|STARTED|Overall Study||5
5254829|NCT00774306|12918948|P1|STARTED|Overall Study||24
5254830|NCT00774267|12918962|P4|NOT COMPLETED|Overall Study||0
5254831|NCT00774267|12918963|P3|NOT COMPLETED|Overall Study||0
5254832|NCT00774267|12918964|P2|NOT COMPLETED|Overall Study||0
5254833|NCT00774267|12918965|P1|NOT COMPLETED|Overall Study||0
5254834|NCT00774267|12918962|P4|COMPLETED|Overall Study||135
5254835|NCT00774267|12918963|P3|COMPLETED|Overall Study||129
5254836|NCT00774267|12918964|P2|COMPLETED|Overall Study||111
5254837|NCT00774267|12918965|P1|COMPLETED|Overall Study||132
5254838|NCT00774267|12918962|P4|STARTED|Overall Study||135
5254839|NCT00774267|12918963|P3|STARTED|Overall Study||129
5254840|NCT00774267|12918964|P2|STARTED|Overall Study||111
5254841|NCT00774267|12918965|P1|STARTED|Overall Study||132
5254842|NCT00774202|12918977|P2|NOT COMPLETED|Overall Study||0
5254843|NCT00774202|12918978|P1|NOT COMPLETED|Overall Study||0
5254844|NCT00774202|12918977|P2|COMPLETED|Overall Study||8
5254845|NCT00774202|12918978|P1|COMPLETED|Overall Study||9
5254846|NCT00774202|12918977|P2|STARTED|Overall Study||8
5254847|NCT00774202|12918978|P1|STARTED|Overall Study||9
5254848|NCT00774163|12918990|P2|NOT COMPLETED|Overall Study||0
5254849|NCT00774163|12918991|P1|NOT COMPLETED|Overall Study||0
5254850|NCT00774163|12918990|P2|COMPLETED|Overall Study||15
5254851|NCT00774163|12918991|P1|COMPLETED|Overall Study||30
5254852|NCT00774163|12918990|P2|STARTED|Overall Study||15
5254853|NCT00774163|12918991|P1|STARTED|Overall Study||30
5254854|NCT00774046|12919029|P1|NOT COMPLETED|Autologous Transplant||0
5254855|NCT00774046|12919029|P1|COMPLETED|Autologous Transplant||4
5254856|NCT00774046|12919029|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
5254857|NCT00774046|12919029|P1|NOT COMPLETED|Stem Cell Mobilization||3
5254858|NCT00774046|12919029|P1|COMPLETED|Stem Cell Mobilization||7
5254859|NCT00774046|12919029|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
5254860|NCT00774046|12919029|P1|NOT COMPLETED|Induction Therapy||0
5254861|NCT00774046|12919029|P1|COMPLETED|Induction Therapy||32
5254862|NCT00774046|12919029|P1|STARTED|Induction Therapy||32
5254863|NCT00774046|12919029|P1|NOT COMPLETED|Enrollment||28
5254864|NCT00774046|12919029|P1|COMPLETED|Enrollment||32
5254865|NCT00774046|12919029|P1|STARTED|Enrollment||60
5254866|NCT00774046|12919029|P1|NOT COMPLETED|Screening||56
5254867|NCT00774046|12919029|P1|COMPLETED|Screening||60
5254868|NCT00774046|12919029|P1|STARTED|Screening||116
5254869|NCT00773968|12919039|P1|NOT COMPLETED|Overall Study||45
5254870|NCT00773968|12919039|P1|COMPLETED|Overall Study||95
5254871|NCT00773968|12919039|P1|Treated|Overall Study||111
5254872|NCT00773968|12919039|P1|STARTED|Overall Study||140
5254873|NCT00773955|12919048|P1|NOT COMPLETED|Overall Study||0
5254874|NCT00773955|12919048|P1|COMPLETED|Overall Study||15
5254875|NCT00773955|12919048|P1|STARTED|Overall Study||15
5254876|NCT00773786|12919055|P2|NOT COMPLETED|Second Intervention (1 Week)||0
5254877|NCT00773786|12919056|P1|NOT COMPLETED|Second Intervention (1 Week)||0
5254878|NCT00773786|12919055|P2|COMPLETED|Second Intervention (1 Week)||10
5254879|NCT00773786|12919056|P1|COMPLETED|Second Intervention (1 Week)||10
5254880|NCT00773786|12919055|P2|STARTED|Second Intervention (1 Week)||10
5254881|NCT00773786|12919056|P1|STARTED|Second Intervention (1 Week)||10
5254882|NCT00773786|12919055|P2|NOT COMPLETED|Washout (1 Week)||0
5254883|NCT00773786|12919056|P1|NOT COMPLETED|Washout (1 Week)||0
5254884|NCT00773786|12919055|P2|COMPLETED|Washout (1 Week)||10
5254885|NCT00773786|12919056|P1|COMPLETED|Washout (1 Week)||10
5254886|NCT00773786|12919055|P2|STARTED|Washout (1 Week)||10
5254887|NCT00773786|12919056|P1|STARTED|Washout (1 Week)||10
5254888|NCT00773786|12919055|P2|NOT COMPLETED|First Intervention (1 Week)||0
5254889|NCT00773786|12919056|P1|NOT COMPLETED|First Intervention (1 Week)||0
5254890|NCT00773786|12919055|P2|COMPLETED|First Intervention (1 Week)||10
5254891|NCT00773786|12919056|P1|COMPLETED|First Intervention (1 Week)||10
5254892|NCT00773786|12919055|P2|STARTED|First Intervention (1 Week)||10
5254893|NCT00773786|12919056|P1|STARTED|First Intervention (1 Week)||10
5254894|NCT00773734|12919070|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
5254895|NCT00773734|12919071|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
5254896|NCT00773734|12919072|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
5254897|NCT00773734|12919073|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
5254898|NCT00773734|12919074|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
5254899|NCT00773734|12919075|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
5254900|NCT00773734|12919070|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
5254901|NCT00773734|12919071|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
5254902|NCT00773734|12919072|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
5254903|NCT00773734|12919073|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
5254904|NCT00773734|12919074|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
5254905|NCT00773734|12919075|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
5254906|NCT00773734|12919070|P6|STARTED|LTE Period: Week 52 to 6 Years||0
5254907|NCT00773734|12919071|P5|STARTED|LTE Period: Week 52 to 6 Years||0
5254908|NCT00773734|12919072|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
5254909|NCT00773734|12919073|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
5254910|NCT00773734|12919074|P2|STARTED|LTE Period: Week 52 to 6 Years||0
5254911|NCT00773734|12919075|P1|STARTED|LTE Period: Week 52 to 6 Years||0
5254912|NCT00773734|12919070|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
5254913|NCT00773734|12919071|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
5254914|NCT00773734|12919072|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
5254915|NCT00773734|12919073|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
5254916|NCT00773734|12919074|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
5254917|NCT00773734|12919075|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
5254918|NCT00773734|12919070|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
5254919|NCT00773734|12919071|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
5254920|NCT00773734|12919072|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
5254921|NCT00773734|12919073|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
5254922|NCT00773734|12919074|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
5254923|NCT00773734|12919075|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
5254924|NCT00773734|12919070|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
5254925|NCT00773734|12919071|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
5254926|NCT00773734|12919072|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
5254927|NCT00773734|12919073|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
5254928|NCT00773734|12919074|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
5254929|NCT00773734|12919075|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
5254930|NCT00773734|12919070|P6|STARTED|Extension: Active Treatment Week 24-52||27
5254931|NCT00773734|12919071|P5|STARTED|Extension: Active Treatment Week 24-52||27
5254932|NCT00773734|12919072|P4|STARTED|Extension: Active Treatment Week 24-52||58
5254933|NCT00773734|12919073|P3|STARTED|Extension: Active Treatment Week 24-52||50
5254934|NCT00773734|12919074|P2|STARTED|Extension: Active Treatment Week 24-52||47
5254935|NCT00773734|12919075|P1|STARTED|Extension: Active Treatment Week 24-52||0
5254936|NCT00773734|12919070|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
5254937|NCT00773734|12919071|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
5254938|NCT00773734|12919072|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
5254939|NCT00773734|12919073|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
5254940|NCT00773734|12919074|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
5254941|NCT00773734|12919075|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
5254942|NCT00773734|12919070|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
5254943|NCT00773734|12919071|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
5254944|NCT00773734|12919072|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
5254945|NCT00773734|12919073|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
5254946|NCT00773734|12919074|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
5254947|NCT00773734|12919075|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
5254948|NCT00773734|12919070|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
5254949|NCT00773734|12919071|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
5254950|NCT00773734|12919072|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
5254951|NCT00773734|12919073|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
5254952|NCT00773734|12919074|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
5254953|NCT00773734|12919075|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
5254954|NCT00773734|12919070|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
5254955|NCT00773734|12919071|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
5254956|NCT00773734|12919072|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
5254957|NCT00773734|12919073|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
5254958|NCT00773734|12919074|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
5254959|NCT00773734|12919075|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
5254960|NCT00773734|12919070|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
5254961|NCT00773734|12919071|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
5255048|NCT00773136|12919889|P1|COMPLETED|Overall Study||19
5254962|NCT00773734|12919072|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
5254963|NCT00773734|12919073|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
5254964|NCT00773734|12919074|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
5254965|NCT00773734|12919075|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
5254966|NCT00773734|12919070|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
5254967|NCT00773734|12919071|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
5254968|NCT00773734|12919072|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
5254969|NCT00773734|12919073|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
5254970|NCT00773734|12919074|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
5254971|NCT00773734|12919075|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
5254972|NCT00773604|12919637|P1|NOT COMPLETED|Overall Study||0
5254973|NCT00773604|12919637|P1|COMPLETED|Overall Study||9
5254974|NCT00773604|12919637|P1|STARTED|Overall Study||9
5254975|NCT00773513|12919643|P2|NOT COMPLETED|Overall Study||1109
5254976|NCT00773513|12919644|P1|NOT COMPLETED|Overall Study||1101
5254977|NCT00773513|12919643|P2|COMPLETED|Overall Study||303
5254978|NCT00773513|12919644|P1|COMPLETED|Overall Study||312
5254979|NCT00773513|12919643|P2|Received Study Treatment|Overall Study||1409
5254980|NCT00773513|12919644|P1|Received Study Treatment|Overall Study||1409
5254981|NCT00773513|12919643|P2|STARTED|Overall Study||1412
5254982|NCT00773513|12919644|P1|STARTED|Overall Study||1413
5254983|NCT00773474|12919664|P1|NOT COMPLETED|Overall Study||0
5254984|NCT00773474|12919664|P1|COMPLETED|Overall Study||29
5254985|NCT00773474|12919664|P1|STARTED|Overall Study||29
5254986|NCT00773461|12919673|P2|NOT COMPLETED|Overall Study||4
5254987|NCT00773461|12919674|P1|NOT COMPLETED|Overall Study||5
5254988|NCT00773461|12919673|P2|COMPLETED|Overall Study||135
5254989|NCT00773461|12919674|P1|COMPLETED|Overall Study||65
5254990|NCT00773461|12919673|P2|STARTED|Overall Study||139
5254991|NCT00773461|12919674|P1|STARTED|Overall Study||70
5254992|NCT00773422|12919715|P3|NOT COMPLETED|Overall Study||0
5254993|NCT00773422|12919716|P2|NOT COMPLETED|Overall Study||0
5254994|NCT00773422|12919717|P1|NOT COMPLETED|Overall Study||0
5254995|NCT00773422|12919715|P3|COMPLETED|Overall Study||10
5254996|NCT00773422|12919716|P2|COMPLETED|Overall Study||9
5254997|NCT00773422|12919717|P1|COMPLETED|Overall Study||11
5254998|NCT00773422|12919715|P3|STARTED|Overall Study||10
5254999|NCT00773422|12919716|P2|STARTED|Overall Study||9
5255000|NCT00773422|12919717|P1|STARTED|Overall Study||11
5255001|NCT00773383|12919728|P1|NOT COMPLETED|Overall Study||31
5255002|NCT00773383|12919728|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
5255003|NCT00773383|12919728|P1|Received Study Drug|Overall Study||34
5255004|NCT00773383|12919728|P1|STARTED|Overall Study||35
5255005|NCT00773370|12919750|P2|NOT COMPLETED|Overall Study||10
5255006|NCT00773370|12919751|P1|NOT COMPLETED|Overall Study||18
5255007|NCT00773370|12919750|P2|COMPLETED|Overall Study||23
5255008|NCT00773370|12919751|P1|COMPLETED|Overall Study||25
5255009|NCT00773370|12919750|P2|STARTED|Overall Study||33
5255010|NCT00773370|12919751|P1|STARTED|Overall Study||43
5255011|NCT00773279|12919763|P2|NOT COMPLETED|Period 2||6
5255012|NCT00773279|12919764|P1|NOT COMPLETED|Period 2||3
5255013|NCT00773279|12919763|P2|COMPLETED|Period 2||111
5255014|NCT00773279|12919764|P1|COMPLETED|Period 2||111
5255015|NCT00773279|12919763|P2|STARTED|Period 2||117
5255016|NCT00773279|12919764|P1|STARTED|Period 2||114
5255017|NCT00773279|12919763|P2|NOT COMPLETED|Period 1||4
5255018|NCT00773279|12919764|P1|NOT COMPLETED|Period 1||7
5255019|NCT00773279|12919763|P2|COMPLETED|Period 1||117
5255020|NCT00773279|12919764|P1|COMPLETED|Period 1||114
5255021|NCT00773279|12919763|P2|STARTED|Period 1||121
5255022|NCT00773279|12919764|P1|STARTED|Period 1||121
5255023|NCT00773253|12919785|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
5255024|NCT00773253|12919786|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
5255025|NCT00773253|12919785|P2|COMPLETED|Second Intervention (Week 24-48)||4
5255026|NCT00773253|12919786|P1|COMPLETED|Second Intervention (Week 24-48)||5
5255027|NCT00773253|12919785|P2|STARTED|Second Intervention (Week 24-48)||4
5255028|NCT00773253|12919786|P1|STARTED|Second Intervention (Week 24-48)||5
5255029|NCT00773253|12919785|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
5255030|NCT00773253|12919786|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
5255031|NCT00773253|12919785|P2|COMPLETED|First Intervention (Week 0-24)||4
5255032|NCT00773253|12919786|P1|COMPLETED|First Intervention (Week 0-24)||5
5255033|NCT00773253|12919785|P2|STARTED|First Intervention (Week 0-24)||5
5255034|NCT00773253|12919786|P1|STARTED|First Intervention (Week 0-24)||5
5255035|NCT00773175|12919796|P2|NOT COMPLETED|Overall Study||2
5255036|NCT00773175|12919797|P1|NOT COMPLETED|Overall Study||2
5255037|NCT00773175|12919796|P2|COMPLETED|Overall Study||73
5255038|NCT00773175|12919797|P1|COMPLETED|Overall Study||71
5255039|NCT00773175|12919796|P2|No Fluids Received|Overall Study||1
5255040|NCT00773175|12919797|P1|No Fluids Received|Overall Study||0
5255041|NCT00773175|12919796|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
5255042|NCT00773175|12919797|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
5255043|NCT00773175|12919796|P2|Initial Fluids Via Randomized Route|Overall Study||59
5255044|NCT00773175|12919797|P1|Initial Fluids Via Randomized Route|Overall Study||73
5255045|NCT00773175|12919796|P2|STARTED|Overall Study||75
5255046|NCT00773175|12919797|P1|STARTED|Overall Study||73
5255047|NCT00773136|12919889|P1|NOT COMPLETED|Overall Study||2
5255049|NCT00773136|12919889|P1|STARTED|Overall Study||21
5255050|NCT00773097|12919894|P1|NOT COMPLETED|Overall Study||7
5255051|NCT00773097|12919894|P1|COMPLETED|Overall Study||39
5255052|NCT00773097|12919894|P1|STARTED|Overall Study||46
5255053|NCT00772967|12919900|P6|NOT COMPLETED|Crossover Treatment 3||0
5255054|NCT00772967|12919901|P5|NOT COMPLETED|Crossover Treatment 3||1
5255055|NCT00772967|12919902|P4|NOT COMPLETED|Crossover Treatment 3||0
5255056|NCT00772967|12919903|P3|NOT COMPLETED|Crossover Treatment 3||0
5255057|NCT00772967|12919904|P2|NOT COMPLETED|Crossover Treatment 3||0
5255058|NCT00772967|12919905|P1|NOT COMPLETED|Crossover Treatment 3||0
5255059|NCT00772967|12919900|P6|COMPLETED|Crossover Treatment 3||3
5255060|NCT00772967|12919901|P5|COMPLETED|Crossover Treatment 3||3
5255061|NCT00772967|12919902|P4|COMPLETED|Crossover Treatment 3||3
5255062|NCT00772967|12919903|P3|COMPLETED|Crossover Treatment 3||3
5255063|NCT00772967|12919904|P2|COMPLETED|Crossover Treatment 3||4
5255064|NCT00772967|12919905|P1|COMPLETED|Crossover Treatment 3||3
5255065|NCT00772967|12919900|P6|STARTED|Crossover Treatment 3||3
5255066|NCT00772967|12919901|P5|STARTED|Crossover Treatment 3||4
5255067|NCT00772967|12919902|P4|STARTED|Crossover Treatment 3||3
5255068|NCT00772967|12919903|P3|STARTED|Crossover Treatment 3||3
5255069|NCT00772967|12919904|P2|STARTED|Crossover Treatment 3||4
5255070|NCT00772967|12919905|P1|STARTED|Crossover Treatment 3||3
5255071|NCT00772967|12919900|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
5255072|NCT00772967|12919901|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
5255073|NCT00772967|12919902|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
5255074|NCT00772967|12919903|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
5255075|NCT00772967|12919904|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
5255076|NCT00772967|12919905|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
5255077|NCT00772967|12919900|P6|COMPLETED|Break 2 (4-7 Days)||3
5255078|NCT00772967|12919901|P5|COMPLETED|Break 2 (4-7 Days)||4
5255079|NCT00772967|12919902|P4|COMPLETED|Break 2 (4-7 Days)||3
5255080|NCT00772967|12919903|P3|COMPLETED|Break 2 (4-7 Days)||3
5255081|NCT00772967|12919904|P2|COMPLETED|Break 2 (4-7 Days)||4
5255082|NCT00772967|12919905|P1|COMPLETED|Break 2 (4-7 Days)||3
5255083|NCT00772967|12919900|P6|STARTED|Break 2 (4-7 Days)||3
5255084|NCT00772967|12919901|P5|STARTED|Break 2 (4-7 Days)||4
5255085|NCT00772967|12919902|P4|STARTED|Break 2 (4-7 Days)||3
5255086|NCT00772967|12919903|P3|STARTED|Break 2 (4-7 Days)||3
5255087|NCT00772967|12919904|P2|STARTED|Break 2 (4-7 Days)||4
5255088|NCT00772967|12919905|P1|STARTED|Break 2 (4-7 Days)||3
5255089|NCT00772967|12919900|P6|NOT COMPLETED|Crossover Treatment 2||0
5255090|NCT00772967|12919901|P5|NOT COMPLETED|Crossover Treatment 2||0
5255091|NCT00772967|12919902|P4|NOT COMPLETED|Crossover Treatment 2||0
5255092|NCT00772967|12919903|P3|NOT COMPLETED|Crossover Treatment 2||0
5255093|NCT00772967|12919904|P2|NOT COMPLETED|Crossover Treatment 2||0
5255094|NCT00772967|12919905|P1|NOT COMPLETED|Crossover Treatment 2||0
5255095|NCT00772967|12919900|P6|COMPLETED|Crossover Treatment 2||3
5255096|NCT00772967|12919901|P5|COMPLETED|Crossover Treatment 2||4
5255097|NCT00772967|12919902|P4|COMPLETED|Crossover Treatment 2||3
5255098|NCT00772967|12919903|P3|COMPLETED|Crossover Treatment 2||3
5255099|NCT00772967|12919904|P2|COMPLETED|Crossover Treatment 2||4
5255100|NCT00772967|12919905|P1|COMPLETED|Crossover Treatment 2||3
5255101|NCT00772967|12919900|P6|STARTED|Crossover Treatment 2||3
5255102|NCT00772967|12919901|P5|STARTED|Crossover Treatment 2||4
5255103|NCT00772967|12919902|P4|STARTED|Crossover Treatment 2||3
5255104|NCT00772967|12919903|P3|STARTED|Crossover Treatment 2||3
5255105|NCT00772967|12919904|P2|STARTED|Crossover Treatment 2||4
5255106|NCT00772967|12919905|P1|STARTED|Crossover Treatment 2||3
5255107|NCT00772967|12919900|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
5255108|NCT00772967|12919901|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
5255109|NCT00772967|12919902|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
5255110|NCT00772967|12919903|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
5255111|NCT00772967|12919904|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
5255112|NCT00772967|12919905|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
5255113|NCT00772967|12919900|P6|COMPLETED|Break 1 (4-7 Days)||3
5255114|NCT00772967|12919901|P5|COMPLETED|Break 1 (4-7 Days)||4
5255115|NCT00772967|12919902|P4|COMPLETED|Break 1 (4-7 Days)||3
5255116|NCT00772967|12919903|P3|COMPLETED|Break 1 (4-7 Days)||3
5255117|NCT00772967|12919904|P2|COMPLETED|Break 1 (4-7 Days)||4
5255118|NCT00772967|12919905|P1|COMPLETED|Break 1 (4-7 Days)||3
5255119|NCT00772967|12919900|P6|STARTED|Break 1 (4-7 Days)||3
5255120|NCT00772967|12919901|P5|STARTED|Break 1 (4-7 Days)||4
5255121|NCT00772967|12919902|P4|STARTED|Break 1 (4-7 Days)||3
5255122|NCT00772967|12919903|P3|STARTED|Break 1 (4-7 Days)||3
5255123|NCT00772967|12919904|P2|STARTED|Break 1 (4-7 Days)||5
5255124|NCT00772967|12919905|P1|STARTED|Break 1 (4-7 Days)||3
5255125|NCT00772967|12919900|P6|NOT COMPLETED|Crossover Treatment 1||0
5255126|NCT00772967|12919901|P5|NOT COMPLETED|Crossover Treatment 1||0
5255127|NCT00772967|12919902|P4|NOT COMPLETED|Crossover Treatment 1||1
5255128|NCT00772967|12919903|P3|NOT COMPLETED|Crossover Treatment 1||0
5255129|NCT00772967|12919904|P2|NOT COMPLETED|Crossover Treatment 1||0
5255130|NCT00772967|12919905|P1|NOT COMPLETED|Crossover Treatment 1||0
5255131|NCT00772967|12919900|P6|COMPLETED|Crossover Treatment 1||3
5255132|NCT00772967|12919901|P5|COMPLETED|Crossover Treatment 1||4
5255133|NCT00772967|12919902|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
5255134|NCT00772967|12919903|P3|COMPLETED|Crossover Treatment 1||3
5255135|NCT00772967|12919904|P2|COMPLETED|Crossover Treatment 1||5
5255136|NCT00772967|12919905|P1|COMPLETED|Crossover Treatment 1||3
5255137|NCT00772967|12919900|P6|STARTED|Crossover Treatment 1||3
5255138|NCT00772967|12919901|P5|STARTED|Crossover Treatment 1||4
5255139|NCT00772967|12919902|P4|STARTED|Crossover Treatment 1||4
5255140|NCT00772967|12919903|P3|STARTED|Crossover Treatment 1||3
5255141|NCT00772967|12919904|P2|STARTED|Crossover Treatment 1||5
5255142|NCT00772967|12919905|P1|STARTED|Crossover Treatment 1||3
5255143|NCT00772954|12919925|P3|NOT COMPLETED|Overall Study||1
5255144|NCT00772954|12919926|P2|NOT COMPLETED|Overall Study||0
5255145|NCT00772954|12919927|P1|NOT COMPLETED|Overall Study||0
5255146|NCT00772954|12919925|P3|COMPLETED|Overall Study||11
5255147|NCT00772954|12919926|P2|COMPLETED|Overall Study||12
5255148|NCT00772954|12919927|P1|COMPLETED|Overall Study||12
5255149|NCT00772954|12919925|P3|STARTED|Overall Study||12
5255150|NCT00772954|12919926|P2|STARTED|Overall Study||12
5255151|NCT00772954|12919927|P1|STARTED|Overall Study||12
5255152|NCT00772941|12919935|P1|NOT COMPLETED|Overall Study||682
5255153|NCT00772941|12919935|P1|COMPLETED|Overall Study||3257
5255154|NCT00772941|12919935|P1|STARTED|Overall Study||3939
5255155|NCT00772928|12919966|P2|NOT COMPLETED|Overall Study||41
5255156|NCT00772928|12919967|P1|NOT COMPLETED|Overall Study||44
5255157|NCT00772928|12919966|P2|COMPLETED|Overall Study||538
5255158|NCT00772928|12919967|P1|COMPLETED|Overall Study||543
5255159|NCT00772928|12919966|P2|STARTED|Overall Study||579
5255160|NCT00772928|12919967|P1|STARTED|Overall Study||587
5255161|NCT00772915|12919977|P1|NOT COMPLETED|Overall Study||15
5255162|NCT00772915|12919977|P1|COMPLETED|Overall Study||23
5255163|NCT00772915|12919977|P1|STARTED|Overall Study||38
5255164|NCT00772889|12919988|P3|NOT COMPLETED|Overall Study||16
5255165|NCT00772889|12919989|P2|NOT COMPLETED|Overall Study||18
5255166|NCT00772889|12919990|P1|NOT COMPLETED|Overall Study||22
5255167|NCT00772889|12919988|P3|COMPLETED|Overall Study||187
5255168|NCT00772889|12919989|P2|COMPLETED|Overall Study||375
5255169|NCT00772889|12919990|P1|COMPLETED|Overall Study||353
5255170|NCT00772889|12919988|P3|Completed at Day 21|Overall Study||203
5255171|NCT00772889|12919989|P2|Completed at Day 21|Overall Study||390
5255172|NCT00772889|12919990|P1|Completed at Day 21|Overall Study||374
5255173|NCT00772889|12919988|P3|STARTED|Overall Study||203
5255174|NCT00772889|12919989|P2|STARTED|Overall Study||393
5255175|NCT00772889|12919990|P1|STARTED|Overall Study||375
5255176|NCT00772772|12920043|P1|NOT COMPLETED|Overall Study||0
5255177|NCT00772772|12920043|P1|COMPLETED|Overall Study||12
5255178|NCT00772772|12920043|P1|STARTED|Overall Study||12
5255179|NCT00772707|12920048|P1|NOT COMPLETED|Overall Study||3
5255180|NCT00772707|12920048|P1|COMPLETED|Overall Study||111
5255181|NCT00772707|12920048|P1|STARTED|Overall Study||114
5255182|NCT00772668|12920053|P1|NOT COMPLETED|Overall Study||3
5255183|NCT00772668|12920053|P1|COMPLETED|Overall Study||0
5255184|NCT00772668|12920053|P1|STARTED|Overall Study||3
5255185|NCT00772629|12920062|P2|NOT COMPLETED|Overall Study||0
5255186|NCT00772629|12920063|P1|NOT COMPLETED|Overall Study||1
5255187|NCT00772629|12920062|P2|COMPLETED|Overall Study||1
5255188|NCT00772629|12920063|P1|COMPLETED|Overall Study||16
5255189|NCT00772629|12920062|P2|STARTED|Overall Study||1
5255190|NCT00772629|12920063|P1|STARTED|Overall Study||17
5255191|NCT00772603|12920072|P3|NOT COMPLETED|Overall Study||26
5255192|NCT00772603|12920073|P2|NOT COMPLETED|Overall Study||40
5255193|NCT00772603|12920074|P1|NOT COMPLETED|Overall Study||52
5255194|NCT00772603|12920072|P3|COMPLETED|Overall Study||95
5255195|NCT00772603|12920073|P2|COMPLETED|Overall Study||82
5255196|NCT00772603|12920074|P1|COMPLETED|Overall Study||71
5255197|NCT00772603|12920072|P3|STARTED|Overall Study||121
5255198|NCT00772603|12920073|P2|STARTED|Overall Study||122
5255199|NCT00772603|12920074|P1|STARTED|Overall Study||123
5255200|NCT00772590|12920098|P4|NOT COMPLETED|Overall Study||0
5255201|NCT00772590|12920099|P3|NOT COMPLETED|Overall Study||0
5255202|NCT00772590|12920100|P2|NOT COMPLETED|Overall Study||0
5255203|NCT00772590|12920101|P1|NOT COMPLETED|Overall Study||0
5255204|NCT00772590|12920098|P4|COMPLETED|Overall Study||17
5255205|NCT00772590|12920099|P3|COMPLETED|Overall Study||18
5255206|NCT00772590|12920100|P2|COMPLETED|Overall Study||19
5255207|NCT00772590|12920101|P1|COMPLETED|Overall Study||19
5255208|NCT00772590|12920098|P4|STARTED|Overall Study||17
5255209|NCT00772590|12920099|P3|STARTED|Overall Study||18
5255210|NCT00772590|12920100|P2|STARTED|Overall Study||19
5255211|NCT00772590|12920101|P1|STARTED|Overall Study||19
5255212|NCT00772577|12920113|P2|NOT COMPLETED|Overall Study||23
5255213|NCT00772577|12920114|P1|NOT COMPLETED|Overall Study||23
5255214|NCT00772577|12920113|P2|COMPLETED|Overall Study||170
5255215|NCT00772577|12920114|P1|COMPLETED|Overall Study||170
5255216|NCT00772577|12920113|P2|STARTED|Overall Study||193
5255217|NCT00772577|12920114|P1|STARTED|Overall Study||193
5255218|NCT00772538|12920130|P2|NOT COMPLETED|Overall Study||26
5255219|NCT00772538|12920131|P1|NOT COMPLETED|Overall Study||20
5255220|NCT00772538|12920130|P2|COMPLETED|Overall Study||211
5255221|NCT00772538|12920131|P1|COMPLETED|Overall Study||202
5255222|NCT00772538|12920130|P2|STARTED|Overall Study||237
5255223|NCT00772538|12920131|P1|STARTED|Overall Study||222
5255224|NCT00772447|12920203|P2|NOT COMPLETED|Overall Study||24
5255225|NCT00772447|12920204|P1|NOT COMPLETED|Overall Study||20
5255226|NCT00772447|12920203|P2|COMPLETED|Overall Study||110
5255227|NCT00772447|12920204|P1|COMPLETED|Overall Study||111
5255228|NCT00772447|12920203|P2|STARTED|Overall Study||134
5255229|NCT00772447|12920204|P1|STARTED|Overall Study||131
5255230|NCT00772382|12920232|P1|NOT COMPLETED|Overall Study||55
5255231|NCT00772382|12920232|P1|COMPLETED|Overall Study||61
5255232|NCT00772382|12920232|P1|STARTED|Overall Study||116
5255233|NCT00772369|12920237|P1|NOT COMPLETED|Overall Study||1
5255234|NCT00772369|12920237|P1|COMPLETED|Overall Study||3213
5255235|NCT00772369|12920237|P1|STARTED|Overall Study||3214
5255236|NCT00772304|12920242|P1|NOT COMPLETED|Overall Study||0
5255237|NCT00772304|12920242|P1|COMPLETED|Overall Study||102
5255238|NCT00772304|12920242|P1|STARTED|Overall Study||102
5255239|NCT00772148|12920248|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
5255240|NCT00772148|12920249|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
5255241|NCT00772148|12920248|P2|COMPLETED|Maintenance Phase (Week 52)||18
5255242|NCT00772148|12920249|P1|COMPLETED|Maintenance Phase (Week 52)||17
5255243|NCT00772148|12920248|P2|STARTED|Maintenance Phase (Week 52)||23
5255244|NCT00772148|12920249|P1|STARTED|Maintenance Phase (Week 52)||21
5255245|NCT00772148|12920248|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
5255246|NCT00772148|12920249|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
5255247|NCT00772148|12920248|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
5255248|NCT00772148|12920249|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
5255249|NCT00772148|12920248|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
5255250|NCT00772148|12920249|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
5255251|NCT00772109|12920269|P4|NOT COMPLETED|Overall Study||31
5255252|NCT00772109|12920270|P3|NOT COMPLETED|Overall Study||19
5255253|NCT00772109|12920271|P2|NOT COMPLETED|Overall Study||19
5255254|NCT00772109|12920272|P1|NOT COMPLETED|Overall Study||21
5255255|NCT00772109|12920269|P4|COMPLETED|Overall Study||1397
5255256|NCT00772109|12920270|P3|COMPLETED|Overall Study||936
5255257|NCT00772109|12920271|P2|COMPLETED|Overall Study||934
5255258|NCT00772109|12920272|P1|COMPLETED|Overall Study||935
5255259|NCT00772109|12920269|P4|STARTED|Overall Study||1428
5255260|NCT00772109|12920270|P3|STARTED|Overall Study||955
5255261|NCT00772109|12920271|P2|STARTED|Overall Study||953
5255262|NCT00772109|12920272|P1|STARTED|Overall Study||956
5255263|NCT00772070|12920296|P2|NOT COMPLETED|Overall Study||10
5255264|NCT00772070|12920297|P1|NOT COMPLETED|Overall Study||2
5255265|NCT00772070|12920296|P2|COMPLETED|Overall Study||61
5255266|NCT00772070|12920297|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
5255267|NCT00772070|12920296|P2|STARTED|Overall Study||71
5255268|NCT00772070|12920297|P1|STARTED|Overall Study||102
5255269|NCT00772031|12920309|P2|NOT COMPLETED|Overall Study||43
5255270|NCT00772031|12920310|P1|NOT COMPLETED|Overall Study||32
5255271|NCT00772031|12920309|P2|COMPLETED|Overall Study||52
5255272|NCT00772031|12920310|P1|COMPLETED|Overall Study||64
5255273|NCT00772031|12920309|P2|STARTED|Overall Study||95
5255274|NCT00772031|12920310|P1|STARTED|Overall Study||96
5255275|NCT00772005|12920336|P4|NOT COMPLETED|Overall Study||26
5255276|NCT00772005|12920337|P3|NOT COMPLETED|Overall Study||28
5255277|NCT00772005|12920338|P2|NOT COMPLETED|Overall Study||30
5255278|NCT00772005|12920339|P1|NOT COMPLETED|Overall Study||25
5255279|NCT00772005|12920336|P4|COMPLETED|Overall Study||46
5255280|NCT00772005|12920337|P3|COMPLETED|Overall Study||44
5255281|NCT00772005|12920338|P2|COMPLETED|Overall Study||40
5255282|NCT00772005|12920339|P1|COMPLETED|Overall Study||46
5255283|NCT00772005|12920336|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
5255284|NCT00772005|12920337|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
5255285|NCT00772005|12920338|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
5255286|NCT00772005|12920339|P1|STARTED|Overall Study||71
5255287|NCT00771953|12921027|P2|NOT COMPLETED|Overall Study||10
5255288|NCT00771953|12921028|P1|NOT COMPLETED|Overall Study||10
5255289|NCT00771953|12921027|P2|COMPLETED|Overall Study||26
5255290|NCT00771953|12921028|P1|COMPLETED|Overall Study||26
5255291|NCT00771953|12921027|P2|STARTED|Overall Study||36
5255292|NCT00771953|12921028|P1|STARTED|Overall Study||36
5255293|NCT00771927|12921038|P2|NOT COMPLETED|Overall Study||237
5255294|NCT00771927|12921039|P1|NOT COMPLETED|Overall Study||255
5255295|NCT00771927|12921038|P2|COMPLETED|Overall Study||256
5255296|NCT00771927|12921039|P1|COMPLETED|Overall Study||256
5255297|NCT00771927|12921038|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
5255298|NCT00771927|12921039|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
5255299|NCT00771914|12921051|P4|NOT COMPLETED|Overall Study||2
5255300|NCT00771914|12921052|P3|NOT COMPLETED|Overall Study||0
5255301|NCT00771914|12921053|P2|NOT COMPLETED|Overall Study||0
5255302|NCT00771914|12921054|P1|NOT COMPLETED|Overall Study||0
5255303|NCT00771914|12921051|P4|COMPLETED|Overall Study||6
5255304|NCT00771914|12921052|P3|COMPLETED|Overall Study||6
5255305|NCT00771914|12921053|P2|COMPLETED|Overall Study||6
5255306|NCT00771914|12921054|P1|COMPLETED|Overall Study||7
5255307|NCT00771914|12921051|P4|STARTED|Overall Study||8
5255308|NCT00771914|12921052|P3|STARTED|Overall Study||6
5255309|NCT00771914|12921053|P2|STARTED|Overall Study||6
5255310|NCT00771914|12921054|P1|STARTED|Overall Study||7
5255311|NCT00771901|12921067|P3|NOT COMPLETED|Overall Study||4
5255312|NCT00771901|12921068|P2|NOT COMPLETED|Overall Study||0
5255313|NCT00771901|12921069|P1|NOT COMPLETED|Overall Study||0
5255314|NCT00771901|12921067|P3|COMPLETED|Overall Study||6
5255315|NCT00771901|12921068|P2|COMPLETED|Overall Study||10
5255316|NCT00771901|12921069|P1|COMPLETED|Overall Study||10
5255317|NCT00771901|12921067|P3|STARTED|Overall Study||10
5255318|NCT00771901|12921068|P2|STARTED|Overall Study||10
5255319|NCT00771901|12921069|P1|STARTED|Overall Study||10
5255320|NCT00771875|12921086|P3|NOT COMPLETED|Overall Study||0
5255321|NCT00771875|12921087|P2|NOT COMPLETED|Overall Study||1
5255322|NCT00771875|12921088|P1|NOT COMPLETED|Overall Study||0
5255323|NCT00771875|12921086|P3|COMPLETED|Overall Study||10
5255324|NCT00771875|12921087|P2|COMPLETED|Overall Study||9
5255325|NCT00771875|12921088|P1|COMPLETED|Overall Study||10
5255326|NCT00771875|12921086|P3|STARTED|Overall Study||10
5255327|NCT00771875|12921087|P2|STARTED|Overall Study||10
5255328|NCT00771875|12921088|P1|STARTED|Overall Study||10
5255329|NCT00771849|12921116|P2|NOT COMPLETED|Overall Study||4
5255330|NCT00771849|12921117|P1|NOT COMPLETED|Overall Study||2
5255331|NCT00771849|12921116|P2|COMPLETED|Overall Study||47
5255332|NCT00771849|12921117|P1|COMPLETED|Overall Study||50
5255333|NCT00771849|12921116|P2|STARTED|Overall Study|One subject was not vaccinated|51
5255334|NCT00771849|12921117|P1|STARTED|Overall Study||52
5255335|NCT00771810|12921128|P3|NOT COMPLETED|Overall Study||7
5255336|NCT00771810|12921129|P2|NOT COMPLETED|Overall Study||5
5255337|NCT00771810|12921130|P1|NOT COMPLETED|Overall Study||5
5255338|NCT00771810|12921128|P3|COMPLETED|Overall Study||6
5255339|NCT00771810|12921129|P2|COMPLETED|Overall Study||6
5255340|NCT00771810|12921130|P1|COMPLETED|Overall Study||5
5255341|NCT00771810|12921128|P3|STARTED|Overall Study||13
5255342|NCT00771810|12921129|P2|STARTED|Overall Study||11
5255343|NCT00771810|12921130|P1|STARTED|Overall Study||10
5255344|NCT00771758|12921168|P3|NOT COMPLETED|Overall Study||2
5255345|NCT00771758|12921169|P2|NOT COMPLETED|Overall Study||12
5255346|NCT00771758|12921170|P1|NOT COMPLETED|Overall Study||8
5255347|NCT00771758|12921168|P3|COMPLETED|Overall Study||19
5255348|NCT00771758|12921169|P2|COMPLETED|Overall Study||31
5255349|NCT00771758|12921170|P1|COMPLETED|Overall Study||36
5255350|NCT00771758|12921168|P3|STARTED|Overall Study||21
5255351|NCT00771758|12921169|P2|STARTED|Overall Study||43
5255352|NCT00771758|12921170|P1|STARTED|Overall Study||44
5255353|NCT00771745|12921320|P2|NOT COMPLETED|Overall Study||0
5255354|NCT00771745|12921321|P1|NOT COMPLETED|Overall Study||0
5255355|NCT00771745|12921320|P2|COMPLETED|Overall Study||5
5255356|NCT00771745|12921321|P1|COMPLETED|Overall Study||6
5255357|NCT00771745|12921320|P2|STARTED|Overall Study||5
5255358|NCT00771745|12921321|P1|STARTED|Overall Study||6
5255359|NCT00771667|12921331|P10|NOT COMPLETED|Maintenance Phase||17
5255360|NCT00771667|12921332|P9|NOT COMPLETED|Maintenance Phase||22
5255361|NCT00771667|12921333|P8|NOT COMPLETED|Maintenance Phase||5
5255362|NCT00771667|12921334|P7|NOT COMPLETED|Maintenance Phase||10
5255363|NCT00771667|12921335|P6|NOT COMPLETED|Maintenance Phase||7
5255364|NCT00771667|12921336|P5|NOT COMPLETED|Maintenance Phase||2
5255365|NCT00771667|12921337|P4|NOT COMPLETED|Maintenance Phase||0
5255366|NCT00771667|12921338|P3|NOT COMPLETED|Maintenance Phase||0
5255367|NCT00771667|12921339|P2|NOT COMPLETED|Maintenance Phase||0
5255368|NCT00771667|12921340|P1|NOT COMPLETED|Maintenance Phase||0
5255369|NCT00771667|12921331|P10|COMPLETED|Maintenance Phase||92
5255370|NCT00771667|12921332|P9|COMPLETED|Maintenance Phase||88
5255371|NCT00771667|12921333|P8|COMPLETED|Maintenance Phase||67
5255372|NCT00771667|12921334|P7|COMPLETED|Maintenance Phase||63
5255373|NCT00771667|12921335|P6|COMPLETED|Maintenance Phase||78
5255374|NCT00771667|12921336|P5|COMPLETED|Maintenance Phase||26
5255375|NCT00771667|12921337|P4|COMPLETED|Maintenance Phase||0
5255376|NCT00771667|12921338|P3|COMPLETED|Maintenance Phase||0
5255377|NCT00771667|12921339|P2|COMPLETED|Maintenance Phase||0
5255378|NCT00771667|12921340|P1|COMPLETED|Maintenance Phase||0
5255379|NCT00771667|12921331|P10|STARTED|Maintenance Phase||109
5255380|NCT00771667|12921332|P9|STARTED|Maintenance Phase||110
5255381|NCT00771667|12921333|P8|STARTED|Maintenance Phase||72
5255382|NCT00771667|12921334|P7|STARTED|Maintenance Phase||73
5255383|NCT00771667|12921335|P6|STARTED|Maintenance Phase||85
5255384|NCT00771667|12921336|P5|STARTED|Maintenance Phase||28
5255385|NCT00771667|12921337|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
5255386|NCT00771667|12921338|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
5255387|NCT00771667|12921339|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
5255388|NCT00771667|12921340|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
5255389|NCT00771667|12921331|P10|NOT COMPLETED|Induction Phase||0
5255390|NCT00771667|12921332|P9|NOT COMPLETED|Induction Phase||0
5255391|NCT00771667|12921333|P8|NOT COMPLETED|Induction Phase||0
5255392|NCT00771667|12921334|P7|NOT COMPLETED|Induction Phase||0
5255393|NCT00771667|12921335|P6|NOT COMPLETED|Induction Phase||0
5255394|NCT00771667|12921336|P5|NOT COMPLETED|Induction Phase||0
5255395|NCT00771667|12921337|P4|NOT COMPLETED|Induction Phase||8
5255396|NCT00771667|12921338|P3|NOT COMPLETED|Induction Phase||12
5255397|NCT00771667|12921339|P2|NOT COMPLETED|Induction Phase||10
5255398|NCT00771667|12921340|P1|NOT COMPLETED|Induction Phase||19
5255399|NCT00771667|12921331|P10|COMPLETED|Induction Phase||0
5255400|NCT00771667|12921332|P9|COMPLETED|Induction Phase||0
5255401|NCT00771667|12921333|P8|COMPLETED|Induction Phase||0
5255402|NCT00771667|12921334|P7|COMPLETED|Induction Phase||0
5255403|NCT00771667|12921335|P6|COMPLETED|Induction Phase||0
5255404|NCT00771667|12921336|P5|COMPLETED|Induction Phase||0
5255405|NCT00771667|12921337|P4|COMPLETED|Induction Phase||123
5255406|NCT00771667|12921338|P3|COMPLETED|Induction Phase||120
5255407|NCT00771667|12921339|P2|COMPLETED|Induction Phase||121
5255408|NCT00771667|12921340|P1|COMPLETED|Induction Phase||113
5255409|NCT00771667|12921331|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255410|NCT00771667|12921332|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255502|NCT00771537|12921628|P1|STARTED|Overall Study||135
5255411|NCT00771667|12921333|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255412|NCT00771667|12921334|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255413|NCT00771667|12921335|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255414|NCT00771667|12921336|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
5255415|NCT00771667|12921337|P4|STARTED|Induction Phase||131
5255416|NCT00771667|12921338|P3|STARTED|Induction Phase||132
5255417|NCT00771667|12921339|P2|STARTED|Induction Phase||131
5255418|NCT00771667|12921340|P1|STARTED|Induction Phase||132
5255419|NCT00771615|12921385|P9|NOT COMPLETED|Overall Study||0
5255420|NCT00771615|12921386|P8|NOT COMPLETED|Overall Study||1
5255421|NCT00771615|12921387|P7|NOT COMPLETED|Overall Study||1
5255422|NCT00771615|12921388|P6|NOT COMPLETED|Overall Study||1
5255423|NCT00771615|12921389|P5|NOT COMPLETED|Overall Study||0
5255424|NCT00771615|12921390|P4|NOT COMPLETED|Overall Study||1
5255425|NCT00771615|12921391|P3|NOT COMPLETED|Overall Study||1
5255426|NCT00771615|12921392|P2|NOT COMPLETED|Overall Study||2
5255427|NCT00771615|12921393|P1|NOT COMPLETED|Overall Study||1
5255428|NCT00771615|12921385|P9|COMPLETED|Overall Study|Up to Day 364|41
5255429|NCT00771615|12921386|P8|COMPLETED|Overall Study|Up to Day 364|58
5255430|NCT00771615|12921387|P7|COMPLETED|Overall Study|Up to Day 364|45
5255431|NCT00771615|12921388|P6|COMPLETED|Overall Study|Up to Day 364|60
5255432|NCT00771615|12921389|P5|COMPLETED|Overall Study|Up to Day 364|40
5255433|NCT00771615|12921390|P4|COMPLETED|Overall Study|Up to Day 364|59
5255434|NCT00771615|12921391|P3|COMPLETED|Overall Study|Up to Day 364|40
5255435|NCT00771615|12921392|P2|COMPLETED|Overall Study|Up to Day 364|70
5255436|NCT00771615|12921393|P1|COMPLETED|Overall Study|Up to Day 364|48
5255437|NCT00771615|12921385|P9|STARTED|Overall Study||41
5255438|NCT00771615|12921386|P8|STARTED|Overall Study||59
5255439|NCT00771615|12921387|P7|STARTED|Overall Study||46
5255440|NCT00771615|12921388|P6|STARTED|Overall Study||61
5255441|NCT00771615|12921389|P5|STARTED|Overall Study||40
5255442|NCT00771615|12921390|P4|STARTED|Overall Study||60
5255443|NCT00771615|12921391|P3|STARTED|Overall Study||41
5255444|NCT00771615|12921392|P2|STARTED|Overall Study||72
5255445|NCT00771615|12921393|P1|STARTED|Overall Study||49
5255446|NCT00771602|12921587|P3|NOT COMPLETED|Overall Study||0
5255447|NCT00771602|12921588|P2|NOT COMPLETED|Overall Study||0
5255448|NCT00771602|12921589|P1|NOT COMPLETED|Overall Study||0
5255449|NCT00771602|12921587|P3|COMPLETED|Overall Study||0
5255450|NCT00771602|12921588|P2|COMPLETED|Overall Study||0
5255451|NCT00771602|12921589|P1|COMPLETED|Overall Study||1
5255452|NCT00771602|12921587|P3|STARTED|Overall Study||0
5255453|NCT00771602|12921588|P2|STARTED|Overall Study||0
5255454|NCT00771602|12921589|P1|STARTED|Overall Study||1
5255455|NCT00771537|12921613|P16|NOT COMPLETED|Overall Study||0
5255456|NCT00771537|12921614|P15|NOT COMPLETED|Overall Study||0
5255457|NCT00771537|12921615|P14|NOT COMPLETED|Overall Study||0
5255458|NCT00771537|12921616|P13|NOT COMPLETED|Overall Study||0
5255459|NCT00771537|12921617|P12|NOT COMPLETED|Overall Study||0
5255460|NCT00771537|12921618|P11|NOT COMPLETED|Overall Study||0
5255461|NCT00771537|12921619|P10|NOT COMPLETED|Overall Study||0
5255462|NCT00771537|12921620|P9|NOT COMPLETED|Overall Study||0
5255463|NCT00771537|12921621|P8|NOT COMPLETED|Overall Study||0
5255464|NCT00771537|12921622|P7|NOT COMPLETED|Overall Study||0
5255465|NCT00771537|12921623|P6|NOT COMPLETED|Overall Study||0
5255466|NCT00771537|12921624|P5|NOT COMPLETED|Overall Study||0
5255467|NCT00771537|12921625|P4|NOT COMPLETED|Overall Study||0
5255468|NCT00771537|12921626|P3|NOT COMPLETED|Overall Study||0
5255469|NCT00771537|12921627|P2|NOT COMPLETED|Overall Study||0
5255470|NCT00771537|12921628|P1|NOT COMPLETED|Overall Study||0
5255471|NCT00771537|12921613|P16|COMPLETED|Overall Study||122
5255472|NCT00771537|12921614|P15|COMPLETED|Overall Study||124
5255473|NCT00771537|12921615|P14|COMPLETED|Overall Study||124
5255474|NCT00771537|12921616|P13|COMPLETED|Overall Study||128
5255475|NCT00771537|12921617|P12|COMPLETED|Overall Study||137
5255476|NCT00771537|12921618|P11|COMPLETED|Overall Study||133
5255477|NCT00771537|12921619|P10|COMPLETED|Overall Study||119
5255478|NCT00771537|12921620|P9|COMPLETED|Overall Study||115
5255479|NCT00771537|12921621|P8|COMPLETED|Overall Study||132
5255480|NCT00771537|12921622|P7|COMPLETED|Overall Study||128
5255481|NCT00771537|12921623|P6|COMPLETED|Overall Study||118
5255482|NCT00771537|12921624|P5|COMPLETED|Overall Study||127
5255483|NCT00771537|12921625|P4|COMPLETED|Overall Study||114
5255484|NCT00771537|12921626|P3|COMPLETED|Overall Study||151
5255485|NCT00771537|12921627|P2|COMPLETED|Overall Study||124
5255486|NCT00771537|12921628|P1|COMPLETED|Overall Study||135
5255487|NCT00771537|12921613|P16|STARTED|Overall Study||122
5255488|NCT00771537|12921614|P15|STARTED|Overall Study||124
5255489|NCT00771537|12921615|P14|STARTED|Overall Study||124
5255490|NCT00771537|12921616|P13|STARTED|Overall Study||128
5255491|NCT00771537|12921617|P12|STARTED|Overall Study||137
5255492|NCT00771537|12921618|P11|STARTED|Overall Study||133
5255493|NCT00771537|12921619|P10|STARTED|Overall Study||119
5255494|NCT00771537|12921620|P9|STARTED|Overall Study||115
5255495|NCT00771537|12921621|P8|STARTED|Overall Study||132
5255496|NCT00771537|12921622|P7|STARTED|Overall Study||128
5255497|NCT00771537|12921623|P6|STARTED|Overall Study||118
5255498|NCT00771537|12921624|P5|STARTED|Overall Study||127
5255499|NCT00771537|12921625|P4|STARTED|Overall Study||114
5255500|NCT00771537|12921626|P3|STARTED|Overall Study||151
5255501|NCT00771537|12921627|P2|STARTED|Overall Study||124
5255503|NCT00771472|12921654|P2|NOT COMPLETED|Overall Study||4
5255504|NCT00771472|12921655|P1|NOT COMPLETED|Overall Study||6
5255505|NCT00771472|12921654|P2|COMPLETED|Overall Study||0
5255506|NCT00771472|12921655|P1|COMPLETED|Overall Study||0
5255507|NCT00771472|12921654|P2|STARTED|Overall Study||4
5255508|NCT00771472|12921655|P1|STARTED|Overall Study||6
5255509|NCT00771407|12921666|P2|NOT COMPLETED|Overall Study||25
5255510|NCT00771407|12921667|P1|NOT COMPLETED|Overall Study||20
5255511|NCT00771407|12921666|P2|COMPLETED|Overall Study||35
5255512|NCT00771407|12921667|P1|COMPLETED|Overall Study||40
5255513|NCT00771407|12921666|P2|STARTED|Overall Study||60
5255514|NCT00771407|12921667|P1|STARTED|Overall Study||60
5255515|NCT00771316|12921675|P2|NOT COMPLETED|Overall Study||1
5255516|NCT00771316|12921676|P1|NOT COMPLETED|Overall Study||2
5255517|NCT00771316|12921675|P2|COMPLETED|Overall Study||1
5255518|NCT00771316|12921676|P1|COMPLETED|Overall Study||2
5255519|NCT00771316|12921675|P2|STARTED|Overall Study||2
5255520|NCT00771316|12921676|P1|STARTED|Overall Study||4
5255521|NCT00771277|12921686|P1|NOT COMPLETED|Overall Study||0
5255522|NCT00771277|12921686|P1|COMPLETED|Overall Study||6
5255523|NCT00771277|12921686|P1|STARTED|Overall Study||6
5255524|NCT00771264|12921694|P2|NOT COMPLETED|Overall Study||5
5255525|NCT00771264|12921695|P1|NOT COMPLETED|Overall Study||7
5255526|NCT00771264|12921694|P2|COMPLETED|Overall Study||105
5255527|NCT00771264|12921695|P1|COMPLETED|Overall Study||103
5255528|NCT00771264|12921694|P2|STARTED|Overall Study||110
5255529|NCT00771264|12921695|P1|STARTED|Overall Study||110
5255530|NCT00771238|12921703|P2|NOT COMPLETED|Overall Study||0
5255531|NCT00771238|12921704|P1|NOT COMPLETED|Overall Study||0
5255532|NCT00771238|12921703|P2|COMPLETED|Overall Study||21
5255533|NCT00771238|12921704|P1|COMPLETED|Overall Study||31
5255534|NCT00771238|12921703|P2|STARTED|Overall Study||21
5255535|NCT00771238|12921704|P1|STARTED|Overall Study||31
5255536|NCT00771173|12921714|P2|NOT COMPLETED|Overall Study||17
5255537|NCT00771173|12921715|P1|NOT COMPLETED|Overall Study||22
5255538|NCT00771173|12921714|P2|COMPLETED|Overall Study||112
5255539|NCT00771173|12921715|P1|COMPLETED|Overall Study||107
5255540|NCT00771173|12921714|P2|STARTED|Overall Study||129
5255541|NCT00771173|12921715|P1|STARTED|Overall Study||129
5255542|NCT00771056|12921721|P1|NOT COMPLETED|Overall Study||5
5255543|NCT00771056|12921721|P1|COMPLETED|Overall Study||18
5255544|NCT00771056|12921721|P1|STARTED|Overall Study||23
5255545|NCT00770991|12921728|P2|NOT COMPLETED|Overall Study||5
5255546|NCT00770991|12921729|P1|NOT COMPLETED|Overall Study||5
5255547|NCT00770991|12921728|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
5255548|NCT00770991|12921729|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
5255549|NCT00770991|12921728|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
5255550|NCT00770991|12921729|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
5255551|NCT00770965|12921745|P4|NOT COMPLETED|Excluded Set||13
5255552|NCT00770965|12921746|P3|NOT COMPLETED|Excluded Set||14
5255553|NCT00770965|12921747|P2|NOT COMPLETED|Excluded Set||13
5255554|NCT00770965|12921748|P1|NOT COMPLETED|Excluded Set||15
5255555|NCT00770965|12921745|P4|COMPLETED|Excluded Set||2
5255556|NCT00770965|12921746|P3|COMPLETED|Excluded Set||2
5255557|NCT00770965|12921747|P2|COMPLETED|Excluded Set||3
5255558|NCT00770965|12921748|P1|COMPLETED|Excluded Set||3
5255559|NCT00770965|12921745|P4|STARTED|Excluded Set||15
5255560|NCT00770965|12921746|P3|STARTED|Excluded Set||16
5255561|NCT00770965|12921747|P2|STARTED|Excluded Set||16
5255562|NCT00770965|12921748|P1|STARTED|Excluded Set||18
5255563|NCT00770965|12921745|P4|NOT COMPLETED|Safety Set||1
5255564|NCT00770965|12921746|P3|NOT COMPLETED|Safety Set||1
5255565|NCT00770965|12921747|P2|NOT COMPLETED|Safety Set||0
5255566|NCT00770965|12921748|P1|NOT COMPLETED|Safety Set||0
5255567|NCT00770965|12921745|P4|COMPLETED|Safety Set||4
5255568|NCT00770965|12921746|P3|COMPLETED|Safety Set||3
5255569|NCT00770965|12921747|P2|COMPLETED|Safety Set||4
5255570|NCT00770965|12921748|P1|COMPLETED|Safety Set||2
5255571|NCT00770965|12921745|P4|STARTED|Safety Set||5
5255572|NCT00770965|12921746|P3|STARTED|Safety Set||4
5255573|NCT00770965|12921747|P2|STARTED|Safety Set||4
5255574|NCT00770965|12921748|P1|STARTED|Safety Set||2
5255575|NCT00770913|12921769|P3|NOT COMPLETED|Overall Study||13
5255576|NCT00770913|12921770|P2|NOT COMPLETED|Overall Study||8
5255577|NCT00770913|12921771|P1|NOT COMPLETED|Overall Study||11
5255578|NCT00770913|12921769|P3|COMPLETED|Overall Study||100
5255579|NCT00770913|12921770|P2|COMPLETED|Overall Study||103
5255580|NCT00770913|12921771|P1|COMPLETED|Overall Study||102
5255581|NCT00770913|12921769|P3|STARTED|Overall Study||113
5255582|NCT00770913|12921770|P2|STARTED|Overall Study||111
5255583|NCT00770913|12921771|P1|STARTED|Overall Study||113
5255584|NCT00770874|12921781|P2|NOT COMPLETED|Overall Study||0
5255585|NCT00770874|12921782|P1|NOT COMPLETED|Overall Study||0
5255586|NCT00770874|12921781|P2|COMPLETED|Overall Study||176
5255587|NCT00770874|12921782|P1|COMPLETED|Overall Study||188
5255588|NCT00770874|12921781|P2|STARTED|Overall Study||176
5255589|NCT00770874|12921782|P1|STARTED|Overall Study||188
5255590|NCT00770861|12921792|P2|NOT COMPLETED|Overall Study||16
5255591|NCT00770861|12921793|P1|NOT COMPLETED|Overall Study||10
5255592|NCT00770861|12921792|P2|COMPLETED|Overall Study||120
5255593|NCT00770861|12921793|P1|COMPLETED|Overall Study||131
5255594|NCT00770861|12921792|P2|STARTED|Overall Study||136
5255595|NCT00770861|12921793|P1|STARTED|Overall Study||141
5255596|NCT00770809|12921804|P3|NOT COMPLETED|Overall Study||23
5255597|NCT00770809|12921805|P2|NOT COMPLETED|Overall Study||10
5255598|NCT00770809|12921806|P1|NOT COMPLETED|Overall Study||17
5255599|NCT00770809|12921804|P3|COMPLETED|Overall Study||44
5255600|NCT00770809|12921805|P2|COMPLETED|Overall Study||110
5255601|NCT00770809|12921806|P1|COMPLETED|Overall Study||101
5255602|NCT00770809|12921804|P3|STARTED|Overall Study||67
5255603|NCT00770809|12921805|P2|STARTED|Overall Study||120
5255604|NCT00770809|12921806|P1|STARTED|Overall Study||118
5255605|NCT00770770|12921816|P2|NOT COMPLETED|Overall Study||1
5255606|NCT00770770|12921817|P1|NOT COMPLETED|Overall Study||10
5255607|NCT00770770|12921816|P2|COMPLETED|Overall Study||5
5255608|NCT00770770|12921817|P1|COMPLETED|Overall Study||4
5255609|NCT00770770|12921816|P2|STARTED|Overall Study||6
5255610|NCT00770770|12921817|P1|STARTED|Overall Study||14
5255611|NCT00770757|12921823|P1|NOT COMPLETED|Overall Study||0
5255612|NCT00770757|12921823|P1|COMPLETED|Overall Study||13
5255613|NCT00770757|12921823|P1|STARTED|Overall Study||13
5255614|NCT00770692|12921835|P4|NOT COMPLETED|Overall Study||11
5255615|NCT00770692|12921836|P3|NOT COMPLETED|Overall Study||14
5255616|NCT00770692|12921837|P2|NOT COMPLETED|Overall Study||9
5255617|NCT00770692|12921838|P1|NOT COMPLETED|Overall Study||12
5255618|NCT00770692|12921835|P4|COMPLETED|Overall Study||66
5255619|NCT00770692|12921836|P3|COMPLETED|Overall Study||70
5255620|NCT00770692|12921837|P2|COMPLETED|Overall Study||74
5255621|NCT00770692|12921838|P1|COMPLETED|Overall Study||69
5255622|NCT00770692|12921835|P4|STARTED|Overall Study||77
5255623|NCT00770692|12921836|P3|STARTED|Overall Study||84
5255624|NCT00770692|12921837|P2|STARTED|Overall Study||83
5255625|NCT00770692|12921838|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
5255626|NCT00770679|12921864|P1|NOT COMPLETED|Overall Study||6
5255627|NCT00770679|12921864|P1|COMPLETED|Overall Study||10
5255628|NCT00770679|12921864|P1|STARTED|Overall Study||16
5255629|NCT00770653|12921872|P2|NOT COMPLETED|Overall Study||29
5255630|NCT00770653|12921873|P1|NOT COMPLETED|Overall Study||32
5255631|NCT00770653|12921872|P2|COMPLETED|Overall Study||121
5255632|NCT00770653|12921873|P1|COMPLETED|Overall Study||123
5255633|NCT00770653|12921872|P2|STARTED|Overall Study||150
5255634|NCT00770653|12921873|P1|STARTED|Overall Study||155
5255635|NCT00770588|12921943|P2|NOT COMPLETED|Overall Study||95
5255636|NCT00770588|12921944|P1|NOT COMPLETED|Overall Study||81
5255637|NCT00770588|12921943|P2|COMPLETED|Overall Study||53
5255638|NCT00770588|12921944|P1|COMPLETED|Overall Study||67
5255639|NCT00770588|12921943|P2|STARTED|Overall Study||148
5255640|NCT00770588|12921944|P1|STARTED|Overall Study||148
5255641|NCT00770562|12921960|P2|NOT COMPLETED|Overall Study||1
5255642|NCT00770562|12921961|P1|NOT COMPLETED|Overall Study||1
5255643|NCT00770562|12921960|P2|COMPLETED|Overall Study||49
5255644|NCT00770562|12921961|P1|COMPLETED|Overall Study||52
5255645|NCT00770562|12921960|P2|STARTED|Overall Study||50
5255646|NCT00770562|12921961|P1|STARTED|Overall Study||53
5255647|NCT00770510|12921972|P1|NOT COMPLETED|Overall Study||5
5255648|NCT00770510|12921972|P1|COMPLETED|Overall Study||67
5255649|NCT00770510|12921972|P1|STARTED|Overall Study||72
5255650|NCT00770484|12922011|P2|NOT COMPLETED|Overall Study||0
5255651|NCT00770484|12922012|P1|NOT COMPLETED|Overall Study||1
5255652|NCT00770484|12922011|P2|COMPLETED|Overall Study||4
5255653|NCT00770484|12922012|P1|COMPLETED|Overall Study||7
5255654|NCT00770484|12922011|P2|STARTED|Overall Study||4
5255655|NCT00770484|12922012|P1|STARTED|Overall Study||8
5255656|NCT00770432|12922020|P2|NOT COMPLETED|Overall Study||7
5255657|NCT00770432|12922021|P1|NOT COMPLETED|Overall Study||4
5255658|NCT00770432|12922020|P2|COMPLETED|Overall Study||94
5255659|NCT00770432|12922021|P1|COMPLETED|Overall Study||98
5255660|NCT00770432|12922020|P2|STARTED|Overall Study||101
5255661|NCT00770432|12922021|P1|STARTED|Overall Study||102
5255662|NCT00770367|12922029|P2|NOT COMPLETED|Second Intervention||0
5255663|NCT00770367|12922030|P1|NOT COMPLETED|Second Intervention||2
5255664|NCT00770367|12922029|P2|COMPLETED|Second Intervention||15
5255665|NCT00770367|12922030|P1|COMPLETED|Second Intervention||16
5255666|NCT00770367|12922029|P2|STARTED|Second Intervention||15
5255667|NCT00770367|12922030|P1|STARTED|Second Intervention||18
5255668|NCT00770367|12922029|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
5255669|NCT00770367|12922030|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
5255670|NCT00770367|12922029|P2|COMPLETED|Washout Period of 4 Weeks||15
5255671|NCT00770367|12922030|P1|COMPLETED|Washout Period of 4 Weeks||18
5255672|NCT00770367|12922029|P2|STARTED|Washout Period of 4 Weeks||16
5255673|NCT00770367|12922030|P1|STARTED|Washout Period of 4 Weeks||18
5255674|NCT00770367|12922029|P2|NOT COMPLETED|First Intervention||2
5255675|NCT00770367|12922030|P1|NOT COMPLETED|First Intervention||0
5255676|NCT00770367|12922029|P2|COMPLETED|First Intervention||16
5255677|NCT00770367|12922030|P1|COMPLETED|First Intervention||18
5255678|NCT00770367|12922029|P2|STARTED|First Intervention||18
5255679|NCT00770367|12922030|P1|STARTED|First Intervention||18
5255680|NCT00770341|12922041|P3|NOT COMPLETED|Overall Study||3
5255681|NCT00770341|12922042|P2|NOT COMPLETED|Overall Study||5
5255682|NCT00770341|12922043|P1|NOT COMPLETED|Overall Study||12
5255683|NCT00770341|12922041|P3|COMPLETED|Overall Study||8
5255684|NCT00770341|12922042|P2|COMPLETED|Overall Study||17
5255685|NCT00770341|12922043|P1|COMPLETED|Overall Study||77
5255686|NCT00770341|12922041|P3|STARTED|Overall Study|Number randomized|11
5255687|NCT00770341|12922042|P2|STARTED|Overall Study|Number randomized|22
5255688|NCT00770341|12922043|P1|STARTED|Overall Study|Number randomized|89
5255689|NCT00770328|12922069|P2|NOT COMPLETED|Overall Study||4
5255690|NCT00770328|12922070|P1|NOT COMPLETED|Overall Study||13
5255691|NCT00770328|12922069|P2|COMPLETED|Overall Study||11
5255692|NCT00770328|12922070|P1|COMPLETED|Overall Study||9
5255693|NCT00770328|12922069|P2|STARTED|Overall Study||15
5255694|NCT00770328|12922070|P1|STARTED|Overall Study||22
5255695|NCT00770315|12922086|P4|NOT COMPLETED|Overall Study||38
5255696|NCT00770315|12922087|P3|NOT COMPLETED|Overall Study||57
5255697|NCT00770315|12922088|P2|NOT COMPLETED|Overall Study||43
5255698|NCT00770315|12922089|P1|NOT COMPLETED|Overall Study||40
5255699|NCT00770315|12922086|P4|COMPLETED|Overall Study||160
5255700|NCT00770315|12922087|P3|COMPLETED|Overall Study||137
5255701|NCT00770315|12922088|P2|COMPLETED|Overall Study||152
5255702|NCT00770315|12922089|P1|COMPLETED|Overall Study||157
5255703|NCT00770315|12922086|P4|STARTED|Overall Study||198
5255704|NCT00770315|12922087|P3|STARTED|Overall Study||194
5255705|NCT00770315|12922088|P2|STARTED|Overall Study||195
5255706|NCT00770315|12922089|P1|STARTED|Overall Study||197
5255707|NCT00770289|12922115|P1|NOT COMPLETED|Overall Study||6
5255708|NCT00770289|12922115|P1|COMPLETED|Overall Study||845
5255709|NCT00770289|12922115|P1|STARTED|Overall Study||851
5255710|NCT00770224|12922124|P2|NOT COMPLETED|Step 2: Maintenance||30
5255711|NCT00770224|12922125|P1|NOT COMPLETED|Step 2: Maintenance||0
5255712|NCT00770224|12922124|P2|COMPLETED|Step 2: Maintenance||41
5255713|NCT00770224|12922125|P1|COMPLETED|Step 2: Maintenance||0
5255714|NCT00770224|12922124|P2|Eligible and Evaluable|Step 2: Maintenance||69
5255715|NCT00770224|12922125|P1|Eligible and Evaluable|Step 2: Maintenance||0
5255716|NCT00770224|12922124|P2|STARTED|Step 2: Maintenance||71
5255717|NCT00770224|12922125|P1|STARTED|Step 2: Maintenance||0
5255718|NCT00770224|12922124|P2|NOT COMPLETED|Step 1: Induction||0
5255719|NCT00770224|12922125|P1|NOT COMPLETED|Step 1: Induction||14
5255720|NCT00770224|12922124|P2|COMPLETED|Step 1: Induction||0
5255721|NCT00770224|12922125|P1|COMPLETED|Step 1: Induction||73
5255722|NCT00770224|12922124|P2|Eligible and Evaluable|Step 1: Induction||0
5255723|NCT00770224|12922125|P1|Eligible and Evaluable|Step 1: Induction||84
5255724|NCT00770224|12922124|P2|STARTED|Step 1: Induction||0
5255725|NCT00770224|12922125|P1|STARTED|Step 1: Induction||87
5255726|NCT00770211|12922137|P2|NOT COMPLETED|Overall Study||2
5255727|NCT00770211|12922138|P1|NOT COMPLETED|Overall Study||1
5255728|NCT00770211|12922137|P2|COMPLETED|Overall Study||87
5255729|NCT00770211|12922138|P1|COMPLETED|Overall Study||181
5255730|NCT00770211|12922137|P2|STARTED|Overall Study||89
5255731|NCT00770211|12922138|P1|STARTED|Overall Study||182
5255732|NCT00770146|12922154|P2|NOT COMPLETED|Follow-up Period||20
5255733|NCT00770146|12922155|P1|NOT COMPLETED|Follow-up Period||11
5255734|NCT00770146|12922154|P2|COMPLETED|Follow-up Period||85
5255735|NCT00770146|12922155|P1|COMPLETED|Follow-up Period||42
5255736|NCT00770146|12922154|P2|STARTED|Follow-up Period||105
5255737|NCT00770146|12922155|P1|STARTED|Follow-up Period||53
5255738|NCT00770146|12922154|P2|NOT COMPLETED|Treatment Period||45
5255739|NCT00770146|12922155|P1|NOT COMPLETED|Treatment Period||9
5255740|NCT00770146|12922154|P2|COMPLETED|Treatment Period||60
5255741|NCT00770146|12922155|P1|COMPLETED|Treatment Period||44
5255742|NCT00770146|12922154|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
5255743|NCT00770146|12922155|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
5255744|NCT00770146|12922154|P2|Treated|Treatment Period||105
5255745|NCT00770146|12922155|P1|Treated|Treatment Period||52
5255746|NCT00770146|12922154|P2|STARTED|Treatment Period||105
5255747|NCT00770146|12922155|P1|STARTED|Treatment Period||53
5255748|NCT00770120|12922199|P1|NOT COMPLETED|Overall Study||61
5255749|NCT00770120|12922199|P1|COMPLETED|Overall Study||0
5255750|NCT00770120|12922199|P1|Not Analyzable|Overall Study||1
5255751|NCT00770120|12922199|P1|Eligible|Overall Study||60
5255752|NCT00770120|12922199|P1|STARTED|Overall Study||61
5255753|NCT00770029|12922208|P2|NOT COMPLETED|Overall Study||3
5255754|NCT00770029|12922209|P1|NOT COMPLETED|Overall Study||6
5255755|NCT00770029|12922208|P2|COMPLETED|Overall Study||89
5255756|NCT00770029|12922209|P1|COMPLETED|Overall Study||178
5255757|NCT00770029|12922208|P2|STARTED|Overall Study||92
5255758|NCT00770029|12922209|P1|STARTED|Overall Study||184
5255759|NCT00769860|12922225|P2|NOT COMPLETED|Overall Study||0
5255760|NCT00769860|12922226|P1|NOT COMPLETED|Overall Study||2
5255761|NCT00769860|12922225|P2|COMPLETED|Overall Study||8
5255762|NCT00769860|12922226|P1|COMPLETED|Overall Study||14
5255763|NCT00769860|12922225|P2|Month 8|Overall Study||8
5255764|NCT00769860|12922226|P1|Month 8|Overall Study||14
5255765|NCT00769860|12922225|P2|Month 4|Overall Study||8
5255766|NCT00769860|12922226|P1|Month 4|Overall Study||16
5255767|NCT00769860|12922225|P2|STARTED|Overall Study||8
5255768|NCT00769860|12922226|P1|STARTED|Overall Study||16
5255769|NCT00769704|12922254|P2|NOT COMPLETED|Overall Study||199
5255770|NCT00769704|12922255|P1|NOT COMPLETED|Overall Study||111
5255771|NCT00769704|12922254|P2|COMPLETED|Overall Study||97
5255772|NCT00769704|12922255|P1|COMPLETED|Overall Study||30
5255773|NCT00769704|12922254|P2|Received Treatment|Overall Study||292
5255774|NCT00769704|12922255|P1|Received Treatment|Overall Study||127
5255775|NCT00769704|12922254|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
5255776|NCT00769704|12922255|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
5255777|NCT00769704|12922254|P2|STARTED|Overall Study||296
5255778|NCT00769704|12922255|P1|STARTED|Overall Study||141
5255779|NCT00769652|12922275|P2|NOT COMPLETED|Overall Study||0
5255780|NCT00769652|12922276|P1|NOT COMPLETED|Overall Study||0
5255781|NCT00769652|12922275|P2|COMPLETED|Overall Study||1
5255782|NCT00769652|12922276|P1|COMPLETED|Overall Study||6
5255783|NCT00769652|12922275|P2|STARTED|Overall Study||1
5255784|NCT00769652|12922276|P1|STARTED|Overall Study||6
5255785|NCT00769600|12922288|P2|NOT COMPLETED|Overall Study||0
5255786|NCT00769600|12922289|P1|NOT COMPLETED|Overall Study||0
5255787|NCT00769600|12922288|P2|COMPLETED|Overall Study||8
5255788|NCT00769600|12922289|P1|COMPLETED|Overall Study||15
5255789|NCT00769600|12922288|P2|STARTED|Overall Study||8
5255790|NCT00769600|12922289|P1|STARTED|Overall Study||15
5255791|NCT00769561|12922305|P2|NOT COMPLETED|Overall Study||5
5255792|NCT00769561|12922306|P1|NOT COMPLETED|Overall Study||3
5255793|NCT00769561|12922305|P2|COMPLETED|Overall Study||24
5255794|NCT00769561|12922306|P1|COMPLETED|Overall Study||26
5255795|NCT00769561|12922305|P2|STARTED|Overall Study||29
5255796|NCT00769561|12922306|P1|STARTED|Overall Study||29
5255797|NCT00769483|12922332|P6|NOT COMPLETED|Overall Study||0
5255798|NCT00769483|12922333|P5|NOT COMPLETED|Overall Study||1
5255799|NCT00769483|12922334|P4|NOT COMPLETED|Overall Study||0
5255800|NCT00769483|12922335|P3|NOT COMPLETED|Overall Study||0
5255801|NCT00769483|12922336|P2|NOT COMPLETED|Overall Study||1
5255802|NCT00769483|12922337|P1|NOT COMPLETED|Overall Study||0
5255803|NCT00769483|12922332|P6|COMPLETED|Overall Study||9
5255804|NCT00769483|12922333|P5|COMPLETED|Overall Study||15
5255805|NCT00769483|12922334|P4|COMPLETED|Overall Study||15
5255806|NCT00769483|12922335|P3|COMPLETED|Overall Study||15
5255807|NCT00769483|12922336|P2|COMPLETED|Overall Study||12
5255808|NCT00769483|12922337|P1|COMPLETED|Overall Study||9
5255809|NCT00769483|12922332|P6|STARTED|Overall Study||9
5255810|NCT00769483|12922333|P5|STARTED|Overall Study||16
5255811|NCT00769483|12922334|P4|STARTED|Overall Study||15
5255812|NCT00769483|12922335|P3|STARTED|Overall Study||15
5255813|NCT00769483|12922336|P2|STARTED|Overall Study||13
5255814|NCT00769483|12922337|P1|STARTED|Overall Study||9
5255815|NCT00769392|12922375|P1|NOT COMPLETED|Overall Study||4
5255816|NCT00769392|12922375|P1|COMPLETED|Overall Study||24
5255817|NCT00769392|12922375|P1|STARTED|Overall Study||28
5255818|NCT00769314|12922382|P2|NOT COMPLETED|Overall Study||13
5255819|NCT00769314|12922383|P1|NOT COMPLETED|Overall Study||17
5255820|NCT00769314|12922382|P2|COMPLETED|Overall Study||384
5255821|NCT00769314|12922383|P1|COMPLETED|Overall Study||361
5255822|NCT00769314|12922382|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
5255823|NCT00769314|12922383|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
5255824|NCT00769184|12922409|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
5255825|NCT00769184|12922410|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
5255826|NCT00769184|12922409|P2|COMPLETED|No Treatment (6 Weeks)||6
5255827|NCT00769184|12922410|P1|COMPLETED|No Treatment (6 Weeks)||5
5255828|NCT00769184|12922409|P2|STARTED|No Treatment (6 Weeks)||7
5255829|NCT00769184|12922410|P1|STARTED|No Treatment (6 Weeks)||6
5255830|NCT00769184|12922409|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
5255831|NCT00769184|12922410|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
5255832|NCT00769184|12922409|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
5255833|NCT00769184|12922410|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
5255834|NCT00769184|12922409|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
5255835|NCT00769184|12922410|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
5255836|NCT00769184|12922409|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
5255837|NCT00769184|12922410|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
5255838|NCT00769184|12922409|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
5255839|NCT00769184|12922410|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
5255840|NCT00769184|12922409|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
5255841|NCT00769184|12922410|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
5255842|NCT00769132|12922418|P4|NOT COMPLETED|Period 4||0
5255843|NCT00769132|12922419|P3|NOT COMPLETED|Period 4||0
5255844|NCT00769132|12922420|P2|NOT COMPLETED|Period 4||1
5255845|NCT00769132|12922421|P1|NOT COMPLETED|Period 4||0
5255846|NCT00769132|12922418|P4|COMPLETED|Period 4||5
5255847|NCT00769132|12922419|P3|COMPLETED|Period 4||6
5255848|NCT00769132|12922420|P2|COMPLETED|Period 4||5
5255849|NCT00769132|12922421|P1|COMPLETED|Period 4||5
5255850|NCT00769132|12922418|P4|STARTED|Period 4||5
5255851|NCT00769132|12922419|P3|STARTED|Period 4||6
5255852|NCT00769132|12922420|P2|STARTED|Period 4||6
5255853|NCT00769132|12922421|P1|STARTED|Period 4||5
5255854|NCT00769132|12922418|P4|NOT COMPLETED|Period 3||0
5255855|NCT00769132|12922419|P3|NOT COMPLETED|Period 3||0
5255856|NCT00769132|12922420|P2|NOT COMPLETED|Period 3||0
5255857|NCT00769132|12922421|P1|NOT COMPLETED|Period 3||1
5255858|NCT00769132|12922418|P4|COMPLETED|Period 3||5
5255859|NCT00769132|12922419|P3|COMPLETED|Period 3||6
5255860|NCT00769132|12922420|P2|COMPLETED|Period 3||6
5255861|NCT00769132|12922421|P1|COMPLETED|Period 3||5
5255862|NCT00769132|12922418|P4|STARTED|Period 3||5
5255863|NCT00769132|12922419|P3|STARTED|Period 3||6
5255864|NCT00769132|12922420|P2|STARTED|Period 3||6
5255865|NCT00769132|12922421|P1|STARTED|Period 3||6
5255866|NCT00769132|12922418|P4|NOT COMPLETED|Period 2||1
5255867|NCT00769132|12922419|P3|NOT COMPLETED|Period 2||0
5255868|NCT00769132|12922420|P2|NOT COMPLETED|Period 2||0
5255869|NCT00769132|12922421|P1|NOT COMPLETED|Period 2||0
5255870|NCT00769132|12922418|P4|COMPLETED|Period 2||5
5255871|NCT00769132|12922419|P3|COMPLETED|Period 2||6
5255872|NCT00769132|12922420|P2|COMPLETED|Period 2||6
5255873|NCT00769132|12922421|P1|COMPLETED|Period 2||6
5255874|NCT00769132|12922418|P4|STARTED|Period 2||6
5255875|NCT00769132|12922419|P3|STARTED|Period 2||6
5255876|NCT00769132|12922420|P2|STARTED|Period 2||6
5255877|NCT00769132|12922421|P1|STARTED|Period 2||6
5255878|NCT00769132|12922418|P4|NOT COMPLETED|Period 1||1
5255879|NCT00769132|12922419|P3|NOT COMPLETED|Period 1||0
5255880|NCT00769132|12922420|P2|NOT COMPLETED|Period 1||0
5255881|NCT00769132|12922421|P1|NOT COMPLETED|Period 1||1
5255882|NCT00769132|12922418|P4|COMPLETED|Period 1||6
5255883|NCT00769132|12922419|P3|COMPLETED|Period 1||6
5255884|NCT00769132|12922420|P2|COMPLETED|Period 1||6
5255885|NCT00769132|12922421|P1|COMPLETED|Period 1||6
5255886|NCT00769132|12922418|P4|STARTED|Period 1||7
5255887|NCT00769132|12922419|P3|STARTED|Period 1||6
5255888|NCT00769132|12922420|P2|STARTED|Period 1||6
5255889|NCT00769132|12922421|P1|STARTED|Period 1||7
5255890|NCT00769119|12922437|P2|NOT COMPLETED|Overall Study||3
5255891|NCT00769119|12922438|P1|NOT COMPLETED|Overall Study||2
5255892|NCT00769119|12922437|P2|COMPLETED|Overall Study||13
5255893|NCT00769119|12922438|P1|COMPLETED|Overall Study||20
5255894|NCT00769119|12922437|P2|STARTED|Overall Study||16
5255895|NCT00769119|12922438|P1|STARTED|Overall Study||22
5255896|NCT00769067|12922484|P2|NOT COMPLETED|Overall Study||94
5255897|NCT00769067|12922485|P1|NOT COMPLETED|Overall Study||94
5255898|NCT00769067|12922484|P2|COMPLETED|Overall Study||0
5255899|NCT00769067|12922485|P1|COMPLETED|Overall Study||0
5255900|NCT00769067|12922484|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
5255901|NCT00769067|12922485|P1|Treated|Overall Study||94
5255902|NCT00769067|12922484|P2|STARTED|Overall Study||94
5255903|NCT00769067|12922485|P1|STARTED|Overall Study||94
5255904|NCT00769015|12922512|P2|NOT COMPLETED|Overall Study||16
5255905|NCT00769015|12922513|P1|NOT COMPLETED|Overall Study||9
5255906|NCT00769015|12922512|P2|COMPLETED|Overall Study||76
5255907|NCT00769015|12922513|P1|COMPLETED|Overall Study||87
5255908|NCT00769015|12922512|P2|STARTED|Overall Study||92
5255909|NCT00769015|12922513|P1|STARTED|Overall Study||96
5255910|NCT00768989|12922533|P2|NOT COMPLETED|On or After Week 36||27
5255911|NCT00768989|12922534|P1|NOT COMPLETED|On or After Week 36||51
5255912|NCT00768989|12922533|P2|COMPLETED|On or After Week 36||0
5255913|NCT00768989|12922534|P1|COMPLETED|On or After Week 36||0
5255914|NCT00768989|12922533|P2|STARTED|On or After Week 36||27
5255915|NCT00768989|12922534|P1|STARTED|On or After Week 36||51
5255916|NCT00768989|12922533|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
5255917|NCT00768989|12922534|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
5255918|NCT00768989|12922533|P2|COMPLETED|Week 24 to Prior to Week 36||27
5255919|NCT00768989|12922534|P1|COMPLETED|Week 24 to Prior to Week 36||51
5255920|NCT00768989|12922533|P2|STARTED|Week 24 to Prior to Week 36||27
5255921|NCT00768989|12922534|P1|STARTED|Week 24 to Prior to Week 36||59
5255922|NCT00768989|12922533|P2|NOT COMPLETED|Prior to Week 24||3
5255923|NCT00768989|12922534|P1|NOT COMPLETED|Prior to Week 24||4
5255924|NCT00768989|12922533|P2|COMPLETED|Prior to Week 24||27
5255925|NCT00768989|12922534|P1|COMPLETED|Prior to Week 24||59
5255926|NCT00768989|12922533|P2|STARTED|Prior to Week 24||30
5255927|NCT00768989|12922534|P1|STARTED|Prior to Week 24||63
5255928|NCT00768898|12922582|P1|NOT COMPLETED|Overall Study||2
5255929|NCT00768898|12922582|P1|COMPLETED|Overall Study||28
5255930|NCT00768898|12922582|P1|STARTED|Overall Study||30
5255931|NCT00768755|12922606|P4|NOT COMPLETED|Phase 2||57
5255932|NCT00768755|12922607|P3|NOT COMPLETED|Phase 2||58
5255933|NCT00768755|12922608|P2|NOT COMPLETED|Phase 2||55
5255934|NCT00768755|12922609|P1|NOT COMPLETED|Phase 2||0
5255935|NCT00768755|12922606|P4|COMPLETED|Phase 2||0
5255936|NCT00768755|12922607|P3|COMPLETED|Phase 2||0
5255937|NCT00768755|12922608|P2|COMPLETED|Phase 2||0
5255938|NCT00768755|12922609|P1|COMPLETED|Phase 2||0
5255939|NCT00768755|12922606|P4|Treated|Phase 2||55
5255940|NCT00768755|12922607|P3|Treated|Phase 2||58
5255941|NCT00768755|12922608|P2|Treated|Phase 2||55
5255942|NCT00768755|12922609|P1|Treated|Phase 2||0
5255943|NCT00768755|12922606|P4|STARTED|Phase 2||57
5255944|NCT00768755|12922607|P3|STARTED|Phase 2||58
5255945|NCT00768755|12922608|P2|STARTED|Phase 2||55
5255946|NCT00768755|12922609|P1|STARTED|Phase 2||0
5255947|NCT00768755|12922606|P4|NOT COMPLETED|Phase 1||0
5255948|NCT00768755|12922607|P3|NOT COMPLETED|Phase 1||0
5255949|NCT00768755|12922608|P2|NOT COMPLETED|Phase 1||0
5255950|NCT00768755|12922609|P1|NOT COMPLETED|Phase 1||10
5255951|NCT00768755|12922606|P4|COMPLETED|Phase 1||0
5255952|NCT00768755|12922607|P3|COMPLETED|Phase 1||0
5255953|NCT00768755|12922608|P2|COMPLETED|Phase 1||0
5255954|NCT00768755|12922609|P1|COMPLETED|Phase 1||0
5255955|NCT00768755|12922606|P4|STARTED|Phase 1||0
5255956|NCT00768755|12922607|P3|STARTED|Phase 1||0
5255957|NCT00768755|12922608|P2|STARTED|Phase 1||0
5255958|NCT00768755|12922609|P1|STARTED|Phase 1||10
5255959|NCT00768716|12922635|P2|NOT COMPLETED|Overall Study||0
5255960|NCT00768716|12922636|P1|NOT COMPLETED|Overall Study||0
5255961|NCT00768716|12922635|P2|COMPLETED|Overall Study||41
5255962|NCT00768716|12922636|P1|COMPLETED|Overall Study||54
5255963|NCT00768716|12922635|P2|STARTED|Overall Study||41
5255964|NCT00768716|12922636|P1|STARTED|Overall Study||54
5255965|NCT00768651|12922657|P1|NOT COMPLETED|Overall Study||1
5255966|NCT00768651|12922657|P1|COMPLETED|Overall Study||7
5255967|NCT00768651|12922657|P1|STARTED|Overall Study||8
5255968|NCT00768599|12922665|P3|NOT COMPLETED|Overall Study||12
5255969|NCT00768599|12922666|P2|NOT COMPLETED|Overall Study||16
5255970|NCT00768599|12922667|P1|NOT COMPLETED|Overall Study||11
5255971|NCT00768599|12922665|P3|COMPLETED|Overall Study||35
5255972|NCT00768599|12922666|P2|COMPLETED|Overall Study||27
5255973|NCT00768599|12922667|P1|COMPLETED|Overall Study||34
5255974|NCT00768599|12922665|P3|STARTED|Overall Study||47
5255975|NCT00768599|12922666|P2|STARTED|Overall Study||43
5255976|NCT00768599|12922667|P1|STARTED|Overall Study||45
5255977|NCT00768560|12922696|P6|NOT COMPLETED|Intervention Set 3||0
5255978|NCT00768560|12922697|P5|NOT COMPLETED|Intervention Set 3||0
5255979|NCT00768560|12922698|P4|NOT COMPLETED|Intervention Set 3||0
5255980|NCT00768560|12922699|P3|NOT COMPLETED|Intervention Set 3||0
5255981|NCT00768560|12922700|P2|NOT COMPLETED|Intervention Set 3||0
5255982|NCT00768560|12922701|P1|NOT COMPLETED|Intervention Set 3||0
5255983|NCT00768560|12922696|P6|COMPLETED|Intervention Set 3||6
5255984|NCT00768560|12922697|P5|COMPLETED|Intervention Set 3||6
5255985|NCT00768560|12922698|P4|COMPLETED|Intervention Set 3||6
5255986|NCT00768560|12922699|P3|COMPLETED|Intervention Set 3||6
5255987|NCT00768560|12922700|P2|COMPLETED|Intervention Set 3||5
5255988|NCT00768560|12922701|P1|COMPLETED|Intervention Set 3||5
5255989|NCT00768560|12922696|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
5255990|NCT00768560|12922697|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
5255991|NCT00768560|12922698|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
5255992|NCT00768560|12922699|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
5255993|NCT00768560|12922700|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
5255994|NCT00768560|12922701|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
5255995|NCT00768560|12922696|P6|NOT COMPLETED|Intervention Set 2||0
5255996|NCT00768560|12922697|P5|NOT COMPLETED|Intervention Set 2||0
5255997|NCT00768560|12922698|P4|NOT COMPLETED|Intervention Set 2||0
5255998|NCT00768560|12922699|P3|NOT COMPLETED|Intervention Set 2||0
5255999|NCT00768560|12922700|P2|NOT COMPLETED|Intervention Set 2||0
5256000|NCT00768560|12922701|P1|NOT COMPLETED|Intervention Set 2||0
5256001|NCT00768560|12922696|P6|COMPLETED|Intervention Set 2||6
5256002|NCT00768560|12922697|P5|COMPLETED|Intervention Set 2||6
5256003|NCT00768560|12922698|P4|COMPLETED|Intervention Set 2||6
5256004|NCT00768560|12922699|P3|COMPLETED|Intervention Set 2||6
5256005|NCT00768560|12922700|P2|COMPLETED|Intervention Set 2||5
5256006|NCT00768560|12922701|P1|COMPLETED|Intervention Set 2||5
5256007|NCT00768560|12922696|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
5256008|NCT00768560|12922697|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
5256009|NCT00768560|12922698|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
5256010|NCT00768560|12922699|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
5256011|NCT00768560|12922700|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
5256012|NCT00768560|12922701|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
5256013|NCT00768560|12922696|P6|NOT COMPLETED|Intervention Set 1||0
5256014|NCT00768560|12922697|P5|NOT COMPLETED|Intervention Set 1||0
5256015|NCT00768560|12922698|P4|NOT COMPLETED|Intervention Set 1||0
5256016|NCT00768560|12922699|P3|NOT COMPLETED|Intervention Set 1||0
5256017|NCT00768560|12922700|P2|NOT COMPLETED|Intervention Set 1||1
5256018|NCT00768560|12922701|P1|NOT COMPLETED|Intervention Set 1||0
5256019|NCT00768560|12922696|P6|COMPLETED|Intervention Set 1||6
5256020|NCT00768560|12922697|P5|COMPLETED|Intervention Set 1||6
5256021|NCT00768560|12922698|P4|COMPLETED|Intervention Set 1||6
5256022|NCT00768560|12922699|P3|COMPLETED|Intervention Set 1||6
5256023|NCT00768560|12922700|P2|COMPLETED|Intervention Set 1||5
5256024|NCT00768560|12922701|P1|COMPLETED|Intervention Set 1||5
5256025|NCT00768560|12922696|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
5256026|NCT00768560|12922697|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
5256027|NCT00768560|12922698|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
5256028|NCT00768560|12922699|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
5256029|NCT00768560|12922700|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
5256030|NCT00768560|12922701|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
5256031|NCT00768560|12922696|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
5256032|NCT00768560|12922697|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
5256033|NCT00768560|12922698|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
5256034|NCT00768560|12922699|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
5256035|NCT00768560|12922700|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
5256036|NCT00768560|12922701|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
5256037|NCT00768521|12922727|P2|NOT COMPLETED|Period 2||0
5256038|NCT00768521|12922728|P1|NOT COMPLETED|Period 2||0
5256039|NCT00768521|12922727|P2|COMPLETED|Period 2||11
5256040|NCT00768521|12922728|P1|COMPLETED|Period 2||9
5256041|NCT00768521|12922727|P2|STARTED|Period 2||11
5256042|NCT00768521|12922728|P1|STARTED|Period 2||9
5256043|NCT00768521|12922727|P2|NOT COMPLETED|Period 1||0
5256044|NCT00768521|12922728|P1|NOT COMPLETED|Period 1||0
5256045|NCT00768521|12922727|P2|COMPLETED|Period 1||11
5256046|NCT00768521|12922728|P1|COMPLETED|Period 1||9
5256047|NCT00768521|12922727|P2|STARTED|Period 1||11
5256048|NCT00768521|12922728|P1|STARTED|Period 1||9
5256049|NCT00768469|12922738|P2|NOT COMPLETED|Overall Study||7
5256050|NCT00768469|12922739|P1|NOT COMPLETED|Overall Study||3
5256051|NCT00768469|12922738|P2|COMPLETED|Overall Study||0
5256052|NCT00768469|12922739|P1|COMPLETED|Overall Study||0
5256053|NCT00768469|12922738|P2|STARTED|Overall Study||7
5256054|NCT00768469|12922739|P1|STARTED|Overall Study||3
5256055|NCT00768430|12922754|P2|NOT COMPLETED|7 Day Endpoint||3
5256056|NCT00768430|12922755|P1|NOT COMPLETED|7 Day Endpoint||2
5256057|NCT00768430|12922754|P2|COMPLETED|7 Day Endpoint||22
5256058|NCT00768430|12922755|P1|COMPLETED|7 Day Endpoint||45
5256059|NCT00768430|12922754|P2|STARTED|7 Day Endpoint||25
5256060|NCT00768430|12922755|P1|STARTED|7 Day Endpoint||47
5256061|NCT00768430|12922754|P2|NOT COMPLETED|24 Hour Endpoint||0
5256062|NCT00768430|12922755|P1|NOT COMPLETED|24 Hour Endpoint||1
5256063|NCT00768430|12922754|P2|COMPLETED|24 Hour Endpoint||25
5256064|NCT00768430|12922755|P1|COMPLETED|24 Hour Endpoint||47
5256065|NCT00768430|12922754|P2|STARTED|24 Hour Endpoint||25
5256066|NCT00768430|12922755|P1|STARTED|24 Hour Endpoint||48
5256067|NCT00768300|12922763|P2|NOT COMPLETED|Overall Study||163
5256068|NCT00768300|12922764|P1|NOT COMPLETED|Overall Study||329
5256069|NCT00768300|12922763|P2|COMPLETED|Overall Study||1
5256070|NCT00768300|12922764|P1|COMPLETED|Overall Study||1
5256071|NCT00768300|12922763|P2|Randomized and Treated|Overall Study||163
5256072|NCT00768300|12922764|P1|Randomized and Treated|Overall Study||329
5256073|NCT00768300|12922763|P2|STARTED|Overall Study||164
5256074|NCT00768300|12922764|P1|STARTED|Overall Study||330
5256075|NCT00768287|12922786|P6|NOT COMPLETED|Surgical Sub-study||0
5256076|NCT00768287|12922787|P5|NOT COMPLETED|Surgical Sub-study||0
5256077|NCT00768287|12922788|P4|NOT COMPLETED|Surgical Sub-study||0
5256078|NCT00768287|12922789|P3|NOT COMPLETED|Surgical Sub-study||0
5256079|NCT00768287|12922790|P2|NOT COMPLETED|Surgical Sub-study||0
5256080|NCT00768287|12922791|P1|NOT COMPLETED|Surgical Sub-study||0
5256081|NCT00768287|12922786|P6|COMPLETED|Surgical Sub-study||17
5256082|NCT00768287|12922787|P5|COMPLETED|Surgical Sub-study||0
5256083|NCT00768287|12922788|P4|COMPLETED|Surgical Sub-study||0
5256084|NCT00768287|12922789|P3|COMPLETED|Surgical Sub-study||0
5256085|NCT00768287|12922790|P2|COMPLETED|Surgical Sub-study||0
5256086|NCT00768287|12922791|P1|COMPLETED|Surgical Sub-study||0
5256087|NCT00768287|12922786|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
5256088|NCT00768287|12922787|P5|STARTED|Surgical Sub-study||0
5256089|NCT00768287|12922788|P4|STARTED|Surgical Sub-study||0
5256090|NCT00768287|12922789|P3|STARTED|Surgical Sub-study||0
5256091|NCT00768287|12922790|P2|STARTED|Surgical Sub-study||0
5256092|NCT00768287|12922791|P1|STARTED|Surgical Sub-study||0
5256093|NCT00768287|12922786|P6|NOT COMPLETED|Treatment Study||0
5256094|NCT00768287|12922787|P5|NOT COMPLETED|Treatment Study||0
5256095|NCT00768287|12922788|P4|NOT COMPLETED|Treatment Study||0
5256096|NCT00768287|12922789|P3|NOT COMPLETED|Treatment Study||0
5256097|NCT00768287|12922790|P2|NOT COMPLETED|Treatment Study||0
5256098|NCT00768287|12922791|P1|NOT COMPLETED|Treatment Study||0
5256099|NCT00768287|12922786|P6|COMPLETED|Treatment Study||0
5256100|NCT00768287|12922787|P5|COMPLETED|Treatment Study||9
5256101|NCT00768287|12922788|P4|COMPLETED|Treatment Study||58
5256102|NCT00768287|12922789|P3|COMPLETED|Treatment Study||0
5256103|NCT00768287|12922790|P2|COMPLETED|Treatment Study||0
5256104|NCT00768287|12922791|P1|COMPLETED|Treatment Study||0
5256105|NCT00768287|12922786|P6|Treated|Treatment Study||0
5256106|NCT00768287|12922787|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
5256107|NCT00768287|12922788|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
5256108|NCT00768287|12922789|P3|Treated|Treatment Study||0
5256109|NCT00768287|12922790|P2|Treated|Treatment Study||0
5256110|NCT00768287|12922791|P1|Treated|Treatment Study||0
5256111|NCT00768287|12922786|P6|STARTED|Treatment Study||0
5256112|NCT00768287|12922787|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
5256113|NCT00768287|12922788|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
5256114|NCT00768287|12922789|P3|STARTED|Treatment Study||0
5256115|NCT00768287|12922790|P2|STARTED|Treatment Study||0
5256116|NCT00768287|12922791|P1|STARTED|Treatment Study||0
5256117|NCT00768287|12922786|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256118|NCT00768287|12922787|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256119|NCT00768287|12922788|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256120|NCT00768287|12922789|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256121|NCT00768287|12922790|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256122|NCT00768287|12922791|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
5256123|NCT00768287|12922786|P6|COMPLETED|Repeat Pharmacokinetic Study||0
5256124|NCT00768287|12922787|P5|COMPLETED|Repeat Pharmacokinetic Study||0
5256125|NCT00768287|12922788|P4|COMPLETED|Repeat Pharmacokinetic Study||0
5256126|NCT00768287|12922789|P3|COMPLETED|Repeat Pharmacokinetic Study||14
5256127|NCT00768287|12922790|P2|COMPLETED|Repeat Pharmacokinetic Study||0
5256128|NCT00768287|12922791|P1|COMPLETED|Repeat Pharmacokinetic Study||0
5256129|NCT00768287|12922786|P6|STARTED|Repeat Pharmacokinetic Study||0
5256130|NCT00768287|12922787|P5|STARTED|Repeat Pharmacokinetic Study||0
5256131|NCT00768287|12922788|P4|STARTED|Repeat Pharmacokinetic Study||0
5256132|NCT00768287|12922789|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
5256133|NCT00768287|12922790|P2|STARTED|Repeat Pharmacokinetic Study||0
5256134|NCT00768287|12922791|P1|STARTED|Repeat Pharmacokinetic Study||0
5256135|NCT00768287|12922786|P6|NOT COMPLETED|Pharmacokinetic Study||0
5256136|NCT00768287|12922787|P5|NOT COMPLETED|Pharmacokinetic Study||0
5256137|NCT00768287|12922788|P4|NOT COMPLETED|Pharmacokinetic Study||0
5256138|NCT00768287|12922789|P3|NOT COMPLETED|Pharmacokinetic Study||0
5256139|NCT00768287|12922790|P2|NOT COMPLETED|Pharmacokinetic Study||0
5256140|NCT00768287|12922791|P1|NOT COMPLETED|Pharmacokinetic Study||0
5256141|NCT00768287|12922786|P6|COMPLETED|Pharmacokinetic Study||0
5256142|NCT00768287|12922787|P5|COMPLETED|Pharmacokinetic Study||0
5256143|NCT00768287|12922788|P4|COMPLETED|Pharmacokinetic Study||0
5256144|NCT00768287|12922789|P3|COMPLETED|Pharmacokinetic Study||0
5256145|NCT00768287|12922790|P2|COMPLETED|Pharmacokinetic Study||16
5256146|NCT00768287|12922791|P1|COMPLETED|Pharmacokinetic Study||16
5256147|NCT00768287|12922786|P6|STARTED|Pharmacokinetic Study||0
5256148|NCT00768287|12922787|P5|STARTED|Pharmacokinetic Study||0
5256149|NCT00768287|12922788|P4|STARTED|Pharmacokinetic Study||0
5256150|NCT00768287|12922789|P3|STARTED|Pharmacokinetic Study||0
5256151|NCT00768287|12922790|P2|STARTED|Pharmacokinetic Study||16
5256152|NCT00768287|12922791|P1|STARTED|Pharmacokinetic Study||16
5256153|NCT00768261|12922830|P4|NOT COMPLETED|Overall Study||0
5256154|NCT00768261|12922831|P3|NOT COMPLETED|Overall Study||25
5256155|NCT00768261|12922832|P2|NOT COMPLETED|Overall Study||0
5256156|NCT00768261|12922833|P1|NOT COMPLETED|Overall Study||0
5256157|NCT00768261|12922830|P4|COMPLETED|Overall Study||56
5256158|NCT00768261|12922831|P3|COMPLETED|Overall Study||14
5256159|NCT00768261|12922832|P2|COMPLETED|Overall Study||18
5256160|NCT00768261|12922833|P1|COMPLETED|Overall Study||14
5256161|NCT00768261|12922830|P4|STARTED|Overall Study||56
5256162|NCT00768261|12922831|P3|STARTED|Overall Study||39
5256163|NCT00768261|12922832|P2|STARTED|Overall Study||18
5256164|NCT00768261|12922833|P1|STARTED|Overall Study||14
5256165|NCT00768248|12922848|P2|NOT COMPLETED|Overall Study||1
5256166|NCT00768248|12922849|P1|NOT COMPLETED|Overall Study||1
5256167|NCT00768248|12922848|P2|COMPLETED|Overall Study||0
5256168|NCT00768248|12922849|P1|COMPLETED|Overall Study||0
5256169|NCT00768248|12922848|P2|STARTED|Overall Study||1
5256170|NCT00768248|12922849|P1|STARTED|Overall Study||1
5256171|NCT00768222|12922865|P2|NOT COMPLETED|Overall Study||4
5256172|NCT00768222|12922866|P1|NOT COMPLETED|Overall Study||4
5256173|NCT00768222|12922865|P2|COMPLETED|Overall Study||47
5256174|NCT00768222|12922866|P1|COMPLETED|Overall Study||46
5256175|NCT00768222|12922865|P2|STARTED|Overall Study||51
5256176|NCT00768222|12922866|P1|STARTED|Overall Study||50
5256177|NCT00768144|12922888|P1|NOT COMPLETED|Overall Study||36
5256178|NCT00768144|12922888|P1|COMPLETED|Overall Study||0
5256179|NCT00768144|12922888|P1|STARTED|Overall Study||36
5256180|NCT00768118|12922894|P1|NOT COMPLETED|Overall Study||0
5256181|NCT00768118|12922894|P1|COMPLETED|Overall Study||11
5256182|NCT00768118|12922894|P1|STARTED|Overall Study||11
5256183|NCT00768066|12922901|P3|NOT COMPLETED|Overall Study||0
5256184|NCT00768066|12922902|P2|NOT COMPLETED|Overall Study||3
5256185|NCT00768066|12922903|P1|NOT COMPLETED|Overall Study||3
5256186|NCT00768066|12922901|P3|COMPLETED|Overall Study||21
5256187|NCT00768066|12922902|P2|COMPLETED|Overall Study||19
5256188|NCT00768066|12922903|P1|COMPLETED|Overall Study||19
5256189|NCT00768066|12922901|P3|STARTED|Overall Study||21
5256190|NCT00768066|12922902|P2|STARTED|Overall Study||22
5256191|NCT00768066|12922903|P1|STARTED|Overall Study||22
5256192|NCT00768053|12922935|P1|NOT COMPLETED|Overall Study||11
5256193|NCT00768053|12922935|P1|COMPLETED|Overall Study||97
5256194|NCT00768053|12922935|P1|STARTED|Overall Study||108
5256195|NCT00768040|12922966|P2|NOT COMPLETED|Overall Study||3
5256196|NCT00768040|12922967|P1|NOT COMPLETED|Overall Study||4
5256197|NCT00768040|12922966|P2|COMPLETED|Overall Study||16
5256198|NCT00768040|12922967|P1|COMPLETED|Overall Study||16
5256199|NCT00768040|12922966|P2|STARTED|Overall Study||19
5256200|NCT00768040|12922967|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
5256201|NCT00767819|12922976|P3|NOT COMPLETED|Overall Study||0
5256202|NCT00767819|12922977|P2|NOT COMPLETED|Overall Study||19
5256203|NCT00767819|12922978|P1|NOT COMPLETED|Overall Study||25
5256204|NCT00767819|12922976|P3|COMPLETED|Overall Study||10
5256205|NCT00767819|12922977|P2|COMPLETED|Overall Study||5
5256206|NCT00767819|12922978|P1|COMPLETED|Overall Study||12
5256207|NCT00767819|12922976|P3|Safety Analysis Set (SAF)|Overall Study||10
5256208|NCT00767819|12922977|P2|Safety Analysis Set (SAF)|Overall Study||24
5256209|NCT00767819|12922978|P1|Safety Analysis Set (SAF)|Overall Study||37
5256210|NCT00767819|12922976|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
5256211|NCT00767819|12922977|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
5256212|NCT00767819|12922978|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
5256213|NCT00767819|12922976|P3|STARTED|Overall Study||10
5256214|NCT00767819|12922977|P2|STARTED|Overall Study||24
5256215|NCT00767819|12922978|P1|STARTED|Overall Study||37
5256216|NCT00767806|12923003|P2|NOT COMPLETED|Overall Study||47
5256217|NCT00767806|12923004|P1|NOT COMPLETED|Overall Study||51
5256218|NCT00767806|12923003|P2|COMPLETED|Overall Study||156
5256219|NCT00767806|12923004|P1|COMPLETED|Overall Study||147
5256220|NCT00767806|12923003|P2|STARTED|Overall Study||203
5256221|NCT00767806|12923004|P1|STARTED|Overall Study||198
5256222|NCT00767767|12923065|P5|NOT COMPLETED|Overall Study||0
5256223|NCT00767767|12923066|P4|NOT COMPLETED|Overall Study||0
5256224|NCT00767767|12923067|P3|NOT COMPLETED|Overall Study||0
5256225|NCT00767767|12923068|P2|NOT COMPLETED|Overall Study||0
5256226|NCT00767767|12923069|P1|NOT COMPLETED|Overall Study||0
5256227|NCT00767767|12923065|P5|COMPLETED|Overall Study||3
5256228|NCT00767767|12923066|P4|COMPLETED|Overall Study||3
5256229|NCT00767767|12923067|P3|COMPLETED|Overall Study||20
5256230|NCT00767767|12923068|P2|COMPLETED|Overall Study||20
5256231|NCT00767767|12923069|P1|COMPLETED|Overall Study||21
5256232|NCT00767767|12923065|P5|STARTED|Overall Study||3
5256233|NCT00767767|12923066|P4|STARTED|Overall Study||3
5256234|NCT00767767|12923067|P3|STARTED|Overall Study||20
5256235|NCT00767767|12923068|P2|STARTED|Overall Study||20
5256236|NCT00767767|12923069|P1|STARTED|Overall Study||21
5256237|NCT00767676|12923081|P1|NOT COMPLETED|Overall Study||54
5256238|NCT00767676|12923081|P1|COMPLETED|Overall Study||205
5256239|NCT00767676|12923081|P1|STARTED|Overall Study||259
5256240|NCT00767624|12923087|P2|NOT COMPLETED|Overall Study||17
5256241|NCT00767624|12923088|P1|NOT COMPLETED|Overall Study||24
5256242|NCT00767624|12923087|P2|COMPLETED|Overall Study||58
5256243|NCT00767624|12923088|P1|COMPLETED|Overall Study||51
5256244|NCT00767624|12923087|P2|STARTED|Overall Study||75
5256245|NCT00767624|12923088|P1|STARTED|Overall Study||75
5256246|NCT00767572|12923096|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
5256247|NCT00767572|12923096|P1|COMPLETED|Second Intervention (12 Weeks)||12
5256248|NCT00767572|12923096|P1|STARTED|Second Intervention (12 Weeks)||12
5256249|NCT00767572|12923096|P1|NOT COMPLETED|Washout (4 Weeks)||0
5256250|NCT00767572|12923096|P1|COMPLETED|Washout (4 Weeks)||12
5256251|NCT00767572|12923096|P1|STARTED|Washout (4 Weeks)||12
5256252|NCT00767572|12923096|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
5256253|NCT00767572|12923096|P1|COMPLETED|First Intervention (12 Weeks)||12
5256254|NCT00767572|12923096|P1|STARTED|First Intervention (12 Weeks)||12
5256255|NCT00767520|12923104|P2|NOT COMPLETED|Overall Study||17
5256256|NCT00767520|12923105|P1|NOT COMPLETED|Overall Study||11
5256257|NCT00767520|12923104|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
5256258|NCT00767520|12923105|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
5256259|NCT00767520|12923104|P2|STARTED|Overall Study||78
5256260|NCT00767520|12923105|P1|STARTED|Overall Study||79
5256261|NCT00767507|12923131|P4|NOT COMPLETED|Overall Study||3
5256262|NCT00767507|12923132|P3|NOT COMPLETED|Overall Study||0
5256263|NCT00767507|12923133|P2|NOT COMPLETED|Overall Study||0
5256264|NCT00767507|12923134|P1|NOT COMPLETED|Overall Study||0
5256265|NCT00767507|12923131|P4|COMPLETED|Overall Study||101
5256266|NCT00767507|12923132|P3|COMPLETED|Overall Study||106
5256267|NCT00767507|12923133|P2|COMPLETED|Overall Study||6
5256268|NCT00767507|12923134|P1|COMPLETED|Overall Study||5
5256269|NCT00767507|12923131|P4|STARTED|Overall Study||104
5256270|NCT00767507|12923132|P3|STARTED|Overall Study||106
5256271|NCT00767507|12923133|P2|STARTED|Overall Study||6
5256272|NCT00767507|12923134|P1|STARTED|Overall Study||5
5256273|NCT00767455|12923158|P1|NOT COMPLETED|Overall Study||19
5256274|NCT00767455|12923158|P1|COMPLETED|Overall Study||40
5256275|NCT00767455|12923158|P1|STARTED|Overall Study||59
5256276|NCT00767364|12923166|P2|NOT COMPLETED|Overall Study||0
5256277|NCT00767364|12923167|P1|NOT COMPLETED|Overall Study||0
5256278|NCT00767364|12923166|P2|COMPLETED|Overall Study||3
5256279|NCT00767364|12923167|P1|COMPLETED|Overall Study||5
5256280|NCT00767364|12923166|P2|STARTED|Overall Study||3
5256281|NCT00767364|12923167|P1|STARTED|Overall Study||5
5256282|NCT00767338|12923179|P4|NOT COMPLETED|Overall Study||0
5256283|NCT00767338|12923180|P3|NOT COMPLETED|Overall Study||0
5256284|NCT00767338|12923181|P2|NOT COMPLETED|Overall Study||2
5256285|NCT00767338|12923182|P1|NOT COMPLETED|Overall Study||1
5256286|NCT00767338|12923179|P4|COMPLETED|Overall Study||0
5256287|NCT00767338|12923180|P3|COMPLETED|Overall Study||0
5256288|NCT00767338|12923181|P2|COMPLETED|Overall Study||0
5256289|NCT00767338|12923182|P1|COMPLETED|Overall Study||0
5256290|NCT00767338|12923179|P4|STARTED|Overall Study||0
5256291|NCT00767338|12923180|P3|STARTED|Overall Study||0
5256292|NCT00767338|12923181|P2|STARTED|Overall Study||2
5256293|NCT00767338|12923182|P1|STARTED|Overall Study||1
5256294|NCT00767325|12923192|P1|NOT COMPLETED|Overall Study||15
5256295|NCT00767325|12923192|P1|COMPLETED|Overall Study||89
5256296|NCT00767325|12923192|P1|STARTED|Overall Study||104
5256297|NCT00767104|12923203|P2|NOT COMPLETED|Overall Study||2
5256298|NCT00767104|12923204|P1|NOT COMPLETED|Overall Study||1
5256299|NCT00767104|12923203|P2|COMPLETED|Overall Study||18
5256300|NCT00767104|12923204|P1|COMPLETED|Overall Study||19
5256301|NCT00767104|12923203|P2|STARTED|Overall Study||20
5256302|NCT00767104|12923204|P1|STARTED|Overall Study||20
5256303|NCT00767039|12923214|P2|NOT COMPLETED|Overall Study||2
5256304|NCT00767039|12923215|P1|NOT COMPLETED|Overall Study||5
5256305|NCT00767039|12923214|P2|COMPLETED|Overall Study||23
5256306|NCT00767039|12923215|P1|COMPLETED|Overall Study||22
5256307|NCT00767039|12923214|P2|STARTED|Overall Study||25
5256308|NCT00767039|12923215|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
5256309|NCT00767000|12923246|P5|NOT COMPLETED|Optional 104-week Extension||4
5256310|NCT00767000|12923247|P4|NOT COMPLETED|Optional 104-week Extension||2
5256311|NCT00767000|12923248|P3|NOT COMPLETED|Optional 104-week Extension||7
5256312|NCT00767000|12923249|P2|NOT COMPLETED|Optional 104-week Extension||3
5256313|NCT00767000|12923250|P1|NOT COMPLETED|Optional 104-week Extension||7
5256314|NCT00767000|12923246|P5|COMPLETED|Optional 104-week Extension||0
5256315|NCT00767000|12923247|P4|COMPLETED|Optional 104-week Extension||0
5256316|NCT00767000|12923248|P3|COMPLETED|Optional 104-week Extension||0
5256317|NCT00767000|12923249|P2|COMPLETED|Optional 104-week Extension||0
5256318|NCT00767000|12923250|P1|COMPLETED|Optional 104-week Extension||0
5256319|NCT00767000|12923246|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
5256320|NCT00767000|12923247|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
5256321|NCT00767000|12923248|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
5256322|NCT00767000|12923249|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
5256323|NCT00767000|12923250|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
5256324|NCT00767000|12923246|P5|NOT COMPLETED|54-week Study||224
5256325|NCT00767000|12923247|P4|NOT COMPLETED|54-week Study||225
5256326|NCT00767000|12923248|P3|NOT COMPLETED|54-week Study||109
5256327|NCT00767000|12923249|P2|NOT COMPLETED|54-week Study||113
5256328|NCT00767000|12923250|P1|NOT COMPLETED|54-week Study||108
5256329|NCT00767000|12923246|P5|COMPLETED|54-week Study||7
5256330|NCT00767000|12923247|P4|COMPLETED|54-week Study||4
5256331|NCT00767000|12923248|P3|COMPLETED|54-week Study||8
5256332|NCT00767000|12923249|P2|COMPLETED|54-week Study||4
5256333|NCT00767000|12923250|P1|COMPLETED|54-week Study||11
5256334|NCT00767000|12923246|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
5256335|NCT00767000|12923247|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
5256336|NCT00767000|12923248|P3|STARTED|54-week Study||117
5256337|NCT00767000|12923249|P2|STARTED|54-week Study||117
5256338|NCT00767000|12923250|P1|STARTED|54-week Study||119
5256339|NCT00766831|12923292|P1|NOT COMPLETED|Overall Study||115
5256340|NCT00766831|12923292|P1|COMPLETED|Overall Study||75
5256341|NCT00766831|12923292|P1|STARTED|Overall Study||190
5256342|NCT00766753|12923310|P2|NOT COMPLETED|Overall Study||0
5256343|NCT00766753|12923311|P1|NOT COMPLETED|Overall Study||0
5256344|NCT00766753|12923310|P2|COMPLETED|Overall Study||11
5256345|NCT00766753|12923311|P1|COMPLETED|Overall Study||11
5256346|NCT00766753|12923310|P2|Completed at Least Four Vaccines|Overall Study||9
5256347|NCT00766753|12923311|P1|Completed at Least Four Vaccines|Overall Study||10
5256348|NCT00766753|12923310|P2|Received at Least One Vaccine|Overall Study||11
5256349|NCT00766753|12923311|P1|Received at Least One Vaccine|Overall Study||11
5256350|NCT00766753|12923310|P2|STARTED|Overall Study||11
5256351|NCT00766753|12923311|P1|STARTED|Overall Study||11
5256352|NCT00766675|12923322|P1|NOT COMPLETED|Overall Study||40
5256353|NCT00766675|12923322|P1|COMPLETED|Overall Study||40
5256354|NCT00766675|12923322|P1|STARTED|Overall Study||80
5256355|NCT00766649|12923335|P1|NOT COMPLETED|Overall Study||10
5256356|NCT00766649|12923335|P1|COMPLETED|Overall Study||1
5256357|NCT00766649|12923335|P1|STARTED|Overall Study||11
5256358|NCT00766636|12923351|P2|NOT COMPLETED|Overall Study||2
5256359|NCT00766636|12923352|P1|NOT COMPLETED|Overall Study||3
5256360|NCT00766636|12923351|P2|COMPLETED|Overall Study||0
5256361|NCT00766636|12923352|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
5256362|NCT00766636|12923351|P2|STARTED|Overall Study||2
5256363|NCT00766636|12923352|P1|STARTED|Overall Study||3
5256364|NCT00766597|12923358|P1|NOT COMPLETED|Overall Study||9
5256365|NCT00766597|12923358|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
5256366|NCT00766597|12923358|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
5256367|NCT00766597|12923358|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
5256368|NCT00766597|12923358|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
5256369|NCT00766597|12923358|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
5256370|NCT00766597|12923358|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
5256371|NCT00766532|12923370|P1|NOT COMPLETED|Overall Study||2
5256372|NCT00766532|12923370|P1|COMPLETED|Overall Study||10
5256373|NCT00766532|12923370|P1|STARTED|Overall Study||12
5256374|NCT00766506|12923376|P2|NOT COMPLETED|Overall Study||2
5256375|NCT00766506|12923377|P1|NOT COMPLETED|Overall Study||5
5256376|NCT00766506|12923376|P2|COMPLETED|Overall Study||48
5256377|NCT00766506|12923377|P1|COMPLETED|Overall Study||53
5256378|NCT00766506|12923376|P2|STARTED|Overall Study||50
5256379|NCT00766506|12923377|P1|STARTED|Overall Study||58
5256380|NCT00766493|12923401|P1|NOT COMPLETED|30 Days Post-Procedure||12
5256381|NCT00766493|12923401|P1|COMPLETED|30 Days Post-Procedure||238
5256382|NCT00766493|12923401|P1|STARTED|30 Days Post-Procedure||250
5256383|NCT00766493|12923401|P1|NOT COMPLETED|Pre-Discharge||0
5256384|NCT00766493|12923401|P1|COMPLETED|Pre-Discharge||250
5256385|NCT00766493|12923401|P1|STARTED|Pre-Discharge||250
5256386|NCT00766467|12923411|P2|NOT COMPLETED|Overall Study||8
5256387|NCT00766467|12923412|P1|NOT COMPLETED|Overall Study||11
5256388|NCT00766467|12923411|P2|COMPLETED|Overall Study||31
5256389|NCT00766467|12923412|P1|COMPLETED|Overall Study||31
5256390|NCT00766467|12923411|P2|Initiated Treatment|Overall Study||38
5256391|NCT00766467|12923412|P1|Initiated Treatment|Overall Study||39
5256392|NCT00766467|12923411|P2|STARTED|Overall Study||39
5256393|NCT00766467|12923412|P1|STARTED|Overall Study||42
5256394|NCT00766415|12923424|P2|NOT COMPLETED|Overall Study||1
5256395|NCT00766415|12923425|P1|NOT COMPLETED|Overall Study||0
5256396|NCT00766415|12923424|P2|COMPLETED|Overall Study||26
5256397|NCT00766415|12923425|P1|COMPLETED|Overall Study||25
5256398|NCT00766415|12923424|P2|STARTED|Overall Study||27
5256399|NCT00766415|12923425|P1|STARTED|Overall Study||25
5256400|NCT00766376|12923473|P1|NOT COMPLETED|Overall Study||27
5256401|NCT00766376|12923473|P1|COMPLETED|Overall Study||124
5256402|NCT00766376|12923473|P1|STARTED|Overall Study||151
5256403|NCT00766363|12923482|P4|NOT COMPLETED|Overall Study||0
5256404|NCT00766363|12923483|P3|NOT COMPLETED|Overall Study||0
5256405|NCT00766363|12923484|P2|NOT COMPLETED|Overall Study||1
5256406|NCT00766363|12923485|P1|NOT COMPLETED|Overall Study||1
5256407|NCT00766363|12923482|P4|COMPLETED|Overall Study||12
5256408|NCT00766363|12923483|P3|COMPLETED|Overall Study||12
5256409|NCT00766363|12923484|P2|COMPLETED|Overall Study||12
5256410|NCT00766363|12923485|P1|COMPLETED|Overall Study||11
5256411|NCT00766363|12923482|P4|PK POPULATION|Overall Study||13
5256412|NCT00766363|12923483|P3|PK POPULATION|Overall Study||10
5256413|NCT00766363|12923484|P2|PK POPULATION|Overall Study||13
5256414|NCT00766363|12923485|P1|PK POPULATION|Overall Study||12
5256415|NCT00766363|12923482|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
5256416|NCT00766363|12923483|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
5256417|NCT00766363|12923484|P2|SAFETY POPULATION|Overall Study||13
5256418|NCT00766363|12923485|P1|SAFETY POPULATION|Overall Study||12
5256419|NCT00766363|12923482|P4|STARTED|Overall Study|Number randomized.|12
5256420|NCT00766363|12923483|P3|STARTED|Overall Study|Number randomized.|12
5256421|NCT00766363|12923484|P2|STARTED|Overall Study||13
5256422|NCT00766363|12923485|P1|STARTED|Overall Study||12
5256423|NCT00766116|12923522|P1|NOT COMPLETED|Overall Study||0
5256424|NCT00766116|12923522|P1|COMPLETED|Overall Study||50
5256425|NCT00766116|12923522|P1|STARTED|Overall Study||50
5256426|NCT00766090|12923531|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5256427|NCT00766090|12923532|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256428|NCT00766090|12923533|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256429|NCT00766090|12923534|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256430|NCT00766090|12923535|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256431|NCT00766090|12923536|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256432|NCT00766090|12923537|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5256433|NCT00766090|12923538|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5256434|NCT00766090|12923539|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5256435|NCT00766090|12923540|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256436|NCT00766090|12923541|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
5256437|NCT00766090|12923542|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
5256438|NCT00766090|12923531|P12|COMPLETED|Treatment Period 3 (28 Days)||6
5256439|NCT00766090|12923532|P11|COMPLETED|Treatment Period 3 (28 Days)||7
5256440|NCT00766090|12923533|P10|COMPLETED|Treatment Period 3 (28 Days)||8
5256441|NCT00766090|12923534|P9|COMPLETED|Treatment Period 3 (28 Days)||6
5256442|NCT00766090|12923535|P8|COMPLETED|Treatment Period 3 (28 Days)||8
5256443|NCT00766090|12923536|P7|COMPLETED|Treatment Period 3 (28 Days)||6
5256444|NCT00766090|12923537|P6|COMPLETED|Treatment Period 3 (28 Days)||22
5256445|NCT00766090|12923538|P5|COMPLETED|Treatment Period 3 (28 Days)||20
5256446|NCT00766090|12923539|P4|COMPLETED|Treatment Period 3 (28 Days)||24
5256447|NCT00766090|12923540|P3|COMPLETED|Treatment Period 3 (28 Days)||20
5256448|NCT00766090|12923541|P2|COMPLETED|Treatment Period 3 (28 Days)||26
5256449|NCT00766090|12923542|P1|COMPLETED|Treatment Period 3 (28 Days)||22
5256450|NCT00766090|12923531|P12|STARTED|Treatment Period 3 (28 Days)||7
5256451|NCT00766090|12923532|P11|STARTED|Treatment Period 3 (28 Days)||7
5256452|NCT00766090|12923533|P10|STARTED|Treatment Period 3 (28 Days)||8
5256453|NCT00766090|12923534|P9|STARTED|Treatment Period 3 (28 Days)||6
5256454|NCT00766090|12923535|P8|STARTED|Treatment Period 3 (28 Days)||8
5256455|NCT00766090|12923536|P7|STARTED|Treatment Period 3 (28 Days)||6
5256456|NCT00766090|12923537|P6|STARTED|Treatment Period 3 (28 Days)||23
5256457|NCT00766090|12923538|P5|STARTED|Treatment Period 3 (28 Days)||21
5256458|NCT00766090|12923539|P4|STARTED|Treatment Period 3 (28 Days)||25
5256459|NCT00766090|12923540|P3|STARTED|Treatment Period 3 (28 Days)||20
5256460|NCT00766090|12923541|P2|STARTED|Treatment Period 3 (28 Days)||27
5256461|NCT00766090|12923542|P1|STARTED|Treatment Period 3 (28 Days)||22
5256462|NCT00766090|12923531|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256463|NCT00766090|12923532|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256464|NCT00766090|12923533|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256465|NCT00766090|12923534|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256466|NCT00766090|12923535|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256467|NCT00766090|12923536|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256468|NCT00766090|12923537|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256469|NCT00766090|12923538|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256470|NCT00766090|12923539|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256471|NCT00766090|12923540|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
5256472|NCT00766090|12923541|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256473|NCT00766090|12923542|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
5256474|NCT00766090|12923531|P12|COMPLETED|Washout Period 2 (14 Days)||7
5256475|NCT00766090|12923532|P11|COMPLETED|Washout Period 2 (14 Days)||7
5256476|NCT00766090|12923533|P10|COMPLETED|Washout Period 2 (14 Days)||8
5256477|NCT00766090|12923534|P9|COMPLETED|Washout Period 2 (14 Days)||6
5256478|NCT00766090|12923535|P8|COMPLETED|Washout Period 2 (14 Days)||8
5256479|NCT00766090|12923536|P7|COMPLETED|Washout Period 2 (14 Days)||6
5256480|NCT00766090|12923537|P6|COMPLETED|Washout Period 2 (14 Days)||23
5256481|NCT00766090|12923538|P5|COMPLETED|Washout Period 2 (14 Days)||21
5256482|NCT00766090|12923539|P4|COMPLETED|Washout Period 2 (14 Days)||25
5256483|NCT00766090|12923540|P3|COMPLETED|Washout Period 2 (14 Days)||20
5256484|NCT00766090|12923541|P2|COMPLETED|Washout Period 2 (14 Days)||27
5256485|NCT00766090|12923542|P1|COMPLETED|Washout Period 2 (14 Days)||22
5256486|NCT00766090|12923531|P12|STARTED|Washout Period 2 (14 Days)||7
5256487|NCT00766090|12923532|P11|STARTED|Washout Period 2 (14 Days)||7
5256488|NCT00766090|12923533|P10|STARTED|Washout Period 2 (14 Days)||8
5256489|NCT00766090|12923534|P9|STARTED|Washout Period 2 (14 Days)||6
5256490|NCT00766090|12923535|P8|STARTED|Washout Period 2 (14 Days)||8
5256491|NCT00766090|12923536|P7|STARTED|Washout Period 2 (14 Days)||6
5256492|NCT00766090|12923537|P6|STARTED|Washout Period 2 (14 Days)||23
5256493|NCT00766090|12923538|P5|STARTED|Washout Period 2 (14 Days)||21
5256494|NCT00766090|12923539|P4|STARTED|Washout Period 2 (14 Days)||25
5256495|NCT00766090|12923540|P3|STARTED|Washout Period 2 (14 Days)||21
5256496|NCT00766090|12923541|P2|STARTED|Washout Period 2 (14 Days)||27
5256497|NCT00766090|12923542|P1|STARTED|Washout Period 2 (14 Days)||22
5256498|NCT00766090|12923531|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256499|NCT00766090|12923532|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256500|NCT00766090|12923533|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256501|NCT00766090|12923534|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256502|NCT00766090|12923535|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256503|NCT00766090|12923536|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256504|NCT00766090|12923537|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256505|NCT00766090|12923538|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
5256506|NCT00766090|12923539|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256507|NCT00766090|12923540|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
5256508|NCT00766090|12923541|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256509|NCT00766090|12923542|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
5256510|NCT00766090|12923531|P12|COMPLETED|Treatment Period 2 (28 Days)||7
5256511|NCT00766090|12923532|P11|COMPLETED|Treatment Period 2 (28 Days)||7
5256512|NCT00766090|12923533|P10|COMPLETED|Treatment Period 2 (28 Days)||8
5256513|NCT00766090|12923534|P9|COMPLETED|Treatment Period 2 (28 Days)||6
5256514|NCT00766090|12923535|P8|COMPLETED|Treatment Period 2 (28 Days)||8
5256515|NCT00766090|12923536|P7|COMPLETED|Treatment Period 2 (28 Days)||6
5256516|NCT00766090|12923537|P6|COMPLETED|Treatment Period 2 (28 Days)||23
5256517|NCT00766090|12923538|P5|COMPLETED|Treatment Period 2 (28 Days)||21
5256518|NCT00766090|12923539|P4|COMPLETED|Treatment Period 2 (28 Days)||25
5256519|NCT00766090|12923540|P3|COMPLETED|Treatment Period 2 (28 Days)||21
5256520|NCT00766090|12923541|P2|COMPLETED|Treatment Period 2 (28 Days)||27
5256521|NCT00766090|12923542|P1|COMPLETED|Treatment Period 2 (28 Days)||22
5256522|NCT00766090|12923531|P12|STARTED|Treatment Period 2 (28 Days)||7
5256523|NCT00766090|12923532|P11|STARTED|Treatment Period 2 (28 Days)||7
5256524|NCT00766090|12923533|P10|STARTED|Treatment Period 2 (28 Days)||8
5256525|NCT00766090|12923534|P9|STARTED|Treatment Period 2 (28 Days)||6
5256526|NCT00766090|12923535|P8|STARTED|Treatment Period 2 (28 Days)||8
5256527|NCT00766090|12923536|P7|STARTED|Treatment Period 2 (28 Days)||6
5256528|NCT00766090|12923537|P6|STARTED|Treatment Period 2 (28 Days)||23
5256529|NCT00766090|12923538|P5|STARTED|Treatment Period 2 (28 Days)||23
5256530|NCT00766090|12923539|P4|STARTED|Treatment Period 2 (28 Days)||25
5256531|NCT00766090|12923540|P3|STARTED|Treatment Period 2 (28 Days)||22
5256532|NCT00766090|12923541|P2|STARTED|Treatment Period 2 (28 Days)||27
5256533|NCT00766090|12923542|P1|STARTED|Treatment Period 2 (28 Days)||22
5256534|NCT00766090|12923531|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256535|NCT00766090|12923532|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256536|NCT00766090|12923533|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256537|NCT00766090|12923534|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256538|NCT00766090|12923535|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256539|NCT00766090|12923536|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256540|NCT00766090|12923537|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256541|NCT00766090|12923538|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256542|NCT00766090|12923539|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256543|NCT00766090|12923540|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
5256544|NCT00766090|12923541|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256545|NCT00766090|12923542|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
5256546|NCT00766090|12923531|P12|COMPLETED|Washout Period 1 (14 Days)||7
5256547|NCT00766090|12923532|P11|COMPLETED|Washout Period 1 (14 Days)||7
5256548|NCT00766090|12923533|P10|COMPLETED|Washout Period 1 (14 Days)||8
5256549|NCT00766090|12923534|P9|COMPLETED|Washout Period 1 (14 Days)||6
5256550|NCT00766090|12923535|P8|COMPLETED|Washout Period 1 (14 Days)||8
5256551|NCT00766090|12923536|P7|COMPLETED|Washout Period 1 (14 Days)||6
5256552|NCT00766090|12923537|P6|COMPLETED|Washout Period 1 (14 Days)||23
5256553|NCT00766090|12923538|P5|COMPLETED|Washout Period 1 (14 Days)||23
5256554|NCT00766090|12923539|P4|COMPLETED|Washout Period 1 (14 Days)||25
5256555|NCT00766090|12923540|P3|COMPLETED|Washout Period 1 (14 Days)||22
5256556|NCT00766090|12923541|P2|COMPLETED|Washout Period 1 (14 Days)||27
5256557|NCT00766090|12923542|P1|COMPLETED|Washout Period 1 (14 Days)||22
5256558|NCT00766090|12923531|P12|STARTED|Washout Period 1 (14 Days)||7
5256559|NCT00766090|12923532|P11|STARTED|Washout Period 1 (14 Days)||7
5256560|NCT00766090|12923533|P10|STARTED|Washout Period 1 (14 Days)||8
5256561|NCT00766090|12923534|P9|STARTED|Washout Period 1 (14 Days)||6
5256562|NCT00766090|12923535|P8|STARTED|Washout Period 1 (14 Days)||8
5256563|NCT00766090|12923536|P7|STARTED|Washout Period 1 (14 Days)||6
5256564|NCT00766090|12923537|P6|STARTED|Washout Period 1 (14 Days)||23
5256565|NCT00766090|12923538|P5|STARTED|Washout Period 1 (14 Days)||23
5256566|NCT00766090|12923539|P4|STARTED|Washout Period 1 (14 Days)||25
5256567|NCT00766090|12923540|P3|STARTED|Washout Period 1 (14 Days)||23
5256568|NCT00766090|12923541|P2|STARTED|Washout Period 1 (14 Days)||27
5256569|NCT00766090|12923542|P1|STARTED|Washout Period 1 (14 Days)||22
5256570|NCT00766090|12923531|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256571|NCT00766090|12923532|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256572|NCT00766090|12923533|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256573|NCT00766090|12923534|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5256574|NCT00766090|12923535|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256575|NCT00766090|12923536|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256576|NCT00766090|12923537|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256577|NCT00766090|12923538|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256578|NCT00766090|12923539|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
5256579|NCT00766090|12923540|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256580|NCT00766090|12923541|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
5256581|NCT00766090|12923542|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
5256582|NCT00766090|12923531|P12|COMPLETED|Treatment Period 1 (28 Days)||7
5256583|NCT00766090|12923532|P11|COMPLETED|Treatment Period 1 (28 Days)||7
5256584|NCT00766090|12923533|P10|COMPLETED|Treatment Period 1 (28 Days)||8
5256585|NCT00766090|12923534|P9|COMPLETED|Treatment Period 1 (28 Days)||6
5256586|NCT00766090|12923535|P8|COMPLETED|Treatment Period 1 (28 Days)||8
5256587|NCT00766090|12923536|P7|COMPLETED|Treatment Period 1 (28 Days)||6
5256588|NCT00766090|12923537|P6|COMPLETED|Treatment Period 1 (28 Days)||23
5256589|NCT00766090|12923538|P5|COMPLETED|Treatment Period 1 (28 Days)||23
5256590|NCT00766090|12923539|P4|COMPLETED|Treatment Period 1 (28 Days)||25
5256591|NCT00766090|12923540|P3|COMPLETED|Treatment Period 1 (28 Days)||23
5256592|NCT00766090|12923541|P2|COMPLETED|Treatment Period 1 (28 Days)||27
5256593|NCT00766090|12923542|P1|COMPLETED|Treatment Period 1 (28 Days)||22
5256594|NCT00766090|12923531|P12|STARTED|Treatment Period 1 (28 Days)||7
5256595|NCT00766090|12923532|P11|STARTED|Treatment Period 1 (28 Days)||7
5256596|NCT00766090|12923533|P10|STARTED|Treatment Period 1 (28 Days)||8
5256597|NCT00766090|12923534|P9|STARTED|Treatment Period 1 (28 Days)||7
5256598|NCT00766090|12923535|P8|STARTED|Treatment Period 1 (28 Days)||8
5256599|NCT00766090|12923536|P7|STARTED|Treatment Period 1 (28 Days)||6
5256600|NCT00766090|12923537|P6|STARTED|Treatment Period 1 (28 Days)||23
5256601|NCT00766090|12923538|P5|STARTED|Treatment Period 1 (28 Days)||23
5256602|NCT00766090|12923539|P4|STARTED|Treatment Period 1 (28 Days)||26
5256603|NCT00766090|12923540|P3|STARTED|Treatment Period 1 (28 Days)||23
5256604|NCT00766090|12923541|P2|STARTED|Treatment Period 1 (28 Days)||27
5256605|NCT00766090|12923542|P1|STARTED|Treatment Period 1 (28 Days)||25
5256606|NCT00766051|12923583|P2|NOT COMPLETED|Overall Study||0
5256607|NCT00766051|12923584|P1|NOT COMPLETED|Overall Study||2
5256608|NCT00766051|12923583|P2|COMPLETED|Overall Study||10
5256609|NCT00766051|12923584|P1|COMPLETED|Overall Study||10
5256610|NCT00766051|12923583|P2|STARTED|Overall Study||10
5256611|NCT00766051|12923584|P1|STARTED|Overall Study||12
5256612|NCT00766038|12923596|P2|NOT COMPLETED|Overall Study||14
5256613|NCT00766038|12923597|P1|NOT COMPLETED|Overall Study||15
5256614|NCT00766038|12923596|P2|COMPLETED|Overall Study||18
5256615|NCT00766038|12923597|P1|COMPLETED|Overall Study||16
5256616|NCT00766038|12923596|P2|STARTED|Overall Study||32
5256617|NCT00766038|12923597|P1|STARTED|Overall Study||31
5256618|NCT00765999|12923613|P1|NOT COMPLETED|Overall Study||784
5256619|NCT00765999|12923613|P1|COMPLETED|Overall Study||770
5256620|NCT00765999|12923613|P1|STARTED|Overall Study||1554
5256621|NCT00765947|12923619|P1|NOT COMPLETED|Overall Study||24
5256622|NCT00765947|12923619|P1|COMPLETED|Overall Study||232
5256623|NCT00765947|12923619|P1|STARTED|Overall Study||256
5256624|NCT00765895|12923630|P2|NOT COMPLETED|Overall Study||0
5256625|NCT00765895|12923631|P1|NOT COMPLETED|Overall Study||0
5256626|NCT00765895|12923630|P2|COMPLETED|Overall Study||65
5256627|NCT00765895|12923631|P1|COMPLETED|Overall Study||65
5256628|NCT00765895|12923630|P2|STARTED|Overall Study||65
5256629|NCT00765895|12923631|P1|STARTED|Overall Study||65
5256630|NCT00765882|12923640|P3|NOT COMPLETED|Overall Study||36
5256631|NCT00765882|12923641|P2|NOT COMPLETED|Overall Study||40
5256632|NCT00765882|12923642|P1|NOT COMPLETED|Overall Study||24
5256633|NCT00765882|12923640|P3|COMPLETED|Overall Study||169
5256634|NCT00765882|12923641|P2|COMPLETED|Overall Study||173
5256635|NCT00765882|12923642|P1|COMPLETED|Overall Study||191
5256636|NCT00765882|12923640|P3|STARTED|Overall Study||205
5256637|NCT00765882|12923641|P2|STARTED|Overall Study||213
5256638|NCT00765882|12923642|P1|STARTED|Overall Study||215
5256639|NCT00765843|12923674|P3|NOT COMPLETED|Overall Study||3
5256640|NCT00765843|12923675|P2|NOT COMPLETED|Overall Study||4
5256641|NCT00765843|12923676|P1|NOT COMPLETED|Overall Study||1
5256642|NCT00765843|12923674|P3|COMPLETED|Overall Study||23
5256643|NCT00765843|12923675|P2|COMPLETED|Overall Study||21
5256644|NCT00765843|12923676|P1|COMPLETED|Overall Study||25
5256645|NCT00765843|12923674|P3|STARTED|Overall Study||26
5256646|NCT00765843|12923675|P2|STARTED|Overall Study||25
5256647|NCT00765843|12923676|P1|STARTED|Overall Study||26
5256648|NCT00765817|12923686|P2|NOT COMPLETED|Overall Study||22
5256649|NCT00765817|12923687|P1|NOT COMPLETED|Overall Study||26
5256650|NCT00765817|12923686|P2|COMPLETED|Overall Study||101
5256651|NCT00765817|12923687|P1|COMPLETED|Overall Study||112
5256652|NCT00765817|12923686|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
5256653|NCT00765817|12923687|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
5256654|NCT00765765|12923725|P1|NOT COMPLETED|Overall Study||0
5256655|NCT00765765|12923725|P1|COMPLETED|Overall Study||6
5256656|NCT00765765|12923725|P1|STARTED|Overall Study||6
5256657|NCT00765726|12923735|P1|NOT COMPLETED|Overall Study||9
5256658|NCT00765726|12923735|P1|COMPLETED|Overall Study||3
5256659|NCT00765726|12923735|P1|STARTED|Overall Study||12
5256660|NCT00765674|12923743|P4|NOT COMPLETED|Overall Study||25
5256661|NCT00765674|12923744|P3|NOT COMPLETED|Overall Study||17
5256662|NCT00765674|12923745|P2|NOT COMPLETED|Overall Study||22
5256663|NCT00765674|12923746|P1|NOT COMPLETED|Overall Study||21
5256664|NCT00765674|12923743|P4|COMPLETED|Overall Study||285
5256665|NCT00765674|12923744|P3|COMPLETED|Overall Study||279
5256666|NCT00765674|12923745|P2|COMPLETED|Overall Study||276
5256667|NCT00765674|12923746|P1|COMPLETED|Overall Study||266
5256668|NCT00765674|12923743|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
5256669|NCT00765674|12923744|P3|STARTED|Overall Study||296
5256670|NCT00765674|12923745|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
5256671|NCT00765674|12923746|P1|STARTED|Overall Study||287
5256672|NCT00765661|12923770|P2|NOT COMPLETED|Overall Study||0
5256673|NCT00765661|12923771|P1|NOT COMPLETED|Overall Study||0
5256674|NCT00765661|12923770|P2|COMPLETED|Overall Study||31
5256675|NCT00765661|12923771|P1|COMPLETED|Overall Study||32
5256676|NCT00765661|12923770|P2|STARTED|Overall Study||31
5256677|NCT00765661|12923771|P1|STARTED|Overall Study||32
5256678|NCT00765648|12923785|P2|NOT COMPLETED|Overall Study||2
5256679|NCT00765648|12923786|P1|NOT COMPLETED|Overall Study||1
5256680|NCT00765648|12923785|P2|COMPLETED|Overall Study||114
5256681|NCT00765648|12923786|P1|COMPLETED|Overall Study||109
5256682|NCT00765648|12923785|P2|STARTED|Overall Study||116
5256683|NCT00765648|12923786|P1|STARTED|Overall Study||110
5256684|NCT00765570|12923804|P2|NOT COMPLETED|Overall Study||0
5256685|NCT00765570|12923805|P1|NOT COMPLETED|Overall Study||2
5256686|NCT00765570|12923804|P2|COMPLETED|Overall Study||3
5256687|NCT00765570|12923805|P1|COMPLETED|Overall Study||7
5256688|NCT00765570|12923804|P2|STARTED|Overall Study||3
5256689|NCT00765570|12923805|P1|STARTED|Overall Study||9
5256690|NCT00765388|12923813|P2|NOT COMPLETED|Period 2||0
5256691|NCT00765388|12923814|P1|NOT COMPLETED|Period 2||0
5256692|NCT00765388|12923813|P2|COMPLETED|Period 2||6
5256693|NCT00765388|12923814|P1|COMPLETED|Period 2||15
5256694|NCT00765388|12923813|P2|STARTED|Period 2||6
5256695|NCT00765388|12923814|P1|STARTED|Period 2||15
5256696|NCT00765388|12923813|P2|NOT COMPLETED|Period 1||5
5256697|NCT00765388|12923814|P1|NOT COMPLETED|Period 1||1
5256698|NCT00765388|12923813|P2|COMPLETED|Period 1||6
5256699|NCT00765388|12923814|P1|COMPLETED|Period 1||15
5256700|NCT00765388|12923813|P2|STARTED|Period 1||11
5256701|NCT00765388|12923814|P1|STARTED|Period 1|A cross-over study|16
5256702|NCT00765375|12923842|P1|NOT COMPLETED|Overall Study||0
5256703|NCT00765375|12923842|P1|COMPLETED|Overall Study||5
5256704|NCT00765375|12923842|P1|STARTED|Overall Study||5
5256705|NCT00765362|12923848|P1|NOT COMPLETED|Overall Study||137
5256706|NCT00765362|12923848|P1|COMPLETED|Overall Study||282
5256707|NCT00765362|12923848|P1|STARTED|Overall Study||419
5256708|NCT00765336|12923856|P2|NOT COMPLETED|Overall Study||16
5256709|NCT00765336|12923857|P1|NOT COMPLETED|Overall Study||19
5256710|NCT00765336|12923856|P2|COMPLETED|Overall Study||73
5256711|NCT00765336|12923857|P1|COMPLETED|Overall Study||72
5256712|NCT00765336|12923856|P2|STARTED|Overall Study||89
5256713|NCT00765336|12923857|P1|STARTED|Overall Study||91
5256714|NCT00765245|12923865|P2|NOT COMPLETED|Overall Study||2
5256715|NCT00765245|12923866|P1|NOT COMPLETED|Overall Study||13
5256716|NCT00765245|12923865|P2|COMPLETED|Overall Study||20
5256717|NCT00765245|12923866|P1|COMPLETED|Overall Study||9
5256718|NCT00765245|12923865|P2|STARTED|Overall Study||22
5256719|NCT00765245|12923866|P1|STARTED|Overall Study||22
5256720|NCT00765232|12923878|P2|NOT COMPLETED|Overall Study||0
5256721|NCT00765232|12923879|P1|NOT COMPLETED|Overall Study||0
5256722|NCT00765232|12923878|P2|COMPLETED|Overall Study||54
5256723|NCT00765232|12923879|P1|COMPLETED|Overall Study||57
5256724|NCT00765232|12923878|P2|STARTED|Overall Study||54
5256725|NCT00765232|12923879|P1|STARTED|Overall Study||57
5256726|NCT00765206|12923887|P4|NOT COMPLETED|Second Intervention||0
5256727|NCT00765206|12923888|P3|NOT COMPLETED|Second Intervention||0
5256728|NCT00765206|12923889|P2|NOT COMPLETED|Second Intervention||0
5256729|NCT00765206|12923890|P1|NOT COMPLETED|Second Intervention||0
5256730|NCT00765206|12923887|P4|COMPLETED|Second Intervention||15
5256731|NCT00765206|12923888|P3|COMPLETED|Second Intervention||15
5256732|NCT00765206|12923889|P2|COMPLETED|Second Intervention||15
5256733|NCT00765206|12923890|P1|COMPLETED|Second Intervention||15
5256734|NCT00765206|12923887|P4|STARTED|Second Intervention||15
5256735|NCT00765206|12923888|P3|STARTED|Second Intervention||15
5256736|NCT00765206|12923889|P2|STARTED|Second Intervention||15
5256737|NCT00765206|12923890|P1|STARTED|Second Intervention||15
5256738|NCT00765206|12923887|P4|NOT COMPLETED|Washout Period of 14 Days||0
5256739|NCT00765206|12923888|P3|NOT COMPLETED|Washout Period of 14 Days||0
5256740|NCT00765206|12923889|P2|NOT COMPLETED|Washout Period of 14 Days||0
5256741|NCT00765206|12923890|P1|NOT COMPLETED|Washout Period of 14 Days||0
5256742|NCT00765206|12923887|P4|COMPLETED|Washout Period of 14 Days||15
5256743|NCT00765206|12923888|P3|COMPLETED|Washout Period of 14 Days||15
5256744|NCT00765206|12923889|P2|COMPLETED|Washout Period of 14 Days||15
5256745|NCT00765206|12923890|P1|COMPLETED|Washout Period of 14 Days||15
5256746|NCT00765206|12923887|P4|STARTED|Washout Period of 14 Days||15
5256747|NCT00765206|12923888|P3|STARTED|Washout Period of 14 Days||15
5256748|NCT00765206|12923889|P2|STARTED|Washout Period of 14 Days||15
5256749|NCT00765206|12923890|P1|STARTED|Washout Period of 14 Days||15
5256750|NCT00765206|12923887|P4|NOT COMPLETED|First Intervention||0
5256751|NCT00765206|12923888|P3|NOT COMPLETED|First Intervention||0
5256752|NCT00765206|12923889|P2|NOT COMPLETED|First Intervention||0
5256753|NCT00765206|12923890|P1|NOT COMPLETED|First Intervention||0
5256754|NCT00765206|12923887|P4|COMPLETED|First Intervention||15
5256755|NCT00765206|12923888|P3|COMPLETED|First Intervention||15
5256756|NCT00765206|12923889|P2|COMPLETED|First Intervention||15
5256757|NCT00765206|12923890|P1|COMPLETED|First Intervention||15
5256758|NCT00765206|12923887|P4|STARTED|First Intervention||15
5256759|NCT00765206|12923888|P3|STARTED|First Intervention||15
5256760|NCT00765206|12923889|P2|STARTED|First Intervention||15
5256761|NCT00765206|12923890|P1|STARTED|First Intervention||15
5256762|NCT00765193|12923896|P1|NOT COMPLETED|Full Body Examination||0
5256763|NCT00765193|12923896|P1|COMPLETED|Full Body Examination||14381
5256764|NCT00765193|12923896|P1|STARTED|Full Body Examination||14381
5256765|NCT00765193|12923896|P1|NOT COMPLETED|Problem Area Examination||0
5256766|NCT00765193|12923896|P1|COMPLETED|Problem Area Examination||14381
5256767|NCT00765193|12923896|P1|STARTED|Problem Area Examination||14381
5256768|NCT00765128|12923903|P2|NOT COMPLETED|Overall Study||0
5256769|NCT00765128|12923904|P1|NOT COMPLETED|Overall Study||0
5256770|NCT00765128|12923903|P2|COMPLETED|Overall Study||9
5256771|NCT00765128|12923904|P1|COMPLETED|Overall Study||8
5256772|NCT00765128|12923903|P2|STARTED|Overall Study||9
5256773|NCT00765128|12923904|P1|STARTED|Overall Study||8
5256774|NCT00765102|12923912|P1|NOT COMPLETED|Overall Study||31
5256775|NCT00765102|12923912|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
5256776|NCT00765102|12923912|P1|STARTED|Overall Study||32
5256777|NCT00765076|12923937|P3|NOT COMPLETED|Overall Study||1
5256778|NCT00765076|12923938|P2|NOT COMPLETED|Overall Study||0
5256779|NCT00765076|12923939|P1|NOT COMPLETED|Overall Study||1
5256780|NCT00765076|12923937|P3|COMPLETED|Overall Study||49
5256781|NCT00765076|12923938|P2|COMPLETED|Overall Study||73
5256782|NCT00765076|12923939|P1|COMPLETED|Overall Study||68
5256783|NCT00765076|12923937|P3|STARTED|Overall Study||50
5256784|NCT00765076|12923938|P2|STARTED|Overall Study||73
5256785|NCT00765076|12923939|P1|STARTED|Overall Study||69
5256786|NCT00765063|12923992|P1|NOT COMPLETED|Overall Study||32
5256787|NCT00765063|12923992|P1|COMPLETED|Overall Study||30
5256788|NCT00765063|12923992|P1|STARTED|Overall Study||62
5256789|NCT00765037|12924008|P1|NOT COMPLETED|Overall Study||6
5256790|NCT00765037|12924008|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
5256791|NCT00765037|12924008|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
5256792|NCT00764946|12924015|P3|NOT COMPLETED|Overall Study||4
5256793|NCT00764946|12924016|P2|NOT COMPLETED|Overall Study||17
5256794|NCT00764946|12924017|P1|NOT COMPLETED|Overall Study||13
5256795|NCT00764946|12924015|P3|COMPLETED|Overall Study||18
5256796|NCT00764946|12924016|P2|COMPLETED|Overall Study||72
5256797|NCT00764946|12924017|P1|COMPLETED|Overall Study||85
5256798|NCT00764946|12924015|P3|TREATED|Overall Study||21
5256799|NCT00764946|12924016|P2|TREATED|Overall Study||88
5256800|NCT00764946|12924017|P1|TREATED|Overall Study||97
5256801|NCT00764946|12924015|P3|STARTED|Overall Study||22
5256802|NCT00764946|12924016|P2|STARTED|Overall Study||89
5256803|NCT00764946|12924017|P1|STARTED|Overall Study||98
5256804|NCT00764881|12924045|P2|NOT COMPLETED|Overall Study||10
5256805|NCT00764881|12924046|P1|NOT COMPLETED|Overall Study||16
5256806|NCT00764881|12924045|P2|COMPLETED|Overall Study||99
5256807|NCT00764881|12924046|P1|COMPLETED|Overall Study||92
5256808|NCT00764881|12924045|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
5256809|NCT00764881|12924046|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
5256810|NCT00764881|12924045|P2|STARTED|Overall Study||109
5256811|NCT00764881|12924046|P1|STARTED|Overall Study||108
5256812|NCT00764868|12924270|P1|NOT COMPLETED|Overall Study||113
5256813|NCT00764868|12924270|P1|COMPLETED|Overall Study||156
5256814|NCT00764868|12924270|P1|STARTED|Overall Study||269
5256815|NCT00764790|12924279|P3|NOT COMPLETED|Overall Study||30
5256816|NCT00764790|12924280|P2|NOT COMPLETED|Overall Study||41
5256817|NCT00764790|12924281|P1|NOT COMPLETED|Overall Study||38
5256818|NCT00764790|12924279|P3|COMPLETED|Overall Study||1074
5256819|NCT00764790|12924280|P2|COMPLETED|Overall Study||1065
5256820|NCT00764790|12924281|P1|COMPLETED|Overall Study||1069
5256821|NCT00764790|12924279|P3|STARTED|Overall Study||1104
5256822|NCT00764790|12924280|P2|STARTED|Overall Study||1106
5256823|NCT00764790|12924281|P1|STARTED|Overall Study||1107
5256824|NCT00764751|12924315|P2|NOT COMPLETED|Overall Study||1
5256825|NCT00764751|12924316|P1|NOT COMPLETED|Overall Study||2
5256826|NCT00764751|12924315|P2|COMPLETED|Overall Study||11
5256827|NCT00764751|12924316|P1|COMPLETED|Overall Study||37
5256828|NCT00764751|12924315|P2|STARTED|Overall Study||12
5256829|NCT00764751|12924316|P1|STARTED|Overall Study||39
5256830|NCT00764699|12924350|P1|NOT COMPLETED|Overall Study||3
5256831|NCT00764699|12924350|P1|COMPLETED|Overall Study||0
5256832|NCT00764699|12924350|P1|STARTED|Overall Study||3
5256833|NCT00764673|12924354|P1|NOT COMPLETED|Overall Study||12
5256834|NCT00764673|12924354|P1|COMPLETED|Overall Study||59
5256835|NCT00764673|12924354|P1|STARTED|Overall Study||71
5256836|NCT00764660|12924364|P2|NOT COMPLETED|Overall Study||11
5256837|NCT00764660|12924365|P1|NOT COMPLETED|Overall Study||22
5256838|NCT00764660|12924364|P2|COMPLETED|Overall Study||55
5256839|NCT00764660|12924365|P1|COMPLETED|Overall Study||53
5256840|NCT00764660|12924364|P2|STARTED|Overall Study||66
5256841|NCT00764660|12924365|P1|STARTED|Overall Study||75
5256842|NCT00764517|12924399|P2|NOT COMPLETED|Overall Study||14
5256843|NCT00764517|12924400|P1|NOT COMPLETED|Overall Study||15
5256844|NCT00764517|12924399|P2|COMPLETED|Overall Study||4
5256845|NCT00764517|12924400|P1|COMPLETED|Overall Study||24
5256846|NCT00764517|12924399|P2|STARTED|Overall Study||18
5256847|NCT00764517|12924400|P1|STARTED|Overall Study||39
5256848|NCT00764504|12924421|P3|NOT COMPLETED|Overall Study||103
5256849|NCT00764504|12924422|P2|NOT COMPLETED|Overall Study||70
5256850|NCT00764504|12924423|P1|NOT COMPLETED|Overall Study||66
5256851|NCT00764504|12924421|P3|COMPLETED|Overall Study||131
5256852|NCT00764504|12924422|P2|COMPLETED|Overall Study||71
5256853|NCT00764504|12924423|P1|COMPLETED|Overall Study||75
5256854|NCT00764504|12924421|P3|STARTED|Overall Study||234
5256855|NCT00764504|12924422|P2|STARTED|Overall Study||141
5256856|NCT00764504|12924423|P1|STARTED|Overall Study||141
5256857|NCT00764478|12924452|P3|NOT COMPLETED|Overall Study||8
5256858|NCT00764478|12924453|P2|NOT COMPLETED|Overall Study||22
5256859|NCT00764478|12924454|P1|NOT COMPLETED|Overall Study||15
5256860|NCT00764478|12924452|P3|COMPLETED|Overall Study||118
5256861|NCT00764478|12924453|P2|COMPLETED|Overall Study||97
5256862|NCT00764478|12924454|P1|COMPLETED|Overall Study||107
5256863|NCT00764478|12924452|P3|STARTED|Overall Study||126
5256864|NCT00764478|12924453|P2|STARTED|Overall Study||119
5256865|NCT00764478|12924454|P1|STARTED|Overall Study||122
5256866|NCT00764465|12924534|P6|NOT COMPLETED|Overall Study||1
5256867|NCT00764465|12924535|P5|NOT COMPLETED|Overall Study||1
5256868|NCT00764465|12924536|P4|NOT COMPLETED|Overall Study||1
5256869|NCT00764465|12924537|P3|NOT COMPLETED|Overall Study||1
5256870|NCT00764465|12924538|P2|NOT COMPLETED|Overall Study||1
5256871|NCT00764465|12924539|P1|NOT COMPLETED|Overall Study||2
5256872|NCT00764465|12924534|P6|COMPLETED|Overall Study||7
5256873|NCT00764465|12924535|P5|COMPLETED|Overall Study||6
5256874|NCT00764465|12924536|P4|COMPLETED|Overall Study||6
5256875|NCT00764465|12924537|P3|COMPLETED|Overall Study||6
5256876|NCT00764465|12924538|P2|COMPLETED|Overall Study||6
5256877|NCT00764465|12924539|P1|COMPLETED|Overall Study||7
5256878|NCT00764465|12924534|P6|STARTED|Overall Study||8
5256879|NCT00764465|12924535|P5|STARTED|Overall Study||7
5256880|NCT00764465|12924536|P4|STARTED|Overall Study||7
5256881|NCT00764465|12924537|P3|STARTED|Overall Study||7
5256882|NCT00764465|12924538|P2|STARTED|Overall Study||7
5256883|NCT00764465|12924539|P1|STARTED|Overall Study||9
5256884|NCT00764361|12924567|P2|NOT COMPLETED|Overall Study||4
5256885|NCT00764361|12924568|P1|NOT COMPLETED|Overall Study||2
5256886|NCT00764361|12924567|P2|COMPLETED|Overall Study||3
5256887|NCT00764361|12924568|P1|COMPLETED|Overall Study||6
5256888|NCT00764361|12924567|P2|STARTED|Overall Study||7
5256889|NCT00764361|12924568|P1|STARTED|Overall Study||8
5256890|NCT00764322|12924576|P1|NOT COMPLETED|Overall Study||20
5256891|NCT00764322|12924576|P1|COMPLETED|Overall Study||480
5256892|NCT00764322|12924576|P1|STARTED|Overall Study||500
5256893|NCT00764309|12924593|P1|NOT COMPLETED|Overall Study||0
5256894|NCT00764309|12924593|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
5256895|NCT00764309|12924593|P1|STARTED|Overall Study|Number of participants treated.|31
5256896|NCT00763971|12924603|P3|NOT COMPLETED|Overall Study||69
5256897|NCT00763971|12924604|P2|NOT COMPLETED|Overall Study||38
5256898|NCT00763971|12924605|P1|NOT COMPLETED|Overall Study||33
5256899|NCT00763971|12924603|P3|COMPLETED|Overall Study||42
5256900|NCT00763971|12924604|P2|COMPLETED|Overall Study||74
5256901|NCT00763971|12924605|P1|COMPLETED|Overall Study||80
5256902|NCT00763971|12924603|P3|STARTED|Overall Study||111
5256903|NCT00763971|12924604|P2|STARTED|Overall Study||112
5256904|NCT00763971|12924605|P1|STARTED|Overall Study||113
5256905|NCT00763958|12924636|P2|NOT COMPLETED|Overall Study||11
5256906|NCT00763958|12924637|P1|NOT COMPLETED|Overall Study||14
5256907|NCT00763958|12924636|P2|COMPLETED|Overall Study||5
5256908|NCT00763958|12924637|P1|COMPLETED|Overall Study||14
5256909|NCT00763958|12924636|P2|STARTED|Overall Study||16
5256910|NCT00763958|12924637|P1|STARTED|Overall Study||28
5256911|NCT00763919|12924647|P1|NOT COMPLETED|Overall Study||13
5256912|NCT00763919|12924647|P1|COMPLETED|Overall Study||30
5256913|NCT00763919|12924647|P1|STARTED|Overall Study||43
5256914|NCT00763867|12924675|P2|NOT COMPLETED|Overall Study||12
5256915|NCT00763867|12924676|P1|NOT COMPLETED|Overall Study||5
5256916|NCT00763867|12924675|P2|COMPLETED|Overall Study||101
5256917|NCT00763867|12924676|P1|COMPLETED|Overall Study||98
5256918|NCT00763867|12924675|P2|STARTED|Overall Study||113
5256919|NCT00763867|12924676|P1|STARTED|Overall Study||103
5256920|NCT00763815|12924772|P2|NOT COMPLETED|Overall Study||84
5256921|NCT00763815|12924773|P1|NOT COMPLETED|Overall Study||52
5256922|NCT00763815|12924772|P2|COMPLETED|Overall Study||239
5256923|NCT00763815|12924773|P1|COMPLETED|Overall Study||109
5256924|NCT00763815|12924772|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
5256925|NCT00763815|12924773|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
5256926|NCT00763815|12924772|P2|Treated/Safety Population|Overall Study||323
5256927|NCT00763815|12924773|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
5256928|NCT00763815|12924772|P2|STARTED|Overall Study||323
5256929|NCT00763815|12924773|P1|STARTED|Overall Study|Randomized.|161
5256930|NCT00763750|12924797|P1|NOT COMPLETED|Overall Study||0
5256931|NCT00763750|12924797|P1|COMPLETED|Overall Study||25
5256932|NCT00763750|12924797|P1|STARTED|Overall Study||25
5256933|NCT00763698|12924801|P1|NOT COMPLETED|Overall Study||10
5256934|NCT00763698|12924801|P1|COMPLETED|Overall Study||76
5256935|NCT00763698|12924801|P1|STARTED|Overall Study||86
5256936|NCT00763490|12924807|P1|NOT COMPLETED|Overall Study||0
5256937|NCT00763490|12924807|P1|COMPLETED|Overall Study||20
5256938|NCT00763490|12924807|P1|STARTED|Overall Study||20
5256939|NCT00763451|12924818|P4|NOT COMPLETED|Overall Study||30
5256940|NCT00763451|12924819|P3|NOT COMPLETED|Overall Study||40
5256941|NCT00763451|12924820|P2|NOT COMPLETED|Overall Study||22
5256942|NCT00763451|12924821|P1|NOT COMPLETED|Overall Study||13
5256943|NCT00763451|12924818|P4|COMPLETED|Overall Study||131
5256944|NCT00763451|12924819|P3|COMPLETED|Overall Study||121
5256945|NCT00763451|12924820|P2|COMPLETED|Overall Study||60
5256946|NCT00763451|12924821|P1|COMPLETED|Overall Study||67
5256947|NCT00763451|12924818|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
5256948|NCT00763451|12924819|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
5256949|NCT00763451|12924820|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
5256950|NCT00763451|12924821|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
5256951|NCT00763451|12924818|P4|Treated/Safety Population|Overall Study||161
5256952|NCT00763451|12924819|P3|Treated/Safety Population|Overall Study||161
5256953|NCT00763451|12924820|P2|Treated/Safety Population|Overall Study||81
5256954|NCT00763451|12924821|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
5256955|NCT00763451|12924818|P4|STARTED|Overall Study||161
5256956|NCT00763451|12924819|P3|STARTED|Overall Study||161
5256957|NCT00763451|12924820|P2|STARTED|Overall Study||82
5256958|NCT00763451|12924821|P1|STARTED|Overall Study|Randomized.|80
5256959|NCT00763412|12924855|P2|NOT COMPLETED|Overall Study||4
5256960|NCT00763412|12924856|P1|NOT COMPLETED|Overall Study||4
5256961|NCT00763412|12924855|P2|COMPLETED|Overall Study||4
5256962|NCT00763412|12924856|P1|COMPLETED|Overall Study||4
5256963|NCT00763412|12924855|P2|STARTED|Overall Study||8
5256964|NCT00763412|12924856|P1|STARTED|Overall Study||8
5256965|NCT00763386|12924880|P2|NOT COMPLETED|Overall Study||40
5256966|NCT00763386|12924881|P1|NOT COMPLETED|Overall Study||48
5256967|NCT00763386|12924880|P2|COMPLETED|Overall Study||127
5256968|NCT00763386|12924881|P1|COMPLETED|Overall Study||116
5256969|NCT00763386|12924880|P2|STARTED|Overall Study||167
5256970|NCT00763386|12924881|P1|STARTED|Overall Study||164
5256971|NCT00763360|12924892|P3|NOT COMPLETED|Overall Study||0
5256972|NCT00763360|12924893|P2|NOT COMPLETED|Overall Study||2
5256973|NCT00763360|12924894|P1|NOT COMPLETED|Overall Study||0
5256974|NCT00763360|12924892|P3|COMPLETED|Overall Study||63
5256975|NCT00763360|12924893|P2|COMPLETED|Overall Study||58
5256976|NCT00763360|12924894|P1|COMPLETED|Overall Study||61
5256977|NCT00763360|12924892|P3|STARTED|Overall Study||63
5256978|NCT00763360|12924893|P2|STARTED|Overall Study||60
5256979|NCT00763360|12924894|P1|STARTED|Overall Study||61
5256980|NCT00763321|12924914|P3|NOT COMPLETED|Double-blind Period||29
5256981|NCT00763321|12924915|P2|NOT COMPLETED|Double-blind Period||21
5256982|NCT00763321|12924916|P1|NOT COMPLETED|Double-blind Period||0
5256983|NCT00763321|12924914|P3|COMPLETED|Double-blind Period||84
5256984|NCT00763321|12924915|P2|COMPLETED|Double-blind Period||88
5256985|NCT00763321|12924916|P1|COMPLETED|Double-blind Period||0
5256986|NCT00763321|12924914|P3|STARTED|Double-blind Period||113
5256987|NCT00763321|12924915|P2|STARTED|Double-blind Period||109
5256988|NCT00763321|12924916|P1|STARTED|Double-blind Period||0
5256989|NCT00763321|12924914|P3|NOT COMPLETED|Open-label Period||0
5256990|NCT00763321|12924915|P2|NOT COMPLETED|Open-label Period||0
5256991|NCT00763321|12924916|P1|NOT COMPLETED|Open-label Period||63
5256992|NCT00763321|12924914|P3|COMPLETED|Open-label Period||0
5256993|NCT00763321|12924915|P2|COMPLETED|Open-label Period||0
5256994|NCT00763321|12924916|P1|COMPLETED|Open-label Period||222
5256995|NCT00763321|12924914|P3|STARTED|Open-label Period||0
5256996|NCT00763321|12924915|P2|STARTED|Open-label Period||0
5256997|NCT00763321|12924916|P1|STARTED|Open-label Period||285
5256998|NCT00763282|12924927|P2|NOT COMPLETED|Overall Study||34
5256999|NCT00763282|12924928|P1|NOT COMPLETED|Overall Study||32
5257000|NCT00763282|12924927|P2|COMPLETED|Overall Study||38
5257001|NCT00763282|12924928|P1|COMPLETED|Overall Study||40
5257002|NCT00763282|12924927|P2|STARTED|Overall Study||72
5257003|NCT00763282|12924928|P1|STARTED|Overall Study||72
5257004|NCT00763269|12924944|P2|NOT COMPLETED|Overall Study||13
5257005|NCT00763269|12924945|P1|NOT COMPLETED|Overall Study||12
5257006|NCT00763269|12924944|P2|COMPLETED|Overall Study||299
5257007|NCT00763269|12924945|P1|COMPLETED|Overall Study||302
5257008|NCT00763269|12924944|P2|STARTED|Overall Study||312
5257009|NCT00763269|12924945|P1|STARTED|Overall Study||314
5257010|NCT00763256|12924959|P2|NOT COMPLETED|Overall Study||10
5257011|NCT00763256|12924960|P1|NOT COMPLETED|Overall Study||7
5257012|NCT00763256|12924959|P2|COMPLETED|Overall Study||8
5257013|NCT00763256|12924960|P1|COMPLETED|Overall Study||8
5257014|NCT00763256|12924959|P2|STARTED|Overall Study||18
5257015|NCT00763256|12924960|P1|STARTED|Overall Study||15
5257016|NCT00763243|12924974|P1|NOT COMPLETED|6-Month Follow-Up Period||0
5257017|NCT00763243|12924974|P1|COMPLETED|6-Month Follow-Up Period||9
5257018|NCT00763243|12924974|P1|STARTED|6-Month Follow-Up Period||9
5257019|NCT00763243|12924974|P1|NOT COMPLETED|1-Month Follow-Up Period||0
5257020|NCT00763243|12924974|P1|COMPLETED|1-Month Follow-Up Period||9
5257021|NCT00763243|12924974|P1|STARTED|1-Month Follow-Up Period||9
5257022|NCT00763243|12924974|P1|NOT COMPLETED|Training Period||0
5257023|NCT00763243|12924974|P1|COMPLETED|Training Period||9
5257024|NCT00763243|12924974|P1|STARTED|Training Period||9
5257025|NCT00763243|12924974|P1|NOT COMPLETED|Waiting Period||0
5257026|NCT00763243|12924974|P1|COMPLETED|Waiting Period||9
5257027|NCT00763243|12924974|P1|STARTED|Waiting Period||9
5257028|NCT00763139|12924996|P2|NOT COMPLETED|Overall Study||3
5257029|NCT00763139|12924997|P1|NOT COMPLETED|Overall Study||5
5257030|NCT00763139|12924996|P2|COMPLETED|Overall Study||14
5257031|NCT00763139|12924997|P1|COMPLETED|Overall Study||12
5257032|NCT00763139|12924996|P2|STARTED|Overall Study||17
5257033|NCT00763139|12924997|P1|STARTED|Overall Study||17
5257034|NCT00763061|12925019|P2|NOT COMPLETED|Overall Study||13
5257035|NCT00763061|12925020|P1|NOT COMPLETED|Overall Study||5
5257036|NCT00763061|12925019|P2|COMPLETED|Overall Study||44
5257037|NCT00763061|12925020|P1|COMPLETED|Overall Study||49
5257038|NCT00763061|12925019|P2|STARTED|Overall Study||57
5257039|NCT00763061|12925020|P1|STARTED|Overall Study||54
5257040|NCT00763048|12925034|P2|NOT COMPLETED|Overall Study||0
5257041|NCT00763048|12925035|P1|NOT COMPLETED|Overall Study||0
5257042|NCT00763048|12925034|P2|COMPLETED|Overall Study||18
5257043|NCT00763048|12925035|P1|COMPLETED|Overall Study||21
5257044|NCT00763048|12925034|P2|STARTED|Overall Study||18
5257045|NCT00763048|12925035|P1|STARTED|Overall Study||21
5257046|NCT00763035|12925059|P2|NOT COMPLETED|Second Intervention||0
5257047|NCT00763035|12925060|P1|NOT COMPLETED|Second Intervention||3
5257048|NCT00763035|12925059|P2|COMPLETED|Second Intervention||3
5257049|NCT00763035|12925060|P1|COMPLETED|Second Intervention||6
5257050|NCT00763035|12925059|P2|STARTED|Second Intervention||3
5257051|NCT00763035|12925060|P1|STARTED|Second Intervention||9
5257052|NCT00763035|12925059|P2|NOT COMPLETED|First Intervention||1
5257053|NCT00763035|12925060|P1|NOT COMPLETED|First Intervention||1
5257054|NCT00763035|12925059|P2|COMPLETED|First Intervention||3
5257055|NCT00763035|12925060|P1|COMPLETED|First Intervention||9
5257056|NCT00763035|12925059|P2|STARTED|First Intervention||4
5257057|NCT00763035|12925060|P1|STARTED|First Intervention||10
5257058|NCT00763009|12925078|P1|NOT COMPLETED|Overall Study||1
5257059|NCT00763009|12925078|P1|COMPLETED|Overall Study||7
5257060|NCT00763009|12925078|P1|STARTED|Overall Study||8
5257061|NCT00762996|12925083|P4|NOT COMPLETED|Period Two||0
5257062|NCT00762996|12925084|P3|NOT COMPLETED|Period Two||0
5257063|NCT00762996|12925085|P2|NOT COMPLETED|Period Two||0
5257064|NCT00762996|12925086|P1|NOT COMPLETED|Period Two||0
5257065|NCT00762996|12925083|P4|COMPLETED|Period Two||16
5257066|NCT00762996|12925084|P3|COMPLETED|Period Two||13
5257067|NCT00762996|12925085|P2|COMPLETED|Period Two||16
5257068|NCT00762996|12925086|P1|COMPLETED|Period Two||15
5257069|NCT00762996|12925083|P4|STARTED|Period Two||16
5257070|NCT00762996|12925084|P3|STARTED|Period Two||13
5257071|NCT00762996|12925085|P2|STARTED|Period Two||16
5257072|NCT00762996|12925086|P1|STARTED|Period Two||15
5257073|NCT00762996|12925083|P4|NOT COMPLETED|Period One||1
5257074|NCT00762996|12925084|P3|NOT COMPLETED|Period One||4
5257075|NCT00762996|12925085|P2|NOT COMPLETED|Period One||0
5257076|NCT00762996|12925086|P1|NOT COMPLETED|Period One||0
5257077|NCT00762996|12925083|P4|COMPLETED|Period One||16
5257078|NCT00762996|12925084|P3|COMPLETED|Period One||13
5257079|NCT00762996|12925085|P2|COMPLETED|Period One||16
5257080|NCT00762996|12925086|P1|COMPLETED|Period One||15
5257081|NCT00762996|12925083|P4|STARTED|Period One||17
5257082|NCT00762996|12925084|P3|STARTED|Period One||17
5257083|NCT00762996|12925085|P2|STARTED|Period One||16
5257084|NCT00762996|12925086|P1|STARTED|Period One||15
5257085|NCT00762970|12925099|P3|NOT COMPLETED|Overall Study||1
5257086|NCT00762970|12925100|P2|NOT COMPLETED|Overall Study||9
5257087|NCT00762970|12925101|P1|NOT COMPLETED|Overall Study||12
5257088|NCT00762970|12925099|P3|COMPLETED|Overall Study||46
5257089|NCT00762970|12925100|P2|COMPLETED|Overall Study||35
5257090|NCT00762970|12925101|P1|COMPLETED|Overall Study||34
5257091|NCT00762970|12925099|P3|STARTED|Overall Study||47
5257092|NCT00762970|12925100|P2|STARTED|Overall Study||44
5257093|NCT00762970|12925101|P1|STARTED|Overall Study||46
5257094|NCT00762931|12925112|P1|NOT COMPLETED|Overall Study||2
5257095|NCT00762931|12925112|P1|COMPLETED|Overall Study||23
5257096|NCT00762931|12925112|P1|STARTED|Overall Study||25
5257097|NCT00762892|12925119|P2|NOT COMPLETED|Overall Study||6
5257098|NCT00762892|12925120|P1|NOT COMPLETED|Overall Study||5
5257099|NCT00762892|12925119|P2|COMPLETED|Overall Study||8
5257100|NCT00762892|12925120|P1|COMPLETED|Overall Study||9
5257101|NCT00762892|12925119|P2|STARTED|Overall Study||14
5257102|NCT00762892|12925120|P1|STARTED|Overall Study||14
5257103|NCT00762853|12925136|P2|NOT COMPLETED|Second Treatment Period||0
5257104|NCT00762853|12925137|P1|NOT COMPLETED|Second Treatment Period||0
5257105|NCT00762853|12925136|P2|COMPLETED|Second Treatment Period||10
5257106|NCT00762853|12925137|P1|COMPLETED|Second Treatment Period||10
5257107|NCT00762853|12925136|P2|STARTED|Second Treatment Period||10
5257108|NCT00762853|12925137|P1|STARTED|Second Treatment Period||10
5257109|NCT00762853|12925136|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
5257110|NCT00762853|12925137|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
5257111|NCT00762853|12925136|P2|COMPLETED|1 Week Washout After Treatment 1||10
5257112|NCT00762853|12925137|P1|COMPLETED|1 Week Washout After Treatment 1||10
5257113|NCT00762853|12925136|P2|STARTED|1 Week Washout After Treatment 1||10
5257114|NCT00762853|12925137|P1|STARTED|1 Week Washout After Treatment 1||10
5257115|NCT00762853|12925136|P2|NOT COMPLETED|First Treatment Period||0
5257116|NCT00762853|12925137|P1|NOT COMPLETED|First Treatment Period||0
5257117|NCT00762853|12925136|P2|COMPLETED|First Treatment Period||10
5257118|NCT00762853|12925137|P1|COMPLETED|First Treatment Period||10
5257119|NCT00762853|12925136|P2|STARTED|First Treatment Period||10
5257120|NCT00762853|12925137|P1|STARTED|First Treatment Period||10
5257121|NCT00762788|12925149|P6|NOT COMPLETED|Overall Study||21
5257122|NCT00762788|12925150|P5|NOT COMPLETED|Overall Study||13
5257123|NCT00762788|12925151|P4|NOT COMPLETED|Overall Study||26
5257124|NCT00762788|12925152|P3|NOT COMPLETED|Overall Study||21
5257125|NCT00762788|12925153|P2|NOT COMPLETED|Overall Study||37
5257126|NCT00762788|12925154|P1|NOT COMPLETED|Overall Study||26
5257127|NCT00762788|12925149|P6|COMPLETED|Overall Study||31
5257128|NCT00762788|12925150|P5|COMPLETED|Overall Study||30
5257129|NCT00762788|12925151|P4|COMPLETED|Overall Study||38
5257130|NCT00762788|12925152|P3|COMPLETED|Overall Study||21
5257131|NCT00762788|12925153|P2|COMPLETED|Overall Study||21
5257132|NCT00762788|12925154|P1|COMPLETED|Overall Study||29
5257133|NCT00762788|12925149|P6|STARTED|Overall Study||52
5257134|NCT00762788|12925150|P5|STARTED|Overall Study||43
5257135|NCT00762788|12925151|P4|STARTED|Overall Study||64
5257136|NCT00762788|12925152|P3|STARTED|Overall Study||42
5257137|NCT00762788|12925153|P2|STARTED|Overall Study||58
5257138|NCT00762788|12925154|P1|STARTED|Overall Study||55
5257139|NCT00762762|12925176|P2|NOT COMPLETED|Overall Study||10
5257140|NCT00762762|12925177|P1|NOT COMPLETED|Overall Study||8
5257141|NCT00762762|12925176|P2|COMPLETED|Overall Study||20
5257142|NCT00762762|12925177|P1|COMPLETED|Overall Study||22
5257143|NCT00762762|12925176|P2|STARTED|Overall Study||30
5257144|NCT00762762|12925177|P1|STARTED|Overall Study||30
5257145|NCT00762723|12925194|P3|NOT COMPLETED|Overall Study||3
5257146|NCT00762723|12925195|P2|NOT COMPLETED|Overall Study||5
5257147|NCT00762723|12925196|P1|NOT COMPLETED|Overall Study||5
5257148|NCT00762723|12925194|P3|COMPLETED|Overall Study||0
5257149|NCT00762723|12925195|P2|COMPLETED|Overall Study||6
5257150|NCT00762723|12925196|P1|COMPLETED|Overall Study||0
5257151|NCT00762723|12925194|P3|STARTED|Overall Study||3
5257152|NCT00762723|12925195|P2|STARTED|Overall Study||11
5257153|NCT00762723|12925196|P1|STARTED|Overall Study||5
5257154|NCT00762710|12925206|P2|NOT COMPLETED|Overall Study||15
5257155|NCT00762710|12925207|P1|NOT COMPLETED|Overall Study||21
5257156|NCT00762710|12925206|P2|COMPLETED|Overall Study||29
5257157|NCT00762710|12925207|P1|COMPLETED|Overall Study||27
5257158|NCT00762710|12925206|P2|STARTED|Overall Study||44
5257159|NCT00762710|12925207|P1|STARTED|Overall Study||48
5257160|NCT00762645|12925215|P2|NOT COMPLETED|Overall Study||2
5257161|NCT00762645|12925216|P1|NOT COMPLETED|Overall Study||4
5257162|NCT00762645|12925215|P2|COMPLETED|Overall Study||12
5257163|NCT00762645|12925216|P1|COMPLETED|Overall Study||12
5257164|NCT00762645|12925215|P2|STARTED|Overall Study||14
5257165|NCT00762645|12925216|P1|STARTED|Overall Study||16
5257166|NCT00762619|12925226|P2|NOT COMPLETED|Overall Study||0
5257167|NCT00762619|12925227|P1|NOT COMPLETED|Overall Study||0
5257168|NCT00762619|12925226|P2|COMPLETED|Overall Study||50
5257169|NCT00762619|12925227|P1|COMPLETED|Overall Study||55
5257170|NCT00762619|12925226|P2|STARTED|Overall Study||50
5257171|NCT00762619|12925227|P1|STARTED|Overall Study||55
5257172|NCT00762606|12925369|P2|NOT COMPLETED|Overall Study||13
5257173|NCT00762606|12925370|P1|NOT COMPLETED|Overall Study||18
5257174|NCT00762606|12925369|P2|COMPLETED|Overall Study||38
5257175|NCT00762606|12925370|P1|COMPLETED|Overall Study||37
5257176|NCT00762606|12925369|P2|STARTED|Overall Study||51
5257177|NCT00762606|12925370|P1|STARTED|Overall Study||55
5257178|NCT00762528|12925380|P2|NOT COMPLETED|Overall Study||0
5257179|NCT00762528|12925381|P1|NOT COMPLETED|Overall Study||0
5257180|NCT00762528|12925380|P2|COMPLETED|Overall Study||25
5257181|NCT00762528|12925381|P1|COMPLETED|Overall Study||24
5257182|NCT00762528|12925380|P2|STARTED|Overall Study||25
5257183|NCT00762528|12925381|P1|STARTED|Overall Study||24
5257184|NCT00762515|12925403|P2|NOT COMPLETED|Overall Study||0
5257185|NCT00762515|12925404|P1|NOT COMPLETED|Overall Study||0
5257186|NCT00762515|12925403|P2|COMPLETED|Overall Study||22
5257187|NCT00762515|12925404|P1|COMPLETED|Overall Study||22
5257188|NCT00762515|12925403|P2|STARTED|Overall Study||22
5257189|NCT00762515|12925404|P1|STARTED|Overall Study||22
5257190|NCT00762502|12925415|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
5257191|NCT00762502|12925416|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
5257192|NCT00762502|12925417|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
5257193|NCT00762502|12925415|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
5257194|NCT00762502|12925416|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
5257195|NCT00762502|12925417|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
5257196|NCT00762502|12925415|P3|STARTED|Month 3 to Month 6 (Period 2)||23
5257197|NCT00762502|12925416|P2|STARTED|Month 3 to Month 6 (Period 2)||5
5257198|NCT00762502|12925417|P1|STARTED|Month 3 to Month 6 (Period 2)||9
5257199|NCT00762502|12925415|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
5257200|NCT00762502|12925416|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
5257201|NCT00762502|12925417|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
5257202|NCT00762502|12925415|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
5257203|NCT00762502|12925416|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
5257204|NCT00762502|12925417|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
5257205|NCT00762502|12925415|P3|STARTED|Baseline to Month 3 (Period 1)||51
5257206|NCT00762502|12925416|P2|STARTED|Baseline to Month 3 (Period 1)||25
5257207|NCT00762502|12925417|P1|STARTED|Baseline to Month 3 (Period 1)||36
5257208|NCT00762476|12925431|P2|NOT COMPLETED|Overall Study||36
5257209|NCT00762476|12925432|P1|NOT COMPLETED|Overall Study||23
5257210|NCT00762476|12925431|P2|COMPLETED|Overall Study||169
5257211|NCT00762476|12925432|P1|COMPLETED|Overall Study||183
5257212|NCT00762476|12925431|P2|STARTED|Overall Study||205
5257213|NCT00762476|12925432|P1|STARTED|Overall Study||206
5257214|NCT00762463|12925444|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
5257215|NCT00762463|12925445|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
5257216|NCT00762463|12925446|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
5257217|NCT00762463|12925447|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
5257218|NCT00762463|12925444|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
5257219|NCT00762463|12925445|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
5257220|NCT00762463|12925446|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
5257221|NCT00762463|12925447|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
5257222|NCT00762463|12925444|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
5257223|NCT00762463|12925445|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
5257224|NCT00762463|12925446|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
5257225|NCT00762463|12925447|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
5257226|NCT00762463|12925444|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
5257227|NCT00762463|12925445|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
5257228|NCT00762463|12925446|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
5257229|NCT00762463|12925447|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
5257230|NCT00762463|12925444|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
5257231|NCT00762463|12925445|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
5257232|NCT00762463|12925446|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
5257233|NCT00762463|12925447|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
5257234|NCT00762463|12925444|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
5257235|NCT00762463|12925445|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
5257236|NCT00762463|12925446|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
5257237|NCT00762463|12925447|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
5257238|NCT00762463|12925444|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
5257239|NCT00762463|12925445|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
5257240|NCT00762463|12925446|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
5257241|NCT00762463|12925447|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
5257242|NCT00762463|12925444|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
5257243|NCT00762463|12925445|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
5257244|NCT00762463|12925446|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
5257245|NCT00762463|12925447|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
5257246|NCT00762463|12925444|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
5257247|NCT00762463|12925445|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
5257248|NCT00762463|12925446|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
5257249|NCT00762463|12925447|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
5257250|NCT00762450|12925532|P3|NOT COMPLETED|3rd Treatment Period||0
5257251|NCT00762450|12925533|P2|NOT COMPLETED|3rd Treatment Period||0
5257252|NCT00762450|12925534|P1|NOT COMPLETED|3rd Treatment Period||0
5257253|NCT00762450|12925532|P3|COMPLETED|3rd Treatment Period||2
5257254|NCT00762450|12925533|P2|COMPLETED|3rd Treatment Period||2
5257255|NCT00762450|12925534|P1|COMPLETED|3rd Treatment Period||2
5257256|NCT00762450|12925532|P3|STARTED|3rd Treatment Period||2
5257257|NCT00762450|12925533|P2|STARTED|3rd Treatment Period||2
5257258|NCT00762450|12925534|P1|STARTED|3rd Treatment Period||2
5257259|NCT00762450|12925532|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
5257260|NCT00762450|12925533|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
5257261|NCT00762450|12925534|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
5257262|NCT00762450|12925532|P3|COMPLETED|Washout After 2nd Treatment Period||2
5257263|NCT00762450|12925533|P2|COMPLETED|Washout After 2nd Treatment Period||2
5257264|NCT00762450|12925534|P1|COMPLETED|Washout After 2nd Treatment Period||2
5257265|NCT00762450|12925532|P3|STARTED|Washout After 2nd Treatment Period||2
5257266|NCT00762450|12925533|P2|STARTED|Washout After 2nd Treatment Period||2
5257267|NCT00762450|12925534|P1|STARTED|Washout After 2nd Treatment Period||2
5257268|NCT00762450|12925532|P3|NOT COMPLETED|2nd Treatment Period||0
5257269|NCT00762450|12925533|P2|NOT COMPLETED|2nd Treatment Period||0
5257270|NCT00762450|12925534|P1|NOT COMPLETED|2nd Treatment Period||0
5257271|NCT00762450|12925532|P3|COMPLETED|2nd Treatment Period||2
5257272|NCT00762450|12925533|P2|COMPLETED|2nd Treatment Period||2
5257273|NCT00762450|12925534|P1|COMPLETED|2nd Treatment Period||2
5257274|NCT00762450|12925532|P3|STARTED|2nd Treatment Period||2
5257275|NCT00762450|12925533|P2|STARTED|2nd Treatment Period||2
5257276|NCT00762450|12925534|P1|STARTED|2nd Treatment Period||2
5257277|NCT00762450|12925532|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
5257278|NCT00762450|12925533|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
5257279|NCT00762450|12925534|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
5257280|NCT00762450|12925532|P3|COMPLETED|Washout After 1st Treatment Period||2
5257281|NCT00762450|12925533|P2|COMPLETED|Washout After 1st Treatment Period||2
5257282|NCT00762450|12925534|P1|COMPLETED|Washout After 1st Treatment Period||2
5257283|NCT00762450|12925532|P3|STARTED|Washout After 1st Treatment Period||2
5257284|NCT00762450|12925533|P2|STARTED|Washout After 1st Treatment Period||2
5257285|NCT00762450|12925534|P1|STARTED|Washout After 1st Treatment Period||2
5257286|NCT00762450|12925532|P3|NOT COMPLETED|1st Treatment Period||0
5257287|NCT00762450|12925533|P2|NOT COMPLETED|1st Treatment Period||0
5257288|NCT00762450|12925534|P1|NOT COMPLETED|1st Treatment Period||0
5257289|NCT00762450|12925532|P3|COMPLETED|1st Treatment Period||2
5257290|NCT00762450|12925533|P2|COMPLETED|1st Treatment Period||2
5257291|NCT00762450|12925534|P1|COMPLETED|1st Treatment Period||2
5257292|NCT00762450|12925532|P3|STARTED|1st Treatment Period||2
5257293|NCT00762450|12925533|P2|STARTED|1st Treatment Period||2
5257294|NCT00762450|12925534|P1|STARTED|1st Treatment Period||2
5257295|NCT00762424|12925544|P2|NOT COMPLETED|Overall Study||0
5257296|NCT00762424|12925545|P1|NOT COMPLETED|Overall Study||0
5257297|NCT00762424|12925544|P2|COMPLETED|Overall Study||25
5257298|NCT00762424|12925545|P1|COMPLETED|Overall Study||28
5257299|NCT00762424|12925544|P2|STARTED|Overall Study||25
5257300|NCT00762424|12925545|P1|STARTED|Overall Study||28
5257301|NCT00762411|12925553|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
5257302|NCT00762411|12925554|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
5257303|NCT00762411|12925553|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
5257304|NCT00762411|12925554|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
5257305|NCT00762411|12925553|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
5257306|NCT00762411|12925554|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
5257307|NCT00762411|12925553|P2|NOT COMPLETED|Delayed Start||26
5257308|NCT00762411|12925554|P1|NOT COMPLETED|Delayed Start||17
5257309|NCT00762411|12925553|P2|COMPLETED|Delayed Start||8
5257310|NCT00762411|12925554|P1|COMPLETED|Delayed Start||5
5257311|NCT00762411|12925553|P2|STARTED|Delayed Start||34
5257312|NCT00762411|12925554|P1|STARTED|Delayed Start||22
5257313|NCT00762411|12925553|P2|NOT COMPLETED|Initial Treatment||521
5257314|NCT00762411|12925554|P1|NOT COMPLETED|Initial Treatment||534
5257315|NCT00762411|12925553|P2|COMPLETED|Initial Treatment||34
5257316|NCT00762411|12925554|P1|COMPLETED|Initial Treatment||22
5257317|NCT00762411|12925553|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
5257318|NCT00762411|12925554|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
5257319|NCT00762411|12925553|P2|STARTED|Initial Treatment||555
5257320|NCT00762411|12925554|P1|STARTED|Initial Treatment||556
5257321|NCT00762385|12925618|P2|NOT COMPLETED|Second Intervention||3
5257322|NCT00762385|12925619|P1|NOT COMPLETED|Second Intervention||3
5257323|NCT00762385|12925618|P2|COMPLETED|Second Intervention||39
5257324|NCT00762385|12925619|P1|COMPLETED|Second Intervention||46
5257325|NCT00762385|12925618|P2|STARTED|Second Intervention||42
5257326|NCT00762385|12925619|P1|STARTED|Second Intervention||49
5257327|NCT00762385|12925618|P2|NOT COMPLETED|First Intervention||4
5257328|NCT00762385|12925619|P1|NOT COMPLETED|First Intervention||2
5257329|NCT00762385|12925618|P2|COMPLETED|First Intervention||42
5257330|NCT00762385|12925619|P1|COMPLETED|First Intervention||49
5257331|NCT00762385|12925618|P2|STARTED|First Intervention||46
5257332|NCT00762385|12925619|P1|STARTED|First Intervention||51
5257333|NCT00762372|12925632|P3|NOT COMPLETED|Overall Study||0
5257334|NCT00762372|12925633|P2|NOT COMPLETED|Overall Study||0
5257335|NCT00762372|12925634|P1|NOT COMPLETED|Overall Study||1
5257336|NCT00762372|12925632|P3|COMPLETED|Overall Study||50
5257337|NCT00762372|12925633|P2|COMPLETED|Overall Study||55
5257338|NCT00762372|12925634|P1|COMPLETED|Overall Study||110
5257339|NCT00762372|12925632|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
5257340|NCT00762372|12925633|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
5257341|NCT00762372|12925634|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
5257342|NCT00762359|12925710|P2|NOT COMPLETED|Overall Study||57
5257343|NCT00762359|12925711|P1|NOT COMPLETED|Overall Study||59
5257344|NCT00762359|12925710|P2|COMPLETED|Overall Study||178
5257345|NCT00762359|12925711|P1|COMPLETED|Overall Study||167
5257346|NCT00762359|12925710|P2|STARTED|Overall Study||235
5257347|NCT00762359|12925711|P1|STARTED|Overall Study||226
5257348|NCT00762320|12925811|P1|NOT COMPLETED|Overall Study||0
5257349|NCT00762320|12925811|P1|COMPLETED|Overall Study||8
5257350|NCT00762320|12925811|P1|STARTED|Overall Study||8
5257351|NCT00762268|12925828|P2|NOT COMPLETED|Overall Study||3
5257352|NCT00762268|12925829|P1|NOT COMPLETED|Overall Study||3
5257353|NCT00762268|12925828|P2|COMPLETED|Overall Study||8
5257354|NCT00762268|12925829|P1|COMPLETED|Overall Study||9
5257355|NCT00762268|12925828|P2|STARTED|Overall Study||11
5257356|NCT00762268|12925829|P1|STARTED|Overall Study||12
5257357|NCT00762229|12925841|P2|NOT COMPLETED|Overall Study||2
5257358|NCT00762229|12925842|P1|NOT COMPLETED|Overall Study||1
5257359|NCT00762229|12925841|P2|COMPLETED|Overall Study||22
5257360|NCT00762229|12925842|P1|COMPLETED|Overall Study||14
5257361|NCT00762229|12925841|P2|STARTED|Overall Study||24
5257362|NCT00762229|12925842|P1|STARTED|Overall Study||15
5257363|NCT00762216|12925850|P1|NOT COMPLETED|Overall Study||0
5257364|NCT00762216|12925850|P1|COMPLETED|Overall Study||71
5257365|NCT00762216|12925850|P1|STARTED|Overall Study||71
5257366|NCT00762177|12925858|P3|NOT COMPLETED|3rd Treatment Period||0
5257367|NCT00762177|12925859|P2|NOT COMPLETED|3rd Treatment Period||0
5257368|NCT00762177|12925860|P1|NOT COMPLETED|3rd Treatment Period||0
5257369|NCT00762177|12925858|P3|COMPLETED|3rd Treatment Period||8
5257370|NCT00762177|12925859|P2|COMPLETED|3rd Treatment Period||8
5257371|NCT00762177|12925860|P1|COMPLETED|3rd Treatment Period||8
5257372|NCT00762177|12925858|P3|STARTED|3rd Treatment Period||8
5257373|NCT00762177|12925859|P2|STARTED|3rd Treatment Period||8
5257374|NCT00762177|12925860|P1|STARTED|3rd Treatment Period||8
5257375|NCT00762177|12925858|P3|NOT COMPLETED|Washout After 2nd Treatment||0
5257376|NCT00762177|12925859|P2|NOT COMPLETED|Washout After 2nd Treatment||0
5257377|NCT00762177|12925860|P1|NOT COMPLETED|Washout After 2nd Treatment||0
5257378|NCT00762177|12925858|P3|COMPLETED|Washout After 2nd Treatment||8
5257379|NCT00762177|12925859|P2|COMPLETED|Washout After 2nd Treatment||8
5257380|NCT00762177|12925860|P1|COMPLETED|Washout After 2nd Treatment||8
5257381|NCT00762177|12925858|P3|STARTED|Washout After 2nd Treatment||8
5257382|NCT00762177|12925859|P2|STARTED|Washout After 2nd Treatment||8
5257383|NCT00762177|12925860|P1|STARTED|Washout After 2nd Treatment||8
5257384|NCT00762177|12925858|P3|NOT COMPLETED|2nd Treatment Period||0
5257385|NCT00762177|12925859|P2|NOT COMPLETED|2nd Treatment Period||0
5257386|NCT00762177|12925860|P1|NOT COMPLETED|2nd Treatment Period||0
5257387|NCT00762177|12925858|P3|COMPLETED|2nd Treatment Period||8
5257388|NCT00762177|12925859|P2|COMPLETED|2nd Treatment Period||8
5257389|NCT00762177|12925860|P1|COMPLETED|2nd Treatment Period||8
5257390|NCT00762177|12925858|P3|STARTED|2nd Treatment Period||8
5257391|NCT00762177|12925859|P2|STARTED|2nd Treatment Period||8
5257392|NCT00762177|12925860|P1|STARTED|2nd Treatment Period||8
5257393|NCT00762177|12925858|P3|NOT COMPLETED|Washout After 1st Treatment||0
5257394|NCT00762177|12925859|P2|NOT COMPLETED|Washout After 1st Treatment||0
5257395|NCT00762177|12925860|P1|NOT COMPLETED|Washout After 1st Treatment||0
5257396|NCT00762177|12925858|P3|COMPLETED|Washout After 1st Treatment||8
5257397|NCT00762177|12925859|P2|COMPLETED|Washout After 1st Treatment||8
5257398|NCT00762177|12925860|P1|COMPLETED|Washout After 1st Treatment||8
5257399|NCT00762177|12925858|P3|STARTED|Washout After 1st Treatment||8
5257400|NCT00762177|12925859|P2|STARTED|Washout After 1st Treatment||8
5257401|NCT00762177|12925860|P1|STARTED|Washout After 1st Treatment||8
5257402|NCT00762177|12925858|P3|NOT COMPLETED|1st Treatment Period||0
5257403|NCT00762177|12925859|P2|NOT COMPLETED|1st Treatment Period||0
5257404|NCT00762177|12925860|P1|NOT COMPLETED|1st Treatment Period||0
5257405|NCT00762177|12925858|P3|COMPLETED|1st Treatment Period||8
5257406|NCT00762177|12925859|P2|COMPLETED|1st Treatment Period||8
5257407|NCT00762177|12925860|P1|COMPLETED|1st Treatment Period||8
5257408|NCT00762177|12925858|P3|STARTED|1st Treatment Period||8
5257409|NCT00762177|12925859|P2|STARTED|1st Treatment Period||8
5257410|NCT00762177|12925860|P1|STARTED|1st Treatment Period||8
5257411|NCT00762164|12925939|P2|NOT COMPLETED|Overall Study||2
5257412|NCT00762164|12925940|P1|NOT COMPLETED|Overall Study||3
5257413|NCT00762164|12925939|P2|COMPLETED|Overall Study||15
5257414|NCT00762164|12925940|P1|COMPLETED|Overall Study||14
5257415|NCT00762164|12925939|P2|STARTED|Overall Study||17
5257416|NCT00762164|12925940|P1|STARTED|Overall Study||17
5257417|NCT00762086|12925950|P2|NOT COMPLETED|Overall Study||4
5257418|NCT00762086|12925951|P1|NOT COMPLETED|Overall Study||6
5257419|NCT00762086|12925950|P2|COMPLETED|Overall Study||24
5257420|NCT00762086|12925951|P1|COMPLETED|Overall Study||33
5257421|NCT00762086|12925950|P2|STARTED|Overall Study||28
5257422|NCT00762086|12925951|P1|STARTED|Overall Study||39
5257423|NCT00762073|12925961|P4|NOT COMPLETED|Overall Study||3
5257424|NCT00762073|12925962|P3|NOT COMPLETED|Overall Study||2
5257425|NCT00762073|12925963|P2|NOT COMPLETED|Overall Study||4
5257426|NCT00762073|12925964|P1|NOT COMPLETED|Overall Study||4
5257427|NCT00762073|12925961|P4|COMPLETED|Overall Study||17
5257428|NCT00762073|12925962|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
5257429|NCT00762073|12925963|P2|COMPLETED|Overall Study||17
5257430|NCT00762073|12925964|P1|COMPLETED|Overall Study||17
5257431|NCT00762073|12925961|P4|STARTED|Overall Study||20
5257432|NCT00762073|12925962|P3|STARTED|Overall Study||20
5257433|NCT00762073|12925963|P2|STARTED|Overall Study||21
5257434|NCT00762073|12925964|P1|STARTED|Overall Study||21
5257435|NCT00762034|12926028|P2|NOT COMPLETED|Maintenance Period||298
5257436|NCT00762034|12926029|P1|NOT COMPLETED|Maintenance Period||294
5257437|NCT00762034|12926028|P2|COMPLETED|Maintenance Period||0
5257438|NCT00762034|12926029|P1|COMPLETED|Maintenance Period||0
5257439|NCT00762034|12926028|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
5257440|NCT00762034|12926029|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
5257441|NCT00762034|12926028|P2|STARTED|Maintenance Period||298
5257442|NCT00762034|12926029|P1|STARTED|Maintenance Period||294
5257443|NCT00762034|12926028|P2|NOT COMPLETED|Induction Period||169
5257444|NCT00762034|12926029|P1|NOT COMPLETED|Induction Period||178
5257445|NCT00762034|12926028|P2|COMPLETED|Induction Period||298
5257446|NCT00762034|12926029|P1|COMPLETED|Induction Period||294
5257447|NCT00762034|12926028|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
5257448|NCT00762034|12926029|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
5257449|NCT00762034|12926028|P2|STARTED|Induction Period||467
5257450|NCT00762034|12926029|P1|STARTED|Induction Period||472
5257451|NCT00762021|12926088|P2|NOT COMPLETED|Overall Study||8
5257452|NCT00762021|12926089|P1|NOT COMPLETED|Overall Study||8
5257453|NCT00762021|12926088|P2|COMPLETED|Overall Study||44
5257454|NCT00762021|12926089|P1|COMPLETED|Overall Study||44
5257455|NCT00762021|12926088|P2|STARTED|Overall Study||52
5257456|NCT00762021|12926089|P1|STARTED|Overall Study||52
5257457|NCT00761969|12926101|P2|NOT COMPLETED|Overall Study||140
5257458|NCT00761969|12926102|P1|NOT COMPLETED|Overall Study||200
5257459|NCT00761969|12926101|P2|COMPLETED|Overall Study||573
5257460|NCT00761969|12926102|P1|COMPLETED|Overall Study||542
5257461|NCT00761969|12926101|P2|STARTED|Overall Study||713
5257462|NCT00761969|12926102|P1|STARTED|Overall Study||742
5257463|NCT00761956|12926112|P2|NOT COMPLETED|Overall Study||54
5257464|NCT00761956|12926113|P1|NOT COMPLETED|Overall Study||35
5257465|NCT00761956|12926112|P2|COMPLETED|Overall Study||48
5257466|NCT00761956|12926113|P1|COMPLETED|Overall Study||52
5257467|NCT00761956|12926112|P2|STARTED|Overall Study||102
5257468|NCT00761956|12926113|P1|STARTED|Overall Study||87
5257469|NCT00761930|12926124|P3|NOT COMPLETED|Overall Study||0
5257470|NCT00761930|12926125|P2|NOT COMPLETED|Overall Study||0
5257471|NCT00761930|12926126|P1|NOT COMPLETED|Overall Study||0
5257472|NCT00761930|12926124|P3|COMPLETED|Overall Study||35
5257473|NCT00761930|12926125|P2|COMPLETED|Overall Study||34
5257474|NCT00761930|12926126|P1|COMPLETED|Overall Study||34
5257475|NCT00761930|12926124|P3|STARTED|Overall Study||35
5257476|NCT00761930|12926125|P2|STARTED|Overall Study||34
5257477|NCT00761930|12926126|P1|STARTED|Overall Study||34
5257478|NCT00761891|12926140|P1|NOT COMPLETED|Overall Study||10
5257479|NCT00761891|12926140|P1|COMPLETED|Overall Study||54
5257480|NCT00761891|12926140|P1|STARTED|Overall Study||64
5257481|NCT00761865|12926147|P2|NOT COMPLETED|Overall Study||7
5257482|NCT00761865|12926148|P1|NOT COMPLETED|Overall Study||8
5257483|NCT00761865|12926147|P2|COMPLETED|Overall Study||11
5257484|NCT00761865|12926148|P1|COMPLETED|Overall Study||8
5257485|NCT00761865|12926147|P2|STARTED|Overall Study||18
5257486|NCT00761865|12926148|P1|STARTED|Overall Study||16
5257487|NCT00761813|12926158|P2|NOT COMPLETED|Overall Study||14
5257488|NCT00761813|12926159|P1|NOT COMPLETED|Overall Study||15
5257489|NCT00761813|12926158|P2|COMPLETED|Overall Study||537
5257490|NCT00761813|12926159|P1|COMPLETED|Overall Study||542
5257491|NCT00761813|12926158|P2|STARTED|Overall Study||551
5257492|NCT00761813|12926159|P1|STARTED|Overall Study||557
5257493|NCT00761774|12926169|P1|NOT COMPLETED|Overall Study||79
5257494|NCT00761774|12926169|P1|COMPLETED|Overall Study||29
5257495|NCT00761774|12926169|P1|STARTED|Overall Study||108
5257496|NCT00761761|12926180|P2|NOT COMPLETED|Overall Study||1
5257497|NCT00761761|12926181|P1|NOT COMPLETED|Overall Study||6
5257498|NCT00761761|12926180|P2|COMPLETED|Overall Study||29
5257499|NCT00761761|12926181|P1|COMPLETED|Overall Study||24
5257500|NCT00761761|12926180|P2|STARTED|Overall Study||30
5257501|NCT00761761|12926181|P1|STARTED|Overall Study||30
5257502|NCT00761748|12926193|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
5257503|NCT00761748|12926194|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
5257504|NCT00761748|12926193|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
5257505|NCT00761748|12926194|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
5257506|NCT00761748|12926193|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
5257507|NCT00761748|12926194|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
5257508|NCT00761748|12926193|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
5257509|NCT00761748|12926194|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
5257510|NCT00761748|12926193|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
5257511|NCT00761748|12926194|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
5257512|NCT00761748|12926193|P2|STARTED|First Intervention (21 +/- 3 Days)||10
5257513|NCT00761748|12926194|P1|STARTED|First Intervention (21 +/- 3 Days)||20
5257514|NCT00761735|12926200|P1|NOT COMPLETED|Overall Study||14
5257515|NCT00761735|12926200|P1|COMPLETED|Overall Study||80
5257516|NCT00761735|12926200|P1|STARTED|Overall Study||94
5257517|NCT00761631|12926216|P6|NOT COMPLETED|Overall Study||5
5257518|NCT00761631|12926217|P5|NOT COMPLETED|Overall Study||22
5257519|NCT00761631|12926218|P4|NOT COMPLETED|Overall Study||3
5257520|NCT00761631|12926219|P3|NOT COMPLETED|Overall Study||16
5257521|NCT00761631|12926220|P2|NOT COMPLETED|Overall Study||7
5257522|NCT00761631|12926221|P1|NOT COMPLETED|Overall Study||15
5257523|NCT00761631|12926216|P6|COMPLETED|Overall Study||294
5257524|NCT00761631|12926217|P5|COMPLETED|Overall Study||277
5257525|NCT00761631|12926218|P4|COMPLETED|Overall Study||116
5257526|NCT00761631|12926219|P3|COMPLETED|Overall Study||160
5257527|NCT00761631|12926220|P2|COMPLETED|Overall Study||174
5257528|NCT00761631|12926221|P1|COMPLETED|Overall Study||111
5257529|NCT00761631|12926216|P6|Vaccinated Dose 2|Overall Study||0
5257530|NCT00761631|12926217|P5|Vaccinated Dose 2|Overall Study||0
5257531|NCT00761631|12926218|P4|Vaccinated Dose 2|Overall Study||0
5257532|NCT00761631|12926219|P3|Vaccinated Dose 2|Overall Study||165
5257533|NCT00761631|12926220|P2|Vaccinated Dose 2|Overall Study||0
5257534|NCT00761631|12926221|P1|Vaccinated Dose 2|Overall Study||112
5257535|NCT00761631|12926216|P6|Vaccinated Dose 1|Overall Study||298
5257536|NCT00761631|12926217|P5|Vaccinated Dose 1|Overall Study||294
5257537|NCT00761631|12926218|P4|Vaccinated Dose 1|Overall Study||118
5257538|NCT00761631|12926219|P3|Vaccinated Dose 1|Overall Study||175
5257539|NCT00761631|12926220|P2|Vaccinated Dose 1|Overall Study||179
5257540|NCT00761631|12926221|P1|Vaccinated Dose 1|Overall Study||124
5257541|NCT00761631|12926216|P6|STARTED|Overall Study||299
5257542|NCT00761631|12926217|P5|STARTED|Overall Study||299
5257543|NCT00761631|12926218|P4|STARTED|Overall Study||119
5257544|NCT00761631|12926219|P3|STARTED|Overall Study||176
5257545|NCT00761631|12926220|P2|STARTED|Overall Study||181
5257546|NCT00761631|12926221|P1|STARTED|Overall Study||126
5257547|NCT00761605|12926256|P1|NOT COMPLETED|Overall Study||141
5257548|NCT00761605|12926256|P1|COMPLETED|Overall Study||246
5257549|NCT00761605|12926256|P1|STARTED|Overall Study||387
5257550|NCT00761592|12926285|P2|NOT COMPLETED|Overall Study||1
5257551|NCT00761592|12926286|P1|NOT COMPLETED|Overall Study||1
5257552|NCT00761592|12926285|P2|COMPLETED|Overall Study||32
5257553|NCT00761592|12926286|P1|COMPLETED|Overall Study||31
5257554|NCT00761592|12926285|P2|STARTED|Overall Study||33
5257555|NCT00761592|12926286|P1|STARTED|Overall Study||32
5257556|NCT00761579|12926300|P1|NOT COMPLETED|Overall Study||92
5257557|NCT00761579|12926300|P1|COMPLETED|Overall Study||98
5257558|NCT00761579|12926300|P1|STARTED|Overall Study||190
5257559|NCT00761527|12926333|P1|NOT COMPLETED|Overall Study||22
5257560|NCT00761527|12926333|P1|COMPLETED|Overall Study||2958
5257561|NCT00761527|12926333|P1|Received One Dose of Study Medication|Overall Study||2978
5257562|NCT00761527|12926333|P1|STARTED|Overall Study||2980
5257563|NCT00761514|12926340|P1|NOT COMPLETED|Overall Study||7
5257564|NCT00761514|12926340|P1|COMPLETED|Overall Study||7
5257565|NCT00761514|12926340|P1|STARTED|Overall Study||14
5257566|NCT00761462|12926347|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
5257567|NCT00761462|12926348|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
5257568|NCT00761462|12926347|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
5257569|NCT00761462|12926348|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
5257570|NCT00761462|12926347|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
5257571|NCT00761462|12926348|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
5257572|NCT00761462|12926347|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
5257573|NCT00761462|12926348|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
5257574|NCT00761462|12926347|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
5257575|NCT00761462|12926348|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
5257576|NCT00761462|12926347|P2|NOT COMPLETED|Treatment||12
5257577|NCT00761462|12926348|P1|NOT COMPLETED|Treatment||23
5257578|NCT00761462|12926347|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
5257579|NCT00761462|12926348|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
5257580|NCT00761462|12926347|P2|STARTED|Treatment|Patients enrolled in study group|519
5257581|NCT00761462|12926348|P1|STARTED|Treatment|Patients enrolled in study group|510
5257582|NCT00761345|12926356|P1|NOT COMPLETED|Overall Study||3
5257583|NCT00761345|12926356|P1|COMPLETED|Overall Study||24
5257584|NCT00761345|12926356|P1|STARTED|Overall Study||27
5257585|NCT00761319|12926362|P2|NOT COMPLETED|Overall Study||34
5257586|NCT00761319|12926363|P1|NOT COMPLETED|Overall Study||48
5257587|NCT00761319|12926362|P2|COMPLETED|Overall Study||318
5257588|NCT00761319|12926363|P1|COMPLETED|Overall Study||305
5257589|NCT00761319|12926362|P2|STARTED|Overall Study||352
5257590|NCT00761319|12926363|P1|STARTED|Overall Study||353
5257591|NCT00761306|12926371|P1|NOT COMPLETED|Overall Study||20
5257592|NCT00761306|12926371|P1|COMPLETED|Overall Study||54
5257593|NCT00761306|12926371|P1|STARTED|Overall Study||74
5257594|NCT00761280|12926382|P2|NOT COMPLETED|First Dose to End of Study||11
5257595|NCT00761280|12926383|P1|NOT COMPLETED|First Dose to End of Study||12
5257596|NCT00761280|12926382|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
5257597|NCT00761280|12926383|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
5257598|NCT00761280|12926382|P2|STARTED|First Dose to End of Study||11
5257599|NCT00761280|12926383|P1|STARTED|First Dose to End of Study||12
5257600|NCT00761280|12926382|P2|NOT COMPLETED|Randomization to First Dose||2
5257601|NCT00761280|12926383|P1|NOT COMPLETED|Randomization to First Dose||2
5257602|NCT00761280|12926382|P2|COMPLETED|Randomization to First Dose||11
5257603|NCT00761280|12926383|P1|COMPLETED|Randomization to First Dose||12
5257604|NCT00761280|12926382|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
5257605|NCT00761280|12926383|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
5257606|NCT00761280|12926382|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
5257607|NCT00761280|12926383|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
5257608|NCT00761280|12926382|P2|STARTED|Randomization to First Dose||13
5257609|NCT00761280|12926383|P1|STARTED|Randomization to First Dose||14
5257610|NCT00761267|12926414|P3|NOT COMPLETED|Overall Study||6
5257611|NCT00761267|12926415|P2|NOT COMPLETED|Overall Study||4
5257612|NCT00761267|12926416|P1|NOT COMPLETED|Overall Study||2
5257613|NCT00761267|12926414|P3|COMPLETED|Overall Study||24
5257614|NCT00761267|12926415|P2|COMPLETED|Overall Study||16
5257615|NCT00761267|12926416|P1|COMPLETED|Overall Study||18
5257616|NCT00761267|12926414|P3|Treated|Overall Study||30
5257617|NCT00761267|12926415|P2|Treated|Overall Study||19
5257618|NCT00761267|12926416|P1|Treated|Overall Study||19
5257619|NCT00761267|12926414|P3|STARTED|Overall Study||30
5257620|NCT00761267|12926415|P2|STARTED|Overall Study||20
5257621|NCT00761267|12926416|P1|STARTED|Overall Study||20
5257622|NCT00761215|12926467|P3|NOT COMPLETED|Overall Study||8
5257623|NCT00761215|12926468|P2|NOT COMPLETED|Overall Study||4
5257624|NCT00761215|12926469|P1|NOT COMPLETED|Overall Study||9
5257625|NCT00761215|12926467|P3|COMPLETED|Overall Study||56
5257626|NCT00761215|12926468|P2|COMPLETED|Overall Study||60
5257627|NCT00761215|12926469|P1|COMPLETED|Overall Study||55
5257628|NCT00761215|12926467|P3|STARTED|Overall Study||64
5257629|NCT00761215|12926468|P2|STARTED|Overall Study||64
5257630|NCT00761215|12926469|P1|STARTED|Overall Study||64
5257631|NCT00761202|12926494|P2|NOT COMPLETED|Overall Study||2
5257632|NCT00761202|12926495|P1|NOT COMPLETED|Overall Study||1
5257633|NCT00761202|12926494|P2|COMPLETED|Overall Study||26
5257634|NCT00761202|12926495|P1|COMPLETED|Overall Study||21
5257635|NCT00761202|12926494|P2|STARTED|Overall Study||28
5257636|NCT00761202|12926495|P1|STARTED|Overall Study||22
5257637|NCT00761189|12926511|P1|NOT COMPLETED|Overall Study||185
5257638|NCT00761189|12926511|P1|COMPLETED|Overall Study||306
5257639|NCT00761189|12926511|P1|STARTED|Overall Study||491
5257640|NCT00761176|12926528|P2|NOT COMPLETED|Overall Study||1
5257641|NCT00761176|12926529|P1|NOT COMPLETED|Overall Study||2
5257642|NCT00761176|12926528|P2|COMPLETED|Overall Study||3
5257643|NCT00761176|12926529|P1|COMPLETED|Overall Study||2
5257644|NCT00761176|12926528|P2|STARTED|Overall Study||4
5257645|NCT00761176|12926529|P1|STARTED|Overall Study||4
5257646|NCT00761150|12926538|P3|NOT COMPLETED|Double-blind Period||29
5257647|NCT00761150|12926539|P2|NOT COMPLETED|Double-blind Period||14
5257648|NCT00761150|12926540|P1|NOT COMPLETED|Double-blind Period||0
5257649|NCT00761150|12926538|P3|COMPLETED|Double-blind Period||89
5257650|NCT00761150|12926539|P2|COMPLETED|Double-blind Period||106
5257651|NCT00761150|12926540|P1|COMPLETED|Double-blind Period||0
5257652|NCT00761150|12926538|P3|STARTED|Double-blind Period||118
5257653|NCT00761150|12926539|P2|STARTED|Double-blind Period||120
5257654|NCT00761150|12926540|P1|STARTED|Double-blind Period||0
5257655|NCT00761150|12926538|P3|NOT COMPLETED|Open-label Period||0
5257656|NCT00761150|12926539|P2|NOT COMPLETED|Open-label Period||0
5257657|NCT00761150|12926540|P1|NOT COMPLETED|Open-label Period||70
5257658|NCT00761150|12926538|P3|COMPLETED|Open-label Period||0
5257659|NCT00761150|12926539|P2|COMPLETED|Open-label Period||0
5257660|NCT00761150|12926540|P1|COMPLETED|Open-label Period||238
5257661|NCT00761150|12926538|P3|STARTED|Open-label Period||0
5257662|NCT00761150|12926539|P2|STARTED|Open-label Period||0
5257663|NCT00761150|12926540|P1|STARTED|Open-label Period||308
5257664|NCT00761137|12926549|P1|NOT COMPLETED|Overall Study||0
5257665|NCT00761137|12926549|P1|COMPLETED|Overall Study||19
5257666|NCT00761137|12926549|P1|3 mg Tropicamide|Overall Study||19
5257667|NCT00761137|12926549|P1|1 mg Tropicamide|Overall Study||19
5257668|NCT00761137|12926549|P1|0.3 mg Tropicamide|Overall Study||19
5257669|NCT00761137|12926549|P1|Placebo|Overall Study||19
5257670|NCT00761137|12926549|P1|STARTED|Overall Study||19
5257671|NCT00761085|12926564|P4|NOT COMPLETED|Overall Study||4
5257672|NCT00761085|12926565|P3|NOT COMPLETED|Overall Study||0
5257673|NCT00761085|12926566|P2|NOT COMPLETED|Overall Study||6
5257674|NCT00761085|12926567|P1|NOT COMPLETED|Overall Study||0
5257675|NCT00761085|12926564|P4|COMPLETED|Overall Study||8
5257676|NCT00761085|12926565|P3|COMPLETED|Overall Study||11
5257677|NCT00761085|12926566|P2|COMPLETED|Overall Study||6
5257678|NCT00761085|12926567|P1|COMPLETED|Overall Study||12
5257679|NCT00761085|12926564|P4|STARTED|Overall Study||12
5257680|NCT00761085|12926565|P3|STARTED|Overall Study||11
5257681|NCT00761085|12926566|P2|STARTED|Overall Study||12
5257682|NCT00761085|12926567|P1|STARTED|Overall Study||12
5257683|NCT00761007|12926585|P4|NOT COMPLETED|Overall Study||7
5257684|NCT00761007|12926586|P3|NOT COMPLETED|Overall Study||18
5257685|NCT00761007|12926587|P2|NOT COMPLETED|Overall Study||11
5257686|NCT00761007|12926588|P1|NOT COMPLETED|Overall Study||13
5257687|NCT00761007|12926585|P4|COMPLETED|Overall Study||131
5257688|NCT00761007|12926586|P3|COMPLETED|Overall Study||121
5257689|NCT00761007|12926587|P2|COMPLETED|Overall Study||124
5257690|NCT00761007|12926588|P1|COMPLETED|Overall Study||129
5257691|NCT00761007|12926585|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
5257692|NCT00761007|12926586|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
5257693|NCT00761007|12926587|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
5257694|NCT00761007|12926588|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
5257695|NCT00761007|12926585|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
5257696|NCT00761007|12926586|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
5257697|NCT00761007|12926587|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
5257698|NCT00761007|12926588|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
5257699|NCT00761007|12926585|P4|STARTED|Overall Study||138
5257700|NCT00761007|12926586|P3|STARTED|Overall Study||139
5257701|NCT00761007|12926587|P2|STARTED|Overall Study||135
5257702|NCT00761007|12926588|P1|STARTED|Overall Study||142
5257703|NCT00760877|12926612|P2|NOT COMPLETED|Overall Study||26
5257704|NCT00760877|12926613|P1|NOT COMPLETED|Overall Study||45
5257705|NCT00760877|12926612|P2|COMPLETED|Overall Study||77
5257706|NCT00760877|12926613|P1|COMPLETED|Overall Study||59
5257707|NCT00760877|12926612|P2|Safety Set|Overall Study||103
5257708|NCT00760877|12926613|P1|Safety Set|Overall Study||101
5257709|NCT00760877|12926612|P2|Cross-over to Nilotinib|Overall Study||46
5257710|NCT00760877|12926613|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
5257711|NCT00760877|12926612|P2|STARTED|Overall Study||103
5257712|NCT00760877|12926613|P1|STARTED|Overall Study||104
5257713|NCT00760838|12926631|P2|NOT COMPLETED|Overall Study||2
5257714|NCT00760838|12926632|P1|NOT COMPLETED|Overall Study||5
5257715|NCT00760838|12926631|P2|COMPLETED|Overall Study||53
5257716|NCT00760838|12926632|P1|COMPLETED|Overall Study||49
5257717|NCT00760838|12926631|P2|STARTED|Overall Study||55
5257718|NCT00760838|12926632|P1|STARTED|Overall Study||54
5257719|NCT00760747|12926650|P2|NOT COMPLETED|Study Period III||3
5257720|NCT00760747|12926651|P1|NOT COMPLETED|Study Period III||3
5257721|NCT00760747|12926650|P2|COMPLETED|Study Period III||38
5257722|NCT00760747|12926651|P1|COMPLETED|Study Period III||41
5257723|NCT00760747|12926650|P2|STARTED|Study Period III||41
5257724|NCT00760747|12926651|P1|STARTED|Study Period III||44
5257725|NCT00760747|12926650|P2|NOT COMPLETED|Study Period II||14
5257726|NCT00760747|12926651|P1|NOT COMPLETED|Study Period II||13
5257727|NCT00760747|12926650|P2|COMPLETED|Study Period II||41
5257728|NCT00760747|12926651|P1|COMPLETED|Study Period II||44
5257729|NCT00760747|12926650|P2|Received at Least One Dose of Study Drug|Study Period II||54
5257730|NCT00760747|12926651|P1|Received at Least One Dose of Study Drug|Study Period II||57
5257731|NCT00760747|12926650|P2|STARTED|Study Period II||55
5257732|NCT00760747|12926651|P1|STARTED|Study Period II||57
5257733|NCT00760669|12926679|P1|NOT COMPLETED|Overall Study||30
5257734|NCT00760669|12926679|P1|COMPLETED|Overall Study||1031
5257735|NCT00760669|12926679|P1|STARTED|Overall Study||1061
5257736|NCT00760617|12926696|P3|NOT COMPLETED|Overall Study||5
5257737|NCT00760617|12926697|P2|NOT COMPLETED|Overall Study||2
5257738|NCT00760617|12926698|P1|NOT COMPLETED|Overall Study||5
5257739|NCT00760617|12926696|P3|COMPLETED|Overall Study||111
5257740|NCT00760617|12926697|P2|COMPLETED|Overall Study||142
5257741|NCT00760617|12926698|P1|COMPLETED|Overall Study||261
5257742|NCT00760617|12926696|P3|STARTED|Overall Study||116
5257743|NCT00760617|12926697|P2|STARTED|Overall Study||144
5257744|NCT00760617|12926698|P1|STARTED|Overall Study||266
5257745|NCT00760578|12926773|P4|NOT COMPLETED|Overall Study||4
5257746|NCT00760578|12926774|P3|NOT COMPLETED|Overall Study||5
5257747|NCT00760578|12926775|P2|NOT COMPLETED|Overall Study||2
5257748|NCT00760578|12926776|P1|NOT COMPLETED|Overall Study||3
5257749|NCT00760578|12926773|P4|COMPLETED|Overall Study||18
5257750|NCT00760578|12926774|P3|COMPLETED|Overall Study||16
5257751|NCT00760578|12926775|P2|COMPLETED|Overall Study||19
5257752|NCT00760578|12926776|P1|COMPLETED|Overall Study||19
5257753|NCT00760578|12926773|P4|Entered Drug Treatment Period|Overall Study||22
5257754|NCT00760578|12926774|P3|Entered Drug Treatment Period|Overall Study||19
5257755|NCT00760578|12926775|P2|Entered Drug Treatment Period|Overall Study||20
5257756|NCT00760578|12926776|P1|Entered Drug Treatment Period|Overall Study||21
5257757|NCT00760578|12926773|P4|STARTED|Overall Study||22
5257758|NCT00760578|12926774|P3|STARTED|Overall Study||21
5257759|NCT00760578|12926775|P2|STARTED|Overall Study||21
5257760|NCT00760578|12926776|P1|STARTED|Overall Study||22
5257761|NCT00760552|12926812|P2|NOT COMPLETED|Overall Study||10
5257762|NCT00760552|12926813|P1|NOT COMPLETED|Overall Study||13
5257763|NCT00760552|12926812|P2|COMPLETED|Overall Study||52
5257764|NCT00760552|12926813|P1|COMPLETED|Overall Study||48
5257765|NCT00760552|12926812|P2|STARTED|Overall Study||62
5257766|NCT00760552|12926813|P1|STARTED|Overall Study||61
5257767|NCT00760526|12926821|P2|NOT COMPLETED|Overall Study||4
5257768|NCT00760526|12926822|P1|NOT COMPLETED|Overall Study||5
5257769|NCT00760526|12926821|P2|COMPLETED|Overall Study||68
5257770|NCT00760526|12926822|P1|COMPLETED|Overall Study||69
5257771|NCT00760526|12926821|P2|STARTED|Overall Study||72
5257772|NCT00760526|12926822|P1|STARTED|Overall Study||74
5257773|NCT00760513|12926849|P2|NOT COMPLETED|Overall Study||7
5257774|NCT00760513|12926850|P1|NOT COMPLETED|Overall Study||5
5257775|NCT00760513|12926849|P2|COMPLETED|Overall Study||45
5257776|NCT00760513|12926850|P1|COMPLETED|Overall Study||46
5257777|NCT00760513|12926849|P2|STARTED|Overall Study||52
5257778|NCT00760513|12926850|P1|STARTED|Overall Study||51
5257779|NCT00760487|12926860|P1|NOT COMPLETED|Overall Study||3
5257780|NCT00760487|12926860|P1|COMPLETED|Overall Study||117
5257781|NCT00760487|12926860|P1|STARTED|Overall Study||120
5257782|NCT00760474|12926866|P2|NOT COMPLETED|Period 2 (P2)||1
5257783|NCT00760474|12926867|P1|NOT COMPLETED|Period 2 (P2)||1
5257784|NCT00760474|12926866|P2|COMPLETED|Period 2 (P2)||11
5257785|NCT00760474|12926867|P1|COMPLETED|Period 2 (P2)||11
5257786|NCT00760474|12926866|P2|STARTED|Period 2 (P2)||12
5257787|NCT00760474|12926867|P1|STARTED|Period 2 (P2)||12
5257788|NCT00760474|12926866|P2|NOT COMPLETED|Placebo Washout Period||1
5257789|NCT00760474|12926867|P1|NOT COMPLETED|Placebo Washout Period||0
5257790|NCT00760474|12926866|P2|COMPLETED|Placebo Washout Period||12
5257791|NCT00760474|12926867|P1|COMPLETED|Placebo Washout Period||12
5257792|NCT00760474|12926866|P2|STARTED|Placebo Washout Period||13
5257793|NCT00760474|12926867|P1|STARTED|Placebo Washout Period||12
5257794|NCT00760474|12926866|P2|NOT COMPLETED|Period 1 (P1)||1
5257795|NCT00760474|12926867|P1|NOT COMPLETED|Period 1 (P1)||1
5257796|NCT00760474|12926866|P2|COMPLETED|Period 1 (P1)||13
5257797|NCT00760474|12926867|P1|COMPLETED|Period 1 (P1)||12
5257798|NCT00760474|12926866|P2|Overall Number of Unique Participants|Period 1 (P1)||13
5257799|NCT00760474|12926867|P1|Overall Number of Unique Participants|Period 1 (P1)||12
5257800|NCT00760474|12926866|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
5257801|NCT00760474|12926867|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
5257802|NCT00760474|12926866|P2|STARTED|Period 1 (P1)||14
5257803|NCT00760474|12926867|P1|STARTED|Period 1 (P1)||13
5257804|NCT00760461|12926903|P1|NOT COMPLETED|Overall Study||44
5257805|NCT00760461|12926903|P1|COMPLETED|Overall Study||0
5257806|NCT00760461|12926903|P1|STARTED|Overall Study||44
5257807|NCT00760435|12926909|P2|NOT COMPLETED|Overall Study||5
5257808|NCT00760435|12926910|P1|NOT COMPLETED|Overall Study||4
5257809|NCT00760435|12926909|P2|COMPLETED|Overall Study||93
5257810|NCT00760435|12926910|P1|COMPLETED|Overall Study||94
5257811|NCT00760435|12926909|P2|STARTED|Overall Study||98
5257812|NCT00760435|12926910|P1|STARTED|Overall Study||98
5257813|NCT00760383|12926924|P2|NOT COMPLETED|Overall Study||7
5257814|NCT00760383|12926925|P1|NOT COMPLETED|Overall Study||5
5257815|NCT00760383|12926924|P2|COMPLETED|Overall Study||12
5257816|NCT00760383|12926925|P1|COMPLETED|Overall Study||16
5257817|NCT00760383|12926924|P2|STARTED|Overall Study||19
5257818|NCT00760383|12926925|P1|STARTED|Overall Study||21
5257819|NCT00760266|12926937|P2|NOT COMPLETED|Overall Study||18
5257820|NCT00760266|12926938|P1|NOT COMPLETED|Overall Study||24
5257821|NCT00760266|12926937|P2|COMPLETED|Overall Study||205
5257822|NCT00760266|12926938|P1|COMPLETED|Overall Study||204
5257823|NCT00760266|12926937|P2|STARTED|Overall Study||223
5257824|NCT00760266|12926938|P1|STARTED|Overall Study||228
5257825|NCT00760214|12926955|P3|NOT COMPLETED|Overall Study||41
5257826|NCT00760214|12926956|P2|NOT COMPLETED|Overall Study||30
5257827|NCT00760214|12926957|P1|NOT COMPLETED|Overall Study||30
5257828|NCT00760214|12926955|P3|COMPLETED|Overall Study||255
5257829|NCT00760214|12926956|P2|COMPLETED|Overall Study||264
5257830|NCT00760214|12926957|P1|COMPLETED|Overall Study||265
5257831|NCT00760214|12926955|P3|STARTED|Overall Study||296
5257832|NCT00760214|12926956|P2|STARTED|Overall Study||294
5257833|NCT00760214|12926957|P1|STARTED|Overall Study||295
5257834|NCT00760084|12926998|P1|NOT COMPLETED|Overall Study||10
5257835|NCT00760084|12926998|P1|COMPLETED|Overall Study||0
5257836|NCT00760084|12926998|P1|STARTED|Overall Study||10
5257837|NCT00760019|12927004|P4|NOT COMPLETED|Overall Study||0
5257838|NCT00760019|12927005|P3|NOT COMPLETED|Overall Study||0
5257839|NCT00760019|12927006|P2|NOT COMPLETED|Overall Study||0
5257840|NCT00760019|12927007|P1|NOT COMPLETED|Overall Study||0
5257841|NCT00760019|12927004|P4|COMPLETED|Overall Study||14
5257842|NCT00760019|12927005|P3|COMPLETED|Overall Study||14
5257843|NCT00760019|12927006|P2|COMPLETED|Overall Study||15
5257844|NCT00760019|12927007|P1|COMPLETED|Overall Study||15
5257845|NCT00760019|12927004|P4|STARTED|Overall Study||14
5257846|NCT00760019|12927005|P3|STARTED|Overall Study||14
5257847|NCT00760019|12927006|P2|STARTED|Overall Study||15
5257848|NCT00760019|12927007|P1|STARTED|Overall Study||15
5257849|NCT00760006|12927015|P2|NOT COMPLETED|Overall Study||0
5257850|NCT00760006|12927016|P1|NOT COMPLETED|Overall Study||0
5257851|NCT00760006|12927015|P2|COMPLETED|Overall Study||138
5257852|NCT00760006|12927016|P1|COMPLETED|Overall Study||86
5257853|NCT00760006|12927015|P2|STARTED|Overall Study||138
5257854|NCT00760006|12927016|P1|STARTED|Overall Study||86
5257855|NCT00759967|12927022|P2|NOT COMPLETED|Second Intervention||0
5257856|NCT00759967|12927023|P1|NOT COMPLETED|Second Intervention||2
5257857|NCT00759967|12927022|P2|COMPLETED|Second Intervention||9
5257858|NCT00759967|12927023|P1|COMPLETED|Second Intervention||8
5257859|NCT00759967|12927022|P2|STARTED|Second Intervention||9
5257860|NCT00759967|12927023|P1|STARTED|Second Intervention||10
5257861|NCT00759967|12927022|P2|NOT COMPLETED|First Intervention||0
5257862|NCT00759967|12927023|P1|NOT COMPLETED|First Intervention||0
5257863|NCT00759967|12927022|P2|COMPLETED|First Intervention||9
5257864|NCT00759967|12927023|P1|COMPLETED|First Intervention||10
5257865|NCT00759967|12927022|P2|STARTED|First Intervention||9
5257866|NCT00759967|12927023|P1|STARTED|First Intervention||10
5257867|NCT00759954|12927041|P2|NOT COMPLETED|Overall Study||2
5257868|NCT00759954|12927042|P1|NOT COMPLETED|Overall Study||2
5257869|NCT00759954|12927041|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
5257870|NCT00759954|12927042|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
5257871|NCT00759954|12927041|P2|STARTED|Overall Study|All assigned participants entered trial|18
5257872|NCT00759954|12927042|P1|STARTED|Overall Study|All assigned participants entered trial|18
5257873|NCT00759941|12927056|P2|NOT COMPLETED|Overall Study||1
5257874|NCT00759941|12927057|P1|NOT COMPLETED|Overall Study||3
5257875|NCT00759941|12927056|P2|COMPLETED|Overall Study||43
5257876|NCT00759941|12927057|P1|COMPLETED|Overall Study||39
5257877|NCT00759941|12927056|P2|STARTED|Overall Study||44
5257878|NCT00759941|12927057|P1|STARTED|Overall Study||42
5257879|NCT00759915|12927071|P2|NOT COMPLETED|Overall Study||1
5257880|NCT00759915|12927072|P1|NOT COMPLETED|Overall Study||1
5257881|NCT00759915|12927071|P2|COMPLETED|Overall Study||17
5257882|NCT00759915|12927072|P1|COMPLETED|Overall Study||17
5257883|NCT00759915|12927071|P2|STARTED|Overall Study||18
5257884|NCT00759915|12927072|P1|STARTED|Overall Study||18
5257885|NCT00759902|12927086|P2|NOT COMPLETED|Overall Study||1
5257886|NCT00759902|12927087|P1|NOT COMPLETED|Overall Study||0
5257887|NCT00759902|12927086|P2|COMPLETED|Overall Study||17
5257888|NCT00759902|12927087|P1|COMPLETED|Overall Study||18
5257889|NCT00759902|12927086|P2|STARTED|Overall Study||18
5257890|NCT00759902|12927087|P1|STARTED|Overall Study||18
5257891|NCT00759863|12927101|P2|NOT COMPLETED|Overall Study||18
5257892|NCT00759863|12927102|P1|NOT COMPLETED|Overall Study||20
5257893|NCT00759863|12927101|P2|COMPLETED|Overall Study||80
5257894|NCT00759863|12927102|P1|COMPLETED|Overall Study||124
5257895|NCT00759863|12927101|P2|STARTED|Overall Study||98
5257896|NCT00759863|12927102|P1|STARTED|Overall Study||144
5257897|NCT00759811|12927114|P2|NOT COMPLETED|Overall Study||1
5257898|NCT00759811|12927115|P1|NOT COMPLETED|Overall Study||2
5257899|NCT00759811|12927114|P2|COMPLETED|Overall Study||24
5257900|NCT00759811|12927115|P1|COMPLETED|Overall Study||23
5257901|NCT00759811|12927114|P2|STARTED|Overall Study||25
5257902|NCT00759811|12927115|P1|STARTED|Overall Study||25
5257903|NCT00759785|12927123|P2|NOT COMPLETED|Overall Study||5
5257904|NCT00759785|12927124|P1|NOT COMPLETED|Overall Study||12
5257905|NCT00759785|12927123|P2|COMPLETED|Overall Study||17
5257906|NCT00759785|12927124|P1|COMPLETED|Overall Study||14
5257907|NCT00759785|12927123|P2|Treated|Overall Study||20
5257908|NCT00759785|12927124|P1|Treated|Overall Study||25
5257909|NCT00759785|12927123|P2|STARTED|Overall Study||22
5257910|NCT00759785|12927124|P1|STARTED|Overall Study||26
5257911|NCT00759772|12927138|P2|NOT COMPLETED|Overall Study||0
5257912|NCT00759772|12927139|P1|NOT COMPLETED|Overall Study||0
5257913|NCT00759772|12927138|P2|COMPLETED|Overall Study||11
5257914|NCT00759772|12927139|P1|COMPLETED|Overall Study||12
5257915|NCT00759772|12927138|P2|STARTED|Overall Study||11
5257916|NCT00759772|12927139|P1|STARTED|Overall Study||12
5257917|NCT00759759|12927147|P2|NOT COMPLETED|Overall Study||1
5257918|NCT00759759|12927148|P1|NOT COMPLETED|Overall Study||4
5257919|NCT00759759|12927147|P2|COMPLETED|Overall Study||17
5257920|NCT00759759|12927148|P1|COMPLETED|Overall Study||14
5257921|NCT00759759|12927147|P2|STARTED|Overall Study||18
5257922|NCT00759759|12927148|P1|STARTED|Overall Study||18
5257923|NCT00759707|12927160|P1|NOT COMPLETED|Overall Study||0
5257924|NCT00759707|12927160|P1|COMPLETED|Overall Study||19
5257925|NCT00759707|12927160|P1|STARTED|Overall Study||19
5257926|NCT00759681|12927166|P2|NOT COMPLETED|Overall Study||10
5257927|NCT00759681|12927167|P1|NOT COMPLETED|Overall Study||10
5257928|NCT00759681|12927166|P2|COMPLETED|Overall Study||100
5257929|NCT00759681|12927167|P1|COMPLETED|Overall Study||97
5257930|NCT00759681|12927166|P2|STARTED|Overall Study||110
5257931|NCT00759681|12927167|P1|STARTED|Overall Study||107
5257932|NCT00759668|12927177|P2|NOT COMPLETED|Overall Study||3
5257933|NCT00759668|12927178|P1|NOT COMPLETED|Overall Study||1
5257934|NCT00759668|12927177|P2|COMPLETED|Overall Study||15
5257935|NCT00759668|12927178|P1|COMPLETED|Overall Study||16
5257936|NCT00759668|12927177|P2|STARTED|Overall Study||18
5257937|NCT00759668|12927178|P1|STARTED|Overall Study||17
5257938|NCT00759655|12927194|P1|NOT COMPLETED|Overall Study||1
5257939|NCT00759655|12927194|P1|COMPLETED|Overall Study||0
5257940|NCT00759655|12927194|P1|STARTED|Overall Study||1
5257941|NCT00759642|12927205|P1|NOT COMPLETED|Overall Study||0
5257942|NCT00759642|12927205|P1|COMPLETED|Overall Study||33
5257943|NCT00759642|12927205|P1|STARTED|Overall Study||33
5257944|NCT00759603|12927209|P1|NOT COMPLETED|Overall Study||0
5257945|NCT00759603|12927209|P1|COMPLETED|Overall Study||59
5257946|NCT00759603|12927209|P1|STARTED|Overall Study||59
5257947|NCT00759577|12927213|P1|NOT COMPLETED|Overall Study||0
5257948|NCT00759577|12927213|P1|COMPLETED|Overall Study||36
5257949|NCT00759577|12927213|P1|STARTED|Overall Study||36
5257950|NCT00759564|12927222|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
5257951|NCT00759564|12927223|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
5257952|NCT00759564|12927224|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
5257953|NCT00759564|12927225|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
5257954|NCT00759564|12927226|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
5257955|NCT00759564|12927222|P5|COMPLETED|Second Intervention Period (4 Days)||3
5257956|NCT00759564|12927223|P4|COMPLETED|Second Intervention Period (4 Days)||1
5257957|NCT00759564|12927224|P3|COMPLETED|Second Intervention Period (4 Days)||8
5257958|NCT00759564|12927225|P2|COMPLETED|Second Intervention Period (4 Days)||8
5257959|NCT00759564|12927226|P1|COMPLETED|Second Intervention Period (4 Days)||8
5257960|NCT00759564|12927222|P5|STARTED|Second Intervention Period (4 Days)||3
5257961|NCT00759564|12927223|P4|STARTED|Second Intervention Period (4 Days)||1
5257962|NCT00759564|12927224|P3|STARTED|Second Intervention Period (4 Days)||8
5257963|NCT00759564|12927225|P2|STARTED|Second Intervention Period (4 Days)||8
5257964|NCT00759564|12927226|P1|STARTED|Second Intervention Period (4 Days)||8
5257965|NCT00759564|12927222|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
5257966|NCT00759564|12927223|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5257967|NCT00759564|12927224|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5257968|NCT00759564|12927225|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5257969|NCT00759564|12927226|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
5257970|NCT00759564|12927222|P5|COMPLETED|Washout Period (at Least 14 Days)||3
5257971|NCT00759564|12927223|P4|COMPLETED|Washout Period (at Least 14 Days)||1
5257972|NCT00759564|12927224|P3|COMPLETED|Washout Period (at Least 14 Days)||8
5257973|NCT00759564|12927225|P2|COMPLETED|Washout Period (at Least 14 Days)||8
5257974|NCT00759564|12927226|P1|COMPLETED|Washout Period (at Least 14 Days)||8
5257975|NCT00759564|12927222|P5|STARTED|Washout Period (at Least 14 Days)||4
5257976|NCT00759564|12927223|P4|STARTED|Washout Period (at Least 14 Days)||1
5257977|NCT00759564|12927224|P3|STARTED|Washout Period (at Least 14 Days)||8
5257978|NCT00759564|12927225|P2|STARTED|Washout Period (at Least 14 Days)||8
5257979|NCT00759564|12927226|P1|STARTED|Washout Period (at Least 14 Days)||8
5257980|NCT00759564|12927222|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
5257981|NCT00759564|12927223|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
5257982|NCT00759564|12927224|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
5257983|NCT00759564|12927225|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
5257984|NCT00759564|12927226|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
5257985|NCT00759564|12927222|P5|COMPLETED|First Intervention Period (4 Days)||4
5257986|NCT00759564|12927223|P4|COMPLETED|First Intervention Period (4 Days)||1
5257987|NCT00759564|12927224|P3|COMPLETED|First Intervention Period (4 Days)||8
5257988|NCT00759564|12927225|P2|COMPLETED|First Intervention Period (4 Days)||8
5257989|NCT00759564|12927226|P1|COMPLETED|First Intervention Period (4 Days)||8
5257990|NCT00759564|12927222|P5|STARTED|First Intervention Period (4 Days)||4
5257991|NCT00759564|12927223|P4|STARTED|First Intervention Period (4 Days)||1
5257992|NCT00759564|12927224|P3|STARTED|First Intervention Period (4 Days)||8
5257993|NCT00759564|12927225|P2|STARTED|First Intervention Period (4 Days)||8
5257994|NCT00759564|12927226|P1|STARTED|First Intervention Period (4 Days)||8
5257995|NCT00759525|12927366|P2|NOT COMPLETED|Second Intervention (14 Days)||0
5257996|NCT00759525|12927367|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5257997|NCT00759525|12927366|P2|COMPLETED|Second Intervention (14 Days)||8
5257998|NCT00759525|12927367|P1|COMPLETED|Second Intervention (14 Days)||7
5257999|NCT00759525|12927366|P2|STARTED|Second Intervention (14 Days)||8
5258000|NCT00759525|12927367|P1|STARTED|Second Intervention (14 Days)||7
5258001|NCT00759525|12927366|P2|NOT COMPLETED|Washout (14 Days)||0
5258002|NCT00759525|12927367|P1|NOT COMPLETED|Washout (14 Days)||0
5258003|NCT00759525|12927366|P2|COMPLETED|Washout (14 Days)||8
5258004|NCT00759525|12927367|P1|COMPLETED|Washout (14 Days)||7
5258005|NCT00759525|12927366|P2|STARTED|Washout (14 Days)||8
5258006|NCT00759525|12927367|P1|STARTED|Washout (14 Days)||7
5258007|NCT00759525|12927366|P2|NOT COMPLETED|First Intervention (14 Days)||0
5258008|NCT00759525|12927367|P1|NOT COMPLETED|First Intervention (14 Days)||0
5258009|NCT00759525|12927366|P2|COMPLETED|First Intervention (14 Days)||8
5258010|NCT00759525|12927367|P1|COMPLETED|First Intervention (14 Days)||7
5258011|NCT00759525|12927366|P2|STARTED|First Intervention (14 Days)||8
5258012|NCT00759525|12927367|P1|STARTED|First Intervention (14 Days)||7
5258013|NCT00759473|12927378|P5|NOT COMPLETED|Overall Study||0
5258014|NCT00759473|12927379|P4|NOT COMPLETED|Overall Study||0
5258015|NCT00759473|12927380|P3|NOT COMPLETED|Overall Study||0
5258016|NCT00759473|12927381|P2|NOT COMPLETED|Overall Study||0
5258017|NCT00759473|12927382|P1|NOT COMPLETED|Overall Study||0
5258018|NCT00759473|12927378|P5|COMPLETED|Overall Study||24
5258019|NCT00759473|12927379|P4|COMPLETED|Overall Study||23
5258020|NCT00759473|12927380|P3|COMPLETED|Overall Study||12
5258021|NCT00759473|12927381|P2|COMPLETED|Overall Study||10
5258022|NCT00759473|12927382|P1|COMPLETED|Overall Study||10
5258023|NCT00759473|12927378|P5|STARTED|Overall Study||24
5258024|NCT00759473|12927379|P4|STARTED|Overall Study||23
5258025|NCT00759473|12927380|P3|STARTED|Overall Study||12
5258026|NCT00759473|12927381|P2|STARTED|Overall Study||10
5258027|NCT00759473|12927382|P1|STARTED|Overall Study||10
5258028|NCT00759408|12927394|P1|NOT COMPLETED|Overall Study||19
5258029|NCT00759408|12927394|P1|COMPLETED|Overall Study||19
5258030|NCT00759408|12927394|P1|STARTED|Overall Study||38
5258031|NCT00759395|12927403|P2|NOT COMPLETED|Overall Study||2
5258032|NCT00759395|12927404|P1|NOT COMPLETED|Overall Study||2
5258033|NCT00759395|12927403|P2|COMPLETED|Overall Study||7
5258034|NCT00759395|12927404|P1|COMPLETED|Overall Study||11
5258035|NCT00759395|12927403|P2|STARTED|Overall Study||9
5258036|NCT00759395|12927404|P1|STARTED|Overall Study||13
5258037|NCT00759356|12927420|P2|NOT COMPLETED|Overall Study||3
5258038|NCT00759356|12927421|P1|NOT COMPLETED|Overall Study||1
5258039|NCT00759356|12927420|P2|COMPLETED|Overall Study||15
5258040|NCT00759356|12927421|P1|COMPLETED|Overall Study||17
5258041|NCT00759356|12927420|P2|STARTED|Overall Study||18
5258042|NCT00759356|12927421|P1|STARTED|Overall Study||18
5258043|NCT00759330|12927437|P4|NOT COMPLETED|Overall Study||2
5258044|NCT00759330|12927438|P3|NOT COMPLETED|Overall Study||0
5258045|NCT00759330|12927439|P2|NOT COMPLETED|Overall Study||1
5258046|NCT00759330|12927440|P1|NOT COMPLETED|Overall Study||1
5258047|NCT00759330|12927437|P4|COMPLETED|Overall Study||41
5258048|NCT00759330|12927438|P3|COMPLETED|Overall Study||22
5258049|NCT00759330|12927439|P2|COMPLETED|Overall Study||41
5258050|NCT00759330|12927440|P1|COMPLETED|Overall Study||19
5258051|NCT00759330|12927437|P4|STARTED|Overall Study||43
5258052|NCT00759330|12927438|P3|STARTED|Overall Study||22
5258053|NCT00759330|12927439|P2|STARTED|Overall Study||42
5258054|NCT00759330|12927440|P1|STARTED|Overall Study||20
5258055|NCT00759187|12927489|P3|NOT COMPLETED|Overall Study||0
5258056|NCT00759187|12927490|P2|NOT COMPLETED|Overall Study||0
5258057|NCT00759187|12927491|P1|NOT COMPLETED|Overall Study||0
5258058|NCT00759187|12927489|P3|COMPLETED|Overall Study||9
5258059|NCT00759187|12927490|P2|COMPLETED|Overall Study||8
5258060|NCT00759187|12927491|P1|COMPLETED|Overall Study||8
5258061|NCT00759187|12927489|P3|STARTED|Overall Study||9
5258062|NCT00759187|12927490|P2|STARTED|Overall Study||8
5258063|NCT00759187|12927491|P1|STARTED|Overall Study||8
5258064|NCT00759174|12927501|P2|NOT COMPLETED|Overall Study||2
5258065|NCT00759174|12927502|P1|NOT COMPLETED|Overall Study||0
5258066|NCT00759174|12927501|P2|COMPLETED|Overall Study||595
5258067|NCT00759174|12927502|P1|COMPLETED|Overall Study||76
5258068|NCT00759174|12927501|P2|STARTED|Overall Study||597
5258069|NCT00759174|12927502|P1|STARTED|Overall Study||76
5258070|NCT00759161|12927511|P1|NOT COMPLETED|Overall Study||0
5258071|NCT00759161|12927511|P1|COMPLETED|Overall Study||35
5258072|NCT00759161|12927511|P1|STARTED|Overall Study||35
5258073|NCT00759148|12927526|P2|NOT COMPLETED|Overall Study||32
5258074|NCT00759148|12927527|P1|NOT COMPLETED|Overall Study||14
5258075|NCT00759148|12927526|P2|COMPLETED|Overall Study||554
5258076|NCT00759148|12927527|P1|COMPLETED|Overall Study||579
5258077|NCT00759148|12927526|P2|STARTED|Overall Study||586
5258078|NCT00759148|12927527|P1|STARTED|Overall Study||593
5258079|NCT00759109|12927537|P2|NOT COMPLETED|Overall Study||35
5258080|NCT00759109|12927538|P1|NOT COMPLETED|Overall Study||39
5258081|NCT00759109|12927537|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
5258082|NCT00759109|12927538|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
5258083|NCT00759109|12927537|P2|STARTED|Overall Study||76
5258084|NCT00759109|12927538|P1|STARTED|Overall Study||74
5258085|NCT00759096|12927554|P1|NOT COMPLETED|Overall Study||0
5258086|NCT00759096|12927554|P1|COMPLETED|Overall Study||30
5258087|NCT00759096|12927554|P1|STARTED|Overall Study||30
5258088|NCT00759031|12927560|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5258089|NCT00759031|12927561|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5258090|NCT00759031|12927560|P2|COMPLETED|Second Intervention (1 Day)||8
5258091|NCT00759031|12927561|P1|COMPLETED|Second Intervention (1 Day)||8
5258092|NCT00759031|12927560|P2|STARTED|Second Intervention (1 Day)||8
5258093|NCT00759031|12927561|P1|STARTED|Second Intervention (1 Day)||8
5258094|NCT00759031|12927560|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
5258095|NCT00759031|12927561|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
5258096|NCT00759031|12927560|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
5258097|NCT00759031|12927561|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
5258098|NCT00759031|12927560|P2|STARTED|Washout After 1st Intervention (1 Week)||8
5258099|NCT00759031|12927561|P1|STARTED|Washout After 1st Intervention (1 Week)||8
5258100|NCT00759031|12927560|P2|NOT COMPLETED|First Intervention (1 Day)||1
5258101|NCT00759031|12927561|P1|NOT COMPLETED|First Intervention (1 Day)||2
5258102|NCT00759031|12927560|P2|COMPLETED|First Intervention (1 Day)||8
5258103|NCT00759031|12927561|P1|COMPLETED|First Intervention (1 Day)||8
5258104|NCT00759031|12927560|P2|STARTED|First Intervention (1 Day)||9
5258105|NCT00759031|12927561|P1|STARTED|First Intervention (1 Day)||10
5258106|NCT00758862|12927567|P1|NOT COMPLETED|Overall Study||1
5258107|NCT00758862|12927567|P1|COMPLETED|Overall Study||19
5258108|NCT00758862|12927567|P1|STARTED|Overall Study||20
5258109|NCT00758836|12927587|P4|NOT COMPLETED|Overall Study||32
5258110|NCT00758836|12927588|P3|NOT COMPLETED|Overall Study||38
5258111|NCT00758836|12927589|P2|NOT COMPLETED|Overall Study||26
5258112|NCT00758836|12927590|P1|NOT COMPLETED|Overall Study||24
5258113|NCT00758836|12927587|P4|COMPLETED|Overall Study||138
5258114|NCT00758836|12927588|P3|COMPLETED|Overall Study||133
5258115|NCT00758836|12927589|P2|COMPLETED|Overall Study||145
5258116|NCT00758836|12927590|P1|COMPLETED|Overall Study||147
5258117|NCT00758836|12927587|P4|Treated|Overall Study||138
5258118|NCT00758836|12927588|P3|Treated|Overall Study||133
5258119|NCT00758836|12927589|P2|Treated|Overall Study||145
5258120|NCT00758836|12927590|P1|Treated|Overall Study||147
5258121|NCT00758836|12927587|P4|STARTED|Overall Study||170
5258122|NCT00758836|12927588|P3|STARTED|Overall Study||171
5258123|NCT00758836|12927589|P2|STARTED|Overall Study||171
5258124|NCT00758836|12927590|P1|STARTED|Overall Study||171
5258125|NCT00758771|12927614|P2|NOT COMPLETED|Overall Study||5
5258126|NCT00758771|12927615|P1|NOT COMPLETED|Overall Study||3
5258127|NCT00758771|12927614|P2|COMPLETED|Overall Study||15
5258128|NCT00758771|12927615|P1|COMPLETED|Overall Study||15
5258129|NCT00758771|12927614|P2|STARTED|Overall Study||20
5258130|NCT00758771|12927615|P1|STARTED|Overall Study||18
5258131|NCT00758758|12927629|P8|NOT COMPLETED|Overall Study||0
5258132|NCT00758758|12927630|P7|NOT COMPLETED|Overall Study||14
5258133|NCT00758758|12927631|P6|NOT COMPLETED|Overall Study||14
5258134|NCT00758758|12927632|P5|NOT COMPLETED|Overall Study||2
5258135|NCT00758758|12927633|P4|NOT COMPLETED|Overall Study||2
5258136|NCT00758758|12927634|P3|NOT COMPLETED|Overall Study||18
5258137|NCT00758758|12927635|P2|NOT COMPLETED|Overall Study||25
5258138|NCT00758758|12927636|P1|NOT COMPLETED|Overall Study||3
5258139|NCT00758758|12927629|P8|COMPLETED|Overall Study||0
5258140|NCT00758758|12927630|P7|COMPLETED|Overall Study||17
5258141|NCT00758758|12927631|P6|COMPLETED|Overall Study||36
5258142|NCT00758758|12927632|P5|COMPLETED|Overall Study||1
5258143|NCT00758758|12927633|P4|COMPLETED|Overall Study||4
5258144|NCT00758758|12927634|P3|COMPLETED|Overall Study||35
5258145|NCT00758758|12927635|P2|COMPLETED|Overall Study||49
5258146|NCT00758758|12927636|P1|COMPLETED|Overall Study||11
5258147|NCT00758758|12927629|P8|STARTED|Overall Study||0
5258148|NCT00758758|12927630|P7|STARTED|Overall Study||31
5258149|NCT00758758|12927631|P6|STARTED|Overall Study||50
5258150|NCT00758758|12927632|P5|STARTED|Overall Study||3
5258151|NCT00758758|12927633|P4|STARTED|Overall Study||6
5258152|NCT00758758|12927634|P3|STARTED|Overall Study||53
5258153|NCT00758758|12927635|P2|STARTED|Overall Study||74
5258154|NCT00758758|12927636|P1|STARTED|Overall Study||14
5258155|NCT00758745|12927664|P2|NOT COMPLETED|Overall Study||21
5258156|NCT00758745|12927665|P1|NOT COMPLETED|Overall Study||21
5258157|NCT00758745|12927664|P2|COMPLETED|Overall Study||60
5258158|NCT00758745|12927665|P1|COMPLETED|Overall Study||60
5258159|NCT00758745|12927664|P2|STARTED|Overall Study||81
5258160|NCT00758745|12927665|P1|STARTED|Overall Study||81
5258161|NCT00758706|12927673|P2|NOT COMPLETED|Overall Study||4
5258162|NCT00758706|12927674|P1|NOT COMPLETED|Overall Study||4
5258163|NCT00758706|12927673|P2|COMPLETED|Overall Study||25
5258164|NCT00758706|12927674|P1|COMPLETED|Overall Study||22
5258165|NCT00758706|12927673|P2|STARTED|Overall Study||29
5258166|NCT00758706|12927674|P1|STARTED|Overall Study||26
5258167|NCT00758680|12927710|P10|NOT COMPLETED|Overall Study||1
5258168|NCT00758680|12927711|P9|NOT COMPLETED|Overall Study||2
5258169|NCT00758680|12927712|P8|NOT COMPLETED|Overall Study||1
5258170|NCT00758680|12927713|P7|NOT COMPLETED|Overall Study||1
5258171|NCT00758680|12927714|P6|NOT COMPLETED|Overall Study||0
5258172|NCT00758680|12927715|P5|NOT COMPLETED|Overall Study||0
5258173|NCT00758680|12927716|P4|NOT COMPLETED|Overall Study||0
5258174|NCT00758680|12927717|P3|NOT COMPLETED|Overall Study||0
5258175|NCT00758680|12927718|P2|NOT COMPLETED|Overall Study||0
5258176|NCT00758680|12927719|P1|NOT COMPLETED|Overall Study||0
5258177|NCT00758680|12927710|P10|COMPLETED|Overall Study||28
5258178|NCT00758680|12927711|P9|COMPLETED|Overall Study||18
5258179|NCT00758680|12927712|P8|COMPLETED|Overall Study||19
5258180|NCT00758680|12927713|P7|COMPLETED|Overall Study||6
5258181|NCT00758680|12927714|P6|COMPLETED|Overall Study||6
5258182|NCT00758680|12927715|P5|COMPLETED|Overall Study||6
5258183|NCT00758680|12927716|P4|COMPLETED|Overall Study||6
5258184|NCT00758680|12927717|P3|COMPLETED|Overall Study||6
5258185|NCT00758680|12927718|P2|COMPLETED|Overall Study||6
5258186|NCT00758680|12927719|P1|COMPLETED|Overall Study||6
5258187|NCT00758680|12927710|P10|STARTED|Overall Study||29
5258188|NCT00758680|12927711|P9|STARTED|Overall Study||20
5258189|NCT00758680|12927712|P8|STARTED|Overall Study||20
5258190|NCT00758680|12927713|P7|STARTED|Overall Study||7
5258191|NCT00758680|12927714|P6|STARTED|Overall Study||6
5258192|NCT00758680|12927715|P5|STARTED|Overall Study||6
5258193|NCT00758680|12927716|P4|STARTED|Overall Study||6
5258194|NCT00758680|12927717|P3|STARTED|Overall Study||6
5258195|NCT00758680|12927718|P2|STARTED|Overall Study||6
5258196|NCT00758680|12927719|P1|STARTED|Overall Study||6
5258197|NCT00758667|12927761|P2|NOT COMPLETED|Overall Study||0
5258198|NCT00758667|12927762|P1|NOT COMPLETED|Overall Study||0
5258199|NCT00758667|12927761|P2|COMPLETED|Overall Study||11
5258200|NCT00758667|12927762|P1|COMPLETED|Overall Study||9
5258201|NCT00758667|12927761|P2|STARTED|Overall Study||11
5258202|NCT00758667|12927762|P1|STARTED|Overall Study||9
5258203|NCT00758602|12927772|P2|NOT COMPLETED|Overall Study||22
5258204|NCT00758602|12927773|P1|NOT COMPLETED|Overall Study||19
5258205|NCT00758602|12927772|P2|COMPLETED|Overall Study||84
5258206|NCT00758602|12927773|P1|COMPLETED|Overall Study||85
5258207|NCT00758602|12927772|P2|STARTED|Overall Study||106
5258208|NCT00758602|12927773|P1|STARTED|Overall Study||104
5258209|NCT00758589|12927799|P4|NOT COMPLETED|Overall Study||6
5258210|NCT00758589|12927800|P3|NOT COMPLETED|Overall Study||6
5258211|NCT00758589|12927801|P2|NOT COMPLETED|Overall Study||3
5258212|NCT00758589|12927802|P1|NOT COMPLETED|Overall Study||3
5258213|NCT00758589|12927799|P4|COMPLETED|Overall Study||85
5258214|NCT00758589|12927800|P3|COMPLETED|Overall Study||86
5258215|NCT00758589|12927801|P2|COMPLETED|Overall Study||87
5258216|NCT00758589|12927802|P1|COMPLETED|Overall Study||92
5258217|NCT00758589|12927799|P4|STARTED|Overall Study||91
5258218|NCT00758589|12927800|P3|STARTED|Overall Study||92
5258219|NCT00758589|12927801|P2|STARTED|Overall Study||90
5258220|NCT00758589|12927802|P1|STARTED|Overall Study||95
5258221|NCT00758576|12927868|P1|NOT COMPLETED|Overall Study||1
5258222|NCT00758576|12927868|P1|COMPLETED|Overall Study||63
5258223|NCT00758576|12927868|P1|STARTED|Overall Study||64
5258224|NCT00758563|12927876|P2|NOT COMPLETED|Overall Study||0
5258225|NCT00758563|12927877|P1|NOT COMPLETED|Overall Study||0
5258226|NCT00758563|12927876|P2|COMPLETED|Overall Study||8
5258227|NCT00758563|12927877|P1|COMPLETED|Overall Study||7
5258228|NCT00758563|12927876|P2|STARTED|Overall Study||8
5258229|NCT00758563|12927877|P1|STARTED|Overall Study||7
5258230|NCT00758550|12927883|P2|NOT COMPLETED|Overall Study||0
5258231|NCT00758550|12927884|P1|NOT COMPLETED|Overall Study||0
5258232|NCT00758550|12927883|P2|COMPLETED|Overall Study||30
5258233|NCT00758550|12927884|P1|COMPLETED|Overall Study||30
5258234|NCT00758550|12927883|P2|STARTED|Overall Study||30
5258235|NCT00758550|12927884|P1|STARTED|Overall Study||30
5258236|NCT00758498|12927895|P3|NOT COMPLETED|Overall Study||5
5258237|NCT00758498|12927896|P2|NOT COMPLETED|Overall Study||2
5258238|NCT00758498|12927897|P1|NOT COMPLETED|Overall Study||3
5258239|NCT00758498|12927895|P3|COMPLETED|Overall Study||137
5258240|NCT00758498|12927896|P2|COMPLETED|Overall Study||141
5258241|NCT00758498|12927897|P1|COMPLETED|Overall Study||139
5258242|NCT00758498|12927895|P3|STARTED|Overall Study||142
5258243|NCT00758498|12927896|P2|STARTED|Overall Study||143
5258244|NCT00758498|12927897|P1|STARTED|Overall Study||142
5258245|NCT00758485|12927982|P2|NOT COMPLETED|Overall Study||3
5258246|NCT00758485|12927983|P1|NOT COMPLETED|Overall Study||1
5258247|NCT00758485|12927982|P2|COMPLETED|Overall Study||67
5258248|NCT00758485|12927983|P1|COMPLETED|Overall Study||69
5258249|NCT00758485|12927982|P2|TREATED|Overall Study||68
5258250|NCT00758485|12927983|P1|TREATED|Overall Study||69
5258251|NCT00758485|12927982|P2|STARTED|Overall Study||70
5258252|NCT00758485|12927983|P1|STARTED|Overall Study||70
5258253|NCT00758459|12927995|P2|NOT COMPLETED|Overall Study||4
5258254|NCT00758459|12927996|P1|NOT COMPLETED|Overall Study||3
5258255|NCT00758459|12927995|P2|COMPLETED|Overall Study||35
5258256|NCT00758459|12927996|P1|COMPLETED|Overall Study||32
5258257|NCT00758459|12927995|P2|STARTED|Overall Study||39
5258258|NCT00758459|12927996|P1|STARTED|Overall Study||35
5258259|NCT00758420|12928030|P2|NOT COMPLETED|Overall Study||0
5258260|NCT00758420|12928031|P1|NOT COMPLETED|Overall Study||0
5258261|NCT00758420|12928030|P2|COMPLETED|Overall Study||38
5258262|NCT00758420|12928031|P1|COMPLETED|Overall Study||39
5258263|NCT00758420|12928030|P2|STARTED|Overall Study||38
5258264|NCT00758420|12928031|P1|STARTED|Overall Study||39
5258265|NCT00758394|12928041|P4|NOT COMPLETED|4th Intervention||0
5258266|NCT00758394|12928042|P3|NOT COMPLETED|4th Intervention||0
5258267|NCT00758394|12928043|P2|NOT COMPLETED|4th Intervention||0
5258268|NCT00758394|12928044|P1|NOT COMPLETED|4th Intervention||0
5258269|NCT00758394|12928041|P4|COMPLETED|4th Intervention||7
5258270|NCT00758394|12928042|P3|COMPLETED|4th Intervention||6
5258271|NCT00758394|12928043|P2|COMPLETED|4th Intervention||6
5258272|NCT00758394|12928044|P1|COMPLETED|4th Intervention||7
5258273|NCT00758394|12928041|P4|STARTED|4th Intervention||7
5258274|NCT00758394|12928042|P3|STARTED|4th Intervention||6
5258275|NCT00758394|12928043|P2|STARTED|4th Intervention||6
5258276|NCT00758394|12928044|P1|STARTED|4th Intervention||7
5258277|NCT00758394|12928041|P4|NOT COMPLETED|Washout After 3rd Intervention||0
5258278|NCT00758394|12928042|P3|NOT COMPLETED|Washout After 3rd Intervention||0
5258279|NCT00758394|12928043|P2|NOT COMPLETED|Washout After 3rd Intervention||0
5258280|NCT00758394|12928044|P1|NOT COMPLETED|Washout After 3rd Intervention||0
5258281|NCT00758394|12928041|P4|COMPLETED|Washout After 3rd Intervention||7
5258282|NCT00758394|12928042|P3|COMPLETED|Washout After 3rd Intervention||6
5258283|NCT00758394|12928043|P2|COMPLETED|Washout After 3rd Intervention||6
5258284|NCT00758394|12928044|P1|COMPLETED|Washout After 3rd Intervention||7
5258285|NCT00758394|12928041|P4|STARTED|Washout After 3rd Intervention||7
5258286|NCT00758394|12928042|P3|STARTED|Washout After 3rd Intervention||6
5258287|NCT00758394|12928043|P2|STARTED|Washout After 3rd Intervention||6
5258288|NCT00758394|12928044|P1|STARTED|Washout After 3rd Intervention||7
5258289|NCT00758394|12928041|P4|NOT COMPLETED|3rd Intervention||1
5258290|NCT00758394|12928042|P3|NOT COMPLETED|3rd Intervention||0
5258291|NCT00758394|12928043|P2|NOT COMPLETED|3rd Intervention||0
5258292|NCT00758394|12928044|P1|NOT COMPLETED|3rd Intervention||1
5258293|NCT00758394|12928041|P4|COMPLETED|3rd Intervention||7
5258294|NCT00758394|12928042|P3|COMPLETED|3rd Intervention||6
5258295|NCT00758394|12928043|P2|COMPLETED|3rd Intervention||6
5258296|NCT00758394|12928044|P1|COMPLETED|3rd Intervention||7
5258297|NCT00758394|12928041|P4|STARTED|3rd Intervention||8
5258298|NCT00758394|12928042|P3|STARTED|3rd Intervention||6
5258299|NCT00758394|12928043|P2|STARTED|3rd Intervention||6
5258300|NCT00758394|12928044|P1|STARTED|3rd Intervention||8
5258301|NCT00758394|12928041|P4|NOT COMPLETED|Washout After 2nd Intervention||0
5258302|NCT00758394|12928042|P3|NOT COMPLETED|Washout After 2nd Intervention||0
5258303|NCT00758394|12928043|P2|NOT COMPLETED|Washout After 2nd Intervention||0
5258304|NCT00758394|12928044|P1|NOT COMPLETED|Washout After 2nd Intervention||0
5258305|NCT00758394|12928041|P4|COMPLETED|Washout After 2nd Intervention||8
5258306|NCT00758394|12928042|P3|COMPLETED|Washout After 2nd Intervention||6
5258307|NCT00758394|12928043|P2|COMPLETED|Washout After 2nd Intervention||6
5258308|NCT00758394|12928044|P1|COMPLETED|Washout After 2nd Intervention||8
5258309|NCT00758394|12928041|P4|STARTED|Washout After 2nd Intervention||8
5258310|NCT00758394|12928042|P3|STARTED|Washout After 2nd Intervention||6
5258311|NCT00758394|12928043|P2|STARTED|Washout After 2nd Intervention||6
5258312|NCT00758394|12928044|P1|STARTED|Washout After 2nd Intervention||8
5258313|NCT00758394|12928041|P4|NOT COMPLETED|2nd Intervention Order||0
5258314|NCT00758394|12928042|P3|NOT COMPLETED|2nd Intervention Order||0
5258315|NCT00758394|12928043|P2|NOT COMPLETED|2nd Intervention Order||1
5258316|NCT00758394|12928044|P1|NOT COMPLETED|2nd Intervention Order||0
5258317|NCT00758394|12928041|P4|COMPLETED|2nd Intervention Order||8
5258318|NCT00758394|12928042|P3|COMPLETED|2nd Intervention Order||6
5258319|NCT00758394|12928043|P2|COMPLETED|2nd Intervention Order||6
5258320|NCT00758394|12928044|P1|COMPLETED|2nd Intervention Order||8
5258321|NCT00758394|12928041|P4|STARTED|2nd Intervention Order||8
5258322|NCT00758394|12928042|P3|STARTED|2nd Intervention Order||6
5258323|NCT00758394|12928043|P2|STARTED|2nd Intervention Order||7
5258324|NCT00758394|12928044|P1|STARTED|2nd Intervention Order||8
5258325|NCT00758394|12928041|P4|NOT COMPLETED|Washout After 1st Intervention||0
5258326|NCT00758394|12928042|P3|NOT COMPLETED|Washout After 1st Intervention||0
5258327|NCT00758394|12928043|P2|NOT COMPLETED|Washout After 1st Intervention||0
5258328|NCT00758394|12928044|P1|NOT COMPLETED|Washout After 1st Intervention||0
5258329|NCT00758394|12928041|P4|COMPLETED|Washout After 1st Intervention||8
5258330|NCT00758394|12928042|P3|COMPLETED|Washout After 1st Intervention||6
5258331|NCT00758394|12928043|P2|COMPLETED|Washout After 1st Intervention||7
5258332|NCT00758394|12928044|P1|COMPLETED|Washout After 1st Intervention||8
5258333|NCT00758394|12928041|P4|STARTED|Washout After 1st Intervention||8
5258334|NCT00758394|12928042|P3|STARTED|Washout After 1st Intervention||6
5258335|NCT00758394|12928043|P2|STARTED|Washout After 1st Intervention||7
5258336|NCT00758394|12928044|P1|STARTED|Washout After 1st Intervention||8
5258337|NCT00758394|12928041|P4|NOT COMPLETED|1st Intervention||0
5258338|NCT00758394|12928042|P3|NOT COMPLETED|1st Intervention||0
5258339|NCT00758394|12928043|P2|NOT COMPLETED|1st Intervention||0
5258340|NCT00758394|12928044|P1|NOT COMPLETED|1st Intervention||0
5258341|NCT00758394|12928041|P4|COMPLETED|1st Intervention||8
5258342|NCT00758394|12928042|P3|COMPLETED|1st Intervention||6
5258343|NCT00758394|12928043|P2|COMPLETED|1st Intervention||7
5258344|NCT00758394|12928044|P1|COMPLETED|1st Intervention||8
5258345|NCT00758394|12928041|P4|STARTED|1st Intervention||8
5258346|NCT00758394|12928042|P3|STARTED|1st Intervention||6
5258347|NCT00758394|12928043|P2|STARTED|1st Intervention||7
5258348|NCT00758394|12928044|P1|STARTED|1st Intervention||8
5258349|NCT00758342|12928056|P2|NOT COMPLETED|Overall Study||1
5258350|NCT00758342|12928057|P1|NOT COMPLETED|Overall Study||4
5258351|NCT00758342|12928056|P2|COMPLETED|Overall Study||17
5258352|NCT00758342|12928057|P1|COMPLETED|Overall Study||15
5258353|NCT00758342|12928056|P2|STARTED|Overall Study||18
5258354|NCT00758342|12928057|P1|STARTED|Overall Study||19
5258355|NCT00758290|12928065|P2|NOT COMPLETED|Overall Study||0
5258356|NCT00758290|12928066|P1|NOT COMPLETED|Overall Study||0
5258357|NCT00758290|12928065|P2|COMPLETED|Overall Study||12
5258358|NCT00758290|12928066|P1|COMPLETED|Overall Study||11
5258359|NCT00758290|12928065|P2|STARTED|Overall Study||12
5258360|NCT00758290|12928066|P1|STARTED|Overall Study||11
5258361|NCT00758264|12928073|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
5258362|NCT00758264|12928074|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
5258363|NCT00758264|12928075|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
5258364|NCT00758264|12928073|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
5258365|NCT00758264|12928074|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
5258366|NCT00758264|12928075|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
5258367|NCT00758264|12928073|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
5258453|NCT00757627|12928339|P1|COMPLETED|Overall Study||419
5258368|NCT00758264|12928074|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
5258369|NCT00758264|12928075|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
5258370|NCT00758264|12928073|P3|NOT COMPLETED|Active Phase||5
5258371|NCT00758264|12928074|P2|NOT COMPLETED|Active Phase||0
5258372|NCT00758264|12928075|P1|NOT COMPLETED|Active Phase||1
5258373|NCT00758264|12928073|P3|COMPLETED|Active Phase||85
5258374|NCT00758264|12928074|P2|COMPLETED|Active Phase||91
5258375|NCT00758264|12928075|P1|COMPLETED|Active Phase||181
5258376|NCT00758264|12928073|P3|STARTED|Active Phase||90
5258377|NCT00758264|12928074|P2|STARTED|Active Phase||91
5258378|NCT00758264|12928075|P1|STARTED|Active Phase||182
5258379|NCT00758160|12928134|P1|NOT COMPLETED|Overall Study||66
5258380|NCT00758160|12928134|P1|COMPLETED|Overall Study||230
5258381|NCT00758160|12928134|P1|STARTED|Overall Study||296
5258382|NCT00758069|12928155|P3|NOT COMPLETED|Overall Study||1
5258383|NCT00758069|12928156|P2|NOT COMPLETED|Overall Study||0
5258384|NCT00758069|12928157|P1|NOT COMPLETED|Overall Study||1
5258385|NCT00758069|12928155|P3|COMPLETED|Overall Study||27
5258386|NCT00758069|12928156|P2|COMPLETED|Overall Study||25
5258387|NCT00758069|12928157|P1|COMPLETED|Overall Study||26
5258388|NCT00758069|12928155|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
5258389|NCT00758069|12928156|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
5258390|NCT00758069|12928157|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
5258391|NCT00758043|12928172|P4|NOT COMPLETED|Overall Study||100
5258392|NCT00758043|12928173|P3|NOT COMPLETED|Overall Study||39
5258393|NCT00758043|12928174|P2|NOT COMPLETED|Overall Study||41
5258394|NCT00758043|12928175|P1|NOT COMPLETED|Overall Study||1
5258395|NCT00758043|12928172|P4|COMPLETED|Overall Study||0
5258396|NCT00758043|12928173|P3|COMPLETED|Overall Study||79
5258397|NCT00758043|12928174|P2|COMPLETED|Overall Study||119
5258398|NCT00758043|12928175|P1|COMPLETED|Overall Study||161
5258399|NCT00758043|12928172|P4|STARTED|Overall Study||100
5258400|NCT00758043|12928173|P3|STARTED|Overall Study||118
5258401|NCT00758043|12928174|P2|STARTED|Overall Study||160
5258402|NCT00758043|12928175|P1|STARTED|Overall Study||162
5258403|NCT00757848|12928203|P2|NOT COMPLETED|Overall Study||2
5258404|NCT00757848|12928204|P1|NOT COMPLETED|Overall Study||3
5258405|NCT00757848|12928203|P2|COMPLETED|Overall Study||27
5258406|NCT00757848|12928204|P1|COMPLETED|Overall Study||24
5258407|NCT00757848|12928203|P2|STARTED|Overall Study||29
5258408|NCT00757848|12928204|P1|STARTED|Overall Study||27
5258409|NCT00757822|12928250|P2|NOT COMPLETED|Overall Study||31
5258410|NCT00757822|12928251|P1|NOT COMPLETED|Overall Study||28
5258411|NCT00757822|12928250|P2|COMPLETED|Overall Study||57
5258412|NCT00757822|12928251|P1|COMPLETED|Overall Study||64
5258413|NCT00757822|12928250|P2|Data Lock, Unblinding Analysis|Overall Study||57
5258414|NCT00757822|12928251|P1|Data Lock, Unblinding Analysis|Overall Study||64
5258415|NCT00757822|12928250|P2|Withdrawn-protocol Deviation|Overall Study||8
5258416|NCT00757822|12928251|P1|Withdrawn-protocol Deviation|Overall Study||9
5258417|NCT00757822|12928250|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
5258418|NCT00757822|12928251|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
5258419|NCT00757822|12928250|P2|Data Entry, QC Assessment|Overall Study||74
5258420|NCT00757822|12928251|P1|Data Entry, QC Assessment|Overall Study||85
5258421|NCT00757822|12928250|P2|2-6 wk Post-op Assessment|Overall Study||74
5258422|NCT00757822|12928251|P1|2-6 wk Post-op Assessment|Overall Study||85
5258423|NCT00757822|12928250|P2|24-48 hr Telephone Assessment|Overall Study||74
5258424|NCT00757822|12928251|P1|24-48 hr Telephone Assessment|Overall Study||85
5258425|NCT00757822|12928250|P2|DOS: Post-operative Assessments|Overall Study||74
5258426|NCT00757822|12928251|P1|DOS: Post-operative Assessments|Overall Study||85
5258427|NCT00757822|12928250|P2|Received Study Intervention|Overall Study||74
5258428|NCT00757822|12928251|P1|Received Study Intervention|Overall Study||85
5258429|NCT00757822|12928250|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
5258430|NCT00757822|12928251|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
5258431|NCT00757822|12928250|P2|Withdrawal by Subject-no Intervention|Overall Study||3
5258432|NCT00757822|12928251|P1|Withdrawal by Subject-no Intervention|Overall Study||1
5258433|NCT00757822|12928250|P2|Day of Surgery (DOS) Assessment|Overall Study||88
5258434|NCT00757822|12928251|P1|Day of Surgery (DOS) Assessment|Overall Study||92
5258435|NCT00757822|12928250|P2|STARTED|Overall Study||88
5258436|NCT00757822|12928251|P1|STARTED|Overall Study||92
5258437|NCT00757783|12928273|P2|NOT COMPLETED|Overall Study||6
5258438|NCT00757783|12928274|P1|NOT COMPLETED|Overall Study||5
5258439|NCT00757783|12928273|P2|COMPLETED|Overall Study||25
5258440|NCT00757783|12928274|P1|COMPLETED|Overall Study||29
5258441|NCT00757783|12928273|P2|STARTED|Overall Study||31
5258442|NCT00757783|12928274|P1|STARTED|Overall Study||34
5258443|NCT00757705|12928310|P1|NOT COMPLETED|Overall Study||121
5258444|NCT00757705|12928310|P1|COMPLETED|Overall Study||178
5258445|NCT00757705|12928310|P1|STARTED|Overall Study||299
5258446|NCT00757666|12928324|P2|NOT COMPLETED|Overall Study||23
5258447|NCT00757666|12928325|P1|NOT COMPLETED|Overall Study||22
5258448|NCT00757666|12928324|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
5258449|NCT00757666|12928325|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
5258450|NCT00757666|12928324|P2|STARTED|Overall Study||34
5258451|NCT00757666|12928325|P1|STARTED|Overall Study||34
5258452|NCT00757627|12928339|P1|NOT COMPLETED|Overall Study||81
5258454|NCT00757627|12928339|P1|STARTED|Overall Study||500
5258455|NCT00757601|12928352|P12|NOT COMPLETED|Period 5||0
5258456|NCT00757601|12928353|P11|NOT COMPLETED|Period 5||0
5258457|NCT00757601|12928354|P10|NOT COMPLETED|Period 5||0
5258458|NCT00757601|12928355|P9|NOT COMPLETED|Period 5||0
5258459|NCT00757601|12928356|P8|NOT COMPLETED|Period 5||0
5258460|NCT00757601|12928357|P7|NOT COMPLETED|Period 5||0
5258461|NCT00757601|12928358|P6|NOT COMPLETED|Period 5||0
5258462|NCT00757601|12928359|P5|NOT COMPLETED|Period 5||0
5258463|NCT00757601|12928360|P4|NOT COMPLETED|Period 5||0
5258464|NCT00757601|12928361|P3|NOT COMPLETED|Period 5||0
5258465|NCT00757601|12928362|P2|NOT COMPLETED|Period 5||0
5258466|NCT00757601|12928363|P1|NOT COMPLETED|Period 5||0
5258467|NCT00757601|12928352|P12|COMPLETED|Period 5||1
5258468|NCT00757601|12928353|P11|COMPLETED|Period 5||2
5258469|NCT00757601|12928354|P10|COMPLETED|Period 5||1
5258470|NCT00757601|12928355|P9|COMPLETED|Period 5||2
5258471|NCT00757601|12928356|P8|COMPLETED|Period 5||2
5258472|NCT00757601|12928357|P7|COMPLETED|Period 5||2
5258473|NCT00757601|12928358|P6|COMPLETED|Period 5||2
5258474|NCT00757601|12928359|P5|COMPLETED|Period 5||2
5258475|NCT00757601|12928360|P4|COMPLETED|Period 5||2
5258476|NCT00757601|12928361|P3|COMPLETED|Period 5||2
5258477|NCT00757601|12928362|P2|COMPLETED|Period 5||2
5258478|NCT00757601|12928363|P1|COMPLETED|Period 5||2
5258479|NCT00757601|12928352|P12|STARTED|Period 5||1
5258480|NCT00757601|12928353|P11|STARTED|Period 5||2
5258481|NCT00757601|12928354|P10|STARTED|Period 5||1
5258482|NCT00757601|12928355|P9|STARTED|Period 5||2
5258483|NCT00757601|12928356|P8|STARTED|Period 5||2
5258484|NCT00757601|12928357|P7|STARTED|Period 5||2
5258485|NCT00757601|12928358|P6|STARTED|Period 5||2
5258486|NCT00757601|12928359|P5|STARTED|Period 5||2
5258487|NCT00757601|12928360|P4|STARTED|Period 5||2
5258488|NCT00757601|12928361|P3|STARTED|Period 5||2
5258489|NCT00757601|12928362|P2|STARTED|Period 5||2
5258490|NCT00757601|12928363|P1|STARTED|Period 5||2
5258491|NCT00757601|12928352|P12|NOT COMPLETED|Period 4||1
5258492|NCT00757601|12928353|P11|NOT COMPLETED|Period 4||0
5258493|NCT00757601|12928354|P10|NOT COMPLETED|Period 4||1
5258494|NCT00757601|12928355|P9|NOT COMPLETED|Period 4||0
5258495|NCT00757601|12928356|P8|NOT COMPLETED|Period 4||0
5258496|NCT00757601|12928357|P7|NOT COMPLETED|Period 4||0
5258497|NCT00757601|12928358|P6|NOT COMPLETED|Period 4||0
5258498|NCT00757601|12928359|P5|NOT COMPLETED|Period 4||0
5258499|NCT00757601|12928360|P4|NOT COMPLETED|Period 4||0
5258500|NCT00757601|12928361|P3|NOT COMPLETED|Period 4||0
5258501|NCT00757601|12928362|P2|NOT COMPLETED|Period 4||0
5258502|NCT00757601|12928363|P1|NOT COMPLETED|Period 4||0
5258503|NCT00757601|12928352|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
5258504|NCT00757601|12928353|P11|COMPLETED|Period 4||2
5258505|NCT00757601|12928354|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
5258506|NCT00757601|12928355|P9|COMPLETED|Period 4||2
5258507|NCT00757601|12928356|P8|COMPLETED|Period 4||2
5258508|NCT00757601|12928357|P7|COMPLETED|Period 4||2
5258509|NCT00757601|12928358|P6|COMPLETED|Period 4||2
5258510|NCT00757601|12928359|P5|COMPLETED|Period 4||2
5258511|NCT00757601|12928360|P4|COMPLETED|Period 4||2
5258512|NCT00757601|12928361|P3|COMPLETED|Period 4||2
5258513|NCT00757601|12928362|P2|COMPLETED|Period 4||2
5258514|NCT00757601|12928363|P1|COMPLETED|Period 4||2
5258515|NCT00757601|12928352|P12|STARTED|Period 4||2
5258516|NCT00757601|12928353|P11|STARTED|Period 4||2
5258517|NCT00757601|12928354|P10|STARTED|Period 4||2
5258518|NCT00757601|12928355|P9|STARTED|Period 4||2
5258519|NCT00757601|12928356|P8|STARTED|Period 4||2
5258520|NCT00757601|12928357|P7|STARTED|Period 4||2
5258521|NCT00757601|12928358|P6|STARTED|Period 4||2
5258522|NCT00757601|12928359|P5|STARTED|Period 4||2
5258523|NCT00757601|12928360|P4|STARTED|Period 4||2
5258524|NCT00757601|12928361|P3|STARTED|Period 4||2
5258525|NCT00757601|12928362|P2|STARTED|Period 4||2
5258526|NCT00757601|12928363|P1|STARTED|Period 4||2
5258527|NCT00757601|12928352|P12|NOT COMPLETED|Period 3||0
5258528|NCT00757601|12928353|P11|NOT COMPLETED|Period 3||0
5258529|NCT00757601|12928354|P10|NOT COMPLETED|Period 3||0
5258530|NCT00757601|12928355|P9|NOT COMPLETED|Period 3||0
5258531|NCT00757601|12928356|P8|NOT COMPLETED|Period 3||0
5258532|NCT00757601|12928357|P7|NOT COMPLETED|Period 3||0
5258533|NCT00757601|12928358|P6|NOT COMPLETED|Period 3||0
5258534|NCT00757601|12928359|P5|NOT COMPLETED|Period 3||0
5258535|NCT00757601|12928360|P4|NOT COMPLETED|Period 3||0
5258536|NCT00757601|12928361|P3|NOT COMPLETED|Period 3||0
5258537|NCT00757601|12928362|P2|NOT COMPLETED|Period 3||0
5258538|NCT00757601|12928363|P1|NOT COMPLETED|Period 3||0
5258539|NCT00757601|12928352|P12|COMPLETED|Period 3||2
5258540|NCT00757601|12928353|P11|COMPLETED|Period 3||2
5258541|NCT00757601|12928354|P10|COMPLETED|Period 3||2
5258542|NCT00757601|12928355|P9|COMPLETED|Period 3||2
5258543|NCT00757601|12928356|P8|COMPLETED|Period 3||2
5258544|NCT00757601|12928357|P7|COMPLETED|Period 3||2
5258545|NCT00757601|12928358|P6|COMPLETED|Period 3||2
5258546|NCT00757601|12928359|P5|COMPLETED|Period 3||2
5258547|NCT00757601|12928360|P4|COMPLETED|Period 3||2
5258548|NCT00757601|12928361|P3|COMPLETED|Period 3||2
5258549|NCT00757601|12928362|P2|COMPLETED|Period 3||2
5258550|NCT00757601|12928363|P1|COMPLETED|Period 3||2
5258551|NCT00757601|12928352|P12|STARTED|Period 3||2
5258552|NCT00757601|12928353|P11|STARTED|Period 3||2
5258553|NCT00757601|12928354|P10|STARTED|Period 3||2
5258554|NCT00757601|12928355|P9|STARTED|Period 3||2
5258555|NCT00757601|12928356|P8|STARTED|Period 3||2
5258556|NCT00757601|12928357|P7|STARTED|Period 3||2
5258557|NCT00757601|12928358|P6|STARTED|Period 3||2
5258558|NCT00757601|12928359|P5|STARTED|Period 3||2
5258559|NCT00757601|12928360|P4|STARTED|Period 3||2
5258560|NCT00757601|12928361|P3|STARTED|Period 3||2
5258561|NCT00757601|12928362|P2|STARTED|Period 3||2
5258562|NCT00757601|12928363|P1|STARTED|Period 3||2
5258563|NCT00757601|12928352|P12|NOT COMPLETED|Period 2||1
5258564|NCT00757601|12928353|P11|NOT COMPLETED|Period 2||0
5258565|NCT00757601|12928354|P10|NOT COMPLETED|Period 2||0
5258566|NCT00757601|12928355|P9|NOT COMPLETED|Period 2||0
5258567|NCT00757601|12928356|P8|NOT COMPLETED|Period 2||0
5258568|NCT00757601|12928357|P7|NOT COMPLETED|Period 2||0
5258569|NCT00757601|12928358|P6|NOT COMPLETED|Period 2||0
5258570|NCT00757601|12928359|P5|NOT COMPLETED|Period 2||0
5258571|NCT00757601|12928360|P4|NOT COMPLETED|Period 2||0
5258572|NCT00757601|12928361|P3|NOT COMPLETED|Period 2||0
5258573|NCT00757601|12928362|P2|NOT COMPLETED|Period 2||0
5258574|NCT00757601|12928363|P1|NOT COMPLETED|Period 2||0
5258575|NCT00757601|12928352|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
5258576|NCT00757601|12928353|P11|COMPLETED|Period 2||2
5258577|NCT00757601|12928354|P10|COMPLETED|Period 2||2
5258578|NCT00757601|12928355|P9|COMPLETED|Period 2||2
5258579|NCT00757601|12928356|P8|COMPLETED|Period 2||2
5258580|NCT00757601|12928357|P7|COMPLETED|Period 2||2
5258581|NCT00757601|12928358|P6|COMPLETED|Period 2||2
5258582|NCT00757601|12928359|P5|COMPLETED|Period 2||2
5258583|NCT00757601|12928360|P4|COMPLETED|Period 2||2
5258584|NCT00757601|12928361|P3|COMPLETED|Period 2||2
5258585|NCT00757601|12928362|P2|COMPLETED|Period 2||2
5258586|NCT00757601|12928363|P1|COMPLETED|Period 2||2
5258587|NCT00757601|12928352|P12|STARTED|Period 2||3
5258588|NCT00757601|12928353|P11|STARTED|Period 2||2
5258589|NCT00757601|12928354|P10|STARTED|Period 2||2
5258590|NCT00757601|12928355|P9|STARTED|Period 2||2
5258591|NCT00757601|12928356|P8|STARTED|Period 2||2
5258592|NCT00757601|12928357|P7|STARTED|Period 2||2
5258593|NCT00757601|12928358|P6|STARTED|Period 2||2
5258594|NCT00757601|12928359|P5|STARTED|Period 2||2
5258595|NCT00757601|12928360|P4|STARTED|Period 2||2
5258596|NCT00757601|12928361|P3|STARTED|Period 2||2
5258597|NCT00757601|12928362|P2|STARTED|Period 2||2
5258598|NCT00757601|12928363|P1|STARTED|Period 2||2
5258599|NCT00757601|12928352|P12|NOT COMPLETED|Period 1||0
5258600|NCT00757601|12928353|P11|NOT COMPLETED|Period 1||0
5258601|NCT00757601|12928354|P10|NOT COMPLETED|Period 1||0
5258602|NCT00757601|12928355|P9|NOT COMPLETED|Period 1||0
5258603|NCT00757601|12928356|P8|NOT COMPLETED|Period 1||0
5258604|NCT00757601|12928357|P7|NOT COMPLETED|Period 1||0
5258605|NCT00757601|12928358|P6|NOT COMPLETED|Period 1||0
5258606|NCT00757601|12928359|P5|NOT COMPLETED|Period 1||0
5258607|NCT00757601|12928360|P4|NOT COMPLETED|Period 1||0
5258608|NCT00757601|12928361|P3|NOT COMPLETED|Period 1||0
5258609|NCT00757601|12928362|P2|NOT COMPLETED|Period 1||0
5258610|NCT00757601|12928363|P1|NOT COMPLETED|Period 1||0
5258611|NCT00757601|12928352|P12|COMPLETED|Period 1||3
5258612|NCT00757601|12928353|P11|COMPLETED|Period 1||2
5258613|NCT00757601|12928354|P10|COMPLETED|Period 1||2
5258614|NCT00757601|12928355|P9|COMPLETED|Period 1||2
5258615|NCT00757601|12928356|P8|COMPLETED|Period 1||2
5258616|NCT00757601|12928357|P7|COMPLETED|Period 1||2
5258617|NCT00757601|12928358|P6|COMPLETED|Period 1||2
5258618|NCT00757601|12928359|P5|COMPLETED|Period 1||2
5258619|NCT00757601|12928360|P4|COMPLETED|Period 1||2
5258620|NCT00757601|12928361|P3|COMPLETED|Period 1||2
5258621|NCT00757601|12928362|P2|COMPLETED|Period 1||2
5258622|NCT00757601|12928363|P1|COMPLETED|Period 1||2
5258623|NCT00757601|12928352|P12|STARTED|Period 1||3
5258624|NCT00757601|12928353|P11|STARTED|Period 1||2
5258625|NCT00757601|12928354|P10|STARTED|Period 1||2
5258626|NCT00757601|12928355|P9|STARTED|Period 1||2
5258627|NCT00757601|12928356|P8|STARTED|Period 1||2
5258628|NCT00757601|12928357|P7|STARTED|Period 1||2
5258629|NCT00757601|12928358|P6|STARTED|Period 1||2
5258630|NCT00757601|12928359|P5|STARTED|Period 1||2
5258631|NCT00757601|12928360|P4|STARTED|Period 1||2
5258632|NCT00757601|12928361|P3|STARTED|Period 1||2
5258633|NCT00757601|12928362|P2|STARTED|Period 1||2
5258634|NCT00757601|12928363|P1|STARTED|Period 1||2
5258635|NCT00757588|12928474|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
5258636|NCT00757588|12928475|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
5258637|NCT00757588|12928474|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
5258638|NCT00757588|12928475|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
5258639|NCT00757588|12928474|P2|STARTED|Period 2: Long-term (52-week) Phase||134
5258640|NCT00757588|12928475|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
5258641|NCT00757588|12928474|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
5258642|NCT00757588|12928475|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
5258643|NCT00757588|12928474|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
5258644|NCT00757588|12928475|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
5258645|NCT00757588|12928474|P2|STARTED|Period 1: Short-term (24-week) Phase||151
5258646|NCT00757588|12928475|P1|STARTED|Period 1: Short-term (24-week) Phase||304
5258647|NCT00757484|12928507|P1|NOT COMPLETED|Overall Study||0
5258648|NCT00757484|12928507|P1|COMPLETED|Overall Study||491
5258649|NCT00757484|12928507|P1|STARTED|Overall Study||491
5258650|NCT00757237|12928516|P2|NOT COMPLETED|Overall Study||25
5258651|NCT00757237|12928517|P1|NOT COMPLETED|Overall Study||13
5258652|NCT00757237|12928516|P2|COMPLETED|Overall Study||111
5258653|NCT00757237|12928517|P1|COMPLETED|Overall Study||124
5258654|NCT00757237|12928516|P2|Treated|Overall Study||132
5258655|NCT00757237|12928517|P1|Treated|Overall Study||136
5258656|NCT00757237|12928516|P2|STARTED|Overall Study||136
5258657|NCT00757237|12928517|P1|STARTED|Overall Study||137
5258658|NCT00757172|12928545|P1|NOT COMPLETED|Overall Study||11
5258659|NCT00757172|12928545|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
5258660|NCT00757172|12928545|P1|STARTED|Overall Study||65
5258661|NCT00757003|12928553|P1|NOT COMPLETED|Overall Study||49
5258662|NCT00757003|12928553|P1|COMPLETED|Overall Study||51
5258663|NCT00757003|12928553|P1|STARTED|Overall Study||100
5258664|NCT00756977|12928561|P2|NOT COMPLETED|Overall Study||11
5258665|NCT00756977|12928562|P1|NOT COMPLETED|Overall Study||21
5258666|NCT00756977|12928561|P2|COMPLETED|Overall Study||187
5258667|NCT00756977|12928562|P1|COMPLETED|Overall Study||175
5258668|NCT00756977|12928561|P2|STARTED|Overall Study||198
5258669|NCT00756977|12928562|P1|STARTED|Overall Study||196
5258670|NCT00756964|12928590|P2|NOT COMPLETED|Overall Study||0
5258671|NCT00756964|12928591|P1|NOT COMPLETED|Overall Study||0
5258672|NCT00756964|12928590|P2|COMPLETED|Overall Study||13
5258673|NCT00756964|12928591|P1|COMPLETED|Overall Study||13
5258674|NCT00756964|12928590|P2|STARTED|Overall Study||13
5258675|NCT00756964|12928591|P1|STARTED|Overall Study||13
5258676|NCT00756938|12928600|P4|NOT COMPLETED|Optional Extension||37
5258677|NCT00756938|12928601|P3|NOT COMPLETED|Optional Extension||0
5258678|NCT00756938|12928602|P2|NOT COMPLETED|Optional Extension||0
5258679|NCT00756938|12928603|P1|NOT COMPLETED|Optional Extension||0
5258680|NCT00756938|12928600|P4|COMPLETED|Optional Extension||53
5258681|NCT00756938|12928601|P3|COMPLETED|Optional Extension||0
5258682|NCT00756938|12928602|P2|COMPLETED|Optional Extension||0
5258683|NCT00756938|12928603|P1|COMPLETED|Optional Extension||0
5258684|NCT00756938|12928600|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
5258685|NCT00756938|12928601|P3|STARTED|Optional Extension||0
5258686|NCT00756938|12928602|P2|STARTED|Optional Extension||0
5258687|NCT00756938|12928603|P1|STARTED|Optional Extension||0
5258688|NCT00756938|12928600|P4|NOT COMPLETED|12-week Base Study||0
5258689|NCT00756938|12928601|P3|NOT COMPLETED|12-week Base Study||2
5258690|NCT00756938|12928602|P2|NOT COMPLETED|12-week Base Study||0
5258691|NCT00756938|12928603|P1|NOT COMPLETED|12-week Base Study||2
5258692|NCT00756938|12928600|P4|COMPLETED|12-week Base Study||0
5258693|NCT00756938|12928601|P3|COMPLETED|12-week Base Study||32
5258694|NCT00756938|12928602|P2|COMPLETED|12-week Base Study||34
5258695|NCT00756938|12928603|P1|COMPLETED|12-week Base Study||31
5258696|NCT00756938|12928600|P4|STARTED|12-week Base Study||0
5258697|NCT00756938|12928601|P3|STARTED|12-week Base Study||34
5258698|NCT00756938|12928602|P2|STARTED|12-week Base Study||34
5258699|NCT00756938|12928603|P1|STARTED|12-week Base Study||33
5258700|NCT00756886|12928631|P2|NOT COMPLETED|Overall Study||7
5258701|NCT00756886|12928632|P1|NOT COMPLETED|Overall Study||11
5258702|NCT00756886|12928631|P2|COMPLETED|Overall Study||25
5258703|NCT00756886|12928632|P1|COMPLETED|Overall Study||30
5258704|NCT00756886|12928631|P2|STARTED|Overall Study||32
5258705|NCT00756886|12928632|P1|STARTED|Overall Study||41
5258706|NCT00756730|12928640|P2|NOT COMPLETED|Overall Study||2
5258707|NCT00756730|12928641|P1|NOT COMPLETED|Overall Study||0
5258708|NCT00756730|12928640|P2|COMPLETED|Overall Study||22
5258709|NCT00756730|12928641|P1|COMPLETED|Overall Study||25
5258710|NCT00756730|12928640|P2|STARTED|Overall Study||24
5258711|NCT00756730|12928641|P1|STARTED|Overall Study||25
5258712|NCT00756717|12928661|P1|NOT COMPLETED|Overall Study||2
5258713|NCT00756717|12928661|P1|COMPLETED|Overall Study||20
5258714|NCT00756717|12928661|P1|STARTED|Overall Study||22
5258715|NCT00756678|12928665|P1|NOT COMPLETED|Overall Study||1
5258716|NCT00756678|12928665|P1|COMPLETED|Overall Study||50
5258717|NCT00756678|12928665|P1|STARTED|Overall Study||51
5258718|NCT00756652|12928678|P2|NOT COMPLETED|Re-Op Phase||0
5258719|NCT00756652|12928679|P1|NOT COMPLETED|Re-Op Phase||2876
5258720|NCT00756652|12928678|P2|COMPLETED|Re-Op Phase||0
5258721|NCT00756652|12928679|P1|COMPLETED|Re-Op Phase||8225
5258722|NCT00756652|12928678|P2|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
5258723|NCT00756652|12928679|P1|STARTED|Re-Op Phase||11101
5258724|NCT00756652|12928678|P2|NOT COMPLETED|Original Phase||921
5258725|NCT00756652|12928679|P1|NOT COMPLETED|Original Phase||35389
5258726|NCT00756652|12928678|P2|COMPLETED|Original Phase||118
5258727|NCT00756652|12928679|P1|COMPLETED|Original Phase|At Year 7|6063
5258728|NCT00756652|12928678|P2|STARTED|Original Phase||1039
5258729|NCT00756652|12928679|P1|STARTED|Original Phase||41452
5258730|NCT00756613|12928687|P2|NOT COMPLETED|Overall Study||70
5258731|NCT00756613|12928688|P1|NOT COMPLETED|Overall Study||86
5258732|NCT00756613|12928687|P2|COMPLETED|Overall Study||462
5258733|NCT00756613|12928688|P1|COMPLETED|Overall Study||426
5258734|NCT00756613|12928687|P2|STARTED|Overall Study||532
5258735|NCT00756613|12928688|P1|STARTED|Overall Study||512
5258736|NCT00756600|12928703|P2|NOT COMPLETED|Overall Study||0
5258737|NCT00756600|12928704|P1|NOT COMPLETED|Overall Study||0
5258738|NCT00756600|12928703|P2|COMPLETED|Overall Study||356
5258739|NCT00756600|12928704|P1|COMPLETED|Overall Study||287
5258740|NCT00756600|12928703|P2|STARTED|Overall Study||356
5258741|NCT00756600|12928704|P1|STARTED|Overall Study||287
5258742|NCT00756574|12928790|P2|NOT COMPLETED|Overall Study||11
5258743|NCT00756574|12928791|P1|NOT COMPLETED|Overall Study||13
5258744|NCT00756574|12928790|P2|COMPLETED|Overall Study||210
5258745|NCT00756574|12928791|P1|COMPLETED|Overall Study||212
5258746|NCT00756574|12928790|P2|STARTED|Overall Study||221
5258747|NCT00756574|12928791|P1|STARTED|Overall Study||225
5258748|NCT00756561|12928801|P1|NOT COMPLETED|Overall Study||0
5258749|NCT00756561|12928801|P1|COMPLETED|Overall Study||10
5258750|NCT00756561|12928801|P1|STARTED|Overall Study||10
5258751|NCT00756548|12928808|P2|NOT COMPLETED|Overall Study||0
5258752|NCT00756548|12928809|P1|NOT COMPLETED|Overall Study||2
5258753|NCT00756548|12928808|P2|COMPLETED|Overall Study||185
5258754|NCT00756548|12928809|P1|COMPLETED|Overall Study||184
5258755|NCT00756548|12928808|P2|STARTED|Overall Study||185
5258756|NCT00756548|12928809|P1|STARTED|Overall Study||186
5258757|NCT00756470|12928835|P1|NOT COMPLETED|Overall Study||5
5258758|NCT00756470|12928835|P1|COMPLETED|Overall Study||10
5258759|NCT00756470|12928835|P1|STARTED|Overall Study||15
5258760|NCT00756457|12928842|P2|NOT COMPLETED|Overall Study||2
5258761|NCT00756457|12928843|P1|NOT COMPLETED|Overall Study||1
5258762|NCT00756457|12928842|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
5258763|NCT00756457|12928843|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
5258764|NCT00756457|12928842|P2|STARTED|Overall Study||19
5258765|NCT00756457|12928843|P1|STARTED|Overall Study||20
5258766|NCT00756444|12928873|P2|NOT COMPLETED|Overall Study||21
5258767|NCT00756444|12928874|P1|NOT COMPLETED|Overall Study||15
5258768|NCT00756444|12928873|P2|COMPLETED|Overall Study||13
5258769|NCT00756444|12928874|P1|COMPLETED|Overall Study||18
5258770|NCT00756444|12928873|P2|STARTED|Overall Study||34
5258771|NCT00756444|12928874|P1|STARTED|Overall Study||33
5258772|NCT00756314|12928885|P2|NOT COMPLETED|Overall Study||59
5258773|NCT00756314|12928886|P1|NOT COMPLETED|Overall Study||2
5258774|NCT00756314|12928885|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
5258775|NCT00756314|12928886|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
5258776|NCT00756314|12928885|P2|STARTED|Overall Study||123
5258777|NCT00756314|12928886|P1|STARTED|Overall Study||123
5258778|NCT00756275|12928902|P2|NOT COMPLETED|Overall Study||28
5258779|NCT00756275|12928903|P1|NOT COMPLETED|Overall Study||29
5258780|NCT00756275|12928902|P2|COMPLETED|Overall Study||49
5258781|NCT00756275|12928903|P1|COMPLETED|Overall Study||31
5258782|NCT00756275|12928902|P2|STARTED|Overall Study||77
5258783|NCT00756275|12928903|P1|STARTED|Overall Study||60
5258784|NCT00756236|12928930|P3|NOT COMPLETED|Overall Study||0
5258785|NCT00756236|12928931|P2|NOT COMPLETED|Overall Study||0
5258786|NCT00756236|12928932|P1|NOT COMPLETED|Overall Study||0
5258787|NCT00756236|12928930|P3|COMPLETED|Overall Study||20
5258788|NCT00756236|12928931|P2|COMPLETED|Overall Study||20
5258789|NCT00756236|12928932|P1|COMPLETED|Overall Study||20
5258790|NCT00756236|12928930|P3|STARTED|Overall Study||20
5258791|NCT00756236|12928931|P2|STARTED|Overall Study||20
5258792|NCT00756236|12928932|P1|STARTED|Overall Study||20
5258793|NCT00756106|12928940|P1|NOT COMPLETED|Overall Study||12
5258794|NCT00756106|12928940|P1|COMPLETED|Overall Study||3
5258795|NCT00756106|12928940|P1|STARTED|Overall Study||15
5258796|NCT00756093|12928952|P4|NOT COMPLETED|Fourth Intervention||0
5258797|NCT00756093|12928953|P3|NOT COMPLETED|Fourth Intervention||0
5258798|NCT00756093|12928954|P2|NOT COMPLETED|Fourth Intervention||0
5258799|NCT00756093|12928955|P1|NOT COMPLETED|Fourth Intervention||0
5258800|NCT00756093|12928952|P4|COMPLETED|Fourth Intervention||5
5258801|NCT00756093|12928953|P3|COMPLETED|Fourth Intervention||5
5258802|NCT00756093|12928954|P2|COMPLETED|Fourth Intervention||5
5258803|NCT00756093|12928955|P1|COMPLETED|Fourth Intervention||5
5258804|NCT00756093|12928952|P4|STARTED|Fourth Intervention||5
5258805|NCT00756093|12928953|P3|STARTED|Fourth Intervention||5
5258806|NCT00756093|12928954|P2|STARTED|Fourth Intervention||5
5258807|NCT00756093|12928955|P1|STARTED|Fourth Intervention||5
5258808|NCT00756093|12928952|P4|NOT COMPLETED|Third Intervention||0
5258809|NCT00756093|12928953|P3|NOT COMPLETED|Third Intervention||0
5258810|NCT00756093|12928954|P2|NOT COMPLETED|Third Intervention||0
5258811|NCT00756093|12928955|P1|NOT COMPLETED|Third Intervention||0
5258812|NCT00756093|12928952|P4|COMPLETED|Third Intervention||5
5258813|NCT00756093|12928953|P3|COMPLETED|Third Intervention||5
5258814|NCT00756093|12928954|P2|COMPLETED|Third Intervention||5
5258815|NCT00756093|12928955|P1|COMPLETED|Third Intervention||5
5258816|NCT00756093|12928952|P4|STARTED|Third Intervention||5
5258817|NCT00756093|12928953|P3|STARTED|Third Intervention||5
5258818|NCT00756093|12928954|P2|STARTED|Third Intervention||5
5258819|NCT00756093|12928955|P1|STARTED|Third Intervention||5
5258820|NCT00756093|12928952|P4|NOT COMPLETED|Second Intervention||0
5258821|NCT00756093|12928953|P3|NOT COMPLETED|Second Intervention||0
5258822|NCT00756093|12928954|P2|NOT COMPLETED|Second Intervention||0
5258823|NCT00756093|12928955|P1|NOT COMPLETED|Second Intervention||0
5258824|NCT00756093|12928952|P4|COMPLETED|Second Intervention||5
5258825|NCT00756093|12928953|P3|COMPLETED|Second Intervention||5
5258826|NCT00756093|12928954|P2|COMPLETED|Second Intervention||5
5258827|NCT00756093|12928955|P1|COMPLETED|Second Intervention||5
5258828|NCT00756093|12928952|P4|STARTED|Second Intervention||5
5258829|NCT00756093|12928953|P3|STARTED|Second Intervention||5
5258830|NCT00756093|12928954|P2|STARTED|Second Intervention||5
5258831|NCT00756093|12928955|P1|STARTED|Second Intervention||5
5258832|NCT00756093|12928952|P4|NOT COMPLETED|First Intervention||0
5258833|NCT00756093|12928953|P3|NOT COMPLETED|First Intervention||0
5258834|NCT00756093|12928954|P2|NOT COMPLETED|First Intervention||0
5258835|NCT00756093|12928955|P1|NOT COMPLETED|First Intervention||0
5258836|NCT00756093|12928952|P4|COMPLETED|First Intervention||5
5258837|NCT00756093|12928953|P3|COMPLETED|First Intervention||5
5258838|NCT00756093|12928954|P2|COMPLETED|First Intervention||5
5258839|NCT00756093|12928955|P1|COMPLETED|First Intervention||5
5258840|NCT00756093|12928952|P4|STARTED|First Intervention||5
5258841|NCT00756093|12928953|P3|STARTED|First Intervention||5
5258842|NCT00756093|12928954|P2|STARTED|First Intervention||5
5258843|NCT00756093|12928955|P1|STARTED|First Intervention||5
5258844|NCT00756002|12928967|P2|NOT COMPLETED|Placebo Run-out||0
5258845|NCT00756002|12928968|P1|NOT COMPLETED|Placebo Run-out||0
5258846|NCT00756002|12928967|P2|COMPLETED|Placebo Run-out||0
5258847|NCT00756002|12928968|P1|COMPLETED|Placebo Run-out||114
5258848|NCT00756002|12928967|P2|STARTED|Placebo Run-out||0
5258849|NCT00756002|12928968|P1|STARTED|Placebo Run-out||114
5258850|NCT00756002|12928967|P2|NOT COMPLETED|Double-Blind Treatment Period||15
5258851|NCT00756002|12928968|P1|NOT COMPLETED|Double-Blind Treatment Period||15
5258852|NCT00756002|12928967|P2|COMPLETED|Double-Blind Treatment Period||115
5258853|NCT00756002|12928968|P1|COMPLETED|Double-Blind Treatment Period||114
5258854|NCT00756002|12928967|P2|STARTED|Double-Blind Treatment Period||130
5258855|NCT00756002|12928968|P1|STARTED|Double-Blind Treatment Period||129
5258856|NCT00756002|12928967|P2|NOT COMPLETED|Placebo Run-in||0
5258857|NCT00756002|12928968|P1|NOT COMPLETED|Placebo Run-in||229
5258858|NCT00756002|12928967|P2|COMPLETED|Placebo Run-in||0
5258859|NCT00756002|12928968|P1|COMPLETED|Placebo Run-in||259
5258860|NCT00756002|12928967|P2|STARTED|Placebo Run-in||0
5258861|NCT00756002|12928968|P1|STARTED|Placebo Run-in||488
5258862|NCT00755937|12929062|P1|NOT COMPLETED|Observational Follow-up||148
5258863|NCT00755937|12929062|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
5258864|NCT00755937|12929062|P1|STARTED|Observational Follow-up||392
5258865|NCT00755937|12929062|P1|NOT COMPLETED|Recruitment||164
5258866|NCT00755937|12929062|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
5258867|NCT00755937|12929062|P1|STARTED|Recruitment|Subjects registered in the program|556
5258868|NCT00755911|12929074|P2|NOT COMPLETED|Overall Study||0
5258869|NCT00755911|12929075|P1|NOT COMPLETED|Overall Study||0
5258870|NCT00755911|12929074|P2|COMPLETED|Overall Study||12
5258871|NCT00755911|12929075|P1|COMPLETED|Overall Study||12
5258872|NCT00755911|12929074|P2|STARTED|Overall Study||12
5258873|NCT00755911|12929075|P1|STARTED|Overall Study||12
5258874|NCT00755846|12929089|P6|NOT COMPLETED|Overall Study||14
5258875|NCT00755846|12929090|P5|NOT COMPLETED|Overall Study||17
5258876|NCT00755846|12929091|P4|NOT COMPLETED|Overall Study||13
5258877|NCT00755846|12929092|P3|NOT COMPLETED|Overall Study||12
5258878|NCT00755846|12929093|P2|NOT COMPLETED|Overall Study||17
5258879|NCT00755846|12929094|P1|NOT COMPLETED|Overall Study||25
5258880|NCT00755846|12929089|P6|COMPLETED|Overall Study||31
5258881|NCT00755846|12929090|P5|COMPLETED|Overall Study||27
5258882|NCT00755846|12929091|P4|COMPLETED|Overall Study||32
5258883|NCT00755846|12929092|P3|COMPLETED|Overall Study||32
5258884|NCT00755846|12929093|P2|COMPLETED|Overall Study||27
5258885|NCT00755846|12929094|P1|COMPLETED|Overall Study||18
5258886|NCT00755846|12929089|P6|STARTED|Overall Study||45
5258887|NCT00755846|12929090|P5|STARTED|Overall Study||44
5258888|NCT00755846|12929091|P4|STARTED|Overall Study||45
5258889|NCT00755846|12929092|P3|STARTED|Overall Study||44
5258890|NCT00755846|12929093|P2|STARTED|Overall Study||44
5258891|NCT00755846|12929094|P1|STARTED|Overall Study||43
5258892|NCT00755807|12929194|P2|NOT COMPLETED|Open-label Extension Phase||16
5258893|NCT00755807|12929195|P1|NOT COMPLETED|Open-label Extension Phase||18
5258894|NCT00755807|12929194|P2|COMPLETED|Open-label Extension Phase||93
5258895|NCT00755807|12929195|P1|COMPLETED|Open-label Extension Phase||82
5258896|NCT00755807|12929194|P2|STARTED|Open-label Extension Phase||109
5258897|NCT00755807|12929195|P1|STARTED|Open-label Extension Phase||100
5258898|NCT00755807|12929194|P2|NOT COMPLETED|Acute Phase||12
5258899|NCT00755807|12929195|P1|NOT COMPLETED|Acute Phase||18
5258900|NCT00755807|12929194|P2|COMPLETED|Acute Phase||109
5258901|NCT00755807|12929195|P1|COMPLETED|Acute Phase||100
5258902|NCT00755807|12929194|P2|STARTED|Acute Phase||121
5258903|NCT00755807|12929195|P1|STARTED|Acute Phase||118
5258904|NCT00755755|12929259|P3|NOT COMPLETED|Overall Study||3
5258905|NCT00755755|12929260|P2|NOT COMPLETED|Overall Study||8
5258906|NCT00755755|12929261|P1|NOT COMPLETED|Overall Study||6
5258907|NCT00755755|12929259|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
5258908|NCT00755755|12929260|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
5258909|NCT00755755|12929261|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
5258910|NCT00755755|12929259|P3|STARTED|Overall Study|Safety population|48
5258911|NCT00755755|12929260|P2|STARTED|Overall Study|Safety population|98
5258912|NCT00755755|12929261|P1|STARTED|Overall Study|Safety population|95
5258913|NCT00755716|12929275|P3|NOT COMPLETED|Overall Study||3
5258914|NCT00755716|12929276|P2|NOT COMPLETED|Overall Study||8
5258915|NCT00755716|12929277|P1|NOT COMPLETED|Overall Study||8
5258916|NCT00755716|12929275|P3|COMPLETED|Overall Study||16
5258917|NCT00755716|12929276|P2|COMPLETED|Overall Study||11
5258918|NCT00755716|12929277|P1|COMPLETED|Overall Study||11
5258919|NCT00755716|12929275|P3|STARTED|Overall Study||19
5258920|NCT00755716|12929276|P2|STARTED|Overall Study||19
5258921|NCT00755716|12929277|P1|STARTED|Overall Study||19
5258922|NCT00755417|12929291|P3|NOT COMPLETED|Overall Study||42
5258923|NCT00755417|12929292|P2|NOT COMPLETED|Overall Study||55
5258924|NCT00755417|12929293|P1|NOT COMPLETED|Overall Study||62
5258925|NCT00755417|12929291|P3|COMPLETED|Overall Study||135
5258926|NCT00755417|12929292|P2|COMPLETED|Overall Study||126
5258927|NCT00755417|12929293|P1|COMPLETED|Overall Study||112
5258928|NCT00755417|12929291|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
5258929|NCT00755417|12929292|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
5258930|NCT00755417|12929293|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
5258931|NCT00755326|12929312|P2|NOT COMPLETED|Overall Study||3
5258932|NCT00755326|12929313|P1|NOT COMPLETED|Overall Study||2
5258933|NCT00755326|12929312|P2|COMPLETED|Overall Study||42
5258934|NCT00755326|12929313|P1|COMPLETED|Overall Study||45
5258935|NCT00755326|12929312|P2|STARTED|Overall Study||45
5258936|NCT00755326|12929313|P1|STARTED|Overall Study||47
5258937|NCT00755274|12929325|P2|NOT COMPLETED|Overall Study||0
5258938|NCT00755274|12929326|P1|NOT COMPLETED|Overall Study||0
5258939|NCT00755274|12929325|P2|COMPLETED|Overall Study||8
5258940|NCT00755274|12929326|P1|COMPLETED|Overall Study||24
5258941|NCT00755274|12929325|P2|STARTED|Overall Study||8
5258942|NCT00755274|12929326|P1|STARTED|Overall Study||24
5258943|NCT00755261|12929346|P1|NOT COMPLETED|Overall Study||2
5258944|NCT00755261|12929346|P1|COMPLETED|Overall Study||4
5258945|NCT00755261|12929346|P1|STARTED|Overall Study||6
5258946|NCT00755235|12929352|P2|NOT COMPLETED|Overall Study||9
5258947|NCT00755235|12929353|P1|NOT COMPLETED|Overall Study||2
5258948|NCT00755235|12929352|P2|COMPLETED|Overall Study||93
5258949|NCT00755235|12929353|P1|COMPLETED|Overall Study||104
5258950|NCT00755235|12929352|P2|STARTED|Overall Study||102
5258951|NCT00755235|12929353|P1|STARTED|Overall Study||106
5258952|NCT00755222|12929363|P2|NOT COMPLETED|Overall Study||2
5258953|NCT00755222|12929364|P1|NOT COMPLETED|Overall Study||8
5258954|NCT00755222|12929363|P2|COMPLETED|Overall Study||34
5258955|NCT00755222|12929364|P1|COMPLETED|Overall Study||103
5258956|NCT00755222|12929363|P2|STARTED|Overall Study||36
5258957|NCT00755222|12929364|P1|STARTED|Overall Study||111
5258958|NCT00755196|12929378|P1|NOT COMPLETED|Overall Study||2
5258959|NCT00755196|12929378|P1|COMPLETED|Overall Study||28
5258960|NCT00755196|12929378|P1|STARTED|Overall Study||30
5258961|NCT00755131|12929385|P2|NOT COMPLETED|Overall Study||0
5258962|NCT00755131|12929386|P1|NOT COMPLETED|Overall Study||0
5258963|NCT00755131|12929385|P2|COMPLETED|Overall Study||38
5258964|NCT00755131|12929386|P1|COMPLETED|Overall Study||37
5258965|NCT00755131|12929385|P2|STARTED|Overall Study||38
5258966|NCT00755131|12929386|P1|STARTED|Overall Study||37
5258967|NCT00755105|12929399|P3|NOT COMPLETED|Overall Study||4
5258968|NCT00755105|12929400|P2|NOT COMPLETED|Overall Study||11
5258969|NCT00755105|12929401|P1|NOT COMPLETED|Overall Study||9
5258970|NCT00755105|12929399|P3|COMPLETED|Overall Study||5
5258971|NCT00755105|12929400|P2|COMPLETED|Overall Study||19
5258972|NCT00755105|12929401|P1|COMPLETED|Overall Study||29
5258973|NCT00755105|12929399|P3|STARTED|Overall Study||9
5258974|NCT00755105|12929400|P2|STARTED|Overall Study||30
5258975|NCT00755105|12929401|P1|STARTED|Overall Study||38
5258976|NCT00755079|12929411|P2|NOT COMPLETED|Overall Study||6
5258977|NCT00755079|12929412|P1|NOT COMPLETED|Overall Study||1
5258978|NCT00755079|12929411|P2|COMPLETED|Overall Study||16
5258979|NCT00755079|12929412|P1|COMPLETED|Overall Study||17
5258980|NCT00755079|12929411|P2|STARTED|Overall Study||22
5258981|NCT00755079|12929412|P1|STARTED|Overall Study||18
5258982|NCT00755040|12929422|P2|NOT COMPLETED|Overall Study||34
5258983|NCT00755040|12929423|P1|NOT COMPLETED|Overall Study||43
5258984|NCT00755040|12929422|P2|COMPLETED|Overall Study||47
5258985|NCT00755040|12929423|P1|COMPLETED|Overall Study||40
5258986|NCT00755040|12929422|P2|STARTED|Overall Study||81
5258987|NCT00755040|12929423|P1|STARTED|Overall Study||83
5258988|NCT00754936|12929431|P1|NOT COMPLETED|Overall Study||12
5258989|NCT00754936|12929431|P1|COMPLETED|Overall Study||59
5258990|NCT00754936|12929431|P1|STARTED|Overall Study||71
5258991|NCT00754923|12929436|P1|NOT COMPLETED|Overall Study||0
5258992|NCT00754923|12929436|P1|COMPLETED|Overall Study||11
5258993|NCT00754923|12929436|P1|STARTED|Overall Study||11
5258994|NCT00754845|12929445|P2|NOT COMPLETED|Overall Study||0
5258995|NCT00754845|12929446|P1|NOT COMPLETED|Overall Study||0
5258996|NCT00754845|12929445|P2|COMPLETED|Overall Study||959
5258997|NCT00754845|12929446|P1|COMPLETED|Overall Study||959
5258998|NCT00754845|12929445|P2|STARTED|Overall Study||959
5258999|NCT00754845|12929446|P1|STARTED|Overall Study||959
5259000|NCT00754832|12929458|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
5259001|NCT00754832|12929459|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
5259002|NCT00754832|12929458|P2|COMPLETED|Second 6 Weeks Intervention||24
5259003|NCT00754832|12929459|P1|COMPLETED|Second 6 Weeks Intervention||17
5259004|NCT00754832|12929458|P2|STARTED|Second 6 Weeks Intervention||26
5259005|NCT00754832|12929459|P1|STARTED|Second 6 Weeks Intervention||17
5259006|NCT00754832|12929458|P2|NOT COMPLETED|2 Weeks Washout||2
5259007|NCT00754832|12929459|P1|NOT COMPLETED|2 Weeks Washout||1
5259008|NCT00754832|12929458|P2|COMPLETED|2 Weeks Washout||26
5259009|NCT00754832|12929459|P1|COMPLETED|2 Weeks Washout||17
5259010|NCT00754832|12929458|P2|STARTED|2 Weeks Washout||28
5259011|NCT00754832|12929459|P1|STARTED|2 Weeks Washout||18
5259012|NCT00754832|12929458|P2|NOT COMPLETED|First 6 Weeks Intervention||2
5259013|NCT00754832|12929459|P1|NOT COMPLETED|First 6 Weeks Intervention||8
5259014|NCT00754832|12929458|P2|COMPLETED|First 6 Weeks Intervention||28
5259015|NCT00754832|12929459|P1|COMPLETED|First 6 Weeks Intervention||18
5259016|NCT00754832|12929458|P2|STARTED|First 6 Weeks Intervention||30
5259017|NCT00754832|12929459|P1|STARTED|First 6 Weeks Intervention||26
5259018|NCT00754793|12929471|P2|NOT COMPLETED|Overall Study||1
5259019|NCT00754793|12929472|P1|NOT COMPLETED|Overall Study||0
5259020|NCT00754793|12929471|P2|COMPLETED|Overall Study||1
5259021|NCT00754793|12929472|P1|COMPLETED|Overall Study||1
5259022|NCT00754793|12929471|P2|STARTED|Overall Study||2
5259023|NCT00754793|12929472|P1|STARTED|Overall Study||1
5259024|NCT00754767|12929480|P2|NOT COMPLETED|Overall Study||0
5259025|NCT00754767|12929481|P1|NOT COMPLETED|Overall Study||0
5259026|NCT00754767|12929480|P2|COMPLETED|Overall Study||0
5259027|NCT00754767|12929481|P1|COMPLETED|Overall Study||2
5259028|NCT00754767|12929480|P2|STARTED|Overall Study||0
5259029|NCT00754767|12929481|P1|STARTED|Overall Study||2
5259030|NCT00754741|12929490|P3|NOT COMPLETED|Overall Study||54
5259031|NCT00754741|12929491|P2|NOT COMPLETED|Overall Study||69
5259032|NCT00754741|12929492|P1|NOT COMPLETED|Overall Study||57
5259033|NCT00754741|12929490|P3|COMPLETED|Overall Study||502
5259034|NCT00754741|12929491|P2|COMPLETED|Overall Study||500
5259035|NCT00754741|12929492|P1|COMPLETED|Overall Study||510
5259036|NCT00754741|12929490|P3|STARTED|Overall Study||556
5259037|NCT00754741|12929491|P2|STARTED|Overall Study||569
5259038|NCT00754741|12929492|P1|STARTED|Overall Study||567
5259039|NCT00754650|12929539|P1|NOT COMPLETED|Overall Study||2
5259040|NCT00754650|12929539|P1|COMPLETED|Overall Study||0
5259041|NCT00754650|12929539|P1|STARTED|Overall Study||2
5259042|NCT00754624|12929544|P1|NOT COMPLETED|Overall Study||69
5259043|NCT00754624|12929544|P1|COMPLETED|Overall Study||160
5259044|NCT00754624|12929544|P1|STARTED|Overall Study||229
5259045|NCT00754572|12929554|P1|NOT COMPLETED|Overall Study||71
5259046|NCT00754572|12929554|P1|COMPLETED|Overall Study||347
5259047|NCT00754572|12929554|P1|STARTED|Overall Study||418
5259048|NCT00754559|12929581|P1|NOT COMPLETED|Overall Study||47
5259049|NCT00754559|12929581|P1|COMPLETED|Overall Study||239
5259050|NCT00754559|12929581|P1|STARTED|Overall Study||286
5259051|NCT00754546|12929605|P1|NOT COMPLETED|Overall Study||0
5259052|NCT00754546|12929605|P1|COMPLETED|Overall Study||20
5259053|NCT00754546|12929605|P1|STARTED|Overall Study||20
5259054|NCT00754494|12929622|P3|NOT COMPLETED|Overall Study||1
5259055|NCT00754494|12929623|P2|NOT COMPLETED|Overall Study||0
5259056|NCT00754494|12929624|P1|NOT COMPLETED|Overall Study||2
5259057|NCT00754494|12929622|P3|COMPLETED|Overall Study||14
5259058|NCT00754494|12929623|P2|COMPLETED|Overall Study||15
5259059|NCT00754494|12929624|P1|COMPLETED|Overall Study||13
5259060|NCT00754494|12929622|P3|STARTED|Overall Study||15
5259061|NCT00754494|12929623|P2|STARTED|Overall Study||15
5259062|NCT00754494|12929624|P1|STARTED|Overall Study||15
5259063|NCT00754468|12929670|P2|NOT COMPLETED|Overall Study||0
5259064|NCT00754468|12929671|P1|NOT COMPLETED|Overall Study||0
5259065|NCT00754468|12929670|P2|COMPLETED|Overall Study||3
5259066|NCT00754468|12929671|P1|COMPLETED|Overall Study||4
5259067|NCT00754468|12929670|P2|STARTED|Overall Study||3
5259068|NCT00754468|12929671|P1|STARTED|Overall Study||4
5259069|NCT00754442|12929681|P2|NOT COMPLETED|Overall Study||3
5259070|NCT00754442|12929682|P1|NOT COMPLETED|Overall Study||5
5259071|NCT00754442|12929681|P2|COMPLETED|Overall Study||6
5259072|NCT00754442|12929682|P1|COMPLETED|Overall Study||6
5259073|NCT00754442|12929681|P2|STARTED|Overall Study|patients 9|9
5259074|NCT00754442|12929682|P1|STARTED|Overall Study|controls 11|11
5259075|NCT00754390|12929689|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
5259076|NCT00754390|12929689|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
5259077|NCT00754390|12929689|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
5259078|NCT00754390|12929689|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
5259079|NCT00754390|12929689|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
5259080|NCT00754390|12929689|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
5259081|NCT00754390|12929689|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
5259082|NCT00754390|12929689|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
5259083|NCT00754390|12929689|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
5259084|NCT00754390|12929689|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
5259085|NCT00754390|12929689|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
5259086|NCT00754390|12929689|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
5259087|NCT00754377|12929698|P2|NOT COMPLETED|Overall Study||0
5259088|NCT00754377|12929699|P1|NOT COMPLETED|Overall Study||0
5259089|NCT00754377|12929698|P2|COMPLETED|Overall Study||42
5259090|NCT00754377|12929699|P1|COMPLETED|Overall Study||50
5259091|NCT00754377|12929698|P2|STARTED|Overall Study||42
5259092|NCT00754377|12929699|P1|STARTED|Overall Study||50
5259093|NCT00754338|12929711|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
5259094|NCT00754338|12929712|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
5259095|NCT00754338|12929713|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
5259096|NCT00754338|12929714|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
5259097|NCT00754338|12929711|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
5259098|NCT00754338|12929712|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
5259099|NCT00754338|12929713|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
5259100|NCT00754338|12929714|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
5259101|NCT00754338|12929711|P4|STARTED|Second Intervention for Phase1&Phase2||19
5259102|NCT00754338|12929712|P3|STARTED|Second Intervention for Phase1&Phase2||16
5259103|NCT00754338|12929713|P2|STARTED|Second Intervention for Phase1&Phase2||18
5259104|NCT00754338|12929714|P1|STARTED|Second Intervention for Phase1&Phase2||17
5259105|NCT00754338|12929711|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
5259106|NCT00754338|12929712|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
5259107|NCT00754338|12929713|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
5259108|NCT00754338|12929714|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
5259109|NCT00754338|12929711|P4|COMPLETED|First Intervention for Phase1&Phase2||19
5259110|NCT00754338|12929712|P3|COMPLETED|First Intervention for Phase1&Phase2||16
5259111|NCT00754338|12929713|P2|COMPLETED|First Intervention for Phase1&Phase2||18
5259112|NCT00754338|12929714|P1|COMPLETED|First Intervention for Phase1&Phase2||17
5259113|NCT00754338|12929711|P4|STARTED|First Intervention for Phase1&Phase2||19
5259114|NCT00754338|12929712|P3|STARTED|First Intervention for Phase1&Phase2||19
5259115|NCT00754338|12929713|P2|STARTED|First Intervention for Phase1&Phase2||21
5259116|NCT00754338|12929714|P1|STARTED|First Intervention for Phase1&Phase2||17
5259117|NCT00754325|12929746|P2|NOT COMPLETED|Progression and Cross-over||21
5259118|NCT00754325|12929747|P1|NOT COMPLETED|Progression and Cross-over||0
5259119|NCT00754325|12929746|P2|COMPLETED|Progression and Cross-over||0
5259120|NCT00754325|12929747|P1|COMPLETED|Progression and Cross-over||0
5259121|NCT00754325|12929746|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
5259122|NCT00754325|12929747|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
5259123|NCT00754325|12929746|P2|NOT COMPLETED|Initial Treatment||49
5259124|NCT00754325|12929747|P1|NOT COMPLETED|Initial Treatment||50
5259125|NCT00754325|12929746|P2|COMPLETED|Initial Treatment||0
5259126|NCT00754325|12929747|P1|COMPLETED|Initial Treatment||0
5259127|NCT00754325|12929746|P2|STARTED|Initial Treatment||49
5259128|NCT00754325|12929747|P1|STARTED|Initial Treatment||50
5259129|NCT00754247|12929769|P3|NOT COMPLETED|Overall Study||5
5259130|NCT00754247|12929770|P2|NOT COMPLETED|Overall Study||5
5259131|NCT00754247|12929771|P1|NOT COMPLETED|Overall Study||5
5259132|NCT00754247|12929769|P3|COMPLETED|Overall Study||5
5259133|NCT00754247|12929770|P2|COMPLETED|Overall Study||5
5259134|NCT00754247|12929771|P1|COMPLETED|Overall Study||5
5259135|NCT00754247|12929769|P3|STARTED|Overall Study||10
5259136|NCT00754247|12929770|P2|STARTED|Overall Study||10
5259137|NCT00754247|12929771|P1|STARTED|Overall Study||10
5259138|NCT00754234|12929800|P1|NOT COMPLETED|Overall Study||3
5259139|NCT00754234|12929800|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
5259140|NCT00754234|12929800|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
5259141|NCT00754208|12929804|P1|NOT COMPLETED|Overall Study||0
5259142|NCT00754208|12929804|P1|COMPLETED|Overall Study||7
5259143|NCT00754208|12929804|P1|STARTED|Overall Study||7
5259144|NCT00754156|12929813|P2|NOT COMPLETED|Overall Study||0
5259145|NCT00754156|12929814|P1|NOT COMPLETED|Overall Study||0
5259146|NCT00754156|12929813|P2|COMPLETED|Overall Study||6
5259147|NCT00754156|12929814|P1|COMPLETED|Overall Study||8
5259148|NCT00754156|12929813|P2|STARTED|Overall Study||6
5259149|NCT00754156|12929814|P1|STARTED|Overall Study||8
5259150|NCT00754130|12929838|P6|NOT COMPLETED|Period 2 (5 Days)||0
5259151|NCT00754130|12929839|P5|NOT COMPLETED|Period 2 (5 Days)||0
5259152|NCT00754130|12929840|P4|NOT COMPLETED|Period 2 (5 Days)||0
5259153|NCT00754130|12929841|P3|NOT COMPLETED|Period 2 (5 Days)||0
5259154|NCT00754130|12929842|P2|NOT COMPLETED|Period 2 (5 Days)||0
5259155|NCT00754130|12929843|P1|NOT COMPLETED|Period 2 (5 Days)||0
5259156|NCT00754130|12929838|P6|COMPLETED|Period 2 (5 Days)||4
5259157|NCT00754130|12929839|P5|COMPLETED|Period 2 (5 Days)||2
5259158|NCT00754130|12929840|P4|COMPLETED|Period 2 (5 Days)||2
5259159|NCT00754130|12929841|P3|COMPLETED|Period 2 (5 Days)||4
5259160|NCT00754130|12929842|P2|COMPLETED|Period 2 (5 Days)||2
5259161|NCT00754130|12929843|P1|COMPLETED|Period 2 (5 Days)||2
5259162|NCT00754130|12929838|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
5259163|NCT00754130|12929839|P5|STARTED|Period 2 (5 Days)||2
5259164|NCT00754130|12929840|P4|STARTED|Period 2 (5 Days)||2
5259165|NCT00754130|12929841|P3|STARTED|Period 2 (5 Days)||4
5259166|NCT00754130|12929842|P2|STARTED|Period 2 (5 Days)||2
5259167|NCT00754130|12929843|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
5259168|NCT00754130|12929838|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
5259169|NCT00754130|12929839|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
5259170|NCT00754130|12929840|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
5259171|NCT00754130|12929841|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
5259172|NCT00754130|12929842|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
5259173|NCT00754130|12929843|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
5259174|NCT00754130|12929838|P6|COMPLETED|Washout Period (>=8 Days)||4
5259175|NCT00754130|12929839|P5|COMPLETED|Washout Period (>=8 Days)||2
5259176|NCT00754130|12929840|P4|COMPLETED|Washout Period (>=8 Days)||2
5259177|NCT00754130|12929841|P3|COMPLETED|Washout Period (>=8 Days)||4
5259178|NCT00754130|12929842|P2|COMPLETED|Washout Period (>=8 Days)||2
5259179|NCT00754130|12929843|P1|COMPLETED|Washout Period (>=8 Days)||2
5259180|NCT00754130|12929838|P6|STARTED|Washout Period (>=8 Days)||4
5259181|NCT00754130|12929839|P5|STARTED|Washout Period (>=8 Days)||2
5259182|NCT00754130|12929840|P4|STARTED|Washout Period (>=8 Days)||2
5259183|NCT00754130|12929841|P3|STARTED|Washout Period (>=8 Days)||4
5259184|NCT00754130|12929842|P2|STARTED|Washout Period (>=8 Days)||2
5259185|NCT00754130|12929843|P1|STARTED|Washout Period (>=8 Days)||2
5259186|NCT00754130|12929838|P6|NOT COMPLETED|Period 1 (5 Days)||0
5259187|NCT00754130|12929839|P5|NOT COMPLETED|Period 1 (5 Days)||0
5259188|NCT00754130|12929840|P4|NOT COMPLETED|Period 1 (5 Days)||0
5259189|NCT00754130|12929841|P3|NOT COMPLETED|Period 1 (5 Days)||0
5259190|NCT00754130|12929842|P2|NOT COMPLETED|Period 1 (5 Days)||0
5259191|NCT00754130|12929843|P1|NOT COMPLETED|Period 1 (5 Days)||0
5259192|NCT00754130|12929838|P6|COMPLETED|Period 1 (5 Days)||4
5259193|NCT00754130|12929839|P5|COMPLETED|Period 1 (5 Days)||2
5259194|NCT00754130|12929840|P4|COMPLETED|Period 1 (5 Days)||2
5259195|NCT00754130|12929841|P3|COMPLETED|Period 1 (5 Days)||4
5259196|NCT00754130|12929842|P2|COMPLETED|Period 1 (5 Days)||2
5259197|NCT00754130|12929843|P1|COMPLETED|Period 1 (5 Days)||2
5259198|NCT00754130|12929838|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
5259199|NCT00754130|12929839|P5|STARTED|Period 1 (5 Days)||2
5259200|NCT00754130|12929840|P4|STARTED|Period 1 (5 Days)||2
5259201|NCT00754130|12929841|P3|STARTED|Period 1 (5 Days)||4
5259202|NCT00754130|12929842|P2|STARTED|Period 1 (5 Days)||2
5259203|NCT00754130|12929843|P1|STARTED|Period 1 (5 Days)||2
5259204|NCT00754065|12929886|P2|NOT COMPLETED|Overall Study||80
5259205|NCT00754065|12929887|P1|NOT COMPLETED|Overall Study||81
5259206|NCT00754065|12929886|P2|COMPLETED|Overall Study||126
5259207|NCT00754065|12929887|P1|COMPLETED|Overall Study||122
5259208|NCT00754065|12929886|P2|Cycle 6|Overall Study||153
5259209|NCT00754065|12929887|P1|Cycle 6|Overall Study||141
5259210|NCT00754065|12929886|P2|Participants Received Treatment|Overall Study||204
5259211|NCT00754065|12929887|P1|Participants Received Treatment|Overall Study||191
5259212|NCT00754065|12929886|P2|STARTED|Overall Study||206
5259213|NCT00754065|12929887|P1|STARTED|Overall Study||203
5259214|NCT00754052|12930127|P2|NOT COMPLETED|Overall Study||3
5259215|NCT00754052|12930128|P1|NOT COMPLETED|Overall Study||5
5259216|NCT00754052|12930127|P2|COMPLETED|Overall Study||0
5259217|NCT00754052|12930128|P1|COMPLETED|Overall Study||0
5259218|NCT00754052|12930127|P2|STARTED|Overall Study||3
5259219|NCT00754052|12930128|P1|STARTED|Overall Study||5
5259220|NCT00754013|12930142|P2|NOT COMPLETED|Overall Study||5
5259221|NCT00754013|12930143|P1|NOT COMPLETED|Overall Study||4
5259222|NCT00754013|12930142|P2|COMPLETED|Overall Study||0
5259223|NCT00754013|12930143|P1|COMPLETED|Overall Study||0
5259224|NCT00754013|12930142|P2|STARTED|Overall Study||5
5259225|NCT00754013|12930143|P1|STARTED|Overall Study||4
5259226|NCT00753948|12930154|P3|NOT COMPLETED|Overall Study||0
5259227|NCT00753948|12930155|P2|NOT COMPLETED|Overall Study||0
5259228|NCT00753948|12930156|P1|NOT COMPLETED|Overall Study||0
5259229|NCT00753948|12930154|P3|COMPLETED|Overall Study||7
5259230|NCT00753948|12930155|P2|COMPLETED|Overall Study||7
5259231|NCT00753948|12930156|P1|COMPLETED|Overall Study||9
5259232|NCT00753948|12930154|P3|STARTED|Overall Study||7
5259233|NCT00753948|12930155|P2|STARTED|Overall Study||7
5259234|NCT00753948|12930156|P1|STARTED|Overall Study||9
5259235|NCT00753935|12930169|P2|NOT COMPLETED|Overall Study||0
5259236|NCT00753935|12930170|P1|NOT COMPLETED|Overall Study||0
5259237|NCT00753935|12930169|P2|COMPLETED|Overall Study||47
5259238|NCT00753935|12930170|P1|COMPLETED|Overall Study||45
5259239|NCT00753935|12930169|P2|STARTED|Overall Study||47
5259240|NCT00753935|12930170|P1|STARTED|Overall Study||45
5259241|NCT00753922|12930180|P4|NOT COMPLETED|Overall Study||23
5259242|NCT00753922|12930181|P3|NOT COMPLETED|Overall Study||63
5259243|NCT00753922|12930182|P2|NOT COMPLETED|Overall Study||94
5259244|NCT00753922|12930183|P1|NOT COMPLETED|Overall Study||246
5259245|NCT00753922|12930180|P4|COMPLETED|Overall Study||37
5259246|NCT00753922|12930181|P3|COMPLETED|Overall Study||82
5259247|NCT00753922|12930182|P2|COMPLETED|Overall Study||157
5259248|NCT00753922|12930183|P1|COMPLETED|Overall Study||306
5259249|NCT00753922|12930180|P4|STARTED|Overall Study||60
5259250|NCT00753922|12930181|P3|STARTED|Overall Study||145
5259251|NCT00753922|12930182|P2|STARTED|Overall Study||251
5259252|NCT00753922|12930183|P1|STARTED|Overall Study||552
5259253|NCT00753896|12930213|P1|NOT COMPLETED|Overall Study||16
5259254|NCT00753896|12930213|P1|COMPLETED|Overall Study||118
5259255|NCT00753896|12930213|P1|STARTED|Overall Study||134
5259256|NCT00753766|12930229|P2|NOT COMPLETED|Overall Study||0
5259257|NCT00753766|12930230|P1|NOT COMPLETED|Overall Study||1
5259258|NCT00753766|12930229|P2|COMPLETED|Overall Study||0
5259259|NCT00753766|12930230|P1|COMPLETED|Overall Study||0
5259260|NCT00753766|12930229|P2|STARTED|Overall Study||0
5259261|NCT00753766|12930230|P1|STARTED|Overall Study||1
5259262|NCT00753714|12930252|P2|NOT COMPLETED|Overall Study||62
5259263|NCT00753714|12930253|P1|NOT COMPLETED|Overall Study||60
5259264|NCT00753714|12930252|P2|COMPLETED|Overall Study||1
5259265|NCT00753714|12930253|P1|COMPLETED|Overall Study||1
5259266|NCT00753714|12930252|P2|STARTED|Overall Study||63
5259267|NCT00753714|12930253|P1|STARTED|Overall Study||61
5259268|NCT00753688|12930269|P2|NOT COMPLETED|Overall Study||246
5259269|NCT00753688|12930270|P1|NOT COMPLETED|Overall Study||123
5259270|NCT00753688|12930269|P2|COMPLETED|Overall Study||0
5259271|NCT00753688|12930270|P1|COMPLETED|Overall Study||0
5259272|NCT00753688|12930269|P2|Ongoing - in Follow-up|Overall Study||31
5259273|NCT00753688|12930270|P1|Ongoing - in Follow-up|Overall Study||15
5259274|NCT00753688|12930269|P2|STARTED|Overall Study||246
5259275|NCT00753688|12930270|P1|STARTED|Overall Study||123
5259276|NCT00753675|12930299|P3|NOT COMPLETED|Overall Study||56
5259277|NCT00753675|12930300|P2|NOT COMPLETED|Overall Study||59
5259278|NCT00753675|12930301|P1|NOT COMPLETED|Overall Study||59
5259279|NCT00753675|12930299|P3|COMPLETED|Overall Study||0
5259280|NCT00753675|12930300|P2|COMPLETED|Overall Study||0
5259281|NCT00753675|12930301|P1|COMPLETED|Overall Study||0
5259282|NCT00753675|12930299|P3|STARTED|Overall Study||56
5259283|NCT00753675|12930300|P2|STARTED|Overall Study||59
5259284|NCT00753675|12930301|P1|STARTED|Overall Study||59
5259285|NCT00753649|12930323|P2|NOT COMPLETED|Overall Study||0
5259286|NCT00753649|12930324|P1|NOT COMPLETED|Overall Study||7
5259287|NCT00753649|12930323|P2|COMPLETED|Overall Study||112
5259288|NCT00753649|12930324|P1|COMPLETED|Overall Study||105
5259289|NCT00753649|12930323|P2|STARTED|Overall Study||112
5259290|NCT00753649|12930324|P1|STARTED|Overall Study||112
5259291|NCT00753636|12930344|P1|NOT COMPLETED|Overall Study||6
5259292|NCT00753636|12930344|P1|COMPLETED|Overall Study||25
5259293|NCT00753636|12930344|P1|STARTED|Overall Study||31
5259294|NCT00753623|12930356|P2|NOT COMPLETED|Phase II (14 Days)||1
5259295|NCT00753623|12930357|P1|NOT COMPLETED|Phase II (14 Days)||0
5259296|NCT00753623|12930356|P2|COMPLETED|Phase II (14 Days)||7
5259297|NCT00753623|12930357|P1|COMPLETED|Phase II (14 Days)||8
5259298|NCT00753623|12930356|P2|STARTED|Phase II (14 Days)||8
5259299|NCT00753623|12930357|P1|STARTED|Phase II (14 Days)||8
5259300|NCT00753623|12930356|P2|NOT COMPLETED|Washout (7 Days)||0
5259301|NCT00753623|12930357|P1|NOT COMPLETED|Washout (7 Days)||1
5259302|NCT00753623|12930356|P2|COMPLETED|Washout (7 Days)||8
5259303|NCT00753623|12930357|P1|COMPLETED|Washout (7 Days)||8
5259304|NCT00753623|12930356|P2|STARTED|Washout (7 Days)||8
5259305|NCT00753623|12930357|P1|STARTED|Washout (7 Days)||9
5259306|NCT00753623|12930356|P2|NOT COMPLETED|Phase I (14 Days)||4
5259307|NCT00753623|12930357|P1|NOT COMPLETED|Phase I (14 Days)||2
5259308|NCT00753623|12930356|P2|COMPLETED|Phase I (14 Days)||8
5259309|NCT00753623|12930357|P1|COMPLETED|Phase I (14 Days)||9
5259310|NCT00753623|12930356|P2|STARTED|Phase I (14 Days)||12
5259311|NCT00753623|12930357|P1|STARTED|Phase I (14 Days)||11
5259312|NCT00753545|12930365|P2|NOT COMPLETED|Overall Study||118
5259313|NCT00753545|12930366|P1|NOT COMPLETED|Overall Study||108
5259314|NCT00753545|12930365|P2|COMPLETED|Overall Study|Patients completing the Study|11
5259315|NCT00753545|12930366|P1|COMPLETED|Overall Study|Patients completing the Study|28
5259316|NCT00753545|12930365|P2|STARTED|Overall Study|Patients randomized|129
5259317|NCT00753545|12930366|P1|STARTED|Overall Study|Patients randomized|136
5259318|NCT00753519|12930404|P2|NOT COMPLETED|Overall Study||2
5259319|NCT00753519|12930405|P1|NOT COMPLETED|Overall Study||0
5259320|NCT00753519|12930404|P2|COMPLETED|Overall Study||13
5259321|NCT00753519|12930405|P1|COMPLETED|Overall Study||13
5259322|NCT00753519|12930404|P2|STARTED|Overall Study||15
5259323|NCT00753519|12930405|P1|STARTED|Overall Study||13
5259324|NCT00753506|12930427|P2|NOT COMPLETED|Overall Study||2
5259325|NCT00753506|12930428|P1|NOT COMPLETED|Overall Study||7
5259326|NCT00753506|12930427|P2|COMPLETED|Overall Study||31
5259327|NCT00753506|12930428|P1|COMPLETED|Overall Study||26
5259328|NCT00753506|12930427|P2|STARTED|Overall Study||33
5259329|NCT00753506|12930428|P1|STARTED|Overall Study||33
5259330|NCT00753454|12930434|P1|NOT COMPLETED|Overall Study||14
5259331|NCT00753454|12930434|P1|COMPLETED|Overall Study||154
5259332|NCT00753454|12930434|P1|STARTED|Overall Study||168
5259333|NCT00753415|12930468|P10|NOT COMPLETED|Part B||1
5259334|NCT00753415|12930469|P9|NOT COMPLETED|Part B||3
5259335|NCT00753415|12930470|P8|NOT COMPLETED|Part B||1
5259336|NCT00753415|12930471|P7|NOT COMPLETED|Part B||0
5259337|NCT00753415|12930472|P6|NOT COMPLETED|Part B||0
5259338|NCT00753415|12930473|P5|NOT COMPLETED|Part B||0
5259339|NCT00753415|12930474|P4|NOT COMPLETED|Part B||0
5259340|NCT00753415|12930475|P3|NOT COMPLETED|Part B||0
5259341|NCT00753415|12930476|P2|NOT COMPLETED|Part B||0
5259342|NCT00753415|12930477|P1|NOT COMPLETED|Part B||0
5259343|NCT00753415|12930468|P10|COMPLETED|Part B||8
5259344|NCT00753415|12930469|P9|COMPLETED|Part B||6
5259345|NCT00753415|12930470|P8|COMPLETED|Part B||6
5259346|NCT00753415|12930471|P7|COMPLETED|Part B||2
5259347|NCT00753415|12930472|P6|COMPLETED|Part B||1
5259348|NCT00753415|12930473|P5|COMPLETED|Part B||0
5259349|NCT00753415|12930474|P4|COMPLETED|Part B||0
5259350|NCT00753415|12930475|P3|COMPLETED|Part B||0
5259351|NCT00753415|12930476|P2|COMPLETED|Part B||0
5259352|NCT00753415|12930477|P1|COMPLETED|Part B||0
5259353|NCT00753415|12930468|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
5259354|NCT00753415|12930469|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
5259355|NCT00753415|12930470|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
5259356|NCT00753415|12930471|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
5259357|NCT00753415|12930472|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
5259358|NCT00753415|12930473|P5|STARTED|Part B||0
5259359|NCT00753415|12930474|P4|STARTED|Part B||0
5259360|NCT00753415|12930475|P3|STARTED|Part B||0
5259361|NCT00753415|12930476|P2|STARTED|Part B||0
5259362|NCT00753415|12930477|P1|STARTED|Part B||0
5259363|NCT00753415|12930468|P10|NOT COMPLETED|Part A||0
5259364|NCT00753415|12930469|P9|NOT COMPLETED|Part A||0
5259365|NCT00753415|12930470|P8|NOT COMPLETED|Part A||0
5259366|NCT00753415|12930471|P7|NOT COMPLETED|Part A||0
5259367|NCT00753415|12930472|P6|NOT COMPLETED|Part A||0
5259368|NCT00753415|12930473|P5|NOT COMPLETED|Part A||0
5259369|NCT00753415|12930474|P4|NOT COMPLETED|Part A||2
5259370|NCT00753415|12930475|P3|NOT COMPLETED|Part A||2
5259371|NCT00753415|12930476|P2|NOT COMPLETED|Part A||0
5259372|NCT00753415|12930477|P1|NOT COMPLETED|Part A||1
5259373|NCT00753415|12930468|P10|COMPLETED|Part A||0
5259374|NCT00753415|12930469|P9|COMPLETED|Part A||0
5259375|NCT00753415|12930470|P8|COMPLETED|Part A||0
5259376|NCT00753415|12930471|P7|COMPLETED|Part A||0
5259377|NCT00753415|12930472|P6|COMPLETED|Part A||0
5259378|NCT00753415|12930473|P5|COMPLETED|Part A||10
5259379|NCT00753415|12930474|P4|COMPLETED|Part A||9
5259380|NCT00753415|12930475|P3|COMPLETED|Part A||8
5259381|NCT00753415|12930476|P2|COMPLETED|Part A||3
5259382|NCT00753415|12930477|P1|COMPLETED|Part A||2
5259383|NCT00753415|12930468|P10|STARTED|Part A||0
5259384|NCT00753415|12930469|P9|STARTED|Part A||0
5259385|NCT00753415|12930470|P8|STARTED|Part A||0
5259386|NCT00753415|12930471|P7|STARTED|Part A||0
5259387|NCT00753415|12930472|P6|STARTED|Part A||0
5259388|NCT00753415|12930473|P5|STARTED|Part A||10
5259389|NCT00753415|12930474|P4|STARTED|Part A||11
5259390|NCT00753415|12930475|P3|STARTED|Part A||10
5259391|NCT00753415|12930476|P2|STARTED|Part A||3
5259392|NCT00753415|12930477|P1|STARTED|Part A||3
5259393|NCT00753363|12930521|P2|NOT COMPLETED|Overall Study||39
5259394|NCT00753363|12930522|P1|NOT COMPLETED|Overall Study||40
5259395|NCT00753363|12930521|P2|COMPLETED|Overall Study||21
5259396|NCT00753363|12930522|P1|COMPLETED|Overall Study||19
5259397|NCT00753363|12930521|P2|STARTED|Overall Study||60
5259398|NCT00753363|12930522|P1|STARTED|Overall Study||59
5259399|NCT00753337|12930532|P1|NOT COMPLETED|Overall Study||0
5259400|NCT00753337|12930532|P1|COMPLETED|Overall Study||123
5259401|NCT00753337|12930532|P1|STARTED|Overall Study||123
5259402|NCT00753298|12930548|P2|NOT COMPLETED|Overall Study||4
5259403|NCT00753298|12930549|P1|NOT COMPLETED|Overall Study||8
5259404|NCT00753298|12930548|P2|COMPLETED|Overall Study||94
5259405|NCT00753298|12930549|P1|COMPLETED|Overall Study||89
5259406|NCT00753298|12930548|P2|STARTED|Overall Study||98
5259407|NCT00753298|12930549|P1|STARTED|Overall Study||97
5259408|NCT00753272|12930567|P2|NOT COMPLETED|Overall Study||4907
5259409|NCT00753272|12930568|P1|NOT COMPLETED|Overall Study||4982
5259410|NCT00753272|12930567|P2|COMPLETED|Overall Study||16895
5259411|NCT00753272|12930568|P1|COMPLETED|Overall Study||16911
5259412|NCT00753272|12930567|P2|STARTED|Overall Study||21802
5259413|NCT00753272|12930568|P1|STARTED|Overall Study||21893
5259414|NCT00753220|12930630|P1|NOT COMPLETED|Overall Study||5
5259415|NCT00753220|12930630|P1|COMPLETED|Overall Study||2
5259416|NCT00753220|12930630|P1|STARTED|Overall Study||7
5259417|NCT00753142|12930637|P3|NOT COMPLETED|Overall Study||0
5259418|NCT00753142|12930638|P2|NOT COMPLETED|Overall Study||0
5259419|NCT00753142|12930639|P1|NOT COMPLETED|Overall Study||0
5259420|NCT00753142|12930637|P3|COMPLETED|Overall Study||13
5259421|NCT00753142|12930638|P2|COMPLETED|Overall Study||7
5259422|NCT00753142|12930639|P1|COMPLETED|Overall Study||8
5259423|NCT00753142|12930637|P3|STARTED|Overall Study||13
5259424|NCT00753142|12930638|P2|STARTED|Overall Study||7
5259425|NCT00753142|12930639|P1|STARTED|Overall Study||8
5259426|NCT00753012|12930652|P2|NOT COMPLETED|Overall Study||1
5259427|NCT00753012|12930653|P1|NOT COMPLETED|Overall Study||8
5259428|NCT00753012|12930652|P2|COMPLETED|Overall Study||8
5259429|NCT00753012|12930653|P1|COMPLETED|Overall Study||7
5259430|NCT00753012|12930652|P2|STARTED|Overall Study||9
5259431|NCT00753012|12930653|P1|STARTED|Overall Study||15
5259432|NCT00752986|12930666|P3|NOT COMPLETED|Overall Study||2
5259433|NCT00752986|12930667|P2|NOT COMPLETED|Overall Study||1
5259434|NCT00752986|12930668|P1|NOT COMPLETED|Overall Study||5
5259435|NCT00752986|12930666|P3|COMPLETED|Overall Study||9
5259436|NCT00752986|12930667|P2|COMPLETED|Overall Study||11
5259437|NCT00752986|12930668|P1|COMPLETED|Overall Study||11
5259438|NCT00752986|12930666|P3|STARTED|Overall Study||11
5259439|NCT00752986|12930667|P2|STARTED|Overall Study||12
5259440|NCT00752986|12930668|P1|STARTED|Overall Study||16
5259441|NCT00752973|12930685|P1|NOT COMPLETED|Overall Study||0
5259442|NCT00752973|12930685|P1|COMPLETED|Overall Study||12
5259443|NCT00752973|12930685|P1|STARTED|Overall Study||12
5259444|NCT00752908|12930697|P2|NOT COMPLETED|Overall Study||0
5259445|NCT00752908|12930698|P1|NOT COMPLETED|Overall Study||0
5259446|NCT00752908|12930697|P2|COMPLETED|Overall Study||13
5259447|NCT00752908|12930698|P1|COMPLETED|Overall Study||14
5259448|NCT00752908|12930697|P2|STARTED|Overall Study||13
5259449|NCT00752908|12930698|P1|STARTED|Overall Study||14
5259450|NCT00752895|12930708|P2|NOT COMPLETED|Overall Study||3
5259451|NCT00752895|12930709|P1|NOT COMPLETED|Overall Study||8
5259452|NCT00752895|12930708|P2|COMPLETED|Overall Study||143
5259453|NCT00752895|12930709|P1|COMPLETED|Overall Study||139
5259454|NCT00752895|12930708|P2|STARTED|Overall Study||146
5259455|NCT00752895|12930709|P1|STARTED|Overall Study||147
5259456|NCT00752856|12930719|P2|NOT COMPLETED|Overall Study||1
5259457|NCT00752856|12930720|P1|NOT COMPLETED|Overall Study||0
5259458|NCT00752856|12930719|P2|COMPLETED|Overall Study||24
5259459|NCT00752856|12930720|P1|COMPLETED|Overall Study||26
5259460|NCT00752856|12930719|P2|STARTED|Overall Study||25
5259461|NCT00752856|12930720|P1|STARTED|Overall Study||26
5259462|NCT00752791|12930732|P1|NOT COMPLETED|Overall Study||16
5259463|NCT00752791|12930732|P1|COMPLETED|Overall Study||43
5259464|NCT00752791|12930732|P1|STARTED|Overall Study||59
5259465|NCT00752726|12930744|P2|NOT COMPLETED|Overall Study||13
5259466|NCT00752726|12930745|P1|NOT COMPLETED|Overall Study||11
5259467|NCT00752726|12930744|P2|COMPLETED|Overall Study||53
5259468|NCT00752726|12930745|P1|COMPLETED|Overall Study||54
5259469|NCT00752726|12930744|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
5259470|NCT00752726|12930745|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
5259471|NCT00752726|12930744|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
5259472|NCT00752726|12930745|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
5259473|NCT00752726|12930744|P2|STARTED|Overall Study||66
5259474|NCT00752726|12930745|P1|STARTED|Overall Study||65
5259475|NCT00752622|12930770|P1|NOT COMPLETED|Interventional Phase||8
5259476|NCT00752622|12930770|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
5259477|NCT00752622|12930770|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
5259478|NCT00752622|12930770|P1|NOT COMPLETED|Observational Phase||43
5259479|NCT00752622|12930770|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
5259480|NCT00752622|12930770|P1|STARTED|Observational Phase||65
5259481|NCT00752622|12930770|P1|NOT COMPLETED|Induction Phase||35
5259482|NCT00752622|12930770|P1|COMPLETED|Induction Phase||65
5259483|NCT00752622|12930770|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
5259484|NCT00752609|12930783|P2|NOT COMPLETED|Overall Study||2
5259485|NCT00752609|12930784|P1|NOT COMPLETED|Overall Study||9
5259486|NCT00752609|12930783|P2|COMPLETED|Overall Study||47
5259487|NCT00752609|12930784|P1|COMPLETED|Overall Study||44
5259488|NCT00752609|12930783|P2|Full Analysis Set|Overall Study||49
5259489|NCT00752609|12930784|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
5259490|NCT00752609|12930783|P2|STARTED|Overall Study||49
5259491|NCT00752609|12930784|P1|STARTED|Overall Study||53
5259492|NCT00752557|12930806|P3|NOT COMPLETED|Overall Study||6
5259493|NCT00752557|12930807|P2|NOT COMPLETED|Overall Study||5
5259494|NCT00752557|12930808|P1|NOT COMPLETED|Overall Study||5
5259495|NCT00752557|12930806|P3|COMPLETED|Overall Study||11
5259496|NCT00752557|12930807|P2|COMPLETED|Overall Study||11
5259497|NCT00752557|12930808|P1|COMPLETED|Overall Study||12
5259498|NCT00752557|12930806|P3|STARTED|Overall Study||17
5259499|NCT00752557|12930807|P2|STARTED|Overall Study||16
5259500|NCT00752557|12930808|P1|STARTED|Overall Study||17
5259501|NCT00752232|12930840|P7|NOT COMPLETED|Overall Study||0
5259502|NCT00752232|12930841|P6|NOT COMPLETED|Overall Study||1
5259503|NCT00752232|12930842|P5|NOT COMPLETED|Overall Study||3
5259504|NCT00752232|12930843|P4|NOT COMPLETED|Overall Study||1
5259505|NCT00752232|12930844|P3|NOT COMPLETED|Overall Study||1
5259506|NCT00752232|12930845|P2|NOT COMPLETED|Overall Study||0
5259507|NCT00752232|12930846|P1|NOT COMPLETED|Overall Study||2
5259508|NCT00752232|12930840|P7|COMPLETED|Overall Study||4
5259509|NCT00752232|12930841|P6|COMPLETED|Overall Study||5
5259510|NCT00752232|12930842|P5|COMPLETED|Overall Study||3
5259511|NCT00752232|12930843|P4|COMPLETED|Overall Study||5
5259512|NCT00752232|12930844|P3|COMPLETED|Overall Study||5
5259513|NCT00752232|12930845|P2|COMPLETED|Overall Study||6
5259514|NCT00752232|12930846|P1|COMPLETED|Overall Study||4
5259515|NCT00752232|12930840|P7|STARTED|Overall Study||4
5259516|NCT00752232|12930841|P6|STARTED|Overall Study||6
5259517|NCT00752232|12930842|P5|STARTED|Overall Study||6
5259518|NCT00752232|12930843|P4|STARTED|Overall Study||6
5259519|NCT00752232|12930844|P3|STARTED|Overall Study||6
5259520|NCT00752232|12930845|P2|STARTED|Overall Study||6
5259521|NCT00752232|12930846|P1|STARTED|Overall Study||6
5259522|NCT00752219|12930920|P2|NOT COMPLETED|Overall Study||6
5259523|NCT00752219|12930921|P1|NOT COMPLETED|Overall Study||11
5259524|NCT00752219|12930920|P2|COMPLETED|Overall Study||96
5259525|NCT00752219|12930921|P1|COMPLETED|Overall Study||91
5259526|NCT00752219|12930920|P2|Treated|Overall Study||102
5259527|NCT00752219|12930921|P1|Treated|Overall Study||101
5259528|NCT00752219|12930920|P2|STARTED|Overall Study||102
5259529|NCT00752219|12930921|P1|STARTED|Overall Study||102
5259530|NCT00752206|12930947|P2|NOT COMPLETED|Overall Study||11
5259531|NCT00752206|12930948|P1|NOT COMPLETED|Overall Study||9
5259532|NCT00752206|12930947|P2|COMPLETED|Overall Study||8
5259533|NCT00752206|12930948|P1|COMPLETED|Overall Study||10
5259534|NCT00752206|12930947|P2|STARTED|Overall Study||19
5259535|NCT00752206|12930948|P1|STARTED|Overall Study||19
5259536|NCT00752128|12930966|P1|NOT COMPLETED|Overall Study||4
5259537|NCT00752128|12930966|P1|COMPLETED|Overall Study||2345
5259538|NCT00752128|12930966|P1|STARTED|Overall Study||2349
5259539|NCT00752102|12930973|P2|NOT COMPLETED|Overall Study||1
5259540|NCT00752102|12930974|P1|NOT COMPLETED|Overall Study||3
5259541|NCT00752102|12930973|P2|COMPLETED|Overall Study||21
5259542|NCT00752102|12930974|P1|COMPLETED|Overall Study||19
5259543|NCT00752102|12930973|P2|STARTED|Overall Study||22
5259544|NCT00752102|12930974|P1|STARTED|Overall Study||22
5259545|NCT00752089|12930980|P1|NOT COMPLETED|Overall Study||6
5259546|NCT00752089|12930980|P1|COMPLETED|Overall Study||14
5259547|NCT00752089|12930980|P1|Received Placebo|Overall Study||18
5259548|NCT00752089|12930980|P1|Received NaF|Overall Study||18
5259549|NCT00752089|12930980|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
5259550|NCT00752089|12930980|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
5259551|NCT00752089|12930980|P1|STARTED|Overall Study||20
5259552|NCT00751998|12930994|P1|NOT COMPLETED|Overall Study||20
5259553|NCT00751998|12930994|P1|COMPLETED|Overall Study||277
5259554|NCT00751998|12930994|P1|STARTED|Overall Study||297
5259555|NCT00751972|12931000|P2|NOT COMPLETED|Overall Study||0
5259556|NCT00751972|12931001|P1|NOT COMPLETED|Overall Study||0
5259557|NCT00751972|12931000|P2|COMPLETED|Overall Study||499
5259558|NCT00751972|12931001|P1|COMPLETED|Overall Study||140
5259559|NCT00751972|12931000|P2|STARTED|Overall Study||499
5259560|NCT00751972|12931001|P1|STARTED|Overall Study||140
5259561|NCT00751933|12931013|P4|NOT COMPLETED|Overall Study||1
5259562|NCT00751933|12931014|P3|NOT COMPLETED|Overall Study||1
5259563|NCT00751933|12931015|P2|NOT COMPLETED|Overall Study||1
5259564|NCT00751933|12931016|P1|NOT COMPLETED|Overall Study||0
5259565|NCT00751933|12931013|P4|COMPLETED|Overall Study||0
5259566|NCT00751933|12931014|P3|COMPLETED|Overall Study||0
5259567|NCT00751933|12931015|P2|COMPLETED|Overall Study||0
5259568|NCT00751933|12931016|P1|COMPLETED|Overall Study||0
5259569|NCT00751933|12931013|P4|STARTED|Overall Study||1
5259570|NCT00751933|12931014|P3|STARTED|Overall Study||1
5259571|NCT00751933|12931015|P2|STARTED|Overall Study||1
5259572|NCT00751933|12931016|P1|STARTED|Overall Study||0
5259573|NCT00751881|12931024|P3|NOT COMPLETED|Extension Study Period||66
5259574|NCT00751881|12931025|P2|NOT COMPLETED|Extension Study Period||71
5259575|NCT00751881|12931026|P1|NOT COMPLETED|Extension Study Period||65
5259576|NCT00751881|12931024|P3|COMPLETED|Extension Study Period||167
5259577|NCT00751881|12931025|P2|COMPLETED|Extension Study Period||194
5259578|NCT00751881|12931026|P1|COMPLETED|Extension Study Period||188
5259579|NCT00751881|12931024|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
5259580|NCT00751881|12931025|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
5259581|NCT00751881|12931026|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
5259582|NCT00751881|12931024|P3|NOT COMPLETED|Core Treatment Period||128
5259583|NCT00751881|12931025|P2|NOT COMPLETED|Core Treatment Period||135
5259584|NCT00751881|12931026|P1|NOT COMPLETED|Core Treatment Period||126
5259585|NCT00751881|12931024|P3|COMPLETED|Core Treatment Period||244
5259586|NCT00751881|12931025|P2|COMPLETED|Core Treatment Period||273
5259587|NCT00751881|12931026|P1|COMPLETED|Core Treatment Period||263
5259588|NCT00751881|12931024|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
5259589|NCT00751881|12931025|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
5259590|NCT00751881|12931026|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
5259591|NCT00751881|12931024|P3|STARTED|Core Treatment Period|Randomized|372
5259592|NCT00751881|12931025|P2|STARTED|Core Treatment Period|Randomized|408
5259593|NCT00751881|12931026|P1|STARTED|Core Treatment Period|Randomized|389
5259594|NCT00751790|12931073|P1|NOT COMPLETED|Overall Study||5
5259595|NCT00751790|12931073|P1|COMPLETED|Overall Study||115
5259596|NCT00751790|12931073|P1|STARTED|Overall Study||120
5259597|NCT00751777|12931079|P2|NOT COMPLETED|Overall Study||3
5259598|NCT00751777|12931080|P1|NOT COMPLETED|Overall Study||11
5259599|NCT00751777|12931079|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
5259600|NCT00751777|12931080|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
5259601|NCT00751777|12931079|P2|STARTED|Overall Study||39
5259602|NCT00751777|12931080|P1|STARTED|Overall Study||81
5259603|NCT00751634|12931096|P1|NOT COMPLETED|Overall Study||0
5259604|NCT00751634|12931096|P1|COMPLETED|Overall Study||20
5259605|NCT00751634|12931096|P1|STARTED|Overall Study||20
5259606|NCT00751621|12931104|P1|NOT COMPLETED|Overall Study||4
5259607|NCT00751621|12931104|P1|COMPLETED|Overall Study||36
5259608|NCT00751621|12931104|P1|STARTED|Overall Study||40
5259609|NCT00751530|12931123|P2|NOT COMPLETED|Overall Study||0
5259610|NCT00751530|12931124|P1|NOT COMPLETED|Overall Study||0
5259611|NCT00751530|12931123|P2|COMPLETED|Overall Study||110
5259612|NCT00751530|12931124|P1|COMPLETED|Overall Study||332
5259613|NCT00751530|12931123|P2|STARTED|Overall Study||110
5259614|NCT00751530|12931124|P1|STARTED|Overall Study||332
5259615|NCT00751400|12931138|P1|NOT COMPLETED|Overall Study||10
5259616|NCT00751400|12931138|P1|COMPLETED|Overall Study||487
5259617|NCT00751400|12931138|P1|Subjects Provided Detailed Use Data|Overall Study||467
5259618|NCT00751400|12931138|P1|Subjects Consumed Drug|Overall Study||485
5259619|NCT00751400|12931138|P1|Subjects Provided Drug|Overall Study||497
5259620|NCT00751400|12931138|P1|STARTED|Overall Study||497
5259621|NCT00751348|12931153|P2|NOT COMPLETED|Overall Study||2
5259622|NCT00751348|12931154|P1|NOT COMPLETED|Overall Study||6
5259623|NCT00751348|12931153|P2|COMPLETED|Overall Study||159
5259624|NCT00751348|12931154|P1|COMPLETED|Overall Study||307
5259625|NCT00751348|12931153|P2|STARTED|Overall Study||161
5259626|NCT00751348|12931154|P1|STARTED|Overall Study||313
5259627|NCT00751296|12931176|P1|NOT COMPLETED|Overall Study||2
5259628|NCT00751296|12931176|P1|COMPLETED|Overall Study||25
5259629|NCT00751296|12931176|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
5259630|NCT00751179|12931183|P2|NOT COMPLETED|Overall Study||15
5259631|NCT00751179|12931184|P1|NOT COMPLETED|Overall Study||14
5259632|NCT00751179|12931183|P2|COMPLETED|Overall Study||70
5259633|NCT00751179|12931184|P1|COMPLETED|Overall Study||62
5259634|NCT00751179|12931183|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
5259635|NCT00751179|12931184|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
5259636|NCT00751140|12931204|P1|NOT COMPLETED|Overall Study||1
5259637|NCT00751140|12931204|P1|COMPLETED|Overall Study||19
5259638|NCT00751140|12931204|P1|STARTED|Overall Study||20
5259639|NCT00751114|12931214|P2|NOT COMPLETED|Overall Study||32
5259640|NCT00751114|12931215|P1|NOT COMPLETED|Overall Study||38
5259641|NCT00751114|12931214|P2|COMPLETED|Overall Study||233
5259642|NCT00751114|12931215|P1|COMPLETED|Overall Study||212
5259643|NCT00751114|12931214|P2|mITT Population|Overall Study||253
5259644|NCT00751114|12931215|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
5259645|NCT00751114|12931214|P2|TREATED = Safety Population|Overall Study||264
5259646|NCT00751114|12931215|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
5259647|NCT00751114|12931214|P2|STARTED|Overall Study||265
5259648|NCT00751114|12931215|P1|STARTED|Overall Study|randomized|250
5259649|NCT00751036|12931240|P2|NOT COMPLETED|Overall Study||46
5259650|NCT00751036|12931241|P1|NOT COMPLETED|Overall Study||48
5259651|NCT00751036|12931240|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
5259652|NCT00751036|12931241|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
5259653|NCT00751036|12931240|P2|STARTED|Overall Study|Started = Treated|46
5259654|NCT00751036|12931241|P1|STARTED|Overall Study|Started = Treated|48
5259655|NCT00751023|12931255|P2|NOT COMPLETED|Overall Study||7
5259656|NCT00751023|12931256|P1|NOT COMPLETED|Overall Study||11
5259657|NCT00751023|12931255|P2|COMPLETED|Overall Study||13
5259658|NCT00751023|12931256|P1|COMPLETED|Overall Study||9
5259659|NCT00751023|12931255|P2|STARTED|Overall Study||20
5259660|NCT00751023|12931256|P1|STARTED|Overall Study||20
5259661|NCT00750919|12931276|P1|NOT COMPLETED|Overall Study||58
5259662|NCT00750919|12931276|P1|COMPLETED|Overall Study||126
5259663|NCT00750919|12931276|P1|STARTED|Overall Study||184
5259664|NCT00750893|12931284|P1|NOT COMPLETED|Overall Study||542
5259665|NCT00750893|12931284|P1|COMPLETED|Overall Study||2569
5259666|NCT00750893|12931284|P1|STARTED|Overall Study||3111
5259667|NCT00750880|12931296|P1|NOT COMPLETED|Overall Study||215
5259668|NCT00750880|12931296|P1|COMPLETED|Overall Study||1466
5259669|NCT00750880|12931296|P1|STARTED|Overall Study||1681
5259670|NCT00750867|12931319|P1|NOT COMPLETED|Overall Study||2
5259671|NCT00750867|12931319|P1|COMPLETED|Overall Study||7
5259672|NCT00750867|12931319|P1|STARTED|Overall Study||9
5259673|NCT00750815|12931326|P2|NOT COMPLETED|Overall Study||0
5259674|NCT00750815|12931327|P1|NOT COMPLETED|Overall Study||0
5259675|NCT00750815|12931326|P2|COMPLETED|Overall Study||46
5259676|NCT00750815|12931327|P1|COMPLETED|Overall Study||12
5259677|NCT00750815|12931326|P2|STARTED|Overall Study||46
5259678|NCT00750815|12931327|P1|STARTED|Overall Study||12
5259679|NCT00750737|12931340|P2|NOT COMPLETED|Overall Study||3
5259680|NCT00750737|12931341|P1|NOT COMPLETED|Overall Study||3
5259681|NCT00750737|12931340|P2|COMPLETED|Overall Study||19
5259682|NCT00750737|12931341|P1|COMPLETED|Overall Study||21
5259683|NCT00750737|12931340|P2|STARTED|Overall Study||22
5259684|NCT00750737|12931341|P1|STARTED|Overall Study||24
5259685|NCT00750555|12931349|P1|NOT COMPLETED|Overall Study||0
5259686|NCT00750555|12931349|P1|COMPLETED|Overall Study||0
5259687|NCT00750555|12931349|P1|STARTED|Overall Study||0
5259688|NCT00750438|12931356|P2|NOT COMPLETED|Overall Study||4
5259689|NCT00750438|12931357|P1|NOT COMPLETED|Overall Study||7
5259690|NCT00750438|12931356|P2|COMPLETED|Overall Study||25
5259691|NCT00750438|12931357|P1|COMPLETED|Overall Study||24
5259692|NCT00750438|12931356|P2|STARTED|Overall Study||29
5259693|NCT00750438|12931357|P1|STARTED|Overall Study||31
5259694|NCT00750373|12931373|P2|NOT COMPLETED|Overall Study||0
5259695|NCT00750373|12931374|P1|NOT COMPLETED|Overall Study||0
5259696|NCT00750373|12931373|P2|COMPLETED|Overall Study||37
5259697|NCT00750373|12931374|P1|COMPLETED|Overall Study||39
5259698|NCT00750373|12931373|P2|STARTED|Overall Study||37
5259699|NCT00750373|12931374|P1|STARTED|Overall Study||39
5259700|NCT00750360|12931386|P6|NOT COMPLETED|Overall Study||0
5259701|NCT00750360|12931387|P5|NOT COMPLETED|Overall Study||0
5259702|NCT00750360|12931388|P4|NOT COMPLETED|Overall Study||0
5259703|NCT00750360|12931389|P3|NOT COMPLETED|Overall Study||0
5259704|NCT00750360|12931390|P2|NOT COMPLETED|Overall Study||0
5259705|NCT00750360|12931391|P1|NOT COMPLETED|Overall Study||0
5259706|NCT00750360|12931386|P6|COMPLETED|Overall Study||71
5259707|NCT00750360|12931387|P5|COMPLETED|Overall Study||46
5259708|NCT00750360|12931388|P4|COMPLETED|Overall Study||79
5259709|NCT00750360|12931389|P3|COMPLETED|Overall Study||384
5259710|NCT00750360|12931390|P2|COMPLETED|Overall Study||1
5259711|NCT00750360|12931391|P1|COMPLETED|Overall Study||294
5259712|NCT00750360|12931386|P6|STARTED|Overall Study||71
5259713|NCT00750360|12931387|P5|STARTED|Overall Study||46
5259714|NCT00750360|12931388|P4|STARTED|Overall Study||79
5259715|NCT00750360|12931389|P3|STARTED|Overall Study||384
5259716|NCT00750360|12931390|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
5259717|NCT00750360|12931391|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
5259718|NCT00750308|12931423|P12|NOT COMPLETED|Fourth Treatment||0
5259719|NCT00750308|12931424|P11|NOT COMPLETED|Fourth Treatment||0
5259720|NCT00750308|12931425|P10|NOT COMPLETED|Fourth Treatment||0
5259721|NCT00750308|12931426|P9|NOT COMPLETED|Fourth Treatment||0
5259722|NCT00750308|12931427|P8|NOT COMPLETED|Fourth Treatment||0
5259723|NCT00750308|12931428|P7|NOT COMPLETED|Fourth Treatment||0
5259724|NCT00750308|12931429|P6|NOT COMPLETED|Fourth Treatment||0
5259725|NCT00750308|12931430|P5|NOT COMPLETED|Fourth Treatment||0
5259726|NCT00750308|12931431|P4|NOT COMPLETED|Fourth Treatment||0
5259727|NCT00750308|12931432|P3|NOT COMPLETED|Fourth Treatment||0
5259728|NCT00750308|12931433|P2|NOT COMPLETED|Fourth Treatment||0
5259729|NCT00750308|12931434|P1|NOT COMPLETED|Fourth Treatment||0
5259730|NCT00750308|12931423|P12|COMPLETED|Fourth Treatment||1
5259731|NCT00750308|12931424|P11|COMPLETED|Fourth Treatment||1
5259732|NCT00750308|12931425|P10|COMPLETED|Fourth Treatment||2
5259733|NCT00750308|12931426|P9|COMPLETED|Fourth Treatment||1
5259734|NCT00750308|12931427|P8|COMPLETED|Fourth Treatment||2
5259735|NCT00750308|12931428|P7|COMPLETED|Fourth Treatment||2
5259736|NCT00750308|12931429|P6|COMPLETED|Fourth Treatment||2
5259737|NCT00750308|12931430|P5|COMPLETED|Fourth Treatment||1
5259738|NCT00750308|12931431|P4|COMPLETED|Fourth Treatment||1
5259739|NCT00750308|12931432|P3|COMPLETED|Fourth Treatment||2
5259740|NCT00750308|12931433|P2|COMPLETED|Fourth Treatment||1
5259741|NCT00750308|12931434|P1|COMPLETED|Fourth Treatment||2
5259742|NCT00750308|12931423|P12|STARTED|Fourth Treatment||1
5259743|NCT00750308|12931424|P11|STARTED|Fourth Treatment||1
5259744|NCT00750308|12931425|P10|STARTED|Fourth Treatment||2
5259745|NCT00750308|12931426|P9|STARTED|Fourth Treatment||1
5259746|NCT00750308|12931427|P8|STARTED|Fourth Treatment||2
5259747|NCT00750308|12931428|P7|STARTED|Fourth Treatment||2
5259748|NCT00750308|12931429|P6|STARTED|Fourth Treatment||2
5259749|NCT00750308|12931430|P5|STARTED|Fourth Treatment||1
5259750|NCT00750308|12931431|P4|STARTED|Fourth Treatment||1
5259751|NCT00750308|12931432|P3|STARTED|Fourth Treatment||2
5259752|NCT00750308|12931433|P2|STARTED|Fourth Treatment||1
5259753|NCT00750308|12931434|P1|STARTED|Fourth Treatment||2
5259754|NCT00750308|12931423|P12|NOT COMPLETED|Washout||0
5259755|NCT00750308|12931424|P11|NOT COMPLETED|Washout||0
5259756|NCT00750308|12931425|P10|NOT COMPLETED|Washout||0
5259757|NCT00750308|12931426|P9|NOT COMPLETED|Washout||0
5259758|NCT00750308|12931427|P8|NOT COMPLETED|Washout||0
5259759|NCT00750308|12931428|P7|NOT COMPLETED|Washout||0
5259760|NCT00750308|12931429|P6|NOT COMPLETED|Washout||0
5259761|NCT00750308|12931430|P5|NOT COMPLETED|Washout||0
5259762|NCT00750308|12931431|P4|NOT COMPLETED|Washout||0
5259763|NCT00750308|12931432|P3|NOT COMPLETED|Washout||0
5259764|NCT00750308|12931433|P2|NOT COMPLETED|Washout||0
5259765|NCT00750308|12931434|P1|NOT COMPLETED|Washout||0
5259766|NCT00750308|12931423|P12|COMPLETED|Washout||1
5259767|NCT00750308|12931424|P11|COMPLETED|Washout||1
5259768|NCT00750308|12931425|P10|COMPLETED|Washout||2
5259769|NCT00750308|12931426|P9|COMPLETED|Washout||1
5259770|NCT00750308|12931427|P8|COMPLETED|Washout||2
5259771|NCT00750308|12931428|P7|COMPLETED|Washout||2
5259772|NCT00750308|12931429|P6|COMPLETED|Washout||2
5259773|NCT00750308|12931430|P5|COMPLETED|Washout||1
5259774|NCT00750308|12931431|P4|COMPLETED|Washout||1
5259775|NCT00750308|12931432|P3|COMPLETED|Washout||2
5259776|NCT00750308|12931433|P2|COMPLETED|Washout||1
5259777|NCT00750308|12931434|P1|COMPLETED|Washout||2
5259778|NCT00750308|12931423|P12|STARTED|Washout||1
5259779|NCT00750308|12931424|P11|STARTED|Washout||1
5259780|NCT00750308|12931425|P10|STARTED|Washout||2
5259781|NCT00750308|12931426|P9|STARTED|Washout||1
5259782|NCT00750308|12931427|P8|STARTED|Washout||2
5259783|NCT00750308|12931428|P7|STARTED|Washout||2
5259784|NCT00750308|12931429|P6|STARTED|Washout||2
5259785|NCT00750308|12931430|P5|STARTED|Washout||1
5259786|NCT00750308|12931431|P4|STARTED|Washout||1
5259787|NCT00750308|12931432|P3|STARTED|Washout||2
5259788|NCT00750308|12931433|P2|STARTED|Washout||1
5259789|NCT00750308|12931434|P1|STARTED|Washout||2
5259790|NCT00750308|12931423|P12|NOT COMPLETED|Third Treatment||0
5259791|NCT00750308|12931424|P11|NOT COMPLETED|Third Treatment||0
5259792|NCT00750308|12931425|P10|NOT COMPLETED|Third Treatment||0
5259793|NCT00750308|12931426|P9|NOT COMPLETED|Third Treatment||0
5259794|NCT00750308|12931427|P8|NOT COMPLETED|Third Treatment||0
5259795|NCT00750308|12931428|P7|NOT COMPLETED|Third Treatment||0
5259796|NCT00750308|12931429|P6|NOT COMPLETED|Third Treatment||0
5259797|NCT00750308|12931430|P5|NOT COMPLETED|Third Treatment||0
5259798|NCT00750308|12931431|P4|NOT COMPLETED|Third Treatment||0
5259799|NCT00750308|12931432|P3|NOT COMPLETED|Third Treatment||0
5259800|NCT00750308|12931433|P2|NOT COMPLETED|Third Treatment||1
5259801|NCT00750308|12931434|P1|NOT COMPLETED|Third Treatment||0
5259802|NCT00750308|12931423|P12|COMPLETED|Third Treatment||1
5259803|NCT00750308|12931424|P11|COMPLETED|Third Treatment||1
5259804|NCT00750308|12931425|P10|COMPLETED|Third Treatment||2
5259805|NCT00750308|12931426|P9|COMPLETED|Third Treatment||1
5259806|NCT00750308|12931427|P8|COMPLETED|Third Treatment||2
5259807|NCT00750308|12931428|P7|COMPLETED|Third Treatment||2
5259808|NCT00750308|12931429|P6|COMPLETED|Third Treatment||2
5259809|NCT00750308|12931430|P5|COMPLETED|Third Treatment||1
5259810|NCT00750308|12931431|P4|COMPLETED|Third Treatment||1
5259811|NCT00750308|12931432|P3|COMPLETED|Third Treatment||2
5259812|NCT00750308|12931433|P2|COMPLETED|Third Treatment||1
5259813|NCT00750308|12931434|P1|COMPLETED|Third Treatment||2
5259814|NCT00750308|12931423|P12|STARTED|Third Treatment||1
5259815|NCT00750308|12931424|P11|STARTED|Third Treatment||1
5259816|NCT00750308|12931425|P10|STARTED|Third Treatment||2
5259817|NCT00750308|12931426|P9|STARTED|Third Treatment||1
5259818|NCT00750308|12931427|P8|STARTED|Third Treatment||2
5259819|NCT00750308|12931428|P7|STARTED|Third Treatment||2
5259820|NCT00750308|12931429|P6|STARTED|Third Treatment||2
5259821|NCT00750308|12931430|P5|STARTED|Third Treatment||1
5259822|NCT00750308|12931431|P4|STARTED|Third Treatment||1
5259823|NCT00750308|12931432|P3|STARTED|Third Treatment||2
5259824|NCT00750308|12931433|P2|STARTED|Third Treatment||2
5259825|NCT00750308|12931434|P1|STARTED|Third Treatment||2
5259826|NCT00750308|12931423|P12|NOT COMPLETED|Washout||0
5259827|NCT00750308|12931424|P11|NOT COMPLETED|Washout||0
5259828|NCT00750308|12931425|P10|NOT COMPLETED|Washout||0
5259829|NCT00750308|12931426|P9|NOT COMPLETED|Washout||0
5259830|NCT00750308|12931427|P8|NOT COMPLETED|Washout||0
5259831|NCT00750308|12931428|P7|NOT COMPLETED|Washout||0
5259832|NCT00750308|12931429|P6|NOT COMPLETED|Washout||0
5259833|NCT00750308|12931430|P5|NOT COMPLETED|Washout||0
5259834|NCT00750308|12931431|P4|NOT COMPLETED|Washout||0
5259835|NCT00750308|12931432|P3|NOT COMPLETED|Washout||0
5259836|NCT00750308|12931433|P2|NOT COMPLETED|Washout||0
5259837|NCT00750308|12931434|P1|NOT COMPLETED|Washout||0
5259838|NCT00750308|12931423|P12|COMPLETED|Washout||1
5259839|NCT00750308|12931424|P11|COMPLETED|Washout||1
5259840|NCT00750308|12931425|P10|COMPLETED|Washout||2
5259841|NCT00750308|12931426|P9|COMPLETED|Washout||1
5259842|NCT00750308|12931427|P8|COMPLETED|Washout||2
5259843|NCT00750308|12931428|P7|COMPLETED|Washout||2
5259844|NCT00750308|12931429|P6|COMPLETED|Washout||2
5259845|NCT00750308|12931430|P5|COMPLETED|Washout||1
5259846|NCT00750308|12931431|P4|COMPLETED|Washout||1
5259847|NCT00750308|12931432|P3|COMPLETED|Washout||2
5259848|NCT00750308|12931433|P2|COMPLETED|Washout||2
5259849|NCT00750308|12931434|P1|COMPLETED|Washout||2
5259850|NCT00750308|12931423|P12|STARTED|Washout||1
5259851|NCT00750308|12931424|P11|STARTED|Washout||1
5259852|NCT00750308|12931425|P10|STARTED|Washout||2
5259853|NCT00750308|12931426|P9|STARTED|Washout||1
5259854|NCT00750308|12931427|P8|STARTED|Washout||2
5259855|NCT00750308|12931428|P7|STARTED|Washout||2
5259856|NCT00750308|12931429|P6|STARTED|Washout||2
5259857|NCT00750308|12931430|P5|STARTED|Washout||1
5259858|NCT00750308|12931431|P4|STARTED|Washout||1
5259859|NCT00750308|12931432|P3|STARTED|Washout||2
5259860|NCT00750308|12931433|P2|STARTED|Washout||2
5259861|NCT00750308|12931434|P1|STARTED|Washout||2
5259862|NCT00750308|12931423|P12|NOT COMPLETED|Second Treatment||0
5259863|NCT00750308|12931424|P11|NOT COMPLETED|Second Treatment||0
5259864|NCT00750308|12931425|P10|NOT COMPLETED|Second Treatment||0
5259865|NCT00750308|12931426|P9|NOT COMPLETED|Second Treatment||1
5259866|NCT00750308|12931427|P8|NOT COMPLETED|Second Treatment||0
5259867|NCT00750308|12931428|P7|NOT COMPLETED|Second Treatment||0
5259868|NCT00750308|12931429|P6|NOT COMPLETED|Second Treatment||1
5259869|NCT00750308|12931430|P5|NOT COMPLETED|Second Treatment||1
5259870|NCT00750308|12931431|P4|NOT COMPLETED|Second Treatment||0
5259871|NCT00750308|12931432|P3|NOT COMPLETED|Second Treatment||0
5259872|NCT00750308|12931433|P2|NOT COMPLETED|Second Treatment||0
5259873|NCT00750308|12931434|P1|NOT COMPLETED|Second Treatment||0
5259874|NCT00750308|12931423|P12|COMPLETED|Second Treatment||1
5259875|NCT00750308|12931424|P11|COMPLETED|Second Treatment||1
5259876|NCT00750308|12931425|P10|COMPLETED|Second Treatment||2
5259877|NCT00750308|12931426|P9|COMPLETED|Second Treatment||1
5259878|NCT00750308|12931427|P8|COMPLETED|Second Treatment||2
5259879|NCT00750308|12931428|P7|COMPLETED|Second Treatment||2
5259880|NCT00750308|12931429|P6|COMPLETED|Second Treatment||2
5259881|NCT00750308|12931430|P5|COMPLETED|Second Treatment||1
5259882|NCT00750308|12931431|P4|COMPLETED|Second Treatment||1
5259883|NCT00750308|12931432|P3|COMPLETED|Second Treatment||2
5259884|NCT00750308|12931433|P2|COMPLETED|Second Treatment||2
5259885|NCT00750308|12931434|P1|COMPLETED|Second Treatment||2
5259886|NCT00750308|12931423|P12|STARTED|Second Treatment||1
5259887|NCT00750308|12931424|P11|STARTED|Second Treatment||1
5259888|NCT00750308|12931425|P10|STARTED|Second Treatment||2
5259889|NCT00750308|12931426|P9|STARTED|Second Treatment||2
5259890|NCT00750308|12931427|P8|STARTED|Second Treatment||2
5259891|NCT00750308|12931428|P7|STARTED|Second Treatment||2
5259892|NCT00750308|12931429|P6|STARTED|Second Treatment||3
5259893|NCT00750308|12931430|P5|STARTED|Second Treatment||2
5259894|NCT00750308|12931431|P4|STARTED|Second Treatment||1
5259895|NCT00750308|12931432|P3|STARTED|Second Treatment||2
5259896|NCT00750308|12931433|P2|STARTED|Second Treatment||2
5259897|NCT00750308|12931434|P1|STARTED|Second Treatment||2
5259898|NCT00750308|12931423|P12|NOT COMPLETED|Washout||0
5259899|NCT00750308|12931424|P11|NOT COMPLETED|Washout||0
5259900|NCT00750308|12931425|P10|NOT COMPLETED|Washout||0
5259901|NCT00750308|12931426|P9|NOT COMPLETED|Washout||0
5259902|NCT00750308|12931427|P8|NOT COMPLETED|Washout||0
5259903|NCT00750308|12931428|P7|NOT COMPLETED|Washout||0
5259904|NCT00750308|12931429|P6|NOT COMPLETED|Washout||0
5259905|NCT00750308|12931430|P5|NOT COMPLETED|Washout||0
5259906|NCT00750308|12931431|P4|NOT COMPLETED|Washout||0
5259907|NCT00750308|12931432|P3|NOT COMPLETED|Washout||0
5259908|NCT00750308|12931433|P2|NOT COMPLETED|Washout||0
5259909|NCT00750308|12931434|P1|NOT COMPLETED|Washout||0
5259910|NCT00750308|12931423|P12|COMPLETED|Washout||1
5259911|NCT00750308|12931424|P11|COMPLETED|Washout||1
5259912|NCT00750308|12931425|P10|COMPLETED|Washout||2
5259913|NCT00750308|12931426|P9|COMPLETED|Washout||2
5259914|NCT00750308|12931427|P8|COMPLETED|Washout||2
5259915|NCT00750308|12931428|P7|COMPLETED|Washout||2
5259916|NCT00750308|12931429|P6|COMPLETED|Washout||3
5259917|NCT00750308|12931430|P5|COMPLETED|Washout||2
5259918|NCT00750308|12931431|P4|COMPLETED|Washout||1
5259919|NCT00750308|12931432|P3|COMPLETED|Washout||2
5259920|NCT00750308|12931433|P2|COMPLETED|Washout||2
5259921|NCT00750308|12931434|P1|COMPLETED|Washout||2
5259922|NCT00750308|12931423|P12|STARTED|Washout||1
5259923|NCT00750308|12931424|P11|STARTED|Washout||1
5259924|NCT00750308|12931425|P10|STARTED|Washout||2
5259925|NCT00750308|12931426|P9|STARTED|Washout||2
5259926|NCT00750308|12931427|P8|STARTED|Washout||2
5259927|NCT00750308|12931428|P7|STARTED|Washout||2
5259928|NCT00750308|12931429|P6|STARTED|Washout||3
5259929|NCT00750308|12931430|P5|STARTED|Washout||2
5259930|NCT00750308|12931431|P4|STARTED|Washout||1
5259931|NCT00750308|12931432|P3|STARTED|Washout||2
5259932|NCT00750308|12931433|P2|STARTED|Washout||2
5259933|NCT00750308|12931434|P1|STARTED|Washout||2
5259934|NCT00750308|12931423|P12|NOT COMPLETED|First Treatment||1
5259935|NCT00750308|12931424|P11|NOT COMPLETED|First Treatment||1
5259936|NCT00750308|12931425|P10|NOT COMPLETED|First Treatment||0
5259937|NCT00750308|12931426|P9|NOT COMPLETED|First Treatment||0
5259938|NCT00750308|12931427|P8|NOT COMPLETED|First Treatment||1
5259939|NCT00750308|12931428|P7|NOT COMPLETED|First Treatment||0
5259940|NCT00750308|12931429|P6|NOT COMPLETED|First Treatment||0
5259941|NCT00750308|12931430|P5|NOT COMPLETED|First Treatment||0
5259942|NCT00750308|12931431|P4|NOT COMPLETED|First Treatment||1
5259943|NCT00750308|12931432|P3|NOT COMPLETED|First Treatment||0
5259944|NCT00750308|12931433|P2|NOT COMPLETED|First Treatment||1
5259945|NCT00750308|12931434|P1|NOT COMPLETED|First Treatment||0
5259946|NCT00750308|12931423|P12|COMPLETED|First Treatment||1
5259947|NCT00750308|12931424|P11|COMPLETED|First Treatment||1
5259948|NCT00750308|12931425|P10|COMPLETED|First Treatment||2
5259949|NCT00750308|12931426|P9|COMPLETED|First Treatment||2
5259950|NCT00750308|12931427|P8|COMPLETED|First Treatment||2
5259951|NCT00750308|12931428|P7|COMPLETED|First Treatment||2
5259952|NCT00750308|12931429|P6|COMPLETED|First Treatment||3
5259953|NCT00750308|12931430|P5|COMPLETED|First Treatment||2
5259954|NCT00750308|12931431|P4|COMPLETED|First Treatment||1
5259955|NCT00750308|12931432|P3|COMPLETED|First Treatment||2
5259956|NCT00750308|12931433|P2|COMPLETED|First Treatment||2
5259957|NCT00750308|12931434|P1|COMPLETED|First Treatment||2
5259958|NCT00750308|12931423|P12|STARTED|First Treatment||2
5259959|NCT00750308|12931424|P11|STARTED|First Treatment||2
5259960|NCT00750308|12931425|P10|STARTED|First Treatment||2
5259961|NCT00750308|12931426|P9|STARTED|First Treatment||2
5259962|NCT00750308|12931427|P8|STARTED|First Treatment||3
5259963|NCT00750308|12931428|P7|STARTED|First Treatment||2
5259964|NCT00750308|12931429|P6|STARTED|First Treatment||3
5259965|NCT00750308|12931430|P5|STARTED|First Treatment||2
5259966|NCT00750308|12931431|P4|STARTED|First Treatment||2
5259967|NCT00750308|12931432|P3|STARTED|First Treatment||2
5259968|NCT00750308|12931433|P2|STARTED|First Treatment||3
5259969|NCT00750308|12931434|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
5259970|NCT00750282|12931452|P4|NOT COMPLETED|Overall Study||1
5259971|NCT00750282|12931453|P3|NOT COMPLETED|Overall Study||1
5259972|NCT00750282|12931454|P2|NOT COMPLETED|Overall Study||1
5259973|NCT00750282|12931455|P1|NOT COMPLETED|Overall Study||0
5259974|NCT00750282|12931452|P4|COMPLETED|Overall Study||147
5259975|NCT00750282|12931453|P3|COMPLETED|Overall Study||125
5259976|NCT00750282|12931454|P2|COMPLETED|Overall Study||81
5259977|NCT00750282|12931455|P1|COMPLETED|Overall Study||69
5259978|NCT00750282|12931452|P4|STARTED|Overall Study||148
5259979|NCT00750282|12931453|P3|STARTED|Overall Study||126
5259980|NCT00750282|12931454|P2|STARTED|Overall Study||82
5259981|NCT00750282|12931455|P1|STARTED|Overall Study||69
5259982|NCT00750269|12931484|P5|NOT COMPLETED|Overall Study||10
5259983|NCT00750269|12931485|P4|NOT COMPLETED|Overall Study||5
5259984|NCT00750269|12931486|P3|NOT COMPLETED|Overall Study||4
5259985|NCT00750269|12931487|P2|NOT COMPLETED|Overall Study||1
5259986|NCT00750269|12931488|P1|NOT COMPLETED|Overall Study||0
5259987|NCT00750269|12931484|P5|COMPLETED|Overall Study||33
5259988|NCT00750269|12931485|P4|COMPLETED|Overall Study||38
5259989|NCT00750269|12931486|P3|COMPLETED|Overall Study||14
5259990|NCT00750269|12931487|P2|COMPLETED|Overall Study||7
5259991|NCT00750269|12931488|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
5259992|NCT00750269|12931484|P5|STARTED|Overall Study||43
5259993|NCT00750269|12931485|P4|STARTED|Overall Study||43
5259994|NCT00750269|12931486|P3|STARTED|Overall Study||18
5259995|NCT00750269|12931487|P2|STARTED|Overall Study||8
5259996|NCT00750269|12931488|P1|STARTED|Overall Study||8
5259997|NCT00750204|12931535|P2|NOT COMPLETED|Overall Study||1
5259998|NCT00750204|12931536|P1|NOT COMPLETED|Overall Study||1
5259999|NCT00750204|12931535|P2|COMPLETED|Overall Study||0
5260000|NCT00750204|12931536|P1|COMPLETED|Overall Study||0
5260001|NCT00750204|12931535|P2|STARTED|Overall Study||1
5260002|NCT00750204|12931536|P1|STARTED|Overall Study||1
5260003|NCT00750191|12931544|P2|NOT COMPLETED|Overall Study||10
5260004|NCT00750191|12931545|P1|NOT COMPLETED|Overall Study||5
5260005|NCT00750191|12931544|P2|COMPLETED|Overall Study||20
5260006|NCT00750191|12931545|P1|COMPLETED|Overall Study||22
5260007|NCT00750191|12931544|P2|STARTED|Overall Study||30
5260008|NCT00750191|12931545|P1|STARTED|Overall Study||27
5260009|NCT00750165|12931557|P1|NOT COMPLETED|Overall Study||11
5260010|NCT00750165|12931557|P1|COMPLETED|Overall Study||21
5260011|NCT00750165|12931557|P1|STARTED|Overall Study||32
5260012|NCT00750152|12931566|P2|NOT COMPLETED|Overall Study||27
5260013|NCT00750152|12931567|P1|NOT COMPLETED|Overall Study||22
5260014|NCT00750152|12931566|P2|COMPLETED|Overall Study||141
5260015|NCT00750152|12931567|P1|COMPLETED|Overall Study||144
5260016|NCT00750152|12931566|P2|STARTED|Overall Study||168
5260017|NCT00750152|12931567|P1|STARTED|Overall Study||166
5260018|NCT00750139|12931579|P4|NOT COMPLETED|Overall Study||46
5260019|NCT00750139|12931580|P3|NOT COMPLETED|Overall Study||101
5260020|NCT00750139|12931581|P2|NOT COMPLETED|Overall Study||59
5260021|NCT00750139|12931582|P1|NOT COMPLETED|Overall Study||89
5260022|NCT00750139|12931579|P4|COMPLETED|Overall Study||73
5260023|NCT00750139|12931580|P3|COMPLETED|Overall Study||135
5260024|NCT00750139|12931581|P2|COMPLETED|Overall Study||59
5260025|NCT00750139|12931582|P1|COMPLETED|Overall Study||145
5260026|NCT00750139|12931579|P4|STARTED|Overall Study||119
5260027|NCT00750139|12931580|P3|STARTED|Overall Study||236
5260028|NCT00750139|12931581|P2|STARTED|Overall Study||118
5260029|NCT00750139|12931582|P1|STARTED|Overall Study||234
5260030|NCT00750061|12931598|P2|NOT COMPLETED|Overall Study||2
5260031|NCT00750061|12931599|P1|NOT COMPLETED|Overall Study||2
5260032|NCT00750061|12931598|P2|COMPLETED|Overall Study||18
5260033|NCT00750061|12931599|P1|COMPLETED|Overall Study||18
5260034|NCT00750061|12931598|P2|STARTED|Overall Study||20
5260035|NCT00750061|12931599|P1|STARTED|Overall Study||20
5260036|NCT00749996|12931609|P2|NOT COMPLETED|Overall Study||13
5260037|NCT00749996|12931610|P1|NOT COMPLETED|Overall Study||18
5260038|NCT00749996|12931609|P2|COMPLETED|Overall Study||58
5260039|NCT00749996|12931610|P1|COMPLETED|Overall Study||57
5260040|NCT00749996|12931609|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
5260041|NCT00749996|12931610|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
5260042|NCT00749996|12931609|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
5260043|NCT00749996|12931610|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
5260044|NCT00749996|12931609|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
5260045|NCT00749996|12931610|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
5260046|NCT00749996|12931609|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
5260047|NCT00749996|12931610|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
5260048|NCT00749996|12931609|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
5260049|NCT00749996|12931610|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
5260050|NCT00749996|12931609|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
5260051|NCT00749996|12931610|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
5260052|NCT00749957|12931620|P2|NOT COMPLETED|Overall Study||0
5260053|NCT00749957|12931621|P1|NOT COMPLETED|Overall Study||0
5260054|NCT00749957|12931620|P2|COMPLETED|Overall Study||6
5260055|NCT00749957|12931621|P1|COMPLETED|Overall Study||6
5260056|NCT00749957|12931620|P2|STARTED|Overall Study||6
5260057|NCT00749957|12931621|P1|STARTED|Overall Study||6
5260058|NCT00749944|12931633|P2|NOT COMPLETED|Overall Study||1
5260059|NCT00749944|12931634|P1|NOT COMPLETED|Overall Study||5
5260060|NCT00749944|12931633|P2|COMPLETED|Overall Study||54
5260061|NCT00749944|12931634|P1|COMPLETED|Overall Study||50
5260062|NCT00749944|12931633|P2|STARTED|Overall Study||55
5260063|NCT00749944|12931634|P1|STARTED|Overall Study||55
5260064|NCT00749931|12931702|P3|NOT COMPLETED|Overall Study||0
5260065|NCT00749931|12931703|P2|NOT COMPLETED|Overall Study||0
5260066|NCT00749931|12931704|P1|NOT COMPLETED|Overall Study||0
5260067|NCT00749931|12931702|P3|COMPLETED|Overall Study||68
5260068|NCT00749931|12931703|P2|COMPLETED|Overall Study||298
5260069|NCT00749931|12931704|P1|COMPLETED|Overall Study||298
5260070|NCT00749931|12931702|P3|STARTED|Overall Study||68
5260071|NCT00749931|12931703|P2|STARTED|Overall Study||298
5260072|NCT00749931|12931704|P1|STARTED|Overall Study||298
5260073|NCT00749879|12931713|P1|NOT COMPLETED|Overall Study||0
5260074|NCT00749879|12931713|P1|COMPLETED|Overall Study||12
5260075|NCT00749879|12931713|P1|STARTED|Overall Study||12
5260076|NCT00749775|12931745|P1|NOT COMPLETED|Overall Study||107
5260077|NCT00749775|12931745|P1|COMPLETED|Overall Study||3210
5260078|NCT00749775|12931745|P1|STARTED|Overall Study||3317
5260079|NCT00749684|12931761|P1|NOT COMPLETED|Overall Study||82
5260080|NCT00749684|12931761|P1|COMPLETED|Overall Study||56
5260081|NCT00749684|12931761|P1|STARTED|Overall Study||138
5260082|NCT00749671|12931768|P2|NOT COMPLETED|Overall Study||0
5260083|NCT00749671|12931769|P1|NOT COMPLETED|Overall Study||0
5260084|NCT00749671|12931768|P2|COMPLETED|Overall Study||9
5260085|NCT00749671|12931769|P1|COMPLETED|Overall Study||11
5260086|NCT00749671|12931768|P2|STARTED|Overall Study||9
5260087|NCT00749671|12931769|P1|STARTED|Overall Study||11
5260088|NCT00749606|12931779|P2|NOT COMPLETED|Year 3 (Observation)||3
5260089|NCT00749606|12931780|P1|NOT COMPLETED|Year 3 (Observation)||0
5260090|NCT00749606|12931779|P2|COMPLETED|Year 3 (Observation)||69
5260091|NCT00749606|12931780|P1|COMPLETED|Year 3 (Observation)||63
5260092|NCT00749606|12931779|P2|STARTED|Year 3 (Observation)||72
5260093|NCT00749606|12931780|P1|STARTED|Year 3 (Observation)||63
5260094|NCT00749606|12931779|P2|NOT COMPLETED|Year 2||8
5260095|NCT00749606|12931780|P1|NOT COMPLETED|Year 2||11
5260096|NCT00749606|12931779|P2|COMPLETED|Year 2||72
5260097|NCT00749606|12931780|P1|COMPLETED|Year 2||63
5260098|NCT00749606|12931779|P2|STARTED|Year 2||80
5260099|NCT00749606|12931780|P1|STARTED|Year 2||74
5260100|NCT00749606|12931779|P2|NOT COMPLETED|Year 1||48
5260101|NCT00749606|12931780|P1|NOT COMPLETED|Year 1||55
5260102|NCT00749606|12931779|P2|COMPLETED|Year 1||80
5260103|NCT00749606|12931780|P1|COMPLETED|Year 1||74
5260104|NCT00749606|12931779|P2|STARTED|Year 1||128
5260105|NCT00749606|12931780|P1|STARTED|Year 1||129
5260106|NCT00749580|12931800|P2|NOT COMPLETED|Overall Study||9
5260107|NCT00749580|12931801|P1|NOT COMPLETED|Overall Study||4
5260108|NCT00749580|12931800|P2|COMPLETED|Overall Study||16
5260109|NCT00749580|12931801|P1|COMPLETED|Overall Study|December 2010|17
5260110|NCT00749580|12931800|P2|STARTED|Overall Study||25
5260111|NCT00749580|12931801|P1|STARTED|Overall Study|September 2008|21
5260112|NCT00749515|12931811|P2|NOT COMPLETED|Overall Study||0
5260113|NCT00749515|12931812|P1|NOT COMPLETED|Overall Study||0
5260114|NCT00749515|12931811|P2|COMPLETED|Overall Study||5
5260115|NCT00749515|12931812|P1|COMPLETED|Overall Study||10
5260116|NCT00749515|12931811|P2|STARTED|Overall Study||5
5260117|NCT00749515|12931812|P1|STARTED|Overall Study||10
5260118|NCT00749476|12931828|P1|NOT COMPLETED|Overall Study||0
5260119|NCT00749476|12931828|P1|COMPLETED|Overall Study||1
5260120|NCT00749476|12931828|P1|STARTED|Overall Study||1
5260121|NCT00749463|12931835|P3|NOT COMPLETED|Overall Study||1
5260122|NCT00749463|12931836|P2|NOT COMPLETED|Overall Study||4
5260123|NCT00749463|12931837|P1|NOT COMPLETED|Overall Study||1
5260124|NCT00749463|12931835|P3|COMPLETED|Overall Study||149
5260125|NCT00749463|12931836|P2|COMPLETED|Overall Study||60
5260126|NCT00749463|12931837|P1|COMPLETED|Overall Study||85
5260127|NCT00749463|12931835|P3|STARTED|Overall Study||150
5260128|NCT00749463|12931836|P2|STARTED|Overall Study||64
5260129|NCT00749463|12931837|P1|STARTED|Overall Study||86
5260130|NCT00749398|12931863|P1|NOT COMPLETED|Overall Study||53
5260131|NCT00749398|12931863|P1|COMPLETED|Overall Study||71
5260132|NCT00749398|12931863|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
5260133|NCT00749268|12931881|P2|NOT COMPLETED|Overall Study||36
5260134|NCT00749268|12931882|P1|NOT COMPLETED|Overall Study||34
5260135|NCT00749268|12931881|P2|COMPLETED|Overall Study||74
5260136|NCT00749268|12931882|P1|COMPLETED|Overall Study||72
5260137|NCT00749268|12931881|P2|STARTED|Overall Study||110
5260138|NCT00749268|12931882|P1|STARTED|Overall Study||106
5260139|NCT00749203|12931906|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
5260140|NCT00749203|12931907|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
5260141|NCT00749203|12931906|P2|COMPLETED|Second Infusion at 2 Weeks||13
5260142|NCT00749203|12931907|P1|COMPLETED|Second Infusion at 2 Weeks||16
5260143|NCT00749203|12931906|P2|STARTED|Second Infusion at 2 Weeks||15
5260144|NCT00749203|12931907|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
5260145|NCT00749203|12931906|P2|NOT COMPLETED|no Infusion at Week 1||4
5260146|NCT00749203|12931907|P1|NOT COMPLETED|no Infusion at Week 1||0
5260147|NCT00749203|12931906|P2|COMPLETED|no Infusion at Week 1||15
5260148|NCT00749203|12931907|P1|COMPLETED|no Infusion at Week 1||22
5260149|NCT00749203|12931906|P2|STARTED|no Infusion at Week 1||19
5260150|NCT00749203|12931907|P1|STARTED|no Infusion at Week 1||22
5260151|NCT00749203|12931906|P2|NOT COMPLETED|First Infusion Day 1||0
5260152|NCT00749203|12931907|P1|NOT COMPLETED|First Infusion Day 1||0
5260153|NCT00749203|12931906|P2|COMPLETED|First Infusion Day 1||19
5260154|NCT00749203|12931907|P1|COMPLETED|First Infusion Day 1||22
5260155|NCT00749203|12931906|P2|STARTED|First Infusion Day 1||19
5260156|NCT00749203|12931907|P1|STARTED|First Infusion Day 1||22
5260157|NCT00749190|12931928|P7|NOT COMPLETED|Overall Study||1
5260158|NCT00749190|12931929|P6|NOT COMPLETED|Overall Study||5
5260159|NCT00749190|12931930|P5|NOT COMPLETED|Overall Study||0
5260160|NCT00749190|12931931|P4|NOT COMPLETED|Overall Study||5
5260161|NCT00749190|12931932|P3|NOT COMPLETED|Overall Study||1
5260162|NCT00749190|12931933|P2|NOT COMPLETED|Overall Study||5
5260163|NCT00749190|12931934|P1|NOT COMPLETED|Overall Study||5
5260164|NCT00749190|12931928|P7|COMPLETED|Overall Study||70
5260165|NCT00749190|12931929|P6|COMPLETED|Overall Study||65
5260166|NCT00749190|12931930|P5|COMPLETED|Overall Study||70
5260167|NCT00749190|12931931|P4|COMPLETED|Overall Study||66
5260168|NCT00749190|12931932|P3|COMPLETED|Overall Study||70
5260169|NCT00749190|12931933|P2|COMPLETED|Overall Study||66
5260170|NCT00749190|12931934|P1|COMPLETED|Overall Study||66
5260171|NCT00749190|12931928|P7|STARTED|Overall Study||71
5260172|NCT00749190|12931929|P6|STARTED|Overall Study||70
5260173|NCT00749190|12931930|P5|STARTED|Overall Study||70
5260174|NCT00749190|12931931|P4|STARTED|Overall Study||71
5260175|NCT00749190|12931932|P3|STARTED|Overall Study||71
5260176|NCT00749190|12931933|P2|STARTED|Overall Study||71
5260177|NCT00749190|12931934|P1|STARTED|Overall Study||71
5260178|NCT00749125|12932013|P2|NOT COMPLETED|Overall Study||18
5260179|NCT00749125|12932014|P1|NOT COMPLETED|Overall Study||11
5260180|NCT00749125|12932013|P2|COMPLETED|Overall Study||34
5260181|NCT00749125|12932014|P1|COMPLETED|Overall Study||36
5260182|NCT00749125|12932013|P2|STARTED|Overall Study||52
5260183|NCT00749125|12932014|P1|STARTED|Overall Study||47
5260184|NCT00749073|12932020|P1|NOT COMPLETED|Overall Study||0
5260185|NCT00749073|12932020|P1|COMPLETED|Overall Study||10
5260186|NCT00749073|12932020|P1|STARTED|Overall Study||10
5260187|NCT00748982|12932028|P2|NOT COMPLETED|Overall Study||0
5260188|NCT00748982|12932029|P1|NOT COMPLETED|Overall Study||0
5260189|NCT00748982|12932028|P2|COMPLETED|Overall Study||4
5260190|NCT00748982|12932029|P1|COMPLETED|Overall Study||12
5260191|NCT00748982|12932028|P2|STARTED|Overall Study||4
5260192|NCT00748982|12932029|P1|STARTED|Overall Study||12
5260193|NCT00748969|12932043|P2|NOT COMPLETED|Overall Study||1
5260194|NCT00748969|12932044|P1|NOT COMPLETED|Overall Study||1
5260195|NCT00748969|12932043|P2|COMPLETED|Overall Study||0
5260196|NCT00748969|12932044|P1|COMPLETED|Overall Study||0
5260197|NCT00748969|12932043|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
5260198|NCT00748969|12932044|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
5260199|NCT00748956|12932055|P3|NOT COMPLETED|Overall Study||0
5260200|NCT00748956|12932056|P2|NOT COMPLETED|Overall Study||0
5260201|NCT00748956|12932057|P1|NOT COMPLETED|Overall Study||0
5260202|NCT00748956|12932055|P3|COMPLETED|Overall Study||5
5260203|NCT00748956|12932056|P2|COMPLETED|Overall Study||5
5260204|NCT00748956|12932057|P1|COMPLETED|Overall Study||0
5260205|NCT00748956|12932055|P3|STARTED|Overall Study||5
5260206|NCT00748956|12932056|P2|STARTED|Overall Study||5
5260207|NCT00748956|12932057|P1|STARTED|Overall Study||0
5260208|NCT00748865|12932080|P2|NOT COMPLETED|Overall Study||0
5260209|NCT00748865|12932081|P1|NOT COMPLETED|Overall Study||0
5260210|NCT00748865|12932080|P2|COMPLETED|Overall Study||10
5260211|NCT00748865|12932081|P1|COMPLETED|Overall Study||10
5260212|NCT00748865|12932080|P2|STARTED|Overall Study||10
5260213|NCT00748865|12932081|P1|STARTED|Overall Study||10
5260214|NCT00748826|12932087|P1|NOT COMPLETED|Overall Study||301
5260215|NCT00748826|12932087|P1|COMPLETED|Overall Study||207
5260216|NCT00748826|12932087|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
5260217|NCT00748709|12932094|P1|NOT COMPLETED|Overall Study||20
5260218|NCT00748709|12932094|P1|COMPLETED|Overall Study||0
5260219|NCT00748709|12932094|P1|STARTED|Overall Study|Treated|20
5260220|NCT00748657|12932106|P1|NOT COMPLETED|Overall Study||0
5260221|NCT00748657|12932106|P1|COMPLETED|Overall Study||36
5260222|NCT00748657|12932106|P1|STARTED|Overall Study||36
5260223|NCT00748579|12932120|P2|NOT COMPLETED|Overall Study||0
5260224|NCT00748579|12932121|P1|NOT COMPLETED|Overall Study||0
5260225|NCT00748579|12932120|P2|COMPLETED|Overall Study||0
5260226|NCT00748579|12932121|P1|COMPLETED|Overall Study||2
5260227|NCT00748579|12932120|P2|STARTED|Overall Study||0
5260228|NCT00748579|12932121|P1|STARTED|Overall Study||2
5260229|NCT00748566|12932137|P1|NOT COMPLETED|Overall Study||112
5260230|NCT00748566|12932137|P1|COMPLETED|Overall Study||60
5260231|NCT00748566|12932137|P1|STARTED|Overall Study||172
5260232|NCT00748553|12932167|P2|NOT COMPLETED|Overall Study||1
5260233|NCT00748553|12932168|P1|NOT COMPLETED|Overall Study||3
5260234|NCT00748553|12932167|P2|COMPLETED|Overall Study||13
5260235|NCT00748553|12932168|P1|COMPLETED|Overall Study||13
5260236|NCT00748553|12932167|P2|STARTED|Overall Study||14
5260237|NCT00748553|12932168|P1|STARTED|Overall Study||16
5260238|NCT00748540|12932175|P1|NOT COMPLETED|Overall Study||1
5260239|NCT00748540|12932175|P1|COMPLETED|Overall Study||49
5260240|NCT00748540|12932175|P1|STARTED|Overall Study||50
5260241|NCT00748410|12932184|P2|NOT COMPLETED|Overall Study||0
5260242|NCT00748410|12932185|P1|NOT COMPLETED|Overall Study||0
5260243|NCT00748410|12932184|P2|COMPLETED|Overall Study||2
5260244|NCT00748410|12932185|P1|COMPLETED|Overall Study||1
5260245|NCT00748410|12932184|P2|STARTED|Overall Study||2
5260246|NCT00748410|12932185|P1|STARTED|Overall Study||1
5260247|NCT00748241|12932201|P1|NOT COMPLETED|Overall Study||8
5260248|NCT00748241|12932201|P1|COMPLETED|Overall Study||11
5260249|NCT00748241|12932201|P1|STARTED|Overall Study||19
5260250|NCT00748189|12932211|P2|NOT COMPLETED|Overall Study||212
5260251|NCT00748189|12932212|P1|NOT COMPLETED|Overall Study||216
5260252|NCT00748189|12932211|P2|COMPLETED|Overall Study||9
5260253|NCT00748189|12932212|P1|COMPLETED|Overall Study||10
5260254|NCT00748189|12932211|P2|STARTED|Overall Study||221
5260255|NCT00748189|12932212|P1|STARTED|Overall Study||226
5260256|NCT00748098|12932267|P2|NOT COMPLETED|Second Taper Period||0
5260257|NCT00748098|12932268|P1|NOT COMPLETED|Second Taper Period||0
5260258|NCT00748098|12932267|P2|COMPLETED|Second Taper Period||61
5260259|NCT00748098|12932268|P1|COMPLETED|Second Taper Period||53
5260260|NCT00748098|12932267|P2|STARTED|Second Taper Period||61
5260261|NCT00748098|12932268|P1|STARTED|Second Taper Period||53
5260262|NCT00748098|12932267|P2|NOT COMPLETED|Second Treatment Intervention Period||3
5260263|NCT00748098|12932268|P1|NOT COMPLETED|Second Treatment Intervention Period||6
5260264|NCT00748098|12932267|P2|COMPLETED|Second Treatment Intervention Period||61
5260265|NCT00748098|12932268|P1|COMPLETED|Second Treatment Intervention Period||53
5260266|NCT00748098|12932267|P2|STARTED|Second Treatment Intervention Period||64
5260267|NCT00748098|12932268|P1|STARTED|Second Treatment Intervention Period||59
5260268|NCT00748098|12932267|P2|NOT COMPLETED|1-Week Washout Period||1
5260269|NCT00748098|12932268|P1|NOT COMPLETED|1-Week Washout Period||2
5260270|NCT00748098|12932267|P2|COMPLETED|1-Week Washout Period||64
5260271|NCT00748098|12932268|P1|COMPLETED|1-Week Washout Period||59
5260272|NCT00748098|12932267|P2|STARTED|1-Week Washout Period||65
5260273|NCT00748098|12932268|P1|STARTED|1-Week Washout Period||61
5260274|NCT00748098|12932267|P2|NOT COMPLETED|First Taper Period||1
5260275|NCT00748098|12932268|P1|NOT COMPLETED|First Taper Period||3
5260276|NCT00748098|12932267|P2|COMPLETED|First Taper Period||65
5260277|NCT00748098|12932268|P1|COMPLETED|First Taper Period||61
5260278|NCT00748098|12932267|P2|STARTED|First Taper Period||66
5260279|NCT00748098|12932268|P1|STARTED|First Taper Period||64
5260280|NCT00748098|12932267|P2|NOT COMPLETED|First Treatment Intervention Period||1
5260281|NCT00748098|12932268|P1|NOT COMPLETED|First Treatment Intervention Period||5
5260282|NCT00748098|12932267|P2|COMPLETED|First Treatment Intervention Period||66
5260283|NCT00748098|12932268|P1|COMPLETED|First Treatment Intervention Period||64
5260284|NCT00748098|12932267|P2|STARTED|First Treatment Intervention Period||67
5260285|NCT00748098|12932268|P1|STARTED|First Treatment Intervention Period||69
5260286|NCT00748085|12932328|P1|NOT COMPLETED|Overall Study||0
5260287|NCT00748085|12932328|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
5260288|NCT00748085|12932328|P1|STARTED|Overall Study||5
5260289|NCT00748072|12932335|P2|NOT COMPLETED|Overall Study||0
5260290|NCT00748072|12932336|P1|NOT COMPLETED|Overall Study||0
5260291|NCT00748072|12932335|P2|COMPLETED|Overall Study||80
5260292|NCT00748072|12932336|P1|COMPLETED|Overall Study||82
5260293|NCT00748072|12932335|P2|STARTED|Overall Study||80
5260294|NCT00748072|12932336|P1|STARTED|Overall Study||82
5260295|NCT00747916|12932342|P1|NOT COMPLETED|Overall Study||0
5260296|NCT00747916|12932342|P1|COMPLETED|Overall Study||3
5260297|NCT00747916|12932342|P1|STARTED|Overall Study||3
5260298|NCT00747812|12932349|P2|NOT COMPLETED|Overall Study||3
5260299|NCT00747812|12932350|P1|NOT COMPLETED|Overall Study||5
5260300|NCT00747812|12932349|P2|COMPLETED|Overall Study||0
5260301|NCT00747812|12932350|P1|COMPLETED|Overall Study||0
5260302|NCT00747812|12932349|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
5260303|NCT00747812|12932350|P1|STARTED|Overall Study||5
5260304|NCT00747747|12932361|P3|NOT COMPLETED|Overall Study||0
5260305|NCT00747747|12932362|P2|NOT COMPLETED|Overall Study||0
5260306|NCT00747747|12932363|P1|NOT COMPLETED|Overall Study||0
5260307|NCT00747747|12932361|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
5260308|NCT00747747|12932362|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
5260309|NCT00747747|12932363|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
5260310|NCT00747747|12932361|P3|STARTED|Overall Study||21
5260311|NCT00747747|12932362|P2|STARTED|Overall Study||14
5260312|NCT00747747|12932363|P1|STARTED|Overall Study||14
5260313|NCT00747643|12932388|P2|NOT COMPLETED|Overall Study||27
5260314|NCT00747643|12932389|P1|NOT COMPLETED|Overall Study||36
5260315|NCT00747643|12932388|P2|COMPLETED|Overall Study||54
5260316|NCT00747643|12932389|P1|COMPLETED|Overall Study||46
5260317|NCT00747643|12932388|P2|STARTED|Overall Study||81
5260318|NCT00747643|12932389|P1|STARTED|Overall Study||82
5260319|NCT00747617|12932403|P2|NOT COMPLETED|Overall Study||1
5260320|NCT00747617|12932404|P1|NOT COMPLETED|Overall Study||3
5260321|NCT00747617|12932403|P2|COMPLETED|Overall Study||11
5260322|NCT00747617|12932404|P1|COMPLETED|Overall Study||10
5260323|NCT00747617|12932403|P2|STARTED|Overall Study||12
5260324|NCT00747617|12932404|P1|STARTED|Overall Study||13
5260325|NCT00747565|12932414|P2|NOT COMPLETED|Overall Study||7
5260326|NCT00747565|12932415|P1|NOT COMPLETED|Overall Study||14
5260327|NCT00747565|12932414|P2|COMPLETED|Overall Study||116
5260328|NCT00747565|12932415|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
5260329|NCT00747565|12932414|P2|STARTED|Overall Study||123
5260330|NCT00747565|12932415|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
5260331|NCT00747552|12932423|P1|NOT COMPLETED|Overall Study||0
5260332|NCT00747552|12932423|P1|COMPLETED|Overall Study||30
5260333|NCT00747552|12932423|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
5260334|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260335|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260336|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260337|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260338|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260339|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260340|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260341|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260342|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260343|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260344|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260345|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260346|NCT00747474|12932428|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
5260347|NCT00747474|12932429|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260348|NCT00747474|12932430|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260349|NCT00747474|12932431|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260350|NCT00747474|12932432|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260351|NCT00747474|12932433|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260352|NCT00747474|12932434|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260353|NCT00747474|12932435|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260354|NCT00747474|12932436|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260355|NCT00747474|12932437|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260356|NCT00747474|12932438|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260357|NCT00747474|12932439|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
5260358|NCT00747474|12932428|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
5260359|NCT00747474|12932429|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260360|NCT00747474|12932430|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260361|NCT00747474|12932431|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260362|NCT00747474|12932432|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260363|NCT00747474|12932433|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260364|NCT00747474|12932434|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260365|NCT00747474|12932435|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260366|NCT00747474|12932436|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260367|NCT00747474|12932437|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260368|NCT00747474|12932438|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260369|NCT00747474|12932439|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
5260370|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260371|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260372|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260373|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260374|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260375|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260376|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260377|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260378|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260379|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260380|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260381|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260382|NCT00747474|12932428|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260383|NCT00747474|12932429|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
5260384|NCT00747474|12932430|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260385|NCT00747474|12932431|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260386|NCT00747474|12932432|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260387|NCT00747474|12932433|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260388|NCT00747474|12932434|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260389|NCT00747474|12932435|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260390|NCT00747474|12932436|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260391|NCT00747474|12932437|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260392|NCT00747474|12932438|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260393|NCT00747474|12932439|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
5260394|NCT00747474|12932428|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260395|NCT00747474|12932429|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
5260396|NCT00747474|12932430|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260397|NCT00747474|12932431|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260398|NCT00747474|12932432|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260399|NCT00747474|12932433|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260400|NCT00747474|12932434|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260401|NCT00747474|12932435|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260402|NCT00747474|12932436|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260403|NCT00747474|12932437|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260404|NCT00747474|12932438|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260405|NCT00747474|12932439|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
5260406|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260407|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260408|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260409|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260410|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260411|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260412|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260413|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260414|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260415|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260416|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260417|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260418|NCT00747474|12932428|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260419|NCT00747474|12932429|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260420|NCT00747474|12932430|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
5260421|NCT00747474|12932431|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260422|NCT00747474|12932432|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260423|NCT00747474|12932433|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260424|NCT00747474|12932434|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260425|NCT00747474|12932435|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260426|NCT00747474|12932436|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260427|NCT00747474|12932437|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260428|NCT00747474|12932438|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260429|NCT00747474|12932439|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
5260430|NCT00747474|12932428|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260431|NCT00747474|12932429|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260432|NCT00747474|12932430|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
5260433|NCT00747474|12932431|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260434|NCT00747474|12932432|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260435|NCT00747474|12932433|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260436|NCT00747474|12932434|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260437|NCT00747474|12932435|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260438|NCT00747474|12932436|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260439|NCT00747474|12932437|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260440|NCT00747474|12932438|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260441|NCT00747474|12932439|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
5260442|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260443|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260444|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260445|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260446|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260447|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260448|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260449|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260450|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260451|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260452|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260453|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260454|NCT00747474|12932428|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260455|NCT00747474|12932429|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260456|NCT00747474|12932430|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260457|NCT00747474|12932431|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
5260458|NCT00747474|12932432|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260459|NCT00747474|12932433|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260460|NCT00747474|12932434|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260461|NCT00747474|12932435|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260462|NCT00747474|12932436|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260463|NCT00747474|12932437|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260464|NCT00747474|12932438|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260465|NCT00747474|12932439|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
5260466|NCT00747474|12932428|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260467|NCT00747474|12932429|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260468|NCT00747474|12932430|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260469|NCT00747474|12932431|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
5260470|NCT00747474|12932432|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260471|NCT00747474|12932433|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260472|NCT00747474|12932434|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260473|NCT00747474|12932435|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260474|NCT00747474|12932436|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260475|NCT00747474|12932437|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260476|NCT00747474|12932438|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260477|NCT00747474|12932439|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
5260478|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260479|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260480|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260481|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260482|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
5260483|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260484|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260485|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260486|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260487|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260488|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260489|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260490|NCT00747474|12932428|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260491|NCT00747474|12932429|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260492|NCT00747474|12932430|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260493|NCT00747474|12932431|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260494|NCT00747474|12932432|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
5260495|NCT00747474|12932433|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260496|NCT00747474|12932434|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260497|NCT00747474|12932435|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260498|NCT00747474|12932436|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260499|NCT00747474|12932437|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260500|NCT00747474|12932438|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260501|NCT00747474|12932439|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
5260502|NCT00747474|12932428|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260503|NCT00747474|12932429|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260504|NCT00747474|12932430|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260505|NCT00747474|12932431|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260506|NCT00747474|12932432|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
5260507|NCT00747474|12932433|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260508|NCT00747474|12932434|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260509|NCT00747474|12932435|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260510|NCT00747474|12932436|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260511|NCT00747474|12932437|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260512|NCT00747474|12932438|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260513|NCT00747474|12932439|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
5260514|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260515|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260516|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260517|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260518|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260519|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260520|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260521|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260522|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260523|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260524|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260525|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260526|NCT00747474|12932428|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260527|NCT00747474|12932429|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260528|NCT00747474|12932430|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260529|NCT00747474|12932431|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260530|NCT00747474|12932432|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260531|NCT00747474|12932433|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
5260532|NCT00747474|12932434|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260533|NCT00747474|12932435|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260534|NCT00747474|12932436|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260535|NCT00747474|12932437|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260536|NCT00747474|12932438|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260537|NCT00747474|12932439|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
5260538|NCT00747474|12932428|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260539|NCT00747474|12932429|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260540|NCT00747474|12932430|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260541|NCT00747474|12932431|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260542|NCT00747474|12932432|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260543|NCT00747474|12932433|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
5260544|NCT00747474|12932434|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260545|NCT00747474|12932435|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260546|NCT00747474|12932436|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260547|NCT00747474|12932437|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260548|NCT00747474|12932438|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260549|NCT00747474|12932439|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
5260550|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260551|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260552|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260553|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260554|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260555|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260556|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260557|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260558|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260559|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260560|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260561|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260562|NCT00747474|12932428|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260563|NCT00747474|12932429|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260564|NCT00747474|12932430|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260565|NCT00747474|12932431|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260566|NCT00747474|12932432|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260567|NCT00747474|12932433|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260568|NCT00747474|12932434|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
5260569|NCT00747474|12932435|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260570|NCT00747474|12932436|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260571|NCT00747474|12932437|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260572|NCT00747474|12932438|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260573|NCT00747474|12932439|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
5260574|NCT00747474|12932428|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260575|NCT00747474|12932429|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260576|NCT00747474|12932430|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260577|NCT00747474|12932431|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260578|NCT00747474|12932432|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260579|NCT00747474|12932433|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260580|NCT00747474|12932434|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
5260581|NCT00747474|12932435|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260582|NCT00747474|12932436|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260583|NCT00747474|12932437|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260584|NCT00747474|12932438|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260585|NCT00747474|12932439|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
5260586|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260587|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260588|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260589|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260590|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260591|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260592|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260593|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260594|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260595|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260596|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260597|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260598|NCT00747474|12932428|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260599|NCT00747474|12932429|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260600|NCT00747474|12932430|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260601|NCT00747474|12932431|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260602|NCT00747474|12932432|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260603|NCT00747474|12932433|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260604|NCT00747474|12932434|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260605|NCT00747474|12932435|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
5260606|NCT00747474|12932436|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260607|NCT00747474|12932437|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260608|NCT00747474|12932438|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260609|NCT00747474|12932439|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
5260610|NCT00747474|12932428|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260611|NCT00747474|12932429|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260612|NCT00747474|12932430|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260613|NCT00747474|12932431|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260614|NCT00747474|12932432|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260615|NCT00747474|12932433|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260616|NCT00747474|12932434|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260617|NCT00747474|12932435|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
5260618|NCT00747474|12932436|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260619|NCT00747474|12932437|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260620|NCT00747474|12932438|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260621|NCT00747474|12932439|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
5260622|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260623|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260624|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260625|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260626|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260627|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260628|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260629|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260630|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260631|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260632|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260633|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260634|NCT00747474|12932428|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260635|NCT00747474|12932429|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260636|NCT00747474|12932430|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260637|NCT00747474|12932431|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260638|NCT00747474|12932432|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260639|NCT00747474|12932433|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260640|NCT00747474|12932434|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260641|NCT00747474|12932435|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260642|NCT00747474|12932436|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
5260643|NCT00747474|12932437|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260644|NCT00747474|12932438|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260645|NCT00747474|12932439|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
5260646|NCT00747474|12932428|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260647|NCT00747474|12932429|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260648|NCT00747474|12932430|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260649|NCT00747474|12932431|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260650|NCT00747474|12932432|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260651|NCT00747474|12932433|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260652|NCT00747474|12932434|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260653|NCT00747474|12932435|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260654|NCT00747474|12932436|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
5260655|NCT00747474|12932437|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260656|NCT00747474|12932438|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260657|NCT00747474|12932439|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
5260658|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260659|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260660|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260661|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260662|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260663|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260664|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260665|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260666|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260667|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260668|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260669|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260670|NCT00747474|12932428|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260671|NCT00747474|12932429|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260672|NCT00747474|12932430|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260673|NCT00747474|12932431|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260674|NCT00747474|12932432|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260675|NCT00747474|12932433|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260676|NCT00747474|12932434|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260677|NCT00747474|12932435|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260678|NCT00747474|12932436|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260679|NCT00747474|12932437|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
5260680|NCT00747474|12932438|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260681|NCT00747474|12932439|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
5260682|NCT00747474|12932428|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260683|NCT00747474|12932429|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260684|NCT00747474|12932430|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260685|NCT00747474|12932431|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260686|NCT00747474|12932432|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260687|NCT00747474|12932433|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260688|NCT00747474|12932434|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260689|NCT00747474|12932435|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260690|NCT00747474|12932436|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260691|NCT00747474|12932437|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
5260692|NCT00747474|12932438|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260693|NCT00747474|12932439|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
5260694|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260695|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260696|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260697|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260698|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260699|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260700|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260701|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260702|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260703|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260704|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260705|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260706|NCT00747474|12932428|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260707|NCT00747474|12932429|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260708|NCT00747474|12932430|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260709|NCT00747474|12932431|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260710|NCT00747474|12932432|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260711|NCT00747474|12932433|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260712|NCT00747474|12932434|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260713|NCT00747474|12932435|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260714|NCT00747474|12932436|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260715|NCT00747474|12932437|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260716|NCT00747474|12932438|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
5260717|NCT00747474|12932439|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
5260718|NCT00747474|12932428|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260719|NCT00747474|12932429|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260720|NCT00747474|12932430|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260721|NCT00747474|12932431|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260722|NCT00747474|12932432|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260723|NCT00747474|12932433|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260724|NCT00747474|12932434|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260725|NCT00747474|12932435|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260726|NCT00747474|12932436|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260727|NCT00747474|12932437|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260728|NCT00747474|12932438|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
5260729|NCT00747474|12932439|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
5260730|NCT00747474|12932428|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260731|NCT00747474|12932429|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260732|NCT00747474|12932430|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260733|NCT00747474|12932431|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260734|NCT00747474|12932432|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260735|NCT00747474|12932433|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260736|NCT00747474|12932434|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260737|NCT00747474|12932435|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260738|NCT00747474|12932436|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260739|NCT00747474|12932437|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260740|NCT00747474|12932438|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260741|NCT00747474|12932439|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260742|NCT00747474|12932428|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260743|NCT00747474|12932429|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260744|NCT00747474|12932430|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260745|NCT00747474|12932431|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260746|NCT00747474|12932432|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260747|NCT00747474|12932433|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260748|NCT00747474|12932434|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260749|NCT00747474|12932435|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260750|NCT00747474|12932436|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260751|NCT00747474|12932437|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260752|NCT00747474|12932438|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
5260753|NCT00747474|12932439|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
5260754|NCT00747474|12932428|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260755|NCT00747474|12932429|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260756|NCT00747474|12932430|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260757|NCT00747474|12932431|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260758|NCT00747474|12932432|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260759|NCT00747474|12932433|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260760|NCT00747474|12932434|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260761|NCT00747474|12932435|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260762|NCT00747474|12932436|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260763|NCT00747474|12932437|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260764|NCT00747474|12932438|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
5260765|NCT00747474|12932439|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
5260766|NCT00747461|12932465|P1|NOT COMPLETED|Overall Study||5
5260767|NCT00747461|12932465|P1|COMPLETED|Overall Study||0
5260768|NCT00747461|12932465|P1|STARTED|Overall Study||5
5260769|NCT00747435|12932470|P1|NOT COMPLETED|Overall Study||6
5260770|NCT00747435|12932470|P1|COMPLETED|Overall Study||67
5260771|NCT00747435|12932470|P1|STARTED|Overall Study||73
5260772|NCT00747344|12932480|P4|NOT COMPLETED|After Controlled Period||1
5260773|NCT00747344|12932481|P3|NOT COMPLETED|After Controlled Period||0
5260774|NCT00747344|12932482|P2|NOT COMPLETED|After Controlled Period||0
5260775|NCT00747344|12932483|P1|NOT COMPLETED|After Controlled Period||0
5260776|NCT00747344|12932480|P4|COMPLETED|After Controlled Period||56
5260777|NCT00747344|12932481|P3|COMPLETED|After Controlled Period||55
5260778|NCT00747344|12932482|P2|COMPLETED|After Controlled Period||0
5260779|NCT00747344|12932483|P1|COMPLETED|After Controlled Period||0
5260780|NCT00747344|12932480|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
5260781|NCT00747344|12932481|P3|STARTED|After Controlled Period||55
5260782|NCT00747344|12932482|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5260783|NCT00747344|12932483|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5260784|NCT00747344|12932480|P4|NOT COMPLETED|Controlled Period||0
5260785|NCT00747344|12932481|P3|NOT COMPLETED|Controlled Period||0
5260786|NCT00747344|12932482|P2|NOT COMPLETED|Controlled Period||4
5260787|NCT00747344|12932483|P1|NOT COMPLETED|Controlled Period||5
5260788|NCT00747344|12932480|P4|COMPLETED|Controlled Period||0
5260789|NCT00747344|12932481|P3|COMPLETED|Controlled Period||0
5260790|NCT00747344|12932482|P2|COMPLETED|Controlled Period||57
5260791|NCT00747344|12932483|P1|COMPLETED|Controlled Period||55
5260792|NCT00747344|12932480|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5260793|NCT00747344|12932481|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5260794|NCT00747344|12932482|P2|STARTED|Controlled Period||61
5260795|NCT00747344|12932483|P1|STARTED|Controlled Period||60
5260796|NCT00747227|12932497|P2|NOT COMPLETED|Overall Study||4
5260797|NCT00747227|12932498|P1|NOT COMPLETED|Overall Study||6
5260798|NCT00747227|12932497|P2|COMPLETED|Overall Study||120
5260799|NCT00747227|12932498|P1|COMPLETED|Overall Study||120
5260800|NCT00747227|12932497|P2|STARTED|Overall Study||124
5260801|NCT00747227|12932498|P1|STARTED|Overall Study||126
5260802|NCT00747214|12932512|P2|NOT COMPLETED|Overall Study||3
5260803|NCT00747214|12932513|P1|NOT COMPLETED|Overall Study||8
5260804|NCT00747214|12932512|P2|COMPLETED|Overall Study||29
5260805|NCT00747214|12932513|P1|COMPLETED|Overall Study||19
5260806|NCT00747214|12932512|P2|STARTED|Overall Study||32
5260807|NCT00747214|12932513|P1|STARTED|Overall Study||27
5260808|NCT00747149|12932527|P2|NOT COMPLETED|Overall Study||43
5260809|NCT00747149|12932528|P1|NOT COMPLETED|Overall Study||1
5260810|NCT00747149|12932527|P2|COMPLETED|Overall Study||401
5260811|NCT00747149|12932528|P1|COMPLETED|Overall Study||153
5260812|NCT00747149|12932527|P2|STARTED|Overall Study||444
5260813|NCT00747149|12932528|P1|STARTED|Overall Study||154
5260814|NCT00747006|12932543|P3|NOT COMPLETED|Overall Study||1
5260815|NCT00747006|12932544|P2|NOT COMPLETED|Overall Study||1
5260816|NCT00747006|12932545|P1|NOT COMPLETED|Overall Study||3
5260817|NCT00747006|12932543|P3|COMPLETED|Overall Study||2
5260818|NCT00747006|12932544|P2|COMPLETED|Overall Study||7
5260819|NCT00747006|12932545|P1|COMPLETED|Overall Study||4
5260820|NCT00747006|12932543|P3|STARTED|Overall Study||3
5260821|NCT00747006|12932544|P2|STARTED|Overall Study||8
5260822|NCT00747006|12932545|P1|STARTED|Overall Study||7
5260823|NCT00746954|12932611|P3|NOT COMPLETED|Overall Study||0
5260824|NCT00746954|12932612|P2|NOT COMPLETED|Overall Study||0
5260825|NCT00746954|12932613|P1|NOT COMPLETED|Overall Study||0
5260826|NCT00746954|12932611|P3|COMPLETED|Overall Study||2
5260827|NCT00746954|12932612|P2|COMPLETED|Overall Study||3
5260828|NCT00746954|12932613|P1|COMPLETED|Overall Study||3
5260829|NCT00746954|12932611|P3|STARTED|Overall Study||2
5260830|NCT00746954|12932612|P2|STARTED|Overall Study||3
5260831|NCT00746954|12932613|P1|STARTED|Overall Study||3
5260832|NCT00746941|12932623|P4|NOT COMPLETED|Overall Study||13
5260833|NCT00746941|12932624|P3|NOT COMPLETED|Overall Study||2
5260834|NCT00746941|12932625|P2|NOT COMPLETED|Overall Study||4
5260835|NCT00746941|12932626|P1|NOT COMPLETED|Overall Study||7
5260836|NCT00746941|12932623|P4|COMPLETED|Overall Study||7
5260837|NCT00746941|12932624|P3|COMPLETED|Overall Study||3
5260838|NCT00746941|12932625|P2|COMPLETED|Overall Study||1
5260839|NCT00746941|12932626|P1|COMPLETED|Overall Study||0
5260840|NCT00746941|12932623|P4|STARTED|Overall Study||20
5260841|NCT00746941|12932624|P3|STARTED|Overall Study||5
5260842|NCT00746941|12932625|P2|STARTED|Overall Study||5
5260843|NCT00746941|12932626|P1|STARTED|Overall Study||7
5260844|NCT00746889|12932654|P2|NOT COMPLETED|Overall Study||4
5260845|NCT00746889|12932655|P1|NOT COMPLETED|Overall Study||4
5260846|NCT00746889|12932654|P2|COMPLETED|Overall Study||35
5260847|NCT00746889|12932655|P1|COMPLETED|Overall Study||36
5260848|NCT00746889|12932654|P2|STARTED|Overall Study||39
5260849|NCT00746889|12932655|P1|STARTED|Overall Study||40
5260850|NCT00746863|12932665|P2|NOT COMPLETED|Overall Study||0
5260851|NCT00746863|12932666|P1|NOT COMPLETED|Overall Study||0
5260852|NCT00746863|12932665|P2|COMPLETED|Overall Study||21
5260853|NCT00746863|12932666|P1|COMPLETED|Overall Study||21
5260854|NCT00746863|12932665|P2|STARTED|Overall Study||21
5260855|NCT00746863|12932666|P1|STARTED|Overall Study||21
5260856|NCT00746798|12932684|P4|NOT COMPLETED|Overall Study||0
5260857|NCT00746798|12932685|P3|NOT COMPLETED|Overall Study||3
5260858|NCT00746798|12932686|P2|NOT COMPLETED|Overall Study||2
5260859|NCT00746798|12932687|P1|NOT COMPLETED|Overall Study||1
5260860|NCT00746798|12932684|P4|COMPLETED|Overall Study||120
5260861|NCT00746798|12932685|P3|COMPLETED|Overall Study||110
5260862|NCT00746798|12932686|P2|COMPLETED|Overall Study||122
5260863|NCT00746798|12932687|P1|COMPLETED|Overall Study||121
5260864|NCT00746798|12932684|P4|STARTED|Overall Study||120
5260865|NCT00746798|12932685|P3|STARTED|Overall Study||113
5260866|NCT00746798|12932686|P2|STARTED|Overall Study||124
5260867|NCT00746798|12932687|P1|STARTED|Overall Study||122
5260868|NCT00746785|12932712|P3|NOT COMPLETED|Overall Study||27
5260869|NCT00746785|12932713|P2|NOT COMPLETED|Overall Study||25
5260870|NCT00746785|12932714|P1|NOT COMPLETED|Overall Study||29
5260871|NCT00746785|12932712|P3|COMPLETED|Overall Study||13
5260872|NCT00746785|12932713|P2|COMPLETED|Overall Study||21
5260873|NCT00746785|12932714|P1|COMPLETED|Overall Study||14
5260874|NCT00746785|12932712|P3|STARTED|Overall Study||40
5260875|NCT00746785|12932713|P2|STARTED|Overall Study||46
5260876|NCT00746785|12932714|P1|STARTED|Overall Study||43
5260877|NCT00746733|12932722|P2|NOT COMPLETED|Fourth Intervention||0
5260878|NCT00746733|12932723|P1|NOT COMPLETED|Fourth Intervention||0
5260879|NCT00746733|12932722|P2|COMPLETED|Fourth Intervention||11
5260880|NCT00746733|12932723|P1|COMPLETED|Fourth Intervention||10
5260881|NCT00746733|12932722|P2|STARTED|Fourth Intervention||11
5260882|NCT00746733|12932723|P1|STARTED|Fourth Intervention||10
5260883|NCT00746733|12932722|P2|NOT COMPLETED|Third Intervention||1
5260884|NCT00746733|12932723|P1|NOT COMPLETED|Third Intervention||1
5260885|NCT00746733|12932722|P2|COMPLETED|Third Intervention||11
5260886|NCT00746733|12932723|P1|COMPLETED|Third Intervention||10
5260887|NCT00746733|12932722|P2|STARTED|Third Intervention||12
5260888|NCT00746733|12932723|P1|STARTED|Third Intervention||11
5260889|NCT00746733|12932722|P2|NOT COMPLETED|Second Intervention||0
5260890|NCT00746733|12932723|P1|NOT COMPLETED|Second Intervention||1
5260891|NCT00746733|12932722|P2|COMPLETED|Second Intervention||12
5260892|NCT00746733|12932723|P1|COMPLETED|Second Intervention||11
5260893|NCT00746733|12932722|P2|STARTED|Second Intervention||12
5260894|NCT00746733|12932723|P1|STARTED|Second Intervention||12
5260895|NCT00746733|12932722|P2|NOT COMPLETED|First Intervention||0
5260896|NCT00746733|12932723|P1|NOT COMPLETED|First Intervention||0
5260897|NCT00746733|12932722|P2|COMPLETED|First Intervention||12
5260898|NCT00746733|12932723|P1|COMPLETED|First Intervention||12
5260899|NCT00746733|12932722|P2|STARTED|First Intervention||12
5260900|NCT00746733|12932723|P1|STARTED|First Intervention||12
5260901|NCT00746694|12932783|P1|NOT COMPLETED|Overall Study||0
5260902|NCT00746694|12932783|P1|COMPLETED|Overall Study||154
5260903|NCT00746694|12932783|P1|STARTED|Overall Study||154
5260904|NCT00746668|12932788|P7|NOT COMPLETED|Overall Study||0
5260905|NCT00746668|12932789|P6|NOT COMPLETED|Overall Study||0
5260906|NCT00746668|12932790|P5|NOT COMPLETED|Overall Study||0
5260907|NCT00746668|12932791|P4|NOT COMPLETED|Overall Study||0
5260908|NCT00746668|12932792|P3|NOT COMPLETED|Overall Study||0
5260909|NCT00746668|12932793|P2|NOT COMPLETED|Overall Study||0
5260910|NCT00746668|12932794|P1|NOT COMPLETED|Overall Study||0
5260911|NCT00746668|12932788|P7|COMPLETED|Overall Study||5
5260912|NCT00746668|12932789|P6|COMPLETED|Overall Study||5
5260913|NCT00746668|12932790|P5|COMPLETED|Overall Study||5
5260914|NCT00746668|12932791|P4|COMPLETED|Overall Study||5
5260915|NCT00746668|12932792|P3|COMPLETED|Overall Study||5
5260916|NCT00746668|12932793|P2|COMPLETED|Overall Study||5
5260917|NCT00746668|12932794|P1|COMPLETED|Overall Study||6
5260918|NCT00746668|12932788|P7|STARTED|Overall Study||5
5260919|NCT00746668|12932789|P6|STARTED|Overall Study||5
5260920|NCT00746668|12932790|P5|STARTED|Overall Study||5
5260921|NCT00746668|12932791|P4|STARTED|Overall Study||5
5260922|NCT00746668|12932792|P3|STARTED|Overall Study||5
5260923|NCT00746668|12932793|P2|STARTED|Overall Study||5
5260924|NCT00746668|12932794|P1|STARTED|Overall Study||6
5260925|NCT00746590|12932807|P1|NOT COMPLETED|Overall Study||1
5260926|NCT00746590|12932807|P1|COMPLETED|Overall Study||0
5260927|NCT00746590|12932807|P1|STARTED|Overall Study||1
5260928|NCT00746564|12932811|P1|NOT COMPLETED|Overall Study||2
5260929|NCT00746564|12932811|P1|COMPLETED|Overall Study||73
5260930|NCT00746564|12932811|P1|STARTED|Overall Study||75
5260931|NCT00746551|12932826|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
5260932|NCT00746551|12932827|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
5260933|NCT00746551|12932826|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
5260934|NCT00746551|12932827|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
5260935|NCT00746551|12932826|P2|STARTED|At Delivery (GA of 39 Weeks)||40
5260936|NCT00746551|12932827|P1|STARTED|At Delivery (GA of 39 Weeks)||40
5260937|NCT00746551|12932826|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
5260938|NCT00746551|12932827|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
5260939|NCT00746551|12932826|P2|COMPLETED|At Gestational Age of 36 Weeks||36
5260940|NCT00746551|12932827|P1|COMPLETED|At Gestational Age of 36 Weeks||38
5260941|NCT00746551|12932826|P2|STARTED|At Gestational Age of 36 Weeks||40
5260942|NCT00746551|12932827|P1|STARTED|At Gestational Age of 36 Weeks||40
5260943|NCT00746512|12932839|P4|NOT COMPLETED|Overall Study||0
5260944|NCT00746512|12932840|P3|NOT COMPLETED|Overall Study||0
5260945|NCT00746512|12932841|P2|NOT COMPLETED|Overall Study||0
5260946|NCT00746512|12932842|P1|NOT COMPLETED|Overall Study||0
5260947|NCT00746512|12932839|P4|COMPLETED|Overall Study||9
5260948|NCT00746512|12932840|P3|COMPLETED|Overall Study||18
5260949|NCT00746512|12932841|P2|COMPLETED|Overall Study||10
5260950|NCT00746512|12932842|P1|COMPLETED|Overall Study||8
5260951|NCT00746512|12932839|P4|STARTED|Overall Study||9
5260952|NCT00746512|12932840|P3|STARTED|Overall Study||18
5260953|NCT00746512|12932841|P2|STARTED|Overall Study||10
5260954|NCT00746512|12932842|P1|STARTED|Overall Study||8
5260955|NCT00746421|12932858|P2|NOT COMPLETED|Overall Study||2
5260956|NCT00746421|12932859|P1|NOT COMPLETED|Overall Study||7
5260957|NCT00746421|12932858|P2|COMPLETED|Overall Study||9
5260958|NCT00746421|12932859|P1|COMPLETED|Overall Study||5
5260959|NCT00746421|12932858|P2|STARTED|Overall Study||11
5260960|NCT00746421|12932859|P1|STARTED|Overall Study||12
5260961|NCT00746395|12932869|P2|NOT COMPLETED|Overall Study||0
5260962|NCT00746395|12932870|P1|NOT COMPLETED|Overall Study||0
5260963|NCT00746395|12932869|P2|COMPLETED|Overall Study||20
5260964|NCT00746395|12932870|P1|COMPLETED|Overall Study||20
5260965|NCT00746395|12932869|P2|STARTED|Overall Study||20
5260966|NCT00746395|12932870|P1|STARTED|Overall Study||20
5260967|NCT00746356|12932878|P2|NOT COMPLETED|Overall Study||7
5260968|NCT00746356|12932879|P1|NOT COMPLETED|Overall Study||11
5260969|NCT00746356|12932878|P2|COMPLETED|Overall Study||40
5260970|NCT00746356|12932879|P1|COMPLETED|Overall Study||70
5260971|NCT00746356|12932878|P2|STARTED|Overall Study||47
5260972|NCT00746356|12932879|P1|STARTED|Overall Study||81
5260973|NCT00746330|12932891|P4|NOT COMPLETED|Period 4||0
5260974|NCT00746330|12932892|P3|NOT COMPLETED|Period 4||0
5260975|NCT00746330|12932893|P2|NOT COMPLETED|Period 4||0
5260976|NCT00746330|12932894|P1|NOT COMPLETED|Period 4||0
5260977|NCT00746330|12932891|P4|COMPLETED|Period 4||7
5260978|NCT00746330|12932892|P3|COMPLETED|Period 4||8
5260979|NCT00746330|12932893|P2|COMPLETED|Period 4||9
5260980|NCT00746330|12932894|P1|COMPLETED|Period 4||7
5260981|NCT00746330|12932891|P4|STARTED|Period 4||7
5260982|NCT00746330|12932892|P3|STARTED|Period 4||8
5260983|NCT00746330|12932893|P2|STARTED|Period 4||9
5260984|NCT00746330|12932894|P1|STARTED|Period 4||7
5260985|NCT00746330|12932891|P4|NOT COMPLETED|Period 3||0
5260986|NCT00746330|12932892|P3|NOT COMPLETED|Period 3||0
5260987|NCT00746330|12932893|P2|NOT COMPLETED|Period 3||0
5260988|NCT00746330|12932894|P1|NOT COMPLETED|Period 3||0
5260989|NCT00746330|12932891|P4|COMPLETED|Period 3||7
5260990|NCT00746330|12932892|P3|COMPLETED|Period 3||8
5260991|NCT00746330|12932893|P2|COMPLETED|Period 3||9
5260992|NCT00746330|12932894|P1|COMPLETED|Period 3||7
5260993|NCT00746330|12932891|P4|STARTED|Period 3||7
5260994|NCT00746330|12932892|P3|STARTED|Period 3||8
5260995|NCT00746330|12932893|P2|STARTED|Period 3||9
5260996|NCT00746330|12932894|P1|STARTED|Period 3||7
5260997|NCT00746330|12932891|P4|NOT COMPLETED|Period 2||0
5260998|NCT00746330|12932892|P3|NOT COMPLETED|Period 2||0
5260999|NCT00746330|12932893|P2|NOT COMPLETED|Period 2||0
5261000|NCT00746330|12932894|P1|NOT COMPLETED|Period 2||0
5261001|NCT00746330|12932891|P4|COMPLETED|Period 2||7
5261002|NCT00746330|12932892|P3|COMPLETED|Period 2||8
5261003|NCT00746330|12932893|P2|COMPLETED|Period 2||9
5261004|NCT00746330|12932894|P1|COMPLETED|Period 2||7
5261005|NCT00746330|12932891|P4|STARTED|Period 2||7
5261006|NCT00746330|12932892|P3|STARTED|Period 2||8
5261007|NCT00746330|12932893|P2|STARTED|Period 2||9
5261008|NCT00746330|12932894|P1|STARTED|Period 2||7
5261009|NCT00746330|12932891|P4|NOT COMPLETED|Period 1||0
5261010|NCT00746330|12932892|P3|NOT COMPLETED|Period 1||1
5261011|NCT00746330|12932893|P2|NOT COMPLETED|Period 1||0
5261012|NCT00746330|12932894|P1|NOT COMPLETED|Period 1||0
5261013|NCT00746330|12932891|P4|COMPLETED|Period 1||7
5261014|NCT00746330|12932892|P3|COMPLETED|Period 1||8
5261015|NCT00746330|12932893|P2|COMPLETED|Period 1||9
5261016|NCT00746330|12932894|P1|COMPLETED|Period 1||7
5261017|NCT00746330|12932891|P4|STARTED|Period 1||7
5261018|NCT00746330|12932892|P3|STARTED|Period 1||9
5261019|NCT00746330|12932893|P2|STARTED|Period 1||9
5261020|NCT00746330|12932894|P1|STARTED|Period 1||7
5261021|NCT00746252|12932924|P2|NOT COMPLETED|Overall Study||2
5261022|NCT00746252|12932925|P1|NOT COMPLETED|Overall Study||1
5261023|NCT00746252|12932924|P2|COMPLETED|Overall Study||0
5261024|NCT00746252|12932925|P1|COMPLETED|Overall Study||0
5261025|NCT00746252|12932924|P2|STARTED|Overall Study||2
5261026|NCT00746252|12932925|P1|STARTED|Overall Study||1
5261027|NCT00746239|12932931|P1|NOT COMPLETED|Overall Study||6
5261028|NCT00746239|12932931|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
5261029|NCT00746239|12932931|P1|STARTED|Overall Study||11
5261030|NCT00746187|12932938|P2|NOT COMPLETED|Overall Study||2
5261031|NCT00746187|12932939|P1|NOT COMPLETED|Overall Study||3
5261032|NCT00746187|12932938|P2|COMPLETED|Overall Study||16
5261033|NCT00746187|12932939|P1|COMPLETED|Overall Study||15
5261034|NCT00746187|12932938|P2|STARTED|Overall Study||18
5261035|NCT00746187|12932939|P1|STARTED|Overall Study||18
5261036|NCT00746122|12932947|P2|NOT COMPLETED|Overall Study||0
5261037|NCT00746122|12932948|P1|NOT COMPLETED|Overall Study||0
5261038|NCT00746122|12932947|P2|COMPLETED|Overall Study||316
5261039|NCT00746122|12932948|P1|COMPLETED|Overall Study||297
5261040|NCT00746122|12932947|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
5261041|NCT00746122|12932948|P1|STARTED|Overall Study||297
5261042|NCT00746096|12932960|P2|NOT COMPLETED|Overall Study||3
5261043|NCT00746096|12932961|P1|NOT COMPLETED|Overall Study||10
5261044|NCT00746096|12932960|P2|COMPLETED|Overall Study||54
5261045|NCT00746096|12932961|P1|COMPLETED|Overall Study||48
5261046|NCT00746096|12932960|P2|STARTED|Overall Study||57
5261047|NCT00746096|12932961|P1|STARTED|Overall Study||58
5261048|NCT00746018|12932969|P1|NOT COMPLETED|Overall Study||0
5261049|NCT00746018|12932969|P1|COMPLETED|Overall Study||39
5261050|NCT00746018|12932969|P1|STARTED|Overall Study||39
5261051|NCT00745940|12932975|P2|NOT COMPLETED|Overall Study||10
5261052|NCT00745940|12932976|P1|NOT COMPLETED|Overall Study||19
5261053|NCT00745940|12932975|P2|COMPLETED|Overall Study||38
5261054|NCT00745940|12932976|P1|COMPLETED|Overall Study||38
5261055|NCT00745940|12932975|P2|STARTED|Overall Study||48
5261056|NCT00745940|12932976|P1|STARTED|Overall Study||57
5261057|NCT00745901|12932992|P2|NOT COMPLETED|Overall Study||21
5261058|NCT00745901|12932993|P1|NOT COMPLETED|Overall Study||24
5261059|NCT00745901|12932992|P2|COMPLETED|Overall Study||156
5261060|NCT00745901|12932993|P1|COMPLETED|Overall Study||154
5261061|NCT00745901|12932992|P2|STARTED|Overall Study|Number of Patients Randomized|177
5261062|NCT00745901|12932993|P1|STARTED|Overall Study|Number of Patients Randomized|178
5261063|NCT00745875|12933039|P2|NOT COMPLETED|Overall Study||4
5261064|NCT00745875|12933040|P1|NOT COMPLETED|Overall Study||4
5261065|NCT00745875|12933039|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
5261066|NCT00745875|12933040|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
5261151|NCT00745290|12933187|P1|STARTED|Overall Study||123
5261067|NCT00745875|12933039|P2|STARTED|Overall Study|Started – Number of patients randomised|30
5261068|NCT00745875|12933040|P1|STARTED|Overall Study|Started – Number of patients randomised|36
5261069|NCT00745849|12933048|P2|NOT COMPLETED|Second Intervention||1
5261070|NCT00745849|12933049|P1|NOT COMPLETED|Second Intervention||2
5261071|NCT00745849|12933048|P2|COMPLETED|Second Intervention||19
5261072|NCT00745849|12933049|P1|COMPLETED|Second Intervention||18
5261073|NCT00745849|12933048|P2|STARTED|Second Intervention||20
5261074|NCT00745849|12933049|P1|STARTED|Second Intervention||20
5261075|NCT00745849|12933048|P2|NOT COMPLETED|Washout Period||0
5261076|NCT00745849|12933049|P1|NOT COMPLETED|Washout Period||0
5261077|NCT00745849|12933048|P2|COMPLETED|Washout Period||20
5261078|NCT00745849|12933049|P1|COMPLETED|Washout Period||20
5261079|NCT00745849|12933048|P2|STARTED|Washout Period||20
5261080|NCT00745849|12933049|P1|STARTED|Washout Period||20
5261081|NCT00745849|12933048|P2|NOT COMPLETED|First Intervention||2
5261082|NCT00745849|12933049|P1|NOT COMPLETED|First Intervention||1
5261083|NCT00745849|12933048|P2|COMPLETED|First Intervention||20
5261084|NCT00745849|12933049|P1|COMPLETED|First Intervention||20
5261085|NCT00745849|12933048|P2|STARTED|First Intervention||22
5261086|NCT00745849|12933049|P1|STARTED|First Intervention||21
5261087|NCT00745823|12933057|P2|NOT COMPLETED|Overall Study||386
5261088|NCT00745823|12933058|P1|NOT COMPLETED|Overall Study||385
5261089|NCT00745823|12933057|P2|COMPLETED|Overall Study||3
5261090|NCT00745823|12933058|P1|COMPLETED|Overall Study||1
5261091|NCT00745823|12933057|P2|TREATED Week 0 - 96|Overall Study||388
5261092|NCT00745823|12933058|P1|TREATED Week 0 - 96|Overall Study||382
5261093|NCT00745823|12933057|P2|STARTED|Overall Study||389
5261094|NCT00745823|12933058|P1|STARTED|Overall Study||386
5261095|NCT00745615|12933086|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
5261096|NCT00745615|12933087|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
5261097|NCT00745615|12933088|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261098|NCT00745615|12933089|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261099|NCT00745615|12933090|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261100|NCT00745615|12933091|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261101|NCT00745615|12933086|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
5261102|NCT00745615|12933087|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
5261103|NCT00745615|12933088|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261104|NCT00745615|12933089|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261105|NCT00745615|12933090|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261106|NCT00745615|12933091|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
5261107|NCT00745615|12933086|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
5261108|NCT00745615|12933087|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
5261109|NCT00745615|12933088|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
5261110|NCT00745615|12933089|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
5261111|NCT00745615|12933090|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
5261112|NCT00745615|12933091|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
5261113|NCT00745615|12933086|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
5261114|NCT00745615|12933087|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
5261115|NCT00745615|12933088|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
5261116|NCT00745615|12933089|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
5261117|NCT00745615|12933090|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
5261118|NCT00745615|12933091|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
5261119|NCT00745615|12933086|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
5261120|NCT00745615|12933087|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
5261121|NCT00745615|12933088|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
5261122|NCT00745615|12933089|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
5261123|NCT00745615|12933090|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
5261124|NCT00745615|12933091|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
5261125|NCT00745615|12933086|P6|STARTED|Double-Blind Extension (36 Weeks)||0
5261126|NCT00745615|12933087|P5|STARTED|Double-Blind Extension (36 Weeks)||0
5261127|NCT00745615|12933088|P4|STARTED|Double-Blind Extension (36 Weeks)||44
5261128|NCT00745615|12933089|P3|STARTED|Double-Blind Extension (36 Weeks)||39
5261129|NCT00745615|12933090|P2|STARTED|Double-Blind Extension (36 Weeks)||94
5261130|NCT00745615|12933091|P1|STARTED|Double-Blind Extension (36 Weeks)||80
5261131|NCT00745498|12933140|P3|NOT COMPLETED|Overall Study||8
5261132|NCT00745498|12933141|P2|NOT COMPLETED|Overall Study||6
5261133|NCT00745498|12933142|P1|NOT COMPLETED|Overall Study||5
5261134|NCT00745498|12933140|P3|COMPLETED|Overall Study||34
5261135|NCT00745498|12933141|P2|COMPLETED|Overall Study||37
5261136|NCT00745498|12933142|P1|COMPLETED|Overall Study||36
5261137|NCT00745498|12933140|P3|STARTED|Overall Study||42
5261138|NCT00745498|12933141|P2|STARTED|Overall Study||43
5261139|NCT00745498|12933142|P1|STARTED|Overall Study||41
5261140|NCT00745420|12933156|P1|NOT COMPLETED|Overall Study||1
5261141|NCT00745420|12933156|P1|COMPLETED|Overall Study||29
5261142|NCT00745420|12933156|P1|STARTED|Overall Study||30
5261143|NCT00745368|12933173|P1|NOT COMPLETED|Overall Study||3
5261144|NCT00745368|12933173|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
5261145|NCT00745368|12933173|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
5261146|NCT00745290|12933186|P2|NOT COMPLETED|Overall Study||0
5261147|NCT00745290|12933187|P1|NOT COMPLETED|Overall Study||0
5261148|NCT00745290|12933186|P2|COMPLETED|Overall Study||122
5261149|NCT00745290|12933187|P1|COMPLETED|Overall Study||123
5261150|NCT00745290|12933186|P2|STARTED|Overall Study||122
5261152|NCT00745251|12933195|P2|NOT COMPLETED|Overall Study||3
5261153|NCT00745251|12933196|P1|NOT COMPLETED|Overall Study||2
5261154|NCT00745251|12933195|P2|COMPLETED|Overall Study||19
5261155|NCT00745251|12933196|P1|COMPLETED|Overall Study||21
5261156|NCT00745251|12933195|P2|STARTED|Overall Study||22
5261157|NCT00745251|12933196|P1|STARTED|Overall Study||23
5261158|NCT00745121|12933206|P2|NOT COMPLETED|Overall Study||2
5261159|NCT00745121|12933207|P1|NOT COMPLETED|Overall Study||9
5261160|NCT00745121|12933206|P2|COMPLETED|Overall Study||26
5261161|NCT00745121|12933207|P1|COMPLETED|Overall Study||11
5261162|NCT00745121|12933206|P2|STARTED|Overall Study||28
5261163|NCT00745121|12933207|P1|STARTED|Overall Study||20
5261164|NCT00745095|12933219|P6|NOT COMPLETED|Overall Study||123
5261165|NCT00745095|12933220|P5|NOT COMPLETED|Overall Study||122
5261166|NCT00745095|12933221|P4|NOT COMPLETED|Overall Study||3
5261167|NCT00745095|12933222|P3|NOT COMPLETED|Overall Study||3
5261168|NCT00745095|12933223|P2|NOT COMPLETED|Overall Study||2
5261169|NCT00745095|12933224|P1|NOT COMPLETED|Overall Study||1
5261170|NCT00745095|12933219|P6|COMPLETED|Overall Study||27
5261171|NCT00745095|12933220|P5|COMPLETED|Overall Study||28
5261172|NCT00745095|12933221|P4|COMPLETED|Overall Study||12
5261173|NCT00745095|12933222|P3|COMPLETED|Overall Study||12
5261174|NCT00745095|12933223|P2|COMPLETED|Overall Study||13
5261175|NCT00745095|12933224|P1|COMPLETED|Overall Study||14
5261176|NCT00745095|12933219|P6|STARTED|Overall Study||150
5261177|NCT00745095|12933220|P5|STARTED|Overall Study||150
5261178|NCT00745095|12933221|P4|STARTED|Overall Study||15
5261179|NCT00745095|12933222|P3|STARTED|Overall Study||15
5261180|NCT00745095|12933223|P2|STARTED|Overall Study||15
5261181|NCT00745095|12933224|P1|STARTED|Overall Study||15
5261182|NCT00745030|12933246|P2|NOT COMPLETED|Overall Study||0
5261183|NCT00745030|12933247|P1|NOT COMPLETED|Overall Study||0
5261184|NCT00745030|12933246|P2|COMPLETED|Overall Study||2
5261185|NCT00745030|12933247|P1|COMPLETED|Overall Study||1
5261186|NCT00745030|12933246|P2|STARTED|Overall Study||2
5261187|NCT00745030|12933247|P1|STARTED|Overall Study||1
5261188|NCT00744978|12933255|P2|NOT COMPLETED|Period 2||1
5261189|NCT00744978|12933256|P1|NOT COMPLETED|Period 2||0
5261190|NCT00744978|12933255|P2|COMPLETED|Period 2||28
5261191|NCT00744978|12933256|P1|COMPLETED|Period 2||26
5261192|NCT00744978|12933255|P2|STARTED|Period 2||29
5261193|NCT00744978|12933256|P1|STARTED|Period 2||26
5261194|NCT00744978|12933255|P2|NOT COMPLETED|Placebo Washout||0
5261195|NCT00744978|12933256|P1|NOT COMPLETED|Placebo Washout||0
5261196|NCT00744978|12933255|P2|COMPLETED|Placebo Washout||29
5261197|NCT00744978|12933256|P1|COMPLETED|Placebo Washout||26
5261198|NCT00744978|12933255|P2|STARTED|Placebo Washout||29
5261199|NCT00744978|12933256|P1|STARTED|Placebo Washout||26
5261200|NCT00744978|12933255|P2|NOT COMPLETED|Period 1||5
5261201|NCT00744978|12933256|P1|NOT COMPLETED|Period 1||6
5261202|NCT00744978|12933255|P2|COMPLETED|Period 1||29
5261203|NCT00744978|12933256|P1|COMPLETED|Period 1||26
5261204|NCT00744978|12933255|P2|Treated|Period 1||33
5261205|NCT00744978|12933256|P1|Treated|Period 1||31
5261206|NCT00744978|12933255|P2|STARTED|Period 1||34
5261207|NCT00744978|12933256|P1|STARTED|Period 1||32
5261208|NCT00744965|12933306|P2|NOT COMPLETED|Overall Study||9
5261209|NCT00744965|12933307|P1|NOT COMPLETED|Overall Study||11
5261210|NCT00744965|12933306|P2|COMPLETED|Overall Study||189
5261211|NCT00744965|12933307|P1|COMPLETED|Overall Study||186
5261212|NCT00744965|12933306|P2|STARTED|Overall Study||198
5261213|NCT00744965|12933307|P1|STARTED|Overall Study||197
5261214|NCT00744939|12933337|P1|NOT COMPLETED|Overall Study||91
5261215|NCT00744939|12933337|P1|COMPLETED|Overall Study||77
5261216|NCT00744939|12933337|P1|Treatment Received|Overall Study||141
5261217|NCT00744939|12933337|P1|STARTED|Overall Study||168
5261218|NCT00744874|12933373|P1|NOT COMPLETED|Overall Study||4
5261219|NCT00744874|12933373|P1|COMPLETED|Overall Study||51
5261220|NCT00744874|12933373|P1|STARTED|Overall Study||55
5261221|NCT00744848|12933391|P2|NOT COMPLETED|Overall Study||0
5261222|NCT00744848|12933392|P1|NOT COMPLETED|Overall Study||0
5261223|NCT00744848|12933391|P2|COMPLETED|Overall Study||101
5261224|NCT00744848|12933392|P1|COMPLETED|Overall Study||103
5261225|NCT00744848|12933391|P2|STARTED|Overall Study||101
5261226|NCT00744848|12933392|P1|STARTED|Overall Study||103
5261227|NCT00744757|12933398|P1|NOT COMPLETED|Overall Study||21
5261228|NCT00744757|12933398|P1|COMPLETED|Overall Study||16
5261229|NCT00744757|12933398|P1|STARTED|Overall Study||37
5261230|NCT00744692|12933411|P1|NOT COMPLETED|Overall Study||0
5261231|NCT00744692|12933411|P1|COMPLETED|Overall Study||22
5261232|NCT00744692|12933411|P1|STARTED|Overall Study||22
5261233|NCT00744653|12933423|P1|NOT COMPLETED|Overall Study||16
5261234|NCT00744653|12933423|P1|COMPLETED|Overall Study||1
5261235|NCT00744653|12933423|P1|STARTED|Overall Study||17
5261236|NCT00744627|12933431|P2|NOT COMPLETED|Overall Study||22
5261237|NCT00744627|12933432|P1|NOT COMPLETED|Overall Study||25
5261238|NCT00744627|12933431|P2|COMPLETED|Overall Study||128
5261239|NCT00744627|12933432|P1|COMPLETED|Overall Study||126
5261240|NCT00744627|12933431|P2|Treated|Overall Study||150
5261241|NCT00744627|12933432|P1|Treated|Overall Study||150
5261242|NCT00744627|12933431|P2|STARTED|Overall Study||150
5261243|NCT00744627|12933432|P1|STARTED|Overall Study||151
5261244|NCT00744523|12933488|P2|NOT COMPLETED|30 Days After the Procedure||5
5261245|NCT00744523|12933489|P1|NOT COMPLETED|30 Days After the Procedure||0
5261246|NCT00744523|12933488|P2|COMPLETED|30 Days After the Procedure||220
5261247|NCT00744523|12933489|P1|COMPLETED|30 Days After the Procedure||37
5261248|NCT00744523|12933488|P2|STARTED|30 Days After the Procedure||225
5261249|NCT00744523|12933489|P1|STARTED|30 Days After the Procedure||37
5261250|NCT00744523|12933488|P2|NOT COMPLETED|Procedure||0
5261251|NCT00744523|12933489|P1|NOT COMPLETED|Procedure||0
5261252|NCT00744523|12933488|P2|COMPLETED|Procedure||225
5261253|NCT00744523|12933489|P1|COMPLETED|Procedure||37
5261254|NCT00744523|12933488|P2|STARTED|Procedure||225
5261255|NCT00744523|12933489|P1|STARTED|Procedure||37
5261256|NCT00744497|12933509|P2|NOT COMPLETED|Overall Study||762
5261257|NCT00744497|12933510|P1|NOT COMPLETED|Overall Study||760
5261258|NCT00744497|12933509|P2|COMPLETED|Overall Study||0
5261259|NCT00744497|12933510|P1|COMPLETED|Overall Study||0
5261260|NCT00744497|12933509|P2|Received Treatment|Overall Study||761
5261261|NCT00744497|12933510|P1|Received Treatment|Overall Study||757
5261262|NCT00744497|12933509|P2|STARTED|Overall Study|Randomized|762
5261263|NCT00744497|12933510|P1|STARTED|Overall Study|Randomized|760
5261264|NCT00744380|12933546|P2|NOT COMPLETED|Overall Study||0
5261265|NCT00744380|12933547|P1|NOT COMPLETED|Overall Study||0
5261266|NCT00744380|12933546|P2|COMPLETED|Overall Study||11
5261267|NCT00744380|12933547|P1|COMPLETED|Overall Study||12
5261268|NCT00744380|12933546|P2|STARTED|Overall Study||11
5261269|NCT00744380|12933547|P1|STARTED|Overall Study||12
5261270|NCT00744328|12933570|P3|NOT COMPLETED|Overall Study||8
5261271|NCT00744328|12933571|P2|NOT COMPLETED|Overall Study||8
5261272|NCT00744328|12933572|P1|NOT COMPLETED|Overall Study||7
5261273|NCT00744328|12933570|P3|COMPLETED|Overall Study||21
5261274|NCT00744328|12933571|P2|COMPLETED|Overall Study||22
5261275|NCT00744328|12933572|P1|COMPLETED|Overall Study||19
5261276|NCT00744328|12933570|P3|STARTED|Overall Study||29
5261277|NCT00744328|12933571|P2|STARTED|Overall Study||30
5261278|NCT00744328|12933572|P1|STARTED|Overall Study||26
5261279|NCT00744263|12933585|P2|NOT COMPLETED|Overall Study||5320
5261280|NCT00744263|12933586|P1|NOT COMPLETED|Overall Study||5236
5261281|NCT00744263|12933585|P2|COMPLETED|Overall Study||36936
5261282|NCT00744263|12933586|P1|COMPLETED|Overall Study||37004
5261283|NCT00744263|12933585|P2|STARTED|Overall Study||42256
5261284|NCT00744263|12933586|P1|STARTED|Overall Study||42240
5261285|NCT00744237|12933609|P3|NOT COMPLETED|Overall Study||15
5261286|NCT00744237|12933610|P2|NOT COMPLETED|Overall Study||27
5261287|NCT00744237|12933611|P1|NOT COMPLETED|Overall Study||27
5261288|NCT00744237|12933609|P3|COMPLETED|Overall Study||59
5261289|NCT00744237|12933610|P2|COMPLETED|Overall Study||46
5261290|NCT00744237|12933611|P1|COMPLETED|Overall Study||56
5261291|NCT00744237|12933609|P3|STARTED|Overall Study||74
5261292|NCT00744237|12933610|P2|STARTED|Overall Study||73
5261293|NCT00744237|12933611|P1|STARTED|Overall Study||83
5261294|NCT00744211|12933625|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
5261295|NCT00744211|12933626|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
5261296|NCT00744211|12933627|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
5261297|NCT00744211|12933625|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
5261298|NCT00744211|12933626|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
5261299|NCT00744211|12933627|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
5261300|NCT00744211|12933625|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
5261301|NCT00744211|12933626|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
5261302|NCT00744211|12933627|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
5261303|NCT00744211|12933625|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
5261304|NCT00744211|12933626|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
5261305|NCT00744211|12933627|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
5261306|NCT00744211|12933625|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
5261307|NCT00744211|12933626|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
5261308|NCT00744211|12933627|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
5261309|NCT00744211|12933625|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
5261310|NCT00744211|12933626|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
5261311|NCT00744211|12933627|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
5261312|NCT00744211|12933625|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
5261313|NCT00744211|12933626|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
5261314|NCT00744211|12933627|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
5261315|NCT00744211|12933625|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
5261316|NCT00744211|12933626|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
5261317|NCT00744211|12933627|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
5261318|NCT00744211|12933625|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
5261319|NCT00744211|12933626|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
5261320|NCT00744211|12933627|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
5261321|NCT00744211|12933625|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
5261322|NCT00744211|12933626|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
5261323|NCT00744211|12933627|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
5261324|NCT00744211|12933625|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
5261325|NCT00744211|12933626|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
5261326|NCT00744211|12933627|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
5261327|NCT00744211|12933625|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
5261328|NCT00744211|12933626|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
5261329|NCT00744211|12933627|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
5261330|NCT00744211|12933625|P3|NOT COMPLETED|Baseline||0
5261331|NCT00744211|12933626|P2|NOT COMPLETED|Baseline||0
5261332|NCT00744211|12933627|P1|NOT COMPLETED|Baseline||0
5261333|NCT00744211|12933625|P3|COMPLETED|Baseline||10
5261334|NCT00744211|12933626|P2|COMPLETED|Baseline||9
5261335|NCT00744211|12933627|P1|COMPLETED|Baseline||10
5261336|NCT00744211|12933625|P3|STARTED|Baseline||10
5261337|NCT00744211|12933626|P2|STARTED|Baseline||9
5261338|NCT00744211|12933627|P1|STARTED|Baseline||10
5261339|NCT00744055|12933645|P2|NOT COMPLETED|Overall Study||14
5261340|NCT00744055|12933646|P1|NOT COMPLETED|Overall Study||7
5261341|NCT00744055|12933645|P2|COMPLETED|Overall Study||32
5261342|NCT00744055|12933646|P1|COMPLETED|Overall Study||43
5261343|NCT00744055|12933645|P2|STARTED|Overall Study||46
5261344|NCT00744055|12933646|P1|STARTED|Overall Study||50
5261345|NCT00744042|12933654|P1|NOT COMPLETED|Overall Study||1
5261346|NCT00744042|12933654|P1|COMPLETED|Overall Study||10
5261347|NCT00744042|12933654|P1|STARTED|Overall Study||11
5261348|NCT00743730|12933670|P3|NOT COMPLETED|Overall Study||5
5261349|NCT00743730|12933671|P2|NOT COMPLETED|Overall Study||4
5261350|NCT00743730|12933672|P1|NOT COMPLETED|Overall Study||5
5261351|NCT00743730|12933670|P3|COMPLETED|Overall Study||28
5261352|NCT00743730|12933671|P2|COMPLETED|Overall Study||30
5261353|NCT00743730|12933672|P1|COMPLETED|Overall Study||22
5261354|NCT00743730|12933670|P3|STARTED|Overall Study||33
5261355|NCT00743730|12933671|P2|STARTED|Overall Study||34
5261356|NCT00743730|12933672|P1|STARTED|Overall Study||27
5261357|NCT00743717|12933688|P2|NOT COMPLETED|Overall Study||0
5261358|NCT00743717|12933689|P1|NOT COMPLETED|Overall Study||0
5261359|NCT00743717|12933688|P2|COMPLETED|Overall Study||2
5261360|NCT00743717|12933689|P1|COMPLETED|Overall Study||2
5261361|NCT00743717|12933688|P2|STARTED|Overall Study||2
5261362|NCT00743717|12933689|P1|STARTED|Overall Study||2
5261363|NCT00743652|12933700|P5|NOT COMPLETED|Overall Study||0
5261364|NCT00743652|12933701|P4|NOT COMPLETED|Overall Study||4
5261365|NCT00743652|12933702|P3|NOT COMPLETED|Overall Study||2
5261366|NCT00743652|12933703|P2|NOT COMPLETED|Overall Study||3
5261367|NCT00743652|12933704|P1|NOT COMPLETED|Overall Study||10
5261368|NCT00743652|12933700|P5|COMPLETED|Overall Study||79
5261369|NCT00743652|12933701|P4|COMPLETED|Overall Study||63
5261370|NCT00743652|12933702|P3|COMPLETED|Overall Study||23
5261371|NCT00743652|12933703|P2|COMPLETED|Overall Study||48
5261372|NCT00743652|12933704|P1|COMPLETED|Overall Study||141
5261373|NCT00743652|12933700|P5|Toddler Dose|Overall Study||0
5261374|NCT00743652|12933701|P4|Toddler Dose|Overall Study||0
5261375|NCT00743652|12933702|P3|Toddler Dose|Overall Study||16
5261376|NCT00743652|12933703|P2|Toddler Dose|Overall Study||23
5261377|NCT00743652|12933704|P1|Toddler Dose|Overall Study||15
5261378|NCT00743652|12933700|P5|Vaccinated Dose 3|Overall Study||0
5261379|NCT00743652|12933701|P4|Vaccinated Dose 3|Overall Study||0
5261380|NCT00743652|12933702|P3|Vaccinated Dose 3|Overall Study||0
5261381|NCT00743652|12933703|P2|Vaccinated Dose 3|Overall Study||0
5261382|NCT00743652|12933704|P1|Vaccinated Dose 3|Overall Study||74
5261383|NCT00743652|12933700|P5|Vaccinated Dose 2|Overall Study||0
5261384|NCT00743652|12933701|P4|Vaccinated Dose 2|Overall Study||49
5261385|NCT00743652|12933702|P3|Vaccinated Dose 2|Overall Study||0
5261386|NCT00743652|12933703|P2|Vaccinated Dose 2|Overall Study||41
5261387|NCT00743652|12933704|P1|Vaccinated Dose 2|Overall Study||112
5261388|NCT00743652|12933700|P5|Vaccinated Dose 1|Overall Study||79
5261389|NCT00743652|12933701|P4|Vaccinated Dose 1|Overall Study||66
5261390|NCT00743652|12933702|P3|Vaccinated Dose 1|Overall Study||25
5261391|NCT00743652|12933703|P2|Vaccinated Dose 1|Overall Study||51
5261392|NCT00743652|12933704|P1|Vaccinated Dose 1|Overall Study||151
5261393|NCT00743652|12933700|P5|STARTED|Overall Study||79
5261394|NCT00743652|12933701|P4|STARTED|Overall Study||67
5261395|NCT00743652|12933702|P3|STARTED|Overall Study||25
5261396|NCT00743652|12933703|P2|STARTED|Overall Study||51
5261397|NCT00743652|12933704|P1|STARTED|Overall Study||151
5261398|NCT00743574|12933779|P1|NOT COMPLETED|Overall Study||24
5261399|NCT00743574|12933779|P1|COMPLETED|Overall Study||12
5261400|NCT00743574|12933779|P1|Dropped Out After Initiating Trial|Overall Study||3
5261401|NCT00743574|12933779|P1|Further Exclusions|Overall Study||8
5261402|NCT00743574|12933779|P1|Dropped Out Before Eligibility Testing|Overall Study||13
5261403|NCT00743574|12933779|P1|STARTED|Overall Study||36
5261404|NCT00743509|12933788|P1|NOT COMPLETED|Overall Study||2
5261405|NCT00743509|12933788|P1|COMPLETED|Overall Study||47
5261406|NCT00743509|12933788|P1|STARTED|Overall Study||49
5261407|NCT00743483|12933793|P1|NOT COMPLETED|Treatment Period||1
5261408|NCT00743483|12933793|P1|COMPLETED|Treatment Period||13
5261409|NCT00743483|12933793|P1|STARTED|Treatment Period||14
5261410|NCT00743483|12933793|P1|NOT COMPLETED|Baseline Period||1
5261411|NCT00743483|12933793|P1|COMPLETED|Baseline Period||14
5261412|NCT00743483|12933793|P1|STARTED|Baseline Period||15
5261413|NCT00743444|12933797|P2|NOT COMPLETED|Second Intervention||0
5261414|NCT00743444|12933798|P1|NOT COMPLETED|Second Intervention||0
5261415|NCT00743444|12933797|P2|COMPLETED|Second Intervention||11
5261416|NCT00743444|12933798|P1|COMPLETED|Second Intervention||14
5261417|NCT00743444|12933797|P2|STARTED|Second Intervention||11
5261418|NCT00743444|12933798|P1|STARTED|Second Intervention||14
5261419|NCT00743444|12933797|P2|NOT COMPLETED|Washout Period||1
5261420|NCT00743444|12933798|P1|NOT COMPLETED|Washout Period||0
5261421|NCT00743444|12933797|P2|COMPLETED|Washout Period||11
5261422|NCT00743444|12933798|P1|COMPLETED|Washout Period||14
5261423|NCT00743444|12933797|P2|STARTED|Washout Period||12
5261424|NCT00743444|12933798|P1|STARTED|Washout Period||14
5261425|NCT00743444|12933797|P2|NOT COMPLETED|First Intervention||1
5261426|NCT00743444|12933798|P1|NOT COMPLETED|First Intervention||0
5261427|NCT00743444|12933797|P2|COMPLETED|First Intervention||12
5261428|NCT00743444|12933798|P1|COMPLETED|First Intervention||14
5261429|NCT00743444|12933797|P2|STARTED|First Intervention||13
5261430|NCT00743444|12933798|P1|STARTED|First Intervention||14
5261431|NCT00743431|12933807|P1|NOT COMPLETED|Overall Study||126
5261432|NCT00743431|12933807|P1|COMPLETED|Overall Study||98
5261433|NCT00743431|12933807|P1|STARTED|Overall Study||224
5261434|NCT00743366|12933811|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
5261435|NCT00743366|12933812|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
5261436|NCT00743366|12933811|P2|COMPLETED|Intervention 2 (8 Days)||7
5261437|NCT00743366|12933812|P1|COMPLETED|Intervention 2 (8 Days)||7
5261438|NCT00743366|12933811|P2|STARTED|Intervention 2 (8 Days)||7
5261439|NCT00743366|12933812|P1|STARTED|Intervention 2 (8 Days)||7
5261440|NCT00743366|12933811|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
5261441|NCT00743366|12933812|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
5261442|NCT00743366|12933811|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
5261443|NCT00743366|12933812|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
5261444|NCT00743366|12933811|P2|STARTED|Intervention 1 (8 Days)||10
5261445|NCT00743366|12933812|P1|STARTED|Intervention 1 (8 Days)||10
5261446|NCT00743340|12933818|P1|NOT COMPLETED|Overall Study||41
5261447|NCT00743340|12933818|P1|COMPLETED|Overall Study||9
5261448|NCT00743340|12933818|P1|STARTED|Overall Study||50
5261449|NCT00743288|12933822|P7|NOT COMPLETED|Overall Study||9
5261450|NCT00743288|12933823|P6|NOT COMPLETED|Overall Study||5
5261451|NCT00743288|12933824|P5|NOT COMPLETED|Overall Study||6
5261452|NCT00743288|12933825|P4|NOT COMPLETED|Overall Study||7
5261453|NCT00743288|12933826|P3|NOT COMPLETED|Overall Study||5
5261454|NCT00743288|12933827|P2|NOT COMPLETED|Overall Study||3
5261455|NCT00743288|12933828|P1|NOT COMPLETED|Overall Study||3
5261456|NCT00743288|12933822|P7|COMPLETED|Overall Study||0
5261457|NCT00743288|12933823|P6|COMPLETED|Overall Study||1
5261458|NCT00743288|12933824|P5|COMPLETED|Overall Study||0
5261459|NCT00743288|12933825|P4|COMPLETED|Overall Study||0
5261460|NCT00743288|12933826|P3|COMPLETED|Overall Study||1
5261461|NCT00743288|12933827|P2|COMPLETED|Overall Study||0
5261462|NCT00743288|12933828|P1|COMPLETED|Overall Study||0
5261463|NCT00743288|12933822|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
5261464|NCT00743288|12933823|P6|STARTED|Overall Study||6
5261465|NCT00743288|12933824|P5|STARTED|Overall Study||6
5261466|NCT00743288|12933825|P4|STARTED|Overall Study||7
5261467|NCT00743288|12933826|P3|STARTED|Overall Study||6
5261468|NCT00743288|12933827|P2|STARTED|Overall Study||3
5261469|NCT00743288|12933828|P1|STARTED|Overall Study||3
5261470|NCT00743275|12933842|P2|NOT COMPLETED|Overall Study||1
5261471|NCT00743275|12933843|P1|NOT COMPLETED|Overall Study||0
5261472|NCT00743275|12933842|P2|COMPLETED|Overall Study||60
5261473|NCT00743275|12933843|P1|COMPLETED|Overall Study||59
5261474|NCT00743275|12933842|P2|STARTED|Overall Study||61
5261475|NCT00743275|12933843|P1|STARTED|Overall Study||59
5261476|NCT00743262|12933855|P1|NOT COMPLETED|Overall Study||0
5261477|NCT00743262|12933855|P1|COMPLETED|Overall Study||15
5261478|NCT00743262|12933855|P1|STARTED|Overall Study||15
5261479|NCT00743249|12933863|P2|NOT COMPLETED|Overall Study||6
5261480|NCT00743249|12933864|P1|NOT COMPLETED|Overall Study||2
5261481|NCT00743249|12933863|P2|COMPLETED|Overall Study||24
5261482|NCT00743249|12933864|P1|COMPLETED|Overall Study||28
5261483|NCT00743249|12933863|P2|STARTED|Overall Study||30
5261484|NCT00743249|12933864|P1|STARTED|Overall Study||30
5261485|NCT00743197|12933874|P2|NOT COMPLETED|Overall Study||2
5261486|NCT00743197|12933875|P1|NOT COMPLETED|Overall Study||1
5261487|NCT00743197|12933874|P2|COMPLETED|Overall Study||0
5261488|NCT00743197|12933875|P1|COMPLETED|Overall Study||0
5261489|NCT00743197|12933874|P2|STARTED|Overall Study||2
5261490|NCT00743197|12933875|P1|STARTED|Overall Study||1
5261491|NCT00743145|12933881|P1|NOT COMPLETED|Overall Study||4
5261492|NCT00743145|12933881|P1|COMPLETED|Overall Study||19
5261493|NCT00743145|12933881|P1|STARTED|Overall Study||23
5261494|NCT00743119|12933895|P1|NOT COMPLETED|Overall Study||4
5261495|NCT00743119|12933895|P1|COMPLETED|Overall Study||30
5261496|NCT00743119|12933895|P1|STARTED|Overall Study||34
5261497|NCT00743106|12933909|P2|NOT COMPLETED|Overall Study||5
5261498|NCT00743106|12933910|P1|NOT COMPLETED|Overall Study||8
5261499|NCT00743106|12933909|P2|COMPLETED|Overall Study||43
5261500|NCT00743106|12933910|P1|COMPLETED|Overall Study||34
5261501|NCT00743106|12933909|P2|STARTED|Overall Study||48
5261502|NCT00743106|12933910|P1|STARTED|Overall Study||42
5261503|NCT00743093|12933920|P2|NOT COMPLETED|Extended Dosing Period||0
5261504|NCT00743093|12933921|P1|NOT COMPLETED|Extended Dosing Period||3
5261505|NCT00743093|12933920|P2|COMPLETED|Extended Dosing Period||1
5261506|NCT00743093|12933921|P1|COMPLETED|Extended Dosing Period||48
5261507|NCT00743093|12933920|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
5261508|NCT00743093|12933921|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
5261509|NCT00743093|12933920|P2|NOT COMPLETED|Base Study Period||5
5261510|NCT00743093|12933921|P1|NOT COMPLETED|Base Study Period||19
5261511|NCT00743093|12933920|P2|COMPLETED|Base Study Period||47
5261512|NCT00743093|12933921|P1|COMPLETED|Base Study Period||205
5261513|NCT00743093|12933920|P2|STARTED|Base Study Period||52
5261514|NCT00743093|12933921|P1|STARTED|Base Study Period||224
5261515|NCT00742963|12933929|P1|NOT COMPLETED|Overall Study||33
5261516|NCT00742963|12933929|P1|COMPLETED|Overall Study||68
5261517|NCT00742963|12933929|P1|Completed All Treatment Cycles|Overall Study||68
5261518|NCT00742963|12933929|P1|STARTED|Overall Study||101
5261519|NCT00742924|12933937|P4|NOT COMPLETED|Overall Study||6
5261520|NCT00742924|12933938|P3|NOT COMPLETED|Overall Study||4
5261521|NCT00742924|12933939|P2|NOT COMPLETED|Overall Study||2
5261522|NCT00742924|12933940|P1|NOT COMPLETED|Overall Study||5
5261523|NCT00742924|12933937|P4|COMPLETED|Overall Study||0
5261524|NCT00742924|12933938|P3|COMPLETED|Overall Study||2
5261525|NCT00742924|12933939|P2|COMPLETED|Overall Study||4
5261526|NCT00742924|12933940|P1|COMPLETED|Overall Study||1
5261527|NCT00742924|12933937|P4|STARTED|Overall Study||6
5261528|NCT00742924|12933938|P3|STARTED|Overall Study||6
5261529|NCT00742924|12933939|P2|STARTED|Overall Study||6
5261530|NCT00742924|12933940|P1|STARTED|Overall Study||6
5261531|NCT00742885|12933952|P2|NOT COMPLETED|Overall Study||0
5261532|NCT00742885|12933953|P1|NOT COMPLETED|Overall Study||1
5261533|NCT00742885|12933952|P2|COMPLETED|Overall Study|to Day 182|50
5261534|NCT00742885|12933953|P1|COMPLETED|Overall Study|to Day 182|49
5261535|NCT00742885|12933952|P2|STARTED|Overall Study||50
5261536|NCT00742885|12933953|P1|STARTED|Overall Study||50
5261537|NCT00742872|12934001|P2|NOT COMPLETED|Overall Study||8
5261538|NCT00742872|12934002|P1|NOT COMPLETED|Overall Study||12
5261539|NCT00742872|12934001|P2|COMPLETED|Overall Study||12
5261540|NCT00742872|12934002|P1|COMPLETED|Overall Study||9
5261541|NCT00742872|12934001|P2|STARTED|Overall Study||20
5261542|NCT00742872|12934002|P1|STARTED|Overall Study||21
5261543|NCT00742859|12934012|P4|NOT COMPLETED|Overall Study||8
5261544|NCT00742859|12934013|P3|NOT COMPLETED|Overall Study||11
5261545|NCT00742859|12934014|P2|NOT COMPLETED|Overall Study||12
5261546|NCT00742859|12934015|P1|NOT COMPLETED|Overall Study||11
5261547|NCT00742859|12934012|P4|COMPLETED|Overall Study||119
5261548|NCT00742859|12934013|P3|COMPLETED|Overall Study||116
5261549|NCT00742859|12934014|P2|COMPLETED|Overall Study||115
5261550|NCT00742859|12934015|P1|COMPLETED|Overall Study||116
5261551|NCT00742859|12934012|P4|STARTED|Overall Study||127
5261552|NCT00742859|12934013|P3|STARTED|Overall Study||127
5261553|NCT00742859|12934014|P2|STARTED|Overall Study||127
5261554|NCT00742859|12934015|P1|STARTED|Overall Study||127
5261555|NCT00742781|12934029|P1|NOT COMPLETED|Overall Study||3
5261556|NCT00742781|12934029|P1|COMPLETED|Overall Study||18
5261557|NCT00742781|12934029|P1|STARTED|Overall Study||21
5261558|NCT00742625|12934038|P1|NOT COMPLETED|Consolidation||21
5261559|NCT00742625|12934038|P1|COMPLETED|Consolidation||20
5261560|NCT00742625|12934038|P1|STARTED|Consolidation||41
5261561|NCT00742625|12934038|P1|NOT COMPLETED|Remission Induction||54
5261562|NCT00742625|12934038|P1|COMPLETED|Remission Induction||41
5261563|NCT00742625|12934038|P1|STARTED|Remission Induction||95
5261564|NCT00742573|12934049|P2|NOT COMPLETED|Overall Study||62
5261565|NCT00742573|12934050|P1|NOT COMPLETED|Overall Study||57
5261566|NCT00742573|12934049|P2|COMPLETED|Overall Study||25
5261567|NCT00742573|12934050|P1|COMPLETED|Overall Study||26
5261568|NCT00742573|12934049|P2|Week 52|Overall Study||25
5261569|NCT00742573|12934050|P1|Week 52|Overall Study||26
5261570|NCT00742573|12934049|P2|Week 24|Overall Study||37
5261571|NCT00742573|12934050|P1|Week 24|Overall Study||39
5261572|NCT00742573|12934049|P2|Week 12|Overall Study||51
5261573|NCT00742573|12934050|P1|Week 12|Overall Study||46
5261574|NCT00742573|12934049|P2|STARTED|Overall Study||87
5261575|NCT00742573|12934050|P1|STARTED|Overall Study||83
5261576|NCT00742560|12934063|P5|NOT COMPLETED|Overall Study||37
5261577|NCT00742560|12934064|P4|NOT COMPLETED|Overall Study||36
5261578|NCT00742560|12934065|P3|NOT COMPLETED|Overall Study||22
5261579|NCT00742560|12934066|P2|NOT COMPLETED|Overall Study||3
5261580|NCT00742560|12934067|P1|NOT COMPLETED|Overall Study||3
5261581|NCT00742560|12934063|P5|COMPLETED|Overall Study||0
5261582|NCT00742560|12934064|P4|COMPLETED|Overall Study||0
5261583|NCT00742560|12934065|P3|COMPLETED|Overall Study||0
5261584|NCT00742560|12934066|P2|COMPLETED|Overall Study||0
5261585|NCT00742560|12934067|P1|COMPLETED|Overall Study||0
5261586|NCT00742560|12934063|P5|STARTED|Overall Study||37
5261587|NCT00742560|12934064|P4|STARTED|Overall Study||36
5261588|NCT00742560|12934065|P3|STARTED|Overall Study||22
5261589|NCT00742560|12934066|P2|STARTED|Overall Study||3
5261590|NCT00742560|12934067|P1|STARTED|Overall Study||3
5261591|NCT00742508|12934141|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
5261592|NCT00742508|12934142|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
5261593|NCT00742508|12934141|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
5261594|NCT00742508|12934142|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
5261595|NCT00742508|12934141|P2|STARTED|4-Week Exploratory Evaluation Period||8
5261596|NCT00742508|12934142|P1|STARTED|4-Week Exploratory Evaluation Period||0
5261597|NCT00742508|12934141|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
5261598|NCT00742508|12934142|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
5261599|NCT00742508|12934141|P2|COMPLETED|8-Week Primary Evaluation Period||8
5261600|NCT00742508|12934142|P1|COMPLETED|8-Week Primary Evaluation Period||11
5261601|NCT00742508|12934141|P2|STARTED|8-Week Primary Evaluation Period||19
5261602|NCT00742508|12934142|P1|STARTED|8-Week Primary Evaluation Period||22
5261603|NCT00742469|12934206|P2|NOT COMPLETED|Overall Study||35
5261604|NCT00742469|12934207|P1|NOT COMPLETED|Overall Study||18
5261605|NCT00742469|12934206|P2|COMPLETED|Overall Study||69
5261606|NCT00742469|12934207|P1|COMPLETED|Overall Study||88
5261607|NCT00742469|12934206|P2|STARTED|Overall Study||104
5261608|NCT00742469|12934207|P1|STARTED|Overall Study||106
5261609|NCT00742417|12934215|P2|NOT COMPLETED|Maintenance II||0
5261610|NCT00742417|12934216|P1|NOT COMPLETED|Maintenance II||0
5261611|NCT00742417|12934215|P2|COMPLETED|Maintenance II||19
5261612|NCT00742417|12934216|P1|COMPLETED|Maintenance II||16
5261613|NCT00742417|12934215|P2|STARTED|Maintenance II||19
5261614|NCT00742417|12934216|P1|STARTED|Maintenance II||16
5261615|NCT00742417|12934215|P2|NOT COMPLETED|Maintenance I||0
5261616|NCT00742417|12934216|P1|NOT COMPLETED|Maintenance I||0
5261617|NCT00742417|12934215|P2|COMPLETED|Maintenance I||19
5261618|NCT00742417|12934216|P1|COMPLETED|Maintenance I||16
5261619|NCT00742417|12934215|P2|STARTED|Maintenance I||19
5261620|NCT00742417|12934216|P1|STARTED|Maintenance I||16
5261621|NCT00742417|12934215|P2|NOT COMPLETED|Intensive Period||1
5261622|NCT00742417|12934216|P1|NOT COMPLETED|Intensive Period||3
5261623|NCT00742417|12934215|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
5261624|NCT00742417|12934216|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
5261625|NCT00742417|12934215|P2|STARTED|Intensive Period||20
5261626|NCT00742417|12934216|P1|STARTED|Intensive Period||19
5261627|NCT00742417|12934215|P2|NOT COMPLETED|Randomized||1
5261628|NCT00742417|12934216|P1|NOT COMPLETED|Randomized||2
5261629|NCT00742417|12934215|P2|COMPLETED|Randomized||20
5261630|NCT00742417|12934216|P1|COMPLETED|Randomized||19
5261631|NCT00742417|12934215|P2|STARTED|Randomized||21
5261632|NCT00742417|12934216|P1|STARTED|Randomized||21
5261633|NCT00742391|12934240|P2|NOT COMPLETED|Overall Study||1
5261634|NCT00742391|12934241|P1|NOT COMPLETED|Overall Study||4
5261635|NCT00742391|12934240|P2|COMPLETED|Overall Study||128
5261636|NCT00742391|12934241|P1|COMPLETED|Overall Study||122
5261637|NCT00742391|12934240|P2|STARTED|Overall Study||129
5261638|NCT00742391|12934241|P1|STARTED|Overall Study||126
5261639|NCT00742326|12934251|P2|NOT COMPLETED|Overall Study||1
5261640|NCT00742326|12934252|P1|NOT COMPLETED|Overall Study||0
5261641|NCT00742326|12934251|P2|COMPLETED|Overall Study||6
5261642|NCT00742326|12934252|P1|COMPLETED|Overall Study||6
5261643|NCT00742326|12934251|P2|STARTED|Overall Study||7
5261644|NCT00742326|12934252|P1|STARTED|Overall Study||6
5261645|NCT00742313|12934262|P2|NOT COMPLETED|Overall Study||0
5261646|NCT00742313|12934263|P1|NOT COMPLETED|Overall Study||1
5261647|NCT00742313|12934262|P2|COMPLETED|Overall Study||19
5261648|NCT00742313|12934263|P1|COMPLETED|Overall Study||24
5261649|NCT00742313|12934262|P2|STARTED|Overall Study||19
5261650|NCT00742313|12934263|P1|STARTED|Overall Study||25
5261651|NCT00742274|12934271|P2|NOT COMPLETED|Overall Study||3
5261652|NCT00742274|12934272|P1|NOT COMPLETED|Overall Study||3
5261653|NCT00742274|12934271|P2|COMPLETED|Overall Study||28
5261654|NCT00742274|12934272|P1|COMPLETED|Overall Study||27
5261655|NCT00742274|12934271|P2|STARTED|Overall Study||31
5261656|NCT00742274|12934272|P1|STARTED|Overall Study||30
5261657|NCT00742235|12934280|P2|NOT COMPLETED|Overall Study||31
5261658|NCT00742235|12934281|P1|NOT COMPLETED|Overall Study||0
5261659|NCT00742235|12934280|P2|COMPLETED|Overall Study||36
5261660|NCT00742235|12934281|P1|COMPLETED|Overall Study||32
5261661|NCT00742235|12934280|P2|STARTED|Overall Study||67
5261662|NCT00742235|12934281|P1|STARTED|Overall Study||32
5261663|NCT00742209|12934294|P5|NOT COMPLETED|Overall Study||25
5261664|NCT00742209|12934295|P4|NOT COMPLETED|Overall Study||37
5261665|NCT00742209|12934296|P3|NOT COMPLETED|Overall Study||46
5261666|NCT00742209|12934297|P2|NOT COMPLETED|Overall Study||18
5261667|NCT00742209|12934298|P1|NOT COMPLETED|Overall Study||34
5261668|NCT00742209|12934294|P5|COMPLETED|Overall Study||37
5261669|NCT00742209|12934295|P4|COMPLETED|Overall Study||97
5261670|NCT00742209|12934296|P3|COMPLETED|Overall Study||88
5261671|NCT00742209|12934297|P2|COMPLETED|Overall Study||49
5261672|NCT00742209|12934298|P1|COMPLETED|Overall Study||95
5261673|NCT00742209|12934294|P5|STARTED|Overall Study||62
5261674|NCT00742209|12934295|P4|STARTED|Overall Study||134
5261675|NCT00742209|12934296|P3|STARTED|Overall Study||134
5261676|NCT00742209|12934297|P2|STARTED|Overall Study||67
5261677|NCT00742209|12934298|P1|STARTED|Overall Study||129
5261678|NCT00742183|12934401|P2|NOT COMPLETED|Overall Study||12
5261679|NCT00742183|12934402|P1|NOT COMPLETED|Overall Study||9
5261680|NCT00742183|12934401|P2|COMPLETED|Overall Study||39
5261681|NCT00742183|12934402|P1|COMPLETED|Overall Study||40
5261682|NCT00742183|12934401|P2|STARTED|Overall Study||51
5261683|NCT00742183|12934402|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
5261684|NCT00742170|12934410|P2|NOT COMPLETED|Overall Study||5
5261685|NCT00742170|12934411|P1|NOT COMPLETED|Overall Study||2
5261686|NCT00742170|12934410|P2|COMPLETED|Overall Study||24
5261687|NCT00742170|12934411|P1|COMPLETED|Overall Study||24
5261688|NCT00742170|12934410|P2|STARTED|Overall Study||29
5261689|NCT00742170|12934411|P1|STARTED|Overall Study||26
5261690|NCT00742079|12934421|P2|NOT COMPLETED|Overall Study||1
5261691|NCT00742079|12934422|P1|NOT COMPLETED|Overall Study||0
5261692|NCT00742079|12934421|P2|COMPLETED|Overall Study||9
5261693|NCT00742079|12934422|P1|COMPLETED|Overall Study||11
5261694|NCT00742079|12934421|P2|Week 2 (Received Dose 2)|Overall Study||9
5261695|NCT00742079|12934422|P1|Week 2 (Received Dose 2)|Overall Study||11
5261696|NCT00742079|12934421|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
5261697|NCT00742079|12934422|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
5261698|NCT00742079|12934421|P2|STARTED|Overall Study||10
5261699|NCT00742079|12934422|P1|STARTED|Overall Study||11
5261700|NCT00742053|12934436|P1|NOT COMPLETED|Overall Study||0
5261701|NCT00742053|12934436|P1|COMPLETED|Overall Study||7
5261702|NCT00742053|12934436|P1|STARTED|Overall Study||7
5261703|NCT00742001|12934443|P3|NOT COMPLETED|Overall Study||1
5261704|NCT00742001|12934444|P2|NOT COMPLETED|Overall Study||0
5261705|NCT00742001|12934445|P1|NOT COMPLETED|Overall Study||0
5261706|NCT00742001|12934443|P3|COMPLETED|Overall Study||3
5261707|NCT00742001|12934444|P2|COMPLETED|Overall Study||4
5261708|NCT00742001|12934445|P1|COMPLETED|Overall Study||4
5261709|NCT00742001|12934443|P3|STARTED|Overall Study||4
5261710|NCT00742001|12934444|P2|STARTED|Overall Study||4
5261711|NCT00742001|12934445|P1|STARTED|Overall Study||4
5261712|NCT00741988|12934461|P2|NOT COMPLETED|Overall Study||4
5261713|NCT00741988|12934462|P1|NOT COMPLETED|Overall Study||4
5261714|NCT00741988|12934461|P2|COMPLETED|Overall Study||36
5261715|NCT00741988|12934462|P1|COMPLETED|Overall Study||38
5261716|NCT00741988|12934461|P2|STARTED|Overall Study||40
5261717|NCT00741988|12934462|P1|STARTED|Overall Study||42
5261718|NCT00741936|12934474|P2|NOT COMPLETED|Overall Study||8
5261719|NCT00741936|12934475|P1|NOT COMPLETED|Overall Study||9
5261720|NCT00741936|12934474|P2|COMPLETED|Overall Study||52
5261721|NCT00741936|12934475|P1|COMPLETED|Overall Study||51
5261722|NCT00741936|12934474|P2|STARTED|Overall Study||60
5261723|NCT00741936|12934475|P1|STARTED|Overall Study||60
5261724|NCT00741858|12934503|P2|NOT COMPLETED|Overall Study||0
5261725|NCT00741858|12934504|P1|NOT COMPLETED|Overall Study||0
5261726|NCT00741858|12934503|P2|COMPLETED|Overall Study||18
5261727|NCT00741858|12934504|P1|COMPLETED|Overall Study||16
5261728|NCT00741858|12934503|P2|STARTED|Overall Study||18
5261729|NCT00741858|12934504|P1|STARTED|Overall Study||16
5261730|NCT00741819|12934510|P1|NOT COMPLETED|Overall Study||8
5261731|NCT00741819|12934510|P1|COMPLETED|Overall Study||65
5261732|NCT00741819|12934510|P1|STARTED|Overall Study||73
5261733|NCT00741611|12934524|P3|NOT COMPLETED|Overall Study||3
5261734|NCT00741611|12934525|P2|NOT COMPLETED|Overall Study||2
5261735|NCT00741611|12934526|P1|NOT COMPLETED|Overall Study||0
5261736|NCT00741611|12934524|P3|COMPLETED|Overall Study||26
5261737|NCT00741611|12934525|P2|COMPLETED|Overall Study||1
5261738|NCT00741611|12934526|P1|COMPLETED|Overall Study||4
5261739|NCT00741611|12934524|P3|STARTED|Overall Study||29
5261740|NCT00741611|12934525|P2|STARTED|Overall Study||3
5261741|NCT00741611|12934526|P1|STARTED|Overall Study||4
5261742|NCT00741598|12934545|P2|NOT COMPLETED|Overall Study||9
5261743|NCT00741598|12934546|P1|NOT COMPLETED|Overall Study||9
5261744|NCT00741598|12934545|P2|COMPLETED|Overall Study||30
5261745|NCT00741598|12934546|P1|COMPLETED|Overall Study||24
5261746|NCT00741598|12934545|P2|STARTED|Overall Study||39
5261747|NCT00741598|12934546|P1|STARTED|Overall Study||33
5261748|NCT00741468|12934560|P1|NOT COMPLETED|Overall Study||0
5261749|NCT00741468|12934560|P1|COMPLETED|Overall Study||18
5261750|NCT00741468|12934560|P1|STARTED|Overall Study||18
5261751|NCT00741390|12934568|P4|NOT COMPLETED|Visit 2||1
5261752|NCT00741390|12934569|P3|NOT COMPLETED|Visit 2||1
5261753|NCT00741390|12934570|P2|NOT COMPLETED|Visit 2||0
5261754|NCT00741390|12934571|P1|NOT COMPLETED|Visit 2||0
5261755|NCT00741390|12934568|P4|COMPLETED|Visit 2||60
5261756|NCT00741390|12934569|P3|COMPLETED|Visit 2||54
5261757|NCT00741390|12934570|P2|COMPLETED|Visit 2||61
5261758|NCT00741390|12934571|P1|COMPLETED|Visit 2||59
5261759|NCT00741390|12934568|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
5261760|NCT00741390|12934569|P3|STARTED|Visit 2||55
5261761|NCT00741390|12934570|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
5261762|NCT00741390|12934571|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
5261763|NCT00741390|12934568|P4|NOT COMPLETED|Visit 1||1
5261764|NCT00741390|12934569|P3|NOT COMPLETED|Visit 1||7
5261765|NCT00741390|12934570|P2|NOT COMPLETED|Visit 1||0
5261766|NCT00741390|12934571|P1|NOT COMPLETED|Visit 1||2
5261767|NCT00741390|12934568|P4|COMPLETED|Visit 1||62
5261768|NCT00741390|12934569|P3|COMPLETED|Visit 1||55
5261769|NCT00741390|12934570|P2|COMPLETED|Visit 1||63
5261770|NCT00741390|12934571|P1|COMPLETED|Visit 1||60
5261771|NCT00741390|12934568|P4|STARTED|Visit 1||63
5261772|NCT00741390|12934569|P3|STARTED|Visit 1||62
5261773|NCT00741390|12934570|P2|STARTED|Visit 1||63
5261774|NCT00741390|12934571|P1|STARTED|Visit 1||62
5261775|NCT00741338|12934592|P2|NOT COMPLETED|Overall Study||1
5261776|NCT00741338|12934593|P1|NOT COMPLETED|Overall Study||0
5261777|NCT00741338|12934592|P2|COMPLETED|Overall Study||2
5261778|NCT00741338|12934593|P1|COMPLETED|Overall Study||3
5261779|NCT00741338|12934592|P2|STARTED|Overall Study||3
5261780|NCT00741338|12934593|P1|STARTED|Overall Study||3
5261781|NCT00741286|12934603|P2|NOT COMPLETED|Overall Study||19
5261782|NCT00741286|12934604|P1|NOT COMPLETED|Overall Study||20
5261783|NCT00741286|12934603|P2|COMPLETED|Overall Study||81
5261784|NCT00741286|12934604|P1|COMPLETED|Overall Study||83
5261785|NCT00741286|12934603|P2|STARTED|Overall Study||100
5261786|NCT00741286|12934604|P1|STARTED|Overall Study||103
5261787|NCT00741273|12934614|P2|NOT COMPLETED|Overall Study||0
5261788|NCT00741273|12934615|P1|NOT COMPLETED|Overall Study||0
5261789|NCT00741273|12934614|P2|COMPLETED|Overall Study||8
5261790|NCT00741273|12934615|P1|COMPLETED|Overall Study||8
5261791|NCT00741273|12934614|P2|STARTED|Overall Study||8
5261792|NCT00741273|12934615|P1|STARTED|Overall Study||8
5261793|NCT00741260|12934638|P7|NOT COMPLETED|Overall Study||7
5261794|NCT00741260|12934639|P6|NOT COMPLETED|Overall Study||45
5261795|NCT00741260|12934640|P5|NOT COMPLETED|Overall Study||9
5261796|NCT00741260|12934641|P4|NOT COMPLETED|Overall Study||6
5261797|NCT00741260|12934642|P3|NOT COMPLETED|Overall Study||4
5261798|NCT00741260|12934643|P2|NOT COMPLETED|Overall Study||8
5261799|NCT00741260|12934644|P1|NOT COMPLETED|Overall Study||6
5261800|NCT00741260|12934638|P7|COMPLETED|Overall Study||0
5261801|NCT00741260|12934639|P6|COMPLETED|Overall Study||20
5261802|NCT00741260|12934640|P5|COMPLETED|Overall Study||0
5261803|NCT00741260|12934641|P4|COMPLETED|Overall Study||0
5261804|NCT00741260|12934642|P3|COMPLETED|Overall Study||0
5261805|NCT00741260|12934643|P2|COMPLETED|Overall Study||0
5261806|NCT00741260|12934644|P1|COMPLETED|Overall Study||0
5261807|NCT00741260|12934638|P7|STARTED|Overall Study||7
5261808|NCT00741260|12934639|P6|STARTED|Overall Study||65
5261809|NCT00741260|12934640|P5|STARTED|Overall Study||9
5261810|NCT00741260|12934641|P4|STARTED|Overall Study||6
5261811|NCT00741260|12934642|P3|STARTED|Overall Study||4
5261812|NCT00741260|12934643|P2|STARTED|Overall Study||8
5261813|NCT00741260|12934644|P1|STARTED|Overall Study||6
5261814|NCT00741156|12934671|P1|NOT COMPLETED|Overall Study||0
5261815|NCT00741156|12934671|P1|COMPLETED|Overall Study||12
5261816|NCT00741156|12934671|P1|STARTED|Overall Study||12
5261817|NCT00741104|12934686|P1|NOT COMPLETED|Overall Study||0
5261818|NCT00741104|12934686|P1|COMPLETED|Overall Study||363
5261819|NCT00741104|12934686|P1|STARTED|Overall Study||363
5261820|NCT00741091|12934693|P1|NOT COMPLETED|Overall Study||57
5261821|NCT00741091|12934693|P1|COMPLETED|Overall Study||1040
5261822|NCT00741091|12934693|P1|STARTED|Overall Study||1097
5261823|NCT00741039|12934703|P2|NOT COMPLETED|Overall Study||0
5261824|NCT00741039|12934704|P1|NOT COMPLETED|Overall Study||2
5261825|NCT00741039|12934703|P2|COMPLETED|Overall Study||25
5261826|NCT00741039|12934704|P1|COMPLETED|Overall Study||100
5261827|NCT00741039|12934703|P2|STARTED|Overall Study||25
5261828|NCT00741039|12934704|P1|STARTED|Overall Study||102
5261829|NCT00741026|12934710|P1|NOT COMPLETED|Overall Study||0
5261830|NCT00741026|12934710|P1|COMPLETED|Overall Study||15
5261831|NCT00741026|12934710|P1|STARTED|Overall Study||15
5261832|NCT00741013|12934741|P3|NOT COMPLETED|Overall Study||1
5261833|NCT00741013|12934742|P2|NOT COMPLETED|Overall Study||2
5261834|NCT00741013|12934743|P1|NOT COMPLETED|Overall Study||1
5261835|NCT00741013|12934741|P3|COMPLETED|Overall Study||6
5261836|NCT00741013|12934742|P2|COMPLETED|Overall Study||6
5261837|NCT00741013|12934743|P1|COMPLETED|Overall Study||6
5261838|NCT00741013|12934741|P3|STARTED|Overall Study||7
5261839|NCT00741013|12934742|P2|STARTED|Overall Study||8
5261840|NCT00741013|12934743|P1|STARTED|Overall Study||7
5261841|NCT00740870|12934754|P1|NOT COMPLETED|Overall Study||21
5261842|NCT00740870|12934754|P1|COMPLETED|Overall Study||150
5261843|NCT00740870|12934754|P1|STARTED|Overall Study||171
5261844|NCT00740857|12934769|P3|NOT COMPLETED|Overall Study||0
5261845|NCT00740857|12934770|P2|NOT COMPLETED|Overall Study||0
5261846|NCT00740857|12934771|P1|NOT COMPLETED|Overall Study||1
5261847|NCT00740857|12934769|P3|COMPLETED|Overall Study||90
5261848|NCT00740857|12934770|P2|COMPLETED|Overall Study||88
5261849|NCT00740857|12934771|P1|COMPLETED|Overall Study||32
5261850|NCT00740857|12934769|P3|STARTED|Overall Study||90
5261851|NCT00740857|12934770|P2|STARTED|Overall Study||88
5261852|NCT00740857|12934771|P1|STARTED|Overall Study||33
5261853|NCT00740831|12934803|P3|NOT COMPLETED|Overall Study||6
5261854|NCT00740831|12934804|P2|NOT COMPLETED|Overall Study||3
5261855|NCT00740831|12934805|P1|NOT COMPLETED|Overall Study||4
5261856|NCT00740831|12934803|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
5261857|NCT00740831|12934804|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
5261858|NCT00740831|12934805|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
5261859|NCT00740831|12934803|P3|STARTED|Overall Study|Safety population|101
5261860|NCT00740831|12934804|P2|STARTED|Overall Study|Safety population|103
5261861|NCT00740831|12934805|P1|STARTED|Overall Study|Safety population|97
5261862|NCT00740792|12934826|P4|NOT COMPLETED|Overall Study||10
5261863|NCT00740792|12934827|P3|NOT COMPLETED|Overall Study||9
5261864|NCT00740792|12934828|P2|NOT COMPLETED|Overall Study||8
5261865|NCT00740792|12934829|P1|NOT COMPLETED|Overall Study||10
5261866|NCT00740792|12934826|P4|COMPLETED|Overall Study||190
5261867|NCT00740792|12934827|P3|COMPLETED|Overall Study||180
5261868|NCT00740792|12934828|P2|COMPLETED|Overall Study||186
5261869|NCT00740792|12934829|P1|COMPLETED|Overall Study||183
5261870|NCT00740792|12934826|P4|STARTED|Overall Study||200
5261871|NCT00740792|12934827|P3|STARTED|Overall Study||189
5261872|NCT00740792|12934828|P2|STARTED|Overall Study||194
5261873|NCT00740792|12934829|P1|STARTED|Overall Study||193
5261874|NCT00740779|12934850|P3|NOT COMPLETED|Overall Study||13
5261875|NCT00740779|12934851|P2|NOT COMPLETED|Overall Study||14
5261876|NCT00740779|12934852|P1|NOT COMPLETED|Overall Study||9
5261877|NCT00740779|12934850|P3|COMPLETED|Overall Study||41
5261878|NCT00740779|12934851|P2|COMPLETED|Overall Study||31
5261879|NCT00740779|12934852|P1|COMPLETED|Overall Study||43
5261880|NCT00740779|12934850|P3|STARTED|Overall Study||54
5261881|NCT00740779|12934851|P2|STARTED|Overall Study||45
5261882|NCT00740779|12934852|P1|STARTED|Overall Study||52
5261883|NCT00740727|12934860|P1|NOT COMPLETED|Overall Study||0
5261884|NCT00740727|12934860|P1|COMPLETED|Overall Study||18
5261885|NCT00740727|12934860|P1|STARTED|Overall Study||18
5261886|NCT00740714|12934869|P3|NOT COMPLETED|Overall Study||29
5261887|NCT00740714|12934870|P2|NOT COMPLETED|Overall Study||19
5261888|NCT00740714|12934871|P1|NOT COMPLETED|Overall Study||17
5261889|NCT00740714|12934869|P3|COMPLETED|Overall Study||174
5261890|NCT00740714|12934870|P2|COMPLETED|Overall Study||182
5261891|NCT00740714|12934871|P1|COMPLETED|Overall Study||179
5261892|NCT00740714|12934869|P3|Active Patients at Study Termination|Overall Study||33
5261893|NCT00740714|12934870|P2|Active Patients at Study Termination|Overall Study||12
5261894|NCT00740714|12934871|P1|Active Patients at Study Termination|Overall Study||24
5261895|NCT00740714|12934869|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
5261896|NCT00740714|12934870|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
5261897|NCT00740714|12934871|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
5261898|NCT00740714|12934869|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
5261899|NCT00740714|12934870|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
5261900|NCT00740714|12934871|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
5261901|NCT00740636|12934947|P2|NOT COMPLETED|Overall Study||4
5261902|NCT00740636|12934948|P1|NOT COMPLETED|Overall Study||2
5261903|NCT00740636|12934947|P2|COMPLETED|Overall Study||63
5261904|NCT00740636|12934948|P1|COMPLETED|Overall Study||23
5261905|NCT00740636|12934947|P2|STARTED|Overall Study||67
5261906|NCT00740636|12934948|P1|STARTED|Overall Study||25
5261907|NCT00740597|12934954|P1|NOT COMPLETED|Overall Study||1
5261908|NCT00740597|12934954|P1|COMPLETED|Overall Study||0
5261909|NCT00740597|12934954|P1|STARTED|Overall Study||1
5261910|NCT00740584|12934958|P1|NOT COMPLETED|Overall Study||1
5261911|NCT00740584|12934958|P1|COMPLETED|Overall Study||11
5261912|NCT00740584|12934958|P1|STARTED|Overall Study||12
5261913|NCT00740480|12934963|P1|NOT COMPLETED|Overall Study||2
5261914|NCT00740480|12934963|P1|COMPLETED|Overall Study||23
5261915|NCT00740480|12934963|P1|STARTED|Overall Study||25
5261916|NCT00740376|12934969|P2|NOT COMPLETED|Overall Study||3
5261917|NCT00740376|12934970|P1|NOT COMPLETED|Overall Study||3
5261918|NCT00740376|12934969|P2|COMPLETED|Overall Study||12
5261919|NCT00740376|12934970|P1|COMPLETED|Overall Study||19
5261920|NCT00740376|12934969|P2|STARTED|Overall Study||15
5261921|NCT00740376|12934970|P1|STARTED|Overall Study||22
5261922|NCT00740220|12934988|P1|NOT COMPLETED|Overall Study||9
5261923|NCT00740220|12934988|P1|COMPLETED|Overall Study||88
5261924|NCT00740220|12934988|P1|STARTED|Overall Study||97
5261925|NCT00740207|12934994|P2|NOT COMPLETED|Overall Study||0
5261926|NCT00740207|12934995|P1|NOT COMPLETED|Overall Study||0
5261927|NCT00740207|12934994|P2|COMPLETED|Overall Study||16
5261928|NCT00740207|12934995|P1|COMPLETED|Overall Study||17
5261929|NCT00740207|12934994|P2|STARTED|Overall Study||16
5261930|NCT00740207|12934995|P1|STARTED|Overall Study||17
5261931|NCT00740181|12935007|P1|NOT COMPLETED|Overall Study||0
5261932|NCT00740181|12935007|P1|COMPLETED|Overall Study||9
5261933|NCT00740181|12935007|P1|STARTED|Overall Study||9
5261934|NCT00740051|12935013|P2|NOT COMPLETED|Overall Study||32
5261935|NCT00740051|12935014|P1|NOT COMPLETED|Overall Study||18
5261936|NCT00740051|12935013|P2|COMPLETED|Overall Study||119
5261937|NCT00740051|12935014|P1|COMPLETED|Overall Study||58
5261938|NCT00740051|12935013|P2|STARTED|Overall Study||151
5261939|NCT00740051|12935014|P1|STARTED|Overall Study||76
5261940|NCT00739999|12935036|P2|NOT COMPLETED|Overall Study||0
5261941|NCT00739999|12935037|P1|NOT COMPLETED|Overall Study||0
5261942|NCT00739999|12935036|P2|COMPLETED|Overall Study||24
5261943|NCT00739999|12935037|P1|COMPLETED|Overall Study||15
5261944|NCT00739999|12935036|P2|STARTED|Overall Study||24
5261945|NCT00739999|12935037|P1|STARTED|Overall Study||15
5261946|NCT00739973|12935117|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
5261947|NCT00739973|12935118|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
5261948|NCT00739973|12935119|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
5261949|NCT00739973|12935120|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
5261950|NCT00739973|12935121|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
5261951|NCT00739973|12935122|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
5261952|NCT00739973|12935123|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
5261953|NCT00739973|12935124|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
5261954|NCT00739973|12935125|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
5261955|NCT00739973|12935117|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
5261956|NCT00739973|12935118|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
5261957|NCT00739973|12935119|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
5261958|NCT00739973|12935120|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
5261959|NCT00739973|12935121|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
5261960|NCT00739973|12935122|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
5261961|NCT00739973|12935123|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
5261962|NCT00739973|12935124|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
5261963|NCT00739973|12935125|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
5261964|NCT00739973|12935117|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
5261965|NCT00739973|12935118|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
5261966|NCT00739973|12935119|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
5261967|NCT00739973|12935120|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
5261968|NCT00739973|12935121|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
5261969|NCT00739973|12935122|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
5261970|NCT00739973|12935123|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
5261971|NCT00739973|12935124|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
5261972|NCT00739973|12935125|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
5261973|NCT00739973|12935117|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261974|NCT00739973|12935118|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261975|NCT00739973|12935119|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261976|NCT00739973|12935120|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261977|NCT00739973|12935121|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261978|NCT00739973|12935122|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261979|NCT00739973|12935123|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261980|NCT00739973|12935124|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261981|NCT00739973|12935125|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
5261982|NCT00739973|12935117|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261983|NCT00739973|12935118|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261984|NCT00739973|12935119|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261985|NCT00739973|12935120|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261986|NCT00739973|12935121|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261987|NCT00739973|12935122|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261988|NCT00739973|12935123|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261989|NCT00739973|12935124|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
5261990|NCT00739973|12935125|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
5261991|NCT00739973|12935117|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261992|NCT00739973|12935118|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261993|NCT00739973|12935119|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261994|NCT00739973|12935120|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261995|NCT00739973|12935121|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261996|NCT00739973|12935122|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261997|NCT00739973|12935123|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261998|NCT00739973|12935124|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
5261999|NCT00739973|12935125|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
5262000|NCT00739960|12935211|P1|NOT COMPLETED|Overall Study||0
5262001|NCT00739960|12935211|P1|COMPLETED|Overall Study||1
5262002|NCT00739960|12935211|P1|STARTED|Overall Study||1
5262003|NCT00739934|12935216|P1|NOT COMPLETED|Voriconazole Oral||3
5262004|NCT00739934|12935216|P1|COMPLETED|Voriconazole Oral||31
5262005|NCT00739934|12935216|P1|STARTED|Voriconazole Oral||34
5262006|NCT00739934|12935216|P1|NOT COMPLETED|Voriconazole IV||6
5262007|NCT00739934|12935216|P1|COMPLETED|Voriconazole IV||34
5262008|NCT00739934|12935216|P1|STARTED|Voriconazole IV||40
5262009|NCT00739908|12935238|P2|NOT COMPLETED|Overall Study||25
5262010|NCT00739908|12935239|P1|NOT COMPLETED|Overall Study||25
5262011|NCT00739908|12935238|P2|COMPLETED|Overall Study||118
5262012|NCT00739908|12935239|P1|COMPLETED|Overall Study||117
5262013|NCT00739908|12935238|P2|STARTED|Overall Study||143
5262014|NCT00739908|12935239|P1|STARTED|Overall Study||142
5262015|NCT00739882|12935259|P2|NOT COMPLETED|Open-label Period||5
5262016|NCT00739882|12935260|P1|NOT COMPLETED|Open-label Period||10
5262017|NCT00739882|12935259|P2|COMPLETED|Open-label Period||9
5262018|NCT00739882|12935260|P1|COMPLETED|Open-label Period||7
5262019|NCT00739882|12935259|P2|STARTED|Open-label Period||14
5262020|NCT00739882|12935260|P1|STARTED|Open-label Period||17
5262021|NCT00739882|12935259|P2|NOT COMPLETED|Double-blind Period||11
5262022|NCT00739882|12935260|P1|NOT COMPLETED|Double-blind Period||19
5262023|NCT00739882|12935259|P2|COMPLETED|Double-blind Period||14
5262024|NCT00739882|12935260|P1|COMPLETED|Double-blind Period||32
5262025|NCT00739882|12935259|P2|STARTED|Double-blind Period||25
5262026|NCT00739882|12935260|P1|STARTED|Double-blind Period||51
5262027|NCT00739765|12935281|P3|NOT COMPLETED|Overall Study||11
5262028|NCT00739765|12935282|P2|NOT COMPLETED|Overall Study||11
5262029|NCT00739765|12935283|P1|NOT COMPLETED|Overall Study||6
5262030|NCT00739765|12935281|P3|COMPLETED|Overall Study||21
5262031|NCT00739765|12935282|P2|COMPLETED|Overall Study||27
5262032|NCT00739765|12935283|P1|COMPLETED|Overall Study||34
5262033|NCT00739765|12935281|P3|STARTED|Overall Study||32
5262034|NCT00739765|12935282|P2|STARTED|Overall Study||38
5262035|NCT00739765|12935283|P1|STARTED|Overall Study||40
5262036|NCT00739752|12935300|P6|NOT COMPLETED|Overall Study||0
5262037|NCT00739752|12935301|P5|NOT COMPLETED|Overall Study||0
5262038|NCT00739752|12935302|P4|NOT COMPLETED|Overall Study||0
5262039|NCT00739752|12935303|P3|NOT COMPLETED|Overall Study||0
5262040|NCT00739752|12935304|P2|NOT COMPLETED|Overall Study||0
5262041|NCT00739752|12935305|P1|NOT COMPLETED|Overall Study||0
5262042|NCT00739752|12935300|P6|COMPLETED|Overall Study||293
5262043|NCT00739752|12935301|P5|COMPLETED|Overall Study||291
5262044|NCT00739752|12935302|P4|COMPLETED|Overall Study||288
5262045|NCT00739752|12935303|P3|COMPLETED|Overall Study||292
5262046|NCT00739752|12935304|P2|COMPLETED|Overall Study||284
5262047|NCT00739752|12935305|P1|COMPLETED|Overall Study||299
5262048|NCT00739752|12935300|P6|STARTED|Overall Study||293
5262049|NCT00739752|12935301|P5|STARTED|Overall Study||291
5262050|NCT00739752|12935302|P4|STARTED|Overall Study||288
5262051|NCT00739752|12935303|P3|STARTED|Overall Study||292
5262052|NCT00739752|12935304|P2|STARTED|Overall Study||284
5262053|NCT00739752|12935305|P1|STARTED|Overall Study||299
5262054|NCT00739674|12935321|P2|NOT COMPLETED|Overall Study||122
5262055|NCT00739674|12935322|P1|NOT COMPLETED|Overall Study||181
5262056|NCT00739674|12935321|P2|COMPLETED|Overall Study||335
5262057|NCT00739674|12935322|P1|COMPLETED|Overall Study||354
5262058|NCT00739674|12935321|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
5262059|NCT00739674|12935322|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
5262060|NCT00739674|12935321|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
5262061|NCT00739674|12935322|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
5262062|NCT00739674|12935321|P2|No Follow-up Data|Overall Study||18
5262063|NCT00739674|12935322|P1|No Follow-up Data|Overall Study||33
5262064|NCT00739674|12935321|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
5262065|NCT00739674|12935322|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
5262066|NCT00739674|12935321|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
5262067|NCT00739674|12935322|P1|Screening Failures|Overall Study||19
5262068|NCT00739674|12935321|P2|STARTED|Overall Study||457
5262069|NCT00739674|12935322|P1|STARTED|Overall Study||535
5262070|NCT00739661|12935350|P2|NOT COMPLETED|Overall Study||42
5262071|NCT00739661|12935351|P1|NOT COMPLETED|Overall Study||46
5262072|NCT00739661|12935350|P2|COMPLETED|Overall Study||10
5262073|NCT00739661|12935351|P1|COMPLETED|Overall Study||6
5262074|NCT00739661|12935350|P2|STARTED|Overall Study||52
5262075|NCT00739661|12935351|P1|STARTED|Overall Study||52
5262076|NCT00739648|12935363|P2|NOT COMPLETED|Overall Study||53
5262077|NCT00739648|12935364|P1|NOT COMPLETED|Overall Study||26
5262078|NCT00739648|12935363|P2|COMPLETED|Overall Study||161
5262079|NCT00739648|12935364|P1|COMPLETED|Overall Study||82
5262080|NCT00739648|12935363|P2|STARTED|Overall Study||214
5262081|NCT00739648|12935364|P1|STARTED|Overall Study||108
5262082|NCT00739596|12935378|P2|NOT COMPLETED|Overall Study||17
5262083|NCT00739596|12935379|P1|NOT COMPLETED|Overall Study||25
5262084|NCT00739596|12935378|P2|COMPLETED|Overall Study||149
5262085|NCT00739596|12935379|P1|COMPLETED|Overall Study||141
5262086|NCT00739596|12935378|P2|STARTED|Overall Study||166
5262087|NCT00739596|12935379|P1|STARTED|Overall Study||166
5262088|NCT00739583|12935395|P2|NOT COMPLETED|Overall Study||0
5262089|NCT00739583|12935396|P1|NOT COMPLETED|Overall Study||0
5262090|NCT00739583|12935395|P2|COMPLETED|Overall Study||10
5262091|NCT00739583|12935396|P1|COMPLETED|Overall Study||10
5262092|NCT00739583|12935395|P2|STARTED|Overall Study||10
5262093|NCT00739583|12935396|P1|STARTED|Overall Study||10
5262094|NCT00739336|12935408|P2|NOT COMPLETED|Overall Study||0
5262095|NCT00739336|12935409|P1|NOT COMPLETED|Overall Study||4
5262096|NCT00739336|12935408|P2|COMPLETED|Overall Study||24
5262097|NCT00739336|12935409|P1|COMPLETED|Overall Study||17
5262098|NCT00739336|12935408|P2|STARTED|Overall Study||24
5262099|NCT00739336|12935409|P1|STARTED|Overall Study||21
5262100|NCT00739310|12935421|P1|NOT COMPLETED|Overall Study||7
5262101|NCT00739310|12935421|P1|COMPLETED|Overall Study||22
5262102|NCT00739310|12935421|P1|STARTED|Overall Study||29
5262103|NCT00739297|12935426|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
5262104|NCT00739297|12935427|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
5262105|NCT00739297|12935428|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
5262106|NCT00739297|12935429|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
5262107|NCT00739297|12935430|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
5262108|NCT00739297|12935431|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
5262109|NCT00739297|12935432|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
5262110|NCT00739297|12935426|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
5262111|NCT00739297|12935427|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
5262112|NCT00739297|12935428|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
5262113|NCT00739297|12935429|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
5262114|NCT00739297|12935430|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
5262115|NCT00739297|12935431|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
5262116|NCT00739297|12935432|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
5262117|NCT00739297|12935426|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
5262118|NCT00739297|12935427|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
5262119|NCT00739297|12935428|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
5262120|NCT00739297|12935429|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
5262121|NCT00739297|12935430|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
5262122|NCT00739297|12935431|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
5262123|NCT00739297|12935432|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
5262124|NCT00739297|12935426|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262125|NCT00739297|12935427|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262126|NCT00739297|12935428|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262127|NCT00739297|12935429|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262128|NCT00739297|12935430|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262129|NCT00739297|12935431|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262130|NCT00739297|12935432|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
5262131|NCT00739297|12935426|P7|COMPLETED|Third Washout Period of 4-7 Days||66
5262132|NCT00739297|12935427|P6|COMPLETED|Third Washout Period of 4-7 Days||8
5262133|NCT00739297|12935428|P5|COMPLETED|Third Washout Period of 4-7 Days||6
5262134|NCT00739297|12935429|P4|COMPLETED|Third Washout Period of 4-7 Days||18
5262135|NCT00739297|12935430|P3|COMPLETED|Third Washout Period of 4-7 Days||6
5262136|NCT00739297|12935431|P2|COMPLETED|Third Washout Period of 4-7 Days||12
5262137|NCT00739297|12935432|P1|COMPLETED|Third Washout Period of 4-7 Days||16
5262138|NCT00739297|12935426|P7|STARTED|Third Washout Period of 4-7 Days||66
5262139|NCT00739297|12935427|P6|STARTED|Third Washout Period of 4-7 Days||8
5262140|NCT00739297|12935428|P5|STARTED|Third Washout Period of 4-7 Days||6
5262141|NCT00739297|12935429|P4|STARTED|Third Washout Period of 4-7 Days||18
5262142|NCT00739297|12935430|P3|STARTED|Third Washout Period of 4-7 Days||6
5262143|NCT00739297|12935431|P2|STARTED|Third Washout Period of 4-7 Days||12
5262144|NCT00739297|12935432|P1|STARTED|Third Washout Period of 4-7 Days||16
5262145|NCT00739297|12935426|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262146|NCT00739297|12935427|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262147|NCT00739297|12935428|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262148|NCT00739297|12935429|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262149|NCT00739297|12935430|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262150|NCT00739297|12935431|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262151|NCT00739297|12935432|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
5262152|NCT00739297|12935426|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
5262153|NCT00739297|12935427|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
5262154|NCT00739297|12935428|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
5262155|NCT00739297|12935429|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
5262156|NCT00739297|12935430|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
5262157|NCT00739297|12935431|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
5262158|NCT00739297|12935432|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
5262159|NCT00739297|12935426|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
5262160|NCT00739297|12935427|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
5262161|NCT00739297|12935428|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
5262162|NCT00739297|12935429|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
5262163|NCT00739297|12935430|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
5262164|NCT00739297|12935431|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
5262165|NCT00739297|12935432|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
5262166|NCT00739297|12935426|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262167|NCT00739297|12935427|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262168|NCT00739297|12935428|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262169|NCT00739297|12935429|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262170|NCT00739297|12935430|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262171|NCT00739297|12935431|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262172|NCT00739297|12935432|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
5262173|NCT00739297|12935426|P7|COMPLETED|Second Washout Period of 4-7 Days||66
5262174|NCT00739297|12935427|P6|COMPLETED|Second Washout Period of 4-7 Days||10
5262175|NCT00739297|12935428|P5|COMPLETED|Second Washout Period of 4-7 Days||6
5262176|NCT00739297|12935429|P4|COMPLETED|Second Washout Period of 4-7 Days||14
5262177|NCT00739297|12935430|P3|COMPLETED|Second Washout Period of 4-7 Days||10
5262178|NCT00739297|12935431|P2|COMPLETED|Second Washout Period of 4-7 Days||8
5262179|NCT00739297|12935432|P1|COMPLETED|Second Washout Period of 4-7 Days||18
5262180|NCT00739297|12935426|P7|STARTED|Second Washout Period of 4-7 Days||66
5262181|NCT00739297|12935427|P6|STARTED|Second Washout Period of 4-7 Days||10
5262182|NCT00739297|12935428|P5|STARTED|Second Washout Period of 4-7 Days||6
5262183|NCT00739297|12935429|P4|STARTED|Second Washout Period of 4-7 Days||14
5262184|NCT00739297|12935430|P3|STARTED|Second Washout Period of 4-7 Days||10
5262185|NCT00739297|12935431|P2|STARTED|Second Washout Period of 4-7 Days||8
5262186|NCT00739297|12935432|P1|STARTED|Second Washout Period of 4-7 Days||18
5262187|NCT00739297|12935426|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262188|NCT00739297|12935427|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262189|NCT00739297|12935428|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262190|NCT00739297|12935429|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262191|NCT00739297|12935430|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262192|NCT00739297|12935431|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262193|NCT00739297|12935432|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
5262194|NCT00739297|12935426|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
5262195|NCT00739297|12935427|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
5262196|NCT00739297|12935428|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
5262197|NCT00739297|12935429|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
5262198|NCT00739297|12935430|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
5262199|NCT00739297|12935431|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
5262200|NCT00739297|12935432|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
5262201|NCT00739297|12935426|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
5262202|NCT00739297|12935427|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
5262203|NCT00739297|12935428|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
5262204|NCT00739297|12935429|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
5262205|NCT00739297|12935430|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
5262206|NCT00739297|12935431|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
5262207|NCT00739297|12935432|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
5262208|NCT00739297|12935426|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
5262209|NCT00739297|12935427|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
5262210|NCT00739297|12935428|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
5262211|NCT00739297|12935429|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
5262212|NCT00739297|12935430|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
5262213|NCT00739297|12935431|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
5262214|NCT00739297|12935432|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
5262215|NCT00739297|12935426|P7|COMPLETED|First Washout Period of 4-7 Days||66
5262216|NCT00739297|12935427|P6|COMPLETED|First Washout Period of 4-7 Days||9
5262217|NCT00739297|12935428|P5|COMPLETED|First Washout Period of 4-7 Days||6
5262218|NCT00739297|12935429|P4|COMPLETED|First Washout Period of 4-7 Days||17
5262219|NCT00739297|12935430|P3|COMPLETED|First Washout Period of 4-7 Days||6
5262220|NCT00739297|12935431|P2|COMPLETED|First Washout Period of 4-7 Days||11
5262221|NCT00739297|12935432|P1|COMPLETED|First Washout Period of 4-7 Days||17
5262222|NCT00739297|12935426|P7|STARTED|First Washout Period of 4-7 Days||68
5262223|NCT00739297|12935427|P6|STARTED|First Washout Period of 4-7 Days||9
5262224|NCT00739297|12935428|P5|STARTED|First Washout Period of 4-7 Days||6
5262225|NCT00739297|12935429|P4|STARTED|First Washout Period of 4-7 Days||19
5262226|NCT00739297|12935430|P3|STARTED|First Washout Period of 4-7 Days||6
5262227|NCT00739297|12935431|P2|STARTED|First Washout Period of 4-7 Days||11
5262228|NCT00739297|12935432|P1|STARTED|First Washout Period of 4-7 Days||17
5262229|NCT00739297|12935426|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262230|NCT00739297|12935427|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262231|NCT00739297|12935428|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262232|NCT00739297|12935429|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262233|NCT00739297|12935430|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262234|NCT00739297|12935431|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262235|NCT00739297|12935432|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
5262236|NCT00739297|12935426|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
5262237|NCT00739297|12935427|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
5262238|NCT00739297|12935428|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
5262239|NCT00739297|12935429|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
5262240|NCT00739297|12935430|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
5262241|NCT00739297|12935431|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
5262242|NCT00739297|12935432|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
5262243|NCT00739297|12935426|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
5262244|NCT00739297|12935427|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
5262245|NCT00739297|12935428|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
5262246|NCT00739297|12935429|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
5262247|NCT00739297|12935430|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
5262248|NCT00739297|12935431|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
5262249|NCT00739297|12935432|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
5262250|NCT00739102|12935460|P1|NOT COMPLETED|Overall Study||15
5262251|NCT00739102|12935460|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
5262252|NCT00739102|12935460|P1|STARTED|Overall Study||250
5262253|NCT00739063|12935476|P1|NOT COMPLETED|Overall Study||8
5262254|NCT00739063|12935476|P1|COMPLETED|Overall Study||3
5262255|NCT00739063|12935476|P1|STARTED|Overall Study||11
5262256|NCT00739050|12935480|P2|NOT COMPLETED|Overall Study||0
5262257|NCT00739050|12935481|P1|NOT COMPLETED|Overall Study||1
5262258|NCT00739050|12935480|P2|COMPLETED|Overall Study||0
5262259|NCT00739050|12935481|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
5262260|NCT00739050|12935480|P2|STARTED|Overall Study||0
5262261|NCT00739050|12935481|P1|STARTED|Overall Study||4
5262262|NCT00739024|12935495|P2|NOT COMPLETED|Overall Study||0
5262263|NCT00739024|12935496|P1|NOT COMPLETED|Overall Study||0
5262264|NCT00739024|12935495|P2|COMPLETED|Overall Study||6
5262265|NCT00739024|12935496|P1|COMPLETED|Overall Study||7
5262266|NCT00739024|12935495|P2|STARTED|Overall Study||6
5262267|NCT00739024|12935496|P1|STARTED|Overall Study||7
5262268|NCT00738972|12935506|P4|NOT COMPLETED|Overall Study||1
5262269|NCT00738972|12935507|P3|NOT COMPLETED|Overall Study||0
5262270|NCT00738972|12935508|P2|NOT COMPLETED|Overall Study||0
5262271|NCT00738972|12935509|P1|NOT COMPLETED|Overall Study||0
5262272|NCT00738972|12935506|P4|COMPLETED|Overall Study||2
5262273|NCT00738972|12935507|P3|COMPLETED|Overall Study||3
5262274|NCT00738972|12935508|P2|COMPLETED|Overall Study||3
5262275|NCT00738972|12935509|P1|COMPLETED|Overall Study||3
5262276|NCT00738972|12935506|P4|STARTED|Overall Study||3
5262277|NCT00738972|12935507|P3|STARTED|Overall Study||3
5262278|NCT00738972|12935508|P2|STARTED|Overall Study||3
5262279|NCT00738972|12935509|P1|STARTED|Overall Study||3
5262280|NCT00738894|12935521|P2|NOT COMPLETED|Overall Study||33
5262281|NCT00738894|12935522|P1|NOT COMPLETED|Overall Study||39
5262282|NCT00738894|12935521|P2|COMPLETED|Overall Study||190
5262283|NCT00738894|12935522|P1|COMPLETED|Overall Study||402
5262284|NCT00738894|12935521|P2|STARTED|Overall Study||223
5262285|NCT00738894|12935522|P1|STARTED|Overall Study||441
5262286|NCT00738881|12935535|P2|NOT COMPLETED|Overall Study||2
5262287|NCT00738881|12935536|P1|NOT COMPLETED|Overall Study||0
5262288|NCT00738881|12935535|P2|COMPLETED|Overall Study||10
5262289|NCT00738881|12935536|P1|COMPLETED|Overall Study||11
5262290|NCT00738881|12935535|P2|STARTED|Overall Study||12
5262291|NCT00738881|12935536|P1|STARTED|Overall Study||11
5262292|NCT00738699|12935550|P2|NOT COMPLETED|Overall Study||140
5262293|NCT00738699|12935551|P1|NOT COMPLETED|Overall Study||275
5262294|NCT00738699|12935550|P2|COMPLETED|Overall Study||0
5262295|NCT00738699|12935551|P1|COMPLETED|Overall Study||0
5262296|NCT00738699|12935550|P2|Participants Treated|Overall Study||139
5262297|NCT00738699|12935551|P1|Participants Treated|Overall Study||273
5262298|NCT00738699|12935550|P2|Participants Not Treated|Overall Study||1
5262299|NCT00738699|12935551|P1|Participants Not Treated|Overall Study||2
5262300|NCT00738699|12935550|P2|STARTED|Overall Study||140
5262301|NCT00738699|12935551|P1|STARTED|Overall Study||275
5262302|NCT00738673|12935569|P2|NOT COMPLETED|Overall Study||11
5262303|NCT00738673|12935570|P1|NOT COMPLETED|Overall Study||24
5262304|NCT00738673|12935569|P2|COMPLETED|Overall Study||1
5262305|NCT00738673|12935570|P1|COMPLETED|Overall Study||1
5262306|NCT00738673|12935569|P2|Intent to Treat Population|Overall Study||12
5262307|NCT00738673|12935570|P1|Intent to Treat Population|Overall Study||24
5262308|NCT00738673|12935569|P2|STARTED|Overall Study||12
5262309|NCT00738673|12935570|P1|STARTED|Overall Study||25
5262310|NCT00738543|12935598|P1|NOT COMPLETED|Control||0
5262311|NCT00738543|12935598|P1|COMPLETED|Control||48
5262312|NCT00738543|12935598|P1|STARTED|Control||48
5262313|NCT00738543|12935598|P1|NOT COMPLETED|Sodium Hypochlorite||0
5262314|NCT00738543|12935598|P1|COMPLETED|Sodium Hypochlorite||48
5262315|NCT00738543|12935598|P1|STARTED|Sodium Hypochlorite||48
5262316|NCT00738543|12935598|P1|NOT COMPLETED|Povidone Iodine||0
5262317|NCT00738543|12935598|P1|COMPLETED|Povidone Iodine||48
5262318|NCT00738543|12935598|P1|STARTED|Povidone Iodine||48
5262319|NCT00738530|12935608|P2|NOT COMPLETED|Overall Study||238
5262320|NCT00738530|12935609|P1|NOT COMPLETED|Overall Study||234
5262321|NCT00738530|12935608|P2|COMPLETED|Overall Study||84
5262322|NCT00738530|12935609|P1|COMPLETED|Overall Study||93
5262323|NCT00738530|12935608|P2|Treated|Overall Study||316
5262324|NCT00738530|12935609|P1|Treated|Overall Study||325
5262325|NCT00738530|12935608|P2|STARTED|Overall Study||322
5262326|NCT00738530|12935609|P1|STARTED|Overall Study||327
5262327|NCT00738426|12935635|P2|NOT COMPLETED|Overall Study||3
5262328|NCT00738426|12935636|P1|NOT COMPLETED|Overall Study||2
5262329|NCT00738426|12935635|P2|COMPLETED|Overall Study||32
5262330|NCT00738426|12935636|P1|COMPLETED|Overall Study||35
5262331|NCT00738426|12935635|P2|STARTED|Overall Study||35
5262332|NCT00738426|12935636|P1|STARTED|Overall Study||37
5262333|NCT00738400|12935644|P2|NOT COMPLETED|Overall Study||7
5262334|NCT00738400|12935645|P1|NOT COMPLETED|Overall Study||4
5262335|NCT00738400|12935644|P2|COMPLETED|Overall Study||67
5262336|NCT00738400|12935645|P1|COMPLETED|Overall Study||72
5262337|NCT00738400|12935644|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
5262338|NCT00738400|12935645|P1|ITT (Intent To Treatment) Population|Overall Study||75
5262339|NCT00738400|12935644|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
5262340|NCT00738400|12935645|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
5262341|NCT00738400|12935644|P2|STARTED|Overall Study||74
5262342|NCT00738400|12935645|P1|STARTED|Overall Study||76
5262343|NCT00738374|12935666|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
5262344|NCT00738374|12935667|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
5262345|NCT00738374|12935668|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
5262346|NCT00738374|12935669|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
5262347|NCT00738374|12935666|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
5262348|NCT00738374|12935667|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
5262349|NCT00738374|12935668|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
5262350|NCT00738374|12935669|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
5262351|NCT00738374|12935666|P4|STARTED|Maintenance Treatment/Observation Phase||32
5262352|NCT00738374|12935667|P3|STARTED|Maintenance Treatment/Observation Phase||34
5262353|NCT00738374|12935668|P2|STARTED|Maintenance Treatment/Observation Phase||7
5262354|NCT00738374|12935669|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
5262355|NCT00738374|12935666|P4|NOT COMPLETED|Induction Treatment Phase||0
5262356|NCT00738374|12935667|P3|NOT COMPLETED|Induction Treatment Phase||0
5262357|NCT00738374|12935668|P2|NOT COMPLETED|Induction Treatment Phase||0
5262358|NCT00738374|12935669|P1|NOT COMPLETED|Induction Treatment Phase||24
5262359|NCT00738374|12935666|P4|COMPLETED|Induction Treatment Phase||0
5262360|NCT00738374|12935667|P3|COMPLETED|Induction Treatment Phase||0
5262361|NCT00738374|12935668|P2|COMPLETED|Induction Treatment Phase||0
5262362|NCT00738374|12935669|P1|COMPLETED|Induction Treatment Phase||73
5262363|NCT00738374|12935666|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
5262364|NCT00738374|12935667|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
5262365|NCT00738374|12935668|P2|STARTED|Induction Treatment Phase||0
5262366|NCT00738374|12935669|P1|STARTED|Induction Treatment Phase||97
5262367|NCT00738361|12935701|P1|NOT COMPLETED|Overall Study||0
5262368|NCT00738361|12935701|P1|COMPLETED|Overall Study||4
5262369|NCT00738361|12935701|P1|STARTED|Overall Study||4
5262370|NCT00738283|12935707|P1|NOT COMPLETED|Overall Study||4
5262371|NCT00738283|12935707|P1|COMPLETED|Overall Study||13
5262372|NCT00738283|12935707|P1|STARTED|Overall Study||17
5262373|NCT00738101|12935711|P1|NOT COMPLETED|Overall Study||7
5262374|NCT00738101|12935711|P1|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
5262375|NCT00738101|12935711|P1|STARTED|Overall Study||293
5262376|NCT00738062|12935726|P3|NOT COMPLETED|Open-Label Extension||0
5262377|NCT00738062|12935727|P2|NOT COMPLETED|Open-Label Extension||0
5262378|NCT00738062|12935728|P1|NOT COMPLETED|Open-Label Extension||17
5262379|NCT00738062|12935726|P3|COMPLETED|Open-Label Extension||0
5262380|NCT00738062|12935727|P2|COMPLETED|Open-Label Extension||0
5262381|NCT00738062|12935728|P1|COMPLETED|Open-Label Extension||57
5262382|NCT00738062|12935726|P3|STARTED|Open-Label Extension||0
5262383|NCT00738062|12935727|P2|STARTED|Open-Label Extension||0
5262384|NCT00738062|12935728|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
5262385|NCT00738062|12935726|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
5262386|NCT00738062|12935727|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
5262387|NCT00738062|12935728|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
5262388|NCT00738062|12935726|P3|COMPLETED|2 Week Randomized Withdrawal||37
5262389|NCT00738062|12935727|P2|COMPLETED|2 Week Randomized Withdrawal||38
5262390|NCT00738062|12935728|P1|COMPLETED|2 Week Randomized Withdrawal||0
5262391|NCT00738062|12935726|P3|STARTED|2 Week Randomized Withdrawal||37
5262392|NCT00738062|12935727|P2|STARTED|2 Week Randomized Withdrawal||38
5262393|NCT00738062|12935728|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
5262394|NCT00738062|12935726|P3|NOT COMPLETED|Open Label Treatment||0
5262395|NCT00738062|12935727|P2|NOT COMPLETED|Open Label Treatment||0
5262396|NCT00738062|12935728|P1|NOT COMPLETED|Open Label Treatment||28
5262397|NCT00738062|12935726|P3|COMPLETED|Open Label Treatment||0
5262398|NCT00738062|12935727|P2|COMPLETED|Open Label Treatment||0
5262399|NCT00738062|12935728|P1|COMPLETED|Open Label Treatment||75
5262400|NCT00738062|12935726|P3|STARTED|Open Label Treatment||0
5262401|NCT00738062|12935727|P2|STARTED|Open Label Treatment||0
5262402|NCT00738062|12935728|P1|STARTED|Open Label Treatment||103
5262403|NCT00738049|12935755|P2|NOT COMPLETED|Washout||0
5262404|NCT00738049|12935756|P1|NOT COMPLETED|Washout||0
5262405|NCT00738049|12935755|P2|COMPLETED|Washout||7
5262406|NCT00738049|12935756|P1|COMPLETED|Washout||13
5262407|NCT00738049|12935755|P2|STARTED|Washout||7
5262408|NCT00738049|12935756|P1|STARTED|Washout||13
5262409|NCT00738049|12935755|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
5262410|NCT00738049|12935756|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
5262411|NCT00738049|12935755|P2|COMPLETED|2nd Intervention(14 Days)||7
5262412|NCT00738049|12935756|P1|COMPLETED|2nd Intervention(14 Days)||13
5262413|NCT00738049|12935755|P2|STARTED|2nd Intervention(14 Days)||7
5262414|NCT00738049|12935756|P1|STARTED|2nd Intervention(14 Days)||13
5262415|NCT00738049|12935755|P2|NOT COMPLETED|1st Intervention(14 Days)||0
5262416|NCT00738049|12935756|P1|NOT COMPLETED|1st Intervention(14 Days)||0
5262417|NCT00738049|12935755|P2|COMPLETED|1st Intervention(14 Days)||7
5262418|NCT00738049|12935756|P1|COMPLETED|1st Intervention(14 Days)||13
5262419|NCT00738049|12935755|P2|STARTED|1st Intervention(14 Days)||7
5262420|NCT00738049|12935756|P1|STARTED|1st Intervention(14 Days)||13
5262421|NCT00738023|12935770|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
5262422|NCT00738023|12935771|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
5262423|NCT00738023|12935770|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
5262424|NCT00738023|12935771|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
5262425|NCT00738023|12935770|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
5262426|NCT00738023|12935771|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
5262427|NCT00738023|12935770|P2|NOT COMPLETED|Saline Infusion||0
5262428|NCT00738023|12935771|P1|NOT COMPLETED|Saline Infusion||0
5262429|NCT00738023|12935770|P2|COMPLETED|Saline Infusion||0
5262430|NCT00738023|12935771|P1|COMPLETED|Saline Infusion||19
5262431|NCT00738023|12935770|P2|STARTED|Saline Infusion||0
5262432|NCT00738023|12935771|P1|STARTED|Saline Infusion||19
5262433|NCT00738023|12935770|P2|NOT COMPLETED|Intralipid Infusion||0
5262434|NCT00738023|12935771|P1|NOT COMPLETED|Intralipid Infusion||0
5262435|NCT00738023|12935770|P2|COMPLETED|Intralipid Infusion||13
5262436|NCT00738023|12935771|P1|COMPLETED|Intralipid Infusion||19
5262437|NCT00738023|12935770|P2|STARTED|Intralipid Infusion||13
5262438|NCT00738023|12935771|P1|STARTED|Intralipid Infusion||19
5262439|NCT00737737|12935781|P2|NOT COMPLETED|Overall Study||0
5262440|NCT00737737|12935782|P1|NOT COMPLETED|Overall Study||0
5262441|NCT00737737|12935781|P2|COMPLETED|Overall Study||2
5262442|NCT00737737|12935782|P1|COMPLETED|Overall Study||2
5262443|NCT00737737|12935781|P2|STARTED|Overall Study||2
5262444|NCT00737737|12935782|P1|STARTED|Overall Study||2
5262445|NCT00737711|12935790|P1|NOT COMPLETED|Overall Study||31
5262446|NCT00737711|12935790|P1|COMPLETED|Overall Study||158
5262447|NCT00737711|12935790|P1|STARTED|Overall Study||189
5262448|NCT00737698|12935824|P3|NOT COMPLETED|Overall Study||4
5262449|NCT00737698|12935825|P2|NOT COMPLETED|Overall Study||5
5262450|NCT00737698|12935826|P1|NOT COMPLETED|Overall Study||6
5262451|NCT00737698|12935824|P3|COMPLETED|Overall Study||17
5262452|NCT00737698|12935825|P2|COMPLETED|Overall Study||37
5262453|NCT00737698|12935826|P1|COMPLETED|Overall Study||17
5262454|NCT00737698|12935824|P3|STARTED|Overall Study||21
5262455|NCT00737698|12935825|P2|STARTED|Overall Study||42
5262456|NCT00737698|12935826|P1|STARTED|Overall Study||23
5262457|NCT00737672|12935836|P2|NOT COMPLETED|Overall Study||83
5262458|NCT00737672|12935837|P1|NOT COMPLETED|Overall Study||80
5262459|NCT00737672|12935836|P2|COMPLETED|Overall Study||65
5262460|NCT00737672|12935837|P1|COMPLETED|Overall Study||65
5262461|NCT00737672|12935836|P2|Per Protocol Population|Overall Study||138
5262462|NCT00737672|12935837|P1|Per Protocol Population|Overall Study||131
5262463|NCT00737672|12935836|P2|Exclusions Due to Protocol Deviations|Overall Study||10
5262464|NCT00737672|12935837|P1|Exclusions Due to Protocol Deviations|Overall Study||14
5262465|NCT00737672|12935836|P2|STARTED|Overall Study||148
5262466|NCT00737672|12935837|P1|STARTED|Overall Study||145
5262467|NCT00737633|12935875|P2|NOT COMPLETED|Overall Study||57
5262468|NCT00737633|12935876|P1|NOT COMPLETED|Overall Study||44
5262469|NCT00737633|12935875|P2|COMPLETED|Overall Study||0
5262470|NCT00737633|12935876|P1|COMPLETED|Overall Study||0
5262471|NCT00737633|12935875|P2|STARTED|Overall Study||57
5262472|NCT00737633|12935876|P1|STARTED|Overall Study||44
5262473|NCT00737594|12935887|P3|NOT COMPLETED|Overall Study||0
5262474|NCT00737594|12935888|P2|NOT COMPLETED|Overall Study||0
5262475|NCT00737594|12935889|P1|NOT COMPLETED|Overall Study||0
5262476|NCT00737594|12935887|P3|COMPLETED|Overall Study||0
5262477|NCT00737594|12935888|P2|COMPLETED|Overall Study||0
5262478|NCT00737594|12935889|P1|COMPLETED|Overall Study||0
5262479|NCT00737594|12935887|P3|STARTED|Overall Study||0
5262480|NCT00737594|12935888|P2|STARTED|Overall Study||0
5262481|NCT00737594|12935889|P1|STARTED|Overall Study||0
5262482|NCT00737568|12935899|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
5262483|NCT00737568|12935900|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
5262484|NCT00737568|12935899|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
5262485|NCT00737568|12935900|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
5262486|NCT00737568|12935899|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
5262487|NCT00737568|12935900|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
5262488|NCT00737568|12935899|P2|NOT COMPLETED|Treatment Period Through Week 240||21
5262489|NCT00737568|12935900|P1|NOT COMPLETED|Treatment Period Through Week 240||20
5262490|NCT00737568|12935899|P2|COMPLETED|Treatment Period Through Week 240||118
5262491|NCT00737568|12935900|P1|COMPLETED|Treatment Period Through Week 240||121
5262492|NCT00737568|12935899|P2|STARTED|Treatment Period Through Week 240||139
5262493|NCT00737568|12935900|P1|STARTED|Treatment Period Through Week 240||141
5262494|NCT00737529|12935930|P1|NOT COMPLETED|Overall Study||133
5262495|NCT00737529|12935930|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
5262496|NCT00737529|12935930|P1|STARTED|Overall Study||134
5262497|NCT00737477|12935944|P1|NOT COMPLETED|Overall Study||34
5262498|NCT00737477|12935944|P1|COMPLETED|Overall Study||62
5262499|NCT00737477|12935944|P1|STARTED|Overall Study||96
5262500|NCT00737464|12935960|P1|NOT COMPLETED|Overall Study||18
5262501|NCT00737464|12935960|P1|COMPLETED|Overall Study||114
5262502|NCT00737464|12935960|P1|STARTED|Overall Study||132
5262503|NCT00737438|12935981|P1|NOT COMPLETED|Overall Study||3
5262504|NCT00737438|12935981|P1|COMPLETED|Overall Study||20
5262505|NCT00737438|12935981|P1|STARTED|Overall Study||23
5262506|NCT00737360|12935985|P1|NOT COMPLETED|Overall Study||0
5262507|NCT00737360|12935985|P1|COMPLETED|Overall Study||27
5262508|NCT00737360|12935985|P1|STARTED|Overall Study||27
5262509|NCT00737282|12935994|P1|NOT COMPLETED|Overall Study||175
5262510|NCT00737282|12935994|P1|COMPLETED|Overall Study||0
5262511|NCT00737282|12935994|P1|STARTED|Overall Study||175
5262512|NCT00737243|12936000|P1|NOT COMPLETED|Overall Study||95
5262513|NCT00737243|12936000|P1|COMPLETED|Overall Study||194
5262514|NCT00737243|12936000|P1|Empiric CUP Therapy|Overall Study||29
5262515|NCT00737243|12936000|P1|Site Specific Therapy Less Responsive|Overall Study||79
5262516|NCT00737243|12936000|P1|Site Specific Therapy More Responsive|Overall Study||115
5262517|NCT00737243|12936000|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
5262518|NCT00737243|12936000|P1|Treated|Overall Study||223
5262519|NCT00737243|12936000|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
5262520|NCT00737243|12936000|P1|Successful Assay Performed|Overall Study||252
5262521|NCT00737243|12936000|P1|STARTED|Overall Study||289
5262522|NCT00737204|12936008|P2|NOT COMPLETED|Overall Study||6
5262523|NCT00737204|12936009|P1|NOT COMPLETED|Overall Study||0
5262524|NCT00737204|12936008|P2|COMPLETED|Overall Study||28
5262525|NCT00737204|12936009|P1|COMPLETED|Overall Study||36
5262526|NCT00737204|12936008|P2|STARTED|Overall Study||34
5262527|NCT00737204|12936009|P1|STARTED|Overall Study||36
5262528|NCT00737178|12936023|P2|NOT COMPLETED|Overall Study||9
5262529|NCT00737178|12936024|P1|NOT COMPLETED|Overall Study||5
5262530|NCT00737178|12936023|P2|COMPLETED|Overall Study||76
5262531|NCT00737178|12936024|P1|COMPLETED|Overall Study||66
5262532|NCT00737178|12936023|P2|STARTED|Overall Study||85
5262533|NCT00737178|12936024|P1|STARTED|Overall Study||71
5262534|NCT00737100|12936037|P3|NOT COMPLETED|Overall Study||7
5262535|NCT00737100|12936038|P2|NOT COMPLETED|Overall Study||7
5262536|NCT00737100|12936039|P1|NOT COMPLETED|Overall Study||7
5262537|NCT00737100|12936037|P3|COMPLETED|Overall Study||169
5262538|NCT00737100|12936038|P2|COMPLETED|Overall Study||159
5262539|NCT00737100|12936039|P1|COMPLETED|Overall Study||161
5262540|NCT00737100|12936037|P3|STARTED|Overall Study||176
5262541|NCT00737100|12936038|P2|STARTED|Overall Study||166
5262542|NCT00737100|12936039|P1|STARTED|Overall Study||168
5262543|NCT00737061|12936083|P1|NOT COMPLETED|1 Year Wearing Period||17
5262544|NCT00737061|12936083|P1|COMPLETED|1 Year Wearing Period||553
5262545|NCT00737061|12936083|P1|STARTED|1 Year Wearing Period||570
5262546|NCT00737061|12936083|P1|NOT COMPLETED|Waiting Period||75
5262547|NCT00737061|12936083|P1|COMPLETED|Waiting Period||570
5262548|NCT00737061|12936083|P1|STARTED|Waiting Period||645
5262549|NCT00737048|12936100|P3|NOT COMPLETED|Overall Study||4
5262550|NCT00737048|12936101|P2|NOT COMPLETED|Overall Study||6
5262551|NCT00737048|12936102|P1|NOT COMPLETED|Overall Study||3
5262552|NCT00737048|12936100|P3|COMPLETED|Overall Study||126
5262553|NCT00737048|12936101|P2|COMPLETED|Overall Study||60
5262554|NCT00737048|12936102|P1|COMPLETED|Overall Study||129
5262555|NCT00737048|12936100|P3|STARTED|Overall Study||130
5262556|NCT00737048|12936101|P2|STARTED|Overall Study||66
5262557|NCT00737048|12936102|P1|STARTED|Overall Study||132
5262558|NCT00736996|12936146|P3|NOT COMPLETED|Overall Study||2
5262559|NCT00736996|12936147|P2|NOT COMPLETED|Overall Study||9
5262560|NCT00736996|12936148|P1|NOT COMPLETED|Overall Study||1
5262561|NCT00736996|12936146|P3|COMPLETED|Overall Study||25
5262562|NCT00736996|12936147|P2|COMPLETED|Overall Study||17
5262563|NCT00736996|12936148|P1|COMPLETED|Overall Study||24
5262564|NCT00736996|12936146|P3|STARTED|Overall Study||27
5262565|NCT00736996|12936147|P2|STARTED|Overall Study||26
5262566|NCT00736996|12936148|P1|STARTED|Overall Study||25
5262567|NCT00736957|12936162|P1|NOT COMPLETED|Overall Study||122
5262568|NCT00736957|12936162|P1|COMPLETED|Overall Study||97
5262569|NCT00736957|12936162|P1|Treated|Overall Study||190
5262570|NCT00736957|12936162|P1|STARTED|Overall Study||219
5262571|NCT00736944|12936172|P1|NOT COMPLETED|Definitive Treatment||1
5262572|NCT00736944|12936172|P1|COMPLETED|Definitive Treatment||28
5262573|NCT00736944|12936172|P1|STARTED|Definitive Treatment||29
5262574|NCT00736944|12936172|P1|NOT COMPLETED|Induction||1
5262575|NCT00736944|12936172|P1|COMPLETED|Induction||29
5262576|NCT00736944|12936172|P1|STARTED|Induction||30
5262577|NCT00736879|12936203|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
5262578|NCT00736879|12936204|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
5262579|NCT00736879|12936205|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
5262580|NCT00736879|12936206|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
5262581|NCT00736879|12936203|P4|COMPLETED|Follow up Period - No Drug Treatment||62
5262582|NCT00736879|12936204|P3|COMPLETED|Follow up Period - No Drug Treatment||66
5262583|NCT00736879|12936205|P2|COMPLETED|Follow up Period - No Drug Treatment||67
5262584|NCT00736879|12936206|P1|COMPLETED|Follow up Period - No Drug Treatment||65
5262585|NCT00736879|12936203|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
5262586|NCT00736879|12936204|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
5262587|NCT00736879|12936205|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
5262588|NCT00736879|12936206|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
5262589|NCT00736879|12936203|P4|NOT COMPLETED|Double Blind Treatment Period||5
5262590|NCT00736879|12936204|P3|NOT COMPLETED|Double Blind Treatment Period||7
5262591|NCT00736879|12936205|P2|NOT COMPLETED|Double Blind Treatment Period||4
5262592|NCT00736879|12936206|P1|NOT COMPLETED|Double Blind Treatment Period||3
5262593|NCT00736879|12936203|P4|COMPLETED|Double Blind Treatment Period||63
5262594|NCT00736879|12936204|P3|COMPLETED|Double Blind Treatment Period||67
5262595|NCT00736879|12936205|P2|COMPLETED|Double Blind Treatment Period||68
5262596|NCT00736879|12936206|P1|COMPLETED|Double Blind Treatment Period||65
5262597|NCT00736879|12936203|P4|STARTED|Double Blind Treatment Period||68
5262598|NCT00736879|12936204|P3|STARTED|Double Blind Treatment Period||74
5262599|NCT00736879|12936205|P2|STARTED|Double Blind Treatment Period||72
5262600|NCT00736879|12936206|P1|STARTED|Double Blind Treatment Period||68
5262601|NCT00736853|12936260|P3|NOT COMPLETED|Double-Blind Period||48
5262602|NCT00736853|12936261|P2|NOT COMPLETED|Double-Blind Period||24
5262603|NCT00736853|12936262|P1|NOT COMPLETED|Double-Blind Period||0
5262604|NCT00736853|12936260|P3|COMPLETED|Double-Blind Period||45
5262605|NCT00736853|12936261|P2|COMPLETED|Double-Blind Period||70
5262606|NCT00736853|12936262|P1|COMPLETED|Double-Blind Period||0
5262607|NCT00736853|12936260|P3|STARTED|Double-Blind Period||93
5262608|NCT00736853|12936261|P2|STARTED|Double-Blind Period||94
5262609|NCT00736853|12936262|P1|STARTED|Double-Blind Period||0
5262610|NCT00736853|12936260|P3|NOT COMPLETED|Open-Label Period||0
5262611|NCT00736853|12936261|P2|NOT COMPLETED|Open-Label Period||0
5262612|NCT00736853|12936262|P1|NOT COMPLETED|Open-Label Period||132
5262613|NCT00736853|12936260|P3|COMPLETED|Open-Label Period||0
5262614|NCT00736853|12936261|P2|COMPLETED|Open-Label Period||0
5262615|NCT00736853|12936262|P1|COMPLETED|Open-Label Period||187
5262616|NCT00736853|12936260|P3|Treated|Open-Label Period||0
5262617|NCT00736853|12936261|P2|Treated|Open-Label Period||0
5262618|NCT00736853|12936262|P1|Treated|Open-Label Period||277
5262619|NCT00736853|12936260|P3|STARTED|Open-Label Period||0
5262620|NCT00736853|12936261|P2|STARTED|Open-Label Period||0
5262621|NCT00736853|12936262|P1|STARTED|Open-Label Period||319
5262622|NCT00736840|12936302|P1|NOT COMPLETED|Overall Study||13
5262623|NCT00736840|12936302|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
5262624|NCT00736840|12936302|P1|STARTED|Overall Study||414
5262625|NCT00736723|12936309|P2|NOT COMPLETED|Overall Study||3
5262626|NCT00736723|12936310|P1|NOT COMPLETED|Overall Study||4
5262627|NCT00736723|12936309|P2|COMPLETED|Overall Study||18
5262628|NCT00736723|12936310|P1|COMPLETED|Overall Study||26
5262629|NCT00736723|12936309|P2|STARTED|Overall Study||21
5262630|NCT00736723|12936310|P1|STARTED|Overall Study||30
5262631|NCT00736645|12936320|P4|NOT COMPLETED|Overall Study||0
5262632|NCT00736645|12936321|P3|NOT COMPLETED|Overall Study||0
5262633|NCT00736645|12936322|P2|NOT COMPLETED|Overall Study||2
5262634|NCT00736645|12936323|P1|NOT COMPLETED|Overall Study||0
5262635|NCT00736645|12936320|P4|COMPLETED|Overall Study||13
5262636|NCT00736645|12936321|P3|COMPLETED|Overall Study||14
5262637|NCT00736645|12936322|P2|COMPLETED|Overall Study||13
5262638|NCT00736645|12936323|P1|COMPLETED|Overall Study||13
5262639|NCT00736645|12936320|P4|STARTED|Overall Study||13
5262640|NCT00736645|12936321|P3|STARTED|Overall Study||14
5262641|NCT00736645|12936322|P2|STARTED|Overall Study||15
5262642|NCT00736645|12936323|P1|STARTED|Overall Study||13
5262643|NCT00736632|12936340|P3|NOT COMPLETED|Overall Study||0
5262644|NCT00736632|12936341|P2|NOT COMPLETED|Overall Study||0
5262645|NCT00736632|12936342|P1|NOT COMPLETED|Overall Study||0
5262646|NCT00736632|12936340|P3|COMPLETED|Overall Study||31
5262647|NCT00736632|12936341|P2|COMPLETED|Overall Study||50
5262648|NCT00736632|12936342|P1|COMPLETED|Overall Study||44
5262649|NCT00736632|12936340|P3|STARTED|Overall Study||31
5262650|NCT00736632|12936341|P2|STARTED|Overall Study||50
5262651|NCT00736632|12936342|P1|STARTED|Overall Study||44
5262652|NCT00736580|12936366|P2|NOT COMPLETED|Overall Study||0
5262653|NCT00736580|12936367|P1|NOT COMPLETED|Overall Study||0
5262654|NCT00736580|12936366|P2|COMPLETED|Overall Study||123
5262655|NCT00736580|12936367|P1|COMPLETED|Overall Study||117
5262656|NCT00736580|12936366|P2|STARTED|Overall Study||123
5262657|NCT00736580|12936367|P1|STARTED|Overall Study||117
5262658|NCT00736502|12936373|P1|NOT COMPLETED|Overall Study||65
5262659|NCT00736502|12936373|P1|COMPLETED|Overall Study||213
5262660|NCT00736502|12936373|P1|STARTED|Overall Study|Entered and treated.|278
5262661|NCT00736489|12936379|P6|NOT COMPLETED|Period 6||0
5262662|NCT00736489|12936380|P5|NOT COMPLETED|Period 6||0
5262663|NCT00736489|12936381|P4|NOT COMPLETED|Period 6||0
5262664|NCT00736489|12936382|P3|NOT COMPLETED|Period 6||0
5262665|NCT00736489|12936383|P2|NOT COMPLETED|Period 6||0
5262666|NCT00736489|12936384|P1|NOT COMPLETED|Period 6||0
5262667|NCT00736489|12936379|P6|COMPLETED|Period 6||5
5262668|NCT00736489|12936380|P5|COMPLETED|Period 6||7
5262669|NCT00736489|12936381|P4|COMPLETED|Period 6||7
5262670|NCT00736489|12936382|P3|COMPLETED|Period 6||6
5262671|NCT00736489|12936383|P2|COMPLETED|Period 6||5
5262672|NCT00736489|12936384|P1|COMPLETED|Period 6||5
5262673|NCT00736489|12936379|P6|STARTED|Period 6||5
5262674|NCT00736489|12936380|P5|STARTED|Period 6||7
5262675|NCT00736489|12936381|P4|STARTED|Period 6||7
5262676|NCT00736489|12936382|P3|STARTED|Period 6||6
5262677|NCT00736489|12936383|P2|STARTED|Period 6||5
5262678|NCT00736489|12936384|P1|STARTED|Period 6||5
5262679|NCT00736489|12936379|P6|NOT COMPLETED|Period 5||0
5262680|NCT00736489|12936380|P5|NOT COMPLETED|Period 5||0
5262681|NCT00736489|12936381|P4|NOT COMPLETED|Period 5||0
5262682|NCT00736489|12936382|P3|NOT COMPLETED|Period 5||0
5262683|NCT00736489|12936383|P2|NOT COMPLETED|Period 5||0
5262684|NCT00736489|12936384|P1|NOT COMPLETED|Period 5||0
5262685|NCT00736489|12936379|P6|COMPLETED|Period 5||5
5262686|NCT00736489|12936380|P5|COMPLETED|Period 5||7
5262687|NCT00736489|12936381|P4|COMPLETED|Period 5||7
5262688|NCT00736489|12936382|P3|COMPLETED|Period 5||6
5262689|NCT00736489|12936383|P2|COMPLETED|Period 5||5
5262690|NCT00736489|12936384|P1|COMPLETED|Period 5||5
5262691|NCT00736489|12936379|P6|STARTED|Period 5||5
5262692|NCT00736489|12936380|P5|STARTED|Period 5||7
5262693|NCT00736489|12936381|P4|STARTED|Period 5||7
5262694|NCT00736489|12936382|P3|STARTED|Period 5||6
5262695|NCT00736489|12936383|P2|STARTED|Period 5||5
5262696|NCT00736489|12936384|P1|STARTED|Period 5||5
5262697|NCT00736489|12936379|P6|NOT COMPLETED|Period 4||0
5262698|NCT00736489|12936380|P5|NOT COMPLETED|Period 4||0
5262699|NCT00736489|12936381|P4|NOT COMPLETED|Period 4||0
5262700|NCT00736489|12936382|P3|NOT COMPLETED|Period 4||0
5262701|NCT00736489|12936383|P2|NOT COMPLETED|Period 4||0
5262702|NCT00736489|12936384|P1|NOT COMPLETED|Period 4||0
5262703|NCT00736489|12936379|P6|COMPLETED|Period 4||5
5262704|NCT00736489|12936380|P5|COMPLETED|Period 4||7
5262705|NCT00736489|12936381|P4|COMPLETED|Period 4||7
5262706|NCT00736489|12936382|P3|COMPLETED|Period 4||6
5262707|NCT00736489|12936383|P2|COMPLETED|Period 4||5
5262708|NCT00736489|12936384|P1|COMPLETED|Period 4||5
5262709|NCT00736489|12936379|P6|STARTED|Period 4||5
5262710|NCT00736489|12936380|P5|STARTED|Period 4||7
5262711|NCT00736489|12936381|P4|STARTED|Period 4||7
5262712|NCT00736489|12936382|P3|STARTED|Period 4||6
5262713|NCT00736489|12936383|P2|STARTED|Period 4||5
5262714|NCT00736489|12936384|P1|STARTED|Period 4||5
5262715|NCT00736489|12936379|P6|NOT COMPLETED|Period 3||0
5262716|NCT00736489|12936380|P5|NOT COMPLETED|Period 3||0
5262717|NCT00736489|12936381|P4|NOT COMPLETED|Period 3||0
5262718|NCT00736489|12936382|P3|NOT COMPLETED|Period 3||0
5262719|NCT00736489|12936383|P2|NOT COMPLETED|Period 3||0
5262720|NCT00736489|12936384|P1|NOT COMPLETED|Period 3||0
5262721|NCT00736489|12936379|P6|COMPLETED|Period 3||5
5262722|NCT00736489|12936380|P5|COMPLETED|Period 3||7
5262723|NCT00736489|12936381|P4|COMPLETED|Period 3||7
5262724|NCT00736489|12936382|P3|COMPLETED|Period 3||6
5262725|NCT00736489|12936383|P2|COMPLETED|Period 3||5
5262726|NCT00736489|12936384|P1|COMPLETED|Period 3||5
5262727|NCT00736489|12936379|P6|STARTED|Period 3||5
5262728|NCT00736489|12936380|P5|STARTED|Period 3||7
5262729|NCT00736489|12936381|P4|STARTED|Period 3||7
5262730|NCT00736489|12936382|P3|STARTED|Period 3||6
5262731|NCT00736489|12936383|P2|STARTED|Period 3||5
5262732|NCT00736489|12936384|P1|STARTED|Period 3||5
5262733|NCT00736489|12936379|P6|NOT COMPLETED|Period 2||0
5262734|NCT00736489|12936380|P5|NOT COMPLETED|Period 2||0
5262735|NCT00736489|12936381|P4|NOT COMPLETED|Period 2||0
5262736|NCT00736489|12936382|P3|NOT COMPLETED|Period 2||0
5262737|NCT00736489|12936383|P2|NOT COMPLETED|Period 2||0
5262738|NCT00736489|12936384|P1|NOT COMPLETED|Period 2||0
5262739|NCT00736489|12936379|P6|COMPLETED|Period 2||5
5262740|NCT00736489|12936380|P5|COMPLETED|Period 2||7
5262741|NCT00736489|12936381|P4|COMPLETED|Period 2||7
5262742|NCT00736489|12936382|P3|COMPLETED|Period 2||6
5262743|NCT00736489|12936383|P2|COMPLETED|Period 2||5
5262744|NCT00736489|12936384|P1|COMPLETED|Period 2||5
5262745|NCT00736489|12936379|P6|STARTED|Period 2||5
5262746|NCT00736489|12936380|P5|STARTED|Period 2||7
5262747|NCT00736489|12936381|P4|STARTED|Period 2||7
5262748|NCT00736489|12936382|P3|STARTED|Period 2||6
5262749|NCT00736489|12936383|P2|STARTED|Period 2||5
5262750|NCT00736489|12936384|P1|STARTED|Period 2||5
5262751|NCT00736489|12936379|P6|NOT COMPLETED|Period 1||1
5262752|NCT00736489|12936380|P5|NOT COMPLETED|Period 1||0
5262753|NCT00736489|12936381|P4|NOT COMPLETED|Period 1||0
5262754|NCT00736489|12936382|P3|NOT COMPLETED|Period 1||0
5262755|NCT00736489|12936383|P2|NOT COMPLETED|Period 1||0
5262756|NCT00736489|12936384|P1|NOT COMPLETED|Period 1||1
5262757|NCT00736489|12936379|P6|COMPLETED|Period 1||5
5262758|NCT00736489|12936380|P5|COMPLETED|Period 1||7
5262759|NCT00736489|12936381|P4|COMPLETED|Period 1||7
5262760|NCT00736489|12936382|P3|COMPLETED|Period 1||6
5262761|NCT00736489|12936383|P2|COMPLETED|Period 1||5
5262762|NCT00736489|12936384|P1|COMPLETED|Period 1||5
5262763|NCT00736489|12936379|P6|STARTED|Period 1||6
5262764|NCT00736489|12936380|P5|STARTED|Period 1||7
5262765|NCT00736489|12936381|P4|STARTED|Period 1||7
5262766|NCT00736489|12936382|P3|STARTED|Period 1||6
5262767|NCT00736489|12936383|P2|STARTED|Period 1||5
5262768|NCT00736489|12936384|P1|STARTED|Period 1|Cross-over study|6
5262769|NCT00736476|12936538|P2|NOT COMPLETED|Overall Study||0
5262770|NCT00736476|12936539|P1|NOT COMPLETED|Overall Study||1
5262771|NCT00736476|12936538|P2|COMPLETED|Overall Study||27
5262772|NCT00736476|12936539|P1|COMPLETED|Overall Study||35
5262773|NCT00736476|12936538|P2|STARTED|Overall Study||27
5262774|NCT00736476|12936539|P1|STARTED|Overall Study||36
5262775|NCT00736450|12936559|P1|NOT COMPLETED|Overall Study||25
5262776|NCT00736450|12936559|P1|COMPLETED|Overall Study||12
5262777|NCT00736450|12936559|P1|STARTED|Overall Study||37
5262778|NCT00736385|12936567|P2|NOT COMPLETED|Overall Study||3
5262779|NCT00736385|12936568|P1|NOT COMPLETED|Overall Study||2
5262780|NCT00736385|12936567|P2|COMPLETED|Overall Study||2
5262781|NCT00736385|12936568|P1|COMPLETED|Overall Study||2
5262782|NCT00736385|12936567|P2|STARTED|Overall Study||5
5262783|NCT00736385|12936568|P1|STARTED|Overall Study||4
5262784|NCT00736333|12936580|P1|NOT COMPLETED|Overall Study||111
5262785|NCT00736333|12936580|P1|COMPLETED|Overall Study||56
5262786|NCT00736333|12936580|P1|STARTED|Overall Study||167
5262787|NCT00736255|12936591|P2|NOT COMPLETED|Overall Study||1
5262788|NCT00736255|12936592|P1|NOT COMPLETED|Overall Study||3
5262789|NCT00736255|12936591|P2|COMPLETED|Overall Study||14
5262790|NCT00736255|12936592|P1|COMPLETED|Overall Study||14
5262791|NCT00736255|12936591|P2|STARTED|Overall Study||15
5262792|NCT00736255|12936592|P1|STARTED|Overall Study||17
5262793|NCT00736242|12936610|P1|NOT COMPLETED|Overall Study||125
5262794|NCT00736242|12936610|P1|COMPLETED|Overall Study||107
5262795|NCT00736242|12936610|P1|Participants in Safety Analysis Set|Overall Study||229
5262796|NCT00736242|12936610|P1|STARTED|Overall Study||232
5262797|NCT00736229|12936624|P3|NOT COMPLETED|Overall Study||0
5262798|NCT00736229|12936625|P2|NOT COMPLETED|Overall Study||0
5262799|NCT00736229|12936626|P1|NOT COMPLETED|Overall Study||0
5262800|NCT00736229|12936624|P3|COMPLETED|Overall Study||84
5262801|NCT00736229|12936625|P2|COMPLETED|Overall Study||71
5262802|NCT00736229|12936626|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
5262803|NCT00736229|12936624|P3|STARTED|Overall Study|Historic Control|84
5262804|NCT00736229|12936625|P2|STARTED|Overall Study|Historic control|71
5262805|NCT00736229|12936626|P1|STARTED|Overall Study|Actively Enrolled|40
5262806|NCT00736190|12936639|P1|NOT COMPLETED|Overall Study||3
5262807|NCT00736190|12936639|P1|COMPLETED|Overall Study||87
5262808|NCT00736190|12936639|P1|STARTED|Overall Study||90
5262809|NCT00736125|12936654|P2|NOT COMPLETED|Overall Study||2
5262810|NCT00736125|12936655|P1|NOT COMPLETED|Overall Study||1
5262811|NCT00736125|12936654|P2|COMPLETED|Overall Study||8
5262812|NCT00736125|12936655|P1|COMPLETED|Overall Study||9
5262813|NCT00736125|12936654|P2|STARTED|Overall Study||10
5262814|NCT00736125|12936655|P1|STARTED|Overall Study||10
5262815|NCT00736099|12936669|P2|NOT COMPLETED|Overall Study||58
5262816|NCT00736099|12936670|P1|NOT COMPLETED|Overall Study||183
5262817|NCT00736099|12936669|P2|COMPLETED|Overall Study|Number who completed treatment.|531
5262818|NCT00736099|12936670|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
5262819|NCT00736099|12936669|P2|STARTED|Overall Study|Number who started treatment.|589
5262820|NCT00736099|12936670|P1|STARTED|Overall Study|Number who started treatment.|1532
5262821|NCT00736073|12936768|P2|NOT COMPLETED|Overall Study||0
5262822|NCT00736073|12936769|P1|NOT COMPLETED|Overall Study||0
5262823|NCT00736073|12936768|P2|COMPLETED|Overall Study||39
5262824|NCT00736073|12936769|P1|COMPLETED|Overall Study||34
5262825|NCT00736073|12936768|P2|STARTED|Overall Study||39
5262826|NCT00736073|12936769|P1|STARTED|Overall Study||34
5262827|NCT00736034|12936779|P1|NOT COMPLETED|Overall Study||2
5262828|NCT00736034|12936779|P1|COMPLETED|Overall Study||16
5262829|NCT00736034|12936779|P1|STARTED|Overall Study||18
5262830|NCT00735969|12936783|P1|NOT COMPLETED|Overall Study||0
5262831|NCT00735969|12936783|P1|COMPLETED|Overall Study||21
5262832|NCT00735969|12936783|P1|STARTED|Overall Study||21
5262833|NCT00735943|12936787|P1|NOT COMPLETED|Overall Study||2
5262834|NCT00735943|12936787|P1|COMPLETED|Overall Study||20
5262835|NCT00735943|12936787|P1|STARTED|Overall Study||22
5262836|NCT00735917|12936804|P1|NOT COMPLETED|Overall Study||0
5262837|NCT00735917|12936804|P1|COMPLETED|Overall Study||19
5262838|NCT00735917|12936804|P1|STARTED|Overall Study||19
5262839|NCT00735904|12936812|P1|NOT COMPLETED|Overall Study||38
5262840|NCT00735904|12936812|P1|COMPLETED|Overall Study||0
5262841|NCT00735904|12936812|P1|STARTED|Overall Study||38
5262842|NCT00735878|12936822|P3|NOT COMPLETED|Phase II- Determined Dose||0
5262843|NCT00735878|12936823|P2|NOT COMPLETED|Phase II- Determined Dose||0
5262844|NCT00735878|12936824|P1|NOT COMPLETED|Phase II- Determined Dose||0
5262845|NCT00735878|12936822|P3|COMPLETED|Phase II- Determined Dose||0
5262846|NCT00735878|12936823|P2|COMPLETED|Phase II- Determined Dose||7
5262847|NCT00735878|12936824|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
5262848|NCT00735878|12936822|P3|STARTED|Phase II- Determined Dose||0
5262849|NCT00735878|12936823|P2|STARTED|Phase II- Determined Dose||7
5262850|NCT00735878|12936824|P1|STARTED|Phase II- Determined Dose||0
5262851|NCT00735878|12936822|P3|NOT COMPLETED|Phase I- Dose Determination||1
5262852|NCT00735878|12936823|P2|NOT COMPLETED|Phase I- Dose Determination||0
5262853|NCT00735878|12936824|P1|NOT COMPLETED|Phase I- Dose Determination||0
5262854|NCT00735878|12936822|P3|COMPLETED|Phase I- Dose Determination||4
5262855|NCT00735878|12936823|P2|COMPLETED|Phase I- Dose Determination||7
5262856|NCT00735878|12936824|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
5262857|NCT00735878|12936822|P3|STARTED|Phase I- Dose Determination||5
5262858|NCT00735878|12936823|P2|STARTED|Phase I- Dose Determination||7
5262859|NCT00735878|12936824|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
5262860|NCT00735839|12936837|P2|NOT COMPLETED|Overall Study||0
5262861|NCT00735839|12936838|P1|NOT COMPLETED|Overall Study||0
5262862|NCT00735839|12936837|P2|COMPLETED|Overall Study||10
5262863|NCT00735839|12936838|P1|COMPLETED|Overall Study||30
5262864|NCT00735839|12936837|P2|STARTED|Overall Study||10
5262865|NCT00735839|12936838|P1|STARTED|Overall Study||30
5262866|NCT00735826|12936846|P1|NOT COMPLETED|Overall Study||0
5262867|NCT00735826|12936846|P1|COMPLETED|Overall Study||10
5262868|NCT00735826|12936846|P1|STARTED|Overall Study||10
5262869|NCT00735787|12936854|P2|NOT COMPLETED|Period 2||1
5262870|NCT00735787|12936855|P1|NOT COMPLETED|Period 2||5
5262871|NCT00735787|12936854|P2|COMPLETED|Period 2||40
5262872|NCT00735787|12936855|P1|COMPLETED|Period 2||13
5262873|NCT00735787|12936854|P2|STARTED|Period 2||41
5262874|NCT00735787|12936855|P1|STARTED|Period 2||18
5262875|NCT00735787|12936854|P2|NOT COMPLETED|Period 1||8
5262876|NCT00735787|12936855|P1|NOT COMPLETED|Period 1||6
5262877|NCT00735787|12936854|P2|COMPLETED|Period 1||41
5262878|NCT00735787|12936855|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
5262879|NCT00735787|12936854|P2|STARTED|Period 1||49
5262880|NCT00735787|12936855|P1|STARTED|Period 1||23
5262881|NCT00735709|12936903|P4|NOT COMPLETED|Overall Study||18
5262882|NCT00735709|12936904|P3|NOT COMPLETED|Overall Study||11
5262883|NCT00735709|12936905|P2|NOT COMPLETED|Overall Study||13
5262884|NCT00735709|12936906|P1|NOT COMPLETED|Overall Study||13
5262885|NCT00735709|12936903|P4|COMPLETED|Overall Study||122
5262886|NCT00735709|12936904|P3|COMPLETED|Overall Study||129
5262887|NCT00735709|12936905|P2|COMPLETED|Overall Study||127
5262888|NCT00735709|12936906|P1|COMPLETED|Overall Study||127
5262889|NCT00735709|12936903|P4|Treated|Overall Study||139
5262890|NCT00735709|12936904|P3|Treated|Overall Study||140
5262891|NCT00735709|12936905|P2|Treated|Overall Study||140
5262892|NCT00735709|12936906|P1|Treated|Overall Study||140
5262893|NCT00735709|12936903|P4|STARTED|Overall Study||140
5262894|NCT00735709|12936904|P3|STARTED|Overall Study||140
5262895|NCT00735709|12936905|P2|STARTED|Overall Study||140
5262896|NCT00735709|12936906|P1|STARTED|Overall Study||140
5262897|NCT00735696|12937016|P1|NOT COMPLETED|Overall Study||2
5262898|NCT00735696|12937016|P1|COMPLETED|Overall Study||39
5262899|NCT00735696|12937016|P1|Received Any Quantity of Study Drug|Overall Study||40
5262900|NCT00735696|12937016|P1|STARTED|Overall Study||41
5262901|NCT00735670|12937030|P2|NOT COMPLETED|Overall Study||5
5262902|NCT00735670|12937031|P1|NOT COMPLETED|Overall Study||4
5262903|NCT00735670|12937030|P2|COMPLETED|Overall Study||6
5262904|NCT00735670|12937031|P1|COMPLETED|Overall Study||6
5262905|NCT00735670|12937030|P2|STARTED|Overall Study||11
5262906|NCT00735670|12937031|P1|STARTED|Overall Study||10
5262907|NCT00735644|12937044|P5|NOT COMPLETED|Overall Study||0
5262908|NCT00735644|12937045|P4|NOT COMPLETED|Overall Study||1
5262909|NCT00735644|12937046|P3|NOT COMPLETED|Overall Study||1
5262910|NCT00735644|12937047|P2|NOT COMPLETED|Overall Study||2
5262911|NCT00735644|12937048|P1|NOT COMPLETED|Overall Study||0
5262912|NCT00735644|12937044|P5|COMPLETED|Overall Study||102
5262913|NCT00735644|12937045|P4|COMPLETED|Overall Study||198
5262914|NCT00735644|12937046|P3|COMPLETED|Overall Study||295
5262915|NCT00735644|12937047|P2|COMPLETED|Overall Study||298
5262916|NCT00735644|12937048|P1|COMPLETED|Overall Study||303
5262917|NCT00735644|12937044|P5|STARTED|Overall Study||102
5262918|NCT00735644|12937045|P4|STARTED|Overall Study||199
5262919|NCT00735644|12937046|P3|STARTED|Overall Study||296
5262920|NCT00735644|12937047|P2|STARTED|Overall Study||300
5262921|NCT00735644|12937048|P1|STARTED|Overall Study||303
5262922|NCT00735618|12937085|P1|NOT COMPLETED|Overall Study||0
5262923|NCT00735618|12937085|P1|COMPLETED|Overall Study||19
5262924|NCT00735618|12937085|P1|STARTED|Overall Study||19
5262925|NCT00735553|12937092|P1|NOT COMPLETED|Overall Study||77
5262926|NCT00735553|12937092|P1|COMPLETED|Overall Study||0
5262927|NCT00735553|12937092|P1|STARTED|Overall Study||77
5262928|NCT00735475|12937102|P2|NOT COMPLETED|Overall Study||11
5262929|NCT00735475|12937103|P1|NOT COMPLETED|Overall Study||8
5262930|NCT00735475|12937102|P2|COMPLETED|Overall Study||626
5262931|NCT00735475|12937103|P1|COMPLETED|Overall Study||623
5262932|NCT00735475|12937102|P2|STARTED|Overall Study||637
5262933|NCT00735475|12937103|P1|STARTED|Overall Study||631
5262934|NCT00735462|12937124|P3|NOT COMPLETED|Overall Study||28
5262935|NCT00735462|12937125|P2|NOT COMPLETED|Overall Study||55
5262936|NCT00735462|12937126|P1|NOT COMPLETED|Overall Study||63
5262937|NCT00735462|12937124|P3|COMPLETED|Overall Study||77
5262938|NCT00735462|12937125|P2|COMPLETED|Overall Study||149
5262939|NCT00735462|12937126|P1|COMPLETED|Overall Study||139
5262940|NCT00735462|12937124|P3|STARTED|Overall Study||105
5262941|NCT00735462|12937125|P2|STARTED|Overall Study||204
5262942|NCT00735462|12937126|P1|STARTED|Overall Study||202
5262943|NCT00735449|12937139|P2|NOT COMPLETED|Overall Study||6
5262944|NCT00735449|12937140|P1|NOT COMPLETED|Overall Study||7
5262945|NCT00735449|12937139|P2|COMPLETED|Overall Study||96
5262946|NCT00735449|12937140|P1|COMPLETED|Overall Study||95
5262947|NCT00735449|12937139|P2|STARTED|Overall Study||102
5262948|NCT00735449|12937140|P1|STARTED|Overall Study||102
5262949|NCT00735436|12937154|P1|NOT COMPLETED|Overall Study||0
5262950|NCT00735436|12937154|P1|COMPLETED|Overall Study||18
5262951|NCT00735436|12937154|P1|STARTED|Overall Study||18
5262952|NCT00735397|12937163|P1|NOT COMPLETED|Overall Study||1183
5262953|NCT00735397|12937163|P1|COMPLETED|Overall Study||35
5262954|NCT00735397|12937163|P1|STARTED|Overall Study||1218
5262955|NCT00735371|12937177|P4|NOT COMPLETED|Overall Study||10
5262956|NCT00735371|12937178|P3|NOT COMPLETED|Overall Study||11
5262957|NCT00735371|12937179|P2|NOT COMPLETED|Overall Study||13
5262958|NCT00735371|12937180|P1|NOT COMPLETED|Overall Study||15
5262959|NCT00735371|12937177|P4|COMPLETED|Overall Study||69
5262960|NCT00735371|12937178|P3|COMPLETED|Overall Study||67
5262961|NCT00735371|12937179|P2|COMPLETED|Overall Study||66
5262962|NCT00735371|12937180|P1|COMPLETED|Overall Study||63
5262963|NCT00735371|12937177|P4|STARTED|Overall Study||79
5262964|NCT00735371|12937178|P3|STARTED|Overall Study||78
5262965|NCT00735371|12937179|P2|STARTED|Overall Study||79
5262966|NCT00735371|12937180|P1|STARTED|Overall Study||78
5262967|NCT00735306|12937198|P1|NOT COMPLETED|Overall Study||0
5262968|NCT00735306|12937198|P1|COMPLETED|Overall Study||12
5262969|NCT00735306|12937198|P1|STARTED|Overall Study||12
5262970|NCT00735254|12937208|P4|NOT COMPLETED|Overall Study||0
5262971|NCT00735254|12937209|P3|NOT COMPLETED|Overall Study||1
5262972|NCT00735254|12937210|P2|NOT COMPLETED|Overall Study||1
5262973|NCT00735254|12937211|P1|NOT COMPLETED|Overall Study||1
5262974|NCT00735254|12937208|P4|COMPLETED|Overall Study||0
5262975|NCT00735254|12937209|P3|COMPLETED|Overall Study||0
5262976|NCT00735254|12937210|P2|COMPLETED|Overall Study||0
5262977|NCT00735254|12937211|P1|COMPLETED|Overall Study||0
5262978|NCT00735254|12937208|P4|STARTED|Overall Study||0
5262979|NCT00735254|12937209|P3|STARTED|Overall Study||1
5262980|NCT00735254|12937210|P2|STARTED|Overall Study||1
5262981|NCT00735254|12937211|P1|STARTED|Overall Study||1
5262982|NCT00735072|12937223|P2|NOT COMPLETED|Overall Study||1
5262983|NCT00735072|12937224|P1|NOT COMPLETED|Overall Study||1
5262984|NCT00735072|12937223|P2|COMPLETED|Overall Study||21
5262985|NCT00735072|12937224|P1|COMPLETED|Overall Study||22
5262986|NCT00735072|12937223|P2|STARTED|Overall Study||22
5262987|NCT00735072|12937224|P1|STARTED|Overall Study||23
5262988|NCT00735007|12937230|P1|NOT COMPLETED|Overall Study||5
5262989|NCT00735007|12937230|P1|COMPLETED|Overall Study||101
5262990|NCT00735007|12937230|P1|STARTED|Overall Study||106
5262991|NCT00734994|12937255|P1|NOT COMPLETED|Overall Study||1
5262992|NCT00734994|12937255|P1|COMPLETED|Overall Study||14
5262993|NCT00734994|12937255|P1|STARTED|Overall Study||15
5262994|NCT00734968|12937262|P2|NOT COMPLETED|Overall Study||1
5262995|NCT00734968|12937263|P1|NOT COMPLETED|Overall Study||1
5262996|NCT00734968|12937262|P2|COMPLETED|Overall Study||75
5262997|NCT00734968|12937263|P1|COMPLETED|Overall Study||76
5262998|NCT00734968|12937262|P2|STARTED|Overall Study||76
5262999|NCT00734968|12937263|P1|STARTED|Overall Study||77
5263000|NCT00734929|12937275|P2|NOT COMPLETED|Overall Study||5
5263001|NCT00734929|12937276|P1|NOT COMPLETED|Overall Study||6
5263002|NCT00734929|12937275|P2|COMPLETED|Overall Study||53
5263003|NCT00734929|12937276|P1|COMPLETED|Overall Study||51
5263004|NCT00734929|12937275|P2|STARTED|Overall Study||58
5263005|NCT00734929|12937276|P1|STARTED|Overall Study||57
5263006|NCT00734903|12937306|P2|NOT COMPLETED|Overall Study||1
5263007|NCT00734903|12937307|P1|NOT COMPLETED|Overall Study||3
5263008|NCT00734903|12937306|P2|COMPLETED|Overall Study||32
5263009|NCT00734903|12937307|P1|COMPLETED|Overall Study||30
5263010|NCT00734903|12937306|P2|Completed 3-month Followup|Overall Study||15
5263011|NCT00734903|12937307|P1|Completed 3-month Followup|Overall Study||14
5263012|NCT00734903|12937306|P2|Completed End of Treatment Assessment|Overall Study||23
5263013|NCT00734903|12937307|P1|Completed End of Treatment Assessment|Overall Study||21
5263014|NCT00734903|12937306|P2|STARTED|Overall Study||33
5263015|NCT00734903|12937307|P1|STARTED|Overall Study||33
5263016|NCT00734851|12937333|P1|NOT COMPLETED|Overall Study||21
5263017|NCT00734851|12937333|P1|COMPLETED|Overall Study||13
5263018|NCT00734851|12937333|P1|STARTED|Overall Study||34
5263019|NCT00734799|12937345|P2|NOT COMPLETED|Overall Study||4
5263020|NCT00734799|12937346|P1|NOT COMPLETED|Overall Study||0
5263021|NCT00734799|12937345|P2|COMPLETED|Overall Study||9
5263022|NCT00734799|12937346|P1|COMPLETED|Overall Study||9
5263023|NCT00734799|12937345|P2|STARTED|Overall Study||13
5263024|NCT00734799|12937346|P1|STARTED|Overall Study||9
5263025|NCT00734747|12937354|P1|NOT COMPLETED|6 Month Follow-up||3
5263026|NCT00734747|12937354|P1|COMPLETED|6 Month Follow-up||66
5263027|NCT00734747|12937354|P1|STARTED|6 Month Follow-up||69
5263028|NCT00734747|12937354|P1|NOT COMPLETED|SRS Procedure||3
5263029|NCT00734747|12937354|P1|COMPLETED|SRS Procedure||69
5263030|NCT00734747|12937354|P1|STARTED|SRS Procedure||72
5263031|NCT00734734|12937361|P1|NOT COMPLETED|Overall Study||0
5263032|NCT00734734|12937361|P1|COMPLETED|Overall Study||64
5263033|NCT00734734|12937361|P1|STARTED|Overall Study||64
5263034|NCT00734656|12937368|P4|NOT COMPLETED|Lab Session 4||1
5263035|NCT00734656|12937369|P3|NOT COMPLETED|Lab Session 4||0
5263036|NCT00734656|12937370|P2|NOT COMPLETED|Lab Session 4||0
5263037|NCT00734656|12937371|P1|NOT COMPLETED|Lab Session 4||0
5263038|NCT00734656|12937368|P4|COMPLETED|Lab Session 4||19
5263039|NCT00734656|12937369|P3|COMPLETED|Lab Session 4||16
5263040|NCT00734656|12937370|P2|COMPLETED|Lab Session 4||18
5263041|NCT00734656|12937371|P1|COMPLETED|Lab Session 4||20
5263042|NCT00734656|12937368|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
5263043|NCT00734656|12937369|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
5263044|NCT00734656|12937370|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
5263045|NCT00734656|12937371|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
5263046|NCT00734656|12937368|P4|NOT COMPLETED|Washout 3||1
5263047|NCT00734656|12937369|P3|NOT COMPLETED|Washout 3||0
5263048|NCT00734656|12937370|P2|NOT COMPLETED|Washout 3||0
5263049|NCT00734656|12937371|P1|NOT COMPLETED|Washout 3||1
5263050|NCT00734656|12937368|P4|COMPLETED|Washout 3||18
5263051|NCT00734656|12937369|P3|COMPLETED|Washout 3||20
5263052|NCT00734656|12937370|P2|COMPLETED|Washout 3||19
5263053|NCT00734656|12937371|P1|COMPLETED|Washout 3||17
5263054|NCT00734656|12937368|P4|STARTED|Washout 3||19
5263055|NCT00734656|12937369|P3|STARTED|Washout 3||20
5263056|NCT00734656|12937370|P2|STARTED|Washout 3||19
5263057|NCT00734656|12937371|P1|STARTED|Washout 3||18
5263058|NCT00734656|12937368|P4|NOT COMPLETED|Lab Session 3||0
5263059|NCT00734656|12937369|P3|NOT COMPLETED|Lab Session 3||0
5263060|NCT00734656|12937370|P2|NOT COMPLETED|Lab Session 3||0
5263061|NCT00734656|12937371|P1|NOT COMPLETED|Lab Session 3||0
5263062|NCT00734656|12937368|P4|COMPLETED|Lab Session 3||19
5263063|NCT00734656|12937369|P3|COMPLETED|Lab Session 3||20
5263064|NCT00734656|12937370|P2|COMPLETED|Lab Session 3||19
5263065|NCT00734656|12937371|P1|COMPLETED|Lab Session 3||18
5263066|NCT00734656|12937368|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
5263067|NCT00734656|12937369|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
5263068|NCT00734656|12937370|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
5263069|NCT00734656|12937371|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
5263070|NCT00734656|12937368|P4|NOT COMPLETED|Washout 2||0
5263071|NCT00734656|12937369|P3|NOT COMPLETED|Washout 2||1
5263072|NCT00734656|12937370|P2|NOT COMPLETED|Washout 2||1
5263073|NCT00734656|12937371|P1|NOT COMPLETED|Washout 2||1
5263074|NCT00734656|12937368|P4|COMPLETED|Washout 2||19
5263075|NCT00734656|12937369|P3|COMPLETED|Washout 2||20
5263076|NCT00734656|12937370|P2|COMPLETED|Washout 2||20
5263077|NCT00734656|12937371|P1|COMPLETED|Washout 2||17
5263078|NCT00734656|12937368|P4|STARTED|Washout 2||19
5263079|NCT00734656|12937369|P3|STARTED|Washout 2||21
5263080|NCT00734656|12937370|P2|STARTED|Washout 2||21
5263081|NCT00734656|12937371|P1|STARTED|Washout 2||18
5263082|NCT00734656|12937368|P4|NOT COMPLETED|Lab Session 2||1
5263083|NCT00734656|12937369|P3|NOT COMPLETED|Lab Session 2||0
5263084|NCT00734656|12937370|P2|NOT COMPLETED|Lab Session 2||0
5263085|NCT00734656|12937371|P1|NOT COMPLETED|Lab Session 2||1
5263086|NCT00734656|12937368|P4|COMPLETED|Lab Session 2||19
5263087|NCT00734656|12937369|P3|COMPLETED|Lab Session 2||21
5263088|NCT00734656|12937370|P2|COMPLETED|Lab Session 2||21
5263089|NCT00734656|12937371|P1|COMPLETED|Lab Session 2||18
5263090|NCT00734656|12937368|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
5263091|NCT00734656|12937369|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
5263092|NCT00734656|12937370|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
5263093|NCT00734656|12937371|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
5263094|NCT00734656|12937368|P4|NOT COMPLETED|Washout 1||3
5263095|NCT00734656|12937369|P3|NOT COMPLETED|Washout 1||2
5263096|NCT00734656|12937370|P2|NOT COMPLETED|Washout 1||5
5263097|NCT00734656|12937371|P1|NOT COMPLETED|Washout 1||1
5263098|NCT00734656|12937368|P4|COMPLETED|Washout 1||18
5263099|NCT00734656|12937369|P3|COMPLETED|Washout 1||24
5263100|NCT00734656|12937370|P2|COMPLETED|Washout 1||18
5263101|NCT00734656|12937371|P1|COMPLETED|Washout 1||21
5263102|NCT00734656|12937368|P4|STARTED|Washout 1||21
5263103|NCT00734656|12937369|P3|STARTED|Washout 1||26
5263104|NCT00734656|12937370|P2|STARTED|Washout 1||23
5263105|NCT00734656|12937371|P1|STARTED|Washout 1||22
5263106|NCT00734656|12937368|P4|NOT COMPLETED|Lab Session 1||0
5263107|NCT00734656|12937369|P3|NOT COMPLETED|Lab Session 1||0
5263108|NCT00734656|12937370|P2|NOT COMPLETED|Lab Session 1||0
5263109|NCT00734656|12937371|P1|NOT COMPLETED|Lab Session 1||2
5263110|NCT00734656|12937368|P4|COMPLETED|Lab Session 1||21
5263111|NCT00734656|12937369|P3|COMPLETED|Lab Session 1||26
5263112|NCT00734656|12937370|P2|COMPLETED|Lab Session 1||23
5263113|NCT00734656|12937371|P1|COMPLETED|Lab Session 1||22
5263114|NCT00734656|12937368|P4|STARTED|Lab Session 1||21
5263115|NCT00734656|12937369|P3|STARTED|Lab Session 1||26
5263116|NCT00734656|12937370|P2|STARTED|Lab Session 1||23
5263117|NCT00734656|12937371|P1|STARTED|Lab Session 1||24
5263118|NCT00734630|12937395|P2|NOT COMPLETED|Overall Study||33
5263119|NCT00734630|12937396|P1|NOT COMPLETED|Overall Study||29
5263120|NCT00734630|12937395|P2|COMPLETED|Overall Study||200
5263121|NCT00734630|12937396|P1|COMPLETED|Overall Study||229
5263122|NCT00734630|12937395|P2|STARTED|Overall Study||233
5263123|NCT00734630|12937396|P1|STARTED|Overall Study||258
5263124|NCT00734617|12937406|P2|NOT COMPLETED|Overall Study||102
5263125|NCT00734617|12937407|P1|NOT COMPLETED|Overall Study||107
5263126|NCT00734617|12937406|P2|COMPLETED|Overall Study||128
5263127|NCT00734617|12937407|P1|COMPLETED|Overall Study||142
5263128|NCT00734617|12937406|P2|STARTED|Overall Study||230
5263129|NCT00734617|12937407|P1|STARTED|Overall Study||249
5263130|NCT00734604|12937419|P6|NOT COMPLETED|Overall Study||6
5263131|NCT00734604|12937420|P5|NOT COMPLETED|Overall Study||8
5263132|NCT00734604|12937421|P4|NOT COMPLETED|Overall Study||9
5263133|NCT00734604|12937422|P3|NOT COMPLETED|Overall Study||6
5263134|NCT00734604|12937423|P2|NOT COMPLETED|Overall Study||12
5263135|NCT00734604|12937424|P1|NOT COMPLETED|Overall Study||3
5263136|NCT00734604|12937419|P6|COMPLETED|Overall Study||58
5263137|NCT00734604|12937420|P5|COMPLETED|Overall Study||55
5263138|NCT00734604|12937421|P4|COMPLETED|Overall Study||54
5263139|NCT00734604|12937422|P3|COMPLETED|Overall Study||57
5263140|NCT00734604|12937423|P2|COMPLETED|Overall Study||51
5263141|NCT00734604|12937424|P1|COMPLETED|Overall Study||59
5263142|NCT00734604|12937419|P6|STARTED|Overall Study||64
5263143|NCT00734604|12937420|P5|STARTED|Overall Study||63
5263144|NCT00734604|12937421|P4|STARTED|Overall Study||63
5263145|NCT00734604|12937422|P3|STARTED|Overall Study||63
5263146|NCT00734604|12937423|P2|STARTED|Overall Study||63
5263147|NCT00734604|12937424|P1|STARTED|Overall Study||62
5263148|NCT00734591|12937474|P2|NOT COMPLETED|Prospective Period||44
5263149|NCT00734591|12937475|P1|NOT COMPLETED|Prospective Period||51
5263150|NCT00734591|12937474|P2|COMPLETED|Prospective Period||1229
5263151|NCT00734591|12937475|P1|COMPLETED|Prospective Period||1307
5263152|NCT00734591|12937474|P2|STARTED|Prospective Period||1273
5263153|NCT00734591|12937475|P1|STARTED|Prospective Period||1358
5263154|NCT00734591|12937474|P2|NOT COMPLETED|Screening for Prospective Period||2291
5263155|NCT00734591|12937475|P1|NOT COMPLETED|Screening for Prospective Period||2517
5263156|NCT00734591|12937474|P2|COMPLETED|Screening for Prospective Period||1273
5263157|NCT00734591|12937475|P1|COMPLETED|Screening for Prospective Period||1358
5263158|NCT00734591|12937474|P2|STARTED|Screening for Prospective Period||3564
5263159|NCT00734591|12937475|P1|STARTED|Screening for Prospective Period||3875
5263160|NCT00734591|12937474|P2|NOT COMPLETED|Retrospective Period||0
5263161|NCT00734591|12937475|P1|NOT COMPLETED|Retrospective Period||0
5263162|NCT00734591|12937474|P2|COMPLETED|Retrospective Period||3564
5263163|NCT00734591|12937475|P1|COMPLETED|Retrospective Period||3875
5263164|NCT00734591|12937474|P2|STARTED|Retrospective Period||3564
5263165|NCT00734591|12937475|P1|STARTED|Retrospective Period||3875
5263166|NCT00734578|12937490|P3|NOT COMPLETED|Overall Study||25
5263167|NCT00734578|12937491|P2|NOT COMPLETED|Overall Study||25
5263168|NCT00734578|12937492|P1|NOT COMPLETED|Overall Study||33
5263169|NCT00734578|12937490|P3|COMPLETED|Overall Study||129
5263170|NCT00734578|12937491|P2|COMPLETED|Overall Study||128
5263171|NCT00734578|12937492|P1|COMPLETED|Overall Study||121
5263172|NCT00734578|12937490|P3|STARTED|Overall Study||154
5263173|NCT00734578|12937491|P2|STARTED|Overall Study||153
5263174|NCT00734578|12937492|P1|STARTED|Overall Study||154
5263175|NCT00734539|12937526|P2|NOT COMPLETED|Long Term Follow up||31
5263176|NCT00734539|12937527|P1|NOT COMPLETED|Long Term Follow up||34
5263177|NCT00734539|12937526|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
5263178|NCT00734539|12937527|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
5263179|NCT00734539|12937526|P2|STARTED|Long Term Follow up||138
5263180|NCT00734539|12937527|P1|STARTED|Long Term Follow up||152
5263181|NCT00734539|12937526|P2|NOT COMPLETED|Main Study||35
5263182|NCT00734539|12937527|P1|NOT COMPLETED|Main Study||37
5263183|NCT00734539|12937526|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
5263184|NCT00734539|12937527|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
5263185|NCT00734539|12937526|P2|STARTED|Main Study||173
5263186|NCT00734539|12937527|P1|STARTED|Main Study||189
5263187|NCT00734500|12937555|P1|NOT COMPLETED|Overall Study||1
5263188|NCT00734500|12937555|P1|COMPLETED|Overall Study||14
5263189|NCT00734500|12937555|P1|STARTED|Overall Study||15
5263190|NCT00734474|12937569|P9|NOT COMPLETED|Overall Study||82
5263191|NCT00734474|12937570|P8|NOT COMPLETED|Overall Study||129
5263192|NCT00734474|12937571|P7|NOT COMPLETED|Overall Study||24
5263193|NCT00734474|12937572|P6|NOT COMPLETED|Overall Study||25
5263194|NCT00734474|12937573|P5|NOT COMPLETED|Overall Study||118
5263195|NCT00734474|12937574|P4|NOT COMPLETED|Overall Study||10
5263196|NCT00734474|12937575|P3|NOT COMPLETED|Overall Study||112
5263197|NCT00734474|12937576|P2|NOT COMPLETED|Overall Study||30
5263198|NCT00734474|12937577|P1|NOT COMPLETED|Overall Study||15
5263199|NCT00734474|12937569|P9|COMPLETED|Overall Study||95
5263200|NCT00734474|12937570|P8|COMPLETED|Overall Study||186
5263201|NCT00734474|12937571|P7|COMPLETED|Overall Study||0
5263202|NCT00734474|12937572|P6|COMPLETED|Overall Study||0
5263203|NCT00734474|12937573|P5|COMPLETED|Overall Study||184
5263204|NCT00734474|12937574|P4|COMPLETED|Overall Study||0
5263205|NCT00734474|12937575|P3|COMPLETED|Overall Study||192
5263206|NCT00734474|12937576|P2|COMPLETED|Overall Study||0
5263207|NCT00734474|12937577|P1|COMPLETED|Overall Study||0
5263208|NCT00734474|12937569|P9|Completed 52-Week Visit|Overall Study||112
5263209|NCT00734474|12937570|P8|Completed 52-Week Visit|Overall Study||238
5263210|NCT00734474|12937571|P7|Completed 52-Week Visit|Overall Study||0
5263211|NCT00734474|12937572|P6|Completed 52-Week Visit|Overall Study||0
5263212|NCT00734474|12937573|P5|Completed 52-Week Visit|Overall Study||243
5263213|NCT00734474|12937574|P4|Completed 52-Week Visit|Overall Study||0
5263214|NCT00734474|12937575|P3|Completed 52-Week Visit|Overall Study||238
5263215|NCT00734474|12937576|P2|Completed 52-Week Visit|Overall Study||0
5263216|NCT00734474|12937577|P1|Completed 52-Week Visit|Overall Study||0
5263217|NCT00734474|12937569|P9|Completed 26-Week Visit|Overall Study||124
5263218|NCT00734474|12937570|P8|Completed 26-Week Visit|Overall Study||270
5263219|NCT00734474|12937571|P7|Completed 26-Week Visit|Overall Study||2
5263220|NCT00734474|12937572|P6|Completed 26-Week Visit|Overall Study||2
5263221|NCT00734474|12937573|P5|Completed 26-Week Visit|Overall Study||268
5263222|NCT00734474|12937574|P4|Completed 26-Week Visit|Overall Study||2
5263223|NCT00734474|12937575|P3|Completed 26-Week Visit|Overall Study||258
5263224|NCT00734474|12937576|P2|Completed 26-Week Visit|Overall Study||0
5263225|NCT00734474|12937577|P1|Completed 26-Week Visit|Overall Study||0
5263226|NCT00734474|12937569|P9|Entered Study After Dose Decision Point|Overall Study||139
5263227|NCT00734474|12937570|P8|Entered Study After Dose Decision Point|Overall Study||273
5263228|NCT00734474|12937571|P7|Entered Study After Dose Decision Point|Overall Study||0
5263229|NCT00734474|12937572|P6|Entered Study After Dose Decision Point|Overall Study||0
5263230|NCT00734474|12937573|P5|Entered Study After Dose Decision Point|Overall Study||281
5263231|NCT00734474|12937574|P4|Entered Study After Dose Decision Point|Overall Study||0
5263232|NCT00734474|12937575|P3|Entered Study After Dose Decision Point|Overall Study||279
5263233|NCT00734474|12937576|P2|Entered Study After Dose Decision Point|Overall Study||0
5263234|NCT00734474|12937577|P1|Entered Study After Dose Decision Point|Overall Study||0
5263235|NCT00734474|12937569|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
5263236|NCT00734474|12937570|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
5263237|NCT00734474|12937571|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
5263238|NCT00734474|12937572|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
5263239|NCT00734474|12937573|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
5263240|NCT00734474|12937574|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
5263241|NCT00734474|12937575|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
5263242|NCT00734474|12937576|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
5263243|NCT00734474|12937577|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
5263244|NCT00734474|12937569|P9|Entered Study Before Dose Decision Point|Overall Study||38
5263245|NCT00734474|12937570|P8|Entered Study Before Dose Decision Point|Overall Study||42
5263246|NCT00734474|12937571|P7|Entered Study Before Dose Decision Point|Overall Study||24
5263247|NCT00734474|12937572|P6|Entered Study Before Dose Decision Point|Overall Study||25
5263248|NCT00734474|12937573|P5|Entered Study Before Dose Decision Point|Overall Study||21
5263249|NCT00734474|12937574|P4|Entered Study Before Dose Decision Point|Overall Study||10
5263250|NCT00734474|12937575|P3|Entered Study Before Dose Decision Point|Overall Study||25
5263251|NCT00734474|12937576|P2|Entered Study Before Dose Decision Point|Overall Study||30
5263252|NCT00734474|12937577|P1|Entered Study Before Dose Decision Point|Overall Study||15
5263253|NCT00734474|12937569|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
5263254|NCT00734474|12937570|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
5263255|NCT00734474|12937571|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
5263256|NCT00734474|12937572|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
5263257|NCT00734474|12937573|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
5263258|NCT00734474|12937574|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
5263259|NCT00734474|12937575|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
5263260|NCT00734474|12937576|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
5263261|NCT00734474|12937577|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
5263262|NCT00734474|12937569|P9|STARTED|Overall Study||177
5263263|NCT00734474|12937570|P8|STARTED|Overall Study||315
5263264|NCT00734474|12937571|P7|STARTED|Overall Study||24
5263265|NCT00734474|12937572|P6|STARTED|Overall Study||25
5263266|NCT00734474|12937573|P5|STARTED|Overall Study||302
5263267|NCT00734474|12937574|P4|STARTED|Overall Study||10
5263268|NCT00734474|12937575|P3|STARTED|Overall Study||304
5263269|NCT00734474|12937576|P2|STARTED|Overall Study||30
5263270|NCT00734474|12937577|P1|STARTED|Overall Study||15
5263271|NCT00734409|12937746|P2|NOT COMPLETED|Overall Study||0
5263272|NCT00734409|12937747|P1|NOT COMPLETED|Overall Study||0
5263273|NCT00734409|12937746|P2|COMPLETED|Overall Study||145
5263274|NCT00734409|12937747|P1|COMPLETED|Overall Study||155
5263275|NCT00734409|12937746|P2|STARTED|Overall Study||145
5263276|NCT00734409|12937747|P1|STARTED|Overall Study||155
5263277|NCT00734344|12937759|P2|NOT COMPLETED|Overall Study||0
5263278|NCT00734344|12937760|P1|NOT COMPLETED|Overall Study||0
5263279|NCT00734344|12937759|P2|COMPLETED|Overall Study||9
5263280|NCT00734344|12937760|P1|COMPLETED|Overall Study||9
5263281|NCT00734344|12937759|P2|STARTED|Overall Study||9
5263282|NCT00734344|12937760|P1|STARTED|Overall Study||9
5263283|NCT00734305|12937830|P7|NOT COMPLETED|Overall Study||0
5263284|NCT00734305|12937831|P6|NOT COMPLETED|Overall Study||0
5263285|NCT00734305|12937832|P5|NOT COMPLETED|Overall Study||0
5263286|NCT00734305|12937833|P4|NOT COMPLETED|Overall Study||0
5263287|NCT00734305|12937834|P3|NOT COMPLETED|Overall Study||0
5263288|NCT00734305|12937835|P2|NOT COMPLETED|Overall Study||0
5263289|NCT00734305|12937836|P1|NOT COMPLETED|Overall Study||1
5263290|NCT00734305|12937830|P7|COMPLETED|Overall Study||18
5263291|NCT00734305|12937831|P6|COMPLETED|Overall Study||4
5263292|NCT00734305|12937832|P5|COMPLETED|Overall Study||5
5263293|NCT00734305|12937833|P4|COMPLETED|Overall Study||3
5263294|NCT00734305|12937834|P3|COMPLETED|Overall Study||4
5263295|NCT00734305|12937835|P2|COMPLETED|Overall Study||3
5263296|NCT00734305|12937836|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
5263297|NCT00734305|12937830|P7|STARTED|Overall Study||18
5263298|NCT00734305|12937831|P6|STARTED|Overall Study||4
5263299|NCT00734305|12937832|P5|STARTED|Overall Study||5
5263300|NCT00734305|12937833|P4|STARTED|Overall Study||3
5263301|NCT00734305|12937834|P3|STARTED|Overall Study||4
5263302|NCT00734305|12937835|P2|STARTED|Overall Study||3
5263303|NCT00734305|12937836|P1|STARTED|Overall Study||7
5263304|NCT00734214|12937867|P2|NOT COMPLETED|Overall Study||4
5263305|NCT00734214|12937868|P1|NOT COMPLETED|Overall Study||4
5263306|NCT00734214|12937867|P2|COMPLETED|Overall Study||126
5263307|NCT00734214|12937868|P1|COMPLETED|Overall Study||124
5263308|NCT00734214|12937867|P2|STARTED|Overall Study||130
5263309|NCT00734214|12937868|P1|STARTED|Overall Study||128
5263310|NCT00734162|12937878|P4|NOT COMPLETED|Open-Label Phase||3
5263311|NCT00734162|12937879|P3|NOT COMPLETED|Open-Label Phase||1
5263312|NCT00734162|12937880|P2|NOT COMPLETED|Open-Label Phase||2
5263313|NCT00734162|12937881|P1|NOT COMPLETED|Open-Label Phase||3
5263314|NCT00734162|12937878|P4|COMPLETED|Open-Label Phase||36
5263315|NCT00734162|12937879|P3|COMPLETED|Open-Label Phase||12
5263316|NCT00734162|12937880|P2|COMPLETED|Open-Label Phase||39
5263317|NCT00734162|12937881|P1|COMPLETED|Open-Label Phase||7
5263318|NCT00734162|12937878|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
5263319|NCT00734162|12937879|P3|STARTED|Open-Label Phase||13
5263320|NCT00734162|12937880|P2|STARTED|Open-Label Phase||41
5263321|NCT00734162|12937881|P1|STARTED|Open-Label Phase||10
5263322|NCT00734162|12937878|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
5263323|NCT00734162|12937879|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
5263324|NCT00734162|12937880|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
5263325|NCT00734162|12937881|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
5263326|NCT00734162|12937878|P4|COMPLETED|Randomized Phase (Through Week 72)||37
5263327|NCT00734162|12937879|P3|COMPLETED|Randomized Phase (Through Week 72)||13
5263328|NCT00734162|12937880|P2|COMPLETED|Randomized Phase (Through Week 72)||41
5263329|NCT00734162|12937881|P1|COMPLETED|Randomized Phase (Through Week 72)||10
5263330|NCT00734162|12937878|P4|STARTED|Randomized Phase (Through Week 72)||41
5263331|NCT00734162|12937879|P3|STARTED|Randomized Phase (Through Week 72)||13
5263332|NCT00734162|12937880|P2|STARTED|Randomized Phase (Through Week 72)||42
5263333|NCT00734162|12937881|P1|STARTED|Randomized Phase (Through Week 72)||10
5263334|NCT00734149|12938105|P1|NOT COMPLETED|Overall Study||1
5263335|NCT00734149|12938105|P1|COMPLETED|Overall Study||44
5263336|NCT00734149|12938105|P1|STARTED|Overall Study||45
5263337|NCT00734097|12938112|P1|NOT COMPLETED|Open Label||16
5263338|NCT00734097|12938112|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
5263339|NCT00734097|12938112|P1|Per Protocol|Open Label||301
5263340|NCT00734097|12938112|P1|Full Analysis|Open Label||311
5263341|NCT00734097|12938112|P1|Safety Analysis|Open Label||317
5263342|NCT00734097|12938112|P1|STARTED|Open Label|Full analysis performed in 311|317
5263343|NCT00734097|12938112|P1|NOT COMPLETED|Screening||20
5263344|NCT00734097|12938112|P1|COMPLETED|Screening|20 participants were screening failure.|317
5263345|NCT00734097|12938112|P1|STARTED|Screening||337
5263346|NCT00734071|12938129|P2|NOT COMPLETED|Overall Study||27
5263347|NCT00734071|12938130|P1|NOT COMPLETED|Overall Study||38
5263348|NCT00734071|12938129|P2|COMPLETED|Overall Study||125
5263349|NCT00734071|12938130|P1|COMPLETED|Overall Study||114
5263350|NCT00734071|12938129|P2|Treated|Overall Study||148
5263351|NCT00734071|12938130|P1|Treated|Overall Study||151
5263352|NCT00734071|12938129|P2|STARTED|Overall Study||152
5263353|NCT00734071|12938130|P1|STARTED|Overall Study||152
5263354|NCT00734032|12938188|P4|NOT COMPLETED|Overall Study||0
5263355|NCT00734032|12938189|P3|NOT COMPLETED|Overall Study||0
5263356|NCT00734032|12938190|P2|NOT COMPLETED|Overall Study||1
5263357|NCT00734032|12938191|P1|NOT COMPLETED|Overall Study||0
5263358|NCT00734032|12938188|P4|COMPLETED|Overall Study||26
5263359|NCT00734032|12938189|P3|COMPLETED|Overall Study||28
5263360|NCT00734032|12938190|P2|COMPLETED|Overall Study||27
5263361|NCT00734032|12938191|P1|COMPLETED|Overall Study||25
5263362|NCT00734032|12938188|P4|STARTED|Overall Study||26
5263363|NCT00734032|12938189|P3|STARTED|Overall Study||28
5263364|NCT00734032|12938190|P2|STARTED|Overall Study||28
5263365|NCT00734032|12938191|P1|STARTED|Overall Study||25
5263366|NCT00733993|12938211|P2|NOT COMPLETED|Overall Study||0
5263367|NCT00733993|12938212|P1|NOT COMPLETED|Overall Study||0
5263368|NCT00733993|12938211|P2|COMPLETED|Overall Study||10
5263369|NCT00733993|12938212|P1|COMPLETED|Overall Study||13
5263370|NCT00733993|12938211|P2|STARTED|Overall Study||10
5263371|NCT00733993|12938212|P1|STARTED|Overall Study||13
5263372|NCT00733980|12938247|P2|NOT COMPLETED|Overall Study||21
5263373|NCT00733980|12938248|P1|NOT COMPLETED|Overall Study||22
5263374|NCT00733980|12938247|P2|COMPLETED|Overall Study||55
5263375|NCT00733980|12938248|P1|COMPLETED|Overall Study||52
5263376|NCT00733980|12938247|P2|STARTED|Overall Study||76
5263377|NCT00733980|12938248|P1|STARTED|Overall Study||74
5263378|NCT00733954|12938292|P2|NOT COMPLETED|Overall Study||2
5263379|NCT00733954|12938293|P1|NOT COMPLETED|Overall Study||8
5263380|NCT00733954|12938292|P2|COMPLETED|Overall Study||123
5263381|NCT00733954|12938293|P1|COMPLETED|Overall Study||116
5263382|NCT00733954|12938292|P2|STARTED|Overall Study||125
5263383|NCT00733954|12938293|P1|STARTED|Overall Study||124
5263384|NCT00733824|12938340|P5|NOT COMPLETED|Phase II||0
5263385|NCT00733824|12938341|P4|NOT COMPLETED|Phase II||0
5263386|NCT00733824|12938342|P3|NOT COMPLETED|Phase II||0
5263387|NCT00733824|12938343|P2|NOT COMPLETED|Phase II||0
5263388|NCT00733824|12938344|P1|NOT COMPLETED|Phase II||0
5263389|NCT00733824|12938340|P5|COMPLETED|Phase II||36
5263390|NCT00733824|12938341|P4|COMPLETED|Phase II||0
5263391|NCT00733824|12938342|P3|COMPLETED|Phase II||0
5263392|NCT00733824|12938343|P2|COMPLETED|Phase II||0
5263393|NCT00733824|12938344|P1|COMPLETED|Phase II||0
5263394|NCT00733824|12938340|P5|STARTED|Phase II||36
5263395|NCT00733824|12938341|P4|STARTED|Phase II||0
5263396|NCT00733824|12938342|P3|STARTED|Phase II||0
5263397|NCT00733824|12938343|P2|STARTED|Phase II||0
5263398|NCT00733824|12938344|P1|STARTED|Phase II||0
5263399|NCT00733824|12938340|P5|NOT COMPLETED|Phase I||0
5263400|NCT00733824|12938341|P4|NOT COMPLETED|Phase I||0
5263401|NCT00733824|12938342|P3|NOT COMPLETED|Phase I||0
5263402|NCT00733824|12938343|P2|NOT COMPLETED|Phase I||0
5263403|NCT00733824|12938344|P1|NOT COMPLETED|Phase I||1
5263404|NCT00733824|12938340|P5|COMPLETED|Phase I||0
5263405|NCT00733824|12938341|P4|COMPLETED|Phase I||6
5263406|NCT00733824|12938342|P3|COMPLETED|Phase I||6
5263407|NCT00733824|12938343|P2|COMPLETED|Phase I||3
5263408|NCT00733824|12938344|P1|COMPLETED|Phase I||9
5263409|NCT00733824|12938340|P5|STARTED|Phase I||0
5263410|NCT00733824|12938341|P4|STARTED|Phase I||6
5263411|NCT00733824|12938342|P3|STARTED|Phase I||6
5263412|NCT00733824|12938343|P2|STARTED|Phase I||3
5263413|NCT00733824|12938344|P1|STARTED|Phase I||10
5263414|NCT00733746|12938363|P1|NOT COMPLETED|Overall Study||5
5263415|NCT00733746|12938363|P1|COMPLETED|Overall Study||114
5263416|NCT00733746|12938363|P1|STARTED|Overall Study||119
5263417|NCT00733512|12938371|P1|NOT COMPLETED|Overall Study||0
5263418|NCT00733512|12938371|P1|COMPLETED|Overall Study||146
5263419|NCT00733512|12938371|P1|STARTED|Overall Study||146
5263420|NCT00733499|12938378|P2|NOT COMPLETED|10 Year Followup||19
5263421|NCT00733499|12938379|P1|NOT COMPLETED|10 Year Followup||20
5263422|NCT00733499|12938378|P2|COMPLETED|10 Year Followup||13
5263423|NCT00733499|12938379|P1|COMPLETED|10 Year Followup||26
5263424|NCT00733499|12938378|P2|STARTED|10 Year Followup||32
5263425|NCT00733499|12938379|P1|STARTED|10 Year Followup||46
5263426|NCT00733499|12938378|P2|NOT COMPLETED|5 Year Followup||25
5263427|NCT00733499|12938379|P1|NOT COMPLETED|5 Year Followup||21
5263428|NCT00733499|12938378|P2|COMPLETED|5 Year Followup||53
5263429|NCT00733499|12938379|P1|COMPLETED|5 Year Followup||70
5263430|NCT00733499|12938378|P2|STARTED|5 Year Followup||78
5263431|NCT00733499|12938379|P1|STARTED|5 Year Followup||91
5263432|NCT00733499|12938378|P2|NOT COMPLETED|24 Months Follow-up||1
5263433|NCT00733499|12938379|P1|NOT COMPLETED|24 Months Follow-up||0
5263434|NCT00733499|12938378|P2|COMPLETED|24 Months Follow-up||95
5263435|NCT00733499|12938379|P1|COMPLETED|24 Months Follow-up||99
5263436|NCT00733499|12938378|P2|STARTED|24 Months Follow-up||96
5263437|NCT00733499|12938379|P1|STARTED|24 Months Follow-up||99
5263438|NCT00733499|12938378|P2|NOT COMPLETED|12 Months Follow-up||1
5263439|NCT00733499|12938379|P1|NOT COMPLETED|12 Months Follow-up||2
5263440|NCT00733499|12938378|P2|COMPLETED|12 Months Follow-up||96
5263441|NCT00733499|12938379|P1|COMPLETED|12 Months Follow-up||99
5263442|NCT00733499|12938378|P2|STARTED|12 Months Follow-up||97
5263443|NCT00733499|12938379|P1|STARTED|12 Months Follow-up||101
5263444|NCT00733499|12938378|P2|NOT COMPLETED|6 Months Follow-up||3
5263445|NCT00733499|12938379|P1|NOT COMPLETED|6 Months Follow-up||0
5263446|NCT00733499|12938378|P2|COMPLETED|6 Months Follow-up||97
5263447|NCT00733499|12938379|P1|COMPLETED|6 Months Follow-up||101
5263448|NCT00733499|12938378|P2|STARTED|6 Months Follow-up||100
5263449|NCT00733499|12938379|P1|STARTED|6 Months Follow-up||101
5263450|NCT00733499|12938378|P2|NOT COMPLETED|3 Months Follow-up||2
5263451|NCT00733499|12938379|P1|NOT COMPLETED|3 Months Follow-up||1
5263452|NCT00733499|12938378|P2|COMPLETED|3 Months Follow-up||100
5263453|NCT00733499|12938379|P1|COMPLETED|3 Months Follow-up||101
5263454|NCT00733499|12938378|P2|STARTED|3 Months Follow-up||102
5263455|NCT00733499|12938379|P1|STARTED|3 Months Follow-up||102
5263456|NCT00733499|12938378|P2|NOT COMPLETED|Pre-operative||1
5263457|NCT00733499|12938379|P1|NOT COMPLETED|Pre-operative||0
5263458|NCT00733499|12938378|P2|COMPLETED|Pre-operative||102
5263459|NCT00733499|12938379|P1|COMPLETED|Pre-operative||102
5263460|NCT00733499|12938378|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
5263461|NCT00733499|12938379|P1|STARTED|Pre-operative||102
5263462|NCT00733421|12938439|P2|NOT COMPLETED|Overall Study||1
5263463|NCT00733421|12938440|P1|NOT COMPLETED|Overall Study||1
5263464|NCT00733421|12938439|P2|COMPLETED|Overall Study|All but one randomised patient|49
5263465|NCT00733421|12938440|P1|COMPLETED|Overall Study|All but one randomsied patient|49
5263466|NCT00733421|12938439|P2|STARTED|Overall Study|November 2008|50
5263467|NCT00733421|12938440|P1|STARTED|Overall Study|November 2008|50
5263468|NCT00733408|12938462|P1|NOT COMPLETED|Overall Study||4
5263469|NCT00733408|12938462|P1|COMPLETED|Overall Study||55
5263470|NCT00733408|12938462|P1|STARTED|Overall Study||59
5263471|NCT00733369|12938474|P2|NOT COMPLETED|Overall Study||9
5263472|NCT00733369|12938475|P1|NOT COMPLETED|Overall Study||10
5263473|NCT00733369|12938474|P2|COMPLETED|Overall Study||47
5263474|NCT00733369|12938475|P1|COMPLETED|Overall Study||40
5263475|NCT00733369|12938474|P2|STARTED|Overall Study||56
5263476|NCT00733369|12938475|P1|STARTED|Overall Study||50
5263477|NCT00733356|12938591|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
5263478|NCT00733356|12938591|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
5263479|NCT00733356|12938591|P1|STARTED|Modified Lab School, Reading Evaluation||26
5263480|NCT00733356|12938591|P1|NOT COMPLETED|Vyvanse Dose Titration||2
5263481|NCT00733356|12938591|P1|COMPLETED|Vyvanse Dose Titration||26
5263482|NCT00733356|12938591|P1|STARTED|Vyvanse Dose Titration||28
5263483|NCT00733343|12938597|P2|NOT COMPLETED|Overall Study||81
5263484|NCT00733343|12938598|P1|NOT COMPLETED|Overall Study||83
5263485|NCT00733343|12938597|P2|COMPLETED|Overall Study||578
5263486|NCT00733343|12938598|P1|COMPLETED|Overall Study||583
5263487|NCT00733343|12938597|P2|STARTED|Overall Study||659
5263488|NCT00733343|12938598|P1|STARTED|Overall Study||666
5263489|NCT00733330|12938688|P2|NOT COMPLETED|Overall Study||4
5263490|NCT00733330|12938689|P1|NOT COMPLETED|Overall Study||2
5263491|NCT00733330|12938688|P2|COMPLETED|Overall Study||48
5263492|NCT00733330|12938689|P1|COMPLETED|Overall Study||30
5263493|NCT00733330|12938688|P2|STARTED|Overall Study||52
5263494|NCT00733330|12938689|P1|STARTED|Overall Study||32
5263495|NCT00733304|12938774|P3|NOT COMPLETED|Overall Study||5
5263496|NCT00733304|12938775|P2|NOT COMPLETED|Overall Study||3
5263497|NCT00733304|12938776|P1|NOT COMPLETED|Overall Study||7
5263498|NCT00733304|12938774|P3|COMPLETED|Overall Study||3
5263499|NCT00733304|12938775|P2|COMPLETED|Overall Study||12
5263500|NCT00733304|12938776|P1|COMPLETED|Overall Study||12
5263501|NCT00733304|12938774|P3|STARTED|Overall Study||8
5263502|NCT00733304|12938775|P2|STARTED|Overall Study||15
5263503|NCT00733304|12938776|P1|STARTED|Overall Study||19
5263504|NCT00733291|12938858|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
5263505|NCT00733291|12938859|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
5263506|NCT00733291|12938860|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
5263507|NCT00733291|12938861|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
5263508|NCT00733291|12938858|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263509|NCT00733291|12938859|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263510|NCT00733291|12938860|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263511|NCT00733291|12938861|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
5263512|NCT00733291|12938858|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263513|NCT00733291|12938859|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263514|NCT00733291|12938860|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
5263515|NCT00733291|12938861|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
5263516|NCT00733291|12938858|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
5263517|NCT00733291|12938859|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
5263518|NCT00733291|12938860|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
5263519|NCT00733291|12938861|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
5263520|NCT00733291|12938858|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
5263521|NCT00733291|12938859|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
5263522|NCT00733291|12938860|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
5263523|NCT00733291|12938861|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
5263524|NCT00733291|12938858|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
5263525|NCT00733291|12938859|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
5263526|NCT00733291|12938860|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
5263527|NCT00733291|12938861|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
5263528|NCT00733291|12938858|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
5263529|NCT00733291|12938859|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
5263530|NCT00733291|12938860|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
5263531|NCT00733291|12938861|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
5263532|NCT00733291|12938858|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263533|NCT00733291|12938859|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263534|NCT00733291|12938860|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263535|NCT00733291|12938861|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
5263536|NCT00733291|12938858|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263537|NCT00733291|12938859|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263538|NCT00733291|12938860|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
5263539|NCT00733291|12938861|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
5263540|NCT00733278|12938883|P1|NOT COMPLETED|Overall Study||0
5263541|NCT00733278|12938883|P1|COMPLETED|Overall Study||7
5263542|NCT00733278|12938883|P1|STARTED|Overall Study||7
5263543|NCT00733226|12938890|P2|NOT COMPLETED|Overall Study||0
5263544|NCT00733226|12938891|P1|NOT COMPLETED|Overall Study||5
5263545|NCT00733226|12938890|P2|COMPLETED|Overall Study||40
5263546|NCT00733226|12938891|P1|COMPLETED|Overall Study||35
5263547|NCT00733226|12938890|P2|STARTED|Overall Study||40
5263548|NCT00733226|12938891|P1|STARTED|Overall Study||40
5263549|NCT00733135|12938907|P1|NOT COMPLETED|Overall Study||2
5263550|NCT00733135|12938907|P1|COMPLETED|Overall Study||131
5263551|NCT00733135|12938907|P1|STARTED|Overall Study||133
5263552|NCT00733096|12938919|P3|NOT COMPLETED|Overall Study||0
5263553|NCT00733096|12938920|P2|NOT COMPLETED|Overall Study||0
5263554|NCT00733096|12938921|P1|NOT COMPLETED|Overall Study||0
5263555|NCT00733096|12938919|P3|COMPLETED|Overall Study||30
5263556|NCT00733096|12938920|P2|COMPLETED|Overall Study||26
5263557|NCT00733096|12938921|P1|COMPLETED|Overall Study||28
5263558|NCT00733096|12938919|P3|STARTED|Overall Study||30
5263559|NCT00733096|12938920|P2|STARTED|Overall Study||26
5263560|NCT00733096|12938921|P1|STARTED|Overall Study||28
5263561|NCT00733005|12938940|P2|NOT COMPLETED|Overall Study||3
5263562|NCT00733005|12938941|P1|NOT COMPLETED|Overall Study||2
5263563|NCT00733005|12938940|P2|COMPLETED|Overall Study||159
5263564|NCT00733005|12938941|P1|COMPLETED|Overall Study||160
5263565|NCT00733005|12938940|P2|STARTED|Overall Study||162
5263566|NCT00733005|12938941|P1|STARTED|Overall Study||162
5263567|NCT00732992|12938951|P2|NOT COMPLETED|Overall Study||6
5263568|NCT00732992|12938952|P1|NOT COMPLETED|Overall Study||6
5263569|NCT00732992|12938951|P2|COMPLETED|Overall Study||0
5263570|NCT00732992|12938952|P1|COMPLETED|Overall Study||0
5263571|NCT00732992|12938951|P2|STARTED|Overall Study||6
5263572|NCT00732992|12938952|P1|STARTED|Overall Study||6
5263573|NCT00732940|12938971|P2|NOT COMPLETED|Overall Study||3
5263574|NCT00732940|12938972|P1|NOT COMPLETED|Overall Study||2
5263575|NCT00732940|12938971|P2|COMPLETED|Overall Study||25
5263576|NCT00732940|12938972|P1|COMPLETED|Overall Study||26
5263577|NCT00732940|12938971|P2|STARTED|Overall Study||28
5263578|NCT00732940|12938972|P1|STARTED|Overall Study||28
5263579|NCT00732901|12939042|P2|NOT COMPLETED|Overall Study||0
5263580|NCT00732901|12939043|P1|NOT COMPLETED|Overall Study||0
5263581|NCT00732901|12939042|P2|COMPLETED|Overall Study||12
5263582|NCT00732901|12939043|P1|COMPLETED|Overall Study||11
5263583|NCT00732901|12939042|P2|STARTED|Overall Study||12
5263584|NCT00732901|12939043|P1|STARTED|Overall Study||11
5263585|NCT00732875|12939053|P1|NOT COMPLETED|Overall Study||35
5263586|NCT00732875|12939053|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
5263587|NCT00732875|12939053|P1|STARTED|Overall Study||92
5263588|NCT00732758|12939061|P2|NOT COMPLETED|Overall Study||16
5263589|NCT00732758|12939062|P1|NOT COMPLETED|Overall Study||8
5263590|NCT00732758|12939061|P2|COMPLETED|Overall Study||63
5263591|NCT00732758|12939062|P1|COMPLETED|Overall Study||70
5263592|NCT00732758|12939061|P2|STARTED|Overall Study||79
5263593|NCT00732758|12939062|P1|STARTED|Overall Study||78
5263594|NCT00732680|12939074|P1|NOT COMPLETED|Overall Study||0
5263595|NCT00732680|12939074|P1|COMPLETED|Overall Study||9
5263596|NCT00732680|12939074|P1|STARTED|Overall Study||9
5263597|NCT00732654|12939081|P3|NOT COMPLETED|Overall Study||0
5263598|NCT00732654|12939082|P2|NOT COMPLETED|Overall Study||1
5263599|NCT00732654|12939083|P1|NOT COMPLETED|Overall Study||0
5263600|NCT00732654|12939081|P3|COMPLETED|Overall Study||10
5263601|NCT00732654|12939082|P2|COMPLETED|Overall Study||9
5263602|NCT00732654|12939083|P1|COMPLETED|Overall Study||10
5263603|NCT00732654|12939081|P3|STARTED|Overall Study||10
5263604|NCT00732654|12939082|P2|STARTED|Overall Study||10
5263605|NCT00732654|12939083|P1|STARTED|Overall Study||10
5263606|NCT00732641|12939102|P2|NOT COMPLETED|Overall Study||112
5263607|NCT00732641|12939103|P1|NOT COMPLETED|Overall Study||106
5263608|NCT00732641|12939102|P2|COMPLETED|Overall Study||9
5263609|NCT00732641|12939103|P1|COMPLETED|Overall Study||17
5263610|NCT00732641|12939102|P2|STARTED|Overall Study||121
5263611|NCT00732641|12939103|P1|STARTED|Overall Study||123
5263612|NCT00732615|12939123|P2|NOT COMPLETED|Overall Study||5
5263613|NCT00732615|12939124|P1|NOT COMPLETED|Overall Study||7
5263614|NCT00732615|12939123|P2|COMPLETED|Overall Study||79
5263615|NCT00732615|12939124|P1|COMPLETED|Overall Study||33
5263616|NCT00732615|12939123|P2|STARTED|Overall Study||84
5263617|NCT00732615|12939124|P1|STARTED|Overall Study||40
5263618|NCT00732498|12939136|P1|NOT COMPLETED|Overall Study||6
5263619|NCT00732498|12939136|P1|COMPLETED|Overall Study||22
5263620|NCT00732498|12939136|P1|STARTED|Overall Study||28
5263621|NCT00732472|12939147|P4|NOT COMPLETED|Overall Study||3
5263622|NCT00732472|12939148|P3|NOT COMPLETED|Overall Study||1
5263623|NCT00732472|12939149|P2|NOT COMPLETED|Overall Study||3
5263624|NCT00732472|12939150|P1|NOT COMPLETED|Overall Study||0
5263625|NCT00732472|12939147|P4|COMPLETED|Overall Study||6
5263626|NCT00732472|12939148|P3|COMPLETED|Overall Study||9
5263627|NCT00732472|12939149|P2|COMPLETED|Overall Study||7
5263628|NCT00732472|12939150|P1|COMPLETED|Overall Study||9
5263629|NCT00732472|12939147|P4|STARTED|Overall Study||9
5263630|NCT00732472|12939148|P3|STARTED|Overall Study||10
5263631|NCT00732472|12939149|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
5263632|NCT00732472|12939150|P1|STARTED|Overall Study||9
5263633|NCT00732381|12939250|P2|NOT COMPLETED|Overall Study||1
5263634|NCT00732381|12939251|P1|NOT COMPLETED|Overall Study||2
5263635|NCT00732381|12939250|P2|COMPLETED|Overall Study||174
5263636|NCT00732381|12939251|P1|COMPLETED|Overall Study||174
5263637|NCT00732381|12939250|P2|STARTED|Overall Study||175
5263638|NCT00732381|12939251|P1|STARTED|Overall Study||176
5263639|NCT00732303|12939259|P1|NOT COMPLETED|Overall Study||2
5263640|NCT00732303|12939259|P1|COMPLETED|Overall Study||6
5263641|NCT00732303|12939259|P1|STARTED|Overall Study||8
5263642|NCT00732251|12939265|P1|NOT COMPLETED|Overall Study||7
5263643|NCT00732251|12939265|P1|COMPLETED|Overall Study||1
5263644|NCT00732251|12939265|P1|STARTED|Overall Study||8
5263645|NCT00732238|12939273|P2|NOT COMPLETED|Overall Study||1
5263646|NCT00732238|12939274|P1|NOT COMPLETED|Overall Study||5
5263647|NCT00732238|12939273|P2|COMPLETED|Overall Study||27
5263648|NCT00732238|12939274|P1|COMPLETED|Overall Study||28
5263649|NCT00732238|12939273|P2|STARTED|Overall Study||28
5263650|NCT00732238|12939274|P1|STARTED|Overall Study||33
5263651|NCT00732225|12939287|P5|NOT COMPLETED|Overall Study||6
5263652|NCT00732225|12939288|P4|NOT COMPLETED|Overall Study||4
5263653|NCT00732225|12939289|P3|NOT COMPLETED|Overall Study||3
5263654|NCT00732225|12939290|P2|NOT COMPLETED|Overall Study||8
5263655|NCT00732225|12939291|P1|NOT COMPLETED|Overall Study||11
5263656|NCT00732225|12939287|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
5263657|NCT00732225|12939288|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
5263658|NCT00732225|12939289|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
5263659|NCT00732225|12939290|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
5263660|NCT00732225|12939291|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
5263661|NCT00732225|12939287|P5|STARTED|Overall Study|55 eyes of 54 patients|54
5263662|NCT00732225|12939288|P4|STARTED|Overall Study|33 eyes of 33 patients|33
5263663|NCT00732225|12939289|P3|STARTED|Overall Study|26 eyes of 26 patients|26
5263664|NCT00732225|12939290|P2|STARTED|Overall Study|41 eyes of 40 patients|40
5263665|NCT00732225|12939291|P1|STARTED|Overall Study|76 eyes of 71 patients|71
5263666|NCT00732212|12939342|P2|NOT COMPLETED|Overall Study||0
5263667|NCT00732212|12939343|P1|NOT COMPLETED|Overall Study||0
5263668|NCT00732212|12939342|P2|COMPLETED|Overall Study||123
5263669|NCT00732212|12939343|P1|COMPLETED|Overall Study||112
5263670|NCT00732212|12939342|P2|Temporarily Suspended|Overall Study||50
5263671|NCT00732212|12939343|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
5263672|NCT00732212|12939342|P2|STARTED|Overall Study||123
5263673|NCT00732212|12939343|P1|STARTED|Overall Study||112
5263674|NCT00732199|12939375|P2|NOT COMPLETED|Overall Study||26
5263675|NCT00732199|12939376|P1|NOT COMPLETED|Overall Study||34
5263676|NCT00732199|12939375|P2|COMPLETED|Overall Study||16
5263677|NCT00732199|12939376|P1|COMPLETED|Overall Study||16
5263678|NCT00732199|12939375|P2|STARTED|Overall Study||42
5263679|NCT00732199|12939376|P1|STARTED|Overall Study||50
5263680|NCT00732160|12939391|P4|NOT COMPLETED|Overall Study||2
5263681|NCT00732160|12939392|P3|NOT COMPLETED|Overall Study||3
5263682|NCT00732160|12939393|P2|NOT COMPLETED|Overall Study||4
5263683|NCT00732160|12939394|P1|NOT COMPLETED|Overall Study||5
5263684|NCT00732160|12939391|P4|COMPLETED|Overall Study||3
5263685|NCT00732160|12939392|P3|COMPLETED|Overall Study||3
5263686|NCT00732160|12939393|P2|COMPLETED|Overall Study||1
5263687|NCT00732160|12939394|P1|COMPLETED|Overall Study||2
5263688|NCT00732160|12939391|P4|LS Aldosterone|Overall Study||5
5263689|NCT00732160|12939392|P3|LS Aldosterone|Overall Study||6
5263690|NCT00732160|12939393|P2|LS Aldosterone|Overall Study||1
5263691|NCT00732160|12939394|P1|LS Aldosterone|Overall Study||2
5263692|NCT00732160|12939391|P4|LS Vehicle|Overall Study||5
5263693|NCT00732160|12939392|P3|LS Vehicle|Overall Study||6
5263694|NCT00732160|12939393|P2|LS Vehicle|Overall Study||1
5263695|NCT00732160|12939394|P1|LS Vehicle|Overall Study||2
5263696|NCT00732160|12939391|P4|HS Aldosterone|Overall Study||3
5263697|NCT00732160|12939392|P3|HS Aldosterone|Overall Study||3
5263698|NCT00732160|12939393|P2|HS Aldosterone|Overall Study||5
5263699|NCT00732160|12939394|P1|HS Aldosterone|Overall Study||7
5263700|NCT00732160|12939391|P4|HS Vehicle|Overall Study||3
5263701|NCT00732160|12939392|P3|HS Vehicle|Overall Study||3
5263702|NCT00732160|12939393|P2|HS Vehicle|Overall Study||5
5263703|NCT00732160|12939394|P1|HS Vehicle|Overall Study||7
5263704|NCT00732160|12939391|P4|STARTED|Overall Study||5
5263705|NCT00732160|12939392|P3|STARTED|Overall Study||6
5263706|NCT00732160|12939393|P2|STARTED|Overall Study||5
5263707|NCT00732160|12939394|P1|STARTED|Overall Study||7
5263708|NCT00732069|12939408|P6|NOT COMPLETED|Third Study Drug||0
5263709|NCT00732069|12939409|P5|NOT COMPLETED|Third Study Drug||0
5263710|NCT00732069|12939410|P4|NOT COMPLETED|Third Study Drug||0
5263711|NCT00732069|12939411|P3|NOT COMPLETED|Third Study Drug||0
5263712|NCT00732069|12939412|P2|NOT COMPLETED|Third Study Drug||0
5263713|NCT00732069|12939413|P1|NOT COMPLETED|Third Study Drug||0
5263714|NCT00732069|12939408|P6|COMPLETED|Third Study Drug||2
5263715|NCT00732069|12939409|P5|COMPLETED|Third Study Drug||3
5263716|NCT00732069|12939410|P4|COMPLETED|Third Study Drug||2
5263717|NCT00732069|12939411|P3|COMPLETED|Third Study Drug||3
5263718|NCT00732069|12939412|P2|COMPLETED|Third Study Drug||3
5263719|NCT00732069|12939413|P1|COMPLETED|Third Study Drug||2
5263720|NCT00732069|12939408|P6|STARTED|Third Study Drug||2
5263721|NCT00732069|12939409|P5|STARTED|Third Study Drug||3
5263722|NCT00732069|12939410|P4|STARTED|Third Study Drug||2
5263723|NCT00732069|12939411|P3|STARTED|Third Study Drug||3
5263724|NCT00732069|12939412|P2|STARTED|Third Study Drug||3
5263725|NCT00732069|12939413|P1|STARTED|Third Study Drug||2
5263726|NCT00732069|12939408|P6|NOT COMPLETED|Washout After Second Study Drug||0
5263727|NCT00732069|12939409|P5|NOT COMPLETED|Washout After Second Study Drug||0
5263728|NCT00732069|12939410|P4|NOT COMPLETED|Washout After Second Study Drug||0
5263729|NCT00732069|12939411|P3|NOT COMPLETED|Washout After Second Study Drug||0
5263730|NCT00732069|12939412|P2|NOT COMPLETED|Washout After Second Study Drug||0
5263731|NCT00732069|12939413|P1|NOT COMPLETED|Washout After Second Study Drug||0
5263732|NCT00732069|12939408|P6|COMPLETED|Washout After Second Study Drug||2
5263733|NCT00732069|12939409|P5|COMPLETED|Washout After Second Study Drug||3
5263734|NCT00732069|12939410|P4|COMPLETED|Washout After Second Study Drug||2
5263735|NCT00732069|12939411|P3|COMPLETED|Washout After Second Study Drug||3
5263736|NCT00732069|12939412|P2|COMPLETED|Washout After Second Study Drug||3
5263737|NCT00732069|12939413|P1|COMPLETED|Washout After Second Study Drug||2
5263738|NCT00732069|12939408|P6|STARTED|Washout After Second Study Drug||2
5263739|NCT00732069|12939409|P5|STARTED|Washout After Second Study Drug||3
5263740|NCT00732069|12939410|P4|STARTED|Washout After Second Study Drug||2
5263741|NCT00732069|12939411|P3|STARTED|Washout After Second Study Drug||3
5263742|NCT00732069|12939412|P2|STARTED|Washout After Second Study Drug||3
5263743|NCT00732069|12939413|P1|STARTED|Washout After Second Study Drug||2
5263744|NCT00732069|12939408|P6|NOT COMPLETED|Second Study Drug||0
5263745|NCT00732069|12939409|P5|NOT COMPLETED|Second Study Drug||0
5263746|NCT00732069|12939410|P4|NOT COMPLETED|Second Study Drug||0
5263747|NCT00732069|12939411|P3|NOT COMPLETED|Second Study Drug||0
5263748|NCT00732069|12939412|P2|NOT COMPLETED|Second Study Drug||0
5263749|NCT00732069|12939413|P1|NOT COMPLETED|Second Study Drug||0
5263750|NCT00732069|12939408|P6|COMPLETED|Second Study Drug||2
5263751|NCT00732069|12939409|P5|COMPLETED|Second Study Drug||3
5263752|NCT00732069|12939410|P4|COMPLETED|Second Study Drug||2
5263753|NCT00732069|12939411|P3|COMPLETED|Second Study Drug||3
5263754|NCT00732069|12939412|P2|COMPLETED|Second Study Drug||3
5263755|NCT00732069|12939413|P1|COMPLETED|Second Study Drug||2
5263756|NCT00732069|12939408|P6|STARTED|Second Study Drug||2
5263757|NCT00732069|12939409|P5|STARTED|Second Study Drug||3
5263758|NCT00732069|12939410|P4|STARTED|Second Study Drug||2
5263759|NCT00732069|12939411|P3|STARTED|Second Study Drug||3
5263760|NCT00732069|12939412|P2|STARTED|Second Study Drug||3
5263761|NCT00732069|12939413|P1|STARTED|Second Study Drug||2
5263762|NCT00732069|12939408|P6|NOT COMPLETED|Washout After First Study Drug||0
5263763|NCT00732069|12939409|P5|NOT COMPLETED|Washout After First Study Drug||0
5263764|NCT00732069|12939410|P4|NOT COMPLETED|Washout After First Study Drug||0
5263765|NCT00732069|12939411|P3|NOT COMPLETED|Washout After First Study Drug||0
5263766|NCT00732069|12939412|P2|NOT COMPLETED|Washout After First Study Drug||0
5263767|NCT00732069|12939413|P1|NOT COMPLETED|Washout After First Study Drug||1
5263768|NCT00732069|12939408|P6|COMPLETED|Washout After First Study Drug||2
5263769|NCT00732069|12939409|P5|COMPLETED|Washout After First Study Drug||3
5263770|NCT00732069|12939410|P4|COMPLETED|Washout After First Study Drug||2
5263771|NCT00732069|12939411|P3|COMPLETED|Washout After First Study Drug||3
5263772|NCT00732069|12939412|P2|COMPLETED|Washout After First Study Drug||3
5263773|NCT00732069|12939413|P1|COMPLETED|Washout After First Study Drug||2
5263774|NCT00732069|12939408|P6|STARTED|Washout After First Study Drug||2
5263775|NCT00732069|12939409|P5|STARTED|Washout After First Study Drug||3
5263776|NCT00732069|12939410|P4|STARTED|Washout After First Study Drug||2
5263777|NCT00732069|12939411|P3|STARTED|Washout After First Study Drug||3
5263778|NCT00732069|12939412|P2|STARTED|Washout After First Study Drug||3
5263779|NCT00732069|12939413|P1|STARTED|Washout After First Study Drug||3
5263780|NCT00732069|12939408|P6|NOT COMPLETED|First Study Drug||0
5263781|NCT00732069|12939409|P5|NOT COMPLETED|First Study Drug||0
5263782|NCT00732069|12939410|P4|NOT COMPLETED|First Study Drug||0
5263783|NCT00732069|12939411|P3|NOT COMPLETED|First Study Drug||0
5263784|NCT00732069|12939412|P2|NOT COMPLETED|First Study Drug||0
5263785|NCT00732069|12939413|P1|NOT COMPLETED|First Study Drug||0
5263786|NCT00732069|12939408|P6|COMPLETED|First Study Drug||2
5263787|NCT00732069|12939409|P5|COMPLETED|First Study Drug||3
5263788|NCT00732069|12939410|P4|COMPLETED|First Study Drug||2
5263789|NCT00732069|12939411|P3|COMPLETED|First Study Drug||3
5263790|NCT00732069|12939412|P2|COMPLETED|First Study Drug||3
5263791|NCT00732069|12939413|P1|COMPLETED|First Study Drug||3
5263792|NCT00732069|12939408|P6|STARTED|First Study Drug||2
5263793|NCT00732069|12939409|P5|STARTED|First Study Drug||3
5263794|NCT00732069|12939410|P4|STARTED|First Study Drug||2
5263795|NCT00732069|12939411|P3|STARTED|First Study Drug||3
5263796|NCT00732069|12939412|P2|STARTED|First Study Drug||3
5263797|NCT00732069|12939413|P1|STARTED|First Study Drug||3
5263798|NCT00732030|12939424|P1|NOT COMPLETED|Overall Study||2
5263799|NCT00732030|12939424|P1|COMPLETED|Overall Study||24
5263800|NCT00732030|12939424|P1|STARTED|Overall Study||26
5263801|NCT00731939|12939431|P1|NOT COMPLETED|Overall Study||34
5263802|NCT00731939|12939431|P1|COMPLETED|Overall Study||90
5263803|NCT00731939|12939431|P1|STARTED|Overall Study||124
5263804|NCT00731874|12939481|P2|NOT COMPLETED|Overall Study||0
5263805|NCT00731874|12939482|P1|NOT COMPLETED|Overall Study||0
5263806|NCT00731874|12939481|P2|COMPLETED|Overall Study||13
5263807|NCT00731874|12939482|P1|COMPLETED|Overall Study||10
5263808|NCT00731874|12939481|P2|STARTED|Overall Study||13
5263809|NCT00731874|12939482|P1|STARTED|Overall Study||10
5263810|NCT00731822|12939508|P2|NOT COMPLETED|Overall Study||1
5263811|NCT00731822|12939509|P1|NOT COMPLETED|Overall Study||4
5263812|NCT00731822|12939508|P2|COMPLETED|Overall Study||39
5263813|NCT00731822|12939509|P1|COMPLETED|Overall Study||16
5263814|NCT00731822|12939508|P2|STARTED|Overall Study||40
5263815|NCT00731822|12939509|P1|STARTED|Overall Study||20
5263816|NCT00731783|12939523|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
5263817|NCT00731783|12939524|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
5263818|NCT00731783|12939523|P2|COMPLETED|12 Month Follow-Up Visit||58
5263819|NCT00731783|12939524|P1|COMPLETED|12 Month Follow-Up Visit||68
5263820|NCT00731783|12939523|P2|STARTED|12 Month Follow-Up Visit||65
5263821|NCT00731783|12939524|P1|STARTED|12 Month Follow-Up Visit||74
5263822|NCT00731783|12939523|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
5263823|NCT00731783|12939524|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
5263824|NCT00731783|12939523|P2|COMPLETED|Six Month Follow-Up Visit||64
5263825|NCT00731783|12939524|P1|COMPLETED|Six Month Follow-Up Visit||71
5263826|NCT00731783|12939523|P2|STARTED|Six Month Follow-Up Visit||67
5263827|NCT00731783|12939524|P1|STARTED|Six Month Follow-Up Visit||77
5263828|NCT00731783|12939523|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
5263829|NCT00731783|12939524|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
5263830|NCT00731783|12939523|P2|COMPLETED|Three Month Follow-Up Visit||57
5263831|NCT00731783|12939524|P1|COMPLETED|Three Month Follow-Up Visit||72
5263832|NCT00731783|12939523|P2|STARTED|Three Month Follow-Up Visit||73
5263833|NCT00731783|12939524|P1|STARTED|Three Month Follow-Up Visit||79
5263834|NCT00731783|12939523|P2|NOT COMPLETED|One Month Follow-Up Visit||22
5263835|NCT00731783|12939524|P1|NOT COMPLETED|One Month Follow-Up Visit||14
5263836|NCT00731783|12939523|P2|COMPLETED|One Month Follow-Up Visit||69
5263837|NCT00731783|12939524|P1|COMPLETED|One Month Follow-Up Visit||78
5263838|NCT00731783|12939523|P2|STARTED|One Month Follow-Up Visit||91
5263839|NCT00731783|12939524|P1|STARTED|One Month Follow-Up Visit||92
5263840|NCT00731770|12939546|P2|NOT COMPLETED|Overall Study||0
5263841|NCT00731770|12939547|P1|NOT COMPLETED|Overall Study||0
5263842|NCT00731770|12939546|P2|COMPLETED|Overall Study||5
5263843|NCT00731770|12939547|P1|COMPLETED|Overall Study||5
5263844|NCT00731770|12939546|P2|STARTED|Overall Study||5
5263845|NCT00731770|12939547|P1|STARTED|Overall Study||5
5263846|NCT00731731|12939558|P3|NOT COMPLETED|Overall Study||3
5263847|NCT00731731|12939559|P2|NOT COMPLETED|Overall Study||0
5263848|NCT00731731|12939560|P1|NOT COMPLETED|Overall Study||0
5263849|NCT00731731|12939558|P3|COMPLETED|Overall Study||107
5263850|NCT00731731|12939559|P2|COMPLETED|Overall Study||3
5263851|NCT00731731|12939560|P1|COMPLETED|Overall Study||12
5263852|NCT00731731|12939558|P3|STARTED|Overall Study||110
5263853|NCT00731731|12939559|P2|STARTED|Overall Study||3
5263854|NCT00731731|12939560|P1|STARTED|Overall Study||12
5263855|NCT00731692|12939578|P3|NOT COMPLETED|Extension Phase||301
5263856|NCT00731692|12939579|P2|NOT COMPLETED|Extension Phase||196
5263857|NCT00731692|12939580|P1|NOT COMPLETED|Extension Phase||74
5263858|NCT00731692|12939578|P3|COMPLETED|Extension Phase||0
5263859|NCT00731692|12939579|P2|COMPLETED|Extension Phase||0
5263860|NCT00731692|12939580|P1|COMPLETED|Extension Phase||0
5263861|NCT00731692|12939578|P3|STARTED|Extension Phase||301
5263862|NCT00731692|12939579|P2|STARTED|Extension Phase||196
5263863|NCT00731692|12939580|P1|STARTED|Extension Phase||74
5263864|NCT00731692|12939578|P3|NOT COMPLETED|Core Study (36 Months)||170
5263865|NCT00731692|12939579|P2|NOT COMPLETED|Core Study (36 Months)||116
5263866|NCT00731692|12939580|P1|NOT COMPLETED|Core Study (36 Months)||68
5263867|NCT00731692|12939578|P3|COMPLETED|Core Study (36 Months)||317
5263868|NCT00731692|12939579|P2|COMPLETED|Core Study (36 Months)||220
5263869|NCT00731692|12939580|P1|COMPLETED|Core Study (36 Months)||79
5263870|NCT00731692|12939578|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
5263871|NCT00731692|12939579|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
5263872|NCT00731692|12939580|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
5263873|NCT00731692|12939578|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
5263874|NCT00731692|12939579|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
5263875|NCT00731692|12939580|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
5263876|NCT00731692|12939578|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
5263877|NCT00731692|12939579|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
5263878|NCT00731692|12939580|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
5263879|NCT00731692|12939578|P3|Safety Set (SAF)|Core Study (36 Months)||487
5263880|NCT00731692|12939579|P2|Safety Set (SAF)|Core Study (36 Months)||336
5263881|NCT00731692|12939580|P1|Safety Set (SAF)|Core Study (36 Months)||0
5263882|NCT00731692|12939578|P3|STARTED|Core Study (36 Months)||487
5263883|NCT00731692|12939579|P2|STARTED|Core Study (36 Months)||336
5263884|NCT00731692|12939580|P1|STARTED|Core Study (36 Months)||147
5263885|NCT00731679|12939626|P2|NOT COMPLETED|Overall Study||26
5263886|NCT00731679|12939627|P1|NOT COMPLETED|Overall Study||22
5263887|NCT00731679|12939626|P2|COMPLETED|Overall Study||283
5263888|NCT00731679|12939627|P1|COMPLETED|Overall Study||292
5263889|NCT00731679|12939626|P2|STARTED|Overall Study||309
5263890|NCT00731679|12939627|P1|STARTED|Overall Study||314
5263891|NCT00731666|12939635|P1|NOT COMPLETED|Overall Study||12
5263892|NCT00731666|12939635|P1|COMPLETED|Overall Study||28
5263893|NCT00731666|12939635|P1|STARTED|Overall Study||40
5263894|NCT00731653|12939641|P1|NOT COMPLETED|Overall Study||9
5263895|NCT00731653|12939641|P1|COMPLETED|Overall Study||72
5263896|NCT00731653|12939641|P1|STARTED|Overall Study||81
5263897|NCT00731640|12939647|P2|NOT COMPLETED|Overall Study||0
5263898|NCT00731640|12939648|P1|NOT COMPLETED|Overall Study||0
5263899|NCT00731640|12939647|P2|COMPLETED|Overall Study||32
5263900|NCT00731640|12939648|P1|COMPLETED|Overall Study||20
5263901|NCT00731640|12939647|P2|STARTED|Overall Study||32
5263902|NCT00731640|12939648|P1|STARTED|Overall Study||20
5263903|NCT00731614|12939662|P2|NOT COMPLETED|Overall Study||13
5263904|NCT00731614|12939663|P1|NOT COMPLETED|Overall Study||7
5263905|NCT00731614|12939662|P2|COMPLETED|Overall Study||18
5263906|NCT00731614|12939663|P1|COMPLETED|Overall Study||16
5263907|NCT00731614|12939662|P2|12 Weeks Posttreatment|Overall Study||23
5263908|NCT00731614|12939663|P1|12 Weeks Posttreatment|Overall Study||18
5263909|NCT00731614|12939662|P2|End of Treatment|Overall Study||24
5263910|NCT00731614|12939663|P1|End of Treatment|Overall Study||16
5263911|NCT00731614|12939662|P2|STARTED|Overall Study||31
5263912|NCT00731614|12939663|P1|STARTED|Overall Study||23
5263913|NCT00731549|12939671|P1|NOT COMPLETED|Overall Study||223
5263914|NCT00731549|12939671|P1|COMPLETED|Overall Study||858
5263915|NCT00731549|12939671|P1|STARTED|Overall Study||1081
5263916|NCT00731484|12939684|P1|NOT COMPLETED|Overall Study||0
5263917|NCT00731484|12939684|P1|COMPLETED|Overall Study||233
5263918|NCT00731484|12939684|P1|STARTED|Overall Study||233
5263919|NCT00731341|12939688|P1|NOT COMPLETED|Overall Study||0
5263920|NCT00731341|12939688|P1|COMPLETED|Overall Study||3
5263921|NCT00731341|12939688|P1|STARTED|Overall Study||3
5263922|NCT00731211|12939697|P1|NOT COMPLETED|Overall Study||0
5263923|NCT00731211|12939697|P1|COMPLETED|Overall Study||55
5263924|NCT00731211|12939697|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
5263925|NCT00731198|12939704|P2|NOT COMPLETED|Overall Study||6
5263926|NCT00731198|12939705|P1|NOT COMPLETED|Overall Study||6
5263927|NCT00731198|12939704|P2|COMPLETED|Overall Study||319
5263928|NCT00731198|12939705|P1|COMPLETED|Overall Study||319
5263929|NCT00731198|12939704|P2|STARTED|Overall Study||325
5263930|NCT00731198|12939705|P1|STARTED|Overall Study||325
5263931|NCT00731133|12939711|P1|NOT COMPLETED|Overall Study||10
5263932|NCT00731133|12939711|P1|COMPLETED|Overall Study||5
5263933|NCT00731133|12939711|P1|STARTED|Overall Study||15
5263934|NCT00731120|12939719|P3|NOT COMPLETED|Overall Study||36
5263935|NCT00731120|12939720|P2|NOT COMPLETED|Overall Study||43
5263936|NCT00731120|12939721|P1|NOT COMPLETED|Overall Study||42
5263937|NCT00731120|12939719|P3|COMPLETED|Overall Study||116
5263938|NCT00731120|12939720|P2|COMPLETED|Overall Study||109
5263939|NCT00731120|12939721|P1|COMPLETED|Overall Study||111
5263940|NCT00731120|12939719|P3|Treated|Overall Study||152
5263941|NCT00731120|12939720|P2|Treated|Overall Study||151
5263942|NCT00731120|12939721|P1|Treated|Overall Study||153
5263943|NCT00731120|12939719|P3|STARTED|Overall Study||152
5263944|NCT00731120|12939720|P2|STARTED|Overall Study||152
5263945|NCT00731120|12939721|P1|STARTED|Overall Study||153
5263946|NCT00731094|12939758|P2|NOT COMPLETED|Overall Study||11
5263947|NCT00731094|12939759|P1|NOT COMPLETED|Overall Study||18
5263948|NCT00731094|12939758|P2|COMPLETED|Overall Study||105
5263949|NCT00731094|12939759|P1|COMPLETED|Overall Study||98
5263950|NCT00731094|12939758|P2|Month 6|Overall Study||107
5263951|NCT00731094|12939759|P1|Month 6|Overall Study||101
5263952|NCT00731094|12939758|P2|STARTED|Overall Study||116
5263953|NCT00731094|12939759|P1|STARTED|Overall Study||116
5263954|NCT00731055|12939829|P1|NOT COMPLETED|Overall Study||0
5263955|NCT00731055|12939829|P1|COMPLETED|Overall Study||16
5263956|NCT00731055|12939829|P1|Received Varenicline 2.0 mg|Overall Study||16
5263957|NCT00731055|12939829|P1|Received Varenicline 1.0 mg|Overall Study||16
5263958|NCT00731055|12939829|P1|Received Varenicline 0.5 mg|Overall Study||16
5263959|NCT00731055|12939829|P1|Received Placebo|Overall Study||16
5263960|NCT00731055|12939829|P1|STARTED|Overall Study|This is a within-subjects study design.|16
5263961|NCT00731042|12939838|P2|NOT COMPLETED|Second Intervention||2
5263962|NCT00731042|12939839|P1|NOT COMPLETED|Second Intervention||0
5263963|NCT00731042|12939838|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
5263964|NCT00731042|12939839|P1|COMPLETED|Second Intervention||16
5263965|NCT00731042|12939838|P2|STARTED|Second Intervention||17
5263966|NCT00731042|12939839|P1|STARTED|Second Intervention||16
5263967|NCT00731042|12939838|P2|NOT COMPLETED|Wash-out||0
5263968|NCT00731042|12939839|P1|NOT COMPLETED|Wash-out||0
5263969|NCT00731042|12939838|P2|COMPLETED|Wash-out||17
5263970|NCT00731042|12939839|P1|COMPLETED|Wash-out||16
5263971|NCT00731042|12939838|P2|STARTED|Wash-out||17
5263972|NCT00731042|12939839|P1|STARTED|Wash-out||16
5263973|NCT00731042|12939838|P2|NOT COMPLETED|First Intervention||0
5263974|NCT00731042|12939839|P1|NOT COMPLETED|First Intervention||0
5263975|NCT00731042|12939838|P2|COMPLETED|First Intervention||17
5263976|NCT00731042|12939839|P1|COMPLETED|First Intervention||16
5263977|NCT00731042|12939838|P2|STARTED|First Intervention||17
5263978|NCT00731042|12939839|P1|STARTED|First Intervention||16
5263979|NCT00730964|12939845|P1|NOT COMPLETED|Overall Study||0
5263980|NCT00730964|12939845|P1|COMPLETED|Overall Study||1039
5263981|NCT00730964|12939845|P1|STARTED|Overall Study||1039
5263982|NCT00730925|12939850|P1|NOT COMPLETED|Overall Study||41
5263983|NCT00730925|12939850|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
5263984|NCT00730925|12939850|P1|STARTED|Overall Study||41
5263985|NCT00730912|12939860|P3|NOT COMPLETED|Overall Study||1
5263986|NCT00730912|12939861|P2|NOT COMPLETED|Overall Study||0
5263987|NCT00730912|12939862|P1|NOT COMPLETED|Overall Study||0
5263988|NCT00730912|12939860|P3|COMPLETED|Overall Study||103
5263989|NCT00730912|12939861|P2|COMPLETED|Overall Study||104
5263990|NCT00730912|12939862|P1|COMPLETED|Overall Study||53
5263991|NCT00730912|12939860|P3|STARTED|Overall Study||104
5263992|NCT00730912|12939861|P2|STARTED|Overall Study||104
5263993|NCT00730912|12939862|P1|STARTED|Overall Study||53
5263994|NCT00730886|12939875|P2|NOT COMPLETED|Overall Study||0
5263995|NCT00730886|12939876|P1|NOT COMPLETED|Overall Study||2
5263996|NCT00730886|12939875|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
5263997|NCT00730886|12939876|P1|COMPLETED|Overall Study||0
5263998|NCT00730886|12939875|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
5263999|NCT00730886|12939876|P1|STARTED|Overall Study||2
5264000|NCT00730847|12939900|P1|NOT COMPLETED|Overall Study||131
5264001|NCT00730847|12939900|P1|COMPLETED|Overall Study||465
5264002|NCT00730847|12939900|P1|STARTED|Overall Study||596
5264003|NCT00730756|12939909|P2|NOT COMPLETED|Overall Study||5
5264004|NCT00730756|12939910|P1|NOT COMPLETED|Overall Study||4
5264005|NCT00730756|12939909|P2|COMPLETED|Overall Study||48
5264006|NCT00730756|12939910|P1|COMPLETED|Overall Study||45
5264007|NCT00730756|12939909|P2|STARTED|Overall Study||53
5264008|NCT00730756|12939910|P1|STARTED|Overall Study||49
5264009|NCT00730730|12939932|P1|NOT COMPLETED|Overall Study||0
5264010|NCT00730730|12939932|P1|COMPLETED|Overall Study||50
5264011|NCT00730730|12939932|P1|STARTED|Overall Study||50
5264012|NCT00730691|12939944|P5|NOT COMPLETED|Overall Study||50
5264013|NCT00730691|12939945|P4|NOT COMPLETED|Overall Study||45
5264014|NCT00730691|12939946|P3|NOT COMPLETED|Overall Study||39
5264015|NCT00730691|12939947|P2|NOT COMPLETED|Overall Study||36
5264016|NCT00730691|12939948|P1|NOT COMPLETED|Overall Study||36
5264017|NCT00730691|12939944|P5|COMPLETED|Overall Study||106
5264018|NCT00730691|12939945|P4|COMPLETED|Overall Study||111
5264019|NCT00730691|12939946|P3|COMPLETED|Overall Study||117
5264020|NCT00730691|12939947|P2|COMPLETED|Overall Study||120
5264021|NCT00730691|12939948|P1|COMPLETED|Overall Study||121
5264022|NCT00730691|12939944|P5|STARTED|Overall Study||156
5264023|NCT00730691|12939945|P4|STARTED|Overall Study||156
5264024|NCT00730691|12939946|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
5264025|NCT00730691|12939947|P2|STARTED|Overall Study||156
5264026|NCT00730691|12939948|P1|STARTED|Overall Study||157
5264027|NCT00730639|12940040|P5|NOT COMPLETED|Overall Study||131
5264028|NCT00730639|12940041|P4|NOT COMPLETED|Overall Study||54
5264029|NCT00730639|12940042|P3|NOT COMPLETED|Overall Study||86
5264030|NCT00730639|12940043|P2|NOT COMPLETED|Overall Study||18
5264031|NCT00730639|12940044|P1|NOT COMPLETED|Overall Study||17
5264032|NCT00730639|12940040|P5|COMPLETED|Overall Study||0
5264033|NCT00730639|12940041|P4|COMPLETED|Overall Study||0
5264034|NCT00730639|12940042|P3|COMPLETED|Overall Study||0
5264035|NCT00730639|12940043|P2|COMPLETED|Overall Study||0
5264036|NCT00730639|12940044|P1|COMPLETED|Overall Study||0
5264037|NCT00730639|12940040|P5|STARTED|Overall Study||131
5264038|NCT00730639|12940041|P4|STARTED|Overall Study||54
5264039|NCT00730639|12940042|P3|STARTED|Overall Study||86
5264040|NCT00730639|12940043|P2|STARTED|Overall Study||18
5264041|NCT00730639|12940044|P1|STARTED|Overall Study||17
5264042|NCT00730483|12940108|P1|NOT COMPLETED|Overall Study||7
5264043|NCT00730483|12940108|P1|COMPLETED|Overall Study||6
5264044|NCT00730483|12940108|P1|6 Months After First DEB-TACE|Overall Study||10
5264045|NCT00730483|12940108|P1|1 Month After First DEB-TACE|Overall Study||13
5264046|NCT00730483|12940108|P1|STARTED|Overall Study||13
5264047|NCT00730405|12940121|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
5264048|NCT00730405|12940122|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
5264049|NCT00730405|12940123|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
5264050|NCT00730405|12940124|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
5264051|NCT00730405|12940125|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
5264052|NCT00730405|12940121|P5|COMPLETED|Overall Study-follow-up Phase||93
5264053|NCT00730405|12940122|P4|COMPLETED|Overall Study-follow-up Phase||100
5264054|NCT00730405|12940123|P3|COMPLETED|Overall Study-follow-up Phase||94
5264055|NCT00730405|12940124|P2|COMPLETED|Overall Study-follow-up Phase||96
5264056|NCT00730405|12940125|P1|COMPLETED|Overall Study-follow-up Phase||95
5264057|NCT00730405|12940121|P5|STARTED|Overall Study-follow-up Phase||115
5264058|NCT00730405|12940122|P4|STARTED|Overall Study-follow-up Phase||117
5264059|NCT00730405|12940123|P3|STARTED|Overall Study-follow-up Phase||117
5264060|NCT00730405|12940124|P2|STARTED|Overall Study-follow-up Phase||117
5264061|NCT00730405|12940125|P1|STARTED|Overall Study-follow-up Phase||116
5264062|NCT00730405|12940121|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
5264063|NCT00730405|12940122|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
5264064|NCT00730405|12940123|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
5264065|NCT00730405|12940124|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
5264066|NCT00730405|12940125|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
5264067|NCT00730405|12940121|P5|COMPLETED|Overall Study-Treatment Phase||95
5264068|NCT00730405|12940122|P4|COMPLETED|Overall Study-Treatment Phase||98
5264069|NCT00730405|12940123|P3|COMPLETED|Overall Study-Treatment Phase||96
5264070|NCT00730405|12940124|P2|COMPLETED|Overall Study-Treatment Phase||96
5264071|NCT00730405|12940125|P1|COMPLETED|Overall Study-Treatment Phase||97
5264072|NCT00730405|12940121|P5|STARTED|Overall Study-Treatment Phase||115
5264073|NCT00730405|12940122|P4|STARTED|Overall Study-Treatment Phase||117
5264074|NCT00730405|12940123|P3|STARTED|Overall Study-Treatment Phase||117
5264075|NCT00730405|12940124|P2|STARTED|Overall Study-Treatment Phase||117
5264076|NCT00730405|12940125|P1|STARTED|Overall Study-Treatment Phase||116
5264077|NCT00730353|12940162|P1|NOT COMPLETED|Overall Study||0
5264078|NCT00730353|12940162|P1|COMPLETED|Overall Study||28
5264079|NCT00730353|12940162|P1|STARTED|Overall Study||28
5264080|NCT00730327|12940172|P2|NOT COMPLETED|Overall Study||37
5264081|NCT00730327|12940173|P1|NOT COMPLETED|Overall Study||27
5264082|NCT00730327|12940172|P2|COMPLETED|Overall Study||93
5264083|NCT00730327|12940173|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
5264084|NCT00730327|12940172|P2|Completed Week 26|Overall Study||99
5264085|NCT00730327|12940173|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
5264086|NCT00730327|12940172|P2|STARTED|Overall Study||130
5264087|NCT00730327|12940173|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
5264088|NCT00730275|12940198|P4|NOT COMPLETED|Overall Study||1
5264089|NCT00730275|12940199|P3|NOT COMPLETED|Overall Study||0
5264090|NCT00730275|12940200|P2|NOT COMPLETED|Overall Study||0
5264091|NCT00730275|12940201|P1|NOT COMPLETED|Overall Study||0
5264092|NCT00730275|12940198|P4|COMPLETED|Overall Study||8
5264093|NCT00730275|12940199|P3|COMPLETED|Overall Study||8
5264094|NCT00730275|12940200|P2|COMPLETED|Overall Study||9
5264095|NCT00730275|12940201|P1|COMPLETED|Overall Study||9
5264096|NCT00730275|12940198|P4|STARTED|Overall Study||9
5264097|NCT00730275|12940199|P3|STARTED|Overall Study||8
5264098|NCT00730275|12940200|P2|STARTED|Overall Study||9
5264099|NCT00730275|12940201|P1|STARTED|Overall Study||9
5264100|NCT00730236|12940227|P1|NOT COMPLETED|Overall Study||6
5264101|NCT00730236|12940227|P1|COMPLETED|Overall Study||23
5264102|NCT00730236|12940227|P1|STARTED|Overall Study||29
5264103|NCT00730171|12940242|P1|NOT COMPLETED|Overall Study||771
5264104|NCT00730171|12940242|P1|COMPLETED|Overall Study||954
5264105|NCT00730171|12940242|P1|IBS-C Safety Population|Overall Study||1119
5264106|NCT00730171|12940242|P1|CC Safety Population|Overall Study||607
5264107|NCT00730171|12940242|P1|STARTED|Overall Study||1725
5264108|NCT00730158|12940252|P2|NOT COMPLETED|Overall Study||1
5264109|NCT00730158|12940253|P1|NOT COMPLETED|Overall Study||1
5264110|NCT00730158|12940252|P2|COMPLETED|Overall Study||15
5264111|NCT00730158|12940253|P1|COMPLETED|Overall Study||16
5264112|NCT00730158|12940252|P2|STARTED|Overall Study||16
5264113|NCT00730158|12940253|P1|STARTED|Overall Study||17
5264114|NCT00730132|12940291|P1|NOT COMPLETED|Overall Study||155
5264115|NCT00730132|12940291|P1|COMPLETED|Overall Study||557
5264116|NCT00730132|12940291|P1|STARTED|Overall Study||712
5264117|NCT00730041|12940309|P2|NOT COMPLETED|Overall Study||2
5264118|NCT00730041|12940310|P1|NOT COMPLETED|Overall Study||0
5264119|NCT00730041|12940309|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
5264120|NCT00730041|12940310|P1|COMPLETED|Overall Study||26
5264121|NCT00730041|12940309|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
5264122|NCT00730041|12940310|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
5264123|NCT00730028|12940333|P5|NOT COMPLETED|Overall Study||82
5264124|NCT00730028|12940334|P4|NOT COMPLETED|Overall Study||56
5264125|NCT00730028|12940335|P3|NOT COMPLETED|Overall Study||45
5264126|NCT00730028|12940336|P2|NOT COMPLETED|Overall Study||66
5264127|NCT00730028|12940337|P1|NOT COMPLETED|Overall Study||60
5264128|NCT00730028|12940333|P5|COMPLETED|Overall Study||175
5264129|NCT00730028|12940334|P4|COMPLETED|Overall Study||207
5264130|NCT00730028|12940335|P3|COMPLETED|Overall Study||221
5264131|NCT00730028|12940336|P2|COMPLETED|Overall Study||194
5264132|NCT00730028|12940337|P1|COMPLETED|Overall Study||204
5264133|NCT00730028|12940333|P5|STARTED|Overall Study||257
5264134|NCT00730028|12940334|P4|STARTED|Overall Study||263
5264135|NCT00730028|12940335|P3|STARTED|Overall Study||266
5264136|NCT00730028|12940336|P2|STARTED|Overall Study||260
5264137|NCT00730028|12940337|P1|STARTED|Overall Study||264
5264138|NCT00730015|12940387|P3|NOT COMPLETED|Overall Study||32
5264139|NCT00730015|12940388|P2|NOT COMPLETED|Overall Study||40
5264140|NCT00730015|12940389|P1|NOT COMPLETED|Overall Study||31
5264141|NCT00730015|12940387|P3|COMPLETED|Overall Study||177
5264142|NCT00730015|12940388|P2|COMPLETED|Overall Study||177
5264143|NCT00730015|12940389|P1|COMPLETED|Overall Study||186
5264144|NCT00730015|12940387|P3|STARTED|Overall Study||209
5264145|NCT00730015|12940388|P2|STARTED|Overall Study||217
5264146|NCT00730015|12940389|P1|STARTED|Overall Study||217
5264147|NCT00729937|12940429|P6|NOT COMPLETED|Overall Study||37
5264148|NCT00729937|12940430|P5|NOT COMPLETED|Overall Study||28
5264149|NCT00729937|12940431|P4|NOT COMPLETED|Overall Study||34
5264150|NCT00729937|12940432|P3|NOT COMPLETED|Overall Study||29
5264151|NCT00729937|12940433|P2|NOT COMPLETED|Overall Study||88
5264152|NCT00729937|12940434|P1|NOT COMPLETED|Overall Study||74
5264153|NCT00729937|12940429|P6|COMPLETED|Overall Study||214
5264154|NCT00729937|12940430|P5|COMPLETED|Overall Study||221
5264155|NCT00729937|12940431|P4|COMPLETED|Overall Study||215
5264156|NCT00729937|12940432|P3|COMPLETED|Overall Study||222
5264157|NCT00729937|12940433|P2|COMPLETED|Overall Study||548
5264158|NCT00729937|12940434|P1|COMPLETED|Overall Study||555
5264159|NCT00729937|12940429|P6|STARTED|Overall Study||251
5264160|NCT00729937|12940430|P5|STARTED|Overall Study||249
5264161|NCT00729937|12940431|P4|STARTED|Overall Study||249
5264162|NCT00729937|12940432|P3|STARTED|Overall Study||251
5264163|NCT00729937|12940433|P2|STARTED|Overall Study||636
5264164|NCT00729937|12940434|P1|STARTED|Overall Study||629
5264165|NCT00729924|12940628|P1|NOT COMPLETED|Overall Study||0
5264166|NCT00729924|12940628|P1|COMPLETED|Overall Study||40
5264167|NCT00729924|12940628|P1|STARTED|Overall Study||40
5264168|NCT00729859|12940638|P3|NOT COMPLETED|Overall Study||0
5264169|NCT00729859|12940639|P2|NOT COMPLETED|Overall Study||2
5264170|NCT00729859|12940640|P1|NOT COMPLETED|Overall Study||0
5264171|NCT00729859|12940638|P3|COMPLETED|Overall Study||8
5264172|NCT00729859|12940639|P2|COMPLETED|Overall Study||6
5264173|NCT00729859|12940640|P1|COMPLETED|Overall Study||8
5264174|NCT00729859|12940638|P3|STARTED|Overall Study||8
5264175|NCT00729859|12940639|P2|STARTED|Overall Study||8
5264176|NCT00729859|12940640|P1|STARTED|Overall Study||8
5264177|NCT00729846|12940677|P2|NOT COMPLETED|Overall Study||0
5264178|NCT00729846|12940678|P1|NOT COMPLETED|Overall Study||0
5264179|NCT00729846|12940677|P2|COMPLETED|Overall Study||11
5264180|NCT00729846|12940678|P1|COMPLETED|Overall Study||11
5264181|NCT00729846|12940677|P2|STARTED|Overall Study||11
5264182|NCT00729846|12940678|P1|STARTED|Overall Study||11
5264183|NCT00729833|12940684|P4|NOT COMPLETED|Overall Study||6
5264184|NCT00729833|12940685|P3|NOT COMPLETED|Overall Study||12
5264185|NCT00729833|12940686|P2|NOT COMPLETED|Overall Study||7
5264186|NCT00729833|12940687|P1|NOT COMPLETED|Overall Study||20
5264187|NCT00729833|12940684|P4|COMPLETED|Overall Study||0
5264188|NCT00729833|12940685|P3|COMPLETED|Overall Study||0
5264189|NCT00729833|12940686|P2|COMPLETED|Overall Study||0
5264190|NCT00729833|12940687|P1|COMPLETED|Overall Study||0
5264191|NCT00729833|12940684|P4|STARTED|Overall Study||6
5264192|NCT00729833|12940685|P3|STARTED|Overall Study||12
5264193|NCT00729833|12940686|P2|STARTED|Overall Study||7
5264194|NCT00729833|12940687|P1|STARTED|Overall Study||20
5264195|NCT00729807|12940726|P1|NOT COMPLETED|Overall Study||0
5264196|NCT00729807|12940726|P1|COMPLETED|Overall Study||6
5264197|NCT00729807|12940726|P1|STARTED|Overall Study||6
5264198|NCT00729781|12940736|P1|NOT COMPLETED|Long-term Follow-up Study||0
5264199|NCT00729781|12940736|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
5264200|NCT00729781|12940736|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
5264201|NCT00729781|12940736|P1|NOT COMPLETED|Original Study||0
5264202|NCT00729781|12940736|P1|COMPLETED|Original Study||45
5264203|NCT00729781|12940736|P1|STARTED|Original Study||45
5264204|NCT00729690|12940745|P3|NOT COMPLETED|Overall Study||2
5264205|NCT00729690|12940746|P2|NOT COMPLETED|Overall Study||2
5264206|NCT00729690|12940747|P1|NOT COMPLETED|Overall Study||0
5264207|NCT00729690|12940745|P3|COMPLETED|Overall Study||14
5264208|NCT00729690|12940746|P2|COMPLETED|Overall Study||14
5264209|NCT00729690|12940747|P1|COMPLETED|Overall Study||16
5264210|NCT00729690|12940745|P3|STARTED|Overall Study||16
5264211|NCT00729690|12940746|P2|STARTED|Overall Study||16
5264212|NCT00729690|12940747|P1|STARTED|Overall Study||16
5264213|NCT00729677|12940764|P1|NOT COMPLETED|Overall Study||0
5264214|NCT00729677|12940764|P1|COMPLETED|Overall Study||64
5264215|NCT00729677|12940764|P1|STARTED|Overall Study||64
5264216|NCT00729651|12940777|P2|NOT COMPLETED|Overall Study||18
5264217|NCT00729651|12940778|P1|NOT COMPLETED|Overall Study||19
5264218|NCT00729651|12940777|P2|COMPLETED|Overall Study||152
5264219|NCT00729651|12940778|P1|COMPLETED|Overall Study||154
5264220|NCT00729651|12940777|P2|STARTED|Overall Study||170
5264221|NCT00729651|12940778|P1|STARTED|Overall Study||173
5264222|NCT00729612|12940790|P1|NOT COMPLETED|Overall Study||10
5264223|NCT00729612|12940790|P1|COMPLETED|Overall Study||53
5264224|NCT00729612|12940790|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
5264225|NCT00729612|12940790|P1|Received Cycle 2|Overall Study||54
5264226|NCT00729612|12940790|P1|Did Not Receive Cycle 2|Overall Study||7
5264227|NCT00729612|12940790|P1|Received Cycle 1|Overall Study||62
5264228|NCT00729612|12940790|P1|Died Before Cycle 1|Overall Study||1
5264229|NCT00729612|12940790|P1|STARTED|Overall Study||63
5264230|NCT00729586|12940799|P2|NOT COMPLETED|Overall Study||1
5264231|NCT00729586|12940800|P1|NOT COMPLETED|Overall Study||1
5264232|NCT00729586|12940799|P2|COMPLETED|Overall Study|Eligible and treated patients|21
5264233|NCT00729586|12940800|P1|COMPLETED|Overall Study|Eligible and treated patients|50
5264234|NCT00729586|12940799|P2|STARTED|Overall Study||22
5264235|NCT00729586|12940800|P1|STARTED|Overall Study||51
5264236|NCT00729560|12940813|P1|NOT COMPLETED|Overall Study||3
5264237|NCT00729560|12940813|P1|COMPLETED|Overall Study||5
5264238|NCT00729560|12940813|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
5264239|NCT00729521|12940820|P3|NOT COMPLETED|Overall Study||0
5264240|NCT00729521|12940821|P2|NOT COMPLETED|Overall Study||0
5264241|NCT00729521|12940822|P1|NOT COMPLETED|Overall Study||0
5264242|NCT00729521|12940820|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
5264243|NCT00729521|12940821|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
5264244|NCT00729521|12940822|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
5264245|NCT00729521|12940820|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
5264246|NCT00729521|12940821|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
5264247|NCT00729521|12940822|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
5264248|NCT00729482|12940830|P1|NOT COMPLETED|Overall Study||0
5264249|NCT00729482|12940830|P1|COMPLETED|Overall Study||54
5264250|NCT00729482|12940830|P1|STARTED|Overall Study||54
5264251|NCT00729469|12940839|P2|NOT COMPLETED|Overall Study||47
5264252|NCT00729469|12940840|P1|NOT COMPLETED|Overall Study||53
5264253|NCT00729469|12940839|P2|COMPLETED|Overall Study||416
5264254|NCT00729469|12940840|P1|COMPLETED|Overall Study||403
5264255|NCT00729469|12940839|P2|STARTED|Overall Study||463
5264256|NCT00729469|12940840|P1|STARTED|Overall Study||456
5264257|NCT00729430|12940878|P2|NOT COMPLETED|Overall Study||50
5264258|NCT00729430|12940879|P1|NOT COMPLETED|Overall Study||47
5264259|NCT00729430|12940878|P2|COMPLETED|Overall Study||128
5264260|NCT00729430|12940879|P1|COMPLETED|Overall Study||133
5264261|NCT00729430|12940878|P2|STARTED|Overall Study||178
5264262|NCT00729430|12940879|P1|STARTED|Overall Study||180
5264263|NCT00729378|12940893|P2|NOT COMPLETED|36-months||6
5264264|NCT00729378|12940894|P1|NOT COMPLETED|36-months||15
5264265|NCT00729378|12940893|P2|COMPLETED|36-months||95
5264266|NCT00729378|12940894|P1|COMPLETED|36-months||105
5264267|NCT00729378|12940893|P2|STARTED|36-months||101
5264268|NCT00729378|12940894|P1|STARTED|36-months||120
5264269|NCT00729378|12940893|P2|NOT COMPLETED|24-months||51
5264270|NCT00729378|12940894|P1|NOT COMPLETED|24-months||72
5264271|NCT00729378|12940893|P2|COMPLETED|24-months||101
5264272|NCT00729378|12940894|P1|COMPLETED|24-months||120
5264273|NCT00729378|12940893|P2|STARTED|24-months||152
5264274|NCT00729378|12940894|P1|STARTED|24-months||192
5264275|NCT00729378|12940893|P2|NOT COMPLETED|12-months||65
5264276|NCT00729378|12940894|P1|NOT COMPLETED|12-months||100
5264277|NCT00729378|12940893|P2|COMPLETED|12-months||152
5264278|NCT00729378|12940894|P1|COMPLETED|12-months||192
5264279|NCT00729378|12940893|P2|STARTED|12-months||217
5264280|NCT00729378|12940894|P1|STARTED|12-months||292
5264281|NCT00729378|12940893|P2|NOT COMPLETED|Baseline||92
5264282|NCT00729378|12940894|P1|NOT COMPLETED|Baseline||138
5264283|NCT00729378|12940893|P2|COMPLETED|Baseline||217
5264284|NCT00729378|12940894|P1|COMPLETED|Baseline||292
5264285|NCT00729378|12940893|P2|STARTED|Baseline||309
5264286|NCT00729378|12940894|P1|STARTED|Baseline||430
5264287|NCT00729365|12941093|P3|NOT COMPLETED|Overall Study||7
5264288|NCT00729365|12941094|P2|NOT COMPLETED|Overall Study||6
5264289|NCT00729365|12941095|P1|NOT COMPLETED|Overall Study||33
5264290|NCT00729365|12941093|P3|COMPLETED|Overall Study|Study terminated|0
5264291|NCT00729365|12941094|P2|COMPLETED|Overall Study|Study Terminated|0
5264292|NCT00729365|12941095|P1|COMPLETED|Overall Study|Study terminated|0
5264293|NCT00729365|12941093|P3|STARTED|Overall Study||7
5264294|NCT00729365|12941094|P2|STARTED|Overall Study||6
5264295|NCT00729365|12941095|P1|STARTED|Overall Study||33
5264296|NCT00729326|12941108|P2|NOT COMPLETED|Overall Study||9
5264297|NCT00729326|12941109|P1|NOT COMPLETED|Overall Study||10
5264298|NCT00729326|12941108|P2|COMPLETED|Overall Study||33
5264299|NCT00729326|12941109|P1|COMPLETED|Overall Study||31
5264300|NCT00729326|12941108|P2|STARTED|Overall Study||42
5264301|NCT00729326|12941109|P1|STARTED|Overall Study||41
5264302|NCT00729248|12941151|P1|NOT COMPLETED|Overall Study||2
5264303|NCT00729248|12941151|P1|COMPLETED|Overall Study||10
5264304|NCT00729248|12941151|P1|STARTED|Overall Study||12
5264305|NCT00729183|12941158|P2|NOT COMPLETED|Overall Study||15
5264306|NCT00729183|12941159|P1|NOT COMPLETED|Overall Study||25
5264307|NCT00729183|12941158|P2|COMPLETED|Overall Study|Completed 24 month visit|90
5264308|NCT00729183|12941159|P1|COMPLETED|Overall Study|Completed 24 month visit|84
5264309|NCT00729183|12941158|P2|STARTED|Overall Study||105
5264310|NCT00729183|12941159|P1|STARTED|Overall Study||109
5264311|NCT00729157|12941191|P1|NOT COMPLETED|Overall Study||1
5264312|NCT00729157|12941191|P1|COMPLETED|Overall Study||40
5264313|NCT00729157|12941191|P1|STARTED|Overall Study||41
5264314|NCT00729053|12941203|P4|NOT COMPLETED|Overall Study||0
5264315|NCT00729053|12941204|P3|NOT COMPLETED|Overall Study||0
5264316|NCT00729053|12941205|P2|NOT COMPLETED|Overall Study||0
5264317|NCT00729053|12941206|P1|NOT COMPLETED|Overall Study||0
5264318|NCT00729053|12941203|P4|COMPLETED|Overall Study||23
5264319|NCT00729053|12941204|P3|COMPLETED|Overall Study||23
5264320|NCT00729053|12941205|P2|COMPLETED|Overall Study||23
5264321|NCT00729053|12941206|P1|COMPLETED|Overall Study||23
5264322|NCT00729053|12941203|P4|STARTED|Overall Study||23
5264323|NCT00729053|12941204|P3|STARTED|Overall Study||23
5264324|NCT00729053|12941205|P2|STARTED|Overall Study||23
5264325|NCT00729053|12941206|P1|STARTED|Overall Study||23
5264326|NCT00728988|12941234|P2|NOT COMPLETED|Overall Study||88
5264327|NCT00728988|12941235|P1|NOT COMPLETED|Overall Study||93
5264328|NCT00728988|12941234|P2|COMPLETED|Overall Study||164
5264329|NCT00728988|12941235|P1|COMPLETED|Overall Study||154
5264330|NCT00728988|12941234|P2|Full Analysis Set|Overall Study||172
5264331|NCT00728988|12941235|P1|Full Analysis Set|Overall Study||163
5264332|NCT00728988|12941234|P2|Treated|Overall Study||250
5264333|NCT00728988|12941235|P1|Treated|Overall Study||245
5264334|NCT00728988|12941234|P2|STARTED|Overall Study||252
5264335|NCT00728988|12941235|P1|STARTED|Overall Study||247
5264336|NCT00728962|12941253|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
5264337|NCT00728962|12941253|P1|COMPLETED|Two Year Post Placement Follow-up||59
5264338|NCT00728962|12941253|P1|STARTED|Two Year Post Placement Follow-up||62
5264339|NCT00728962|12941253|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
5264340|NCT00728962|12941253|P1|COMPLETED|One Year Post Placement Follow-up||62
5264341|NCT00728962|12941253|P1|STARTED|One Year Post Placement Follow-up||62
5264342|NCT00728962|12941253|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
5264343|NCT00728962|12941253|P1|COMPLETED|Permanent Prosthesis Placement||62
5264344|NCT00728962|12941253|P1|STARTED|Permanent Prosthesis Placement||65
5264345|NCT00728962|12941253|P1|NOT COMPLETED|Implant Placement Surgery||10
5264346|NCT00728962|12941253|P1|COMPLETED|Implant Placement Surgery||65
5264347|NCT00728962|12941253|P1|STARTED|Implant Placement Surgery||75
5264348|NCT00728949|12941259|P2|NOT COMPLETED|Overall Study||4
5264349|NCT00728949|12941260|P1|NOT COMPLETED|Overall Study||11
5264350|NCT00728949|12941259|P2|COMPLETED|Overall Study||27
5264351|NCT00728949|12941260|P1|COMPLETED|Overall Study||51
5264352|NCT00728949|12941259|P2|STARTED|Overall Study||31
5264353|NCT00728949|12941260|P1|STARTED|Overall Study||62
5264354|NCT00728936|12941285|P7|NOT COMPLETED|Overall Study||0
5264355|NCT00728936|12941286|P6|NOT COMPLETED|Overall Study||1
5264356|NCT00728936|12941287|P5|NOT COMPLETED|Overall Study||0
5264357|NCT00728936|12941288|P4|NOT COMPLETED|Overall Study||0
5264358|NCT00728936|12941289|P3|NOT COMPLETED|Overall Study||0
5264359|NCT00728936|12941290|P2|NOT COMPLETED|Overall Study||0
5264360|NCT00728936|12941291|P1|NOT COMPLETED|Overall Study||0
5264361|NCT00728936|12941285|P7|COMPLETED|Overall Study||7
5264362|NCT00728936|12941286|P6|COMPLETED|Overall Study||7
5264363|NCT00728936|12941287|P5|COMPLETED|Overall Study||8
5264364|NCT00728936|12941288|P4|COMPLETED|Overall Study||8
5264365|NCT00728936|12941289|P3|COMPLETED|Overall Study||9
5264366|NCT00728936|12941290|P2|COMPLETED|Overall Study||8
5264367|NCT00728936|12941291|P1|COMPLETED|Overall Study||10
5264368|NCT00728936|12941285|P7|STARTED|Overall Study||7
5264369|NCT00728936|12941286|P6|STARTED|Overall Study||8
5264370|NCT00728936|12941287|P5|STARTED|Overall Study||8
5264371|NCT00728936|12941288|P4|STARTED|Overall Study||8
5264372|NCT00728936|12941289|P3|STARTED|Overall Study||9
5264373|NCT00728936|12941290|P2|STARTED|Overall Study||8
5264374|NCT00728936|12941291|P1|STARTED|Overall Study||10
5264375|NCT00728923|12941307|P1|NOT COMPLETED|Overall Study||0
5264376|NCT00728923|12941307|P1|COMPLETED|Overall Study||9
5264377|NCT00728923|12941307|P1|STARTED|Overall Study||9
5264378|NCT00728910|12941312|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
5264379|NCT00728910|12941312|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
5264380|NCT00728910|12941312|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
5264381|NCT00728910|12941312|P1|NOT COMPLETED|Atorvastatin+ABT335||0
5264382|NCT00728910|12941312|P1|COMPLETED|Atorvastatin+ABT335||22
5264383|NCT00728910|12941312|P1|STARTED|Atorvastatin+ABT335||22
5264384|NCT00728910|12941312|P1|NOT COMPLETED|Atorvastatin||3
5264385|NCT00728910|12941312|P1|COMPLETED|Atorvastatin||22
5264386|NCT00728910|12941312|P1|STARTED|Atorvastatin||25
5264387|NCT00728884|12941324|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
5264388|NCT00728884|12941324|P1|COMPLETED|Two Year Post Placement Follow-up||145
5264389|NCT00728884|12941324|P1|STARTED|Two Year Post Placement Follow-up||145
5264390|NCT00728884|12941324|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
5264391|NCT00728884|12941324|P1|COMPLETED|One Year Post Placement Follow-up||145
5264392|NCT00728884|12941324|P1|STARTED|One Year Post Placement Follow-up||149
5264393|NCT00728884|12941324|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
5264394|NCT00728884|12941324|P1|COMPLETED|Permanent Prosthesis Placement||149
5264395|NCT00728884|12941324|P1|STARTED|Permanent Prosthesis Placement||162
5264396|NCT00728884|12941324|P1|NOT COMPLETED|Implant Placement Surgery||0
5264397|NCT00728884|12941324|P1|COMPLETED|Implant Placement Surgery||162
5264398|NCT00728884|12941324|P1|STARTED|Implant Placement Surgery||162
5264399|NCT00728845|12941330|P2|NOT COMPLETED|Overall Study||0
5264400|NCT00728845|12941331|P1|NOT COMPLETED|Overall Study||0
5264401|NCT00728845|12941330|P2|COMPLETED|Overall Study||0
5264402|NCT00728845|12941331|P1|COMPLETED|Overall Study||8
5264403|NCT00728845|12941330|P2|STARTED|Overall Study||0
5264404|NCT00728845|12941331|P1|STARTED|Overall Study||8
5264405|NCT00728819|12941347|P2|NOT COMPLETED|Overall Study||29
5264406|NCT00728819|12941348|P1|NOT COMPLETED|Overall Study||36
5264407|NCT00728819|12941347|P2|COMPLETED|Overall Study||139
5264408|NCT00728819|12941348|P1|COMPLETED|Overall Study||135
5264409|NCT00728819|12941347|P2|STARTED|Overall Study||168
5264410|NCT00728819|12941348|P1|STARTED|Overall Study||171
5264411|NCT00728754|12941360|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
5264412|NCT00728754|12941361|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
5264413|NCT00728754|12941360|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
5264414|NCT00728754|12941361|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
5264415|NCT00728754|12941360|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
5264416|NCT00728754|12941361|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
5264417|NCT00728754|12941360|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
5264418|NCT00728754|12941361|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
5264419|NCT00728754|12941360|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
5264420|NCT00728754|12941361|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
5264421|NCT00728754|12941360|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
5264422|NCT00728754|12941361|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
5264423|NCT00728754|12941360|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
5264424|NCT00728754|12941361|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
5264425|NCT00728754|12941360|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
5264426|NCT00728754|12941361|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
5264427|NCT00728754|12941360|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
5264428|NCT00728754|12941361|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
5264429|NCT00728754|12941360|P2|NOT COMPLETED|Implant Placement Surgery||0
5264430|NCT00728754|12941361|P1|NOT COMPLETED|Implant Placement Surgery||0
5264431|NCT00728754|12941360|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
5264432|NCT00728754|12941361|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
5264433|NCT00728754|12941360|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
5264434|NCT00728754|12941361|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
5264435|NCT00728728|12941369|P2|NOT COMPLETED|Overall Study||12
5264436|NCT00728728|12941370|P1|NOT COMPLETED|Overall Study||4
5264437|NCT00728728|12941369|P2|COMPLETED|Overall Study||34
5264438|NCT00728728|12941370|P1|COMPLETED|Overall Study||38
5264439|NCT00728728|12941369|P2|STARTED|Overall Study||46
5264440|NCT00728728|12941370|P1|STARTED|Overall Study||42
5264441|NCT00728689|12941390|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
5264442|NCT00728689|12941391|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
5264443|NCT00728689|12941390|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
5264444|NCT00728689|12941391|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
5264445|NCT00728689|12941390|P2|STARTED|Second Intervention (Days 11 - 13)||6
5264446|NCT00728689|12941391|P1|STARTED|Second Intervention (Days 11 - 13)||5
5264447|NCT00728689|12941390|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
5264448|NCT00728689|12941391|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
5264449|NCT00728689|12941390|P2|COMPLETED|Washout Period (Days 4 - 10)||6
5264450|NCT00728689|12941391|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
5264451|NCT00728689|12941390|P2|STARTED|Washout Period (Days 4 - 10)||6
5264452|NCT00728689|12941391|P1|STARTED|Washout Period (Days 4 - 10)||6
5264453|NCT00728689|12941390|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
5264454|NCT00728689|12941391|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
5264455|NCT00728689|12941390|P2|COMPLETED|First Intervention (Days 1 - 3)||6
5264456|NCT00728689|12941391|P1|COMPLETED|First Intervention (Days 1 - 3)||6
5264457|NCT00728689|12941390|P2|STARTED|First Intervention (Days 1 - 3)||6
5264458|NCT00728689|12941391|P1|STARTED|First Intervention (Days 1 - 3)||6
5264459|NCT00728507|12941409|P2|NOT COMPLETED|Overall Study||8
5264460|NCT00728507|12941410|P1|NOT COMPLETED|Overall Study||2
5264461|NCT00728507|12941409|P2|COMPLETED|Overall Study||51
5264462|NCT00728507|12941410|P1|COMPLETED|Overall Study||60
5264463|NCT00728507|12941409|P2|STARTED|Overall Study||59
5264464|NCT00728507|12941410|P1|STARTED|Overall Study||62
5264465|NCT00728494|12941420|P2|NOT COMPLETED|Overall Study||7
5264466|NCT00728494|12941421|P1|NOT COMPLETED|Overall Study||9
5264467|NCT00728494|12941420|P2|COMPLETED|Overall Study||32
5264468|NCT00728494|12941421|P1|COMPLETED|Overall Study||51
5264469|NCT00728494|12941420|P2|STARTED|Overall Study||39
5264470|NCT00728494|12941421|P1|STARTED|Overall Study||60
5264471|NCT00728481|12941439|P2|NOT COMPLETED|Overall Study||4
5264472|NCT00728481|12941440|P1|NOT COMPLETED|Overall Study||1
5264473|NCT00728481|12941439|P2|COMPLETED|Overall Study||28
5264474|NCT00728481|12941440|P1|COMPLETED|Overall Study||18
5264475|NCT00728481|12941439|P2|STARTED|Overall Study||32
5264476|NCT00728481|12941440|P1|STARTED|Overall Study||19
5264477|NCT00728468|12941456|P1|NOT COMPLETED|Overall Study||16
5264478|NCT00728468|12941456|P1|COMPLETED|Overall Study||0
5264479|NCT00728468|12941456|P1|Treated|Overall Study||15
5264480|NCT00728468|12941456|P1|STARTED|Overall Study||16
5264481|NCT00728416|12941480|P2|NOT COMPLETED|Overall Study||2
5264482|NCT00728416|12941481|P1|NOT COMPLETED|Overall Study||2
5264483|NCT00728416|12941480|P2|COMPLETED|Overall Study||163
5264484|NCT00728416|12941481|P1|COMPLETED|Overall Study||166
5264485|NCT00728416|12941480|P2|STARTED|Overall Study||165
5264486|NCT00728416|12941481|P1|STARTED|Overall Study||168
5264487|NCT00728260|12941489|P1|NOT COMPLETED|Overall Study||0
5264488|NCT00728260|12941489|P1|COMPLETED|Overall Study||1421
5264489|NCT00728260|12941489|P1|STARTED|Overall Study||1421
5264490|NCT00728182|12941497|P2|NOT COMPLETED|Overall Study||3
5264491|NCT00728182|12941498|P1|NOT COMPLETED|Overall Study||3
5264492|NCT00728182|12941497|P2|COMPLETED|Overall Study||90
5264493|NCT00728182|12941498|P1|COMPLETED|Overall Study||89
5264494|NCT00728182|12941497|P2|STARTED|Overall Study||93
5264495|NCT00728182|12941498|P1|STARTED|Overall Study||92
5264496|NCT00728130|12941526|P1|NOT COMPLETED|Overall Study||3
5264497|NCT00728130|12941526|P1|COMPLETED|Overall Study||19
5264498|NCT00728130|12941526|P1|STARTED|Overall Study||22
5264499|NCT00727961|12941531|P1|NOT COMPLETED|Overall Study||37
5264500|NCT00727961|12941531|P1|COMPLETED|Overall Study||21
5264501|NCT00727961|12941531|P1|STARTED|Overall Study||58
5264502|NCT00727909|12941541|P4|NOT COMPLETED|Overall Study||5
5264503|NCT00727909|12941542|P3|NOT COMPLETED|Overall Study||9
5264504|NCT00727909|12941543|P2|NOT COMPLETED|Overall Study||11
5264505|NCT00727909|12941544|P1|NOT COMPLETED|Overall Study||5
5264506|NCT00727909|12941541|P4|COMPLETED|Overall Study||70
5264507|NCT00727909|12941542|P3|COMPLETED|Overall Study||58
5264508|NCT00727909|12941543|P2|COMPLETED|Overall Study||61
5264509|NCT00727909|12941544|P1|COMPLETED|Overall Study||60
5264510|NCT00727909|12941541|P4|STARTED|Overall Study||75
5264511|NCT00727909|12941542|P3|STARTED|Overall Study||67
5264512|NCT00727909|12941543|P2|STARTED|Overall Study||72
5264513|NCT00727909|12941544|P1|STARTED|Overall Study||65
5264514|NCT00727857|12941551|P3|NOT COMPLETED|Overall Study||68
5264515|NCT00727857|12941552|P2|NOT COMPLETED|Overall Study||64
5264516|NCT00727857|12941553|P1|NOT COMPLETED|Overall Study||44
5264517|NCT00727857|12941551|P3|COMPLETED|Overall Study||142
5264518|NCT00727857|12941552|P2|COMPLETED|Overall Study||125
5264519|NCT00727857|12941553|P1|COMPLETED|Overall Study||157
5264520|NCT00727857|12941551|P3|STARTED|Overall Study||210
5264521|NCT00727857|12941552|P2|STARTED|Overall Study||189
5264522|NCT00727857|12941553|P1|STARTED|Overall Study||201
5264523|NCT00727844|12941641|P4|NOT COMPLETED|Second Randomization||0
5264524|NCT00727844|12941642|P3|NOT COMPLETED|Second Randomization||0
5264525|NCT00727844|12941643|P2|NOT COMPLETED|Second Randomization||0
5264526|NCT00727844|12941644|P1|NOT COMPLETED|Second Randomization||0
5264527|NCT00727844|12941641|P4|COMPLETED|Second Randomization||16
5264528|NCT00727844|12941642|P3|COMPLETED|Second Randomization||17
5264529|NCT00727844|12941643|P2|COMPLETED|Second Randomization||0
5264530|NCT00727844|12941644|P1|COMPLETED|Second Randomization||0
5264531|NCT00727844|12941641|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
5264532|NCT00727844|12941642|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
5264533|NCT00727844|12941643|P2|STARTED|Second Randomization||0
5264534|NCT00727844|12941644|P1|STARTED|Second Randomization||0
5264535|NCT00727844|12941641|P4|NOT COMPLETED|Initial Randomization||0
5264536|NCT00727844|12941642|P3|NOT COMPLETED|Initial Randomization||0
5264537|NCT00727844|12941643|P2|NOT COMPLETED|Initial Randomization||0
5264538|NCT00727844|12941644|P1|NOT COMPLETED|Initial Randomization||2
5264539|NCT00727844|12941641|P4|COMPLETED|Initial Randomization||0
5264540|NCT00727844|12941642|P3|COMPLETED|Initial Randomization||0
5264541|NCT00727844|12941643|P2|COMPLETED|Initial Randomization||20
5264542|NCT00727844|12941644|P1|COMPLETED|Initial Randomization||19
5264543|NCT00727844|12941641|P4|Included in MITT Analysis|Initial Randomization||0
5264544|NCT00727844|12941642|P3|Included in MITT Analysis|Initial Randomization||0
5264545|NCT00727844|12941643|P2|Included in MITT Analysis|Initial Randomization||20
5264546|NCT00727844|12941644|P1|Included in MITT Analysis|Initial Randomization||19
5264547|NCT00727844|12941641|P4|STARTED|Initial Randomization||0
5264548|NCT00727844|12941642|P3|STARTED|Initial Randomization||0
5264549|NCT00727844|12941643|P2|STARTED|Initial Randomization||20
5264550|NCT00727844|12941644|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
5264551|NCT00727740|12941651|P2|NOT COMPLETED|Overall Study||0
5264552|NCT00727740|12941652|P1|NOT COMPLETED|Overall Study||0
5264553|NCT00727740|12941651|P2|COMPLETED|Overall Study||61
5264554|NCT00727740|12941652|P1|COMPLETED|Overall Study||56
5264555|NCT00727740|12941651|P2|STARTED|Overall Study||61
5264556|NCT00727740|12941652|P1|STARTED|Overall Study||56
5264557|NCT00727714|12941658|P1|NOT COMPLETED|Overall Study||2
5264558|NCT00727714|12941658|P1|COMPLETED|Overall Study||93
5264559|NCT00727714|12941658|P1|STARTED|Overall Study||95
5264560|NCT00727649|12941668|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
5264561|NCT00727649|12941669|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
5264562|NCT00727649|12941668|P2|COMPLETED|Second Intervention (4-weeks)||34
5264563|NCT00727649|12941669|P1|COMPLETED|Second Intervention (4-weeks)||29
5264564|NCT00727649|12941668|P2|STARTED|Second Intervention (4-weeks)||37
5264565|NCT00727649|12941669|P1|STARTED|Second Intervention (4-weeks)||30
5264566|NCT00727649|12941668|P2|NOT COMPLETED|Wash-out (2-weeks)||3
5264567|NCT00727649|12941669|P1|NOT COMPLETED|Wash-out (2-weeks)||4
5264568|NCT00727649|12941668|P2|COMPLETED|Wash-out (2-weeks)||37
5264569|NCT00727649|12941669|P1|COMPLETED|Wash-out (2-weeks)||30
5264570|NCT00727649|12941668|P2|STARTED|Wash-out (2-weeks)||40
5264571|NCT00727649|12941669|P1|STARTED|Wash-out (2-weeks)||34
5264572|NCT00727649|12941668|P2|NOT COMPLETED|First Intervention (4-weeks)||3
5264573|NCT00727649|12941669|P1|NOT COMPLETED|First Intervention (4-weeks)||3
5264574|NCT00727649|12941668|P2|COMPLETED|First Intervention (4-weeks)||40
5264575|NCT00727649|12941669|P1|COMPLETED|First Intervention (4-weeks)||34
5264576|NCT00727649|12941668|P2|STARTED|First Intervention (4-weeks)||43
5264577|NCT00727649|12941669|P1|STARTED|First Intervention (4-weeks)||37
5264578|NCT00727636|12941683|P2|NOT COMPLETED|Overall Study||0
5264579|NCT00727636|12941684|P1|NOT COMPLETED|Overall Study||4
5264580|NCT00727636|12941683|P2|COMPLETED|Overall Study||15
5264581|NCT00727636|12941684|P1|COMPLETED|Overall Study||33
5264582|NCT00727636|12941683|P2|STARTED|Overall Study||15
5264583|NCT00727636|12941684|P1|STARTED|Overall Study||37
5264584|NCT00727597|12941698|P2|NOT COMPLETED|Overall Study||0
5264585|NCT00727597|12941699|P1|NOT COMPLETED|Overall Study||0
5264586|NCT00727597|12941698|P2|COMPLETED|Overall Study||50
5264587|NCT00727597|12941699|P1|COMPLETED|Overall Study||51
5264588|NCT00727597|12941698|P2|STARTED|Overall Study||50
5264589|NCT00727597|12941699|P1|STARTED|Overall Study||51
5264590|NCT00727571|12941711|P4|NOT COMPLETED|Overall Study||6
5264591|NCT00727571|12941712|P3|NOT COMPLETED|Overall Study||30
5264592|NCT00727571|12941713|P2|NOT COMPLETED|Overall Study||55
5264593|NCT00727571|12941714|P1|NOT COMPLETED|Overall Study||1
5264594|NCT00727571|12941711|P4|COMPLETED|Overall Study||163
5264595|NCT00727571|12941712|P3|COMPLETED|Overall Study||135
5264596|NCT00727571|12941713|P2|COMPLETED|Overall Study||173
5264597|NCT00727571|12941714|P1|COMPLETED|Overall Study||231
5264598|NCT00727571|12941711|P4|STARTED|Overall Study||169
5264599|NCT00727571|12941712|P3|STARTED|Overall Study||165
5264600|NCT00727571|12941713|P2|STARTED|Overall Study||228
5264601|NCT00727571|12941714|P1|STARTED|Overall Study||232
5264602|NCT00727558|12941741|P2|NOT COMPLETED|Overall Study||3
5264603|NCT00727558|12941742|P1|NOT COMPLETED|Overall Study||2
5264604|NCT00727558|12941741|P2|COMPLETED|Overall Study||118
5264605|NCT00727558|12941742|P1|COMPLETED|Overall Study||125
5264606|NCT00727558|12941741|P2|STARTED|Overall Study||121
5264607|NCT00727558|12941742|P1|STARTED|Overall Study||127
5264608|NCT00727532|12941760|P1|NOT COMPLETED|Overall Study||2
5264609|NCT00727532|12941760|P1|COMPLETED|Overall Study||7
5264610|NCT00727532|12941760|P1|STARTED|Overall Study||9
5264611|NCT00727506|12941772|P6|NOT COMPLETED|Overall Study||39
5264612|NCT00727506|12941773|P5|NOT COMPLETED|Overall Study||41
5264613|NCT00727506|12941774|P4|NOT COMPLETED|Overall Study||39
5264614|NCT00727506|12941775|P3|NOT COMPLETED|Overall Study||18
5264615|NCT00727506|12941776|P2|NOT COMPLETED|Overall Study||8
5264616|NCT00727506|12941777|P1|NOT COMPLETED|Overall Study||6
5264617|NCT00727506|12941772|P6|COMPLETED|Overall Study||0
5264618|NCT00727506|12941773|P5|COMPLETED|Overall Study||0
5264619|NCT00727506|12941774|P4|COMPLETED|Overall Study||0
5264620|NCT00727506|12941775|P3|COMPLETED|Overall Study||0
5264621|NCT00727506|12941776|P2|COMPLETED|Overall Study||0
5264622|NCT00727506|12941777|P1|COMPLETED|Overall Study||0
5264623|NCT00727506|12941772|P6|STARTED|Overall Study|Randomized|39
5264624|NCT00727506|12941773|P5|STARTED|Overall Study|Randomized|41
5264625|NCT00727506|12941774|P4|STARTED|Overall Study|Randomized|39
5264626|NCT00727506|12941775|P3|STARTED|Overall Study|Entered|18
5264627|NCT00727506|12941776|P2|STARTED|Overall Study|Entered|8
5264628|NCT00727506|12941777|P1|STARTED|Overall Study|Entered|6
5264629|NCT00727441|12941873|P3|NOT COMPLETED|Overall Study||25
5264630|NCT00727441|12941874|P2|NOT COMPLETED|Overall Study||22
5264631|NCT00727441|12941875|P1|NOT COMPLETED|Overall Study||18
5264632|NCT00727441|12941873|P3|COMPLETED|Overall Study||5
5264633|NCT00727441|12941874|P2|COMPLETED|Overall Study||6
5264634|NCT00727441|12941875|P1|COMPLETED|Overall Study||11
5264635|NCT00727441|12941873|P3|STARTED|Overall Study||30
5264636|NCT00727441|12941874|P2|STARTED|Overall Study||28
5264637|NCT00727441|12941875|P1|STARTED|Overall Study||29
5264638|NCT00727415|12941895|P1|NOT COMPLETED|Phase II||0
5264639|NCT00727415|12941895|P1|COMPLETED|Phase II||33
5264640|NCT00727415|12941895|P1|STARTED|Phase II||33
5264641|NCT00727415|12941895|P1|NOT COMPLETED|Phase I||2
5264642|NCT00727415|12941895|P1|COMPLETED|Phase I||7
5264643|NCT00727415|12941895|P1|STARTED|Phase I||9
5264644|NCT00727402|12941904|P1|NOT COMPLETED|Overall Study||116
5264645|NCT00727402|12941904|P1|COMPLETED|Overall Study||89
5264646|NCT00727402|12941904|P1|STARTED|Overall Study||205
5264647|NCT00727337|12941912|P4|NOT COMPLETED|Overall Study||9
5264648|NCT00727337|12941913|P3|NOT COMPLETED|Overall Study||10
5264649|NCT00727337|12941914|P2|NOT COMPLETED|Overall Study||10
5264650|NCT00727337|12941915|P1|NOT COMPLETED|Overall Study||7
5264651|NCT00727337|12941912|P4|COMPLETED|Overall Study||64
5264652|NCT00727337|12941913|P3|COMPLETED|Overall Study||63
5264653|NCT00727337|12941914|P2|COMPLETED|Overall Study||55
5264654|NCT00727337|12941915|P1|COMPLETED|Overall Study||61
5264655|NCT00727337|12941912|P4|STARTED|Overall Study||73
5264656|NCT00727337|12941913|P3|STARTED|Overall Study||73
5264657|NCT00727337|12941914|P2|STARTED|Overall Study||65
5264658|NCT00727337|12941915|P1|STARTED|Overall Study||68
5264659|NCT00727311|12941933|P1|NOT COMPLETED|Overall Study||1107
5264660|NCT00727311|12941933|P1|COMPLETED|Overall Study||1195
5264661|NCT00727311|12941933|P1|STARTED|Overall Study||2302
5264662|NCT00727298|12941940|P1|NOT COMPLETED|Overall Study||1257
5264663|NCT00727298|12941940|P1|COMPLETED|Overall Study||3228
5264664|NCT00727298|12941940|P1|STARTED|Overall Study||4485
5264665|NCT00727272|12941946|P3|NOT COMPLETED|Period III||0
5264666|NCT00727272|12941947|P2|NOT COMPLETED|Period III||0
5264667|NCT00727272|12941948|P1|NOT COMPLETED|Period III||0
5264668|NCT00727272|12941946|P3|COMPLETED|Period III||7
5264669|NCT00727272|12941947|P2|COMPLETED|Period III||9
5264670|NCT00727272|12941948|P1|COMPLETED|Period III||9
5264671|NCT00727272|12941946|P3|STARTED|Period III||7
5264672|NCT00727272|12941947|P2|STARTED|Period III||9
5264673|NCT00727272|12941948|P1|STARTED|Period III||9
5264674|NCT00727272|12941946|P3|NOT COMPLETED|Washout Period B||1
5264675|NCT00727272|12941947|P2|NOT COMPLETED|Washout Period B||0
5264676|NCT00727272|12941948|P1|NOT COMPLETED|Washout Period B||0
5264677|NCT00727272|12941946|P3|COMPLETED|Washout Period B|personal reasons|7
5264678|NCT00727272|12941947|P2|COMPLETED|Washout Period B||9
5264679|NCT00727272|12941948|P1|COMPLETED|Washout Period B||9
5264680|NCT00727272|12941946|P3|STARTED|Washout Period B||8
5264681|NCT00727272|12941947|P2|STARTED|Washout Period B||9
5264682|NCT00727272|12941948|P1|STARTED|Washout Period B||9
5264683|NCT00727272|12941946|P3|NOT COMPLETED|Period II||0
5264684|NCT00727272|12941947|P2|NOT COMPLETED|Period II||0
5264685|NCT00727272|12941948|P1|NOT COMPLETED|Period II||0
5264686|NCT00727272|12941946|P3|COMPLETED|Period II||8
5264687|NCT00727272|12941947|P2|COMPLETED|Period II||9
5264688|NCT00727272|12941948|P1|COMPLETED|Period II||9
5264689|NCT00727272|12941946|P3|STARTED|Period II||8
5264690|NCT00727272|12941947|P2|STARTED|Period II||9
5264691|NCT00727272|12941948|P1|STARTED|Period II||9
5264692|NCT00727272|12941946|P3|NOT COMPLETED|Washout Period A||1
5264693|NCT00727272|12941947|P2|NOT COMPLETED|Washout Period A||0
5264694|NCT00727272|12941948|P1|NOT COMPLETED|Washout Period A||0
5264695|NCT00727272|12941946|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
5264696|NCT00727272|12941947|P2|COMPLETED|Washout Period A||9
5264697|NCT00727272|12941948|P1|COMPLETED|Washout Period A||9
5264698|NCT00727272|12941946|P3|STARTED|Washout Period A||9
5264699|NCT00727272|12941947|P2|STARTED|Washout Period A||9
5264700|NCT00727272|12941948|P1|STARTED|Washout Period A||9
5264701|NCT00727272|12941946|P3|NOT COMPLETED|Period I||0
5264702|NCT00727272|12941947|P2|NOT COMPLETED|Period I||0
5264703|NCT00727272|12941948|P1|NOT COMPLETED|Period I||0
5264704|NCT00727272|12941946|P3|COMPLETED|Period I||9
5264705|NCT00727272|12941947|P2|COMPLETED|Period I||9
5264706|NCT00727272|12941948|P1|COMPLETED|Period I||9
5264707|NCT00727272|12941946|P3|STARTED|Period I||9
5264708|NCT00727272|12941947|P2|STARTED|Period I||9
5264709|NCT00727272|12941948|P1|STARTED|Period I||9
5264710|NCT00727259|12941965|P1|NOT COMPLETED|Overall Study||1055
5264711|NCT00727259|12941965|P1|COMPLETED|Overall Study||940
5264712|NCT00727259|12941965|P1|STARTED|Overall Study||1995
5264713|NCT00727246|12941974|P4|NOT COMPLETED|Overall Study||2
5264714|NCT00727246|12941975|P3|NOT COMPLETED|Overall Study||1
5264715|NCT00727246|12941976|P2|NOT COMPLETED|Overall Study||1
5264716|NCT00727246|12941977|P1|NOT COMPLETED|Overall Study||0
5264717|NCT00727246|12941974|P4|COMPLETED|Overall Study||3
5264718|NCT00727246|12941975|P3|COMPLETED|Overall Study||7
5264719|NCT00727246|12941976|P2|COMPLETED|Overall Study||2
5264720|NCT00727246|12941977|P1|COMPLETED|Overall Study||3
5264721|NCT00727246|12941974|P4|STARTED|Overall Study||5
5264722|NCT00727246|12941975|P3|STARTED|Overall Study||8
5264723|NCT00727246|12941976|P2|STARTED|Overall Study||3
5264724|NCT00727246|12941977|P1|STARTED|Overall Study||3
5264725|NCT00727220|12941993|P2|NOT COMPLETED|Overall Study||4
5264726|NCT00727220|12941994|P1|NOT COMPLETED|Overall Study||1
5264727|NCT00727220|12941993|P2|COMPLETED|Overall Study||17
5264728|NCT00727220|12941994|P1|COMPLETED|Overall Study||20
5264729|NCT00727220|12941993|P2|STARTED|Overall Study||21
5264730|NCT00727220|12941994|P1|STARTED|Overall Study||21
5264731|NCT00727194|12942000|P3|NOT COMPLETED|Treatment Period 2||0
5264732|NCT00727194|12942001|P2|NOT COMPLETED|Treatment Period 2||1
5264733|NCT00727194|12942002|P1|NOT COMPLETED|Treatment Period 2||0
5264734|NCT00727194|12942000|P3|COMPLETED|Treatment Period 2||0
5264735|NCT00727194|12942001|P2|COMPLETED|Treatment Period 2||5
5264736|NCT00727194|12942002|P1|COMPLETED|Treatment Period 2||6
5264737|NCT00727194|12942000|P3|STARTED|Treatment Period 2||0
5264738|NCT00727194|12942001|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
5264739|NCT00727194|12942002|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
5264740|NCT00727194|12942000|P3|NOT COMPLETED|Washout Period||0
5264741|NCT00727194|12942001|P2|NOT COMPLETED|Washout Period||0
5264742|NCT00727194|12942002|P1|NOT COMPLETED|Washout Period||0
5264743|NCT00727194|12942000|P3|COMPLETED|Washout Period||0
5264744|NCT00727194|12942001|P2|COMPLETED|Washout Period||7
5264745|NCT00727194|12942002|P1|COMPLETED|Washout Period||7
5264746|NCT00727194|12942000|P3|STARTED|Washout Period||0
5264747|NCT00727194|12942001|P2|STARTED|Washout Period||7
5264748|NCT00727194|12942002|P1|STARTED|Washout Period||7
5264749|NCT00727194|12942000|P3|NOT COMPLETED|Treatment Period 1||0
5264750|NCT00727194|12942001|P2|NOT COMPLETED|Treatment Period 1||0
5264751|NCT00727194|12942002|P1|NOT COMPLETED|Treatment Period 1||0
5264752|NCT00727194|12942000|P3|COMPLETED|Treatment Period 1||0
5264753|NCT00727194|12942001|P2|COMPLETED|Treatment Period 1||7
5264754|NCT00727194|12942002|P1|COMPLETED|Treatment Period 1||7
5264755|NCT00727194|12942000|P3|STARTED|Treatment Period 1||0
5264756|NCT00727194|12942001|P2|STARTED|Treatment Period 1||7
5264757|NCT00727194|12942002|P1|STARTED|Treatment Period 1||7
5264758|NCT00727194|12942000|P3|NOT COMPLETED|Screening Period||16
5264759|NCT00727194|12942001|P2|NOT COMPLETED|Screening Period||0
5264760|NCT00727194|12942002|P1|NOT COMPLETED|Screening Period||0
5264761|NCT00727194|12942000|P3|COMPLETED|Screening Period||0
5264762|NCT00727194|12942001|P2|COMPLETED|Screening Period||7
5264763|NCT00727194|12942002|P1|COMPLETED|Screening Period||7
5264764|NCT00727194|12942000|P3|STARTED|Screening Period||16
5264765|NCT00727194|12942001|P2|STARTED|Screening Period||7
5264766|NCT00727194|12942002|P1|STARTED|Screening Period||7
5264767|NCT00727090|12942038|P2|NOT COMPLETED|Overall Study||0
5264768|NCT00727090|12942039|P1|NOT COMPLETED|Overall Study||0
5264769|NCT00727090|12942038|P2|COMPLETED|Overall Study||3
5264770|NCT00727090|12942039|P1|COMPLETED|Overall Study||3
5264771|NCT00727090|12942038|P2|STARTED|Overall Study||3
5264772|NCT00727090|12942039|P1|STARTED|Overall Study||3
5264773|NCT00727064|12942057|P2|NOT COMPLETED|Overall Study||0
5264774|NCT00727064|12942058|P1|NOT COMPLETED|Overall Study||0
5264775|NCT00727064|12942057|P2|COMPLETED|Overall Study||7
5264776|NCT00727064|12942058|P1|COMPLETED|Overall Study||7
5264777|NCT00727064|12942057|P2|STARTED|Overall Study||7
5264778|NCT00727064|12942058|P1|STARTED|Overall Study||7
5264779|NCT00727025|12942074|P1|NOT COMPLETED|Overall Study||23
5264780|NCT00727025|12942074|P1|COMPLETED|Overall Study||51
5264781|NCT00727025|12942074|P1|STARTED|Overall Study||74
5264782|NCT00726999|12942086|P2|NOT COMPLETED|Overall Study||1
5264783|NCT00726999|12942087|P1|NOT COMPLETED|Overall Study||3
5264784|NCT00726999|12942086|P2|COMPLETED|Overall Study||30
5264785|NCT00726999|12942087|P1|COMPLETED|Overall Study||29
5264786|NCT00726999|12942086|P2|STARTED|Overall Study||31
5264787|NCT00726999|12942087|P1|STARTED|Overall Study||32
5264788|NCT00726986|12942099|P1|NOT COMPLETED|Maintenance Phase||3
5264789|NCT00726986|12942099|P1|COMPLETED|Maintenance Phase||0
5264790|NCT00726986|12942099|P1|STARTED|Maintenance Phase||3
5264791|NCT00726986|12942099|P1|NOT COMPLETED|Induction Phase||15
5264792|NCT00726986|12942099|P1|COMPLETED|Induction Phase||3
5264793|NCT00726986|12942099|P1|Maintance|Induction Phase||3
5264794|NCT00726986|12942099|P1|STARTED|Induction Phase||18
5264795|NCT00726895|12942106|P2|NOT COMPLETED|Second Intervention||0
5264796|NCT00726895|12942107|P1|NOT COMPLETED|Second Intervention||0
5264797|NCT00726895|12942106|P2|COMPLETED|Second Intervention||11
5264798|NCT00726895|12942107|P1|COMPLETED|Second Intervention||12
5264799|NCT00726895|12942106|P2|STARTED|Second Intervention||11
5264800|NCT00726895|12942107|P1|STARTED|Second Intervention||12
5264801|NCT00726895|12942106|P2|NOT COMPLETED|Washout Period of 7 Days||1
5264802|NCT00726895|12942107|P1|NOT COMPLETED|Washout Period of 7 Days||0
5264803|NCT00726895|12942106|P2|COMPLETED|Washout Period of 7 Days||11
5264804|NCT00726895|12942107|P1|COMPLETED|Washout Period of 7 Days||12
5264805|NCT00726895|12942106|P2|STARTED|Washout Period of 7 Days||12
5264806|NCT00726895|12942107|P1|STARTED|Washout Period of 7 Days||12
5264807|NCT00726895|12942106|P2|NOT COMPLETED|First Intervention||0
5264808|NCT00726895|12942107|P1|NOT COMPLETED|First Intervention||0
5264809|NCT00726895|12942106|P2|COMPLETED|First Intervention||12
5264810|NCT00726895|12942107|P1|COMPLETED|First Intervention||12
5264811|NCT00726895|12942106|P2|STARTED|First Intervention||12
5264812|NCT00726895|12942107|P1|STARTED|First Intervention||12
5264813|NCT00726882|12942120|P1|NOT COMPLETED|Overall Study||22
5264814|NCT00726882|12942120|P1|COMPLETED|Overall Study||13
5264815|NCT00726882|12942120|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
5264816|NCT00726882|12942120|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
5264817|NCT00726882|12942120|P1|STARTED|Overall Study||35
5264818|NCT00726830|12942128|P2|NOT COMPLETED|Overall Study||0
5264819|NCT00726830|12942129|P1|NOT COMPLETED|Overall Study||0
5264820|NCT00726830|12942128|P2|COMPLETED|Overall Study||0
5264821|NCT00726830|12942129|P1|COMPLETED|Overall Study||1
5264822|NCT00726830|12942128|P2|STARTED|Overall Study||0
5264823|NCT00726830|12942129|P1|STARTED|Overall Study||1
5264824|NCT00726752|12942135|P1|NOT COMPLETED|Overall Study||6
5264825|NCT00726752|12942135|P1|COMPLETED|Overall Study||0
5264826|NCT00726752|12942135|P1|STARTED|Overall Study||6
5264827|NCT00726739|12942151|P2|NOT COMPLETED|Overall Study||0
5264828|NCT00726739|12942152|P1|NOT COMPLETED|Overall Study||1
5264829|NCT00726739|12942151|P2|COMPLETED|Overall Study||10
5264830|NCT00726739|12942152|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
5264831|NCT00726739|12942151|P2|STARTED|Overall Study||10
5264832|NCT00726739|12942152|P1|STARTED|Overall Study||11
5264833|NCT00726713|12942168|P2|NOT COMPLETED|Overall Study||7
5264834|NCT00726713|12942169|P1|NOT COMPLETED|Overall Study||7
5264835|NCT00726713|12942168|P2|COMPLETED|Overall Study||101
5264836|NCT00726713|12942169|P1|COMPLETED|Overall Study||99
5264837|NCT00726713|12942168|P2|STARTED|Overall Study||108
5264838|NCT00726713|12942169|P1|STARTED|Overall Study||106
5264839|NCT00726661|12942197|P2|NOT COMPLETED|Overall Study||418
5264840|NCT00726661|12942198|P1|NOT COMPLETED|Overall Study||814
5264841|NCT00726661|12942197|P2|COMPLETED|Overall Study||17
5264842|NCT00726661|12942198|P1|COMPLETED|Overall Study||18
5264843|NCT00726661|12942197|P2|STARTED|Overall Study||435
5264844|NCT00726661|12942198|P1|STARTED|Overall Study||832
5264845|NCT00726622|12942215|P2|NOT COMPLETED|Overall Study||3
5264846|NCT00726622|12942216|P1|NOT COMPLETED|Overall Study||18
5264847|NCT00726622|12942215|P2|COMPLETED|Overall Study||240
5264848|NCT00726622|12942216|P1|COMPLETED|Overall Study||225
5264849|NCT00726622|12942215|P2|STARTED|Overall Study||243
5264850|NCT00726622|12942216|P1|STARTED|Overall Study||243
5264851|NCT00726609|12942234|P1|NOT COMPLETED|Overall Study||98
5264852|NCT00726609|12942234|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
5264853|NCT00726609|12942234|P1|STARTED|Overall Study||214
5264854|NCT00726557|12942238|P1|NOT COMPLETED|Overall Study||128
5264855|NCT00726557|12942238|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
5264856|NCT00726557|12942238|P1|STARTED|Overall Study||246
5264857|NCT00726453|12942245|P2|NOT COMPLETED|38 mm Length Group||3
5264858|NCT00726453|12942246|P1|NOT COMPLETED|38 mm Length Group||0
5264859|NCT00726453|12942245|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
5264860|NCT00726453|12942246|P1|COMPLETED|38 mm Length Group||0
5264861|NCT00726453|12942245|P2|STARTED|38 mm Length Group||114
5264862|NCT00726453|12942246|P1|STARTED|38 mm Length Group||0
5264863|NCT00726453|12942245|P2|NOT COMPLETED|Primary Enrollment Group||0
5264864|NCT00726453|12942246|P1|NOT COMPLETED|Primary Enrollment Group||31
5264865|NCT00726453|12942245|P2|COMPLETED|Primary Enrollment Group||0
5264866|NCT00726453|12942246|P1|COMPLETED|Primary Enrollment Group||1371
5264867|NCT00726453|12942245|P2|STARTED|Primary Enrollment Group||0
5264868|NCT00726453|12942246|P1|STARTED|Primary Enrollment Group||1402
5264869|NCT00726414|12942256|P2|NOT COMPLETED|Second Intervention||0
5264870|NCT00726414|12942257|P1|NOT COMPLETED|Second Intervention||0
5264871|NCT00726414|12942256|P2|COMPLETED|Second Intervention||11
5264872|NCT00726414|12942257|P1|COMPLETED|Second Intervention||11
5264873|NCT00726414|12942256|P2|STARTED|Second Intervention||11
5264874|NCT00726414|12942257|P1|STARTED|Second Intervention||11
5264875|NCT00726414|12942256|P2|NOT COMPLETED|Washout Period of 7 Days||0
5264876|NCT00726414|12942257|P1|NOT COMPLETED|Washout Period of 7 Days||0
5264877|NCT00726414|12942256|P2|COMPLETED|Washout Period of 7 Days||11
5264878|NCT00726414|12942257|P1|COMPLETED|Washout Period of 7 Days||11
5264879|NCT00726414|12942256|P2|STARTED|Washout Period of 7 Days||11
5264880|NCT00726414|12942257|P1|STARTED|Washout Period of 7 Days||11
5264881|NCT00726414|12942256|P2|NOT COMPLETED|First Intervention||0
5264882|NCT00726414|12942257|P1|NOT COMPLETED|First Intervention||0
5264883|NCT00726414|12942256|P2|COMPLETED|First Intervention||11
5264884|NCT00726414|12942257|P1|COMPLETED|First Intervention||11
5264885|NCT00726414|12942256|P2|STARTED|First Intervention||11
5264886|NCT00726414|12942257|P1|STARTED|First Intervention||11
5264887|NCT00726375|12942267|P1|NOT COMPLETED|Overall Study||0
5264888|NCT00726375|12942267|P1|COMPLETED|Overall Study||34
5264889|NCT00726375|12942267|P1|STARTED|Overall Study||34
5264890|NCT00726323|12942274|P2|NOT COMPLETED|Overall Study||31
5264891|NCT00726323|12942275|P1|NOT COMPLETED|Overall Study||37
5264892|NCT00726323|12942274|P2|COMPLETED|Overall Study||6
5264893|NCT00726323|12942275|P1|COMPLETED|Overall Study||0
5264894|NCT00726323|12942274|P2|STARTED|Overall Study||37
5264895|NCT00726323|12942275|P1|STARTED|Overall Study||37
5264896|NCT00726232|12942305|P8|NOT COMPLETED|Expansion Phase||38
5264897|NCT00726232|12942306|P7|NOT COMPLETED|Expansion Phase||24
5264898|NCT00726232|12942307|P6|NOT COMPLETED|Expansion Phase||0
5264899|NCT00726232|12942308|P5|NOT COMPLETED|Expansion Phase||0
5264900|NCT00726232|12942309|P4|NOT COMPLETED|Expansion Phase||0
5264901|NCT00726232|12942310|P3|NOT COMPLETED|Expansion Phase||0
5264902|NCT00726232|12942311|P2|NOT COMPLETED|Expansion Phase||0
5264903|NCT00726232|12942312|P1|NOT COMPLETED|Expansion Phase||0
5264904|NCT00726232|12942305|P8|COMPLETED|Expansion Phase||1
5264905|NCT00726232|12942306|P7|COMPLETED|Expansion Phase||10
5264906|NCT00726232|12942307|P6|COMPLETED|Expansion Phase||0
5264907|NCT00726232|12942308|P5|COMPLETED|Expansion Phase||0
5264908|NCT00726232|12942309|P4|COMPLETED|Expansion Phase||0
5264909|NCT00726232|12942310|P3|COMPLETED|Expansion Phase||0
5264910|NCT00726232|12942311|P2|COMPLETED|Expansion Phase||0
5264911|NCT00726232|12942312|P1|COMPLETED|Expansion Phase||0
5264912|NCT00726232|12942305|P8|ITT Participants|Expansion Phase||39
5264913|NCT00726232|12942306|P7|ITT Participants|Expansion Phase||34
5264914|NCT00726232|12942307|P6|ITT Participants|Expansion Phase||0
5264915|NCT00726232|12942308|P5|ITT Participants|Expansion Phase||0
5264916|NCT00726232|12942309|P4|ITT Participants|Expansion Phase||0
5264917|NCT00726232|12942310|P3|ITT Participants|Expansion Phase||0
5264918|NCT00726232|12942311|P2|ITT Participants|Expansion Phase||0
5264919|NCT00726232|12942312|P1|ITT Participants|Expansion Phase||0
5264920|NCT00726232|12942305|P8|Safety Evaluable Participants|Expansion Phase||39
5264921|NCT00726232|12942306|P7|Safety Evaluable Participants|Expansion Phase||34
5264922|NCT00726232|12942307|P6|Safety Evaluable Participants|Expansion Phase||0
5264923|NCT00726232|12942308|P5|Safety Evaluable Participants|Expansion Phase||0
5264924|NCT00726232|12942309|P4|Safety Evaluable Participants|Expansion Phase||0
5264925|NCT00726232|12942310|P3|Safety Evaluable Participants|Expansion Phase||0
5264926|NCT00726232|12942311|P2|Safety Evaluable Participants|Expansion Phase||0
5264927|NCT00726232|12942312|P1|Safety Evaluable Participants|Expansion Phase||0
5264928|NCT00726232|12942305|P8|STARTED|Expansion Phase||39
5264929|NCT00726232|12942306|P7|STARTED|Expansion Phase||34
5264930|NCT00726232|12942307|P6|STARTED|Expansion Phase||0
5264931|NCT00726232|12942308|P5|STARTED|Expansion Phase||0
5264932|NCT00726232|12942309|P4|STARTED|Expansion Phase||0
5264933|NCT00726232|12942310|P3|STARTED|Expansion Phase||0
5264934|NCT00726232|12942311|P2|STARTED|Expansion Phase||0
5264935|NCT00726232|12942312|P1|STARTED|Expansion Phase||0
5264936|NCT00726232|12942305|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
5264937|NCT00726232|12942306|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
5264938|NCT00726232|12942307|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
5264939|NCT00726232|12942308|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
5264940|NCT00726232|12942309|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
5264941|NCT00726232|12942310|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
5264942|NCT00726232|12942311|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
5264943|NCT00726232|12942312|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
5264944|NCT00726232|12942305|P8|COMPLETED|Initial Phase (Dose-finding)||0
5264945|NCT00726232|12942306|P7|COMPLETED|Initial Phase (Dose-finding)||0
5264946|NCT00726232|12942307|P6|COMPLETED|Initial Phase (Dose-finding)||0
5264947|NCT00726232|12942308|P5|COMPLETED|Initial Phase (Dose-finding)||1
5264948|NCT00726232|12942309|P4|COMPLETED|Initial Phase (Dose-finding)||0
5264949|NCT00726232|12942310|P3|COMPLETED|Initial Phase (Dose-finding)||2
5264950|NCT00726232|12942311|P2|COMPLETED|Initial Phase (Dose-finding)||2
5264951|NCT00726232|12942312|P1|COMPLETED|Initial Phase (Dose-finding)||6
5264952|NCT00726232|12942305|P8|ITT Participants|Initial Phase (Dose-finding)||0
5264953|NCT00726232|12942306|P7|ITT Participants|Initial Phase (Dose-finding)||0
5264954|NCT00726232|12942307|P6|ITT Participants|Initial Phase (Dose-finding)||9
5264955|NCT00726232|12942308|P5|ITT Participants|Initial Phase (Dose-finding)||22
5264956|NCT00726232|12942309|P4|ITT Participants|Initial Phase (Dose-finding)||8
5264957|NCT00726232|12942310|P3|ITT Participants|Initial Phase (Dose-finding)||7
5264958|NCT00726232|12942311|P2|ITT Participants|Initial Phase (Dose-finding)||8
5264959|NCT00726232|12942312|P1|ITT Participants|Initial Phase (Dose-finding)||19
5264960|NCT00726232|12942305|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
5264961|NCT00726232|12942306|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
5264962|NCT00726232|12942307|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
5264963|NCT00726232|12942308|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
5264964|NCT00726232|12942309|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
5264965|NCT00726232|12942310|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
5264966|NCT00726232|12942311|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
5264967|NCT00726232|12942312|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
5264968|NCT00726232|12942305|P8|STARTED|Initial Phase (Dose-finding)||0
5264969|NCT00726232|12942306|P7|STARTED|Initial Phase (Dose-finding)||0
5264970|NCT00726232|12942307|P6|STARTED|Initial Phase (Dose-finding)||9
5264971|NCT00726232|12942308|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
5264972|NCT00726232|12942309|P4|STARTED|Initial Phase (Dose-finding)||8
5264973|NCT00726232|12942310|P3|STARTED|Initial Phase (Dose-finding)||7
5264974|NCT00726232|12942311|P2|STARTED|Initial Phase (Dose-finding)||8
5264975|NCT00726232|12942312|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
5264976|NCT00726180|12942358|P1|NOT COMPLETED|Overall Study||0
5264977|NCT00726180|12942358|P1|COMPLETED|Overall Study||1
5264978|NCT00726180|12942358|P1|STARTED|Overall Study||1
5264979|NCT00726063|12942364|P2|NOT COMPLETED|Overall Study||7
5264980|NCT00726063|12942365|P1|NOT COMPLETED|Overall Study||9
5264981|NCT00726063|12942364|P2|COMPLETED|Overall Study|Number of implants = 239|112
5264982|NCT00726063|12942365|P1|COMPLETED|Overall Study|Number of implants =230|113
5264983|NCT00726063|12942364|P2|STARTED|Overall Study|Number of implants= 246|119
5264984|NCT00726063|12942365|P1|STARTED|Overall Study|Number of implants= 239|122
5264985|NCT00726037|12942371|P1|NOT COMPLETED|Overall Study||0
5264986|NCT00726037|12942371|P1|COMPLETED|Overall Study||7
5264987|NCT00726037|12942371|P1|STARTED|Overall Study||7
5264988|NCT00725985|12942379|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
5264989|NCT00725985|12942380|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
5264990|NCT00725985|12942381|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
5264991|NCT00725985|12942382|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264992|NCT00725985|12942383|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264993|NCT00725985|12942384|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264994|NCT00725985|12942385|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264995|NCT00725985|12942386|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264996|NCT00725985|12942387|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264997|NCT00725985|12942388|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264998|NCT00725985|12942389|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5264999|NCT00725985|12942390|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
5265000|NCT00725985|12942379|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
5265001|NCT00725985|12942380|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
5265002|NCT00725985|12942381|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
5265003|NCT00725985|12942382|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
5265004|NCT00725985|12942383|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
5265005|NCT00725985|12942384|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
5265006|NCT00725985|12942385|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
5265007|NCT00725985|12942386|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
5265008|NCT00725985|12942387|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
5265009|NCT00725985|12942388|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
5265010|NCT00725985|12942389|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
5265011|NCT00725985|12942390|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
5265012|NCT00725985|12942379|P12|STARTED|LTFU (No Cladribine Treatment)||14
5265013|NCT00725985|12942380|P11|STARTED|LTFU (No Cladribine Treatment)||36
5265014|NCT00725985|12942381|P10|STARTED|LTFU (No Cladribine Treatment)||34
5265015|NCT00725985|12942382|P9|STARTED|LTFU (No Cladribine Treatment)||0
5265016|NCT00725985|12942383|P8|STARTED|LTFU (No Cladribine Treatment)||0
5265017|NCT00725985|12942384|P7|STARTED|LTFU (No Cladribine Treatment)||0
5265018|NCT00725985|12942385|P6|STARTED|LTFU (No Cladribine Treatment)||0
5265019|NCT00725985|12942386|P5|STARTED|LTFU (No Cladribine Treatment)||0
5265020|NCT00725985|12942387|P4|STARTED|LTFU (No Cladribine Treatment)||0
5265021|NCT00725985|12942388|P3|STARTED|LTFU (No Cladribine Treatment)||0
5265022|NCT00725985|12942389|P2|STARTED|LTFU (No Cladribine Treatment)||0
5265023|NCT00725985|12942390|P1|STARTED|LTFU (No Cladribine Treatment)||0
5265024|NCT00725985|12942379|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265025|NCT00725985|12942380|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265026|NCT00725985|12942381|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265027|NCT00725985|12942382|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
5265028|NCT00725985|12942383|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
5265029|NCT00725985|12942384|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
5265030|NCT00725985|12942385|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265031|NCT00725985|12942386|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265032|NCT00725985|12942387|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265033|NCT00725985|12942388|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265034|NCT00725985|12942389|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265035|NCT00725985|12942390|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
5265036|NCT00725985|12942379|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
5265037|NCT00725985|12942380|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
5265038|NCT00725985|12942381|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
5265039|NCT00725985|12942382|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
5265040|NCT00725985|12942383|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
5265041|NCT00725985|12942384|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
5265042|NCT00725985|12942385|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
5265043|NCT00725985|12942386|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
5265044|NCT00725985|12942387|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
5265045|NCT00725985|12942388|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
5265046|NCT00725985|12942389|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
5265047|NCT00725985|12942390|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
5265048|NCT00725985|12942379|P12|STARTED|LTFU (With Cladribine Treatment)||0
5265049|NCT00725985|12942380|P11|STARTED|LTFU (With Cladribine Treatment)||0
5265050|NCT00725985|12942381|P10|STARTED|LTFU (With Cladribine Treatment)||0
5265051|NCT00725985|12942382|P9|STARTED|LTFU (With Cladribine Treatment)||17
5265052|NCT00725985|12942383|P8|STARTED|LTFU (With Cladribine Treatment)||9
5265053|NCT00725985|12942384|P7|STARTED|LTFU (With Cladribine Treatment)||9
5265054|NCT00725985|12942385|P6|STARTED|LTFU (With Cladribine Treatment)||0
5265055|NCT00725985|12942386|P5|STARTED|LTFU (With Cladribine Treatment)||0
5265056|NCT00725985|12942387|P4|STARTED|LTFU (With Cladribine Treatment)||0
5265057|NCT00725985|12942388|P3|STARTED|LTFU (With Cladribine Treatment)||0
5265058|NCT00725985|12942389|P2|STARTED|LTFU (With Cladribine Treatment)||0
5265059|NCT00725985|12942390|P1|STARTED|LTFU (With Cladribine Treatment)||0
5265060|NCT00725985|12942379|P12|NOT COMPLETED|OLMP||0
5265061|NCT00725985|12942380|P11|NOT COMPLETED|OLMP||0
5265062|NCT00725985|12942381|P10|NOT COMPLETED|OLMP||0
5265063|NCT00725985|12942382|P9|NOT COMPLETED|OLMP||0
5265064|NCT00725985|12942383|P8|NOT COMPLETED|OLMP||0
5265065|NCT00725985|12942384|P7|NOT COMPLETED|OLMP||0
5265066|NCT00725985|12942385|P6|NOT COMPLETED|OLMP||53
5265067|NCT00725985|12942386|P5|NOT COMPLETED|OLMP||23
5265068|NCT00725985|12942387|P4|NOT COMPLETED|OLMP||18
5265069|NCT00725985|12942388|P3|NOT COMPLETED|OLMP||0
5265070|NCT00725985|12942389|P2|NOT COMPLETED|OLMP||0
5265071|NCT00725985|12942390|P1|NOT COMPLETED|OLMP||0
5265072|NCT00725985|12942379|P12|COMPLETED|OLMP||0
5265073|NCT00725985|12942380|P11|COMPLETED|OLMP||0
5265074|NCT00725985|12942381|P10|COMPLETED|OLMP||0
5265075|NCT00725985|12942382|P9|COMPLETED|OLMP||0
5265076|NCT00725985|12942383|P8|COMPLETED|OLMP||0
5265077|NCT00725985|12942384|P7|COMPLETED|OLMP||0
5265078|NCT00725985|12942385|P6|COMPLETED|OLMP||7
5265079|NCT00725985|12942386|P5|COMPLETED|OLMP||2
5265080|NCT00725985|12942387|P4|COMPLETED|OLMP||6
5265081|NCT00725985|12942388|P3|COMPLETED|OLMP||0
5265082|NCT00725985|12942389|P2|COMPLETED|OLMP||0
5265083|NCT00725985|12942390|P1|COMPLETED|OLMP||0
5265084|NCT00725985|12942379|P12|STARTED|OLMP||0
5265085|NCT00725985|12942380|P11|STARTED|OLMP||0
5265086|NCT00725985|12942381|P10|STARTED|OLMP||0
5265087|NCT00725985|12942382|P9|STARTED|OLMP||0
5265088|NCT00725985|12942383|P8|STARTED|OLMP||0
5265089|NCT00725985|12942384|P7|STARTED|OLMP||0
5265090|NCT00725985|12942385|P6|STARTED|OLMP||60
5265091|NCT00725985|12942386|P5|STARTED|OLMP||25
5265092|NCT00725985|12942387|P4|STARTED|OLMP||24
5265093|NCT00725985|12942388|P3|STARTED|OLMP||0
5265094|NCT00725985|12942389|P2|STARTED|OLMP||0
5265095|NCT00725985|12942390|P1|STARTED|OLMP||0
5265096|NCT00725985|12942379|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265097|NCT00725985|12942380|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265098|NCT00725985|12942381|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265099|NCT00725985|12942382|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265100|NCT00725985|12942383|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265101|NCT00725985|12942384|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265102|NCT00725985|12942385|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265103|NCT00725985|12942386|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265104|NCT00725985|12942387|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
5265105|NCT00725985|12942388|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
5265106|NCT00725985|12942389|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
5265107|NCT00725985|12942390|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
5265108|NCT00725985|12942379|P12|COMPLETED|ITP (Up to 96 Weeks)||0
5265109|NCT00725985|12942380|P11|COMPLETED|ITP (Up to 96 Weeks)||0
5265110|NCT00725985|12942381|P10|COMPLETED|ITP (Up to 96 Weeks)||0
5265111|NCT00725985|12942382|P9|COMPLETED|ITP (Up to 96 Weeks)||0
5265112|NCT00725985|12942383|P8|COMPLETED|ITP (Up to 96 Weeks)||0
5265113|NCT00725985|12942384|P7|COMPLETED|ITP (Up to 96 Weeks)||0
5265114|NCT00725985|12942385|P6|COMPLETED|ITP (Up to 96 Weeks)||0
5265115|NCT00725985|12942386|P5|COMPLETED|ITP (Up to 96 Weeks)||0
5265116|NCT00725985|12942387|P4|COMPLETED|ITP (Up to 96 Weeks)||0
5265117|NCT00725985|12942388|P3|COMPLETED|ITP (Up to 96 Weeks)||104
5265118|NCT00725985|12942389|P2|COMPLETED|ITP (Up to 96 Weeks)||131
5265119|NCT00725985|12942390|P1|COMPLETED|ITP (Up to 96 Weeks)||104
5265120|NCT00725985|12942379|P12|Treated|ITP (Up to 96 Weeks)||0
5265121|NCT00725985|12942380|P11|Treated|ITP (Up to 96 Weeks)||0
5265122|NCT00725985|12942381|P10|Treated|ITP (Up to 96 Weeks)||0
5265123|NCT00725985|12942382|P9|Treated|ITP (Up to 96 Weeks)||0
5265124|NCT00725985|12942383|P8|Treated|ITP (Up to 96 Weeks)||0
5265125|NCT00725985|12942384|P7|Treated|ITP (Up to 96 Weeks)||0
5265126|NCT00725985|12942385|P6|Treated|ITP (Up to 96 Weeks)||0
5265127|NCT00725985|12942386|P5|Treated|ITP (Up to 96 Weeks)||0
5265128|NCT00725985|12942387|P4|Treated|ITP (Up to 96 Weeks)||0
5265129|NCT00725985|12942388|P3|Treated|ITP (Up to 96 Weeks)||206
5265130|NCT00725985|12942389|P2|Treated|ITP (Up to 96 Weeks)||206
5265131|NCT00725985|12942390|P1|Treated|ITP (Up to 96 Weeks)||204
5265132|NCT00725985|12942379|P12|STARTED|ITP (Up to 96 Weeks)||0
5265133|NCT00725985|12942380|P11|STARTED|ITP (Up to 96 Weeks)||0
5265134|NCT00725985|12942381|P10|STARTED|ITP (Up to 96 Weeks)||0
5265135|NCT00725985|12942382|P9|STARTED|ITP (Up to 96 Weeks)||0
5265136|NCT00725985|12942383|P8|STARTED|ITP (Up to 96 Weeks)||0
5265137|NCT00725985|12942384|P7|STARTED|ITP (Up to 96 Weeks)||0
5265138|NCT00725985|12942385|P6|STARTED|ITP (Up to 96 Weeks)||0
5265139|NCT00725985|12942386|P5|STARTED|ITP (Up to 96 Weeks)||0
5265140|NCT00725985|12942387|P4|STARTED|ITP (Up to 96 Weeks)||0
5265141|NCT00725985|12942388|P3|STARTED|ITP (Up to 96 Weeks)||206
5265142|NCT00725985|12942389|P2|STARTED|ITP (Up to 96 Weeks)||206
5265143|NCT00725985|12942390|P1|STARTED|ITP (Up to 96 Weeks)||205
5265144|NCT00725959|12942418|P2|NOT COMPLETED|Overall Study||197
5265145|NCT00725959|12942419|P1|NOT COMPLETED|Overall Study||289
5265146|NCT00725959|12942418|P2|COMPLETED|Overall Study||439
5265147|NCT00725959|12942419|P1|COMPLETED|Overall Study||653
5265148|NCT00725959|12942418|P2|STARTED|Overall Study||636
5265149|NCT00725959|12942419|P1|STARTED|Overall Study||942
5265150|NCT00725920|12942427|P2|NOT COMPLETED|Overall Study||6
5265151|NCT00725920|12942428|P1|NOT COMPLETED|Overall Study||3
5265152|NCT00725920|12942427|P2|COMPLETED|Overall Study||12
5265153|NCT00725920|12942428|P1|COMPLETED|Overall Study||14
5265154|NCT00725920|12942427|P2|STARTED|Overall Study||18
5265155|NCT00725920|12942428|P1|STARTED|Overall Study||17
5265156|NCT00725842|12942434|P1|NOT COMPLETED|Overall Study||40
5265157|NCT00725842|12942434|P1|COMPLETED|Overall Study||57
5265158|NCT00725842|12942434|P1|Participants Eligible for Analysis|Overall Study||90
5265159|NCT00725842|12942434|P1|STARTED|Overall Study||97
5265160|NCT00725764|12942441|P1|NOT COMPLETED|Overall Study||14
5265161|NCT00725764|12942441|P1|COMPLETED|Overall Study||0
5265162|NCT00725764|12942441|P1|STARTED|Overall Study||14
5265163|NCT00725751|12942461|P2|NOT COMPLETED|Overall Study||108
5265164|NCT00725751|12942462|P1|NOT COMPLETED|Overall Study||34
5265165|NCT00725751|12942461|P2|COMPLETED|Overall Study||150
5265166|NCT00725751|12942462|P1|COMPLETED|Overall Study||56
5265167|NCT00725751|12942461|P2|STARTED|Overall Study||258
5265168|NCT00725751|12942462|P1|STARTED|Overall Study||90
5265169|NCT00725725|12942474|P3|NOT COMPLETED|Overall Study||5
5265170|NCT00725725|12942475|P2|NOT COMPLETED|Overall Study||4
5265171|NCT00725725|12942476|P1|NOT COMPLETED|Overall Study||4
5265172|NCT00725725|12942474|P3|COMPLETED|Overall Study||12
5265173|NCT00725725|12942475|P2|COMPLETED|Overall Study||11
5265174|NCT00725725|12942476|P1|COMPLETED|Overall Study||10
5265175|NCT00725725|12942474|P3|Treated|Overall Study||14
5265176|NCT00725725|12942475|P2|Treated|Overall Study||15
5265177|NCT00725725|12942476|P1|Treated|Overall Study||11
5265178|NCT00725725|12942474|P3|STARTED|Overall Study||17
5265179|NCT00725725|12942475|P2|STARTED|Overall Study||15
5265180|NCT00725725|12942476|P1|STARTED|Overall Study||14
5265181|NCT00725712|12942519|P2|NOT COMPLETED|Overall Study||26
5265182|NCT00725712|12942520|P1|NOT COMPLETED|Overall Study||48
5265183|NCT00725712|12942519|P2|COMPLETED|Overall Study||0
5265184|NCT00725712|12942520|P1|COMPLETED|Overall Study||0
5265185|NCT00725712|12942519|P2|STARTED|Overall Study||26
5265186|NCT00725712|12942520|P1|STARTED|Overall Study||48
5265187|NCT00725621|12942556|P1|NOT COMPLETED|Overall Study||271
5265188|NCT00725621|12942556|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
5265189|NCT00725621|12942556|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
5265190|NCT00725608|12942579|P1|NOT COMPLETED|Overall Study||167
5265191|NCT00725608|12942579|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
5265192|NCT00725608|12942579|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
5265193|NCT00725543|12942585|P1|NOT COMPLETED|Overall Study||153
5265194|NCT00725543|12942585|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
5265195|NCT00725543|12942585|P1|STARTED|Overall Study||358
5265196|NCT00725530|12942594|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
5265197|NCT00725530|12942595|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
5265198|NCT00725530|12942594|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
5265199|NCT00725530|12942595|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
5265200|NCT00725530|12942594|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
5265201|NCT00725530|12942595|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
5265202|NCT00725530|12942594|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
5265203|NCT00725530|12942595|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
5265204|NCT00725530|12942594|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
5265205|NCT00725530|12942595|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
5265206|NCT00725530|12942594|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
5265207|NCT00725530|12942595|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
5265208|NCT00725504|12942601|P1|NOT COMPLETED|Overall Study||0
5265209|NCT00725504|12942601|P1|COMPLETED|Overall Study||71
5265210|NCT00725504|12942601|P1|STARTED|Overall Study||71
5265211|NCT00725491|12942610|P2|NOT COMPLETED|Overall Study||18
5265212|NCT00725491|12942611|P1|NOT COMPLETED|Overall Study||9
5265213|NCT00725491|12942610|P2|COMPLETED|Overall Study||102
5265214|NCT00725491|12942611|P1|COMPLETED|Overall Study||104
5265215|NCT00725491|12942610|P2|STARTED|Overall Study|Intent-to-Treat Group|120
5265216|NCT00725491|12942611|P1|STARTED|Overall Study|Intent-to-Treat Group|113
5265217|NCT00725452|12942617|P1|NOT COMPLETED|Overall Study||11
5265218|NCT00725452|12942617|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
5265219|NCT00725452|12942617|P1|STARTED|Overall Study||26
5265220|NCT00725361|12942626|P1|NOT COMPLETED|Overall Study||4
5265221|NCT00725361|12942626|P1|COMPLETED|Overall Study||16
5265222|NCT00725361|12942626|P1|STARTED|Overall Study||20
5265223|NCT00725322|12942636|P2|NOT COMPLETED|Second Injection Visit||0
5265224|NCT00725322|12942637|P1|NOT COMPLETED|Second Injection Visit||0
5265225|NCT00725322|12942636|P2|COMPLETED|Second Injection Visit||14
5265226|NCT00725322|12942637|P1|COMPLETED|Second Injection Visit||13
5265227|NCT00725322|12942636|P2|STARTED|Second Injection Visit||14
5265228|NCT00725322|12942637|P1|STARTED|Second Injection Visit||13
5265229|NCT00725322|12942636|P2|NOT COMPLETED|Washout (28 Days)||1
5265230|NCT00725322|12942637|P1|NOT COMPLETED|Washout (28 Days)||2
5265231|NCT00725322|12942636|P2|COMPLETED|Washout (28 Days)||14
5265232|NCT00725322|12942637|P1|COMPLETED|Washout (28 Days)||13
5265233|NCT00725322|12942636|P2|STARTED|Washout (28 Days)||15
5265234|NCT00725322|12942637|P1|STARTED|Washout (28 Days)||15
5265235|NCT00725322|12942636|P2|NOT COMPLETED|First Injection Visit||0
5265236|NCT00725322|12942637|P1|NOT COMPLETED|First Injection Visit||0
5265237|NCT00725322|12942636|P2|COMPLETED|First Injection Visit||15
5265238|NCT00725322|12942637|P1|COMPLETED|First Injection Visit||15
5265239|NCT00725322|12942636|P2|STARTED|First Injection Visit||15
5265240|NCT00725322|12942637|P1|STARTED|First Injection Visit||15
5265241|NCT00725296|12942645|P1|NOT COMPLETED|Overall Study||62
5265242|NCT00725296|12942645|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
5265243|NCT00725296|12942645|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
5265244|NCT00725283|12942654|P1|NOT COMPLETED|Overall Study||24
5265245|NCT00725283|12942654|P1|COMPLETED|Overall Study||10
5265246|NCT00725283|12942654|P1|STARTED|Overall Study||34
5265247|NCT00725270|12942666|P2|NOT COMPLETED|Overall Study||0
5265248|NCT00725270|12942667|P1|NOT COMPLETED|Overall Study||0
5265249|NCT00725270|12942666|P2|COMPLETED|Overall Study||7
5265250|NCT00725270|12942667|P1|COMPLETED|Overall Study||5
5265251|NCT00725270|12942666|P2|STARTED|Overall Study||7
5265252|NCT00725270|12942667|P1|STARTED|Overall Study||5
5265253|NCT00725205|12942675|P1|NOT COMPLETED|Overall Study||87
5265254|NCT00725205|12942675|P1|COMPLETED|Overall Study||207
5265255|NCT00725205|12942675|P1|STARTED|Overall Study||294
5265256|NCT00725153|12942681|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
5265257|NCT00725153|12942682|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
5265258|NCT00725153|12942681|P2|COMPLETED|Period Two, 10 Hours of Wear||28
5265259|NCT00725153|12942682|P1|COMPLETED|Period Two, 10 Hours of Wear||27
5265260|NCT00725153|12942681|P2|STARTED|Period Two, 10 Hours of Wear||28
5265261|NCT00725153|12942682|P1|STARTED|Period Two, 10 Hours of Wear||27
5265262|NCT00725153|12942681|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
5265263|NCT00725153|12942682|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
5265264|NCT00725153|12942681|P2|COMPLETED|Period One, 10 Hours of Wear||28
5265265|NCT00725153|12942682|P1|COMPLETED|Period One, 10 Hours of Wear||27
5265266|NCT00725153|12942681|P2|STARTED|Period One, 10 Hours of Wear||28
5265267|NCT00725153|12942682|P1|STARTED|Period One, 10 Hours of Wear||27
5265268|NCT00725101|12942688|P1|NOT COMPLETED|Overall Study||495
5265269|NCT00725101|12942688|P1|COMPLETED|Overall Study||1205
5265270|NCT00725101|12942688|P1|STARTED|Overall Study||1700
5265271|NCT00725075|12942711|P3|NOT COMPLETED|Overall Study||9
5265272|NCT00725075|12942712|P2|NOT COMPLETED|Overall Study||8
5265273|NCT00725075|12942713|P1|NOT COMPLETED|Overall Study||11
5265274|NCT00725075|12942711|P3|COMPLETED|Overall Study||61
5265275|NCT00725075|12942712|P2|COMPLETED|Overall Study||65
5265276|NCT00725075|12942713|P1|COMPLETED|Overall Study||61
5265277|NCT00725075|12942711|P3|Treated|Overall Study||70
5265278|NCT00725075|12942712|P2|Treated|Overall Study||73
5265279|NCT00725075|12942713|P1|Treated|Overall Study||71
5265280|NCT00725075|12942711|P3|STARTED|Overall Study||70
5265281|NCT00725075|12942712|P2|STARTED|Overall Study||73
5265282|NCT00725075|12942713|P1|STARTED|Overall Study||72
5265283|NCT00725049|12942759|P2|NOT COMPLETED|Overall Study||0
5265284|NCT00725049|12942760|P1|NOT COMPLETED|Overall Study||0
5265285|NCT00725049|12942759|P2|COMPLETED|Overall Study||20
5265286|NCT00725049|12942760|P1|COMPLETED|Overall Study||17
5265287|NCT00725049|12942759|P2|STARTED|Overall Study||20
5265288|NCT00725049|12942760|P1|STARTED|Overall Study||17
5265289|NCT00725010|12942766|P1|NOT COMPLETED|Overall Study||25
5265290|NCT00725010|12942766|P1|COMPLETED|Overall Study||25
5265291|NCT00725010|12942766|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
5265292|NCT00724984|12942780|P6|NOT COMPLETED|Overall Study||5
5265293|NCT00724984|12942781|P5|NOT COMPLETED|Overall Study||4
5265294|NCT00724984|12942782|P4|NOT COMPLETED|Overall Study||2
5265295|NCT00724984|12942783|P3|NOT COMPLETED|Overall Study||0
5265296|NCT00724984|12942784|P2|NOT COMPLETED|Overall Study||1
5265297|NCT00724984|12942785|P1|NOT COMPLETED|Overall Study||1
5265298|NCT00724984|12942780|P6|COMPLETED|Overall Study||9
5265299|NCT00724984|12942781|P5|COMPLETED|Overall Study||12
5265300|NCT00724984|12942782|P4|COMPLETED|Overall Study||7
5265301|NCT00724984|12942783|P3|COMPLETED|Overall Study||3
5265302|NCT00724984|12942784|P2|COMPLETED|Overall Study||7
5265303|NCT00724984|12942785|P1|COMPLETED|Overall Study||4
5265304|NCT00724984|12942780|P6|STARTED|Overall Study||14
5265305|NCT00724984|12942781|P5|STARTED|Overall Study||16
5265306|NCT00724984|12942782|P4|STARTED|Overall Study||9
5265307|NCT00724984|12942783|P3|STARTED|Overall Study||3
5265308|NCT00724984|12942784|P2|STARTED|Overall Study||8
5265309|NCT00724984|12942785|P1|STARTED|Overall Study||5
5265310|NCT00724971|12942799|P1|NOT COMPLETED|Overall Study||6
5265311|NCT00724971|12942799|P1|COMPLETED|Overall Study||4
5265312|NCT00724971|12942799|P1|STARTED|Overall Study||10
5265313|NCT00724958|12942814|P1|NOT COMPLETED|Overall Study||182
5265314|NCT00724958|12942814|P1|COMPLETED|Overall Study||166
5265315|NCT00724958|12942814|P1|STARTED|Overall Study||348
5265316|NCT00724945|12942823|P2|NOT COMPLETED|Period 2||0
5265317|NCT00724945|12942824|P1|NOT COMPLETED|Period 2||4
5265318|NCT00724945|12942823|P2|COMPLETED|Period 2||54
5265319|NCT00724945|12942824|P1|COMPLETED|Period 2||51
5265320|NCT00724945|12942823|P2|STARTED|Period 2||54
5265321|NCT00724945|12942824|P1|STARTED|Period 2||55
5265322|NCT00724945|12942823|P2|NOT COMPLETED|Period 1||1
5265323|NCT00724945|12942824|P1|NOT COMPLETED|Period 1||3
5265324|NCT00724945|12942823|P2|COMPLETED|Period 1||54
5265325|NCT00724945|12942824|P1|COMPLETED|Period 1||55
5265326|NCT00724945|12942823|P2|STARTED|Period 1||55
5265327|NCT00724945|12942824|P1|STARTED|Period 1||58
5265328|NCT00724932|12942836|P2|NOT COMPLETED|Overall Study||3
5265329|NCT00724932|12942837|P1|NOT COMPLETED|Overall Study||5
5265330|NCT00724932|12942836|P2|COMPLETED|Overall Study||67
5265331|NCT00724932|12942837|P1|COMPLETED|Overall Study||65
5265332|NCT00724932|12942836|P2|STARTED|Overall Study||70
5265333|NCT00724932|12942837|P1|STARTED|Overall Study||70
5265334|NCT00724893|12942908|P2|NOT COMPLETED|Overall Study||458
5265335|NCT00724893|12942909|P1|NOT COMPLETED|Overall Study||364
5265336|NCT00724893|12942908|P2|COMPLETED|Overall Study||670
5265337|NCT00724893|12942909|P1|COMPLETED|Overall Study||938
5265338|NCT00724893|12942908|P2|STARTED|Overall Study||1128
5265339|NCT00724893|12942909|P1|STARTED|Overall Study||1302
5265340|NCT00724867|12942977|P1|NOT COMPLETED|Overall Study||128
5265341|NCT00724867|12942977|P1|COMPLETED|Overall Study||140
5265342|NCT00724867|12942977|P1|STARTED|Overall Study||268
5265343|NCT00724854|12943017|P2|NOT COMPLETED|Overall Study||31
5265344|NCT00724854|12943018|P1|NOT COMPLETED|Overall Study||403
5265345|NCT00724854|12943017|P2|COMPLETED|Overall Study||41
5265346|NCT00724854|12943018|P1|COMPLETED|Overall Study||607
5265347|NCT00724854|12943017|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
5265348|NCT00724854|12943018|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
5265349|NCT00724815|12943035|P2|NOT COMPLETED|Overall Study||39
5265350|NCT00724815|12943036|P1|NOT COMPLETED|Overall Study||43
5265351|NCT00724815|12943035|P2|COMPLETED|Overall Study||226
5265352|NCT00724815|12943036|P1|COMPLETED|Overall Study||222
5265353|NCT00724815|12943035|P2|STARTED|Overall Study|subjects randomized|265
5265354|NCT00724815|12943036|P1|STARTED|Overall Study|subjects randomized|265
5265355|NCT00724750|12943050|P2|NOT COMPLETED|Overall Study||0
5265356|NCT00724750|12943051|P1|NOT COMPLETED|Overall Study||0
5265357|NCT00724750|12943050|P2|COMPLETED|Overall Study||42
5265358|NCT00724750|12943051|P1|COMPLETED|Overall Study||45
5265359|NCT00724750|12943050|P2|STARTED|Overall Study||42
5265360|NCT00724750|12943051|P1|STARTED|Overall Study||45
5265361|NCT00724711|12943069|P2|NOT COMPLETED|Overall Study||17
5265362|NCT00724711|12943070|P1|NOT COMPLETED|Overall Study||17
5265363|NCT00724711|12943069|P2|COMPLETED|Overall Study||139
5265364|NCT00724711|12943070|P1|COMPLETED|Overall Study||138
5265365|NCT00724711|12943069|P2|STARTED|Overall Study||156
5265366|NCT00724711|12943070|P1|STARTED|Overall Study||155
5265367|NCT00724698|12943102|P1|NOT COMPLETED|Overall Study||90
5265368|NCT00724698|12943102|P1|COMPLETED|Overall Study||2921
5265369|NCT00724698|12943102|P1|STARTED|Overall Study||3011
5265370|NCT00724594|12943109|P4|NOT COMPLETED|Overall Study||1
5265371|NCT00724594|12943110|P3|NOT COMPLETED|Overall Study||0
5265372|NCT00724594|12943111|P2|NOT COMPLETED|Overall Study||0
5265373|NCT00724594|12943112|P1|NOT COMPLETED|Overall Study||0
5265374|NCT00724594|12943109|P4|COMPLETED|Overall Study||10
5265375|NCT00724594|12943110|P3|COMPLETED|Overall Study||11
5265376|NCT00724594|12943111|P2|COMPLETED|Overall Study||12
5265377|NCT00724594|12943112|P1|COMPLETED|Overall Study||12
5265378|NCT00724594|12943109|P4|STARTED|Overall Study||11
5265379|NCT00724594|12943110|P3|STARTED|Overall Study||11
5265380|NCT00724594|12943111|P2|STARTED|Overall Study||12
5265381|NCT00724594|12943112|P1|STARTED|Overall Study||12
5265382|NCT00724568|12943147|P2|NOT COMPLETED|Overall Study||0
5265383|NCT00724568|12943148|P1|NOT COMPLETED|Overall Study||0
5265384|NCT00724568|12943147|P2|COMPLETED|Overall Study||32
5265385|NCT00724568|12943148|P1|COMPLETED|Overall Study||42
5265386|NCT00724568|12943147|P2|STARTED|Overall Study||32
5265387|NCT00724568|12943148|P1|STARTED|Overall Study||42
5265388|NCT00724503|12943155|P2|NOT COMPLETED|Overall Study||220
5265389|NCT00724503|12943156|P1|NOT COMPLETED|Overall Study||210
5265390|NCT00724503|12943155|P2|COMPLETED|Overall Study||43
5265391|NCT00724503|12943156|P1|COMPLETED|Overall Study||57
5265392|NCT00724503|12943155|P2|STARTED|Overall Study||263
5265393|NCT00724503|12943156|P1|STARTED|Overall Study||267
5265394|NCT00724477|12943164|P1|NOT COMPLETED|Overall Study||0
5265395|NCT00724477|12943164|P1|COMPLETED|Overall Study||1663
5265396|NCT00724477|12943164|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
5265397|NCT00724464|12943168|P1|NOT COMPLETED|Overall Study||23
5265398|NCT00724464|12943168|P1|COMPLETED|Overall Study||309
5265399|NCT00724464|12943168|P1|STARTED|Overall Study||332
5265400|NCT00724451|12943180|P1|NOT COMPLETED|Overall Study||802
5265401|NCT00724451|12943180|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
5265402|NCT00724451|12943180|P1|Received Antiviral Treatment|Overall Study||500
5265403|NCT00724451|12943180|P1|STARTED|Overall Study||1128
5265404|NCT00724373|12943186|P1|NOT COMPLETED|Overall Study||171
5265405|NCT00724373|12943186|P1|COMPLETED|Overall Study||271
5265406|NCT00724373|12943186|P1|STARTED|Overall Study||442
5265407|NCT00724347|12943190|P1|NOT COMPLETED|Overall Study||2
5265408|NCT00724347|12943190|P1|COMPLETED|Overall Study||16
5265409|NCT00724347|12943190|P1|Baseline Testing|Overall Study||18
5265410|NCT00724347|12943190|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
5265411|NCT00724308|12943196|P2|NOT COMPLETED|Overall Study||97
5265412|NCT00724308|12943197|P1|NOT COMPLETED|Overall Study||80
5265413|NCT00724308|12943196|P2|COMPLETED|Overall Study||210
5265414|NCT00724308|12943197|P1|COMPLETED|Overall Study||190
5265415|NCT00724308|12943196|P2|STARTED|Overall Study||307
5265416|NCT00724308|12943197|P1|STARTED|Overall Study||270
5265417|NCT00724282|12943203|P1|NOT COMPLETED|Overall Study||4
5265418|NCT00724282|12943203|P1|COMPLETED|Overall Study||16
5265419|NCT00724282|12943203|P1|STARTED|Overall Study||20
5265420|NCT00724243|12943207|P1|NOT COMPLETED|Overall Study||15
5265421|NCT00724243|12943207|P1|COMPLETED|Overall Study||18
5265422|NCT00724243|12943207|P1|STARTED|Overall Study||33
5265423|NCT00724152|12943217|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
5265424|NCT00724152|12943218|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
5265425|NCT00724152|12943219|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
5265426|NCT00724152|12943217|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
5265427|NCT00724152|12943218|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
5265428|NCT00724152|12943219|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
5265429|NCT00724152|12943217|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
5265430|NCT00724152|12943218|P2|STARTED|Three-arm Study Period (+Standard Care)||2
5265431|NCT00724152|12943219|P1|STARTED|Three-arm Study Period (+Standard Care)||4
5265432|NCT00724152|12943217|P3|NOT COMPLETED|Two-arm Study Period||0
5265433|NCT00724152|12943218|P2|NOT COMPLETED|Two-arm Study Period||2
5265434|NCT00724152|12943219|P1|NOT COMPLETED|Two-arm Study Period||3
5265435|NCT00724152|12943217|P3|COMPLETED|Two-arm Study Period||0
5265436|NCT00724152|12943218|P2|COMPLETED|Two-arm Study Period||9
5265437|NCT00724152|12943219|P1|COMPLETED|Two-arm Study Period||11
5265438|NCT00724152|12943217|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
5265439|NCT00724152|12943218|P2|STARTED|Two-arm Study Period||11
5265440|NCT00724152|12943219|P1|STARTED|Two-arm Study Period||14
5265441|NCT00724126|12943236|P2|NOT COMPLETED|Overall Study||15
5265442|NCT00724126|12943237|P1|NOT COMPLETED|Overall Study||19
5265443|NCT00724126|12943236|P2|COMPLETED|Overall Study||301
5265444|NCT00724126|12943237|P1|COMPLETED|Overall Study||302
5265445|NCT00724126|12943236|P2|STARTED|Overall Study||316
5265446|NCT00724126|12943237|P1|STARTED|Overall Study||321
5265447|NCT00724061|12943245|P1|NOT COMPLETED|Maintenance Therapy||0
5265448|NCT00724061|12943245|P1|COMPLETED|Maintenance Therapy||2
5265449|NCT00724061|12943245|P1|STARTED|Maintenance Therapy||2
5265450|NCT00724061|12943245|P1|NOT COMPLETED|Dose Escalation Phase||5
5265451|NCT00724061|12943245|P1|COMPLETED|Dose Escalation Phase||2
5265452|NCT00724061|12943245|P1|STARTED|Dose Escalation Phase||7
5265453|NCT00724009|12943252|P1|NOT COMPLETED|Overall Study||0
5265454|NCT00724009|12943252|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
5265455|NCT00724009|12943252|P1|STARTED|Overall Study||29
5265456|NCT00723957|12943265|P2|NOT COMPLETED|Overall Study||53
5265457|NCT00723957|12943266|P1|NOT COMPLETED|Overall Study||51
5265458|NCT00723957|12943265|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
5265459|NCT00723957|12943266|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
5265460|NCT00723957|12943265|P2|STARTED|Overall Study|Randomized|99
5265461|NCT00723957|12943266|P1|STARTED|Overall Study|Randomized|98
5265462|NCT00723944|12943290|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
5265463|NCT00723944|12943291|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
5265464|NCT00723944|12943290|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
5265465|NCT00723944|12943291|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
5265466|NCT00723944|12943290|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
5265467|NCT00723944|12943291|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
5265468|NCT00723944|12943290|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
5265469|NCT00723944|12943291|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
5265470|NCT00723944|12943290|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
5265471|NCT00723944|12943291|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
5265472|NCT00723944|12943290|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
5265473|NCT00723944|12943291|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
5265474|NCT00723944|12943290|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
5265475|NCT00723944|12943291|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
5265476|NCT00723944|12943290|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
5265477|NCT00723944|12943291|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
5265478|NCT00723944|12943290|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
5265479|NCT00723944|12943291|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
5265480|NCT00723944|12943290|P2|NOT COMPLETED|Implant Placement Surgery||0
5265481|NCT00723944|12943291|P1|NOT COMPLETED|Implant Placement Surgery||0
5265482|NCT00723944|12943290|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
5265483|NCT00723944|12943291|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
5265484|NCT00723944|12943290|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
5265485|NCT00723944|12943291|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
5265486|NCT00723931|12943297|P1|NOT COMPLETED|Overall Study||0
5265487|NCT00723931|12943297|P1|COMPLETED|Overall Study||1267
5265488|NCT00723931|12943297|P1|STARTED|Overall Study||1267
5265489|NCT00723892|12943304|P2|NOT COMPLETED|Overall Study||87
5265490|NCT00723892|12943305|P1|NOT COMPLETED|Overall Study||107
5265491|NCT00723892|12943304|P2|COMPLETED|Overall Study||168
5265492|NCT00723892|12943305|P1|COMPLETED|Overall Study||206
5265493|NCT00723892|12943304|P2|STARTED|Overall Study||255
5265494|NCT00723892|12943305|P1|STARTED|Overall Study||313
5265495|NCT00723840|12943312|P1|NOT COMPLETED|Overall Study||82
5265496|NCT00723840|12943312|P1|COMPLETED|Overall Study||163
5265497|NCT00723840|12943312|P1|STARTED|Overall Study||245
5265498|NCT00723827|12943323|P1|NOT COMPLETED|Overall Study||0
5265499|NCT00723827|12943323|P1|COMPLETED|Overall Study||682
5265500|NCT00723827|12943323|P1|STARTED|Overall Study||682
5265501|NCT00723801|12943333|P2|NOT COMPLETED|Overall Study||3
5265502|NCT00723801|12943334|P1|NOT COMPLETED|Overall Study||3
5265503|NCT00723801|12943333|P2|COMPLETED|Overall Study||17
5265504|NCT00723801|12943334|P1|COMPLETED|Overall Study||17
5265505|NCT00723801|12943333|P2|STARTED|Overall Study||20
5265506|NCT00723801|12943334|P1|STARTED|Overall Study||20
5265507|NCT00723788|12943342|P1|NOT COMPLETED|Overall Study||0
5265508|NCT00723788|12943342|P1|COMPLETED|Overall Study||21
5265509|NCT00723788|12943342|P1|STARTED|Overall Study||21
5265510|NCT00723749|12943348|P1|NOT COMPLETED|Overall Study||163
5265511|NCT00723749|12943348|P1|COMPLETED|Overall Study||182
5265512|NCT00723749|12943348|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
5265513|NCT00723736|12943355|P1|NOT COMPLETED|Overall Study||1
5265514|NCT00723736|12943355|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
5265515|NCT00723736|12943355|P1|STARTED|Overall Study||100
5265516|NCT00723710|12943359|P1|NOT COMPLETED|Overall Study||174
5265517|NCT00723710|12943359|P1|COMPLETED|Overall Study||120
5265518|NCT00723710|12943359|P1|STARTED|Overall Study||294
5265519|NCT00723697|12943363|P1|NOT COMPLETED|Overall Study||18
5265520|NCT00723697|12943363|P1|COMPLETED|Overall Study||1289
5265521|NCT00723697|12943363|P1|STARTED|Overall Study||1307
5265522|NCT00723645|12943371|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
5265523|NCT00723645|12943371|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
5265524|NCT00723645|12943371|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
5265525|NCT00723645|12943371|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
5265526|NCT00723645|12943371|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
5265527|NCT00723645|12943371|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
5265528|NCT00723645|12943371|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
5265529|NCT00723645|12943371|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
5265530|NCT00723645|12943371|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
5265531|NCT00723632|12943376|P1|NOT COMPLETED|Overall Study||203
5265532|NCT00723632|12943376|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
5265533|NCT00723632|12943376|P1|STARTED|Overall Study||901
5265534|NCT00723606|12943384|P2|NOT COMPLETED|Overall Study||7
5265535|NCT00723606|12943385|P1|NOT COMPLETED|Overall Study||4
5265536|NCT00723606|12943384|P2|COMPLETED|Overall Study||180
5265537|NCT00723606|12943385|P1|COMPLETED|Overall Study||185
5265538|NCT00723606|12943384|P2|STARTED|Overall Study||187
5265539|NCT00723606|12943385|P1|STARTED|Overall Study||189
5265540|NCT00723580|12943401|P1|NOT COMPLETED|Overall Study||0
5265541|NCT00723580|12943401|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
5265542|NCT00723580|12943401|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
5265543|NCT00723580|12943401|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
5265544|NCT00723554|12943405|P1|NOT COMPLETED|Overall Study||29
5265545|NCT00723554|12943405|P1|COMPLETED|Overall Study||34
5265546|NCT00723554|12943405|P1|STARTED|Overall Study||63
5265547|NCT00723528|12943455|P7|NOT COMPLETED|Period 2: After Controlled Period||4
5265548|NCT00723528|12943456|P6|NOT COMPLETED|Period 2: After Controlled Period||6
5265549|NCT00723528|12943457|P5|NOT COMPLETED|Period 2: After Controlled Period||2
5265550|NCT00723528|12943458|P4|NOT COMPLETED|Period 2: After Controlled Period||1
5265551|NCT00723528|12943459|P3|NOT COMPLETED|Period 2: After Controlled Period||0
5265552|NCT00723528|12943460|P2|NOT COMPLETED|Period 2: After Controlled Period||0
5265553|NCT00723528|12943461|P1|NOT COMPLETED|Period 2: After Controlled Period||0
5265554|NCT00723528|12943455|P7|COMPLETED|Period 2: After Controlled Period||54
5265555|NCT00723528|12943456|P6|COMPLETED|Period 2: After Controlled Period||58
5265556|NCT00723528|12943457|P5|COMPLETED|Period 2: After Controlled Period||11
5265557|NCT00723528|12943458|P4|COMPLETED|Period 2: After Controlled Period||14
5265558|NCT00723528|12943459|P3|COMPLETED|Period 2: After Controlled Period||0
5265559|NCT00723528|12943460|P2|COMPLETED|Period 2: After Controlled Period||0
5265560|NCT00723528|12943461|P1|COMPLETED|Period 2: After Controlled Period||0
5265561|NCT00723528|12943455|P7|STARTED|Period 2: After Controlled Period||58
5265562|NCT00723528|12943456|P6|STARTED|Period 2: After Controlled Period||64
5265563|NCT00723528|12943457|P5|STARTED|Period 2: After Controlled Period||13
5265564|NCT00723528|12943458|P4|STARTED|Period 2: After Controlled Period||15
5265565|NCT00723528|12943459|P3|STARTED|Period 2: After Controlled Period||0
5265566|NCT00723528|12943460|P2|STARTED|Period 2: After Controlled Period||0
5265567|NCT00723528|12943461|P1|STARTED|Period 2: After Controlled Period||0
5265568|NCT00723528|12943455|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
5265569|NCT00723528|12943456|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
5265570|NCT00723528|12943457|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
5265571|NCT00723528|12943458|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
5265572|NCT00723528|12943459|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
5265573|NCT00723528|12943460|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
5265574|NCT00723528|12943461|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
5265575|NCT00723528|12943455|P7|COMPLETED|Period 1: Controlled Period (CP)||0
5265576|NCT00723528|12943456|P6|COMPLETED|Period 1: Controlled Period (CP)||0
5265577|NCT00723528|12943457|P5|COMPLETED|Period 1: Controlled Period (CP)||0
5265578|NCT00723528|12943458|P4|COMPLETED|Period 1: Controlled Period (CP)||0
5265579|NCT00723528|12943459|P3|COMPLETED|Period 1: Controlled Period (CP)||58
5265580|NCT00723528|12943460|P2|COMPLETED|Period 1: Controlled Period (CP)||64
5265581|NCT00723528|12943461|P1|COMPLETED|Period 1: Controlled Period (CP)||28
5265582|NCT00723528|12943455|P7|STARTED|Period 1: Controlled Period (CP)||0
5265583|NCT00723528|12943456|P6|STARTED|Period 1: Controlled Period (CP)||0
5265584|NCT00723528|12943457|P5|STARTED|Period 1: Controlled Period (CP)||0
5265585|NCT00723528|12943458|P4|STARTED|Period 1: Controlled Period (CP)||0
5265586|NCT00723528|12943459|P3|STARTED|Period 1: Controlled Period (CP)||62
5265587|NCT00723528|12943460|P2|STARTED|Period 1: Controlled Period (CP)||64
5265588|NCT00723528|12943461|P1|STARTED|Period 1: Controlled Period (CP)||32
5265589|NCT00723489|12943523|P4|NOT COMPLETED|Overall Study||3
5265590|NCT00723489|12943524|P3|NOT COMPLETED|Overall Study||0
5265591|NCT00723489|12943525|P2|NOT COMPLETED|Overall Study||4
5265592|NCT00723489|12943526|P1|NOT COMPLETED|Overall Study||1
5265593|NCT00723489|12943523|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
5265594|NCT00723489|12943524|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
5265595|NCT00723489|12943525|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
5265596|NCT00723489|12943526|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
5265597|NCT00723489|12943523|P4|STARTED|Overall Study||23
5265598|NCT00723489|12943524|P3|STARTED|Overall Study||19
5265599|NCT00723489|12943525|P2|STARTED|Overall Study||19
5265600|NCT00723489|12943526|P1|STARTED|Overall Study||21
5265601|NCT00723450|12943554|P3|NOT COMPLETED|Randomized Phase||67
5265602|NCT00723450|12943555|P2|NOT COMPLETED|Randomized Phase||65
5265603|NCT00723450|12943556|P1|NOT COMPLETED|Randomized Phase||0
5265604|NCT00723450|12943554|P3|COMPLETED|Randomized Phase||20
5265605|NCT00723450|12943555|P2|COMPLETED|Randomized Phase||21
5265606|NCT00723450|12943556|P1|COMPLETED|Randomized Phase||0
5265607|NCT00723450|12943554|P3|STARTED|Randomized Phase||87
5265608|NCT00723450|12943555|P2|STARTED|Randomized Phase||86
5265609|NCT00723450|12943556|P1|STARTED|Randomized Phase||0
5265610|NCT00723450|12943554|P3|NOT COMPLETED|Open-Label Phase||0
5265611|NCT00723450|12943555|P2|NOT COMPLETED|Open-Label Phase||0
5265612|NCT00723450|12943556|P1|NOT COMPLETED|Open-Label Phase||125
5265613|NCT00723450|12943554|P3|COMPLETED|Open-Label Phase||0
5265614|NCT00723450|12943555|P2|COMPLETED|Open-Label Phase||0
5265615|NCT00723450|12943556|P1|COMPLETED|Open-Label Phase||173
5265616|NCT00723450|12943554|P3|STARTED|Open-Label Phase||0
5265617|NCT00723450|12943555|P2|STARTED|Open-Label Phase||0
5265618|NCT00723450|12943556|P1|STARTED|Open-Label Phase||298
5265619|NCT00723398|12943602|P5|NOT COMPLETED|Overall Study||9
5265620|NCT00723398|12943603|P4|NOT COMPLETED|Overall Study||5
5265621|NCT00723398|12943604|P3|NOT COMPLETED|Overall Study||17
5265622|NCT00723398|12943605|P2|NOT COMPLETED|Overall Study||15
5265623|NCT00723398|12943606|P1|NOT COMPLETED|Overall Study||6
5265624|NCT00723398|12943602|P5|COMPLETED|Overall Study||44
5265625|NCT00723398|12943603|P4|COMPLETED|Overall Study||49
5265626|NCT00723398|12943604|P3|COMPLETED|Overall Study||36
5265627|NCT00723398|12943605|P2|COMPLETED|Overall Study||38
5265628|NCT00723398|12943606|P1|COMPLETED|Overall Study||47
5265629|NCT00723398|12943602|P5|STARTED|Overall Study||53
5265630|NCT00723398|12943603|P4|STARTED|Overall Study||54
5265631|NCT00723398|12943604|P3|STARTED|Overall Study||53
5265632|NCT00723398|12943605|P2|STARTED|Overall Study||53
5265633|NCT00723398|12943606|P1|STARTED|Overall Study||53
5265634|NCT00723294|12943668|P1|NOT COMPLETED|Overall Study||13
5265635|NCT00723294|12943668|P1|COMPLETED|Overall Study||86
5265636|NCT00723294|12943668|P1|STARTED|Overall Study||99
5265637|NCT00723255|12943673|P1|NOT COMPLETED|Overall Study||4
5265638|NCT00723255|12943673|P1|COMPLETED|Overall Study|Eligible and treated patients|49
5265639|NCT00723255|12943673|P1|STARTED|Overall Study||53
5265640|NCT00723229|12943700|P2|NOT COMPLETED|Second Intervention||0
5265641|NCT00723229|12943701|P1|NOT COMPLETED|Second Intervention||0
5265642|NCT00723229|12943700|P2|COMPLETED|Second Intervention||20
5265643|NCT00723229|12943701|P1|COMPLETED|Second Intervention||18
5265644|NCT00723229|12943700|P2|STARTED|Second Intervention||20
5265645|NCT00723229|12943701|P1|STARTED|Second Intervention||18
5265646|NCT00723229|12943700|P2|NOT COMPLETED|First Intervention||3
5265647|NCT00723229|12943701|P1|NOT COMPLETED|First Intervention||7
5265648|NCT00723229|12943700|P2|COMPLETED|First Intervention||20
5265649|NCT00723229|12943701|P1|COMPLETED|First Intervention||18
5265650|NCT00723229|12943700|P2|STARTED|First Intervention||23
5265651|NCT00723229|12943701|P1|STARTED|First Intervention||25
5265652|NCT00723203|12943713|P1|NOT COMPLETED|Overall Study||3
5265653|NCT00723203|12943713|P1|COMPLETED|Overall Study||13
5265654|NCT00723203|12943713|P1|STARTED|Overall Study||16
5265655|NCT00723190|12943717|P1|NOT COMPLETED|Overall Study||142
5265656|NCT00723190|12943717|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
5265657|NCT00723190|12943717|P1|SAFETY POPULATION|Overall Study||301
5265658|NCT00723190|12943717|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
5265659|NCT00723177|12943735|P3|NOT COMPLETED|Overall Study||5
5265660|NCT00723177|12943736|P2|NOT COMPLETED|Overall Study||4
5265661|NCT00723177|12943737|P1|NOT COMPLETED|Overall Study||5
5265662|NCT00723177|12943735|P3|COMPLETED|Overall Study||10
5265663|NCT00723177|12943736|P2|COMPLETED|Overall Study||10
5265664|NCT00723177|12943737|P1|COMPLETED|Overall Study||10
5265665|NCT00723177|12943735|P3|STARTED|Overall Study||15
5265666|NCT00723177|12943736|P2|STARTED|Overall Study||14
5265667|NCT00723177|12943737|P1|STARTED|Overall Study||15
5265668|NCT00723125|12943750|P2|NOT COMPLETED|Overall Study||6
5265669|NCT00723125|12943751|P1|NOT COMPLETED|Overall Study||18
5265670|NCT00723125|12943750|P2|COMPLETED|Overall Study||21
5265671|NCT00723125|12943751|P1|COMPLETED|Overall Study||15
5265672|NCT00723125|12943750|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
5265673|NCT00723125|12943751|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
5265674|NCT00723099|12943761|P1|NOT COMPLETED|Overall Study||1
5265675|NCT00723099|12943761|P1|COMPLETED|Overall Study||72
5265676|NCT00723099|12943761|P1|STARTED|Overall Study||73
5265677|NCT00723073|12943775|P2|NOT COMPLETED|Overall Study||0
5265678|NCT00723073|12943776|P1|NOT COMPLETED|Overall Study||0
5265679|NCT00723073|12943775|P2|COMPLETED|Overall Study||174
5265680|NCT00723073|12943776|P1|COMPLETED|Overall Study||149
5265681|NCT00723073|12943775|P2|STARTED|Overall Study||174
5265682|NCT00723073|12943776|P1|STARTED|Overall Study||149
5265683|NCT00723021|12943800|P5|NOT COMPLETED|Intervention Period 5||0
5265684|NCT00723021|12943801|P4|NOT COMPLETED|Intervention Period 5||0
5265685|NCT00723021|12943802|P3|NOT COMPLETED|Intervention Period 5||0
5265686|NCT00723021|12943803|P2|NOT COMPLETED|Intervention Period 5||0
5265687|NCT00723021|12943804|P1|NOT COMPLETED|Intervention Period 5||0
5265688|NCT00723021|12943800|P5|COMPLETED|Intervention Period 5||2
5265689|NCT00723021|12943801|P4|COMPLETED|Intervention Period 5||3
5265690|NCT00723021|12943802|P3|COMPLETED|Intervention Period 5||3
5265691|NCT00723021|12943803|P2|COMPLETED|Intervention Period 5||3
5265692|NCT00723021|12943804|P1|COMPLETED|Intervention Period 5||3
5265693|NCT00723021|12943800|P5|STARTED|Intervention Period 5||2
5265694|NCT00723021|12943801|P4|STARTED|Intervention Period 5||3
5265695|NCT00723021|12943802|P3|STARTED|Intervention Period 5||3
5265696|NCT00723021|12943803|P2|STARTED|Intervention Period 5||3
5265697|NCT00723021|12943804|P1|STARTED|Intervention Period 5||3
5265698|NCT00723021|12943800|P5|NOT COMPLETED|Intervention Period 4||1
5265699|NCT00723021|12943801|P4|NOT COMPLETED|Intervention Period 4||0
5265700|NCT00723021|12943802|P3|NOT COMPLETED|Intervention Period 4||0
5265701|NCT00723021|12943803|P2|NOT COMPLETED|Intervention Period 4||0
5265702|NCT00723021|12943804|P1|NOT COMPLETED|Intervention Period 4||0
5265703|NCT00723021|12943800|P5|COMPLETED|Intervention Period 4||2
5265704|NCT00723021|12943801|P4|COMPLETED|Intervention Period 4||3
5265705|NCT00723021|12943802|P3|COMPLETED|Intervention Period 4||3
5265706|NCT00723021|12943803|P2|COMPLETED|Intervention Period 4||3
5265707|NCT00723021|12943804|P1|COMPLETED|Intervention Period 4||3
5265708|NCT00723021|12943800|P5|STARTED|Intervention Period 4||3
5265709|NCT00723021|12943801|P4|STARTED|Intervention Period 4||3
5265710|NCT00723021|12943802|P3|STARTED|Intervention Period 4||3
5265711|NCT00723021|12943803|P2|STARTED|Intervention Period 4||3
5265712|NCT00723021|12943804|P1|STARTED|Intervention Period 4||3
5265713|NCT00723021|12943800|P5|NOT COMPLETED|Intervention Period 3||0
5265714|NCT00723021|12943801|P4|NOT COMPLETED|Intervention Period 3||0
5265715|NCT00723021|12943802|P3|NOT COMPLETED|Intervention Period 3||0
5265716|NCT00723021|12943803|P2|NOT COMPLETED|Intervention Period 3||0
5265717|NCT00723021|12943804|P1|NOT COMPLETED|Intervention Period 3||0
5265718|NCT00723021|12943800|P5|COMPLETED|Intervention Period 3||3
5265719|NCT00723021|12943801|P4|COMPLETED|Intervention Period 3||3
5265720|NCT00723021|12943802|P3|COMPLETED|Intervention Period 3||3
5265721|NCT00723021|12943803|P2|COMPLETED|Intervention Period 3||3
5265722|NCT00723021|12943804|P1|COMPLETED|Intervention Period 3||3
5265723|NCT00723021|12943800|P5|STARTED|Intervention Period 3||3
5265724|NCT00723021|12943801|P4|STARTED|Intervention Period 3||3
5265725|NCT00723021|12943802|P3|STARTED|Intervention Period 3||3
5265726|NCT00723021|12943803|P2|STARTED|Intervention Period 3||3
5265727|NCT00723021|12943804|P1|STARTED|Intervention Period 3||3
5265728|NCT00723021|12943800|P5|NOT COMPLETED|Intervention Period 2||0
5265729|NCT00723021|12943801|P4|NOT COMPLETED|Intervention Period 2||0
5265730|NCT00723021|12943802|P3|NOT COMPLETED|Intervention Period 2||0
5265731|NCT00723021|12943803|P2|NOT COMPLETED|Intervention Period 2||0
5265732|NCT00723021|12943804|P1|NOT COMPLETED|Intervention Period 2||0
5265733|NCT00723021|12943800|P5|COMPLETED|Intervention Period 2||3
5265734|NCT00723021|12943801|P4|COMPLETED|Intervention Period 2||3
5265735|NCT00723021|12943802|P3|COMPLETED|Intervention Period 2||3
5265736|NCT00723021|12943803|P2|COMPLETED|Intervention Period 2||3
5265737|NCT00723021|12943804|P1|COMPLETED|Intervention Period 2||3
5265738|NCT00723021|12943800|P5|STARTED|Intervention Period 2||3
5265739|NCT00723021|12943801|P4|STARTED|Intervention Period 2||3
5265740|NCT00723021|12943802|P3|STARTED|Intervention Period 2||3
5265741|NCT00723021|12943803|P2|STARTED|Intervention Period 2||3
5265742|NCT00723021|12943804|P1|STARTED|Intervention Period 2||3
5265743|NCT00723021|12943800|P5|NOT COMPLETED|Intervention Period 1||0
5265744|NCT00723021|12943801|P4|NOT COMPLETED|Intervention Period 1||0
5265745|NCT00723021|12943802|P3|NOT COMPLETED|Intervention Period 1||0
5265746|NCT00723021|12943803|P2|NOT COMPLETED|Intervention Period 1||0
5265747|NCT00723021|12943804|P1|NOT COMPLETED|Intervention Period 1||0
5265748|NCT00723021|12943800|P5|COMPLETED|Intervention Period 1||3
5265749|NCT00723021|12943801|P4|COMPLETED|Intervention Period 1||3
5265750|NCT00723021|12943802|P3|COMPLETED|Intervention Period 1||3
5265751|NCT00723021|12943803|P2|COMPLETED|Intervention Period 1||3
5265752|NCT00723021|12943804|P1|COMPLETED|Intervention Period 1||3
5265753|NCT00723021|12943800|P5|STARTED|Intervention Period 1||3
5265754|NCT00723021|12943801|P4|STARTED|Intervention Period 1||3
5265755|NCT00723021|12943802|P3|STARTED|Intervention Period 1||3
5265756|NCT00723021|12943803|P2|STARTED|Intervention Period 1||3
5265757|NCT00723021|12943804|P1|STARTED|Intervention Period 1||3
5265758|NCT00723008|12943858|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
5265759|NCT00723008|12943859|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
5265760|NCT00723008|12943858|P2|COMPLETED|4-Week Unblinded Treatment||3
5265761|NCT00723008|12943859|P1|COMPLETED|4-Week Unblinded Treatment||4
5265762|NCT00723008|12943858|P2|STARTED|4-Week Unblinded Treatment||4
5265763|NCT00723008|12943859|P1|STARTED|4-Week Unblinded Treatment||5
5265764|NCT00723008|12943858|P2|NOT COMPLETED|4-Week Double Blinded||5
5265765|NCT00723008|12943859|P1|NOT COMPLETED|4-Week Double Blinded||5
5265766|NCT00723008|12943858|P2|COMPLETED|4-Week Double Blinded||4
5265767|NCT00723008|12943859|P1|COMPLETED|4-Week Double Blinded||5
5265768|NCT00723008|12943858|P2|STARTED|4-Week Double Blinded||9
5265769|NCT00723008|12943859|P1|STARTED|4-Week Double Blinded||10
5265770|NCT00723008|12943858|P2|NOT COMPLETED|Enrollment||0
5265771|NCT00723008|12943859|P1|NOT COMPLETED|Enrollment||1
5265772|NCT00723008|12943858|P2|COMPLETED|Enrollment||9
5265773|NCT00723008|12943859|P1|COMPLETED|Enrollment||10
5265774|NCT00723008|12943858|P2|STARTED|Enrollment||9
5265775|NCT00723008|12943859|P1|STARTED|Enrollment||11
5265776|NCT00722865|12943881|P1|NOT COMPLETED|Overall Study||2
5265777|NCT00722865|12943881|P1|COMPLETED|Overall Study||23
5265778|NCT00722865|12943881|P1|STARTED|Overall Study||25
5265779|NCT00722800|12943891|P2|NOT COMPLETED|Overall Study||0
5265780|NCT00722800|12943892|P1|NOT COMPLETED|Overall Study||2
5265781|NCT00722800|12943891|P2|COMPLETED|Overall Study||2
5265782|NCT00722800|12943892|P1|COMPLETED|Overall Study||0
5265783|NCT00722800|12943891|P2|STARTED|Overall Study||2
5265784|NCT00722800|12943892|P1|STARTED|Overall Study||2
5265785|NCT00722761|12943904|P2|NOT COMPLETED|Overall Study||6
5265786|NCT00722761|12943905|P1|NOT COMPLETED|Overall Study||6
5265787|NCT00722761|12943904|P2|COMPLETED|Overall Study||8
5265788|NCT00722761|12943905|P1|COMPLETED|Overall Study||10
5265789|NCT00722761|12943904|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
5265790|NCT00722761|12943905|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
5265791|NCT00722761|12943904|P2|STARTED|Overall Study||14
5265792|NCT00722761|12943905|P1|STARTED|Overall Study||16
5265793|NCT00722722|12943916|P3|NOT COMPLETED|Overall Study||0
5265794|NCT00722722|12943917|P2|NOT COMPLETED|Overall Study||0
5265795|NCT00722722|12943918|P1|NOT COMPLETED|Overall Study||0
5265796|NCT00722722|12943916|P3|COMPLETED|Overall Study||10
5265797|NCT00722722|12943917|P2|COMPLETED|Overall Study||5
5265798|NCT00722722|12943918|P1|COMPLETED|Overall Study||3
5265799|NCT00722722|12943916|P3|STARTED|Overall Study||10
5265800|NCT00722722|12943917|P2|STARTED|Overall Study||5
5265801|NCT00722722|12943918|P1|STARTED|Overall Study||3
5265802|NCT00722566|12943928|P2|NOT COMPLETED|Overall Study||35
5265803|NCT00722566|12943929|P1|NOT COMPLETED|Overall Study||67
5265804|NCT00722566|12943928|P2|COMPLETED|Overall Study|Completed 8 cycles|39
5265805|NCT00722566|12943929|P1|COMPLETED|Overall Study|Completed 8 cycles|81
5265806|NCT00722566|12943928|P2|STARTED|Overall Study||74
5265807|NCT00722566|12943929|P1|STARTED|Overall Study|One patient randomized and not dosed|148
5265808|NCT00722553|12943937|P1|NOT COMPLETED|Overall Study||0
5265809|NCT00722553|12943937|P1|COMPLETED|Overall Study||30
5265810|NCT00722553|12943937|P1|STARTED|Overall Study||30
5265811|NCT00722436|12943947|P2|NOT COMPLETED|Overall Study||0
5265812|NCT00722436|12943948|P1|NOT COMPLETED|Overall Study||0
5265813|NCT00722436|12943947|P2|COMPLETED|Overall Study||11
5265814|NCT00722436|12943948|P1|COMPLETED|Overall Study||9
5265815|NCT00722436|12943947|P2|STARTED|Overall Study||11
5265816|NCT00722436|12943948|P1|STARTED|Overall Study||9
5265817|NCT00722423|12943962|P2|NOT COMPLETED|Overall Study||1
5265818|NCT00722423|12943963|P1|NOT COMPLETED|Overall Study||0
5265819|NCT00722423|12943962|P2|COMPLETED|Overall Study||181
5265820|NCT00722423|12943963|P1|COMPLETED|Overall Study||182
5265821|NCT00722423|12943962|P2|STARTED|Overall Study||182
5265822|NCT00722423|12943963|P1|STARTED|Overall Study||182
5265823|NCT00722371|12943978|P7|NOT COMPLETED|Overall Study||51
5265824|NCT00722371|12943979|P6|NOT COMPLETED|Overall Study||53
5265825|NCT00722371|12943980|P5|NOT COMPLETED|Overall Study||48
5265826|NCT00722371|12943981|P4|NOT COMPLETED|Overall Study||63
5265827|NCT00722371|12943982|P3|NOT COMPLETED|Overall Study||65
5265828|NCT00722371|12943983|P2|NOT COMPLETED|Overall Study||72
5265829|NCT00722371|12943984|P1|NOT COMPLETED|Overall Study||56
5265830|NCT00722371|12943978|P7|COMPLETED|Overall Study||179
5265831|NCT00722371|12943979|P6|COMPLETED|Overall Study||178
5265832|NCT00722371|12943980|P5|COMPLETED|Overall Study||182
5265833|NCT00722371|12943981|P4|COMPLETED|Overall Study||167
5265834|NCT00722371|12943982|P3|COMPLETED|Overall Study||168
5265835|NCT00722371|12943983|P2|COMPLETED|Overall Study||158
5265836|NCT00722371|12943984|P1|COMPLETED|Overall Study||175
5265837|NCT00722371|12943978|P7|STARTED|Overall Study||230
5265838|NCT00722371|12943979|P6|STARTED|Overall Study||231
5265839|NCT00722371|12943980|P5|STARTED|Overall Study||230
5265840|NCT00722371|12943981|P4|STARTED|Overall Study||230
5265841|NCT00722371|12943982|P3|STARTED|Overall Study||233
5265842|NCT00722371|12943983|P2|STARTED|Overall Study||230
5265843|NCT00722371|12943984|P1|STARTED|Overall Study||231
5265844|NCT00722137|12944037|P2|NOT COMPLETED|Overall Study||48
5265845|NCT00722137|12944038|P1|NOT COMPLETED|Overall Study||45
5265846|NCT00722137|12944037|P2|COMPLETED|Overall Study||195
5265847|NCT00722137|12944038|P1|COMPLETED|Overall Study||199
5265848|NCT00722137|12944037|P2|STARTED|Overall Study||243
5265849|NCT00722137|12944038|P1|STARTED|Overall Study||244
5265850|NCT00722124|12944067|P3|NOT COMPLETED|Overall Study||20
5265851|NCT00722124|12944068|P2|NOT COMPLETED|Overall Study||14
5265852|NCT00722124|12944069|P1|NOT COMPLETED|Overall Study||17
5265853|NCT00722124|12944067|P3|COMPLETED|Overall Study||20
5265854|NCT00722124|12944068|P2|COMPLETED|Overall Study||26
5265855|NCT00722124|12944069|P1|COMPLETED|Overall Study||23
5265856|NCT00722124|12944067|P3|STARTED|Overall Study||40
5265857|NCT00722124|12944068|P2|STARTED|Overall Study||40
5265858|NCT00722124|12944069|P1|STARTED|Overall Study||40
5265859|NCT00722111|12944079|P2|NOT COMPLETED|Overall Study||0
5265860|NCT00722111|12944080|P1|NOT COMPLETED|Overall Study||0
5265861|NCT00722111|12944079|P2|COMPLETED|Overall Study||72
5265862|NCT00722111|12944080|P1|COMPLETED|Overall Study||11
5265863|NCT00722111|12944079|P2|STARTED|Overall Study||72
5265864|NCT00722111|12944080|P1|STARTED|Overall Study||11
5265865|NCT00722072|12944087|P1|NOT COMPLETED|Overall Study||3
5265866|NCT00722072|12944087|P1|COMPLETED|Overall Study||9
5265867|NCT00722072|12944087|P1|STARTED|Overall Study||12
5265868|NCT00722020|12944097|P2|NOT COMPLETED|Overall Study||0
5265869|NCT00722020|12944098|P1|NOT COMPLETED|Overall Study||0
5265870|NCT00722020|12944097|P2|COMPLETED|Overall Study||24
5265871|NCT00722020|12944098|P1|COMPLETED|Overall Study||19
5265872|NCT00722020|12944097|P2|STARTED|Overall Study||24
5265873|NCT00722020|12944098|P1|STARTED|Overall Study||19
5265874|NCT00722007|12944106|P1|NOT COMPLETED|Overall Study||30
5265875|NCT00722007|12944106|P1|COMPLETED|Overall Study||117
5265876|NCT00722007|12944106|P1|STARTED|Overall Study||147
5265877|NCT00721968|12944116|P2|NOT COMPLETED|Overall Study||0
5265878|NCT00721968|12944117|P1|NOT COMPLETED|Overall Study||2
5265879|NCT00721968|12944116|P2|COMPLETED|Overall Study||17
5265880|NCT00721968|12944117|P1|COMPLETED|Overall Study||25
5265881|NCT00721968|12944116|P2|STARTED|Overall Study||17
5265882|NCT00721968|12944117|P1|STARTED|Overall Study||27
5265883|NCT00721955|12944128|P3|NOT COMPLETED|Overall Study||2
5265884|NCT00721955|12944129|P2|NOT COMPLETED|Overall Study||0
5265885|NCT00721955|12944130|P1|NOT COMPLETED|Overall Study||0
5265886|NCT00721955|12944128|P3|COMPLETED|Overall Study||103
5265887|NCT00721955|12944129|P2|COMPLETED|Overall Study||104
5265888|NCT00721955|12944130|P1|COMPLETED|Overall Study||105
5265889|NCT00721955|12944128|P3|STARTED|Overall Study||105
5265890|NCT00721955|12944129|P2|STARTED|Overall Study||104
5265891|NCT00721955|12944130|P1|STARTED|Overall Study||105
5265892|NCT00721799|12944144|P1|NOT COMPLETED|Overall Study||8
5265893|NCT00721799|12944144|P1|COMPLETED|Overall Study||25
5265894|NCT00721799|12944144|P1|Received FLT PET Scan #2|Overall Study||25
5265895|NCT00721799|12944144|P1|Recieved FLT PET Scan 1|Overall Study||26
5265896|NCT00721799|12944144|P1|STARTED|Overall Study||33
5265897|NCT00721734|12944184|P5|NOT COMPLETED|Overall Study||6
5265898|NCT00721734|12944185|P4|NOT COMPLETED|Overall Study||6
5265899|NCT00721734|12944186|P3|NOT COMPLETED|Overall Study||8
5265900|NCT00721734|12944187|P2|NOT COMPLETED|Overall Study||12
5265901|NCT00721734|12944188|P1|NOT COMPLETED|Overall Study||8
5265902|NCT00721734|12944184|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
5265903|NCT00721734|12944185|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
5265904|NCT00721734|12944186|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
5265905|NCT00721734|12944187|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
5265906|NCT00721734|12944188|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
5265907|NCT00721734|12944184|P5|STARTED|Overall Study||8
5265908|NCT00721734|12944185|P4|STARTED|Overall Study||8
5265909|NCT00721734|12944186|P3|STARTED|Overall Study||10
5265910|NCT00721734|12944187|P2|STARTED|Overall Study||12
5265911|NCT00721734|12944188|P1|STARTED|Overall Study||12
5265912|NCT00721630|12944300|P1|NOT COMPLETED|Overall Study||1
5265913|NCT00721630|12944300|P1|COMPLETED|Overall Study||23
5265914|NCT00721630|12944300|P1|STARTED|Overall Study||24
5265915|NCT00721617|12944305|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
5265916|NCT00721617|12944305|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
5265917|NCT00721617|12944305|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
5265918|NCT00721617|12944305|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
5265919|NCT00721617|12944305|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
5265920|NCT00721617|12944305|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
5265921|NCT00721617|12944305|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
5265922|NCT00721617|12944305|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
5265923|NCT00721617|12944305|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
5265924|NCT00721617|12944305|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
5265925|NCT00721617|12944305|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
5265926|NCT00721617|12944305|P1|STARTED|8 Hours Into Dextrose Infusion||12
5265927|NCT00721617|12944305|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
5265928|NCT00721617|12944305|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
5265929|NCT00721617|12944305|P1|STARTED|4 Hours Into Dextrose Infusion||12
5265930|NCT00721617|12944305|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
5265931|NCT00721617|12944305|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
5265932|NCT00721617|12944305|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
5265933|NCT00721617|12944305|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
5265934|NCT00721617|12944305|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
5265935|NCT00721617|12944305|P1|STARTED|8 Hours Into Intralipid Infusion||12
5265936|NCT00721617|12944305|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
5265937|NCT00721617|12944305|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
5265938|NCT00721617|12944305|P1|STARTED|4 Hours Into Intralipid Infusion||12
5265939|NCT00721617|12944305|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
5265940|NCT00721617|12944305|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
5265941|NCT00721617|12944305|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
5265942|NCT00721617|12944305|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
5265943|NCT00721617|12944305|P1|COMPLETED|8 Hours Into Saline Infusion||12
5265944|NCT00721617|12944305|P1|STARTED|8 Hours Into Saline Infusion||12
5265945|NCT00721617|12944305|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
5265946|NCT00721617|12944305|P1|COMPLETED|4 Hours Into Saline Infusion||12
5265947|NCT00721617|12944305|P1|STARTED|4 Hours Into Saline Infusion||12
5265948|NCT00721617|12944305|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
5265949|NCT00721617|12944305|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
5265950|NCT00721617|12944305|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
5265951|NCT00721578|12944329|P2|NOT COMPLETED|Overall Study||2
5265952|NCT00721578|12944330|P1|NOT COMPLETED|Overall Study||2
5265953|NCT00721578|12944329|P2|COMPLETED|Overall Study||9
5265954|NCT00721578|12944330|P1|COMPLETED|Overall Study||10
5265955|NCT00721578|12944329|P2|STARTED|Overall Study||11
5265956|NCT00721578|12944330|P1|STARTED|Overall Study||12
5265957|NCT00721539|12944342|P1|NOT COMPLETED|Overall Study||0
5265958|NCT00721539|12944342|P1|COMPLETED|Overall Study||9
5265959|NCT00721539|12944342|P1|STARTED|Overall Study||9
5265960|NCT00721513|12944349|P1|NOT COMPLETED|Overall Study||0
5265961|NCT00721513|12944349|P1|COMPLETED|Overall Study||20
5265962|NCT00721513|12944349|P1|STARTED|Overall Study||20
5265963|NCT00721500|12944361|P4|NOT COMPLETED|Period Three||0
5265964|NCT00721500|12944362|P3|NOT COMPLETED|Period Three||0
5265965|NCT00721500|12944363|P2|NOT COMPLETED|Period Three||0
5265966|NCT00721500|12944364|P1|NOT COMPLETED|Period Three||0
5265967|NCT00721500|12944361|P4|COMPLETED|Period Three||6
5265968|NCT00721500|12944362|P3|COMPLETED|Period Three||6
5265969|NCT00721500|12944363|P2|COMPLETED|Period Three||7
5265970|NCT00721500|12944364|P1|COMPLETED|Period Three||6
5265971|NCT00721500|12944361|P4|STARTED|Period Three||6
5265972|NCT00721500|12944362|P3|STARTED|Period Three||6
5265973|NCT00721500|12944363|P2|STARTED|Period Three||7
5265974|NCT00721500|12944364|P1|STARTED|Period Three||6
5265975|NCT00721500|12944361|P4|NOT COMPLETED|Period Two||0
5265976|NCT00721500|12944362|P3|NOT COMPLETED|Period Two||0
5265977|NCT00721500|12944363|P2|NOT COMPLETED|Period Two||0
5265978|NCT00721500|12944364|P1|NOT COMPLETED|Period Two||0
5265979|NCT00721500|12944361|P4|COMPLETED|Period Two||6
5265980|NCT00721500|12944362|P3|COMPLETED|Period Two||6
5265981|NCT00721500|12944363|P2|COMPLETED|Period Two||7
5265982|NCT00721500|12944364|P1|COMPLETED|Period Two||6
5265983|NCT00721500|12944361|P4|STARTED|Period Two||6
5265984|NCT00721500|12944362|P3|STARTED|Period Two||6
5265985|NCT00721500|12944363|P2|STARTED|Period Two||7
5265986|NCT00721500|12944364|P1|STARTED|Period Two||6
5265987|NCT00721500|12944361|P4|NOT COMPLETED|Period One||0
5265988|NCT00721500|12944362|P3|NOT COMPLETED|Period One||0
5265989|NCT00721500|12944363|P2|NOT COMPLETED|Period One||0
5265990|NCT00721500|12944364|P1|NOT COMPLETED|Period One||0
5265991|NCT00721500|12944361|P4|COMPLETED|Period One||6
5265992|NCT00721500|12944362|P3|COMPLETED|Period One||6
5265993|NCT00721500|12944363|P2|COMPLETED|Period One||7
5265994|NCT00721500|12944364|P1|COMPLETED|Period One||6
5265995|NCT00721500|12944361|P4|STARTED|Period One||6
5265996|NCT00721500|12944362|P3|STARTED|Period One||6
5265997|NCT00721500|12944363|P2|STARTED|Period One||7
5265998|NCT00721500|12944364|P1|STARTED|Period One||6
5265999|NCT00721409|12944385|P3|NOT COMPLETED|Overall Study||79
5266000|NCT00721409|12944386|P2|NOT COMPLETED|Overall Study||82
5266001|NCT00721409|12944387|P1|NOT COMPLETED|Overall Study||12
5266002|NCT00721409|12944385|P3|COMPLETED|Overall Study||2
5266003|NCT00721409|12944386|P2|COMPLETED|Overall Study||2
5266004|NCT00721409|12944387|P1|COMPLETED|Overall Study||0
5266005|NCT00721409|12944385|P3|Treated|Overall Study||77
5266006|NCT00721409|12944386|P2|Treated|Overall Study||83
5266007|NCT00721409|12944387|P1|Treated|Overall Study||12
5266008|NCT00721409|12944385|P3|STARTED|Overall Study||81
5266009|NCT00721409|12944386|P2|STARTED|Overall Study||84
5266010|NCT00721409|12944387|P1|STARTED|Overall Study||12
5266011|NCT00721396|12944514|P4|NOT COMPLETED|Overall Study||10
5266012|NCT00721396|12944515|P3|NOT COMPLETED|Overall Study||10
5266013|NCT00721396|12944516|P2|NOT COMPLETED|Overall Study||36
5266014|NCT00721396|12944517|P1|NOT COMPLETED|Overall Study||30
5266015|NCT00721396|12944514|P4|COMPLETED|Overall Study||302
5266016|NCT00721396|12944515|P3|COMPLETED|Overall Study||308
5266017|NCT00721396|12944516|P2|COMPLETED|Overall Study||592
5266018|NCT00721396|12944517|P1|COMPLETED|Overall Study||597
5266019|NCT00721396|12944514|P4|STARTED|Overall Study||312
5266020|NCT00721396|12944515|P3|STARTED|Overall Study||318
5266021|NCT00721396|12944516|P2|STARTED|Overall Study||628
5266022|NCT00721396|12944517|P1|STARTED|Overall Study||627
5266023|NCT00721357|12944555|P2|NOT COMPLETED|Overall Study||0
5266024|NCT00721357|12944556|P1|NOT COMPLETED|Overall Study||0
5266025|NCT00721357|12944555|P2|COMPLETED|Overall Study||15
5266026|NCT00721357|12944556|P1|COMPLETED|Overall Study||15
5266027|NCT00721357|12944555|P2|STARTED|Overall Study||15
5266028|NCT00721357|12944556|P1|STARTED|Overall Study||15
5266029|NCT00721279|12944568|P2|NOT COMPLETED|Overall Study||24
5266030|NCT00721279|12944569|P1|NOT COMPLETED|Overall Study||36
5266031|NCT00721279|12944568|P2|COMPLETED|Overall Study||73
5266032|NCT00721279|12944569|P1|COMPLETED|Overall Study||416
5266033|NCT00721279|12944568|P2|STARTED|Overall Study||97
5266034|NCT00721279|12944569|P1|STARTED|Overall Study||452
5266035|NCT00721253|12944583|P3|NOT COMPLETED|Overall Study||0
5266036|NCT00721253|12944584|P2|NOT COMPLETED|Overall Study||0
5266037|NCT00721253|12944585|P1|NOT COMPLETED|Overall Study||0
5266038|NCT00721253|12944583|P3|COMPLETED|Overall Study||0
5266039|NCT00721253|12944584|P2|COMPLETED|Overall Study||22
5266040|NCT00721253|12944585|P1|COMPLETED|Overall Study||20
5266041|NCT00721253|12944583|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
5266042|NCT00721253|12944584|P2|STARTED|Overall Study||22
5266043|NCT00721253|12944585|P1|STARTED|Overall Study||20
5266044|NCT00721227|12944597|P2|NOT COMPLETED|Overall Study||0
5266045|NCT00721227|12944598|P1|NOT COMPLETED|Overall Study||4
5266046|NCT00721227|12944597|P2|COMPLETED|Overall Study||6
5266047|NCT00721227|12944598|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
5266048|NCT00721227|12944597|P2|STARTED|Overall Study||6
5266049|NCT00721227|12944598|P1|STARTED|Overall Study||9
5266050|NCT00721214|12944608|P1|NOT COMPLETED|Overall Study||4
5266051|NCT00721214|12944608|P1|COMPLETED|Overall Study||12
5266052|NCT00721214|12944608|P1|STARTED|Overall Study||16
5266053|NCT00721188|12944619|P1|NOT COMPLETED|Overall Study||0
5266054|NCT00721188|12944619|P1|COMPLETED|Overall Study||11
5266055|NCT00721188|12944619|P1|STARTED|Overall Study||11
5266056|NCT00721175|12944636|P2|NOT COMPLETED|Overall Study||0
5266057|NCT00721175|12944637|P1|NOT COMPLETED|Overall Study||0
5266058|NCT00721175|12944636|P2|COMPLETED|Overall Study||54
5266059|NCT00721175|12944637|P1|COMPLETED|Overall Study||54
5266060|NCT00721175|12944636|P2|STARTED|Overall Study||54
5266061|NCT00721175|12944637|P1|STARTED|Overall Study||54
5266062|NCT00721162|12944649|P1|NOT COMPLETED|Overall Study||0
5266063|NCT00721162|12944649|P1|COMPLETED|Overall Study||60
5266064|NCT00721162|12944649|P1|Received Any Amount of Study Drug|Overall Study||60
5266065|NCT00721162|12944649|P1|STARTED|Overall Study||60
5266066|NCT00721149|12944658|P1|NOT COMPLETED|Overall Study||1
5266067|NCT00721149|12944658|P1|COMPLETED|Overall Study||9
5266068|NCT00721149|12944658|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
5266069|NCT00721136|12944671|P4|NOT COMPLETED|Overall Study||0
5266070|NCT00721136|12944672|P3|NOT COMPLETED|Overall Study||0
5266071|NCT00721136|12944673|P2|NOT COMPLETED|Overall Study||0
5266072|NCT00721136|12944674|P1|NOT COMPLETED|Overall Study||0
5266073|NCT00721136|12944671|P4|COMPLETED|Overall Study||8
5266074|NCT00721136|12944672|P3|COMPLETED|Overall Study||8
5266075|NCT00721136|12944673|P2|COMPLETED|Overall Study||42
5266076|NCT00721136|12944674|P1|COMPLETED|Overall Study||42
5266077|NCT00721136|12944671|P4|STARTED|Overall Study||8
5266078|NCT00721136|12944672|P3|STARTED|Overall Study||8
5266079|NCT00721136|12944673|P2|STARTED|Overall Study||42
5266080|NCT00721136|12944674|P1|STARTED|Overall Study||42
5266081|NCT00721123|12944692|P1|NOT COMPLETED|Overall Study||183
5266082|NCT00721123|12944692|P1|COMPLETED|Overall Study||355
5266083|NCT00721123|12944692|P1|STARTED|Overall Study||538
5266084|NCT00721110|12944770|P4|NOT COMPLETED|Overall Study||0
5266085|NCT00721110|12944771|P3|NOT COMPLETED|Overall Study||1
5266086|NCT00721110|12944772|P2|NOT COMPLETED|Overall Study||0
5266087|NCT00721110|12944773|P1|NOT COMPLETED|Overall Study||1
5266088|NCT00721110|12944770|P4|COMPLETED|Overall Study||16
5266089|NCT00721110|12944771|P3|COMPLETED|Overall Study||15
5266090|NCT00721110|12944772|P2|COMPLETED|Overall Study||16
5266091|NCT00721110|12944773|P1|COMPLETED|Overall Study||15
5266092|NCT00721110|12944770|P4|STARTED|Overall Study||16
5266093|NCT00721110|12944771|P3|STARTED|Overall Study||16
5266094|NCT00721110|12944772|P2|STARTED|Overall Study||16
5266095|NCT00721110|12944773|P1|STARTED|Overall Study||16
5266096|NCT00720941|12944801|P2|NOT COMPLETED|Overall Study||415
5266097|NCT00720941|12944802|P1|NOT COMPLETED|Overall Study||413
5266098|NCT00720941|12944801|P2|COMPLETED|Overall Study||138
5266099|NCT00720941|12944802|P1|COMPLETED|Overall Study||144
5266100|NCT00720941|12944801|P2|Ongoing|Overall Study||23
5266101|NCT00720941|12944802|P1|Ongoing|Overall Study||34
5266102|NCT00720941|12944801|P2|STARTED|Overall Study||553
5266103|NCT00720941|12944802|P1|STARTED|Overall Study||557
5266104|NCT00720876|12944842|P1|NOT COMPLETED|Overall Study||2
5266105|NCT00720876|12944842|P1|COMPLETED|Overall Study||28
5266106|NCT00720876|12944842|P1|STARTED|Overall Study||30
5266107|NCT00720798|12944848|P1|NOT COMPLETED|Overall Study||756
5266108|NCT00720798|12944848|P1|COMPLETED|Overall Study||1311
5266109|NCT00720798|12944848|P1|STARTED|Overall Study||2067
5266110|NCT00720759|12944871|P4|NOT COMPLETED|Overall Study||0
5266111|NCT00720759|12944872|P3|NOT COMPLETED|Overall Study||1
5266112|NCT00720759|12944873|P2|NOT COMPLETED|Overall Study||1
5266113|NCT00720759|12944874|P1|NOT COMPLETED|Overall Study||0
5266114|NCT00720759|12944871|P4|COMPLETED|Overall Study||6
5266115|NCT00720759|12944872|P3|COMPLETED|Overall Study||5
5266116|NCT00720759|12944873|P2|COMPLETED|Overall Study||5
5266117|NCT00720759|12944874|P1|COMPLETED|Overall Study||6
5266118|NCT00720759|12944871|P4|STARTED|Overall Study||6
5266119|NCT00720759|12944872|P3|STARTED|Overall Study||6
5266120|NCT00720759|12944873|P2|STARTED|Overall Study||6
5266121|NCT00720759|12944874|P1|STARTED|Overall Study||6
5266122|NCT00720629|12944884|P1|NOT COMPLETED|Overall Study||0
5266123|NCT00720629|12944884|P1|COMPLETED|Overall Study||8
5266124|NCT00720629|12944884|P1|STARTED|Overall Study||8
5266125|NCT00720499|12944894|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
5266126|NCT00720499|12944895|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
5266127|NCT00720499|12944894|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
5266128|NCT00720499|12944895|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
5266129|NCT00720499|12944894|P2|STARTED|Treatment Period 2 (4 Weeks)||70
5266130|NCT00720499|12944895|P1|STARTED|Treatment Period 2 (4 Weeks)||66
5266131|NCT00720499|12944894|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
5266132|NCT00720499|12944895|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
5266133|NCT00720499|12944894|P2|COMPLETED|Washout Period (2 Weeks)||70
5266134|NCT00720499|12944895|P1|COMPLETED|Washout Period (2 Weeks)||66
5266135|NCT00720499|12944894|P2|STARTED|Washout Period (2 Weeks)||70
5266136|NCT00720499|12944895|P1|STARTED|Washout Period (2 Weeks)||66
5266137|NCT00720499|12944894|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
5266138|NCT00720499|12944895|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
5266139|NCT00720499|12944894|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
5266140|NCT00720499|12944895|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
5266141|NCT00720499|12944894|P2|STARTED|Treatment Period 1 (4 Weeks)||72
5266142|NCT00720499|12944895|P1|STARTED|Treatment Period 1 (4 Weeks)||69
5266143|NCT00720473|12944959|P2|NOT COMPLETED|Overall Study||8
5266144|NCT00720473|12944960|P1|NOT COMPLETED|Overall Study||30
5266145|NCT00720473|12944959|P2|COMPLETED|Overall Study||16
5266146|NCT00720473|12944960|P1|COMPLETED|Overall Study||15
5266147|NCT00720473|12944959|P2|STARTED|Overall Study||24
5266148|NCT00720473|12944960|P1|STARTED|Overall Study||45
5266149|NCT00720434|12944988|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
5266150|NCT00720434|12944989|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
5266151|NCT00720434|12944990|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
5266152|NCT00720434|12944991|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
5266153|NCT00720434|12944988|P4|COMPLETED|Open-Label Period (Week 5-72)||4
5266154|NCT00720434|12944989|P3|COMPLETED|Open-Label Period (Week 5-72)||4
5266155|NCT00720434|12944990|P2|COMPLETED|Open-Label Period (Week 5-72)||5
5266156|NCT00720434|12944991|P1|COMPLETED|Open-Label Period (Week 5-72)||4
5266157|NCT00720434|12944988|P4|STARTED|Open-Label Period (Week 5-72)||8
5266158|NCT00720434|12944989|P3|STARTED|Open-Label Period (Week 5-72)||8
5266159|NCT00720434|12944990|P2|STARTED|Open-Label Period (Week 5-72)||8
5266160|NCT00720434|12944991|P1|STARTED|Open-Label Period (Week 5-72)||10
5266161|NCT00720434|12944988|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
5266162|NCT00720434|12944989|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
5266163|NCT00720434|12944990|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
5266164|NCT00720434|12944991|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
5266165|NCT00720434|12944988|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
5266166|NCT00720434|12944989|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
5266167|NCT00720434|12944990|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
5266168|NCT00720434|12944991|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
5266169|NCT00720434|12944988|P4|STARTED|Double-Blind Period (Week 1-4)||8
5266170|NCT00720434|12944989|P3|STARTED|Double-Blind Period (Week 1-4)||8
5266171|NCT00720434|12944990|P2|STARTED|Double-Blind Period (Week 1-4)||9
5266172|NCT00720434|12944991|P1|STARTED|Double-Blind Period (Week 1-4)||10
5266173|NCT00720382|12945015|P2|NOT COMPLETED|Overall Study||59
5266174|NCT00720382|12945016|P1|NOT COMPLETED|Overall Study||176
5266175|NCT00720382|12945015|P2|COMPLETED|Overall Study||178
5266176|NCT00720382|12945016|P1|COMPLETED|Overall Study||290
5266177|NCT00720382|12945015|P2|STARTED|Overall Study||237
5266178|NCT00720382|12945016|P1|STARTED|Overall Study||466
5266179|NCT00720369|12945026|P2|NOT COMPLETED|Overall Study||0
5266180|NCT00720369|12945027|P1|NOT COMPLETED|Overall Study||1
5266181|NCT00720369|12945026|P2|COMPLETED|Overall Study||8
5266182|NCT00720369|12945027|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
5266183|NCT00720369|12945026|P2|STARTED|Overall Study||8
5266184|NCT00720369|12945027|P1|STARTED|Overall Study||11
5266185|NCT00720356|12945035|P1|NOT COMPLETED|Follow up Until Death||5
5266186|NCT00720356|12945035|P1|COMPLETED|Follow up Until Death||43
5266187|NCT00720356|12945035|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
5266188|NCT00720356|12945035|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
5266189|NCT00720356|12945035|P1|COMPLETED|Went on to be Treated Cycle 3||44
5266190|NCT00720356|12945035|P1|STARTED|Went on to be Treated Cycle 3||46
5266191|NCT00720356|12945035|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
5266192|NCT00720356|12945035|P1|COMPLETED|Reached 1st Response/2 Cycles||46
5266193|NCT00720356|12945035|P1|STARTED|Reached 1st Response/2 Cycles||48
5266194|NCT00720356|12945035|P1|NOT COMPLETED|Registration to Study||67
5266195|NCT00720356|12945035|P1|COMPLETED|Registration to Study||48
5266196|NCT00720356|12945035|P1|Completed Registration Step 2|Registration to Study||48
5266197|NCT00720356|12945035|P1|Completed Registration Step 1|Registration to Study||115
5266198|NCT00720356|12945035|P1|STARTED|Registration to Study||115
5266199|NCT00720343|12945049|P1|NOT COMPLETED|Overall Study||6
5266200|NCT00720343|12945049|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
5266201|NCT00720343|12945049|P1|STARTED|Overall Study||54
5266202|NCT00720330|12945058|P3|NOT COMPLETED|Overall Study||0
5266203|NCT00720330|12945059|P2|NOT COMPLETED|Overall Study||0
5266204|NCT00720330|12945060|P1|NOT COMPLETED|Overall Study||0
5266205|NCT00720330|12945058|P3|COMPLETED|Overall Study||3
5266206|NCT00720330|12945059|P2|COMPLETED|Overall Study||4
5266207|NCT00720330|12945060|P1|COMPLETED|Overall Study||5
5266208|NCT00720330|12945058|P3|STARTED|Overall Study||3
5266209|NCT00720330|12945059|P2|STARTED|Overall Study||4
5266210|NCT00720330|12945060|P1|STARTED|Overall Study||5
5266211|NCT00720278|12945083|P3|NOT COMPLETED|Overall Study||6
5266212|NCT00720278|12945084|P2|NOT COMPLETED|Overall Study||4
5266213|NCT00720278|12945085|P1|NOT COMPLETED|Overall Study||7
5266214|NCT00720278|12945083|P3|COMPLETED|Overall Study||172
5266215|NCT00720278|12945084|P2|COMPLETED|Overall Study||166
5266216|NCT00720278|12945085|P1|COMPLETED|Overall Study||171
5266217|NCT00720278|12945083|P3|STARTED|Overall Study|1 subject was randomized in error|178
5266218|NCT00720278|12945084|P2|STARTED|Overall Study|1 subject was randomized in error|170
5266219|NCT00720278|12945085|P1|STARTED|Overall Study|1 subject was randomized in error|178
5266220|NCT00720226|12945107|P2|NOT COMPLETED|Overall Study||4
5266221|NCT00720226|12945108|P1|NOT COMPLETED|Overall Study||7
5266222|NCT00720226|12945107|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
5266223|NCT00720226|12945108|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
5266224|NCT00720226|12945107|P2|STARTED|Overall Study||52
5266225|NCT00720226|12945108|P1|STARTED|Overall Study||54
5266226|NCT00720213|12945116|P3|NOT COMPLETED|Treatment Period||0
5266227|NCT00720213|12945117|P2|NOT COMPLETED|Treatment Period||0
5266228|NCT00720213|12945118|P1|NOT COMPLETED|Treatment Period||0
5266229|NCT00720213|12945116|P3|COMPLETED|Treatment Period||17
5266230|NCT00720213|12945117|P2|COMPLETED|Treatment Period||20
5266231|NCT00720213|12945118|P1|COMPLETED|Treatment Period||0
5266232|NCT00720213|12945116|P3|STARTED|Treatment Period||17
5266233|NCT00720213|12945117|P2|STARTED|Treatment Period||20
5266234|NCT00720213|12945118|P1|STARTED|Treatment Period||0
5266235|NCT00720213|12945116|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
5266236|NCT00720213|12945117|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
5266237|NCT00720213|12945118|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
5266238|NCT00720213|12945116|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
5266239|NCT00720213|12945117|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
5266240|NCT00720213|12945118|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
5266241|NCT00720213|12945116|P3|STARTED|Screening Phase With Diagnostic PSG||0
5266242|NCT00720213|12945117|P2|STARTED|Screening Phase With Diagnostic PSG||0
5266243|NCT00720213|12945118|P1|STARTED|Screening Phase With Diagnostic PSG||44
5266244|NCT00720122|12945156|P1|NOT COMPLETED|Overall Study||9
5266245|NCT00720122|12945156|P1|COMPLETED|Overall Study||19
5266246|NCT00720122|12945156|P1|STARTED|Overall Study||28
5266247|NCT00720109|12945160|P3|NOT COMPLETED|Risk Stratification Period||8
5266248|NCT00720109|12945161|P2|NOT COMPLETED|Risk Stratification Period||15
5266249|NCT00720109|12945162|P1|NOT COMPLETED|Risk Stratification Period||0
5266250|NCT00720109|12945160|P3|COMPLETED|Risk Stratification Period||1
5266251|NCT00720109|12945161|P2|COMPLETED|Risk Stratification Period||33
5266252|NCT00720109|12945162|P1|COMPLETED|Risk Stratification Period||0
5266253|NCT00720109|12945160|P3|STARTED|Risk Stratification Period||9
5266254|NCT00720109|12945161|P2|STARTED|Risk Stratification Period||48
5266255|NCT00720109|12945162|P1|STARTED|Risk Stratification Period||0
5266256|NCT00720109|12945160|P3|NOT COMPLETED|Induction Period||0
5266257|NCT00720109|12945161|P2|NOT COMPLETED|Induction Period||0
5266258|NCT00720109|12945162|P1|NOT COMPLETED|Induction Period||6
5266259|NCT00720109|12945160|P3|COMPLETED|Induction Period||0
5266260|NCT00720109|12945161|P2|COMPLETED|Induction Period||0
5266261|NCT00720109|12945162|P1|COMPLETED|Induction Period||57
5266262|NCT00720109|12945160|P3|STARTED|Induction Period||0
5266263|NCT00720109|12945161|P2|STARTED|Induction Period||0
5266264|NCT00720109|12945162|P1|STARTED|Induction Period||63
5266265|NCT00720096|12945182|P2|NOT COMPLETED|Overall Study||2
5266266|NCT00720096|12945183|P1|NOT COMPLETED|Overall Study||0
5266267|NCT00720096|12945182|P2|COMPLETED|Overall Study||0
5266268|NCT00720096|12945183|P1|COMPLETED|Overall Study||2
5266269|NCT00720096|12945182|P2|STARTED|Overall Study||2
5266270|NCT00720096|12945183|P1|STARTED|Overall Study||2
5266271|NCT00720083|12945195|P2|NOT COMPLETED|Overall Study||2
5266272|NCT00720083|12945196|P1|NOT COMPLETED|Overall Study||1
5266273|NCT00720083|12945195|P2|COMPLETED|Overall Study||13
5266274|NCT00720083|12945196|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
5266275|NCT00720083|12945195|P2|STARTED|Overall Study||15
5266276|NCT00720083|12945196|P1|STARTED|Overall Study||17
5266277|NCT00720057|12945204|P2|NOT COMPLETED|Overall Study||3
5266278|NCT00720057|12945205|P1|NOT COMPLETED|Overall Study||1
5266279|NCT00720057|12945204|P2|COMPLETED|Overall Study||156
5266280|NCT00720057|12945205|P1|COMPLETED|Overall Study||152
5266281|NCT00720057|12945204|P2|STARTED|Overall Study||159
5266282|NCT00720057|12945205|P1|STARTED|Overall Study||153
5266283|NCT00719953|12945221|P1|NOT COMPLETED|Overall Study||4
5266284|NCT00719953|12945221|P1|COMPLETED|Overall Study||26
5266285|NCT00719953|12945221|P1|STARTED|Overall Study||30
5266286|NCT00719914|12945227|P2|NOT COMPLETED|Overall Study||0
5266287|NCT00719914|12945228|P1|NOT COMPLETED|Overall Study||0
5266288|NCT00719914|12945227|P2|COMPLETED|Overall Study||7
5266289|NCT00719914|12945228|P1|COMPLETED|Overall Study||10
5266290|NCT00719914|12945227|P2|STARTED|Overall Study||7
5266291|NCT00719914|12945228|P1|STARTED|Overall Study||10
5266292|NCT00719901|12945234|P1|NOT COMPLETED|Overall Study||11
5266293|NCT00719901|12945234|P1|COMPLETED|Overall Study||0
5266294|NCT00719901|12945234|P1|STARTED|Overall Study||11
5266295|NCT00719862|12945246|P2|NOT COMPLETED|Overall Study||6
5266296|NCT00719862|12945247|P1|NOT COMPLETED|Overall Study||8
5266297|NCT00719862|12945246|P2|COMPLETED|Overall Study||233
5266298|NCT00719862|12945247|P1|COMPLETED|Overall Study||234
5266299|NCT00719862|12945246|P2|STARTED|Overall Study|1 subject was randomized in error|239
5266300|NCT00719862|12945247|P1|STARTED|Overall Study||242
5266301|NCT00719849|12945265|P2|NOT COMPLETED|Overall Study||1
5266302|NCT00719849|12945266|P1|NOT COMPLETED|Overall Study||0
5266303|NCT00719849|12945265|P2|COMPLETED|Overall Study||8
5266304|NCT00719849|12945266|P1|COMPLETED|Overall Study||4
5266305|NCT00719849|12945265|P2|STARTED|Overall Study||9
5266306|NCT00719849|12945266|P1|STARTED|Overall Study||4
5266307|NCT00719810|12945305|P3|NOT COMPLETED|Overall Study||8
5266308|NCT00719810|12945306|P2|NOT COMPLETED|Overall Study||4
5266309|NCT00719810|12945307|P1|NOT COMPLETED|Overall Study||3
5266310|NCT00719810|12945305|P3|COMPLETED|Overall Study||42
5266311|NCT00719810|12945306|P2|COMPLETED|Overall Study||47
5266312|NCT00719810|12945307|P1|COMPLETED|Overall Study||46
5266313|NCT00719810|12945305|P3|STARTED|Overall Study||50
5266314|NCT00719810|12945306|P2|STARTED|Overall Study||51
5266315|NCT00719810|12945307|P1|STARTED|Overall Study||49
5266316|NCT00719732|12945318|P1|NOT COMPLETED|Overall Study||22
5266317|NCT00719732|12945318|P1|COMPLETED|Overall Study||196
5266318|NCT00719732|12945318|P1|STARTED|Overall Study||218
5266319|NCT00719706|12945324|P2|NOT COMPLETED|Overall Study||6
5266320|NCT00719706|12945325|P1|NOT COMPLETED|Overall Study||9
5266321|NCT00719706|12945324|P2|COMPLETED|Overall Study||14
5266322|NCT00719706|12945325|P1|COMPLETED|Overall Study||11
5266323|NCT00719706|12945324|P2|STARTED|Overall Study||20
5266324|NCT00719706|12945325|P1|STARTED|Overall Study||20
5266325|NCT00719680|12945339|P1|NOT COMPLETED|Overall Study||5
5266326|NCT00719680|12945339|P1|COMPLETED|Overall Study||16
5266327|NCT00719680|12945339|P1|STARTED|Overall Study||21
5266328|NCT00719615|12945362|P3|NOT COMPLETED|Overall Study||0
5266329|NCT00719615|12945363|P2|NOT COMPLETED|Overall Study||0
5266330|NCT00719615|12945364|P1|NOT COMPLETED|Overall Study||0
5266331|NCT00719615|12945362|P3|COMPLETED|Overall Study||24
5266332|NCT00719615|12945363|P2|COMPLETED|Overall Study||45
5266333|NCT00719615|12945364|P1|COMPLETED|Overall Study||42
5266334|NCT00719615|12945362|P3|STARTED|Overall Study||24
5266335|NCT00719615|12945363|P2|STARTED|Overall Study||45
5266336|NCT00719615|12945364|P1|STARTED|Overall Study||42
5266337|NCT00719576|12945374|P2|NOT COMPLETED|Overall Study||5
5266338|NCT00719576|12945375|P1|NOT COMPLETED|Overall Study||2
5266339|NCT00719576|12945374|P2|COMPLETED|Overall Study||67
5266340|NCT00719576|12945375|P1|COMPLETED|Overall Study||70
5266341|NCT00719576|12945374|P2|STARTED|Overall Study||72
5266342|NCT00719576|12945375|P1|STARTED|Overall Study||72
5266343|NCT00719563|12945395|P2|NOT COMPLETED|Overall Study||42
5266344|NCT00719563|12945396|P1|NOT COMPLETED|Overall Study||38
5266345|NCT00719563|12945395|P2|COMPLETED|Overall Study||128
5266346|NCT00719563|12945396|P1|COMPLETED|Overall Study||133
5266347|NCT00719563|12945395|P2|STARTED|Overall Study||170
5266348|NCT00719563|12945396|P1|STARTED|Overall Study||171
5266349|NCT00719537|12945428|P2|NOT COMPLETED|Overall Study||1
5266350|NCT00719537|12945429|P1|NOT COMPLETED|Overall Study||1
5266351|NCT00719537|12945428|P2|COMPLETED|Overall Study||0
5266352|NCT00719537|12945429|P1|COMPLETED|Overall Study||1
5266353|NCT00719537|12945428|P2|STARTED|Overall Study||1
5266354|NCT00719537|12945429|P1|STARTED|Overall Study||2
5266355|NCT00719472|12945435|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
5266356|NCT00719472|12945435|P1|COMPLETED|Received Cycle 2 Treatment||304
5266357|NCT00719472|12945435|P1|STARTED|Received Cycle 2 Treatment||372
5266358|NCT00719472|12945435|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
5266359|NCT00719472|12945435|P1|COMPLETED|Received Cycle 1 Treatment||372
5266360|NCT00719472|12945435|P1|STARTED|Received Cycle 1 Treatment||425
5266361|NCT00719472|12945435|P1|NOT COMPLETED|Enrolled in Study||26
5266362|NCT00719472|12945435|P1|COMPLETED|Enrolled in Study||425
5266363|NCT00719472|12945435|P1|STARTED|Enrolled in Study||451
5266364|NCT00719355|12945446|P2|NOT COMPLETED|Overall Study||13
5266365|NCT00719355|12945447|P1|NOT COMPLETED|Overall Study||18
5266366|NCT00719355|12945446|P2|COMPLETED|Overall Study||39
5266367|NCT00719355|12945447|P1|COMPLETED|Overall Study||33
5266368|NCT00719355|12945446|P2|Completed 32 Weeks|Overall Study||39
5266369|NCT00719355|12945447|P1|Completed 32 Weeks|Overall Study||33
5266370|NCT00719355|12945446|P2|Completed 24 Weeks|Overall Study||43
5266371|NCT00719355|12945447|P1|Completed 24 Weeks|Overall Study||34
5266372|NCT00719355|12945446|P2|Completed 12 Weeks|Overall Study||46
5266373|NCT00719355|12945447|P1|Completed 12 Weeks|Overall Study||43
5266374|NCT00719355|12945446|P2|Completed 6 Weeks|Overall Study||48
5266375|NCT00719355|12945447|P1|Completed 6 Weeks|Overall Study||49
5266376|NCT00719355|12945446|P2|STARTED|Overall Study||52
5266377|NCT00719355|12945447|P1|STARTED|Overall Study||51
5266378|NCT00719329|12945458|P3|NOT COMPLETED|Overall Study||1
5266379|NCT00719329|12945459|P2|NOT COMPLETED|Overall Study||2
5266380|NCT00719329|12945460|P1|NOT COMPLETED|Overall Study||0
5266381|NCT00719329|12945458|P3|COMPLETED|Overall Study||646
5266382|NCT00719329|12945459|P2|COMPLETED|Overall Study||569
5266383|NCT00719329|12945460|P1|COMPLETED|Overall Study||705
5266384|NCT00719329|12945458|P3|Day 7 Swab|Overall Study||561
5266385|NCT00719329|12945459|P2|Day 7 Swab|Overall Study||467
5266386|NCT00719329|12945460|P1|Day 7 Swab|Overall Study||593
5266387|NCT00719329|12945458|P3|Day 3 Swab|Overall Study||578
5266388|NCT00719329|12945459|P2|Day 3 Swab|Overall Study||501
5266389|NCT00719329|12945460|P1|Day 3 Swab|Overall Study||614
5266390|NCT00719329|12945458|P3|Day 1 Swab|Overall Study||646
5266391|NCT00719329|12945459|P2|Day 1 Swab|Overall Study||569
5266392|NCT00719329|12945460|P1|Day 1 Swab|Overall Study||705
5266393|NCT00719329|12945458|P3|STARTED|Overall Study||647
5266394|NCT00719329|12945459|P2|STARTED|Overall Study||571
5266395|NCT00719329|12945460|P1|STARTED|Overall Study||705
5266396|NCT00719264|12945476|P2|NOT COMPLETED|Overall Study||183
5266397|NCT00719264|12945477|P1|NOT COMPLETED|Overall Study||182
5266398|NCT00719264|12945476|P2|COMPLETED|Overall Study||0
5266399|NCT00719264|12945477|P1|COMPLETED|Overall Study||0
5266400|NCT00719264|12945476|P2|Safety Set|Overall Study||181
5266401|NCT00719264|12945477|P1|Safety Set|Overall Study||180
5266402|NCT00719264|12945476|P2|Full Analysis Set|Overall Study||183
5266403|NCT00719264|12945477|P1|Full Analysis Set|Overall Study||182
5266404|NCT00719264|12945476|P2|STARTED|Overall Study||183
5266405|NCT00719264|12945477|P1|STARTED|Overall Study||182
5266406|NCT00719212|12945496|P1|NOT COMPLETED|Overall Study||44
5266407|NCT00719212|12945496|P1|COMPLETED|Overall Study||17
5266408|NCT00719212|12945496|P1|STARTED|Overall Study||61
5266409|NCT00719186|12945508|P2|NOT COMPLETED|Overall Study||0
5266410|NCT00719186|12945509|P1|NOT COMPLETED|Overall Study||0
5266411|NCT00719186|12945508|P2|COMPLETED|Overall Study||374
5266412|NCT00719186|12945509|P1|COMPLETED|Overall Study||376
5266413|NCT00719186|12945508|P2|STARTED|Overall Study||374
5266414|NCT00719186|12945509|P1|STARTED|Overall Study||376
5266415|NCT00719160|12945523|P2|NOT COMPLETED|Overall Study||0
5266416|NCT00719160|12945524|P1|NOT COMPLETED|Overall Study||0
5266417|NCT00719160|12945523|P2|COMPLETED|Overall Study||6
5266418|NCT00719160|12945524|P1|COMPLETED|Overall Study||6
5266419|NCT00719160|12945523|P2|STARTED|Overall Study||6
5266420|NCT00719160|12945524|P1|STARTED|Overall Study||6
5266421|NCT00719134|12945531|P1|NOT COMPLETED|Overall Study||10
5266422|NCT00719134|12945531|P1|COMPLETED|Overall Study||66
5266423|NCT00719134|12945531|P1|STARTED|Overall Study||76
5266424|NCT00719043|12945544|P7|NOT COMPLETED|Overall Study||28
5266425|NCT00719043|12945545|P6|NOT COMPLETED|Overall Study||34
5266426|NCT00719043|12945546|P5|NOT COMPLETED|Overall Study||27
5266427|NCT00719043|12945547|P4|NOT COMPLETED|Overall Study||23
5266428|NCT00719043|12945548|P3|NOT COMPLETED|Overall Study||20
5266429|NCT00719043|12945549|P2|NOT COMPLETED|Overall Study||25
5266430|NCT00719043|12945550|P1|NOT COMPLETED|Overall Study||32
5266431|NCT00719043|12945544|P7|COMPLETED|Overall Study|Up to Day 909|92
5266432|NCT00719043|12945545|P6|COMPLETED|Overall Study|Up to Day 909|86
5266433|NCT00719043|12945546|P5|COMPLETED|Overall Study|Up to Day 909|95
5266434|NCT00719043|12945547|P4|COMPLETED|Overall Study|Up to Day 909|96
5266435|NCT00719043|12945548|P3|COMPLETED|Overall Study|Up to Day 909|99
5266436|NCT00719043|12945549|P2|COMPLETED|Overall Study|Up to Day 909|96
5266437|NCT00719043|12945550|P1|COMPLETED|Overall Study|Up to Day 909|88
5266438|NCT00719043|12945544|P7|STARTED|Overall Study||120
5266439|NCT00719043|12945545|P6|STARTED|Overall Study||120
5266440|NCT00719043|12945546|P5|STARTED|Overall Study||122
5266441|NCT00719043|12945547|P4|STARTED|Overall Study||119
5266442|NCT00719043|12945548|P3|STARTED|Overall Study||119
5266443|NCT00719043|12945549|P2|STARTED|Overall Study||121
5266444|NCT00719043|12945550|P1|STARTED|Overall Study||120
5266445|NCT00718887|12945674|P2|NOT COMPLETED|Overall Study||9
5266446|NCT00718887|12945675|P1|NOT COMPLETED|Overall Study||5
5266447|NCT00718887|12945674|P2|COMPLETED|Overall Study||68
5266448|NCT00718887|12945675|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
5266449|NCT00718887|12945674|P2|STARTED|Overall Study|Participants who received treatment.|77
5266450|NCT00718887|12945675|P1|STARTED|Overall Study|Participants who received treatment.|89
5266451|NCT00718861|12945699|P2|NOT COMPLETED|Overall Study||18
5266452|NCT00718861|12945700|P1|NOT COMPLETED|Overall Study||21
5266453|NCT00718861|12945699|P2|COMPLETED|Overall Study||77
5266454|NCT00718861|12945700|P1|COMPLETED|Overall Study||74
5266455|NCT00718861|12945699|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
5266456|NCT00718861|12945700|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
5266457|NCT00718861|12945699|P2|Safety Set|Overall Study||95
5266458|NCT00718861|12945700|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
5266459|NCT00718861|12945699|P2|STARTED|Overall Study||95
5266460|NCT00718861|12945700|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
5266461|NCT00718809|12945728|P2|NOT COMPLETED|Overall Study||9
5266462|NCT00718809|12945729|P1|NOT COMPLETED|Overall Study||12
5266463|NCT00718809|12945728|P2|COMPLETED|Overall Study||0
5266464|NCT00718809|12945729|P1|COMPLETED|Overall Study||0
5266465|NCT00718809|12945728|P2|STARTED|Overall Study||9
5266466|NCT00718809|12945729|P1|STARTED|Overall Study||12
5266467|NCT00718770|12945743|P1|NOT COMPLETED|Overall Study||8
5266468|NCT00718770|12945743|P1|COMPLETED|Overall Study||2
5266469|NCT00718770|12945743|P1|STARTED|Overall Study||10
5266470|NCT00718718|12945754|P10|NOT COMPLETED|Week 12 to End of Study||0
5266471|NCT00718718|12945755|P9|NOT COMPLETED|Week 12 to End of Study||1
5266472|NCT00718718|12945756|P8|NOT COMPLETED|Week 12 to End of Study||1
5266473|NCT00718718|12945757|P7|NOT COMPLETED|Week 12 to End of Study||2
5266474|NCT00718718|12945758|P6|NOT COMPLETED|Week 12 to End of Study||3
5266475|NCT00718718|12945759|P5|NOT COMPLETED|Week 12 to End of Study||0
5266476|NCT00718718|12945760|P4|NOT COMPLETED|Week 12 to End of Study||1
5266477|NCT00718718|12945761|P3|NOT COMPLETED|Week 12 to End of Study||0
5266478|NCT00718718|12945762|P2|NOT COMPLETED|Week 12 to End of Study||1
5266479|NCT00718718|12945763|P1|NOT COMPLETED|Week 12 to End of Study||0
5266480|NCT00718718|12945754|P10|COMPLETED|Week 12 to End of Study||31
5266481|NCT00718718|12945755|P9|COMPLETED|Week 12 to End of Study||27
5266482|NCT00718718|12945756|P8|COMPLETED|Week 12 to End of Study||27
5266483|NCT00718718|12945757|P7|COMPLETED|Week 12 to End of Study||27
5266484|NCT00718718|12945758|P6|COMPLETED|Week 12 to End of Study||24
5266485|NCT00718718|12945759|P5|COMPLETED|Week 12 to End of Study||0
5266486|NCT00718718|12945760|P4|COMPLETED|Week 12 to End of Study||15
5266487|NCT00718718|12945761|P3|COMPLETED|Week 12 to End of Study||0
5266488|NCT00718718|12945762|P2|COMPLETED|Week 12 to End of Study||17
5266489|NCT00718718|12945763|P1|COMPLETED|Week 12 to End of Study||0
5266490|NCT00718718|12945754|P10|Treated|Week 12 to End of Study||31
5266491|NCT00718718|12945755|P9|Treated|Week 12 to End of Study||28
5266492|NCT00718718|12945756|P8|Treated|Week 12 to End of Study||28
5266493|NCT00718718|12945757|P7|Treated|Week 12 to End of Study||29
5266494|NCT00718718|12945758|P6|Treated|Week 12 to End of Study||26
5266495|NCT00718718|12945759|P5|Treated|Week 12 to End of Study||0
5266496|NCT00718718|12945760|P4|Treated|Week 12 to End of Study||16
5266497|NCT00718718|12945761|P3|Treated|Week 12 to End of Study||0
5266498|NCT00718718|12945762|P2|Treated|Week 12 to End of Study||18
5266499|NCT00718718|12945763|P1|Treated|Week 12 to End of Study||0
5266500|NCT00718718|12945754|P10|STARTED|Week 12 to End of Study||31
5266501|NCT00718718|12945755|P9|STARTED|Week 12 to End of Study||28
5266502|NCT00718718|12945756|P8|STARTED|Week 12 to End of Study||28
5266503|NCT00718718|12945757|P7|STARTED|Week 12 to End of Study||29
5266504|NCT00718718|12945758|P6|STARTED|Week 12 to End of Study||27
5266505|NCT00718718|12945759|P5|STARTED|Week 12 to End of Study||0
5266506|NCT00718718|12945760|P4|STARTED|Week 12 to End of Study||16
5266507|NCT00718718|12945761|P3|STARTED|Week 12 to End of Study||0
5266508|NCT00718718|12945762|P2|STARTED|Week 12 to End of Study||18
5266509|NCT00718718|12945763|P1|STARTED|Week 12 to End of Study||0
5266510|NCT00718718|12945754|P10|NOT COMPLETED|Prior to Week 12||0
5266511|NCT00718718|12945755|P9|NOT COMPLETED|Prior to Week 12||2
5266512|NCT00718718|12945756|P8|NOT COMPLETED|Prior to Week 12||2
5266513|NCT00718718|12945757|P7|NOT COMPLETED|Prior to Week 12||1
5266514|NCT00718718|12945758|P6|NOT COMPLETED|Prior to Week 12||0
5266515|NCT00718718|12945759|P5|NOT COMPLETED|Prior to Week 12||3
5266516|NCT00718718|12945760|P4|NOT COMPLETED|Prior to Week 12||0
5266517|NCT00718718|12945761|P3|NOT COMPLETED|Prior to Week 12||1
5266518|NCT00718718|12945762|P2|NOT COMPLETED|Prior to Week 12||0
5266519|NCT00718718|12945763|P1|NOT COMPLETED|Prior to Week 12||1
5266520|NCT00718718|12945754|P10|COMPLETED|Prior to Week 12||31
5266521|NCT00718718|12945755|P9|COMPLETED|Prior to Week 12||28
5266522|NCT00718718|12945756|P8|COMPLETED|Prior to Week 12||28
5266523|NCT00718718|12945757|P7|COMPLETED|Prior to Week 12||29
5266524|NCT00718718|12945758|P6|COMPLETED|Prior to Week 12||0
5266525|NCT00718718|12945759|P5|COMPLETED|Prior to Week 12||27
5266526|NCT00718718|12945760|P4|COMPLETED|Prior to Week 12||0
5266527|NCT00718718|12945761|P3|COMPLETED|Prior to Week 12||16
5266528|NCT00718718|12945762|P2|COMPLETED|Prior to Week 12||0
5266529|NCT00718718|12945763|P1|COMPLETED|Prior to Week 12||18
5266530|NCT00718718|12945754|P10|STARTED|Prior to Week 12||31
5266531|NCT00718718|12945755|P9|STARTED|Prior to Week 12||30
5266532|NCT00718718|12945756|P8|STARTED|Prior to Week 12||30
5266533|NCT00718718|12945757|P7|STARTED|Prior to Week 12||30
5266534|NCT00718718|12945758|P6|STARTED|Prior to Week 12||0
5266535|NCT00718718|12945759|P5|STARTED|Prior to Week 12||30
5266536|NCT00718718|12945760|P4|STARTED|Prior to Week 12||0
5266537|NCT00718718|12945761|P3|STARTED|Prior to Week 12||17
5266538|NCT00718718|12945762|P2|STARTED|Prior to Week 12||0
5266539|NCT00718718|12945763|P1|STARTED|Prior to Week 12||19
5266540|NCT00718666|12945806|P3|NOT COMPLETED|Booster Phase Year 5||6
5266541|NCT00718666|12945807|P2|NOT COMPLETED|Booster Phase Year 5||0
5266542|NCT00718666|12945808|P1|NOT COMPLETED|Booster Phase Year 5||2
5266543|NCT00718666|12945806|P3|COMPLETED|Booster Phase Year 5||94
5266544|NCT00718666|12945807|P2|COMPLETED|Booster Phase Year 5||46
5266545|NCT00718666|12945808|P1|COMPLETED|Booster Phase Year 5||36
5266546|NCT00718666|12945806|P3|STARTED|Booster Phase Year 5||100
5266547|NCT00718666|12945807|P2|STARTED|Booster Phase Year 5||46
5266548|NCT00718666|12945808|P1|STARTED|Booster Phase Year 5||38
5266549|NCT00718666|12945806|P3|NOT COMPLETED|Persistence Phase Year 5||0
5266550|NCT00718666|12945807|P2|NOT COMPLETED|Persistence Phase Year 5||0
5266551|NCT00718666|12945808|P1|NOT COMPLETED|Persistence Phase Year 5||0
5266552|NCT00718666|12945806|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
5266553|NCT00718666|12945807|P2|COMPLETED|Persistence Phase Year 5||82
5266554|NCT00718666|12945808|P1|COMPLETED|Persistence Phase Year 5||70
5266555|NCT00718666|12945806|P3|STARTED|Persistence Phase Year 5||0
5266556|NCT00718666|12945807|P2|STARTED|Persistence Phase Year 5||82
5266557|NCT00718666|12945808|P1|STARTED|Persistence Phase Year 5||70
5266558|NCT00718666|12945806|P3|NOT COMPLETED|Persistence Phase Year 3||0
5266559|NCT00718666|12945807|P2|NOT COMPLETED|Persistence Phase Year 3||0
5266560|NCT00718666|12945808|P1|NOT COMPLETED|Persistence Phase Year 3||0
5266561|NCT00718666|12945806|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
5266562|NCT00718666|12945807|P2|COMPLETED|Persistence Phase Year 3||104
5266563|NCT00718666|12945808|P1|COMPLETED|Persistence Phase Year 3||98
5266564|NCT00718666|12945806|P3|STARTED|Persistence Phase Year 3||0
5266565|NCT00718666|12945807|P2|STARTED|Persistence Phase Year 3||104
5266566|NCT00718666|12945808|P1|STARTED|Persistence Phase Year 3||98
5266567|NCT00718666|12945806|P3|NOT COMPLETED|Persistence Phase Year 1||0
5266568|NCT00718666|12945807|P2|NOT COMPLETED|Persistence Phase Year 1||0
5266569|NCT00718666|12945808|P1|NOT COMPLETED|Persistence Phase Year 1||0
5266570|NCT00718666|12945806|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
5266571|NCT00718666|12945807|P2|COMPLETED|Persistence Phase Year 1||130
5266572|NCT00718666|12945808|P1|COMPLETED|Persistence Phase Year 1||118
5266573|NCT00718666|12945806|P3|STARTED|Persistence Phase Year 1||0
5266574|NCT00718666|12945807|P2|STARTED|Persistence Phase Year 1||130
5266575|NCT00718666|12945808|P1|STARTED|Persistence Phase Year 1||118
5266576|NCT00718640|12945892|P1|NOT COMPLETED|Overall Study||7
5266577|NCT00718640|12945892|P1|COMPLETED|Overall Study||3
5266578|NCT00718640|12945892|P1|STARTED|Overall Study||10
5266579|NCT00718549|12945904|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
5266580|NCT00718549|12945905|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
5266581|NCT00718549|12945906|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
5266582|NCT00718549|12945904|P3|COMPLETED|Maintenance/ Observation Phase||3
5266583|NCT00718549|12945905|P2|COMPLETED|Maintenance/ Observation Phase||5
5266584|NCT00718549|12945906|P1|COMPLETED|Maintenance/ Observation Phase||0
5266585|NCT00718549|12945904|P3|STARTED|Maintenance/ Observation Phase||33
5266586|NCT00718549|12945905|P2|STARTED|Maintenance/ Observation Phase||33
5266587|NCT00718549|12945906|P1|STARTED|Maintenance/ Observation Phase||0
5266588|NCT00718549|12945904|P3|NOT COMPLETED|Induction Phase||0
5266589|NCT00718549|12945905|P2|NOT COMPLETED|Induction Phase||0
5266590|NCT00718549|12945906|P1|NOT COMPLETED|Induction Phase||62
5266591|NCT00718549|12945904|P3|COMPLETED|Induction Phase||0
5266592|NCT00718549|12945905|P2|COMPLETED|Induction Phase||0
5266593|NCT00718549|12945906|P1|COMPLETED|Induction Phase||66
5266594|NCT00718549|12945904|P3|STARTED|Induction Phase||0
5266595|NCT00718549|12945905|P2|STARTED|Induction Phase||0
5266596|NCT00718549|12945906|P1|STARTED|Induction Phase||128
5266597|NCT00718523|12945931|P2|NOT COMPLETED|Overall Study||24
5266598|NCT00718523|12945932|P1|NOT COMPLETED|Overall Study||18
5266599|NCT00718523|12945931|P2|COMPLETED|Overall Study||62
5266600|NCT00718523|12945932|P1|COMPLETED|Overall Study||66
5266601|NCT00718523|12945931|P2|STARTED|Overall Study||86
5266602|NCT00718523|12945932|P1|STARTED|Overall Study||84
5266603|NCT00718510|12945944|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5266604|NCT00718510|12945945|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
5266605|NCT00718510|12945944|P2|COMPLETED|Second Intervention (3 Weeks)||7
5266606|NCT00718510|12945945|P1|COMPLETED|Second Intervention (3 Weeks)||6
5266607|NCT00718510|12945944|P2|STARTED|Second Intervention (3 Weeks)||7
5266608|NCT00718510|12945945|P1|STARTED|Second Intervention (3 Weeks)||7
5266609|NCT00718510|12945944|P2|NOT COMPLETED|Washout (5 Days)||0
5266610|NCT00718510|12945945|P1|NOT COMPLETED|Washout (5 Days)||0
5266611|NCT00718510|12945944|P2|COMPLETED|Washout (5 Days)||7
5266612|NCT00718510|12945945|P1|COMPLETED|Washout (5 Days)||7
5266613|NCT00718510|12945944|P2|STARTED|Washout (5 Days)||7
5266614|NCT00718510|12945945|P1|STARTED|Washout (5 Days)||7
5266615|NCT00718510|12945944|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
5266616|NCT00718510|12945945|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
5266617|NCT00718510|12945944|P2|COMPLETED|First Intervention (3 Weeks)||7
5266618|NCT00718510|12945945|P1|COMPLETED|First Intervention (3 Weeks)||7
5266619|NCT00718510|12945944|P2|Received Intervention|First Intervention (3 Weeks)||7
5266620|NCT00718510|12945945|P1|Received Intervention|First Intervention (3 Weeks)||7
5266621|NCT00718510|12945944|P2|STARTED|First Intervention (3 Weeks)||8
5266622|NCT00718510|12945945|P1|STARTED|First Intervention (3 Weeks)||7
5266623|NCT00718328|12945957|P2|NOT COMPLETED|Overall Study||0
5266624|NCT00718328|12945958|P1|NOT COMPLETED|Overall Study||1
5266625|NCT00718328|12945957|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
5266626|NCT00718328|12945958|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
5266627|NCT00718328|12945957|P2|STARTED|Overall Study||0
5266628|NCT00718328|12945958|P1|STARTED|Overall Study||1
5266629|NCT00718315|12945967|P3|NOT COMPLETED|Overall Study||21
5266630|NCT00718315|12945968|P2|NOT COMPLETED|Overall Study||22
5266631|NCT00718315|12945969|P1|NOT COMPLETED|Overall Study||19
5266632|NCT00718315|12945967|P3|COMPLETED|Overall Study||46
5266633|NCT00718315|12945968|P2|COMPLETED|Overall Study||45
5266634|NCT00718315|12945969|P1|COMPLETED|Overall Study||48
5266635|NCT00718315|12945967|P3|STARTED|Overall Study||67
5266636|NCT00718315|12945968|P2|STARTED|Overall Study||67
5266637|NCT00718315|12945969|P1|STARTED|Overall Study||67
5266638|NCT00718302|12946003|P2|NOT COMPLETED|Overall Study||0
5266639|NCT00718302|12946004|P1|NOT COMPLETED|Overall Study||0
5266640|NCT00718302|12946003|P2|COMPLETED|Overall Study||114
5266641|NCT00718302|12946004|P1|COMPLETED|Overall Study||119
5266642|NCT00718302|12946003|P2|STARTED|Overall Study||114
5266643|NCT00718302|12946004|P1|STARTED|Overall Study||119
5266644|NCT00718237|12946020|P2|NOT COMPLETED|Overall Study||15
5266645|NCT00718237|12946021|P1|NOT COMPLETED|Overall Study||13
5266646|NCT00718237|12946020|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
5266647|NCT00718237|12946021|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
5266648|NCT00718237|12946020|P2|Vaccinated at Visit 3|Overall Study||369
5266649|NCT00718237|12946021|P1|Vaccinated at Visit 3|Overall Study||371
5266650|NCT00718237|12946020|P2|Vaccinated at Visit 2|Overall Study||374
5266651|NCT00718237|12946021|P1|Vaccinated at Visit 2|Overall Study||373
5266652|NCT00718237|12946020|P2|Vaccinated at Visit 1|Overall Study||381
5266653|NCT00718237|12946021|P1|Vaccinated at Visit 1|Overall Study||380
5266654|NCT00718237|12946020|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
5266655|NCT00718237|12946021|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
5266656|NCT00718159|12946038|P7|NOT COMPLETED|Overall Study||1
5266657|NCT00718159|12946039|P6|NOT COMPLETED|Overall Study||1
5266658|NCT00718159|12946040|P5|NOT COMPLETED|Overall Study||8
5266659|NCT00718159|12946041|P4|NOT COMPLETED|Overall Study||4
5266660|NCT00718159|12946042|P3|NOT COMPLETED|Overall Study||3
5266661|NCT00718159|12946043|P2|NOT COMPLETED|Overall Study||3
5266662|NCT00718159|12946044|P1|NOT COMPLETED|Overall Study||3
5266663|NCT00718159|12946038|P7|COMPLETED|Overall Study||0
5266664|NCT00718159|12946039|P6|COMPLETED|Overall Study||0
5266665|NCT00718159|12946040|P5|COMPLETED|Overall Study||0
5266666|NCT00718159|12946041|P4|COMPLETED|Overall Study||0
5266667|NCT00718159|12946042|P3|COMPLETED|Overall Study||0
5266668|NCT00718159|12946043|P2|COMPLETED|Overall Study||0
5266669|NCT00718159|12946044|P1|COMPLETED|Overall Study||0
5266670|NCT00718159|12946038|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
5266671|NCT00718159|12946039|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
5266672|NCT00718159|12946040|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
5266673|NCT00718159|12946041|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
5266674|NCT00718159|12946042|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5266675|NCT00718159|12946043|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
5266676|NCT00718159|12946044|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5266677|NCT00718159|12946038|P7|STARTED|Overall Study||1
5266678|NCT00718159|12946039|P6|STARTED|Overall Study||1
5266679|NCT00718159|12946040|P5|STARTED|Overall Study||8
5266680|NCT00718159|12946041|P4|STARTED|Overall Study||4
5266681|NCT00718159|12946042|P3|STARTED|Overall Study||3
5266682|NCT00718159|12946043|P2|STARTED|Overall Study||3
5266683|NCT00718159|12946044|P1|STARTED|Overall Study||3
5266684|NCT00718120|12946070|P2|NOT COMPLETED|Overall Study||0
5266685|NCT00718120|12946071|P1|NOT COMPLETED|Overall Study||0
5266686|NCT00718120|12946070|P2|COMPLETED|Overall Study||55
5266687|NCT00718120|12946071|P1|COMPLETED|Overall Study||55
5266688|NCT00718120|12946070|P2|STARTED|Overall Study||55
5266689|NCT00718120|12946071|P1|STARTED|Overall Study||55
5266690|NCT00718094|12946091|P2|NOT COMPLETED|Overall Study||0
5266691|NCT00718094|12946092|P1|NOT COMPLETED|Overall Study||0
5266692|NCT00718094|12946091|P2|COMPLETED|Overall Study||5
5266693|NCT00718094|12946092|P1|COMPLETED|Overall Study||15
5266694|NCT00718094|12946091|P2|STARTED|Overall Study||5
5266695|NCT00718094|12946092|P1|STARTED|Overall Study||15
5266696|NCT00718081|12946101|P3|NOT COMPLETED|Overall Study||21
5266697|NCT00718081|12946102|P2|NOT COMPLETED|Overall Study||4
5266698|NCT00718081|12946103|P1|NOT COMPLETED|Overall Study||7
5266699|NCT00718081|12946101|P3|COMPLETED|Overall Study||9
5266700|NCT00718081|12946102|P2|COMPLETED|Overall Study||25
5266701|NCT00718081|12946103|P1|COMPLETED|Overall Study||22
5266702|NCT00718081|12946101|P3|STARTED|Overall Study||30
5266703|NCT00718081|12946102|P2|STARTED|Overall Study||29
5266704|NCT00718081|12946103|P1|STARTED|Overall Study||29
5266705|NCT00718042|12946120|P6|NOT COMPLETED|Donor Follow-up||0
5266706|NCT00718042|12946121|P5|NOT COMPLETED|Donor Follow-up||19
5266707|NCT00718042|12946122|P4|NOT COMPLETED|Donor Follow-up||0
5266708|NCT00718042|12946123|P3|NOT COMPLETED|Donor Follow-up||0
5266709|NCT00718042|12946124|P2|NOT COMPLETED|Donor Follow-up||0
5266710|NCT00718042|12946125|P1|NOT COMPLETED|Donor Follow-up||13
5266711|NCT00718042|12946120|P6|COMPLETED|Donor Follow-up||0
5266712|NCT00718042|12946121|P5|COMPLETED|Donor Follow-up||24
5266713|NCT00718042|12946122|P4|COMPLETED|Donor Follow-up||0
5266714|NCT00718042|12946123|P3|COMPLETED|Donor Follow-up||0
5266715|NCT00718042|12946124|P2|COMPLETED|Donor Follow-up||0
5266716|NCT00718042|12946125|P1|COMPLETED|Donor Follow-up||23
5266717|NCT00718042|12946120|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
5266718|NCT00718042|12946121|P5|STARTED|Donor Follow-up||43
5266719|NCT00718042|12946122|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
5266720|NCT00718042|12946123|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
5266721|NCT00718042|12946124|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
5266722|NCT00718042|12946125|P1|STARTED|Donor Follow-up||36
5266723|NCT00718042|12946120|P6|NOT COMPLETED|ESA Chagas Testing||0
5266724|NCT00718042|12946121|P5|NOT COMPLETED|ESA Chagas Testing||0
5266725|NCT00718042|12946122|P4|NOT COMPLETED|ESA Chagas Testing||0
5266726|NCT00718042|12946123|P3|NOT COMPLETED|ESA Chagas Testing||0
5266727|NCT00718042|12946124|P2|NOT COMPLETED|ESA Chagas Testing||0
5266728|NCT00718042|12946125|P1|NOT COMPLETED|ESA Chagas Testing||0
5266729|NCT00718042|12946120|P6|COMPLETED|ESA Chagas Testing||330
5266730|NCT00718042|12946121|P5|COMPLETED|ESA Chagas Testing||43
5266731|NCT00718042|12946122|P4|COMPLETED|ESA Chagas Testing||110
5266732|NCT00718042|12946123|P3|COMPLETED|ESA Chagas Testing||524
5266733|NCT00718042|12946124|P2|COMPLETED|ESA Chagas Testing||287
5266734|NCT00718042|12946125|P1|COMPLETED|ESA Chagas Testing||36
5266735|NCT00718042|12946120|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
5266736|NCT00718042|12946121|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
5266737|NCT00718042|12946122|P4|STARTED|ESA Chagas Testing||110
5266738|NCT00718042|12946123|P3|STARTED|ESA Chagas Testing||524
5266739|NCT00718042|12946124|P2|STARTED|ESA Chagas Testing||287
5266740|NCT00718042|12946125|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
5266741|NCT00718042|12946120|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
5266742|NCT00718042|12946121|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
5266743|NCT00718042|12946122|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
5266744|NCT00718042|12946123|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
5266745|NCT00718042|12946124|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
5266746|NCT00718042|12946125|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
5266747|NCT00718042|12946120|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
5266748|NCT00718042|12946121|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
5266749|NCT00718042|12946122|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
5266750|NCT00718042|12946123|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
5266751|NCT00718042|12946124|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
5266752|NCT00718042|12946125|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
5266753|NCT00718042|12946120|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
5266754|NCT00718042|12946121|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
5266755|NCT00718042|12946122|P4|STARTED|ABBOTT PRISM Chagas Testing||110
5266756|NCT00718042|12946123|P3|STARTED|ABBOTT PRISM Chagas Testing||525
5266757|NCT00718042|12946124|P2|STARTED|ABBOTT PRISM Chagas Testing||289
5266758|NCT00718042|12946125|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
5266759|NCT00717977|12946137|P1|NOT COMPLETED|Overall Study||0
5266760|NCT00717977|12946137|P1|COMPLETED|Overall Study||74
5266761|NCT00717977|12946137|P1|STARTED|Overall Study||74
5266762|NCT00717912|12946165|P6|NOT COMPLETED|Overall Study||0
5266763|NCT00717912|12946166|P5|NOT COMPLETED|Overall Study||0
5266764|NCT00717912|12946167|P4|NOT COMPLETED|Overall Study||0
5266765|NCT00717912|12946168|P3|NOT COMPLETED|Overall Study||0
5266766|NCT00717912|12946169|P2|NOT COMPLETED|Overall Study||0
5266767|NCT00717912|12946170|P1|NOT COMPLETED|Overall Study||0
5266768|NCT00717912|12946165|P6|COMPLETED|Overall Study||1
5266769|NCT00717912|12946166|P5|COMPLETED|Overall Study||1
5266770|NCT00717912|12946167|P4|COMPLETED|Overall Study||1
5266771|NCT00717912|12946168|P3|COMPLETED|Overall Study||1
5266772|NCT00717912|12946169|P2|COMPLETED|Overall Study||1
5266773|NCT00717912|12946170|P1|COMPLETED|Overall Study||1
5266774|NCT00717912|12946165|P6|STARTED|Overall Study||1
5266775|NCT00717912|12946166|P5|STARTED|Overall Study||1
5266776|NCT00717912|12946167|P4|STARTED|Overall Study||1
5266777|NCT00717912|12946168|P3|STARTED|Overall Study||1
5266778|NCT00717912|12946169|P2|STARTED|Overall Study||1
5266779|NCT00717912|12946170|P1|STARTED|Overall Study||1
5266780|NCT00717886|12946181|P1|NOT COMPLETED|Overall Study||4
5266781|NCT00717886|12946181|P1|COMPLETED|Overall Study||9
5266782|NCT00717886|12946181|P1|STARTED|Overall Study||13
5266783|NCT00717873|12946187|P2|NOT COMPLETED|Overall Study||0
5266784|NCT00717873|12946188|P1|NOT COMPLETED|Overall Study||0
5266785|NCT00717873|12946187|P2|COMPLETED|Overall Study||59
5266786|NCT00717873|12946188|P1|COMPLETED|Overall Study||46
5266787|NCT00717873|12946187|P2|STARTED|Overall Study||59
5266788|NCT00717873|12946188|P1|STARTED|Overall Study||46
5266789|NCT00717860|12946196|P2|NOT COMPLETED|Overall Study||28
5266790|NCT00717860|12946197|P1|NOT COMPLETED|Overall Study||27
5266791|NCT00717860|12946196|P2|COMPLETED|Overall Study||32
5266792|NCT00717860|12946197|P1|COMPLETED|Overall Study||34
5266793|NCT00717860|12946196|P2|STARTED|Overall Study||60
5266794|NCT00717860|12946197|P1|STARTED|Overall Study||61
5266795|NCT00717756|12946207|P1|NOT COMPLETED|Overall Study||1
5266796|NCT00717756|12946207|P1|COMPLETED|Overall Study||40
5266797|NCT00717756|12946207|P1|STARTED|Overall Study||41
5266798|NCT00717574|12946213|P2|NOT COMPLETED|Overall Study||2
5266799|NCT00717574|12946214|P1|NOT COMPLETED|Overall Study||2
5266800|NCT00717574|12946213|P2|COMPLETED|Overall Study||14
5266801|NCT00717574|12946214|P1|COMPLETED|Overall Study||14
5266802|NCT00717574|12946213|P2|STARTED|Overall Study||16
5266803|NCT00717574|12946214|P1|STARTED|Overall Study||16
5266804|NCT00717522|12946220|P1|NOT COMPLETED|Overall Study||7
5266805|NCT00717522|12946220|P1|COMPLETED|Overall Study||0
5266806|NCT00717522|12946220|P1|STARTED|Overall Study||7
5266807|NCT00717418|12946229|P4|NOT COMPLETED|1-Year Follow-Up||4
5266808|NCT00717418|12946230|P3|NOT COMPLETED|1-Year Follow-Up||434
5266809|NCT00717418|12946231|P2|NOT COMPLETED|1-Year Follow-Up||51
5266810|NCT00717418|12946232|P1|NOT COMPLETED|1-Year Follow-Up||147
5266811|NCT00717418|12946229|P4|COMPLETED|1-Year Follow-Up||0
5266812|NCT00717418|12946230|P3|COMPLETED|1-Year Follow-Up||74
5266813|NCT00717418|12946231|P2|COMPLETED|1-Year Follow-Up||23
5266814|NCT00717418|12946232|P1|COMPLETED|1-Year Follow-Up||33
5266815|NCT00717418|12946229|P4|STARTED|1-Year Follow-Up||4
5266816|NCT00717418|12946230|P3|STARTED|1-Year Follow-Up||508
5266817|NCT00717418|12946231|P2|STARTED|1-Year Follow-Up||74
5266818|NCT00717418|12946232|P1|STARTED|1-Year Follow-Up||180
5266819|NCT00717418|12946229|P4|NOT COMPLETED|Baseline||15
5266820|NCT00717418|12946230|P3|NOT COMPLETED|Baseline||0
5266821|NCT00717418|12946231|P2|NOT COMPLETED|Baseline||0
5266822|NCT00717418|12946232|P1|NOT COMPLETED|Baseline||0
5266823|NCT00717418|12946229|P4|COMPLETED|Baseline||4
5266824|NCT00717418|12946230|P3|COMPLETED|Baseline||508
5266825|NCT00717418|12946231|P2|COMPLETED|Baseline||74
5266826|NCT00717418|12946232|P1|COMPLETED|Baseline||180
5266827|NCT00717418|12946229|P4|STARTED|Baseline||19
5266828|NCT00717418|12946230|P3|STARTED|Baseline||508
5266829|NCT00717418|12946231|P2|STARTED|Baseline||74
5266830|NCT00717418|12946232|P1|STARTED|Baseline||180
5266831|NCT00717405|12946237|P1|NOT COMPLETED|Overall Study||0
5266832|NCT00717405|12946237|P1|COMPLETED|Overall Study||52
5266833|NCT00717405|12946237|P1|STARTED|Overall Study||52
5266834|NCT00717366|12946256|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
5266835|NCT00717366|12946257|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
5266836|NCT00717366|12946256|P2|COMPLETED|Extension Period (52 Weeks)||12
5266837|NCT00717366|12946257|P1|COMPLETED|Extension Period (52 Weeks)||5
5266838|NCT00717366|12946256|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
5266839|NCT00717366|12946257|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
5266840|NCT00717366|12946256|P2|STARTED|Extension Period (52 Weeks)||28
5266841|NCT00717366|12946257|P1|STARTED|Extension Period (52 Weeks)||9
5266842|NCT00717366|12946256|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
5266843|NCT00717366|12946257|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
5266844|NCT00717366|12946256|P2|COMPLETED|Core Study Period (20 Weeks)||35
5266845|NCT00717366|12946257|P1|COMPLETED|Core Study Period (20 Weeks)||12
5266846|NCT00717366|12946256|P2|STARTED|Core Study Period (20 Weeks)||48
5266847|NCT00717366|12946257|P1|STARTED|Core Study Period (20 Weeks)||16
5266848|NCT00717314|12946281|P2|NOT COMPLETED|Overall Study||10
5266849|NCT00717314|12946282|P1|NOT COMPLETED|Overall Study||6
5266850|NCT00717314|12946281|P2|COMPLETED|Overall Study||34
5266851|NCT00717314|12946282|P1|COMPLETED|Overall Study||37
5266852|NCT00717314|12946281|P2|STARTED|Overall Study||44
5266853|NCT00717314|12946282|P1|STARTED|Overall Study||43
5266854|NCT00717288|12946303|P3|NOT COMPLETED|Overall Study||0
5266855|NCT00717288|12946304|P2|NOT COMPLETED|Overall Study||0
5266856|NCT00717288|12946305|P1|NOT COMPLETED|Overall Study||0
5266857|NCT00717288|12946303|P3|COMPLETED|Overall Study||25
5266858|NCT00717288|12946304|P2|COMPLETED|Overall Study||29
5266859|NCT00717288|12946305|P1|COMPLETED|Overall Study||28
5266860|NCT00717288|12946303|P3|STARTED|Overall Study||25
5266861|NCT00717288|12946304|P2|STARTED|Overall Study||29
5266862|NCT00717288|12946305|P1|STARTED|Overall Study||28
5266863|NCT00717275|12946319|P1|NOT COMPLETED|Overall Study||3
5266864|NCT00717275|12946319|P1|COMPLETED|Overall Study||0
5266865|NCT00717275|12946319|P1|STARTED|Overall Study||3
5266866|NCT00717249|12946325|P2|NOT COMPLETED|Overall Study||15
5266867|NCT00717249|12946326|P1|NOT COMPLETED|Overall Study||22
5266868|NCT00717249|12946325|P2|COMPLETED|Overall Study||150
5266869|NCT00717249|12946326|P1|COMPLETED|Overall Study||304
5266870|NCT00717249|12946325|P2|STARTED|Overall Study||165
5266871|NCT00717249|12946326|P1|STARTED|Overall Study||326
5266872|NCT00717236|12946340|P2|NOT COMPLETED|Open-Label Period||21
5266873|NCT00717236|12946341|P1|NOT COMPLETED|Open-Label Period||125
5266874|NCT00717236|12946340|P2|COMPLETED|Open-Label Period||163
5266875|NCT00717236|12946341|P1|COMPLETED|Open-Label Period||646
5266876|NCT00717236|12946340|P2|STARTED|Open-Label Period||184
5266877|NCT00717236|12946341|P1|STARTED|Open-Label Period||771
5266878|NCT00717236|12946340|P2|NOT COMPLETED|Double-Blind Period||28
5266879|NCT00717236|12946341|P1|NOT COMPLETED|Double-Blind Period||80
5266880|NCT00717236|12946340|P2|COMPLETED|Double-Blind Period||184
5266881|NCT00717236|12946341|P1|COMPLETED|Double-Blind Period||771
5266882|NCT00717236|12946340|P2|STARTED|Double-Blind Period||212
5266883|NCT00717236|12946341|P1|STARTED|Double-Blind Period||851
5266884|NCT00717197|12946410|P1|NOT COMPLETED|Overall Study||7
5266885|NCT00717197|12946410|P1|COMPLETED|Overall Study||23
5266886|NCT00717197|12946410|P1|STARTED|Overall Study||30
5266887|NCT00717093|12946416|P2|NOT COMPLETED|Overall Study||48
5266888|NCT00717093|12946417|P1|NOT COMPLETED|Overall Study||44
5266889|NCT00717093|12946416|P2|COMPLETED|Overall Study||170
5266890|NCT00717093|12946417|P1|COMPLETED|Overall Study||170
5266891|NCT00717093|12946416|P2|Received Treatment|Overall Study||218
5266892|NCT00717093|12946417|P1|Received Treatment|Overall Study||213
5266893|NCT00717093|12946416|P2|STARTED|Overall Study||218
5266894|NCT00717093|12946417|P1|STARTED|Overall Study||214
5266895|NCT00717067|12946434|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
5266896|NCT00717067|12946435|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
5266897|NCT00717067|12946436|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
5266898|NCT00717067|12946437|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
5266899|NCT00717067|12946438|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
5266900|NCT00717067|12946434|P5|COMPLETED|Part 2: End Stage Renal Disease||6
5266901|NCT00717067|12946435|P4|COMPLETED|Part 2: End Stage Renal Disease||0
5266902|NCT00717067|12946436|P3|COMPLETED|Part 2: End Stage Renal Disease||0
5266903|NCT00717067|12946437|P2|COMPLETED|Part 2: End Stage Renal Disease||0
5266904|NCT00717067|12946438|P1|COMPLETED|Part 2: End Stage Renal Disease||0
5266905|NCT00717067|12946434|P5|STARTED|Part 2: End Stage Renal Disease||6
5266906|NCT00717067|12946435|P4|STARTED|Part 2: End Stage Renal Disease||0
5266907|NCT00717067|12946436|P3|STARTED|Part 2: End Stage Renal Disease||0
5266908|NCT00717067|12946437|P2|STARTED|Part 2: End Stage Renal Disease||0
5266909|NCT00717067|12946438|P1|STARTED|Part 2: End Stage Renal Disease||0
5266910|NCT00717067|12946434|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
5266911|NCT00717067|12946435|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
5266912|NCT00717067|12946436|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
5266913|NCT00717067|12946437|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
5266914|NCT00717067|12946438|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
5266915|NCT00717067|12946434|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
5266916|NCT00717067|12946435|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
5266917|NCT00717067|12946436|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
5266918|NCT00717067|12946437|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
5266919|NCT00717067|12946438|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
5266920|NCT00717067|12946434|P5|STARTED|Part 1b: Severe Renal Impairment||0
5266921|NCT00717067|12946435|P4|STARTED|Part 1b: Severe Renal Impairment||6
5266922|NCT00717067|12946436|P3|STARTED|Part 1b: Severe Renal Impairment||0
5266923|NCT00717067|12946437|P2|STARTED|Part 1b: Severe Renal Impairment||0
5266924|NCT00717067|12946438|P1|STARTED|Part 1b: Severe Renal Impairment||0
5266925|NCT00717067|12946434|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266926|NCT00717067|12946435|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266927|NCT00717067|12946436|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
5266928|NCT00717067|12946437|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266929|NCT00717067|12946438|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266930|NCT00717067|12946434|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266931|NCT00717067|12946435|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
5266932|NCT00717067|12946436|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
5266933|NCT00717067|12946437|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
5266934|NCT00717067|12946438|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
5266935|NCT00717067|12946434|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
5266936|NCT00717067|12946435|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
5266937|NCT00717067|12946436|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
5266938|NCT00717067|12946437|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
5266939|NCT00717067|12946438|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
5266940|NCT00717054|12946522|P2|NOT COMPLETED|Overall Study||0
5266941|NCT00717054|12946523|P1|NOT COMPLETED|Overall Study||0
5266942|NCT00717054|12946522|P2|COMPLETED|Overall Study||57
5266943|NCT00717054|12946523|P1|COMPLETED|Overall Study||58
5266944|NCT00717054|12946522|P2|STARTED|Overall Study||57
5266945|NCT00717054|12946523|P1|STARTED|Overall Study||58
5266946|NCT00717041|12946535|P1|NOT COMPLETED|Overall Study||0
5266947|NCT00717041|12946535|P1|COMPLETED|Overall Study||1206
5266948|NCT00717041|12946535|P1|STARTED|Overall Study||1206
5266949|NCT00716976|12946545|P2|NOT COMPLETED|Overall Study||9
5266950|NCT00716976|12946546|P1|NOT COMPLETED|Overall Study||20
5266951|NCT00716976|12946545|P2|COMPLETED|Overall Study||57
5266952|NCT00716976|12946546|P1|COMPLETED|Overall Study||45
5266953|NCT00716976|12946545|P2|STARTED|Overall Study||66
5266954|NCT00716976|12946546|P1|STARTED|Overall Study||65
5266955|NCT00716963|12946568|P6|NOT COMPLETED|Overall Study||0
5266956|NCT00716963|12946569|P5|NOT COMPLETED|Overall Study||0
5266957|NCT00716963|12946570|P4|NOT COMPLETED|Overall Study||0
5266958|NCT00716963|12946571|P3|NOT COMPLETED|Overall Study||0
5266959|NCT00716963|12946572|P2|NOT COMPLETED|Overall Study||0
5266960|NCT00716963|12946573|P1|NOT COMPLETED|Overall Study||1
5266961|NCT00716963|12946568|P6|COMPLETED|Overall Study||1
5266962|NCT00716963|12946569|P5|COMPLETED|Overall Study||1
5266963|NCT00716963|12946570|P4|COMPLETED|Overall Study||1
5266964|NCT00716963|12946571|P3|COMPLETED|Overall Study||1
5266965|NCT00716963|12946572|P2|COMPLETED|Overall Study||1
5266966|NCT00716963|12946573|P1|COMPLETED|Overall Study||1
5266967|NCT00716963|12946568|P6|STARTED|Overall Study||1
5266968|NCT00716963|12946569|P5|STARTED|Overall Study||1
5266969|NCT00716963|12946570|P4|STARTED|Overall Study||1
5266970|NCT00716963|12946571|P3|STARTED|Overall Study||1
5266971|NCT00716963|12946572|P2|STARTED|Overall Study||1
5266972|NCT00716963|12946573|P1|STARTED|Overall Study||2
5266973|NCT00716859|12946586|P2|NOT COMPLETED|Overall Study||5
5266974|NCT00716859|12946587|P1|NOT COMPLETED|Overall Study||9
5266975|NCT00716859|12946586|P2|COMPLETED|Overall Study||64
5266976|NCT00716859|12946587|P1|COMPLETED|Overall Study||61
5266977|NCT00716859|12946586|P2|Received Treatment|Overall Study||68
5266978|NCT00716859|12946587|P1|Received Treatment|Overall Study||69
5266979|NCT00716859|12946586|P2|STARTED|Overall Study||69
5266980|NCT00716859|12946587|P1|STARTED|Overall Study||70
5266981|NCT00716820|12946611|P1|NOT COMPLETED|Overall Study||0
5266982|NCT00716820|12946611|P1|COMPLETED|Overall Study||472
5266983|NCT00716820|12946611|P1|STARTED|Overall Study||472
5266984|NCT00716807|12946646|P4|NOT COMPLETED|Overall Study||0
5266985|NCT00716807|12946647|P3|NOT COMPLETED|Overall Study||0
5266986|NCT00716807|12946648|P2|NOT COMPLETED|Overall Study||0
5266987|NCT00716807|12946649|P1|NOT COMPLETED|Overall Study||0
5266988|NCT00716807|12946646|P4|COMPLETED|Overall Study||15
5266989|NCT00716807|12946647|P3|COMPLETED|Overall Study||18
5266990|NCT00716807|12946648|P2|COMPLETED|Overall Study||5
5266991|NCT00716807|12946649|P1|COMPLETED|Overall Study||8
5266992|NCT00716807|12946646|P4|STARTED|Overall Study||15
5266993|NCT00716807|12946647|P3|STARTED|Overall Study||18
5266994|NCT00716807|12946648|P2|STARTED|Overall Study||5
5266995|NCT00716807|12946649|P1|STARTED|Overall Study||8
5266996|NCT00716742|12946662|P3|NOT COMPLETED|3 Year Follow-up||21
5266997|NCT00716742|12946663|P2|NOT COMPLETED|3 Year Follow-up||32
5266998|NCT00716742|12946664|P1|NOT COMPLETED|3 Year Follow-up||30
5266999|NCT00716742|12946662|P3|COMPLETED|3 Year Follow-up||29
5267000|NCT00716742|12946663|P2|COMPLETED|3 Year Follow-up||35
5267001|NCT00716742|12946664|P1|COMPLETED|3 Year Follow-up||26
5267002|NCT00716742|12946662|P3|STARTED|3 Year Follow-up||50
5267003|NCT00716742|12946663|P2|STARTED|3 Year Follow-up||67
5267004|NCT00716742|12946664|P1|STARTED|3 Year Follow-up||56
5267005|NCT00716742|12946662|P3|NOT COMPLETED|2 Year Follow-up||102
5267006|NCT00716742|12946663|P2|NOT COMPLETED|2 Year Follow-up||96
5267007|NCT00716742|12946664|P1|NOT COMPLETED|2 Year Follow-up||104
5267008|NCT00716742|12946662|P3|COMPLETED|2 Year Follow-up||50
5267009|NCT00716742|12946663|P2|COMPLETED|2 Year Follow-up||67
5267010|NCT00716742|12946664|P1|COMPLETED|2 Year Follow-up||56
5267011|NCT00716742|12946662|P3|STARTED|2 Year Follow-up||152
5267012|NCT00716742|12946663|P2|STARTED|2 Year Follow-up||163
5267013|NCT00716742|12946664|P1|STARTED|2 Year Follow-up||160
5267014|NCT00716742|12946662|P3|NOT COMPLETED|1 Year Follow-up||200
5267015|NCT00716742|12946663|P2|NOT COMPLETED|1 Year Follow-up||193
5267016|NCT00716742|12946664|P1|NOT COMPLETED|1 Year Follow-up||187
5267017|NCT00716742|12946662|P3|COMPLETED|1 Year Follow-up||152
5267018|NCT00716742|12946663|P2|COMPLETED|1 Year Follow-up||163
5267019|NCT00716742|12946664|P1|COMPLETED|1 Year Follow-up||160
5267020|NCT00716742|12946662|P3|STARTED|1 Year Follow-up||352
5267021|NCT00716742|12946663|P2|STARTED|1 Year Follow-up||356
5267022|NCT00716742|12946664|P1|STARTED|1 Year Follow-up||347
5267023|NCT00716742|12946662|P3|NOT COMPLETED|Baseline||13
5267024|NCT00716742|12946663|P2|NOT COMPLETED|Baseline||14
5267025|NCT00716742|12946664|P1|NOT COMPLETED|Baseline||17
5267026|NCT00716742|12946662|P3|COMPLETED|Baseline||352
5267027|NCT00716742|12946663|P2|COMPLETED|Baseline||356
5267028|NCT00716742|12946664|P1|COMPLETED|Baseline||347
5267029|NCT00716742|12946662|P3|STARTED|Baseline||365
5267030|NCT00716742|12946663|P2|STARTED|Baseline||370
5267031|NCT00716742|12946664|P1|STARTED|Baseline||364
5267032|NCT00716625|12946672|P1|NOT COMPLETED|Overall Study||1
5267033|NCT00716625|12946672|P1|COMPLETED|Overall Study||1673
5267034|NCT00716625|12946672|P1|STARTED|Overall Study||1674
5267035|NCT00716482|12946697|P1|NOT COMPLETED|Overall Study||119
5267036|NCT00716482|12946697|P1|COMPLETED|Overall Study||1562
5267037|NCT00716482|12946697|P1|STARTED|Overall Study||1681
5267038|NCT00716456|12946710|P3|NOT COMPLETED|Overall Study||0
5267039|NCT00716456|12946711|P2|NOT COMPLETED|Overall Study||2
5267040|NCT00716456|12946712|P1|NOT COMPLETED|Overall Study||0
5267041|NCT00716456|12946710|P3|COMPLETED|Overall Study||13
5267042|NCT00716456|12946711|P2|COMPLETED|Overall Study||3
5267043|NCT00716456|12946712|P1|COMPLETED|Overall Study||3
5267044|NCT00716456|12946710|P3|STARTED|Overall Study||13
5267045|NCT00716456|12946711|P2|STARTED|Overall Study||5
5267046|NCT00716456|12946712|P1|STARTED|Overall Study||3
5267047|NCT00716443|12946720|P1|NOT COMPLETED|Overall Study||0
5267048|NCT00716443|12946720|P1|COMPLETED|Overall Study||51
5267049|NCT00716443|12946720|P1|STARTED|Overall Study||51
5267050|NCT00716417|12946763|P10|NOT COMPLETED|Overall Study||3
5267051|NCT00716417|12946764|P9|NOT COMPLETED|Overall Study||5
5267052|NCT00716417|12946765|P8|NOT COMPLETED|Overall Study||3
5267053|NCT00716417|12946766|P7|NOT COMPLETED|Overall Study||7
5267054|NCT00716417|12946767|P6|NOT COMPLETED|Overall Study||3
5267055|NCT00716417|12946768|P5|NOT COMPLETED|Overall Study||1
5267056|NCT00716417|12946769|P4|NOT COMPLETED|Overall Study||11
5267057|NCT00716417|12946770|P3|NOT COMPLETED|Overall Study||5
5267058|NCT00716417|12946771|P2|NOT COMPLETED|Overall Study||6
5267059|NCT00716417|12946772|P1|NOT COMPLETED|Overall Study||3
5267060|NCT00716417|12946763|P10|COMPLETED|Overall Study||0
5267061|NCT00716417|12946764|P9|COMPLETED|Overall Study||0
5267062|NCT00716417|12946765|P8|COMPLETED|Overall Study||0
5267063|NCT00716417|12946766|P7|COMPLETED|Overall Study||0
5267064|NCT00716417|12946767|P6|COMPLETED|Overall Study||0
5267065|NCT00716417|12946768|P5|COMPLETED|Overall Study||0
5267066|NCT00716417|12946769|P4|COMPLETED|Overall Study||0
5267067|NCT00716417|12946770|P3|COMPLETED|Overall Study||0
5267068|NCT00716417|12946771|P2|COMPLETED|Overall Study||0
5267069|NCT00716417|12946772|P1|COMPLETED|Overall Study||0
5267070|NCT00716417|12946763|P10|STARTED|Overall Study||3
5267071|NCT00716417|12946764|P9|STARTED|Overall Study||5
5267072|NCT00716417|12946765|P8|STARTED|Overall Study||3
5267073|NCT00716417|12946766|P7|STARTED|Overall Study||7
5267074|NCT00716417|12946767|P6|STARTED|Overall Study||3
5267075|NCT00716417|12946768|P5|STARTED|Overall Study||1
5267076|NCT00716417|12946769|P4|STARTED|Overall Study||11
5267077|NCT00716417|12946770|P3|STARTED|Overall Study||5
5267078|NCT00716417|12946771|P2|STARTED|Overall Study||6
5267079|NCT00716417|12946772|P1|STARTED|Overall Study||3
5267080|NCT00716274|12946819|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
5267081|NCT00716274|12946820|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
5267082|NCT00716274|12946821|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
5267083|NCT00716274|12946822|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
5267084|NCT00716274|12946823|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
5267085|NCT00716274|12946824|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
5267086|NCT00716274|12946819|P6|COMPLETED|Study Period III (16-Weeks)||19
5267087|NCT00716274|12946820|P5|COMPLETED|Study Period III (16-Weeks)||32
5267088|NCT00716274|12946821|P4|COMPLETED|Study Period III (16-Weeks)||17
5267089|NCT00716274|12946822|P3|COMPLETED|Study Period III (16-Weeks)||16
5267090|NCT00716274|12946823|P2|COMPLETED|Study Period III (16-Weeks)||0
5267091|NCT00716274|12946824|P1|COMPLETED|Study Period III (16-Weeks)||0
5267092|NCT00716274|12946819|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
5267093|NCT00716274|12946820|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
5267094|NCT00716274|12946821|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
5267095|NCT00716274|12946822|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
5267096|NCT00716274|12946823|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
5267182|NCT00715910|12947049|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267097|NCT00716274|12946824|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
5267098|NCT00716274|12946819|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
5267099|NCT00716274|12946820|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
5267100|NCT00716274|12946821|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
5267101|NCT00716274|12946822|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
5267102|NCT00716274|12946823|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
5267103|NCT00716274|12946824|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
5267104|NCT00716274|12946819|P6|COMPLETED|Study Period II (16-Weeks)||19
5267105|NCT00716274|12946820|P5|COMPLETED|Study Period II (16-Weeks)||0
5267106|NCT00716274|12946821|P4|COMPLETED|Study Period II (16-Weeks)||0
5267107|NCT00716274|12946822|P3|COMPLETED|Study Period II (16-Weeks)||0
5267108|NCT00716274|12946823|P2|COMPLETED|Study Period II (16-Weeks)||35
5267109|NCT00716274|12946824|P1|COMPLETED|Study Period II (16-Weeks)||36
5267110|NCT00716274|12946819|P6|STARTED|Study Period II (16-Weeks)||21
5267111|NCT00716274|12946820|P5|STARTED|Study Period II (16-Weeks)||0
5267112|NCT00716274|12946821|P4|STARTED|Study Period II (16-Weeks)||0
5267113|NCT00716274|12946822|P3|STARTED|Study Period II (16-Weeks)||0
5267114|NCT00716274|12946823|P2|STARTED|Study Period II (16-Weeks)||44
5267115|NCT00716274|12946824|P1|STARTED|Study Period II (16-Weeks)||45
5267116|NCT00716144|12946958|P4|NOT COMPLETED|Overall Study||12
5267117|NCT00716144|12946959|P3|NOT COMPLETED|Overall Study||12
5267118|NCT00716144|12946960|P2|NOT COMPLETED|Overall Study||7
5267119|NCT00716144|12946961|P1|NOT COMPLETED|Overall Study||9
5267120|NCT00716144|12946958|P4|COMPLETED|Overall Study||33
5267121|NCT00716144|12946959|P3|COMPLETED|Overall Study||33
5267122|NCT00716144|12946960|P2|COMPLETED|Overall Study||38
5267123|NCT00716144|12946961|P1|COMPLETED|Overall Study||32
5267124|NCT00716144|12946958|P4|STARTED|Overall Study||45
5267125|NCT00716144|12946959|P3|STARTED|Overall Study||45
5267126|NCT00716144|12946960|P2|STARTED|Overall Study||45
5267127|NCT00716144|12946961|P1|STARTED|Overall Study||41
5267128|NCT00716092|12946986|P3|NOT COMPLETED|Overall Study||0
5267129|NCT00716092|12946987|P2|NOT COMPLETED|Overall Study||1
5267130|NCT00716092|12946988|P1|NOT COMPLETED|Overall Study||2
5267131|NCT00716092|12946986|P3|COMPLETED|Overall Study||41
5267132|NCT00716092|12946987|P2|COMPLETED|Overall Study||39
5267133|NCT00716092|12946988|P1|COMPLETED|Overall Study||38
5267134|NCT00716092|12946986|P3|STARTED|Overall Study||41
5267135|NCT00716092|12946987|P2|STARTED|Overall Study||40
5267136|NCT00716092|12946988|P1|STARTED|Overall Study||40
5267137|NCT00716079|12947019|P2|NOT COMPLETED|Overall Study||15
5267138|NCT00716079|12947020|P1|NOT COMPLETED|Overall Study||9
5267139|NCT00716079|12947019|P2|COMPLETED|Overall Study||1421
5267140|NCT00716079|12947020|P1|COMPLETED|Overall Study||1394
5267141|NCT00716079|12947019|P2|STARTED|Overall Study||1436
5267142|NCT00716079|12947020|P1|STARTED|Overall Study||1403
5267143|NCT00715962|12947030|P2|NOT COMPLETED|Overall Study||2
5267144|NCT00715962|12947031|P1|NOT COMPLETED|Overall Study||6
5267145|NCT00715962|12947030|P2|COMPLETED|Overall Study||48
5267146|NCT00715962|12947031|P1|COMPLETED|Overall Study||44
5267147|NCT00715962|12947030|P2|STARTED|Overall Study||50
5267148|NCT00715962|12947031|P1|STARTED|Overall Study||50
5267149|NCT00715949|12947041|P1|NOT COMPLETED|Overall Study||4
5267150|NCT00715949|12947041|P1|COMPLETED|Overall Study|116 patients completed first test|116
5267151|NCT00715949|12947041|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
5267152|NCT00715910|12947049|P6|NOT COMPLETED|Booster and ESFU Phase||13
5267153|NCT00715910|12947050|P5|NOT COMPLETED|Booster and ESFU Phase||2
5267154|NCT00715910|12947051|P4|NOT COMPLETED|Booster and ESFU Phase||11
5267155|NCT00715910|12947052|P3|NOT COMPLETED|Booster and ESFU Phase||0
5267156|NCT00715910|12947053|P2|NOT COMPLETED|Booster and ESFU Phase||0
5267157|NCT00715910|12947054|P1|NOT COMPLETED|Booster and ESFU Phase||0
5267158|NCT00715910|12947049|P6|COMPLETED|Booster and ESFU Phase||88
5267159|NCT00715910|12947050|P5|COMPLETED|Booster and ESFU Phase||36
5267160|NCT00715910|12947051|P4|COMPLETED|Booster and ESFU Phase||172
5267161|NCT00715910|12947052|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267162|NCT00715910|12947053|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267163|NCT00715910|12947054|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267164|NCT00715910|12947049|P6|STARTED|Booster and ESFU Phase||101
5267165|NCT00715910|12947050|P5|STARTED|Booster and ESFU Phase||38
5267166|NCT00715910|12947051|P4|STARTED|Booster and ESFU Phase||183
5267167|NCT00715910|12947052|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267168|NCT00715910|12947053|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267169|NCT00715910|12947054|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
5267170|NCT00715910|12947049|P6|NOT COMPLETED|Year 5||0
5267171|NCT00715910|12947050|P5|NOT COMPLETED|Year 5||0
5267172|NCT00715910|12947051|P4|NOT COMPLETED|Year 5||0
5267173|NCT00715910|12947052|P3|NOT COMPLETED|Year 5||0
5267174|NCT00715910|12947053|P2|NOT COMPLETED|Year 5||0
5267175|NCT00715910|12947054|P1|NOT COMPLETED|Year 5||0
5267176|NCT00715910|12947049|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267177|NCT00715910|12947050|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267178|NCT00715910|12947051|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267179|NCT00715910|12947052|P3|COMPLETED|Year 5||38
5267180|NCT00715910|12947053|P2|COMPLETED|Year 5||56
5267181|NCT00715910|12947054|P1|COMPLETED|Year 5||218
5267183|NCT00715910|12947050|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267184|NCT00715910|12947051|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
5267185|NCT00715910|12947052|P3|STARTED|Year 5||38
5267186|NCT00715910|12947053|P2|STARTED|Year 5||56
5267187|NCT00715910|12947054|P1|STARTED|Year 5||218
5267188|NCT00715910|12947049|P6|NOT COMPLETED|Year 3||0
5267189|NCT00715910|12947050|P5|NOT COMPLETED|Year 3||0
5267190|NCT00715910|12947051|P4|NOT COMPLETED|Year 3||0
5267191|NCT00715910|12947052|P3|NOT COMPLETED|Year 3||0
5267192|NCT00715910|12947053|P2|NOT COMPLETED|Year 3||0
5267193|NCT00715910|12947054|P1|NOT COMPLETED|Year 3||0
5267194|NCT00715910|12947049|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267195|NCT00715910|12947050|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267196|NCT00715910|12947051|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267197|NCT00715910|12947052|P3|COMPLETED|Year 3||56
5267198|NCT00715910|12947053|P2|COMPLETED|Year 3||86
5267199|NCT00715910|12947054|P1|COMPLETED|Year 3||345
5267200|NCT00715910|12947049|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267201|NCT00715910|12947050|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267202|NCT00715910|12947051|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
5267203|NCT00715910|12947052|P3|STARTED|Year 3||56
5267204|NCT00715910|12947053|P2|STARTED|Year 3||86
5267205|NCT00715910|12947054|P1|STARTED|Year 3||345
5267206|NCT00715910|12947049|P6|NOT COMPLETED|Year 1||0
5267207|NCT00715910|12947050|P5|NOT COMPLETED|Year 1||0
5267208|NCT00715910|12947051|P4|NOT COMPLETED|Year 1||0
5267209|NCT00715910|12947052|P3|NOT COMPLETED|Year 1||0
5267210|NCT00715910|12947053|P2|NOT COMPLETED|Year 1||0
5267211|NCT00715910|12947054|P1|NOT COMPLETED|Year 1||0
5267212|NCT00715910|12947049|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267213|NCT00715910|12947050|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267214|NCT00715910|12947051|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267215|NCT00715910|12947052|P3|COMPLETED|Year 1||68
5267216|NCT00715910|12947053|P2|COMPLETED|Year 1||147
5267217|NCT00715910|12947054|P1|COMPLETED|Year 1||433
5267218|NCT00715910|12947049|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267219|NCT00715910|12947050|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267220|NCT00715910|12947051|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
5267221|NCT00715910|12947052|P3|STARTED|Year 1||68
5267222|NCT00715910|12947053|P2|STARTED|Year 1||147
5267223|NCT00715910|12947054|P1|STARTED|Year 1||433
5267224|NCT00715884|12947130|P2|NOT COMPLETED|Overall Study||1
5267225|NCT00715884|12947131|P1|NOT COMPLETED|Overall Study||8
5267226|NCT00715884|12947130|P2|COMPLETED|Overall Study||225
5267227|NCT00715884|12947131|P1|COMPLETED|Overall Study||444
5267228|NCT00715884|12947130|P2|STARTED|Overall Study||226
5267229|NCT00715884|12947131|P1|STARTED|Overall Study||452
5267230|NCT00715793|12947173|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
5267231|NCT00715793|12947174|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
5267232|NCT00715793|12947173|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
5267233|NCT00715793|12947174|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
5267234|NCT00715793|12947173|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
5267235|NCT00715793|12947174|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
5267236|NCT00715793|12947173|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
5267237|NCT00715793|12947174|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
5267238|NCT00715793|12947173|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
5267239|NCT00715793|12947174|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
5267240|NCT00715793|12947173|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
5267241|NCT00715793|12947174|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
5267242|NCT00715754|12947186|P1|NOT COMPLETED|Overall Study||0
5267243|NCT00715754|12947186|P1|COMPLETED|Overall Study||47
5267244|NCT00715754|12947186|P1|STARTED|Overall Study||47
5267245|NCT00715741|12947196|P4|NOT COMPLETED|Overall Study||0
5267246|NCT00715741|12947197|P3|NOT COMPLETED|Overall Study||0
5267247|NCT00715741|12947198|P2|NOT COMPLETED|Overall Study||0
5267248|NCT00715741|12947199|P1|NOT COMPLETED|Overall Study||0
5267249|NCT00715741|12947196|P4|COMPLETED|Overall Study||25
5267250|NCT00715741|12947197|P3|COMPLETED|Overall Study||25
5267251|NCT00715741|12947198|P2|COMPLETED|Overall Study||25
5267252|NCT00715741|12947199|P1|COMPLETED|Overall Study||25
5267253|NCT00715741|12947196|P4|STARTED|Overall Study||25
5267254|NCT00715741|12947197|P3|STARTED|Overall Study||25
5267255|NCT00715741|12947198|P2|STARTED|Overall Study||25
5267256|NCT00715741|12947199|P1|STARTED|Overall Study||25
5267257|NCT00715728|12947223|P2|NOT COMPLETED|Overall Study||0
5267258|NCT00715728|12947224|P1|NOT COMPLETED|Overall Study||0
5267259|NCT00715728|12947223|P2|COMPLETED|Overall Study||14
5267260|NCT00715728|12947224|P1|COMPLETED|Overall Study||14
5267261|NCT00715728|12947223|P2|STARTED|Overall Study||14
5267262|NCT00715728|12947224|P1|STARTED|Overall Study||14
5267263|NCT00715676|12947235|P3|NOT COMPLETED|Overall Study||32
5267264|NCT00715676|12947236|P2|NOT COMPLETED|Overall Study||11
5267265|NCT00715676|12947237|P1|NOT COMPLETED|Overall Study||6
5267266|NCT00715676|12947235|P3|COMPLETED|Overall Study||21
5267267|NCT00715676|12947236|P2|COMPLETED|Overall Study||43
5267268|NCT00715676|12947237|P1|COMPLETED|Overall Study||43
5267269|NCT00715676|12947235|P3|STARTED|Overall Study||53
5267270|NCT00715676|12947236|P2|STARTED|Overall Study||54
5267359|NCT00715117|12947521|P1|NOT COMPLETED|Overall Study||0
5267271|NCT00715676|12947237|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
5267272|NCT00715650|12947265|P2|NOT COMPLETED|Follow-up||5
5267273|NCT00715650|12947266|P1|NOT COMPLETED|Follow-up||13
5267274|NCT00715650|12947265|P2|COMPLETED|Follow-up||37
5267275|NCT00715650|12947266|P1|COMPLETED|Follow-up||29
5267276|NCT00715650|12947265|P2|Completed Month 6 Follow-up|Follow-up||37
5267277|NCT00715650|12947266|P1|Completed Month 6 Follow-up|Follow-up||29
5267278|NCT00715650|12947265|P2|Completed Month 3 Follow-up|Follow-up||40
5267279|NCT00715650|12947266|P1|Completed Month 3 Follow-up|Follow-up||35
5267280|NCT00715650|12947265|P2|Completed Month 1 Follow-up|Follow-up||38
5267281|NCT00715650|12947266|P1|Completed Month 1 Follow-up|Follow-up||40
5267282|NCT00715650|12947265|P2|STARTED|Follow-up||42
5267283|NCT00715650|12947266|P1|STARTED|Follow-up||42
5267284|NCT00715650|12947265|P2|NOT COMPLETED|Intervention||3
5267285|NCT00715650|12947266|P1|NOT COMPLETED|Intervention||5
5267286|NCT00715650|12947265|P2|COMPLETED|Intervention||42
5267287|NCT00715650|12947266|P1|COMPLETED|Intervention||42
5267288|NCT00715650|12947265|P2|Attended ≥ 3 Sessions|Intervention||17
5267289|NCT00715650|12947266|P1|Attended ≥ 3 Sessions|Intervention||23
5267290|NCT00715650|12947265|P2|Attended ≥ 2 Sessions|Intervention||33
5267291|NCT00715650|12947266|P1|Attended ≥ 2 Sessions|Intervention||36
5267292|NCT00715650|12947265|P2|Received Any Session|Intervention||38
5267293|NCT00715650|12947266|P1|Received Any Session|Intervention||39
5267294|NCT00715650|12947265|P2|STARTED|Intervention||45
5267295|NCT00715650|12947266|P1|STARTED|Intervention||47
5267296|NCT00715624|12947280|P2|NOT COMPLETED|Overall Study||116
5267297|NCT00715624|12947281|P1|NOT COMPLETED|Overall Study||52
5267298|NCT00715624|12947280|P2|COMPLETED|Overall Study||213
5267299|NCT00715624|12947281|P1|COMPLETED|Overall Study||115
5267300|NCT00715624|12947280|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
5267301|NCT00715624|12947281|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
5267302|NCT00715624|12947280|P2|Treated/Safety Population|Overall Study||328
5267303|NCT00715624|12947281|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
5267304|NCT00715624|12947280|P2|STARTED|Overall Study||329
5267305|NCT00715624|12947281|P1|STARTED|Overall Study|Randomized|167
5267306|NCT00715559|12947309|P1|NOT COMPLETED|Overall Study||1
5267307|NCT00715559|12947309|P1|COMPLETED|Overall Study||2
5267308|NCT00715559|12947309|P1|STARTED|Overall Study||3
5267309|NCT00715520|12947319|P3|NOT COMPLETED|Overall Study||2
5267310|NCT00715520|12947320|P2|NOT COMPLETED|Overall Study||1
5267311|NCT00715520|12947321|P1|NOT COMPLETED|Overall Study||10
5267312|NCT00715520|12947319|P3|COMPLETED|Overall Study||1
5267313|NCT00715520|12947320|P2|COMPLETED|Overall Study||9
5267314|NCT00715520|12947321|P1|COMPLETED|Overall Study||10
5267315|NCT00715520|12947319|P3|STARTED|Overall Study||3
5267316|NCT00715520|12947320|P2|STARTED|Overall Study||10
5267317|NCT00715520|12947321|P1|STARTED|Overall Study||20
5267318|NCT00715429|12947336|P2|NOT COMPLETED|Overall Study||1
5267319|NCT00715429|12947337|P1|NOT COMPLETED|Overall Study||0
5267320|NCT00715429|12947336|P2|COMPLETED|Overall Study||6
5267321|NCT00715429|12947337|P1|COMPLETED|Overall Study||7
5267322|NCT00715429|12947336|P2|STARTED|Overall Study||7
5267323|NCT00715429|12947337|P1|STARTED|Overall Study||7
5267324|NCT00715403|12947352|P7|NOT COMPLETED|Overall Study||1
5267325|NCT00715403|12947353|P6|NOT COMPLETED|Overall Study||19
5267326|NCT00715403|12947354|P5|NOT COMPLETED|Overall Study||6
5267327|NCT00715403|12947355|P4|NOT COMPLETED|Overall Study||9
5267328|NCT00715403|12947356|P3|NOT COMPLETED|Overall Study||4
5267329|NCT00715403|12947357|P2|NOT COMPLETED|Overall Study||1
5267330|NCT00715403|12947358|P1|NOT COMPLETED|Overall Study||1
5267331|NCT00715403|12947352|P7|COMPLETED|Overall Study||0
5267332|NCT00715403|12947353|P6|COMPLETED|Overall Study||0
5267333|NCT00715403|12947354|P5|COMPLETED|Overall Study||0
5267334|NCT00715403|12947355|P4|COMPLETED|Overall Study||0
5267335|NCT00715403|12947356|P3|COMPLETED|Overall Study||0
5267336|NCT00715403|12947357|P2|COMPLETED|Overall Study||0
5267337|NCT00715403|12947358|P1|COMPLETED|Overall Study||0
5267338|NCT00715403|12947352|P7|STARTED|Overall Study||1
5267339|NCT00715403|12947353|P6|STARTED|Overall Study||19
5267340|NCT00715403|12947354|P5|STARTED|Overall Study||6
5267341|NCT00715403|12947355|P4|STARTED|Overall Study||9
5267342|NCT00715403|12947356|P3|STARTED|Overall Study||4
5267343|NCT00715403|12947357|P2|STARTED|Overall Study||1
5267344|NCT00715403|12947358|P1|STARTED|Overall Study||1
5267345|NCT00715390|12947493|P1|NOT COMPLETED|Overall Study||0
5267346|NCT00715390|12947493|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
5267347|NCT00715390|12947493|P1|Eligible|Overall Study||234
5267348|NCT00715390|12947493|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
5267349|NCT00715299|12947497|P1|NOT COMPLETED|Overall Study||6
5267350|NCT00715299|12947497|P1|COMPLETED|Overall Study||30
5267351|NCT00715299|12947497|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
5267352|NCT00715208|12947503|P2|NOT COMPLETED|Overall Study||9
5267353|NCT00715208|12947504|P1|NOT COMPLETED|Overall Study||1
5267354|NCT00715208|12947503|P2|COMPLETED|Overall Study||39
5267355|NCT00715208|12947504|P1|COMPLETED|Overall Study||6
5267356|NCT00715208|12947503|P2|STARTED|Overall Study||48
5267357|NCT00715208|12947504|P1|STARTED|Overall Study||7
5267358|NCT00715117|12947520|P2|NOT COMPLETED|Overall Study||1
5267360|NCT00715117|12947520|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
5267361|NCT00715117|12947521|P1|COMPLETED|Overall Study||6
5267362|NCT00715117|12947520|P2|Completion fo 8 Week Study|Overall Study||6
5267363|NCT00715117|12947521|P1|Completion fo 8 Week Study|Overall Study||6
5267364|NCT00715117|12947520|P2|STARTED|Overall Study||6
5267365|NCT00715117|12947521|P1|STARTED|Overall Study||6
5267366|NCT00715104|12947535|P3|NOT COMPLETED|Overall Study||0
5267367|NCT00715104|12947536|P2|NOT COMPLETED|Overall Study||0
5267368|NCT00715104|12947537|P1|NOT COMPLETED|Overall Study||0
5267369|NCT00715104|12947535|P3|COMPLETED|Overall Study||8
5267370|NCT00715104|12947536|P2|COMPLETED|Overall Study||16
5267371|NCT00715104|12947537|P1|COMPLETED|Overall Study||18
5267372|NCT00715104|12947535|P3|STARTED|Overall Study||8
5267373|NCT00715104|12947536|P2|STARTED|Overall Study||16
5267374|NCT00715104|12947537|P1|STARTED|Overall Study||18
5267375|NCT00715078|12947589|P3|NOT COMPLETED|Overall Study||38
5267376|NCT00715078|12947590|P2|NOT COMPLETED|Overall Study||36
5267377|NCT00715078|12947591|P1|NOT COMPLETED|Overall Study||30
5267378|NCT00715078|12947589|P3|COMPLETED|Overall Study||3
5267379|NCT00715078|12947590|P2|COMPLETED|Overall Study||4
5267380|NCT00715078|12947591|P1|COMPLETED|Overall Study||11
5267381|NCT00715078|12947589|P3|Received ≥ 1 Leukapheresis|Overall Study||40
5267382|NCT00715078|12947590|P2|Received ≥ 1 Leukapheresis|Overall Study||40
5267383|NCT00715078|12947591|P1|Received ≥ 1 Leukapheresis|Overall Study||40
5267384|NCT00715078|12947589|P3|Received ≥ 1 Study Infusion|Overall Study||39
5267385|NCT00715078|12947590|P2|Received ≥ 1 Study Infusion|Overall Study||40
5267386|NCT00715078|12947591|P1|Received ≥ 1 Study Infusion|Overall Study||40
5267387|NCT00715078|12947589|P3|STARTED|Overall Study||41
5267388|NCT00715078|12947590|P2|STARTED|Overall Study||40
5267389|NCT00715078|12947591|P1|STARTED|Overall Study||41
5267390|NCT00715026|12947599|P1|NOT COMPLETED|Overall Study||10
5267391|NCT00715026|12947599|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
5267392|NCT00715026|12947599|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
5267393|NCT00715026|12947599|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
5267394|NCT00714948|12947604|P1|NOT COMPLETED|Overall Study||2
5267395|NCT00714948|12947604|P1|COMPLETED|Overall Study||0
5267396|NCT00714948|12947604|P1|STARTED|Overall Study||2
5267397|NCT00714870|12947610|P2|NOT COMPLETED|Overall Study||5
5267398|NCT00714870|12947611|P1|NOT COMPLETED|Overall Study||27
5267399|NCT00714870|12947610|P2|COMPLETED|Overall Study||22
5267400|NCT00714870|12947611|P1|COMPLETED|Overall Study||22
5267401|NCT00714870|12947610|P2|STARTED|Overall Study||27
5267402|NCT00714870|12947611|P1|STARTED|Overall Study||49
5267403|NCT00714792|12947619|P2|NOT COMPLETED|Overall Study||0
5267404|NCT00714792|12947620|P1|NOT COMPLETED|Overall Study||0
5267405|NCT00714792|12947619|P2|COMPLETED|Overall Study||8
5267406|NCT00714792|12947620|P1|COMPLETED|Overall Study||10
5267407|NCT00714792|12947619|P2|STARTED|Overall Study||8
5267408|NCT00714792|12947620|P1|STARTED|Overall Study||10
5267409|NCT00714753|12947626|P1|NOT COMPLETED|Overall Study||0
5267410|NCT00714753|12947626|P1|COMPLETED|Overall Study||5
5267411|NCT00714753|12947626|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
5267412|NCT00714753|12947626|P1|HDR Brachytherapy|Overall Study||5
5267413|NCT00714753|12947626|P1|STARTED|Overall Study||5
5267414|NCT00714714|12947635|P1|NOT COMPLETED|Overall Study||1
5267415|NCT00714714|12947635|P1|COMPLETED|Overall Study||24
5267416|NCT00714714|12947635|P1|STARTED|Overall Study||25
5267417|NCT00714688|12947644|P3|NOT COMPLETED|Overall Study||37
5267418|NCT00714688|12947645|P2|NOT COMPLETED|Overall Study||35
5267419|NCT00714688|12947646|P1|NOT COMPLETED|Overall Study||29
5267420|NCT00714688|12947644|P3|COMPLETED|Overall Study||55
5267421|NCT00714688|12947645|P2|COMPLETED|Overall Study||55
5267422|NCT00714688|12947646|P1|COMPLETED|Overall Study||68
5267423|NCT00714688|12947644|P3|STARTED|Overall Study||92
5267424|NCT00714688|12947645|P2|STARTED|Overall Study||90
5267425|NCT00714688|12947646|P1|STARTED|Overall Study||97
5267426|NCT00714571|12947669|P6|NOT COMPLETED|Stage 2||0
5267427|NCT00714571|12947670|P5|NOT COMPLETED|Stage 2||0
5267428|NCT00714571|12947671|P4|NOT COMPLETED|Stage 2||0
5267429|NCT00714571|12947672|P3|NOT COMPLETED|Stage 2||0
5267430|NCT00714571|12947673|P2|NOT COMPLETED|Stage 2||0
5267431|NCT00714571|12947674|P1|NOT COMPLETED|Stage 2||0
5267432|NCT00714571|12947669|P6|COMPLETED|Stage 2||15
5267433|NCT00714571|12947670|P5|COMPLETED|Stage 2||15
5267434|NCT00714571|12947671|P4|COMPLETED|Stage 2||0
5267435|NCT00714571|12947672|P3|COMPLETED|Stage 2||0
5267436|NCT00714571|12947673|P2|COMPLETED|Stage 2||0
5267437|NCT00714571|12947674|P1|COMPLETED|Stage 2||0
5267438|NCT00714571|12947669|P6|STARTED|Stage 2||15
5267439|NCT00714571|12947670|P5|STARTED|Stage 2||15
5267440|NCT00714571|12947671|P4|STARTED|Stage 2||0
5267441|NCT00714571|12947672|P3|STARTED|Stage 2||0
5267442|NCT00714571|12947673|P2|STARTED|Stage 2||0
5267443|NCT00714571|12947674|P1|STARTED|Stage 2||0
5267444|NCT00714571|12947669|P6|NOT COMPLETED|Stage 1||0
5267445|NCT00714571|12947670|P5|NOT COMPLETED|Stage 1||0
5267446|NCT00714571|12947671|P4|NOT COMPLETED|Stage 1||0
5267447|NCT00714571|12947672|P3|NOT COMPLETED|Stage 1||1
5267448|NCT00714571|12947673|P2|NOT COMPLETED|Stage 1||0
5267449|NCT00714571|12947674|P1|NOT COMPLETED|Stage 1||0
5267450|NCT00714571|12947669|P6|COMPLETED|Stage 1||0
5267451|NCT00714571|12947670|P5|COMPLETED|Stage 1||0
5267452|NCT00714571|12947671|P4|COMPLETED|Stage 1||14
5267453|NCT00714571|12947672|P3|COMPLETED|Stage 1||10
5267454|NCT00714571|12947673|P2|COMPLETED|Stage 1||15
5267455|NCT00714571|12947674|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
5267456|NCT00714571|12947669|P6|STARTED|Stage 1||0
5267457|NCT00714571|12947670|P5|STARTED|Stage 1||0
5267458|NCT00714571|12947671|P4|STARTED|Stage 1||14
5267459|NCT00714571|12947672|P3|STARTED|Stage 1||11
5267460|NCT00714571|12947673|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
5267461|NCT00714571|12947674|P1|STARTED|Stage 1||12
5267462|NCT00714493|12947688|P1|NOT COMPLETED|Overall Study||49
5267463|NCT00714493|12947688|P1|COMPLETED|Overall Study||154
5267464|NCT00714493|12947688|P1|STARTED|Overall Study||203
5267465|NCT00714415|12947700|P2|NOT COMPLETED|Overall Study||0
5267466|NCT00714415|12947701|P1|NOT COMPLETED|Overall Study||2
5267467|NCT00714415|12947700|P2|COMPLETED|Overall Study||55
5267468|NCT00714415|12947701|P1|COMPLETED|Overall Study||23
5267469|NCT00714415|12947700|P2|STARTED|Overall Study||55
5267470|NCT00714415|12947701|P1|STARTED|Overall Study||25
5267471|NCT00714389|12947733|P1|NOT COMPLETED|Overall Study||0
5267472|NCT00714389|12947733|P1|COMPLETED|Overall Study||12
5267473|NCT00714389|12947733|P1|STARTED|Overall Study||12
5267474|NCT00714311|12947740|P2|NOT COMPLETED|Overall Study||22
5267475|NCT00714311|12947741|P1|NOT COMPLETED|Overall Study||13
5267476|NCT00714311|12947740|P2|COMPLETED|Overall Study||30
5267477|NCT00714311|12947741|P1|COMPLETED|Overall Study||39
5267478|NCT00714311|12947740|P2|STARTED|Overall Study||52
5267479|NCT00714311|12947741|P1|STARTED|Overall Study||52
5267480|NCT00714285|12947751|P4|NOT COMPLETED|Overall Study||1
5267481|NCT00714285|12947752|P3|NOT COMPLETED|Overall Study||0
5267482|NCT00714285|12947753|P2|NOT COMPLETED|Overall Study||3
5267483|NCT00714285|12947754|P1|NOT COMPLETED|Overall Study||0
5267484|NCT00714285|12947751|P4|COMPLETED|Overall Study|Completed upto Day 180|104
5267485|NCT00714285|12947752|P3|COMPLETED|Overall Study|Completed upto Day 180|105
5267486|NCT00714285|12947753|P2|COMPLETED|Overall Study|Completed upto Day 180|102
5267487|NCT00714285|12947754|P1|COMPLETED|Overall Study|Completed upto Day 180|105
5267488|NCT00714285|12947751|P4|STARTED|Overall Study||105
5267489|NCT00714285|12947752|P3|STARTED|Overall Study||105
5267490|NCT00714285|12947753|P2|STARTED|Overall Study||105
5267491|NCT00714285|12947754|P1|STARTED|Overall Study||105
5267492|NCT00714259|12947804|P1|NOT COMPLETED|Overall Study||2
5267493|NCT00714259|12947804|P1|COMPLETED|Overall Study||3
5267494|NCT00714259|12947804|P1|STARTED|Overall Study||5
5267495|NCT00714233|12947818|P4|NOT COMPLETED|Overall Study||4
5267496|NCT00714233|12947819|P3|NOT COMPLETED|Overall Study||1
5267497|NCT00714233|12947820|P2|NOT COMPLETED|Overall Study||1
5267498|NCT00714233|12947821|P1|NOT COMPLETED|Overall Study||4
5267499|NCT00714233|12947818|P4|COMPLETED|Overall Study||6
5267500|NCT00714233|12947819|P3|COMPLETED|Overall Study||10
5267501|NCT00714233|12947820|P2|COMPLETED|Overall Study||10
5267502|NCT00714233|12947821|P1|COMPLETED|Overall Study||6
5267503|NCT00714233|12947818|P4|STARTED|Overall Study||10
5267504|NCT00714233|12947819|P3|STARTED|Overall Study||11
5267505|NCT00714233|12947820|P2|STARTED|Overall Study||11
5267506|NCT00714233|12947821|P1|STARTED|Overall Study||10
5267507|NCT00714168|12947850|P2|NOT COMPLETED|Overall Study||59
5267508|NCT00714168|12947851|P1|NOT COMPLETED|Overall Study||44
5267509|NCT00714168|12947850|P2|COMPLETED|Overall Study||139
5267510|NCT00714168|12947851|P1|COMPLETED|Overall Study||121
5267511|NCT00714168|12947850|P2|STARTED|Overall Study||198
5267512|NCT00714168|12947851|P1|STARTED|Overall Study||165
5267513|NCT00714051|12947867|P2|NOT COMPLETED|Overall Study||1
5267514|NCT00714051|12947868|P1|NOT COMPLETED|Overall Study||1
5267515|NCT00714051|12947867|P2|COMPLETED|Overall Study||27
5267516|NCT00714051|12947868|P1|COMPLETED|Overall Study||26
5267517|NCT00714051|12947867|P2|STARTED|Overall Study||28
5267518|NCT00714051|12947868|P1|STARTED|Overall Study||27
5267519|NCT00713830|12947876|P2|NOT COMPLETED|Overall Study||177
5267520|NCT00713830|12947877|P1|NOT COMPLETED|Overall Study||82
5267521|NCT00713830|12947876|P2|COMPLETED|Overall Study||396
5267522|NCT00713830|12947877|P1|COMPLETED|Overall Study||204
5267523|NCT00713830|12947876|P2|Subgroup for Standardized Meal Test|Overall Study||313
5267524|NCT00713830|12947877|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
5267525|NCT00713830|12947876|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
5267526|NCT00713830|12947877|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
5267527|NCT00713830|12947876|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
5267528|NCT00713830|12947877|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
5267529|NCT00713830|12947876|P2|STARTED|Overall Study||573
5267530|NCT00713830|12947877|P1|STARTED|Overall Study|Randomized.|286
5267531|NCT00713817|12947915|P2|NOT COMPLETED|Overall Study||0
5267532|NCT00713817|12947916|P1|NOT COMPLETED|Overall Study||0
5267533|NCT00713817|12947915|P2|COMPLETED|Overall Study||9
5267534|NCT00713817|12947916|P1|COMPLETED|Overall Study||10
5267535|NCT00713817|12947915|P2|STARTED|Overall Study||9
5267536|NCT00713817|12947916|P1|STARTED|Overall Study||10
5267537|NCT00713700|12947934|P1|NOT COMPLETED|Overall Study||4
5267538|NCT00713700|12947934|P1|COMPLETED|Overall Study||188
5267539|NCT00713700|12947934|P1|STARTED|Overall Study||192
5267540|NCT00713661|12947943|P4|NOT COMPLETED|Overall Study||0
5267541|NCT00713661|12947944|P3|NOT COMPLETED|Overall Study||0
5267542|NCT00713661|12947945|P2|NOT COMPLETED|Overall Study||0
5267543|NCT00713661|12947946|P1|NOT COMPLETED|Overall Study||0
5267544|NCT00713661|12947943|P4|COMPLETED|Overall Study||5
5267545|NCT00713661|12947944|P3|COMPLETED|Overall Study||4
5267546|NCT00713661|12947945|P2|COMPLETED|Overall Study||9
5267547|NCT00713661|12947946|P1|COMPLETED|Overall Study||7
5267548|NCT00713661|12947943|P4|STARTED|Overall Study||5
5267549|NCT00713661|12947944|P3|STARTED|Overall Study||4
5267550|NCT00713661|12947945|P2|STARTED|Overall Study||9
5267551|NCT00713661|12947946|P1|STARTED|Overall Study||7
5267552|NCT00713648|12947960|P1|NOT COMPLETED|Overall Study||8
5267553|NCT00713648|12947960|P1|COMPLETED|Overall Study||33
5267554|NCT00713648|12947960|P1|STARTED|Overall Study||41
5267555|NCT00713609|12947973|P6|NOT COMPLETED|Overall Study||8
5267556|NCT00713609|12947974|P5|NOT COMPLETED|Overall Study||19
5267557|NCT00713609|12947975|P4|NOT COMPLETED|Overall Study||9
5267558|NCT00713609|12947976|P3|NOT COMPLETED|Overall Study||15
5267559|NCT00713609|12947977|P2|NOT COMPLETED|Overall Study||15
5267560|NCT00713609|12947978|P1|NOT COMPLETED|Overall Study||21
5267561|NCT00713609|12947973|P6|COMPLETED|Overall Study||47
5267562|NCT00713609|12947974|P5|COMPLETED|Overall Study||87
5267563|NCT00713609|12947975|P4|COMPLETED|Overall Study||99
5267564|NCT00713609|12947976|P3|COMPLETED|Overall Study||92
5267565|NCT00713609|12947977|P2|COMPLETED|Overall Study||90
5267566|NCT00713609|12947978|P1|COMPLETED|Overall Study||85
5267567|NCT00713609|12947973|P6|STARTED|Overall Study||55
5267568|NCT00713609|12947974|P5|STARTED|Overall Study||106
5267569|NCT00713609|12947975|P4|STARTED|Overall Study||108
5267570|NCT00713609|12947976|P3|STARTED|Overall Study||107
5267571|NCT00713609|12947977|P2|STARTED|Overall Study||105
5267572|NCT00713609|12947978|P1|STARTED|Overall Study||106
5267573|NCT00713596|12948013|P3|NOT COMPLETED|Overall Study||2
5267574|NCT00713596|12948014|P2|NOT COMPLETED|Overall Study||3
5267575|NCT00713596|12948015|P1|NOT COMPLETED|Overall Study||2
5267576|NCT00713596|12948013|P3|COMPLETED|Overall Study||6
5267577|NCT00713596|12948014|P2|COMPLETED|Overall Study||5
5267578|NCT00713596|12948015|P1|COMPLETED|Overall Study||7
5267579|NCT00713596|12948013|P3|STARTED|Overall Study||8
5267580|NCT00713596|12948014|P2|STARTED|Overall Study||8
5267581|NCT00713596|12948015|P1|STARTED|Overall Study||9
5267582|NCT00713583|12948028|P2|NOT COMPLETED|Overall Study||0
5267583|NCT00713583|12948029|P1|NOT COMPLETED|Overall Study||0
5267584|NCT00713583|12948028|P2|COMPLETED|Overall Study||40
5267585|NCT00713583|12948029|P1|COMPLETED|Overall Study||45
5267586|NCT00713583|12948028|P2|STARTED|Overall Study||40
5267587|NCT00713583|12948029|P1|STARTED|Overall Study||45
5267588|NCT00713544|12948041|P6|NOT COMPLETED|Overall Study||9
5267589|NCT00713544|12948042|P5|NOT COMPLETED|Overall Study||8
5267590|NCT00713544|12948043|P4|NOT COMPLETED|Overall Study||10
5267591|NCT00713544|12948044|P3|NOT COMPLETED|Overall Study||11
5267592|NCT00713544|12948045|P2|NOT COMPLETED|Overall Study||6
5267593|NCT00713544|12948046|P1|NOT COMPLETED|Overall Study||7
5267594|NCT00713544|12948041|P6|COMPLETED|Overall Study||67
5267595|NCT00713544|12948042|P5|COMPLETED|Overall Study||57
5267596|NCT00713544|12948043|P4|COMPLETED|Overall Study||66
5267597|NCT00713544|12948044|P3|COMPLETED|Overall Study||41
5267598|NCT00713544|12948045|P2|COMPLETED|Overall Study||46
5267599|NCT00713544|12948046|P1|COMPLETED|Overall Study||45
5267600|NCT00713544|12948041|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
5267601|NCT00713544|12948042|P5|STARTED|Overall Study||65
5267602|NCT00713544|12948043|P4|STARTED|Overall Study||76
5267603|NCT00713544|12948044|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
5267604|NCT00713544|12948045|P2|STARTED|Overall Study||52
5267605|NCT00713544|12948046|P1|STARTED|Overall Study||52
5267606|NCT00713479|12948084|P2|NOT COMPLETED|Next Medication Condition||0
5267607|NCT00713479|12948085|P1|NOT COMPLETED|Next Medication Condition||0
5267608|NCT00713479|12948084|P2|COMPLETED|Next Medication Condition||6
5267609|NCT00713479|12948085|P1|COMPLETED|Next Medication Condition||2
5267610|NCT00713479|12948084|P2|STARTED|Next Medication Condition||6
5267611|NCT00713479|12948085|P1|STARTED|Next Medication Condition||2
5267612|NCT00713479|12948084|P2|NOT COMPLETED|Washout||0
5267613|NCT00713479|12948085|P1|NOT COMPLETED|Washout||0
5267614|NCT00713479|12948084|P2|COMPLETED|Washout||6
5267615|NCT00713479|12948085|P1|COMPLETED|Washout||2
5267616|NCT00713479|12948084|P2|STARTED|Washout||6
5267617|NCT00713479|12948085|P1|STARTED|Washout||2
5267618|NCT00713479|12948084|P2|NOT COMPLETED|First Medication Condition||0
5267619|NCT00713479|12948085|P1|NOT COMPLETED|First Medication Condition||4
5267620|NCT00713479|12948084|P2|COMPLETED|First Medication Condition||6
5267621|NCT00713479|12948085|P1|COMPLETED|First Medication Condition||2
5267622|NCT00713479|12948084|P2|STARTED|First Medication Condition||6
5267623|NCT00713479|12948085|P1|STARTED|First Medication Condition||6
5267624|NCT00713349|12948097|P1|NOT COMPLETED|Overall Study||1
5267625|NCT00713349|12948097|P1|COMPLETED|Overall Study||24
5267626|NCT00713349|12948097|P1|STARTED|Overall Study||25
5267627|NCT00713323|12948103|P1|NOT COMPLETED|Overall Study||146
5267628|NCT00713323|12948103|P1|COMPLETED|Overall Study||234
5267629|NCT00713323|12948103|P1|STARTED|Overall Study||380
5267630|NCT00713310|12948116|P2|NOT COMPLETED|Overall Study||6
5267631|NCT00713310|12948117|P1|NOT COMPLETED|Overall Study||5
5267632|NCT00713310|12948116|P2|COMPLETED|Overall Study||36
5267633|NCT00713310|12948117|P1|COMPLETED|Overall Study||36
5267634|NCT00713310|12948116|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
5267635|NCT00713310|12948117|P1|mITT Population|Overall Study||41
5267636|NCT00713310|12948116|P2|STARTED|Overall Study||42
5267637|NCT00713310|12948117|P1|STARTED|Overall Study||41
5267638|NCT00713258|12948127|P2|NOT COMPLETED|Overall Study||6
5267639|NCT00713258|12948128|P1|NOT COMPLETED|Overall Study||5
5267640|NCT00713258|12948127|P2|COMPLETED|Overall Study||28
5267641|NCT00713258|12948128|P1|COMPLETED|Overall Study||36
5267642|NCT00713258|12948127|P2|STARTED|Overall Study||34
5267643|NCT00713258|12948128|P1|STARTED|Overall Study||41
5267644|NCT00713219|12948136|P1|NOT COMPLETED|Overall Study||2
5267645|NCT00713219|12948136|P1|COMPLETED|Overall Study||12
5267646|NCT00713219|12948136|P1|STARTED|Overall Study||14
5267647|NCT00713206|12948142|P2|NOT COMPLETED|Overall Study||3
5267648|NCT00713206|12948143|P1|NOT COMPLETED|Overall Study||7
5267649|NCT00713206|12948142|P2|COMPLETED|Overall Study||27
5267650|NCT00713206|12948143|P1|COMPLETED|Overall Study||55
5267651|NCT00713206|12948142|P2|STARTED|Overall Study||30
5267652|NCT00713206|12948143|P1|STARTED|Overall Study||62
5267653|NCT00712985|12948149|P1|NOT COMPLETED|Overall Study||5
5267654|NCT00712985|12948149|P1|COMPLETED|Overall Study||13
5267655|NCT00712985|12948149|P1|STARTED|Overall Study||18
5267656|NCT00712959|12948155|P2|NOT COMPLETED|Overall Study||3
5267657|NCT00712959|12948156|P1|NOT COMPLETED|Overall Study||19
5267658|NCT00712959|12948155|P2|COMPLETED|Overall Study||404
5267659|NCT00712959|12948156|P1|COMPLETED|Overall Study||342
5267660|NCT00712959|12948155|P2|STARTED|Overall Study||407
5267661|NCT00712959|12948156|P1|STARTED|Overall Study||361
5267662|NCT00712933|12948174|P1|NOT COMPLETED|Overall Study||367
5267663|NCT00712933|12948174|P1|COMPLETED|Overall Study||368
5267664|NCT00712933|12948174|P1|STARTED|Overall Study||735
5267665|NCT00712920|12948204|P3|NOT COMPLETED|Overall Study||12
5267666|NCT00712920|12948205|P2|NOT COMPLETED|Overall Study||17
5267667|NCT00712920|12948206|P1|NOT COMPLETED|Overall Study||17
5267668|NCT00712920|12948204|P3|COMPLETED|Overall Study||180
5267669|NCT00712920|12948205|P2|COMPLETED|Overall Study||180
5267670|NCT00712920|12948206|P1|COMPLETED|Overall Study||175
5267671|NCT00712920|12948204|P3|STARTED|Overall Study||192
5267672|NCT00712920|12948205|P2|STARTED|Overall Study|3 subjects were randomized in error|197
5267673|NCT00712920|12948206|P1|STARTED|Overall Study||192
5267674|NCT00712725|12948234|P8|NOT COMPLETED|Overall Study||11
5267675|NCT00712725|12948235|P7|NOT COMPLETED|Overall Study||22
5267676|NCT00712725|12948236|P6|NOT COMPLETED|Overall Study||16
5267677|NCT00712725|12948237|P5|NOT COMPLETED|Overall Study||19
5267678|NCT00712725|12948238|P4|NOT COMPLETED|Overall Study||17
5267679|NCT00712725|12948239|P3|NOT COMPLETED|Overall Study||10
5267680|NCT00712725|12948240|P2|NOT COMPLETED|Overall Study||6
5267681|NCT00712725|12948241|P1|NOT COMPLETED|Overall Study||29
5267682|NCT00712725|12948234|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
5267683|NCT00712725|12948235|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
5267684|NCT00712725|12948236|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
5267685|NCT00712725|12948237|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
5267686|NCT00712725|12948238|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
5267687|NCT00712725|12948239|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
5267688|NCT00712725|12948240|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
5267689|NCT00712725|12948241|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
5267690|NCT00712725|12948234|P8|STARTED|Overall Study||74
5267691|NCT00712725|12948235|P7|STARTED|Overall Study||83
5267692|NCT00712725|12948236|P6|STARTED|Overall Study||84
5267693|NCT00712725|12948237|P5|STARTED|Overall Study||86
5267694|NCT00712725|12948238|P4|STARTED|Overall Study||84
5267695|NCT00712725|12948239|P3|STARTED|Overall Study||57
5267696|NCT00712725|12948240|P2|STARTED|Overall Study||39
5267697|NCT00712725|12948241|P1|STARTED|Overall Study||169
5267698|NCT00712673|12948302|P4|NOT COMPLETED|Overall Study||70
5267699|NCT00712673|12948303|P3|NOT COMPLETED|Overall Study||57
5267700|NCT00712673|12948304|P2|NOT COMPLETED|Overall Study||21
5267701|NCT00712673|12948305|P1|NOT COMPLETED|Overall Study||21
5267702|NCT00712673|12948302|P4|COMPLETED|Overall Study||185
5267703|NCT00712673|12948303|P3|COMPLETED|Overall Study||198
5267704|NCT00712673|12948304|P2|COMPLETED|Overall Study||64
5267705|NCT00712673|12948305|P1|COMPLETED|Overall Study||64
5267706|NCT00712673|12948302|P4|Subgroup for Standardized Meal Test|Overall Study||0
5267707|NCT00712673|12948303|P3|Subgroup for Standardized Meal Test|Overall Study||255
5267708|NCT00712673|12948304|P2|Subgroup for Standardized Meal Test|Overall Study||0
5267709|NCT00712673|12948305|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
5267710|NCT00712673|12948302|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
5267711|NCT00712673|12948303|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
5267712|NCT00712673|12948304|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
5267713|NCT00712673|12948305|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
5267714|NCT00712673|12948302|P4|Safety Population|Overall Study||255
5267715|NCT00712673|12948303|P3|Safety Population|Overall Study||255
5267716|NCT00712673|12948304|P2|Safety Population|Overall Study||85
5267809|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||1
5267717|NCT00712673|12948305|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
5267718|NCT00712673|12948302|P4|STARTED|Overall Study||255
5267719|NCT00712673|12948303|P3|STARTED|Overall Study||255
5267720|NCT00712673|12948304|P2|STARTED|Overall Study||85
5267721|NCT00712673|12948305|P1|STARTED|Overall Study|Randomized.|85
5267722|NCT00712543|12948369|P2|NOT COMPLETED|Day 8-14||2
5267723|NCT00712543|12948370|P1|NOT COMPLETED|Day 8-14||0
5267724|NCT00712543|12948369|P2|COMPLETED|Day 8-14||25
5267725|NCT00712543|12948370|P1|COMPLETED|Day 8-14||23
5267726|NCT00712543|12948369|P2|STARTED|Day 8-14||27
5267727|NCT00712543|12948370|P1|STARTED|Day 8-14||23
5267728|NCT00712543|12948369|P2|NOT COMPLETED|Day 1-7||0
5267729|NCT00712543|12948370|P1|NOT COMPLETED|Day 1-7||0
5267730|NCT00712543|12948369|P2|COMPLETED|Day 1-7||27
5267731|NCT00712543|12948370|P1|COMPLETED|Day 1-7||23
5267732|NCT00712543|12948369|P2|STARTED|Day 1-7||27
5267733|NCT00712543|12948370|P1|STARTED|Day 1-7||23
5267734|NCT00712530|12948379|P3|NOT COMPLETED|Overall Study||0
5267735|NCT00712530|12948380|P2|NOT COMPLETED|Overall Study||0
5267736|NCT00712530|12948381|P1|NOT COMPLETED|Overall Study||0
5267737|NCT00712530|12948379|P3|COMPLETED|Overall Study||3
5267738|NCT00712530|12948380|P2|COMPLETED|Overall Study||3
5267739|NCT00712530|12948381|P1|COMPLETED|Overall Study||3
5267740|NCT00712530|12948379|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
5267741|NCT00712530|12948380|P2|STARTED|Overall Study||3
5267742|NCT00712530|12948381|P1|STARTED|Overall Study||3
5267743|NCT00712348|12948404|P1|NOT COMPLETED|Overall Study||1
5267744|NCT00712348|12948404|P1|COMPLETED|Overall Study||30
5267745|NCT00712348|12948404|P1|STARTED|Overall Study||31
5267746|NCT00712335|12948416|P5|NOT COMPLETED|Overall Study||0
5267747|NCT00712335|12948417|P4|NOT COMPLETED|Overall Study||5
5267748|NCT00712335|12948418|P3|NOT COMPLETED|Overall Study||5
5267749|NCT00712335|12948419|P2|NOT COMPLETED|Overall Study||17
5267750|NCT00712335|12948420|P1|NOT COMPLETED|Overall Study||3
5267751|NCT00712335|12948416|P5|COMPLETED|Overall Study||30
5267752|NCT00712335|12948417|P4|COMPLETED|Overall Study||19
5267753|NCT00712335|12948418|P3|COMPLETED|Overall Study||6
5267754|NCT00712335|12948419|P2|COMPLETED|Overall Study||15
5267755|NCT00712335|12948420|P1|COMPLETED|Overall Study||5
5267756|NCT00712335|12948416|P5|STARTED|Overall Study||30
5267757|NCT00712335|12948417|P4|STARTED|Overall Study||24
5267758|NCT00712335|12948418|P3|STARTED|Overall Study||11
5267759|NCT00712335|12948419|P2|STARTED|Overall Study||32
5267760|NCT00712335|12948420|P1|STARTED|Overall Study||8
5267761|NCT00712270|12948465|P1|NOT COMPLETED|Overall Study||14
5267762|NCT00712270|12948465|P1|COMPLETED|Overall Study||7
5267763|NCT00712270|12948465|P1|STARTED|Overall Study||21
5267764|NCT00712244|12948478|P4|NOT COMPLETED|Overall Study||1
5267765|NCT00712244|12948479|P3|NOT COMPLETED|Overall Study||2
5267766|NCT00712244|12948480|P2|NOT COMPLETED|Overall Study||1
5267767|NCT00712244|12948481|P1|NOT COMPLETED|Overall Study||4
5267768|NCT00712244|12948478|P4|COMPLETED|Overall Study||26
5267769|NCT00712244|12948479|P3|COMPLETED|Overall Study||25
5267770|NCT00712244|12948480|P2|COMPLETED|Overall Study||28
5267771|NCT00712244|12948481|P1|COMPLETED|Overall Study||25
5267772|NCT00712244|12948478|P4|STARTED|Overall Study||27
5267773|NCT00712244|12948479|P3|STARTED|Overall Study||27
5267774|NCT00712244|12948480|P2|STARTED|Overall Study||29
5267775|NCT00712244|12948481|P1|STARTED|Overall Study||29
5267776|NCT00712179|12948523|P1|NOT COMPLETED|Overall Study||12
5267777|NCT00712179|12948523|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
5267778|NCT00712179|12948523|P1|STARTED|Overall Study||49
5267779|NCT00712166|12948529|P2|NOT COMPLETED|Overall Study||1
5267780|NCT00712166|12948530|P1|NOT COMPLETED|Overall Study||0
5267781|NCT00712166|12948529|P2|COMPLETED|Overall Study||75
5267782|NCT00712166|12948530|P1|COMPLETED|Overall Study||81
5267783|NCT00712166|12948529|P2|STARTED|Overall Study||76
5267784|NCT00712166|12948530|P1|STARTED|Overall Study||81
5267785|NCT00712075|12948557|P3|NOT COMPLETED|Overall Study||11
5267786|NCT00712075|12948558|P2|NOT COMPLETED|Overall Study||4
5267787|NCT00712075|12948559|P1|NOT COMPLETED|Overall Study||5
5267788|NCT00712075|12948557|P3|COMPLETED|Overall Study||14
5267789|NCT00712075|12948558|P2|COMPLETED|Overall Study||26
5267790|NCT00712075|12948559|P1|COMPLETED|Overall Study||17
5267791|NCT00712075|12948557|P3|STARTED|Overall Study||25
5267792|NCT00712075|12948558|P2|STARTED|Overall Study||30
5267793|NCT00712075|12948559|P1|STARTED|Overall Study||22
5267794|NCT00712010|12948573|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
5267795|NCT00712010|12948573|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
5267796|NCT00712010|12948573|P1|STARTED|7th and Last Protein Testing (1 Day)||23
5267797|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||0
5267798|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||23
5267799|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||23
5267800|NCT00712010|12948573|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
5267801|NCT00712010|12948573|P1|COMPLETED|6th Protein Testing (1 Day)||23
5267802|NCT00712010|12948573|P1|STARTED|6th Protein Testing (1 Day)||23
5267803|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||0
5267804|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||23
5267805|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||23
5267806|NCT00712010|12948573|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
5267807|NCT00712010|12948573|P1|COMPLETED|5th Protein Testing (1 Day)||23
5267808|NCT00712010|12948573|P1|STARTED|5th Protein Testing (1 Day)||23
5267810|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||23
5267811|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||24
5267812|NCT00712010|12948573|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
5267813|NCT00712010|12948573|P1|COMPLETED|4th Protein Testing (1 Day)||24
5267814|NCT00712010|12948573|P1|STARTED|4th Protein Testing (1 Day)||24
5267815|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||0
5267816|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||24
5267817|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||24
5267818|NCT00712010|12948573|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
5267819|NCT00712010|12948573|P1|COMPLETED|3rd Protein Testing (1 Day)||24
5267820|NCT00712010|12948573|P1|STARTED|3rd Protein Testing (1 Day)||24
5267821|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||0
5267822|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||24
5267823|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||24
5267824|NCT00712010|12948573|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
5267825|NCT00712010|12948573|P1|COMPLETED|2nd Protein Testing (1 Day)||24
5267826|NCT00712010|12948573|P1|STARTED|2nd Protein Testing (1 Day)||24
5267827|NCT00712010|12948573|P1|NOT COMPLETED|Washout (7 Days)||0
5267828|NCT00712010|12948573|P1|COMPLETED|Washout (7 Days)||24
5267829|NCT00712010|12948573|P1|STARTED|Washout (7 Days)||24
5267830|NCT00712010|12948573|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
5267831|NCT00712010|12948573|P1|COMPLETED|1st Protein Testing (1 Day)||24
5267832|NCT00712010|12948573|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
5267833|NCT00711997|12948598|P2|NOT COMPLETED|Overall Study||0
5267834|NCT00711997|12948599|P1|NOT COMPLETED|Overall Study||0
5267835|NCT00711997|12948598|P2|COMPLETED|Overall Study||6
5267836|NCT00711997|12948599|P1|COMPLETED|Overall Study||3
5267837|NCT00711997|12948598|P2|STARTED|Overall Study||6
5267838|NCT00711997|12948599|P1|STARTED|Overall Study||3
5267839|NCT00711971|12948612|P3|NOT COMPLETED|Overall Study||1
5267840|NCT00711971|12948613|P2|NOT COMPLETED|Overall Study||4
5267841|NCT00711971|12948614|P1|NOT COMPLETED|Overall Study||3
5267842|NCT00711971|12948612|P3|COMPLETED|Overall Study||41
5267843|NCT00711971|12948613|P2|COMPLETED|Overall Study||38
5267844|NCT00711971|12948614|P1|COMPLETED|Overall Study||39
5267845|NCT00711971|12948612|P3|STARTED|Overall Study||42
5267846|NCT00711971|12948613|P2|STARTED|Overall Study||42
5267847|NCT00711971|12948614|P1|STARTED|Overall Study||42
5267848|NCT00711958|12948648|P2|NOT COMPLETED|Overall Study||23
5267849|NCT00711958|12948649|P1|NOT COMPLETED|Overall Study||33
5267850|NCT00711958|12948648|P2|COMPLETED|Overall Study||17
5267851|NCT00711958|12948649|P1|COMPLETED|Overall Study||41
5267852|NCT00711958|12948648|P2|STARTED|Overall Study||40
5267853|NCT00711958|12948649|P1|STARTED|Overall Study||74
5267854|NCT00711880|12948657|P2|NOT COMPLETED|Overall Study||7
5267855|NCT00711880|12948658|P1|NOT COMPLETED|Overall Study||13
5267856|NCT00711880|12948657|P2|COMPLETED|Overall Study||55
5267857|NCT00711880|12948658|P1|COMPLETED|Overall Study||50
5267858|NCT00711880|12948657|P2|STARTED|Overall Study||62
5267859|NCT00711880|12948658|P1|STARTED|Overall Study||63
5267860|NCT00711867|12948696|P2|NOT COMPLETED|Overall Study||4
5267861|NCT00711867|12948697|P1|NOT COMPLETED|Overall Study||5
5267862|NCT00711867|12948696|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
5267863|NCT00711867|12948697|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
5267864|NCT00711867|12948696|P2|STARTED|Overall Study||25
5267865|NCT00711867|12948697|P1|STARTED|Overall Study||30
5267866|NCT00711828|12948703|P1|NOT COMPLETED|Overall Study||0
5267867|NCT00711828|12948703|P1|COMPLETED|Overall Study||21
5267868|NCT00711828|12948703|P1|STARTED|Overall Study||21
5267869|NCT00711802|12948720|P8|NOT COMPLETED|Overall Study||2
5267870|NCT00711802|12948721|P7|NOT COMPLETED|Overall Study||5
5267871|NCT00711802|12948722|P6|NOT COMPLETED|Overall Study||8
5267872|NCT00711802|12948723|P5|NOT COMPLETED|Overall Study||14
5267873|NCT00711802|12948724|P4|NOT COMPLETED|Overall Study||3
5267874|NCT00711802|12948725|P3|NOT COMPLETED|Overall Study||6
5267875|NCT00711802|12948726|P2|NOT COMPLETED|Overall Study||6
5267876|NCT00711802|12948727|P1|NOT COMPLETED|Overall Study||2
5267877|NCT00711802|12948720|P8|COMPLETED|Overall Study||13
5267878|NCT00711802|12948721|P7|COMPLETED|Overall Study||25
5267879|NCT00711802|12948722|P6|COMPLETED|Overall Study||34
5267880|NCT00711802|12948723|P5|COMPLETED|Overall Study||69
5267881|NCT00711802|12948724|P4|COMPLETED|Overall Study||35
5267882|NCT00711802|12948725|P3|COMPLETED|Overall Study||69
5267883|NCT00711802|12948726|P2|COMPLETED|Overall Study||32
5267884|NCT00711802|12948727|P1|COMPLETED|Overall Study||73
5267885|NCT00711802|12948720|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
5267886|NCT00711802|12948721|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
5267887|NCT00711802|12948722|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
5267888|NCT00711802|12948723|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
5267889|NCT00711802|12948724|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
5267890|NCT00711802|12948725|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
5267891|NCT00711802|12948726|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
5267892|NCT00711802|12948727|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
5267893|NCT00711802|12948720|P8|STARTED|Overall Study||15
5267894|NCT00711802|12948721|P7|STARTED|Overall Study||30
5267895|NCT00711802|12948722|P6|STARTED|Overall Study||42
5267896|NCT00711802|12948723|P5|STARTED|Overall Study||83
5267897|NCT00711802|12948724|P4|STARTED|Overall Study||38
5267898|NCT00711802|12948725|P3|STARTED|Overall Study||75
5267899|NCT00711802|12948726|P2|STARTED|Overall Study||38
5267900|NCT00711802|12948727|P1|STARTED|Overall Study||75
5267901|NCT00711711|12948759|P2|NOT COMPLETED|Overall Study||6
5267902|NCT00711711|12948760|P1|NOT COMPLETED|Overall Study||1
5267903|NCT00711711|12948759|P2|COMPLETED|Overall Study||24
5267904|NCT00711711|12948760|P1|COMPLETED|Overall Study||29
5267905|NCT00711711|12948759|P2|Seventh Postsurgical Day|Overall Study||27
5267906|NCT00711711|12948760|P1|Seventh Postsurgical Day|Overall Study||29
5267907|NCT00711711|12948759|P2|Second Postsurgical Day|Overall Study||30
5267908|NCT00711711|12948760|P1|Second Postsurgical Day|Overall Study||30
5267909|NCT00711711|12948759|P2|STARTED|Overall Study||30
5267910|NCT00711711|12948760|P1|STARTED|Overall Study||30
5267911|NCT00711646|12948770|P2|NOT COMPLETED|Overall Study||3
5267912|NCT00711646|12948771|P1|NOT COMPLETED|Overall Study||12
5267913|NCT00711646|12948770|P2|COMPLETED|Overall Study||62
5267914|NCT00711646|12948771|P1|COMPLETED|Overall Study||112
5267915|NCT00711646|12948770|P2|STARTED|Overall Study||65
5267916|NCT00711646|12948771|P1|STARTED|Overall Study||124
5267917|NCT00711594|12948793|P4|NOT COMPLETED|Overall Study||62
5267918|NCT00711594|12948794|P3|NOT COMPLETED|Overall Study||6
5267919|NCT00711594|12948795|P2|NOT COMPLETED|Overall Study||3
5267920|NCT00711594|12948796|P1|NOT COMPLETED|Overall Study||3
5267921|NCT00711594|12948793|P4|COMPLETED|Overall Study||0
5267922|NCT00711594|12948794|P3|COMPLETED|Overall Study||0
5267923|NCT00711594|12948795|P2|COMPLETED|Overall Study||0
5267924|NCT00711594|12948796|P1|COMPLETED|Overall Study||0
5267925|NCT00711594|12948793|P4|STARTED|Overall Study||62
5267926|NCT00711594|12948794|P3|STARTED|Overall Study||6
5267927|NCT00711594|12948795|P2|STARTED|Overall Study||3
5267928|NCT00711594|12948796|P1|STARTED|Overall Study||3
5267929|NCT00711555|12948833|P1|NOT COMPLETED|Overall Study||3
5267930|NCT00711555|12948833|P1|COMPLETED|Overall Study||19
5267931|NCT00711555|12948833|P1|STARTED|Overall Study||22
5267932|NCT00711529|12948842|P2|NOT COMPLETED|Overall Study||6
5267933|NCT00711529|12948843|P1|NOT COMPLETED|Overall Study||4
5267934|NCT00711529|12948842|P2|COMPLETED|Overall Study||8
5267935|NCT00711529|12948843|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
5267936|NCT00711529|12948842|P2|STARTED|Overall Study||14
5267937|NCT00711529|12948843|P1|STARTED|Overall Study||13
5267938|NCT00711516|12948867|P2|NOT COMPLETED|Overall Study||3
5267939|NCT00711516|12948868|P1|NOT COMPLETED|Overall Study||1
5267940|NCT00711516|12948867|P2|COMPLETED|Overall Study||16
5267941|NCT00711516|12948868|P1|COMPLETED|Overall Study||20
5267942|NCT00711516|12948867|P2|STARTED|Overall Study||19
5267943|NCT00711516|12948868|P1|STARTED|Overall Study||21
5267944|NCT00711490|12948962|P1|NOT COMPLETED|Overall Study||0
5267945|NCT00711490|12948962|P1|COMPLETED|Overall Study||5
5267946|NCT00711490|12948962|P1|STARTED|Overall Study||5
5267947|NCT00711477|12948975|P2|NOT COMPLETED|Overall Study||3
5267948|NCT00711477|12948976|P1|NOT COMPLETED|Overall Study||3
5267949|NCT00711477|12948975|P2|COMPLETED|Overall Study||20
5267950|NCT00711477|12948976|P1|COMPLETED|Overall Study||20
5267951|NCT00711477|12948975|P2|STARTED|Overall Study||23
5267952|NCT00711477|12948976|P1|STARTED|Overall Study||23
5267953|NCT00711464|12949004|P1|NOT COMPLETED|Overall Study||0
5267954|NCT00711464|12949004|P1|COMPLETED|Overall Study||29
5267955|NCT00711464|12949004|P1|STARTED|Overall Study||29
5267956|NCT00711425|12949022|P1|NOT COMPLETED|Overall Study||4
5267957|NCT00711425|12949022|P1|COMPLETED|Overall Study||41
5267958|NCT00711425|12949022|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
5267959|NCT00711412|12949028|P1|NOT COMPLETED|Survival Follow up Until Death||12
5267960|NCT00711412|12949028|P1|COMPLETED|Survival Follow up Until Death||26
5267961|NCT00711412|12949028|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
5267962|NCT00711412|12949028|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
5267963|NCT00711412|12949028|P1|COMPLETED|Evaluation for Response and Surgery||28
5267964|NCT00711412|12949028|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
5267965|NCT00711412|12949028|P1|NOT COMPLETED|Combination Treatment||1
5267966|NCT00711412|12949028|P1|COMPLETED|Combination Treatment||33
5267967|NCT00711412|12949028|P1|STARTED|Combination Treatment||34
5267968|NCT00711412|12949028|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
5267969|NCT00711412|12949028|P1|COMPLETED|Evaluated for Combination Treatment||34
5267970|NCT00711412|12949028|P1|STARTED|Evaluated for Combination Treatment||40
5267971|NCT00711412|12949028|P1|NOT COMPLETED|Induction Treatment||4
5267972|NCT00711412|12949028|P1|COMPLETED|Induction Treatment||40
5267973|NCT00711412|12949028|P1|Started Induction Treatment|Induction Treatment||43
5267974|NCT00711412|12949028|P1|Registered to Study|Induction Treatment||44
5267975|NCT00711412|12949028|P1|STARTED|Induction Treatment||44
5267976|NCT00711347|12949042|P2|NOT COMPLETED|Overall Study||0
5267977|NCT00711347|12949043|P1|NOT COMPLETED|Overall Study||0
5267978|NCT00711347|12949042|P2|COMPLETED|Overall Study||14
5267979|NCT00711347|12949043|P1|COMPLETED|Overall Study||14
5267980|NCT00711347|12949042|P2|STARTED|Overall Study||14
5267981|NCT00711347|12949043|P1|STARTED|Overall Study||14
5267982|NCT00711269|12949063|P4|NOT COMPLETED|Overall Study||14
5267983|NCT00711269|12949064|P3|NOT COMPLETED|Overall Study||50
5267984|NCT00711269|12949065|P2|NOT COMPLETED|Overall Study||48
5267985|NCT00711269|12949066|P1|NOT COMPLETED|Overall Study||44
5267986|NCT00711269|12949063|P4|COMPLETED|Overall Study||51
5267987|NCT00711269|12949064|P3|COMPLETED|Overall Study||83
5267988|NCT00711269|12949065|P2|COMPLETED|Overall Study||83
5267989|NCT00711269|12949066|P1|COMPLETED|Overall Study||87
5267990|NCT00711269|12949063|P4|STARTED|Overall Study||65
5267991|NCT00711269|12949064|P3|STARTED|Overall Study||133
5267992|NCT00711269|12949065|P2|STARTED|Overall Study||131
5267993|NCT00711269|12949066|P1|STARTED|Overall Study||131
5267994|NCT00711243|12949106|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
5267995|NCT00711243|12949107|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
5267996|NCT00711243|12949108|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
5267997|NCT00711243|12949109|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
5267998|NCT00711243|12949110|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
5267999|NCT00711243|12949111|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
5268000|NCT00711243|12949106|P6|COMPLETED|Follow up Every 3 Months Until Death||37
5268001|NCT00711243|12949107|P5|COMPLETED|Follow up Every 3 Months Until Death||3
5268002|NCT00711243|12949108|P4|COMPLETED|Follow up Every 3 Months Until Death||3
5268003|NCT00711243|12949109|P3|COMPLETED|Follow up Every 3 Months Until Death||3
5268004|NCT00711243|12949110|P2|COMPLETED|Follow up Every 3 Months Until Death||3
5268005|NCT00711243|12949111|P1|COMPLETED|Follow up Every 3 Months Until Death||3
5268006|NCT00711243|12949106|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
5268007|NCT00711243|12949107|P5|STARTED|Follow up Every 3 Months Until Death||3
5268008|NCT00711243|12949108|P4|STARTED|Follow up Every 3 Months Until Death||3
5268009|NCT00711243|12949109|P3|STARTED|Follow up Every 3 Months Until Death||3
5268010|NCT00711243|12949110|P2|STARTED|Follow up Every 3 Months Until Death||3
5268011|NCT00711243|12949111|P1|STARTED|Follow up Every 3 Months Until Death||3
5268012|NCT00711243|12949106|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
5268013|NCT00711243|12949107|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
5268014|NCT00711243|12949108|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
5268015|NCT00711243|12949109|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
5268016|NCT00711243|12949110|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
5268017|NCT00711243|12949111|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
5268018|NCT00711243|12949106|P6|COMPLETED|Treated Cycle 5 After First Response||37
5268019|NCT00711243|12949107|P5|COMPLETED|Treated Cycle 5 After First Response||2
5268020|NCT00711243|12949108|P4|COMPLETED|Treated Cycle 5 After First Response||2
5268021|NCT00711243|12949109|P3|COMPLETED|Treated Cycle 5 After First Response||3
5268022|NCT00711243|12949110|P2|COMPLETED|Treated Cycle 5 After First Response||1
5268023|NCT00711243|12949111|P1|COMPLETED|Treated Cycle 5 After First Response||2
5268024|NCT00711243|12949106|P6|STARTED|Treated Cycle 5 After First Response||41
5268025|NCT00711243|12949107|P5|STARTED|Treated Cycle 5 After First Response||3
5268026|NCT00711243|12949108|P4|STARTED|Treated Cycle 5 After First Response||2
5268027|NCT00711243|12949109|P3|STARTED|Treated Cycle 5 After First Response||3
5268028|NCT00711243|12949110|P2|STARTED|Treated Cycle 5 After First Response||3
5268029|NCT00711243|12949111|P1|STARTED|Treated Cycle 5 After First Response||3
5268030|NCT00711243|12949106|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
5268031|NCT00711243|12949107|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
5268032|NCT00711243|12949108|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
5268033|NCT00711243|12949109|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
5268034|NCT00711243|12949110|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
5268035|NCT00711243|12949111|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
5268036|NCT00711243|12949106|P6|COMPLETED|Reached First Response/4 Cycles||41
5268037|NCT00711243|12949107|P5|COMPLETED|Reached First Response/4 Cycles||3
5268038|NCT00711243|12949108|P4|COMPLETED|Reached First Response/4 Cycles||2
5268039|NCT00711243|12949109|P3|COMPLETED|Reached First Response/4 Cycles||3
5268040|NCT00711243|12949110|P2|COMPLETED|Reached First Response/4 Cycles||3
5268041|NCT00711243|12949111|P1|COMPLETED|Reached First Response/4 Cycles||3
5268042|NCT00711243|12949106|P6|STARTED|Reached First Response/4 Cycles||43
5268043|NCT00711243|12949107|P5|STARTED|Reached First Response/4 Cycles||3
5268044|NCT00711243|12949108|P4|STARTED|Reached First Response/4 Cycles||3
5268045|NCT00711243|12949109|P3|STARTED|Reached First Response/4 Cycles||3
5268046|NCT00711243|12949110|P2|STARTED|Reached First Response/4 Cycles||3
5268047|NCT00711243|12949111|P1|STARTED|Reached First Response/4 Cycles||3
5268048|NCT00711243|12949106|P6|NOT COMPLETED|Registed and Started Treatment||1
5268049|NCT00711243|12949107|P5|NOT COMPLETED|Registed and Started Treatment||0
5268050|NCT00711243|12949108|P4|NOT COMPLETED|Registed and Started Treatment||0
5268051|NCT00711243|12949109|P3|NOT COMPLETED|Registed and Started Treatment||0
5268052|NCT00711243|12949110|P2|NOT COMPLETED|Registed and Started Treatment||0
5268053|NCT00711243|12949111|P1|NOT COMPLETED|Registed and Started Treatment||0
5268054|NCT00711243|12949106|P6|COMPLETED|Registed and Started Treatment||43
5268055|NCT00711243|12949107|P5|COMPLETED|Registed and Started Treatment||3
5268056|NCT00711243|12949108|P4|COMPLETED|Registed and Started Treatment||3
5268057|NCT00711243|12949109|P3|COMPLETED|Registed and Started Treatment||3
5268058|NCT00711243|12949110|P2|COMPLETED|Registed and Started Treatment||3
5268059|NCT00711243|12949111|P1|COMPLETED|Registed and Started Treatment||3
5268060|NCT00711243|12949106|P6|Started Treatment|Registed and Started Treatment||43
5268061|NCT00711243|12949107|P5|Started Treatment|Registed and Started Treatment||3
5268062|NCT00711243|12949108|P4|Started Treatment|Registed and Started Treatment||3
5268063|NCT00711243|12949109|P3|Started Treatment|Registed and Started Treatment||3
5268064|NCT00711243|12949110|P2|Started Treatment|Registed and Started Treatment||3
5268065|NCT00711243|12949111|P1|Started Treatment|Registed and Started Treatment||3
5268066|NCT00711243|12949106|P6|Registered to Study|Registed and Started Treatment||44
5268067|NCT00711243|12949107|P5|Registered to Study|Registed and Started Treatment||3
5268068|NCT00711243|12949108|P4|Registered to Study|Registed and Started Treatment||3
5268069|NCT00711243|12949109|P3|Registered to Study|Registed and Started Treatment||3
5268070|NCT00711243|12949110|P2|Registered to Study|Registed and Started Treatment||3
5268071|NCT00711243|12949111|P1|Registered to Study|Registed and Started Treatment||3
5268072|NCT00711243|12949106|P6|STARTED|Registed and Started Treatment||44
5268073|NCT00711243|12949107|P5|STARTED|Registed and Started Treatment||3
5268074|NCT00711243|12949108|P4|STARTED|Registed and Started Treatment||3
5268075|NCT00711243|12949109|P3|STARTED|Registed and Started Treatment||3
5268076|NCT00711243|12949110|P2|STARTED|Registed and Started Treatment||3
5268077|NCT00711243|12949111|P1|STARTED|Registed and Started Treatment||3
5268078|NCT00711191|12949134|P3|NOT COMPLETED|Overall Study||12
5268079|NCT00711191|12949135|P2|NOT COMPLETED|Overall Study||5
5268080|NCT00711191|12949136|P1|NOT COMPLETED|Overall Study||3
5268081|NCT00711191|12949134|P3|COMPLETED|Overall Study||1
5268082|NCT00711191|12949135|P2|COMPLETED|Overall Study||1
5268083|NCT00711191|12949136|P1|COMPLETED|Overall Study||0
5268084|NCT00711191|12949134|P3|STARTED|Overall Study||13
5268085|NCT00711191|12949135|P2|STARTED|Overall Study||6
5268086|NCT00711191|12949136|P1|STARTED|Overall Study||3
5268087|NCT00711113|12949173|P1|NOT COMPLETED|Overall Study||11
5268088|NCT00711113|12949173|P1|COMPLETED|Overall Study||36
5268089|NCT00711113|12949173|P1|STARTED|Overall Study||47
5268090|NCT00711100|12949179|P1|NOT COMPLETED|Overall Study||13
5268091|NCT00711100|12949179|P1|COMPLETED|Overall Study||91
5268092|NCT00711100|12949179|P1|STARTED|Overall Study||104
5268093|NCT00711087|12949197|P2|NOT COMPLETED|Overall Study||0
5268094|NCT00711087|12949198|P1|NOT COMPLETED|Overall Study||1
5268095|NCT00711087|12949197|P2|COMPLETED|Overall Study||0
5268096|NCT00711087|12949198|P1|COMPLETED|Overall Study||0
5268097|NCT00711087|12949197|P2|STARTED|Overall Study||0
5268098|NCT00711087|12949198|P1|STARTED|Overall Study||1
5268099|NCT00711022|12949204|P1|NOT COMPLETED|Overall Study||11
5268100|NCT00711022|12949204|P1|COMPLETED|Overall Study||40
5268101|NCT00711022|12949204|P1|STARTED|Overall Study||51
5268102|NCT00711009|12949210|P2|NOT COMPLETED|Overall Study||19
5268103|NCT00711009|12949211|P1|NOT COMPLETED|Overall Study||15
5268104|NCT00711009|12949210|P2|COMPLETED|Overall Study||82
5268105|NCT00711009|12949211|P1|COMPLETED|Overall Study||90
5268106|NCT00711009|12949210|P2|STARTED|Overall Study||101
5268107|NCT00711009|12949211|P1|STARTED|Overall Study||105
5268108|NCT00710996|12949382|P3|NOT COMPLETED|Overall Study||0
5268109|NCT00710996|12949383|P2|NOT COMPLETED|Overall Study||4
5268110|NCT00710996|12949384|P1|NOT COMPLETED|Overall Study||1
5268111|NCT00710996|12949382|P3|COMPLETED|Overall Study||21
5268112|NCT00710996|12949383|P2|COMPLETED|Overall Study||16
5268113|NCT00710996|12949384|P1|COMPLETED|Overall Study||16
5268114|NCT00710996|12949382|P3|STARTED|Overall Study||21
5268115|NCT00710996|12949383|P2|STARTED|Overall Study||20
5268116|NCT00710996|12949384|P1|STARTED|Overall Study||17
5268117|NCT00710970|12949392|P1|NOT COMPLETED|Overall Study||10
5268118|NCT00710970|12949392|P1|COMPLETED|Overall Study||18
5268119|NCT00710970|12949392|P1|STARTED|Overall Study||28
5268120|NCT00710944|12949399|P3|NOT COMPLETED|Overall Study||2
5268121|NCT00710944|12949400|P2|NOT COMPLETED|Overall Study||9
5268122|NCT00710944|12949401|P1|NOT COMPLETED|Overall Study||10
5268123|NCT00710944|12949399|P3|COMPLETED|Overall Study||17
5268124|NCT00710944|12949400|P2|COMPLETED|Overall Study||49
5268125|NCT00710944|12949401|P1|COMPLETED|Overall Study||45
5268126|NCT00710944|12949399|P3|STARTED|Overall Study||19
5268127|NCT00710944|12949400|P2|STARTED|Overall Study||58
5268128|NCT00710944|12949401|P1|STARTED|Overall Study||55
5268129|NCT00710931|12949409|P1|NOT COMPLETED|Overall Study||5
5268130|NCT00710931|12949409|P1|COMPLETED|Overall Study||29
5268131|NCT00710931|12949409|P1|STARTED|Overall Study||34
5268132|NCT00710905|12949413|P1|NOT COMPLETED|Overall Study||16
5268133|NCT00710905|12949413|P1|COMPLETED|Overall Study||34
5268134|NCT00710905|12949413|P1|STARTED|Overall Study||50
5268135|NCT00710879|12949419|P2|NOT COMPLETED|Overall Study||4
5268136|NCT00710879|12949420|P1|NOT COMPLETED|Overall Study||2
5268137|NCT00710879|12949419|P2|COMPLETED|Overall Study||113
5268138|NCT00710879|12949420|P1|COMPLETED|Overall Study||58
5268139|NCT00710879|12949419|P2|STARTED|Overall Study||117
5268140|NCT00710879|12949420|P1|STARTED|Overall Study||60
5268141|NCT00710866|12949432|P2|NOT COMPLETED|Overall Study||6
5268142|NCT00710866|12949433|P1|NOT COMPLETED|Overall Study||9
5268143|NCT00710866|12949432|P2|COMPLETED|Overall Study||128
5268144|NCT00710866|12949433|P1|COMPLETED|Overall Study||124
5268145|NCT00710866|12949432|P2|STARTED|Overall Study||134
5268146|NCT00710866|12949433|P1|STARTED|Overall Study||133
5268147|NCT00710840|12949455|P2|NOT COMPLETED|Overall Study||3
5268148|NCT00710840|12949456|P1|NOT COMPLETED|Overall Study||0
5268149|NCT00710840|12949455|P2|COMPLETED|Overall Study||19
5268150|NCT00710840|12949456|P1|COMPLETED|Overall Study||22
5268151|NCT00710840|12949455|P2|STARTED|Overall Study||22
5268152|NCT00710840|12949456|P1|STARTED|Overall Study||22
5268153|NCT00710814|12949470|P2|NOT COMPLETED|Overall Study||3
5268154|NCT00710814|12949471|P1|NOT COMPLETED|Overall Study||1
5268155|NCT00710814|12949470|P2|COMPLETED|Overall Study||13
5268156|NCT00710814|12949471|P1|COMPLETED|Overall Study||14
5268157|NCT00710814|12949470|P2|STARTED|Overall Study||16
5268158|NCT00710814|12949471|P1|STARTED|Overall Study||15
5268159|NCT00710762|12949479|P2|NOT COMPLETED|Overall Study||40
5268160|NCT00710762|12949480|P1|NOT COMPLETED|Overall Study||39
5268161|NCT00710762|12949479|P2|COMPLETED|Overall Study||0
5268162|NCT00710762|12949480|P1|COMPLETED|Overall Study||5
5268163|NCT00710762|12949479|P2|STARTED|Overall Study||40
5268164|NCT00710762|12949480|P1|STARTED|Overall Study||44
5268165|NCT00710749|12949496|P2|NOT COMPLETED|Second Intervention||0
5268166|NCT00710749|12949497|P1|NOT COMPLETED|Second Intervention||0
5268167|NCT00710749|12949496|P2|COMPLETED|Second Intervention||30
5268168|NCT00710749|12949497|P1|COMPLETED|Second Intervention||29
5268169|NCT00710749|12949496|P2|STARTED|Second Intervention||30
5268170|NCT00710749|12949497|P1|STARTED|Second Intervention||29
5268171|NCT00710749|12949496|P2|NOT COMPLETED|First Intervention||0
5268172|NCT00710749|12949497|P1|NOT COMPLETED|First Intervention||1
5268173|NCT00710749|12949496|P2|COMPLETED|First Intervention||30
5268174|NCT00710749|12949497|P1|COMPLETED|First Intervention||29
5268175|NCT00710749|12949496|P2|STARTED|First Intervention||30
5268176|NCT00710749|12949497|P1|STARTED|First Intervention||30
5268177|NCT00710749|12949496|P2|NOT COMPLETED|Clinic Baseline Recording||0
5268178|NCT00710749|12949497|P1|NOT COMPLETED|Clinic Baseline Recording||0
5268179|NCT00710749|12949496|P2|COMPLETED|Clinic Baseline Recording||30
5268180|NCT00710749|12949497|P1|COMPLETED|Clinic Baseline Recording||30
5268181|NCT00710749|12949496|P2|STARTED|Clinic Baseline Recording||30
5268182|NCT00710749|12949497|P1|STARTED|Clinic Baseline Recording||30
5268183|NCT00710684|12949508|P3|NOT COMPLETED|Overall Study||64
5268184|NCT00710684|12949509|P2|NOT COMPLETED|Overall Study||74
5268185|NCT00710684|12949510|P1|NOT COMPLETED|Overall Study||74
5268186|NCT00710684|12949508|P3|COMPLETED|Overall Study||172
5268187|NCT00710684|12949509|P2|COMPLETED|Overall Study||147
5268188|NCT00710684|12949510|P1|COMPLETED|Overall Study||151
5268189|NCT00710684|12949508|P3|STARTED|Overall Study||236
5268190|NCT00710684|12949509|P2|STARTED|Overall Study||221
5268191|NCT00710684|12949510|P1|STARTED|Overall Study||225
5268192|NCT00710606|12949567|P2|NOT COMPLETED|Overall Study||2
5268193|NCT00710606|12949568|P1|NOT COMPLETED|Overall Study||0
5268194|NCT00710606|12949567|P2|COMPLETED|Overall Study||18
5268195|NCT00710606|12949568|P1|COMPLETED|Overall Study||20
5268196|NCT00710606|12949567|P2|STARTED|Overall Study||20
5268197|NCT00710606|12949568|P1|STARTED|Overall Study||20
5268198|NCT00710593|12949580|P2|NOT COMPLETED|Overall Study||5
5268199|NCT00710593|12949581|P1|NOT COMPLETED|Overall Study||15
5268200|NCT00710593|12949580|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
5268201|NCT00710593|12949581|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
5268202|NCT00710593|12949580|P2|STARTED|Overall Study||30
5268203|NCT00710593|12949581|P1|STARTED|Overall Study||69
5268204|NCT00710554|12949624|P2|NOT COMPLETED|Overall Study||24
5268205|NCT00710554|12949625|P1|NOT COMPLETED|Overall Study||49
5268206|NCT00710554|12949624|P2|COMPLETED|Overall Study||94
5268207|NCT00710554|12949625|P1|COMPLETED|Overall Study||79
5268208|NCT00710554|12949624|P2|STARTED|Overall Study||118
5268209|NCT00710554|12949625|P1|STARTED|Overall Study||128
5268210|NCT00710424|12949653|P2|NOT COMPLETED|Overall Study||23
5268211|NCT00710424|12949654|P1|NOT COMPLETED|Overall Study||44
5268212|NCT00710424|12949653|P2|COMPLETED|Overall Study||125
5268213|NCT00710424|12949654|P1|COMPLETED|Overall Study||105
5268214|NCT00710424|12949653|P2|STARTED|Overall Study||148
5268215|NCT00710424|12949654|P1|STARTED|Overall Study||149
5268216|NCT00710385|12949678|P1|NOT COMPLETED|Overall Study||5
5268217|NCT00710385|12949678|P1|COMPLETED|Overall Study||12
5268218|NCT00710385|12949678|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
5268219|NCT00710203|12949695|P1|NOT COMPLETED|Overall Study||0
5268220|NCT00710203|12949695|P1|COMPLETED|Overall Study||10
5268221|NCT00710203|12949695|P1|STARTED|Overall Study||10
5268222|NCT00710034|12949723|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
5268223|NCT00710034|12949724|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
5268224|NCT00710034|12949723|P2|COMPLETED|Completed 12 Weeks of Treatment||138
5268225|NCT00710034|12949724|P1|COMPLETED|Completed 12 Weeks of Treatment||141
5268226|NCT00710034|12949723|P2|STARTED|Completed 12 Weeks of Treatment||149
5268227|NCT00710034|12949724|P1|STARTED|Completed 12 Weeks of Treatment||154
5268228|NCT00710034|12949723|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
5268229|NCT00710034|12949724|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
5268230|NCT00710034|12949723|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
5268231|NCT00710034|12949724|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
5268232|NCT00710034|12949723|P2|STARTED|Completed 6 Weeks of Treatment||196
5268233|NCT00710034|12949724|P1|STARTED|Completed 6 Weeks of Treatment||195
5268234|NCT00710021|12949741|P3|NOT COMPLETED|Overall Study||1
5268235|NCT00710021|12949742|P2|NOT COMPLETED|Overall Study||3
5268236|NCT00710021|12949743|P1|NOT COMPLETED|Overall Study||1
5268237|NCT00710021|12949741|P3|COMPLETED|Overall Study||18
5268238|NCT00710021|12949742|P2|COMPLETED|Overall Study||16
5268239|NCT00710021|12949743|P1|COMPLETED|Overall Study||18
5268240|NCT00710021|12949741|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
5268241|NCT00710021|12949742|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
5268242|NCT00710021|12949743|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
5268243|NCT00710021|12949741|P3|STARTED|Overall Study||19
5268244|NCT00710021|12949742|P2|STARTED|Overall Study||19
5268245|NCT00710021|12949743|P1|STARTED|Overall Study||19
5268246|NCT00709995|12949858|P2|NOT COMPLETED|Overall Study||5
5268247|NCT00709995|12949859|P1|NOT COMPLETED|Overall Study||5
5268248|NCT00709995|12949858|P2|COMPLETED|Overall Study||1
5268249|NCT00709995|12949859|P1|COMPLETED|Overall Study||6
5268250|NCT00709995|12949858|P2|Progressive Disease|Overall Study||1
5268251|NCT00709995|12949859|P1|Progressive Disease|Overall Study||6
5268252|NCT00709995|12949858|P2|STARTED|Overall Study||6
5268253|NCT00709995|12949859|P1|STARTED|Overall Study||11
5268254|NCT00709956|12949877|P2|NOT COMPLETED|Overall Study||4
5268255|NCT00709956|12949878|P1|NOT COMPLETED|Overall Study||3
5268256|NCT00709956|12949877|P2|COMPLETED|Overall Study||33
5268257|NCT00709956|12949878|P1|COMPLETED|Overall Study||30
5268258|NCT00709956|12949877|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
5268259|NCT00709956|12949878|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
5268260|NCT00709956|12949877|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
5268261|NCT00709956|12949878|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
5268262|NCT00709891|12949886|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
5268263|NCT00709891|12949886|P1|COMPLETED|Longitudinal Follow-up Phase||5020
5268264|NCT00709891|12949886|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
5268265|NCT00709891|12949886|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
5268266|NCT00709891|12949886|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
5268267|NCT00709891|12949886|P1|STARTED|Baseline, Cross-sectional Phase||47208
5268268|NCT00709878|12949895|P4|NOT COMPLETED|Overall Study||0
5268269|NCT00709878|12949896|P3|NOT COMPLETED|Overall Study||0
5268270|NCT00709878|12949897|P2|NOT COMPLETED|Overall Study||0
5268271|NCT00709878|12949898|P1|NOT COMPLETED|Overall Study||0
5268272|NCT00709878|12949895|P4|COMPLETED|Overall Study||8
5268273|NCT00709878|12949896|P3|COMPLETED|Overall Study||8
5268274|NCT00709878|12949897|P2|COMPLETED|Overall Study||8
5268275|NCT00709878|12949898|P1|COMPLETED|Overall Study||8
5268276|NCT00709878|12949895|P4|STARTED|Overall Study||8
5268277|NCT00709878|12949896|P3|STARTED|Overall Study||8
5268278|NCT00709878|12949897|P2|STARTED|Overall Study||8
5268279|NCT00709878|12949898|P1|STARTED|Overall Study||8
5268280|NCT00709852|12949908|P2|NOT COMPLETED|Period 2||2
5268281|NCT00709852|12949909|P1|NOT COMPLETED|Period 2||9
5268282|NCT00709852|12949908|P2|COMPLETED|Period 2||169
5268283|NCT00709852|12949909|P1|COMPLETED|Period 2||211
5268284|NCT00709852|12949908|P2|STARTED|Period 2||171
5268285|NCT00709852|12949909|P1|STARTED|Period 2||220
5268286|NCT00709852|12949908|P2|NOT COMPLETED|Period 1||3
5268287|NCT00709852|12949909|P1|NOT COMPLETED|Period 1||8
5268288|NCT00709852|12949908|P2|COMPLETED|Period 1||171
5268289|NCT00709852|12949909|P1|COMPLETED|Period 1||220
5268290|NCT00709852|12949908|P2|STARTED|Period 1||174
5268291|NCT00709852|12949909|P1|STARTED|Period 1||228
5268292|NCT00709826|12950064|P2|NOT COMPLETED|Overall Study||1
5268293|NCT00709826|12950065|P1|NOT COMPLETED|Overall Study||2
5268294|NCT00709826|12950064|P2|COMPLETED|Overall Study||38
5268295|NCT00709826|12950065|P1|COMPLETED|Overall Study||68
5268296|NCT00709826|12950064|P2|STARTED|Overall Study||39
5268297|NCT00709826|12950065|P1|STARTED|Overall Study||70
5268298|NCT00709761|12950073|P1|NOT COMPLETED|Overall Study||27
5268299|NCT00709761|12950073|P1|COMPLETED|Overall Study||33
5268300|NCT00709761|12950073|P1|STARTED|Overall Study||60
5268301|NCT00709735|12950084|P2|NOT COMPLETED|Overall Study||2
5268302|NCT00709735|12950085|P1|NOT COMPLETED|Overall Study||3
5268303|NCT00709735|12950084|P2|COMPLETED|Overall Study||10
5268304|NCT00709735|12950085|P1|COMPLETED|Overall Study||8
5268305|NCT00709735|12950084|P2|STARTED|Overall Study||12
5268306|NCT00709735|12950085|P1|STARTED|Overall Study||11
5268307|NCT00709722|12950093|P1|NOT COMPLETED|Overall Study||1
5268308|NCT00709722|12950093|P1|COMPLETED|Overall Study||20
5268309|NCT00709722|12950093|P1|STARTED|Overall Study||21
5268310|NCT00709696|12950101|P2|NOT COMPLETED|Overall Study||0
5268311|NCT00709696|12950102|P1|NOT COMPLETED|Overall Study||0
5268312|NCT00709696|12950101|P2|COMPLETED|Overall Study||3
5268313|NCT00709696|12950102|P1|COMPLETED|Overall Study||4
5268314|NCT00709696|12950101|P2|STARTED|Overall Study||3
5268315|NCT00709696|12950102|P1|STARTED|Overall Study||4
5268316|NCT00709618|12950108|P1|NOT COMPLETED|Overall Study||30
5268317|NCT00709618|12950108|P1|COMPLETED|Overall Study||14
5268318|NCT00709618|12950108|P1|STARTED|Overall Study||44
5268319|NCT00709592|12950120|P2|NOT COMPLETED|Overall Study||1
5268320|NCT00709592|12950121|P1|NOT COMPLETED|Overall Study||0
5268321|NCT00709592|12950120|P2|COMPLETED|Overall Study||22
5268322|NCT00709592|12950121|P1|COMPLETED|Overall Study||19
5268323|NCT00709592|12950120|P2|STARTED|Overall Study||23
5268324|NCT00709592|12950121|P1|STARTED|Overall Study||19
5268325|NCT00709319|12950143|P1|NOT COMPLETED|Overall Study||6
5268326|NCT00709319|12950143|P1|COMPLETED|Overall Study||81
5268327|NCT00709319|12950143|P1|STARTED|Overall Study||87
5268328|NCT00709306|12950155|P4|NOT COMPLETED|Overall Study||10
5268329|NCT00709306|12950156|P3|NOT COMPLETED|Overall Study||10
5268330|NCT00709306|12950157|P2|NOT COMPLETED|Overall Study||14
5268331|NCT00709306|12950158|P1|NOT COMPLETED|Overall Study||9
5268332|NCT00709306|12950155|P4|COMPLETED|Overall Study||37
5268333|NCT00709306|12950156|P3|COMPLETED|Overall Study||48
5268334|NCT00709306|12950157|P2|COMPLETED|Overall Study||30
5268335|NCT00709306|12950158|P1|COMPLETED|Overall Study||39
5268336|NCT00709306|12950155|P4|STARTED|Overall Study||47
5268337|NCT00709306|12950156|P3|STARTED|Overall Study||58
5268338|NCT00709306|12950157|P2|STARTED|Overall Study||44
5268339|NCT00709306|12950158|P1|STARTED|Overall Study||48
5268340|NCT00709228|12950172|P1|NOT COMPLETED|Overall Study||332
5268341|NCT00709228|12950172|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
5268342|NCT00709228|12950172|P1|STARTED|Overall Study||496
5268343|NCT00709202|12950178|P2|NOT COMPLETED|Overall Study||6
5268344|NCT00709202|12950179|P1|NOT COMPLETED|Overall Study||6
5268345|NCT00709202|12950178|P2|COMPLETED|Overall Study||15
5268346|NCT00709202|12950179|P1|COMPLETED|Overall Study||13
5268347|NCT00709202|12950178|P2|STARTED|Overall Study||21
5268348|NCT00709202|12950179|P1|STARTED|Overall Study||19
5268349|NCT00709124|12950207|P2|NOT COMPLETED|Overall Study||1
5268350|NCT00709124|12950208|P1|NOT COMPLETED|Overall Study||4
5268351|NCT00709124|12950207|P2|COMPLETED|Overall Study||17
5268352|NCT00709124|12950208|P1|COMPLETED|Overall Study||12
5268353|NCT00709124|12950207|P2|STARTED|Overall Study||18
5268354|NCT00709124|12950208|P1|STARTED|Overall Study||16
5268355|NCT00709111|12950242|P1|NOT COMPLETED|Overall Study||2
5268356|NCT00709111|12950242|P1|COMPLETED|Overall Study||32
5268357|NCT00709111|12950242|P1|Week 22/24|Overall Study||33
5268358|NCT00709111|12950242|P1|STARTED|Overall Study||34
5268359|NCT00709098|12950283|P3|NOT COMPLETED|Open-label Period||14
5268360|NCT00709098|12950284|P2|NOT COMPLETED|Open-label Period||0
5268361|NCT00709098|12950285|P1|NOT COMPLETED|Open-label Period||0
5268362|NCT00709098|12950283|P3|COMPLETED|Open-label Period||18
5268363|NCT00709098|12950284|P2|COMPLETED|Open-label Period||0
5268364|NCT00709098|12950285|P1|COMPLETED|Open-label Period||0
5268365|NCT00709098|12950283|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
5268366|NCT00709098|12950284|P2|STARTED|Open-label Period||0
5268367|NCT00709098|12950285|P1|STARTED|Open-label Period||0
5268368|NCT00709098|12950283|P3|NOT COMPLETED|Double-blind Period||0
5268369|NCT00709098|12950284|P2|NOT COMPLETED|Double-blind Period||8
5268370|NCT00709098|12950285|P1|NOT COMPLETED|Double-blind Period||6
5268371|NCT00709098|12950283|P3|COMPLETED|Double-blind Period||0
5268372|NCT00709098|12950284|P2|COMPLETED|Double-blind Period||16
5268373|NCT00709098|12950285|P1|COMPLETED|Double-blind Period||19
5268374|NCT00709098|12950283|P3|STARTED|Double-blind Period||0
5268375|NCT00709098|12950284|P2|STARTED|Double-blind Period||24
5268376|NCT00709098|12950285|P1|STARTED|Double-blind Period||25
5268377|NCT00709059|12950304|P1|NOT COMPLETED|Overall Study||94
5268378|NCT00709059|12950304|P1|COMPLETED|Overall Study||444
5268379|NCT00709059|12950304|P1|STARTED|Overall Study||538
5268380|NCT00708942|12950313|P5|NOT COMPLETED|Overall Study||1
5268381|NCT00708942|12950314|P4|NOT COMPLETED|Overall Study||0
5268382|NCT00708942|12950315|P3|NOT COMPLETED|Overall Study||2
5268383|NCT00708942|12950316|P2|NOT COMPLETED|Overall Study||1
5268384|NCT00708942|12950317|P1|NOT COMPLETED|Overall Study||7
5268385|NCT00708942|12950313|P5|COMPLETED|Overall Study||2
5268386|NCT00708942|12950314|P4|COMPLETED|Overall Study||10
5268387|NCT00708942|12950315|P3|COMPLETED|Overall Study||9
5268388|NCT00708942|12950316|P2|COMPLETED|Overall Study||11
5268389|NCT00708942|12950317|P1|COMPLETED|Overall Study||40
5268390|NCT00708942|12950313|P5|STARTED|Overall Study||3
5268391|NCT00708942|12950314|P4|STARTED|Overall Study||10
5268392|NCT00708942|12950315|P3|STARTED|Overall Study||11
5268393|NCT00708942|12950316|P2|STARTED|Overall Study||12
5268394|NCT00708942|12950317|P1|STARTED|Overall Study||47
5268395|NCT00708877|12950339|P1|NOT COMPLETED|Overall Study||0
5268396|NCT00708877|12950339|P1|COMPLETED|Overall Study||5
5268397|NCT00708877|12950339|P1|STARTED|Overall Study||5
5268398|NCT00708851|12950343|P1|NOT COMPLETED|Overall Study||0
5268399|NCT00708851|12950343|P1|COMPLETED|Overall Study||12
5268400|NCT00708851|12950343|P1|STARTED|Overall Study||12
5268401|NCT00708734|12950351|P1|NOT COMPLETED|Overall Study||7
5268402|NCT00708734|12950351|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
5268403|NCT00708734|12950351|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
5268404|NCT00708721|12950355|P4|NOT COMPLETED|Overall Study||0
5268405|NCT00708721|12950356|P3|NOT COMPLETED|Overall Study||0
5268406|NCT00708721|12950357|P2|NOT COMPLETED|Overall Study||0
5268407|NCT00708721|12950358|P1|NOT COMPLETED|Overall Study||0
5268408|NCT00708721|12950355|P4|COMPLETED|Overall Study||2
5268409|NCT00708721|12950356|P3|COMPLETED|Overall Study||3
5268410|NCT00708721|12950357|P2|COMPLETED|Overall Study||4
5268411|NCT00708721|12950358|P1|COMPLETED|Overall Study||2
5268412|NCT00708721|12950355|P4|STARTED|Overall Study||2
5268413|NCT00708721|12950356|P3|STARTED|Overall Study||3
5268414|NCT00708721|12950357|P2|STARTED|Overall Study||4
5268415|NCT00708721|12950358|P1|STARTED|Overall Study||2
5268416|NCT00708708|12950371|P1|NOT COMPLETED|Overall Study||742
5268417|NCT00708708|12950371|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
5268418|NCT00708708|12950371|P1|STARTED|Overall Study||955
5268419|NCT00708682|12950419|P1|NOT COMPLETED|Toddler Dose||8
5268420|NCT00708682|12950419|P1|COMPLETED|Toddler Dose||183
5268421|NCT00708682|12950419|P1|STARTED|Toddler Dose||191
5268422|NCT00708682|12950419|P1|NOT COMPLETED|After Infant Series||1
5268423|NCT00708682|12950419|P1|COMPLETED|After Infant Series||191
5268424|NCT00708682|12950419|P1|STARTED|After Infant Series||192
5268425|NCT00708682|12950419|P1|NOT COMPLETED|Infant Series||33
5268426|NCT00708682|12950419|P1|COMPLETED|Infant Series||192
5268427|NCT00708682|12950419|P1|Vaccinated Dose 3|Infant Series||194
5268428|NCT00708682|12950419|P1|Vaccinated Dose 2|Infant Series||214
5268429|NCT00708682|12950419|P1|Vaccinated Dose 1|Infant Series||223
5268430|NCT00708682|12950419|P1|STARTED|Infant Series||225
5268431|NCT00708643|12950440|P2|NOT COMPLETED|Overall Study||1
5268432|NCT00708643|12950441|P1|NOT COMPLETED|Overall Study||0
5268433|NCT00708643|12950440|P2|COMPLETED|Overall Study||39
5268434|NCT00708643|12950441|P1|COMPLETED|Overall Study||40
5268435|NCT00708643|12950440|P2|STARTED|Overall Study||40
5268436|NCT00708643|12950441|P1|STARTED|Overall Study||40
5268437|NCT00708552|12950461|P4|NOT COMPLETED|Overall Study||21
5268438|NCT00708552|12950462|P3|NOT COMPLETED|Overall Study||15
5268439|NCT00708552|12950463|P2|NOT COMPLETED|Overall Study||18
5268440|NCT00708552|12950464|P1|NOT COMPLETED|Overall Study||27
5268441|NCT00708552|12950461|P4|COMPLETED|Overall Study||130
5268442|NCT00708552|12950462|P3|COMPLETED|Overall Study||118
5268443|NCT00708552|12950463|P2|COMPLETED|Overall Study||127
5268444|NCT00708552|12950464|P1|COMPLETED|Overall Study||118
5268445|NCT00708552|12950461|P4|STARTED|Overall Study||151
5268446|NCT00708552|12950462|P3|STARTED|Overall Study||133
5268447|NCT00708552|12950463|P2|STARTED|Overall Study||145
5268448|NCT00708552|12950464|P1|STARTED|Overall Study||145
5268449|NCT00708526|12950614|P2|NOT COMPLETED|Return of Cognitive Function||0
5268450|NCT00708526|12950615|P1|NOT COMPLETED|Return of Cognitive Function||0
5268451|NCT00708526|12950614|P2|COMPLETED|Return of Cognitive Function||11
5268452|NCT00708526|12950615|P1|COMPLETED|Return of Cognitive Function||11
5268453|NCT00708526|12950614|P2|STARTED|Return of Cognitive Function||11
5268454|NCT00708526|12950615|P1|STARTED|Return of Cognitive Function||11
5268455|NCT00708526|12950614|P2|NOT COMPLETED|Wake up After Anesthesia||0
5268456|NCT00708526|12950615|P1|NOT COMPLETED|Wake up After Anesthesia||0
5268457|NCT00708526|12950614|P2|COMPLETED|Wake up After Anesthesia||11
5268458|NCT00708526|12950615|P1|COMPLETED|Wake up After Anesthesia||11
5268459|NCT00708526|12950614|P2|STARTED|Wake up After Anesthesia||11
5268460|NCT00708526|12950615|P1|STARTED|Wake up After Anesthesia||11
5268461|NCT00708500|12950626|P3|NOT COMPLETED|FOLLOWUP||15
5268462|NCT00708500|12950627|P2|NOT COMPLETED|FOLLOWUP||15
5268463|NCT00708500|12950628|P1|NOT COMPLETED|FOLLOWUP||40
5268464|NCT00708500|12950626|P3|COMPLETED|FOLLOWUP||143
5268465|NCT00708500|12950627|P2|COMPLETED|FOLLOWUP||136
5268466|NCT00708500|12950628|P1|COMPLETED|FOLLOWUP||37
5268467|NCT00708500|12950626|P3|STARTED|FOLLOWUP||158
5268468|NCT00708500|12950627|P2|STARTED|FOLLOWUP||151
5268469|NCT00708500|12950628|P1|STARTED|FOLLOWUP||77
5268470|NCT00708500|12950626|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
5268471|NCT00708500|12950627|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
5268472|NCT00708500|12950628|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
5268473|NCT00708500|12950626|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
5268474|NCT00708500|12950627|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
5268475|NCT00708500|12950628|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
5268476|NCT00708500|12950626|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
5268477|NCT00708500|12950627|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
5268478|NCT00708500|12950628|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
5268479|NCT00708500|12950626|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
5268480|NCT00708500|12950627|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
5268481|NCT00708500|12950628|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
5268482|NCT00708500|12950626|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
5268483|NCT00708500|12950627|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
5268484|NCT00708500|12950628|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
5268485|NCT00708500|12950626|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
5268486|NCT00708500|12950627|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
5268487|NCT00708500|12950628|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
5268488|NCT00708500|12950626|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
5268489|NCT00708500|12950627|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
5268490|NCT00708500|12950628|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
5268491|NCT00708461|12950647|P2|NOT COMPLETED|Overall Study||200
5268492|NCT00708461|12950648|P1|NOT COMPLETED|Overall Study||141
5268493|NCT00708461|12950647|P2|COMPLETED|Overall Study||795
5268494|NCT00708461|12950648|P1|COMPLETED|Overall Study||611
5268495|NCT00708461|12950647|P2|STARTED|Overall Study||995
5268496|NCT00708461|12950648|P1|STARTED|Overall Study||752
5268497|NCT00708435|12950656|P2|NOT COMPLETED|Overall Study||17
5268498|NCT00708435|12950657|P1|NOT COMPLETED|Overall Study||25
5268499|NCT00708435|12950656|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
5268500|NCT00708435|12950657|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
5268501|NCT00708435|12950656|P2|STARTED|Overall Study||109
5268502|NCT00708435|12950657|P1|STARTED|Overall Study||107
5268503|NCT00708422|12950684|P2|NOT COMPLETED|Overall Study||1
5268504|NCT00708422|12950685|P1|NOT COMPLETED|Overall Study||4
5268505|NCT00708422|12950684|P2|COMPLETED|Overall Study||114
5268506|NCT00708422|12950685|P1|COMPLETED|Overall Study||112
5268507|NCT00708422|12950684|P2|STARTED|Overall Study||115
5268508|NCT00708422|12950685|P1|STARTED|Overall Study||116
5268509|NCT00708305|12950693|P4|NOT COMPLETED|Period 4||0
5268510|NCT00708305|12950694|P3|NOT COMPLETED|Period 4||0
5268511|NCT00708305|12950695|P2|NOT COMPLETED|Period 4||0
5268512|NCT00708305|12950696|P1|NOT COMPLETED|Period 4||0
5268513|NCT00708305|12950693|P4|COMPLETED|Period 4||14
5268514|NCT00708305|12950694|P3|COMPLETED|Period 4||14
5268515|NCT00708305|12950695|P2|COMPLETED|Period 4||14
5268516|NCT00708305|12950696|P1|COMPLETED|Period 4||12
5268517|NCT00708305|12950693|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
5268518|NCT00708305|12950694|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
5268519|NCT00708305|12950695|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
5268520|NCT00708305|12950696|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
5268521|NCT00708305|12950693|P4|NOT COMPLETED|Period 3||0
5268522|NCT00708305|12950694|P3|NOT COMPLETED|Period 3||0
5268523|NCT00708305|12950695|P2|NOT COMPLETED|Period 3||2
5268524|NCT00708305|12950696|P1|NOT COMPLETED|Period 3||1
5268525|NCT00708305|12950693|P4|COMPLETED|Period 3||14
5268526|NCT00708305|12950694|P3|COMPLETED|Period 3||14
5268527|NCT00708305|12950695|P2|COMPLETED|Period 3||12
5268528|NCT00708305|12950696|P1|COMPLETED|Period 3||14
5268529|NCT00708305|12950693|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
5268530|NCT00708305|12950694|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
5268531|NCT00708305|12950695|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
5268532|NCT00708305|12950696|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
5268533|NCT00708305|12950693|P4|NOT COMPLETED|Period 2||1
5268534|NCT00708305|12950694|P3|NOT COMPLETED|Period 2||0
5268535|NCT00708305|12950695|P2|NOT COMPLETED|Period 2||2
5268536|NCT00708305|12950696|P1|NOT COMPLETED|Period 2||1
5268537|NCT00708305|12950693|P4|COMPLETED|Period 2||14
5268538|NCT00708305|12950694|P3|COMPLETED|Period 2||16
5268539|NCT00708305|12950695|P2|COMPLETED|Period 2||13
5268540|NCT00708305|12950696|P1|COMPLETED|Period 2||14
5268541|NCT00708305|12950693|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
5268542|NCT00708305|12950694|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
5268543|NCT00708305|12950695|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
5268544|NCT00708305|12950696|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
5268545|NCT00708305|12950693|P4|NOT COMPLETED|Period 1||2
5268546|NCT00708305|12950694|P3|NOT COMPLETED|Period 1||1
5268547|NCT00708305|12950695|P2|NOT COMPLETED|Period 1||0
5268548|NCT00708305|12950696|P1|NOT COMPLETED|Period 1||1
5268549|NCT00708305|12950693|P4|COMPLETED|Period 1||14
5268550|NCT00708305|12950694|P3|COMPLETED|Period 1||16
5268551|NCT00708305|12950695|P2|COMPLETED|Period 1||16
5268552|NCT00708305|12950696|P1|COMPLETED|Period 1||15
5268553|NCT00708305|12950693|P4|STARTED|Period 1||16
5268554|NCT00708305|12950694|P3|STARTED|Period 1||17
5268555|NCT00708305|12950695|P2|STARTED|Period 1||16
5268556|NCT00708305|12950696|P1|STARTED|Period 1||16
5268557|NCT00708227|12950732|P4|NOT COMPLETED|Overall Study||3
5268558|NCT00708227|12950733|P3|NOT COMPLETED|Overall Study||1
5268559|NCT00708227|12950734|P2|NOT COMPLETED|Overall Study||5
5268560|NCT00708227|12950735|P1|NOT COMPLETED|Overall Study||1
5268561|NCT00708227|12950732|P4|COMPLETED|Overall Study||22
5268562|NCT00708227|12950733|P3|COMPLETED|Overall Study||17
5268563|NCT00708227|12950734|P2|COMPLETED|Overall Study||21
5268564|NCT00708227|12950735|P1|COMPLETED|Overall Study||18
5268565|NCT00708227|12950732|P4|STARTED|Overall Study||25
5268566|NCT00708227|12950733|P3|STARTED|Overall Study||18
5268567|NCT00708227|12950734|P2|STARTED|Overall Study||26
5268568|NCT00708227|12950735|P1|STARTED|Overall Study||19
5268569|NCT00708214|12950768|P3|NOT COMPLETED|Overall Study||8
5268570|NCT00708214|12950769|P2|NOT COMPLETED|Overall Study||13
5268571|NCT00708214|12950770|P1|NOT COMPLETED|Overall Study||7
5268572|NCT00708214|12950768|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
5268573|NCT00708214|12950769|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
5268574|NCT00708214|12950770|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
5268575|NCT00708214|12950768|P3|STARTED|Overall Study||8
5268576|NCT00708214|12950769|P2|STARTED|Overall Study||13
5268577|NCT00708214|12950770|P1|STARTED|Overall Study||7
5268578|NCT00708201|12950813|P2|NOT COMPLETED|Overall Study||6
5268579|NCT00708201|12950814|P1|NOT COMPLETED|Overall Study||7
5268580|NCT00708201|12950813|P2|COMPLETED|Overall Study||137
5268581|NCT00708201|12950814|P1|COMPLETED|Overall Study||130
5268582|NCT00708201|12950813|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
5268583|NCT00708201|12950814|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
5268584|NCT00708201|12950813|P2|STARTED|Overall Study||143
5268585|NCT00708201|12950814|P1|STARTED|Overall Study||137
5268586|NCT00708175|12950838|P2|NOT COMPLETED|Overall Study||21
5268587|NCT00708175|12950839|P1|NOT COMPLETED|Overall Study||18
5268588|NCT00708175|12950838|P2|COMPLETED|Overall Study||57
5268589|NCT00708175|12950839|P1|COMPLETED|Overall Study||60
5268590|NCT00708175|12950838|P2|STARTED|Overall Study||78
5268591|NCT00708175|12950839|P1|STARTED|Overall Study||78
5268592|NCT00708162|12950855|P2|NOT COMPLETED|Open-Label Phase||30
5268593|NCT00708162|12950856|P1|NOT COMPLETED|Open-Label Phase||44
5268594|NCT00708162|12950855|P2|COMPLETED|Open-Label Phase||121
5268595|NCT00708162|12950856|P1|COMPLETED|Open-Label Phase||152
5268596|NCT00708162|12950855|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
5268673|NCT00708123|12950899|P3|COMPLETED|Period 1||11
5268597|NCT00708162|12950856|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
5268598|NCT00708162|12950855|P2|NOT COMPLETED|Randomized Phase||154
5268599|NCT00708162|12950856|P1|NOT COMPLETED|Randomized Phase||156
5268600|NCT00708162|12950855|P2|COMPLETED|Randomized Phase||209
5268601|NCT00708162|12950856|P1|COMPLETED|Randomized Phase||205
5268602|NCT00708162|12950855|P2|Randomized and Treated|Randomized Phase||358
5268603|NCT00708162|12950856|P1|Randomized and Treated|Randomized Phase||354
5268604|NCT00708162|12950855|P2|STARTED|Randomized Phase||363
5268605|NCT00708162|12950856|P1|STARTED|Randomized Phase||361
5268606|NCT00708123|12950897|P5|NOT COMPLETED|Period 5||0
5268607|NCT00708123|12950898|P4|NOT COMPLETED|Period 5||0
5268608|NCT00708123|12950899|P3|NOT COMPLETED|Period 5||0
5268609|NCT00708123|12950900|P2|NOT COMPLETED|Period 5||0
5268610|NCT00708123|12950901|P1|NOT COMPLETED|Period 5||0
5268611|NCT00708123|12950897|P5|COMPLETED|Period 5||10
5268612|NCT00708123|12950898|P4|COMPLETED|Period 5||11
5268613|NCT00708123|12950899|P3|COMPLETED|Period 5||11
5268614|NCT00708123|12950900|P2|COMPLETED|Period 5||10
5268615|NCT00708123|12950901|P1|COMPLETED|Period 5||10
5268616|NCT00708123|12950897|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
5268617|NCT00708123|12950898|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
5268618|NCT00708123|12950899|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
5268619|NCT00708123|12950900|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
5268620|NCT00708123|12950901|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
5268621|NCT00708123|12950897|P5|NOT COMPLETED|Period 4||0
5268622|NCT00708123|12950898|P4|NOT COMPLETED|Period 4||0
5268623|NCT00708123|12950899|P3|NOT COMPLETED|Period 4||0
5268624|NCT00708123|12950900|P2|NOT COMPLETED|Period 4||1
5268625|NCT00708123|12950901|P1|NOT COMPLETED|Period 4||0
5268626|NCT00708123|12950897|P5|COMPLETED|Period 4||11
5268627|NCT00708123|12950898|P4|COMPLETED|Period 4||10
5268628|NCT00708123|12950899|P3|COMPLETED|Period 4||10
5268629|NCT00708123|12950900|P2|COMPLETED|Period 4||11
5268630|NCT00708123|12950901|P1|COMPLETED|Period 4||10
5268631|NCT00708123|12950897|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
5268632|NCT00708123|12950898|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
5268633|NCT00708123|12950899|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
5268634|NCT00708123|12950900|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
5268635|NCT00708123|12950901|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
5268636|NCT00708123|12950897|P5|NOT COMPLETED|Period 3||0
5268637|NCT00708123|12950898|P4|NOT COMPLETED|Period 3||1
5268638|NCT00708123|12950899|P3|NOT COMPLETED|Period 3||1
5268639|NCT00708123|12950900|P2|NOT COMPLETED|Period 3||0
5268640|NCT00708123|12950901|P1|NOT COMPLETED|Period 3||0
5268641|NCT00708123|12950897|P5|COMPLETED|Period 3||10
5268642|NCT00708123|12950898|P4|COMPLETED|Period 3||11
5268643|NCT00708123|12950899|P3|COMPLETED|Period 3||10
5268644|NCT00708123|12950900|P2|COMPLETED|Period 3||10
5268645|NCT00708123|12950901|P1|COMPLETED|Period 3||12
5268646|NCT00708123|12950897|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
5268647|NCT00708123|12950898|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
5268648|NCT00708123|12950899|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
5268649|NCT00708123|12950900|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
5268650|NCT00708123|12950901|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
5268651|NCT00708123|12950897|P5|NOT COMPLETED|Period 2||0
5268652|NCT00708123|12950898|P4|NOT COMPLETED|Period 2||1
5268653|NCT00708123|12950899|P3|NOT COMPLETED|Period 2||0
5268654|NCT00708123|12950900|P2|NOT COMPLETED|Period 2||0
5268655|NCT00708123|12950901|P1|NOT COMPLETED|Period 2||1
5268656|NCT00708123|12950897|P5|COMPLETED|Period 2||11
5268657|NCT00708123|12950898|P4|COMPLETED|Period 2||10
5268658|NCT00708123|12950899|P3|COMPLETED|Period 2||12
5268659|NCT00708123|12950900|P2|COMPLETED|Period 2||12
5268660|NCT00708123|12950901|P1|COMPLETED|Period 2||10
5268661|NCT00708123|12950897|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
5268662|NCT00708123|12950898|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
5268663|NCT00708123|12950899|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
5268664|NCT00708123|12950900|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
5268665|NCT00708123|12950901|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
5268666|NCT00708123|12950897|P5|NOT COMPLETED|Period 1||0
5268667|NCT00708123|12950898|P4|NOT COMPLETED|Period 1||1
5268668|NCT00708123|12950899|P3|NOT COMPLETED|Period 1||1
5268669|NCT00708123|12950900|P2|NOT COMPLETED|Period 1||1
5268670|NCT00708123|12950901|P1|NOT COMPLETED|Period 1||0
5268671|NCT00708123|12950897|P5|COMPLETED|Period 1||12
5268672|NCT00708123|12950898|P4|COMPLETED|Period 1||11
5268674|NCT00708123|12950900|P2|COMPLETED|Period 1||11
5268675|NCT00708123|12950901|P1|COMPLETED|Period 1||12
5268676|NCT00708123|12950897|P5|STARTED|Period 1||12
5268677|NCT00708123|12950898|P4|STARTED|Period 1||12
5268678|NCT00708123|12950899|P3|STARTED|Period 1||12
5268679|NCT00708123|12950900|P2|STARTED|Period 1||12
5268680|NCT00708123|12950901|P1|STARTED|Period 1||12
5268681|NCT00708110|12950925|P4|NOT COMPLETED|Overall Study||0
5268682|NCT00708110|12950926|P3|NOT COMPLETED|Overall Study||0
5268683|NCT00708110|12950927|P2|NOT COMPLETED|Overall Study||0
5268684|NCT00708110|12950928|P1|NOT COMPLETED|Overall Study||0
5268685|NCT00708110|12950925|P4|COMPLETED|Overall Study||10
5268686|NCT00708110|12950926|P3|COMPLETED|Overall Study||9
5268687|NCT00708110|12950927|P2|COMPLETED|Overall Study||9
5268688|NCT00708110|12950928|P1|COMPLETED|Overall Study||7
5268689|NCT00708110|12950925|P4|STARTED|Overall Study||10
5268690|NCT00708110|12950926|P3|STARTED|Overall Study||9
5268691|NCT00708110|12950927|P2|STARTED|Overall Study||9
5268692|NCT00708110|12950928|P1|STARTED|Overall Study||7
5268693|NCT00708097|12951034|P5|NOT COMPLETED|Period 5||0
5268694|NCT00708097|12951035|P4|NOT COMPLETED|Period 5||0
5268695|NCT00708097|12951036|P3|NOT COMPLETED|Period 5||0
5268696|NCT00708097|12951037|P2|NOT COMPLETED|Period 5||0
5268697|NCT00708097|12951038|P1|NOT COMPLETED|Period 5||0
5268698|NCT00708097|12951034|P5|COMPLETED|Period 5||12
5268699|NCT00708097|12951035|P4|COMPLETED|Period 5||10
5268700|NCT00708097|12951036|P3|COMPLETED|Period 5||11
5268701|NCT00708097|12951037|P2|COMPLETED|Period 5||9
5268702|NCT00708097|12951038|P1|COMPLETED|Period 5||8
5268703|NCT00708097|12951034|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
5268704|NCT00708097|12951035|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
5268705|NCT00708097|12951036|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
5268706|NCT00708097|12951037|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
5268707|NCT00708097|12951038|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
5268708|NCT00708097|12951034|P5|NOT COMPLETED|Period 4||0
5268709|NCT00708097|12951035|P4|NOT COMPLETED|Period 4||0
5268710|NCT00708097|12951036|P3|NOT COMPLETED|Period 4||0
5268711|NCT00708097|12951037|P2|NOT COMPLETED|Period 4||0
5268712|NCT00708097|12951038|P1|NOT COMPLETED|Period 4||0
5268713|NCT00708097|12951034|P5|COMPLETED|Period 4||8
5268714|NCT00708097|12951035|P4|COMPLETED|Period 4||11
5268715|NCT00708097|12951036|P3|COMPLETED|Period 4||10
5268716|NCT00708097|12951037|P2|COMPLETED|Period 4||9
5268717|NCT00708097|12951038|P1|COMPLETED|Period 4||12
5268718|NCT00708097|12951034|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
5268719|NCT00708097|12951035|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
5268720|NCT00708097|12951036|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
5268721|NCT00708097|12951037|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
5268722|NCT00708097|12951038|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
5268723|NCT00708097|12951034|P5|NOT COMPLETED|Period 3||0
5268724|NCT00708097|12951035|P4|NOT COMPLETED|Period 3||0
5268725|NCT00708097|12951036|P3|NOT COMPLETED|Period 3||0
5268726|NCT00708097|12951037|P2|NOT COMPLETED|Period 3||0
5268727|NCT00708097|12951038|P1|NOT COMPLETED|Period 3||0
5268728|NCT00708097|12951034|P5|COMPLETED|Period 3||10
5268729|NCT00708097|12951035|P4|COMPLETED|Period 3||10
5268730|NCT00708097|12951036|P3|COMPLETED|Period 3||10
5268731|NCT00708097|12951037|P2|COMPLETED|Period 3||11
5268732|NCT00708097|12951038|P1|COMPLETED|Period 3||9
5268733|NCT00708097|12951034|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
5268734|NCT00708097|12951035|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
5268735|NCT00708097|12951036|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
5268736|NCT00708097|12951037|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
5268737|NCT00708097|12951038|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
5268738|NCT00708097|12951034|P5|NOT COMPLETED|Period 2||0
5268739|NCT00708097|12951035|P4|NOT COMPLETED|Period 2||1
5268740|NCT00708097|12951036|P3|NOT COMPLETED|Period 2||1
5268741|NCT00708097|12951037|P2|NOT COMPLETED|Period 2||1
5268742|NCT00708097|12951038|P1|NOT COMPLETED|Period 2||0
5268743|NCT00708097|12951034|P5|COMPLETED|Period 2||10
5268744|NCT00708097|12951035|P4|COMPLETED|Period 2||10
5268745|NCT00708097|12951036|P3|COMPLETED|Period 2||9
5268746|NCT00708097|12951037|P2|COMPLETED|Period 2||11
5268747|NCT00708097|12951038|P1|COMPLETED|Period 2||10
5268748|NCT00708097|12951034|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
5268749|NCT00708097|12951035|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
5268750|NCT00708097|12951036|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
5268751|NCT00708097|12951037|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
5268845|NCT00707746|12951348|P2|STARTED|Treatment Period||22
5268752|NCT00708097|12951038|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
5268753|NCT00708097|12951034|P5|NOT COMPLETED|Period 1||1
5268754|NCT00708097|12951035|P4|NOT COMPLETED|Period 1||2
5268755|NCT00708097|12951036|P3|NOT COMPLETED|Period 1||0
5268756|NCT00708097|12951037|P2|NOT COMPLETED|Period 1||1
5268757|NCT00708097|12951038|P1|NOT COMPLETED|Period 1||0
5268758|NCT00708097|12951034|P5|COMPLETED|Period 1||10
5268759|NCT00708097|12951035|P4|COMPLETED|Period 1||9
5268760|NCT00708097|12951036|P3|COMPLETED|Period 1||12
5268761|NCT00708097|12951037|P2|COMPLETED|Period 1||11
5268762|NCT00708097|12951038|P1|COMPLETED|Period 1||11
5268763|NCT00708097|12951034|P5|STARTED|Period 1||11
5268764|NCT00708097|12951035|P4|STARTED|Period 1||11
5268765|NCT00708097|12951036|P3|STARTED|Period 1||12
5268766|NCT00708097|12951037|P2|STARTED|Period 1||12
5268767|NCT00708097|12951038|P1|STARTED|Period 1||11
5268768|NCT00708071|12951068|P1|NOT COMPLETED|Overall Study||0
5268769|NCT00708071|12951068|P1|COMPLETED|Overall Study||45
5268770|NCT00708071|12951068|P1|STARTED|Overall Study|Randomized and treated|45
5268771|NCT00708032|12951148|P2|NOT COMPLETED|Overall Study||16
5268772|NCT00708032|12951149|P1|NOT COMPLETED|Overall Study||10
5268773|NCT00708032|12951148|P2|COMPLETED|Overall Study||22
5268774|NCT00708032|12951149|P1|COMPLETED|Overall Study||26
5268775|NCT00708032|12951148|P2|STARTED|Overall Study||38
5268776|NCT00708032|12951149|P1|STARTED|Overall Study||36
5268777|NCT00708019|12951165|P2|NOT COMPLETED|Overall Study||15
5268778|NCT00708019|12951166|P1|NOT COMPLETED|Overall Study||15
5268779|NCT00708019|12951165|P2|COMPLETED|Overall Study||78
5268780|NCT00708019|12951166|P1|COMPLETED|Overall Study||77
5268781|NCT00708019|12951165|P2|STARTED|Overall Study||93
5268782|NCT00708019|12951166|P1|STARTED|Overall Study||92
5268783|NCT00707993|12951176|P2|NOT COMPLETED|Overall Study||94
5268784|NCT00707993|12951177|P1|NOT COMPLETED|Overall Study||89
5268785|NCT00707993|12951176|P2|COMPLETED|Overall Study||125
5268786|NCT00707993|12951177|P1|COMPLETED|Overall Study||133
5268787|NCT00707993|12951176|P2|STARTED|Overall Study||219
5268788|NCT00707993|12951177|P1|STARTED|Overall Study||222
5268789|NCT00707980|12951219|P1|NOT COMPLETED|Overall Study||310
5268790|NCT00707980|12951219|P1|COMPLETED|Overall Study||526
5268791|NCT00707980|12951219|P1|Received Treatment|Overall Study||834
5268792|NCT00707980|12951219|P1|STARTED|Overall Study||836
5268793|NCT00707967|12951237|P3|NOT COMPLETED|Overall Study||0
5268794|NCT00707967|12951238|P2|NOT COMPLETED|Overall Study||0
5268795|NCT00707967|12951239|P1|NOT COMPLETED|Overall Study||0
5268796|NCT00707967|12951237|P3|COMPLETED|Overall Study||7
5268797|NCT00707967|12951238|P2|COMPLETED|Overall Study||8
5268798|NCT00707967|12951239|P1|COMPLETED|Overall Study||22
5268799|NCT00707967|12951237|P3|STARTED|Overall Study||7
5268800|NCT00707967|12951238|P2|STARTED|Overall Study||8
5268801|NCT00707967|12951239|P1|STARTED|Overall Study||22
5268802|NCT00707954|12951303|P5|NOT COMPLETED|Overall Study||1
5268803|NCT00707954|12951304|P4|NOT COMPLETED|Overall Study||0
5268804|NCT00707954|12951305|P3|NOT COMPLETED|Overall Study||0
5268805|NCT00707954|12951306|P2|NOT COMPLETED|Overall Study||0
5268806|NCT00707954|12951307|P1|NOT COMPLETED|Overall Study||0
5268807|NCT00707954|12951303|P5|COMPLETED|Overall Study||9
5268808|NCT00707954|12951304|P4|COMPLETED|Overall Study||13
5268809|NCT00707954|12951305|P3|COMPLETED|Overall Study||14
5268810|NCT00707954|12951306|P2|COMPLETED|Overall Study||12
5268811|NCT00707954|12951307|P1|COMPLETED|Overall Study||12
5268812|NCT00707954|12951303|P5|STARTED|Overall Study||10
5268813|NCT00707954|12951304|P4|STARTED|Overall Study||13
5268814|NCT00707954|12951305|P3|STARTED|Overall Study||14
5268815|NCT00707954|12951306|P2|STARTED|Overall Study||12
5268816|NCT00707954|12951307|P1|STARTED|Overall Study||12
5268817|NCT00707915|12951319|P1|NOT COMPLETED|Overall Study||0
5268818|NCT00707915|12951319|P1|COMPLETED|Overall Study||30
5268819|NCT00707915|12951319|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
5268820|NCT00707915|12951319|P1|STARTED|Overall Study||30
5268821|NCT00707863|12951330|P2|NOT COMPLETED|Overall Study||3
5268822|NCT00707863|12951331|P1|NOT COMPLETED|Overall Study||0
5268823|NCT00707863|12951330|P2|COMPLETED|Overall Study||8
5268824|NCT00707863|12951331|P1|COMPLETED|Overall Study||6
5268825|NCT00707863|12951330|P2|STARTED|Overall Study||11
5268826|NCT00707863|12951331|P1|STARTED|Overall Study||6
5268827|NCT00707759|12951339|P2|NOT COMPLETED|Overall Study||2
5268828|NCT00707759|12951340|P1|NOT COMPLETED|Overall Study||2
5268829|NCT00707759|12951339|P2|COMPLETED|Overall Study||12
5268830|NCT00707759|12951340|P1|COMPLETED|Overall Study||12
5268831|NCT00707759|12951339|P2|STARTED|Overall Study||14
5268832|NCT00707759|12951340|P1|STARTED|Overall Study||14
5268833|NCT00707746|12951348|P2|NOT COMPLETED|Follow-up Period||0
5268834|NCT00707746|12951349|P1|NOT COMPLETED|Follow-up Period||0
5268835|NCT00707746|12951348|P2|COMPLETED|Follow-up Period||21
5268836|NCT00707746|12951349|P1|COMPLETED|Follow-up Period||12
5268837|NCT00707746|12951348|P2|STARTED|Follow-up Period||21
5268838|NCT00707746|12951349|P1|STARTED|Follow-up Period||12
5268839|NCT00707746|12951348|P2|NOT COMPLETED|Treatment Period||5
5268840|NCT00707746|12951349|P1|NOT COMPLETED|Treatment Period||2
5268841|NCT00707746|12951348|P2|COMPLETED|Treatment Period||17
5268842|NCT00707746|12951349|P1|COMPLETED|Treatment Period||10
5268843|NCT00707746|12951348|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
5268844|NCT00707746|12951349|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
5268846|NCT00707746|12951349|P1|STARTED|Treatment Period||12
5268847|NCT00707655|12951397|P2|NOT COMPLETED|Overall Study||2
5268848|NCT00707655|12951398|P1|NOT COMPLETED|Overall Study||0
5268849|NCT00707655|12951397|P2|COMPLETED|Overall Study||3
5268850|NCT00707655|12951398|P1|COMPLETED|Overall Study||3
5268851|NCT00707655|12951397|P2|STARTED|Overall Study||5
5268852|NCT00707655|12951398|P1|STARTED|Overall Study||3
5268853|NCT00707577|12951410|P2|NOT COMPLETED|Overall Study||38
5268854|NCT00707577|12951411|P1|NOT COMPLETED|Overall Study||54
5268855|NCT00707577|12951410|P2|COMPLETED|Overall Study||118
5268856|NCT00707577|12951411|P1|COMPLETED|Overall Study||120
5268857|NCT00707577|12951410|P2|STARTED|Overall Study||156
5268858|NCT00707577|12951411|P1|STARTED|Overall Study||174
5268859|NCT00707486|12951417|P1|NOT COMPLETED|Overall Study||1
5268860|NCT00707486|12951417|P1|COMPLETED|Overall Study||71
5268861|NCT00707486|12951417|P1|STARTED|Overall Study||72
5268862|NCT00707447|12951428|P2|NOT COMPLETED|Overall Study||8
5268863|NCT00707447|12951429|P1|NOT COMPLETED|Overall Study||8
5268864|NCT00707447|12951428|P2|COMPLETED|Overall Study||85
5268865|NCT00707447|12951429|P1|COMPLETED|Overall Study||81
5268866|NCT00707447|12951428|P2|STARTED|Overall Study||93
5268867|NCT00707447|12951429|P1|STARTED|Overall Study||89
5268868|NCT00707434|12951453|P1|NOT COMPLETED|Overall Study||1
5268869|NCT00707434|12951453|P1|COMPLETED|Overall Study||5
5268870|NCT00707434|12951453|P1|STARTED|Overall Study||6
5268871|NCT00707343|12951457|P1|NOT COMPLETED|Overall Study||0
5268872|NCT00707343|12951457|P1|COMPLETED|Overall Study||15
5268873|NCT00707343|12951457|P1|STARTED|Overall Study||15
5268874|NCT00707239|12951464|P3|NOT COMPLETED|Overall Study||14
5268875|NCT00707239|12951465|P2|NOT COMPLETED|Overall Study||11
5268876|NCT00707239|12951466|P1|NOT COMPLETED|Overall Study||19
5268877|NCT00707239|12951464|P3|COMPLETED|Overall Study||21
5268878|NCT00707239|12951465|P2|COMPLETED|Overall Study||25
5268879|NCT00707239|12951466|P1|COMPLETED|Overall Study||18
5268880|NCT00707239|12951464|P3|Treated|Overall Study||34
5268881|NCT00707239|12951465|P2|Treated|Overall Study||35
5268882|NCT00707239|12951466|P1|Treated|Overall Study||36
5268883|NCT00707239|12951464|P3|STARTED|Overall Study||35
5268884|NCT00707239|12951465|P2|STARTED|Overall Study||36
5268885|NCT00707239|12951466|P1|STARTED|Overall Study||37
5268886|NCT00707174|12951514|P2|NOT COMPLETED|Overall Study||7
5268887|NCT00707174|12951515|P1|NOT COMPLETED|Overall Study||5
5268888|NCT00707174|12951514|P2|COMPLETED|Overall Study||37
5268889|NCT00707174|12951515|P1|COMPLETED|Overall Study||41
5268890|NCT00707174|12951514|P2|STARTED|Overall Study||44
5268891|NCT00707174|12951515|P1|STARTED|Overall Study||46
5268892|NCT00707161|12951521|P1|NOT COMPLETED|Overall Study||6
5268893|NCT00707161|12951521|P1|COMPLETED|Overall Study||0
5268894|NCT00707161|12951521|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
5268895|NCT00707057|12951527|P2|NOT COMPLETED|Overall Study||4
5268896|NCT00707057|12951528|P1|NOT COMPLETED|Overall Study||8
5268897|NCT00707057|12951527|P2|COMPLETED|Overall Study||83
5268898|NCT00707057|12951528|P1|COMPLETED|Overall Study||161
5268899|NCT00707057|12951527|P2|STARTED|Overall Study||87
5268900|NCT00707057|12951528|P1|STARTED|Overall Study||169
5268901|NCT00707031|12951562|P2|NOT COMPLETED|Overall Study||99
5268902|NCT00707031|12951563|P1|NOT COMPLETED|Overall Study||104
5268903|NCT00707031|12951562|P2|COMPLETED|Overall Study||220
5268904|NCT00707031|12951563|P1|COMPLETED|Overall Study||216
5268905|NCT00707031|12951562|P2|Modified Intent-to-Treat Population|Overall Study||315
5268906|NCT00707031|12951563|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
5268907|NCT00707031|12951562|P2|Treated/Safety Population|Overall Study||316
5268908|NCT00707031|12951563|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
5268909|NCT00707031|12951562|P2|STARTED|Overall Study||319
5268910|NCT00707031|12951563|P1|STARTED|Overall Study|Randomized|320
5268911|NCT00706992|12951592|P7|NOT COMPLETED|Overall Study||3
5268912|NCT00706992|12951593|P6|NOT COMPLETED|Overall Study||2
5268913|NCT00706992|12951594|P5|NOT COMPLETED|Overall Study||4
5268914|NCT00706992|12951595|P4|NOT COMPLETED|Overall Study||2
5268915|NCT00706992|12951596|P3|NOT COMPLETED|Overall Study||6
5268916|NCT00706992|12951597|P2|NOT COMPLETED|Overall Study||5
5268917|NCT00706992|12951598|P1|NOT COMPLETED|Overall Study||5
5268918|NCT00706992|12951592|P7|COMPLETED|Overall Study||3
5268919|NCT00706992|12951593|P6|COMPLETED|Overall Study||3
5268920|NCT00706992|12951594|P5|COMPLETED|Overall Study||2
5268921|NCT00706992|12951595|P4|COMPLETED|Overall Study||6
5268922|NCT00706992|12951596|P3|COMPLETED|Overall Study||3
5268923|NCT00706992|12951597|P2|COMPLETED|Overall Study||3
5268924|NCT00706992|12951598|P1|COMPLETED|Overall Study||3
5268925|NCT00706992|12951592|P7|STARTED|Overall Study||6
5268926|NCT00706992|12951593|P6|STARTED|Overall Study||5
5268927|NCT00706992|12951594|P5|STARTED|Overall Study||6
5268928|NCT00706992|12951595|P4|STARTED|Overall Study||8
5268929|NCT00706992|12951596|P3|STARTED|Overall Study||9
5268930|NCT00706992|12951597|P2|STARTED|Overall Study||8
5268931|NCT00706992|12951598|P1|STARTED|Overall Study||8
5268932|NCT00706979|12951617|P2|NOT COMPLETED|Overall Study||0
5268933|NCT00706979|12951618|P1|NOT COMPLETED|Overall Study||0
5268934|NCT00706979|12951617|P2|COMPLETED|Overall Study||423
5268935|NCT00706979|12951618|P1|COMPLETED|Overall Study||426
5268936|NCT00706979|12951617|P2|STARTED|Overall Study||423
5268937|NCT00706979|12951618|P1|STARTED|Overall Study||426
5268938|NCT00706966|12951630|P1|NOT COMPLETED|Overall Study||1
5268939|NCT00706966|12951630|P1|COMPLETED|Overall Study||9
5268940|NCT00706966|12951630|P1|STARTED|Overall Study||10
5268941|NCT00706914|12951666|P3|NOT COMPLETED|Overall Study||1
5268942|NCT00706914|12951667|P2|NOT COMPLETED|Overall Study||4
5268943|NCT00706914|12951668|P1|NOT COMPLETED|Overall Study||6
5268944|NCT00706914|12951666|P3|COMPLETED|Overall Study||30
5268945|NCT00706914|12951667|P2|COMPLETED|Overall Study||58
5268946|NCT00706914|12951668|P1|COMPLETED|Overall Study||57
5268947|NCT00706914|12951666|P3|STARTED|Overall Study||31
5268948|NCT00706914|12951667|P2|STARTED|Overall Study||62
5268949|NCT00706914|12951668|P1|STARTED|Overall Study||63
5268950|NCT00706901|12951691|P3|NOT COMPLETED|Overall Study||8
5268951|NCT00706901|12951692|P2|NOT COMPLETED|Overall Study||5
5268952|NCT00706901|12951693|P1|NOT COMPLETED|Overall Study||8
5268953|NCT00706901|12951691|P3|COMPLETED|Overall Study||51
5268954|NCT00706901|12951692|P2|COMPLETED|Overall Study||57
5268955|NCT00706901|12951693|P1|COMPLETED|Overall Study||51
5268956|NCT00706901|12951691|P3|STARTED|Overall Study||59
5268957|NCT00706901|12951692|P2|STARTED|Overall Study||62
5268958|NCT00706901|12951693|P1|STARTED|Overall Study||59
5268959|NCT00706849|12951718|P2|NOT COMPLETED|Follow-up Period||3
5268960|NCT00706849|12951719|P1|NOT COMPLETED|Follow-up Period||0
5268961|NCT00706849|12951718|P2|COMPLETED|Follow-up Period||25
5268962|NCT00706849|12951719|P1|COMPLETED|Follow-up Period||3
5268963|NCT00706849|12951718|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
5268964|NCT00706849|12951719|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
5268965|NCT00706849|12951718|P2|NOT COMPLETED|Treatment Period||10
5268966|NCT00706849|12951719|P1|NOT COMPLETED|Treatment Period||0
5268967|NCT00706849|12951718|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
5268968|NCT00706849|12951719|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
5268969|NCT00706849|12951718|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
5268970|NCT00706849|12951719|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
5268971|NCT00706849|12951718|P2|STARTED|Treatment Period||83
5268972|NCT00706849|12951719|P1|STARTED|Treatment Period||41
5268973|NCT00706836|12951763|P1|NOT COMPLETED|Overall Study||0
5268974|NCT00706836|12951763|P1|COMPLETED|Overall Study||16
5268975|NCT00706836|12951763|P1|STARTED|Overall Study||16
5268976|NCT00706823|12951773|P2|NOT COMPLETED|Overall Study||0
5268977|NCT00706823|12951774|P1|NOT COMPLETED|Overall Study||0
5268978|NCT00706823|12951773|P2|COMPLETED|Overall Study||25
5268979|NCT00706823|12951774|P1|COMPLETED|Overall Study||25
5268980|NCT00706823|12951773|P2|STARTED|Overall Study||25
5268981|NCT00706823|12951774|P1|STARTED|Overall Study||25
5268982|NCT00706810|12951790|P1|NOT COMPLETED|Overall Study||1
5268983|NCT00706810|12951790|P1|COMPLETED|Overall Study||7
5268984|NCT00706810|12951790|P1|STARTED|Overall Study||8
5268985|NCT00706797|12951797|P2|NOT COMPLETED|Overall Study||71
5268986|NCT00706797|12951798|P1|NOT COMPLETED|Overall Study||69
5268987|NCT00706797|12951797|P2|COMPLETED|Overall Study||0
5268988|NCT00706797|12951798|P1|COMPLETED|Overall Study||1
5268989|NCT00706797|12951797|P2|Safety Population|Overall Study||71
5268990|NCT00706797|12951798|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
5268991|NCT00706797|12951797|P2|STARTED|Overall Study||71
5268992|NCT00706797|12951798|P1|STARTED|Overall Study||70
5268993|NCT00706784|12951840|P2|NOT COMPLETED|Overall Study||0
5268994|NCT00706784|12951841|P1|NOT COMPLETED|Overall Study||0
5268995|NCT00706784|12951840|P2|COMPLETED|Overall Study||3
5268996|NCT00706784|12951841|P1|COMPLETED|Overall Study||3
5268997|NCT00706784|12951840|P2|STARTED|Overall Study||3
5268998|NCT00706784|12951841|P1|STARTED|Overall Study||3
5268999|NCT00706719|12951850|P3|NOT COMPLETED|Overall Study||4
5269000|NCT00706719|12951851|P2|NOT COMPLETED|Overall Study||1
5269001|NCT00706719|12951852|P1|NOT COMPLETED|Overall Study||0
5269002|NCT00706719|12951850|P3|COMPLETED|Overall Study||1
5269003|NCT00706719|12951851|P2|COMPLETED|Overall Study||6
5269004|NCT00706719|12951852|P1|COMPLETED|Overall Study||5
5269005|NCT00706719|12951850|P3|STARTED|Overall Study||5
5269006|NCT00706719|12951851|P2|STARTED|Overall Study||7
5269007|NCT00706719|12951852|P1|STARTED|Overall Study||5
5269008|NCT00706706|12951867|P1|NOT COMPLETED|Overall Study||105
5269009|NCT00706706|12951867|P1|COMPLETED|Overall Study||0
5269010|NCT00706706|12951867|P1|STARTED|Overall Study||105
5269011|NCT00706654|12951877|P4|NOT COMPLETED|Depot Maintenance Phase||70
5269012|NCT00706654|12951878|P3|NOT COMPLETED|Depot Maintenance Phase||88
5269013|NCT00706654|12951879|P2|NOT COMPLETED|Depot Maintenance Phase||69
5269014|NCT00706654|12951880|P1|NOT COMPLETED|Depot Maintenance Phase||0
5269015|NCT00706654|12951877|P4|COMPLETED|Depot Maintenance Phase||61
5269016|NCT00706654|12951878|P3|COMPLETED|Depot Maintenance Phase||178
5269017|NCT00706654|12951879|P2|COMPLETED|Depot Maintenance Phase||196
5269018|NCT00706654|12951880|P1|COMPLETED|Depot Maintenance Phase||0
5269019|NCT00706654|12951877|P4|STARTED|Depot Maintenance Phase||131
5269020|NCT00706654|12951878|P3|STARTED|Depot Maintenance Phase||266
5269021|NCT00706654|12951879|P2|STARTED|Depot Maintenance Phase||265
5269022|NCT00706654|12951880|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
5269023|NCT00706654|12951877|P4|NOT COMPLETED|Oral Stabilization Phase||0
5269024|NCT00706654|12951878|P3|NOT COMPLETED|Oral Stabilization Phase||0
5269025|NCT00706654|12951879|P2|NOT COMPLETED|Oral Stabilization Phase||0
5269026|NCT00706654|12951880|P1|NOT COMPLETED|Oral Stabilization Phase||180
5269027|NCT00706654|12951877|P4|COMPLETED|Oral Stabilization Phase||0
5269028|NCT00706654|12951878|P3|COMPLETED|Oral Stabilization Phase||0
5269029|NCT00706654|12951879|P2|COMPLETED|Oral Stabilization Phase||0
5269030|NCT00706654|12951880|P1|COMPLETED|Oral Stabilization Phase||662
5269031|NCT00706654|12951877|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269032|NCT00706654|12951878|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269033|NCT00706654|12951879|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269034|NCT00706654|12951880|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
5269035|NCT00706654|12951877|P4|NOT COMPLETED|Conversion Phase||0
5269036|NCT00706654|12951878|P3|NOT COMPLETED|Conversion Phase||0
5269037|NCT00706654|12951879|P2|NOT COMPLETED|Conversion Phase||0
5269038|NCT00706654|12951880|P1|NOT COMPLETED|Conversion Phase||95
5269039|NCT00706654|12951877|P4|COMPLETED|Conversion Phase||0
5269040|NCT00706654|12951878|P3|COMPLETED|Conversion Phase||0
5269041|NCT00706654|12951879|P2|COMPLETED|Conversion Phase||0
5269042|NCT00706654|12951880|P1|COMPLETED|Conversion Phase||614
5269043|NCT00706654|12951877|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
5269044|NCT00706654|12951878|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
5269045|NCT00706654|12951879|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
5269046|NCT00706654|12951880|P1|STARTED|Conversion Phase||709
5269047|NCT00706641|12951899|P1|NOT COMPLETED|Radical Cystectomy||1
5269048|NCT00706641|12951899|P1|COMPLETED|Radical Cystectomy||22
5269049|NCT00706641|12951899|P1|STARTED|Radical Cystectomy||23
5269050|NCT00706641|12951899|P1|NOT COMPLETED|Dasatinib Administration||2
5269051|NCT00706641|12951899|P1|COMPLETED|Dasatinib Administration||23
5269052|NCT00706641|12951899|P1|Toxicity Evaluation|Dasatinib Administration||24
5269053|NCT00706641|12951899|P1|STARTED|Dasatinib Administration||25
5269054|NCT00706628|12951913|P4|NOT COMPLETED|Overall Study||3
5269055|NCT00706628|12951914|P3|NOT COMPLETED|Overall Study||16
5269056|NCT00706628|12951915|P2|NOT COMPLETED|Overall Study||21
5269057|NCT00706628|12951916|P1|NOT COMPLETED|Overall Study||47
5269058|NCT00706628|12951913|P4|COMPLETED|Overall Study||0
5269059|NCT00706628|12951914|P3|COMPLETED|Overall Study||0
5269060|NCT00706628|12951915|P2|COMPLETED|Overall Study||0
5269061|NCT00706628|12951916|P1|COMPLETED|Overall Study||0
5269062|NCT00706628|12951913|P4|STARTED|Overall Study||3
5269063|NCT00706628|12951914|P3|STARTED|Overall Study||16
5269064|NCT00706628|12951915|P2|STARTED|Overall Study||21
5269065|NCT00706628|12951916|P1|STARTED|Overall Study||47
5269066|NCT00706589|12951966|P2|NOT COMPLETED|Overall Study||4
5269067|NCT00706589|12951967|P1|NOT COMPLETED|Overall Study||3
5269068|NCT00706589|12951966|P2|COMPLETED|Overall Study||25
5269069|NCT00706589|12951967|P1|COMPLETED|Overall Study||29
5269070|NCT00706589|12951966|P2|STARTED|Overall Study||29
5269071|NCT00706589|12951967|P1|STARTED|Overall Study||32
5269072|NCT00706563|12951975|P2|NOT COMPLETED|Overall Study||0
5269073|NCT00706563|12951976|P1|NOT COMPLETED|Overall Study||0
5269074|NCT00706563|12951975|P2|COMPLETED|Overall Study||59
5269075|NCT00706563|12951976|P1|COMPLETED|Overall Study||61
5269076|NCT00706563|12951975|P2|STARTED|Overall Study||59
5269077|NCT00706563|12951976|P1|STARTED|Overall Study||61
5269078|NCT00706550|12952000|P2|NOT COMPLETED|Overall Study||28
5269079|NCT00706550|12952001|P1|NOT COMPLETED|Overall Study||7
5269080|NCT00706550|12952000|P2|COMPLETED|Overall Study||36
5269081|NCT00706550|12952001|P1|COMPLETED|Overall Study||36
5269082|NCT00706550|12952000|P2|STARTED|Overall Study||64
5269083|NCT00706550|12952001|P1|STARTED|Overall Study||43
5269084|NCT00706511|12952021|P4|NOT COMPLETED|Overall Study||0
5269085|NCT00706511|12952022|P3|NOT COMPLETED|Overall Study||0
5269086|NCT00706511|12952023|P2|NOT COMPLETED|Overall Study||0
5269087|NCT00706511|12952024|P1|NOT COMPLETED|Overall Study||1
5269088|NCT00706511|12952021|P4|COMPLETED|Overall Study||10
5269089|NCT00706511|12952022|P3|COMPLETED|Overall Study||3
5269090|NCT00706511|12952023|P2|COMPLETED|Overall Study||4
5269091|NCT00706511|12952024|P1|COMPLETED|Overall Study||9
5269092|NCT00706511|12952021|P4|STARTED|Overall Study||10
5269093|NCT00706511|12952022|P3|STARTED|Overall Study||3
5269094|NCT00706511|12952023|P2|STARTED|Overall Study||4
5269095|NCT00706511|12952024|P1|STARTED|Overall Study||10
5269096|NCT00706485|12952056|P1|NOT COMPLETED|Overall Study||0
5269097|NCT00706485|12952056|P1|COMPLETED|Overall Study||5
5269098|NCT00706485|12952056|P1|STARTED|Overall Study||5
5269099|NCT00706446|12952068|P6|NOT COMPLETED|Overall Study||38
5269100|NCT00706446|12952069|P5|NOT COMPLETED|Overall Study||44
5269101|NCT00706446|12952070|P4|NOT COMPLETED|Overall Study||22
5269102|NCT00706446|12952071|P3|NOT COMPLETED|Overall Study||37
5269103|NCT00706446|12952072|P2|NOT COMPLETED|Overall Study||49
5269104|NCT00706446|12952073|P1|NOT COMPLETED|Overall Study||26
5269105|NCT00706446|12952068|P6|COMPLETED|Overall Study||7
5269106|NCT00706446|12952069|P5|COMPLETED|Overall Study||10
5269107|NCT00706446|12952070|P4|COMPLETED|Overall Study||4
5269108|NCT00706446|12952071|P3|COMPLETED|Overall Study||7
5269109|NCT00706446|12952072|P2|COMPLETED|Overall Study||8
5269110|NCT00706446|12952073|P1|COMPLETED|Overall Study||3
5269111|NCT00706446|12952068|P6|STARTED|Overall Study||45
5269112|NCT00706446|12952069|P5|STARTED|Overall Study||54
5269113|NCT00706446|12952070|P4|STARTED|Overall Study||26
5269114|NCT00706446|12952071|P3|STARTED|Overall Study||44
5269115|NCT00706446|12952072|P2|STARTED|Overall Study||57
5269116|NCT00706446|12952073|P1|STARTED|Overall Study||29
5269117|NCT00706433|12952115|P4|NOT COMPLETED|Overall Study||2
5269118|NCT00706433|12952116|P3|NOT COMPLETED|Overall Study||10
5269119|NCT00706433|12952117|P2|NOT COMPLETED|Overall Study||3
5269120|NCT00706433|12952118|P1|NOT COMPLETED|Overall Study||5
5269121|NCT00706433|12952115|P4|COMPLETED|Overall Study||64
5269122|NCT00706433|12952116|P3|COMPLETED|Overall Study||57
5269123|NCT00706433|12952117|P2|COMPLETED|Overall Study||62
5269124|NCT00706433|12952118|P1|COMPLETED|Overall Study||63
5269125|NCT00706433|12952115|P4|STARTED|Overall Study||66
5269126|NCT00706433|12952116|P3|STARTED|Overall Study||67
5269127|NCT00706433|12952117|P2|STARTED|Overall Study||65
5269128|NCT00706433|12952118|P1|STARTED|Overall Study||68
5269129|NCT00706407|12952434|P1|NOT COMPLETED|Overall Study||9
5269130|NCT00706407|12952434|P1|COMPLETED|Overall Study||33
5269131|NCT00706407|12952434|P1|STARTED|Overall Study||42
5269132|NCT00706381|12952445|P4|NOT COMPLETED|Overall Study||0
5269133|NCT00706381|12952446|P3|NOT COMPLETED|Overall Study||1
5269134|NCT00706381|12952447|P2|NOT COMPLETED|Overall Study||1
5269135|NCT00706381|12952448|P1|NOT COMPLETED|Overall Study||0
5269136|NCT00706381|12952445|P4|COMPLETED|Overall Study||9
5269137|NCT00706381|12952446|P3|COMPLETED|Overall Study||5
5269138|NCT00706381|12952447|P2|COMPLETED|Overall Study||5
5269139|NCT00706381|12952448|P1|COMPLETED|Overall Study||10
5269140|NCT00706381|12952445|P4|Intervention 5 (1 Day)|Overall Study||9
5269141|NCT00706381|12952446|P3|Intervention 5 (1 Day)|Overall Study||5
5269142|NCT00706381|12952447|P2|Intervention 5 (1 Day)|Overall Study||5
5269143|NCT00706381|12952448|P1|Intervention 5 (1 Day)|Overall Study||10
5269144|NCT00706381|12952445|P4|Intervention 4 (1 Day)|Overall Study||9
5269145|NCT00706381|12952446|P3|Intervention 4 (1 Day)|Overall Study||6
5269146|NCT00706381|12952447|P2|Intervention 4 (1 Day)|Overall Study||5
5269147|NCT00706381|12952448|P1|Intervention 4 (1 Day)|Overall Study||10
5269148|NCT00706381|12952445|P4|Intervention 3 (1 Day)|Overall Study||9
5269149|NCT00706381|12952446|P3|Intervention 3 (1 Day)|Overall Study||6
5269150|NCT00706381|12952447|P2|Intervention 3 (1 Day)|Overall Study||6
5269151|NCT00706381|12952448|P1|Intervention 3 (1 Day)|Overall Study||10
5269152|NCT00706381|12952445|P4|Intervention 2 (1 Day)|Overall Study||9
5269153|NCT00706381|12952446|P3|Intervention 2 (1 Day)|Overall Study||6
5269154|NCT00706381|12952447|P2|Intervention 2 (1 Day)|Overall Study||6
5269155|NCT00706381|12952448|P1|Intervention 2 (1 Day)|Overall Study||10
5269156|NCT00706381|12952445|P4|Intervention 1 (1 Day)|Overall Study||9
5269157|NCT00706381|12952446|P3|Intervention 1 (1 Day)|Overall Study||6
5269158|NCT00706381|12952447|P2|Intervention 1 (1 Day)|Overall Study||6
5269159|NCT00706381|12952448|P1|Intervention 1 (1 Day)|Overall Study||10
5269160|NCT00706381|12952445|P4|STARTED|Overall Study||9
5269161|NCT00706381|12952446|P3|STARTED|Overall Study||6
5269162|NCT00706381|12952447|P2|STARTED|Overall Study||6
5269163|NCT00706381|12952448|P1|STARTED|Overall Study||10
5269164|NCT00706355|12952469|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
5269165|NCT00706355|12952470|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
5269166|NCT00706355|12952471|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
5269167|NCT00706355|12952472|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
5269168|NCT00706355|12952469|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
5269169|NCT00706355|12952470|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
5269170|NCT00706355|12952471|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
5269171|NCT00706355|12952472|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
5269172|NCT00706355|12952469|P4|STARTED|Period 4: PF-04217903 150 mg||4
5269173|NCT00706355|12952470|P3|STARTED|Period 4: PF-04217903 150 mg||0
5269174|NCT00706355|12952471|P2|STARTED|Period 4: PF-04217903 150 mg||0
5269175|NCT00706355|12952472|P1|STARTED|Period 4: PF-04217903 150 mg||0
5269176|NCT00706355|12952469|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
5269177|NCT00706355|12952470|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
5269178|NCT00706355|12952471|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
5269179|NCT00706355|12952472|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
5269180|NCT00706355|12952469|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
5269181|NCT00706355|12952470|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
5269182|NCT00706355|12952471|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
5269183|NCT00706355|12952472|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
5269184|NCT00706355|12952469|P4|STARTED|Period 3: PF-04217903 200 mg||0
5269185|NCT00706355|12952470|P3|STARTED|Period 3: PF-04217903 200 mg||2
5269186|NCT00706355|12952471|P2|STARTED|Period 3: PF-04217903 200 mg||0
5269187|NCT00706355|12952472|P1|STARTED|Period 3: PF-04217903 200 mg||0
5269188|NCT00706355|12952469|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
5269189|NCT00706355|12952470|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
5269190|NCT00706355|12952471|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
5269191|NCT00706355|12952472|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
5269192|NCT00706355|12952469|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
5269193|NCT00706355|12952470|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
5269194|NCT00706355|12952471|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
5269195|NCT00706355|12952472|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
5269196|NCT00706355|12952469|P4|STARTED|Period 2: PF-04217903 100 mg||0
5269197|NCT00706355|12952470|P3|STARTED|Period 2: PF-04217903 100 mg||0
5269198|NCT00706355|12952471|P2|STARTED|Period 2: PF-04217903 100 mg||7
5269199|NCT00706355|12952472|P1|STARTED|Period 2: PF-04217903 100 mg||0
5269200|NCT00706355|12952469|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
5269201|NCT00706355|12952470|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
5269202|NCT00706355|12952471|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
5269203|NCT00706355|12952472|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
5269204|NCT00706355|12952469|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
5269205|NCT00706355|12952470|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
5269206|NCT00706355|12952471|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
5269207|NCT00706355|12952472|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
5269208|NCT00706355|12952469|P4|STARTED|Period 1: PF-04217903 50 mg||0
5269209|NCT00706355|12952470|P3|STARTED|Period 1: PF-04217903 50 mg||0
5269210|NCT00706355|12952471|P2|STARTED|Period 1: PF-04217903 50 mg||0
5269211|NCT00706355|12952472|P1|STARTED|Period 1: PF-04217903 50 mg||3
5269212|NCT00706342|12952524|P1|NOT COMPLETED|Overall Study||18
5269213|NCT00706342|12952524|P1|COMPLETED|Overall Study||0
5269214|NCT00706342|12952524|P1|STARTED|Overall Study||18
5269215|NCT00706329|12952533|P1|NOT COMPLETED|Overall Study||0
5269216|NCT00706329|12952533|P1|COMPLETED|Overall Study||25
5269217|NCT00706329|12952533|P1|STARTED|Overall Study||25
5269218|NCT00706238|12952537|P1|NOT COMPLETED|Overall Study||5
5269219|NCT00706238|12952537|P1|COMPLETED|Overall Study||0
5269220|NCT00706238|12952537|P1|STARTED|Overall Study||5
5269221|NCT00706134|12952554|P4|NOT COMPLETED|Overall Study||11
5269222|NCT00706134|12952555|P3|NOT COMPLETED|Overall Study||6
5269223|NCT00706134|12952556|P2|NOT COMPLETED|Overall Study||19
5269224|NCT00706134|12952557|P1|NOT COMPLETED|Overall Study||20
5269225|NCT00706134|12952554|P4|COMPLETED|Overall Study||175
5269226|NCT00706134|12952555|P3|COMPLETED|Overall Study||183
5269227|NCT00706134|12952556|P2|COMPLETED|Overall Study||173
5269228|NCT00706134|12952557|P1|COMPLETED|Overall Study||169
5269229|NCT00706134|12952554|P4|Entered Double-blind Period|Overall Study||186
5269230|NCT00706134|12952555|P3|Entered Double-blind Period|Overall Study||189
5269231|NCT00706134|12952556|P2|Entered Double-blind Period|Overall Study||192
5269232|NCT00706134|12952557|P1|Entered Double-blind Period|Overall Study||187
5269233|NCT00706134|12952554|P4|STARTED|Overall Study||186
5269234|NCT00706134|12952555|P3|STARTED|Overall Study||189
5269235|NCT00706134|12952556|P2|STARTED|Overall Study||192
5269236|NCT00706134|12952557|P1|STARTED|Overall Study||189
5269237|NCT00706121|12952591|P4|NOT COMPLETED|Overall Study||352
5269238|NCT00706121|12952592|P3|NOT COMPLETED|Overall Study||404
5269239|NCT00706121|12952593|P2|NOT COMPLETED|Overall Study||396
5269240|NCT00706121|12952594|P1|NOT COMPLETED|Overall Study||396
5269241|NCT00706121|12952591|P4|COMPLETED|Overall Study||1577
5269242|NCT00706121|12952592|P3|COMPLETED|Overall Study||1626
5269243|NCT00706121|12952593|P2|COMPLETED|Overall Study||1700
5269244|NCT00706121|12952594|P1|COMPLETED|Overall Study||1643
5269245|NCT00706121|12952591|P4|STARTED|Overall Study||1929
5269246|NCT00706121|12952592|P3|STARTED|Overall Study||2030
5269247|NCT00706121|12952593|P2|STARTED|Overall Study||2096
5269248|NCT00706121|12952594|P1|STARTED|Overall Study||2039
5269249|NCT00706095|12952623|P3|NOT COMPLETED|Overall Study||5
5269250|NCT00706095|12952624|P2|NOT COMPLETED|Overall Study||7
5269251|NCT00706095|12952625|P1|NOT COMPLETED|Overall Study||6
5269252|NCT00706095|12952623|P3|COMPLETED|Overall Study||0
5269253|NCT00706095|12952624|P2|COMPLETED|Overall Study||0
5269254|NCT00706095|12952625|P1|COMPLETED|Overall Study||0
5269255|NCT00706095|12952623|P3|STARTED|Overall Study||5
5269256|NCT00706095|12952624|P2|STARTED|Overall Study||7
5269257|NCT00706095|12952625|P1|STARTED|Overall Study||6
5269258|NCT00706030|12952643|P4|NOT COMPLETED|Overall Study||16
5269259|NCT00706030|12952644|P3|NOT COMPLETED|Overall Study||60
5269260|NCT00706030|12952645|P2|NOT COMPLETED|Overall Study||6
5269261|NCT00706030|12952646|P1|NOT COMPLETED|Overall Study||6
5269262|NCT00706030|12952643|P4|COMPLETED|Overall Study||0
5269263|NCT00706030|12952644|P3|COMPLETED|Overall Study||4
5269264|NCT00706030|12952645|P2|COMPLETED|Overall Study||0
5269265|NCT00706030|12952646|P1|COMPLETED|Overall Study||0
5269266|NCT00706030|12952643|P4|Treated|Overall Study||15
5269267|NCT00706030|12952644|P3|Treated|Overall Study||64
5269268|NCT00706030|12952645|P2|Treated|Overall Study||6
5269269|NCT00706030|12952646|P1|Treated|Overall Study||6
5269270|NCT00706030|12952643|P4|STARTED|Overall Study||16
5269271|NCT00706030|12952644|P3|STARTED|Overall Study||64
5269272|NCT00706030|12952645|P2|STARTED|Overall Study||6
5269273|NCT00706030|12952646|P1|STARTED|Overall Study||6
5269274|NCT00706004|12952661|P1|NOT COMPLETED|Overall Study||2
5269275|NCT00706004|12952661|P1|COMPLETED|Overall Study||7
5269276|NCT00706004|12952661|P1|STARTED|Overall Study||9
5269277|NCT00705939|12952689|P3|NOT COMPLETED|Overall Study||4
5269278|NCT00705939|12952690|P2|NOT COMPLETED|Overall Study||2
5269279|NCT00705939|12952691|P1|NOT COMPLETED|Overall Study||0
5269280|NCT00705939|12952689|P3|COMPLETED|Overall Study||14
5269281|NCT00705939|12952690|P2|COMPLETED|Overall Study||12
5269282|NCT00705939|12952691|P1|COMPLETED|Overall Study||12
5269283|NCT00705939|12952689|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
5269284|NCT00705939|12952690|P2|STARTED|Overall Study||14
5269285|NCT00705939|12952691|P1|STARTED|Overall Study||12
5269286|NCT00705874|12952721|P7|NOT COMPLETED|Overall Study||0
5269287|NCT00705874|12952722|P6|NOT COMPLETED|Overall Study||4
5269288|NCT00705874|12952723|P5|NOT COMPLETED|Overall Study||12
5269289|NCT00705874|12952724|P4|NOT COMPLETED|Overall Study||1
5269290|NCT00705874|12952725|P3|NOT COMPLETED|Overall Study||2
5269291|NCT00705874|12952726|P2|NOT COMPLETED|Overall Study||1
5269292|NCT00705874|12952727|P1|NOT COMPLETED|Overall Study||2
5269293|NCT00705874|12952721|P7|COMPLETED|Overall Study||3
5269294|NCT00705874|12952722|P6|COMPLETED|Overall Study||28
5269295|NCT00705874|12952723|P5|COMPLETED|Overall Study||36
5269296|NCT00705874|12952724|P4|COMPLETED|Overall Study||33
5269297|NCT00705874|12952725|P3|COMPLETED|Overall Study||32
5269298|NCT00705874|12952726|P2|COMPLETED|Overall Study||8
5269299|NCT00705874|12952727|P1|COMPLETED|Overall Study||10
5269300|NCT00705874|12952721|P7|STARTED|Overall Study||3
5269301|NCT00705874|12952722|P6|STARTED|Overall Study||32
5269302|NCT00705874|12952723|P5|STARTED|Overall Study||48
5269303|NCT00705874|12952724|P4|STARTED|Overall Study||34
5269304|NCT00705874|12952725|P3|STARTED|Overall Study||34
5269305|NCT00705874|12952726|P2|STARTED|Overall Study||9
5269306|NCT00705874|12952727|P1|STARTED|Overall Study||12
5269307|NCT00705783|12952745|P3|NOT COMPLETED|Depot Maintenance Phase||131
5269308|NCT00705783|12952746|P2|NOT COMPLETED|Depot Maintenance Phase||246
5269309|NCT00705783|12952747|P1|NOT COMPLETED|Depot Maintenance Phase||0
5269310|NCT00705783|12952745|P3|COMPLETED|Depot Maintenance Phase||3
5269311|NCT00705783|12952746|P2|COMPLETED|Depot Maintenance Phase||23
5269312|NCT00705783|12952747|P1|COMPLETED|Depot Maintenance Phase||0
5269313|NCT00705783|12952745|P3|STARTED|Depot Maintenance Phase||134
5269314|NCT00705783|12952746|P2|STARTED|Depot Maintenance Phase||269
5269315|NCT00705783|12952747|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
5269316|NCT00705783|12952745|P3|NOT COMPLETED|Depot Stabilization Phase||0
5269317|NCT00705783|12952746|P2|NOT COMPLETED|Depot Stabilization Phase||0
5269318|NCT00705783|12952747|P1|NOT COMPLETED|Depot Stabilization Phase||173
5269319|NCT00705783|12952745|P3|COMPLETED|Depot Stabilization Phase||0
5269320|NCT00705783|12952746|P2|COMPLETED|Depot Stabilization Phase||0
5269321|NCT00705783|12952747|P1|COMPLETED|Depot Stabilization Phase||403
5269322|NCT00705783|12952745|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269323|NCT00705783|12952746|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269324|NCT00705783|12952747|P1|STARTED|Depot Stabilization Phase||576
5269325|NCT00705783|12952745|P3|NOT COMPLETED|Oral Stabilization Phase||0
5269326|NCT00705783|12952746|P2|NOT COMPLETED|Oral Stabilization Phase||0
5269327|NCT00705783|12952747|P1|NOT COMPLETED|Oral Stabilization Phase||134
5269328|NCT00705783|12952745|P3|COMPLETED|Oral Stabilization Phase||0
5269329|NCT00705783|12952746|P2|COMPLETED|Oral Stabilization Phase||0
5269330|NCT00705783|12952747|P1|COMPLETED|Oral Stabilization Phase||576
5269331|NCT00705783|12952745|P3|Received Study Medication|Oral Stabilization Phase||0
5269332|NCT00705783|12952746|P2|Received Study Medication|Oral Stabilization Phase||0
5269333|NCT00705783|12952747|P1|Received Study Medication|Oral Stabilization Phase||709
5269334|NCT00705783|12952745|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269335|NCT00705783|12952746|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
5269336|NCT00705783|12952747|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
5269337|NCT00705783|12952745|P3|NOT COMPLETED|Conversion Phase||0
5269338|NCT00705783|12952746|P2|NOT COMPLETED|Conversion Phase||0
5269339|NCT00705783|12952747|P1|NOT COMPLETED|Conversion Phase||133
5269340|NCT00705783|12952745|P3|COMPLETED|Conversion Phase||0
5269341|NCT00705783|12952746|P2|COMPLETED|Conversion Phase||0
5269342|NCT00705783|12952747|P1|COMPLETED|Conversion Phase||500
5269343|NCT00705783|12952745|P3|Received Study Medication|Conversion Phase||0
5269344|NCT00705783|12952746|P2|Received Study Medication|Conversion Phase||0
5269345|NCT00705783|12952747|P1|Received Study Medication|Conversion Phase||632
5269346|NCT00705783|12952745|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
5269347|NCT00705783|12952746|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
5269348|NCT00705783|12952747|P1|STARTED|Conversion Phase||633
5269349|NCT00705757|12952777|P3|NOT COMPLETED|Overall Study||11
5269350|NCT00705757|12952778|P2|NOT COMPLETED|Overall Study||8
5269351|NCT00705757|12952779|P1|NOT COMPLETED|Overall Study||13
5269352|NCT00705757|12952777|P3|COMPLETED|Overall Study||17
5269353|NCT00705757|12952778|P2|COMPLETED|Overall Study||21
5269354|NCT00705757|12952779|P1|COMPLETED|Overall Study||19
5269355|NCT00705757|12952777|P3|STARTED|Overall Study||28
5269356|NCT00705757|12952778|P2|STARTED|Overall Study||29
5269357|NCT00705757|12952779|P1|STARTED|Overall Study||32
5269358|NCT00705718|12952789|P2|NOT COMPLETED|Overall Study||22
5269359|NCT00705718|12952790|P1|NOT COMPLETED|Overall Study||7
5269360|NCT00705718|12952789|P2|COMPLETED|Overall Study||128
5269361|NCT00705718|12952790|P1|COMPLETED|Overall Study||37
5269362|NCT00705718|12952789|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
5269363|NCT00705718|12952790|P1|12 Month Follow up|Overall Study|2 Deaths|37
5269364|NCT00705718|12952789|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
5269365|NCT00705718|12952790|P1|6 Month Follow up|Overall Study|3 Deaths|40
5269366|NCT00705718|12952789|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
5269367|NCT00705718|12952790|P1|1 Month Follow up|Overall Study|1 Death|43
5269368|NCT00705718|12952789|P2|STARTED|Overall Study||150
5269369|NCT00705718|12952790|P1|STARTED|Overall Study||44
5269370|NCT00705679|12952811|P5|NOT COMPLETED|Overall Study||69
5269371|NCT00705679|12952812|P4|NOT COMPLETED|Overall Study||80
5269372|NCT00705679|12952813|P3|NOT COMPLETED|Overall Study||115
5269373|NCT00705679|12952814|P2|NOT COMPLETED|Overall Study||139
5269374|NCT00705679|12952815|P1|NOT COMPLETED|Overall Study||65
5269375|NCT00705679|12952811|P5|COMPLETED|Overall Study||934
5269376|NCT00705679|12952812|P4|COMPLETED|Overall Study||927
5269377|NCT00705679|12952813|P3|COMPLETED|Overall Study||894
5269378|NCT00705679|12952814|P2|COMPLETED|Overall Study||864
5269379|NCT00705679|12952815|P1|COMPLETED|Overall Study||942
5269380|NCT00705679|12952811|P5|STARTED|Overall Study||1003
5269381|NCT00705679|12952812|P4|STARTED|Overall Study||1007
5269382|NCT00705679|12952813|P3|STARTED|Overall Study||1009
5269383|NCT00705679|12952814|P2|STARTED|Overall Study||1003
5269384|NCT00705679|12952815|P1|STARTED|Overall Study||1007
5269385|NCT00705666|12952850|P1|NOT COMPLETED|Overall Study||339
5269386|NCT00705666|12952850|P1|COMPLETED|Overall Study||450
5269387|NCT00705666|12952850|P1|STARTED|Overall Study||789
5269388|NCT00705653|12952854|P1|NOT COMPLETED|Overall Study||0
5269389|NCT00705653|12952854|P1|COMPLETED|Overall Study||46
5269390|NCT00705653|12952854|P1|STARTED|Overall Study||46
5269391|NCT00705614|12952861|P2|NOT COMPLETED|Switch to Remicade||49
5269392|NCT00705614|12952862|P1|NOT COMPLETED|Switch to Remicade||0
5269393|NCT00705614|12952861|P2|COMPLETED|Switch to Remicade||249
5269394|NCT00705614|12952862|P1|COMPLETED|Switch to Remicade||0
5269395|NCT00705614|12952861|P2|STARTED|Switch to Remicade||298
5269396|NCT00705614|12952862|P1|STARTED|Switch to Remicade||0
5269397|NCT00705614|12952861|P2|NOT COMPLETED|Initial Intervention||321
5269398|NCT00705614|12952862|P1|NOT COMPLETED|Initial Intervention||518
5269399|NCT00705614|12952861|P2|COMPLETED|Initial Intervention||800
5269400|NCT00705614|12952862|P1|COMPLETED|Initial Intervention||1023
5269401|NCT00705614|12952861|P2|STARTED|Initial Intervention||1121
5269402|NCT00705614|12952862|P1|STARTED|Initial Intervention||1541
5269403|NCT00705575|12952911|P2|NOT COMPLETED|Overall Study||46
5269404|NCT00705575|12952912|P1|NOT COMPLETED|Overall Study||23
5269405|NCT00705575|12952911|P2|COMPLETED|Overall Study||293
5269406|NCT00705575|12952912|P1|COMPLETED|Overall Study||326
5269407|NCT00705575|12952911|P2|STARTED|Overall Study||339
5269408|NCT00705575|12952912|P1|STARTED|Overall Study||349
5269409|NCT00705536|12952926|P4|NOT COMPLETED|Completed Study||0
5269410|NCT00705536|12952927|P3|NOT COMPLETED|Completed Study||0
5269411|NCT00705536|12952928|P2|NOT COMPLETED|Completed Study||0
5269412|NCT00705536|12952929|P1|NOT COMPLETED|Completed Study||0
5269413|NCT00705536|12952926|P4|COMPLETED|Completed Study||6
5269414|NCT00705536|12952927|P3|COMPLETED|Completed Study||7
5269415|NCT00705536|12952928|P2|COMPLETED|Completed Study||6
5269416|NCT00705536|12952929|P1|COMPLETED|Completed Study||6
5269417|NCT00705536|12952926|P4|STARTED|Completed Study||6
5269418|NCT00705536|12952927|P3|STARTED|Completed Study||7
5269419|NCT00705536|12952928|P2|STARTED|Completed Study||6
5269420|NCT00705536|12952929|P1|STARTED|Completed Study||6
5269421|NCT00705536|12952926|P4|NOT COMPLETED|Start Period 2||0
5269422|NCT00705536|12952927|P3|NOT COMPLETED|Start Period 2||0
5269423|NCT00705536|12952928|P2|NOT COMPLETED|Start Period 2||0
5269424|NCT00705536|12952929|P1|NOT COMPLETED|Start Period 2||0
5269425|NCT00705536|12952926|P4|COMPLETED|Start Period 2||6
5269426|NCT00705536|12952927|P3|COMPLETED|Start Period 2||7
5269427|NCT00705536|12952928|P2|COMPLETED|Start Period 2||6
5269428|NCT00705536|12952929|P1|COMPLETED|Start Period 2||6
5269429|NCT00705536|12952926|P4|STARTED|Start Period 2||6
5269430|NCT00705536|12952927|P3|STARTED|Start Period 2||7
5269431|NCT00705536|12952928|P2|STARTED|Start Period 2||6
5269432|NCT00705536|12952929|P1|STARTED|Start Period 2||6
5269433|NCT00705536|12952926|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
5269434|NCT00705536|12952927|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
5269435|NCT00705536|12952928|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
5269436|NCT00705536|12952929|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
5269437|NCT00705536|12952926|P4|COMPLETED|Washout Period of at Least 6 Days||6
5269438|NCT00705536|12952927|P3|COMPLETED|Washout Period of at Least 6 Days||7
5269439|NCT00705536|12952928|P2|COMPLETED|Washout Period of at Least 6 Days||6
5269440|NCT00705536|12952929|P1|COMPLETED|Washout Period of at Least 6 Days||6
5269441|NCT00705536|12952926|P4|STARTED|Washout Period of at Least 6 Days||6
5269442|NCT00705536|12952927|P3|STARTED|Washout Period of at Least 6 Days||7
5269443|NCT00705536|12952928|P2|STARTED|Washout Period of at Least 6 Days||6
5269444|NCT00705536|12952929|P1|STARTED|Washout Period of at Least 6 Days||6
5269445|NCT00705536|12952926|P4|NOT COMPLETED|Start Period 1||1
5269446|NCT00705536|12952927|P3|NOT COMPLETED|Start Period 1||0
5269447|NCT00705536|12952928|P2|NOT COMPLETED|Start Period 1||0
5269448|NCT00705536|12952929|P1|NOT COMPLETED|Start Period 1||0
5269449|NCT00705536|12952926|P4|COMPLETED|Start Period 1||6
5269450|NCT00705536|12952927|P3|COMPLETED|Start Period 1||7
5269451|NCT00705536|12952928|P2|COMPLETED|Start Period 1||6
5269452|NCT00705536|12952929|P1|COMPLETED|Start Period 1||6
5269453|NCT00705536|12952926|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
5269454|NCT00705536|12952927|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
5269455|NCT00705536|12952928|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
5269456|NCT00705536|12952929|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
5269457|NCT00705536|12952926|P4|STARTED|Start Period 1||7
5269458|NCT00705536|12952927|P3|STARTED|Start Period 1||7
5269459|NCT00705536|12952928|P2|STARTED|Start Period 1||6
5269460|NCT00705536|12952929|P1|STARTED|Start Period 1||6
5269461|NCT00705523|12952990|P2|NOT COMPLETED|Overall Study||3
5269462|NCT00705523|12952991|P1|NOT COMPLETED|Overall Study||2
5269463|NCT00705523|12952990|P2|COMPLETED|Overall Study||18
5269464|NCT00705523|12952991|P1|COMPLETED|Overall Study||17
5269465|NCT00705523|12952990|P2|STARTED|Overall Study||21
5269466|NCT00705523|12952991|P1|STARTED|Overall Study||19
5269467|NCT00705484|12953001|P2|NOT COMPLETED|Overall Study||408
5269468|NCT00705484|12953002|P1|NOT COMPLETED|Overall Study||382
5269469|NCT00705484|12953001|P2|COMPLETED|Overall Study||772
5269470|NCT00705484|12953002|P1|COMPLETED|Overall Study||677
5269471|NCT00705484|12953001|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
5269472|NCT00705484|12953002|P1|Follow-up Period|Overall Study||1059
5269473|NCT00705484|12953001|P2|STARTED|Overall Study|Number Enrolled|1180
5269474|NCT00705484|12953002|P1|STARTED|Overall Study|Number Enrolled|1059
5269475|NCT00705432|12953016|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
5269476|NCT00705432|12953017|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
5269477|NCT00705432|12953018|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
5269478|NCT00705432|12953019|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
5269479|NCT00705432|12953020|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
5269480|NCT00705432|12953021|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
5269481|NCT00705432|12953016|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
5269482|NCT00705432|12953017|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
5269483|NCT00705432|12953018|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
5269484|NCT00705432|12953019|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
5269485|NCT00705432|12953020|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
5269486|NCT00705432|12953021|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
5269487|NCT00705432|12953016|P6|STARTED|Follow-up Period (Upto Week 72)||53
5269488|NCT00705432|12953017|P5|STARTED|Follow-up Period (Upto Week 72)||44
5269489|NCT00705432|12953018|P4|STARTED|Follow-up Period (Upto Week 72)||42
5269490|NCT00705432|12953019|P3|STARTED|Follow-up Period (Upto Week 72)||291
5269491|NCT00705432|12953020|P2|STARTED|Follow-up Period (Upto Week 72)||295
5269492|NCT00705432|12953021|P1|STARTED|Follow-up Period (Upto Week 72)||278
5269493|NCT00705432|12953016|P6|NOT COMPLETED|Treatment Period||30
5269494|NCT00705432|12953017|P5|NOT COMPLETED|Treatment Period||28
5269495|NCT00705432|12953018|P4|NOT COMPLETED|Treatment Period||41
5269496|NCT00705432|12953019|P3|NOT COMPLETED|Treatment Period||121
5269497|NCT00705432|12953020|P2|NOT COMPLETED|Treatment Period||111
5269498|NCT00705432|12953021|P1|NOT COMPLETED|Treatment Period||163
5269499|NCT00705432|12953016|P6|COMPLETED|Treatment Period||25
5269500|NCT00705432|12953017|P5|COMPLETED|Treatment Period||24
5269501|NCT00705432|12953018|P4|COMPLETED|Treatment Period||11
5269502|NCT00705432|12953019|P3|COMPLETED|Treatment Period||190
5269503|NCT00705432|12953020|P2|COMPLETED|Treatment Period||205
5269504|NCT00705432|12953021|P1|COMPLETED|Treatment Period||148
5269505|NCT00705432|12953016|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
5269506|NCT00705432|12953017|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
5269507|NCT00705432|12953018|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
5269508|NCT00705432|12953019|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
5269509|NCT00705432|12953020|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
5269510|NCT00705432|12953021|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
5269511|NCT00705432|12953016|P6|STARTED|Treatment Period||55
5269512|NCT00705432|12953017|P5|STARTED|Treatment Period||52
5269513|NCT00705432|12953018|P4|STARTED|Treatment Period||52
5269514|NCT00705432|12953019|P3|STARTED|Treatment Period||311
5269515|NCT00705432|12953020|P2|STARTED|Treatment Period||316
5269516|NCT00705432|12953021|P1|STARTED|Treatment Period||311
5269517|NCT00705406|12953058|P2|NOT COMPLETED|Overall Study||5
5269518|NCT00705406|12953059|P1|NOT COMPLETED|Overall Study||4
5269519|NCT00705406|12953058|P2|COMPLETED|Overall Study||197
5269520|NCT00705406|12953059|P1|COMPLETED|Overall Study||199
5269521|NCT00705406|12953058|P2|STARTED|Overall Study||202
5269522|NCT00705406|12953059|P1|STARTED|Overall Study||203
5269523|NCT00705367|12953083|P2|NOT COMPLETED|Long-term Extension Period||0
5269524|NCT00705367|12953084|P1|NOT COMPLETED|Long-term Extension Period||9
5269525|NCT00705367|12953083|P2|COMPLETED|Long-term Extension Period||0
5269526|NCT00705367|12953084|P1|COMPLETED|Long-term Extension Period||0
5269527|NCT00705367|12953083|P2|STARTED|Long-term Extension Period||0
5269528|NCT00705367|12953084|P1|STARTED|Long-term Extension Period||9
5269529|NCT00705367|12953083|P2|NOT COMPLETED|Short-term Period||0
5269530|NCT00705367|12953084|P1|NOT COMPLETED|Short-term Period||0
5269531|NCT00705367|12953083|P2|COMPLETED|Short-term Period||3
5269532|NCT00705367|12953084|P1|COMPLETED|Short-term Period||6
5269533|NCT00705367|12953083|P2|STARTED|Short-term Period||3
5269534|NCT00705367|12953084|P1|STARTED|Short-term Period||6
5269535|NCT00705341|12953111|P4|NOT COMPLETED|Phase 2: Trial||4
5269536|NCT00705341|12953112|P3|NOT COMPLETED|Phase 2: Trial||7
5269537|NCT00705341|12953113|P2|NOT COMPLETED|Phase 2: Trial||0
5269538|NCT00705341|12953114|P1|NOT COMPLETED|Phase 2: Trial||0
5269539|NCT00705341|12953111|P4|COMPLETED|Phase 2: Trial||28
5269540|NCT00705341|12953112|P3|COMPLETED|Phase 2: Trial||23
5269541|NCT00705341|12953113|P2|COMPLETED|Phase 2: Trial||0
5269542|NCT00705341|12953114|P1|COMPLETED|Phase 2: Trial||0
5269543|NCT00705341|12953111|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
5269544|NCT00705341|12953112|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
5269545|NCT00705341|12953113|P2|STARTED|Phase 2: Trial||0
5269546|NCT00705341|12953114|P1|STARTED|Phase 2: Trial||0
5269547|NCT00705341|12953111|P4|NOT COMPLETED|Phase 1:Control Challenge||0
5269548|NCT00705341|12953112|P3|NOT COMPLETED|Phase 1:Control Challenge||0
5269549|NCT00705341|12953113|P2|NOT COMPLETED|Phase 1:Control Challenge||0
5269550|NCT00705341|12953114|P1|NOT COMPLETED|Phase 1:Control Challenge||0
5269551|NCT00705341|12953111|P4|COMPLETED|Phase 1:Control Challenge||0
5269552|NCT00705341|12953112|P3|COMPLETED|Phase 1:Control Challenge||0
5269553|NCT00705341|12953113|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
5269554|NCT00705341|12953114|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
5269555|NCT00705341|12953111|P4|STARTED|Phase 1:Control Challenge||0
5269556|NCT00705341|12953112|P3|STARTED|Phase 1:Control Challenge||0
5269557|NCT00705341|12953113|P2|STARTED|Phase 1:Control Challenge||93
5269558|NCT00705341|12953114|P1|STARTED|Phase 1:Control Challenge||126
5269559|NCT00705289|12953122|P1|NOT COMPLETED|Overall Study||131
5269560|NCT00705289|12953122|P1|COMPLETED|Overall Study||597
5269561|NCT00705289|12953122|P1|STARTED|Overall Study||728
5269562|NCT00705263|12953146|P1|NOT COMPLETED|Overall Study||2
5269563|NCT00705263|12953146|P1|COMPLETED|Overall Study||108
5269564|NCT00705263|12953146|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
5269565|NCT00705250|12953150|P1|NOT COMPLETED|Overall Study||2
5269566|NCT00705250|12953150|P1|COMPLETED|Overall Study||34
5269567|NCT00705250|12953150|P1|STARTED|Overall Study||36
5269568|NCT00705224|12953154|P1|NOT COMPLETED|Overall Study||11
5269569|NCT00705224|12953154|P1|COMPLETED|Overall Study||239
5269570|NCT00705224|12953154|P1|STARTED|Overall Study||250
5269571|NCT00705159|12953170|P4|NOT COMPLETED|Overall Study||4
5269572|NCT00705159|12953171|P3|NOT COMPLETED|Overall Study||5
5269573|NCT00705159|12953172|P2|NOT COMPLETED|Overall Study||2
5269574|NCT00705159|12953173|P1|NOT COMPLETED|Overall Study||0
5269575|NCT00705159|12953170|P4|COMPLETED|Overall Study||30
5269576|NCT00705159|12953171|P3|COMPLETED|Overall Study||29
5269577|NCT00705159|12953172|P2|COMPLETED|Overall Study||33
5269578|NCT00705159|12953173|P1|COMPLETED|Overall Study||34
5269579|NCT00705159|12953170|P4|STARTED|Overall Study||34
5269580|NCT00705159|12953171|P3|STARTED|Overall Study||34
5269581|NCT00705159|12953172|P2|STARTED|Overall Study||35
5269582|NCT00705159|12953173|P1|STARTED|Overall Study||34
5269583|NCT00705146|12953193|P2|NOT COMPLETED|Overall Study||1
5269584|NCT00705146|12953194|P1|NOT COMPLETED|Overall Study||1
5269585|NCT00705146|12953193|P2|COMPLETED|Overall Study||23
5269586|NCT00705146|12953194|P1|COMPLETED|Overall Study||31
5269587|NCT00705146|12953193|P2|STARTED|Overall Study||24
5269588|NCT00705146|12953194|P1|STARTED|Overall Study||32
5269589|NCT00705107|12953202|P1|NOT COMPLETED|Overall Study||49
5269590|NCT00705107|12953202|P1|COMPLETED|Overall Study||218
5269591|NCT00705107|12953202|P1|STARTED|Overall Study||267
5269592|NCT00705081|12953209|P2|NOT COMPLETED|Overall Study||0
5269593|NCT00705081|12953210|P1|NOT COMPLETED|Overall Study||0
5269594|NCT00705081|12953209|P2|COMPLETED|Overall Study||198
5269595|NCT00705081|12953210|P1|COMPLETED|Overall Study||255
5269596|NCT00705081|12953209|P2|STARTED|Overall Study||198
5269597|NCT00705081|12953210|P1|STARTED|Overall Study||255
5269598|NCT00705016|12953223|P3|NOT COMPLETED|Overall Study||58
5269599|NCT00705016|12953224|P2|NOT COMPLETED|Overall Study||58
5269600|NCT00705016|12953225|P1|NOT COMPLETED|Overall Study||60
5269601|NCT00705016|12953223|P3|COMPLETED|Overall Study||4
5269602|NCT00705016|12953224|P2|COMPLETED|Overall Study||2
5269603|NCT00705016|12953225|P1|COMPLETED|Overall Study||2
5269604|NCT00705016|12953223|P3|STARTED|Overall Study||62
5269605|NCT00705016|12953224|P2|STARTED|Overall Study||60
5269606|NCT00705016|12953225|P1|STARTED|Overall Study||62
5269607|NCT00705003|12953254|P3|NOT COMPLETED|Treated||3
5269608|NCT00705003|12953255|P2|NOT COMPLETED|Treated||6
5269609|NCT00705003|12953256|P1|NOT COMPLETED|Treated||13
5269610|NCT00705003|12953254|P3|COMPLETED|Treated||30
5269611|NCT00705003|12953255|P2|COMPLETED|Treated||28
5269612|NCT00705003|12953256|P1|COMPLETED|Treated||54
5269613|NCT00705003|12953254|P3|STARTED|Treated||33
5269614|NCT00705003|12953255|P2|STARTED|Treated||34
5269615|NCT00705003|12953256|P1|STARTED|Treated||67
5269616|NCT00705003|12953254|P3|NOT COMPLETED|Enrolled||1
5269617|NCT00705003|12953255|P2|NOT COMPLETED|Enrolled||3
5269618|NCT00705003|12953256|P1|NOT COMPLETED|Enrolled||4
5269619|NCT00705003|12953254|P3|COMPLETED|Enrolled||33
5269620|NCT00705003|12953255|P2|COMPLETED|Enrolled||34
5269621|NCT00705003|12953256|P1|COMPLETED|Enrolled||67
5269622|NCT00705003|12953254|P3|STARTED|Enrolled||34
5269623|NCT00705003|12953255|P2|STARTED|Enrolled||37
5269624|NCT00705003|12953256|P1|STARTED|Enrolled||71
5269625|NCT00704964|12953276|P1|NOT COMPLETED|Overall Study||328
5269626|NCT00704964|12953276|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
5269627|NCT00704964|12953276|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
5269628|NCT00704938|12953283|P2|NOT COMPLETED|Overall Study||0
5269629|NCT00704938|12953284|P1|NOT COMPLETED|Overall Study||0
5269630|NCT00704938|12953283|P2|COMPLETED|Overall Study||1
5269631|NCT00704938|12953284|P1|COMPLETED|Overall Study||2
5269632|NCT00704938|12953283|P2|STARTED|Overall Study||1
5269633|NCT00704938|12953284|P1|STARTED|Overall Study||2
5269634|NCT00704912|12953295|P3|NOT COMPLETED|Overall Study||7
5269635|NCT00704912|12953296|P2|NOT COMPLETED|Overall Study||4
5269636|NCT00704912|12953297|P1|NOT COMPLETED|Overall Study||6
5269637|NCT00704912|12953295|P3|COMPLETED|Overall Study||43
5269638|NCT00704912|12953296|P2|COMPLETED|Overall Study||45
5269639|NCT00704912|12953297|P1|COMPLETED|Overall Study||44
5269640|NCT00704912|12953295|P3|STARTED|Overall Study||50
5269641|NCT00704912|12953296|P2|STARTED|Overall Study||49
5269642|NCT00704912|12953297|P1|STARTED|Overall Study||50
5269643|NCT00704847|12953316|P2|NOT COMPLETED|Overall Study||170
5269644|NCT00704847|12953317|P1|NOT COMPLETED|Overall Study||221
5269645|NCT00704847|12953316|P2|COMPLETED|Overall Study||339
5269646|NCT00704847|12953317|P1|COMPLETED|Overall Study||300
5269647|NCT00704847|12953316|P2|STARTED|Overall Study||509
5269648|NCT00704847|12953317|P1|STARTED|Overall Study||521
5269649|NCT00704808|12953337|P1|NOT COMPLETED|Overall Study||131
5269650|NCT00704808|12953337|P1|COMPLETED|Overall Study||49
5269651|NCT00704808|12953337|P1|STARTED|Overall Study||180
5269652|NCT00704769|12953341|P1|NOT COMPLETED|Overall Study||0
5269653|NCT00704769|12953341|P1|COMPLETED|Overall Study||591
5269654|NCT00704769|12953341|P1|STARTED|Overall Study||591
5269655|NCT00704730|12953348|P2|NOT COMPLETED|Overall Study||96
5269656|NCT00704730|12953349|P1|NOT COMPLETED|Overall Study||121
5269657|NCT00704730|12953348|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
5269658|NCT00704730|12953349|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
5269659|NCT00704730|12953348|P2|STARTED|Overall Study|Randomized|111
5269660|NCT00704730|12953349|P1|STARTED|Overall Study|Randomized|219
5269661|NCT00704717|12953365|P1|NOT COMPLETED|Overall Study||0
5269662|NCT00704717|12953365|P1|COMPLETED|Overall Study||185
5269663|NCT00704717|12953365|P1|STARTED|Overall Study||185
5269664|NCT00704535|12953369|P1|NOT COMPLETED|Overall Study||146
5269665|NCT00704535|12953369|P1|COMPLETED|Overall Study||3959
5269666|NCT00704535|12953369|P1|STARTED|Overall Study||4105
5269667|NCT00704522|12953382|P2|NOT COMPLETED|Overall Study||45
5269668|NCT00704522|12953383|P1|NOT COMPLETED|Overall Study||183
5269669|NCT00704522|12953382|P2|COMPLETED|Overall Study||75
5269670|NCT00704522|12953383|P1|COMPLETED|Overall Study||298
5269671|NCT00704522|12953382|P2|STARTED|Overall Study||120
5269672|NCT00704522|12953383|P1|STARTED|Overall Study||481
5269673|NCT00704496|12953392|P2|NOT COMPLETED|Overall Study||0
5269674|NCT00704496|12953393|P1|NOT COMPLETED|Overall Study||0
5269675|NCT00704496|12953392|P2|COMPLETED|Overall Study||0
5269676|NCT00704496|12953393|P1|COMPLETED|Overall Study||0
5269677|NCT00704496|12953392|P2|STARTED|Overall Study||0
5269678|NCT00704496|12953393|P1|STARTED|Overall Study||0
5269679|NCT00704418|12953403|P2|NOT COMPLETED|Overall Study||6
5269680|NCT00704418|12953404|P1|NOT COMPLETED|Overall Study||5
5269681|NCT00704418|12953403|P2|COMPLETED|Overall Study||72
5269682|NCT00704418|12953404|P1|COMPLETED|Overall Study||73
5269683|NCT00704418|12953403|P2|STARTED|Overall Study||78
5269684|NCT00704418|12953404|P1|STARTED|Overall Study||78
5269685|NCT00704405|12953417|P5|NOT COMPLETED|Overall Study (C Population)||0
5269686|NCT00704405|12953418|P4|NOT COMPLETED|Overall Study (C Population)||1
5269687|NCT00704405|12953419|P3|NOT COMPLETED|Overall Study (C Population)||1
5269688|NCT00704405|12953420|P2|NOT COMPLETED|Overall Study (C Population)||3
5269689|NCT00704405|12953421|P1|NOT COMPLETED|Overall Study (C Population)||1
5269690|NCT00704405|12953417|P5|COMPLETED|Overall Study (C Population)||14
5269691|NCT00704405|12953418|P4|COMPLETED|Overall Study (C Population)||14
5269692|NCT00704405|12953419|P3|COMPLETED|Overall Study (C Population)||14
5269693|NCT00704405|12953420|P2|COMPLETED|Overall Study (C Population)||11
5269694|NCT00704405|12953421|P1|COMPLETED|Overall Study (C Population)||15
5269695|NCT00704405|12953417|P5|STARTED|Overall Study (C Population)||14
5269696|NCT00704405|12953418|P4|STARTED|Overall Study (C Population)||15
5269697|NCT00704405|12953419|P3|STARTED|Overall Study (C Population)||15
5269698|NCT00704405|12953420|P2|STARTED|Overall Study (C Population)||14
5269699|NCT00704405|12953421|P1|STARTED|Overall Study (C Population)||16
5269700|NCT00704405|12953417|P5|NOT COMPLETED|Overall Study (NC Population)||5
5269701|NCT00704405|12953418|P4|NOT COMPLETED|Overall Study (NC Population)||4
5269702|NCT00704405|12953419|P3|NOT COMPLETED|Overall Study (NC Population)||3
5269703|NCT00704405|12953420|P2|NOT COMPLETED|Overall Study (NC Population)||4
5269704|NCT00704405|12953421|P1|NOT COMPLETED|Overall Study (NC Population)||5
5269705|NCT00704405|12953417|P5|COMPLETED|Overall Study (NC Population)||37
5269706|NCT00704405|12953418|P4|COMPLETED|Overall Study (NC Population)||38
5269707|NCT00704405|12953419|P3|COMPLETED|Overall Study (NC Population)||38
5269708|NCT00704405|12953420|P2|COMPLETED|Overall Study (NC Population)||40
5269709|NCT00704405|12953421|P1|COMPLETED|Overall Study (NC Population)||37
5269710|NCT00704405|12953417|P5|STARTED|Overall Study (NC Population)||42
5269711|NCT00704405|12953418|P4|STARTED|Overall Study (NC Population)||42
5269712|NCT00704405|12953419|P3|STARTED|Overall Study (NC Population)||41
5269713|NCT00704405|12953420|P2|STARTED|Overall Study (NC Population)||44
5269714|NCT00704405|12953421|P1|STARTED|Overall Study (NC Population)||42
5269715|NCT00704379|12953451|P2|NOT COMPLETED|Overall Study||7
5269716|NCT00704379|12953452|P1|NOT COMPLETED|Overall Study||7
5269717|NCT00704379|12953451|P2|COMPLETED|Overall Study||41
5269718|NCT00704379|12953452|P1|COMPLETED|Overall Study||39
5269719|NCT00704379|12953451|P2|STARTED|Overall Study||48
5269720|NCT00704379|12953452|P1|STARTED|Overall Study||46
5269721|NCT00704353|12953470|P2|NOT COMPLETED|Overall Study||114
5269722|NCT00704353|12953471|P1|NOT COMPLETED|Overall Study||98
5269723|NCT00704353|12953470|P2|COMPLETED|Overall Study||255
5269724|NCT00704353|12953471|P1|COMPLETED|Overall Study||268
5269725|NCT00704353|12953470|P2|STARTED|Overall Study||369
5269726|NCT00704353|12953471|P1|STARTED|Overall Study||366
5269727|NCT00704340|12953479|P2|NOT COMPLETED|Overall Study||2
5269728|NCT00704340|12953480|P1|NOT COMPLETED|Overall Study||2
5269729|NCT00704340|12953479|P2|COMPLETED|Overall Study||115
5269730|NCT00704340|12953480|P1|COMPLETED|Overall Study||118
5269731|NCT00704340|12953479|P2|STARTED|Overall Study||117
5269732|NCT00704340|12953480|P1|STARTED|Overall Study||120
5269733|NCT00704184|12953495|P5|NOT COMPLETED|Open-Label Treatment||3
5269734|NCT00704184|12953496|P4|NOT COMPLETED|Open-Label Treatment||5
5269735|NCT00704184|12953497|P3|NOT COMPLETED|Open-Label Treatment||4
5269736|NCT00704184|12953498|P2|NOT COMPLETED|Open-Label Treatment||2
5269737|NCT00704184|12953499|P1|NOT COMPLETED|Open-Label Treatment||1
5269738|NCT00704184|12953495|P5|COMPLETED|Open-Label Treatment||16
5269739|NCT00704184|12953496|P4|COMPLETED|Open-Label Treatment||13
5269740|NCT00704184|12953497|P3|COMPLETED|Open-Label Treatment||16
5269741|NCT00704184|12953498|P2|COMPLETED|Open-Label Treatment||16
5269742|NCT00704184|12953499|P1|COMPLETED|Open-Label Treatment||18
5269743|NCT00704184|12953495|P5|STARTED|Open-Label Treatment||19
5269744|NCT00704184|12953496|P4|STARTED|Open-Label Treatment||18
5269745|NCT00704184|12953497|P3|STARTED|Open-Label Treatment||20
5269746|NCT00704184|12953498|P2|STARTED|Open-Label Treatment||18
5269747|NCT00704184|12953499|P1|STARTED|Open-Label Treatment||19
5269748|NCT00704184|12953495|P5|NOT COMPLETED|Double-Blind Treatment||0
5269749|NCT00704184|12953496|P4|NOT COMPLETED|Double-Blind Treatment||0
5269750|NCT00704184|12953497|P3|NOT COMPLETED|Double-Blind Treatment||0
5269751|NCT00704184|12953498|P2|NOT COMPLETED|Double-Blind Treatment||0
5269752|NCT00704184|12953499|P1|NOT COMPLETED|Double-Blind Treatment||1
5269753|NCT00704184|12953495|P5|COMPLETED|Double-Blind Treatment||19
5269754|NCT00704184|12953496|P4|COMPLETED|Double-Blind Treatment||18
5269755|NCT00704184|12953497|P3|COMPLETED|Double-Blind Treatment||20
5269756|NCT00704184|12953498|P2|COMPLETED|Double-Blind Treatment||18
5269757|NCT00704184|12953499|P1|COMPLETED|Double-Blind Treatment||19
5269758|NCT00704184|12953495|P5|Treated|Double-Blind Treatment||19
5269759|NCT00704184|12953496|P4|Treated|Double-Blind Treatment||18
5269760|NCT00704184|12953497|P3|Treated|Double-Blind Treatment||20
5269761|NCT00704184|12953498|P2|Treated|Double-Blind Treatment||18
5269762|NCT00704184|12953499|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
5269763|NCT00704184|12953495|P5|STARTED|Double-Blind Treatment||19
5269764|NCT00704184|12953496|P4|STARTED|Double-Blind Treatment||18
5269765|NCT00704184|12953497|P3|STARTED|Double-Blind Treatment||20
5269766|NCT00704184|12953498|P2|STARTED|Double-Blind Treatment||18
5269767|NCT00704184|12953499|P1|STARTED|Double-Blind Treatment||20
5269768|NCT00704171|12953538|P2|NOT COMPLETED|Overall Study||0
5269769|NCT00704171|12953539|P1|NOT COMPLETED|Overall Study||1
5269770|NCT00704171|12953538|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
5269771|NCT00704171|12953539|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
5269772|NCT00704171|12953538|P2|STARTED|Overall Study||59
5269773|NCT00704171|12953539|P1|STARTED|Overall Study||62
5269774|NCT00704132|12953557|P2|NOT COMPLETED|Overall Study||2
5269775|NCT00704132|12953558|P1|NOT COMPLETED|Overall Study||1
5269776|NCT00704132|12953557|P2|COMPLETED|Overall Study||22
5269777|NCT00704132|12953558|P1|COMPLETED|Overall Study||25
5269778|NCT00704132|12953557|P2|STARTED|Overall Study||24
5269779|NCT00704132|12953558|P1|STARTED|Overall Study||26
5269780|NCT00704028|12953566|P2|NOT COMPLETED|Overall Study||21
5269781|NCT00704028|12953567|P1|NOT COMPLETED|Overall Study||12
5269782|NCT00704028|12953566|P2|COMPLETED|Overall Study||57
5269783|NCT00704028|12953567|P1|COMPLETED|Overall Study||70
5269784|NCT00704028|12953566|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
5269785|NCT00704028|12953567|P1|STARTED|Overall Study||82
5269786|NCT00703976|12953575|P2|NOT COMPLETED|Overall Study||0
5269787|NCT00703976|12953576|P1|NOT COMPLETED|Overall Study||0
5269788|NCT00703976|12953575|P2|COMPLETED|Overall Study||41
5269789|NCT00703976|12953576|P1|COMPLETED|Overall Study||37
5269790|NCT00703976|12953575|P2|STARTED|Overall Study||41
5269791|NCT00703976|12953576|P1|STARTED|Overall Study||37
5269792|NCT00703963|12953586|P2|NOT COMPLETED|Overall Study||14
5269793|NCT00703963|12953587|P1|NOT COMPLETED|Overall Study||7
5269794|NCT00703963|12953586|P2|COMPLETED|Overall Study||86
5269795|NCT00703963|12953587|P1|COMPLETED|Overall Study||93
5269796|NCT00703963|12953586|P2|STARTED|Overall Study||100
5269797|NCT00703963|12953587|P1|STARTED|Overall Study||100
5269798|NCT00703937|12953599|P2|NOT COMPLETED|Overall Study||93
5269799|NCT00703937|12953600|P1|NOT COMPLETED|Overall Study||65
5269800|NCT00703937|12953599|P2|COMPLETED|Overall Study||267
5269801|NCT00703937|12953600|P1|COMPLETED|Overall Study||278
5269802|NCT00703937|12953599|P2|STARTED|Overall Study||360
5269803|NCT00703937|12953600|P1|STARTED|Overall Study||343
5269804|NCT00703924|12953608|P2|NOT COMPLETED|Overall Study||1
5269805|NCT00703924|12953609|P1|NOT COMPLETED|Overall Study||1
5269806|NCT00703924|12953608|P2|COMPLETED|Overall Study||41
5269807|NCT00703924|12953609|P1|COMPLETED|Overall Study||49
5269808|NCT00703924|12953608|P2|STARTED|Overall Study||42
5269809|NCT00703924|12953609|P1|STARTED|Overall Study||50
5269810|NCT00703911|12953625|P1|NOT COMPLETED|Overall Study||10
5269811|NCT00703911|12953625|P1|COMPLETED|Overall Study||92
5269812|NCT00703911|12953625|P1|STARTED|Overall Study||102
5269813|NCT00703885|12953653|P1|NOT COMPLETED|Overall Study||0
5269814|NCT00703885|12953653|P1|COMPLETED|Overall Study||16
5269815|NCT00703885|12953653|P1|STARTED|Overall Study||16
5269816|NCT00703846|12953658|P1|NOT COMPLETED|Overall Study||137
5269817|NCT00703846|12953658|P1|COMPLETED|Overall Study||363
5269818|NCT00703846|12953658|P1|STARTED|Overall Study||500
5269819|NCT00703820|12953674|P2|NOT COMPLETED|Overall Study||34
5269820|NCT00703820|12953675|P1|NOT COMPLETED|Overall Study||35
5269821|NCT00703820|12953674|P2|COMPLETED|Overall Study||95
5269822|NCT00703820|12953675|P1|COMPLETED|Overall Study||98
5269823|NCT00703820|12953674|P2|STARTED|Overall Study||129
5269824|NCT00703820|12953675|P1|STARTED|Overall Study||133
5269825|NCT00703781|12953684|P2|NOT COMPLETED|Overall Study||2
5269826|NCT00703781|12953685|P1|NOT COMPLETED|Overall Study||2
5269827|NCT00703781|12953684|P2|COMPLETED|Overall Study||61
5269828|NCT00703781|12953685|P1|COMPLETED|Overall Study||61
5269829|NCT00703781|12953684|P2|STARTED|Overall Study||63
5269830|NCT00703781|12953685|P1|STARTED|Overall Study||63
5269831|NCT00703729|12953695|P2|NOT COMPLETED|Overall Study||3
5269832|NCT00703729|12953696|P1|NOT COMPLETED|Overall Study||0
5269833|NCT00703729|12953695|P2|COMPLETED|Overall Study||21
5269834|NCT00703729|12953696|P1|COMPLETED|Overall Study||25
5269835|NCT00703729|12953695|P2|STARTED|Overall Study||24
5269836|NCT00703729|12953696|P1|STARTED|Overall Study||25
5269837|NCT00703677|12953730|P1|NOT COMPLETED|Overall Study||3
5269838|NCT00703677|12953730|P1|COMPLETED|Overall Study||14
5269839|NCT00703677|12953730|P1|STARTED|Overall Study||17
5269840|NCT00703664|12953746|P3|NOT COMPLETED|Overall Study||0
5269841|NCT00703664|12953747|P2|NOT COMPLETED|Overall Study||0
5269842|NCT00703664|12953748|P1|NOT COMPLETED|Overall Study||0
5269843|NCT00703664|12953746|P3|COMPLETED|Overall Study||39
5269844|NCT00703664|12953747|P2|COMPLETED|Overall Study||4
5269845|NCT00703664|12953748|P1|COMPLETED|Overall Study||22
5269846|NCT00703664|12953746|P3|STARTED|Overall Study||39
5269847|NCT00703664|12953747|P2|STARTED|Overall Study||4
5269848|NCT00703664|12953748|P1|STARTED|Overall Study||22
5269849|NCT00703534|12953770|P2|NOT COMPLETED|Overall Study||25
5269850|NCT00703534|12953771|P1|NOT COMPLETED|Overall Study||30
5269851|NCT00703534|12953770|P2|COMPLETED|Overall Study||218
5269852|NCT00703534|12953771|P1|COMPLETED|Overall Study||205
5269853|NCT00703534|12953770|P2|STARTED|Overall Study||243
5269854|NCT00703534|12953771|P1|STARTED|Overall Study||235
5269855|NCT00703508|12953777|P1|NOT COMPLETED|Overall Study||0
5269856|NCT00703508|12953777|P1|COMPLETED|Overall Study||26
5269857|NCT00703508|12953777|P1|STARTED|Overall Study||26
5269858|NCT00703391|12953791|P2|NOT COMPLETED|Overall Study||0
5269859|NCT00703391|12953792|P1|NOT COMPLETED|Overall Study||0
5269860|NCT00703391|12953791|P2|COMPLETED|Overall Study||6
5269861|NCT00703391|12953792|P1|COMPLETED|Overall Study||12
5269862|NCT00703391|12953791|P2|STARTED|Overall Study||6
5269863|NCT00703391|12953792|P1|STARTED|Overall Study||12
5269864|NCT00703339|12953836|P1|NOT COMPLETED|Overall Study||0
5269865|NCT00703339|12953836|P1|COMPLETED|Overall Study||1
5269866|NCT00703339|12953836|P1|STARTED|Overall Study||1
5269867|NCT00703326|12953843|P2|NOT COMPLETED|Overall Study||225
5269868|NCT00703326|12953844|P1|NOT COMPLETED|Overall Study||447
5269869|NCT00703326|12953843|P2|COMPLETED|Overall Study||160
5269870|NCT00703326|12953844|P1|COMPLETED|Overall Study||312
5269871|NCT00703326|12953843|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
5269872|NCT00703326|12953844|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
5269873|NCT00703326|12953843|P2|STARTED|Overall Study||385
5269874|NCT00703326|12953844|P1|STARTED|Overall Study||759
5269875|NCT00703261|12953866|P2|NOT COMPLETED|Overall Study||6
5269876|NCT00703261|12953867|P1|NOT COMPLETED|Overall Study||6
5269877|NCT00703261|12953866|P2|COMPLETED|Overall Study||35
5269878|NCT00703261|12953867|P1|COMPLETED|Overall Study||36
5269879|NCT00703261|12953866|P2|STARTED|Overall Study||41
5269880|NCT00703261|12953867|P1|STARTED|Overall Study||42
5269881|NCT00703157|12953876|P2|NOT COMPLETED|Overall Study||2
5269882|NCT00703157|12953877|P1|NOT COMPLETED|Overall Study||4
5269883|NCT00703157|12953876|P2|COMPLETED|Overall Study||24
5269884|NCT00703157|12953877|P1|COMPLETED|Overall Study||22
5269885|NCT00703157|12953876|P2|24 Months FU|Overall Study||24
5269886|NCT00703157|12953877|P1|24 Months FU|Overall Study||22
5269887|NCT00703157|12953876|P2|6 Months FU|Overall Study||25
5269888|NCT00703157|12953877|P1|6 Months FU|Overall Study||25
5269889|NCT00703157|12953876|P2|STARTED|Overall Study||26
5269890|NCT00703157|12953877|P1|STARTED|Overall Study||26
5269891|NCT00703118|12953911|P3|NOT COMPLETED|Overall Study||22
5269892|NCT00703118|12953912|P2|NOT COMPLETED|Overall Study||16
5269893|NCT00703118|12953913|P1|NOT COMPLETED|Overall Study||21
5269894|NCT00703118|12953911|P3|COMPLETED|Overall Study||110
5269895|NCT00703118|12953912|P2|COMPLETED|Overall Study||248
5269896|NCT00703118|12953913|P1|COMPLETED|Overall Study||245
5269897|NCT00703118|12953911|P3|STARTED|Overall Study||132
5269898|NCT00703118|12953912|P2|STARTED|Overall Study||264
5269899|NCT00703118|12953913|P1|STARTED|Overall Study||266
5269900|NCT00703092|12953944|P1|NOT COMPLETED|Overall Study||2
5269901|NCT00703092|12953944|P1|COMPLETED|Overall Study||0
5269902|NCT00703092|12953944|P1|STARTED|Overall Study||2
5269903|NCT00703053|12953958|P9|NOT COMPLETED|Overall Study||1
5269904|NCT00703053|12953959|P8|NOT COMPLETED|Overall Study||6
5269905|NCT00703053|12953960|P7|NOT COMPLETED|Overall Study||7
5269906|NCT00703053|12953961|P6|NOT COMPLETED|Overall Study||6
5269907|NCT00703053|12953962|P5|NOT COMPLETED|Overall Study||1
5269908|NCT00703053|12953963|P4|NOT COMPLETED|Overall Study||3
5269909|NCT00703053|12953964|P3|NOT COMPLETED|Overall Study||3
5269910|NCT00703053|12953965|P2|NOT COMPLETED|Overall Study||2
5269911|NCT00703053|12953966|P1|NOT COMPLETED|Overall Study||1
5269912|NCT00703053|12953958|P9|COMPLETED|Overall Study||102
5269913|NCT00703053|12953959|P8|COMPLETED|Overall Study||91
5269914|NCT00703053|12953960|P7|COMPLETED|Overall Study||45
5269915|NCT00703053|12953961|P6|COMPLETED|Overall Study||43
5269916|NCT00703053|12953962|P5|COMPLETED|Overall Study||50
5269917|NCT00703053|12953963|P4|COMPLETED|Overall Study||46
5269918|NCT00703053|12953964|P3|COMPLETED|Overall Study||48
5269919|NCT00703053|12953965|P2|COMPLETED|Overall Study||24
5269920|NCT00703053|12953966|P1|COMPLETED|Overall Study||26
5269921|NCT00703053|12953958|P9|STARTED|Overall Study||103
5269922|NCT00703053|12953959|P8|STARTED|Overall Study||97
5269923|NCT00703053|12953960|P7|STARTED|Overall Study||52
5269924|NCT00703053|12953961|P6|STARTED|Overall Study||49
5269925|NCT00703053|12953962|P5|STARTED|Overall Study||51
5269926|NCT00703053|12953963|P4|STARTED|Overall Study||49
5269927|NCT00703053|12953964|P3|STARTED|Overall Study||51
5269928|NCT00703053|12953965|P2|STARTED|Overall Study||26
5269929|NCT00703053|12953966|P1|STARTED|Overall Study||27
5269930|NCT00703014|12954152|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
5269931|NCT00703014|12954153|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
5269932|NCT00703014|12954154|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
5269933|NCT00703014|12954155|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
5269934|NCT00703014|12954152|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
5269935|NCT00703014|12954153|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
5269936|NCT00703014|12954154|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
5269937|NCT00703014|12954155|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
5269938|NCT00703014|12954152|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
5269939|NCT00703014|12954153|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
5269940|NCT00703014|12954154|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
5269941|NCT00703014|12954155|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
5269942|NCT00703014|12954152|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
5269943|NCT00703014|12954153|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
5269944|NCT00703014|12954154|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
5269945|NCT00703014|12954155|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
5269946|NCT00703014|12954152|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
5269947|NCT00703014|12954153|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
5269948|NCT00703014|12954154|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
5269949|NCT00703014|12954155|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
5269950|NCT00703014|12954152|P4|COMPLETED|Mothers Follow Up Trial P05712||0
5269951|NCT00703014|12954153|P3|COMPLETED|Mothers Follow Up Trial P05712||0
5269952|NCT00703014|12954154|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
5269953|NCT00703014|12954155|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
5269954|NCT00703014|12954152|P4|STARTED|Mothers Follow Up Trial P05712||0
5269955|NCT00703014|12954153|P3|STARTED|Mothers Follow Up Trial P05712||0
5269956|NCT00703014|12954154|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
5269957|NCT00703014|12954155|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
5269958|NCT00703014|12954152|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
5269959|NCT00703014|12954153|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
5269960|NCT00703014|12954154|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
5269961|NCT00703014|12954155|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
5269962|NCT00703014|12954152|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
5269963|NCT00703014|12954153|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
5269964|NCT00703014|12954154|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
5269965|NCT00703014|12954155|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
5269966|NCT00703014|12954152|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
5269967|NCT00703014|12954153|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
5269968|NCT00703014|12954154|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
5269969|NCT00703014|12954155|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
5269970|NCT00703014|12954152|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
5269971|NCT00703014|12954153|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
5269972|NCT00703014|12954154|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
5269973|NCT00703014|12954155|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
5269974|NCT00703014|12954152|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
5269975|NCT00703014|12954153|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
5269976|NCT00703014|12954154|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
5269977|NCT00703014|12954155|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
5269978|NCT00702962|12954175|P2|NOT COMPLETED|Overall Study||1
5269979|NCT00702962|12954176|P1|NOT COMPLETED|Overall Study||1
5269980|NCT00702962|12954175|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
5269981|NCT00702962|12954176|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
5269982|NCT00702962|12954175|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
5269983|NCT00702962|12954176|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
5269984|NCT00702949|12954187|P3|NOT COMPLETED|Overall Study||8
5269985|NCT00702949|12954188|P2|NOT COMPLETED|Overall Study||9
5269986|NCT00702949|12954189|P1|NOT COMPLETED|Overall Study||5
5269987|NCT00702949|12954187|P3|COMPLETED|Overall Study||54
5269988|NCT00702949|12954188|P2|COMPLETED|Overall Study||57
5269989|NCT00702949|12954189|P1|COMPLETED|Overall Study||58
5269990|NCT00702949|12954187|P3|Evaluable for Primary Endpoint|Overall Study||51
5269991|NCT00702949|12954188|P2|Evaluable for Primary Endpoint|Overall Study||56
5269992|NCT00702949|12954189|P1|Evaluable for Primary Endpoint|Overall Study||56
5269993|NCT00702949|12954187|P3|STARTED|Overall Study||62
5269994|NCT00702949|12954188|P2|STARTED|Overall Study||66
5269995|NCT00702949|12954189|P1|STARTED|Overall Study||63
5269996|NCT00702923|12954214|P1|NOT COMPLETED|Overall Study||1
5269997|NCT00702923|12954214|P1|COMPLETED|Overall Study||11
5269998|NCT00702923|12954214|P1|STARTED|Overall Study||12
5269999|NCT00702884|12954223|P1|NOT COMPLETED|Overall Study||0
5270000|NCT00702884|12954223|P1|COMPLETED|Overall Study||25
5270001|NCT00702884|12954223|P1|STARTED|Overall Study||25
5270002|NCT00702845|12954237|P2|NOT COMPLETED|Overall Study||8
5270003|NCT00702845|12954238|P1|NOT COMPLETED|Overall Study||22
5270004|NCT00702845|12954237|P2|COMPLETED|Overall Study||121
5270005|NCT00702845|12954238|P1|COMPLETED|Overall Study||246
5270006|NCT00702845|12954237|P2|Randomized|Overall Study||128
5270007|NCT00702845|12954238|P1|Randomized|Overall Study||268
5270008|NCT00702845|12954237|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
5270009|NCT00702845|12954238|P1|STARTED|Overall Study||268
5270010|NCT00702780|12954278|P2|NOT COMPLETED|Overall Study||8
5270011|NCT00702780|12954279|P1|NOT COMPLETED|Overall Study||9
5270012|NCT00702780|12954278|P2|COMPLETED|Overall Study||29
5270013|NCT00702780|12954279|P1|COMPLETED|Overall Study||28
5270014|NCT00702780|12954278|P2|STARTED|Overall Study||37
5270015|NCT00702780|12954279|P1|STARTED|Overall Study||37
5270016|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
5270017|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
5270018|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
5270019|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
5270020|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
5270021|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
5270022|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
5270023|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
5270024|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
5270025|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
5270026|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
5270027|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
5270028|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
5270029|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
5270030|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
5270031|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
5270032|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
5270033|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
5270034|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
5270035|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
5270036|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
5270037|NCT00702754|12954287|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
5270038|NCT00702754|12954287|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
5270039|NCT00702754|12954287|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
5270040|NCT00702715|12954300|P2|NOT COMPLETED|Overall Study||0
5270041|NCT00702715|12954301|P1|NOT COMPLETED|Overall Study||1
5270042|NCT00702715|12954300|P2|COMPLETED|Overall Study||33
5270043|NCT00702715|12954301|P1|COMPLETED|Overall Study||34
5270044|NCT00702715|12954300|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
5270045|NCT00702715|12954301|P1|STARTED|Overall Study||35
5270046|NCT00702702|12954314|P1|NOT COMPLETED|Overall Study||56
5270047|NCT00702702|12954314|P1|COMPLETED|Overall Study||0
5270048|NCT00702702|12954314|P1|STARTED|Overall Study||56
5270049|NCT00702689|12954322|P1|NOT COMPLETED|Overall Study||6
5270050|NCT00702689|12954322|P1|COMPLETED|Overall Study||14
5270051|NCT00702689|12954322|P1|STARTED|Overall Study||20
5270052|NCT00702650|12954333|P1|NOT COMPLETED|Overall Study||20
5270053|NCT00702650|12954333|P1|COMPLETED|Overall Study||135
5270054|NCT00702650|12954333|P1|STARTED|Overall Study||155
5270055|NCT00702624|12954353|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
5270056|NCT00702624|12954354|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
5270057|NCT00702624|12954355|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
5270058|NCT00702624|12954356|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
5270059|NCT00702624|12954353|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
5270060|NCT00702624|12954354|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
5270061|NCT00702624|12954355|P2|COMPLETED|Fetuses/Infant Follow-up||0
5270062|NCT00702624|12954356|P1|COMPLETED|Fetuses/Infant Follow-up||0
5270063|NCT00702624|12954353|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
5270064|NCT00702624|12954354|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
5270065|NCT00702624|12954355|P2|Live Born Infants|Fetuses/Infant Follow-up||0
5270066|NCT00702624|12954356|P1|Live Born Infants|Fetuses/Infant Follow-up||0
5270067|NCT00702624|12954353|P4|STARTED|Fetuses/Infant Follow-up||55
5270068|NCT00702624|12954354|P3|STARTED|Fetuses/Infant Follow-up||88
5270069|NCT00702624|12954355|P2|STARTED|Fetuses/Infant Follow-up||0
5270070|NCT00702624|12954356|P1|STARTED|Fetuses/Infant Follow-up||0
5270071|NCT00702624|12954353|P4|NOT COMPLETED|Expectant Mother Follow-up||0
5270072|NCT00702624|12954354|P3|NOT COMPLETED|Expectant Mother Follow-up||0
5270073|NCT00702624|12954355|P2|NOT COMPLETED|Expectant Mother Follow-up||0
5270074|NCT00702624|12954356|P1|NOT COMPLETED|Expectant Mother Follow-up||7
5270075|NCT00702624|12954353|P4|COMPLETED|Expectant Mother Follow-up||0
5270076|NCT00702624|12954354|P3|COMPLETED|Expectant Mother Follow-up||0
5270077|NCT00702624|12954355|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
5270078|NCT00702624|12954356|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
5270079|NCT00702624|12954353|P4|STARTED|Expectant Mother Follow-up||0
5270080|NCT00702624|12954354|P3|STARTED|Expectant Mother Follow-up||0
5270081|NCT00702624|12954355|P2|STARTED|Expectant Mother Follow-up||45
5270082|NCT00702624|12954356|P1|STARTED|Expectant Mother Follow-up||68
5270083|NCT00702624|12954353|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
5270084|NCT00702624|12954354|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
5270085|NCT00702624|12954355|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
5270086|NCT00702624|12954356|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
5270087|NCT00702624|12954353|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
5270088|NCT00702624|12954354|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
5270089|NCT00702624|12954355|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
5270090|NCT00702624|12954356|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
5270091|NCT00702624|12954353|P4|STARTED|Base Study P05690 (NCT00702845)||0
5270092|NCT00702624|12954354|P3|STARTED|Base Study P05690 (NCT00702845)||0
5270093|NCT00702624|12954355|P2|STARTED|Base Study P05690 (NCT00702845)||128
5270094|NCT00702624|12954356|P1|STARTED|Base Study P05690 (NCT00702845)||268
5270095|NCT00702546|12954374|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
5270096|NCT00702546|12954375|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
5270097|NCT00702546|12954374|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
5270098|NCT00702546|12954375|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
5270099|NCT00702546|12954374|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
5270100|NCT00702546|12954375|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
5270101|NCT00702546|12954374|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
5270102|NCT00702546|12954375|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
5270103|NCT00702546|12954374|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
5270104|NCT00702546|12954375|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
5270105|NCT00702546|12954374|P2|STARTED|Base Study P05690 (NCT00702845)||128
5270106|NCT00702546|12954375|P1|STARTED|Base Study P05690 (NCT00702845)||268
5270107|NCT00702520|12954395|P4|NOT COMPLETED|Follow-up Study P05783||0
5270108|NCT00702520|12954396|P3|NOT COMPLETED|Follow-up Study P05783||0
5270109|NCT00702520|12954397|P2|NOT COMPLETED|Follow-up Study P05783||0
5270110|NCT00702520|12954398|P1|NOT COMPLETED|Follow-up Study P05783||0
5270111|NCT00702520|12954395|P4|COMPLETED|Follow-up Study P05783||11
5270112|NCT00702520|12954396|P3|COMPLETED|Follow-up Study P05783||8
5270113|NCT00702520|12954397|P2|COMPLETED|Follow-up Study P05783||8
5270114|NCT00702520|12954398|P1|COMPLETED|Follow-up Study P05783||7
5270115|NCT00702520|12954395|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
5270116|NCT00702520|12954396|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
5270117|NCT00702520|12954397|P2|STARTED|Follow-up Study P05783||8
5270118|NCT00702520|12954398|P1|STARTED|Follow-up Study P05783||7
5270119|NCT00702520|12954395|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
5270120|NCT00702520|12954396|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
5270121|NCT00702520|12954397|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
5270122|NCT00702520|12954398|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
5270123|NCT00702520|12954395|P4|COMPLETED|Base Study P05788 - Follow-Up||0
5270124|NCT00702520|12954396|P3|COMPLETED|Base Study P05788 - Follow-Up||0
5270125|NCT00702520|12954397|P2|COMPLETED|Base Study P05788 - Follow-Up||8
5270126|NCT00702520|12954398|P1|COMPLETED|Base Study P05788 - Follow-Up||7
5270127|NCT00702520|12954395|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
5270128|NCT00702520|12954396|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
5270129|NCT00702520|12954397|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
5270130|NCT00702520|12954398|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
5270131|NCT00702520|12954395|P4|STARTED|Base Study P05788 - Follow-Up||0
5270132|NCT00702520|12954396|P3|STARTED|Base Study P05788 - Follow-Up||0
5270133|NCT00702520|12954397|P2|STARTED|Base Study P05788 - Follow-Up||18
5270134|NCT00702520|12954398|P1|STARTED|Base Study P05788 - Follow-Up||22
5270135|NCT00702520|12954395|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
5270136|NCT00702520|12954396|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
5270137|NCT00702520|12954397|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
5270138|NCT00702520|12954398|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
5270139|NCT00702520|12954395|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
5270140|NCT00702520|12954396|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
5270141|NCT00702520|12954397|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
5270142|NCT00702520|12954398|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
5270143|NCT00702520|12954395|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
5270144|NCT00702520|12954396|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
5270145|NCT00702520|12954397|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
5270146|NCT00702520|12954398|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
5270147|NCT00702520|12954395|P4|STARTED|Base Study P05788 - Embryo Transfer||0
5270148|NCT00702520|12954396|P3|STARTED|Base Study P05788 - Embryo Transfer||0
5270149|NCT00702520|12954397|P2|STARTED|Base Study P05788 - Embryo Transfer||24
5270150|NCT00702520|12954398|P1|STARTED|Base Study P05788 - Embryo Transfer||25
5270151|NCT00702520|12954395|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
5270152|NCT00702520|12954396|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
5270153|NCT00702520|12954397|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
5270154|NCT00702520|12954398|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
5270155|NCT00702520|12954395|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
5270156|NCT00702520|12954396|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
5270157|NCT00702520|12954397|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
5270158|NCT00702520|12954398|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
5270159|NCT00702520|12954395|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
5270160|NCT00702520|12954396|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
5270161|NCT00702520|12954397|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
5270162|NCT00702520|12954398|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
5270163|NCT00702520|12954395|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
5270164|NCT00702520|12954396|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
5270165|NCT00702520|12954397|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
5270166|NCT00702520|12954398|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
5270167|NCT00702520|12954395|P4|STARTED|Base Study P05788 - Assigned Treatment||0
5270168|NCT00702520|12954396|P3|STARTED|Base Study P05788 - Assigned Treatment||0
5270169|NCT00702520|12954397|P2|STARTED|Base Study P05788 - Assigned Treatment||25
5270170|NCT00702520|12954398|P1|STARTED|Base Study P05788 - Assigned Treatment||25
5270171|NCT00702507|12954414|P1|NOT COMPLETED|Follow-up Phase||27
5270172|NCT00702507|12954414|P1|COMPLETED|Follow-up Phase||132
5270173|NCT00702507|12954414|P1|STARTED|Follow-up Phase||159
5270174|NCT00702507|12954414|P1|NOT COMPLETED|Initial Treatment Phase||41
5270175|NCT00702507|12954414|P1|COMPLETED|Initial Treatment Phase||159
5270176|NCT00702507|12954414|P1|STARTED|Initial Treatment Phase||200
5270177|NCT00702468|12954428|P2|NOT COMPLETED|Overall Study||16
5270178|NCT00702468|12954429|P1|NOT COMPLETED|Overall Study||3
5270179|NCT00702468|12954428|P2|COMPLETED|Overall Study||2
5270180|NCT00702468|12954429|P1|COMPLETED|Overall Study||15
5270181|NCT00702468|12954428|P2|STARTED|Overall Study||18
5270182|NCT00702468|12954429|P1|STARTED|Overall Study||18
5270183|NCT00702403|12954451|P1|NOT COMPLETED|From Engraftment to Study Completion||27
5270184|NCT00702403|12954451|P1|COMPLETED|From Engraftment to Study Completion||13
5270185|NCT00702403|12954451|P1|Patient Drop-outs|From Engraftment to Study Completion||27
5270186|NCT00702403|12954451|P1|STARTED|From Engraftment to Study Completion||40
5270187|NCT00702403|12954451|P1|NOT COMPLETED|From Consent to Engraftment||17
5270188|NCT00702403|12954451|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
5270189|NCT00702403|12954451|P1|Ineligible for Study Drug|From Consent to Engraftment||17
5270190|NCT00702403|12954451|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
5270191|NCT00702377|12954461|P2|NOT COMPLETED|Overall Study||3
5270192|NCT00702377|12954462|P1|NOT COMPLETED|Overall Study||1
5270193|NCT00702377|12954461|P2|COMPLETED|Overall Study||53
5270194|NCT00702377|12954462|P1|COMPLETED|Overall Study||52
5270195|NCT00702377|12954461|P2|STARTED|Overall Study||56
5270196|NCT00702377|12954462|P1|STARTED|Overall Study||53
5270197|NCT00702364|12954474|P2|NOT COMPLETED|Overall Study||4
5270198|NCT00702364|12954475|P1|NOT COMPLETED|Overall Study||2
5270199|NCT00702364|12954474|P2|COMPLETED|Overall Study||25
5270200|NCT00702364|12954475|P1|COMPLETED|Overall Study||24
5270201|NCT00702364|12954474|P2|STARTED|Overall Study||29
5270202|NCT00702364|12954475|P1|STARTED|Overall Study||26
5270203|NCT00702338|12954487|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
5270204|NCT00702338|12954488|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
5270205|NCT00702338|12954489|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
5270206|NCT00702338|12954487|P3|COMPLETED|Follow-up Study: Infant FU||0
5270207|NCT00702338|12954488|P2|COMPLETED|Follow-up Study: Infant FU||0
5270208|NCT00702338|12954489|P1|COMPLETED|Follow-up Study: Infant FU||0
5270209|NCT00702338|12954487|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
5270210|NCT00702338|12954488|P2|STARTED|Follow-up Study: Infant FU||0
5270211|NCT00702338|12954489|P1|STARTED|Follow-up Study: Infant FU||0
5270212|NCT00702338|12954487|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
5270213|NCT00702338|12954488|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
5270214|NCT00702338|12954489|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
5270215|NCT00702338|12954487|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
5270216|NCT00702338|12954488|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
5270217|NCT00702338|12954489|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
5270218|NCT00702338|12954487|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
5270219|NCT00702338|12954488|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
5270220|NCT00702338|12954489|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
5270221|NCT00702338|12954487|P3|NOT COMPLETED|Base Study (NCT00697255)||0
5270222|NCT00702338|12954488|P2|NOT COMPLETED|Base Study (NCT00697255)||2
5270223|NCT00702338|12954489|P1|NOT COMPLETED|Base Study (NCT00697255)||3
5270224|NCT00702338|12954487|P3|COMPLETED|Base Study (NCT00697255)||0
5270225|NCT00702338|12954488|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
5270226|NCT00702338|12954489|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
5270227|NCT00702338|12954487|P3|STARTED|Base Study (NCT00697255)||0
5270228|NCT00702338|12954488|P2|STARTED|Base Study (NCT00697255)||3
5270229|NCT00702338|12954489|P1|STARTED|Base Study (NCT00697255)||5
5270230|NCT00702325|12954505|P2|NOT COMPLETED|Overall Study||53
5270231|NCT00702325|12954506|P1|NOT COMPLETED|Overall Study||38
5270232|NCT00702325|12954505|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
5270233|NCT00702325|12954506|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
5270234|NCT00702325|12954505|P2|STARTED|Overall Study|Randomized|155
5270235|NCT00702325|12954506|P1|STARTED|Overall Study|Randomized|156
5270236|NCT00702299|12954558|P1|NOT COMPLETED|Overall Study||0
5270237|NCT00702299|12954558|P1|COMPLETED|Overall Study||15
5270238|NCT00702299|12954558|P1|STARTED|Overall Study||15
5270239|NCT00702273|12954571|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
5270240|NCT00702273|12954572|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
5270241|NCT00702273|12954571|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
5270242|NCT00702273|12954572|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
5270243|NCT00702273|12954571|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
5270244|NCT00702273|12954572|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
5270245|NCT00702273|12954571|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
5270246|NCT00702273|12954572|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
5270247|NCT00702273|12954571|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
5270248|NCT00702273|12954572|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
5270249|NCT00702273|12954571|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
5270250|NCT00702273|12954572|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
5270251|NCT00702273|12954571|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
5270252|NCT00702273|12954572|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
5270253|NCT00702234|12954590|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
5270254|NCT00702234|12954591|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
5270255|NCT00702234|12954590|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
5270256|NCT00702234|12954591|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
5270257|NCT00702234|12954590|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
5270258|NCT00702234|12954591|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
5270259|NCT00702234|12954590|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
5270260|NCT00702234|12954591|P1|STARTED|Follow-up Study: Fetuses/Infants||0
5270261|NCT00702234|12954590|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
5270262|NCT00702234|12954591|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
5270263|NCT00702234|12954590|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
5270264|NCT00702234|12954591|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
5270265|NCT00702234|12954590|P2|STARTED|Follow-up Study: Expectant Mothers||0
5270266|NCT00702234|12954591|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
5270267|NCT00702234|12954590|P2|NOT COMPLETED|Base Study (NCT00696878)||0
5270268|NCT00702234|12954591|P1|NOT COMPLETED|Base Study (NCT00696878)||504
5270269|NCT00702234|12954590|P2|COMPLETED|Base Study (NCT00696878)||0
5270270|NCT00702234|12954591|P1|COMPLETED|Base Study (NCT00696878)||178
5270271|NCT00702234|12954590|P2|STARTED|Base Study (NCT00696878)||0
5270272|NCT00702234|12954591|P1|STARTED|Base Study (NCT00696878)||682
5270273|NCT00702221|12954602|P2|NOT COMPLETED|Overall Study||3
5270274|NCT00702221|12954603|P1|NOT COMPLETED|Overall Study||4
5270275|NCT00702221|12954602|P2|COMPLETED|Overall Study||7
5270276|NCT00702221|12954603|P1|COMPLETED|Overall Study||6
5270277|NCT00702221|12954602|P2|STARTED|Overall Study||10
5270278|NCT00702221|12954603|P1|STARTED|Overall Study||10
5270279|NCT00702208|12954609|P1|NOT COMPLETED|Overall Study||31
5270280|NCT00702208|12954609|P1|COMPLETED|Overall Study||167
5270281|NCT00702208|12954609|P1|STARTED|Overall Study||198
5270282|NCT00702143|12954618|P3|NOT COMPLETED|Overall Study||1
5270283|NCT00702143|12954619|P2|NOT COMPLETED|Overall Study||0
5270284|NCT00702143|12954620|P1|NOT COMPLETED|Overall Study||0
5270285|NCT00702143|12954618|P3|COMPLETED|Overall Study||78
5270286|NCT00702143|12954619|P2|COMPLETED|Overall Study||60
5270287|NCT00702143|12954620|P1|COMPLETED|Overall Study||45
5270288|NCT00702143|12954618|P3|STARTED|Overall Study||79
5270289|NCT00702143|12954619|P2|STARTED|Overall Study||60
5270290|NCT00702143|12954620|P1|STARTED|Overall Study||45
5270291|NCT00701935|12954634|P2|NOT COMPLETED|Overall Study||11
5270292|NCT00701935|12954635|P1|NOT COMPLETED|Overall Study||16
5270293|NCT00701935|12954634|P2|COMPLETED|Overall Study||26
5270294|NCT00701935|12954635|P1|COMPLETED|Overall Study||27
5270295|NCT00701935|12954634|P2|STARTED|Overall Study||37
5270296|NCT00701935|12954635|P1|STARTED|Overall Study||43
5270297|NCT00701805|12954669|P4|NOT COMPLETED|Overall Study||4
5270298|NCT00701805|12954670|P3|NOT COMPLETED|Overall Study||7
5270299|NCT00701805|12954671|P2|NOT COMPLETED|Overall Study||4
5270300|NCT00701805|12954672|P1|NOT COMPLETED|Overall Study||3
5270301|NCT00701805|12954669|P4|COMPLETED|Overall Study||22
5270302|NCT00701805|12954670|P3|COMPLETED|Overall Study||16
5270303|NCT00701805|12954671|P2|COMPLETED|Overall Study||25
5270304|NCT00701805|12954672|P1|COMPLETED|Overall Study||23
5270305|NCT00701805|12954669|P4|STARTED|Overall Study||26
5270306|NCT00701805|12954670|P3|STARTED|Overall Study||23
5270307|NCT00701805|12954671|P2|STARTED|Overall Study||29
5270308|NCT00701805|12954672|P1|STARTED|Overall Study||26
5270309|NCT00701779|12954722|P1|NOT COMPLETED|Overall Study||9
5270310|NCT00701779|12954722|P1|COMPLETED|Overall Study||54
5270311|NCT00701779|12954722|P1|12 Month|Overall Study||54
5270312|NCT00701779|12954722|P1|9 Month|Overall Study||56
5270313|NCT00701779|12954722|P1|6 Month|Overall Study||58
5270314|NCT00701779|12954722|P1|3 Month|Overall Study||60
5270315|NCT00701779|12954722|P1|STARTED|Overall Study||63
5270316|NCT00701727|12954734|P2|NOT COMPLETED|Second Treatment Period||0
5270317|NCT00701727|12954735|P1|NOT COMPLETED|Second Treatment Period||2
5270318|NCT00701727|12954734|P2|COMPLETED|Second Treatment Period||13
5270319|NCT00701727|12954735|P1|COMPLETED|Second Treatment Period||13
5270320|NCT00701727|12954734|P2|STARTED|Second Treatment Period||13
5270321|NCT00701727|12954735|P1|STARTED|Second Treatment Period||15
5270322|NCT00701727|12954734|P2|NOT COMPLETED|First Treatment Period||2
5270323|NCT00701727|12954735|P1|NOT COMPLETED|First Treatment Period||1
5270324|NCT00701727|12954734|P2|COMPLETED|First Treatment Period||13
5270325|NCT00701727|12954735|P1|COMPLETED|First Treatment Period||15
5270326|NCT00701727|12954734|P2|STARTED|First Treatment Period||15
5270327|NCT00701727|12954735|P1|STARTED|First Treatment Period||16
5270328|NCT00701714|12954755|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
5270329|NCT00701714|12954756|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
5270330|NCT00701714|12954755|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
5270331|NCT00701714|12954756|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
5270332|NCT00701714|12954755|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
5270333|NCT00701714|12954756|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
5270334|NCT00701714|12954755|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
5270335|NCT00701714|12954756|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
5270336|NCT00701714|12954755|P2|COMPLETED|Treatment Period (up to 1 Year)||29
5270337|NCT00701714|12954756|P1|COMPLETED|Treatment Period (up to 1 Year)||37
5270338|NCT00701714|12954755|P2|STARTED|Treatment Period (up to 1 Year)||163
5270339|NCT00701714|12954756|P1|STARTED|Treatment Period (up to 1 Year)||174
5270340|NCT00701675|12954771|P3|NOT COMPLETED|Overall Study||7
5270341|NCT00701675|12954772|P2|NOT COMPLETED|Overall Study||8
5270342|NCT00701675|12954773|P1|NOT COMPLETED|Overall Study||4
5270343|NCT00701675|12954771|P3|COMPLETED|Overall Study||7
5270344|NCT00701675|12954772|P2|COMPLETED|Overall Study||6
5270345|NCT00701675|12954773|P1|COMPLETED|Overall Study||10
5270346|NCT00701675|12954771|P3|STARTED|Overall Study||14
5270347|NCT00701675|12954772|P2|STARTED|Overall Study||14
5270348|NCT00701675|12954773|P1|STARTED|Overall Study||14
5270349|NCT00701662|12954781|P1|NOT COMPLETED|Overall Study||1
5270350|NCT00701662|12954781|P1|COMPLETED|Overall Study||7
5270351|NCT00701662|12954781|P1|STARTED|Overall Study||8
5270352|NCT00701636|12954800|P2|NOT COMPLETED|Overall Study||0
5270353|NCT00701636|12954801|P1|NOT COMPLETED|Overall Study||0
5270354|NCT00701636|12954800|P2|COMPLETED|Overall Study||15
5270355|NCT00701636|12954801|P1|COMPLETED|Overall Study||15
5270356|NCT00701636|12954800|P2|STARTED|Overall Study||15
5270357|NCT00701636|12954801|P1|STARTED|Overall Study||15
5270358|NCT00701558|12954806|P1|NOT COMPLETED|Overall Study||15
5270359|NCT00701558|12954806|P1|COMPLETED|Overall Study||4
5270360|NCT00701558|12954806|P1|STARTED|Overall Study||19
5270361|NCT00701441|12954814|P2|NOT COMPLETED|Overall Study||4
5270362|NCT00701441|12954815|P1|NOT COMPLETED|Overall Study||0
5270363|NCT00701441|12954814|P2|COMPLETED|Overall Study||12
5270364|NCT00701441|12954815|P1|COMPLETED|Overall Study||9
5270365|NCT00701441|12954814|P2|STARTED|Overall Study||16
5270366|NCT00701441|12954815|P1|STARTED|Overall Study||9
5270367|NCT00701415|12954827|P2|NOT COMPLETED|Overall Study||1
5270368|NCT00701415|12954828|P1|NOT COMPLETED|Overall Study||1
5270369|NCT00701415|12954827|P2|COMPLETED|Overall Study||14
5270370|NCT00701415|12954828|P1|COMPLETED|Overall Study||15
5270371|NCT00701415|12954827|P2|STARTED|Overall Study||15
5270372|NCT00701415|12954828|P1|STARTED|Overall Study||16
5270373|NCT00701389|12954838|P4|NOT COMPLETED|Period 4||0
5270374|NCT00701389|12954839|P3|NOT COMPLETED|Period 4||0
5270375|NCT00701389|12954840|P2|NOT COMPLETED|Period 4||0
5270376|NCT00701389|12954841|P1|NOT COMPLETED|Period 4||0
5270377|NCT00701389|12954838|P4|COMPLETED|Period 4||6
5270378|NCT00701389|12954839|P3|COMPLETED|Period 4||6
5270379|NCT00701389|12954840|P2|COMPLETED|Period 4||6
5270380|NCT00701389|12954841|P1|COMPLETED|Period 4||6
5270381|NCT00701389|12954838|P4|STARTED|Period 4||6
5270382|NCT00701389|12954839|P3|STARTED|Period 4||6
5270383|NCT00701389|12954840|P2|STARTED|Period 4||6
5270384|NCT00701389|12954841|P1|STARTED|Period 4||6
5270385|NCT00701389|12954838|P4|NOT COMPLETED|Period 3||0
5270386|NCT00701389|12954839|P3|NOT COMPLETED|Period 3||0
5270387|NCT00701389|12954840|P2|NOT COMPLETED|Period 3||0
5270388|NCT00701389|12954841|P1|NOT COMPLETED|Period 3||0
5270389|NCT00701389|12954838|P4|COMPLETED|Period 3||6
5270390|NCT00701389|12954839|P3|COMPLETED|Period 3||6
5270391|NCT00701389|12954840|P2|COMPLETED|Period 3||6
5270392|NCT00701389|12954841|P1|COMPLETED|Period 3||6
5270393|NCT00701389|12954838|P4|STARTED|Period 3||6
5270394|NCT00701389|12954839|P3|STARTED|Period 3||6
5270395|NCT00701389|12954840|P2|STARTED|Period 3||6
5270396|NCT00701389|12954841|P1|STARTED|Period 3||6
5270397|NCT00701389|12954838|P4|NOT COMPLETED|Period 2||0
5270398|NCT00701389|12954839|P3|NOT COMPLETED|Period 2||0
5270399|NCT00701389|12954840|P2|NOT COMPLETED|Period 2||0
5270400|NCT00701389|12954841|P1|NOT COMPLETED|Period 2||0
5270401|NCT00701389|12954838|P4|COMPLETED|Period 2||6
5270402|NCT00701389|12954839|P3|COMPLETED|Period 2||6
5270403|NCT00701389|12954840|P2|COMPLETED|Period 2||6
5270404|NCT00701389|12954841|P1|COMPLETED|Period 2||6
5270405|NCT00701389|12954838|P4|STARTED|Period 2||6
5270406|NCT00701389|12954839|P3|STARTED|Period 2||6
5270407|NCT00701389|12954840|P2|STARTED|Period 2||6
5270408|NCT00701389|12954841|P1|STARTED|Period 2||6
5270409|NCT00701389|12954838|P4|NOT COMPLETED|Period 1||0
5270410|NCT00701389|12954839|P3|NOT COMPLETED|Period 1||0
5270411|NCT00701389|12954840|P2|NOT COMPLETED|Period 1||0
5270412|NCT00701389|12954841|P1|NOT COMPLETED|Period 1||0
5270413|NCT00701389|12954838|P4|COMPLETED|Period 1||6
5270414|NCT00701389|12954839|P3|COMPLETED|Period 1||6
5270415|NCT00701389|12954840|P2|COMPLETED|Period 1||6
5270416|NCT00701389|12954841|P1|COMPLETED|Period 1||6
5270417|NCT00701389|12954838|P4|STARTED|Period 1||6
5270418|NCT00701389|12954839|P3|STARTED|Period 1||6
5270419|NCT00701389|12954840|P2|STARTED|Period 1||6
5270420|NCT00701389|12954841|P1|STARTED|Period 1||6
5270421|NCT00701376|12954859|P1|NOT COMPLETED|Overall Study||1
5270422|NCT00701376|12954859|P1|COMPLETED|Overall Study||105
5270423|NCT00701376|12954859|P1|STARTED|Overall Study||106
5270424|NCT00701363|12954887|P4|NOT COMPLETED|Treatment Phase 2||0
5270425|NCT00701363|12954888|P3|NOT COMPLETED|Treatment Phase 2||2
5270426|NCT00701363|12954889|P2|NOT COMPLETED|Treatment Phase 2||0
5270427|NCT00701363|12954890|P1|NOT COMPLETED|Treatment Phase 2||0
5270428|NCT00701363|12954887|P4|COMPLETED|Treatment Phase 2||26
5270429|NCT00701363|12954888|P3|COMPLETED|Treatment Phase 2||68
5270430|NCT00701363|12954889|P2|COMPLETED|Treatment Phase 2||13
5270431|NCT00701363|12954890|P1|COMPLETED|Treatment Phase 2||0
5270432|NCT00701363|12954887|P4|STARTED|Treatment Phase 2||26
5270433|NCT00701363|12954888|P3|STARTED|Treatment Phase 2||70
5270434|NCT00701363|12954889|P2|STARTED|Treatment Phase 2||13
5270435|NCT00701363|12954890|P1|STARTED|Treatment Phase 2||0
5270436|NCT00701363|12954887|P4|NOT COMPLETED|Treatment Phase 1||0
5270437|NCT00701363|12954888|P3|NOT COMPLETED|Treatment Phase 1||0
5270438|NCT00701363|12954889|P2|NOT COMPLETED|Treatment Phase 1||0
5270439|NCT00701363|12954890|P1|NOT COMPLETED|Treatment Phase 1||15
5270440|NCT00701363|12954887|P4|COMPLETED|Treatment Phase 1||0
5270441|NCT00701363|12954888|P3|COMPLETED|Treatment Phase 1||0
5270442|NCT00701363|12954889|P2|COMPLETED|Treatment Phase 1||0
5270443|NCT00701363|12954890|P1|COMPLETED|Treatment Phase 1||109
5270444|NCT00701363|12954887|P4|STARTED|Treatment Phase 1||0
5270445|NCT00701363|12954888|P3|STARTED|Treatment Phase 1||0
5270446|NCT00701363|12954889|P2|STARTED|Treatment Phase 1||0
5270447|NCT00701363|12954890|P1|STARTED|Treatment Phase 1||124
5270448|NCT00701363|12954887|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
5270449|NCT00701363|12954888|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
5270450|NCT00701363|12954889|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
5270451|NCT00701363|12954890|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
5270452|NCT00701363|12954887|P4|COMPLETED|Screening (Pre-assignment) Phase||0
5270453|NCT00701363|12954888|P3|COMPLETED|Screening (Pre-assignment) Phase||0
5270454|NCT00701363|12954889|P2|COMPLETED|Screening (Pre-assignment) Phase||0
5270455|NCT00701363|12954890|P1|COMPLETED|Screening (Pre-assignment) Phase||124
5270456|NCT00701363|12954887|P4|STARTED|Screening (Pre-assignment) Phase||0
5270457|NCT00701363|12954888|P3|STARTED|Screening (Pre-assignment) Phase||0
5270458|NCT00701363|12954889|P2|STARTED|Screening (Pre-assignment) Phase||0
5270459|NCT00701363|12954890|P1|STARTED|Screening (Pre-assignment) Phase||128
5270460|NCT00701311|12954930|P1|NOT COMPLETED|Overall Study||8
5270547|NCT00700999|12955133|P2|COMPLETED|Overall Study||20
5270461|NCT00701311|12954930|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
5270462|NCT00701311|12954930|P1|STARTED|Overall Study||17
5270463|NCT00701129|12954934|P1|NOT COMPLETED|Overall Study||2
5270464|NCT00701129|12954934|P1|COMPLETED|Overall Study||2
5270465|NCT00701129|12954934|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
5270466|NCT00701129|12954934|P1|STARTED|Overall Study||4
5270467|NCT00701103|12954956|P11|NOT COMPLETED|Overall Study||11
5270468|NCT00701103|12954957|P10|NOT COMPLETED|Overall Study||11
5270469|NCT00701103|12954958|P9|NOT COMPLETED|Overall Study||9
5270470|NCT00701103|12954959|P8|NOT COMPLETED|Overall Study||7
5270471|NCT00701103|12954960|P7|NOT COMPLETED|Overall Study||8
5270472|NCT00701103|12954961|P6|NOT COMPLETED|Overall Study||6
5270473|NCT00701103|12954962|P5|NOT COMPLETED|Overall Study||6
5270474|NCT00701103|12954963|P4|NOT COMPLETED|Overall Study||6
5270475|NCT00701103|12954964|P3|NOT COMPLETED|Overall Study||8
5270476|NCT00701103|12954965|P2|NOT COMPLETED|Overall Study||3
5270477|NCT00701103|12954966|P1|NOT COMPLETED|Overall Study||5
5270478|NCT00701103|12954956|P11|COMPLETED|Overall Study||0
5270479|NCT00701103|12954957|P10|COMPLETED|Overall Study||0
5270480|NCT00701103|12954958|P9|COMPLETED|Overall Study||0
5270481|NCT00701103|12954959|P8|COMPLETED|Overall Study||0
5270482|NCT00701103|12954960|P7|COMPLETED|Overall Study||0
5270483|NCT00701103|12954961|P6|COMPLETED|Overall Study||0
5270484|NCT00701103|12954962|P5|COMPLETED|Overall Study||0
5270485|NCT00701103|12954963|P4|COMPLETED|Overall Study||0
5270486|NCT00701103|12954964|P3|COMPLETED|Overall Study||0
5270487|NCT00701103|12954965|P2|COMPLETED|Overall Study||0
5270488|NCT00701103|12954966|P1|COMPLETED|Overall Study||0
5270489|NCT00701103|12954956|P11|STARTED|Overall Study||11
5270490|NCT00701103|12954957|P10|STARTED|Overall Study||11
5270491|NCT00701103|12954958|P9|STARTED|Overall Study||9
5270492|NCT00701103|12954959|P8|STARTED|Overall Study||7
5270493|NCT00701103|12954960|P7|STARTED|Overall Study||8
5270494|NCT00701103|12954961|P6|STARTED|Overall Study||6
5270495|NCT00701103|12954962|P5|STARTED|Overall Study||6
5270496|NCT00701103|12954963|P4|STARTED|Overall Study||6
5270497|NCT00701103|12954964|P3|STARTED|Overall Study||8
5270498|NCT00701103|12954965|P2|STARTED|Overall Study||3
5270499|NCT00701103|12954966|P1|STARTED|Overall Study||5
5270500|NCT00701090|12955072|P2|NOT COMPLETED|Overall Study||51
5270501|NCT00701090|12955073|P1|NOT COMPLETED|Overall Study||48
5270502|NCT00701090|12955072|P2|COMPLETED|Overall Study||468
5270503|NCT00701090|12955073|P1|COMPLETED|Overall Study||468
5270504|NCT00701090|12955072|P2|STARTED|Overall Study||519
5270505|NCT00701090|12955073|P1|STARTED|Overall Study||516
5270506|NCT00701064|12955091|P2|NOT COMPLETED|Overall Study||4
5270507|NCT00701064|12955092|P1|NOT COMPLETED|Overall Study||4
5270508|NCT00701064|12955091|P2|COMPLETED|Overall Study||32
5270509|NCT00701064|12955092|P1|COMPLETED|Overall Study||31
5270510|NCT00701064|12955091|P2|STARTED|Overall Study||36
5270511|NCT00701064|12955092|P1|STARTED|Overall Study||35
5270512|NCT00701051|12955104|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
5270513|NCT00701051|12955105|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
5270514|NCT00701051|12955106|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
5270515|NCT00701051|12955104|P3|COMPLETED|Detraining Intervention (Optional)||6
5270516|NCT00701051|12955105|P2|COMPLETED|Detraining Intervention (Optional)||6
5270517|NCT00701051|12955106|P1|COMPLETED|Detraining Intervention (Optional)||0
5270518|NCT00701051|12955104|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
5270519|NCT00701051|12955105|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
5270520|NCT00701051|12955106|P1|STARTED|Detraining Intervention (Optional)||0
5270521|NCT00701051|12955104|P3|NOT COMPLETED|Exercise Intervention||3
5270522|NCT00701051|12955105|P2|NOT COMPLETED|Exercise Intervention||5
5270523|NCT00701051|12955106|P1|NOT COMPLETED|Exercise Intervention||0
5270524|NCT00701051|12955104|P3|COMPLETED|Exercise Intervention||9
5270525|NCT00701051|12955105|P2|COMPLETED|Exercise Intervention||14
5270526|NCT00701051|12955106|P1|COMPLETED|Exercise Intervention||0
5270527|NCT00701051|12955104|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
5270528|NCT00701051|12955105|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
5270529|NCT00701051|12955106|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
5270530|NCT00701051|12955104|P3|NOT COMPLETED|Screening||0
5270531|NCT00701051|12955105|P2|NOT COMPLETED|Screening||0
5270532|NCT00701051|12955106|P1|NOT COMPLETED|Screening||59
5270533|NCT00701051|12955104|P3|COMPLETED|Screening||0
5270534|NCT00701051|12955105|P2|COMPLETED|Screening||0
5270535|NCT00701051|12955106|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
5270536|NCT00701051|12955104|P3|STARTED|Screening||0
5270537|NCT00701051|12955105|P2|STARTED|Screening||0
5270538|NCT00701051|12955106|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
5270539|NCT00701038|12955124|P2|NOT COMPLETED|Overall Study||4
5270540|NCT00701038|12955125|P1|NOT COMPLETED|Overall Study||4
5270541|NCT00701038|12955124|P2|COMPLETED|Overall Study||23
5270542|NCT00701038|12955125|P1|COMPLETED|Overall Study||23
5270543|NCT00701038|12955124|P2|STARTED|Overall Study||27
5270544|NCT00701038|12955125|P1|STARTED|Overall Study||27
5270545|NCT00700999|12955133|P2|NOT COMPLETED|Overall Study||9
5270546|NCT00700999|12955134|P1|NOT COMPLETED|Overall Study||15
5270548|NCT00700999|12955134|P1|COMPLETED|Overall Study||21
5270549|NCT00700999|12955133|P2|Second MRI Scan|Overall Study||18
5270550|NCT00700999|12955134|P1|Second MRI Scan|Overall Study||19
5270551|NCT00700999|12955133|P2|First MRI Scan|Overall Study||22
5270552|NCT00700999|12955134|P1|First MRI Scan|Overall Study||29
5270553|NCT00700999|12955133|P2|STARTED|Overall Study||29
5270554|NCT00700999|12955134|P1|STARTED|Overall Study||36
5270555|NCT00700973|12955142|P2|NOT COMPLETED|Overall Study||7
5270556|NCT00700973|12955143|P1|NOT COMPLETED|Overall Study||8
5270557|NCT00700973|12955142|P2|COMPLETED|Overall Study||63
5270558|NCT00700973|12955143|P1|COMPLETED|Overall Study||63
5270559|NCT00700973|12955142|P2|STARTED|Overall Study||70
5270560|NCT00700973|12955143|P1|STARTED|Overall Study||71
5270561|NCT00700882|12955149|P1|NOT COMPLETED|Overall Study||59
5270562|NCT00700882|12955149|P1|COMPLETED|Overall Study||22
5270563|NCT00700882|12955149|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
5270564|NCT00700882|12955149|P1|Eligible and Treated Patients|Overall Study||73
5270565|NCT00700882|12955149|P1|Received Protocol Therapy|Overall Study||75
5270566|NCT00700882|12955149|P1|STARTED|Overall Study||81
5270567|NCT00700817|12955158|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
5270568|NCT00700817|12955159|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
5270569|NCT00700817|12955160|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
5270570|NCT00700817|12955161|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
5270571|NCT00700817|12955162|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
5270572|NCT00700817|12955158|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
5270573|NCT00700817|12955159|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
5270574|NCT00700817|12955160|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
5270575|NCT00700817|12955161|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
5270576|NCT00700817|12955162|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
5270577|NCT00700817|12955158|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
5270578|NCT00700817|12955159|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
5270579|NCT00700817|12955160|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
5270580|NCT00700817|12955161|P2|STARTED|Week 52-78 (Extension Period 2)||150
5270581|NCT00700817|12955162|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
5270582|NCT00700817|12955158|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
5270583|NCT00700817|12955159|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
5270584|NCT00700817|12955160|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
5270585|NCT00700817|12955161|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
5270586|NCT00700817|12955162|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
5270587|NCT00700817|12955158|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
5270588|NCT00700817|12955159|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
5270589|NCT00700817|12955160|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
5270590|NCT00700817|12955161|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
5270591|NCT00700817|12955162|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
5270592|NCT00700817|12955158|P5|STARTED|Week 26-52 (Extension Period 1)||0
5270593|NCT00700817|12955159|P4|STARTED|Week 26-52 (Extension Period 1)||0
5270594|NCT00700817|12955160|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
5270595|NCT00700817|12955161|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
5270596|NCT00700817|12955162|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
5270597|NCT00700817|12955158|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
5270598|NCT00700817|12955159|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
5270599|NCT00700817|12955160|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
5270600|NCT00700817|12955161|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
5270601|NCT00700817|12955162|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
5270602|NCT00700817|12955158|P5|COMPLETED|Week 0-26 (Main Period)||0
5270603|NCT00700817|12955159|P4|COMPLETED|Week 0-26 (Main Period)||0
5270604|NCT00700817|12955160|P3|COMPLETED|Week 0-26 (Main Period)||194
5270605|NCT00700817|12955161|P2|COMPLETED|Week 0-26 (Main Period)||191
5270606|NCT00700817|12955162|P1|COMPLETED|Week 0-26 (Main Period)||169
5270607|NCT00700817|12955158|P5|Exposed|Week 0-26 (Main Period)||0
5270608|NCT00700817|12955159|P4|Exposed|Week 0-26 (Main Period)||0
5270609|NCT00700817|12955160|P3|Exposed|Week 0-26 (Main Period)||219
5270610|NCT00700817|12955161|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
5270611|NCT00700817|12955162|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
5270612|NCT00700817|12955158|P5|STARTED|Week 0-26 (Main Period)||0
5270613|NCT00700817|12955159|P4|STARTED|Week 0-26 (Main Period)||0
5270614|NCT00700817|12955160|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
5270615|NCT00700817|12955161|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
5270616|NCT00700817|12955162|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
5270617|NCT00700804|12955544|P2|NOT COMPLETED|Overall Study||4
5270618|NCT00700804|12955545|P1|NOT COMPLETED|Overall Study||3
5270619|NCT00700804|12955544|P2|COMPLETED|Overall Study||13
5270620|NCT00700804|12955545|P1|COMPLETED|Overall Study||14
5270621|NCT00700804|12955544|P2|STARTED|Overall Study||17
5270622|NCT00700804|12955545|P1|STARTED|Overall Study||17
5270623|NCT00700752|12955553|P2|NOT COMPLETED|Second Intervention||0
5270624|NCT00700752|12955554|P1|NOT COMPLETED|Second Intervention||0
5270625|NCT00700752|12955553|P2|COMPLETED|Second Intervention||18
5270626|NCT00700752|12955554|P1|COMPLETED|Second Intervention||20
5270627|NCT00700752|12955553|P2|STARTED|Second Intervention||18
5270628|NCT00700752|12955554|P1|STARTED|Second Intervention||20
5270629|NCT00700752|12955553|P2|NOT COMPLETED|First Intervention||2
5270630|NCT00700752|12955554|P1|NOT COMPLETED|First Intervention||0
5270631|NCT00700752|12955553|P2|COMPLETED|First Intervention||18
5270632|NCT00700752|12955554|P1|COMPLETED|First Intervention||20
5270633|NCT00700752|12955553|P2|STARTED|First Intervention||20
5270634|NCT00700752|12955554|P1|STARTED|First Intervention||20
5270635|NCT00700739|12955562|P2|NOT COMPLETED|Overall Study||4
5270636|NCT00700739|12955563|P1|NOT COMPLETED|Overall Study||4
5270637|NCT00700739|12955562|P2|COMPLETED|Overall Study||12
5270638|NCT00700739|12955563|P1|COMPLETED|Overall Study||18
5270639|NCT00700739|12955562|P2|STARTED|Overall Study||16
5270640|NCT00700739|12955563|P1|STARTED|Overall Study||22
5270641|NCT00700713|12955602|P3|NOT COMPLETED|Overall Study||2
5270642|NCT00700713|12955603|P2|NOT COMPLETED|Overall Study||0
5270643|NCT00700713|12955604|P1|NOT COMPLETED|Overall Study||1
5270644|NCT00700713|12955602|P3|COMPLETED|Overall Study||65
5270645|NCT00700713|12955603|P2|COMPLETED|Overall Study||66
5270646|NCT00700713|12955604|P1|COMPLETED|Overall Study||47
5270647|NCT00700713|12955602|P3|STARTED|Overall Study||67
5270648|NCT00700713|12955603|P2|STARTED|Overall Study||66
5270649|NCT00700713|12955604|P1|STARTED|Overall Study||48
5270650|NCT00700635|12955621|P3|NOT COMPLETED|Overall Study||1
5270651|NCT00700635|12955622|P2|NOT COMPLETED|Overall Study||8
5270652|NCT00700635|12955623|P1|NOT COMPLETED|Overall Study||11
5270653|NCT00700635|12955621|P3|COMPLETED|Overall Study||110
5270654|NCT00700635|12955622|P2|COMPLETED|Overall Study||103
5270655|NCT00700635|12955623|P1|COMPLETED|Overall Study||100
5270656|NCT00700635|12955621|P3|STARTED|Overall Study||111
5270657|NCT00700635|12955622|P2|STARTED|Overall Study||111
5270658|NCT00700635|12955623|P1|STARTED|Overall Study||111
5270659|NCT00700622|12955645|P2|NOT COMPLETED|Overall Study||5
5270660|NCT00700622|12955646|P1|NOT COMPLETED|Overall Study||13
5270661|NCT00700622|12955645|P2|COMPLETED|Overall Study||60
5270662|NCT00700622|12955646|P1|COMPLETED|Overall Study||52
5270663|NCT00700622|12955645|P2|STARTED|Overall Study||65
5270664|NCT00700622|12955646|P1|STARTED|Overall Study||65
5270665|NCT00700570|12955654|P2|NOT COMPLETED|Overall Study||26
5270666|NCT00700570|12955655|P1|NOT COMPLETED|Overall Study||11
5270667|NCT00700570|12955654|P2|COMPLETED|Overall Study||0
5270668|NCT00700570|12955655|P1|COMPLETED|Overall Study||8
5270669|NCT00700570|12955654|P2|STARTED|Overall Study||26
5270670|NCT00700570|12955655|P1|STARTED|Overall Study||19
5270671|NCT00700440|12955667|P1|NOT COMPLETED|Overall Study||0
5270672|NCT00700440|12955667|P1|COMPLETED|Overall Study||100
5270673|NCT00700440|12955667|P1|STARTED|Overall Study||100
5270674|NCT00700427|12955671|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
5270675|NCT00700427|12955672|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
5270676|NCT00700427|12955673|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
5270677|NCT00700427|12955674|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
5270678|NCT00700427|12955675|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
5270679|NCT00700427|12955671|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
5270680|NCT00700427|12955672|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
5270681|NCT00700427|12955673|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
5270682|NCT00700427|12955674|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
5270683|NCT00700427|12955675|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
5270684|NCT00700427|12955671|P5|STARTED|Study Period 4 (Open-Label Extension)||180
5270685|NCT00700427|12955672|P4|STARTED|Study Period 4 (Open-Label Extension)||0
5270686|NCT00700427|12955673|P3|STARTED|Study Period 4 (Open-Label Extension)||0
5270687|NCT00700427|12955674|P2|STARTED|Study Period 4 (Open-Label Extension)||0
5270688|NCT00700427|12955675|P1|STARTED|Study Period 4 (Open-Label Extension)||0
5270689|NCT00700427|12955671|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270690|NCT00700427|12955672|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
5270691|NCT00700427|12955673|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
5270692|NCT00700427|12955674|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270693|NCT00700427|12955675|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270694|NCT00700427|12955671|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270695|NCT00700427|12955672|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
5270696|NCT00700427|12955673|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
5270697|NCT00700427|12955674|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270698|NCT00700427|12955675|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
5270699|NCT00700427|12955671|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
5270700|NCT00700427|12955672|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
5270701|NCT00700427|12955673|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
5270702|NCT00700427|12955674|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
5270703|NCT00700427|12955675|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
5270704|NCT00700427|12955671|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270705|NCT00700427|12955672|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270706|NCT00700427|12955673|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270707|NCT00700427|12955674|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
5270708|NCT00700427|12955675|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270709|NCT00700427|12955671|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270710|NCT00700427|12955672|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270711|NCT00700427|12955673|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270712|NCT00700427|12955674|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
5270713|NCT00700427|12955675|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
5270714|NCT00700427|12955671|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
5270715|NCT00700427|12955672|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
5270716|NCT00700427|12955673|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
5270717|NCT00700427|12955674|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
5270718|NCT00700427|12955675|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
5270719|NCT00700427|12955671|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270720|NCT00700427|12955672|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270721|NCT00700427|12955673|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270722|NCT00700427|12955674|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270723|NCT00700427|12955675|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
5270724|NCT00700427|12955671|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270725|NCT00700427|12955672|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270726|NCT00700427|12955673|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270727|NCT00700427|12955674|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
5270728|NCT00700427|12955675|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
5270729|NCT00700427|12955671|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
5270730|NCT00700427|12955672|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
5270731|NCT00700427|12955673|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
5270732|NCT00700427|12955674|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
5270733|NCT00700427|12955675|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
5270734|NCT00700427|12955671|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
5270735|NCT00700427|12955672|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
5270736|NCT00700427|12955673|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
5270737|NCT00700427|12955674|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
5270738|NCT00700427|12955675|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
5270739|NCT00700401|12955697|P1|NOT COMPLETED|Overall Study||94
5270740|NCT00700401|12955697|P1|COMPLETED|Overall Study||168
5270741|NCT00700401|12955697|P1|STARTED|Overall Study||262
5270742|NCT00700375|12955710|P2|NOT COMPLETED|Overall Study||0
5270743|NCT00700375|12955711|P1|NOT COMPLETED|Overall Study||0
5270744|NCT00700375|12955710|P2|COMPLETED|Overall Study||29
5270745|NCT00700375|12955711|P1|COMPLETED|Overall Study||30
5270746|NCT00700375|12955710|P2|2 Days After Creatinine Mesurement|Overall Study||29
5270747|NCT00700375|12955711|P1|2 Days After Creatinine Mesurement|Overall Study||30
5270748|NCT00700375|12955710|P2|STARTED|Overall Study||29
5270749|NCT00700375|12955711|P1|STARTED|Overall Study||30
5270750|NCT00700310|12955721|P4|NOT COMPLETED|Overall Study||26
5270751|NCT00700310|12955722|P3|NOT COMPLETED|Overall Study||16
5270752|NCT00700310|12955723|P2|NOT COMPLETED|Overall Study||26
5270753|NCT00700310|12955724|P1|NOT COMPLETED|Overall Study||21
5270754|NCT00700310|12955721|P4|COMPLETED|Overall Study||145
5270755|NCT00700310|12955722|P3|COMPLETED|Overall Study||158
5270756|NCT00700310|12955723|P2|COMPLETED|Overall Study||154
5270757|NCT00700310|12955724|P1|COMPLETED|Overall Study||166
5270758|NCT00700310|12955721|P4|STARTED|Overall Study||171
5270759|NCT00700310|12955722|P3|STARTED|Overall Study||174
5270760|NCT00700310|12955723|P2|STARTED|Overall Study||180
5270761|NCT00700310|12955724|P1|STARTED|Overall Study||187
5270762|NCT00700271|12955744|P2|NOT COMPLETED|Overall Study||12
5270763|NCT00700271|12955745|P1|NOT COMPLETED|Overall Study||14
5270764|NCT00700271|12955744|P2|COMPLETED|Overall Study||256
5270765|NCT00700271|12955745|P1|COMPLETED|Overall Study||264
5270766|NCT00700271|12955744|P2|STARTED|Overall Study||268
5270767|NCT00700271|12955745|P1|STARTED|Overall Study||278
5270768|NCT00700180|12955773|P2|NOT COMPLETED|Overall Study||149
5270769|NCT00700180|12955774|P1|NOT COMPLETED|Overall Study||154
5270770|NCT00700180|12955773|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
5270771|NCT00700180|12955774|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
5270772|NCT00700180|12955773|P2|STARTED|Overall Study||149
5270773|NCT00700180|12955774|P1|STARTED|Overall Study||154
5270774|NCT00700141|12955796|P1|NOT COMPLETED|Overall Study||0
5270775|NCT00700141|12955796|P1|COMPLETED|Overall Study||482
5270776|NCT00700141|12955796|P1|STARTED|Overall Study||482
5270777|NCT00700115|12955803|P2|NOT COMPLETED|Overall Study||1
5270778|NCT00700115|12955804|P1|NOT COMPLETED|Overall Study||1
5270779|NCT00700115|12955803|P2|COMPLETED|Overall Study||19
5270780|NCT00700115|12955804|P1|COMPLETED|Overall Study||39
5270781|NCT00700115|12955803|P2|STARTED|Overall Study||20
5270782|NCT00700115|12955804|P1|STARTED|Overall Study||40
5270783|NCT00700102|12955814|P2|NOT COMPLETED|Overall Study||395
5270784|NCT00700102|12955815|P1|NOT COMPLETED|Overall Study||402
5270785|NCT00700102|12955814|P2|COMPLETED|Overall Study||14
5270786|NCT00700102|12955815|P1|COMPLETED|Overall Study||9
5270787|NCT00700102|12955814|P2|Received at Least One Dose|Overall Study||403
5270788|NCT00700102|12955815|P1|Received at Least One Dose|Overall Study||407
5270789|NCT00700102|12955814|P2|Intention to Treat|Overall Study||409
5270790|NCT00700102|12955815|P1|Intention to Treat|Overall Study||410
5270791|NCT00700102|12955814|P2|STARTED|Overall Study||409
5270792|NCT00700102|12955815|P1|STARTED|Overall Study||411
5270793|NCT00700063|12955839|P8|NOT COMPLETED|Overall Study||0
5270794|NCT00700063|12955840|P7|NOT COMPLETED|Overall Study||0
5270795|NCT00700063|12955841|P6|NOT COMPLETED|Overall Study||0
5270796|NCT00700063|12955842|P5|NOT COMPLETED|Overall Study||2
5270797|NCT00700063|12955843|P4|NOT COMPLETED|Overall Study||2
5270798|NCT00700063|12955844|P3|NOT COMPLETED|Overall Study||0
5270799|NCT00700063|12955845|P2|NOT COMPLETED|Overall Study||0
5270800|NCT00700063|12955846|P1|NOT COMPLETED|Overall Study||1
5270801|NCT00700063|12955839|P8|COMPLETED|Overall Study||33
5270802|NCT00700063|12955840|P7|COMPLETED|Overall Study||32
5270803|NCT00700063|12955841|P6|COMPLETED|Overall Study||34
5270804|NCT00700063|12955842|P5|COMPLETED|Overall Study||31
5270805|NCT00700063|12955843|P4|COMPLETED|Overall Study||31
5270806|NCT00700063|12955844|P3|COMPLETED|Overall Study||33
5270807|NCT00700063|12955845|P2|COMPLETED|Overall Study||34
5270808|NCT00700063|12955846|P1|COMPLETED|Overall Study||32
5270809|NCT00700063|12955839|P8|STARTED|Overall Study||33
5270810|NCT00700063|12955840|P7|STARTED|Overall Study||32
5270811|NCT00700063|12955841|P6|STARTED|Overall Study||34
5270812|NCT00700063|12955842|P5|STARTED|Overall Study||33
5270813|NCT00700063|12955843|P4|STARTED|Overall Study||33
5270814|NCT00700063|12955844|P3|STARTED|Overall Study||33
5270815|NCT00700063|12955845|P2|STARTED|Overall Study||34
5270816|NCT00700063|12955846|P1|STARTED|Overall Study||33
5270817|NCT00700011|12955954|P2|NOT COMPLETED|Overall Study||1
5270818|NCT00700011|12955955|P1|NOT COMPLETED|Overall Study||0
5270819|NCT00700011|12955954|P2|COMPLETED|Overall Study||1
5270820|NCT00700011|12955955|P1|COMPLETED|Overall Study||8
5270821|NCT00700011|12955954|P2|STARTED|Overall Study||2
5270822|NCT00700011|12955955|P1|STARTED|Overall Study||8
5270823|NCT00699998|12955971|P4|NOT COMPLETED|Overall Study||82
5270824|NCT00699998|12955972|P3|NOT COMPLETED|Overall Study||206
5270825|NCT00699998|12955973|P2|NOT COMPLETED|Overall Study||86
5270826|NCT00699998|12955974|P1|NOT COMPLETED|Overall Study||199
5270827|NCT00699998|12955971|P4|COMPLETED|Overall Study||958
5270828|NCT00699998|12955972|P3|COMPLETED|Overall Study||3417
5270829|NCT00699998|12955973|P2|COMPLETED|Overall Study||957
5270830|NCT00699998|12955974|P1|COMPLETED|Overall Study||3421
5270831|NCT00699998|12955971|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
5270832|NCT00699998|12955972|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
5270833|NCT00699998|12955973|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
5270834|NCT00699998|12955974|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
5270835|NCT00699998|12955971|P4|STARTED|Overall Study||1040
5270836|NCT00699998|12955972|P3|STARTED|Overall Study||3623
5270837|NCT00699998|12955973|P2|STARTED|Overall Study||1043
5270838|NCT00699998|12955974|P1|STARTED|Overall Study||3620
5270839|NCT00699972|12956019|P3|NOT COMPLETED|Overall Study||35
5270840|NCT00699972|12956020|P2|NOT COMPLETED|Overall Study||19
5270841|NCT00699972|12956021|P1|NOT COMPLETED|Overall Study||16
5270842|NCT00699972|12956019|P3|COMPLETED|Overall Study||100
5270843|NCT00699972|12956020|P2|COMPLETED|Overall Study||114
5270844|NCT00699972|12956021|P1|COMPLETED|Overall Study||106
5270845|NCT00699972|12956019|P3|STARTED|Overall Study||135
5270846|NCT00699972|12956020|P2|STARTED|Overall Study||133
5270847|NCT00699972|12956021|P1|STARTED|Overall Study||122
5270848|NCT00699907|12956038|P3|NOT COMPLETED|Overall Study||8
5270849|NCT00699907|12956039|P2|NOT COMPLETED|Overall Study||10
5270850|NCT00699907|12956040|P1|NOT COMPLETED|Overall Study||2
5270851|NCT00699907|12956038|P3|COMPLETED|Overall Study||48
5270852|NCT00699907|12956039|P2|COMPLETED|Overall Study||47
5270853|NCT00699907|12956040|P1|COMPLETED|Overall Study||12
5270854|NCT00699907|12956038|P3|STARTED|Overall Study||56
5270855|NCT00699907|12956039|P2|STARTED|Overall Study||57
5270856|NCT00699907|12956040|P1|STARTED|Overall Study||14
5270857|NCT00699842|12956075|P3|NOT COMPLETED|Overall Study||0
5270858|NCT00699842|12956076|P2|NOT COMPLETED|Overall Study||1
5270859|NCT00699842|12956077|P1|NOT COMPLETED|Overall Study||0
5270860|NCT00699842|12956075|P3|COMPLETED|Overall Study||0
5270861|NCT00699842|12956076|P2|COMPLETED|Overall Study||4
5270862|NCT00699842|12956077|P1|COMPLETED|Overall Study||3
5270863|NCT00699842|12956075|P3|STARTED|Overall Study||0
5270864|NCT00699842|12956076|P2|STARTED|Overall Study||5
5270865|NCT00699842|12956077|P1|STARTED|Overall Study||3
5270866|NCT00699816|12956090|P2|NOT COMPLETED|Overall Study||3
5270867|NCT00699816|12956091|P1|NOT COMPLETED|Overall Study||1
5270868|NCT00699816|12956090|P2|COMPLETED|Overall Study||112
5270869|NCT00699816|12956091|P1|COMPLETED|Overall Study||114
5270870|NCT00699816|12956090|P2|STARTED|Overall Study||115
5270871|NCT00699816|12956091|P1|STARTED|Overall Study||115
5270872|NCT00699751|12956109|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
5270873|NCT00699751|12956110|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
5270874|NCT00699751|12956109|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
5270875|NCT00699751|12956110|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
5270876|NCT00699751|12956109|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
5270877|NCT00699751|12956110|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
5270878|NCT00699751|12956109|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
5270879|NCT00699751|12956110|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
5270880|NCT00699751|12956109|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
5270881|NCT00699751|12956110|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
5270882|NCT00699751|12956109|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
5270883|NCT00699751|12956110|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
5270965|NCT00699608|12956217|P6|COMPLETED|First 4-14 Day Washout Period||15
5270884|NCT00699751|12956109|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
5270885|NCT00699751|12956110|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
5270886|NCT00699751|12956109|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
5270887|NCT00699751|12956110|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
5270888|NCT00699751|12956109|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
5270889|NCT00699751|12956110|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
5270890|NCT00699751|12956109|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
5270891|NCT00699751|12956110|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
5270892|NCT00699751|12956109|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
5270893|NCT00699751|12956110|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
5270894|NCT00699751|12956109|P2|STARTED|Period 1: Without/Before Drug Switch||307
5270895|NCT00699751|12956110|P1|STARTED|Period 1: Without/Before Drug Switch||614
5270896|NCT00699699|12956195|P1|NOT COMPLETED|Overall Study||57
5270897|NCT00699699|12956195|P1|COMPLETED|Overall Study||1223
5270898|NCT00699699|12956195|P1|STARTED|Overall Study||1280
5270899|NCT00699660|12956204|P2|NOT COMPLETED|Overall Study||8
5270900|NCT00699660|12956205|P1|NOT COMPLETED|Overall Study||14
5270901|NCT00699660|12956204|P2|COMPLETED|Overall Study||208
5270902|NCT00699660|12956205|P1|COMPLETED|Overall Study||176
5270903|NCT00699660|12956204|P2|STARTED|Overall Study||216
5270904|NCT00699660|12956205|P1|STARTED|Overall Study||190
5270905|NCT00699608|12956217|P6|NOT COMPLETED|Third Intervention||0
5270906|NCT00699608|12956218|P5|NOT COMPLETED|Third Intervention||0
5270907|NCT00699608|12956219|P4|NOT COMPLETED|Third Intervention||0
5270908|NCT00699608|12956220|P3|NOT COMPLETED|Third Intervention||0
5270909|NCT00699608|12956221|P2|NOT COMPLETED|Third Intervention||0
5270910|NCT00699608|12956222|P1|NOT COMPLETED|Third Intervention||0
5270911|NCT00699608|12956217|P6|COMPLETED|Third Intervention||15
5270912|NCT00699608|12956218|P5|COMPLETED|Third Intervention||14
5270913|NCT00699608|12956219|P4|COMPLETED|Third Intervention||14
5270914|NCT00699608|12956220|P3|COMPLETED|Third Intervention||13
5270915|NCT00699608|12956221|P2|COMPLETED|Third Intervention||15
5270916|NCT00699608|12956222|P1|COMPLETED|Third Intervention||16
5270917|NCT00699608|12956217|P6|STARTED|Third Intervention||15
5270918|NCT00699608|12956218|P5|STARTED|Third Intervention||14
5270919|NCT00699608|12956219|P4|STARTED|Third Intervention||14
5270920|NCT00699608|12956220|P3|STARTED|Third Intervention||13
5270921|NCT00699608|12956221|P2|STARTED|Third Intervention||15
5270922|NCT00699608|12956222|P1|STARTED|Third Intervention||16
5270923|NCT00699608|12956217|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270924|NCT00699608|12956218|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270925|NCT00699608|12956219|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270926|NCT00699608|12956220|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270927|NCT00699608|12956221|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270928|NCT00699608|12956222|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
5270929|NCT00699608|12956217|P6|COMPLETED|Second 4-14 Day Washout Period||15
5270930|NCT00699608|12956218|P5|COMPLETED|Second 4-14 Day Washout Period||14
5270931|NCT00699608|12956219|P4|COMPLETED|Second 4-14 Day Washout Period||14
5270932|NCT00699608|12956220|P3|COMPLETED|Second 4-14 Day Washout Period||13
5270933|NCT00699608|12956221|P2|COMPLETED|Second 4-14 Day Washout Period||15
5270934|NCT00699608|12956222|P1|COMPLETED|Second 4-14 Day Washout Period||16
5270935|NCT00699608|12956217|P6|STARTED|Second 4-14 Day Washout Period||15
5270936|NCT00699608|12956218|P5|STARTED|Second 4-14 Day Washout Period||14
5270937|NCT00699608|12956219|P4|STARTED|Second 4-14 Day Washout Period||14
5270938|NCT00699608|12956220|P3|STARTED|Second 4-14 Day Washout Period||13
5270939|NCT00699608|12956221|P2|STARTED|Second 4-14 Day Washout Period||15
5270940|NCT00699608|12956222|P1|STARTED|Second 4-14 Day Washout Period||16
5270941|NCT00699608|12956217|P6|NOT COMPLETED|Second Intervention||0
5270942|NCT00699608|12956218|P5|NOT COMPLETED|Second Intervention||0
5270943|NCT00699608|12956219|P4|NOT COMPLETED|Second Intervention||1
5270944|NCT00699608|12956220|P3|NOT COMPLETED|Second Intervention||1
5270945|NCT00699608|12956221|P2|NOT COMPLETED|Second Intervention||0
5270946|NCT00699608|12956222|P1|NOT COMPLETED|Second Intervention||0
5270947|NCT00699608|12956217|P6|COMPLETED|Second Intervention||15
5270948|NCT00699608|12956218|P5|COMPLETED|Second Intervention||14
5270949|NCT00699608|12956219|P4|COMPLETED|Second Intervention||14
5270950|NCT00699608|12956220|P3|COMPLETED|Second Intervention||13
5270951|NCT00699608|12956221|P2|COMPLETED|Second Intervention||15
5270952|NCT00699608|12956222|P1|COMPLETED|Second Intervention||16
5270953|NCT00699608|12956217|P6|STARTED|Second Intervention||15
5270954|NCT00699608|12956218|P5|STARTED|Second Intervention||14
5270955|NCT00699608|12956219|P4|STARTED|Second Intervention||15
5270956|NCT00699608|12956220|P3|STARTED|Second Intervention||14
5270957|NCT00699608|12956221|P2|STARTED|Second Intervention||15
5270958|NCT00699608|12956222|P1|STARTED|Second Intervention||16
5270959|NCT00699608|12956217|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
5270960|NCT00699608|12956218|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
5270961|NCT00699608|12956219|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
5270962|NCT00699608|12956220|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
5270963|NCT00699608|12956221|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
5270964|NCT00699608|12956222|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
5270966|NCT00699608|12956218|P5|COMPLETED|First 4-14 Day Washout Period||14
5270967|NCT00699608|12956219|P4|COMPLETED|First 4-14 Day Washout Period||15
5270968|NCT00699608|12956220|P3|COMPLETED|First 4-14 Day Washout Period||14
5270969|NCT00699608|12956221|P2|COMPLETED|First 4-14 Day Washout Period||15
5270970|NCT00699608|12956222|P1|COMPLETED|First 4-14 Day Washout Period||16
5270971|NCT00699608|12956217|P6|STARTED|First 4-14 Day Washout Period||15
5270972|NCT00699608|12956218|P5|STARTED|First 4-14 Day Washout Period||14
5270973|NCT00699608|12956219|P4|STARTED|First 4-14 Day Washout Period||15
5270974|NCT00699608|12956220|P3|STARTED|First 4-14 Day Washout Period||14
5270975|NCT00699608|12956221|P2|STARTED|First 4-14 Day Washout Period||15
5270976|NCT00699608|12956222|P1|STARTED|First 4-14 Day Washout Period||16
5270977|NCT00699608|12956217|P6|NOT COMPLETED|First Intervention||0
5270978|NCT00699608|12956218|P5|NOT COMPLETED|First Intervention||1
5270979|NCT00699608|12956219|P4|NOT COMPLETED|First Intervention||0
5270980|NCT00699608|12956220|P3|NOT COMPLETED|First Intervention||1
5270981|NCT00699608|12956221|P2|NOT COMPLETED|First Intervention||0
5270982|NCT00699608|12956222|P1|NOT COMPLETED|First Intervention||0
5270983|NCT00699608|12956217|P6|COMPLETED|First Intervention||15
5270984|NCT00699608|12956218|P5|COMPLETED|First Intervention||14
5270985|NCT00699608|12956219|P4|COMPLETED|First Intervention||15
5270986|NCT00699608|12956220|P3|COMPLETED|First Intervention||14
5270987|NCT00699608|12956221|P2|COMPLETED|First Intervention||15
5270988|NCT00699608|12956222|P1|COMPLETED|First Intervention||16
5270989|NCT00699608|12956217|P6|STARTED|First Intervention||15
5270990|NCT00699608|12956218|P5|STARTED|First Intervention||15
5270991|NCT00699608|12956219|P4|STARTED|First Intervention||15
5270992|NCT00699608|12956220|P3|STARTED|First Intervention||15
5270993|NCT00699608|12956221|P2|STARTED|First Intervention||15
5270994|NCT00699608|12956222|P1|STARTED|First Intervention||16
5270995|NCT00699582|12956275|P3|NOT COMPLETED|Overall Study||28
5270996|NCT00699582|12956276|P2|NOT COMPLETED|Overall Study||22
5270997|NCT00699582|12956277|P1|NOT COMPLETED|Overall Study||18
5270998|NCT00699582|12956275|P3|COMPLETED|Overall Study||93
5270999|NCT00699582|12956276|P2|COMPLETED|Overall Study||108
5271000|NCT00699582|12956277|P1|COMPLETED|Overall Study||120
5271001|NCT00699582|12956275|P3|STARTED|Overall Study||121
5271002|NCT00699582|12956276|P2|STARTED|Overall Study||130
5271003|NCT00699582|12956277|P1|STARTED|Overall Study||138
5271004|NCT00699556|12956291|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5271005|NCT00699556|12956292|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5271006|NCT00699556|12956291|P2|COMPLETED|Second Intervention (1 Day)||11
5271007|NCT00699556|12956292|P1|COMPLETED|Second Intervention (1 Day)||11
5271008|NCT00699556|12956291|P2|STARTED|Second Intervention (1 Day)||11
5271009|NCT00699556|12956292|P1|STARTED|Second Intervention (1 Day)||11
5271010|NCT00699556|12956291|P2|NOT COMPLETED|First Intervention (1 Day)||0
5271011|NCT00699556|12956292|P1|NOT COMPLETED|First Intervention (1 Day)||0
5271012|NCT00699556|12956291|P2|COMPLETED|First Intervention (1 Day)||11
5271013|NCT00699556|12956292|P1|COMPLETED|First Intervention (1 Day)||11
5271014|NCT00699556|12956291|P2|STARTED|First Intervention (1 Day)||11
5271015|NCT00699556|12956292|P1|STARTED|First Intervention (1 Day)||11
5271016|NCT00699491|12956306|P6|NOT COMPLETED|Overall Study||0
5271017|NCT00699491|12956307|P5|NOT COMPLETED|Overall Study||0
5271018|NCT00699491|12956308|P4|NOT COMPLETED|Overall Study||0
5271019|NCT00699491|12956309|P3|NOT COMPLETED|Overall Study||0
5271020|NCT00699491|12956310|P2|NOT COMPLETED|Overall Study||0
5271021|NCT00699491|12956311|P1|NOT COMPLETED|Overall Study||0
5271022|NCT00699491|12956306|P6|COMPLETED|Overall Study||22
5271023|NCT00699491|12956307|P5|COMPLETED|Overall Study||8
5271024|NCT00699491|12956308|P4|COMPLETED|Overall Study||6
5271025|NCT00699491|12956309|P3|COMPLETED|Overall Study||7
5271026|NCT00699491|12956310|P2|COMPLETED|Overall Study||2
5271027|NCT00699491|12956311|P1|COMPLETED|Overall Study||3
5271028|NCT00699491|12956306|P6|STARTED|Overall Study||22
5271029|NCT00699491|12956307|P5|STARTED|Overall Study||8
5271030|NCT00699491|12956308|P4|STARTED|Overall Study||6
5271031|NCT00699491|12956309|P3|STARTED|Overall Study||7
5271032|NCT00699491|12956310|P2|STARTED|Overall Study||2
5271033|NCT00699491|12956311|P1|STARTED|Overall Study||3
5271034|NCT00699413|12956332|P2|NOT COMPLETED|Overall Study||4
5271035|NCT00699413|12956333|P1|NOT COMPLETED|Overall Study||4
5271036|NCT00699413|12956332|P2|COMPLETED|Overall Study||0
5271037|NCT00699413|12956333|P1|COMPLETED|Overall Study||0
5271038|NCT00699413|12956332|P2|STARTED|Overall Study||4
5271039|NCT00699413|12956333|P1|STARTED|Overall Study||4
5271040|NCT00699400|12956348|P6|NOT COMPLETED|Overall Study||11
5271041|NCT00699400|12956349|P5|NOT COMPLETED|Overall Study||0
5271042|NCT00699400|12956350|P4|NOT COMPLETED|Overall Study||0
5271043|NCT00699400|12956351|P3|NOT COMPLETED|Overall Study||0
5271044|NCT00699400|12956352|P2|NOT COMPLETED|Overall Study||0
5271045|NCT00699400|12956353|P1|NOT COMPLETED|Overall Study||0
5271046|NCT00699400|12956348|P6|COMPLETED|Overall Study||0
5271047|NCT00699400|12956349|P5|COMPLETED|Overall Study||4
5271048|NCT00699400|12956350|P4|COMPLETED|Overall Study||6
5271049|NCT00699400|12956351|P3|COMPLETED|Overall Study||138
5271050|NCT00699400|12956352|P2|COMPLETED|Overall Study||3
5271051|NCT00699400|12956353|P1|COMPLETED|Overall Study||42
5271052|NCT00699400|12956348|P6|STARTED|Overall Study||11
5271053|NCT00699400|12956349|P5|STARTED|Overall Study||4
5271054|NCT00699400|12956350|P4|STARTED|Overall Study||6
5271055|NCT00699400|12956351|P3|STARTED|Overall Study||138
5271056|NCT00699400|12956352|P2|STARTED|Overall Study||3
5271057|NCT00699400|12956353|P1|STARTED|Overall Study||42
5271058|NCT00699374|12956387|P2|NOT COMPLETED|Overall Study||544
5271059|NCT00699374|12956388|P1|NOT COMPLETED|Overall Study||530
5271060|NCT00699374|12956387|P2|COMPLETED|Overall Study||0
5271061|NCT00699374|12956388|P1|COMPLETED|Overall Study||0
5271062|NCT00699374|12956387|P2|Treated|Overall Study||542
5271063|NCT00699374|12956388|P1|Treated|Overall Study||526
5271064|NCT00699374|12956387|P2|STARTED|Overall Study||544
5271065|NCT00699374|12956388|P1|STARTED|Overall Study||530
5271066|NCT00699348|12956400|P1|NOT COMPLETED|Overall Study||90
5271067|NCT00699348|12956400|P1|COMPLETED|Overall Study||261
5271068|NCT00699348|12956400|P1|STARTED|Overall Study||351
5271069|NCT00699335|12956409|P1|NOT COMPLETED|Overall Study||228
5271070|NCT00699335|12956409|P1|COMPLETED|Overall Study||5080
5271071|NCT00699335|12956409|P1|STARTED|Overall Study||5308
5271072|NCT00699283|12956442|P2|NOT COMPLETED|Overall Study||8
5271073|NCT00699283|12956443|P1|NOT COMPLETED|Overall Study||33
5271074|NCT00699283|12956442|P2|COMPLETED|Overall Study||7
5271075|NCT00699283|12956443|P1|COMPLETED|Overall Study||14
5271076|NCT00699283|12956442|P2|STARTED|Overall Study||15
5271077|NCT00699283|12956443|P1|STARTED|Overall Study||47
5271078|NCT00699218|12956448|P1|NOT COMPLETED|Overall Study||0
5271079|NCT00699218|12956448|P1|COMPLETED|Overall Study||15
5271080|NCT00699218|12956448|P1|STARTED|Overall Study||15
5271081|NCT00699192|12956456|P3|NOT COMPLETED|Overall Study||11
5271082|NCT00699192|12956457|P2|NOT COMPLETED|Overall Study||12
5271083|NCT00699192|12956458|P1|NOT COMPLETED|Overall Study||16
5271084|NCT00699192|12956456|P3|COMPLETED|Overall Study||261
5271085|NCT00699192|12956457|P2|COMPLETED|Overall Study||260
5271086|NCT00699192|12956458|P1|COMPLETED|Overall Study||259
5271087|NCT00699192|12956456|P3|STARTED|Overall Study||272
5271088|NCT00699192|12956457|P2|STARTED|Overall Study||272
5271089|NCT00699192|12956458|P1|STARTED|Overall Study||275
5271090|NCT00699153|12956480|P2|NOT COMPLETED|Overall Study||2
5271091|NCT00699153|12956481|P1|NOT COMPLETED|Overall Study||3
5271092|NCT00699153|12956480|P2|COMPLETED|Overall Study||200
5271093|NCT00699153|12956481|P1|COMPLETED|Overall Study||200
5271094|NCT00699153|12956480|P2|STARTED|Overall Study|Intent to treat population|202
5271095|NCT00699153|12956481|P1|STARTED|Overall Study|Intent to treat population|203
5271096|NCT00699140|12956493|P1|NOT COMPLETED|Overall Study||0
5271097|NCT00699140|12956493|P1|COMPLETED|Overall Study||18
5271098|NCT00699140|12956493|P1|STARTED|Overall Study||18
5271099|NCT00699010|12956507|P2|NOT COMPLETED|Overall Study||0
5271100|NCT00699010|12956508|P1|NOT COMPLETED|Overall Study||0
5271101|NCT00699010|12956507|P2|COMPLETED|Overall Study||15
5271102|NCT00699010|12956508|P1|COMPLETED|Overall Study||15
5271103|NCT00699010|12956507|P2|STARTED|Overall Study||15
5271104|NCT00699010|12956508|P1|STARTED|Overall Study||15
5271105|NCT00698997|12956516|P2|NOT COMPLETED|Overall Study||27
5271106|NCT00698997|12956517|P1|NOT COMPLETED|Overall Study||10
5271107|NCT00698997|12956516|P2|COMPLETED|Overall Study|36 - final assessment completed|36
5271108|NCT00698997|12956517|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
5271109|NCT00698997|12956516|P2|STARTED|Overall Study|1 enrollment|63
5271110|NCT00698997|12956517|P1|STARTED|Overall Study|1 enrollment|55
5271111|NCT00698932|12956531|P2|NOT COMPLETED|Overall Study||36
5271112|NCT00698932|12956532|P1|NOT COMPLETED|Overall Study||22
5271113|NCT00698932|12956531|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
5271114|NCT00698932|12956532|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
5271115|NCT00698932|12956531|P2|STARTED|Overall Study|Randomized and treated|284
5271116|NCT00698932|12956532|P1|STARTED|Overall Study|Randomized and treated|284
5271117|NCT00698867|12956548|P1|NOT COMPLETED|Overall Study||91
5271118|NCT00698867|12956548|P1|COMPLETED|Overall Study||27
5271119|NCT00698867|12956548|P1|Subjects With 4 Year Data|Overall Study||34
5271120|NCT00698867|12956548|P1|Subjects With 3 Year Data|Overall Study||35
5271121|NCT00698867|12956548|P1|Subjects With 2 Year Data|Overall Study||55
5271122|NCT00698867|12956548|P1|Subjects With 1 Year Data|Overall Study||68
5271123|NCT00698867|12956548|P1|STARTED|Overall Study||118
5271124|NCT00698841|12956558|P1|NOT COMPLETED|Overall Study||18
5271125|NCT00698841|12956558|P1|COMPLETED|Overall Study||33
5271126|NCT00698841|12956558|P1|STARTED|Overall Study||51
5271127|NCT00698815|12956572|P3|NOT COMPLETED|Overall Study||10
5271128|NCT00698815|12956573|P2|NOT COMPLETED|Overall Study||14
5271129|NCT00698815|12956574|P1|NOT COMPLETED|Overall Study||10
5271130|NCT00698815|12956572|P3|COMPLETED|Overall Study||31
5271131|NCT00698815|12956573|P2|COMPLETED|Overall Study||33
5271132|NCT00698815|12956574|P1|COMPLETED|Overall Study||32
5271133|NCT00698815|12956572|P3|STARTED|Overall Study||41
5271134|NCT00698815|12956573|P2|STARTED|Overall Study||47
5271135|NCT00698815|12956574|P1|STARTED|Overall Study||42
5271136|NCT00698685|12956591|P1|NOT COMPLETED|Overall Study||2
5271137|NCT00698685|12956591|P1|COMPLETED|Overall Study||12
5271138|NCT00698685|12956591|P1|STARTED|Overall Study||14
5271139|NCT00698646|12956599|P3|NOT COMPLETED|Overall Study||29
5271140|NCT00698646|12956600|P2|NOT COMPLETED|Overall Study||31
5271141|NCT00698646|12956601|P1|NOT COMPLETED|Overall Study||36
5271142|NCT00698646|12956599|P3|COMPLETED|Overall Study||99
5271143|NCT00698646|12956600|P2|COMPLETED|Overall Study||97
5271144|NCT00698646|12956601|P1|COMPLETED|Overall Study||92
5271145|NCT00698646|12956599|P3|STARTED|Overall Study||128
5271146|NCT00698646|12956600|P2|STARTED|Overall Study||128
5271147|NCT00698646|12956601|P1|STARTED|Overall Study||128
5271148|NCT00698581|12956626|P2|NOT COMPLETED|Overall Study||12
5271149|NCT00698581|12956627|P1|NOT COMPLETED|Overall Study||45
5271150|NCT00698581|12956626|P2|COMPLETED|Overall Study||8
5271151|NCT00698581|12956627|P1|COMPLETED|Overall Study||23
5271152|NCT00698581|12956626|P2|STARTED|Overall Study||20
5271153|NCT00698581|12956627|P1|STARTED|Overall Study||68
5271154|NCT00698516|12956638|P1|NOT COMPLETED|Overall Study||5
5271155|NCT00698516|12956638|P1|COMPLETED|Overall Study||45
5271156|NCT00698516|12956638|P1|STARTED|Overall Study||50
5271157|NCT00698451|12956656|P1|NOT COMPLETED|Overall Study||39
5271158|NCT00698451|12956656|P1|COMPLETED|Overall Study||15
5271159|NCT00698451|12956656|P1|STARTED|Overall Study||54
5271160|NCT00698204|12956663|P2|NOT COMPLETED|Overall Study||0
5271161|NCT00698204|12956664|P1|NOT COMPLETED|Overall Study||1
5271162|NCT00698204|12956663|P2|COMPLETED|Overall Study||20
5271163|NCT00698204|12956664|P1|COMPLETED|Overall Study||19
5271164|NCT00698204|12956663|P2|STARTED|Overall Study||20
5271165|NCT00698204|12956664|P1|STARTED|Overall Study||20
5271166|NCT00698139|12956675|P3|NOT COMPLETED|Overall Study||0
5271167|NCT00698139|12956676|P2|NOT COMPLETED|Overall Study||0
5271168|NCT00698139|12956677|P1|NOT COMPLETED|Overall Study||0
5271169|NCT00698139|12956675|P3|COMPLETED|Overall Study||1
5271170|NCT00698139|12956676|P2|COMPLETED|Overall Study||1
5271171|NCT00698139|12956677|P1|COMPLETED|Overall Study||1
5271172|NCT00698139|12956675|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
5271173|NCT00698139|12956676|P2|2nd Visit|Overall Study||1
5271174|NCT00698139|12956677|P1|2nd Visit|Overall Study||1
5271175|NCT00698139|12956675|P3|STARTED|Overall Study||1
5271176|NCT00698139|12956676|P2|STARTED|Overall Study||1
5271177|NCT00698139|12956677|P1|STARTED|Overall Study||1
5271178|NCT00698035|12956693|P2|NOT COMPLETED|Overall Study||2
5271179|NCT00698035|12956694|P1|NOT COMPLETED|Overall Study||4
5271180|NCT00698035|12956693|P2|COMPLETED|Overall Study||34
5271181|NCT00698035|12956694|P1|COMPLETED|Overall Study||35
5271182|NCT00698035|12956693|P2|STARTED|Overall Study||36
5271183|NCT00698035|12956694|P1|STARTED|Overall Study||39
5271184|NCT00698022|12956714|P3|NOT COMPLETED|Overall Study||2
5271185|NCT00698022|12956715|P2|NOT COMPLETED|Overall Study||10
5271186|NCT00698022|12956716|P1|NOT COMPLETED|Overall Study||16
5271187|NCT00698022|12956714|P3|COMPLETED|Overall Study||14
5271188|NCT00698022|12956715|P2|COMPLETED|Overall Study||20
5271189|NCT00698022|12956716|P1|COMPLETED|Overall Study||14
5271190|NCT00698022|12956714|P3|STARTED|Overall Study||16
5271191|NCT00698022|12956715|P2|STARTED|Overall Study||30
5271192|NCT00698022|12956716|P1|STARTED|Overall Study||30
5271193|NCT00698009|12956724|P1|NOT COMPLETED|Overall Study||1
5271194|NCT00698009|12956724|P1|COMPLETED|Overall Study||0
5271195|NCT00698009|12956724|P1|STARTED|Overall Study||1
5271196|NCT00697827|12956730|P2|NOT COMPLETED|Overall Study||1
5271197|NCT00697827|12956731|P1|NOT COMPLETED|Overall Study||2
5271198|NCT00697827|12956730|P2|COMPLETED|Overall Study||15
5271199|NCT00697827|12956731|P1|COMPLETED|Overall Study||26
5271200|NCT00697827|12956730|P2|STARTED|Overall Study||16
5271201|NCT00697827|12956731|P1|STARTED|Overall Study||28
5271202|NCT00697801|12956742|P3|NOT COMPLETED|Overall Study||24
5271203|NCT00697801|12956743|P2|NOT COMPLETED|Overall Study||12
5271204|NCT00697801|12956744|P1|NOT COMPLETED|Overall Study||12
5271205|NCT00697801|12956742|P3|COMPLETED|Overall Study||45
5271206|NCT00697801|12956743|P2|COMPLETED|Overall Study||58
5271207|NCT00697801|12956744|P1|COMPLETED|Overall Study||57
5271208|NCT00697801|12956742|P3|STARTED|Overall Study||69
5271209|NCT00697801|12956743|P2|STARTED|Overall Study||70
5271210|NCT00697801|12956744|P1|STARTED|Overall Study||69
5271211|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271212|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271213|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271214|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271215|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271216|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271217|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271218|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271219|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
5271220|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271221|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271222|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271223|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271224|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271225|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271226|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271227|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
5271228|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271229|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271230|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271231|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271232|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271233|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271234|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
5271235|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271236|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271237|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271238|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271239|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271240|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271241|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271242|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271243|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271244|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
5271245|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271246|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271247|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271248|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271249|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271250|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271251|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271252|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
5271253|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271254|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271255|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271256|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271257|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271258|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
5271259|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271260|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271261|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271262|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271263|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271264|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271265|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271266|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271267|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271268|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271269|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
5271270|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271271|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271272|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271273|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271274|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271275|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271276|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271277|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
5271278|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271279|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271280|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271281|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271282|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
5271283|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271284|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271285|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271286|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
5271287|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271288|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271289|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271290|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271291|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271292|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271293|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271294|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
5271295|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271296|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271297|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271298|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271299|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271300|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271301|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271302|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
5271303|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271304|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271305|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271306|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
5271307|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271308|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271309|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271310|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271311|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271312|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271313|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271314|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271315|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271316|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271317|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271318|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271319|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
5271320|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271321|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271322|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271323|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271324|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271325|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271326|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271327|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
5271328|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271329|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271330|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
5271331|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271332|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271333|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271334|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271335|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271336|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271337|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271338|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271339|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271340|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271341|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271342|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271343|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271344|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
5271345|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271346|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271347|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271348|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271349|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271350|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271351|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271352|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
5271353|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271354|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
5271355|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271356|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271357|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271358|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271359|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271360|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271361|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
5271362|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271363|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271364|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271365|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271366|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271367|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271368|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271369|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
5271370|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271371|NCT00697788|12956758|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271372|NCT00697788|12956759|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271373|NCT00697788|12956760|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271374|NCT00697788|12956761|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271375|NCT00697788|12956762|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271376|NCT00697788|12956763|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271377|NCT00697788|12956764|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
5271378|NCT00697788|12956765|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
5271379|NCT00697788|12956758|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271380|NCT00697788|12956759|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271381|NCT00697788|12956760|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271382|NCT00697788|12956761|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271383|NCT00697788|12956762|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271384|NCT00697788|12956763|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271385|NCT00697788|12956764|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271386|NCT00697788|12956765|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271387|NCT00697788|12956758|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271388|NCT00697788|12956759|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271389|NCT00697788|12956760|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271390|NCT00697788|12956761|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271391|NCT00697788|12956762|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271392|NCT00697788|12956763|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271393|NCT00697788|12956764|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
5271394|NCT00697788|12956765|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
5271395|NCT00697788|12956758|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
5271396|NCT00697788|12956759|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
5271397|NCT00697788|12956760|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
5271398|NCT00697788|12956761|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
5271399|NCT00697788|12956762|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
5271400|NCT00697788|12956763|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
5271401|NCT00697788|12956764|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
5271402|NCT00697788|12956765|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
5271403|NCT00697697|12956809|P2|NOT COMPLETED|Overall Study||54
5271404|NCT00697697|12956810|P1|NOT COMPLETED|Overall Study||49
5271405|NCT00697697|12956809|P2|COMPLETED|Overall Study||44
5271406|NCT00697697|12956810|P1|COMPLETED|Overall Study||45
5271407|NCT00697697|12956809|P2|STARTED|Overall Study||98
5271408|NCT00697697|12956810|P1|STARTED|Overall Study||94
5271409|NCT00697619|12956820|P2|NOT COMPLETED|Overall Study||8
5271410|NCT00697619|12956821|P1|NOT COMPLETED|Overall Study||6
5271411|NCT00697619|12956820|P2|COMPLETED|Overall Study||22
5271412|NCT00697619|12956821|P1|COMPLETED|Overall Study||24
5271413|NCT00697619|12956820|P2|STARTED|Overall Study||30
5271414|NCT00697619|12956821|P1|STARTED|Overall Study||30
5271415|NCT00697593|12956827|P1|NOT COMPLETED|Overall Study||19
5271416|NCT00697593|12956827|P1|COMPLETED|Overall Study||51
5271417|NCT00697593|12956827|P1|STARTED|Overall Study||70
5271418|NCT00697541|12956860|P2|NOT COMPLETED|Overall Study||1
5271419|NCT00697541|12956861|P1|NOT COMPLETED|Overall Study||2
5271420|NCT00697541|12956860|P2|COMPLETED|Overall Study||9
5271421|NCT00697541|12956861|P1|COMPLETED|Overall Study||8
5271422|NCT00697541|12956860|P2|STARTED|Overall Study||10
5271423|NCT00697541|12956861|P1|STARTED|Overall Study||10
5271424|NCT00697515|12956871|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
5271425|NCT00697515|12956872|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
5271426|NCT00697515|12956871|P2|COMPLETED|Second Intervention (Crossover Period)||51
5271427|NCT00697515|12956872|P1|COMPLETED|Second Intervention (Crossover Period)||52
5271428|NCT00697515|12956871|P2|STARTED|Second Intervention (Crossover Period)||52
5271429|NCT00697515|12956872|P1|STARTED|Second Intervention (Crossover Period)||53
5271430|NCT00697515|12956871|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
5271431|NCT00697515|12956872|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
5271432|NCT00697515|12956871|P2|COMPLETED|First Intervention (Crossover Period)||52
5271433|NCT00697515|12956872|P1|COMPLETED|First Intervention (Crossover Period)||53
5271434|NCT00697515|12956871|P2|STARTED|First Intervention (Crossover Period)||64
5271435|NCT00697515|12956872|P1|STARTED|First Intervention (Crossover Period)||63
5271436|NCT00697515|12956871|P2|NOT COMPLETED|Dose Optimization Period||0
5271437|NCT00697515|12956872|P1|NOT COMPLETED|Dose Optimization Period||15
5271438|NCT00697515|12956871|P2|COMPLETED|Dose Optimization Period||0
5271439|NCT00697515|12956872|P1|COMPLETED|Dose Optimization Period||127
5271440|NCT00697515|12956871|P2|STARTED|Dose Optimization Period||0
5271441|NCT00697515|12956872|P1|STARTED|Dose Optimization Period||142
5271442|NCT00697463|12956900|P1|NOT COMPLETED|Overall Study||1
5271443|NCT00697463|12956900|P1|COMPLETED|Overall Study||21
5271444|NCT00697463|12956900|P1|STARTED|Overall Study||22
5271445|NCT00697346|12956907|P3|NOT COMPLETED|Overall Study||1
5271446|NCT00697346|12956908|P2|NOT COMPLETED|Overall Study||26
5271447|NCT00697346|12956909|P1|NOT COMPLETED|Overall Study||28
5271448|NCT00697346|12956907|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
5271449|NCT00697346|12956908|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
5271450|NCT00697346|12956909|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
5271451|NCT00697346|12956907|P3|STARTED|Overall Study||2
5271452|NCT00697346|12956908|P2|STARTED|Overall Study||28
5271453|NCT00697346|12956909|P1|STARTED|Overall Study||28
5271454|NCT00697255|12957017|P2|NOT COMPLETED|Stage 1b||2
5271455|NCT00697255|12957018|P1|NOT COMPLETED|Stage 1b||0
5271456|NCT00697255|12957017|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
5271457|NCT00697255|12957018|P1|COMPLETED|Stage 1b||0
5271458|NCT00697255|12957017|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
5271459|NCT00697255|12957018|P1|STARTED|Stage 1b||0
5271460|NCT00697255|12957017|P2|NOT COMPLETED|Stage 1a||0
5271461|NCT00697255|12957018|P1|NOT COMPLETED|Stage 1a||3
5271462|NCT00697255|12957017|P2|COMPLETED|Stage 1a||0
5271463|NCT00697255|12957018|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
5271464|NCT00697255|12957017|P2|STARTED|Stage 1a||0
5271465|NCT00697255|12957018|P1|STARTED|Stage 1a||5
5271466|NCT00697203|12957038|P4|NOT COMPLETED|Overall Study||7
5271467|NCT00697203|12957039|P3|NOT COMPLETED|Overall Study||8
5271468|NCT00697203|12957040|P2|NOT COMPLETED|Overall Study||6
5271469|NCT00697203|12957041|P1|NOT COMPLETED|Overall Study||9
5271470|NCT00697203|12957038|P4|COMPLETED|Overall Study||67
5271471|NCT00697203|12957039|P3|COMPLETED|Overall Study||66
5271472|NCT00697203|12957040|P2|COMPLETED|Overall Study||62
5271473|NCT00697203|12957041|P1|COMPLETED|Overall Study||67
5271474|NCT00697203|12957038|P4|STARTED|Overall Study||74
5271475|NCT00697203|12957039|P3|STARTED|Overall Study||74
5271476|NCT00697203|12957040|P2|STARTED|Overall Study||68
5271477|NCT00697203|12957041|P1|STARTED|Overall Study||76
5271478|NCT00697190|12957071|P2|NOT COMPLETED|Second Intervention||0
5271479|NCT00697190|12957072|P1|NOT COMPLETED|Second Intervention||0
5271480|NCT00697190|12957071|P2|COMPLETED|Second Intervention||20
5271481|NCT00697190|12957072|P1|COMPLETED|Second Intervention||18
5271482|NCT00697190|12957071|P2|STARTED|Second Intervention||20
5271483|NCT00697190|12957072|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
5271484|NCT00697190|12957071|P2|NOT COMPLETED|First Intervention||0
5271485|NCT00697190|12957072|P1|NOT COMPLETED|First Intervention||0
5271486|NCT00697190|12957071|P2|COMPLETED|First Intervention||20
5271487|NCT00697190|12957072|P1|COMPLETED|First Intervention||19
5271488|NCT00697190|12957071|P2|STARTED|First Intervention||20
5271489|NCT00697190|12957072|P1|STARTED|First Intervention||19
5271490|NCT00697112|12957106|P1|NOT COMPLETED|Overall Study||10
5271491|NCT00697112|12957106|P1|COMPLETED|Overall Study||43
5271492|NCT00697112|12957106|P1|Met the Inclusion Criteria|Overall Study||52
5271493|NCT00697112|12957106|P1|STARTED|Overall Study||53
5271494|NCT00697073|12957130|P1|NOT COMPLETED|Overall Study||9
5271495|NCT00697073|12957130|P1|COMPLETED|Overall Study||59
5271496|NCT00697073|12957130|P1|STARTED|Overall Study||68
5271497|NCT00696878|12957134|P1|NOT COMPLETED|Overall Study||504
5271498|NCT00696878|12957134|P1|COMPLETED|Overall Study||178
5271499|NCT00696878|12957134|P1|STARTED|Overall Study||682
5271500|NCT00696800|12957208|P2|NOT COMPLETED|Overall Study||48
5271501|NCT00696800|12957209|P1|NOT COMPLETED|Overall Study||85
5271502|NCT00696800|12957208|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
5271503|NCT00696800|12957209|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
5271504|NCT00696800|12957208|P2|Treated (ITT)|Overall Study|The ITT group|750
5271505|NCT00696800|12957209|P1|Treated (ITT)|Overall Study|The ITT group|756
5271506|NCT00696800|12957208|P2|STARTED|Overall Study||752
5271507|NCT00696800|12957209|P1|STARTED|Overall Study||757
5271508|NCT00696787|12957262|P3|NOT COMPLETED|Overall Study||26
5271509|NCT00696787|12957263|P2|NOT COMPLETED|Overall Study||20
5271510|NCT00696787|12957264|P1|NOT COMPLETED|Overall Study||15
5271511|NCT00696787|12957262|P3|COMPLETED|Overall Study||17
5271512|NCT00696787|12957263|P2|COMPLETED|Overall Study||22
5271513|NCT00696787|12957264|P1|COMPLETED|Overall Study||25
5271514|NCT00696787|12957262|P3|STARTED|Overall Study||43
5271515|NCT00696787|12957263|P2|STARTED|Overall Study||42
5271516|NCT00696787|12957264|P1|STARTED|Overall Study||40
5271517|NCT00696774|12957278|P3|NOT COMPLETED|Period III||0
5271518|NCT00696774|12957279|P2|NOT COMPLETED|Period III||7
5271519|NCT00696774|12957280|P1|NOT COMPLETED|Period III||7
5271520|NCT00696774|12957278|P3|COMPLETED|Period III||0
5271521|NCT00696774|12957279|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
5271522|NCT00696774|12957280|P1|COMPLETED|Period III||106
5271523|NCT00696774|12957278|P3|STARTED|Period III||0
5271524|NCT00696774|12957279|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
5271525|NCT00696774|12957280|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
5271526|NCT00696774|12957278|P3|NOT COMPLETED|Period II||36
5271527|NCT00696774|12957279|P2|NOT COMPLETED|Period II||0
5271528|NCT00696774|12957280|P1|NOT COMPLETED|Period II||0
5271529|NCT00696774|12957278|P3|COMPLETED|Period II||0
5271530|NCT00696774|12957279|P2|COMPLETED|Period II||91
5271531|NCT00696774|12957280|P1|COMPLETED|Period II||115
5271532|NCT00696774|12957278|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
5271533|NCT00696774|12957279|P2|STARTED|Period II||91
5271534|NCT00696774|12957280|P1|STARTED|Period II||115
5271535|NCT00696761|12957318|P4|NOT COMPLETED|Overall Study||10
5271536|NCT00696761|12957319|P3|NOT COMPLETED|Overall Study||11
5271537|NCT00696761|12957320|P2|NOT COMPLETED|Overall Study||26
5271538|NCT00696761|12957321|P1|NOT COMPLETED|Overall Study||20
5271539|NCT00696761|12957318|P4|COMPLETED|Overall Study||44
5271540|NCT00696761|12957319|P3|COMPLETED|Overall Study||30
5271541|NCT00696761|12957320|P2|COMPLETED|Overall Study||50
5271542|NCT00696761|12957321|P1|COMPLETED|Overall Study||41
5271543|NCT00696761|12957318|P4|STARTED|Overall Study||54
5271544|NCT00696761|12957319|P3|STARTED|Overall Study||41
5271545|NCT00696761|12957320|P2|STARTED|Overall Study||76
5271546|NCT00696761|12957321|P1|STARTED|Overall Study||61
5271547|NCT00696709|12957340|P5|NOT COMPLETED|Overall Study||3
5271548|NCT00696709|12957341|P4|NOT COMPLETED|Overall Study||5
5271549|NCT00696709|12957342|P3|NOT COMPLETED|Overall Study||1
5271550|NCT00696709|12957343|P2|NOT COMPLETED|Overall Study||3
5271551|NCT00696709|12957344|P1|NOT COMPLETED|Overall Study||3
5271552|NCT00696709|12957340|P5|COMPLETED|Overall Study||62
5271553|NCT00696709|12957341|P4|COMPLETED|Overall Study||59
5271554|NCT00696709|12957342|P3|COMPLETED|Overall Study||32
5271555|NCT00696709|12957343|P2|COMPLETED|Overall Study||60
5271556|NCT00696709|12957344|P1|COMPLETED|Overall Study||62
5271557|NCT00696709|12957340|P5|Vaccination 4 (~Day 90)|Overall Study||63
5271558|NCT00696709|12957341|P4|Vaccination 4 (~Day 90)|Overall Study||59
5271559|NCT00696709|12957342|P3|Vaccination 4 (~Day 90)|Overall Study||32
5271560|NCT00696709|12957343|P2|Vaccination 4 (~Day 90)|Overall Study||60
5271561|NCT00696709|12957344|P1|Vaccination 4 (~Day 90)|Overall Study||62
5271562|NCT00696709|12957340|P5|Vaccination 3 (~Day 60)|Overall Study||63
5271563|NCT00696709|12957341|P4|Vaccination 3 (~Day 60)|Overall Study||59
5271564|NCT00696709|12957342|P3|Vaccination 3 (~Day 60)|Overall Study||32
5271565|NCT00696709|12957343|P2|Vaccination 3 (~Day 60)|Overall Study||60
5271566|NCT00696709|12957344|P1|Vaccination 3 (~Day 60)|Overall Study||64
5271567|NCT00696709|12957340|P5|Vaccination 2 (~Day 30)|Overall Study||64
5271568|NCT00696709|12957341|P4|Vaccination 2 (~Day 30)|Overall Study||61
5271569|NCT00696709|12957342|P3|Vaccination 2 (~Day 30)|Overall Study||32
5271570|NCT00696709|12957343|P2|Vaccination 2 (~Day 30)|Overall Study||60
5271571|NCT00696709|12957344|P1|Vaccination 2 (~Day 30)|Overall Study||64
5271572|NCT00696709|12957340|P5|Vaccination 1 (Day 1)|Overall Study||65
5271573|NCT00696709|12957341|P4|Vaccination 1 (Day 1)|Overall Study||64
5271574|NCT00696709|12957342|P3|Vaccination 1 (Day 1)|Overall Study||32
5271575|NCT00696709|12957343|P2|Vaccination 1 (Day 1)|Overall Study||63
5271576|NCT00696709|12957344|P1|Vaccination 1 (Day 1)|Overall Study||65
5271577|NCT00696709|12957340|P5|STARTED|Overall Study||65
5271578|NCT00696709|12957341|P4|STARTED|Overall Study||64
5271579|NCT00696709|12957342|P3|STARTED|Overall Study||33
5271580|NCT00696709|12957343|P2|STARTED|Overall Study||63
5271581|NCT00696709|12957344|P1|STARTED|Overall Study||65
5271582|NCT00696696|12957380|P1|NOT COMPLETED|Overall Study||18
5271583|NCT00696696|12957380|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
5271584|NCT00696696|12957380|P1|STARTED|Overall Study||44
5271585|NCT00696657|12957395|P9|NOT COMPLETED|Overall Study||9
5271586|NCT00696657|12957396|P8|NOT COMPLETED|Overall Study||3
5271587|NCT00696657|12957397|P7|NOT COMPLETED|Overall Study||15
5271588|NCT00696657|12957398|P6|NOT COMPLETED|Overall Study||12
5271589|NCT00696657|12957399|P5|NOT COMPLETED|Overall Study||10
5271590|NCT00696657|12957400|P4|NOT COMPLETED|Overall Study||11
5271591|NCT00696657|12957401|P3|NOT COMPLETED|Overall Study||8
5271592|NCT00696657|12957402|P2|NOT COMPLETED|Overall Study||5
5271593|NCT00696657|12957403|P1|NOT COMPLETED|Overall Study||1
5271594|NCT00696657|12957395|P9|COMPLETED|Overall Study||41
5271595|NCT00696657|12957396|P8|COMPLETED|Overall Study||42
5271596|NCT00696657|12957397|P7|COMPLETED|Overall Study||30
5271597|NCT00696657|12957398|P6|COMPLETED|Overall Study||33
5271598|NCT00696657|12957399|P5|COMPLETED|Overall Study||34
5271599|NCT00696657|12957400|P4|COMPLETED|Overall Study||38
5271600|NCT00696657|12957401|P3|COMPLETED|Overall Study||36
5271601|NCT00696657|12957402|P2|COMPLETED|Overall Study||42
5271602|NCT00696657|12957403|P1|COMPLETED|Overall Study||45
5271603|NCT00696657|12957395|P9|EXPOSED|Overall Study||50
5271604|NCT00696657|12957396|P8|EXPOSED|Overall Study||45
5271605|NCT00696657|12957397|P7|EXPOSED|Overall Study||45
5271606|NCT00696657|12957398|P6|EXPOSED|Overall Study||43
5271607|NCT00696657|12957399|P5|EXPOSED|Overall Study||44
5271608|NCT00696657|12957400|P4|EXPOSED|Overall Study||48
5271609|NCT00696657|12957401|P3|EXPOSED|Overall Study||43
5271610|NCT00696657|12957402|P2|EXPOSED|Overall Study||47
5271611|NCT00696657|12957403|P1|EXPOSED|Overall Study||46
5271612|NCT00696657|12957395|P9|STARTED|Overall Study||50
5271613|NCT00696657|12957396|P8|STARTED|Overall Study||45
5271614|NCT00696657|12957397|P7|STARTED|Overall Study||45
5271615|NCT00696657|12957398|P6|STARTED|Overall Study||45
5271616|NCT00696657|12957399|P5|STARTED|Overall Study||44
5271617|NCT00696657|12957400|P4|STARTED|Overall Study||49
5271618|NCT00696657|12957401|P3|STARTED|Overall Study||44
5271619|NCT00696657|12957402|P2|STARTED|Overall Study||47
5271620|NCT00696657|12957403|P1|STARTED|Overall Study||46
5271621|NCT00696618|12957730|P3|NOT COMPLETED|Overall Study||0
5271622|NCT00696618|12957731|P2|NOT COMPLETED|Overall Study||0
5271623|NCT00696618|12957732|P1|NOT COMPLETED|Overall Study||0
5271624|NCT00696618|12957730|P3|COMPLETED|Overall Study||3
5271625|NCT00696618|12957731|P2|COMPLETED|Overall Study||3
5271626|NCT00696618|12957732|P1|COMPLETED|Overall Study||3
5271627|NCT00696618|12957730|P3|STARTED|Overall Study||3
5271628|NCT00696618|12957731|P2|STARTED|Overall Study||3
5271629|NCT00696618|12957732|P1|STARTED|Overall Study||3
5271630|NCT00696488|12957746|P1|NOT COMPLETED|Overall Study||0
5271631|NCT00696488|12957746|P1|COMPLETED|Overall Study||20
5271632|NCT00696488|12957746|P1|STARTED|Overall Study||20
5271633|NCT00696449|12957754|P4|NOT COMPLETED|Overall Study||3
5271634|NCT00696449|12957755|P3|NOT COMPLETED|Overall Study||1
5271635|NCT00696449|12957756|P2|NOT COMPLETED|Overall Study||6
5271636|NCT00696449|12957757|P1|NOT COMPLETED|Overall Study||3
5271637|NCT00696449|12957754|P4|COMPLETED|Overall Study||13
5271638|NCT00696449|12957755|P3|COMPLETED|Overall Study||14
5271639|NCT00696449|12957756|P2|COMPLETED|Overall Study||9
5271640|NCT00696449|12957757|P1|COMPLETED|Overall Study||12
5271641|NCT00696449|12957754|P4|STARTED|Overall Study||16
5271642|NCT00696449|12957755|P3|STARTED|Overall Study||15
5271643|NCT00696449|12957756|P2|STARTED|Overall Study||15
5271644|NCT00696449|12957757|P1|STARTED|Overall Study||15
5271645|NCT00696436|12957772|P5|NOT COMPLETED|Overall Study||13
5271646|NCT00696436|12957773|P4|NOT COMPLETED|Overall Study||22
5271647|NCT00696436|12957774|P3|NOT COMPLETED|Overall Study||28
5271648|NCT00696436|12957775|P2|NOT COMPLETED|Overall Study||30
5271649|NCT00696436|12957776|P1|NOT COMPLETED|Overall Study||23
5271650|NCT00696436|12957772|P5|COMPLETED|Overall Study||141
5271651|NCT00696436|12957773|P4|COMPLETED|Overall Study||268
5271652|NCT00696436|12957774|P3|COMPLETED|Overall Study||254
5271653|NCT00696436|12957775|P2|COMPLETED|Overall Study||255
5271654|NCT00696436|12957776|P1|COMPLETED|Overall Study||257
5271655|NCT00696436|12957772|P5|STARTED|Overall Study|Randomized participants only.|154
5271656|NCT00696436|12957773|P4|STARTED|Overall Study|Randomized participants only.|290
5271657|NCT00696436|12957774|P3|STARTED|Overall Study|Randomized participants only.|282
5271658|NCT00696436|12957775|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
5271659|NCT00696436|12957776|P1|STARTED|Overall Study|Randomized participants only.|280
5271660|NCT00696423|12957860|P2|NOT COMPLETED|Overall Study||5
5271661|NCT00696423|12957861|P1|NOT COMPLETED|Overall Study||0
5271662|NCT00696423|12957860|P2|COMPLETED|Overall Study||218
5271663|NCT00696423|12957861|P1|COMPLETED|Overall Study||244
5271664|NCT00696423|12957860|P2|STARTED|Overall Study||223
5271665|NCT00696423|12957861|P1|STARTED|Overall Study||244
5271666|NCT00696410|12957893|P2|NOT COMPLETED|Overall Study||0
5271667|NCT00696410|12957894|P1|NOT COMPLETED|Overall Study||13
5271668|NCT00696410|12957893|P2|COMPLETED|Overall Study||10
5271669|NCT00696410|12957894|P1|COMPLETED|Overall Study||25
5271670|NCT00696410|12957893|P2|STARTED|Overall Study||10
5271671|NCT00696410|12957894|P1|STARTED|Overall Study||38
5271672|NCT00696384|12957908|P3|NOT COMPLETED|Double Blind Phase||6
5271673|NCT00696384|12957909|P2|NOT COMPLETED|Double Blind Phase||11
5271674|NCT00696384|12957910|P1|NOT COMPLETED|Double Blind Phase||0
5271675|NCT00696384|12957908|P3|COMPLETED|Double Blind Phase||145
5271676|NCT00696384|12957909|P2|COMPLETED|Double Blind Phase||137
5271677|NCT00696384|12957910|P1|COMPLETED|Double Blind Phase||0
5271678|NCT00696384|12957908|P3|STARTED|Double Blind Phase||151
5271679|NCT00696384|12957909|P2|STARTED|Double Blind Phase||148
5271680|NCT00696384|12957910|P1|STARTED|Double Blind Phase||0
5271681|NCT00696384|12957908|P3|NOT COMPLETED|Open Label Phase||0
5271682|NCT00696384|12957909|P2|NOT COMPLETED|Open Label Phase||0
5271683|NCT00696384|12957910|P1|NOT COMPLETED|Open Label Phase||119
5271684|NCT00696384|12957908|P3|COMPLETED|Open Label Phase||0
5271685|NCT00696384|12957909|P2|COMPLETED|Open Label Phase||0
5271686|NCT00696384|12957910|P1|COMPLETED|Open Label Phase||299
5271687|NCT00696384|12957908|P3|STARTED|Open Label Phase||0
5271688|NCT00696384|12957909|P2|STARTED|Open Label Phase||0
5271689|NCT00696384|12957910|P1|STARTED|Open Label Phase||418
5271690|NCT00696293|12957924|P1|NOT COMPLETED|Overall Study||2
5271691|NCT00696293|12957924|P1|COMPLETED|Overall Study||28
5271692|NCT00696293|12957924|P1|STARTED|Overall Study||30
5271693|NCT00696241|12957934|P5|NOT COMPLETED|Overall Study||12
5271694|NCT00696241|12957935|P4|NOT COMPLETED|Overall Study||14
5271695|NCT00696241|12957936|P3|NOT COMPLETED|Overall Study||24
5271696|NCT00696241|12957937|P2|NOT COMPLETED|Overall Study||22
5271697|NCT00696241|12957938|P1|NOT COMPLETED|Overall Study||24
5271698|NCT00696241|12957934|P5|COMPLETED|Overall Study||130
5271699|NCT00696241|12957935|P4|COMPLETED|Overall Study||268
5271700|NCT00696241|12957936|P3|COMPLETED|Overall Study||261
5271701|NCT00696241|12957937|P2|COMPLETED|Overall Study||261
5271702|NCT00696241|12957938|P1|COMPLETED|Overall Study||259
5271703|NCT00696241|12957934|P5|STARTED|Overall Study||142
5271704|NCT00696241|12957935|P4|STARTED|Overall Study||282
5271705|NCT00696241|12957936|P3|STARTED|Overall Study||285
5271706|NCT00696241|12957937|P2|STARTED|Overall Study||283
5271707|NCT00696241|12957938|P1|STARTED|Overall Study||283
5271708|NCT00696137|12958020|P1|NOT COMPLETED|Overall Study||2
5271709|NCT00696137|12958020|P1|COMPLETED|Overall Study||3
5271710|NCT00696137|12958020|P1|STARTED|Overall Study||5
5271711|NCT00696072|12958026|P2|NOT COMPLETED|Overall Study||63
5271712|NCT00696072|12958027|P1|NOT COMPLETED|Overall Study||57
5271713|NCT00696072|12958026|P2|COMPLETED|Overall Study||0
5271714|NCT00696072|12958027|P1|COMPLETED|Overall Study||0
5271715|NCT00696072|12958026|P2|STARTED|Overall Study||63
5271716|NCT00696072|12958027|P1|STARTED|Overall Study||57
5271717|NCT00696020|12958048|P4|NOT COMPLETED|Overall Study||4
5271718|NCT00696020|12958049|P3|NOT COMPLETED|Overall Study||3
5271719|NCT00696020|12958050|P2|NOT COMPLETED|Overall Study||2
5271720|NCT00696020|12958051|P1|NOT COMPLETED|Overall Study||4
5271721|NCT00696020|12958048|P4|COMPLETED|Overall Study||84
5271722|NCT00696020|12958049|P3|COMPLETED|Overall Study||90
5271723|NCT00696020|12958050|P2|COMPLETED|Overall Study||87
5271724|NCT00696020|12958051|P1|COMPLETED|Overall Study||86
5271725|NCT00696020|12958048|P4|STARTED|Overall Study||88
5271726|NCT00696020|12958049|P3|STARTED|Overall Study||93
5271727|NCT00696020|12958050|P2|STARTED|Overall Study||89
5271728|NCT00696020|12958051|P1|STARTED|Overall Study||90
5271729|NCT00695955|12958159|P1|NOT COMPLETED|Cohort 2||104
5271730|NCT00695955|12958159|P1|COMPLETED|Cohort 2||203
5271731|NCT00695955|12958159|P1|STARTED|Cohort 2||307
5271732|NCT00695955|12958159|P1|NOT COMPLETED|Cohort 1||102
5271733|NCT00695955|12958159|P1|COMPLETED|Cohort 1||260
5271734|NCT00695955|12958159|P1|STARTED|Cohort 1||362
5271735|NCT00695903|12958171|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
5271736|NCT00695903|12958172|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
5271737|NCT00695903|12958171|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
5271738|NCT00695903|12958172|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
5271739|NCT00695903|12958171|P2|STARTED|Had Test of Cure (TOC) Assessment||4
5271740|NCT00695903|12958172|P1|STARTED|Had Test of Cure (TOC) Assessment||7
5271741|NCT00695903|12958171|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
5271742|NCT00695903|12958172|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
5271743|NCT00695903|12958171|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
5271744|NCT00695903|12958172|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
5271745|NCT00695903|12958171|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
5271746|NCT00695903|12958172|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
5271747|NCT00695903|12958171|P2|STARTED|Had End of Therapy (EOT) Assessment||19
5271748|NCT00695903|12958172|P1|STARTED|Had End of Therapy (EOT) Assessment||19
5271749|NCT00695864|12958184|P1|NOT COMPLETED|Ondansetron||5
5271750|NCT00695864|12958184|P1|COMPLETED|Ondansetron||9
5271751|NCT00695864|12958184|P1|STARTED|Ondansetron||14
5271752|NCT00695864|12958184|P1|NOT COMPLETED|Placebo||5
5271753|NCT00695864|12958184|P1|COMPLETED|Placebo||9
5271754|NCT00695864|12958184|P1|STARTED|Placebo||14
5271755|NCT00695669|12958194|P4|NOT COMPLETED|Overall Study||4
5271756|NCT00695669|12958195|P3|NOT COMPLETED|Overall Study||3
5271757|NCT00695669|12958196|P2|NOT COMPLETED|Overall Study||4
5271758|NCT00695669|12958197|P1|NOT COMPLETED|Overall Study||4
5271759|NCT00695669|12958194|P4|COMPLETED|Overall Study||74
5271760|NCT00695669|12958195|P3|COMPLETED|Overall Study||75
5271761|NCT00695669|12958196|P2|COMPLETED|Overall Study||74
5271762|NCT00695669|12958197|P1|COMPLETED|Overall Study||74
5271763|NCT00695669|12958194|P4|STARTED|Overall Study||78
5271764|NCT00695669|12958195|P3|STARTED|Overall Study||78
5271765|NCT00695669|12958196|P2|STARTED|Overall Study||78
5271766|NCT00695669|12958197|P1|STARTED|Overall Study||78
5271767|NCT00695578|12958273|P2|NOT COMPLETED|Overall Study||0
5271768|NCT00695578|12958274|P1|NOT COMPLETED|Overall Study||0
5271769|NCT00695578|12958273|P2|COMPLETED|Overall Study||10
5271770|NCT00695578|12958274|P1|COMPLETED|Overall Study||10
5271771|NCT00695578|12958273|P2|STARTED|Overall Study||10
5271772|NCT00695578|12958274|P1|STARTED|Overall Study||10
5271773|NCT00695565|12958282|P2|NOT COMPLETED|Overall Study||9
5271774|NCT00695565|12958283|P1|NOT COMPLETED|Overall Study||13
5271775|NCT00695565|12958282|P2|COMPLETED|Overall Study||81
5271776|NCT00695565|12958283|P1|COMPLETED|Overall Study||77
5271777|NCT00695565|12958282|P2|STARTED|Overall Study||90
5271778|NCT00695565|12958283|P1|STARTED|Overall Study||90
5271779|NCT00695500|12958317|P2|NOT COMPLETED|Overall Study||5
5271780|NCT00695500|12958318|P1|NOT COMPLETED|Overall Study||3
5271781|NCT00695500|12958317|P2|COMPLETED|Overall Study||17
5271782|NCT00695500|12958318|P1|COMPLETED|Overall Study||21
5271783|NCT00695500|12958317|P2|STARTED|Overall Study||22
5271784|NCT00695500|12958318|P1|STARTED|Overall Study||24
5271785|NCT00695435|12958328|P3|NOT COMPLETED|Overall Study||0
5271786|NCT00695435|12958329|P2|NOT COMPLETED|Overall Study||0
5271787|NCT00695435|12958330|P1|NOT COMPLETED|Overall Study||0
5271788|NCT00695435|12958328|P3|COMPLETED|Overall Study||7
5271789|NCT00695435|12958329|P2|COMPLETED|Overall Study||7
5271790|NCT00695435|12958330|P1|COMPLETED|Overall Study||7
5271791|NCT00695435|12958328|P3|STARTED|Overall Study||7
5271792|NCT00695435|12958329|P2|STARTED|Overall Study||7
5271793|NCT00695435|12958330|P1|STARTED|Overall Study||7
5271794|NCT00695409|12958341|P1|NOT COMPLETED|Overall Study||0
5271795|NCT00695409|12958341|P1|COMPLETED|Overall Study||122
5271796|NCT00695409|12958341|P1|STARTED|Overall Study||122
5271797|NCT00695396|12958356|P3|NOT COMPLETED|Overall Study||8
5271798|NCT00695396|12958357|P2|NOT COMPLETED|Overall Study||8
5271799|NCT00695396|12958358|P1|NOT COMPLETED|Overall Study||7
5271800|NCT00695396|12958356|P3|COMPLETED|Overall Study||1
5271801|NCT00695396|12958357|P2|COMPLETED|Overall Study||0
5271802|NCT00695396|12958358|P1|COMPLETED|Overall Study||1
5271803|NCT00695396|12958356|P3|STARTED|Overall Study||9
5271804|NCT00695396|12958357|P2|STARTED|Overall Study||8
5271805|NCT00695396|12958358|P1|STARTED|Overall Study||8
5271806|NCT00695318|12958374|P2|NOT COMPLETED|Overall Study||1
5271807|NCT00695318|12958375|P1|NOT COMPLETED|Overall Study||5
5271808|NCT00695318|12958374|P2|COMPLETED|Overall Study||6
5271809|NCT00695318|12958375|P1|COMPLETED|Overall Study||5
5271810|NCT00695318|12958374|P2|STARTED|Overall Study||7
5271811|NCT00695318|12958375|P1|STARTED|Overall Study||10
5271812|NCT00695292|12958386|P1|NOT COMPLETED|Overall Study||0
5271813|NCT00695292|12958386|P1|COMPLETED|Overall Study||37
5271814|NCT00695292|12958386|P1|STARTED|Overall Study||37
5271815|NCT00695188|12958393|P2|NOT COMPLETED|Overall Study||0
5271816|NCT00695188|12958394|P1|NOT COMPLETED|Overall Study||0
5271817|NCT00695188|12958393|P2|COMPLETED|Overall Study||9
5271818|NCT00695188|12958394|P1|COMPLETED|Overall Study||10
5271819|NCT00695188|12958393|P2|STARTED|Overall Study||9
5271820|NCT00695188|12958394|P1|STARTED|Overall Study||10
5271821|NCT00695136|12958400|P1|NOT COMPLETED|Overall Study||2
5271822|NCT00695136|12958400|P1|COMPLETED|Overall Study||5
5271823|NCT00695136|12958400|P1|STARTED|Overall Study|7|7
5271824|NCT00695097|12958406|P2|NOT COMPLETED|Overall Study||0
5271825|NCT00695097|12958407|P1|NOT COMPLETED|Overall Study||1
5271826|NCT00695097|12958406|P2|COMPLETED|Overall Study||5
5271827|NCT00695097|12958407|P1|COMPLETED|Overall Study||9
5271828|NCT00695097|12958406|P2|STARTED|Overall Study||5
5271829|NCT00695097|12958407|P1|STARTED|Overall Study||10
5271830|NCT00695019|12958416|P3|NOT COMPLETED|Overall Study||10
5271831|NCT00695019|12958417|P2|NOT COMPLETED|Overall Study||14
5271832|NCT00695019|12958418|P1|NOT COMPLETED|Overall Study||13
5271833|NCT00695019|12958416|P3|COMPLETED|Overall Study||47
5271834|NCT00695019|12958417|P2|COMPLETED|Overall Study||39
5271835|NCT00695019|12958418|P1|COMPLETED|Overall Study||46
5271836|NCT00695019|12958416|P3|STARTED|Overall Study||57
5271837|NCT00695019|12958417|P2|STARTED|Overall Study||53
5271838|NCT00695019|12958418|P1|STARTED|Overall Study||59
5271839|NCT00694707|12958452|P5|NOT COMPLETED|Overall Study||40
5271840|NCT00694707|12958453|P4|NOT COMPLETED|Overall Study||50
5271841|NCT00694707|12958454|P3|NOT COMPLETED|Overall Study||51
5271842|NCT00694707|12958455|P2|NOT COMPLETED|Overall Study||55
5271843|NCT00694707|12958456|P1|NOT COMPLETED|Overall Study||72
5271844|NCT00694707|12958452|P5|COMPLETED|Overall Study||101
5271845|NCT00694707|12958453|P4|COMPLETED|Overall Study||98
5271846|NCT00694707|12958454|P3|COMPLETED|Overall Study||96
5271847|NCT00694707|12958455|P2|COMPLETED|Overall Study||90
5271848|NCT00694707|12958456|P1|COMPLETED|Overall Study||79
5271849|NCT00694707|12958452|P5|STARTED|Overall Study||141
5271850|NCT00694707|12958453|P4|STARTED|Overall Study||148
5271851|NCT00694707|12958454|P3|STARTED|Overall Study||147
5271852|NCT00694707|12958455|P2|STARTED|Overall Study||145
5271853|NCT00694707|12958456|P1|STARTED|Overall Study||151
5271854|NCT00694603|12958473|P1|NOT COMPLETED|Overall Study||0
5271855|NCT00694603|12958473|P1|COMPLETED|Overall Study||18
5271856|NCT00694603|12958473|P1|STARTED|Overall Study||18
5271857|NCT00694564|12958478|P1|NOT COMPLETED|Overall Study||2
5271858|NCT00694564|12958478|P1|COMPLETED|Overall Study||6
5271859|NCT00694564|12958478|P1|STARTED|Overall Study||8
5271860|NCT00694551|12958485|P3|NOT COMPLETED|Overall Study||1
5271861|NCT00694551|12958486|P2|NOT COMPLETED|Overall Study||0
5271862|NCT00694551|12958487|P1|NOT COMPLETED|Overall Study||1
5271863|NCT00694551|12958485|P3|COMPLETED|Overall Study||8
5271864|NCT00694551|12958486|P2|COMPLETED|Overall Study||10
5271865|NCT00694551|12958487|P1|COMPLETED|Overall Study||9
5271866|NCT00694551|12958485|P3|STARTED|Overall Study||9
5271867|NCT00694551|12958486|P2|STARTED|Overall Study||10
5271868|NCT00694551|12958487|P1|STARTED|Overall Study||10
5271869|NCT00694473|12958501|P1|NOT COMPLETED|Overall Study||7
5271870|NCT00694473|12958501|P1|COMPLETED|Overall Study|Dec 2010|69
5271871|NCT00694473|12958501|P1|STARTED|Overall Study|Aug 2008|76
5271872|NCT00694369|12958516|P5|NOT COMPLETED|Overall Study||6
5271873|NCT00694369|12958517|P4|NOT COMPLETED|Overall Study||3
5271874|NCT00694369|12958518|P3|NOT COMPLETED|Overall Study||2
5271875|NCT00694369|12958519|P2|NOT COMPLETED|Overall Study||3
5271876|NCT00694369|12958520|P1|NOT COMPLETED|Overall Study||1
5271877|NCT00694369|12958516|P5|COMPLETED|Overall Study||56
5271878|NCT00694369|12958517|P4|COMPLETED|Overall Study||189
5271879|NCT00694369|12958518|P3|COMPLETED|Overall Study||95
5271880|NCT00694369|12958519|P2|COMPLETED|Overall Study||188
5271881|NCT00694369|12958520|P1|COMPLETED|Overall Study||45
5271882|NCT00694369|12958516|P5|STARTED|Overall Study||62
5271883|NCT00694369|12958517|P4|STARTED|Overall Study||192
5271884|NCT00694369|12958518|P3|STARTED|Overall Study||97
5271885|NCT00694369|12958519|P2|STARTED|Overall Study||191
5271886|NCT00694369|12958520|P1|STARTED|Overall Study||46
5271887|NCT00694356|12958540|P3|NOT COMPLETED|Overall Study||6
5271888|NCT00694356|12958541|P2|NOT COMPLETED|Overall Study||6
5271889|NCT00694356|12958542|P1|NOT COMPLETED|Overall Study||3
5271890|NCT00694356|12958540|P3|COMPLETED|Overall Study||0
5271891|NCT00694356|12958541|P2|COMPLETED|Overall Study||0
5271892|NCT00694356|12958542|P1|COMPLETED|Overall Study||0
5271893|NCT00694356|12958540|P3|STARTED|Overall Study||6
5271894|NCT00694356|12958541|P2|STARTED|Overall Study||6
5271895|NCT00694356|12958542|P1|STARTED|Overall Study||3
5271896|NCT00694304|12958577|P1|NOT COMPLETED|Overall Study||207
5271897|NCT00694304|12958577|P1|COMPLETED|Overall Study||328
5271898|NCT00694304|12958577|P1|STARTED|Overall Study||535
5271899|NCT00694161|12958590|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
5271900|NCT00694161|12958590|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
5271901|NCT00694161|12958590|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
5271902|NCT00694161|12958590|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
5271903|NCT00694161|12958590|P1|COMPLETED|Part 1 (up to Week 6)||35
5271904|NCT00694161|12958590|P1|STARTED|Part 1 (up to Week 6)||35
5271905|NCT00694122|12958629|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
5271906|NCT00694122|12958630|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
5271907|NCT00694122|12958629|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
5271908|NCT00694122|12958630|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
5271909|NCT00694122|12958629|P2|STARTED|Second Intervention (3-4 Weeks)||5
5271910|NCT00694122|12958630|P1|STARTED|Second Intervention (3-4 Weeks)||10
5271911|NCT00694122|12958629|P2|NOT COMPLETED|Washout (1 Day)||0
5271912|NCT00694122|12958630|P1|NOT COMPLETED|Washout (1 Day)||0
5271913|NCT00694122|12958629|P2|COMPLETED|Washout (1 Day)||5
5271914|NCT00694122|12958630|P1|COMPLETED|Washout (1 Day)||10
5271915|NCT00694122|12958629|P2|STARTED|Washout (1 Day)||5
5271916|NCT00694122|12958630|P1|STARTED|Washout (1 Day)||10
5271917|NCT00694122|12958629|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
5271918|NCT00694122|12958630|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
5271919|NCT00694122|12958629|P2|COMPLETED|First Intervention (3-4 Weeks)||5
5271920|NCT00694122|12958630|P1|COMPLETED|First Intervention (3-4 Weeks)||10
5271921|NCT00694122|12958629|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
5271922|NCT00694122|12958630|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
5271923|NCT00694109|12958646|P1|NOT COMPLETED|Overall Study||117
5271924|NCT00694109|12958646|P1|COMPLETED|Overall Study||25
5271925|NCT00694109|12958646|P1|Completed Consented Length of Treatment|Overall Study||60
5271926|NCT00694109|12958646|P1|Consented 2 Years Additional Treatment|Overall Study||42
5271927|NCT00694109|12958646|P1|Treated|Overall Study||141
5271928|NCT00694109|12958646|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
5271929|NCT00694096|12958670|P1|NOT COMPLETED|Overall Study||5
5271930|NCT00694096|12958670|P1|COMPLETED|Overall Study||20
5271931|NCT00694096|12958670|P1|STARTED|Overall Study||25
5271932|NCT00694070|12958676|P1|NOT COMPLETED|Overall Study||0
5271933|NCT00694070|12958676|P1|COMPLETED|Overall Study||51
5271934|NCT00694070|12958676|P1|STARTED|Overall Study||51
5271935|NCT00694018|12958684|P2|NOT COMPLETED|Overall Study||9
5271936|NCT00694018|12958685|P1|NOT COMPLETED|Overall Study||13
5271937|NCT00694018|12958684|P2|COMPLETED|Overall Study||102
5271938|NCT00694018|12958685|P1|COMPLETED|Overall Study||105
5271939|NCT00694018|12958684|P2|6 Months|Overall Study||101
5271940|NCT00694018|12958685|P1|6 Months|Overall Study||106
5271941|NCT00694018|12958684|P2|STARTED|Overall Study||111
5271942|NCT00694018|12958685|P1|STARTED|Overall Study||118
5271943|NCT00693992|12958693|P2|NOT COMPLETED|Overall Study||0
5271944|NCT00693992|12958694|P1|NOT COMPLETED|Overall Study||0
5271945|NCT00693992|12958693|P2|COMPLETED|Overall Study||104
5271946|NCT00693992|12958694|P1|COMPLETED|Overall Study||106
5271947|NCT00693992|12958693|P2|STARTED|Overall Study||104
5271948|NCT00693992|12958694|P1|STARTED|Overall Study||106
5271949|NCT00693784|12958710|P1|NOT COMPLETED|Overall Study||4
5271950|NCT00693784|12958710|P1|COMPLETED|Overall Study||11
5271951|NCT00693784|12958710|P1|104-week Extended Follow-up|Overall Study||11
5271952|NCT00693784|12958710|P1|52-week Extended Follow-up|Overall Study||13
5271953|NCT00693784|12958710|P1|26-Week Primary Endpoint|Overall Study||15
5271954|NCT00693784|12958710|P1|STARTED|Overall Study||15
5271955|NCT00693719|12958716|P1|NOT COMPLETED|Overall Study||0
5271956|NCT00693719|12958716|P1|COMPLETED|Overall Study||31
5271957|NCT00693719|12958716|P1|STARTED|Overall Study||31
5271958|NCT00693706|12958723|P2|NOT COMPLETED|Overall Study||1
5271959|NCT00693706|12958724|P1|NOT COMPLETED|Overall Study||0
5271960|NCT00693706|12958723|P2|COMPLETED|Overall Study||98
5271961|NCT00693706|12958724|P1|COMPLETED|Overall Study||101
5271962|NCT00693706|12958723|P2|STARTED|Overall Study||99
5271963|NCT00693706|12958724|P1|STARTED|Overall Study||101
5271964|NCT00693693|12958751|P3|NOT COMPLETED|Overall Study||2
5271965|NCT00693693|12958752|P2|NOT COMPLETED|Overall Study||1
5271966|NCT00693693|12958753|P1|NOT COMPLETED|Overall Study||1
5271967|NCT00693693|12958751|P3|COMPLETED|Overall Study||7
5271968|NCT00693693|12958752|P2|COMPLETED|Overall Study||8
5271969|NCT00693693|12958753|P1|COMPLETED|Overall Study||6
5271970|NCT00693693|12958751|P3|STARTED|Overall Study||9
5271971|NCT00693693|12958752|P2|STARTED|Overall Study||9
5271972|NCT00693693|12958753|P1|STARTED|Overall Study||7
5271973|NCT00693654|12958763|P2|NOT COMPLETED|Overall Study||0
5271974|NCT00693654|12958764|P1|NOT COMPLETED|Overall Study||0
5271975|NCT00693654|12958763|P2|COMPLETED|Overall Study||14
5271976|NCT00693654|12958764|P1|COMPLETED|Overall Study||14
5271977|NCT00693654|12958763|P2|STARTED|Overall Study||14
5271978|NCT00693654|12958764|P1|STARTED|Overall Study||14
5271979|NCT00693628|12958774|P2|NOT COMPLETED|Overall Study||0
5271980|NCT00693628|12958775|P1|NOT COMPLETED|Overall Study||0
5271981|NCT00693628|12958774|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
5271982|NCT00693628|12958775|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
5271983|NCT00693628|12958774|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
5271984|NCT00693628|12958775|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
5271985|NCT00693498|12958783|P2|NOT COMPLETED|Overall Study||0
5271986|NCT00693498|12958784|P1|NOT COMPLETED|Overall Study||0
5271987|NCT00693498|12958783|P2|COMPLETED|Overall Study||81
5271988|NCT00693498|12958784|P1|COMPLETED|Overall Study||81
5271989|NCT00693498|12958783|P2|STARTED|Overall Study||81
5271990|NCT00693498|12958784|P1|STARTED|Overall Study||81
5271991|NCT00693485|12958795|P3|NOT COMPLETED|Overall Study||0
5271992|NCT00693485|12958796|P2|NOT COMPLETED|Overall Study||2
5271993|NCT00693485|12958797|P1|NOT COMPLETED|Overall Study||0
5271994|NCT00693485|12958795|P3|COMPLETED|Overall Study||24
5271995|NCT00693485|12958796|P2|COMPLETED|Overall Study||19
5271996|NCT00693485|12958797|P1|COMPLETED|Overall Study||25
5271997|NCT00693485|12958795|P3|STARTED|Overall Study||24
5271998|NCT00693485|12958796|P2|STARTED|Overall Study||21
5271999|NCT00693485|12958797|P1|STARTED|Overall Study||25
5272000|NCT00693472|12958812|P4|NOT COMPLETED|Part 2||2
5272001|NCT00693472|12958813|P3|NOT COMPLETED|Part 2||2
5272002|NCT00693472|12958814|P2|NOT COMPLETED|Part 2||0
5272003|NCT00693472|12958815|P1|NOT COMPLETED|Part 2||0
5272004|NCT00693472|12958812|P4|COMPLETED|Part 2||4
5272005|NCT00693472|12958813|P3|COMPLETED|Part 2||6
5272006|NCT00693472|12958814|P2|COMPLETED|Part 2||0
5272007|NCT00693472|12958815|P1|COMPLETED|Part 2||0
5272008|NCT00693472|12958812|P4|STARTED|Part 2||6
5272009|NCT00693472|12958813|P3|STARTED|Part 2||8
5272010|NCT00693472|12958814|P2|STARTED|Part 2||0
5272011|NCT00693472|12958815|P1|STARTED|Part 2||0
5272012|NCT00693472|12958812|P4|NOT COMPLETED|Part 1||0
5272013|NCT00693472|12958813|P3|NOT COMPLETED|Part 1||0
5272014|NCT00693472|12958814|P2|NOT COMPLETED|Part 1||4
5272015|NCT00693472|12958815|P1|NOT COMPLETED|Part 1||6
5272016|NCT00693472|12958812|P4|COMPLETED|Part 1||0
5272017|NCT00693472|12958813|P3|COMPLETED|Part 1||0
5272018|NCT00693472|12958814|P2|COMPLETED|Part 1||9
5272019|NCT00693472|12958815|P1|COMPLETED|Part 1||13
5272020|NCT00693472|12958812|P4|STARTED|Part 1||0
5272021|NCT00693472|12958813|P3|STARTED|Part 1||0
5272022|NCT00693472|12958814|P2|STARTED|Part 1||13
5272023|NCT00693472|12958815|P1|STARTED|Part 1||19
5272024|NCT00693420|12958835|P2|NOT COMPLETED|Overall Study||15
5272025|NCT00693420|12958836|P1|NOT COMPLETED|Overall Study||6
5272026|NCT00693420|12958835|P2|COMPLETED|Overall Study||126
5272027|NCT00693420|12958836|P1|COMPLETED|Overall Study||131
5272028|NCT00693420|12958835|P2|STARTED|Overall Study||141
5272029|NCT00693420|12958836|P1|STARTED|Overall Study||137
5272030|NCT00693303|12958860|P1|NOT COMPLETED|Overall Study||0
5272031|NCT00693303|12958860|P1|COMPLETED|Overall Study||21
5272032|NCT00693303|12958860|P1|STARTED|Overall Study||21
5272033|NCT00693238|12958866|P2|NOT COMPLETED|Overall Study||0
5272034|NCT00693238|12958867|P1|NOT COMPLETED|Overall Study||0
5272035|NCT00693238|12958866|P2|COMPLETED|Overall Study||106
5272036|NCT00693238|12958867|P1|COMPLETED|Overall Study||122
5272037|NCT00693238|12958866|P2|STARTED|Overall Study||106
5272038|NCT00693238|12958867|P1|STARTED|Overall Study||122
5272039|NCT00693225|12958875|P2|NOT COMPLETED|Overall Study||5
5272040|NCT00693225|12958876|P1|NOT COMPLETED|Overall Study||2
5272041|NCT00693225|12958875|P2|COMPLETED|Overall Study||43
5272042|NCT00693225|12958876|P1|COMPLETED|Overall Study||41
5272043|NCT00693225|12958875|P2|STARTED|Overall Study||48
5272044|NCT00693225|12958876|P1|STARTED|Overall Study||43
5272045|NCT00693160|12958888|P2|NOT COMPLETED|Overall Study||0
5272046|NCT00693160|12958889|P1|NOT COMPLETED|Overall Study||0
5272047|NCT00693160|12958888|P2|COMPLETED|Overall Study||16
5272048|NCT00693160|12958889|P1|COMPLETED|Overall Study||14
5272049|NCT00693160|12958888|P2|STARTED|Overall Study||16
5272050|NCT00693160|12958889|P1|STARTED|Overall Study||14
5272051|NCT00693017|12958899|P2|NOT COMPLETED|Overall Study||2
5272052|NCT00693017|12958900|P1|NOT COMPLETED|Overall Study||2
5272053|NCT00693017|12958899|P2|COMPLETED|Overall Study||0
5272054|NCT00693017|12958900|P1|COMPLETED|Overall Study||0
5272055|NCT00693017|12958899|P2|STARTED|Overall Study||2
5272056|NCT00693017|12958900|P1|STARTED|Overall Study||2
5272057|NCT00692913|12958910|P2|NOT COMPLETED|Overall Study||30
5272058|NCT00692913|12958911|P1|NOT COMPLETED|Overall Study||29
5272059|NCT00692913|12958910|P2|COMPLETED|Overall Study||228
5272060|NCT00692913|12958911|P1|COMPLETED|Overall Study||228
5272061|NCT00692913|12958910|P2|STARTED|Overall Study||258
5272062|NCT00692913|12958911|P1|STARTED|Overall Study||257
5272063|NCT00692770|12958933|P2|NOT COMPLETED|Overall Study||558
5272064|NCT00692770|12958934|P1|NOT COMPLETED|Overall Study||556
5272065|NCT00692770|12958933|P2|COMPLETED|Overall Study||0
5272066|NCT00692770|12958934|P1|COMPLETED|Overall Study||0
5272067|NCT00692770|12958933|P2|Participants Received Treatment|Overall Study||554
5272068|NCT00692770|12958934|P1|Participants Received Treatment|Overall Study||553
5272069|NCT00692770|12958933|P2|STARTED|Overall Study||558
5272070|NCT00692770|12958934|P1|STARTED|Overall Study||556
5272071|NCT00692692|12958958|P2|NOT COMPLETED|Overall Study||0
5272072|NCT00692692|12958959|P1|NOT COMPLETED|Overall Study||0
5272073|NCT00692692|12958958|P2|COMPLETED|Overall Study||16
5272074|NCT00692692|12958959|P1|COMPLETED|Overall Study||20
5272075|NCT00692692|12958958|P2|STARTED|Overall Study||16
5272076|NCT00692692|12958959|P1|STARTED|Overall Study||20
5272077|NCT00692419|12958969|P2|NOT COMPLETED|Overall Study||18
5272078|NCT00692419|12958970|P1|NOT COMPLETED|Overall Study||16
5272079|NCT00692419|12958969|P2|COMPLETED|Overall Study||102
5272080|NCT00692419|12958970|P1|COMPLETED|Overall Study||84
5272081|NCT00692419|12958969|P2|STARTED|Overall Study||120
5272082|NCT00692419|12958970|P1|STARTED|Overall Study||100
5272083|NCT00692406|12958980|P1|NOT COMPLETED|Overall Study||57
5272084|NCT00692406|12958980|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
5272085|NCT00692406|12958980|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
5272086|NCT00692341|12958994|P3|NOT COMPLETED|Overall Study||0
5272087|NCT00692341|12958995|P2|NOT COMPLETED|Overall Study||0
5272088|NCT00692341|12958996|P1|NOT COMPLETED|Overall Study||0
5272089|NCT00692341|12958994|P3|COMPLETED|Overall Study||8
5272090|NCT00692341|12958995|P2|COMPLETED|Overall Study||8
5272091|NCT00692341|12958996|P1|COMPLETED|Overall Study||8
5272092|NCT00692341|12958994|P3|STARTED|Overall Study||8
5272093|NCT00692341|12958995|P2|STARTED|Overall Study||8
5272094|NCT00692341|12958996|P1|STARTED|Overall Study||8
5272095|NCT00692237|12959042|P2|NOT COMPLETED|Overall Study||4
5272096|NCT00692237|12959043|P1|NOT COMPLETED|Overall Study||1
5272097|NCT00692237|12959042|P2|COMPLETED|Overall Study||25
5272098|NCT00692237|12959043|P1|COMPLETED|Overall Study||29
5272099|NCT00692237|12959042|P2|STARTED|Overall Study||29
5272100|NCT00692237|12959043|P1|STARTED|Overall Study||30
5272101|NCT00692211|12959053|P2|NOT COMPLETED|Overall Study||0
5272102|NCT00692211|12959054|P1|NOT COMPLETED|Overall Study||0
5272103|NCT00692211|12959053|P2|COMPLETED|Overall Study||202
5272104|NCT00692211|12959054|P1|COMPLETED|Overall Study||202
5272105|NCT00692211|12959053|P2|STARTED|Overall Study||202
5272106|NCT00692211|12959054|P1|STARTED|Overall Study||202
5272107|NCT00692198|12959062|P2|NOT COMPLETED|Overall Study||0
5272108|NCT00692198|12959063|P1|NOT COMPLETED|Overall Study||0
5272109|NCT00692198|12959062|P2|COMPLETED|Overall Study||370
5272110|NCT00692198|12959063|P1|COMPLETED|Overall Study||368
5272111|NCT00692198|12959062|P2|STARTED|Overall Study||370
5272112|NCT00692198|12959063|P1|STARTED|Overall Study||368
5272113|NCT00692185|12959098|P2|NOT COMPLETED|Overall Study||3
5272114|NCT00692185|12959099|P1|NOT COMPLETED|Overall Study||3
5272115|NCT00692185|12959098|P2|COMPLETED|Overall Study||9
5272116|NCT00692185|12959099|P1|COMPLETED|Overall Study||8
5272117|NCT00692185|12959098|P2|STARTED|Overall Study||12
5272118|NCT00692185|12959099|P1|STARTED|Overall Study||11
5272119|NCT00692094|12959111|P4|NOT COMPLETED|Overall Study||0
5272120|NCT00692094|12959112|P3|NOT COMPLETED|Overall Study||0
5272121|NCT00692094|12959113|P2|NOT COMPLETED|Overall Study||0
5272122|NCT00692094|12959114|P1|NOT COMPLETED|Overall Study||0
5272123|NCT00692094|12959111|P4|COMPLETED|Overall Study||0
5272124|NCT00692094|12959112|P3|COMPLETED|Overall Study||0
5272125|NCT00692094|12959113|P2|COMPLETED|Overall Study||0
5272126|NCT00692094|12959114|P1|COMPLETED|Overall Study||0
5272127|NCT00692094|12959111|P4|STARTED|Overall Study||0
5272128|NCT00692094|12959112|P3|STARTED|Overall Study||0
5272129|NCT00692094|12959113|P2|STARTED|Overall Study||0
5272130|NCT00692094|12959114|P1|STARTED|Overall Study||0
5272131|NCT00692003|12959130|P2|NOT COMPLETED|Overall Study||1
5272132|NCT00692003|12959131|P1|NOT COMPLETED|Overall Study||5
5272133|NCT00692003|12959130|P2|COMPLETED|Overall Study||0
5272134|NCT00692003|12959131|P1|COMPLETED|Overall Study||0
5272135|NCT00692003|12959130|P2|STARTED|Overall Study||1
5272136|NCT00692003|12959131|P1|STARTED|Overall Study||5
5272137|NCT00691938|12959146|P7|NOT COMPLETED|Overall Study||0
5272138|NCT00691938|12959147|P6|NOT COMPLETED|Overall Study||0
5272139|NCT00691938|12959148|P5|NOT COMPLETED|Overall Study||0
5272140|NCT00691938|12959149|P4|NOT COMPLETED|Overall Study||0
5272141|NCT00691938|12959150|P3|NOT COMPLETED|Overall Study||0
5272142|NCT00691938|12959151|P2|NOT COMPLETED|Overall Study||0
5272143|NCT00691938|12959152|P1|NOT COMPLETED|Overall Study||1
5272144|NCT00691938|12959146|P7|COMPLETED|Overall Study||14
5272145|NCT00691938|12959147|P6|COMPLETED|Overall Study||6
5272146|NCT00691938|12959148|P5|COMPLETED|Overall Study||10
5272147|NCT00691938|12959149|P4|COMPLETED|Overall Study||8
5272148|NCT00691938|12959150|P3|COMPLETED|Overall Study||6
5272149|NCT00691938|12959151|P2|COMPLETED|Overall Study||3
5272150|NCT00691938|12959152|P1|COMPLETED|Overall Study||4
5272151|NCT00691938|12959146|P7|STARTED|Overall Study||14
5272152|NCT00691938|12959147|P6|STARTED|Overall Study||6
5272153|NCT00691938|12959148|P5|STARTED|Overall Study||10
5272154|NCT00691938|12959149|P4|STARTED|Overall Study||8
5272155|NCT00691938|12959150|P3|STARTED|Overall Study||6
5272156|NCT00691938|12959151|P2|STARTED|Overall Study||3
5272157|NCT00691938|12959152|P1|STARTED|Overall Study||5
5272158|NCT00691808|12959176|P3|NOT COMPLETED|Overall Study||0
5272159|NCT00691808|12959177|P2|NOT COMPLETED|Overall Study||1
5272160|NCT00691808|12959178|P1|NOT COMPLETED|Overall Study||0
5272161|NCT00691808|12959176|P3|COMPLETED|Overall Study||32
5272162|NCT00691808|12959177|P2|COMPLETED|Overall Study||35
5272163|NCT00691808|12959178|P1|COMPLETED|Overall Study||35
5272164|NCT00691808|12959176|P3|STARTED|Overall Study||32
5272165|NCT00691808|12959177|P2|STARTED|Overall Study||36
5272166|NCT00691808|12959178|P1|STARTED|Overall Study||35
5272167|NCT00691704|12959219|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
5272168|NCT00691704|12959219|P1|COMPLETED|Two Years of Maintenance Therapy||3
5272169|NCT00691704|12959219|P1|STARTED|Two Years of Maintenance Therapy||16
5272170|NCT00691704|12959219|P1|NOT COMPLETED|Induction Therapy||2
5272171|NCT00691704|12959219|P1|COMPLETED|Induction Therapy||16
5272172|NCT00691704|12959219|P1|STARTED|Induction Therapy||18
5272173|NCT00691665|12959229|P2|NOT COMPLETED|Overall Study||0
5272174|NCT00691665|12959230|P1|NOT COMPLETED|Overall Study||0
5272175|NCT00691665|12959229|P2|COMPLETED|Overall Study||65
5272176|NCT00691665|12959230|P1|COMPLETED|Overall Study||65
5272177|NCT00691665|12959229|P2|STARTED|Overall Study||65
5272178|NCT00691665|12959230|P1|STARTED|Overall Study||65
5272179|NCT00691652|12959242|P1|NOT COMPLETED|Overall Study||1
5272180|NCT00691652|12959242|P1|COMPLETED|Overall Study||1
5272181|NCT00691652|12959242|P1|STARTED|Overall Study||2
5272182|NCT00691600|12959254|P2|NOT COMPLETED|Overall Study||0
5272183|NCT00691600|12959255|P1|NOT COMPLETED|Overall Study||0
5272184|NCT00691600|12959254|P2|COMPLETED|Overall Study||11
5272185|NCT00691600|12959255|P1|COMPLETED|Overall Study||12
5272186|NCT00691600|12959254|P2|STARTED|Overall Study||11
5272187|NCT00691600|12959255|P1|STARTED|Overall Study||12
5272188|NCT00691574|12959267|P2|NOT COMPLETED|Overall Study||0
5272189|NCT00691574|12959268|P1|NOT COMPLETED|Overall Study||0
5272190|NCT00691574|12959267|P2|COMPLETED|Overall Study||0
5272191|NCT00691574|12959268|P1|COMPLETED|Overall Study||0
5272192|NCT00691574|12959267|P2|STARTED|Overall Study||0
5272193|NCT00691574|12959268|P1|STARTED|Overall Study||0
5272194|NCT00691483|12959280|P2|NOT COMPLETED|Overall Study||25
5272195|NCT00691483|12959281|P1|NOT COMPLETED|Overall Study||68
5272196|NCT00691483|12959280|P2|COMPLETED|Overall Study||141
5272197|NCT00691483|12959281|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
5272198|NCT00691483|12959280|P2|Received Treatment|Overall Study||165
5272199|NCT00691483|12959281|P1|Received Treatment|Overall Study||486
5272200|NCT00691483|12959280|P2|STARTED|Overall Study||166
5272201|NCT00691483|12959281|P1|STARTED|Overall Study||493
5272202|NCT00691444|12959300|P3|NOT COMPLETED|Overall Study||0
5272203|NCT00691444|12959301|P2|NOT COMPLETED|Overall Study||0
5272204|NCT00691444|12959302|P1|NOT COMPLETED|Overall Study||0
5272205|NCT00691444|12959300|P3|COMPLETED|Overall Study||0
5272206|NCT00691444|12959301|P2|COMPLETED|Overall Study||0
5272207|NCT00691444|12959302|P1|COMPLETED|Overall Study||0
5272208|NCT00691444|12959300|P3|STARTED|Overall Study||0
5272209|NCT00691444|12959301|P2|STARTED|Overall Study||0
5272210|NCT00691444|12959302|P1|STARTED|Overall Study||0
5272211|NCT00691327|12959315|P2|NOT COMPLETED|Overall Study||2508
5272212|NCT00691327|12959316|P1|NOT COMPLETED|Overall Study||2841
5272213|NCT00691327|12959315|P2|COMPLETED|Overall Study||36766
5272214|NCT00691327|12959316|P1|COMPLETED|Overall Study||42214
5272215|NCT00691327|12959315|P2|STARTED|Overall Study||39274
5272216|NCT00691327|12959316|P1|STARTED|Overall Study||45055
5272217|NCT00691301|12959324|P1|NOT COMPLETED|Overall Study||54
5272218|NCT00691301|12959324|P1|COMPLETED|Overall Study||1
5272219|NCT00691301|12959324|P1|STARTED|Overall Study||55
5272220|NCT00691210|12959344|P8|NOT COMPLETED|Overall Study||0
5272221|NCT00691210|12959345|P7|NOT COMPLETED|Overall Study||0
5272222|NCT00691210|12959346|P6|NOT COMPLETED|Overall Study||1
5272223|NCT00691210|12959347|P5|NOT COMPLETED|Overall Study||0
5272224|NCT00691210|12959348|P4|NOT COMPLETED|Overall Study||3
5272225|NCT00691210|12959349|P3|NOT COMPLETED|Overall Study||0
5272226|NCT00691210|12959350|P2|NOT COMPLETED|Overall Study||0
5272227|NCT00691210|12959351|P1|NOT COMPLETED|Overall Study||0
5272228|NCT00691210|12959344|P8|COMPLETED|Overall Study||0
5272229|NCT00691210|12959345|P7|COMPLETED|Overall Study||6
5272230|NCT00691210|12959346|P6|COMPLETED|Overall Study||6
5272231|NCT00691210|12959347|P5|COMPLETED|Overall Study||5
5272232|NCT00691210|12959348|P4|COMPLETED|Overall Study||6
5272233|NCT00691210|12959349|P3|COMPLETED|Overall Study||3
5272234|NCT00691210|12959350|P2|COMPLETED|Overall Study||5
5272235|NCT00691210|12959351|P1|COMPLETED|Overall Study||3
5272236|NCT00691210|12959344|P8|STARTED|Overall Study||0
5272237|NCT00691210|12959345|P7|STARTED|Overall Study||6
5272238|NCT00691210|12959346|P6|STARTED|Overall Study||7
5272239|NCT00691210|12959347|P5|STARTED|Overall Study||5
5272240|NCT00691210|12959348|P4|STARTED|Overall Study||9
5272241|NCT00691210|12959349|P3|STARTED|Overall Study||3
5272242|NCT00691210|12959350|P2|STARTED|Overall Study||5
5272243|NCT00691210|12959351|P1|STARTED|Overall Study||3
5272244|NCT00691197|12959371|P2|NOT COMPLETED|Overall Study||5
5272245|NCT00691197|12959372|P1|NOT COMPLETED|Overall Study||11
5272246|NCT00691197|12959371|P2|COMPLETED|Overall Study||75
5272247|NCT00691197|12959372|P1|COMPLETED|Overall Study||155
5272248|NCT00691197|12959371|P2|STARTED|Overall Study||80
5272249|NCT00691197|12959372|P1|STARTED|Overall Study||166
5272250|NCT00691132|12959386|P2|NOT COMPLETED|Overall Study||13
5272251|NCT00691132|12959387|P1|NOT COMPLETED|Overall Study||12
5272252|NCT00691132|12959386|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
5272253|NCT00691132|12959387|P1|COMPLETED|Overall Study||41
5272254|NCT00691132|12959386|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
5272255|NCT00691132|12959387|P1|STARTED|Overall Study||53
5272256|NCT00691093|12959406|P1|NOT COMPLETED|Overall Study||7
5272257|NCT00691093|12959406|P1|COMPLETED|Overall Study||816
5272258|NCT00691093|12959406|P1|STARTED|Overall Study||823
5272259|NCT00691054|12959440|P1|NOT COMPLETED|Overall Study||1
5272260|NCT00691054|12959440|P1|COMPLETED|Overall Study||19
5272261|NCT00691054|12959440|P1|STARTED|Overall Study||20
5272262|NCT00691028|12959452|P4|NOT COMPLETED|Double-blind Period||0
5272263|NCT00691028|12959453|P3|NOT COMPLETED|Double-blind Period||9
5272264|NCT00691028|12959454|P2|NOT COMPLETED|Double-blind Period||13
5272265|NCT00691028|12959455|P1|NOT COMPLETED|Double-blind Period||13
5272266|NCT00691028|12959452|P4|COMPLETED|Double-blind Period||0
5272267|NCT00691028|12959453|P3|COMPLETED|Double-blind Period||95
5272268|NCT00691028|12959454|P2|COMPLETED|Double-blind Period||91
5272269|NCT00691028|12959455|P1|COMPLETED|Double-blind Period||86
5272270|NCT00691028|12959452|P4|STARTED|Double-blind Period||0
5272271|NCT00691028|12959453|P3|STARTED|Double-blind Period||104
5272272|NCT00691028|12959454|P2|STARTED|Double-blind Period||104
5272273|NCT00691028|12959455|P1|STARTED|Double-blind Period||99
5272274|NCT00691028|12959452|P4|NOT COMPLETED|Open-label Period||20
5272275|NCT00691028|12959453|P3|NOT COMPLETED|Open-label Period||0
5272276|NCT00691028|12959454|P2|NOT COMPLETED|Open-label Period||0
5272277|NCT00691028|12959455|P1|NOT COMPLETED|Open-label Period||0
5272278|NCT00691028|12959452|P4|COMPLETED|Open-label Period||307
5272279|NCT00691028|12959453|P3|COMPLETED|Open-label Period||0
5272280|NCT00691028|12959454|P2|COMPLETED|Open-label Period||0
5272281|NCT00691028|12959455|P1|COMPLETED|Open-label Period||0
5272282|NCT00691028|12959452|P4|STARTED|Open-label Period||327
5272283|NCT00691028|12959453|P3|STARTED|Open-label Period||0
5272284|NCT00691028|12959454|P2|STARTED|Open-label Period||0
5272285|NCT00691028|12959455|P1|STARTED|Open-label Period||0
5272286|NCT00691015|12959488|P1|NOT COMPLETED|Overall Study||1
5272287|NCT00691015|12959488|P1|COMPLETED|Overall Study||47
5272288|NCT00691015|12959488|P1|STARTED|Overall Study||48
5272289|NCT00690924|12959499|P1|NOT COMPLETED|Overall Study||0
5272290|NCT00690924|12959499|P1|COMPLETED|Overall Study||16
5272291|NCT00690924|12959499|P1|STARTED|Overall Study||16
5272292|NCT00690898|12959503|P1|NOT COMPLETED|TREATMENT||26
5272293|NCT00690898|12959503|P1|COMPLETED|TREATMENT||64
5272294|NCT00690898|12959503|P1|STARTED|TREATMENT|Total number of patients treated.|90
5272295|NCT00690898|12959503|P1|NOT COMPLETED|SCREENING||18
5272296|NCT00690898|12959503|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
5272297|NCT00690898|12959503|P1|STARTED|SCREENING|Total of patients screened for the study.|108
5272298|NCT00690833|12959517|P1|NOT COMPLETED|Overall Study||2
5272299|NCT00690833|12959517|P1|COMPLETED|Overall Study||39
5272300|NCT00690833|12959517|P1|STARTED|Overall Study||41
5272301|NCT00690820|12959523|P2|NOT COMPLETED|Period 2||0
5272302|NCT00690820|12959524|P1|NOT COMPLETED|Period 2||0
5272303|NCT00690820|12959523|P2|COMPLETED|Period 2||8
5272304|NCT00690820|12959524|P1|COMPLETED|Period 2||8
5272305|NCT00690820|12959523|P2|STARTED|Period 2||8
5272306|NCT00690820|12959524|P1|STARTED|Period 2||8
5272307|NCT00690820|12959523|P2|NOT COMPLETED|Period 1||1
5272308|NCT00690820|12959524|P1|NOT COMPLETED|Period 1||0
5272309|NCT00690820|12959523|P2|COMPLETED|Period 1||8
5272310|NCT00690820|12959524|P1|COMPLETED|Period 1||8
5272311|NCT00690820|12959523|P2|STARTED|Period 1||9
5272312|NCT00690820|12959524|P1|STARTED|Period 1||8
5272313|NCT00690794|12959546|P2|NOT COMPLETED|Overall Study||35
5272314|NCT00690794|12959547|P1|NOT COMPLETED|Overall Study||21
5272315|NCT00690794|12959546|P2|COMPLETED|Overall Study||328
5272316|NCT00690794|12959547|P1|COMPLETED|Overall Study||342
5272317|NCT00690794|12959546|P2|STARTED|Overall Study||363
5272318|NCT00690794|12959547|P1|STARTED|Overall Study||363
5272319|NCT00690755|12959562|P7|NOT COMPLETED|Overall Study||0
5272320|NCT00690755|12959563|P6|NOT COMPLETED|Overall Study||4
5272321|NCT00690755|12959564|P5|NOT COMPLETED|Overall Study||0
5272322|NCT00690755|12959565|P4|NOT COMPLETED|Overall Study||5
5272323|NCT00690755|12959566|P3|NOT COMPLETED|Overall Study||46
5272324|NCT00690755|12959567|P2|NOT COMPLETED|Overall Study||0
5272325|NCT00690755|12959568|P1|NOT COMPLETED|Overall Study||2
5272326|NCT00690755|12959562|P7|COMPLETED|Overall Study||0
5272327|NCT00690755|12959563|P6|COMPLETED|Overall Study||6
5272328|NCT00690755|12959564|P5|COMPLETED|Overall Study||0
5272329|NCT00690755|12959565|P4|COMPLETED|Overall Study||15
5272330|NCT00690755|12959566|P3|COMPLETED|Overall Study||51
5272331|NCT00690755|12959567|P2|COMPLETED|Overall Study||0
5272332|NCT00690755|12959568|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
5272333|NCT00690755|12959562|P7|STARTED|Overall Study||0
5272334|NCT00690755|12959563|P6|STARTED|Overall Study||10
5272335|NCT00690755|12959564|P5|STARTED|Overall Study||0
5272336|NCT00690755|12959565|P4|STARTED|Overall Study||20
5272337|NCT00690755|12959566|P3|STARTED|Overall Study||97
5272338|NCT00690755|12959567|P2|STARTED|Overall Study||0
5272339|NCT00690755|12959568|P1|STARTED|Overall Study||30
5272340|NCT00690612|12959584|P1|NOT COMPLETED|Overall Study||3
5272341|NCT00690612|12959584|P1|COMPLETED|Overall Study||32
5272342|NCT00690612|12959584|P1|STARTED|Overall Study||35
5272343|NCT00690573|12959589|P1|NOT COMPLETED|Overall Study||9
5272344|NCT00690573|12959589|P1|COMPLETED|Overall Study||16
5272345|NCT00690573|12959589|P1|STARTED|Overall Study||25
5272346|NCT00690495|12959599|P2|NOT COMPLETED|Overall Study||0
5272347|NCT00690495|12959600|P1|NOT COMPLETED|Overall Study||0
5272348|NCT00690495|12959599|P2|COMPLETED|Overall Study||50
5272349|NCT00690495|12959600|P1|COMPLETED|Overall Study||50
5272350|NCT00690495|12959599|P2|Primary Endpoint|Overall Study||50
5272351|NCT00690495|12959600|P1|Primary Endpoint|Overall Study||50
5272352|NCT00690495|12959599|P2|STARTED|Overall Study||50
5272353|NCT00690495|12959600|P1|STARTED|Overall Study||50
5272354|NCT00690482|12959608|P2|NOT COMPLETED|Overall Study||3
5272355|NCT00690482|12959609|P1|NOT COMPLETED|Overall Study||4
5272356|NCT00690482|12959608|P2|COMPLETED|Overall Study||54
5272357|NCT00690482|12959609|P1|COMPLETED|Overall Study||57
5272358|NCT00690482|12959608|P2|STARTED|Overall Study||57
5272359|NCT00690482|12959609|P1|STARTED|Overall Study||61
5272360|NCT00690443|12959643|P2|NOT COMPLETED|Overall Study||2
5272361|NCT00690443|12959644|P1|NOT COMPLETED|Overall Study||1
5272362|NCT00690443|12959643|P2|COMPLETED|Overall Study||19
5272363|NCT00690443|12959644|P1|COMPLETED|Overall Study||22
5272364|NCT00690443|12959643|P2|STARTED|Overall Study||21
5272365|NCT00690443|12959644|P1|STARTED|Overall Study||23
5272366|NCT00690430|12959654|P3|NOT COMPLETED|Extension Phase||13
5272367|NCT00690430|12959655|P2|NOT COMPLETED|Extension Phase||5
5272368|NCT00690430|12959656|P1|NOT COMPLETED|Extension Phase||18
5272369|NCT00690430|12959654|P3|COMPLETED|Extension Phase||2
5272370|NCT00690430|12959655|P2|COMPLETED|Extension Phase||1
5272371|NCT00690430|12959656|P1|COMPLETED|Extension Phase||2
5272372|NCT00690430|12959654|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
5272373|NCT00690430|12959655|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
5272374|NCT00690430|12959656|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
5272375|NCT00690430|12959654|P3|NOT COMPLETED|Core Phase||0
5272376|NCT00690430|12959655|P2|NOT COMPLETED|Core Phase||23
5272377|NCT00690430|12959656|P1|NOT COMPLETED|Core Phase||18
5272378|NCT00690430|12959654|P3|COMPLETED|Core Phase||0
5272379|NCT00690430|12959655|P2|COMPLETED|Core Phase||34
5272380|NCT00690430|12959656|P1|COMPLETED|Core Phase||35
5272381|NCT00690430|12959654|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
5272382|NCT00690430|12959655|P2|STARTED|Core Phase||57
5272383|NCT00690430|12959656|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
5272384|NCT00690378|12959685|P2|NOT COMPLETED|Overall Study||14
5272385|NCT00690378|12959686|P1|NOT COMPLETED|Overall Study||20
5272386|NCT00690378|12959685|P2|COMPLETED|Overall Study|Up to LFU visit|54
5272387|NCT00690378|12959686|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
5272388|NCT00690378|12959685|P2|Treated|Overall Study||67
5272389|NCT00690378|12959686|P1|Treated|Overall Study||68
5272390|NCT00690378|12959685|P2|STARTED|Overall Study|Randomized|68
5272391|NCT00690378|12959686|P1|STARTED|Overall Study|Randomized|69
5272392|NCT00690339|12959734|P4|NOT COMPLETED|Overall Study||25
5272393|NCT00690339|12959735|P3|NOT COMPLETED|Overall Study||57
5272394|NCT00690339|12959736|P2|NOT COMPLETED|Overall Study||81
5272395|NCT00690339|12959737|P1|NOT COMPLETED|Overall Study||117
5272396|NCT00690339|12959734|P4|COMPLETED|Overall Study||43
5272397|NCT00690339|12959735|P3|COMPLETED|Overall Study||99
5272398|NCT00690339|12959736|P2|COMPLETED|Overall Study||144
5272399|NCT00690339|12959737|P1|COMPLETED|Overall Study||375
5272400|NCT00690339|12959734|P4|STARTED|Overall Study||68
5272401|NCT00690339|12959735|P3|STARTED|Overall Study||156
5272402|NCT00690339|12959736|P2|STARTED|Overall Study||225
5272403|NCT00690339|12959737|P1|STARTED|Overall Study||492
5272404|NCT00690274|12959753|P2|NOT COMPLETED|Overall Study||8
5272405|NCT00690274|12959754|P1|NOT COMPLETED|Overall Study||6
5272406|NCT00690274|12959753|P2|COMPLETED|Overall Study||15
5272407|NCT00690274|12959754|P1|COMPLETED|Overall Study||23
5272408|NCT00690274|12959753|P2|STARTED|Overall Study||23
5272409|NCT00690274|12959754|P1|STARTED|Overall Study||29
5272410|NCT00690235|12959764|P2|NOT COMPLETED|Overall Study||4
5272411|NCT00690235|12959765|P1|NOT COMPLETED|Overall Study||5
5272412|NCT00690235|12959764|P2|COMPLETED|Overall Study||12
5272413|NCT00690235|12959765|P1|COMPLETED|Overall Study||12
5272414|NCT00690235|12959764|P2|STARTED|Overall Study||16
5272415|NCT00690235|12959765|P1|STARTED|Overall Study||17
5272416|NCT00690040|12959773|P2|NOT COMPLETED|Overall Study||0
5272417|NCT00690040|12959774|P1|NOT COMPLETED|Overall Study||0
5272418|NCT00690040|12959773|P2|COMPLETED|Overall Study||148
5272419|NCT00690040|12959774|P1|COMPLETED|Overall Study||145
5272420|NCT00690040|12959773|P2|STARTED|Overall Study||148
5272421|NCT00690040|12959774|P1|STARTED|Overall Study||145
5272422|NCT00689936|12959783|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
5272423|NCT00689936|12959784|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
5272424|NCT00689936|12959785|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
5272425|NCT00689936|12959783|P3|COMPLETED|Long-Term Follow Up Phase||315
5272426|NCT00689936|12959784|P2|COMPLETED|Long-Term Follow Up Phase||275
5272427|NCT00689936|12959785|P1|COMPLETED|Long-Term Follow Up Phase||255
5272428|NCT00689936|12959783|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
5272429|NCT00689936|12959784|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
5272430|NCT00689936|12959785|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
5272431|NCT00689936|12959783|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
5272432|NCT00689936|12959784|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
5272433|NCT00689936|12959785|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
5272434|NCT00689936|12959783|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
5272435|NCT00689936|12959784|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
5272436|NCT00689936|12959785|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
5272437|NCT00689936|12959783|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
5272438|NCT00689936|12959784|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
5272439|NCT00689936|12959785|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
5272440|NCT00689936|12959783|P3|NOT COMPLETED|Active Treatment Phase||547
5272441|NCT00689936|12959784|P2|NOT COMPLETED|Active Treatment Phase||541
5272442|NCT00689936|12959785|P1|NOT COMPLETED|Active Treatment Phase||535
5272443|NCT00689936|12959783|P3|COMPLETED|Active Treatment Phase||0
5272444|NCT00689936|12959784|P2|COMPLETED|Active Treatment Phase||0
5272445|NCT00689936|12959785|P1|COMPLETED|Active Treatment Phase||0
5272446|NCT00689936|12959783|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
5272447|NCT00689936|12959784|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
5272448|NCT00689936|12959785|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
5272449|NCT00689936|12959783|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
5272450|NCT00689936|12959784|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
5272451|NCT00689936|12959785|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
5272452|NCT00689936|12959783|P3|STARTED|Active Treatment Phase||547
5272453|NCT00689936|12959784|P2|STARTED|Active Treatment Phase||541
5272454|NCT00689936|12959785|P1|STARTED|Active Treatment Phase||535
5272455|NCT00689884|12959925|P1|NOT COMPLETED|Overall Study||0
5272456|NCT00689884|12959925|P1|COMPLETED|Overall Study||7
5272457|NCT00689884|12959925|P1|STARTED|Overall Study||7
5272458|NCT00689871|12959934|P4|NOT COMPLETED|Overall Study||7
5272459|NCT00689871|12959935|P3|NOT COMPLETED|Overall Study||73
5272460|NCT00689871|12959936|P2|NOT COMPLETED|Overall Study||52
5272461|NCT00689871|12959937|P1|NOT COMPLETED|Overall Study||175
5272462|NCT00689871|12959934|P4|COMPLETED|Overall Study|4 Patients discontinued|8
5272463|NCT00689871|12959935|P3|COMPLETED|Overall Study|28 Patients discontinued|74
5272464|NCT00689871|12959936|P2|COMPLETED|Overall Study|35 Patients discontinued|46
5272465|NCT00689871|12959937|P1|COMPLETED|Overall Study|35 Patients discontinued|280
5272466|NCT00689871|12959934|P4|STARTED|Overall Study|25 Implants|15
5272467|NCT00689871|12959935|P3|STARTED|Overall Study|288 Implants|147
5272468|NCT00689871|12959936|P2|STARTED|Overall Study|127 Implants|98
5272469|NCT00689871|12959937|P1|STARTED|Overall Study|908 Implants|455
5272470|NCT00689819|12959953|P2|NOT COMPLETED|Overall Study||15
5272471|NCT00689819|12959954|P1|NOT COMPLETED|Overall Study||20
5272472|NCT00689819|12959953|P2|COMPLETED|Overall Study||43
5272473|NCT00689819|12959954|P1|COMPLETED|Overall Study||45
5272474|NCT00689819|12959953|P2|STARTED|Overall Study||58
5272475|NCT00689819|12959954|P1|STARTED|Overall Study||65
5272476|NCT00689793|12959964|P2|NOT COMPLETED|Overall Study||5
5272477|NCT00689793|12959965|P1|NOT COMPLETED|Overall Study||4
5272478|NCT00689793|12959964|P2|COMPLETED|Overall Study||71
5272479|NCT00689793|12959965|P1|COMPLETED|Overall Study||74
5272480|NCT00689793|12959964|P2|STARTED|Overall Study||76
5272481|NCT00689793|12959965|P1|STARTED|Overall Study||78
5272482|NCT00689728|12959984|P3|NOT COMPLETED|Optional Follow-Up||6
5272483|NCT00689728|12959985|P2|NOT COMPLETED|Optional Follow-Up||6
5272484|NCT00689728|12959986|P1|NOT COMPLETED|Optional Follow-Up||3
5272485|NCT00689728|12959984|P3|COMPLETED|Optional Follow-Up||4
5272486|NCT00689728|12959985|P2|COMPLETED|Optional Follow-Up||5
5272487|NCT00689728|12959986|P1|COMPLETED|Optional Follow-Up||6
5272488|NCT00689728|12959984|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
5272489|NCT00689728|12959985|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
5272490|NCT00689728|12959986|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
5272491|NCT00689728|12959984|P3|NOT COMPLETED|Rescue||1
5272492|NCT00689728|12959985|P2|NOT COMPLETED|Rescue||2
5272493|NCT00689728|12959986|P1|NOT COMPLETED|Rescue||1
5272494|NCT00689728|12959984|P3|COMPLETED|Rescue||29
5272495|NCT00689728|12959985|P2|COMPLETED|Rescue||24
5272496|NCT00689728|12959986|P1|COMPLETED|Rescue||30
5272497|NCT00689728|12959984|P3|STARTED|Rescue||30
5272498|NCT00689728|12959985|P2|STARTED|Rescue||26
5272499|NCT00689728|12959986|P1|STARTED|Rescue||31
5272500|NCT00689728|12959984|P3|NOT COMPLETED|Double-Blind Treatment||5
5272501|NCT00689728|12959985|P2|NOT COMPLETED|Double-Blind Treatment||4
5272502|NCT00689728|12959986|P1|NOT COMPLETED|Double-Blind Treatment||4
5272503|NCT00689728|12959984|P3|COMPLETED|Double-Blind Treatment||30
5272504|NCT00689728|12959985|P2|COMPLETED|Double-Blind Treatment||26
5272505|NCT00689728|12959986|P1|COMPLETED|Double-Blind Treatment||31
5272506|NCT00689728|12959984|P3|STARTED|Double-Blind Treatment||35
5272507|NCT00689728|12959985|P2|STARTED|Double-Blind Treatment||30
5272508|NCT00689728|12959986|P1|STARTED|Double-Blind Treatment||35
5272509|NCT00689611|12960069|P2|NOT COMPLETED|Overall Study||46
5272510|NCT00689611|12960070|P1|NOT COMPLETED|Overall Study||41
5272511|NCT00689611|12960069|P2|COMPLETED|Overall Study||146
5272512|NCT00689611|12960070|P1|COMPLETED|Overall Study||159
5272513|NCT00689611|12960069|P2|STARTED|Overall Study||192
5272514|NCT00689611|12960070|P1|STARTED|Overall Study||200
5272515|NCT00689481|12960080|P2|NOT COMPLETED|Overall Study||14
5272516|NCT00689481|12960081|P1|NOT COMPLETED|Overall Study||24
5272517|NCT00689481|12960080|P2|COMPLETED|Overall Study||95
5272518|NCT00689481|12960081|P1|COMPLETED|Overall Study||190
5272519|NCT00689481|12960080|P2|STARTED|Overall Study||109
5272520|NCT00689481|12960081|P1|STARTED|Overall Study||214
5272521|NCT00689390|12960099|P2|NOT COMPLETED|Overall Study||10
5272522|NCT00689390|12960100|P1|NOT COMPLETED|Overall Study||426
5272523|NCT00689390|12960099|P2|COMPLETED|Overall Study||37
5272524|NCT00689390|12960100|P1|COMPLETED|Overall Study||1481
5272525|NCT00689390|12960099|P2|STARTED|Overall Study||47
5272526|NCT00689390|12960100|P1|STARTED|Overall Study||1907
5272527|NCT00689351|12960118|P2|NOT COMPLETED|Toddler Dose||0
5272528|NCT00689351|12960119|P1|NOT COMPLETED|Toddler Dose||0
5272529|NCT00689351|12960118|P2|COMPLETED|Toddler Dose||88
5272530|NCT00689351|12960119|P1|COMPLETED|Toddler Dose||84
5272531|NCT00689351|12960118|P2|STARTED|Toddler Dose||88
5272532|NCT00689351|12960119|P1|STARTED|Toddler Dose||84
5272533|NCT00689351|12960118|P2|NOT COMPLETED|After Infant Series||0
5272534|NCT00689351|12960119|P1|NOT COMPLETED|After Infant Series||1
5272535|NCT00689351|12960118|P2|COMPLETED|After Infant Series||88
5272536|NCT00689351|12960119|P1|COMPLETED|After Infant Series||84
5272537|NCT00689351|12960118|P2|STARTED|After Infant Series||88
5272538|NCT00689351|12960119|P1|STARTED|After Infant Series||85
5272539|NCT00689351|12960118|P2|NOT COMPLETED|Infant Series of Dosing||1
5272540|NCT00689351|12960119|P1|NOT COMPLETED|Infant Series of Dosing||6
5272541|NCT00689351|12960118|P2|COMPLETED|Infant Series of Dosing||88
5272542|NCT00689351|12960119|P1|COMPLETED|Infant Series of Dosing||85
5272543|NCT00689351|12960118|P2|Vaccinated Dose 3|Infant Series of Dosing||88
5272544|NCT00689351|12960119|P1|Vaccinated Dose 3|Infant Series of Dosing||85
5272545|NCT00689351|12960118|P2|Vaccinated Dose 2|Infant Series of Dosing||88
5272546|NCT00689351|12960119|P1|Vaccinated Dose 2|Infant Series of Dosing||86
5272547|NCT00689351|12960118|P2|Vaccinated Dose 1|Infant Series of Dosing||89
5272548|NCT00689351|12960119|P1|Vaccinated Dose 1|Infant Series of Dosing||88
5272549|NCT00689351|12960118|P2|STARTED|Infant Series of Dosing||89
5272550|NCT00689351|12960119|P1|STARTED|Infant Series of Dosing||91
5272551|NCT00689338|12960151|P1|NOT COMPLETED|Overall Study||143
5272552|NCT00689338|12960151|P1|COMPLETED|Overall Study||73
5272553|NCT00689338|12960151|P1|STARTED|Overall Study||216
5272554|NCT00689299|12960164|P3|NOT COMPLETED|Overall Study||5
5272555|NCT00689299|12960165|P2|NOT COMPLETED|Overall Study||3
5272556|NCT00689299|12960166|P1|NOT COMPLETED|Overall Study||7
5272557|NCT00689299|12960164|P3|COMPLETED|Overall Study||49
5272558|NCT00689299|12960165|P2|COMPLETED|Overall Study||54
5272559|NCT00689299|12960166|P1|COMPLETED|Overall Study||51
5272560|NCT00689299|12960164|P3|STARTED|Overall Study||54
5272561|NCT00689299|12960165|P2|STARTED|Overall Study||57
5272562|NCT00689299|12960166|P1|STARTED|Overall Study||58
5272563|NCT00689260|12960176|P2|NOT COMPLETED|Overall Study||0
5272564|NCT00689260|12960177|P1|NOT COMPLETED|Overall Study||2
5272565|NCT00689260|12960176|P2|COMPLETED|Overall Study||21
5272566|NCT00689260|12960177|P1|COMPLETED|Overall Study||19
5272567|NCT00689260|12960176|P2|STARTED|Overall Study||21
5272568|NCT00689260|12960177|P1|STARTED|Overall Study||21
5272569|NCT00689221|12960195|P2|NOT COMPLETED|Overall Study||36
5272570|NCT00689221|12960196|P1|NOT COMPLETED|Overall Study||39
5272571|NCT00689221|12960195|P2|COMPLETED|Overall Study||237
5272572|NCT00689221|12960196|P1|COMPLETED|Overall Study||233
5272573|NCT00689221|12960195|P2|STARTED|Overall Study||273
5272574|NCT00689221|12960196|P1|STARTED|Overall Study||272
5272575|NCT00689117|12960225|P4|NOT COMPLETED|Overall Study||31
5272576|NCT00689117|12960226|P3|NOT COMPLETED|Overall Study||59
5272577|NCT00689117|12960227|P2|NOT COMPLETED|Overall Study||51
5272578|NCT00689117|12960228|P1|NOT COMPLETED|Overall Study||62
5272579|NCT00689117|12960225|P4|COMPLETED|Overall Study||211
5272580|NCT00689117|12960226|P3|COMPLETED|Overall Study||405
5272581|NCT00689117|12960227|P2|COMPLETED|Overall Study||416
5272582|NCT00689117|12960228|P1|COMPLETED|Overall Study||414
5272583|NCT00689117|12960225|P4|STARTED|Overall Study||242
5272584|NCT00689117|12960226|P3|STARTED|Overall Study||464
5272585|NCT00689117|12960227|P2|STARTED|Overall Study||467
5272586|NCT00689117|12960228|P1|STARTED|Overall Study||476
5272587|NCT00689104|12960258|P4|NOT COMPLETED|Overall Study||50
5272588|NCT00689104|12960259|P3|NOT COMPLETED|Overall Study||45
5272589|NCT00689104|12960260|P2|NOT COMPLETED|Overall Study||57
5272590|NCT00689104|12960261|P1|NOT COMPLETED|Overall Study||44
5272591|NCT00689104|12960258|P4|COMPLETED|Overall Study||445
5272592|NCT00689104|12960259|P3|COMPLETED|Overall Study||453
5272593|NCT00689104|12960260|P2|COMPLETED|Overall Study||440
5272594|NCT00689104|12960261|P1|COMPLETED|Overall Study||453
5272595|NCT00689104|12960258|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
5272596|NCT00689104|12960259|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
5272597|NCT00689104|12960260|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
5272598|NCT00689104|12960261|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
5272599|NCT00689104|12960258|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
5272600|NCT00689104|12960259|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
5272601|NCT00689104|12960260|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
5272602|NCT00689104|12960261|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
5272603|NCT00689104|12960258|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
5272604|NCT00689104|12960259|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
5272605|NCT00689104|12960260|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
5272606|NCT00689104|12960261|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
5272607|NCT00689104|12960258|P4|STARTED|Overall Study||495
5272608|NCT00689104|12960259|P3|STARTED|Overall Study||498
5272609|NCT00689104|12960260|P2|STARTED|Overall Study||497
5272610|NCT00689104|12960261|P1|STARTED|Overall Study||497
5272611|NCT00689091|12960393|P2|NOT COMPLETED|Overall Study||1394
5272612|NCT00689091|12960394|P1|NOT COMPLETED|Overall Study||1371
5272613|NCT00689091|12960393|P2|COMPLETED|Overall Study||9376
5272614|NCT00689091|12960394|P1|COMPLETED|Overall Study||9460
5272615|NCT00689091|12960393|P2|STARTED|Overall Study||10770
5272616|NCT00689091|12960394|P1|STARTED|Overall Study||10831
5272617|NCT00689078|12960416|P4|NOT COMPLETED|Overall Study||1
5272618|NCT00689078|12960417|P3|NOT COMPLETED|Overall Study||1
5272619|NCT00689078|12960418|P2|NOT COMPLETED|Overall Study||2
5272620|NCT00689078|12960419|P1|NOT COMPLETED|Overall Study||0
5272621|NCT00689078|12960416|P4|COMPLETED|Overall Study||8
5272622|NCT00689078|12960417|P3|COMPLETED|Overall Study||8
5272623|NCT00689078|12960418|P2|COMPLETED|Overall Study||7
5272624|NCT00689078|12960419|P1|COMPLETED|Overall Study||9
5272625|NCT00689078|12960416|P4|STARTED|Overall Study||9
5272626|NCT00689078|12960417|P3|STARTED|Overall Study||9
5272627|NCT00689078|12960418|P2|STARTED|Overall Study||9
5272628|NCT00689078|12960419|P1|STARTED|Overall Study||9
5272629|NCT00689052|12960467|P2|NOT COMPLETED|Overall Study||30
5272630|NCT00689052|12960468|P1|NOT COMPLETED|Overall Study||31
5272631|NCT00689052|12960467|P2|COMPLETED|Overall Study||0
5272632|NCT00689052|12960468|P1|COMPLETED|Overall Study||0
5272633|NCT00689052|12960467|P2|STARTED|Overall Study||30
5272634|NCT00689052|12960468|P1|STARTED|Overall Study||31
5272635|NCT00689026|12960500|P2|NOT COMPLETED|Overall Study||6
5272636|NCT00689026|12960501|P1|NOT COMPLETED|Overall Study||13
5272637|NCT00689026|12960500|P2|COMPLETED|Overall Study||24
5272638|NCT00689026|12960501|P1|COMPLETED|Overall Study||17
5272639|NCT00689026|12960500|P2|STARTED|Overall Study||30
5272640|NCT00689026|12960501|P1|STARTED|Overall Study||30
5272641|NCT00688935|12960507|P1|NOT COMPLETED|Overall Study||0
5272642|NCT00688935|12960507|P1|COMPLETED|Overall Study||0
5272643|NCT00688935|12960507|P1|STARTED|Overall Study||0
5272644|NCT00688870|12960514|P2|NOT COMPLETED|Toddler Dose||0
5272645|NCT00688870|12960515|P1|NOT COMPLETED|Toddler Dose||0
5272646|NCT00688870|12960514|P2|COMPLETED|Toddler Dose||84
5272647|NCT00688870|12960515|P1|COMPLETED|Toddler Dose||80
5272648|NCT00688870|12960514|P2|STARTED|Toddler Dose||84
5272649|NCT00688870|12960515|P1|STARTED|Toddler Dose||80
5272650|NCT00688870|12960514|P2|NOT COMPLETED|After Infant Series||0
5272651|NCT00688870|12960515|P1|NOT COMPLETED|After Infant Series||0
5272652|NCT00688870|12960514|P2|COMPLETED|After Infant Series||84
5272653|NCT00688870|12960515|P1|COMPLETED|After Infant Series||80
5272654|NCT00688870|12960514|P2|STARTED|After Infant Series||84
5272655|NCT00688870|12960515|P1|STARTED|After Infant Series||80
5272656|NCT00688870|12960514|P2|NOT COMPLETED|Infant Series||0
5272657|NCT00688870|12960515|P1|NOT COMPLETED|Infant Series||4
5272658|NCT00688870|12960514|P2|COMPLETED|Infant Series||84
5272659|NCT00688870|12960515|P1|COMPLETED|Infant Series||80
5272660|NCT00688870|12960514|P2|Vaccinated Dose 3|Infant Series||84
5272661|NCT00688870|12960515|P1|Vaccinated Dose 3|Infant Series||80
5272662|NCT00688870|12960514|P2|Vaccinated Dose 2|Infant Series||84
5272663|NCT00688870|12960515|P1|Vaccinated Dose 2|Infant Series||80
5272664|NCT00688870|12960514|P2|Vaccinated Dose 1|Infant Series||84
5272665|NCT00688870|12960515|P1|Vaccinated Dose 1|Infant Series||83
5272666|NCT00688870|12960514|P2|STARTED|Infant Series||84
5272667|NCT00688870|12960515|P1|STARTED|Infant Series||84
5272668|NCT00688844|12960547|P1|NOT COMPLETED|Overall Study||10
5272669|NCT00688844|12960547|P1|COMPLETED|Overall Study||48
5272670|NCT00688844|12960547|P1|STARTED|Overall Study||58
5272671|NCT00688753|12960557|P1|NOT COMPLETED|Overall Study||92
5272672|NCT00688753|12960557|P1|COMPLETED|Overall Study||0
5272673|NCT00688753|12960557|P1|STARTED|Overall Study||92
5272674|NCT00688740|12960568|P2|NOT COMPLETED|Overall Study||35
5272675|NCT00688740|12960569|P1|NOT COMPLETED|Overall Study||66
5272676|NCT00688740|12960568|P2|COMPLETED|Overall Study||711
5272677|NCT00688740|12960569|P1|COMPLETED|Overall Study||679
5272678|NCT00688740|12960568|P2|STARTED|Overall Study||746
5272679|NCT00688740|12960569|P1|STARTED|Overall Study||745
5272680|NCT00688701|12960582|P4|NOT COMPLETED|Overall Study||11
5272681|NCT00688701|12960583|P3|NOT COMPLETED|Overall Study||10
5272682|NCT00688701|12960584|P2|NOT COMPLETED|Overall Study||5
5272683|NCT00688701|12960585|P1|NOT COMPLETED|Overall Study||4
5272684|NCT00688701|12960582|P4|COMPLETED|Overall Study||108
5272685|NCT00688701|12960583|P3|COMPLETED|Overall Study||110
5272686|NCT00688701|12960584|P2|COMPLETED|Overall Study||56
5272687|NCT00688701|12960585|P1|COMPLETED|Overall Study||57
5272688|NCT00688701|12960582|P4|Subgroup for Standardized Meal Test|Overall Study||65
5272689|NCT00688701|12960583|P3|Subgroup for Standardized Meal Test|Overall Study||60
5272690|NCT00688701|12960584|P2|Subgroup for Standardized Meal Test|Overall Study||35
5272691|NCT00688701|12960585|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
5272692|NCT00688701|12960582|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
5272693|NCT00688701|12960583|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
5272694|NCT00688701|12960584|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
5272695|NCT00688701|12960585|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
5272696|NCT00688701|12960582|P4|Treated/Safety Population|Overall Study||119
5272697|NCT00688701|12960583|P3|Treated/Safety Population|Overall Study||120
5272698|NCT00688701|12960584|P2|Treated/Safety Population|Overall Study||61
5272699|NCT00688701|12960585|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
5272700|NCT00688701|12960582|P4|STARTED|Overall Study||119
5272701|NCT00688701|12960583|P3|STARTED|Overall Study||120
5272702|NCT00688701|12960584|P2|STARTED|Overall Study||61
5272703|NCT00688701|12960585|P1|STARTED|Overall Study|Randomized|61
5272704|NCT00688688|12960626|P3|NOT COMPLETED|Overall Study||192
5272705|NCT00688688|12960627|P2|NOT COMPLETED|Overall Study||179
5272706|NCT00688688|12960628|P1|NOT COMPLETED|Overall Study||186
5272707|NCT00688688|12960626|P3|COMPLETED|Overall Study||621
5272708|NCT00688688|12960627|P2|COMPLETED|Overall Study||645
5272709|NCT00688688|12960628|P1|COMPLETED|Overall Study||629
5272710|NCT00688688|12960626|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
5272711|NCT00688688|12960627|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
5272712|NCT00688688|12960628|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
5272713|NCT00688688|12960626|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
5272714|NCT00688688|12960627|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
5272715|NCT00688688|12960628|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
5272716|NCT00688688|12960626|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
5272717|NCT00688688|12960627|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
5272718|NCT00688688|12960628|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
5272719|NCT00688688|12960626|P3|STARTED|Overall Study||813
5272720|NCT00688688|12960627|P2|STARTED|Overall Study||824
5272721|NCT00688688|12960628|P1|STARTED|Overall Study||815
5272722|NCT00688662|12960719|P2|NOT COMPLETED|Overall Study||18
5272723|NCT00688662|12960720|P1|NOT COMPLETED|Overall Study||23
5272724|NCT00688662|12960719|P2|COMPLETED|Overall Study||55
5272725|NCT00688662|12960720|P1|COMPLETED|Overall Study||118
5272726|NCT00688662|12960719|P2|STARTED|Overall Study||73
5272727|NCT00688662|12960720|P1|STARTED|Overall Study||141
5272728|NCT00688636|12960730|P2|NOT COMPLETED|Overall Study||1
5272729|NCT00688636|12960731|P1|NOT COMPLETED|Overall Study||2
5272730|NCT00688636|12960730|P2|COMPLETED|Overall Study||12
5272731|NCT00688636|12960731|P1|COMPLETED|Overall Study||9
5272732|NCT00688636|12960730|P2|STARTED|Overall Study||13
5272733|NCT00688636|12960731|P1|STARTED|Overall Study||11
5272734|NCT00688623|12960745|P1|NOT COMPLETED|Overall Study||55
5272735|NCT00688623|12960745|P1|COMPLETED|Overall Study||18
5272736|NCT00688623|12960745|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
5272737|NCT00688623|12960745|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
5272738|NCT00688623|12960745|P1|STARTED|Overall Study|Intent to treat (ITT)|73
5272739|NCT00688597|12960759|P3|NOT COMPLETED|Overall Study||0
5272740|NCT00688597|12960760|P2|NOT COMPLETED|Overall Study||0
5272741|NCT00688597|12960761|P1|NOT COMPLETED|Overall Study||3
5272742|NCT00688597|12960759|P3|COMPLETED|Overall Study||0
5272743|NCT00688597|12960760|P2|COMPLETED|Overall Study||0
5272744|NCT00688597|12960761|P1|COMPLETED|Overall Study||0
5272745|NCT00688597|12960759|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
5272746|NCT00688597|12960760|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
5272747|NCT00688597|12960761|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
5272748|NCT00688597|12960759|P3|STARTED|Overall Study||0
5272749|NCT00688597|12960760|P2|STARTED|Overall Study||0
5272750|NCT00688597|12960761|P1|STARTED|Overall Study||3
5272751|NCT00688545|12960774|P2|NOT COMPLETED|Overall Study||15
5272752|NCT00688545|12960775|P1|NOT COMPLETED|Overall Study||5
5272753|NCT00688545|12960774|P2|COMPLETED|Overall Study||204
5272754|NCT00688545|12960775|P1|COMPLETED|Overall Study||50
5272755|NCT00688545|12960774|P2|Switched Treatment at Least Once|Overall Study||13
5272756|NCT00688545|12960775|P1|Switched Treatment at Least Once|Overall Study||6
5272757|NCT00688545|12960774|P2|STARTED|Overall Study||219
5272758|NCT00688545|12960775|P1|STARTED|Overall Study||55
5272759|NCT00688519|12960785|P2|NOT COMPLETED|Overall Study||15
5272760|NCT00688519|12960786|P1|NOT COMPLETED|Overall Study||19
5272761|NCT00688519|12960785|P2|COMPLETED|Overall Study||98
5272762|NCT00688519|12960786|P1|COMPLETED|Overall Study||204
5272763|NCT00688519|12960785|P2|STARTED|Overall Study||113
5272764|NCT00688519|12960786|P1|STARTED|Overall Study||223
5272765|NCT00688467|12960804|P2|NOT COMPLETED|Treatment Period 2||2
5272766|NCT00688467|12960805|P1|NOT COMPLETED|Treatment Period 2||0
5272767|NCT00688467|12960804|P2|COMPLETED|Treatment Period 2||6
5272768|NCT00688467|12960805|P1|COMPLETED|Treatment Period 2||7
5272769|NCT00688467|12960804|P2|STARTED|Treatment Period 2||8
5272770|NCT00688467|12960805|P1|STARTED|Treatment Period 2||7
5272771|NCT00688467|12960804|P2|NOT COMPLETED|Treatment Period 1||2
5272772|NCT00688467|12960805|P1|NOT COMPLETED|Treatment Period 1||2
5272773|NCT00688467|12960804|P2|COMPLETED|Treatment Period 1||8
5272774|NCT00688467|12960805|P1|COMPLETED|Treatment Period 1||7
5272775|NCT00688467|12960804|P2|STARTED|Treatment Period 1||10
5272776|NCT00688467|12960805|P1|STARTED|Treatment Period 1||9
5272777|NCT00688376|12960837|P2|NOT COMPLETED|Blinded Extension Phase||5
5272778|NCT00688376|12960838|P1|NOT COMPLETED|Blinded Extension Phase||5
5272779|NCT00688376|12960837|P2|COMPLETED|Blinded Extension Phase||20
5272780|NCT00688376|12960838|P1|COMPLETED|Blinded Extension Phase||29
5272781|NCT00688376|12960837|P2|STARTED|Blinded Extension Phase||25
5272782|NCT00688376|12960838|P1|STARTED|Blinded Extension Phase||34
5272783|NCT00688376|12960837|P2|NOT COMPLETED|Double-Blind Phase||7
5272784|NCT00688376|12960838|P1|NOT COMPLETED|Double-Blind Phase||6
5272785|NCT00688376|12960837|P2|COMPLETED|Double-Blind Phase||25
5272786|NCT00688376|12960838|P1|COMPLETED|Double-Blind Phase||34
5272787|NCT00688376|12960837|P2|Safety Population|Double-Blind Phase||31
5272788|NCT00688376|12960838|P1|Safety Population|Double-Blind Phase||40
5272789|NCT00688376|12960837|P2|STARTED|Double-Blind Phase||32
5272790|NCT00688376|12960838|P1|STARTED|Double-Blind Phase||40
5272791|NCT00688324|12960852|P1|NOT COMPLETED|Overall Study||8
5272792|NCT00688324|12960852|P1|COMPLETED|Overall Study||28
5272793|NCT00688324|12960852|P1|STARTED|Overall Study||36
5272794|NCT00688259|12960897|P2|NOT COMPLETED|Overall Study||8
5272795|NCT00688259|12960898|P1|NOT COMPLETED|Overall Study||7
5272796|NCT00688259|12960897|P2|COMPLETED|Overall Study||36
5272797|NCT00688259|12960898|P1|COMPLETED|Overall Study||37
5272798|NCT00688259|12960897|P2|End to Active Treatment,|Overall Study||37
5272799|NCT00688259|12960898|P1|End to Active Treatment,|Overall Study||37
5272800|NCT00688259|12960897|P2|STARTED|Overall Study||44
5272801|NCT00688259|12960898|P1|STARTED|Overall Study||44
5272802|NCT00688155|12960918|P4|NOT COMPLETED|Overall Study||1
5272803|NCT00688155|12960919|P3|NOT COMPLETED|Overall Study||1
5272804|NCT00688155|12960920|P2|NOT COMPLETED|Overall Study||2
5272805|NCT00688155|12960921|P1|NOT COMPLETED|Overall Study||2
5272806|NCT00688155|12960918|P4|COMPLETED|Overall Study||17
5272807|NCT00688155|12960919|P3|COMPLETED|Overall Study||18
5272808|NCT00688155|12960920|P2|COMPLETED|Overall Study||16
5272809|NCT00688155|12960921|P1|COMPLETED|Overall Study||16
5272810|NCT00688155|12960918|P4|STARTED|Overall Study||18
5272811|NCT00688155|12960919|P3|STARTED|Overall Study||19
5272812|NCT00688155|12960920|P2|STARTED|Overall Study||18
5272813|NCT00688155|12960921|P1|STARTED|Overall Study||18
5272814|NCT00688103|12960941|P2|NOT COMPLETED|Overall Study||13
5272815|NCT00688103|12960942|P1|NOT COMPLETED|Overall Study||30
5272816|NCT00688103|12960941|P2|COMPLETED|Overall Study||64
5272817|NCT00688103|12960942|P1|COMPLETED|Overall Study||44
5272818|NCT00688103|12960941|P2|Actually Treated|Overall Study||76
5272819|NCT00688103|12960942|P1|Actually Treated|Overall Study||71
5272820|NCT00688103|12960941|P2|STARTED|Overall Study||77
5272821|NCT00688103|12960942|P1|STARTED|Overall Study||74
5272822|NCT00688064|12960954|P2|NOT COMPLETED|Overall Study||26
5272823|NCT00688064|12960955|P1|NOT COMPLETED|Overall Study||21
5272824|NCT00688064|12960954|P2|COMPLETED|Overall Study||201
5272825|NCT00688064|12960955|P1|COMPLETED|Overall Study||211
5272826|NCT00688064|12960954|P2|STARTED|Overall Study||227
5272827|NCT00688064|12960955|P1|STARTED|Overall Study||232
5272828|NCT00687973|12960971|P2|NOT COMPLETED|Overall Study||38
5272829|NCT00687973|12960972|P1|NOT COMPLETED|Overall Study||24
5272830|NCT00687973|12960971|P2|COMPLETED|Overall Study||162
5272831|NCT00687973|12960972|P1|COMPLETED|Overall Study||169
5272832|NCT00687973|12960971|P2|STARTED|Overall Study||200
5272833|NCT00687973|12960972|P1|STARTED|Overall Study||193
5272834|NCT00687908|12961001|P2|NOT COMPLETED|Overall Study||42
5272835|NCT00687908|12961002|P1|NOT COMPLETED|Overall Study||18
5272836|NCT00687908|12961001|P2|COMPLETED|Overall Study||78
5272837|NCT00687908|12961002|P1|COMPLETED|Overall Study||105
5272838|NCT00687908|12961001|P2|STARTED|Overall Study||120
5272839|NCT00687908|12961002|P1|STARTED|Overall Study||123
5272840|NCT00687856|12961016|P1|NOT COMPLETED|Overall Study||0
5272841|NCT00687856|12961016|P1|COMPLETED|Overall Study||211
5272842|NCT00687856|12961016|P1|STARTED|Overall Study||211
5272843|NCT00687830|12961022|P2|NOT COMPLETED|Overall Study||0
5272844|NCT00687830|12961023|P1|NOT COMPLETED|Overall Study||0
5272845|NCT00687830|12961022|P2|COMPLETED|Overall Study||68
5272846|NCT00687830|12961023|P1|COMPLETED|Overall Study||68
5272847|NCT00687830|12961022|P2|STARTED|Overall Study||68
5272848|NCT00687830|12961023|P1|STARTED|Overall Study||68
5272849|NCT00687804|12961034|P3|NOT COMPLETED|Open-Label Extension Study||11
5272850|NCT00687804|12961035|P2|NOT COMPLETED|Open-Label Extension Study||11
5272851|NCT00687804|12961036|P1|NOT COMPLETED|Open-Label Extension Study||10
5272852|NCT00687804|12961034|P3|COMPLETED|Open-Label Extension Study||63
5272853|NCT00687804|12961035|P2|COMPLETED|Open-Label Extension Study||72
5272854|NCT00687804|12961036|P1|COMPLETED|Open-Label Extension Study||73
5272855|NCT00687804|12961034|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
5272856|NCT00687804|12961035|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
5272857|NCT00687804|12961036|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
5272858|NCT00687804|12961034|P3|STARTED|Open-Label Extension Study||74
5272859|NCT00687804|12961035|P2|STARTED|Open-Label Extension Study||83
5272860|NCT00687804|12961036|P1|STARTED|Open-Label Extension Study||83
5272861|NCT00687804|12961034|P3|NOT COMPLETED|Core Study||13
5272862|NCT00687804|12961035|P2|NOT COMPLETED|Core Study||15
5272863|NCT00687804|12961036|P1|NOT COMPLETED|Core Study||14
5272864|NCT00687804|12961034|P3|COMPLETED|Core Study||98
5272865|NCT00687804|12961035|P2|COMPLETED|Core Study||103
5272866|NCT00687804|12961036|P1|COMPLETED|Core Study||102
5272867|NCT00687804|12961034|P3|STARTED|Core Study||111
5272868|NCT00687804|12961035|P2|STARTED|Core Study||118
5272869|NCT00687804|12961036|P1|STARTED|Core Study||116
5272870|NCT00687739|12961083|P4|NOT COMPLETED|Overall Study||2
5272871|NCT00687739|12961084|P3|NOT COMPLETED|Overall Study||2
5272872|NCT00687739|12961085|P2|NOT COMPLETED|Overall Study||3
5272873|NCT00687739|12961086|P1|NOT COMPLETED|Overall Study||2
5272874|NCT00687739|12961083|P4|COMPLETED|Overall Study||12
5272875|NCT00687739|12961084|P3|COMPLETED|Overall Study||23
5272876|NCT00687739|12961085|P2|COMPLETED|Overall Study||12
5272877|NCT00687739|12961086|P1|COMPLETED|Overall Study||23
5272878|NCT00687739|12961083|P4|STARTED|Overall Study||14
5272879|NCT00687739|12961084|P3|STARTED|Overall Study||25
5272880|NCT00687739|12961085|P2|STARTED|Overall Study||15
5272881|NCT00687739|12961086|P1|STARTED|Overall Study||25
5272882|NCT00687713|12961112|P2|NOT COMPLETED|Overall Study||40
5272883|NCT00687713|12961113|P1|NOT COMPLETED|Overall Study||32
5272884|NCT00687713|12961112|P2|COMPLETED|Overall Study||64
5272885|NCT00687713|12961113|P1|COMPLETED|Overall Study||68
5272886|NCT00687713|12961112|P2|STARTED|Overall Study||104
5272887|NCT00687713|12961113|P1|STARTED|Overall Study||100
5272888|NCT00687674|12961121|P1|NOT COMPLETED|Overall Study||2
5272889|NCT00687674|12961121|P1|COMPLETED|Overall Study||11
5272890|NCT00687674|12961121|P1|STARTED|Overall Study||13
5272891|NCT00687609|12961128|P1|NOT COMPLETED|Overall Study||3
5272892|NCT00687609|12961128|P1|COMPLETED|Overall Study||4
5272893|NCT00687609|12961128|P1|STARTED|Overall Study||7
5272894|NCT00687544|12961142|P1|NOT COMPLETED|Overall Study||11
5272895|NCT00687544|12961142|P1|COMPLETED|Overall Study||0
5272896|NCT00687544|12961142|P1|STARTED|Overall Study||11
5272897|NCT00687531|12961151|P1|NOT COMPLETED|Overall Study||135
5272898|NCT00687531|12961151|P1|COMPLETED|Overall Study||250
5272899|NCT00687531|12961151|P1|RECEIVED TREATMENT|Overall Study||281
5272900|NCT00687531|12961151|P1|STARTED|Overall Study|Completed screening procedures|385
5272901|NCT00687453|12961167|P2|NOT COMPLETED|Overall Study||6
5272902|NCT00687453|12961168|P1|NOT COMPLETED|Overall Study||3
5272903|NCT00687453|12961167|P2|COMPLETED|Overall Study||7
5272904|NCT00687453|12961168|P1|COMPLETED|Overall Study||8
5272905|NCT00687453|12961167|P2|STARTED|Overall Study||13
5272906|NCT00687453|12961168|P1|STARTED|Overall Study||11
5272907|NCT00687440|12961174|P1|NOT COMPLETED|Overall Study||12
5272908|NCT00687440|12961174|P1|COMPLETED|Overall Study||15
5272909|NCT00687440|12961174|P1|STARTED|Overall Study|Number of screened participants|27
5272910|NCT00687401|12961178|P1|NOT COMPLETED|Overall Study||30
5272911|NCT00687401|12961178|P1|COMPLETED|Overall Study||129
5272912|NCT00687401|12961178|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
5272913|NCT00687362|12961183|P1|NOT COMPLETED|Overall Study||3
5272914|NCT00687362|12961183|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
5272915|NCT00687362|12961183|P1|STARTED|Overall Study||22
5272916|NCT00687323|12961187|P1|NOT COMPLETED|Overall Study||180
5272917|NCT00687323|12961187|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
5272918|NCT00687323|12961187|P1|Received Treatment|Overall Study||47
5272919|NCT00687323|12961187|P1|STARTED|Overall Study|Number of screened participants|195
5272920|NCT00687297|12961203|P2|NOT COMPLETED|Maintenance||1
5272921|NCT00687297|12961204|P1|NOT COMPLETED|Maintenance||3
5272922|NCT00687297|12961203|P2|COMPLETED|Maintenance||25
5272923|NCT00687297|12961204|P1|COMPLETED|Maintenance||29
5272924|NCT00687297|12961203|P2|STARTED|Maintenance||26
5272925|NCT00687297|12961204|P1|STARTED|Maintenance||32
5272926|NCT00687297|12961203|P2|NOT COMPLETED|Induction||55
5272927|NCT00687297|12961204|P1|NOT COMPLETED|Induction||45
5272928|NCT00687297|12961203|P2|COMPLETED|Induction||26
5272929|NCT00687297|12961204|P1|COMPLETED|Induction||32
5272930|NCT00687297|12961203|P2|STARTED|Induction||81
5272931|NCT00687297|12961204|P1|STARTED|Induction||77
5272932|NCT00687297|12961203|P2|NOT COMPLETED|Randomization||1
5272933|NCT00687297|12961204|P1|NOT COMPLETED|Randomization||3
5272934|NCT00687297|12961203|P2|COMPLETED|Randomization||81
5272935|NCT00687297|12961204|P1|COMPLETED|Randomization||77
5272936|NCT00687297|12961203|P2|STARTED|Randomization||82
5272937|NCT00687297|12961204|P1|STARTED|Randomization||80
5272938|NCT00687271|12961218|P4|NOT COMPLETED|Overall Study||0
5272939|NCT00687271|12961219|P3|NOT COMPLETED|Overall Study||5
5272940|NCT00687271|12961220|P2|NOT COMPLETED|Overall Study||6
5272941|NCT00687271|12961221|P1|NOT COMPLETED|Overall Study||3
5272942|NCT00687271|12961218|P4|COMPLETED|Overall Study||48
5272943|NCT00687271|12961219|P3|COMPLETED|Overall Study||91
5272944|NCT00687271|12961220|P2|COMPLETED|Overall Study||90
5272945|NCT00687271|12961221|P1|COMPLETED|Overall Study||91
5272946|NCT00687271|12961218|P4|Treated|Overall Study||48
5272947|NCT00687271|12961219|P3|Treated|Overall Study||96
5272948|NCT00687271|12961220|P2|Treated|Overall Study||95
5272949|NCT00687271|12961221|P1|Treated|Overall Study||94
5272950|NCT00687271|12961218|P4|STARTED|Overall Study||48
5272951|NCT00687271|12961219|P3|STARTED|Overall Study||96
5272952|NCT00687271|12961220|P2|STARTED|Overall Study||96
5272953|NCT00687271|12961221|P1|STARTED|Overall Study||94
5272954|NCT00687219|12961259|P1|NOT COMPLETED|Overall Study||51
5272955|NCT00687219|12961259|P1|COMPLETED|Overall Study||51
5272956|NCT00687219|12961259|P1|STARTED|Overall Study||102
5272957|NCT00687193|12961271|P6|NOT COMPLETED|Overall Study||4
5272958|NCT00687193|12961272|P5|NOT COMPLETED|Overall Study||2
5272959|NCT00687193|12961273|P4|NOT COMPLETED|Overall Study||4
5272960|NCT00687193|12961274|P3|NOT COMPLETED|Overall Study||2
5272961|NCT00687193|12961275|P2|NOT COMPLETED|Overall Study||4
5272962|NCT00687193|12961276|P1|NOT COMPLETED|Overall Study||2
5272963|NCT00687193|12961271|P6|COMPLETED|Overall Study||48
5272964|NCT00687193|12961272|P5|COMPLETED|Overall Study||52
5272965|NCT00687193|12961273|P4|COMPLETED|Overall Study||49
5272966|NCT00687193|12961274|P3|COMPLETED|Overall Study||50
5272967|NCT00687193|12961275|P2|COMPLETED|Overall Study||49
5272968|NCT00687193|12961276|P1|COMPLETED|Overall Study||51
5272969|NCT00687193|12961271|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
5272970|NCT00687193|12961272|P5|STARTED|Overall Study||54
5272971|NCT00687193|12961273|P4|STARTED|Overall Study||53
5272972|NCT00687193|12961274|P3|STARTED|Overall Study||52
5272973|NCT00687193|12961275|P2|STARTED|Overall Study||53
5272974|NCT00687193|12961276|P1|STARTED|Overall Study||53
5272975|NCT00687167|12961440|P2|NOT COMPLETED|Second Intervention||0
5272976|NCT00687167|12961441|P1|NOT COMPLETED|Second Intervention||0
5272977|NCT00687167|12961440|P2|COMPLETED|Second Intervention||17
5272978|NCT00687167|12961441|P1|COMPLETED|Second Intervention||17
5272979|NCT00687167|12961440|P2|STARTED|Second Intervention||17
5272980|NCT00687167|12961441|P1|STARTED|Second Intervention||17
5272981|NCT00687167|12961440|P2|NOT COMPLETED|Washout Period of 28 Days||0
5272982|NCT00687167|12961441|P1|NOT COMPLETED|Washout Period of 28 Days||0
5272983|NCT00687167|12961440|P2|COMPLETED|Washout Period of 28 Days||17
5272984|NCT00687167|12961441|P1|COMPLETED|Washout Period of 28 Days||17
5272985|NCT00687167|12961440|P2|STARTED|Washout Period of 28 Days||17
5272986|NCT00687167|12961441|P1|STARTED|Washout Period of 28 Days||17
5272987|NCT00687167|12961440|P2|NOT COMPLETED|First Intervention||0
5272988|NCT00687167|12961441|P1|NOT COMPLETED|First Intervention||0
5272989|NCT00687167|12961440|P2|COMPLETED|First Intervention||17
5272990|NCT00687167|12961441|P1|COMPLETED|First Intervention||17
5272991|NCT00687167|12961440|P2|STARTED|First Intervention||17
5272992|NCT00687167|12961441|P1|STARTED|First Intervention||17
5272993|NCT00687102|12961451|P2|NOT COMPLETED|Overall Study||0
5272994|NCT00687102|12961452|P1|NOT COMPLETED|Overall Study||0
5272995|NCT00687102|12961451|P2|COMPLETED|Overall Study||765
5272996|NCT00687102|12961452|P1|COMPLETED|Overall Study||733
5272997|NCT00687102|12961451|P2|STARTED|Overall Study||765
5272998|NCT00687102|12961452|P1|STARTED|Overall Study||733
5272999|NCT00687076|12961474|P2|NOT COMPLETED|Overall Study||30
5273000|NCT00687076|12961475|P1|NOT COMPLETED|Overall Study||32
5273001|NCT00687076|12961474|P2|COMPLETED|Overall Study||21
5273002|NCT00687076|12961475|P1|COMPLETED|Overall Study||19
5273003|NCT00687076|12961474|P2|STARTED|Overall Study||51
5273004|NCT00687076|12961475|P1|STARTED|Overall Study||51
5273005|NCT00686998|12961486|P3|NOT COMPLETED|Overall Study||4
5273006|NCT00686998|12961487|P2|NOT COMPLETED|Overall Study||8
5273007|NCT00686998|12961488|P1|NOT COMPLETED|Overall Study||13
5273008|NCT00686998|12961486|P3|COMPLETED|Overall Study||18
5273009|NCT00686998|12961487|P2|COMPLETED|Overall Study||33
5273010|NCT00686998|12961488|P1|COMPLETED|Overall Study||30
5273011|NCT00686998|12961486|P3|Completed Scheduled Treatment|Overall Study||18
5273012|NCT00686998|12961487|P2|Completed Scheduled Treatment|Overall Study||33
5273013|NCT00686998|12961488|P1|Completed Scheduled Treatment|Overall Study||30
5273014|NCT00686998|12961486|P3|Eligible for Efficacy Analysis|Overall Study||21
5273015|NCT00686998|12961487|P2|Eligible for Efficacy Analysis|Overall Study||39
5273016|NCT00686998|12961488|P1|Eligible for Efficacy Analysis|Overall Study||42
5273017|NCT00686998|12961486|P3|Received Treatment|Overall Study||22
5273018|NCT00686998|12961487|P2|Received Treatment|Overall Study||41
5273019|NCT00686998|12961488|P1|Received Treatment|Overall Study||43
5273020|NCT00686998|12961486|P3|Randomized|Overall Study||22
5273021|NCT00686998|12961487|P2|Randomized|Overall Study||41
5273022|NCT00686998|12961488|P1|Randomized|Overall Study||43
5273023|NCT00686998|12961486|P3|STARTED|Overall Study|Randomized & received study medication|22
5273024|NCT00686998|12961487|P2|STARTED|Overall Study|Randomized & received study medication|41
5273025|NCT00686998|12961488|P1|STARTED|Overall Study|Randomized & received study medication|43
5273026|NCT00686972|12961496|P1|NOT COMPLETED|Overall Study||51
5273027|NCT00686972|12961496|P1|COMPLETED|Overall Study||0
5273028|NCT00686972|12961496|P1|STARTED|Overall Study||51
5273029|NCT00686959|12961502|P2|NOT COMPLETED|Overall Study||117
5273030|NCT00686959|12961503|P1|NOT COMPLETED|Overall Study||124
5273031|NCT00686959|12961502|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
5273032|NCT00686959|12961503|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
5273033|NCT00686959|12961502|P2|Entered Consolidation Phase|Overall Study||202
5273034|NCT00686959|12961503|P1|Entered Consolidation Phase|Overall Study||229
5273035|NCT00686959|12961502|P2|Received at Least One Dose of Study Drug|Overall Study||272
5273036|NCT00686959|12961503|P1|Received at Least One Dose of Study Drug|Overall Study||283
5273037|NCT00686959|12961502|P2|STARTED|Overall Study||297
5273038|NCT00686959|12961503|P1|STARTED|Overall Study||301
5273039|NCT00686920|12961523|P2|NOT COMPLETED|Overall Study||36
5273040|NCT00686920|12961524|P1|NOT COMPLETED|Overall Study||132
5273041|NCT00686920|12961523|P2|COMPLETED|Overall Study||34
5273042|NCT00686920|12961524|P1|COMPLETED|Overall Study||120
5273043|NCT00686920|12961523|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
5273044|NCT00686920|12961524|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
5273045|NCT00686920|12961523|P2|STARTED|Overall Study||70
5273046|NCT00686920|12961524|P1|STARTED|Overall Study||252
5273047|NCT00686894|12961536|P1|NOT COMPLETED|Overall Study||6
5273048|NCT00686894|12961536|P1|COMPLETED|Overall Study||1
5273049|NCT00686894|12961536|P1|STARTED|Overall Study||7
5273050|NCT00686881|12961542|P2|NOT COMPLETED|Overall Study||81
5273051|NCT00686881|12961543|P1|NOT COMPLETED|Overall Study||82
5273052|NCT00686881|12961542|P2|COMPLETED|Overall Study||53
5273053|NCT00686881|12961543|P1|COMPLETED|Overall Study||45
5273054|NCT00686881|12961542|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
5273055|NCT00686881|12961543|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
5273056|NCT00686855|12961555|P2|NOT COMPLETED|Overall Study||1
5273057|NCT00686855|12961556|P1|NOT COMPLETED|Overall Study||1
5273058|NCT00686855|12961555|P2|COMPLETED|Overall Study||17
5273059|NCT00686855|12961556|P1|COMPLETED|Overall Study||27
5273060|NCT00686855|12961555|P2|STARTED|Overall Study||18
5273061|NCT00686855|12961556|P1|STARTED|Overall Study||28
5273062|NCT00686842|12961562|P1|NOT COMPLETED|Overall Study||0
5273063|NCT00686842|12961562|P1|COMPLETED|Overall Study||17
5273064|NCT00686842|12961562|P1|STARTED|Overall Study||17
5273065|NCT00686803|12961569|P3|NOT COMPLETED|Overall Study||0
5273066|NCT00686803|12961570|P2|NOT COMPLETED|Overall Study||0
5273067|NCT00686803|12961571|P1|NOT COMPLETED|Overall Study||0
5273068|NCT00686803|12961569|P3|COMPLETED|Overall Study||3
5273069|NCT00686803|12961570|P2|COMPLETED|Overall Study||12
5273070|NCT00686803|12961571|P1|COMPLETED|Overall Study||6
5273071|NCT00686803|12961569|P3|STARTED|Overall Study||3
5273072|NCT00686803|12961570|P2|STARTED|Overall Study||12
5273073|NCT00686803|12961571|P1|STARTED|Overall Study||6
5273074|NCT00686790|12961582|P1|NOT COMPLETED|Overall Study||16
5273075|NCT00686790|12961582|P1|COMPLETED|Overall Study||32
5273076|NCT00686790|12961582|P1|STARTED|Overall Study||48
5273077|NCT00686777|12961590|P1|NOT COMPLETED|Overall Study||10
5273078|NCT00686777|12961590|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
5273079|NCT00686777|12961590|P1|Completed 24 Weeks of Follow-up|Overall Study||70
5273080|NCT00686777|12961590|P1|Included in Follow-up (All Treated)|Overall Study||75
5273081|NCT00686777|12961590|P1|Completed 48 Weeks of Treatment|Overall Study||65
5273082|NCT00686777|12961590|P1|Completed 24 Weeks of Treatment|Overall Study||69
5273083|NCT00686777|12961590|P1|STARTED|Overall Study||75
5273084|NCT00686725|12961598|P2|NOT COMPLETED|Overall Study||42
5273085|NCT00686725|12961599|P1|NOT COMPLETED|Overall Study||46
5273086|NCT00686725|12961598|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
5273087|NCT00686725|12961599|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
5273088|NCT00686725|12961598|P2|STARTED|Overall Study||52
5273089|NCT00686725|12961599|P1|STARTED|Overall Study||47
5273090|NCT00686712|12961624|P3|NOT COMPLETED|Overall Study||13
5273091|NCT00686712|12961625|P2|NOT COMPLETED|Overall Study||11
5273092|NCT00686712|12961626|P1|NOT COMPLETED|Overall Study||10
5273093|NCT00686712|12961624|P3|COMPLETED|Overall Study||17
5273094|NCT00686712|12961625|P2|COMPLETED|Overall Study||14
5273095|NCT00686712|12961626|P1|COMPLETED|Overall Study||20
5273096|NCT00686712|12961624|P3|STARTED|Overall Study||30
5273097|NCT00686712|12961625|P2|STARTED|Overall Study||25
5273098|NCT00686712|12961626|P1|STARTED|Overall Study||30
5273099|NCT00686699|12961654|P2|NOT COMPLETED|Treatment Period 2||0
5273100|NCT00686699|12961655|P1|NOT COMPLETED|Treatment Period 2||0
5273101|NCT00686699|12961654|P2|COMPLETED|Treatment Period 2||5
5273102|NCT00686699|12961655|P1|COMPLETED|Treatment Period 2||4
5273103|NCT00686699|12961654|P2|STARTED|Treatment Period 2||5
5273104|NCT00686699|12961655|P1|STARTED|Treatment Period 2||4
5273105|NCT00686699|12961654|P2|NOT COMPLETED|Treatment Period 1||2
5273106|NCT00686699|12961655|P1|NOT COMPLETED|Treatment Period 1||0
5273107|NCT00686699|12961654|P2|COMPLETED|Treatment Period 1||5
5273108|NCT00686699|12961655|P1|COMPLETED|Treatment Period 1||4
5273109|NCT00686699|12961654|P2|STARTED|Treatment Period 1||7
5273110|NCT00686699|12961655|P1|STARTED|Treatment Period 1||4
5273111|NCT00686686|12961679|P1|NOT COMPLETED|Overall Study||6
5273112|NCT00686686|12961679|P1|COMPLETED|Overall Study||17
5273113|NCT00686686|12961679|P1|STARTED|Overall Study||23
5273114|NCT00686647|12961687|P1|NOT COMPLETED|Overall Study||2
5273115|NCT00686647|12961687|P1|COMPLETED|Overall Study||91
5273116|NCT00686647|12961687|P1|STARTED|Overall Study||93
5273117|NCT00686634|12961693|P1|NOT COMPLETED|Overall Study||6
5273118|NCT00686634|12961693|P1|COMPLETED|Overall Study||102
5273119|NCT00686634|12961693|P1|STARTED|Overall Study||108
5273120|NCT00686595|12961700|P1|NOT COMPLETED|Overall Study||7
5273121|NCT00686595|12961700|P1|COMPLETED|Overall Study||31
5273122|NCT00686595|12961700|P1|STARTED|Overall Study||38
5273123|NCT00686582|12961728|P3|NOT COMPLETED|Overall Study||0
5273124|NCT00686582|12961729|P2|NOT COMPLETED|Overall Study||14
5273125|NCT00686582|12961730|P1|NOT COMPLETED|Overall Study||18
5273126|NCT00686582|12961728|P3|COMPLETED|Overall Study||121
5273127|NCT00686582|12961729|P2|COMPLETED|Overall Study||77
5273128|NCT00686582|12961730|P1|COMPLETED|Overall Study||74
5273129|NCT00686582|12961728|P3|Booster Vaccination|Overall Study||0
5273130|NCT00686582|12961729|P2|Booster Vaccination|Overall Study||77
5273131|NCT00686582|12961730|P1|Booster Vaccination|Overall Study||75
5273132|NCT00686582|12961728|P3|STARTED|Overall Study||121
5273133|NCT00686582|12961729|P2|STARTED|Overall Study||91
5273134|NCT00686582|12961730|P1|STARTED|Overall Study||92
5273135|NCT00686543|12961760|P4|NOT COMPLETED|Overall Study||3
5273136|NCT00686543|12961761|P3|NOT COMPLETED|Overall Study||5
5273137|NCT00686543|12961762|P2|NOT COMPLETED|Overall Study||1
5273138|NCT00686543|12961763|P1|NOT COMPLETED|Overall Study||14
5273139|NCT00686543|12961760|P4|COMPLETED|Overall Study||17
5273140|NCT00686543|12961761|P3|COMPLETED|Overall Study||15
5273141|NCT00686543|12961762|P2|COMPLETED|Overall Study||20
5273142|NCT00686543|12961763|P1|COMPLETED|Overall Study||0
5273143|NCT00686543|12961760|P4|STARTED|Overall Study||20
5273144|NCT00686543|12961761|P3|STARTED|Overall Study||20
5273145|NCT00686543|12961762|P2|STARTED|Overall Study||21
5273146|NCT00686543|12961763|P1|STARTED|Overall Study||14
5273147|NCT00686517|12961784|P3|NOT COMPLETED|Follow-up||10
5273148|NCT00686517|12961785|P2|NOT COMPLETED|Follow-up||10
5273149|NCT00686517|12961786|P1|NOT COMPLETED|Follow-up||8
5273150|NCT00686517|12961784|P3|COMPLETED|Follow-up||29
5273151|NCT00686517|12961785|P2|COMPLETED|Follow-up||28
5273152|NCT00686517|12961786|P1|COMPLETED|Follow-up||29
5273153|NCT00686517|12961784|P3|STARTED|Follow-up||39
5273154|NCT00686517|12961785|P2|STARTED|Follow-up||38
5273155|NCT00686517|12961786|P1|STARTED|Follow-up||37
5273156|NCT00686517|12961784|P3|NOT COMPLETED|Treatment||1
5273157|NCT00686517|12961785|P2|NOT COMPLETED|Treatment||3
5273158|NCT00686517|12961786|P1|NOT COMPLETED|Treatment||6
5273159|NCT00686517|12961784|P3|COMPLETED|Treatment||42
5273160|NCT00686517|12961785|P2|COMPLETED|Treatment||40
5273161|NCT00686517|12961786|P1|COMPLETED|Treatment||38
5273162|NCT00686517|12961784|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
5273163|NCT00686517|12961785|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
5273164|NCT00686517|12961786|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
5273165|NCT00686517|12961784|P3|STARTED|Treatment||43
5273166|NCT00686517|12961785|P2|STARTED|Treatment||43
5273167|NCT00686517|12961786|P1|STARTED|Treatment||44
5273168|NCT00686374|12961809|P1|NOT COMPLETED|Overall Study||61
5273169|NCT00686374|12961809|P1|COMPLETED|Overall Study||39
5273170|NCT00686374|12961809|P1|STARTED|Overall Study||100
5273171|NCT00686335|12961820|P1|NOT COMPLETED|Treatment Period||0
5273172|NCT00686335|12961820|P1|COMPLETED|Treatment Period||7
5273173|NCT00686335|12961820|P1|STARTED|Treatment Period||7
5273174|NCT00686335|12961820|P1|NOT COMPLETED|Run-in Period||5
5273175|NCT00686335|12961820|P1|COMPLETED|Run-in Period||7
5273176|NCT00686335|12961820|P1|STARTED|Run-in Period||12
5273177|NCT00686257|12961828|P2|NOT COMPLETED|Overall Study||0
5273178|NCT00686257|12961829|P1|NOT COMPLETED|Overall Study||0
5273179|NCT00686257|12961828|P2|COMPLETED|Overall Study||31
5273180|NCT00686257|12961829|P1|COMPLETED|Overall Study||29
5273181|NCT00686257|12961828|P2|STARTED|Overall Study||31
5273182|NCT00686257|12961829|P1|STARTED|Overall Study||29
5273183|NCT00686231|12961849|P4|NOT COMPLETED|Combination Test - Visit 2||0
5273184|NCT00686231|12961850|P3|NOT COMPLETED|Combination Test - Visit 2||0
5273185|NCT00686231|12961851|P2|NOT COMPLETED|Combination Test - Visit 2||0
5273186|NCT00686231|12961852|P1|NOT COMPLETED|Combination Test - Visit 2||0
5273187|NCT00686231|12961849|P4|COMPLETED|Combination Test - Visit 2||9
5273188|NCT00686231|12961850|P3|COMPLETED|Combination Test - Visit 2||10
5273189|NCT00686231|12961851|P2|COMPLETED|Combination Test - Visit 2||0
5273190|NCT00686231|12961852|P1|COMPLETED|Combination Test - Visit 2||0
5273191|NCT00686231|12961849|P4|STARTED|Combination Test - Visit 2||9
5273192|NCT00686231|12961850|P3|STARTED|Combination Test - Visit 2||10
5273193|NCT00686231|12961851|P2|STARTED|Combination Test - Visit 2||0
5273194|NCT00686231|12961852|P1|STARTED|Combination Test - Visit 2||0
5273195|NCT00686231|12961849|P4|NOT COMPLETED|Dose Test - Visit 1||0
5273196|NCT00686231|12961850|P3|NOT COMPLETED|Dose Test - Visit 1||0
5273197|NCT00686231|12961851|P2|NOT COMPLETED|Dose Test - Visit 1||0
5273198|NCT00686231|12961852|P1|NOT COMPLETED|Dose Test - Visit 1||0
5273199|NCT00686231|12961849|P4|COMPLETED|Dose Test - Visit 1||0
5273200|NCT00686231|12961850|P3|COMPLETED|Dose Test - Visit 1||0
5273201|NCT00686231|12961851|P2|COMPLETED|Dose Test - Visit 1||7
5273202|NCT00686231|12961852|P1|COMPLETED|Dose Test - Visit 1||12
5273203|NCT00686231|12961849|P4|STARTED|Dose Test - Visit 1||0
5273204|NCT00686231|12961850|P3|STARTED|Dose Test - Visit 1||0
5273205|NCT00686231|12961851|P2|STARTED|Dose Test - Visit 1||7
5273206|NCT00686231|12961852|P1|STARTED|Dose Test - Visit 1||12
5273207|NCT00686205|12961864|P2|NOT COMPLETED|Overall Study||981
5273208|NCT00686205|12961865|P1|NOT COMPLETED|Overall Study||6007
5273209|NCT00686205|12961864|P2|COMPLETED|Overall Study||1524
5273210|NCT00686205|12961865|P1|COMPLETED|Overall Study||15599
5273211|NCT00686205|12961864|P2|STARTED|Overall Study||2505
5273212|NCT00686205|12961865|P1|STARTED|Overall Study||21606
5273213|NCT00686166|12961871|P1|NOT COMPLETED|Overall Study||20
5273214|NCT00686166|12961871|P1|COMPLETED|Overall Study||63
5273215|NCT00686166|12961871|P1|Eligible and Began Protocol Therapy|Overall Study||74
5273216|NCT00686166|12961871|P1|Eligible|Overall Study||78
5273217|NCT00686166|12961871|P1|STARTED|Overall Study||83
5273218|NCT00686127|12961883|P2|NOT COMPLETED|Overall Study||6
5273219|NCT00686127|12961884|P1|NOT COMPLETED|Overall Study||14
5273220|NCT00686127|12961883|P2|COMPLETED|Overall Study||1
5273221|NCT00686127|12961884|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
5273222|NCT00686127|12961883|P2|STARTED|Overall Study||7
5273223|NCT00686127|12961884|P1|STARTED|Overall Study||14
5273224|NCT00686075|12961900|P10|NOT COMPLETED|Overall Study||10
5273225|NCT00686075|12961901|P9|NOT COMPLETED|Overall Study||6
5273226|NCT00686075|12961902|P8|NOT COMPLETED|Overall Study||2
5273227|NCT00686075|12961903|P7|NOT COMPLETED|Overall Study||0
5273228|NCT00686075|12961904|P6|NOT COMPLETED|Overall Study||3
5273229|NCT00686075|12961905|P5|NOT COMPLETED|Overall Study||4
5273230|NCT00686075|12961906|P4|NOT COMPLETED|Overall Study||9
5273231|NCT00686075|12961907|P3|NOT COMPLETED|Overall Study||6
5273232|NCT00686075|12961908|P2|NOT COMPLETED|Overall Study||10
5273233|NCT00686075|12961909|P1|NOT COMPLETED|Overall Study||8
5273234|NCT00686075|12961900|P10|COMPLETED|Overall Study||69
5273235|NCT00686075|12961901|P9|COMPLETED|Overall Study||75
5273236|NCT00686075|12961902|P8|COMPLETED|Overall Study||76
5273237|NCT00686075|12961903|P7|COMPLETED|Overall Study||82
5273238|NCT00686075|12961904|P6|COMPLETED|Overall Study||37
5273239|NCT00686075|12961905|P5|COMPLETED|Overall Study||36
5273240|NCT00686075|12961906|P4|COMPLETED|Overall Study||71
5273241|NCT00686075|12961907|P3|COMPLETED|Overall Study||74
5273242|NCT00686075|12961908|P2|COMPLETED|Overall Study||71
5273243|NCT00686075|12961909|P1|COMPLETED|Overall Study||71
5273244|NCT00686075|12961900|P10|Treated|Overall Study||78
5273245|NCT00686075|12961901|P9|Treated|Overall Study||80
5273246|NCT00686075|12961902|P8|Treated|Overall Study||77
5273247|NCT00686075|12961903|P7|Treated|Overall Study||82
5273248|NCT00686075|12961904|P6|Treated|Overall Study||40
5273249|NCT00686075|12961905|P5|Treated|Overall Study||40
5273250|NCT00686075|12961906|P4|Treated|Overall Study||80
5273251|NCT00686075|12961907|P3|Treated|Overall Study||80
5273252|NCT00686075|12961908|P2|Treated|Overall Study||79
5273253|NCT00686075|12961909|P1|Treated|Overall Study||78
5273254|NCT00686075|12961900|P10|STARTED|Overall Study||79
5273255|NCT00686075|12961901|P9|STARTED|Overall Study||81
5273256|NCT00686075|12961902|P8|STARTED|Overall Study||78
5273257|NCT00686075|12961903|P7|STARTED|Overall Study||82
5273258|NCT00686075|12961904|P6|STARTED|Overall Study||40
5273259|NCT00686075|12961905|P5|STARTED|Overall Study||40
5273260|NCT00686075|12961906|P4|STARTED|Overall Study||80
5273261|NCT00686075|12961907|P3|STARTED|Overall Study||80
5273262|NCT00686075|12961908|P2|STARTED|Overall Study||81
5273263|NCT00686075|12961909|P1|STARTED|Overall Study||79
5273264|NCT00686036|12962103|P2|NOT COMPLETED|Overall Study||6
5273265|NCT00686036|12962104|P1|NOT COMPLETED|Overall Study||9
5273266|NCT00686036|12962103|P2|COMPLETED|Overall Study||2
5273267|NCT00686036|12962104|P1|COMPLETED|Overall Study||0
5273268|NCT00686036|12962103|P2|STARTED|Overall Study||8
5273269|NCT00686036|12962104|P1|STARTED|Overall Study||9
5273270|NCT00685945|12962116|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
5273271|NCT00685945|12962116|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
5273272|NCT00685945|12962116|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
5273273|NCT00685945|12962116|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
5273274|NCT00685945|12962116|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
5273275|NCT00685945|12962116|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
5273276|NCT00685945|12962116|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
5273277|NCT00685945|12962116|P1|COMPLETED|L-NMMA + Bradykinin||23
5273278|NCT00685945|12962116|P1|STARTED|L-NMMA + Bradykinin||24
5273279|NCT00685945|12962116|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
5273280|NCT00685945|12962116|P1|COMPLETED|Control (Bradykinin Infusion)||24
5273281|NCT00685945|12962116|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
5273282|NCT00685932|12962133|P2|NOT COMPLETED|Overall Study||20
5273283|NCT00685932|12962134|P1|NOT COMPLETED|Overall Study||21
5273284|NCT00685932|12962133|P2|COMPLETED|Overall Study||58
5273285|NCT00685932|12962134|P1|COMPLETED|Overall Study||55
5273286|NCT00685932|12962133|P2|STARTED|Overall Study||78
5273287|NCT00685932|12962134|P1|STARTED|Overall Study||76
5273288|NCT00685880|12962144|P2|NOT COMPLETED|Overall Study||0
5273289|NCT00685880|12962145|P1|NOT COMPLETED|Overall Study||0
5273290|NCT00685880|12962144|P2|COMPLETED|Overall Study||2
5273291|NCT00685880|12962145|P1|COMPLETED|Overall Study||0
5273292|NCT00685880|12962144|P2|STARTED|Overall Study||2
5273293|NCT00685880|12962145|P1|STARTED|Overall Study||0
5273294|NCT00685802|12962151|P2|NOT COMPLETED|Second Intervention||0
5273295|NCT00685802|12962152|P1|NOT COMPLETED|Second Intervention||0
5273296|NCT00685802|12962151|P2|COMPLETED|Second Intervention||15
5273297|NCT00685802|12962152|P1|COMPLETED|Second Intervention||14
5273298|NCT00685802|12962151|P2|STARTED|Second Intervention||15
5273299|NCT00685802|12962152|P1|STARTED|Second Intervention||14
5273300|NCT00685802|12962151|P2|NOT COMPLETED|Washout Period of 7 Days||1
5273301|NCT00685802|12962152|P1|NOT COMPLETED|Washout Period of 7 Days||2
5273302|NCT00685802|12962151|P2|COMPLETED|Washout Period of 7 Days||15
5273303|NCT00685802|12962152|P1|COMPLETED|Washout Period of 7 Days||14
5273304|NCT00685802|12962151|P2|STARTED|Washout Period of 7 Days||16
5273305|NCT00685802|12962152|P1|STARTED|Washout Period of 7 Days||16
5273306|NCT00685802|12962151|P2|NOT COMPLETED|First Intervention||0
5273307|NCT00685802|12962152|P1|NOT COMPLETED|First Intervention||0
5273308|NCT00685802|12962151|P2|COMPLETED|First Intervention||16
5273309|NCT00685802|12962152|P1|COMPLETED|First Intervention||16
5273310|NCT00685802|12962151|P2|STARTED|First Intervention||16
5273311|NCT00685802|12962152|P1|STARTED|First Intervention||16
5273312|NCT00685763|12962162|P1|NOT COMPLETED|Overall Study||2
5273313|NCT00685763|12962162|P1|COMPLETED|Overall Study||11
5273314|NCT00685763|12962162|P1|STARTED|Overall Study||13
5273315|NCT00685750|12962173|P7|NOT COMPLETED|Overall Study||1
5273316|NCT00685750|12962174|P6|NOT COMPLETED|Overall Study||0
5273317|NCT00685750|12962175|P5|NOT COMPLETED|Overall Study||0
5273318|NCT00685750|12962176|P4|NOT COMPLETED|Overall Study||0
5273319|NCT00685750|12962177|P3|NOT COMPLETED|Overall Study||2
5273320|NCT00685750|12962178|P2|NOT COMPLETED|Overall Study||0
5273321|NCT00685750|12962179|P1|NOT COMPLETED|Overall Study||0
5273322|NCT00685750|12962173|P7|COMPLETED|Overall Study||9
5273323|NCT00685750|12962174|P6|COMPLETED|Overall Study||20
5273324|NCT00685750|12962175|P5|COMPLETED|Overall Study||15
5273325|NCT00685750|12962176|P4|COMPLETED|Overall Study||2
5273326|NCT00685750|12962177|P3|COMPLETED|Overall Study||19
5273327|NCT00685750|12962178|P2|COMPLETED|Overall Study||3
5273328|NCT00685750|12962179|P1|COMPLETED|Overall Study||17
5273329|NCT00685750|12962173|P7|STARTED|Overall Study||10
5273330|NCT00685750|12962174|P6|STARTED|Overall Study||20
5273331|NCT00685750|12962175|P5|STARTED|Overall Study||15
5273332|NCT00685750|12962176|P4|STARTED|Overall Study||2
5273333|NCT00685750|12962177|P3|STARTED|Overall Study||21
5273334|NCT00685750|12962178|P2|STARTED|Overall Study||3
5273335|NCT00685750|12962179|P1|STARTED|Overall Study||17
5273336|NCT00685698|12962207|P1|NOT COMPLETED|Overall Study||13
5273337|NCT00685698|12962207|P1|COMPLETED|Overall Study||25
5273338|NCT00685698|12962207|P1|STARTED|Overall Study||38
5273339|NCT00685685|12962242|P2|NOT COMPLETED|Second Intervention||0
5273340|NCT00685685|12962243|P1|NOT COMPLETED|Second Intervention||0
5273341|NCT00685685|12962242|P2|COMPLETED|Second Intervention||26
5273342|NCT00685685|12962243|P1|COMPLETED|Second Intervention||25
5273343|NCT00685685|12962242|P2|STARTED|Second Intervention||26
5273344|NCT00685685|12962243|P1|STARTED|Second Intervention||25
5273345|NCT00685685|12962242|P2|NOT COMPLETED|Washout Period of 7 Days||1
5273346|NCT00685685|12962243|P1|NOT COMPLETED|Washout Period of 7 Days||2
5273347|NCT00685685|12962242|P2|COMPLETED|Washout Period of 7 Days||26
5273348|NCT00685685|12962243|P1|COMPLETED|Washout Period of 7 Days||25
5273349|NCT00685685|12962242|P2|STARTED|Washout Period of 7 Days||27
5273350|NCT00685685|12962243|P1|STARTED|Washout Period of 7 Days||27
5273351|NCT00685685|12962242|P2|NOT COMPLETED|First Intervention||0
5273352|NCT00685685|12962243|P1|NOT COMPLETED|First Intervention||0
5273353|NCT00685685|12962242|P2|COMPLETED|First Intervention||27
5273354|NCT00685685|12962243|P1|COMPLETED|First Intervention||27
5273355|NCT00685685|12962242|P2|STARTED|First Intervention||27
5273356|NCT00685685|12962243|P1|STARTED|First Intervention||27
5273357|NCT00685659|12962256|P3|NOT COMPLETED|Overall Study||15
5273358|NCT00685659|12962257|P2|NOT COMPLETED|Overall Study||25
5273359|NCT00685659|12962258|P1|NOT COMPLETED|Overall Study||31
5273360|NCT00685659|12962256|P3|COMPLETED|Overall Study||92
5273361|NCT00685659|12962257|P2|COMPLETED|Overall Study||81
5273362|NCT00685659|12962258|P1|COMPLETED|Overall Study||77
5273363|NCT00685659|12962256|P3|STARTED|Overall Study||107
5273364|NCT00685659|12962257|P2|STARTED|Overall Study||106
5273365|NCT00685659|12962258|P1|STARTED|Overall Study||108
5273366|NCT00685516|12962356|P3|NOT COMPLETED|Overall Study||7
5273367|NCT00685516|12962357|P2|NOT COMPLETED|Overall Study||5
5273368|NCT00685516|12962358|P1|NOT COMPLETED|Overall Study||8
5273369|NCT00685516|12962356|P3|COMPLETED|Overall Study||26
5273370|NCT00685516|12962357|P2|COMPLETED|Overall Study||33
5273371|NCT00685516|12962358|P1|COMPLETED|Overall Study||34
5273372|NCT00685516|12962356|P3|STARTED|Overall Study||33
5273373|NCT00685516|12962357|P2|STARTED|Overall Study||38
5273374|NCT00685516|12962358|P1|STARTED|Overall Study||42
5273375|NCT00685477|12962375|P6|NOT COMPLETED|Overall Study||0
5273376|NCT00685477|12962376|P5|NOT COMPLETED|Overall Study||0
5273377|NCT00685477|12962377|P4|NOT COMPLETED|Overall Study||0
5273378|NCT00685477|12962378|P3|NOT COMPLETED|Overall Study||0
5273379|NCT00685477|12962379|P2|NOT COMPLETED|Overall Study||0
5273380|NCT00685477|12962380|P1|NOT COMPLETED|Overall Study||0
5273381|NCT00685477|12962375|P6|COMPLETED|Overall Study||10
5273382|NCT00685477|12962376|P5|COMPLETED|Overall Study||10
5273383|NCT00685477|12962377|P4|COMPLETED|Overall Study||10
5273384|NCT00685477|12962378|P3|COMPLETED|Overall Study||10
5273385|NCT00685477|12962379|P2|COMPLETED|Overall Study||10
5273386|NCT00685477|12962380|P1|COMPLETED|Overall Study||10
5273387|NCT00685477|12962375|P6|STARTED|Overall Study||10
5273388|NCT00685477|12962376|P5|STARTED|Overall Study||10
5273389|NCT00685477|12962377|P4|STARTED|Overall Study||10
5273390|NCT00685477|12962378|P3|STARTED|Overall Study||10
5273391|NCT00685477|12962379|P2|STARTED|Overall Study||10
5273392|NCT00685477|12962380|P1|STARTED|Overall Study||10
5273393|NCT00685399|12962396|P8|NOT COMPLETED|Extension||0
5273394|NCT00685399|12962397|P7|NOT COMPLETED|Extension||0
5273395|NCT00685399|12962398|P6|NOT COMPLETED|Extension||0
5273396|NCT00685399|12962399|P5|NOT COMPLETED|Extension||0
5273397|NCT00685399|12962400|P4|NOT COMPLETED|Extension||7
5273398|NCT00685399|12962401|P3|NOT COMPLETED|Extension||0
5273399|NCT00685399|12962402|P2|NOT COMPLETED|Extension||0
5273400|NCT00685399|12962403|P1|NOT COMPLETED|Extension||0
5273401|NCT00685399|12962396|P8|COMPLETED|Extension||0
5273402|NCT00685399|12962397|P7|COMPLETED|Extension||0
5273403|NCT00685399|12962398|P6|COMPLETED|Extension||0
5273404|NCT00685399|12962399|P5|COMPLETED|Extension||0
5273405|NCT00685399|12962400|P4|COMPLETED|Extension||21
5273406|NCT00685399|12962401|P3|COMPLETED|Extension||0
5273407|NCT00685399|12962402|P2|COMPLETED|Extension||0
5273408|NCT00685399|12962403|P1|COMPLETED|Extension||0
5273409|NCT00685399|12962396|P8|STARTED|Extension||0
5273410|NCT00685399|12962397|P7|STARTED|Extension||0
5273411|NCT00685399|12962398|P6|STARTED|Extension||0
5273412|NCT00685399|12962399|P5|STARTED|Extension||0
5273413|NCT00685399|12962400|P4|STARTED|Extension||28
5273414|NCT00685399|12962401|P3|STARTED|Extension||0
5273415|NCT00685399|12962402|P2|STARTED|Extension||0
5273416|NCT00685399|12962403|P1|STARTED|Extension||0
5273417|NCT00685399|12962396|P8|NOT COMPLETED|Treatment Period 2||2
5273418|NCT00685399|12962397|P7|NOT COMPLETED|Treatment Period 2||0
5273419|NCT00685399|12962398|P6|NOT COMPLETED|Treatment Period 2||2
5273420|NCT00685399|12962399|P5|NOT COMPLETED|Treatment Period 2||0
5273421|NCT00685399|12962400|P4|NOT COMPLETED|Treatment Period 2||0
5273422|NCT00685399|12962401|P3|NOT COMPLETED|Treatment Period 2||3
5273423|NCT00685399|12962402|P2|NOT COMPLETED|Treatment Period 2||12
5273424|NCT00685399|12962403|P1|NOT COMPLETED|Treatment Period 2||0
5273425|NCT00685399|12962396|P8|COMPLETED|Treatment Period 2||10
5273426|NCT00685399|12962397|P7|COMPLETED|Treatment Period 2||13
5273427|NCT00685399|12962398|P6|COMPLETED|Treatment Period 2||10
5273428|NCT00685399|12962399|P5|COMPLETED|Treatment Period 2||4
5273429|NCT00685399|12962400|P4|COMPLETED|Treatment Period 2|in extension period only|0
5273430|NCT00685399|12962401|P3|COMPLETED|Treatment Period 2||2
5273431|NCT00685399|12962402|P2|COMPLETED|Treatment Period 2||2
5273432|NCT00685399|12962403|P1|COMPLETED|Treatment Period 2||0
5273433|NCT00685399|12962396|P8|STARTED|Treatment Period 2||12
5273434|NCT00685399|12962397|P7|STARTED|Treatment Period 2||13
5273435|NCT00685399|12962398|P6|STARTED|Treatment Period 2||12
5273436|NCT00685399|12962399|P5|STARTED|Treatment Period 2||4
5273437|NCT00685399|12962400|P4|STARTED|Treatment Period 2|in extension period only|0
5273438|NCT00685399|12962401|P3|STARTED|Treatment Period 2||5
5273439|NCT00685399|12962402|P2|STARTED|Treatment Period 2||14
5273440|NCT00685399|12962403|P1|STARTED|Treatment Period 2||0
5273441|NCT00685399|12962396|P8|NOT COMPLETED|Treatment Period 1||0
5273442|NCT00685399|12962397|P7|NOT COMPLETED|Treatment Period 1||0
5273443|NCT00685399|12962398|P6|NOT COMPLETED|Treatment Period 1||0
5273444|NCT00685399|12962399|P5|NOT COMPLETED|Treatment Period 1||0
5273445|NCT00685399|12962400|P4|NOT COMPLETED|Treatment Period 1||0
5273446|NCT00685399|12962401|P3|NOT COMPLETED|Treatment Period 1||0
5273447|NCT00685399|12962402|P2|NOT COMPLETED|Treatment Period 1||0
5273448|NCT00685399|12962403|P1|NOT COMPLETED|Treatment Period 1||6
5273449|NCT00685399|12962396|P8|COMPLETED|Treatment Period 1||0
5273450|NCT00685399|12962397|P7|COMPLETED|Treatment Period 1||0
5273451|NCT00685399|12962398|P6|COMPLETED|Treatment Period 1||0
5273452|NCT00685399|12962399|P5|COMPLETED|Treatment Period 1||0
5273453|NCT00685399|12962400|P4|COMPLETED|Treatment Period 1||0
5273454|NCT00685399|12962401|P3|COMPLETED|Treatment Period 1||0
5273455|NCT00685399|12962402|P2|COMPLETED|Treatment Period 1||0
5273456|NCT00685399|12962403|P1|COMPLETED|Treatment Period 1||10
5273457|NCT00685399|12962396|P8|STARTED|Treatment Period 1||0
5273458|NCT00685399|12962397|P7|STARTED|Treatment Period 1||0
5273459|NCT00685399|12962398|P6|STARTED|Treatment Period 1||0
5273460|NCT00685399|12962399|P5|STARTED|Treatment Period 1||0
5273461|NCT00685399|12962400|P4|STARTED|Treatment Period 1||0
5273462|NCT00685399|12962401|P3|STARTED|Treatment Period 1||0
5273463|NCT00685399|12962402|P2|STARTED|Treatment Period 1||0
5273464|NCT00685399|12962403|P1|STARTED|Treatment Period 1||16
5273465|NCT00685373|12962436|P1|NOT COMPLETED|Overall Study||15
5273466|NCT00685373|12962436|P1|COMPLETED|Overall Study||151
5273467|NCT00685373|12962436|P1|STARTED|Overall Study||166
5273468|NCT00685334|12962445|P2|NOT COMPLETED|Overall Study||7
5273469|NCT00685334|12962446|P1|NOT COMPLETED|Overall Study||10
5273470|NCT00685334|12962445|P2|COMPLETED|Overall Study||3
5273471|NCT00685334|12962446|P1|COMPLETED|Overall Study||2
5273472|NCT00685334|12962445|P2|STARTED|Overall Study||10
5273473|NCT00685334|12962446|P1|STARTED|Overall Study||12
5273474|NCT00685295|12962456|P2|NOT COMPLETED|Overall Study||0
5273475|NCT00685295|12962457|P1|NOT COMPLETED|Overall Study||0
5273476|NCT00685295|12962456|P2|COMPLETED|Overall Study||30
5273477|NCT00685295|12962457|P1|COMPLETED|Overall Study||30
5273478|NCT00685295|12962456|P2|STARTED|Overall Study||30
5273479|NCT00685295|12962457|P1|STARTED|Overall Study||30
5273480|NCT00685178|12962471|P4|NOT COMPLETED|Overall Study||14
5273481|NCT00685178|12962472|P3|NOT COMPLETED|Overall Study||12
5273482|NCT00685178|12962473|P2|NOT COMPLETED|Overall Study||19
5273483|NCT00685178|12962474|P1|NOT COMPLETED|Overall Study||13
5273484|NCT00685178|12962471|P4|COMPLETED|Overall Study||33
5273485|NCT00685178|12962472|P3|COMPLETED|Overall Study||27
5273486|NCT00685178|12962473|P2|COMPLETED|Overall Study||26
5273487|NCT00685178|12962474|P1|COMPLETED|Overall Study||27
5273488|NCT00685178|12962471|P4|STARTED|Overall Study||47
5273489|NCT00685178|12962472|P3|STARTED|Overall Study||39
5273490|NCT00685178|12962473|P2|STARTED|Overall Study||45
5273491|NCT00685178|12962474|P1|STARTED|Overall Study||40
5273492|NCT00685165|12962488|P2|NOT COMPLETED|Second Intervention||0
5273493|NCT00685165|12962489|P1|NOT COMPLETED|Second Intervention||0
5273494|NCT00685165|12962488|P2|COMPLETED|Second Intervention||11
5273495|NCT00685165|12962489|P1|COMPLETED|Second Intervention||10
5273496|NCT00685165|12962488|P2|STARTED|Second Intervention||11
5273497|NCT00685165|12962489|P1|STARTED|Second Intervention||10
5273498|NCT00685165|12962488|P2|NOT COMPLETED|Washout Period of 14 Days||0
5273499|NCT00685165|12962489|P1|NOT COMPLETED|Washout Period of 14 Days||1
5273500|NCT00685165|12962488|P2|COMPLETED|Washout Period of 14 Days||11
5273501|NCT00685165|12962489|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
5273502|NCT00685165|12962488|P2|STARTED|Washout Period of 14 Days||11
5273503|NCT00685165|12962489|P1|STARTED|Washout Period of 14 Days||11
5273504|NCT00685165|12962488|P2|NOT COMPLETED|First Intervention||0
5273505|NCT00685165|12962489|P1|NOT COMPLETED|First Intervention||0
5273506|NCT00685165|12962488|P2|COMPLETED|First Intervention||11
5273507|NCT00685165|12962489|P1|COMPLETED|First Intervention||11
5273508|NCT00685165|12962488|P2|STARTED|First Intervention||11
5273509|NCT00685165|12962489|P1|STARTED|First Intervention||11
5273510|NCT00685139|12962499|P2|NOT COMPLETED|Second Intervention||0
5273511|NCT00685139|12962500|P1|NOT COMPLETED|Second Intervention||0
5273512|NCT00685139|12962499|P2|COMPLETED|Second Intervention||17
5273513|NCT00685139|12962500|P1|COMPLETED|Second Intervention||17
5273514|NCT00685139|12962499|P2|STARTED|Second Intervention||17
5273515|NCT00685139|12962500|P1|STARTED|Second Intervention||17
5273516|NCT00685139|12962499|P2|NOT COMPLETED|Washout Period of 28 Days||0
5273517|NCT00685139|12962500|P1|NOT COMPLETED|Washout Period of 28 Days||0
5273518|NCT00685139|12962499|P2|COMPLETED|Washout Period of 28 Days||17
5273519|NCT00685139|12962500|P1|COMPLETED|Washout Period of 28 Days||17
5273520|NCT00685139|12962499|P2|STARTED|Washout Period of 28 Days||17
5273521|NCT00685139|12962500|P1|STARTED|Washout Period of 28 Days||17
5273522|NCT00685139|12962499|P2|NOT COMPLETED|First Intervention||0
5273523|NCT00685139|12962500|P1|NOT COMPLETED|First Intervention||0
5273524|NCT00685139|12962499|P2|COMPLETED|First Intervention||17
5273525|NCT00685139|12962500|P1|COMPLETED|First Intervention||17
5273526|NCT00685139|12962499|P2|STARTED|First Intervention||17
5273527|NCT00685139|12962500|P1|STARTED|First Intervention||17
5273528|NCT00685035|12962508|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
5273529|NCT00685035|12962509|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
5273530|NCT00685035|12962508|P2|COMPLETED|Period 3: 2nd Intervention||8
5273531|NCT00685035|12962509|P1|COMPLETED|Period 3: 2nd Intervention||8
5273532|NCT00685035|12962508|P2|STARTED|Period 3: 2nd Intervention||8
5273533|NCT00685035|12962509|P1|STARTED|Period 3: 2nd Intervention||8
5273534|NCT00685035|12962508|P2|NOT COMPLETED|Period 2: 2-day Washout||0
5273535|NCT00685035|12962509|P1|NOT COMPLETED|Period 2: 2-day Washout||0
5273536|NCT00685035|12962508|P2|COMPLETED|Period 2: 2-day Washout||8
5273537|NCT00685035|12962509|P1|COMPLETED|Period 2: 2-day Washout||8
5273538|NCT00685035|12962508|P2|STARTED|Period 2: 2-day Washout||8
5273539|NCT00685035|12962509|P1|STARTED|Period 2: 2-day Washout||8
5273540|NCT00685035|12962508|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
5273541|NCT00685035|12962509|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
5273542|NCT00685035|12962508|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
5273543|NCT00685035|12962509|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
5273544|NCT00685035|12962508|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
5273545|NCT00685035|12962509|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
5273546|NCT00684996|12962533|P1|NOT COMPLETED|Overall Study||5
5273547|NCT00684996|12962533|P1|COMPLETED|Overall Study||0
5273548|NCT00684996|12962533|P1|Eligible|Overall Study||5
5273549|NCT00684996|12962533|P1|STARTED|Overall Study||5
5273550|NCT00684983|12962548|P2|NOT COMPLETED|Overall Study||0
5273551|NCT00684983|12962549|P1|NOT COMPLETED|Overall Study||0
5273552|NCT00684983|12962548|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
5273553|NCT00684983|12962549|P1|COMPLETED|Overall Study||19
5273554|NCT00684983|12962548|P2|STARTED|Overall Study||45
5273555|NCT00684983|12962549|P1|STARTED|Overall Study||19
5273556|NCT00684814|12962565|P2|NOT COMPLETED|Second Intervention||0
5273557|NCT00684814|12962566|P1|NOT COMPLETED|Second Intervention||1
5273558|NCT00684814|12962565|P2|COMPLETED|Second Intervention||15
5273559|NCT00684814|12962566|P1|COMPLETED|Second Intervention||16
5273560|NCT00684814|12962565|P2|STARTED|Second Intervention||15
5273561|NCT00684814|12962566|P1|STARTED|Second Intervention||17
5273562|NCT00684814|12962565|P2|NOT COMPLETED|Washout Period of 7 Days||4
5273563|NCT00684814|12962566|P1|NOT COMPLETED|Washout Period of 7 Days||2
5273564|NCT00684814|12962565|P2|COMPLETED|Washout Period of 7 Days||15
5273565|NCT00684814|12962566|P1|COMPLETED|Washout Period of 7 Days||17
5273566|NCT00684814|12962565|P2|STARTED|Washout Period of 7 Days||19
5273567|NCT00684814|12962566|P1|STARTED|Washout Period of 7 Days||19
5273568|NCT00684814|12962565|P2|NOT COMPLETED|First Intervention||0
5273569|NCT00684814|12962566|P1|NOT COMPLETED|First Intervention||0
5273570|NCT00684814|12962565|P2|COMPLETED|First Intervention||19
5273571|NCT00684814|12962566|P1|COMPLETED|First Intervention||19
5273572|NCT00684814|12962565|P2|STARTED|First Intervention||19
5273573|NCT00684814|12962566|P1|STARTED|First Intervention||19
5273574|NCT00684788|12962578|P2|NOT COMPLETED|Overall Study||0
5273575|NCT00684788|12962579|P1|NOT COMPLETED|Overall Study||0
5273576|NCT00684788|12962578|P2|COMPLETED|Overall Study||18
5273577|NCT00684788|12962579|P1|COMPLETED|Overall Study||17
5273578|NCT00684788|12962578|P2|STARTED|Overall Study||18
5273579|NCT00684788|12962579|P1|STARTED|Overall Study||17
5273580|NCT00684775|12962599|P2|NOT COMPLETED|Overall Study||0
5273581|NCT00684775|12962600|P1|NOT COMPLETED|Overall Study||0
5273582|NCT00684775|12962599|P2|COMPLETED|Overall Study||19
5273583|NCT00684775|12962600|P1|COMPLETED|Overall Study||19
5273584|NCT00684775|12962599|P2|STARTED|Overall Study||19
5273585|NCT00684775|12962600|P1|STARTED|Overall Study||19
5273586|NCT00684762|12962618|P2|NOT COMPLETED|Second Intervention||0
5273587|NCT00684762|12962619|P1|NOT COMPLETED|Second Intervention||0
5273588|NCT00684762|12962618|P2|COMPLETED|Second Intervention||14
5273589|NCT00684762|12962619|P1|COMPLETED|Second Intervention||14
5273590|NCT00684762|12962618|P2|STARTED|Second Intervention||14
5273591|NCT00684762|12962619|P1|STARTED|Second Intervention||14
5273592|NCT00684762|12962618|P2|NOT COMPLETED|Washout Period of 7 Days||2
5273593|NCT00684762|12962619|P1|NOT COMPLETED|Washout Period of 7 Days||2
5273594|NCT00684762|12962618|P2|COMPLETED|Washout Period of 7 Days||14
5273595|NCT00684762|12962619|P1|COMPLETED|Washout Period of 7 Days||14
5273596|NCT00684762|12962618|P2|STARTED|Washout Period of 7 Days||16
5273597|NCT00684762|12962619|P1|STARTED|Washout Period of 7 Days||16
5273598|NCT00684762|12962618|P2|NOT COMPLETED|First Intervention||0
5273599|NCT00684762|12962619|P1|NOT COMPLETED|First Intervention||0
5273600|NCT00684762|12962618|P2|COMPLETED|First Intervention||16
5273601|NCT00684762|12962619|P1|COMPLETED|First Intervention||16
5273602|NCT00684762|12962618|P2|STARTED|First Intervention||16
5273603|NCT00684762|12962619|P1|STARTED|First Intervention||16
5273604|NCT00684749|12962629|P1|NOT COMPLETED|Overall Study||0
5273605|NCT00684749|12962629|P1|COMPLETED|Overall Study||142
5273606|NCT00684749|12962629|P1|STARTED|Overall Study||142
5273607|NCT00684723|12962633|P2|NOT COMPLETED|Second Intervention||0
5273608|NCT00684723|12962634|P1|NOT COMPLETED|Second Intervention||0
5273609|NCT00684723|12962633|P2|COMPLETED|Second Intervention||27
5273610|NCT00684723|12962634|P1|COMPLETED|Second Intervention||27
5273611|NCT00684723|12962633|P2|STARTED|Second Intervention||27
5273612|NCT00684723|12962634|P1|STARTED|Second Intervention||27
5273613|NCT00684723|12962633|P2|NOT COMPLETED|Washout Period of 7 Days||0
5273614|NCT00684723|12962634|P1|NOT COMPLETED|Washout Period of 7 Days||0
5273615|NCT00684723|12962633|P2|COMPLETED|Washout Period of 7 Days||27
5273616|NCT00684723|12962634|P1|COMPLETED|Washout Period of 7 Days||27
5273617|NCT00684723|12962633|P2|STARTED|Washout Period of 7 Days||27
5273618|NCT00684723|12962634|P1|STARTED|Washout Period of 7 Days||27
5273619|NCT00684723|12962633|P2|NOT COMPLETED|First Intervention||0
5273620|NCT00684723|12962634|P1|NOT COMPLETED|First Intervention||0
5273621|NCT00684723|12962633|P2|COMPLETED|First Intervention||27
5273622|NCT00684723|12962634|P1|COMPLETED|First Intervention||27
5273623|NCT00684723|12962633|P2|STARTED|First Intervention||27
5273624|NCT00684723|12962634|P1|STARTED|First Intervention||27
5273625|NCT00684671|12962647|P3|NOT COMPLETED|Overall Study||0
5273626|NCT00684671|12962648|P2|NOT COMPLETED|Overall Study||0
5273627|NCT00684671|12962649|P1|NOT COMPLETED|Overall Study||3
5273628|NCT00684671|12962647|P3|COMPLETED|Overall Study||164
5273629|NCT00684671|12962648|P2|COMPLETED|Overall Study||170
5273630|NCT00684671|12962649|P1|COMPLETED|Overall Study||169
5273631|NCT00684671|12962647|P3|STARTED|Overall Study||164
5273632|NCT00684671|12962648|P2|STARTED|Overall Study||170
5273633|NCT00684671|12962649|P1|STARTED|Overall Study||172
5273634|NCT00684645|12962678|P1|NOT COMPLETED|Overall Study||114
5273635|NCT00684645|12962678|P1|COMPLETED|Overall Study||72
5273636|NCT00684645|12962678|P1|STARTED|Overall Study||186
5273637|NCT00684593|12962698|P2|NOT COMPLETED|Overall Study||2
5273638|NCT00684593|12962699|P1|NOT COMPLETED|Overall Study||0
5273639|NCT00684593|12962698|P2|COMPLETED|Overall Study||8
5273640|NCT00684593|12962699|P1|COMPLETED|Overall Study||21
5273641|NCT00684593|12962698|P2|STARTED|Overall Study||10
5273642|NCT00684593|12962699|P1|STARTED|Overall Study||21
5273643|NCT00684567|12962711|P1|NOT COMPLETED|Monotherapy Period||14
5273644|NCT00684567|12962711|P1|COMPLETED|Monotherapy Period||9
5273645|NCT00684567|12962711|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
5273646|NCT00684567|12962711|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
5273647|NCT00684567|12962711|P1|COMPLETED|Concomitant Radiotherapy Period||28
5273648|NCT00684567|12962711|P1|STARTED|Concomitant Radiotherapy Period||30
5273649|NCT00684554|12962721|P2|NOT COMPLETED|Overall Study||0
5273650|NCT00684554|12962722|P1|NOT COMPLETED|Overall Study||0
5273651|NCT00684554|12962721|P2|COMPLETED|Overall Study||10
5273652|NCT00684554|12962722|P1|COMPLETED|Overall Study||10
5273653|NCT00684554|12962721|P2|STARTED|Overall Study||10
5273654|NCT00684554|12962722|P1|STARTED|Overall Study||10
5273655|NCT00684541|12962732|P2|NOT COMPLETED|Overall Study||3
5273656|NCT00684541|12962733|P1|NOT COMPLETED|Overall Study||3
5273657|NCT00684541|12962732|P2|COMPLETED|Overall Study||23
5273658|NCT00684541|12962733|P1|COMPLETED|Overall Study||20
5273659|NCT00684541|12962732|P2|STARTED|Overall Study||26
5273660|NCT00684541|12962733|P1|STARTED|Overall Study||23
5273661|NCT00684515|12962744|P3|NOT COMPLETED|Overall Study||1
5273662|NCT00684515|12962745|P2|NOT COMPLETED|Overall Study||3
5273663|NCT00684515|12962746|P1|NOT COMPLETED|Overall Study||4
5273664|NCT00684515|12962744|P3|COMPLETED|Overall Study||27
5273665|NCT00684515|12962745|P2|COMPLETED|Overall Study||26
5273666|NCT00684515|12962746|P1|COMPLETED|Overall Study||29
5273667|NCT00684515|12962744|P3|STARTED|Overall Study||28
5273668|NCT00684515|12962745|P2|STARTED|Overall Study||29
5273669|NCT00684515|12962746|P1|STARTED|Overall Study||33
5273670|NCT00684424|12962769|P1|NOT COMPLETED|Overall Study||5
5273671|NCT00684424|12962769|P1|COMPLETED|Overall Study||194
5273672|NCT00684424|12962769|P1|STARTED|Overall Study||199
5273673|NCT00684411|12962784|P1|NOT COMPLETED|Overall Study||12
5273674|NCT00684411|12962784|P1|COMPLETED|Overall Study||0
5273675|NCT00684411|12962784|P1|Disease Evaluable|Overall Study||11
5273676|NCT00684411|12962784|P1|STARTED|Overall Study||12
5273677|NCT00684320|12962792|P2|NOT COMPLETED|Overall Study||0
5273678|NCT00684320|12962793|P1|NOT COMPLETED|Overall Study||4
5273679|NCT00684320|12962792|P2|COMPLETED|Overall Study||22
5273680|NCT00684320|12962793|P1|COMPLETED|Overall Study||22
5273681|NCT00684320|12962792|P2|STARTED|Overall Study||22
5273682|NCT00684320|12962793|P1|STARTED|Overall Study||26
5273683|NCT00684307|12962806|P5|NOT COMPLETED|Overall Study||25
5273684|NCT00684307|12962807|P4|NOT COMPLETED|Overall Study||32
5273685|NCT00684307|12962808|P3|NOT COMPLETED|Overall Study||28
5273686|NCT00684307|12962809|P2|NOT COMPLETED|Overall Study||22
5273687|NCT00684307|12962810|P1|NOT COMPLETED|Overall Study||24
5273688|NCT00684307|12962806|P5|COMPLETED|Overall Study||293
5273689|NCT00684307|12962807|P4|COMPLETED|Overall Study||128
5273690|NCT00684307|12962808|P3|COMPLETED|Overall Study||128
5273691|NCT00684307|12962809|P2|COMPLETED|Overall Study||129
5273692|NCT00684307|12962810|P1|COMPLETED|Overall Study||140
5273693|NCT00684307|12962806|P5|On Treatment Period Completed|Overall Study||293
5273694|NCT00684307|12962807|P4|On Treatment Period Completed|Overall Study||128
5273695|NCT00684307|12962808|P3|On Treatment Period Completed|Overall Study||128
5273696|NCT00684307|12962809|P2|On Treatment Period Completed|Overall Study||129
5273697|NCT00684307|12962810|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
5273698|NCT00684307|12962806|P5|On Treatment Period Started|Overall Study||318
5273699|NCT00684307|12962807|P4|On Treatment Period Started|Overall Study||160
5273700|NCT00684307|12962808|P3|On Treatment Period Started|Overall Study||156
5273701|NCT00684307|12962809|P2|On Treatment Period Started|Overall Study||151
5273702|NCT00684307|12962810|P1|On Treatment Period Started|Overall Study||164
5273703|NCT00684307|12962806|P5|STARTED|Overall Study||318
5273704|NCT00684307|12962807|P4|STARTED|Overall Study||160
5273705|NCT00684307|12962808|P3|STARTED|Overall Study||156
5273706|NCT00684307|12962809|P2|STARTED|Overall Study||151
5273707|NCT00684307|12962810|P1|STARTED|Overall Study|Patients who received treatment|164
5273708|NCT00684255|12962877|P1|NOT COMPLETED|Overall Study||0
5273709|NCT00684255|12962877|P1|COMPLETED|Overall Study||1
5273710|NCT00684255|12962877|P1|STARTED|Overall Study||1
5273711|NCT00684242|12962882|P1|NOT COMPLETED|Overall Study||0
5273712|NCT00684242|12962882|P1|COMPLETED|Overall Study||3
5273713|NCT00684242|12962882|P1|STARTED|Overall Study||3
5273714|NCT00684203|12962892|P6|NOT COMPLETED|Overall Study||0
5273715|NCT00684203|12962893|P5|NOT COMPLETED|Overall Study||0
5273716|NCT00684203|12962894|P4|NOT COMPLETED|Overall Study||0
5273717|NCT00684203|12962895|P3|NOT COMPLETED|Overall Study||9
5273718|NCT00684203|12962896|P2|NOT COMPLETED|Overall Study||8
5273719|NCT00684203|12962897|P1|NOT COMPLETED|Overall Study||9
5273720|NCT00684203|12962892|P6|COMPLETED|Overall Study||2
5273721|NCT00684203|12962893|P5|COMPLETED|Overall Study||17
5273722|NCT00684203|12962894|P4|COMPLETED|Overall Study||6
5273723|NCT00684203|12962895|P3|COMPLETED|Overall Study||12
5273724|NCT00684203|12962896|P2|COMPLETED|Overall Study||23
5273725|NCT00684203|12962897|P1|COMPLETED|Overall Study||31
5273726|NCT00684203|12962892|P6|STARTED|Overall Study||2
5273727|NCT00684203|12962893|P5|STARTED|Overall Study||17
5273728|NCT00684203|12962894|P4|STARTED|Overall Study||6
5273729|NCT00684203|12962895|P3|STARTED|Overall Study||21
5273730|NCT00684203|12962896|P2|STARTED|Overall Study||31
5273731|NCT00684203|12962897|P1|STARTED|Overall Study||40
5273732|NCT00684177|12962958|P2|NOT COMPLETED|Overall Study||23
5273733|NCT00684177|12962959|P1|NOT COMPLETED|Overall Study||21
5273734|NCT00684177|12962958|P2|COMPLETED|Overall Study||141
5273735|NCT00684177|12962959|P1|COMPLETED|Overall Study||322
5273736|NCT00684177|12962958|P2|STARTED|Overall Study||164
5273737|NCT00684177|12962959|P1|STARTED|Overall Study||343
5273738|NCT00684138|12962977|P2|NOT COMPLETED|Overall Study||8
5273739|NCT00684138|12962978|P1|NOT COMPLETED|Overall Study||3
5273740|NCT00684138|12962977|P2|COMPLETED|Overall Study||131
5273741|NCT00684138|12962978|P1|COMPLETED|Overall Study||138
5273742|NCT00684138|12962977|P2|STARTED|Overall Study||139
5273743|NCT00684138|12962978|P1|STARTED|Overall Study||141
5273744|NCT00684073|12962994|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
5273745|NCT00684073|12962994|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
5273746|NCT00684073|12962994|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
5273747|NCT00684073|12962994|P1|NOT COMPLETED|Selection||7
5273748|NCT00684073|12962994|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
5273749|NCT00684073|12962994|P1|STARTED|Selection||60
5273750|NCT00684060|12963004|P2|NOT COMPLETED|Overall Study||3
5273751|NCT00684060|12963005|P1|NOT COMPLETED|Overall Study||3
5273752|NCT00684060|12963004|P2|COMPLETED|Overall Study||26
5273753|NCT00684060|12963005|P1|COMPLETED|Overall Study||55
5273754|NCT00684060|12963004|P2|STARTED|Overall Study||29
5273755|NCT00684060|12963005|P1|STARTED|Overall Study||58
5273756|NCT00684047|12963028|P3|NOT COMPLETED|Overall Study||5
5273757|NCT00684047|12963029|P2|NOT COMPLETED|Overall Study||16
5273758|NCT00684047|12963030|P1|NOT COMPLETED|Overall Study||13
5273759|NCT00684047|12963028|P3|COMPLETED|Overall Study||52
5273760|NCT00684047|12963029|P2|COMPLETED|Overall Study||94
5273761|NCT00684047|12963030|P1|COMPLETED|Overall Study||59
5273762|NCT00684047|12963028|P3|STARTED|Overall Study||57
5273763|NCT00684047|12963029|P2|STARTED|Overall Study||110
5273764|NCT00684047|12963030|P1|STARTED|Overall Study||72
5273765|NCT00684021|12963044|P4|NOT COMPLETED|Overall Study||2
5273766|NCT00684021|12963045|P3|NOT COMPLETED|Overall Study||2
5273767|NCT00684021|12963046|P2|NOT COMPLETED|Overall Study||2
5273768|NCT00684021|12963047|P1|NOT COMPLETED|Overall Study||2
5273769|NCT00684021|12963044|P4|COMPLETED|Overall Study||15
5273770|NCT00684021|12963045|P3|COMPLETED|Overall Study||34
5273771|NCT00684021|12963046|P2|COMPLETED|Overall Study||22
5273772|NCT00684021|12963047|P1|COMPLETED|Overall Study||41
5273773|NCT00684021|12963044|P4|STARTED|Overall Study||17
5273774|NCT00684021|12963045|P3|STARTED|Overall Study||36
5273775|NCT00684021|12963046|P2|STARTED|Overall Study||24
5273776|NCT00684021|12963047|P1|STARTED|Overall Study||43
5273777|NCT00683930|12963088|P3|NOT COMPLETED|Overall Study||9
5273778|NCT00683930|12963089|P2|NOT COMPLETED|Overall Study||3
5273779|NCT00683930|12963090|P1|NOT COMPLETED|Overall Study||7
5273780|NCT00683930|12963088|P3|COMPLETED|Overall Study||28
5273781|NCT00683930|12963089|P2|COMPLETED|Overall Study||18
5273782|NCT00683930|12963090|P1|COMPLETED|Overall Study||29
5273783|NCT00683930|12963088|P3|STARTED|Overall Study||37
5273784|NCT00683930|12963089|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
5273785|NCT00683930|12963090|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
5273786|NCT00683917|12963108|P1|NOT COMPLETED|Overall Study||10
5273787|NCT00683917|12963108|P1|COMPLETED|Overall Study||0
5273788|NCT00683917|12963108|P1|STARTED|Overall Study||10
5273789|NCT00683904|12963118|P2|NOT COMPLETED|Dose Level 2||2
5273790|NCT00683904|12963119|P1|NOT COMPLETED|Dose Level 2||0
5273791|NCT00683904|12963118|P2|COMPLETED|Dose Level 2||4
5273792|NCT00683904|12963119|P1|COMPLETED|Dose Level 2||0
5273793|NCT00683904|12963118|P2|STARTED|Dose Level 2||6
5273794|NCT00683904|12963119|P1|STARTED|Dose Level 2||0
5273795|NCT00683904|12963118|P2|NOT COMPLETED|Dose Level 1||0
5273796|NCT00683904|12963119|P1|NOT COMPLETED|Dose Level 1||3
5273797|NCT00683904|12963118|P2|COMPLETED|Dose Level 1||0
5273798|NCT00683904|12963119|P1|COMPLETED|Dose Level 1||3
5273799|NCT00683904|12963118|P2|STARTED|Dose Level 1||0
5273800|NCT00683904|12963119|P1|STARTED|Dose Level 1||6
5273801|NCT00683878|12963155|P3|NOT COMPLETED|Overall Study||14
5273802|NCT00683878|12963156|P2|NOT COMPLETED|Overall Study||16
5273803|NCT00683878|12963157|P1|NOT COMPLETED|Overall Study||23
5273804|NCT00683878|12963155|P3|COMPLETED|Overall Study||126
5273805|NCT00683878|12963156|P2|COMPLETED|Overall Study||125
5273806|NCT00683878|12963157|P1|COMPLETED|Overall Study||116
5273807|NCT00683878|12963155|P3|STARTED|Overall Study||140
5273808|NCT00683878|12963156|P2|STARTED|Overall Study||141
5273809|NCT00683878|12963157|P1|STARTED|Overall Study||139
5273810|NCT00683852|12963185|P3|NOT COMPLETED|30-Day Phase 2 Period||9
5273811|NCT00683852|12963186|P2|NOT COMPLETED|30-Day Phase 2 Period||5
5273812|NCT00683852|12963187|P1|NOT COMPLETED|30-Day Phase 2 Period||6
5273813|NCT00683852|12963185|P3|COMPLETED|30-Day Phase 2 Period||75
5273814|NCT00683852|12963186|P2|COMPLETED|30-Day Phase 2 Period||78
5273815|NCT00683852|12963187|P1|COMPLETED|30-Day Phase 2 Period||48
5273816|NCT00683852|12963185|P3|STARTED|30-Day Phase 2 Period||84
5273817|NCT00683852|12963186|P2|STARTED|30-Day Phase 2 Period||83
5273818|NCT00683852|12963187|P1|STARTED|30-Day Phase 2 Period||54
5273819|NCT00683852|12963185|P3|NOT COMPLETED|30-Day Phase 1 Period||1
5273820|NCT00683852|12963186|P2|NOT COMPLETED|30-Day Phase 1 Period||1
5273821|NCT00683852|12963187|P1|NOT COMPLETED|30-Day Phase 1 Period||2
5273822|NCT00683852|12963185|P3|COMPLETED|30-Day Phase 1 Period||84
5273823|NCT00683852|12963186|P2|COMPLETED|30-Day Phase 1 Period||83
5273824|NCT00683852|12963187|P1|COMPLETED|30-Day Phase 1 Period||54
5273825|NCT00683852|12963185|P3|STARTED|30-Day Phase 1 Period||85
5273826|NCT00683852|12963186|P2|STARTED|30-Day Phase 1 Period||84
5273827|NCT00683852|12963187|P1|STARTED|30-Day Phase 1 Period||56
5273828|NCT00683826|12963221|P1|NOT COMPLETED|Overall Study||1
5273829|NCT00683826|12963221|P1|COMPLETED|Overall Study||7
5273830|NCT00683826|12963221|P1|4g Leucine|Overall Study||7
5273831|NCT00683826|12963221|P1|8g Leucine|Overall Study||8
5273832|NCT00683826|12963221|P1|0g Leucine|Overall Study||8
5273833|NCT00683826|12963221|P1|STARTED|Overall Study||8
5273834|NCT00683800|12963231|P2|NOT COMPLETED|Overall Study||366
5273835|NCT00683800|12963232|P1|NOT COMPLETED|Overall Study||432
5273836|NCT00683800|12963231|P2|COMPLETED|Overall Study||719
5273837|NCT00683800|12963232|P1|COMPLETED|Overall Study||669
5273838|NCT00683800|12963231|P2|Treated|Overall Study||1052
5273839|NCT00683800|12963232|P1|Treated|Overall Study||1066
5273840|NCT00683800|12963231|P2|STARTED|Overall Study||1085
5273841|NCT00683800|12963232|P1|STARTED|Overall Study||1101
5273842|NCT00683787|12963299|P3|NOT COMPLETED|Overall Study||2
5273843|NCT00683787|12963300|P2|NOT COMPLETED|Overall Study||3
5273844|NCT00683787|12963301|P1|NOT COMPLETED|Overall Study||3
5273845|NCT00683787|12963299|P3|COMPLETED|Overall Study||0
5273846|NCT00683787|12963300|P2|COMPLETED|Overall Study||0
5273847|NCT00683787|12963301|P1|COMPLETED|Overall Study||0
5273848|NCT00683787|12963299|P3|STARTED|Overall Study||2
5273849|NCT00683787|12963300|P2|STARTED|Overall Study||3
5273850|NCT00683787|12963301|P1|STARTED|Overall Study||3
5273851|NCT00683774|12963320|P2|NOT COMPLETED|Overall Study||1
5273852|NCT00683774|12963321|P1|NOT COMPLETED|Overall Study||3
5273853|NCT00683774|12963320|P2|COMPLETED|Overall Study||9
5273854|NCT00683774|12963321|P1|COMPLETED|Overall Study||8
5273855|NCT00683774|12963320|P2|STARTED|Overall Study||10
5273856|NCT00683774|12963321|P1|STARTED|Overall Study||11
5273857|NCT00683696|12963331|P2|NOT COMPLETED|Overall Study||405
5273858|NCT00683696|12963332|P1|NOT COMPLETED|Overall Study||404
5273859|NCT00683696|12963331|P2|COMPLETED|Overall Study||0
5273860|NCT00683696|12963332|P1|COMPLETED|Overall Study||0
5273861|NCT00683696|12963331|P2|STARTED|Overall Study||405
5273862|NCT00683696|12963332|P1|STARTED|Overall Study||404
5273863|NCT00683657|12963351|P2|NOT COMPLETED|Overall Study||1
5273864|NCT00683657|12963352|P1|NOT COMPLETED|Overall Study||1
5273865|NCT00683657|12963351|P2|COMPLETED|Overall Study||46
5273866|NCT00683657|12963352|P1|COMPLETED|Overall Study||45
5273867|NCT00683657|12963351|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
5273868|NCT00683657|12963352|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
5273869|NCT00683657|12963351|P2|STARTED|Overall Study||47
5273870|NCT00683657|12963352|P1|STARTED|Overall Study||46
5273871|NCT00683644|12963368|P2|NOT COMPLETED|Overall Study||14
5273872|NCT00683644|12963369|P1|NOT COMPLETED|Overall Study||13
5273873|NCT00683644|12963368|P2|COMPLETED|Overall Study||44
5273874|NCT00683644|12963369|P1|COMPLETED|Overall Study||45
5273875|NCT00683644|12963368|P2|STARTED|Overall Study||58
5273876|NCT00683644|12963369|P1|STARTED|Overall Study||58
5273877|NCT00683618|12963382|P3|NOT COMPLETED|Extension Treatment Period||0
5273878|NCT00683618|12963383|P2|NOT COMPLETED|Extension Treatment Period||0
5273879|NCT00683618|12963384|P1|NOT COMPLETED|Extension Treatment Period||3
5273880|NCT00683618|12963382|P3|COMPLETED|Extension Treatment Period||0
5273881|NCT00683618|12963383|P2|COMPLETED|Extension Treatment Period||23
5273882|NCT00683618|12963384|P1|COMPLETED|Extension Treatment Period||33
5273883|NCT00683618|12963382|P3|STARTED|Extension Treatment Period||0
5273884|NCT00683618|12963383|P2|STARTED|Extension Treatment Period||23
5273885|NCT00683618|12963384|P1|STARTED|Extension Treatment Period||36
5273886|NCT00683618|12963382|P3|NOT COMPLETED|Randomised Treatment Period||6
5273887|NCT00683618|12963383|P2|NOT COMPLETED|Randomised Treatment Period||2
5273888|NCT00683618|12963384|P1|NOT COMPLETED|Randomised Treatment Period||6
5273889|NCT00683618|12963382|P3|COMPLETED|Randomised Treatment Period||140
5273890|NCT00683618|12963383|P2|COMPLETED|Randomised Treatment Period||143
5273891|NCT00683618|12963384|P1|COMPLETED|Randomised Treatment Period||139
5273892|NCT00683618|12963382|P3|STARTED|Randomised Treatment Period||146
5273893|NCT00683618|12963383|P2|STARTED|Randomised Treatment Period||145
5273894|NCT00683618|12963384|P1|STARTED|Randomised Treatment Period||145
5273895|NCT00683592|12963434|P2|NOT COMPLETED|Overall Study||46
5273896|NCT00683592|12963435|P1|NOT COMPLETED|Overall Study||47
5273897|NCT00683592|12963434|P2|COMPLETED|Overall Study||195
5273898|NCT00683592|12963435|P1|COMPLETED|Overall Study||193
5273899|NCT00683592|12963434|P2|Safety Population|Overall Study||233
5273900|NCT00683592|12963435|P1|Safety Population|Overall Study||235
5273901|NCT00683592|12963434|P2|Intent to Treat Population|Overall Study||232
5273902|NCT00683592|12963435|P1|Intent to Treat Population|Overall Study||231
5273903|NCT00683592|12963434|P2|STARTED|Overall Study||241
5273904|NCT00683592|12963435|P1|STARTED|Overall Study||240
5273905|NCT00683475|12963453|P2|NOT COMPLETED|Overall Study||3
5273906|NCT00683475|12963454|P1|NOT COMPLETED|Overall Study||4
5273907|NCT00683475|12963453|P2|COMPLETED|Overall Study||66
5273908|NCT00683475|12963454|P1|COMPLETED|Overall Study||65
5273909|NCT00683475|12963453|P2|Received Any Quantity of Study Drug|Overall Study||66
5273910|NCT00683475|12963454|P1|Received Any Quantity of Study Drug|Overall Study||66
5273911|NCT00683475|12963453|P2|STARTED|Overall Study||69
5273912|NCT00683475|12963454|P1|STARTED|Overall Study||69
5273913|NCT00683449|12963489|P5|NOT COMPLETED|Overall Study||0
5273914|NCT00683449|12963490|P4|NOT COMPLETED|Overall Study||0
5273915|NCT00683449|12963491|P3|NOT COMPLETED|Overall Study||0
5273916|NCT00683449|12963492|P2|NOT COMPLETED|Overall Study||1
5273917|NCT00683449|12963493|P1|NOT COMPLETED|Overall Study||0
5273918|NCT00683449|12963489|P5|COMPLETED|Overall Study||2
5273919|NCT00683449|12963490|P4|COMPLETED|Overall Study||6
5273920|NCT00683449|12963491|P3|COMPLETED|Overall Study||3
5273921|NCT00683449|12963492|P2|COMPLETED|Overall Study||12
5273922|NCT00683449|12963493|P1|COMPLETED|Overall Study||5
5273923|NCT00683449|12963489|P5|STARTED|Overall Study||2
5273924|NCT00683449|12963490|P4|STARTED|Overall Study||6
5273925|NCT00683449|12963491|P3|STARTED|Overall Study||3
5273926|NCT00683449|12963492|P2|STARTED|Overall Study||13
5273927|NCT00683449|12963493|P1|STARTED|Overall Study||5
5273928|NCT00683410|12963515|P1|NOT COMPLETED|Overall Study||0
5273929|NCT00683410|12963515|P1|COMPLETED|Overall Study||3366
5273930|NCT00683410|12963515|P1|Vaccinated Dose 4|Overall Study||175
5273931|NCT00683410|12963515|P1|Vaccinated Dose 3|Overall Study||817
5273932|NCT00683410|12963515|P1|Vaccinated Dose 2|Overall Study||1623
5273933|NCT00683410|12963515|P1|Vaccinated Dose 1|Overall Study||3240
5273934|NCT00683410|12963515|P1|STARTED|Overall Study||3366
5273935|NCT00683384|12963519|P1|NOT COMPLETED|Overall Study||2
5273936|NCT00683384|12963519|P1|COMPLETED|Overall Study||91
5273937|NCT00683384|12963519|P1|STARTED|Overall Study||93
5273938|NCT00683332|12963523|P1|NOT COMPLETED|Overall Study||0
5273939|NCT00683332|12963523|P1|COMPLETED|Overall Study||621
5273940|NCT00683332|12963523|P1|STARTED|Overall Study||621
5273941|NCT00683293|12963529|P2|NOT COMPLETED|Overall Study||3
5273942|NCT00683293|12963530|P1|NOT COMPLETED|Overall Study||2
5273943|NCT00683293|12963529|P2|COMPLETED|Overall Study||47
5273944|NCT00683293|12963530|P1|COMPLETED|Overall Study||48
5273945|NCT00683293|12963529|P2|STARTED|Overall Study||50
5273946|NCT00683293|12963530|P1|STARTED|Overall Study||50
5273947|NCT00683163|12963540|P2|NOT COMPLETED|Overall Study||0
5273948|NCT00683163|12963541|P1|NOT COMPLETED|Overall Study||0
5273949|NCT00683163|12963540|P2|COMPLETED|Overall Study||22
5273950|NCT00683163|12963541|P1|COMPLETED|Overall Study||22
5273951|NCT00683163|12963540|P2|STARTED|Overall Study||22
5273952|NCT00683163|12963541|P1|STARTED|Overall Study||22
5273953|NCT00683085|12963549|P1|NOT COMPLETED|Overall Study||0
5273954|NCT00683085|12963549|P1|COMPLETED|Overall Study||2
5273955|NCT00683085|12963549|P1|STARTED|Overall Study||2
5273956|NCT00683046|12963554|P1|NOT COMPLETED|Overall Study||0
5273957|NCT00683046|12963554|P1|COMPLETED|Overall Study||204
5273958|NCT00683046|12963554|P1|STARTED|Overall Study||204
5273959|NCT00683020|12963561|P2|NOT COMPLETED|Overall Study||55
5273960|NCT00683020|12963562|P1|NOT COMPLETED|Overall Study||55
5273961|NCT00683020|12963561|P2|COMPLETED|Overall Study||125
5273962|NCT00683020|12963562|P1|COMPLETED|Overall Study||127
5273963|NCT00683020|12963561|P2|STARTED|Overall Study||180
5273964|NCT00683020|12963562|P1|STARTED|Overall Study||182
5273965|NCT00682929|12963593|P3|NOT COMPLETED|Overall Study||2
5273966|NCT00682929|12963594|P2|NOT COMPLETED|Overall Study||5
5273967|NCT00682929|12963595|P1|NOT COMPLETED|Overall Study||6
5273968|NCT00682929|12963593|P3|COMPLETED|Overall Study||12
5273969|NCT00682929|12963594|P2|COMPLETED|Overall Study||9
5273970|NCT00682929|12963595|P1|COMPLETED|Overall Study||7
5273971|NCT00682929|12963593|P3|STARTED|Overall Study||14
5273972|NCT00682929|12963594|P2|STARTED|Overall Study||14
5273973|NCT00682929|12963595|P1|STARTED|Overall Study||13
5273974|NCT00682890|12963764|P2|NOT COMPLETED|Overall Study||2
5273975|NCT00682890|12963765|P1|NOT COMPLETED|Overall Study||2
5273976|NCT00682890|12963764|P2|COMPLETED|Overall Study||9
5273977|NCT00682890|12963765|P1|COMPLETED|Overall Study||10
5273978|NCT00682890|12963764|P2|STARTED|Overall Study||11
5273979|NCT00682890|12963765|P1|STARTED|Overall Study||12
5273980|NCT00682851|12963775|P2|NOT COMPLETED|Overall Study||0
5273981|NCT00682851|12963776|P1|NOT COMPLETED|Overall Study||0
5273982|NCT00682851|12963775|P2|COMPLETED|Overall Study||268
5273983|NCT00682851|12963776|P1|COMPLETED|Overall Study||251
5273984|NCT00682851|12963775|P2|STARTED|Overall Study||268
5273985|NCT00682851|12963776|P1|STARTED|Overall Study||251
5273986|NCT00682838|12963792|P4|NOT COMPLETED|Overall Study||0
5273987|NCT00682838|12963793|P3|NOT COMPLETED|Overall Study||0
5273988|NCT00682838|12963794|P2|NOT COMPLETED|Overall Study||0
5273989|NCT00682838|12963795|P1|NOT COMPLETED|Overall Study||0
5273990|NCT00682838|12963792|P4|COMPLETED|Overall Study||73
5273991|NCT00682838|12963793|P3|COMPLETED|Overall Study||75
5273992|NCT00682838|12963794|P2|COMPLETED|Overall Study||67
5273993|NCT00682838|12963795|P1|COMPLETED|Overall Study||65
5273994|NCT00682838|12963792|P4|STARTED|Overall Study||73
5273995|NCT00682838|12963793|P3|STARTED|Overall Study||75
5273996|NCT00682838|12963794|P2|STARTED|Overall Study||67
5273997|NCT00682838|12963795|P1|STARTED|Overall Study||65
5273998|NCT00682786|12963807|P2|NOT COMPLETED|Overall Study||3
5273999|NCT00682786|12963808|P1|NOT COMPLETED|Overall Study||2
5274000|NCT00682786|12963807|P2|COMPLETED|Overall Study||34
5274001|NCT00682786|12963808|P1|COMPLETED|Overall Study||96
5274002|NCT00682786|12963807|P2|STARTED|Overall Study||37
5274003|NCT00682786|12963808|P1|STARTED|Overall Study||98
5274004|NCT00682734|12963845|P3|NOT COMPLETED|48 Hour Follow-up||11
5274005|NCT00682734|12963846|P2|NOT COMPLETED|48 Hour Follow-up||6
5274006|NCT00682734|12963847|P1|NOT COMPLETED|48 Hour Follow-up||6
5274007|NCT00682734|12963845|P3|COMPLETED|48 Hour Follow-up||106
5274008|NCT00682734|12963846|P2|COMPLETED|48 Hour Follow-up||111
5274009|NCT00682734|12963847|P1|COMPLETED|48 Hour Follow-up||107
5274010|NCT00682734|12963845|P3|STARTED|48 Hour Follow-up||117
5274011|NCT00682734|12963846|P2|STARTED|48 Hour Follow-up||117
5274012|NCT00682734|12963847|P1|STARTED|48 Hour Follow-up||113
5274013|NCT00682734|12963845|P3|NOT COMPLETED|Emergency Department Portion||1
5274014|NCT00682734|12963846|P2|NOT COMPLETED|Emergency Department Portion||1
5274015|NCT00682734|12963847|P1|NOT COMPLETED|Emergency Department Portion||0
5274016|NCT00682734|12963845|P3|COMPLETED|Emergency Department Portion||117
5274017|NCT00682734|12963846|P2|COMPLETED|Emergency Department Portion||117
5274018|NCT00682734|12963847|P1|COMPLETED|Emergency Department Portion||113
5274019|NCT00682734|12963845|P3|STARTED|Emergency Department Portion||118
5274020|NCT00682734|12963846|P2|STARTED|Emergency Department Portion||118
5274021|NCT00682734|12963847|P1|STARTED|Emergency Department Portion||113
5274022|NCT00682643|12963857|P2|NOT COMPLETED|Overall Study||169
5274023|NCT00682643|12963858|P1|NOT COMPLETED|Overall Study||78
5274024|NCT00682643|12963857|P2|COMPLETED|Overall Study||199
5274025|NCT00682643|12963858|P1|COMPLETED|Overall Study||104
5274026|NCT00682643|12963857|P2|STARTED|Overall Study||368
5274027|NCT00682643|12963858|P1|STARTED|Overall Study||182
5274028|NCT00682617|12963892|P2|NOT COMPLETED|Overall Study||7
5274029|NCT00682617|12963893|P1|NOT COMPLETED|Overall Study||3
5274030|NCT00682617|12963892|P2|COMPLETED|Overall Study||21
5274031|NCT00682617|12963893|P1|COMPLETED|Overall Study||10
5274032|NCT00682617|12963892|P2|STARTED|Overall Study||28
5274033|NCT00682617|12963893|P1|STARTED|Overall Study||13
5274034|NCT00682565|12963906|P3|NOT COMPLETED|Overall Study||0
5274035|NCT00682565|12963907|P2|NOT COMPLETED|Overall Study||3
5274036|NCT00682565|12963908|P1|NOT COMPLETED|Overall Study||1
5274037|NCT00682565|12963906|P3|COMPLETED|Overall Study||29
5274038|NCT00682565|12963907|P2|COMPLETED|Overall Study||32
5274039|NCT00682565|12963908|P1|COMPLETED|Overall Study||30
5274040|NCT00682565|12963906|P3|STARTED|Overall Study||29
5274041|NCT00682565|12963907|P2|STARTED|Overall Study||35
5274042|NCT00682565|12963908|P1|STARTED|Overall Study||31
5274043|NCT00682539|12963932|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
5274044|NCT00682539|12963933|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
5274045|NCT00682539|12963934|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
5274046|NCT00682539|12963932|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
5274047|NCT00682539|12963933|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
5274048|NCT00682539|12963934|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
5274049|NCT00682539|12963932|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
5274050|NCT00682539|12963933|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
5274051|NCT00682539|12963934|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
5274052|NCT00682539|12963932|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
5274053|NCT00682539|12963933|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
5274054|NCT00682539|12963934|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
5274055|NCT00682539|12963932|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
5274056|NCT00682539|12963933|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
5274057|NCT00682539|12963934|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
5274058|NCT00682539|12963932|P3|STARTED|Bevacizumab vs Triamcinolone||0
5274059|NCT00682539|12963933|P2|STARTED|Bevacizumab vs Triamcinolone||16
5274060|NCT00682539|12963934|P1|STARTED|Bevacizumab vs Triamcinolone||18
5274061|NCT00682461|12963947|P2|NOT COMPLETED|Overall Study||31
5274062|NCT00682461|12963948|P1|NOT COMPLETED|Overall Study||25
5274063|NCT00682461|12963947|P2|COMPLETED|Overall Study||69
5274064|NCT00682461|12963948|P1|COMPLETED|Overall Study||75
5274065|NCT00682461|12963947|P2|STARTED|Overall Study||100
5274066|NCT00682461|12963948|P1|STARTED|Overall Study||100
5274067|NCT00682435|12963962|P1|NOT COMPLETED|Overall Study||7
5274068|NCT00682435|12963962|P1|COMPLETED|Overall Study||223
5274069|NCT00682435|12963962|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
5274070|NCT00682435|12963962|P1|Ensured Enrolled Only Once|Overall Study||228
5274071|NCT00682435|12963962|P1|STARTED|Overall Study||230
5274072|NCT00682357|12963972|P3|NOT COMPLETED|Overall Study||0
5274073|NCT00682357|12963973|P2|NOT COMPLETED|Overall Study||0
5274074|NCT00682357|12963974|P1|NOT COMPLETED|Overall Study||0
5274075|NCT00682357|12963972|P3|COMPLETED|Overall Study||5
5274076|NCT00682357|12963973|P2|COMPLETED|Overall Study||10
5274077|NCT00682357|12963974|P1|COMPLETED|Overall Study||10
5274078|NCT00682357|12963972|P3|STARTED|Overall Study||5
5274079|NCT00682357|12963973|P2|STARTED|Overall Study||10
5274080|NCT00682357|12963974|P1|STARTED|Overall Study||10
5274081|NCT00681889|12963991|P1|NOT COMPLETED|Overall Study||0
5274082|NCT00681889|12963991|P1|COMPLETED|Overall Study||9
5274083|NCT00681889|12963991|P1|STARTED|Overall Study||9
5274084|NCT00681863|12963995|P1|NOT COMPLETED|Overall Study||23
5274085|NCT00681863|12963995|P1|COMPLETED|Overall Study||22
5274086|NCT00681863|12963995|P1|STARTED|Overall Study||45
5274087|NCT00681824|12964043|P3|NOT COMPLETED|Overall Study||1
5274088|NCT00681824|12964044|P2|NOT COMPLETED|Overall Study||1
5274089|NCT00681824|12964045|P1|NOT COMPLETED|Overall Study||1
5274090|NCT00681824|12964043|P3|COMPLETED|Overall Study||33
5274091|NCT00681824|12964044|P2|COMPLETED|Overall Study||12
5274092|NCT00681824|12964045|P1|COMPLETED|Overall Study||27
5274093|NCT00681824|12964043|P3|STARTED|Overall Study||34
5274094|NCT00681824|12964044|P2|STARTED|Overall Study||13
5274095|NCT00681824|12964045|P1|STARTED|Overall Study||28
5274096|NCT00681811|12964063|P2|NOT COMPLETED|Overall Study||4
5274097|NCT00681811|12964064|P1|NOT COMPLETED|Overall Study||3
5274098|NCT00681811|12964063|P2|COMPLETED|Overall Study||1
5274099|NCT00681811|12964064|P1|COMPLETED|Overall Study||3
5274100|NCT00681811|12964063|P2|STARTED|Overall Study||5
5274101|NCT00681811|12964064|P1|STARTED|Overall Study||6
5274102|NCT00681668|12964092|P1|NOT COMPLETED|Overall Study||2
5274103|NCT00681668|12964092|P1|COMPLETED|Overall Study||3
5274104|NCT00681668|12964092|P1|STARTED|Overall Study||5
5274105|NCT00681629|12964101|P2|NOT COMPLETED|Overall Study||2
5274106|NCT00681629|12964102|P1|NOT COMPLETED|Overall Study||5
5274107|NCT00681629|12964101|P2|COMPLETED|Overall Study||0
5274108|NCT00681629|12964102|P1|COMPLETED|Overall Study||0
5274109|NCT00681629|12964101|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
5274110|NCT00681629|12964102|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
5274111|NCT00681590|12964148|P2|NOT COMPLETED|Overall Study||12
5274112|NCT00681590|12964149|P1|NOT COMPLETED|Overall Study||2
5274113|NCT00681590|12964148|P2|COMPLETED|Overall Study||59
5274114|NCT00681590|12964149|P1|COMPLETED|Overall Study||32
5274115|NCT00681590|12964148|P2|STARTED|Overall Study||71
5274116|NCT00681590|12964149|P1|STARTED|Overall Study||34
5274117|NCT00681564|12964159|P2|NOT COMPLETED|Overall Study||8
5274118|NCT00681564|12964160|P1|NOT COMPLETED|Overall Study||6
5274119|NCT00681564|12964159|P2|COMPLETED|Overall Study||47
5274120|NCT00681564|12964160|P1|COMPLETED|Overall Study||41
5274121|NCT00681564|12964159|P2|STARTED|Overall Study||55
5274122|NCT00681564|12964160|P1|STARTED|Overall Study||47
5274123|NCT00681538|12964190|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
5274124|NCT00681538|12964191|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
5274125|NCT00681538|12964190|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
5274126|NCT00681538|12964191|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
5274127|NCT00681538|12964190|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
5274128|NCT00681538|12964191|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
5274129|NCT00681538|12964190|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
5274130|NCT00681538|12964191|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
5274131|NCT00681538|12964190|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
5274132|NCT00681538|12964191|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
5274133|NCT00681538|12964190|P2|STARTED|Phase A- 4 Weeks Single Blind||0
5274134|NCT00681538|12964191|P1|STARTED|Phase A- 4 Weeks Single Blind||572
5274135|NCT00681473|12964221|P1|NOT COMPLETED|Overall Study||0
5274136|NCT00681473|12964221|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
5274137|NCT00681473|12964221|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
5274138|NCT00681291|12964229|P2|NOT COMPLETED|Overall Study||27
5274139|NCT00681291|12964230|P1|NOT COMPLETED|Overall Study||13
5274140|NCT00681291|12964229|P2|COMPLETED|Overall Study||57
5274141|NCT00681291|12964230|P1|COMPLETED|Overall Study||75
5274142|NCT00681291|12964229|P2|STARTED|Overall Study||84
5274143|NCT00681291|12964230|P1|STARTED|Overall Study||88
5274144|NCT00681265|12964242|P1|NOT COMPLETED|Overall Study||0
5274145|NCT00681265|12964242|P1|COMPLETED|Overall Study||16
5274146|NCT00681265|12964242|P1|STARTED|Overall Study||16
5274147|NCT00681187|12964252|P2|NOT COMPLETED|Overall Study||2
5274148|NCT00681187|12964253|P1|NOT COMPLETED|Overall Study||1
5274149|NCT00681187|12964252|P2|COMPLETED|Overall Study||13
5274150|NCT00681187|12964253|P1|COMPLETED|Overall Study||10
5274151|NCT00681187|12964252|P2|STARTED|Overall Study||15
5274152|NCT00681187|12964253|P1|STARTED|Overall Study||11
5274153|NCT00681109|12964288|P3|NOT COMPLETED|Overall Study||0
5274154|NCT00681109|12964289|P2|NOT COMPLETED|Overall Study||6
5274155|NCT00681109|12964290|P1|NOT COMPLETED|Overall Study||2
5274156|NCT00681109|12964288|P3|COMPLETED|Overall Study||15
5274157|NCT00681109|12964289|P2|COMPLETED|Overall Study||24
5274158|NCT00681109|12964290|P1|COMPLETED|Overall Study||28
5274159|NCT00681109|12964288|P3|STARTED|Overall Study||15
5274160|NCT00681109|12964289|P2|STARTED|Overall Study||30
5274161|NCT00681109|12964290|P1|STARTED|Overall Study||30
5274162|NCT00681083|12964307|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
5274163|NCT00681083|12964308|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
5274164|NCT00681083|12964307|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
5274165|NCT00681083|12964308|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
5274166|NCT00681083|12964307|P2|STARTED|Night 2 (Crossover of Night 1)||10
5274167|NCT00681083|12964308|P1|STARTED|Night 2 (Crossover of Night 1)||10
5274168|NCT00681083|12964307|P2|NOT COMPLETED|Night 1||3
5274169|NCT00681083|12964308|P1|NOT COMPLETED|Night 1||3
5274170|NCT00681083|12964307|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
5274171|NCT00681083|12964308|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
5274172|NCT00681083|12964307|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
5274173|NCT00681083|12964308|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
5274174|NCT00681044|12964316|P1|NOT COMPLETED|Overall Study||0
5274175|NCT00681044|12964316|P1|COMPLETED|Overall Study||4
5274176|NCT00681044|12964316|P1|STARTED|Overall Study||4
5274177|NCT00681031|12964324|P1|NOT COMPLETED|Overall Study||0
5274178|NCT00681031|12964324|P1|COMPLETED|Overall Study||96
5274179|NCT00681031|12964324|P1|STARTED|Overall Study||96
5274180|NCT00680992|12964331|P3|NOT COMPLETED|Overall Study||12
5274181|NCT00680992|12964332|P2|NOT COMPLETED|Overall Study||252
5274182|NCT00680992|12964333|P1|NOT COMPLETED|Overall Study||268
5274183|NCT00680992|12964331|P3|COMPLETED|Overall Study||0
5274184|NCT00680992|12964332|P2|COMPLETED|Overall Study||0
5274185|NCT00680992|12964333|P1|COMPLETED|Overall Study||0
5274186|NCT00680992|12964331|P3|Efficacy Analysis Set|Overall Study||11
5274187|NCT00680992|12964332|P2|Efficacy Analysis Set|Overall Study||242
5274188|NCT00680992|12964333|P1|Efficacy Analysis Set|Overall Study||260
5274189|NCT00680992|12964331|P3|Safety Analysis Set|Overall Study||12
5274190|NCT00680992|12964332|P2|Safety Analysis Set|Overall Study||249
5274191|NCT00680992|12964333|P1|Safety Analysis Set|Overall Study||265
5274192|NCT00680992|12964331|P3|STARTED|Overall Study||12
5274193|NCT00680992|12964332|P2|STARTED|Overall Study||252
5274194|NCT00680992|12964333|P1|STARTED|Overall Study||268
5274195|NCT00680953|12964349|P3|NOT COMPLETED|Overall Study||47
5274196|NCT00680953|12964350|P2|NOT COMPLETED|Overall Study||95
5274197|NCT00680953|12964351|P1|NOT COMPLETED|Overall Study||86
5274198|NCT00680953|12964349|P3|COMPLETED|Overall Study||204
5274199|NCT00680953|12964350|P2|COMPLETED|Overall Study||416
5274200|NCT00680953|12964351|P1|COMPLETED|Overall Study||414
5274201|NCT00680953|12964349|P3|STARTED|Overall Study||251
5274202|NCT00680953|12964350|P2|STARTED|Overall Study||511
5274203|NCT00680953|12964351|P1|STARTED|Overall Study||500
5274204|NCT00680914|12964367|P2|NOT COMPLETED|Overall Study||4
5274205|NCT00680914|12964368|P1|NOT COMPLETED|Overall Study||10
5274206|NCT00680914|12964367|P2|COMPLETED|Overall Study||125
5274207|NCT00680914|12964368|P1|COMPLETED|Overall Study||364
5274208|NCT00680914|12964367|P2|STARTED|Overall Study||129
5274209|NCT00680914|12964368|P1|STARTED|Overall Study||374
5274210|NCT00680901|12964402|P2|NOT COMPLETED|Overall Study||76
5274211|NCT00680901|12964403|P1|NOT COMPLETED|Overall Study||73
5274212|NCT00680901|12964402|P2|COMPLETED|Overall Study||197
5274213|NCT00680901|12964403|P1|COMPLETED|Overall Study||199
5274214|NCT00680901|12964402|P2|Ongoing: In Follow Up|Overall Study||41
5274215|NCT00680901|12964403|P1|Ongoing: In Follow Up|Overall Study||45
5274216|NCT00680901|12964402|P2|Ongoing: On Study Treatment|Overall Study||13
5274217|NCT00680901|12964403|P1|Ongoing: On Study Treatment|Overall Study||16
5274218|NCT00680901|12964402|P2|STARTED|Overall Study||273
5274219|NCT00680901|12964403|P1|STARTED|Overall Study||272
5274220|NCT00680862|12964435|P1|NOT COMPLETED|Overall Study||0
5274221|NCT00680862|12964435|P1|COMPLETED|Overall Study||25
5274222|NCT00680862|12964435|P1|STARTED|Overall Study||25
5274223|NCT00680836|12964441|P2|NOT COMPLETED|Overall Study||2
5274224|NCT00680836|12964442|P1|NOT COMPLETED|Overall Study||8
5274225|NCT00680836|12964441|P2|COMPLETED|Overall Study||25
5274226|NCT00680836|12964442|P1|COMPLETED|Overall Study||19
5274227|NCT00680836|12964441|P2|STARTED|Overall Study||27
5274228|NCT00680836|12964442|P1|STARTED|Overall Study||27
5274229|NCT00680823|12964461|P3|NOT COMPLETED|Overall Study||0
5274230|NCT00680823|12964462|P2|NOT COMPLETED|Overall Study||0
5274231|NCT00680823|12964463|P1|NOT COMPLETED|Overall Study||0
5274232|NCT00680823|12964461|P3|COMPLETED|Overall Study||50
5274233|NCT00680823|12964462|P2|COMPLETED|Overall Study||50
5274234|NCT00680823|12964463|P1|COMPLETED|Overall Study||50
5274235|NCT00680823|12964461|P3|STARTED|Overall Study||50
5274236|NCT00680823|12964462|P2|STARTED|Overall Study||50
5274237|NCT00680823|12964463|P1|STARTED|Overall Study||50
5274238|NCT00680797|12964481|P4|NOT COMPLETED|Overall Study||0
5274239|NCT00680797|12964482|P3|NOT COMPLETED|Overall Study||0
5274240|NCT00680797|12964483|P2|NOT COMPLETED|Overall Study||0
5274241|NCT00680797|12964484|P1|NOT COMPLETED|Overall Study||0
5274242|NCT00680797|12964481|P4|COMPLETED|Overall Study||8
5274243|NCT00680797|12964482|P3|COMPLETED|Overall Study||8
5274244|NCT00680797|12964483|P2|COMPLETED|Overall Study||8
5274245|NCT00680797|12964484|P1|COMPLETED|Overall Study||9
5274246|NCT00680797|12964481|P4|STARTED|Overall Study||8
5274247|NCT00680797|12964482|P3|STARTED|Overall Study||8
5274248|NCT00680797|12964483|P2|STARTED|Overall Study||8
5274249|NCT00680797|12964484|P1|STARTED|Overall Study||9
5274250|NCT00680771|12964496|P2|NOT COMPLETED|Overall Study||2
5274251|NCT00680771|12964497|P1|NOT COMPLETED|Overall Study||6
5274252|NCT00680771|12964496|P2|COMPLETED|Overall Study||11
5274253|NCT00680771|12964497|P1|COMPLETED|Overall Study||9
5274254|NCT00680771|12964496|P2|STARTED|Overall Study||13
5274255|NCT00680771|12964497|P1|STARTED|Overall Study||15
5274256|NCT00680745|12964507|P4|NOT COMPLETED|Overall Study||13
5274257|NCT00680745|12964508|P3|NOT COMPLETED|Overall Study||10
5274258|NCT00680745|12964509|P2|NOT COMPLETED|Overall Study||13
5274259|NCT00680745|12964510|P1|NOT COMPLETED|Overall Study||14
5274260|NCT00680745|12964507|P4|COMPLETED|Overall Study||133
5274261|NCT00680745|12964508|P3|COMPLETED|Overall Study||141
5274262|NCT00680745|12964509|P2|COMPLETED|Overall Study||132
5274263|NCT00680745|12964510|P1|COMPLETED|Overall Study||140
5274264|NCT00680745|12964507|P4|STARTED|Overall Study|Safety Analysis Set|146
5274265|NCT00680745|12964508|P3|STARTED|Overall Study|Safety Analysis Set|151
5274266|NCT00680745|12964509|P2|STARTED|Overall Study|Safety Analysis Set|145
5274267|NCT00680745|12964510|P1|STARTED|Overall Study|Safety Analysis Set|154
5274268|NCT00680706|12964542|P2|NOT COMPLETED|Overall Study||5
5274269|NCT00680706|12964543|P1|NOT COMPLETED|Overall Study||7
5274270|NCT00680706|12964542|P2|COMPLETED|Overall Study||55
5274271|NCT00680706|12964543|P1|COMPLETED|Overall Study||63
5274272|NCT00680706|12964542|P2|STARTED|Overall Study||60
5274273|NCT00680706|12964543|P1|STARTED|Overall Study||70
5274274|NCT00680628|12964553|P2|NOT COMPLETED|Overall Study||0
5274275|NCT00680628|12964554|P1|NOT COMPLETED|Overall Study||0
5274276|NCT00680628|12964553|P2|COMPLETED|Overall Study||40
5274277|NCT00680628|12964554|P1|COMPLETED|Overall Study||43
5274278|NCT00680628|12964553|P2|STARTED|Overall Study||40
5274279|NCT00680628|12964554|P1|STARTED|Overall Study||43
5274280|NCT00680524|12964564|P1|NOT COMPLETED|Overall Study||3
5274281|NCT00680524|12964564|P1|COMPLETED|Overall Study||17
5274282|NCT00680524|12964564|P1|STARTED|Overall Study||20
5274283|NCT00680459|12964570|P2|NOT COMPLETED|Overall Study||0
5274284|NCT00680459|12964571|P1|NOT COMPLETED|Overall Study||0
5274285|NCT00680459|12964570|P2|COMPLETED|Overall Study||6
5274286|NCT00680459|12964571|P1|COMPLETED|Overall Study||7
5274287|NCT00680459|12964570|P2|STARTED|Overall Study||6
5274288|NCT00680459|12964571|P1|STARTED|Overall Study||7
5274289|NCT00680407|12964584|P3|NOT COMPLETED|Overall Study||3
5274290|NCT00680407|12964585|P2|NOT COMPLETED|Overall Study||5
5274291|NCT00680407|12964586|P1|NOT COMPLETED|Overall Study||8
5274292|NCT00680407|12964584|P3|COMPLETED|Overall Study||22
5274293|NCT00680407|12964585|P2|COMPLETED|Overall Study||22
5274294|NCT00680407|12964586|P1|COMPLETED|Overall Study||18
5274295|NCT00680407|12964584|P3|STARTED|Overall Study||25
5274296|NCT00680407|12964585|P2|STARTED|Overall Study||27
5274297|NCT00680407|12964586|P1|STARTED|Overall Study||26
5274298|NCT00680368|12964600|P1|NOT COMPLETED|Overall Study||15
5274299|NCT00680368|12964600|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
5274300|NCT00680368|12964600|P1|STARTED|Overall Study||112
5274301|NCT00680316|12964608|P2|NOT COMPLETED|Overall Study||0
5274302|NCT00680316|12964609|P1|NOT COMPLETED|Overall Study||0
5274303|NCT00680316|12964608|P2|COMPLETED|Overall Study||2
5274304|NCT00680316|12964609|P1|COMPLETED|Overall Study||1
5274305|NCT00680316|12964608|P2|STARTED|Overall Study||2
5274306|NCT00680316|12964609|P1|STARTED|Overall Study||1
5274307|NCT00680225|12964621|P1|NOT COMPLETED|Overall Study||2
5274308|NCT00680225|12964621|P1|COMPLETED|Overall Study||8
5274309|NCT00680225|12964621|P1|STARTED|Overall Study||10
5274310|NCT00680186|12964628|P2|NOT COMPLETED|Overall Study||116
5274311|NCT00680186|12964629|P1|NOT COMPLETED|Overall Study||125
5274312|NCT00680186|12964628|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
5274313|NCT00680186|12964629|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
5274314|NCT00680186|12964628|P2|STARTED|Overall Study|Started treatment.|1288
5274315|NCT00680186|12964629|P1|STARTED|Overall Study|Started treatment.|1280
5274316|NCT00680121|12964655|P2|NOT COMPLETED|Overall Study||23
5274317|NCT00680121|12964656|P1|NOT COMPLETED|Overall Study||27
5274318|NCT00680121|12964655|P2|COMPLETED|Overall Study||37
5274319|NCT00680121|12964656|P1|COMPLETED|Overall Study||33
5274320|NCT00680121|12964655|P2|STARTED|Overall Study||60
5274321|NCT00680121|12964656|P1|STARTED|Overall Study||60
5274322|NCT00680056|12964670|P2|NOT COMPLETED|Second Intervention||1
5274323|NCT00680056|12964671|P1|NOT COMPLETED|Second Intervention||3
5274324|NCT00680056|12964670|P2|COMPLETED|Second Intervention||14
5274325|NCT00680056|12964671|P1|COMPLETED|Second Intervention||12
5274326|NCT00680056|12964670|P2|STARTED|Second Intervention||15
5274327|NCT00680056|12964671|P1|STARTED|Second Intervention||15
5274328|NCT00680056|12964670|P2|NOT COMPLETED|Washout Period of One Week||0
5274329|NCT00680056|12964671|P1|NOT COMPLETED|Washout Period of One Week||0
5274330|NCT00680056|12964670|P2|COMPLETED|Washout Period of One Week||15
5274331|NCT00680056|12964671|P1|COMPLETED|Washout Period of One Week||15
5274332|NCT00680056|12964670|P2|STARTED|Washout Period of One Week||15
5274333|NCT00680056|12964671|P1|STARTED|Washout Period of One Week||15
5274334|NCT00680056|12964670|P2|NOT COMPLETED|First Intervention||2
5274335|NCT00680056|12964671|P1|NOT COMPLETED|First Intervention||1
5274336|NCT00680056|12964670|P2|COMPLETED|First Intervention||15
5274337|NCT00680056|12964671|P1|COMPLETED|First Intervention||15
5274338|NCT00680056|12964670|P2|STARTED|First Intervention||17
5274339|NCT00680056|12964671|P1|STARTED|First Intervention||16
5274340|NCT00680043|12964682|P3|NOT COMPLETED|Overall Study||4
5274341|NCT00680043|12964683|P2|NOT COMPLETED|Overall Study||1
5274342|NCT00680043|12964684|P1|NOT COMPLETED|Overall Study||2
5274343|NCT00680043|12964682|P3|COMPLETED|Overall Study||34
5274344|NCT00680043|12964683|P2|COMPLETED|Overall Study||36
5274345|NCT00680043|12964684|P1|COMPLETED|Overall Study||37
5274346|NCT00680043|12964682|P3|STARTED|Overall Study||38
5274347|NCT00680043|12964683|P2|STARTED|Overall Study||37
5274348|NCT00680043|12964684|P1|STARTED|Overall Study||39
5274349|NCT00680017|12964700|P2|NOT COMPLETED|Overall Study||12
5274350|NCT00680017|12964701|P1|NOT COMPLETED|Overall Study||17
5274351|NCT00680017|12964700|P2|COMPLETED|Overall Study||128
5274352|NCT00680017|12964701|P1|COMPLETED|Overall Study||123
5274353|NCT00680017|12964700|P2|STARTED|Overall Study||140
5274354|NCT00680017|12964701|P1|STARTED|Overall Study||140
5274355|NCT00679952|12964711|P2|NOT COMPLETED|Overall Study||0
5274356|NCT00679952|12964712|P1|NOT COMPLETED|Overall Study||0
5274357|NCT00679952|12964711|P2|COMPLETED|Overall Study||82
5274358|NCT00679952|12964712|P1|COMPLETED|Overall Study||86
5274359|NCT00679952|12964711|P2|STARTED|Overall Study||82
5274360|NCT00679952|12964712|P1|STARTED|Overall Study||86
5274361|NCT00679939|12964720|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
5274362|NCT00679939|12964721|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
5274363|NCT00679939|12964720|P2|COMPLETED|24-Week Open-Label (OL) Period||80
5274364|NCT00679939|12964721|P1|COMPLETED|24-Week Open-Label (OL) Period||69
5274365|NCT00679939|12964720|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
5274451|NCT00679302|12965075|P1|COMPLETED|Overall Study||76
5274366|NCT00679939|12964721|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
5274367|NCT00679939|12964720|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
5274368|NCT00679939|12964721|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
5274369|NCT00679939|12964720|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
5274370|NCT00679939|12964721|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
5274371|NCT00679939|12964720|P2|STARTED|52-Week Double-Blind (DB) Period||112
5274372|NCT00679939|12964721|P1|STARTED|52-Week Double-Blind (DB) Period||114
5274373|NCT00679913|12964872|P2|NOT COMPLETED|Overall Study||13
5274374|NCT00679913|12964873|P1|NOT COMPLETED|Overall Study||18
5274375|NCT00679913|12964872|P2|COMPLETED|Overall Study||86
5274376|NCT00679913|12964873|P1|COMPLETED|Overall Study||83
5274377|NCT00679913|12964872|P2|STARTED|Overall Study||99
5274378|NCT00679913|12964873|P1|STARTED|Overall Study||101
5274379|NCT00679783|12964888|P7|NOT COMPLETED|Overall Study||1
5274380|NCT00679783|12964889|P6|NOT COMPLETED|Overall Study||0
5274381|NCT00679783|12964890|P5|NOT COMPLETED|Overall Study||1
5274382|NCT00679783|12964891|P4|NOT COMPLETED|Overall Study||20
5274383|NCT00679783|12964892|P3|NOT COMPLETED|Overall Study||1
5274384|NCT00679783|12964893|P2|NOT COMPLETED|Overall Study||3
5274385|NCT00679783|12964894|P1|NOT COMPLETED|Overall Study||2
5274386|NCT00679783|12964888|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
5274387|NCT00679783|12964889|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
5274388|NCT00679783|12964890|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
5274389|NCT00679783|12964891|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
5274390|NCT00679783|12964892|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
5274391|NCT00679783|12964893|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
5274392|NCT00679783|12964894|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
5274393|NCT00679783|12964888|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
5274394|NCT00679783|12964889|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
5274395|NCT00679783|12964890|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
5274396|NCT00679783|12964891|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
5274397|NCT00679783|12964892|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
5274398|NCT00679783|12964893|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
5274399|NCT00679783|12964894|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
5274400|NCT00679627|12964947|P2|NOT COMPLETED|Overall Study||685
5274401|NCT00679627|12964948|P1|NOT COMPLETED|Overall Study||699
5274402|NCT00679627|12964947|P2|COMPLETED|Overall Study||339
5274403|NCT00679627|12964948|P1|COMPLETED|Overall Study||322
5274404|NCT00679627|12964947|P2|STARTED|Overall Study||1024
5274405|NCT00679627|12964948|P1|STARTED|Overall Study||1021
5274406|NCT00679549|12964972|P2|NOT COMPLETED|Overall Study||9
5274407|NCT00679549|12964973|P1|NOT COMPLETED|Overall Study||6
5274408|NCT00679549|12964972|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
5274409|NCT00679549|12964973|P1|COMPLETED|Overall Study||69
5274410|NCT00679549|12964972|P2|STARTED|Overall Study||75
5274411|NCT00679549|12964973|P1|STARTED|Overall Study||75
5274412|NCT00679432|12964983|P4|NOT COMPLETED|Overall Study||32
5274413|NCT00679432|12964984|P3|NOT COMPLETED|Overall Study||53
5274414|NCT00679432|12964985|P2|NOT COMPLETED|Overall Study||38
5274415|NCT00679432|12964986|P1|NOT COMPLETED|Overall Study||37
5274416|NCT00679432|12964983|P4|COMPLETED|Overall Study||95
5274417|NCT00679432|12964984|P3|COMPLETED|Overall Study||76
5274418|NCT00679432|12964985|P2|COMPLETED|Overall Study||89
5274419|NCT00679432|12964986|P1|COMPLETED|Overall Study||89
5274420|NCT00679432|12964983|P4|STARTED|Overall Study||127
5274421|NCT00679432|12964984|P3|STARTED|Overall Study||129
5274422|NCT00679432|12964985|P2|STARTED|Overall Study||127
5274423|NCT00679432|12964986|P1|STARTED|Overall Study||126
5274424|NCT00679380|12965008|P4|NOT COMPLETED|Overall Study||28
5274425|NCT00679380|12965009|P3|NOT COMPLETED|Overall Study||35
5274426|NCT00679380|12965010|P2|NOT COMPLETED|Overall Study||33
5274427|NCT00679380|12965011|P1|NOT COMPLETED|Overall Study||42
5274428|NCT00679380|12965008|P4|COMPLETED|Overall Study||61
5274429|NCT00679380|12965009|P3|COMPLETED|Overall Study||68
5274430|NCT00679380|12965010|P2|COMPLETED|Overall Study||76
5274431|NCT00679380|12965011|P1|COMPLETED|Overall Study||67
5274432|NCT00679380|12965008|P4|STARTED|Overall Study||89
5274433|NCT00679380|12965009|P3|STARTED|Overall Study||103
5274434|NCT00679380|12965010|P2|STARTED|Overall Study||109
5274435|NCT00679380|12965011|P1|STARTED|Overall Study||109
5274436|NCT00679367|12965029|P1|NOT COMPLETED|Overall Study||12
5274437|NCT00679367|12965029|P1|COMPLETED|Overall Study||4
5274438|NCT00679367|12965029|P1|STARTED|Overall Study||16
5274439|NCT00679354|12965035|P1|NOT COMPLETED|Overall Study||30
5274440|NCT00679354|12965035|P1|COMPLETED|Overall Study||0
5274441|NCT00679354|12965035|P1|STARTED|Overall Study||30
5274442|NCT00679341|12965053|P2|NOT COMPLETED|Overall Study||51
5274443|NCT00679341|12965054|P1|NOT COMPLETED|Overall Study||53
5274444|NCT00679341|12965053|P2|COMPLETED|Overall Study||19
5274445|NCT00679341|12965054|P1|COMPLETED|Overall Study||14
5274446|NCT00679341|12965053|P2|STARTED|Overall Study||70
5274447|NCT00679341|12965054|P1|STARTED|Overall Study||67
5274448|NCT00679302|12965074|P2|NOT COMPLETED|Overall Study||4
5274449|NCT00679302|12965075|P1|NOT COMPLETED|Overall Study||8
5274450|NCT00679302|12965074|P2|COMPLETED|Overall Study||73
5274452|NCT00679302|12965074|P2|STARTED|Overall Study||77
5274453|NCT00679302|12965075|P1|STARTED|Overall Study||84
5274454|NCT00679289|12965086|P3|NOT COMPLETED|Overall Study||23
5274455|NCT00679289|12965087|P2|NOT COMPLETED|Overall Study||6
5274456|NCT00679289|12965088|P1|NOT COMPLETED|Overall Study||5
5274457|NCT00679289|12965086|P3|COMPLETED|Overall Study||1
5274458|NCT00679289|12965087|P2|COMPLETED|Overall Study||0
5274459|NCT00679289|12965088|P1|COMPLETED|Overall Study||1
5274460|NCT00679289|12965086|P3|STARTED|Overall Study||24
5274461|NCT00679289|12965087|P2|STARTED|Overall Study||6
5274462|NCT00679289|12965088|P1|STARTED|Overall Study||6
5274463|NCT00679263|12965110|P3|NOT COMPLETED|Visit 2/Dose 1||0
5274464|NCT00679263|12965111|P2|NOT COMPLETED|Visit 2/Dose 1||1
5274465|NCT00679263|12965112|P1|NOT COMPLETED|Visit 2/Dose 1||2
5274466|NCT00679263|12965110|P3|COMPLETED|Visit 2/Dose 1||11
5274467|NCT00679263|12965111|P2|COMPLETED|Visit 2/Dose 1||5
5274468|NCT00679263|12965112|P1|COMPLETED|Visit 2/Dose 1||9
5274469|NCT00679263|12965110|P3|STARTED|Visit 2/Dose 1||11
5274470|NCT00679263|12965111|P2|STARTED|Visit 2/Dose 1||6
5274471|NCT00679263|12965112|P1|STARTED|Visit 2/Dose 1||11
5274472|NCT00679263|12965110|P3|NOT COMPLETED|Visit 3/Dose 2||0
5274473|NCT00679263|12965111|P2|NOT COMPLETED|Visit 3/Dose 2||5
5274474|NCT00679263|12965112|P1|NOT COMPLETED|Visit 3/Dose 2||1
5274475|NCT00679263|12965110|P3|COMPLETED|Visit 3/Dose 2||11
5274476|NCT00679263|12965111|P2|COMPLETED|Visit 3/Dose 2||6
5274477|NCT00679263|12965112|P1|COMPLETED|Visit 3/Dose 2||9
5274478|NCT00679263|12965110|P3|STARTED|Visit 3/Dose 2||11
5274479|NCT00679263|12965111|P2|STARTED|Visit 3/Dose 2||11
5274480|NCT00679263|12965112|P1|STARTED|Visit 3/Dose 2||10
5274481|NCT00679211|12965123|P1|NOT COMPLETED|Overall Study||110
5274482|NCT00679211|12965123|P1|COMPLETED|Overall Study||0
5274483|NCT00679211|12965123|P1|STARTED|Overall Study||110
5274484|NCT00679172|12965140|P5|NOT COMPLETED|Overall Study||0
5274485|NCT00679172|12965141|P4|NOT COMPLETED|Overall Study||1
5274486|NCT00679172|12965142|P3|NOT COMPLETED|Overall Study||1
5274487|NCT00679172|12965143|P2|NOT COMPLETED|Overall Study||1
5274488|NCT00679172|12965144|P1|NOT COMPLETED|Overall Study||1
5274489|NCT00679172|12965140|P5|COMPLETED|Overall Study||37
5274490|NCT00679172|12965141|P4|COMPLETED|Overall Study||38
5274491|NCT00679172|12965142|P3|COMPLETED|Overall Study||35
5274492|NCT00679172|12965143|P2|COMPLETED|Overall Study||37
5274493|NCT00679172|12965144|P1|COMPLETED|Overall Study||36
5274494|NCT00679172|12965140|P5|STARTED|Overall Study||37
5274495|NCT00679172|12965141|P4|STARTED|Overall Study||39
5274496|NCT00679172|12965142|P3|STARTED|Overall Study||36
5274497|NCT00679172|12965143|P2|STARTED|Overall Study||38
5274498|NCT00679172|12965144|P1|STARTED|Overall Study||37
5274499|NCT00679081|12965207|P1|NOT COMPLETED|Overall Study||1
5274500|NCT00679081|12965207|P1|COMPLETED|Overall Study||14
5274501|NCT00679081|12965207|P1|STARTED|Overall Study|Study design was within-subject control.|15
5274502|NCT00679055|12965217|P2|NOT COMPLETED|Overall Study||5
5274503|NCT00679055|12965218|P1|NOT COMPLETED|Overall Study||2
5274504|NCT00679055|12965217|P2|COMPLETED|Overall Study||1
5274505|NCT00679055|12965218|P1|COMPLETED|Overall Study||6
5274506|NCT00679055|12965217|P2|STARTED|Overall Study||6
5274507|NCT00679055|12965218|P1|STARTED|Overall Study||8
5274508|NCT00679029|12965228|P1|NOT COMPLETED|Overall Study||5
5274509|NCT00679029|12965228|P1|COMPLETED|Overall Study||10
5274510|NCT00679029|12965228|P1|STARTED|Overall Study||15
5274511|NCT00678899|12965235|P1|NOT COMPLETED|Overall Study||1
5274512|NCT00678899|12965235|P1|COMPLETED|Overall Study||49
5274513|NCT00678899|12965235|P1|STARTED|Overall Study||50
5274514|NCT00678886|12965244|P4|NOT COMPLETED|Overall Study||9
5274515|NCT00678886|12965245|P3|NOT COMPLETED|Overall Study||9
5274516|NCT00678886|12965246|P2|NOT COMPLETED|Overall Study||0
5274517|NCT00678886|12965247|P1|NOT COMPLETED|Overall Study||0
5274518|NCT00678886|12965244|P4|COMPLETED|Overall Study||153
5274519|NCT00678886|12965245|P3|COMPLETED|Overall Study||72
5274520|NCT00678886|12965246|P2|COMPLETED|Overall Study||19
5274521|NCT00678886|12965247|P1|COMPLETED|Overall Study||10
5274522|NCT00678886|12965244|P4|STARTED|Overall Study||162
5274523|NCT00678886|12965245|P3|STARTED|Overall Study||81
5274524|NCT00678886|12965246|P2|STARTED|Overall Study||19
5274525|NCT00678886|12965247|P1|STARTED|Overall Study||10
5274526|NCT00678834|12965294|P3|NOT COMPLETED|Overall Study||9
5274527|NCT00678834|12965295|P2|NOT COMPLETED|Overall Study||0
5274528|NCT00678834|12965296|P1|NOT COMPLETED|Overall Study||16
5274529|NCT00678834|12965294|P3|COMPLETED|Overall Study||16
5274530|NCT00678834|12965295|P2|COMPLETED|Overall Study||15
5274531|NCT00678834|12965296|P1|COMPLETED|Overall Study||24
5274532|NCT00678834|12965294|P3|STARTED|Overall Study||25
5274533|NCT00678834|12965295|P2|STARTED|Overall Study||15
5274534|NCT00678834|12965296|P1|STARTED|Overall Study||40
5274535|NCT00678795|12965316|P2|NOT COMPLETED|Overall Study||6
5274536|NCT00678795|12965317|P1|NOT COMPLETED|Overall Study||11
5274537|NCT00678795|12965316|P2|COMPLETED|Overall Study||62
5274538|NCT00678795|12965317|P1|COMPLETED|Overall Study||56
5274539|NCT00678795|12965316|P2|STARTED|Overall Study||68
5274540|NCT00678795|12965317|P1|STARTED|Overall Study||67
5274541|NCT00678691|12965339|P2|NOT COMPLETED|Overall Study||4
5274542|NCT00678691|12965340|P1|NOT COMPLETED|Overall Study||6
5274543|NCT00678691|12965339|P2|COMPLETED|Overall Study||24
5274544|NCT00678691|12965340|P1|COMPLETED|Overall Study||21
5274545|NCT00678691|12965339|P2|STARTED|Overall Study||28
5274546|NCT00678691|12965340|P1|STARTED|Overall Study||27
5274547|NCT00678652|12965350|P4|NOT COMPLETED|Overall Study||0
5274548|NCT00678652|12965351|P3|NOT COMPLETED|Overall Study||1
5274549|NCT00678652|12965352|P2|NOT COMPLETED|Overall Study||0
5274550|NCT00678652|12965353|P1|NOT COMPLETED|Overall Study||3
5274551|NCT00678652|12965350|P4|COMPLETED|Overall Study||9
5274552|NCT00678652|12965351|P3|COMPLETED|Overall Study||8
5274553|NCT00678652|12965352|P2|COMPLETED|Overall Study||9
5274554|NCT00678652|12965353|P1|COMPLETED|Overall Study||6
5274555|NCT00678652|12965350|P4|STARTED|Overall Study||9
5274556|NCT00678652|12965351|P3|STARTED|Overall Study||9
5274557|NCT00678652|12965352|P2|STARTED|Overall Study||9
5274558|NCT00678652|12965353|P1|STARTED|Overall Study||9
5274559|NCT00678639|12965377|P2|NOT COMPLETED|Overall Study||0
5274560|NCT00678639|12965378|P1|NOT COMPLETED|Overall Study||2
5274561|NCT00678639|12965377|P2|COMPLETED|Overall Study||57
5274562|NCT00678639|12965378|P1|COMPLETED|Overall Study||51
5274563|NCT00678639|12965377|P2|Hospital Discharge|Overall Study||57
5274564|NCT00678639|12965378|P1|Hospital Discharge|Overall Study||53
5274565|NCT00678639|12965377|P2|STARTED|Overall Study||57
5274566|NCT00678639|12965378|P1|STARTED|Overall Study||53
5274567|NCT00678587|12965393|P2|NOT COMPLETED|Overall Study||18
5274568|NCT00678587|12965394|P1|NOT COMPLETED|Overall Study||20
5274569|NCT00678587|12965393|P2|COMPLETED|Overall Study||127
5274570|NCT00678587|12965394|P1|COMPLETED|Overall Study||127
5274571|NCT00678587|12965393|P2|STARTED|Overall Study||145
5274572|NCT00678587|12965394|P1|STARTED|Overall Study||147
5274573|NCT00678574|12965428|P2|NOT COMPLETED|Overall Study||0
5274574|NCT00678574|12965429|P1|NOT COMPLETED|Overall Study||0
5274575|NCT00678574|12965428|P2|COMPLETED|Overall Study||27
5274576|NCT00678574|12965429|P1|COMPLETED|Overall Study||18
5274577|NCT00678574|12965428|P2|STARTED|Overall Study||27
5274578|NCT00678574|12965429|P1|STARTED|Overall Study||18
5274579|NCT00678535|12965437|P2|NOT COMPLETED|Overall Study||98
5274580|NCT00678535|12965438|P1|NOT COMPLETED|Overall Study||93
5274581|NCT00678535|12965437|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
5274582|NCT00678535|12965438|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
5274583|NCT00678535|12965437|P2|STARTED|Overall Study|ITT population|449
5274584|NCT00678535|12965438|P1|STARTED|Overall Study|ITT population|455
5274585|NCT00678470|12965454|P1|NOT COMPLETED|Overall Study||4
5274586|NCT00678470|12965454|P1|COMPLETED|Overall Study||14
5274587|NCT00678470|12965454|P1|STARTED|Overall Study||18
5274588|NCT00678444|12965460|P2|NOT COMPLETED|Overall Study||0
5274589|NCT00678444|12965461|P1|NOT COMPLETED|Overall Study||0
5274590|NCT00678444|12965460|P2|COMPLETED|Overall Study||99
5274591|NCT00678444|12965461|P1|COMPLETED|Overall Study||100
5274592|NCT00678444|12965460|P2|STARTED|Overall Study||99
5274593|NCT00678444|12965461|P1|STARTED|Overall Study||100
5274594|NCT00678418|12965471|P2|NOT COMPLETED|Part B (Open Label)||0
5274595|NCT00678418|12965472|P1|NOT COMPLETED|Part B (Open Label)||43
5274596|NCT00678418|12965471|P2|COMPLETED|Part B (Open Label)||0
5274597|NCT00678418|12965472|P1|COMPLETED|Part B (Open Label)||71
5274598|NCT00678418|12965471|P2|STARTED|Part B (Open Label)||0
5274599|NCT00678418|12965472|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
5274600|NCT00678418|12965471|P2|NOT COMPLETED|Part A (Double Blind)||77
5274601|NCT00678418|12965472|P1|NOT COMPLETED|Part A (Double Blind)||59
5274602|NCT00678418|12965471|P2|COMPLETED|Part A (Double Blind)||47
5274603|NCT00678418|12965472|P1|COMPLETED|Part A (Double Blind)||67
5274604|NCT00678418|12965471|P2|STARTED|Part A (Double Blind)||124
5274605|NCT00678418|12965472|P1|STARTED|Part A (Double Blind)||126
5274606|NCT00678392|12965488|P2|NOT COMPLETED|Overall Study||362
5274607|NCT00678392|12965489|P1|NOT COMPLETED|Overall Study||361
5274608|NCT00678392|12965488|P2|COMPLETED|Overall Study||0
5274609|NCT00678392|12965489|P1|COMPLETED|Overall Study||0
5274610|NCT00678392|12965488|P2|Treated|Overall Study||355
5274611|NCT00678392|12965489|P1|Treated|Overall Study||359
5274612|NCT00678392|12965488|P2|STARTED|Overall Study||362
5274613|NCT00678392|12965489|P1|STARTED|Overall Study||361
5274614|NCT00678379|12965524|P3|NOT COMPLETED|Overall Study||4
5274615|NCT00678379|12965525|P2|NOT COMPLETED|Overall Study||3
5274616|NCT00678379|12965526|P1|NOT COMPLETED|Overall Study||6
5274617|NCT00678379|12965524|P3|COMPLETED|Overall Study||36
5274618|NCT00678379|12965525|P2|COMPLETED|Overall Study||37
5274619|NCT00678379|12965526|P1|COMPLETED|Overall Study||34
5274620|NCT00678379|12965524|P3|STARTED|Overall Study||40
5274621|NCT00678379|12965525|P2|STARTED|Overall Study||40
5274622|NCT00678379|12965526|P1|STARTED|Overall Study||40
5274623|NCT00678301|12965554|P2|NOT COMPLETED|Overall Study||2
5274624|NCT00678301|12965555|P1|NOT COMPLETED|Overall Study||8
5274625|NCT00678301|12965554|P2|COMPLETED|Overall Study||116
5274626|NCT00678301|12965555|P1|COMPLETED|Overall Study||231
5274627|NCT00678301|12965554|P2|STARTED|Overall Study||118
5274628|NCT00678301|12965555|P1|STARTED|Overall Study||239
5274629|NCT00678288|12965613|P2|NOT COMPLETED|Overall Study||6
5274630|NCT00678288|12965614|P1|NOT COMPLETED|Overall Study||10
5274631|NCT00678288|12965613|P2|COMPLETED|Overall Study||0
5274632|NCT00678288|12965614|P1|COMPLETED|Overall Study||0
5274633|NCT00678288|12965613|P2|STARTED|Overall Study||6
5274634|NCT00678288|12965614|P1|STARTED|Overall Study||10
5274635|NCT00678249|12965631|P3|NOT COMPLETED|Overall Study||0
5274636|NCT00678249|12965632|P2|NOT COMPLETED|Overall Study||0
5274637|NCT00678249|12965633|P1|NOT COMPLETED|Overall Study||0
5274638|NCT00678249|12965631|P3|COMPLETED|Overall Study||37
5274639|NCT00678249|12965632|P2|COMPLETED|Overall Study||93
5274640|NCT00678249|12965633|P1|COMPLETED|Overall Study||97
5274641|NCT00678249|12965631|P3|STARTED|Overall Study||37
5274642|NCT00678249|12965632|P2|STARTED|Overall Study||93
5274643|NCT00678249|12965633|P1|STARTED|Overall Study||97
5274644|NCT00678210|12965669|P4|NOT COMPLETED|Overall Study||20
5274645|NCT00678210|12965670|P3|NOT COMPLETED|Overall Study||6
5274646|NCT00678210|12965671|P2|NOT COMPLETED|Overall Study||11
5274647|NCT00678210|12965672|P1|NOT COMPLETED|Overall Study||11
5274648|NCT00678210|12965669|P4|COMPLETED|Overall Study||30
5274649|NCT00678210|12965670|P3|COMPLETED|Overall Study||43
5274650|NCT00678210|12965671|P2|COMPLETED|Overall Study||38
5274651|NCT00678210|12965672|P1|COMPLETED|Overall Study||38
5274652|NCT00678210|12965669|P4|STARTED|Overall Study||50
5274653|NCT00678210|12965670|P3|STARTED|Overall Study||49
5274654|NCT00678210|12965671|P2|STARTED|Overall Study||49
5274655|NCT00678210|12965672|P1|STARTED|Overall Study||49
5274656|NCT00678080|12965708|P2|NOT COMPLETED|Overall Study||1
5274657|NCT00678080|12965709|P1|NOT COMPLETED|Overall Study||3
5274658|NCT00678080|12965708|P2|COMPLETED|Overall Study||13
5274659|NCT00678080|12965709|P1|COMPLETED|Overall Study||8
5274660|NCT00678080|12965708|P2|STARTED|Overall Study||14
5274661|NCT00678080|12965709|P1|STARTED|Overall Study||11
5274662|NCT00678041|12965735|P2|NOT COMPLETED|Overall Study||5
5274663|NCT00678041|12965736|P1|NOT COMPLETED|Overall Study||5
5274664|NCT00678041|12965735|P2|COMPLETED|Overall Study||0
5274665|NCT00678041|12965736|P1|COMPLETED|Overall Study||0
5274666|NCT00678041|12965735|P2|STARTED|Overall Study||5
5274667|NCT00678041|12965736|P1|STARTED|Overall Study||5
5274668|NCT00678015|12965748|P1|NOT COMPLETED|Overall Study||0
5274669|NCT00678015|12965748|P1|COMPLETED|Overall Study||12
5274670|NCT00678015|12965748|P1|STARTED|Overall Study||12
5274671|NCT00677924|12965757|P2|NOT COMPLETED|Overall Study||0
5274672|NCT00677924|12965758|P1|NOT COMPLETED|Overall Study||0
5274673|NCT00677924|12965757|P2|COMPLETED|Overall Study||6
5274674|NCT00677924|12965758|P1|COMPLETED|Overall Study||3
5274675|NCT00677924|12965757|P2|STARTED|Overall Study||6
5274676|NCT00677924|12965758|P1|STARTED|Overall Study||3
5274677|NCT00677898|12965768|P2|NOT COMPLETED|Overall Study||18
5274678|NCT00677898|12965769|P1|NOT COMPLETED|Overall Study||20
5274679|NCT00677898|12965768|P2|COMPLETED|Overall Study||102
5274680|NCT00677898|12965769|P1|COMPLETED|Overall Study||99
5274681|NCT00677898|12965768|P2|STARTED|Overall Study||120
5274682|NCT00677898|12965769|P1|STARTED|Overall Study||119
5274683|NCT00677833|12965789|P4|NOT COMPLETED|Overall Study||3
5274684|NCT00677833|12965790|P3|NOT COMPLETED|Overall Study||2
5274685|NCT00677833|12965791|P2|NOT COMPLETED|Overall Study||0
5274686|NCT00677833|12965792|P1|NOT COMPLETED|Overall Study||4
5274687|NCT00677833|12965789|P4|COMPLETED|Overall Study||128
5274688|NCT00677833|12965790|P3|COMPLETED|Overall Study||122
5274689|NCT00677833|12965791|P2|COMPLETED|Overall Study||51
5274690|NCT00677833|12965792|P1|COMPLETED|Overall Study||51
5274691|NCT00677833|12965789|P4|STARTED|Overall Study||131
5274692|NCT00677833|12965790|P3|STARTED|Overall Study||124
5274693|NCT00677833|12965791|P2|STARTED|Overall Study||51
5274694|NCT00677833|12965792|P1|STARTED|Overall Study||55
5274695|NCT00677820|12965842|P2|NOT COMPLETED|Overall Study||0
5274696|NCT00677820|12965843|P1|NOT COMPLETED|Overall Study||1
5274697|NCT00677820|12965842|P2|COMPLETED|Overall Study||60
5274698|NCT00677820|12965843|P1|COMPLETED|Overall Study||239
5274699|NCT00677820|12965842|P2|STARTED|Overall Study||60
5274700|NCT00677820|12965843|P1|STARTED|Overall Study||240
5274701|NCT00677807|12965864|P3|NOT COMPLETED|Overall Study||20
5274702|NCT00677807|12965865|P2|NOT COMPLETED|Overall Study||11
5274703|NCT00677807|12965866|P1|NOT COMPLETED|Overall Study||18
5274704|NCT00677807|12965864|P3|COMPLETED|Overall Study||105
5274705|NCT00677807|12965865|P2|COMPLETED|Overall Study||135
5274706|NCT00677807|12965866|P1|COMPLETED|Overall Study||126
5274707|NCT00677807|12965864|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
5274708|NCT00677807|12965865|P2|Safety/ITT: Received Study Drug|Overall Study||146
5274709|NCT00677807|12965866|P1|Safety/ITT: Received Study Drug|Overall Study||144
5274710|NCT00677807|12965864|P3|STARTED|Overall Study||125
5274711|NCT00677807|12965865|P2|STARTED|Overall Study||146
5274712|NCT00677807|12965866|P1|STARTED|Overall Study||144
5274713|NCT00677690|12965897|P2|NOT COMPLETED|Overall Study||0
5274714|NCT00677690|12965898|P1|NOT COMPLETED|Overall Study||0
5274715|NCT00677690|12965897|P2|COMPLETED|Overall Study||41
5274716|NCT00677690|12965898|P1|COMPLETED|Overall Study||42
5274717|NCT00677690|12965897|P2|STARTED|Overall Study||41
5274718|NCT00677690|12965898|P1|STARTED|Overall Study||42
5274719|NCT00677534|12965912|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
5274720|NCT00677534|12965912|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
5274721|NCT00677534|12965912|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
5274722|NCT00677534|12965912|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
5274723|NCT00677534|12965912|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
5274724|NCT00677534|12965912|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
5274725|NCT00677534|12965912|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
5274726|NCT00677534|12965912|P1|COMPLETED|Washout (Weeks 1-4)||7
5274727|NCT00677534|12965912|P1|STARTED|Washout (Weeks 1-4)||10
5274728|NCT00677365|12965920|P4|NOT COMPLETED|Overall Study||3
5274729|NCT00677365|12965921|P3|NOT COMPLETED|Overall Study||2
5274730|NCT00677365|12965922|P2|NOT COMPLETED|Overall Study||1
5274731|NCT00677365|12965923|P1|NOT COMPLETED|Overall Study||2
5274732|NCT00677365|12965920|P4|COMPLETED|Overall Study||36
5274733|NCT00677365|12965921|P3|COMPLETED|Overall Study||35
5274734|NCT00677365|12965922|P2|COMPLETED|Overall Study||37
5274735|NCT00677365|12965923|P1|COMPLETED|Overall Study||35
5274736|NCT00677365|12965920|P4|STARTED|Overall Study||39
5274737|NCT00677365|12965921|P3|STARTED|Overall Study||37
5274738|NCT00677365|12965922|P2|STARTED|Overall Study||38
5274739|NCT00677365|12965923|P1|STARTED|Overall Study||37
5274740|NCT00677352|12965955|P2|NOT COMPLETED|Tapering Phase||10
5274741|NCT00677352|12965956|P1|NOT COMPLETED|Tapering Phase||6
5274742|NCT00677352|12965955|P2|COMPLETED|Tapering Phase||112
5274743|NCT00677352|12965956|P1|COMPLETED|Tapering Phase||126
5274744|NCT00677352|12965955|P2|STARTED|Tapering Phase||122
5274745|NCT00677352|12965956|P1|STARTED|Tapering Phase||132
5274746|NCT00677352|12965955|P2|NOT COMPLETED|Treatment Phase||42
5274747|NCT00677352|12965956|P1|NOT COMPLETED|Treatment Phase||25
5274748|NCT00677352|12965955|P2|COMPLETED|Treatment Phase||122
5274749|NCT00677352|12965956|P1|COMPLETED|Treatment Phase||132
5274750|NCT00677352|12965955|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
5274751|NCT00677352|12965956|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
5274752|NCT00677235|12965976|P2|NOT COMPLETED|Overall Study||38
5274753|NCT00677235|12965977|P1|NOT COMPLETED|Overall Study||41
5274754|NCT00677235|12965976|P2|COMPLETED|Overall Study||94
5274755|NCT00677235|12965977|P1|COMPLETED|Overall Study||97
5274756|NCT00677235|12965976|P2|STARTED|Overall Study||132
5274757|NCT00677235|12965977|P1|STARTED|Overall Study||138
5274758|NCT00677092|12966017|P1|NOT COMPLETED|Overall Study||6
5274759|NCT00677092|12966017|P1|COMPLETED|Overall Study||6
5274760|NCT00677092|12966017|P1|Received Study Treatment|Overall Study||11
5274761|NCT00677092|12966017|P1|STARTED|Overall Study||12
5274762|NCT00677040|12966026|P1|NOT COMPLETED|Overall Study||0
5274763|NCT00677040|12966026|P1|COMPLETED|Overall Study||20
5274764|NCT00677040|12966026|P1|STARTED|Overall Study||20
5274765|NCT00677014|12966034|P3|NOT COMPLETED|Overall Study||49
5274766|NCT00677014|12966035|P2|NOT COMPLETED|Overall Study||41
5274767|NCT00677014|12966036|P1|NOT COMPLETED|Overall Study||44
5274768|NCT00677014|12966034|P3|COMPLETED|Overall Study||283
5274769|NCT00677014|12966035|P2|COMPLETED|Overall Study||282
5274770|NCT00677014|12966036|P1|COMPLETED|Overall Study||281
5274771|NCT00677014|12966034|P3|STARTED|Overall Study||332
5274772|NCT00677014|12966035|P2|STARTED|Overall Study||323
5274773|NCT00677014|12966036|P1|STARTED|Overall Study||325
5274774|NCT00676897|12966046|P2|NOT COMPLETED|Overall Study||0
5274775|NCT00676897|12966047|P1|NOT COMPLETED|Overall Study||0
5274776|NCT00676897|12966046|P2|COMPLETED|Overall Study||10
5274777|NCT00676897|12966047|P1|COMPLETED|Overall Study||8
5274778|NCT00676897|12966046|P2|STARTED|Overall Study||10
5274779|NCT00676897|12966047|P1|STARTED|Overall Study||8
5274780|NCT00676806|12966057|P2|NOT COMPLETED|Overall Study||0
5274781|NCT00676806|12966058|P1|NOT COMPLETED|Overall Study||0
5274782|NCT00676806|12966057|P2|COMPLETED|Overall Study||3
5274783|NCT00676806|12966058|P1|COMPLETED|Overall Study||3
5274784|NCT00676806|12966057|P2|STARTED|Overall Study||3
5274785|NCT00676806|12966058|P1|STARTED|Overall Study||3
5274786|NCT00676793|12966074|P1|NOT COMPLETED|Overall Study||13
5274787|NCT00676793|12966074|P1|COMPLETED|Overall Study||19
5274788|NCT00676793|12966074|P1|STARTED|Overall Study||32
5274789|NCT00676780|12966079|P1|NOT COMPLETED|Overall Study||7
5274790|NCT00676780|12966079|P1|COMPLETED|Overall Study||26
5274791|NCT00676780|12966079|P1|STARTED|Overall Study||33
5274792|NCT00676715|12966089|P4|NOT COMPLETED|Overall Study||40
5274793|NCT00676715|12966090|P3|NOT COMPLETED|Overall Study||41
5274794|NCT00676715|12966091|P2|NOT COMPLETED|Overall Study||47
5274795|NCT00676715|12966092|P1|NOT COMPLETED|Overall Study||40
5274796|NCT00676715|12966089|P4|COMPLETED|Overall Study||14
5274797|NCT00676715|12966090|P3|COMPLETED|Overall Study||14
5274798|NCT00676715|12966091|P2|COMPLETED|Overall Study||8
5274799|NCT00676715|12966092|P1|COMPLETED|Overall Study||14
5274800|NCT00676715|12966089|P4|STARTED|Overall Study||54
5274801|NCT00676715|12966090|P3|STARTED|Overall Study||55
5274802|NCT00676715|12966091|P2|STARTED|Overall Study||55
5274803|NCT00676715|12966092|P1|STARTED|Overall Study||54
5274804|NCT00676689|12966122|P1|NOT COMPLETED|Overall Study||61
5274805|NCT00676689|12966122|P1|COMPLETED|Overall Study||20
5274806|NCT00676689|12966122|P1|1 Year Follow-up|Overall Study||64
5274807|NCT00676689|12966122|P1|30 Day Follow-up|Overall Study||78
5274808|NCT00676689|12966122|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
5274809|NCT00676689|12966122|P1|STARTED|Overall Study||81
5274810|NCT00676676|12966128|P1|NOT COMPLETED|Overall Study||0
5274811|NCT00676676|12966128|P1|COMPLETED|Overall Study||9
5274812|NCT00676676|12966128|P1|STARTED|Overall Study||9
5274813|NCT00676663|12966134|P2|NOT COMPLETED|Overall Study||38
5274814|NCT00676663|12966135|P1|NOT COMPLETED|Overall Study||45
5274815|NCT00676663|12966134|P2|COMPLETED|Overall Study||26
5274816|NCT00676663|12966135|P1|COMPLETED|Overall Study||21
5274817|NCT00676663|12966134|P2|STARTED|Overall Study||64
5274818|NCT00676663|12966135|P1|STARTED|Overall Study||66
5274819|NCT00676650|12966151|P2|NOT COMPLETED|Overall Study||289
5274820|NCT00676650|12966152|P1|NOT COMPLETED|Overall Study||584
5274821|NCT00676650|12966151|P2|COMPLETED|Overall Study||0
5274822|NCT00676650|12966152|P1|COMPLETED|Overall Study||0
5274823|NCT00676650|12966151|P2|Treated|Overall Study||285
5274824|NCT00676650|12966152|P1|Treated|Overall Study||581
5274825|NCT00676650|12966151|P2|STARTED|Overall Study||289
5274826|NCT00676650|12966152|P1|STARTED|Overall Study||584
5274827|NCT00676585|12966172|P2|NOT COMPLETED|Overall Study||0
5274828|NCT00676585|12966173|P1|NOT COMPLETED|Overall Study||0
5274829|NCT00676585|12966172|P2|COMPLETED|Overall Study||25
5274830|NCT00676585|12966173|P1|COMPLETED|Overall Study||25
5274831|NCT00676585|12966172|P2|STARTED|Overall Study||25
5274832|NCT00676585|12966173|P1|STARTED|Overall Study||25
5274833|NCT00676572|12966185|P2|NOT COMPLETED|Overall Study||0
5274834|NCT00676572|12966186|P1|NOT COMPLETED|Overall Study||0
5274835|NCT00676572|12966185|P2|COMPLETED|Overall Study||6
5274836|NCT00676572|12966186|P1|COMPLETED|Overall Study||6
5274837|NCT00676572|12966185|P2|STARTED|Overall Study||6
5274838|NCT00676572|12966186|P1|STARTED|Overall Study||6
5274839|NCT00676520|12966194|P1|NOT COMPLETED|Overall Study||731
5274840|NCT00676520|12966194|P1|COMPLETED|Overall Study||7309
5274841|NCT00676520|12966194|P1|STARTED|Overall Study||8040
5274842|NCT00676494|12966251|P1|NOT COMPLETED|Overall Study||14
5274843|NCT00676494|12966251|P1|COMPLETED|Overall Study||158
5274844|NCT00676494|12966251|P1|STARTED|Overall Study||172
5274845|NCT00676455|12966257|P1|NOT COMPLETED|Overall Study||0
5274846|NCT00676455|12966257|P1|COMPLETED|Overall Study||14
5274847|NCT00676455|12966257|P1|STARTED|Overall Study||14
5274848|NCT00676403|12966268|P6|NOT COMPLETED|Overall Study||5
5274849|NCT00676403|12966269|P5|NOT COMPLETED|Overall Study||1
5274850|NCT00676403|12966270|P4|NOT COMPLETED|Overall Study||5
5274851|NCT00676403|12966271|P3|NOT COMPLETED|Overall Study||1
5274852|NCT00676403|12966272|P2|NOT COMPLETED|Overall Study||2
5274853|NCT00676403|12966273|P1|NOT COMPLETED|Overall Study||2
5274854|NCT00676403|12966268|P6|COMPLETED|Overall Study||18
5274855|NCT00676403|12966269|P5|COMPLETED|Overall Study||23
5274856|NCT00676403|12966270|P4|COMPLETED|Overall Study||17
5274857|NCT00676403|12966271|P3|COMPLETED|Overall Study||22
5274858|NCT00676403|12966272|P2|COMPLETED|Overall Study||20
5274859|NCT00676403|12966273|P1|COMPLETED|Overall Study||21
5274860|NCT00676403|12966268|P6|STARTED|Overall Study||23
5274861|NCT00676403|12966269|P5|STARTED|Overall Study||24
5274862|NCT00676403|12966270|P4|STARTED|Overall Study||22
5274863|NCT00676403|12966271|P3|STARTED|Overall Study||23
5274864|NCT00676403|12966272|P2|STARTED|Overall Study||22
5274865|NCT00676403|12966273|P1|STARTED|Overall Study||23
5274866|NCT00676364|12966403|P2|NOT COMPLETED|Overall Study||0
5274867|NCT00676364|12966404|P1|NOT COMPLETED|Overall Study||0
5274868|NCT00676364|12966403|P2|COMPLETED|Overall Study||57
5274869|NCT00676364|12966404|P1|COMPLETED|Overall Study||57
5274870|NCT00676364|12966403|P2|STARTED|Overall Study||57
5274871|NCT00676364|12966404|P1|STARTED|Overall Study||57
5274872|NCT00676338|12966416|P4|NOT COMPLETED|Overall Study||23
5274873|NCT00676338|12966417|P3|NOT COMPLETED|Overall Study||30
5274874|NCT00676338|12966418|P2|NOT COMPLETED|Overall Study||33
5274875|NCT00676338|12966419|P1|NOT COMPLETED|Overall Study||38
5274876|NCT00676338|12966416|P4|COMPLETED|Overall Study||140
5274877|NCT00676338|12966417|P3|COMPLETED|Overall Study||133
5274878|NCT00676338|12966418|P2|COMPLETED|Overall Study||213
5274879|NCT00676338|12966419|P1|COMPLETED|Overall Study||210
5274880|NCT00676338|12966416|P4|STARTED|Overall Study||163
5274881|NCT00676338|12966417|P3|STARTED|Overall Study||163
5274882|NCT00676338|12966418|P2|STARTED|Overall Study||246
5274883|NCT00676338|12966419|P1|STARTED|Overall Study||248
5274884|NCT00676208|12966471|P2|NOT COMPLETED|Overall Study||6
5274885|NCT00676208|12966472|P1|NOT COMPLETED|Overall Study||2
5274886|NCT00676208|12966471|P2|COMPLETED|Overall Study||13
5274887|NCT00676208|12966472|P1|COMPLETED|Overall Study||12
5274888|NCT00676208|12966471|P2|STARTED|Overall Study||19
5274889|NCT00676208|12966472|P1|STARTED|Overall Study||14
5274890|NCT00676195|12966480|P1|NOT COMPLETED|Overall Study||3
5274891|NCT00676195|12966480|P1|COMPLETED|Overall Study||21
5274892|NCT00676195|12966480|P1|STARTED|Overall Study||24
5274893|NCT00676182|12966490|P1|NOT COMPLETED|Overall Study||0
5274894|NCT00676182|12966490|P1|COMPLETED|Overall Study||75
5274895|NCT00676182|12966490|P1|STARTED|Overall Study||75
5274896|NCT00676143|12966505|P2|NOT COMPLETED|Overall Study||260
5274897|NCT00676143|12966506|P1|NOT COMPLETED|Overall Study||156
5274898|NCT00676143|12966505|P2|COMPLETED|Overall Study||398
5274899|NCT00676143|12966506|P1|COMPLETED|Overall Study||285
5274900|NCT00676143|12966505|P2|Treated|Overall Study||654
5274901|NCT00676143|12966506|P1|Treated|Overall Study||439
5274902|NCT00676143|12966505|P2|STARTED|Overall Study||658
5274903|NCT00676143|12966506|P1|STARTED|Overall Study||441
5274904|NCT00676130|12966546|P2|NOT COMPLETED|Overall Study||4
5274905|NCT00676130|12966547|P1|NOT COMPLETED|Overall Study||3
5274906|NCT00676130|12966546|P2|COMPLETED|Overall Study||73
5274907|NCT00676130|12966547|P1|COMPLETED|Overall Study||73
5274908|NCT00676130|12966546|P2|STARTED|Overall Study||77
5274909|NCT00676130|12966547|P1|STARTED|Overall Study||76
5274910|NCT00676091|12966557|P2|NOT COMPLETED|Toddler Dose||0
5274911|NCT00676091|12966558|P1|NOT COMPLETED|Toddler Dose||3
5274912|NCT00676091|12966557|P2|COMPLETED|Toddler Dose||156
5274913|NCT00676091|12966558|P1|COMPLETED|Toddler Dose||153
5274914|NCT00676091|12966557|P2|STARTED|Toddler Dose||156
5274915|NCT00676091|12966558|P1|STARTED|Toddler Dose||156
5274916|NCT00676091|12966557|P2|NOT COMPLETED|After Infant Series||3
5274917|NCT00676091|12966558|P1|NOT COMPLETED|After Infant Series||1
5274918|NCT00676091|12966557|P2|COMPLETED|After Infant Series||156
5274919|NCT00676091|12966558|P1|COMPLETED|After Infant Series||156
5274920|NCT00676091|12966557|P2|STARTED|After Infant Series||159
5274921|NCT00676091|12966558|P1|STARTED|After Infant Series||157
5274922|NCT00676091|12966557|P2|NOT COMPLETED|Infant Series||18
5274923|NCT00676091|12966558|P1|NOT COMPLETED|Infant Series||20
5274924|NCT00676091|12966557|P2|COMPLETED|Infant Series||159
5274925|NCT00676091|12966558|P1|COMPLETED|Infant Series||157
5274926|NCT00676091|12966557|P2|Vaccinated Dose 3|Infant Series||161
5274927|NCT00676091|12966558|P1|Vaccinated Dose 3|Infant Series||158
5274928|NCT00676091|12966557|P2|Vaccinated Dose 2|Infant Series||162
5274929|NCT00676091|12966558|P1|Vaccinated Dose 2|Infant Series||159
5274930|NCT00676091|12966557|P2|Vaccinated Dose 1|Infant Series||162
5274931|NCT00676091|12966558|P1|Vaccinated Dose 1|Infant Series||163
5274932|NCT00676091|12966557|P2|STARTED|Infant Series||177
5274933|NCT00676091|12966558|P1|STARTED|Infant Series||177
5274934|NCT00676065|12966593|P3|NOT COMPLETED|Overall Study||0
5274935|NCT00676065|12966594|P2|NOT COMPLETED|Overall Study||0
5274936|NCT00676065|12966595|P1|NOT COMPLETED|Overall Study||0
5274937|NCT00676065|12966593|P3|COMPLETED|Overall Study||26341
5274938|NCT00676065|12966594|P2|COMPLETED|Overall Study||15428
5274939|NCT00676065|12966595|P1|COMPLETED|Overall Study||16534
5274940|NCT00676065|12966593|P3|STARTED|Overall Study||26341
5274941|NCT00676065|12966594|P2|STARTED|Overall Study||15428
5274942|NCT00676065|12966595|P1|STARTED|Overall Study||16534
5274943|NCT00676052|12966615|P6|NOT COMPLETED|Overall Study||6
5274944|NCT00676052|12966616|P5|NOT COMPLETED|Overall Study||6
5274945|NCT00676052|12966617|P4|NOT COMPLETED|Overall Study||5
5274946|NCT00676052|12966618|P3|NOT COMPLETED|Overall Study||6
5274947|NCT00676052|12966619|P2|NOT COMPLETED|Overall Study||7
5274948|NCT00676052|12966620|P1|NOT COMPLETED|Overall Study||9
5274949|NCT00676052|12966615|P6|COMPLETED|Overall Study||91
5274950|NCT00676052|12966616|P5|COMPLETED|Overall Study||89
5274951|NCT00676052|12966617|P4|COMPLETED|Overall Study||92
5274952|NCT00676052|12966618|P3|COMPLETED|Overall Study||90
5274953|NCT00676052|12966619|P2|COMPLETED|Overall Study||88
5274954|NCT00676052|12966620|P1|COMPLETED|Overall Study||87
5274955|NCT00676052|12966615|P6|STARTED|Overall Study||97
5274956|NCT00676052|12966616|P5|STARTED|Overall Study||95
5274957|NCT00676052|12966617|P4|STARTED|Overall Study||97
5274958|NCT00676052|12966618|P3|STARTED|Overall Study||96
5274959|NCT00676052|12966619|P2|STARTED|Overall Study||95
5274960|NCT00676052|12966620|P1|STARTED|Overall Study||96
5274961|NCT00676026|12966652|P1|NOT COMPLETED|Overall Study||0
5274962|NCT00676026|12966652|P1|COMPLETED|Overall Study||8
5274963|NCT00676026|12966652|P1|STARTED|Overall Study||8
5274964|NCT00676013|12966656|P1|NOT COMPLETED|Overall Study||1
5274965|NCT00676013|12966656|P1|COMPLETED|Overall Study||157
5274966|NCT00676013|12966656|P1|STARTED|Overall Study||158
5274967|NCT00675987|12966665|P2|NOT COMPLETED|Overall Study||0
5274968|NCT00675987|12966666|P1|NOT COMPLETED|Overall Study||0
5274969|NCT00675987|12966665|P2|COMPLETED|Overall Study||27
5274970|NCT00675987|12966666|P1|COMPLETED|Overall Study||26
5274971|NCT00675987|12966665|P2|STARTED|Overall Study||27
5274972|NCT00675987|12966666|P1|STARTED|Overall Study||26
5274973|NCT00675948|12966690|P2|NOT COMPLETED|Overall Study||3
5274974|NCT00675948|12966691|P1|NOT COMPLETED|Overall Study||39
5274975|NCT00675948|12966690|P2|COMPLETED|Overall Study||1
5274976|NCT00675948|12966691|P1|COMPLETED|Overall Study||0
5274977|NCT00675948|12966690|P2|STARTED|Overall Study||4
5274978|NCT00675948|12966691|P1|STARTED|Overall Study||39
5274979|NCT00675922|12966701|P1|NOT COMPLETED|Overall Study||0
5274980|NCT00675922|12966701|P1|COMPLETED|Overall Study||98
5274981|NCT00675922|12966701|P1|STARTED|Overall Study||98
5274982|NCT00675909|12966709|P3|NOT COMPLETED|Overall Study||0
5274983|NCT00675909|12966710|P2|NOT COMPLETED|Overall Study||0
5274984|NCT00675909|12966711|P1|NOT COMPLETED|Overall Study||0
5274985|NCT00675909|12966709|P3|COMPLETED|Overall Study||60
5274986|NCT00675909|12966710|P2|COMPLETED|Overall Study||60
5274987|NCT00675909|12966711|P1|COMPLETED|Overall Study||60
5274988|NCT00675909|12966709|P3|STARTED|Overall Study||60
5274989|NCT00675909|12966710|P2|STARTED|Overall Study||60
5274990|NCT00675909|12966711|P1|STARTED|Overall Study||60
5274991|NCT00675792|12966733|P2|NOT COMPLETED|Overall Study||0
5274992|NCT00675792|12966734|P1|NOT COMPLETED|Overall Study||0
5274993|NCT00675792|12966733|P2|COMPLETED|Overall Study||49
5274994|NCT00675792|12966734|P1|COMPLETED|Overall Study||51
5274995|NCT00675792|12966733|P2|STARTED|Overall Study||49
5274996|NCT00675792|12966734|P1|STARTED|Overall Study||51
5274997|NCT00675766|12966754|P4|NOT COMPLETED|Overall Study||26
5274998|NCT00675766|12966755|P3|NOT COMPLETED|Overall Study||21
5274999|NCT00675766|12966756|P2|NOT COMPLETED|Overall Study||5
5275000|NCT00675766|12966757|P1|NOT COMPLETED|Overall Study||6
5275001|NCT00675766|12966754|P4|COMPLETED|Overall Study||11
5275002|NCT00675766|12966755|P3|COMPLETED|Overall Study||29
5275003|NCT00675766|12966756|P2|COMPLETED|Overall Study||25
5275004|NCT00675766|12966757|P1|COMPLETED|Overall Study||100
5275005|NCT00675766|12966754|P4|Year 3|Overall Study||11
5275006|NCT00675766|12966755|P3|Year 3|Overall Study||29
5275007|NCT00675766|12966756|P2|Year 3|Overall Study||25
5275008|NCT00675766|12966757|P1|Year 3|Overall Study||100
5275009|NCT00675766|12966754|P4|Year 2|Overall Study||20
5275010|NCT00675766|12966755|P3|Year 2|Overall Study||34
5275011|NCT00675766|12966756|P2|Year 2|Overall Study||28
5275012|NCT00675766|12966757|P1|Year 2|Overall Study||105
5275013|NCT00675766|12966754|P4|STARTED|Overall Study||37
5275014|NCT00675766|12966755|P3|STARTED|Overall Study||50
5275015|NCT00675766|12966756|P2|STARTED|Overall Study||30
5275016|NCT00675766|12966757|P1|STARTED|Overall Study||106
5275017|NCT00675597|12966767|P1|NOT COMPLETED|Overall Study||3
5275018|NCT00675597|12966767|P1|COMPLETED|Overall Study||23
5275019|NCT00675597|12966767|P1|STARTED|Overall Study||26
5275020|NCT00675584|12966773|P2|NOT COMPLETED|Overall Study||26
5275021|NCT00675584|12966774|P1|NOT COMPLETED|Overall Study||39
5275022|NCT00675584|12966773|P2|COMPLETED|Overall Study||113
5275023|NCT00675584|12966774|P1|COMPLETED|Overall Study||100
5275024|NCT00675584|12966773|P2|STARTED|Overall Study||139
5275025|NCT00675584|12966774|P1|STARTED|Overall Study||139
5275026|NCT00675558|12966803|P3|NOT COMPLETED|Second Operation||0
5275027|NCT00675558|12966804|P2|NOT COMPLETED|Second Operation||0
5275028|NCT00675558|12966805|P1|NOT COMPLETED|Second Operation||0
5275029|NCT00675558|12966803|P3|COMPLETED|Second Operation||10
5275030|NCT00675558|12966804|P2|COMPLETED|Second Operation||0
5275031|NCT00675558|12966805|P1|COMPLETED|Second Operation||0
5275032|NCT00675558|12966803|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
5275033|NCT00675558|12966804|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
5275034|NCT00675558|12966805|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
5275035|NCT00675558|12966803|P3|NOT COMPLETED|Surgery||0
5275036|NCT00675558|12966804|P2|NOT COMPLETED|Surgery||0
5275037|NCT00675558|12966805|P1|NOT COMPLETED|Surgery||0
5275038|NCT00675558|12966803|P3|COMPLETED|Surgery||30
5275039|NCT00675558|12966804|P2|COMPLETED|Surgery||10
5275040|NCT00675558|12966805|P1|COMPLETED|Surgery||10
5275041|NCT00675558|12966803|P3|STARTED|Surgery||30
5275042|NCT00675558|12966804|P2|STARTED|Surgery||10
5275043|NCT00675558|12966805|P1|STARTED|Surgery||10
5275044|NCT00675506|12966821|P2|NOT COMPLETED|Overall Study||12
5275045|NCT00675506|12966822|P1|NOT COMPLETED|Overall Study||12
5275046|NCT00675506|12966821|P2|COMPLETED|Overall Study||17
5275047|NCT00675506|12966822|P1|COMPLETED|Overall Study||19
5275048|NCT00675506|12966821|P2|Received Intervention|Overall Study||29
5275049|NCT00675506|12966822|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
5275050|NCT00675506|12966821|P2|STARTED|Overall Study||29
5275051|NCT00675506|12966822|P1|STARTED|Overall Study||31
5275052|NCT00675441|12966838|P1|NOT COMPLETED|Overall Study||3
5275053|NCT00675441|12966838|P1|COMPLETED|Overall Study||2
5275054|NCT00675441|12966838|P1|STARTED|Overall Study||5
5275055|NCT00675428|12966844|P2|NOT COMPLETED|Overall Study||3
5275056|NCT00675428|12966845|P1|NOT COMPLETED|Overall Study||3
5275057|NCT00675428|12966844|P2|COMPLETED|Overall Study||0
5275058|NCT00675428|12966845|P1|COMPLETED|Overall Study||0
5275059|NCT00675428|12966844|P2|STARTED|Overall Study||3
5275060|NCT00675428|12966845|P1|STARTED|Overall Study||3
5275061|NCT00675415|12966865|P2|NOT COMPLETED|Overall Study||8
5275062|NCT00675415|12966866|P1|NOT COMPLETED|Overall Study||8
5275063|NCT00675415|12966865|P2|COMPLETED|Overall Study||123
5275064|NCT00675415|12966866|P1|COMPLETED|Overall Study||124
5275065|NCT00675415|12966865|P2|STARTED|Overall Study||131
5275066|NCT00675415|12966866|P1|STARTED|Overall Study||132
5275067|NCT00675259|12966878|P1|NOT COMPLETED|Overall Study||14
5275068|NCT00675259|12966878|P1|COMPLETED|Overall Study||19
5275069|NCT00675259|12966878|P1|STARTED|Overall Study||33
5275070|NCT00675103|12966887|P1|NOT COMPLETED|Overall Study||3
5275071|NCT00675103|12966887|P1|COMPLETED|Overall Study||4
5275072|NCT00675103|12966887|P1|STARTED|Overall Study||7
5275073|NCT00674986|12966894|P2|NOT COMPLETED|Overall Study||81
5275074|NCT00674986|12966895|P1|NOT COMPLETED|Overall Study||43
5275075|NCT00674986|12966894|P2|COMPLETED|Overall Study||188
5275076|NCT00674986|12966895|P1|COMPLETED|Overall Study||187
5275077|NCT00674986|12966894|P2|Intent to Treat Population|Overall Study||256
5275078|NCT00674986|12966895|P1|Intent to Treat Population|Overall Study||227
5275079|NCT00674986|12966894|P2|STARTED|Overall Study||269
5275080|NCT00674986|12966895|P1|STARTED|Overall Study||230
5275081|NCT00674973|12966916|P2|NOT COMPLETED|Overall Study||102
5275082|NCT00674973|12966917|P1|NOT COMPLETED|Overall Study||100
5275083|NCT00674973|12966916|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
5275084|NCT00674973|12966917|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
5275085|NCT00674973|12966916|P2|Switch to Open-Label Erlotinib|Overall Study||0
5275086|NCT00674973|12966917|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
5275087|NCT00674973|12966916|P2|STARTED|Overall Study||104
5275088|NCT00674973|12966917|P1|STARTED|Overall Study||103
5275089|NCT00674817|12966931|P1|NOT COMPLETED|Period 6||0
5275090|NCT00674817|12966931|P1|COMPLETED|Period 6||38
5275091|NCT00674817|12966931|P1|STARTED|Period 6||38
5275092|NCT00674817|12966931|P1|NOT COMPLETED|Period 5||0
5275093|NCT00674817|12966931|P1|COMPLETED|Period 5||38
5275094|NCT00674817|12966931|P1|STARTED|Period 5||38
5275095|NCT00674817|12966931|P1|NOT COMPLETED|Period 4||1
5275096|NCT00674817|12966931|P1|COMPLETED|Period 4||38
5275097|NCT00674817|12966931|P1|STARTED|Period 4||39
5275098|NCT00674817|12966931|P1|NOT COMPLETED|Period 3||2
5275099|NCT00674817|12966931|P1|COMPLETED|Period 3||39
5275100|NCT00674817|12966931|P1|STARTED|Period 3||41
5275101|NCT00674817|12966931|P1|NOT COMPLETED|Period 2||0
5275102|NCT00674817|12966931|P1|COMPLETED|Period 2||41
5275103|NCT00674817|12966931|P1|STARTED|Period 2||41
5275104|NCT00674817|12966931|P1|NOT COMPLETED|Period 1||3
5275105|NCT00674817|12966931|P1|COMPLETED|Period 1||41
5275106|NCT00674817|12966931|P1|STARTED|Period 1||44
5275107|NCT00674765|12967079|P2|NOT COMPLETED|Overall Study||29
5275108|NCT00674765|12967080|P1|NOT COMPLETED|Overall Study||36
5275109|NCT00674765|12967079|P2|COMPLETED|Overall Study||46
5275110|NCT00674765|12967080|P1|COMPLETED|Overall Study||45
5275111|NCT00674765|12967079|P2|STARTED|Overall Study||75
5275112|NCT00674765|12967080|P1|STARTED|Overall Study||81
5275113|NCT00674739|12967089|P3|NOT COMPLETED|Overall Study||32
5275114|NCT00674739|12967090|P2|NOT COMPLETED|Overall Study||59
5275115|NCT00674739|12967091|P1|NOT COMPLETED|Overall Study||57
5275116|NCT00674739|12967089|P3|COMPLETED|Overall Study||65
5275117|NCT00674739|12967090|P2|COMPLETED|Overall Study||136
5275118|NCT00674739|12967091|P1|COMPLETED|Overall Study||121
5275119|NCT00674739|12967089|P3|STARTED|Overall Study||97
5275120|NCT00674739|12967090|P2|STARTED|Overall Study||195
5275121|NCT00674739|12967091|P1|STARTED|Overall Study||178
5275122|NCT00674700|12967108|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
5275123|NCT00674700|12967109|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
5275124|NCT00674700|12967110|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
5275125|NCT00674700|12967108|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
5275126|NCT00674700|12967109|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
5275127|NCT00674700|12967110|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
5275128|NCT00674700|12967108|P3|STARTED|Year 2 Follow-up Without Treatment||153
5275129|NCT00674700|12967109|P2|STARTED|Year 2 Follow-up Without Treatment||135
5275130|NCT00674700|12967110|P1|STARTED|Year 2 Follow-up Without Treatment||139
5275131|NCT00674700|12967108|P3|NOT COMPLETED|Year 1||17
5275132|NCT00674700|12967109|P2|NOT COMPLETED|Year 1||34
5275133|NCT00674700|12967110|P1|NOT COMPLETED|Year 1||31
5275134|NCT00674700|12967108|P3|COMPLETED|Year 1||153
5275135|NCT00674700|12967109|P2|COMPLETED|Year 1||135
5275136|NCT00674700|12967110|P1|COMPLETED|Year 1||139
5275137|NCT00674700|12967108|P3|STARTED|Year 1||170
5275138|NCT00674700|12967109|P2|STARTED|Year 1||169
5275139|NCT00674700|12967110|P1|STARTED|Year 1||170
5275140|NCT00674661|12967123|P2|NOT COMPLETED|Overall Study||15
5275141|NCT00674661|12967124|P1|NOT COMPLETED|Overall Study||11
5275142|NCT00674661|12967123|P2|COMPLETED|Overall Study||48
5275143|NCT00674661|12967124|P1|COMPLETED|Overall Study||56
5275144|NCT00674661|12967123|P2|STARTED|Overall Study||63
5275145|NCT00674661|12967124|P1|STARTED|Overall Study||67
5275146|NCT00674622|12967133|P3|NOT COMPLETED|Overall Study||0
5275147|NCT00674622|12967134|P2|NOT COMPLETED|Overall Study||4
5275148|NCT00674622|12967135|P1|NOT COMPLETED|Overall Study||1
5275149|NCT00674622|12967133|P3|COMPLETED|Overall Study||22
5275150|NCT00674622|12967134|P2|COMPLETED|Overall Study||18
5275151|NCT00674622|12967135|P1|COMPLETED|Overall Study||21
5275152|NCT00674622|12967133|P3|STARTED|Overall Study||22
5275153|NCT00674622|12967134|P2|STARTED|Overall Study||22
5275154|NCT00674622|12967135|P1|STARTED|Overall Study||22
5275155|NCT00674609|12967158|P3|NOT COMPLETED|Overall Study||8
5275156|NCT00674609|12967159|P2|NOT COMPLETED|Overall Study||13
5275157|NCT00674609|12967160|P1|NOT COMPLETED|Overall Study||12
5275158|NCT00674609|12967158|P3|COMPLETED|Overall Study||51
5275159|NCT00674609|12967159|P2|COMPLETED|Overall Study||45
5275160|NCT00674609|12967160|P1|COMPLETED|Overall Study||48
5275161|NCT00674609|12967158|P3|STARTED|Overall Study||59
5275162|NCT00674609|12967159|P2|STARTED|Overall Study||58
5275163|NCT00674609|12967160|P1|STARTED|Overall Study||60
5275164|NCT00674583|12967194|P2|NOT COMPLETED|Overall Study||0
5275165|NCT00674583|12967195|P1|NOT COMPLETED|Overall Study||0
5275166|NCT00674583|12967194|P2|COMPLETED|Overall Study||103
5275167|NCT00674583|12967195|P1|COMPLETED|Overall Study||311
5275168|NCT00674583|12967194|P2|STARTED|Overall Study||103
5275169|NCT00674583|12967195|P1|STARTED|Overall Study||311
5275170|NCT00674570|12967222|P3|NOT COMPLETED|Overall Study||0
5275171|NCT00674570|12967223|P2|NOT COMPLETED|Overall Study||2
5275172|NCT00674570|12967224|P1|NOT COMPLETED|Overall Study||0
5275173|NCT00674570|12967222|P3|COMPLETED|Overall Study||35
5275174|NCT00674570|12967223|P2|COMPLETED|Overall Study||32
5275175|NCT00674570|12967224|P1|COMPLETED|Overall Study||37
5275176|NCT00674570|12967222|P3|STARTED|Overall Study||35
5275177|NCT00674570|12967223|P2|STARTED|Overall Study||34
5275178|NCT00674570|12967224|P1|STARTED|Overall Study||37
5275179|NCT00674492|12967232|P1|NOT COMPLETED|Overall Study||0
5275180|NCT00674492|12967232|P1|COMPLETED|Overall Study||21
5275181|NCT00674492|12967232|P1|STARTED|Overall Study||21
5275182|NCT00674479|12967236|P1|NOT COMPLETED|Overall Study||0
5275183|NCT00674479|12967236|P1|COMPLETED|Overall Study||51
5275184|NCT00674479|12967236|P1|STARTED|Overall Study||51
5275185|NCT00674466|12967245|P3|NOT COMPLETED|Overall Study||9
5275186|NCT00674466|12967246|P2|NOT COMPLETED|Overall Study||8
5275187|NCT00674466|12967247|P1|NOT COMPLETED|Overall Study||7
5275188|NCT00674466|12967245|P3|COMPLETED|Overall Study||21
5275189|NCT00674466|12967246|P2|COMPLETED|Overall Study||22
5275190|NCT00674466|12967247|P1|COMPLETED|Overall Study||23
5275191|NCT00674466|12967245|P3|STARTED|Overall Study||30
5275192|NCT00674466|12967246|P2|STARTED|Overall Study||30
5275193|NCT00674466|12967247|P1|STARTED|Overall Study||30
5275194|NCT00674362|12967263|P2|NOT COMPLETED|Open Label||0
5275195|NCT00674362|12967264|P1|NOT COMPLETED|Open Label||2
5275196|NCT00674362|12967263|P2|COMPLETED|Open Label||7
5275197|NCT00674362|12967264|P1|COMPLETED|Open Label||18
5275198|NCT00674362|12967263|P2|STARTED|Open Label||7
5275199|NCT00674362|12967264|P1|STARTED|Open Label||20
5275200|NCT00674362|12967263|P2|NOT COMPLETED|Double Blind||18
5275201|NCT00674362|12967264|P1|NOT COMPLETED|Double Blind||12
5275202|NCT00674362|12967263|P2|COMPLETED|Double Blind||80
5275203|NCT00674362|12967264|P1|COMPLETED|Double Blind||84
5275204|NCT00674362|12967263|P2|STARTED|Double Blind||98
5275205|NCT00674362|12967264|P1|STARTED|Double Blind||96
5275206|NCT00674323|12967332|P3|NOT COMPLETED|Overall Study||0
5275207|NCT00674323|12967333|P2|NOT COMPLETED|Overall Study||1
5275208|NCT00674323|12967334|P1|NOT COMPLETED|Overall Study||1
5275209|NCT00674323|12967332|P3|COMPLETED|Overall Study||21
5275210|NCT00674323|12967333|P2|COMPLETED|Overall Study||20
5275211|NCT00674323|12967334|P1|COMPLETED|Overall Study||18
5275212|NCT00674323|12967332|P3|STARTED|Overall Study||21
5275213|NCT00674323|12967333|P2|STARTED|Overall Study||21
5275214|NCT00674323|12967334|P1|STARTED|Overall Study||19
5275215|NCT00674297|12967351|P4|NOT COMPLETED|Overall Study||3
5275216|NCT00674297|12967352|P3|NOT COMPLETED|Overall Study||4
5275217|NCT00674297|12967353|P2|NOT COMPLETED|Overall Study||0
5275218|NCT00674297|12967354|P1|NOT COMPLETED|Overall Study||10
5275219|NCT00674297|12967351|P4|COMPLETED|Overall Study||4
5275220|NCT00674297|12967352|P3|COMPLETED|Overall Study||5
5275221|NCT00674297|12967353|P2|COMPLETED|Overall Study||7
5275222|NCT00674297|12967354|P1|COMPLETED|Overall Study||8
5275223|NCT00674297|12967351|P4|STARTED|Overall Study||7
5275224|NCT00674297|12967352|P3|STARTED|Overall Study||9
5275225|NCT00674297|12967353|P2|STARTED|Overall Study||7
5275226|NCT00674297|12967354|P1|STARTED|Overall Study||18
5275227|NCT00674219|12967371|P2|NOT COMPLETED|Overall Study||0
5275228|NCT00674219|12967372|P1|NOT COMPLETED|Overall Study||0
5275229|NCT00674219|12967371|P2|COMPLETED|Overall Study||7
5275230|NCT00674219|12967372|P1|COMPLETED|Overall Study||10
5275231|NCT00674219|12967371|P2|STARTED|Overall Study||7
5275232|NCT00674219|12967372|P1|STARTED|Overall Study||10
5275233|NCT00674206|12967378|P1|NOT COMPLETED|Overall Study||0
5275234|NCT00674206|12967378|P1|COMPLETED|Overall Study||6
5275235|NCT00674206|12967378|P1|STARTED|Overall Study||6
5275236|NCT00674154|12967385|P2|NOT COMPLETED|Overall Study||3
5275237|NCT00674154|12967386|P1|NOT COMPLETED|Overall Study||3
5275238|NCT00674154|12967385|P2|COMPLETED|Overall Study||20
5275239|NCT00674154|12967386|P1|COMPLETED|Overall Study||20
5275240|NCT00674154|12967385|P2|STARTED|Overall Study||23
5275241|NCT00674154|12967386|P1|STARTED|Overall Study||23
5275242|NCT00674128|12967394|P2|NOT COMPLETED|Overall Study||23
5275243|NCT00674128|12967395|P1|NOT COMPLETED|Overall Study||25
5275244|NCT00674128|12967394|P2|COMPLETED|Overall Study||21
5275245|NCT00674128|12967395|P1|COMPLETED|Overall Study||25
5275246|NCT00674128|12967394|P2|STARTED|Overall Study||44
5275247|NCT00674128|12967395|P1|STARTED|Overall Study||50
5275248|NCT00674115|12967401|P4|NOT COMPLETED|Third Intervention||0
5275249|NCT00674115|12967402|P3|NOT COMPLETED|Third Intervention||0
5275250|NCT00674115|12967403|P2|NOT COMPLETED|Third Intervention||0
5275251|NCT00674115|12967404|P1|NOT COMPLETED|Third Intervention||0
5275252|NCT00674115|12967401|P4|COMPLETED|Third Intervention||0
5275253|NCT00674115|12967402|P3|COMPLETED|Third Intervention||0
5275254|NCT00674115|12967403|P2|COMPLETED|Third Intervention||16
5275255|NCT00674115|12967404|P1|COMPLETED|Third Intervention||14
5275256|NCT00674115|12967401|P4|STARTED|Third Intervention||0
5275257|NCT00674115|12967402|P3|STARTED|Third Intervention||0
5275258|NCT00674115|12967403|P2|STARTED|Third Intervention||16
5275259|NCT00674115|12967404|P1|STARTED|Third Intervention||14
5275260|NCT00674115|12967401|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
5275261|NCT00674115|12967402|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
5275262|NCT00674115|12967403|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5275263|NCT00674115|12967404|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5275264|NCT00674115|12967401|P4|COMPLETED|Washout Period of 2 Weeks||0
5275265|NCT00674115|12967402|P3|COMPLETED|Washout Period of 2 Weeks||0
5275266|NCT00674115|12967403|P2|COMPLETED|Washout Period of 2 Weeks||16
5275267|NCT00674115|12967404|P1|COMPLETED|Washout Period of 2 Weeks||14
5275268|NCT00674115|12967401|P4|STARTED|Washout Period of 2 Weeks||0
5275269|NCT00674115|12967402|P3|STARTED|Washout Period of 2 Weeks||0
5275270|NCT00674115|12967403|P2|STARTED|Washout Period of 2 Weeks||16
5275271|NCT00674115|12967404|P1|STARTED|Washout Period of 2 Weeks||14
5275272|NCT00674115|12967401|P4|NOT COMPLETED|Second Intervention||0
5275273|NCT00674115|12967402|P3|NOT COMPLETED|Second Intervention||0
5275274|NCT00674115|12967403|P2|NOT COMPLETED|Second Intervention||0
5275275|NCT00674115|12967404|P1|NOT COMPLETED|Second Intervention||0
5275276|NCT00674115|12967401|P4|COMPLETED|Second Intervention||16
5275277|NCT00674115|12967402|P3|COMPLETED|Second Intervention||14
5275278|NCT00674115|12967403|P2|COMPLETED|Second Intervention||16
5275279|NCT00674115|12967404|P1|COMPLETED|Second Intervention||14
5275280|NCT00674115|12967401|P4|STARTED|Second Intervention||16
5275281|NCT00674115|12967402|P3|STARTED|Second Intervention||14
5275282|NCT00674115|12967403|P2|STARTED|Second Intervention||16
5275283|NCT00674115|12967404|P1|STARTED|Second Intervention||14
5275284|NCT00674115|12967401|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
5275285|NCT00674115|12967402|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
5275286|NCT00674115|12967403|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5275287|NCT00674115|12967404|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5275288|NCT00674115|12967401|P4|COMPLETED|Washout Period of 2 Weeks||16
5275289|NCT00674115|12967402|P3|COMPLETED|Washout Period of 2 Weeks||14
5275290|NCT00674115|12967403|P2|COMPLETED|Washout Period of 2 Weeks||16
5275291|NCT00674115|12967404|P1|COMPLETED|Washout Period of 2 Weeks||14
5275292|NCT00674115|12967401|P4|STARTED|Washout Period of 2 Weeks||16
5275293|NCT00674115|12967402|P3|STARTED|Washout Period of 2 Weeks||14
5275294|NCT00674115|12967403|P2|STARTED|Washout Period of 2 Weeks||16
5275295|NCT00674115|12967404|P1|STARTED|Washout Period of 2 Weeks||14
5275296|NCT00674115|12967401|P4|NOT COMPLETED|First Intervention||0
5275297|NCT00674115|12967402|P3|NOT COMPLETED|First Intervention||0
5275298|NCT00674115|12967403|P2|NOT COMPLETED|First Intervention||0
5275299|NCT00674115|12967404|P1|NOT COMPLETED|First Intervention||0
5275300|NCT00674115|12967401|P4|COMPLETED|First Intervention||16
5275301|NCT00674115|12967402|P3|COMPLETED|First Intervention||14
5275302|NCT00674115|12967403|P2|COMPLETED|First Intervention||16
5275303|NCT00674115|12967404|P1|COMPLETED|First Intervention||14
5275304|NCT00674115|12967401|P4|STARTED|First Intervention||16
5275305|NCT00674115|12967402|P3|STARTED|First Intervention||14
5275306|NCT00674115|12967403|P2|STARTED|First Intervention||16
5275307|NCT00674115|12967404|P1|STARTED|First Intervention||14
5275308|NCT00673959|12967413|P2|NOT COMPLETED|Overall Study||0
5275309|NCT00673959|12967414|P1|NOT COMPLETED|Overall Study||0
5275310|NCT00673959|12967413|P2|COMPLETED|Overall Study||10
5275311|NCT00673959|12967414|P1|COMPLETED|Overall Study||10
5275312|NCT00673959|12967413|P2|STARTED|Overall Study||10
5275313|NCT00673959|12967414|P1|STARTED|Overall Study||10
5275314|NCT00673933|12967420|P1|NOT COMPLETED|Overall Study||3
5275315|NCT00673933|12967420|P1|COMPLETED|Overall Study||17
5275316|NCT00673933|12967420|P1|STARTED|Overall Study||20
5275317|NCT00673894|12967438|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
5275318|NCT00673894|12967439|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
5275319|NCT00673894|12967438|P2|COMPLETED|Second Intervention 4 Weeks||7
5275320|NCT00673894|12967439|P1|COMPLETED|Second Intervention 4 Weeks||6
5275321|NCT00673894|12967438|P2|STARTED|Second Intervention 4 Weeks||7
5275322|NCT00673894|12967439|P1|STARTED|Second Intervention 4 Weeks||6
5275323|NCT00673894|12967438|P2|NOT COMPLETED|Washout 4-6 Weeks||0
5275324|NCT00673894|12967439|P1|NOT COMPLETED|Washout 4-6 Weeks||0
5275325|NCT00673894|12967438|P2|COMPLETED|Washout 4-6 Weeks||7
5275326|NCT00673894|12967439|P1|COMPLETED|Washout 4-6 Weeks||6
5275327|NCT00673894|12967438|P2|STARTED|Washout 4-6 Weeks||7
5275328|NCT00673894|12967439|P1|STARTED|Washout 4-6 Weeks||6
5275329|NCT00673894|12967438|P2|NOT COMPLETED|First Intervention 4 Weeks||0
5275330|NCT00673894|12967439|P1|NOT COMPLETED|First Intervention 4 Weeks||2
5275331|NCT00673894|12967438|P2|COMPLETED|First Intervention 4 Weeks||7
5275332|NCT00673894|12967439|P1|COMPLETED|First Intervention 4 Weeks||6
5275333|NCT00673894|12967438|P2|STARTED|First Intervention 4 Weeks||7
5275334|NCT00673894|12967439|P1|STARTED|First Intervention 4 Weeks||8
5275335|NCT00673881|12967447|P1|NOT COMPLETED|Overall Study||1
5275336|NCT00673881|12967447|P1|COMPLETED|Overall Study||24
5275337|NCT00673881|12967447|P1|STARTED|Overall Study||25
5275338|NCT00673855|12967454|P2|NOT COMPLETED|Second Intervention||0
5275339|NCT00673855|12967455|P1|NOT COMPLETED|Second Intervention||0
5275340|NCT00673855|12967454|P2|COMPLETED|Second Intervention||10
5275341|NCT00673855|12967455|P1|COMPLETED|Second Intervention||10
5275342|NCT00673855|12967454|P2|STARTED|Second Intervention||10
5275343|NCT00673855|12967455|P1|STARTED|Second Intervention||10
5275344|NCT00673855|12967454|P2|NOT COMPLETED|First Intervention||0
5275345|NCT00673855|12967455|P1|NOT COMPLETED|First Intervention||0
5275346|NCT00673855|12967454|P2|COMPLETED|First Intervention||10
5275347|NCT00673855|12967455|P1|COMPLETED|First Intervention||10
5275348|NCT00673855|12967454|P2|STARTED|First Intervention||10
5275349|NCT00673855|12967455|P1|STARTED|First Intervention||10
5275350|NCT00673816|12967461|P1|NOT COMPLETED|Overall Study||2
5275351|NCT00673816|12967461|P1|COMPLETED|Overall Study||0
5275352|NCT00673816|12967461|P1|STARTED|Overall Study||2
5275353|NCT00673790|12967471|P3|NOT COMPLETED|Overall Study||12
5275354|NCT00673790|12967472|P2|NOT COMPLETED|Overall Study||38
5275355|NCT00673790|12967473|P1|NOT COMPLETED|Overall Study||45
5275356|NCT00673790|12967471|P3|COMPLETED|Overall Study||90
5275357|NCT00673790|12967472|P2|COMPLETED|Overall Study||174
5275358|NCT00673790|12967473|P1|COMPLETED|Overall Study||178
5275359|NCT00673790|12967471|P3|STARTED|Overall Study||102
5275360|NCT00673790|12967472|P2|STARTED|Overall Study||212
5275361|NCT00673790|12967473|P1|STARTED|Overall Study||223
5275362|NCT00673764|12967483|P2|NOT COMPLETED|Overall Study||0
5275363|NCT00673764|12967484|P1|NOT COMPLETED|Overall Study||0
5275364|NCT00673764|12967483|P2|COMPLETED|Overall Study||24
5275365|NCT00673764|12967484|P1|COMPLETED|Overall Study||24
5275366|NCT00673764|12967483|P2|STARTED|Overall Study||24
5275367|NCT00673764|12967484|P1|STARTED|Overall Study||24
5275368|NCT00673738|12967492|P1|NOT COMPLETED|Overall Study||0
5275369|NCT00673738|12967492|P1|COMPLETED|Overall Study||27
5275370|NCT00673738|12967492|P1|STARTED|Overall Study||27
5275371|NCT00673712|12967500|P2|NOT COMPLETED|Overall Study||0
5275372|NCT00673712|12967501|P1|NOT COMPLETED|Overall Study||0
5275373|NCT00673712|12967500|P2|COMPLETED|Overall Study||326
5275374|NCT00673712|12967501|P1|COMPLETED|Overall Study||321
5275375|NCT00673712|12967500|P2|STARTED|Overall Study||326
5275376|NCT00673712|12967501|P1|STARTED|Overall Study||321
5275377|NCT00673673|12967511|P1|NOT COMPLETED|Overall Study||36
5275378|NCT00673673|12967511|P1|COMPLETED|Overall Study||3
5275379|NCT00673673|12967511|P1|STARTED|Overall Study||39
5275380|NCT00673660|12967517|P1|NOT COMPLETED|Overall Study||107
5275381|NCT00673660|12967517|P1|COMPLETED|Overall Study||268
5275382|NCT00673660|12967517|P1|STARTED|Overall Study||375
5275383|NCT00673595|12967530|P2|NOT COMPLETED|Overall Study||0
5275384|NCT00673595|12967531|P1|NOT COMPLETED|Overall Study||0
5275385|NCT00673595|12967530|P2|COMPLETED|Overall Study||11
5275386|NCT00673595|12967531|P1|COMPLETED|Overall Study||8
5275387|NCT00673595|12967530|P2|STARTED|Overall Study||11
5275388|NCT00673595|12967531|P1|STARTED|Overall Study||8
5275389|NCT00673465|12967539|P12|NOT COMPLETED|Part 2 (India)||0
5275390|NCT00673465|12967540|P11|NOT COMPLETED|Part 2 (India)||0
5275391|NCT00673465|12967541|P10|NOT COMPLETED|Part 2 (India)||0
5275392|NCT00673465|12967542|P9|NOT COMPLETED|Part 2 (India)||0
5275393|NCT00673465|12967543|P8|NOT COMPLETED|Part 2 (India)||0
5275394|NCT00673465|12967544|P7|NOT COMPLETED|Part 2 (India)||0
5275395|NCT00673465|12967545|P6|NOT COMPLETED|Part 2 (India)||0
5275396|NCT00673465|12967546|P5|NOT COMPLETED|Part 2 (India)||0
5275397|NCT00673465|12967547|P4|NOT COMPLETED|Part 2 (India)||0
5275398|NCT00673465|12967548|P3|NOT COMPLETED|Part 2 (India)||0
5275399|NCT00673465|12967549|P2|NOT COMPLETED|Part 2 (India)||0
5275400|NCT00673465|12967550|P1|NOT COMPLETED|Part 2 (India)||0
5275401|NCT00673465|12967539|P12|COMPLETED|Part 2 (India)||0
5275402|NCT00673465|12967540|P11|COMPLETED|Part 2 (India)||0
5275403|NCT00673465|12967541|P10|COMPLETED|Part 2 (India)||0
5275404|NCT00673465|12967542|P9|COMPLETED|Part 2 (India)||0
5275405|NCT00673465|12967543|P8|COMPLETED|Part 2 (India)||0
5275406|NCT00673465|12967544|P7|COMPLETED|Part 2 (India)||0
5275407|NCT00673465|12967545|P6|COMPLETED|Part 2 (India)||0
5275408|NCT00673465|12967546|P5|COMPLETED|Part 2 (India)||0
5275409|NCT00673465|12967547|P4|COMPLETED|Part 2 (India)||0
5275410|NCT00673465|12967548|P3|COMPLETED|Part 2 (India)||0
5275411|NCT00673465|12967549|P2|COMPLETED|Part 2 (India)||0
5275412|NCT00673465|12967550|P1|COMPLETED|Part 2 (India)||0
5275413|NCT00673465|12967539|P12|STARTED|Part 2 (India)||0
5275414|NCT00673465|12967540|P11|STARTED|Part 2 (India)||0
5275415|NCT00673465|12967541|P10|STARTED|Part 2 (India)||0
5275416|NCT00673465|12967542|P9|STARTED|Part 2 (India)||0
5275417|NCT00673465|12967543|P8|STARTED|Part 2 (India)||0
5275418|NCT00673465|12967544|P7|STARTED|Part 2 (India)||0
5275419|NCT00673465|12967545|P6|STARTED|Part 2 (India)||0
5275420|NCT00673465|12967546|P5|STARTED|Part 2 (India)||0
5275421|NCT00673465|12967547|P4|STARTED|Part 2 (India)||0
5275422|NCT00673465|12967548|P3|STARTED|Part 2 (India)||0
5275423|NCT00673465|12967549|P2|STARTED|Part 2 (India)||0
5275424|NCT00673465|12967550|P1|STARTED|Part 2 (India)||0
5275425|NCT00673465|12967539|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275426|NCT00673465|12967540|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275427|NCT00673465|12967541|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275428|NCT00673465|12967542|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275429|NCT00673465|12967543|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275430|NCT00673465|12967544|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275431|NCT00673465|12967545|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275432|NCT00673465|12967546|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275433|NCT00673465|12967547|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275434|NCT00673465|12967548|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275435|NCT00673465|12967549|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275436|NCT00673465|12967550|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
5275437|NCT00673465|12967539|P12|COMPLETED|Part 1/Period 3 (United States)||0
5275438|NCT00673465|12967540|P11|COMPLETED|Part 1/Period 3 (United States)||0
5275439|NCT00673465|12967541|P10|COMPLETED|Part 1/Period 3 (United States)||0
5275440|NCT00673465|12967542|P9|COMPLETED|Part 1/Period 3 (United States)||0
5275441|NCT00673465|12967543|P8|COMPLETED|Part 1/Period 3 (United States)||0
5275442|NCT00673465|12967544|P7|COMPLETED|Part 1/Period 3 (United States)||0
5275443|NCT00673465|12967545|P6|COMPLETED|Part 1/Period 3 (United States)||1
5275444|NCT00673465|12967546|P5|COMPLETED|Part 1/Period 3 (United States)||1
5275445|NCT00673465|12967547|P4|COMPLETED|Part 1/Period 3 (United States)||3
5275446|NCT00673465|12967548|P3|COMPLETED|Part 1/Period 3 (United States)||3
5275447|NCT00673465|12967549|P2|COMPLETED|Part 1/Period 3 (United States)||3
5275448|NCT00673465|12967550|P1|COMPLETED|Part 1/Period 3 (United States)||3
5275449|NCT00673465|12967539|P12|STARTED|Part 1/Period 3 (United States)||0
5275450|NCT00673465|12967540|P11|STARTED|Part 1/Period 3 (United States)||0
5275451|NCT00673465|12967541|P10|STARTED|Part 1/Period 3 (United States)||0
5275452|NCT00673465|12967542|P9|STARTED|Part 1/Period 3 (United States)||0
5275453|NCT00673465|12967543|P8|STARTED|Part 1/Period 3 (United States)||0
5275454|NCT00673465|12967544|P7|STARTED|Part 1/Period 3 (United States)||0
5275455|NCT00673465|12967545|P6|STARTED|Part 1/Period 3 (United States)||1
5275456|NCT00673465|12967546|P5|STARTED|Part 1/Period 3 (United States)||1
5275457|NCT00673465|12967547|P4|STARTED|Part 1/Period 3 (United States)||3
5275458|NCT00673465|12967548|P3|STARTED|Part 1/Period 3 (United States)||3
5275459|NCT00673465|12967549|P2|STARTED|Part 1/Period 3 (United States)||3
5275460|NCT00673465|12967550|P1|STARTED|Part 1/Period 3 (United States)||3
5275461|NCT00673465|12967539|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275462|NCT00673465|12967540|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275463|NCT00673465|12967541|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275464|NCT00673465|12967542|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275465|NCT00673465|12967543|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275466|NCT00673465|12967544|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275467|NCT00673465|12967545|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275468|NCT00673465|12967546|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
5275469|NCT00673465|12967547|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275470|NCT00673465|12967548|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275471|NCT00673465|12967549|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275472|NCT00673465|12967550|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
5275473|NCT00673465|12967539|P12|COMPLETED|Part 1/Period 2 (United States)||0
5275474|NCT00673465|12967540|P11|COMPLETED|Part 1/Period 2 (United States)||0
5275475|NCT00673465|12967541|P10|COMPLETED|Part 1/Period 2 (United States)||0
5275476|NCT00673465|12967542|P9|COMPLETED|Part 1/Period 2 (United States)||0
5275477|NCT00673465|12967543|P8|COMPLETED|Part 1/Period 2 (United States)||0
5275478|NCT00673465|12967544|P7|COMPLETED|Part 1/Period 2 (United States)||0
5275479|NCT00673465|12967545|P6|COMPLETED|Part 1/Period 2 (United States)||1
5275480|NCT00673465|12967546|P5|COMPLETED|Part 1/Period 2 (United States)||1
5275481|NCT00673465|12967547|P4|COMPLETED|Part 1/Period 2 (United States)||3
5275482|NCT00673465|12967548|P3|COMPLETED|Part 1/Period 2 (United States)||3
5275483|NCT00673465|12967549|P2|COMPLETED|Part 1/Period 2 (United States)||3
5275484|NCT00673465|12967550|P1|COMPLETED|Part 1/Period 2 (United States)||3
5275485|NCT00673465|12967539|P12|STARTED|Part 1/Period 2 (United States)||0
5275486|NCT00673465|12967540|P11|STARTED|Part 1/Period 2 (United States)||0
5275487|NCT00673465|12967541|P10|STARTED|Part 1/Period 2 (United States)||0
5275488|NCT00673465|12967542|P9|STARTED|Part 1/Period 2 (United States)||0
5275489|NCT00673465|12967543|P8|STARTED|Part 1/Period 2 (United States)||0
5275490|NCT00673465|12967544|P7|STARTED|Part 1/Period 2 (United States)||0
5275491|NCT00673465|12967545|P6|STARTED|Part 1/Period 2 (United States)||1
5275492|NCT00673465|12967546|P5|STARTED|Part 1/Period 2 (United States)||2
5275493|NCT00673465|12967547|P4|STARTED|Part 1/Period 2 (United States)||3
5275494|NCT00673465|12967548|P3|STARTED|Part 1/Period 2 (United States)||3
5275495|NCT00673465|12967549|P2|STARTED|Part 1/Period 2 (United States)||3
5275496|NCT00673465|12967550|P1|STARTED|Part 1/Period 2 (United States)||3
5275497|NCT00673465|12967539|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275498|NCT00673465|12967540|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275499|NCT00673465|12967541|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275500|NCT00673465|12967542|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275501|NCT00673465|12967543|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275502|NCT00673465|12967544|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275503|NCT00673465|12967545|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
5275504|NCT00673465|12967546|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
5275505|NCT00673465|12967547|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275506|NCT00673465|12967548|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275507|NCT00673465|12967549|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275508|NCT00673465|12967550|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
5275509|NCT00673465|12967539|P12|COMPLETED|Part 1/Period 1 (United States)||0
5275510|NCT00673465|12967540|P11|COMPLETED|Part 1/Period 1 (United States)||0
5275511|NCT00673465|12967541|P10|COMPLETED|Part 1/Period 1 (United States)||0
5275512|NCT00673465|12967542|P9|COMPLETED|Part 1/Period 1 (United States)||0
5275513|NCT00673465|12967543|P8|COMPLETED|Part 1/Period 1 (United States)||0
5275514|NCT00673465|12967544|P7|COMPLETED|Part 1/Period 1 (United States)||0
5275515|NCT00673465|12967545|P6|COMPLETED|Part 1/Period 1 (United States)||1
5275516|NCT00673465|12967546|P5|COMPLETED|Part 1/Period 1 (United States)||2
5275517|NCT00673465|12967547|P4|COMPLETED|Part 1/Period 1 (United States)||3
5275518|NCT00673465|12967548|P3|COMPLETED|Part 1/Period 1 (United States)||3
5275519|NCT00673465|12967549|P2|COMPLETED|Part 1/Period 1 (United States)||3
5275520|NCT00673465|12967550|P1|COMPLETED|Part 1/Period 1 (United States)||3
5275521|NCT00673465|12967539|P12|STARTED|Part 1/Period 1 (United States)||0
5275522|NCT00673465|12967540|P11|STARTED|Part 1/Period 1 (United States)||0
5275523|NCT00673465|12967541|P10|STARTED|Part 1/Period 1 (United States)||0
5275524|NCT00673465|12967542|P9|STARTED|Part 1/Period 1 (United States)||0
5275525|NCT00673465|12967543|P8|STARTED|Part 1/Period 1 (United States)||0
5275526|NCT00673465|12967544|P7|STARTED|Part 1/Period 1 (United States)||0
5275527|NCT00673465|12967545|P6|STARTED|Part 1/Period 1 (United States)||2
5275528|NCT00673465|12967546|P5|STARTED|Part 1/Period 1 (United States)||3
5275529|NCT00673465|12967547|P4|STARTED|Part 1/Period 1 (United States)||3
5275530|NCT00673465|12967548|P3|STARTED|Part 1/Period 1 (United States)||3
5275531|NCT00673465|12967549|P2|STARTED|Part 1/Period 1 (United States)||3
5275532|NCT00673465|12967550|P1|STARTED|Part 1/Period 1 (United States)||3
5275533|NCT00673452|12967599|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
5275534|NCT00673452|12967600|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
5275535|NCT00673452|12967599|P2|COMPLETED|Continuation Double-Blind Phase||153
5275536|NCT00673452|12967600|P1|COMPLETED|Continuation Double-Blind Phase||151
5275537|NCT00673452|12967599|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
5275538|NCT00673452|12967600|P1|STARTED|Continuation Double-Blind Phase||176
5275539|NCT00673452|12967599|P2|NOT COMPLETED|Acute Double-Blind Phase||80
5275540|NCT00673452|12967600|P1|NOT COMPLETED|Acute Double-Blind Phase||87
5275541|NCT00673452|12967599|P2|COMPLETED|Acute Double-Blind Phase||187
5275542|NCT00673452|12967600|P1|COMPLETED|Acute Double-Blind Phase||176
5275543|NCT00673452|12967599|P2|STARTED|Acute Double-Blind Phase||267
5275544|NCT00673452|12967600|P1|STARTED|Acute Double-Blind Phase||263
5275545|NCT00673439|12967634|P1|NOT COMPLETED|Overall Study||0
5275546|NCT00673439|12967634|P1|COMPLETED|Overall Study||3
5275547|NCT00673439|12967634|P1|STARTED|Overall Study||3
5275548|NCT00673400|12967639|P1|NOT COMPLETED|Overall Study||0
5275549|NCT00673400|12967639|P1|COMPLETED|Overall Study||52
5275550|NCT00673400|12967639|P1|STARTED|Overall Study||52
5275551|NCT00673387|12967664|P8|NOT COMPLETED|Overall Study||35
5275552|NCT00673387|12967665|P7|NOT COMPLETED|Overall Study||30
5275553|NCT00673387|12967666|P6|NOT COMPLETED|Overall Study||34
5275554|NCT00673387|12967667|P5|NOT COMPLETED|Overall Study||30
5275555|NCT00673387|12967668|P4|NOT COMPLETED|Overall Study||26
5275556|NCT00673387|12967669|P3|NOT COMPLETED|Overall Study||31
5275557|NCT00673387|12967670|P2|NOT COMPLETED|Overall Study||23
5275558|NCT00673387|12967671|P1|NOT COMPLETED|Overall Study||29
5275559|NCT00673387|12967664|P8|COMPLETED|Overall Study||40
5275560|NCT00673387|12967665|P7|COMPLETED|Overall Study||48
5275561|NCT00673387|12967666|P6|COMPLETED|Overall Study||44
5275562|NCT00673387|12967667|P5|COMPLETED|Overall Study||48
5275563|NCT00673387|12967668|P4|COMPLETED|Overall Study||49
5275564|NCT00673387|12967669|P3|COMPLETED|Overall Study||41
5275565|NCT00673387|12967670|P2|COMPLETED|Overall Study||54
5275566|NCT00673387|12967671|P1|COMPLETED|Overall Study||46
5275567|NCT00673387|12967664|P8|STARTED|Overall Study||75
5275568|NCT00673387|12967665|P7|STARTED|Overall Study||78
5275569|NCT00673387|12967666|P6|STARTED|Overall Study||78
5275570|NCT00673387|12967667|P5|STARTED|Overall Study||78
5275571|NCT00673387|12967668|P4|STARTED|Overall Study||75
5275572|NCT00673387|12967669|P3|STARTED|Overall Study||72
5275573|NCT00673387|12967670|P2|STARTED|Overall Study||77
5275574|NCT00673387|12967671|P1|STARTED|Overall Study||75
5275575|NCT00673361|12967887|P1|NOT COMPLETED|Overall Study||2
5275576|NCT00673361|12967887|P1|COMPLETED|Overall Study||7
5275577|NCT00673361|12967887|P1|STARTED|Overall Study||9
5275578|NCT00673309|12967901|P10|NOT COMPLETED|Overall Study||0
5275579|NCT00673309|12967902|P9|NOT COMPLETED|Overall Study||0
5275580|NCT00673309|12967903|P8|NOT COMPLETED|Overall Study||0
5275581|NCT00673309|12967904|P7|NOT COMPLETED|Overall Study||0
5275582|NCT00673309|12967905|P6|NOT COMPLETED|Overall Study||0
5275583|NCT00673309|12967906|P5|NOT COMPLETED|Overall Study||0
5275584|NCT00673309|12967907|P4|NOT COMPLETED|Overall Study||0
5275585|NCT00673309|12967908|P3|NOT COMPLETED|Overall Study||0
5275586|NCT00673309|12967909|P2|NOT COMPLETED|Overall Study||0
5275587|NCT00673309|12967910|P1|NOT COMPLETED|Overall Study||0
5275588|NCT00673309|12967901|P10|COMPLETED|Overall Study||30
5275589|NCT00673309|12967902|P9|COMPLETED|Overall Study||17
5275590|NCT00673309|12967903|P8|COMPLETED|Overall Study||13
5275591|NCT00673309|12967904|P7|COMPLETED|Overall Study||14
5275592|NCT00673309|12967905|P6|COMPLETED|Overall Study||35
5275593|NCT00673309|12967906|P5|COMPLETED|Overall Study||18
5275594|NCT00673309|12967907|P4|COMPLETED|Overall Study||25
5275595|NCT00673309|12967908|P3|COMPLETED|Overall Study||14
5275596|NCT00673309|12967909|P2|COMPLETED|Overall Study||14
5275597|NCT00673309|12967910|P1|COMPLETED|Overall Study||64
5275598|NCT00673309|12967901|P10|STARTED|Overall Study||30
5275599|NCT00673309|12967902|P9|STARTED|Overall Study||17
5275600|NCT00673309|12967903|P8|STARTED|Overall Study||13
5275601|NCT00673309|12967904|P7|STARTED|Overall Study||14
5275602|NCT00673309|12967905|P6|STARTED|Overall Study||35
5275603|NCT00673309|12967906|P5|STARTED|Overall Study||18
5275604|NCT00673309|12967907|P4|STARTED|Overall Study||25
5275605|NCT00673309|12967908|P3|STARTED|Overall Study||14
5275606|NCT00673309|12967909|P2|STARTED|Overall Study||14
5275607|NCT00673309|12967910|P1|STARTED|Overall Study||64
5275608|NCT00673257|12967923|P1|NOT COMPLETED|Overall Study||5
5275609|NCT00673257|12967923|P1|COMPLETED|Overall Study||102
5275610|NCT00673257|12967923|P1|STARTED|Overall Study||107
5275611|NCT00673231|12967932|P4|NOT COMPLETED|Overall Study||18
5275612|NCT00673231|12967933|P3|NOT COMPLETED|Overall Study||26
5275613|NCT00673231|12967934|P2|NOT COMPLETED|Overall Study||22
5275614|NCT00673231|12967935|P1|NOT COMPLETED|Overall Study||29
5275615|NCT00673231|12967932|P4|COMPLETED|Overall Study||178
5275616|NCT00673231|12967933|P3|COMPLETED|Overall Study||186
5275617|NCT00673231|12967934|P2|COMPLETED|Overall Study||180
5275618|NCT00673231|12967935|P1|COMPLETED|Overall Study||168
5275619|NCT00673231|12967932|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
5275620|NCT00673231|12967933|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
5275621|NCT00673231|12967934|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
5275622|NCT00673231|12967935|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
5275623|NCT00673179|12967967|P2|NOT COMPLETED|Overall Study||0
5275624|NCT00673179|12967968|P1|NOT COMPLETED|Overall Study||3
5275625|NCT00673179|12967967|P2|COMPLETED|Overall Study||0
5275626|NCT00673179|12967968|P1|COMPLETED|Overall Study||4
5275627|NCT00673179|12967967|P2|STARTED|Overall Study||0
5275628|NCT00673179|12967968|P1|STARTED|Overall Study||7
5275629|NCT00673153|12967974|P1|NOT COMPLETED|Overall Study||1
5275630|NCT00673153|12967974|P1|COMPLETED|Overall Study||30
5275631|NCT00673153|12967974|P1|STARTED|Overall Study||31
5275632|NCT00673127|12967982|P1|NOT COMPLETED|Overall Study||0
5275633|NCT00673127|12967982|P1|COMPLETED|Overall Study||57
5275634|NCT00673127|12967982|P1|STARTED|Overall Study||57
5275635|NCT00673114|12967987|P1|NOT COMPLETED|Overall Study||0
5275636|NCT00673114|12967987|P1|COMPLETED|Overall Study||3
5275637|NCT00673114|12967987|P1|STARTED|Overall Study||3
5275638|NCT00673075|12968000|P2|NOT COMPLETED|Overall Study||7
5275639|NCT00673075|12968001|P1|NOT COMPLETED|Overall Study||9
5275640|NCT00673075|12968000|P2|COMPLETED|Overall Study||11
5275641|NCT00673075|12968001|P1|COMPLETED|Overall Study||12
5275642|NCT00673075|12968000|P2|STARTED|Overall Study||18
5275643|NCT00673075|12968001|P1|STARTED|Overall Study||21
5275644|NCT00673049|12968017|P4|NOT COMPLETED|After Progression on Erlotinib||83
5275645|NCT00673049|12968018|P3|NOT COMPLETED|After Progression on Erlotinib||0
5275646|NCT00673049|12968019|P2|NOT COMPLETED|After Progression on Erlotinib||0
5275647|NCT00673049|12968020|P1|NOT COMPLETED|After Progression on Erlotinib||0
5275648|NCT00673049|12968017|P4|COMPLETED|After Progression on Erlotinib||0
5275649|NCT00673049|12968018|P3|COMPLETED|After Progression on Erlotinib||0
5275650|NCT00673049|12968019|P2|COMPLETED|After Progression on Erlotinib||0
5275651|NCT00673049|12968020|P1|COMPLETED|After Progression on Erlotinib||0
5275652|NCT00673049|12968017|P4|STARTED|After Progression on Erlotinib||83
5275653|NCT00673049|12968018|P3|STARTED|After Progression on Erlotinib||0
5275654|NCT00673049|12968019|P2|STARTED|After Progression on Erlotinib||0
5275655|NCT00673049|12968020|P1|STARTED|After Progression on Erlotinib||0
5275656|NCT00673049|12968017|P4|NOT COMPLETED|Before Progression on Erlotinib||0
5275657|NCT00673049|12968018|P3|NOT COMPLETED|Before Progression on Erlotinib||1
5275658|NCT00673049|12968019|P2|NOT COMPLETED|Before Progression on Erlotinib||290
5275659|NCT00673049|12968020|P1|NOT COMPLETED|Before Progression on Erlotinib||292
5275660|NCT00673049|12968017|P4|COMPLETED|Before Progression on Erlotinib||0
5275661|NCT00673049|12968018|P3|COMPLETED|Before Progression on Erlotinib||0
5275662|NCT00673049|12968019|P2|COMPLETED|Before Progression on Erlotinib||0
5275663|NCT00673049|12968020|P1|COMPLETED|Before Progression on Erlotinib||0
5275664|NCT00673049|12968017|P4|Treated|Before Progression on Erlotinib||0
5275665|NCT00673049|12968018|P3|Treated|Before Progression on Erlotinib||1
5275666|NCT00673049|12968019|P2|Treated|Before Progression on Erlotinib||289
5275667|NCT00673049|12968020|P1|Treated|Before Progression on Erlotinib||289
5275668|NCT00673049|12968017|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
5275669|NCT00673049|12968018|P3|STARTED|Before Progression on Erlotinib||1
5275670|NCT00673049|12968019|P2|STARTED|Before Progression on Erlotinib||290
5275671|NCT00673049|12968020|P1|STARTED|Before Progression on Erlotinib||292
5275672|NCT00672984|12968044|P3|NOT COMPLETED|Third Intervention||1
5275673|NCT00672984|12968045|P2|NOT COMPLETED|Third Intervention||0
5275674|NCT00672984|12968046|P1|NOT COMPLETED|Third Intervention||1
5275675|NCT00672984|12968044|P3|COMPLETED|Third Intervention||23
5275676|NCT00672984|12968045|P2|COMPLETED|Third Intervention||17
5275677|NCT00672984|12968046|P1|COMPLETED|Third Intervention||21
5275678|NCT00672984|12968044|P3|STARTED|Third Intervention||24
5275679|NCT00672984|12968045|P2|STARTED|Third Intervention||17
5275680|NCT00672984|12968046|P1|STARTED|Third Intervention||22
5275681|NCT00672984|12968044|P3|NOT COMPLETED|Second Intervention||1
5275682|NCT00672984|12968045|P2|NOT COMPLETED|Second Intervention||6
5275683|NCT00672984|12968046|P1|NOT COMPLETED|Second Intervention||0
5275684|NCT00672984|12968044|P3|COMPLETED|Second Intervention||24
5275685|NCT00672984|12968045|P2|COMPLETED|Second Intervention||17
5275686|NCT00672984|12968046|P1|COMPLETED|Second Intervention||22
5275687|NCT00672984|12968044|P3|STARTED|Second Intervention||25
5275688|NCT00672984|12968045|P2|STARTED|Second Intervention||23
5275689|NCT00672984|12968046|P1|STARTED|Second Intervention||22
5275690|NCT00672984|12968044|P3|NOT COMPLETED|First Intervention||2
5275691|NCT00672984|12968045|P2|NOT COMPLETED|First Intervention||2
5275692|NCT00672984|12968046|P1|NOT COMPLETED|First Intervention||9
5275693|NCT00672984|12968044|P3|COMPLETED|First Intervention||25
5275694|NCT00672984|12968045|P2|COMPLETED|First Intervention||23
5275695|NCT00672984|12968046|P1|COMPLETED|First Intervention||22
5275696|NCT00672984|12968044|P3|STARTED|First Intervention||27
5275697|NCT00672984|12968045|P2|STARTED|First Intervention||25
5275698|NCT00672984|12968046|P1|STARTED|First Intervention||31
5275699|NCT00672958|12968097|P2|NOT COMPLETED|Overall Study||56
5275700|NCT00672958|12968098|P1|NOT COMPLETED|Overall Study||64
5275701|NCT00672958|12968097|P2|COMPLETED|Overall Study||244
5275702|NCT00672958|12968098|P1|COMPLETED|Overall Study||236
5275703|NCT00672958|12968097|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
5275704|NCT00672958|12968098|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
5275705|NCT00672958|12968097|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
5275706|NCT00672958|12968098|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
5275707|NCT00672958|12968097|P2|STARTED|Overall Study||300
5275708|NCT00672958|12968098|P1|STARTED|Overall Study||300
5275709|NCT00672932|12968130|P2|NOT COMPLETED|Overall Study||0
5275710|NCT00672932|12968131|P1|NOT COMPLETED|Overall Study||0
5275711|NCT00672932|12968130|P2|COMPLETED|Overall Study||9
5275712|NCT00672932|12968131|P1|COMPLETED|Overall Study||9
5275713|NCT00672932|12968130|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
5275714|NCT00672932|12968131|P1|Rolled Over to Raltegravir|Overall Study||0
5275715|NCT00672932|12968130|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
5275716|NCT00672932|12968131|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
5275717|NCT00672932|12968130|P2|Completed Initial 12-week Assignment|Overall Study||9
5275718|NCT00672932|12968131|P1|Completed Initial 12-week Assignment|Overall Study||9
5275719|NCT00672932|12968130|P2|STARTED|Overall Study||9
5275720|NCT00672932|12968131|P1|STARTED|Overall Study||9
5275721|NCT00672854|12968141|P2|NOT COMPLETED|Overall Study||0
5275722|NCT00672854|12968142|P1|NOT COMPLETED|Overall Study||0
5275723|NCT00672854|12968141|P2|COMPLETED|Overall Study||51
5275724|NCT00672854|12968142|P1|COMPLETED|Overall Study||49
5275725|NCT00672854|12968141|P2|STARTED|Overall Study||51
5275726|NCT00672854|12968142|P1|STARTED|Overall Study||49
5275727|NCT00672841|12968164|P2|NOT COMPLETED|Overall Study||15
5275728|NCT00672841|12968165|P1|NOT COMPLETED|Overall Study||1
5275729|NCT00672841|12968164|P2|COMPLETED|Overall Study||32
5275730|NCT00672841|12968165|P1|COMPLETED|Overall Study||16
5275731|NCT00672841|12968164|P2|STARTED|Overall Study||47
5275732|NCT00672841|12968165|P1|STARTED|Overall Study||17
5275733|NCT00672737|12968177|P1|NOT COMPLETED|Overall Study||8
5275734|NCT00672737|12968177|P1|COMPLETED|Overall Study||48
5275735|NCT00672737|12968177|P1|STARTED|Overall Study||56
5275736|NCT00672646|12968187|P3|NOT COMPLETED|Overall Study||3
5275737|NCT00672646|12968188|P2|NOT COMPLETED|Overall Study||1
5275738|NCT00672646|12968189|P1|NOT COMPLETED|Overall Study||0
5275739|NCT00672646|12968187|P3|COMPLETED|Overall Study||37
5275740|NCT00672646|12968188|P2|COMPLETED|Overall Study||22
5275741|NCT00672646|12968189|P1|COMPLETED|Overall Study||40
5275742|NCT00672646|12968187|P3|STARTED|Overall Study||40
5275743|NCT00672646|12968188|P2|STARTED|Overall Study||23
5275744|NCT00672646|12968189|P1|STARTED|Overall Study||40
5275745|NCT00672633|12968214|P2|NOT COMPLETED|Overall Study||1
5275746|NCT00672633|12968215|P1|NOT COMPLETED|Overall Study||0
5275747|NCT00672633|12968214|P2|COMPLETED|Overall Study||12
5275748|NCT00672633|12968215|P1|COMPLETED|Overall Study||12
5275749|NCT00672633|12968214|P2|STARTED|Overall Study||13
5275750|NCT00672633|12968215|P1|STARTED|Overall Study||12
5275751|NCT00672620|12968229|P4|NOT COMPLETED|Overall Study||42
5275752|NCT00672620|12968230|P3|NOT COMPLETED|Overall Study||31
5275753|NCT00672620|12968231|P2|NOT COMPLETED|Overall Study||54
5275754|NCT00672620|12968232|P1|NOT COMPLETED|Overall Study||33
5275755|NCT00672620|12968229|P4|COMPLETED|Overall Study||110
5275756|NCT00672620|12968230|P3|COMPLETED|Overall Study||122
5275757|NCT00672620|12968231|P2|COMPLETED|Overall Study||99
5275758|NCT00672620|12968232|P1|COMPLETED|Overall Study||120
5275759|NCT00672620|12968229|P4|Treated|Overall Study||150
5275760|NCT00672620|12968230|P3|Treated|Overall Study||153
5275761|NCT00672620|12968231|P2|Treated|Overall Study||149
5275762|NCT00672620|12968232|P1|Treated|Overall Study||151
5275763|NCT00672620|12968229|P4|STARTED|Overall Study||152
5275764|NCT00672620|12968230|P3|STARTED|Overall Study||153
5275765|NCT00672620|12968231|P2|STARTED|Overall Study||153
5275766|NCT00672620|12968232|P1|STARTED|Overall Study||153
5275767|NCT00672594|12968286|P1|NOT COMPLETED|Overall Study||3
5275768|NCT00672594|12968286|P1|COMPLETED|Overall Study||27
5275769|NCT00672594|12968286|P1|STARTED|Overall Study||30
5275770|NCT00672555|12968297|P1|NOT COMPLETED|Overall Study||6
5275771|NCT00672555|12968297|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
5275772|NCT00672555|12968297|P1|STARTED|Overall Study||70
5275773|NCT00672490|12968308|P2|NOT COMPLETED|Overall Study||32
5275774|NCT00672490|12968309|P1|NOT COMPLETED|Overall Study||24
5275775|NCT00672490|12968308|P2|COMPLETED|Overall Study||157
5275776|NCT00672490|12968309|P1|COMPLETED|Overall Study||163
5275777|NCT00672490|12968308|P2|STARTED|Overall Study||189
5275778|NCT00672490|12968309|P1|STARTED|Overall Study||187
5275779|NCT00672477|12968333|P2|NOT COMPLETED|Overall Study||26
5275780|NCT00672477|12968334|P1|NOT COMPLETED|Overall Study||27
5275781|NCT00672477|12968333|P2|COMPLETED|Overall Study||88
5275782|NCT00672477|12968334|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
5275783|NCT00672477|12968333|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
5275784|NCT00672477|12968334|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
5275785|NCT00672451|12968344|P2|NOT COMPLETED|Overall Study||0
5275786|NCT00672451|12968345|P1|NOT COMPLETED|Overall Study||0
5275787|NCT00672451|12968344|P2|COMPLETED|Overall Study||2
5275788|NCT00672451|12968345|P1|COMPLETED|Overall Study||1
5275789|NCT00672451|12968344|P2|STARTED|Overall Study||2
5275790|NCT00672451|12968345|P1|STARTED|Overall Study||1
5275791|NCT00672438|12968355|P2|NOT COMPLETED|Infusion 2||0
5275792|NCT00672438|12968356|P1|NOT COMPLETED|Infusion 2||0
5275793|NCT00672438|12968355|P2|COMPLETED|Infusion 2||118
5275794|NCT00672438|12968356|P1|COMPLETED|Infusion 2||119
5275795|NCT00672438|12968355|P2|STARTED|Infusion 2||118
5275796|NCT00672438|12968356|P1|STARTED|Infusion 2||119
5275797|NCT00672438|12968355|P2|NOT COMPLETED|Washout||0
5275798|NCT00672438|12968356|P1|NOT COMPLETED|Washout||0
5275799|NCT00672438|12968355|P2|COMPLETED|Washout||118
5275800|NCT00672438|12968356|P1|COMPLETED|Washout||119
5275801|NCT00672438|12968355|P2|STARTED|Washout||118
5275802|NCT00672438|12968356|P1|STARTED|Washout||119
5275803|NCT00672438|12968355|P2|NOT COMPLETED|Infusion 1||0
5275804|NCT00672438|12968356|P1|NOT COMPLETED|Infusion 1||0
5275805|NCT00672438|12968355|P2|COMPLETED|Infusion 1||118
5275806|NCT00672438|12968356|P1|COMPLETED|Infusion 1||119
5275807|NCT00672438|12968355|P2|STARTED|Infusion 1||118
5275808|NCT00672438|12968356|P1|STARTED|Infusion 1||119
5275809|NCT00672256|12968387|P1|NOT COMPLETED|Overall Study||44
5275810|NCT00672256|12968387|P1|COMPLETED|Overall Study||18
5275811|NCT00672256|12968387|P1|STARTED|Overall Study|January 2007|62
5275812|NCT00672243|12968394|P1|NOT COMPLETED|Overall Study||0
5275813|NCT00672243|12968394|P1|COMPLETED|Overall Study||32
5275814|NCT00672243|12968394|P1|STARTED|Overall Study||32
5275815|NCT00672204|12968402|P1|NOT COMPLETED|Overall Study||20
5275816|NCT00672204|12968402|P1|COMPLETED|Overall Study||3
5275817|NCT00672204|12968402|P1|STARTED|Overall Study||23
5275818|NCT00672178|12968406|P1|NOT COMPLETED|Overall Study||0
5275819|NCT00672178|12968406|P1|COMPLETED|Overall Study||1
5275820|NCT00672178|12968406|P1|STARTED|Overall Study||1
5275821|NCT00672139|12968412|P2|NOT COMPLETED|Overall Study||45
5275822|NCT00672139|12968413|P1|NOT COMPLETED|Overall Study||30
5275823|NCT00672139|12968412|P2|COMPLETED|Overall Study||47
5275824|NCT00672139|12968413|P1|COMPLETED|Overall Study||27
5275825|NCT00672139|12968412|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
5275826|NCT00672139|12968413|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
5275827|NCT00672100|12968422|P3|NOT COMPLETED|Overall Study||0
5275828|NCT00672100|12968423|P2|NOT COMPLETED|Overall Study||0
5275829|NCT00672100|12968424|P1|NOT COMPLETED|Overall Study||0
5275830|NCT00672100|12968422|P3|COMPLETED|Overall Study||12
5275831|NCT00672100|12968423|P2|COMPLETED|Overall Study||12
5275832|NCT00672100|12968424|P1|COMPLETED|Overall Study||12
5275833|NCT00672100|12968422|P3|PACU (Within 8 Hours)|Overall Study||12
5275834|NCT00672100|12968423|P2|PACU (Within 8 Hours)|Overall Study||12
5275835|NCT00672100|12968424|P1|PACU (Within 8 Hours)|Overall Study||12
5275836|NCT00672100|12968422|P3|STARTED|Overall Study||12
5275837|NCT00672100|12968423|P2|STARTED|Overall Study||12
5275838|NCT00672100|12968424|P1|STARTED|Overall Study||12
5275839|NCT00671970|12968441|P2|NOT COMPLETED|Overall Study||0
5275840|NCT00671970|12968442|P1|NOT COMPLETED|Overall Study||0
5275841|NCT00671970|12968441|P2|COMPLETED|Overall Study||25
5275842|NCT00671970|12968442|P1|COMPLETED|Overall Study||32
5275843|NCT00671970|12968441|P2|STARTED|Overall Study||25
5275844|NCT00671970|12968442|P1|STARTED|Overall Study||32
5275845|NCT00671931|12968470|P5|NOT COMPLETED|Overall Study||1
5275846|NCT00671931|12968471|P4|NOT COMPLETED|Overall Study||2
5275847|NCT00671931|12968472|P3|NOT COMPLETED|Overall Study||0
5275848|NCT00671931|12968473|P2|NOT COMPLETED|Overall Study||0
5275849|NCT00671931|12968474|P1|NOT COMPLETED|Overall Study||1
5275850|NCT00671931|12968470|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
5275851|NCT00671931|12968471|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
5275852|NCT00671931|12968472|P3|COMPLETED|Overall Study|all completed|9
5275853|NCT00671931|12968473|P2|COMPLETED|Overall Study|All completed|8
5275854|NCT00671931|12968474|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
5275855|NCT00671931|12968470|P5|STARTED|Overall Study||8
5275856|NCT00671931|12968471|P4|STARTED|Overall Study||10
5275857|NCT00671931|12968472|P3|STARTED|Overall Study||9
5275858|NCT00671931|12968473|P2|STARTED|Overall Study||8
5275859|NCT00671931|12968474|P1|STARTED|Overall Study||9
5275860|NCT00671918|12968486|P1|NOT COMPLETED|Overall Study||17
5275861|NCT00671918|12968486|P1|COMPLETED|Overall Study||169
5275862|NCT00671918|12968486|P1|STARTED|Overall Study||186
5275863|NCT00671879|12968494|P3|NOT COMPLETED|Overall Study||6
5275864|NCT00671879|12968495|P2|NOT COMPLETED|Overall Study||4
5275865|NCT00671879|12968496|P1|NOT COMPLETED|Overall Study||0
5275866|NCT00671879|12968494|P3|COMPLETED|Overall Study||274
5275867|NCT00671879|12968495|P2|COMPLETED|Overall Study||275
5275868|NCT00671879|12968496|P1|COMPLETED|Overall Study||281
5275869|NCT00671879|12968494|P3|STARTED|Overall Study||280
5275870|NCT00671879|12968495|P2|STARTED|Overall Study||279
5275871|NCT00671879|12968496|P1|STARTED|Overall Study||281
5275872|NCT00671853|12968509|P2|NOT COMPLETED|Overall Study||27
5275873|NCT00671853|12968510|P1|NOT COMPLETED|Overall Study||20
5275874|NCT00671853|12968509|P2|COMPLETED|Overall Study||18
5275875|NCT00671853|12968510|P1|COMPLETED|Overall Study||26
5275876|NCT00671853|12968509|P2|STARTED|Overall Study||45
5275877|NCT00671853|12968510|P1|STARTED|Overall Study||46
5275878|NCT00671788|12968526|P1|NOT COMPLETED|Overall Study||14
5275879|NCT00671788|12968526|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
5275880|NCT00671788|12968526|P1|STARTED|Overall Study||35
5275881|NCT00671749|12968533|P1|NOT COMPLETED|Overall Study||8
5275882|NCT00671749|12968533|P1|COMPLETED|Overall Study||92
5275883|NCT00671749|12968533|P1|STARTED|Overall Study||100
5275884|NCT00671723|12968546|P3|NOT COMPLETED|Overall Study||0
5275885|NCT00671723|12968547|P2|NOT COMPLETED|Overall Study||0
5275886|NCT00671723|12968548|P1|NOT COMPLETED|Overall Study||0
5275887|NCT00671723|12968546|P3|COMPLETED|Overall Study||11
5275888|NCT00671723|12968547|P2|COMPLETED|Overall Study||11
5275889|NCT00671723|12968548|P1|COMPLETED|Overall Study||11
5275890|NCT00671723|12968546|P3|STARTED|Overall Study||11
5275891|NCT00671723|12968547|P2|STARTED|Overall Study||11
5275892|NCT00671723|12968548|P1|STARTED|Overall Study||11
5275893|NCT00671671|12968561|P2|NOT COMPLETED|Overall Study||0
5275894|NCT00671671|12968562|P1|NOT COMPLETED|Overall Study||0
5275895|NCT00671671|12968561|P2|COMPLETED|Overall Study||10
5275896|NCT00671671|12968562|P1|COMPLETED|Overall Study||10
5275897|NCT00671671|12968561|P2|STARTED|Overall Study||10
5275898|NCT00671671|12968562|P1|STARTED|Overall Study||10
5275899|NCT00671606|12968588|P1|NOT COMPLETED|Overall Study||0
5275900|NCT00671606|12968588|P1|COMPLETED|Overall Study||5
5275901|NCT00671606|12968588|P1|STARTED|Overall Study||5
5275902|NCT00671554|12968592|P1|NOT COMPLETED|Overall Study||3
5275903|NCT00671554|12968592|P1|COMPLETED|Overall Study||0
5275904|NCT00671554|12968592|P1|STARTED|Overall Study||3
5275905|NCT00671528|12968600|P3|NOT COMPLETED|Overall Study||0
5275906|NCT00671528|12968601|P2|NOT COMPLETED|Overall Study||0
5275907|NCT00671528|12968602|P1|NOT COMPLETED|Overall Study||0
5275908|NCT00671528|12968600|P3|COMPLETED|Overall Study||1
5275909|NCT00671528|12968601|P2|COMPLETED|Overall Study||1
5275910|NCT00671528|12968602|P1|COMPLETED|Overall Study||1
5275911|NCT00671528|12968600|P3|STARTED|Overall Study||1
5275912|NCT00671528|12968601|P2|STARTED|Overall Study||1
5275913|NCT00671528|12968602|P1|STARTED|Overall Study||1
5275914|NCT00671515|12968613|P1|NOT COMPLETED|Phase 2||4
5275915|NCT00671515|12968613|P1|COMPLETED|Phase 2||9
5275916|NCT00671515|12968613|P1|STARTED|Phase 2||13
5275917|NCT00671515|12968613|P1|NOT COMPLETED|Phase 1||3
5275918|NCT00671515|12968613|P1|COMPLETED|Phase 1||20
5275919|NCT00671515|12968613|P1|STARTED|Phase 1||23
5275920|NCT00671502|12968621|P3|NOT COMPLETED|Overall Study||27
5275921|NCT00671502|12968622|P2|NOT COMPLETED|Overall Study||39
5275922|NCT00671502|12968623|P1|NOT COMPLETED|Overall Study||39
5275923|NCT00671502|12968621|P3|COMPLETED|Overall Study||252
5275924|NCT00671502|12968622|P2|COMPLETED|Overall Study||241
5275925|NCT00671502|12968623|P1|COMPLETED|Overall Study||242
5275926|NCT00671502|12968621|P3|STARTED|Overall Study||279
5275927|NCT00671502|12968622|P2|STARTED|Overall Study||280
5275928|NCT00671502|12968623|P1|STARTED|Overall Study||281
5275929|NCT00671437|12968631|P1|NOT COMPLETED|Overall Study||15
5275930|NCT00671437|12968631|P1|COMPLETED|Overall Study||27
5275931|NCT00671437|12968631|P1|STARTED|Overall Study||42
5275932|NCT00671177|12968652|P2|NOT COMPLETED|Overall Study||1
5275933|NCT00671177|12968653|P1|NOT COMPLETED|Overall Study||2
5275934|NCT00671177|12968652|P2|COMPLETED|Overall Study||114
5275935|NCT00671177|12968653|P1|COMPLETED|Overall Study||112
5275936|NCT00671177|12968652|P2|STARTED|Overall Study||115
5275937|NCT00671177|12968653|P1|STARTED|Overall Study||114
5275938|NCT00671060|12968665|P2|NOT COMPLETED|Overall Study||1
5275939|NCT00671060|12968666|P1|NOT COMPLETED|Overall Study||1
5275940|NCT00671060|12968665|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
5275941|NCT00671060|12968666|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
5275942|NCT00671060|12968665|P2|STARTED|Overall Study||76
5275943|NCT00671060|12968666|P1|STARTED|Overall Study||77
5275944|NCT00671034|12968675|P3|NOT COMPLETED|Overall Study||24
5275945|NCT00671034|12968676|P2|NOT COMPLETED|Overall Study||20
5275946|NCT00671034|12968677|P1|NOT COMPLETED|Overall Study||39
5275947|NCT00671034|12968675|P3|COMPLETED|Overall Study||31
5275948|NCT00671034|12968676|P2|COMPLETED|Overall Study||22
5275949|NCT00671034|12968677|P1|COMPLETED|Overall Study||30
5275950|NCT00671034|12968675|P3|STARTED|Overall Study||55
5275951|NCT00671034|12968676|P2|STARTED|Overall Study||42
5275952|NCT00671034|12968677|P1|STARTED|Overall Study||69
5275953|NCT00670982|12968714|P2|NOT COMPLETED|Overall Study||0
5275954|NCT00670982|12968715|P1|NOT COMPLETED|Overall Study||0
5275955|NCT00670982|12968714|P2|COMPLETED|Overall Study||7
5275956|NCT00670982|12968715|P1|COMPLETED|Overall Study||22
5275957|NCT00670982|12968714|P2|STARTED|Overall Study||7
5275958|NCT00670982|12968715|P1|STARTED|Overall Study||22
5275959|NCT00670956|12968724|P1|NOT COMPLETED|Overall Study||0
5275960|NCT00670956|12968724|P1|COMPLETED|Overall Study||1
5275961|NCT00670956|12968724|P1|STARTED|Overall Study||1
5275962|NCT00670930|12968732|P2|NOT COMPLETED|Overall Study||1
5275963|NCT00670930|12968733|P1|NOT COMPLETED|Overall Study||1
5275964|NCT00670930|12968732|P2|COMPLETED|Overall Study||12
5275965|NCT00670930|12968733|P1|COMPLETED|Overall Study||22
5275966|NCT00670930|12968732|P2|Intent to Treat (ITT) Population|Overall Study||12
5275967|NCT00670930|12968733|P1|Intent to Treat (ITT) Population|Overall Study||23
5275968|NCT00670930|12968732|P2|STARTED|Overall Study||13
5275969|NCT00670930|12968733|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
5275970|NCT00670800|12968749|P2|NOT COMPLETED|Overall Study||2
5275971|NCT00670800|12968750|P1|NOT COMPLETED|Overall Study||0
5275972|NCT00670800|12968749|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
5275973|NCT00670800|12968750|P1|COMPLETED|Overall Study||7
5275974|NCT00670800|12968749|P2|STARTED|Overall Study||7
5275975|NCT00670800|12968750|P1|STARTED|Overall Study||7
5275976|NCT00670774|12968766|P1|NOT COMPLETED|Overall Study||0
5275977|NCT00670774|12968766|P1|COMPLETED|Overall Study||26
5275978|NCT00670774|12968766|P1|STARTED|Overall Study||26
5275979|NCT00670748|12968781|P4|NOT COMPLETED|Overall Study||1
5275980|NCT00670748|12968782|P3|NOT COMPLETED|Overall Study||2
5275981|NCT00670748|12968783|P2|NOT COMPLETED|Overall Study||2
5275982|NCT00670748|12968784|P1|NOT COMPLETED|Overall Study||3
5275983|NCT00670748|12968781|P4|COMPLETED|Overall Study||4
5275984|NCT00670748|12968782|P3|COMPLETED|Overall Study||5
5275985|NCT00670748|12968783|P2|COMPLETED|Overall Study||14
5275986|NCT00670748|12968784|P1|COMPLETED|Overall Study||14
5275987|NCT00670748|12968781|P4|STARTED|Overall Study||5
5275988|NCT00670748|12968782|P3|STARTED|Overall Study||7
5275989|NCT00670748|12968783|P2|STARTED|Overall Study||16
5275990|NCT00670748|12968784|P1|STARTED|Overall Study||17
5275991|NCT00670709|12968804|P2|NOT COMPLETED|Overall Study||0
5275992|NCT00670709|12968805|P1|NOT COMPLETED|Overall Study||0
5275993|NCT00670709|12968804|P2|COMPLETED|Overall Study||15
5275994|NCT00670709|12968805|P1|COMPLETED|Overall Study||27
5275995|NCT00670709|12968804|P2|STARTED|Overall Study||15
5275996|NCT00670709|12968805|P1|STARTED|Overall Study||27
5275997|NCT00670631|12968813|P1|NOT COMPLETED|Overall Study||0
5275998|NCT00670631|12968813|P1|COMPLETED|Overall Study||0
5275999|NCT00670631|12968813|P1|STARTED|Overall Study||0
5276000|NCT00670540|12968819|P1|NOT COMPLETED|Overall Study||3325
5276001|NCT00670540|12968819|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
5276002|NCT00670540|12968819|P1|STARTED|Overall Study||8256
5276003|NCT00670488|12968839|P10|NOT COMPLETED|Overall Study||2
5276004|NCT00670488|12968840|P9|NOT COMPLETED|Overall Study||3
5276005|NCT00670488|12968841|P8|NOT COMPLETED|Overall Study||3
5276006|NCT00670488|12968842|P7|NOT COMPLETED|Overall Study||17
5276007|NCT00670488|12968843|P6|NOT COMPLETED|Overall Study||5
5276008|NCT00670488|12968844|P5|NOT COMPLETED|Overall Study||3
5276009|NCT00670488|12968845|P4|NOT COMPLETED|Overall Study||7
5276010|NCT00670488|12968846|P3|NOT COMPLETED|Overall Study||3
5276011|NCT00670488|12968847|P2|NOT COMPLETED|Overall Study||58
5276012|NCT00670488|12968848|P1|NOT COMPLETED|Overall Study||3
5276013|NCT00670488|12968839|P10|COMPLETED|Overall Study||0
5276014|NCT00670488|12968840|P9|COMPLETED|Overall Study||0
5276015|NCT00670488|12968841|P8|COMPLETED|Overall Study||0
5276016|NCT00670488|12968842|P7|COMPLETED|Overall Study||0
5276017|NCT00670488|12968843|P6|COMPLETED|Overall Study||0
5276018|NCT00670488|12968844|P5|COMPLETED|Overall Study||0
5276019|NCT00670488|12968845|P4|COMPLETED|Overall Study||0
5276020|NCT00670488|12968846|P3|COMPLETED|Overall Study||0
5276021|NCT00670488|12968847|P2|COMPLETED|Overall Study||0
5276022|NCT00670488|12968848|P1|COMPLETED|Overall Study||0
5276023|NCT00670488|12968839|P10|STARTED|Overall Study||2
5276024|NCT00670488|12968840|P9|STARTED|Overall Study||3
5276025|NCT00670488|12968841|P8|STARTED|Overall Study||3
5276026|NCT00670488|12968842|P7|STARTED|Overall Study||17
5276027|NCT00670488|12968843|P6|STARTED|Overall Study||5
5276028|NCT00670488|12968844|P5|STARTED|Overall Study||3
5276029|NCT00670488|12968845|P4|STARTED|Overall Study||7
5276030|NCT00670488|12968846|P3|STARTED|Overall Study||3
5276031|NCT00670488|12968847|P2|STARTED|Overall Study||58
5276032|NCT00670488|12968848|P1|STARTED|Overall Study||3
5276033|NCT00670462|12969002|P2|NOT COMPLETED|Overall Study||31
5276034|NCT00670462|12969003|P1|NOT COMPLETED|Overall Study||30
5276035|NCT00670462|12969002|P2|COMPLETED|Overall Study||76
5276036|NCT00670462|12969003|P1|COMPLETED|Overall Study||76
5276037|NCT00670462|12969002|P2|STARTED|Overall Study||107
5276038|NCT00670462|12969003|P1|STARTED|Overall Study||106
5276039|NCT00670449|12969035|P4|NOT COMPLETED|Overall Study||8
5276040|NCT00670449|12969036|P3|NOT COMPLETED|Overall Study||9
5276041|NCT00670449|12969037|P2|NOT COMPLETED|Overall Study||10
5276042|NCT00670449|12969038|P1|NOT COMPLETED|Overall Study||9
5276043|NCT00670449|12969035|P4|COMPLETED|Overall Study||15
5276044|NCT00670449|12969036|P3|COMPLETED|Overall Study||18
5276045|NCT00670449|12969037|P2|COMPLETED|Overall Study||36
5276046|NCT00670449|12969038|P1|COMPLETED|Overall Study||38
5276047|NCT00670449|12969035|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
5276048|NCT00670449|12969036|P3|Switched to 0.5mg (Open Label)|Overall Study||23
5276049|NCT00670449|12969037|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
5276050|NCT00670449|12969038|P1|Switched to 0.5mg (Open Label)|Overall Study||45
5276051|NCT00670449|12969035|P4|STARTED|Overall Study||23
5276052|NCT00670449|12969036|P3|STARTED|Overall Study||27
5276053|NCT00670449|12969037|P2|STARTED|Overall Study||46
5276054|NCT00670449|12969038|P1|STARTED|Overall Study||47
5276055|NCT00670306|12969062|P1|NOT COMPLETED|Overall Study||55
5276056|NCT00670306|12969062|P1|COMPLETED|Overall Study||473
5276057|NCT00670306|12969062|P1|STARTED|Overall Study||528
5276058|NCT00670267|12969066|P1|NOT COMPLETED|Overall Study||1
5276059|NCT00670267|12969066|P1|COMPLETED|Overall Study||9
5276060|NCT00670267|12969066|P1|STARTED|Overall Study||10
5276061|NCT00670241|12969077|P3|NOT COMPLETED|Overall Study||27
5276062|NCT00670241|12969078|P2|NOT COMPLETED|Overall Study||21
5276063|NCT00670241|12969079|P1|NOT COMPLETED|Overall Study||12
5276064|NCT00670241|12969077|P3|COMPLETED|Overall Study||64
5276065|NCT00670241|12969078|P2|COMPLETED|Overall Study||163
5276066|NCT00670241|12969079|P1|COMPLETED|Overall Study||171
5276067|NCT00670241|12969077|P3|STARTED|Overall Study||91
5276068|NCT00670241|12969078|P2|STARTED|Overall Study||184
5276069|NCT00670241|12969079|P1|STARTED|Overall Study||183
5276070|NCT00670228|12969101|P2|NOT COMPLETED|Overall Study||3
5276071|NCT00670228|12969102|P1|NOT COMPLETED|Overall Study||5
5276072|NCT00670228|12969101|P2|COMPLETED|Overall Study||12
5276073|NCT00670228|12969102|P1|COMPLETED|Overall Study||13
5276074|NCT00670228|12969101|P2|STARTED|Overall Study||15
5276075|NCT00670228|12969102|P1|STARTED|Overall Study||18
5276076|NCT00670202|12969116|P2|NOT COMPLETED|Overall Study||0
5276077|NCT00670202|12969117|P1|NOT COMPLETED|Overall Study||0
5276078|NCT00670202|12969116|P2|COMPLETED|Overall Study||0
5276079|NCT00670202|12969117|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
5276080|NCT00670202|12969116|P2|STARTED|Overall Study||0
5276081|NCT00670202|12969117|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
5276082|NCT00670111|12969126|P3|NOT COMPLETED|Six Months to Twelve Months||0
5276083|NCT00670111|12969127|P2|NOT COMPLETED|Six Months to Twelve Months||0
5276084|NCT00670111|12969128|P1|NOT COMPLETED|Six Months to Twelve Months||0
5276085|NCT00670111|12969126|P3|COMPLETED|Six Months to Twelve Months||0
5276086|NCT00670111|12969127|P2|COMPLETED|Six Months to Twelve Months||8
5276087|NCT00670111|12969128|P1|COMPLETED|Six Months to Twelve Months||4
5276088|NCT00670111|12969126|P3|STARTED|Six Months to Twelve Months||0
5276089|NCT00670111|12969127|P2|STARTED|Six Months to Twelve Months||8
5276090|NCT00670111|12969128|P1|STARTED|Six Months to Twelve Months||4
5276091|NCT00670111|12969126|P3|NOT COMPLETED|One Month to Six Months||0
5276092|NCT00670111|12969127|P2|NOT COMPLETED|One Month to Six Months||0
5276093|NCT00670111|12969128|P1|NOT COMPLETED|One Month to Six Months||0
5276094|NCT00670111|12969126|P3|COMPLETED|One Month to Six Months||0
5276095|NCT00670111|12969127|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
5276096|NCT00670111|12969128|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
5276097|NCT00670111|12969126|P3|STARTED|One Month to Six Months||0
5276098|NCT00670111|12969127|P2|STARTED|One Month to Six Months||8
5276099|NCT00670111|12969128|P1|STARTED|One Month to Six Months||4
5276100|NCT00670111|12969126|P3|NOT COMPLETED|One Month Period B||0
5276101|NCT00670111|12969127|P2|NOT COMPLETED|One Month Period B||0
5276102|NCT00670111|12969128|P1|NOT COMPLETED|One Month Period B||0
5276103|NCT00670111|12969126|P3|COMPLETED|One Month Period B||0
5276104|NCT00670111|12969127|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
5276105|NCT00670111|12969128|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
5276106|NCT00670111|12969126|P3|STARTED|One Month Period B||0
5276107|NCT00670111|12969127|P2|STARTED|One Month Period B||8
5276108|NCT00670111|12969128|P1|STARTED|One Month Period B||4
5276109|NCT00670111|12969126|P3|NOT COMPLETED|One Month Period A||0
5276110|NCT00670111|12969127|P2|NOT COMPLETED|One Month Period A||0
5276111|NCT00670111|12969128|P1|NOT COMPLETED|One Month Period A||0
5276112|NCT00670111|12969126|P3|COMPLETED|One Month Period A||0
5276113|NCT00670111|12969127|P2|COMPLETED|One Month Period A||8
5276114|NCT00670111|12969128|P1|COMPLETED|One Month Period A||4
5276115|NCT00670111|12969126|P3|STARTED|One Month Period A||0
5276116|NCT00670111|12969127|P2|STARTED|One Month Period A||8
5276117|NCT00670111|12969128|P1|STARTED|One Month Period A||4
5276118|NCT00670111|12969126|P3|NOT COMPLETED|Enrollment to One Month||19
5276119|NCT00670111|12969127|P2|NOT COMPLETED|Enrollment to One Month||0
5276120|NCT00670111|12969128|P1|NOT COMPLETED|Enrollment to One Month||1
5276121|NCT00670111|12969126|P3|COMPLETED|Enrollment to One Month||0
5276122|NCT00670111|12969127|P2|COMPLETED|Enrollment to One Month||8
5276123|NCT00670111|12969128|P1|COMPLETED|Enrollment to One Month||4
5276124|NCT00670111|12969126|P3|STARTED|Enrollment to One Month||19
5276125|NCT00670111|12969127|P2|STARTED|Enrollment to One Month||8
5276126|NCT00670111|12969128|P1|STARTED|Enrollment to One Month||5
5276127|NCT00670046|12969138|P2|NOT COMPLETED|Overall Study||2
5276128|NCT00670046|12969139|P1|NOT COMPLETED|Overall Study||1
5276129|NCT00670046|12969138|P2|COMPLETED|Overall Study||6
5276130|NCT00670046|12969139|P1|COMPLETED|Overall Study||6
5276131|NCT00670046|12969138|P2|STARTED|Overall Study||8
5276132|NCT00670046|12969139|P1|STARTED|Overall Study||7
5276133|NCT00670007|12969153|P1|NOT COMPLETED|Overall Study||9
5276134|NCT00670007|12969153|P1|COMPLETED|Overall Study||131
5276135|NCT00670007|12969153|P1|STARTED|Overall Study||140
5276136|NCT00669955|12969180|P2|NOT COMPLETED|Overall Study||27
5276137|NCT00669955|12969181|P1|NOT COMPLETED|Overall Study||14
5276138|NCT00669955|12969180|P2|COMPLETED|Overall Study||195
5276139|NCT00669955|12969181|P1|COMPLETED|Overall Study||204
5276140|NCT00669955|12969180|P2|STARTED|Overall Study||222
5276141|NCT00669955|12969181|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
5276142|NCT00669942|12969211|P12|NOT COMPLETED|Healthy Volunteers||0
5276143|NCT00669942|12969212|P11|NOT COMPLETED|Healthy Volunteers||1
5276144|NCT00669942|12969213|P10|NOT COMPLETED|Healthy Volunteers||0
5276145|NCT00669942|12969214|P9|NOT COMPLETED|Healthy Volunteers||0
5276146|NCT00669942|12969215|P8|NOT COMPLETED|Healthy Volunteers||0
5276147|NCT00669942|12969216|P7|NOT COMPLETED|Healthy Volunteers||0
5276148|NCT00669942|12969217|P6|NOT COMPLETED|Healthy Volunteers||0
5276149|NCT00669942|12969218|P5|NOT COMPLETED|Healthy Volunteers||0
5276150|NCT00669942|12969219|P4|NOT COMPLETED|Healthy Volunteers||0
5276151|NCT00669942|12969220|P3|NOT COMPLETED|Healthy Volunteers||0
5276152|NCT00669942|12969221|P2|NOT COMPLETED|Healthy Volunteers||0
5276153|NCT00669942|12969222|P1|NOT COMPLETED|Healthy Volunteers||0
5276154|NCT00669942|12969211|P12|COMPLETED|Healthy Volunteers||2
5276155|NCT00669942|12969212|P11|COMPLETED|Healthy Volunteers||2
5276156|NCT00669942|12969213|P10|COMPLETED|Healthy Volunteers||3
5276157|NCT00669942|12969214|P9|COMPLETED|Healthy Volunteers||0
5276158|NCT00669942|12969215|P8|COMPLETED|Healthy Volunteers||0
5276159|NCT00669942|12969216|P7|COMPLETED|Healthy Volunteers||0
5276160|NCT00669942|12969217|P6|COMPLETED|Healthy Volunteers||0
5276161|NCT00669942|12969218|P5|COMPLETED|Healthy Volunteers||0
5276162|NCT00669942|12969219|P4|COMPLETED|Healthy Volunteers||0
5276163|NCT00669942|12969220|P3|COMPLETED|Healthy Volunteers||0
5276164|NCT00669942|12969221|P2|COMPLETED|Healthy Volunteers||0
5276165|NCT00669942|12969222|P1|COMPLETED|Healthy Volunteers||0
5276166|NCT00669942|12969211|P12|STARTED|Healthy Volunteers||2
5276167|NCT00669942|12969212|P11|STARTED|Healthy Volunteers||3
5276168|NCT00669942|12969213|P10|STARTED|Healthy Volunteers||3
5276169|NCT00669942|12969214|P9|STARTED|Healthy Volunteers||0
5276170|NCT00669942|12969215|P8|STARTED|Healthy Volunteers||0
5276171|NCT00669942|12969216|P7|STARTED|Healthy Volunteers||0
5276172|NCT00669942|12969217|P6|STARTED|Healthy Volunteers||0
5276173|NCT00669942|12969218|P5|STARTED|Healthy Volunteers||0
5276174|NCT00669942|12969219|P4|STARTED|Healthy Volunteers||0
5276175|NCT00669942|12969220|P3|STARTED|Healthy Volunteers||0
5276176|NCT00669942|12969221|P2|STARTED|Healthy Volunteers||0
5276177|NCT00669942|12969222|P1|STARTED|Healthy Volunteers||0
5276178|NCT00669942|12969211|P12|NOT COMPLETED|Parts 2 and 3||0
5276179|NCT00669942|12969212|P11|NOT COMPLETED|Parts 2 and 3||0
5276180|NCT00669942|12969213|P10|NOT COMPLETED|Parts 2 and 3||0
5276181|NCT00669942|12969214|P9|NOT COMPLETED|Parts 2 and 3||3
5276182|NCT00669942|12969215|P8|NOT COMPLETED|Parts 2 and 3||2
5276183|NCT00669942|12969216|P7|NOT COMPLETED|Parts 2 and 3||0
5276184|NCT00669942|12969217|P6|NOT COMPLETED|Parts 2 and 3||2
5276185|NCT00669942|12969218|P5|NOT COMPLETED|Parts 2 and 3||0
5276186|NCT00669942|12969219|P4|NOT COMPLETED|Parts 2 and 3||0
5276187|NCT00669942|12969220|P3|NOT COMPLETED|Parts 2 and 3||0
5276188|NCT00669942|12969221|P2|NOT COMPLETED|Parts 2 and 3||0
5276189|NCT00669942|12969222|P1|NOT COMPLETED|Parts 2 and 3||0
5276190|NCT00669942|12969211|P12|COMPLETED|Parts 2 and 3||0
5276191|NCT00669942|12969212|P11|COMPLETED|Parts 2 and 3||0
5276192|NCT00669942|12969213|P10|COMPLETED|Parts 2 and 3||0
5276193|NCT00669942|12969214|P9|COMPLETED|Parts 2 and 3||23
5276194|NCT00669942|12969215|P8|COMPLETED|Parts 2 and 3||24
5276195|NCT00669942|12969216|P7|COMPLETED|Parts 2 and 3||6
5276196|NCT00669942|12969217|P6|COMPLETED|Parts 2 and 3||4
5276197|NCT00669942|12969218|P5|COMPLETED|Parts 2 and 3||0
5276198|NCT00669942|12969219|P4|COMPLETED|Parts 2 and 3||0
5276199|NCT00669942|12969220|P3|COMPLETED|Parts 2 and 3||0
5276200|NCT00669942|12969221|P2|COMPLETED|Parts 2 and 3||0
5276201|NCT00669942|12969222|P1|COMPLETED|Parts 2 and 3||0
5276202|NCT00669942|12969211|P12|STARTED|Parts 2 and 3||0
5276203|NCT00669942|12969212|P11|STARTED|Parts 2 and 3||0
5276204|NCT00669942|12969213|P10|STARTED|Parts 2 and 3||0
5276205|NCT00669942|12969214|P9|STARTED|Parts 2 and 3||26
5276206|NCT00669942|12969215|P8|STARTED|Parts 2 and 3||26
5276207|NCT00669942|12969216|P7|STARTED|Parts 2 and 3||6
5276208|NCT00669942|12969217|P6|STARTED|Parts 2 and 3||6
5276209|NCT00669942|12969218|P5|STARTED|Parts 2 and 3||0
5276210|NCT00669942|12969219|P4|STARTED|Parts 2 and 3||0
5276211|NCT00669942|12969220|P3|STARTED|Parts 2 and 3||0
5276212|NCT00669942|12969221|P2|STARTED|Parts 2 and 3||0
5276213|NCT00669942|12969222|P1|STARTED|Parts 2 and 3||0
5276214|NCT00669942|12969211|P12|NOT COMPLETED|Part 1||0
5276215|NCT00669942|12969212|P11|NOT COMPLETED|Part 1||0
5276216|NCT00669942|12969213|P10|NOT COMPLETED|Part 1||0
5276217|NCT00669942|12969214|P9|NOT COMPLETED|Part 1||0
5276218|NCT00669942|12969215|P8|NOT COMPLETED|Part 1||0
5276219|NCT00669942|12969216|P7|NOT COMPLETED|Part 1||0
5276220|NCT00669942|12969217|P6|NOT COMPLETED|Part 1||0
5276221|NCT00669942|12969218|P5|NOT COMPLETED|Part 1||0
5276222|NCT00669942|12969219|P4|NOT COMPLETED|Part 1||0
5276223|NCT00669942|12969220|P3|NOT COMPLETED|Part 1||0
5276224|NCT00669942|12969221|P2|NOT COMPLETED|Part 1||0
5276225|NCT00669942|12969222|P1|NOT COMPLETED|Part 1||0
5276226|NCT00669942|12969211|P12|COMPLETED|Part 1||0
5276227|NCT00669942|12969212|P11|COMPLETED|Part 1||0
5276228|NCT00669942|12969213|P10|COMPLETED|Part 1||0
5276229|NCT00669942|12969214|P9|COMPLETED|Part 1||0
5276230|NCT00669942|12969215|P8|COMPLETED|Part 1||0
5276231|NCT00669942|12969216|P7|COMPLETED|Part 1||0
5276232|NCT00669942|12969217|P6|COMPLETED|Part 1||0
5276233|NCT00669942|12969218|P5|COMPLETED|Part 1||8
5276234|NCT00669942|12969219|P4|COMPLETED|Part 1||6
5276235|NCT00669942|12969220|P3|COMPLETED|Part 1||6
5276236|NCT00669942|12969221|P2|COMPLETED|Part 1||6
5276237|NCT00669942|12969222|P1|COMPLETED|Part 1||6
5276238|NCT00669942|12969211|P12|STARTED|Part 1||0
5276239|NCT00669942|12969212|P11|STARTED|Part 1||0
5276240|NCT00669942|12969213|P10|STARTED|Part 1||0
5276241|NCT00669942|12969214|P9|STARTED|Part 1||0
5276242|NCT00669942|12969215|P8|STARTED|Part 1||0
5276243|NCT00669942|12969216|P7|STARTED|Part 1||0
5276244|NCT00669942|12969217|P6|STARTED|Part 1||0
5276245|NCT00669942|12969218|P5|STARTED|Part 1||8
5276246|NCT00669942|12969219|P4|STARTED|Part 1||6
5276247|NCT00669942|12969220|P3|STARTED|Part 1||6
5276248|NCT00669942|12969221|P2|STARTED|Part 1||6
5276249|NCT00669942|12969222|P1|STARTED|Part 1||6
5276250|NCT00669916|12969286|P2|NOT COMPLETED|Overall Study||0
5276251|NCT00669916|12969287|P1|NOT COMPLETED|Overall Study||0
5276252|NCT00669916|12969286|P2|COMPLETED|Overall Study||18
5276253|NCT00669916|12969287|P1|COMPLETED|Overall Study||18
5276254|NCT00669916|12969286|P2|STARTED|Overall Study||18
5276255|NCT00669916|12969287|P1|STARTED|Overall Study||18
5276256|NCT00669903|12969305|P4|NOT COMPLETED|Overall Study||4
5276257|NCT00669903|12969306|P3|NOT COMPLETED|Overall Study||5
5276258|NCT00669903|12969307|P2|NOT COMPLETED|Overall Study||5
5276259|NCT00669903|12969308|P1|NOT COMPLETED|Overall Study||1
5276260|NCT00669903|12969305|P4|COMPLETED|Overall Study||18
5276261|NCT00669903|12969306|P3|COMPLETED|Overall Study||13
5276262|NCT00669903|12969307|P2|COMPLETED|Overall Study||32
5276263|NCT00669903|12969308|P1|COMPLETED|Overall Study||22
5276264|NCT00669903|12969305|P4|Completed Treatment Period|Overall Study||19
5276265|NCT00669903|12969306|P3|Completed Treatment Period|Overall Study||13
5276266|NCT00669903|12969307|P2|Completed Treatment Period|Overall Study||33
5276267|NCT00669903|12969308|P1|Completed Treatment Period|Overall Study||23
5276268|NCT00669903|12969305|P4|STARTED|Overall Study||22
5276269|NCT00669903|12969306|P3|STARTED|Overall Study||18
5276270|NCT00669903|12969307|P2|STARTED|Overall Study||37
5276271|NCT00669903|12969308|P1|STARTED|Overall Study||23
5276272|NCT00669877|12969338|P1|NOT COMPLETED|Overall Study||4
5276273|NCT00669877|12969338|P1|COMPLETED|Overall Study||52
5276274|NCT00669877|12969338|P1|STARTED|Overall Study||56
5276275|NCT00669864|12969343|P1|NOT COMPLETED|Overall Study||9
5276276|NCT00669864|12969343|P1|COMPLETED|Overall Study||284
5276277|NCT00669864|12969343|P1|STARTED|Overall Study||293
5276278|NCT00669682|12969352|P1|NOT COMPLETED|Overall Study||0
5276279|NCT00669682|12969352|P1|COMPLETED|Overall Study||9
5276280|NCT00669682|12969352|P1|STARTED|Overall Study||9
5276281|NCT00669669|12969357|P1|NOT COMPLETED|Overall Study||1
5276282|NCT00669669|12969357|P1|COMPLETED|Overall Study||11
5276283|NCT00669669|12969357|P1|STARTED|Overall Study||12
5276284|NCT00669617|12969362|P5|NOT COMPLETED|Period 5||0
5276285|NCT00669617|12969363|P4|NOT COMPLETED|Period 5||0
5276286|NCT00669617|12969364|P3|NOT COMPLETED|Period 5||0
5276287|NCT00669617|12969365|P2|NOT COMPLETED|Period 5||0
5276288|NCT00669617|12969366|P1|NOT COMPLETED|Period 5||0
5276289|NCT00669617|12969362|P5|COMPLETED|Period 5||17
5276290|NCT00669617|12969363|P4|COMPLETED|Period 5||18
5276291|NCT00669617|12969364|P3|COMPLETED|Period 5||17
5276292|NCT00669617|12969365|P2|COMPLETED|Period 5||17
5276293|NCT00669617|12969366|P1|COMPLETED|Period 5||17
5276294|NCT00669617|12969362|P5|STARTED|Period 5||17
5276295|NCT00669617|12969363|P4|STARTED|Period 5||18
5276296|NCT00669617|12969364|P3|STARTED|Period 5||17
5276297|NCT00669617|12969365|P2|STARTED|Period 5||17
5276298|NCT00669617|12969366|P1|STARTED|Period 5||17
5276299|NCT00669617|12969362|P5|NOT COMPLETED|Period 4||0
5276300|NCT00669617|12969363|P4|NOT COMPLETED|Period 4||0
5276301|NCT00669617|12969364|P3|NOT COMPLETED|Period 4||0
5276302|NCT00669617|12969365|P2|NOT COMPLETED|Period 4||0
5276303|NCT00669617|12969366|P1|NOT COMPLETED|Period 4||0
5276304|NCT00669617|12969362|P5|COMPLETED|Period 4||17
5276305|NCT00669617|12969363|P4|COMPLETED|Period 4||18
5276306|NCT00669617|12969364|P3|COMPLETED|Period 4||17
5276307|NCT00669617|12969365|P2|COMPLETED|Period 4||17
5276308|NCT00669617|12969366|P1|COMPLETED|Period 4||17
5276309|NCT00669617|12969362|P5|STARTED|Period 4||17
5276310|NCT00669617|12969363|P4|STARTED|Period 4||18
5276311|NCT00669617|12969364|P3|STARTED|Period 4||17
5276312|NCT00669617|12969365|P2|STARTED|Period 4||17
5276313|NCT00669617|12969366|P1|STARTED|Period 4||17
5276314|NCT00669617|12969362|P5|NOT COMPLETED|Period 3||0
5276315|NCT00669617|12969363|P4|NOT COMPLETED|Period 3||0
5276316|NCT00669617|12969364|P3|NOT COMPLETED|Period 3||0
5276317|NCT00669617|12969365|P2|NOT COMPLETED|Period 3||0
5276318|NCT00669617|12969366|P1|NOT COMPLETED|Period 3||1
5276319|NCT00669617|12969362|P5|COMPLETED|Period 3||17
5276320|NCT00669617|12969363|P4|COMPLETED|Period 3||18
5276321|NCT00669617|12969364|P3|COMPLETED|Period 3||17
5276322|NCT00669617|12969365|P2|COMPLETED|Period 3||17
5276323|NCT00669617|12969366|P1|COMPLETED|Period 3||17
5276324|NCT00669617|12969362|P5|STARTED|Period 3||17
5276325|NCT00669617|12969363|P4|STARTED|Period 3||18
5276326|NCT00669617|12969364|P3|STARTED|Period 3||17
5276327|NCT00669617|12969365|P2|STARTED|Period 3||17
5276328|NCT00669617|12969366|P1|STARTED|Period 3||18
5276329|NCT00669617|12969362|P5|NOT COMPLETED|Period 2||0
5276330|NCT00669617|12969363|P4|NOT COMPLETED|Period 2||0
5276331|NCT00669617|12969364|P3|NOT COMPLETED|Period 2||0
5276332|NCT00669617|12969365|P2|NOT COMPLETED|Period 2||0
5276333|NCT00669617|12969366|P1|NOT COMPLETED|Period 2||0
5276334|NCT00669617|12969362|P5|COMPLETED|Period 2||17
5276335|NCT00669617|12969363|P4|COMPLETED|Period 2||18
5276336|NCT00669617|12969364|P3|COMPLETED|Period 2||17
5276337|NCT00669617|12969365|P2|COMPLETED|Period 2||17
5276338|NCT00669617|12969366|P1|COMPLETED|Period 2||18
5276339|NCT00669617|12969362|P5|STARTED|Period 2||17
5276340|NCT00669617|12969363|P4|STARTED|Period 2||18
5276341|NCT00669617|12969364|P3|STARTED|Period 2||17
5276342|NCT00669617|12969365|P2|STARTED|Period 2||17
5276343|NCT00669617|12969366|P1|STARTED|Period 2||18
5276344|NCT00669617|12969362|P5|NOT COMPLETED|Period 1||1
5276345|NCT00669617|12969363|P4|NOT COMPLETED|Period 1||0
5276346|NCT00669617|12969364|P3|NOT COMPLETED|Period 1||1
5276347|NCT00669617|12969365|P2|NOT COMPLETED|Period 1||0
5276348|NCT00669617|12969366|P1|NOT COMPLETED|Period 1||0
5276349|NCT00669617|12969362|P5|COMPLETED|Period 1||17
5276350|NCT00669617|12969363|P4|COMPLETED|Period 1||18
5276351|NCT00669617|12969364|P3|COMPLETED|Period 1||17
5276352|NCT00669617|12969365|P2|COMPLETED|Period 1||17
5276353|NCT00669617|12969366|P1|COMPLETED|Period 1||18
5276354|NCT00669617|12969362|P5|STARTED|Period 1||18
5276355|NCT00669617|12969363|P4|STARTED|Period 1||18
5276356|NCT00669617|12969364|P3|STARTED|Period 1||18
5276357|NCT00669617|12969365|P2|STARTED|Period 1||17
5276358|NCT00669617|12969366|P1|STARTED|Period 1||18
5276359|NCT00669578|12969380|P2|NOT COMPLETED|Overall Study||0
5276360|NCT00669578|12969381|P1|NOT COMPLETED|Overall Study||0
5276361|NCT00669578|12969380|P2|COMPLETED|Overall Study||65
5276362|NCT00669578|12969381|P1|COMPLETED|Overall Study||12
5276363|NCT00669578|12969380|P2|STARTED|Overall Study||65
5276364|NCT00669578|12969381|P1|STARTED|Overall Study||12
5276365|NCT00669552|12969394|P1|NOT COMPLETED|Overall Study||0
5276366|NCT00669552|12969394|P1|COMPLETED|Overall Study||11
5276367|NCT00669552|12969394|P1|STARTED|Overall Study||11
5276368|NCT00669539|12969400|P2|NOT COMPLETED|Overall Study||9
5276369|NCT00669539|12969401|P1|NOT COMPLETED|Overall Study||8
5276370|NCT00669539|12969400|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
5276371|NCT00669539|12969401|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
5276372|NCT00669539|12969400|P2|STARTED|Overall Study||52
5276373|NCT00669539|12969401|P1|STARTED|Overall Study||94
5276374|NCT00669461|12969407|P1|NOT COMPLETED|Overall Study||0
5276375|NCT00669461|12969407|P1|COMPLETED|Overall Study||1
5276376|NCT00669461|12969407|P1|STARTED|Overall Study||1
5276377|NCT00669396|12969414|P2|NOT COMPLETED|Overall Study||12
5276378|NCT00669396|12969415|P1|NOT COMPLETED|Overall Study||10
5276379|NCT00669396|12969414|P2|COMPLETED|Overall Study||22
5276380|NCT00669396|12969415|P1|COMPLETED|Overall Study||13
5276381|NCT00669396|12969414|P2|STARTED|Overall Study||34
5276382|NCT00669396|12969415|P1|STARTED|Overall Study||23
5276383|NCT00669383|12969429|P2|NOT COMPLETED|Overall Study||0
5276384|NCT00669383|12969430|P1|NOT COMPLETED|Overall Study||0
5276385|NCT00669383|12969429|P2|COMPLETED|Overall Study||41
5276386|NCT00669383|12969430|P1|COMPLETED|Overall Study||44
5276387|NCT00669383|12969429|P2|STARTED|Overall Study||41
5276388|NCT00669383|12969430|P1|STARTED|Overall Study||44
5276389|NCT00669331|12969442|P2|NOT COMPLETED|Blinded Treatment Period||39
5276390|NCT00669331|12969443|P1|NOT COMPLETED|Blinded Treatment Period||42
5276391|NCT00669331|12969442|P2|COMPLETED|Blinded Treatment Period||189
5276392|NCT00669331|12969443|P1|COMPLETED|Blinded Treatment Period||191
5276393|NCT00669331|12969442|P2|STARTED|Blinded Treatment Period||228
5276394|NCT00669331|12969443|P1|STARTED|Blinded Treatment Period||233
5276395|NCT00669331|12969442|P2|NOT COMPLETED|Randomisation to First Dose||13
5276396|NCT00669331|12969443|P1|NOT COMPLETED|Randomisation to First Dose||11
5276397|NCT00669331|12969442|P2|COMPLETED|Randomisation to First Dose||228
5276398|NCT00669331|12969443|P1|COMPLETED|Randomisation to First Dose||233
5276399|NCT00669331|12969442|P2|STARTED|Randomisation to First Dose||241
5276400|NCT00669331|12969443|P1|STARTED|Randomisation to First Dose||244
5276401|NCT00669318|12969485|P1|NOT COMPLETED|Overall Study||2
5276402|NCT00669318|12969485|P1|COMPLETED|Overall Study||39
5276403|NCT00669318|12969485|P1|STARTED|Overall Study||41
5276404|NCT00669279|12969495|P2|NOT COMPLETED|Overall Study||0
5276405|NCT00669279|12969496|P1|NOT COMPLETED|Overall Study||0
5276406|NCT00669279|12969495|P2|COMPLETED|Overall Study||19
5276407|NCT00669279|12969496|P1|COMPLETED|Overall Study||22
5276408|NCT00669279|12969495|P2|STARTED|Overall Study||19
5276409|NCT00669279|12969496|P1|STARTED|Overall Study||22
5276410|NCT00669240|12969502|P1|NOT COMPLETED|Overall Study||165
5276411|NCT00669240|12969502|P1|COMPLETED|Overall Study||402
5276412|NCT00669240|12969502|P1|Received Treatment|Overall Study||551
5276413|NCT00669240|12969502|P1|Assigned to Treatment|Overall Study||566
5276414|NCT00669240|12969502|P1|STARTED|Overall Study||567
5276415|NCT00669214|12969518|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
5276416|NCT00669214|12969519|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
5276417|NCT00669214|12969518|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
5276418|NCT00669214|12969519|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
5276419|NCT00669214|12969518|P2|STARTED|Open-Label Treatment Period (Week 24)||55
5276420|NCT00669214|12969519|P1|STARTED|Open-Label Treatment Period (Week 24)||22
5276421|NCT00669214|12969518|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
5276422|NCT00669214|12969519|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
5276423|NCT00669214|12969518|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
5276424|NCT00669214|12969519|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
5276425|NCT00669214|12969518|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
5276426|NCT00669214|12969519|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
5276427|NCT00669162|12969551|P1|NOT COMPLETED|Overall Study||1
5276428|NCT00669162|12969551|P1|COMPLETED|Overall Study||26
5276429|NCT00669162|12969551|P1|STARTED|Overall Study||27
5276430|NCT00669110|12969557|P2|NOT COMPLETED|Overall Study||13
5276431|NCT00669110|12969558|P1|NOT COMPLETED|Overall Study||8
5276432|NCT00669110|12969557|P2|COMPLETED|Overall Study||7
5276433|NCT00669110|12969558|P1|COMPLETED|Overall Study||12
5276434|NCT00669110|12969557|P2|STARTED|Overall Study||20
5276435|NCT00669110|12969558|P1|STARTED|Overall Study||20
5276436|NCT00669071|12969594|P1|NOT COMPLETED|Overall Study||4
5276437|NCT00669071|12969594|P1|COMPLETED|Overall Study||52
5276438|NCT00669071|12969594|P1|STARTED|Overall Study||56
5276439|NCT00669032|12969615|P2|NOT COMPLETED|Overall Study||59
5276440|NCT00669032|12969616|P1|NOT COMPLETED|Overall Study||44
5276441|NCT00669032|12969615|P2|COMPLETED|Overall Study||94
5276442|NCT00669032|12969616|P1|COMPLETED|Overall Study||109
5276443|NCT00669032|12969615|P2|STARTED|Overall Study||153
5276444|NCT00669032|12969616|P1|STARTED|Overall Study||153
5276445|NCT00669019|12969644|P1|NOT COMPLETED|Overall Study||0
5276446|NCT00669019|12969644|P1|COMPLETED|Overall Study||23
5276447|NCT00669019|12969644|P1|STARTED|Overall Study||23
5276448|NCT00668902|12969652|P3|NOT COMPLETED|Overall Study||0
5276449|NCT00668902|12969653|P2|NOT COMPLETED|Overall Study||0
5276450|NCT00668902|12969654|P1|NOT COMPLETED|Overall Study||0
5276451|NCT00668902|12969652|P3|COMPLETED|Overall Study||5
5276452|NCT00668902|12969653|P2|COMPLETED|Overall Study||10
5276453|NCT00668902|12969654|P1|COMPLETED|Overall Study||10
5276454|NCT00668902|12969652|P3|STARTED|Overall Study||5
5276455|NCT00668902|12969653|P2|STARTED|Overall Study||10
5276456|NCT00668902|12969654|P1|STARTED|Overall Study||10
5276457|NCT00668863|12969662|P1|NOT COMPLETED|Overall Study||71
5276458|NCT00668863|12969662|P1|COMPLETED|Overall Study||0
5276459|NCT00668863|12969662|P1|STARTED|Overall Study||71
5276460|NCT00668811|12969681|P1|NOT COMPLETED|Overall Study||0
5276461|NCT00668811|12969681|P1|COMPLETED|Overall Study||23
5276462|NCT00668811|12969681|P1|STARTED|Overall Study||23
5276463|NCT00668785|12969686|P1|NOT COMPLETED|Overall Study||0
5276464|NCT00668785|12969686|P1|COMPLETED|Overall Study||6
5276465|NCT00668785|12969686|P1|STARTED|Overall Study||6
5276466|NCT00668746|12969694|P2|NOT COMPLETED|Overall Study||1
5276467|NCT00668746|12969695|P1|NOT COMPLETED|Overall Study||2
5276468|NCT00668746|12969694|P2|COMPLETED|Overall Study||11
5276469|NCT00668746|12969695|P1|COMPLETED|Overall Study||21
5276470|NCT00668746|12969694|P2|STARTED|Overall Study||12
5276471|NCT00668746|12969695|P1|STARTED|Overall Study||23
5276472|NCT00668733|12969715|P2|NOT COMPLETED|Overall Study||7
5276473|NCT00668733|12969716|P1|NOT COMPLETED|Overall Study||2
5276474|NCT00668733|12969715|P2|COMPLETED|Overall Study||83
5276475|NCT00668733|12969716|P1|COMPLETED|Overall Study||87
5276476|NCT00668733|12969715|P2|STARTED|Overall Study||90
5276477|NCT00668733|12969716|P1|STARTED|Overall Study||89
5276478|NCT00668564|12969722|P1|NOT COMPLETED|Overall Study||0
5276479|NCT00668564|12969722|P1|COMPLETED|Overall Study||18
5276480|NCT00668564|12969722|P1|STARTED|Overall Study||18
5276481|NCT00668525|12969730|P3|NOT COMPLETED|Overall Study||53
5276482|NCT00668525|12969731|P2|NOT COMPLETED|Overall Study||93
5276483|NCT00668525|12969732|P1|NOT COMPLETED|Overall Study||77
5276484|NCT00668525|12969730|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
5276485|NCT00668525|12969731|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
5276486|NCT00668525|12969732|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
5276487|NCT00668525|12969730|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
5276488|NCT00668525|12969731|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
5276489|NCT00668525|12969732|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
5276490|NCT00668434|12969745|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
5276491|NCT00668434|12969746|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
5276492|NCT00668434|12969745|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
5276493|NCT00668434|12969746|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
5276494|NCT00668434|12969745|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
5276495|NCT00668434|12969746|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
5276496|NCT00668434|12969745|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
5276497|NCT00668434|12969746|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
5276498|NCT00668434|12969745|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
5276499|NCT00668434|12969746|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
5276500|NCT00668434|12969745|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
5276501|NCT00668434|12969746|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
5276502|NCT00668395|12969761|P3|NOT COMPLETED|Overall Study||1
5276503|NCT00668395|12969762|P2|NOT COMPLETED|Overall Study||6
5276504|NCT00668395|12969763|P1|NOT COMPLETED|Overall Study||6
5276505|NCT00668395|12969761|P3|COMPLETED|Overall Study||5
5276506|NCT00668395|12969762|P2|COMPLETED|Overall Study||16
5276507|NCT00668395|12969763|P1|COMPLETED|Overall Study||39
5276508|NCT00668395|12969761|P3|STARTED|Overall Study||6
5276509|NCT00668395|12969762|P2|STARTED|Overall Study||22
5276510|NCT00668395|12969763|P1|STARTED|Overall Study||45
5276511|NCT00668382|12969771|P1|NOT COMPLETED|Overall Study||0
5276512|NCT00668382|12969771|P1|COMPLETED|Overall Study||11
5276513|NCT00668382|12969771|P1|STARTED|Overall Study|beginning of trial|11
5276514|NCT00668317|12969775|P1|NOT COMPLETED|Overall Study||2
5276515|NCT00668317|12969775|P1|COMPLETED|Overall Study||3
5276516|NCT00668317|12969775|P1|STARTED|Overall Study||5
5276517|NCT00668265|12969781|P2|NOT COMPLETED|Overall Study||5
5276518|NCT00668265|12969782|P1|NOT COMPLETED|Overall Study||9
5276519|NCT00668265|12969781|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
5276520|NCT00668265|12969782|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
5276521|NCT00668265|12969781|P2|STARTED|Overall Study||5
5276522|NCT00668265|12969782|P1|STARTED|Overall Study||9
5276523|NCT00668200|12969790|P1|NOT COMPLETED|Overall Study||3
5276524|NCT00668200|12969790|P1|COMPLETED|Overall Study||77
5276525|NCT00668200|12969790|P1|Intent to Treat (ITT)|Overall Study||80
5276526|NCT00668200|12969790|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
5276527|NCT00668200|12969790|P1|STARTED|Overall Study||80
5276528|NCT00668148|12969796|P1|NOT COMPLETED|Overall Study||10
5276529|NCT00668148|12969796|P1|COMPLETED|Overall Study||103
5276530|NCT00668148|12969796|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
5276531|NCT00668148|12969796|P1|STARTED|Overall Study||113
5276532|NCT00667992|12969835|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
5276533|NCT00667992|12969836|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
5276534|NCT00667992|12969835|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
5276535|NCT00667992|12969836|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
5276536|NCT00667992|12969835|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
5276537|NCT00667992|12969836|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
5276538|NCT00667992|12969835|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
5276539|NCT00667992|12969836|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
5276540|NCT00667992|12969835|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
5276541|NCT00667992|12969836|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
5276542|NCT00667992|12969835|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
5276543|NCT00667992|12969836|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
5276544|NCT00667992|12969835|P2|NOT COMPLETED|Wash-out||5
5276545|NCT00667992|12969836|P1|NOT COMPLETED|Wash-out||7
5276546|NCT00667992|12969835|P2|COMPLETED|Wash-out||36
5276547|NCT00667992|12969836|P1|COMPLETED|Wash-out||34
5276548|NCT00667992|12969835|P2|STARTED|Wash-out||41
5276549|NCT00667992|12969836|P1|STARTED|Wash-out||41
5276550|NCT00667992|12969835|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
5276551|NCT00667992|12969836|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
5276552|NCT00667992|12969835|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
5276553|NCT00667992|12969836|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
5276554|NCT00667992|12969835|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
5276555|NCT00667992|12969836|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
5276556|NCT00667992|12969835|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
5276557|NCT00667992|12969836|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
5276558|NCT00667992|12969835|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
5276559|NCT00667992|12969836|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
5276560|NCT00667992|12969835|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
5276561|NCT00667992|12969836|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
5276562|NCT00667875|12969893|P3|NOT COMPLETED|Overall Study||13
5276563|NCT00667875|12969894|P2|NOT COMPLETED|Overall Study||11
5276564|NCT00667875|12969895|P1|NOT COMPLETED|Overall Study||10
5276565|NCT00667875|12969893|P3|COMPLETED|Overall Study||8
5276566|NCT00667875|12969894|P2|COMPLETED|Overall Study||10
5276567|NCT00667875|12969895|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
5276568|NCT00667875|12969893|P3|Subjects Included in Analysisd|Overall Study||19
5276569|NCT00667875|12969894|P2|Subjects Included in Analysisd|Overall Study||21
5276570|NCT00667875|12969895|P1|Subjects Included in Analysisd|Overall Study||20
5276571|NCT00667875|12969893|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
5276572|NCT00667875|12969894|P2|STARTED|Overall Study||21
5276573|NCT00667875|12969895|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
5276574|NCT00667849|12969914|P2|NOT COMPLETED|Overall Study||121
5276575|NCT00667849|12969915|P1|NOT COMPLETED|Overall Study||108
5276576|NCT00667849|12969914|P2|COMPLETED|Overall Study||130
5276577|NCT00667849|12969915|P1|COMPLETED|Overall Study||142
5276578|NCT00667849|12969914|P2|STARTED|Overall Study||251
5276579|NCT00667849|12969915|P1|STARTED|Overall Study||250
5276580|NCT00667810|12969929|P4|NOT COMPLETED|Overall Study||2
5276581|NCT00667810|12969930|P3|NOT COMPLETED|Overall Study||222
5276582|NCT00667810|12969931|P2|NOT COMPLETED|Overall Study||170
5276583|NCT00667810|12969932|P1|NOT COMPLETED|Overall Study||167
5276584|NCT00667810|12969929|P4|COMPLETED|Overall Study||9
5276585|NCT00667810|12969930|P3|COMPLETED|Overall Study||124
5276586|NCT00667810|12969931|P2|COMPLETED|Overall Study||94
5276587|NCT00667810|12969932|P1|COMPLETED|Overall Study||102
5276588|NCT00667810|12969929|P4|Treated|Overall Study||11
5276589|NCT00667810|12969930|P3|Treated|Overall Study||344
5276590|NCT00667810|12969931|P2|Treated|Overall Study||263
5276591|NCT00667810|12969932|P1|Treated|Overall Study||267
5276592|NCT00667810|12969929|P4|STARTED|Overall Study||11
5276593|NCT00667810|12969930|P3|STARTED|Overall Study||346
5276594|NCT00667810|12969931|P2|STARTED|Overall Study||264
5276595|NCT00667810|12969932|P1|STARTED|Overall Study||269
5276596|NCT00667745|12969991|P2|NOT COMPLETED|Overall Study||21
5276597|NCT00667745|12969992|P1|NOT COMPLETED|Overall Study||25
5276598|NCT00667745|12969991|P2|COMPLETED|Overall Study||121
5276599|NCT00667745|12969992|P1|COMPLETED|Overall Study||116
5276600|NCT00667745|12969991|P2|STARTED|Overall Study||142
5276601|NCT00667745|12969992|P1|STARTED|Overall Study||141
5276602|NCT00667732|12970008|P3|NOT COMPLETED|Extension (26 Weeks)||0
5276603|NCT00667732|12970009|P2|NOT COMPLETED|Extension (26 Weeks)||0
5276604|NCT00667732|12970010|P1|NOT COMPLETED|Extension (26 Weeks)||0
5276605|NCT00667732|12970008|P3|COMPLETED|Extension (26 Weeks)||17
5276606|NCT00667732|12970009|P2|COMPLETED|Extension (26 Weeks)||14
5276607|NCT00667732|12970010|P1|COMPLETED|Extension (26 Weeks)||0
5276608|NCT00667732|12970008|P3|STARTED|Extension (26 Weeks)||17
5276609|NCT00667732|12970009|P2|STARTED|Extension (26 Weeks)||14
5276610|NCT00667732|12970010|P1|STARTED|Extension (26 Weeks)||0
5276611|NCT00667732|12970008|P3|NOT COMPLETED|Randomization (24 Weeks)||0
5276612|NCT00667732|12970009|P2|NOT COMPLETED|Randomization (24 Weeks)||1
5276613|NCT00667732|12970010|P1|NOT COMPLETED|Randomization (24 Weeks)||0
5276614|NCT00667732|12970008|P3|COMPLETED|Randomization (24 Weeks)||17
5276615|NCT00667732|12970009|P2|COMPLETED|Randomization (24 Weeks)||16
5276616|NCT00667732|12970010|P1|COMPLETED|Randomization (24 Weeks)||0
5276617|NCT00667732|12970008|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
5276618|NCT00667732|12970009|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
5276619|NCT00667732|12970010|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
5276620|NCT00667732|12970008|P3|STARTED|Randomization (24 Weeks)||17
5276621|NCT00667732|12970009|P2|STARTED|Randomization (24 Weeks)||17
5276622|NCT00667732|12970010|P1|STARTED|Randomization (24 Weeks)||0
5276623|NCT00667732|12970008|P3|NOT COMPLETED|Run -In (8 Weeks)||0
5276624|NCT00667732|12970009|P2|NOT COMPLETED|Run -In (8 Weeks)||0
5276625|NCT00667732|12970010|P1|NOT COMPLETED|Run -In (8 Weeks)||7
5276626|NCT00667732|12970008|P3|COMPLETED|Run -In (8 Weeks)||0
5276627|NCT00667732|12970009|P2|COMPLETED|Run -In (8 Weeks)||0
5276628|NCT00667732|12970010|P1|COMPLETED|Run -In (8 Weeks)||34
5276629|NCT00667732|12970008|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
5276630|NCT00667732|12970009|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
5276631|NCT00667732|12970010|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
5276632|NCT00667732|12970008|P3|STARTED|Run -In (8 Weeks)||0
5276633|NCT00667732|12970009|P2|STARTED|Run -In (8 Weeks)||0
5276634|NCT00667732|12970010|P1|STARTED|Run -In (8 Weeks)||41
5276635|NCT00667693|12970023|P2|NOT COMPLETED|Overall Study||2
5276636|NCT00667693|12970024|P1|NOT COMPLETED|Overall Study||0
5276637|NCT00667693|12970023|P2|COMPLETED|Overall Study||50
5276638|NCT00667693|12970024|P1|COMPLETED|Overall Study||49
5276639|NCT00667693|12970023|P2|STARTED|Overall Study||52
5276640|NCT00667693|12970024|P1|STARTED|Overall Study||49
5276641|NCT00667615|12970038|P1|NOT COMPLETED|Overall Study||0
5276642|NCT00667615|12970038|P1|COMPLETED|Overall Study||30
5276643|NCT00667615|12970038|P1|STARTED|Overall Study||30
5276644|NCT00667602|12970046|P3|NOT COMPLETED|Overall Study||18
5276645|NCT00667602|12970047|P2|NOT COMPLETED|Overall Study||15
5276646|NCT00667602|12970048|P1|NOT COMPLETED|Overall Study||8
5276647|NCT00667602|12970046|P3|COMPLETED|Overall Study||197
5276648|NCT00667602|12970047|P2|COMPLETED|Overall Study||213
5276649|NCT00667602|12970048|P1|COMPLETED|Overall Study||211
5276650|NCT00667602|12970046|P3|STARTED|Overall Study||215
5276651|NCT00667602|12970047|P2|STARTED|Overall Study||228
5276652|NCT00667602|12970048|P1|STARTED|Overall Study||219
5276653|NCT00667589|12970098|P4|NOT COMPLETED|Overall Study||1
5276654|NCT00667589|12970099|P3|NOT COMPLETED|Overall Study||3
5276655|NCT00667589|12970100|P2|NOT COMPLETED|Overall Study||0
5276656|NCT00667589|12970101|P1|NOT COMPLETED|Overall Study||1
5276657|NCT00667589|12970098|P4|COMPLETED|Overall Study||1
5276658|NCT00667589|12970099|P3|COMPLETED|Overall Study||0
5276659|NCT00667589|12970100|P2|COMPLETED|Overall Study||0
5276660|NCT00667589|12970101|P1|COMPLETED|Overall Study||0
5276661|NCT00667589|12970098|P4|STARTED|Overall Study||2
5276662|NCT00667589|12970099|P3|STARTED|Overall Study||3
5276663|NCT00667589|12970100|P2|STARTED|Overall Study||0
5276664|NCT00667589|12970101|P1|STARTED|Overall Study||1
5276665|NCT00667576|12970116|P5|NOT COMPLETED|Overall Study||1
5276666|NCT00667576|12970117|P4|NOT COMPLETED|Overall Study||4
5276667|NCT00667576|12970118|P3|NOT COMPLETED|Overall Study||2
5276668|NCT00667576|12970119|P2|NOT COMPLETED|Overall Study||1
5276669|NCT00667576|12970120|P1|NOT COMPLETED|Overall Study||2
5276670|NCT00667576|12970116|P5|COMPLETED|Overall Study||29
5276671|NCT00667576|12970117|P4|COMPLETED|Overall Study||27
5276672|NCT00667576|12970118|P3|COMPLETED|Overall Study||29
5276673|NCT00667576|12970119|P2|COMPLETED|Overall Study||30
5276674|NCT00667576|12970120|P1|COMPLETED|Overall Study||28
5276675|NCT00667576|12970116|P5|STARTED|Overall Study||30
5276676|NCT00667576|12970117|P4|STARTED|Overall Study||31
5276677|NCT00667576|12970118|P3|STARTED|Overall Study||31
5276678|NCT00667576|12970119|P2|STARTED|Overall Study||31
5276679|NCT00667576|12970120|P1|STARTED|Overall Study||30
5276680|NCT00667563|12970167|P1|NOT COMPLETED|Overall Study||24
5276681|NCT00667563|12970167|P1|COMPLETED|Overall Study||126
5276682|NCT00667563|12970167|P1|STARTED|Overall Study||150
5276683|NCT00667511|12970177|P1|NOT COMPLETED|Intervention 2: Home NHD||4
5276684|NCT00667511|12970177|P1|COMPLETED|Intervention 2: Home NHD||39
5276685|NCT00667511|12970177|P1|STARTED|Intervention 2: Home NHD||43
5276686|NCT00667511|12970177|P1|NOT COMPLETED|Training/Transition Period||8
5276687|NCT00667511|12970177|P1|COMPLETED|Training/Transition Period||43
5276688|NCT00667511|12970177|P1|STARTED|Training/Transition Period||51
5276689|NCT00667511|12970177|P1|NOT COMPLETED|Intervention 1: Home DHD||7
5276690|NCT00667511|12970177|P1|COMPLETED|Intervention 1: Home DHD||51
5276691|NCT00667511|12970177|P1|STARTED|Intervention 1: Home DHD||58
5276692|NCT00667459|12970187|P2|NOT COMPLETED|Overall Study||45
5276693|NCT00667459|12970188|P1|NOT COMPLETED|Overall Study||8
5276694|NCT00667459|12970187|P2|COMPLETED|Overall Study||220
5276695|NCT00667459|12970188|P1|COMPLETED|Overall Study||272
5276696|NCT00667459|12970187|P2|STARTED|Overall Study||265
5276697|NCT00667459|12970188|P1|STARTED|Overall Study||280
5276698|NCT00667446|12970230|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
5276699|NCT00667446|12970231|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
5276700|NCT00667446|12970230|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
5276701|NCT00667446|12970231|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
5276702|NCT00667446|12970230|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
5276703|NCT00667446|12970231|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
5276704|NCT00667446|12970230|P2|NOT COMPLETED|Treatment Period (36 Months)||25
5276705|NCT00667446|12970231|P1|NOT COMPLETED|Treatment Period (36 Months)||23
5276706|NCT00667446|12970230|P2|COMPLETED|Treatment Period (36 Months)||13
5276707|NCT00667446|12970231|P1|COMPLETED|Treatment Period (36 Months)||11
5276708|NCT00667446|12970230|P2|STARTED|Treatment Period (36 Months)||38
5276709|NCT00667446|12970231|P1|STARTED|Treatment Period (36 Months)||34
5276710|NCT00667420|12970253|P1|NOT COMPLETED|Overall Study||10
5276711|NCT00667420|12970253|P1|COMPLETED|Overall Study||7
5276712|NCT00667420|12970253|P1|Completion of Surgery/Re-staging|Overall Study||11
5276713|NCT00667420|12970253|P1|Completion of Pre-operative EOX-P|Overall Study||15
5276714|NCT00667420|12970253|P1|STARTED|Overall Study||17
5276715|NCT00667394|12970263|P2|NOT COMPLETED|Overall Study||0
5276716|NCT00667394|12970264|P1|NOT COMPLETED|Overall Study||4
5276717|NCT00667394|12970263|P2|COMPLETED|Overall Study||1
5276718|NCT00667394|12970264|P1|COMPLETED|Overall Study||37
5276719|NCT00667394|12970263|P2|STARTED|Overall Study||1
5276720|NCT00667394|12970264|P1|STARTED|Overall Study||41
5276721|NCT00667381|12970274|P2|NOT COMPLETED|Overall Study||0
5276722|NCT00667381|12970275|P1|NOT COMPLETED|Overall Study||0
5276723|NCT00667381|12970274|P2|COMPLETED|Overall Study||503
5276724|NCT00667381|12970275|P1|COMPLETED|Overall Study||501
5276725|NCT00667381|12970274|P2|STARTED|Overall Study||503
5276726|NCT00667381|12970275|P1|STARTED|Overall Study||501
5276727|NCT00667368|12970291|P2|NOT COMPLETED|Overall Study||172
5276728|NCT00667368|12970292|P1|NOT COMPLETED|Overall Study||200
5276729|NCT00667368|12970291|P2|COMPLETED|Overall Study||511
5276730|NCT00667368|12970292|P1|COMPLETED|Overall Study||482
5276731|NCT00667368|12970291|P2|STARTED|Overall Study||683
5276732|NCT00667368|12970292|P1|STARTED|Overall Study||682
5276733|NCT00667355|12970300|P1|NOT COMPLETED|Overall Study||11
5276734|NCT00667355|12970300|P1|COMPLETED|Overall Study||30
5276735|NCT00667355|12970300|P1|STARTED|Overall Study||41
5276736|NCT00667342|12970325|P3|NOT COMPLETED|Overall Study||9
5276737|NCT00667342|12970326|P2|NOT COMPLETED|Overall Study||0
5276738|NCT00667342|12970327|P1|NOT COMPLETED|Overall Study||14
5276739|NCT00667342|12970325|P3|COMPLETED|Overall Study||3
5276740|NCT00667342|12970326|P2|COMPLETED|Overall Study||0
5276741|NCT00667342|12970327|P1|COMPLETED|Overall Study||17
5276742|NCT00667342|12970325|P3|STARTED|Overall Study||12
5276743|NCT00667342|12970326|P2|STARTED|Overall Study||0
5276744|NCT00667342|12970327|P1|STARTED|Overall Study||31
5276745|NCT00667277|12970365|P1|NOT COMPLETED|Overall Study||2
5276746|NCT00667277|12970365|P1|COMPLETED|Overall Study||11
5276747|NCT00667277|12970365|P1|STARTED|Overall Study||13
5276748|NCT00667251|12970372|P2|NOT COMPLETED|Overall Study||95
5276749|NCT00667251|12970373|P1|NOT COMPLETED|Overall Study||70
5276750|NCT00667251|12970372|P2|COMPLETED|Overall Study||231
5276751|NCT00667251|12970373|P1|COMPLETED|Overall Study||256
5276752|NCT00667251|12970372|P2|Not Started|Overall Study||1
5276753|NCT00667251|12970373|P1|Not Started|Overall Study||4
5276754|NCT00667251|12970372|P2|Monotherapy|Overall Study||232
5276755|NCT00667251|12970373|P1|Monotherapy|Overall Study||225
5276756|NCT00667251|12970372|P2|Combination Rx|Overall Study||325
5276757|NCT00667251|12970373|P1|Combination Rx|Overall Study||322
5276758|NCT00667251|12970372|P2|STARTED|Overall Study||326
5276759|NCT00667251|12970373|P1|STARTED|Overall Study||326
5276760|NCT00667225|12970399|P2|NOT COMPLETED|Overall Study||1
5276761|NCT00667225|12970400|P1|NOT COMPLETED|Overall Study||1
5276762|NCT00667225|12970399|P2|COMPLETED|Overall Study||12
5276763|NCT00667225|12970400|P1|COMPLETED|Overall Study||15
5276764|NCT00667225|12970399|P2|STARTED|Overall Study||13
5276765|NCT00667225|12970400|P1|STARTED|Overall Study||16
5276766|NCT00667186|12970410|P2|NOT COMPLETED|Overall Study||0
5276767|NCT00667186|12970411|P1|NOT COMPLETED|Overall Study||0
5276768|NCT00667186|12970410|P2|COMPLETED|Overall Study||4880
5276769|NCT00667186|12970411|P1|COMPLETED|Overall Study||4692
5276770|NCT00667186|12970410|P2|STARTED|Overall Study||4880
5276771|NCT00667186|12970411|P1|STARTED|Overall Study||4692
5276772|NCT00667095|12970421|P2|NOT COMPLETED|Overall Study||1
5276773|NCT00667095|12970422|P1|NOT COMPLETED|Overall Study||0
5276774|NCT00667095|12970421|P2|COMPLETED|Overall Study||9
5276775|NCT00667095|12970422|P1|COMPLETED|Overall Study||11
5276776|NCT00667095|12970421|P2|STARTED|Overall Study||10
5276777|NCT00667095|12970422|P1|STARTED|Overall Study||11
5276778|NCT00667017|12970438|P1|NOT COMPLETED|Overall Study||1
5276779|NCT00667017|12970438|P1|COMPLETED|Overall Study||0
5276780|NCT00667017|12970438|P1|STARTED|Overall Study||1
5276781|NCT00666978|12970444|P2|NOT COMPLETED|Overall Study||83
5276782|NCT00666978|12970445|P1|NOT COMPLETED|Overall Study||78
5276783|NCT00666978|12970444|P2|COMPLETED|Overall Study||187
5276784|NCT00666978|12970445|P1|COMPLETED|Overall Study||192
5276785|NCT00666978|12970444|P2|STARTED|Overall Study||270
5276786|NCT00666978|12970445|P1|STARTED|Overall Study||270
5276787|NCT00666965|12970458|P4|NOT COMPLETED|Overall Study||15
5276788|NCT00666965|12970459|P3|NOT COMPLETED|Overall Study||2
5276789|NCT00666965|12970460|P2|NOT COMPLETED|Overall Study||4
5276790|NCT00666965|12970461|P1|NOT COMPLETED|Overall Study||3
5276791|NCT00666965|12970458|P4|COMPLETED|Overall Study||42
5276792|NCT00666965|12970459|P3|COMPLETED|Overall Study||56
5276793|NCT00666965|12970460|P2|COMPLETED|Overall Study||53
5276794|NCT00666965|12970461|P1|COMPLETED|Overall Study||55
5276795|NCT00666965|12970458|P4|STARTED|Overall Study||57
5276796|NCT00666965|12970459|P3|STARTED|Overall Study||58
5276797|NCT00666965|12970460|P2|STARTED|Overall Study||57
5276798|NCT00666965|12970461|P1|STARTED|Overall Study||58
5276799|NCT00666926|12970491|P16|NOT COMPLETED|Overall Study||8
5276800|NCT00666926|12970492|P15|NOT COMPLETED|Overall Study||7
5276801|NCT00666926|12970493|P14|NOT COMPLETED|Overall Study||4
5276802|NCT00666926|12970494|P13|NOT COMPLETED|Overall Study||3
5276803|NCT00666926|12970495|P12|NOT COMPLETED|Overall Study||33
5276804|NCT00666926|12970496|P11|NOT COMPLETED|Overall Study||6
5276805|NCT00666926|12970497|P10|NOT COMPLETED|Overall Study||10
5276806|NCT00666926|12970498|P9|NOT COMPLETED|Overall Study||3
5276807|NCT00666926|12970499|P8|NOT COMPLETED|Overall Study||1
5276808|NCT00666926|12970500|P7|NOT COMPLETED|Overall Study||4
5276809|NCT00666926|12970501|P6|NOT COMPLETED|Overall Study||4
5276810|NCT00666926|12970502|P5|NOT COMPLETED|Overall Study||3
5276811|NCT00666926|12970503|P4|NOT COMPLETED|Overall Study||4
5276812|NCT00666926|12970504|P3|NOT COMPLETED|Overall Study||3
5276813|NCT00666926|12970505|P2|NOT COMPLETED|Overall Study||4
5276814|NCT00666926|12970506|P1|NOT COMPLETED|Overall Study||2
5276815|NCT00666926|12970491|P16|COMPLETED|Overall Study||0
5276816|NCT00666926|12970492|P15|COMPLETED|Overall Study||0
5276817|NCT00666926|12970493|P14|COMPLETED|Overall Study||0
5276818|NCT00666926|12970494|P13|COMPLETED|Overall Study||0
5276819|NCT00666926|12970495|P12|COMPLETED|Overall Study||0
5276820|NCT00666926|12970496|P11|COMPLETED|Overall Study||0
5276821|NCT00666926|12970497|P10|COMPLETED|Overall Study||0
5276822|NCT00666926|12970498|P9|COMPLETED|Overall Study||0
5276823|NCT00666926|12970499|P8|COMPLETED|Overall Study||0
5276824|NCT00666926|12970500|P7|COMPLETED|Overall Study||0
5276825|NCT00666926|12970501|P6|COMPLETED|Overall Study||0
5276826|NCT00666926|12970502|P5|COMPLETED|Overall Study||0
5276827|NCT00666926|12970503|P4|COMPLETED|Overall Study||0
5276828|NCT00666926|12970504|P3|COMPLETED|Overall Study||0
5276829|NCT00666926|12970505|P2|COMPLETED|Overall Study||0
5276830|NCT00666926|12970506|P1|COMPLETED|Overall Study||0
5276831|NCT00666926|12970491|P16|STARTED|Overall Study||8
5276832|NCT00666926|12970492|P15|STARTED|Overall Study||7
5276833|NCT00666926|12970493|P14|STARTED|Overall Study||4
5276834|NCT00666926|12970494|P13|STARTED|Overall Study||3
5276835|NCT00666926|12970495|P12|STARTED|Overall Study||33
5276836|NCT00666926|12970496|P11|STARTED|Overall Study||6
5276837|NCT00666926|12970497|P10|STARTED|Overall Study||10
5276838|NCT00666926|12970498|P9|STARTED|Overall Study||3
5276839|NCT00666926|12970499|P8|STARTED|Overall Study||1
5276840|NCT00666926|12970500|P7|STARTED|Overall Study||4
5276841|NCT00666926|12970501|P6|STARTED|Overall Study||4
5276842|NCT00666926|12970502|P5|STARTED|Overall Study||3
5276843|NCT00666926|12970503|P4|STARTED|Overall Study||4
5276844|NCT00666926|12970504|P3|STARTED|Overall Study||3
5276845|NCT00666926|12970505|P2|STARTED|Overall Study||4
5276846|NCT00666926|12970506|P1|STARTED|Overall Study||2
5276847|NCT00666848|12970800|P3|NOT COMPLETED|Overall Study||0
5276848|NCT00666848|12970801|P2|NOT COMPLETED|Overall Study||0
5276849|NCT00666848|12970802|P1|NOT COMPLETED|Overall Study||0
5276850|NCT00666848|12970800|P3|COMPLETED|Overall Study|finished Aim 3|7
5276851|NCT00666848|12970801|P2|COMPLETED|Overall Study|finished Aim 1|9
5276852|NCT00666848|12970802|P1|COMPLETED|Overall Study|finished Aim 2|8
5276853|NCT00666848|12970800|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
5276854|NCT00666848|12970801|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
5276855|NCT00666848|12970802|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
5276856|NCT00666835|12970815|P2|NOT COMPLETED|Overall Study||22
5276857|NCT00666835|12970816|P1|NOT COMPLETED|Overall Study||53
5276858|NCT00666835|12970815|P2|COMPLETED|Overall Study||142
5276859|NCT00666835|12970816|P1|COMPLETED|Overall Study||261
5276860|NCT00666835|12970815|P2|STARTED|Overall Study||164
5276861|NCT00666835|12970816|P1|STARTED|Overall Study||314
5276862|NCT00666757|12970826|P2|NOT COMPLETED|Overall Study||97
5276863|NCT00666757|12970827|P1|NOT COMPLETED|Overall Study||100
5276864|NCT00666757|12970826|P2|COMPLETED|Overall Study||281
5276865|NCT00666757|12970827|P1|COMPLETED|Overall Study||272
5276866|NCT00666757|12970826|P2|STARTED|Overall Study||378
5276867|NCT00666757|12970827|P1|STARTED|Overall Study||372
5276868|NCT00666718|12970886|P2|NOT COMPLETED|Overall Study||18
5276869|NCT00666718|12970887|P1|NOT COMPLETED|Overall Study||12
5276870|NCT00666718|12970886|P2|COMPLETED|Overall Study||169
5276871|NCT00666718|12970887|P1|COMPLETED|Overall Study||175
5276872|NCT00666718|12970886|P2|STARTED|Overall Study||187
5276873|NCT00666718|12970887|P1|STARTED|Overall Study||187
5276874|NCT00666705|12970913|P1|NOT COMPLETED|Overall Study||1
5276875|NCT00666705|12970913|P1|COMPLETED|Overall Study||17
5276876|NCT00666705|12970913|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
5276877|NCT00666705|12970913|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
5276878|NCT00666705|12970913|P1|Washout (Days 4 - 5)|Overall Study||18
5276879|NCT00666705|12970913|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
5276880|NCT00666705|12970913|P1|STARTED|Overall Study||18
5276881|NCT00666679|12970932|P2|NOT COMPLETED|Second Intervention||1
5276882|NCT00666679|12970933|P1|NOT COMPLETED|Second Intervention||1
5276883|NCT00666679|12970932|P2|COMPLETED|Second Intervention||64
5276884|NCT00666679|12970933|P1|COMPLETED|Second Intervention||61
5276885|NCT00666679|12970932|P2|STARTED|Second Intervention||65
5276886|NCT00666679|12970933|P1|STARTED|Second Intervention||62
5276887|NCT00666679|12970932|P2|NOT COMPLETED|Washout Period of 1 Week||2
5276888|NCT00666679|12970933|P1|NOT COMPLETED|Washout Period of 1 Week||0
5276889|NCT00666679|12970932|P2|COMPLETED|Washout Period of 1 Week||65
5276890|NCT00666679|12970933|P1|COMPLETED|Washout Period of 1 Week||62
5276891|NCT00666679|12970932|P2|STARTED|Washout Period of 1 Week||67
5276892|NCT00666679|12970933|P1|STARTED|Washout Period of 1 Week||62
5276893|NCT00666679|12970932|P2|NOT COMPLETED|First Intervention||1
5276894|NCT00666679|12970933|P1|NOT COMPLETED|First Intervention||4
5276895|NCT00666679|12970932|P2|COMPLETED|First Intervention||67
5276896|NCT00666679|12970933|P1|COMPLETED|First Intervention||62
5276897|NCT00666679|12970932|P2|STARTED|First Intervention||68
5276898|NCT00666679|12970933|P1|STARTED|First Intervention||66
5276899|NCT00666666|12970953|P1|NOT COMPLETED|Overall Study||0
5276900|NCT00666666|12970953|P1|COMPLETED|Overall Study||55
5276901|NCT00666666|12970953|P1|STARTED|Overall Study||55
5276902|NCT00666588|12970963|P4|NOT COMPLETED|Overall Study||2
5276903|NCT00666588|12970964|P3|NOT COMPLETED|Overall Study||0
5276904|NCT00666588|12970965|P2|NOT COMPLETED|Overall Study||0
5276905|NCT00666588|12970966|P1|NOT COMPLETED|Overall Study||4
5276906|NCT00666588|12970963|P4|COMPLETED|Overall Study||20
5276907|NCT00666588|12970964|P3|COMPLETED|Overall Study||6
5276908|NCT00666588|12970965|P2|COMPLETED|Overall Study||6
5276909|NCT00666588|12970966|P1|COMPLETED|Overall Study||14
5276910|NCT00666588|12970963|P4|STARTED|Overall Study||22
5276911|NCT00666588|12970964|P3|STARTED|Overall Study||6
5276912|NCT00666588|12970965|P2|STARTED|Overall Study||6
5276913|NCT00666588|12970966|P1|STARTED|Overall Study||18
5276914|NCT00666562|12970999|P3|NOT COMPLETED|Overall Study||0
5276915|NCT00666562|12971000|P2|NOT COMPLETED|Overall Study||2
5276916|NCT00666562|12971001|P1|NOT COMPLETED|Overall Study||0
5276917|NCT00666562|12970999|P3|COMPLETED|Overall Study||10
5276918|NCT00666562|12971000|P2|COMPLETED|Overall Study||8
5276919|NCT00666562|12971001|P1|COMPLETED|Overall Study||11
5276920|NCT00666562|12970999|P3|STARTED|Overall Study||10
5276921|NCT00666562|12971000|P2|STARTED|Overall Study||10
5276922|NCT00666562|12971001|P1|STARTED|Overall Study||11
5276923|NCT00666536|12971048|P2|NOT COMPLETED|Overall Study||37
5276924|NCT00666536|12971049|P1|NOT COMPLETED|Overall Study||33
5276925|NCT00666536|12971048|P2|COMPLETED|Overall Study||322
5276926|NCT00666536|12971049|P1|COMPLETED|Overall Study||336
5276927|NCT00666536|12971048|P2|STARTED|Overall Study||359
5276928|NCT00666536|12971049|P1|STARTED|Overall Study||369
5276929|NCT00666458|12971067|P2|NOT COMPLETED|Overall Study||24
5276930|NCT00666458|12971068|P1|NOT COMPLETED|Overall Study||38
5276931|NCT00666458|12971067|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
5276932|NCT00666458|12971068|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
5276933|NCT00666458|12971067|P2|STARTED|Overall Study|Randomized and treated|398
5276934|NCT00666458|12971068|P1|STARTED|Overall Study|Randomized and treated|403
5276935|NCT00666406|12971080|P2|NOT COMPLETED|Second PK Infusion||0
5276936|NCT00666406|12971081|P1|NOT COMPLETED|Second PK Infusion||0
5276937|NCT00666406|12971080|P2|COMPLETED|Second PK Infusion||3
5276938|NCT00666406|12971081|P1|COMPLETED|Second PK Infusion||6
5276939|NCT00666406|12971080|P2|STARTED|Second PK Infusion||3
5276940|NCT00666406|12971081|P1|STARTED|Second PK Infusion||6
5276941|NCT00666406|12971080|P2|NOT COMPLETED|First PK Infusion||0
5276942|NCT00666406|12971081|P1|NOT COMPLETED|First PK Infusion||0
5276943|NCT00666406|12971080|P2|COMPLETED|First PK Infusion||3
5276944|NCT00666406|12971081|P1|COMPLETED|First PK Infusion||6
5276945|NCT00666406|12971080|P2|STARTED|First PK Infusion||3
5276946|NCT00666406|12971081|P1|STARTED|First PK Infusion||6
5276947|NCT00666328|12971156|P1|NOT COMPLETED|Overall Study||5
5276948|NCT00666328|12971156|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
5276949|NCT00666328|12971156|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
5276950|NCT00666328|12971156|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
5276951|NCT00666276|12971169|P1|NOT COMPLETED|Overall Study||34
5276952|NCT00666276|12971169|P1|COMPLETED|Overall Study||970
5276953|NCT00666276|12971169|P1|STARTED|Overall Study||1004
5276954|NCT00666263|12971193|P2|NOT COMPLETED|End of Study Visit||0
5276955|NCT00666263|12971194|P1|NOT COMPLETED|End of Study Visit||0
5276956|NCT00666263|12971193|P2|COMPLETED|End of Study Visit||22
5276957|NCT00666263|12971194|P1|COMPLETED|End of Study Visit||22
5276958|NCT00666263|12971193|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
5276959|NCT00666263|12971194|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
5276960|NCT00666263|12971193|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
5276961|NCT00666263|12971194|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
5276962|NCT00666263|12971193|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
5276963|NCT00666263|12971194|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
5276964|NCT00666263|12971193|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
5276965|NCT00666263|12971194|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
5276966|NCT00666263|12971193|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
5276967|NCT00666263|12971194|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
5276968|NCT00666263|12971193|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
5276969|NCT00666263|12971194|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
5276970|NCT00666263|12971193|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
5276971|NCT00666263|12971194|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
5276972|NCT00666263|12971193|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
5276973|NCT00666263|12971194|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
5276974|NCT00666263|12971193|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
5276975|NCT00666263|12971194|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
5276976|NCT00666263|12971193|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
5276977|NCT00666263|12971194|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
5276978|NCT00666263|12971193|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
5276979|NCT00666263|12971194|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
5276980|NCT00666263|12971193|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
5276981|NCT00666263|12971194|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
5276982|NCT00666263|12971193|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
5276983|NCT00666263|12971194|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
5276984|NCT00666263|12971193|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
5276985|NCT00666263|12971194|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
5276986|NCT00666263|12971193|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
5276987|NCT00666263|12971194|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
5276988|NCT00666263|12971193|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
5276989|NCT00666263|12971194|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
5276990|NCT00666224|12971338|P2|NOT COMPLETED|Open-Label||85
5276991|NCT00666224|12971339|P1|NOT COMPLETED|Open-Label||35
5276992|NCT00666224|12971338|P2|COMPLETED|Open-Label||126
5276993|NCT00666224|12971339|P1|COMPLETED|Open-Label||163
5276994|NCT00666224|12971338|P2|STARTED|Open-Label||211
5276995|NCT00666224|12971339|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
5276996|NCT00666224|12971338|P2|NOT COMPLETED|Double-Blind||27
5276997|NCT00666224|12971339|P1|NOT COMPLETED|Double-Blind||45
5276998|NCT00666224|12971338|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
5276999|NCT00666224|12971339|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
5277000|NCT00666224|12971338|P2|STARTED|Double-Blind||238
5277001|NCT00666224|12971339|P1|STARTED|Double-Blind||243
5277002|NCT00666211|12971358|P2|NOT COMPLETED|Overall Study||38
5277003|NCT00666211|12971359|P1|NOT COMPLETED|Overall Study||20
5277004|NCT00666211|12971358|P2|COMPLETED|Overall Study||18
5277005|NCT00666211|12971359|P1|COMPLETED|Overall Study||22
5277006|NCT00666211|12971358|P2|STARTED|Overall Study||56
5277007|NCT00666211|12971359|P1|STARTED|Overall Study||42
5277008|NCT00666198|12971377|P1|NOT COMPLETED|Overall Study||33
5277009|NCT00666198|12971377|P1|COMPLETED|Overall Study||3304
5277010|NCT00666198|12971377|P1|STARTED|Overall Study||3337
5277011|NCT00666029|12971392|P2|NOT COMPLETED|Overall Study||0
5277012|NCT00666029|12971393|P1|NOT COMPLETED|Overall Study||1
5277013|NCT00666029|12971392|P2|COMPLETED|Overall Study||20
5277014|NCT00666029|12971393|P1|COMPLETED|Overall Study||19
5277015|NCT00666029|12971392|P2|STARTED|Overall Study||20
5277016|NCT00666029|12971393|P1|STARTED|Overall Study||20
5277017|NCT00665925|12971405|P4|NOT COMPLETED|Overall Study||21
5277018|NCT00665925|12971406|P3|NOT COMPLETED|Overall Study||26
5277019|NCT00665925|12971407|P2|NOT COMPLETED|Overall Study||17
5277020|NCT00665925|12971408|P1|NOT COMPLETED|Overall Study||15
5277021|NCT00665925|12971405|P4|COMPLETED|Overall Study|Participants completed the study|131
5277022|NCT00665925|12971406|P3|COMPLETED|Overall Study|Participants completed the study|126
5277023|NCT00665925|12971407|P2|COMPLETED|Overall Study|Participants completed the study|59
5277024|NCT00665925|12971408|P1|COMPLETED|Overall Study|Participants completed the study|62
5277025|NCT00665925|12971405|P4|STARTED|Overall Study|Participants randomized|152
5277026|NCT00665925|12971406|P3|STARTED|Overall Study|Participants randomized|152
5277027|NCT00665925|12971407|P2|STARTED|Overall Study|Participants randomized|76
5277028|NCT00665925|12971408|P1|STARTED|Overall Study|Participants randomized|77
5277029|NCT00665847|12971819|P1|NOT COMPLETED|Overall Study||25
5277030|NCT00665847|12971819|P1|COMPLETED|Overall Study||76
5277031|NCT00665847|12971819|P1|STARTED|Overall Study||101
5277032|NCT00665704|12971831|P1|NOT COMPLETED|Overall Study||0
5277033|NCT00665704|12971831|P1|COMPLETED|Overall Study||9
5277034|NCT00665704|12971831|P1|STARTED|Overall Study||9
5277035|NCT00665652|12971836|P1|NOT COMPLETED|Overall Study||6
5277036|NCT00665652|12971836|P1|COMPLETED|Overall Study||2
5277037|NCT00665652|12971836|P1|STARTED|Overall Study||8
5277038|NCT00665626|12971842|P2|NOT COMPLETED|Overall Study||22
5277039|NCT00665626|12971843|P1|NOT COMPLETED|Overall Study||10
5277040|NCT00665626|12971842|P2|COMPLETED|Overall Study|Participants completed the study|124
5277041|NCT00665626|12971843|P1|COMPLETED|Overall Study|Participants completed the study|63
5277042|NCT00665626|12971842|P2|STARTED|Overall Study|Participants randomized|146
5277043|NCT00665626|12971843|P1|STARTED|Overall Study|Participants randomized|73
5277044|NCT00665561|12971911|P2|NOT COMPLETED|Overall Study||534
5277045|NCT00665561|12971912|P1|NOT COMPLETED|Overall Study||502
5277046|NCT00665561|12971911|P2|COMPLETED|Overall Study||596
5277047|NCT00665561|12971912|P1|COMPLETED|Overall Study||814
5277048|NCT00665561|12971911|P2|STARTED|Overall Study||1130
5277049|NCT00665561|12971912|P1|STARTED|Overall Study||1316
5277050|NCT00665470|12971948|P2|NOT COMPLETED|Overall Study||0
5277051|NCT00665470|12971949|P1|NOT COMPLETED|Overall Study||0
5277052|NCT00665470|12971948|P2|COMPLETED|Overall Study||0
5277053|NCT00665470|12971949|P1|COMPLETED|Overall Study||10
5277054|NCT00665470|12971948|P2|STARTED|Overall Study||0
5277055|NCT00665470|12971949|P1|STARTED|Overall Study||10
5277056|NCT00665457|12971957|P1|NOT COMPLETED|Overall Study||0
5277057|NCT00665457|12971957|P1|COMPLETED|Overall Study||3
5277058|NCT00665457|12971957|P1|STARTED|Overall Study||3
5277059|NCT00665444|12971962|P1|NOT COMPLETED|Overall Study||2
5277060|NCT00665444|12971962|P1|COMPLETED|Overall Study||1
5277061|NCT00665444|12971962|P1|STARTED|Overall Study||3
5277062|NCT00665431|12971974|P3|NOT COMPLETED|Overall Study||24
5277063|NCT00665431|12971975|P2|NOT COMPLETED|Overall Study||57
5277064|NCT00665431|12971976|P1|NOT COMPLETED|Overall Study||40
5277065|NCT00665431|12971974|P3|COMPLETED|Overall Study||98
5277066|NCT00665431|12971975|P2|COMPLETED|Overall Study||188
5277067|NCT00665431|12971976|P1|COMPLETED|Overall Study||203
5277068|NCT00665431|12971974|P3|STARTED|Overall Study|Safety population|122
5277069|NCT00665431|12971975|P2|STARTED|Overall Study|Safety population|245
5277070|NCT00665431|12971976|P1|STARTED|Overall Study|Safety population|243
5277071|NCT00665366|12972019|P2|NOT COMPLETED|Overall Study||59
5277072|NCT00665366|12972020|P1|NOT COMPLETED|Overall Study||58
5277073|NCT00665366|12972019|P2|COMPLETED|Overall Study||122
5277074|NCT00665366|12972020|P1|COMPLETED|Overall Study||131
5277075|NCT00665366|12972019|P2|STARTED|Overall Study|Participants randomized|181
5277076|NCT00665366|12972020|P1|STARTED|Overall Study|Participants randomized|189
5277077|NCT00665353|12972048|P1|NOT COMPLETED|Study Step 2||14
5277078|NCT00665353|12972048|P1|COMPLETED|Study Step 2||2
5277079|NCT00665353|12972048|P1|STARTED|Study Step 2||16
5277080|NCT00665353|12972048|P1|NOT COMPLETED|Study Step 1||3
5277081|NCT00665353|12972048|P1|COMPLETED|Study Step 1||16
5277082|NCT00665353|12972048|P1|STARTED|Study Step 1||19
5277083|NCT00665132|12972058|P1|NOT COMPLETED|Overall Study||0
5277084|NCT00665132|12972058|P1|COMPLETED|Overall Study||10
5277085|NCT00665132|12972058|P1|STARTED|Overall Study||10
5277086|NCT00665002|12972065|P1|NOT COMPLETED|Overall Study||12
5277087|NCT00665002|12972065|P1|COMPLETED|Overall Study||4
5277088|NCT00665002|12972065|P1|STARTED|Overall Study||16
5277089|NCT00664859|12972073|P3|NOT COMPLETED|Overall Study||21
5277090|NCT00664859|12972074|P2|NOT COMPLETED|Overall Study||10
5277091|NCT00664859|12972075|P1|NOT COMPLETED|Overall Study||17
5277092|NCT00664859|12972073|P3|COMPLETED|Overall Study||23
5277093|NCT00664859|12972074|P2|COMPLETED|Overall Study||35
5277094|NCT00664859|12972075|P1|COMPLETED|Overall Study||34
5277095|NCT00664859|12972073|P3|STARTED|Overall Study||44
5277096|NCT00664859|12972074|P2|STARTED|Overall Study||45
5277097|NCT00664859|12972075|P1|STARTED|Overall Study||51
5277098|NCT00664755|12972088|P2|NOT COMPLETED|Overall Study||0
5277099|NCT00664755|12972089|P1|NOT COMPLETED|Overall Study||0
5277100|NCT00664755|12972088|P2|COMPLETED|Overall Study||73
5277101|NCT00664755|12972089|P1|COMPLETED|Overall Study||67
5277102|NCT00664755|12972088|P2|STARTED|Overall Study||73
5277103|NCT00664755|12972089|P1|STARTED|Overall Study||67
5277104|NCT00664742|12972095|P1|NOT COMPLETED|Overall Study||126
5277105|NCT00664742|12972095|P1|COMPLETED|Overall Study||481
5277106|NCT00664742|12972095|P1|STARTED|Overall Study||607
5277107|NCT00664560|12972103|P3|NOT COMPLETED|Overall Study||19
5277108|NCT00664560|12972104|P2|NOT COMPLETED|Overall Study||35
5277109|NCT00664560|12972105|P1|NOT COMPLETED|Overall Study||39
5277110|NCT00664560|12972103|P3|COMPLETED|Overall Study||105
5277111|NCT00664560|12972104|P2|COMPLETED|Overall Study||208
5277112|NCT00664560|12972105|P1|COMPLETED|Overall Study||208
5277113|NCT00664560|12972103|P3|STARTED|Overall Study|Safety Population|124
5277114|NCT00664560|12972104|P2|STARTED|Overall Study|Safety Population|243
5277115|NCT00664560|12972105|P1|STARTED|Overall Study|Safety Population|247
5277116|NCT00664534|12972148|P2|NOT COMPLETED|Overall Study||33
5277117|NCT00664534|12972149|P1|NOT COMPLETED|Overall Study||41
5277118|NCT00664534|12972148|P2|COMPLETED|Overall Study||138
5277119|NCT00664534|12972149|P1|COMPLETED|Overall Study||132
5277120|NCT00664534|12972148|P2|STARTED|Overall Study||171
5277121|NCT00664534|12972149|P1|STARTED|Overall Study||173
5277122|NCT00664521|12972177|P2|NOT COMPLETED|Overall Study||1
5277123|NCT00664521|12972178|P1|NOT COMPLETED|Overall Study||6
5277124|NCT00664521|12972177|P2|COMPLETED|Overall Study||8
5277125|NCT00664521|12972178|P1|COMPLETED|Overall Study||12
5277126|NCT00664521|12972177|P2|STARTED|Overall Study||9
5277127|NCT00664521|12972178|P1|STARTED|Overall Study||18
5277128|NCT00664430|12972198|P1|NOT COMPLETED|Overall Study||13
5277129|NCT00664430|12972198|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
5277130|NCT00664430|12972198|P1|STARTED|Overall Study||13
5277131|NCT00664326|12972204|P1|NOT COMPLETED|Overall Study||48
5277132|NCT00664326|12972204|P1|COMPLETED|Overall Study|transitioned to rollover study|1
5277133|NCT00664326|12972204|P1|STARTED|Overall Study||49
5277134|NCT00664209|12972223|P1|NOT COMPLETED|Study Treatment Period||6
5277135|NCT00664209|12972223|P1|COMPLETED|Study Treatment Period||0
5277136|NCT00664209|12972223|P1|STARTED|Study Treatment Period||6
5277137|NCT00664209|12972223|P1|NOT COMPLETED|Motor Fluctuations Screen||7
5277138|NCT00664209|12972223|P1|COMPLETED|Motor Fluctuations Screen||6
5277139|NCT00664209|12972223|P1|STARTED|Motor Fluctuations Screen||13
5277140|NCT00664105|12972231|P1|NOT COMPLETED|Overall Study||24
5277141|NCT00664105|12972231|P1|COMPLETED|Overall Study||39
5277142|NCT00664105|12972231|P1|STARTED|Overall Study||63
5277143|NCT00664066|12972238|P1|NOT COMPLETED|Overall Study||3
5277144|NCT00664066|12972238|P1|COMPLETED|Overall Study||0
5277145|NCT00664066|12972238|P1|STARTED|Overall Study||3
5277146|NCT00663962|12972244|P2|NOT COMPLETED|Overall Study||0
5277147|NCT00663962|12972245|P1|NOT COMPLETED|Overall Study||1
5277148|NCT00663962|12972244|P2|COMPLETED|Overall Study||8
5277149|NCT00663962|12972245|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
5277150|NCT00663962|12972244|P2|STARTED|Overall Study||8
5277151|NCT00663962|12972245|P1|STARTED|Overall Study||7
5277152|NCT00663923|12972251|P1|NOT COMPLETED|Overall Study||2
5277153|NCT00663923|12972251|P1|COMPLETED|Overall Study||48
5277154|NCT00663923|12972251|P1|STARTED|Overall Study||50
5277155|NCT00663858|12972268|P3|NOT COMPLETED|Overall Study||20
5277156|NCT00663858|12972269|P2|NOT COMPLETED|Overall Study||10
5277157|NCT00663858|12972270|P1|NOT COMPLETED|Overall Study||34
5277158|NCT00663858|12972268|P3|COMPLETED|Overall Study||82
5277159|NCT00663858|12972269|P2|COMPLETED|Overall Study||96
5277160|NCT00663858|12972270|P1|COMPLETED|Overall Study||178
5277161|NCT00663858|12972268|P3|STARTED|Overall Study||102
5277162|NCT00663858|12972269|P2|STARTED|Overall Study||106
5277163|NCT00663858|12972270|P1|STARTED|Overall Study||212
5277164|NCT00663819|12972280|P2|NOT COMPLETED|Overall Study||0
5277165|NCT00663819|12972281|P1|NOT COMPLETED|Overall Study||0
5277166|NCT00663819|12972280|P2|COMPLETED|Overall Study||135
5277167|NCT00663819|12972281|P1|COMPLETED|Overall Study||123
5277168|NCT00663819|12972280|P2|STARTED|Overall Study||135
5277169|NCT00663819|12972281|P1|STARTED|Overall Study||123
5277170|NCT00663793|12972295|P2|NOT COMPLETED|Overall Study||0
5277171|NCT00663793|12972296|P1|NOT COMPLETED|Overall Study||0
5277172|NCT00663793|12972295|P2|COMPLETED|Overall Study||8
5277173|NCT00663793|12972296|P1|COMPLETED|Overall Study||8
5277174|NCT00663793|12972295|P2|STARTED|Overall Study||8
5277175|NCT00663793|12972296|P1|STARTED|Overall Study||8
5277176|NCT00663702|12972308|P2|NOT COMPLETED|Overall Study||10
5277177|NCT00663702|12972309|P1|NOT COMPLETED|Overall Study||18
5277178|NCT00663702|12972308|P2|COMPLETED|Overall Study||61
5277179|NCT00663702|12972309|P1|COMPLETED|Overall Study||34
5277180|NCT00663702|12972308|P2|STARTED|Overall Study||71
5277181|NCT00663702|12972309|P1|STARTED|Overall Study||52
5277182|NCT00663403|12972332|P1|NOT COMPLETED|Overall Study||0
5277183|NCT00663403|12972332|P1|COMPLETED|Overall Study||8
5277184|NCT00663403|12972332|P1|STARTED|Overall Study||8
5277185|NCT00663260|12972345|P3|NOT COMPLETED|Overall Study||16
5277186|NCT00663260|12972346|P2|NOT COMPLETED|Overall Study||11
5277187|NCT00663260|12972347|P1|NOT COMPLETED|Overall Study||21
5277188|NCT00663260|12972345|P3|COMPLETED|Overall Study||69
5277189|NCT00663260|12972346|P2|COMPLETED|Overall Study||72
5277190|NCT00663260|12972347|P1|COMPLETED|Overall Study||63
5277191|NCT00663260|12972345|P3|STARTED|Overall Study||85
5277192|NCT00663260|12972346|P2|STARTED|Overall Study||83
5277193|NCT00663260|12972347|P1|STARTED|Overall Study||84
5277194|NCT00663234|12972361|P1|NOT COMPLETED|Overall Study||1
5277195|NCT00663234|12972361|P1|COMPLETED|Overall Study||27
5277196|NCT00663234|12972361|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
5277197|NCT00663234|12972361|P1|STARTED|Overall Study||28
5277198|NCT00663208|12972394|P7|NOT COMPLETED|Follow-up Period||1
5277199|NCT00663208|12972395|P6|NOT COMPLETED|Follow-up Period||0
5277200|NCT00663208|12972396|P5|NOT COMPLETED|Follow-up Period||0
5277201|NCT00663208|12972397|P4|NOT COMPLETED|Follow-up Period||2
5277202|NCT00663208|12972398|P3|NOT COMPLETED|Follow-up Period||3
5277203|NCT00663208|12972399|P2|NOT COMPLETED|Follow-up Period||0
5277204|NCT00663208|12972400|P1|NOT COMPLETED|Follow-up Period||3
5277205|NCT00663208|12972394|P7|COMPLETED|Follow-up Period||5
5277206|NCT00663208|12972395|P6|COMPLETED|Follow-up Period||4
5277207|NCT00663208|12972396|P5|COMPLETED|Follow-up Period||4
5277208|NCT00663208|12972397|P4|COMPLETED|Follow-up Period||2
5277209|NCT00663208|12972398|P3|COMPLETED|Follow-up Period||1
5277210|NCT00663208|12972399|P2|COMPLETED|Follow-up Period||3
5277211|NCT00663208|12972400|P1|COMPLETED|Follow-up Period||1
5277212|NCT00663208|12972394|P7|STARTED|Follow-up Period||6
5277213|NCT00663208|12972395|P6|STARTED|Follow-up Period||4
5277214|NCT00663208|12972396|P5|STARTED|Follow-up Period||4
5277215|NCT00663208|12972397|P4|STARTED|Follow-up Period||4
5277216|NCT00663208|12972398|P3|STARTED|Follow-up Period||4
5277217|NCT00663208|12972399|P2|STARTED|Follow-up Period||3
5277218|NCT00663208|12972400|P1|STARTED|Follow-up Period||4
5277219|NCT00663208|12972394|P7|NOT COMPLETED|Treatment Period||0
5277220|NCT00663208|12972395|P6|NOT COMPLETED|Treatment Period||0
5277221|NCT00663208|12972396|P5|NOT COMPLETED|Treatment Period||0
5277222|NCT00663208|12972397|P4|NOT COMPLETED|Treatment Period||0
5277223|NCT00663208|12972398|P3|NOT COMPLETED|Treatment Period||0
5277224|NCT00663208|12972399|P2|NOT COMPLETED|Treatment Period||1
5277225|NCT00663208|12972400|P1|NOT COMPLETED|Treatment Period||0
5277226|NCT00663208|12972394|P7|COMPLETED|Treatment Period||6
5277227|NCT00663208|12972395|P6|COMPLETED|Treatment Period||4
5277228|NCT00663208|12972396|P5|COMPLETED|Treatment Period||4
5277229|NCT00663208|12972397|P4|COMPLETED|Treatment Period||4
5277230|NCT00663208|12972398|P3|COMPLETED|Treatment Period||4
5277231|NCT00663208|12972399|P2|COMPLETED|Treatment Period||3
5277232|NCT00663208|12972400|P1|COMPLETED|Treatment Period||4
5277233|NCT00663208|12972394|P7|STARTED|Treatment Period||6
5277234|NCT00663208|12972395|P6|STARTED|Treatment Period||4
5277235|NCT00663208|12972396|P5|STARTED|Treatment Period||4
5277236|NCT00663208|12972397|P4|STARTED|Treatment Period||4
5277237|NCT00663208|12972398|P3|STARTED|Treatment Period||4
5277238|NCT00663208|12972399|P2|STARTED|Treatment Period||4
5277239|NCT00663208|12972400|P1|STARTED|Treatment Period||4
5277240|NCT00663169|12972552|P2|NOT COMPLETED|Overall Study||0
5277241|NCT00663169|12972553|P1|NOT COMPLETED|Overall Study||0
5277242|NCT00663169|12972552|P2|COMPLETED|Overall Study||3
5277243|NCT00663169|12972553|P1|COMPLETED|Overall Study||3
5277244|NCT00663169|12972552|P2|STARTED|Overall Study||3
5277245|NCT00663169|12972553|P1|STARTED|Overall Study||3
5277246|NCT00663117|12972578|P2|NOT COMPLETED|Overall Study||0
5277247|NCT00663117|12972579|P1|NOT COMPLETED|Overall Study||1
5277248|NCT00663117|12972578|P2|COMPLETED|Overall Study||20
5277249|NCT00663117|12972579|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
5277250|NCT00663117|12972578|P2|STARTED|Overall Study||20
5277251|NCT00663117|12972579|P1|STARTED|Overall Study||20
5277252|NCT00663052|12972593|P2|NOT COMPLETED|Overall Study||10
5277253|NCT00663052|12972594|P1|NOT COMPLETED|Overall Study||12
5277254|NCT00663052|12972593|P2|COMPLETED|Overall Study||127
5277255|NCT00663052|12972594|P1|COMPLETED|Overall Study||124
5277256|NCT00663052|12972593|P2|STARTED|Overall Study||137
5277257|NCT00663052|12972594|P1|STARTED|Overall Study||136
5277258|NCT00663039|12972674|P2|NOT COMPLETED|Overall Study||4
5277259|NCT00663039|12972675|P1|NOT COMPLETED|Overall Study||4
5277260|NCT00663039|12972674|P2|COMPLETED|Overall Study||9
5277261|NCT00663039|12972675|P1|COMPLETED|Overall Study||10
5277262|NCT00663039|12972674|P2|STARTED|Overall Study||13
5277263|NCT00663039|12972675|P1|STARTED|Overall Study||14
5277264|NCT00663026|12972700|P3|NOT COMPLETED|Overall Study||4
5277265|NCT00663026|12972701|P2|NOT COMPLETED|Overall Study||6
5277266|NCT00663026|12972702|P1|NOT COMPLETED|Overall Study||2
5277267|NCT00663026|12972700|P3|COMPLETED|Overall Study||27
5277268|NCT00663026|12972701|P2|COMPLETED|Overall Study||23
5277269|NCT00663026|12972702|P1|COMPLETED|Overall Study||17
5277270|NCT00663026|12972700|P3|STARTED|Overall Study||31
5277271|NCT00663026|12972701|P2|STARTED|Overall Study||29
5277272|NCT00663026|12972702|P1|STARTED|Overall Study||19
5277273|NCT00662909|12972725|P3|NOT COMPLETED|Overall Study||53
5277274|NCT00662909|12972726|P2|NOT COMPLETED|Overall Study||59
5277275|NCT00662909|12972727|P1|NOT COMPLETED|Overall Study||69
5277276|NCT00662909|12972725|P3|COMPLETED|Overall Study||380
5277277|NCT00662909|12972726|P2|COMPLETED|Overall Study||383
5277278|NCT00662909|12972727|P1|COMPLETED|Overall Study||385
5277279|NCT00662909|12972725|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
5277280|NCT00662909|12972726|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
5277281|NCT00662909|12972727|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
5277282|NCT00662909|12972725|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
5277283|NCT00662909|12972726|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
5277284|NCT00662909|12972727|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
5277285|NCT00662909|12972725|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
5277286|NCT00662909|12972726|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
5277287|NCT00662909|12972727|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
5277288|NCT00662909|12972725|P3|STARTED|Overall Study||433
5277289|NCT00662909|12972726|P2|STARTED|Overall Study||442
5277290|NCT00662909|12972727|P1|STARTED|Overall Study||454
5277291|NCT00662857|12972825|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
5277292|NCT00662857|12972826|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
5277293|NCT00662857|12972825|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
5277294|NCT00662857|12972826|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
5277295|NCT00662857|12972825|P2|STARTED|Lispro Dosing Period (1 Day)||14
5277296|NCT00662857|12972826|P1|STARTED|Lispro Dosing Period (1 Day)||12
5277297|NCT00662857|12972825|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
5277298|NCT00662857|12972826|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
5277299|NCT00662857|12972825|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
5277300|NCT00662857|12972826|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
5277301|NCT00662857|12972825|P2|STARTED|Washout 2 (3 - 14 Days)||14
5277302|NCT00662857|12972826|P1|STARTED|Washout 2 (3 - 14 Days)||13
5277303|NCT00662857|12972825|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
5277304|NCT00662857|12972826|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
5277305|NCT00662857|12972825|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
5277306|NCT00662857|12972826|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
5277307|NCT00662857|12972825|P2|STARTED|TI Dosing Period 2 (1 Day)||14
5277308|NCT00662857|12972826|P1|STARTED|TI Dosing Period 2 (1 Day)||13
5277309|NCT00662857|12972825|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
5277310|NCT00662857|12972826|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
5277311|NCT00662857|12972825|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
5277312|NCT00662857|12972826|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
5277313|NCT00662857|12972825|P2|STARTED|Washout 1 (3 - 14 Days)||16
5277314|NCT00662857|12972826|P1|STARTED|Washout 1 (3 - 14 Days)||13
5277315|NCT00662857|12972825|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
5277316|NCT00662857|12972826|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
5277317|NCT00662857|12972825|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
5277318|NCT00662857|12972826|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
5277319|NCT00662857|12972825|P2|STARTED|TI Dosing Period 1 (1 Day)||16
5277320|NCT00662857|12972826|P1|STARTED|TI Dosing Period 1 (1 Day)||13
5277321|NCT00662831|12972841|P2|NOT COMPLETED|Overall Study||59
5277322|NCT00662831|12972842|P1|NOT COMPLETED|Overall Study||106
5277323|NCT00662831|12972841|P2|COMPLETED|Overall Study||33
5277324|NCT00662831|12972842|P1|COMPLETED|Overall Study||78
5277325|NCT00662831|12972841|P2|STARTED|Overall Study||92
5277326|NCT00662831|12972842|P1|STARTED|Overall Study||184
5277327|NCT00662818|12972882|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
5277328|NCT00662818|12972883|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
5277329|NCT00662818|12972882|P2|COMPLETED|Period 2 (6 Weeks)||41
5277330|NCT00662818|12972883|P1|COMPLETED|Period 2 (6 Weeks)||38
5277331|NCT00662818|12972882|P2|STARTED|Period 2 (6 Weeks)||53
5277332|NCT00662818|12972883|P1|STARTED|Period 2 (6 Weeks)||51
5277333|NCT00662818|12972882|P2|NOT COMPLETED|Wash-Out (14 Days)||5
5277334|NCT00662818|12972883|P1|NOT COMPLETED|Wash-Out (14 Days)||5
5277335|NCT00662818|12972882|P2|COMPLETED|Wash-Out (14 Days)||53
5277336|NCT00662818|12972883|P1|COMPLETED|Wash-Out (14 Days)||51
5277337|NCT00662818|12972882|P2|STARTED|Wash-Out (14 Days)||58
5277338|NCT00662818|12972883|P1|STARTED|Wash-Out (14 Days)||56
5277339|NCT00662818|12972882|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
5277340|NCT00662818|12972883|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
5277341|NCT00662818|12972882|P2|COMPLETED|Period 1 (6 Weeks)||58
5277342|NCT00662818|12972883|P1|COMPLETED|Period 1 (6 Weeks)||56
5277343|NCT00662818|12972882|P2|Treated|Period 1 (6 Weeks)||58
5277344|NCT00662818|12972883|P1|Treated|Period 1 (6 Weeks)||56
5277345|NCT00662818|12972882|P2|STARTED|Period 1 (6 Weeks)||81
5277346|NCT00662818|12972883|P1|STARTED|Period 1 (6 Weeks)||84
5277347|NCT00662675|12972907|P2|NOT COMPLETED|Overall Study||0
5277348|NCT00662675|12972908|P1|NOT COMPLETED|Overall Study||0
5277349|NCT00662675|12972907|P2|COMPLETED|Overall Study||20
5277350|NCT00662675|12972908|P1|COMPLETED|Overall Study||20
5277351|NCT00662675|12972907|P2|STARTED|Overall Study||20
5277352|NCT00662675|12972908|P1|STARTED|Overall Study||20
5277353|NCT00662649|12972922|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
5277354|NCT00662649|12972923|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
5277355|NCT00662649|12972924|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
5277356|NCT00662649|12972925|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
5277357|NCT00662649|12972926|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
5277358|NCT00662649|12972922|P5|COMPLETED|Extension Study (Month 24 to 60)||126
5277359|NCT00662649|12972923|P4|COMPLETED|Extension Study (Month 24 to 60)||112
5277360|NCT00662649|12972924|P3|COMPLETED|Extension Study (Month 24 to 60)||0
5277361|NCT00662649|12972925|P2|COMPLETED|Extension Study (Month 24 to 60)||290
5277362|NCT00662649|12972926|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
5277363|NCT00662649|12972922|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
5277364|NCT00662649|12972923|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
5277365|NCT00662649|12972924|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
5277366|NCT00662649|12972925|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
5277367|NCT00662649|12972926|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
5277368|NCT00662649|12972922|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
5277369|NCT00662649|12972923|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
5277370|NCT00662649|12972924|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
5277371|NCT00662649|12972925|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
5277372|NCT00662649|12972926|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
5277373|NCT00662649|12972922|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
5277374|NCT00662649|12972923|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
5277375|NCT00662649|12972924|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
5277376|NCT00662649|12972925|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
5277377|NCT00662649|12972926|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
5277378|NCT00662649|12972922|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
5277379|NCT00662649|12972923|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
5277380|NCT00662649|12972924|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
5277381|NCT00662649|12972925|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
5277382|NCT00662649|12972926|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
5277383|NCT00662649|12972922|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
5277384|NCT00662649|12972923|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
5277385|NCT00662649|12972924|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
5277386|NCT00662649|12972925|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
5277387|NCT00662649|12972926|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
5277388|NCT00662649|12972922|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
5277389|NCT00662649|12972923|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
5277390|NCT00662649|12972924|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
5277391|NCT00662649|12972925|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
5277392|NCT00662649|12972926|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
5277393|NCT00662649|12972922|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
5277394|NCT00662649|12972923|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
5277395|NCT00662649|12972924|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
5277396|NCT00662649|12972925|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
5277397|NCT00662649|12972926|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
5277398|NCT00662649|12972922|P5|STARTED|Extension Study (Month 24 to 60)||155
5277399|NCT00662649|12972923|P4|STARTED|Extension Study (Month 24 to 60)||145
5277400|NCT00662649|12972924|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
5277401|NCT00662649|12972925|P2|STARTED|Extension Study (Month 24 to 60)||331
5277402|NCT00662649|12972926|P1|STARTED|Extension Study (Month 24 to 60)||289
5277403|NCT00662649|12972922|P5|NOT COMPLETED|Core Study (24 Months)||0
5277404|NCT00662649|12972923|P4|NOT COMPLETED|Core Study (24 Months)||0
5277405|NCT00662649|12972924|P3|NOT COMPLETED|Core Study (24 Months)||86
5277406|NCT00662649|12972925|P2|NOT COMPLETED|Core Study (24 Months)||56
5277407|NCT00662649|12972926|P1|NOT COMPLETED|Core Study (24 Months)||97
5277408|NCT00662649|12972922|P5|COMPLETED|Core Study (24 Months)||0
5277409|NCT00662649|12972923|P4|COMPLETED|Core Study (24 Months)||0
5277410|NCT00662649|12972924|P3|COMPLETED|Core Study (24 Months)||332
5277411|NCT00662649|12972925|P2|COMPLETED|Core Study (24 Months)||369
5277412|NCT00662649|12972926|P1|COMPLETED|Core Study (24 Months)||332
5277413|NCT00662649|12972922|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
5277414|NCT00662649|12972923|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
5277415|NCT00662649|12972924|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
5277416|NCT00662649|12972925|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
5277417|NCT00662649|12972926|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
5277418|NCT00662649|12972922|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
5277419|NCT00662649|12972923|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
5277420|NCT00662649|12972924|P3|STARTED|Core Study (24 Months)||418
5277421|NCT00662649|12972925|P2|STARTED|Core Study (24 Months)||425
5277422|NCT00662649|12972926|P1|STARTED|Core Study (24 Months)||429
5277423|NCT00662558|12972966|P2|NOT COMPLETED|Overall Study||110
5277424|NCT00662558|12972967|P1|NOT COMPLETED|Overall Study||56
5277425|NCT00662558|12972966|P2|COMPLETED|Overall Study||294
5277426|NCT00662558|12972967|P1|COMPLETED|Overall Study||342
5277427|NCT00662558|12972966|P2|Received Treatment|Overall Study||396
5277428|NCT00662558|12972967|P1|Received Treatment|Overall Study||396
5277429|NCT00662558|12972966|P2|STARTED|Overall Study||404
5277430|NCT00662558|12972967|P1|STARTED|Overall Study||398
5277431|NCT00662545|12973001|P2|NOT COMPLETED|Overall Study||0
5277432|NCT00662545|12973002|P1|NOT COMPLETED|Overall Study||0
5277433|NCT00662545|12973001|P2|COMPLETED|Overall Study||5
5277434|NCT00662545|12973002|P1|COMPLETED|Overall Study||5
5277435|NCT00662545|12973001|P2|STARTED|Overall Study||5
5277436|NCT00662545|12973002|P1|STARTED|Overall Study||5
5277437|NCT00662532|12973018|P2|NOT COMPLETED|Overall Study||2
5277438|NCT00662532|12973019|P1|NOT COMPLETED|Overall Study||0
5277439|NCT00662532|12973018|P2|COMPLETED|Overall Study||20
5277440|NCT00662532|12973019|P1|COMPLETED|Overall Study||22
5277441|NCT00662532|12973018|P2|STARTED|Overall Study||22
5277442|NCT00662532|12973019|P1|STARTED|Overall Study||22
5277443|NCT00662389|12973029|P1|NOT COMPLETED|Overall Study||0
5277444|NCT00662389|12973029|P1|COMPLETED|Overall Study||4
5277445|NCT00662389|12973029|P1|STARTED|Overall Study||4
5277446|NCT00662363|12973034|P2|NOT COMPLETED|Overall Study||10
5277447|NCT00662363|12973035|P1|NOT COMPLETED|Overall Study||11
5277448|NCT00662363|12973034|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
5277449|NCT00662363|12973035|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
5277450|NCT00662363|12973034|P2|STARTED|Overall Study||32
5277451|NCT00662363|12973035|P1|STARTED|Overall Study||32
5277452|NCT00662311|12973046|P3|NOT COMPLETED|Overall Study||0
5277453|NCT00662311|12973047|P2|NOT COMPLETED|Overall Study||0
5277454|NCT00662311|12973048|P1|NOT COMPLETED|Overall Study||1
5277455|NCT00662311|12973046|P3|COMPLETED|Overall Study||0
5277456|NCT00662311|12973047|P2|COMPLETED|Overall Study||0
5277457|NCT00662311|12973048|P1|COMPLETED|Overall Study||4
5277458|NCT00662311|12973046|P3|STARTED|Overall Study||0
5277459|NCT00662311|12973047|P2|STARTED|Overall Study||0
5277460|NCT00662311|12973048|P1|STARTED|Overall Study||5
5277461|NCT00662298|12973071|P1|NOT COMPLETED|Overall Study||0
5277462|NCT00662298|12973071|P1|COMPLETED|Overall Study||5
5277463|NCT00662298|12973071|P1|STARTED|Overall Study||5
5277464|NCT00662259|12973083|P2|NOT COMPLETED|Overall Study||0
5277465|NCT00662259|12973084|P1|NOT COMPLETED|Overall Study||2
5277466|NCT00662259|12973083|P2|COMPLETED|Overall Study||11
5277467|NCT00662259|12973084|P1|COMPLETED|Overall Study||19
5277468|NCT00662259|12973083|P2|STARTED|Overall Study||11
5277469|NCT00662259|12973084|P1|STARTED|Overall Study||21
5277470|NCT00662207|12973098|P1|NOT COMPLETED|Overall Study||0
5277471|NCT00662207|12973098|P1|COMPLETED|Overall Study||3
5277472|NCT00662207|12973098|P1|STARTED|Overall Study||3
5277473|NCT00662155|12973109|P4|NOT COMPLETED|Overall Study||4
5277474|NCT00662155|12973110|P3|NOT COMPLETED|Overall Study||7
5277475|NCT00662155|12973111|P2|NOT COMPLETED|Overall Study||5
5277476|NCT00662155|12973112|P1|NOT COMPLETED|Overall Study||3
5277477|NCT00662155|12973109|P4|COMPLETED|Overall Study||14
5277478|NCT00662155|12973110|P3|COMPLETED|Overall Study||13
5277479|NCT00662155|12973111|P2|COMPLETED|Overall Study||15
5277480|NCT00662155|12973112|P1|COMPLETED|Overall Study||13
5277481|NCT00662155|12973109|P4|STARTED|Overall Study||18
5277482|NCT00662155|12973110|P3|STARTED|Overall Study||20
5277483|NCT00662155|12973111|P2|STARTED|Overall Study||20
5277484|NCT00662155|12973112|P1|STARTED|Overall Study||16
5277485|NCT00662129|12973126|P1|NOT COMPLETED|Overall Study||3
5277486|NCT00662129|12973126|P1|COMPLETED|Overall Study||47
5277487|NCT00662129|12973126|P1|STARTED|Overall Study||50
5277488|NCT00662038|12973136|P1|NOT COMPLETED|Overall Study||631
5277489|NCT00662038|12973136|P1|COMPLETED|Overall Study||427
5277490|NCT00662038|12973136|P1|STARTED|Overall Study||1058
5277491|NCT00662025|12973140|P1|NOT COMPLETED|Overall Study||63
5277492|NCT00662025|12973140|P1|COMPLETED|Overall Study||0
5277493|NCT00662025|12973140|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
5277494|NCT00662012|12973160|P1|NOT COMPLETED|Overall Study||87
5277495|NCT00662012|12973160|P1|COMPLETED|Overall Study||327
5277496|NCT00662012|12973160|P1|STARTED|Overall Study||414
5277497|NCT00661999|12973168|P3|NOT COMPLETED|Overall Study||57
5277498|NCT00661999|12973169|P2|NOT COMPLETED|Overall Study||50
5277499|NCT00661999|12973170|P1|NOT COMPLETED|Overall Study||59
5277500|NCT00661999|12973168|P3|COMPLETED|Overall Study||106
5277501|NCT00661999|12973169|P2|COMPLETED|Overall Study||113
5277502|NCT00661999|12973170|P1|COMPLETED|Overall Study||105
5277503|NCT00661999|12973168|P3|STARTED|Overall Study||163
5277504|NCT00661999|12973169|P2|STARTED|Overall Study||163
5277505|NCT00661999|12973170|P1|STARTED|Overall Study||164
5277506|NCT00661960|12973226|P3|NOT COMPLETED|Overall Study||1
5277507|NCT00661960|12973227|P2|NOT COMPLETED|Overall Study||3
5277508|NCT00661960|12973228|P1|NOT COMPLETED|Overall Study||0
5277509|NCT00661960|12973226|P3|COMPLETED|Overall Study||9
5277510|NCT00661960|12973227|P2|COMPLETED|Overall Study||7
5277511|NCT00661960|12973228|P1|COMPLETED|Overall Study||5
5277512|NCT00661960|12973226|P3|STARTED|Overall Study||10
5277513|NCT00661960|12973227|P2|STARTED|Overall Study||10
5277514|NCT00661960|12973228|P1|STARTED|Overall Study||5
5277515|NCT00661895|12973238|P2|NOT COMPLETED|Overall Study||0
5277516|NCT00661895|12973239|P1|NOT COMPLETED|Overall Study||0
5277517|NCT00661895|12973238|P2|COMPLETED|Overall Study||50
5277518|NCT00661895|12973239|P1|COMPLETED|Overall Study||49
5277519|NCT00661895|12973238|P2|STARTED|Overall Study||50
5277520|NCT00661895|12973239|P1|STARTED|Overall Study||49
5277521|NCT00661830|12973247|P2|NOT COMPLETED|Overall Study||42
5277522|NCT00661830|12973248|P1|NOT COMPLETED|Overall Study||40
5277523|NCT00661830|12973247|P2|COMPLETED|Overall Study||6
5277524|NCT00661830|12973248|P1|COMPLETED|Overall Study||9
5277525|NCT00661830|12973247|P2|STARTED|Overall Study||48
5277526|NCT00661830|12973248|P1|STARTED|Overall Study||49
5277527|NCT00661778|12973260|P1|NOT COMPLETED|Overall Study||50
5277528|NCT00661778|12973260|P1|COMPLETED|Overall Study||0
5277529|NCT00661778|12973260|P1|STARTED|Overall Study||50
5277530|NCT00661726|12973267|P1|NOT COMPLETED|Overall Study||1
5277531|NCT00661726|12973267|P1|COMPLETED|Overall Study||5
5277532|NCT00661726|12973267|P1|STARTED|Overall Study||6
5277533|NCT00661713|12973290|P8|NOT COMPLETED|Overall Study||11
5277534|NCT00661713|12973291|P7|NOT COMPLETED|Overall Study||64
5277535|NCT00661713|12973292|P6|NOT COMPLETED|Overall Study||37
5277536|NCT00661713|12973293|P5|NOT COMPLETED|Overall Study||20
5277537|NCT00661713|12973294|P4|NOT COMPLETED|Overall Study||28
5277538|NCT00661713|12973295|P3|NOT COMPLETED|Overall Study||17
5277539|NCT00661713|12973296|P2|NOT COMPLETED|Overall Study||39
5277540|NCT00661713|12973297|P1|NOT COMPLETED|Overall Study||16
5277541|NCT00661713|12973290|P8|COMPLETED|Overall Study||117
5277542|NCT00661713|12973291|P7|COMPLETED|Overall Study||309
5277543|NCT00661713|12973292|P6|COMPLETED|Overall Study||216
5277544|NCT00661713|12973293|P5|COMPLETED|Overall Study||107
5277545|NCT00661713|12973294|P4|COMPLETED|Overall Study||219
5277546|NCT00661713|12973295|P3|COMPLETED|Overall Study||111
5277547|NCT00661713|12973296|P2|COMPLETED|Overall Study||208
5277548|NCT00661713|12973297|P1|COMPLETED|Overall Study||112
5277549|NCT00661713|12973290|P8|STARTED|Overall Study||128
5277550|NCT00661713|12973291|P7|STARTED|Overall Study||373
5277551|NCT00661713|12973292|P6|STARTED|Overall Study||253
5277552|NCT00661713|12973293|P5|STARTED|Overall Study||127
5277553|NCT00661713|12973294|P4|STARTED|Overall Study||247
5277554|NCT00661713|12973295|P3|STARTED|Overall Study||128
5277555|NCT00661713|12973296|P2|STARTED|Overall Study||247
5277556|NCT00661713|12973297|P1|STARTED|Overall Study||128
5277557|NCT00661687|12973389|P1|NOT COMPLETED|Overall Study||15
5277558|NCT00661687|12973389|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
5277559|NCT00661687|12973389|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
5277560|NCT00661674|12973399|P6|NOT COMPLETED|Overall Study||0
5277561|NCT00661674|12973400|P5|NOT COMPLETED|Overall Study||0
5277562|NCT00661674|12973401|P4|NOT COMPLETED|Overall Study||0
5277563|NCT00661674|12973402|P3|NOT COMPLETED|Overall Study||0
5277564|NCT00661674|12973403|P2|NOT COMPLETED|Overall Study||0
5277565|NCT00661674|12973404|P1|NOT COMPLETED|Overall Study||0
5277566|NCT00661674|12973399|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
5277567|NCT00661674|12973400|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
5277568|NCT00661674|12973401|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
5277569|NCT00661674|12973402|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
5277570|NCT00661674|12973403|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
5277571|NCT00661674|12973404|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
5277572|NCT00661674|12973399|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
5277573|NCT00661674|12973400|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
5277574|NCT00661674|12973401|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
5277575|NCT00661674|12973402|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
5277576|NCT00661674|12973403|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
5277577|NCT00661674|12973404|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
5277578|NCT00661661|12973417|P2|NOT COMPLETED|Overall Study||39
5277579|NCT00661661|12973418|P1|NOT COMPLETED|Overall Study||140
5277580|NCT00661661|12973417|P2|COMPLETED|Overall Study||66
5277581|NCT00661661|12973418|P1|COMPLETED|Overall Study||242
5277582|NCT00661661|12973417|P2|STARTED|Overall Study||105
5277583|NCT00661661|12973418|P1|STARTED|Overall Study||382
5277584|NCT00661622|12973494|P2|NOT COMPLETED|Overall Study||0
5277585|NCT00661622|12973495|P1|NOT COMPLETED|Overall Study||1
5277586|NCT00661622|12973494|P2|COMPLETED|Overall Study||27
5277587|NCT00661622|12973495|P1|COMPLETED|Overall Study||25
5277588|NCT00661622|12973494|P2|STARTED|Overall Study||27
5277589|NCT00661622|12973495|P1|STARTED|Overall Study||26
5277590|NCT00661609|12973509|P1|NOT COMPLETED|Overall Study||41
5277591|NCT00661609|12973509|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
5277592|NCT00661609|12973509|P1|STARTED|Overall Study|All dosed patients|41
5277593|NCT00661583|12973519|P3|NOT COMPLETED|Overall Study||0
5277594|NCT00661583|12973520|P2|NOT COMPLETED|Overall Study||0
5277595|NCT00661583|12973521|P1|NOT COMPLETED|Overall Study||0
5277596|NCT00661583|12973519|P3|COMPLETED|Overall Study||10
5277597|NCT00661583|12973520|P2|COMPLETED|Overall Study||10
5277598|NCT00661583|12973521|P1|COMPLETED|Overall Study||10
5277599|NCT00661583|12973519|P3|STARTED|Overall Study||10
5277600|NCT00661583|12973520|P2|STARTED|Overall Study||10
5277601|NCT00661583|12973521|P1|STARTED|Overall Study||10
5277602|NCT00661570|12973538|P1|NOT COMPLETED|Overall Study||0
5277603|NCT00661570|12973538|P1|COMPLETED|Overall Study||26
5277604|NCT00661570|12973538|P1|STARTED|Overall Study||26
5277605|NCT00661557|12973547|P2|NOT COMPLETED|Overall Study||0
5277606|NCT00661557|12973548|P1|NOT COMPLETED|Overall Study||9
5277607|NCT00661557|12973547|P2|COMPLETED|Overall Study||79
5277608|NCT00661557|12973548|P1|COMPLETED|Overall Study||183
5277609|NCT00661557|12973547|P2|STARTED|Overall Study||79
5277610|NCT00661557|12973548|P1|STARTED|Overall Study||192
5277611|NCT00661544|12973572|P1|NOT COMPLETED|Overall Study||0
5277612|NCT00661544|12973572|P1|COMPLETED|Overall Study||48
5277613|NCT00661544|12973572|P1|STARTED|Overall Study||48
5277614|NCT00661531|12973576|P1|NOT COMPLETED|Overall Study||3
5277615|NCT00661531|12973576|P1|COMPLETED|Overall Study||8
5277616|NCT00661531|12973576|P1|STARTED|Overall Study||11
5277617|NCT00661505|12973581|P1|NOT COMPLETED|Overall Study||30
5277618|NCT00661505|12973581|P1|COMPLETED|Overall Study||102
5277619|NCT00661505|12973581|P1|STARTED|Overall Study||132
5277620|NCT00661492|12973609|P2|NOT COMPLETED|Overall Study||29
5277621|NCT00661492|12973610|P1|NOT COMPLETED|Overall Study||68
5277622|NCT00661492|12973609|P2|COMPLETED|Overall Study||11
5277623|NCT00661492|12973610|P1|COMPLETED|Overall Study||7
5277624|NCT00661492|12973609|P2|STARTED|Overall Study||40
5277625|NCT00661492|12973610|P1|STARTED|Overall Study||75
5277626|NCT00661479|12973634|P4|NOT COMPLETED|Overall Study||0
5277627|NCT00661479|12973635|P3|NOT COMPLETED|Overall Study||0
5277628|NCT00661479|12973636|P2|NOT COMPLETED|Overall Study||0
5277629|NCT00661479|12973637|P1|NOT COMPLETED|Overall Study||0
5277630|NCT00661479|12973634|P4|COMPLETED|Overall Study||3
5277631|NCT00661479|12973635|P3|COMPLETED|Overall Study||3
5277632|NCT00661479|12973636|P2|COMPLETED|Overall Study||3
5277633|NCT00661479|12973637|P1|COMPLETED|Overall Study||12
5277634|NCT00661479|12973634|P4|STARTED|Overall Study||3
5277635|NCT00661479|12973635|P3|STARTED|Overall Study||3
5277636|NCT00661479|12973636|P2|STARTED|Overall Study||3
5277637|NCT00661479|12973637|P1|STARTED|Overall Study||12
5277638|NCT00661453|12973650|P1|NOT COMPLETED|Overall Study||13
5277639|NCT00661453|12973650|P1|COMPLETED|Overall Study||25
5277640|NCT00661453|12973650|P1|STARTED|Overall Study||38
5277641|NCT00661427|12973656|P2|NOT COMPLETED|Overall Study||7
5277642|NCT00661427|12973657|P1|NOT COMPLETED|Overall Study||5
5277643|NCT00661427|12973656|P2|COMPLETED|Overall Study||19
5277644|NCT00661427|12973657|P1|COMPLETED|Overall Study||30
5277645|NCT00661427|12973656|P2|STARTED|Overall Study||26
5277646|NCT00661427|12973657|P1|STARTED|Overall Study||35
5277647|NCT00661388|12973665|P1|NOT COMPLETED|Overall Study||24
5277648|NCT00661388|12973665|P1|COMPLETED|Overall Study||51
5277649|NCT00661388|12973665|P1|STARTED|Overall Study||75
5277650|NCT00661362|12973688|P2|NOT COMPLETED|Overall Study||40
5277651|NCT00661362|12973689|P1|NOT COMPLETED|Overall Study||29
5277652|NCT00661362|12973688|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
5277653|NCT00661362|12973689|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
5277654|NCT00661362|12973688|P2|STARTED|Overall Study|Randomized and treated|287
5277655|NCT00661362|12973689|P1|STARTED|Overall Study|Randomized and treated|283
5277656|NCT00661271|12973707|P2|NOT COMPLETED|Overall Study||25
5277657|NCT00661271|12973708|P1|NOT COMPLETED|Overall Study||28
5277658|NCT00661271|12973707|P2|COMPLETED|Overall Study||20
5277659|NCT00661271|12973708|P1|COMPLETED|Overall Study||20
5277660|NCT00661271|12973707|P2|STARTED|Overall Study||45
5277661|NCT00661271|12973708|P1|STARTED|Overall Study||48
5277662|NCT00661258|12973718|P2|NOT COMPLETED|Overall Study||1
5277663|NCT00661258|12973719|P1|NOT COMPLETED|Overall Study||3
5277664|NCT00661258|12973718|P2|COMPLETED|Overall Study||33
5277665|NCT00661258|12973719|P1|COMPLETED|Overall Study||31
5277666|NCT00661258|12973718|P2|STARTED|Overall Study||34
5277667|NCT00661258|12973719|P1|STARTED|Overall Study||34
5277668|NCT00661193|12973729|P2|NOT COMPLETED|Overall Study||26
5277669|NCT00661193|12973730|P1|NOT COMPLETED|Overall Study||33
5277670|NCT00661193|12973729|P2|COMPLETED|Overall Study||0
5277671|NCT00661193|12973730|P1|COMPLETED|Overall Study||0
5277672|NCT00661193|12973729|P2|STARTED|Overall Study||26
5277673|NCT00661193|12973730|P1|STARTED|Overall Study||33
5277674|NCT00661141|12973741|P6|NOT COMPLETED|Overall Study||0
5277675|NCT00661141|12973742|P5|NOT COMPLETED|Overall Study||0
5277676|NCT00661141|12973743|P4|NOT COMPLETED|Overall Study||0
5277677|NCT00661141|12973744|P3|NOT COMPLETED|Overall Study||0
5277678|NCT00661141|12973745|P2|NOT COMPLETED|Overall Study||0
5277679|NCT00661141|12973746|P1|NOT COMPLETED|Overall Study||0
5277680|NCT00661141|12973741|P6|COMPLETED|Overall Study||4
5277681|NCT00661141|12973742|P5|COMPLETED|Overall Study||4
5277682|NCT00661141|12973743|P4|COMPLETED|Overall Study||4
5277683|NCT00661141|12973744|P3|COMPLETED|Overall Study||4
5277684|NCT00661141|12973745|P2|COMPLETED|Overall Study||8
5277685|NCT00661141|12973746|P1|COMPLETED|Overall Study||8
5277686|NCT00661141|12973741|P6|Administered 30 Minutes After Ethanol|Overall Study||0
5277687|NCT00661141|12973742|P5|Administered 30 Minutes After Ethanol|Overall Study||0
5277688|NCT00661141|12973743|P4|Administered 30 Minutes After Ethanol|Overall Study||2
5277689|NCT00661141|12973744|P3|Administered 30 Minutes After Ethanol|Overall Study||2
5277690|NCT00661141|12973745|P2|Administered 30 Minutes After Ethanol|Overall Study||2
5277691|NCT00661141|12973746|P1|Administered 30 Minutes After Ethanol|Overall Study||2
5277692|NCT00661141|12973741|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
5277693|NCT00661141|12973742|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
5277694|NCT00661141|12973743|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
5277695|NCT00661141|12973744|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
5277696|NCT00661141|12973745|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
5277697|NCT00661141|12973746|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
5277698|NCT00661141|12973741|P6|STARTED|Overall Study||4
5277699|NCT00661141|12973742|P5|STARTED|Overall Study||4
5277700|NCT00661141|12973743|P4|STARTED|Overall Study||4
5277701|NCT00661141|12973744|P3|STARTED|Overall Study||4
5277702|NCT00661141|12973745|P2|STARTED|Overall Study||8
5277703|NCT00661141|12973746|P1|STARTED|Overall Study||8
5277704|NCT00661089|12973955|P2|NOT COMPLETED|Overall Study||2
5277705|NCT00661089|12973956|P1|NOT COMPLETED|Overall Study||0
5277706|NCT00661089|12973955|P2|COMPLETED|Overall Study||9
5277707|NCT00661089|12973956|P1|COMPLETED|Overall Study||10
5277708|NCT00661089|12973955|P2|STARTED|Overall Study||11
5277709|NCT00661089|12973956|P1|STARTED|Overall Study||10
5277710|NCT00661037|12973966|P2|NOT COMPLETED|Overall Study||257
5277711|NCT00661037|12973967|P1|NOT COMPLETED|Overall Study||154
5277712|NCT00661037|12973966|P2|COMPLETED|Overall Study||1027
5277713|NCT00661037|12973967|P1|COMPLETED|Overall Study||682
5277714|NCT00661037|12973966|P2|Deaths|Overall Study||188
5277715|NCT00661037|12973967|P1|Deaths|Overall Study||108
5277716|NCT00661037|12973966|P2|Witdrawn|Overall Study||68
5277717|NCT00661037|12973967|P1|Witdrawn|Overall Study||47
5277718|NCT00661037|12973966|P2|STARTED|Overall Study||1284
5277719|NCT00661037|12973967|P1|STARTED|Overall Study||836
5277720|NCT00660985|12973979|P2|NOT COMPLETED|Overall Study||0
5277721|NCT00660985|12973980|P1|NOT COMPLETED|Overall Study||1
5277722|NCT00660985|12973979|P2|COMPLETED|Overall Study||25
5277723|NCT00660985|12973980|P1|COMPLETED|Overall Study||25
5277724|NCT00660985|12973979|P2|STARTED|Overall Study||25
5277725|NCT00660985|12973980|P1|STARTED|Overall Study||26
5277726|NCT00660907|12974004|P2|NOT COMPLETED|Overall Study||94
5277727|NCT00660907|12974005|P1|NOT COMPLETED|Overall Study||84
5277728|NCT00660907|12974004|P2|COMPLETED|Overall Study||314
5277729|NCT00660907|12974005|P1|COMPLETED|Overall Study||322
5277730|NCT00660907|12974004|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
5277731|NCT00660907|12974005|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
5277732|NCT00660829|12974019|P2|NOT COMPLETED|Overall Study||19
5277733|NCT00660829|12974020|P1|NOT COMPLETED|Overall Study||18
5277734|NCT00660829|12974019|P2|COMPLETED|Overall Study||249
5277735|NCT00660829|12974020|P1|COMPLETED|Overall Study||250
5277736|NCT00660829|12974019|P2|STARTED|Overall Study|2 subjects were randomized in error|268
5277737|NCT00660829|12974020|P1|STARTED|Overall Study|2 subjects were randomized in error|268
5277738|NCT00660816|12974038|P2|NOT COMPLETED|Overall Study||19
5277739|NCT00660816|12974039|P1|NOT COMPLETED|Overall Study||20
5277740|NCT00660816|12974038|P2|COMPLETED|Overall Study||3
5277741|NCT00660816|12974039|P1|COMPLETED|Overall Study||4
5277742|NCT00660816|12974038|P2|STARTED|Overall Study||22
5277743|NCT00660816|12974039|P1|STARTED|Overall Study||24
5277744|NCT00660790|12974051|P1|NOT COMPLETED|3 Months to 2 Years||17
5277745|NCT00660790|12974051|P1|COMPLETED|3 Months to 2 Years||77
5277746|NCT00660790|12974051|P1|STARTED|3 Months to 2 Years||94
5277747|NCT00660790|12974051|P1|NOT COMPLETED|Baseline to 3 Months||3
5277748|NCT00660790|12974051|P1|COMPLETED|Baseline to 3 Months||94
5277749|NCT00660790|12974051|P1|STARTED|Baseline to 3 Months||97
5277750|NCT00660699|12974055|P1|NOT COMPLETED|Overall Study||2
5277751|NCT00660699|12974055|P1|COMPLETED|Overall Study||48
5277752|NCT00660699|12974055|P1|STARTED|Overall Study||50
5277753|NCT00660660|12974071|P2|NOT COMPLETED|Overall Study||9
5277754|NCT00660660|12974072|P1|NOT COMPLETED|Overall Study||5
5277755|NCT00660660|12974071|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
5277756|NCT00660660|12974072|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
5277757|NCT00660660|12974071|P2|Met Criteria for MITT Population|Overall Study||125
5277758|NCT00660660|12974072|P1|Met Criteria for MITT Population|Overall Study||137
5277759|NCT00660660|12974071|P2|STARTED|Overall Study|Randomized|133
5277760|NCT00660660|12974072|P1|STARTED|Overall Study|Randomized|143
5277761|NCT00660595|12974172|P2|NOT COMPLETED|Overall Study||9
5277762|NCT00660595|12974173|P1|NOT COMPLETED|Overall Study||18
5277763|NCT00660595|12974172|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
5277764|NCT00660595|12974173|P1|COMPLETED|Overall Study||1
5277765|NCT00660595|12974172|P2|STARTED|Overall Study||10
5277766|NCT00660595|12974173|P1|STARTED|Overall Study||19
5277767|NCT00660543|12974185|P1|NOT COMPLETED|Overall Study||0
5277768|NCT00660543|12974185|P1|COMPLETED|Overall Study||14
5277769|NCT00660543|12974185|P1|STARTED|Overall Study||14
5277770|NCT00660517|12974198|P4|NOT COMPLETED|Overall Study||7
5277771|NCT00660517|12974199|P3|NOT COMPLETED|Overall Study||7
5277772|NCT00660517|12974200|P2|NOT COMPLETED|Overall Study||8
5277773|NCT00660517|12974201|P1|NOT COMPLETED|Overall Study||8
5277774|NCT00660517|12974198|P4|COMPLETED|Overall Study||144
5277775|NCT00660517|12974199|P3|COMPLETED|Overall Study||144
5277776|NCT00660517|12974200|P2|COMPLETED|Overall Study||144
5277777|NCT00660517|12974201|P1|COMPLETED|Overall Study||145
5277778|NCT00660517|12974198|P4|STARTED|Overall Study||151
5277779|NCT00660517|12974199|P3|STARTED|Overall Study||151
5277780|NCT00660517|12974200|P2|STARTED|Overall Study||152
5277781|NCT00660517|12974201|P1|STARTED|Overall Study||153
5277782|NCT00660504|12974221|P2|NOT COMPLETED|Overall Study||1
5277783|NCT00660504|12974222|P1|NOT COMPLETED|Overall Study||0
5277784|NCT00660504|12974221|P2|COMPLETED|Overall Study||150
5277785|NCT00660504|12974222|P1|COMPLETED|Overall Study||149
5277786|NCT00660504|12974221|P2|STARTED|Overall Study||151
5277787|NCT00660504|12974222|P1|STARTED|Overall Study||149
5277788|NCT00660400|12974234|P1|NOT COMPLETED|Overall Study||4
5277789|NCT00660400|12974234|P1|COMPLETED|Overall Study||21
5277790|NCT00660400|12974234|P1|STARTED|Overall Study||25
5277791|NCT00660387|12974243|P2|NOT COMPLETED|Overall Study||3
5277792|NCT00660387|12974244|P1|NOT COMPLETED|Overall Study||2
5277793|NCT00660387|12974243|P2|COMPLETED|Overall Study||31
5277794|NCT00660387|12974244|P1|COMPLETED|Overall Study||35
5277795|NCT00660387|12974243|P2|STARTED|Overall Study||34
5277796|NCT00660387|12974244|P1|STARTED|Overall Study||37
5277797|NCT00660348|12974298|P2|NOT COMPLETED|Overall Study||0
5277798|NCT00660348|12974299|P1|NOT COMPLETED|Overall Study||1
5277799|NCT00660348|12974298|P2|COMPLETED|Overall Study||0
5277800|NCT00660348|12974299|P1|COMPLETED|Overall Study||0
5277801|NCT00660348|12974298|P2|STARTED|Overall Study||0
5277802|NCT00660348|12974299|P1|STARTED|Overall Study||1
5277803|NCT00660309|12974307|P2|NOT COMPLETED|Overall Study||3
5277804|NCT00660309|12974308|P1|NOT COMPLETED|Overall Study||2
5277805|NCT00660309|12974307|P2|COMPLETED|Overall Study||19
5277806|NCT00660309|12974308|P1|COMPLETED|Overall Study||21
5277807|NCT00660309|12974307|P2|Pharmacodynamic Analysis Set|Overall Study||20
5277808|NCT00660309|12974308|P1|Pharmacodynamic Analysis Set|Overall Study||22
5277809|NCT00660309|12974307|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
5277810|NCT00660309|12974308|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
5277811|NCT00660309|12974307|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
5277812|NCT00660309|12974308|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
5277813|NCT00660192|12974349|P2|NOT COMPLETED|Overall Study||3
5277814|NCT00660192|12974350|P1|NOT COMPLETED|Overall Study||2
5277815|NCT00660192|12974349|P2|COMPLETED|Overall Study||10
5277816|NCT00660192|12974350|P1|COMPLETED|Overall Study||10
5277817|NCT00660192|12974349|P2|STARTED|Overall Study||13
5277818|NCT00660192|12974350|P1|STARTED|Overall Study||12
5277819|NCT00660179|12974361|P3|NOT COMPLETED|Overall Study||41
5277820|NCT00660179|12974362|P2|NOT COMPLETED|Overall Study||58
5277821|NCT00660179|12974363|P1|NOT COMPLETED|Overall Study||56
5277822|NCT00660179|12974361|P3|COMPLETED|Overall Study||201
5277823|NCT00660179|12974362|P2|COMPLETED|Overall Study||192
5277824|NCT00660179|12974363|P1|COMPLETED|Overall Study||194
5277825|NCT00660179|12974361|P3|STARTED|Overall Study||242
5277826|NCT00660179|12974362|P2|STARTED|Overall Study||250
5277827|NCT00660179|12974363|P1|STARTED|Overall Study||250
5277828|NCT00660075|12974397|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
5277829|NCT00660075|12974398|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
5277830|NCT00660075|12974397|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
5277831|NCT00660075|12974398|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
5277832|NCT00660075|12974397|P2|STARTED|Second Intervention (Week 11 to Week 16||18
5277833|NCT00660075|12974398|P1|STARTED|Second Intervention (Week 11 to Week 16||18
5277834|NCT00660075|12974397|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
5277835|NCT00660075|12974398|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
5277836|NCT00660075|12974397|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
5277837|NCT00660075|12974398|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
5277838|NCT00660075|12974397|P2|STARTED|Washout Period (Week 7 to Week 10)||18
5277839|NCT00660075|12974398|P1|STARTED|Washout Period (Week 7 to Week 10)||18
5277840|NCT00660075|12974397|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
5277841|NCT00660075|12974398|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
5277842|NCT00660075|12974397|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
5277843|NCT00660075|12974398|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
5277844|NCT00660075|12974397|P2|STARTED|First Intervention (Week 1 to Week 6)||18
5277845|NCT00660075|12974398|P1|STARTED|First Intervention (Week 1 to Week 6)||18
5277846|NCT00660049|12974404|P1|NOT COMPLETED|Overall Study||6
5277847|NCT00660049|12974404|P1|COMPLETED|Overall Study||6
5277848|NCT00660049|12974404|P1|STARTED|Overall Study||12
5277849|NCT00660023|12974408|P1|NOT COMPLETED|Overall Study||29
5277850|NCT00660023|12974408|P1|COMPLETED|Overall Study||95
5277851|NCT00660023|12974408|P1|Treated|Overall Study||114
5277852|NCT00660023|12974408|P1|STARTED|Overall Study||124
5277853|NCT00660010|12974419|P1|NOT COMPLETED|Overall Study||9
5277854|NCT00660010|12974419|P1|COMPLETED|Overall Study||46
5277855|NCT00660010|12974419|P1|STARTED|Overall Study||55
5277856|NCT00659984|12974433|P1|NOT COMPLETED|Overall Study||1
5277857|NCT00659984|12974433|P1|COMPLETED|Overall Study||14
5277858|NCT00659984|12974433|P1|STARTED|Overall Study||15
5277859|NCT00659945|12974446|P2|NOT COMPLETED|Overall Study||0
5277860|NCT00659945|12974447|P1|NOT COMPLETED|Overall Study||0
5277861|NCT00659945|12974446|P2|COMPLETED|Overall Study||75
5277862|NCT00659945|12974447|P1|COMPLETED|Overall Study||75
5277863|NCT00659945|12974446|P2|STARTED|Overall Study||75
5277864|NCT00659945|12974447|P1|STARTED|Overall Study||75
5277865|NCT00659880|12974453|P1|NOT COMPLETED|Overall Study||5
5277866|NCT00659880|12974453|P1|COMPLETED|Overall Study|60 months|4
5277867|NCT00659880|12974453|P1|24 Months|Overall Study||6
5277868|NCT00659880|12974453|P1|12 Months|Overall Study||7
5277869|NCT00659880|12974453|P1|6 Months|Overall Study||9
5277870|NCT00659880|12974453|P1|6 Weeks|Overall Study||9
5277871|NCT00659880|12974453|P1|STARTED|Overall Study||9
5277872|NCT00659828|12974458|P1|NOT COMPLETED|Overall Study||0
5277873|NCT00659828|12974458|P1|COMPLETED|Overall Study||1
5277874|NCT00659828|12974458|P1|STARTED|Overall Study||1
5277875|NCT00659815|12974466|P2|NOT COMPLETED|Overall Study||4
5277876|NCT00659815|12974467|P1|NOT COMPLETED|Overall Study||4
5277877|NCT00659815|12974466|P2|COMPLETED|Overall Study||147
5277878|NCT00659815|12974467|P1|COMPLETED|Overall Study||153
5277879|NCT00659815|12974466|P2|STARTED|Overall Study||151
5277880|NCT00659815|12974467|P1|STARTED|Overall Study||157
5277881|NCT00659802|12974480|P3|NOT COMPLETED|Overall Study||11
5277882|NCT00659802|12974481|P2|NOT COMPLETED|Overall Study||18
5277883|NCT00659802|12974482|P1|NOT COMPLETED|Overall Study||15
5277884|NCT00659802|12974480|P3|COMPLETED|Overall Study||64
5277885|NCT00659802|12974481|P2|COMPLETED|Overall Study||57
5277886|NCT00659802|12974482|P1|COMPLETED|Overall Study||59
5277887|NCT00659802|12974480|P3|STARTED|Overall Study||75
5277888|NCT00659802|12974481|P2|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
5277889|NCT00659802|12974482|P1|STARTED|Overall Study||74
5277890|NCT00659789|12974498|P2|NOT COMPLETED|Overall Study||7
5277891|NCT00659789|12974499|P1|NOT COMPLETED|Overall Study||7
5277892|NCT00659789|12974498|P2|COMPLETED|Overall Study||36
5277893|NCT00659789|12974499|P1|COMPLETED|Overall Study||86
5277894|NCT00659789|12974498|P2|STARTED|Overall Study||43
5277895|NCT00659789|12974499|P1|STARTED|Overall Study||93
5277896|NCT00659737|12974517|P2|NOT COMPLETED|Overall Study||0
5277897|NCT00659737|12974518|P1|NOT COMPLETED|Overall Study||0
5277898|NCT00659737|12974517|P2|COMPLETED|Overall Study||58
5277899|NCT00659737|12974518|P1|COMPLETED|Overall Study||57
5277900|NCT00659737|12974517|P2|STARTED|Overall Study||58
5277901|NCT00659737|12974518|P1|STARTED|Overall Study||57
5277902|NCT00659724|12974524|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
5277903|NCT00659724|12974524|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
5277904|NCT00659724|12974524|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
5277905|NCT00659724|12974524|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
5277906|NCT00659724|12974524|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
5277907|NCT00659724|12974524|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
5277908|NCT00659633|12974542|P1|NOT COMPLETED|Overall Study||0
5277909|NCT00659633|12974542|P1|COMPLETED|Overall Study||10
5277910|NCT00659633|12974542|P1|STARTED|Overall Study||10
5277911|NCT00659607|12974546|P1|NOT COMPLETED|Overall Study||316
5277912|NCT00659607|12974546|P1|COMPLETED|Overall Study||3616
5277913|NCT00659607|12974546|P1|STARTED|Overall Study||3932
5277914|NCT00659581|12974564|P1|NOT COMPLETED|Overall Study||8582
5277915|NCT00659581|12974564|P1|COMPLETED|Overall Study||12412
5277916|NCT00659581|12974564|P1|STARTED|Overall Study||20994
5277917|NCT00659529|12974576|P1|NOT COMPLETED|Overall Study||16
5277918|NCT00659529|12974576|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
5277919|NCT00659529|12974576|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
5277920|NCT00659529|12974576|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
5277921|NCT00659490|12974583|P3|NOT COMPLETED|Overall Study||1
5277922|NCT00659490|12974584|P2|NOT COMPLETED|Overall Study||0
5277923|NCT00659490|12974585|P1|NOT COMPLETED|Overall Study||2
5277924|NCT00659490|12974583|P3|COMPLETED|Overall Study||30
5277925|NCT00659490|12974584|P2|COMPLETED|Overall Study||59
5277926|NCT00659490|12974585|P1|COMPLETED|Overall Study||59
5277927|NCT00659490|12974583|P3|STARTED|Overall Study||31
5277928|NCT00659490|12974584|P2|STARTED|Overall Study||59
5277929|NCT00659490|12974585|P1|STARTED|Overall Study||61
5277930|NCT00659438|12974658|P2|NOT COMPLETED|Overall Study||8
5277931|NCT00659438|12974659|P1|NOT COMPLETED|Overall Study||14
5277932|NCT00659438|12974658|P2|COMPLETED|Overall Study||40
5277933|NCT00659438|12974659|P1|COMPLETED|Overall Study||33
5277934|NCT00659438|12974658|P2|Safety Analysis Set|Overall Study||47
5277935|NCT00659438|12974659|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
5277936|NCT00659438|12974658|P2|Secondary Analysis Set|Overall Study||48
5277937|NCT00659438|12974659|P1|Secondary Analysis Set|Overall Study||47
5277938|NCT00659438|12974658|P2|Assessable Set : Primary Analysis|Overall Study||45
5277939|NCT00659438|12974659|P1|Assessable Set : Primary Analysis|Overall Study||44
5277940|NCT00659438|12974658|P2|STARTED|Overall Study||48
5277941|NCT00659438|12974659|P1|STARTED|Overall Study||47
5277942|NCT00659425|12974691|P10|NOT COMPLETED|Overall Study||13
5277943|NCT00659425|12974692|P9|NOT COMPLETED|Overall Study||6
5277944|NCT00659425|12974693|P8|NOT COMPLETED|Overall Study||11
5277945|NCT00659425|12974694|P7|NOT COMPLETED|Overall Study||8
5277946|NCT00659425|12974695|P6|NOT COMPLETED|Overall Study||4
5277947|NCT00659425|12974696|P5|NOT COMPLETED|Overall Study||4
5277948|NCT00659425|12974697|P4|NOT COMPLETED|Overall Study||4
5277949|NCT00659425|12974698|P3|NOT COMPLETED|Overall Study||1
5277950|NCT00659425|12974699|P2|NOT COMPLETED|Overall Study||1
5277951|NCT00659425|12974700|P1|NOT COMPLETED|Overall Study||1
5277952|NCT00659425|12974691|P10|COMPLETED|Overall Study||1
5277953|NCT00659425|12974692|P9|COMPLETED|Overall Study||0
5277954|NCT00659425|12974693|P8|COMPLETED|Overall Study||0
5277955|NCT00659425|12974694|P7|COMPLETED|Overall Study||0
5277956|NCT00659425|12974695|P6|COMPLETED|Overall Study||1
5277957|NCT00659425|12974696|P5|COMPLETED|Overall Study||0
5277958|NCT00659425|12974697|P4|COMPLETED|Overall Study||0
5277959|NCT00659425|12974698|P3|COMPLETED|Overall Study||0
5277960|NCT00659425|12974699|P2|COMPLETED|Overall Study||0
5277961|NCT00659425|12974700|P1|COMPLETED|Overall Study||0
5277962|NCT00659425|12974691|P10|STARTED|Overall Study||14
5277963|NCT00659425|12974692|P9|STARTED|Overall Study||6
5277964|NCT00659425|12974693|P8|STARTED|Overall Study||11
5277965|NCT00659425|12974694|P7|STARTED|Overall Study||8
5277966|NCT00659425|12974695|P6|STARTED|Overall Study||5
5277967|NCT00659425|12974696|P5|STARTED|Overall Study||4
5277968|NCT00659425|12974697|P4|STARTED|Overall Study||4
5277969|NCT00659425|12974698|P3|STARTED|Overall Study||1
5277970|NCT00659425|12974699|P2|STARTED|Overall Study||1
5277971|NCT00659425|12974700|P1|STARTED|Overall Study||1
5277972|NCT00659373|12974931|P2|NOT COMPLETED|Overall Study||7
5277973|NCT00659373|12974932|P1|NOT COMPLETED|Overall Study||5
5277974|NCT00659373|12974931|P2|COMPLETED|Overall Study||54
5277975|NCT00659373|12974932|P1|COMPLETED|Overall Study||20
5277976|NCT00659373|12974931|P2|STARTED|Overall Study||61
5277977|NCT00659373|12974932|P1|STARTED|Overall Study||25
5277978|NCT00659360|12974938|P1|NOT COMPLETED|Overall Study||0
5277979|NCT00659360|12974938|P1|COMPLETED|Overall Study||17
5277980|NCT00659360|12974938|P1|STARTED|Overall Study||17
5277981|NCT00659334|12974954|P7|NOT COMPLETED|Overall Study||1
5277982|NCT00659334|12974955|P6|NOT COMPLETED|Overall Study||0
5277983|NCT00659334|12974956|P5|NOT COMPLETED|Overall Study||0
5277984|NCT00659334|12974957|P4|NOT COMPLETED|Overall Study||0
5277985|NCT00659334|12974958|P3|NOT COMPLETED|Overall Study||0
5277986|NCT00659334|12974959|P2|NOT COMPLETED|Overall Study||5
5277987|NCT00659334|12974960|P1|NOT COMPLETED|Overall Study||8
5277988|NCT00659334|12974954|P7|COMPLETED|Overall Study|1 screen failure|20
5277989|NCT00659334|12974955|P6|COMPLETED|Overall Study||0
5277990|NCT00659334|12974956|P5|COMPLETED|Overall Study||1
5277991|NCT00659334|12974957|P4|COMPLETED|Overall Study||2
5277992|NCT00659334|12974958|P3|COMPLETED|Overall Study||5
5277993|NCT00659334|12974959|P2|COMPLETED|Overall Study|5 Screen failures|36
5277994|NCT00659334|12974960|P1|COMPLETED|Overall Study|8 Screen failures|38
5277995|NCT00659334|12974954|P7|STARTED|Overall Study||21
5277996|NCT00659334|12974955|P6|STARTED|Overall Study||0
5277997|NCT00659334|12974956|P5|STARTED|Overall Study||1
5277998|NCT00659334|12974957|P4|STARTED|Overall Study||2
5277999|NCT00659334|12974958|P3|STARTED|Overall Study||5
5278000|NCT00659334|12974959|P2|STARTED|Overall Study||41
5278001|NCT00659334|12974960|P1|STARTED|Overall Study||46
5278002|NCT00659295|12974978|P2|NOT COMPLETED|Overall Study||5603
5278003|NCT00659295|12974979|P1|NOT COMPLETED|Overall Study||2708
5278004|NCT00659295|12974978|P2|COMPLETED|Overall Study||32038
5278005|NCT00659295|12974979|P1|COMPLETED|Overall Study||10821
5278006|NCT00659295|12974978|P2|STARTED|Overall Study||37641
5278007|NCT00659295|12974979|P1|STARTED|Overall Study||13529
5278008|NCT00659269|12974987|P2|NOT COMPLETED|Overall Study||1
5278009|NCT00659269|12974988|P1|NOT COMPLETED|Overall Study||1
5278010|NCT00659269|12974987|P2|COMPLETED|Overall Study||161
5278011|NCT00659269|12974988|P1|COMPLETED|Overall Study||156
5278012|NCT00659269|12974987|P2|Group 3 (Taxanes)|Overall Study||97
5278013|NCT00659269|12974988|P1|Group 3 (Taxanes)|Overall Study||92
5278014|NCT00659269|12974987|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
5278015|NCT00659269|12974988|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
5278016|NCT00659269|12974987|P2|Group 1 (Heavy Metals)|Overall Study||52
5278017|NCT00659269|12974988|P1|Group 1 (Heavy Metals)|Overall Study||52
5278018|NCT00659269|12974987|P2|STARTED|Overall Study||162
5278019|NCT00659269|12974988|P1|STARTED|Overall Study||157
5278020|NCT00659230|12975018|P2|NOT COMPLETED|Overall Study||12
5278021|NCT00659230|12975019|P1|NOT COMPLETED|Overall Study||9
5278022|NCT00659230|12975018|P2|COMPLETED|Overall Study||37
5278023|NCT00659230|12975019|P1|COMPLETED|Overall Study||42
5278024|NCT00659230|12975018|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
5278025|NCT00659230|12975019|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
5278026|NCT00659165|12975033|P2|NOT COMPLETED|Overall Study||0
5278027|NCT00659165|12975034|P1|NOT COMPLETED|Overall Study||0
5278028|NCT00659165|12975033|P2|COMPLETED|Overall Study||5
5278029|NCT00659165|12975034|P1|COMPLETED|Overall Study||5
5278030|NCT00659165|12975033|P2|STARTED|Overall Study||5
5278031|NCT00659165|12975034|P1|STARTED|Overall Study||5
5278032|NCT00659061|12975042|P2|NOT COMPLETED|Overall Study||15
5278033|NCT00659061|12975043|P1|NOT COMPLETED|Overall Study||21
5278034|NCT00659061|12975042|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
5278035|NCT00659061|12975043|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
5278036|NCT00659061|12975042|P2|STARTED|Overall Study||302
5278037|NCT00659061|12975043|P1|STARTED|Overall Study||308
5278038|NCT00658996|12975061|P2|NOT COMPLETED|Second Intervention||1
5278039|NCT00658996|12975062|P1|NOT COMPLETED|Second Intervention||1
5278040|NCT00658996|12975061|P2|COMPLETED|Second Intervention||104
5278041|NCT00658996|12975062|P1|COMPLETED|Second Intervention||105
5278042|NCT00658996|12975061|P2|STARTED|Second Intervention||105
5278043|NCT00658996|12975062|P1|STARTED|Second Intervention||106
5278044|NCT00658996|12975061|P2|NOT COMPLETED|Crossover Period||1
5278045|NCT00658996|12975062|P1|NOT COMPLETED|Crossover Period||2
5278046|NCT00658996|12975061|P2|COMPLETED|Crossover Period||105
5278047|NCT00658996|12975062|P1|COMPLETED|Crossover Period||106
5278048|NCT00658996|12975061|P2|STARTED|Crossover Period||106
5278049|NCT00658996|12975062|P1|STARTED|Crossover Period||108
5278050|NCT00658996|12975061|P2|NOT COMPLETED|First Intervention||1
5278051|NCT00658996|12975062|P1|NOT COMPLETED|First Intervention||1
5278052|NCT00658996|12975061|P2|COMPLETED|First Intervention||106
5278053|NCT00658996|12975062|P1|COMPLETED|First Intervention||108
5278054|NCT00658996|12975061|P2|STARTED|First Intervention||107
5278055|NCT00658996|12975062|P1|STARTED|First Intervention||109
5278056|NCT00658879|12975072|P1|NOT COMPLETED|Overall Study||1
5278057|NCT00658879|12975072|P1|COMPLETED|Overall Study||250
5278058|NCT00658879|12975072|P1|STARTED|Overall Study||251
5278059|NCT00658814|12975089|P2|NOT COMPLETED|Maintenance Therapy||1
5278060|NCT00658814|12975090|P1|NOT COMPLETED|Maintenance Therapy||3
5278061|NCT00658814|12975089|P2|COMPLETED|Maintenance Therapy||7
5278062|NCT00658814|12975090|P1|COMPLETED|Maintenance Therapy||17
5278063|NCT00658814|12975089|P2|Eligible|Maintenance Therapy||8
5278064|NCT00658814|12975090|P1|Eligible|Maintenance Therapy||19
5278065|NCT00658814|12975089|P2|STARTED|Maintenance Therapy||8
5278066|NCT00658814|12975090|P1|STARTED|Maintenance Therapy||20
5278067|NCT00658814|12975089|P2|NOT COMPLETED|Consolidation Therapy||3
5278068|NCT00658814|12975090|P1|NOT COMPLETED|Consolidation Therapy||2
5278069|NCT00658814|12975089|P2|COMPLETED|Consolidation Therapy||10
5278070|NCT00658814|12975090|P1|COMPLETED|Consolidation Therapy||22
5278071|NCT00658814|12975089|P2|Eligible|Consolidation Therapy||11
5278072|NCT00658814|12975090|P1|Eligible|Consolidation Therapy||22
5278073|NCT00658814|12975089|P2|STARTED|Consolidation Therapy||13
5278074|NCT00658814|12975090|P1|STARTED|Consolidation Therapy||24
5278075|NCT00658814|12975089|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
5278076|NCT00658814|12975090|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
5278077|NCT00658814|12975089|P2|COMPLETED|Remission Induction Chemotherapy||41
5278078|NCT00658814|12975090|P1|COMPLETED|Remission Induction Chemotherapy||75
5278079|NCT00658814|12975089|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
5278080|NCT00658814|12975090|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
5278081|NCT00658814|12975089|P2|Eligible|Remission Induction Chemotherapy||57
5278082|NCT00658814|12975090|P1|Eligible|Remission Induction Chemotherapy||82
5278083|NCT00658814|12975089|P2|STARTED|Remission Induction Chemotherapy||59
5278084|NCT00658814|12975090|P1|STARTED|Remission Induction Chemotherapy||83
5278085|NCT00658788|12975104|P1|NOT COMPLETED|Overall Study||74
5278086|NCT00658788|12975104|P1|COMPLETED|Overall Study||231
5278087|NCT00658788|12975104|P1|STARTED|Overall Study||305
5278088|NCT00658775|12975159|P2|NOT COMPLETED|Overall Study||43
5278089|NCT00658775|12975160|P1|NOT COMPLETED|Overall Study||42
5278090|NCT00658775|12975159|P2|COMPLETED|Overall Study||485
5278091|NCT00658775|12975160|P1|COMPLETED|Overall Study||495
5278092|NCT00658775|12975159|P2|STARTED|Overall Study|Treated|528
5278093|NCT00658775|12975160|P1|STARTED|Overall Study|Treated|537
5278094|NCT00658736|12975172|P2|NOT COMPLETED|Overall Study||2
5278095|NCT00658736|12975173|P1|NOT COMPLETED|Overall Study||6
5278096|NCT00658736|12975172|P2|COMPLETED|Overall Study||19
5278097|NCT00658736|12975173|P1|COMPLETED|Overall Study||13
5278098|NCT00658736|12975172|P2|STARTED|Overall Study||21
5278099|NCT00658736|12975173|P1|STARTED|Overall Study||19
5278100|NCT00658723|12975183|P3|NOT COMPLETED|Overall Study||7
5278101|NCT00658723|12975184|P2|NOT COMPLETED|Overall Study||4
5278102|NCT00658723|12975185|P1|NOT COMPLETED|Overall Study||4
5278103|NCT00658723|12975183|P3|COMPLETED|Overall Study||44
5278104|NCT00658723|12975184|P2|COMPLETED|Overall Study||26
5278105|NCT00658723|12975185|P1|COMPLETED|Overall Study||56
5278106|NCT00658723|12975183|P3|STARTED|Overall Study||51
5278107|NCT00658723|12975184|P2|STARTED|Overall Study||30
5278108|NCT00658723|12975185|P1|STARTED|Overall Study||60
5278109|NCT00658697|12975212|P1|NOT COMPLETED|Overall Study||0
5278110|NCT00658697|12975212|P1|COMPLETED|Overall Study||41
5278111|NCT00658697|12975212|P1|STARTED|Overall Study||41
5278112|NCT00658684|12975223|P4|NOT COMPLETED|Overall Study||1
5278113|NCT00658684|12975224|P3|NOT COMPLETED|Overall Study||3
5278114|NCT00658684|12975225|P2|NOT COMPLETED|Overall Study||15
5278115|NCT00658684|12975226|P1|NOT COMPLETED|Overall Study||19
5278116|NCT00658684|12975223|P4|COMPLETED|Overall Study||27
5278117|NCT00658684|12975224|P3|COMPLETED|Overall Study||22
5278118|NCT00658684|12975225|P2|COMPLETED|Overall Study||84
5278119|NCT00658684|12975226|P1|COMPLETED|Overall Study||133
5278120|NCT00658684|12975223|P4|STARTED|Overall Study||28
5278121|NCT00658684|12975224|P3|STARTED|Overall Study||25
5278122|NCT00658684|12975225|P2|STARTED|Overall Study||99
5278123|NCT00658684|12975226|P1|STARTED|Overall Study||152
5278124|NCT00658658|12975281|P5|NOT COMPLETED|Overall Study||5
5278125|NCT00658658|12975282|P4|NOT COMPLETED|Overall Study||2
5278126|NCT00658658|12975283|P3|NOT COMPLETED|Overall Study||0
5278127|NCT00658658|12975284|P2|NOT COMPLETED|Overall Study||2
5278128|NCT00658658|12975285|P1|NOT COMPLETED|Overall Study||5
5278129|NCT00658658|12975281|P5|COMPLETED|Overall Study||3
5278130|NCT00658658|12975282|P4|COMPLETED|Overall Study||4
5278131|NCT00658658|12975283|P3|COMPLETED|Overall Study||4
5278132|NCT00658658|12975284|P2|COMPLETED|Overall Study||5
5278133|NCT00658658|12975285|P1|COMPLETED|Overall Study||1
5278134|NCT00658658|12975281|P5|STARTED|Overall Study||8
5278135|NCT00658658|12975282|P4|STARTED|Overall Study||6
5278136|NCT00658658|12975283|P3|STARTED|Overall Study||4
5278137|NCT00658658|12975284|P2|STARTED|Overall Study||7
5278138|NCT00658658|12975285|P1|STARTED|Overall Study||6
5278139|NCT00658632|12975344|P2|NOT COMPLETED|Overall Study||65
5278140|NCT00658632|12975345|P1|NOT COMPLETED|Overall Study||64
5278141|NCT00658632|12975344|P2|COMPLETED|Overall Study||633
5278142|NCT00658632|12975345|P1|COMPLETED|Overall Study||618
5278143|NCT00658632|12975344|P2|STARTED|Overall Study|Treated|698
5278144|NCT00658632|12975345|P1|STARTED|Overall Study|Treated|682
5278145|NCT00658619|12975360|P5|NOT COMPLETED|Overall Study||2
5278146|NCT00658619|12975361|P4|NOT COMPLETED|Overall Study||12
5278147|NCT00658619|12975362|P3|NOT COMPLETED|Overall Study||10
5278148|NCT00658619|12975363|P2|NOT COMPLETED|Overall Study||1
5278149|NCT00658619|12975364|P1|NOT COMPLETED|Overall Study||0
5278150|NCT00658619|12975360|P5|COMPLETED|Overall Study||21
5278151|NCT00658619|12975361|P4|COMPLETED|Overall Study||37
5278152|NCT00658619|12975362|P3|COMPLETED|Overall Study||31
5278153|NCT00658619|12975363|P2|COMPLETED|Overall Study||2
5278154|NCT00658619|12975364|P1|COMPLETED|Overall Study||3
5278155|NCT00658619|12975360|P5|STARTED|Overall Study||23
5278156|NCT00658619|12975361|P4|STARTED|Overall Study||49
5278157|NCT00658619|12975362|P3|STARTED|Overall Study||41
5278158|NCT00658619|12975363|P2|STARTED|Overall Study||3
5278159|NCT00658619|12975364|P1|STARTED|Overall Study||3
5278160|NCT00658606|12975386|P2|NOT COMPLETED|Overall Study||23
5278161|NCT00658606|12975387|P1|NOT COMPLETED|Overall Study||16
5278162|NCT00658606|12975386|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
5278163|NCT00658606|12975387|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
5278164|NCT00658606|12975386|P2|Completed Treatment|Overall Study||44
5278165|NCT00658606|12975387|P1|Completed Treatment|Overall Study||42
5278166|NCT00658606|12975386|P2|STARTED|Overall Study||49
5278167|NCT00658606|12975387|P1|STARTED|Overall Study||49
5278168|NCT00658567|12975416|P3|NOT COMPLETED|Overall Study||6
5278169|NCT00658567|12975417|P2|NOT COMPLETED|Overall Study||4
5278170|NCT00658567|12975418|P1|NOT COMPLETED|Overall Study||8
5278171|NCT00658567|12975416|P3|COMPLETED|Overall Study||35
5278172|NCT00658567|12975417|P2|COMPLETED|Overall Study||38
5278173|NCT00658567|12975418|P1|COMPLETED|Overall Study||32
5278174|NCT00658567|12975416|P3|STARTED|Overall Study||41
5278175|NCT00658567|12975417|P2|STARTED|Overall Study||42
5278176|NCT00658567|12975418|P1|STARTED|Overall Study||40
5278177|NCT00658541|12975429|P2|NOT COMPLETED|Second Intervention||0
5278178|NCT00658541|12975430|P1|NOT COMPLETED|Second Intervention||0
5278179|NCT00658541|12975429|P2|COMPLETED|Second Intervention||17
5278180|NCT00658541|12975430|P1|COMPLETED|Second Intervention||18
5278181|NCT00658541|12975429|P2|STARTED|Second Intervention||17
5278182|NCT00658541|12975430|P1|STARTED|Second Intervention||18
5278183|NCT00658541|12975429|P2|NOT COMPLETED|Washout Period of 7 Days||2
5278184|NCT00658541|12975430|P1|NOT COMPLETED|Washout Period of 7 Days||1
5278185|NCT00658541|12975429|P2|COMPLETED|Washout Period of 7 Days||17
5278186|NCT00658541|12975430|P1|COMPLETED|Washout Period of 7 Days||18
5278187|NCT00658541|12975429|P2|STARTED|Washout Period of 7 Days||19
5278188|NCT00658541|12975430|P1|STARTED|Washout Period of 7 Days||19
5278189|NCT00658541|12975429|P2|NOT COMPLETED|First Intervention||0
5278190|NCT00658541|12975430|P1|NOT COMPLETED|First Intervention||0
5278191|NCT00658541|12975429|P2|COMPLETED|First Intervention||19
5278192|NCT00658541|12975430|P1|COMPLETED|First Intervention||19
5278193|NCT00658541|12975429|P2|STARTED|First Intervention||19
5278194|NCT00658541|12975430|P1|STARTED|First Intervention||19
5278195|NCT00658528|12975442|P2|NOT COMPLETED|Overall Study||45
5278196|NCT00658528|12975443|P1|NOT COMPLETED|Overall Study||40
5278197|NCT00658528|12975442|P2|COMPLETED|Overall Study||479
5278198|NCT00658528|12975443|P1|COMPLETED|Overall Study||491
5278199|NCT00658528|12975442|P2|STARTED|Overall Study|Treated|524
5278200|NCT00658528|12975443|P1|STARTED|Overall Study|Treated|531
5278201|NCT00658515|12975455|P2|NOT COMPLETED|Overall Study||265
5278202|NCT00658515|12975456|P1|NOT COMPLETED|Overall Study||312
5278203|NCT00658515|12975455|P2|COMPLETED|Overall Study||7668
5278204|NCT00658515|12975456|P1|COMPLETED|Overall Study||7626
5278205|NCT00658515|12975455|P2|STARTED|Overall Study||7933
5278206|NCT00658515|12975456|P1|STARTED|Overall Study||7938
5278207|NCT00658411|12975468|P1|NOT COMPLETED|Overall Study||0
5278208|NCT00658411|12975468|P1|COMPLETED|Overall Study||5
5278209|NCT00658411|12975468|P1|STARTED|Overall Study||5
5278210|NCT00658385|12975476|P1|NOT COMPLETED|Overall Study||0
5278211|NCT00658385|12975476|P1|COMPLETED|Overall Study||5
5278212|NCT00658385|12975476|P1|STARTED|Overall Study||5
5278213|NCT00658359|12975483|P3|NOT COMPLETED|Overall Study||46
5278214|NCT00658359|12975484|P2|NOT COMPLETED|Overall Study||45
5278215|NCT00658359|12975485|P1|NOT COMPLETED|Overall Study||28
5278216|NCT00658359|12975483|P3|COMPLETED|Overall Study||8
5278217|NCT00658359|12975484|P2|COMPLETED|Overall Study||15
5278218|NCT00658359|12975485|P1|COMPLETED|Overall Study||36
5278219|NCT00658359|12975483|P3|STARTED|Overall Study||54
5278220|NCT00658359|12975484|P2|STARTED|Overall Study||60
5278221|NCT00658359|12975485|P1|STARTED|Overall Study||64
5278222|NCT00658333|12975573|P2|NOT COMPLETED|Overall Study||1
5278223|NCT00658333|12975574|P1|NOT COMPLETED|Overall Study||2
5278224|NCT00658333|12975573|P2|COMPLETED|Overall Study||14
5278225|NCT00658333|12975574|P1|COMPLETED|Overall Study||13
5278226|NCT00658333|12975573|P2|STARTED|Overall Study||15
5278227|NCT00658333|12975574|P1|STARTED|Overall Study||15
5278228|NCT00658320|12975584|P2|NOT COMPLETED|Extension Study: After Month 24||0
5278229|NCT00658320|12975585|P1|NOT COMPLETED|Extension Study: After Month 24||2
5278230|NCT00658320|12975584|P2|COMPLETED|Extension Study: After Month 24||0
5278231|NCT00658320|12975585|P1|COMPLETED|Extension Study: After Month 24||42
5278232|NCT00658320|12975584|P2|STARTED|Extension Study: After Month 24||0
5278233|NCT00658320|12975585|P1|STARTED|Extension Study: After Month 24||44
5278234|NCT00658320|12975584|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
5278235|NCT00658320|12975585|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
5278236|NCT00658320|12975584|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
5278237|NCT00658320|12975585|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
5278238|NCT00658320|12975584|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
5278239|NCT00658320|12975585|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
5278240|NCT00658320|12975584|P2|STARTED|Extension Study: Month 12 to Month 24||57
5278241|NCT00658320|12975585|P1|STARTED|Extension Study: Month 12 to Month 24||53
5278242|NCT00658320|12975584|P2|NOT COMPLETED|Core Study: 12 Months||3
5278243|NCT00658320|12975585|P1|NOT COMPLETED|Core Study: 12 Months||5
5278244|NCT00658320|12975584|P2|COMPLETED|Core Study: 12 Months||58
5278245|NCT00658320|12975585|P1|COMPLETED|Core Study: 12 Months||56
5278246|NCT00658320|12975584|P2|STARTED|Core Study: 12 Months||61
5278247|NCT00658320|12975585|P1|STARTED|Core Study: 12 Months||61
5278248|NCT00658138|12975608|P1|NOT COMPLETED|Overall Study||21
5278249|NCT00658138|12975608|P1|COMPLETED|Overall Study||40
5278250|NCT00658138|12975608|P1|STARTED|Overall Study||61
5278251|NCT00658112|12975613|P1|NOT COMPLETED|Overall Study||9
5278252|NCT00658112|12975613|P1|COMPLETED|Overall Study||11
5278253|NCT00658112|12975613|P1|STARTED|Overall Study||20
5278254|NCT00657917|12975617|P1|NOT COMPLETED|Overall Study||0
5278255|NCT00657917|12975617|P1|COMPLETED|Overall Study||1
5278256|NCT00657917|12975617|P1|STARTED|Overall Study||1
5278257|NCT00657709|12975628|P5|NOT COMPLETED|Overall Study||33
5278258|NCT00657709|12975629|P4|NOT COMPLETED|Overall Study||14
5278259|NCT00657709|12975630|P3|NOT COMPLETED|Overall Study||28
5278260|NCT00657709|12975631|P2|NOT COMPLETED|Overall Study||33
5278261|NCT00657709|12975632|P1|NOT COMPLETED|Overall Study||23
5278262|NCT00657709|12975628|P5|COMPLETED|Overall Study||457
5278263|NCT00657709|12975629|P4|COMPLETED|Overall Study||645
5278264|NCT00657709|12975630|P3|COMPLETED|Overall Study||792
5278265|NCT00657709|12975631|P2|COMPLETED|Overall Study||795
5278266|NCT00657709|12975632|P1|COMPLETED|Overall Study||810
5278267|NCT00657709|12975628|P5|STARTED|Overall Study||490
5278268|NCT00657709|12975629|P4|STARTED|Overall Study||659
5278269|NCT00657709|12975630|P3|STARTED|Overall Study||820
5278270|NCT00657709|12975631|P2|STARTED|Overall Study||828
5278271|NCT00657709|12975632|P1|STARTED|Overall Study||833
5278272|NCT00657657|12975673|P1|NOT COMPLETED|Overall Study||0
5278273|NCT00657657|12975673|P1|COMPLETED|Overall Study||29
5278274|NCT00657657|12975673|P1|STARTED|Overall Study||29
5278275|NCT00657618|12975681|P1|NOT COMPLETED|Overall Study||43
5278276|NCT00657618|12975681|P1|COMPLETED|Overall Study||34
5278277|NCT00657618|12975681|P1|STARTED|Overall Study||77
5278278|NCT00657605|12975686|P1|NOT COMPLETED|Overall Study||0
5278279|NCT00657605|12975686|P1|COMPLETED|Overall Study||3
5278280|NCT00657605|12975686|P1|STARTED|Overall Study||3
5278281|NCT00657553|12975693|P2|NOT COMPLETED|Overall Study||5
5278282|NCT00657553|12975694|P1|NOT COMPLETED|Overall Study||5
5278283|NCT00657553|12975693|P2|COMPLETED|Overall Study||0
5278284|NCT00657553|12975694|P1|COMPLETED|Overall Study||0
5278285|NCT00657553|12975693|P2|STARTED|Overall Study||5
5278286|NCT00657553|12975694|P1|STARTED|Overall Study||5
5278287|NCT00657540|12975702|P2|NOT COMPLETED|Overall Study||4
5278288|NCT00657540|12975703|P1|NOT COMPLETED|Overall Study||1
5278289|NCT00657540|12975702|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
5278290|NCT00657540|12975703|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
5278291|NCT00657540|12975702|P2|STARTED|Overall Study||31
5278292|NCT00657540|12975703|P1|STARTED|Overall Study||29
5278293|NCT00657371|12975717|P1|NOT COMPLETED|Overall Study||39
5278294|NCT00657371|12975717|P1|COMPLETED|Overall Study||249
5278295|NCT00657371|12975717|P1|STARTED|Overall Study||288
5278296|NCT00657358|12975722|P1|NOT COMPLETED|Overall Study||6
5278297|NCT00657358|12975722|P1|COMPLETED|Overall Study||16
5278298|NCT00657358|12975722|P1|STARTED|Overall Study||22
5278299|NCT00657280|12975730|P1|NOT COMPLETED|Overall Study||0
5278300|NCT00657280|12975730|P1|COMPLETED|Overall Study||16
5278301|NCT00657280|12975730|P1|STARTED|Overall Study||16
5278302|NCT00657267|12975734|P1|NOT COMPLETED|Overall Study||54
5278303|NCT00657267|12975734|P1|COMPLETED|Overall Study||4
5278304|NCT00657267|12975734|P1|STARTED|Overall Study||58
5278305|NCT00657150|12975744|P2|NOT COMPLETED|Treatment||97
5278306|NCT00657150|12975745|P1|NOT COMPLETED|Treatment||107
5278307|NCT00657150|12975744|P2|COMPLETED|Treatment||906
5278308|NCT00657150|12975745|P1|COMPLETED|Treatment||903
5278309|NCT00657150|12975744|P2|STARTED|Treatment||1003
5278310|NCT00657150|12975745|P1|STARTED|Treatment||1010
5278311|NCT00657150|12975744|P2|NOT COMPLETED|Overall Study||93
5278312|NCT00657150|12975745|P1|NOT COMPLETED|Overall Study||115
5278313|NCT00657150|12975744|P2|COMPLETED|Overall Study||910
5278314|NCT00657150|12975745|P1|COMPLETED|Overall Study||895
5278315|NCT00657150|12975744|P2|STARTED|Overall Study||1003
5278316|NCT00657150|12975745|P1|STARTED|Overall Study||1010
5278317|NCT00657046|12975776|P3|NOT COMPLETED|Overall Study||2
5278318|NCT00657046|12975777|P2|NOT COMPLETED|Overall Study||3
5278319|NCT00657046|12975778|P1|NOT COMPLETED|Overall Study||4
5278320|NCT00657046|12975776|P3|COMPLETED|Overall Study||21
5278321|NCT00657046|12975777|P2|COMPLETED|Overall Study||29
5278322|NCT00657046|12975778|P1|COMPLETED|Overall Study||26
5278323|NCT00657046|12975776|P3|Had Visits up to Visit 18|Overall Study||23
5278324|NCT00657046|12975777|P2|Had Visits up to Visit 18|Overall Study||30
5278325|NCT00657046|12975778|P1|Had Visits up to Visit 18|Overall Study||28
5278326|NCT00657046|12975776|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
5278327|NCT00657046|12975777|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
5278328|NCT00657046|12975778|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
5278329|NCT00657046|12975776|P3|STARTED|Overall Study||23
5278330|NCT00657046|12975777|P2|STARTED|Overall Study||32
5278331|NCT00657046|12975778|P1|STARTED|Overall Study||30
5278332|NCT00657020|12975810|P2|NOT COMPLETED|PERIOD 2||0
5278333|NCT00657020|12975811|P1|NOT COMPLETED|PERIOD 2||0
5278334|NCT00657020|12975810|P2|COMPLETED|PERIOD 2||11
5278335|NCT00657020|12975811|P1|COMPLETED|PERIOD 2||11
5278336|NCT00657020|12975810|P2|STARTED|PERIOD 2||11
5278337|NCT00657020|12975811|P1|STARTED|PERIOD 2||11
5278338|NCT00657020|12975810|P2|NOT COMPLETED|PERIOD 1||1
5278339|NCT00657020|12975811|P1|NOT COMPLETED|PERIOD 1||0
5278340|NCT00657020|12975810|P2|COMPLETED|PERIOD 1||11
5278341|NCT00657020|12975811|P1|COMPLETED|PERIOD 1||11
5278342|NCT00657020|12975810|P2|STARTED|PERIOD 1||12
5278343|NCT00657020|12975811|P1|STARTED|PERIOD 1||11
5278344|NCT00656968|12975841|P2|NOT COMPLETED|Overall Study||0
5278345|NCT00656968|12975842|P1|NOT COMPLETED|Overall Study||0
5278346|NCT00656968|12975841|P2|COMPLETED|Overall Study||117
5278347|NCT00656968|12975842|P1|COMPLETED|Overall Study||115
5278348|NCT00656968|12975841|P2|STARTED|Overall Study||117
5278349|NCT00656968|12975842|P1|STARTED|Overall Study||115
5278350|NCT00656916|12975852|P2|NOT COMPLETED|Overall Study||0
5278351|NCT00656916|12975853|P1|NOT COMPLETED|Overall Study||0
5278352|NCT00656916|12975852|P2|COMPLETED|Overall Study||0
5278353|NCT00656916|12975853|P1|COMPLETED|Overall Study||1
5278354|NCT00656916|12975852|P2|STARTED|Overall Study||0
5278355|NCT00656916|12975853|P1|STARTED|Overall Study||1
5278356|NCT00656851|12975861|P2|NOT COMPLETED|Overall Study||4
5278357|NCT00656851|12975862|P1|NOT COMPLETED|Overall Study||0
5278358|NCT00656851|12975861|P2|COMPLETED|Overall Study||8
5278359|NCT00656851|12975862|P1|COMPLETED|Overall Study||12
5278360|NCT00656851|12975861|P2|STARTED|Overall Study||12
5278361|NCT00656851|12975862|P1|STARTED|Overall Study||12
5278362|NCT00656799|12975884|P1|NOT COMPLETED|Overall Study||2
5278363|NCT00656799|12975884|P1|COMPLETED|Overall Study||4
5278364|NCT00656799|12975884|P1|STARTED|Overall Study||6
5278365|NCT00656669|12975906|P1|NOT COMPLETED|AC (Cycles 6-9)||2
5278366|NCT00656669|12975906|P1|COMPLETED|AC (Cycles 6-9)||15
5278367|NCT00656669|12975906|P1|STARTED|AC (Cycles 6-9)||17
5278368|NCT00656669|12975906|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
5278369|NCT00656669|12975906|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
5278370|NCT00656669|12975906|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
5278371|NCT00656669|12975906|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
5278372|NCT00656669|12975906|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
5278373|NCT00656669|12975906|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
5278374|NCT00656656|12975915|P1|NOT COMPLETED|Overall Study||0
5278375|NCT00656656|12975915|P1|COMPLETED|Overall Study||23
5278376|NCT00656656|12975915|P1|STARTED|Overall Study||23
5278377|NCT00656630|12975923|P3|NOT COMPLETED|Overall Study||2
5278378|NCT00656630|12975924|P2|NOT COMPLETED|Overall Study||2
5278379|NCT00656630|12975925|P1|NOT COMPLETED|Overall Study||2
5278380|NCT00656630|12975923|P3|COMPLETED|Overall Study||17
5278381|NCT00656630|12975924|P2|COMPLETED|Overall Study||25
5278382|NCT00656630|12975925|P1|COMPLETED|Overall Study||20
5278383|NCT00656630|12975923|P3|STARTED|Overall Study||19
5278384|NCT00656630|12975924|P2|STARTED|Overall Study||27
5278385|NCT00656630|12975925|P1|STARTED|Overall Study||22
5278386|NCT00656617|12975945|P1|NOT COMPLETED|Overall Study||7
5278387|NCT00656617|12975945|P1|COMPLETED|Overall Study||99
5278388|NCT00656617|12975945|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
5278389|NCT00656617|12975945|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
5278390|NCT00656617|12975945|P1|STARTED|Overall Study||106
5278391|NCT00656513|12975954|P3|NOT COMPLETED|Overall Study||22
5278392|NCT00656513|12975955|P2|NOT COMPLETED|Overall Study||30
5278393|NCT00656513|12975956|P1|NOT COMPLETED|Overall Study||4
5278394|NCT00656513|12975954|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
5278395|NCT00656513|12975955|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
5278396|NCT00656513|12975956|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
5278397|NCT00656513|12975954|P3|STARTED|Overall Study||75
5278398|NCT00656513|12975955|P2|STARTED|Overall Study||73
5278399|NCT00656513|12975956|P1|STARTED|Overall Study||48
5278400|NCT00656487|12975978|P3|NOT COMPLETED|Overall Study||0
5278401|NCT00656487|12975979|P2|NOT COMPLETED|Overall Study||4
5278402|NCT00656487|12975980|P1|NOT COMPLETED|Overall Study||2
5278403|NCT00656487|12975978|P3|COMPLETED|Overall Study||20
5278404|NCT00656487|12975979|P2|COMPLETED|Overall Study||19
5278405|NCT00656487|12975980|P1|COMPLETED|Overall Study||21
5278406|NCT00656487|12975978|P3|STARTED|Overall Study||20
5278407|NCT00656487|12975979|P2|STARTED|Overall Study||23
5278408|NCT00656487|12975980|P1|STARTED|Overall Study||23
5278409|NCT00656474|12976003|P1|NOT COMPLETED|Overall Study||1
5278410|NCT00656474|12976003|P1|COMPLETED|Overall Study||11
5278411|NCT00656474|12976003|P1|STARTED|Overall Study||12
5278412|NCT00656448|12976012|P2|NOT COMPLETED|Overall Study||0
5278413|NCT00656448|12976013|P1|NOT COMPLETED|Overall Study||0
5278414|NCT00656448|12976012|P2|COMPLETED|Overall Study||25
5278415|NCT00656448|12976013|P1|COMPLETED|Overall Study||25
5278416|NCT00656448|12976012|P2|STARTED|Overall Study||25
5278417|NCT00656448|12976013|P1|STARTED|Overall Study||25
5278418|NCT00656370|12976021|P1|NOT COMPLETED|Overall Study||10
5278419|NCT00656370|12976021|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
5278420|NCT00656370|12976021|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
5278421|NCT00656305|12976037|P2|NOT COMPLETED|Overall Study||7
5278422|NCT00656305|12976038|P1|NOT COMPLETED|Overall Study||22
5278423|NCT00656305|12976037|P2|COMPLETED|Overall Study||21
5278424|NCT00656305|12976038|P1|COMPLETED|Overall Study||65
5278425|NCT00656305|12976037|P2|STARTED|Overall Study||28
5278426|NCT00656305|12976038|P1|STARTED|Overall Study||87
5278427|NCT00656292|12976050|P2|NOT COMPLETED|Overall Study||5
5278428|NCT00656292|12976051|P1|NOT COMPLETED|Overall Study||3
5278429|NCT00656292|12976050|P2|COMPLETED|Overall Study||24
5278430|NCT00656292|12976051|P1|COMPLETED|Overall Study||29
5278431|NCT00656292|12976050|P2|STARTED|Overall Study||29
5278432|NCT00656292|12976051|P1|STARTED|Overall Study||32
5278433|NCT00656201|12976069|P2|NOT COMPLETED|Overall Study||32
5278434|NCT00656201|12976070|P1|NOT COMPLETED|Overall Study||29
5278435|NCT00656201|12976069|P2|COMPLETED|Overall Study||201
5278436|NCT00656201|12976070|P1|COMPLETED|Overall Study||206
5278437|NCT00656201|12976069|P2|STARTED|Overall Study||233
5278438|NCT00656201|12976070|P1|STARTED|Overall Study||235
5278439|NCT00656175|12976078|P2|NOT COMPLETED|Overall Study||1
5278440|NCT00656175|12976079|P1|NOT COMPLETED|Overall Study||1
5278441|NCT00656175|12976078|P2|COMPLETED|Overall Study||20
5278442|NCT00656175|12976079|P1|COMPLETED|Overall Study||17
5278443|NCT00656175|12976078|P2|STARTED|Overall Study||21
5278444|NCT00656175|12976079|P1|STARTED|Overall Study||18
5278445|NCT00656136|12976087|P2|NOT COMPLETED|Overall Study||390
5278446|NCT00656136|12976088|P1|NOT COMPLETED|Overall Study||195
5278447|NCT00656136|12976087|P2|COMPLETED|Overall Study||0
5278448|NCT00656136|12976088|P1|COMPLETED|Overall Study||0
5278449|NCT00656136|12976087|P2|STARTED|Overall Study|Randomised patients.|390
5278450|NCT00656136|12976088|P1|STARTED|Overall Study|Randomised patients.|195
5278451|NCT00656084|12976098|P1|NOT COMPLETED|Overall Study||7
5278452|NCT00656084|12976098|P1|COMPLETED|Overall Study||9
5278453|NCT00656084|12976098|P1|STARTED|Overall Study||16
5278454|NCT00656058|12976105|P1|NOT COMPLETED|Overall Study||6
5278455|NCT00656058|12976105|P1|COMPLETED|Overall Study||19
5278456|NCT00656058|12976105|P1|STARTED|Overall Study||25
5278457|NCT00656019|12976118|P4|NOT COMPLETED|Overall Study||0
5278458|NCT00656019|12976119|P3|NOT COMPLETED|Overall Study||0
5278459|NCT00656019|12976120|P2|NOT COMPLETED|Overall Study||1
5278460|NCT00656019|12976121|P1|NOT COMPLETED|Overall Study||14
5278461|NCT00656019|12976118|P4|COMPLETED|Overall Study||4
5278462|NCT00656019|12976119|P3|COMPLETED|Overall Study||11
5278463|NCT00656019|12976120|P2|COMPLETED|Overall Study||18
5278464|NCT00656019|12976121|P1|COMPLETED|Overall Study||15
5278465|NCT00656019|12976118|P4|STARTED|Overall Study||4
5278466|NCT00656019|12976119|P3|STARTED|Overall Study||11
5278467|NCT00656019|12976120|P2|STARTED|Overall Study||19
5278468|NCT00656019|12976121|P1|STARTED|Overall Study||29
5278469|NCT00655928|12976133|P2|NOT COMPLETED|Overall Study||2
5278470|NCT00655928|12976134|P1|NOT COMPLETED|Overall Study||3
5278471|NCT00655928|12976133|P2|COMPLETED|Overall Study||24
5278472|NCT00655928|12976134|P1|COMPLETED|Overall Study||23
5278473|NCT00655928|12976133|P2|STARTED|Overall Study||26
5278474|NCT00655928|12976134|P1|STARTED|Overall Study||26
5278475|NCT00655889|12976140|P1|NOT COMPLETED|Overall Study||2
5278476|NCT00655889|12976140|P1|COMPLETED|Overall Study||11
5278477|NCT00655889|12976140|P1|STARTED|Overall Study||13
5278478|NCT00655876|12976147|P2|NOT COMPLETED|Overall Study||7
5278479|NCT00655876|12976148|P1|NOT COMPLETED|Overall Study||9
5278480|NCT00655876|12976147|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
5278481|NCT00655876|12976148|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
5278482|NCT00655876|12976147|P2|STARTED|Overall Study||176
5278483|NCT00655876|12976148|P1|STARTED|Overall Study||168
5278484|NCT00655863|12976167|P3|NOT COMPLETED|Overall Study||1
5278485|NCT00655863|12976168|P2|NOT COMPLETED|Overall Study||0
5278486|NCT00655863|12976169|P1|NOT COMPLETED|Overall Study||0
5278487|NCT00655863|12976167|P3|COMPLETED|Overall Study||21
5278488|NCT00655863|12976168|P2|COMPLETED|Overall Study||25
5278489|NCT00655863|12976169|P1|COMPLETED|Overall Study||24
5278490|NCT00655863|12976167|P3|STARTED|Overall Study||22
5278491|NCT00655863|12976168|P2|STARTED|Overall Study||25
5278492|NCT00655863|12976169|P1|STARTED|Overall Study||24
5278493|NCT00655850|12976228|P1|NOT COMPLETED|Overall Study||3
5278494|NCT00655850|12976228|P1|COMPLETED|Overall Study||36
5278495|NCT00655850|12976228|P1|STARTED|Overall Study||39
5278496|NCT00655824|12976235|P1|NOT COMPLETED|Overall Study||84
5278497|NCT00655824|12976235|P1|COMPLETED|Overall Study||8
5278498|NCT00655824|12976235|P1|STARTED|Overall Study||92
5278499|NCT00655811|12976269|P1|NOT COMPLETED|Overall Study||0
5278500|NCT00655811|12976269|P1|COMPLETED|Overall Study||40
5278501|NCT00655811|12976269|P1|STARTED|Overall Study||40
5278502|NCT00655746|12976283|P1|NOT COMPLETED|Overall Study||1
5278503|NCT00655746|12976283|P1|COMPLETED|Overall Study||13
5278504|NCT00655746|12976283|P1|STARTED|Overall Study||14
5278505|NCT00655733|12976302|P2|NOT COMPLETED|Overall Study||8
5278506|NCT00655733|12976303|P1|NOT COMPLETED|Overall Study||7
5278507|NCT00655733|12976302|P2|COMPLETED|Overall Study||42
5278508|NCT00655733|12976303|P1|COMPLETED|Overall Study||44
5278509|NCT00655733|12976302|P2|STARTED|Overall Study||50
5278510|NCT00655733|12976303|P1|STARTED|Overall Study||51
5278511|NCT00655707|12976331|P1|NOT COMPLETED|Overall Study||0
5278512|NCT00655707|12976331|P1|COMPLETED|Overall Study||5
5278513|NCT00655707|12976331|P1|STARTED|Overall Study||5
5278514|NCT00655668|12976336|P1|NOT COMPLETED|Overall Study||54
5278515|NCT00655668|12976336|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
5278516|NCT00655668|12976336|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
5278517|NCT00655642|12976348|P4|NOT COMPLETED|Overall Study||2
5278518|NCT00655642|12976349|P3|NOT COMPLETED|Overall Study||2
5278519|NCT00655642|12976350|P2|NOT COMPLETED|Overall Study||3
5278520|NCT00655642|12976351|P1|NOT COMPLETED|Overall Study||1
5278521|NCT00655642|12976348|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
5278522|NCT00655642|12976349|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
5278523|NCT00655642|12976350|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
5278524|NCT00655642|12976351|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
5278525|NCT00655642|12976348|P4|STARTED|Overall Study||41
5278526|NCT00655642|12976349|P3|STARTED|Overall Study||45
5278527|NCT00655642|12976350|P2|STARTED|Overall Study||43
5278528|NCT00655642|12976351|P1|STARTED|Overall Study||42
5278529|NCT00655629|12976363|P2|NOT COMPLETED|Overall Study||23
5278530|NCT00655629|12976364|P1|NOT COMPLETED|Overall Study||21
5278531|NCT00655629|12976363|P2|COMPLETED|Overall Study||144
5278532|NCT00655629|12976364|P1|COMPLETED|Overall Study||151
5278533|NCT00655629|12976363|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
5278534|NCT00655629|12976364|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
5278535|NCT00655629|12976363|P2|STARTED|Overall Study||167
5278536|NCT00655629|12976364|P1|STARTED|Overall Study||172
5278537|NCT00655564|12976400|P1|NOT COMPLETED|Overall Study||3
5278538|NCT00655564|12976400|P1|COMPLETED|Overall Study||12
5278539|NCT00655564|12976400|P1|STARTED|Overall Study||15
5278540|NCT00655551|12976408|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
5278541|NCT00655551|12976409|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
5278542|NCT00655551|12976410|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
5278543|NCT00655551|12976408|P3|COMPLETED|Period 4 (up to 7 Days)||0
5278544|NCT00655551|12976409|P2|COMPLETED|Period 4 (up to 7 Days)||23
5278545|NCT00655551|12976410|P1|COMPLETED|Period 4 (up to 7 Days)||0
5278546|NCT00655551|12976408|P3|STARTED|Period 4 (up to 7 Days)||0
5278547|NCT00655551|12976409|P2|STARTED|Period 4 (up to 7 Days)||25
5278548|NCT00655551|12976410|P1|STARTED|Period 4 (up to 7 Days)||0
5278549|NCT00655551|12976408|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
5278550|NCT00655551|12976409|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
5278551|NCT00655551|12976410|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
5278552|NCT00655551|12976408|P3|COMPLETED|Period 3 (up to 7 Days)||21
5278553|NCT00655551|12976409|P2|COMPLETED|Period 3 (up to 7 Days)||0
5278554|NCT00655551|12976410|P1|COMPLETED|Period 3 (up to 7 Days)||0
5278555|NCT00655551|12976408|P3|STARTED|Period 3 (up to 7 Days)||25
5278556|NCT00655551|12976409|P2|STARTED|Period 3 (up to 7 Days)||0
5278557|NCT00655551|12976410|P1|STARTED|Period 3 (up to 7 Days)||0
5278558|NCT00655551|12976408|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
5278559|NCT00655551|12976409|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
5278560|NCT00655551|12976410|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
5278561|NCT00655551|12976408|P3|COMPLETED|Period 2 (up to 7 Days)||0
5278562|NCT00655551|12976409|P2|COMPLETED|Period 2 (up to 7 Days)||24
5278563|NCT00655551|12976410|P1|COMPLETED|Period 2 (up to 7 Days)||0
5278564|NCT00655551|12976408|P3|STARTED|Period 2 (up to 7 Days)||0
5278565|NCT00655551|12976409|P2|STARTED|Period 2 (up to 7 Days)||25
5278566|NCT00655551|12976410|P1|STARTED|Period 2 (up to 7 Days)||0
5278567|NCT00655551|12976408|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
5278568|NCT00655551|12976409|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
5278569|NCT00655551|12976410|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
5278570|NCT00655551|12976408|P3|COMPLETED|Period 1 (up to 7 Days)||0
5278571|NCT00655551|12976409|P2|COMPLETED|Period 1 (up to 7 Days)||0
5278572|NCT00655551|12976410|P1|COMPLETED|Period 1 (up to 7 Days)||25
5278573|NCT00655551|12976408|P3|STARTED|Period 1 (up to 7 Days)||0
5278574|NCT00655551|12976409|P2|STARTED|Period 1 (up to 7 Days)||0
5278575|NCT00655551|12976410|P1|STARTED|Period 1 (up to 7 Days)||25
5278576|NCT00655551|12976408|P3|NOT COMPLETED|All Periods Combined||4
5278577|NCT00655551|12976409|P2|NOT COMPLETED|All Periods Combined||3
5278578|NCT00655551|12976410|P1|NOT COMPLETED|All Periods Combined||0
5278579|NCT00655551|12976408|P3|COMPLETED|All Periods Combined||21
5278580|NCT00655551|12976409|P2|COMPLETED|All Periods Combined||47
5278581|NCT00655551|12976410|P1|COMPLETED|All Periods Combined||25
5278582|NCT00655551|12976408|P3|STARTED|All Periods Combined||25
5278583|NCT00655551|12976409|P2|STARTED|All Periods Combined||50
5278584|NCT00655551|12976410|P1|STARTED|All Periods Combined||25
5278585|NCT00655538|12976426|P2|NOT COMPLETED|Overall Study||27
5278586|NCT00655538|12976427|P1|NOT COMPLETED|Overall Study||24
5278587|NCT00655538|12976426|P2|COMPLETED|Overall Study||211
5278588|NCT00655538|12976427|P1|COMPLETED|Overall Study||214
5278589|NCT00655538|12976426|P2|STARTED|Overall Study||238
5278590|NCT00655538|12976427|P1|STARTED|Overall Study||238
5278591|NCT00655486|12976447|P1|NOT COMPLETED|Overall Study||28
5278592|NCT00655486|12976447|P1|COMPLETED|Overall Study||69
5278593|NCT00655486|12976447|P1|STARTED|Overall Study||97
5278594|NCT00655473|12976454|P2|NOT COMPLETED|Overall Study||15
5278595|NCT00655473|12976455|P1|NOT COMPLETED|Overall Study||11
5278596|NCT00655473|12976454|P2|COMPLETED|Overall Study||51
5278597|NCT00655473|12976455|P1|COMPLETED|Overall Study||53
5278598|NCT00655473|12976454|P2|STARTED|Overall Study||66
5278599|NCT00655473|12976455|P1|STARTED|Overall Study||64
5278600|NCT00655356|12976475|P2|NOT COMPLETED|Overall Study||10
5278601|NCT00655356|12976476|P1|NOT COMPLETED|Overall Study||17
5278602|NCT00655356|12976475|P2|COMPLETED|Overall Study||98
5278603|NCT00655356|12976476|P1|COMPLETED|Overall Study||93
5278604|NCT00655356|12976475|P2|STARTED|Overall Study||108
5278605|NCT00655356|12976476|P1|STARTED|Overall Study||110
5278606|NCT00655083|12976490|P2|NOT COMPLETED|Overall Study||0
5278607|NCT00655083|12976491|P1|NOT COMPLETED|Overall Study||0
5278608|NCT00655083|12976490|P2|COMPLETED|Overall Study||8
5278609|NCT00655083|12976491|P1|COMPLETED|Overall Study||12
5278610|NCT00655083|12976490|P2|STARTED|Overall Study||8
5278611|NCT00655083|12976491|P1|STARTED|Overall Study||12
5278612|NCT00655057|12976506|P3|NOT COMPLETED|Overall Study||0
5278613|NCT00655057|12976507|P2|NOT COMPLETED|Overall Study||0
5278614|NCT00655057|12976508|P1|NOT COMPLETED|Overall Study||0
5278615|NCT00655057|12976506|P3|COMPLETED|Overall Study||0
5278616|NCT00655057|12976507|P2|COMPLETED|Overall Study||0
5278617|NCT00655057|12976508|P1|COMPLETED|Overall Study||0
5278618|NCT00655057|12976506|P3|STARTED|Overall Study||0
5278619|NCT00655057|12976507|P2|STARTED|Overall Study||0
5278620|NCT00655057|12976508|P1|STARTED|Overall Study||0
5278621|NCT00654992|12976518|P2|NOT COMPLETED|Overall Study||0
5278622|NCT00654992|12976519|P1|NOT COMPLETED|Overall Study||0
5278623|NCT00654992|12976518|P2|COMPLETED|Overall Study||35
5278624|NCT00654992|12976519|P1|COMPLETED|Overall Study||36
5278625|NCT00654992|12976518|P2|STARTED|Overall Study||35
5278626|NCT00654992|12976519|P1|STARTED|Overall Study||36
5278627|NCT00654953|12976528|P3|NOT COMPLETED|Overall Study||22
5278628|NCT00654953|12976529|P2|NOT COMPLETED|Overall Study||28
5278629|NCT00654953|12976530|P1|NOT COMPLETED|Overall Study||30
5278630|NCT00654953|12976528|P3|COMPLETED|Overall Study||8
5278631|NCT00654953|12976529|P2|COMPLETED|Overall Study||8
5278632|NCT00654953|12976530|P1|COMPLETED|Overall Study||6
5278633|NCT00654953|12976528|P3|STARTED|Overall Study||30
5278634|NCT00654953|12976529|P2|STARTED|Overall Study||36
5278635|NCT00654953|12976530|P1|STARTED|Overall Study||36
5278636|NCT00654940|12976540|P2|NOT COMPLETED|Period 2||0
5278637|NCT00654940|12976541|P1|NOT COMPLETED|Period 2||0
5278638|NCT00654940|12976540|P2|COMPLETED|Period 2||11
5278639|NCT00654940|12976541|P1|COMPLETED|Period 2||12
5278640|NCT00654940|12976540|P2|STARTED|Period 2||11
5278641|NCT00654940|12976541|P1|STARTED|Period 2||12
5278642|NCT00654940|12976540|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5278643|NCT00654940|12976541|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5278644|NCT00654940|12976540|P2|COMPLETED|Washout Period of 2 Weeks||11
5278645|NCT00654940|12976541|P1|COMPLETED|Washout Period of 2 Weeks||12
5278646|NCT00654940|12976540|P2|STARTED|Washout Period of 2 Weeks||11
5278647|NCT00654940|12976541|P1|STARTED|Washout Period of 2 Weeks||12
5278648|NCT00654940|12976540|P2|NOT COMPLETED|Period 1||1
5278649|NCT00654940|12976541|P1|NOT COMPLETED|Period 1||1
5278650|NCT00654940|12976540|P2|COMPLETED|Period 1||11
5278651|NCT00654940|12976541|P1|COMPLETED|Period 1||12
5278652|NCT00654940|12976540|P2|Received Study Treatment|Period 1||12
5278653|NCT00654940|12976541|P1|Received Study Treatment|Period 1||12
5278654|NCT00654940|12976540|P2|STARTED|Period 1|Assigned to study treatment.|12
5278655|NCT00654940|12976541|P1|STARTED|Period 1|Assigned to study treatment.|13
5278656|NCT00654927|12976553|P1|NOT COMPLETED|Overall Study||107
5278657|NCT00654927|12976553|P1|COMPLETED|Overall Study||70
5278658|NCT00654927|12976553|P1|STARTED|Overall Study||177
5278659|NCT00654901|12976565|P4|NOT COMPLETED|Overall Study||0
5278660|NCT00654901|12976566|P3|NOT COMPLETED|Overall Study||2
5278661|NCT00654901|12976567|P2|NOT COMPLETED|Overall Study||0
5278662|NCT00654901|12976568|P1|NOT COMPLETED|Overall Study||4
5278663|NCT00654901|12976565|P4|COMPLETED|Overall Study||113
5278664|NCT00654901|12976566|P3|COMPLETED|Overall Study||250
5278665|NCT00654901|12976567|P2|COMPLETED|Overall Study||262
5278666|NCT00654901|12976568|P1|COMPLETED|Overall Study||250
5278667|NCT00654901|12976565|P4|STARTED|Overall Study||113
5278668|NCT00654901|12976566|P3|STARTED|Overall Study||252
5278669|NCT00654901|12976567|P2|STARTED|Overall Study||262
5278670|NCT00654901|12976568|P1|STARTED|Overall Study||254
5278671|NCT00654875|12976588|P2|NOT COMPLETED|Overall Study||17
5278672|NCT00654875|12976589|P1|NOT COMPLETED|Overall Study||17
5278673|NCT00654875|12976588|P2|COMPLETED|Overall Study||147
5278674|NCT00654875|12976589|P1|COMPLETED|Overall Study||147
5278675|NCT00654875|12976588|P2|STARTED|Overall Study||164
5278676|NCT00654875|12976589|P1|STARTED|Overall Study||164
5278677|NCT00654836|12976607|P1|NOT COMPLETED|Overall Study||0
5278678|NCT00654836|12976607|P1|COMPLETED|Overall Study||32
5278679|NCT00654836|12976607|P1|STARTED|Overall Study||32
5278680|NCT00654784|12976615|P2|NOT COMPLETED|Overall Study||0
5278681|NCT00654784|12976616|P1|NOT COMPLETED|Overall Study||0
5278682|NCT00654784|12976615|P2|COMPLETED|Overall Study||8
5278683|NCT00654784|12976616|P1|COMPLETED|Overall Study||13
5278684|NCT00654784|12976615|P2|STARTED|Overall Study||8
5278685|NCT00654784|12976616|P1|STARTED|Overall Study||13
5278686|NCT00654745|12976622|P1|NOT COMPLETED|Overall Study||43
5278687|NCT00654745|12976622|P1|COMPLETED|Overall Study||164
5278688|NCT00654745|12976622|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
5278689|NCT00654732|12976662|P2|NOT COMPLETED|Overall Study||6
5278690|NCT00654732|12976663|P1|NOT COMPLETED|Overall Study||4
5278691|NCT00654732|12976662|P2|COMPLETED|Overall Study||26
5278692|NCT00654732|12976663|P1|COMPLETED|Overall Study||22
5278693|NCT00654732|12976662|P2|STARTED|Overall Study||32
5278694|NCT00654732|12976663|P1|STARTED|Overall Study||26
5278695|NCT00654654|12976669|P1|NOT COMPLETED|Overall Study||7
5278696|NCT00654654|12976669|P1|COMPLETED|Overall Study||43
5278697|NCT00654654|12976669|P1|STARTED|Overall Study||50
5278698|NCT00654641|12976676|P2|NOT COMPLETED|Overall Study||3
5278699|NCT00654641|12976677|P1|NOT COMPLETED|Overall Study||2
5278700|NCT00654641|12976676|P2|COMPLETED|Overall Study||23
5278701|NCT00654641|12976677|P1|COMPLETED|Overall Study||26
5278702|NCT00654641|12976676|P2|STARTED|Overall Study||26
5278703|NCT00654641|12976677|P1|STARTED|Overall Study||28
5278704|NCT00654628|12976683|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
5278705|NCT00654628|12976683|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
5278706|NCT00654628|12976683|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
5278707|NCT00654628|12976683|P1|NOT COMPLETED|6-week Active Treatment Period||21
5278708|NCT00654628|12976683|P1|COMPLETED|6-week Active Treatment Period||152
5278709|NCT00654628|12976683|P1|STARTED|6-week Active Treatment Period||173
5278710|NCT00654615|12976700|P2|NOT COMPLETED|Overall Study||7
5278711|NCT00654615|12976701|P1|NOT COMPLETED|Overall Study||8
5278712|NCT00654615|12976700|P2|COMPLETED|Overall Study||23
5278713|NCT00654615|12976701|P1|COMPLETED|Overall Study||22
5278714|NCT00654615|12976700|P2|STARTED|Overall Study||30
5278715|NCT00654615|12976701|P1|STARTED|Overall Study||30
5278716|NCT00654511|12976713|P4|NOT COMPLETED|Overall Study||0
5278717|NCT00654511|12976714|P3|NOT COMPLETED|Overall Study||0
5278718|NCT00654511|12976715|P2|NOT COMPLETED|Overall Study||0
5278719|NCT00654511|12976716|P1|NOT COMPLETED|Overall Study||0
5278720|NCT00654511|12976713|P4|COMPLETED|Overall Study||25
5278721|NCT00654511|12976714|P3|COMPLETED|Overall Study||25
5278722|NCT00654511|12976715|P2|COMPLETED|Overall Study||25
5278723|NCT00654511|12976716|P1|COMPLETED|Overall Study||26
5278724|NCT00654511|12976713|P4|STARTED|Overall Study||25
5278725|NCT00654511|12976714|P3|STARTED|Overall Study||25
5278726|NCT00654511|12976715|P2|STARTED|Overall Study||25
5278727|NCT00654511|12976716|P1|STARTED|Overall Study||26
5278728|NCT00654498|12976732|P2|NOT COMPLETED|Overall Study||12
5278729|NCT00654498|12976733|P1|NOT COMPLETED|Overall Study||14
5278730|NCT00654498|12976732|P2|COMPLETED|Overall Study||91
5278731|NCT00654498|12976733|P1|COMPLETED|Overall Study||189
5278732|NCT00654498|12976732|P2|STARTED|Overall Study||103
5278733|NCT00654498|12976733|P1|STARTED|Overall Study||203
5278734|NCT00654420|12976765|P4|NOT COMPLETED|Phase II||38
5278735|NCT00654420|12976766|P3|NOT COMPLETED|Phase II||37
5278736|NCT00654420|12976767|P2|NOT COMPLETED|Phase II||0
5278737|NCT00654420|12976768|P1|NOT COMPLETED|Phase II||0
5278738|NCT00654420|12976765|P4|COMPLETED|Phase II||0
5278739|NCT00654420|12976766|P3|COMPLETED|Phase II||0
5278740|NCT00654420|12976767|P2|COMPLETED|Phase II||0
5278741|NCT00654420|12976768|P1|COMPLETED|Phase II||0
5278742|NCT00654420|12976765|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
5278743|NCT00654420|12976766|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
5278744|NCT00654420|12976767|P2|STARTED|Phase II||0
5278745|NCT00654420|12976768|P1|STARTED|Phase II||0
5278746|NCT00654420|12976765|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
5278747|NCT00654420|12976766|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
5278748|NCT00654420|12976767|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
5278749|NCT00654420|12976768|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
5278750|NCT00654420|12976765|P4|COMPLETED|Phase I (Dose Escalation)||0
5278751|NCT00654420|12976766|P3|COMPLETED|Phase I (Dose Escalation)||0
5278752|NCT00654420|12976767|P2|COMPLETED|Phase I (Dose Escalation)||0
5278753|NCT00654420|12976768|P1|COMPLETED|Phase I (Dose Escalation)||0
5278754|NCT00654420|12976765|P4|STARTED|Phase I (Dose Escalation)||0
5278755|NCT00654420|12976766|P3|STARTED|Phase I (Dose Escalation)||0
5278756|NCT00654420|12976767|P2|STARTED|Phase I (Dose Escalation)||16
5278757|NCT00654420|12976768|P1|STARTED|Phase I (Dose Escalation)||4
5278758|NCT00654381|12976794|P6|NOT COMPLETED|Extension Stage||3
5278759|NCT00654381|12976795|P5|NOT COMPLETED|Extension Stage||3
5278760|NCT00654381|12976796|P4|NOT COMPLETED|Extension Stage||9
5278761|NCT00654381|12976797|P3|NOT COMPLETED|Extension Stage||11
5278762|NCT00654381|12976798|P2|NOT COMPLETED|Extension Stage||2
5278763|NCT00654381|12976799|P1|NOT COMPLETED|Extension Stage||1
5278764|NCT00654381|12976794|P6|COMPLETED|Extension Stage||73
5278765|NCT00654381|12976795|P5|COMPLETED|Extension Stage||68
5278766|NCT00654381|12976796|P4|COMPLETED|Extension Stage||142
5278767|NCT00654381|12976797|P3|COMPLETED|Extension Stage||142
5278768|NCT00654381|12976798|P2|COMPLETED|Extension Stage||36
5278769|NCT00654381|12976799|P1|COMPLETED|Extension Stage||33
5278770|NCT00654381|12976794|P6|STARTED|Extension Stage||76
5278771|NCT00654381|12976795|P5|STARTED|Extension Stage||71
5278772|NCT00654381|12976796|P4|STARTED|Extension Stage||151
5278773|NCT00654381|12976797|P3|STARTED|Extension Stage||153
5278774|NCT00654381|12976798|P2|STARTED|Extension Stage||38
5278775|NCT00654381|12976799|P1|STARTED|Extension Stage||34
5278776|NCT00654381|12976794|P6|NOT COMPLETED|2nd Stage||3
5278777|NCT00654381|12976795|P5|NOT COMPLETED|2nd Stage||8
5278778|NCT00654381|12976796|P4|NOT COMPLETED|2nd Stage||4
5278779|NCT00654381|12976797|P3|NOT COMPLETED|2nd Stage||3
5278780|NCT00654381|12976798|P2|NOT COMPLETED|2nd Stage||0
5278781|NCT00654381|12976799|P1|NOT COMPLETED|2nd Stage||2
5278782|NCT00654381|12976794|P6|COMPLETED|2nd Stage||76
5278783|NCT00654381|12976795|P5|COMPLETED|2nd Stage||71
5278784|NCT00654381|12976796|P4|COMPLETED|2nd Stage||151
5278785|NCT00654381|12976797|P3|COMPLETED|2nd Stage||153
5278786|NCT00654381|12976798|P2|COMPLETED|2nd Stage||38
5278787|NCT00654381|12976799|P1|COMPLETED|2nd Stage||34
5278788|NCT00654381|12976794|P6|STARTED|2nd Stage||79
5278789|NCT00654381|12976795|P5|STARTED|2nd Stage||79
5278790|NCT00654381|12976796|P4|STARTED|2nd Stage||155
5278791|NCT00654381|12976797|P3|STARTED|2nd Stage||156
5278792|NCT00654381|12976798|P2|STARTED|2nd Stage||38
5278793|NCT00654381|12976799|P1|STARTED|2nd Stage||36
5278794|NCT00654381|12976794|P6|NOT COMPLETED|1st Stage||2
5278795|NCT00654381|12976795|P5|NOT COMPLETED|1st Stage||2
5278796|NCT00654381|12976796|P4|NOT COMPLETED|1st Stage||5
5278797|NCT00654381|12976797|P3|NOT COMPLETED|1st Stage||3
5278798|NCT00654381|12976798|P2|NOT COMPLETED|1st Stage||3
5278799|NCT00654381|12976799|P1|NOT COMPLETED|1st Stage||3
5278800|NCT00654381|12976794|P6|COMPLETED|1st Stage||79
5278801|NCT00654381|12976795|P5|COMPLETED|1st Stage||79
5278802|NCT00654381|12976796|P4|COMPLETED|1st Stage||155
5278803|NCT00654381|12976797|P3|COMPLETED|1st Stage||156
5278804|NCT00654381|12976798|P2|COMPLETED|1st Stage||38
5278805|NCT00654381|12976799|P1|COMPLETED|1st Stage||36
5278806|NCT00654381|12976794|P6|STARTED|1st Stage||81
5278807|NCT00654381|12976795|P5|STARTED|1st Stage||81
5278808|NCT00654381|12976796|P4|STARTED|1st Stage||160
5278809|NCT00654381|12976797|P3|STARTED|1st Stage||159
5278810|NCT00654381|12976798|P2|STARTED|1st Stage||41
5278811|NCT00654381|12976799|P1|STARTED|1st Stage||39
5278812|NCT00654368|12976836|P3|NOT COMPLETED|Overall Study||32
5278813|NCT00654368|12976837|P2|NOT COMPLETED|Overall Study||48
5278814|NCT00654368|12976838|P1|NOT COMPLETED|Overall Study||53
5278815|NCT00654368|12976836|P3|COMPLETED|Overall Study||75
5278816|NCT00654368|12976837|P2|COMPLETED|Overall Study||50
5278817|NCT00654368|12976838|P1|COMPLETED|Overall Study||0
5278818|NCT00654368|12976836|P3|STARTED|Overall Study||107
5278819|NCT00654368|12976837|P2|STARTED|Overall Study||98
5278820|NCT00654368|12976838|P1|STARTED|Overall Study||53
5278821|NCT00654355|12976871|P2|NOT COMPLETED|Overall Study||2
5278822|NCT00654355|12976872|P1|NOT COMPLETED|Overall Study||2
5278823|NCT00654355|12976871|P2|COMPLETED|Overall Study||13
5278824|NCT00654355|12976872|P1|COMPLETED|Overall Study||13
5278825|NCT00654355|12976871|P2|STARTED|Overall Study||15
5278826|NCT00654355|12976872|P1|STARTED|Overall Study||15
5278827|NCT00654329|12976886|P4|NOT COMPLETED|Overall Study||0
5278828|NCT00654329|12976887|P3|NOT COMPLETED|Overall Study||0
5278829|NCT00654329|12976888|P2|NOT COMPLETED|Overall Study||0
5278830|NCT00654329|12976889|P1|NOT COMPLETED|Overall Study||0
5278831|NCT00654329|12976886|P4|COMPLETED|Overall Study||27
5278832|NCT00654329|12976887|P3|COMPLETED|Overall Study||23
5278833|NCT00654329|12976888|P2|COMPLETED|Overall Study||28
5278834|NCT00654329|12976889|P1|COMPLETED|Overall Study||23
5278835|NCT00654329|12976886|P4|STARTED|Overall Study||27
5278836|NCT00654329|12976887|P3|STARTED|Overall Study||23
5278837|NCT00654329|12976888|P2|STARTED|Overall Study||28
5278838|NCT00654329|12976889|P1|STARTED|Overall Study||23
5278839|NCT00654238|12976903|P1|NOT COMPLETED|Overall Study||4
5278840|NCT00654238|12976903|P1|COMPLETED|Overall Study||55
5278841|NCT00654238|12976903|P1|STARTED|Overall Study||59
5278842|NCT00654186|12976908|P1|NOT COMPLETED|Overall Study||5
5278843|NCT00654186|12976908|P1|COMPLETED|Overall Study||27
5278844|NCT00654186|12976908|P1|STARTED|Overall Study||32
5278845|NCT00654147|12976916|P2|NOT COMPLETED|Overall Study||4
5278846|NCT00654147|12976917|P1|NOT COMPLETED|Overall Study||2
5278847|NCT00654147|12976916|P2|COMPLETED|Overall Study||19
5278848|NCT00654147|12976917|P1|COMPLETED|Overall Study||19
5278849|NCT00654147|12976916|P2|STARTED|Overall Study||23
5278850|NCT00654147|12976917|P1|STARTED|Overall Study||21
5278851|NCT00654095|12976933|P1|NOT COMPLETED|Overall Study||32
5278852|NCT00654095|12976933|P1|COMPLETED|Overall Study||114
5278853|NCT00654095|12976933|P1|STARTED|Overall Study||146
5278854|NCT00654069|12976940|P3|NOT COMPLETED|Overall Study||18
5278855|NCT00654069|12976941|P2|NOT COMPLETED|Overall Study||11
5278856|NCT00654069|12976942|P1|NOT COMPLETED|Overall Study||17
5278857|NCT00654069|12976940|P3|COMPLETED|Overall Study||116
5278858|NCT00654069|12976941|P2|COMPLETED|Overall Study||124
5278859|NCT00654069|12976942|P1|COMPLETED|Overall Study||119
5278860|NCT00654069|12976940|P3|STARTED|Overall Study||134
5278861|NCT00654069|12976941|P2|STARTED|Overall Study||135
5278862|NCT00654069|12976942|P1|STARTED|Overall Study||136
5278863|NCT00654030|12976950|P1|NOT COMPLETED|Overall Study||1
5278864|NCT00654030|12976950|P1|COMPLETED|Overall Study||11
5278865|NCT00654030|12976950|P1|STARTED|Overall Study||12
5278866|NCT00654004|12976956|P2|NOT COMPLETED|Overall Study||0
5278867|NCT00654004|12976957|P1|NOT COMPLETED|Overall Study||1
5278868|NCT00654004|12976956|P2|COMPLETED|Overall Study||12
5278869|NCT00654004|12976957|P1|COMPLETED|Overall Study||13
5278870|NCT00654004|12976956|P2|STARTED|Overall Study||12
5278871|NCT00654004|12976957|P1|STARTED|Overall Study||14
5278872|NCT00653991|12976973|P2|NOT COMPLETED|6 Month Follow-up||141
5278873|NCT00653991|12976974|P1|NOT COMPLETED|6 Month Follow-up||133
5278874|NCT00653991|12976973|P2|COMPLETED|6 Month Follow-up||350
5278875|NCT00653991|12976974|P1|COMPLETED|6 Month Follow-up||311
5278876|NCT00653991|12976973|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
5278877|NCT00653991|12976974|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
5278878|NCT00653991|12976973|P2|NOT COMPLETED|3 Month Follow-up||157
5278879|NCT00653991|12976974|P1|NOT COMPLETED|3 Month Follow-up||150
5278880|NCT00653991|12976973|P2|COMPLETED|3 Month Follow-up||334
5278881|NCT00653991|12976974|P1|COMPLETED|3 Month Follow-up||294
5278882|NCT00653991|12976973|P2|STARTED|3 Month Follow-up||491
5278883|NCT00653991|12976974|P1|STARTED|3 Month Follow-up||444
5278884|NCT00653939|12976986|P2|NOT COMPLETED|Overall Study||15
5278885|NCT00653939|12976987|P1|NOT COMPLETED|Overall Study||12
5278886|NCT00653939|12976986|P2|COMPLETED|Overall Study||17
5278887|NCT00653939|12976987|P1|COMPLETED|Overall Study||19
5278888|NCT00653939|12976986|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
5278889|NCT00653939|12976987|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
5278890|NCT00653861|12977003|P1|NOT COMPLETED|Overall Study||0
5278891|NCT00653861|12977003|P1|COMPLETED|Overall Study||72
5278892|NCT00653861|12977003|P1|STARTED|Overall Study||72
5278893|NCT00653523|12977012|P1|NOT COMPLETED|Overall Study||19
5278894|NCT00653523|12977012|P1|COMPLETED|Overall Study||132
5278895|NCT00653523|12977012|P1|STARTED|Overall Study||151
5278896|NCT00653328|12977016|P1|NOT COMPLETED|Overall Study||15
5278897|NCT00653328|12977016|P1|COMPLETED|Overall Study||0
5278898|NCT00653328|12977016|P1|STARTED|Overall Study||15
5278899|NCT00653263|12977023|P1|NOT COMPLETED|Overall Study||2
5278900|NCT00653263|12977023|P1|COMPLETED|Overall Study||6
5278901|NCT00653263|12977023|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
5278902|NCT00653224|12977031|P2|NOT COMPLETED|Overall Study||7
5278903|NCT00653224|12977032|P1|NOT COMPLETED|Overall Study||7
5278904|NCT00653224|12977031|P2|COMPLETED|Overall Study||280
5278905|NCT00653224|12977032|P1|COMPLETED|Overall Study||286
5278906|NCT00653224|12977031|P2|STARTED|Overall Study||287
5278907|NCT00653224|12977032|P1|STARTED|Overall Study||293
5278908|NCT00653159|12977218|P2|NOT COMPLETED|Overall Study||3
5278909|NCT00653159|12977219|P1|NOT COMPLETED|Overall Study||5
5278910|NCT00653159|12977218|P2|COMPLETED|Overall Study||9
5278911|NCT00653159|12977219|P1|COMPLETED|Overall Study||6
5278912|NCT00653159|12977218|P2|STARTED|Overall Study||12
5278913|NCT00653159|12977219|P1|STARTED|Overall Study||11
5278914|NCT00653133|12977235|P2|NOT COMPLETED|Overall Study||0
5278915|NCT00653133|12977236|P1|NOT COMPLETED|Overall Study||0
5278916|NCT00653133|12977235|P2|COMPLETED|Overall Study||497
5278917|NCT00653133|12977236|P1|COMPLETED|Overall Study||1324
5278918|NCT00653133|12977235|P2|STARTED|Overall Study||497
5278919|NCT00653133|12977236|P1|STARTED|Overall Study||1324
5278920|NCT00653068|12977246|P1|NOT COMPLETED|Overall Study||50
5278921|NCT00653068|12977246|P1|COMPLETED|Overall Study||20
5278922|NCT00653068|12977246|P1|STARTED|Overall Study||70
5278923|NCT00652951|12977260|P3|NOT COMPLETED|Booster Phase||0
5278924|NCT00652951|12977261|P2|NOT COMPLETED|Booster Phase||1
5278925|NCT00652951|12977262|P1|NOT COMPLETED|Booster Phase||1
5278926|NCT00652951|12977260|P3|COMPLETED|Booster Phase||258
5278927|NCT00652951|12977261|P2|COMPLETED|Booster Phase||258
5278928|NCT00652951|12977262|P1|COMPLETED|Booster Phase||256
5278929|NCT00652951|12977260|P3|STARTED|Booster Phase||258
5278930|NCT00652951|12977261|P2|STARTED|Booster Phase||259
5278931|NCT00652951|12977262|P1|STARTED|Booster Phase||257
5278932|NCT00652951|12977260|P3|NOT COMPLETED|Primary Phase||0
5278933|NCT00652951|12977261|P2|NOT COMPLETED|Primary Phase||0
5278934|NCT00652951|12977262|P1|NOT COMPLETED|Primary Phase||0
5278935|NCT00652951|12977260|P3|COMPLETED|Primary Phase||260
5278936|NCT00652951|12977261|P2|COMPLETED|Primary Phase||260
5278937|NCT00652951|12977262|P1|COMPLETED|Primary Phase||260
5278938|NCT00652951|12977260|P3|STARTED|Primary Phase||260
5278939|NCT00652951|12977261|P2|STARTED|Primary Phase||260
5278940|NCT00652951|12977262|P1|STARTED|Primary Phase||260
5278941|NCT00652938|12977399|P3|NOT COMPLETED|Overall Study||5
5278942|NCT00652938|12977400|P2|NOT COMPLETED|Overall Study||7
5278943|NCT00652938|12977401|P1|NOT COMPLETED|Overall Study||1
5278944|NCT00652938|12977399|P3|COMPLETED|Overall Study||242
5278945|NCT00652938|12977400|P2|COMPLETED|Overall Study||240
5278946|NCT00652938|12977401|P1|COMPLETED|Overall Study||246
5278947|NCT00652938|12977399|P3|STARTED|Overall Study||247
5278948|NCT00652938|12977400|P2|STARTED|Overall Study||247
5278949|NCT00652938|12977401|P1|STARTED|Overall Study||247
5278950|NCT00652899|12977466|P1|NOT COMPLETED|Overall Study||2
5278951|NCT00652899|12977466|P1|COMPLETED|Overall Study||12
5278952|NCT00652899|12977466|P1|STARTED|Overall Study||14
5278953|NCT00652834|12977476|P1|NOT COMPLETED|Overall Study||5
5278954|NCT00652834|12977476|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
5278955|NCT00652834|12977476|P1|STARTED|Overall Study||23
5278956|NCT00652743|12977483|P3|NOT COMPLETED|Months 42-48||0
5278957|NCT00652743|12977484|P2|NOT COMPLETED|Months 42-48||0
5278958|NCT00652743|12977485|P1|NOT COMPLETED|Months 42-48||0
5278959|NCT00652743|12977483|P3|COMPLETED|Months 42-48||367
5278960|NCT00652743|12977484|P2|COMPLETED|Months 42-48||170
5278961|NCT00652743|12977485|P1|COMPLETED|Months 42-48||196
5278962|NCT00652743|12977483|P3|STARTED|Months 42-48||367
5278963|NCT00652743|12977484|P2|STARTED|Months 42-48||170
5278964|NCT00652743|12977485|P1|STARTED|Months 42-48||196
5278965|NCT00652743|12977483|P3|NOT COMPLETED|Months 36-42||9
5278966|NCT00652743|12977484|P2|NOT COMPLETED|Months 36-42||5
5278967|NCT00652743|12977485|P1|NOT COMPLETED|Months 36-42||6
5278968|NCT00652743|12977483|P3|COMPLETED|Months 36-42||381
5278969|NCT00652743|12977484|P2|COMPLETED|Months 36-42||180
5278970|NCT00652743|12977485|P1|COMPLETED|Months 36-42||210
5278971|NCT00652743|12977483|P3|STARTED|Months 36-42||390
5278972|NCT00652743|12977484|P2|STARTED|Months 36-42||185
5278973|NCT00652743|12977485|P1|STARTED|Months 36-42||216
5278974|NCT00652743|12977483|P3|NOT COMPLETED|Months 24-30||11
5278975|NCT00652743|12977484|P2|NOT COMPLETED|Months 24-30||1
5278976|NCT00652743|12977485|P1|NOT COMPLETED|Months 24-30||5
5278977|NCT00652743|12977483|P3|COMPLETED|Months 24-30||422
5278978|NCT00652743|12977484|P2|COMPLETED|Months 24-30||185
5278979|NCT00652743|12977485|P1|COMPLETED|Months 24-30||207
5278980|NCT00652743|12977483|P3|STARTED|Months 24-30||433
5278981|NCT00652743|12977484|P2|STARTED|Months 24-30||186
5278982|NCT00652743|12977485|P1|STARTED|Months 24-30||212
5278983|NCT00652743|12977483|P3|NOT COMPLETED|Months 12-18||7
5278984|NCT00652743|12977484|P2|NOT COMPLETED|Months 12-18||2
5278985|NCT00652743|12977485|P1|NOT COMPLETED|Months 12-18||1
5278986|NCT00652743|12977483|P3|COMPLETED|Months 12-18||430
5278987|NCT00652743|12977484|P2|COMPLETED|Months 12-18||186
5278988|NCT00652743|12977485|P1|COMPLETED|Months 12-18||218
5278989|NCT00652743|12977483|P3|STARTED|Months 12-18||437
5278990|NCT00652743|12977484|P2|STARTED|Months 12-18||188
5278991|NCT00652743|12977485|P1|STARTED|Months 12-18||219
5278992|NCT00652626|12977567|P7|NOT COMPLETED|Extension Phase||3
5278993|NCT00652626|12977568|P6|NOT COMPLETED|Extension Phase||12
5278994|NCT00652626|12977569|P5|NOT COMPLETED|Extension Phase||0
5278995|NCT00652626|12977570|P4|NOT COMPLETED|Extension Phase||0
5278996|NCT00652626|12977571|P3|NOT COMPLETED|Extension Phase||0
5278997|NCT00652626|12977572|P2|NOT COMPLETED|Extension Phase||0
5278998|NCT00652626|12977573|P1|NOT COMPLETED|Extension Phase||0
5278999|NCT00652626|12977567|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
5279000|NCT00652626|12977568|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
5279001|NCT00652626|12977569|P5|COMPLETED|Extension Phase||0
5279002|NCT00652626|12977570|P4|COMPLETED|Extension Phase||0
5279003|NCT00652626|12977571|P3|COMPLETED|Extension Phase||0
5279004|NCT00652626|12977572|P2|COMPLETED|Extension Phase||0
5279005|NCT00652626|12977573|P1|COMPLETED|Extension Phase||0
5279006|NCT00652626|12977567|P7|STARTED|Extension Phase||4
5279007|NCT00652626|12977568|P6|STARTED|Extension Phase||14
5279008|NCT00652626|12977569|P5|STARTED|Extension Phase||0
5279009|NCT00652626|12977570|P4|STARTED|Extension Phase||0
5279010|NCT00652626|12977571|P3|STARTED|Extension Phase||0
5279011|NCT00652626|12977572|P2|STARTED|Extension Phase||0
5279012|NCT00652626|12977573|P1|STARTED|Extension Phase||0
5279013|NCT00652626|12977567|P7|NOT COMPLETED|Initial Treatment Phase||0
5279014|NCT00652626|12977568|P6|NOT COMPLETED|Initial Treatment Phase||0
5279015|NCT00652626|12977569|P5|NOT COMPLETED|Initial Treatment Phase||3
5279016|NCT00652626|12977570|P4|NOT COMPLETED|Initial Treatment Phase||1
5279017|NCT00652626|12977571|P3|NOT COMPLETED|Initial Treatment Phase||1
5279018|NCT00652626|12977572|P2|NOT COMPLETED|Initial Treatment Phase||0
5279019|NCT00652626|12977573|P1|NOT COMPLETED|Initial Treatment Phase||0
5279020|NCT00652626|12977567|P7|COMPLETED|Initial Treatment Phase||0
5279021|NCT00652626|12977568|P6|COMPLETED|Initial Treatment Phase||0
5279022|NCT00652626|12977569|P5|COMPLETED|Initial Treatment Phase||5
5279023|NCT00652626|12977570|P4|COMPLETED|Initial Treatment Phase||5
5279024|NCT00652626|12977571|P3|COMPLETED|Initial Treatment Phase||6
5279025|NCT00652626|12977572|P2|COMPLETED|Initial Treatment Phase||5
5279026|NCT00652626|12977573|P1|COMPLETED|Initial Treatment Phase||5
5279027|NCT00652626|12977567|P7|Received Study Drug|Initial Treatment Phase||0
5279028|NCT00652626|12977568|P6|Received Study Drug|Initial Treatment Phase||0
5279029|NCT00652626|12977569|P5|Received Study Drug|Initial Treatment Phase||6
5279030|NCT00652626|12977570|P4|Received Study Drug|Initial Treatment Phase||5
5279031|NCT00652626|12977571|P3|Received Study Drug|Initial Treatment Phase||6
5279032|NCT00652626|12977572|P2|Received Study Drug|Initial Treatment Phase||5
5279033|NCT00652626|12977573|P1|Received Study Drug|Initial Treatment Phase||5
5279034|NCT00652626|12977567|P7|STARTED|Initial Treatment Phase||0
5279035|NCT00652626|12977568|P6|STARTED|Initial Treatment Phase||0
5279036|NCT00652626|12977569|P5|STARTED|Initial Treatment Phase||8
5279037|NCT00652626|12977570|P4|STARTED|Initial Treatment Phase||6
5279038|NCT00652626|12977571|P3|STARTED|Initial Treatment Phase||7
5279039|NCT00652626|12977572|P2|STARTED|Initial Treatment Phase||5
5279040|NCT00652626|12977573|P1|STARTED|Initial Treatment Phase||5
5279041|NCT00652366|12977642|P5|NOT COMPLETED|Overall Study||36
5279042|NCT00652366|12977643|P4|NOT COMPLETED|Overall Study||179
5279043|NCT00652366|12977644|P3|NOT COMPLETED|Overall Study||71
5279044|NCT00652366|12977645|P2|NOT COMPLETED|Overall Study||75
5279045|NCT00652366|12977646|P1|NOT COMPLETED|Overall Study||106
5279046|NCT00652366|12977642|P5|COMPLETED|Overall Study||0
5279047|NCT00652366|12977643|P4|COMPLETED|Overall Study||0
5279048|NCT00652366|12977644|P3|COMPLETED|Overall Study||0
5279049|NCT00652366|12977645|P2|COMPLETED|Overall Study||0
5279050|NCT00652366|12977646|P1|COMPLETED|Overall Study||0
5279051|NCT00652366|12977642|P5|STARTED|Overall Study||36
5279052|NCT00652366|12977643|P4|STARTED|Overall Study||179
5279053|NCT00652366|12977644|P3|STARTED|Overall Study||71
5279054|NCT00652366|12977645|P2|STARTED|Overall Study||75
5279055|NCT00652366|12977646|P1|STARTED|Overall Study||106
5279056|NCT00652340|12977681|P2|NOT COMPLETED|Overall Study||3
5279057|NCT00652340|12977682|P1|NOT COMPLETED|Overall Study||4
5279058|NCT00652340|12977681|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
5279059|NCT00652340|12977682|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
5279060|NCT00652340|12977681|P2|STARTED|Overall Study||42
5279061|NCT00652340|12977682|P1|STARTED|Overall Study||78
5279062|NCT00652327|12977692|P2|NOT COMPLETED|Overall Study||5
5279063|NCT00652327|12977693|P1|NOT COMPLETED|Overall Study||0
5279064|NCT00652327|12977692|P2|COMPLETED|Overall Study||36
5279065|NCT00652327|12977693|P1|COMPLETED|Overall Study||42
5279066|NCT00652327|12977692|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
5279067|NCT00652327|12977693|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
5279068|NCT00652314|12977701|P2|NOT COMPLETED|Overall Study||9
5279069|NCT00652314|12977702|P1|NOT COMPLETED|Overall Study||9
5279070|NCT00652314|12977701|P2|COMPLETED|Overall Study||26
5279071|NCT00652314|12977702|P1|COMPLETED|Overall Study||53
5279072|NCT00652314|12977701|P2|STARTED|Overall Study||35
5279073|NCT00652314|12977702|P1|STARTED|Overall Study||62
5279074|NCT00652145|12977718|P2|NOT COMPLETED|Overall Study||0
5279075|NCT00652145|12977719|P1|NOT COMPLETED|Overall Study||0
5279076|NCT00652145|12977718|P2|COMPLETED|Overall Study||26
5279077|NCT00652145|12977719|P1|COMPLETED|Overall Study||26
5279078|NCT00652145|12977718|P2|STARTED|Overall Study||26
5279079|NCT00652145|12977719|P1|STARTED|Overall Study||26
5279080|NCT00652093|12977735|P6|NOT COMPLETED|Overall Study||0
5279081|NCT00652093|12977736|P5|NOT COMPLETED|Overall Study||2
5279082|NCT00652093|12977737|P4|NOT COMPLETED|Overall Study||0
5279083|NCT00652093|12977738|P3|NOT COMPLETED|Overall Study||1
5279084|NCT00652093|12977739|P2|NOT COMPLETED|Overall Study||0
5279085|NCT00652093|12977740|P1|NOT COMPLETED|Overall Study||0
5279086|NCT00652093|12977735|P6|COMPLETED|Overall Study||4
5279087|NCT00652093|12977736|P5|COMPLETED|Overall Study||2
5279088|NCT00652093|12977737|P4|COMPLETED|Overall Study||4
5279089|NCT00652093|12977738|P3|COMPLETED|Overall Study||3
5279090|NCT00652093|12977739|P2|COMPLETED|Overall Study||4
5279091|NCT00652093|12977740|P1|COMPLETED|Overall Study||4
5279092|NCT00652093|12977735|P6|STARTED|Overall Study||4
5279093|NCT00652093|12977736|P5|STARTED|Overall Study||4
5279094|NCT00652093|12977737|P4|STARTED|Overall Study||4
5279095|NCT00652093|12977738|P3|STARTED|Overall Study||4
5279096|NCT00652093|12977739|P2|STARTED|Overall Study||4
5279097|NCT00652093|12977740|P1|STARTED|Overall Study||4
5279098|NCT00652080|12977820|P1|NOT COMPLETED|Overall Study||4
5279099|NCT00652080|12977820|P1|COMPLETED|Overall Study||31
5279100|NCT00652080|12977820|P1|STARTED|Overall Study||35
5279101|NCT00652028|12977830|P4|NOT COMPLETED|Overall Study||0
5279102|NCT00652028|12977831|P3|NOT COMPLETED|Overall Study||1
5279103|NCT00652028|12977832|P2|NOT COMPLETED|Overall Study||1
5279104|NCT00652028|12977833|P1|NOT COMPLETED|Overall Study||1
5279105|NCT00652028|12977830|P4|COMPLETED|Overall Study||14
5279106|NCT00652028|12977831|P3|COMPLETED|Overall Study||14
5279107|NCT00652028|12977832|P2|COMPLETED|Overall Study||13
5279108|NCT00652028|12977833|P1|COMPLETED|Overall Study||15
5279109|NCT00652028|12977830|P4|STARTED|Overall Study||14
5279110|NCT00652028|12977831|P3|STARTED|Overall Study||15
5279111|NCT00652028|12977832|P2|STARTED|Overall Study||14
5279112|NCT00652028|12977833|P1|STARTED|Overall Study||16
5279113|NCT00651937|12977877|P2|NOT COMPLETED|Overall Study||1
5279114|NCT00651937|12977878|P1|NOT COMPLETED|Overall Study||4
5279115|NCT00651937|12977877|P2|COMPLETED|Overall Study||40
5279116|NCT00651937|12977878|P1|COMPLETED|Overall Study||35
5279117|NCT00651937|12977877|P2|STARTED|Overall Study||41
5279118|NCT00651937|12977878|P1|STARTED|Overall Study||39
5279119|NCT00651924|12977888|P2|NOT COMPLETED|Overall Study||7
5279120|NCT00651924|12977889|P1|NOT COMPLETED|Overall Study||0
5279121|NCT00651924|12977888|P2|COMPLETED|Overall Study||2
5279122|NCT00651924|12977889|P1|COMPLETED|Overall Study||18
5279123|NCT00651924|12977888|P2|STARTED|Overall Study||9
5279124|NCT00651924|12977889|P1|STARTED|Overall Study||18
5279125|NCT00651820|12977895|P1|NOT COMPLETED|Overall Study||2
5279126|NCT00651820|12977895|P1|COMPLETED|Overall Study||26
5279127|NCT00651820|12977895|P1|STARTED|Overall Study||28
5279128|NCT00651794|12977905|P3|NOT COMPLETED|Overall Study||21
5279129|NCT00651794|12977906|P2|NOT COMPLETED|Overall Study||22
5279130|NCT00651794|12977907|P1|NOT COMPLETED|Overall Study||21
5279131|NCT00651794|12977905|P3|COMPLETED|Overall Study||10
5279132|NCT00651794|12977906|P2|COMPLETED|Overall Study||9
5279133|NCT00651794|12977907|P1|COMPLETED|Overall Study||15
5279134|NCT00651794|12977905|P3|STARTED|Overall Study||31
5279135|NCT00651794|12977906|P2|STARTED|Overall Study||31
5279136|NCT00651794|12977907|P1|STARTED|Overall Study||36
5279137|NCT00651755|12977927|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
5279138|NCT00651755|12977928|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
5279139|NCT00651755|12977927|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
5279140|NCT00651755|12977928|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
5279141|NCT00651755|12977927|P2|STARTED|Cycle 2 (Second 21 Days)||9
5279142|NCT00651755|12977928|P1|STARTED|Cycle 2 (Second 21 Days)||10
5279143|NCT00651755|12977927|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
5279144|NCT00651755|12977928|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
5279145|NCT00651755|12977927|P2|COMPLETED|Cycle 1 (First 21 Days)||9
5279146|NCT00651755|12977928|P1|COMPLETED|Cycle 1 (First 21 Days)||10
5279147|NCT00651755|12977927|P2|STARTED|Cycle 1 (First 21 Days)||9
5279148|NCT00651755|12977928|P1|STARTED|Cycle 1 (First 21 Days)||11
5279149|NCT00651664|12977954|P10|NOT COMPLETED|Overall Study||7
5279150|NCT00651664|12977955|P9|NOT COMPLETED|Overall Study||7
5279151|NCT00651664|12977956|P8|NOT COMPLETED|Overall Study||7
5279152|NCT00651664|12977957|P7|NOT COMPLETED|Overall Study||6
5279153|NCT00651664|12977958|P6|NOT COMPLETED|Overall Study||3
5279154|NCT00651664|12977959|P5|NOT COMPLETED|Overall Study||6
5279155|NCT00651664|12977960|P4|NOT COMPLETED|Overall Study||14
5279156|NCT00651664|12977961|P3|NOT COMPLETED|Overall Study||3
5279157|NCT00651664|12977962|P2|NOT COMPLETED|Overall Study||3
5279158|NCT00651664|12977963|P1|NOT COMPLETED|Overall Study||3
5279159|NCT00651664|12977954|P10|COMPLETED|Overall Study||0
5279160|NCT00651664|12977955|P9|COMPLETED|Overall Study||0
5279161|NCT00651664|12977956|P8|COMPLETED|Overall Study||0
5279162|NCT00651664|12977957|P7|COMPLETED|Overall Study||0
5279163|NCT00651664|12977958|P6|COMPLETED|Overall Study||0
5279164|NCT00651664|12977959|P5|COMPLETED|Overall Study||0
5279165|NCT00651664|12977960|P4|COMPLETED|Overall Study||0
5279166|NCT00651664|12977961|P3|COMPLETED|Overall Study||0
5279167|NCT00651664|12977962|P2|COMPLETED|Overall Study||0
5279168|NCT00651664|12977963|P1|COMPLETED|Overall Study||0
5279169|NCT00651664|12977954|P10|STARTED|Overall Study||7
5279170|NCT00651664|12977955|P9|STARTED|Overall Study||7
5279171|NCT00651664|12977956|P8|STARTED|Overall Study||7
5279172|NCT00651664|12977957|P7|STARTED|Overall Study||6
5279173|NCT00651664|12977958|P6|STARTED|Overall Study||3
5279174|NCT00651664|12977959|P5|STARTED|Overall Study||6
5279175|NCT00651664|12977960|P4|STARTED|Overall Study||14
5279176|NCT00651664|12977961|P3|STARTED|Overall Study||3
5279177|NCT00651664|12977962|P2|STARTED|Overall Study||3
5279178|NCT00651664|12977963|P1|STARTED|Overall Study||3
5279179|NCT00651625|12978089|P2|NOT COMPLETED|Overall Study||0
5279180|NCT00651625|12978090|P1|NOT COMPLETED|Overall Study||0
5279181|NCT00651625|12978089|P2|COMPLETED|Overall Study||218
5279182|NCT00651625|12978090|P1|COMPLETED|Overall Study||219
5279183|NCT00651625|12978089|P2|STARTED|Overall Study||218
5279184|NCT00651625|12978090|P1|STARTED|Overall Study||219
5279185|NCT00651573|12978104|P2|NOT COMPLETED|Overall Study||3
5279186|NCT00651573|12978105|P1|NOT COMPLETED|Overall Study||2
5279187|NCT00651573|12978104|P2|COMPLETED|Overall Study||354
5279188|NCT00651573|12978105|P1|COMPLETED|Overall Study||363
5279189|NCT00651573|12978104|P2|STARTED|Overall Study||357
5279190|NCT00651573|12978105|P1|STARTED|Overall Study||365
5279191|NCT00651482|12978121|P1|NOT COMPLETED|Overall Study||0
5279192|NCT00651482|12978121|P1|COMPLETED|Overall Study||10
5279193|NCT00651482|12978121|P1|STARTED|Overall Study||10
5279194|NCT00651313|12978135|P2|NOT COMPLETED|Overall Study||6
5279195|NCT00651313|12978136|P1|NOT COMPLETED|Overall Study||6
5279196|NCT00651313|12978135|P2|COMPLETED|Overall Study||37
5279197|NCT00651313|12978136|P1|COMPLETED|Overall Study||35
5279198|NCT00651313|12978135|P2|STARTED|Overall Study||43
5279199|NCT00651313|12978136|P1|STARTED|Overall Study||41
5279200|NCT00651261|12978144|P2|NOT COMPLETED|Overall Study||306
5279201|NCT00651261|12978145|P1|NOT COMPLETED|Overall Study||291
5279202|NCT00651261|12978144|P2|COMPLETED|Overall Study||51
5279203|NCT00651261|12978145|P1|COMPLETED|Overall Study||69
5279204|NCT00651261|12978144|P2|STARTED|Overall Study||357
5279205|NCT00651261|12978145|P1|STARTED|Overall Study||360
5279206|NCT00651183|12978161|P2|NOT COMPLETED|Overall Study||10
5279207|NCT00651183|12978162|P1|NOT COMPLETED|Overall Study||20
5279208|NCT00651183|12978161|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
5279209|NCT00651183|12978162|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
5279210|NCT00651183|12978161|P2|STARTED|Overall Study||97
5279211|NCT00651183|12978162|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
5279212|NCT00651157|12978174|P1|NOT COMPLETED|Overall Study||2
5279213|NCT00651157|12978174|P1|COMPLETED|Overall Study||21
5279214|NCT00651157|12978174|P1|STARTED|Overall Study||23
5279215|NCT00651118|12978184|P4|NOT COMPLETED|Overall Study||7
5279216|NCT00651118|12978185|P3|NOT COMPLETED|Overall Study||11
5279217|NCT00651118|12978186|P2|NOT COMPLETED|Overall Study||7
5279218|NCT00651118|12978187|P1|NOT COMPLETED|Overall Study||9
5279219|NCT00651118|12978184|P4|COMPLETED|Overall Study||203
5279220|NCT00651118|12978185|P3|COMPLETED|Overall Study||197
5279221|NCT00651118|12978186|P2|COMPLETED|Overall Study||200
5279222|NCT00651118|12978187|P1|COMPLETED|Overall Study||198
5279223|NCT00651118|12978184|P4|STARTED|Overall Study||210
5279224|NCT00651118|12978185|P3|STARTED|Overall Study||208
5279225|NCT00651118|12978186|P2|STARTED|Overall Study||207
5279226|NCT00651118|12978187|P1|STARTED|Overall Study||207
5279227|NCT00651040|12978207|P2|NOT COMPLETED|Overall Study||1
5279228|NCT00651040|12978208|P1|NOT COMPLETED|Overall Study||3
5279229|NCT00651040|12978207|P2|COMPLETED|Overall Study||14
5279230|NCT00651040|12978208|P1|COMPLETED|Overall Study||13
5279231|NCT00651040|12978207|P2|STARTED|Overall Study||15
5279232|NCT00651040|12978208|P1|STARTED|Overall Study||16
5279233|NCT00650936|12978214|P1|NOT COMPLETED|Overall Study||70
5279234|NCT00650936|12978214|P1|COMPLETED|Overall Study||930
5279235|NCT00650936|12978214|P1|STARTED|Overall Study||1000
5279236|NCT00650858|12978223|P3|NOT COMPLETED|Overall Study||0
5279237|NCT00650858|12978224|P2|NOT COMPLETED|Overall Study||0
5279238|NCT00650858|12978225|P1|NOT COMPLETED|Overall Study||0
5279239|NCT00650858|12978223|P3|COMPLETED|Overall Study||36
5279240|NCT00650858|12978224|P2|COMPLETED|Overall Study||8
5279241|NCT00650858|12978225|P1|COMPLETED|Overall Study||8
5279242|NCT00650858|12978223|P3|STARTED|Overall Study||36
5279243|NCT00650858|12978224|P2|STARTED|Overall Study||8
5279244|NCT00650858|12978225|P1|STARTED|Overall Study||8
5279245|NCT00650845|12978256|P2|NOT COMPLETED|Overall Study||13
5279246|NCT00650845|12978257|P1|NOT COMPLETED|Overall Study||5
5279247|NCT00650845|12978256|P2|COMPLETED|Overall Study||44
5279248|NCT00650845|12978257|P1|COMPLETED|Overall Study||70
5279249|NCT00650845|12978256|P2|STARTED|Overall Study||57
5279250|NCT00650845|12978257|P1|STARTED|Overall Study||75
5279251|NCT00650806|12978277|P4|NOT COMPLETED|Overall Study||26
5279252|NCT00650806|12978278|P3|NOT COMPLETED|Overall Study||29
5279253|NCT00650806|12978279|P2|NOT COMPLETED|Overall Study||21
5279254|NCT00650806|12978280|P1|NOT COMPLETED|Overall Study||18
5279255|NCT00650806|12978277|P4|COMPLETED|Overall Study||70
5279256|NCT00650806|12978278|P3|COMPLETED|Overall Study||64
5279257|NCT00650806|12978279|P2|COMPLETED|Overall Study||77
5279258|NCT00650806|12978280|P1|COMPLETED|Overall Study||71
5279259|NCT00650806|12978277|P4|STARTED|Overall Study||96
5279260|NCT00650806|12978278|P3|STARTED|Overall Study||93
5279261|NCT00650806|12978279|P2|STARTED|Overall Study||98
5279262|NCT00650806|12978280|P1|STARTED|Overall Study||89
5279263|NCT00650767|12978322|P4|NOT COMPLETED|Overall Study||11
5279264|NCT00650767|12978323|P3|NOT COMPLETED|Overall Study||14
5279265|NCT00650767|12978324|P2|NOT COMPLETED|Overall Study||9
5279266|NCT00650767|12978325|P1|NOT COMPLETED|Overall Study||5
5279267|NCT00650767|12978322|P4|COMPLETED|Overall Study||39
5279268|NCT00650767|12978323|P3|COMPLETED|Overall Study||36
5279269|NCT00650767|12978324|P2|COMPLETED|Overall Study||41
5279270|NCT00650767|12978325|P1|COMPLETED|Overall Study||46
5279271|NCT00650767|12978322|P4|STARTED|Overall Study||50
5279272|NCT00650767|12978323|P3|STARTED|Overall Study||50
5279273|NCT00650767|12978324|P2|STARTED|Overall Study||50
5279274|NCT00650767|12978325|P1|STARTED|Overall Study||51
5279275|NCT00650585|12978829|P2|NOT COMPLETED|Overall Study||1477
5279276|NCT00650585|12978830|P1|NOT COMPLETED|Overall Study||1797
5279277|NCT00650585|12978829|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
5279278|NCT00650585|12978830|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
5279279|NCT00650585|12978829|P2|STARTED|Overall Study||3990
5279280|NCT00650585|12978830|P1|STARTED|Overall Study||4348
5279281|NCT00650546|12978850|P1|NOT COMPLETED|Overall Study||0
5279282|NCT00650546|12978850|P1|COMPLETED|Overall Study||8
5279283|NCT00650546|12978850|P1|STARTED|Overall Study||8
5279284|NCT00650260|12978857|P2|NOT COMPLETED|Overall Study||0
5279285|NCT00650260|12978858|P1|NOT COMPLETED|Overall Study||0
5279286|NCT00650260|12978857|P2|COMPLETED|Overall Study||21
5279287|NCT00650260|12978858|P1|COMPLETED|Overall Study||21
5279288|NCT00650260|12978857|P2|STARTED|Overall Study||21
5279289|NCT00650260|12978858|P1|STARTED|Overall Study||21
5279290|NCT00650104|12978874|P1|NOT COMPLETED|Overall Study||41
5279291|NCT00650104|12978874|P1|COMPLETED|Overall Study||42
5279292|NCT00650104|12978874|P1|STARTED|Overall Study||83
5279293|NCT00650091|12978889|P3|NOT COMPLETED|Amended Study Design||0
5279294|NCT00650091|12978890|P2|NOT COMPLETED|Amended Study Design||20
5279295|NCT00650091|12978891|P1|NOT COMPLETED|Amended Study Design||23
5279296|NCT00650091|12978889|P3|COMPLETED|Amended Study Design||0
5279297|NCT00650091|12978890|P2|COMPLETED|Amended Study Design||111
5279298|NCT00650091|12978891|P1|COMPLETED|Amended Study Design||110
5279299|NCT00650091|12978889|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
5279300|NCT00650091|12978890|P2|STARTED|Amended Study Design||131
5279301|NCT00650091|12978891|P1|STARTED|Amended Study Design||133
5279302|NCT00650091|12978889|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
5279303|NCT00650091|12978890|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
5279304|NCT00650091|12978891|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
5279305|NCT00650091|12978889|P3|COMPLETED|Initial Study Design - Interim Analysis||77
5279306|NCT00650091|12978890|P2|COMPLETED|Initial Study Design - Interim Analysis||78
5279307|NCT00650091|12978891|P1|COMPLETED|Initial Study Design - Interim Analysis||81
5279308|NCT00650091|12978889|P3|STARTED|Initial Study Design - Interim Analysis||77
5279309|NCT00650091|12978890|P2|STARTED|Initial Study Design - Interim Analysis||78
5279310|NCT00650091|12978891|P1|STARTED|Initial Study Design - Interim Analysis||81
5279311|NCT00650078|12978911|P2|NOT COMPLETED|Overall Study||13
5279312|NCT00650078|12978912|P1|NOT COMPLETED|Overall Study||14
5279313|NCT00650078|12978911|P2|COMPLETED|Overall Study||106
5279314|NCT00650078|12978912|P1|COMPLETED|Overall Study||217
5279315|NCT00650078|12978911|P2|STARTED|Overall Study||119
5279316|NCT00650078|12978912|P1|STARTED|Overall Study||231
5279317|NCT00649961|12978920|P1|NOT COMPLETED|Overall Study||0
5279318|NCT00649961|12978920|P1|COMPLETED|Overall Study||18
5279319|NCT00649961|12978920|P1|STARTED|Overall Study||18
5279320|NCT00649792|12978924|P1|NOT COMPLETED|Overall Study||68
5279321|NCT00649792|12978924|P1|COMPLETED|Overall Study||146
5279322|NCT00649792|12978924|P1|STARTED|Overall Study||214
5279323|NCT00649428|12978934|P2|NOT COMPLETED|Overall Study||15
5279324|NCT00649428|12978935|P1|NOT COMPLETED|Overall Study||20
5279325|NCT00649428|12978934|P2|COMPLETED|Overall Study||88
5279326|NCT00649428|12978935|P1|COMPLETED|Overall Study||80
5279327|NCT00649428|12978934|P2|STARTED|Overall Study||103
5279328|NCT00649428|12978935|P1|STARTED|Overall Study||100
5279329|NCT00649389|12978951|P4|NOT COMPLETED|Overall Study||111
5279330|NCT00649389|12978952|P3|NOT COMPLETED|Overall Study||88
5279331|NCT00649389|12978953|P2|NOT COMPLETED|Overall Study||106
5279332|NCT00649389|12978954|P1|NOT COMPLETED|Overall Study||71
5279333|NCT00649389|12978951|P4|COMPLETED|Overall Study||516
5279334|NCT00649389|12978952|P3|COMPLETED|Overall Study||512
5279335|NCT00649389|12978953|P2|COMPLETED|Overall Study||531
5279336|NCT00649389|12978954|P1|COMPLETED|Overall Study||557
5279337|NCT00649389|12978951|P4|STARTED|Overall Study||627
5279338|NCT00649389|12978952|P3|STARTED|Overall Study||600
5279339|NCT00649389|12978953|P2|STARTED|Overall Study||637
5279340|NCT00649389|12978954|P1|STARTED|Overall Study||628
5279341|NCT00649220|12978976|P1|NOT COMPLETED|Overall Study||3
5279342|NCT00649220|12978976|P1|COMPLETED|Overall Study||16
5279343|NCT00649220|12978976|P1|STARTED|Overall Study||19
5279344|NCT00648908|12978987|P1|NOT COMPLETED|Overall Study||115
5279345|NCT00648908|12978987|P1|COMPLETED|Overall Study||154
5279346|NCT00648908|12978987|P1|STARTED|Overall Study||269
5279347|NCT00648895|12978997|P2|NOT COMPLETED|Overall Study||1
5279348|NCT00648895|12978998|P1|NOT COMPLETED|Overall Study||0
5279349|NCT00648895|12978997|P2|COMPLETED|Overall Study||5
5279350|NCT00648895|12978998|P1|COMPLETED|Overall Study||6
5279351|NCT00648895|12978997|P2|STARTED|Overall Study||6
5279352|NCT00648895|12978998|P1|STARTED|Overall Study||6
5279353|NCT00648739|12979004|P7|NOT COMPLETED|Overall Study||1
5279354|NCT00648739|12979005|P6|NOT COMPLETED|Overall Study||5
5279355|NCT00648739|12979006|P5|NOT COMPLETED|Overall Study||2
5279356|NCT00648739|12979007|P4|NOT COMPLETED|Overall Study||2
5279357|NCT00648739|12979008|P3|NOT COMPLETED|Overall Study||3
5279358|NCT00648739|12979009|P2|NOT COMPLETED|Overall Study||2
5279359|NCT00648739|12979010|P1|NOT COMPLETED|Overall Study||2
5279360|NCT00648739|12979004|P7|COMPLETED|Overall Study||0
5279361|NCT00648739|12979005|P6|COMPLETED|Overall Study||2
5279362|NCT00648739|12979006|P5|COMPLETED|Overall Study||1
5279363|NCT00648739|12979007|P4|COMPLETED|Overall Study||1
5279364|NCT00648739|12979008|P3|COMPLETED|Overall Study||0
5279365|NCT00648739|12979009|P2|COMPLETED|Overall Study||3
5279366|NCT00648739|12979010|P1|COMPLETED|Overall Study||2
5279367|NCT00648739|12979004|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
5279368|NCT00648739|12979005|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
5279369|NCT00648739|12979006|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
5279370|NCT00648739|12979007|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
5279371|NCT00648739|12979008|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
5279372|NCT00648739|12979009|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
5279373|NCT00648739|12979010|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
5279374|NCT00648739|12979004|P7|STARTED|Overall Study||1
5279375|NCT00648739|12979005|P6|STARTED|Overall Study||7
5279376|NCT00648739|12979006|P5|STARTED|Overall Study||3
5279377|NCT00648739|12979007|P4|STARTED|Overall Study||3
5279378|NCT00648739|12979008|P3|STARTED|Overall Study||3
5279379|NCT00648739|12979009|P2|STARTED|Overall Study||5
5279380|NCT00648739|12979010|P1|STARTED|Overall Study||4
5279381|NCT00648648|12979076|P28|NOT COMPLETED|Overall Study||12
5279382|NCT00648648|12979077|P27|NOT COMPLETED|Overall Study||26
5279383|NCT00648648|12979078|P26|NOT COMPLETED|Overall Study||4
5279384|NCT00648648|12979079|P25|NOT COMPLETED|Overall Study||4
5279385|NCT00648648|12979080|P24|NOT COMPLETED|Overall Study||4
5279386|NCT00648648|12979081|P23|NOT COMPLETED|Overall Study||14
5279387|NCT00648648|12979082|P22|NOT COMPLETED|Overall Study||10
5279388|NCT00648648|12979083|P21|NOT COMPLETED|Overall Study||6
5279389|NCT00648648|12979084|P20|NOT COMPLETED|Overall Study||7
5279390|NCT00648648|12979085|P19|NOT COMPLETED|Overall Study||5
5279391|NCT00648648|12979086|P18|NOT COMPLETED|Overall Study||6
5279392|NCT00648648|12979087|P17|NOT COMPLETED|Overall Study||14
5279393|NCT00648648|12979088|P16|NOT COMPLETED|Overall Study||11
5279394|NCT00648648|12979089|P15|NOT COMPLETED|Overall Study||4
5279395|NCT00648648|12979090|P14|NOT COMPLETED|Overall Study||5
5279396|NCT00648648|12979091|P13|NOT COMPLETED|Overall Study||6
5279397|NCT00648648|12979092|P12|NOT COMPLETED|Overall Study||13
5279398|NCT00648648|12979093|P11|NOT COMPLETED|Overall Study||6
5279399|NCT00648648|12979094|P10|NOT COMPLETED|Overall Study||10
5279400|NCT00648648|12979095|P9|NOT COMPLETED|Overall Study||3
5279401|NCT00648648|12979096|P8|NOT COMPLETED|Overall Study||1
5279402|NCT00648648|12979097|P7|NOT COMPLETED|Overall Study||10
5279403|NCT00648648|12979098|P6|NOT COMPLETED|Overall Study||1
5279404|NCT00648648|12979099|P5|NOT COMPLETED|Overall Study||9
5279405|NCT00648648|12979100|P4|NOT COMPLETED|Overall Study||4
5279406|NCT00648648|12979101|P3|NOT COMPLETED|Overall Study||0
5279407|NCT00648648|12979102|P2|NOT COMPLETED|Overall Study||0
5279408|NCT00648648|12979103|P1|NOT COMPLETED|Overall Study||0
5279409|NCT00648648|12979076|P28|COMPLETED|Overall Study||0
5279410|NCT00648648|12979077|P27|COMPLETED|Overall Study||0
5279411|NCT00648648|12979078|P26|COMPLETED|Overall Study||0
5279412|NCT00648648|12979079|P25|COMPLETED|Overall Study||0
5279413|NCT00648648|12979080|P24|COMPLETED|Overall Study||0
5279414|NCT00648648|12979081|P23|COMPLETED|Overall Study||0
5279415|NCT00648648|12979082|P22|COMPLETED|Overall Study||0
5279416|NCT00648648|12979083|P21|COMPLETED|Overall Study||0
5279417|NCT00648648|12979084|P20|COMPLETED|Overall Study||0
5279418|NCT00648648|12979085|P19|COMPLETED|Overall Study||0
5279419|NCT00648648|12979086|P18|COMPLETED|Overall Study||0
5279420|NCT00648648|12979087|P17|COMPLETED|Overall Study||2
5279421|NCT00648648|12979088|P16|COMPLETED|Overall Study||0
5279422|NCT00648648|12979089|P15|COMPLETED|Overall Study||0
5279423|NCT00648648|12979090|P14|COMPLETED|Overall Study||0
5279424|NCT00648648|12979091|P13|COMPLETED|Overall Study||0
5279425|NCT00648648|12979092|P12|COMPLETED|Overall Study||0
5279426|NCT00648648|12979093|P11|COMPLETED|Overall Study||0
5279427|NCT00648648|12979094|P10|COMPLETED|Overall Study||0
5279428|NCT00648648|12979095|P9|COMPLETED|Overall Study||0
5279429|NCT00648648|12979096|P8|COMPLETED|Overall Study||0
5279430|NCT00648648|12979097|P7|COMPLETED|Overall Study||0
5279431|NCT00648648|12979098|P6|COMPLETED|Overall Study||0
5279432|NCT00648648|12979099|P5|COMPLETED|Overall Study||0
5279433|NCT00648648|12979100|P4|COMPLETED|Overall Study||0
5279434|NCT00648648|12979101|P3|COMPLETED|Overall Study||3
5279435|NCT00648648|12979102|P2|COMPLETED|Overall Study||3
5279436|NCT00648648|12979103|P1|COMPLETED|Overall Study||3
5279437|NCT00648648|12979076|P28|Treated|Overall Study||12
5279438|NCT00648648|12979077|P27|Treated|Overall Study||26
5279439|NCT00648648|12979078|P26|Treated|Overall Study||4
5279440|NCT00648648|12979079|P25|Treated|Overall Study||4
5279441|NCT00648648|12979080|P24|Treated|Overall Study||4
5279442|NCT00648648|12979081|P23|Treated|Overall Study||14
5279443|NCT00648648|12979082|P22|Treated|Overall Study||10
5279444|NCT00648648|12979083|P21|Treated|Overall Study||6
5279445|NCT00648648|12979084|P20|Treated|Overall Study||7
5279446|NCT00648648|12979085|P19|Treated|Overall Study||4
5279447|NCT00648648|12979086|P18|Treated|Overall Study||6
5279448|NCT00648648|12979087|P17|Treated|Overall Study||16
5279449|NCT00648648|12979088|P16|Treated|Overall Study||11
5279450|NCT00648648|12979089|P15|Treated|Overall Study||4
5279451|NCT00648648|12979090|P14|Treated|Overall Study||5
5279452|NCT00648648|12979091|P13|Treated|Overall Study||6
5279453|NCT00648648|12979092|P12|Treated|Overall Study||13
5279454|NCT00648648|12979093|P11|Treated|Overall Study||6
5279455|NCT00648648|12979094|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
5279456|NCT00648648|12979095|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
5279457|NCT00648648|12979096|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
5279458|NCT00648648|12979097|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
5279459|NCT00648648|12979098|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
5279460|NCT00648648|12979099|P5|Treated|Overall Study||8
5279461|NCT00648648|12979100|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
5279462|NCT00648648|12979101|P3|Treated|Overall Study||3
5279463|NCT00648648|12979102|P2|Treated|Overall Study||3
5279464|NCT00648648|12979103|P1|Treated|Overall Study||3
5279465|NCT00648648|12979076|P28|STARTED|Overall Study||12
5279466|NCT00648648|12979077|P27|STARTED|Overall Study||26
5279467|NCT00648648|12979078|P26|STARTED|Overall Study||4
5279468|NCT00648648|12979079|P25|STARTED|Overall Study||4
5279469|NCT00648648|12979080|P24|STARTED|Overall Study||4
5279470|NCT00648648|12979081|P23|STARTED|Overall Study||14
5279471|NCT00648648|12979082|P22|STARTED|Overall Study||10
5279472|NCT00648648|12979083|P21|STARTED|Overall Study||6
5279473|NCT00648648|12979084|P20|STARTED|Overall Study||7
5279474|NCT00648648|12979085|P19|STARTED|Overall Study||5
5279475|NCT00648648|12979086|P18|STARTED|Overall Study||6
5279476|NCT00648648|12979087|P17|STARTED|Overall Study||16
5279477|NCT00648648|12979088|P16|STARTED|Overall Study||11
5279478|NCT00648648|12979089|P15|STARTED|Overall Study||4
5279479|NCT00648648|12979090|P14|STARTED|Overall Study||5
5279480|NCT00648648|12979091|P13|STARTED|Overall Study||6
5279481|NCT00648648|12979092|P12|STARTED|Overall Study||13
5279482|NCT00648648|12979093|P11|STARTED|Overall Study||6
5279483|NCT00648648|12979094|P10|STARTED|Overall Study||10
5279484|NCT00648648|12979095|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
5279485|NCT00648648|12979096|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
5279486|NCT00648648|12979097|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
5279487|NCT00648648|12979098|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
5279488|NCT00648648|12979099|P5|STARTED|Overall Study||9
5279489|NCT00648648|12979100|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
5279490|NCT00648648|12979101|P3|STARTED|Overall Study||3
5279491|NCT00648648|12979102|P2|STARTED|Overall Study||3
5279492|NCT00648648|12979103|P1|STARTED|Overall Study||3
5279493|NCT00648375|12979331|P2|NOT COMPLETED|Overall Study||0
5279494|NCT00648375|12979332|P1|NOT COMPLETED|Overall Study||0
5279495|NCT00648375|12979331|P2|COMPLETED|Overall Study||2
5279496|NCT00648375|12979332|P1|COMPLETED|Overall Study||1
5279497|NCT00648375|12979331|P2|STARTED|Overall Study||2
5279498|NCT00648375|12979332|P1|STARTED|Overall Study||1
5279499|NCT00648167|12979344|P1|NOT COMPLETED|Overall Study||7
5279500|NCT00648167|12979344|P1|COMPLETED|Overall Study||48
5279501|NCT00648167|12979344|P1|Start Dose 6 g/Day|Overall Study||21
5279502|NCT00648167|12979344|P1|Start Dose 4.5 g/Day|Overall Study||34
5279503|NCT00648167|12979344|P1|STARTED|Overall Study||55
5279504|NCT00648115|12979351|P3|NOT COMPLETED|Overall Study||0
5279505|NCT00648115|12979352|P2|NOT COMPLETED|Overall Study||0
5279506|NCT00648115|12979353|P1|NOT COMPLETED|Overall Study||0
5279507|NCT00648115|12979351|P3|COMPLETED|Overall Study||27
5279508|NCT00648115|12979352|P2|COMPLETED|Overall Study||42
5279509|NCT00648115|12979353|P1|COMPLETED|Overall Study||42
5279510|NCT00648115|12979351|P3|STARTED|Overall Study||27
5279511|NCT00648115|12979352|P2|STARTED|Overall Study||42
5279512|NCT00648115|12979353|P1|STARTED|Overall Study||42
5279513|NCT00648037|12979364|P1|NOT COMPLETED|Overall Study||16
5279514|NCT00648037|12979364|P1|COMPLETED|Overall Study||10
5279515|NCT00648037|12979364|P1|STARTED|Overall Study||26
5279516|NCT00647998|12979370|P2|NOT COMPLETED|Overall Study||0
5279517|NCT00647998|12979371|P1|NOT COMPLETED|Overall Study||0
5279518|NCT00647998|12979370|P2|COMPLETED|Overall Study||9
5279519|NCT00647998|12979371|P1|COMPLETED|Overall Study||9
5279520|NCT00647998|12979370|P2|STARTED|Overall Study||9
5279521|NCT00647998|12979371|P1|STARTED|Overall Study||9
5279522|NCT00647699|12979383|P2|NOT COMPLETED|Overall Study||12
5279523|NCT00647699|12979384|P1|NOT COMPLETED|Overall Study||8
5279524|NCT00647699|12979383|P2|COMPLETED|Overall Study||62
5279525|NCT00647699|12979384|P1|COMPLETED|Overall Study||65
5279526|NCT00647699|12979383|P2|STARTED|Overall Study||74
5279527|NCT00647699|12979384|P1|STARTED|Overall Study||73
5279528|NCT00647556|12979392|P2|NOT COMPLETED|Overall Study||2
5279529|NCT00647556|12979393|P1|NOT COMPLETED|Overall Study||3
5279530|NCT00647556|12979392|P2|COMPLETED|Overall Study||13
5279531|NCT00647556|12979393|P1|COMPLETED|Overall Study||12
5279532|NCT00647556|12979392|P2|STARTED|Overall Study||15
5279533|NCT00647556|12979393|P1|STARTED|Overall Study||15
5279534|NCT00647426|12979407|P1|NOT COMPLETED|Overall Study||2
5279535|NCT00647426|12979407|P1|COMPLETED|Overall Study||5
5279536|NCT00647426|12979407|P1|STARTED|Overall Study||7
5279537|NCT00647400|12979416|P2|NOT COMPLETED|Overall Study||13
5279538|NCT00647400|12979417|P1|NOT COMPLETED|Overall Study||22
5279539|NCT00647400|12979416|P2|COMPLETED|Overall Study||45
5279540|NCT00647400|12979417|P1|COMPLETED|Overall Study||67
5279541|NCT00647400|12979416|P2|STARTED|Overall Study||58
5279542|NCT00647400|12979417|P1|STARTED|Overall Study||89
5279543|NCT00647348|12979429|P2|NOT COMPLETED|Overall Study||6
5279544|NCT00647348|12979430|P1|NOT COMPLETED|Overall Study||3
5279545|NCT00647348|12979429|P2|COMPLETED|Overall Study||64
5279546|NCT00647348|12979430|P1|COMPLETED|Overall Study||67
5279547|NCT00647348|12979429|P2|STARTED|Overall Study||70
5279548|NCT00647348|12979430|P1|STARTED|Overall Study||70
5279549|NCT00647270|12979455|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
5279550|NCT00647270|12979456|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
5279551|NCT00647270|12979457|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
5279552|NCT00647270|12979455|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
5279553|NCT00647270|12979456|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
5279554|NCT00647270|12979457|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
5279555|NCT00647270|12979455|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
5279556|NCT00647270|12979456|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
5279557|NCT00647270|12979457|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
5279558|NCT00647270|12979455|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
5279559|NCT00647270|12979456|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
5279560|NCT00647270|12979457|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
5279561|NCT00647270|12979455|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
5279562|NCT00647270|12979456|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
5279563|NCT00647270|12979457|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
5279564|NCT00647270|12979455|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
5279565|NCT00647270|12979456|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
5279566|NCT00647270|12979457|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
5279567|NCT00646958|12979483|P3|NOT COMPLETED|Overall Study||9
5279568|NCT00646958|12979484|P2|NOT COMPLETED|Overall Study||9
5279569|NCT00646958|12979485|P1|NOT COMPLETED|Overall Study||11
5279570|NCT00646958|12979483|P3|COMPLETED|Overall Study||40
5279571|NCT00646958|12979484|P2|COMPLETED|Overall Study||41
5279572|NCT00646958|12979485|P1|COMPLETED|Overall Study||40
5279573|NCT00646958|12979483|P3|STARTED|Overall Study|No. Participants Randomized|49
5279574|NCT00646958|12979484|P2|STARTED|Overall Study|No. Participants Randomized|50
5279575|NCT00646958|12979485|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
5279576|NCT00646906|12979500|P7|NOT COMPLETED|Crossover Period 2||1
5279577|NCT00646906|12979501|P6|NOT COMPLETED|Crossover Period 2||0
5279578|NCT00646906|12979502|P5|NOT COMPLETED|Crossover Period 2||0
5279579|NCT00646906|12979503|P4|NOT COMPLETED|Crossover Period 2||1
5279580|NCT00646906|12979504|P3|NOT COMPLETED|Crossover Period 2||2
5279581|NCT00646906|12979505|P2|NOT COMPLETED|Crossover Period 2||1
5279582|NCT00646906|12979506|P1|NOT COMPLETED|Crossover Period 2||0
5279583|NCT00646906|12979500|P7|COMPLETED|Crossover Period 2||4
5279584|NCT00646906|12979501|P6|COMPLETED|Crossover Period 2||4
5279585|NCT00646906|12979502|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
5279586|NCT00646906|12979503|P4|COMPLETED|Crossover Period 2||8
5279587|NCT00646906|12979504|P3|COMPLETED|Crossover Period 2||8
5279588|NCT00646906|12979505|P2|COMPLETED|Crossover Period 2||8
5279589|NCT00646906|12979506|P1|COMPLETED|Crossover Period 2||8
5279590|NCT00646906|12979500|P7|STARTED|Crossover Period 2||5
5279591|NCT00646906|12979501|P6|STARTED|Crossover Period 2||4
5279592|NCT00646906|12979502|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
5279593|NCT00646906|12979503|P4|STARTED|Crossover Period 2||9
5279594|NCT00646906|12979504|P3|STARTED|Crossover Period 2||10
5279595|NCT00646906|12979505|P2|STARTED|Crossover Period 2||9
5279596|NCT00646906|12979506|P1|STARTED|Crossover Period 2||8
5279597|NCT00646906|12979500|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
5279598|NCT00646906|12979501|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
5279599|NCT00646906|12979502|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
5279600|NCT00646906|12979503|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
5279601|NCT00646906|12979504|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
5279602|NCT00646906|12979505|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
5279603|NCT00646906|12979506|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
5279604|NCT00646906|12979500|P7|COMPLETED|Washout (>/= 14 Days)||5
5279605|NCT00646906|12979501|P6|COMPLETED|Washout (>/= 14 Days)||4
5279606|NCT00646906|12979502|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
5279607|NCT00646906|12979503|P4|COMPLETED|Washout (>/= 14 Days)||9
5279608|NCT00646906|12979504|P3|COMPLETED|Washout (>/= 14 Days)||10
5279609|NCT00646906|12979505|P2|COMPLETED|Washout (>/= 14 Days)||9
5279610|NCT00646906|12979506|P1|COMPLETED|Washout (>/= 14 Days)||8
5279611|NCT00646906|12979500|P7|STARTED|Washout (>/= 14 Days)||5
5279612|NCT00646906|12979501|P6|STARTED|Washout (>/= 14 Days)||4
5279613|NCT00646906|12979502|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
5279614|NCT00646906|12979503|P4|STARTED|Washout (>/= 14 Days)||9
5279615|NCT00646906|12979504|P3|STARTED|Washout (>/= 14 Days)||10
5279616|NCT00646906|12979505|P2|STARTED|Washout (>/= 14 Days)||9
5279617|NCT00646906|12979506|P1|STARTED|Washout (>/= 14 Days)||8
5279618|NCT00646906|12979500|P7|NOT COMPLETED|Crossover Period 1||0
5279619|NCT00646906|12979501|P6|NOT COMPLETED|Crossover Period 1||1
5279620|NCT00646906|12979502|P5|NOT COMPLETED|Crossover Period 1||0
5279621|NCT00646906|12979503|P4|NOT COMPLETED|Crossover Period 1||0
5279622|NCT00646906|12979504|P3|NOT COMPLETED|Crossover Period 1||0
5279623|NCT00646906|12979505|P2|NOT COMPLETED|Crossover Period 1||0
5279624|NCT00646906|12979506|P1|NOT COMPLETED|Crossover Period 1||1
5279625|NCT00646906|12979500|P7|COMPLETED|Crossover Period 1||5
5279626|NCT00646906|12979501|P6|COMPLETED|Crossover Period 1||4
5279627|NCT00646906|12979502|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
5279628|NCT00646906|12979503|P4|COMPLETED|Crossover Period 1||9
5279629|NCT00646906|12979504|P3|COMPLETED|Crossover Period 1||10
5279630|NCT00646906|12979505|P2|COMPLETED|Crossover Period 1||9
5279631|NCT00646906|12979506|P1|COMPLETED|Crossover Period 1||8
5279632|NCT00646906|12979500|P7|STARTED|Crossover Period 1||5
5279633|NCT00646906|12979501|P6|STARTED|Crossover Period 1||5
5279634|NCT00646906|12979502|P5|STARTED|Crossover Period 1||8
5279635|NCT00646906|12979503|P4|STARTED|Crossover Period 1||9
5279636|NCT00646906|12979504|P3|STARTED|Crossover Period 1||10
5279637|NCT00646906|12979505|P2|STARTED|Crossover Period 1||9
5279638|NCT00646906|12979506|P1|STARTED|Crossover Period 1||9
5279639|NCT00646776|12979525|P2|NOT COMPLETED|Overall Study||13
5279640|NCT00646776|12979526|P1|NOT COMPLETED|Overall Study||1
5279641|NCT00646776|12979525|P2|COMPLETED|Overall Study||5
5279642|NCT00646776|12979526|P1|COMPLETED|Overall Study||14
5279643|NCT00646776|12979525|P2|STARTED|Overall Study|Treated on Day 1|18
5279644|NCT00646776|12979526|P1|STARTED|Overall Study|Treated on Day 1|15
5279645|NCT00646763|12979575|P2|NOT COMPLETED|Overall Study||0
5279646|NCT00646763|12979576|P1|NOT COMPLETED|Overall Study||0
5279647|NCT00646763|12979575|P2|COMPLETED|Overall Study||17
5279648|NCT00646763|12979576|P1|COMPLETED|Overall Study||18
5279649|NCT00646763|12979575|P2|STARTED|Overall Study||17
5279650|NCT00646763|12979576|P1|STARTED|Overall Study||18
5279651|NCT00646646|12979590|P4|NOT COMPLETED|Overall Study||0
5279652|NCT00646646|12979591|P3|NOT COMPLETED|Overall Study||0
5279653|NCT00646646|12979592|P2|NOT COMPLETED|Overall Study||0
5279654|NCT00646646|12979593|P1|NOT COMPLETED|Overall Study||0
5279655|NCT00646646|12979590|P4|COMPLETED|Overall Study||20
5279656|NCT00646646|12979591|P3|COMPLETED|Overall Study||15
5279657|NCT00646646|12979592|P2|COMPLETED|Overall Study||15
5279658|NCT00646646|12979593|P1|COMPLETED|Overall Study||15
5279659|NCT00646646|12979590|P4|STARTED|Overall Study||20
5279660|NCT00646646|12979591|P3|STARTED|Overall Study||15
5279661|NCT00646646|12979592|P2|STARTED|Overall Study||15
5279662|NCT00646646|12979593|P1|STARTED|Overall Study||15
5279663|NCT00646581|12979605|P2|NOT COMPLETED|Overall Study||0
5279664|NCT00646581|12979606|P1|NOT COMPLETED|Overall Study||0
5279665|NCT00646581|12979605|P2|COMPLETED|Overall Study||15
5279666|NCT00646581|12979606|P1|COMPLETED|Overall Study||15
5279667|NCT00646581|12979605|P2|STARTED|Overall Study||15
5279668|NCT00646581|12979606|P1|STARTED|Overall Study||15
5279669|NCT00646399|12979624|P2|NOT COMPLETED|Overall Study||74
5279670|NCT00646399|12979625|P1|NOT COMPLETED|Overall Study||83
5279671|NCT00646399|12979624|P2|COMPLETED|Overall Study||713
5279672|NCT00646399|12979625|P1|COMPLETED|Overall Study||709
5279673|NCT00646399|12979624|P2|STARTED|Overall Study||787
5279674|NCT00646399|12979625|P1|STARTED|Overall Study||792
5279675|NCT00646282|12979633|P2|NOT COMPLETED|Overall Study||4
5279676|NCT00646282|12979634|P1|NOT COMPLETED|Overall Study||4
5279677|NCT00646282|12979633|P2|COMPLETED|Overall Study||0
5279678|NCT00646282|12979634|P1|COMPLETED|Overall Study||0
5279679|NCT00646282|12979633|P2|STARTED|Overall Study||4
5279680|NCT00646282|12979634|P1|STARTED|Overall Study||4
5279681|NCT00646113|12979640|P1|NOT COMPLETED|Overall Study||8
5279682|NCT00646113|12979640|P1|COMPLETED|Overall Study||61
5279683|NCT00646113|12979640|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
5279684|NCT00646048|12979644|P1|NOT COMPLETED|Overall Study||16
5279685|NCT00646048|12979644|P1|COMPLETED|Overall Study||27
5279686|NCT00646048|12979644|P1|STARTED|Overall Study||43
5279687|NCT00645970|12979652|P2|NOT COMPLETED|Overall Study||186
5279688|NCT00645970|12979653|P1|NOT COMPLETED|Overall Study||109
5279689|NCT00645970|12979652|P2|COMPLETED|Overall Study||32
5279690|NCT00645970|12979653|P1|COMPLETED|Overall Study||32
5279691|NCT00645970|12979652|P2|1 Year|Overall Study||42
5279692|NCT00645970|12979653|P1|1 Year|Overall Study||37
5279693|NCT00645970|12979652|P2|6 Months|Overall Study||97
5279694|NCT00645970|12979653|P1|6 Months|Overall Study||58
5279695|NCT00645970|12979652|P2|STARTED|Overall Study||218
5279696|NCT00645970|12979653|P1|STARTED|Overall Study||141
5279697|NCT00645944|12979661|P2|NOT COMPLETED|Received Medication||3
5279698|NCT00645944|12979662|P1|NOT COMPLETED|Received Medication||6
5279699|NCT00645944|12979661|P2|COMPLETED|Received Medication||14
5279700|NCT00645944|12979662|P1|COMPLETED|Received Medication||13
5279701|NCT00645944|12979661|P2|STARTED|Received Medication||17
5279702|NCT00645944|12979662|P1|STARTED|Received Medication||19
5279703|NCT00645944|12979661|P2|NOT COMPLETED|Randomized||2
5279704|NCT00645944|12979662|P1|NOT COMPLETED|Randomized||1
5279705|NCT00645944|12979661|P2|COMPLETED|Randomized||17
5279706|NCT00645944|12979662|P1|COMPLETED|Randomized||19
5279707|NCT00645944|12979661|P2|STARTED|Randomized||19
5279708|NCT00645944|12979662|P1|STARTED|Randomized||20
5279709|NCT00645853|12979670|P2|NOT COMPLETED|Overall Study||57
5279710|NCT00645853|12979671|P1|NOT COMPLETED|Overall Study||92
5279711|NCT00645853|12979670|P2|COMPLETED|Overall Study||178
5279712|NCT00645853|12979671|P1|COMPLETED|Overall Study||196
5279713|NCT00645853|12979670|P2|AZ Study Closure in Hungary|Overall Study||40
5279714|NCT00645853|12979671|P1|AZ Study Closure in Hungary|Overall Study||60
5279715|NCT00645853|12979670|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
5279716|NCT00645853|12979671|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
5279717|NCT00645853|12979670|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
5279718|NCT00645853|12979671|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
5279719|NCT00645853|12979670|P2|STARTED|Overall Study||235
5279720|NCT00645853|12979671|P1|STARTED|Overall Study||288
5279721|NCT00645840|12979689|P1|NOT COMPLETED|Overall Study||3
5279722|NCT00645840|12979689|P1|COMPLETED|Overall Study||12
5279723|NCT00645840|12979689|P1|STARTED|Overall Study||15
5279724|NCT00645827|12979696|P2|NOT COMPLETED|Overall Study||0
5279725|NCT00645827|12979697|P1|NOT COMPLETED|Overall Study||0
5279726|NCT00645827|12979696|P2|COMPLETED|Overall Study||17
5279727|NCT00645827|12979697|P1|COMPLETED|Overall Study||14
5279728|NCT00645827|12979696|P2|STARTED|Overall Study||17
5279729|NCT00645827|12979697|P1|STARTED|Overall Study||14
5279730|NCT00645788|12979707|P4|NOT COMPLETED|Overall Study||14
5279731|NCT00645788|12979708|P3|NOT COMPLETED|Overall Study||18
5279732|NCT00645788|12979709|P2|NOT COMPLETED|Overall Study||27
5279733|NCT00645788|12979710|P1|NOT COMPLETED|Overall Study||20
5279734|NCT00645788|12979707|P4|COMPLETED|Overall Study||21
5279735|NCT00645788|12979708|P3|COMPLETED|Overall Study||47
5279736|NCT00645788|12979709|P2|COMPLETED|Overall Study||67
5279737|NCT00645788|12979710|P1|COMPLETED|Overall Study||74
5279738|NCT00645788|12979707|P4|Participants Receive Treatment|Overall Study||35
5279739|NCT00645788|12979708|P3|Participants Receive Treatment|Overall Study||65
5279740|NCT00645788|12979709|P2|Participants Receive Treatment|Overall Study||93
5279741|NCT00645788|12979710|P1|Participants Receive Treatment|Overall Study||93
5279742|NCT00645788|12979707|P4|STARTED|Overall Study||35
5279743|NCT00645788|12979708|P3|STARTED|Overall Study||65
5279744|NCT00645788|12979709|P2|STARTED|Overall Study||94
5279745|NCT00645788|12979710|P1|STARTED|Overall Study||94
5279746|NCT00645762|12979760|P1|NOT COMPLETED|Overall Study||4
5279747|NCT00645762|12979760|P1|COMPLETED|Overall Study||67
5279748|NCT00645762|12979760|P1|STARTED|Overall Study||71
5279749|NCT00645710|12979769|P3|NOT COMPLETED|Overall Study||0
5279750|NCT00645710|12979770|P2|NOT COMPLETED|Overall Study||0
5279751|NCT00645710|12979771|P1|NOT COMPLETED|Overall Study||0
5279752|NCT00645710|12979769|P3|COMPLETED|Overall Study||10
5279753|NCT00645710|12979770|P2|COMPLETED|Overall Study||3
5279754|NCT00645710|12979771|P1|COMPLETED|Overall Study||3
5279755|NCT00645710|12979769|P3|STARTED|Overall Study||10
5279756|NCT00645710|12979770|P2|STARTED|Overall Study||3
5279757|NCT00645710|12979771|P1|STARTED|Overall Study||3
5279758|NCT00645671|12979788|P2|NOT COMPLETED|Overall Study||6
5279759|NCT00645671|12979789|P1|NOT COMPLETED|Overall Study||1
5279760|NCT00645671|12979788|P2|COMPLETED|Overall Study||193
5279761|NCT00645671|12979789|P1|COMPLETED|Overall Study||200
5279762|NCT00645671|12979788|P2|STARTED|Overall Study||199
5279763|NCT00645671|12979789|P1|STARTED|Overall Study||201
5279764|NCT00645593|12979803|P2|NOT COMPLETED|Overall Study||0
5279765|NCT00645593|12979804|P1|NOT COMPLETED|Overall Study||1
5279766|NCT00645593|12979803|P2|COMPLETED|Overall Study||60
5279767|NCT00645593|12979804|P1|COMPLETED|Overall Study||28
5279768|NCT00645593|12979803|P2|STARTED|Overall Study||60
5279769|NCT00645593|12979804|P1|STARTED|Overall Study||29
5279770|NCT00645567|12979816|P1|NOT COMPLETED|Overall Study||1
5279771|NCT00645567|12979816|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
5279772|NCT00645567|12979816|P1|STARTED|Overall Study||5
5279773|NCT00645528|12979824|P1|NOT COMPLETED|Overall Study||7
5279774|NCT00645528|12979824|P1|COMPLETED|Overall Study||32
5279775|NCT00645528|12979824|P1|STARTED|Overall Study||39
5279776|NCT00645450|12979835|P2|NOT COMPLETED|Overall Study||0
5279777|NCT00645450|12979836|P1|NOT COMPLETED|Overall Study||0
5279778|NCT00645450|12979835|P2|COMPLETED|Overall Study||4
5279779|NCT00645450|12979836|P1|COMPLETED|Overall Study||5
5279780|NCT00645450|12979835|P2|STARTED|Overall Study||4
5279781|NCT00645450|12979836|P1|STARTED|Overall Study||5
5279782|NCT00645411|12979846|P4|NOT COMPLETED|Overall Study||103
5279783|NCT00645411|12979847|P3|NOT COMPLETED|Overall Study||151
5279784|NCT00645411|12979848|P2|NOT COMPLETED|Overall Study||6
5279785|NCT00645411|12979849|P1|NOT COMPLETED|Overall Study||13
5279786|NCT00645411|12979846|P4|COMPLETED|Overall Study||919
5279787|NCT00645411|12979847|P3|COMPLETED|Overall Study||1457
5279788|NCT00645411|12979848|P2|COMPLETED|Overall Study||312
5279789|NCT00645411|12979849|P1|COMPLETED|Overall Study||643
5279790|NCT00645411|12979846|P4|STARTED|Overall Study||1022
5279791|NCT00645411|12979847|P3|STARTED|Overall Study||1608
5279792|NCT00645411|12979848|P2|STARTED|Overall Study||318
5279793|NCT00645411|12979849|P1|STARTED|Overall Study||656
5279794|NCT00645359|12979881|P1|NOT COMPLETED|Overall Study||0
5279795|NCT00645359|12979881|P1|COMPLETED|Overall Study||9
5279796|NCT00645359|12979881|P1|STARTED|Overall Study||9
5279797|NCT00645333|12979886|P1|NOT COMPLETED|Overall Study||0
5279798|NCT00645333|12979886|P1|COMPLETED|Overall Study||30
5279799|NCT00645333|12979886|P1|STARTED|Overall Study||30
5279800|NCT00645164|12979891|P1|NOT COMPLETED|Overall Study||7
5279801|NCT00645164|12979891|P1|COMPLETED|Overall Study||52
5279802|NCT00645164|12979891|P1|STARTED|Overall Study||59
5279803|NCT00645099|12979897|P2|NOT COMPLETED|Overall Study||42
5279804|NCT00645099|12979898|P1|NOT COMPLETED|Overall Study||71
5279805|NCT00645099|12979897|P2|COMPLETED|Overall Study||178
5279806|NCT00645099|12979898|P1|COMPLETED|Overall Study||168
5279807|NCT00645099|12979897|P2|STARTED|Overall Study||220
5279808|NCT00645099|12979898|P1|STARTED|Overall Study||239
5279809|NCT00645047|12979942|P2|NOT COMPLETED|Overall Study||39
5279810|NCT00645047|12979943|P1|NOT COMPLETED|Overall Study||43
5279811|NCT00645047|12979942|P2|COMPLETED|Overall Study||65
5279812|NCT00645047|12979943|P1|COMPLETED|Overall Study|6 month follow up|60
5279813|NCT00645047|12979942|P2|Post|Overall Study||80
5279814|NCT00645047|12979943|P1|Post|Overall Study||74
5279815|NCT00645047|12979942|P2|STARTED|Overall Study||104
5279816|NCT00645047|12979943|P1|STARTED|Overall Study||103
5279817|NCT00644995|12979967|P2|NOT COMPLETED|Overall Study||4
5279818|NCT00644995|12979968|P1|NOT COMPLETED|Overall Study||2
5279819|NCT00644995|12979967|P2|COMPLETED|Overall Study||23
5279820|NCT00644995|12979968|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
5279821|NCT00644995|12979967|P2|Completed 4 Month Assessment|Overall Study||24
5279822|NCT00644995|12979968|P1|Completed 4 Month Assessment|Overall Study||23
5279823|NCT00644995|12979967|P2|STARTED|Overall Study||27
5279824|NCT00644995|12979968|P1|STARTED|Overall Study||25
5279825|NCT00644969|12979988|P2|NOT COMPLETED|Post Treatment Phase||3
5279826|NCT00644969|12979989|P1|NOT COMPLETED|Post Treatment Phase||10
5279827|NCT00644969|12979988|P2|COMPLETED|Post Treatment Phase||37
5279828|NCT00644969|12979989|P1|COMPLETED|Post Treatment Phase||61
5279829|NCT00644969|12979988|P2|STARTED|Post Treatment Phase||40
5279830|NCT00644969|12979989|P1|STARTED|Post Treatment Phase||71
5279831|NCT00644969|12979988|P2|NOT COMPLETED|Treatment Phase||3
5279832|NCT00644969|12979989|P1|NOT COMPLETED|Treatment Phase||14
5279833|NCT00644969|12979988|P2|COMPLETED|Treatment Phase||40
5279834|NCT00644969|12979989|P1|COMPLETED|Treatment Phase||71
5279835|NCT00644969|12979988|P2|STARTED|Treatment Phase||43
5279836|NCT00644969|12979989|P1|STARTED|Treatment Phase||85
5279837|NCT00644917|12980035|P1|NOT COMPLETED|Overall Study||2
5279838|NCT00644917|12980035|P1|COMPLETED|Overall Study||36
5279839|NCT00644917|12980035|P1|STARTED|Overall Study||38
5279840|NCT00644787|12980043|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
5279841|NCT00644787|12980044|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
5279842|NCT00644787|12980045|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
5279843|NCT00644787|12980043|P3|COMPLETED|Period 2: Double Blind Phase||55
5279844|NCT00644787|12980044|P2|COMPLETED|Period 2: Double Blind Phase||49
5279845|NCT00644787|12980045|P1|COMPLETED|Period 2: Double Blind Phase||0
5279846|NCT00644787|12980043|P3|STARTED|Period 2: Double Blind Phase||62
5279847|NCT00644787|12980044|P2|STARTED|Period 2: Double Blind Phase||58
5279848|NCT00644787|12980045|P1|STARTED|Period 2: Double Blind Phase||0
5279849|NCT00644787|12980043|P3|NOT COMPLETED|Period 1: Titration Phase||0
5279850|NCT00644787|12980044|P2|NOT COMPLETED|Period 1: Titration Phase||0
5279851|NCT00644787|12980045|P1|NOT COMPLETED|Period 1: Titration Phase||27
5279852|NCT00644787|12980043|P3|COMPLETED|Period 1: Titration Phase||0
5279853|NCT00644787|12980044|P2|COMPLETED|Period 1: Titration Phase||0
5279854|NCT00644787|12980045|P1|COMPLETED|Period 1: Titration Phase||129
5279855|NCT00644787|12980043|P3|STARTED|Period 1: Titration Phase||0
5279856|NCT00644787|12980044|P2|STARTED|Period 1: Titration Phase||0
5279857|NCT00644787|12980045|P1|STARTED|Period 1: Titration Phase||156
5279858|NCT00644657|12980073|P1|NOT COMPLETED|Overall Study||0
5279859|NCT00644657|12980073|P1|COMPLETED|Overall Study||27
5279860|NCT00644657|12980073|P1|STARTED|Overall Study||27
5279861|NCT00644592|12980080|P2|NOT COMPLETED|Overall Study||0
5279862|NCT00644592|12980081|P1|NOT COMPLETED|Overall Study||0
5279863|NCT00644592|12980080|P2|COMPLETED|Overall Study||6
5279864|NCT00644592|12980081|P1|COMPLETED|Overall Study||5
5279865|NCT00644592|12980080|P2|STARTED|Overall Study||6
5279866|NCT00644592|12980081|P1|STARTED|Overall Study||5
5279867|NCT00644423|12980089|P2|NOT COMPLETED|Overall Study||1
5279868|NCT00644423|12980090|P1|NOT COMPLETED|Overall Study||1
5279869|NCT00644423|12980089|P2|COMPLETED|Overall Study||4
5279870|NCT00644423|12980090|P1|COMPLETED|Overall Study||5
5279871|NCT00644423|12980089|P2|STARTED|Overall Study||5
5279872|NCT00644423|12980090|P1|STARTED|Overall Study||6
5279873|NCT00644358|12980108|P1|NOT COMPLETED|Overall Study||362
5279874|NCT00644358|12980108|P1|COMPLETED|Overall Study||254
5279875|NCT00644358|12980108|P1|STARTED|Overall Study||616
5279876|NCT00644332|12980115|P1|NOT COMPLETED|Overall Study||21
5279877|NCT00644332|12980115|P1|COMPLETED|Overall Study||150
5279878|NCT00644332|12980115|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
5279879|NCT00644280|12980130|P2|NOT COMPLETED|Overall Study||0
5279880|NCT00644280|12980131|P1|NOT COMPLETED|Overall Study||0
5279881|NCT00644280|12980130|P2|COMPLETED|Overall Study||5
5279882|NCT00644280|12980131|P1|COMPLETED|Overall Study||6
5279883|NCT00644280|12980130|P2|STARTED|Overall Study||5
5279884|NCT00644280|12980131|P1|STARTED|Overall Study||6
5279885|NCT00644228|12980141|P2|NOT COMPLETED|Maintenance||135
5279886|NCT00644228|12980142|P1|NOT COMPLETED|Maintenance||143
5279887|NCT00644228|12980141|P2|COMPLETED|Maintenance||0
5279888|NCT00644228|12980142|P1|COMPLETED|Maintenance||0
5279889|NCT00644228|12980141|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
5279890|NCT00644228|12980142|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
5279891|NCT00644228|12980141|P2|NOT COMPLETED|Induction Therapy||105
5279892|NCT00644228|12980142|P1|NOT COMPLETED|Induction Therapy||83
5279893|NCT00644228|12980141|P2|COMPLETED|Induction Therapy||137
5279894|NCT00644228|12980142|P1|COMPLETED|Induction Therapy||146
5279895|NCT00644228|12980141|P2|STARTED|Induction Therapy||242
5279896|NCT00644228|12980142|P1|STARTED|Induction Therapy||229
5279897|NCT00644228|12980141|P2|NOT COMPLETED|Randomization & Eligibility||22
5279898|NCT00644228|12980142|P1|NOT COMPLETED|Randomization & Eligibility||32
5279899|NCT00644228|12980141|P2|COMPLETED|Randomization & Eligibility||242
5279900|NCT00644228|12980142|P1|COMPLETED|Randomization & Eligibility||229
5279901|NCT00644228|12980141|P2|Eligible and Analyzable|Randomization & Eligibility||242
5279902|NCT00644228|12980142|P1|Eligible and Analyzable|Randomization & Eligibility||229
5279903|NCT00644228|12980141|P2|STARTED|Randomization & Eligibility||264
5279904|NCT00644228|12980142|P1|STARTED|Randomization & Eligibility||261
5279905|NCT00644189|12980152|P4|NOT COMPLETED|Phase II||0
5279906|NCT00644189|12980153|P3|NOT COMPLETED|Phase II||0
5279907|NCT00644189|12980154|P2|NOT COMPLETED|Phase II||0
5279908|NCT00644189|12980155|P1|NOT COMPLETED|Phase II||0
5279909|NCT00644189|12980152|P4|COMPLETED|Phase II||50
5279910|NCT00644189|12980153|P3|COMPLETED|Phase II||0
5279911|NCT00644189|12980154|P2|COMPLETED|Phase II||0
5279912|NCT00644189|12980155|P1|COMPLETED|Phase II||0
5279913|NCT00644189|12980152|P4|Completed All 6 Cycles of Treatment|Phase II||19
5279914|NCT00644189|12980153|P3|Completed All 6 Cycles of Treatment|Phase II||0
5279915|NCT00644189|12980154|P2|Completed All 6 Cycles of Treatment|Phase II||0
5279916|NCT00644189|12980155|P1|Completed All 6 Cycles of Treatment|Phase II||0
5279917|NCT00644189|12980152|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
5279918|NCT00644189|12980153|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
5279919|NCT00644189|12980154|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
5279920|NCT00644189|12980155|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
5279921|NCT00644189|12980152|P4|NOT COMPLETED|Phase I||0
5279922|NCT00644189|12980153|P3|NOT COMPLETED|Phase I||0
5279923|NCT00644189|12980154|P2|NOT COMPLETED|Phase I||0
5279924|NCT00644189|12980155|P1|NOT COMPLETED|Phase I||0
5279925|NCT00644189|12980152|P4|COMPLETED|Phase I||18
5279926|NCT00644189|12980153|P3|COMPLETED|Phase I||6
5279927|NCT00644189|12980154|P2|COMPLETED|Phase I||3
5279928|NCT00644189|12980155|P1|COMPLETED|Phase I||3
5279929|NCT00644189|12980152|P4|STARTED|Phase I||18
5279930|NCT00644189|12980153|P3|STARTED|Phase I||6
5279931|NCT00644189|12980154|P2|STARTED|Phase I||3
5279932|NCT00644189|12980155|P1|STARTED|Phase I||3
5279933|NCT00644059|12980171|P3|NOT COMPLETED|Overall Study||65
5279934|NCT00644059|12980172|P2|NOT COMPLETED|Overall Study||123
5279935|NCT00644059|12980173|P1|NOT COMPLETED|Overall Study||124
5279936|NCT00644059|12980171|P3|COMPLETED|Overall Study||969
5279937|NCT00644059|12980172|P2|COMPLETED|Overall Study||1726
5279938|NCT00644059|12980173|P1|COMPLETED|Overall Study||1895
5279939|NCT00644059|12980171|P3|STARTED|Overall Study||1034
5279940|NCT00644059|12980172|P2|STARTED|Overall Study||1849
5279941|NCT00644059|12980173|P1|STARTED|Overall Study||2019
5279942|NCT00643916|12980263|P6|NOT COMPLETED|Overall Study||1
5279943|NCT00643916|12980264|P5|NOT COMPLETED|Overall Study||2
5279944|NCT00643916|12980265|P4|NOT COMPLETED|Overall Study||2
5279945|NCT00643916|12980266|P3|NOT COMPLETED|Overall Study||6
5279946|NCT00643916|12980267|P2|NOT COMPLETED|Overall Study||6
5279947|NCT00643916|12980268|P1|NOT COMPLETED|Overall Study||4
5279948|NCT00643916|12980263|P6|COMPLETED|Overall Study||66
5279949|NCT00643916|12980264|P5|COMPLETED|Overall Study||57
5279950|NCT00643916|12980265|P4|COMPLETED|Overall Study||60
5279951|NCT00643916|12980266|P3|COMPLETED|Overall Study||62
5279952|NCT00643916|12980267|P2|COMPLETED|Overall Study||61
5279953|NCT00643916|12980268|P1|COMPLETED|Overall Study||51
5279954|NCT00643916|12980263|P6|STARTED|Overall Study||67
5279955|NCT00643916|12980264|P5|STARTED|Overall Study||59
5279956|NCT00643916|12980265|P4|STARTED|Overall Study||62
5279957|NCT00643916|12980266|P3|STARTED|Overall Study||68
5279958|NCT00643916|12980267|P2|STARTED|Overall Study||67
5279959|NCT00643916|12980268|P1|STARTED|Overall Study||55
5279960|NCT00643864|12980288|P1|NOT COMPLETED|Post-test Assessment||0
5279961|NCT00643864|12980288|P1|COMPLETED|Post-test Assessment||3
5279962|NCT00643864|12980288|P1|STARTED|Post-test Assessment||3
5279963|NCT00643864|12980288|P1|NOT COMPLETED|Pre-test Assessment||0
5279964|NCT00643864|12980288|P1|COMPLETED|Pre-test Assessment||3
5279965|NCT00643864|12980288|P1|STARTED|Pre-test Assessment||3
5279966|NCT00643851|12980297|P3|NOT COMPLETED|Overall Study||30
5279967|NCT00643851|12980298|P2|NOT COMPLETED|Overall Study||33
5279968|NCT00643851|12980299|P1|NOT COMPLETED|Overall Study||17
5279969|NCT00643851|12980297|P3|COMPLETED|Overall Study||171
5279970|NCT00643851|12980298|P2|COMPLETED|Overall Study||170
5279971|NCT00643851|12980299|P1|COMPLETED|Overall Study||177
5279972|NCT00643851|12980297|P3|STARTED|Overall Study||201
5279973|NCT00643851|12980298|P2|STARTED|Overall Study||203
5279974|NCT00643851|12980299|P1|STARTED|Overall Study||194
5279975|NCT00643760|12980327|P5|NOT COMPLETED|Overall Study||19
5279976|NCT00643760|12980328|P4|NOT COMPLETED|Overall Study||38
5279977|NCT00643760|12980329|P3|NOT COMPLETED|Overall Study||19
5279978|NCT00643760|12980330|P2|NOT COMPLETED|Overall Study||15
5279979|NCT00643760|12980331|P1|NOT COMPLETED|Overall Study||30
5279980|NCT00643760|12980327|P5|COMPLETED|Overall Study||47
5279981|NCT00643760|12980328|P4|COMPLETED|Overall Study||79
5279982|NCT00643760|12980329|P3|COMPLETED|Overall Study||37
5279983|NCT00643760|12980330|P2|COMPLETED|Overall Study||47
5279984|NCT00643760|12980331|P1|COMPLETED|Overall Study||90
5279985|NCT00643760|12980327|P5|ITT Population|Overall Study||66
5279986|NCT00643760|12980328|P4|ITT Population|Overall Study||116
5279987|NCT00643760|12980329|P3|ITT Population|Overall Study||56
5279988|NCT00643760|12980330|P2|ITT Population|Overall Study||62
5279989|NCT00643760|12980331|P1|ITT Population|Overall Study||120
5279990|NCT00643760|12980327|P5|Safety Population/Treated With Drug|Overall Study||66
5279991|NCT00643760|12980328|P4|Safety Population/Treated With Drug|Overall Study||116
5279992|NCT00643760|12980329|P3|Safety Population/Treated With Drug|Overall Study||56
5279993|NCT00643760|12980330|P2|Safety Population/Treated With Drug|Overall Study||62
5279994|NCT00643760|12980331|P1|Safety Population/Treated With Drug|Overall Study||120
5279995|NCT00643760|12980327|P5|STARTED|Overall Study||66
5279996|NCT00643760|12980328|P4|STARTED|Overall Study||117
5279997|NCT00643760|12980329|P3|STARTED|Overall Study||56
5279998|NCT00643760|12980330|P2|STARTED|Overall Study||62
5279999|NCT00643760|12980331|P1|STARTED|Overall Study||120
5280000|NCT00643682|12980435|P2|NOT COMPLETED|Overall Study||509
5280001|NCT00643682|12980436|P1|NOT COMPLETED|Overall Study||522
5280002|NCT00643682|12980435|P2|COMPLETED|Overall Study||492
5280003|NCT00643682|12980436|P1|COMPLETED|Overall Study||477
5280004|NCT00643682|12980435|P2|STARTED|Overall Study||1001
5280005|NCT00643682|12980436|P1|STARTED|Overall Study||999
5280006|NCT00643604|12980448|P1|NOT COMPLETED|Overall Study||1
5280007|NCT00643604|12980448|P1|COMPLETED|Overall Study||6
5280008|NCT00643604|12980448|P1|STARTED|Overall Study||7
5280009|NCT00643578|12980465|P2|NOT COMPLETED|Overall Study||0
5280010|NCT00643578|12980466|P1|NOT COMPLETED|Overall Study||2
5280011|NCT00643578|12980465|P2|COMPLETED|Overall Study||6
5280012|NCT00643578|12980466|P1|COMPLETED|Overall Study||4
5280013|NCT00643578|12980465|P2|STARTED|Overall Study||6
5280014|NCT00643578|12980466|P1|STARTED|Overall Study||6
5280015|NCT00643565|12980476|P2|NOT COMPLETED|Overall Study||67
5280016|NCT00643565|12980477|P1|NOT COMPLETED|Overall Study||73
5280017|NCT00643565|12980476|P2|COMPLETED|Overall Study||7
5280018|NCT00643565|12980477|P1|COMPLETED|Overall Study||7
5280019|NCT00643565|12980476|P2|STARTED|Overall Study||74
5280020|NCT00643565|12980477|P1|STARTED|Overall Study||80
5280021|NCT00643487|12980499|P1|NOT COMPLETED|Overall Study||3
5280022|NCT00643487|12980499|P1|COMPLETED|Overall Study||5
5280023|NCT00643487|12980499|P1|STARTED|Overall Study||8
5280024|NCT00643448|12980506|P3|NOT COMPLETED|Overall Study||6
5280025|NCT00643448|12980507|P2|NOT COMPLETED|Overall Study||5
5280026|NCT00643448|12980508|P1|NOT COMPLETED|Overall Study||4
5280027|NCT00643448|12980506|P3|COMPLETED|Overall Study||16
5280028|NCT00643448|12980507|P2|COMPLETED|Overall Study||17
5280029|NCT00643448|12980508|P1|COMPLETED|Overall Study||17
5280030|NCT00643448|12980506|P3|STARTED|Overall Study||22
5280031|NCT00643448|12980507|P2|STARTED|Overall Study||22
5280032|NCT00643448|12980508|P1|STARTED|Overall Study||21
5280033|NCT00643279|12980525|P2|NOT COMPLETED|Overall Study||13
5280034|NCT00643279|12980526|P1|NOT COMPLETED|Overall Study||16
5280035|NCT00643279|12980525|P2|COMPLETED|Overall Study||127
5280036|NCT00643279|12980526|P1|COMPLETED|Overall Study||118
5280037|NCT00643279|12980525|P2|STARTED|Overall Study||140
5280038|NCT00643279|12980526|P1|STARTED|Overall Study||134
5280039|NCT00643201|12980548|P2|NOT COMPLETED|Completed Study Follow Up||79
5280040|NCT00643201|12980549|P1|NOT COMPLETED|Completed Study Follow Up||70
5280041|NCT00643201|12980548|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
5280042|NCT00643201|12980549|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
5280043|NCT00643201|12980548|P2|STARTED|Completed Study Follow Up||2639
5280044|NCT00643201|12980549|P1|STARTED|Completed Study Follow Up||2617
5280045|NCT00643201|12980548|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
5280046|NCT00643201|12980549|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
5280047|NCT00643201|12980548|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
5280048|NCT00643201|12980549|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
5280049|NCT00643201|12980548|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
5280050|NCT00643201|12980549|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
5280051|NCT00643162|12980597|P2|NOT COMPLETED|Overall Study||1
5280052|NCT00643162|12980598|P1|NOT COMPLETED|Overall Study||1
5280053|NCT00643162|12980597|P2|COMPLETED|Overall Study||4
5280054|NCT00643162|12980598|P1|COMPLETED|Overall Study||6
5280055|NCT00643162|12980597|P2|STARTED|Overall Study||5
5280056|NCT00643162|12980598|P1|STARTED|Overall Study||7
5280057|NCT00643123|12980610|P2|NOT COMPLETED|Overall Study||1
5280058|NCT00643123|12980611|P1|NOT COMPLETED|Overall Study||5
5280059|NCT00643123|12980610|P2|COMPLETED|Overall Study||11
5280060|NCT00643123|12980611|P1|COMPLETED|Overall Study||10
5280061|NCT00643123|12980610|P2|STARTED|Overall Study||12
5280062|NCT00643123|12980611|P1|STARTED|Overall Study||15
5280063|NCT00643097|12980622|P3|NOT COMPLETED|Overall Study||0
5280064|NCT00643097|12980623|P2|NOT COMPLETED|Overall Study||0
5280065|NCT00643097|12980624|P1|NOT COMPLETED|Overall Study||0
5280066|NCT00643097|12980622|P3|COMPLETED|Overall Study||10
5280067|NCT00643097|12980623|P2|COMPLETED|Overall Study||12
5280068|NCT00643097|12980624|P1|COMPLETED|Overall Study||18
5280069|NCT00643097|12980622|P3|STARTED|Overall Study||10
5280070|NCT00643097|12980623|P2|STARTED|Overall Study||12
5280071|NCT00643097|12980624|P1|STARTED|Overall Study||18
5280072|NCT00643006|12980643|P2|NOT COMPLETED|Overall Study||4
5280073|NCT00643006|12980644|P1|NOT COMPLETED|Overall Study||5
5280074|NCT00643006|12980643|P2|COMPLETED|Overall Study||29
5280075|NCT00643006|12980644|P1|COMPLETED|Overall Study||29
5280076|NCT00643006|12980643|P2|STARTED|Overall Study||33
5280077|NCT00643006|12980644|P1|STARTED|Overall Study||34
5280078|NCT00642993|12980654|P2|NOT COMPLETED|Overall Study||16
5280079|NCT00642993|12980655|P1|NOT COMPLETED|Overall Study||106
5280080|NCT00642993|12980654|P2|COMPLETED|Overall Study||118
5280081|NCT00642993|12980655|P1|COMPLETED|Overall Study||161
5280082|NCT00642993|12980654|P2|STARTED|Overall Study||134
5280083|NCT00642993|12980655|P1|STARTED|Overall Study||267
5280084|NCT00642902|12980673|P4|NOT COMPLETED|Overall Study||40
5280085|NCT00642902|12980674|P3|NOT COMPLETED|Overall Study||43
5280086|NCT00642902|12980675|P2|NOT COMPLETED|Overall Study||42
5280087|NCT00642902|12980676|P1|NOT COMPLETED|Overall Study||40
5280088|NCT00642902|12980673|P4|COMPLETED|Overall Study||25
5280089|NCT00642902|12980674|P3|COMPLETED|Overall Study||21
5280090|NCT00642902|12980675|P2|COMPLETED|Overall Study||21
5280091|NCT00642902|12980676|P1|COMPLETED|Overall Study||23
5280092|NCT00642902|12980673|P4|Treated|Overall Study||65
5280093|NCT00642902|12980674|P3|Treated|Overall Study||63
5280094|NCT00642902|12980675|P2|Treated|Overall Study||63
5280095|NCT00642902|12980676|P1|Treated|Overall Study||63
5280096|NCT00642902|12980673|P4|STARTED|Overall Study||65
5280097|NCT00642902|12980674|P3|STARTED|Overall Study||64
5280098|NCT00642902|12980675|P2|STARTED|Overall Study||63
5280099|NCT00642902|12980676|P1|STARTED|Overall Study||63
5280100|NCT00642850|12980698|P1|NOT COMPLETED|Overall Study||33
5280101|NCT00642850|12980698|P1|COMPLETED|Overall Study||155
5280102|NCT00642850|12980698|P1|STARTED|Overall Study||188
5280103|NCT00642811|12980714|P6|NOT COMPLETED|Overall Study||1
5280104|NCT00642811|12980715|P5|NOT COMPLETED|Overall Study||1
5280105|NCT00642811|12980716|P4|NOT COMPLETED|Overall Study||1
5280106|NCT00642811|12980717|P3|NOT COMPLETED|Overall Study||0
5280107|NCT00642811|12980718|P2|NOT COMPLETED|Overall Study||4
5280108|NCT00642811|12980719|P1|NOT COMPLETED|Overall Study||3
5280109|NCT00642811|12980714|P6|COMPLETED|Overall Study||13
5280110|NCT00642811|12980715|P5|COMPLETED|Overall Study||13
5280111|NCT00642811|12980716|P4|COMPLETED|Overall Study||15
5280112|NCT00642811|12980717|P3|COMPLETED|Overall Study||13
5280113|NCT00642811|12980718|P2|COMPLETED|Overall Study||17
5280114|NCT00642811|12980719|P1|COMPLETED|Overall Study||17
5280115|NCT00642811|12980714|P6|STARTED|Overall Study||14
5280116|NCT00642811|12980715|P5|STARTED|Overall Study||14
5280117|NCT00642811|12980716|P4|STARTED|Overall Study||16
5280118|NCT00642811|12980717|P3|STARTED|Overall Study||13
5280119|NCT00642811|12980718|P2|STARTED|Overall Study||21
5280120|NCT00642811|12980719|P1|STARTED|Overall Study||20
5280121|NCT00642772|12980741|P1|NOT COMPLETED|Overall Study||10
5280122|NCT00642772|12980741|P1|COMPLETED|Overall Study||14
5280123|NCT00642772|12980741|P1|STARTED|Overall Study||24
5280124|NCT00642759|12980745|P1|NOT COMPLETED|Overall Study||1
5280125|NCT00642759|12980745|P1|COMPLETED|Overall Study||35
5280126|NCT00642759|12980745|P1|STARTED|Overall Study||36
5280127|NCT00642746|12980754|P2|NOT COMPLETED|Overall Study||0
5280128|NCT00642746|12980755|P1|NOT COMPLETED|Overall Study||1
5280129|NCT00642746|12980754|P2|COMPLETED|Overall Study||1
5280130|NCT00642746|12980755|P1|COMPLETED|Overall Study||9
5280131|NCT00642746|12980754|P2|STARTED|Overall Study||1
5280132|NCT00642746|12980755|P1|STARTED|Overall Study||10
5280133|NCT00642707|12980769|P4|NOT COMPLETED|Overall Study||2
5280134|NCT00642707|12980770|P3|NOT COMPLETED|Overall Study||0
5280135|NCT00642707|12980771|P2|NOT COMPLETED|Overall Study||0
5280136|NCT00642707|12980772|P1|NOT COMPLETED|Overall Study||1
5280137|NCT00642707|12980769|P4|COMPLETED|Overall Study||8
5280138|NCT00642707|12980770|P3|COMPLETED|Overall Study||12
5280139|NCT00642707|12980771|P2|COMPLETED|Overall Study||11
5280140|NCT00642707|12980772|P1|COMPLETED|Overall Study||10
5280141|NCT00642707|12980769|P4|STARTED|Overall Study||10
5280142|NCT00642707|12980770|P3|STARTED|Overall Study||12
5280143|NCT00642707|12980771|P2|STARTED|Overall Study||11
5280144|NCT00642707|12980772|P1|STARTED|Overall Study||11
5280145|NCT00642694|12980784|P2|NOT COMPLETED|Overall Study||4
5280146|NCT00642694|12980785|P1|NOT COMPLETED|Overall Study||6
5280147|NCT00642694|12980784|P2|COMPLETED|Overall Study||11
5280148|NCT00642694|12980785|P1|COMPLETED|Overall Study||8
5280149|NCT00642694|12980784|P2|STARTED|Overall Study||15
5280150|NCT00642694|12980785|P1|STARTED|Overall Study||14
5280151|NCT00642668|12980807|P1|NOT COMPLETED|Overall Study||14
5280152|NCT00642668|12980807|P1|COMPLETED|Overall Study||21
5280153|NCT00642668|12980807|P1|STARTED|Overall Study||35
5280154|NCT00642642|12980815|P1|NOT COMPLETED|Treatment & Follow Up||17
5280155|NCT00642642|12980815|P1|COMPLETED|Treatment & Follow Up||92
5280156|NCT00642642|12980815|P1|STARTED|Treatment & Follow Up||109
5280157|NCT00642642|12980815|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
5280158|NCT00642642|12980815|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
5280159|NCT00642642|12980815|P1|STARTED|Biopsy & Product Manufacture||122
5280160|NCT00642616|12980832|P4|NOT COMPLETED|Overall Study||7
5280161|NCT00642616|12980833|P3|NOT COMPLETED|Overall Study||9
5280162|NCT00642616|12980834|P2|NOT COMPLETED|Overall Study||7
5280163|NCT00642616|12980835|P1|NOT COMPLETED|Overall Study||9
5280164|NCT00642616|12980832|P4|COMPLETED|Overall Study||1
5280165|NCT00642616|12980833|P3|COMPLETED|Overall Study||0
5280166|NCT00642616|12980834|P2|COMPLETED|Overall Study||1
5280167|NCT00642616|12980835|P1|COMPLETED|Overall Study||0
5280168|NCT00642616|12980832|P4|STARTED|Overall Study||8
5280169|NCT00642616|12980833|P3|STARTED|Overall Study||9
5280170|NCT00642616|12980834|P2|STARTED|Overall Study||8
5280171|NCT00642616|12980835|P1|STARTED|Overall Study||9
5280172|NCT00642603|12980859|P2|NOT COMPLETED|Overall Study||18
5280173|NCT00642603|12980860|P1|NOT COMPLETED|Overall Study||21
5280174|NCT00642603|12980859|P2|COMPLETED|Overall Study||2
5280175|NCT00642603|12980860|P1|COMPLETED|Overall Study||0
5280176|NCT00642603|12980859|P2|Safety Population|Overall Study||20
5280177|NCT00642603|12980860|P1|Safety Population|Overall Study||19
5280178|NCT00642603|12980859|P2|STARTED|Overall Study||20
5280179|NCT00642603|12980860|P1|STARTED|Overall Study||21
5280180|NCT00642473|12980868|P2|NOT COMPLETED|Overall Study||11
5280181|NCT00642473|12980869|P1|NOT COMPLETED|Overall Study||4
5280182|NCT00642473|12980868|P2|COMPLETED|Overall Study||5
5280183|NCT00642473|12980869|P1|COMPLETED|Overall Study||14
5280184|NCT00642473|12980868|P2|STARTED|Overall Study||16
5280185|NCT00642473|12980869|P1|STARTED|Overall Study||18
5280186|NCT00642460|12980883|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
5280187|NCT00642460|12980884|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
5280188|NCT00642460|12980885|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
5280189|NCT00642460|12980886|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
5280190|NCT00642460|12980887|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
5280191|NCT00642460|12980888|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
5280192|NCT00642460|12980883|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
5280193|NCT00642460|12980884|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
5280194|NCT00642460|12980885|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
5280195|NCT00642460|12980886|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
5280196|NCT00642460|12980887|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
5280197|NCT00642460|12980888|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
5280198|NCT00642460|12980883|P6|STARTED|Part III: Open-Label Up to Week 260||59
5280199|NCT00642460|12980884|P5|STARTED|Part III: Open-Label Up to Week 260||53
5280200|NCT00642460|12980885|P4|STARTED|Part III: Open-Label Up to Week 260||0
5280201|NCT00642460|12980886|P3|STARTED|Part III: Open-Label Up to Week 260||0
5280202|NCT00642460|12980887|P2|STARTED|Part III: Open-Label Up to Week 260||0
5280203|NCT00642460|12980888|P1|STARTED|Part III: Open-Label Up to Week 260||0
5280204|NCT00642460|12980883|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
5280205|NCT00642460|12980884|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
5280206|NCT00642460|12980885|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
5280207|NCT00642460|12980886|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
5280208|NCT00642460|12980887|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
5280209|NCT00642460|12980888|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
5280210|NCT00642460|12980883|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
5280211|NCT00642460|12980884|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
5280212|NCT00642460|12980885|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
5280213|NCT00642460|12980886|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
5280214|NCT00642460|12980887|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
5280215|NCT00642460|12980888|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
5280216|NCT00642460|12980883|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
5280217|NCT00642460|12980884|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
5280218|NCT00642460|12980885|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
5280219|NCT00642460|12980886|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
5280220|NCT00642460|12980887|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
5280221|NCT00642460|12980888|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
5280222|NCT00642460|12980883|P6|STARTED|Part II: Open-Label Up to Week 92||0
5280223|NCT00642460|12980884|P5|STARTED|Part II: Open-Label Up to Week 92||0
5280224|NCT00642460|12980885|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
5280225|NCT00642460|12980886|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
5280226|NCT00642460|12980887|P2|STARTED|Part II: Open-Label Up to Week 92||40
5280227|NCT00642460|12980888|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
5280228|NCT00642460|12980883|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
5280229|NCT00642460|12980884|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
5280230|NCT00642460|12980885|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
5280231|NCT00642460|12980886|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
5280232|NCT00642460|12980887|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
5280233|NCT00642460|12980888|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
5280234|NCT00642460|12980883|P6|COMPLETED|Part I: 12 Week Double-Blind||0
5280235|NCT00642460|12980884|P5|COMPLETED|Part I: 12 Week Double-Blind||0
5280236|NCT00642460|12980885|P4|COMPLETED|Part I: 12 Week Double-Blind||0
5280237|NCT00642460|12980886|P3|COMPLETED|Part I: 12 Week Double-Blind||36
5280238|NCT00642460|12980887|P2|COMPLETED|Part I: 12 Week Double-Blind||37
5280239|NCT00642460|12980888|P1|COMPLETED|Part I: 12 Week Double-Blind||36
5280240|NCT00642460|12980883|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
5280241|NCT00642460|12980884|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
5280242|NCT00642460|12980885|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
5280243|NCT00642460|12980886|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
5280244|NCT00642460|12980887|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
5280245|NCT00642460|12980888|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
5280246|NCT00642460|12980883|P6|STARTED|Part I: 12 Week Double-Blind||0
5280247|NCT00642460|12980884|P5|STARTED|Part I: 12 Week Double-Blind||0
5280248|NCT00642460|12980885|P4|STARTED|Part I: 12 Week Double-Blind||0
5280249|NCT00642460|12980886|P3|STARTED|Part I: 12 Week Double-Blind||37
5280250|NCT00642460|12980887|P2|STARTED|Part I: 12 Week Double-Blind||38
5280251|NCT00642460|12980888|P1|STARTED|Part I: 12 Week Double-Blind||37
5280252|NCT00642382|12980954|P2|NOT COMPLETED|Overall Study||0
5280253|NCT00642382|12980955|P1|NOT COMPLETED|Overall Study||0
5280254|NCT00642382|12980954|P2|COMPLETED|Overall Study||0
5280255|NCT00642382|12980955|P1|COMPLETED|Overall Study||0
5280256|NCT00642382|12980954|P2|STARTED|Overall Study||0
5280257|NCT00642382|12980955|P1|STARTED|Overall Study||0
5280258|NCT00642369|12980963|P2|NOT COMPLETED|Overall Study||6
5280259|NCT00642369|12980964|P1|NOT COMPLETED|Overall Study||5
5280260|NCT00642369|12980963|P2|COMPLETED|Overall Study||24
5280261|NCT00642369|12980964|P1|COMPLETED|Overall Study||25
5280262|NCT00642369|12980963|P2|STARTED|Overall Study||30
5280263|NCT00642369|12980964|P1|STARTED|Overall Study||30
5280264|NCT00642356|12980974|P2|NOT COMPLETED|Overall Study||3
5280265|NCT00642356|12980975|P1|NOT COMPLETED|Overall Study||2
5280266|NCT00642356|12980974|P2|COMPLETED|Overall Study||4
5280267|NCT00642356|12980975|P1|COMPLETED|Overall Study||5
5280268|NCT00642356|12980974|P2|STARTED|Overall Study||7
5280269|NCT00642356|12980975|P1|STARTED|Overall Study||7
5280270|NCT00642304|12980983|P1|NOT COMPLETED|Overall Study||6
5280271|NCT00642304|12980983|P1|COMPLETED|Overall Study||14
5280272|NCT00642304|12980983|P1|STARTED|Overall Study||20
5280273|NCT00642278|12980999|P7|NOT COMPLETED|Overall Study||5
5280274|NCT00642278|12981000|P6|NOT COMPLETED|Overall Study||7
5280275|NCT00642278|12981001|P5|NOT COMPLETED|Overall Study||8
5280276|NCT00642278|12981002|P4|NOT COMPLETED|Overall Study||9
5280277|NCT00642278|12981003|P3|NOT COMPLETED|Overall Study||5
5280278|NCT00642278|12981004|P2|NOT COMPLETED|Overall Study||5
5280279|NCT00642278|12981005|P1|NOT COMPLETED|Overall Study||10
5280280|NCT00642278|12980999|P7|COMPLETED|Overall Study||60
5280281|NCT00642278|12981000|P6|COMPLETED|Overall Study||57
5280282|NCT00642278|12981001|P5|COMPLETED|Overall Study||56
5280283|NCT00642278|12981002|P4|COMPLETED|Overall Study||56
5280284|NCT00642278|12981003|P3|COMPLETED|Overall Study||59
5280285|NCT00642278|12981004|P2|COMPLETED|Overall Study||59
5280286|NCT00642278|12981005|P1|COMPLETED|Overall Study||55
5280287|NCT00642278|12980999|P7|STARTED|Overall Study||65
5280288|NCT00642278|12981000|P6|STARTED|Overall Study||64
5280289|NCT00642278|12981001|P5|STARTED|Overall Study||64
5280290|NCT00642278|12981002|P4|STARTED|Overall Study||65
5280291|NCT00642278|12981003|P3|STARTED|Overall Study||64
5280292|NCT00642278|12981004|P2|STARTED|Overall Study||64
5280293|NCT00642278|12981005|P1|STARTED|Overall Study||65
5280294|NCT00642174|12981058|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
5280295|NCT00642174|12981059|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
5280296|NCT00642174|12981058|P2|COMPLETED|Period 2 - Crossover Drug||16
5280297|NCT00642174|12981059|P1|COMPLETED|Period 2 - Crossover Drug||18
5280298|NCT00642174|12981058|P2|STARTED|Period 2 - Crossover Drug||16
5280299|NCT00642174|12981059|P1|STARTED|Period 2 - Crossover Drug||18
5280300|NCT00642174|12981058|P2|NOT COMPLETED|Period 1 - Initial Drug||1
5280301|NCT00642174|12981059|P1|NOT COMPLETED|Period 1 - Initial Drug||0
5280302|NCT00642174|12981058|P2|COMPLETED|Period 1 - Initial Drug||16
5280303|NCT00642174|12981059|P1|COMPLETED|Period 1 - Initial Drug||18
5280304|NCT00642174|12981058|P2|STARTED|Period 1 - Initial Drug||17
5280305|NCT00642174|12981059|P1|STARTED|Period 1 - Initial Drug||18
5280306|NCT00642018|12981075|P2|NOT COMPLETED|Overall Study||79
5280307|NCT00642018|12981076|P1|NOT COMPLETED|Overall Study||28
5280308|NCT00642018|12981075|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
5280309|NCT00642018|12981076|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
5280310|NCT00642018|12981075|P2|Received at Least One Dose of Study Drug|Overall Study||98
5280311|NCT00642018|12981076|P1|Received at Least One Dose of Study Drug|Overall Study||51
5280312|NCT00642018|12981075|P2|STARTED|Overall Study||102
5280313|NCT00642018|12981076|P1|STARTED|Overall Study||52
5280314|NCT00641862|12981106|P2|NOT COMPLETED|Overall Study||38
5280315|NCT00641862|12981107|P1|NOT COMPLETED|Overall Study||44
5280316|NCT00641862|12981106|P2|COMPLETED|Overall Study||145
5280317|NCT00641862|12981107|P1|COMPLETED|Overall Study||139
5280318|NCT00641862|12981106|P2|STARTED|Overall Study||183
5280319|NCT00641862|12981107|P1|STARTED|Overall Study||183
5280320|NCT00641797|12981125|P2|NOT COMPLETED|Overall Study||0
5280321|NCT00641797|12981126|P1|NOT COMPLETED|Overall Study||0
5280322|NCT00641797|12981125|P2|COMPLETED|Overall Study||15
5280323|NCT00641797|12981126|P1|COMPLETED|Overall Study||11
5280324|NCT00641797|12981125|P2|STARTED|Overall Study||15
5280325|NCT00641797|12981126|P1|STARTED|Overall Study||11
5280326|NCT00641745|12981134|P2|NOT COMPLETED|Overall Study||113
5280327|NCT00641745|12981135|P1|NOT COMPLETED|Overall Study||280
5280328|NCT00641745|12981134|P2|COMPLETED|Overall Study||89
5280329|NCT00641745|12981135|P1|COMPLETED|Overall Study||147
5280330|NCT00641745|12981134|P2|STARTED|Overall Study||202
5280331|NCT00641745|12981135|P1|STARTED|Overall Study||427
5280332|NCT00641719|12981143|P2|NOT COMPLETED|Overall Study||37
5280333|NCT00641719|12981144|P1|NOT COMPLETED|Overall Study||30
5280334|NCT00641719|12981143|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
5280335|NCT00641719|12981144|P1|COMPLETED|Overall Study||99
5280336|NCT00641719|12981143|P2|STARTED|Overall Study||129
5280337|NCT00641719|12981144|P1|STARTED|Overall Study||129
5280338|NCT00641706|12981168|P2|NOT COMPLETED|Overall Study||3
5280339|NCT00641706|12981169|P1|NOT COMPLETED|Overall Study||9
5280340|NCT00641706|12981168|P2|COMPLETED|Overall Study||4
5280341|NCT00641706|12981169|P1|COMPLETED|Overall Study||28
5280342|NCT00641706|12981168|P2|STARTED|Overall Study||7
5280343|NCT00641706|12981169|P1|STARTED|Overall Study||37
5280344|NCT00641667|12981181|P1|NOT COMPLETED|Overall Study||6
5280345|NCT00641667|12981181|P1|COMPLETED|Overall Study||60
5280346|NCT00641667|12981181|P1|STARTED|Overall Study||66
5280347|NCT00641641|12981191|P1|NOT COMPLETED|Overall Study||0
5280348|NCT00641641|12981191|P1|COMPLETED|Overall Study||16
5280349|NCT00641641|12981191|P1|STARTED|Overall Study||16
5280350|NCT00641563|12981195|P2|NOT COMPLETED|Infusion 2||0
5280351|NCT00641563|12981196|P1|NOT COMPLETED|Infusion 2||0
5280352|NCT00641563|12981195|P2|COMPLETED|Infusion 2||5
5280353|NCT00641563|12981196|P1|COMPLETED|Infusion 2||5
5280354|NCT00641563|12981195|P2|STARTED|Infusion 2||5
5280355|NCT00641563|12981196|P1|STARTED|Infusion 2||5
5280356|NCT00641563|12981195|P2|NOT COMPLETED|Infusion 1||0
5280357|NCT00641563|12981196|P1|NOT COMPLETED|Infusion 1||0
5280358|NCT00641563|12981195|P2|COMPLETED|Infusion 1||5
5280359|NCT00641563|12981196|P1|COMPLETED|Infusion 1||5
5280360|NCT00641563|12981195|P2|STARTED|Infusion 1||5
5280361|NCT00641563|12981196|P1|STARTED|Infusion 1||5
5280362|NCT00641537|12981209|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
5280363|NCT00641537|12981210|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
5280364|NCT00641537|12981211|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
5280365|NCT00641537|12981212|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
5280366|NCT00641537|12981213|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
5280367|NCT00641537|12981214|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
5280368|NCT00641537|12981215|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
5280369|NCT00641537|12981216|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
5280370|NCT00641537|12981209|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
5280371|NCT00641537|12981210|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
5280372|NCT00641537|12981211|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
5280373|NCT00641537|12981212|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
5280374|NCT00641537|12981213|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
5280375|NCT00641537|12981214|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
5280376|NCT00641537|12981215|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
5280377|NCT00641537|12981216|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
5280378|NCT00641537|12981209|P8|STARTED|24-Week Supplemental Follow-up Period||11
5280379|NCT00641537|12981210|P7|STARTED|24-Week Supplemental Follow-up Period||9
5280380|NCT00641537|12981211|P6|STARTED|24-Week Supplemental Follow-up Period||15
5280381|NCT00641537|12981212|P5|STARTED|24-Week Supplemental Follow-up Period||198
5280382|NCT00641537|12981213|P4|STARTED|24-Week Supplemental Follow-up Period||151
5280383|NCT00641537|12981214|P3|STARTED|24-Week Supplemental Follow-up Period||143
5280384|NCT00641537|12981215|P2|STARTED|24-Week Supplemental Follow-up Period||69
5280385|NCT00641537|12981216|P1|STARTED|24-Week Supplemental Follow-up Period||75
5280386|NCT00641537|12981209|P8|NOT COMPLETED|96-week Period||6
5280387|NCT00641537|12981210|P7|NOT COMPLETED|96-week Period||5
5280388|NCT00641537|12981211|P6|NOT COMPLETED|96-week Period||7
5280389|NCT00641537|12981212|P5|NOT COMPLETED|96-week Period||18
5280390|NCT00641537|12981213|P4|NOT COMPLETED|96-week Period||12
5280391|NCT00641537|12981214|P3|NOT COMPLETED|96-week Period||20
5280392|NCT00641537|12981215|P2|NOT COMPLETED|96-week Period||10
5280393|NCT00641537|12981216|P1|NOT COMPLETED|96-week Period||9
5280394|NCT00641537|12981209|P8|COMPLETED|96-week Period||16
5280395|NCT00641537|12981210|P7|COMPLETED|96-week Period||12
5280396|NCT00641537|12981211|P6|COMPLETED|96-week Period||15
5280397|NCT00641537|12981212|P5|COMPLETED|96-week Period||226
5280398|NCT00641537|12981213|P4|COMPLETED|96-week Period||174
5280399|NCT00641537|12981214|P3|COMPLETED|96-week Period||166
5280400|NCT00641537|12981215|P2|COMPLETED|96-week Period||82
5280401|NCT00641537|12981216|P1|COMPLETED|96-week Period||89
5280402|NCT00641537|12981209|P8|STARTED|96-week Period||22
5280403|NCT00641537|12981210|P7|STARTED|96-week Period||17
5280404|NCT00641537|12981211|P6|STARTED|96-week Period||22
5280405|NCT00641537|12981212|P5|STARTED|96-week Period||244
5280406|NCT00641537|12981213|P4|STARTED|96-week Period||186
5280407|NCT00641537|12981214|P3|STARTED|96-week Period||186
5280408|NCT00641537|12981215|P2|STARTED|96-week Period||92
5280409|NCT00641537|12981216|P1|STARTED|96-week Period||98
5280410|NCT00641147|12981271|P2|NOT COMPLETED|Completed 16 Months.||0
5280411|NCT00641147|12981272|P1|NOT COMPLETED|Completed 16 Months.||2
5280412|NCT00641147|12981271|P2|COMPLETED|Completed 16 Months.||19
5280413|NCT00641147|12981272|P1|COMPLETED|Completed 16 Months.||13
5280414|NCT00641147|12981271|P2|STARTED|Completed 16 Months.||19
5280415|NCT00641147|12981272|P1|STARTED|Completed 16 Months.||15
5280416|NCT00641147|12981271|P2|NOT COMPLETED|Completed 12 Months.||2
5280417|NCT00641147|12981272|P1|NOT COMPLETED|Completed 12 Months.||1
5280418|NCT00641147|12981271|P2|COMPLETED|Completed 12 Months.||19
5280419|NCT00641147|12981272|P1|COMPLETED|Completed 12 Months.||15
5280420|NCT00641147|12981271|P2|STARTED|Completed 12 Months.||21
5280421|NCT00641147|12981272|P1|STARTED|Completed 12 Months.||16
5280422|NCT00641147|12981271|P2|NOT COMPLETED|Completed 8 Months.||2
5280423|NCT00641147|12981272|P1|NOT COMPLETED|Completed 8 Months.||3
5280424|NCT00641147|12981271|P2|COMPLETED|Completed 8 Months.||21
5280425|NCT00641147|12981272|P1|COMPLETED|Completed 8 Months.||16
5280426|NCT00641147|12981271|P2|STARTED|Completed 8 Months.||23
5280427|NCT00641147|12981272|P1|STARTED|Completed 8 Months.||19
5280428|NCT00641147|12981271|P2|NOT COMPLETED|Completed 4 Months.||0
5280429|NCT00641147|12981272|P1|NOT COMPLETED|Completed 4 Months.||2
5280430|NCT00641147|12981271|P2|COMPLETED|Completed 4 Months.||23
5280431|NCT00641147|12981272|P1|COMPLETED|Completed 4 Months.||19
5280432|NCT00641147|12981271|P2|STARTED|Completed 4 Months.||23
5280433|NCT00641147|12981272|P1|STARTED|Completed 4 Months.||21
5280434|NCT00641108|12981316|P2|NOT COMPLETED|Overall Study||0
5280435|NCT00641108|12981317|P1|NOT COMPLETED|Overall Study||0
5280436|NCT00641108|12981316|P2|COMPLETED|Overall Study||0
5280437|NCT00641108|12981317|P1|COMPLETED|Overall Study||0
5280438|NCT00641108|12981316|P2|STARTED|Overall Study||0
5280439|NCT00641108|12981317|P1|STARTED|Overall Study||0
5280440|NCT00641056|12981325|P2|NOT COMPLETED|Overall Study||25
5280441|NCT00641056|12981326|P1|NOT COMPLETED|Overall Study||29
5280442|NCT00641056|12981325|P2|COMPLETED|Overall Study||209
5280443|NCT00641056|12981326|P1|COMPLETED|Overall Study||204
5280444|NCT00641056|12981325|P2|Intent to Treat (ITT)|Overall Study||223
5280445|NCT00641056|12981326|P1|Intent to Treat (ITT)|Overall Study||233
5280446|NCT00641056|12981325|P2|STARTED|Overall Study||234
5280447|NCT00641056|12981326|P1|STARTED|Overall Study||233
5280448|NCT00641043|12981354|P2|NOT COMPLETED|Overall Study||15
5280449|NCT00641043|12981355|P1|NOT COMPLETED|Overall Study||19
5280450|NCT00641043|12981354|P2|COMPLETED|Overall Study|number who completed treatment|244
5280451|NCT00641043|12981355|P1|COMPLETED|Overall Study|number who completed treatment|111
5280452|NCT00641043|12981354|P2|STARTED|Overall Study|number who started treatment|259
5280453|NCT00641043|12981355|P1|STARTED|Overall Study|number who started treatment|130
5280454|NCT00640978|12981385|P1|NOT COMPLETED|Overall Study||0
5280455|NCT00640978|12981385|P1|COMPLETED|Overall Study||15
5280456|NCT00640978|12981385|P1|STARTED|Overall Study||15
5280457|NCT00640926|12981392|P3|NOT COMPLETED|Overall Study||8
5280458|NCT00640926|12981393|P2|NOT COMPLETED|Overall Study||6
5280459|NCT00640926|12981394|P1|NOT COMPLETED|Overall Study||8
5280460|NCT00640926|12981392|P3|COMPLETED|Overall Study||45
5280461|NCT00640926|12981393|P2|COMPLETED|Overall Study||46
5280462|NCT00640926|12981394|P1|COMPLETED|Overall Study||45
5280463|NCT00640926|12981392|P3|STARTED|Overall Study||53
5280464|NCT00640926|12981393|P2|STARTED|Overall Study||52
5280465|NCT00640926|12981394|P1|STARTED|Overall Study||53
5280466|NCT00640835|12981407|P2|NOT COMPLETED|Overall Study||57
5280467|NCT00640835|12981408|P1|NOT COMPLETED|Overall Study||76
5280468|NCT00640835|12981407|P2|COMPLETED|Overall Study||131
5280469|NCT00640835|12981408|P1|COMPLETED|Overall Study||118
5280470|NCT00640835|12981407|P2|STARTED|Overall Study||188
5280471|NCT00640835|12981408|P1|STARTED|Overall Study||194
5280472|NCT00640822|12981419|P3|NOT COMPLETED|Overall Study||25
5280473|NCT00640822|12981420|P2|NOT COMPLETED|Overall Study||59
5280474|NCT00640822|12981421|P1|NOT COMPLETED|Overall Study||43
5280475|NCT00640822|12981419|P3|COMPLETED|Overall Study||77
5280476|NCT00640822|12981420|P2|COMPLETED|Overall Study||258
5280477|NCT00640822|12981421|P1|COMPLETED|Overall Study||279
5280478|NCT00640822|12981419|P3|STARTED|Overall Study||102
5280479|NCT00640822|12981420|P2|STARTED|Overall Study||317
5280480|NCT00640822|12981421|P1|STARTED|Overall Study||322
5280481|NCT00640653|12981434|P5|NOT COMPLETED|Overall Study||5
5280482|NCT00640653|12981435|P4|NOT COMPLETED|Overall Study||2
5280483|NCT00640653|12981436|P3|NOT COMPLETED|Overall Study||0
5280484|NCT00640653|12981437|P2|NOT COMPLETED|Overall Study||3
5280485|NCT00640653|12981438|P1|NOT COMPLETED|Overall Study||3
5280486|NCT00640653|12981434|P5|COMPLETED|Overall Study||129
5280487|NCT00640653|12981435|P4|COMPLETED|Overall Study||132
5280488|NCT00640653|12981436|P3|COMPLETED|Overall Study||129
5280489|NCT00640653|12981437|P2|COMPLETED|Overall Study||131
5280490|NCT00640653|12981438|P1|COMPLETED|Overall Study||128
5280491|NCT00640653|12981434|P5|Followed-up at 24 mo|Overall Study||112
5280492|NCT00640653|12981435|P4|Followed-up at 24 mo|Overall Study||112
5280493|NCT00640653|12981436|P3|Followed-up at 24 mo|Overall Study||105
5280494|NCT00640653|12981437|P2|Followed-up at 24 mo|Overall Study||116
5280495|NCT00640653|12981438|P1|Followed-up at 24 mo|Overall Study||114
5280496|NCT00640653|12981434|P5|Followed-up at 18 mo|Overall Study||117
5280497|NCT00640653|12981435|P4|Followed-up at 18 mo|Overall Study||117
5280498|NCT00640653|12981436|P3|Followed-up at 18 mo|Overall Study||113
5280499|NCT00640653|12981437|P2|Followed-up at 18 mo|Overall Study||112
5280500|NCT00640653|12981438|P1|Followed-up at 18 mo|Overall Study||118
5280501|NCT00640653|12981434|P5|Followed-up at 12 mo|Overall Study||116
5280502|NCT00640653|12981435|P4|Followed-up at 12 mo|Overall Study||122
5280503|NCT00640653|12981436|P3|Followed-up at 12 mo|Overall Study||115
5280504|NCT00640653|12981437|P2|Followed-up at 12 mo|Overall Study||121
5280505|NCT00640653|12981438|P1|Followed-up at 12 mo|Overall Study||124
5280506|NCT00640653|12981434|P5|Followed-up at 6 mo|Overall Study||125
5280507|NCT00640653|12981435|P4|Followed-up at 6 mo|Overall Study||130
5280508|NCT00640653|12981436|P3|Followed-up at 6 mo|Overall Study||124
5280509|NCT00640653|12981437|P2|Followed-up at 6 mo|Overall Study||130
5280510|NCT00640653|12981438|P1|Followed-up at 6 mo|Overall Study||127
5280511|NCT00640653|12981434|P5|Followed-up at 3 mo|Overall Study||126
5280512|NCT00640653|12981435|P4|Followed-up at 3 mo|Overall Study||129
5280513|NCT00640653|12981436|P3|Followed-up at 3 mo|Overall Study||125
5280514|NCT00640653|12981437|P2|Followed-up at 3 mo|Overall Study||127
5280515|NCT00640653|12981438|P1|Followed-up at 3 mo|Overall Study||126
5280516|NCT00640653|12981434|P5|STARTED|Overall Study||134
5280517|NCT00640653|12981435|P4|STARTED|Overall Study||134
5280518|NCT00640653|12981436|P3|STARTED|Overall Study||129
5280519|NCT00640653|12981437|P2|STARTED|Overall Study||134
5280520|NCT00640653|12981438|P1|STARTED|Overall Study||131
5280521|NCT00640614|12981472|P2|NOT COMPLETED|Overall Study||0
5280522|NCT00640614|12981473|P1|NOT COMPLETED|Overall Study||1
5280523|NCT00640614|12981472|P2|COMPLETED|Overall Study||110
5280524|NCT00640614|12981473|P1|COMPLETED|Overall Study||124
5280525|NCT00640614|12981472|P2|STARTED|Overall Study||110
5280526|NCT00640614|12981473|P1|STARTED|Overall Study||125
5280527|NCT00640601|12981515|P1|NOT COMPLETED|Overall Study||112
5280528|NCT00640601|12981515|P1|COMPLETED|Overall Study||183
5280529|NCT00640601|12981515|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
5280530|NCT00640562|12981531|P2|NOT COMPLETED|Overall Study||26
5280531|NCT00640562|12981532|P1|NOT COMPLETED|Overall Study||18
5280532|NCT00640562|12981531|P2|COMPLETED|Overall Study||81
5280533|NCT00640562|12981532|P1|COMPLETED|Overall Study||91
5280534|NCT00640562|12981531|P2|STARTED|Overall Study||107
5280535|NCT00640562|12981532|P1|STARTED|Overall Study||109
5280536|NCT00640510|12981560|P2|NOT COMPLETED|Overall Study||2
5280537|NCT00640510|12981561|P1|NOT COMPLETED|Overall Study||1
5280538|NCT00640510|12981560|P2|COMPLETED|Overall Study||15
5280539|NCT00640510|12981561|P1|COMPLETED|Overall Study||16
5280540|NCT00640510|12981560|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
5280541|NCT00640510|12981561|P1|STARTED|Overall Study||17
5280542|NCT00640393|12981573|P3|NOT COMPLETED|Part 2||3
5280543|NCT00640393|12981574|P2|NOT COMPLETED|Part 2||10
5280544|NCT00640393|12981575|P1|NOT COMPLETED|Part 2||0
5280545|NCT00640393|12981573|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
5280546|NCT00640393|12981574|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
5280547|NCT00640393|12981575|P1|COMPLETED|Part 2||0
5280548|NCT00640393|12981573|P3|STARTED|Part 2||38
5280549|NCT00640393|12981574|P2|STARTED|Part 2||37
5280550|NCT00640393|12981575|P1|STARTED|Part 2||0
5280551|NCT00640393|12981573|P3|NOT COMPLETED|Randomization||0
5280552|NCT00640393|12981574|P2|NOT COMPLETED|Randomization||0
5280553|NCT00640393|12981575|P1|NOT COMPLETED|Randomization||19
5280554|NCT00640393|12981573|P3|COMPLETED|Randomization||0
5280555|NCT00640393|12981574|P2|COMPLETED|Randomization||0
5280556|NCT00640393|12981575|P1|COMPLETED|Randomization||75
5280557|NCT00640393|12981573|P3|STARTED|Randomization||0
5280558|NCT00640393|12981574|P2|STARTED|Randomization||0
5280559|NCT00640393|12981575|P1|STARTED|Randomization||94
5280560|NCT00640393|12981573|P3|NOT COMPLETED|Part 1||0
5280561|NCT00640393|12981574|P2|NOT COMPLETED|Part 1||0
5280562|NCT00640393|12981575|P1|NOT COMPLETED|Part 1||5
5280563|NCT00640393|12981573|P3|COMPLETED|Part 1||0
5280564|NCT00640393|12981574|P2|COMPLETED|Part 1||0
5280565|NCT00640393|12981575|P1|COMPLETED|Part 1||94
5280566|NCT00640393|12981573|P3|STARTED|Part 1||0
5280567|NCT00640393|12981574|P2|STARTED|Part 1||0
5280568|NCT00640393|12981575|P1|STARTED|Part 1||99
5280569|NCT00640341|12981640|P3|NOT COMPLETED|Overall Study||7
5280570|NCT00640341|12981641|P2|NOT COMPLETED|Overall Study||5
5280571|NCT00640341|12981642|P1|NOT COMPLETED|Overall Study||21
5280572|NCT00640341|12981640|P3|COMPLETED|Overall Study||163
5280573|NCT00640341|12981641|P2|COMPLETED|Overall Study||165
5280574|NCT00640341|12981642|P1|COMPLETED|Overall Study||149
5280575|NCT00640341|12981640|P3|Eligible Participants at Baseline|Overall Study||168
5280576|NCT00640341|12981641|P2|Eligible Participants at Baseline|Overall Study||167
5280577|NCT00640341|12981642|P1|Eligible Participants at Baseline|Overall Study||165
5280578|NCT00640341|12981640|P3|STARTED|Overall Study||170
5280579|NCT00640341|12981641|P2|STARTED|Overall Study||170
5280580|NCT00640341|12981642|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
5280581|NCT00640328|12981662|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
5280582|NCT00640328|12981663|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
5280583|NCT00640328|12981664|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
5280584|NCT00640328|12981665|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
5280585|NCT00640328|12981666|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
5280586|NCT00640328|12981667|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
5280587|NCT00640328|12981662|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
5280588|NCT00640328|12981663|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
5280589|NCT00640328|12981664|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
5280590|NCT00640328|12981665|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
5280591|NCT00640328|12981666|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
5280592|NCT00640328|12981667|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
5280593|NCT00640328|12981662|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
5280594|NCT00640328|12981663|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
5280595|NCT00640328|12981664|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
5280596|NCT00640328|12981665|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
5280597|NCT00640328|12981666|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
5280598|NCT00640328|12981667|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
5280599|NCT00640328|12981662|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
5280600|NCT00640328|12981663|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
5280601|NCT00640328|12981664|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
5280602|NCT00640328|12981665|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
5280603|NCT00640328|12981666|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
5280604|NCT00640328|12981667|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
5280605|NCT00640328|12981662|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
5280606|NCT00640328|12981663|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
5280607|NCT00640328|12981664|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
5280608|NCT00640328|12981665|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
5280609|NCT00640328|12981666|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
5280610|NCT00640328|12981667|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
5280611|NCT00640328|12981662|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
5280612|NCT00640328|12981663|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
5280613|NCT00640328|12981664|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
5280614|NCT00640328|12981665|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
5280615|NCT00640328|12981666|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
5280616|NCT00640328|12981667|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
5280617|NCT00640328|12981662|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
5280618|NCT00640328|12981663|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
5280619|NCT00640328|12981664|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
5280620|NCT00640328|12981665|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
5280621|NCT00640328|12981666|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
5280622|NCT00640328|12981667|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
5280623|NCT00640328|12981662|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
5280624|NCT00640328|12981663|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
5280625|NCT00640328|12981664|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
5280626|NCT00640328|12981665|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
5280627|NCT00640328|12981666|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
5280628|NCT00640328|12981667|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
5280629|NCT00640328|12981662|P6|STARTED|First Treatment Period (Weeks 0-24)||4
5280630|NCT00640328|12981663|P5|STARTED|First Treatment Period (Weeks 0-24)||4
5280631|NCT00640328|12981664|P4|STARTED|First Treatment Period (Weeks 0-24)||4
5280632|NCT00640328|12981665|P3|STARTED|First Treatment Period (Weeks 0-24)||7
5280633|NCT00640328|12981666|P2|STARTED|First Treatment Period (Weeks 0-24)||11
5280634|NCT00640328|12981667|P1|STARTED|First Treatment Period (Weeks 0-24)||8
5280635|NCT00640315|12981833|P2|NOT COMPLETED|Overall Study||1
5280636|NCT00640315|12981834|P1|NOT COMPLETED|Overall Study||0
5280637|NCT00640315|12981833|P2|COMPLETED|Overall Study||12
5280638|NCT00640315|12981834|P1|COMPLETED|Overall Study||10
5280639|NCT00640315|12981833|P2|Participants Received Treatment|Overall Study||13
5280640|NCT00640315|12981834|P1|Participants Received Treatment|Overall Study||10
5280641|NCT00640315|12981833|P2|STARTED|Overall Study||13
5280642|NCT00640315|12981834|P1|STARTED|Overall Study||10
5280643|NCT00640289|12981960|P1|NOT COMPLETED|Overall Study||13
5280644|NCT00640289|12981960|P1|COMPLETED|Overall Study||59
5280645|NCT00640289|12981960|P1|STARTED|Overall Study||72
5280646|NCT00640250|12981965|P1|NOT COMPLETED|Overall Study||0
5280647|NCT00640250|12981965|P1|COMPLETED|Overall Study||48
5280648|NCT00640250|12981965|P1|STARTED|Overall Study||48
5280649|NCT00640224|12982072|P4|NOT COMPLETED|Overall Study||0
5280650|NCT00640224|12982073|P3|NOT COMPLETED|Overall Study||0
5280651|NCT00640224|12982074|P2|NOT COMPLETED|Overall Study||3
5280652|NCT00640224|12982075|P1|NOT COMPLETED|Overall Study||6
5280653|NCT00640224|12982072|P4|COMPLETED|Overall Study||0
5280654|NCT00640224|12982073|P3|COMPLETED|Overall Study||0
5280655|NCT00640224|12982074|P2|COMPLETED|Overall Study||20
5280656|NCT00640224|12982075|P1|COMPLETED|Overall Study||17
5280657|NCT00640224|12982072|P4|STARTED|Overall Study||0
5280658|NCT00640224|12982073|P3|STARTED|Overall Study||0
5280659|NCT00640224|12982074|P2|STARTED|Overall Study||23
5280660|NCT00640224|12982075|P1|STARTED|Overall Study||23
5280661|NCT00640146|12982175|P2|NOT COMPLETED|Overall Study||6
5280662|NCT00640146|12982176|P1|NOT COMPLETED|Overall Study||4
5280663|NCT00640146|12982175|P2|COMPLETED|Overall Study||12
5280664|NCT00640146|12982176|P1|COMPLETED|Overall Study||15
5280665|NCT00640146|12982175|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
5280666|NCT00640146|12982176|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
5280667|NCT00640146|12982175|P2|STARTED|Overall Study||18
5280668|NCT00640146|12982176|P1|STARTED|Overall Study||19
5280669|NCT00640133|12982188|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
5280670|NCT00640133|12982189|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
5280671|NCT00640133|12982188|P2|COMPLETED|Open Label Phase (Month 4-12)||0
5280672|NCT00640133|12982189|P1|COMPLETED|Open Label Phase (Month 4-12)||24
5280673|NCT00640133|12982188|P2|STARTED|Open Label Phase (Month 4-12)||0
5280674|NCT00640133|12982189|P1|STARTED|Open Label Phase (Month 4-12)||27
5280675|NCT00640133|12982188|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
5280676|NCT00640133|12982189|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
5280677|NCT00640133|12982188|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
5280678|NCT00640133|12982189|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
5280679|NCT00640133|12982188|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
5280680|NCT00640133|12982189|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
5280681|NCT00640042|12982209|P1|NOT COMPLETED|Treatment||926
5280682|NCT00640042|12982209|P1|COMPLETED|Treatment||561
5280683|NCT00640042|12982209|P1|STARTED|Treatment||1487
5280684|NCT00640042|12982209|P1|NOT COMPLETED|Enrollment||83
5280685|NCT00640042|12982209|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
5280686|NCT00640042|12982209|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
5280687|NCT00640016|12982225|P4|NOT COMPLETED|Overall Study||3
5280688|NCT00640016|12982226|P3|NOT COMPLETED|Overall Study||3
5280689|NCT00640016|12982227|P2|NOT COMPLETED|Overall Study||2
5280690|NCT00640016|12982228|P1|NOT COMPLETED|Overall Study||2
5280691|NCT00640016|12982225|P4|COMPLETED|Overall Study||1
5280692|NCT00640016|12982226|P3|COMPLETED|Overall Study||1
5280693|NCT00640016|12982227|P2|COMPLETED|Overall Study||1
5280694|NCT00640016|12982228|P1|COMPLETED|Overall Study||1
5280695|NCT00640016|12982225|P4|Treated|Overall Study||4
5280696|NCT00640016|12982226|P3|Treated|Overall Study||4
5280697|NCT00640016|12982227|P2|Treated|Overall Study||2
5280698|NCT00640016|12982228|P1|Treated|Overall Study||3
5280699|NCT00640016|12982225|P4|STARTED|Overall Study||4
5280700|NCT00640016|12982226|P3|STARTED|Overall Study||4
5280701|NCT00640016|12982227|P2|STARTED|Overall Study||3
5280702|NCT00640016|12982228|P1|STARTED|Overall Study||3
5280703|NCT00639860|12982272|P1|NOT COMPLETED|Overall Study||0
5280704|NCT00639860|12982272|P1|COMPLETED|Overall Study||10
5280705|NCT00639860|12982272|P1|STARTED|Overall Study||10
5280706|NCT00639769|12982280|P1|NOT COMPLETED|Overall Study||40
5280707|NCT00639769|12982280|P1|COMPLETED|Overall Study||0
5280708|NCT00639769|12982280|P1|STARTED|Overall Study||40
5280709|NCT00639717|12982285|P1|NOT COMPLETED|Overall Study||0
5280710|NCT00639717|12982285|P1|COMPLETED|Overall Study||48
5280711|NCT00639717|12982285|P1|STARTED|Overall Study||48
5280712|NCT00639678|12982297|P4|NOT COMPLETED|Overall Study||0
5280713|NCT00639678|12982298|P3|NOT COMPLETED|Overall Study||11
5280714|NCT00639678|12982299|P2|NOT COMPLETED|Overall Study||1
5280715|NCT00639678|12982300|P1|NOT COMPLETED|Overall Study||4
5280716|NCT00639678|12982297|P4|COMPLETED|Overall Study||23
5280717|NCT00639678|12982298|P3|COMPLETED|Overall Study||206
5280718|NCT00639678|12982299|P2|COMPLETED|Overall Study||5
5280719|NCT00639678|12982300|P1|COMPLETED|Overall Study||70
5280720|NCT00639678|12982297|P4|STARTED|Overall Study||23
5280721|NCT00639678|12982298|P3|STARTED|Overall Study||217
5280722|NCT00639678|12982299|P2|STARTED|Overall Study||6
5280723|NCT00639678|12982300|P1|STARTED|Overall Study||74
5280724|NCT00639626|12982360|P1|NOT COMPLETED|Overall Study||0
5280725|NCT00639626|12982360|P1|COMPLETED|Overall Study||0
5280726|NCT00639626|12982360|P1|STARTED|Overall Study||0
5280727|NCT00639509|12982365|P1|NOT COMPLETED|Overall Study||1
5280728|NCT00639509|12982365|P1|COMPLETED|Overall Study||23
5280729|NCT00639509|12982365|P1|STARTED|Overall Study||24
5280730|NCT00639457|12982373|P2|NOT COMPLETED|Overall Study||3
5280731|NCT00639457|12982374|P1|NOT COMPLETED|Overall Study||2
5280732|NCT00639457|12982373|P2|COMPLETED|Overall Study||19
5280733|NCT00639457|12982374|P1|COMPLETED|Overall Study||20
5280734|NCT00639457|12982373|P2|STARTED|Overall Study||22
5280735|NCT00639457|12982374|P1|STARTED|Overall Study||22
5280736|NCT00639418|12982412|P4|NOT COMPLETED|Overall Study||0
5280737|NCT00639418|12982413|P3|NOT COMPLETED|Overall Study||0
5280738|NCT00639418|12982414|P2|NOT COMPLETED|Overall Study||0
5280739|NCT00639418|12982415|P1|NOT COMPLETED|Overall Study||0
5280740|NCT00639418|12982412|P4|COMPLETED|Overall Study||46930
5280741|NCT00639418|12982413|P3|COMPLETED|Overall Study||36496
5280742|NCT00639418|12982414|P2|COMPLETED|Overall Study||35967
5280743|NCT00639418|12982415|P1|COMPLETED|Overall Study||28101
5280744|NCT00639418|12982412|P4|STARTED|Overall Study||46930
5280745|NCT00639418|12982413|P3|STARTED|Overall Study||36496
5280746|NCT00639418|12982414|P2|STARTED|Overall Study||35967
5280747|NCT00639418|12982415|P1|STARTED|Overall Study||28101
5280748|NCT00639379|12982433|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
5280749|NCT00639379|12982434|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
5280750|NCT00639379|12982433|P2|COMPLETED|Period 2 - 2 Weeks||45
5280751|NCT00639379|12982434|P1|COMPLETED|Period 2 - 2 Weeks||39
5280752|NCT00639379|12982433|P2|STARTED|Period 2 - 2 Weeks||45
5280753|NCT00639379|12982434|P1|STARTED|Period 2 - 2 Weeks||39
5280754|NCT00639379|12982433|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
5280755|NCT00639379|12982434|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
5280756|NCT00639379|12982433|P2|COMPLETED|Period 1 - 2 Weeks||45
5280757|NCT00639379|12982434|P1|COMPLETED|Period 1 - 2 Weeks||39
5280758|NCT00639379|12982433|P2|STARTED|Period 1 - 2 Weeks||45
5280759|NCT00639379|12982434|P1|STARTED|Period 1 - 2 Weeks||44
5280760|NCT00639223|12982450|P2|NOT COMPLETED|Overall Study||2
5280761|NCT00639223|12982451|P1|NOT COMPLETED|Overall Study||0
5280762|NCT00639223|12982450|P2|COMPLETED|Overall Study||19
5280763|NCT00639223|12982451|P1|COMPLETED|Overall Study||22
5280764|NCT00639223|12982450|P2|STARTED|Overall Study||21
5280765|NCT00639223|12982451|P1|STARTED|Overall Study||22
5280766|NCT00639158|12982461|P2|NOT COMPLETED|Overall Study||30
5280767|NCT00639158|12982462|P1|NOT COMPLETED|Overall Study||26
5280768|NCT00639158|12982461|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
5280769|NCT00639158|12982462|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
5280770|NCT00639158|12982461|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
5280771|NCT00639158|12982462|P1|STARTED|Overall Study|All randomized subjects were treated.|272
5280772|NCT00639093|12982484|P2|NOT COMPLETED|Overall Study||0
5280773|NCT00639093|12982485|P1|NOT COMPLETED|Overall Study||0
5280774|NCT00639093|12982484|P2|COMPLETED|Overall Study|46|46
5280775|NCT00639093|12982485|P1|COMPLETED|Overall Study|45|45
5280776|NCT00639093|12982484|P2|STARTED|Overall Study|46|46
5280777|NCT00639093|12982485|P1|STARTED|Overall Study|45|45
5280778|NCT00639002|12982491|P1|NOT COMPLETED|Overall Study||13
5280779|NCT00639002|12982491|P1|COMPLETED|Overall Study||0
5280780|NCT00639002|12982491|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
5280781|NCT00639002|12982491|P1|Received Ruxolitinib|Overall Study||13
5280782|NCT00639002|12982491|P1|STARTED|Overall Study||13
5280783|NCT00638989|12982500|P3|NOT COMPLETED|Overall Study||1
5280784|NCT00638989|12982501|P2|NOT COMPLETED|Overall Study||0
5280785|NCT00638989|12982502|P1|NOT COMPLETED|Overall Study||0
5280786|NCT00638989|12982500|P3|COMPLETED|Overall Study||9
5280787|NCT00638989|12982501|P2|COMPLETED|Overall Study||10
5280788|NCT00638989|12982502|P1|COMPLETED|Overall Study||10
5280789|NCT00638989|12982500|P3|STARTED|Overall Study||10
5280790|NCT00638989|12982501|P2|STARTED|Overall Study||10
5280791|NCT00638989|12982502|P1|STARTED|Overall Study||10
5280792|NCT00638963|12982542|P2|NOT COMPLETED|Overall Study||0
5280793|NCT00638963|12982543|P1|NOT COMPLETED|Overall Study||1
5280794|NCT00638963|12982542|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
5280795|NCT00638963|12982543|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
5280796|NCT00638963|12982542|P2|STARTED|Overall Study|Received randomized treatment assignment|3
5280797|NCT00638963|12982543|P1|STARTED|Overall Study|Received randomized treatment assignment|3
5280798|NCT00638937|12982562|P1|NOT COMPLETED|Overall Study||0
5280799|NCT00638937|12982562|P1|COMPLETED|Overall Study||37
5280800|NCT00638937|12982562|P1|STARTED|Overall Study||37
5280801|NCT00638924|12982573|P1|NOT COMPLETED|Overall Study||0
5280802|NCT00638924|12982573|P1|COMPLETED|Overall Study||40
5280803|NCT00638924|12982573|P1|2 Months|Overall Study||40
5280804|NCT00638924|12982573|P1|STARTED|Overall Study||40
5280805|NCT00638885|12982578|P1|NOT COMPLETED|Overall Study||0
5280806|NCT00638885|12982578|P1|COMPLETED|Overall Study||142
5280807|NCT00638885|12982578|P1|STARTED|Overall Study||142
5280808|NCT00638846|12982584|P2|NOT COMPLETED|Overall Study||6
5280809|NCT00638846|12982585|P1|NOT COMPLETED|Overall Study||4
5280810|NCT00638846|12982584|P2|COMPLETED|Overall Study||133
5280811|NCT00638846|12982585|P1|COMPLETED|Overall Study||133
5280812|NCT00638846|12982584|P2|STARTED|Overall Study||139
5280813|NCT00638846|12982585|P1|STARTED|Overall Study||137
5280814|NCT00638820|12982601|P1|NOT COMPLETED|Overall Study||0
5280815|NCT00638820|12982601|P1|COMPLETED|Overall Study||3
5280816|NCT00638820|12982601|P1|STARTED|Overall Study||3
5280817|NCT00638716|12982611|P3|NOT COMPLETED|Overall Study||12
5280818|NCT00638716|12982612|P2|NOT COMPLETED|Overall Study||15
5280819|NCT00638716|12982613|P1|NOT COMPLETED|Overall Study||7
5280820|NCT00638716|12982611|P3|COMPLETED|Overall Study||46
5280821|NCT00638716|12982612|P2|COMPLETED|Overall Study||37
5280822|NCT00638716|12982613|P1|COMPLETED|Overall Study||43
5280823|NCT00638716|12982611|P3|STARTED|Overall Study||58
5280824|NCT00638716|12982612|P2|STARTED|Overall Study||52
5280825|NCT00638716|12982613|P1|STARTED|Overall Study||50
5280826|NCT00638690|12982629|P2|NOT COMPLETED|Overall Study||342
5280827|NCT00638690|12982630|P1|NOT COMPLETED|Overall Study||681
5280828|NCT00638690|12982629|P2|COMPLETED|Overall Study||56
5280829|NCT00638690|12982630|P1|COMPLETED|Overall Study||116
5280830|NCT00638690|12982629|P2|STARTED|Overall Study||398
5280831|NCT00638690|12982630|P1|STARTED|Overall Study||797
5280832|NCT00638651|12982643|P1|NOT COMPLETED|Overall Study||0
5280833|NCT00638651|12982643|P1|COMPLETED|Overall Study||3
5280834|NCT00638651|12982643|P1|STARTED|Overall Study||3
5280835|NCT00638508|12982650|P2|NOT COMPLETED|Overall Study||2
5280836|NCT00638508|12982651|P1|NOT COMPLETED|Overall Study||5
5280837|NCT00638508|12982650|P2|COMPLETED|Overall Study||30
5280838|NCT00638508|12982651|P1|COMPLETED|Overall Study||30
5280839|NCT00638508|12982650|P2|STARTED|Overall Study||32
5280840|NCT00638508|12982651|P1|STARTED|Overall Study||35
5280841|NCT00638456|12982697|P2|NOT COMPLETED|Overall Study||2
5280842|NCT00638456|12982698|P1|NOT COMPLETED|Overall Study||6
5280843|NCT00638456|12982697|P2|COMPLETED|Overall Study||9
5280844|NCT00638456|12982698|P1|COMPLETED|Overall Study||15
5280845|NCT00638456|12982697|P2|STARTED|Overall Study||11
5280846|NCT00638456|12982698|P1|STARTED|Overall Study||21
5280847|NCT00638443|12982708|P2|NOT COMPLETED|Second Intervention||0
5280848|NCT00638443|12982709|P1|NOT COMPLETED|Second Intervention||0
5280849|NCT00638443|12982708|P2|COMPLETED|Second Intervention||14
5280850|NCT00638443|12982709|P1|COMPLETED|Second Intervention||12
5280851|NCT00638443|12982708|P2|STARTED|Second Intervention||14
5280852|NCT00638443|12982709|P1|STARTED|Second Intervention||12
5280853|NCT00638443|12982708|P2|NOT COMPLETED|Washout||0
5280854|NCT00638443|12982709|P1|NOT COMPLETED|Washout||0
5280855|NCT00638443|12982708|P2|COMPLETED|Washout||14
5280856|NCT00638443|12982709|P1|COMPLETED|Washout||12
5280857|NCT00638443|12982708|P2|STARTED|Washout||14
5280858|NCT00638443|12982709|P1|STARTED|Washout||12
5280859|NCT00638443|12982708|P2|NOT COMPLETED|First Intervention||1
5280860|NCT00638443|12982709|P1|NOT COMPLETED|First Intervention||2
5280861|NCT00638443|12982708|P2|COMPLETED|First Intervention||14
5280862|NCT00638443|12982709|P1|COMPLETED|First Intervention||12
5280863|NCT00638443|12982708|P2|STARTED|First Intervention||15
5280864|NCT00638443|12982709|P1|STARTED|First Intervention||14
5280865|NCT00638404|12982739|P2|NOT COMPLETED|Overall Study||0
5280866|NCT00638404|12982740|P1|NOT COMPLETED|Overall Study||8
5280867|NCT00638404|12982739|P2|COMPLETED|Overall Study||100
5280868|NCT00638404|12982740|P1|COMPLETED|Overall Study||192
5280869|NCT00638404|12982739|P2|STARTED|Overall Study||100
5280870|NCT00638404|12982740|P1|STARTED|Overall Study||200
5280871|NCT00638378|12982752|P1|NOT COMPLETED|Overall Study||22
5280872|NCT00638378|12982752|P1|COMPLETED|Overall Study||0
5280873|NCT00638378|12982752|P1|STARTED|Overall Study||22
5280874|NCT00638365|12982762|P3|NOT COMPLETED|Overall Study||0
5280875|NCT00638365|12982763|P2|NOT COMPLETED|Overall Study||0
5280876|NCT00638365|12982764|P1|NOT COMPLETED|Overall Study||0
5280877|NCT00638365|12982762|P3|COMPLETED|Overall Study||8
5280878|NCT00638365|12982763|P2|COMPLETED|Overall Study||10
5280879|NCT00638365|12982764|P1|COMPLETED|Overall Study||9
5280880|NCT00638365|12982762|P3|STARTED|Overall Study||8
5280881|NCT00638365|12982763|P2|STARTED|Overall Study||10
5280882|NCT00638365|12982764|P1|STARTED|Overall Study||9
5280883|NCT00638274|12982774|P2|NOT COMPLETED|Overall Study||5
5280884|NCT00638274|12982775|P1|NOT COMPLETED|Overall Study||6
5280885|NCT00638274|12982774|P2|COMPLETED|Overall Study||172
5280886|NCT00638274|12982775|P1|COMPLETED|Overall Study||173
5280887|NCT00638274|12982774|P2|STARTED|Overall Study||177
5280888|NCT00638274|12982775|P1|STARTED|Overall Study||179
5280889|NCT00638235|12982792|P9|NOT COMPLETED|Overall Study||18
5280890|NCT00638235|12982793|P8|NOT COMPLETED|Overall Study||1
5280891|NCT00638235|12982794|P7|NOT COMPLETED|Overall Study||0
5280892|NCT00638235|12982795|P6|NOT COMPLETED|Overall Study||26
5280893|NCT00638235|12982796|P5|NOT COMPLETED|Overall Study||13
5280894|NCT00638235|12982797|P4|NOT COMPLETED|Overall Study||10
5280895|NCT00638235|12982798|P3|NOT COMPLETED|Overall Study||18
5280896|NCT00638235|12982799|P2|NOT COMPLETED|Overall Study||3
5280897|NCT00638235|12982800|P1|NOT COMPLETED|Overall Study||31
5280898|NCT00638235|12982792|P9|COMPLETED|Overall Study||124
5280899|NCT00638235|12982793|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
5280900|NCT00638235|12982794|P7|COMPLETED|Overall Study||23
5280901|NCT00638235|12982795|P6|COMPLETED|Overall Study||113
5280902|NCT00638235|12982796|P5|COMPLETED|Overall Study||42
5280903|NCT00638235|12982797|P4|COMPLETED|Overall Study||46
5280904|NCT00638235|12982798|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
5280905|NCT00638235|12982799|P2|COMPLETED|Overall Study||23
5280906|NCT00638235|12982800|P1|COMPLETED|Overall Study||110
5280907|NCT00638235|12982792|P9|STARTED|Overall Study||142
5280908|NCT00638235|12982793|P8|STARTED|Overall Study||35
5280909|NCT00638235|12982794|P7|STARTED|Overall Study||23
5280910|NCT00638235|12982795|P6|STARTED|Overall Study||139
5280911|NCT00638235|12982796|P5|STARTED|Overall Study||55
5280912|NCT00638235|12982797|P4|STARTED|Overall Study||56
5280913|NCT00638235|12982798|P3|STARTED|Overall Study||81
5280914|NCT00638235|12982799|P2|STARTED|Overall Study||26
5280915|NCT00638235|12982800|P1|STARTED|Overall Study||141
5280916|NCT00638222|12983201|P3|NOT COMPLETED|Overall Study||0
5280917|NCT00638222|12983202|P2|NOT COMPLETED|Overall Study||0
5280918|NCT00638222|12983203|P1|NOT COMPLETED|Overall Study||0
5280919|NCT00638222|12983201|P3|COMPLETED|Overall Study||6
5280920|NCT00638222|12983202|P2|COMPLETED|Overall Study||0
5280921|NCT00638222|12983203|P1|COMPLETED|Overall Study||0
5280922|NCT00638222|12983201|P3|STARTED|Overall Study||6
5280923|NCT00638222|12983202|P2|STARTED|Overall Study||0
5280924|NCT00638222|12983203|P1|STARTED|Overall Study||0
5280925|NCT00638183|12983210|P1|NOT COMPLETED|Overall Study||119
5280926|NCT00638183|12983210|P1|COMPLETED|Overall Study||266
5280927|NCT00638183|12983210|P1|STARTED|Overall Study||385
5280928|NCT00638157|12983219|P2|NOT COMPLETED|Overall Study||4
5280929|NCT00638157|12983220|P1|NOT COMPLETED|Overall Study||7
5280930|NCT00638157|12983219|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
5280931|NCT00638157|12983220|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
5280932|NCT00638157|12983219|P2|Treated|Overall Study||12
5280933|NCT00638157|12983220|P1|Treated|Overall Study||10
5280934|NCT00638157|12983219|P2|STARTED|Overall Study||12
5280935|NCT00638157|12983220|P1|STARTED|Overall Study||12
5280936|NCT00638027|12983230|P2|NOT COMPLETED|Overall Study||2
5280937|NCT00638027|12983231|P1|NOT COMPLETED|Overall Study||0
5280938|NCT00638027|12983230|P2|COMPLETED|Overall Study|all 10 included in analyses|8
5280939|NCT00638027|12983231|P1|COMPLETED|Overall Study||11
5280940|NCT00638027|12983230|P2|STARTED|Overall Study||10
5280941|NCT00638027|12983231|P1|STARTED|Overall Study||11
5280942|NCT00638014|12983243|P2|NOT COMPLETED|Overall Study||0
5280943|NCT00638014|12983244|P1|NOT COMPLETED|Overall Study||0
5280944|NCT00638014|12983243|P2|COMPLETED|Overall Study||28
5280945|NCT00638014|12983244|P1|COMPLETED|Overall Study||23
5280946|NCT00638014|12983243|P2|STARTED|Overall Study||28
5280947|NCT00638014|12983244|P1|STARTED|Overall Study||23
5280948|NCT00637923|12983254|P2|NOT COMPLETED|Overall Study||19
5280949|NCT00637923|12983255|P1|NOT COMPLETED|Overall Study||30
5280950|NCT00637923|12983254|P2|COMPLETED|Overall Study||18
5280951|NCT00637923|12983255|P1|COMPLETED|Overall Study||45
5280952|NCT00637923|12983254|P2|STARTED|Overall Study||37
5280953|NCT00637923|12983255|P1|STARTED|Overall Study||75
5280954|NCT00637806|12983278|P4|NOT COMPLETED|Extension Phase||1
5280955|NCT00637806|12983279|P3|NOT COMPLETED|Extension Phase||0
5280956|NCT00637806|12983280|P2|NOT COMPLETED|Extension Phase||0
5280957|NCT00637806|12983281|P1|NOT COMPLETED|Extension Phase||0
5280958|NCT00637806|12983278|P4|COMPLETED|Extension Phase||0
5280959|NCT00637806|12983279|P3|COMPLETED|Extension Phase||0
5280960|NCT00637806|12983280|P2|COMPLETED|Extension Phase||0
5280961|NCT00637806|12983281|P1|COMPLETED|Extension Phase||0
5280962|NCT00637806|12983278|P4|STARTED|Extension Phase||1
5280963|NCT00637806|12983279|P3|STARTED|Extension Phase||0
5280964|NCT00637806|12983280|P2|STARTED|Extension Phase||0
5280965|NCT00637806|12983281|P1|STARTED|Extension Phase||0
5280966|NCT00637806|12983278|P4|NOT COMPLETED|Double-blind Phase||0
5280967|NCT00637806|12983279|P3|NOT COMPLETED|Double-blind Phase||1
5280968|NCT00637806|12983280|P2|NOT COMPLETED|Double-blind Phase||0
5280969|NCT00637806|12983281|P1|NOT COMPLETED|Double-blind Phase||2
5280970|NCT00637806|12983278|P4|COMPLETED|Double-blind Phase||0
5280971|NCT00637806|12983279|P3|COMPLETED|Double-blind Phase||1
5280972|NCT00637806|12983280|P2|COMPLETED|Double-blind Phase||0
5280973|NCT00637806|12983281|P1|COMPLETED|Double-blind Phase||0
5280974|NCT00637806|12983278|P4|STARTED|Double-blind Phase||0
5280975|NCT00637806|12983279|P3|STARTED|Double-blind Phase||2
5280976|NCT00637806|12983280|P2|STARTED|Double-blind Phase||0
5280977|NCT00637806|12983281|P1|STARTED|Double-blind Phase||2
5280978|NCT00637780|12983299|P1|NOT COMPLETED|Overall Study||0
5280979|NCT00637780|12983299|P1|COMPLETED|Overall Study||2
5280980|NCT00637780|12983299|P1|STARTED|Overall Study||2
5280981|NCT00637728|12983316|P3|NOT COMPLETED|Extension Phase||0
5280982|NCT00637728|12983317|P2|NOT COMPLETED|Extension Phase||0
5280983|NCT00637728|12983318|P1|NOT COMPLETED|Extension Phase||0
5280984|NCT00637728|12983316|P3|COMPLETED|Extension Phase||0
5280985|NCT00637728|12983317|P2|COMPLETED|Extension Phase||0
5280986|NCT00637728|12983318|P1|COMPLETED|Extension Phase||0
5280987|NCT00637728|12983316|P3|STARTED|Extension Phase||0
5280988|NCT00637728|12983317|P2|STARTED|Extension Phase||0
5280989|NCT00637728|12983318|P1|STARTED|Extension Phase||0
5280990|NCT00637728|12983316|P3|NOT COMPLETED|Double-blind Phase||0
5280991|NCT00637728|12983317|P2|NOT COMPLETED|Double-blind Phase||1
5280992|NCT00637728|12983318|P1|NOT COMPLETED|Double-blind Phase||4
5280993|NCT00637728|12983316|P3|COMPLETED|Double-blind Phase||0
5280994|NCT00637728|12983317|P2|COMPLETED|Double-blind Phase||0
5280995|NCT00637728|12983318|P1|COMPLETED|Double-blind Phase||0
5280996|NCT00637728|12983316|P3|STARTED|Double-blind Phase||0
5280997|NCT00637728|12983317|P2|STARTED|Double-blind Phase||1
5280998|NCT00637728|12983318|P1|STARTED|Double-blind Phase||4
5280999|NCT00637572|12983333|P2|NOT COMPLETED|Overall Study||7
5281000|NCT00637572|12983334|P1|NOT COMPLETED|Overall Study||3
5281001|NCT00637572|12983333|P2|COMPLETED|Overall Study||24
5281002|NCT00637572|12983334|P1|COMPLETED|Overall Study||29
5281003|NCT00637572|12983333|P2|STARTED|Overall Study||31
5281004|NCT00637572|12983334|P1|STARTED|Overall Study||32
5281005|NCT00637494|12983362|P2|NOT COMPLETED|Overall Study||43
5281006|NCT00637494|12983363|P1|NOT COMPLETED|Overall Study||32
5281007|NCT00637494|12983362|P2|COMPLETED|Overall Study||108
5281008|NCT00637494|12983363|P1|COMPLETED|Overall Study||109
5281009|NCT00637494|12983362|P2|STARTED|Overall Study||151
5281010|NCT00637494|12983363|P1|STARTED|Overall Study||141
5281011|NCT00637416|12983373|P2|NOT COMPLETED|Overall Study||2
5281012|NCT00637416|12983374|P1|NOT COMPLETED|Overall Study||1
5281013|NCT00637416|12983373|P2|COMPLETED|Overall Study||3
5281014|NCT00637416|12983374|P1|COMPLETED|Overall Study||3
5281015|NCT00637416|12983373|P2|STARTED|Overall Study||5
5281016|NCT00637416|12983374|P1|STARTED|Overall Study||4
5281017|NCT00637377|12983384|P4|NOT COMPLETED|Overall Study||29
5281018|NCT00637377|12983385|P3|NOT COMPLETED|Overall Study||37
5281019|NCT00637377|12983386|P2|NOT COMPLETED|Overall Study||32
5281020|NCT00637377|12983387|P1|NOT COMPLETED|Overall Study||27
5281021|NCT00637377|12983384|P4|COMPLETED|Overall Study||284
5281022|NCT00637377|12983385|P3|COMPLETED|Overall Study||274
5281023|NCT00637377|12983386|P2|COMPLETED|Overall Study||281
5281024|NCT00637377|12983387|P1|COMPLETED|Overall Study||276
5281025|NCT00637377|12983384|P4|Participants Treated (FAS)|Overall Study||306
5281026|NCT00637377|12983385|P3|Participants Treated (FAS)|Overall Study||296
5281027|NCT00637377|12983386|P2|Participants Treated (FAS)|Overall Study||309
5281028|NCT00637377|12983387|P1|Participants Treated (FAS)|Overall Study||291
5281029|NCT00637377|12983384|P4|Participants Received Treatment|Overall Study|safety population|307
5281030|NCT00637377|12983385|P3|Participants Received Treatment|Overall Study|safety population|297
5281031|NCT00637377|12983386|P2|Participants Received Treatment|Overall Study|safety population|309
5281032|NCT00637377|12983387|P1|Participants Received Treatment|Overall Study|safety population|291
5281033|NCT00637377|12983384|P4|STARTED|Overall Study||313
5281034|NCT00637377|12983385|P3|STARTED|Overall Study||311
5281035|NCT00637377|12983386|P2|STARTED|Overall Study||313
5281036|NCT00637377|12983387|P1|STARTED|Overall Study||303
5281037|NCT00637312|12983415|P2|NOT COMPLETED|Overall Study||17
5281038|NCT00637312|12983416|P1|NOT COMPLETED|Overall Study||42
5281039|NCT00637312|12983415|P2|COMPLETED|Overall Study||19
5281040|NCT00637312|12983416|P1|COMPLETED|Overall Study||30
5281041|NCT00637312|12983415|P2|STARTED|Overall Study||36
5281042|NCT00637312|12983416|P1|STARTED|Overall Study||72
5281043|NCT00637299|12983424|P2|NOT COMPLETED|Overall Study||0
5281044|NCT00637299|12983425|P1|NOT COMPLETED|Overall Study||0
5281045|NCT00637299|12983424|P2|COMPLETED|Overall Study||10
5281046|NCT00637299|12983425|P1|COMPLETED|Overall Study||10
5281047|NCT00637299|12983424|P2|STARTED|Overall Study||10
5281048|NCT00637299|12983425|P1|STARTED|Overall Study||10
5281049|NCT00637273|12983436|P3|NOT COMPLETED|Overall Study||41
5281050|NCT00637273|12983437|P2|NOT COMPLETED|Overall Study||28
5281051|NCT00637273|12983438|P1|NOT COMPLETED|Overall Study||43
5281052|NCT00637273|12983436|P3|COMPLETED|Overall Study||131
5281053|NCT00637273|12983437|P2|COMPLETED|Overall Study||144
5281054|NCT00637273|12983438|P1|COMPLETED|Overall Study||127
5281055|NCT00637273|12983436|P3|Intent to Treat (ITT)|Overall Study||165
5281056|NCT00637273|12983437|P2|Intent to Treat (ITT)|Overall Study||166
5281057|NCT00637273|12983438|P1|Intent to Treat (ITT)|Overall Study||160
5281058|NCT00637273|12983436|P3|STARTED|Overall Study||172
5281059|NCT00637273|12983437|P2|STARTED|Overall Study||172
5281060|NCT00637273|12983438|P1|STARTED|Overall Study||170
5281061|NCT00637247|12983481|P2|NOT COMPLETED|Overall Study||0
5281062|NCT00637247|12983482|P1|NOT COMPLETED|Overall Study||0
5281063|NCT00637247|12983481|P2|COMPLETED|Overall Study||70
5281064|NCT00637247|12983482|P1|COMPLETED|Overall Study||72
5281065|NCT00637247|12983481|P2|STARTED|Overall Study||70
5281066|NCT00637247|12983482|P1|STARTED|Overall Study||72
5281067|NCT00637195|12983496|P2|NOT COMPLETED|Overall Study||1
5281068|NCT00637195|12983497|P1|NOT COMPLETED|Overall Study||3
5281069|NCT00637195|12983496|P2|COMPLETED|Overall Study||75
5281070|NCT00637195|12983497|P1|COMPLETED|Overall Study||73
5281071|NCT00637195|12983496|P2|STARTED|Overall Study||76
5281072|NCT00637195|12983497|P1|STARTED|Overall Study||76
5281073|NCT00637156|12983533|P2|NOT COMPLETED|Overall Study||24
5281074|NCT00637156|12983534|P1|NOT COMPLETED|Overall Study||10
5281075|NCT00637156|12983533|P2|COMPLETED|Overall Study||164
5281076|NCT00637156|12983534|P1|COMPLETED|Overall Study||199
5281077|NCT00637156|12983533|P2|STARTED|Overall Study||188
5281078|NCT00637156|12983534|P1|STARTED|Overall Study||209
5281079|NCT00637000|12983576|P2|NOT COMPLETED|Overall Study||3
5281080|NCT00637000|12983577|P1|NOT COMPLETED|Overall Study||4
5281081|NCT00637000|12983576|P2|COMPLETED|Overall Study||15
5281082|NCT00637000|12983577|P1|COMPLETED|Overall Study||16
5281083|NCT00637000|12983576|P2|Evaluable|Overall Study||16
5281084|NCT00637000|12983577|P1|Evaluable|Overall Study||18
5281085|NCT00637000|12983576|P2|STARTED|Overall Study|Randomized and treated|18
5281086|NCT00637000|12983577|P1|STARTED|Overall Study|Randomized and treated|20
5281087|NCT00636987|12983617|P1|NOT COMPLETED|Overall Study||189
5281088|NCT00636987|12983617|P1|COMPLETED|Overall Study||108
5281089|NCT00636987|12983617|P1|STARTED|Overall Study||297
5281090|NCT00636961|12983627|P2|NOT COMPLETED|Period 2||0
5281091|NCT00636961|12983628|P1|NOT COMPLETED|Period 2||1
5281092|NCT00636961|12983627|P2|COMPLETED|Period 2||12
5281093|NCT00636961|12983628|P1|COMPLETED|Period 2||12
5281094|NCT00636961|12983627|P2|STARTED|Period 2||12
5281095|NCT00636961|12983628|P1|STARTED|Period 2||13
5281096|NCT00636961|12983627|P2|NOT COMPLETED|Period 1||1
5281097|NCT00636961|12983628|P1|NOT COMPLETED|Period 1||1
5281098|NCT00636961|12983627|P2|COMPLETED|Period 1||12
5281099|NCT00636961|12983628|P1|COMPLETED|Period 1||13
5281100|NCT00636961|12983627|P2|STARTED|Period 1||13
5281101|NCT00636961|12983628|P1|STARTED|Period 1||14
5281102|NCT00636818|12983642|P1|NOT COMPLETED|Overall Study||11
5281103|NCT00636818|12983642|P1|COMPLETED|Overall Study||34
5281104|NCT00636818|12983642|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
5281105|NCT00636818|12983642|P1|STARTED|Overall Study||45
5281106|NCT00636805|12983657|P1|NOT COMPLETED|Overall Study||0
5281107|NCT00636805|12983657|P1|COMPLETED|Overall Study||63
5281108|NCT00636805|12983657|P1|STARTED|Overall Study||63
5281109|NCT00636792|12983667|P1|NOT COMPLETED|Overall Study||33
5281110|NCT00636792|12983667|P1|COMPLETED|Overall Study||40
5281111|NCT00636792|12983667|P1|STARTED|Overall Study||73
5281112|NCT00636701|12983674|P2|NOT COMPLETED|Overall Study||0
5281113|NCT00636701|12983675|P1|NOT COMPLETED|Overall Study||0
5281114|NCT00636701|12983674|P2|COMPLETED|Overall Study||2
5281115|NCT00636701|12983675|P1|COMPLETED|Overall Study||2
5281116|NCT00636701|12983674|P2|STARTED|Overall Study||2
5281117|NCT00636701|12983675|P1|STARTED|Overall Study||2
5281118|NCT00636675|12983683|P2|NOT COMPLETED|Overall Study||41
5281119|NCT00636675|12983684|P1|NOT COMPLETED|Overall Study||140
5281120|NCT00636675|12983683|P2|COMPLETED|Overall Study||734
5281121|NCT00636675|12983684|P1|COMPLETED|Overall Study||811
5281122|NCT00636675|12983683|P2|STARTED|Overall Study||775
5281123|NCT00636675|12983684|P1|STARTED|Overall Study||951
5281124|NCT00636649|12983696|P2|NOT COMPLETED|Overall Study||0
5281125|NCT00636649|12983697|P1|NOT COMPLETED|Overall Study||0
5281126|NCT00636649|12983696|P2|COMPLETED|Overall Study||20
5281127|NCT00636649|12983697|P1|COMPLETED|Overall Study||20
5281128|NCT00636649|12983696|P2|STARTED|Overall Study||20
5281129|NCT00636649|12983697|P1|STARTED|Overall Study||20
5281130|NCT00636636|12983727|P2|NOT COMPLETED|Overall Study||39
5281131|NCT00636636|12983728|P1|NOT COMPLETED|Overall Study||36
5281132|NCT00636636|12983727|P2|COMPLETED|Overall Study||192
5281133|NCT00636636|12983728|P1|COMPLETED|Overall Study||185
5281134|NCT00636636|12983727|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
5281135|NCT00636636|12983728|P1|379|Overall Study||186
5281136|NCT00636636|12983727|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
5281137|NCT00636636|12983728|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
5281138|NCT00636636|12983727|P2|STARTED|Overall Study||231
5281139|NCT00636636|12983728|P1|STARTED|Overall Study||221
5281140|NCT00636610|12983744|P2|NOT COMPLETED|Overall Study||83
5281141|NCT00636610|12983745|P1|NOT COMPLETED|Overall Study||92
5281142|NCT00636610|12983744|P2|COMPLETED|Overall Study||18
5281143|NCT00636610|12983745|P1|COMPLETED|Overall Study||6
5281144|NCT00636610|12983744|P2|STARTED|Overall Study||101
5281145|NCT00636610|12983745|P1|STARTED|Overall Study||98
5281146|NCT00636506|12983755|P1|NOT COMPLETED|Overall Study||16
5281147|NCT00636506|12983755|P1|COMPLETED|Overall Study||60
5281148|NCT00636506|12983755|P1|STARTED|Overall Study||76
5281149|NCT00636441|12983802|P7|NOT COMPLETED|Overall Study||18
5281150|NCT00636441|12983803|P6|NOT COMPLETED|Overall Study||1
5281151|NCT00636441|12983804|P5|NOT COMPLETED|Overall Study||0
5281152|NCT00636441|12983805|P4|NOT COMPLETED|Overall Study||0
5281153|NCT00636441|12983806|P3|NOT COMPLETED|Overall Study||1
5281154|NCT00636441|12983807|P2|NOT COMPLETED|Overall Study||1
5281155|NCT00636441|12983808|P1|NOT COMPLETED|Overall Study||0
5281156|NCT00636441|12983802|P7|COMPLETED|Overall Study||0
5281157|NCT00636441|12983803|P6|COMPLETED|Overall Study||6
5281158|NCT00636441|12983804|P5|COMPLETED|Overall Study||6
5281159|NCT00636441|12983805|P4|COMPLETED|Overall Study||6
5281160|NCT00636441|12983806|P3|COMPLETED|Overall Study||5
5281161|NCT00636441|12983807|P2|COMPLETED|Overall Study||6
5281162|NCT00636441|12983808|P1|COMPLETED|Overall Study||6
5281163|NCT00636441|12983802|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
5281164|NCT00636441|12983803|P6|Assigned Treatment|Overall Study||7
5281165|NCT00636441|12983804|P5|Assigned Treatment|Overall Study||6
5281166|NCT00636441|12983805|P4|Assigned Treatment|Overall Study||6
5281167|NCT00636441|12983806|P3|Assigned Treatment|Overall Study||6
5281168|NCT00636441|12983807|P2|Assigned Treatment|Overall Study||7
5281169|NCT00636441|12983808|P1|Assigned Treatment|Overall Study||6
5281170|NCT00636441|12983802|P7|STARTED|Overall Study||18
5281171|NCT00636441|12983803|P6|STARTED|Overall Study||7
5281172|NCT00636441|12983804|P5|STARTED|Overall Study||6
5281173|NCT00636441|12983805|P4|STARTED|Overall Study||6
5281174|NCT00636441|12983806|P3|STARTED|Overall Study||6
5281175|NCT00636441|12983807|P2|STARTED|Overall Study||7
5281176|NCT00636441|12983808|P1|STARTED|Overall Study||6
5281177|NCT00636389|12983837|P2|NOT COMPLETED|Period 2 - 1 Week||0
5281178|NCT00636389|12983838|P1|NOT COMPLETED|Period 2 - 1 Week||0
5281179|NCT00636389|12983837|P2|COMPLETED|Period 2 - 1 Week||5
5281180|NCT00636389|12983838|P1|COMPLETED|Period 2 - 1 Week||7
5281181|NCT00636389|12983837|P2|STARTED|Period 2 - 1 Week||5
5281182|NCT00636389|12983838|P1|STARTED|Period 2 - 1 Week||7
5281183|NCT00636389|12983837|P2|NOT COMPLETED|Period 1 - 1 Week||0
5281184|NCT00636389|12983838|P1|NOT COMPLETED|Period 1 - 1 Week||0
5281185|NCT00636389|12983837|P2|COMPLETED|Period 1 - 1 Week||5
5281186|NCT00636389|12983838|P1|COMPLETED|Period 1 - 1 Week||7
5281187|NCT00636389|12983837|P2|STARTED|Period 1 - 1 Week||5
5281188|NCT00636389|12983838|P1|STARTED|Period 1 - 1 Week||7
5281189|NCT00636363|12983851|P3|NOT COMPLETED|Overall Study||18
5281190|NCT00636363|12983852|P2|NOT COMPLETED|Overall Study||20
5281191|NCT00636363|12983853|P1|NOT COMPLETED|Overall Study||13
5281192|NCT00636363|12983851|P3|COMPLETED|Overall Study||163
5281193|NCT00636363|12983852|P2|COMPLETED|Overall Study||156
5281194|NCT00636363|12983853|P1|COMPLETED|Overall Study||165
5281195|NCT00636363|12983851|P3|STARTED|Overall Study||181
5281196|NCT00636363|12983852|P2|STARTED|Overall Study||176
5281197|NCT00636363|12983853|P1|STARTED|Overall Study||178
5281198|NCT00636220|12983867|P1|NOT COMPLETED|Overall Study||0
5281199|NCT00636220|12983867|P1|COMPLETED|Overall Study||101
5281200|NCT00636220|12983867|P1|STARTED|Overall Study||101
5281201|NCT00636207|12983874|P7|NOT COMPLETED|Overall Study||0
5281202|NCT00636207|12983875|P6|NOT COMPLETED|Overall Study||0
5281203|NCT00636207|12983876|P5|NOT COMPLETED|Overall Study||1
5281204|NCT00636207|12983877|P4|NOT COMPLETED|Overall Study||0
5281205|NCT00636207|12983878|P3|NOT COMPLETED|Overall Study||0
5281206|NCT00636207|12983879|P2|NOT COMPLETED|Overall Study||1
5281207|NCT00636207|12983880|P1|NOT COMPLETED|Overall Study||1
5281208|NCT00636207|12983874|P7|COMPLETED|Overall Study||3
5281209|NCT00636207|12983875|P6|COMPLETED|Overall Study||1
5281210|NCT00636207|12983876|P5|COMPLETED|Overall Study||8
5281211|NCT00636207|12983877|P4|COMPLETED|Overall Study||6
5281212|NCT00636207|12983878|P3|COMPLETED|Overall Study||18
5281213|NCT00636207|12983879|P2|COMPLETED|Overall Study||7
5281214|NCT00636207|12983880|P1|COMPLETED|Overall Study||0
5281215|NCT00636207|12983874|P7|STARTED|Overall Study||3
5281216|NCT00636207|12983875|P6|STARTED|Overall Study||1
5281217|NCT00636207|12983876|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
5281218|NCT00636207|12983877|P4|STARTED|Overall Study||6
5281219|NCT00636207|12983878|P3|STARTED|Overall Study||18
5281220|NCT00636207|12983879|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
5281221|NCT00636207|12983880|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
5281222|NCT00636194|12983944|P2|NOT COMPLETED|Overall Study||0
5281223|NCT00636194|12983945|P1|NOT COMPLETED|Overall Study||3
5281224|NCT00636194|12983944|P2|COMPLETED|Overall Study||175
5281225|NCT00636194|12983945|P1|COMPLETED|Overall Study||172
5281226|NCT00636194|12983944|P2|STARTED|Overall Study||175
5281227|NCT00636194|12983945|P1|STARTED|Overall Study||175
5281228|NCT00636181|12983958|P3|NOT COMPLETED|Overall Study||10
5281229|NCT00636181|12983959|P2|NOT COMPLETED|Overall Study||6
5281230|NCT00636181|12983960|P1|NOT COMPLETED|Overall Study||8
5281231|NCT00636181|12983958|P3|COMPLETED|Overall Study||47
5281232|NCT00636181|12983959|P2|COMPLETED|Overall Study||47
5281233|NCT00636181|12983960|P1|COMPLETED|Overall Study||46
5281234|NCT00636181|12983958|P3|STARTED|Overall Study||57
5281235|NCT00636181|12983959|P2|STARTED|Overall Study||53
5281236|NCT00636181|12983960|P1|STARTED|Overall Study||54
5281237|NCT00636168|12983988|P2|NOT COMPLETED|Long Term Follow-Up||14
5281238|NCT00636168|12983989|P1|NOT COMPLETED|Long Term Follow-Up||11
5281239|NCT00636168|12983988|P2|COMPLETED|Long Term Follow-Up||129
5281240|NCT00636168|12983989|P1|COMPLETED|Long Term Follow-Up||130
5281241|NCT00636168|12983988|P2|STARTED|Long Term Follow-Up||143
5281242|NCT00636168|12983989|P1|STARTED|Long Term Follow-Up||141
5281243|NCT00636168|12983988|P2|NOT COMPLETED|Treated With Study Drug||331
5281244|NCT00636168|12983989|P1|NOT COMPLETED|Treated With Study Drug||408
5281245|NCT00636168|12983988|P2|COMPLETED|Treated With Study Drug||143
5281246|NCT00636168|12983989|P1|COMPLETED|Treated With Study Drug||63
5281247|NCT00636168|12983988|P2|STARTED|Treated With Study Drug||474
5281248|NCT00636168|12983989|P1|STARTED|Treated With Study Drug||471
5281249|NCT00636168|12983988|P2|NOT COMPLETED|Randomized to Study Drug||2
5281250|NCT00636168|12983989|P1|NOT COMPLETED|Randomized to Study Drug||4
5281251|NCT00636168|12983988|P2|COMPLETED|Randomized to Study Drug||474
5281252|NCT00636168|12983989|P1|COMPLETED|Randomized to Study Drug||471
5281253|NCT00636168|12983988|P2|STARTED|Randomized to Study Drug||476
5281254|NCT00636168|12983989|P1|STARTED|Randomized to Study Drug||475
5281255|NCT00636155|12984017|P1|NOT COMPLETED|Overall Study||18
5281256|NCT00636155|12984017|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
5281257|NCT00636155|12984017|P1|STARTED|Overall Study||20
5281258|NCT00636077|12984023|P4|NOT COMPLETED|Week 4||0
5281259|NCT00636077|12984024|P3|NOT COMPLETED|Week 4||0
5281260|NCT00636077|12984025|P2|NOT COMPLETED|Week 4||0
5281261|NCT00636077|12984026|P1|NOT COMPLETED|Week 4||0
5281262|NCT00636077|12984023|P4|COMPLETED|Week 4||3
5281263|NCT00636077|12984024|P3|COMPLETED|Week 4||3
5281264|NCT00636077|12984025|P2|COMPLETED|Week 4||3
5281265|NCT00636077|12984026|P1|COMPLETED|Week 4||3
5281266|NCT00636077|12984023|P4|STARTED|Week 4||3
5281267|NCT00636077|12984024|P3|STARTED|Week 4||3
5281268|NCT00636077|12984025|P2|STARTED|Week 4||3
5281269|NCT00636077|12984026|P1|STARTED|Week 4||3
5281270|NCT00636077|12984023|P4|NOT COMPLETED|Week 3||0
5281271|NCT00636077|12984024|P3|NOT COMPLETED|Week 3||0
5281272|NCT00636077|12984025|P2|NOT COMPLETED|Week 3||0
5281273|NCT00636077|12984026|P1|NOT COMPLETED|Week 3||0
5281274|NCT00636077|12984023|P4|COMPLETED|Week 3||3
5281275|NCT00636077|12984024|P3|COMPLETED|Week 3||3
5281276|NCT00636077|12984025|P2|COMPLETED|Week 3||3
5281277|NCT00636077|12984026|P1|COMPLETED|Week 3||3
5281278|NCT00636077|12984023|P4|STARTED|Week 3||3
5281279|NCT00636077|12984024|P3|STARTED|Week 3||3
5281280|NCT00636077|12984025|P2|STARTED|Week 3||3
5281281|NCT00636077|12984026|P1|STARTED|Week 3||3
5281282|NCT00636077|12984023|P4|NOT COMPLETED|Week 2||0
5281283|NCT00636077|12984024|P3|NOT COMPLETED|Week 2||0
5281284|NCT00636077|12984025|P2|NOT COMPLETED|Week 2||0
5281285|NCT00636077|12984026|P1|NOT COMPLETED|Week 2||0
5281286|NCT00636077|12984023|P4|COMPLETED|Week 2||3
5281287|NCT00636077|12984024|P3|COMPLETED|Week 2||3
5281288|NCT00636077|12984025|P2|COMPLETED|Week 2||3
5281289|NCT00636077|12984026|P1|COMPLETED|Week 2||3
5281290|NCT00636077|12984023|P4|STARTED|Week 2||3
5281291|NCT00636077|12984024|P3|STARTED|Week 2||3
5281292|NCT00636077|12984025|P2|STARTED|Week 2||3
5281293|NCT00636077|12984026|P1|STARTED|Week 2||3
5281294|NCT00636077|12984023|P4|NOT COMPLETED|Week 1||0
5281295|NCT00636077|12984024|P3|NOT COMPLETED|Week 1||0
5281296|NCT00636077|12984025|P2|NOT COMPLETED|Week 1||0
5281297|NCT00636077|12984026|P1|NOT COMPLETED|Week 1||0
5281298|NCT00636077|12984023|P4|COMPLETED|Week 1||3
5281299|NCT00636077|12984024|P3|COMPLETED|Week 1||3
5281300|NCT00636077|12984025|P2|COMPLETED|Week 1||3
5281301|NCT00636077|12984026|P1|COMPLETED|Week 1||3
5281302|NCT00636077|12984023|P4|STARTED|Week 1||3
5281303|NCT00636077|12984024|P3|STARTED|Week 1||3
5281304|NCT00636077|12984025|P2|STARTED|Week 1||3
5281305|NCT00636077|12984026|P1|STARTED|Week 1||3
5281306|NCT00635999|12984059|P3|NOT COMPLETED|Overall Study||1
5281307|NCT00635999|12984060|P2|NOT COMPLETED|Overall Study||2
5281308|NCT00635999|12984061|P1|NOT COMPLETED|Overall Study||4
5281309|NCT00635999|12984059|P3|COMPLETED|Overall Study||23
5281310|NCT00635999|12984060|P2|COMPLETED|Overall Study||23
5281311|NCT00635999|12984061|P1|COMPLETED|Overall Study||23
5281312|NCT00635999|12984059|P3|STARTED|Overall Study||24
5281313|NCT00635999|12984060|P2|STARTED|Overall Study||25
5281314|NCT00635999|12984061|P1|STARTED|Overall Study||27
5281315|NCT00635882|12984078|P6|NOT COMPLETED|Overall Study||0
5281316|NCT00635882|12984079|P5|NOT COMPLETED|Overall Study||0
5281317|NCT00635882|12984080|P4|NOT COMPLETED|Overall Study||0
5281318|NCT00635882|12984081|P3|NOT COMPLETED|Overall Study||0
5281319|NCT00635882|12984082|P2|NOT COMPLETED|Overall Study||0
5281320|NCT00635882|12984083|P1|NOT COMPLETED|Overall Study||1
5281321|NCT00635882|12984078|P6|COMPLETED|Overall Study||13
5281322|NCT00635882|12984079|P5|COMPLETED|Overall Study||16
5281323|NCT00635882|12984080|P4|COMPLETED|Overall Study||15
5281324|NCT00635882|12984081|P3|COMPLETED|Overall Study||12
5281325|NCT00635882|12984082|P2|COMPLETED|Overall Study||17
5281326|NCT00635882|12984083|P1|COMPLETED|Overall Study||19
5281327|NCT00635882|12984078|P6|STARTED|Overall Study||13
5281328|NCT00635882|12984079|P5|STARTED|Overall Study||16
5281329|NCT00635882|12984080|P4|STARTED|Overall Study||15
5281330|NCT00635882|12984081|P3|STARTED|Overall Study||12
5281331|NCT00635882|12984082|P2|STARTED|Overall Study||17
5281332|NCT00635882|12984083|P1|STARTED|Overall Study||20
5281333|NCT00635830|12984147|P2|NOT COMPLETED|Overall Study||0
5281334|NCT00635830|12984148|P1|NOT COMPLETED|Overall Study||0
5281335|NCT00635830|12984147|P2|COMPLETED|Overall Study||20
5281336|NCT00635830|12984148|P1|COMPLETED|Overall Study||20
5281337|NCT00635830|12984147|P2|STARTED|Overall Study||20
5281338|NCT00635830|12984148|P1|STARTED|Overall Study||20
5281339|NCT00635817|12984158|P4|NOT COMPLETED|Overall Study||0
5281340|NCT00635817|12984159|P3|NOT COMPLETED|Overall Study||2
5281341|NCT00635817|12984160|P2|NOT COMPLETED|Overall Study||2
5281342|NCT00635817|12984161|P1|NOT COMPLETED|Overall Study||6
5281343|NCT00635817|12984158|P4|COMPLETED|Overall Study||21
5281344|NCT00635817|12984159|P3|COMPLETED|Overall Study||19
5281345|NCT00635817|12984160|P2|COMPLETED|Overall Study||19
5281346|NCT00635817|12984161|P1|COMPLETED|Overall Study||15
5281347|NCT00635817|12984158|P4|STARTED|Overall Study||21
5281348|NCT00635817|12984159|P3|STARTED|Overall Study||21
5281349|NCT00635817|12984160|P2|STARTED|Overall Study||21
5281350|NCT00635817|12984161|P1|STARTED|Overall Study||21
5281351|NCT00635804|12984213|P8|NOT COMPLETED|Overall Study||0
5281352|NCT00635804|12984214|P7|NOT COMPLETED|Overall Study||0
5281353|NCT00635804|12984215|P6|NOT COMPLETED|Overall Study||1
5281354|NCT00635804|12984216|P5|NOT COMPLETED|Overall Study||0
5281355|NCT00635804|12984217|P4|NOT COMPLETED|Overall Study||0
5281356|NCT00635804|12984218|P3|NOT COMPLETED|Overall Study||0
5281357|NCT00635804|12984219|P2|NOT COMPLETED|Overall Study||0
5281358|NCT00635804|12984220|P1|NOT COMPLETED|Overall Study||1
5281359|NCT00635804|12984213|P8|COMPLETED|Overall Study||14
5281360|NCT00635804|12984214|P7|COMPLETED|Overall Study||3
5281361|NCT00635804|12984215|P6|COMPLETED|Overall Study||11
5281362|NCT00635804|12984216|P5|COMPLETED|Overall Study||6
5281363|NCT00635804|12984217|P4|COMPLETED|Overall Study||6
5281364|NCT00635804|12984218|P3|COMPLETED|Overall Study||6
5281365|NCT00635804|12984219|P2|COMPLETED|Overall Study||6
5281366|NCT00635804|12984220|P1|COMPLETED|Overall Study||6
5281367|NCT00635804|12984213|P8|STARTED|Overall Study||14
5281368|NCT00635804|12984214|P7|STARTED|Overall Study||3
5281369|NCT00635804|12984215|P6|STARTED|Overall Study||12
5281370|NCT00635804|12984216|P5|STARTED|Overall Study||6
5281371|NCT00635804|12984217|P4|STARTED|Overall Study||6
5281372|NCT00635804|12984218|P3|STARTED|Overall Study||6
5281373|NCT00635804|12984219|P2|STARTED|Overall Study||6
5281374|NCT00635804|12984220|P1|STARTED|Overall Study||7
5281375|NCT00635778|12984324|P7|NOT COMPLETED|Overall Study||6
5281376|NCT00635778|12984325|P6|NOT COMPLETED|Overall Study||21
5281377|NCT00635778|12984326|P5|NOT COMPLETED|Overall Study||8
5281378|NCT00635778|12984327|P4|NOT COMPLETED|Overall Study||8
5281379|NCT00635778|12984328|P3|NOT COMPLETED|Overall Study||3
5281380|NCT00635778|12984329|P2|NOT COMPLETED|Overall Study||3
5281381|NCT00635778|12984330|P1|NOT COMPLETED|Overall Study||1
5281382|NCT00635778|12984324|P7|COMPLETED|Overall Study||0
5281383|NCT00635778|12984325|P6|COMPLETED|Overall Study||0
5281384|NCT00635778|12984326|P5|COMPLETED|Overall Study||0
5281385|NCT00635778|12984327|P4|COMPLETED|Overall Study||0
5281386|NCT00635778|12984328|P3|COMPLETED|Overall Study||0
5281387|NCT00635778|12984329|P2|COMPLETED|Overall Study||0
5281388|NCT00635778|12984330|P1|COMPLETED|Overall Study||0
5281389|NCT00635778|12984324|P7|STARTED|Overall Study||6
5281390|NCT00635778|12984325|P6|STARTED|Overall Study||21
5281391|NCT00635778|12984326|P5|STARTED|Overall Study||8
5281392|NCT00635778|12984327|P4|STARTED|Overall Study||8
5281393|NCT00635778|12984328|P3|STARTED|Overall Study||3
5281394|NCT00635778|12984329|P2|STARTED|Overall Study||3
5281395|NCT00635778|12984330|P1|STARTED|Overall Study||1
5281396|NCT00635739|12984383|P2|NOT COMPLETED|Overall Study||2
5281397|NCT00635739|12984384|P1|NOT COMPLETED|Overall Study||3
5281398|NCT00635739|12984383|P2|COMPLETED|Overall Study||36
5281399|NCT00635739|12984384|P1|COMPLETED|Overall Study||39
5281400|NCT00635739|12984383|P2|STARTED|Overall Study||38
5281401|NCT00635739|12984384|P1|STARTED|Overall Study||42
5281402|NCT00635700|12984394|P2|NOT COMPLETED|Overall Study||14
5281403|NCT00635700|12984395|P1|NOT COMPLETED|Overall Study||15
5281404|NCT00635700|12984394|P2|COMPLETED|Overall Study||13
5281405|NCT00635700|12984395|P1|COMPLETED|Overall Study||9
5281406|NCT00635700|12984394|P2|STARTED|Overall Study||27
5281407|NCT00635700|12984395|P1|STARTED|Overall Study||24
5281408|NCT00635661|12984401|P1|NOT COMPLETED|Overall Study||4
5281409|NCT00635661|12984401|P1|COMPLETED|Overall Study||30
5281410|NCT00635661|12984401|P1|STARTED|Overall Study||34
5281411|NCT00635648|12984405|P1|NOT COMPLETED|Overall Study||37
5281412|NCT00635648|12984405|P1|COMPLETED|Overall Study||26
5281413|NCT00635648|12984405|P1|STARTED|Overall Study||63
5281414|NCT00635609|12984414|P2|NOT COMPLETED|Overall Study||3
5281415|NCT00635609|12984415|P1|NOT COMPLETED|Overall Study||7
5281416|NCT00635609|12984414|P2|COMPLETED|Overall Study||42
5281417|NCT00635609|12984415|P1|COMPLETED|Overall Study||41
5281418|NCT00635609|12984414|P2|STARTED|Overall Study||45
5281419|NCT00635609|12984415|P1|STARTED|Overall Study||48
5281420|NCT00635570|12984427|P2|NOT COMPLETED|Overall Study||11
5281421|NCT00635570|12984428|P1|NOT COMPLETED|Overall Study||15
5281422|NCT00635570|12984427|P2|COMPLETED|Overall Study||126
5281423|NCT00635570|12984428|P1|COMPLETED|Overall Study||121
5281424|NCT00635570|12984427|P2|STARTED|Overall Study||137
5281425|NCT00635570|12984428|P1|STARTED|Overall Study||136
5281426|NCT00635492|12984442|P2|NOT COMPLETED|Overall Study||282
5281427|NCT00635492|12984443|P1|NOT COMPLETED|Overall Study||279
5281428|NCT00635492|12984442|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
5281429|NCT00635492|12984443|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
5281430|NCT00635492|12984442|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
5281431|NCT00635492|12984443|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
5281432|NCT00635479|12984489|P2|NOT COMPLETED|Overall Study||18
5281433|NCT00635479|12984490|P1|NOT COMPLETED|Overall Study||6
5281434|NCT00635479|12984489|P2|COMPLETED|Overall Study||42
5281435|NCT00635479|12984490|P1|COMPLETED|Overall Study||49
5281436|NCT00635479|12984489|P2|STARTED|Overall Study||60
5281437|NCT00635479|12984490|P1|STARTED|Overall Study||55
5281438|NCT00635453|12984498|P2|NOT COMPLETED|Overall Study||174
5281439|NCT00635453|12984499|P1|NOT COMPLETED|Overall Study||154
5281440|NCT00635453|12984498|P2|COMPLETED|Overall Study||181
5281441|NCT00635453|12984499|P1|COMPLETED|Overall Study||206
5281442|NCT00635453|12984498|P2|3 Years Assessment|Overall Study||204
5281443|NCT00635453|12984499|P1|3 Years Assessment|Overall Study||246
5281444|NCT00635453|12984498|P2|12 Months Assessment|Overall Study||260
5281445|NCT00635453|12984499|P1|12 Months Assessment|Overall Study||285
5281446|NCT00635453|12984498|P2|6 Months Assessment|Overall Study||311
5281447|NCT00635453|12984499|P1|6 Months Assessment|Overall Study||322
5281448|NCT00635453|12984498|P2|STARTED|Overall Study||355
5281449|NCT00635453|12984499|P1|STARTED|Overall Study||360
5281450|NCT00635427|12984516|P5|NOT COMPLETED|Overall Study||8
5281451|NCT00635427|12984517|P4|NOT COMPLETED|Overall Study||9
5281452|NCT00635427|12984518|P3|NOT COMPLETED|Overall Study||11
5281453|NCT00635427|12984519|P2|NOT COMPLETED|Overall Study||6
5281454|NCT00635427|12984520|P1|NOT COMPLETED|Overall Study||12
5281455|NCT00635427|12984516|P5|COMPLETED|Overall Study||30
5281456|NCT00635427|12984517|P4|COMPLETED|Overall Study||7
5281457|NCT00635427|12984518|P3|COMPLETED|Overall Study||5
5281458|NCT00635427|12984519|P2|COMPLETED|Overall Study||6
5281459|NCT00635427|12984520|P1|COMPLETED|Overall Study||1
5281460|NCT00635427|12984516|P5|STARTED|Overall Study||38
5281461|NCT00635427|12984517|P4|STARTED|Overall Study||16
5281462|NCT00635427|12984518|P3|STARTED|Overall Study||16
5281463|NCT00635427|12984519|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
5281464|NCT00635427|12984520|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
5281465|NCT00635362|12984542|P2|NOT COMPLETED|Overall Study||8
5281466|NCT00635362|12984543|P1|NOT COMPLETED|Overall Study||13
5281467|NCT00635362|12984542|P2|COMPLETED|Overall Study||12
5281468|NCT00635362|12984543|P1|COMPLETED|Overall Study||9
5281469|NCT00635362|12984542|P2|STARTED|Overall Study||20
5281470|NCT00635362|12984543|P1|STARTED|Overall Study||22
5281471|NCT00635349|12984559|P2|NOT COMPLETED|Overall Study||48
5281472|NCT00635349|12984560|P1|NOT COMPLETED|Overall Study||44
5281473|NCT00635349|12984559|P2|COMPLETED|Overall Study||19
5281474|NCT00635349|12984560|P1|COMPLETED|Overall Study||29
5281475|NCT00635349|12984559|P2|STARTED|Overall Study||67
5281476|NCT00635349|12984560|P1|STARTED|Overall Study||73
5281477|NCT00635232|12984583|P5|NOT COMPLETED|Overall Study||8
5281478|NCT00635232|12984584|P4|NOT COMPLETED|Overall Study||10
5281479|NCT00635232|12984585|P3|NOT COMPLETED|Overall Study||3
5281480|NCT00635232|12984586|P2|NOT COMPLETED|Overall Study||20
5281481|NCT00635232|12984587|P1|NOT COMPLETED|Overall Study||14
5281482|NCT00635232|12984583|P5|COMPLETED|Overall Study||20
5281483|NCT00635232|12984584|P4|COMPLETED|Overall Study||48
5281484|NCT00635232|12984585|P3|COMPLETED|Overall Study||55
5281485|NCT00635232|12984586|P2|COMPLETED|Overall Study||39
5281486|NCT00635232|12984587|P1|COMPLETED|Overall Study||44
5281487|NCT00635232|12984583|P5|STARTED|Overall Study||28
5281488|NCT00635232|12984584|P4|STARTED|Overall Study||58
5281489|NCT00635232|12984585|P3|STARTED|Overall Study||58
5281490|NCT00635232|12984586|P2|STARTED|Overall Study||59
5281491|NCT00635232|12984587|P1|STARTED|Overall Study||58
5281492|NCT00635219|12984614|P5|NOT COMPLETED|Overall Study||42
5281493|NCT00635219|12984615|P4|NOT COMPLETED|Overall Study||34
5281494|NCT00635219|12984616|P3|NOT COMPLETED|Overall Study||35
5281495|NCT00635219|12984617|P2|NOT COMPLETED|Overall Study||25
5281496|NCT00635219|12984618|P1|NOT COMPLETED|Overall Study||25
5281497|NCT00635219|12984614|P5|COMPLETED|Overall Study||113
5281498|NCT00635219|12984615|P4|COMPLETED|Overall Study||117
5281499|NCT00635219|12984616|P3|COMPLETED|Overall Study||122
5281500|NCT00635219|12984617|P2|COMPLETED|Overall Study||130
5281501|NCT00635219|12984618|P1|COMPLETED|Overall Study||123
5281502|NCT00635219|12984614|P5|STARTED|Overall Study||155
5281503|NCT00635219|12984615|P4|STARTED|Overall Study||151
5281504|NCT00635219|12984616|P3|STARTED|Overall Study||157
5281505|NCT00635219|12984617|P2|STARTED|Overall Study||155
5281506|NCT00635219|12984618|P1|STARTED|Overall Study||148
5281507|NCT00635167|12984675|P1|NOT COMPLETED|Overall Study||0
5281508|NCT00635167|12984675|P1|COMPLETED|Overall Study||1
5281509|NCT00635167|12984675|P1|STARTED|Overall Study||1
5281510|NCT00635154|12984681|P1|NOT COMPLETED|Overall Study||33
5281511|NCT00635154|12984681|P1|COMPLETED|Overall Study||21
5281512|NCT00635154|12984681|P1|STARTED|Overall Study||54
5281513|NCT00635128|12984693|P2|NOT COMPLETED|Overall Study||0
5281514|NCT00635128|12984694|P1|NOT COMPLETED|Overall Study||0
5281515|NCT00635128|12984693|P2|COMPLETED|Overall Study||64
5281516|NCT00635128|12984694|P1|COMPLETED|Overall Study||351
5281517|NCT00635128|12984693|P2|STARTED|Overall Study||64
5281518|NCT00635128|12984694|P1|STARTED|Overall Study||351
5281519|NCT00635102|12984724|P2|NOT COMPLETED|Overall Study||8
5281520|NCT00635102|12984725|P1|NOT COMPLETED|Overall Study||7
5281521|NCT00635102|12984724|P2|COMPLETED|Overall Study||22
5281522|NCT00635102|12984725|P1|COMPLETED|Overall Study||20
5281523|NCT00635102|12984724|P2|STARTED|Overall Study||30
5281524|NCT00635102|12984725|P1|STARTED|Overall Study||27
5281525|NCT00635089|12984819|P1|NOT COMPLETED|Overall Study||78
5281526|NCT00635089|12984819|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
5281527|NCT00635089|12984819|P1|Completed >/= 16 Weeks of Study|Overall Study||181
5281528|NCT00635089|12984819|P1|STARTED|Overall Study||190
5281529|NCT00635050|12984846|P1|NOT COMPLETED|Overall Study||1
5281530|NCT00635050|12984846|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
5281531|NCT00635050|12984846|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
5281532|NCT00635024|12984853|P1|NOT COMPLETED|Overall Study||1
5281533|NCT00635024|12984853|P1|COMPLETED|Overall Study||0
5281534|NCT00635024|12984853|P1|STARTED|Overall Study||1
5281535|NCT00634933|12984864|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
5281536|NCT00634933|12984865|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
5281537|NCT00634933|12984866|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
5281538|NCT00634933|12984867|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
5281539|NCT00634933|12984868|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
5281540|NCT00634933|12984864|P5|COMPLETED|Part B: Week 24 to Week 52||22
5281541|NCT00634933|12984865|P4|COMPLETED|Part B: Week 24 to Week 52||25
5281542|NCT00634933|12984866|P3|COMPLETED|Part B: Week 24 to Week 52||33
5281543|NCT00634933|12984867|P2|COMPLETED|Part B: Week 24 to Week 52||42
5281544|NCT00634933|12984868|P1|COMPLETED|Part B: Week 24 to Week 52||0
5281545|NCT00634933|12984864|P5|STARTED|Part B: Week 24 to Week 52||32
5281546|NCT00634933|12984865|P4|STARTED|Part B: Week 24 to Week 52||31
5281547|NCT00634933|12984866|P3|STARTED|Part B: Week 24 to Week 52||55
5281548|NCT00634933|12984867|P2|STARTED|Part B: Week 24 to Week 52||56
5281549|NCT00634933|12984868|P1|STARTED|Part B: Week 24 to Week 52||0
5281550|NCT00634933|12984864|P5|NOT COMPLETED|Between Part A and Part B||0
5281551|NCT00634933|12984865|P4|NOT COMPLETED|Between Part A and Part B||0
5281552|NCT00634933|12984866|P3|NOT COMPLETED|Between Part A and Part B||0
5281553|NCT00634933|12984867|P2|NOT COMPLETED|Between Part A and Part B||1
5281554|NCT00634933|12984868|P1|NOT COMPLETED|Between Part A and Part B||0
5281555|NCT00634933|12984864|P5|COMPLETED|Between Part A and Part B||32
5281556|NCT00634933|12984865|P4|COMPLETED|Between Part A and Part B||31
5281557|NCT00634933|12984866|P3|COMPLETED|Between Part A and Part B||55
5281558|NCT00634933|12984867|P2|COMPLETED|Between Part A and Part B||56
5281559|NCT00634933|12984868|P1|COMPLETED|Between Part A and Part B||0
5281560|NCT00634933|12984864|P5|STARTED|Between Part A and Part B||32
5281561|NCT00634933|12984865|P4|STARTED|Between Part A and Part B||31
5281562|NCT00634933|12984866|P3|STARTED|Between Part A and Part B||55
5281563|NCT00634933|12984867|P2|STARTED|Between Part A and Part B||57
5281564|NCT00634933|12984868|P1|STARTED|Between Part A and Part B||0
5281565|NCT00634933|12984864|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
5281566|NCT00634933|12984865|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
5281567|NCT00634933|12984866|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
5281568|NCT00634933|12984867|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
5281569|NCT00634933|12984868|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
5281570|NCT00634933|12984864|P5|COMPLETED|Part A: Baseline to Week 24||0
5281571|NCT00634933|12984865|P4|COMPLETED|Part A: Baseline to Week 24||0
5281572|NCT00634933|12984866|P3|COMPLETED|Part A: Baseline to Week 24||55
5281573|NCT00634933|12984867|P2|COMPLETED|Part A: Baseline to Week 24||57
5281574|NCT00634933|12984868|P1|COMPLETED|Part A: Baseline to Week 24||63
5281575|NCT00634933|12984864|P5|STARTED|Part A: Baseline to Week 24||0
5281576|NCT00634933|12984865|P4|STARTED|Part A: Baseline to Week 24||0
5281577|NCT00634933|12984866|P3|STARTED|Part A: Baseline to Week 24||73
5281578|NCT00634933|12984867|P2|STARTED|Part A: Baseline to Week 24||75
5281579|NCT00634933|12984868|P1|STARTED|Part A: Baseline to Week 24||74
5281580|NCT00634920|12984937|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
5281581|NCT00634920|12984938|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
5281582|NCT00634920|12984939|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
5281583|NCT00634920|12984937|P3|COMPLETED|Period 2 - Post-Randomization||0
5281584|NCT00634920|12984938|P2|COMPLETED|Period 2 - Post-Randomization||68
5281585|NCT00634920|12984939|P1|COMPLETED|Period 2 - Post-Randomization||43
5281586|NCT00634920|12984937|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
5281587|NCT00634920|12984938|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
5281588|NCT00634920|12984939|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
5281589|NCT00634920|12984937|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
5281590|NCT00634920|12984938|P2|STARTED|Period 2 - Post-Randomization||100
5281591|NCT00634920|12984939|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
5281592|NCT00634920|12984937|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
5281593|NCT00634920|12984938|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
5281594|NCT00634920|12984939|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
5281595|NCT00634920|12984937|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
5281596|NCT00634920|12984938|P2|COMPLETED|Period 1 - Pre-Randomization||0
5281597|NCT00634920|12984939|P1|COMPLETED|Period 1 - Pre-Randomization||0
5281598|NCT00634920|12984937|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
5281599|NCT00634920|12984938|P2|STARTED|Period 1 - Pre-Randomization||0
5281600|NCT00634920|12984939|P1|STARTED|Period 1 - Pre-Randomization||0
5281601|NCT00634907|12984983|P2|NOT COMPLETED|Overall Study||17
5281602|NCT00634907|12984984|P1|NOT COMPLETED|Overall Study||17
5281603|NCT00634907|12984983|P2|COMPLETED|Overall Study||115
5281604|NCT00634907|12984984|P1|COMPLETED|Overall Study||114
5281605|NCT00634907|12984983|P2|STARTED|Overall Study||132
5281606|NCT00634907|12984984|P1|STARTED|Overall Study||131
5281607|NCT00634842|12985008|P2|NOT COMPLETED|Overall Study||18
5281608|NCT00634842|12985009|P1|NOT COMPLETED|Overall Study||15
5281609|NCT00634842|12985008|P2|COMPLETED|Overall Study||104
5281610|NCT00634842|12985009|P1|COMPLETED|Overall Study||107
5281611|NCT00634842|12985008|P2|STARTED|Overall Study||122
5281612|NCT00634842|12985009|P1|STARTED|Overall Study||122
5281613|NCT00634751|12985025|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
5281614|NCT00634751|12985026|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
5281615|NCT00634751|12985027|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
5281616|NCT00634751|12985028|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
5281617|NCT00634751|12985025|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
5281618|NCT00634751|12985026|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
5281619|NCT00634751|12985027|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
5281620|NCT00634751|12985028|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
5281621|NCT00634751|12985025|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
5281622|NCT00634751|12985026|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
5281623|NCT00634751|12985027|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
5281624|NCT00634751|12985028|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
5281625|NCT00634751|12985025|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281626|NCT00634751|12985026|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281627|NCT00634751|12985027|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
5281628|NCT00634751|12985028|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281629|NCT00634751|12985025|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281630|NCT00634751|12985026|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281631|NCT00634751|12985027|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
5281632|NCT00634751|12985028|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
5281633|NCT00634751|12985025|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
5281634|NCT00634751|12985026|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
5281635|NCT00634751|12985027|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
5281636|NCT00634751|12985028|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
5281637|NCT00634751|12985025|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281638|NCT00634751|12985026|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281639|NCT00634751|12985027|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281640|NCT00634751|12985028|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
5281641|NCT00634751|12985025|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281642|NCT00634751|12985026|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281643|NCT00634751|12985027|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
5281644|NCT00634751|12985028|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
5281645|NCT00634751|12985025|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
5281646|NCT00634751|12985026|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
5281647|NCT00634751|12985027|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
5281648|NCT00634751|12985028|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
5281649|NCT00634647|12985046|P1|NOT COMPLETED|Overall Study||7
5281650|NCT00634647|12985046|P1|COMPLETED|Overall Study||17
5281651|NCT00634647|12985046|P1|STARTED|Overall Study||24
5281652|NCT00634621|12985052|P1|NOT COMPLETED|Overall Study||0
5281653|NCT00634621|12985052|P1|COMPLETED|Overall Study||283
5281654|NCT00634621|12985052|P1|STARTED|Overall Study||283
5281655|NCT00634582|12985060|P1|NOT COMPLETED|Overall Study||0
5281656|NCT00634582|12985060|P1|COMPLETED|Overall Study||2
5281657|NCT00634582|12985060|P1|STARTED|Overall Study||2
5281658|NCT00634569|12985066|P2|NOT COMPLETED|Overall Study||5
5281659|NCT00634569|12985067|P1|NOT COMPLETED|Overall Study||0
5281660|NCT00634569|12985066|P2|COMPLETED|Overall Study||5
5281661|NCT00634569|12985067|P1|COMPLETED|Overall Study||14
5281662|NCT00634569|12985066|P2|STARTED|Overall Study||10
5281663|NCT00634569|12985067|P1|STARTED|Overall Study||14
5281664|NCT00634543|12985081|P2|NOT COMPLETED|Overall Study||21
5281665|NCT00634543|12985082|P1|NOT COMPLETED|Overall Study||19
5281666|NCT00634543|12985081|P2|COMPLETED|Overall Study||63
5281667|NCT00634543|12985082|P1|COMPLETED|Overall Study||59
5281668|NCT00634543|12985081|P2|Treated|Overall Study||80
5281669|NCT00634543|12985082|P1|Treated|Overall Study||76
5281670|NCT00634543|12985081|P2|STARTED|Overall Study||84
5281671|NCT00634543|12985082|P1|STARTED|Overall Study||78
5281672|NCT00634504|12985100|P2|NOT COMPLETED|Overall Study||0
5281673|NCT00634504|12985101|P1|NOT COMPLETED|Overall Study||1
5281674|NCT00634504|12985100|P2|COMPLETED|Overall Study||9
5281675|NCT00634504|12985101|P1|COMPLETED|Overall Study||10
5281676|NCT00634504|12985100|P2|STARTED|Overall Study||9
5281677|NCT00634504|12985101|P1|STARTED|Overall Study||11
5281678|NCT00634322|12985110|P3|NOT COMPLETED|Overall Study||0
5281679|NCT00634322|12985111|P2|NOT COMPLETED|Overall Study||0
5281680|NCT00634322|12985112|P1|NOT COMPLETED|Overall Study||0
5281681|NCT00634322|12985110|P3|COMPLETED|Overall Study||5
5281682|NCT00634322|12985111|P2|COMPLETED|Overall Study||1
5281683|NCT00634322|12985112|P1|COMPLETED|Overall Study||1
5281684|NCT00634322|12985110|P3|STARTED|Overall Study||5
5281685|NCT00634322|12985111|P2|STARTED|Overall Study||1
5281686|NCT00634322|12985112|P1|STARTED|Overall Study||1
5281687|NCT00634283|12985120|P1|NOT COMPLETED|Overall Study||0
5281688|NCT00634283|12985120|P1|COMPLETED|Overall Study||6
5281689|NCT00634283|12985120|P1|STARTED|Overall Study||6
5281690|NCT00634270|12985130|P2|NOT COMPLETED|Overall Study||1
5281691|NCT00634270|12985131|P1|NOT COMPLETED|Overall Study||3
5281692|NCT00634270|12985130|P2|COMPLETED|Overall Study||12
5281693|NCT00634270|12985131|P1|COMPLETED|Overall Study||46
5281694|NCT00634270|12985130|P2|STARTED|Overall Study||13
5281695|NCT00634270|12985131|P1|STARTED|Overall Study|February 12, 2008|49
5281696|NCT00634244|12985160|P3|NOT COMPLETED|Overall Study||0
5281697|NCT00634244|12985161|P2|NOT COMPLETED|Overall Study||13
5281698|NCT00634244|12985162|P1|NOT COMPLETED|Overall Study||1
5281699|NCT00634244|12985160|P3|COMPLETED|Overall Study||20
5281700|NCT00634244|12985161|P2|COMPLETED|Overall Study||24
5281701|NCT00634244|12985162|P1|COMPLETED|Overall Study||34
5281702|NCT00634244|12985160|P3|Eligible and Treated|Overall Study||20
5281703|NCT00634244|12985161|P2|Eligible and Treated|Overall Study||36
5281704|NCT00634244|12985162|P1|Eligible and Treated|Overall Study||35
5281705|NCT00634244|12985160|P3|STARTED|Overall Study||20
5281706|NCT00634244|12985161|P2|STARTED|Overall Study||37
5281707|NCT00634244|12985162|P1|STARTED|Overall Study||35
5281708|NCT00634179|12985173|P1|NOT COMPLETED|Phase II: Maintenance||1
5281709|NCT00634179|12985173|P1|COMPLETED|Phase II: Maintenance||29
5281710|NCT00634179|12985173|P1|STARTED|Phase II: Maintenance||30
5281711|NCT00634179|12985173|P1|NOT COMPLETED|Phase I: Induction||0
5281712|NCT00634179|12985173|P1|COMPLETED|Phase I: Induction||19
5281713|NCT00634179|12985173|P1|STARTED|Phase I: Induction||19
5281714|NCT00634166|12985182|P2|NOT COMPLETED|Overall Study||60
5281715|NCT00634166|12985183|P1|NOT COMPLETED|Overall Study||60
5281716|NCT00634166|12985182|P2|COMPLETED|Overall Study||78
5281717|NCT00634166|12985183|P1|COMPLETED|Overall Study||22
5281718|NCT00634166|12985182|P2|STARTED|Overall Study||138
5281719|NCT00634166|12985183|P1|STARTED|Overall Study||82
5281720|NCT00634114|12985192|P3|NOT COMPLETED|Overall Study||39
5281721|NCT00634114|12985193|P2|NOT COMPLETED|Overall Study||35
5281722|NCT00634114|12985194|P1|NOT COMPLETED|Overall Study||28
5281723|NCT00634114|12985192|P3|COMPLETED|Overall Study|Completed|148
5281724|NCT00634114|12985193|P2|COMPLETED|Overall Study|Completed|154
5281725|NCT00634114|12985194|P1|COMPLETED|Overall Study|Completed|160
5281726|NCT00634114|12985192|P3|STARTED|Overall Study|Randomised|187
5281727|NCT00634114|12985193|P2|STARTED|Overall Study|Randomised|189
5281728|NCT00634114|12985194|P1|STARTED|Overall Study|Randomised|188
5281729|NCT00634088|12985212|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
5281730|NCT00634088|12985213|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
5281731|NCT00634088|12985214|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
5281732|NCT00634088|12985215|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
5281733|NCT00634088|12985212|P4|COMPLETED|Time Period 4: Triplet Combination||0
5281734|NCT00634088|12985213|P3|COMPLETED|Time Period 4: Triplet Combination||0
5281735|NCT00634088|12985214|P2|COMPLETED|Time Period 4: Triplet Combination||0
5281736|NCT00634088|12985215|P1|COMPLETED|Time Period 4: Triplet Combination||0
5281737|NCT00634088|12985212|P4|STARTED|Time Period 4: Triplet Combination||0
5281738|NCT00634088|12985213|P3|STARTED|Time Period 4: Triplet Combination||0
5281739|NCT00634088|12985214|P2|STARTED|Time Period 4: Triplet Combination||0
5281740|NCT00634088|12985215|P1|STARTED|Time Period 4: Triplet Combination||0
5281741|NCT00634088|12985212|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
5281742|NCT00634088|12985213|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
5281743|NCT00634088|12985214|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
5281744|NCT00634088|12985215|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
5281745|NCT00634088|12985212|P4|COMPLETED|Time Period 3: Dose Level 3||0
5281746|NCT00634088|12985213|P3|COMPLETED|Time Period 3: Dose Level 3||0
5281747|NCT00634088|12985214|P2|COMPLETED|Time Period 3: Dose Level 3||0
5281748|NCT00634088|12985215|P1|COMPLETED|Time Period 3: Dose Level 3||0
5281749|NCT00634088|12985212|P4|STARTED|Time Period 3: Dose Level 3||0
5281750|NCT00634088|12985213|P3|STARTED|Time Period 3: Dose Level 3||1
5281751|NCT00634088|12985214|P2|STARTED|Time Period 3: Dose Level 3||0
5281752|NCT00634088|12985215|P1|STARTED|Time Period 3: Dose Level 3||0
5281753|NCT00634088|12985212|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
5281754|NCT00634088|12985213|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
5281755|NCT00634088|12985214|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
5281756|NCT00634088|12985215|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
5281757|NCT00634088|12985212|P4|COMPLETED|Time Period 2: Dose Level 2||0
5281758|NCT00634088|12985213|P3|COMPLETED|Time Period 2: Dose Level 2||0
5281759|NCT00634088|12985214|P2|COMPLETED|Time Period 2: Dose Level 2||0
5281760|NCT00634088|12985215|P1|COMPLETED|Time Period 2: Dose Level 2||0
5281761|NCT00634088|12985212|P4|STARTED|Time Period 2: Dose Level 2||0
5281762|NCT00634088|12985213|P3|STARTED|Time Period 2: Dose Level 2||0
5281763|NCT00634088|12985214|P2|STARTED|Time Period 2: Dose Level 2||3
5281764|NCT00634088|12985215|P1|STARTED|Time Period 2: Dose Level 2||0
5281765|NCT00634088|12985212|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
5281766|NCT00634088|12985213|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
5281767|NCT00634088|12985214|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
5281768|NCT00634088|12985215|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
5281769|NCT00634088|12985212|P4|COMPLETED|Time Period 1: Dose Level 1||0
5281770|NCT00634088|12985213|P3|COMPLETED|Time Period 1: Dose Level 1||0
5281771|NCT00634088|12985214|P2|COMPLETED|Time Period 1: Dose Level 1||0
5281772|NCT00634088|12985215|P1|COMPLETED|Time Period 1: Dose Level 1||0
5281773|NCT00634088|12985212|P4|STARTED|Time Period 1: Dose Level 1||0
5281774|NCT00634088|12985213|P3|STARTED|Time Period 1: Dose Level 1||0
5281775|NCT00634088|12985214|P2|STARTED|Time Period 1: Dose Level 1||0
5281776|NCT00634088|12985215|P1|STARTED|Time Period 1: Dose Level 1||6
5281777|NCT00634049|12985266|P1|NOT COMPLETED|Overall Study||3
5281778|NCT00634049|12985266|P1|COMPLETED|Overall Study||146
5281779|NCT00634049|12985266|P1|STARTED|Overall Study||149
5281780|NCT00634036|12985345|P2|NOT COMPLETED|Overall Study||2
5281781|NCT00634036|12985346|P1|NOT COMPLETED|Overall Study||2
5281782|NCT00634036|12985345|P2|COMPLETED|Overall Study||9
5281783|NCT00634036|12985346|P1|COMPLETED|Overall Study||10
5281784|NCT00634036|12985345|P2|STARTED|Overall Study||11
5281785|NCT00634036|12985346|P1|STARTED|Overall Study||12
5281786|NCT00634010|12985360|P2|NOT COMPLETED|Overall Study||14
5281787|NCT00634010|12985361|P1|NOT COMPLETED|Overall Study||10
5281788|NCT00634010|12985360|P2|COMPLETED|Overall Study||4
5281789|NCT00634010|12985361|P1|COMPLETED|Overall Study||8
5281790|NCT00634010|12985360|P2|STARTED|Overall Study||18
5281791|NCT00634010|12985361|P1|STARTED|Overall Study||18
5281792|NCT00633984|12985369|P2|NOT COMPLETED|Overall Study||13
5281793|NCT00633984|12985370|P1|NOT COMPLETED|Overall Study||9
5281794|NCT00633984|12985369|P2|COMPLETED|Overall Study||69
5281795|NCT00633984|12985370|P1|COMPLETED|Overall Study||78
5281796|NCT00633984|12985369|P2|STARTED|Overall Study||82
5281797|NCT00633984|12985370|P1|STARTED|Overall Study||87
5281798|NCT00633945|12985378|P1|NOT COMPLETED|Overall Study||2
5281799|NCT00633945|12985378|P1|COMPLETED|Overall Study||3
5281800|NCT00633945|12985378|P1|STARTED|Overall Study||5
5281801|NCT00633932|12985394|P3|NOT COMPLETED|Overall Study||11
5281802|NCT00633932|12985395|P2|NOT COMPLETED|Overall Study||14
5281803|NCT00633932|12985396|P1|NOT COMPLETED|Overall Study||12
5281804|NCT00633932|12985394|P3|COMPLETED|Overall Study||180
5281805|NCT00633932|12985395|P2|COMPLETED|Overall Study||176
5281806|NCT00633932|12985396|P1|COMPLETED|Overall Study||179
5281807|NCT00633932|12985394|P3|STARTED|Overall Study|Randomised|191
5281808|NCT00633932|12985395|P2|STARTED|Overall Study|Randomised|190
5281809|NCT00633932|12985396|P1|STARTED|Overall Study|Randomised|191
5281810|NCT00633919|12985409|P2|NOT COMPLETED|Overall Study||22
5281811|NCT00633919|12985410|P1|NOT COMPLETED|Overall Study||27
5281812|NCT00633919|12985409|P2|COMPLETED|Overall Study||39
5281813|NCT00633919|12985410|P1|COMPLETED|Overall Study||36
5281814|NCT00633919|12985409|P2|STARTED|Overall Study||61
5281815|NCT00633919|12985410|P1|STARTED|Overall Study||63
5281816|NCT00633893|12985427|P3|NOT COMPLETED|Overall Study||188
5281817|NCT00633893|12985428|P2|NOT COMPLETED|Overall Study||129
5281818|NCT00633893|12985429|P1|NOT COMPLETED|Overall Study||114
5281819|NCT00633893|12985427|P3|COMPLETED|Overall Study||641
5281820|NCT00633893|12985428|P2|COMPLETED|Overall Study||684
5281821|NCT00633893|12985429|P1|COMPLETED|Overall Study||726
5281822|NCT00633893|12985427|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
5281823|NCT00633893|12985428|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
5281824|NCT00633893|12985429|P1|STARTED|Overall Study||840
5281825|NCT00633880|12985503|P3|NOT COMPLETED|Randomized Double Blind||0
5281826|NCT00633880|12985504|P2|NOT COMPLETED|Randomized Double Blind||0
5281827|NCT00633880|12985505|P1|NOT COMPLETED|Randomized Double Blind||0
5281828|NCT00633880|12985503|P3|COMPLETED|Randomized Double Blind||51
5281829|NCT00633880|12985504|P2|COMPLETED|Randomized Double Blind||50
5281830|NCT00633880|12985505|P1|COMPLETED|Randomized Double Blind||0
5281831|NCT00633880|12985503|P3|STARTED|Randomized Double Blind||51
5281832|NCT00633880|12985504|P2|STARTED|Randomized Double Blind||50
5281833|NCT00633880|12985505|P1|STARTED|Randomized Double Blind||0
5281834|NCT00633880|12985503|P3|NOT COMPLETED|Open Label Titration||0
5281835|NCT00633880|12985504|P2|NOT COMPLETED|Open Label Titration||0
5281836|NCT00633880|12985505|P1|NOT COMPLETED|Open Label Titration||80
5281837|NCT00633880|12985503|P3|COMPLETED|Open Label Titration||0
5281838|NCT00633880|12985504|P2|COMPLETED|Open Label Titration||0
5281839|NCT00633880|12985505|P1|COMPLETED|Open Label Titration||101
5281840|NCT00633880|12985503|P3|STARTED|Open Label Titration||0
5281841|NCT00633880|12985504|P2|STARTED|Open Label Titration||0
5281842|NCT00633880|12985505|P1|STARTED|Open Label Titration||181
5281843|NCT00633867|12985534|P2|NOT COMPLETED|Overall Study||0
5281844|NCT00633867|12985535|P1|NOT COMPLETED|Overall Study||0
5281845|NCT00633867|12985534|P2|COMPLETED|Overall Study||60
5281846|NCT00633867|12985535|P1|COMPLETED|Overall Study||60
5281847|NCT00633867|12985534|P2|STARTED|Overall Study||60
5281848|NCT00633867|12985535|P1|STARTED|Overall Study||60
5281849|NCT00633750|12985541|P1|NOT COMPLETED|Overall Study||5
5281850|NCT00633750|12985541|P1|COMPLETED|Overall Study||42
5281851|NCT00633750|12985541|P1|STARTED|Overall Study||47
5281852|NCT00633594|12985550|P3|NOT COMPLETED|Overall Study||10
5281853|NCT00633594|12985551|P2|NOT COMPLETED|Overall Study||5
5281854|NCT00633594|12985552|P1|NOT COMPLETED|Overall Study||0
5281855|NCT00633594|12985550|P3|COMPLETED|Overall Study||16
5281856|NCT00633594|12985551|P2|COMPLETED|Overall Study||3
5281857|NCT00633594|12985552|P1|COMPLETED|Overall Study||5
5281858|NCT00633594|12985550|P3|STARTED|Overall Study||26
5281859|NCT00633594|12985551|P2|STARTED|Overall Study||8
5281860|NCT00633594|12985552|P1|STARTED|Overall Study||5
5281861|NCT00633477|12985581|P2|NOT COMPLETED|Overall Study||0
5281862|NCT00633477|12985582|P1|NOT COMPLETED|Overall Study||2
5281863|NCT00633477|12985581|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
5281864|NCT00633477|12985582|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
5281865|NCT00633477|12985581|P2|Completed Study Through Day 28|Overall Study||8
5281866|NCT00633477|12985582|P1|Completed Study Through Day 28|Overall Study||4
5281867|NCT00633477|12985581|P2|Prematurely Discontinued Study Drug|Overall Study||0
5281868|NCT00633477|12985582|P1|Prematurely Discontinued Study Drug|Overall Study||1
5281869|NCT00633477|12985581|P2|Randomized But Not Treated|Overall Study||0
5281870|NCT00633477|12985582|P1|Randomized But Not Treated|Overall Study||1
5281871|NCT00633477|12985581|P2|STARTED|Overall Study||11
5281872|NCT00633477|12985582|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
5281873|NCT00633464|12985598|P2|NOT COMPLETED|Overall Study||2
5281874|NCT00633464|12985599|P1|NOT COMPLETED|Overall Study||0
5281875|NCT00633464|12985598|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
5281876|NCT00633464|12985599|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
5281877|NCT00633464|12985598|P2|Treated|Overall Study||37
5281878|NCT00633464|12985599|P1|Treated|Overall Study||40
5281879|NCT00633464|12985598|P2|STARTED|Overall Study||39
5281880|NCT00633464|12985599|P1|STARTED|Overall Study||40
5281881|NCT00633399|12985621|P2|NOT COMPLETED|Overall Study||15
5281882|NCT00633399|12985622|P1|NOT COMPLETED|Overall Study||22
5281883|NCT00633399|12985621|P2|COMPLETED|Overall Study||53
5281884|NCT00633399|12985622|P1|COMPLETED|Overall Study||49
5281885|NCT00633399|12985621|P2|STARTED|Overall Study||68
5281886|NCT00633399|12985622|P1|STARTED|Overall Study||71
5281887|NCT00633360|12985634|P2|NOT COMPLETED|Overall Study||3
5281888|NCT00633360|12985635|P1|NOT COMPLETED|Overall Study||4
5281889|NCT00633360|12985634|P2|COMPLETED|Overall Study||13
5281890|NCT00633360|12985635|P1|COMPLETED|Overall Study||12
5281891|NCT00633360|12985634|P2|STARTED|Overall Study||16
5281892|NCT00633360|12985635|P1|STARTED|Overall Study||16
5281893|NCT00633256|12985645|P2|NOT COMPLETED|Overall Study||3
5281894|NCT00633256|12985646|P1|NOT COMPLETED|Overall Study||4
5281895|NCT00633256|12985645|P2|COMPLETED|Overall Study||10
5281896|NCT00633256|12985646|P1|COMPLETED|Overall Study||8
5281897|NCT00633256|12985645|P2|STARTED|Overall Study||13
5281898|NCT00633256|12985646|P1|STARTED|Overall Study||12
5281899|NCT00633243|12985658|P2|NOT COMPLETED|Overall Study||7
5281900|NCT00633243|12985659|P1|NOT COMPLETED|Overall Study||1
5281901|NCT00633243|12985658|P2|COMPLETED|Overall Study||2
5281902|NCT00633243|12985659|P1|COMPLETED|Overall Study||11
5281903|NCT00633243|12985658|P2|STARTED|Overall Study||9
5281904|NCT00633243|12985659|P1|STARTED|Overall Study||12
5281905|NCT00633217|12985667|P2|NOT COMPLETED|Overall Study||23
5281906|NCT00633217|12985668|P1|NOT COMPLETED|Overall Study||15
5281907|NCT00633217|12985667|P2|COMPLETED|Overall Study||103
5281908|NCT00633217|12985668|P1|COMPLETED|Overall Study||106
5281909|NCT00633217|12985667|P2|STARTED|Overall Study||126
5281910|NCT00633217|12985668|P1|STARTED|Overall Study||121
5281911|NCT00633152|12985680|P2|NOT COMPLETED|Overall Study||6
5281912|NCT00633152|12985681|P1|NOT COMPLETED|Overall Study||14
5281913|NCT00633152|12985680|P2|COMPLETED|Overall Study||41
5281914|NCT00633152|12985681|P1|COMPLETED|Overall Study||89
5281915|NCT00633152|12985680|P2|Clinically Evaluable Population|Overall Study||39
5281916|NCT00633152|12985681|P1|Clinically Evaluable Population|Overall Study||86
5281917|NCT00633152|12985680|P2|MITT and Safety Population|Overall Study||45
5281918|NCT00633152|12985681|P1|MITT and Safety Population|Overall Study||98
5281919|NCT00633152|12985680|P2|STARTED|Overall Study||47
5281920|NCT00633152|12985681|P1|STARTED|Overall Study||103
5281921|NCT00633139|12985692|P3|NOT COMPLETED|Overall Study||1
5281922|NCT00633139|12985693|P2|NOT COMPLETED|Overall Study||1
5281923|NCT00633139|12985694|P1|NOT COMPLETED|Overall Study||0
5281924|NCT00633139|12985692|P3|COMPLETED|Overall Study||3
5281925|NCT00633139|12985693|P2|COMPLETED|Overall Study||4
5281926|NCT00633139|12985694|P1|COMPLETED|Overall Study||4
5281927|NCT00633139|12985692|P3|STARTED|Overall Study||4
5281928|NCT00633139|12985693|P2|STARTED|Overall Study||5
5281929|NCT00633139|12985694|P1|STARTED|Overall Study||4
5281930|NCT00633126|12985708|P1|NOT COMPLETED|Overall Study||1
5281931|NCT00633126|12985708|P1|COMPLETED|Overall Study||8
5281932|NCT00633126|12985708|P1|STARTED|Overall Study||9
5281933|NCT00633087|12985713|P1|NOT COMPLETED|Overall Study||0
5281934|NCT00633087|12985713|P1|COMPLETED|Overall Study||12
5281935|NCT00633087|12985713|P1|STARTED|Overall Study||12
5281936|NCT00633074|12985722|P2|NOT COMPLETED|Overall Study||0
5281937|NCT00633074|12985723|P1|NOT COMPLETED|Overall Study||1
5281938|NCT00633074|12985722|P2|COMPLETED|Overall Study||360
5281939|NCT00633074|12985723|P1|COMPLETED|Overall Study||359
5281940|NCT00633074|12985722|P2|STARTED|Overall Study||360
5281941|NCT00633074|12985723|P1|STARTED|Overall Study||360
5281942|NCT00633061|12985753|P2|NOT COMPLETED|Overall Study||0
5281943|NCT00633061|12985754|P1|NOT COMPLETED|Overall Study||86
5281944|NCT00633061|12985753|P2|COMPLETED|Overall Study||0
5281945|NCT00633061|12985754|P1|COMPLETED|Overall Study||50
5281946|NCT00633061|12985753|P2|Had Prior Thrombosis Identified|Overall Study||0
5281947|NCT00633061|12985754|P1|Had Prior Thrombosis Identified|Overall Study||25
5281948|NCT00633061|12985753|P2|Met Criteria for Imaging|Overall Study||0
5281949|NCT00633061|12985754|P1|Met Criteria for Imaging|Overall Study||25
5281950|NCT00633061|12985753|P2|STARTED|Overall Study||0
5281951|NCT00633061|12985754|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
5281952|NCT00633022|12985765|P3|NOT COMPLETED|Overall Study||5
5281953|NCT00633022|12985766|P2|NOT COMPLETED|Overall Study||1
5281954|NCT00633022|12985767|P1|NOT COMPLETED|Overall Study||1
5281955|NCT00633022|12985765|P3|COMPLETED|Overall Study||27
5281956|NCT00633022|12985766|P2|COMPLETED|Overall Study||32
5281957|NCT00633022|12985767|P1|COMPLETED|Overall Study||33
5281958|NCT00633022|12985765|P3|STARTED|Overall Study||32
5281959|NCT00633022|12985766|P2|STARTED|Overall Study||33
5281960|NCT00633022|12985767|P1|STARTED|Overall Study||34
5281961|NCT00633009|12985805|P3|NOT COMPLETED|Overall Study||1
5281962|NCT00633009|12985806|P2|NOT COMPLETED|Overall Study||4
5281963|NCT00633009|12985807|P1|NOT COMPLETED|Overall Study||4
5281964|NCT00633009|12985805|P3|COMPLETED|Overall Study||10
5281965|NCT00633009|12985806|P2|COMPLETED|Overall Study||23
5281966|NCT00633009|12985807|P1|COMPLETED|Overall Study||8
5281967|NCT00633009|12985805|P3|STARTED|Overall Study||11
5281968|NCT00633009|12985806|P2|STARTED|Overall Study||27
5281969|NCT00633009|12985807|P1|STARTED|Overall Study||12
5281970|NCT00632970|12985820|P2|NOT COMPLETED|Overall Study||0
5281971|NCT00632970|12985821|P1|NOT COMPLETED|Overall Study||0
5281972|NCT00632970|12985820|P2|COMPLETED|Overall Study||3
5281973|NCT00632970|12985821|P1|COMPLETED|Overall Study||3
5281974|NCT00632970|12985820|P2|STARTED|Overall Study||3
5281975|NCT00632970|12985821|P1|STARTED|Overall Study||3
5281976|NCT00632931|12985829|P3|NOT COMPLETED|Part 2||24
5281977|NCT00632931|12985830|P2|NOT COMPLETED|Part 2||0
5281978|NCT00632931|12985831|P1|NOT COMPLETED|Part 2||0
5281979|NCT00632931|12985829|P3|COMPLETED|Part 2||0
5281980|NCT00632931|12985830|P2|COMPLETED|Part 2||0
5281981|NCT00632931|12985831|P1|COMPLETED|Part 2||0
5281982|NCT00632931|12985829|P3|STARTED|Part 2||24
5281983|NCT00632931|12985830|P2|STARTED|Part 2||0
5281984|NCT00632931|12985831|P1|STARTED|Part 2||0
5281985|NCT00632931|12985829|P3|NOT COMPLETED|Post-Part 1 Washout||0
5281986|NCT00632931|12985830|P2|NOT COMPLETED|Post-Part 1 Washout||0
5281987|NCT00632931|12985831|P1|NOT COMPLETED|Post-Part 1 Washout||0
5281988|NCT00632931|12985829|P3|COMPLETED|Post-Part 1 Washout||0
5281989|NCT00632931|12985830|P2|COMPLETED|Post-Part 1 Washout||12
5281990|NCT00632931|12985831|P1|COMPLETED|Post-Part 1 Washout||12
5281991|NCT00632931|12985829|P3|STARTED|Post-Part 1 Washout||0
5281992|NCT00632931|12985830|P2|STARTED|Post-Part 1 Washout||12
5281993|NCT00632931|12985831|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
5281994|NCT00632931|12985829|P3|NOT COMPLETED|Part 1, Period 2||0
5281995|NCT00632931|12985830|P2|NOT COMPLETED|Part 1, Period 2||0
5281996|NCT00632931|12985831|P1|NOT COMPLETED|Part 1, Period 2||0
5281997|NCT00632931|12985829|P3|COMPLETED|Part 1, Period 2||0
5281998|NCT00632931|12985830|P2|COMPLETED|Part 1, Period 2||12
5281999|NCT00632931|12985831|P1|COMPLETED|Part 1, Period 2||11
5282000|NCT00632931|12985829|P3|STARTED|Part 1, Period 2||0
5282001|NCT00632931|12985830|P2|STARTED|Part 1, Period 2||12
5282002|NCT00632931|12985831|P1|STARTED|Part 1, Period 2||11
5282003|NCT00632931|12985829|P3|NOT COMPLETED|Part 1, Washout||0
5282004|NCT00632931|12985830|P2|NOT COMPLETED|Part 1, Washout||0
5282005|NCT00632931|12985831|P1|NOT COMPLETED|Part 1, Washout||0
5282006|NCT00632931|12985829|P3|COMPLETED|Part 1, Washout||0
5282007|NCT00632931|12985830|P2|COMPLETED|Part 1, Washout||12
5282008|NCT00632931|12985831|P1|COMPLETED|Part 1, Washout||11
5282009|NCT00632931|12985829|P3|STARTED|Part 1, Washout||0
5282010|NCT00632931|12985830|P2|STARTED|Part 1, Washout||12
5282011|NCT00632931|12985831|P1|STARTED|Part 1, Washout||11
5282012|NCT00632931|12985829|P3|NOT COMPLETED|Part 1, Period 1||0
5282013|NCT00632931|12985830|P2|NOT COMPLETED|Part 1, Period 1||0
5282014|NCT00632931|12985831|P1|NOT COMPLETED|Part 1, Period 1||2
5282015|NCT00632931|12985829|P3|COMPLETED|Part 1, Period 1||0
5282016|NCT00632931|12985830|P2|COMPLETED|Part 1, Period 1||12
5282017|NCT00632931|12985831|P1|COMPLETED|Part 1, Period 1||11
5282018|NCT00632931|12985829|P3|STARTED|Part 1, Period 1||0
5282019|NCT00632931|12985830|P2|STARTED|Part 1, Period 1||12
5282020|NCT00632931|12985831|P1|STARTED|Part 1, Period 1||13
5282021|NCT00632827|12985850|P1|NOT COMPLETED|Overall Study||10
5282022|NCT00632827|12985850|P1|COMPLETED|Overall Study||11
5282023|NCT00632827|12985850|P1|Evaluated Post Stem Cell Transplant|Overall Study||16
5282024|NCT00632827|12985850|P1|Received M-CHOP|Overall Study||18
5282025|NCT00632827|12985850|P1|Received GVD|Overall Study||21
5282026|NCT00632827|12985850|P1|STARTED|Overall Study||21
5282027|NCT00632814|12985860|P3|NOT COMPLETED|Overall Study||0
5282028|NCT00632814|12985861|P2|NOT COMPLETED|Overall Study||0
5282029|NCT00632814|12985862|P1|NOT COMPLETED|Overall Study||0
5282030|NCT00632814|12985860|P3|COMPLETED|Overall Study||8
5282031|NCT00632814|12985861|P2|COMPLETED|Overall Study||13
5282032|NCT00632814|12985862|P1|COMPLETED|Overall Study||11
5282033|NCT00632814|12985860|P3|STARTED|Overall Study||8
5282034|NCT00632814|12985861|P2|STARTED|Overall Study||13
5282035|NCT00632814|12985862|P1|STARTED|Overall Study||11
5282036|NCT00632749|12985908|P14|NOT COMPLETED|Overall Study||6
5282037|NCT00632749|12985909|P13|NOT COMPLETED|Overall Study||3
5282038|NCT00632749|12985910|P12|NOT COMPLETED|Overall Study||4
5282039|NCT00632749|12985911|P11|NOT COMPLETED|Overall Study||7
5282040|NCT00632749|12985912|P10|NOT COMPLETED|Overall Study||3
5282041|NCT00632749|12985913|P9|NOT COMPLETED|Overall Study||5
5282042|NCT00632749|12985914|P8|NOT COMPLETED|Overall Study||4
5282043|NCT00632749|12985915|P7|NOT COMPLETED|Overall Study||5
5282044|NCT00632749|12985916|P6|NOT COMPLETED|Overall Study||8
5282045|NCT00632749|12985917|P5|NOT COMPLETED|Overall Study||7
5282046|NCT00632749|12985918|P4|NOT COMPLETED|Overall Study||4
5282047|NCT00632749|12985919|P3|NOT COMPLETED|Overall Study||3
5282048|NCT00632749|12985920|P2|NOT COMPLETED|Overall Study||5
5282049|NCT00632749|12985921|P1|NOT COMPLETED|Overall Study||4
5282050|NCT00632749|12985908|P14|COMPLETED|Overall Study||0
5282051|NCT00632749|12985909|P13|COMPLETED|Overall Study||0
5282052|NCT00632749|12985910|P12|COMPLETED|Overall Study||0
5282053|NCT00632749|12985911|P11|COMPLETED|Overall Study||0
5282054|NCT00632749|12985912|P10|COMPLETED|Overall Study||0
5282055|NCT00632749|12985913|P9|COMPLETED|Overall Study||0
5282056|NCT00632749|12985914|P8|COMPLETED|Overall Study||0
5282057|NCT00632749|12985915|P7|COMPLETED|Overall Study||0
5282058|NCT00632749|12985916|P6|COMPLETED|Overall Study||0
5282059|NCT00632749|12985917|P5|COMPLETED|Overall Study||0
5282060|NCT00632749|12985918|P4|COMPLETED|Overall Study||0
5282061|NCT00632749|12985919|P3|COMPLETED|Overall Study||0
5282062|NCT00632749|12985920|P2|COMPLETED|Overall Study||0
5282063|NCT00632749|12985921|P1|COMPLETED|Overall Study||0
5282064|NCT00632749|12985908|P14|Not Treated|Overall Study||0
5282065|NCT00632749|12985909|P13|Not Treated|Overall Study||0
5282066|NCT00632749|12985910|P12|Not Treated|Overall Study||0
5282067|NCT00632749|12985911|P11|Not Treated|Overall Study||0
5282068|NCT00632749|12985912|P10|Not Treated|Overall Study||0
5282069|NCT00632749|12985913|P9|Not Treated|Overall Study||0
5282070|NCT00632749|12985914|P8|Not Treated|Overall Study||0
5282071|NCT00632749|12985915|P7|Not Treated|Overall Study||1
5282072|NCT00632749|12985916|P6|Not Treated|Overall Study||1
5282073|NCT00632749|12985917|P5|Not Treated|Overall Study||0
5282074|NCT00632749|12985918|P4|Not Treated|Overall Study||0
5282075|NCT00632749|12985919|P3|Not Treated|Overall Study||0
5282076|NCT00632749|12985920|P2|Not Treated|Overall Study||2
5282077|NCT00632749|12985921|P1|Not Treated|Overall Study||0
5282078|NCT00632749|12985908|P14|Treated|Overall Study||6
5282079|NCT00632749|12985909|P13|Treated|Overall Study||3
5282080|NCT00632749|12985910|P12|Treated|Overall Study||4
5282081|NCT00632749|12985911|P11|Treated|Overall Study||7
5282082|NCT00632749|12985912|P10|Treated|Overall Study||3
5282083|NCT00632749|12985913|P9|Treated|Overall Study||5
5282084|NCT00632749|12985914|P8|Treated|Overall Study||4
5282085|NCT00632749|12985915|P7|Treated|Overall Study||4
5282086|NCT00632749|12985916|P6|Treated|Overall Study||7
5282087|NCT00632749|12985917|P5|Treated|Overall Study||7
5282088|NCT00632749|12985918|P4|Treated|Overall Study||4
5282089|NCT00632749|12985919|P3|Treated|Overall Study||3
5282090|NCT00632749|12985920|P2|Treated|Overall Study||3
5282091|NCT00632749|12985921|P1|Treated|Overall Study||4
5282092|NCT00632749|12985908|P14|STARTED|Overall Study||6
5282093|NCT00632749|12985909|P13|STARTED|Overall Study||3
5282094|NCT00632749|12985910|P12|STARTED|Overall Study||4
5282095|NCT00632749|12985911|P11|STARTED|Overall Study||7
5282096|NCT00632749|12985912|P10|STARTED|Overall Study||3
5282097|NCT00632749|12985913|P9|STARTED|Overall Study||5
5282098|NCT00632749|12985914|P8|STARTED|Overall Study||4
5282099|NCT00632749|12985915|P7|STARTED|Overall Study||5
5282100|NCT00632749|12985916|P6|STARTED|Overall Study||8
5282101|NCT00632749|12985917|P5|STARTED|Overall Study||7
5282102|NCT00632749|12985918|P4|STARTED|Overall Study||4
5282103|NCT00632749|12985919|P3|STARTED|Overall Study||3
5282104|NCT00632749|12985920|P2|STARTED|Overall Study||5
5282105|NCT00632749|12985921|P1|STARTED|Overall Study||4
5282106|NCT00632736|12986215|P1|NOT COMPLETED|Overall Study||268
5282107|NCT00632736|12986215|P1|COMPLETED|Overall Study||151
5282108|NCT00632736|12986215|P1|STARTED|Overall Study||419
5282109|NCT00632632|12986222|P2|NOT COMPLETED|Overall Study||3
5282110|NCT00632632|12986223|P1|NOT COMPLETED|Overall Study||0
5282111|NCT00632632|12986222|P2|COMPLETED|Overall Study||9
5282112|NCT00632632|12986223|P1|COMPLETED|Overall Study||13
5282113|NCT00632632|12986222|P2|STARTED|Overall Study||12
5282114|NCT00632632|12986223|P1|STARTED|Overall Study||13
5282115|NCT00632619|12986235|P2|NOT COMPLETED|Overall Study||4
5282116|NCT00632619|12986236|P1|NOT COMPLETED|Overall Study||8
5282117|NCT00632619|12986235|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
5282118|NCT00632619|12986236|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
5282119|NCT00632619|12986235|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
5282120|NCT00632619|12986236|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
5282121|NCT00632541|12986250|P1|NOT COMPLETED|Overall Study||7
5282122|NCT00632541|12986250|P1|COMPLETED|Overall Study||11
5282123|NCT00632541|12986250|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
5282124|NCT00632502|12986259|P2|NOT COMPLETED|Overall Study||1
5282125|NCT00632502|12986260|P1|NOT COMPLETED|Overall Study||3
5282126|NCT00632502|12986259|P2|COMPLETED|Overall Study||11
5282127|NCT00632502|12986260|P1|COMPLETED|Overall Study||22
5282128|NCT00632502|12986259|P2|Completed Treatment|Overall Study||9
5282129|NCT00632502|12986260|P1|Completed Treatment|Overall Study||19
5282130|NCT00632502|12986259|P2|Treated|Overall Study||12
5282131|NCT00632502|12986260|P1|Treated|Overall Study||22
5282132|NCT00632502|12986259|P2|STARTED|Overall Study||12
5282133|NCT00632502|12986260|P1|STARTED|Overall Study||25
5282134|NCT00632489|12986288|P3|NOT COMPLETED|Overall Study||0
5282135|NCT00632489|12986289|P2|NOT COMPLETED|Overall Study||5
5282136|NCT00632489|12986290|P1|NOT COMPLETED|Overall Study||15
5282137|NCT00632489|12986288|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
5282138|NCT00632489|12986289|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
5282139|NCT00632489|12986290|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
5282140|NCT00632489|12986288|P3|STARTED|Overall Study||0
5282141|NCT00632489|12986289|P2|STARTED|Overall Study||5
5282142|NCT00632489|12986290|P1|STARTED|Overall Study||15
5282143|NCT00632463|12986304|P3|NOT COMPLETED|Overall Study||0
5282144|NCT00632463|12986305|P2|NOT COMPLETED|Overall Study||1
5282145|NCT00632463|12986306|P1|NOT COMPLETED|Overall Study||0
5282146|NCT00632463|12986304|P3|COMPLETED|Overall Study||7
5282147|NCT00632463|12986305|P2|COMPLETED|Overall Study||6
5282148|NCT00632463|12986306|P1|COMPLETED|Overall Study||7
5282149|NCT00632463|12986304|P3|STARTED|Overall Study||7
5282150|NCT00632463|12986305|P2|STARTED|Overall Study||7
5282151|NCT00632463|12986306|P1|STARTED|Overall Study||7
5282152|NCT00632424|12986323|P1|NOT COMPLETED|Overall Study||18
5282153|NCT00632424|12986323|P1|COMPLETED|Overall Study||0
5282154|NCT00632424|12986323|P1|STARTED|Overall Study||18
5282155|NCT00632411|12986347|P2|NOT COMPLETED|Overall Study||176
5282156|NCT00632411|12986348|P1|NOT COMPLETED|Overall Study||160
5282157|NCT00632411|12986347|P2|COMPLETED|Overall Study||473
5282158|NCT00632411|12986348|P1|COMPLETED|Overall Study||489
5282159|NCT00632411|12986347|P2|STARTED|Overall Study||649
5282160|NCT00632411|12986348|P1|STARTED|Overall Study||649
5282161|NCT00632359|12986354|P1|NOT COMPLETED|Overall Study||2
5282162|NCT00632359|12986354|P1|COMPLETED|Overall Study||31
5282163|NCT00632359|12986354|P1|STARTED|Overall Study||33
5282164|NCT00632281|12986360|P1|NOT COMPLETED|Overall Study||0
5282165|NCT00632281|12986360|P1|COMPLETED|Overall Study||38
5282166|NCT00632281|12986360|P1|STARTED|Overall Study||38
5282167|NCT00632229|12986367|P2|NOT COMPLETED|Overall Study||6
5282168|NCT00632229|12986368|P1|NOT COMPLETED|Overall Study||6
5282169|NCT00632229|12986367|P2|COMPLETED|Overall Study||11
5282170|NCT00632229|12986368|P1|COMPLETED|Overall Study||11
5282171|NCT00632229|12986367|P2|STARTED|Overall Study||17
5282172|NCT00632229|12986368|P1|STARTED|Overall Study||17
5282173|NCT00632203|12986378|P2|NOT COMPLETED|Overall Study||0
5282174|NCT00632203|12986379|P1|NOT COMPLETED|Overall Study||1
5282175|NCT00632203|12986378|P2|COMPLETED|Overall Study||27
5282176|NCT00632203|12986379|P1|COMPLETED|Overall Study||25
5282177|NCT00632203|12986378|P2|STARTED|Overall Study||27
5282178|NCT00632203|12986379|P1|STARTED|Overall Study||26
5282179|NCT00632125|12986397|P1|NOT COMPLETED|Overall Study||302
5282180|NCT00632125|12986397|P1|COMPLETED|Overall Study||1393
5282181|NCT00632125|12986397|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
5282182|NCT00632099|12986403|P2|NOT COMPLETED|Overall Study||3
5282183|NCT00632099|12986404|P1|NOT COMPLETED|Overall Study||3
5282184|NCT00632099|12986403|P2|COMPLETED|Overall Study||8
5282185|NCT00632099|12986404|P1|COMPLETED|Overall Study||7
5282186|NCT00632099|12986403|P2|STARTED|Overall Study||11
5282187|NCT00632099|12986404|P1|STARTED|Overall Study||10
5282188|NCT00632021|12986412|P2|NOT COMPLETED|Overall Study||7
5282189|NCT00632021|12986413|P1|NOT COMPLETED|Overall Study||4
5282190|NCT00632021|12986412|P2|COMPLETED|Overall Study||423
5282191|NCT00632021|12986413|P1|COMPLETED|Overall Study||428
5282192|NCT00632021|12986412|P2|STARTED|Overall Study||430
5282193|NCT00632021|12986413|P1|STARTED|Overall Study||432
5282194|NCT00631969|12986423|P2|NOT COMPLETED|Overall Study||21
5282195|NCT00631969|12986424|P1|NOT COMPLETED|Overall Study||15
5282196|NCT00631969|12986423|P2|COMPLETED|Overall Study||155
5282197|NCT00631969|12986424|P1|COMPLETED|Overall Study||171
5282198|NCT00631969|12986423|P2|Received Treatment|Overall Study|safety population|174
5282199|NCT00631969|12986424|P1|Received Treatment|Overall Study|safety population|184
5282200|NCT00631969|12986423|P2|STARTED|Overall Study||176
5282201|NCT00631969|12986424|P1|STARTED|Overall Study||186
5282202|NCT00631917|12986470|P2|NOT COMPLETED|Overall Study||108
5282203|NCT00631917|12986471|P1|NOT COMPLETED|Overall Study||88
5282204|NCT00631917|12986470|P2|COMPLETED|Overall Study||291
5282205|NCT00631917|12986471|P1|COMPLETED|Overall Study||287
5282206|NCT00631917|12986470|P2|STARTED|Overall Study||399
5282207|NCT00631917|12986471|P1|STARTED|Overall Study||375
5282208|NCT00631748|12986487|P2|NOT COMPLETED|Overall Study||22
5282209|NCT00631748|12986488|P1|NOT COMPLETED|Overall Study||18
5282210|NCT00631748|12986487|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
5282211|NCT00631748|12986488|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
5282212|NCT00631748|12986487|P2|STARTED|Overall Study||31
5282213|NCT00631748|12986488|P1|STARTED|Overall Study||29
5282214|NCT00631696|12986498|P2|NOT COMPLETED|Overall Study||40
5282215|NCT00631696|12986499|P1|NOT COMPLETED|Overall Study||37
5282216|NCT00631696|12986498|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
5282217|NCT00631696|12986499|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
5282218|NCT00631696|12986498|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
5282219|NCT00631696|12986499|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
5282220|NCT00631696|12986498|P2|Received Study Treatment (Tx)|Overall Study||109
5282221|NCT00631696|12986499|P1|Received Study Treatment (Tx)|Overall Study||111
5282222|NCT00631696|12986498|P2|STARTED|Overall Study||110
5282223|NCT00631696|12986499|P1|STARTED|Overall Study||112
5282224|NCT00631670|12986525|P2|NOT COMPLETED|Overall Study||0
5282225|NCT00631670|12986526|P1|NOT COMPLETED|Overall Study||0
5282226|NCT00631670|12986525|P2|COMPLETED|Overall Study||0
5282227|NCT00631670|12986526|P1|COMPLETED|Overall Study||21
5282228|NCT00631670|12986525|P2|STARTED|Overall Study||0
5282229|NCT00631670|12986526|P1|STARTED|Overall Study||21
5282230|NCT00631657|12986542|P3|NOT COMPLETED|7-Day Discontinuation Period||1
5282231|NCT00631657|12986543|P2|NOT COMPLETED|7-Day Discontinuation Period||1
5282232|NCT00631657|12986544|P1|NOT COMPLETED|7-Day Discontinuation Period||2
5282233|NCT00631657|12986542|P3|COMPLETED|7-Day Discontinuation Period||65
5282234|NCT00631657|12986543|P2|COMPLETED|7-Day Discontinuation Period||136
5282235|NCT00631657|12986544|P1|COMPLETED|7-Day Discontinuation Period||65
5282236|NCT00631657|12986542|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
5282237|NCT00631657|12986543|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
5282238|NCT00631657|12986544|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
5282239|NCT00631657|12986542|P3|STARTED|7-Day Discontinuation Period||66
5282240|NCT00631657|12986543|P2|STARTED|7-Day Discontinuation Period||137
5282241|NCT00631657|12986544|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
5282242|NCT00631657|12986542|P3|NOT COMPLETED|6-Month Treatment Period||50
5282243|NCT00631657|12986543|P2|NOT COMPLETED|6-Month Treatment Period||0
5282244|NCT00631657|12986544|P1|NOT COMPLETED|6-Month Treatment Period||141
5282245|NCT00631657|12986542|P3|COMPLETED|6-Month Treatment Period||66
5282246|NCT00631657|12986543|P2|COMPLETED|6-Month Treatment Period||0
5282247|NCT00631657|12986544|P1|COMPLETED|6-Month Treatment Period||203
5282248|NCT00631657|12986542|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
5282249|NCT00631657|12986543|P2|Treated|6-Month Treatment Period||0
5282250|NCT00631657|12986544|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
5282251|NCT00631657|12986542|P3|STARTED|6-Month Treatment Period||116
5282252|NCT00631657|12986543|P2|STARTED|6-Month Treatment Period||0
5282253|NCT00631657|12986544|P1|STARTED|6-Month Treatment Period||344
5282254|NCT00631566|12986574|P3|NOT COMPLETED|Overall Study||0
5282255|NCT00631566|12986575|P2|NOT COMPLETED|Overall Study||4
5282256|NCT00631566|12986576|P1|NOT COMPLETED|Overall Study||2
5282257|NCT00631566|12986574|P3|COMPLETED|Overall Study||501
5282258|NCT00631566|12986575|P2|COMPLETED|Overall Study||24
5282259|NCT00631566|12986576|P1|COMPLETED|Overall Study||19
5282260|NCT00631566|12986574|P3|STARTED|Overall Study||501
5282261|NCT00631566|12986575|P2|STARTED|Overall Study||28
5282262|NCT00631566|12986576|P1|STARTED|Overall Study||21
5282263|NCT00631540|12986593|P1|NOT COMPLETED|Overall Study||14
5282264|NCT00631540|12986593|P1|COMPLETED|Overall Study||86
5282265|NCT00631540|12986593|P1|STARTED|Overall Study||100
5282266|NCT00631488|12986605|P3|NOT COMPLETED|Overall Study||2
5282267|NCT00631488|12986606|P2|NOT COMPLETED|Overall Study||2
5282268|NCT00631488|12986607|P1|NOT COMPLETED|Overall Study||4
5282269|NCT00631488|12986605|P3|COMPLETED|Overall Study||47
5282270|NCT00631488|12986606|P2|COMPLETED|Overall Study||47
5282271|NCT00631488|12986607|P1|COMPLETED|Overall Study||44
5282272|NCT00631488|12986605|P3|Completed Post-Treatment Period|Overall Study||47
5282273|NCT00631488|12986606|P2|Completed Post-Treatment Period|Overall Study||47
5282274|NCT00631488|12986607|P1|Completed Post-Treatment Period|Overall Study||44
5282275|NCT00631488|12986605|P3|STARTED|Overall Study||49
5282276|NCT00631488|12986606|P2|STARTED|Overall Study||49
5282277|NCT00631488|12986607|P1|STARTED|Overall Study||48
5282278|NCT00631475|12986627|P1|NOT COMPLETED|Overall Study||45
5282279|NCT00631475|12986627|P1|COMPLETED|Overall Study||83
5282280|NCT00631475|12986627|P1|STARTED|Overall Study||128
5282281|NCT00631449|12986637|P2|NOT COMPLETED|Overall Study||0
5282282|NCT00631449|12986638|P1|NOT COMPLETED|Overall Study||0
5282283|NCT00631449|12986637|P2|COMPLETED|Overall Study||15
5282284|NCT00631449|12986638|P1|COMPLETED|Overall Study||15
5282285|NCT00631449|12986637|P2|STARTED|Overall Study||15
5282286|NCT00631449|12986638|P1|STARTED|Overall Study||15
5282287|NCT00631410|12986646|P2|NOT COMPLETED|Overall Study||6
5282288|NCT00631410|12986647|P1|NOT COMPLETED|Overall Study||6
5282289|NCT00631410|12986646|P2|COMPLETED|Overall Study||0
5282290|NCT00631410|12986647|P1|COMPLETED|Overall Study||0
5282291|NCT00631410|12986646|P2|STARTED|Overall Study||6
5282292|NCT00631410|12986647|P1|STARTED|Overall Study||6
5282293|NCT00631371|12986666|P2|NOT COMPLETED|Overall Study||391
5282294|NCT00631371|12986667|P1|NOT COMPLETED|Overall Study||400
5282295|NCT00631371|12986666|P2|COMPLETED|Overall Study||0
5282296|NCT00631371|12986667|P1|COMPLETED|Overall Study||0
5282297|NCT00631371|12986666|P2|Treated|Overall Study||391
5282298|NCT00631371|12986667|P1|Treated|Overall Study||393
5282299|NCT00631371|12986666|P2|STARTED|Overall Study||391
5282300|NCT00631371|12986667|P1|STARTED|Overall Study||400
5282301|NCT00631358|12986681|P2|NOT COMPLETED|Overall Study||2
5282302|NCT00631358|12986682|P1|NOT COMPLETED|Overall Study||6
5282303|NCT00631358|12986681|P2|COMPLETED|Overall Study||45
5282304|NCT00631358|12986682|P1|COMPLETED|Overall Study||44
5282305|NCT00631358|12986681|P2|STARTED|Overall Study||47
5282306|NCT00631358|12986682|P1|STARTED|Overall Study||50
5282307|NCT00631189|12986700|P4|NOT COMPLETED|Treatment Phase||7
5282308|NCT00631189|12986701|P3|NOT COMPLETED|Treatment Phase||11
5282309|NCT00631189|12986702|P2|NOT COMPLETED|Treatment Phase||7
5282310|NCT00631189|12986703|P1|NOT COMPLETED|Treatment Phase||0
5282311|NCT00631189|12986700|P4|COMPLETED|Treatment Phase||103
5282312|NCT00631189|12986701|P3|COMPLETED|Treatment Phase||92
5282313|NCT00631189|12986702|P2|COMPLETED|Treatment Phase||97
5282314|NCT00631189|12986703|P1|COMPLETED|Treatment Phase||0
5282315|NCT00631189|12986700|P4|STARTED|Treatment Phase||110
5282316|NCT00631189|12986701|P3|STARTED|Treatment Phase||103
5282317|NCT00631189|12986702|P2|STARTED|Treatment Phase||104
5282318|NCT00631189|12986703|P1|STARTED|Treatment Phase||0
5282319|NCT00631189|12986700|P4|NOT COMPLETED|Initial Phase||0
5282320|NCT00631189|12986701|P3|NOT COMPLETED|Initial Phase||0
5282321|NCT00631189|12986702|P2|NOT COMPLETED|Initial Phase||0
5282322|NCT00631189|12986703|P1|NOT COMPLETED|Initial Phase||351
5282323|NCT00631189|12986700|P4|COMPLETED|Initial Phase||0
5282324|NCT00631189|12986701|P3|COMPLETED|Initial Phase||0
5282325|NCT00631189|12986702|P2|COMPLETED|Initial Phase||0
5282326|NCT00631189|12986703|P1|COMPLETED|Initial Phase||317
5282327|NCT00631189|12986700|P4|STARTED|Initial Phase||0
5282328|NCT00631189|12986701|P3|STARTED|Initial Phase||0
5282329|NCT00631189|12986702|P2|STARTED|Initial Phase||0
5282330|NCT00631189|12986703|P1|STARTED|Initial Phase||668
5282331|NCT00631137|12986747|P2|NOT COMPLETED|Overall Study||0
5282332|NCT00631137|12986748|P1|NOT COMPLETED|Overall Study||1
5282333|NCT00631137|12986747|P2|COMPLETED|Overall Study||0
5282334|NCT00631137|12986748|P1|COMPLETED|Overall Study||0
5282335|NCT00631137|12986747|P2|STARTED|Overall Study||0
5282336|NCT00631137|12986748|P1|STARTED|Overall Study||1
5282337|NCT00631020|12986766|P1|NOT COMPLETED|Overall Study||8
5282338|NCT00631020|12986766|P1|COMPLETED|Overall Study||26
5282339|NCT00631020|12986766|P1|STARTED|Overall Study||34
5282340|NCT00631007|12986781|P6|NOT COMPLETED|Overall Study||15
5282341|NCT00631007|12986782|P5|NOT COMPLETED|Overall Study||12
5282342|NCT00631007|12986783|P4|NOT COMPLETED|Overall Study||9
5282343|NCT00631007|12986784|P3|NOT COMPLETED|Overall Study||10
5282344|NCT00631007|12986785|P2|NOT COMPLETED|Overall Study||11
5282345|NCT00631007|12986786|P1|NOT COMPLETED|Overall Study||11
5282346|NCT00631007|12986781|P6|COMPLETED|Overall Study||46
5282347|NCT00631007|12986782|P5|COMPLETED|Overall Study||48
5282348|NCT00631007|12986783|P4|COMPLETED|Overall Study||53
5282349|NCT00631007|12986784|P3|COMPLETED|Overall Study||53
5282350|NCT00631007|12986785|P2|COMPLETED|Overall Study||50
5282351|NCT00631007|12986786|P1|COMPLETED|Overall Study||49
5282352|NCT00631007|12986781|P6|STARTED|Overall Study||61
5282353|NCT00631007|12986782|P5|STARTED|Overall Study||60
5282354|NCT00631007|12986783|P4|STARTED|Overall Study||62
5282355|NCT00631007|12986784|P3|STARTED|Overall Study||63
5282356|NCT00631007|12986785|P2|STARTED|Overall Study||61
5282357|NCT00631007|12986786|P1|STARTED|Overall Study||60
5282358|NCT00630994|12986806|P1|NOT COMPLETED|Overall Study||4
5282359|NCT00630994|12986806|P1|COMPLETED|Overall Study||0
5282360|NCT00630994|12986806|P1|STARTED|Overall Study||4
5282361|NCT00630955|12986817|P3|NOT COMPLETED|Overall Study||12
5282362|NCT00630955|12986818|P2|NOT COMPLETED|Overall Study||6
5282363|NCT00630955|12986819|P1|NOT COMPLETED|Overall Study||3
5282364|NCT00630955|12986817|P3|COMPLETED|Overall Study||28
5282365|NCT00630955|12986818|P2|COMPLETED|Overall Study||31
5282366|NCT00630955|12986819|P1|COMPLETED|Overall Study||31
5282367|NCT00630955|12986817|P3|STARTED|Overall Study||40
5282368|NCT00630955|12986818|P2|STARTED|Overall Study||37
5282369|NCT00630955|12986819|P1|STARTED|Overall Study||34
5282370|NCT00630916|12986836|P1|NOT COMPLETED|Overall Study||210
5282371|NCT00630916|12986836|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
5282372|NCT00630916|12986836|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
5282373|NCT00630916|12986836|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
5282374|NCT00630877|12986846|P3|NOT COMPLETED|Overall Study||10
5282375|NCT00630877|12986847|P2|NOT COMPLETED|Overall Study||15
5282376|NCT00630877|12986848|P1|NOT COMPLETED|Overall Study||19
5282377|NCT00630877|12986846|P3|COMPLETED|Overall Study||80
5282378|NCT00630877|12986847|P2|COMPLETED|Overall Study||75
5282379|NCT00630877|12986848|P1|COMPLETED|Overall Study||72
5282380|NCT00630877|12986846|P3|STARTED|Overall Study||90
5282381|NCT00630877|12986847|P2|STARTED|Overall Study||90
5282382|NCT00630877|12986848|P1|STARTED|Overall Study|For all arms, started means treated.|91
5282383|NCT00630864|12986866|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
5282384|NCT00630864|12986866|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
5282385|NCT00630864|12986866|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
5282386|NCT00630864|12986866|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
5282387|NCT00630864|12986866|P1|COMPLETED|Part 1 (up to Week 6)||20
5282388|NCT00630864|12986866|P1|STARTED|Part 1 (up to Week 6)||21
5282389|NCT00630838|12986905|P2|NOT COMPLETED|Overall Study||2
5282390|NCT00630838|12986906|P1|NOT COMPLETED|Overall Study||0
5282391|NCT00630838|12986905|P2|COMPLETED|Overall Study||28
5282392|NCT00630838|12986906|P1|COMPLETED|Overall Study||32
5282393|NCT00630838|12986905|P2|STARTED|Overall Study||30
5282394|NCT00630838|12986906|P1|STARTED|Overall Study||32
5282395|NCT00630825|12986918|P4|NOT COMPLETED|Overall Study||6
5282396|NCT00630825|12986919|P3|NOT COMPLETED|Overall Study||8
5282397|NCT00630825|12986920|P2|NOT COMPLETED|Overall Study||7
5282398|NCT00630825|12986921|P1|NOT COMPLETED|Overall Study||9
5282399|NCT00630825|12986918|P4|COMPLETED|Overall Study||60
5282400|NCT00630825|12986919|P3|COMPLETED|Overall Study||58
5282401|NCT00630825|12986920|P2|COMPLETED|Overall Study||58
5282402|NCT00630825|12986921|P1|COMPLETED|Overall Study||56
5282403|NCT00630825|12986918|P4|Received at Least One Dose of Study Drug|Overall Study||66
5282404|NCT00630825|12986919|P3|Received at Least One Dose of Study Drug|Overall Study||66
5282405|NCT00630825|12986920|P2|Received at Least One Dose of Study Drug|Overall Study||65
5282406|NCT00630825|12986921|P1|Received at Least One Dose of Study Drug|Overall Study||65
5282407|NCT00630825|12986918|P4|STARTED|Overall Study||66
5282408|NCT00630825|12986919|P3|STARTED|Overall Study||66
5282409|NCT00630825|12986920|P2|STARTED|Overall Study||65
5282410|NCT00630825|12986921|P1|STARTED|Overall Study||65
5282411|NCT00630786|12986993|P3|NOT COMPLETED|Overall Study||2
5282412|NCT00630786|12986994|P2|NOT COMPLETED|Overall Study||2
5282413|NCT00630786|12986995|P1|NOT COMPLETED|Overall Study||1
5282414|NCT00630786|12986993|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
5282415|NCT00630786|12986994|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
5282416|NCT00630786|12986995|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
5282417|NCT00630786|12986993|P3|Received Study Medication|Overall Study||8
5282418|NCT00630786|12986994|P2|Received Study Medication|Overall Study||25
5282419|NCT00630786|12986995|P1|Received Study Medication|Overall Study||19
5282420|NCT00630786|12986993|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
5282421|NCT00630786|12986994|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
5282422|NCT00630786|12986995|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
5282423|NCT00630747|12987014|P1|NOT COMPLETED|Overall Study||9
5282424|NCT00630747|12987014|P1|COMPLETED|Overall Study||85
5282425|NCT00630747|12987014|P1|Participants Treated in Phase I of Study|Overall Study||94
5282426|NCT00630747|12987014|P1|STARTED|Overall Study||94
5282427|NCT00630734|12987026|P3|NOT COMPLETED|Overall Study||1
5282428|NCT00630734|12987027|P2|NOT COMPLETED|Overall Study||1
5282429|NCT00630734|12987028|P1|NOT COMPLETED|Overall Study||2
5282430|NCT00630734|12987026|P3|COMPLETED|Overall Study||7
5282431|NCT00630734|12987027|P2|COMPLETED|Overall Study||12
5282432|NCT00630734|12987028|P1|COMPLETED|Overall Study||9
5282433|NCT00630734|12987026|P3|STARTED|Overall Study||8
5282434|NCT00630734|12987027|P2|STARTED|Overall Study||13
5282435|NCT00630734|12987028|P1|STARTED|Overall Study||11
5282436|NCT00630539|12987067|P4|NOT COMPLETED|Overall Study||3
5282437|NCT00630539|12987068|P3|NOT COMPLETED|Overall Study||1
5282438|NCT00630539|12987069|P2|NOT COMPLETED|Overall Study||4
5282439|NCT00630539|12987070|P1|NOT COMPLETED|Overall Study||1
5282440|NCT00630539|12987067|P4|COMPLETED|Overall Study||27
5282441|NCT00630539|12987068|P3|COMPLETED|Overall Study||28
5282442|NCT00630539|12987069|P2|COMPLETED|Overall Study||29
5282443|NCT00630539|12987070|P1|COMPLETED|Overall Study||33
5282444|NCT00630539|12987067|P4|STARTED|Overall Study||30
5282445|NCT00630539|12987068|P3|STARTED|Overall Study||29
5282446|NCT00630539|12987069|P2|STARTED|Overall Study||33
5282447|NCT00630539|12987070|P1|STARTED|Overall Study||34
5282448|NCT00630487|12987126|P2|NOT COMPLETED|Overall Study||0
5282449|NCT00630487|12987127|P1|NOT COMPLETED|Overall Study||0
5282450|NCT00630487|12987126|P2|COMPLETED|Overall Study||0
5282451|NCT00630487|12987127|P1|COMPLETED|Overall Study||0
5282452|NCT00630487|12987126|P2|STARTED|Overall Study||0
5282453|NCT00630487|12987127|P1|STARTED|Overall Study||0
5282454|NCT00630409|12987161|P1|NOT COMPLETED|Overall Study||1
5282455|NCT00630409|12987161|P1|COMPLETED|Overall Study||4
5282456|NCT00630409|12987161|P1|STARTED|Overall Study||5
5282457|NCT00630396|12987166|P1|NOT COMPLETED|Overall Study||7
5282458|NCT00630396|12987166|P1|COMPLETED|Overall Study||53
5282459|NCT00630396|12987166|P1|STARTED|Overall Study||60
5282460|NCT00630344|12987172|P1|NOT COMPLETED|Overall Study||36
5282461|NCT00630344|12987172|P1|COMPLETED|Overall Study||0
5282462|NCT00630344|12987172|P1|STARTED|Overall Study||36
5282463|NCT00630331|12987184|P3|NOT COMPLETED|Overall Study||188
5282464|NCT00630331|12987185|P2|NOT COMPLETED|Overall Study||166
5282465|NCT00630331|12987186|P1|NOT COMPLETED|Overall Study||206
5282466|NCT00630331|12987184|P3|COMPLETED|Overall Study||3712
5282467|NCT00630331|12987185|P2|COMPLETED|Overall Study||3510
5282468|NCT00630331|12987186|P1|COMPLETED|Overall Study||3622
5282469|NCT00630331|12987184|P3|STARTED|Overall Study||3900
5282470|NCT00630331|12987185|P2|STARTED|Overall Study||3676
5282471|NCT00630331|12987186|P1|STARTED|Overall Study||3828
5282472|NCT00630305|12987227|P1|NOT COMPLETED|Overall Study||2
5282473|NCT00630305|12987227|P1|COMPLETED|Overall Study||35
5282474|NCT00630305|12987227|P1|STARTED|Overall Study||37
5282475|NCT00630292|12987249|P1|NOT COMPLETED|Overall Study||1
5282476|NCT00630292|12987249|P1|COMPLETED|Overall Study||5
5282477|NCT00630292|12987249|P1|STARTED|Overall Study||6
5282478|NCT00630058|12987255|P2|NOT COMPLETED|Overall Study||4
5282479|NCT00630058|12987256|P1|NOT COMPLETED|Overall Study||4
5282480|NCT00630058|12987255|P2|COMPLETED|Overall Study||6
5282481|NCT00630058|12987256|P1|COMPLETED|Overall Study||6
5282482|NCT00630058|12987255|P2|STARTED|Overall Study||10
5282483|NCT00630058|12987256|P1|STARTED|Overall Study||10
5282484|NCT00629850|12987274|P2|NOT COMPLETED|Overall Study||0
5282485|NCT00629850|12987275|P1|NOT COMPLETED|Overall Study||0
5282486|NCT00629850|12987274|P2|COMPLETED|Overall Study||0
5282487|NCT00629850|12987275|P1|COMPLETED|Overall Study||1
5282488|NCT00629850|12987274|P2|STARTED|Overall Study||0
5282489|NCT00629850|12987275|P1|STARTED|Overall Study||1
5282490|NCT00629772|12987287|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
5282491|NCT00629772|12987288|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
5282492|NCT00629772|12987287|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
5282493|NCT00629772|12987288|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
5282494|NCT00629772|12987287|P2|STARTED|Second Intervention Week 14 - Week 26||12
5282495|NCT00629772|12987288|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
5282496|NCT00629772|12987287|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
5282497|NCT00629772|12987288|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
5282498|NCT00629772|12987287|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
5282499|NCT00629772|12987288|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
5282500|NCT00629772|12987287|P2|STARTED|First Intervention - Day 0 - Week 14||12
5282501|NCT00629772|12987288|P1|STARTED|First Intervention - Day 0 - Week 14||12
5282502|NCT00629707|12987308|P2|NOT COMPLETED|Overall Study||2
5282503|NCT00629707|12987309|P1|NOT COMPLETED|Overall Study||0
5282504|NCT00629707|12987308|P2|COMPLETED|Overall Study||8
5282505|NCT00629707|12987309|P1|COMPLETED|Overall Study||10
5282506|NCT00629707|12987308|P2|STARTED|Overall Study||10
5282507|NCT00629707|12987309|P1|STARTED|Overall Study||10
5282508|NCT00629525|12987315|P1|NOT COMPLETED|Overall Study||3
5282509|NCT00629525|12987315|P1|COMPLETED|Overall Study||32
5282510|NCT00629525|12987315|P1|STARTED|Overall Study||35
5282511|NCT00629499|12987323|P1|NOT COMPLETED|Overall Study||0
5282512|NCT00629499|12987323|P1|COMPLETED|Overall Study||63
5282513|NCT00629499|12987323|P1|STARTED|Overall Study||63
5282514|NCT00629265|12987329|P2|NOT COMPLETED|Overall Study||20
5282515|NCT00629265|12987330|P1|NOT COMPLETED|Overall Study||32
5282516|NCT00629265|12987329|P2|COMPLETED|Overall Study||34
5282517|NCT00629265|12987330|P1|COMPLETED|Overall Study||84
5282518|NCT00629265|12987329|P2|STARTED|Overall Study||54
5282519|NCT00629265|12987330|P1|STARTED|Overall Study||116
5282520|NCT00629239|12987340|P2|NOT COMPLETED|Overall Study||4
5282521|NCT00629239|12987341|P1|NOT COMPLETED|Overall Study||8
5282522|NCT00629239|12987340|P2|COMPLETED|Overall Study||28
5282523|NCT00629239|12987341|P1|COMPLETED|Overall Study||26
5282524|NCT00629239|12987340|P2|STARTED|Overall Study||32
5282525|NCT00629239|12987341|P1|STARTED|Overall Study||34
5282526|NCT00629122|12987375|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
5282527|NCT00629122|12987376|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
5282528|NCT00629122|12987375|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
5282529|NCT00629122|12987376|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
5282530|NCT00629122|12987375|P2|STARTED|Third Period: Day 6-8 (Oral)||3
5282531|NCT00629122|12987376|P1|STARTED|Third Period: Day 6-8 (Oral)||2
5282532|NCT00629122|12987375|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
5282533|NCT00629122|12987376|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
5282534|NCT00629122|12987375|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
5282535|NCT00629122|12987376|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
5282536|NCT00629122|12987375|P2|STARTED|Second Period: Day 3-5 (Washout)||3
5282537|NCT00629122|12987376|P1|STARTED|Second Period: Day 3-5 (Washout)||2
5282538|NCT00629122|12987375|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
5282539|NCT00629122|12987376|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
5282540|NCT00629122|12987375|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
5282541|NCT00629122|12987376|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
5282542|NCT00629122|12987375|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
5282543|NCT00629122|12987376|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
5282544|NCT00629083|12987394|P2|NOT COMPLETED|Overall Study||14
5282545|NCT00629083|12987395|P1|NOT COMPLETED|Overall Study||28
5282546|NCT00629083|12987394|P2|COMPLETED|Overall Study||103
5282547|NCT00629083|12987395|P1|COMPLETED|Overall Study||200
5282548|NCT00629083|12987394|P2|STARTED|Overall Study||117
5282549|NCT00629083|12987395|P1|STARTED|Overall Study||228
5282550|NCT00629018|12987415|P2|NOT COMPLETED|Overall Study||0
5282551|NCT00629018|12987416|P1|NOT COMPLETED|Overall Study||0
5282552|NCT00629018|12987415|P2|COMPLETED|Overall Study||55
5282553|NCT00629018|12987416|P1|COMPLETED|Overall Study||55
5282554|NCT00629018|12987415|P2|STARTED|Overall Study||55
5282555|NCT00629018|12987416|P1|STARTED|Overall Study||55
5282556|NCT00628927|12987426|P2|NOT COMPLETED|Overall Study||0
5282557|NCT00628927|12987427|P1|NOT COMPLETED|Overall Study||8
5282558|NCT00628927|12987426|P2|COMPLETED|Overall Study||30
5282559|NCT00628927|12987427|P1|COMPLETED|Overall Study||175
5282560|NCT00628927|12987426|P2|STARTED|Overall Study||30
5282561|NCT00628927|12987427|P1|STARTED|Overall Study||183
5282562|NCT00628901|12987440|P2|NOT COMPLETED|Overall Study||1
5282563|NCT00628901|12987441|P1|NOT COMPLETED|Overall Study||3
5282564|NCT00628901|12987440|P2|COMPLETED|Overall Study||29
5282565|NCT00628901|12987441|P1|COMPLETED|Overall Study||27
5282566|NCT00628901|12987440|P2|STARTED|Overall Study||30
5282567|NCT00628901|12987441|P1|STARTED|Overall Study||30
5282568|NCT00628862|12987472|P3|NOT COMPLETED|Overall Study||22
5282569|NCT00628862|12987473|P2|NOT COMPLETED|Overall Study||17
5282570|NCT00628862|12987474|P1|NOT COMPLETED|Overall Study||11
5282571|NCT00628862|12987472|P3|COMPLETED|Overall Study|randomised patients|186
5282572|NCT00628862|12987473|P2|COMPLETED|Overall Study|randomised patients|182
5282573|NCT00628862|12987474|P1|COMPLETED|Overall Study|randomised patients|195
5282574|NCT00628862|12987472|P3|STARTED|Overall Study|randomised patients|208
5282575|NCT00628862|12987473|P2|STARTED|Overall Study|randomised patients|199
5282576|NCT00628862|12987474|P1|STARTED|Overall Study|randomised patients|206
5282577|NCT00628758|12987520|P2|NOT COMPLETED|Overall Study||42
5282578|NCT00628758|12987521|P1|NOT COMPLETED|Overall Study||44
5282579|NCT00628758|12987520|P2|COMPLETED|Overall Study||179
5282580|NCT00628758|12987521|P1|COMPLETED|Overall Study||165
5282581|NCT00628758|12987520|P2|STARTED|Overall Study||221
5282582|NCT00628758|12987521|P1|STARTED|Overall Study||209
5282583|NCT00628628|12987535|P2|NOT COMPLETED|Overall Study||0
5282584|NCT00628628|12987536|P1|NOT COMPLETED|Overall Study||0
5282585|NCT00628628|12987535|P2|COMPLETED|Overall Study||40
5282586|NCT00628628|12987536|P1|COMPLETED|Overall Study||40
5282587|NCT00628628|12987535|P2|STARTED|Overall Study||40
5282588|NCT00628628|12987536|P1|STARTED|Overall Study||40
5282589|NCT00628589|12987545|P3|NOT COMPLETED|Overall Study||3
5282590|NCT00628589|12987546|P2|NOT COMPLETED|Overall Study||2
5282591|NCT00628589|12987547|P1|NOT COMPLETED|Overall Study||1
5282592|NCT00628589|12987545|P3|COMPLETED|Overall Study||110
5282593|NCT00628589|12987546|P2|COMPLETED|Overall Study||114
5282594|NCT00628589|12987547|P1|COMPLETED|Overall Study||114
5282595|NCT00628589|12987545|P3|STARTED|Overall Study||113
5282596|NCT00628589|12987546|P2|STARTED|Overall Study||116
5282597|NCT00628589|12987547|P1|STARTED|Overall Study||115
5282598|NCT00628498|12987561|P1|NOT COMPLETED|Overall Study||52
5282599|NCT00628498|12987561|P1|COMPLETED|Overall Study||1154
5282600|NCT00628498|12987561|P1|STARTED|Overall Study||1206
5282601|NCT00628446|12987565|P1|NOT COMPLETED|Overall Study||7
5282602|NCT00628446|12987565|P1|COMPLETED|Overall Study||38
5282603|NCT00628446|12987565|P1|STARTED|Overall Study||45
5282604|NCT00628407|12987570|P1|NOT COMPLETED|Overall Study||0
5282605|NCT00628407|12987570|P1|COMPLETED|Overall Study||13
5282606|NCT00628407|12987570|P1|STARTED|Overall Study||13
5282607|NCT00628355|12987576|P2|NOT COMPLETED|Overall Study||1
5282608|NCT00628355|12987577|P1|NOT COMPLETED|Overall Study||1
5282609|NCT00628355|12987576|P2|COMPLETED|Overall Study||14
5282610|NCT00628355|12987577|P1|COMPLETED|Overall Study||14
5282611|NCT00628355|12987576|P2|STARTED|Overall Study||15
5282612|NCT00628355|12987577|P1|STARTED|Overall Study||15
5282613|NCT00628251|12987588|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
5282614|NCT00628251|12987589|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
5282615|NCT00628251|12987590|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
5282616|NCT00628251|12987588|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
5282617|NCT00628251|12987589|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
5282618|NCT00628251|12987590|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
5282619|NCT00628251|12987588|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
5282620|NCT00628251|12987589|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
5282621|NCT00628251|12987590|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
5282622|NCT00628251|12987588|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
5282623|NCT00628251|12987589|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
5282624|NCT00628251|12987590|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
5282625|NCT00628251|12987588|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
5282626|NCT00628251|12987589|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
5282627|NCT00628251|12987590|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
5282628|NCT00628251|12987588|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
5282629|NCT00628251|12987589|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
5282630|NCT00628251|12987590|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
5282631|NCT00628251|12987588|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
5282632|NCT00628251|12987589|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
5282633|NCT00628251|12987590|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
5282634|NCT00628251|12987588|P3|NOT COMPLETED|Randomised Part||1
5282635|NCT00628251|12987589|P2|NOT COMPLETED|Randomised Part||0
5282636|NCT00628251|12987590|P1|NOT COMPLETED|Randomised Part||0
5282637|NCT00628251|12987588|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
5282638|NCT00628251|12987589|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
5282639|NCT00628251|12987590|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
5282640|NCT00628251|12987588|P3|STARTED|Randomised Part|Patients randomised|33
5282641|NCT00628251|12987589|P2|STARTED|Randomised Part|Patients randomised|32
5282642|NCT00628251|12987590|P1|STARTED|Randomised Part|Patients randomised|32
5282643|NCT00628212|12987636|P4|NOT COMPLETED|Overall Study||5
5282644|NCT00628212|12987637|P3|NOT COMPLETED|Overall Study||3
5282645|NCT00628212|12987638|P2|NOT COMPLETED|Overall Study||1
5282646|NCT00628212|12987639|P1|NOT COMPLETED|Overall Study||3
5282647|NCT00628212|12987636|P4|COMPLETED|Overall Study||76
5282648|NCT00628212|12987637|P3|COMPLETED|Overall Study||76
5282649|NCT00628212|12987638|P2|COMPLETED|Overall Study||83
5282650|NCT00628212|12987639|P1|COMPLETED|Overall Study||77
5282651|NCT00628212|12987636|P4|STARTED|Overall Study||81
5282652|NCT00628212|12987637|P3|STARTED|Overall Study||79
5282653|NCT00628212|12987638|P2|STARTED|Overall Study||84
5282654|NCT00628212|12987639|P1|STARTED|Overall Study||80
5282655|NCT00628147|12987663|P2|NOT COMPLETED|Overall Study||1
5282656|NCT00628147|12987664|P1|NOT COMPLETED|Overall Study||7
5282657|NCT00628147|12987663|P2|COMPLETED|Overall Study||141
5282658|NCT00628147|12987664|P1|COMPLETED|Overall Study||135
5282659|NCT00628147|12987663|P2|STARTED|Overall Study||142
5282660|NCT00628147|12987664|P1|STARTED|Overall Study||142
5282661|NCT00628134|12987676|P2|NOT COMPLETED|Overall Study||0
5282662|NCT00628134|12987677|P1|NOT COMPLETED|Overall Study||0
5282663|NCT00628134|12987676|P2|COMPLETED|Overall Study||4
5282664|NCT00628134|12987677|P1|COMPLETED|Overall Study||4
5282665|NCT00628134|12987676|P2|STARTED|Overall Study||4
5282666|NCT00628134|12987677|P1|STARTED|Overall Study||4
5282667|NCT00628108|12987687|P2|NOT COMPLETED|Overall Study||3
5282668|NCT00628108|12987688|P1|NOT COMPLETED|Overall Study||1
5282669|NCT00628108|12987687|P2|COMPLETED|Overall Study||43
5282670|NCT00628108|12987688|P1|COMPLETED|Overall Study||22
5282671|NCT00628108|12987687|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
5282672|NCT00628108|12987688|P1|Safety Population|Overall Study||24
5282673|NCT00628108|12987687|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
5282674|NCT00628108|12987688|P1|STARTED|Overall Study||23
5282675|NCT00628030|12987720|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
5282676|NCT00628030|12987721|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
5282677|NCT00628030|12987720|P2|COMPLETED|Post to 6 Month Follow-up||33
5282678|NCT00628030|12987721|P1|COMPLETED|Post to 6 Month Follow-up||27
5282679|NCT00628030|12987720|P2|STARTED|Post to 6 Month Follow-up||63
5282680|NCT00628030|12987721|P1|STARTED|Post to 6 Month Follow-up||59
5282681|NCT00628030|12987720|P2|NOT COMPLETED|Baseline to Post-Assessment||29
5282682|NCT00628030|12987721|P1|NOT COMPLETED|Baseline to Post-Assessment||33
5282683|NCT00628030|12987720|P2|COMPLETED|Baseline to Post-Assessment||63
5282684|NCT00628030|12987721|P1|COMPLETED|Baseline to Post-Assessment||59
5282685|NCT00628030|12987720|P2|STARTED|Baseline to Post-Assessment||92
5282686|NCT00628030|12987721|P1|STARTED|Baseline to Post-Assessment||92
5282687|NCT00627978|12987737|P2|NOT COMPLETED|Overall Study||0
5282688|NCT00627978|12987738|P1|NOT COMPLETED|Overall Study||0
5282689|NCT00627978|12987737|P2|COMPLETED|Overall Study||5
5282690|NCT00627978|12987738|P1|COMPLETED|Overall Study||10
5282691|NCT00627978|12987737|P2|STARTED|Overall Study||5
5282692|NCT00627978|12987738|P1|STARTED|Overall Study||10
5282693|NCT00627926|12987747|P3|NOT COMPLETED|Overall Study||95
5282694|NCT00627926|12987748|P2|NOT COMPLETED|Overall Study||104
5282695|NCT00627926|12987749|P1|NOT COMPLETED|Overall Study||159
5282696|NCT00627926|12987747|P3|COMPLETED|Overall Study||268
5282697|NCT00627926|12987748|P2|COMPLETED|Overall Study||260
5282698|NCT00627926|12987749|P1|COMPLETED|Overall Study||202
5282699|NCT00627926|12987747|P3|STARTED|Overall Study||363
5282700|NCT00627926|12987748|P2|STARTED|Overall Study||364
5282701|NCT00627926|12987749|P1|STARTED|Overall Study||361
5282702|NCT00627861|12987793|P1|NOT COMPLETED|Overall Study||0
5282703|NCT00627861|12987793|P1|COMPLETED|Overall Study||1
5282704|NCT00627861|12987793|P1|STARTED|Overall Study||1
5282705|NCT00627705|12987801|P2|NOT COMPLETED|Overall Study||6
5282706|NCT00627705|12987802|P1|NOT COMPLETED|Overall Study||2
5282707|NCT00627705|12987801|P2|COMPLETED|Overall Study||12
5282708|NCT00627705|12987802|P1|COMPLETED|Overall Study||13
5282709|NCT00627705|12987801|P2|STARTED|Overall Study||18
5282710|NCT00627705|12987802|P1|STARTED|Overall Study||15
5282711|NCT00627679|12987822|P4|NOT COMPLETED|Overall Study||0
5282712|NCT00627679|12987823|P3|NOT COMPLETED|Overall Study||0
5282713|NCT00627679|12987824|P2|NOT COMPLETED|Overall Study||0
5282714|NCT00627679|12987825|P1|NOT COMPLETED|Overall Study||0
5282715|NCT00627679|12987822|P4|COMPLETED|Overall Study||4
5282716|NCT00627679|12987823|P3|COMPLETED|Overall Study||4
5282717|NCT00627679|12987824|P2|COMPLETED|Overall Study||4
5282718|NCT00627679|12987825|P1|COMPLETED|Overall Study||4
5282719|NCT00627679|12987822|P4|STARTED|Overall Study||4
5282720|NCT00627679|12987823|P3|STARTED|Overall Study||4
5282721|NCT00627679|12987824|P2|STARTED|Overall Study||4
5282722|NCT00627679|12987825|P1|STARTED|Overall Study||4
5282723|NCT00627523|12987853|P2|NOT COMPLETED|Overall Study||2
5282724|NCT00627523|12987854|P1|NOT COMPLETED|Overall Study||2
5282725|NCT00627523|12987853|P2|COMPLETED|Overall Study||20
5282726|NCT00627523|12987854|P1|COMPLETED|Overall Study||19
5282727|NCT00627523|12987853|P2|STARTED|Overall Study||22
5282728|NCT00627523|12987854|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
5282729|NCT00627497|12987882|P4|NOT COMPLETED|Overall Study||0
5282730|NCT00627497|12987883|P3|NOT COMPLETED|Overall Study||0
5282731|NCT00627497|12987884|P2|NOT COMPLETED|Overall Study||1
5282732|NCT00627497|12987885|P1|NOT COMPLETED|Overall Study||1
5282733|NCT00627497|12987882|P4|COMPLETED|Overall Study||2
5282734|NCT00627497|12987883|P3|COMPLETED|Overall Study||4
5282735|NCT00627497|12987884|P2|COMPLETED|Overall Study||11
5282736|NCT00627497|12987885|P1|COMPLETED|Overall Study||13
5282737|NCT00627497|12987882|P4|STARTED|Overall Study||2
5282738|NCT00627497|12987883|P3|STARTED|Overall Study||4
5282739|NCT00627497|12987884|P2|STARTED|Overall Study||12
5282740|NCT00627497|12987885|P1|STARTED|Overall Study||14
5282741|NCT00627458|12987946|P3|NOT COMPLETED|Overall Study||6
5282742|NCT00627458|12987947|P2|NOT COMPLETED|Overall Study||7
5282743|NCT00627458|12987948|P1|NOT COMPLETED|Overall Study||4
5282744|NCT00627458|12987946|P3|COMPLETED|Overall Study||133
5282745|NCT00627458|12987947|P2|COMPLETED|Overall Study||130
5282746|NCT00627458|12987948|P1|COMPLETED|Overall Study||123
5282747|NCT00627458|12987946|P3|STARTED|Overall Study||139
5282748|NCT00627458|12987947|P2|STARTED|Overall Study||137
5282749|NCT00627458|12987948|P1|STARTED|Overall Study||127
5282750|NCT00627445|12988023|P2|NOT COMPLETED|Overall Study||12
5282751|NCT00627445|12988024|P1|NOT COMPLETED|Overall Study||9
5282752|NCT00627445|12988023|P2|COMPLETED|Overall Study||210
5282753|NCT00627445|12988024|P1|COMPLETED|Overall Study||210
5282754|NCT00627445|12988023|P2|Exposed to Study Drug|Overall Study||222
5282755|NCT00627445|12988024|P1|Exposed to Study Drug|Overall Study||219
5282756|NCT00627445|12988023|P2|STARTED|Overall Study||222
5282757|NCT00627445|12988024|P1|STARTED|Overall Study||219
5282758|NCT00627406|12988048|P4|NOT COMPLETED|Overall Study||0
5282759|NCT00627406|12988049|P3|NOT COMPLETED|Overall Study||0
5282760|NCT00627406|12988050|P2|NOT COMPLETED|Overall Study||0
5282761|NCT00627406|12988051|P1|NOT COMPLETED|Overall Study||0
5282762|NCT00627406|12988048|P4|COMPLETED|Overall Study||141
5282763|NCT00627406|12988049|P3|COMPLETED|Overall Study||125
5282764|NCT00627406|12988050|P2|COMPLETED|Overall Study||58
5282765|NCT00627406|12988051|P1|COMPLETED|Overall Study||60
5282766|NCT00627406|12988048|P4|STARTED|Overall Study||141
5282767|NCT00627406|12988049|P3|STARTED|Overall Study||125
5282768|NCT00627406|12988050|P2|STARTED|Overall Study||58
5282769|NCT00627406|12988051|P1|STARTED|Overall Study||60
5282770|NCT00627393|12988067|P2|NOT COMPLETED|Per-Protocol Analysis||13
5282771|NCT00627393|12988068|P1|NOT COMPLETED|Per-Protocol Analysis||10
5282772|NCT00627393|12988067|P2|COMPLETED|Per-Protocol Analysis||35
5282773|NCT00627393|12988068|P1|COMPLETED|Per-Protocol Analysis||39
5282774|NCT00627393|12988067|P2|STARTED|Per-Protocol Analysis||48
5282775|NCT00627393|12988068|P1|STARTED|Per-Protocol Analysis||49
5282776|NCT00627393|12988067|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
5282777|NCT00627393|12988068|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
5282778|NCT00627393|12988067|P2|COMPLETED|Intention-To-Treat Analysis||48
5282779|NCT00627393|12988068|P1|COMPLETED|Intention-To-Treat Analysis||49
5282780|NCT00627393|12988067|P2|STARTED|Intention-To-Treat Analysis||56
5282781|NCT00627393|12988068|P1|STARTED|Intention-To-Treat Analysis||58
5282782|NCT00627367|12988089|P2|NOT COMPLETED|Overall Study||0
5282783|NCT00627367|12988090|P1|NOT COMPLETED|Overall Study||0
5282784|NCT00627367|12988089|P2|COMPLETED|Overall Study||112
5282785|NCT00627367|12988090|P1|COMPLETED|Overall Study||112
5282786|NCT00627367|12988089|P2|STARTED|Overall Study||112
5282787|NCT00627367|12988090|P1|STARTED|Overall Study||112
5282788|NCT00627094|12988104|P2|NOT COMPLETED|Overall Study||15
5282789|NCT00627094|12988105|P1|NOT COMPLETED|Overall Study||12
5282790|NCT00627094|12988104|P2|COMPLETED|Overall Study||45
5282791|NCT00627094|12988105|P1|COMPLETED|Overall Study||48
5282792|NCT00627094|12988104|P2|STARTED|Overall Study||60
5282793|NCT00627094|12988105|P1|STARTED|Overall Study||60
5282794|NCT00627042|12988117|P1|NOT COMPLETED|Overall Study||2
5282795|NCT00627042|12988117|P1|COMPLETED|Overall Study||40
5282796|NCT00627042|12988117|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
5282797|NCT00627042|12988117|P1|STARTED|Overall Study||42
5282798|NCT00627016|12988129|P2|NOT COMPLETED|Overall Study||6
5282799|NCT00627016|12988130|P1|NOT COMPLETED|Overall Study||6
5282800|NCT00627016|12988129|P2|COMPLETED|Overall Study||146
5282801|NCT00627016|12988130|P1|COMPLETED|Overall Study||147
5282802|NCT00627016|12988129|P2|STARTED|Overall Study||152
5282803|NCT00627016|12988130|P1|STARTED|Overall Study||153
5282804|NCT00626925|12988142|P2|NOT COMPLETED|Overall Study||9
5282805|NCT00626925|12988143|P1|NOT COMPLETED|Overall Study||12
5282806|NCT00626925|12988142|P2|COMPLETED|Overall Study||62
5282807|NCT00626925|12988143|P1|COMPLETED|Overall Study||55
5282808|NCT00626925|12988142|P2|STARTED|Overall Study||71
5282809|NCT00626925|12988143|P1|STARTED|Overall Study||67
5282810|NCT00626912|12988177|P2|NOT COMPLETED|Overall Study||10
5282811|NCT00626912|12988178|P1|NOT COMPLETED|Overall Study||2
5282812|NCT00626912|12988177|P2|COMPLETED|Overall Study||215
5282813|NCT00626912|12988178|P1|COMPLETED|Overall Study||220
5282814|NCT00626912|12988177|P2|STARTED|Overall Study||225
5282815|NCT00626912|12988178|P1|STARTED|Overall Study||222
5282816|NCT00626821|12988190|P1|NOT COMPLETED|Overall Study||221
5282817|NCT00626821|12988190|P1|COMPLETED|Overall Study||2796
5282818|NCT00626821|12988190|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
5282819|NCT00626821|12988190|P1|STARTED|Overall Study||3017
5282820|NCT00626808|12988198|P4|NOT COMPLETED|Overall Study||0
5282821|NCT00626808|12988199|P3|NOT COMPLETED|Overall Study||0
5282822|NCT00626808|12988200|P2|NOT COMPLETED|Overall Study||0
5282823|NCT00626808|12988201|P1|NOT COMPLETED|Overall Study||0
5282824|NCT00626808|12988198|P4|COMPLETED|Overall Study||2906
5282825|NCT00626808|12988199|P3|COMPLETED|Overall Study||30011
5282826|NCT00626808|12988200|P2|COMPLETED|Overall Study||34316
5282827|NCT00626808|12988201|P1|COMPLETED|Overall Study||254464
5282828|NCT00626808|12988198|P4|STARTED|Overall Study||2906
5282829|NCT00626808|12988199|P3|STARTED|Overall Study||30011
5282830|NCT00626808|12988200|P2|STARTED|Overall Study||34316
5282831|NCT00626808|12988201|P1|STARTED|Overall Study||254464
5282832|NCT00626795|12988270|P3|NOT COMPLETED|Blinded Treatment||9
5282833|NCT00626795|12988271|P2|NOT COMPLETED|Blinded Treatment||5
5282834|NCT00626795|12988272|P1|NOT COMPLETED|Blinded Treatment||10
5282835|NCT00626795|12988270|P3|COMPLETED|Blinded Treatment||196
5282836|NCT00626795|12988271|P2|COMPLETED|Blinded Treatment||200
5282837|NCT00626795|12988272|P1|COMPLETED|Blinded Treatment||194
5282838|NCT00626795|12988270|P3|STARTED|Blinded Treatment||205
5282839|NCT00626795|12988271|P2|STARTED|Blinded Treatment||205
5282840|NCT00626795|12988272|P1|STARTED|Blinded Treatment||204
5282841|NCT00626795|12988270|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
5282842|NCT00626795|12988271|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
5282843|NCT00626795|12988272|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
5282844|NCT00626795|12988270|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
5282845|NCT00626795|12988271|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
5282846|NCT00626795|12988272|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
5282847|NCT00626795|12988270|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
5282848|NCT00626795|12988271|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
5282849|NCT00626795|12988272|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
5282850|NCT00626782|12988301|P2|NOT COMPLETED|Overall Study||0
5282851|NCT00626782|12988302|P1|NOT COMPLETED|Overall Study||0
5282852|NCT00626782|12988301|P2|COMPLETED|Overall Study||12
5282853|NCT00626782|12988302|P1|COMPLETED|Overall Study||12
5282854|NCT00626782|12988301|P2|STARTED|Overall Study||12
5282855|NCT00626782|12988302|P1|STARTED|Overall Study||12
5282856|NCT00626743|12988312|P2|NOT COMPLETED|Treatment Period 2||0
5282857|NCT00626743|12988313|P1|NOT COMPLETED|Treatment Period 2||0
5282858|NCT00626743|12988312|P2|COMPLETED|Treatment Period 2||6
5282859|NCT00626743|12988313|P1|COMPLETED|Treatment Period 2||6
5282860|NCT00626743|12988312|P2|STARTED|Treatment Period 2||6
5282861|NCT00626743|12988313|P1|STARTED|Treatment Period 2||6
5282862|NCT00626743|12988312|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
5282863|NCT00626743|12988313|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
5282864|NCT00626743|12988312|P2|COMPLETED|Wash-out Period of 6 Days||6
5282865|NCT00626743|12988313|P1|COMPLETED|Wash-out Period of 6 Days||6
5282866|NCT00626743|12988312|P2|STARTED|Wash-out Period of 6 Days||6
5282867|NCT00626743|12988313|P1|STARTED|Wash-out Period of 6 Days||6
5282868|NCT00626743|12988312|P2|NOT COMPLETED|Treatment Period 1||1
5282869|NCT00626743|12988313|P1|NOT COMPLETED|Treatment Period 1||0
5282870|NCT00626743|12988312|P2|COMPLETED|Treatment Period 1||6
5282871|NCT00626743|12988313|P1|COMPLETED|Treatment Period 1||6
5282872|NCT00626743|12988312|P2|STARTED|Treatment Period 1||7
5282873|NCT00626743|12988313|P1|STARTED|Treatment Period 1||6
5282874|NCT00626639|12988323|P2|NOT COMPLETED|Overall Study||2
5282875|NCT00626639|12988324|P1|NOT COMPLETED|Overall Study||2
5282876|NCT00626639|12988323|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
5282877|NCT00626639|12988324|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
5282878|NCT00626639|12988323|P2|STARTED|Overall Study||3
5282879|NCT00626639|12988324|P1|STARTED|Overall Study||2
5282880|NCT00626626|12988344|P2|NOT COMPLETED|Overall Study||0
5282881|NCT00626626|12988345|P1|NOT COMPLETED|Overall Study||0
5282882|NCT00626626|12988344|P2|COMPLETED|Overall Study||3
5282883|NCT00626626|12988345|P1|COMPLETED|Overall Study||5
5282884|NCT00626626|12988344|P2|STARTED|Overall Study||3
5282885|NCT00626626|12988345|P1|STARTED|Overall Study||5
5282886|NCT00626574|12988357|P2|NOT COMPLETED|Overall Study||0
5282887|NCT00626574|12988358|P1|NOT COMPLETED|Overall Study||0
5282888|NCT00626574|12988357|P2|COMPLETED|Overall Study||1
5282889|NCT00626574|12988358|P1|COMPLETED|Overall Study||2
5282890|NCT00626574|12988357|P2|STARTED|Overall Study||1
5282891|NCT00626574|12988358|P1|STARTED|Overall Study||2
5282892|NCT00626561|12988370|P1|NOT COMPLETED|Overall Study||4
5282893|NCT00626561|12988370|P1|COMPLETED|Overall Study||0
5282894|NCT00626561|12988370|P1|STARTED|Overall Study||4
5282895|NCT00626548|12988376|P2|NOT COMPLETED|Overall Study||716
5282896|NCT00626548|12988377|P1|NOT COMPLETED|Overall Study||705
5282897|NCT00626548|12988376|P2|COMPLETED|Overall Study||0
5282898|NCT00626548|12988377|P1|COMPLETED|Overall Study||0
5282899|NCT00626548|12988376|P2|Patients Received Treatment|Overall Study||712
5282900|NCT00626548|12988377|P1|Patients Received Treatment|Overall Study||703
5282901|NCT00626548|12988376|P2|STARTED|Overall Study||716
5282902|NCT00626548|12988377|P1|STARTED|Overall Study||705
5282903|NCT00626522|12988391|P6|NOT COMPLETED|Overall Study||2
5282904|NCT00626522|12988392|P5|NOT COMPLETED|Overall Study||7
5282905|NCT00626522|12988393|P4|NOT COMPLETED|Overall Study||2
5282906|NCT00626522|12988394|P3|NOT COMPLETED|Overall Study||8
5282907|NCT00626522|12988395|P2|NOT COMPLETED|Overall Study||7
5282908|NCT00626522|12988396|P1|NOT COMPLETED|Overall Study||6
5282909|NCT00626522|12988391|P6|COMPLETED|Overall Study||57
5282910|NCT00626522|12988392|P5|COMPLETED|Overall Study||58
5282911|NCT00626522|12988393|P4|COMPLETED|Overall Study||74
5282912|NCT00626522|12988394|P3|COMPLETED|Overall Study||117
5282913|NCT00626522|12988395|P2|COMPLETED|Overall Study||113
5282914|NCT00626522|12988396|P1|COMPLETED|Overall Study||115
5282915|NCT00626522|12988391|P6|STARTED|Overall Study||59
5282916|NCT00626522|12988392|P5|STARTED|Overall Study||65
5282917|NCT00626522|12988393|P4|STARTED|Overall Study||76
5282918|NCT00626522|12988394|P3|STARTED|Overall Study||125
5282919|NCT00626522|12988395|P2|STARTED|Overall Study||120
5282920|NCT00626522|12988396|P1|STARTED|Overall Study||121
5282921|NCT00626444|12988434|P1|NOT COMPLETED|Overall Study||0
5282922|NCT00626444|12988434|P1|COMPLETED|Overall Study||2
5282923|NCT00626444|12988434|P1|STARTED|Overall Study||2
5282924|NCT00626431|12988441|P2|NOT COMPLETED|Overall Study||45
5282925|NCT00626431|12988442|P1|NOT COMPLETED|Overall Study||17
5282926|NCT00626431|12988441|P2|COMPLETED|Overall Study||114
5282927|NCT00626431|12988442|P1|COMPLETED|Overall Study||134
5282928|NCT00626431|12988441|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
5282929|NCT00626431|12988442|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
5282930|NCT00626405|12988459|P2|NOT COMPLETED|Overall Study||1
5282931|NCT00626405|12988460|P1|NOT COMPLETED|Overall Study||1
5282932|NCT00626405|12988459|P2|COMPLETED|Overall Study||51
5282933|NCT00626405|12988460|P1|COMPLETED|Overall Study||42
5282934|NCT00626405|12988459|P2|STARTED|Overall Study||52
5282935|NCT00626405|12988460|P1|STARTED|Overall Study||43
5282936|NCT00626392|12988476|P6|NOT COMPLETED|Coadministration Period||6
5282937|NCT00626392|12988477|P5|NOT COMPLETED|Coadministration Period||5
5282938|NCT00626392|12988478|P4|NOT COMPLETED|Coadministration Period||7
5282939|NCT00626392|12988479|P3|NOT COMPLETED|Coadministration Period||10
5282940|NCT00626392|12988480|P2|NOT COMPLETED|Coadministration Period||5
5282941|NCT00626392|12988481|P1|NOT COMPLETED|Coadministration Period||4
5282942|NCT00626392|12988476|P6|COMPLETED|Coadministration Period||38
5282943|NCT00626392|12988477|P5|COMPLETED|Coadministration Period||36
5282944|NCT00626392|12988478|P4|COMPLETED|Coadministration Period||36
5282945|NCT00626392|12988479|P3|COMPLETED|Coadministration Period||31
5282946|NCT00626392|12988480|P2|COMPLETED|Coadministration Period||38
5282947|NCT00626392|12988481|P1|COMPLETED|Coadministration Period||40
5282948|NCT00626392|12988476|P6|STARTED|Coadministration Period||44
5282949|NCT00626392|12988477|P5|STARTED|Coadministration Period||41
5282950|NCT00626392|12988478|P4|STARTED|Coadministration Period||43
5282951|NCT00626392|12988479|P3|STARTED|Coadministration Period||41
5282952|NCT00626392|12988480|P2|STARTED|Coadministration Period||43
5282953|NCT00626392|12988481|P1|STARTED|Coadministration Period||44
5282954|NCT00626392|12988476|P6|NOT COMPLETED|Run-in Period||1
5282955|NCT00626392|12988477|P5|NOT COMPLETED|Run-in Period||4
5282956|NCT00626392|12988478|P4|NOT COMPLETED|Run-in Period||1
5282957|NCT00626392|12988479|P3|NOT COMPLETED|Run-in Period||3
5282958|NCT00626392|12988480|P2|NOT COMPLETED|Run-in Period||1
5282959|NCT00626392|12988481|P1|NOT COMPLETED|Run-in Period||1
5282960|NCT00626392|12988476|P6|COMPLETED|Run-in Period||44
5282961|NCT00626392|12988477|P5|COMPLETED|Run-in Period||41
5282962|NCT00626392|12988478|P4|COMPLETED|Run-in Period||43
5282963|NCT00626392|12988479|P3|COMPLETED|Run-in Period||41
5282964|NCT00626392|12988480|P2|COMPLETED|Run-in Period||43
5282965|NCT00626392|12988481|P1|COMPLETED|Run-in Period||44
5282966|NCT00626392|12988476|P6|STARTED|Run-in Period||45
5282967|NCT00626392|12988477|P5|STARTED|Run-in Period||45
5282968|NCT00626392|12988478|P4|STARTED|Run-in Period||44
5282969|NCT00626392|12988479|P3|STARTED|Run-in Period||44
5282970|NCT00626392|12988480|P2|STARTED|Run-in Period||44
5282971|NCT00626392|12988481|P1|STARTED|Run-in Period||45
5282972|NCT00626366|12988495|P2|NOT COMPLETED|Overall Study||0
5282973|NCT00626366|12988496|P1|NOT COMPLETED|Overall Study||0
5282974|NCT00626366|12988495|P2|COMPLETED|Overall Study||9
5282975|NCT00626366|12988496|P1|COMPLETED|Overall Study||9
5282976|NCT00626366|12988495|P2|STARTED|Overall Study||9
5282977|NCT00626366|12988496|P1|STARTED|Overall Study||9
5282978|NCT00626340|12988502|P1|NOT COMPLETED|Overall Study||0
5282979|NCT00626340|12988502|P1|COMPLETED|Overall Study||18
5282980|NCT00626340|12988502|P1|STARTED|Overall Study||18
5282981|NCT00626327|12988509|P3|NOT COMPLETED|Overall Study||88
5282982|NCT00626327|12988510|P2|NOT COMPLETED|Overall Study||59
5282983|NCT00626327|12988511|P1|NOT COMPLETED|Overall Study||78
5282984|NCT00626327|12988509|P3|COMPLETED|Overall Study||422
5282985|NCT00626327|12988510|P2|COMPLETED|Overall Study||557
5282986|NCT00626327|12988511|P1|COMPLETED|Overall Study||426
5282987|NCT00626327|12988509|P3|STARTED|Overall Study||510
5282988|NCT00626327|12988510|P2|STARTED|Overall Study||616
5282989|NCT00626327|12988511|P1|STARTED|Overall Study||504
5282990|NCT00626275|12988537|P8|NOT COMPLETED|Part B||1
5282991|NCT00626275|12988538|P7|NOT COMPLETED|Part B||1
5282992|NCT00626275|12988539|P6|NOT COMPLETED|Part B||0
5282993|NCT00626275|12988540|P5|NOT COMPLETED|Part B||0
5282994|NCT00626275|12988541|P4|NOT COMPLETED|Part B||0
5282995|NCT00626275|12988542|P3|NOT COMPLETED|Part B||0
5282996|NCT00626275|12988543|P2|NOT COMPLETED|Part B||0
5282997|NCT00626275|12988544|P1|NOT COMPLETED|Part B||0
5282998|NCT00626275|12988537|P8|COMPLETED|Part B||23
5282999|NCT00626275|12988538|P7|COMPLETED|Part B||19
5283000|NCT00626275|12988539|P6|COMPLETED|Part B||0
5283001|NCT00626275|12988540|P5|COMPLETED|Part B||0
5283002|NCT00626275|12988541|P4|COMPLETED|Part B||0
5283003|NCT00626275|12988542|P3|COMPLETED|Part B||0
5283004|NCT00626275|12988543|P2|COMPLETED|Part B||0
5283005|NCT00626275|12988544|P1|COMPLETED|Part B||0
5283006|NCT00626275|12988537|P8|STARTED|Part B||24
5283007|NCT00626275|12988538|P7|STARTED|Part B||20
5283008|NCT00626275|12988539|P6|STARTED|Part B||0
5283009|NCT00626275|12988540|P5|STARTED|Part B||0
5283010|NCT00626275|12988541|P4|STARTED|Part B||0
5283011|NCT00626275|12988542|P3|STARTED|Part B||0
5283012|NCT00626275|12988543|P2|STARTED|Part B||0
5283013|NCT00626275|12988544|P1|STARTED|Part B||0
5283014|NCT00626275|12988537|P8|NOT COMPLETED|Re-randomization Period for Part B||0
5283015|NCT00626275|12988538|P7|NOT COMPLETED|Re-randomization Period for Part B||0
5283016|NCT00626275|12988539|P6|NOT COMPLETED|Re-randomization Period for Part B||0
5283017|NCT00626275|12988540|P5|NOT COMPLETED|Re-randomization Period for Part B||0
5283018|NCT00626275|12988541|P4|NOT COMPLETED|Re-randomization Period for Part B||0
5283019|NCT00626275|12988542|P3|NOT COMPLETED|Re-randomization Period for Part B||0
5283020|NCT00626275|12988543|P2|NOT COMPLETED|Re-randomization Period for Part B||0
5283021|NCT00626275|12988544|P1|NOT COMPLETED|Re-randomization Period for Part B||0
5283022|NCT00626275|12988537|P8|COMPLETED|Re-randomization Period for Part B||24
5283023|NCT00626275|12988538|P7|COMPLETED|Re-randomization Period for Part B||20
5283024|NCT00626275|12988539|P6|COMPLETED|Re-randomization Period for Part B||0
5283025|NCT00626275|12988540|P5|COMPLETED|Re-randomization Period for Part B||0
5283026|NCT00626275|12988541|P4|COMPLETED|Re-randomization Period for Part B||0
5283027|NCT00626275|12988542|P3|COMPLETED|Re-randomization Period for Part B||0
5283028|NCT00626275|12988543|P2|COMPLETED|Re-randomization Period for Part B||0
5283029|NCT00626275|12988544|P1|COMPLETED|Re-randomization Period for Part B||0
5283030|NCT00626275|12988537|P8|STARTED|Re-randomization Period for Part B||24
5283031|NCT00626275|12988538|P7|STARTED|Re-randomization Period for Part B||20
5283032|NCT00626275|12988539|P6|STARTED|Re-randomization Period for Part B||0
5283033|NCT00626275|12988540|P5|STARTED|Re-randomization Period for Part B||0
5283034|NCT00626275|12988541|P4|STARTED|Re-randomization Period for Part B||0
5283035|NCT00626275|12988542|P3|STARTED|Re-randomization Period for Part B||0
5283036|NCT00626275|12988543|P2|STARTED|Re-randomization Period for Part B||0
5283037|NCT00626275|12988544|P1|STARTED|Re-randomization Period for Part B||0
5283038|NCT00626275|12988537|P8|NOT COMPLETED|Part A - Treatment Period 3||0
5283039|NCT00626275|12988538|P7|NOT COMPLETED|Part A - Treatment Period 3||0
5283040|NCT00626275|12988539|P6|NOT COMPLETED|Part A - Treatment Period 3||0
5283041|NCT00626275|12988540|P5|NOT COMPLETED|Part A - Treatment Period 3||0
5283042|NCT00626275|12988541|P4|NOT COMPLETED|Part A - Treatment Period 3||0
5283043|NCT00626275|12988542|P3|NOT COMPLETED|Part A - Treatment Period 3||0
5283044|NCT00626275|12988543|P2|NOT COMPLETED|Part A - Treatment Period 3||0
5283045|NCT00626275|12988544|P1|NOT COMPLETED|Part A - Treatment Period 3||0
5283046|NCT00626275|12988537|P8|COMPLETED|Part A - Treatment Period 3||0
5283047|NCT00626275|12988538|P7|COMPLETED|Part A - Treatment Period 3||0
5283048|NCT00626275|12988539|P6|COMPLETED|Part A - Treatment Period 3||8
5283049|NCT00626275|12988540|P5|COMPLETED|Part A - Treatment Period 3||9
5283050|NCT00626275|12988541|P4|COMPLETED|Part A - Treatment Period 3||8
5283051|NCT00626275|12988542|P3|COMPLETED|Part A - Treatment Period 3||6
5283052|NCT00626275|12988543|P2|COMPLETED|Part A - Treatment Period 3||7
5283053|NCT00626275|12988544|P1|COMPLETED|Part A - Treatment Period 3||6
5283054|NCT00626275|12988537|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
5283055|NCT00626275|12988538|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
5283056|NCT00626275|12988539|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
5283057|NCT00626275|12988540|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
5283058|NCT00626275|12988541|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
5283059|NCT00626275|12988542|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
5283060|NCT00626275|12988543|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
5283061|NCT00626275|12988544|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
5283062|NCT00626275|12988537|P8|STARTED|Part A - Treatment Period 3||0
5283063|NCT00626275|12988538|P7|STARTED|Part A - Treatment Period 3||0
5283064|NCT00626275|12988539|P6|STARTED|Part A - Treatment Period 3||8
5283065|NCT00626275|12988540|P5|STARTED|Part A - Treatment Period 3||9
5283066|NCT00626275|12988541|P4|STARTED|Part A - Treatment Period 3||8
5283067|NCT00626275|12988542|P3|STARTED|Part A - Treatment Period 3||6
5283068|NCT00626275|12988543|P2|STARTED|Part A - Treatment Period 3||7
5283069|NCT00626275|12988544|P1|STARTED|Part A - Treatment Period 3||6
5283070|NCT00626275|12988537|P8|NOT COMPLETED|Part A - Washout Period 2||0
5283071|NCT00626275|12988538|P7|NOT COMPLETED|Part A - Washout Period 2||0
5283072|NCT00626275|12988539|P6|NOT COMPLETED|Part A - Washout Period 2||0
5283073|NCT00626275|12988540|P5|NOT COMPLETED|Part A - Washout Period 2||0
5283074|NCT00626275|12988541|P4|NOT COMPLETED|Part A - Washout Period 2||0
5283075|NCT00626275|12988542|P3|NOT COMPLETED|Part A - Washout Period 2||0
5283076|NCT00626275|12988543|P2|NOT COMPLETED|Part A - Washout Period 2||0
5283077|NCT00626275|12988544|P1|NOT COMPLETED|Part A - Washout Period 2||0
5283078|NCT00626275|12988537|P8|COMPLETED|Part A - Washout Period 2||0
5283079|NCT00626275|12988538|P7|COMPLETED|Part A - Washout Period 2||0
5283080|NCT00626275|12988539|P6|COMPLETED|Part A - Washout Period 2||8
5283081|NCT00626275|12988540|P5|COMPLETED|Part A - Washout Period 2||9
5283082|NCT00626275|12988541|P4|COMPLETED|Part A - Washout Period 2||8
5283083|NCT00626275|12988542|P3|COMPLETED|Part A - Washout Period 2||6
5283084|NCT00626275|12988543|P2|COMPLETED|Part A - Washout Period 2||7
5283085|NCT00626275|12988544|P1|COMPLETED|Part A - Washout Period 2||6
5283086|NCT00626275|12988537|P8|STARTED|Part A - Washout Period 2||0
5283087|NCT00626275|12988538|P7|STARTED|Part A - Washout Period 2||0
5283088|NCT00626275|12988539|P6|STARTED|Part A - Washout Period 2||8
5283089|NCT00626275|12988540|P5|STARTED|Part A - Washout Period 2||9
5283090|NCT00626275|12988541|P4|STARTED|Part A - Washout Period 2||8
5283091|NCT00626275|12988542|P3|STARTED|Part A - Washout Period 2||6
5283092|NCT00626275|12988543|P2|STARTED|Part A - Washout Period 2||7
5283093|NCT00626275|12988544|P1|STARTED|Part A - Washout Period 2||6
5283094|NCT00626275|12988537|P8|NOT COMPLETED|Part A - Treatment Period 2||0
5283095|NCT00626275|12988538|P7|NOT COMPLETED|Part A - Treatment Period 2||0
5283096|NCT00626275|12988539|P6|NOT COMPLETED|Part A - Treatment Period 2||0
5283097|NCT00626275|12988540|P5|NOT COMPLETED|Part A - Treatment Period 2||0
5283098|NCT00626275|12988541|P4|NOT COMPLETED|Part A - Treatment Period 2||0
5283099|NCT00626275|12988542|P3|NOT COMPLETED|Part A - Treatment Period 2||0
5283100|NCT00626275|12988543|P2|NOT COMPLETED|Part A - Treatment Period 2||0
5283101|NCT00626275|12988544|P1|NOT COMPLETED|Part A - Treatment Period 2||0
5283102|NCT00626275|12988537|P8|COMPLETED|Part A - Treatment Period 2||0
5283103|NCT00626275|12988538|P7|COMPLETED|Part A - Treatment Period 2||0
5283104|NCT00626275|12988539|P6|COMPLETED|Part A - Treatment Period 2||8
5283105|NCT00626275|12988540|P5|COMPLETED|Part A - Treatment Period 2||9
5283106|NCT00626275|12988541|P4|COMPLETED|Part A - Treatment Period 2||8
5283107|NCT00626275|12988542|P3|COMPLETED|Part A - Treatment Period 2||6
5283108|NCT00626275|12988543|P2|COMPLETED|Part A - Treatment Period 2||7
5283109|NCT00626275|12988544|P1|COMPLETED|Part A - Treatment Period 2||6
5283110|NCT00626275|12988537|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
5283111|NCT00626275|12988538|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
5283112|NCT00626275|12988539|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
5283113|NCT00626275|12988540|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
5283114|NCT00626275|12988541|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
5283115|NCT00626275|12988542|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
5283116|NCT00626275|12988543|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
5283117|NCT00626275|12988544|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
5283118|NCT00626275|12988537|P8|STARTED|Part A - Treatment Period 2||0
5283119|NCT00626275|12988538|P7|STARTED|Part A - Treatment Period 2||0
5283120|NCT00626275|12988539|P6|STARTED|Part A - Treatment Period 2||8
5283121|NCT00626275|12988540|P5|STARTED|Part A - Treatment Period 2||9
5283122|NCT00626275|12988541|P4|STARTED|Part A - Treatment Period 2||8
5283123|NCT00626275|12988542|P3|STARTED|Part A - Treatment Period 2||6
5283124|NCT00626275|12988543|P2|STARTED|Part A - Treatment Period 2||7
5283125|NCT00626275|12988544|P1|STARTED|Part A - Treatment Period 2||6
5283126|NCT00626275|12988537|P8|NOT COMPLETED|Part A - Washout Period 1||0
5283127|NCT00626275|12988538|P7|NOT COMPLETED|Part A - Washout Period 1||0
5283128|NCT00626275|12988539|P6|NOT COMPLETED|Part A - Washout Period 1||0
5283129|NCT00626275|12988540|P5|NOT COMPLETED|Part A - Washout Period 1||0
5283130|NCT00626275|12988541|P4|NOT COMPLETED|Part A - Washout Period 1||0
5283131|NCT00626275|12988542|P3|NOT COMPLETED|Part A - Washout Period 1||0
5283132|NCT00626275|12988543|P2|NOT COMPLETED|Part A - Washout Period 1||0
5283133|NCT00626275|12988544|P1|NOT COMPLETED|Part A - Washout Period 1||0
5283134|NCT00626275|12988537|P8|COMPLETED|Part A - Washout Period 1||0
5283135|NCT00626275|12988538|P7|COMPLETED|Part A - Washout Period 1||0
5283136|NCT00626275|12988539|P6|COMPLETED|Part A - Washout Period 1||8
5283137|NCT00626275|12988540|P5|COMPLETED|Part A - Washout Period 1||9
5283138|NCT00626275|12988541|P4|COMPLETED|Part A - Washout Period 1||8
5283139|NCT00626275|12988542|P3|COMPLETED|Part A - Washout Period 1||6
5283140|NCT00626275|12988543|P2|COMPLETED|Part A - Washout Period 1||7
5283141|NCT00626275|12988544|P1|COMPLETED|Part A - Washout Period 1||6
5283142|NCT00626275|12988537|P8|STARTED|Part A - Washout Period 1||0
5283143|NCT00626275|12988538|P7|STARTED|Part A - Washout Period 1||0
5283144|NCT00626275|12988539|P6|STARTED|Part A - Washout Period 1||8
5283145|NCT00626275|12988540|P5|STARTED|Part A - Washout Period 1||9
5283146|NCT00626275|12988541|P4|STARTED|Part A - Washout Period 1||8
5283147|NCT00626275|12988542|P3|STARTED|Part A - Washout Period 1||6
5283148|NCT00626275|12988543|P2|STARTED|Part A - Washout Period 1||7
5283149|NCT00626275|12988544|P1|STARTED|Part A - Washout Period 1||6
5283150|NCT00626275|12988537|P8|NOT COMPLETED|Part A - Treatment Period 1||0
5283151|NCT00626275|12988538|P7|NOT COMPLETED|Part A - Treatment Period 1||0
5283152|NCT00626275|12988539|P6|NOT COMPLETED|Part A - Treatment Period 1||0
5283153|NCT00626275|12988540|P5|NOT COMPLETED|Part A - Treatment Period 1||0
5283154|NCT00626275|12988541|P4|NOT COMPLETED|Part A - Treatment Period 1||0
5283155|NCT00626275|12988542|P3|NOT COMPLETED|Part A - Treatment Period 1||1
5283156|NCT00626275|12988543|P2|NOT COMPLETED|Part A - Treatment Period 1||0
5283157|NCT00626275|12988544|P1|NOT COMPLETED|Part A - Treatment Period 1||1
5283158|NCT00626275|12988537|P8|COMPLETED|Part A - Treatment Period 1||0
5283159|NCT00626275|12988538|P7|COMPLETED|Part A - Treatment Period 1||0
5283160|NCT00626275|12988539|P6|COMPLETED|Part A - Treatment Period 1||8
5283161|NCT00626275|12988540|P5|COMPLETED|Part A - Treatment Period 1||9
5283162|NCT00626275|12988541|P4|COMPLETED|Part A - Treatment Period 1||8
5283163|NCT00626275|12988542|P3|COMPLETED|Part A - Treatment Period 1||6
5283164|NCT00626275|12988543|P2|COMPLETED|Part A - Treatment Period 1||7
5283165|NCT00626275|12988544|P1|COMPLETED|Part A - Treatment Period 1||6
5283166|NCT00626275|12988537|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
5283167|NCT00626275|12988538|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
5283168|NCT00626275|12988539|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
5283169|NCT00626275|12988540|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
5283170|NCT00626275|12988541|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
5283171|NCT00626275|12988542|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
5283172|NCT00626275|12988543|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
5283173|NCT00626275|12988544|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
5283174|NCT00626275|12988537|P8|STARTED|Part A - Treatment Period 1||0
5283175|NCT00626275|12988538|P7|STARTED|Part A - Treatment Period 1||0
5283176|NCT00626275|12988539|P6|STARTED|Part A - Treatment Period 1||8
5283177|NCT00626275|12988540|P5|STARTED|Part A - Treatment Period 1||9
5283178|NCT00626275|12988541|P4|STARTED|Part A - Treatment Period 1||8
5283179|NCT00626275|12988542|P3|STARTED|Part A - Treatment Period 1||7
5283180|NCT00626275|12988543|P2|STARTED|Part A - Treatment Period 1||7
5283181|NCT00626275|12988544|P1|STARTED|Part A - Treatment Period 1||7
5283182|NCT00626210|12988584|P1|NOT COMPLETED|Overall Study||0
5283183|NCT00626210|12988584|P1|COMPLETED|Overall Study||2
5283184|NCT00626210|12988584|P1|STARTED|Overall Study||2
5283185|NCT00626093|12988588|P1|NOT COMPLETED|Overall Study||23
5283186|NCT00626093|12988588|P1|COMPLETED|Overall Study||54
5283187|NCT00626093|12988588|P1|STARTED|Overall Study||77
5283188|NCT00626028|12988595|P2|NOT COMPLETED|Overall Study||9
5283189|NCT00626028|12988596|P1|NOT COMPLETED|Overall Study||6
5283190|NCT00626028|12988595|P2|COMPLETED|Overall Study||59
5283191|NCT00626028|12988596|P1|COMPLETED|Overall Study||62
5283192|NCT00626028|12988595|P2|STARTED|Overall Study||68
5283193|NCT00626028|12988596|P1|STARTED|Overall Study||68
5283194|NCT00625989|12988610|P2|NOT COMPLETED|Overall Study||0
5283195|NCT00625989|12988611|P1|NOT COMPLETED|Overall Study||0
5283196|NCT00625989|12988610|P2|COMPLETED|Overall Study||6
5283197|NCT00625989|12988611|P1|COMPLETED|Overall Study||6
5283198|NCT00625989|12988610|P2|STARTED|Overall Study||6
5283199|NCT00625989|12988611|P1|STARTED|Overall Study||6
5283200|NCT00625872|12988620|P2|NOT COMPLETED|Overall Study||6
5283201|NCT00625872|12988621|P1|NOT COMPLETED|Overall Study||4
5283202|NCT00625872|12988620|P2|COMPLETED|Overall Study||5
5283203|NCT00625872|12988621|P1|COMPLETED|Overall Study||8
5283204|NCT00625872|12988620|P2|Treated|Overall Study||10
5283205|NCT00625872|12988621|P1|Treated|Overall Study||12
5283206|NCT00625872|12988620|P2|STARTED|Overall Study||11
5283207|NCT00625872|12988621|P1|STARTED|Overall Study||12
5283208|NCT00625846|12988735|P4|NOT COMPLETED|Overall Study||2
5283209|NCT00625846|12988736|P3|NOT COMPLETED|Overall Study||1
5283210|NCT00625846|12988737|P2|NOT COMPLETED|Overall Study||0
5283211|NCT00625846|12988738|P1|NOT COMPLETED|Overall Study||2
5283212|NCT00625846|12988735|P4|COMPLETED|Overall Study||60
5283213|NCT00625846|12988736|P3|COMPLETED|Overall Study||15
5283214|NCT00625846|12988737|P2|COMPLETED|Overall Study||35
5283215|NCT00625846|12988738|P1|COMPLETED|Overall Study||37
5283216|NCT00625846|12988735|P4|STARTED|Overall Study||62
5283217|NCT00625846|12988736|P3|STARTED|Overall Study||16
5283218|NCT00625846|12988737|P2|STARTED|Overall Study||35
5283219|NCT00625846|12988738|P1|STARTED|Overall Study||39
5283220|NCT00625820|12988764|P1|NOT COMPLETED|Overall Study||1
5283221|NCT00625820|12988764|P1|COMPLETED|Overall Study||16
5283222|NCT00625820|12988764|P1|STARTED|Overall Study||17
5283223|NCT00625807|12988772|P2|NOT COMPLETED|Overall Study||8
5283224|NCT00625807|12988773|P1|NOT COMPLETED|Overall Study||2
5283225|NCT00625807|12988772|P2|COMPLETED|Overall Study||20
5283226|NCT00625807|12988773|P1|COMPLETED|Overall Study||20
5283227|NCT00625807|12988772|P2|STARTED|Overall Study||28
5283228|NCT00625807|12988773|P1|STARTED|Overall Study||22
5283229|NCT00625742|12988789|P1|NOT COMPLETED|Overall Study||12
5283230|NCT00625742|12988789|P1|COMPLETED|Overall Study||3
5283231|NCT00625742|12988789|P1|STARTED|Overall Study||15
5283232|NCT00625729|12988794|P1|NOT COMPLETED|Overall Study||0
5283233|NCT00625729|12988794|P1|COMPLETED|Overall Study||6
5283234|NCT00625729|12988794|P1|STARTED|Overall Study||6
5283235|NCT00625703|12988803|P1|NOT COMPLETED|Overall Study||0
5283236|NCT00625703|12988803|P1|COMPLETED|Overall Study||0
5283237|NCT00625703|12988803|P1|STARTED|Overall Study||0
5283238|NCT00625586|12988808|P1|NOT COMPLETED|Overall Study||1
5283239|NCT00625586|12988808|P1|COMPLETED|Overall Study||1
5283240|NCT00625586|12988808|P1|STARTED|Overall Study||2
5283241|NCT00625443|12988821|P3|NOT COMPLETED|Overall Study||5
5283242|NCT00625443|12988822|P2|NOT COMPLETED|Overall Study||11
5283243|NCT00625443|12988823|P1|NOT COMPLETED|Overall Study||2
5283244|NCT00625443|12988821|P3|COMPLETED|Overall Study||10
5283245|NCT00625443|12988822|P2|COMPLETED|Overall Study||15
5283246|NCT00625443|12988823|P1|COMPLETED|Overall Study||10
5283247|NCT00625443|12988821|P3|STARTED|Overall Study||15
5283248|NCT00625443|12988822|P2|STARTED|Overall Study||26
5283249|NCT00625443|12988823|P1|STARTED|Overall Study||12
5283250|NCT00625404|12988853|P2|NOT COMPLETED|Overall Study||173
5283251|NCT00625404|12988854|P1|NOT COMPLETED|Overall Study||207
5283252|NCT00625404|12988853|P2|COMPLETED|Overall Study||885
5283253|NCT00625404|12988854|P1|COMPLETED|Overall Study||855
5283254|NCT00625404|12988853|P2|STARTED|Overall Study||1058
5283255|NCT00625404|12988854|P1|STARTED|Overall Study||1062
5283256|NCT00625391|12988886|P4|NOT COMPLETED|Overall Study||1
5283257|NCT00625391|12988887|P3|NOT COMPLETED|Overall Study||5
5283258|NCT00625391|12988888|P2|NOT COMPLETED|Overall Study||8
5283259|NCT00625391|12988889|P1|NOT COMPLETED|Overall Study||7
5283260|NCT00625391|12988886|P4|COMPLETED|Overall Study||37
5283261|NCT00625391|12988887|P3|COMPLETED|Overall Study||37
5283262|NCT00625391|12988888|P2|COMPLETED|Overall Study||39
5283263|NCT00625391|12988889|P1|COMPLETED|Overall Study||37
5283264|NCT00625391|12988886|P4|STARTED|Overall Study||38
5283265|NCT00625391|12988887|P3|STARTED|Overall Study||42
5283266|NCT00625391|12988888|P2|STARTED|Overall Study||47
5283267|NCT00625391|12988889|P1|STARTED|Overall Study||44
5283268|NCT00625365|12988903|P1|NOT COMPLETED|Overall Study||7
5283269|NCT00625365|12988903|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
5283270|NCT00625365|12988903|P1|STARTED|Overall Study||1060
5283271|NCT00625183|12988909|P1|NOT COMPLETED|Overall Study||1
5283272|NCT00625183|12988909|P1|COMPLETED|Overall Study||4
5283273|NCT00625183|12988909|P1|STARTED|Overall Study||5
5283274|NCT00625131|12988920|P3|NOT COMPLETED|Overall Study||5
5283275|NCT00625131|12988921|P2|NOT COMPLETED|Overall Study||2
5283276|NCT00625131|12988922|P1|NOT COMPLETED|Overall Study||4
5283277|NCT00625131|12988920|P3|COMPLETED|Overall Study||0
5283278|NCT00625131|12988921|P2|COMPLETED|Overall Study||42
5283279|NCT00625131|12988922|P1|COMPLETED|Overall Study||34
5283280|NCT00625131|12988920|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
5283281|NCT00625131|12988921|P2|STARTED|Overall Study||44
5283282|NCT00625131|12988922|P1|STARTED|Overall Study||38
5283283|NCT00624923|12988934|P2|NOT COMPLETED|Overall Study||23
5283284|NCT00624923|12988935|P1|NOT COMPLETED|Overall Study||38
5283285|NCT00624923|12988934|P2|COMPLETED|Overall Study||101
5283286|NCT00624923|12988935|P1|COMPLETED|Overall Study||89
5283287|NCT00624923|12988934|P2|STARTED|Overall Study||124
5283288|NCT00624923|12988935|P1|STARTED|Overall Study||127
5283289|NCT00624832|12988951|P4|NOT COMPLETED|Overall Study||1
5283290|NCT00624832|12988952|P3|NOT COMPLETED|Overall Study||0
5283291|NCT00624832|12988953|P2|NOT COMPLETED|Overall Study||1
5283292|NCT00624832|12988954|P1|NOT COMPLETED|Overall Study||2
5283293|NCT00624832|12988951|P4|COMPLETED|Overall Study||15
5283294|NCT00624832|12988952|P3|COMPLETED|Overall Study||10
5283295|NCT00624832|12988953|P2|COMPLETED|Overall Study||15
5283296|NCT00624832|12988954|P1|COMPLETED|Overall Study||16
5283297|NCT00624832|12988951|P4|STARTED|Overall Study||16
5283298|NCT00624832|12988952|P3|STARTED|Overall Study||10
5283299|NCT00624832|12988953|P2|STARTED|Overall Study||16
5283300|NCT00624832|12988954|P1|STARTED|Overall Study||18
5283301|NCT00624819|12988970|P4|NOT COMPLETED|Follow-up Period: Year 4||0
5283302|NCT00624819|12988971|P3|NOT COMPLETED|Follow-up Period: Year 4||1
5283303|NCT00624819|12988972|P2|NOT COMPLETED|Follow-up Period: Year 4||1
5283304|NCT00624819|12988973|P1|NOT COMPLETED|Follow-up Period: Year 4||1
5283305|NCT00624819|12988970|P4|COMPLETED|Follow-up Period: Year 4||100
5283306|NCT00624819|12988971|P3|COMPLETED|Follow-up Period: Year 4||64
5283307|NCT00624819|12988972|P2|COMPLETED|Follow-up Period: Year 4||19
5283308|NCT00624819|12988973|P1|COMPLETED|Follow-up Period: Year 4||263
5283309|NCT00624819|12988970|P4|STARTED|Follow-up Period: Year 4||100
5283310|NCT00624819|12988971|P3|STARTED|Follow-up Period: Year 4||65
5283311|NCT00624819|12988972|P2|STARTED|Follow-up Period: Year 4||20
5283312|NCT00624819|12988973|P1|STARTED|Follow-up Period: Year 4||264
5283313|NCT00624819|12988970|P4|NOT COMPLETED|Follow-up Period: Year 2||0
5283314|NCT00624819|12988971|P3|NOT COMPLETED|Follow-up Period: Year 2||0
5283315|NCT00624819|12988972|P2|NOT COMPLETED|Follow-up Period: Year 2||0
5283316|NCT00624819|12988973|P1|NOT COMPLETED|Follow-up Period: Year 2||0
5283317|NCT00624819|12988970|P4|COMPLETED|Follow-up Period: Year 2||0
5283318|NCT00624819|12988971|P3|COMPLETED|Follow-up Period: Year 2||96
5283319|NCT00624819|12988972|P2|COMPLETED|Follow-up Period: Year 2||31
5283320|NCT00624819|12988973|P1|COMPLETED|Follow-up Period: Year 2||370
5283321|NCT00624819|12988970|P4|STARTED|Follow-up Period: Year 2||0
5283322|NCT00624819|12988971|P3|STARTED|Follow-up Period: Year 2||96
5283323|NCT00624819|12988972|P2|STARTED|Follow-up Period: Year 2||31
5283324|NCT00624819|12988973|P1|STARTED|Follow-up Period: Year 2||370
5283325|NCT00624819|12988970|P4|NOT COMPLETED|Follow-up Period: Year 1||0
5283326|NCT00624819|12988971|P3|NOT COMPLETED|Follow-up Period: Year 1||0
5283327|NCT00624819|12988972|P2|NOT COMPLETED|Follow-up Period: Year 1||0
5283328|NCT00624819|12988973|P1|NOT COMPLETED|Follow-up Period: Year 1||0
5283329|NCT00624819|12988970|P4|COMPLETED|Follow-up Period: Year 1||0
5283330|NCT00624819|12988971|P3|COMPLETED|Follow-up Period: Year 1||102
5283331|NCT00624819|12988972|P2|COMPLETED|Follow-up Period: Year 1||31
5283332|NCT00624819|12988973|P1|COMPLETED|Follow-up Period: Year 1||391
5283333|NCT00624819|12988970|P4|STARTED|Follow-up Period: Year 1||0
5283334|NCT00624819|12988971|P3|STARTED|Follow-up Period: Year 1||102
5283335|NCT00624819|12988972|P2|STARTED|Follow-up Period: Year 1||31
5283336|NCT00624819|12988973|P1|STARTED|Follow-up Period: Year 1||391
5283337|NCT00624806|12989133|P2|NOT COMPLETED|Overall Study||0
5283338|NCT00624806|12989134|P1|NOT COMPLETED|Overall Study||0
5283339|NCT00624806|12989133|P2|COMPLETED|Overall Study||8
5283340|NCT00624806|12989134|P1|COMPLETED|Overall Study||10
5283341|NCT00624806|12989133|P2|STARTED|Overall Study||8
5283342|NCT00624806|12989134|P1|STARTED|Overall Study||10
5283343|NCT00624780|12989150|P6|NOT COMPLETED|Follow-up (Week 26)||0
5283344|NCT00624780|12989151|P5|NOT COMPLETED|Follow-up (Week 26)||2
5283345|NCT00624780|12989152|P4|NOT COMPLETED|Follow-up (Week 26)||0
5283346|NCT00624780|12989153|P3|NOT COMPLETED|Follow-up (Week 26)||2
5283347|NCT00624780|12989154|P2|NOT COMPLETED|Follow-up (Week 26)||1
5283348|NCT00624780|12989155|P1|NOT COMPLETED|Follow-up (Week 26)||2
5283349|NCT00624780|12989150|P6|COMPLETED|Follow-up (Week 26)||29
5283350|NCT00624780|12989151|P5|COMPLETED|Follow-up (Week 26)||93
5283351|NCT00624780|12989152|P4|COMPLETED|Follow-up (Week 26)||26
5283352|NCT00624780|12989153|P3|COMPLETED|Follow-up (Week 26)||89
5283353|NCT00624780|12989154|P2|COMPLETED|Follow-up (Week 26)||27
5283354|NCT00624780|12989155|P1|COMPLETED|Follow-up (Week 26)||102
5283355|NCT00624780|12989150|P6|STARTED|Follow-up (Week 26)||29
5283356|NCT00624780|12989151|P5|STARTED|Follow-up (Week 26)||95
5283357|NCT00624780|12989152|P4|STARTED|Follow-up (Week 26)||26
5283358|NCT00624780|12989153|P3|STARTED|Follow-up (Week 26)||91
5283359|NCT00624780|12989154|P2|STARTED|Follow-up (Week 26)||28
5283360|NCT00624780|12989155|P1|STARTED|Follow-up (Week 26)||104
5283361|NCT00624780|12989150|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
5283362|NCT00624780|12989151|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
5283363|NCT00624780|12989152|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
5283364|NCT00624780|12989153|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
5283365|NCT00624780|12989154|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
5283366|NCT00624780|12989155|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
5283367|NCT00624780|12989150|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
5283368|NCT00624780|12989151|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
5283369|NCT00624780|12989152|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
5283370|NCT00624780|12989153|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
5283371|NCT00624780|12989154|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
5283372|NCT00624780|12989155|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
5283373|NCT00624780|12989150|P6|STARTED|Treatment Discontinuation (Week 25)||30
5283374|NCT00624780|12989151|P5|STARTED|Treatment Discontinuation (Week 25)||95
5283375|NCT00624780|12989152|P4|STARTED|Treatment Discontinuation (Week 25)||27
5283376|NCT00624780|12989153|P3|STARTED|Treatment Discontinuation (Week 25)||94
5283377|NCT00624780|12989154|P2|STARTED|Treatment Discontinuation (Week 25)||28
5283378|NCT00624780|12989155|P1|STARTED|Treatment Discontinuation (Week 25)||106
5283379|NCT00624780|12989150|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
5283380|NCT00624780|12989151|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
5283381|NCT00624780|12989152|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
5283382|NCT00624780|12989153|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
5283383|NCT00624780|12989154|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
5283384|NCT00624780|12989155|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
5283385|NCT00624780|12989150|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
5283386|NCT00624780|12989151|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
5283387|NCT00624780|12989152|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
5283388|NCT00624780|12989153|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
5283389|NCT00624780|12989154|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
5283390|NCT00624780|12989155|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
5283391|NCT00624780|12989150|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
5283392|NCT00624780|12989151|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
5283393|NCT00624780|12989152|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
5283394|NCT00624780|12989153|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
5283395|NCT00624780|12989154|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
5283396|NCT00624780|12989155|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
5283397|NCT00624780|12989150|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
5283398|NCT00624780|12989151|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
5283399|NCT00624780|12989152|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
5283400|NCT00624780|12989153|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
5283401|NCT00624780|12989154|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
5283402|NCT00624780|12989155|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
5283403|NCT00624780|12989150|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
5283404|NCT00624780|12989151|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
5283405|NCT00624780|12989152|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
5283406|NCT00624780|12989153|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
5283407|NCT00624780|12989154|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
5283408|NCT00624780|12989155|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
5283409|NCT00624780|12989150|P6|STARTED|Treatment Optimization (Up to Week 12)||50
5283410|NCT00624780|12989151|P5|STARTED|Treatment Optimization (Up to Week 12)||153
5283411|NCT00624780|12989152|P4|STARTED|Treatment Optimization (Up to Week 12)||52
5283412|NCT00624780|12989153|P3|STARTED|Treatment Optimization (Up to Week 12)||154
5283413|NCT00624780|12989154|P2|STARTED|Treatment Optimization (Up to Week 12)||52
5283414|NCT00624780|12989155|P1|STARTED|Treatment Optimization (Up to Week 12)||154
5283415|NCT00624650|12989339|P2|NOT COMPLETED|Overall Study||1
5283416|NCT00624650|12989340|P1|NOT COMPLETED|Overall Study||1
5283417|NCT00624650|12989339|P2|COMPLETED|Overall Study||15
5283418|NCT00624650|12989340|P1|COMPLETED|Overall Study||16
5283419|NCT00624650|12989339|P2|STARTED|Overall Study||16
5283420|NCT00624650|12989340|P1|STARTED|Overall Study||17
5283421|NCT00624585|12989346|P1|NOT COMPLETED|Overall Study||12
5283422|NCT00624585|12989346|P1|COMPLETED|Overall Study||6
5283423|NCT00624585|12989346|P1|STARTED|Overall Study||18
5283424|NCT00624559|12989357|P4|NOT COMPLETED|Overall Study||0
5283425|NCT00624559|12989358|P3|NOT COMPLETED|Overall Study||0
5283426|NCT00624559|12989359|P2|NOT COMPLETED|Overall Study||0
5283427|NCT00624559|12989360|P1|NOT COMPLETED|Overall Study||0
5283428|NCT00624559|12989357|P4|COMPLETED|Overall Study||3
5283429|NCT00624559|12989358|P3|COMPLETED|Overall Study||3
5283430|NCT00624559|12989359|P2|COMPLETED|Overall Study||3
5283431|NCT00624559|12989360|P1|COMPLETED|Overall Study||3
5283432|NCT00624559|12989357|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
5283433|NCT00624559|12989358|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
5283434|NCT00624559|12989359|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
5283435|NCT00624559|12989360|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
5283436|NCT00624520|12989376|P2|NOT COMPLETED|Overall Study||8
5283437|NCT00624520|12989377|P1|NOT COMPLETED|Overall Study||12
5283438|NCT00624520|12989376|P2|COMPLETED|Overall Study||39
5283439|NCT00624520|12989377|P1|COMPLETED|Overall Study||44
5283440|NCT00624520|12989376|P2|STARTED|Overall Study||47
5283441|NCT00624520|12989377|P1|STARTED|Overall Study||56
5283442|NCT00624468|12989404|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
5283443|NCT00624468|12989405|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
5283444|NCT00624468|12989406|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
5283445|NCT00624468|12989407|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
5283446|NCT00624468|12989404|P4|COMPLETED|Safety Follow-up (SFU) Period||11
5283447|NCT00624468|12989405|P3|COMPLETED|Safety Follow-up (SFU) Period||11
5283448|NCT00624468|12989406|P2|COMPLETED|Safety Follow-up (SFU) Period||0
5283449|NCT00624468|12989407|P1|COMPLETED|Safety Follow-up (SFU) Period||0
5283450|NCT00624468|12989404|P4|STARTED|Safety Follow-up (SFU) Period||14
5283451|NCT00624468|12989405|P3|STARTED|Safety Follow-up (SFU) Period||13
5283452|NCT00624468|12989406|P2|STARTED|Safety Follow-up (SFU) Period||0
5283453|NCT00624468|12989407|P1|STARTED|Safety Follow-up (SFU) Period||0
5283454|NCT00624468|12989404|P4|NOT COMPLETED|Double-blind Period||0
5283455|NCT00624468|12989405|P3|NOT COMPLETED|Double-blind Period||0
5283456|NCT00624468|12989406|P2|NOT COMPLETED|Double-blind Period||13
5283457|NCT00624468|12989407|P1|NOT COMPLETED|Double-blind Period||14
5283458|NCT00624468|12989404|P4|COMPLETED|Double-blind Period||0
5283459|NCT00624468|12989405|P3|COMPLETED|Double-blind Period||0
5283460|NCT00624468|12989406|P2|COMPLETED|Double-blind Period||4
5283461|NCT00624468|12989407|P1|COMPLETED|Double-blind Period||3
5283462|NCT00624468|12989404|P4|STARTED|Double-blind Period||0
5283463|NCT00624468|12989405|P3|STARTED|Double-blind Period||0
5283464|NCT00624468|12989406|P2|STARTED|Double-blind Period||17
5283465|NCT00624468|12989407|P1|STARTED|Double-blind Period||17
5283466|NCT00624442|12989438|P5|NOT COMPLETED|Overall Study||2
5283467|NCT00624442|12989439|P4|NOT COMPLETED|Overall Study||0
5283468|NCT00624442|12989440|P3|NOT COMPLETED|Overall Study||2
5283469|NCT00624442|12989441|P2|NOT COMPLETED|Overall Study||1
5283470|NCT00624442|12989442|P1|NOT COMPLETED|Overall Study||0
5283471|NCT00624442|12989438|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
5283472|NCT00624442|12989439|P4|COMPLETED|Overall Study||8
5283473|NCT00624442|12989440|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
5283474|NCT00624442|12989441|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
5283475|NCT00624442|12989442|P1|COMPLETED|Overall Study||8
5283476|NCT00624442|12989438|P5|STARTED|Overall Study||10
5283477|NCT00624442|12989439|P4|STARTED|Overall Study||8
5283478|NCT00624442|12989440|P3|STARTED|Overall Study||10
5283479|NCT00624442|12989441|P2|STARTED|Overall Study||9
5283480|NCT00624442|12989442|P1|STARTED|Overall Study||8
5283481|NCT00624416|12989468|P1|NOT COMPLETED|Overall Study||0
5283482|NCT00624416|12989468|P1|COMPLETED|Overall Study||10
5283483|NCT00624416|12989468|P1|STARTED|Overall Study||10
5283484|NCT00624377|12989474|P1|NOT COMPLETED|Overall Study||644
5283485|NCT00624377|12989474|P1|COMPLETED|Overall Study||1387
5283486|NCT00624377|12989474|P1|STARTED|Overall Study||2031
5283487|NCT00624338|12989488|P3|NOT COMPLETED|Overall Study||46
5283488|NCT00624338|12989489|P2|NOT COMPLETED|Overall Study||83
5283489|NCT00624338|12989490|P1|NOT COMPLETED|Overall Study||47
5283490|NCT00624338|12989488|P3|COMPLETED|Overall Study||111
5283491|NCT00624338|12989489|P2|COMPLETED|Overall Study||62
5283492|NCT00624338|12989490|P1|COMPLETED|Overall Study||112
5283493|NCT00624338|12989488|P3|Treated|Overall Study||154
5283494|NCT00624338|12989489|P2|Treated|Overall Study||144
5283495|NCT00624338|12989490|P1|Treated|Overall Study||157
5283496|NCT00624338|12989488|P3|STARTED|Overall Study||157
5283497|NCT00624338|12989489|P2|STARTED|Overall Study||145
5283498|NCT00624338|12989490|P1|STARTED|Overall Study||159
5283499|NCT00624286|12989512|P2|NOT COMPLETED|Overall Study||27
5283500|NCT00624286|12989513|P1|NOT COMPLETED|Overall Study||25
5283501|NCT00624286|12989512|P2|COMPLETED|Overall Study||178
5283502|NCT00624286|12989513|P1|COMPLETED|Overall Study||186
5283503|NCT00624286|12989512|P2|STARTED|Overall Study||205
5283504|NCT00624286|12989513|P1|STARTED|Overall Study||211
5283505|NCT00624234|12989527|P6|NOT COMPLETED|Overall Study||0
5283506|NCT00624234|12989528|P5|NOT COMPLETED|Overall Study||0
5283507|NCT00624234|12989529|P4|NOT COMPLETED|Overall Study||0
5283508|NCT00624234|12989530|P3|NOT COMPLETED|Overall Study||0
5283509|NCT00624234|12989531|P2|NOT COMPLETED|Overall Study||0
5283510|NCT00624234|12989532|P1|NOT COMPLETED|Overall Study||0
5283511|NCT00624234|12989527|P6|COMPLETED|Overall Study||14
5283512|NCT00624234|12989528|P5|COMPLETED|Overall Study||18
5283513|NCT00624234|12989529|P4|COMPLETED|Overall Study||14
5283514|NCT00624234|12989530|P3|COMPLETED|Overall Study||26
5283515|NCT00624234|12989531|P2|COMPLETED|Overall Study||9
5283516|NCT00624234|12989532|P1|COMPLETED|Overall Study||8
5283517|NCT00624234|12989527|P6|STARTED|Overall Study||14
5283518|NCT00624234|12989528|P5|STARTED|Overall Study||18
5283519|NCT00624234|12989529|P4|STARTED|Overall Study||14
5283520|NCT00624234|12989530|P3|STARTED|Overall Study||26
5283521|NCT00624234|12989531|P2|STARTED|Overall Study||9
5283522|NCT00624234|12989532|P1|STARTED|Overall Study||8
5283523|NCT00624221|12989548|P2|NOT COMPLETED|Overall Study||0
5283524|NCT00624221|12989549|P1|NOT COMPLETED|Overall Study||0
5283525|NCT00624221|12989548|P2|COMPLETED|Overall Study||20
5283526|NCT00624221|12989549|P1|COMPLETED|Overall Study||20
5283527|NCT00624221|12989548|P2|STARTED|Overall Study||20
5283528|NCT00624221|12989549|P1|STARTED|Overall Study||20
5283529|NCT00624195|12989557|P2|NOT COMPLETED|Overall Study||7
5283530|NCT00624195|12989558|P1|NOT COMPLETED|Overall Study||3
5283531|NCT00624195|12989557|P2|COMPLETED|Overall Study||23
5283532|NCT00624195|12989558|P1|COMPLETED|Overall Study||26
5283533|NCT00624195|12989557|P2|STARTED|Overall Study||30
5283534|NCT00624195|12989558|P1|STARTED|Overall Study||29
5283535|NCT00624065|12989566|P2|NOT COMPLETED|Overall Study||24
5283536|NCT00624065|12989567|P1|NOT COMPLETED|Overall Study||19
5283537|NCT00624065|12989566|P2|COMPLETED|Overall Study||192
5283538|NCT00624065|12989567|P1|COMPLETED|Overall Study||197
5283539|NCT00624065|12989566|P2|STARTED|Overall Study||216
5283540|NCT00624065|12989567|P1|STARTED|Overall Study||216
5283541|NCT00624052|12989579|P4|NOT COMPLETED|Overall Study||4
5283542|NCT00624052|12989580|P3|NOT COMPLETED|Overall Study||3
5283543|NCT00624052|12989581|P2|NOT COMPLETED|Overall Study||14
5283544|NCT00624052|12989582|P1|NOT COMPLETED|Overall Study||15
5283545|NCT00624052|12989579|P4|COMPLETED|Overall Study||88
5283546|NCT00624052|12989580|P3|COMPLETED|Overall Study||88
5283547|NCT00624052|12989581|P2|COMPLETED|Overall Study||422
5283548|NCT00624052|12989582|P1|COMPLETED|Overall Study||204
5283549|NCT00624052|12989579|P4|STARTED|Overall Study||92
5283550|NCT00624052|12989580|P3|STARTED|Overall Study||91
5283551|NCT00624052|12989581|P2|STARTED|Overall Study||436
5283552|NCT00624052|12989582|P1|STARTED|Overall Study||219
5283553|NCT00624013|12989633|P2|NOT COMPLETED|Overall Study||6
5283554|NCT00624013|12989634|P1|NOT COMPLETED|Overall Study||8
5283555|NCT00624013|12989633|P2|COMPLETED|Overall Study||39
5283556|NCT00624013|12989634|P1|COMPLETED|Overall Study||36
5283557|NCT00624013|12989633|P2|STARTED|Overall Study||45
5283558|NCT00624013|12989634|P1|STARTED|Overall Study||44
5283559|NCT00623974|12989646|P4|NOT COMPLETED|Overall Study||0
5283560|NCT00623974|12989647|P3|NOT COMPLETED|Overall Study||0
5283561|NCT00623974|12989648|P2|NOT COMPLETED|Overall Study||0
5283562|NCT00623974|12989649|P1|NOT COMPLETED|Overall Study||0
5283563|NCT00623974|12989646|P4|COMPLETED|Overall Study||0
5283564|NCT00623974|12989647|P3|COMPLETED|Overall Study||0
5283565|NCT00623974|12989648|P2|COMPLETED|Overall Study||0
5283566|NCT00623974|12989649|P1|COMPLETED|Overall Study||0
5283567|NCT00623974|12989646|P4|STARTED|Overall Study||0
5283568|NCT00623974|12989647|P3|STARTED|Overall Study||0
5283569|NCT00623974|12989648|P2|STARTED|Overall Study||0
5283570|NCT00623974|12989649|P1|STARTED|Overall Study||0
5283571|NCT00623935|12989659|P1|NOT COMPLETED|Overall Study||2
5283572|NCT00623935|12989659|P1|COMPLETED|Overall Study||54
5283573|NCT00623935|12989659|P1|STARTED|Overall Study||56
5283574|NCT00623831|12989666|P2|NOT COMPLETED|Overall Study||1
5283575|NCT00623831|12989667|P1|NOT COMPLETED|Overall Study||1
5283576|NCT00623831|12989666|P2|COMPLETED|Overall Study||3
5283577|NCT00623831|12989667|P1|COMPLETED|Overall Study||12
5283578|NCT00623831|12989666|P2|STARTED|Overall Study||4
5283579|NCT00623831|12989667|P1|STARTED|Overall Study||13
5283580|NCT00623805|12989679|P2|NOT COMPLETED|Overall Study||22
5283581|NCT00623805|12989680|P1|NOT COMPLETED|Overall Study||20
5283582|NCT00623805|12989679|P2|COMPLETED|Overall Study||39
5283583|NCT00623805|12989680|P1|COMPLETED|Overall Study||42
5283584|NCT00623805|12989679|P2|STARTED|Overall Study||61
5283585|NCT00623805|12989680|P1|STARTED|Overall Study||62
5283586|NCT00623779|12989697|P3|NOT COMPLETED|Overall Study||1
5283587|NCT00623779|12989698|P2|NOT COMPLETED|Overall Study||3
5283588|NCT00623779|12989699|P1|NOT COMPLETED|Overall Study||3
5283589|NCT00623779|12989697|P3|COMPLETED|Overall Study||44
5283590|NCT00623779|12989698|P2|COMPLETED|Overall Study||39
5283591|NCT00623779|12989699|P1|COMPLETED|Overall Study||38
5283592|NCT00623779|12989697|P3|STARTED|Overall Study||45
5283593|NCT00623779|12989698|P2|STARTED|Overall Study||42
5283594|NCT00623779|12989699|P1|STARTED|Overall Study||41
5283595|NCT00623766|12989748|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
5283596|NCT00623766|12989749|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
5283597|NCT00623766|12989748|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
5283598|NCT00623766|12989749|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
5283599|NCT00623766|12989748|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
5283600|NCT00623766|12989749|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
5283601|NCT00623766|12989748|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
5283602|NCT00623766|12989749|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
5283603|NCT00623766|12989748|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
5283604|NCT00623766|12989749|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
5283605|NCT00623766|12989748|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
5283606|NCT00623766|12989749|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
5283607|NCT00623727|12989773|P2|NOT COMPLETED|Open Label Extension Period||0
5283608|NCT00623727|12989774|P1|NOT COMPLETED|Open Label Extension Period||0
5283609|NCT00623727|12989773|P2|COMPLETED|Open Label Extension Period||0
5283610|NCT00623727|12989774|P1|COMPLETED|Open Label Extension Period||20
5283611|NCT00623727|12989773|P2|STARTED|Open Label Extension Period||0
5283612|NCT00623727|12989774|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
5283613|NCT00623727|12989773|P2|NOT COMPLETED|Open Label Follow-up||8
5283614|NCT00623727|12989774|P1|NOT COMPLETED|Open Label Follow-up||0
5283615|NCT00623727|12989773|P2|COMPLETED|Open Label Follow-up||18
5283616|NCT00623727|12989774|P1|COMPLETED|Open Label Follow-up||0
5283617|NCT00623727|12989773|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
5283618|NCT00623727|12989774|P1|STARTED|Open Label Follow-up||0
5283619|NCT00623727|12989773|P2|NOT COMPLETED|Double Blind (DB)||32
5283620|NCT00623727|12989774|P1|NOT COMPLETED|Double Blind (DB)||36
5283621|NCT00623727|12989773|P2|COMPLETED|Double Blind (DB)||41
5283622|NCT00623727|12989774|P1|COMPLETED|Double Blind (DB)||34
5283623|NCT00623727|12989773|P2|Participants Received Treatment|Double Blind (DB)||72
5283624|NCT00623727|12989774|P1|Participants Received Treatment|Double Blind (DB)||67
5283625|NCT00623727|12989773|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
5283795|NCT00622700|12990243|P2|COMPLETED|Core Treatment Period||150
5283626|NCT00623727|12989774|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
5283627|NCT00623714|12989794|P2|NOT COMPLETED|Period 2||0
5283628|NCT00623714|12989795|P1|NOT COMPLETED|Period 2||0
5283629|NCT00623714|12989794|P2|COMPLETED|Period 2||7
5283630|NCT00623714|12989795|P1|COMPLETED|Period 2||6
5283631|NCT00623714|12989794|P2|STARTED|Period 2||7
5283632|NCT00623714|12989795|P1|STARTED|Period 2||6
5283633|NCT00623714|12989794|P2|NOT COMPLETED|Period 1||0
5283634|NCT00623714|12989795|P1|NOT COMPLETED|Period 1||0
5283635|NCT00623714|12989794|P2|COMPLETED|Period 1||7
5283636|NCT00623714|12989795|P1|COMPLETED|Period 1||6
5283637|NCT00623714|12989794|P2|STARTED|Period 1||7
5283638|NCT00623714|12989795|P1|STARTED|Period 1||6
5283639|NCT00623636|12989805|P2|NOT COMPLETED|Open Label||412
5283640|NCT00623636|12989806|P1|NOT COMPLETED|Open Label||0
5283641|NCT00623636|12989805|P2|COMPLETED|Open Label||263
5283642|NCT00623636|12989806|P1|COMPLETED|Open Label||0
5283643|NCT00623636|12989805|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
5283644|NCT00623636|12989806|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
5283645|NCT00623636|12989805|P2|NOT COMPLETED|Double Blind||28
5283646|NCT00623636|12989806|P1|NOT COMPLETED|Double Blind||33
5283647|NCT00623636|12989805|P2|COMPLETED|Double Blind||422
5283648|NCT00623636|12989806|P1|COMPLETED|Double Blind||419
5283649|NCT00623636|12989805|P2|STARTED|Double Blind||450
5283650|NCT00623636|12989806|P1|STARTED|Double Blind||452
5283651|NCT00623623|12989829|P2|NOT COMPLETED|Overall Study||1
5283652|NCT00623623|12989830|P1|NOT COMPLETED|Overall Study||1
5283653|NCT00623623|12989829|P2|COMPLETED|Overall Study||948
5283654|NCT00623623|12989830|P1|COMPLETED|Overall Study||949
5283655|NCT00623623|12989829|P2|STARTED|Overall Study||949
5283656|NCT00623623|12989830|P1|STARTED|Overall Study||950
5283657|NCT00623597|12989886|P2|NOT COMPLETED|Overall Study||0
5283658|NCT00623597|12989887|P1|NOT COMPLETED|Overall Study||1
5283659|NCT00623597|12989886|P2|COMPLETED|Overall Study||13
5283660|NCT00623597|12989887|P1|COMPLETED|Overall Study||4
5283661|NCT00623597|12989886|P2|STARTED|Overall Study||13
5283662|NCT00623597|12989887|P1|STARTED|Overall Study||5
5283663|NCT00623545|12989950|P1|NOT COMPLETED|Overall Study||10
5283664|NCT00623545|12989950|P1|COMPLETED|Overall Study||18
5283665|NCT00623545|12989950|P1|STARTED|Overall Study||28
5283666|NCT00623506|12989957|P2|NOT COMPLETED|Overall Study||4
5283667|NCT00623506|12989958|P1|NOT COMPLETED|Overall Study||4
5283668|NCT00623506|12989957|P2|COMPLETED|Overall Study||11
5283669|NCT00623506|12989958|P1|COMPLETED|Overall Study||11
5283670|NCT00623506|12989957|P2|Week 4|Overall Study||11
5283671|NCT00623506|12989958|P1|Week 4|Overall Study||11
5283672|NCT00623506|12989957|P2|STARTED|Overall Study||15
5283673|NCT00623506|12989958|P1|STARTED|Overall Study||15
5283674|NCT00623480|12989970|P2|NOT COMPLETED|Overall Study||7
5283675|NCT00623480|12989971|P1|NOT COMPLETED|Overall Study||7
5283676|NCT00623480|12989970|P2|COMPLETED|Overall Study||35
5283677|NCT00623480|12989971|P1|COMPLETED|Overall Study||35
5283678|NCT00623480|12989970|P2|STARTED|Overall Study||42
5283679|NCT00623480|12989971|P1|STARTED|Overall Study||42
5283680|NCT00623467|12989983|P1|NOT COMPLETED|Overall Study||7
5283681|NCT00623467|12989983|P1|COMPLETED|Overall Study||336
5283682|NCT00623467|12989983|P1|STARTED|Overall Study||343
5283683|NCT00623441|12990047|P1|NOT COMPLETED|Overall Study||0
5283684|NCT00623441|12990047|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
5283685|NCT00623441|12990047|P1|STARTED|Overall Study||8314
5283686|NCT00623428|12990053|P2|NOT COMPLETED|Follow-up Period||15
5283687|NCT00623428|12990054|P1|NOT COMPLETED|Follow-up Period||29
5283688|NCT00623428|12990053|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
5283689|NCT00623428|12990054|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
5283690|NCT00623428|12990053|P2|STARTED|Follow-up Period||93
5283691|NCT00623428|12990054|P1|STARTED|Follow-up Period||95
5283692|NCT00623428|12990053|P2|NOT COMPLETED|Treatment Period||27
5283693|NCT00623428|12990054|P1|NOT COMPLETED|Treatment Period||0
5283694|NCT00623428|12990053|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
5283695|NCT00623428|12990054|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
5283696|NCT00623428|12990053|P2|STARTED|Treatment Period||93
5283697|NCT00623428|12990054|P1|STARTED|Treatment Period||95
5283698|NCT00623233|12990072|P1|NOT COMPLETED|Overall Study||24
5283699|NCT00623233|12990072|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
5283700|NCT00623233|12990072|P1|STARTED|Overall Study||52
5283701|NCT00623194|12990079|P1|NOT COMPLETED|Overall Study||5
5283702|NCT00623194|12990079|P1|COMPLETED|Overall Study||141
5283703|NCT00623194|12990079|P1|STARTED|Overall Study||146
5283704|NCT00623181|12990101|P2|NOT COMPLETED|Overall Study||0
5283705|NCT00623181|12990102|P1|NOT COMPLETED|Overall Study||0
5283706|NCT00623181|12990101|P2|COMPLETED|Overall Study||54
5283707|NCT00623181|12990102|P1|COMPLETED|Overall Study||56
5283708|NCT00623181|12990101|P2|STARTED|Overall Study||54
5283709|NCT00623181|12990102|P1|STARTED|Overall Study||56
5283710|NCT00623103|12990116|P2|NOT COMPLETED|Overall Study||113
5283711|NCT00623103|12990117|P1|NOT COMPLETED|Overall Study||111
5283712|NCT00623103|12990116|P2|COMPLETED|Overall Study||175
5283713|NCT00623103|12990117|P1|COMPLETED|Overall Study||184
5283714|NCT00623103|12990116|P2|Safety Set: Received Study Drug|Overall Study||288
5283796|NCT00622700|12990244|P1|COMPLETED|Core Treatment Period||141
5283715|NCT00623103|12990117|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
5283716|NCT00623103|12990116|P2|STARTED|Overall Study||288
5283717|NCT00623103|12990117|P1|STARTED|Overall Study||295
5283718|NCT00623012|12990137|P1|NOT COMPLETED|Overall Study||0
5283719|NCT00623012|12990137|P1|COMPLETED|Overall Study||2
5283720|NCT00623012|12990137|P1|STARTED|Overall Study||2
5283721|NCT00622908|12990145|P2|NOT COMPLETED|Overall Study||10
5283722|NCT00622908|12990146|P1|NOT COMPLETED|Overall Study||3
5283723|NCT00622908|12990145|P2|COMPLETED|Overall Study||122
5283724|NCT00622908|12990146|P1|COMPLETED|Overall Study||134
5283725|NCT00622908|12990145|P2|STARTED|Overall Study|Intent to treat population|132
5283726|NCT00622908|12990146|P1|STARTED|Overall Study|Intent to treat population|137
5283727|NCT00622895|12990158|P1|NOT COMPLETED|Overall Study||0
5283728|NCT00622895|12990158|P1|COMPLETED|Overall Study||3
5283729|NCT00622895|12990158|P1|STARTED|Overall Study||3
5283730|NCT00622869|12990176|P3|NOT COMPLETED|Overall Study||39
5283731|NCT00622869|12990177|P2|NOT COMPLETED|Overall Study||57
5283732|NCT00622869|12990178|P1|NOT COMPLETED|Overall Study||43
5283733|NCT00622869|12990176|P3|COMPLETED|Overall Study||204
5283734|NCT00622869|12990177|P2|COMPLETED|Overall Study||174
5283735|NCT00622869|12990178|P1|COMPLETED|Overall Study||202
5283736|NCT00622869|12990176|P3|STARTED|Overall Study||243
5283737|NCT00622869|12990177|P2|STARTED|Overall Study||231
5283738|NCT00622869|12990178|P1|STARTED|Overall Study||245
5283739|NCT00622739|12990197|P2|NOT COMPLETED|Overall Study||6
5283740|NCT00622739|12990198|P1|NOT COMPLETED|Overall Study||2
5283741|NCT00622739|12990197|P2|COMPLETED|Overall Study||9
5283742|NCT00622739|12990198|P1|COMPLETED|Overall Study||11
5283743|NCT00622739|12990197|P2|STARTED|Overall Study||15
5283744|NCT00622739|12990198|P1|STARTED|Overall Study||13
5283745|NCT00622726|12990216|P2|NOT COMPLETED|August, 2010 to April, 2013||5
5283746|NCT00622726|12990217|P1|NOT COMPLETED|August, 2010 to April, 2013||1
5283747|NCT00622726|12990216|P2|COMPLETED|August, 2010 to April, 2013||68
5283748|NCT00622726|12990217|P1|COMPLETED|August, 2010 to April, 2013||69
5283749|NCT00622726|12990216|P2|STARTED|August, 2010 to April, 2013||73
5283750|NCT00622726|12990217|P1|STARTED|August, 2010 to April, 2013||70
5283751|NCT00622726|12990216|P2|NOT COMPLETED|March, 2008 to August, 2010||2
5283752|NCT00622726|12990217|P1|NOT COMPLETED|March, 2008 to August, 2010||5
5283753|NCT00622726|12990216|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
5283754|NCT00622726|12990217|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
5283755|NCT00622726|12990216|P2|STARTED|March, 2008 to August, 2010||75
5283756|NCT00622726|12990217|P1|STARTED|March, 2008 to August, 2010||75
5283757|NCT00622713|12990227|P1|NOT COMPLETED|Overall Study||59
5283758|NCT00622713|12990227|P1|COMPLETED|Overall Study||169
5283759|NCT00622713|12990227|P1|Intent to Treat (ITT) Population|Overall Study||218
5283760|NCT00622713|12990227|P1|Exposed to Study Drug|Overall Study||226
5283761|NCT00622713|12990227|P1|STARTED|Overall Study||228
5283762|NCT00622700|12990238|P7|NOT COMPLETED|Extension Treatment Period||30
5283763|NCT00622700|12990239|P6|NOT COMPLETED|Extension Treatment Period||17
5283764|NCT00622700|12990240|P5|NOT COMPLETED|Extension Treatment Period||39
5283765|NCT00622700|12990241|P4|NOT COMPLETED|Extension Treatment Period||21
5283766|NCT00622700|12990242|P3|NOT COMPLETED|Extension Treatment Period||0
5283767|NCT00622700|12990243|P2|NOT COMPLETED|Extension Treatment Period||0
5283768|NCT00622700|12990244|P1|NOT COMPLETED|Extension Treatment Period||0
5283769|NCT00622700|12990238|P7|COMPLETED|Extension Treatment Period||120
5283770|NCT00622700|12990239|P6|COMPLETED|Extension Treatment Period||50
5283771|NCT00622700|12990240|P5|COMPLETED|Extension Treatment Period||103
5283772|NCT00622700|12990241|P4|COMPLETED|Extension Treatment Period||43
5283773|NCT00622700|12990242|P3|COMPLETED|Extension Treatment Period||0
5283774|NCT00622700|12990243|P2|COMPLETED|Extension Treatment Period||0
5283775|NCT00622700|12990244|P1|COMPLETED|Extension Treatment Period||0
5283776|NCT00622700|12990238|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
5283777|NCT00622700|12990239|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
5283778|NCT00622700|12990240|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
5283779|NCT00622700|12990241|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
5283780|NCT00622700|12990242|P3|STARTED|Extension Treatment Period||0
5283781|NCT00622700|12990243|P2|STARTED|Extension Treatment Period||0
5283782|NCT00622700|12990244|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
5283783|NCT00622700|12990238|P7|NOT COMPLETED|Core Treatment Period||0
5283784|NCT00622700|12990239|P6|NOT COMPLETED|Core Treatment Period||0
5283785|NCT00622700|12990240|P5|NOT COMPLETED|Core Treatment Period||0
5283786|NCT00622700|12990241|P4|NOT COMPLETED|Core Treatment Period||0
5283787|NCT00622700|12990242|P3|NOT COMPLETED|Core Treatment Period||53
5283788|NCT00622700|12990243|P2|NOT COMPLETED|Core Treatment Period||55
5283789|NCT00622700|12990244|P1|NOT COMPLETED|Core Treatment Period||56
5283790|NCT00622700|12990238|P7|COMPLETED|Core Treatment Period||0
5283791|NCT00622700|12990239|P6|COMPLETED|Core Treatment Period||0
5283792|NCT00622700|12990240|P5|COMPLETED|Core Treatment Period||0
5283793|NCT00622700|12990241|P4|COMPLETED|Core Treatment Period||0
5283794|NCT00622700|12990242|P3|COMPLETED|Core Treatment Period||163
5283797|NCT00622700|12990238|P7|Treated|Core Treatment Period||0
5283798|NCT00622700|12990239|P6|Treated|Core Treatment Period||0
5283799|NCT00622700|12990240|P5|Treated|Core Treatment Period||0
5283800|NCT00622700|12990241|P4|Treated|Core Treatment Period||0
5283801|NCT00622700|12990242|P3|Treated|Core Treatment Period||214
5283802|NCT00622700|12990243|P2|Treated|Core Treatment Period||203
5283803|NCT00622700|12990244|P1|Treated|Core Treatment Period||197
5283804|NCT00622700|12990238|P7|STARTED|Core Treatment Period||0
5283805|NCT00622700|12990239|P6|STARTED|Core Treatment Period||0
5283806|NCT00622700|12990240|P5|STARTED|Core Treatment Period||0
5283807|NCT00622700|12990241|P4|STARTED|Core Treatment Period||0
5283808|NCT00622700|12990242|P3|STARTED|Core Treatment Period||216
5283809|NCT00622700|12990243|P2|STARTED|Core Treatment Period||205
5283810|NCT00622700|12990244|P1|STARTED|Core Treatment Period||197
5283811|NCT00622635|12990303|P6|NOT COMPLETED|Treatment Period 3||0
5283812|NCT00622635|12990304|P5|NOT COMPLETED|Treatment Period 3||0
5283813|NCT00622635|12990305|P4|NOT COMPLETED|Treatment Period 3||3
5283814|NCT00622635|12990306|P3|NOT COMPLETED|Treatment Period 3||0
5283815|NCT00622635|12990307|P2|NOT COMPLETED|Treatment Period 3||0
5283816|NCT00622635|12990308|P1|NOT COMPLETED|Treatment Period 3||0
5283817|NCT00622635|12990303|P6|COMPLETED|Treatment Period 3||10
5283818|NCT00622635|12990304|P5|COMPLETED|Treatment Period 3||9
5283819|NCT00622635|12990305|P4|COMPLETED|Treatment Period 3||10
5283820|NCT00622635|12990306|P3|COMPLETED|Treatment Period 3||10
5283821|NCT00622635|12990307|P2|COMPLETED|Treatment Period 3||10
5283822|NCT00622635|12990308|P1|COMPLETED|Treatment Period 3||12
5283823|NCT00622635|12990303|P6|STARTED|Treatment Period 3||10
5283824|NCT00622635|12990304|P5|STARTED|Treatment Period 3||9
5283825|NCT00622635|12990305|P4|STARTED|Treatment Period 3||13
5283826|NCT00622635|12990306|P3|STARTED|Treatment Period 3||10
5283827|NCT00622635|12990307|P2|STARTED|Treatment Period 3||10
5283828|NCT00622635|12990308|P1|STARTED|Treatment Period 3||12
5283829|NCT00622635|12990303|P6|NOT COMPLETED|Treatment Period 2||0
5283830|NCT00622635|12990304|P5|NOT COMPLETED|Treatment Period 2||0
5283831|NCT00622635|12990305|P4|NOT COMPLETED|Treatment Period 2||0
5283832|NCT00622635|12990306|P3|NOT COMPLETED|Treatment Period 2||0
5283833|NCT00622635|12990307|P2|NOT COMPLETED|Treatment Period 2||0
5283834|NCT00622635|12990308|P1|NOT COMPLETED|Treatment Period 2||1
5283835|NCT00622635|12990303|P6|COMPLETED|Treatment Period 2||10
5283836|NCT00622635|12990304|P5|COMPLETED|Treatment Period 2||9
5283837|NCT00622635|12990305|P4|COMPLETED|Treatment Period 2||13
5283838|NCT00622635|12990306|P3|COMPLETED|Treatment Period 2||10
5283839|NCT00622635|12990307|P2|COMPLETED|Treatment Period 2||10
5283840|NCT00622635|12990308|P1|COMPLETED|Treatment Period 2||12
5283841|NCT00622635|12990303|P6|STARTED|Treatment Period 2||10
5283842|NCT00622635|12990304|P5|STARTED|Treatment Period 2||9
5283843|NCT00622635|12990305|P4|STARTED|Treatment Period 2||13
5283844|NCT00622635|12990306|P3|STARTED|Treatment Period 2||10
5283845|NCT00622635|12990307|P2|STARTED|Treatment Period 2||10
5283846|NCT00622635|12990308|P1|STARTED|Treatment Period 2||13
5283847|NCT00622635|12990303|P6|NOT COMPLETED|Treatment Period 1||0
5283848|NCT00622635|12990304|P5|NOT COMPLETED|Treatment Period 1||1
5283849|NCT00622635|12990305|P4|NOT COMPLETED|Treatment Period 1||0
5283850|NCT00622635|12990306|P3|NOT COMPLETED|Treatment Period 1||1
5283851|NCT00622635|12990307|P2|NOT COMPLETED|Treatment Period 1||1
5283852|NCT00622635|12990308|P1|NOT COMPLETED|Treatment Period 1||0
5283853|NCT00622635|12990303|P6|COMPLETED|Treatment Period 1||10
5283854|NCT00622635|12990304|P5|COMPLETED|Treatment Period 1||9
5283855|NCT00622635|12990305|P4|COMPLETED|Treatment Period 1||13
5283856|NCT00622635|12990306|P3|COMPLETED|Treatment Period 1||10
5283857|NCT00622635|12990307|P2|COMPLETED|Treatment Period 1||10
5283858|NCT00622635|12990308|P1|COMPLETED|Treatment Period 1||13
5283859|NCT00622635|12990303|P6|STARTED|Treatment Period 1||10
5283860|NCT00622635|12990304|P5|STARTED|Treatment Period 1||10
5283861|NCT00622635|12990305|P4|STARTED|Treatment Period 1||13
5283862|NCT00622635|12990306|P3|STARTED|Treatment Period 1||11
5283863|NCT00622635|12990307|P2|STARTED|Treatment Period 1||11
5283864|NCT00622635|12990308|P1|STARTED|Treatment Period 1||13
5283865|NCT00622544|12990373|P1|NOT COMPLETED|Overall Study||9
5283866|NCT00622544|12990373|P1|COMPLETED|Overall Study|35|35
5283867|NCT00622544|12990373|P1|STARTED|Overall Study||44
5283868|NCT00622518|12990380|P2|NOT COMPLETED|Overall Study||0
5283869|NCT00622518|12990381|P1|NOT COMPLETED|Overall Study||0
5283870|NCT00622518|12990380|P2|COMPLETED|Overall Study||60
5283871|NCT00622518|12990381|P1|COMPLETED|Overall Study||59
5283872|NCT00622518|12990380|P2|STARTED|Overall Study||60
5283873|NCT00622518|12990381|P1|STARTED|Overall Study||59
5283874|NCT00622440|12990391|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
5283875|NCT00622440|12990392|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
5283876|NCT00622440|12990391|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
5283877|NCT00622440|12990392|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
5283878|NCT00622440|12990391|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
5283879|NCT00622440|12990392|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
5283880|NCT00622440|12990391|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
5283881|NCT00622440|12990392|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
5283882|NCT00622440|12990391|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
5283883|NCT00622440|12990392|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
5283884|NCT00622440|12990391|P2|STARTED|Week 12 - Week 48 (Treatment)||34
5283885|NCT00622440|12990392|P1|STARTED|Week 12 - Week 48 (Treatment)||31
5283886|NCT00622440|12990391|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
5283887|NCT00622440|12990392|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
5283888|NCT00622440|12990391|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
5283889|NCT00622440|12990392|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
5283890|NCT00622440|12990391|P2|STARTED|Baseline - Week 12 (Treatment)||35
5283891|NCT00622440|12990392|P1|STARTED|Baseline - Week 12 (Treatment)||35
5283892|NCT00622427|12990406|P2|NOT COMPLETED|Overall Study||0
5283893|NCT00622427|12990407|P1|NOT COMPLETED|Overall Study||0
5283894|NCT00622427|12990406|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
5283895|NCT00622427|12990407|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
5283896|NCT00622427|12990406|P2|STARTED|Overall Study||16
5283897|NCT00622427|12990407|P1|STARTED|Overall Study||16
5283898|NCT00622401|12990418|P3|NOT COMPLETED|Overall Study||0
5283899|NCT00622401|12990419|P2|NOT COMPLETED|Overall Study||2
5283900|NCT00622401|12990420|P1|NOT COMPLETED|Overall Study||3
5283901|NCT00622401|12990418|P3|COMPLETED|Overall Study||0
5283902|NCT00622401|12990419|P2|COMPLETED|Overall Study||0
5283903|NCT00622401|12990420|P1|COMPLETED|Overall Study||3
5283904|NCT00622401|12990418|P3|STARTED|Overall Study|Never Opened|0
5283905|NCT00622401|12990419|P2|STARTED|Overall Study||2
5283906|NCT00622401|12990420|P1|STARTED|Overall Study||6
5283907|NCT00622388|12990427|P1|NOT COMPLETED|Overall Study||72
5283908|NCT00622388|12990427|P1|COMPLETED|Overall Study||9
5283909|NCT00622388|12990427|P1|STARTED|Overall Study||81
5283910|NCT00622336|12990445|P1|NOT COMPLETED|Extension Phase||21
5283911|NCT00622336|12990445|P1|COMPLETED|Extension Phase||0
5283912|NCT00622336|12990445|P1|STARTED|Extension Phase||21
5283913|NCT00622336|12990445|P1|NOT COMPLETED|Treatment Phase||309
5283914|NCT00622336|12990445|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
5283915|NCT00622336|12990445|P1|Safety Population|Treatment Phase||330
5283916|NCT00622336|12990445|P1|STARTED|Treatment Phase||330
5283917|NCT00622284|12990456|P2|NOT COMPLETED|Overall Study||171
5283918|NCT00622284|12990457|P1|NOT COMPLETED|Overall Study||189
5283919|NCT00622284|12990456|P2|COMPLETED|Overall Study|Number who completed treatment.|604
5283920|NCT00622284|12990457|P1|COMPLETED|Overall Study|Number who completed treatment.|587
5283921|NCT00622284|12990456|P2|STARTED|Overall Study|Number who started treatment.|775
5283922|NCT00622284|12990457|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
5283923|NCT00622180|12990519|P2|NOT COMPLETED|Overall Study||2
5283924|NCT00622180|12990520|P1|NOT COMPLETED|Overall Study||1
5283925|NCT00622180|12990519|P2|COMPLETED|Overall Study||5
5283926|NCT00622180|12990520|P1|COMPLETED|Overall Study||5
5283927|NCT00622180|12990519|P2|STARTED|Overall Study||7
5283928|NCT00622180|12990520|P1|STARTED|Overall Study||6
5283929|NCT00622167|12990526|P1|NOT COMPLETED|Overall Study||20
5283930|NCT00622167|12990526|P1|COMPLETED|Overall Study||4
5283931|NCT00622167|12990526|P1|STARTED|Overall Study||24
5283932|NCT00621985|12990530|P1|NOT COMPLETED|Dexamethasone Admission||1
5283933|NCT00621985|12990530|P1|COMPLETED|Dexamethasone Admission||4
5283934|NCT00621985|12990530|P1|STARTED|Dexamethasone Admission||5
5283935|NCT00621985|12990530|P1|NOT COMPLETED|Hydrocortisone Admission||0
5283936|NCT00621985|12990530|P1|COMPLETED|Hydrocortisone Admission||5
5283937|NCT00621985|12990530|P1|STARTED|Hydrocortisone Admission||5
5283938|NCT00621959|12990538|P2|NOT COMPLETED|Overall Study||9
5283939|NCT00621959|12990539|P1|NOT COMPLETED|Overall Study||7
5283940|NCT00621959|12990538|P2|COMPLETED|Overall Study||292
5283941|NCT00621959|12990539|P1|COMPLETED|Overall Study||288
5283942|NCT00621959|12990538|P2|STARTED|Overall Study||301
5283943|NCT00621959|12990539|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
5283944|NCT00621946|12990549|P2|NOT COMPLETED|Overall Study||1
5283945|NCT00621946|12990550|P1|NOT COMPLETED|Overall Study||0
5283946|NCT00621946|12990549|P2|COMPLETED|Overall Study||12
5283947|NCT00621946|12990550|P1|COMPLETED|Overall Study||13
5283948|NCT00621946|12990549|P2|STARTED|Overall Study||13
5283949|NCT00621946|12990550|P1|STARTED|Overall Study||13
5283950|NCT00621933|12990566|P1|NOT COMPLETED|Overall Study||0
5283951|NCT00621933|12990566|P1|COMPLETED|Overall Study||399
5283952|NCT00621933|12990566|P1|STARTED|Overall Study||399
5283953|NCT00621855|12990578|P5|NOT COMPLETED|Overall Study||55
5283954|NCT00621855|12990579|P4|NOT COMPLETED|Overall Study||67
5283955|NCT00621855|12990580|P3|NOT COMPLETED|Overall Study||81
5283956|NCT00621855|12990581|P2|NOT COMPLETED|Overall Study||61
5283957|NCT00621855|12990582|P1|NOT COMPLETED|Overall Study||76
5283958|NCT00621855|12990578|P5|COMPLETED|Overall Study|Completed means completed treatment|318
5283959|NCT00621855|12990579|P4|COMPLETED|Overall Study|Completed means completed treatment|284
5283960|NCT00621855|12990580|P3|COMPLETED|Overall Study|Completed means completed treatment|330
5283961|NCT00621855|12990581|P2|COMPLETED|Overall Study|Completed means completed treatment|310
5283962|NCT00621855|12990582|P1|COMPLETED|Overall Study|Completed means completed treatment|296
5283963|NCT00621855|12990578|P5|STARTED|Overall Study|Started means randomised to treatment|373
5283964|NCT00621855|12990579|P4|STARTED|Overall Study|Started means randomised to treatment|351
5283965|NCT00621855|12990580|P3|STARTED|Overall Study|Started means randomised to treatment|411
5283966|NCT00621855|12990581|P2|STARTED|Overall Study|Started means randomised to treatment|371
5283967|NCT00621855|12990582|P1|STARTED|Overall Study|Started means randomised to treatment|372
5283968|NCT00621842|12990624|P1|NOT COMPLETED|Overall Study||19
5283969|NCT00621842|12990624|P1|COMPLETED|Overall Study||38
5283970|NCT00621842|12990624|P1|STARTED|Overall Study||57
5283971|NCT00621777|12990641|P2|NOT COMPLETED|Randomized Phase||19
5283972|NCT00621777|12990642|P1|NOT COMPLETED|Randomized Phase||7
5283973|NCT00621777|12990641|P2|COMPLETED|Randomized Phase||28
5283974|NCT00621777|12990642|P1|COMPLETED|Randomized Phase||33
5283975|NCT00621777|12990641|P2|STARTED|Randomized Phase||47
5283976|NCT00621777|12990642|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
5283977|NCT00621777|12990641|P2|NOT COMPLETED|Open Phase||0
5283978|NCT00621777|12990642|P1|NOT COMPLETED|Open Phase||116
5283979|NCT00621777|12990641|P2|COMPLETED|Open Phase||0
5283980|NCT00621777|12990642|P1|COMPLETED|Open Phase||87
5283981|NCT00621777|12990641|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
5283982|NCT00621777|12990642|P1|STARTED|Open Phase||203
5283983|NCT00621764|12990657|P4|NOT COMPLETED|Overall Study||1
5283984|NCT00621764|12990658|P3|NOT COMPLETED|Overall Study||0
5283985|NCT00621764|12990659|P2|NOT COMPLETED|Overall Study||0
5283986|NCT00621764|12990660|P1|NOT COMPLETED|Overall Study||0
5283987|NCT00621764|12990657|P4|COMPLETED|Overall Study||98
5283988|NCT00621764|12990658|P3|COMPLETED|Overall Study||101
5283989|NCT00621764|12990659|P2|COMPLETED|Overall Study||50
5283990|NCT00621764|12990660|P1|COMPLETED|Overall Study||50
5283991|NCT00621764|12990657|P4|STARTED|Overall Study||99
5283992|NCT00621764|12990658|P3|STARTED|Overall Study||101
5283993|NCT00621764|12990659|P2|STARTED|Overall Study||50
5283994|NCT00621764|12990660|P1|STARTED|Overall Study||50
5283995|NCT00621686|12990692|P2|NOT COMPLETED|Overall Study||0
5283996|NCT00621686|12990693|P1|NOT COMPLETED|Overall Study||0
5283997|NCT00621686|12990692|P2|COMPLETED|Overall Study||35
5283998|NCT00621686|12990693|P1|COMPLETED|Overall Study||19
5283999|NCT00621686|12990692|P2|STARTED|Overall Study||35
5284000|NCT00621686|12990693|P1|STARTED|Overall Study||19
5284001|NCT00621621|12990706|P2|NOT COMPLETED|Overall Study||0
5284002|NCT00621621|12990707|P1|NOT COMPLETED|Overall Study||30
5284003|NCT00621621|12990706|P2|COMPLETED|Overall Study||705
5284004|NCT00621621|12990707|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
5284005|NCT00621621|12990706|P2|STARTED|Overall Study||705
5284006|NCT00621621|12990707|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
5284007|NCT00621582|12990715|P1|NOT COMPLETED|Overall Study||106
5284008|NCT00621582|12990715|P1|COMPLETED|Overall Study||4812
5284009|NCT00621582|12990715|P1|STARTED|Overall Study||4918
5284010|NCT00621543|12990722|P1|NOT COMPLETED|Overall Study||23
5284011|NCT00621543|12990722|P1|COMPLETED|Overall Study||97
5284012|NCT00621543|12990722|P1|STARTED|Overall Study||120
5284013|NCT00621530|12990729|P2|NOT COMPLETED|Overall Study||3
5284014|NCT00621530|12990730|P1|NOT COMPLETED|Overall Study||2
5284015|NCT00621530|12990729|P2|COMPLETED|Overall Study||29
5284016|NCT00621530|12990730|P1|COMPLETED|Overall Study||28
5284017|NCT00621530|12990729|P2|STARTED|Overall Study||32
5284018|NCT00621530|12990730|P1|STARTED|Overall Study||30
5284019|NCT00621517|12990746|P2|NOT COMPLETED|Overall Study||7
5284020|NCT00621517|12990747|P1|NOT COMPLETED|Overall Study||7
5284021|NCT00621517|12990746|P2|COMPLETED|Overall Study||24
5284022|NCT00621517|12990747|P1|COMPLETED|Overall Study||22
5284023|NCT00621517|12990746|P2|STARTED|Overall Study||31
5284024|NCT00621517|12990747|P1|STARTED|Overall Study||29
5284025|NCT00621504|12990759|P2|NOT COMPLETED|Overall Study||25
5284026|NCT00621504|12990760|P1|NOT COMPLETED|Overall Study||26
5284027|NCT00621504|12990759|P2|COMPLETED|Overall Study||282
5284028|NCT00621504|12990760|P1|COMPLETED|Overall Study||273
5284029|NCT00621504|12990759|P2|STARTED|Overall Study||307
5284030|NCT00621504|12990760|P1|STARTED|Overall Study||299
5284031|NCT00621348|12990769|P3|NOT COMPLETED|Overall Study||0
5284032|NCT00621348|12990770|P2|NOT COMPLETED|Overall Study||0
5284033|NCT00621348|12990771|P1|NOT COMPLETED|Overall Study||0
5284034|NCT00621348|12990769|P3|COMPLETED|Overall Study||56
5284035|NCT00621348|12990770|P2|COMPLETED|Overall Study||53
5284036|NCT00621348|12990771|P1|COMPLETED|Overall Study||58
5284037|NCT00621348|12990769|P3|STARTED|Overall Study||56
5284038|NCT00621348|12990770|P2|STARTED|Overall Study||53
5284039|NCT00621348|12990771|P1|STARTED|Overall Study||58
5284040|NCT00621322|12990794|P6|NOT COMPLETED|Overall Study||4
5284041|NCT00621322|12990795|P5|NOT COMPLETED|Overall Study||1
5284042|NCT00621322|12990796|P4|NOT COMPLETED|Overall Study||3
5284043|NCT00621322|12990797|P3|NOT COMPLETED|Overall Study||2
5284044|NCT00621322|12990798|P2|NOT COMPLETED|Overall Study||0
5284045|NCT00621322|12990799|P1|NOT COMPLETED|Overall Study||1
5284046|NCT00621322|12990794|P6|COMPLETED|Overall Study||36
5284047|NCT00621322|12990795|P5|COMPLETED|Overall Study||39
5284048|NCT00621322|12990796|P4|COMPLETED|Overall Study||37
5284049|NCT00621322|12990797|P3|COMPLETED|Overall Study||38
5284050|NCT00621322|12990798|P2|COMPLETED|Overall Study||10
5284051|NCT00621322|12990799|P1|COMPLETED|Overall Study||9
5284052|NCT00621322|12990794|P6|STARTED|Overall Study||40
5284053|NCT00621322|12990795|P5|STARTED|Overall Study||40
5284054|NCT00621322|12990796|P4|STARTED|Overall Study||40
5284055|NCT00621322|12990797|P3|STARTED|Overall Study||40
5284056|NCT00621322|12990798|P2|STARTED|Overall Study||10
5284057|NCT00621322|12990799|P1|STARTED|Overall Study||10
5284058|NCT00621309|12990879|P6|NOT COMPLETED|Overall Study||1
5284059|NCT00621309|12990880|P5|NOT COMPLETED|Overall Study||1
5284060|NCT00621309|12990881|P4|NOT COMPLETED|Overall Study||1
5284061|NCT00621309|12990882|P3|NOT COMPLETED|Overall Study||1
5284062|NCT00621309|12990883|P2|NOT COMPLETED|Overall Study||0
5284063|NCT00621309|12990884|P1|NOT COMPLETED|Overall Study||2
5284064|NCT00621309|12990879|P6|COMPLETED|Overall Study||3
5284065|NCT00621309|12990880|P5|COMPLETED|Overall Study||3
5284066|NCT00621309|12990881|P4|COMPLETED|Overall Study||5
5284067|NCT00621309|12990882|P3|COMPLETED|Overall Study||4
5284068|NCT00621309|12990883|P2|COMPLETED|Overall Study||4
5284069|NCT00621309|12990884|P1|COMPLETED|Overall Study||4
5284070|NCT00621309|12990879|P6|STARTED|Overall Study||4
5284071|NCT00621309|12990880|P5|STARTED|Overall Study||4
5284072|NCT00621309|12990881|P4|STARTED|Overall Study||6
5284073|NCT00621309|12990882|P3|STARTED|Overall Study||5
5284074|NCT00621309|12990883|P2|STARTED|Overall Study||4
5284075|NCT00621309|12990884|P1|STARTED|Overall Study||6
5284076|NCT00621296|12990890|P1|NOT COMPLETED|Overall Study||14
5284077|NCT00621296|12990890|P1|COMPLETED|Overall Study||1
5284078|NCT00621296|12990890|P1|STARTED|Overall Study||15
5284079|NCT00621257|12990899|P5|NOT COMPLETED|Overall Study||9
5284080|NCT00621257|12990900|P4|NOT COMPLETED|Overall Study||6
5284081|NCT00621257|12990901|P3|NOT COMPLETED|Overall Study||3
5284082|NCT00621257|12990902|P2|NOT COMPLETED|Overall Study||3
5284083|NCT00621257|12990903|P1|NOT COMPLETED|Overall Study||4
5284084|NCT00621257|12990899|P5|COMPLETED|Overall Study||22
5284085|NCT00621257|12990900|P4|COMPLETED|Overall Study||26
5284086|NCT00621257|12990901|P3|COMPLETED|Overall Study||20
5284087|NCT00621257|12990902|P2|COMPLETED|Overall Study||21
5284088|NCT00621257|12990903|P1|COMPLETED|Overall Study||20
5284089|NCT00621257|12990899|P5|STARTED|Overall Study||31
5284090|NCT00621257|12990900|P4|STARTED|Overall Study||32
5284091|NCT00621257|12990901|P3|STARTED|Overall Study||23
5284092|NCT00621257|12990902|P2|STARTED|Overall Study||24
5284093|NCT00621257|12990903|P1|STARTED|Overall Study||24
5284094|NCT00621244|12990919|P4|NOT COMPLETED|Overall Study||23
5284095|NCT00621244|12990920|P3|NOT COMPLETED|Overall Study||33
5284096|NCT00621244|12990921|P2|NOT COMPLETED|Overall Study||34
5284097|NCT00621244|12990922|P1|NOT COMPLETED|Overall Study||86
5284098|NCT00621244|12990919|P4|COMPLETED|Overall Study||0
5284099|NCT00621244|12990920|P3|COMPLETED|Overall Study||0
5284100|NCT00621244|12990921|P2|COMPLETED|Overall Study||0
5284101|NCT00621244|12990922|P1|COMPLETED|Overall Study||0
5284102|NCT00621244|12990919|P4|STARTED|Overall Study||23
5284103|NCT00621244|12990920|P3|STARTED|Overall Study||33
5284104|NCT00621244|12990921|P2|STARTED|Overall Study||34
5284105|NCT00621244|12990922|P1|STARTED|Overall Study||86
5284106|NCT00621192|12991026|P4|NOT COMPLETED|Overall Study||3
5284107|NCT00621192|12991027|P3|NOT COMPLETED|Overall Study||5
5284108|NCT00621192|12991028|P2|NOT COMPLETED|Overall Study||9
5284109|NCT00621192|12991029|P1|NOT COMPLETED|Overall Study||4
5284110|NCT00621192|12991026|P4|COMPLETED|Overall Study||24
5284111|NCT00621192|12991027|P3|COMPLETED|Overall Study||26
5284112|NCT00621192|12991028|P2|COMPLETED|Overall Study||94
5284113|NCT00621192|12991029|P1|COMPLETED|Overall Study||35
5284114|NCT00621192|12991026|P4|Efficacy Population|Overall Study||27
5284115|NCT00621192|12991027|P3|Efficacy Population|Overall Study||28
5284116|NCT00621192|12991028|P2|Efficacy Population|Overall Study||101
5284117|NCT00621192|12991029|P1|Efficacy Population|Overall Study||39
5284118|NCT00621192|12991026|P4|Safety Population|Overall Study||27
5284119|NCT00621192|12991027|P3|Safety Population|Overall Study||31
5284120|NCT00621192|12991028|P2|Safety Population|Overall Study||103
5284121|NCT00621192|12991029|P1|Safety Population|Overall Study||39
5284122|NCT00621192|12991026|P4|STARTED|Overall Study||27
5284123|NCT00621192|12991027|P3|STARTED|Overall Study||31
5284124|NCT00621192|12991028|P2|STARTED|Overall Study||103
5284125|NCT00621192|12991029|P1|STARTED|Overall Study||39
5284126|NCT00621153|12991053|P2|NOT COMPLETED|Overall Study||15
5284127|NCT00621153|12991054|P1|NOT COMPLETED|Overall Study||20
5284128|NCT00621153|12991053|P2|COMPLETED|Overall Study|completed|101
5284129|NCT00621153|12991054|P1|COMPLETED|Overall Study|completed|97
5284130|NCT00621153|12991053|P2|Discontinued|Overall Study||15
5284131|NCT00621153|12991054|P1|Discontinued|Overall Study||20
5284132|NCT00621153|12991053|P2|STARTED|Overall Study|randomised|116
5284133|NCT00621153|12991054|P1|STARTED|Overall Study|randomised|117
5284134|NCT00621140|12991062|P2|NOT COMPLETED|Overall Study||18
5284135|NCT00621140|12991063|P1|NOT COMPLETED|Overall Study||15
5284136|NCT00621140|12991062|P2|COMPLETED|Overall Study|number who completed treatment|318
5284137|NCT00621140|12991063|P1|COMPLETED|Overall Study|number who completed treatment|152
5284138|NCT00621140|12991062|P2|STARTED|Overall Study|number who started treatment|336
5284139|NCT00621140|12991063|P1|STARTED|Overall Study|number who started treatment|167
5284140|NCT00621049|12991097|P2|NOT COMPLETED|Maintenance Treatment||0
5284141|NCT00621049|12991098|P1|NOT COMPLETED|Maintenance Treatment||15
5284142|NCT00621049|12991097|P2|COMPLETED|Maintenance Treatment||0
5284143|NCT00621049|12991098|P1|COMPLETED|Maintenance Treatment||34
5284144|NCT00621049|12991097|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
5284145|NCT00621049|12991098|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
5284146|NCT00621049|12991097|P2|NOT COMPLETED|Adjuvant Treatment||10
5284147|NCT00621049|12991098|P1|NOT COMPLETED|Adjuvant Treatment||3
5284148|NCT00621049|12991097|P2|COMPLETED|Adjuvant Treatment||47
5284149|NCT00621049|12991098|P1|COMPLETED|Adjuvant Treatment||52
5284150|NCT00621049|12991097|P2|STARTED|Adjuvant Treatment||57
5284151|NCT00621049|12991098|P1|STARTED|Adjuvant Treatment||55
5284152|NCT00621023|12991110|P1|NOT COMPLETED|Overall Study||6
5284153|NCT00621023|12991110|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
5284154|NCT00621023|12991110|P1|STARTED|Overall Study||6
5284155|NCT00620945|12991116|P1|NOT COMPLETED|Overall Study||0
5284156|NCT00620945|12991116|P1|COMPLETED|Overall Study||87
5284157|NCT00620945|12991116|P1|STARTED|Overall Study|Total number in the study|87
5284158|NCT00620854|12991127|P6|NOT COMPLETED|Period 3||0
5284159|NCT00620854|12991128|P5|NOT COMPLETED|Period 3||0
5284160|NCT00620854|12991129|P4|NOT COMPLETED|Period 3||0
5284161|NCT00620854|12991130|P3|NOT COMPLETED|Period 3||0
5284162|NCT00620854|12991131|P2|NOT COMPLETED|Period 3||0
5284163|NCT00620854|12991132|P1|NOT COMPLETED|Period 3||0
5284164|NCT00620854|12991127|P6|COMPLETED|Period 3||4
5284165|NCT00620854|12991128|P5|COMPLETED|Period 3||4
5284166|NCT00620854|12991129|P4|COMPLETED|Period 3||3
5284167|NCT00620854|12991130|P3|COMPLETED|Period 3||3
5284168|NCT00620854|12991131|P2|COMPLETED|Period 3||4
5284169|NCT00620854|12991132|P1|COMPLETED|Period 3||4
5284170|NCT00620854|12991127|P6|STARTED|Period 3||4
5284171|NCT00620854|12991128|P5|STARTED|Period 3||4
5284172|NCT00620854|12991129|P4|STARTED|Period 3||3
5284173|NCT00620854|12991130|P3|STARTED|Period 3||3
5284174|NCT00620854|12991131|P2|STARTED|Period 3||4
5284175|NCT00620854|12991132|P1|STARTED|Period 3||4
5284176|NCT00620854|12991127|P6|NOT COMPLETED|Washout 2||0
5284177|NCT00620854|12991128|P5|NOT COMPLETED|Washout 2||0
5284178|NCT00620854|12991129|P4|NOT COMPLETED|Washout 2||0
5284179|NCT00620854|12991130|P3|NOT COMPLETED|Washout 2||0
5284180|NCT00620854|12991131|P2|NOT COMPLETED|Washout 2||0
5284181|NCT00620854|12991132|P1|NOT COMPLETED|Washout 2||0
5284182|NCT00620854|12991127|P6|COMPLETED|Washout 2||4
5284183|NCT00620854|12991128|P5|COMPLETED|Washout 2||4
5284184|NCT00620854|12991129|P4|COMPLETED|Washout 2||3
5284185|NCT00620854|12991130|P3|COMPLETED|Washout 2||3
5284186|NCT00620854|12991131|P2|COMPLETED|Washout 2||4
5284187|NCT00620854|12991132|P1|COMPLETED|Washout 2||4
5284188|NCT00620854|12991127|P6|STARTED|Washout 2||4
5284189|NCT00620854|12991128|P5|STARTED|Washout 2||4
5284190|NCT00620854|12991129|P4|STARTED|Washout 2||3
5284191|NCT00620854|12991130|P3|STARTED|Washout 2||3
5284192|NCT00620854|12991131|P2|STARTED|Washout 2||4
5284193|NCT00620854|12991132|P1|STARTED|Washout 2||4
5284194|NCT00620854|12991127|P6|NOT COMPLETED|Period 2||0
5284195|NCT00620854|12991128|P5|NOT COMPLETED|Period 2||0
5284196|NCT00620854|12991129|P4|NOT COMPLETED|Period 2||0
5284197|NCT00620854|12991130|P3|NOT COMPLETED|Period 2||0
5284198|NCT00620854|12991131|P2|NOT COMPLETED|Period 2||0
5284199|NCT00620854|12991132|P1|NOT COMPLETED|Period 2||0
5284200|NCT00620854|12991127|P6|COMPLETED|Period 2||4
5284201|NCT00620854|12991128|P5|COMPLETED|Period 2||4
5284202|NCT00620854|12991129|P4|COMPLETED|Period 2||3
5284203|NCT00620854|12991130|P3|COMPLETED|Period 2||3
5284204|NCT00620854|12991131|P2|COMPLETED|Period 2||4
5284205|NCT00620854|12991132|P1|COMPLETED|Period 2||4
5284206|NCT00620854|12991127|P6|STARTED|Period 2||4
5284207|NCT00620854|12991128|P5|STARTED|Period 2||4
5284208|NCT00620854|12991129|P4|STARTED|Period 2||3
5284209|NCT00620854|12991130|P3|STARTED|Period 2||3
5284210|NCT00620854|12991131|P2|STARTED|Period 2||4
5284211|NCT00620854|12991132|P1|STARTED|Period 2||4
5284212|NCT00620854|12991127|P6|NOT COMPLETED|Washout 1||0
5284213|NCT00620854|12991128|P5|NOT COMPLETED|Washout 1||0
5284214|NCT00620854|12991129|P4|NOT COMPLETED|Washout 1||1
5284215|NCT00620854|12991130|P3|NOT COMPLETED|Washout 1||1
5284216|NCT00620854|12991131|P2|NOT COMPLETED|Washout 1||0
5284217|NCT00620854|12991132|P1|NOT COMPLETED|Washout 1||0
5284218|NCT00620854|12991127|P6|COMPLETED|Washout 1||4
5284219|NCT00620854|12991128|P5|COMPLETED|Washout 1||4
5284220|NCT00620854|12991129|P4|COMPLETED|Washout 1||3
5284221|NCT00620854|12991130|P3|COMPLETED|Washout 1||3
5284222|NCT00620854|12991131|P2|COMPLETED|Washout 1||4
5284223|NCT00620854|12991132|P1|COMPLETED|Washout 1||4
5284224|NCT00620854|12991127|P6|STARTED|Washout 1||4
5284225|NCT00620854|12991128|P5|STARTED|Washout 1||4
5284226|NCT00620854|12991129|P4|STARTED|Washout 1||4
5284227|NCT00620854|12991130|P3|STARTED|Washout 1||4
5284228|NCT00620854|12991131|P2|STARTED|Washout 1||4
5284229|NCT00620854|12991132|P1|STARTED|Washout 1||4
5284230|NCT00620854|12991127|P6|NOT COMPLETED|Period 1||0
5284231|NCT00620854|12991128|P5|NOT COMPLETED|Period 1||0
5284232|NCT00620854|12991129|P4|NOT COMPLETED|Period 1||0
5284233|NCT00620854|12991130|P3|NOT COMPLETED|Period 1||0
5284234|NCT00620854|12991131|P2|NOT COMPLETED|Period 1||0
5284235|NCT00620854|12991132|P1|NOT COMPLETED|Period 1||0
5284236|NCT00620854|12991127|P6|COMPLETED|Period 1||4
5284237|NCT00620854|12991128|P5|COMPLETED|Period 1||4
5284238|NCT00620854|12991129|P4|COMPLETED|Period 1||4
5284239|NCT00620854|12991130|P3|COMPLETED|Period 1||4
5284240|NCT00620854|12991131|P2|COMPLETED|Period 1||4
5284241|NCT00620854|12991132|P1|COMPLETED|Period 1||4
5284242|NCT00620854|12991127|P6|STARTED|Period 1||4
5284243|NCT00620854|12991128|P5|STARTED|Period 1||4
5284244|NCT00620854|12991129|P4|STARTED|Period 1||4
5284245|NCT00620854|12991130|P3|STARTED|Period 1||4
5284246|NCT00620854|12991131|P2|STARTED|Period 1||4
5284247|NCT00620854|12991132|P1|STARTED|Period 1||4
5284248|NCT00620828|12991145|P2|NOT COMPLETED|Overall Study||0
5284249|NCT00620828|12991146|P1|NOT COMPLETED|Overall Study||0
5284250|NCT00620828|12991145|P2|COMPLETED|Overall Study||35
5284251|NCT00620828|12991146|P1|COMPLETED|Overall Study||32
5284252|NCT00620828|12991145|P2|Number of Subjects Enrolled = 67|Overall Study||35
5284253|NCT00620828|12991146|P1|Number of Subjects Enrolled = 67|Overall Study||32
5284254|NCT00620828|12991145|P2|STARTED|Overall Study||35
5284255|NCT00620828|12991146|P1|STARTED|Overall Study||32
5284256|NCT00620815|12991163|P3|NOT COMPLETED|Overall Study||7
5284257|NCT00620815|12991164|P2|NOT COMPLETED|Overall Study||11
5284258|NCT00620815|12991165|P1|NOT COMPLETED|Overall Study||4
5284259|NCT00620815|12991163|P3|COMPLETED|Overall Study||192
5284260|NCT00620815|12991164|P2|COMPLETED|Overall Study||192
5284261|NCT00620815|12991165|P1|COMPLETED|Overall Study||195
5284262|NCT00620815|12991163|P3|STARTED|Overall Study||199
5284263|NCT00620815|12991164|P2|STARTED|Overall Study||203
5284264|NCT00620815|12991165|P1|STARTED|Overall Study||199
5284265|NCT00620776|12991205|P2|NOT COMPLETED|Overall Study||16
5284266|NCT00620776|12991206|P1|NOT COMPLETED|Overall Study||12
5284267|NCT00620776|12991205|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
5284268|NCT00620776|12991206|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
5284269|NCT00620776|12991205|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
5284270|NCT00620776|12991206|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
5284271|NCT00620776|12991205|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
5284272|NCT00620776|12991206|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
5284273|NCT00620763|12991234|P2|NOT COMPLETED|Period: Second Intervention||0
5284274|NCT00620763|12991235|P1|NOT COMPLETED|Period: Second Intervention||1
5284275|NCT00620763|12991234|P2|COMPLETED|Period: Second Intervention||7
5284276|NCT00620763|12991235|P1|COMPLETED|Period: Second Intervention||9
5284277|NCT00620763|12991234|P2|STARTED|Period: Second Intervention||7
5284278|NCT00620763|12991235|P1|STARTED|Period: Second Intervention||10
5284279|NCT00620763|12991234|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
5284280|NCT00620763|12991235|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
5284281|NCT00620763|12991234|P2|COMPLETED|Period: Washout Period of 1 Week||7
5284282|NCT00620763|12991235|P1|COMPLETED|Period: Washout Period of 1 Week||10
5284283|NCT00620763|12991234|P2|STARTED|Period: Washout Period of 1 Week||7
5284284|NCT00620763|12991235|P1|STARTED|Period: Washout Period of 1 Week||10
5284285|NCT00620763|12991234|P2|NOT COMPLETED|Period: First Intervention||5
5284286|NCT00620763|12991235|P1|NOT COMPLETED|Period: First Intervention||0
5284287|NCT00620763|12991234|P2|COMPLETED|Period: First Intervention||7
5284288|NCT00620763|12991235|P1|COMPLETED|Period: First Intervention||10
5284289|NCT00620763|12991234|P2|STARTED|Period: First Intervention||12
5284290|NCT00620763|12991235|P1|STARTED|Period: First Intervention||10
5284291|NCT00620750|12991241|P1|NOT COMPLETED|Overall Study||25
5284292|NCT00620750|12991241|P1|COMPLETED|Overall Study||40
5284293|NCT00620750|12991241|P1|STARTED|Overall Study||65
5284294|NCT00620711|12991245|P1|NOT COMPLETED|Overall Study||0
5284295|NCT00620711|12991245|P1|COMPLETED|Overall Study||4
5284296|NCT00620711|12991245|P1|STARTED|Overall Study||4
5284297|NCT00620698|12991250|P1|NOT COMPLETED|Overall Study||29
5284298|NCT00620698|12991250|P1|COMPLETED|Overall Study||60
5284299|NCT00620698|12991250|P1|STARTED|Overall Study||89
5284300|NCT00620659|12991256|P6|NOT COMPLETED|Treatment Period 3||0
5284301|NCT00620659|12991257|P5|NOT COMPLETED|Treatment Period 3||0
5284302|NCT00620659|12991258|P4|NOT COMPLETED|Treatment Period 3||1
5284303|NCT00620659|12991259|P3|NOT COMPLETED|Treatment Period 3||0
5284304|NCT00620659|12991260|P2|NOT COMPLETED|Treatment Period 3||2
5284305|NCT00620659|12991261|P1|NOT COMPLETED|Treatment Period 3||0
5284306|NCT00620659|12991256|P6|COMPLETED|Treatment Period 3||20
5284307|NCT00620659|12991257|P5|COMPLETED|Treatment Period 3||15
5284308|NCT00620659|12991258|P4|COMPLETED|Treatment Period 3||17
5284309|NCT00620659|12991259|P3|COMPLETED|Treatment Period 3||19
5284310|NCT00620659|12991260|P2|COMPLETED|Treatment Period 3||16
5284311|NCT00620659|12991261|P1|COMPLETED|Treatment Period 3||16
5284312|NCT00620659|12991256|P6|STARTED|Treatment Period 3||20
5284313|NCT00620659|12991257|P5|STARTED|Treatment Period 3||15
5284314|NCT00620659|12991258|P4|STARTED|Treatment Period 3||18
5284315|NCT00620659|12991259|P3|STARTED|Treatment Period 3||19
5284316|NCT00620659|12991260|P2|STARTED|Treatment Period 3||18
5284317|NCT00620659|12991261|P1|STARTED|Treatment Period 3||16
5284318|NCT00620659|12991256|P6|NOT COMPLETED|Placebo Washout Period 2||0
5284319|NCT00620659|12991257|P5|NOT COMPLETED|Placebo Washout Period 2||0
5284320|NCT00620659|12991258|P4|NOT COMPLETED|Placebo Washout Period 2||0
5284321|NCT00620659|12991259|P3|NOT COMPLETED|Placebo Washout Period 2||0
5284322|NCT00620659|12991260|P2|NOT COMPLETED|Placebo Washout Period 2||0
5284323|NCT00620659|12991261|P1|NOT COMPLETED|Placebo Washout Period 2||2
5284324|NCT00620659|12991256|P6|COMPLETED|Placebo Washout Period 2||20
5284325|NCT00620659|12991257|P5|COMPLETED|Placebo Washout Period 2||15
5284326|NCT00620659|12991258|P4|COMPLETED|Placebo Washout Period 2||18
5284327|NCT00620659|12991259|P3|COMPLETED|Placebo Washout Period 2||19
5284328|NCT00620659|12991260|P2|COMPLETED|Placebo Washout Period 2||18
5284329|NCT00620659|12991261|P1|COMPLETED|Placebo Washout Period 2||16
5284330|NCT00620659|12991256|P6|STARTED|Placebo Washout Period 2||20
5284331|NCT00620659|12991257|P5|STARTED|Placebo Washout Period 2||15
5284332|NCT00620659|12991258|P4|STARTED|Placebo Washout Period 2||18
5284333|NCT00620659|12991259|P3|STARTED|Placebo Washout Period 2||19
5284334|NCT00620659|12991260|P2|STARTED|Placebo Washout Period 2||18
5284335|NCT00620659|12991261|P1|STARTED|Placebo Washout Period 2||18
5284336|NCT00620659|12991256|P6|NOT COMPLETED|Treatment Period 2||0
5284337|NCT00620659|12991257|P5|NOT COMPLETED|Treatment Period 2||5
5284338|NCT00620659|12991258|P4|NOT COMPLETED|Treatment Period 2||0
5284339|NCT00620659|12991259|P3|NOT COMPLETED|Treatment Period 2||1
5284340|NCT00620659|12991260|P2|NOT COMPLETED|Treatment Period 2||3
5284341|NCT00620659|12991261|P1|NOT COMPLETED|Treatment Period 2||0
5284342|NCT00620659|12991256|P6|COMPLETED|Treatment Period 2||20
5284343|NCT00620659|12991257|P5|COMPLETED|Treatment Period 2||15
5284344|NCT00620659|12991258|P4|COMPLETED|Treatment Period 2||18
5284345|NCT00620659|12991259|P3|COMPLETED|Treatment Period 2||19
5284346|NCT00620659|12991260|P2|COMPLETED|Treatment Period 2||18
5284347|NCT00620659|12991261|P1|COMPLETED|Treatment Period 2||18
5284348|NCT00620659|12991256|P6|STARTED|Treatment Period 2||20
5284349|NCT00620659|12991257|P5|STARTED|Treatment Period 2||20
5284350|NCT00620659|12991258|P4|STARTED|Treatment Period 2||18
5284351|NCT00620659|12991259|P3|STARTED|Treatment Period 2||20
5284352|NCT00620659|12991260|P2|STARTED|Treatment Period 2||21
5284353|NCT00620659|12991261|P1|STARTED|Treatment Period 2||18
5284354|NCT00620659|12991256|P6|NOT COMPLETED|Placebo Washout Period 1||0
5284355|NCT00620659|12991257|P5|NOT COMPLETED|Placebo Washout Period 1||0
5284356|NCT00620659|12991258|P4|NOT COMPLETED|Placebo Washout Period 1||1
5284357|NCT00620659|12991259|P3|NOT COMPLETED|Placebo Washout Period 1||0
5284358|NCT00620659|12991260|P2|NOT COMPLETED|Placebo Washout Period 1||0
5284359|NCT00620659|12991261|P1|NOT COMPLETED|Placebo Washout Period 1||0
5284360|NCT00620659|12991256|P6|COMPLETED|Placebo Washout Period 1||20
5284361|NCT00620659|12991257|P5|COMPLETED|Placebo Washout Period 1||20
5284362|NCT00620659|12991258|P4|COMPLETED|Placebo Washout Period 1||18
5284363|NCT00620659|12991259|P3|COMPLETED|Placebo Washout Period 1||20
5284364|NCT00620659|12991260|P2|COMPLETED|Placebo Washout Period 1||21
5284365|NCT00620659|12991261|P1|COMPLETED|Placebo Washout Period 1||18
5284366|NCT00620659|12991256|P6|STARTED|Placebo Washout Period 1||20
5284367|NCT00620659|12991257|P5|STARTED|Placebo Washout Period 1||20
5284368|NCT00620659|12991258|P4|STARTED|Placebo Washout Period 1||19
5284369|NCT00620659|12991259|P3|STARTED|Placebo Washout Period 1||20
5284370|NCT00620659|12991260|P2|STARTED|Placebo Washout Period 1||21
5284371|NCT00620659|12991261|P1|STARTED|Placebo Washout Period 1||18
5284372|NCT00620659|12991256|P6|NOT COMPLETED|Treatment Period 1||0
5284373|NCT00620659|12991257|P5|NOT COMPLETED|Treatment Period 1||1
5284374|NCT00620659|12991258|P4|NOT COMPLETED|Treatment Period 1||3
5284375|NCT00620659|12991259|P3|NOT COMPLETED|Treatment Period 1||1
5284376|NCT00620659|12991260|P2|NOT COMPLETED|Treatment Period 1||0
5284377|NCT00620659|12991261|P1|NOT COMPLETED|Treatment Period 1||3
5284378|NCT00620659|12991256|P6|COMPLETED|Treatment Period 1||20
5284379|NCT00620659|12991257|P5|COMPLETED|Treatment Period 1||20
5284380|NCT00620659|12991258|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
5284381|NCT00620659|12991259|P3|COMPLETED|Treatment Period 1||20
5284382|NCT00620659|12991260|P2|COMPLETED|Treatment Period 1||21
5284383|NCT00620659|12991261|P1|COMPLETED|Treatment Period 1||18
5284384|NCT00620659|12991256|P6|STARTED|Treatment Period 1||20
5284385|NCT00620659|12991257|P5|STARTED|Treatment Period 1||21
5284386|NCT00620659|12991258|P4|STARTED|Treatment Period 1||21
5284387|NCT00620659|12991259|P3|STARTED|Treatment Period 1||21
5284388|NCT00620659|12991260|P2|STARTED|Treatment Period 1||21
5284389|NCT00620659|12991261|P1|STARTED|Treatment Period 1||21
5284390|NCT00620555|12991279|P1|NOT COMPLETED|Overall Study||21
5284391|NCT00620555|12991279|P1|COMPLETED|Overall Study||44
5284392|NCT00620555|12991279|P1|STARTED|Overall Study||65
5284393|NCT00620542|12991288|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
5284394|NCT00620542|12991289|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
5284395|NCT00620542|12991290|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
5284396|NCT00620542|12991291|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
5284397|NCT00620542|12991288|P4|COMPLETED|Part B (2 Year Core Study)||547
5284398|NCT00620542|12991289|P3|COMPLETED|Part B (2 Year Core Study)||546
5284399|NCT00620542|12991290|P2|COMPLETED|Part B (2 Year Core Study)||0
5284400|NCT00620542|12991291|P1|COMPLETED|Part B (2 Year Core Study)||0
5284401|NCT00620542|12991288|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
5284402|NCT00620542|12991289|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
5284403|NCT00620542|12991290|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
5284404|NCT00620542|12991291|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
5284405|NCT00620542|12991288|P4|Received Treatment|Part B (2 Year Core Study)||689
5284406|NCT00620542|12991289|P3|Received Treatment|Part B (2 Year Core Study)||691
5284407|NCT00620542|12991290|P2|Received Treatment|Part B (2 Year Core Study)||0
5284408|NCT00620542|12991291|P1|Received Treatment|Part B (2 Year Core Study)||0
5284409|NCT00620542|12991288|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
5284410|NCT00620542|12991289|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
5284411|NCT00620542|12991290|P2|STARTED|Part B (2 Year Core Study)||0
5284412|NCT00620542|12991291|P1|STARTED|Part B (2 Year Core Study)||0
5284413|NCT00620542|12991288|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
5284414|NCT00620542|12991289|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
5284415|NCT00620542|12991290|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
5284416|NCT00620542|12991291|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
5284417|NCT00620542|12991288|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
5284418|NCT00620542|12991289|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
5284419|NCT00620542|12991290|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
5284420|NCT00620542|12991291|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
5284421|NCT00620542|12991288|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
5284422|NCT00620542|12991289|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
5284423|NCT00620542|12991290|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
5284424|NCT00620542|12991291|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
5284425|NCT00620542|12991288|P4|STARTED|Part A (Run-in - 2 Weeks)||0
5284426|NCT00620542|12991289|P3|STARTED|Part A (Run-in - 2 Weeks)||0
5284427|NCT00620542|12991290|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
5284428|NCT00620542|12991291|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
5284429|NCT00620503|12991329|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284430|NCT00620503|12991330|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284431|NCT00620503|12991331|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284432|NCT00620503|12991332|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284433|NCT00620503|12991333|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284434|NCT00620503|12991334|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
5284435|NCT00620503|12991329|P6|COMPLETED|Follow-up (up to 14 Days)||2
5284436|NCT00620503|12991330|P5|COMPLETED|Follow-up (up to 14 Days)||2
5284437|NCT00620503|12991331|P4|COMPLETED|Follow-up (up to 14 Days)||2
5284438|NCT00620503|12991332|P3|COMPLETED|Follow-up (up to 14 Days)||2
5284439|NCT00620503|12991333|P2|COMPLETED|Follow-up (up to 14 Days)||2
5284440|NCT00620503|12991334|P1|COMPLETED|Follow-up (up to 14 Days)||2
5284441|NCT00620503|12991329|P6|STARTED|Follow-up (up to 14 Days)||2
5284442|NCT00620503|12991330|P5|STARTED|Follow-up (up to 14 Days)||2
5284443|NCT00620503|12991331|P4|STARTED|Follow-up (up to 14 Days)||2
5284444|NCT00620503|12991332|P3|STARTED|Follow-up (up to 14 Days)||2
5284445|NCT00620503|12991333|P2|STARTED|Follow-up (up to 14 Days)||2
5284446|NCT00620503|12991334|P1|STARTED|Follow-up (up to 14 Days)||2
5284447|NCT00620503|12991329|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284448|NCT00620503|12991330|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284449|NCT00620503|12991331|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284450|NCT00620503|12991332|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284451|NCT00620503|12991333|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284452|NCT00620503|12991334|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
5284453|NCT00620503|12991329|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284454|NCT00620503|12991330|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284455|NCT00620503|12991331|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284456|NCT00620503|12991332|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284457|NCT00620503|12991333|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284458|NCT00620503|12991334|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
5284459|NCT00620503|12991329|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284460|NCT00620503|12991330|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284461|NCT00620503|12991331|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284462|NCT00620503|12991332|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284463|NCT00620503|12991333|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284464|NCT00620503|12991334|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
5284465|NCT00620503|12991329|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
5284466|NCT00620503|12991330|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
5284467|NCT00620503|12991331|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
5284468|NCT00620503|12991332|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
5284469|NCT00620503|12991333|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
5284470|NCT00620503|12991334|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
5284471|NCT00620503|12991329|P6|COMPLETED|Washout (at Least 1 Day)||2
5284472|NCT00620503|12991330|P5|COMPLETED|Washout (at Least 1 Day)||2
5284473|NCT00620503|12991331|P4|COMPLETED|Washout (at Least 1 Day)||2
5284474|NCT00620503|12991332|P3|COMPLETED|Washout (at Least 1 Day)||2
5284475|NCT00620503|12991333|P2|COMPLETED|Washout (at Least 1 Day)||2
5284476|NCT00620503|12991334|P1|COMPLETED|Washout (at Least 1 Day)||2
5284477|NCT00620503|12991329|P6|STARTED|Washout (at Least 1 Day)||2
5284478|NCT00620503|12991330|P5|STARTED|Washout (at Least 1 Day)||2
5284479|NCT00620503|12991331|P4|STARTED|Washout (at Least 1 Day)||2
5284480|NCT00620503|12991332|P3|STARTED|Washout (at Least 1 Day)||2
5284481|NCT00620503|12991333|P2|STARTED|Washout (at Least 1 Day)||2
5284482|NCT00620503|12991334|P1|STARTED|Washout (at Least 1 Day)||2
5284483|NCT00620503|12991329|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284484|NCT00620503|12991330|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284485|NCT00620503|12991331|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284486|NCT00620503|12991332|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284487|NCT00620503|12991333|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284488|NCT00620503|12991334|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
5284489|NCT00620503|12991329|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284490|NCT00620503|12991330|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284491|NCT00620503|12991331|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284492|NCT00620503|12991332|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284493|NCT00620503|12991333|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284494|NCT00620503|12991334|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
5284495|NCT00620503|12991329|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
5284496|NCT00620503|12991330|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
5284497|NCT00620503|12991331|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
5284498|NCT00620503|12991332|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
5284499|NCT00620503|12991333|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
5284500|NCT00620503|12991334|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
5284501|NCT00620503|12991329|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
5284502|NCT00620503|12991330|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
5284503|NCT00620503|12991331|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
5284504|NCT00620503|12991332|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
5284505|NCT00620503|12991333|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
5284506|NCT00620503|12991334|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
5284507|NCT00620503|12991329|P6|COMPLETED|Washout (at Least 1 Day)||2
5284508|NCT00620503|12991330|P5|COMPLETED|Washout (at Least 1 Day)||2
5284509|NCT00620503|12991331|P4|COMPLETED|Washout (at Least 1 Day)||2
5284510|NCT00620503|12991332|P3|COMPLETED|Washout (at Least 1 Day)||2
5284511|NCT00620503|12991333|P2|COMPLETED|Washout (at Least 1 Day)||2
5284512|NCT00620503|12991334|P1|COMPLETED|Washout (at Least 1 Day)||2
5284513|NCT00620503|12991329|P6|STARTED|Washout (at Least 1 Day)||2
5284514|NCT00620503|12991330|P5|STARTED|Washout (at Least 1 Day)||2
5284515|NCT00620503|12991331|P4|STARTED|Washout (at Least 1 Day)||2
5284516|NCT00620503|12991332|P3|STARTED|Washout (at Least 1 Day)||2
5284517|NCT00620503|12991333|P2|STARTED|Washout (at Least 1 Day)||2
5284518|NCT00620503|12991334|P1|STARTED|Washout (at Least 1 Day)||2
5284519|NCT00620503|12991329|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284520|NCT00620503|12991330|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284521|NCT00620503|12991331|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284522|NCT00620503|12991332|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284523|NCT00620503|12991333|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284524|NCT00620503|12991334|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
5284525|NCT00620503|12991329|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284526|NCT00620503|12991330|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284527|NCT00620503|12991331|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284528|NCT00620503|12991332|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284529|NCT00620503|12991333|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284530|NCT00620503|12991334|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
5284531|NCT00620503|12991329|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
5284532|NCT00620503|12991330|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
5284533|NCT00620503|12991331|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
5284534|NCT00620503|12991332|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
5284535|NCT00620503|12991333|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
5284536|NCT00620503|12991334|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
5284537|NCT00620503|12991329|P6|NOT COMPLETED|Screening (up to 21 Days)||0
5284538|NCT00620503|12991330|P5|NOT COMPLETED|Screening (up to 21 Days)||0
5284539|NCT00620503|12991331|P4|NOT COMPLETED|Screening (up to 21 Days)||0
5284540|NCT00620503|12991332|P3|NOT COMPLETED|Screening (up to 21 Days)||0
5284541|NCT00620503|12991333|P2|NOT COMPLETED|Screening (up to 21 Days)||0
5284542|NCT00620503|12991334|P1|NOT COMPLETED|Screening (up to 21 Days)||0
5284543|NCT00620503|12991329|P6|COMPLETED|Screening (up to 21 Days)||2
5284544|NCT00620503|12991330|P5|COMPLETED|Screening (up to 21 Days)||2
5284545|NCT00620503|12991331|P4|COMPLETED|Screening (up to 21 Days)||2
5284546|NCT00620503|12991332|P3|COMPLETED|Screening (up to 21 Days)||2
5284547|NCT00620503|12991333|P2|COMPLETED|Screening (up to 21 Days)||2
5284548|NCT00620503|12991334|P1|COMPLETED|Screening (up to 21 Days)||2
5284549|NCT00620503|12991329|P6|STARTED|Screening (up to 21 Days)||2
5284550|NCT00620503|12991330|P5|STARTED|Screening (up to 21 Days)||2
5284551|NCT00620503|12991331|P4|STARTED|Screening (up to 21 Days)||2
5284552|NCT00620503|12991332|P3|STARTED|Screening (up to 21 Days)||2
5284553|NCT00620503|12991333|P2|STARTED|Screening (up to 21 Days)||2
5284554|NCT00620503|12991334|P1|STARTED|Screening (up to 21 Days)||2
5284555|NCT00620464|12991356|P2|NOT COMPLETED|Overall Study||24
5284556|NCT00620464|12991357|P1|NOT COMPLETED|Overall Study||20
5284557|NCT00620464|12991356|P2|COMPLETED|Overall Study||32
5284558|NCT00620464|12991357|P1|COMPLETED|Overall Study||32
5284559|NCT00620464|12991356|P2|STARTED|Overall Study||56
5284560|NCT00620464|12991357|P1|STARTED|Overall Study||52
5284561|NCT00620425|12991365|P1|NOT COMPLETED|Overall Study||0
5284562|NCT00620425|12991365|P1|COMPLETED|Overall Study||18
5284563|NCT00620425|12991365|P1|STARTED|Overall Study||18
5284564|NCT00620373|12991376|P1|NOT COMPLETED|Overall Study||33
5284565|NCT00620373|12991376|P1|COMPLETED|Overall Study||936
5284566|NCT00620373|12991376|P1|STARTED|Overall Study||969
5284567|NCT00620321|12991394|P2|NOT COMPLETED|Overall Study||16
5284568|NCT00620321|12991395|P1|NOT COMPLETED|Overall Study||8
5284569|NCT00620321|12991394|P2|COMPLETED|Overall Study||0
5284570|NCT00620321|12991395|P1|COMPLETED|Overall Study||0
5284571|NCT00620321|12991394|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
5284572|NCT00620321|12991395|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
5284573|NCT00620321|12991394|P2|STARTED|Overall Study||16
5284574|NCT00620321|12991395|P1|STARTED|Overall Study||8
5284575|NCT00620282|12991414|P3|NOT COMPLETED|Overall Study||1
5284576|NCT00620282|12991415|P2|NOT COMPLETED|Overall Study||2
5284577|NCT00620282|12991416|P1|NOT COMPLETED|Overall Study||0
5284578|NCT00620282|12991414|P3|COMPLETED|Overall Study||16
5284579|NCT00620282|12991415|P2|COMPLETED|Overall Study||14
5284580|NCT00620282|12991416|P1|COMPLETED|Overall Study||16
5284581|NCT00620282|12991414|P3|STARTED|Overall Study||17
5284582|NCT00620282|12991415|P2|STARTED|Overall Study||16
5284583|NCT00620282|12991416|P1|STARTED|Overall Study||16
5284584|NCT00620126|12991465|P2|NOT COMPLETED|Overall Study||5
5284585|NCT00620126|12991466|P1|NOT COMPLETED|Overall Study||11
5284586|NCT00620126|12991465|P2|COMPLETED|Overall Study||17
5284587|NCT00620126|12991466|P1|COMPLETED|Overall Study||14
5284588|NCT00620126|12991465|P2|STARTED|Overall Study||22
5284589|NCT00620126|12991466|P1|STARTED|Overall Study||25
5284590|NCT00620113|12991480|P4|NOT COMPLETED|Overall Study||10
5284591|NCT00620113|12991481|P3|NOT COMPLETED|Overall Study||5
5284592|NCT00620113|12991482|P2|NOT COMPLETED|Overall Study||7
5284593|NCT00620113|12991483|P1|NOT COMPLETED|Overall Study||13
5284594|NCT00620113|12991480|P4|COMPLETED|Overall Study||59
5284595|NCT00620113|12991481|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
5284596|NCT00620113|12991482|P2|COMPLETED|Overall Study||67
5284597|NCT00620113|12991483|P1|COMPLETED|Overall Study||60
5284598|NCT00620113|12991480|P4|Efficacy/Safety Population|Overall Study||69
5284599|NCT00620113|12991481|P3|Efficacy/Safety Population|Overall Study||70
5284600|NCT00620113|12991482|P2|Efficacy/Safety Population|Overall Study||74
5284601|NCT00620113|12991483|P1|Efficacy/Safety Population|Overall Study||73
5284602|NCT00620113|12991480|P4|STARTED|Overall Study||69
5284603|NCT00620113|12991481|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
5284604|NCT00620113|12991482|P2|STARTED|Overall Study||74
5284605|NCT00620113|12991483|P1|STARTED|Overall Study||73
5284606|NCT00620074|12991533|P1|NOT COMPLETED|Overall Study||1
5284607|NCT00620074|12991533|P1|COMPLETED|Overall Study||5
5284608|NCT00620074|12991533|P1|STARTED|Overall Study||6
5284609|NCT00620061|12991541|P1|NOT COMPLETED|Overall Study||153
5284610|NCT00620061|12991541|P1|COMPLETED|Overall Study||286
5284611|NCT00620061|12991541|P1|STARTED|Overall Study||439
5284612|NCT00620035|12991556|P1|NOT COMPLETED|Overall Study||145
5284613|NCT00620035|12991556|P1|COMPLETED|Overall Study||156
5284614|NCT00620035|12991556|P1|STARTED|Overall Study||301
5284615|NCT00620022|12991566|P2|NOT COMPLETED|Treatment Period 2||2
5284616|NCT00620022|12991567|P1|NOT COMPLETED|Treatment Period 2||2
5284617|NCT00620022|12991566|P2|COMPLETED|Treatment Period 2||35
5284618|NCT00620022|12991567|P1|COMPLETED|Treatment Period 2||39
5284619|NCT00620022|12991566|P2|STARTED|Treatment Period 2||37
5284620|NCT00620022|12991567|P1|STARTED|Treatment Period 2||41
5284621|NCT00620022|12991566|P2|NOT COMPLETED|Treatment Period 1||6
5284622|NCT00620022|12991567|P1|NOT COMPLETED|Treatment Period 1||5
5284623|NCT00620022|12991566|P2|COMPLETED|Treatment Period 1||37
5284624|NCT00620022|12991567|P1|COMPLETED|Treatment Period 1||41
5284625|NCT00620022|12991566|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
5284626|NCT00620022|12991567|P1|STARTED|Treatment Period 1||46
5284627|NCT00619983|12991579|P4|NOT COMPLETED|Gabapentin Alone||0
5284628|NCT00619983|12991580|P3|NOT COMPLETED|Gabapentin Alone||0
5284629|NCT00619983|12991581|P2|NOT COMPLETED|Gabapentin Alone||0
5284630|NCT00619983|12991582|P1|NOT COMPLETED|Gabapentin Alone||0
5284631|NCT00619983|12991579|P4|COMPLETED|Gabapentin Alone||3
5284632|NCT00619983|12991580|P3|COMPLETED|Gabapentin Alone||4
5284633|NCT00619983|12991581|P2|COMPLETED|Gabapentin Alone||4
5284634|NCT00619983|12991582|P1|COMPLETED|Gabapentin Alone||3
5284635|NCT00619983|12991579|P4|STARTED|Gabapentin Alone||3
5284636|NCT00619983|12991580|P3|STARTED|Gabapentin Alone||4
5284637|NCT00619983|12991581|P2|STARTED|Gabapentin Alone||4
5284638|NCT00619983|12991582|P1|STARTED|Gabapentin Alone||3
5284639|NCT00619983|12991579|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
5284640|NCT00619983|12991580|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
5284641|NCT00619983|12991581|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
5284642|NCT00619983|12991582|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
5284643|NCT00619983|12991579|P4|COMPLETED|Test Drug Plus Gabapentin||3
5284644|NCT00619983|12991580|P3|COMPLETED|Test Drug Plus Gabapentin||4
5284645|NCT00619983|12991581|P2|COMPLETED|Test Drug Plus Gabapentin||4
5284646|NCT00619983|12991582|P1|COMPLETED|Test Drug Plus Gabapentin||3
5284647|NCT00619983|12991579|P4|STARTED|Test Drug Plus Gabapentin||3
5284648|NCT00619983|12991580|P3|STARTED|Test Drug Plus Gabapentin||4
5284649|NCT00619983|12991581|P2|STARTED|Test Drug Plus Gabapentin||4
5284650|NCT00619983|12991582|P1|STARTED|Test Drug Plus Gabapentin||3
5284651|NCT00619983|12991579|P4|NOT COMPLETED|Test Drug Alone||3
5284652|NCT00619983|12991580|P3|NOT COMPLETED|Test Drug Alone||2
5284653|NCT00619983|12991581|P2|NOT COMPLETED|Test Drug Alone||1
5284654|NCT00619983|12991582|P1|NOT COMPLETED|Test Drug Alone||2
5284655|NCT00619983|12991579|P4|COMPLETED|Test Drug Alone||3
5284656|NCT00619983|12991580|P3|COMPLETED|Test Drug Alone||4
5284657|NCT00619983|12991581|P2|COMPLETED|Test Drug Alone||4
5284658|NCT00619983|12991582|P1|COMPLETED|Test Drug Alone||3
5284659|NCT00619983|12991579|P4|STARTED|Test Drug Alone||6
5284660|NCT00619983|12991580|P3|STARTED|Test Drug Alone||6
5284661|NCT00619983|12991581|P2|STARTED|Test Drug Alone||5
5284662|NCT00619983|12991582|P1|STARTED|Test Drug Alone||5
5284663|NCT00619970|12991595|P3|NOT COMPLETED|Overall Study||2
5284664|NCT00619970|12991596|P2|NOT COMPLETED|Overall Study||3
5284665|NCT00619970|12991597|P1|NOT COMPLETED|Overall Study||0
5284666|NCT00619970|12991595|P3|COMPLETED|Overall Study||24
5284667|NCT00619970|12991596|P2|COMPLETED|Overall Study||46
5284668|NCT00619970|12991597|P1|COMPLETED|Overall Study||40
5284669|NCT00619970|12991595|P3|STARTED|Overall Study||26
5284670|NCT00619970|12991596|P2|STARTED|Overall Study||49
5284671|NCT00619970|12991597|P1|STARTED|Overall Study||40
5284672|NCT00619957|12991609|P2|NOT COMPLETED|Month 48 Open-Label||17
5284673|NCT00619957|12991610|P1|NOT COMPLETED|Month 48 Open-Label||12
5284674|NCT00619957|12991609|P2|COMPLETED|Month 48 Open-Label||134
5284675|NCT00619957|12991610|P1|COMPLETED|Month 48 Open-Label||55
5284676|NCT00619957|12991609|P2|STARTED|Month 48 Open-Label||151
5284677|NCT00619957|12991610|P1|STARTED|Month 48 Open-Label||67
5284678|NCT00619957|12991609|P2|NOT COMPLETED|Month 24 Double-Blind||17
5284679|NCT00619957|12991610|P1|NOT COMPLETED|Month 24 Double-Blind||18
5284680|NCT00619957|12991609|P2|COMPLETED|Month 24 Double-Blind||175
5284681|NCT00619957|12991610|P1|COMPLETED|Month 24 Double-Blind||75
5284682|NCT00619957|12991609|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
5284683|NCT00619957|12991610|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
5284684|NCT00619957|12991609|P2|STARTED|Month 24 Double-Blind||192
5284685|NCT00619957|12991610|P1|STARTED|Month 24 Double-Blind||93
5284686|NCT00619918|12991692|P2|NOT COMPLETED|Overall Study||22
5284687|NCT00619918|12991693|P1|NOT COMPLETED|Overall Study||20
5284688|NCT00619918|12991692|P2|COMPLETED|Overall Study||195
5284689|NCT00619918|12991693|P1|COMPLETED|Overall Study||210
5284690|NCT00619918|12991692|P2|STARTED|Overall Study||217
5284691|NCT00619918|12991693|P1|STARTED|Overall Study||230
5284692|NCT00619892|12991703|P2|NOT COMPLETED|Overall Study||2
5284693|NCT00619892|12991704|P1|NOT COMPLETED|Overall Study||3
5284694|NCT00619892|12991703|P2|COMPLETED|Overall Study||11
5284695|NCT00619892|12991704|P1|COMPLETED|Overall Study||10
5284696|NCT00619892|12991703|P2|STARTED|Overall Study||13
5284697|NCT00619892|12991704|P1|STARTED|Overall Study||13
5284698|NCT00619866|12991715|P5|NOT COMPLETED|Weeks 13 - 24||2
5284699|NCT00619866|12991716|P4|NOT COMPLETED|Weeks 13 - 24||4
5284700|NCT00619866|12991717|P3|NOT COMPLETED|Weeks 13 - 24||5
5284701|NCT00619866|12991718|P2|NOT COMPLETED|Weeks 13 - 24||7
5284702|NCT00619866|12991719|P1|NOT COMPLETED|Weeks 13 - 24||0
5284703|NCT00619866|12991715|P5|COMPLETED|Weeks 13 - 24||18
5284704|NCT00619866|12991716|P4|COMPLETED|Weeks 13 - 24||14
5284705|NCT00619866|12991717|P3|COMPLETED|Weeks 13 - 24||37
5284706|NCT00619866|12991718|P2|COMPLETED|Weeks 13 - 24||38
5284707|NCT00619866|12991719|P1|COMPLETED|Weeks 13 - 24||0
5284708|NCT00619866|12991715|P5|STARTED|Weeks 13 - 24||20
5284709|NCT00619866|12991716|P4|STARTED|Weeks 13 - 24||18
5284710|NCT00619866|12991717|P3|STARTED|Weeks 13 - 24||42
5284711|NCT00619866|12991718|P2|STARTED|Weeks 13 - 24||45
5284712|NCT00619866|12991719|P1|STARTED|Weeks 13 - 24||0
5284713|NCT00619866|12991715|P5|NOT COMPLETED|Weeks 1 - 12||0
5284714|NCT00619866|12991716|P4|NOT COMPLETED|Weeks 1 - 12||0
5284715|NCT00619866|12991717|P3|NOT COMPLETED|Weeks 1 - 12||10
5284716|NCT00619866|12991718|P2|NOT COMPLETED|Weeks 1 - 12||6
5284717|NCT00619866|12991719|P1|NOT COMPLETED|Weeks 1 - 12||14
5284718|NCT00619866|12991715|P5|COMPLETED|Weeks 1 - 12||0
5284719|NCT00619866|12991716|P4|COMPLETED|Weeks 1 - 12||0
5284720|NCT00619866|12991717|P3|COMPLETED|Weeks 1 - 12||42
5284721|NCT00619866|12991718|P2|COMPLETED|Weeks 1 - 12||45
5284722|NCT00619866|12991719|P1|COMPLETED|Weeks 1 - 12||38
5284723|NCT00619866|12991715|P5|STARTED|Weeks 1 - 12||0
5284724|NCT00619866|12991716|P4|STARTED|Weeks 1 - 12||0
5284725|NCT00619866|12991717|P3|STARTED|Weeks 1 - 12||52
5284726|NCT00619866|12991718|P2|STARTED|Weeks 1 - 12||51
5284727|NCT00619866|12991719|P1|STARTED|Weeks 1 - 12||52
5284728|NCT00619827|12991806|P2|NOT COMPLETED|Overall Study||4
5284729|NCT00619827|12991807|P1|NOT COMPLETED|Overall Study||3
5284730|NCT00619827|12991806|P2|COMPLETED|Overall Study||40
5284731|NCT00619827|12991807|P1|COMPLETED|Overall Study||42
5284732|NCT00619827|12991806|P2|STARTED|Overall Study||44
5284733|NCT00619827|12991807|P1|STARTED|Overall Study||45
5284734|NCT00619801|12991815|P2|NOT COMPLETED|Overall Study||3
5284735|NCT00619801|12991816|P1|NOT COMPLETED|Overall Study||1
5284736|NCT00619801|12991815|P2|COMPLETED|Overall Study||111
5284737|NCT00619801|12991816|P1|COMPLETED|Overall Study||58
5284738|NCT00619801|12991815|P2|Safety Population|Overall Study||114
5284739|NCT00619801|12991816|P1|Safety Population|Overall Study||59
5284740|NCT00619801|12991815|P2|STARTED|Overall Study||114
5284741|NCT00619801|12991816|P1|STARTED|Overall Study||59
5284742|NCT00619762|12991846|P1|NOT COMPLETED|Overall Study||3
5284743|NCT00619762|12991846|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
5284744|NCT00619762|12991846|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
5284745|NCT00619723|12991853|P2|NOT COMPLETED|Overall Study||6
5284746|NCT00619723|12991854|P1|NOT COMPLETED|Overall Study||2
5284747|NCT00619723|12991853|P2|COMPLETED|Overall Study||61
5284748|NCT00619723|12991854|P1|COMPLETED|Overall Study||61
5284749|NCT00619723|12991853|P2|STARTED|Overall Study||67
5284750|NCT00619723|12991854|P1|STARTED|Overall Study||63
5284751|NCT00619684|12991864|P1|NOT COMPLETED|Overall Study||0
5284752|NCT00619684|12991864|P1|COMPLETED|Overall Study||18
5284753|NCT00619684|12991864|P1|STARTED|Overall Study||18
5284754|NCT00619645|12991873|P1|NOT COMPLETED|Overall Study||1
5284755|NCT00619645|12991873|P1|COMPLETED|Overall Study||7
5284756|NCT00619645|12991873|P1|STARTED|Overall Study||8
5284757|NCT00619619|12991887|P8|NOT COMPLETED|Overall Study||3
5284758|NCT00619619|12991888|P7|NOT COMPLETED|Overall Study||1
5284759|NCT00619619|12991889|P6|NOT COMPLETED|Overall Study||0
5284760|NCT00619619|12991890|P5|NOT COMPLETED|Overall Study||2
5284761|NCT00619619|12991891|P4|NOT COMPLETED|Overall Study||1
5284762|NCT00619619|12991892|P3|NOT COMPLETED|Overall Study||1
5284763|NCT00619619|12991893|P2|NOT COMPLETED|Overall Study||0
5284764|NCT00619619|12991894|P1|NOT COMPLETED|Overall Study||0
5284765|NCT00619619|12991887|P8|COMPLETED|Overall Study||5
5284766|NCT00619619|12991888|P7|COMPLETED|Overall Study||7
5284767|NCT00619619|12991889|P6|COMPLETED|Overall Study||7
5284768|NCT00619619|12991890|P5|COMPLETED|Overall Study||5
5284769|NCT00619619|12991891|P4|COMPLETED|Overall Study||6
5284770|NCT00619619|12991892|P3|COMPLETED|Overall Study||8
5284771|NCT00619619|12991893|P2|COMPLETED|Overall Study||7
5284772|NCT00619619|12991894|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
5284773|NCT00619619|12991887|P8|Entered the Extension Study|Overall Study||7
5284774|NCT00619619|12991888|P7|Entered the Extension Study|Overall Study||6
5284775|NCT00619619|12991889|P6|Entered the Extension Study|Overall Study||6
5284776|NCT00619619|12991890|P5|Entered the Extension Study|Overall Study||7
5284777|NCT00619619|12991891|P4|Entered the Extension Study|Overall Study||3
5284778|NCT00619619|12991892|P3|Entered the Extension Study|Overall Study||8
5284779|NCT00619619|12991893|P2|Entered the Extension Study|Overall Study||5
5284780|NCT00619619|12991894|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
5284781|NCT00619619|12991887|P8|STARTED|Overall Study||8
5284782|NCT00619619|12991888|P7|STARTED|Overall Study||8
5284783|NCT00619619|12991889|P6|STARTED|Overall Study||7
5284784|NCT00619619|12991890|P5|STARTED|Overall Study||7
5284785|NCT00619619|12991891|P4|STARTED|Overall Study||7
5284786|NCT00619619|12991892|P3|STARTED|Overall Study||9
5284787|NCT00619619|12991893|P2|STARTED|Overall Study||7
5284788|NCT00619619|12991894|P1|STARTED|Overall Study||6
5284789|NCT00619515|12991979|P1|NOT COMPLETED|Overall Study||73
5284790|NCT00619515|12991979|P1|COMPLETED|Overall Study||0
5284791|NCT00619515|12991979|P1|STARTED|Overall Study||73
5284792|NCT00619502|12991993|P2|NOT COMPLETED|Overall Study||10
5284793|NCT00619502|12991994|P1|NOT COMPLETED|Overall Study||8
5284794|NCT00619502|12991993|P2|COMPLETED|Overall Study||114
5284795|NCT00619502|12991994|P1|COMPLETED|Overall Study||122
5284796|NCT00619502|12991993|P2|STARTED|Overall Study||124
5284797|NCT00619502|12991994|P1|STARTED|Overall Study||130
5284798|NCT00619489|12992006|P2|NOT COMPLETED|Overall Study||34
5284799|NCT00619489|12992007|P1|NOT COMPLETED|Overall Study||23
5284800|NCT00619489|12992006|P2|COMPLETED|Overall Study||1
5284801|NCT00619489|12992007|P1|COMPLETED|Overall Study||14
5284802|NCT00619489|12992006|P2|STARTED|Overall Study||35
5284803|NCT00619489|12992007|P1|STARTED|Overall Study||37
5284804|NCT00619476|12992029|P4|NOT COMPLETED|Overall Study||34
5284805|NCT00619476|12992030|P3|NOT COMPLETED|Overall Study||24
5284806|NCT00619476|12992031|P2|NOT COMPLETED|Overall Study||22
5284807|NCT00619476|12992032|P1|NOT COMPLETED|Overall Study||31
5284808|NCT00619476|12992029|P4|COMPLETED|Overall Study||56
5284809|NCT00619476|12992030|P3|COMPLETED|Overall Study||60
5284810|NCT00619476|12992031|P2|COMPLETED|Overall Study||85
5284811|NCT00619476|12992032|P1|COMPLETED|Overall Study||64
5284812|NCT00619476|12992029|P4|Safety Population|Overall Study||87
5284813|NCT00619476|12992030|P3|Safety Population|Overall Study||82
5284814|NCT00619476|12992031|P2|Safety Population|Overall Study||107
5284815|NCT00619476|12992032|P1|Safety Population|Overall Study||95
5284816|NCT00619476|12992029|P4|Intent-to-Treat Population|Overall Study||87
5284817|NCT00619476|12992030|P3|Intent-to-Treat Population|Overall Study||82
5284818|NCT00619476|12992031|P2|Intent-to-Treat Population|Overall Study||107
5284819|NCT00619476|12992032|P1|Intent-to-Treat Population|Overall Study||95
5284820|NCT00619476|12992029|P4|STARTED|Overall Study||90
5284821|NCT00619476|12992030|P3|STARTED|Overall Study||84
5284822|NCT00619476|12992031|P2|STARTED|Overall Study||107
5284823|NCT00619476|12992032|P1|STARTED|Overall Study||95
5284824|NCT00619385|12992117|P3|NOT COMPLETED|Overall Study||4
5284825|NCT00619385|12992118|P2|NOT COMPLETED|Overall Study||2
5284826|NCT00619385|12992119|P1|NOT COMPLETED|Overall Study||1
5284827|NCT00619385|12992117|P3|COMPLETED|Overall Study||6
5284828|NCT00619385|12992118|P2|COMPLETED|Overall Study||6
5284829|NCT00619385|12992119|P1|COMPLETED|Overall Study||6
5284830|NCT00619385|12992117|P3|STARTED|Overall Study||10
5284831|NCT00619385|12992118|P2|STARTED|Overall Study||8
5284832|NCT00619385|12992119|P1|STARTED|Overall Study||7
5284833|NCT00619359|12992134|P2|NOT COMPLETED|Overall Study||81
5284834|NCT00619359|12992135|P1|NOT COMPLETED|Overall Study||67
5284835|NCT00619359|12992134|P2|COMPLETED|Overall Study||1094
5284836|NCT00619359|12992135|P1|COMPLETED|Overall Study||1080
5284837|NCT00619359|12992134|P2|STARTED|Overall Study||1175
5284838|NCT00619359|12992135|P1|STARTED|Overall Study||1147
5284839|NCT00619307|12992147|P2|NOT COMPLETED|Overall Study||4
5284840|NCT00619307|12992148|P1|NOT COMPLETED|Overall Study||4
5284841|NCT00619307|12992147|P2|COMPLETED|Overall Study||53
5284842|NCT00619307|12992148|P1|COMPLETED|Overall Study||56
5284843|NCT00619307|12992147|P2|STARTED|Overall Study||57
5284844|NCT00619307|12992148|P1|STARTED|Overall Study||60
5284845|NCT00619255|12992164|P2|NOT COMPLETED|Overall Study||0
5284846|NCT00619255|12992165|P1|NOT COMPLETED|Overall Study||2
5284847|NCT00619255|12992164|P2|COMPLETED|Overall Study||61
5284848|NCT00619255|12992165|P1|COMPLETED|Overall Study||57
5284849|NCT00619255|12992164|P2|STARTED|Overall Study||61
5284850|NCT00619255|12992165|P1|STARTED|Overall Study||59
5284851|NCT00619242|12992179|P1|NOT COMPLETED|Overall Study||0
5284852|NCT00619242|12992179|P1|COMPLETED|Overall Study||3
5284853|NCT00619242|12992179|P1|STARTED|Overall Study||3
5284854|NCT00619229|12992185|P2|NOT COMPLETED|Overall Study||2
5284855|NCT00619229|12992186|P1|NOT COMPLETED|Overall Study||4
5284856|NCT00619229|12992185|P2|COMPLETED|Overall Study||16
5284857|NCT00619229|12992186|P1|COMPLETED|Overall Study||14
5284858|NCT00619229|12992185|P2|Full Analysis Set (FAS)|Overall Study||17
5284859|NCT00619229|12992186|P1|Full Analysis Set (FAS)|Overall Study||16
5284860|NCT00619229|12992185|P2|STARTED|Overall Study||18
5284861|NCT00619229|12992186|P1|STARTED|Overall Study||18
5284862|NCT00619190|12992214|P2|NOT COMPLETED|Overall Study||0
5284863|NCT00619190|12992215|P1|NOT COMPLETED|Overall Study||1
5284864|NCT00619190|12992214|P2|COMPLETED|Overall Study||9
5284865|NCT00619190|12992215|P1|COMPLETED|Overall Study||20
5284866|NCT00619190|12992214|P2|STARTED|Overall Study||9
5284867|NCT00619190|12992215|P1|STARTED|Overall Study||21
5284868|NCT00619177|12992225|P1|NOT COMPLETED|Overall Study||508
5284869|NCT00619177|12992225|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
5284870|NCT00619177|12992225|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
5284871|NCT00619151|12992235|P2|NOT COMPLETED|Overall Study||0
5284872|NCT00619151|12992236|P1|NOT COMPLETED|Overall Study||1
5284873|NCT00619151|12992235|P2|COMPLETED|Overall Study||0
5284874|NCT00619151|12992236|P1|COMPLETED|Overall Study||1
5284875|NCT00619151|12992235|P2|STARTED|Overall Study||0
5284876|NCT00619151|12992236|P1|STARTED|Overall Study||2
5284877|NCT00619112|12992246|P2|NOT COMPLETED|Overall Study||2
5284878|NCT00619112|12992247|P1|NOT COMPLETED|Overall Study||1
5284879|NCT00619112|12992246|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
5284880|NCT00619112|12992247|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
5284881|NCT00619112|12992246|P2|STARTED|Overall Study||20
5284882|NCT00619112|12992247|P1|STARTED|Overall Study||40
5284883|NCT00619099|12992268|P2|NOT COMPLETED|Overall Study||19
5284884|NCT00619099|12992269|P1|NOT COMPLETED|Overall Study||33
5284885|NCT00619099|12992268|P2|COMPLETED|Overall Study||4
5284886|NCT00619099|12992269|P1|COMPLETED|Overall Study||11
5284887|NCT00619099|12992268|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
5284888|NCT00619099|12992269|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
5284889|NCT00619099|12992268|P2|STARTED|Overall Study|All randomized subjects|23
5284890|NCT00619099|12992269|P1|STARTED|Overall Study|All randomized subjects|44
5284891|NCT00619073|12992275|P2|NOT COMPLETED|Second Intervention - 60 Days||0
5284892|NCT00619073|12992276|P1|NOT COMPLETED|Second Intervention - 60 Days||0
5284893|NCT00619073|12992275|P2|COMPLETED|Second Intervention - 60 Days||8
5284894|NCT00619073|12992276|P1|COMPLETED|Second Intervention - 60 Days||8
5284895|NCT00619073|12992275|P2|STARTED|Second Intervention - 60 Days||8
5284896|NCT00619073|12992276|P1|STARTED|Second Intervention - 60 Days||8
5284897|NCT00619073|12992275|P2|NOT COMPLETED|Washout Period (30 Days)||0
5284898|NCT00619073|12992276|P1|NOT COMPLETED|Washout Period (30 Days)||0
5284899|NCT00619073|12992275|P2|COMPLETED|Washout Period (30 Days)||8
5284900|NCT00619073|12992276|P1|COMPLETED|Washout Period (30 Days)||8
5284901|NCT00619073|12992275|P2|STARTED|Washout Period (30 Days)||8
5284902|NCT00619073|12992276|P1|STARTED|Washout Period (30 Days)||8
5284903|NCT00619073|12992275|P2|NOT COMPLETED|First Intervention - 60 Days||0
5284904|NCT00619073|12992276|P1|NOT COMPLETED|First Intervention - 60 Days||0
5284905|NCT00619073|12992275|P2|COMPLETED|First Intervention - 60 Days||8
5284906|NCT00619073|12992276|P1|COMPLETED|First Intervention - 60 Days||8
5284907|NCT00619073|12992275|P2|STARTED|First Intervention - 60 Days||8
5284908|NCT00619073|12992276|P1|STARTED|First Intervention - 60 Days||8
5284909|NCT00619060|12992282|P2|NOT COMPLETED|Overall Study||0
5284910|NCT00619060|12992283|P1|NOT COMPLETED|Overall Study||0
5284911|NCT00619060|12992282|P2|COMPLETED|Overall Study||12
5284912|NCT00619060|12992283|P1|COMPLETED|Overall Study||10
5284913|NCT00619060|12992282|P2|STARTED|Overall Study||12
5284914|NCT00619060|12992283|P1|STARTED|Overall Study||10
5284915|NCT00618995|12992291|P4|NOT COMPLETED|Period 4||0
5284916|NCT00618995|12992292|P3|NOT COMPLETED|Period 4||0
5284917|NCT00618995|12992293|P2|NOT COMPLETED|Period 4||0
5284918|NCT00618995|12992294|P1|NOT COMPLETED|Period 4||1
5284919|NCT00618995|12992291|P4|COMPLETED|Period 4||6
5284920|NCT00618995|12992292|P3|COMPLETED|Period 4||4
5284921|NCT00618995|12992293|P2|COMPLETED|Period 4||6
5284922|NCT00618995|12992294|P1|COMPLETED|Period 4||5
5284923|NCT00618995|12992291|P4|STARTED|Period 4||6
5284924|NCT00618995|12992292|P3|STARTED|Period 4||4
5284925|NCT00618995|12992293|P2|STARTED|Period 4||6
5284926|NCT00618995|12992294|P1|STARTED|Period 4||6
5284927|NCT00618995|12992291|P4|NOT COMPLETED|Period 3||0
5284928|NCT00618995|12992292|P3|NOT COMPLETED|Period 3||0
5284929|NCT00618995|12992293|P2|NOT COMPLETED|Period 3||0
5284930|NCT00618995|12992294|P1|NOT COMPLETED|Period 3||0
5284931|NCT00618995|12992291|P4|COMPLETED|Period 3||6
5284932|NCT00618995|12992292|P3|COMPLETED|Period 3||4
5284933|NCT00618995|12992293|P2|COMPLETED|Period 3||6
5284934|NCT00618995|12992294|P1|COMPLETED|Period 3||6
5284935|NCT00618995|12992291|P4|STARTED|Period 3||6
5284936|NCT00618995|12992292|P3|STARTED|Period 3||4
5284937|NCT00618995|12992293|P2|STARTED|Period 3||6
5284938|NCT00618995|12992294|P1|STARTED|Period 3||6
5284939|NCT00618995|12992291|P4|NOT COMPLETED|Period 2||0
5284940|NCT00618995|12992292|P3|NOT COMPLETED|Period 2||1
5284941|NCT00618995|12992293|P2|NOT COMPLETED|Period 2||0
5284942|NCT00618995|12992294|P1|NOT COMPLETED|Period 2||0
5284943|NCT00618995|12992291|P4|COMPLETED|Period 2||6
5284944|NCT00618995|12992292|P3|COMPLETED|Period 2||4
5284945|NCT00618995|12992293|P2|COMPLETED|Period 2||6
5284946|NCT00618995|12992294|P1|COMPLETED|Period 2||6
5284947|NCT00618995|12992291|P4|STARTED|Period 2||6
5284948|NCT00618995|12992292|P3|STARTED|Period 2||5
5284949|NCT00618995|12992293|P2|STARTED|Period 2||6
5284950|NCT00618995|12992294|P1|STARTED|Period 2||6
5284951|NCT00618995|12992291|P4|NOT COMPLETED|Period 1||0
5284952|NCT00618995|12992292|P3|NOT COMPLETED|Period 1||2
5284953|NCT00618995|12992293|P2|NOT COMPLETED|Period 1||1
5284954|NCT00618995|12992294|P1|NOT COMPLETED|Period 1||0
5284955|NCT00618995|12992291|P4|COMPLETED|Period 1||6
5284956|NCT00618995|12992292|P3|COMPLETED|Period 1||5
5284957|NCT00618995|12992293|P2|COMPLETED|Period 1||6
5284958|NCT00618995|12992294|P1|COMPLETED|Period 1||6
5284959|NCT00618995|12992291|P4|STARTED|Period 1||6
5284960|NCT00618995|12992292|P3|STARTED|Period 1||7
5284961|NCT00618995|12992293|P2|STARTED|Period 1||7
5284962|NCT00618995|12992294|P1|STARTED|Period 1||6
5284963|NCT00618982|12992308|P1|NOT COMPLETED|Overall Study||50
5284964|NCT00618982|12992308|P1|COMPLETED|Overall Study||33
5284965|NCT00618982|12992308|P1|STARTED|Overall Study||83
5284966|NCT00618956|12992331|P2|NOT COMPLETED|Overall Study||50
5284967|NCT00618956|12992332|P1|NOT COMPLETED|Overall Study||25
5284968|NCT00618956|12992331|P2|COMPLETED|Overall Study||160
5284969|NCT00618956|12992332|P1|COMPLETED|Overall Study||86
5284970|NCT00618956|12992331|P2|STARTED|Overall Study||210
5284971|NCT00618956|12992332|P1|STARTED|Overall Study||111
5284972|NCT00618839|12992348|P1|NOT COMPLETED|Overall Study||0
5284973|NCT00618839|12992348|P1|COMPLETED|Overall Study||15
5284974|NCT00618839|12992348|P1|STARTED|Overall Study||15
5284975|NCT00618826|12992357|P1|NOT COMPLETED|Overall Study||1
5284976|NCT00618826|12992357|P1|COMPLETED|Overall Study||13
5284977|NCT00618826|12992357|P1|STARTED|Overall Study||14
5284978|NCT00618813|12992362|P1|NOT COMPLETED|Overall Study||4
5284979|NCT00618813|12992362|P1|COMPLETED|Overall Study||31
5284980|NCT00618813|12992362|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
5284981|NCT00618813|12992362|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
5284982|NCT00618813|12992362|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
5284983|NCT00618813|12992362|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
5284984|NCT00618813|12992362|P1|STARTED|Overall Study||35
5284985|NCT00618787|12992372|P2|NOT COMPLETED|Overall Study||2
5284986|NCT00618787|12992373|P1|NOT COMPLETED|Overall Study||3
5284987|NCT00618787|12992372|P2|COMPLETED|Overall Study||21
5284988|NCT00618787|12992373|P1|COMPLETED|Overall Study||19
5284989|NCT00618787|12992372|P2|STARTED|Overall Study||23
5284990|NCT00618787|12992373|P1|STARTED|Overall Study||22
5284991|NCT00618774|12992381|P2|NOT COMPLETED|Overall Study||3
5284992|NCT00618774|12992382|P1|NOT COMPLETED|Overall Study||6
5284993|NCT00618774|12992381|P2|COMPLETED|Overall Study||45
5284994|NCT00618774|12992382|P1|COMPLETED|Overall Study||205
5284995|NCT00618774|12992381|P2|STARTED|Overall Study||48
5284996|NCT00618774|12992382|P1|STARTED|Overall Study||211
5284997|NCT00618748|12992415|P3|NOT COMPLETED|Overall Study||14
5284998|NCT00618748|12992416|P2|NOT COMPLETED|Overall Study||5
5284999|NCT00618748|12992417|P1|NOT COMPLETED|Overall Study||11
5285000|NCT00618748|12992415|P3|COMPLETED|Overall Study||6
5285001|NCT00618748|12992416|P2|COMPLETED|Overall Study||20
5285002|NCT00618748|12992417|P1|COMPLETED|Overall Study||45
5285003|NCT00618748|12992415|P3|STARTED|Overall Study||20
5285004|NCT00618748|12992416|P2|STARTED|Overall Study||25
5285005|NCT00618748|12992417|P1|STARTED|Overall Study||56
5285006|NCT00618722|12992462|P4|NOT COMPLETED|Overall Study||4
5285007|NCT00618722|12992463|P3|NOT COMPLETED|Overall Study||3
5285008|NCT00618722|12992464|P2|NOT COMPLETED|Overall Study||2
5285009|NCT00618722|12992465|P1|NOT COMPLETED|Overall Study||3
5285010|NCT00618722|12992462|P4|COMPLETED|Overall Study||18
5285011|NCT00618722|12992463|P3|COMPLETED|Overall Study||19
5285012|NCT00618722|12992464|P2|COMPLETED|Overall Study||18
5285013|NCT00618722|12992465|P1|COMPLETED|Overall Study||18
5285014|NCT00618722|12992462|P4|Received Treatment|Overall Study||22
5285015|NCT00618722|12992463|P3|Received Treatment|Overall Study||22
5285016|NCT00618722|12992464|P2|Received Treatment|Overall Study||20
5285017|NCT00618722|12992465|P1|Received Treatment|Overall Study||20
5285018|NCT00618722|12992462|P4|STARTED|Overall Study||22
5285019|NCT00618722|12992463|P3|STARTED|Overall Study||22
5285020|NCT00618722|12992464|P2|STARTED|Overall Study||20
5285021|NCT00618722|12992465|P1|STARTED|Overall Study||21
5285022|NCT00618618|12992503|P4|NOT COMPLETED|Overall Study||1
5285023|NCT00618618|12992504|P3|NOT COMPLETED|Overall Study||3
5285024|NCT00618618|12992505|P2|NOT COMPLETED|Overall Study||3
5285025|NCT00618618|12992506|P1|NOT COMPLETED|Overall Study||4
5285026|NCT00618618|12992503|P4|COMPLETED|Overall Study||13
5285027|NCT00618618|12992504|P3|COMPLETED|Overall Study||18
5285028|NCT00618618|12992505|P2|COMPLETED|Overall Study||11
5285029|NCT00618618|12992506|P1|COMPLETED|Overall Study||20
5285030|NCT00618618|12992503|P4|Received Treatment|Overall Study||14
5285031|NCT00618618|12992504|P3|Received Treatment|Overall Study||20
5285032|NCT00618618|12992505|P2|Received Treatment|Overall Study||13
5285033|NCT00618618|12992506|P1|Received Treatment|Overall Study||24
5285034|NCT00618618|12992503|P4|STARTED|Overall Study||14
5285035|NCT00618618|12992504|P3|STARTED|Overall Study||21
5285036|NCT00618618|12992505|P2|STARTED|Overall Study||14
5285037|NCT00618618|12992506|P1|STARTED|Overall Study||24
5285038|NCT00618540|12992552|P1|NOT COMPLETED|Overall Study||0
5285039|NCT00618540|12992552|P1|COMPLETED|Overall Study||1
5285040|NCT00618540|12992552|P1|STARTED|Overall Study||1
5285041|NCT00618514|12992565|P3|NOT COMPLETED|Overall Study||4
5285042|NCT00618514|12992566|P2|NOT COMPLETED|Overall Study||12
5285043|NCT00618514|12992567|P1|NOT COMPLETED|Overall Study||11
5285044|NCT00618514|12992565|P3|COMPLETED|Overall Study||12
5285045|NCT00618514|12992566|P2|COMPLETED|Overall Study||26
5285046|NCT00618514|12992567|P1|COMPLETED|Overall Study||25
5285047|NCT00618514|12992565|P3|STARTED|Overall Study||16
5285048|NCT00618514|12992566|P2|STARTED|Overall Study||38
5285049|NCT00618514|12992567|P1|STARTED|Overall Study||36
5285050|NCT00618449|12992587|P2|NOT COMPLETED|Overall Study||110
5285051|NCT00618449|12992588|P1|NOT COMPLETED|Overall Study||98
5285052|NCT00618449|12992587|P2|COMPLETED|Overall Study||558
5285053|NCT00618449|12992588|P1|COMPLETED|Overall Study||581
5285054|NCT00618449|12992587|P2|1-year, Post-treatment|Overall Study||558
5285055|NCT00618449|12992588|P1|1-year, Post-treatment|Overall Study||581
5285056|NCT00618449|12992587|P2|1-month, Post-treatment|Overall Study||656
5285057|NCT00618449|12992588|P1|1-month, Post-treatment|Overall Study||666
5285058|NCT00618449|12992587|P2|STARTED|Overall Study||668
5285059|NCT00618449|12992588|P1|STARTED|Overall Study||679
5285060|NCT00618436|12992596|P2|NOT COMPLETED|Overall Study||0
5285061|NCT00618436|12992597|P1|NOT COMPLETED|Overall Study||0
5285062|NCT00618436|12992596|P2|COMPLETED|Overall Study||18
5285063|NCT00618436|12992597|P1|COMPLETED|Overall Study||34
5285064|NCT00618436|12992596|P2|STARTED|Overall Study||18
5285065|NCT00618436|12992597|P1|STARTED|Overall Study||34
5285066|NCT00618410|12992607|P2|NOT COMPLETED|Second Intervention||0
5285067|NCT00618410|12992608|P1|NOT COMPLETED|Second Intervention||0
5285068|NCT00618410|12992607|P2|COMPLETED|Second Intervention||5
5285069|NCT00618410|12992608|P1|COMPLETED|Second Intervention||7
5285070|NCT00618410|12992607|P2|STARTED|Second Intervention||5
5285071|NCT00618410|12992608|P1|STARTED|Second Intervention||7
5285072|NCT00618410|12992607|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
5285073|NCT00618410|12992608|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
5285074|NCT00618410|12992607|P2|COMPLETED|Washout Period (2 Weeks)||5
5285075|NCT00618410|12992608|P1|COMPLETED|Washout Period (2 Weeks)||7
5285076|NCT00618410|12992607|P2|STARTED|Washout Period (2 Weeks)||6
5285077|NCT00618410|12992608|P1|STARTED|Washout Period (2 Weeks)||7
5285078|NCT00618410|12992607|P2|NOT COMPLETED|First Intervention||0
5285079|NCT00618410|12992608|P1|NOT COMPLETED|First Intervention||0
5285080|NCT00618410|12992607|P2|COMPLETED|First Intervention||6
5285081|NCT00618410|12992608|P1|COMPLETED|First Intervention||7
5285082|NCT00618410|12992607|P2|STARTED|First Intervention||6
5285083|NCT00618410|12992608|P1|STARTED|First Intervention||7
5285084|NCT00618371|12992624|P1|NOT COMPLETED|Overall Study||2
5285085|NCT00618371|12992624|P1|COMPLETED|Overall Study||10
5285086|NCT00618371|12992624|P1|STARTED|Overall Study||12
5285087|NCT00618332|12992631|P2|NOT COMPLETED|Overall Study||0
5285088|NCT00618332|12992632|P1|NOT COMPLETED|Overall Study||0
5285089|NCT00618332|12992631|P2|COMPLETED|Overall Study||20
5285090|NCT00618332|12992632|P1|COMPLETED|Overall Study||20
5285091|NCT00618332|12992631|P2|STARTED|Overall Study||20
5285092|NCT00618332|12992632|P1|STARTED|Overall Study||20
5285093|NCT00618072|12992657|P3|NOT COMPLETED|Overall Study||4
5285094|NCT00618072|12992658|P2|NOT COMPLETED|Overall Study||1
5285095|NCT00618072|12992659|P1|NOT COMPLETED|Overall Study||2
5285096|NCT00618072|12992657|P3|COMPLETED|Overall Study||11
5285097|NCT00618072|12992658|P2|COMPLETED|Overall Study||14
5285098|NCT00618072|12992659|P1|COMPLETED|Overall Study||14
5285099|NCT00618072|12992657|P3|STARTED|Overall Study||15
5285100|NCT00618072|12992658|P2|STARTED|Overall Study||15
5285101|NCT00618072|12992659|P1|STARTED|Overall Study||16
5285102|NCT00617981|12992693|P2|NOT COMPLETED|Overall Study||102
5285103|NCT00617981|12992694|P1|NOT COMPLETED|Overall Study||110
5285104|NCT00617981|12992693|P2|COMPLETED|Overall Study||245
5285105|NCT00617981|12992694|P1|COMPLETED|Overall Study||244
5285106|NCT00617981|12992693|P2|STARTED|Overall Study||347
5285107|NCT00617981|12992694|P1|STARTED|Overall Study||354
5285108|NCT00617942|12992702|P2|NOT COMPLETED|Overall Study||4
5285109|NCT00617942|12992703|P1|NOT COMPLETED|Overall Study||8
5285110|NCT00617942|12992702|P2|COMPLETED|Overall Study||19
5285111|NCT00617942|12992703|P1|COMPLETED|Overall Study||29
5285112|NCT00617942|12992702|P2|STARTED|Overall Study||23
5285113|NCT00617942|12992703|P1|STARTED|Overall Study||37
5285114|NCT00617929|12992715|P1|NOT COMPLETED|Overall Study||1
5285115|NCT00617929|12992715|P1|COMPLETED|Overall Study||11
5285116|NCT00617929|12992715|P1|STARTED|Overall Study||12
5285117|NCT00617903|12992727|P2|NOT COMPLETED|Overall Study||7
5285118|NCT00617903|12992728|P1|NOT COMPLETED|Overall Study||3
5285119|NCT00617903|12992727|P2|COMPLETED|Overall Study||35
5285120|NCT00617903|12992728|P1|COMPLETED|Overall Study||38
5285121|NCT00617903|12992727|P2|STARTED|Overall Study||42
5285122|NCT00617903|12992728|P1|STARTED|Overall Study||41
5285123|NCT00617890|12992774|P4|NOT COMPLETED|Overall Study||115
5285124|NCT00617890|12992775|P3|NOT COMPLETED|Overall Study||35
5285125|NCT00617890|12992776|P2|NOT COMPLETED|Overall Study||28
5285126|NCT00617890|12992777|P1|NOT COMPLETED|Overall Study||31
5285127|NCT00617890|12992774|P4|COMPLETED|Overall Study||1
5285128|NCT00617890|12992775|P3|COMPLETED|Overall Study||0
5285129|NCT00617890|12992776|P2|COMPLETED|Overall Study||5
5285130|NCT00617890|12992777|P1|COMPLETED|Overall Study||4
5285131|NCT00617890|12992774|P4|Received Treatment|Overall Study||115
5285132|NCT00617890|12992775|P3|Received Treatment|Overall Study||34
5285133|NCT00617890|12992776|P2|Received Treatment|Overall Study||33
5285134|NCT00617890|12992777|P1|Received Treatment|Overall Study||34
5285135|NCT00617890|12992774|P4|STARTED|Overall Study||116
5285136|NCT00617890|12992775|P3|STARTED|Overall Study||35
5285137|NCT00617890|12992776|P2|STARTED|Overall Study||33
5285138|NCT00617890|12992777|P1|STARTED|Overall Study||35
5285139|NCT00617851|12992813|P4|NOT COMPLETED|Overall Study||25
5285140|NCT00617851|12992814|P3|NOT COMPLETED|Overall Study||45
5285141|NCT00617851|12992815|P2|NOT COMPLETED|Overall Study||40
5285142|NCT00617851|12992816|P1|NOT COMPLETED|Overall Study||47
5285143|NCT00617851|12992813|P4|COMPLETED|Overall Study||192
5285144|NCT00617851|12992814|P3|COMPLETED|Overall Study||384
5285145|NCT00617851|12992815|P2|COMPLETED|Overall Study||391
5285146|NCT00617851|12992816|P1|COMPLETED|Overall Study||383
5285147|NCT00617851|12992813|P4|STARTED|Overall Study||217
5285148|NCT00617851|12992814|P3|STARTED|Overall Study||429
5285149|NCT00617851|12992815|P2|STARTED|Overall Study||431
5285150|NCT00617851|12992816|P1|STARTED|Overall Study||430
5285151|NCT00617773|12992854|P1|NOT COMPLETED|Overall Study||24
5285152|NCT00617773|12992854|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
5285153|NCT00617773|12992854|P1|STARTED|Overall Study||31
5285154|NCT00617734|12992871|P2|NOT COMPLETED|Overall Study||6
5285155|NCT00617734|12992872|P1|NOT COMPLETED|Overall Study||8
5285156|NCT00617734|12992871|P2|COMPLETED|Overall Study||42
5285157|NCT00617734|12992872|P1|COMPLETED|Overall Study||41
5285158|NCT00617734|12992871|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
5285159|NCT00617734|12992872|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
5285160|NCT00617734|12992871|P2|STARTED|Overall Study||48
5285161|NCT00617734|12992872|P1|STARTED|Overall Study||49
5285162|NCT00617708|12992893|P3|NOT COMPLETED|Overall Study||64
5285163|NCT00617708|12992894|P2|NOT COMPLETED|Overall Study||60
5285164|NCT00617708|12992895|P1|NOT COMPLETED|Overall Study||10
5285165|NCT00617708|12992893|P3|COMPLETED|Overall Study||0
5285166|NCT00617708|12992894|P2|COMPLETED|Overall Study||0
5285167|NCT00617708|12992895|P1|COMPLETED|Overall Study||0
5285168|NCT00617708|12992893|P3|Eligible and Began Protocol Therapy|Overall Study||59
5285169|NCT00617708|12992894|P2|Eligible and Began Protocol Therapy|Overall Study||57
5285170|NCT00617708|12992895|P1|Eligible and Began Protocol Therapy|Overall Study||9
5285171|NCT00617708|12992893|P3|STARTED|Overall Study||64
5285172|NCT00617708|12992894|P2|STARTED|Overall Study||60
5285173|NCT00617708|12992895|P1|STARTED|Overall Study||10
5285174|NCT00617669|12992912|P2|NOT COMPLETED|Overall Study||451
5285175|NCT00617669|12992913|P1|NOT COMPLETED|Overall Study||430
5285176|NCT00617669|12992912|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
5285177|NCT00617669|12992913|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
5285178|NCT00617669|12992912|P2|Patients Who Received IP|Overall Study||525
5285179|NCT00617669|12992913|P1|Patients Who Received IP|Overall Study||522
5285180|NCT00617669|12992912|P2|STARTED|Overall Study||528
5285181|NCT00617669|12992913|P1|STARTED|Overall Study||524
5285182|NCT00617604|12992935|P2|NOT COMPLETED|Overall Study||20
5285183|NCT00617604|12992936|P1|NOT COMPLETED|Overall Study||18
5285184|NCT00617604|12992935|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
5285185|NCT00617604|12992936|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
5285186|NCT00617604|12992935|P2|Completed 12 Weeks of Treatment|Overall Study||83
5285187|NCT00617604|12992936|P1|Completed 12 Weeks of Treatment|Overall Study||89
5285188|NCT00617604|12992935|P2|Received Treatment|Overall Study||105
5285189|NCT00617604|12992936|P1|Received Treatment|Overall Study||107
5285190|NCT00617604|12992935|P2|STARTED|Overall Study||108
5285191|NCT00617604|12992936|P1|STARTED|Overall Study||110
5285192|NCT00617591|12992980|P1|NOT COMPLETED|Overall Study||10
5285193|NCT00617591|12992980|P1|COMPLETED|Overall Study||47
5285194|NCT00617591|12992980|P1|STARTED|Overall Study||57
5285195|NCT00617539|12992988|P1|NOT COMPLETED|Overall Study||0
5285196|NCT00617539|12992988|P1|COMPLETED|Overall Study||30
5285197|NCT00617539|12992988|P1|STARTED|Overall Study||30
5285198|NCT00617461|12992996|P2|NOT COMPLETED|6-Day Down-Titration Period||2
5285199|NCT00617461|12992997|P1|NOT COMPLETED|6-Day Down-Titration Period||2
5285200|NCT00617461|12992996|P2|COMPLETED|6-Day Down-Titration Period||35
5285201|NCT00617461|12992997|P1|COMPLETED|6-Day Down-Titration Period||39
5285202|NCT00617461|12992996|P2|STARTED|6-Day Down-Titration Period||37
5285203|NCT00617461|12992997|P1|STARTED|6-Day Down-Titration Period||41
5285204|NCT00617461|12992996|P2|NOT COMPLETED|Second Treatment Intervention Period||4
5285205|NCT00617461|12992997|P1|NOT COMPLETED|Second Treatment Intervention Period||0
5285206|NCT00617461|12992996|P2|COMPLETED|Second Treatment Intervention Period||37
5285207|NCT00617461|12992997|P1|COMPLETED|Second Treatment Intervention Period||41
5285208|NCT00617461|12992996|P2|STARTED|Second Treatment Intervention Period||41
5285209|NCT00617461|12992997|P1|STARTED|Second Treatment Intervention Period||41
5285210|NCT00617461|12992996|P2|NOT COMPLETED|4-Day Crossover Period||0
5285211|NCT00617461|12992997|P1|NOT COMPLETED|4-Day Crossover Period||1
5285212|NCT00617461|12992996|P2|COMPLETED|4-Day Crossover Period||40
5285213|NCT00617461|12992997|P1|COMPLETED|4-Day Crossover Period||41
5285214|NCT00617461|12992996|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
5285215|NCT00617461|12992997|P1|STARTED|4-Day Crossover Period||42
5285216|NCT00617461|12992996|P2|NOT COMPLETED|First Treatment Intervention Period||3
5285217|NCT00617461|12992997|P1|NOT COMPLETED|First Treatment Intervention Period||10
5285218|NCT00617461|12992996|P2|COMPLETED|First Treatment Intervention Period||41
5285219|NCT00617461|12992997|P1|COMPLETED|First Treatment Intervention Period||42
5285220|NCT00617461|12992996|P2|STARTED|First Treatment Intervention Period||44
5285221|NCT00617461|12992997|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
5285222|NCT00617409|12993053|P3|NOT COMPLETED|Overall Study||27
5285223|NCT00617409|12993054|P2|NOT COMPLETED|Overall Study||18
5285224|NCT00617409|12993055|P1|NOT COMPLETED|Overall Study||16
5285225|NCT00617409|12993053|P3|COMPLETED|Overall Study||4
5285226|NCT00617409|12993054|P2|COMPLETED|Overall Study||2
5285227|NCT00617409|12993055|P1|COMPLETED|Overall Study||2
5285228|NCT00617409|12993053|P3|STARTED|Overall Study||31
5285229|NCT00617409|12993054|P2|STARTED|Overall Study||20
5285230|NCT00617409|12993055|P1|STARTED|Overall Study||18
5285231|NCT00617396|12993066|P1|NOT COMPLETED|Overall Study||0
5285232|NCT00617396|12993066|P1|COMPLETED|Overall Study||25
5285233|NCT00617396|12993066|P1|STARTED|Overall Study||25
5285234|NCT00617357|12993070|P1|NOT COMPLETED|Overall Study||16
5285235|NCT00617357|12993070|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
5285236|NCT00617357|12993070|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
5285237|NCT00617344|12993083|P3|NOT COMPLETED|Overall Study||8
5285238|NCT00617344|12993084|P2|NOT COMPLETED|Overall Study||22
5285239|NCT00617344|12993085|P1|NOT COMPLETED|Overall Study||25
5285240|NCT00617344|12993083|P3|COMPLETED|Overall Study||45
5285241|NCT00617344|12993084|P2|COMPLETED|Overall Study||81
5285242|NCT00617344|12993085|P1|COMPLETED|Overall Study||79
5285243|NCT00617344|12993083|P3|Received Vaccination 3|Overall Study||45
5285244|NCT00617344|12993084|P2|Received Vaccination 3|Overall Study||81
5285245|NCT00617344|12993085|P1|Received Vaccination 3|Overall Study||79
5285246|NCT00617344|12993083|P3|Received Vaccination 2|Overall Study||46
5285247|NCT00617344|12993084|P2|Received Vaccination 2|Overall Study||85
5285248|NCT00617344|12993085|P1|Received Vaccination 2|Overall Study||86
5285249|NCT00617344|12993083|P3|Received Vaccination 1|Overall Study||53
5285250|NCT00617344|12993084|P2|Received Vaccination 1|Overall Study||103
5285251|NCT00617344|12993085|P1|Received Vaccination 1|Overall Study||104
5285252|NCT00617344|12993083|P3|STARTED|Overall Study||53
5285253|NCT00617344|12993084|P2|STARTED|Overall Study||103
5285254|NCT00617344|12993085|P1|STARTED|Overall Study||104
5285255|NCT00617305|12993113|P3|NOT COMPLETED|Overall Study||1
5285256|NCT00617305|12993114|P2|NOT COMPLETED|Overall Study||0
5285257|NCT00617305|12993115|P1|NOT COMPLETED|Overall Study||8
5285258|NCT00617305|12993113|P3|COMPLETED|Overall Study||0
5285259|NCT00617305|12993114|P2|COMPLETED|Overall Study||4
5285260|NCT00617305|12993115|P1|COMPLETED|Overall Study||25
5285261|NCT00617305|12993113|P3|Completed 24-week Primary Analysis|Overall Study||0
5285262|NCT00617305|12993114|P2|Completed 24-week Primary Analysis|Overall Study||4
5285263|NCT00617305|12993115|P1|Completed 24-week Primary Analysis|Overall Study||31
5285264|NCT00617305|12993113|P3|STARTED|Overall Study||1
5285265|NCT00617305|12993114|P2|STARTED|Overall Study||4
5285266|NCT00617305|12993115|P1|STARTED|Overall Study||33
5285267|NCT00617279|12993171|P2|NOT COMPLETED|Overall Study||17
5285268|NCT00617279|12993172|P1|NOT COMPLETED|Overall Study||14
5285269|NCT00617279|12993171|P2|COMPLETED|Overall Study||0
5285270|NCT00617279|12993172|P1|COMPLETED|Overall Study||0
5285271|NCT00617279|12993171|P2|STARTED|Overall Study||17
5285272|NCT00617279|12993172|P1|STARTED|Overall Study||14
5285273|NCT00617240|12993228|P2|NOT COMPLETED|Overall Study||0
5285274|NCT00617240|12993229|P1|NOT COMPLETED|Overall Study||1
5285275|NCT00617240|12993228|P2|COMPLETED|Overall Study||4
5285276|NCT00617240|12993229|P1|COMPLETED|Overall Study||4
5285277|NCT00617240|12993228|P2|STARTED|Overall Study||4
5285278|NCT00617240|12993229|P1|STARTED|Overall Study||5
5285279|NCT00617201|12993249|P2|NOT COMPLETED|Overall Study||13
5285280|NCT00617201|12993250|P1|NOT COMPLETED|Overall Study||9
5285281|NCT00617201|12993249|P2|COMPLETED|Overall Study||12
5285282|NCT00617201|12993250|P1|COMPLETED|Overall Study||16
5285283|NCT00617201|12993249|P2|STARTED|Overall Study||25
5285284|NCT00617201|12993250|P1|STARTED|Overall Study||25
5285285|NCT00617188|12993258|P1|NOT COMPLETED|Overall Study||0
5285286|NCT00617188|12993258|P1|COMPLETED|Overall Study||26
5285287|NCT00617188|12993258|P1|STARTED|Overall Study||26
5285288|NCT00617175|12993269|P2|NOT COMPLETED|Overall Study||0
5285289|NCT00617175|12993270|P1|NOT COMPLETED|Overall Study||0
5285290|NCT00617175|12993269|P2|COMPLETED|Overall Study||948
5285291|NCT00617175|12993270|P1|COMPLETED|Overall Study||954
5285292|NCT00617175|12993269|P2|STARTED|Overall Study||948
5285293|NCT00617175|12993270|P1|STARTED|Overall Study||954
5285294|NCT00617123|12993278|P2|NOT COMPLETED|Study Treatment Period||16
5285295|NCT00617123|12993279|P1|NOT COMPLETED|Study Treatment Period||17
5285296|NCT00617123|12993278|P2|COMPLETED|Study Treatment Period||79
5285297|NCT00617123|12993279|P1|COMPLETED|Study Treatment Period||81
5285298|NCT00617123|12993278|P2|Treated|Study Treatment Period||95
5285299|NCT00617123|12993279|P1|Treated|Study Treatment Period|1 participant was not treated|97
5285300|NCT00617123|12993278|P2|STARTED|Study Treatment Period||95
5285301|NCT00617123|12993279|P1|STARTED|Study Treatment Period||98
5285302|NCT00617123|12993278|P2|NOT COMPLETED|Referral Screening Period||26
5285303|NCT00617123|12993279|P1|NOT COMPLETED|Referral Screening Period||39
5285304|NCT00617123|12993278|P2|COMPLETED|Referral Screening Period||95
5285305|NCT00617123|12993279|P1|COMPLETED|Referral Screening Period||98
5285306|NCT00617123|12993278|P2|STARTED|Referral Screening Period||121
5285307|NCT00617123|12993279|P1|STARTED|Referral Screening Period||137
5285308|NCT00617097|12993295|P2|NOT COMPLETED|Overall Study||0
5285309|NCT00617097|12993296|P1|NOT COMPLETED|Overall Study||0
5285310|NCT00617097|12993295|P2|COMPLETED|Overall Study||25
5285311|NCT00617097|12993296|P1|COMPLETED|Overall Study||25
5285312|NCT00617097|12993295|P2|STARTED|Overall Study||25
5285313|NCT00617097|12993296|P1|STARTED|Overall Study||25
5285314|NCT00617084|12993310|P2|NOT COMPLETED|Overall Study||26
5285315|NCT00617084|12993311|P1|NOT COMPLETED|Overall Study||21
5285316|NCT00617084|12993310|P2|COMPLETED|Overall Study||1126
5285317|NCT00617084|12993311|P1|COMPLETED|Overall Study||1119
5285318|NCT00617084|12993310|P2|STARTED|Overall Study||1152
5285319|NCT00617084|12993311|P1|STARTED|Overall Study||1140
5285320|NCT00617058|12993322|P3|NOT COMPLETED|Overall Study||0
5285321|NCT00617058|12993323|P2|NOT COMPLETED|Overall Study||0
5285322|NCT00617058|12993324|P1|NOT COMPLETED|Overall Study||0
5285323|NCT00617058|12993322|P3|COMPLETED|Overall Study||0
5285324|NCT00617058|12993323|P2|COMPLETED|Overall Study||0
5285325|NCT00617058|12993324|P1|COMPLETED|Overall Study||1
5285326|NCT00617058|12993322|P3|STARTED|Overall Study||0
5285327|NCT00617058|12993323|P2|STARTED|Overall Study||0
5285328|NCT00617058|12993324|P1|STARTED|Overall Study||1
5285329|NCT00616967|12993364|P3|NOT COMPLETED|Overall Study||1
5285330|NCT00616967|12993365|P2|NOT COMPLETED|Overall Study||0
5285331|NCT00616967|12993366|P1|NOT COMPLETED|Overall Study||0
5285332|NCT00616967|12993364|P3|COMPLETED|Overall Study||30
5285333|NCT00616967|12993365|P2|COMPLETED|Overall Study||31
5285334|NCT00616967|12993366|P1|COMPLETED|Overall Study||6
5285335|NCT00616967|12993364|P3|STARTED|Overall Study||31
5285336|NCT00616967|12993365|P2|STARTED|Overall Study||31
5285337|NCT00616967|12993366|P1|STARTED|Overall Study||6
5285338|NCT00616941|12993391|P3|NOT COMPLETED|Overall Study||6
5285339|NCT00616941|12993392|P2|NOT COMPLETED|Overall Study||5
5285340|NCT00616941|12993393|P1|NOT COMPLETED|Overall Study||1
5285341|NCT00616941|12993391|P3|COMPLETED|Overall Study||5
5285342|NCT00616941|12993392|P2|COMPLETED|Overall Study||8
5285343|NCT00616941|12993393|P1|COMPLETED|Overall Study||3
5285344|NCT00616941|12993391|P3|STARTED|Overall Study||11
5285345|NCT00616941|12993392|P2|STARTED|Overall Study||13
5285346|NCT00616941|12993393|P1|STARTED|Overall Study||4
5285347|NCT00616928|12993420|P4|NOT COMPLETED|Overall Study||7
5285348|NCT00616928|12993421|P3|NOT COMPLETED|Overall Study||17
5285349|NCT00616928|12993422|P2|NOT COMPLETED|Overall Study||18
5285350|NCT00616928|12993423|P1|NOT COMPLETED|Overall Study||62
5285351|NCT00616928|12993420|P4|COMPLETED|Overall Study||364
5285352|NCT00616928|12993421|P3|COMPLETED|Overall Study||1101
5285353|NCT00616928|12993422|P2|COMPLETED|Overall Study||750
5285354|NCT00616928|12993423|P1|COMPLETED|Overall Study||2242
5285355|NCT00616928|12993420|P4|STARTED|Overall Study||371
5285356|NCT00616928|12993421|P3|STARTED|Overall Study||1118
5285357|NCT00616928|12993422|P2|STARTED|Overall Study||768
5285358|NCT00616928|12993423|P1|STARTED|Overall Study||2304
5285359|NCT00616902|12993487|P2|NOT COMPLETED|Overall Study||6
5285360|NCT00616902|12993488|P1|NOT COMPLETED|Overall Study||6
5285361|NCT00616902|12993487|P2|COMPLETED|Overall Study||0
5285362|NCT00616902|12993488|P1|COMPLETED|Overall Study||0
5285363|NCT00616902|12993487|P2|STARTED|Overall Study||6
5285364|NCT00616902|12993488|P1|STARTED|Overall Study||6
5285365|NCT00616772|12993514|P2|NOT COMPLETED|Overall Study||102
5285366|NCT00616772|12993515|P1|NOT COMPLETED|Overall Study||115
5285367|NCT00616772|12993514|P2|COMPLETED|Overall Study||240
5285368|NCT00616772|12993515|P1|COMPLETED|Overall Study||225
5285369|NCT00616772|12993514|P2|Treated|Overall Study||339
5285370|NCT00616772|12993515|P1|Treated|Overall Study||337
5285371|NCT00616772|12993514|P2|STARTED|Overall Study||342
5285372|NCT00616772|12993515|P1|STARTED|Overall Study||340
5285373|NCT00616759|12993531|P2|NOT COMPLETED|Overall Study||2
5285374|NCT00616759|12993532|P1|NOT COMPLETED|Overall Study||3
5285375|NCT00616759|12993531|P2|COMPLETED|Overall Study||8
5285376|NCT00616759|12993532|P1|COMPLETED|Overall Study||7
5285377|NCT00616759|12993531|P2|STARTED|Overall Study||10
5285378|NCT00616759|12993532|P1|STARTED|Overall Study||10
5285379|NCT00616655|12993541|P3|NOT COMPLETED|Overall Study||48
5285380|NCT00616655|12993542|P2|NOT COMPLETED|Overall Study||41
5285381|NCT00616655|12993543|P1|NOT COMPLETED|Overall Study||35
5285382|NCT00616655|12993541|P3|COMPLETED|Overall Study||103
5285383|NCT00616655|12993542|P2|COMPLETED|Overall Study||112
5285384|NCT00616655|12993543|P1|COMPLETED|Overall Study||117
5285385|NCT00616655|12993541|P3|STARTED|Overall Study||151
5285386|NCT00616655|12993542|P2|STARTED|Overall Study||153
5285387|NCT00616655|12993543|P1|STARTED|Overall Study||152
5285388|NCT00616642|12993583|P2|NOT COMPLETED|Overall Study||1
5285389|NCT00616642|12993584|P1|NOT COMPLETED|Overall Study||0
5285390|NCT00616642|12993583|P2|COMPLETED|Overall Study||0
5285391|NCT00616642|12993584|P1|COMPLETED|Overall Study||0
5285392|NCT00616642|12993583|P2|STARTED|Overall Study||1
5285393|NCT00616642|12993584|P1|STARTED|Overall Study||0
5285394|NCT00616629|12993595|P5|NOT COMPLETED|Overall Study||0
5285395|NCT00616629|12993596|P4|NOT COMPLETED|Overall Study||0
5285396|NCT00616629|12993597|P3|NOT COMPLETED|Overall Study||1
5285397|NCT00616629|12993598|P2|NOT COMPLETED|Overall Study||2
5285398|NCT00616629|12993599|P1|NOT COMPLETED|Overall Study||2
5285399|NCT00616629|12993595|P5|COMPLETED|Overall Study||12
5285400|NCT00616629|12993596|P4|COMPLETED|Overall Study||2
5285401|NCT00616629|12993597|P3|COMPLETED|Overall Study||13
5285402|NCT00616629|12993598|P2|COMPLETED|Overall Study||12
5285403|NCT00616629|12993599|P1|COMPLETED|Overall Study||11
5285404|NCT00616629|12993595|P5|STARTED|Overall Study||12
5285405|NCT00616629|12993596|P4|STARTED|Overall Study||2
5285406|NCT00616629|12993597|P3|STARTED|Overall Study|One patient never received study drug|14
5285407|NCT00616629|12993598|P2|STARTED|Overall Study|Two patients never received study drug|14
5285408|NCT00616629|12993599|P1|STARTED|Overall Study|Two patients never received study drug|13
5285409|NCT00616603|12993644|P3|NOT COMPLETED|Overall Study||2
5285410|NCT00616603|12993645|P2|NOT COMPLETED|Overall Study||0
5285411|NCT00616603|12993646|P1|NOT COMPLETED|Overall Study||2
5285412|NCT00616603|12993644|P3|COMPLETED|Overall Study||13
5285413|NCT00616603|12993645|P2|COMPLETED|Overall Study||14
5285414|NCT00616603|12993646|P1|COMPLETED|Overall Study||12
5285415|NCT00616603|12993644|P3|STARTED|Overall Study||15
5285416|NCT00616603|12993645|P2|STARTED|Overall Study||14
5285417|NCT00616603|12993646|P1|STARTED|Overall Study||14
5285418|NCT00616577|12993657|P3|NOT COMPLETED|Overall Study||0
5285419|NCT00616577|12993658|P2|NOT COMPLETED|Overall Study||0
5285420|NCT00616577|12993659|P1|NOT COMPLETED|Overall Study||0
5285421|NCT00616577|12993657|P3|COMPLETED|Overall Study||7
5285422|NCT00616577|12993658|P2|COMPLETED|Overall Study||9
5285423|NCT00616577|12993659|P1|COMPLETED|Overall Study||6
5285424|NCT00616577|12993657|P3|STARTED|Overall Study||7
5285425|NCT00616577|12993658|P2|STARTED|Overall Study||9
5285426|NCT00616577|12993659|P1|STARTED|Overall Study||6
5285427|NCT00616434|12993669|P2|NOT COMPLETED|Overall Study||8
5285428|NCT00616434|12993670|P1|NOT COMPLETED|Overall Study||6
5285429|NCT00616434|12993669|P2|COMPLETED|Overall Study||53
5285430|NCT00616434|12993670|P1|COMPLETED|Overall Study||56
5285431|NCT00616434|12993669|P2|STARTED|Overall Study||61
5285432|NCT00616434|12993670|P1|STARTED|Overall Study||62
5285433|NCT00616421|12993683|P3|NOT COMPLETED|Overall Study||41
5285434|NCT00616421|12993684|P2|NOT COMPLETED|Overall Study||38
5285435|NCT00616421|12993685|P1|NOT COMPLETED|Overall Study||26
5285436|NCT00616421|12993683|P3|COMPLETED|Overall Study||1229
5285437|NCT00616421|12993684|P2|COMPLETED|Overall Study||1240
5285438|NCT00616421|12993685|P1|COMPLETED|Overall Study||333
5285439|NCT00616421|12993683|P3|STARTED|Overall Study||1270
5285440|NCT00616421|12993684|P2|STARTED|Overall Study||1278
5285441|NCT00616421|12993685|P1|STARTED|Overall Study||359
5285442|NCT00616343|12993722|P1|NOT COMPLETED|Overall Study||0
5285443|NCT00616343|12993722|P1|COMPLETED|Overall Study||9
5285444|NCT00616343|12993722|P1|STARTED|Overall Study||9
5285445|NCT00616239|12993726|P1|NOT COMPLETED|Overall Study||2
5285446|NCT00616239|12993726|P1|COMPLETED|Overall Study||18
5285447|NCT00616239|12993726|P1|STARTED|Overall Study||20
5285448|NCT00616200|12993730|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
5285449|NCT00616200|12993730|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
5285450|NCT00616200|12993730|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
5285451|NCT00616200|12993730|P1|NOT COMPLETED|Two Week Standard Diet||1
5285452|NCT00616200|12993730|P1|COMPLETED|Two Week Standard Diet||16
5285453|NCT00616200|12993730|P1|STARTED|Two Week Standard Diet||17
5285454|NCT00616122|12993736|P4|NOT COMPLETED|Overall Study||11
5285455|NCT00616122|12993737|P3|NOT COMPLETED|Overall Study||0
5285456|NCT00616122|12993738|P2|NOT COMPLETED|Overall Study||0
5285457|NCT00616122|12993739|P1|NOT COMPLETED|Overall Study||0
5285458|NCT00616122|12993736|P4|COMPLETED|Overall Study||0
5285459|NCT00616122|12993737|P3|COMPLETED|Overall Study||10
5285460|NCT00616122|12993738|P2|COMPLETED|Overall Study||7
5285461|NCT00616122|12993739|P1|COMPLETED|Overall Study||4
5285462|NCT00616122|12993736|P4|STARTED|Overall Study||11
5285463|NCT00616122|12993737|P3|STARTED|Overall Study||10
5285464|NCT00616122|12993738|P2|STARTED|Overall Study||7
5285465|NCT00616122|12993739|P1|STARTED|Overall Study||4
5285466|NCT00616109|12993749|P1|NOT COMPLETED|Overall Study||0
5285467|NCT00616109|12993749|P1|COMPLETED|Overall Study||16
5285468|NCT00616109|12993749|P1|STARTED|Overall Study||16
5285469|NCT00616018|12993756|P1|NOT COMPLETED|Overall Study||3
5285470|NCT00616018|12993756|P1|COMPLETED|Overall Study||24
5285471|NCT00616018|12993756|P1|STARTED|Overall Study||27
5285472|NCT00615992|12993761|P1|NOT COMPLETED|Overall Study||67
5285473|NCT00615992|12993761|P1|COMPLETED|Overall Study||687
5285474|NCT00615992|12993761|P1|STARTED|Overall Study||754
5285475|NCT00615927|12993772|P2|NOT COMPLETED|Overall Study||0
5285476|NCT00615927|12993773|P1|NOT COMPLETED|Overall Study||0
5285477|NCT00615927|12993772|P2|COMPLETED|Overall Study||32
5285478|NCT00615927|12993773|P1|COMPLETED|Overall Study||32
5285479|NCT00615927|12993772|P2|STARTED|Overall Study||32
5285480|NCT00615927|12993773|P1|STARTED|Overall Study||32
5285481|NCT00615914|12993787|P1|NOT COMPLETED|Overall Study||637
5285482|NCT00615914|12993787|P1|COMPLETED|Overall Study||1008
5285483|NCT00615914|12993787|P1|STARTED|Overall Study|The number of patients enrolled|1645
5285484|NCT00615901|12993794|P1|NOT COMPLETED|Overall Study||9
5285485|NCT00615901|12993794|P1|COMPLETED|Overall Study||29
5285486|NCT00615901|12993794|P1|STARTED|Overall Study||38
5285487|NCT00615836|12993802|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
5285488|NCT00615836|12993803|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
5285489|NCT00615836|12993804|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
5285490|NCT00615836|12993805|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
5285491|NCT00615836|12993806|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
5285492|NCT00615836|12993802|P5|COMPLETED|Extension Study (FE992026 CS31)||0
5285493|NCT00615836|12993803|P4|COMPLETED|Extension Study (FE992026 CS31)||53
5285494|NCT00615836|12993804|P3|COMPLETED|Extension Study (FE992026 CS31)||59
5285495|NCT00615836|12993805|P2|COMPLETED|Extension Study (FE992026 CS31)||58
5285496|NCT00615836|12993806|P1|COMPLETED|Extension Study (FE992026 CS31)||0
5285497|NCT00615836|12993802|P5|STARTED|Extension Study (FE992026 CS31)||0
5285498|NCT00615836|12993803|P4|STARTED|Extension Study (FE992026 CS31)||137
5285499|NCT00615836|12993804|P3|STARTED|Extension Study (FE992026 CS31)||132
5285500|NCT00615836|12993805|P2|STARTED|Extension Study (FE992026 CS31)||144
5285501|NCT00615836|12993806|P1|STARTED|Extension Study (FE992026 CS31)||141
5285502|NCT00615836|12993802|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
5285503|NCT00615836|12993803|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
5285504|NCT00615836|12993804|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
5285505|NCT00615836|12993805|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
5285506|NCT00615836|12993806|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
5285507|NCT00615836|12993802|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
5285508|NCT00615836|12993803|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
5285509|NCT00615836|12993804|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
5285510|NCT00615836|12993805|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
5285511|NCT00615836|12993806|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
5285512|NCT00615836|12993802|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
5285513|NCT00615836|12993803|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
5285514|NCT00615836|12993804|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
5285515|NCT00615836|12993805|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
5285516|NCT00615836|12993806|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
5285517|NCT00615836|12993802|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
5285518|NCT00615836|12993803|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
5285519|NCT00615836|12993804|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
5285520|NCT00615836|12993805|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
5285521|NCT00615836|12993806|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
5285522|NCT00615719|12993866|P1|NOT COMPLETED|Overall Study||5
5285523|NCT00615719|12993866|P1|COMPLETED|Overall Study||30
5285524|NCT00615719|12993866|P1|STARTED|Overall Study||35
5285525|NCT00615589|12993870|P1|NOT COMPLETED|Overall Study||0
5285526|NCT00615589|12993870|P1|COMPLETED|Overall Study||22
5285527|NCT00615589|12993870|P1|STARTED|Overall Study||22
5285528|NCT00615550|12993880|P2|NOT COMPLETED|Overall Study||1
5285529|NCT00615550|12993881|P1|NOT COMPLETED|Overall Study||6
5285530|NCT00615550|12993880|P2|COMPLETED|Overall Study||235
5285531|NCT00615550|12993881|P1|COMPLETED|Overall Study||223
5285532|NCT00615550|12993880|P2|STARTED|Overall Study||236
5285533|NCT00615550|12993881|P1|STARTED|Overall Study||229
5285534|NCT00615472|12993897|P2|NOT COMPLETED|Overall Study||0
5285535|NCT00615472|12993898|P1|NOT COMPLETED|Overall Study||0
5285536|NCT00615472|12993897|P2|COMPLETED|Overall Study||28
5285537|NCT00615472|12993898|P1|COMPLETED|Overall Study||30
5285538|NCT00615472|12993897|P2|STARTED|Overall Study||28
5285539|NCT00615472|12993898|P1|STARTED|Overall Study||30
5285540|NCT00615459|12993904|P4|NOT COMPLETED|Period III||0
5285541|NCT00615459|12993905|P3|NOT COMPLETED|Period III||1
5285542|NCT00615459|12993906|P2|NOT COMPLETED|Period III||3
5285543|NCT00615459|12993907|P1|NOT COMPLETED|Period III||0
5285544|NCT00615459|12993904|P4|COMPLETED|Period III||41
5285545|NCT00615459|12993905|P3|COMPLETED|Period III||39
5285546|NCT00615459|12993906|P2|COMPLETED|Period III||37
5285547|NCT00615459|12993907|P1|COMPLETED|Period III||36
5285548|NCT00615459|12993904|P4|STARTED|Period III||41
5285549|NCT00615459|12993905|P3|STARTED|Period III||40
5285550|NCT00615459|12993906|P2|STARTED|Period III||40
5285551|NCT00615459|12993907|P1|STARTED|Period III||36
5285552|NCT00615459|12993904|P4|NOT COMPLETED|Period II||1
5285553|NCT00615459|12993905|P3|NOT COMPLETED|Period II||0
5285554|NCT00615459|12993906|P2|NOT COMPLETED|Period II||0
5285555|NCT00615459|12993907|P1|NOT COMPLETED|Period II||1
5285556|NCT00615459|12993904|P4|COMPLETED|Period II||41
5285557|NCT00615459|12993905|P3|COMPLETED|Period II||40
5285558|NCT00615459|12993906|P2|COMPLETED|Period II||40
5285559|NCT00615459|12993907|P1|COMPLETED|Period II||36
5285560|NCT00615459|12993904|P4|STARTED|Period II||42
5285561|NCT00615459|12993905|P3|STARTED|Period II||40
5285562|NCT00615459|12993906|P2|STARTED|Period II||40
5285563|NCT00615459|12993907|P1|STARTED|Period II||37
5285564|NCT00615459|12993904|P4|NOT COMPLETED|Period I||1
5285565|NCT00615459|12993905|P3|NOT COMPLETED|Period I||2
5285566|NCT00615459|12993906|P2|NOT COMPLETED|Period I||1
5285567|NCT00615459|12993907|P1|NOT COMPLETED|Period I||4
5285568|NCT00615459|12993904|P4|COMPLETED|Period I||42
5285569|NCT00615459|12993905|P3|COMPLETED|Period I||40
5285570|NCT00615459|12993906|P2|COMPLETED|Period I||40
5285571|NCT00615459|12993907|P1|COMPLETED|Period I||37
5285572|NCT00615459|12993904|P4|STARTED|Period I||43
5285573|NCT00615459|12993905|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
5285574|NCT00615459|12993906|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
5285575|NCT00615459|12993907|P1|STARTED|Period I||41
5285576|NCT00615433|12993925|P4|NOT COMPLETED|Overall Study||45
5285577|NCT00615433|12993926|P3|NOT COMPLETED|Overall Study||39
5285578|NCT00615433|12993927|P2|NOT COMPLETED|Overall Study||53
5285579|NCT00615433|12993928|P1|NOT COMPLETED|Overall Study||43
5285580|NCT00615433|12993925|P4|COMPLETED|Overall Study||71
5285581|NCT00615433|12993926|P3|COMPLETED|Overall Study||84
5285582|NCT00615433|12993927|P2|COMPLETED|Overall Study||66
5285583|NCT00615433|12993928|P1|COMPLETED|Overall Study||77
5285584|NCT00615433|12993925|P4|STARTED|Overall Study||116
5285585|NCT00615433|12993926|P3|STARTED|Overall Study||123
5285586|NCT00615433|12993927|P2|STARTED|Overall Study||119
5285587|NCT00615433|12993928|P1|STARTED|Overall Study||120
5285588|NCT00615420|12993944|P2|NOT COMPLETED|Overall Study||27
5285589|NCT00615420|12993945|P1|NOT COMPLETED|Overall Study||31
5285590|NCT00615420|12993944|P2|COMPLETED|Overall Study||25
5285591|NCT00615420|12993945|P1|COMPLETED|Overall Study||23
5285592|NCT00615420|12993944|P2|STARTED|Overall Study||52
5285593|NCT00615420|12993945|P1|STARTED|Overall Study||54
5285594|NCT00615290|12993953|P1|NOT COMPLETED|Overall Study||8
5285595|NCT00615290|12993953|P1|COMPLETED|Overall Study||34
5285596|NCT00615290|12993953|P1|STARTED|Overall Study||42
5285597|NCT00615264|12993967|P2|NOT COMPLETED|Overall Study||52
5285598|NCT00615264|12993968|P1|NOT COMPLETED|Overall Study||50
5285599|NCT00615264|12993967|P2|COMPLETED|Overall Study||180
5285600|NCT00615264|12993968|P1|COMPLETED|Overall Study||175
5285601|NCT00615264|12993967|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
5285602|NCT00615264|12993968|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
5285603|NCT00615264|12993967|P2|Received at Least One Dose (ITT)|Overall Study||231
5285604|NCT00615264|12993968|P1|Received at Least One Dose (ITT)|Overall Study||225
5285605|NCT00615264|12993967|P2|STARTED|Overall Study||232
5285606|NCT00615264|12993968|P1|STARTED|Overall Study||225
5285607|NCT00615199|12993980|P4|NOT COMPLETED|Overall Study||2
5285608|NCT00615199|12993981|P3|NOT COMPLETED|Overall Study||1
5285609|NCT00615199|12993982|P2|NOT COMPLETED|Overall Study||2
5285610|NCT00615199|12993983|P1|NOT COMPLETED|Overall Study||8
5285611|NCT00615199|12993980|P4|COMPLETED|Overall Study||33
5285612|NCT00615199|12993981|P3|COMPLETED|Overall Study||33
5285613|NCT00615199|12993982|P2|COMPLETED|Overall Study||34
5285614|NCT00615199|12993983|P1|COMPLETED|Overall Study||26
5285615|NCT00615199|12993980|P4|STARTED|Overall Study||35
5285616|NCT00615199|12993981|P3|STARTED|Overall Study||34
5285617|NCT00615199|12993982|P2|STARTED|Overall Study||36
5285618|NCT00615199|12993983|P1|STARTED|Overall Study||34
5285619|NCT00615108|12994017|P1|NOT COMPLETED|Overall Study||507
5285620|NCT00615108|12994017|P1|COMPLETED|Overall Study||2641
5285621|NCT00615108|12994017|P1|STARTED|Overall Study||3148
5285622|NCT00615069|12994032|P1|NOT COMPLETED|Overall Study||16
5285623|NCT00615069|12994032|P1|COMPLETED|Overall Study||19
5285624|NCT00615069|12994032|P1|STARTED|Overall Study||35
5285625|NCT00615056|12994041|P4|NOT COMPLETED|Overall Study||35
5285626|NCT00615056|12994042|P3|NOT COMPLETED|Overall Study||36
5285627|NCT00615056|12994043|P2|NOT COMPLETED|Overall Study||51
5285628|NCT00615056|12994044|P1|NOT COMPLETED|Overall Study||49
5285629|NCT00615056|12994041|P4|COMPLETED|Overall Study||0
5285630|NCT00615056|12994042|P3|COMPLETED|Overall Study||0
5285631|NCT00615056|12994043|P2|COMPLETED|Overall Study||0
5285632|NCT00615056|12994044|P1|COMPLETED|Overall Study||0
5285633|NCT00615056|12994041|P4|Treated|Overall Study||35
5285634|NCT00615056|12994042|P3|Treated|Overall Study||36
5285635|NCT00615056|12994043|P2|Treated|Overall Study||51
5285636|NCT00615056|12994044|P1|Treated|Overall Study||46
5285637|NCT00615056|12994041|P4|STARTED|Overall Study||35
5285638|NCT00615056|12994042|P3|STARTED|Overall Study||36
5285639|NCT00615056|12994043|P2|STARTED|Overall Study||51
5285640|NCT00615056|12994044|P1|STARTED|Overall Study||49
5285641|NCT00615030|12994074|P12|NOT COMPLETED|Period III||0
5285642|NCT00615030|12994075|P11|NOT COMPLETED|Period III||0
5285643|NCT00615030|12994076|P10|NOT COMPLETED|Period III||0
5285644|NCT00615030|12994077|P9|NOT COMPLETED|Period III||0
5285645|NCT00615030|12994078|P8|NOT COMPLETED|Period III||0
5285646|NCT00615030|12994079|P7|NOT COMPLETED|Period III||0
5285647|NCT00615030|12994080|P6|NOT COMPLETED|Period III||0
5285648|NCT00615030|12994081|P5|NOT COMPLETED|Period III||0
5285649|NCT00615030|12994082|P4|NOT COMPLETED|Period III||1
5285650|NCT00615030|12994083|P3|NOT COMPLETED|Period III||0
5285651|NCT00615030|12994084|P2|NOT COMPLETED|Period III||0
5285652|NCT00615030|12994085|P1|NOT COMPLETED|Period III||1
5285653|NCT00615030|12994074|P12|COMPLETED|Period III||6
5285654|NCT00615030|12994075|P11|COMPLETED|Period III||7
5285655|NCT00615030|12994076|P10|COMPLETED|Period III||8
5285656|NCT00615030|12994077|P9|COMPLETED|Period III||7
5285657|NCT00615030|12994078|P8|COMPLETED|Period III||7
5285658|NCT00615030|12994079|P7|COMPLETED|Period III||6
5285659|NCT00615030|12994080|P6|COMPLETED|Period III||5
5285660|NCT00615030|12994081|P5|COMPLETED|Period III||8
5285661|NCT00615030|12994082|P4|COMPLETED|Period III||6
5285662|NCT00615030|12994083|P3|COMPLETED|Period III||8
5285663|NCT00615030|12994084|P2|COMPLETED|Period III||8
5285664|NCT00615030|12994085|P1|COMPLETED|Period III||7
5285665|NCT00615030|12994074|P12|STARTED|Period III||6
5285666|NCT00615030|12994075|P11|STARTED|Period III||7
5285667|NCT00615030|12994076|P10|STARTED|Period III||8
5285668|NCT00615030|12994077|P9|STARTED|Period III||7
5285669|NCT00615030|12994078|P8|STARTED|Period III||7
5285670|NCT00615030|12994079|P7|STARTED|Period III||6
5285671|NCT00615030|12994080|P6|STARTED|Period III||5
5285672|NCT00615030|12994081|P5|STARTED|Period III||8
5285673|NCT00615030|12994082|P4|STARTED|Period III||7
5285674|NCT00615030|12994083|P3|STARTED|Period III||8
5285675|NCT00615030|12994084|P2|STARTED|Period III||8
5285676|NCT00615030|12994085|P1|STARTED|Period III||8
5285677|NCT00615030|12994074|P12|NOT COMPLETED|Period II||0
5285678|NCT00615030|12994075|P11|NOT COMPLETED|Period II||0
5285679|NCT00615030|12994076|P10|NOT COMPLETED|Period II||0
5285680|NCT00615030|12994077|P9|NOT COMPLETED|Period II||1
5285681|NCT00615030|12994078|P8|NOT COMPLETED|Period II||0
5285682|NCT00615030|12994079|P7|NOT COMPLETED|Period II||1
5285683|NCT00615030|12994080|P6|NOT COMPLETED|Period II||0
5285684|NCT00615030|12994081|P5|NOT COMPLETED|Period II||0
5285685|NCT00615030|12994082|P4|NOT COMPLETED|Period II||1
5285686|NCT00615030|12994083|P3|NOT COMPLETED|Period II||1
5285687|NCT00615030|12994084|P2|NOT COMPLETED|Period II||0
5285688|NCT00615030|12994085|P1|NOT COMPLETED|Period II||0
5285689|NCT00615030|12994074|P12|COMPLETED|Period II||6
5285690|NCT00615030|12994075|P11|COMPLETED|Period II||7
5285691|NCT00615030|12994076|P10|COMPLETED|Period II||8
5285692|NCT00615030|12994077|P9|COMPLETED|Period II||7
5285693|NCT00615030|12994078|P8|COMPLETED|Period II||7
5285694|NCT00615030|12994079|P7|COMPLETED|Period II||6
5285695|NCT00615030|12994080|P6|COMPLETED|Period II||5
5285696|NCT00615030|12994081|P5|COMPLETED|Period II||8
5285697|NCT00615030|12994082|P4|COMPLETED|Period II||7
5285698|NCT00615030|12994083|P3|COMPLETED|Period II||8
5285699|NCT00615030|12994084|P2|COMPLETED|Period II||8
5285700|NCT00615030|12994085|P1|COMPLETED|Period II||8
5285701|NCT00615030|12994074|P12|STARTED|Period II||6
5285702|NCT00615030|12994075|P11|STARTED|Period II||7
5285703|NCT00615030|12994076|P10|STARTED|Period II||8
5285704|NCT00615030|12994077|P9|STARTED|Period II||8
5285705|NCT00615030|12994078|P8|STARTED|Period II||7
5285706|NCT00615030|12994079|P7|STARTED|Period II||7
5285707|NCT00615030|12994080|P6|STARTED|Period II||5
5285708|NCT00615030|12994081|P5|STARTED|Period II||8
5285709|NCT00615030|12994082|P4|STARTED|Period II||8
5285710|NCT00615030|12994083|P3|STARTED|Period II||9
5285711|NCT00615030|12994084|P2|STARTED|Period II||8
5285712|NCT00615030|12994085|P1|STARTED|Period II||8
5285713|NCT00615030|12994074|P12|NOT COMPLETED|Period I||1
5285714|NCT00615030|12994075|P11|NOT COMPLETED|Period I||1
5285715|NCT00615030|12994076|P10|NOT COMPLETED|Period I||0
5285716|NCT00615030|12994077|P9|NOT COMPLETED|Period I||1
5285717|NCT00615030|12994078|P8|NOT COMPLETED|Period I||0
5285718|NCT00615030|12994079|P7|NOT COMPLETED|Period I||0
5285719|NCT00615030|12994080|P6|NOT COMPLETED|Period I||1
5285720|NCT00615030|12994081|P5|NOT COMPLETED|Period I||1
5285721|NCT00615030|12994082|P4|NOT COMPLETED|Period I||0
5285722|NCT00615030|12994083|P3|NOT COMPLETED|Period I||0
5285723|NCT00615030|12994084|P2|NOT COMPLETED|Period I||0
5285724|NCT00615030|12994085|P1|NOT COMPLETED|Period I||1
5285725|NCT00615030|12994074|P12|COMPLETED|Period I||6
5285726|NCT00615030|12994075|P11|COMPLETED|Period I||7
5285727|NCT00615030|12994076|P10|COMPLETED|Period I||8
5285728|NCT00615030|12994077|P9|COMPLETED|Period I||8
5285729|NCT00615030|12994078|P8|COMPLETED|Period I||7
5285730|NCT00615030|12994079|P7|COMPLETED|Period I||7
5285731|NCT00615030|12994080|P6|COMPLETED|Period I||5
5285732|NCT00615030|12994081|P5|COMPLETED|Period I||8
5285733|NCT00615030|12994082|P4|COMPLETED|Period I||8
5285734|NCT00615030|12994083|P3|COMPLETED|Period I||9
5285735|NCT00615030|12994084|P2|COMPLETED|Period I||8
5285736|NCT00615030|12994085|P1|COMPLETED|Period I||8
5285737|NCT00615030|12994074|P12|STARTED|Period I||7
5285738|NCT00615030|12994075|P11|STARTED|Period I||8
5285739|NCT00615030|12994076|P10|STARTED|Period I||8
5285740|NCT00615030|12994077|P9|STARTED|Period I||9
5285741|NCT00615030|12994078|P8|STARTED|Period I||7
5285742|NCT00615030|12994079|P7|STARTED|Period I||7
5285743|NCT00615030|12994080|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
5285744|NCT00615030|12994081|P5|STARTED|Period I||9
5285745|NCT00615030|12994082|P4|STARTED|Period I||8
5285746|NCT00615030|12994083|P3|STARTED|Period I||9
5285747|NCT00615030|12994084|P2|STARTED|Period I||8
5285748|NCT00615030|12994085|P1|STARTED|Period I||9
5285749|NCT00615017|12994105|P6|NOT COMPLETED|Overall Study||3
5285750|NCT00615017|12994106|P5|NOT COMPLETED|Overall Study||1
5285751|NCT00615017|12994107|P4|NOT COMPLETED|Overall Study||1
5285752|NCT00615017|12994108|P3|NOT COMPLETED|Overall Study||5
5285753|NCT00615017|12994109|P2|NOT COMPLETED|Overall Study||1
5285754|NCT00615017|12994110|P1|NOT COMPLETED|Overall Study||0
5285755|NCT00615017|12994105|P6|COMPLETED|Overall Study|Patient completed the study drug|20
5285756|NCT00615017|12994106|P5|COMPLETED|Overall Study|Patient completed the study drug|7
5285757|NCT00615017|12994107|P4|COMPLETED|Overall Study|Patient completed the study drug|9
5285758|NCT00615017|12994108|P3|COMPLETED|Overall Study|Patient completed the study drug|7
5285759|NCT00615017|12994109|P2|COMPLETED|Overall Study|Patient completed the study drug|8
5285760|NCT00615017|12994110|P1|COMPLETED|Overall Study|Patient completed the study drug|8
5285761|NCT00615017|12994105|P6|STARTED|Overall Study|Patients received treatment|23
5285762|NCT00615017|12994106|P5|STARTED|Overall Study|Patients received treatment|8
5285763|NCT00615017|12994107|P4|STARTED|Overall Study|Patients received treatment|10
5285764|NCT00615017|12994108|P3|STARTED|Overall Study|Patients received treatment|12
5285765|NCT00615017|12994109|P2|STARTED|Overall Study|Patients received treatment|9
5285766|NCT00615017|12994110|P1|STARTED|Overall Study|Patients received treatment|8
5285767|NCT00614991|12994268|P6|NOT COMPLETED|Overall Study||0
5285768|NCT00614991|12994269|P5|NOT COMPLETED|Overall Study||1
5285769|NCT00614991|12994270|P4|NOT COMPLETED|Overall Study||0
5285770|NCT00614991|12994271|P3|NOT COMPLETED|Overall Study||0
5285771|NCT00614991|12994272|P2|NOT COMPLETED|Overall Study||3
5285772|NCT00614991|12994273|P1|NOT COMPLETED|Overall Study||3
5285773|NCT00614991|12994268|P6|COMPLETED|Overall Study||6
5285774|NCT00614991|12994269|P5|COMPLETED|Overall Study||6
5285775|NCT00614991|12994270|P4|COMPLETED|Overall Study||7
5285776|NCT00614991|12994271|P3|COMPLETED|Overall Study||7
5285777|NCT00614991|12994272|P2|COMPLETED|Overall Study||6
5285778|NCT00614991|12994273|P1|COMPLETED|Overall Study||5
5285779|NCT00614991|12994268|P6|STARTED|Overall Study||6
5285780|NCT00614991|12994269|P5|STARTED|Overall Study||7
5285781|NCT00614991|12994270|P4|STARTED|Overall Study||7
5285782|NCT00614991|12994271|P3|STARTED|Overall Study||7
5285783|NCT00614991|12994272|P2|STARTED|Overall Study||9
5285784|NCT00614991|12994273|P1|STARTED|Overall Study||8
5285785|NCT00614939|12994307|P2|NOT COMPLETED|Overall Study||43
5285786|NCT00614939|12994308|P1|NOT COMPLETED|Overall Study||35
5285787|NCT00614939|12994307|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
5285788|NCT00614939|12994308|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
5285789|NCT00614939|12994307|P2|STARTED|Overall Study|Randomized and treated|85
5285790|NCT00614939|12994308|P1|STARTED|Overall Study|Randomized and treated|85
5285791|NCT00614926|12994342|P2|NOT COMPLETED|Overall Study||0
5285792|NCT00614926|12994343|P1|NOT COMPLETED|Overall Study||4
5285793|NCT00614926|12994342|P2|COMPLETED|Overall Study||7
5285794|NCT00614926|12994343|P1|COMPLETED|Overall Study||21
5285795|NCT00614926|12994342|P2|STARTED|Overall Study||7
5285796|NCT00614926|12994343|P1|STARTED|Overall Study||25
5285797|NCT00614913|12994351|P1|NOT COMPLETED|Overall Study||0
5285798|NCT00614913|12994351|P1|COMPLETED|Overall Study||76
5285799|NCT00614913|12994351|P1|STARTED|Overall Study||76
5285800|NCT00614874|12994356|P1|NOT COMPLETED|Overall Study||2
5285801|NCT00614874|12994356|P1|COMPLETED|Overall Study||14
5285802|NCT00614874|12994356|P1|STARTED|Overall Study||16
5285803|NCT00614822|12994363|P1|NOT COMPLETED|Overall Study||3
5285804|NCT00614822|12994363|P1|COMPLETED|Overall Study||47
5285805|NCT00614822|12994363|P1|STARTED|Overall Study||50
5285806|NCT00614744|12994372|P2|NOT COMPLETED|Overall Study||6
5285807|NCT00614744|12994373|P1|NOT COMPLETED|Overall Study||5
5285808|NCT00614744|12994372|P2|COMPLETED|Overall Study||79
5285809|NCT00614744|12994373|P1|COMPLETED|Overall Study||78
5285810|NCT00614744|12994372|P2|STARTED|Overall Study||85
5285811|NCT00614744|12994373|P1|STARTED|Overall Study||83
5285812|NCT00614614|12994399|P5|NOT COMPLETED|Booster Vaccination Phase||13
5285813|NCT00614614|12994400|P4|NOT COMPLETED|Booster Vaccination Phase||19
5285814|NCT00614614|12994401|P3|NOT COMPLETED|Booster Vaccination Phase||27
5285815|NCT00614614|12994402|P2|NOT COMPLETED|Booster Vaccination Phase||6
5285816|NCT00614614|12994403|P1|NOT COMPLETED|Booster Vaccination Phase||0
5285817|NCT00614614|12994399|P5|COMPLETED|Booster Vaccination Phase||396
5285818|NCT00614614|12994400|P4|COMPLETED|Booster Vaccination Phase||210
5285819|NCT00614614|12994401|P3|COMPLETED|Booster Vaccination Phase||405
5285820|NCT00614614|12994402|P2|COMPLETED|Booster Vaccination Phase||227
5285821|NCT00614614|12994403|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
5285822|NCT00614614|12994399|P5|STARTED|Booster Vaccination Phase||409
5285823|NCT00614614|12994400|P4|STARTED|Booster Vaccination Phase||229
5285824|NCT00614614|12994401|P3|STARTED|Booster Vaccination Phase||432
5285825|NCT00614614|12994402|P2|STARTED|Booster Vaccination Phase||233
5285826|NCT00614614|12994403|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
5285827|NCT00614614|12994399|P5|NOT COMPLETED|Primary Vaccination Phase||0
5285828|NCT00614614|12994400|P4|NOT COMPLETED|Primary Vaccination Phase||0
5285829|NCT00614614|12994401|P3|NOT COMPLETED|Primary Vaccination Phase||0
5285830|NCT00614614|12994402|P2|NOT COMPLETED|Primary Vaccination Phase||17
5285831|NCT00614614|12994403|P1|NOT COMPLETED|Primary Vaccination Phase||90
5285832|NCT00614614|12994399|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285833|NCT00614614|12994400|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285834|NCT00614614|12994401|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285835|NCT00614614|12994402|P2|COMPLETED|Primary Vaccination Phase||265
5285836|NCT00614614|12994403|P1|COMPLETED|Primary Vaccination Phase||1182
5285837|NCT00614614|12994399|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285838|NCT00614614|12994400|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285839|NCT00614614|12994401|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
5285840|NCT00614614|12994402|P2|STARTED|Primary Vaccination Phase||282
5285841|NCT00614614|12994403|P1|STARTED|Primary Vaccination Phase||1272
5285842|NCT00614575|12994526|P1|NOT COMPLETED|Overall Study||228
5285843|NCT00614575|12994526|P1|COMPLETED|Overall Study||861
5285844|NCT00614575|12994526|P1|STARTED|Overall Study|The number of patients enrolled.|1089
5285845|NCT00614523|12994537|P2|NOT COMPLETED|Overall Study||131
5285846|NCT00614523|12994538|P1|NOT COMPLETED|Overall Study||63
5285847|NCT00614523|12994537|P2|COMPLETED|Overall Study||36
5285848|NCT00614523|12994538|P1|COMPLETED|Overall Study||20
5285849|NCT00614523|12994537|P2|STARTED|Overall Study||167
5285850|NCT00614523|12994538|P1|STARTED|Overall Study||83
5285851|NCT00614484|12994562|P1|NOT COMPLETED|Overall Study||0
5285852|NCT00614484|12994562|P1|COMPLETED|Overall Study||28
5285853|NCT00614484|12994562|P1|STARTED|Overall Study||28
5285854|NCT00614458|12994567|P1|NOT COMPLETED|Overall Study||0
5285855|NCT00614458|12994567|P1|COMPLETED|Overall Study||6
5285856|NCT00614458|12994567|P1|STARTED|Overall Study||6
5285857|NCT00614445|12994573|P2|NOT COMPLETED|Overall Study||49
5285858|NCT00614445|12994574|P1|NOT COMPLETED|Overall Study||28
5285859|NCT00614445|12994573|P2|COMPLETED|Overall Study||91
5285860|NCT00614445|12994574|P1|COMPLETED|Overall Study||112
5285861|NCT00614445|12994573|P2|STARTED|Overall Study||140
5285862|NCT00614445|12994574|P1|STARTED|Overall Study||140
5285863|NCT00614432|12994582|P2|NOT COMPLETED|Overall Study||0
5285864|NCT00614432|12994583|P1|NOT COMPLETED|Overall Study||0
5285865|NCT00614432|12994582|P2|COMPLETED|Overall Study||6
5285866|NCT00614432|12994583|P1|COMPLETED|Overall Study||4
5285867|NCT00614432|12994582|P2|STARTED|Overall Study||6
5285868|NCT00614432|12994583|P1|STARTED|Overall Study||4
5285869|NCT00614406|12994591|P2|NOT COMPLETED|Overall Study||0
5285870|NCT00614406|12994592|P1|NOT COMPLETED|Overall Study||0
5285871|NCT00614406|12994591|P2|COMPLETED|Overall Study||4
5285872|NCT00614406|12994592|P1|COMPLETED|Overall Study||7
5285873|NCT00614406|12994591|P2|STARTED|Overall Study||4
5285874|NCT00614406|12994592|P1|STARTED|Overall Study||7
5285875|NCT00614393|12994603|P5|NOT COMPLETED|Overall Study||180
5285876|NCT00614393|12994604|P4|NOT COMPLETED|Overall Study||180
5285877|NCT00614393|12994605|P3|NOT COMPLETED|Overall Study||10
5285878|NCT00614393|12994606|P2|NOT COMPLETED|Overall Study||8
5285879|NCT00614393|12994607|P1|NOT COMPLETED|Overall Study||180
5285880|NCT00614393|12994603|P5|COMPLETED|Overall Study||0
5285881|NCT00614393|12994604|P4|COMPLETED|Overall Study||0
5285882|NCT00614393|12994605|P3|COMPLETED|Overall Study||0
5285883|NCT00614393|12994606|P2|COMPLETED|Overall Study||0
5285884|NCT00614393|12994607|P1|COMPLETED|Overall Study||0
5285885|NCT00614393|12994603|P5|Treated|Overall Study||178
5285886|NCT00614393|12994604|P4|Treated|Overall Study||180
5285887|NCT00614393|12994605|P3|Treated|Overall Study||10
5285888|NCT00614393|12994606|P2|Treated|Overall Study||8
5285889|NCT00614393|12994607|P1|Treated|Overall Study||180
5285890|NCT00614393|12994603|P5|STARTED|Overall Study||180
5285891|NCT00614393|12994604|P4|STARTED|Overall Study||180
5285892|NCT00614393|12994605|P3|STARTED|Overall Study||10
5285893|NCT00614393|12994606|P2|STARTED|Overall Study||8
5285894|NCT00614393|12994607|P1|STARTED|Overall Study||180
5285895|NCT00614380|12994653|P4|NOT COMPLETED|Overall Study||2
5285896|NCT00614380|12994654|P3|NOT COMPLETED|Overall Study||1
5285897|NCT00614380|12994655|P2|NOT COMPLETED|Overall Study||8
5285898|NCT00614380|12994656|P1|NOT COMPLETED|Overall Study||35
5285899|NCT00614380|12994653|P4|COMPLETED|Overall Study||179
5285900|NCT00614380|12994654|P3|COMPLETED|Overall Study||24
5285901|NCT00614380|12994655|P2|COMPLETED|Overall Study||198
5285902|NCT00614380|12994656|P1|COMPLETED|Overall Study||529
5285903|NCT00614380|12994653|P4|STARTED|Overall Study||181
5285904|NCT00614380|12994654|P3|STARTED|Overall Study||25
5285905|NCT00614380|12994655|P2|STARTED|Overall Study||206
5285906|NCT00614380|12994656|P1|STARTED|Overall Study||564
5285907|NCT00614315|12994705|P1|NOT COMPLETED|Overall Study||0
5285908|NCT00614315|12994705|P1|COMPLETED|Overall Study||30
5285909|NCT00614315|12994705|P1|STARTED|Overall Study||30
5285910|NCT00614198|12994712|P2|NOT COMPLETED|Stage 2||12
5285911|NCT00614198|12994713|P1|NOT COMPLETED|Stage 2||8
5285912|NCT00614198|12994712|P2|COMPLETED|Stage 2||17
5285913|NCT00614198|12994713|P1|COMPLETED|Stage 2||18
5285914|NCT00614198|12994712|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
5285915|NCT00614198|12994713|P1|STARTED|Stage 2||26
5285916|NCT00614198|12994712|P2|NOT COMPLETED|Stage 1||5
5285917|NCT00614198|12994713|P1|NOT COMPLETED|Stage 1||12
5285918|NCT00614198|12994712|P2|COMPLETED|Stage 1||29
5285919|NCT00614198|12994713|P1|COMPLETED|Stage 1||26
5285920|NCT00614198|12994712|P2|STARTED|Stage 1||34
5285921|NCT00614198|12994713|P1|STARTED|Stage 1||38
5285922|NCT00614120|12994723|P4|NOT COMPLETED|Overall Study||16
5285923|NCT00614120|12994724|P3|NOT COMPLETED|Overall Study||59
5285924|NCT00614120|12994725|P2|NOT COMPLETED|Overall Study||46
5285925|NCT00614120|12994726|P1|NOT COMPLETED|Overall Study||29
5285926|NCT00614120|12994723|P4|COMPLETED|Overall Study||215
5285927|NCT00614120|12994724|P3|COMPLETED|Overall Study||175
5285928|NCT00614120|12994725|P2|COMPLETED|Overall Study||187
5285929|NCT00614120|12994726|P1|COMPLETED|Overall Study||202
5285930|NCT00614120|12994723|P4|Exposed to Study Drug|Overall Study||231
5285931|NCT00614120|12994724|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
5285932|NCT00614120|12994725|P2|Exposed to Study Drug|Overall Study||233
5285933|NCT00614120|12994726|P1|Exposed to Study Drug|Overall Study||231
5285934|NCT00614120|12994723|P4|STARTED|Overall Study|Randomised|231
5285935|NCT00614120|12994724|P3|STARTED|Overall Study|Randomised|234
5285936|NCT00614120|12994725|P2|STARTED|Overall Study|Randomised|233
5285937|NCT00614120|12994726|P1|STARTED|Overall Study|Randomised|231
5285938|NCT00614055|12994767|P3|NOT COMPLETED|Overall Study||5
5285939|NCT00614055|12994768|P2|NOT COMPLETED|Overall Study||6
5285940|NCT00614055|12994769|P1|NOT COMPLETED|Overall Study||4
5285941|NCT00614055|12994767|P3|COMPLETED|Overall Study||55
5285942|NCT00614055|12994768|P2|COMPLETED|Overall Study||53
5285943|NCT00614055|12994769|P1|COMPLETED|Overall Study||55
5285944|NCT00614055|12994767|P3|Exposed|Overall Study||60
5285945|NCT00614055|12994768|P2|Exposed|Overall Study||59
5285946|NCT00614055|12994769|P1|Exposed|Overall Study||59
5285947|NCT00614055|12994767|P3|STARTED|Overall Study||60
5285948|NCT00614055|12994768|P2|STARTED|Overall Study||59
5285949|NCT00614055|12994769|P1|STARTED|Overall Study||59
5285950|NCT00613951|12994816|P3|NOT COMPLETED|Overall Study||5
5285951|NCT00613951|12994817|P2|NOT COMPLETED|Overall Study||5
5285952|NCT00613951|12994818|P1|NOT COMPLETED|Overall Study||7
5285953|NCT00613951|12994816|P3|COMPLETED|Overall Study||57
5285954|NCT00613951|12994817|P2|COMPLETED|Overall Study||54
5285955|NCT00613951|12994818|P1|COMPLETED|Overall Study||54
5285956|NCT00613951|12994816|P3|Exposed|Overall Study||62
5285957|NCT00613951|12994817|P2|Exposed|Overall Study||59
5285958|NCT00613951|12994818|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
5285959|NCT00613951|12994816|P3|STARTED|Overall Study||62
5285960|NCT00613951|12994817|P2|STARTED|Overall Study||59
5285961|NCT00613951|12994818|P1|STARTED|Overall Study||61
5285962|NCT00613938|12994863|P4|NOT COMPLETED|Overall Study||26
5285963|NCT00613938|12994864|P3|NOT COMPLETED|Overall Study||23
5285964|NCT00613938|12994865|P2|NOT COMPLETED|Overall Study||28
5285965|NCT00613938|12994866|P1|NOT COMPLETED|Overall Study||20
5285966|NCT00613938|12994863|P4|COMPLETED|Overall Study||253
5285967|NCT00613938|12994864|P3|COMPLETED|Overall Study||255
5285968|NCT00613938|12994865|P2|COMPLETED|Overall Study||247
5285969|NCT00613938|12994866|P1|COMPLETED|Overall Study||49
5285970|NCT00613938|12994863|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
5285971|NCT00613938|12994864|P3|STARTED|Overall Study||278
5285972|NCT00613938|12994865|P2|STARTED|Overall Study||275
5285973|NCT00613938|12994866|P1|STARTED|Overall Study||69
5285974|NCT00613925|12994898|P2|NOT COMPLETED|Overall Study||1
5285975|NCT00613925|12994899|P1|NOT COMPLETED|Overall Study||0
5285976|NCT00613925|12994898|P2|COMPLETED|Overall Study||32
5285977|NCT00613925|12994899|P1|COMPLETED|Overall Study||37
5285978|NCT00613925|12994898|P2|STARTED|Overall Study||33
5285979|NCT00613925|12994899|P1|STARTED|Overall Study||37
5285980|NCT00613834|12994909|P2|NOT COMPLETED|Overall Study||3
5285981|NCT00613834|12994910|P1|NOT COMPLETED|Overall Study||0
5285982|NCT00613834|12994909|P2|COMPLETED|Overall Study||26
5285983|NCT00613834|12994910|P1|COMPLETED|Overall Study||29
5285984|NCT00613834|12994909|P2|STARTED|Overall Study||29
5285985|NCT00613834|12994910|P1|STARTED|Overall Study||29
5285986|NCT00613821|12994922|P2|NOT COMPLETED|Overall Study||1
5285987|NCT00613821|12994923|P1|NOT COMPLETED|Overall Study||2
5285988|NCT00613821|12994922|P2|COMPLETED|Overall Study||39
5285989|NCT00613821|12994923|P1|COMPLETED|Overall Study||38
5285990|NCT00613821|12994922|P2|STARTED|Overall Study||40
5285991|NCT00613821|12994923|P1|STARTED|Overall Study||40
5285992|NCT00613730|12994929|P1|NOT COMPLETED|Overall Study||3
5285993|NCT00613730|12994929|P1|COMPLETED|Overall Study||0
5285994|NCT00613730|12994929|P1|STARTED|Overall Study||3
5285995|NCT00613626|12994938|P3|NOT COMPLETED|Overall Study||0
5285996|NCT00613626|12994939|P2|NOT COMPLETED|Overall Study||1
5285997|NCT00613626|12994940|P1|NOT COMPLETED|Overall Study||0
5285998|NCT00613626|12994938|P3|COMPLETED|Overall Study||7
5285999|NCT00613626|12994939|P2|COMPLETED|Overall Study||33
5286000|NCT00613626|12994940|P1|COMPLETED|Overall Study||33
5286001|NCT00613626|12994938|P3|1st Dose ZD6474|Overall Study||7
5286002|NCT00613626|12994939|P2|1st Dose ZD6474|Overall Study||34
5286003|NCT00613626|12994940|P1|1st Dose ZD6474|Overall Study||33
5286004|NCT00613626|12994938|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
5286005|NCT00613626|12994939|P2|STARTED|Overall Study||34
5286006|NCT00613626|12994940|P1|STARTED|Overall Study||33
5286007|NCT00613574|12994956|P1|NOT COMPLETED|Overall Study||6
5286008|NCT00613574|12994956|P1|COMPLETED|Overall Study||401
5286009|NCT00613574|12994956|P1|STARTED|Overall Study||407
5286010|NCT00613509|12994968|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
5286011|NCT00613509|12994969|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
5286012|NCT00613509|12994968|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
5286013|NCT00613509|12994969|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
5286014|NCT00613509|12994968|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
5286015|NCT00613509|12994969|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
5286016|NCT00613509|12994968|P2|NOT COMPLETED|Cycle 1||8
5286017|NCT00613509|12994969|P1|NOT COMPLETED|Cycle 1||5
5286018|NCT00613509|12994968|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
5286019|NCT00613509|12994969|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
5286020|NCT00613509|12994968|P2|STARTED|Cycle 1||12
5286021|NCT00613509|12994969|P1|STARTED|Cycle 1||11
5286022|NCT00613405|12994993|P2|NOT COMPLETED|Overall Study||0
5286023|NCT00613405|12994994|P1|NOT COMPLETED|Overall Study||0
5286024|NCT00613405|12994993|P2|COMPLETED|Overall Study||42
5286025|NCT00613405|12994994|P1|COMPLETED|Overall Study||45
5286026|NCT00613405|12994993|P2|STARTED|Overall Study||42
5286027|NCT00613405|12994994|P1|STARTED|Overall Study||45
5286028|NCT00613379|12995003|P3|NOT COMPLETED|Overall Study||0
5286029|NCT00613379|12995004|P2|NOT COMPLETED|Overall Study||0
5286030|NCT00613379|12995005|P1|NOT COMPLETED|Overall Study||0
5286031|NCT00613379|12995003|P3|COMPLETED|Overall Study||11
5286032|NCT00613379|12995004|P2|COMPLETED|Overall Study||10
5286033|NCT00613379|12995005|P1|COMPLETED|Overall Study||10
5286034|NCT00613379|12995003|P3|STARTED|Overall Study||11
5286035|NCT00613379|12995004|P2|STARTED|Overall Study||10
5286036|NCT00613379|12995005|P1|STARTED|Overall Study||10
5286037|NCT00613366|12995015|P2|NOT COMPLETED|Overall Study||2
5286038|NCT00613366|12995016|P1|NOT COMPLETED|Overall Study||3
5286039|NCT00613366|12995015|P2|COMPLETED|Overall Study||18
5286040|NCT00613366|12995016|P1|COMPLETED|Overall Study||17
5286041|NCT00613366|12995015|P2|STARTED|Overall Study||20
5286042|NCT00613366|12995016|P1|STARTED|Overall Study||20
5286043|NCT00613327|12995024|P1|NOT COMPLETED|Overall Study||101
5286044|NCT00613327|12995024|P1|COMPLETED|Overall Study||244
5286045|NCT00613327|12995024|P1|STARTED|Overall Study||345
5286046|NCT00613314|12995043|P1|NOT COMPLETED|Overall Study||155
5286047|NCT00613314|12995043|P1|COMPLETED|Overall Study||15113
5286048|NCT00613314|12995043|P1|STARTED|Overall Study||15268
5286049|NCT00613301|12995051|P1|NOT COMPLETED|Overall Study||228
5286050|NCT00613301|12995051|P1|COMPLETED|Overall Study||188
5286051|NCT00613301|12995051|P1|STARTED|Overall Study||416
5286052|NCT00613106|12995060|P2|NOT COMPLETED|Overall Study||9
5286053|NCT00613106|12995061|P1|NOT COMPLETED|Overall Study||20
5286054|NCT00613106|12995060|P2|COMPLETED|Overall Study||38
5286055|NCT00613106|12995061|P1|COMPLETED|Overall Study||112
5286056|NCT00613106|12995060|P2|STARTED|Overall Study||47
5286057|NCT00613106|12995061|P1|STARTED|Overall Study||132
5286058|NCT00613080|12995067|P1|NOT COMPLETED|Overall Study||11
5286059|NCT00613080|12995067|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
5286060|NCT00613080|12995067|P1|STARTED|Overall Study||79
5286061|NCT00613028|12995081|P2|NOT COMPLETED|Overall Study||1
5286062|NCT00613028|12995082|P1|NOT COMPLETED|Overall Study||0
5286063|NCT00613028|12995081|P2|COMPLETED|Overall Study||12
5286064|NCT00613028|12995082|P1|COMPLETED|Overall Study||10
5286065|NCT00613028|12995081|P2|STARTED|Overall Study||13
5286066|NCT00613028|12995082|P1|STARTED|Overall Study||10
5286067|NCT00613015|12995102|P6|NOT COMPLETED|Overall Study||3
5286068|NCT00613015|12995103|P5|NOT COMPLETED|Overall Study||2
5286069|NCT00613015|12995104|P4|NOT COMPLETED|Overall Study||3
5286070|NCT00613015|12995105|P3|NOT COMPLETED|Overall Study||3
5286071|NCT00613015|12995106|P2|NOT COMPLETED|Overall Study||1
5286072|NCT00613015|12995107|P1|NOT COMPLETED|Overall Study||0
5286073|NCT00613015|12995102|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
5286074|NCT00613015|12995103|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
5286075|NCT00613015|12995104|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
5286076|NCT00613015|12995105|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
5286077|NCT00613015|12995106|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
5286078|NCT00613015|12995107|P1|COMPLETED|Overall Study||13
5286079|NCT00613015|12995102|P6|STARTED|Overall Study||19
5286080|NCT00613015|12995103|P5|STARTED|Overall Study||15
5286081|NCT00613015|12995104|P4|STARTED|Overall Study||24
5286082|NCT00613015|12995105|P3|STARTED|Overall Study||26
5286083|NCT00613015|12995106|P2|STARTED|Overall Study||12
5286084|NCT00613015|12995107|P1|STARTED|Overall Study||13
5286085|NCT00612924|12995129|P2|NOT COMPLETED|Overall Study||9
5286086|NCT00612924|12995130|P1|NOT COMPLETED|Overall Study||7
5286087|NCT00612924|12995129|P2|COMPLETED|Overall Study||85
5286088|NCT00612924|12995130|P1|COMPLETED|Overall Study||94
5286089|NCT00612924|12995129|P2|STARTED|Overall Study||94
5286090|NCT00612924|12995130|P1|STARTED|Overall Study||101
5286091|NCT00612807|12995143|P2|NOT COMPLETED|Overall Study||0
5286092|NCT00612807|12995144|P1|NOT COMPLETED|Overall Study||2
5286093|NCT00612807|12995143|P2|COMPLETED|Overall Study||28
5286094|NCT00612807|12995144|P1|COMPLETED|Overall Study||12
5286095|NCT00612807|12995143|P2|STARTED|Overall Study||28
5286096|NCT00612807|12995144|P1|STARTED|Overall Study||14
5286097|NCT00612768|12995152|P1|NOT COMPLETED|Overall Study||0
5286098|NCT00612768|12995152|P1|COMPLETED|Overall Study||50
5286099|NCT00612768|12995152|P1|STARTED|Overall Study||50
5286100|NCT00612690|12995179|P2|NOT COMPLETED|Overall Study||118
5286101|NCT00612690|12995180|P1|NOT COMPLETED|Overall Study||115
5286102|NCT00612690|12995179|P2|COMPLETED|Overall Study||89
5286103|NCT00612690|12995180|P1|COMPLETED|Overall Study||160
5286104|NCT00612690|12995179|P2|STARTED|Overall Study||207
5286105|NCT00612690|12995180|P1|STARTED|Overall Study||275
5286106|NCT00612677|12995188|P1|NOT COMPLETED|Overall Study||1
5286107|NCT00612677|12995188|P1|COMPLETED|Overall Study||0
5286108|NCT00612677|12995188|P1|STARTED|Overall Study||1
5286109|NCT00612586|12995196|P2|NOT COMPLETED|Overall Study||41
5286110|NCT00612586|12995197|P1|NOT COMPLETED|Overall Study||43
5286111|NCT00612586|12995196|P2|COMPLETED|Overall Study||18
5286112|NCT00612586|12995197|P1|COMPLETED|Overall Study||15
5286113|NCT00612586|12995196|P2|Received at Least 1 Dose|Overall Study||58
5286114|NCT00612586|12995197|P1|Received at Least 1 Dose|Overall Study||57
5286115|NCT00612586|12995196|P2|STARTED|Overall Study||59
5286116|NCT00612586|12995197|P1|STARTED|Overall Study||58
5286117|NCT00612573|12995215|P4|NOT COMPLETED|Overall Study||13
5286118|NCT00612573|12995216|P3|NOT COMPLETED|Overall Study||9
5286119|NCT00612573|12995217|P2|NOT COMPLETED|Overall Study||14
5286120|NCT00612573|12995218|P1|NOT COMPLETED|Overall Study||12
5286121|NCT00612573|12995215|P4|COMPLETED|Overall Study||54
5286122|NCT00612573|12995216|P3|COMPLETED|Overall Study||52
5286123|NCT00612573|12995217|P2|COMPLETED|Overall Study||51
5286124|NCT00612573|12995218|P1|COMPLETED|Overall Study||52
5286125|NCT00612573|12995215|P4|STARTED|Overall Study||67
5286126|NCT00612573|12995216|P3|STARTED|Overall Study||61
5286127|NCT00612573|12995217|P2|STARTED|Overall Study||65
5286128|NCT00612573|12995218|P1|STARTED|Overall Study||64
5286129|NCT00612560|12995244|P4|NOT COMPLETED|Overall Study||0
5286130|NCT00612560|12995245|P3|NOT COMPLETED|Overall Study||0
5286131|NCT00612560|12995246|P2|NOT COMPLETED|Overall Study||0
5286132|NCT00612560|12995247|P1|NOT COMPLETED|Overall Study||0
5286133|NCT00612560|12995244|P4|COMPLETED|Overall Study||6
5286134|NCT00612560|12995245|P3|COMPLETED|Overall Study||8
5286135|NCT00612560|12995246|P2|COMPLETED|Overall Study||7
5286136|NCT00612560|12995247|P1|COMPLETED|Overall Study||7
5286137|NCT00612560|12995244|P4|STARTED|Overall Study||6
5286138|NCT00612560|12995245|P3|STARTED|Overall Study||8
5286139|NCT00612560|12995246|P2|STARTED|Overall Study||7
5286140|NCT00612560|12995247|P1|STARTED|Overall Study||7
5286141|NCT00612534|12995273|P4|NOT COMPLETED|Overall Study||17
5286142|NCT00612534|12995274|P3|NOT COMPLETED|Overall Study||7
5286143|NCT00612534|12995275|P2|NOT COMPLETED|Overall Study||17
5286144|NCT00612534|12995276|P1|NOT COMPLETED|Overall Study||13
5286145|NCT00612534|12995273|P4|COMPLETED|Overall Study||7
5286146|NCT00612534|12995274|P3|COMPLETED|Overall Study||13
5286147|NCT00612534|12995275|P2|COMPLETED|Overall Study||9
5286148|NCT00612534|12995276|P1|COMPLETED|Overall Study||11
5286149|NCT00612534|12995273|P4|STARTED|Overall Study||24
5286150|NCT00612534|12995274|P3|STARTED|Overall Study||20
5286151|NCT00612534|12995275|P2|STARTED|Overall Study||26
5286152|NCT00612534|12995276|P1|STARTED|Overall Study||24
5286153|NCT00612508|12995288|P2|NOT COMPLETED|Overall Study||4
5286154|NCT00612508|12995289|P1|NOT COMPLETED|Overall Study||3
5286155|NCT00612508|12995288|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
5286156|NCT00612508|12995289|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
5286157|NCT00612508|12995288|P2|STARTED|Overall Study||7
5286158|NCT00612508|12995289|P1|STARTED|Overall Study||7
5286159|NCT00612456|12995300|P3|NOT COMPLETED|Overall Study||0
5286160|NCT00612456|12995301|P2|NOT COMPLETED|Overall Study||2
5286161|NCT00612456|12995302|P1|NOT COMPLETED|Overall Study||2
5286162|NCT00612456|12995300|P3|COMPLETED|Overall Study||16
5286163|NCT00612456|12995301|P2|COMPLETED|Overall Study||25
5286164|NCT00612456|12995302|P1|COMPLETED|Overall Study||25
5286165|NCT00612456|12995300|P3|STARTED|Overall Study||16
5286166|NCT00612456|12995301|P2|STARTED|Overall Study||27
5286167|NCT00612456|12995302|P1|STARTED|Overall Study||27
5286168|NCT00612430|12995348|P2|NOT COMPLETED|Overall Study||0
5286169|NCT00612430|12995349|P1|NOT COMPLETED|Overall Study||0
5286170|NCT00612430|12995348|P2|COMPLETED|Overall Study||27
5286171|NCT00612430|12995349|P1|COMPLETED|Overall Study||32
5286172|NCT00612430|12995348|P2|STARTED|Overall Study||27
5286173|NCT00612430|12995349|P1|STARTED|Overall Study||32
5286174|NCT00612352|12995365|P2|NOT COMPLETED|Overall Study||6
5286175|NCT00612352|12995366|P1|NOT COMPLETED|Overall Study||9
5286176|NCT00612352|12995365|P2|COMPLETED|Overall Study||109
5286177|NCT00612352|12995366|P1|COMPLETED|Overall Study||56
5286178|NCT00612352|12995365|P2|Placebo|Overall Study||4
5286179|NCT00612352|12995366|P1|Placebo|Overall Study||4
5286180|NCT00612352|12995365|P2|40%mg|Overall Study||0
5286181|NCT00612352|12995366|P1|40%mg|Overall Study||1
5286182|NCT00612352|12995365|P2|100%mg|Overall Study||1
5286183|NCT00612352|12995366|P1|100%mg|Overall Study||2
5286184|NCT00612352|12995365|P2|Placebo & 100%mg|Overall Study||0
5286185|NCT00612352|12995366|P1|Placebo & 100%mg|Overall Study||1
5286186|NCT00612352|12995365|P2|40%mg & 100%mg|Overall Study||1
5286187|NCT00612352|12995366|P1|40%mg & 100%mg|Overall Study||1
5286188|NCT00612352|12995365|P2|STARTED|Overall Study||115
5286189|NCT00612352|12995366|P1|STARTED|Overall Study||65
5286190|NCT00612339|12995480|P1|NOT COMPLETED|Overall Study||0
5286191|NCT00612339|12995480|P1|COMPLETED|Overall Study||41
5286192|NCT00612339|12995480|P1|STARTED|Overall Study||41
5286193|NCT00612313|12995486|P2|NOT COMPLETED|Overall Study||13
5286194|NCT00612313|12995487|P1|NOT COMPLETED|Overall Study||17
5286195|NCT00612313|12995486|P2|COMPLETED|Overall Study||62
5286196|NCT00612313|12995487|P1|COMPLETED|Overall Study||52
5286197|NCT00612313|12995486|P2|STARTED|Overall Study||75
5286198|NCT00612313|12995487|P1|STARTED|Overall Study||69
5286199|NCT00612235|12995507|P4|NOT COMPLETED|Overall Study||0
5286200|NCT00612235|12995508|P3|NOT COMPLETED|Overall Study||0
5286201|NCT00612235|12995509|P2|NOT COMPLETED|Overall Study||0
5286202|NCT00612235|12995510|P1|NOT COMPLETED|Overall Study||0
5286203|NCT00612235|12995507|P4|COMPLETED|Overall Study||20
5286204|NCT00612235|12995508|P3|COMPLETED|Overall Study||20
5286205|NCT00612235|12995509|P2|COMPLETED|Overall Study||20
5286206|NCT00612235|12995510|P1|COMPLETED|Overall Study||20
5286207|NCT00612235|12995507|P4|STARTED|Overall Study||20
5286208|NCT00612235|12995508|P3|STARTED|Overall Study||20
5286209|NCT00612235|12995509|P2|STARTED|Overall Study||20
5286210|NCT00612235|12995510|P1|STARTED|Overall Study||20
5286211|NCT00612222|12995521|P1|NOT COMPLETED|Overall Study||0
5286212|NCT00612222|12995521|P1|COMPLETED|Overall Study||4
5286213|NCT00612222|12995521|P1|STARTED|Overall Study||4
5286214|NCT00612105|12995529|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
5286215|NCT00612105|12995530|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
5286216|NCT00612105|12995529|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
5286217|NCT00612105|12995530|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
5286218|NCT00612105|12995529|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
5286219|NCT00612105|12995530|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
5286220|NCT00612105|12995529|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
5286221|NCT00612105|12995530|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
5286222|NCT00612105|12995529|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
5286223|NCT00612105|12995530|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
5286224|NCT00612105|12995529|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
5286225|NCT00612105|12995530|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
5286226|NCT00612105|12995529|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
5286227|NCT00612105|12995530|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
5286228|NCT00612105|12995529|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
5286229|NCT00612105|12995530|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
5286230|NCT00612105|12995529|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
5286231|NCT00612105|12995530|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
5286232|NCT00612066|12995580|P1|NOT COMPLETED|Overall Study||1
5286233|NCT00612066|12995580|P1|COMPLETED|Overall Study||1
5286234|NCT00612066|12995580|P1|STARTED|Overall Study||2
5286235|NCT00612040|12995587|P3|NOT COMPLETED|Overall Study||7
5286236|NCT00612040|12995588|P2|NOT COMPLETED|Overall Study||7
5286237|NCT00612040|12995589|P1|NOT COMPLETED|Overall Study||5
5286238|NCT00612040|12995587|P3|COMPLETED|Overall Study||52
5286239|NCT00612040|12995588|P2|COMPLETED|Overall Study||52
5286240|NCT00612040|12995589|P1|COMPLETED|Overall Study||55
5286241|NCT00612040|12995587|P3|Exposed|Overall Study||59
5286242|NCT00612040|12995588|P2|Exposed|Overall Study||59
5286243|NCT00612040|12995589|P1|Exposed|Overall Study||60
5286244|NCT00612040|12995587|P3|STARTED|Overall Study||59
5286245|NCT00612040|12995588|P2|STARTED|Overall Study||59
5286246|NCT00612040|12995589|P1|STARTED|Overall Study||60
5286247|NCT00611923|12995635|P2|NOT COMPLETED|Overall Study||2
5286248|NCT00611923|12995636|P1|NOT COMPLETED|Overall Study||2
5286249|NCT00611923|12995635|P2|COMPLETED|Overall Study||11
5286250|NCT00611923|12995636|P1|COMPLETED|Overall Study||10
5286251|NCT00611923|12995635|P2|STARTED|Overall Study||13
5286252|NCT00611923|12995636|P1|STARTED|Overall Study||12
5286253|NCT00611897|12995652|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
5286254|NCT00611897|12995653|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
5286255|NCT00611897|12995652|P2|COMPLETED|Day 2: Crossover Treatment||8
5286256|NCT00611897|12995653|P1|COMPLETED|Day 2: Crossover Treatment||8
5286257|NCT00611897|12995652|P2|STARTED|Day 2: Crossover Treatment||8
5286258|NCT00611897|12995653|P1|STARTED|Day 2: Crossover Treatment||8
5286259|NCT00611897|12995652|P2|NOT COMPLETED|Day 1: Initial Treatment||0
5286260|NCT00611897|12995653|P1|NOT COMPLETED|Day 1: Initial Treatment||0
5286261|NCT00611897|12995652|P2|COMPLETED|Day 1: Initial Treatment||8
5286262|NCT00611897|12995653|P1|COMPLETED|Day 1: Initial Treatment||8
5286263|NCT00611897|12995652|P2|STARTED|Day 1: Initial Treatment||8
5286264|NCT00611897|12995653|P1|STARTED|Day 1: Initial Treatment||8
5286265|NCT00611884|12995681|P4|NOT COMPLETED|Overall Study||6
5286266|NCT00611884|12995682|P3|NOT COMPLETED|Overall Study||4
5286267|NCT00611884|12995683|P2|NOT COMPLETED|Overall Study||9
5286268|NCT00611884|12995684|P1|NOT COMPLETED|Overall Study||9
5286269|NCT00611884|12995681|P4|COMPLETED|Overall Study||56
5286270|NCT00611884|12995682|P3|COMPLETED|Overall Study||58
5286271|NCT00611884|12995683|P2|COMPLETED|Overall Study||51
5286272|NCT00611884|12995684|P1|COMPLETED|Overall Study||52
5286273|NCT00611884|12995681|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
5286274|NCT00611884|12995682|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
5286275|NCT00611884|12995683|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
5286276|NCT00611884|12995684|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
5286277|NCT00611884|12995681|P4|STARTED|Overall Study||62
5286278|NCT00611884|12995682|P3|STARTED|Overall Study||62
5286279|NCT00611884|12995683|P2|STARTED|Overall Study||60
5286280|NCT00611884|12995684|P1|STARTED|Overall Study||61
5286281|NCT00611858|12995738|P1|NOT COMPLETED|Overall Study||4
5286282|NCT00611858|12995738|P1|COMPLETED|Overall Study||9
5286283|NCT00611858|12995738|P1|STARTED|Overall Study||13
5286284|NCT00611806|12995750|P2|NOT COMPLETED|Overall Study||3
5286285|NCT00611806|12995751|P1|NOT COMPLETED|Overall Study||16
5286286|NCT00611806|12995750|P2|COMPLETED|Overall Study||43
5286287|NCT00611806|12995751|P1|COMPLETED|Overall Study||78
5286288|NCT00611806|12995750|P2|STARTED|Overall Study||46
5286289|NCT00611806|12995751|P1|STARTED|Overall Study||94
5286290|NCT00611767|12995765|P2|NOT COMPLETED|Overall Study||2
5286291|NCT00611767|12995766|P1|NOT COMPLETED|Overall Study||9
5286292|NCT00611767|12995765|P2|COMPLETED|Overall Study||22
5286293|NCT00611767|12995766|P1|COMPLETED|Overall Study||40
5286294|NCT00611767|12995765|P2|Placebo Test Day|Overall Study||1
5286295|NCT00611767|12995766|P1|Placebo Test Day|Overall Study||6
5286296|NCT00611767|12995765|P2|Thiopental Test Day|Overall Study||1
5286297|NCT00611767|12995766|P1|Thiopental Test Day|Overall Study||3
5286298|NCT00611767|12995765|P2|STARTED|Overall Study||24
5286299|NCT00611767|12995766|P1|STARTED|Overall Study||49
5286300|NCT00611715|12995928|P2|NOT COMPLETED|Overall Study||6
5286301|NCT00611715|12995929|P1|NOT COMPLETED|Overall Study||41
5286302|NCT00611715|12995928|P2|COMPLETED|Overall Study||0
5286303|NCT00611715|12995929|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
5286304|NCT00611715|12995928|P2|STARTED|Overall Study||6
5286305|NCT00611715|12995929|P1|STARTED|Overall Study||42
5286306|NCT00611624|12995941|P1|NOT COMPLETED|Overall Study||0
5286307|NCT00611624|12995941|P1|COMPLETED|Overall Study||28
5286308|NCT00611624|12995941|P1|STARTED|Overall Study||28
5286309|NCT00611559|12995949|P3|NOT COMPLETED|Overall Study||1
5286310|NCT00611559|12995950|P2|NOT COMPLETED|Overall Study||1
5286311|NCT00611559|12995951|P1|NOT COMPLETED|Overall Study||1
5286312|NCT00611559|12995949|P3|COMPLETED|Overall Study||56
5286313|NCT00611559|12995950|P2|COMPLETED|Overall Study||114
5286314|NCT00611559|12995951|P1|COMPLETED|Overall Study||110
5286315|NCT00611559|12995949|P3|STARTED|Overall Study||57
5286316|NCT00611559|12995950|P2|STARTED|Overall Study||115
5286317|NCT00611559|12995951|P1|STARTED|Overall Study||111
5286318|NCT00611533|12996010|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
5286319|NCT00611533|12996011|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5286320|NCT00611533|12996010|P2|COMPLETED|Second Intervention (6 Weeks)||4
5286321|NCT00611533|12996011|P1|COMPLETED|Second Intervention (6 Weeks)||8
5286322|NCT00611533|12996010|P2|STARTED|Second Intervention (6 Weeks)||6
5286323|NCT00611533|12996011|P1|STARTED|Second Intervention (6 Weeks)||8
5286324|NCT00611533|12996010|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
5286325|NCT00611533|12996011|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5286326|NCT00611533|12996010|P2|COMPLETED|First Intervention (6 Weeks)||6
5286327|NCT00611533|12996011|P1|COMPLETED|First Intervention (6 Weeks)||8
5286328|NCT00611533|12996010|P2|STARTED|First Intervention (6 Weeks)||8
5286329|NCT00611533|12996011|P1|STARTED|First Intervention (6 Weeks)||8
5286330|NCT00611468|12996030|P4|NOT COMPLETED|Overall Study||0
5286331|NCT00611468|12996031|P3|NOT COMPLETED|Overall Study||0
5286332|NCT00611468|12996032|P2|NOT COMPLETED|Overall Study||1
5286333|NCT00611468|12996033|P1|NOT COMPLETED|Overall Study||0
5286334|NCT00611468|12996030|P4|COMPLETED|Overall Study||13
5286335|NCT00611468|12996031|P3|COMPLETED|Overall Study||6
5286336|NCT00611468|12996032|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
5286337|NCT00611468|12996033|P1|COMPLETED|Overall Study||3
5286338|NCT00611468|12996030|P4|STARTED|Overall Study||13
5286339|NCT00611468|12996031|P3|STARTED|Overall Study||6
5286340|NCT00611468|12996032|P2|STARTED|Overall Study||7
5286341|NCT00611468|12996033|P1|STARTED|Overall Study||3
5286342|NCT00611455|12996045|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
5286343|NCT00611455|12996046|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
5286344|NCT00611455|12996047|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
5286345|NCT00611455|12996045|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
5286346|NCT00611455|12996046|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
5286347|NCT00611455|12996047|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
5286348|NCT00611455|12996045|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
5286349|NCT00611455|12996046|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
5286350|NCT00611455|12996047|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
5286351|NCT00611455|12996045|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
5286352|NCT00611455|12996046|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
5286353|NCT00611455|12996047|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
5286354|NCT00611455|12996045|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
5286355|NCT00611455|12996046|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
5286356|NCT00611455|12996047|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
5286357|NCT00611455|12996045|P3|STARTED|OL Treatment Period (120 Weeks)||0
5286358|NCT00611455|12996046|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
5286359|NCT00611455|12996047|P1|STARTED|OL Treatment Period (120 Weeks)||0
5286360|NCT00611455|12996045|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
5286361|NCT00611455|12996046|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
5286362|NCT00611455|12996047|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
5286363|NCT00611455|12996045|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
5286364|NCT00611455|12996046|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
5286365|NCT00611455|12996047|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
5286366|NCT00611455|12996045|P3|STARTED|DB Treatment Period (24 Weeks)||0
5286367|NCT00611455|12996046|P2|STARTED|DB Treatment Period (24 Weeks)||131
5286368|NCT00611455|12996047|P1|STARTED|DB Treatment Period (24 Weeks)||134
5286369|NCT00611442|12996175|P2|NOT COMPLETED|Overall Study||2
5286370|NCT00611442|12996176|P1|NOT COMPLETED|Overall Study||1
5286371|NCT00611442|12996175|P2|COMPLETED|Overall Study||94
5286372|NCT00611442|12996176|P1|COMPLETED|Overall Study||94
5286373|NCT00611442|12996175|P2|STARTED|Overall Study||96
5286374|NCT00611442|12996176|P1|STARTED|Overall Study||95
5286375|NCT00611403|12996190|P2|NOT COMPLETED|Post Treatment Extension Phase||1
5286376|NCT00611403|12996191|P1|NOT COMPLETED|Post Treatment Extension Phase||4
5286377|NCT00611403|12996190|P2|COMPLETED|Post Treatment Extension Phase||24
5286378|NCT00611403|12996191|P1|COMPLETED|Post Treatment Extension Phase||22
5286379|NCT00611403|12996190|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
5286380|NCT00611403|12996191|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
5286381|NCT00611403|12996190|P2|NOT COMPLETED|Treatment Phase||11
5286382|NCT00611403|12996191|P1|NOT COMPLETED|Treatment Phase||6
5286383|NCT00611403|12996190|P2|COMPLETED|Treatment Phase||58
5286384|NCT00611403|12996191|P1|COMPLETED|Treatment Phase||62
5286385|NCT00611403|12996190|P2|STARTED|Treatment Phase||69
5286386|NCT00611403|12996191|P1|STARTED|Treatment Phase||68
5286387|NCT00611351|12996201|P1|NOT COMPLETED|Overall Study||2
5286388|NCT00611351|12996201|P1|COMPLETED|Overall Study||3
5286389|NCT00611351|12996201|P1|STARTED|Overall Study||5
5286390|NCT00611325|12996210|P2|NOT COMPLETED|Overall Study||0
5286391|NCT00611325|12996211|P1|NOT COMPLETED|Overall Study||0
5286392|NCT00611325|12996210|P2|COMPLETED|Overall Study||28
5286393|NCT00611325|12996211|P1|COMPLETED|Overall Study||28
5286394|NCT00611325|12996210|P2|STARTED|Overall Study||28
5286395|NCT00611325|12996211|P1|STARTED|Overall Study||28
5286396|NCT00611247|12996227|P2|NOT COMPLETED|Overall Study||21
5286397|NCT00611247|12996228|P1|NOT COMPLETED|Overall Study||2
5286398|NCT00611247|12996227|P2|COMPLETED|Overall Study||10
5286399|NCT00611247|12996228|P1|COMPLETED|Overall Study||3
5286400|NCT00611247|12996227|P2|STARTED|Overall Study||31
5286401|NCT00611247|12996228|P1|STARTED|Overall Study||5
5286402|NCT00611130|12996240|P2|NOT COMPLETED|Overall Study||47
5286403|NCT00611130|12996241|P1|NOT COMPLETED|Overall Study||49
5286404|NCT00611130|12996240|P2|COMPLETED|Overall Study||47
5286405|NCT00611130|12996241|P1|COMPLETED|Overall Study||43
5286406|NCT00611130|12996240|P2|Completed 12 Week Treatment Phase|Overall Study||64
5286407|NCT00611130|12996241|P1|Completed 12 Week Treatment Phase|Overall Study||61
5286408|NCT00611130|12996240|P2|STARTED|Overall Study||94
5286409|NCT00611130|12996241|P1|STARTED|Overall Study||92
5286410|NCT00611026|12996251|P3|NOT COMPLETED|Double-blind Treatment Period||98
5286411|NCT00611026|12996252|P2|NOT COMPLETED|Double-blind Treatment Period||88
5286412|NCT00611026|12996253|P1|NOT COMPLETED|Double-blind Treatment Period||47
5286413|NCT00611026|12996251|P3|COMPLETED|Double-blind Treatment Period||862
5286414|NCT00611026|12996252|P2|COMPLETED|Double-blind Treatment Period||885
5286415|NCT00611026|12996253|P1|COMPLETED|Double-blind Treatment Period||431
5286416|NCT00611026|12996251|P3|STARTED|Double-blind Treatment Period||960
5286417|NCT00611026|12996252|P2|STARTED|Double-blind Treatment Period||973
5286418|NCT00611026|12996253|P1|STARTED|Double-blind Treatment Period||478
5286419|NCT00611026|12996251|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
5286420|NCT00611026|12996252|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
5286421|NCT00611026|12996253|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
5286422|NCT00611026|12996251|P3|COMPLETED|Randomized to Double-blind Treatment||960
5286423|NCT00611026|12996252|P2|COMPLETED|Randomized to Double-blind Treatment||973
5286424|NCT00611026|12996253|P1|COMPLETED|Randomized to Double-blind Treatment||478
5286425|NCT00611026|12996251|P3|STARTED|Randomized to Double-blind Treatment||963
5286426|NCT00611026|12996252|P2|STARTED|Randomized to Double-blind Treatment||974
5286427|NCT00611026|12996253|P1|STARTED|Randomized to Double-blind Treatment||480
5286428|NCT00610987|12996319|P2|NOT COMPLETED|Overall Study||0
5286429|NCT00610987|12996320|P1|NOT COMPLETED|Overall Study||0
5286430|NCT00610987|12996319|P2|COMPLETED|Overall Study||71
5286431|NCT00610987|12996320|P1|COMPLETED|Overall Study||75
5286432|NCT00610987|12996319|P2|STARTED|Overall Study||71
5286433|NCT00610987|12996320|P1|STARTED|Overall Study||75
5286434|NCT00610883|12996326|P1|NOT COMPLETED|Overall Study||0
5286435|NCT00610883|12996326|P1|COMPLETED|Overall Study||17
5286436|NCT00610883|12996326|P1|STARTED|Overall Study||17
5286437|NCT00610857|12996330|P1|NOT COMPLETED|Overall Study||2
5286438|NCT00610857|12996330|P1|COMPLETED|Overall Study||35
5286439|NCT00610857|12996330|P1|STARTED|Overall Study||37
5286440|NCT00610740|12996337|P1|NOT COMPLETED|Overall Study||0
5286441|NCT00610740|12996337|P1|COMPLETED|Overall Study||18
5286442|NCT00610740|12996337|P1|STARTED|Overall Study||18
5286443|NCT00610727|12996349|P6|NOT COMPLETED|Overall Study||0
5286444|NCT00610727|12996350|P5|NOT COMPLETED|Overall Study||0
5286445|NCT00610727|12996351|P4|NOT COMPLETED|Overall Study||0
5286446|NCT00610727|12996352|P3|NOT COMPLETED|Overall Study||0
5286447|NCT00610727|12996353|P2|NOT COMPLETED|Overall Study||0
5286448|NCT00610727|12996354|P1|NOT COMPLETED|Overall Study||0
5286449|NCT00610727|12996349|P6|COMPLETED|Overall Study||8
5286450|NCT00610727|12996350|P5|COMPLETED|Overall Study||8
5286451|NCT00610727|12996351|P4|COMPLETED|Overall Study||8
5286452|NCT00610727|12996352|P3|COMPLETED|Overall Study||8
5286453|NCT00610727|12996353|P2|COMPLETED|Overall Study||8
5286454|NCT00610727|12996354|P1|COMPLETED|Overall Study||14
5286455|NCT00610727|12996349|P6|STARTED|Overall Study||8
5286456|NCT00610727|12996350|P5|STARTED|Overall Study||8
5286457|NCT00610727|12996351|P4|STARTED|Overall Study||8
5286458|NCT00610727|12996352|P3|STARTED|Overall Study||8
5286459|NCT00610727|12996353|P2|STARTED|Overall Study||8
5286460|NCT00610727|12996354|P1|STARTED|Overall Study||14
5286461|NCT00610714|12996374|P2|NOT COMPLETED|Overall Study||24
5286462|NCT00610714|12996375|P1|NOT COMPLETED|Overall Study||26
5286463|NCT00610714|12996374|P2|COMPLETED|Overall Study||82
5286464|NCT00610714|12996375|P1|COMPLETED|Overall Study||79
5286465|NCT00610714|12996374|P2|STARTED|Overall Study||106
5286466|NCT00610714|12996375|P1|STARTED|Overall Study||105
5286467|NCT00610701|12996387|P2|NOT COMPLETED|Overall Study||11
5286468|NCT00610701|12996388|P1|NOT COMPLETED|Overall Study||10
5286469|NCT00610701|12996387|P2|COMPLETED|Overall Study||9
5286470|NCT00610701|12996388|P1|COMPLETED|Overall Study||5
5286471|NCT00610701|12996387|P2|STARTED|Overall Study||20
5286472|NCT00610701|12996388|P1|STARTED|Overall Study||15
5286473|NCT00610688|12996397|P3|NOT COMPLETED|Overall Study||8
5286474|NCT00610688|12996398|P2|NOT COMPLETED|Overall Study||13
5286475|NCT00610688|12996399|P1|NOT COMPLETED|Overall Study||9
5286476|NCT00610688|12996397|P3|COMPLETED|Overall Study||55
5286477|NCT00610688|12996398|P2|COMPLETED|Overall Study||52
5286478|NCT00610688|12996399|P1|COMPLETED|Overall Study||55
5286479|NCT00610688|12996397|P3|STARTED|Overall Study||63
5286480|NCT00610688|12996398|P2|STARTED|Overall Study||65
5286481|NCT00610688|12996399|P1|STARTED|Overall Study||64
5286482|NCT00610675|12996413|P1|NOT COMPLETED|Overall Study||220
5286483|NCT00610675|12996413|P1|COMPLETED|Overall Study||126
5286484|NCT00610675|12996413|P1|Treated|Overall Study||342
5286485|NCT00610675|12996413|P1|STARTED|Overall Study||346
5286486|NCT00610649|12996435|P11|NOT COMPLETED|Overall Study||1
5286487|NCT00610649|12996436|P10|NOT COMPLETED|Overall Study||1
5286488|NCT00610649|12996437|P9|NOT COMPLETED|Overall Study||0
5286489|NCT00610649|12996438|P8|NOT COMPLETED|Overall Study||0
5286490|NCT00610649|12996439|P7|NOT COMPLETED|Overall Study||0
5286491|NCT00610649|12996440|P6|NOT COMPLETED|Overall Study||0
5286492|NCT00610649|12996441|P5|NOT COMPLETED|Overall Study||0
5286493|NCT00610649|12996442|P4|NOT COMPLETED|Overall Study||0
5286494|NCT00610649|12996443|P3|NOT COMPLETED|Overall Study||0
5286495|NCT00610649|12996444|P2|NOT COMPLETED|Overall Study||1
5286496|NCT00610649|12996445|P1|NOT COMPLETED|Overall Study||1
5286497|NCT00610649|12996435|P11|COMPLETED|Overall Study||9
5286498|NCT00610649|12996436|P10|COMPLETED|Overall Study||9
5286499|NCT00610649|12996437|P9|COMPLETED|Overall Study||10
5286500|NCT00610649|12996438|P8|COMPLETED|Overall Study||2
5286501|NCT00610649|12996439|P7|COMPLETED|Overall Study||4
5286502|NCT00610649|12996440|P6|COMPLETED|Overall Study||2
5286503|NCT00610649|12996441|P5|COMPLETED|Overall Study||4
5286504|NCT00610649|12996442|P4|COMPLETED|Overall Study||2
5286505|NCT00610649|12996443|P3|COMPLETED|Overall Study||4
5286506|NCT00610649|12996444|P2|COMPLETED|Overall Study||1
5286507|NCT00610649|12996445|P1|COMPLETED|Overall Study||3
5286508|NCT00610649|12996435|P11|STARTED|Overall Study||10
5286509|NCT00610649|12996436|P10|STARTED|Overall Study||10
5286510|NCT00610649|12996437|P9|STARTED|Overall Study||10
5286511|NCT00610649|12996438|P8|STARTED|Overall Study||2
5286512|NCT00610649|12996439|P7|STARTED|Overall Study||4
5286513|NCT00610649|12996440|P6|STARTED|Overall Study||2
5286514|NCT00610649|12996441|P5|STARTED|Overall Study||4
5286515|NCT00610649|12996442|P4|STARTED|Overall Study||2
5286516|NCT00610649|12996443|P3|STARTED|Overall Study||4
5286517|NCT00610649|12996444|P2|STARTED|Overall Study||2
5286518|NCT00610649|12996445|P1|STARTED|Overall Study||4
5286519|NCT00610558|12996502|P3|NOT COMPLETED|Overall Study||6
5286520|NCT00610558|12996503|P2|NOT COMPLETED|Overall Study||6
5286521|NCT00610558|12996504|P1|NOT COMPLETED|Overall Study||5
5286522|NCT00610558|12996502|P3|COMPLETED|Overall Study||14
5286523|NCT00610558|12996503|P2|COMPLETED|Overall Study||14
5286524|NCT00610558|12996504|P1|COMPLETED|Overall Study||15
5286525|NCT00610558|12996502|P3|STARTED|Overall Study||20
5286526|NCT00610558|12996503|P2|STARTED|Overall Study||20
5286527|NCT00610558|12996504|P1|STARTED|Overall Study||20
5286528|NCT00610532|12996512|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
5286529|NCT00610532|12996512|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
5286530|NCT00610532|12996512|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
5286531|NCT00610532|12996512|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
5286532|NCT00610532|12996512|P1|COMPLETED|Intravenous Phenytoin Alone||8
5286533|NCT00610532|12996512|P1|STARTED|Intravenous Phenytoin Alone||8
5286534|NCT00610467|12996520|P2|NOT COMPLETED|Overall Study||0
5286535|NCT00610467|12996521|P1|NOT COMPLETED|Overall Study||0
5286536|NCT00610467|12996520|P2|COMPLETED|Overall Study||1
5286537|NCT00610467|12996521|P1|COMPLETED|Overall Study||1
5286538|NCT00610467|12996520|P2|STARTED|Overall Study||1
5286539|NCT00610467|12996521|P1|STARTED|Overall Study||1
5286540|NCT00610441|12996531|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
5286541|NCT00610441|12996532|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
5286542|NCT00610441|12996533|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
5286543|NCT00610441|12996534|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
5286544|NCT00610441|12996531|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
5286545|NCT00610441|12996532|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
5286546|NCT00610441|12996533|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
5286547|NCT00610441|12996534|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
5286548|NCT00610441|12996531|P4|STARTED|Treatment Period 2 - 3 Weeks||16
5286549|NCT00610441|12996532|P3|STARTED|Treatment Period 2 - 3 Weeks||9
5286550|NCT00610441|12996533|P2|STARTED|Treatment Period 2 - 3 Weeks||13
5286551|NCT00610441|12996534|P1|STARTED|Treatment Period 2 - 3 Weeks||12
5286552|NCT00610441|12996531|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
5286553|NCT00610441|12996532|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
5286554|NCT00610441|12996533|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
5286555|NCT00610441|12996534|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
5286556|NCT00610441|12996531|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
5286557|NCT00610441|12996532|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
5286558|NCT00610441|12996533|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
5286559|NCT00610441|12996534|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
5286560|NCT00610441|12996531|P4|STARTED|Placebo Washout Period - 2 Weeks||16
5286561|NCT00610441|12996532|P3|STARTED|Placebo Washout Period - 2 Weeks||11
5286562|NCT00610441|12996533|P2|STARTED|Placebo Washout Period - 2 Weeks||14
5286563|NCT00610441|12996534|P1|STARTED|Placebo Washout Period - 2 Weeks||12
5286564|NCT00610441|12996531|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
5286565|NCT00610441|12996532|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
5286566|NCT00610441|12996533|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
5286567|NCT00610441|12996534|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
5286568|NCT00610441|12996531|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
5286569|NCT00610441|12996532|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
5286570|NCT00610441|12996533|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
5286571|NCT00610441|12996534|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
5286572|NCT00610441|12996531|P4|STARTED|Treatment Period 1 - 3 Weeks||18
5286573|NCT00610441|12996532|P3|STARTED|Treatment Period 1 - 3 Weeks||18
5286574|NCT00610441|12996533|P2|STARTED|Treatment Period 1 - 3 Weeks||16
5286575|NCT00610441|12996534|P1|STARTED|Treatment Period 1 - 3 Weeks||15
5286576|NCT00610428|12996628|P3|NOT COMPLETED|Overall Study||2
5286577|NCT00610428|12996629|P2|NOT COMPLETED|Overall Study||1
5286578|NCT00610428|12996630|P1|NOT COMPLETED|Overall Study||0
5286579|NCT00610428|12996628|P3|COMPLETED|Overall Study||25
5286580|NCT00610428|12996629|P2|COMPLETED|Overall Study||23
5286581|NCT00610428|12996630|P1|COMPLETED|Overall Study||24
5286582|NCT00610428|12996628|P3|STARTED|Overall Study||27
5286583|NCT00610428|12996629|P2|STARTED|Overall Study||24
5286584|NCT00610428|12996630|P1|STARTED|Overall Study||24
5286585|NCT00610363|12996643|P2|NOT COMPLETED|Overall Study||3
5286586|NCT00610363|12996644|P1|NOT COMPLETED|Overall Study||11
5286587|NCT00610363|12996643|P2|COMPLETED|Overall Study||38
5286588|NCT00610363|12996644|P1|COMPLETED|Overall Study||31
5286589|NCT00610363|12996643|P2|STARTED|Overall Study||41
5286590|NCT00610363|12996644|P1|STARTED|Overall Study||42
5286591|NCT00610311|12996662|P1|NOT COMPLETED|Overall Study||0
5286592|NCT00610311|12996662|P1|COMPLETED|Overall Study||3
5286593|NCT00610311|12996662|P1|STARTED|Overall Study||3
5286594|NCT00610207|12996669|P1|NOT COMPLETED|Overall Study||3
5286595|NCT00610207|12996669|P1|COMPLETED|Overall Study||18
5286596|NCT00610207|12996669|P1|STARTED|Overall Study||21
5286597|NCT00610168|12996676|P2|NOT COMPLETED|Overall Study||0
5286598|NCT00610168|12996677|P1|NOT COMPLETED|Overall Study||2
5286599|NCT00610168|12996676|P2|COMPLETED|Overall Study||7
5286600|NCT00610168|12996677|P1|COMPLETED|Overall Study||73
5286601|NCT00610168|12996676|P2|STARTED|Overall Study||7
5286602|NCT00610168|12996677|P1|STARTED|Overall Study||75
5286603|NCT00610155|12996696|P6|NOT COMPLETED|Period 3||0
5286604|NCT00610155|12996697|P5|NOT COMPLETED|Period 3||0
5286605|NCT00610155|12996698|P4|NOT COMPLETED|Period 3||0
5286606|NCT00610155|12996699|P3|NOT COMPLETED|Period 3||0
5286607|NCT00610155|12996700|P2|NOT COMPLETED|Period 3||0
5286608|NCT00610155|12996701|P1|NOT COMPLETED|Period 3||1
5286609|NCT00610155|12996696|P6|COMPLETED|Period 3||1
5286610|NCT00610155|12996697|P5|COMPLETED|Period 3||3
5286611|NCT00610155|12996698|P4|COMPLETED|Period 3||3
5286612|NCT00610155|12996699|P3|COMPLETED|Period 3||3
5286613|NCT00610155|12996700|P2|COMPLETED|Period 3||3
5286614|NCT00610155|12996701|P1|COMPLETED|Period 3||3
5286615|NCT00610155|12996696|P6|STARTED|Period 3||1
5286616|NCT00610155|12996697|P5|STARTED|Period 3||3
5286617|NCT00610155|12996698|P4|STARTED|Period 3||3
5286618|NCT00610155|12996699|P3|STARTED|Period 3||3
5286619|NCT00610155|12996700|P2|STARTED|Period 3||3
5286620|NCT00610155|12996701|P1|STARTED|Period 3||4
5286621|NCT00610155|12996696|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286622|NCT00610155|12996697|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286623|NCT00610155|12996698|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286624|NCT00610155|12996699|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286625|NCT00610155|12996700|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286626|NCT00610155|12996701|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
5286627|NCT00610155|12996696|P6|COMPLETED|Washout Period 2 (7 Days)||1
5286628|NCT00610155|12996697|P5|COMPLETED|Washout Period 2 (7 Days)||3
5286629|NCT00610155|12996698|P4|COMPLETED|Washout Period 2 (7 Days)||3
5286630|NCT00610155|12996699|P3|COMPLETED|Washout Period 2 (7 Days)||3
5286631|NCT00610155|12996700|P2|COMPLETED|Washout Period 2 (7 Days)||3
5286632|NCT00610155|12996701|P1|COMPLETED|Washout Period 2 (7 Days)||4
5286633|NCT00610155|12996696|P6|STARTED|Washout Period 2 (7 Days)||1
5286634|NCT00610155|12996697|P5|STARTED|Washout Period 2 (7 Days)||3
5286635|NCT00610155|12996698|P4|STARTED|Washout Period 2 (7 Days)||3
5286636|NCT00610155|12996699|P3|STARTED|Washout Period 2 (7 Days)||3
5286637|NCT00610155|12996700|P2|STARTED|Washout Period 2 (7 Days)||3
5286638|NCT00610155|12996701|P1|STARTED|Washout Period 2 (7 Days)||4
5286639|NCT00610155|12996696|P6|NOT COMPLETED|Period 2||0
5286640|NCT00610155|12996697|P5|NOT COMPLETED|Period 2||0
5286641|NCT00610155|12996698|P4|NOT COMPLETED|Period 2||0
5286642|NCT00610155|12996699|P3|NOT COMPLETED|Period 2||0
5286643|NCT00610155|12996700|P2|NOT COMPLETED|Period 2||0
5286644|NCT00610155|12996701|P1|NOT COMPLETED|Period 2||0
5286645|NCT00610155|12996696|P6|COMPLETED|Period 2||1
5286646|NCT00610155|12996697|P5|COMPLETED|Period 2||3
5286647|NCT00610155|12996698|P4|COMPLETED|Period 2||3
5286648|NCT00610155|12996699|P3|COMPLETED|Period 2||3
5286649|NCT00610155|12996700|P2|COMPLETED|Period 2||3
5286650|NCT00610155|12996701|P1|COMPLETED|Period 2||4
5286651|NCT00610155|12996696|P6|STARTED|Period 2||1
5286652|NCT00610155|12996697|P5|STARTED|Period 2||3
5286653|NCT00610155|12996698|P4|STARTED|Period 2||3
5286654|NCT00610155|12996699|P3|STARTED|Period 2||3
5286655|NCT00610155|12996700|P2|STARTED|Period 2||3
5286656|NCT00610155|12996701|P1|STARTED|Period 2||4
5286657|NCT00610155|12996696|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286658|NCT00610155|12996697|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286659|NCT00610155|12996698|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286660|NCT00610155|12996699|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286661|NCT00610155|12996700|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286662|NCT00610155|12996701|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
5286663|NCT00610155|12996696|P6|COMPLETED|Washout Period 1 (7 Days)||1
5286664|NCT00610155|12996697|P5|COMPLETED|Washout Period 1 (7 Days)||3
5286665|NCT00610155|12996698|P4|COMPLETED|Washout Period 1 (7 Days)||3
5286666|NCT00610155|12996699|P3|COMPLETED|Washout Period 1 (7 Days)||3
5286667|NCT00610155|12996700|P2|COMPLETED|Washout Period 1 (7 Days)||3
5286668|NCT00610155|12996701|P1|COMPLETED|Washout Period 1 (7 Days)||4
5286669|NCT00610155|12996696|P6|STARTED|Washout Period 1 (7 Days)||1
5286670|NCT00610155|12996697|P5|STARTED|Washout Period 1 (7 Days)||3
5286671|NCT00610155|12996698|P4|STARTED|Washout Period 1 (7 Days)||3
5286672|NCT00610155|12996699|P3|STARTED|Washout Period 1 (7 Days)||3
5286673|NCT00610155|12996700|P2|STARTED|Washout Period 1 (7 Days)||3
5286674|NCT00610155|12996701|P1|STARTED|Washout Period 1 (7 Days)||4
5286675|NCT00610155|12996696|P6|NOT COMPLETED|Period 1||0
5286676|NCT00610155|12996697|P5|NOT COMPLETED|Period 1||0
5286677|NCT00610155|12996698|P4|NOT COMPLETED|Period 1||0
5286678|NCT00610155|12996699|P3|NOT COMPLETED|Period 1||1
5286679|NCT00610155|12996700|P2|NOT COMPLETED|Period 1||0
5286680|NCT00610155|12996701|P1|NOT COMPLETED|Period 1||0
5286681|NCT00610155|12996696|P6|COMPLETED|Period 1||1
5286682|NCT00610155|12996697|P5|COMPLETED|Period 1||3
5286683|NCT00610155|12996698|P4|COMPLETED|Period 1||3
5286684|NCT00610155|12996699|P3|COMPLETED|Period 1||3
5286685|NCT00610155|12996700|P2|COMPLETED|Period 1||3
5286686|NCT00610155|12996701|P1|COMPLETED|Period 1||4
5286687|NCT00610155|12996696|P6|STARTED|Period 1||1
5286688|NCT00610155|12996697|P5|STARTED|Period 1||3
5286689|NCT00610155|12996698|P4|STARTED|Period 1||3
5286690|NCT00610155|12996699|P3|STARTED|Period 1||4
5286691|NCT00610155|12996700|P2|STARTED|Period 1||3
5286692|NCT00610155|12996701|P1|STARTED|Period 1||4
5286693|NCT00610129|12996748|P1|NOT COMPLETED|Overall Study||3
5286694|NCT00610129|12996748|P1|COMPLETED|Overall Study||25
5286695|NCT00610129|12996748|P1|STARTED|Overall Study||28
5286696|NCT00609986|12996754|P2|NOT COMPLETED|Overall Study||3
5286697|NCT00609986|12996755|P1|NOT COMPLETED|Overall Study||8
5286698|NCT00609986|12996754|P2|COMPLETED|Overall Study||49
5286699|NCT00609986|12996755|P1|COMPLETED|Overall Study||44
5286700|NCT00609986|12996754|P2|Received Transplant|Overall Study||49
5286701|NCT00609986|12996755|P1|Received Transplant|Overall Study||44
5286702|NCT00609986|12996754|P2|STARTED|Overall Study||52
5286703|NCT00609986|12996755|P1|STARTED|Overall Study||52
5286704|NCT00609973|12996769|P2|NOT COMPLETED|Overall Study||6
5286705|NCT00609973|12996770|P1|NOT COMPLETED|Overall Study||8
5286706|NCT00609973|12996769|P2|COMPLETED|Overall Study||10
5286707|NCT00609973|12996770|P1|COMPLETED|Overall Study||9
5286708|NCT00609973|12996769|P2|STARTED|Overall Study||16
5286709|NCT00609973|12996770|P1|STARTED|Overall Study||17
5286710|NCT00609947|12996778|P1|NOT COMPLETED|Overall Study||1
5286711|NCT00609947|12996778|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
5286712|NCT00609947|12996778|P1|STARTED|Overall Study||241
5286713|NCT00609869|12996783|P1|NOT COMPLETED|Overall Study||11
5286714|NCT00609869|12996783|P1|COMPLETED|Overall Study||18
5286715|NCT00609869|12996783|P1|STARTED|Overall Study||29
5286716|NCT00609804|12996791|P2|NOT COMPLETED|Overall Study||28
5286717|NCT00609804|12996792|P1|NOT COMPLETED|Overall Study||25
5286718|NCT00609804|12996791|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
5286719|NCT00609804|12996792|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
5286720|NCT00609804|12996791|P2|STARTED|Overall Study||28
5286721|NCT00609804|12996792|P1|STARTED|Overall Study||25
5286722|NCT00609765|12996802|P1|NOT COMPLETED|Overall Study||1
5286723|NCT00609765|12996802|P1|COMPLETED|Overall Study||0
5286724|NCT00609765|12996802|P1|STARTED|Overall Study||1
5286725|NCT00609739|12996807|P1|NOT COMPLETED|Overall Study||0
5286726|NCT00609739|12996807|P1|COMPLETED|Overall Study||1
5286727|NCT00609739|12996807|P1|STARTED|Overall Study||1
5286728|NCT00609674|12996816|P2|NOT COMPLETED|Overall Study||7
5286729|NCT00609674|12996817|P1|NOT COMPLETED|Overall Study||7
5286730|NCT00609674|12996816|P2|COMPLETED|Overall Study||153
5286731|NCT00609674|12996817|P1|COMPLETED|Overall Study||148
5286732|NCT00609674|12996816|P2|STARTED|Overall Study||160
5286733|NCT00609674|12996817|P1|STARTED|Overall Study||155
5286734|NCT00609622|12996853|P2|NOT COMPLETED|Overall Study||95
5286735|NCT00609622|12996854|P1|NOT COMPLETED|Overall Study||96
5286736|NCT00609622|12996853|P2|COMPLETED|Overall Study||0
5286737|NCT00609622|12996854|P1|COMPLETED|Overall Study||0
5286738|NCT00609622|12996853|P2|STARTED|Overall Study||95
5286739|NCT00609622|12996854|P1|STARTED|Overall Study||96
5286740|NCT00609609|12996876|P2|NOT COMPLETED|Overall Study||2
5286741|NCT00609609|12996877|P1|NOT COMPLETED|Overall Study||6
5286742|NCT00609609|12996876|P2|COMPLETED|Overall Study||49
5286743|NCT00609609|12996877|P1|COMPLETED|Overall Study||24
5286744|NCT00609609|12996876|P2|STARTED|Overall Study||51
5286745|NCT00609609|12996877|P1|STARTED|Overall Study||30
5286746|NCT00609518|12996889|P2|NOT COMPLETED|Overall Study||40
5286747|NCT00609518|12996890|P1|NOT COMPLETED|Overall Study||43
5286748|NCT00609518|12996889|P2|COMPLETED|Overall Study||17
5286749|NCT00609518|12996890|P1|COMPLETED|Overall Study||11
5286750|NCT00609518|12996889|P2|Completed 6 Treatment Cycles|Overall Study||22
5286751|NCT00609518|12996890|P1|Completed 6 Treatment Cycles|Overall Study||19
5286752|NCT00609518|12996889|P2|STARTED|Overall Study||57
5286753|NCT00609518|12996890|P1|STARTED|Overall Study||54
5286754|NCT00609492|12996905|P3|NOT COMPLETED|Overall Study||7
5286755|NCT00609492|12996906|P2|NOT COMPLETED|Overall Study||3
5286756|NCT00609492|12996907|P1|NOT COMPLETED|Overall Study||1
5286757|NCT00609492|12996905|P3|COMPLETED|Overall Study||122
5286758|NCT00609492|12996906|P2|COMPLETED|Overall Study||69
5286759|NCT00609492|12996907|P1|COMPLETED|Overall Study||43
5286760|NCT00609492|12996905|P3|STARTED|Overall Study||129
5286761|NCT00609492|12996906|P2|STARTED|Overall Study||72
5286762|NCT00609492|12996907|P1|STARTED|Overall Study||44
5286763|NCT00609466|12996992|P3|NOT COMPLETED|Overall Study||4
5286764|NCT00609466|12996993|P2|NOT COMPLETED|Overall Study||6
5286765|NCT00609466|12996994|P1|NOT COMPLETED|Overall Study||2
5286766|NCT00609466|12996992|P3|COMPLETED|Overall Study||95
5286767|NCT00609466|12996993|P2|COMPLETED|Overall Study||90
5286768|NCT00609466|12996994|P1|COMPLETED|Overall Study||94
5286769|NCT00609466|12996992|P3|STARTED|Overall Study||99
5286770|NCT00609466|12996993|P2|STARTED|Overall Study||96
5286771|NCT00609466|12996994|P1|STARTED|Overall Study||96
5286772|NCT00609362|12997022|P2|NOT COMPLETED|Overall Study||1
5286773|NCT00609362|12997023|P1|NOT COMPLETED|Overall Study||3
5286774|NCT00609362|12997022|P2|COMPLETED|Overall Study||27
5286775|NCT00609362|12997023|P1|COMPLETED|Overall Study||26
5286776|NCT00609362|12997022|P2|STARTED|Overall Study||28
5286777|NCT00609362|12997023|P1|STARTED|Overall Study||29
5286778|NCT00609336|12997033|P1|NOT COMPLETED|Overall Study||13
5286779|NCT00609336|12997033|P1|COMPLETED|Overall Study||22
5286780|NCT00609336|12997033|P1|Surgery|Overall Study||22
5286781|NCT00609336|12997033|P1|STARTED|Overall Study||35
5286782|NCT00609271|12997047|P2|NOT COMPLETED|Overall Study||13
5286783|NCT00609271|12997048|P1|NOT COMPLETED|Overall Study||16
5286784|NCT00609271|12997047|P2|COMPLETED|Overall Study||60
5286785|NCT00609271|12997048|P1|COMPLETED|Overall Study||59
5286786|NCT00609271|12997047|P2|STARTED|Overall Study||73
5286787|NCT00609271|12997048|P1|STARTED|Overall Study||75
5286788|NCT00609245|12997084|P1|NOT COMPLETED|Overall Study||1
5286789|NCT00609245|12997084|P1|COMPLETED|Overall Study||12
5286790|NCT00609245|12997084|P1|STARTED|Overall Study||13
5286791|NCT00609167|12997092|P2|NOT COMPLETED|Overall Study||7
5286792|NCT00609167|12997093|P1|NOT COMPLETED|Overall Study||8
5286793|NCT00609167|12997092|P2|COMPLETED|Overall Study||23
5286794|NCT00609167|12997093|P1|COMPLETED|Overall Study||25
5286795|NCT00609167|12997092|P2|STARTED|Overall Study||30
5286796|NCT00609167|12997093|P1|STARTED|Overall Study||33
5286797|NCT00609128|12997115|P1|NOT COMPLETED|Overall Study||0
5286798|NCT00609128|12997115|P1|COMPLETED|Overall Study||21
5286799|NCT00609128|12997115|P1|STARTED|Overall Study||21
5286800|NCT00608985|12997124|P4|NOT COMPLETED|Overall Study||9
5286801|NCT00608985|12997125|P3|NOT COMPLETED|Overall Study||6
5286802|NCT00608985|12997126|P2|NOT COMPLETED|Overall Study||13
5286803|NCT00608985|12997127|P1|NOT COMPLETED|Overall Study||16
5286804|NCT00608985|12997124|P4|COMPLETED|Overall Study|Completed follow-up|159
5286805|NCT00608985|12997125|P3|COMPLETED|Overall Study|Completed follow-up|170
5286806|NCT00608985|12997126|P2|COMPLETED|Overall Study|Completed follow-up|173
5286807|NCT00608985|12997127|P1|COMPLETED|Overall Study|Completed follow-up|161
5286808|NCT00608985|12997124|P4|Completed Double-blind Treatment|Overall Study||161
5286809|NCT00608985|12997125|P3|Completed Double-blind Treatment|Overall Study||171
5286810|NCT00608985|12997126|P2|Completed Double-blind Treatment|Overall Study||174
5286811|NCT00608985|12997127|P1|Completed Double-blind Treatment|Overall Study||163
5286812|NCT00608985|12997124|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
5286813|NCT00608985|12997125|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
5286814|NCT00608985|12997126|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
5286815|NCT00608985|12997127|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
5286816|NCT00608959|12997159|P1|NOT COMPLETED|Part 2||0
5286817|NCT00608959|12997159|P1|COMPLETED|Part 2||25
5286818|NCT00608959|12997159|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
5286819|NCT00608959|12997159|P1|NOT COMPLETED|Part 1||1
5286820|NCT00608959|12997159|P1|COMPLETED|Part 1||24
5286821|NCT00608959|12997159|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
5286822|NCT00608907|12997172|P3|NOT COMPLETED|Overall Study||1
5286823|NCT00608907|12997173|P2|NOT COMPLETED|Overall Study||0
5286824|NCT00608907|12997174|P1|NOT COMPLETED|Overall Study||12
5286825|NCT00608907|12997172|P3|COMPLETED|Overall Study||17
5286826|NCT00608907|12997173|P2|COMPLETED|Overall Study||13
5286827|NCT00608907|12997174|P1|COMPLETED|Overall Study||18
5286828|NCT00608907|12997172|P3|STARTED|Overall Study||18
5286829|NCT00608907|12997173|P2|STARTED|Overall Study||13
5286830|NCT00608907|12997174|P1|STARTED|Overall Study||30
5286831|NCT00608894|12997184|P2|NOT COMPLETED|Overall Study||2
5286832|NCT00608894|12997185|P1|NOT COMPLETED|Overall Study||0
5286833|NCT00608894|12997184|P2|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
5286834|NCT00608894|12997185|P1|COMPLETED|Overall Study||7
5286835|NCT00608894|12997184|P2|STARTED|Overall Study||6
5286836|NCT00608894|12997185|P1|STARTED|Overall Study||7
5286837|NCT00608881|12997197|P2|NOT COMPLETED|Overall Study||66
5286838|NCT00608881|12997198|P1|NOT COMPLETED|Overall Study||79
5286839|NCT00608881|12997197|P2|COMPLETED|Overall Study||240
5286840|NCT00608881|12997198|P1|COMPLETED|Overall Study||224
5286841|NCT00608881|12997197|P2|STARTED|Overall Study||306
5286842|NCT00608881|12997198|P1|STARTED|Overall Study||303
5286843|NCT00608868|12997232|P1|NOT COMPLETED|Overall Study||15
5286844|NCT00608868|12997232|P1|COMPLETED|Overall Study||141
5286845|NCT00608868|12997232|P1|Per Protocol (PP) Population|Overall Study||121
5286846|NCT00608868|12997232|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
5286847|NCT00608868|12997232|P1|Treatment Completed|Overall Study||141
5286848|NCT00608868|12997232|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
5286849|NCT00608868|12997232|P1|Enrolled|Overall Study||156
5286850|NCT00608868|12997232|P1|STARTED|Overall Study||156
5286851|NCT00608842|12997243|P4|NOT COMPLETED|Overall Study||1
5286852|NCT00608842|12997244|P3|NOT COMPLETED|Overall Study||2
5286853|NCT00608842|12997245|P2|NOT COMPLETED|Overall Study||1
5286854|NCT00608842|12997246|P1|NOT COMPLETED|Overall Study||1
5286855|NCT00608842|12997243|P4|COMPLETED|Overall Study||16
5286856|NCT00608842|12997244|P3|COMPLETED|Overall Study||13
5286857|NCT00608842|12997245|P2|COMPLETED|Overall Study||14
5286858|NCT00608842|12997246|P1|COMPLETED|Overall Study||14
5286859|NCT00608842|12997243|P4|STARTED|Overall Study||17
5286860|NCT00608842|12997244|P3|STARTED|Overall Study||15
5286861|NCT00608842|12997245|P2|STARTED|Overall Study||15
5286862|NCT00608842|12997246|P1|STARTED|Overall Study||15
5286863|NCT00608829|12997280|P1|NOT COMPLETED|Overall Study||15
5286864|NCT00608829|12997280|P1|COMPLETED|Overall Study||8
5286865|NCT00608829|12997280|P1|STARTED|Overall Study||23
5286866|NCT00608777|12997284|P1|NOT COMPLETED|Overall Study||0
5286867|NCT00608777|12997284|P1|COMPLETED|Overall Study||6
5286868|NCT00608777|12997284|P1|STARTED|Overall Study||6
5286869|NCT00608634|12997291|P3|NOT COMPLETED|Overall Study||1
5286870|NCT00608634|12997292|P2|NOT COMPLETED|Overall Study||1
5286871|NCT00608634|12997293|P1|NOT COMPLETED|Overall Study||2
5286872|NCT00608634|12997291|P3|COMPLETED|Overall Study||27
5286873|NCT00608634|12997292|P2|COMPLETED|Overall Study||26
5286874|NCT00608634|12997293|P1|COMPLETED|Overall Study||26
5286875|NCT00608634|12997291|P3|STARTED|Overall Study||28
5286876|NCT00608634|12997292|P2|STARTED|Overall Study||27
5286877|NCT00608634|12997293|P1|STARTED|Overall Study||28
5286878|NCT00608582|12997306|P2|NOT COMPLETED|Overall Study||4
5286879|NCT00608582|12997307|P1|NOT COMPLETED|Overall Study||4
5286880|NCT00608582|12997306|P2|COMPLETED|Overall Study||7
5286881|NCT00608582|12997307|P1|COMPLETED|Overall Study||10
5286882|NCT00608582|12997306|P2|STARTED|Overall Study||11
5286883|NCT00608582|12997307|P1|STARTED|Overall Study||14
5286884|NCT00608569|12997317|P2|NOT COMPLETED|Overall Study||9
5286885|NCT00608569|12997318|P1|NOT COMPLETED|Overall Study||10
5286886|NCT00608569|12997317|P2|COMPLETED|Overall Study||119
5286887|NCT00608569|12997318|P1|COMPLETED|Overall Study||119
5286888|NCT00608569|12997317|P2|STARTED|Overall Study||128
5286889|NCT00608569|12997318|P1|STARTED|Overall Study||129
5286890|NCT00608543|12997338|P1|NOT COMPLETED|Overall Study||4
5286891|NCT00608543|12997338|P1|COMPLETED|Overall Study||13
5286892|NCT00608543|12997338|P1|STARTED|Overall Study||17
5286893|NCT00608530|12997351|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
5286894|NCT00608530|12997352|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
5286895|NCT00608530|12997353|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
5286896|NCT00608530|12997354|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
5286897|NCT00608530|12997351|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
5286898|NCT00608530|12997352|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
5286899|NCT00608530|12997353|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
5286900|NCT00608530|12997354|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
5286901|NCT00608530|12997351|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
5286902|NCT00608530|12997352|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
5286903|NCT00608530|12997353|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
5286904|NCT00608530|12997354|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
5286905|NCT00608530|12997351|P4|STARTED|Study 2 Nurse-delivered Treatments||34
5286906|NCT00608530|12997352|P3|STARTED|Study 2 Nurse-delivered Treatments||33
5286907|NCT00608530|12997353|P2|STARTED|Study 2 Nurse-delivered Treatments||0
5286908|NCT00608530|12997354|P1|STARTED|Study 2 Nurse-delivered Treatments||0
5286909|NCT00608530|12997351|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
5286910|NCT00608530|12997352|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
5286911|NCT00608530|12997353|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
5286912|NCT00608530|12997354|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
5286913|NCT00608530|12997351|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
5286914|NCT00608530|12997352|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
5286915|NCT00608530|12997353|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
5286916|NCT00608530|12997354|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
5286917|NCT00608530|12997351|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
5286918|NCT00608530|12997352|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
5286919|NCT00608530|12997353|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
5286920|NCT00608530|12997354|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
5286921|NCT00608530|12997351|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
5286922|NCT00608530|12997352|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
5286923|NCT00608530|12997353|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
5286924|NCT00608530|12997354|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
5286925|NCT00608517|12997375|P3|NOT COMPLETED|Overall Study||0
5286926|NCT00608517|12997376|P2|NOT COMPLETED|Overall Study||0
5286927|NCT00608517|12997377|P1|NOT COMPLETED|Overall Study||1
5286928|NCT00608517|12997375|P3|COMPLETED|Overall Study||1
5286929|NCT00608517|12997376|P2|COMPLETED|Overall Study||3
5286930|NCT00608517|12997377|P1|COMPLETED|Overall Study||1
5286931|NCT00608517|12997375|P3|STARTED|Overall Study||1
5286932|NCT00608517|12997376|P2|STARTED|Overall Study||3
5286933|NCT00608517|12997377|P1|STARTED|Overall Study||2
5286934|NCT00608491|12997405|P2|NOT COMPLETED|Overall Study||22
5286935|NCT00608491|12997406|P1|NOT COMPLETED|Overall Study||21
5286936|NCT00608491|12997405|P2|COMPLETED|Overall Study||72
5286937|NCT00608491|12997406|P1|COMPLETED|Overall Study||73
5286938|NCT00608491|12997405|P2|STARTED|Overall Study||94
5286939|NCT00608491|12997406|P1|STARTED|Overall Study||94
5286940|NCT00608465|12997550|P1|NOT COMPLETED|Overall Study||0
5286941|NCT00608465|12997550|P1|COMPLETED|Overall Study||4
5286942|NCT00608465|12997550|P1|STARTED|Overall Study||4
5286943|NCT00608426|12997557|P2|NOT COMPLETED|Overall Study||905
5286944|NCT00608426|12997558|P1|NOT COMPLETED|Overall Study||836
5286945|NCT00608426|12997557|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
5286946|NCT00608426|12997558|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
5286947|NCT00608426|12997557|P2|STARTED|Overall Study||2519
5286948|NCT00608426|12997558|P1|STARTED|Overall Study||2604
5286949|NCT00608322|12997570|P2|NOT COMPLETED|Overall Study||1
5286950|NCT00608322|12997571|P1|NOT COMPLETED|Overall Study||2
5286951|NCT00608322|12997570|P2|COMPLETED|Overall Study||22
5286952|NCT00608322|12997571|P1|COMPLETED|Overall Study||24
5286953|NCT00608322|12997570|P2|STARTED|Overall Study||23
5286954|NCT00608322|12997571|P1|STARTED|Overall Study||26
5286955|NCT00608244|12997577|P1|NOT COMPLETED|Overall Study||2
5286956|NCT00608244|12997577|P1|COMPLETED|Overall Study||57
5286957|NCT00608244|12997577|P1|STARTED|Overall Study||59
5286958|NCT00608205|12997588|P2|NOT COMPLETED|Overall Study||3
5286959|NCT00608205|12997589|P1|NOT COMPLETED|Overall Study||3
5286960|NCT00608205|12997588|P2|COMPLETED|Overall Study||31
5286961|NCT00608205|12997589|P1|COMPLETED|Overall Study||32
5286962|NCT00608205|12997588|P2|STARTED|Overall Study||34
5286963|NCT00608205|12997589|P1|STARTED|Overall Study||35
5286964|NCT00608140|12997679|P2|NOT COMPLETED|Overall Study||1
5286965|NCT00608140|12997680|P1|NOT COMPLETED|Overall Study||1
5286966|NCT00608140|12997679|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
5286967|NCT00608140|12997680|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
5286968|NCT00608140|12997679|P2|STARTED|Overall Study||1
5286969|NCT00608140|12997680|P1|STARTED|Overall Study||1
5286970|NCT00608023|12997706|P3|NOT COMPLETED|Overall Study||14
5286971|NCT00608023|12997707|P2|NOT COMPLETED|Overall Study||22
5286972|NCT00608023|12997708|P1|NOT COMPLETED|Overall Study||12
5286973|NCT00608023|12997706|P3|COMPLETED|Overall Study||72
5286974|NCT00608023|12997707|P2|COMPLETED|Overall Study||63
5286975|NCT00608023|12997708|P1|COMPLETED|Overall Study||80
5286976|NCT00608023|12997706|P3|STARTED|Overall Study||86
5286977|NCT00608023|12997707|P2|STARTED|Overall Study||85
5286978|NCT00608023|12997708|P1|STARTED|Overall Study||92
5286979|NCT00607997|12997732|P4|NOT COMPLETED|Overall Study||16
5286980|NCT00607997|12997733|P3|NOT COMPLETED|Overall Study||24
5286981|NCT00607997|12997734|P2|NOT COMPLETED|Overall Study||27
5286982|NCT00607997|12997735|P1|NOT COMPLETED|Overall Study||27
5286983|NCT00607997|12997732|P4|COMPLETED|Overall Study||4
5286984|NCT00607997|12997733|P3|COMPLETED|Overall Study||5
5286985|NCT00607997|12997734|P2|COMPLETED|Overall Study||8
5286986|NCT00607997|12997735|P1|COMPLETED|Overall Study||2
5286987|NCT00607997|12997732|P4|STARTED|Overall Study||20
5286988|NCT00607997|12997733|P3|STARTED|Overall Study||29
5286989|NCT00607997|12997734|P2|STARTED|Overall Study||35
5286990|NCT00607997|12997735|P1|STARTED|Overall Study||29
5286991|NCT00607919|12997793|P2|NOT COMPLETED|Open-Label Phase||12
5286992|NCT00607919|12997794|P1|NOT COMPLETED|Open-Label Phase||10
5286993|NCT00607919|12997793|P2|COMPLETED|Open-Label Phase||59
5286994|NCT00607919|12997794|P1|COMPLETED|Open-Label Phase||74
5286995|NCT00607919|12997793|P2|STARTED|Open-Label Phase||71
5286996|NCT00607919|12997794|P1|STARTED|Open-Label Phase||84
5286997|NCT00607919|12997793|P2|NOT COMPLETED|Acute Phase||16
5286998|NCT00607919|12997794|P1|NOT COMPLETED|Acute Phase||34
5286999|NCT00607919|12997793|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
5287000|NCT00607919|12997794|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
5287001|NCT00607919|12997793|P2|STARTED|Acute Phase||89
5287002|NCT00607919|12997794|P1|STARTED|Acute Phase||120
5287003|NCT00607893|12997852|P2|NOT COMPLETED|Overall Study||4
5287004|NCT00607893|12997853|P1|NOT COMPLETED|Overall Study||6
5287005|NCT00607893|12997852|P2|COMPLETED|Overall Study||72
5287006|NCT00607893|12997853|P1|COMPLETED|Overall Study||71
5287007|NCT00607893|12997852|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
5287008|NCT00607893|12997853|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
5287009|NCT00607893|12997852|P2|Completed 8 Week Visit|Overall Study||72
5287010|NCT00607893|12997853|P1|Completed 8 Week Visit|Overall Study||71
5287011|NCT00607893|12997852|P2|Completed Baseline Visit|Overall Study||75
5287012|NCT00607893|12997853|P1|Completed Baseline Visit|Overall Study||74
5287013|NCT00607893|12997852|P2|STARTED|Overall Study||76
5287014|NCT00607893|12997853|P1|STARTED|Overall Study||77
5287015|NCT00607880|12997881|P2|NOT COMPLETED|Overall Study||0
5287016|NCT00607880|12997882|P1|NOT COMPLETED|Overall Study||1
5287017|NCT00607880|12997881|P2|COMPLETED|Overall Study||50
5287018|NCT00607880|12997882|P1|COMPLETED|Overall Study||49
5287019|NCT00607880|12997881|P2|STARTED|Overall Study||50
5287020|NCT00607880|12997882|P1|STARTED|Overall Study||50
5287021|NCT00607867|12997896|P2|NOT COMPLETED|Overall Study||0
5287022|NCT00607867|12997897|P1|NOT COMPLETED|Overall Study||0
5287023|NCT00607867|12997896|P2|COMPLETED|Overall Study||7
5287024|NCT00607867|12997897|P1|COMPLETED|Overall Study||7
5287025|NCT00607867|12997896|P2|STARTED|Overall Study||7
5287026|NCT00607867|12997897|P1|STARTED|Overall Study||7
5287027|NCT00607815|12997915|P2|NOT COMPLETED|Overall Study||11
5287028|NCT00607815|12997916|P1|NOT COMPLETED|Overall Study||23
5287029|NCT00607815|12997915|P2|COMPLETED|Overall Study||25
5287030|NCT00607815|12997916|P1|COMPLETED|Overall Study||20
5287031|NCT00607815|12997915|P2|STARTED|Overall Study||36
5287032|NCT00607815|12997916|P1|STARTED|Overall Study||43
5287033|NCT00607789|12997932|P2|NOT COMPLETED|Overall Study||6
5287034|NCT00607789|12997933|P1|NOT COMPLETED|Overall Study||7
5287035|NCT00607789|12997932|P2|COMPLETED|Overall Study||14
5287036|NCT00607789|12997933|P1|COMPLETED|Overall Study||13
5287037|NCT00607789|12997932|P2|STARTED|Overall Study||20
5287038|NCT00607789|12997933|P1|STARTED|Overall Study|20 participants were randomized in each group|20
5287039|NCT00607724|12997948|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
5287040|NCT00607724|12997949|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
5287041|NCT00607724|12997950|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
5287042|NCT00607724|12997951|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
5287043|NCT00607724|12997952|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
5287044|NCT00607724|12997953|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
5287045|NCT00607724|12997954|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
5287046|NCT00607724|12997948|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
5287047|NCT00607724|12997949|P6|COMPLETED|Stage 2: Expanded Cohort||0
5287048|NCT00607724|12997950|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
5287049|NCT00607724|12997951|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
5287050|NCT00607724|12997952|P3|COMPLETED|Stage 2: Expanded Cohort||0
5287051|NCT00607724|12997953|P2|COMPLETED|Stage 2: Expanded Cohort||0
5287052|NCT00607724|12997954|P1|COMPLETED|Stage 2: Expanded Cohort||0
5287053|NCT00607724|12997948|P7|STARTED|Stage 2: Expanded Cohort||16
5287054|NCT00607724|12997949|P6|STARTED|Stage 2: Expanded Cohort||12
5287055|NCT00607724|12997950|P5|STARTED|Stage 2: Expanded Cohort||14
5287056|NCT00607724|12997951|P4|STARTED|Stage 2: Expanded Cohort||6
5287057|NCT00607724|12997952|P3|STARTED|Stage 2: Expanded Cohort||0
5287058|NCT00607724|12997953|P2|STARTED|Stage 2: Expanded Cohort||0
5287059|NCT00607724|12997954|P1|STARTED|Stage 2: Expanded Cohort||0
5287060|NCT00607724|12997948|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
5287061|NCT00607724|12997949|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
5287062|NCT00607724|12997950|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
5287063|NCT00607724|12997951|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
5287064|NCT00607724|12997952|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
5287065|NCT00607724|12997953|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
5287066|NCT00607724|12997954|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
5287067|NCT00607724|12997948|P7|COMPLETED|Stage 1: Dose Escalation||0
5287068|NCT00607724|12997949|P6|COMPLETED|Stage 1: Dose Escalation||0
5287069|NCT00607724|12997950|P5|COMPLETED|Stage 1: Dose Escalation||0
5287070|NCT00607724|12997951|P4|COMPLETED|Stage 1: Dose Escalation||0
5287071|NCT00607724|12997952|P3|COMPLETED|Stage 1: Dose Escalation||0
5287072|NCT00607724|12997953|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
5287073|NCT00607724|12997954|P1|COMPLETED|Stage 1: Dose Escalation||0
5287074|NCT00607724|12997948|P7|STARTED|Stage 1: Dose Escalation||0
5287075|NCT00607724|12997949|P6|STARTED|Stage 1: Dose Escalation||0
5287076|NCT00607724|12997950|P5|STARTED|Stage 1: Dose Escalation||0
5287077|NCT00607724|12997951|P4|STARTED|Stage 1: Dose Escalation||0
5287078|NCT00607724|12997952|P3|STARTED|Stage 1: Dose Escalation||4
5287079|NCT00607724|12997953|P2|STARTED|Stage 1: Dose Escalation||9
5287080|NCT00607724|12997954|P1|STARTED|Stage 1: Dose Escalation||7
5287081|NCT00607672|12998033|P3|NOT COMPLETED|Overall Study||5
5287082|NCT00607672|12998034|P2|NOT COMPLETED|Overall Study||3
5287083|NCT00607672|12998035|P1|NOT COMPLETED|Overall Study||4
5287084|NCT00607672|12998033|P3|COMPLETED|Overall Study||22
5287085|NCT00607672|12998034|P2|COMPLETED|Overall Study||24
5287086|NCT00607672|12998035|P1|COMPLETED|Overall Study||28
5287087|NCT00607672|12998033|P3|STARTED|Overall Study||27
5287088|NCT00607672|12998034|P2|STARTED|Overall Study||27
5287089|NCT00607672|12998035|P1|STARTED|Overall Study||32
5287090|NCT00607620|12998081|P2|NOT COMPLETED|Overall Study||0
5287091|NCT00607620|12998082|P1|NOT COMPLETED|Overall Study||0
5287092|NCT00607620|12998081|P2|COMPLETED|Overall Study||469
5287093|NCT00607620|12998082|P1|COMPLETED|Overall Study||409
5287094|NCT00607620|12998081|P2|STARTED|Overall Study||469
5287095|NCT00607620|12998082|P1|STARTED|Overall Study||409
5287096|NCT00607594|12998096|P1|NOT COMPLETED|Overall Study||0
5287097|NCT00607594|12998096|P1|COMPLETED|Overall Study||21
5287098|NCT00607594|12998096|P1|STARTED|Overall Study||21
5287099|NCT00607477|12998110|P2|NOT COMPLETED|Overall Study||0
5287100|NCT00607477|12998111|P1|NOT COMPLETED|Overall Study||0
5287101|NCT00607477|12998110|P2|COMPLETED|Overall Study||2
5287102|NCT00607477|12998111|P1|COMPLETED|Overall Study||0
5287103|NCT00607477|12998110|P2|STARTED|Overall Study||2
5287104|NCT00607477|12998111|P1|STARTED|Overall Study||0
5287105|NCT00607386|12998117|P1|NOT COMPLETED|Overall Study||1
5287106|NCT00607386|12998117|P1|COMPLETED|Overall Study||27
5287107|NCT00607386|12998117|P1|STARTED|Overall Study||28
5287108|NCT00607373|12998132|P2|NOT COMPLETED|Follow-up Period||5
5287109|NCT00607373|12998133|P1|NOT COMPLETED|Follow-up Period||1
5287110|NCT00607373|12998132|P2|COMPLETED|Follow-up Period||6
5287111|NCT00607373|12998133|P1|COMPLETED|Follow-up Period||0
5287112|NCT00607373|12998132|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
5287113|NCT00607373|12998133|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
5287114|NCT00607373|12998132|P2|NOT COMPLETED|Treatment Period||6
5287115|NCT00607373|12998133|P1|NOT COMPLETED|Treatment Period||0
5287116|NCT00607373|12998132|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
5287117|NCT00607373|12998133|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
5287118|NCT00607373|12998132|P2|STARTED|Treatment Period||34
5287119|NCT00607373|12998133|P1|STARTED|Treatment Period||17
5287120|NCT00607321|12998177|P1|NOT COMPLETED|Overall Study||0
5287121|NCT00607321|12998177|P1|COMPLETED|Overall Study||60
5287122|NCT00607321|12998177|P1|STARTED|Overall Study||60
5287123|NCT00607269|12998187|P2|NOT COMPLETED|Overall Study||0
5287124|NCT00607269|12998188|P1|NOT COMPLETED|Overall Study||0
5287125|NCT00607269|12998187|P2|COMPLETED|Overall Study||64
5287126|NCT00607269|12998188|P1|COMPLETED|Overall Study||67
5287127|NCT00607269|12998187|P2|STARTED|Overall Study||64
5287128|NCT00607269|12998188|P1|STARTED|Overall Study||67
5287129|NCT00607243|12998202|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
5287130|NCT00607243|12998203|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
5287131|NCT00607243|12998202|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
5287132|NCT00607243|12998203|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
5287133|NCT00607243|12998202|P2|STARTED|Telephone Safety Assessment Period||41
5287134|NCT00607243|12998203|P1|STARTED|Telephone Safety Assessment Period||82
5287135|NCT00607243|12998202|P2|NOT COMPLETED|Initial Post-vaccination Period||0
5287136|NCT00607243|12998203|P1|NOT COMPLETED|Initial Post-vaccination Period||0
5287137|NCT00607243|12998202|P2|COMPLETED|Initial Post-vaccination Period||41
5287138|NCT00607243|12998203|P1|COMPLETED|Initial Post-vaccination Period||82
5287139|NCT00607243|12998202|P2|STARTED|Initial Post-vaccination Period||41
5287140|NCT00607243|12998203|P1|STARTED|Initial Post-vaccination Period||82
5287141|NCT00607126|12998211|P2|NOT COMPLETED|Overall Study||0
5287142|NCT00607126|12998212|P1|NOT COMPLETED|Overall Study||0
5287143|NCT00607126|12998211|P2|COMPLETED|Overall Study||19
5287144|NCT00607126|12998212|P1|COMPLETED|Overall Study||17
5287145|NCT00607126|12998211|P2|STARTED|Overall Study||19
5287146|NCT00607126|12998212|P1|STARTED|Overall Study||17
5287147|NCT00607113|12998226|P2|NOT COMPLETED|Overall Study||0
5287148|NCT00607113|12998227|P1|NOT COMPLETED|Overall Study||0
5287149|NCT00607113|12998226|P2|COMPLETED|Overall Study||20
5287150|NCT00607113|12998227|P1|COMPLETED|Overall Study||19
5287151|NCT00607113|12998226|P2|STARTED|Overall Study||20
5287152|NCT00607113|12998227|P1|STARTED|Overall Study||19
5287153|NCT00607087|12998235|P3|NOT COMPLETED|Period 3||0
5287154|NCT00607087|12998236|P2|NOT COMPLETED|Period 3||2
5287155|NCT00607087|12998237|P1|NOT COMPLETED|Period 3||2
5287156|NCT00607087|12998235|P3|COMPLETED|Period 3||84
5287157|NCT00607087|12998236|P2|COMPLETED|Period 3||84
5287158|NCT00607087|12998237|P1|COMPLETED|Period 3||84
5287159|NCT00607087|12998235|P3|STARTED|Period 3||84
5287160|NCT00607087|12998236|P2|STARTED|Period 3||86
5287161|NCT00607087|12998237|P1|STARTED|Period 3||86
5287162|NCT00607087|12998235|P3|NOT COMPLETED|Period 2||5
5287163|NCT00607087|12998236|P2|NOT COMPLETED|Period 2||3
5287164|NCT00607087|12998237|P1|NOT COMPLETED|Period 2||1
5287165|NCT00607087|12998235|P3|COMPLETED|Period 2||84
5287166|NCT00607087|12998236|P2|COMPLETED|Period 2||86
5287167|NCT00607087|12998237|P1|COMPLETED|Period 2||86
5287168|NCT00607087|12998235|P3|STARTED|Period 2||89
5287169|NCT00607087|12998236|P2|STARTED|Period 2||89
5287170|NCT00607087|12998237|P1|STARTED|Period 2||87
5287171|NCT00607087|12998235|P3|NOT COMPLETED|Period 1||5
5287172|NCT00607087|12998236|P2|NOT COMPLETED|Period 1||6
5287173|NCT00607087|12998237|P1|NOT COMPLETED|Period 1||12
5287174|NCT00607087|12998235|P3|COMPLETED|Period 1||89
5287175|NCT00607087|12998236|P2|COMPLETED|Period 1||89
5287176|NCT00607087|12998237|P1|COMPLETED|Period 1||87
5287177|NCT00607087|12998235|P3|STARTED|Period 1||94
5287178|NCT00607087|12998236|P2|STARTED|Period 1||95
5287179|NCT00607087|12998237|P1|STARTED|Period 1||99
5287180|NCT00607087|12998235|P3|NOT COMPLETED|Overall Study||10
5287181|NCT00607087|12998236|P2|NOT COMPLETED|Overall Study||11
5287182|NCT00607087|12998237|P1|NOT COMPLETED|Overall Study||15
5287183|NCT00607087|12998235|P3|COMPLETED|Overall Study||84
5287184|NCT00607087|12998236|P2|COMPLETED|Overall Study||84
5287185|NCT00607087|12998237|P1|COMPLETED|Overall Study||84
5287186|NCT00607087|12998235|P3|STARTED|Overall Study||94
5287187|NCT00607087|12998236|P2|STARTED|Overall Study||95
5287188|NCT00607087|12998237|P1|STARTED|Overall Study||99
5287189|NCT00607048|12998295|P6|NOT COMPLETED|Overall Study||5
5287190|NCT00607048|12998296|P5|NOT COMPLETED|Overall Study||6
5287191|NCT00607048|12998297|P4|NOT COMPLETED|Overall Study||3
5287192|NCT00607048|12998298|P3|NOT COMPLETED|Overall Study||4
5287193|NCT00607048|12998299|P2|NOT COMPLETED|Overall Study||4
5287194|NCT00607048|12998300|P1|NOT COMPLETED|Overall Study||3
5287195|NCT00607048|12998295|P6|COMPLETED|Overall Study||2
5287196|NCT00607048|12998296|P5|COMPLETED|Overall Study||0
5287197|NCT00607048|12998297|P4|COMPLETED|Overall Study||0
5287198|NCT00607048|12998298|P3|COMPLETED|Overall Study||3
5287199|NCT00607048|12998299|P2|COMPLETED|Overall Study||2
5287200|NCT00607048|12998300|P1|COMPLETED|Overall Study||0
5287201|NCT00607048|12998295|P6|STARTED|Overall Study||7
5287202|NCT00607048|12998296|P5|STARTED|Overall Study||6
5287203|NCT00607048|12998297|P4|STARTED|Overall Study||3
5287204|NCT00607048|12998298|P3|STARTED|Overall Study||7
5287205|NCT00607048|12998299|P2|STARTED|Overall Study||6
5287206|NCT00607048|12998300|P1|STARTED|Overall Study||3
5287207|NCT00607022|12998385|P3|NOT COMPLETED|Overall Study||0
5287208|NCT00607022|12998386|P2|NOT COMPLETED|Overall Study||0
5287209|NCT00607022|12998387|P1|NOT COMPLETED|Overall Study||1
5287210|NCT00607022|12998385|P3|COMPLETED|Overall Study||19
5287211|NCT00607022|12998386|P2|COMPLETED|Overall Study||15
5287212|NCT00607022|12998387|P1|COMPLETED|Overall Study||6
5287213|NCT00607022|12998385|P3|STARTED|Overall Study||19
5287214|NCT00607022|12998386|P2|STARTED|Overall Study||15
5287215|NCT00607022|12998387|P1|STARTED|Overall Study||7
5287216|NCT00606944|12998397|P2|NOT COMPLETED|Overall Study||0
5287217|NCT00606944|12998398|P1|NOT COMPLETED|Overall Study||0
5287218|NCT00606944|12998397|P2|COMPLETED|Overall Study||100
5287219|NCT00606944|12998398|P1|COMPLETED|Overall Study||98
5287220|NCT00606944|12998397|P2|STARTED|Overall Study||100
5287221|NCT00606944|12998398|P1|STARTED|Overall Study||98
5287222|NCT00606931|12998404|P1|NOT COMPLETED|Overall Study||3
5287223|NCT00606931|12998404|P1|COMPLETED|Overall Study||19
5287224|NCT00606931|12998404|P1|STARTED|Overall Study||22
5287225|NCT00606905|12998412|P2|NOT COMPLETED|Overall Study||15
5287226|NCT00606905|12998413|P1|NOT COMPLETED|Overall Study||15
5287227|NCT00606905|12998412|P2|COMPLETED|Overall Study||24
5287228|NCT00606905|12998413|P1|COMPLETED|Overall Study||23
5287229|NCT00606905|12998412|P2|Pregnancy|Overall Study||33
5287230|NCT00606905|12998413|P1|Pregnancy|Overall Study||29
5287231|NCT00606905|12998412|P2|STARTED|Overall Study||39
5287232|NCT00606905|12998413|P1|STARTED|Overall Study||38
5287233|NCT00606892|12998419|P2|NOT COMPLETED|Second Intervention||0
5287234|NCT00606892|12998420|P1|NOT COMPLETED|Second Intervention||0
5287235|NCT00606892|12998419|P2|COMPLETED|Second Intervention||4
5287236|NCT00606892|12998420|P1|COMPLETED|Second Intervention||8
5287237|NCT00606892|12998419|P2|STARTED|Second Intervention||4
5287238|NCT00606892|12998420|P1|STARTED|Second Intervention||8
5287239|NCT00606892|12998419|P2|NOT COMPLETED|Washout Period||0
5287240|NCT00606892|12998420|P1|NOT COMPLETED|Washout Period||0
5287241|NCT00606892|12998419|P2|COMPLETED|Washout Period||4
5287242|NCT00606892|12998420|P1|COMPLETED|Washout Period||8
5287243|NCT00606892|12998419|P2|STARTED|Washout Period||4
5287244|NCT00606892|12998420|P1|STARTED|Washout Period||8
5287245|NCT00606892|12998419|P2|NOT COMPLETED|First Intervention||4
5287246|NCT00606892|12998420|P1|NOT COMPLETED|First Intervention||1
5287247|NCT00606892|12998419|P2|COMPLETED|First Intervention||4
5287248|NCT00606892|12998420|P1|COMPLETED|First Intervention||8
5287249|NCT00606892|12998419|P2|STARTED|First Intervention||8
5287250|NCT00606892|12998420|P1|STARTED|First Intervention||9
5287251|NCT00606892|12998419|P2|NOT COMPLETED|Adaptation||0
5287252|NCT00606892|12998420|P1|NOT COMPLETED|Adaptation||0
5287253|NCT00606892|12998419|P2|COMPLETED|Adaptation||8
5287254|NCT00606892|12998420|P1|COMPLETED|Adaptation||9
5287255|NCT00606892|12998419|P2|STARTED|Adaptation||8
5287256|NCT00606892|12998420|P1|STARTED|Adaptation||9
5287257|NCT00606801|12998454|P2|NOT COMPLETED|Intervention||3
5287258|NCT00606801|12998455|P1|NOT COMPLETED|Intervention||3
5287259|NCT00606801|12998454|P2|COMPLETED|Intervention||14
5287260|NCT00606801|12998455|P1|COMPLETED|Intervention||14
5287261|NCT00606801|12998454|P2|STARTED|Intervention||17
5287262|NCT00606801|12998455|P1|STARTED|Intervention||17
5287263|NCT00606801|12998454|P2|NOT COMPLETED|Adaptation||0
5287264|NCT00606801|12998455|P1|NOT COMPLETED|Adaptation||0
5287265|NCT00606801|12998454|P2|COMPLETED|Adaptation||17
5287266|NCT00606801|12998455|P1|COMPLETED|Adaptation||17
5287267|NCT00606801|12998454|P2|STARTED|Adaptation||17
5287268|NCT00606801|12998455|P1|STARTED|Adaptation||17
5287269|NCT00606684|12998483|P7|NOT COMPLETED|Double-Blind Treatment Period||8
5287270|NCT00606684|12998484|P6|NOT COMPLETED|Double-Blind Treatment Period||9
5287271|NCT00606684|12998485|P5|NOT COMPLETED|Double-Blind Treatment Period||9
5287272|NCT00606684|12998486|P4|NOT COMPLETED|Double-Blind Treatment Period||10
5287273|NCT00606684|12998487|P3|NOT COMPLETED|Double-Blind Treatment Period||11
5287274|NCT00606684|12998488|P2|NOT COMPLETED|Double-Blind Treatment Period||16
5287275|NCT00606684|12998489|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5287276|NCT00606684|12998483|P7|COMPLETED|Double-Blind Treatment Period||91
5287277|NCT00606684|12998484|P6|COMPLETED|Double-Blind Treatment Period||92
5287278|NCT00606684|12998485|P5|COMPLETED|Double-Blind Treatment Period||92
5287279|NCT00606684|12998486|P4|COMPLETED|Double-Blind Treatment Period||91
5287280|NCT00606684|12998487|P3|COMPLETED|Double-Blind Treatment Period||88
5287281|NCT00606684|12998488|P2|COMPLETED|Double-Blind Treatment Period||85
5287282|NCT00606684|12998489|P1|COMPLETED|Double-Blind Treatment Period||0
5287283|NCT00606684|12998483|P7|STARTED|Double-Blind Treatment Period||99
5287284|NCT00606684|12998484|P6|STARTED|Double-Blind Treatment Period||101
5287285|NCT00606684|12998485|P5|STARTED|Double-Blind Treatment Period||101
5287286|NCT00606684|12998486|P4|STARTED|Double-Blind Treatment Period||101
5287287|NCT00606684|12998487|P3|STARTED|Double-Blind Treatment Period||99
5287288|NCT00606684|12998488|P2|STARTED|Double-Blind Treatment Period||101
5287289|NCT00606684|12998489|P1|STARTED|Double-Blind Treatment Period||0
5287290|NCT00606684|12998483|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287291|NCT00606684|12998484|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287292|NCT00606684|12998485|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287293|NCT00606684|12998486|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287294|NCT00606684|12998487|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287295|NCT00606684|12998488|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
5287296|NCT00606684|12998489|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
5287297|NCT00606684|12998483|P7|COMPLETED|2-week Single-Blind Run-in Period||0
5287298|NCT00606684|12998484|P6|COMPLETED|2-week Single-Blind Run-in Period||0
5287299|NCT00606684|12998485|P5|COMPLETED|2-week Single-Blind Run-in Period||0
5287300|NCT00606684|12998486|P4|COMPLETED|2-week Single-Blind Run-in Period||0
5287301|NCT00606684|12998487|P3|COMPLETED|2-week Single-Blind Run-in Period||0
5287302|NCT00606684|12998488|P2|COMPLETED|2-week Single-Blind Run-in Period||0
5287303|NCT00606684|12998489|P1|COMPLETED|2-week Single-Blind Run-in Period||605
5287304|NCT00606684|12998483|P7|STARTED|2-week Single-Blind Run-in Period||0
5287305|NCT00606684|12998484|P6|STARTED|2-week Single-Blind Run-in Period||0
5287306|NCT00606684|12998485|P5|STARTED|2-week Single-Blind Run-in Period||0
5287307|NCT00606684|12998486|P4|STARTED|2-week Single-Blind Run-in Period||0
5287308|NCT00606684|12998487|P3|STARTED|2-week Single-Blind Run-in Period||0
5287309|NCT00606684|12998488|P2|STARTED|2-week Single-Blind Run-in Period||0
5287310|NCT00606684|12998489|P1|STARTED|2-week Single-Blind Run-in Period||851
5287311|NCT00606632|12998521|P1|NOT COMPLETED|Overall Study||22
5287312|NCT00606632|12998521|P1|COMPLETED|Overall Study||204
5287313|NCT00606632|12998521|P1|STARTED|Overall Study||226
5287314|NCT00606593|12998534|P10|NOT COMPLETED|Overall Study||0
5287315|NCT00606593|12998535|P9|NOT COMPLETED|Overall Study||1
5287316|NCT00606593|12998536|P8|NOT COMPLETED|Overall Study||2
5287317|NCT00606593|12998537|P7|NOT COMPLETED|Overall Study||1
5287318|NCT00606593|12998538|P6|NOT COMPLETED|Overall Study||0
5287319|NCT00606593|12998539|P5|NOT COMPLETED|Overall Study||1
5287320|NCT00606593|12998540|P4|NOT COMPLETED|Overall Study||1
5287321|NCT00606593|12998541|P3|NOT COMPLETED|Overall Study||2
5287322|NCT00606593|12998542|P2|NOT COMPLETED|Overall Study||0
5287323|NCT00606593|12998543|P1|NOT COMPLETED|Overall Study||1
5287324|NCT00606593|12998534|P10|COMPLETED|Overall Study||11
5287325|NCT00606593|12998535|P9|COMPLETED|Overall Study||11
5287326|NCT00606593|12998536|P8|COMPLETED|Overall Study||9
5287327|NCT00606593|12998537|P7|COMPLETED|Overall Study||10
5287328|NCT00606593|12998538|P6|COMPLETED|Overall Study||11
5287329|NCT00606593|12998539|P5|COMPLETED|Overall Study||11
5287330|NCT00606593|12998540|P4|COMPLETED|Overall Study||10
5287331|NCT00606593|12998541|P3|COMPLETED|Overall Study||9
5287332|NCT00606593|12998542|P2|COMPLETED|Overall Study||11
5287333|NCT00606593|12998543|P1|COMPLETED|Overall Study||10
5287334|NCT00606593|12998534|P10|5th Double-blind Treatment|Overall Study||11
5287335|NCT00606593|12998535|P9|5th Double-blind Treatment|Overall Study||11
5287336|NCT00606593|12998536|P8|5th Double-blind Treatment|Overall Study||9
5287337|NCT00606593|12998537|P7|5th Double-blind Treatment|Overall Study||10
5287338|NCT00606593|12998538|P6|5th Double-blind Treatment|Overall Study||11
5287339|NCT00606593|12998539|P5|5th Double-blind Treatment|Overall Study||11
5287340|NCT00606593|12998540|P4|5th Double-blind Treatment|Overall Study||10
5287341|NCT00606593|12998541|P3|5th Double-blind Treatment|Overall Study||9
5287342|NCT00606593|12998542|P2|5th Double-blind Treatment|Overall Study||11
5287343|NCT00606593|12998543|P1|5th Double-blind Treatment|Overall Study||10
5287344|NCT00606593|12998534|P10|4th Double-blind Treatment|Overall Study||11
5287345|NCT00606593|12998535|P9|4th Double-blind Treatment|Overall Study||11
5287346|NCT00606593|12998536|P8|4th Double-blind Treatment|Overall Study||9
5287347|NCT00606593|12998537|P7|4th Double-blind Treatment|Overall Study||10
5287348|NCT00606593|12998538|P6|4th Double-blind Treatment|Overall Study||11
5287349|NCT00606593|12998539|P5|4th Double-blind Treatment|Overall Study||11
5287350|NCT00606593|12998540|P4|4th Double-blind Treatment|Overall Study||10
5287351|NCT00606593|12998541|P3|4th Double-blind Treatment|Overall Study||10
5287352|NCT00606593|12998542|P2|4th Double-blind Treatment|Overall Study||11
5287353|NCT00606593|12998543|P1|4th Double-blind Treatment|Overall Study||10
5287354|NCT00606593|12998534|P10|3rd Double-blind Treatment|Overall Study||11
5287355|NCT00606593|12998535|P9|3rd Double-blind Treatment|Overall Study||12
5287356|NCT00606593|12998536|P8|3rd Double-blind Treatment|Overall Study||9
5287357|NCT00606593|12998537|P7|3rd Double-blind Treatment|Overall Study||10
5287358|NCT00606593|12998538|P6|3rd Double-blind Treatment|Overall Study||11
5287359|NCT00606593|12998539|P5|3rd Double-blind Treatment|Overall Study||11
5287360|NCT00606593|12998540|P4|3rd Double-blind Treatment|Overall Study||10
5287361|NCT00606593|12998541|P3|3rd Double-blind Treatment|Overall Study||10
5287362|NCT00606593|12998542|P2|3rd Double-blind Treatment|Overall Study||11
5287363|NCT00606593|12998543|P1|3rd Double-blind Treatment|Overall Study||11
5287364|NCT00606593|12998534|P10|2nd Double-blind Treatment|Overall Study||11
5287365|NCT00606593|12998535|P9|2nd Double-blind Treatment|Overall Study||12
5287366|NCT00606593|12998536|P8|2nd Double-blind Treatment|Overall Study||9
5287367|NCT00606593|12998537|P7|2nd Double-blind Treatment|Overall Study||10
5287368|NCT00606593|12998538|P6|2nd Double-blind Treatment|Overall Study||11
5287369|NCT00606593|12998539|P5|2nd Double-blind Treatment|Overall Study||12
5287370|NCT00606593|12998540|P4|2nd Double-blind Treatment|Overall Study||10
5287371|NCT00606593|12998541|P3|2nd Double-blind Treatment|Overall Study||11
5287372|NCT00606593|12998542|P2|2nd Double-blind Treatment|Overall Study||11
5287373|NCT00606593|12998543|P1|2nd Double-blind Treatment|Overall Study||11
5287374|NCT00606593|12998534|P10|1st Double-blind Treatment|Overall Study||11
5287375|NCT00606593|12998535|P9|1st Double-blind Treatment|Overall Study||12
5287376|NCT00606593|12998536|P8|1st Double-blind Treatment|Overall Study||11
5287377|NCT00606593|12998537|P7|1st Double-blind Treatment|Overall Study||11
5287378|NCT00606593|12998538|P6|1st Double-blind Treatment|Overall Study||11
5287379|NCT00606593|12998539|P5|1st Double-blind Treatment|Overall Study||12
5287380|NCT00606593|12998540|P4|1st Double-blind Treatment|Overall Study||11
5287381|NCT00606593|12998541|P3|1st Double-blind Treatment|Overall Study||11
5287382|NCT00606593|12998542|P2|1st Double-blind Treatment|Overall Study||11
5287383|NCT00606593|12998543|P1|1st Double-blind Treatment|Overall Study||11
5287384|NCT00606593|12998534|P10|STARTED|Overall Study|Randomized participants|11
5287385|NCT00606593|12998535|P9|STARTED|Overall Study|Randomized participants|12
5287386|NCT00606593|12998536|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
5287387|NCT00606593|12998537|P7|STARTED|Overall Study|Randomized participants|11
5287388|NCT00606593|12998538|P6|STARTED|Overall Study|Randomized participants|11
5287389|NCT00606593|12998539|P5|STARTED|Overall Study|Randomized participants|12
5287390|NCT00606593|12998540|P4|STARTED|Overall Study|Randomized participants|11
5287391|NCT00606593|12998541|P3|STARTED|Overall Study|Randomized participants|11
5287392|NCT00606593|12998542|P2|STARTED|Overall Study|Randomized participants|11
5287393|NCT00606593|12998543|P1|STARTED|Overall Study|Randomized participants|11
5287394|NCT00606580|12998564|P3|NOT COMPLETED|Overall Study||22
5287395|NCT00606580|12998565|P2|NOT COMPLETED|Overall Study||3
5287396|NCT00606580|12998566|P1|NOT COMPLETED|Overall Study||2
5287397|NCT00606580|12998564|P3|COMPLETED|Overall Study||103
5287398|NCT00606580|12998565|P2|COMPLETED|Overall Study||122
5287399|NCT00606580|12998566|P1|COMPLETED|Overall Study||123
5287400|NCT00606580|12998564|P3|STARTED|Overall Study||125
5287401|NCT00606580|12998565|P2|STARTED|Overall Study||125
5287402|NCT00606580|12998566|P1|STARTED|Overall Study||125
5287403|NCT00606554|12998609|P2|NOT COMPLETED|Overall Study||0
5287404|NCT00606554|12998610|P1|NOT COMPLETED|Overall Study||0
5287405|NCT00606554|12998609|P2|COMPLETED|Overall Study||18
5287406|NCT00606554|12998610|P1|COMPLETED|Overall Study||15
5287407|NCT00606554|12998609|P2|STARTED|Overall Study||18
5287408|NCT00606554|12998610|P1|STARTED|Overall Study||15
5287409|NCT00606502|12998632|P2|NOT COMPLETED|Treatment||3
5287410|NCT00606502|12998633|P1|NOT COMPLETED|Treatment||0
5287411|NCT00606502|12998632|P2|COMPLETED|Treatment||98
5287412|NCT00606502|12998633|P1|COMPLETED|Treatment||97
5287413|NCT00606502|12998632|P2|STARTED|Treatment||101
5287414|NCT00606502|12998633|P1|STARTED|Treatment||97
5287415|NCT00606502|12998632|P2|NOT COMPLETED|Randomization||0
5287416|NCT00606502|12998633|P1|NOT COMPLETED|Randomization||3
5287417|NCT00606502|12998632|P2|COMPLETED|Randomization||101
5287418|NCT00606502|12998633|P1|COMPLETED|Randomization||97
5287419|NCT00606502|12998632|P2|STARTED|Randomization||101
5287420|NCT00606502|12998633|P1|STARTED|Randomization||100
5287421|NCT00606489|12998647|P2|NOT COMPLETED|Overall Study||0
5287422|NCT00606489|12998648|P1|NOT COMPLETED|Overall Study||0
5287423|NCT00606489|12998647|P2|COMPLETED|Overall Study||40
5287424|NCT00606489|12998648|P1|COMPLETED|Overall Study||21
5287425|NCT00606489|12998647|P2|STARTED|Overall Study||40
5287426|NCT00606489|12998648|P1|STARTED|Overall Study||21
5287427|NCT00606320|12998654|P1|NOT COMPLETED|Overall Study||37
5287428|NCT00606320|12998654|P1|COMPLETED|Overall Study||22
5287429|NCT00606320|12998654|P1|STARTED|Overall Study||59
5287430|NCT00606307|12998659|P1|NOT COMPLETED|Overall Study||11
5287431|NCT00606307|12998659|P1|COMPLETED|Overall Study||18
5287432|NCT00606307|12998659|P1|STARTED|Overall Study||29
5287433|NCT00606294|12998667|P2|NOT COMPLETED|Overall Study||0
5287434|NCT00606294|12998668|P1|NOT COMPLETED|Overall Study||36
5287435|NCT00606294|12998667|P2|COMPLETED|Overall Study||19
5287436|NCT00606294|12998668|P1|COMPLETED|Overall Study||161
5287437|NCT00606294|12998667|P2|STARTED|Overall Study||19
5287438|NCT00606294|12998668|P1|STARTED|Overall Study||197
5287439|NCT00606281|12998682|P2|NOT COMPLETED|Overall Study||66
5287440|NCT00606281|12998683|P1|NOT COMPLETED|Overall Study||56
5287441|NCT00606281|12998682|P2|COMPLETED|Overall Study||64
5287442|NCT00606281|12998683|P1|COMPLETED|Overall Study||72
5287443|NCT00606281|12998682|P2|STARTED|Overall Study||130
5287444|NCT00606281|12998683|P1|STARTED|Overall Study||128
5287445|NCT00606229|12998691|P1|NOT COMPLETED|Overall Study||22
5287446|NCT00606229|12998691|P1|COMPLETED|Overall Study||19
5287447|NCT00606229|12998691|P1|STARTED|Overall Study||41
5287448|NCT00606177|12998698|P2|NOT COMPLETED|Overall Study||25
5287449|NCT00606177|12998699|P1|NOT COMPLETED|Overall Study||27
5287450|NCT00606177|12998698|P2|COMPLETED|Overall Study||19
5287451|NCT00606177|12998699|P1|COMPLETED|Overall Study||28
5287452|NCT00606177|12998698|P2|STARTED|Overall Study||44
5287453|NCT00606177|12998699|P1|STARTED|Overall Study||55
5287454|NCT00606138|12998709|P2|NOT COMPLETED|Overall Study||0
5287455|NCT00606138|12998710|P1|NOT COMPLETED|Overall Study||0
5287456|NCT00606138|12998709|P2|COMPLETED|Overall Study||2
5287457|NCT00606138|12998710|P1|COMPLETED|Overall Study||6
5287458|NCT00606138|12998709|P2|STARTED|Overall Study||2
5287459|NCT00606138|12998710|P1|STARTED|Overall Study||6
5287460|NCT00606086|12998726|P2|NOT COMPLETED|Overall Study||15
5287461|NCT00606086|12998727|P1|NOT COMPLETED|Overall Study||12
5287462|NCT00606086|12998726|P2|COMPLETED|Overall Study||53
5287463|NCT00606086|12998727|P1|COMPLETED|Overall Study||60
5287464|NCT00606086|12998726|P2|STARTED|Overall Study||68
5287465|NCT00606086|12998727|P1|STARTED|Overall Study||72
5287466|NCT00606047|12998733|P1|NOT COMPLETED|Overall Study||0
5287467|NCT00606047|12998733|P1|COMPLETED|Overall Study||200
5287468|NCT00606047|12998733|P1|STARTED|Overall Study||200
5287469|NCT00606034|12998737|P1|NOT COMPLETED|Overall Study||1
5287470|NCT00606034|12998737|P1|COMPLETED|Overall Study||20
5287471|NCT00606034|12998737|P1|STARTED|Overall Study||21
5287472|NCT00606021|12998745|P3|NOT COMPLETED|Maintenance Phase||17
5287473|NCT00606021|12998746|P2|NOT COMPLETED|Maintenance Phase||23
5287474|NCT00606021|12998747|P1|NOT COMPLETED|Maintenance Phase||0
5287475|NCT00606021|12998745|P3|COMPLETED|Maintenance Phase||10
5287476|NCT00606021|12998746|P2|COMPLETED|Maintenance Phase||5
5287477|NCT00606021|12998747|P1|COMPLETED|Maintenance Phase||0
5287478|NCT00606021|12998745|P3|STARTED|Maintenance Phase||27
5287479|NCT00606021|12998746|P2|STARTED|Maintenance Phase||28
5287480|NCT00606021|12998747|P1|STARTED|Maintenance Phase||0
5287481|NCT00606021|12998745|P3|NOT COMPLETED|Induction Phase||0
5287482|NCT00606021|12998746|P2|NOT COMPLETED|Induction Phase||0
5287483|NCT00606021|12998747|P1|NOT COMPLETED|Induction Phase||87
5287484|NCT00606021|12998745|P3|COMPLETED|Induction Phase||0
5287485|NCT00606021|12998746|P2|COMPLETED|Induction Phase||0
5287486|NCT00606021|12998747|P1|COMPLETED|Induction Phase||19
5287487|NCT00606021|12998745|P3|STARTED|Induction Phase||0
5287488|NCT00606021|12998746|P2|STARTED|Induction Phase||0
5287489|NCT00606021|12998747|P1|STARTED|Induction Phase||106
5287490|NCT00606008|12998765|P1|NOT COMPLETED|Overall Study||5
5287491|NCT00606008|12998765|P1|COMPLETED|Overall Study||25
5287492|NCT00606008|12998765|P1|STARTED|Overall Study||30
5287493|NCT00605917|12998779|P1|NOT COMPLETED|Overall Study||79
5287494|NCT00605917|12998779|P1|COMPLETED|Overall Study||908
5287495|NCT00605917|12998779|P1|STARTED|Overall Study||987
5287496|NCT00605904|12998820|P2|NOT COMPLETED|Infusion Sessions||3
5287497|NCT00605904|12998821|P1|NOT COMPLETED|Infusion Sessions||1
5287498|NCT00605904|12998820|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
5287499|NCT00605904|12998821|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
5287500|NCT00605904|12998820|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
5287501|NCT00605904|12998821|P1|Yohimbine Infusion|Infusion Sessions||12
5287502|NCT00605904|12998820|P2|mCPP Infusion|Infusion Sessions||13
5287503|NCT00605904|12998821|P1|mCPP Infusion|Infusion Sessions||12
5287504|NCT00605904|12998820|P2|Saline Infusion|Infusion Sessions||14
5287505|NCT00605904|12998821|P1|Saline Infusion|Infusion Sessions||13
5287506|NCT00605904|12998820|P2|STARTED|Infusion Sessions||16
5287507|NCT00605904|12998821|P1|STARTED|Infusion Sessions||13
5287508|NCT00605904|12998820|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
5287509|NCT00605904|12998821|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
5287510|NCT00605904|12998820|P2|COMPLETED|Baseline Data Collection and Dosing||16
5287511|NCT00605904|12998821|P1|COMPLETED|Baseline Data Collection and Dosing||13
5287512|NCT00605904|12998820|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
5287513|NCT00605904|12998821|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
5287514|NCT00605865|12998831|P1|NOT COMPLETED|Overall Study||115
5287515|NCT00605865|12998831|P1|COMPLETED|Overall Study||2157
5287516|NCT00605865|12998831|P1|STARTED|Overall Study||2272
5287517|NCT00605839|12998873|P3|NOT COMPLETED|Overall Study||0
5287518|NCT00605839|12998874|P2|NOT COMPLETED|Overall Study||0
5287519|NCT00605839|12998875|P1|NOT COMPLETED|Overall Study||1
5287520|NCT00605839|12998873|P3|COMPLETED|Overall Study||28
5287521|NCT00605839|12998874|P2|COMPLETED|Overall Study||37
5287522|NCT00605839|12998875|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
5287523|NCT00605839|12998873|P3|STARTED|Overall Study||28
5287524|NCT00605839|12998874|P2|STARTED|Overall Study||37
5287525|NCT00605839|12998875|P1|STARTED|Overall Study||40
5287526|NCT00605813|12998883|P1|NOT COMPLETED|Overall Study||25
5287527|NCT00605813|12998883|P1|COMPLETED|Overall Study||517
5287528|NCT00605813|12998883|P1|STARTED|Overall Study||542
5287529|NCT00605722|12998896|P1|NOT COMPLETED|Overall Study||51
5287530|NCT00605722|12998896|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
5287531|NCT00605722|12998896|P1|STARTED|Overall Study||51
5287532|NCT00605696|12998908|P2|NOT COMPLETED|Overall Study||0
5287533|NCT00605696|12998909|P1|NOT COMPLETED|Overall Study||0
5287534|NCT00605696|12998908|P2|COMPLETED|Overall Study||11
5287535|NCT00605696|12998909|P1|COMPLETED|Overall Study||7
5287536|NCT00605696|12998908|P2|STARTED|Overall Study||11
5287537|NCT00605696|12998909|P1|STARTED|Overall Study||7
5287538|NCT00605657|12998917|P1|NOT COMPLETED|Overall Study||2
5287539|NCT00605657|12998917|P1|COMPLETED|Overall Study||3
5287540|NCT00605657|12998917|P1|STARTED|Overall Study||5
5287541|NCT00605566|12998922|P1|NOT COMPLETED|Overall Study||3
5287542|NCT00605566|12998922|P1|COMPLETED|Overall Study||19
5287543|NCT00605566|12998922|P1|STARTED|Overall Study||22
5287544|NCT00605540|12998930|P1|NOT COMPLETED|Overall Study||38
5287545|NCT00605540|12998930|P1|COMPLETED|Overall Study||95
5287546|NCT00605540|12998930|P1|STARTED|Overall Study||133
5287547|NCT00605475|12998948|P10|NOT COMPLETED|Overall Study||2
5287548|NCT00605475|12998949|P9|NOT COMPLETED|Overall Study||2
5287549|NCT00605475|12998950|P8|NOT COMPLETED|Overall Study||0
5287550|NCT00605475|12998951|P7|NOT COMPLETED|Overall Study||1
5287551|NCT00605475|12998952|P6|NOT COMPLETED|Overall Study||2
5287552|NCT00605475|12998953|P5|NOT COMPLETED|Overall Study||1
5287553|NCT00605475|12998954|P4|NOT COMPLETED|Overall Study||0
5287554|NCT00605475|12998955|P3|NOT COMPLETED|Overall Study||0
5287555|NCT00605475|12998956|P2|NOT COMPLETED|Overall Study||0
5287556|NCT00605475|12998957|P1|NOT COMPLETED|Overall Study||0
5287557|NCT00605475|12998948|P10|COMPLETED|Overall Study||8
5287558|NCT00605475|12998949|P9|COMPLETED|Overall Study||18
5287559|NCT00605475|12998950|P8|COMPLETED|Overall Study||24
5287560|NCT00605475|12998951|P7|COMPLETED|Overall Study||22
5287561|NCT00605475|12998952|P6|COMPLETED|Overall Study||22
5287562|NCT00605475|12998953|P5|COMPLETED|Overall Study||24
5287563|NCT00605475|12998954|P4|COMPLETED|Overall Study||45
5287564|NCT00605475|12998955|P3|COMPLETED|Overall Study||45
5287565|NCT00605475|12998956|P2|COMPLETED|Overall Study||5
5287566|NCT00605475|12998957|P1|COMPLETED|Overall Study||10
5287567|NCT00605475|12998948|P10|STARTED|Overall Study||10
5287568|NCT00605475|12998949|P9|STARTED|Overall Study||20
5287569|NCT00605475|12998950|P8|STARTED|Overall Study||24
5287570|NCT00605475|12998951|P7|STARTED|Overall Study||23
5287571|NCT00605475|12998952|P6|STARTED|Overall Study||24
5287572|NCT00605475|12998953|P5|STARTED|Overall Study||25
5287573|NCT00605475|12998954|P4|STARTED|Overall Study||45
5287574|NCT00605475|12998955|P3|STARTED|Overall Study||45
5287575|NCT00605475|12998956|P2|STARTED|Overall Study||5
5287576|NCT00605475|12998957|P1|STARTED|Overall Study||10
5287577|NCT00605423|12999081|P2|NOT COMPLETED|Overall Study||0
5287578|NCT00605423|12999082|P1|NOT COMPLETED|Overall Study||0
5287579|NCT00605423|12999081|P2|COMPLETED|Overall Study||2
5287580|NCT00605423|12999082|P1|COMPLETED|Overall Study||4
5287581|NCT00605423|12999081|P2|STARTED|Overall Study||2
5287582|NCT00605423|12999082|P1|STARTED|Overall Study||4
5287583|NCT00605384|12999094|P2|NOT COMPLETED|Overall Study||1
5287584|NCT00605384|12999095|P1|NOT COMPLETED|Overall Study||1
5287585|NCT00605384|12999094|P2|COMPLETED|Overall Study|study terminated early|0
5287586|NCT00605384|12999095|P1|COMPLETED|Overall Study|study terminated early|0
5287587|NCT00605384|12999094|P2|STARTED|Overall Study||1
5287588|NCT00605384|12999095|P1|STARTED|Overall Study||1
5287589|NCT00605358|12999125|P2|NOT COMPLETED|Overall Study||0
5287590|NCT00605358|12999126|P1|NOT COMPLETED|Overall Study||0
5287591|NCT00605358|12999125|P2|COMPLETED|Overall Study||80
5287592|NCT00605358|12999126|P1|COMPLETED|Overall Study||81
5287593|NCT00605358|12999125|P2|STARTED|Overall Study||80
5287594|NCT00605358|12999126|P1|STARTED|Overall Study||81
5287595|NCT00605345|12999134|P2|NOT COMPLETED|Overall Study||3
5287596|NCT00605345|12999135|P1|NOT COMPLETED|Overall Study||1
5287597|NCT00605345|12999134|P2|COMPLETED|Overall Study||22
5287598|NCT00605345|12999135|P1|COMPLETED|Overall Study||45
5287599|NCT00605345|12999134|P2|STARTED|Overall Study||25
5287600|NCT00605345|12999135|P1|STARTED|Overall Study||46
5287601|NCT00605319|12999151|P1|NOT COMPLETED|Overall Study||6
5287602|NCT00605319|12999151|P1|COMPLETED|Overall Study||11
5287603|NCT00605319|12999151|P1|STARTED|Overall Study||17
5287604|NCT00605306|12999163|P2|NOT COMPLETED|Overall Study||1
5287605|NCT00605306|12999164|P1|NOT COMPLETED|Overall Study||0
5287606|NCT00605306|12999163|P2|COMPLETED|Overall Study||13
5287607|NCT00605306|12999164|P1|COMPLETED|Overall Study||14
5287608|NCT00605306|12999163|P2|STARTED|Overall Study||14
5287609|NCT00605306|12999164|P1|STARTED|Overall Study||14
5287610|NCT00605293|12999178|P2|NOT COMPLETED|Overall Study||5
5287611|NCT00605293|12999179|P1|NOT COMPLETED|Overall Study||17
5287612|NCT00605293|12999178|P2|COMPLETED|Overall Study||31
5287613|NCT00605293|12999179|P1|COMPLETED|Overall Study||48
5287614|NCT00605293|12999178|P2|STARTED|Overall Study||36
5287615|NCT00605293|12999179|P1|STARTED|Overall Study||65
5287616|NCT00605280|12999199|P4|NOT COMPLETED|Year 3 Extension||9
5287617|NCT00605280|12999200|P3|NOT COMPLETED|Year 3 Extension||0
5287618|NCT00605280|12999201|P2|NOT COMPLETED|Year 3 Extension||0
5287619|NCT00605280|12999202|P1|NOT COMPLETED|Year 3 Extension||8
5287620|NCT00605280|12999199|P4|COMPLETED|Year 3 Extension||45
5287621|NCT00605280|12999200|P3|COMPLETED|Year 3 Extension||0
5287622|NCT00605280|12999201|P2|COMPLETED|Year 3 Extension||0
5287623|NCT00605280|12999202|P1|COMPLETED|Year 3 Extension||38
5287624|NCT00605280|12999199|P4|Received 0.3 mg Treatment|Year 3 Extension||54
5287625|NCT00605280|12999200|P3|Received 0.3 mg Treatment|Year 3 Extension||0
5287626|NCT00605280|12999201|P2|Received 0.3 mg Treatment|Year 3 Extension||0
5287627|NCT00605280|12999202|P1|Received 0.3 mg Treatment|Year 3 Extension||46
5287628|NCT00605280|12999199|P4|STARTED|Year 3 Extension||54
5287629|NCT00605280|12999200|P3|STARTED|Year 3 Extension||0
5287630|NCT00605280|12999201|P2|STARTED|Year 3 Extension||0
5287631|NCT00605280|12999202|P1|STARTED|Year 3 Extension||46
5287632|NCT00605280|12999199|P4|NOT COMPLETED|Year 2||22
5287633|NCT00605280|12999200|P3|NOT COMPLETED|Year 2||6
5287634|NCT00605280|12999201|P2|NOT COMPLETED|Year 2||6
5287635|NCT00605280|12999202|P1|NOT COMPLETED|Year 2||24
5287636|NCT00605280|12999199|P4|COMPLETED|Year 2||102
5287637|NCT00605280|12999200|P3|COMPLETED|Year 2||0
5287638|NCT00605280|12999201|P2|COMPLETED|Year 2||5
5287639|NCT00605280|12999202|P1|COMPLETED|Year 2||102
5287640|NCT00605280|12999199|P4|Received 0.3 mg Treatment|Year 2||0
5287641|NCT00605280|12999200|P3|Received 0.3 mg Treatment|Year 2||2
5287642|NCT00605280|12999201|P2|Received 0.3 mg Treatment|Year 2||3
5287643|NCT00605280|12999202|P1|Received 0.3 mg Treatment|Year 2||126
5287644|NCT00605280|12999199|P4|STARTED|Year 2||124
5287645|NCT00605280|12999200|P3|STARTED|Year 2||6
5287646|NCT00605280|12999201|P2|STARTED|Year 2||11
5287647|NCT00605280|12999202|P1|STARTED|Year 2||126
5287648|NCT00605280|12999199|P4|NOT COMPLETED|Year 1||19
5287649|NCT00605280|12999200|P3|NOT COMPLETED|Year 1||1
5287650|NCT00605280|12999201|P2|NOT COMPLETED|Year 1||11
5287651|NCT00605280|12999202|P1|NOT COMPLETED|Year 1||19
5287652|NCT00605280|12999199|P4|COMPLETED|Year 1||124
5287653|NCT00605280|12999200|P3|COMPLETED|Year 1||6
5287654|NCT00605280|12999201|P2|COMPLETED|Year 1||11
5287655|NCT00605280|12999202|P1|COMPLETED|Year 1||126
5287656|NCT00605280|12999199|P4|Received 0.3 mg Treatment|Year 1||0
5287657|NCT00605280|12999200|P3|Received 0.3 mg Treatment|Year 1||3
5287658|NCT00605280|12999201|P2|Received 0.3 mg Treatment|Year 1||13
5287659|NCT00605280|12999202|P1|Received 0.3 mg Treatment|Year 1||144
5287660|NCT00605280|12999199|P4|STARTED|Year 1||143
5287661|NCT00605280|12999200|P3|STARTED|Year 1||7
5287662|NCT00605280|12999201|P2|STARTED|Year 1||22
5287663|NCT00605280|12999202|P1|STARTED|Year 1||145
5287664|NCT00605267|12999236|P2|NOT COMPLETED|Overall Study||9
5287665|NCT00605267|12999237|P1|NOT COMPLETED|Overall Study||3
5287666|NCT00605267|12999236|P2|COMPLETED|Overall Study|Breast surgery performed|90
5287667|NCT00605267|12999237|P1|COMPLETED|Overall Study|Breast surgery performed|95
5287668|NCT00605267|12999236|P2|STARTED|Overall Study||99
5287669|NCT00605267|12999237|P1|STARTED|Overall Study||98
5287670|NCT00605202|12999275|P2|NOT COMPLETED|Second Intervention||0
5287671|NCT00605202|12999276|P1|NOT COMPLETED|Second Intervention||0
5287672|NCT00605202|12999275|P2|COMPLETED|Second Intervention||5
5287673|NCT00605202|12999276|P1|COMPLETED|Second Intervention||5
5287674|NCT00605202|12999275|P2|STARTED|Second Intervention||5
5287675|NCT00605202|12999276|P1|STARTED|Second Intervention||5
5287676|NCT00605202|12999275|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
5287677|NCT00605202|12999276|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
5287678|NCT00605202|12999275|P2|COMPLETED|Washout Period of 3 Weeks||5
5287679|NCT00605202|12999276|P1|COMPLETED|Washout Period of 3 Weeks||5
5287680|NCT00605202|12999275|P2|STARTED|Washout Period of 3 Weeks||5
5287681|NCT00605202|12999276|P1|STARTED|Washout Period of 3 Weeks||5
5287682|NCT00605202|12999275|P2|NOT COMPLETED|First Intervention||0
5287683|NCT00605202|12999276|P1|NOT COMPLETED|First Intervention||0
5287684|NCT00605202|12999275|P2|COMPLETED|First Intervention||5
5287685|NCT00605202|12999276|P1|COMPLETED|First Intervention||5
5287686|NCT00605202|12999275|P2|STARTED|First Intervention||5
5287687|NCT00605202|12999276|P1|STARTED|First Intervention||5
5287688|NCT00605189|12999285|P3|NOT COMPLETED|Overall Study||0
5287689|NCT00605189|12999286|P2|NOT COMPLETED|Overall Study||2
5287690|NCT00605189|12999287|P1|NOT COMPLETED|Overall Study||3
5287691|NCT00605189|12999285|P3|COMPLETED|Overall Study||9
5287692|NCT00605189|12999286|P2|COMPLETED|Overall Study||19
5287693|NCT00605189|12999287|P1|COMPLETED|Overall Study||17
5287694|NCT00605189|12999285|P3|STARTED|Overall Study||9
5287695|NCT00605189|12999286|P2|STARTED|Overall Study||21
5287696|NCT00605189|12999287|P1|STARTED|Overall Study||20
5287697|NCT00605176|12999298|P3|NOT COMPLETED|Overall Study||9
5287698|NCT00605176|12999299|P2|NOT COMPLETED|Overall Study||6
5287699|NCT00605176|12999300|P1|NOT COMPLETED|Overall Study||11
5287700|NCT00605176|12999298|P3|COMPLETED|Overall Study||150
5287701|NCT00605176|12999299|P2|COMPLETED|Overall Study||154
5287702|NCT00605176|12999300|P1|COMPLETED|Overall Study||149
5287703|NCT00605176|12999298|P3|STARTED|Overall Study||159
5287704|NCT00605176|12999299|P2|STARTED|Overall Study||160
5287705|NCT00605176|12999300|P1|STARTED|Overall Study||160
5287706|NCT00605150|12999317|P1|NOT COMPLETED|Overall Study||1
5287707|NCT00605150|12999317|P1|COMPLETED|Overall Study||10
5287708|NCT00605150|12999317|P1|STARTED|Overall Study|11 started|11
5287709|NCT00605085|12999324|P2|NOT COMPLETED|Overall Study||25
5287710|NCT00605085|12999325|P1|NOT COMPLETED|Overall Study||50
5287711|NCT00605085|12999324|P2|COMPLETED|Overall Study||638
5287712|NCT00605085|12999325|P1|COMPLETED|Overall Study||1962
5287713|NCT00605085|12999324|P2|STARTED|Overall Study||663
5287714|NCT00605085|12999325|P1|STARTED|Overall Study||2012
5287715|NCT00605072|12999334|P3|NOT COMPLETED|Overall Study||4
5287716|NCT00605072|12999335|P2|NOT COMPLETED|Overall Study||11
5287717|NCT00605072|12999336|P1|NOT COMPLETED|Overall Study||7
5287718|NCT00605072|12999334|P3|COMPLETED|Overall Study||11
5287719|NCT00605072|12999335|P2|COMPLETED|Overall Study||9
5287720|NCT00605072|12999336|P1|COMPLETED|Overall Study||11
5287721|NCT00605072|12999334|P3|STARTED|Overall Study||15
5287722|NCT00605072|12999335|P2|STARTED|Overall Study||20
5287723|NCT00605072|12999336|P1|STARTED|Overall Study||18
5287724|NCT00605033|12999358|P2|NOT COMPLETED|Overall Study||8
5287725|NCT00605033|12999359|P1|NOT COMPLETED|Overall Study||7
5287726|NCT00605033|12999358|P2|COMPLETED|Overall Study||90
5287727|NCT00605033|12999359|P1|COMPLETED|Overall Study||136
5287728|NCT00605033|12999358|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
5287729|NCT00605033|12999359|P1|STARTED|Overall Study||143
5287730|NCT00604968|12999365|P1|NOT COMPLETED|Overall Study||0
5287731|NCT00604968|12999365|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
5287732|NCT00604968|12999365|P1|STARTED|Overall Study||25
5287733|NCT00604890|12999382|P4|NOT COMPLETED|Overall Study||4
5287734|NCT00604890|12999383|P3|NOT COMPLETED|Overall Study||1
5287735|NCT00604890|12999384|P2|NOT COMPLETED|Overall Study||0
5287736|NCT00604890|12999385|P1|NOT COMPLETED|Overall Study||3
5287737|NCT00604890|12999382|P4|COMPLETED|Overall Study||42
5287738|NCT00604890|12999383|P3|COMPLETED|Overall Study||47
5287739|NCT00604890|12999384|P2|COMPLETED|Overall Study||45
5287740|NCT00604890|12999385|P1|COMPLETED|Overall Study||44
5287741|NCT00604890|12999382|P4|STARTED|Overall Study||46
5287742|NCT00604890|12999383|P3|STARTED|Overall Study||48
5287743|NCT00604890|12999384|P2|STARTED|Overall Study||45
5287744|NCT00604890|12999385|P1|STARTED|Overall Study||47
5287745|NCT00604825|12999403|P4|NOT COMPLETED|Overall Study||11
5287746|NCT00604825|12999404|P3|NOT COMPLETED|Overall Study||16
5287747|NCT00604825|12999405|P2|NOT COMPLETED|Overall Study||15
5287748|NCT00604825|12999406|P1|NOT COMPLETED|Overall Study||9
5287749|NCT00604825|12999403|P4|COMPLETED|Overall Study||79
5287750|NCT00604825|12999404|P3|COMPLETED|Overall Study||73
5287751|NCT00604825|12999405|P2|COMPLETED|Overall Study||72
5287752|NCT00604825|12999406|P1|COMPLETED|Overall Study||81
5287753|NCT00604825|12999403|P4|STARTED|Overall Study||90
5287754|NCT00604825|12999404|P3|STARTED|Overall Study||89
5287755|NCT00604825|12999405|P2|STARTED|Overall Study||87
5287756|NCT00604825|12999406|P1|STARTED|Overall Study||90
5287757|NCT00604812|12999607|P6|NOT COMPLETED|Overall Study||0
5287758|NCT00604812|12999608|P5|NOT COMPLETED|Overall Study||0
5287759|NCT00604812|12999609|P4|NOT COMPLETED|Overall Study||0
5287760|NCT00604812|12999610|P3|NOT COMPLETED|Overall Study||0
5287761|NCT00604812|12999611|P2|NOT COMPLETED|Overall Study||0
5287762|NCT00604812|12999612|P1|NOT COMPLETED|Overall Study||0
5287763|NCT00604812|12999607|P6|COMPLETED|Overall Study||1
5287764|NCT00604812|12999608|P5|COMPLETED|Overall Study||5
5287765|NCT00604812|12999609|P4|COMPLETED|Overall Study||3
5287766|NCT00604812|12999610|P3|COMPLETED|Overall Study||10
5287767|NCT00604812|12999611|P2|COMPLETED|Overall Study||3
5287768|NCT00604812|12999612|P1|COMPLETED|Overall Study||9
5287769|NCT00604812|12999607|P6|STARTED|Overall Study||1
5287770|NCT00604812|12999608|P5|STARTED|Overall Study||5
5287771|NCT00604812|12999609|P4|STARTED|Overall Study||3
5287772|NCT00604812|12999610|P3|STARTED|Overall Study||10
5287773|NCT00604812|12999611|P2|STARTED|Overall Study||3
5287774|NCT00604812|12999612|P1|STARTED|Overall Study||9
5287775|NCT00604786|12999634|P2|NOT COMPLETED|Overall Study||0
5287776|NCT00604786|12999635|P1|NOT COMPLETED|Overall Study||2
5287777|NCT00604786|12999634|P2|COMPLETED|Overall Study||4
5287778|NCT00604786|12999635|P1|COMPLETED|Overall Study||12
5287779|NCT00604786|12999634|P2|STARTED|Overall Study||4
5287780|NCT00604786|12999635|P1|STARTED|Overall Study||14
5287781|NCT00604721|12999641|P1|NOT COMPLETED|Overall Study||2
5287782|NCT00604721|12999641|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
5287783|NCT00604721|12999641|P1|STARTED|Overall Study||19
5287784|NCT00604708|12999649|P2|NOT COMPLETED|Overall Study||40
5287785|NCT00604708|12999650|P1|NOT COMPLETED|Overall Study||31
5287786|NCT00604708|12999649|P2|COMPLETED|Overall Study||397
5287787|NCT00604708|12999650|P1|COMPLETED|Overall Study||399
5287788|NCT00604708|12999649|P2|STARTED|Overall Study||437
5287789|NCT00604708|12999650|P1|STARTED|Overall Study||430
5287790|NCT00604695|12999660|P2|NOT COMPLETED|Overall Study||4
5287791|NCT00604695|12999661|P1|NOT COMPLETED|Overall Study||0
5287792|NCT00604695|12999660|P2|COMPLETED|Overall Study||16
5287793|NCT00604695|12999661|P1|COMPLETED|Overall Study||20
5287794|NCT00604695|12999660|P2|STARTED|Overall Study||20
5287795|NCT00604695|12999661|P1|STARTED|Overall Study||20
5287796|NCT00604669|12999683|P1|NOT COMPLETED|Overall Study||7
5287797|NCT00604669|12999683|P1|COMPLETED|Overall Study||163
5287798|NCT00604669|12999683|P1|STARTED|Overall Study||170
5287799|NCT00604565|12999689|P2|NOT COMPLETED|Overall Study||3
5287800|NCT00604565|12999690|P1|NOT COMPLETED|Overall Study||0
5287801|NCT00604565|12999689|P2|COMPLETED|Overall Study||4
5287802|NCT00604565|12999690|P1|COMPLETED|Overall Study||4
5287803|NCT00604565|12999689|P2|STARTED|Overall Study||7
5287804|NCT00604565|12999690|P1|STARTED|Overall Study||4
5287805|NCT00604552|12999700|P2|NOT COMPLETED|Overall Study||0
5287806|NCT00604552|12999701|P1|NOT COMPLETED|Overall Study||0
5287807|NCT00604552|12999700|P2|COMPLETED|Overall Study||160
5287808|NCT00604552|12999701|P1|COMPLETED|Overall Study||189
5287809|NCT00604552|12999700|P2|STARTED|Overall Study||160
5287810|NCT00604552|12999701|P1|STARTED|Overall Study||189
5287811|NCT00604500|12999709|P1|NOT COMPLETED|Overall Study||11
5287812|NCT00604500|12999709|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
5287813|NCT00604500|12999709|P1|STARTED|Overall Study||272
5287814|NCT00604461|12999716|P1|NOT COMPLETED|Overall Study||1
5287815|NCT00604461|12999716|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
5287816|NCT00604461|12999716|P1|STARTED|Overall Study||13
5287817|NCT00604383|12999723|P2|NOT COMPLETED|Overall Study||84
5287818|NCT00604383|12999724|P1|NOT COMPLETED|Overall Study||87
5287819|NCT00604383|12999723|P2|COMPLETED|Overall Study||256
5287820|NCT00604383|12999724|P1|COMPLETED|Overall Study||258
5287821|NCT00604383|12999723|P2|Received Extended Treatment|Overall Study||141
5287822|NCT00604383|12999724|P1|Received Extended Treatment|Overall Study||136
5287823|NCT00604383|12999723|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
5287824|NCT00604383|12999724|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
5287825|NCT00604383|12999723|P2|STARTED|Overall Study||340
5287826|NCT00604383|12999724|P1|STARTED|Overall Study||345
5287827|NCT00604279|12999740|P2|NOT COMPLETED|Overall Study||38
5287828|NCT00604279|12999741|P1|NOT COMPLETED|Overall Study||64
5287829|NCT00604279|12999740|P2|COMPLETED|Overall Study||185
5287830|NCT00604279|12999741|P1|COMPLETED|Overall Study||165
5287831|NCT00604279|12999740|P2|STARTED|Overall Study||223
5287832|NCT00604279|12999741|P1|STARTED|Overall Study||229
5287833|NCT00604214|12999757|P2|NOT COMPLETED|Day 91 to Day 180||32
5287834|NCT00604214|12999758|P1|NOT COMPLETED|Day 91 to Day 180||26
5287835|NCT00604214|12999757|P2|COMPLETED|Day 91 to Day 180||521
5287836|NCT00604214|12999758|P1|COMPLETED|Day 91 to Day 180||529
5287837|NCT00604214|12999757|P2|STARTED|Day 91 to Day 180||553
5287838|NCT00604214|12999758|P1|STARTED|Day 91 to Day 180||555
5287839|NCT00604214|12999757|P2|NOT COMPLETED|Day 29 to Day 90||79
5287840|NCT00604214|12999758|P1|NOT COMPLETED|Day 29 to Day 90||68
5287841|NCT00604214|12999757|P2|COMPLETED|Day 29 to Day 90||553
5287842|NCT00604214|12999758|P1|COMPLETED|Day 29 to Day 90||555
5287843|NCT00604214|12999757|P2|STARTED|Day 29 to Day 90||632
5287844|NCT00604214|12999758|P1|STARTED|Day 29 to Day 90||623
5287845|NCT00604214|12999757|P2|NOT COMPLETED|Baseline to Day 28||213
5287846|NCT00604214|12999758|P1|NOT COMPLETED|Baseline to Day 28||228
5287847|NCT00604214|12999757|P2|COMPLETED|Baseline to Day 28||632
5287848|NCT00604214|12999758|P1|COMPLETED|Baseline to Day 28||623
5287849|NCT00604214|12999757|P2|Received Study Drug|Baseline to Day 28||833
5287850|NCT00604214|12999758|P1|Received Study Drug|Baseline to Day 28||833
5287851|NCT00604214|12999757|P2|STARTED|Baseline to Day 28||845
5287852|NCT00604214|12999758|P1|STARTED|Baseline to Day 28||851
5287853|NCT00604201|12999788|P1|NOT COMPLETED|Overall Study||10
5287854|NCT00604201|12999788|P1|COMPLETED|Overall Study||21
5287855|NCT00604201|12999788|P1|STARTED|Overall Study||31
5287856|NCT00604188|12999806|P2|NOT COMPLETED|Overall Study||25
5287857|NCT00604188|12999807|P1|NOT COMPLETED|Overall Study||27
5287858|NCT00604188|12999806|P2|COMPLETED|Overall Study||70
5287859|NCT00604188|12999807|P1|COMPLETED|Overall Study||66
5287860|NCT00604188|12999806|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
5287861|NCT00604188|12999807|P1|STARTED|Overall Study||93
5287862|NCT00604175|12999830|P3|NOT COMPLETED|Week 29 Through Week 72||4
5287863|NCT00604175|12999831|P2|NOT COMPLETED|Week 29 Through Week 72||7
5287864|NCT00604175|12999832|P1|NOT COMPLETED|Week 29 Through Week 72||12
5287865|NCT00604175|12999830|P3|COMPLETED|Week 29 Through Week 72||89
5287866|NCT00604175|12999831|P2|COMPLETED|Week 29 Through Week 72||85
5287867|NCT00604175|12999832|P1|COMPLETED|Week 29 Through Week 72||108
5287868|NCT00604175|12999830|P3|STARTED|Week 29 Through Week 72||93
5287869|NCT00604175|12999831|P2|STARTED|Week 29 Through Week 72||92
5287870|NCT00604175|12999832|P1|STARTED|Week 29 Through Week 72||120
5287871|NCT00604175|12999830|P3|NOT COMPLETED|Entry Through Week 28||1
5287872|NCT00604175|12999831|P2|NOT COMPLETED|Entry Through Week 28||3
5287873|NCT00604175|12999832|P1|NOT COMPLETED|Entry Through Week 28||10
5287874|NCT00604175|12999830|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
5287875|NCT00604175|12999831|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
5287876|NCT00604175|12999832|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
5287877|NCT00604175|12999830|P3|STARTED|Entry Through Week 28||94
5287878|NCT00604175|12999831|P2|STARTED|Entry Through Week 28||95
5287879|NCT00604175|12999832|P1|STARTED|Entry Through Week 28||130
5287880|NCT00604162|12999885|P1|NOT COMPLETED|Overall Study||4
5287881|NCT00604162|12999885|P1|COMPLETED|Overall Study||328
5287882|NCT00604162|12999885|P1|STARTED|Overall Study||332
5287883|NCT00604045|12999898|P2|NOT COMPLETED|Overall Study||1
5287884|NCT00604045|12999899|P1|NOT COMPLETED|Overall Study||1
5287885|NCT00604045|12999898|P2|COMPLETED|Overall Study||9
5287886|NCT00604045|12999899|P1|COMPLETED|Overall Study||14
5287887|NCT00604045|12999898|P2|STARTED|Overall Study||10
5287888|NCT00604045|12999899|P1|STARTED|Overall Study||15
5287889|NCT00604019|12999907|P2|NOT COMPLETED|Overall Study||0
5287890|NCT00604019|12999908|P1|NOT COMPLETED|Overall Study||0
5287891|NCT00604019|12999907|P2|COMPLETED|Overall Study||118
5287892|NCT00604019|12999908|P1|COMPLETED|Overall Study||134
5287893|NCT00604019|12999907|P2|STARTED|Overall Study||118
5287894|NCT00604019|12999908|P1|STARTED|Overall Study||134
5287895|NCT00603993|12999914|P1|NOT COMPLETED|Overall Study||20
5287896|NCT00603993|12999914|P1|COMPLETED|Overall Study||68
5287897|NCT00603993|12999914|P1|STARTED|Overall Study||88
5287898|NCT00603980|12999927|P1|NOT COMPLETED|Main Study||1
5287899|NCT00603980|12999927|P1|COMPLETED|Main Study||14
5287900|NCT00603980|12999927|P1|STARTED|Main Study||15
5287901|NCT00603980|12999927|P1|NOT COMPLETED|Study Qualification||16
5287902|NCT00603980|12999927|P1|COMPLETED|Study Qualification||15
5287903|NCT00603980|12999927|P1|STARTED|Study Qualification||31
5287904|NCT00603915|13000043|P1|NOT COMPLETED|Overall Study||1
5287905|NCT00603915|13000043|P1|COMPLETED|Overall Study||19
5287906|NCT00603915|13000043|P1|STARTED|Overall Study||20
5287907|NCT00603902|13000051|P3|NOT COMPLETED|Overall Study||769
5287908|NCT00603902|13000052|P2|NOT COMPLETED|Overall Study||686
5287909|NCT00603902|13000053|P1|NOT COMPLETED|Overall Study||329
5287910|NCT00603902|13000051|P3|COMPLETED|Overall Study||834
5287911|NCT00603902|13000052|P2|COMPLETED|Overall Study||917
5287912|NCT00603902|13000053|P1|COMPLETED|Overall Study||473
5287913|NCT00603902|13000051|P3|STARTED|Overall Study||1603
5287914|NCT00603902|13000052|P2|STARTED|Overall Study||1603
5287915|NCT00603902|13000053|P1|STARTED|Overall Study||802
5287916|NCT00603889|13000064|P1|NOT COMPLETED|Overall Study||0
5287917|NCT00603889|13000064|P1|COMPLETED|Overall Study||12
5287918|NCT00603889|13000064|P1|STARTED|Overall Study||12
5287919|NCT00603837|13000073|P2|NOT COMPLETED|Overall Study||0
5287920|NCT00603837|13000074|P1|NOT COMPLETED|Overall Study||3
5287921|NCT00603837|13000073|P2|COMPLETED|Overall Study||19
5287922|NCT00603837|13000074|P1|COMPLETED|Overall Study||17
5287923|NCT00603837|13000073|P2|STARTED|Overall Study||19
5287924|NCT00603837|13000074|P1|STARTED|Overall Study||20
5287925|NCT00603798|13000083|P3|NOT COMPLETED|Overall Study||10
5287926|NCT00603798|13000084|P2|NOT COMPLETED|Overall Study||7
5287927|NCT00603798|13000085|P1|NOT COMPLETED|Overall Study||10
5287928|NCT00603798|13000083|P3|COMPLETED|Overall Study||154
5287929|NCT00603798|13000084|P2|COMPLETED|Overall Study||157
5287930|NCT00603798|13000085|P1|COMPLETED|Overall Study||152
5287931|NCT00603798|13000083|P3|STARTED|Overall Study||164
5287932|NCT00603798|13000084|P2|STARTED|Overall Study||164
5287933|NCT00603798|13000085|P1|STARTED|Overall Study||162
5287934|NCT00603746|13000108|P6|NOT COMPLETED|Overall Study||13
5287935|NCT00603746|13000109|P5|NOT COMPLETED|Overall Study||17
5287936|NCT00603746|13000110|P4|NOT COMPLETED|Overall Study||13
5287937|NCT00603746|13000111|P3|NOT COMPLETED|Overall Study||8
5287938|NCT00603746|13000112|P2|NOT COMPLETED|Overall Study||18
5287939|NCT00603746|13000113|P1|NOT COMPLETED|Overall Study||38
5287940|NCT00603746|13000108|P6|COMPLETED|Overall Study||97
5287941|NCT00603746|13000109|P5|COMPLETED|Overall Study||85
5287942|NCT00603746|13000110|P4|COMPLETED|Overall Study||94
5287943|NCT00603746|13000111|P3|COMPLETED|Overall Study||93
5287944|NCT00603746|13000112|P2|COMPLETED|Overall Study||81
5287945|NCT00603746|13000113|P1|COMPLETED|Overall Study||65
5287946|NCT00603746|13000108|P6|STARTED|Overall Study||110
5287947|NCT00603746|13000109|P5|STARTED|Overall Study||102
5287948|NCT00603746|13000110|P4|STARTED|Overall Study||107
5287949|NCT00603746|13000111|P3|STARTED|Overall Study||101
5287950|NCT00603746|13000112|P2|STARTED|Overall Study||99
5287951|NCT00603746|13000113|P1|STARTED|Overall Study||103
5287952|NCT00603733|13000261|P2|NOT COMPLETED|Maintenance Phase ITT||16
5287953|NCT00603733|13000262|P1|NOT COMPLETED|Maintenance Phase ITT||10
5287954|NCT00603733|13000261|P2|COMPLETED|Maintenance Phase ITT||66
5287955|NCT00603733|13000262|P1|COMPLETED|Maintenance Phase ITT||61
5287956|NCT00603733|13000261|P2|STARTED|Maintenance Phase ITT||82
5287957|NCT00603733|13000262|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
5287958|NCT00603733|13000261|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
5287959|NCT00603733|13000262|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
5287960|NCT00603733|13000261|P2|COMPLETED|Run-In Phase - 4 Weeks||36
5287961|NCT00603733|13000262|P1|COMPLETED|Run-In Phase - 4 Weeks||35
5287962|NCT00603733|13000261|P2|STARTED|Run-In Phase - 4 Weeks||49
5287963|NCT00603733|13000262|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
5287964|NCT00603733|13000261|P2|NOT COMPLETED|Active Phase ITT||17
5287965|NCT00603733|13000262|P1|NOT COMPLETED|Active Phase ITT||11
5287966|NCT00603733|13000261|P2|COMPLETED|Active Phase ITT||78
5287967|NCT00603733|13000262|P1|COMPLETED|Active Phase ITT||84
5287968|NCT00603733|13000261|P2|STARTED|Active Phase ITT||95
5287969|NCT00603733|13000262|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
5287970|NCT00603720|13000277|P5|NOT COMPLETED|Overall Study||0
5287971|NCT00603720|13000278|P4|NOT COMPLETED|Overall Study||0
5287972|NCT00603720|13000279|P3|NOT COMPLETED|Overall Study||0
5287973|NCT00603720|13000280|P2|NOT COMPLETED|Overall Study||0
5287974|NCT00603720|13000281|P1|NOT COMPLETED|Overall Study||0
5287975|NCT00603720|13000277|P5|COMPLETED|Overall Study||12
5287976|NCT00603720|13000278|P4|COMPLETED|Overall Study||10
5287977|NCT00603720|13000279|P3|COMPLETED|Overall Study||12
5287978|NCT00603720|13000280|P2|COMPLETED|Overall Study||10
5287979|NCT00603720|13000281|P1|COMPLETED|Overall Study||10
5287980|NCT00603720|13000277|P5|STARTED|Overall Study||12
5287981|NCT00603720|13000278|P4|STARTED|Overall Study||10
5287982|NCT00603720|13000279|P3|STARTED|Overall Study||12
5287983|NCT00603720|13000280|P2|STARTED|Overall Study||10
5287984|NCT00603720|13000281|P1|STARTED|Overall Study||10
5287985|NCT00603642|13000295|P2|NOT COMPLETED|Overall Study||0
5287986|NCT00603642|13000296|P1|NOT COMPLETED|Overall Study||0
5287987|NCT00603642|13000295|P2|COMPLETED|Overall Study||22
5287988|NCT00603642|13000296|P1|COMPLETED|Overall Study||12
5287989|NCT00603642|13000295|P2|STARTED|Overall Study||22
5287990|NCT00603642|13000296|P1|STARTED|Overall Study||12
5287991|NCT00603590|13000312|P2|NOT COMPLETED|Overall Study||51
5287992|NCT00603590|13000313|P1|NOT COMPLETED|Overall Study||76
5287993|NCT00603590|13000312|P2|COMPLETED|Overall Study||183
5287994|NCT00603590|13000313|P1|COMPLETED|Overall Study||165
5287995|NCT00603590|13000312|P2|Eight Months|Overall Study||194
5287996|NCT00603590|13000313|P1|Eight Months|Overall Study||178
5287997|NCT00603590|13000312|P2|Four Months|Overall Study||200
5287998|NCT00603590|13000313|P1|Four Months|Overall Study||187
5287999|NCT00603590|13000312|P2|One Month|Overall Study||212
5288000|NCT00603590|13000313|P1|One Month|Overall Study||204
5288001|NCT00603590|13000312|P2|STARTED|Overall Study||234
5288002|NCT00603590|13000313|P1|STARTED|Overall Study||241
5288003|NCT00603564|13000325|P2|NOT COMPLETED|Overall Study||0
5288004|NCT00603564|13000326|P1|NOT COMPLETED|Overall Study||0
5288005|NCT00603564|13000325|P2|COMPLETED|Overall Study|February 2008|27
5288006|NCT00603564|13000326|P1|COMPLETED|Overall Study|February 2008|20
5288007|NCT00603564|13000325|P2|STARTED|Overall Study|January 2006|27
5288008|NCT00603564|13000326|P1|STARTED|Overall Study|January 2006|20
5288009|NCT00603538|13000337|P3|NOT COMPLETED|Overall Study||2
5288010|NCT00603538|13000338|P2|NOT COMPLETED|Overall Study||4
5288011|NCT00603538|13000339|P1|NOT COMPLETED|Overall Study||3
5288012|NCT00603538|13000337|P3|COMPLETED|Overall Study||4
5288013|NCT00603538|13000338|P2|COMPLETED|Overall Study||3
5288014|NCT00603538|13000339|P1|COMPLETED|Overall Study||3
5288015|NCT00603538|13000337|P3|STARTED|Overall Study||6
5288016|NCT00603538|13000338|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
5288017|NCT00603538|13000339|P1|STARTED|Overall Study||6
5288018|NCT00603525|13000379|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
5288019|NCT00603525|13000380|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
5288020|NCT00603525|13000381|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
5288021|NCT00603525|13000379|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
5288022|NCT00603525|13000380|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
5288023|NCT00603525|13000381|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
5288024|NCT00603525|13000379|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
5288025|NCT00603525|13000380|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
5288026|NCT00603525|13000381|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
5288027|NCT00603525|13000379|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
5288028|NCT00603525|13000380|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
5288029|NCT00603525|13000381|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
5288030|NCT00603525|13000379|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
5288031|NCT00603525|13000380|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
5288032|NCT00603525|13000381|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
5288033|NCT00603525|13000379|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
5288034|NCT00603525|13000380|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
5288035|NCT00603525|13000381|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
5288036|NCT00603525|13000379|P3|STARTED|OL Treatment Period (120 Weeks)||0
5288037|NCT00603525|13000380|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
5288038|NCT00603525|13000381|P1|STARTED|OL Treatment Period (120 Weeks)||0
5288039|NCT00603525|13000379|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
5288040|NCT00603525|13000380|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
5288041|NCT00603525|13000381|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
5288042|NCT00603525|13000379|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
5288043|NCT00603525|13000380|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
5288044|NCT00603525|13000381|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
5288045|NCT00603525|13000379|P3|STARTED|DB Treatment Period (24 Weeks)||0
5288046|NCT00603525|13000380|P2|STARTED|DB Treatment Period (24 Weeks)||85
5288047|NCT00603525|13000381|P1|STARTED|DB Treatment Period (24 Weeks)||84
5288048|NCT00603512|13000513|P5|NOT COMPLETED|Overall Study||5
5288049|NCT00603512|13000514|P4|NOT COMPLETED|Overall Study||7
5288050|NCT00603512|13000515|P3|NOT COMPLETED|Overall Study||5
5288051|NCT00603512|13000516|P2|NOT COMPLETED|Overall Study||5
5288052|NCT00603512|13000517|P1|NOT COMPLETED|Overall Study||2
5288053|NCT00603512|13000513|P5|COMPLETED|Overall Study||23
5288054|NCT00603512|13000514|P4|COMPLETED|Overall Study||21
5288055|NCT00603512|13000515|P3|COMPLETED|Overall Study||23
5288056|NCT00603512|13000516|P2|COMPLETED|Overall Study||23
5288057|NCT00603512|13000517|P1|COMPLETED|Overall Study||26
5288058|NCT00603512|13000513|P5|Treated|Overall Study||28
5288059|NCT00603512|13000514|P4|Treated|Overall Study||26
5288060|NCT00603512|13000515|P3|Treated|Overall Study||27
5288061|NCT00603512|13000516|P2|Treated|Overall Study||27
5288062|NCT00603512|13000517|P1|Treated|Overall Study||28
5288063|NCT00603512|13000513|P5|STARTED|Overall Study||28
5288064|NCT00603512|13000514|P4|STARTED|Overall Study||28
5288065|NCT00603512|13000515|P3|STARTED|Overall Study||28
5288066|NCT00603512|13000516|P2|STARTED|Overall Study||28
5288067|NCT00603512|13000517|P1|STARTED|Overall Study||28
5288068|NCT00603473|13000659|P1|NOT COMPLETED|Overall Study||9
5288069|NCT00603473|13000659|P1|COMPLETED|Overall Study||80
5288070|NCT00603473|13000659|P1|STARTED|Overall Study||89
5288071|NCT00603447|13000672|P7|NOT COMPLETED|Overall Study||24
5288072|NCT00603447|13000673|P6|NOT COMPLETED|Overall Study||2
5288073|NCT00603447|13000674|P5|NOT COMPLETED|Overall Study||5
5288074|NCT00603447|13000675|P4|NOT COMPLETED|Overall Study||2
5288075|NCT00603447|13000676|P3|NOT COMPLETED|Overall Study||2
5288076|NCT00603447|13000677|P2|NOT COMPLETED|Overall Study||3
5288077|NCT00603447|13000678|P1|NOT COMPLETED|Overall Study||0
5288078|NCT00603447|13000672|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
5288079|NCT00603447|13000673|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
5288080|NCT00603447|13000674|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
5288081|NCT00603447|13000675|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
5288082|NCT00603447|13000676|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
5288083|NCT00603447|13000677|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
5288084|NCT00603447|13000678|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
5288085|NCT00603447|13000672|P7|STARTED|Overall Study||44
5288086|NCT00603447|13000673|P6|STARTED|Overall Study||8
5288087|NCT00603447|13000674|P5|STARTED|Overall Study||6
5288088|NCT00603447|13000675|P4|STARTED|Overall Study||6
5288089|NCT00603447|13000676|P3|STARTED|Overall Study||8
5288090|NCT00603447|13000677|P2|STARTED|Overall Study||6
5288091|NCT00603447|13000678|P1|STARTED|Overall Study||6
5288092|NCT00603408|13000700|P1|NOT COMPLETED|Overall Study||0
5288093|NCT00603408|13000700|P1|COMPLETED|Overall Study||5
5288094|NCT00603408|13000700|P1|STARTED|Overall Study||5
5288095|NCT00603382|13000717|P6|NOT COMPLETED|Overall Study||18
5288096|NCT00603382|13000718|P5|NOT COMPLETED|Overall Study||9
5288097|NCT00603382|13000719|P4|NOT COMPLETED|Overall Study||12
5288098|NCT00603382|13000720|P3|NOT COMPLETED|Overall Study||9
5288099|NCT00603382|13000721|P2|NOT COMPLETED|Overall Study||14
5288100|NCT00603382|13000722|P1|NOT COMPLETED|Overall Study||18
5288101|NCT00603382|13000717|P6|COMPLETED|Overall Study||84
5288102|NCT00603382|13000718|P5|COMPLETED|Overall Study||86
5288103|NCT00603382|13000719|P4|COMPLETED|Overall Study||98
5288104|NCT00603382|13000720|P3|COMPLETED|Overall Study||91
5288105|NCT00603382|13000721|P2|COMPLETED|Overall Study||83
5288106|NCT00603382|13000722|P1|COMPLETED|Overall Study||76
5288107|NCT00603382|13000717|P6|STARTED|Overall Study||102
5288108|NCT00603382|13000718|P5|STARTED|Overall Study||95
5288109|NCT00603382|13000719|P4|STARTED|Overall Study||110
5288110|NCT00603382|13000720|P3|STARTED|Overall Study||100
5288111|NCT00603382|13000721|P2|STARTED|Overall Study||97
5288112|NCT00603382|13000722|P1|STARTED|Overall Study||94
5288113|NCT00603304|13000870|P2|NOT COMPLETED|Overall Study||31
5288114|NCT00603304|13000871|P1|NOT COMPLETED|Overall Study||32
5288115|NCT00603304|13000870|P2|COMPLETED|Overall Study||155
5288116|NCT00603304|13000871|P1|COMPLETED|Overall Study||151
5288117|NCT00603304|13000870|P2|STARTED|Overall Study||186
5288118|NCT00603304|13000871|P1|STARTED|Overall Study||183
5288119|NCT00603291|13000908|P3|NOT COMPLETED|Overall Study||96
5288120|NCT00603291|13000909|P2|NOT COMPLETED|Overall Study||87
5288121|NCT00603291|13000910|P1|NOT COMPLETED|Overall Study||20
5288122|NCT00603291|13000908|P3|COMPLETED|Overall Study||157
5288123|NCT00603291|13000909|P2|COMPLETED|Overall Study||169
5288124|NCT00603291|13000910|P1|COMPLETED|Overall Study||75
5288125|NCT00603291|13000908|P3|STARTED|Overall Study||253
5288126|NCT00603291|13000909|P2|STARTED|Overall Study||256
5288127|NCT00603291|13000910|P1|STARTED|Overall Study||95
5288128|NCT00603278|13000927|P6|NOT COMPLETED|Overall Study||19
5288129|NCT00603278|13000928|P5|NOT COMPLETED|Overall Study||13
5288130|NCT00603278|13000929|P4|NOT COMPLETED|Overall Study||11
5288131|NCT00603278|13000930|P3|NOT COMPLETED|Overall Study||14
5288132|NCT00603278|13000931|P2|NOT COMPLETED|Overall Study||17
5288133|NCT00603278|13000932|P1|NOT COMPLETED|Overall Study||41
5288134|NCT00603278|13000927|P6|COMPLETED|Overall Study||81
5288135|NCT00603278|13000928|P5|COMPLETED|Overall Study||86
5288136|NCT00603278|13000929|P4|COMPLETED|Overall Study||92
5288137|NCT00603278|13000930|P3|COMPLETED|Overall Study||87
5288138|NCT00603278|13000931|P2|COMPLETED|Overall Study||88
5288139|NCT00603278|13000932|P1|COMPLETED|Overall Study||66
5288140|NCT00603278|13000927|P6|STARTED|Overall Study||100
5288141|NCT00603278|13000928|P5|STARTED|Overall Study||99
5288142|NCT00603278|13000929|P4|STARTED|Overall Study||103
5288143|NCT00603278|13000930|P3|STARTED|Overall Study||101
5288144|NCT00603278|13000931|P2|STARTED|Overall Study||105
5288145|NCT00603278|13000932|P1|STARTED|Overall Study||107
5288146|NCT00603265|13001081|P3|NOT COMPLETED|Overall Study||5
5288147|NCT00603265|13001082|P2|NOT COMPLETED|Overall Study||16
5288148|NCT00603265|13001083|P1|NOT COMPLETED|Overall Study||7
5288149|NCT00603265|13001081|P3|COMPLETED|Overall Study||67
5288150|NCT00603265|13001082|P2|COMPLETED|Overall Study||62
5288151|NCT00603265|13001083|P1|COMPLETED|Overall Study||69
5288152|NCT00603265|13001081|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
5288153|NCT00603265|13001082|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
5288154|NCT00603265|13001083|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
5288155|NCT00603265|13001081|P3|STARTED|Overall Study||72
5288156|NCT00603265|13001082|P2|STARTED|Overall Study||78
5288157|NCT00603265|13001083|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
5288158|NCT00603239|13001111|P2|NOT COMPLETED|Overall Study||4
5288159|NCT00603239|13001112|P1|NOT COMPLETED|Overall Study||15
5288160|NCT00603239|13001111|P2|COMPLETED|Overall Study||50
5288161|NCT00603239|13001112|P1|COMPLETED|Overall Study||96
5288162|NCT00603239|13001111|P2|STARTED|Overall Study||54
5288163|NCT00603239|13001112|P1|STARTED|Overall Study||111
5288164|NCT00603187|13001138|P1|NOT COMPLETED|Overall Study||0
5288165|NCT00603187|13001138|P1|COMPLETED|Overall Study||4
5288166|NCT00603187|13001138|P1|STARTED|Overall Study||4
5288167|NCT00603044|13001146|P2|NOT COMPLETED|Overall Study||0
5288168|NCT00603044|13001147|P1|NOT COMPLETED|Overall Study||0
5288169|NCT00603044|13001146|P2|COMPLETED|Overall Study||13
5288170|NCT00603044|13001147|P1|COMPLETED|Overall Study||11
5288171|NCT00603044|13001146|P2|STARTED|Overall Study||13
5288172|NCT00603044|13001147|P1|STARTED|Overall Study||11
5288173|NCT00603018|13001163|P1|NOT COMPLETED|Overall Study||0
5288174|NCT00603018|13001163|P1|COMPLETED|Overall Study||23
5288175|NCT00603018|13001163|P1|STARTED|Overall Study||23
5288176|NCT00602979|13001173|P5|NOT COMPLETED|Overall Study||3
5288177|NCT00602979|13001174|P4|NOT COMPLETED|Overall Study||3
5288178|NCT00602979|13001175|P3|NOT COMPLETED|Overall Study||3
5288179|NCT00602979|13001176|P2|NOT COMPLETED|Overall Study||3
5288180|NCT00602979|13001177|P1|NOT COMPLETED|Overall Study||3
5288181|NCT00602979|13001173|P5|COMPLETED|Overall Study||45
5288182|NCT00602979|13001174|P4|COMPLETED|Overall Study||45
5288183|NCT00602979|13001175|P3|COMPLETED|Overall Study||45
5288184|NCT00602979|13001176|P2|COMPLETED|Overall Study||45
5288185|NCT00602979|13001177|P1|COMPLETED|Overall Study||45
5288186|NCT00602979|13001173|P5|STARTED|Overall Study||48
5288187|NCT00602979|13001174|P4|STARTED|Overall Study||48
5288188|NCT00602979|13001175|P3|STARTED|Overall Study||48
5288189|NCT00602979|13001176|P2|STARTED|Overall Study||48
5288190|NCT00602979|13001177|P1|STARTED|Overall Study||48
5288191|NCT00602953|13001194|P5|NOT COMPLETED|Overall Study||0
5288192|NCT00602953|13001195|P4|NOT COMPLETED|Overall Study||0
5288193|NCT00602953|13001196|P3|NOT COMPLETED|Overall Study||0
5288194|NCT00602953|13001197|P2|NOT COMPLETED|Overall Study||0
5288195|NCT00602953|13001198|P1|NOT COMPLETED|Overall Study||0
5288196|NCT00602953|13001194|P5|COMPLETED|Overall Study||0
5288197|NCT00602953|13001195|P4|COMPLETED|Overall Study||13
5288198|NCT00602953|13001196|P3|COMPLETED|Overall Study||47
5288199|NCT00602953|13001197|P2|COMPLETED|Overall Study||26
5288200|NCT00602953|13001198|P1|COMPLETED|Overall Study||15
5288201|NCT00602953|13001194|P5|STARTED|Overall Study||0
5288202|NCT00602953|13001195|P4|STARTED|Overall Study||13
5288203|NCT00602953|13001196|P3|STARTED|Overall Study||47
5288204|NCT00602953|13001197|P2|STARTED|Overall Study||26
5288205|NCT00602953|13001198|P1|STARTED|Overall Study||15
5288206|NCT00602927|13001227|P2|NOT COMPLETED|Period 3: 13 Days||3
5288207|NCT00602927|13001228|P1|NOT COMPLETED|Period 3: 13 Days||2
5288208|NCT00602927|13001227|P2|COMPLETED|Period 3: 13 Days||9
5288209|NCT00602927|13001228|P1|COMPLETED|Period 3: 13 Days||13
5288210|NCT00602927|13001227|P2|STARTED|Period 3: 13 Days||12
5288211|NCT00602927|13001228|P1|STARTED|Period 3: 13 Days||15
5288212|NCT00602927|13001227|P2|NOT COMPLETED|Period 2: 14 Days||2
5288213|NCT00602927|13001228|P1|NOT COMPLETED|Period 2: 14 Days||0
5288214|NCT00602927|13001227|P2|COMPLETED|Period 2: 14 Days||12
5288215|NCT00602927|13001228|P1|COMPLETED|Period 2: 14 Days||15
5288216|NCT00602927|13001227|P2|STARTED|Period 2: 14 Days||14
5288217|NCT00602927|13001228|P1|STARTED|Period 2: 14 Days||15
5288218|NCT00602927|13001227|P2|NOT COMPLETED|Period 1: 13 Days||5
5288219|NCT00602927|13001228|P1|NOT COMPLETED|Period 1: 13 Days||4
5288220|NCT00602927|13001227|P2|COMPLETED|Period 1: 13 Days||14
5288221|NCT00602927|13001228|P1|COMPLETED|Period 1: 13 Days||15
5288222|NCT00602927|13001227|P2|STARTED|Period 1: 13 Days||19
5288223|NCT00602927|13001228|P1|STARTED|Period 1: 13 Days||19
5288224|NCT00602836|13001236|P1|NOT COMPLETED|Overall Study||5
5288225|NCT00602836|13001236|P1|COMPLETED|Overall Study||39
5288226|NCT00602836|13001236|P1|STARTED|Overall Study||44
5288227|NCT00602797|13001245|P1|NOT COMPLETED|Overall Study||1
5288228|NCT00602797|13001245|P1|COMPLETED|Overall Study||19
5288229|NCT00602797|13001245|P1|STARTED|Overall Study||20
5288230|NCT00602771|13001253|P2|NOT COMPLETED|Overall Study||0
5288231|NCT00602771|13001254|P1|NOT COMPLETED|Overall Study||1
5288232|NCT00602771|13001253|P2|COMPLETED|Overall Study||21
5288233|NCT00602771|13001254|P1|COMPLETED|Overall Study||62
5288234|NCT00602771|13001253|P2|STARTED|Overall Study||21
5288235|NCT00602771|13001254|P1|STARTED|Overall Study||63
5288236|NCT00602667|13001263|P3|NOT COMPLETED|Overall Study||63
5288237|NCT00602667|13001264|P2|NOT COMPLETED|Overall Study||81
5288238|NCT00602667|13001265|P1|NOT COMPLETED|Overall Study||19
5288239|NCT00602667|13001263|P3|COMPLETED|Overall Study||14
5288240|NCT00602667|13001264|P2|COMPLETED|Overall Study||75
5288241|NCT00602667|13001265|P1|COMPLETED|Overall Study||38
5288242|NCT00602667|13001263|P3|STARTED|Overall Study||77
5288243|NCT00602667|13001264|P2|STARTED|Overall Study||156
5288244|NCT00602667|13001265|P1|STARTED|Overall Study||57
5288245|NCT00602641|13001444|P2|NOT COMPLETED|Overall Study||152
5288246|NCT00602641|13001445|P1|NOT COMPLETED|Overall Study||154
5288247|NCT00602641|13001444|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
5288248|NCT00602641|13001445|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
5288249|NCT00602641|13001444|P2|Started Protocol Therapy|Overall Study||150
5288250|NCT00602641|13001445|P1|Started Protocol Therapy|Overall Study||148
5288251|NCT00602641|13001444|P2|STARTED|Overall Study||152
5288252|NCT00602641|13001445|P1|STARTED|Overall Study||154
5288253|NCT00602537|13001459|P2|NOT COMPLETED|Follow Up Study Comparison||3
5288254|NCT00602537|13001460|P1|NOT COMPLETED|Follow Up Study Comparison||11
5288255|NCT00602537|13001459|P2|COMPLETED|Follow Up Study Comparison||14
5288256|NCT00602537|13001460|P1|COMPLETED|Follow Up Study Comparison||31
5288257|NCT00602537|13001459|P2|STARTED|Follow Up Study Comparison||17
5288258|NCT00602537|13001460|P1|STARTED|Follow Up Study Comparison||42
5288259|NCT00602537|13001459|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
5288260|NCT00602537|13001460|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
5288261|NCT00602537|13001459|P2|COMPLETED|12 Week Double Blind Comparison||17
5288262|NCT00602537|13001460|P1|COMPLETED|12 Week Double Blind Comparison||42
5288263|NCT00602537|13001459|P2|Responded|12 Week Double Blind Comparison||22
5288264|NCT00602537|13001460|P1|Responded|12 Week Double Blind Comparison||44
5288265|NCT00602537|13001459|P2|STARTED|12 Week Double Blind Comparison||64
5288266|NCT00602537|13001460|P1|STARTED|12 Week Double Blind Comparison||65
5288267|NCT00602472|13001470|P2|NOT COMPLETED|Overall Study||58
5288268|NCT00602472|13001471|P1|NOT COMPLETED|Overall Study||21
5288269|NCT00602472|13001470|P2|COMPLETED|Overall Study|number who completed treatment|734
5288270|NCT00602472|13001471|P1|COMPLETED|Overall Study|number who completed treatment|242
5288271|NCT00602472|13001470|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
5288272|NCT00602472|13001471|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
5288273|NCT00602459|13001505|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
5288274|NCT00602459|13001506|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
5288275|NCT00602459|13001507|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
5288276|NCT00602459|13001508|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
5288277|NCT00602459|13001505|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
5288278|NCT00602459|13001506|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
5288279|NCT00602459|13001507|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
5288280|NCT00602459|13001508|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
5288281|NCT00602459|13001505|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
5288282|NCT00602459|13001506|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
5288283|NCT00602459|13001507|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
5288284|NCT00602459|13001508|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
5288285|NCT00602459|13001505|P4|NOT COMPLETED|Initial Registration/Randomization||0
5288286|NCT00602459|13001506|P3|NOT COMPLETED|Initial Registration/Randomization||3
5288287|NCT00602459|13001507|P2|NOT COMPLETED|Initial Registration/Randomization||10
5288288|NCT00602459|13001508|P1|NOT COMPLETED|Initial Registration/Randomization||5
5288289|NCT00602459|13001505|P4|COMPLETED|Initial Registration/Randomization||0
5288290|NCT00602459|13001506|P3|COMPLETED|Initial Registration/Randomization||137
5288291|NCT00602459|13001507|P2|COMPLETED|Initial Registration/Randomization||130
5288292|NCT00602459|13001508|P1|COMPLETED|Initial Registration/Randomization||133
5288293|NCT00602459|13001505|P4|STARTED|Initial Registration/Randomization||0
5288294|NCT00602459|13001506|P3|STARTED|Initial Registration/Randomization||140
5288295|NCT00602459|13001507|P2|STARTED|Initial Registration/Randomization||140
5288296|NCT00602459|13001508|P1|STARTED|Initial Registration/Randomization||138
5288297|NCT00602446|13001529|P1|NOT COMPLETED|Overall Study||0
5288298|NCT00602446|13001529|P1|COMPLETED|Overall Study||3
5288299|NCT00602446|13001529|P1|STARTED|Overall Study||3
5288300|NCT00602420|13001536|P2|NOT COMPLETED|Overall Study||24
5288301|NCT00602420|13001537|P1|NOT COMPLETED|Overall Study||25
5288302|NCT00602420|13001536|P2|COMPLETED|Overall Study||229
5288303|NCT00602420|13001537|P1|COMPLETED|Overall Study||232
5288304|NCT00602420|13001536|P2|STARTED|Overall Study||253
5288305|NCT00602420|13001537|P1|STARTED|Overall Study||257
5288306|NCT00602355|13001546|P3|NOT COMPLETED|Overall Study||10
5288307|NCT00602355|13001547|P2|NOT COMPLETED|Overall Study||18
5288308|NCT00602355|13001548|P1|NOT COMPLETED|Overall Study||9
5288309|NCT00602355|13001546|P3|COMPLETED|Overall Study||43
5288310|NCT00602355|13001547|P2|COMPLETED|Overall Study||38
5288311|NCT00602355|13001548|P1|COMPLETED|Overall Study||44
5288312|NCT00602355|13001546|P3|STARTED|Overall Study||53
5288313|NCT00602355|13001547|P2|STARTED|Overall Study||56
5288314|NCT00602355|13001548|P1|STARTED|Overall Study||53
5288315|NCT00602290|13001571|P3|NOT COMPLETED|Overall Study||1
5288316|NCT00602290|13001572|P2|NOT COMPLETED|Overall Study||2
5288317|NCT00602290|13001573|P1|NOT COMPLETED|Overall Study||2
5288318|NCT00602290|13001571|P3|COMPLETED|Overall Study||46
5288319|NCT00602290|13001572|P2|COMPLETED|Overall Study||46
5288320|NCT00602290|13001573|P1|COMPLETED|Overall Study||46
5288321|NCT00602290|13001571|P3|STARTED|Overall Study||47
5288322|NCT00602290|13001572|P2|STARTED|Overall Study||48
5288323|NCT00602290|13001573|P1|STARTED|Overall Study||48
5288324|NCT00602225|13001584|P1|NOT COMPLETED|Overall Study||0
5288325|NCT00602225|13001584|P1|COMPLETED|Overall Study||50
5288326|NCT00602225|13001584|P1|STARTED|Overall Study||50
5288327|NCT00602043|13001597|P1|NOT COMPLETED|Overall Study||5
5288328|NCT00602043|13001597|P1|COMPLETED|Overall Study||15
5288329|NCT00602043|13001597|P1|STARTED|Overall Study||20
5288330|NCT00601965|13001611|P4|NOT COMPLETED|Overall Study||1
5288331|NCT00601965|13001612|P3|NOT COMPLETED|Overall Study||0
5288332|NCT00601965|13001613|P2|NOT COMPLETED|Overall Study||2
5288333|NCT00601965|13001614|P1|NOT COMPLETED|Overall Study||0
5288334|NCT00601965|13001611|P4|COMPLETED|Overall Study||17
5288335|NCT00601965|13001612|P3|COMPLETED|Overall Study||19
5288336|NCT00601965|13001613|P2|COMPLETED|Overall Study||16
5288337|NCT00601965|13001614|P1|COMPLETED|Overall Study||18
5288338|NCT00601965|13001611|P4|STARTED|Overall Study||18
5288339|NCT00601965|13001612|P3|STARTED|Overall Study||19
5288340|NCT00601965|13001613|P2|STARTED|Overall Study||18
5288341|NCT00601965|13001614|P1|STARTED|Overall Study||18
5288342|NCT00601952|13001630|P2|NOT COMPLETED|Overall Study||0
5288343|NCT00601952|13001631|P1|NOT COMPLETED|Overall Study||2
5288344|NCT00601952|13001630|P2|COMPLETED|Overall Study||17
5288345|NCT00601952|13001631|P1|COMPLETED|Overall Study||12
5288346|NCT00601952|13001630|P2|STARTED|Overall Study||17
5288347|NCT00601952|13001631|P1|STARTED|Overall Study||14
5288348|NCT00601926|13001637|P1|NOT COMPLETED|Overall Study||0
5288349|NCT00601926|13001637|P1|COMPLETED|Overall Study||5
5288350|NCT00601926|13001637|P1|STARTED|Overall Study||5
5288351|NCT00601900|13001645|P2|NOT COMPLETED|Overall Study||3
5288352|NCT00601900|13001646|P1|NOT COMPLETED|Overall Study||0
5288353|NCT00601900|13001645|P2|COMPLETED|Overall Study||196
5288354|NCT00601900|13001646|P1|COMPLETED|Overall Study||195
5288355|NCT00601900|13001645|P2|STARTED|Overall Study||199
5288356|NCT00601900|13001646|P1|STARTED|Overall Study||195
5288357|NCT00601835|13001662|P2|NOT COMPLETED|Overall Study||14
5288358|NCT00601835|13001663|P1|NOT COMPLETED|Overall Study||60
5288359|NCT00601835|13001662|P2|COMPLETED|Overall Study||686
5288360|NCT00601835|13001663|P1|COMPLETED|Overall Study||2890
5288361|NCT00601835|13001662|P2|STARTED|Overall Study||700
5288362|NCT00601835|13001663|P1|STARTED|Overall Study||2950
5288363|NCT00601796|13001673|P1|NOT COMPLETED|Overall Study||0
5288364|NCT00601796|13001673|P1|COMPLETED|Overall Study||24
5288365|NCT00601796|13001673|P1|STARTED|Overall Study||24
5288366|NCT00601731|13001692|P4|NOT COMPLETED|Overall Study||1
5288367|NCT00601731|13001693|P3|NOT COMPLETED|Overall Study||15
5288368|NCT00601731|13001694|P2|NOT COMPLETED|Overall Study||0
5288369|NCT00601731|13001695|P1|NOT COMPLETED|Overall Study||23
5288370|NCT00601731|13001692|P4|COMPLETED|Overall Study||29
5288371|NCT00601731|13001693|P3|COMPLETED|Overall Study||151
5288372|NCT00601731|13001694|P2|COMPLETED|Overall Study||43
5288373|NCT00601731|13001695|P1|COMPLETED|Overall Study||120
5288374|NCT00601731|13001692|P4|STARTED|Overall Study||30
5288375|NCT00601731|13001693|P3|STARTED|Overall Study||166
5288376|NCT00601731|13001694|P2|STARTED|Overall Study||43
5288377|NCT00601731|13001695|P1|STARTED|Overall Study||143
5288378|NCT00601718|13001745|P1|NOT COMPLETED|Overall Study||0
5288379|NCT00601718|13001745|P1|COMPLETED|Overall Study||29
5288380|NCT00601718|13001745|P1|STARTED|Overall Study||29
5288381|NCT00601705|13001752|P1|NOT COMPLETED|Overall Study||1
5288382|NCT00601705|13001752|P1|COMPLETED|Overall Study||60
5288383|NCT00601705|13001752|P1|STARTED|Overall Study||61
5288384|NCT00601640|13001764|P3|NOT COMPLETED|Overall Study||10
5288385|NCT00601640|13001765|P2|NOT COMPLETED|Overall Study||5
5288386|NCT00601640|13001766|P1|NOT COMPLETED|Overall Study||5
5288387|NCT00601640|13001764|P3|COMPLETED|Overall Study||42
5288388|NCT00601640|13001765|P2|COMPLETED|Overall Study||47
5288389|NCT00601640|13001766|P1|COMPLETED|Overall Study||47
5288390|NCT00601640|13001764|P3|STARTED|Overall Study||52
5288391|NCT00601640|13001765|P2|STARTED|Overall Study||52
5288392|NCT00601640|13001766|P1|STARTED|Overall Study||52
5288393|NCT00601627|13001780|P1|NOT COMPLETED|Overall Study||0
5288394|NCT00601627|13001780|P1|COMPLETED|Overall Study||51
5288395|NCT00601627|13001780|P1|STARTED|Overall Study||51
5288396|NCT00601523|13001791|P2|NOT COMPLETED|Overall Study||26
5288397|NCT00601523|13001792|P1|NOT COMPLETED|Overall Study||77
5288398|NCT00601523|13001791|P2|COMPLETED|Overall Study||117
5288399|NCT00601523|13001792|P1|COMPLETED|Overall Study||291
5288400|NCT00601523|13001791|P2|STARTED|Overall Study||143
5288401|NCT00601523|13001792|P1|STARTED|Overall Study||368
5288402|NCT00601458|13001827|P3|NOT COMPLETED|Overall Study||2
5288403|NCT00601458|13001828|P2|NOT COMPLETED|Overall Study||5
5288404|NCT00601458|13001829|P1|NOT COMPLETED|Overall Study||4
5288405|NCT00601458|13001827|P3|COMPLETED|Overall Study||28
5288406|NCT00601458|13001828|P2|COMPLETED|Overall Study||29
5288407|NCT00601458|13001829|P1|COMPLETED|Overall Study||32
5288408|NCT00601458|13001827|P3|STARTED|Overall Study||30
5288409|NCT00601458|13001828|P2|STARTED|Overall Study||34
5288410|NCT00601458|13001829|P1|STARTED|Overall Study||36
5288411|NCT00601419|13001840|P1|NOT COMPLETED|Overall Study||4
5288412|NCT00601419|13001840|P1|COMPLETED|Overall Study||226
5288413|NCT00601419|13001840|P1|STARTED|Overall Study||230
5288414|NCT00601367|13001864|P1|NOT COMPLETED|Overall Study||187
5288415|NCT00601367|13001864|P1|COMPLETED|Overall Study||293
5288416|NCT00601367|13001864|P1|STARTED|Overall Study||480
5288417|NCT00601354|13001870|P2|NOT COMPLETED|Overall Study||5
5288418|NCT00601354|13001871|P1|NOT COMPLETED|Overall Study||4
5288419|NCT00601354|13001870|P2|COMPLETED|Overall Study||4
5288420|NCT00601354|13001871|P1|COMPLETED|Overall Study||4
5288421|NCT00601354|13001870|P2|STARTED|Overall Study||9
5288422|NCT00601354|13001871|P1|STARTED|Overall Study||8
5288423|NCT00601250|13001883|P2|NOT COMPLETED|Overall Study||39
5288424|NCT00601250|13001884|P1|NOT COMPLETED|Overall Study||14
5288425|NCT00601250|13001883|P2|COMPLETED|Overall Study|number who completed treatment|484
5288426|NCT00601250|13001884|P1|COMPLETED|Overall Study|number who completed treatment|163
5288427|NCT00601250|13001883|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
5288428|NCT00601250|13001884|P1|STARTED|Overall Study|number who started treatment|177
5288429|NCT00601172|13001920|P2|NOT COMPLETED|Overall Study||127
5288430|NCT00601172|13001921|P1|NOT COMPLETED|Overall Study||141
5288431|NCT00601172|13001920|P2|COMPLETED|Overall Study||228
5288432|NCT00601172|13001921|P1|COMPLETED|Overall Study||214
5288433|NCT00601172|13001920|P2|STARTED|Overall Study||355
5288434|NCT00601172|13001921|P1|STARTED|Overall Study||355
5288435|NCT00601146|13001970|P1|NOT COMPLETED|Overall Study||0
5288436|NCT00601146|13001970|P1|COMPLETED|Overall Study||39
5288437|NCT00601146|13001970|P1|STARTED|Overall Study||39
5288438|NCT00601107|13001978|P4|NOT COMPLETED|Overall Study||12
5288439|NCT00601107|13001979|P3|NOT COMPLETED|Overall Study||12
5288440|NCT00601107|13001980|P2|NOT COMPLETED|Overall Study||9
5288441|NCT00601107|13001981|P1|NOT COMPLETED|Overall Study||13
5288442|NCT00601107|13001978|P4|COMPLETED|Overall Study||13
5288443|NCT00601107|13001979|P3|COMPLETED|Overall Study||16
5288444|NCT00601107|13001980|P2|COMPLETED|Overall Study||22
5288445|NCT00601107|13001981|P1|COMPLETED|Overall Study||14
5288446|NCT00601107|13001978|P4|Treated|Overall Study||25
5288447|NCT00601107|13001979|P3|Treated|Overall Study||28
5288448|NCT00601107|13001980|P2|Treated|Overall Study||31
5288449|NCT00601107|13001981|P1|Treated|Overall Study||27
5288450|NCT00601107|13001978|P4|STARTED|Overall Study||25
5288451|NCT00601107|13001979|P3|STARTED|Overall Study||28
5288452|NCT00601107|13001980|P2|STARTED|Overall Study||31
5288453|NCT00601107|13001981|P1|STARTED|Overall Study|Randomized.|27
5288454|NCT00600938|13002001|P4|NOT COMPLETED|Extension Study||1
5288455|NCT00600938|13002002|P3|NOT COMPLETED|Extension Study||9
5288456|NCT00600938|13002003|P2|NOT COMPLETED|Extension Study||5
5288457|NCT00600938|13002004|P1|NOT COMPLETED|Extension Study||9
5288458|NCT00600938|13002001|P4|COMPLETED|Extension Study||0
5288459|NCT00600938|13002002|P3|COMPLETED|Extension Study||33
5288460|NCT00600938|13002003|P2|COMPLETED|Extension Study||24
5288461|NCT00600938|13002004|P1|COMPLETED|Extension Study||65
5288462|NCT00600938|13002001|P4|Extension Safety Set|Extension Study||1
5288463|NCT00600938|13002002|P3|Extension Safety Set|Extension Study||42
5288464|NCT00600938|13002003|P2|Extension Safety Set|Extension Study||29
5288465|NCT00600938|13002004|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
5288466|NCT00600938|13002001|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
5288467|NCT00600938|13002002|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
5288528|NCT00600886|13002068|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
5288468|NCT00600938|13002003|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
5288469|NCT00600938|13002004|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
5288470|NCT00600938|13002001|P4|NOT COMPLETED|Core Study||0
5288471|NCT00600938|13002002|P3|NOT COMPLETED|Core Study||0
5288472|NCT00600938|13002003|P2|NOT COMPLETED|Core Study||21
5288473|NCT00600938|13002004|P1|NOT COMPLETED|Core Study||16
5288474|NCT00600938|13002001|P4|COMPLETED|Core Study||0
5288475|NCT00600938|13002002|P3|COMPLETED|Core Study||0
5288476|NCT00600938|13002003|P2|COMPLETED|Core Study||78
5288477|NCT00600938|13002004|P1|COMPLETED|Core Study||82
5288478|NCT00600938|13002001|P4|Per Protocol Set (PPS)|Core Study||0
5288479|NCT00600938|13002002|P3|Per Protocol Set (PPS)|Core Study||0
5288480|NCT00600938|13002003|P2|Per Protocol Set (PPS)|Core Study||81
5288481|NCT00600938|13002004|P1|Per Protocol Set (PPS)|Core Study||91
5288482|NCT00600938|13002001|P4|Core Safety Set|Core Study||0
5288483|NCT00600938|13002002|P3|Core Safety Set|Core Study||0
5288484|NCT00600938|13002003|P2|Core Safety Set|Core Study||91
5288485|NCT00600938|13002004|P1|Core Safety Set|Core Study||96
5288486|NCT00600938|13002001|P4|STARTED|Core Study||0
5288487|NCT00600938|13002002|P3|STARTED|Core Study||0
5288488|NCT00600938|13002003|P2|STARTED|Core Study||99
5288489|NCT00600938|13002004|P1|STARTED|Core Study||98
5288490|NCT00600886|13002068|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
5288491|NCT00600886|13002069|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
5288492|NCT00600886|13002068|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
5288493|NCT00600886|13002069|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
5288494|NCT00600886|13002068|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
5288495|NCT00600886|13002069|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
5288496|NCT00600886|13002068|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
5288497|NCT00600886|13002069|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
5288498|NCT00600886|13002068|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
5288499|NCT00600886|13002069|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
5288500|NCT00600886|13002068|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
5288501|NCT00600886|13002069|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
5288502|NCT00600886|13002068|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
5288503|NCT00600886|13002069|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
5288504|NCT00600886|13002068|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
5288505|NCT00600886|13002069|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
5288506|NCT00600886|13002068|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
5288507|NCT00600886|13002069|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
5288508|NCT00600886|13002068|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
5288509|NCT00600886|13002069|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
5288510|NCT00600886|13002068|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
5288511|NCT00600886|13002069|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
5288512|NCT00600886|13002068|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
5288513|NCT00600886|13002069|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
5288514|NCT00600886|13002068|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
5288515|NCT00600886|13002069|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
5288516|NCT00600886|13002068|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
5288517|NCT00600886|13002069|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
5288518|NCT00600886|13002068|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
5288519|NCT00600886|13002069|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
5288520|NCT00600886|13002068|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
5288521|NCT00600886|13002069|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
5288522|NCT00600886|13002068|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
5288523|NCT00600886|13002069|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
5288524|NCT00600886|13002068|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
5288525|NCT00600886|13002069|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
5288526|NCT00600886|13002068|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
5288527|NCT00600886|13002069|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
5288616|NCT00600119|13002424|P3|COMPLETED|Follow-up Period||27
5288529|NCT00600886|13002069|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
5288530|NCT00600821|13002133|P2|NOT COMPLETED|Overall Study||60
5288531|NCT00600821|13002134|P1|NOT COMPLETED|Overall Study||58
5288532|NCT00600821|13002133|P2|COMPLETED|Overall Study||0
5288533|NCT00600821|13002134|P1|COMPLETED|Overall Study||0
5288534|NCT00600821|13002133|P2|Treated|Overall Study||59
5288535|NCT00600821|13002134|P1|Treated|Overall Study||58
5288536|NCT00600821|13002133|P2|STARTED|Overall Study||60
5288537|NCT00600821|13002134|P1|STARTED|Overall Study||58
5288538|NCT00600756|13002162|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
5288539|NCT00600756|13002163|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
5288540|NCT00600756|13002162|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
5288541|NCT00600756|13002163|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
5288542|NCT00600756|13002162|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
5288543|NCT00600756|13002163|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
5288544|NCT00600756|13002162|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
5288545|NCT00600756|13002163|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
5288546|NCT00600756|13002162|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
5288547|NCT00600756|13002163|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
5288548|NCT00600756|13002162|P2|STARTED|Overall Study Analysis After 12 Months||403
5288549|NCT00600756|13002163|P1|STARTED|Overall Study Analysis After 12 Months||395
5288550|NCT00600756|13002162|P2|NOT COMPLETED|Analysis After 6 Months||120
5288551|NCT00600756|13002163|P1|NOT COMPLETED|Analysis After 6 Months||131
5288552|NCT00600756|13002162|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
5288553|NCT00600756|13002163|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
5288554|NCT00600756|13002162|P2|STARTED|Analysis After 6 Months||403
5288555|NCT00600756|13002163|P1|STARTED|Analysis After 6 Months||395
5288556|NCT00600743|13002233|P4|NOT COMPLETED|Overall Study||0
5288557|NCT00600743|13002234|P3|NOT COMPLETED|Overall Study||0
5288558|NCT00600743|13002235|P2|NOT COMPLETED|Overall Study||0
5288559|NCT00600743|13002236|P1|NOT COMPLETED|Overall Study||0
5288560|NCT00600743|13002233|P4|COMPLETED|Overall Study||7
5288561|NCT00600743|13002234|P3|COMPLETED|Overall Study||8
5288562|NCT00600743|13002235|P2|COMPLETED|Overall Study||4
5288563|NCT00600743|13002236|P1|COMPLETED|Overall Study||4
5288564|NCT00600743|13002233|P4|STARTED|Overall Study||7
5288565|NCT00600743|13002234|P3|STARTED|Overall Study||8
5288566|NCT00600743|13002235|P2|STARTED|Overall Study||4
5288567|NCT00600743|13002236|P1|STARTED|Overall Study||4
5288568|NCT00600704|13002265|P2|NOT COMPLETED|Overall Study||0
5288569|NCT00600704|13002266|P1|NOT COMPLETED|Overall Study||0
5288570|NCT00600704|13002265|P2|COMPLETED|Overall Study||92
5288571|NCT00600704|13002266|P1|COMPLETED|Overall Study||100
5288572|NCT00600704|13002265|P2|STARTED|Overall Study||92
5288573|NCT00600704|13002266|P1|STARTED|Overall Study||100
5288574|NCT00600613|13002272|P1|NOT COMPLETED|Overall Study||1
5288575|NCT00600613|13002272|P1|COMPLETED|Overall Study||5
5288576|NCT00600613|13002272|P1|STARTED|Overall Study||6
5288577|NCT00600353|13002278|P2|NOT COMPLETED|Overall Study||1
5288578|NCT00600353|13002279|P1|NOT COMPLETED|Overall Study||1
5288579|NCT00600353|13002278|P2|COMPLETED|Overall Study||9
5288580|NCT00600353|13002279|P1|COMPLETED|Overall Study||9
5288581|NCT00600353|13002278|P2|STARTED|Overall Study||10
5288582|NCT00600353|13002279|P1|STARTED|Overall Study||10
5288583|NCT00600340|13002293|P2|NOT COMPLETED|Overall Study||0
5288584|NCT00600340|13002294|P1|NOT COMPLETED|Overall Study||0
5288585|NCT00600340|13002293|P2|COMPLETED|Overall Study||279
5288586|NCT00600340|13002294|P1|COMPLETED|Overall Study||285
5288587|NCT00600340|13002293|P2|STARTED|Overall Study||279
5288588|NCT00600340|13002294|P1|STARTED|Overall Study||285
5288589|NCT00600171|13002342|P6|NOT COMPLETED|Overall Study||5
5288590|NCT00600171|13002343|P5|NOT COMPLETED|Overall Study||8
5288591|NCT00600171|13002344|P4|NOT COMPLETED|Overall Study||12
5288592|NCT00600171|13002345|P3|NOT COMPLETED|Overall Study||10
5288593|NCT00600171|13002346|P2|NOT COMPLETED|Overall Study||17
5288594|NCT00600171|13002347|P1|NOT COMPLETED|Overall Study||16
5288595|NCT00600171|13002342|P6|COMPLETED|Overall Study||97
5288596|NCT00600171|13002343|P5|COMPLETED|Overall Study||93
5288597|NCT00600171|13002344|P4|COMPLETED|Overall Study||88
5288598|NCT00600171|13002345|P3|COMPLETED|Overall Study||91
5288599|NCT00600171|13002346|P2|COMPLETED|Overall Study||84
5288600|NCT00600171|13002347|P1|COMPLETED|Overall Study||86
5288601|NCT00600171|13002342|P6|STARTED|Overall Study||102
5288602|NCT00600171|13002343|P5|STARTED|Overall Study||101
5288603|NCT00600171|13002344|P4|STARTED|Overall Study||100
5288604|NCT00600171|13002345|P3|STARTED|Overall Study||101
5288605|NCT00600171|13002346|P2|STARTED|Overall Study||101
5288606|NCT00600171|13002347|P1|STARTED|Overall Study||102
5288607|NCT00600119|13002421|P6|NOT COMPLETED|Follow-up Period||1
5288608|NCT00600119|13002422|P5|NOT COMPLETED|Follow-up Period||0
5288609|NCT00600119|13002423|P4|NOT COMPLETED|Follow-up Period||0
5288610|NCT00600119|13002424|P3|NOT COMPLETED|Follow-up Period||0
5288611|NCT00600119|13002425|P2|NOT COMPLETED|Follow-up Period||0
5288612|NCT00600119|13002426|P1|NOT COMPLETED|Follow-up Period||1
5288613|NCT00600119|13002421|P6|COMPLETED|Follow-up Period||20
5288614|NCT00600119|13002422|P5|COMPLETED|Follow-up Period||31
5288615|NCT00600119|13002423|P4|COMPLETED|Follow-up Period||28
5288617|NCT00600119|13002425|P2|COMPLETED|Follow-up Period||28
5288618|NCT00600119|13002426|P1|COMPLETED|Follow-up Period||26
5288619|NCT00600119|13002421|P6|STARTED|Follow-up Period||21
5288620|NCT00600119|13002422|P5|STARTED|Follow-up Period||31
5288621|NCT00600119|13002423|P4|STARTED|Follow-up Period||28
5288622|NCT00600119|13002424|P3|STARTED|Follow-up Period||27
5288623|NCT00600119|13002425|P2|STARTED|Follow-up Period||28
5288624|NCT00600119|13002426|P1|STARTED|Follow-up Period||27
5288625|NCT00600119|13002421|P6|NOT COMPLETED|Double-blind Treatment Period||14
5288626|NCT00600119|13002422|P5|NOT COMPLETED|Double-blind Treatment Period||6
5288627|NCT00600119|13002423|P4|NOT COMPLETED|Double-blind Treatment Period||2
5288628|NCT00600119|13002424|P3|NOT COMPLETED|Double-blind Treatment Period||0
5288629|NCT00600119|13002425|P2|NOT COMPLETED|Double-blind Treatment Period||5
5288630|NCT00600119|13002426|P1|NOT COMPLETED|Double-blind Treatment Period||5
5288631|NCT00600119|13002421|P6|COMPLETED|Double-blind Treatment Period||21
5288632|NCT00600119|13002422|P5|COMPLETED|Double-blind Treatment Period||31
5288633|NCT00600119|13002423|P4|COMPLETED|Double-blind Treatment Period||28
5288634|NCT00600119|13002424|P3|COMPLETED|Double-blind Treatment Period||27
5288635|NCT00600119|13002425|P2|COMPLETED|Double-blind Treatment Period||28
5288636|NCT00600119|13002426|P1|COMPLETED|Double-blind Treatment Period||27
5288637|NCT00600119|13002421|P6|STARTED|Double-blind Treatment Period||35
5288638|NCT00600119|13002422|P5|STARTED|Double-blind Treatment Period||37
5288639|NCT00600119|13002423|P4|STARTED|Double-blind Treatment Period||30
5288640|NCT00600119|13002424|P3|STARTED|Double-blind Treatment Period||27
5288641|NCT00600119|13002425|P2|STARTED|Double-blind Treatment Period||33
5288642|NCT00600119|13002426|P1|STARTED|Double-blind Treatment Period||32
5288643|NCT00600119|13002421|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
5288644|NCT00600119|13002422|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
5288645|NCT00600119|13002423|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
5288646|NCT00600119|13002424|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
5288647|NCT00600119|13002425|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
5288648|NCT00600119|13002426|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
5288649|NCT00600119|13002421|P6|COMPLETED|Single-blind Placebo run-in Period||35
5288650|NCT00600119|13002422|P5|COMPLETED|Single-blind Placebo run-in Period||37
5288651|NCT00600119|13002423|P4|COMPLETED|Single-blind Placebo run-in Period||30
5288652|NCT00600119|13002424|P3|COMPLETED|Single-blind Placebo run-in Period||27
5288653|NCT00600119|13002425|P2|COMPLETED|Single-blind Placebo run-in Period||33
5288654|NCT00600119|13002426|P1|COMPLETED|Single-blind Placebo run-in Period||32
5288655|NCT00600119|13002421|P6|STARTED|Single-blind Placebo run-in Period||37
5288656|NCT00600119|13002422|P5|STARTED|Single-blind Placebo run-in Period||39
5288657|NCT00600119|13002423|P4|STARTED|Single-blind Placebo run-in Period||31
5288658|NCT00600119|13002424|P3|STARTED|Single-blind Placebo run-in Period||29
5288659|NCT00600119|13002425|P2|STARTED|Single-blind Placebo run-in Period||35
5288660|NCT00600119|13002426|P1|STARTED|Single-blind Placebo run-in Period||36
5288661|NCT00600106|13002460|P2|NOT COMPLETED|Overall Study||1
5288662|NCT00600106|13002461|P1|NOT COMPLETED|Overall Study||1
5288663|NCT00600106|13002460|P2|COMPLETED|Overall Study||18
5288664|NCT00600106|13002461|P1|COMPLETED|Overall Study||17
5288665|NCT00600106|13002460|P2|STARTED|Overall Study||19
5288666|NCT00600106|13002461|P1|STARTED|Overall Study||18
5288667|NCT00600080|13002493|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
5288668|NCT00600080|13002494|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
5288669|NCT00600080|13002493|P2|COMPLETED|Period 2: One-week to Two-weeks||32
5288670|NCT00600080|13002494|P1|COMPLETED|Period 2: One-week to Two-weeks||28
5288671|NCT00600080|13002493|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
5288672|NCT00600080|13002494|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
5288673|NCT00600080|13002493|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
5288674|NCT00600080|13002494|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
5288675|NCT00600080|13002493|P2|COMPLETED|Period 1: Baseline to One-week||32
5288676|NCT00600080|13002494|P1|COMPLETED|Period 1: Baseline to One-week||28
5288677|NCT00600080|13002493|P2|STARTED|Period 1: Baseline to One-week||32
5288678|NCT00600080|13002494|P1|STARTED|Period 1: Baseline to One-week||28
5288679|NCT00600067|13002508|P2|NOT COMPLETED|Overall Study||7
5288680|NCT00600067|13002509|P1|NOT COMPLETED|Overall Study||3
5288681|NCT00600067|13002508|P2|COMPLETED|Overall Study||68
5288682|NCT00600067|13002509|P1|COMPLETED|Overall Study||52
5288683|NCT00600067|13002508|P2|STARTED|Overall Study||75
5288684|NCT00600067|13002509|P1|STARTED|Overall Study||55
5288685|NCT00600028|13002519|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
5288686|NCT00600028|13002520|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
5288687|NCT00600028|13002519|P2|COMPLETED|Second Intervention (12 Weeks)||8
5288688|NCT00600028|13002520|P1|COMPLETED|Second Intervention (12 Weeks)||12
5288689|NCT00600028|13002519|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
5288690|NCT00600028|13002520|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
5288691|NCT00600028|13002519|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
5288692|NCT00600028|13002520|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
5288693|NCT00600028|13002519|P2|COMPLETED|First Intervention (12 Weeks)||10
5288694|NCT00600028|13002520|P1|COMPLETED|First Intervention (12 Weeks)||12
5288695|NCT00600028|13002519|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
5288696|NCT00600028|13002520|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
5288697|NCT00600015|13002534|P2|NOT COMPLETED|Overall Study||35
5288698|NCT00600015|13002535|P1|NOT COMPLETED|Overall Study||60
5288699|NCT00600015|13002534|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
5288700|NCT00600015|13002535|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
5288701|NCT00600015|13002534|P2|STARTED|Overall Study||55
5288702|NCT00600015|13002535|P1|STARTED|Overall Study||111
5288703|NCT00599924|13002550|P7|NOT COMPLETED|Overall Study||5
5288704|NCT00599924|13002551|P6|NOT COMPLETED|Overall Study||4
5288705|NCT00599924|13002552|P5|NOT COMPLETED|Overall Study||6
5288706|NCT00599924|13002553|P4|NOT COMPLETED|Overall Study||8
5288707|NCT00599924|13002554|P3|NOT COMPLETED|Overall Study||2
5288708|NCT00599924|13002555|P2|NOT COMPLETED|Overall Study||5
5288709|NCT00599924|13002556|P1|NOT COMPLETED|Overall Study||3
5288710|NCT00599924|13002550|P7|COMPLETED|Overall Study||3
5288711|NCT00599924|13002551|P6|COMPLETED|Overall Study||2
5288712|NCT00599924|13002552|P5|COMPLETED|Overall Study||3
5288713|NCT00599924|13002553|P4|COMPLETED|Overall Study||4
5288714|NCT00599924|13002554|P3|COMPLETED|Overall Study||3
5288715|NCT00599924|13002555|P2|COMPLETED|Overall Study||4
5288716|NCT00599924|13002556|P1|COMPLETED|Overall Study||1
5288717|NCT00599924|13002550|P7|STARTED|Overall Study||8
5288718|NCT00599924|13002551|P6|STARTED|Overall Study||6
5288719|NCT00599924|13002552|P5|STARTED|Overall Study||9
5288720|NCT00599924|13002553|P4|STARTED|Overall Study||12
5288721|NCT00599924|13002554|P3|STARTED|Overall Study||5
5288722|NCT00599924|13002555|P2|STARTED|Overall Study||9
5288723|NCT00599924|13002556|P1|STARTED|Overall Study||4
5288724|NCT00599872|13002643|P2|NOT COMPLETED|Overall Study||33
5288725|NCT00599872|13002644|P1|NOT COMPLETED|Overall Study||49
5288726|NCT00599872|13002643|P2|COMPLETED|Overall Study||181
5288727|NCT00599872|13002644|P1|COMPLETED|Overall Study||167
5288728|NCT00599872|13002643|P2|STARTED|Overall Study||214
5288729|NCT00599872|13002644|P1|STARTED|Overall Study||216
5288730|NCT00599755|13002660|P1|NOT COMPLETED|Overall Study||19
5288731|NCT00599755|13002660|P1|COMPLETED|Overall Study||49
5288732|NCT00599755|13002660|P1|STARTED|Overall Study||68
5288733|NCT00599521|13002671|P2|NOT COMPLETED|Overall Study||69
5288734|NCT00599521|13002672|P1|NOT COMPLETED|Overall Study||60
5288735|NCT00599521|13002671|P2|COMPLETED|Overall Study||462
5288736|NCT00599521|13002672|P1|COMPLETED|Overall Study||475
5288737|NCT00599521|13002671|P2|STARTED|Overall Study||531
5288738|NCT00599521|13002672|P1|STARTED|Overall Study||535
5288739|NCT00599339|13002686|P1|NOT COMPLETED|Overall Study||664
5288740|NCT00599339|13002686|P1|COMPLETED|Overall Study||1531
5288741|NCT00599339|13002686|P1|Safety Set|Overall Study||2179
5288742|NCT00599339|13002686|P1|STARTED|Overall Study||2195
5288743|NCT00599326|13002788|P1|NOT COMPLETED|Overall Study||2
5288744|NCT00599326|13002788|P1|COMPLETED|Overall Study||8
5288745|NCT00599326|13002788|P1|STARTED|Overall Study||10
5288746|NCT00599313|13002793|P1|NOT COMPLETED|Overall Study||36
5288747|NCT00599313|13002793|P1|COMPLETED|Overall Study||0
5288748|NCT00599313|13002793|P1|STARTED|Overall Study||36
5288749|NCT00599248|13002804|P4|NOT COMPLETED|Overall Study||0
5288750|NCT00599248|13002805|P3|NOT COMPLETED|Overall Study||0
5288751|NCT00599248|13002806|P2|NOT COMPLETED|Overall Study||0
5288752|NCT00599248|13002807|P1|NOT COMPLETED|Overall Study||0
5288753|NCT00599248|13002804|P4|COMPLETED|Overall Study||3
5288754|NCT00599248|13002805|P3|COMPLETED|Overall Study||3
5288755|NCT00599248|13002806|P2|COMPLETED|Overall Study||3
5288756|NCT00599248|13002807|P1|COMPLETED|Overall Study||3
5288757|NCT00599248|13002804|P4|STARTED|Overall Study||3
5288758|NCT00599248|13002805|P3|STARTED|Overall Study||3
5288759|NCT00599248|13002806|P2|STARTED|Overall Study||3
5288760|NCT00599248|13002807|P1|STARTED|Overall Study||3
5288761|NCT00599196|13002835|P1|NOT COMPLETED|Overall Study||381
5288762|NCT00599196|13002835|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
5288763|NCT00599196|13002835|P1|STARTED|Overall Study||381
5288764|NCT00599131|13002841|P1|NOT COMPLETED|Overall Study||0
5288765|NCT00599131|13002841|P1|COMPLETED|Overall Study||4
5288766|NCT00599131|13002841|P1|STARTED|Overall Study||4
5288767|NCT00599053|13002851|P2|NOT COMPLETED|Overall Study||0
5288768|NCT00599053|13002852|P1|NOT COMPLETED|Overall Study||0
5288769|NCT00599053|13002851|P2|COMPLETED|Overall Study||2
5288770|NCT00599053|13002852|P1|COMPLETED|Overall Study||5
5288771|NCT00599053|13002851|P2|STARTED|Overall Study||2
5288772|NCT00599053|13002852|P1|STARTED|Overall Study||5
5288773|NCT00599027|13002866|P2|NOT COMPLETED|Overall Study||3
5288774|NCT00599027|13002867|P1|NOT COMPLETED|Overall Study||1
5288775|NCT00599027|13002866|P2|COMPLETED|Overall Study||22
5288776|NCT00599027|13002867|P1|COMPLETED|Overall Study||25
5288777|NCT00599027|13002866|P2|STARTED|Overall Study||25
5288778|NCT00599027|13002867|P1|STARTED|Overall Study||26
5288779|NCT00599014|13002873|P1|NOT COMPLETED|Overall Study||0
5288780|NCT00599014|13002873|P1|COMPLETED|Overall Study||335
5288781|NCT00599014|13002873|P1|STARTED|Overall Study||335
5288782|NCT00598871|13002880|P2|NOT COMPLETED|Overall Study||1
5288783|NCT00598871|13002881|P1|NOT COMPLETED|Overall Study||0
5288784|NCT00598871|13002880|P2|COMPLETED|Overall Study||8
5288785|NCT00598871|13002881|P1|COMPLETED|Overall Study||3
5288786|NCT00598871|13002880|P2|STARTED|Overall Study||9
5288787|NCT00598871|13002881|P1|STARTED|Overall Study||3
5288788|NCT00598832|13002891|P2|NOT COMPLETED|Overall Study||82
5288789|NCT00598832|13002892|P1|NOT COMPLETED|Overall Study||62
5288790|NCT00598832|13002891|P2|COMPLETED|Overall Study||460
5288791|NCT00598832|13002892|P1|COMPLETED|Overall Study||471
5288792|NCT00598832|13002891|P2|STARTED|Overall Study||542
5288793|NCT00598832|13002892|P1|STARTED|Overall Study||533
5288794|NCT00598819|13002906|P1|NOT COMPLETED|Overall Study||0
5288795|NCT00598819|13002906|P1|COMPLETED|Overall Study||14
5288796|NCT00598819|13002906|P1|STARTED|Overall Study||14
5288797|NCT00598806|13002916|P2|NOT COMPLETED|Overall Study||64
5288798|NCT00598806|13002917|P1|NOT COMPLETED|Overall Study||73
5288799|NCT00598806|13002916|P2|COMPLETED|Overall Study||346
5288800|NCT00598806|13002917|P1|COMPLETED|Overall Study||329
5288801|NCT00598806|13002916|P2|STARTED|Overall Study||410
5288802|NCT00598806|13002917|P1|STARTED|Overall Study||402
5288803|NCT00598702|13002945|P8|NOT COMPLETED|Overall Study||0
5288804|NCT00598702|13002946|P7|NOT COMPLETED|Overall Study||1
5288805|NCT00598702|13002947|P6|NOT COMPLETED|Overall Study||12
5288806|NCT00598702|13002948|P5|NOT COMPLETED|Overall Study||3
5288807|NCT00598702|13002949|P4|NOT COMPLETED|Overall Study||8
5288808|NCT00598702|13002950|P3|NOT COMPLETED|Overall Study||2
5288809|NCT00598702|13002951|P2|NOT COMPLETED|Overall Study||2
5288810|NCT00598702|13002952|P1|NOT COMPLETED|Overall Study||0
5288811|NCT00598702|13002945|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
5288812|NCT00598702|13002946|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
5288813|NCT00598702|13002947|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
5288814|NCT00598702|13002948|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
5288815|NCT00598702|13002949|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
5288816|NCT00598702|13002950|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
5288817|NCT00598702|13002951|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
5288818|NCT00598702|13002952|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
5288819|NCT00598702|13002945|P8|STARTED|Overall Study||4
5288820|NCT00598702|13002946|P7|STARTED|Overall Study||1
5288821|NCT00598702|13002947|P6|STARTED|Overall Study||42
5288822|NCT00598702|13002948|P5|STARTED|Overall Study||9
5288823|NCT00598702|13002949|P4|STARTED|Overall Study||33
5288824|NCT00598702|13002950|P3|STARTED|Overall Study||7
5288825|NCT00598702|13002951|P2|STARTED|Overall Study||3
5288826|NCT00598702|13002952|P1|STARTED|Overall Study||1
5288827|NCT00598689|13002996|P2|NOT COMPLETED|Overall Study||0
5288828|NCT00598689|13002997|P1|NOT COMPLETED|Overall Study||0
5288829|NCT00598689|13002996|P2|COMPLETED|Overall Study||40
5288830|NCT00598689|13002997|P1|COMPLETED|Overall Study||40
5288831|NCT00598689|13002996|P2|STARTED|Overall Study||40
5288832|NCT00598689|13002997|P1|STARTED|Overall Study||40
5288833|NCT00598663|13003009|P2|NOT COMPLETED|Second Intervention (6 Months)||1
5288834|NCT00598663|13003010|P1|NOT COMPLETED|Second Intervention (6 Months)||4
5288835|NCT00598663|13003009|P2|COMPLETED|Second Intervention (6 Months)||69
5288836|NCT00598663|13003010|P1|COMPLETED|Second Intervention (6 Months)||69
5288837|NCT00598663|13003009|P2|STARTED|Second Intervention (6 Months)||70
5288838|NCT00598663|13003010|P1|STARTED|Second Intervention (6 Months)||73
5288839|NCT00598663|13003009|P2|NOT COMPLETED|Washout (4 Months)||1
5288840|NCT00598663|13003010|P1|NOT COMPLETED|Washout (4 Months)||0
5288841|NCT00598663|13003009|P2|COMPLETED|Washout (4 Months)||70
5288842|NCT00598663|13003010|P1|COMPLETED|Washout (4 Months)||73
5288843|NCT00598663|13003009|P2|STARTED|Washout (4 Months)||71
5288844|NCT00598663|13003010|P1|STARTED|Washout (4 Months)||73
5288845|NCT00598663|13003009|P2|NOT COMPLETED|First Intervention (6 Months)||6
5288846|NCT00598663|13003010|P1|NOT COMPLETED|First Intervention (6 Months)||3
5288847|NCT00598663|13003009|P2|COMPLETED|First Intervention (6 Months)||71
5288848|NCT00598663|13003010|P1|COMPLETED|First Intervention (6 Months)||73
5288849|NCT00598663|13003009|P2|STARTED|First Intervention (6 Months)||77
5288850|NCT00598663|13003010|P1|STARTED|First Intervention (6 Months)||76
5288851|NCT00598650|13003028|P1|NOT COMPLETED|Overall Study||27
5288852|NCT00598650|13003028|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
5288853|NCT00598650|13003028|P1|STARTED|Overall Study||108
5288854|NCT00598585|13003037|P2|NOT COMPLETED|Overall Study||0
5288855|NCT00598585|13003038|P1|NOT COMPLETED|Overall Study||1
5288856|NCT00598585|13003037|P2|COMPLETED|Overall Study||6
5288857|NCT00598585|13003038|P1|COMPLETED|Overall Study||5
5288858|NCT00598585|13003037|P2|STARTED|Overall Study||6
5288859|NCT00598585|13003038|P1|STARTED|Overall Study||6
5288860|NCT00598559|13003047|P3|NOT COMPLETED|Overall Study||3
5288861|NCT00598559|13003048|P2|NOT COMPLETED|Overall Study||28
5288862|NCT00598559|13003049|P1|NOT COMPLETED|Overall Study||27
5288863|NCT00598559|13003047|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
5288864|NCT00598559|13003048|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
5288865|NCT00598559|13003049|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
5288866|NCT00598559|13003047|P3|STARTED|Overall Study||30
5288867|NCT00598559|13003048|P2|STARTED|Overall Study||91
5288868|NCT00598559|13003049|P1|STARTED|Overall Study||92
5288869|NCT00598507|13003066|P1|NOT COMPLETED|Overall Study||0
5288870|NCT00598507|13003066|P1|COMPLETED|Overall Study||35
5288871|NCT00598507|13003066|P1|STARTED|Overall Study||35
5288872|NCT00598481|13003073|P1|NOT COMPLETED|Treatment||1
5288873|NCT00598481|13003073|P1|COMPLETED|Treatment||11
5288874|NCT00598481|13003073|P1|STARTED|Treatment||12
5288875|NCT00598481|13003073|P1|NOT COMPLETED|Baseline||0
5288876|NCT00598481|13003073|P1|COMPLETED|Baseline||12
5288877|NCT00598481|13003073|P1|STARTED|Baseline||12
5288878|NCT00598442|13003083|P3|NOT COMPLETED|Overall Study||24
5288879|NCT00598442|13003084|P2|NOT COMPLETED|Overall Study||39
5288880|NCT00598442|13003085|P1|NOT COMPLETED|Overall Study||43
5288881|NCT00598442|13003083|P3|COMPLETED|Overall Study||139
5288882|NCT00598442|13003084|P2|COMPLETED|Overall Study||124
5288883|NCT00598442|13003085|P1|COMPLETED|Overall Study||124
5288884|NCT00598442|13003083|P3|STARTED|Overall Study||163
5288885|NCT00598442|13003084|P2|STARTED|Overall Study||163
5288886|NCT00598442|13003085|P1|STARTED|Overall Study||167
5288887|NCT00598273|13003102|P3|NOT COMPLETED|Overall Study||39
5288888|NCT00598273|13003103|P2|NOT COMPLETED|Overall Study||38
5288889|NCT00598273|13003104|P1|NOT COMPLETED|Overall Study||41
5288890|NCT00598273|13003102|P3|COMPLETED|Overall Study||125
5288891|NCT00598273|13003103|P2|COMPLETED|Overall Study||127
5288892|NCT00598273|13003104|P1|COMPLETED|Overall Study||120
5288893|NCT00598273|13003102|P3|STARTED|Overall Study||164
5288894|NCT00598273|13003103|P2|STARTED|Overall Study||165
5288895|NCT00598273|13003104|P1|STARTED|Overall Study||161
5288896|NCT00598078|13003118|P2|NOT COMPLETED|Period 3 (Day 3)||0
5288897|NCT00598078|13003119|P1|NOT COMPLETED|Period 3 (Day 3)||0
5288898|NCT00598078|13003118|P2|COMPLETED|Period 3 (Day 3)||10
5288899|NCT00598078|13003119|P1|COMPLETED|Period 3 (Day 3)||9
5288900|NCT00598078|13003118|P2|STARTED|Period 3 (Day 3)||10
5288901|NCT00598078|13003119|P1|STARTED|Period 3 (Day 3)||9
5288902|NCT00598078|13003118|P2|NOT COMPLETED|Period 2 (Day 2)||0
5288903|NCT00598078|13003119|P1|NOT COMPLETED|Period 2 (Day 2)||1
5288904|NCT00598078|13003118|P2|COMPLETED|Period 2 (Day 2)||10
5288905|NCT00598078|13003119|P1|COMPLETED|Period 2 (Day 2)||9
5288906|NCT00598078|13003118|P2|STARTED|Period 2 (Day 2)||10
5288907|NCT00598078|13003119|P1|STARTED|Period 2 (Day 2)||10
5288908|NCT00598078|13003118|P2|NOT COMPLETED|Period 1 (Day 1)||0
5288909|NCT00598078|13003119|P1|NOT COMPLETED|Period 1 (Day 1)||0
5288910|NCT00598078|13003118|P2|COMPLETED|Period 1 (Day 1)||10
5288911|NCT00598078|13003119|P1|COMPLETED|Period 1 (Day 1)||10
5288912|NCT00598078|13003118|P2|STARTED|Period 1 (Day 1)||10
5288913|NCT00598078|13003119|P1|STARTED|Period 1 (Day 1)||10
5288914|NCT00597909|13003130|P3|NOT COMPLETED|Overall Study||0
5288915|NCT00597909|13003131|P2|NOT COMPLETED|Overall Study||0
5288916|NCT00597909|13003132|P1|NOT COMPLETED|Overall Study||0
5288917|NCT00597909|13003130|P3|COMPLETED|Overall Study||0
5288918|NCT00597909|13003131|P2|COMPLETED|Overall Study||0
5288919|NCT00597909|13003132|P1|COMPLETED|Overall Study||0
5288920|NCT00597909|13003130|P3|STARTED|Overall Study||0
5288921|NCT00597909|13003131|P2|STARTED|Overall Study||0
5288922|NCT00597909|13003132|P1|STARTED|Overall Study||0
5288923|NCT00597896|13003142|P2|NOT COMPLETED|Overall Study||2
5288924|NCT00597896|13003143|P1|NOT COMPLETED|Overall Study||3
5288925|NCT00597896|13003142|P2|COMPLETED|Overall Study||24
5288926|NCT00597896|13003143|P1|COMPLETED|Overall Study||21
5288927|NCT00597896|13003142|P2|STARTED|Overall Study||26
5288928|NCT00597896|13003143|P1|STARTED|Overall Study||24
5288929|NCT00597818|13003173|P4|NOT COMPLETED|Overall Study||10
5288930|NCT00597818|13003174|P3|NOT COMPLETED|Overall Study||19
5288931|NCT00597818|13003175|P2|NOT COMPLETED|Overall Study||16
5288932|NCT00597818|13003176|P1|NOT COMPLETED|Overall Study||18
5288933|NCT00597818|13003173|P4|COMPLETED|Overall Study||20
5288934|NCT00597818|13003174|P3|COMPLETED|Overall Study||12
5288935|NCT00597818|13003175|P2|COMPLETED|Overall Study||14
5288936|NCT00597818|13003176|P1|COMPLETED|Overall Study||12
5288937|NCT00597818|13003173|P4|STARTED|Overall Study||30
5288938|NCT00597818|13003174|P3|STARTED|Overall Study||31
5288939|NCT00597818|13003175|P2|STARTED|Overall Study||30
5288940|NCT00597818|13003176|P1|STARTED|Overall Study||30
5288941|NCT00597766|13003201|P3|NOT COMPLETED|Follow-up 3, Week 12||0
5288942|NCT00597766|13003202|P2|NOT COMPLETED|Follow-up 3, Week 12||0
5288943|NCT00597766|13003203|P1|NOT COMPLETED|Follow-up 3, Week 12||0
5288944|NCT00597766|13003201|P3|COMPLETED|Follow-up 3, Week 12||9
5288945|NCT00597766|13003202|P2|COMPLETED|Follow-up 3, Week 12||9
5288946|NCT00597766|13003203|P1|COMPLETED|Follow-up 3, Week 12||8
5288947|NCT00597766|13003201|P3|STARTED|Follow-up 3, Week 12||9
5288948|NCT00597766|13003202|P2|STARTED|Follow-up 3, Week 12||9
5288949|NCT00597766|13003203|P1|STARTED|Follow-up 3, Week 12||8
5288950|NCT00597766|13003201|P3|NOT COMPLETED|Follow-up 2, Week 8||1
5288951|NCT00597766|13003202|P2|NOT COMPLETED|Follow-up 2, Week 8||0
5288952|NCT00597766|13003203|P1|NOT COMPLETED|Follow-up 2, Week 8||0
5288953|NCT00597766|13003201|P3|COMPLETED|Follow-up 2, Week 8||9
5288954|NCT00597766|13003202|P2|COMPLETED|Follow-up 2, Week 8||9
5288955|NCT00597766|13003203|P1|COMPLETED|Follow-up 2, Week 8||8
5288956|NCT00597766|13003201|P3|STARTED|Follow-up 2, Week 8||10
5288957|NCT00597766|13003202|P2|STARTED|Follow-up 2, Week 8||9
5288958|NCT00597766|13003203|P1|STARTED|Follow-up 2, Week 8||8
5288959|NCT00597766|13003201|P3|NOT COMPLETED|Follow-up 1, Week 4||0
5288960|NCT00597766|13003202|P2|NOT COMPLETED|Follow-up 1, Week 4||0
5288961|NCT00597766|13003203|P1|NOT COMPLETED|Follow-up 1, Week 4||1
5288962|NCT00597766|13003201|P3|COMPLETED|Follow-up 1, Week 4||10
5288963|NCT00597766|13003202|P2|COMPLETED|Follow-up 1, Week 4||9
5288964|NCT00597766|13003203|P1|COMPLETED|Follow-up 1, Week 4||8
5288965|NCT00597766|13003201|P3|STARTED|Follow-up 1, Week 4||10
5288966|NCT00597766|13003202|P2|STARTED|Follow-up 1, Week 4||9
5288967|NCT00597766|13003203|P1|STARTED|Follow-up 1, Week 4||9
5288968|NCT00597766|13003201|P3|NOT COMPLETED|Enrolled||0
5288969|NCT00597766|13003202|P2|NOT COMPLETED|Enrolled||0
5288970|NCT00597766|13003203|P1|NOT COMPLETED|Enrolled||0
5288971|NCT00597766|13003201|P3|COMPLETED|Enrolled||10
5288972|NCT00597766|13003202|P2|COMPLETED|Enrolled||9
5288973|NCT00597766|13003203|P1|COMPLETED|Enrolled||9
5288974|NCT00597766|13003201|P3|STARTED|Enrolled||10
5288975|NCT00597766|13003202|P2|STARTED|Enrolled||9
5288976|NCT00597766|13003203|P1|STARTED|Enrolled||9
5288977|NCT00597753|13003222|P2|NOT COMPLETED|Overall Study||69
5288978|NCT00597753|13003223|P1|NOT COMPLETED|Overall Study||166
5288979|NCT00597753|13003222|P2|COMPLETED|Overall Study||202
5288980|NCT00597753|13003223|P1|COMPLETED|Overall Study||366
5288981|NCT00597753|13003222|P2|STARTED|Overall Study||271
5288982|NCT00597753|13003223|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
5288983|NCT00597727|13003237|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
5288984|NCT00597727|13003238|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
5288985|NCT00597727|13003239|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
5288986|NCT00597727|13003240|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
5288987|NCT00597727|13003241|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
5288988|NCT00597727|13003237|P5|COMPLETED|Open-label Extended Maintenance Phase||1
5288989|NCT00597727|13003238|P4|COMPLETED|Open-label Extended Maintenance Phase||14
5288990|NCT00597727|13003239|P3|COMPLETED|Open-label Extended Maintenance Phase||23
5288991|NCT00597727|13003240|P2|COMPLETED|Open-label Extended Maintenance Phase||0
5288992|NCT00597727|13003241|P1|COMPLETED|Open-label Extended Maintenance Phase||0
5288993|NCT00597727|13003237|P5|STARTED|Open-label Extended Maintenance Phase||3
5288994|NCT00597727|13003238|P4|STARTED|Open-label Extended Maintenance Phase||17
5288995|NCT00597727|13003239|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
5288996|NCT00597727|13003240|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
5288997|NCT00597727|13003241|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
5288998|NCT00597727|13003237|P5|NOT COMPLETED|12 Month Blinded Phase||1
5288999|NCT00597727|13003238|P4|NOT COMPLETED|12 Month Blinded Phase||10
5289000|NCT00597727|13003239|P3|NOT COMPLETED|12 Month Blinded Phase||0
5289001|NCT00597727|13003240|P2|NOT COMPLETED|12 Month Blinded Phase||0
5289002|NCT00597727|13003241|P1|NOT COMPLETED|12 Month Blinded Phase||0
5289003|NCT00597727|13003237|P5|COMPLETED|12 Month Blinded Phase||3
5289004|NCT00597727|13003238|P4|COMPLETED|12 Month Blinded Phase||17
5289005|NCT00597727|13003239|P3|COMPLETED|12 Month Blinded Phase||0
5289006|NCT00597727|13003240|P2|COMPLETED|12 Month Blinded Phase||15
5289007|NCT00597727|13003241|P1|COMPLETED|12 Month Blinded Phase||14
5289008|NCT00597727|13003237|P5|STARTED|12 Month Blinded Phase||4
5289009|NCT00597727|13003238|P4|STARTED|12 Month Blinded Phase||27
5289010|NCT00597727|13003239|P3|STARTED|12 Month Blinded Phase||0
5289011|NCT00597727|13003240|P2|STARTED|12 Month Blinded Phase||15
5289012|NCT00597727|13003241|P1|STARTED|12 Month Blinded Phase||14
5289013|NCT00597714|13003257|P3|NOT COMPLETED|Overall Study||10
5289014|NCT00597714|13003258|P2|NOT COMPLETED|Overall Study||46
5289015|NCT00597714|13003259|P1|NOT COMPLETED|Overall Study||56
5289016|NCT00597714|13003257|P3|COMPLETED|Overall Study||84
5289017|NCT00597714|13003258|P2|COMPLETED|Overall Study||11
5289018|NCT00597714|13003259|P1|COMPLETED|Overall Study||24
5289019|NCT00597714|13003257|P3|STARTED|Overall Study||94
5289020|NCT00597714|13003258|P2|STARTED|Overall Study||57
5289021|NCT00597714|13003259|P1|STARTED|Overall Study||80
5289022|NCT00597701|13003271|P2|NOT COMPLETED|Overall Study||8
5289023|NCT00597701|13003272|P1|NOT COMPLETED|Overall Study||7
5289024|NCT00597701|13003271|P2|COMPLETED|Overall Study||13
5289025|NCT00597701|13003272|P1|COMPLETED|Overall Study||18
5289026|NCT00597701|13003271|P2|STARTED|Overall Study||21
5289027|NCT00597701|13003272|P1|STARTED|Overall Study||25
5289028|NCT00597675|13003280|P2|NOT COMPLETED|Open Label Phase||0
5289029|NCT00597675|13003281|P1|NOT COMPLETED|Open Label Phase||0
5289030|NCT00597675|13003280|P2|COMPLETED|Open Label Phase||5
5289031|NCT00597675|13003281|P1|COMPLETED|Open Label Phase||2
5289032|NCT00597675|13003280|P2|STARTED|Open Label Phase||5
5289033|NCT00597675|13003281|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
5289034|NCT00597675|13003280|P2|NOT COMPLETED|Blinded Phase||1
5289035|NCT00597675|13003281|P1|NOT COMPLETED|Blinded Phase||2
5289036|NCT00597675|13003280|P2|COMPLETED|Blinded Phase||5
5289037|NCT00597675|13003281|P1|COMPLETED|Blinded Phase||2
5289038|NCT00597675|13003280|P2|STARTED|Blinded Phase||6
5289039|NCT00597675|13003281|P1|STARTED|Blinded Phase||4
5289040|NCT00597584|13003294|P2|NOT COMPLETED|Overall Study||63
5289041|NCT00597584|13003295|P1|NOT COMPLETED|Overall Study||128
5289042|NCT00597584|13003294|P2|COMPLETED|Overall Study||211
5289043|NCT00597584|13003295|P1|COMPLETED|Overall Study||421
5289044|NCT00597584|13003294|P2|STARTED|Overall Study||274
5289045|NCT00597584|13003295|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
5289046|NCT00597558|13003305|P1|NOT COMPLETED|Overall Study||4
5289047|NCT00597558|13003305|P1|COMPLETED|Overall Study||9
5289048|NCT00597558|13003305|P1|STARTED|Overall Study||13
5289049|NCT00597545|13003313|P2|NOT COMPLETED|Overall Study||0
5289050|NCT00597545|13003314|P1|NOT COMPLETED|Overall Study||0
5289051|NCT00597545|13003313|P2|COMPLETED|Overall Study||6
5289052|NCT00597545|13003314|P1|COMPLETED|Overall Study||4
5289053|NCT00597545|13003313|P2|STARTED|Overall Study||6
5289054|NCT00597545|13003314|P1|STARTED|Overall Study||4
5289055|NCT00597519|13003320|P1|NOT COMPLETED|Overall Study||1
5289056|NCT00597519|13003320|P1|COMPLETED|Overall Study||27
5289057|NCT00597519|13003320|P1|STARTED|Overall Study||28
5289058|NCT00597506|13003324|P1|NOT COMPLETED|Overall Study||1
5289059|NCT00597506|13003324|P1|COMPLETED|Overall Study||49
5289060|NCT00597506|13003324|P1|STARTED|Overall Study||50
5289061|NCT00597493|13003329|P1|NOT COMPLETED|Overall Study||0
5289062|NCT00597493|13003329|P1|COMPLETED|Overall Study||32
5289063|NCT00597493|13003329|P1|STARTED|Overall Study||32
5289064|NCT00597428|13003348|P2|NOT COMPLETED|Overall Study||71
5289065|NCT00597428|13003349|P1|NOT COMPLETED|Overall Study||61
5289066|NCT00597428|13003348|P2|COMPLETED|Overall Study||152
5289067|NCT00597428|13003349|P1|COMPLETED|Overall Study||153
5289068|NCT00597428|13003348|P2|STARTED|Overall Study||223
5289069|NCT00597428|13003349|P1|STARTED|Overall Study||214
5289070|NCT00597402|13003365|P1|NOT COMPLETED|Overall Study||0
5289071|NCT00597402|13003365|P1|COMPLETED|Overall Study||125
5289072|NCT00597402|13003365|P1|STARTED|Overall Study||125
5289073|NCT00597376|13003374|P2|NOT COMPLETED|Overall Study||4
5289074|NCT00597376|13003375|P1|NOT COMPLETED|Overall Study||8
5289075|NCT00597376|13003374|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
5289076|NCT00597376|13003375|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
5289077|NCT00597376|13003374|P2|STARTED|Overall Study||53
5289078|NCT00597376|13003375|P1|STARTED|Overall Study||51
5289079|NCT00597272|13003392|P7|NOT COMPLETED|Overall Study||0
5289080|NCT00597272|13003393|P6|NOT COMPLETED|Overall Study||0
5289081|NCT00597272|13003394|P5|NOT COMPLETED|Overall Study||0
5289082|NCT00597272|13003395|P4|NOT COMPLETED|Overall Study||0
5289083|NCT00597272|13003396|P3|NOT COMPLETED|Overall Study||0
5289084|NCT00597272|13003397|P2|NOT COMPLETED|Overall Study||0
5289085|NCT00597272|13003398|P1|NOT COMPLETED|Overall Study||0
5289086|NCT00597272|13003392|P7|COMPLETED|Overall Study||10
5289087|NCT00597272|13003393|P6|COMPLETED|Overall Study||10
5289088|NCT00597272|13003394|P5|COMPLETED|Overall Study||1
5289089|NCT00597272|13003395|P4|COMPLETED|Overall Study||1
5289090|NCT00597272|13003396|P3|COMPLETED|Overall Study||10
5289091|NCT00597272|13003397|P2|COMPLETED|Overall Study||1
5289092|NCT00597272|13003398|P1|COMPLETED|Overall Study||1
5289093|NCT00597272|13003392|P7|STARTED|Overall Study||10
5289094|NCT00597272|13003393|P6|STARTED|Overall Study||10
5289095|NCT00597272|13003394|P5|STARTED|Overall Study||1
5289096|NCT00597272|13003395|P4|STARTED|Overall Study||1
5289097|NCT00597272|13003396|P3|STARTED|Overall Study||10
5289098|NCT00597272|13003397|P2|STARTED|Overall Study||1
5289099|NCT00597272|13003398|P1|STARTED|Overall Study||1
5289100|NCT00597207|13003416|P2|NOT COMPLETED|Overall Study||7
5289101|NCT00597207|13003417|P1|NOT COMPLETED|Overall Study||5
5289102|NCT00597207|13003416|P2|COMPLETED|Overall Study||2125
5289103|NCT00597207|13003417|P1|COMPLETED|Overall Study||2094
5289104|NCT00597207|13003416|P2|STARTED|Overall Study||2132
5289105|NCT00597207|13003417|P1|STARTED|Overall Study||2099
5289106|NCT00597116|13003425|P2|NOT COMPLETED|Overall Study||11
5289107|NCT00597116|13003426|P1|NOT COMPLETED|Overall Study||14
5289108|NCT00597116|13003425|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
5289109|NCT00597116|13003426|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
5289110|NCT00597116|13003425|P2|STARTED|Overall Study||11
5289111|NCT00597116|13003426|P1|STARTED|Overall Study||14
5289112|NCT00597038|13003440|P2|NOT COMPLETED|Overall Study||4
5289113|NCT00597038|13003441|P1|NOT COMPLETED|Overall Study||2
5289114|NCT00597038|13003440|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
5289115|NCT00597038|13003441|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
5289116|NCT00597038|13003440|P2|STARTED|Overall Study||34
5289117|NCT00597038|13003441|P1|STARTED|Overall Study||16
5289118|NCT00597012|13003452|P2|NOT COMPLETED|Overall Study||8
5289119|NCT00597012|13003453|P1|NOT COMPLETED|Overall Study||13
5289120|NCT00597012|13003452|P2|COMPLETED|Overall Study||169
5289121|NCT00597012|13003453|P1|COMPLETED|Overall Study||161
5289122|NCT00597012|13003452|P2|STARTED|Overall Study||177
5289123|NCT00597012|13003453|P1|STARTED|Overall Study||174
5289124|NCT00596960|13003465|P2|NOT COMPLETED|Overall Study||9
5289125|NCT00596960|13003466|P1|NOT COMPLETED|Overall Study||11
5289126|NCT00596960|13003465|P2|COMPLETED|Overall Study||60
5289127|NCT00596960|13003466|P1|COMPLETED|Overall Study||59
5289128|NCT00596960|13003465|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
5289129|NCT00596960|13003466|P1|STARTED|Overall Study||70
5289130|NCT00596947|13003478|P2|NOT COMPLETED|Overall Study||3
5289131|NCT00596947|13003479|P1|NOT COMPLETED|Overall Study||6
5289132|NCT00596947|13003478|P2|COMPLETED|Overall Study||6
5289133|NCT00596947|13003479|P1|COMPLETED|Overall Study||3
5289134|NCT00596947|13003478|P2|STARTED|Overall Study||9
5289135|NCT00596947|13003479|P1|STARTED|Overall Study||9
5289136|NCT00596934|13003519|P1|NOT COMPLETED|Overall Study||2
5289137|NCT00596934|13003519|P1|COMPLETED|Overall Study||7
5289138|NCT00596934|13003519|P1|STARTED|Overall Study||9
5289139|NCT00596830|13003532|P2|NOT COMPLETED|Overall Study||339
5289140|NCT00596830|13003533|P1|NOT COMPLETED|Overall Study||342
5289141|NCT00596830|13003532|P2|COMPLETED|Overall Study||0
5289142|NCT00596830|13003533|P1|COMPLETED|Overall Study||0
5289143|NCT00596830|13003532|P2|Treated|Overall Study||332
5289144|NCT00596830|13003533|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
5289145|NCT00596830|13003532|P2|STARTED|Overall Study||339
5289146|NCT00596830|13003533|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
5289147|NCT00596817|13003559|P2|NOT COMPLETED|Double-blind Period||79
5289148|NCT00596817|13003560|P1|NOT COMPLETED|Double-blind Period||88
5289149|NCT00596817|13003559|P2|COMPLETED|Double-blind Period||125
5289150|NCT00596817|13003560|P1|COMPLETED|Double-blind Period||104
5289151|NCT00596817|13003559|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
5289152|NCT00596817|13003560|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
5289153|NCT00596817|13003559|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
5289154|NCT00596817|13003560|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
5289155|NCT00596817|13003559|P2|COMPLETED|Open-label Period to Double-blind Period||400
5289156|NCT00596817|13003560|P1|COMPLETED|Open-label Period to Double-blind Period||0
5289157|NCT00596817|13003559|P2|STARTED|Open-label Period to Double-blind Period||492
5289158|NCT00596817|13003560|P1|STARTED|Open-label Period to Double-blind Period||0
5289159|NCT00596817|13003559|P2|NOT COMPLETED|Open-label Period||147
5289160|NCT00596817|13003560|P1|NOT COMPLETED|Open-label Period||0
5289161|NCT00596817|13003559|P2|COMPLETED|Open-label Period||492
5289162|NCT00596817|13003560|P1|COMPLETED|Open-label Period||0
5289163|NCT00596817|13003559|P2|STARTED|Open-label Period||639
5289164|NCT00596817|13003560|P1|STARTED|Open-label Period||0
5289165|NCT00596752|13003585|P2|NOT COMPLETED|Overall Study||143
5289166|NCT00596752|13003586|P1|NOT COMPLETED|Overall Study||126
5289167|NCT00596752|13003585|P2|COMPLETED|Overall Study||282
5289168|NCT00596752|13003586|P1|COMPLETED|Overall Study||289
5289169|NCT00596752|13003585|P2|Randomized and Treated|Overall Study||424
5289170|NCT00596752|13003586|P1|Randomized and Treated|Overall Study||415
5289171|NCT00596752|13003585|P2|STARTED|Overall Study||425
5289172|NCT00596752|13003586|P1|STARTED|Overall Study||415
5289173|NCT00596687|13003616|P2|NOT COMPLETED|Overall Study||9
5289174|NCT00596687|13003617|P1|NOT COMPLETED|Overall Study||14
5289175|NCT00596687|13003616|P2|COMPLETED|Overall Study||107
5289176|NCT00596687|13003617|P1|COMPLETED|Overall Study||104
5289177|NCT00596687|13003616|P2|STARTED|Overall Study||116
5289178|NCT00596687|13003617|P1|STARTED|Overall Study||118
5289179|NCT00596635|13003628|P3|NOT COMPLETED|Overall Study||8
5289180|NCT00596635|13003629|P2|NOT COMPLETED|Overall Study||13
5289181|NCT00596635|13003630|P1|NOT COMPLETED|Overall Study||7
5289182|NCT00596635|13003628|P3|COMPLETED|Overall Study||11
5289183|NCT00596635|13003629|P2|COMPLETED|Overall Study||7
5289184|NCT00596635|13003630|P1|COMPLETED|Overall Study||10
5289185|NCT00596635|13003628|P3|STARTED|Overall Study||19
5289186|NCT00596635|13003629|P2|STARTED|Overall Study||20
5289187|NCT00596635|13003630|P1|STARTED|Overall Study||17
5289188|NCT00596622|13003647|P1|NOT COMPLETED|Overall Study||13
5289189|NCT00596622|13003647|P1|COMPLETED|Overall Study||33
5289190|NCT00596622|13003647|P1|STARTED|Overall Study||46
5289191|NCT00596466|13003656|P1|NOT COMPLETED|Overall Study||17
5289192|NCT00596466|13003656|P1|COMPLETED|Overall Study||58
5289193|NCT00596466|13003656|P1|Enrolled, Treated|Overall Study||73
5289194|NCT00596466|13003656|P1|STARTED|Overall Study||75
5289195|NCT00596453|13003664|P2|NOT COMPLETED|Overall Study||3
5289196|NCT00596453|13003665|P1|NOT COMPLETED|Overall Study||1
5289197|NCT00596453|13003664|P2|COMPLETED|Overall Study||12
5289198|NCT00596453|13003665|P1|COMPLETED|Overall Study||12
5289199|NCT00596453|13003664|P2|STARTED|Overall Study||15
5289200|NCT00596453|13003665|P1|STARTED|Overall Study||13
5289201|NCT00596440|13003673|P2|NOT COMPLETED|Overall Study||80
5289202|NCT00596440|13003674|P1|NOT COMPLETED|Overall Study||65
5289203|NCT00596440|13003673|P2|COMPLETED|Overall Study||41
5289204|NCT00596440|13003674|P1|COMPLETED|Overall Study||48
5289205|NCT00596440|13003673|P2|Showed to First Treatment Session|Overall Study||52
5289206|NCT00596440|13003674|P1|Showed to First Treatment Session|Overall Study||61
5289207|NCT00596440|13003673|P2|Showed to Eligibility Visit|Overall Study||72
5289208|NCT00596440|13003674|P1|Showed to Eligibility Visit|Overall Study||85
5289209|NCT00596440|13003673|P2|STARTED|Overall Study||121
5289210|NCT00596440|13003674|P1|STARTED|Overall Study||113
5289211|NCT00596427|13003686|P2|NOT COMPLETED|Overall Study||2
5289212|NCT00596427|13003687|P1|NOT COMPLETED|Overall Study||4
5289213|NCT00596427|13003686|P2|COMPLETED|Overall Study||28
5289214|NCT00596427|13003687|P1|COMPLETED|Overall Study||26
5289215|NCT00596427|13003686|P2|STARTED|Overall Study||30
5289216|NCT00596427|13003687|P1|STARTED|Overall Study||30
5289217|NCT00596362|13003715|P1|NOT COMPLETED|Overall Study||1
5289218|NCT00596362|13003715|P1|COMPLETED|Overall Study||0
5289219|NCT00596362|13003715|P1|STARTED|Overall Study||1
5289220|NCT00596271|13003722|P3|NOT COMPLETED|Overall Study||1
5289221|NCT00596271|13003723|P2|NOT COMPLETED|Overall Study||6
5289222|NCT00596271|13003724|P1|NOT COMPLETED|Overall Study||5
5289223|NCT00596271|13003722|P3|COMPLETED|Overall Study||61
5289224|NCT00596271|13003723|P2|COMPLETED|Overall Study||59
5289225|NCT00596271|13003724|P1|COMPLETED|Overall Study||60
5289226|NCT00596271|13003722|P3|STARTED|Overall Study||62
5289227|NCT00596271|13003723|P2|STARTED|Overall Study||65
5289228|NCT00596271|13003724|P1|STARTED|Overall Study||65
5289229|NCT00596167|13003733|P1|NOT COMPLETED|Overall Study||0
5289230|NCT00596167|13003733|P1|COMPLETED|Overall Study||6
5289231|NCT00596167|13003733|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
5289232|NCT00596102|13003740|P3|NOT COMPLETED|Up to Month 60||637
5289233|NCT00596102|13003741|P2|NOT COMPLETED|Up to Month 60||338
5289234|NCT00596102|13003742|P1|NOT COMPLETED|Up to Month 60||2181
5289235|NCT00596102|13003740|P3|COMPLETED|Up to Month 60||0
5289236|NCT00596102|13003741|P2|COMPLETED|Up to Month 60||0
5289237|NCT00596102|13003742|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
5289238|NCT00596102|13003740|P3|STARTED|Up to Month 60||637
5289239|NCT00596102|13003741|P2|STARTED|Up to Month 60||338
5289240|NCT00596102|13003742|P1|STARTED|Up to Month 60||2283
5289241|NCT00596102|13003740|P3|NOT COMPLETED|Up to Month 6||0
5289242|NCT00596102|13003741|P2|NOT COMPLETED|Up to Month 6||0
5289243|NCT00596102|13003742|P1|NOT COMPLETED|Up to Month 6||0
5289244|NCT00596102|13003740|P3|COMPLETED|Up to Month 6||637
5289245|NCT00596102|13003741|P2|COMPLETED|Up to Month 6||338
5289246|NCT00596102|13003742|P1|COMPLETED|Up to Month 6||2283
5289247|NCT00596102|13003740|P3|STARTED|Up to Month 6||637
5289248|NCT00596102|13003741|P2|STARTED|Up to Month 6||338
5289249|NCT00596102|13003742|P1|STARTED|Up to Month 6||2283
5289250|NCT00596011|13003751|P2|NOT COMPLETED|Overall Study||10
5289251|NCT00596011|13003752|P1|NOT COMPLETED|Overall Study||13
5289252|NCT00596011|13003751|P2|COMPLETED|Overall Study||38
5289253|NCT00596011|13003752|P1|COMPLETED|Overall Study||36
5289254|NCT00596011|13003751|P2|STARTED|Overall Study||48
5289255|NCT00596011|13003752|P1|STARTED|Overall Study||49
5289256|NCT00595959|13003768|P1|NOT COMPLETED|Overall Study||2
5289257|NCT00595959|13003768|P1|COMPLETED|Overall Study||63
5289258|NCT00595959|13003768|P1|STARTED|Overall Study||65
5289259|NCT00595946|13003785|P2|NOT COMPLETED|Overall Study||69
5289260|NCT00595946|13003786|P1|NOT COMPLETED|Overall Study||64
5289261|NCT00595946|13003785|P2|COMPLETED|Overall Study||152
5289262|NCT00595946|13003786|P1|COMPLETED|Overall Study||154
5289263|NCT00595946|13003785|P2|STARTED|Overall Study||221
5289264|NCT00595946|13003786|P1|STARTED|Overall Study||218
5289265|NCT00595920|13003802|P1|NOT COMPLETED|Overall Study||116
5289266|NCT00595920|13003802|P1|COMPLETED|Overall Study||0
5289267|NCT00595920|13003802|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
5289268|NCT00595920|13003802|P1|STARTED|Overall Study||116
5289269|NCT00595881|13003806|P1|NOT COMPLETED|Overall Study||0
5289270|NCT00595881|13003806|P1|COMPLETED|Overall Study||420
5289271|NCT00595881|13003806|P1|STARTED|Overall Study||420
5289272|NCT00595868|13003813|P2|NOT COMPLETED|Overall Study||50
5289273|NCT00595868|13003814|P1|NOT COMPLETED|Overall Study||45
5289274|NCT00595868|13003813|P2|COMPLETED|Overall Study||61
5289275|NCT00595868|13003814|P1|COMPLETED|Overall Study||62
5289276|NCT00595868|13003813|P2|STARTED|Overall Study||111
5289277|NCT00595868|13003814|P1|STARTED|Overall Study||107
5289278|NCT00595790|13003825|P3|NOT COMPLETED|Overall Study||3
5289279|NCT00595790|13003826|P2|NOT COMPLETED|Overall Study||1
5289280|NCT00595790|13003827|P1|NOT COMPLETED|Overall Study||2
5289281|NCT00595790|13003825|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
5289282|NCT00595790|13003826|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
5289283|NCT00595790|13003827|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
5289284|NCT00595790|13003825|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
5289285|NCT00595790|13003826|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
5289286|NCT00595790|13003827|P1|STARTED|Overall Study||125
5289287|NCT00595764|13003837|P2|NOT COMPLETED|Overall Study||43
5289288|NCT00595764|13003838|P1|NOT COMPLETED|Overall Study||39
5289289|NCT00595764|13003837|P2|COMPLETED|Overall Study||27
5289290|NCT00595764|13003838|P1|COMPLETED|Overall Study||32
5289291|NCT00595764|13003837|P2|STARTED|Overall Study||70
5289292|NCT00595764|13003838|P1|STARTED|Overall Study||71
5289293|NCT00595621|13003854|P2|NOT COMPLETED|Randomization and Study||1
5289294|NCT00595621|13003855|P1|NOT COMPLETED|Randomization and Study||2
5289295|NCT00595621|13003854|P2|COMPLETED|Randomization and Study||8
5289296|NCT00595621|13003855|P1|COMPLETED|Randomization and Study||8
5289297|NCT00595621|13003854|P2|STARTED|Randomization and Study||9
5289298|NCT00595621|13003855|P1|STARTED|Randomization and Study||10
5289299|NCT00595621|13003854|P2|NOT COMPLETED|Open Label Run in||0
5289300|NCT00595621|13003855|P1|NOT COMPLETED|Open Label Run in||3
5289301|NCT00595621|13003854|P2|COMPLETED|Open Label Run in||0
5289302|NCT00595621|13003855|P1|COMPLETED|Open Label Run in||19
5289303|NCT00595621|13003854|P2|STARTED|Open Label Run in||0
5289304|NCT00595621|13003855|P1|STARTED|Open Label Run in||22
5289305|NCT00595582|13003872|P1|NOT COMPLETED|Overall Study||10
5289306|NCT00595582|13003872|P1|COMPLETED|Overall Study||0
5289307|NCT00595582|13003872|P1|STARTED|Overall Study||10
5289308|NCT00595556|13003878|P2|NOT COMPLETED|Overall Study||1
5289309|NCT00595556|13003879|P1|NOT COMPLETED|Overall Study||3
5289310|NCT00595556|13003878|P2|COMPLETED|Overall Study||19
5289311|NCT00595556|13003879|P1|COMPLETED|Overall Study||17
5289312|NCT00595556|13003878|P2|STARTED|Overall Study||20
5289313|NCT00595556|13003879|P1|STARTED|Overall Study||20
5289314|NCT00595530|13003893|P1|NOT COMPLETED|Overall Study||0
5289315|NCT00595530|13003893|P1|COMPLETED|Overall Study||3
5289316|NCT00595530|13003893|P1|STARTED|Overall Study||3
5289317|NCT00595517|13003898|P1|NOT COMPLETED|Overall Study||19
5289318|NCT00595517|13003898|P1|COMPLETED|Overall Study||111
5289319|NCT00595517|13003898|P1|STARTED|Overall Study||130
5289320|NCT00595504|13003907|P2|NOT COMPLETED|Overall Study||3
5289321|NCT00595504|13003908|P1|NOT COMPLETED|Overall Study||2
5289322|NCT00595504|13003907|P2|COMPLETED|Overall Study||6
5289323|NCT00595504|13003908|P1|COMPLETED|Overall Study||14
5289324|NCT00595504|13003907|P2|STARTED|Overall Study||9
5289325|NCT00595504|13003908|P1|STARTED|Overall Study||16
5289326|NCT00595478|13003920|P2|NOT COMPLETED|36-week Follow-up Period||8
5289327|NCT00595478|13003921|P1|NOT COMPLETED|36-week Follow-up Period||9
5289328|NCT00595478|13003920|P2|COMPLETED|36-week Follow-up Period||30
5289329|NCT00595478|13003921|P1|COMPLETED|36-week Follow-up Period||28
5289330|NCT00595478|13003920|P2|STARTED|36-week Follow-up Period||38
5289331|NCT00595478|13003921|P1|STARTED|36-week Follow-up Period||37
5289332|NCT00595478|13003920|P2|NOT COMPLETED|Treatment||0
5289333|NCT00595478|13003921|P1|NOT COMPLETED|Treatment||0
5289334|NCT00595478|13003920|P2|COMPLETED|Treatment||38
5289335|NCT00595478|13003921|P1|COMPLETED|Treatment||37
5289336|NCT00595478|13003920|P2|STARTED|Treatment||38
5289337|NCT00595478|13003921|P1|STARTED|Treatment||37
5289338|NCT00595465|13003932|P3|NOT COMPLETED|Overall Study||7
5289339|NCT00595465|13003933|P2|NOT COMPLETED|Overall Study||4
5289340|NCT00595465|13003934|P1|NOT COMPLETED|Overall Study||6
5289341|NCT00595465|13003932|P3|COMPLETED|Overall Study||121
5289342|NCT00595465|13003933|P2|COMPLETED|Overall Study||125
5289343|NCT00595465|13003934|P1|COMPLETED|Overall Study||124
5289344|NCT00595465|13003932|P3|STARTED|Overall Study||128
5289345|NCT00595465|13003933|P2|STARTED|Overall Study||129
5289346|NCT00595465|13003934|P1|STARTED|Overall Study||130
5289347|NCT00595413|13003946|P4|NOT COMPLETED|Overall Study||4
5289348|NCT00595413|13003947|P3|NOT COMPLETED|Overall Study||8
5289349|NCT00595413|13003948|P2|NOT COMPLETED|Overall Study||5
5289350|NCT00595413|13003949|P1|NOT COMPLETED|Overall Study||7
5289351|NCT00595413|13003946|P4|COMPLETED|Overall Study||75
5289352|NCT00595413|13003947|P3|COMPLETED|Overall Study||70
5289353|NCT00595413|13003948|P2|COMPLETED|Overall Study||73
5289354|NCT00595413|13003949|P1|COMPLETED|Overall Study||69
5289355|NCT00595413|13003946|P4|STARTED|Overall Study||79
5289356|NCT00595413|13003947|P3|STARTED|Overall Study||78
5289357|NCT00595413|13003948|P2|STARTED|Overall Study||78
5289358|NCT00595413|13003949|P1|STARTED|Overall Study||76
5289359|NCT00595361|13003977|P2|NOT COMPLETED|Overall Study||0
5289360|NCT00595361|13003978|P1|NOT COMPLETED|Overall Study||0
5289361|NCT00595361|13003977|P2|COMPLETED|Overall Study||18
5289362|NCT00595361|13003978|P1|COMPLETED|Overall Study||12
5289363|NCT00595361|13003977|P2|STARTED|Overall Study||18
5289364|NCT00595361|13003978|P1|STARTED|Overall Study||12
5289365|NCT00595335|13003990|P2|NOT COMPLETED|Six Months to Twelve Months||1
5289366|NCT00595335|13003991|P1|NOT COMPLETED|Six Months to Twelve Months||1
5289367|NCT00595335|13003990|P2|COMPLETED|Six Months to Twelve Months||9
5289368|NCT00595335|13003991|P1|COMPLETED|Six Months to Twelve Months||10
5289369|NCT00595335|13003990|P2|STARTED|Six Months to Twelve Months||10
5289370|NCT00595335|13003991|P1|STARTED|Six Months to Twelve Months||11
5289371|NCT00595335|13003990|P2|NOT COMPLETED|Baseline to Six Months||2
5289372|NCT00595335|13003991|P1|NOT COMPLETED|Baseline to Six Months||2
5289373|NCT00595335|13003990|P2|COMPLETED|Baseline to Six Months||10
5289374|NCT00595335|13003991|P1|COMPLETED|Baseline to Six Months||11
5289375|NCT00595335|13003990|P2|STARTED|Baseline to Six Months||12
5289376|NCT00595335|13003991|P1|STARTED|Baseline to Six Months||13
5289377|NCT00595309|13004011|P1|NOT COMPLETED|Overall Study||4
5289378|NCT00595309|13004011|P1|COMPLETED|Overall Study||194
5289379|NCT00595309|13004011|P1|STARTED|Overall Study||198
5289380|NCT00595270|13004018|P3|NOT COMPLETED|Overall Study||8
5289381|NCT00595270|13004019|P2|NOT COMPLETED|Overall Study||10
5289382|NCT00595270|13004020|P1|NOT COMPLETED|Overall Study||6
5289383|NCT00595270|13004018|P3|COMPLETED|Overall Study||108
5289384|NCT00595270|13004019|P2|COMPLETED|Overall Study||107
5289385|NCT00595270|13004020|P1|COMPLETED|Overall Study||110
5289386|NCT00595270|13004018|P3|STARTED|Overall Study||116
5289387|NCT00595270|13004019|P2|STARTED|Overall Study||117
5289388|NCT00595270|13004020|P1|STARTED|Overall Study||116
5289389|NCT00595231|13004030|P2|NOT COMPLETED|Overall Study||5
5289390|NCT00595231|13004031|P1|NOT COMPLETED|Overall Study||5
5289391|NCT00595231|13004030|P2|COMPLETED|Overall Study||114
5289392|NCT00595231|13004031|P1|COMPLETED|Overall Study||115
5289393|NCT00595231|13004030|P2|STARTED|Overall Study||119
5289394|NCT00595231|13004031|P1|STARTED|Overall Study||120
5289395|NCT00595153|13004050|P3|NOT COMPLETED|Overall Study||25
5289396|NCT00595153|13004051|P2|NOT COMPLETED|Overall Study||16
5289397|NCT00595153|13004052|P1|NOT COMPLETED|Overall Study||4
5289398|NCT00595153|13004050|P3|COMPLETED|Overall Study||36
5289399|NCT00595153|13004051|P2|COMPLETED|Overall Study||26
5289400|NCT00595153|13004052|P1|COMPLETED|Overall Study||20
5289401|NCT00595153|13004050|P3|STARTED|Overall Study||61
5289402|NCT00595153|13004051|P2|STARTED|Overall Study||42
5289403|NCT00595153|13004052|P1|STARTED|Overall Study||24
5289404|NCT00595127|13004060|P1|NOT COMPLETED|Overall Study||10
5289405|NCT00595127|13004060|P1|COMPLETED|Overall Study||11
5289406|NCT00595127|13004060|P1|STARTED|Overall Study||21
5289407|NCT00595114|13004066|P2|NOT COMPLETED|Overall Study||0
5289408|NCT00595114|13004067|P1|NOT COMPLETED|Overall Study||0
5289409|NCT00595114|13004066|P2|COMPLETED|Overall Study||19
5289410|NCT00595114|13004067|P1|COMPLETED|Overall Study||24
5289411|NCT00595114|13004066|P2|STARTED|Overall Study||19
5289412|NCT00595114|13004067|P1|STARTED|Overall Study||24
5289413|NCT00595088|13004073|P1|NOT COMPLETED|Overall Study||40
5289414|NCT00595088|13004073|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
5289415|NCT00595088|13004073|P1|STARTED|Overall Study||47
5289416|NCT00595075|13004081|P2|NOT COMPLETED|Overall Study||0
5289417|NCT00595075|13004082|P1|NOT COMPLETED|Overall Study||1
5289418|NCT00595075|13004081|P2|COMPLETED|Overall Study||5
5289419|NCT00595075|13004082|P1|COMPLETED|Overall Study||5
5289420|NCT00595075|13004081|P2|STARTED|Overall Study||5
5289421|NCT00595075|13004082|P1|STARTED|Overall Study||6
5289422|NCT00594958|13004103|P3|NOT COMPLETED|Overall Study||10
5289423|NCT00594958|13004104|P2|NOT COMPLETED|Overall Study||3
5289424|NCT00594958|13004105|P1|NOT COMPLETED|Overall Study||14
5289425|NCT00594958|13004103|P3|COMPLETED|Overall Study||202
5289426|NCT00594958|13004104|P2|COMPLETED|Overall Study||210
5289427|NCT00594958|13004105|P1|COMPLETED|Overall Study||200
5289428|NCT00594958|13004103|P3|Randomized and at Least 1 Vaccination|Overall Study||211
5289429|NCT00594958|13004104|P2|Randomized and at Least 1 Vaccination|Overall Study||213
5289430|NCT00594958|13004105|P1|Randomized and at Least 1 Vaccination|Overall Study||212
5289431|NCT00594958|13004103|P3|STARTED|Overall Study||212
5289432|NCT00594958|13004104|P2|STARTED|Overall Study||213
5289433|NCT00594958|13004105|P1|STARTED|Overall Study||214
5289434|NCT00594945|13004116|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
5289435|NCT00594945|13004117|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
5289436|NCT00594945|13004118|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
5289437|NCT00594945|13004116|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
5289438|NCT00594945|13004117|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
5289439|NCT00594945|13004118|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
5289440|NCT00594945|13004116|P3|STARTED|Cohort 2 / Treatment Period 2||2
5289441|NCT00594945|13004117|P2|STARTED|Cohort 2 / Treatment Period 2||3
5289442|NCT00594945|13004118|P1|STARTED|Cohort 2 / Treatment Period 2||0
5289443|NCT00594945|13004116|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
5289444|NCT00594945|13004117|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
5289445|NCT00594945|13004118|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
5289446|NCT00594945|13004116|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
5289447|NCT00594945|13004117|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
5289448|NCT00594945|13004118|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
5289449|NCT00594945|13004116|P3|STARTED|Cohort 1 / Treatment Period 1||2
5289450|NCT00594945|13004117|P2|STARTED|Cohort 1 / Treatment Period 1||0
5289451|NCT00594945|13004118|P1|STARTED|Cohort 1 / Treatment Period 1||4
5289452|NCT00594906|13004126|P2|NOT COMPLETED|Overall Study||2
5289453|NCT00594906|13004127|P1|NOT COMPLETED|Overall Study||1
5289454|NCT00594906|13004126|P2|COMPLETED|Overall Study||1
5289455|NCT00594906|13004127|P1|COMPLETED|Overall Study||6
5289456|NCT00594906|13004126|P2|STARTED|Overall Study||3
5289457|NCT00594906|13004127|P1|STARTED|Overall Study||7
5289458|NCT00594880|13004135|P2|NOT COMPLETED|Overall Study||1
5289459|NCT00594880|13004136|P1|NOT COMPLETED|Overall Study||2
5289460|NCT00594880|13004135|P2|COMPLETED|Overall Study||10
5289461|NCT00594880|13004136|P1|COMPLETED|Overall Study||10
5289462|NCT00594880|13004135|P2|STARTED|Overall Study||11
5289463|NCT00594880|13004136|P1|STARTED|Overall Study||12
5289464|NCT00594854|13004148|P2|NOT COMPLETED|Overall Study||10
5289465|NCT00594854|13004149|P1|NOT COMPLETED|Overall Study||7
5289466|NCT00594854|13004148|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
5289467|NCT00594854|13004149|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
5289468|NCT00594854|13004148|P2|STARTED|Overall Study||11
5289469|NCT00594854|13004149|P1|STARTED|Overall Study||9
5289470|NCT00594815|13004159|P1|NOT COMPLETED|Overall Study||9
5289471|NCT00594815|13004159|P1|COMPLETED|Overall Study||43
5289472|NCT00594815|13004159|P1|STARTED|Overall Study||52
5289473|NCT00594685|13004164|P1|NOT COMPLETED|Overall Study||0
5289474|NCT00594685|13004164|P1|COMPLETED|Overall Study||10
5289475|NCT00594685|13004164|P1|STARTED|Overall Study||10
5289476|NCT00594659|13004184|P3|NOT COMPLETED|Overall Study||7
5289477|NCT00594659|13004185|P2|NOT COMPLETED|Overall Study||9
5289478|NCT00594659|13004186|P1|NOT COMPLETED|Overall Study||13
5289479|NCT00594659|13004184|P3|COMPLETED|Overall Study||9
5289480|NCT00594659|13004185|P2|COMPLETED|Overall Study||21
5289481|NCT00594659|13004186|P1|COMPLETED|Overall Study||16
5289482|NCT00594659|13004184|P3|STARTED|Overall Study||16
5289483|NCT00594659|13004185|P2|STARTED|Overall Study||30
5289484|NCT00594659|13004186|P1|STARTED|Overall Study||29
5289485|NCT00594646|13004197|P1|NOT COMPLETED|Overall Study||16
5289486|NCT00594646|13004197|P1|COMPLETED|Overall Study||84
5289487|NCT00594646|13004197|P1|STARTED|Overall Study||100
5289488|NCT00594568|13004205|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
5289489|NCT00594568|13004206|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
5289490|NCT00594568|13004207|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
5289491|NCT00594568|13004205|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
5289492|NCT00594568|13004206|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
5289493|NCT00594568|13004207|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
5289494|NCT00594568|13004205|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
5289495|NCT00594568|13004206|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
5289496|NCT00594568|13004207|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
5289497|NCT00594568|13004205|P3|NOT COMPLETED|Delayed Start||66
5289498|NCT00594568|13004206|P2|NOT COMPLETED|Delayed Start||77
5289499|NCT00594568|13004207|P1|NOT COMPLETED|Delayed Start||98
5289500|NCT00594568|13004205|P3|COMPLETED|Delayed Start||55
5289501|NCT00594568|13004206|P2|COMPLETED|Delayed Start||76
5289502|NCT00594568|13004207|P1|COMPLETED|Delayed Start||91
5289503|NCT00594568|13004205|P3|STARTED|Delayed Start||121
5289504|NCT00594568|13004206|P2|STARTED|Delayed Start||153
5289505|NCT00594568|13004207|P1|STARTED|Delayed Start||189
5289506|NCT00594568|13004205|P3|NOT COMPLETED|Initial Treatment||408
5289507|NCT00594568|13004206|P2|NOT COMPLETED|Initial Treatment||354
5289508|NCT00594568|13004207|P1|NOT COMPLETED|Initial Treatment||312
5289509|NCT00594568|13004205|P3|COMPLETED|Initial Treatment||121
5289510|NCT00594568|13004206|P2|COMPLETED|Initial Treatment||153
5289511|NCT00594568|13004207|P1|COMPLETED|Initial Treatment||189
5289512|NCT00594568|13004205|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
5289513|NCT00594568|13004206|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
5289514|NCT00594568|13004207|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
5289515|NCT00594568|13004205|P3|STARTED|Initial Treatment||529
5289516|NCT00594568|13004206|P2|STARTED|Initial Treatment||507
5289517|NCT00594568|13004207|P1|STARTED|Initial Treatment||501
5289518|NCT00594516|13004295|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
5289519|NCT00594516|13004296|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
5289520|NCT00594516|13004297|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
5289521|NCT00594516|13004295|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
5289522|NCT00594516|13004296|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
5289523|NCT00594516|13004297|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
5289524|NCT00594516|13004295|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
5289525|NCT00594516|13004296|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
5289526|NCT00594516|13004297|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
5289527|NCT00594516|13004295|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
5289528|NCT00594516|13004296|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
5289529|NCT00594516|13004297|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
5289530|NCT00594516|13004295|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
5289531|NCT00594516|13004296|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
5289532|NCT00594516|13004297|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
5289533|NCT00594516|13004295|P3|STARTED|Open Label (OL): Tapentadol IR||0
5289534|NCT00594516|13004296|P2|STARTED|Open Label (OL): Tapentadol IR||0
5289535|NCT00594516|13004297|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
5289536|NCT00594464|13004305|P1|NOT COMPLETED|Overall Study||3
5289537|NCT00594464|13004305|P1|COMPLETED|Overall Study||11
5289538|NCT00594464|13004305|P1|STARTED|Overall Study||14
5289539|NCT00594425|13004320|P3|NOT COMPLETED|Overall Study||10
5289540|NCT00594425|13004321|P2|NOT COMPLETED|Overall Study||14
5289541|NCT00594425|13004322|P1|NOT COMPLETED|Overall Study||7
5289542|NCT00594425|13004320|P3|COMPLETED|Overall Study||42
5289543|NCT00594425|13004321|P2|COMPLETED|Overall Study||34
5289544|NCT00594425|13004322|P1|COMPLETED|Overall Study||43
5289545|NCT00594425|13004320|P3|STARTED|Overall Study||52
5289546|NCT00594425|13004321|P2|STARTED|Overall Study||48
5289547|NCT00594425|13004322|P1|STARTED|Overall Study||50
5289548|NCT00594399|13004434|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
5289549|NCT00594399|13004435|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
5289550|NCT00594399|13004436|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
5289551|NCT00594399|13004434|P3|COMPLETED|Rerandomization Arm 1 Only||82
5289552|NCT00594399|13004435|P2|COMPLETED|Rerandomization Arm 1 Only||114
5289553|NCT00594399|13004436|P1|COMPLETED|Rerandomization Arm 1 Only||79
5289554|NCT00594399|13004434|P3|Rerandomization|Rerandomization Arm 1 Only||82
5289555|NCT00594399|13004435|P2|Rerandomization|Rerandomization Arm 1 Only||114
5289556|NCT00594399|13004436|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
5289557|NCT00594399|13004434|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
5289558|NCT00594399|13004435|P2|STARTED|Rerandomization Arm 1 Only||118
5289559|NCT00594399|13004436|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
5289560|NCT00594399|13004434|P3|NOT COMPLETED|Initial 3 Month Counseling||0
5289561|NCT00594399|13004435|P2|NOT COMPLETED|Initial 3 Month Counseling||4
5289562|NCT00594399|13004436|P1|NOT COMPLETED|Initial 3 Month Counseling||17
5289563|NCT00594399|13004434|P3|COMPLETED|Initial 3 Month Counseling||0
5289564|NCT00594399|13004435|P2|COMPLETED|Initial 3 Month Counseling||118
5289565|NCT00594399|13004436|P1|COMPLETED|Initial 3 Month Counseling||163
5289566|NCT00594399|13004434|P3|STARTED|Initial 3 Month Counseling||0
5289567|NCT00594399|13004435|P2|STARTED|Initial 3 Month Counseling||122
5289568|NCT00594399|13004436|P1|STARTED|Initial 3 Month Counseling||180
5289569|NCT00594386|13004458|P1|NOT COMPLETED|Overall Study||258
5289570|NCT00594386|13004458|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
5289571|NCT00594386|13004458|P1|STARTED|Overall Study||258
5289572|NCT00594308|13004464|P1|NOT COMPLETED|Overall Study||0
5289573|NCT00594308|13004464|P1|COMPLETED|Overall Study||10
5289574|NCT00594308|13004464|P1|STARTED|Overall Study||10
5289575|NCT00594256|13004472|P1|NOT COMPLETED|Overall Study||0
5289576|NCT00594256|13004472|P1|COMPLETED|Overall Study||8
5289577|NCT00594256|13004472|P1|STARTED|Overall Study||8
5289578|NCT00594230|13004482|P2|NOT COMPLETED|Overall Study||9
5289579|NCT00594230|13004483|P1|NOT COMPLETED|Overall Study||15
5289580|NCT00594230|13004482|P2|COMPLETED|Overall Study||1
5289581|NCT00594230|13004483|P1|COMPLETED|Overall Study||1
5289582|NCT00594230|13004482|P2|STARTED|Overall Study||10
5289583|NCT00594230|13004483|P1|STARTED|Overall Study||16
5289584|NCT00594204|13004491|P2|NOT COMPLETED|Overall Study||45
5289585|NCT00594204|13004492|P1|NOT COMPLETED|Overall Study||58
5289586|NCT00594204|13004491|P2|COMPLETED|Overall Study||154
5289587|NCT00594204|13004492|P1|COMPLETED|Overall Study||336
5289588|NCT00594204|13004491|P2|Received Treatment|Overall Study||198
5289589|NCT00594204|13004492|P1|Received Treatment|Overall Study||390
5289590|NCT00594204|13004491|P2|STARTED|Overall Study||199
5289591|NCT00594204|13004492|P1|STARTED|Overall Study||394
5289592|NCT00594178|13004502|P1|NOT COMPLETED|Overall Study||5
5289593|NCT00594178|13004502|P1|COMPLETED|Overall Study||12
5289594|NCT00594178|13004502|P1|STARTED|Overall Study||17
5289595|NCT00594165|13004507|P1|NOT COMPLETED|Overall Study||217
5289596|NCT00594165|13004507|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
5289597|NCT00594165|13004507|P1|STARTED|Overall Study||217
5289598|NCT00594100|13004513|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
5289599|NCT00594100|13004513|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
5289600|NCT00594100|13004513|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
5289601|NCT00594100|13004513|P1|NOT COMPLETED|Procedure||9
5289602|NCT00594100|13004513|P1|COMPLETED|Procedure||236
5289603|NCT00594100|13004513|P1|STARTED|Procedure||245
5289604|NCT00594061|13004522|P1|NOT COMPLETED|Overall Study||0
5289605|NCT00594061|13004522|P1|COMPLETED|Overall Study||9
5289606|NCT00594061|13004522|P1|STARTED|Overall Study||9
5289607|NCT00594035|13004529|P2|NOT COMPLETED|Overall Study||3
5289608|NCT00594035|13004530|P1|NOT COMPLETED|Overall Study||2
5289609|NCT00594035|13004529|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
5289610|NCT00594035|13004530|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
5289611|NCT00594035|13004529|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
5289612|NCT00594035|13004530|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
5289613|NCT00594022|13004538|P2|NOT COMPLETED|Overall Study||0
5289614|NCT00594022|13004539|P1|NOT COMPLETED|Overall Study||0
5289615|NCT00594022|13004538|P2|COMPLETED|Overall Study||173
5289616|NCT00594022|13004539|P1|COMPLETED|Overall Study||176
5289617|NCT00594022|13004538|P2|STARTED|Overall Study||173
5289618|NCT00594022|13004539|P1|STARTED|Overall Study||176
5289619|NCT00594009|13004553|P1|NOT COMPLETED|Overall Study||0
5289620|NCT00594009|13004553|P1|COMPLETED|Overall Study||1
5289621|NCT00594009|13004553|P1|STARTED|Overall Study||1
5289622|NCT00593957|13004560|P3|NOT COMPLETED|Overall Study||2
5289623|NCT00593957|13004561|P2|NOT COMPLETED|Overall Study||1
5289624|NCT00593957|13004562|P1|NOT COMPLETED|Overall Study||0
5289625|NCT00593957|13004560|P3|COMPLETED|Overall Study||10
5289626|NCT00593957|13004561|P2|COMPLETED|Overall Study||12
5289627|NCT00593957|13004562|P1|COMPLETED|Overall Study||13
5289628|NCT00593957|13004560|P3|STARTED|Overall Study||12
5289629|NCT00593957|13004561|P2|STARTED|Overall Study||13
5289630|NCT00593957|13004562|P1|STARTED|Overall Study||13
5289631|NCT00593918|13004586|P2|NOT COMPLETED|Overall Study||24
5289632|NCT00593918|13004587|P1|NOT COMPLETED|Overall Study||5
5289633|NCT00593918|13004586|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
5289634|NCT00593918|13004587|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
5289635|NCT00593918|13004586|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
5289636|NCT00593918|13004587|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
5289637|NCT00593866|13004595|P1|NOT COMPLETED|Overall Study||0
5289638|NCT00593866|13004595|P1|COMPLETED|Overall Study||50
5289639|NCT00593866|13004595|P1|STARTED|Overall Study||50
5289640|NCT00593840|13004600|P1|NOT COMPLETED|Overall Study||1
5289641|NCT00593840|13004600|P1|COMPLETED|Overall Study||72
5289642|NCT00593840|13004600|P1|STARTED|Overall Study||73
5289643|NCT00593827|13004612|P2|NOT COMPLETED|Overall Study||2
5289644|NCT00593827|13004613|P1|NOT COMPLETED|Overall Study||0
5289645|NCT00593827|13004612|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
5289646|NCT00593827|13004613|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
5289647|NCT00593827|13004612|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
5289648|NCT00593827|13004613|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
5289649|NCT00593827|13004612|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
5289650|NCT00593827|13004613|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
5289651|NCT00593827|13004612|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
5289652|NCT00593827|13004613|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
5289653|NCT00593814|13004637|P2|NOT COMPLETED|Overall Study||0
5289654|NCT00593814|13004638|P1|NOT COMPLETED|Overall Study||24
5289655|NCT00593814|13004637|P2|COMPLETED|Overall Study||120
5289656|NCT00593814|13004638|P1|COMPLETED|Overall Study||115
5289657|NCT00593814|13004637|P2|STARTED|Overall Study||120
5289658|NCT00593814|13004638|P1|STARTED|Overall Study||139
5289659|NCT00593736|13004650|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
5289660|NCT00593736|13004651|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
5289661|NCT00593736|13004652|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
5289662|NCT00593736|13004653|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
5289663|NCT00593736|13004650|P4|COMPLETED|Treatment Period and Placebo Run-out||28
5289664|NCT00593736|13004651|P3|COMPLETED|Treatment Period and Placebo Run-out||30
5289665|NCT00593736|13004652|P2|COMPLETED|Treatment Period and Placebo Run-out||31
5289666|NCT00593736|13004653|P1|COMPLETED|Treatment Period and Placebo Run-out||29
5289667|NCT00593736|13004650|P4|STARTED|Treatment Period and Placebo Run-out||32
5289668|NCT00593736|13004651|P3|STARTED|Treatment Period and Placebo Run-out||35
5289669|NCT00593736|13004652|P2|STARTED|Treatment Period and Placebo Run-out||33
5289670|NCT00593736|13004653|P1|STARTED|Treatment Period and Placebo Run-out||32
5289671|NCT00593736|13004650|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
5289672|NCT00593736|13004651|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
5289673|NCT00593736|13004652|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
5289674|NCT00593736|13004653|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
5289675|NCT00593736|13004650|P4|COMPLETED|Screening Period and Placebo Run-in||132
5289676|NCT00593736|13004651|P3|COMPLETED|Screening Period and Placebo Run-in||0
5289677|NCT00593736|13004652|P2|COMPLETED|Screening Period and Placebo Run-in||0
5289678|NCT00593736|13004653|P1|COMPLETED|Screening Period and Placebo Run-in||0
5289679|NCT00593736|13004650|P4|STARTED|Screening Period and Placebo Run-in||549
5289680|NCT00593736|13004651|P3|STARTED|Screening Period and Placebo Run-in||0
5289681|NCT00593736|13004652|P2|STARTED|Screening Period and Placebo Run-in||0
5289682|NCT00593736|13004653|P1|STARTED|Screening Period and Placebo Run-in||0
5289683|NCT00593684|13004901|P2|NOT COMPLETED|Overall Study||1
5289684|NCT00593684|13004902|P1|NOT COMPLETED|Overall Study||2
5289685|NCT00593684|13004901|P2|COMPLETED|Overall Study||24
5289686|NCT00593684|13004902|P1|COMPLETED|Overall Study||23
5289687|NCT00593684|13004901|P2|STARTED|Overall Study||25
5289688|NCT00593684|13004902|P1|STARTED|Overall Study||25
5289689|NCT00593645|13004914|P1|NOT COMPLETED|Overall Study||0
5289690|NCT00593645|13004914|P1|COMPLETED|Overall Study||7
5289691|NCT00593645|13004914|P1|STARTED|Overall Study||7
5289692|NCT00593606|13004928|P1|NOT COMPLETED|Overall Study||27
5289693|NCT00593606|13004928|P1|COMPLETED|Overall Study||97
5289694|NCT00593606|13004928|P1|Treatment Period Completed|Overall Study||99
5289695|NCT00593606|13004928|P1|Full Analysis Set|Overall Study||114
5289696|NCT00593606|13004928|P1|Start of Treatment - Safety Set|Overall Study||116
5289697|NCT00593606|13004928|P1|STARTED|Overall Study||124
5289698|NCT00593554|13005026|P2|NOT COMPLETED|Overall Study||5
5289699|NCT00593554|13005027|P1|NOT COMPLETED|Overall Study||3
5289700|NCT00593554|13005026|P2|COMPLETED|Overall Study||0
5289701|NCT00593554|13005027|P1|COMPLETED|Overall Study||0
5289702|NCT00593554|13005026|P2|STARTED|Overall Study||5
5289703|NCT00593554|13005027|P1|STARTED|Overall Study||3
5289704|NCT00593450|13005049|P4|NOT COMPLETED|Overall Study||29
5289705|NCT00593450|13005050|P3|NOT COMPLETED|Overall Study||13
5289706|NCT00593450|13005051|P2|NOT COMPLETED|Overall Study||21
5289707|NCT00593450|13005052|P1|NOT COMPLETED|Overall Study||17
5289708|NCT00593450|13005049|P4|COMPLETED|Overall Study||271
5289709|NCT00593450|13005050|P3|COMPLETED|Overall Study||285
5289710|NCT00593450|13005051|P2|COMPLETED|Overall Study||265
5289711|NCT00593450|13005052|P1|COMPLETED|Overall Study||284
5289712|NCT00593450|13005049|P4|STARTED|Overall Study||300
5289713|NCT00593450|13005050|P3|STARTED|Overall Study||298
5289714|NCT00593450|13005051|P2|STARTED|Overall Study||286
5289715|NCT00593450|13005052|P1|STARTED|Overall Study||301
5289716|NCT00593385|13005122|P1|NOT COMPLETED|Overall Study||40
5289717|NCT00593385|13005122|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
5289718|NCT00593385|13005122|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
5289719|NCT00593385|13005122|P1|STARTED|Overall Study||165
5289720|NCT00593372|13005159|P2|NOT COMPLETED|Overall Study||0
5289721|NCT00593372|13005160|P1|NOT COMPLETED|Overall Study||0
5289722|NCT00593372|13005159|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
5289723|NCT00593372|13005160|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
5289724|NCT00593372|13005159|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
5289725|NCT00593372|13005160|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
5289726|NCT00593346|13005166|P1|NOT COMPLETED|Overall Study||0
5289727|NCT00593346|13005166|P1|COMPLETED|Overall Study||151
5289728|NCT00593346|13005166|P1|STARTED|Overall Study||151
5289729|NCT00593333|13005183|P2|NOT COMPLETED|Overall Study||11
5289730|NCT00593333|13005184|P1|NOT COMPLETED|Overall Study||10
5289731|NCT00593333|13005183|P2|COMPLETED|Overall Study||45
5289732|NCT00593333|13005184|P1|COMPLETED|Overall Study||44
5289733|NCT00593333|13005183|P2|STARTED|Overall Study||56
5289734|NCT00593333|13005184|P1|STARTED|Overall Study||54
5289735|NCT00593320|13005192|P2|NOT COMPLETED|Overall Study||0
5289736|NCT00593320|13005193|P1|NOT COMPLETED|Overall Study||0
5289737|NCT00593320|13005192|P2|COMPLETED|Overall Study||1
5289738|NCT00593320|13005193|P1|COMPLETED|Overall Study||1
5289739|NCT00593320|13005192|P2|STARTED|Overall Study||1
5289740|NCT00593320|13005193|P1|STARTED|Overall Study||1
5289741|NCT00593112|13005207|P2|NOT COMPLETED|Overall Study||0
5289742|NCT00593112|13005208|P1|NOT COMPLETED|Overall Study||10
5289743|NCT00593112|13005207|P2|COMPLETED|Overall Study||12
5289744|NCT00593112|13005208|P1|COMPLETED|Overall Study||17
5289745|NCT00593112|13005207|P2|STARTED|Overall Study||12
5289746|NCT00593112|13005208|P1|STARTED|Overall Study||27
5289747|NCT00592943|13005220|P2|NOT COMPLETED|Overall Study||0
5289748|NCT00592943|13005221|P1|NOT COMPLETED|Overall Study||0
5289749|NCT00592943|13005220|P2|COMPLETED|Overall Study||6
5289750|NCT00592943|13005221|P1|COMPLETED|Overall Study||6
5289751|NCT00592943|13005220|P2|STARTED|Overall Study||6
5289752|NCT00592943|13005221|P1|STARTED|Overall Study||6
5289753|NCT00592904|13005235|P4|NOT COMPLETED|Overall Study||11
5289754|NCT00592904|13005236|P3|NOT COMPLETED|Overall Study||17
5289755|NCT00592904|13005237|P2|NOT COMPLETED|Overall Study||55
5289756|NCT00592904|13005238|P1|NOT COMPLETED|Overall Study||25
5289757|NCT00592904|13005235|P4|COMPLETED|Overall Study||19
5289758|NCT00592904|13005236|P3|COMPLETED|Overall Study||10
5289759|NCT00592904|13005237|P2|COMPLETED|Overall Study||93
5289760|NCT00592904|13005238|P1|COMPLETED|Overall Study||32
5289761|NCT00592904|13005235|P4|STARTED|Overall Study||30
5289762|NCT00592904|13005236|P3|STARTED|Overall Study||27
5289763|NCT00592904|13005237|P2|STARTED|Overall Study||148
5289764|NCT00592904|13005238|P1|STARTED|Overall Study||57
5289765|NCT00592852|13005264|P1|NOT COMPLETED|Overall Study||6
5289766|NCT00592852|13005264|P1|COMPLETED|Overall Study||7
5289767|NCT00592852|13005264|P1|STARTED|Overall Study||13
5289768|NCT00592839|13005272|P3|NOT COMPLETED|Overall Study||6
5289769|NCT00592839|13005273|P2|NOT COMPLETED|Overall Study||4
5289770|NCT00592839|13005274|P1|NOT COMPLETED|Overall Study||2
5289771|NCT00592839|13005272|P3|COMPLETED|Overall Study||46
5289772|NCT00592839|13005273|P2|COMPLETED|Overall Study||48
5289773|NCT00592839|13005274|P1|COMPLETED|Overall Study||51
5289774|NCT00592839|13005272|P3|STARTED|Overall Study||52
5289775|NCT00592839|13005273|P2|STARTED|Overall Study||52
5289776|NCT00592839|13005274|P1|STARTED|Overall Study||53
5289777|NCT00592774|13005302|P5|NOT COMPLETED|Overall Study||14
5289778|NCT00592774|13005303|P4|NOT COMPLETED|Overall Study||14
5289779|NCT00592774|13005304|P3|NOT COMPLETED|Overall Study||4
5289780|NCT00592774|13005305|P2|NOT COMPLETED|Overall Study||32
5289781|NCT00592774|13005306|P1|NOT COMPLETED|Overall Study||11
5289782|NCT00592774|13005302|P5|COMPLETED|Overall Study||9
5289783|NCT00592774|13005303|P4|COMPLETED|Overall Study||8
5289784|NCT00592774|13005304|P3|COMPLETED|Overall Study||18
5289785|NCT00592774|13005305|P2|COMPLETED|Overall Study||21
5289786|NCT00592774|13005306|P1|COMPLETED|Overall Study||15
5289787|NCT00592774|13005302|P5|STARTED|Overall Study||23
5289788|NCT00592774|13005303|P4|STARTED|Overall Study||22
5289789|NCT00592774|13005304|P3|STARTED|Overall Study||22
5289790|NCT00592774|13005305|P2|STARTED|Overall Study||53
5289791|NCT00592774|13005306|P1|STARTED|Overall Study||26
5289792|NCT00592761|13005363|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
5289793|NCT00592761|13005364|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
5289794|NCT00592761|13005363|P2|COMPLETED|Second Intervention (2 Weeks)||9
5289795|NCT00592761|13005364|P1|COMPLETED|Second Intervention (2 Weeks)||9
5289796|NCT00592761|13005363|P2|STARTED|Second Intervention (2 Weeks)||9
5289797|NCT00592761|13005364|P1|STARTED|Second Intervention (2 Weeks)||9
5289798|NCT00592761|13005363|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
5289799|NCT00592761|13005364|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
5289800|NCT00592761|13005363|P2|COMPLETED|First Intervention (2 Weeks)||9
5289801|NCT00592761|13005364|P1|COMPLETED|First Intervention (2 Weeks)||9
5289802|NCT00592761|13005363|P2|STARTED|First Intervention (2 Weeks)||9
5289803|NCT00592761|13005364|P1|STARTED|First Intervention (2 Weeks)||9
5289804|NCT00592683|13005378|P2|NOT COMPLETED|Overall Study||4
5289805|NCT00592683|13005379|P1|NOT COMPLETED|Overall Study||4
5289806|NCT00592683|13005378|P2|COMPLETED|Overall Study||6
5289807|NCT00592683|13005379|P1|COMPLETED|Overall Study||6
5289808|NCT00592683|13005378|P2|STARTED|Overall Study||10
5289809|NCT00592683|13005379|P1|STARTED|Overall Study||10
5289810|NCT00592631|13005389|P2|NOT COMPLETED|Overall Study||2
5289811|NCT00592631|13005390|P1|NOT COMPLETED|Overall Study||0
5289812|NCT00592631|13005389|P2|COMPLETED|Overall Study||9
5289813|NCT00592631|13005390|P1|COMPLETED|Overall Study||16
5289814|NCT00592631|13005389|P2|STARTED|Overall Study||11
5289815|NCT00592631|13005390|P1|STARTED|Overall Study||16
5289816|NCT00592553|13005399|P3|NOT COMPLETED|Overall Study||0
5289817|NCT00592553|13005400|P2|NOT COMPLETED|Overall Study||0
5289818|NCT00592553|13005401|P1|NOT COMPLETED|Overall Study||1
5289819|NCT00592553|13005399|P3|COMPLETED|Overall Study||57
5289820|NCT00592553|13005400|P2|COMPLETED|Overall Study||57
5289821|NCT00592553|13005401|P1|COMPLETED|Overall Study||59
5289822|NCT00592553|13005399|P3|ITT Population|Overall Study||57
5289823|NCT00592553|13005400|P2|ITT Population|Overall Study||57
5289824|NCT00592553|13005401|P1|ITT Population|Overall Study||60
5289825|NCT00592553|13005399|P3|As-treated Population|Overall Study||57
5289826|NCT00592553|13005400|P2|As-treated Population|Overall Study||57
5289827|NCT00592553|13005401|P1|As-treated Population|Overall Study||60
5289828|NCT00592553|13005399|P3|STARTED|Overall Study||57
5289829|NCT00592553|13005400|P2|STARTED|Overall Study||57
5289830|NCT00592553|13005401|P1|STARTED|Overall Study||60
5289831|NCT00592488|13005477|P2|NOT COMPLETED|Overall Study||0
5289832|NCT00592488|13005478|P1|NOT COMPLETED|Overall Study||0
5289833|NCT00592488|13005477|P2|COMPLETED|Overall Study||7
5289834|NCT00592488|13005478|P1|COMPLETED|Overall Study||6
5289835|NCT00592488|13005477|P2|STARTED|Overall Study||7
5289836|NCT00592488|13005478|P1|STARTED|Overall Study||6
5289837|NCT00592475|13005491|P3|NOT COMPLETED|Overall Study||0
5289838|NCT00592475|13005492|P2|NOT COMPLETED|Overall Study||0
5289839|NCT00592475|13005493|P1|NOT COMPLETED|Overall Study||0
5289840|NCT00592475|13005491|P3|COMPLETED|Overall Study||5
5289841|NCT00592475|13005492|P2|COMPLETED|Overall Study||9
5289842|NCT00592475|13005493|P1|COMPLETED|Overall Study||6
5289843|NCT00592475|13005491|P3|STARTED|Overall Study||5
5289844|NCT00592475|13005492|P2|STARTED|Overall Study||9
5289845|NCT00592475|13005493|P1|STARTED|Overall Study||6
5289846|NCT00592384|13005518|P2|NOT COMPLETED|Overall Study||6
5289847|NCT00592384|13005519|P1|NOT COMPLETED|Overall Study||5
5289848|NCT00592384|13005518|P2|COMPLETED|Overall Study||63
5289849|NCT00592384|13005519|P1|COMPLETED|Overall Study||59
5289850|NCT00592384|13005518|P2|STARTED|Overall Study||69
5289851|NCT00592384|13005519|P1|STARTED|Overall Study||64
5289852|NCT00592358|13005527|P1|NOT COMPLETED|Overall Study||6
5289853|NCT00592358|13005527|P1|COMPLETED|Overall Study||11
5289854|NCT00592358|13005527|P1|STARTED|Overall Study||17
5289855|NCT00592319|13005534|P2|NOT COMPLETED|Overall Study||3
5289856|NCT00592319|13005535|P1|NOT COMPLETED|Overall Study||0
5289857|NCT00592319|13005534|P2|COMPLETED|Overall Study||5
5289858|NCT00592319|13005535|P1|COMPLETED|Overall Study||2
5289859|NCT00592319|13005534|P2|STARTED|Overall Study||8
5289860|NCT00592319|13005535|P1|STARTED|Overall Study||2
5289861|NCT00592176|13005543|P1|NOT COMPLETED|Overall Study||0
5289862|NCT00592176|13005543|P1|COMPLETED|Overall Study||5
5289863|NCT00592176|13005543|P1|STARTED|Overall Study||5
5289864|NCT00592124|13005554|P6|NOT COMPLETED|Overall Study||3
5289865|NCT00592124|13005555|P5|NOT COMPLETED|Overall Study||3
5289866|NCT00592124|13005556|P4|NOT COMPLETED|Overall Study||3
5289867|NCT00592124|13005557|P3|NOT COMPLETED|Overall Study||6
5289868|NCT00592124|13005558|P2|NOT COMPLETED|Overall Study||5
5289869|NCT00592124|13005559|P1|NOT COMPLETED|Overall Study||4
5289870|NCT00592124|13005554|P6|COMPLETED|Overall Study||24
5289871|NCT00592124|13005555|P5|COMPLETED|Overall Study||24
5289872|NCT00592124|13005556|P4|COMPLETED|Overall Study||24
5289873|NCT00592124|13005557|P3|COMPLETED|Overall Study||24
5289874|NCT00592124|13005558|P2|COMPLETED|Overall Study||24
5289875|NCT00592124|13005559|P1|COMPLETED|Overall Study||24
5289876|NCT00592124|13005554|P6|STARTED|Overall Study||27
5289877|NCT00592124|13005555|P5|STARTED|Overall Study||27
5289878|NCT00592124|13005556|P4|STARTED|Overall Study||27
5289879|NCT00592124|13005557|P3|STARTED|Overall Study||30
5289880|NCT00592124|13005558|P2|STARTED|Overall Study||29
5289881|NCT00592124|13005559|P1|STARTED|Overall Study||28
5289882|NCT00592072|13005610|P2|NOT COMPLETED|Second Sequence||0
5289883|NCT00592072|13005611|P1|NOT COMPLETED|Second Sequence||0
5289884|NCT00592072|13005610|P2|COMPLETED|Second Sequence||5
5289885|NCT00592072|13005611|P1|COMPLETED|Second Sequence||5
5289886|NCT00592072|13005610|P2|STARTED|Second Sequence||5
5289887|NCT00592072|13005611|P1|STARTED|Second Sequence||5
5289888|NCT00592072|13005610|P2|NOT COMPLETED|Wash Out Period||1
5289889|NCT00592072|13005611|P1|NOT COMPLETED|Wash Out Period||1
5289890|NCT00592072|13005610|P2|COMPLETED|Wash Out Period||5
5289891|NCT00592072|13005611|P1|COMPLETED|Wash Out Period||5
5289892|NCT00592072|13005610|P2|STARTED|Wash Out Period||6
5289893|NCT00592072|13005611|P1|STARTED|Wash Out Period||6
5289894|NCT00592072|13005610|P2|NOT COMPLETED|First Sequence||0
5289895|NCT00592072|13005611|P1|NOT COMPLETED|First Sequence||0
5289896|NCT00592072|13005610|P2|COMPLETED|First Sequence||6
5289897|NCT00592072|13005611|P1|COMPLETED|First Sequence||6
5289898|NCT00592072|13005610|P2|STARTED|First Sequence||6
5289899|NCT00592072|13005611|P1|STARTED|First Sequence||6
5289900|NCT00592007|13005633|P1|NOT COMPLETED|Overall Study||2
5289901|NCT00592007|13005633|P1|COMPLETED|Overall Study||5
5289902|NCT00592007|13005633|P1|STARTED|Overall Study||7
5289903|NCT00591942|13005638|P2|NOT COMPLETED|Overall Study||0
5289904|NCT00591942|13005639|P1|NOT COMPLETED|Overall Study||0
5289905|NCT00591942|13005638|P2|COMPLETED|Overall Study||36
5289906|NCT00591942|13005639|P1|COMPLETED|Overall Study||36
5289907|NCT00591942|13005638|P2|STARTED|Overall Study||36
5289908|NCT00591942|13005639|P1|STARTED|Overall Study||36
5289909|NCT00591864|13005645|P1|NOT COMPLETED|Overall Study||5
5289910|NCT00591864|13005645|P1|COMPLETED|Overall Study||84
5289911|NCT00591864|13005645|P1|STARTED|Overall Study||89
5289912|NCT00591851|13005651|P1|NOT COMPLETED|Overall Study||6
5289913|NCT00591851|13005651|P1|COMPLETED|Overall Study||64
5289914|NCT00591851|13005651|P1|STARTED|Overall Study||70
5289915|NCT00591838|13005660|P5|NOT COMPLETED|Overall Study||0
5289916|NCT00591838|13005661|P4|NOT COMPLETED|Overall Study||1
5289917|NCT00591838|13005662|P3|NOT COMPLETED|Overall Study||0
5289918|NCT00591838|13005663|P2|NOT COMPLETED|Overall Study||0
5289919|NCT00591838|13005664|P1|NOT COMPLETED|Overall Study||0
5289920|NCT00591838|13005660|P5|COMPLETED|Overall Study||51
5289921|NCT00591838|13005661|P4|COMPLETED|Overall Study||5
5289922|NCT00591838|13005662|P3|COMPLETED|Overall Study||6
5289923|NCT00591838|13005663|P2|COMPLETED|Overall Study||6
5289924|NCT00591838|13005664|P1|COMPLETED|Overall Study||5
5289925|NCT00591838|13005660|P5|STARTED|Overall Study||51
5289926|NCT00591838|13005661|P4|STARTED|Overall Study||6
5289927|NCT00591838|13005662|P3|STARTED|Overall Study||6
5289928|NCT00591838|13005663|P2|STARTED|Overall Study||6
5289929|NCT00591838|13005664|P1|STARTED|Overall Study||5
5289930|NCT00591825|13005689|P4|NOT COMPLETED|Overall Study||0
5289931|NCT00591825|13005690|P3|NOT COMPLETED|Overall Study||0
5289932|NCT00591825|13005691|P2|NOT COMPLETED|Overall Study||0
5289933|NCT00591825|13005692|P1|NOT COMPLETED|Overall Study||0
5289934|NCT00591825|13005689|P4|COMPLETED|Overall Study||14
5289935|NCT00591825|13005690|P3|COMPLETED|Overall Study||13
5289936|NCT00591825|13005691|P2|COMPLETED|Overall Study||13
5289937|NCT00591825|13005692|P1|COMPLETED|Overall Study||14
5289938|NCT00591825|13005689|P4|STARTED|Overall Study||14
5289939|NCT00591825|13005690|P3|STARTED|Overall Study||13
5289940|NCT00591825|13005691|P2|STARTED|Overall Study||13
5289941|NCT00591825|13005692|P1|STARTED|Overall Study||14
5289942|NCT00591786|13005728|P10|NOT COMPLETED|Overall Study||0
5289943|NCT00591786|13005729|P9|NOT COMPLETED|Overall Study||0
5289944|NCT00591786|13005730|P8|NOT COMPLETED|Overall Study||0
5289945|NCT00591786|13005731|P7|NOT COMPLETED|Overall Study||0
5289946|NCT00591786|13005732|P6|NOT COMPLETED|Overall Study||0
5289947|NCT00591786|13005733|P5|NOT COMPLETED|Overall Study||0
5289948|NCT00591786|13005734|P4|NOT COMPLETED|Overall Study||0
5289949|NCT00591786|13005735|P3|NOT COMPLETED|Overall Study||1
5289950|NCT00591786|13005736|P2|NOT COMPLETED|Overall Study||0
5289951|NCT00591786|13005737|P1|NOT COMPLETED|Overall Study||0
5289952|NCT00591786|13005728|P10|COMPLETED|Overall Study||10
5289953|NCT00591786|13005729|P9|COMPLETED|Overall Study||10
5289954|NCT00591786|13005730|P8|COMPLETED|Overall Study||10
5289955|NCT00591786|13005731|P7|COMPLETED|Overall Study||10
5289956|NCT00591786|13005732|P6|COMPLETED|Overall Study||10
5289957|NCT00591786|13005733|P5|COMPLETED|Overall Study||10
5289958|NCT00591786|13005734|P4|COMPLETED|Overall Study||11
5289959|NCT00591786|13005735|P3|COMPLETED|Overall Study||10
5289960|NCT00591786|13005736|P2|COMPLETED|Overall Study||9
5289961|NCT00591786|13005737|P1|COMPLETED|Overall Study||9
5289962|NCT00591786|13005728|P10|Treated Participants|Overall Study||10
5289963|NCT00591786|13005729|P9|Treated Participants|Overall Study||10
5289964|NCT00591786|13005730|P8|Treated Participants|Overall Study||10
5289965|NCT00591786|13005731|P7|Treated Participants|Overall Study||10
5289966|NCT00591786|13005732|P6|Treated Participants|Overall Study||10
5289967|NCT00591786|13005733|P5|Treated Participants|Overall Study||10
5289968|NCT00591786|13005734|P4|Treated Participants|Overall Study||11
5289969|NCT00591786|13005735|P3|Treated Participants|Overall Study||10
5289970|NCT00591786|13005736|P2|Treated Participants|Overall Study||9
5289971|NCT00591786|13005737|P1|Treated Participants|Overall Study||9
5289972|NCT00591786|13005728|P10|STARTED|Overall Study||10
5289973|NCT00591786|13005729|P9|STARTED|Overall Study||10
5289974|NCT00591786|13005730|P8|STARTED|Overall Study||10
5289975|NCT00591786|13005731|P7|STARTED|Overall Study||10
5289976|NCT00591786|13005732|P6|STARTED|Overall Study||10
5289977|NCT00591786|13005733|P5|STARTED|Overall Study||10
5289978|NCT00591786|13005734|P4|STARTED|Overall Study||11
5289979|NCT00591786|13005735|P3|STARTED|Overall Study||11
5289980|NCT00591786|13005736|P2|STARTED|Overall Study||9
5289981|NCT00591786|13005737|P1|STARTED|Overall Study||9
5289982|NCT00591773|13005782|P3|NOT COMPLETED|Overall Study||16
5289983|NCT00591773|13005783|P2|NOT COMPLETED|Overall Study||24
5289984|NCT00591773|13005784|P1|NOT COMPLETED|Overall Study||16
5289985|NCT00591773|13005782|P3|COMPLETED|Overall Study||168
5289986|NCT00591773|13005783|P2|COMPLETED|Overall Study||158
5289987|NCT00591773|13005784|P1|COMPLETED|Overall Study||169
5289988|NCT00591773|13005782|P3|STARTED|Overall Study||184
5289989|NCT00591773|13005783|P2|STARTED|Overall Study||182
5289990|NCT00591773|13005784|P1|STARTED|Overall Study||185
5289991|NCT00591760|13005836|P2|NOT COMPLETED|Overall Study||0
5289992|NCT00591760|13005837|P1|NOT COMPLETED|Overall Study||0
5289993|NCT00591760|13005836|P2|COMPLETED|Overall Study||28
5289994|NCT00591760|13005837|P1|COMPLETED|Overall Study||28
5289995|NCT00591760|13005836|P2|STARTED|Overall Study||28
5289996|NCT00591760|13005837|P1|STARTED|Overall Study||28
5289997|NCT00591734|13005843|P1|NOT COMPLETED|Overall Study||53
5289998|NCT00591734|13005843|P1|COMPLETED|Overall Study||4
5289999|NCT00591734|13005843|P1|STARTED|Overall Study||57
5290000|NCT00591721|13005849|P2|NOT COMPLETED|Overall Study||22
5290001|NCT00591721|13005850|P1|NOT COMPLETED|Overall Study||21
5290002|NCT00591721|13005849|P2|COMPLETED|Overall Study||70
5290003|NCT00591721|13005850|P1|COMPLETED|Overall Study||68
5290004|NCT00591721|13005849|P2|STARTED|Overall Study||92
5290005|NCT00591721|13005850|P1|STARTED|Overall Study||89
5290006|NCT00591591|13005858|P2|NOT COMPLETED|Overall Study||39
5290007|NCT00591591|13005859|P1|NOT COMPLETED|Overall Study||11
5290008|NCT00591591|13005858|P2|COMPLETED|Overall Study||94
5290009|NCT00591591|13005859|P1|COMPLETED|Overall Study||165
5290010|NCT00591591|13005858|P2|STARTED|Overall Study||133
5290011|NCT00591591|13005859|P1|STARTED|Overall Study||176
5290012|NCT00591578|13005876|P3|NOT COMPLETED|Open-Label Extension Phase||0
5290013|NCT00591578|13005877|P2|NOT COMPLETED|Open-Label Extension Phase||10
5290014|NCT00591578|13005878|P1|NOT COMPLETED|Open-Label Extension Phase||6
5290015|NCT00591578|13005876|P3|COMPLETED|Open-Label Extension Phase||0
5290016|NCT00591578|13005877|P2|COMPLETED|Open-Label Extension Phase||105
5290017|NCT00591578|13005878|P1|COMPLETED|Open-Label Extension Phase||49
5290018|NCT00591578|13005876|P3|STARTED|Open-Label Extension Phase||0
5290019|NCT00591578|13005877|P2|STARTED|Open-Label Extension Phase||115
5290020|NCT00591578|13005878|P1|STARTED|Open-Label Extension Phase||55
5290021|NCT00591578|13005876|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
5290022|NCT00591578|13005877|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
5290023|NCT00591578|13005878|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
5290024|NCT00591578|13005876|P3|COMPLETED|Double-Blind Treatment Phase||244
5290025|NCT00591578|13005877|P2|COMPLETED|Double-Blind Treatment Phase||249
5290026|NCT00591578|13005878|P1|COMPLETED|Double-Blind Treatment Phase||249
5290027|NCT00591578|13005876|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
5290028|NCT00591578|13005877|P2|STARTED|Double-Blind Treatment Phase||329
5290029|NCT00591578|13005878|P1|STARTED|Double-Blind Treatment Phase||327
5290030|NCT00591565|13005929|P1|NOT COMPLETED|Overall Study||5
5290031|NCT00591565|13005929|P1|COMPLETED|Overall Study||8
5290032|NCT00591565|13005929|P1|STARTED|Overall Study||13
5290033|NCT00591409|13005943|P10|NOT COMPLETED|Overall Study||1
5290034|NCT00591409|13005944|P9|NOT COMPLETED|Overall Study||0
5290035|NCT00591409|13005945|P8|NOT COMPLETED|Overall Study||0
5290036|NCT00591409|13005946|P7|NOT COMPLETED|Overall Study||0
5290037|NCT00591409|13005947|P6|NOT COMPLETED|Overall Study||0
5290038|NCT00591409|13005948|P5|NOT COMPLETED|Overall Study||1
5290039|NCT00591409|13005949|P4|NOT COMPLETED|Overall Study||0
5290040|NCT00591409|13005950|P3|NOT COMPLETED|Overall Study||0
5290041|NCT00591409|13005951|P2|NOT COMPLETED|Overall Study||0
5290042|NCT00591409|13005952|P1|NOT COMPLETED|Overall Study||0
5290043|NCT00591409|13005943|P10|COMPLETED|Overall Study||10
5290044|NCT00591409|13005944|P9|COMPLETED|Overall Study||9
5290045|NCT00591409|13005945|P8|COMPLETED|Overall Study||10
5290046|NCT00591409|13005946|P7|COMPLETED|Overall Study||10
5290047|NCT00591409|13005947|P6|COMPLETED|Overall Study||10
5290048|NCT00591409|13005948|P5|COMPLETED|Overall Study||9
5290049|NCT00591409|13005949|P4|COMPLETED|Overall Study||10
5290050|NCT00591409|13005950|P3|COMPLETED|Overall Study||10
5290051|NCT00591409|13005951|P2|COMPLETED|Overall Study||10
5290052|NCT00591409|13005952|P1|COMPLETED|Overall Study||10
5290053|NCT00591409|13005943|P10|Treated|Overall Study||10
5290054|NCT00591409|13005944|P9|Treated|Overall Study||9
5290055|NCT00591409|13005945|P8|Treated|Overall Study||10
5290056|NCT00591409|13005946|P7|Treated|Overall Study||10
5290057|NCT00591409|13005947|P6|Treated|Overall Study||10
5290058|NCT00591409|13005948|P5|Treated|Overall Study||9
5290059|NCT00591409|13005949|P4|Treated|Overall Study||10
5290060|NCT00591409|13005950|P3|Treated|Overall Study||10
5290061|NCT00591409|13005951|P2|Treated|Overall Study||10
5290062|NCT00591409|13005952|P1|Treated|Overall Study||10
5290063|NCT00591409|13005943|P10|STARTED|Overall Study||11
5290064|NCT00591409|13005944|P9|STARTED|Overall Study||9
5290065|NCT00591409|13005945|P8|STARTED|Overall Study||10
5290066|NCT00591409|13005946|P7|STARTED|Overall Study||10
5290067|NCT00591409|13005947|P6|STARTED|Overall Study||10
5290068|NCT00591409|13005948|P5|STARTED|Overall Study||10
5290069|NCT00591409|13005949|P4|STARTED|Overall Study||10
5290070|NCT00591409|13005950|P3|STARTED|Overall Study||10
5290071|NCT00591409|13005951|P2|STARTED|Overall Study||10
5290072|NCT00591409|13005952|P1|STARTED|Overall Study||10
5290073|NCT00591370|13005994|P1|NOT COMPLETED|Overall Study||2
5290074|NCT00591370|13005994|P1|COMPLETED|Overall Study||49
5290075|NCT00591370|13005994|P1|STARTED|Overall Study||51
5290076|NCT00591344|13006002|P2|NOT COMPLETED|Overall Study||8
5290077|NCT00591344|13006003|P1|NOT COMPLETED|Overall Study||5
5290078|NCT00591344|13006002|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
5290079|NCT00591344|13006003|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
5290080|NCT00591344|13006002|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
5290081|NCT00591344|13006003|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
5290082|NCT00591344|13006002|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
5290083|NCT00591344|13006003|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
5290084|NCT00591305|13006015|P2|NOT COMPLETED|Overall Study||0
5290085|NCT00591305|13006016|P1|NOT COMPLETED|Overall Study||0
5290086|NCT00591305|13006015|P2|COMPLETED|Overall Study||0
5290087|NCT00591305|13006016|P1|COMPLETED|Overall Study||1
5290088|NCT00591305|13006015|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
5290089|NCT00591305|13006016|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
5290090|NCT00591305|13006015|P2|STARTED|Overall Study||0
5290091|NCT00591305|13006016|P1|STARTED|Overall Study||1
5290092|NCT00591266|13006029|P3|NOT COMPLETED|Overall Study||14
5290093|NCT00591266|13006030|P2|NOT COMPLETED|Overall Study||11
5290094|NCT00591266|13006031|P1|NOT COMPLETED|Overall Study||9
5290095|NCT00591266|13006029|P3|COMPLETED|Overall Study||175
5290096|NCT00591266|13006030|P2|COMPLETED|Overall Study||177
5290097|NCT00591266|13006031|P1|COMPLETED|Overall Study||180
5290098|NCT00591266|13006029|P3|STARTED|Overall Study|Randomized only|189
5290099|NCT00591266|13006030|P2|STARTED|Overall Study|Randomized only|188
5290100|NCT00591266|13006031|P1|STARTED|Overall Study|Randomized only|189
5290101|NCT00591253|13006084|P3|NOT COMPLETED|Overall Study||15
5290102|NCT00591253|13006085|P2|NOT COMPLETED|Overall Study||21
5290103|NCT00591253|13006086|P1|NOT COMPLETED|Overall Study||14
5290104|NCT00591253|13006084|P3|COMPLETED|Overall Study||123
5290105|NCT00591253|13006085|P2|COMPLETED|Overall Study||116
5290106|NCT00591253|13006086|P1|COMPLETED|Overall Study||126
5290107|NCT00591253|13006084|P3|STARTED|Overall Study|Randomized or Treated|138
5290108|NCT00591253|13006085|P2|STARTED|Overall Study|Randomized or Treated|137
5290109|NCT00591253|13006086|P1|STARTED|Overall Study|Randomized or Treated|140
5290110|NCT00591240|13006138|P2|NOT COMPLETED|Overall Study||0
5290111|NCT00591240|13006139|P1|NOT COMPLETED|Overall Study||0
5290112|NCT00591240|13006138|P2|COMPLETED|Overall Study||222
5290113|NCT00591240|13006139|P1|COMPLETED|Overall Study||116
5290114|NCT00591240|13006138|P2|STARTED|Overall Study||222
5290115|NCT00591240|13006139|P1|STARTED|Overall Study||116
5290116|NCT00591227|13006147|P2|NOT COMPLETED|Overall Study||0
5290117|NCT00591227|13006148|P1|NOT COMPLETED|Overall Study||0
5290118|NCT00591227|13006147|P2|COMPLETED|Overall Study||87
5290119|NCT00591227|13006148|P1|COMPLETED|Overall Study||89
5290120|NCT00591227|13006147|P2|STARTED|Overall Study||87
5290121|NCT00591227|13006148|P1|STARTED|Overall Study||89
5290122|NCT00591214|13006154|P1|NOT COMPLETED|Overall Study||8
5290123|NCT00591214|13006154|P1|COMPLETED|Overall Study||2
5290124|NCT00591214|13006154|P1|STARTED|Overall Study||10
5290125|NCT00591149|13006163|P1|NOT COMPLETED|Overall Study||5
5290126|NCT00591149|13006163|P1|COMPLETED|Overall Study||11
5290127|NCT00591149|13006163|P1|STARTED|Overall Study||16
5290128|NCT00591019|13006167|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
5290129|NCT00591019|13006168|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
5290130|NCT00591019|13006167|P2|COMPLETED|Intevention 2 (14 Days)||3
5290131|NCT00591019|13006168|P1|COMPLETED|Intevention 2 (14 Days)||2
5290132|NCT00591019|13006167|P2|STARTED|Intevention 2 (14 Days)||3
5290133|NCT00591019|13006168|P1|STARTED|Intevention 2 (14 Days)||2
5290134|NCT00591019|13006167|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
5290135|NCT00591019|13006168|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
5290136|NCT00591019|13006167|P2|COMPLETED|Intervention 1 (14 Days)||3
5290137|NCT00591019|13006168|P1|COMPLETED|Intervention 1 (14 Days)||2
5290138|NCT00591019|13006167|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
5290139|NCT00591019|13006168|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
5290140|NCT00591019|13006167|P2|NOT COMPLETED|Baseline (1 Day)||0
5290141|NCT00591019|13006168|P1|NOT COMPLETED|Baseline (1 Day)||0
5290142|NCT00591019|13006167|P2|COMPLETED|Baseline (1 Day)||4
5290143|NCT00591019|13006168|P1|COMPLETED|Baseline (1 Day)||3
5290144|NCT00591019|13006167|P2|STARTED|Baseline (1 Day)||4
5290145|NCT00591019|13006168|P1|STARTED|Baseline (1 Day)||3
5290146|NCT00591006|13006179|P24|NOT COMPLETED|Overall Study||1
5290147|NCT00591006|13006180|P23|NOT COMPLETED|Overall Study||1
5290148|NCT00591006|13006181|P22|NOT COMPLETED|Overall Study||0
5290149|NCT00591006|13006182|P21|NOT COMPLETED|Overall Study||0
5290150|NCT00591006|13006183|P20|NOT COMPLETED|Overall Study||0
5290151|NCT00591006|13006184|P19|NOT COMPLETED|Overall Study||0
5290152|NCT00591006|13006185|P18|NOT COMPLETED|Overall Study||0
5290153|NCT00591006|13006186|P17|NOT COMPLETED|Overall Study||0
5290154|NCT00591006|13006187|P16|NOT COMPLETED|Overall Study||1
5290155|NCT00591006|13006188|P15|NOT COMPLETED|Overall Study||0
5290156|NCT00591006|13006189|P14|NOT COMPLETED|Overall Study||0
5290157|NCT00591006|13006190|P13|NOT COMPLETED|Overall Study||0
5290158|NCT00591006|13006191|P12|NOT COMPLETED|Overall Study||0
5290159|NCT00591006|13006192|P11|NOT COMPLETED|Overall Study||0
5290160|NCT00591006|13006193|P10|NOT COMPLETED|Overall Study||0
5290161|NCT00591006|13006194|P9|NOT COMPLETED|Overall Study||0
5290162|NCT00591006|13006195|P8|NOT COMPLETED|Overall Study||0
5290163|NCT00591006|13006196|P7|NOT COMPLETED|Overall Study||0
5290164|NCT00591006|13006197|P6|NOT COMPLETED|Overall Study||0
5290165|NCT00591006|13006198|P5|NOT COMPLETED|Overall Study||0
5290166|NCT00591006|13006199|P4|NOT COMPLETED|Overall Study||0
5290167|NCT00591006|13006200|P3|NOT COMPLETED|Overall Study||0
5290168|NCT00591006|13006201|P2|NOT COMPLETED|Overall Study||0
5290169|NCT00591006|13006202|P1|NOT COMPLETED|Overall Study||0
5290170|NCT00591006|13006179|P24|COMPLETED|Overall Study||0
5290171|NCT00591006|13006180|P23|COMPLETED|Overall Study||0
5290172|NCT00591006|13006181|P22|COMPLETED|Overall Study||1
5290173|NCT00591006|13006182|P21|COMPLETED|Overall Study||0
5290174|NCT00591006|13006183|P20|COMPLETED|Overall Study||1
5290175|NCT00591006|13006184|P19|COMPLETED|Overall Study||0
5290176|NCT00591006|13006185|P18|COMPLETED|Overall Study||1
5290177|NCT00591006|13006186|P17|COMPLETED|Overall Study||0
5290178|NCT00591006|13006187|P16|COMPLETED|Overall Study||0
5290179|NCT00591006|13006188|P15|COMPLETED|Overall Study||0
5290180|NCT00591006|13006189|P14|COMPLETED|Overall Study||2
5290181|NCT00591006|13006190|P13|COMPLETED|Overall Study||1
5290182|NCT00591006|13006191|P12|COMPLETED|Overall Study||1
5290183|NCT00591006|13006192|P11|COMPLETED|Overall Study||0
5290184|NCT00591006|13006193|P10|COMPLETED|Overall Study||1
5290185|NCT00591006|13006194|P9|COMPLETED|Overall Study||1
5290186|NCT00591006|13006195|P8|COMPLETED|Overall Study||0
5290187|NCT00591006|13006196|P7|COMPLETED|Overall Study||1
5290188|NCT00591006|13006197|P6|COMPLETED|Overall Study||0
5290189|NCT00591006|13006198|P5|COMPLETED|Overall Study||1
5290190|NCT00591006|13006199|P4|COMPLETED|Overall Study||1
5290191|NCT00591006|13006200|P3|COMPLETED|Overall Study||1
5290192|NCT00591006|13006201|P2|COMPLETED|Overall Study||0
5290193|NCT00591006|13006202|P1|COMPLETED|Overall Study||1
5290194|NCT00591006|13006179|P24|Treatment #4|Overall Study||0
5290195|NCT00591006|13006180|P23|Treatment #4|Overall Study||0
5290196|NCT00591006|13006181|P22|Treatment #4|Overall Study||1
5290197|NCT00591006|13006182|P21|Treatment #4|Overall Study||0
5290198|NCT00591006|13006183|P20|Treatment #4|Overall Study||1
5290199|NCT00591006|13006184|P19|Treatment #4|Overall Study||0
5290200|NCT00591006|13006185|P18|Treatment #4|Overall Study||1
5290201|NCT00591006|13006186|P17|Treatment #4|Overall Study||0
5290202|NCT00591006|13006187|P16|Treatment #4|Overall Study||0
5290203|NCT00591006|13006188|P15|Treatment #4|Overall Study||0
5290204|NCT00591006|13006189|P14|Treatment #4|Overall Study||2
5290205|NCT00591006|13006190|P13|Treatment #4|Overall Study||1
5290206|NCT00591006|13006191|P12|Treatment #4|Overall Study||1
5290207|NCT00591006|13006192|P11|Treatment #4|Overall Study||0
5290208|NCT00591006|13006193|P10|Treatment #4|Overall Study||1
5290209|NCT00591006|13006194|P9|Treatment #4|Overall Study||1
5290210|NCT00591006|13006195|P8|Treatment #4|Overall Study||0
5290211|NCT00591006|13006196|P7|Treatment #4|Overall Study||1
5290212|NCT00591006|13006197|P6|Treatment #4|Overall Study||0
5290213|NCT00591006|13006198|P5|Treatment #4|Overall Study||1
5290214|NCT00591006|13006199|P4|Treatment #4|Overall Study||1
5290215|NCT00591006|13006200|P3|Treatment #4|Overall Study||1
5290216|NCT00591006|13006201|P2|Treatment #4|Overall Study||0
5290217|NCT00591006|13006202|P1|Treatment #4|Overall Study||1
5290218|NCT00591006|13006179|P24|Treatment #3|Overall Study||1
5290219|NCT00591006|13006180|P23|Treatment #3|Overall Study||1
5290220|NCT00591006|13006181|P22|Treatment #3|Overall Study||1
5290221|NCT00591006|13006182|P21|Treatment #3|Overall Study||0
5290222|NCT00591006|13006183|P20|Treatment #3|Overall Study||1
5290223|NCT00591006|13006184|P19|Treatment #3|Overall Study||0
5290224|NCT00591006|13006185|P18|Treatment #3|Overall Study||1
5290225|NCT00591006|13006186|P17|Treatment #3|Overall Study||0
5290226|NCT00591006|13006187|P16|Treatment #3|Overall Study||0
5290227|NCT00591006|13006188|P15|Treatment #3|Overall Study||0
5290228|NCT00591006|13006189|P14|Treatment #3|Overall Study||2
5290229|NCT00591006|13006190|P13|Treatment #3|Overall Study||1
5290230|NCT00591006|13006191|P12|Treatment #3|Overall Study||1
5290231|NCT00591006|13006192|P11|Treatment #3|Overall Study||0
5290232|NCT00591006|13006193|P10|Treatment #3|Overall Study||1
5290233|NCT00591006|13006194|P9|Treatment #3|Overall Study||1
5290234|NCT00591006|13006195|P8|Treatment #3|Overall Study||0
5290235|NCT00591006|13006196|P7|Treatment #3|Overall Study||1
5290236|NCT00591006|13006197|P6|Treatment #3|Overall Study||0
5290237|NCT00591006|13006198|P5|Treatment #3|Overall Study||1
5290238|NCT00591006|13006199|P4|Treatment #3|Overall Study||1
5290239|NCT00591006|13006200|P3|Treatment #3|Overall Study||1
5290240|NCT00591006|13006201|P2|Treatment #3|Overall Study||0
5290241|NCT00591006|13006202|P1|Treatment #3|Overall Study||1
5290242|NCT00591006|13006179|P24|Treatment #2|Overall Study||1
5290243|NCT00591006|13006180|P23|Treatment #2|Overall Study||1
5290244|NCT00591006|13006181|P22|Treatment #2|Overall Study||1
5290245|NCT00591006|13006182|P21|Treatment #2|Overall Study||0
5290246|NCT00591006|13006183|P20|Treatment #2|Overall Study||1
5290247|NCT00591006|13006184|P19|Treatment #2|Overall Study||0
5290248|NCT00591006|13006185|P18|Treatment #2|Overall Study||1
5290249|NCT00591006|13006186|P17|Treatment #2|Overall Study||0
5290250|NCT00591006|13006187|P16|Treatment #2|Overall Study||0
5290251|NCT00591006|13006188|P15|Treatment #2|Overall Study||0
5290252|NCT00591006|13006189|P14|Treatment #2|Overall Study||2
5290253|NCT00591006|13006190|P13|Treatment #2|Overall Study||1
5290254|NCT00591006|13006191|P12|Treatment #2|Overall Study||1
5290255|NCT00591006|13006192|P11|Treatment #2|Overall Study||0
5290256|NCT00591006|13006193|P10|Treatment #2|Overall Study||1
5290257|NCT00591006|13006194|P9|Treatment #2|Overall Study||1
5290258|NCT00591006|13006195|P8|Treatment #2|Overall Study||0
5290259|NCT00591006|13006196|P7|Treatment #2|Overall Study||1
5290260|NCT00591006|13006197|P6|Treatment #2|Overall Study||0
5290261|NCT00591006|13006198|P5|Treatment #2|Overall Study||1
5290262|NCT00591006|13006199|P4|Treatment #2|Overall Study||1
5290263|NCT00591006|13006200|P3|Treatment #2|Overall Study||1
5290264|NCT00591006|13006201|P2|Treatment #2|Overall Study||0
5290265|NCT00591006|13006202|P1|Treatment #2|Overall Study||1
5290266|NCT00591006|13006179|P24|STARTED|Overall Study||1
5290267|NCT00591006|13006180|P23|STARTED|Overall Study||1
5290268|NCT00591006|13006181|P22|STARTED|Overall Study||1
5290269|NCT00591006|13006182|P21|STARTED|Overall Study||0
5290270|NCT00591006|13006183|P20|STARTED|Overall Study||1
5290271|NCT00591006|13006184|P19|STARTED|Overall Study||0
5290272|NCT00591006|13006185|P18|STARTED|Overall Study||1
5290273|NCT00591006|13006186|P17|STARTED|Overall Study||0
5290274|NCT00591006|13006187|P16|STARTED|Overall Study||1
5290275|NCT00591006|13006188|P15|STARTED|Overall Study||0
5290276|NCT00591006|13006189|P14|STARTED|Overall Study||2
5290277|NCT00591006|13006190|P13|STARTED|Overall Study||1
5290278|NCT00591006|13006191|P12|STARTED|Overall Study||1
5290279|NCT00591006|13006192|P11|STARTED|Overall Study||0
5290280|NCT00591006|13006193|P10|STARTED|Overall Study||1
5290281|NCT00591006|13006194|P9|STARTED|Overall Study||1
5290282|NCT00591006|13006195|P8|STARTED|Overall Study||0
5290283|NCT00591006|13006196|P7|STARTED|Overall Study||1
5290284|NCT00591006|13006197|P6|STARTED|Overall Study||0
5290285|NCT00591006|13006198|P5|STARTED|Overall Study||1
5290286|NCT00591006|13006199|P4|STARTED|Overall Study||1
5290287|NCT00591006|13006200|P3|STARTED|Overall Study||1
5290288|NCT00591006|13006201|P2|STARTED|Overall Study||0
5290289|NCT00591006|13006202|P1|STARTED|Overall Study||1
5290290|NCT00590980|13006220|P1|NOT COMPLETED|Overall Study||10
5290291|NCT00590980|13006220|P1|COMPLETED|Overall Study||72
5290292|NCT00590980|13006220|P1|STARTED|Overall Study||82
5290293|NCT00590967|13006226|P2|NOT COMPLETED|Overall Study||5
5290294|NCT00590967|13006227|P1|NOT COMPLETED|Overall Study||3
5290295|NCT00590967|13006226|P2|COMPLETED|Overall Study||20
5290296|NCT00590967|13006227|P1|COMPLETED|Overall Study||41
5290297|NCT00590967|13006226|P2|STARTED|Overall Study||25
5290298|NCT00590967|13006227|P1|STARTED|Overall Study||44
5290299|NCT00590902|13006239|P1|NOT COMPLETED|Overall Study||1
5290300|NCT00590902|13006239|P1|COMPLETED|Overall Study||80
5290301|NCT00590902|13006239|P1|STARTED|Overall Study||81
5290302|NCT00590889|13006245|P2|NOT COMPLETED|Overall Study||299
5290303|NCT00590889|13006246|P1|NOT COMPLETED|Overall Study||286
5290304|NCT00590889|13006245|P2|COMPLETED|Overall Study||104
5290305|NCT00590889|13006246|P1|COMPLETED|Overall Study||118
5290306|NCT00590889|13006245|P2|STARTED|Overall Study||403
5290307|NCT00590889|13006246|P1|STARTED|Overall Study||404
5290308|NCT00590863|13006255|P3|NOT COMPLETED|Overall Study||78
5290309|NCT00590863|13006256|P2|NOT COMPLETED|Overall Study||82
5290310|NCT00590863|13006257|P1|NOT COMPLETED|Overall Study||84
5290311|NCT00590863|13006255|P3|COMPLETED|Overall Study||146
5290312|NCT00590863|13006256|P2|COMPLETED|Overall Study||138
5290313|NCT00590863|13006257|P1|COMPLETED|Overall Study||137
5290314|NCT00590863|13006255|P3|STARTED|Overall Study||224
5290315|NCT00590863|13006256|P2|STARTED|Overall Study||220
5290316|NCT00590863|13006257|P1|STARTED|Overall Study||221
5290317|NCT00590824|13006272|P4|NOT COMPLETED|Overall Study||1
5290318|NCT00590824|13006273|P3|NOT COMPLETED|Overall Study||1
5290319|NCT00590824|13006274|P2|NOT COMPLETED|Overall Study||2
5290320|NCT00590824|13006275|P1|NOT COMPLETED|Overall Study||0
5290321|NCT00590824|13006272|P4|COMPLETED|Overall Study||0
5290322|NCT00590824|13006273|P3|COMPLETED|Overall Study||1
5290323|NCT00590824|13006274|P2|COMPLETED|Overall Study||7
5290324|NCT00590824|13006275|P1|COMPLETED|Overall Study||11
5290325|NCT00590824|13006272|P4|STARTED|Overall Study||1
5290326|NCT00590824|13006273|P3|STARTED|Overall Study||2
5290327|NCT00590824|13006274|P2|STARTED|Overall Study||9
5290328|NCT00590824|13006275|P1|STARTED|Overall Study||11
5290329|NCT00590772|13006295|P1|NOT COMPLETED|Overall Study||0
5290330|NCT00590772|13006295|P1|COMPLETED|Overall Study||31
5290331|NCT00590772|13006295|P1|STARTED|Overall Study||31
5290332|NCT00590759|13006301|P1|NOT COMPLETED|Overall Study||80
5290333|NCT00590759|13006301|P1|COMPLETED|Overall Study||70
5290334|NCT00590759|13006301|P1|STARTED|Overall Study||150
5290335|NCT00590720|13006308|P2|NOT COMPLETED|Overall Study||1
5290336|NCT00590720|13006309|P1|NOT COMPLETED|Overall Study||1
5290337|NCT00590720|13006308|P2|COMPLETED|Overall Study||6
5290338|NCT00590720|13006309|P1|COMPLETED|Overall Study||3
5290339|NCT00590720|13006308|P2|STARTED|Overall Study||7
5290340|NCT00590720|13006309|P1|STARTED|Overall Study||4
5290341|NCT00590707|13006353|P2|NOT COMPLETED|Overall Study||0
5290342|NCT00590707|13006354|P1|NOT COMPLETED|Overall Study||0
5290343|NCT00590707|13006353|P2|COMPLETED|Overall Study||100
5290344|NCT00590707|13006354|P1|COMPLETED|Overall Study||100
5290345|NCT00590707|13006353|P2|STARTED|Overall Study||100
5290346|NCT00590707|13006354|P1|STARTED|Overall Study||100
5290347|NCT00590590|13006371|P3|NOT COMPLETED|Overall Study||6
5290348|NCT00590590|13006372|P2|NOT COMPLETED|Overall Study||6
5290349|NCT00590590|13006373|P1|NOT COMPLETED|Overall Study||7
5290350|NCT00590590|13006371|P3|COMPLETED|Overall Study||21
5290351|NCT00590590|13006372|P2|COMPLETED|Overall Study||33
5290352|NCT00590590|13006373|P1|COMPLETED|Overall Study||32
5290353|NCT00590590|13006371|P3|STARTED|Overall Study||27
5290354|NCT00590590|13006372|P2|STARTED|Overall Study||39
5290355|NCT00590590|13006373|P1|STARTED|Overall Study||39
5290356|NCT00590577|13006400|P4|NOT COMPLETED|Overall Study||93
5290357|NCT00590577|13006401|P3|NOT COMPLETED|Overall Study||73
5290358|NCT00590577|13006402|P2|NOT COMPLETED|Overall Study||76
5290359|NCT00590577|13006403|P1|NOT COMPLETED|Overall Study||77
5290360|NCT00590577|13006400|P4|COMPLETED|Overall Study||71
5290361|NCT00590577|13006401|P3|COMPLETED|Overall Study||90
5290362|NCT00590577|13006402|P2|COMPLETED|Overall Study||89
5290363|NCT00590577|13006403|P1|COMPLETED|Overall Study||83
5290364|NCT00590577|13006400|P4|STARTED|Overall Study||164
5290365|NCT00590577|13006401|P3|STARTED|Overall Study||163
5290366|NCT00590577|13006402|P2|STARTED|Overall Study||165
5290367|NCT00590577|13006403|P1|STARTED|Overall Study||160
5290368|NCT00590564|13006421|P1|NOT COMPLETED|Overall Study||18
5290369|NCT00590564|13006421|P1|COMPLETED|Overall Study||24
5290370|NCT00590564|13006421|P1|STARTED|Overall Study||42
5290371|NCT00590538|13006425|P1|NOT COMPLETED|Overall Study||2
5290372|NCT00590538|13006425|P1|COMPLETED|Overall Study||7
5290373|NCT00590538|13006425|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
5290374|NCT00590460|13006433|P1|NOT COMPLETED|Overall Study||0
5290375|NCT00590460|13006433|P1|COMPLETED|Overall Study||5
5290376|NCT00590460|13006433|P1|STARTED|Overall Study||5
5290377|NCT00590395|13006446|P1|NOT COMPLETED|Overall Study||0
5290378|NCT00590395|13006446|P1|COMPLETED|Overall Study||19
5290379|NCT00590395|13006446|P1|STARTED|Overall Study||19
5290380|NCT00590369|13006452|P2|NOT COMPLETED|Overall Study||0
5290381|NCT00590369|13006453|P1|NOT COMPLETED|Overall Study||0
5290382|NCT00590369|13006452|P2|COMPLETED|Overall Study||5
5290383|NCT00590369|13006453|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
5290384|NCT00590369|13006452|P2|STARTED|Overall Study||5
5290385|NCT00590369|13006453|P1|STARTED|Overall Study||6
5290386|NCT00590317|13006471|P2|NOT COMPLETED|Overall Study||5
5290387|NCT00590317|13006472|P1|NOT COMPLETED|Overall Study||1
5290388|NCT00590317|13006471|P2|COMPLETED|Overall Study||27
5290389|NCT00590317|13006472|P1|COMPLETED|Overall Study||31
5290390|NCT00590317|13006471|P2|STARTED|Overall Study||32
5290391|NCT00590317|13006472|P1|STARTED|Overall Study||32
5290392|NCT00590226|13006484|P2|NOT COMPLETED|Overall Study||0
5290393|NCT00590226|13006485|P1|NOT COMPLETED|Overall Study||0
5290394|NCT00590226|13006484|P2|COMPLETED|Overall Study||63
5290395|NCT00590226|13006485|P1|COMPLETED|Overall Study||67
5290396|NCT00590226|13006484|P2|STARTED|Overall Study||63
5290397|NCT00590226|13006485|P1|STARTED|Overall Study||67
5290398|NCT00590161|13006495|P2|NOT COMPLETED|Overall Study||3
5290399|NCT00590161|13006496|P1|NOT COMPLETED|Overall Study||3
5290400|NCT00590161|13006495|P2|COMPLETED|Overall Study||26
5290401|NCT00590161|13006496|P1|COMPLETED|Overall Study||23
5290402|NCT00590161|13006495|P2|STARTED|Overall Study||29
5290403|NCT00590161|13006496|P1|STARTED|Overall Study||26
5290404|NCT00590135|13006502|P1|NOT COMPLETED|Overall Study||59
5290405|NCT00590135|13006502|P1|COMPLETED|Overall Study||0
5290406|NCT00590135|13006502|P1|STARTED|Overall Study||59
5290407|NCT00590044|13006512|P2|NOT COMPLETED|Overall Study||2
5290408|NCT00590044|13006513|P1|NOT COMPLETED|Overall Study||4
5290409|NCT00590044|13006512|P2|COMPLETED|Overall Study||34
5290410|NCT00590044|13006513|P1|COMPLETED|Overall Study||34
5290411|NCT00590044|13006512|P2|STARTED|Overall Study||36
5290412|NCT00590044|13006513|P1|STARTED|Overall Study||38
5290413|NCT00590031|13006525|P1|NOT COMPLETED|Overall Study||6
5290414|NCT00590031|13006525|P1|COMPLETED|Overall Study||55
5290415|NCT00590031|13006525|P1|STARTED|Overall Study||61
5290416|NCT00590018|13006532|P2|NOT COMPLETED|Overall Study||0
5290417|NCT00590018|13006533|P1|NOT COMPLETED|Overall Study||0
5290418|NCT00590018|13006532|P2|COMPLETED|Overall Study||9
5290419|NCT00590018|13006533|P1|COMPLETED|Overall Study||9
5290420|NCT00590018|13006532|P2|STARTED|Overall Study||9
5290421|NCT00590018|13006533|P1|STARTED|Overall Study||9
5290422|NCT00590005|13006541|P2|NOT COMPLETED|Overall Study||0
5290423|NCT00590005|13006542|P1|NOT COMPLETED|Overall Study||0
5290424|NCT00590005|13006541|P2|COMPLETED|Overall Study||119
5290425|NCT00590005|13006542|P1|COMPLETED|Overall Study||106
5290426|NCT00590005|13006541|P2|STARTED|Overall Study||119
5290427|NCT00590005|13006542|P1|STARTED|Overall Study||106
5290428|NCT00589979|13006552|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
5290429|NCT00589979|13006553|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
5290430|NCT00589979|13006554|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
5290431|NCT00589979|13006552|P3|COMPLETED|Double-Blind Treatment Period 3||38
5290432|NCT00589979|13006553|P2|COMPLETED|Double-Blind Treatment Period 3||46
5290433|NCT00589979|13006554|P1|COMPLETED|Double-Blind Treatment Period 3||0
5290434|NCT00589979|13006552|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
5290435|NCT00589979|13006553|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
5290436|NCT00589979|13006554|P1|STARTED|Double-Blind Treatment Period 3||0
5290437|NCT00589979|13006552|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
5290438|NCT00589979|13006553|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
5290439|NCT00589979|13006554|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
5290440|NCT00589979|13006552|P3|COMPLETED|Double-Blind Treatment Period 2||39
5290441|NCT00589979|13006553|P2|COMPLETED|Double-Blind Treatment Period 2||47
5290442|NCT00589979|13006554|P1|COMPLETED|Double-Blind Treatment Period 2||0
5290443|NCT00589979|13006552|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
5290444|NCT00589979|13006553|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
5290445|NCT00589979|13006554|P1|STARTED|Double-Blind Treatment Period 2||0
5290446|NCT00589979|13006552|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
5290447|NCT00589979|13006553|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
5290448|NCT00589979|13006554|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
5290449|NCT00589979|13006552|P3|COMPLETED|Double-Blind Treatment Period 1||41
5290450|NCT00589979|13006553|P2|COMPLETED|Double-Blind Treatment Period 1||48
5290451|NCT00589979|13006554|P1|COMPLETED|Double-Blind Treatment Period 1||0
5290452|NCT00589979|13006552|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
5290453|NCT00589979|13006553|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
5290454|NCT00589979|13006554|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
5290455|NCT00589979|13006552|P3|NOT COMPLETED|Run-In Period||0
5290456|NCT00589979|13006553|P2|NOT COMPLETED|Run-In Period||0
5290457|NCT00589979|13006554|P1|NOT COMPLETED|Run-In Period||76
5290458|NCT00589979|13006552|P3|COMPLETED|Run-In Period||0
5290459|NCT00589979|13006553|P2|COMPLETED|Run-In Period||0
5290460|NCT00589979|13006554|P1|COMPLETED|Run-In Period||93
5290461|NCT00589979|13006552|P3|STARTED|Run-In Period||0
5290462|NCT00589979|13006553|P2|STARTED|Run-In Period||0
5290463|NCT00589979|13006554|P1|STARTED|Run-In Period||169
5290464|NCT00589914|13006593|P2|NOT COMPLETED|Overall Study||137
5290465|NCT00589914|13006594|P1|NOT COMPLETED|Overall Study||150
5290466|NCT00589914|13006593|P2|COMPLETED|Overall Study||471
5290467|NCT00589914|13006594|P1|COMPLETED|Overall Study||456
5290468|NCT00589914|13006593|P2|STARTED|Overall Study||608
5290469|NCT00589914|13006594|P1|STARTED|Overall Study||606
5290470|NCT00589888|13006604|P5|NOT COMPLETED|64-gram Oral Fat Load||0
5290471|NCT00589888|13006605|P4|NOT COMPLETED|64-gram Oral Fat Load||0
5290472|NCT00589888|13006606|P3|NOT COMPLETED|64-gram Oral Fat Load||0
5290473|NCT00589888|13006607|P2|NOT COMPLETED|64-gram Oral Fat Load||0
5290474|NCT00589888|13006608|P1|NOT COMPLETED|64-gram Oral Fat Load||0
5290475|NCT00589888|13006604|P5|COMPLETED|64-gram Oral Fat Load||13
5290476|NCT00589888|13006605|P4|COMPLETED|64-gram Oral Fat Load||0
5290477|NCT00589888|13006606|P3|COMPLETED|64-gram Oral Fat Load||0
5290478|NCT00589888|13006607|P2|COMPLETED|64-gram Oral Fat Load||0
5290479|NCT00589888|13006608|P1|COMPLETED|64-gram Oral Fat Load||0
5290480|NCT00589888|13006604|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
5290564|NCT00589784|13006676|P1|COMPLETED|Overall Study||35
5290481|NCT00589888|13006605|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
5290482|NCT00589888|13006606|P3|STARTED|64-gram Oral Fat Load||0
5290483|NCT00589888|13006607|P2|STARTED|64-gram Oral Fat Load||0
5290484|NCT00589888|13006608|P1|STARTED|64-gram Oral Fat Load||0
5290485|NCT00589888|13006604|P5|NOT COMPLETED|32-gram Oral Fat Load||0
5290486|NCT00589888|13006605|P4|NOT COMPLETED|32-gram Oral Fat Load||0
5290487|NCT00589888|13006606|P3|NOT COMPLETED|32-gram Oral Fat Load||0
5290488|NCT00589888|13006607|P2|NOT COMPLETED|32-gram Oral Fat Load||0
5290489|NCT00589888|13006608|P1|NOT COMPLETED|32-gram Oral Fat Load||0
5290490|NCT00589888|13006604|P5|COMPLETED|32-gram Oral Fat Load||0
5290491|NCT00589888|13006605|P4|COMPLETED|32-gram Oral Fat Load||13
5290492|NCT00589888|13006606|P3|COMPLETED|32-gram Oral Fat Load||0
5290493|NCT00589888|13006607|P2|COMPLETED|32-gram Oral Fat Load||0
5290494|NCT00589888|13006608|P1|COMPLETED|32-gram Oral Fat Load||0
5290495|NCT00589888|13006604|P5|STARTED|32-gram Oral Fat Load||0
5290496|NCT00589888|13006605|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
5290497|NCT00589888|13006606|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
5290498|NCT00589888|13006607|P2|STARTED|32-gram Oral Fat Load||0
5290499|NCT00589888|13006608|P1|STARTED|32-gram Oral Fat Load||0
5290500|NCT00589888|13006604|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290501|NCT00589888|13006605|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290502|NCT00589888|13006606|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290503|NCT00589888|13006607|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290504|NCT00589888|13006608|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290505|NCT00589888|13006604|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290506|NCT00589888|13006605|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290507|NCT00589888|13006606|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
5290508|NCT00589888|13006607|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290509|NCT00589888|13006608|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
5290510|NCT00589888|13006604|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
5290511|NCT00589888|13006605|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
5290512|NCT00589888|13006606|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
5290513|NCT00589888|13006607|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
5290514|NCT00589888|13006608|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
5290515|NCT00589888|13006604|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
5290516|NCT00589888|13006605|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
5290517|NCT00589888|13006606|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
5290518|NCT00589888|13006607|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
5290519|NCT00589888|13006608|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
5290520|NCT00589888|13006604|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
5290521|NCT00589888|13006605|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
5290522|NCT00589888|13006606|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
5290523|NCT00589888|13006607|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
5290524|NCT00589888|13006608|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
5290525|NCT00589888|13006604|P5|STARTED|Intralipid 20% @ 20cc/hr||0
5290526|NCT00589888|13006605|P4|STARTED|Intralipid 20% @ 20cc/hr||0
5290527|NCT00589888|13006606|P3|STARTED|Intralipid 20% @ 20cc/hr||0
5290528|NCT00589888|13006607|P2|STARTED|Intralipid 20% @ 20cc/hr||13
5290529|NCT00589888|13006608|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
5290530|NCT00589888|13006604|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
5290531|NCT00589888|13006605|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
5290532|NCT00589888|13006606|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
5290533|NCT00589888|13006607|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
5290534|NCT00589888|13006608|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
5290535|NCT00589888|13006604|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
5290536|NCT00589888|13006605|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
5290537|NCT00589888|13006606|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
5290538|NCT00589888|13006607|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
5290539|NCT00589888|13006608|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
5290540|NCT00589888|13006604|P5|STARTED|Normal Saline @ 40cc/Hour||0
5290541|NCT00589888|13006605|P4|STARTED|Normal Saline @ 40cc/Hour||0
5290542|NCT00589888|13006606|P3|STARTED|Normal Saline @ 40cc/Hour||0
5290543|NCT00589888|13006607|P2|STARTED|Normal Saline @ 40cc/Hour||0
5290544|NCT00589888|13006608|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
5290545|NCT00589849|13006640|P1|NOT COMPLETED|Overall Study||0
5290546|NCT00589849|13006640|P1|COMPLETED|Overall Study||32
5290547|NCT00589849|13006640|P1|STARTED|Overall Study||32
5290548|NCT00589836|13006644|P1|NOT COMPLETED|Overall Study||0
5290549|NCT00589836|13006644|P1|COMPLETED|Overall Study||20
5290550|NCT00589836|13006644|P1|STARTED|Overall Study||20
5290551|NCT00589797|13006650|P2|NOT COMPLETED|Overall Study||23
5290552|NCT00589797|13006651|P1|NOT COMPLETED|Overall Study||73
5290553|NCT00589797|13006650|P2|COMPLETED|Overall Study||89
5290554|NCT00589797|13006651|P1|COMPLETED|Overall Study||191
5290555|NCT00589797|13006650|P2|24 Months|Overall Study||89
5290556|NCT00589797|13006651|P1|24 Months|Overall Study||191
5290557|NCT00589797|13006650|P2|Baseline|Overall Study||106
5290558|NCT00589797|13006651|P1|Baseline|Overall Study||218
5290559|NCT00589797|13006650|P2|STARTED|Overall Study||112
5290560|NCT00589797|13006651|P1|STARTED|Overall Study||264
5290561|NCT00589784|13006675|P2|NOT COMPLETED|Overall Study||10
5290562|NCT00589784|13006676|P1|NOT COMPLETED|Overall Study||1
5290563|NCT00589784|13006675|P2|COMPLETED|Overall Study||4
5290565|NCT00589784|13006675|P2|STARTED|Overall Study||14
5290566|NCT00589784|13006676|P1|STARTED|Overall Study||36
5290567|NCT00589693|13006683|P2|NOT COMPLETED|Overall Study||29
5290568|NCT00589693|13006684|P1|NOT COMPLETED|Overall Study||44
5290569|NCT00589693|13006683|P2|COMPLETED|Overall Study||83
5290570|NCT00589693|13006684|P1|COMPLETED|Overall Study||71
5290571|NCT00589693|13006683|P2|STARTED|Overall Study||112
5290572|NCT00589693|13006684|P1|STARTED|Overall Study||115
5290573|NCT00589667|13006698|P1|NOT COMPLETED|Overall Study||3
5290574|NCT00589667|13006698|P1|COMPLETED|Overall Study||23
5290575|NCT00589667|13006698|P1|STARTED|Overall Study||26
5290576|NCT00589628|13006705|P2|NOT COMPLETED|Overall Study||1
5290577|NCT00589628|13006706|P1|NOT COMPLETED|Overall Study||0
5290578|NCT00589628|13006705|P2|COMPLETED|Overall Study||5
5290579|NCT00589628|13006706|P1|COMPLETED|Overall Study||7
5290580|NCT00589628|13006705|P2|STARTED|Overall Study||6
5290581|NCT00589628|13006706|P1|STARTED|Overall Study||7
5290582|NCT00589602|13006712|P1|NOT COMPLETED|Overall Study||1
5290583|NCT00589602|13006712|P1|COMPLETED|Overall Study||12
5290584|NCT00589602|13006712|P1|STARTED|Overall Study||13
5290585|NCT00589563|13006720|P1|NOT COMPLETED|Overall Study||0
5290586|NCT00589563|13006720|P1|COMPLETED|Overall Study||32
5290587|NCT00589563|13006720|P1|STARTED|Overall Study||32
5290588|NCT00589550|13006737|P1|NOT COMPLETED|Overall Study||1
5290589|NCT00589550|13006737|P1|COMPLETED|Overall Study||0
5290590|NCT00589550|13006737|P1|Withdrew From Study|Overall Study||1
5290591|NCT00589550|13006737|P1|STARTED|Overall Study||1
5290592|NCT00589472|13006747|P1|NOT COMPLETED|Overall Study||1
5290593|NCT00589472|13006747|P1|COMPLETED|Overall Study||18
5290594|NCT00589472|13006747|P1|STARTED|Overall Study||19
5290595|NCT00589329|13006759|P2|NOT COMPLETED|Overall Study||0
5290596|NCT00589329|13006760|P1|NOT COMPLETED|Overall Study||0
5290597|NCT00589329|13006759|P2|COMPLETED|Overall Study||10
5290598|NCT00589329|13006760|P1|COMPLETED|Overall Study||10
5290599|NCT00589329|13006759|P2|STARTED|Overall Study||10
5290600|NCT00589329|13006760|P1|STARTED|Overall Study||10
5290601|NCT00589303|13006770|P2|NOT COMPLETED|Overall Study||1
5290602|NCT00589303|13006771|P1|NOT COMPLETED|Overall Study||2
5290603|NCT00589303|13006770|P2|COMPLETED|Overall Study||12
5290604|NCT00589303|13006771|P1|COMPLETED|Overall Study||12
5290605|NCT00589303|13006770|P2|STARTED|Overall Study||13
5290606|NCT00589303|13006771|P1|STARTED|Overall Study||14
5290607|NCT00589290|13006777|P1|NOT COMPLETED|Overall Study||1
5290608|NCT00589290|13006777|P1|COMPLETED|Overall Study||40
5290609|NCT00589290|13006777|P1|STARTED|Overall Study||41
5290610|NCT00589277|13006787|P2|NOT COMPLETED|Overall Study||286
5290611|NCT00589277|13006788|P1|NOT COMPLETED|Overall Study||460
5290612|NCT00589277|13006787|P2|COMPLETED|Overall Study||524
5290613|NCT00589277|13006788|P1|COMPLETED|Overall Study||762
5290614|NCT00589277|13006787|P2|Completed 3 Month Follow Up|Overall Study||524
5290615|NCT00589277|13006788|P1|Completed 3 Month Follow Up|Overall Study||762
5290616|NCT00589277|13006787|P2|Completed 2 Week Follow Up|Overall Study||424
5290617|NCT00589277|13006788|P1|Completed 2 Week Follow Up|Overall Study||603
5290618|NCT00589277|13006787|P2|STARTED|Overall Study||810
5290619|NCT00589277|13006788|P1|STARTED|Overall Study||1222
5290620|NCT00589121|13006800|P2|NOT COMPLETED|Overall Study||7
5290621|NCT00589121|13006801|P1|NOT COMPLETED|Overall Study||2
5290622|NCT00589121|13006800|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
5290623|NCT00589121|13006801|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
5290624|NCT00589121|13006800|P2|STARTED|Overall Study||86
5290625|NCT00589121|13006801|P1|STARTED|Overall Study||12
5290626|NCT00589108|13006823|P3|NOT COMPLETED|Overall Study||5
5290627|NCT00589108|13006824|P2|NOT COMPLETED|Overall Study||4
5290628|NCT00589108|13006825|P1|NOT COMPLETED|Overall Study||4
5290629|NCT00589108|13006823|P3|COMPLETED|Overall Study||75
5290630|NCT00589108|13006824|P2|COMPLETED|Overall Study||76
5290631|NCT00589108|13006825|P1|COMPLETED|Overall Study||76
5290632|NCT00589108|13006823|P3|STARTED|Overall Study||80
5290633|NCT00589108|13006824|P2|STARTED|Overall Study||80
5290634|NCT00589108|13006825|P1|STARTED|Overall Study||80
5290635|NCT00589056|13006845|P1|NOT COMPLETED|Overall Study||3
5290636|NCT00589056|13006845|P1|COMPLETED|Overall Study||52
5290637|NCT00589056|13006845|P1|STARTED|Overall Study||55
5290638|NCT00588965|13006851|P1|NOT COMPLETED|Overall Study||0
5290639|NCT00588965|13006851|P1|COMPLETED|Overall Study||35
5290640|NCT00588965|13006851|P1|STARTED|Overall Study||35
5290641|NCT00588952|13006861|P2|NOT COMPLETED|Overall Study||7
5290642|NCT00588952|13006862|P1|NOT COMPLETED|Overall Study||3
5290643|NCT00588952|13006861|P2|COMPLETED|Overall Study||63
5290644|NCT00588952|13006862|P1|COMPLETED|Overall Study||26
5290645|NCT00588952|13006861|P2|STARTED|Overall Study||70
5290646|NCT00588952|13006862|P1|STARTED|Overall Study||29
5290647|NCT00588900|13006882|P1|NOT COMPLETED|Overall Study||0
5290648|NCT00588900|13006882|P1|COMPLETED|Overall Study||5
5290649|NCT00588900|13006882|P1|STARTED|Overall Study||5
5290650|NCT00588861|13006890|P2|NOT COMPLETED|10 Years||114
5290651|NCT00588861|13006891|P1|NOT COMPLETED|10 Years||107
5290652|NCT00588861|13006890|P2|COMPLETED|10 Years||0
5290653|NCT00588861|13006891|P1|COMPLETED|10 Years||0
5290654|NCT00588861|13006890|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
5290655|NCT00588861|13006891|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
5290656|NCT00588861|13006890|P2|NOT COMPLETED|8 Years||114
5290657|NCT00588861|13006891|P1|NOT COMPLETED|8 Years||105
5290658|NCT00588861|13006890|P2|COMPLETED|8 Years||0
5290659|NCT00588861|13006891|P1|COMPLETED|8 Years||2
5290660|NCT00588861|13006890|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
5290661|NCT00588861|13006891|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
5290662|NCT00588861|13006890|P2|NOT COMPLETED|6 Years||109
5290663|NCT00588861|13006891|P1|NOT COMPLETED|6 Years||104
5290664|NCT00588861|13006890|P2|COMPLETED|6 Years||5
5290665|NCT00588861|13006891|P1|COMPLETED|6 Years||3
5290666|NCT00588861|13006890|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
5290667|NCT00588861|13006891|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
5290668|NCT00588861|13006890|P2|NOT COMPLETED|4 Years||103
5290669|NCT00588861|13006891|P1|NOT COMPLETED|4 Years||91
5290670|NCT00588861|13006890|P2|COMPLETED|4 Years||11
5290671|NCT00588861|13006891|P1|COMPLETED|4 Years||16
5290672|NCT00588861|13006890|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
5290673|NCT00588861|13006891|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
5290674|NCT00588861|13006890|P2|NOT COMPLETED|2 Years||87
5290675|NCT00588861|13006891|P1|NOT COMPLETED|2 Years||92
5290676|NCT00588861|13006890|P2|COMPLETED|2 Years||27
5290677|NCT00588861|13006891|P1|COMPLETED|2 Years||15
5290678|NCT00588861|13006890|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
5290679|NCT00588861|13006891|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
5290680|NCT00588861|13006890|P2|NOT COMPLETED|1 Year||82
5290681|NCT00588861|13006891|P1|NOT COMPLETED|1 Year||89
5290682|NCT00588861|13006890|P2|COMPLETED|1 Year||32
5290683|NCT00588861|13006891|P1|COMPLETED|1 Year||18
5290684|NCT00588861|13006890|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
5290685|NCT00588861|13006891|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
5290686|NCT00588861|13006890|P2|NOT COMPLETED|6 Months||73
5290687|NCT00588861|13006891|P1|NOT COMPLETED|6 Months||98
5290688|NCT00588861|13006890|P2|COMPLETED|6 Months||41
5290689|NCT00588861|13006891|P1|COMPLETED|6 Months||9
5290690|NCT00588861|13006890|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
5290691|NCT00588861|13006891|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
5290692|NCT00588861|13006890|P2|NOT COMPLETED|Pre-Operative||86
5290693|NCT00588861|13006891|P1|NOT COMPLETED|Pre-Operative||95
5290694|NCT00588861|13006890|P2|COMPLETED|Pre-Operative||114
5290695|NCT00588861|13006891|P1|COMPLETED|Pre-Operative||107
5290696|NCT00588861|13006890|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
5290697|NCT00588861|13006891|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
5290698|NCT00588848|13006901|P2|NOT COMPLETED|Overall Study||3
5290699|NCT00588848|13006902|P1|NOT COMPLETED|Overall Study||0
5290700|NCT00588848|13006901|P2|COMPLETED|Overall Study||5
5290701|NCT00588848|13006902|P1|COMPLETED|Overall Study||3
5290702|NCT00588848|13006901|P2|STARTED|Overall Study||8
5290703|NCT00588848|13006902|P1|STARTED|Overall Study||3
5290704|NCT00588822|13006912|P1|NOT COMPLETED|Overall Study||8
5290705|NCT00588822|13006912|P1|COMPLETED|Overall Study||13
5290706|NCT00588822|13006912|P1|STARTED|Overall Study||21
5290707|NCT00588809|13006921|P1|NOT COMPLETED|Overall Study||0
5290708|NCT00588809|13006921|P1|COMPLETED|Overall Study||47
5290709|NCT00588809|13006921|P1|STARTED|Overall Study||47
5290710|NCT00588770|13006932|P2|NOT COMPLETED|Overall Study||200
5290711|NCT00588770|13006933|P1|NOT COMPLETED|Overall Study||159
5290712|NCT00588770|13006932|P2|COMPLETED|Overall Study||3
5290713|NCT00588770|13006933|P1|COMPLETED|Overall Study||41
5290714|NCT00588770|13006932|P2|Start Protocol Therapy|Overall Study||194
5290715|NCT00588770|13006933|P1|Start Protocol Therapy|Overall Study||200
5290716|NCT00588770|13006932|P2|Eligible|Overall Study||183
5290717|NCT00588770|13006933|P1|Eligible|Overall Study||188
5290718|NCT00588770|13006932|P2|STARTED|Overall Study||203
5290719|NCT00588770|13006933|P1|STARTED|Overall Study||200
5290720|NCT00588731|13006945|P2|NOT COMPLETED|Overall Study||2
5290721|NCT00588731|13006946|P1|NOT COMPLETED|Overall Study||3
5290722|NCT00588731|13006945|P2|COMPLETED|Overall Study||18
5290723|NCT00588731|13006946|P1|COMPLETED|Overall Study||18
5290724|NCT00588731|13006945|P2|STARTED|Overall Study||20
5290725|NCT00588731|13006946|P1|STARTED|Overall Study||21
5290726|NCT00588692|13006956|P2|NOT COMPLETED|Overall Study||3
5290727|NCT00588692|13006957|P1|NOT COMPLETED|Overall Study||7
5290728|NCT00588692|13006956|P2|COMPLETED|Overall Study||27
5290729|NCT00588692|13006957|P1|COMPLETED|Overall Study||23
5290730|NCT00588692|13006956|P2|STARTED|Overall Study||30
5290731|NCT00588692|13006957|P1|STARTED|Overall Study||30
5290732|NCT00588666|13006993|P1|NOT COMPLETED|Overall Study||4
5290733|NCT00588666|13006993|P1|COMPLETED|Overall Study||47
5290734|NCT00588666|13006993|P1|STARTED|Overall Study||51
5290735|NCT00588640|13006998|P1|NOT COMPLETED|Overall Study||2
5290736|NCT00588640|13006998|P1|COMPLETED|Overall Study||8
5290737|NCT00588640|13006998|P1|STARTED|Overall Study||10
5290738|NCT00588536|13007002|P1|NOT COMPLETED|Overall Study||0
5290739|NCT00588536|13007002|P1|COMPLETED|Overall Study||5
5290740|NCT00588536|13007002|P1|STARTED|Overall Study||5
5290741|NCT00588471|13007008|P2|NOT COMPLETED|Overall Study||0
5290742|NCT00588471|13007009|P1|NOT COMPLETED|Overall Study||0
5290743|NCT00588471|13007008|P2|COMPLETED|Overall Study||29
5290744|NCT00588471|13007009|P1|COMPLETED|Overall Study||28
5290745|NCT00588471|13007008|P2|STARTED|Overall Study||29
5290746|NCT00588471|13007009|P1|STARTED|Overall Study||28
5290747|NCT00588445|13007017|P1|NOT COMPLETED|Overall Study||15
5290748|NCT00588445|13007017|P1|COMPLETED|Overall Study||50
5290749|NCT00588445|13007017|P1|STARTED|Overall Study||65
5290750|NCT00588406|13007025|P2|NOT COMPLETED|Overall Study||0
5290751|NCT00588406|13007026|P1|NOT COMPLETED|Overall Study||0
5290752|NCT00588406|13007025|P2|COMPLETED|Overall Study||49
5290753|NCT00588406|13007026|P1|COMPLETED|Overall Study||46
5290754|NCT00588406|13007025|P2|STARTED|Overall Study||49
5290755|NCT00588406|13007026|P1|STARTED|Overall Study||46
5290756|NCT00588380|13007034|P1|NOT COMPLETED|Overall Study||0
5290757|NCT00588380|13007034|P1|COMPLETED|Overall Study||88
5290758|NCT00588380|13007034|P1|STARTED|Overall Study||88
5290759|NCT00588354|13007041|P2|NOT COMPLETED|Baseline to 4 Weeks||1
5290760|NCT00588354|13007042|P1|NOT COMPLETED|Baseline to 4 Weeks||0
5290761|NCT00588354|13007041|P2|COMPLETED|Baseline to 4 Weeks||14
5290762|NCT00588354|13007042|P1|COMPLETED|Baseline to 4 Weeks||9
5290763|NCT00588354|13007041|P2|STARTED|Baseline to 4 Weeks||15
5290764|NCT00588354|13007042|P1|STARTED|Baseline to 4 Weeks||9
5290765|NCT00588354|13007041|P2|NOT COMPLETED|Baseline to 2 Weeks||0
5290766|NCT00588354|13007042|P1|NOT COMPLETED|Baseline to 2 Weeks||2
5290767|NCT00588354|13007041|P2|COMPLETED|Baseline to 2 Weeks||15
5290768|NCT00588354|13007042|P1|COMPLETED|Baseline to 2 Weeks||9
5290769|NCT00588354|13007041|P2|STARTED|Baseline to 2 Weeks||15
5290770|NCT00588354|13007042|P1|STARTED|Baseline to 2 Weeks||11
5290771|NCT00588341|13007062|P1|NOT COMPLETED|Overall Study||5
5290772|NCT00588341|13007062|P1|COMPLETED|Overall Study||19
5290773|NCT00588341|13007062|P1|STARTED|Overall Study||24
5290774|NCT00588237|13007066|P1|NOT COMPLETED|Overall Study||4
5290775|NCT00588237|13007066|P1|COMPLETED|Overall Study||38
5290776|NCT00588237|13007066|P1|STARTED|Overall Study||42
5290777|NCT00588159|13007072|P2|NOT COMPLETED|Overall Study||11
5290778|NCT00588159|13007073|P1|NOT COMPLETED|Overall Study||15
5290779|NCT00588159|13007072|P2|COMPLETED|Overall Study||63
5290780|NCT00588159|13007073|P1|COMPLETED|Overall Study||57
5290781|NCT00588159|13007072|P2|STARTED|Overall Study||74
5290782|NCT00588159|13007073|P1|STARTED|Overall Study||72
5290783|NCT00588146|13007089|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
5290784|NCT00588146|13007090|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
5290785|NCT00588146|13007089|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
5290786|NCT00588146|13007090|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
5290787|NCT00588146|13007089|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
5290788|NCT00588146|13007090|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
5290789|NCT00588146|13007089|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
5290790|NCT00588146|13007090|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
5290791|NCT00588146|13007089|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
5290792|NCT00588146|13007090|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
5290793|NCT00588146|13007089|P2|STARTED|First Intervention (Baseline to 6 mo)||5
5290794|NCT00588146|13007090|P1|STARTED|First Intervention (Baseline to 6 mo)||5
5290795|NCT00588094|13007096|P1|NOT COMPLETED|Overall Study||5
5290796|NCT00588094|13007096|P1|COMPLETED|Overall Study||15
5290797|NCT00588094|13007096|P1|STARTED|Overall Study||20
5290798|NCT00587990|13007103|P3|NOT COMPLETED|Overall Study||1
5290799|NCT00587990|13007104|P2|NOT COMPLETED|Overall Study||0
5290800|NCT00587990|13007105|P1|NOT COMPLETED|Overall Study||0
5290801|NCT00587990|13007103|P3|COMPLETED|Overall Study||2
5290802|NCT00587990|13007104|P2|COMPLETED|Overall Study||4
5290803|NCT00587990|13007105|P1|COMPLETED|Overall Study||2
5290804|NCT00587990|13007103|P3|STARTED|Overall Study||3
5290805|NCT00587990|13007104|P2|STARTED|Overall Study||4
5290806|NCT00587990|13007105|P1|STARTED|Overall Study||2
5290807|NCT00587964|13007148|P1|NOT COMPLETED|Overall Study||12
5290808|NCT00587964|13007148|P1|COMPLETED|Overall Study||39
5290809|NCT00587964|13007148|P1|STARTED|Overall Study||51
5290810|NCT00587860|13007154|P2|NOT COMPLETED|Overall Study||5
5290811|NCT00587860|13007155|P1|NOT COMPLETED|Overall Study||5
5290812|NCT00587860|13007154|P2|COMPLETED|Overall Study||30
5290813|NCT00587860|13007155|P1|COMPLETED|Overall Study||30
5290814|NCT00587860|13007154|P2|STARTED|Overall Study||35
5290815|NCT00587860|13007155|P1|STARTED|Overall Study||35
5290816|NCT00587847|13007175|P1|NOT COMPLETED|Overall Study||7
5290817|NCT00587847|13007175|P1|COMPLETED|Overall Study||5
5290818|NCT00587847|13007175|P1|STARTED|Overall Study||12
5290819|NCT00587834|13007180|P1|NOT COMPLETED|Overall Study||0
5290820|NCT00587834|13007180|P1|COMPLETED|Overall Study||96
5290821|NCT00587834|13007180|P1|STARTED|Overall Study||96
5290822|NCT00587795|13007198|P2|NOT COMPLETED|Overall Study||0
5290823|NCT00587795|13007199|P1|NOT COMPLETED|Overall Study||1
5290824|NCT00587795|13007198|P2|COMPLETED|Overall Study||0
5290825|NCT00587795|13007199|P1|COMPLETED|Overall Study||0
5290826|NCT00587795|13007198|P2|STARTED|Overall Study||0
5290827|NCT00587795|13007199|P1|STARTED|Overall Study||1
5290828|NCT00587769|13007205|P1|NOT COMPLETED|Overall Study||0
5290829|NCT00587769|13007205|P1|COMPLETED|Overall Study||38
5290830|NCT00587769|13007205|P1|STARTED|Overall Study||38
5290831|NCT00587678|13007213|P3|NOT COMPLETED|Overall Study||8
5290832|NCT00587678|13007214|P2|NOT COMPLETED|Overall Study||4
5290833|NCT00587678|13007215|P1|NOT COMPLETED|Overall Study||6
5290834|NCT00587678|13007213|P3|COMPLETED|Overall Study||33
5290835|NCT00587678|13007214|P2|COMPLETED|Overall Study||18
5290836|NCT00587678|13007215|P1|COMPLETED|Overall Study||16
5290837|NCT00587678|13007213|P3|STARTED|Overall Study||41
5290838|NCT00587678|13007214|P2|STARTED|Overall Study||22
5290839|NCT00587678|13007215|P1|STARTED|Overall Study||22
5290840|NCT00587639|13007253|P1|NOT COMPLETED|Overall Study||1
5290841|NCT00587639|13007253|P1|COMPLETED|Overall Study||7
5290842|NCT00587639|13007253|P1|STARTED|Overall Study||8
5290843|NCT00587587|13007260|P2|NOT COMPLETED|Overall Study||1
5290844|NCT00587587|13007261|P1|NOT COMPLETED|Overall Study||6
5290845|NCT00587587|13007260|P2|COMPLETED|Overall Study||12
5290846|NCT00587587|13007261|P1|COMPLETED|Overall Study||11
5290847|NCT00587587|13007260|P2|STARTED|Overall Study||13
5290848|NCT00587587|13007261|P1|STARTED|Overall Study||17
5290849|NCT00587483|13007284|P3|NOT COMPLETED|Overall Study||0
5290850|NCT00587483|13007285|P2|NOT COMPLETED|Overall Study||0
5290851|NCT00587483|13007286|P1|NOT COMPLETED|Overall Study||0
5290852|NCT00587483|13007284|P3|COMPLETED|Overall Study||112
5290853|NCT00587483|13007285|P2|COMPLETED|Overall Study||115
5290854|NCT00587483|13007286|P1|COMPLETED|Overall Study||115
5290855|NCT00587483|13007284|P3|STARTED|Overall Study||112
5290856|NCT00587483|13007285|P2|STARTED|Overall Study||115
5290857|NCT00587483|13007286|P1|STARTED|Overall Study||115
5290858|NCT00587457|13007315|P3|NOT COMPLETED|Overall Study||5
5290859|NCT00587457|13007316|P2|NOT COMPLETED|Overall Study||3
5290860|NCT00587457|13007317|P1|NOT COMPLETED|Overall Study||3
5290861|NCT00587457|13007315|P3|COMPLETED|Overall Study||0
5290862|NCT00587457|13007316|P2|COMPLETED|Overall Study||0
5290863|NCT00587457|13007317|P1|COMPLETED|Overall Study||0
5290864|NCT00587457|13007315|P3|STARTED|Overall Study||5
5290865|NCT00587457|13007316|P2|STARTED|Overall Study||3
5290866|NCT00587457|13007317|P1|STARTED|Overall Study||3
5290867|NCT00587431|13007354|P2|NOT COMPLETED|Overall Study||1
5290868|NCT00587431|13007355|P1|NOT COMPLETED|Overall Study||1
5290869|NCT00587431|13007354|P2|COMPLETED|Overall Study||38
5290870|NCT00587431|13007355|P1|COMPLETED|Overall Study||62
5290871|NCT00587431|13007354|P2|STARTED|Overall Study||39
5290872|NCT00587431|13007355|P1|STARTED|Overall Study||63
5290873|NCT00587288|13007366|P2|NOT COMPLETED|Overall Study||9
5290874|NCT00587288|13007367|P1|NOT COMPLETED|Overall Study||3
5290875|NCT00587288|13007366|P2|COMPLETED|Overall Study||44
5290876|NCT00587288|13007367|P1|COMPLETED|Overall Study||50
5290877|NCT00587288|13007366|P2|STARTED|Overall Study||53
5290878|NCT00587288|13007367|P1|STARTED|Overall Study||53
5290879|NCT00587223|13007385|P1|NOT COMPLETED|Overall Study||1
5290880|NCT00587223|13007385|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
5290881|NCT00587223|13007385|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
5290882|NCT00587171|13007402|P2|NOT COMPLETED|Overall Study||1
5290883|NCT00587171|13007403|P1|NOT COMPLETED|Overall Study||1
5290884|NCT00587171|13007402|P2|COMPLETED|Overall Study||9
5290885|NCT00587171|13007403|P1|COMPLETED|Overall Study||8
5290886|NCT00587171|13007402|P2|STARTED|Overall Study||10
5290887|NCT00587171|13007403|P1|STARTED|Overall Study||9
5290888|NCT00587158|13007433|P2|NOT COMPLETED|Overall Study||8
5290889|NCT00587158|13007434|P1|NOT COMPLETED|Overall Study||5
5290890|NCT00587158|13007433|P2|COMPLETED|Overall Study||43
5290891|NCT00587158|13007434|P1|COMPLETED|Overall Study||44
5290892|NCT00587158|13007433|P2|Continued in Study|Overall Study||46
5290893|NCT00587158|13007434|P1|Continued in Study|Overall Study||45
5290894|NCT00587158|13007433|P2|STARTED|Overall Study||51
5290895|NCT00587158|13007434|P1|STARTED|Overall Study||49
5290896|NCT00587132|13007468|P4|NOT COMPLETED|Overall Study||0
5290897|NCT00587132|13007469|P3|NOT COMPLETED|Overall Study||0
5290898|NCT00587132|13007470|P2|NOT COMPLETED|Overall Study||0
5290899|NCT00587132|13007471|P1|NOT COMPLETED|Overall Study||0
5290900|NCT00587132|13007468|P4|COMPLETED|Overall Study||0
5290901|NCT00587132|13007469|P3|COMPLETED|Overall Study||0
5290902|NCT00587132|13007470|P2|COMPLETED|Overall Study||0
5290903|NCT00587132|13007471|P1|COMPLETED|Overall Study||4
5290904|NCT00587132|13007468|P4|STARTED|Overall Study||0
5290905|NCT00587132|13007469|P3|STARTED|Overall Study||0
5290906|NCT00587132|13007470|P2|STARTED|Overall Study||0
5290907|NCT00587132|13007471|P1|STARTED|Overall Study||4
5290908|NCT00587067|13007481|P1|NOT COMPLETED|Overall Study||0
5290909|NCT00587067|13007481|P1|COMPLETED|Overall Study||34
5290910|NCT00587067|13007481|P1|STARTED|Overall Study||34
5290911|NCT00587054|13007487|P1|NOT COMPLETED|Overall Study||9
5290912|NCT00587054|13007487|P1|COMPLETED|Overall Study||120
5290913|NCT00587054|13007487|P1|STARTED|Overall Study||129
5290914|NCT00587041|13007494|P3|NOT COMPLETED|Overall Study||0
5290915|NCT00587041|13007495|P2|NOT COMPLETED|Overall Study||0
5290916|NCT00587041|13007496|P1|NOT COMPLETED|Overall Study||0
5290917|NCT00587041|13007494|P3|COMPLETED|Overall Study||14
5290918|NCT00587041|13007495|P2|COMPLETED|Overall Study||14
5290919|NCT00587041|13007496|P1|COMPLETED|Overall Study||12
5290920|NCT00587041|13007494|P3|STARTED|Overall Study||14
5290921|NCT00587041|13007495|P2|STARTED|Overall Study||14
5290922|NCT00587041|13007496|P1|STARTED|Overall Study||12
5290923|NCT00586924|13007513|P6|NOT COMPLETED|Overall Study||33
5290924|NCT00586924|13007514|P5|NOT COMPLETED|Overall Study||4
5290925|NCT00586924|13007515|P4|NOT COMPLETED|Overall Study||3
5290926|NCT00586924|13007516|P3|NOT COMPLETED|Overall Study||3
5290927|NCT00586924|13007517|P2|NOT COMPLETED|Overall Study||3
5290928|NCT00586924|13007518|P1|NOT COMPLETED|Overall Study||3
5290929|NCT00586924|13007513|P6|COMPLETED|Overall Study||0
5290930|NCT00586924|13007514|P5|COMPLETED|Overall Study||0
5290931|NCT00586924|13007515|P4|COMPLETED|Overall Study||0
5290932|NCT00586924|13007516|P3|COMPLETED|Overall Study||0
5290933|NCT00586924|13007517|P2|COMPLETED|Overall Study||0
5290934|NCT00586924|13007518|P1|COMPLETED|Overall Study||0
5290935|NCT00586924|13007513|P6|STARTED|Overall Study||33
5290936|NCT00586924|13007514|P5|STARTED|Overall Study||4
5290937|NCT00586924|13007515|P4|STARTED|Overall Study||3
5290938|NCT00586924|13007516|P3|STARTED|Overall Study||3
5290939|NCT00586924|13007517|P2|STARTED|Overall Study||3
5290940|NCT00586924|13007518|P1|STARTED|Overall Study||3
5290941|NCT00586898|13007718|P1|NOT COMPLETED|Overall Study||7
5290942|NCT00586898|13007718|P1|COMPLETED|Overall Study||29
5290943|NCT00586898|13007718|P1|STARTED|Overall Study||36
5290944|NCT00586846|13007722|P1|NOT COMPLETED|Overall Study||6
5290945|NCT00586846|13007722|P1|COMPLETED|Overall Study||34
5290946|NCT00586846|13007722|P1|STARTED|Overall Study||40
5290947|NCT00586820|13007728|P2|NOT COMPLETED|Overall Study||0
5290948|NCT00586820|13007729|P1|NOT COMPLETED|Overall Study||1
5290949|NCT00586820|13007728|P2|COMPLETED|Overall Study||11
5290950|NCT00586820|13007729|P1|COMPLETED|Overall Study||11
5290951|NCT00586820|13007728|P2|STARTED|Overall Study||11
5290952|NCT00586820|13007729|P1|STARTED|Overall Study||12
5290953|NCT00586729|13007739|P2|NOT COMPLETED|Overall Study||1
5290954|NCT00586729|13007740|P1|NOT COMPLETED|Overall Study||3
5290955|NCT00586729|13007739|P2|COMPLETED|Overall Study||8
5290956|NCT00586729|13007740|P1|COMPLETED|Overall Study||11
5290957|NCT00586729|13007739|P2|STARTED|Overall Study||9
5290958|NCT00586729|13007740|P1|STARTED|Overall Study||14
5290959|NCT00586716|13007752|P2|NOT COMPLETED|Overall Study||0
5290960|NCT00586716|13007753|P1|NOT COMPLETED|Overall Study||0
5290961|NCT00586716|13007752|P2|COMPLETED|Overall Study||8
5290962|NCT00586716|13007753|P1|COMPLETED|Overall Study||14
5290963|NCT00586716|13007752|P2|STARTED|Overall Study||8
5290964|NCT00586716|13007753|P1|STARTED|Overall Study||14
5290965|NCT00586703|13007760|P1|NOT COMPLETED|Overall Study||12
5290966|NCT00586703|13007760|P1|COMPLETED|Overall Study||4
5290967|NCT00586703|13007760|P1|STARTED|Overall Study||16
5290968|NCT00586690|13007767|P2|NOT COMPLETED|Overall Study||0
5290969|NCT00586690|13007768|P1|NOT COMPLETED|Overall Study||16
5290970|NCT00586690|13007767|P2|COMPLETED|Overall Study||22
5290971|NCT00586690|13007768|P1|COMPLETED|Overall Study||5
5290972|NCT00586690|13007767|P2|STARTED|Overall Study||22
5290973|NCT00586690|13007768|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
5290974|NCT00586664|13007778|P3|NOT COMPLETED|Overall Study||1
5290975|NCT00586664|13007779|P2|NOT COMPLETED|Overall Study||7
5290976|NCT00586664|13007780|P1|NOT COMPLETED|Overall Study||5
5290977|NCT00586664|13007778|P3|COMPLETED|Overall Study||43
5290978|NCT00586664|13007779|P2|COMPLETED|Overall Study||36
5290979|NCT00586664|13007780|P1|COMPLETED|Overall Study||38
5290980|NCT00586664|13007778|P3|STARTED|Overall Study||44
5290981|NCT00586664|13007779|P2|STARTED|Overall Study||43
5290982|NCT00586664|13007780|P1|STARTED|Overall Study||43
5290983|NCT00586625|13007826|P2|NOT COMPLETED|Overall Study||17
5290984|NCT00586625|13007827|P1|NOT COMPLETED|Overall Study||43
5290985|NCT00586625|13007826|P2|COMPLETED|Overall Study||269
5290986|NCT00586625|13007827|P1|COMPLETED|Overall Study||532
5290987|NCT00586625|13007826|P2|STARTED|Overall Study||286
5290988|NCT00586625|13007827|P1|STARTED|Overall Study||575
5290989|NCT00586612|13007835|P2|NOT COMPLETED|Booster Phase||1
5290990|NCT00586612|13007836|P1|NOT COMPLETED|Booster Phase||3
5290991|NCT00586612|13007835|P2|COMPLETED|Booster Phase||143
5290992|NCT00586612|13007836|P1|COMPLETED|Booster Phase||151
5290993|NCT00586612|13007835|P2|STARTED|Booster Phase||144
5290994|NCT00586612|13007836|P1|STARTED|Booster Phase||154
5290995|NCT00586612|13007835|P2|NOT COMPLETED|Primary Phase||3
5290996|NCT00586612|13007836|P1|NOT COMPLETED|Primary Phase||1
5290997|NCT00586612|13007835|P2|COMPLETED|Primary Phase||147
5290998|NCT00586612|13007836|P1|COMPLETED|Primary Phase||162
5290999|NCT00586612|13007835|P2|STARTED|Primary Phase||150
5291000|NCT00586612|13007836|P1|STARTED|Primary Phase||163
5291001|NCT00586573|13007902|P1|NOT COMPLETED|Overall Study||6
5291002|NCT00586573|13007902|P1|COMPLETED|Overall Study||28
5291003|NCT00586573|13007902|P1|STARTED|Overall Study||34
5291004|NCT00586521|13007906|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
5291005|NCT00586521|13007906|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
5291006|NCT00586521|13007906|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
5291007|NCT00586521|13007906|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
5291008|NCT00586521|13007906|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
5291009|NCT00586521|13007906|P1|STARTED|On Demand Treatment (Months 1-6)||20
5291010|NCT00586495|13007913|P1|NOT COMPLETED|Follow-up||92
5291011|NCT00586495|13007913|P1|COMPLETED|Follow-up||0
5291012|NCT00586495|13007913|P1|STARTED|Follow-up||92
5291013|NCT00586495|13007913|P1|NOT COMPLETED|Treatment Period||95
5291014|NCT00586495|13007913|P1|COMPLETED|Treatment Period||0
5291015|NCT00586495|13007913|P1|STARTED|Treatment Period||95
5291016|NCT00586482|13007925|P2|NOT COMPLETED|Overall Study||0
5291017|NCT00586482|13007926|P1|NOT COMPLETED|Overall Study||0
5291018|NCT00586482|13007925|P2|COMPLETED|Overall Study||24
5291019|NCT00586482|13007926|P1|COMPLETED|Overall Study||22
5291020|NCT00586482|13007925|P2|STARTED|Overall Study||24
5291021|NCT00586482|13007926|P1|STARTED|Overall Study||22
5291022|NCT00586469|13007942|P2|NOT COMPLETED|Overall Study||1
5291023|NCT00586469|13007943|P1|NOT COMPLETED|Overall Study||0
5291024|NCT00586469|13007942|P2|COMPLETED|Overall Study||499
5291025|NCT00586469|13007943|P1|COMPLETED|Overall Study||500
5291026|NCT00586469|13007942|P2|STARTED|Overall Study||500
5291027|NCT00586469|13007943|P1|STARTED|Overall Study||500
5291028|NCT00586339|13007970|P3|NOT COMPLETED|Overall Study||6
5291029|NCT00586339|13007971|P2|NOT COMPLETED|Overall Study||7
5291030|NCT00586339|13007972|P1|NOT COMPLETED|Overall Study||7
5291031|NCT00586339|13007970|P3|COMPLETED|Overall Study||24
5291032|NCT00586339|13007971|P2|COMPLETED|Overall Study||52
5291033|NCT00586339|13007972|P1|COMPLETED|Overall Study||54
5291034|NCT00586339|13007970|P3|STARTED|Overall Study||30
5291035|NCT00586339|13007971|P2|STARTED|Overall Study||59
5291036|NCT00586339|13007972|P1|STARTED|Overall Study||61
5291037|NCT00586326|13008073|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
5291038|NCT00586326|13008073|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
5291039|NCT00586326|13008073|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
5291040|NCT00586326|13008073|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
5291041|NCT00586326|13008073|P1|COMPLETED|Device Placed toTreatment-ITT||100
5291042|NCT00586326|13008073|P1|STARTED|Device Placed toTreatment-ITT||118
5291043|NCT00586326|13008073|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
5291044|NCT00586326|13008073|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
5291045|NCT00586326|13008073|P1|STARTED|Enrollment to Device Placement-Enrolled||133
5291046|NCT00586313|13008084|P1|NOT COMPLETED|Overall Study||2
5291047|NCT00586313|13008084|P1|COMPLETED|Overall Study||19
5291048|NCT00586313|13008084|P1|STARTED|Overall Study||21
5291049|NCT00586261|13008091|P2|NOT COMPLETED|Overall Study||0
5291050|NCT00586261|13008092|P1|NOT COMPLETED|Overall Study||0
5291051|NCT00586261|13008091|P2|COMPLETED|Overall Study||19
5291052|NCT00586261|13008092|P1|COMPLETED|Overall Study||17
5291053|NCT00586261|13008091|P2|STARTED|Overall Study||19
5291054|NCT00586261|13008092|P1|STARTED|Overall Study||17
5291055|NCT00586196|13008100|P2|NOT COMPLETED|Overall Study||0
5291056|NCT00586196|13008101|P1|NOT COMPLETED|Overall Study||0
5291057|NCT00586196|13008100|P2|COMPLETED|Overall Study||9
5291058|NCT00586196|13008101|P1|COMPLETED|Overall Study||7
5291059|NCT00586196|13008100|P2|STARTED|Overall Study||9
5291060|NCT00586196|13008101|P1|STARTED|Overall Study||7
5291061|NCT00586170|13008111|P2|NOT COMPLETED|Overall Study||0
5291062|NCT00586170|13008112|P1|NOT COMPLETED|Overall Study||0
5291063|NCT00586170|13008111|P2|COMPLETED|Overall Study||3
5291064|NCT00586170|13008112|P1|COMPLETED|Overall Study||5
5291065|NCT00586170|13008111|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
5291066|NCT00586170|13008112|P1|STARTED|Overall Study||5
5291067|NCT00586157|13008120|P2|NOT COMPLETED|Second Intervention||1
5291068|NCT00586157|13008121|P1|NOT COMPLETED|Second Intervention||2
5291069|NCT00586157|13008120|P2|COMPLETED|Second Intervention||14
5291070|NCT00586157|13008121|P1|COMPLETED|Second Intervention||12
5291071|NCT00586157|13008120|P2|STARTED|Second Intervention||15
5291072|NCT00586157|13008121|P1|STARTED|Second Intervention||14
5291073|NCT00586157|13008120|P2|NOT COMPLETED|First Intervention||0
5291074|NCT00586157|13008121|P1|NOT COMPLETED|First Intervention||1
5291075|NCT00586157|13008120|P2|COMPLETED|First Intervention||15
5291076|NCT00586157|13008121|P1|COMPLETED|First Intervention||14
5291077|NCT00586157|13008120|P2|STARTED|First Intervention||15
5291078|NCT00586157|13008121|P1|STARTED|First Intervention||15
5291079|NCT00586105|13008131|P1|NOT COMPLETED|Overall Study||39
5291080|NCT00586105|13008131|P1|COMPLETED|Overall Study||0
5291081|NCT00586105|13008131|P1|STARTED|Overall Study||39
5291082|NCT00586066|13008146|P2|NOT COMPLETED|Overall Study||10
5291083|NCT00586066|13008147|P1|NOT COMPLETED|Overall Study||18
5291084|NCT00586066|13008146|P2|COMPLETED|Overall Study||14
5291085|NCT00586066|13008147|P1|COMPLETED|Overall Study||30
5291086|NCT00586066|13008146|P2|STARTED|Overall Study||24
5291087|NCT00586066|13008147|P1|STARTED|Overall Study||48
5291088|NCT00586001|13008159|P2|NOT COMPLETED|Overall Study||1
5291089|NCT00586001|13008160|P1|NOT COMPLETED|Overall Study||4
5291090|NCT00586001|13008159|P2|COMPLETED|Overall Study||10
5291091|NCT00586001|13008160|P1|COMPLETED|Overall Study||22
5291092|NCT00586001|13008159|P2|STARTED|Overall Study||11
5291093|NCT00586001|13008160|P1|STARTED|Overall Study||26
5291094|NCT00585975|13008204|P2|NOT COMPLETED|Overall Study||13
5291095|NCT00585975|13008205|P1|NOT COMPLETED|Overall Study||15
5291096|NCT00585975|13008204|P2|COMPLETED|Overall Study||278
5291097|NCT00585975|13008205|P1|COMPLETED|Overall Study||262
5291098|NCT00585975|13008204|P2|STARTED|Overall Study||291
5291099|NCT00585975|13008205|P1|STARTED|Overall Study||277
5291100|NCT00585923|13008215|P2|NOT COMPLETED|Overall Study||33
5291101|NCT00585923|13008216|P1|NOT COMPLETED|Overall Study||31
5291102|NCT00585923|13008215|P2|COMPLETED|Overall Study||26
5291103|NCT00585923|13008216|P1|COMPLETED|Overall Study||25
5291104|NCT00585923|13008215|P2|STARTED|Overall Study||59
5291105|NCT00585923|13008216|P1|STARTED|Overall Study||56
5291106|NCT00585910|13008230|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
5291107|NCT00585910|13008230|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
5291108|NCT00585910|13008230|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
5291109|NCT00585910|13008230|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
5291110|NCT00585910|13008230|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
5291111|NCT00585910|13008230|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
5291112|NCT00585780|13008240|P4|NOT COMPLETED|Overall Study||8
5291113|NCT00585780|13008241|P3|NOT COMPLETED|Overall Study||13
5291114|NCT00585780|13008242|P2|NOT COMPLETED|Overall Study||9
5291115|NCT00585780|13008243|P1|NOT COMPLETED|Overall Study||8
5291116|NCT00585780|13008240|P4|COMPLETED|Overall Study||14
5291117|NCT00585780|13008241|P3|COMPLETED|Overall Study||21
5291118|NCT00585780|13008242|P2|COMPLETED|Overall Study||14
5291119|NCT00585780|13008243|P1|COMPLETED|Overall Study||13
5291120|NCT00585780|13008240|P4|STARTED|Overall Study||22
5291121|NCT00585780|13008241|P3|STARTED|Overall Study||34
5291122|NCT00585780|13008242|P2|STARTED|Overall Study||23
5291123|NCT00585780|13008243|P1|STARTED|Overall Study||21
5291124|NCT00585715|13008259|P2|NOT COMPLETED|Overall Study||0
5291125|NCT00585715|13008260|P1|NOT COMPLETED|Overall Study||3
5291126|NCT00585715|13008259|P2|COMPLETED|Overall Study||11
5291127|NCT00585715|13008260|P1|COMPLETED|Overall Study||8
5291128|NCT00585715|13008259|P2|STARTED|Overall Study||11
5291129|NCT00585715|13008260|P1|STARTED|Overall Study||11
5291130|NCT00585689|13008268|P1|NOT COMPLETED|Overall Study||7
5291131|NCT00585689|13008268|P1|COMPLETED|Overall Study||22
5291132|NCT00585689|13008268|P1|STARTED|Overall Study||29
5291133|NCT00585650|13008274|P2|NOT COMPLETED|Overall Study||0
5291134|NCT00585650|13008275|P1|NOT COMPLETED|Overall Study||0
5291135|NCT00585650|13008274|P2|COMPLETED|Overall Study||12
5291136|NCT00585650|13008275|P1|COMPLETED|Overall Study||8
5291137|NCT00585650|13008274|P2|STARTED|Overall Study||12
5291138|NCT00585650|13008275|P1|STARTED|Overall Study||8
5291139|NCT00585637|13008285|P4|NOT COMPLETED|6-month Time Point||6
5291140|NCT00585637|13008286|P3|NOT COMPLETED|6-month Time Point||11
5291141|NCT00585637|13008287|P2|NOT COMPLETED|6-month Time Point||13
5291142|NCT00585637|13008288|P1|NOT COMPLETED|6-month Time Point||6
5291143|NCT00585637|13008285|P4|COMPLETED|6-month Time Point||77
5291144|NCT00585637|13008286|P3|COMPLETED|6-month Time Point||72
5291145|NCT00585637|13008287|P2|COMPLETED|6-month Time Point||68
5291146|NCT00585637|13008288|P1|COMPLETED|6-month Time Point||75
5291147|NCT00585637|13008285|P4|STARTED|6-month Time Point||83
5291148|NCT00585637|13008286|P3|STARTED|6-month Time Point||83
5291149|NCT00585637|13008287|P2|STARTED|6-month Time Point||81
5291150|NCT00585637|13008288|P1|STARTED|6-month Time Point||81
5291151|NCT00585637|13008285|P4|NOT COMPLETED|3-month Time Point||5
5291152|NCT00585637|13008286|P3|NOT COMPLETED|3-month Time Point||7
5291153|NCT00585637|13008287|P2|NOT COMPLETED|3-month Time Point||14
5291154|NCT00585637|13008288|P1|NOT COMPLETED|3-month Time Point||10
5291155|NCT00585637|13008285|P4|COMPLETED|3-month Time Point||78
5291156|NCT00585637|13008286|P3|COMPLETED|3-month Time Point||76
5291157|NCT00585637|13008287|P2|COMPLETED|3-month Time Point||67
5291158|NCT00585637|13008288|P1|COMPLETED|3-month Time Point||71
5291159|NCT00585637|13008285|P4|STARTED|3-month Time Point||83
5291160|NCT00585637|13008286|P3|STARTED|3-month Time Point||83
5291161|NCT00585637|13008287|P2|STARTED|3-month Time Point||81
5291162|NCT00585637|13008288|P1|STARTED|3-month Time Point||81
5291163|NCT00585637|13008285|P4|NOT COMPLETED|Baseline||0
5291164|NCT00585637|13008286|P3|NOT COMPLETED|Baseline||0
5291165|NCT00585637|13008287|P2|NOT COMPLETED|Baseline||0
5291166|NCT00585637|13008288|P1|NOT COMPLETED|Baseline||0
5291167|NCT00585637|13008285|P4|COMPLETED|Baseline||83
5291168|NCT00585637|13008286|P3|COMPLETED|Baseline||83
5291169|NCT00585637|13008287|P2|COMPLETED|Baseline||81
5291170|NCT00585637|13008288|P1|COMPLETED|Baseline||81
5291171|NCT00585637|13008285|P4|STARTED|Baseline||83
5291172|NCT00585637|13008286|P3|STARTED|Baseline||83
5291173|NCT00585637|13008287|P2|STARTED|Baseline||81
5291174|NCT00585637|13008288|P1|STARTED|Baseline||81
5291175|NCT00585611|13008316|P2|NOT COMPLETED|Overall Study||0
5291176|NCT00585611|13008317|P1|NOT COMPLETED|Overall Study||0
5291177|NCT00585611|13008316|P2|COMPLETED|Overall Study||0
5291178|NCT00585611|13008317|P1|COMPLETED|Overall Study||0
5291179|NCT00585611|13008316|P2|STARTED|Overall Study||0
5291180|NCT00585611|13008317|P1|STARTED|Overall Study||0
5291181|NCT00585585|13008327|P1|NOT COMPLETED|Overall Study||1
5291182|NCT00585585|13008327|P1|COMPLETED|Overall Study||0
5291183|NCT00585585|13008327|P1|Patients Receiving Drug|Overall Study||1
5291184|NCT00585585|13008327|P1|STARTED|Overall Study||1
5291185|NCT00585546|13008331|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
5291186|NCT00585546|13008331|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
5291187|NCT00585546|13008331|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
5291188|NCT00585546|13008331|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
5291189|NCT00585546|13008331|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
5291190|NCT00585546|13008331|P1|STARTED|LVAD Implantation Required for 4 Months||18
5291191|NCT00585533|13008345|P1|NOT COMPLETED|Overall Study||9
5291192|NCT00585533|13008345|P1|COMPLETED|Overall Study||31
5291193|NCT00585533|13008345|P1|STARTED|Overall Study||40
5291194|NCT00585494|13008350|P1|NOT COMPLETED|Overall Study||56
5291195|NCT00585494|13008350|P1|COMPLETED|Overall Study||244
5291196|NCT00585494|13008350|P1|STARTED|Overall Study||300
5291197|NCT00585468|13008354|P2|NOT COMPLETED|Second Intervention||0
5291198|NCT00585468|13008355|P1|NOT COMPLETED|Second Intervention||0
5291199|NCT00585468|13008354|P2|COMPLETED|Second Intervention||10
5291200|NCT00585468|13008355|P1|COMPLETED|Second Intervention||9
5291201|NCT00585468|13008354|P2|STARTED|Second Intervention||10
5291202|NCT00585468|13008355|P1|STARTED|Second Intervention||9
5291203|NCT00585468|13008354|P2|NOT COMPLETED|First Intervention||1
5291204|NCT00585468|13008355|P1|NOT COMPLETED|First Intervention||1
5291205|NCT00585468|13008354|P2|COMPLETED|First Intervention||10
5291206|NCT00585468|13008355|P1|COMPLETED|First Intervention||9
5291207|NCT00585468|13008354|P2|STARTED|First Intervention||11
5291208|NCT00585468|13008355|P1|STARTED|First Intervention||10
5291209|NCT00585377|13008375|P1|NOT COMPLETED|Overall Study||0
5291210|NCT00585377|13008375|P1|COMPLETED|Overall Study||50
5291211|NCT00585377|13008375|P1|STARTED|Overall Study||50
5291212|NCT00585351|13008387|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
5291213|NCT00585351|13008388|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
5291214|NCT00585351|13008389|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
5291215|NCT00585351|13008390|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
5291216|NCT00585351|13008391|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
5291217|NCT00585351|13008392|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
5291218|NCT00585351|13008393|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
5291219|NCT00585351|13008394|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
5291220|NCT00585351|13008387|P8|COMPLETED|Enrollment Period (Intervention)||2
5291221|NCT00585351|13008388|P7|COMPLETED|Enrollment Period (Intervention)||5
5291222|NCT00585351|13008389|P6|COMPLETED|Enrollment Period (Intervention)||5
5291223|NCT00585351|13008390|P5|COMPLETED|Enrollment Period (Intervention)||3
5291224|NCT00585351|13008391|P4|COMPLETED|Enrollment Period (Intervention)||15
5291225|NCT00585351|13008392|P3|COMPLETED|Enrollment Period (Intervention)||15
5291226|NCT00585351|13008393|P2|COMPLETED|Enrollment Period (Intervention)||0
5291227|NCT00585351|13008394|P1|COMPLETED|Enrollment Period (Intervention)||0
5291228|NCT00585351|13008387|P8|STARTED|Enrollment Period (Intervention)||3
5291229|NCT00585351|13008388|P7|STARTED|Enrollment Period (Intervention)||7
5291230|NCT00585351|13008389|P6|STARTED|Enrollment Period (Intervention)||7
5291231|NCT00585351|13008390|P5|STARTED|Enrollment Period (Intervention)||5
5291232|NCT00585351|13008391|P4|STARTED|Enrollment Period (Intervention)||15
5291233|NCT00585351|13008392|P3|STARTED|Enrollment Period (Intervention)||15
5291234|NCT00585351|13008393|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
5291235|NCT00585351|13008394|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
5291236|NCT00585351|13008387|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
5291237|NCT00585351|13008388|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
5291238|NCT00585351|13008389|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
5291239|NCT00585351|13008390|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
5291240|NCT00585351|13008391|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
5291241|NCT00585351|13008392|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
5291242|NCT00585351|13008393|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
5291243|NCT00585351|13008394|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
5291244|NCT00585351|13008387|P8|COMPLETED|Notification Period (Informed Consent)||0
5291245|NCT00585351|13008388|P7|COMPLETED|Notification Period (Informed Consent)||0
5291246|NCT00585351|13008389|P6|COMPLETED|Notification Period (Informed Consent)||0
5291247|NCT00585351|13008390|P5|COMPLETED|Notification Period (Informed Consent)||0
5291248|NCT00585351|13008391|P4|COMPLETED|Notification Period (Informed Consent)||0
5291249|NCT00585351|13008392|P3|COMPLETED|Notification Period (Informed Consent)||0
5291250|NCT00585351|13008393|P2|COMPLETED|Notification Period (Informed Consent)||25
5291251|NCT00585351|13008394|P1|COMPLETED|Notification Period (Informed Consent)||27
5291252|NCT00585351|13008387|P8|STARTED|Notification Period (Informed Consent)||0
5291253|NCT00585351|13008388|P7|STARTED|Notification Period (Informed Consent)||0
5291254|NCT00585351|13008389|P6|STARTED|Notification Period (Informed Consent)||0
5291255|NCT00585351|13008390|P5|STARTED|Notification Period (Informed Consent)||0
5291256|NCT00585351|13008391|P4|STARTED|Notification Period (Informed Consent)||0
5291257|NCT00585351|13008392|P3|STARTED|Notification Period (Informed Consent)||0
5291258|NCT00585351|13008393|P2|STARTED|Notification Period (Informed Consent)||50
5291259|NCT00585351|13008394|P1|STARTED|Notification Period (Informed Consent)||50
5291260|NCT00585325|13008410|P2|NOT COMPLETED|Overall Study||1
5291261|NCT00585325|13008411|P1|NOT COMPLETED|Overall Study||1
5291262|NCT00585325|13008410|P2|COMPLETED|Overall Study||12
5291263|NCT00585325|13008411|P1|COMPLETED|Overall Study||9
5291264|NCT00585325|13008410|P2|STARTED|Overall Study||13
5291265|NCT00585325|13008411|P1|STARTED|Overall Study||10
5291266|NCT00585312|13008419|P2|NOT COMPLETED|Overall Study||44
5291267|NCT00585312|13008420|P1|NOT COMPLETED|Overall Study||51
5291268|NCT00585312|13008419|P2|COMPLETED|Overall Study||7
5291269|NCT00585312|13008420|P1|COMPLETED|Overall Study||4
5291270|NCT00585312|13008419|P2|Treated|Overall Study||48
5291271|NCT00585312|13008420|P1|Treated|Overall Study||53
5291272|NCT00585312|13008419|P2|STARTED|Overall Study|STARTED=Randomized|51
5291273|NCT00585312|13008420|P1|STARTED|Overall Study|STARTED=Randomized|55
5291274|NCT00585286|13008432|P1|NOT COMPLETED|Overall Study||1
5291275|NCT00585286|13008432|P1|COMPLETED|Overall Study||14
5291276|NCT00585286|13008432|P1|STARTED|Overall Study||15
5291277|NCT00585247|13008441|P2|NOT COMPLETED|Overall Study||0
5291278|NCT00585247|13008442|P1|NOT COMPLETED|Overall Study||0
5291279|NCT00585247|13008441|P2|COMPLETED|Overall Study||13
5291280|NCT00585247|13008442|P1|COMPLETED|Overall Study||14
5291281|NCT00585247|13008441|P2|STARTED|Overall Study||13
5291282|NCT00585247|13008442|P1|STARTED|Overall Study||14
5291283|NCT00585221|13008448|P1|NOT COMPLETED|Overall Study||8
5291284|NCT00585221|13008448|P1|COMPLETED|Overall Study||0
5291285|NCT00585221|13008448|P1|STARTED|Overall Study||8
5291286|NCT00585182|13008453|P1|NOT COMPLETED|Overall Study||0
5291287|NCT00585182|13008453|P1|COMPLETED|Overall Study||28
5291288|NCT00585182|13008453|P1|STARTED|Overall Study||28
5291289|NCT00585169|13008458|P1|NOT COMPLETED|Overall Study||1
5291290|NCT00585169|13008458|P1|COMPLETED|Overall Study||28
5291291|NCT00585169|13008458|P1|STARTED|Overall Study||29
5291292|NCT00585104|13008464|P1|NOT COMPLETED|Overall Study||4
5291293|NCT00585104|13008464|P1|COMPLETED|Overall Study||6
5291294|NCT00585104|13008464|P1|STARTED|Overall Study||10
5291295|NCT00585078|13008468|P1|NOT COMPLETED|Overall Study||40
5291296|NCT00585078|13008468|P1|COMPLETED|Overall Study||0
5291297|NCT00585078|13008468|P1|Response Evaluable|Overall Study||24
5291298|NCT00585078|13008468|P1|Toxicity Evaluable|Overall Study||36
5291299|NCT00585078|13008468|P1|Treated|Overall Study||37
5291300|NCT00585078|13008468|P1|STARTED|Overall Study||40
5291301|NCT00585052|13008475|P1|NOT COMPLETED|Overall Study||1
5291302|NCT00585052|13008475|P1|COMPLETED|Overall Study||10
5291303|NCT00585052|13008475|P1|STARTED|Overall Study||11
5291304|NCT00585039|13008482|P2|NOT COMPLETED|Overall Study||0
5291305|NCT00585039|13008483|P1|NOT COMPLETED|Overall Study||2
5291306|NCT00585039|13008482|P2|COMPLETED|Overall Study||44
5291307|NCT00585039|13008483|P1|COMPLETED|Overall Study||55
5291308|NCT00585039|13008482|P2|STARTED|Overall Study||44
5291309|NCT00585039|13008483|P1|STARTED|Overall Study||57
5291310|NCT00585013|13008493|P2|NOT COMPLETED|Overall Study||0
5291311|NCT00585013|13008494|P1|NOT COMPLETED|Overall Study||0
5291312|NCT00585013|13008493|P2|COMPLETED|Overall Study||8
5291313|NCT00585013|13008494|P1|COMPLETED|Overall Study||8
5291314|NCT00585013|13008493|P2|STARTED|Overall Study||8
5291315|NCT00585013|13008494|P1|STARTED|Overall Study||8
5291316|NCT00584987|13008512|P4|NOT COMPLETED|Overall Study||1
5291317|NCT00584987|13008513|P3|NOT COMPLETED|Overall Study||1
5291318|NCT00584987|13008514|P2|NOT COMPLETED|Overall Study||1
5291319|NCT00584987|13008515|P1|NOT COMPLETED|Overall Study||1
5291320|NCT00584987|13008512|P4|COMPLETED|Overall Study||15
5291321|NCT00584987|13008513|P3|COMPLETED|Overall Study||16
5291322|NCT00584987|13008514|P2|COMPLETED|Overall Study||15
5291323|NCT00584987|13008515|P1|COMPLETED|Overall Study||14
5291324|NCT00584987|13008512|P4|STARTED|Overall Study||16
5291325|NCT00584987|13008513|P3|STARTED|Overall Study||17
5291326|NCT00584987|13008514|P2|STARTED|Overall Study||16
5291327|NCT00584987|13008515|P1|STARTED|Overall Study||15
5291328|NCT00584948|13008547|P2|NOT COMPLETED|Overall Study||11
5291329|NCT00584948|13008548|P1|NOT COMPLETED|Overall Study||13
5291330|NCT00584948|13008547|P2|COMPLETED|Overall Study||36
5291331|NCT00584948|13008548|P1|COMPLETED|Overall Study||34
5291332|NCT00584948|13008547|P2|STARTED|Overall Study||47
5291333|NCT00584948|13008548|P1|STARTED|Overall Study||47
5291334|NCT00584935|13008556|P1|NOT COMPLETED|Overall Study||0
5291335|NCT00584935|13008556|P1|COMPLETED|Overall Study||3
5291336|NCT00584935|13008556|P1|STARTED|Overall Study||3
5291337|NCT00584922|13008563|P1|NOT COMPLETED|Overall Study||0
5291338|NCT00584922|13008563|P1|COMPLETED|Overall Study||175
5291339|NCT00584922|13008563|P1|STARTED|Overall Study||175
5291340|NCT00584909|13008567|P1|NOT COMPLETED|Overall Study||4
5291341|NCT00584909|13008567|P1|COMPLETED|Overall Study||9
5291342|NCT00584909|13008567|P1|STARTED|Overall Study||13
5291343|NCT00584857|13008572|P1|NOT COMPLETED|Overall Study||0
5291344|NCT00584857|13008572|P1|COMPLETED|Overall Study||30
5291345|NCT00584857|13008572|P1|STARTED|Overall Study||30
5291346|NCT00584844|13008577|P1|NOT COMPLETED|Overall Study||79
5291347|NCT00584844|13008577|P1|COMPLETED|Overall Study||405
5291348|NCT00584844|13008577|P1|STARTED|Overall Study||484
5291349|NCT00584831|13008587|P19|NOT COMPLETED|Intervention 4||0
5291350|NCT00584831|13008588|P18|NOT COMPLETED|Intervention 4||0
5291351|NCT00584831|13008589|P17|NOT COMPLETED|Intervention 4||0
5291352|NCT00584831|13008590|P16|NOT COMPLETED|Intervention 4||0
5291353|NCT00584831|13008591|P15|NOT COMPLETED|Intervention 4||0
5291354|NCT00584831|13008592|P14|NOT COMPLETED|Intervention 4||0
5291355|NCT00584831|13008593|P13|NOT COMPLETED|Intervention 4||0
5291356|NCT00584831|13008594|P12|NOT COMPLETED|Intervention 4||0
5291357|NCT00584831|13008595|P11|NOT COMPLETED|Intervention 4||0
5291358|NCT00584831|13008596|P10|NOT COMPLETED|Intervention 4||0
5291359|NCT00584831|13008597|P9|NOT COMPLETED|Intervention 4||0
5291360|NCT00584831|13008598|P8|NOT COMPLETED|Intervention 4||0
5291361|NCT00584831|13008599|P7|NOT COMPLETED|Intervention 4||0
5291362|NCT00584831|13008600|P6|NOT COMPLETED|Intervention 4||0
5291363|NCT00584831|13008601|P5|NOT COMPLETED|Intervention 4||0
5291364|NCT00584831|13008602|P4|NOT COMPLETED|Intervention 4||0
5291365|NCT00584831|13008603|P3|NOT COMPLETED|Intervention 4||0
5291366|NCT00584831|13008604|P2|NOT COMPLETED|Intervention 4||0
5291367|NCT00584831|13008605|P1|NOT COMPLETED|Intervention 4||0
5291368|NCT00584831|13008587|P19|COMPLETED|Intervention 4||1
5291369|NCT00584831|13008588|P18|COMPLETED|Intervention 4||1
5291370|NCT00584831|13008589|P17|COMPLETED|Intervention 4||4
5291371|NCT00584831|13008590|P16|COMPLETED|Intervention 4||1
5291372|NCT00584831|13008591|P15|COMPLETED|Intervention 4||2
5291373|NCT00584831|13008592|P14|COMPLETED|Intervention 4||1
5291374|NCT00584831|13008593|P13|COMPLETED|Intervention 4||2
5291375|NCT00584831|13008594|P12|COMPLETED|Intervention 4||1
5291376|NCT00584831|13008595|P11|COMPLETED|Intervention 4||2
5291377|NCT00584831|13008596|P10|COMPLETED|Intervention 4||2
5291378|NCT00584831|13008597|P9|COMPLETED|Intervention 4||3
5291379|NCT00584831|13008598|P8|COMPLETED|Intervention 4||2
5291380|NCT00584831|13008599|P7|COMPLETED|Intervention 4||6
5291381|NCT00584831|13008600|P6|COMPLETED|Intervention 4||1
5291382|NCT00584831|13008601|P5|COMPLETED|Intervention 4||2
5291383|NCT00584831|13008602|P4|COMPLETED|Intervention 4||1
5291384|NCT00584831|13008603|P3|COMPLETED|Intervention 4||2
5291385|NCT00584831|13008604|P2|COMPLETED|Intervention 4||3
5291386|NCT00584831|13008605|P1|COMPLETED|Intervention 4||1
5291387|NCT00584831|13008587|P19|STARTED|Intervention 4||1
5291388|NCT00584831|13008588|P18|STARTED|Intervention 4||1
5291389|NCT00584831|13008589|P17|STARTED|Intervention 4||4
5291390|NCT00584831|13008590|P16|STARTED|Intervention 4||1
5291391|NCT00584831|13008591|P15|STARTED|Intervention 4||2
5291392|NCT00584831|13008592|P14|STARTED|Intervention 4||1
5291393|NCT00584831|13008593|P13|STARTED|Intervention 4||2
5291394|NCT00584831|13008594|P12|STARTED|Intervention 4||1
5291395|NCT00584831|13008595|P11|STARTED|Intervention 4||2
5291396|NCT00584831|13008596|P10|STARTED|Intervention 4||2
5291397|NCT00584831|13008597|P9|STARTED|Intervention 4||3
5291398|NCT00584831|13008598|P8|STARTED|Intervention 4||2
5291399|NCT00584831|13008599|P7|STARTED|Intervention 4||6
5291400|NCT00584831|13008600|P6|STARTED|Intervention 4||1
5291401|NCT00584831|13008601|P5|STARTED|Intervention 4||2
5291402|NCT00584831|13008602|P4|STARTED|Intervention 4||1
5291403|NCT00584831|13008603|P3|STARTED|Intervention 4||2
5291404|NCT00584831|13008604|P2|STARTED|Intervention 4||3
5291405|NCT00584831|13008605|P1|STARTED|Intervention 4||1
5291406|NCT00584831|13008587|P19|NOT COMPLETED|Intervention 3||0
5291407|NCT00584831|13008588|P18|NOT COMPLETED|Intervention 3||0
5291408|NCT00584831|13008589|P17|NOT COMPLETED|Intervention 3||0
5291409|NCT00584831|13008590|P16|NOT COMPLETED|Intervention 3||0
5291410|NCT00584831|13008591|P15|NOT COMPLETED|Intervention 3||0
5291411|NCT00584831|13008592|P14|NOT COMPLETED|Intervention 3||0
5291412|NCT00584831|13008593|P13|NOT COMPLETED|Intervention 3||0
5291413|NCT00584831|13008594|P12|NOT COMPLETED|Intervention 3||0
5291414|NCT00584831|13008595|P11|NOT COMPLETED|Intervention 3||0
5291415|NCT00584831|13008596|P10|NOT COMPLETED|Intervention 3||0
5291416|NCT00584831|13008597|P9|NOT COMPLETED|Intervention 3||0
5291417|NCT00584831|13008598|P8|NOT COMPLETED|Intervention 3||0
5291418|NCT00584831|13008599|P7|NOT COMPLETED|Intervention 3||0
5291419|NCT00584831|13008600|P6|NOT COMPLETED|Intervention 3||0
5291420|NCT00584831|13008601|P5|NOT COMPLETED|Intervention 3||0
5291421|NCT00584831|13008602|P4|NOT COMPLETED|Intervention 3||0
5291422|NCT00584831|13008603|P3|NOT COMPLETED|Intervention 3||0
5291423|NCT00584831|13008604|P2|NOT COMPLETED|Intervention 3||0
5291424|NCT00584831|13008605|P1|NOT COMPLETED|Intervention 3||0
5291425|NCT00584831|13008587|P19|COMPLETED|Intervention 3||1
5291426|NCT00584831|13008588|P18|COMPLETED|Intervention 3||1
5291427|NCT00584831|13008589|P17|COMPLETED|Intervention 3||4
5291428|NCT00584831|13008590|P16|COMPLETED|Intervention 3||1
5291429|NCT00584831|13008591|P15|COMPLETED|Intervention 3||3
5291430|NCT00584831|13008592|P14|COMPLETED|Intervention 3||1
5291431|NCT00584831|13008593|P13|COMPLETED|Intervention 3||2
5291432|NCT00584831|13008594|P12|COMPLETED|Intervention 3||1
5291433|NCT00584831|13008595|P11|COMPLETED|Intervention 3||2
5291434|NCT00584831|13008596|P10|COMPLETED|Intervention 3||2
5291435|NCT00584831|13008597|P9|COMPLETED|Intervention 3||4
5291436|NCT00584831|13008598|P8|COMPLETED|Intervention 3||2
5291437|NCT00584831|13008599|P7|COMPLETED|Intervention 3||6
5291438|NCT00584831|13008600|P6|COMPLETED|Intervention 3||1
5291439|NCT00584831|13008601|P5|COMPLETED|Intervention 3||2
5291440|NCT00584831|13008602|P4|COMPLETED|Intervention 3||1
5291441|NCT00584831|13008603|P3|COMPLETED|Intervention 3||2
5291442|NCT00584831|13008604|P2|COMPLETED|Intervention 3||3
5291443|NCT00584831|13008605|P1|COMPLETED|Intervention 3||1
5291444|NCT00584831|13008587|P19|STARTED|Intervention 3||1
5291445|NCT00584831|13008588|P18|STARTED|Intervention 3||1
5291446|NCT00584831|13008589|P17|STARTED|Intervention 3||4
5291447|NCT00584831|13008590|P16|STARTED|Intervention 3||1
5291448|NCT00584831|13008591|P15|STARTED|Intervention 3||3
5291449|NCT00584831|13008592|P14|STARTED|Intervention 3||1
5291450|NCT00584831|13008593|P13|STARTED|Intervention 3||2
5291451|NCT00584831|13008594|P12|STARTED|Intervention 3||1
5291452|NCT00584831|13008595|P11|STARTED|Intervention 3||2
5291453|NCT00584831|13008596|P10|STARTED|Intervention 3||2
5291454|NCT00584831|13008597|P9|STARTED|Intervention 3||4
5291455|NCT00584831|13008598|P8|STARTED|Intervention 3||2
5291456|NCT00584831|13008599|P7|STARTED|Intervention 3||6
5291457|NCT00584831|13008600|P6|STARTED|Intervention 3||1
5291458|NCT00584831|13008601|P5|STARTED|Intervention 3||2
5291459|NCT00584831|13008602|P4|STARTED|Intervention 3||1
5291460|NCT00584831|13008603|P3|STARTED|Intervention 3||2
5291461|NCT00584831|13008604|P2|STARTED|Intervention 3||3
5291462|NCT00584831|13008605|P1|STARTED|Intervention 3||1
5291463|NCT00584831|13008587|P19|NOT COMPLETED|Intervention 2||0
5291464|NCT00584831|13008588|P18|NOT COMPLETED|Intervention 2||0
5291465|NCT00584831|13008589|P17|NOT COMPLETED|Intervention 2||0
5291466|NCT00584831|13008590|P16|NOT COMPLETED|Intervention 2||0
5291467|NCT00584831|13008591|P15|NOT COMPLETED|Intervention 2||0
5291468|NCT00584831|13008592|P14|NOT COMPLETED|Intervention 2||0
5291469|NCT00584831|13008593|P13|NOT COMPLETED|Intervention 2||0
5291470|NCT00584831|13008594|P12|NOT COMPLETED|Intervention 2||0
5291471|NCT00584831|13008595|P11|NOT COMPLETED|Intervention 2||0
5291472|NCT00584831|13008596|P10|NOT COMPLETED|Intervention 2||0
5291473|NCT00584831|13008597|P9|NOT COMPLETED|Intervention 2||0
5291474|NCT00584831|13008598|P8|NOT COMPLETED|Intervention 2||0
5291475|NCT00584831|13008599|P7|NOT COMPLETED|Intervention 2||0
5291476|NCT00584831|13008600|P6|NOT COMPLETED|Intervention 2||0
5291477|NCT00584831|13008601|P5|NOT COMPLETED|Intervention 2||0
5291478|NCT00584831|13008602|P4|NOT COMPLETED|Intervention 2||0
5291479|NCT00584831|13008603|P3|NOT COMPLETED|Intervention 2||0
5291480|NCT00584831|13008604|P2|NOT COMPLETED|Intervention 2||0
5291481|NCT00584831|13008605|P1|NOT COMPLETED|Intervention 2||0
5291482|NCT00584831|13008587|P19|COMPLETED|Intervention 2||1
5291483|NCT00584831|13008588|P18|COMPLETED|Intervention 2||1
5291484|NCT00584831|13008589|P17|COMPLETED|Intervention 2||4
5291485|NCT00584831|13008590|P16|COMPLETED|Intervention 2||1
5291486|NCT00584831|13008591|P15|COMPLETED|Intervention 2||3
5291487|NCT00584831|13008592|P14|COMPLETED|Intervention 2||1
5291488|NCT00584831|13008593|P13|COMPLETED|Intervention 2||2
5291489|NCT00584831|13008594|P12|COMPLETED|Intervention 2||1
5291490|NCT00584831|13008595|P11|COMPLETED|Intervention 2||2
5291491|NCT00584831|13008596|P10|COMPLETED|Intervention 2||2
5291492|NCT00584831|13008597|P9|COMPLETED|Intervention 2||4
5291493|NCT00584831|13008598|P8|COMPLETED|Intervention 2||2
5291494|NCT00584831|13008599|P7|COMPLETED|Intervention 2||6
5291495|NCT00584831|13008600|P6|COMPLETED|Intervention 2||1
5291496|NCT00584831|13008601|P5|COMPLETED|Intervention 2||2
5291497|NCT00584831|13008602|P4|COMPLETED|Intervention 2||1
5291498|NCT00584831|13008603|P3|COMPLETED|Intervention 2||2
5291499|NCT00584831|13008604|P2|COMPLETED|Intervention 2||3
5291500|NCT00584831|13008605|P1|COMPLETED|Intervention 2||1
5291501|NCT00584831|13008587|P19|STARTED|Intervention 2||1
5291502|NCT00584831|13008588|P18|STARTED|Intervention 2||1
5291503|NCT00584831|13008589|P17|STARTED|Intervention 2||4
5291504|NCT00584831|13008590|P16|STARTED|Intervention 2||1
5291505|NCT00584831|13008591|P15|STARTED|Intervention 2||3
5291506|NCT00584831|13008592|P14|STARTED|Intervention 2||1
5291507|NCT00584831|13008593|P13|STARTED|Intervention 2||2
5291508|NCT00584831|13008594|P12|STARTED|Intervention 2||1
5291509|NCT00584831|13008595|P11|STARTED|Intervention 2||2
5291510|NCT00584831|13008596|P10|STARTED|Intervention 2||2
5291511|NCT00584831|13008597|P9|STARTED|Intervention 2||4
5291512|NCT00584831|13008598|P8|STARTED|Intervention 2||2
5291513|NCT00584831|13008599|P7|STARTED|Intervention 2||6
5291514|NCT00584831|13008600|P6|STARTED|Intervention 2||1
5291515|NCT00584831|13008601|P5|STARTED|Intervention 2||2
5291516|NCT00584831|13008602|P4|STARTED|Intervention 2||1
5291517|NCT00584831|13008603|P3|STARTED|Intervention 2||2
5291518|NCT00584831|13008604|P2|STARTED|Intervention 2||3
5291519|NCT00584831|13008605|P1|STARTED|Intervention 2||1
5291520|NCT00584831|13008587|P19|NOT COMPLETED|Intervention 1||0
5291521|NCT00584831|13008588|P18|NOT COMPLETED|Intervention 1||0
5291522|NCT00584831|13008589|P17|NOT COMPLETED|Intervention 1||0
5291523|NCT00584831|13008590|P16|NOT COMPLETED|Intervention 1||0
5291524|NCT00584831|13008591|P15|NOT COMPLETED|Intervention 1||0
5291525|NCT00584831|13008592|P14|NOT COMPLETED|Intervention 1||0
5291526|NCT00584831|13008593|P13|NOT COMPLETED|Intervention 1||0
5291527|NCT00584831|13008594|P12|NOT COMPLETED|Intervention 1||0
5291528|NCT00584831|13008595|P11|NOT COMPLETED|Intervention 1||0
5291529|NCT00584831|13008596|P10|NOT COMPLETED|Intervention 1||0
5291530|NCT00584831|13008597|P9|NOT COMPLETED|Intervention 1||0
5291531|NCT00584831|13008598|P8|NOT COMPLETED|Intervention 1||0
5291532|NCT00584831|13008599|P7|NOT COMPLETED|Intervention 1||0
5291533|NCT00584831|13008600|P6|NOT COMPLETED|Intervention 1||0
5291534|NCT00584831|13008601|P5|NOT COMPLETED|Intervention 1||0
5291535|NCT00584831|13008602|P4|NOT COMPLETED|Intervention 1||0
5291536|NCT00584831|13008603|P3|NOT COMPLETED|Intervention 1||0
5291537|NCT00584831|13008604|P2|NOT COMPLETED|Intervention 1||0
5291538|NCT00584831|13008605|P1|NOT COMPLETED|Intervention 1||0
5291539|NCT00584831|13008587|P19|COMPLETED|Intervention 1||1
5291540|NCT00584831|13008588|P18|COMPLETED|Intervention 1||1
5291541|NCT00584831|13008589|P17|COMPLETED|Intervention 1||4
5291542|NCT00584831|13008590|P16|COMPLETED|Intervention 1||1
5291543|NCT00584831|13008591|P15|COMPLETED|Intervention 1||3
5291544|NCT00584831|13008592|P14|COMPLETED|Intervention 1||1
5291545|NCT00584831|13008593|P13|COMPLETED|Intervention 1||2
5291546|NCT00584831|13008594|P12|COMPLETED|Intervention 1||1
5291547|NCT00584831|13008595|P11|COMPLETED|Intervention 1||2
5291548|NCT00584831|13008596|P10|COMPLETED|Intervention 1||2
5291549|NCT00584831|13008597|P9|COMPLETED|Intervention 1||4
5291550|NCT00584831|13008598|P8|COMPLETED|Intervention 1||2
5291551|NCT00584831|13008599|P7|COMPLETED|Intervention 1||6
5291552|NCT00584831|13008600|P6|COMPLETED|Intervention 1||1
5291553|NCT00584831|13008601|P5|COMPLETED|Intervention 1||2
5291554|NCT00584831|13008602|P4|COMPLETED|Intervention 1||1
5291555|NCT00584831|13008603|P3|COMPLETED|Intervention 1||2
5291556|NCT00584831|13008604|P2|COMPLETED|Intervention 1||3
5291557|NCT00584831|13008605|P1|COMPLETED|Intervention 1||1
5291558|NCT00584831|13008587|P19|STARTED|Intervention 1||1
5291559|NCT00584831|13008588|P18|STARTED|Intervention 1||1
5291560|NCT00584831|13008589|P17|STARTED|Intervention 1||4
5291561|NCT00584831|13008590|P16|STARTED|Intervention 1||1
5291562|NCT00584831|13008591|P15|STARTED|Intervention 1||3
5291563|NCT00584831|13008592|P14|STARTED|Intervention 1||1
5291564|NCT00584831|13008593|P13|STARTED|Intervention 1||2
5291565|NCT00584831|13008594|P12|STARTED|Intervention 1||1
5291566|NCT00584831|13008595|P11|STARTED|Intervention 1||2
5291567|NCT00584831|13008596|P10|STARTED|Intervention 1||2
5291568|NCT00584831|13008597|P9|STARTED|Intervention 1||4
5291569|NCT00584831|13008598|P8|STARTED|Intervention 1||2
5291570|NCT00584831|13008599|P7|STARTED|Intervention 1||6
5291571|NCT00584831|13008600|P6|STARTED|Intervention 1||1
5291572|NCT00584831|13008601|P5|STARTED|Intervention 1||2
5291573|NCT00584831|13008602|P4|STARTED|Intervention 1||1
5291574|NCT00584831|13008603|P3|STARTED|Intervention 1||2
5291575|NCT00584831|13008604|P2|STARTED|Intervention 1||3
5291576|NCT00584831|13008605|P1|STARTED|Intervention 1||1
5291577|NCT00584805|13008627|P1|NOT COMPLETED|Overall Study||99
5291578|NCT00584805|13008627|P1|COMPLETED|Overall Study||39
5291579|NCT00584805|13008627|P1|STARTED|Overall Study||138
5291580|NCT00584740|13008640|P2|NOT COMPLETED|Overall Study||6
5291581|NCT00584740|13008641|P1|NOT COMPLETED|Overall Study||12
5291582|NCT00584740|13008640|P2|COMPLETED|Overall Study||14
5291583|NCT00584740|13008641|P1|COMPLETED|Overall Study||27
5291584|NCT00584740|13008640|P2|STARTED|Overall Study||20
5291585|NCT00584740|13008641|P1|STARTED|Overall Study||39
5291586|NCT00584727|13008659|P6|NOT COMPLETED|Third Intervention||2
5291587|NCT00584727|13008660|P5|NOT COMPLETED|Third Intervention||4
5291588|NCT00584727|13008661|P4|NOT COMPLETED|Third Intervention||0
5291589|NCT00584727|13008662|P3|NOT COMPLETED|Third Intervention||1
5291590|NCT00584727|13008663|P2|NOT COMPLETED|Third Intervention||0
5291591|NCT00584727|13008664|P1|NOT COMPLETED|Third Intervention||0
5291592|NCT00584727|13008659|P6|COMPLETED|Third Intervention||14
5291593|NCT00584727|13008660|P5|COMPLETED|Third Intervention||12
5291594|NCT00584727|13008661|P4|COMPLETED|Third Intervention||14
5291595|NCT00584727|13008662|P3|COMPLETED|Third Intervention||14
5291596|NCT00584727|13008663|P2|COMPLETED|Third Intervention||17
5291597|NCT00584727|13008664|P1|COMPLETED|Third Intervention||17
5291598|NCT00584727|13008659|P6|STARTED|Third Intervention||16
5291599|NCT00584727|13008660|P5|STARTED|Third Intervention||16
5291600|NCT00584727|13008661|P4|STARTED|Third Intervention||14
5291601|NCT00584727|13008662|P3|STARTED|Third Intervention||15
5291602|NCT00584727|13008663|P2|STARTED|Third Intervention||17
5291603|NCT00584727|13008664|P1|STARTED|Third Intervention||17
5291604|NCT00584727|13008659|P6|NOT COMPLETED|Second Intervention||0
5291605|NCT00584727|13008660|P5|NOT COMPLETED|Second Intervention||0
5291606|NCT00584727|13008661|P4|NOT COMPLETED|Second Intervention||0
5291607|NCT00584727|13008662|P3|NOT COMPLETED|Second Intervention||0
5291608|NCT00584727|13008663|P2|NOT COMPLETED|Second Intervention||0
5291609|NCT00584727|13008664|P1|NOT COMPLETED|Second Intervention||0
5291610|NCT00584727|13008659|P6|COMPLETED|Second Intervention||16
5291611|NCT00584727|13008660|P5|COMPLETED|Second Intervention||16
5291612|NCT00584727|13008661|P4|COMPLETED|Second Intervention||14
5291613|NCT00584727|13008662|P3|COMPLETED|Second Intervention||15
5291614|NCT00584727|13008663|P2|COMPLETED|Second Intervention||17
5291615|NCT00584727|13008664|P1|COMPLETED|Second Intervention||17
5291616|NCT00584727|13008659|P6|STARTED|Second Intervention||16
5291617|NCT00584727|13008660|P5|STARTED|Second Intervention||16
5291618|NCT00584727|13008661|P4|STARTED|Second Intervention||14
5291619|NCT00584727|13008662|P3|STARTED|Second Intervention||15
5291620|NCT00584727|13008663|P2|STARTED|Second Intervention||17
5291621|NCT00584727|13008664|P1|STARTED|Second Intervention||17
5291622|NCT00584727|13008659|P6|NOT COMPLETED|First Intervention||0
5291623|NCT00584727|13008660|P5|NOT COMPLETED|First Intervention||0
5291624|NCT00584727|13008661|P4|NOT COMPLETED|First Intervention||0
5291625|NCT00584727|13008662|P3|NOT COMPLETED|First Intervention||1
5291626|NCT00584727|13008663|P2|NOT COMPLETED|First Intervention||0
5291627|NCT00584727|13008664|P1|NOT COMPLETED|First Intervention||0
5291628|NCT00584727|13008659|P6|COMPLETED|First Intervention||16
5291629|NCT00584727|13008660|P5|COMPLETED|First Intervention||16
5291630|NCT00584727|13008661|P4|COMPLETED|First Intervention||14
5291631|NCT00584727|13008662|P3|COMPLETED|First Intervention||15
5291632|NCT00584727|13008663|P2|COMPLETED|First Intervention||17
5291633|NCT00584727|13008664|P1|COMPLETED|First Intervention||17
5291634|NCT00584727|13008659|P6|STARTED|First Intervention||16
5291635|NCT00584727|13008660|P5|STARTED|First Intervention||16
5291636|NCT00584727|13008661|P4|STARTED|First Intervention||14
5291637|NCT00584727|13008662|P3|STARTED|First Intervention||16
5291638|NCT00584727|13008663|P2|STARTED|First Intervention||17
5291639|NCT00584727|13008664|P1|STARTED|First Intervention||17
5291640|NCT00584701|13008688|P1|NOT COMPLETED|Follow-up||12
5291641|NCT00584701|13008688|P1|COMPLETED|Follow-up||34
5291642|NCT00584701|13008688|P1|STARTED|Follow-up||46
5291643|NCT00584701|13008688|P1|NOT COMPLETED|Active Risperidone||3
5291644|NCT00584701|13008688|P1|COMPLETED|Active Risperidone||46
5291645|NCT00584701|13008688|P1|STARTED|Active Risperidone||49
5291646|NCT00584558|13008693|P1|NOT COMPLETED|Overall Study||0
5291647|NCT00584558|13008693|P1|COMPLETED|Overall Study||2420
5291648|NCT00584558|13008693|P1|STARTED|Overall Study||2420
5291649|NCT00584480|13008698|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
5291650|NCT00584480|13008698|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
5291651|NCT00584480|13008698|P1|STARTED|Second 8 Weeks (40 Treatments)||10
5291652|NCT00584480|13008698|P1|NOT COMPLETED|4-Week Break From Treatment||0
5291653|NCT00584480|13008698|P1|COMPLETED|4-Week Break From Treatment||10
5291654|NCT00584480|13008698|P1|STARTED|4-Week Break From Treatment||10
5291655|NCT00584480|13008698|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
5291656|NCT00584480|13008698|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
5291657|NCT00584480|13008698|P1|STARTED|First 8 Weeks (40 Treatments)||10
5291658|NCT00584454|13008702|P1|NOT COMPLETED|Overall Study||4
5291659|NCT00584454|13008702|P1|COMPLETED|Overall Study||6
5291660|NCT00584454|13008702|P1|STARTED|Overall Study||10
5291661|NCT00584415|13008706|P1|NOT COMPLETED|Overall Study||7
5291662|NCT00584415|13008706|P1|COMPLETED|Overall Study||112
5291663|NCT00584415|13008706|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
5291664|NCT00584402|13008711|P1|NOT COMPLETED|Overall Study||0
5291665|NCT00584402|13008711|P1|COMPLETED|Overall Study||8
5291666|NCT00584402|13008711|P1|STARTED|Overall Study||8
5291667|NCT00584285|13008716|P1|NOT COMPLETED|Overall Study||0
5291668|NCT00584285|13008716|P1|COMPLETED|Overall Study||18
5291669|NCT00584285|13008716|P1|STARTED|Overall Study||18
5291670|NCT00584220|13008720|P2|NOT COMPLETED|Second Period||0
5291671|NCT00584220|13008721|P1|NOT COMPLETED|Second Period||0
5291672|NCT00584220|13008720|P2|COMPLETED|Second Period||39
5291673|NCT00584220|13008721|P1|COMPLETED|Second Period||48
5291674|NCT00584220|13008720|P2|STARTED|Second Period||39
5291675|NCT00584220|13008721|P1|STARTED|Second Period||48
5291676|NCT00584220|13008720|P2|NOT COMPLETED|First Period||0
5291677|NCT00584220|13008721|P1|NOT COMPLETED|First Period||0
5291678|NCT00584220|13008720|P2|COMPLETED|First Period||39
5291679|NCT00584220|13008721|P1|COMPLETED|First Period||48
5291680|NCT00584220|13008720|P2|STARTED|First Period||39
5291681|NCT00584220|13008721|P1|STARTED|First Period||48
5291682|NCT00584194|13008729|P1|NOT COMPLETED|Overall Study||135
5291683|NCT00584194|13008729|P1|COMPLETED|Overall Study||143
5291684|NCT00584194|13008729|P1|STARTED|Overall Study||278
5291685|NCT00584077|13008737|P1|NOT COMPLETED|Overall Study||0
5291686|NCT00584077|13008737|P1|COMPLETED|Overall Study||15
5291687|NCT00584077|13008737|P1|STARTED|Overall Study||15
5291688|NCT00584012|13008742|P1|NOT COMPLETED|Overall Study||1
5291689|NCT00584012|13008742|P1|COMPLETED|Overall Study||8
5291690|NCT00584012|13008742|P1|STARTED|Overall Study||9
5291691|NCT00583947|13008748|P2|NOT COMPLETED|Open Label Period||0
5291692|NCT00583947|13008749|P1|NOT COMPLETED|Open Label Period||0
5291693|NCT00583947|13008748|P2|COMPLETED|Open Label Period||24
5291694|NCT00583947|13008749|P1|COMPLETED|Open Label Period||22
5291695|NCT00583947|13008748|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
5291696|NCT00583947|13008749|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
5291697|NCT00583947|13008748|P2|NOT COMPLETED|Washout||0
5291698|NCT00583947|13008749|P1|NOT COMPLETED|Washout||0
5291699|NCT00583947|13008748|P2|COMPLETED|Washout||24
5291700|NCT00583947|13008749|P1|COMPLETED|Washout||22
5291701|NCT00583947|13008748|P2|STARTED|Washout||24
5291702|NCT00583947|13008749|P1|STARTED|Washout||22
5291703|NCT00583947|13008748|P2|NOT COMPLETED|Cross-over Period||2
5291704|NCT00583947|13008749|P1|NOT COMPLETED|Cross-over Period||5
5291705|NCT00583947|13008748|P2|COMPLETED|Cross-over Period||24
5291706|NCT00583947|13008749|P1|COMPLETED|Cross-over Period||22
5291707|NCT00583947|13008748|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
5291708|NCT00583947|13008749|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
5291709|NCT00583908|13008799|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291710|NCT00583908|13008800|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291711|NCT00583908|13008801|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291712|NCT00583908|13008802|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291713|NCT00583908|13008803|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291714|NCT00583908|13008804|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291715|NCT00583908|13008805|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291716|NCT00583908|13008806|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291717|NCT00583908|13008807|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291718|NCT00583908|13008808|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291719|NCT00583908|13008809|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291720|NCT00583908|13008810|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
5291721|NCT00583908|13008799|P12|COMPLETED|Period 4 - Fourth Intervention||1
5291722|NCT00583908|13008800|P11|COMPLETED|Period 4 - Fourth Intervention||1
5291723|NCT00583908|13008801|P10|COMPLETED|Period 4 - Fourth Intervention||1
5291724|NCT00583908|13008802|P9|COMPLETED|Period 4 - Fourth Intervention||1
5291725|NCT00583908|13008803|P8|COMPLETED|Period 4 - Fourth Intervention||1
5291726|NCT00583908|13008804|P7|COMPLETED|Period 4 - Fourth Intervention||1
5291727|NCT00583908|13008805|P6|COMPLETED|Period 4 - Fourth Intervention||1
5291728|NCT00583908|13008806|P5|COMPLETED|Period 4 - Fourth Intervention||2
5291729|NCT00583908|13008807|P4|COMPLETED|Period 4 - Fourth Intervention||1
5291730|NCT00583908|13008808|P3|COMPLETED|Period 4 - Fourth Intervention||1
5291731|NCT00583908|13008809|P2|COMPLETED|Period 4 - Fourth Intervention||2
5291732|NCT00583908|13008810|P1|COMPLETED|Period 4 - Fourth Intervention||1
5291733|NCT00583908|13008799|P12|STARTED|Period 4 - Fourth Intervention||1
5291734|NCT00583908|13008800|P11|STARTED|Period 4 - Fourth Intervention||1
5291735|NCT00583908|13008801|P10|STARTED|Period 4 - Fourth Intervention||1
5291736|NCT00583908|13008802|P9|STARTED|Period 4 - Fourth Intervention||1
5291737|NCT00583908|13008803|P8|STARTED|Period 4 - Fourth Intervention||1
5291738|NCT00583908|13008804|P7|STARTED|Period 4 - Fourth Intervention||1
5291739|NCT00583908|13008805|P6|STARTED|Period 4 - Fourth Intervention||1
5291740|NCT00583908|13008806|P5|STARTED|Period 4 - Fourth Intervention||2
5291741|NCT00583908|13008807|P4|STARTED|Period 4 - Fourth Intervention||1
5291742|NCT00583908|13008808|P3|STARTED|Period 4 - Fourth Intervention||1
5291743|NCT00583908|13008809|P2|STARTED|Period 4 - Fourth Intervention||2
5291744|NCT00583908|13008810|P1|STARTED|Period 4 - Fourth Intervention||1
5291745|NCT00583908|13008799|P12|NOT COMPLETED|Period 3 - Third Intervention||0
5291746|NCT00583908|13008800|P11|NOT COMPLETED|Period 3 - Third Intervention||0
5291747|NCT00583908|13008801|P10|NOT COMPLETED|Period 3 - Third Intervention||0
5291748|NCT00583908|13008802|P9|NOT COMPLETED|Period 3 - Third Intervention||0
5291749|NCT00583908|13008803|P8|NOT COMPLETED|Period 3 - Third Intervention||0
5291750|NCT00583908|13008804|P7|NOT COMPLETED|Period 3 - Third Intervention||0
5291751|NCT00583908|13008805|P6|NOT COMPLETED|Period 3 - Third Intervention||0
5291752|NCT00583908|13008806|P5|NOT COMPLETED|Period 3 - Third Intervention||0
5291753|NCT00583908|13008807|P4|NOT COMPLETED|Period 3 - Third Intervention||0
5291754|NCT00583908|13008808|P3|NOT COMPLETED|Period 3 - Third Intervention||0
5291755|NCT00583908|13008809|P2|NOT COMPLETED|Period 3 - Third Intervention||0
5291756|NCT00583908|13008810|P1|NOT COMPLETED|Period 3 - Third Intervention||0
5291757|NCT00583908|13008799|P12|COMPLETED|Period 3 - Third Intervention||1
5291758|NCT00583908|13008800|P11|COMPLETED|Period 3 - Third Intervention||1
5291759|NCT00583908|13008801|P10|COMPLETED|Period 3 - Third Intervention||1
5291760|NCT00583908|13008802|P9|COMPLETED|Period 3 - Third Intervention||1
5291761|NCT00583908|13008803|P8|COMPLETED|Period 3 - Third Intervention||1
5291762|NCT00583908|13008804|P7|COMPLETED|Period 3 - Third Intervention||1
5291763|NCT00583908|13008805|P6|COMPLETED|Period 3 - Third Intervention||1
5291764|NCT00583908|13008806|P5|COMPLETED|Period 3 - Third Intervention||2
5291765|NCT00583908|13008807|P4|COMPLETED|Period 3 - Third Intervention||1
5291766|NCT00583908|13008808|P3|COMPLETED|Period 3 - Third Intervention||1
5291767|NCT00583908|13008809|P2|COMPLETED|Period 3 - Third Intervention||2
5291768|NCT00583908|13008810|P1|COMPLETED|Period 3 - Third Intervention||1
5291769|NCT00583908|13008799|P12|STARTED|Period 3 - Third Intervention||1
5291770|NCT00583908|13008800|P11|STARTED|Period 3 - Third Intervention||1
5291771|NCT00583908|13008801|P10|STARTED|Period 3 - Third Intervention||1
5291772|NCT00583908|13008802|P9|STARTED|Period 3 - Third Intervention||1
5291773|NCT00583908|13008803|P8|STARTED|Period 3 - Third Intervention||1
5291774|NCT00583908|13008804|P7|STARTED|Period 3 - Third Intervention||1
5291775|NCT00583908|13008805|P6|STARTED|Period 3 - Third Intervention||1
5291776|NCT00583908|13008806|P5|STARTED|Period 3 - Third Intervention||2
5291777|NCT00583908|13008807|P4|STARTED|Period 3 - Third Intervention||1
5291778|NCT00583908|13008808|P3|STARTED|Period 3 - Third Intervention||1
5291779|NCT00583908|13008809|P2|STARTED|Period 3 - Third Intervention||2
5291780|NCT00583908|13008810|P1|STARTED|Period 3 - Third Intervention||1
5291781|NCT00583908|13008799|P12|NOT COMPLETED|Period 2 - Second Intervention||0
5291782|NCT00583908|13008800|P11|NOT COMPLETED|Period 2 - Second Intervention||0
5291783|NCT00583908|13008801|P10|NOT COMPLETED|Period 2 - Second Intervention||0
5291784|NCT00583908|13008802|P9|NOT COMPLETED|Period 2 - Second Intervention||0
5291785|NCT00583908|13008803|P8|NOT COMPLETED|Period 2 - Second Intervention||0
5291786|NCT00583908|13008804|P7|NOT COMPLETED|Period 2 - Second Intervention||0
5291787|NCT00583908|13008805|P6|NOT COMPLETED|Period 2 - Second Intervention||0
5291788|NCT00583908|13008806|P5|NOT COMPLETED|Period 2 - Second Intervention||0
5291789|NCT00583908|13008807|P4|NOT COMPLETED|Period 2 - Second Intervention||0
5291790|NCT00583908|13008808|P3|NOT COMPLETED|Period 2 - Second Intervention||0
5291791|NCT00583908|13008809|P2|NOT COMPLETED|Period 2 - Second Intervention||0
5291792|NCT00583908|13008810|P1|NOT COMPLETED|Period 2 - Second Intervention||0
5291793|NCT00583908|13008799|P12|COMPLETED|Period 2 - Second Intervention||1
5291794|NCT00583908|13008800|P11|COMPLETED|Period 2 - Second Intervention||1
5291795|NCT00583908|13008801|P10|COMPLETED|Period 2 - Second Intervention||1
5291796|NCT00583908|13008802|P9|COMPLETED|Period 2 - Second Intervention||1
5291797|NCT00583908|13008803|P8|COMPLETED|Period 2 - Second Intervention||1
5291798|NCT00583908|13008804|P7|COMPLETED|Period 2 - Second Intervention||1
5291799|NCT00583908|13008805|P6|COMPLETED|Period 2 - Second Intervention||1
5291800|NCT00583908|13008806|P5|COMPLETED|Period 2 - Second Intervention||2
5291801|NCT00583908|13008807|P4|COMPLETED|Period 2 - Second Intervention||1
5291802|NCT00583908|13008808|P3|COMPLETED|Period 2 - Second Intervention||1
5291803|NCT00583908|13008809|P2|COMPLETED|Period 2 - Second Intervention||2
5291804|NCT00583908|13008810|P1|COMPLETED|Period 2 - Second Intervention||1
5291805|NCT00583908|13008799|P12|STARTED|Period 2 - Second Intervention||1
5291806|NCT00583908|13008800|P11|STARTED|Period 2 - Second Intervention||1
5291807|NCT00583908|13008801|P10|STARTED|Period 2 - Second Intervention||1
5291808|NCT00583908|13008802|P9|STARTED|Period 2 - Second Intervention||1
5291809|NCT00583908|13008803|P8|STARTED|Period 2 - Second Intervention||1
5291810|NCT00583908|13008804|P7|STARTED|Period 2 - Second Intervention||1
5291811|NCT00583908|13008805|P6|STARTED|Period 2 - Second Intervention||1
5291812|NCT00583908|13008806|P5|STARTED|Period 2 - Second Intervention||2
5291813|NCT00583908|13008807|P4|STARTED|Period 2 - Second Intervention||1
5291814|NCT00583908|13008808|P3|STARTED|Period 2 - Second Intervention||1
5291815|NCT00583908|13008809|P2|STARTED|Period 2 - Second Intervention||2
5291816|NCT00583908|13008810|P1|STARTED|Period 2 - Second Intervention||1
5291817|NCT00583908|13008799|P12|NOT COMPLETED|Period 1 - First Intervention||0
5291818|NCT00583908|13008800|P11|NOT COMPLETED|Period 1 - First Intervention||0
5291819|NCT00583908|13008801|P10|NOT COMPLETED|Period 1 - First Intervention||0
5291820|NCT00583908|13008802|P9|NOT COMPLETED|Period 1 - First Intervention||0
5291821|NCT00583908|13008803|P8|NOT COMPLETED|Period 1 - First Intervention||0
5291822|NCT00583908|13008804|P7|NOT COMPLETED|Period 1 - First Intervention||0
5291823|NCT00583908|13008805|P6|NOT COMPLETED|Period 1 - First Intervention||0
5291824|NCT00583908|13008806|P5|NOT COMPLETED|Period 1 - First Intervention||0
5291825|NCT00583908|13008807|P4|NOT COMPLETED|Period 1 - First Intervention||0
5291826|NCT00583908|13008808|P3|NOT COMPLETED|Period 1 - First Intervention||0
5291827|NCT00583908|13008809|P2|NOT COMPLETED|Period 1 - First Intervention||0
5291828|NCT00583908|13008810|P1|NOT COMPLETED|Period 1 - First Intervention||0
5291829|NCT00583908|13008799|P12|COMPLETED|Period 1 - First Intervention||1
5291830|NCT00583908|13008800|P11|COMPLETED|Period 1 - First Intervention||1
5291831|NCT00583908|13008801|P10|COMPLETED|Period 1 - First Intervention||1
5291832|NCT00583908|13008802|P9|COMPLETED|Period 1 - First Intervention||1
5291833|NCT00583908|13008803|P8|COMPLETED|Period 1 - First Intervention||1
5291834|NCT00583908|13008804|P7|COMPLETED|Period 1 - First Intervention||1
5291835|NCT00583908|13008805|P6|COMPLETED|Period 1 - First Intervention||1
5291836|NCT00583908|13008806|P5|COMPLETED|Period 1 - First Intervention||2
5291837|NCT00583908|13008807|P4|COMPLETED|Period 1 - First Intervention||1
5291838|NCT00583908|13008808|P3|COMPLETED|Period 1 - First Intervention||1
5291839|NCT00583908|13008809|P2|COMPLETED|Period 1 - First Intervention||2
5291840|NCT00583908|13008810|P1|COMPLETED|Period 1 - First Intervention||1
5291841|NCT00583908|13008799|P12|STARTED|Period 1 - First Intervention||1
5291842|NCT00583908|13008800|P11|STARTED|Period 1 - First Intervention||1
5291843|NCT00583908|13008801|P10|STARTED|Period 1 - First Intervention||1
5291844|NCT00583908|13008802|P9|STARTED|Period 1 - First Intervention||1
5291845|NCT00583908|13008803|P8|STARTED|Period 1 - First Intervention||1
5291846|NCT00583908|13008804|P7|STARTED|Period 1 - First Intervention||1
5291847|NCT00583908|13008805|P6|STARTED|Period 1 - First Intervention||1
5291848|NCT00583908|13008806|P5|STARTED|Period 1 - First Intervention||2
5291849|NCT00583908|13008807|P4|STARTED|Period 1 - First Intervention||1
5291850|NCT00583908|13008808|P3|STARTED|Period 1 - First Intervention||1
5291851|NCT00583908|13008809|P2|STARTED|Period 1 - First Intervention||2
5291852|NCT00583908|13008810|P1|STARTED|Period 1 - First Intervention||1
5291853|NCT00583804|13008864|P1|NOT COMPLETED|Overall Study||0
5291854|NCT00583804|13008864|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
5291855|NCT00583804|13008864|P1|STARTED|Overall Study||10
5291856|NCT00583791|13008870|P1|NOT COMPLETED|Overall Study||73
5291857|NCT00583791|13008870|P1|COMPLETED|Overall Study||18
5291858|NCT00583791|13008870|P1|STARTED|Overall Study||91
5291859|NCT00583713|13008877|P3|NOT COMPLETED|Overall Study||0
5291860|NCT00583713|13008878|P2|NOT COMPLETED|Overall Study||0
5291861|NCT00583713|13008879|P1|NOT COMPLETED|Overall Study||0
5291862|NCT00583713|13008877|P3|COMPLETED|Overall Study||6
5291863|NCT00583713|13008878|P2|COMPLETED|Overall Study||6
5291864|NCT00583713|13008879|P1|COMPLETED|Overall Study||6
5291865|NCT00583713|13008877|P3|STARTED|Overall Study||6
5291866|NCT00583713|13008878|P2|STARTED|Overall Study||6
5291867|NCT00583713|13008879|P1|STARTED|Overall Study||6
5291868|NCT00583700|13008904|P2|NOT COMPLETED|Overall Study||4
5291869|NCT00583700|13008905|P1|NOT COMPLETED|Overall Study||3
5291870|NCT00583700|13008904|P2|COMPLETED|Overall Study||23
5291871|NCT00583700|13008905|P1|COMPLETED|Overall Study||24
5291872|NCT00583700|13008904|P2|STARTED|Overall Study||27
5291873|NCT00583700|13008905|P1|STARTED|Overall Study||27
5291874|NCT00583661|13008913|P1|NOT COMPLETED|Overall Study||0
5291875|NCT00583661|13008913|P1|COMPLETED|Overall Study||48
5291876|NCT00583661|13008913|P1|STARTED|Overall Study||48
5291877|NCT00583622|13008920|P1|NOT COMPLETED|Overall Study||0
5291878|NCT00583622|13008920|P1|COMPLETED|Overall Study||12
5291879|NCT00583622|13008920|P1|STARTED|Overall Study||12
5291880|NCT00583596|13008925|P1|NOT COMPLETED|Overall Study||284
5291881|NCT00583596|13008925|P1|COMPLETED|Overall Study||152
5291882|NCT00583596|13008925|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
5291883|NCT00583557|13008930|P1|NOT COMPLETED|Overall Study||70
5291884|NCT00583557|13008930|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
5291885|NCT00583557|13008930|P1|Received at Least 1 Dose Belimumab|Overall Study||153
5291886|NCT00583557|13008930|P1|STARTED|Overall Study||155
5291887|NCT00583492|13008936|P2|NOT COMPLETED|Overall Study||0
5291888|NCT00583492|13008937|P1|NOT COMPLETED|Overall Study||0
5291889|NCT00583492|13008936|P2|COMPLETED|Overall Study||23
5291890|NCT00583492|13008937|P1|COMPLETED|Overall Study||21
5291891|NCT00583492|13008936|P2|STARTED|Overall Study||23
5291892|NCT00583492|13008937|P1|STARTED|Overall Study||21
5291893|NCT00583466|13008953|P1|NOT COMPLETED|Overall Study||0
5291894|NCT00583466|13008953|P1|COMPLETED|Overall Study||18
5291895|NCT00583466|13008953|P1|STARTED|Overall Study||18
5291896|NCT00583453|13008961|P2|NOT COMPLETED|Overall Study||2
5291897|NCT00583453|13008962|P1|NOT COMPLETED|Overall Study||0
5291898|NCT00583453|13008961|P2|COMPLETED|Overall Study||6
5291899|NCT00583453|13008962|P1|COMPLETED|Overall Study||9
5291900|NCT00583453|13008961|P2|STARTED|Overall Study||8
5291901|NCT00583453|13008962|P1|STARTED|Overall Study||9
5291902|NCT00583414|13008976|P1|NOT COMPLETED|Overall Study||0
5291903|NCT00583414|13008976|P1|COMPLETED|Overall Study||401
5291904|NCT00583414|13008976|P1|STARTED|Overall Study||401
5291905|NCT00583375|13008982|P2|NOT COMPLETED|Overall Study||0
5291906|NCT00583375|13008983|P1|NOT COMPLETED|Overall Study||0
5291907|NCT00583375|13008982|P2|COMPLETED|Overall Study||272
5291908|NCT00583375|13008983|P1|COMPLETED|Overall Study||142
5291909|NCT00583375|13008982|P2|STARTED|Overall Study||272
5291910|NCT00583375|13008983|P1|STARTED|Overall Study||142
5291911|NCT00583362|13008999|P1|NOT COMPLETED|Overall Study||202
5291912|NCT00583362|13008999|P1|COMPLETED|Overall Study||96
5291913|NCT00583362|13008999|P1|STARTED|Overall Study||298
5291914|NCT00583219|13009023|P1|NOT COMPLETED|Phase 2||1
5291915|NCT00583219|13009023|P1|COMPLETED|Phase 2||21
5291916|NCT00583219|13009023|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
5291917|NCT00583219|13009023|P1|NOT COMPLETED|Phase 1||0
5291918|NCT00583219|13009023|P1|COMPLETED|Phase 1||9
5291919|NCT00583219|13009023|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
5291920|NCT00583115|13009040|P1|NOT COMPLETED|Overall Study||1
5291921|NCT00583115|13009040|P1|COMPLETED|Overall Study||0
5291922|NCT00583115|13009040|P1|STARTED|Overall Study||1
5291923|NCT00583102|13009045|P1|NOT COMPLETED|Overall Study||3
5291924|NCT00583102|13009045|P1|COMPLETED|Overall Study||20
5291925|NCT00583102|13009045|P1|STARTED|Overall Study||23
5291926|NCT00583050|13009049|P1|NOT COMPLETED|Overall Study||0
5291927|NCT00583050|13009049|P1|COMPLETED|Overall Study||1366
5291928|NCT00583050|13009049|P1|STARTED|Overall Study||1366
5291929|NCT00582998|13009055|P2|NOT COMPLETED|Overall Study||0
5291930|NCT00582998|13009056|P1|NOT COMPLETED|Overall Study||0
5291931|NCT00582998|13009055|P2|COMPLETED|Overall Study||130
5291932|NCT00582998|13009056|P1|COMPLETED|Overall Study||119
5291933|NCT00582998|13009055|P2|STARTED|Overall Study||130
5291934|NCT00582998|13009056|P1|STARTED|Overall Study||119
5291935|NCT00582972|13009062|P1|NOT COMPLETED|Overall Study||2
5291936|NCT00582972|13009062|P1|COMPLETED|Overall Study||21
5291937|NCT00582972|13009062|P1|STARTED|Overall Study||23
5291938|NCT00582946|13009067|P1|NOT COMPLETED|Overall Study||0
5291939|NCT00582946|13009067|P1|COMPLETED|Overall Study||16
5291940|NCT00582946|13009067|P1|STARTED|Overall Study||16
5291941|NCT00582933|13009071|P1|NOT COMPLETED|Overall Study||3
5291942|NCT00582933|13009071|P1|COMPLETED|Overall Study||92
5291943|NCT00582933|13009071|P1|STARTED|Overall Study||95
5291944|NCT00582907|13009075|P4|NOT COMPLETED|4th Course||0
5291945|NCT00582907|13009076|P3|NOT COMPLETED|4th Course||0
5291946|NCT00582907|13009077|P2|NOT COMPLETED|4th Course||0
5291947|NCT00582907|13009078|P1|NOT COMPLETED|4th Course||0
5291948|NCT00582907|13009075|P4|COMPLETED|4th Course||3
5291949|NCT00582907|13009076|P3|COMPLETED|4th Course||3
5291950|NCT00582907|13009077|P2|COMPLETED|4th Course||3
5291951|NCT00582907|13009078|P1|COMPLETED|4th Course||2
5291952|NCT00582907|13009075|P4|STARTED|4th Course||3
5291953|NCT00582907|13009076|P3|STARTED|4th Course||3
5291954|NCT00582907|13009077|P2|STARTED|4th Course||3
5291955|NCT00582907|13009078|P1|STARTED|4th Course||2
5291956|NCT00582907|13009075|P4|NOT COMPLETED|3rd Course||0
5291957|NCT00582907|13009076|P3|NOT COMPLETED|3rd Course||0
5291958|NCT00582907|13009077|P2|NOT COMPLETED|3rd Course||0
5291959|NCT00582907|13009078|P1|NOT COMPLETED|3rd Course||0
5291960|NCT00582907|13009075|P4|COMPLETED|3rd Course||3
5291961|NCT00582907|13009076|P3|COMPLETED|3rd Course||3
5291962|NCT00582907|13009077|P2|COMPLETED|3rd Course||3
5291963|NCT00582907|13009078|P1|COMPLETED|3rd Course||2
5291964|NCT00582907|13009075|P4|STARTED|3rd Course||3
5291965|NCT00582907|13009076|P3|STARTED|3rd Course||3
5291966|NCT00582907|13009077|P2|STARTED|3rd Course||3
5291967|NCT00582907|13009078|P1|STARTED|3rd Course||2
5291968|NCT00582907|13009075|P4|NOT COMPLETED|2nd Course||0
5291969|NCT00582907|13009076|P3|NOT COMPLETED|2nd Course||0
5291970|NCT00582907|13009077|P2|NOT COMPLETED|2nd Course||0
5291971|NCT00582907|13009078|P1|NOT COMPLETED|2nd Course||1
5291972|NCT00582907|13009075|P4|COMPLETED|2nd Course||3
5291973|NCT00582907|13009076|P3|COMPLETED|2nd Course||3
5291974|NCT00582907|13009077|P2|COMPLETED|2nd Course||3
5291975|NCT00582907|13009078|P1|COMPLETED|2nd Course||2
5291976|NCT00582907|13009075|P4|STARTED|2nd Course||3
5291977|NCT00582907|13009076|P3|STARTED|2nd Course||3
5291978|NCT00582907|13009077|P2|STARTED|2nd Course||3
5291979|NCT00582907|13009078|P1|STARTED|2nd Course||3
5291980|NCT00582907|13009075|P4|NOT COMPLETED|1st Course||1
5291981|NCT00582907|13009076|P3|NOT COMPLETED|1st Course||0
5291982|NCT00582907|13009077|P2|NOT COMPLETED|1st Course||0
5291983|NCT00582907|13009078|P1|NOT COMPLETED|1st Course||1
5291984|NCT00582907|13009075|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
5291985|NCT00582907|13009076|P3|COMPLETED|1st Course||3
5291986|NCT00582907|13009077|P2|COMPLETED|1st Course||3
5291987|NCT00582907|13009078|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
5291988|NCT00582907|13009075|P4|STARTED|1st Course||4
5291989|NCT00582907|13009076|P3|STARTED|1st Course||3
5291990|NCT00582907|13009077|P2|STARTED|1st Course||3
5291991|NCT00582907|13009078|P1|STARTED|1st Course||4
5291992|NCT00582894|13009110|P1|NOT COMPLETED|Overall Study||0
5291993|NCT00582894|13009110|P1|COMPLETED|Overall Study||17
5291994|NCT00582894|13009110|P1|Day 100 Post Transplant|Overall Study||17
5291995|NCT00582894|13009110|P1|STARTED|Overall Study||17
5291996|NCT00582816|13009117|P1|NOT COMPLETED|Overall Study||3
5291997|NCT00582816|13009117|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
5291998|NCT00582816|13009117|P1|STARTED|Overall Study||9
5291999|NCT00582790|13009127|P1|NOT COMPLETED|Overall Study||1
5292000|NCT00582790|13009127|P1|COMPLETED|Overall Study||11
5292001|NCT00582790|13009127|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
5292002|NCT00582738|13009136|P2|NOT COMPLETED|Overall Study||18
5292003|NCT00582738|13009137|P1|NOT COMPLETED|Overall Study||9
5292004|NCT00582738|13009136|P2|COMPLETED|Overall Study||4
5292005|NCT00582738|13009137|P1|COMPLETED|Overall Study||12
5292006|NCT00582738|13009136|P2|STARTED|Overall Study||22
5292007|NCT00582738|13009137|P1|STARTED|Overall Study||21
5292008|NCT00582712|13009161|P1|NOT COMPLETED|Overall Study||4
5292009|NCT00582712|13009161|P1|COMPLETED|Overall Study||1
5292010|NCT00582712|13009161|P1|STARTED|Overall Study||5
5292011|NCT00582660|13009167|P2|NOT COMPLETED|Overall Study||0
5292012|NCT00582660|13009168|P1|NOT COMPLETED|Overall Study||0
5292013|NCT00582660|13009167|P2|COMPLETED|Overall Study||20
5292014|NCT00582660|13009168|P1|COMPLETED|Overall Study||20
5292015|NCT00582660|13009167|P2|STARTED|Overall Study||20
5292016|NCT00582660|13009168|P1|STARTED|Overall Study||20
5292017|NCT00582608|13009176|P1|NOT COMPLETED|Overall Study||12
5292018|NCT00582608|13009176|P1|COMPLETED|Overall Study||0
5292019|NCT00582608|13009176|P1|STARTED|Overall Study||12
5292020|NCT00582556|13009183|P3|NOT COMPLETED|Overall Study||2
5292021|NCT00582556|13009184|P2|NOT COMPLETED|Overall Study||1
5292022|NCT00582556|13009185|P1|NOT COMPLETED|Overall Study||0
5292023|NCT00582556|13009183|P3|COMPLETED|Overall Study||12
5292024|NCT00582556|13009184|P2|COMPLETED|Overall Study||14
5292025|NCT00582556|13009185|P1|COMPLETED|Overall Study||14
5292026|NCT00582556|13009183|P3|STARTED|Overall Study||14
5292027|NCT00582556|13009184|P2|STARTED|Overall Study||15
5292028|NCT00582556|13009185|P1|STARTED|Overall Study||14
5292029|NCT00582517|13009204|P2|NOT COMPLETED|Overall Study||0
5292030|NCT00582517|13009205|P1|NOT COMPLETED|Overall Study||0
5292031|NCT00582517|13009204|P2|COMPLETED|Overall Study||55
5292032|NCT00582517|13009205|P1|COMPLETED|Overall Study||45
5292033|NCT00582517|13009204|P2|STARTED|Overall Study||55
5292034|NCT00582517|13009205|P1|STARTED|Overall Study||45
5292035|NCT00582491|13009213|P2|NOT COMPLETED|Overall Study||0
5292036|NCT00582491|13009214|P1|NOT COMPLETED|Overall Study||1
5292037|NCT00582491|13009213|P2|COMPLETED|Overall Study||10
5292038|NCT00582491|13009214|P1|COMPLETED|Overall Study||10
5292039|NCT00582491|13009213|P2|STARTED|Overall Study||10
5292040|NCT00582491|13009214|P1|STARTED|Overall Study||11
5292041|NCT00582426|13009238|P2|NOT COMPLETED|Overall Study||13
5292042|NCT00582426|13009239|P1|NOT COMPLETED|Overall Study||20
5292043|NCT00582426|13009238|P2|COMPLETED|Overall Study||58
5292044|NCT00582426|13009239|P1|COMPLETED|Overall Study||48
5292045|NCT00582426|13009238|P2|STARTED|Overall Study||71
5292046|NCT00582426|13009239|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
5292047|NCT00582400|13009265|P1|NOT COMPLETED|Overall Study||3
5292048|NCT00582400|13009265|P1|COMPLETED|Overall Study||6
5292049|NCT00582400|13009265|P1|STARTED|Overall Study||9
5292050|NCT00582361|13009274|P2|NOT COMPLETED|Overall Study||0
5292051|NCT00582361|13009275|P1|NOT COMPLETED|Overall Study||0
5292052|NCT00582361|13009274|P2|COMPLETED|Overall Study||38
5292053|NCT00582361|13009275|P1|COMPLETED|Overall Study||25
5292054|NCT00582361|13009274|P2|STARTED|Overall Study||38
5292055|NCT00582361|13009275|P1|STARTED|Overall Study||25
5292056|NCT00582309|13009286|P3|NOT COMPLETED|Overall Study||2
5292057|NCT00582309|13009287|P2|NOT COMPLETED|Overall Study||0
5292058|NCT00582309|13009288|P1|NOT COMPLETED|Overall Study||0
5292059|NCT00582309|13009286|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
5292060|NCT00582309|13009287|P2|COMPLETED|Overall Study||49
5292061|NCT00582309|13009288|P1|COMPLETED|Overall Study||56
5292062|NCT00582309|13009286|P3|STARTED|Overall Study||46
5292063|NCT00582309|13009287|P2|STARTED|Overall Study||49
5292064|NCT00582309|13009288|P1|STARTED|Overall Study||56
5292065|NCT00582205|13009296|P1|NOT COMPLETED|Overall Study||10
5292066|NCT00582205|13009296|P1|COMPLETED|Overall Study||11
5292067|NCT00582205|13009296|P1|STARTED|Overall Study||21
5292068|NCT00582166|13009301|P1|NOT COMPLETED|Overall Study||2
5292069|NCT00582166|13009301|P1|COMPLETED|Overall Study||16
5292070|NCT00582166|13009301|P1|STARTED|Overall Study||18
5292071|NCT00582114|13009311|P2|NOT COMPLETED|Overall Study||54
5292072|NCT00582114|13009312|P1|NOT COMPLETED|Overall Study||42
5292073|NCT00582114|13009311|P2|COMPLETED|Overall Study||46
5292074|NCT00582114|13009312|P1|COMPLETED|Overall Study||58
5292075|NCT00582114|13009311|P2|STARTED|Overall Study||100
5292076|NCT00582114|13009312|P1|STARTED|Overall Study||100
5292077|NCT00582075|13009320|P1|NOT COMPLETED|Overall Study||0
5292078|NCT00582075|13009320|P1|COMPLETED|Overall Study||25
5292079|NCT00582075|13009320|P1|STARTED|Overall Study||25
5292080|NCT00582036|13009327|P2|NOT COMPLETED|Overall Study||1
5292081|NCT00582036|13009328|P1|NOT COMPLETED|Overall Study||0
5292082|NCT00582036|13009327|P2|COMPLETED|Overall Study|One patient withdrew consent|5
5292083|NCT00582036|13009328|P1|COMPLETED|Overall Study||5
5292084|NCT00582036|13009327|P2|STARTED|Overall Study||6
5292085|NCT00582036|13009328|P1|STARTED|Overall Study||5
5292086|NCT00582010|13009336|P2|NOT COMPLETED|Overall Study||1
5292087|NCT00582010|13009337|P1|NOT COMPLETED|Overall Study||0
5292088|NCT00582010|13009336|P2|COMPLETED|Overall Study||39
5292089|NCT00582010|13009337|P1|COMPLETED|Overall Study||40
5292090|NCT00582010|13009336|P2|STARTED|Overall Study||40
5292091|NCT00582010|13009337|P1|STARTED|Overall Study||40
5292092|NCT00581971|13009359|P1|NOT COMPLETED|Overall Study||0
5292093|NCT00581971|13009359|P1|COMPLETED|Overall Study||30
5292094|NCT00581971|13009359|P1|STARTED|Overall Study||30
5292095|NCT00581945|13009366|P2|NOT COMPLETED|Overall Study||10
5292096|NCT00581945|13009367|P1|NOT COMPLETED|Overall Study||9
5292097|NCT00581945|13009366|P2|COMPLETED|Overall Study||63
5292098|NCT00581945|13009367|P1|COMPLETED|Overall Study||65
5292099|NCT00581945|13009366|P2|STARTED|Overall Study||73
5292100|NCT00581945|13009367|P1|STARTED|Overall Study||74
5292101|NCT00581919|13009383|P1|NOT COMPLETED|Overall Study||24
5292102|NCT00581919|13009383|P1|COMPLETED|Overall Study||8
5292103|NCT00581919|13009383|P1|STARTED|Overall Study||32
5292104|NCT00581867|13009389|P2|NOT COMPLETED|Second Intervention||0
5292105|NCT00581867|13009390|P1|NOT COMPLETED|Second Intervention||0
5292106|NCT00581867|13009389|P2|COMPLETED|Second Intervention||14
5292107|NCT00581867|13009390|P1|COMPLETED|Second Intervention||15
5292108|NCT00581867|13009389|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
5292109|NCT00581867|13009390|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
5292110|NCT00581867|13009389|P2|NOT COMPLETED|First Intervention||0
5292111|NCT00581867|13009390|P1|NOT COMPLETED|First Intervention||0
5292112|NCT00581867|13009389|P2|COMPLETED|First Intervention||15
5292113|NCT00581867|13009390|P1|COMPLETED|First Intervention||16
5292114|NCT00581867|13009389|P2|STARTED|First Intervention||15
5292115|NCT00581867|13009390|P1|STARTED|First Intervention||16
5292116|NCT00581854|13009398|P1|NOT COMPLETED|Overall Study||0
5292117|NCT00581854|13009398|P1|COMPLETED|Overall Study||22
5292118|NCT00581854|13009398|P1|STARTED|Overall Study||22
5292119|NCT00581828|13009402|P1|NOT COMPLETED|Overall Study||1
5292120|NCT00581828|13009402|P1|COMPLETED|Overall Study||18
5292121|NCT00581828|13009402|P1|STARTED|Overall Study||19
5292122|NCT00581776|13009406|P1|NOT COMPLETED|Overall Study||3
5292123|NCT00581776|13009406|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
5292124|NCT00581776|13009406|P1|STARTED|Overall Study||30
5292125|NCT00581581|13009415|P2|NOT COMPLETED|Overall Study||0
5292126|NCT00581581|13009416|P1|NOT COMPLETED|Overall Study||0
5292127|NCT00581581|13009415|P2|COMPLETED|Overall Study||30
5292128|NCT00581581|13009416|P1|COMPLETED|Overall Study||32
5292129|NCT00581581|13009415|P2|STARTED|Overall Study||30
5292130|NCT00581581|13009416|P1|STARTED|Overall Study||32
5292131|NCT00581555|13009424|P2|NOT COMPLETED|Overall Study||20
5292132|NCT00581555|13009425|P1|NOT COMPLETED|Overall Study||43
5292133|NCT00581555|13009424|P2|COMPLETED|Overall Study||38
5292134|NCT00581555|13009425|P1|COMPLETED|Overall Study||19
5292135|NCT00581555|13009424|P2|STARTED|Overall Study||58
5292136|NCT00581555|13009425|P1|STARTED|Overall Study||62
5292137|NCT00581542|13009449|P2|NOT COMPLETED|Overall Study||23
5292138|NCT00581542|13009450|P1|NOT COMPLETED|Overall Study||11
5292139|NCT00581542|13009449|P2|COMPLETED|Overall Study||39
5292140|NCT00581542|13009450|P1|COMPLETED|Overall Study||51
5292141|NCT00581542|13009449|P2|STARTED|Overall Study||62
5292142|NCT00581542|13009450|P1|STARTED|Overall Study||62
5292143|NCT00581529|13009458|P1|NOT COMPLETED|Overall Study||0
5292144|NCT00581529|13009458|P1|COMPLETED|Overall Study||34
5292145|NCT00581529|13009458|P1|STARTED|Overall Study||34
5292146|NCT00581399|13009467|P2|NOT COMPLETED|Overall Study||0
5292147|NCT00581399|13009468|P1|NOT COMPLETED|Overall Study||0
5292148|NCT00581399|13009467|P2|COMPLETED|Overall Study||48
5292149|NCT00581399|13009468|P1|COMPLETED|Overall Study||46
5292150|NCT00581399|13009467|P2|STARTED|Overall Study||48
5292151|NCT00581399|13009468|P1|STARTED|Overall Study||46
5292152|NCT00581386|13009479|P3|NOT COMPLETED|Overall Study||0
5292153|NCT00581386|13009480|P2|NOT COMPLETED|Overall Study||0
5292154|NCT00581386|13009481|P1|NOT COMPLETED|Overall Study||0
5292155|NCT00581386|13009479|P3|COMPLETED|Overall Study|04/15/2009|72
5292156|NCT00581386|13009480|P2|COMPLETED|Overall Study|04/15/2009|73
5292157|NCT00581386|13009481|P1|COMPLETED|Overall Study|04/15/2009|73
5292158|NCT00581386|13009479|P3|STARTED|Overall Study|05/30/2007|72
5292159|NCT00581386|13009480|P2|STARTED|Overall Study|05/30/2007|73
5292160|NCT00581386|13009481|P1|STARTED|Overall Study|05/30/2007|73
5292161|NCT00581360|13009504|P1|NOT COMPLETED|Overall Study||1
5292162|NCT00581360|13009504|P1|COMPLETED|Overall Study||9
5292163|NCT00581360|13009504|P1|STARTED|Overall Study||10
5292164|NCT00581347|13009514|P2|NOT COMPLETED|Overall Study||0
5292165|NCT00581347|13009515|P1|NOT COMPLETED|Overall Study||0
5292166|NCT00581347|13009514|P2|COMPLETED|Overall Study||3707
5292167|NCT00581347|13009515|P1|COMPLETED|Overall Study||3839
5292168|NCT00581347|13009514|P2|STARTED|Overall Study||3707
5292169|NCT00581347|13009515|P1|STARTED|Overall Study||3839
5292170|NCT00581308|13009523|P1|NOT COMPLETED|60 Months||3
5292171|NCT00581308|13009523|P1|COMPLETED|60 Months||158
5292172|NCT00581308|13009523|P1|STARTED|60 Months||161
5292173|NCT00581308|13009523|P1|NOT COMPLETED|48 Months||9
5292174|NCT00581308|13009523|P1|COMPLETED|48 Months||161
5292175|NCT00581308|13009523|P1|STARTED|48 Months||170
5292176|NCT00581308|13009523|P1|NOT COMPLETED|36 Months||6
5292177|NCT00581308|13009523|P1|COMPLETED|36 Months||170
5292178|NCT00581308|13009523|P1|STARTED|36 Months||176
5292179|NCT00581308|13009523|P1|NOT COMPLETED|24 Months||6
5292180|NCT00581308|13009523|P1|COMPLETED|24 Months||176
5292181|NCT00581308|13009523|P1|STARTED|24 Months||182
5292182|NCT00581308|13009523|P1|NOT COMPLETED|Month 12||20
5292183|NCT00581308|13009523|P1|COMPLETED|Month 12||182
5292184|NCT00581308|13009523|P1|STARTED|Month 12||202
5292185|NCT00581308|13009523|P1|NOT COMPLETED|Month 6||3
5292186|NCT00581308|13009523|P1|COMPLETED|Month 6||202
5292187|NCT00581308|13009523|P1|STARTED|Month 6||205
5292188|NCT00581308|13009523|P1|NOT COMPLETED|Month 1||8
5292189|NCT00581308|13009523|P1|COMPLETED|Month 1||205
5292190|NCT00581308|13009523|P1|STARTED|Month 1||213
5292191|NCT00581308|13009523|P1|NOT COMPLETED|Pre Discharge||2
5292192|NCT00581308|13009523|P1|COMPLETED|Pre Discharge||213
5292193|NCT00581308|13009523|P1|STARTED|Pre Discharge||215
5292194|NCT00581256|13009532|P2|NOT COMPLETED|Overall Study||0
5292195|NCT00581256|13009533|P1|NOT COMPLETED|Overall Study||0
5292196|NCT00581256|13009532|P2|COMPLETED|Overall Study||26
5292197|NCT00581256|13009533|P1|COMPLETED|Overall Study||28
5292198|NCT00581256|13009532|P2|STARTED|Overall Study||26
5292199|NCT00581256|13009533|P1|STARTED|Overall Study||28
5292200|NCT00581230|13009545|P1|NOT COMPLETED|Overall Study||0
5292201|NCT00581230|13009545|P1|COMPLETED|Overall Study||51
5292202|NCT00581230|13009545|P1|Laryngoscopy With RAMP|Overall Study||51
5292203|NCT00581230|13009545|P1|Laryngoscopy Without RAMP|Overall Study||51
5292204|NCT00581230|13009545|P1|STARTED|Overall Study||51
5292205|NCT00581113|13009554|P2|NOT COMPLETED|Overall Study||1
5292206|NCT00581113|13009555|P1|NOT COMPLETED|Overall Study||0
5292207|NCT00581113|13009554|P2|COMPLETED|Overall Study||3
5292208|NCT00581113|13009555|P1|COMPLETED|Overall Study||4
5292209|NCT00581113|13009554|P2|STARTED|Overall Study||4
5292210|NCT00581113|13009555|P1|STARTED|Overall Study||4
5292211|NCT00581100|13009565|P2|NOT COMPLETED|Overall Study||5
5292212|NCT00581100|13009566|P1|NOT COMPLETED|Overall Study||7
5292213|NCT00581100|13009565|P2|COMPLETED|Overall Study||29
5292214|NCT00581100|13009566|P1|COMPLETED|Overall Study||31
5292215|NCT00581100|13009565|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
5292216|NCT00581100|13009566|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
5292217|NCT00581100|13009565|P2|STARTED|Overall Study||34
5292218|NCT00581100|13009566|P1|STARTED|Overall Study||38
5292219|NCT00581061|13009602|P1|NOT COMPLETED|Overall Study||0
5292220|NCT00581061|13009602|P1|COMPLETED|Overall Study||13
5292221|NCT00581061|13009602|P1|STARTED|Overall Study||13
5292222|NCT00581048|13009608|P1|NOT COMPLETED|Overall Study||0
5292223|NCT00581048|13009608|P1|COMPLETED|Overall Study||33
5292224|NCT00581048|13009608|P1|STARTED|Overall Study||33
5292225|NCT00580983|13009619|P1|NOT COMPLETED|Overall Study||7
5292226|NCT00580983|13009619|P1|COMPLETED|Overall Study||73
5292227|NCT00580983|13009619|P1|STARTED|Overall Study||80
5292228|NCT00580970|13009626|P1|NOT COMPLETED|Treatment (Lovastatin)||19
5292229|NCT00580970|13009626|P1|COMPLETED|Treatment (Lovastatin)||53
5292230|NCT00580970|13009626|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
5292231|NCT00580970|13009626|P1|STARTED|Treatment (Lovastatin)||72
5292232|NCT00580970|13009626|P1|NOT COMPLETED|Pre-treatment||1
5292233|NCT00580970|13009626|P1|COMPLETED|Pre-treatment||72
5292234|NCT00580970|13009626|P1|STARTED|Pre-treatment||73
5292235|NCT00580957|13009632|P2|NOT COMPLETED|Overall Study||7
5292236|NCT00580957|13009633|P1|NOT COMPLETED|Overall Study||7
5292237|NCT00580957|13009632|P2|COMPLETED|Overall Study||21
5292238|NCT00580957|13009633|P1|COMPLETED|Overall Study||21
5292239|NCT00580957|13009632|P2|STARTED|Overall Study||28
5292240|NCT00580957|13009633|P1|STARTED|Overall Study||28
5292241|NCT00580866|13009641|P2|NOT COMPLETED|Overall Study||2
5292242|NCT00580866|13009642|P1|NOT COMPLETED|Overall Study||2
5292243|NCT00580866|13009641|P2|COMPLETED|Overall Study||5
5292244|NCT00580866|13009642|P1|COMPLETED|Overall Study||8
5292245|NCT00580866|13009641|P2|STARTED|Overall Study||7
5292246|NCT00580866|13009642|P1|STARTED|Overall Study||10
5292247|NCT00580853|13009653|P3|NOT COMPLETED|Overall Study||0
5292248|NCT00580853|13009654|P2|NOT COMPLETED|Overall Study||0
5292249|NCT00580853|13009655|P1|NOT COMPLETED|Overall Study||0
5292250|NCT00580853|13009653|P3|COMPLETED|Overall Study||21
5292251|NCT00580853|13009654|P2|COMPLETED|Overall Study||21
5292252|NCT00580853|13009655|P1|COMPLETED|Overall Study||20
5292253|NCT00580853|13009653|P3|STARTED|Overall Study||21
5292254|NCT00580853|13009654|P2|STARTED|Overall Study||21
5292255|NCT00580853|13009655|P1|STARTED|Overall Study||20
5292256|NCT00580840|13009666|P4|NOT COMPLETED|Double-Blind||15
5292257|NCT00580840|13009667|P3|NOT COMPLETED|Double-Blind||9
5292258|NCT00580840|13009668|P2|NOT COMPLETED|Double-Blind||7
5292259|NCT00580840|13009669|P1|NOT COMPLETED|Double-Blind||0
5292260|NCT00580840|13009666|P4|COMPLETED|Double-Blind||54
5292261|NCT00580840|13009667|P3|COMPLETED|Double-Blind||61
5292262|NCT00580840|13009668|P2|COMPLETED|Double-Blind||63
5292263|NCT00580840|13009669|P1|COMPLETED|Double-Blind||0
5292264|NCT00580840|13009666|P4|STARTED|Double-Blind||69
5292265|NCT00580840|13009667|P3|STARTED|Double-Blind||70
5292266|NCT00580840|13009668|P2|STARTED|Double-Blind||70
5292267|NCT00580840|13009669|P1|STARTED|Double-Blind||0
5292268|NCT00580840|13009666|P4|NOT COMPLETED|Run-in||0
5292269|NCT00580840|13009667|P3|NOT COMPLETED|Run-in||0
5292270|NCT00580840|13009668|P2|NOT COMPLETED|Run-in||0
5292271|NCT00580840|13009669|P1|NOT COMPLETED|Run-in||124
5292272|NCT00580840|13009666|P4|COMPLETED|Run-in||0
5292273|NCT00580840|13009667|P3|COMPLETED|Run-in||0
5292274|NCT00580840|13009668|P2|COMPLETED|Run-in||0
5292275|NCT00580840|13009669|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
5292276|NCT00580840|13009666|P4|STARTED|Run-in||0
5292277|NCT00580840|13009667|P3|STARTED|Run-in||0
5292278|NCT00580840|13009668|P2|STARTED|Run-in||0
5292279|NCT00580840|13009669|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
5292280|NCT00580801|13009777|P3|NOT COMPLETED|Overall Study||3
5292281|NCT00580801|13009778|P2|NOT COMPLETED|Overall Study||1
5292282|NCT00580801|13009779|P1|NOT COMPLETED|Overall Study||6
5292283|NCT00580801|13009777|P3|COMPLETED|Overall Study||5
5292284|NCT00580801|13009778|P2|COMPLETED|Overall Study||7
5292285|NCT00580801|13009779|P1|COMPLETED|Overall Study||2
5292286|NCT00580801|13009777|P3|STARTED|Overall Study||8
5292287|NCT00580801|13009778|P2|STARTED|Overall Study||8
5292288|NCT00580801|13009779|P1|STARTED|Overall Study||8
5292289|NCT00580788|13009818|P4|NOT COMPLETED|Overall Study||1
5292290|NCT00580788|13009819|P3|NOT COMPLETED|Overall Study||0
5292291|NCT00580788|13009820|P2|NOT COMPLETED|Overall Study||0
5292292|NCT00580788|13009821|P1|NOT COMPLETED|Overall Study||0
5292293|NCT00580788|13009818|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
5292294|NCT00580788|13009819|P3|COMPLETED|Overall Study||3
5292295|NCT00580788|13009820|P2|COMPLETED|Overall Study||6
5292296|NCT00580788|13009821|P1|COMPLETED|Overall Study||3
5292297|NCT00580788|13009818|P4|STARTED|Overall Study||2
5292298|NCT00580788|13009819|P3|STARTED|Overall Study||3
5292299|NCT00580788|13009820|P2|STARTED|Overall Study||6
5292300|NCT00580788|13009821|P1|STARTED|Overall Study||3
5292301|NCT00580723|13009879|P1|NOT COMPLETED|Overall Study||8
5292302|NCT00580723|13009879|P1|COMPLETED|Overall Study||16
5292303|NCT00580723|13009879|P1|STARTED|Overall Study||24
5292304|NCT00580671|13009888|P3|NOT COMPLETED|Overall Study||17
5292305|NCT00580671|13009889|P2|NOT COMPLETED|Overall Study||16
5292306|NCT00580671|13009890|P1|NOT COMPLETED|Overall Study||16
5292307|NCT00580671|13009888|P3|COMPLETED|Overall Study||34
5292308|NCT00580671|13009889|P2|COMPLETED|Overall Study||35
5292309|NCT00580671|13009890|P1|COMPLETED|Overall Study||35
5292310|NCT00580671|13009888|P3|STARTED|Overall Study||51
5292311|NCT00580671|13009889|P2|STARTED|Overall Study||51
5292312|NCT00580671|13009890|P1|STARTED|Overall Study||51
5292313|NCT00580645|13009907|P3|NOT COMPLETED|Overall Study||0
5292314|NCT00580645|13009908|P2|NOT COMPLETED|Overall Study||0
5292315|NCT00580645|13009909|P1|NOT COMPLETED|Overall Study||0
5292316|NCT00580645|13009907|P3|COMPLETED|Overall Study||20
5292317|NCT00580645|13009908|P2|COMPLETED|Overall Study||20
5292318|NCT00580645|13009909|P1|COMPLETED|Overall Study||20
5292319|NCT00580645|13009907|P3|STARTED|Overall Study||20
5292320|NCT00580645|13009908|P2|STARTED|Overall Study||20
5292321|NCT00580645|13009909|P1|STARTED|Overall Study||20
5292322|NCT00580606|13009922|P2|NOT COMPLETED|Open Label (OL)||12
5292323|NCT00580606|13009923|P1|NOT COMPLETED|Open Label (OL)||9
5292324|NCT00580606|13009922|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
5292325|NCT00580606|13009923|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
5292326|NCT00580606|13009922|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
5292327|NCT00580606|13009923|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
5292328|NCT00580606|13009922|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
5292329|NCT00580606|13009923|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
5292330|NCT00580606|13009922|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
5292331|NCT00580606|13009923|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
5292332|NCT00580606|13009922|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
5292333|NCT00580606|13009923|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
5292334|NCT00580606|13009922|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
5292335|NCT00580606|13009923|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
5292336|NCT00580606|13009922|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
5292337|NCT00580606|13009923|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
5292338|NCT00580606|13009922|P2|NOT COMPLETED|Double Blind (DB)||0
5292339|NCT00580606|13009923|P1|NOT COMPLETED|Double Blind (DB)||0
5292340|NCT00580606|13009922|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
5292341|NCT00580606|13009923|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
5292342|NCT00580606|13009922|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
5292343|NCT00580606|13009923|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
5292344|NCT00580606|13009922|P2|STARTED|Double Blind (DB)||20
5292345|NCT00580606|13009923|P1|STARTED|Double Blind (DB)||20
5292346|NCT00580502|13009941|P1|NOT COMPLETED|Overall Study||0
5292347|NCT00580502|13009941|P1|COMPLETED|Overall Study||50
5292348|NCT00580502|13009941|P1|STARTED|Overall Study||50
5292349|NCT00580398|13009950|P2|NOT COMPLETED|Overall Study||0
5292350|NCT00580398|13009951|P1|NOT COMPLETED|Overall Study||0
5292351|NCT00580398|13009950|P2|COMPLETED|Overall Study||32
5292352|NCT00580398|13009951|P1|COMPLETED|Overall Study||17
5292353|NCT00580398|13009950|P2|STARTED|Overall Study||32
5292354|NCT00580398|13009951|P1|STARTED|Overall Study||17
5292355|NCT00580372|13009959|P1|NOT COMPLETED|Overall Study||0
5292356|NCT00580372|13009959|P1|COMPLETED|Overall Study||231
5292357|NCT00580372|13009959|P1|STARTED|Overall Study||231
5292358|NCT00580333|13009963|P1|NOT COMPLETED|Overall Study||0
5292359|NCT00580333|13009963|P1|COMPLETED|Overall Study||51
5292360|NCT00580333|13009963|P1|STARTED|Overall Study||51
5292361|NCT00580294|13009970|P1|NOT COMPLETED|Overall Study||0
5292362|NCT00580294|13009970|P1|COMPLETED|Overall Study||12
5292363|NCT00580294|13009970|P1|STARTED|Overall Study||12
5292364|NCT00580229|13009974|P1|NOT COMPLETED|Overall Study||0
5292365|NCT00580229|13009974|P1|COMPLETED|Overall Study||50
5292366|NCT00580229|13009974|P1|STARTED|Overall Study||50
5292367|NCT00580151|13009982|P2|NOT COMPLETED|Overall Study||0
5292368|NCT00580151|13009983|P1|NOT COMPLETED|Overall Study||0
5292369|NCT00580151|13009982|P2|COMPLETED|Overall Study||0
5292370|NCT00580151|13009983|P1|COMPLETED|Overall Study||9
5292371|NCT00580151|13009982|P2|STARTED|Overall Study||0
5292372|NCT00580151|13009983|P1|STARTED|Overall Study||9
5292373|NCT00580138|13009991|P1|NOT COMPLETED|Overall Study||0
5292374|NCT00580138|13009991|P1|COMPLETED|Overall Study||30
5292375|NCT00580138|13009991|P1|STARTED|Overall Study||30
5292376|NCT00580073|13009995|P1|NOT COMPLETED|Overall Study||0
5292377|NCT00580073|13009995|P1|COMPLETED|Overall Study||6
5292378|NCT00580073|13009995|P1|STARTED|Overall Study||6
5292379|NCT00580047|13010004|P3|NOT COMPLETED|Overall Study||2
5292380|NCT00580047|13010005|P2|NOT COMPLETED|Overall Study||2
5292381|NCT00580047|13010006|P1|NOT COMPLETED|Overall Study||3
5292382|NCT00580047|13010004|P3|COMPLETED|Overall Study||10
5292383|NCT00580047|13010005|P2|COMPLETED|Overall Study||21
5292384|NCT00580047|13010006|P1|COMPLETED|Overall Study||21
5292385|NCT00580047|13010004|P3|STARTED|Overall Study||12
5292386|NCT00580047|13010005|P2|STARTED|Overall Study||23
5292387|NCT00580047|13010006|P1|STARTED|Overall Study||24
5292388|NCT00580034|13010017|P2|NOT COMPLETED|Overall Study||0
5292389|NCT00580034|13010018|P1|NOT COMPLETED|Overall Study||10
5292390|NCT00580034|13010017|P2|COMPLETED|Overall Study||88
5292391|NCT00580034|13010018|P1|COMPLETED|Overall Study||78
5292392|NCT00580034|13010017|P2|STARTED|Overall Study||88
5292393|NCT00580034|13010018|P1|STARTED|Overall Study||88
5292394|NCT00579982|13010024|P1|NOT COMPLETED|Overall Study||8
5292395|NCT00579982|13010024|P1|COMPLETED|Overall Study||89
5292396|NCT00579982|13010024|P1|STARTED|Overall Study||97
5292397|NCT00579878|13010046|P3|NOT COMPLETED|Overall Study||10
5292398|NCT00579878|13010047|P2|NOT COMPLETED|Overall Study||3
5292399|NCT00579878|13010048|P1|NOT COMPLETED|Overall Study||7
5292400|NCT00579878|13010046|P3|COMPLETED|Overall Study||14
5292401|NCT00579878|13010047|P2|COMPLETED|Overall Study||20
5292402|NCT00579878|13010048|P1|COMPLETED|Overall Study||15
5292403|NCT00579878|13010046|P3|STARTED|Overall Study||24
5292404|NCT00579878|13010047|P2|STARTED|Overall Study||23
5292405|NCT00579878|13010048|P1|STARTED|Overall Study||22
5292406|NCT00579826|13010058|P2|NOT COMPLETED|Overall Study||3
5292407|NCT00579826|13010059|P1|NOT COMPLETED|Overall Study||5
5292408|NCT00579826|13010058|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
5292409|NCT00579826|13010059|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
5292410|NCT00579826|13010058|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
5292411|NCT00579826|13010059|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
5292412|NCT00579826|13010058|P2|STARTED|Overall Study||26
5292413|NCT00579826|13010059|P1|STARTED|Overall Study||29
5292414|NCT00579813|13010071|P2|NOT COMPLETED|Overall Study||0
5292415|NCT00579813|13010072|P1|NOT COMPLETED|Overall Study||0
5292416|NCT00579813|13010071|P2|COMPLETED|Overall Study||10
5292417|NCT00579813|13010072|P1|COMPLETED|Overall Study||60
5292418|NCT00579813|13010071|P2|STARTED|Overall Study||10
5292419|NCT00579813|13010072|P1|STARTED|Overall Study||60
5292420|NCT00579670|13010093|P5|NOT COMPLETED|Overall Study||0
5292421|NCT00579670|13010094|P4|NOT COMPLETED|Overall Study||22
5292422|NCT00579670|13010095|P3|NOT COMPLETED|Overall Study||4
5292423|NCT00579670|13010096|P2|NOT COMPLETED|Overall Study||1
5292424|NCT00579670|13010097|P1|NOT COMPLETED|Overall Study||2
5292425|NCT00579670|13010093|P5|COMPLETED|Overall Study||5
5292426|NCT00579670|13010094|P4|COMPLETED|Overall Study||263
5292427|NCT00579670|13010095|P3|COMPLETED|Overall Study||84
5292428|NCT00579670|13010096|P2|COMPLETED|Overall Study||56
5292429|NCT00579670|13010097|P1|COMPLETED|Overall Study||13
5292430|NCT00579670|13010093|P5|Population: Within SmPC (Completed)|Overall Study||0
5292431|NCT00579670|13010094|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
5292432|NCT00579670|13010095|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
5292433|NCT00579670|13010096|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
5292434|NCT00579670|13010097|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
5292435|NCT00579670|13010093|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
5292436|NCT00579670|13010094|P4|Population: Within SmPC (Started)|Overall Study||159
5292437|NCT00579670|13010095|P3|Population: Within SmPC (Started)|Overall Study||83
5292438|NCT00579670|13010096|P2|Population: Within SmPC (Started)|Overall Study||56
5292439|NCT00579670|13010097|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
5292440|NCT00579670|13010093|P5|STARTED|Overall Study||5
5292441|NCT00579670|13010094|P4|STARTED|Overall Study||285
5292442|NCT00579670|13010095|P3|STARTED|Overall Study||88
5292443|NCT00579670|13010096|P2|STARTED|Overall Study||57
5292444|NCT00579670|13010097|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
5292445|NCT00579527|13010309|P1|NOT COMPLETED|Overall Study||4
5292446|NCT00579527|13010309|P1|COMPLETED|Overall Study||10
5292447|NCT00579527|13010309|P1|STARTED|Overall Study||14
5292448|NCT00579501|13010321|P1|NOT COMPLETED|Overall Study||29
5292449|NCT00579501|13010321|P1|COMPLETED|Overall Study||0
5292450|NCT00579501|13010321|P1|STARTED|Overall Study||29
5292451|NCT00579436|13010328|P2|NOT COMPLETED|Overall Study||0
5292452|NCT00579436|13010329|P1|NOT COMPLETED|Overall Study||0
5292453|NCT00579436|13010328|P2|COMPLETED|Overall Study||14
5292454|NCT00579436|13010329|P1|COMPLETED|Overall Study||19
5292455|NCT00579436|13010328|P2|STARTED|Overall Study||14
5292456|NCT00579436|13010329|P1|STARTED|Overall Study||19
5292457|NCT00579345|13010349|P8|NOT COMPLETED|Overall Study||2
5292458|NCT00579345|13010350|P7|NOT COMPLETED|Overall Study||0
5292459|NCT00579345|13010351|P6|NOT COMPLETED|Overall Study||0
5292460|NCT00579345|13010352|P5|NOT COMPLETED|Overall Study||0
5292461|NCT00579345|13010353|P4|NOT COMPLETED|Overall Study||1
5292462|NCT00579345|13010354|P3|NOT COMPLETED|Overall Study||2
5292463|NCT00579345|13010355|P2|NOT COMPLETED|Overall Study||1
5292464|NCT00579345|13010356|P1|NOT COMPLETED|Overall Study||5
5292465|NCT00579345|13010349|P8|COMPLETED|Overall Study||42
5292466|NCT00579345|13010350|P7|COMPLETED|Overall Study||57
5292467|NCT00579345|13010351|P6|COMPLETED|Overall Study||78
5292468|NCT00579345|13010352|P5|COMPLETED|Overall Study||90
5292469|NCT00579345|13010353|P4|COMPLETED|Overall Study||143
5292470|NCT00579345|13010354|P3|COMPLETED|Overall Study||389
5292471|NCT00579345|13010355|P2|COMPLETED|Overall Study||168
5292472|NCT00579345|13010356|P1|COMPLETED|Overall Study||544
5292473|NCT00579345|13010349|P8|STARTED|Overall Study||44
5292474|NCT00579345|13010350|P7|STARTED|Overall Study||57
5292475|NCT00579345|13010351|P6|STARTED|Overall Study||78
5292476|NCT00579345|13010352|P5|STARTED|Overall Study||90
5292477|NCT00579345|13010353|P4|STARTED|Overall Study||144
5292478|NCT00579345|13010354|P3|STARTED|Overall Study||391
5292479|NCT00579345|13010355|P2|STARTED|Overall Study||169
5292480|NCT00579345|13010356|P1|STARTED|Overall Study||549
5292481|NCT00579280|13010391|P3|NOT COMPLETED|Overall Study||0
5292482|NCT00579280|13010392|P2|NOT COMPLETED|Overall Study||3
5292483|NCT00579280|13010393|P1|NOT COMPLETED|Overall Study||2
5292484|NCT00579280|13010391|P3|COMPLETED|Overall Study|LOCF evaluable sample|51
5292485|NCT00579280|13010392|P2|COMPLETED|Overall Study|LOCF evaluable sample|46
5292486|NCT00579280|13010393|P1|COMPLETED|Overall Study|LOCF evaluable sample|47
5292487|NCT00579280|13010391|P3|STARTED|Overall Study||51
5292488|NCT00579280|13010392|P2|STARTED|Overall Study||49
5292489|NCT00579280|13010393|P1|STARTED|Overall Study||49
5292490|NCT00579254|13010431|P1|NOT COMPLETED|Overall Study||112
5292491|NCT00579254|13010431|P1|COMPLETED|Overall Study||0
5292492|NCT00579254|13010431|P1|STARTED|Overall Study||112
5292493|NCT00579137|13010435|P1|NOT COMPLETED|Overall Study||0
5292494|NCT00579137|13010435|P1|COMPLETED|Overall Study||3
5292495|NCT00579137|13010435|P1|STARTED|Overall Study||3
5292496|NCT00579111|13010444|P2|NOT COMPLETED|Overall Study||1
5292497|NCT00579111|13010445|P1|NOT COMPLETED|Overall Study||2
5292498|NCT00579111|13010444|P2|COMPLETED|Overall Study||0
5292499|NCT00579111|13010445|P1|COMPLETED|Overall Study||1
5292500|NCT00579111|13010444|P2|STARTED|Overall Study||1
5292501|NCT00579111|13010445|P1|STARTED|Overall Study||3
5292502|NCT00579098|13010455|P2|NOT COMPLETED|Overall Study||8
5292503|NCT00579098|13010456|P1|NOT COMPLETED|Overall Study||9
5292504|NCT00579098|13010455|P2|COMPLETED|Overall Study||55
5292505|NCT00579098|13010456|P1|COMPLETED|Overall Study||53
5292506|NCT00579098|13010455|P2|STARTED|Overall Study||63
5292507|NCT00579098|13010456|P1|STARTED|Overall Study||62
5292508|NCT00579059|13010472|P2|NOT COMPLETED|Overall Study||10
5292509|NCT00579059|13010473|P1|NOT COMPLETED|Overall Study||21
5292510|NCT00579059|13010472|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
5292511|NCT00579059|13010473|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
5292512|NCT00579059|13010472|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
5292513|NCT00579059|13010473|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
5292514|NCT00579059|13010472|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
5292515|NCT00579059|13010473|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
5292516|NCT00579059|13010472|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
5292517|NCT00579059|13010473|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
5292518|NCT00579059|13010472|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
5292519|NCT00579059|13010473|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
5292520|NCT00579059|13010472|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
5292521|NCT00579059|13010473|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
5292522|NCT00579059|13010472|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
5292523|NCT00579059|13010473|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
5292524|NCT00578968|13010484|P3|NOT COMPLETED|Intervention||0
5292525|NCT00578968|13010485|P2|NOT COMPLETED|Intervention||0
5292526|NCT00578968|13010486|P1|NOT COMPLETED|Intervention||0
5292527|NCT00578968|13010484|P3|COMPLETED|Intervention||0
5292528|NCT00578968|13010485|P2|COMPLETED|Intervention||12
5292529|NCT00578968|13010486|P1|COMPLETED|Intervention||12
5292530|NCT00578968|13010484|P3|STARTED|Intervention||0
5292531|NCT00578968|13010485|P2|STARTED|Intervention||12
5292532|NCT00578968|13010486|P1|STARTED|Intervention||12
5292533|NCT00578968|13010484|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
5292534|NCT00578968|13010485|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
5292535|NCT00578968|13010486|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
5292536|NCT00578968|13010484|P3|COMPLETED|Baseline (Prior to Intervention)||12
5292537|NCT00578968|13010485|P2|COMPLETED|Baseline (Prior to Intervention)||12
5292538|NCT00578968|13010486|P1|COMPLETED|Baseline (Prior to Intervention)||12
5292539|NCT00578968|13010484|P3|STARTED|Baseline (Prior to Intervention)||12
5292540|NCT00578968|13010485|P2|STARTED|Baseline (Prior to Intervention)||12
5292541|NCT00578968|13010486|P1|STARTED|Baseline (Prior to Intervention)||12
5292542|NCT00578942|13010547|P1|NOT COMPLETED|Overall Study||1
5292543|NCT00578942|13010547|P1|COMPLETED|Overall Study||47
5292544|NCT00578942|13010547|P1|STARTED|Overall Study||48
5292545|NCT00578929|13010557|P4|NOT COMPLETED|Randomized Period||14
5292546|NCT00578929|13010558|P3|NOT COMPLETED|Randomized Period||8
5292547|NCT00578929|13010559|P2|NOT COMPLETED|Randomized Period||14
5292548|NCT00578929|13010560|P1|NOT COMPLETED|Randomized Period||17
5292549|NCT00578929|13010557|P4|COMPLETED|Randomized Period||283
5292550|NCT00578929|13010558|P3|COMPLETED|Randomized Period||288
5292551|NCT00578929|13010559|P2|COMPLETED|Randomized Period||283
5292552|NCT00578929|13010560|P1|COMPLETED|Randomized Period||281
5292553|NCT00578929|13010557|P4|STARTED|Randomized Period||297
5292554|NCT00578929|13010558|P3|STARTED|Randomized Period||296
5292555|NCT00578929|13010559|P2|STARTED|Randomized Period||297
5292556|NCT00578929|13010560|P1|STARTED|Randomized Period||298
5292557|NCT00578929|13010557|P4|NOT COMPLETED|Vehicle Run-In Period||0
5292558|NCT00578929|13010558|P3|NOT COMPLETED|Vehicle Run-In Period||0
5292559|NCT00578929|13010559|P2|NOT COMPLETED|Vehicle Run-In Period||0
5292560|NCT00578929|13010560|P1|NOT COMPLETED|Vehicle Run-In Period||0
5292561|NCT00578929|13010557|P4|COMPLETED|Vehicle Run-In Period||0
5292562|NCT00578929|13010558|P3|COMPLETED|Vehicle Run-In Period||0
5292563|NCT00578929|13010559|P2|COMPLETED|Vehicle Run-In Period||2388
5292564|NCT00578929|13010560|P1|COMPLETED|Vehicle Run-In Period||0
5292565|NCT00578929|13010557|P4|STARTED|Vehicle Run-In Period||0
5292566|NCT00578929|13010558|P3|STARTED|Vehicle Run-In Period||0
5292567|NCT00578929|13010559|P2|STARTED|Vehicle Run-In Period||2388
5292568|NCT00578929|13010560|P1|STARTED|Vehicle Run-In Period||0
5292569|NCT00578903|13010575|P1|NOT COMPLETED|Overall Study||0
5292570|NCT00578903|13010575|P1|COMPLETED|Overall Study||22
5292571|NCT00578903|13010575|P1|STARTED|Overall Study||22
5292572|NCT00578877|13010586|P2|NOT COMPLETED|Overall Study||128
5292573|NCT00578877|13010587|P1|NOT COMPLETED|Overall Study||81
5292574|NCT00578877|13010586|P2|COMPLETED|Overall Study||172
5292575|NCT00578877|13010587|P1|COMPLETED|Overall Study||69
5292576|NCT00578877|13010586|P2|STARTED|Overall Study||300
5292577|NCT00578877|13010587|P1|STARTED|Overall Study||150
5292578|NCT00578864|13010595|P2|NOT COMPLETED|Overall Study||0
5292579|NCT00578864|13010596|P1|NOT COMPLETED|Overall Study||1
5292580|NCT00578864|13010595|P2|COMPLETED|Overall Study||6
5292581|NCT00578864|13010596|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
5292582|NCT00578864|13010595|P2|STARTED|Overall Study||6
5292583|NCT00578864|13010596|P1|STARTED|Overall Study||7
5292584|NCT00578812|13010612|P2|NOT COMPLETED|Overall Study||7
5292585|NCT00578812|13010613|P1|NOT COMPLETED|Overall Study||6
5292586|NCT00578812|13010612|P2|COMPLETED|Overall Study||185
5292587|NCT00578812|13010613|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
5292588|NCT00578812|13010612|P2|STARTED|Overall Study||192
5292589|NCT00578812|13010613|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
5292590|NCT00578786|13010652|P3|NOT COMPLETED|Overall Study||30
5292591|NCT00578786|13010653|P2|NOT COMPLETED|Overall Study||66
5292592|NCT00578786|13010654|P1|NOT COMPLETED|Overall Study||39
5292593|NCT00578786|13010652|P3|COMPLETED|Overall Study||67
5292594|NCT00578786|13010653|P2|COMPLETED|Overall Study||124
5292595|NCT00578786|13010654|P1|COMPLETED|Overall Study||57
5292596|NCT00578786|13010652|P3|STARTED|Overall Study||97
5292597|NCT00578786|13010653|P2|STARTED|Overall Study||190
5292598|NCT00578786|13010654|P1|STARTED|Overall Study||96
5292599|NCT00578734|13010735|P2|NOT COMPLETED|Overall Study||0
5292600|NCT00578734|13010736|P1|NOT COMPLETED|Overall Study||0
5292601|NCT00578734|13010735|P2|COMPLETED|Overall Study||81
5292602|NCT00578734|13010736|P1|COMPLETED|Overall Study||84
5292603|NCT00578734|13010735|P2|STARTED|Overall Study||81
5292604|NCT00578734|13010736|P1|STARTED|Overall Study||84
5292605|NCT00578669|13010746|P2|NOT COMPLETED|Overall Study||0
5292606|NCT00578669|13010747|P1|NOT COMPLETED|Overall Study||0
5292607|NCT00578669|13010746|P2|COMPLETED|Overall Study||99
5292608|NCT00578669|13010747|P1|COMPLETED|Overall Study||107
5292609|NCT00578669|13010746|P2|STARTED|Overall Study||99
5292610|NCT00578669|13010747|P1|STARTED|Overall Study||107
5292611|NCT00578643|13010755|P1|NOT COMPLETED|Overall Study||2
5292612|NCT00578643|13010755|P1|COMPLETED|Overall Study||13
5292613|NCT00578643|13010755|P1|STARTED|Overall Study||15
5292614|NCT00578617|13010764|P2|NOT COMPLETED|Overall Study||0
5292615|NCT00578617|13010765|P1|NOT COMPLETED|Overall Study||0
5292616|NCT00578617|13010764|P2|COMPLETED|Overall Study||29
5292617|NCT00578617|13010765|P1|COMPLETED|Overall Study||31
5292618|NCT00578617|13010764|P2|STARTED|Overall Study||29
5292619|NCT00578617|13010765|P1|STARTED|Overall Study||31
5292620|NCT00578565|13010771|P1|NOT COMPLETED|Overall Study||3
5292621|NCT00578565|13010771|P1|COMPLETED|Overall Study||7
5292622|NCT00578565|13010771|P1|STARTED|Overall Study||10
5292623|NCT00578552|13010783|P3|NOT COMPLETED|Overall Study||15
5292624|NCT00578552|13010784|P2|NOT COMPLETED|Overall Study||14
5292625|NCT00578552|13010785|P1|NOT COMPLETED|Overall Study||15
5292626|NCT00578552|13010783|P3|COMPLETED|Overall Study||11
5292627|NCT00578552|13010784|P2|COMPLETED|Overall Study||13
5292628|NCT00578552|13010785|P1|COMPLETED|Overall Study||12
5292629|NCT00578552|13010783|P3|STARTED|Overall Study||26
5292630|NCT00578552|13010784|P2|STARTED|Overall Study||27
5292631|NCT00578552|13010785|P1|STARTED|Overall Study||27
5292632|NCT00578539|13010793|P1|NOT COMPLETED|Overall Study||0
5292633|NCT00578539|13010793|P1|COMPLETED|Overall Study||24
5292634|NCT00578539|13010793|P1|STARTED|Overall Study||24
5292635|NCT00578461|13010797|P1|NOT COMPLETED|Overall Study||0
5292636|NCT00578461|13010797|P1|COMPLETED|Overall Study||26
5292637|NCT00578461|13010797|P1|STARTED|Overall Study||26
5292638|NCT00578448|13010801|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
5292639|NCT00578448|13010801|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
5292640|NCT00578448|13010801|P1|STARTED|1 Year Long Term Extension (LTE)||9
5292641|NCT00578448|13010801|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
5292642|NCT00578448|13010801|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
5292643|NCT00578448|13010801|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
5292644|NCT00578383|13010819|P4|NOT COMPLETED|Overall Study||6
5292645|NCT00578383|13010820|P3|NOT COMPLETED|Overall Study||6
5292646|NCT00578383|13010821|P2|NOT COMPLETED|Overall Study||16
5292647|NCT00578383|13010822|P1|NOT COMPLETED|Overall Study||16
5292648|NCT00578383|13010819|P4|COMPLETED|Overall Study||9
5292649|NCT00578383|13010820|P3|COMPLETED|Overall Study||13
5292650|NCT00578383|13010821|P2|COMPLETED|Overall Study||20
5292651|NCT00578383|13010822|P1|COMPLETED|Overall Study||21
5292652|NCT00578383|13010819|P4|STARTED|Overall Study||15
5292653|NCT00578383|13010820|P3|STARTED|Overall Study||19
5292654|NCT00578383|13010821|P2|STARTED|Overall Study||36
5292655|NCT00578383|13010822|P1|STARTED|Overall Study||37
5292656|NCT00578344|13010852|P1|NOT COMPLETED|Overall Study||2
5292657|NCT00578344|13010852|P1|COMPLETED|Overall Study||6
5292658|NCT00578344|13010852|P1|STARTED|Overall Study||8
5292659|NCT00578331|13010860|P2|NOT COMPLETED|Overall Study||125
5292660|NCT00578331|13010861|P1|NOT COMPLETED|Overall Study||116
5292661|NCT00578331|13010860|P2|COMPLETED|Overall Study||320
5292662|NCT00578331|13010861|P1|COMPLETED|Overall Study||329
5292663|NCT00578331|13010860|P2|STARTED|Overall Study||445
5292664|NCT00578331|13010861|P1|STARTED|Overall Study||445
5292665|NCT00578318|13010871|P2|NOT COMPLETED|Overall Study||0
5292666|NCT00578318|13010872|P1|NOT COMPLETED|Overall Study||3
5292667|NCT00578318|13010871|P2|COMPLETED|Overall Study||8
5292668|NCT00578318|13010872|P1|COMPLETED|Overall Study||5
5292669|NCT00578318|13010871|P2|STARTED|Overall Study||8
5292670|NCT00578318|13010872|P1|STARTED|Overall Study||8
5292671|NCT00578305|13010881|P3|NOT COMPLETED|Safety Follow-up Phase||46
5292672|NCT00578305|13010882|P2|NOT COMPLETED|Safety Follow-up Phase||45
5292673|NCT00578305|13010883|P1|NOT COMPLETED|Safety Follow-up Phase||46
5292674|NCT00578305|13010881|P3|COMPLETED|Safety Follow-up Phase||8
5292675|NCT00578305|13010882|P2|COMPLETED|Safety Follow-up Phase||9
5292676|NCT00578305|13010883|P1|COMPLETED|Safety Follow-up Phase||11
5292677|NCT00578305|13010881|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
5292678|NCT00578305|13010882|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
5292679|NCT00578305|13010883|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
5292680|NCT00578305|13010881|P3|NOT COMPLETED|Extension Phase||3
5292681|NCT00578305|13010882|P2|NOT COMPLETED|Extension Phase||1
5292682|NCT00578305|13010883|P1|NOT COMPLETED|Extension Phase||4
5292683|NCT00578305|13010881|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
5292684|NCT00578305|13010882|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
5292685|NCT00578305|13010883|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
5292686|NCT00578305|13010881|P3|STARTED|Extension Phase||43
5292687|NCT00578305|13010882|P2|STARTED|Extension Phase||50
5292688|NCT00578305|13010883|P1|STARTED|Extension Phase||53
5292689|NCT00578305|13010881|P3|NOT COMPLETED|Double-blind Treatment Phase||14
5292690|NCT00578305|13010882|P2|NOT COMPLETED|Double-blind Treatment Phase||4
5292691|NCT00578305|13010883|P1|NOT COMPLETED|Double-blind Treatment Phase||3
5292692|NCT00578305|13010881|P3|COMPLETED|Double-blind Treatment Phase||49
5292693|NCT00578305|13010882|P2|COMPLETED|Double-blind Treatment Phase||56
5292694|NCT00578305|13010883|P1|COMPLETED|Double-blind Treatment Phase||59
5292695|NCT00578305|13010881|P3|Treated|Double-blind Treatment Phase||63
5292696|NCT00578305|13010882|P2|Treated|Double-blind Treatment Phase||60
5292697|NCT00578305|13010883|P1|Treated|Double-blind Treatment Phase||62
5292698|NCT00578305|13010881|P3|STARTED|Double-blind Treatment Phase||63
5292699|NCT00578305|13010882|P2|STARTED|Double-blind Treatment Phase||60
5292700|NCT00578305|13010883|P1|STARTED|Double-blind Treatment Phase||62
5292701|NCT00578292|13010942|P1|NOT COMPLETED|Overall Study||3
5292702|NCT00578292|13010942|P1|COMPLETED|Overall Study||7
5292703|NCT00578292|13010942|P1|STARTED|Overall Study||10
5292704|NCT00578279|13010956|P2|NOT COMPLETED|Overall Study||0
5292705|NCT00578279|13010957|P1|NOT COMPLETED|Overall Study||0
5292706|NCT00578279|13010956|P2|COMPLETED|Overall Study||10
5292707|NCT00578279|13010957|P1|COMPLETED|Overall Study||10
5292708|NCT00578279|13010956|P2|STARTED|Overall Study||10
5292709|NCT00578279|13010957|P1|STARTED|Overall Study||10
5292710|NCT00578227|13010966|P3|NOT COMPLETED|Overall Study||4
5292711|NCT00578227|13010967|P2|NOT COMPLETED|Overall Study||2
5292712|NCT00578227|13010968|P1|NOT COMPLETED|Overall Study||5
5292713|NCT00578227|13010966|P3|COMPLETED|Overall Study||267
5292714|NCT00578227|13010967|P2|COMPLETED|Overall Study||268
5292715|NCT00578227|13010968|P1|COMPLETED|Overall Study||267
5292716|NCT00578227|13010966|P3|STARTED|Overall Study||271
5292717|NCT00578227|13010967|P2|STARTED|Overall Study||270
5292718|NCT00578227|13010968|P1|STARTED|Overall Study||272
5292719|NCT00578214|13011041|P3|NOT COMPLETED|Overall Study||0
5292720|NCT00578214|13011042|P2|NOT COMPLETED|Overall Study||0
5292721|NCT00578214|13011043|P1|NOT COMPLETED|Overall Study||0
5292722|NCT00578214|13011041|P3|COMPLETED|Overall Study||31
5292723|NCT00578214|13011042|P2|COMPLETED|Overall Study||22
5292724|NCT00578214|13011043|P1|COMPLETED|Overall Study||22
5292725|NCT00578214|13011041|P3|STARTED|Overall Study||31
5292726|NCT00578214|13011042|P2|STARTED|Overall Study||22
5292727|NCT00578214|13011043|P1|STARTED|Overall Study||22
5292728|NCT00578175|13011093|P3|NOT COMPLETED|Overall Study||24
5292729|NCT00578175|13011094|P2|NOT COMPLETED|Overall Study||43
5292730|NCT00578175|13011095|P1|NOT COMPLETED|Overall Study||70
5292731|NCT00578175|13011093|P3|COMPLETED|Overall Study||365
5292732|NCT00578175|13011094|P2|COMPLETED|Overall Study||646
5292733|NCT00578175|13011095|P1|COMPLETED|Overall Study||635
5292734|NCT00578175|13011093|P3|STARTED|Overall Study||389
5292735|NCT00578175|13011094|P2|STARTED|Overall Study||689
5292736|NCT00578175|13011095|P1|STARTED|Overall Study||705
5292737|NCT00578136|13011174|P2|NOT COMPLETED|Overall Study||1
5292738|NCT00578136|13011175|P1|NOT COMPLETED|Overall Study||1
5292739|NCT00578136|13011174|P2|COMPLETED|Overall Study||26
5292740|NCT00578136|13011175|P1|COMPLETED|Overall Study||26
5292741|NCT00578136|13011174|P2|STARTED|Overall Study||27
5292742|NCT00578136|13011175|P1|STARTED|Overall Study||27
5292743|NCT00578071|13011183|P1|NOT COMPLETED|Overall Study||0
5292744|NCT00578071|13011183|P1|COMPLETED|Overall Study||29
5292745|NCT00578071|13011183|P1|STARTED|Overall Study||29
5292746|NCT00577889|13011193|P3|NOT COMPLETED|Overall Study||0
5292747|NCT00577889|13011194|P2|NOT COMPLETED|Overall Study||0
5292748|NCT00577889|13011195|P1|NOT COMPLETED|Overall Study||1
5292749|NCT00577889|13011193|P3|COMPLETED|Overall Study||6
5292750|NCT00577889|13011194|P2|COMPLETED|Overall Study||6
5292751|NCT00577889|13011195|P1|COMPLETED|Overall Study||8
5292752|NCT00577889|13011193|P3|STARTED|Overall Study||6
5292753|NCT00577889|13011194|P2|STARTED|Overall Study||6
5292754|NCT00577889|13011195|P1|STARTED|Overall Study||9
5292755|NCT00577863|13011214|P2|NOT COMPLETED|Overall Study||14
5292756|NCT00577863|13011215|P1|NOT COMPLETED|Overall Study||10
5292757|NCT00577863|13011214|P2|COMPLETED|Overall Study||94
5292758|NCT00577863|13011215|P1|COMPLETED|Overall Study||82
5292759|NCT00577863|13011214|P2|Received at Least One Injection|Overall Study||107
5292760|NCT00577863|13011215|P1|Received at Least One Injection|Overall Study||92
5292761|NCT00577863|13011214|P2|STARTED|Overall Study||108
5292762|NCT00577863|13011215|P1|STARTED|Overall Study||92
5292763|NCT00577824|13011257|P3|NOT COMPLETED|Overall Study||2
5292764|NCT00577824|13011258|P2|NOT COMPLETED|Overall Study||20
5292765|NCT00577824|13011259|P1|NOT COMPLETED|Overall Study||7
5292766|NCT00577824|13011257|P3|COMPLETED|Overall Study||34
5292767|NCT00577824|13011258|P2|COMPLETED|Overall Study||53
5292768|NCT00577824|13011259|P1|COMPLETED|Overall Study||65
5292769|NCT00577824|13011257|P3|Full Analysis Set|Overall Study||35
5292770|NCT00577824|13011258|P2|Full Analysis Set|Overall Study||72
5292771|NCT00577824|13011259|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
5292772|NCT00577824|13011257|P3|STARTED|Overall Study||36
5292773|NCT00577824|13011258|P2|STARTED|Overall Study||73
5292774|NCT00577824|13011259|P1|STARTED|Overall Study|Started=Randomized|72
5292775|NCT00577772|13011317|P2|NOT COMPLETED|Overall Study||1
5292776|NCT00577772|13011318|P1|NOT COMPLETED|Overall Study||0
5292777|NCT00577772|13011317|P2|COMPLETED|Overall Study||6
5292778|NCT00577772|13011318|P1|COMPLETED|Overall Study||10
5292779|NCT00577772|13011317|P2|STARTED|Overall Study||7
5292780|NCT00577772|13011318|P1|STARTED|Overall Study||10
5292781|NCT00577720|13011328|P4|NOT COMPLETED|Overall Study||7
5292782|NCT00577720|13011329|P3|NOT COMPLETED|Overall Study||1
5292783|NCT00577720|13011330|P2|NOT COMPLETED|Overall Study||1
5292784|NCT00577720|13011331|P1|NOT COMPLETED|Overall Study||4
5292785|NCT00577720|13011328|P4|COMPLETED|Overall Study||65
5292786|NCT00577720|13011329|P3|COMPLETED|Overall Study||35
5292787|NCT00577720|13011330|P2|COMPLETED|Overall Study||35
5292788|NCT00577720|13011331|P1|COMPLETED|Overall Study||33
5292789|NCT00577720|13011328|P4|ITT (Intent to Treat) Population|Overall Study||65
5292790|NCT00577720|13011329|P3|ITT (Intent to Treat) Population|Overall Study||35
5292791|NCT00577720|13011330|P2|ITT (Intent to Treat) Population|Overall Study||35
5292792|NCT00577720|13011331|P1|ITT (Intent to Treat) Population|Overall Study||34
5292793|NCT00577720|13011328|P4|STARTED|Overall Study||72
5292794|NCT00577720|13011329|P3|STARTED|Overall Study||36
5292795|NCT00577720|13011330|P2|STARTED|Overall Study||36
5292796|NCT00577720|13011331|P1|STARTED|Overall Study||37
5292797|NCT00577707|13011349|P1|NOT COMPLETED|Overall Study||3
5292798|NCT00577707|13011349|P1|COMPLETED|Overall Study||6
5292799|NCT00577707|13011349|P1|STARTED|Overall Study||9
5292800|NCT00577655|13011357|P2|NOT COMPLETED|Overall Study||4
5292801|NCT00577655|13011358|P1|NOT COMPLETED|Overall Study||1
5292802|NCT00577655|13011357|P2|COMPLETED|Overall Study||47
5292803|NCT00577655|13011358|P1|COMPLETED|Overall Study||51
5292804|NCT00577655|13011357|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
5292805|NCT00577655|13011358|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
5292806|NCT00577642|13011396|P1|NOT COMPLETED|Overall Study||1
5292807|NCT00577642|13011396|P1|COMPLETED|Overall Study||28
5292808|NCT00577642|13011396|P1|STARTED|Overall Study||29
5292809|NCT00577629|13011400|P1|NOT COMPLETED|Long Term Follow-Up||25
5292810|NCT00577629|13011400|P1|COMPLETED|Long Term Follow-Up||13
5292811|NCT00577629|13011400|P1|STARTED|Long Term Follow-Up||38
5292812|NCT00577629|13011400|P1|NOT COMPLETED|Treatment Period||1
5292813|NCT00577629|13011400|P1|COMPLETED|Treatment Period||38
5292814|NCT00577629|13011400|P1|STARTED|Treatment Period||39
5292815|NCT00577590|13011411|P3|NOT COMPLETED|Overall Study||0
5292816|NCT00577590|13011412|P2|NOT COMPLETED|Overall Study||0
5292817|NCT00577590|13011413|P1|NOT COMPLETED|Overall Study||0
5292818|NCT00577590|13011411|P3|COMPLETED|Overall Study||23
5292819|NCT00577590|13011412|P2|COMPLETED|Overall Study||27
5292820|NCT00577590|13011413|P1|COMPLETED|Overall Study||28
5292821|NCT00577590|13011411|P3|STARTED|Overall Study||23
5292822|NCT00577590|13011412|P2|STARTED|Overall Study||27
5292823|NCT00577590|13011413|P1|STARTED|Overall Study||28
5292824|NCT00577512|13011421|P1|NOT COMPLETED|Overall Study||4
5292825|NCT00577512|13011421|P1|COMPLETED|Overall Study||0
5292826|NCT00577512|13011421|P1|STARTED|Overall Study||4
5292827|NCT00577473|13011427|P2|NOT COMPLETED|Overall Study||24
5292828|NCT00577473|13011428|P1|NOT COMPLETED|Overall Study||21
5292829|NCT00577473|13011427|P2|COMPLETED|Overall Study||123
5292830|NCT00577473|13011428|P1|COMPLETED|Overall Study||133
5292831|NCT00577473|13011427|P2|ITT Population|Overall Study||136
5292832|NCT00577473|13011428|P1|ITT Population|Overall Study||150
5292833|NCT00577473|13011427|P2|STARTED|Overall Study||147
5292834|NCT00577473|13011428|P1|STARTED|Overall Study||154
5292835|NCT00577460|13011459|P3|NOT COMPLETED|Overall Study||27
5292836|NCT00577460|13011460|P2|NOT COMPLETED|Overall Study||19
5292837|NCT00577460|13011461|P1|NOT COMPLETED|Overall Study||16
5292838|NCT00577460|13011459|P3|COMPLETED|Overall Study||112
5292839|NCT00577460|13011460|P2|COMPLETED|Overall Study||104
5292840|NCT00577460|13011461|P1|COMPLETED|Overall Study||113
5292841|NCT00577460|13011459|P3|STARTED|Overall Study||139
5292842|NCT00577460|13011460|P2|STARTED|Overall Study||123
5292843|NCT00577460|13011461|P1|STARTED|Overall Study||129
5292844|NCT00577408|13011570|P2|NOT COMPLETED|Overall Study||23
5292845|NCT00577408|13011571|P1|NOT COMPLETED|Overall Study||12
5292846|NCT00577408|13011570|P2|COMPLETED|Overall Study||9
5292847|NCT00577408|13011571|P1|COMPLETED|Overall Study||16
5292848|NCT00577408|13011570|P2|STARTED|Overall Study||32
5292849|NCT00577408|13011571|P1|STARTED|Overall Study||28
5292850|NCT00577395|13011579|P2|NOT COMPLETED|Overall Study||6
5292851|NCT00577395|13011580|P1|NOT COMPLETED|Overall Study||7
5292852|NCT00577395|13011579|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
5292853|NCT00577395|13011580|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
5292854|NCT00577395|13011579|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
5292855|NCT00577395|13011580|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
5292856|NCT00577382|13011590|P2|NOT COMPLETED|Overall Study||31
5292857|NCT00577382|13011591|P1|NOT COMPLETED|Overall Study||21
5292858|NCT00577382|13011590|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
5292859|NCT00577382|13011591|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
5292860|NCT00577382|13011590|P2|STARTED|Overall Study||31
5292861|NCT00577382|13011591|P1|STARTED|Overall Study||21
5292862|NCT00577356|13011603|P1|NOT COMPLETED|Overall Study||0
5292863|NCT00577356|13011603|P1|COMPLETED|Overall Study||6
5292864|NCT00577356|13011603|P1|STARTED|Overall Study||6
5292865|NCT00577135|13011611|P4|NOT COMPLETED|Overall Study||0
5292866|NCT00577135|13011612|P3|NOT COMPLETED|Overall Study||0
5292867|NCT00577135|13011613|P2|NOT COMPLETED|Overall Study||0
5292868|NCT00577135|13011614|P1|NOT COMPLETED|Overall Study||0
5292869|NCT00577135|13011611|P4|COMPLETED|Overall Study||75
5292870|NCT00577135|13011612|P3|COMPLETED|Overall Study||77
5292871|NCT00577135|13011613|P2|COMPLETED|Overall Study||82
5292872|NCT00577135|13011614|P1|COMPLETED|Overall Study||74
5292873|NCT00577135|13011611|P4|STARTED|Overall Study||75
5292874|NCT00577135|13011612|P3|STARTED|Overall Study||77
5292875|NCT00577135|13011613|P2|STARTED|Overall Study||82
5292876|NCT00577135|13011614|P1|STARTED|Overall Study||74
5292877|NCT00577122|13011734|P2|NOT COMPLETED|Overall Study||16
5292878|NCT00577122|13011735|P1|NOT COMPLETED|Overall Study||14
5292879|NCT00577122|13011734|P2|COMPLETED|Overall Study||0
5292880|NCT00577122|13011735|P1|COMPLETED|Overall Study||0
5292881|NCT00577122|13011734|P2|STARTED|Overall Study||16
5292882|NCT00577122|13011735|P1|STARTED|Overall Study||14
5292883|NCT00577096|13011749|P2|NOT COMPLETED|Long Term Participation||0
5292884|NCT00577096|13011750|P1|NOT COMPLETED|Long Term Participation||0
5292885|NCT00577096|13011749|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
5292886|NCT00577096|13011750|P1|COMPLETED|Long Term Participation||34
5292887|NCT00577096|13011749|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
5292888|NCT00577096|13011750|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
5292889|NCT00577096|13011749|P2|NOT COMPLETED|Short Term Participation||8
5292890|NCT00577096|13011750|P1|NOT COMPLETED|Short Term Participation||7
5292891|NCT00577096|13011749|P2|COMPLETED|Short Term Participation||58
5292892|NCT00577096|13011750|P1|COMPLETED|Short Term Participation||62
5292893|NCT00577096|13011749|P2|STARTED|Short Term Participation||66
5292894|NCT00577096|13011750|P1|STARTED|Short Term Participation||69
5292895|NCT00577083|13011776|P2|NOT COMPLETED|Second Intervention (14days)||0
5292896|NCT00577083|13011777|P1|NOT COMPLETED|Second Intervention (14days)||0
5292897|NCT00577083|13011776|P2|COMPLETED|Second Intervention (14days)||52
5292898|NCT00577083|13011777|P1|COMPLETED|Second Intervention (14days)||48
5292899|NCT00577083|13011776|P2|STARTED|Second Intervention (14days)||52
5292900|NCT00577083|13011777|P1|STARTED|Second Intervention (14days)||48
5292901|NCT00577083|13011776|P2|NOT COMPLETED|Washout (14 Days)||0
5292902|NCT00577083|13011777|P1|NOT COMPLETED|Washout (14 Days)||0
5292903|NCT00577083|13011776|P2|COMPLETED|Washout (14 Days)||52
5292904|NCT00577083|13011777|P1|COMPLETED|Washout (14 Days)||48
5292905|NCT00577083|13011776|P2|STARTED|Washout (14 Days)||52
5292906|NCT00577083|13011777|P1|STARTED|Washout (14 Days)||48
5292907|NCT00577083|13011776|P2|NOT COMPLETED|First Intervention (14 Days)||0
5292908|NCT00577083|13011777|P1|NOT COMPLETED|First Intervention (14 Days)||0
5292909|NCT00577083|13011776|P2|COMPLETED|First Intervention (14 Days)||52
5292910|NCT00577083|13011777|P1|COMPLETED|First Intervention (14 Days)||48
5292911|NCT00577083|13011776|P2|STARTED|First Intervention (14 Days)||52
5292912|NCT00577083|13011777|P1|STARTED|First Intervention (14 Days)||48
5292913|NCT00577031|13011789|P1|NOT COMPLETED|Overall Study||205
5292914|NCT00577031|13011789|P1|COMPLETED|Overall Study||0
5292915|NCT00577031|13011789|P1|STARTED|Overall Study||205
5292916|NCT00577005|13011810|P2|NOT COMPLETED|Overall Study||3
5292917|NCT00577005|13011811|P1|NOT COMPLETED|Overall Study||5
5292918|NCT00577005|13011810|P2|COMPLETED|Overall Study||9
5292919|NCT00577005|13011811|P1|COMPLETED|Overall Study||11
5292920|NCT00577005|13011810|P2|STARTED|Overall Study||12
5292921|NCT00577005|13011811|P1|STARTED|Overall Study||16
5292922|NCT00576927|13011825|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
5292923|NCT00576927|13011825|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
5292924|NCT00576927|13011825|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
5292925|NCT00576927|13011825|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
5292926|NCT00576927|13011825|P1|COMPLETED|Sleep Hygiene With Study Drug||22
5292927|NCT00576927|13011825|P1|STARTED|Sleep Hygiene With Study Drug||22
5292928|NCT00576927|13011825|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
5292929|NCT00576927|13011825|P1|COMPLETED|Sleep Hygiene With the Placebo||22
5292930|NCT00576927|13011825|P1|STARTED|Sleep Hygiene With the Placebo||23
5292931|NCT00576927|13011825|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
5292932|NCT00576927|13011825|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
5292933|NCT00576927|13011825|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
5292934|NCT00576927|13011825|P1|NOT COMPLETED|Baseline||13
5292935|NCT00576927|13011825|P1|COMPLETED|Baseline||30
5292936|NCT00576927|13011825|P1|STARTED|Baseline||43
5292937|NCT00576927|13011825|P1|NOT COMPLETED|Clinical Assessment||36
5292938|NCT00576927|13011825|P1|COMPLETED|Clinical Assessment||43
5292939|NCT00576927|13011825|P1|STARTED|Clinical Assessment||79
5292940|NCT00576901|13011837|P1|NOT COMPLETED|Overall Study||3
5292941|NCT00576901|13011837|P1|COMPLETED|Overall Study||20
5292942|NCT00576901|13011837|P1|STARTED|Overall Study||23
5292943|NCT00576836|13011845|P2|NOT COMPLETED|Overall Study||2
5292944|NCT00576836|13011846|P1|NOT COMPLETED|Overall Study||0
5292945|NCT00576836|13011845|P2|COMPLETED|Overall Study||5
5292946|NCT00576836|13011846|P1|COMPLETED|Overall Study||0
5292947|NCT00576836|13011845|P2|STARTED|Overall Study||7
5292948|NCT00576836|13011846|P1|STARTED|Overall Study||0
5292949|NCT00576823|13011861|P3|NOT COMPLETED|40-week Safety Extension Phase||0
5292950|NCT00576823|13011862|P2|NOT COMPLETED|40-week Safety Extension Phase||0
5292951|NCT00576823|13011863|P1|NOT COMPLETED|40-week Safety Extension Phase||1
5292952|NCT00576823|13011861|P3|COMPLETED|40-week Safety Extension Phase||6
5292953|NCT00576823|13011862|P2|COMPLETED|40-week Safety Extension Phase||6
5292954|NCT00576823|13011863|P1|COMPLETED|40-week Safety Extension Phase||10
5292955|NCT00576823|13011861|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
5292956|NCT00576823|13011862|P2|STARTED|40-week Safety Extension Phase||6
5292957|NCT00576823|13011863|P1|STARTED|40-week Safety Extension Phase||11
5292958|NCT00576823|13011861|P3|NOT COMPLETED|12-week Efficacy Phase||0
5292959|NCT00576823|13011862|P2|NOT COMPLETED|12-week Efficacy Phase||0
5292960|NCT00576823|13011863|P1|NOT COMPLETED|12-week Efficacy Phase||1
5292961|NCT00576823|13011861|P3|COMPLETED|12-week Efficacy Phase||7
5292962|NCT00576823|13011862|P2|COMPLETED|12-week Efficacy Phase||6
5292963|NCT00576823|13011863|P1|COMPLETED|12-week Efficacy Phase||11
5292964|NCT00576823|13011861|P3|STARTED|12-week Efficacy Phase||7
5292965|NCT00576823|13011862|P2|STARTED|12-week Efficacy Phase||6
5292966|NCT00576823|13011863|P1|STARTED|12-week Efficacy Phase||12
5292967|NCT00576758|13011879|P2|NOT COMPLETED|Follow-up Period||17
5292968|NCT00576758|13011880|P1|NOT COMPLETED|Follow-up Period||27
5292969|NCT00576758|13011879|P2|COMPLETED|Follow-up Period||34
5292970|NCT00576758|13011880|P1|COMPLETED|Follow-up Period||28
5292971|NCT00576758|13011879|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
5292972|NCT00576758|13011880|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
5292973|NCT00576758|13011879|P2|NOT COMPLETED|Extension Treatment Period||43
5292974|NCT00576758|13011880|P1|NOT COMPLETED|Extension Treatment Period||42
5292975|NCT00576758|13011879|P2|COMPLETED|Extension Treatment Period||30
5292976|NCT00576758|13011880|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
5292977|NCT00576758|13011879|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
5292978|NCT00576758|13011880|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
5292979|NCT00576758|13011879|P2|NOT COMPLETED|Induction Treatment Period||5
5292980|NCT00576758|13011880|P1|NOT COMPLETED|Induction Treatment Period||8
5292981|NCT00576758|13011879|P2|COMPLETED|Induction Treatment Period||83
5292982|NCT00576758|13011880|P1|COMPLETED|Induction Treatment Period||79
5292983|NCT00576758|13011879|P2|Received Treatment|Induction Treatment Period||87
5292984|NCT00576758|13011880|P1|Received Treatment|Induction Treatment Period||86
5292985|NCT00576758|13011879|P2|STARTED|Induction Treatment Period||88
5292986|NCT00576758|13011880|P1|STARTED|Induction Treatment Period||87
5292987|NCT00576732|13011926|P6|NOT COMPLETED|OPEN LABEL||8
5292988|NCT00576732|13011927|P5|NOT COMPLETED|OPEN LABEL||4
5292989|NCT00576732|13011928|P4|NOT COMPLETED|OPEN LABEL||11
5292990|NCT00576732|13011929|P3|NOT COMPLETED|OPEN LABEL||0
5292991|NCT00576732|13011930|P2|NOT COMPLETED|OPEN LABEL||0
5292992|NCT00576732|13011931|P1|NOT COMPLETED|OPEN LABEL||0
5292993|NCT00576732|13011926|P6|COMPLETED|OPEN LABEL||17
5292994|NCT00576732|13011927|P5|COMPLETED|OPEN LABEL||20
5292995|NCT00576732|13011928|P4|COMPLETED|OPEN LABEL||19
5292996|NCT00576732|13011929|P3|COMPLETED|OPEN LABEL||0
5292997|NCT00576732|13011930|P2|COMPLETED|OPEN LABEL||0
5292998|NCT00576732|13011931|P1|COMPLETED|OPEN LABEL||0
5292999|NCT00576732|13011926|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
5293000|NCT00576732|13011927|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
5293001|NCT00576732|13011928|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
5293002|NCT00576732|13011929|P3|STARTED|OPEN LABEL||0
5293003|NCT00576732|13011930|P2|STARTED|OPEN LABEL||0
5293004|NCT00576732|13011931|P1|STARTED|OPEN LABEL||0
5293005|NCT00576732|13011926|P6|NOT COMPLETED|DOUBLE BLIND||0
5293006|NCT00576732|13011927|P5|NOT COMPLETED|DOUBLE BLIND||0
5293007|NCT00576732|13011928|P4|NOT COMPLETED|DOUBLE BLIND||0
5293008|NCT00576732|13011929|P3|NOT COMPLETED|DOUBLE BLIND||6
5293009|NCT00576732|13011930|P2|NOT COMPLETED|DOUBLE BLIND||5
5293010|NCT00576732|13011931|P1|NOT COMPLETED|DOUBLE BLIND||8
5293011|NCT00576732|13011926|P6|COMPLETED|DOUBLE BLIND||0
5293012|NCT00576732|13011927|P5|COMPLETED|DOUBLE BLIND||0
5293013|NCT00576732|13011928|P4|COMPLETED|DOUBLE BLIND||0
5293014|NCT00576732|13011929|P3|COMPLETED|DOUBLE BLIND||25
5293015|NCT00576732|13011930|P2|COMPLETED|DOUBLE BLIND||25
5293016|NCT00576732|13011931|P1|COMPLETED|DOUBLE BLIND||27
5293017|NCT00576732|13011926|P6|STARTED|DOUBLE BLIND||0
5293018|NCT00576732|13011927|P5|STARTED|DOUBLE BLIND||0
5293019|NCT00576732|13011928|P4|STARTED|DOUBLE BLIND||0
5293020|NCT00576732|13011929|P3|STARTED|DOUBLE BLIND||31
5293021|NCT00576732|13011930|P2|STARTED|DOUBLE BLIND||30
5293022|NCT00576732|13011931|P1|STARTED|DOUBLE BLIND||35
5293023|NCT00576693|13011963|P2|NOT COMPLETED|Overall Study||24
5293024|NCT00576693|13011964|P1|NOT COMPLETED|Overall Study||10
5293025|NCT00576693|13011963|P2|COMPLETED|Overall Study||203
5293026|NCT00576693|13011964|P1|COMPLETED|Overall Study||214
5293027|NCT00576693|13011963|P2|STARTED|Overall Study||227
5293028|NCT00576693|13011964|P1|STARTED|Overall Study||224
5293029|NCT00576680|13011970|P1|NOT COMPLETED|Overall Study||0
5293030|NCT00576680|13011970|P1|COMPLETED|Overall Study||43
5293031|NCT00576680|13011970|P1|STARTED|Overall Study||43
5293032|NCT00576628|13011976|P1|NOT COMPLETED|Overall Study||43
5293033|NCT00576628|13011976|P1|COMPLETED|Overall Study||82
5293034|NCT00576628|13011976|P1|STARTED|Overall Study||125
5293035|NCT00576576|13011996|P1|NOT COMPLETED|Overall Study||7
5293036|NCT00576576|13011996|P1|COMPLETED|Overall Study||20
5293037|NCT00576576|13011996|P1|STARTED|Overall Study||27
5293038|NCT00576524|13012004|P2|NOT COMPLETED|Overall Study||0
5293039|NCT00576524|13012005|P1|NOT COMPLETED|Overall Study||0
5293040|NCT00576524|13012004|P2|COMPLETED|Overall Study||0
5293041|NCT00576524|13012005|P1|COMPLETED|Overall Study||2
5293042|NCT00576524|13012004|P2|STARTED|Overall Study||0
5293043|NCT00576524|13012005|P1|STARTED|Overall Study||2
5293044|NCT00576472|13012030|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
5293045|NCT00576472|13012031|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
5293046|NCT00576472|13012032|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
5293047|NCT00576472|13012033|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
5293048|NCT00576472|13012034|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
5293049|NCT00576472|13012035|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
5293050|NCT00576472|13012036|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
5293051|NCT00576472|13012037|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
5293052|NCT00576472|13012038|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
5293053|NCT00576472|13012039|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
5293054|NCT00576472|13012040|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
5293055|NCT00576472|13012041|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
5293056|NCT00576472|13012042|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
5293057|NCT00576472|13012043|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
5293058|NCT00576472|13012044|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
5293059|NCT00576472|13012030|P15|COMPLETED|MPH Home Maintenance Phase||68
5293060|NCT00576472|13012031|P14|COMPLETED|MPH Home Maintenance Phase||0
5293061|NCT00576472|13012032|P13|COMPLETED|MPH Home Maintenance Phase||0
5293062|NCT00576472|13012033|P12|COMPLETED|MPH Home Maintenance Phase||0
5293063|NCT00576472|13012034|P11|COMPLETED|MPH Home Maintenance Phase||0
5293064|NCT00576472|13012035|P10|COMPLETED|MPH Home Maintenance Phase||0
5293065|NCT00576472|13012036|P9|COMPLETED|MPH Home Maintenance Phase||0
5293066|NCT00576472|13012037|P8|COMPLETED|MPH Home Maintenance Phase||0
5293067|NCT00576472|13012038|P7|COMPLETED|MPH Home Maintenance Phase||0
5293068|NCT00576472|13012039|P6|COMPLETED|MPH Home Maintenance Phase||0
5293069|NCT00576472|13012040|P5|COMPLETED|MPH Home Maintenance Phase||0
5293070|NCT00576472|13012041|P4|COMPLETED|MPH Home Maintenance Phase||0
5293071|NCT00576472|13012042|P3|COMPLETED|MPH Home Maintenance Phase||0
5293072|NCT00576472|13012043|P2|COMPLETED|MPH Home Maintenance Phase||0
5293073|NCT00576472|13012044|P1|COMPLETED|MPH Home Maintenance Phase||0
5293074|NCT00576472|13012030|P15|STARTED|MPH Home Maintenance Phase||91
5293075|NCT00576472|13012031|P14|STARTED|MPH Home Maintenance Phase||27
5293076|NCT00576472|13012032|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293077|NCT00576472|13012033|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293078|NCT00576472|13012034|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293079|NCT00576472|13012035|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293080|NCT00576472|13012036|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293081|NCT00576472|13012037|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293082|NCT00576472|13012038|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293083|NCT00576472|13012039|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293084|NCT00576472|13012040|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293085|NCT00576472|13012041|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293086|NCT00576472|13012042|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293087|NCT00576472|13012043|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293088|NCT00576472|13012044|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
5293089|NCT00576472|13012030|P15|NOT COMPLETED|MPH Cross Over Phase||0
5293090|NCT00576472|13012031|P14|NOT COMPLETED|MPH Cross Over Phase||0
5293091|NCT00576472|13012032|P13|NOT COMPLETED|MPH Cross Over Phase||0
5293092|NCT00576472|13012033|P12|NOT COMPLETED|MPH Cross Over Phase||1
5293093|NCT00576472|13012034|P11|NOT COMPLETED|MPH Cross Over Phase||1
5293094|NCT00576472|13012035|P10|NOT COMPLETED|MPH Cross Over Phase||0
5293095|NCT00576472|13012036|P9|NOT COMPLETED|MPH Cross Over Phase||2
5293096|NCT00576472|13012037|P8|NOT COMPLETED|MPH Cross Over Phase||0
5293097|NCT00576472|13012038|P7|NOT COMPLETED|MPH Cross Over Phase||12
5293098|NCT00576472|13012039|P6|NOT COMPLETED|MPH Cross Over Phase||0
5293099|NCT00576472|13012040|P5|NOT COMPLETED|MPH Cross Over Phase||0
5293100|NCT00576472|13012041|P4|NOT COMPLETED|MPH Cross Over Phase||0
5293101|NCT00576472|13012042|P3|NOT COMPLETED|MPH Cross Over Phase||0
5293102|NCT00576472|13012043|P2|NOT COMPLETED|MPH Cross Over Phase||0
5293103|NCT00576472|13012044|P1|NOT COMPLETED|MPH Cross Over Phase||0
5293104|NCT00576472|13012030|P15|COMPLETED|MPH Cross Over Phase||0
5293105|NCT00576472|13012031|P14|COMPLETED|MPH Cross Over Phase||0
5293106|NCT00576472|13012032|P13|COMPLETED|MPH Cross Over Phase||21
5293107|NCT00576472|13012033|P12|COMPLETED|MPH Cross Over Phase||17
5293108|NCT00576472|13012034|P11|COMPLETED|MPH Cross Over Phase||22
5293109|NCT00576472|13012035|P10|COMPLETED|MPH Cross Over Phase||22
5293110|NCT00576472|13012036|P9|COMPLETED|MPH Cross Over Phase||16
5293111|NCT00576472|13012037|P8|COMPLETED|MPH Cross Over Phase||20
5293112|NCT00576472|13012038|P7|COMPLETED|MPH Cross Over Phase||0
5293113|NCT00576472|13012039|P6|COMPLETED|MPH Cross Over Phase||0
5293114|NCT00576472|13012040|P5|COMPLETED|MPH Cross Over Phase||0
5293115|NCT00576472|13012041|P4|COMPLETED|MPH Cross Over Phase||0
5293116|NCT00576472|13012042|P3|COMPLETED|MPH Cross Over Phase||0
5293117|NCT00576472|13012043|P2|COMPLETED|MPH Cross Over Phase||0
5293118|NCT00576472|13012044|P1|COMPLETED|MPH Cross Over Phase||0
5293119|NCT00576472|13012030|P15|STARTED|MPH Cross Over Phase||0
5293120|NCT00576472|13012031|P14|STARTED|MPH Cross Over Phase||0
5293121|NCT00576472|13012032|P13|STARTED|MPH Cross Over Phase||21
5293122|NCT00576472|13012033|P12|STARTED|MPH Cross Over Phase||18
5293123|NCT00576472|13012034|P11|STARTED|MPH Cross Over Phase||23
5293124|NCT00576472|13012035|P10|STARTED|MPH Cross Over Phase||22
5293125|NCT00576472|13012036|P9|STARTED|MPH Cross Over Phase||18
5293126|NCT00576472|13012037|P8|STARTED|MPH Cross Over Phase||20
5293127|NCT00576472|13012038|P7|STARTED|MPH Cross Over Phase||12
5293128|NCT00576472|13012039|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293129|NCT00576472|13012040|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293130|NCT00576472|13012041|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293131|NCT00576472|13012042|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293132|NCT00576472|13012043|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293133|NCT00576472|13012044|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
5293134|NCT00576472|13012030|P15|NOT COMPLETED|MPH In-Lab Phase||0
5293135|NCT00576472|13012031|P14|NOT COMPLETED|MPH In-Lab Phase||0
5293136|NCT00576472|13012032|P13|NOT COMPLETED|MPH In-Lab Phase||0
5293137|NCT00576472|13012033|P12|NOT COMPLETED|MPH In-Lab Phase||0
5293138|NCT00576472|13012034|P11|NOT COMPLETED|MPH In-Lab Phase||0
5293139|NCT00576472|13012035|P10|NOT COMPLETED|MPH In-Lab Phase||0
5293140|NCT00576472|13012036|P9|NOT COMPLETED|MPH In-Lab Phase||0
5293141|NCT00576472|13012037|P8|NOT COMPLETED|MPH In-Lab Phase||0
5293142|NCT00576472|13012038|P7|NOT COMPLETED|MPH In-Lab Phase||0
5293143|NCT00576472|13012039|P6|NOT COMPLETED|MPH In-Lab Phase||0
5293144|NCT00576472|13012040|P5|NOT COMPLETED|MPH In-Lab Phase||0
5293145|NCT00576472|13012041|P4|NOT COMPLETED|MPH In-Lab Phase||335
5293146|NCT00576472|13012042|P3|NOT COMPLETED|MPH In-Lab Phase||0
5293147|NCT00576472|13012043|P2|NOT COMPLETED|MPH In-Lab Phase||0
5293148|NCT00576472|13012044|P1|NOT COMPLETED|MPH In-Lab Phase||0
5293149|NCT00576472|13012030|P15|COMPLETED|MPH In-Lab Phase||0
5293150|NCT00576472|13012031|P14|COMPLETED|MPH In-Lab Phase||0
5293151|NCT00576472|13012032|P13|COMPLETED|MPH In-Lab Phase||0
5293152|NCT00576472|13012033|P12|COMPLETED|MPH In-Lab Phase||0
5293153|NCT00576472|13012034|P11|COMPLETED|MPH In-Lab Phase||0
5293154|NCT00576472|13012035|P10|COMPLETED|MPH In-Lab Phase||0
5293155|NCT00576472|13012036|P9|COMPLETED|MPH In-Lab Phase||0
5293156|NCT00576472|13012037|P8|COMPLETED|MPH In-Lab Phase||0
5293157|NCT00576472|13012038|P7|COMPLETED|MPH In-Lab Phase||0
5293158|NCT00576472|13012039|P6|COMPLETED|MPH In-Lab Phase||67
5293159|NCT00576472|13012040|P5|COMPLETED|MPH In-Lab Phase||67
5293160|NCT00576472|13012041|P4|COMPLETED|MPH In-Lab Phase||0
5293161|NCT00576472|13012042|P3|COMPLETED|MPH In-Lab Phase||0
5293162|NCT00576472|13012043|P2|COMPLETED|MPH In-Lab Phase||0
5293163|NCT00576472|13012044|P1|COMPLETED|MPH In-Lab Phase||0
5293164|NCT00576472|13012030|P15|STARTED|MPH In-Lab Phase||0
5293165|NCT00576472|13012031|P14|STARTED|MPH In-Lab Phase||0
5293166|NCT00576472|13012032|P13|STARTED|MPH In-Lab Phase||0
5293167|NCT00576472|13012033|P12|STARTED|MPH In-Lab Phase||0
5293168|NCT00576472|13012034|P11|STARTED|MPH In-Lab Phase||0
5293169|NCT00576472|13012035|P10|STARTED|MPH In-Lab Phase||0
5293170|NCT00576472|13012036|P9|STARTED|MPH In-Lab Phase||0
5293171|NCT00576472|13012037|P8|STARTED|MPH In-Lab Phase||0
5293172|NCT00576472|13012038|P7|STARTED|MPH In-Lab Phase||0
5293173|NCT00576472|13012039|P6|STARTED|MPH In-Lab Phase||67
5293174|NCT00576472|13012040|P5|STARTED|MPH In-Lab Phase||67
5293175|NCT00576472|13012041|P4|STARTED|MPH In-Lab Phase||335
5293176|NCT00576472|13012042|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
5293177|NCT00576472|13012043|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
5293178|NCT00576472|13012044|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
5293179|NCT00576472|13012030|P15|NOT COMPLETED|Initial Screening||0
5293180|NCT00576472|13012031|P14|NOT COMPLETED|Initial Screening||0
5293181|NCT00576472|13012032|P13|NOT COMPLETED|Initial Screening||0
5293182|NCT00576472|13012033|P12|NOT COMPLETED|Initial Screening||0
5293183|NCT00576472|13012034|P11|NOT COMPLETED|Initial Screening||0
5293184|NCT00576472|13012035|P10|NOT COMPLETED|Initial Screening||0
5293185|NCT00576472|13012036|P9|NOT COMPLETED|Initial Screening||0
5293186|NCT00576472|13012037|P8|NOT COMPLETED|Initial Screening||0
5293187|NCT00576472|13012038|P7|NOT COMPLETED|Initial Screening||0
5293188|NCT00576472|13012039|P6|NOT COMPLETED|Initial Screening||0
5293189|NCT00576472|13012040|P5|NOT COMPLETED|Initial Screening||0
5293190|NCT00576472|13012041|P4|NOT COMPLETED|Initial Screening||0
5293191|NCT00576472|13012042|P3|NOT COMPLETED|Initial Screening||0
5293192|NCT00576472|13012043|P2|NOT COMPLETED|Initial Screening||0
5293193|NCT00576472|13012044|P1|NOT COMPLETED|Initial Screening||0
5293194|NCT00576472|13012030|P15|COMPLETED|Initial Screening||0
5293195|NCT00576472|13012031|P14|COMPLETED|Initial Screening||0
5293196|NCT00576472|13012032|P13|COMPLETED|Initial Screening||0
5293197|NCT00576472|13012033|P12|COMPLETED|Initial Screening||0
5293198|NCT00576472|13012034|P11|COMPLETED|Initial Screening||0
5293199|NCT00576472|13012035|P10|COMPLETED|Initial Screening||0
5293200|NCT00576472|13012036|P9|COMPLETED|Initial Screening||0
5293201|NCT00576472|13012037|P8|COMPLETED|Initial Screening||0
5293202|NCT00576472|13012038|P7|COMPLETED|Initial Screening||0
5293203|NCT00576472|13012039|P6|COMPLETED|Initial Screening||0
5293204|NCT00576472|13012040|P5|COMPLETED|Initial Screening||0
5293205|NCT00576472|13012041|P4|COMPLETED|Initial Screening||0
5293206|NCT00576472|13012042|P3|COMPLETED|Initial Screening||199
5293207|NCT00576472|13012043|P2|COMPLETED|Initial Screening||40
5293208|NCT00576472|13012044|P1|COMPLETED|Initial Screening||230
5293209|NCT00576472|13012030|P15|STARTED|Initial Screening||0
5293210|NCT00576472|13012031|P14|STARTED|Initial Screening||0
5293211|NCT00576472|13012032|P13|STARTED|Initial Screening||0
5293212|NCT00576472|13012033|P12|STARTED|Initial Screening||0
5293213|NCT00576472|13012034|P11|STARTED|Initial Screening||0
5293214|NCT00576472|13012035|P10|STARTED|Initial Screening||0
5293215|NCT00576472|13012036|P9|STARTED|Initial Screening||0
5293216|NCT00576472|13012037|P8|STARTED|Initial Screening||0
5293217|NCT00576472|13012038|P7|STARTED|Initial Screening||0
5293218|NCT00576472|13012039|P6|STARTED|Initial Screening||0
5293219|NCT00576472|13012040|P5|STARTED|Initial Screening||0
5293220|NCT00576472|13012041|P4|STARTED|Initial Screening||0
5293221|NCT00576472|13012042|P3|STARTED|Initial Screening||199
5293222|NCT00576472|13012043|P2|STARTED|Initial Screening||40
5293223|NCT00576472|13012044|P1|STARTED|Initial Screening||230
5293224|NCT00576420|13012137|P3|NOT COMPLETED|Overall Study||1
5293225|NCT00576420|13012138|P2|NOT COMPLETED|Overall Study||0
5293226|NCT00576420|13012139|P1|NOT COMPLETED|Overall Study||0
5293227|NCT00576420|13012137|P3|COMPLETED|Overall Study||22
5293228|NCT00576420|13012138|P2|COMPLETED|Overall Study||24
5293229|NCT00576420|13012139|P1|COMPLETED|Overall Study||26
5293230|NCT00576420|13012137|P3|STARTED|Overall Study||23
5293231|NCT00576420|13012138|P2|STARTED|Overall Study||24
5293232|NCT00576420|13012139|P1|STARTED|Overall Study||26
5293233|NCT00576407|13012304|P1|NOT COMPLETED|Overall Study||8
5293234|NCT00576407|13012304|P1|COMPLETED|Overall Study||18
5293235|NCT00576407|13012304|P1|STARTED|Overall Study||26
5293236|NCT00576381|13012316|P1|NOT COMPLETED|Overall Study||7
5293237|NCT00576381|13012316|P1|COMPLETED|Overall Study||23
5293238|NCT00576381|13012316|P1|STARTED|Overall Study||30
5293239|NCT00576316|13012320|P1|NOT COMPLETED|Overall Study||20
5293240|NCT00576316|13012320|P1|COMPLETED|Overall Study|Number of patients who completed study|181
5293241|NCT00576316|13012320|P1|STARTED|Overall Study|Number of patients recruited|201
5293242|NCT00576303|13012325|P1|NOT COMPLETED|Long Term Safety Period||16
5293243|NCT00576303|13012325|P1|COMPLETED|Long Term Safety Period||162
5293244|NCT00576303|13012325|P1|STARTED|Long Term Safety Period||178
5293245|NCT00576303|13012325|P1|NOT COMPLETED|Efficacy Evaluation Period||5
5293246|NCT00576303|13012325|P1|COMPLETED|Efficacy Evaluation Period||178
5293247|NCT00576303|13012325|P1|STARTED|Efficacy Evaluation Period||183
5293248|NCT00576303|13012325|P1|NOT COMPLETED|Dose Titration Period||17
5293249|NCT00576303|13012325|P1|COMPLETED|Dose Titration Period||183
5293250|NCT00576303|13012325|P1|STARTED|Dose Titration Period||200
5293251|NCT00576251|13012336|P2|NOT COMPLETED|Overall Study||1
5293252|NCT00576251|13012337|P1|NOT COMPLETED|Overall Study||1
5293253|NCT00576251|13012336|P2|COMPLETED|Overall Study||111
5293254|NCT00576251|13012337|P1|COMPLETED|Overall Study||108
5293255|NCT00576251|13012336|P2|STARTED|Overall Study||112
5293256|NCT00576251|13012337|P1|STARTED|Overall Study||109
5293257|NCT00576199|13012343|P1|NOT COMPLETED|Overall Study||30
5293258|NCT00576199|13012343|P1|COMPLETED|Overall Study||0
5293259|NCT00576199|13012343|P1|STARTED|Overall Study||30
5293260|NCT00576147|13012352|P1|NOT COMPLETED|Overall Study||0
5293261|NCT00576147|13012352|P1|COMPLETED|Overall Study||431
5293262|NCT00576147|13012352|P1|STARTED|Overall Study||431
5293263|NCT00576056|13012356|P1|NOT COMPLETED|Overall Study||14
5293264|NCT00576056|13012356|P1|COMPLETED|Overall Study||5
5293265|NCT00576056|13012356|P1|STARTED|Overall Study||19
5293266|NCT00575965|13012361|P1|NOT COMPLETED|Overall Study||0
5293267|NCT00575965|13012361|P1|COMPLETED|Overall Study||18
5293268|NCT00575965|13012361|P1|STARTED|Overall Study||18
5293269|NCT00575887|13012366|P1|NOT COMPLETED|Overall Study||0
5293270|NCT00575887|13012366|P1|COMPLETED|Overall Study||25
5293271|NCT00575887|13012366|P1|STARTED|Overall Study||25
5293272|NCT00575666|13012372|P2|NOT COMPLETED|Overall Study||3
5293273|NCT00575666|13012373|P1|NOT COMPLETED|Overall Study||4
5293274|NCT00575666|13012372|P2|COMPLETED|Overall Study||21
5293275|NCT00575666|13012373|P1|COMPLETED|Overall Study||17
5293276|NCT00575666|13012372|P2|STARTED|Overall Study||24
5293277|NCT00575666|13012373|P1|STARTED|Overall Study||21
5293278|NCT00575588|13012413|P2|NOT COMPLETED|Overall Study||283
5293279|NCT00575588|13012414|P1|NOT COMPLETED|Overall Study||263
5293280|NCT00575588|13012413|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
5293281|NCT00575588|13012414|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
5293282|NCT00575588|13012413|P2|STARTED|Overall Study|Randomized and treated|430
5293283|NCT00575588|13012414|P1|STARTED|Overall Study|Randomized and treated|428
5293284|NCT00575510|13012437|P3|NOT COMPLETED|Overall Study||17
5293285|NCT00575510|13012438|P2|NOT COMPLETED|Overall Study||13
5293286|NCT00575510|13012439|P1|NOT COMPLETED|Overall Study||12
5293287|NCT00575510|13012437|P3|COMPLETED|Overall Study||96
5293288|NCT00575510|13012438|P2|COMPLETED|Overall Study||101
5293289|NCT00575510|13012439|P1|COMPLETED|Overall Study||102
5293290|NCT00575510|13012437|P3|STARTED|Overall Study||113
5293291|NCT00575510|13012438|P2|STARTED|Overall Study||114
5293292|NCT00575510|13012439|P1|STARTED|Overall Study||114
5293293|NCT00575380|13012452|P2|NOT COMPLETED|Overall Study||3
5293294|NCT00575380|13012453|P1|NOT COMPLETED|Overall Study||1
5293295|NCT00575380|13012452|P2|COMPLETED|Overall Study||55
5293296|NCT00575380|13012453|P1|COMPLETED|Overall Study||57
5293297|NCT00575380|13012452|P2|STARTED|Overall Study||58
5293298|NCT00575380|13012453|P1|STARTED|Overall Study||58
5293299|NCT00575367|13012463|P2|NOT COMPLETED|Overall Study||0
5293300|NCT00575367|13012464|P1|NOT COMPLETED|Overall Study||0
5293301|NCT00575367|13012463|P2|COMPLETED|Overall Study||18
5293302|NCT00575367|13012464|P1|COMPLETED|Overall Study||19
5293303|NCT00575367|13012463|P2|STARTED|Overall Study||18
5293304|NCT00575367|13012464|P1|STARTED|Overall Study||19
5293305|NCT00575185|13012472|P2|NOT COMPLETED|Overall Study||0
5293306|NCT00575185|13012473|P1|NOT COMPLETED|Overall Study||0
5293307|NCT00575185|13012472|P2|COMPLETED|Overall Study||11
5293308|NCT00575185|13012473|P1|COMPLETED|Overall Study||12
5293309|NCT00575185|13012472|P2|STARTED|Overall Study||11
5293310|NCT00575185|13012473|P1|STARTED|Overall Study||12
5293311|NCT00575159|13012481|P1|NOT COMPLETED|Overall Study||0
5293312|NCT00575159|13012481|P1|COMPLETED|Overall Study||10
5293313|NCT00575159|13012481|P1|STARTED|Overall Study||10
5293314|NCT00575146|13012589|P1|NOT COMPLETED|Overall Study||3
5293315|NCT00575146|13012589|P1|COMPLETED|Overall Study||17
5293316|NCT00575146|13012589|P1|STARTED|Overall Study||20
5293317|NCT00575094|13012595|P1|NOT COMPLETED|Overall Study||3
5293318|NCT00575094|13012595|P1|COMPLETED|Overall Study||6
5293319|NCT00575094|13012595|P1|STARTED|Overall Study||9
5293320|NCT00575042|13012599|P1|NOT COMPLETED|Overall Study||3
5293321|NCT00575042|13012599|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
5293322|NCT00575042|13012599|P1|STARTED|Overall Study||20
5293323|NCT00575029|13012604|P1|NOT COMPLETED|Overall Study||0
5293324|NCT00575029|13012604|P1|COMPLETED|Overall Study||7
5293325|NCT00575029|13012604|P1|STARTED|Overall Study||7
5293326|NCT00575016|13012613|P4|NOT COMPLETED|Treatment Cycle 2||0
5293327|NCT00575016|13012614|P3|NOT COMPLETED|Treatment Cycle 2||0
5293328|NCT00575016|13012615|P2|NOT COMPLETED|Treatment Cycle 2||0
5293329|NCT00575016|13012616|P1|NOT COMPLETED|Treatment Cycle 2||1
5293330|NCT00575016|13012613|P4|COMPLETED|Treatment Cycle 2||0
5293331|NCT00575016|13012614|P3|COMPLETED|Treatment Cycle 2||0
5293332|NCT00575016|13012615|P2|COMPLETED|Treatment Cycle 2||0
5293333|NCT00575016|13012616|P1|COMPLETED|Treatment Cycle 2||30
5293334|NCT00575016|13012613|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
5293335|NCT00575016|13012614|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
5293336|NCT00575016|13012615|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
5293337|NCT00575016|13012616|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
5293338|NCT00575016|13012613|P4|NOT COMPLETED|Treatment Cycle 1||5
5293339|NCT00575016|13012614|P3|NOT COMPLETED|Treatment Cycle 1||4
5293340|NCT00575016|13012615|P2|NOT COMPLETED|Treatment Cycle 1||5
5293341|NCT00575016|13012616|P1|NOT COMPLETED|Treatment Cycle 1||9
5293342|NCT00575016|13012613|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
5293343|NCT00575016|13012614|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
5293344|NCT00575016|13012615|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
5293345|NCT00575016|13012616|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
5293346|NCT00575016|13012613|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
5293347|NCT00575016|13012614|P3|STARTED|Treatment Cycle 1||19
5293348|NCT00575016|13012615|P2|STARTED|Treatment Cycle 1||21
5293349|NCT00575016|13012616|P1|STARTED|Treatment Cycle 1||17
5293350|NCT00574990|13012637|P3|NOT COMPLETED|Overall Study||0
5293351|NCT00574990|13012638|P2|NOT COMPLETED|Overall Study||0
5293352|NCT00574990|13012639|P1|NOT COMPLETED|Overall Study||0
5293353|NCT00574990|13012637|P3|COMPLETED|Overall Study||8
5293354|NCT00574990|13012638|P2|COMPLETED|Overall Study||19
5293355|NCT00574990|13012639|P1|COMPLETED|Overall Study||12
5293356|NCT00574990|13012637|P3|STARTED|Overall Study||8
5293357|NCT00574990|13012638|P2|STARTED|Overall Study||19
5293358|NCT00574990|13012639|P1|STARTED|Overall Study||12
5293359|NCT00574951|13012650|P1|NOT COMPLETED|Overall Study||1
5293360|NCT00574951|13012650|P1|COMPLETED|Overall Study||22
5293361|NCT00574951|13012650|P1|STARTED|Overall Study||23
5293362|NCT00574912|13012658|P1|NOT COMPLETED|Overall Study||8
5293363|NCT00574912|13012658|P1|COMPLETED|Overall Study||12
5293364|NCT00574912|13012658|P1|Completed 2.0|Overall Study||12
5293365|NCT00574912|13012658|P1|Completed 1.5|Overall Study||12
5293366|NCT00574912|13012658|P1|Completed 1.0|Overall Study||12
5293367|NCT00574912|13012658|P1|Completed 0.5|Overall Study||12
5293368|NCT00574912|13012658|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
5293369|NCT00574912|13012658|P1|STARTED|Overall Study||20
5293370|NCT00574873|13012672|P2|NOT COMPLETED|Overall Study||251
5293371|NCT00574873|13012673|P1|NOT COMPLETED|Overall Study||238
5293372|NCT00574873|13012672|P2|COMPLETED|Overall Study||1
5293373|NCT00574873|13012673|P1|COMPLETED|Overall Study||12
5293374|NCT00574873|13012672|P2|Treated|Overall Study||251
5293375|NCT00574873|13012673|P1|Treated|Overall Study||248
5293376|NCT00574873|13012672|P2|STARTED|Overall Study||252
5293377|NCT00574873|13012673|P1|STARTED|Overall Study||250
5293378|NCT00574847|13012691|P2|NOT COMPLETED|Overall Study||7
5293379|NCT00574847|13012692|P1|NOT COMPLETED|Overall Study||8
5293380|NCT00574847|13012691|P2|COMPLETED|Overall Study||56
5293381|NCT00574847|13012692|P1|COMPLETED|Overall Study||56
5293382|NCT00574847|13012691|P2|STARTED|Overall Study||63
5293383|NCT00574847|13012692|P1|STARTED|Overall Study||64
5293384|NCT00574834|13012727|P3|NOT COMPLETED|Overall Study||0
5293385|NCT00574834|13012728|P2|NOT COMPLETED|Overall Study||0
5293386|NCT00574834|13012729|P1|NOT COMPLETED|Overall Study||0
5293387|NCT00574834|13012727|P3|COMPLETED|Overall Study||4
5293388|NCT00574834|13012728|P2|COMPLETED|Overall Study||4
5293389|NCT00574834|13012729|P1|COMPLETED|Overall Study||9
5293390|NCT00574834|13012727|P3|STARTED|Overall Study||4
5293391|NCT00574834|13012728|P2|STARTED|Overall Study||4
5293392|NCT00574834|13012729|P1|STARTED|Overall Study||9
5293393|NCT00574795|13012737|P1|NOT COMPLETED|Toddler Dose||1
5293394|NCT00574795|13012737|P1|COMPLETED|Toddler Dose||184
5293395|NCT00574795|13012737|P1|STARTED|Toddler Dose||185
5293396|NCT00574795|13012737|P1|NOT COMPLETED|After Infant Series||3
5293397|NCT00574795|13012737|P1|COMPLETED|After Infant Series||185
5293398|NCT00574795|13012737|P1|STARTED|After Infant Series||188
5293399|NCT00574795|13012737|P1|NOT COMPLETED|Infant Series||5
5293400|NCT00574795|13012737|P1|COMPLETED|Infant Series||188
5293401|NCT00574795|13012737|P1|Vaccinated Dose 3|Infant Series||190
5293402|NCT00574795|13012737|P1|Vaccinated Dose 2|Infant Series||190
5293403|NCT00574795|13012737|P1|Vaccinated Dose 1|Infant Series||193
5293404|NCT00574795|13012737|P1|STARTED|Infant Series||193
5293405|NCT00574704|13012758|P4|NOT COMPLETED|Overall Study||0
5293406|NCT00574704|13012759|P3|NOT COMPLETED|Overall Study||1
5293407|NCT00574704|13012760|P2|NOT COMPLETED|Overall Study||0
5293408|NCT00574704|13012761|P1|NOT COMPLETED|Overall Study||0
5293409|NCT00574704|13012758|P4|COMPLETED|Overall Study||10
5293410|NCT00574704|13012759|P3|COMPLETED|Overall Study||9
5293411|NCT00574704|13012760|P2|COMPLETED|Overall Study||10
5293412|NCT00574704|13012761|P1|COMPLETED|Overall Study||10
5293413|NCT00574704|13012758|P4|STARTED|Overall Study||10
5293414|NCT00574704|13012759|P3|STARTED|Overall Study||10
5293415|NCT00574704|13012760|P2|STARTED|Overall Study||10
5293416|NCT00574704|13012761|P1|STARTED|Overall Study||10
5293417|NCT00574548|13012773|P2|NOT COMPLETED|Overall Study||16
5293418|NCT00574548|13012774|P1|NOT COMPLETED|Overall Study||61
5293419|NCT00574548|13012773|P2|COMPLETED|Overall Study||222
5293420|NCT00574548|13012774|P1|COMPLETED|Overall Study||421
5293421|NCT00574548|13012773|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
5293422|NCT00574548|13012774|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
5293423|NCT00574548|13012773|P2|Received Vax 2|Overall Study||223
5293424|NCT00574548|13012774|P1|Received Vax 2|Overall Study||427
5293425|NCT00574548|13012773|P2|Withdrawn Before Vax 2|Overall Study||11
5293426|NCT00574548|13012774|P1|Withdrawn Before Vax 2|Overall Study||41
5293427|NCT00574548|13012773|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
5293428|NCT00574548|13012774|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
5293429|NCT00574548|13012773|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
5293430|NCT00574548|13012774|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
5293431|NCT00574548|13012773|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
5293432|NCT00574548|13012774|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
5293433|NCT00574548|13012773|P2|STARTED|Overall Study||238
5293434|NCT00574548|13012774|P1|STARTED|Overall Study||482
5293435|NCT00574405|13012820|P2|NOT COMPLETED|Overall Study||2
5293436|NCT00574405|13012821|P1|NOT COMPLETED|Overall Study||3
5293437|NCT00574405|13012820|P2|COMPLETED|Overall Study||10
5293438|NCT00574405|13012821|P1|COMPLETED|Overall Study||9
5293439|NCT00574405|13012820|P2|STARTED|Overall Study||12
5293440|NCT00574405|13012821|P1|STARTED|Overall Study||12
5293441|NCT00574340|13012827|P2|NOT COMPLETED|Study 2 (2 Days)||0
5293442|NCT00574340|13012828|P1|NOT COMPLETED|Study 2 (2 Days)||0
5293443|NCT00574340|13012827|P2|COMPLETED|Study 2 (2 Days)||6
5293444|NCT00574340|13012828|P1|COMPLETED|Study 2 (2 Days)||6
5293445|NCT00574340|13012827|P2|STARTED|Study 2 (2 Days)||6
5293446|NCT00574340|13012828|P1|STARTED|Study 2 (2 Days)||6
5293447|NCT00574340|13012827|P2|NOT COMPLETED|Study 1 (2 Days)||0
5293448|NCT00574340|13012828|P1|NOT COMPLETED|Study 1 (2 Days)||0
5293449|NCT00574340|13012827|P2|COMPLETED|Study 1 (2 Days)||10
5293450|NCT00574340|13012828|P1|COMPLETED|Study 1 (2 Days)||10
5293451|NCT00574340|13012827|P2|STARTED|Study 1 (2 Days)||10
5293452|NCT00574340|13012828|P1|STARTED|Study 1 (2 Days)||10
5293453|NCT00574288|13012841|P7|NOT COMPLETED|Overall Study||28
5293454|NCT00574288|13012842|P6|NOT COMPLETED|Overall Study||26
5293455|NCT00574288|13012843|P5|NOT COMPLETED|Overall Study||2
5293456|NCT00574288|13012844|P4|NOT COMPLETED|Overall Study||2
5293457|NCT00574288|13012845|P3|NOT COMPLETED|Overall Study||3
5293458|NCT00574288|13012846|P2|NOT COMPLETED|Overall Study||3
5293459|NCT00574288|13012847|P1|NOT COMPLETED|Overall Study||20
5293460|NCT00574288|13012841|P7|COMPLETED|Overall Study||14
5293461|NCT00574288|13012842|P6|COMPLETED|Overall Study||4
5293462|NCT00574288|13012843|P5|COMPLETED|Overall Study||1
5293463|NCT00574288|13012844|P4|COMPLETED|Overall Study||1
5293464|NCT00574288|13012845|P3|COMPLETED|Overall Study||0
5293465|NCT00574288|13012846|P2|COMPLETED|Overall Study||0
5293466|NCT00574288|13012847|P1|COMPLETED|Overall Study||0
5293467|NCT00574288|13012841|P7|STARTED|Overall Study||42
5293468|NCT00574288|13012842|P6|STARTED|Overall Study||30
5293469|NCT00574288|13012843|P5|STARTED|Overall Study||3
5293470|NCT00574288|13012844|P4|STARTED|Overall Study||3
5293471|NCT00574288|13012845|P3|STARTED|Overall Study||3
5293472|NCT00574288|13012846|P2|STARTED|Overall Study||3
5293473|NCT00574288|13012847|P1|STARTED|Overall Study||20
5293474|NCT00574275|13012885|P2|NOT COMPLETED|Overall Study||271
5293475|NCT00574275|13012886|P1|NOT COMPLETED|Overall Study||275
5293476|NCT00574275|13012885|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
5293477|NCT00574275|13012886|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
5293478|NCT00574275|13012885|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
5293479|NCT00574275|13012886|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
5293480|NCT00574275|13012885|P2|TREATED|Overall Study||268
5293481|NCT00574275|13012886|P1|TREATED|Overall Study||273
5293482|NCT00574275|13012885|P2|STARTED|Overall Study||271
5293483|NCT00574275|13012886|P1|STARTED|Overall Study||275
5293484|NCT00574249|13012904|P2|NOT COMPLETED|Overall Study||28
5293485|NCT00574249|13012905|P1|NOT COMPLETED|Overall Study||26
5293486|NCT00574249|13012904|P2|COMPLETED|Overall Study||338
5293487|NCT00574249|13012905|P1|COMPLETED|Overall Study||338
5293488|NCT00574249|13012904|P2|STARTED|Overall Study||366
5293489|NCT00574249|13012905|P1|STARTED|Overall Study||364
5293490|NCT00574236|13012945|P1|NOT COMPLETED|Overall Study||0
5293491|NCT00574236|13012945|P1|COMPLETED|Overall Study||4
5293492|NCT00574236|13012945|P1|STARTED|Overall Study||4
5293493|NCT00574197|13012950|P1|NOT COMPLETED|Overall Study||5
5293494|NCT00574197|13012950|P1|COMPLETED|Overall Study||6
5293495|NCT00574197|13012950|P1|STARTED|Overall Study||11
5293496|NCT00574171|13012955|P1|NOT COMPLETED|Overall Study||0
5293497|NCT00574171|13012955|P1|COMPLETED|Overall Study||29
5293498|NCT00574171|13012955|P1|STARTED|Overall Study||29
5293499|NCT00574145|13012961|P2|NOT COMPLETED|Overall Study||1
5293500|NCT00574145|13012962|P1|NOT COMPLETED|Overall Study||2
5293501|NCT00574145|13012961|P2|COMPLETED|Overall Study||21
5293502|NCT00574145|13012962|P1|COMPLETED|Overall Study||20
5293503|NCT00574145|13012961|P2|STARTED|Overall Study||22
5293504|NCT00574145|13012962|P1|STARTED|Overall Study||22
5293505|NCT00574119|13012972|P1|NOT COMPLETED|Overall Study||4
5293506|NCT00574119|13012972|P1|COMPLETED|Overall Study||12
5293507|NCT00574119|13012972|P1|STARTED|Overall Study||16
5293508|NCT00574080|13012986|P2|NOT COMPLETED|Overall Study||10
5293509|NCT00574080|13012987|P1|NOT COMPLETED|Overall Study||10
5293510|NCT00574080|13012986|P2|COMPLETED|Overall Study||0
5293511|NCT00574080|13012987|P1|COMPLETED|Overall Study||0
5293512|NCT00574080|13012986|P2|STARTED|Overall Study||10
5293513|NCT00574080|13012987|P1|STARTED|Overall Study||10
5293514|NCT00574067|13012997|P4|NOT COMPLETED|Overall Study||0
5293515|NCT00574067|13012998|P3|NOT COMPLETED|Overall Study||0
5293516|NCT00574067|13012999|P2|NOT COMPLETED|Overall Study||1
5293517|NCT00574067|13013000|P1|NOT COMPLETED|Overall Study||1
5293518|NCT00574067|13012997|P4|COMPLETED|Overall Study||53
5293519|NCT00574067|13012998|P3|COMPLETED|Overall Study||54
5293520|NCT00574067|13012999|P2|COMPLETED|Overall Study||52
5293521|NCT00574067|13013000|P1|COMPLETED|Overall Study||52
5293522|NCT00574067|13012997|P4|STARTED|Overall Study||53
5293523|NCT00574067|13012998|P3|STARTED|Overall Study||54
5293524|NCT00574067|13012999|P2|STARTED|Overall Study||53
5293525|NCT00574067|13013000|P1|STARTED|Overall Study||53
5293526|NCT00573989|13013034|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
5293527|NCT00573989|13013035|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
5293528|NCT00573989|13013036|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
5293529|NCT00573989|13013037|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
5293530|NCT00573989|13013034|P4|COMPLETED|Erlotinib 125mg- Phase II||12
5293531|NCT00573989|13013035|P3|COMPLETED|Erlotinib 125mg- Phase II||0
5293532|NCT00573989|13013036|P2|COMPLETED|Erlotinib 125mg- Phase II||0
5293533|NCT00573989|13013037|P1|COMPLETED|Erlotinib 125mg- Phase II||0
5293534|NCT00573989|13013034|P4|STARTED|Erlotinib 125mg- Phase II||12
5293535|NCT00573989|13013035|P3|STARTED|Erlotinib 125mg- Phase II||0
5293536|NCT00573989|13013036|P2|STARTED|Erlotinib 125mg- Phase II||0
5293537|NCT00573989|13013037|P1|STARTED|Erlotinib 125mg- Phase II||0
5293538|NCT00573989|13013034|P4|NOT COMPLETED|Erlotinib Phase I||0
5293539|NCT00573989|13013035|P3|NOT COMPLETED|Erlotinib Phase I||0
5293540|NCT00573989|13013036|P2|NOT COMPLETED|Erlotinib Phase I||0
5293541|NCT00573989|13013037|P1|NOT COMPLETED|Erlotinib Phase I||0
5293542|NCT00573989|13013034|P4|COMPLETED|Erlotinib Phase I||0
5293543|NCT00573989|13013035|P3|COMPLETED|Erlotinib Phase I||5
5293544|NCT00573989|13013036|P2|COMPLETED|Erlotinib Phase I||6
5293545|NCT00573989|13013037|P1|COMPLETED|Erlotinib Phase I||4
5293546|NCT00573989|13013034|P4|STARTED|Erlotinib Phase I||0
5293547|NCT00573989|13013035|P3|STARTED|Erlotinib Phase I||5
5293548|NCT00573989|13013036|P2|STARTED|Erlotinib Phase I||6
5293549|NCT00573989|13013037|P1|STARTED|Erlotinib Phase I||4
5293550|NCT00573937|13013056|P2|NOT COMPLETED|Overall Study||1
5293551|NCT00573937|13013057|P1|NOT COMPLETED|Overall Study||0
5293552|NCT00573937|13013056|P2|COMPLETED|Overall Study||0
5293553|NCT00573937|13013057|P1|COMPLETED|Overall Study||0
5293554|NCT00573937|13013056|P2|STARTED|Overall Study||1
5293555|NCT00573937|13013057|P1|STARTED|Overall Study||0
5293556|NCT00573872|13013065|P1|NOT COMPLETED|Overall Study||11
5293557|NCT00573872|13013065|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
5293558|NCT00573872|13013065|P1|STARTED|Overall Study|# of patients that signed consent|43
5293559|NCT00573859|13013071|P1|NOT COMPLETED|Smoking Versus Abstinence||12
5293560|NCT00573859|13013071|P1|COMPLETED|Smoking Versus Abstinence||15
5293561|NCT00573859|13013071|P1|STARTED|Smoking Versus Abstinence||27
5293562|NCT00573859|13013071|P1|NOT COMPLETED|Medication Versus Placebo||12
5293563|NCT00573859|13013071|P1|COMPLETED|Medication Versus Placebo||15
5293564|NCT00573859|13013071|P1|STARTED|Medication Versus Placebo||27
5293565|NCT00573833|13013077|P1|NOT COMPLETED|Overall Study||2
5293566|NCT00573833|13013077|P1|COMPLETED|Overall Study||21
5293567|NCT00573833|13013077|P1|STARTED|Overall Study||23
5293568|NCT00573794|13013084|P1|NOT COMPLETED|Overall Study||330
5293569|NCT00573794|13013084|P1|COMPLETED|Overall Study||255
5293570|NCT00573794|13013084|P1|STARTED|Overall Study||585
5293571|NCT00573768|13013115|P3|NOT COMPLETED|Overall Study||4
5293572|NCT00573768|13013116|P2|NOT COMPLETED|Overall Study||2
5293573|NCT00573768|13013117|P1|NOT COMPLETED|Overall Study||2
5293574|NCT00573768|13013115|P3|COMPLETED|Overall Study||87
5293575|NCT00573768|13013116|P2|COMPLETED|Overall Study||89
5293576|NCT00573768|13013117|P1|COMPLETED|Overall Study||87
5293577|NCT00573768|13013115|P3|STARTED|Overall Study||91
5293578|NCT00573768|13013116|P2|STARTED|Overall Study||91
5293579|NCT00573768|13013117|P1|STARTED|Overall Study||89
5293580|NCT00573755|13013127|P2|NOT COMPLETED|Overall Study||0
5293581|NCT00573755|13013128|P1|NOT COMPLETED|Overall Study||1
5293582|NCT00573755|13013127|P2|COMPLETED|Overall Study||2
5293583|NCT00573755|13013128|P1|COMPLETED|Overall Study||1
5293584|NCT00573755|13013127|P2|STARTED|Overall Study||2
5293585|NCT00573755|13013128|P1|STARTED|Overall Study||2
5293586|NCT00573534|13013144|P1|NOT COMPLETED|Overall Study||3
5293587|NCT00573534|13013144|P1|COMPLETED|Overall Study||5
5293588|NCT00573534|13013144|P1|STARTED|Overall Study||8
5293589|NCT00573508|13013151|P2|NOT COMPLETED|Overall Study||41
5293590|NCT00573508|13013152|P1|NOT COMPLETED|Overall Study||64
5293591|NCT00573508|13013151|P2|COMPLETED|Overall Study||345
5293592|NCT00573508|13013152|P1|COMPLETED|Overall Study||318
5293593|NCT00573508|13013151|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
5293594|NCT00573508|13013152|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
5293595|NCT00573508|13013151|P2|STARTED|Overall Study||386
5293596|NCT00573508|13013152|P1|STARTED|Overall Study||382
5293597|NCT00573469|13013185|P3|NOT COMPLETED|Overall Study||4
5293598|NCT00573469|13013186|P2|NOT COMPLETED|Overall Study||4
5293599|NCT00573469|13013187|P1|NOT COMPLETED|Overall Study||6
5293600|NCT00573469|13013185|P3|COMPLETED|Overall Study||22
5293601|NCT00573469|13013186|P2|COMPLETED|Overall Study||21
5293602|NCT00573469|13013187|P1|COMPLETED|Overall Study||20
5293603|NCT00573469|13013185|P3|STARTED|Overall Study||26
5293604|NCT00573469|13013186|P2|STARTED|Overall Study||25
5293605|NCT00573469|13013187|P1|STARTED|Overall Study||26
5293606|NCT00573443|13013210|P3|NOT COMPLETED|Open-Label Extension Phase||0
5293607|NCT00573443|13013211|P2|NOT COMPLETED|Open-Label Extension Phase||0
5293608|NCT00573443|13013212|P1|NOT COMPLETED|Open-Label Extension Phase||18
5293609|NCT00573443|13013210|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293610|NCT00573443|13013211|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293611|NCT00573443|13013212|P1|COMPLETED|Open-Label Extension Phase||235
5293612|NCT00573443|13013210|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293613|NCT00573443|13013211|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293614|NCT00573443|13013212|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
5293615|NCT00573443|13013210|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293616|NCT00573443|13013211|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293617|NCT00573443|13013212|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
5293618|NCT00573443|13013210|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293619|NCT00573443|13013211|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
5293620|NCT00573443|13013212|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
5293621|NCT00573443|13013210|P3|NOT COMPLETED|Double-Blind Phase||15
5293622|NCT00573443|13013211|P2|NOT COMPLETED|Double-Blind Phase||19
5293623|NCT00573443|13013212|P1|NOT COMPLETED|Double-Blind Phase||9
5293624|NCT00573443|13013210|P3|COMPLETED|Double-Blind Phase||94
5293625|NCT00573443|13013211|P2|COMPLETED|Double-Blind Phase||88
5293626|NCT00573443|13013212|P1|COMPLETED|Double-Blind Phase||101
5293627|NCT00573443|13013210|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
5293628|NCT00573443|13013211|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
5293629|NCT00573443|13013212|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
5293630|NCT00573443|13013210|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
5293631|NCT00573443|13013211|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
5293632|NCT00573443|13013212|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
5293633|NCT00573443|13013210|P3|STARTED|Double-Blind Phase||109
5293634|NCT00573443|13013211|P2|STARTED|Double-Blind Phase||107
5293635|NCT00573443|13013212|P1|STARTED|Double-Blind Phase||110
5293636|NCT00573430|13013242|P3|NOT COMPLETED|Overall Study||10
5293637|NCT00573430|13013243|P2|NOT COMPLETED|Overall Study||5
5293638|NCT00573430|13013244|P1|NOT COMPLETED|Overall Study||1
5293639|NCT00573430|13013242|P3|COMPLETED|Overall Study||33
5293640|NCT00573430|13013243|P2|COMPLETED|Overall Study||40
5293641|NCT00573430|13013244|P1|COMPLETED|Overall Study||39
5293642|NCT00573430|13013242|P3|STARTED|Overall Study|randomized|43
5293643|NCT00573430|13013243|P2|STARTED|Overall Study|randomized|45
5293644|NCT00573430|13013244|P1|STARTED|Overall Study|randomized|40
5293645|NCT00573391|13013266|P2|NOT COMPLETED|Overall Study||2
5293646|NCT00573391|13013267|P1|NOT COMPLETED|Overall Study||3
5293647|NCT00573391|13013266|P2|COMPLETED|Overall Study||0
5293648|NCT00573391|13013267|P1|COMPLETED|Overall Study||0
5293649|NCT00573391|13013266|P2|STARTED|Overall Study||2
5293650|NCT00573391|13013267|P1|STARTED|Overall Study||3
5293651|NCT00573313|13013277|P4|NOT COMPLETED|Overall Study||0
5293652|NCT00573313|13013278|P3|NOT COMPLETED|Overall Study||6
5293653|NCT00573313|13013279|P2|NOT COMPLETED|Overall Study||0
5293654|NCT00573313|13013280|P1|NOT COMPLETED|Overall Study||5
5293655|NCT00573313|13013277|P4|COMPLETED|Overall Study||26
5293656|NCT00573313|13013278|P3|COMPLETED|Overall Study||13
5293657|NCT00573313|13013279|P2|COMPLETED|Overall Study||28
5293658|NCT00573313|13013280|P1|COMPLETED|Overall Study||13
5293659|NCT00573313|13013277|P4|STARTED|Overall Study||26
5293660|NCT00573313|13013278|P3|STARTED|Overall Study|Nineteen recruited to start.|19
5293661|NCT00573313|13013279|P2|STARTED|Overall Study||28
5293662|NCT00573313|13013280|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
5293663|NCT00573287|13013290|P2|NOT COMPLETED|Overall Study||3
5293664|NCT00573287|13013291|P1|NOT COMPLETED|Overall Study||4
5293665|NCT00573287|13013290|P2|COMPLETED|Overall Study||4
5293666|NCT00573287|13013291|P1|COMPLETED|Overall Study||3
5293667|NCT00573287|13013290|P2|STARTED|Overall Study||7
5293668|NCT00573287|13013291|P1|STARTED|Overall Study||7
5293669|NCT00573261|13013301|P2|NOT COMPLETED|Overall Study||5
5293670|NCT00573261|13013302|P1|NOT COMPLETED|Overall Study||6
5293671|NCT00573261|13013301|P2|COMPLETED|Overall Study||15
5293672|NCT00573261|13013302|P1|COMPLETED|Overall Study||14
5293673|NCT00573261|13013301|P2|STARTED|Overall Study||20
5293674|NCT00573261|13013302|P1|STARTED|Overall Study||20
5293675|NCT00573248|13013330|P2|NOT COMPLETED|Overall Study||11
5293676|NCT00573248|13013331|P1|NOT COMPLETED|Overall Study||15
5293677|NCT00573248|13013330|P2|COMPLETED|Overall Study||27
5293678|NCT00573248|13013331|P1|COMPLETED|Overall Study||25
5293679|NCT00573248|13013330|P2|Nicotine Patches and Placebo Patches|Overall Study||27
5293680|NCT00573248|13013331|P1|Nicotine Patches and Placebo Patches|Overall Study||25
5293681|NCT00573248|13013330|P2|STARTED|Overall Study||38
5293682|NCT00573248|13013331|P1|STARTED|Overall Study||40
5293683|NCT00573183|13013345|P2|NOT COMPLETED|Overall Study||63
5293684|NCT00573183|13013346|P1|NOT COMPLETED|Overall Study||72
5293685|NCT00573183|13013345|P2|COMPLETED|Overall Study||174
5293686|NCT00573183|13013346|P1|COMPLETED|Overall Study||162
5293687|NCT00573183|13013345|P2|STARTED|Overall Study||237
5293688|NCT00573183|13013346|P1|STARTED|Overall Study||234
5293689|NCT00573170|13013354|P6|NOT COMPLETED|Third Treatment Period||2
5293690|NCT00573170|13013355|P5|NOT COMPLETED|Third Treatment Period||0
5293691|NCT00573170|13013356|P4|NOT COMPLETED|Third Treatment Period||0
5293692|NCT00573170|13013357|P3|NOT COMPLETED|Third Treatment Period||0
5293693|NCT00573170|13013358|P2|NOT COMPLETED|Third Treatment Period||0
5293694|NCT00573170|13013359|P1|NOT COMPLETED|Third Treatment Period||1
5293695|NCT00573170|13013354|P6|COMPLETED|Third Treatment Period||51
5293696|NCT00573170|13013355|P5|COMPLETED|Third Treatment Period||51
5293697|NCT00573170|13013356|P4|COMPLETED|Third Treatment Period||56
5293698|NCT00573170|13013357|P3|COMPLETED|Third Treatment Period||55
5293699|NCT00573170|13013358|P2|COMPLETED|Third Treatment Period||54
5293700|NCT00573170|13013359|P1|COMPLETED|Third Treatment Period||50
5293701|NCT00573170|13013354|P6|STARTED|Third Treatment Period||53
5293702|NCT00573170|13013355|P5|STARTED|Third Treatment Period||51
5293703|NCT00573170|13013356|P4|STARTED|Third Treatment Period||56
5293704|NCT00573170|13013357|P3|STARTED|Third Treatment Period||55
5293705|NCT00573170|13013358|P2|STARTED|Third Treatment Period||54
5293706|NCT00573170|13013359|P1|STARTED|Third Treatment Period||51
5293707|NCT00573170|13013354|P6|NOT COMPLETED|Second Washout Period||2
5293708|NCT00573170|13013355|P5|NOT COMPLETED|Second Washout Period||8
5293709|NCT00573170|13013356|P4|NOT COMPLETED|Second Washout Period||5
5293710|NCT00573170|13013357|P3|NOT COMPLETED|Second Washout Period||4
5293711|NCT00573170|13013358|P2|NOT COMPLETED|Second Washout Period||4
5293712|NCT00573170|13013359|P1|NOT COMPLETED|Second Washout Period||5
5293713|NCT00573170|13013354|P6|COMPLETED|Second Washout Period||53
5293714|NCT00573170|13013355|P5|COMPLETED|Second Washout Period||51
5293715|NCT00573170|13013356|P4|COMPLETED|Second Washout Period||56
5293716|NCT00573170|13013357|P3|COMPLETED|Second Washout Period||55
5293717|NCT00573170|13013358|P2|COMPLETED|Second Washout Period||54
5293718|NCT00573170|13013359|P1|COMPLETED|Second Washout Period||51
5293719|NCT00573170|13013354|P6|STARTED|Second Washout Period||55
5293720|NCT00573170|13013355|P5|STARTED|Second Washout Period||59
5293721|NCT00573170|13013356|P4|STARTED|Second Washout Period||61
5293722|NCT00573170|13013357|P3|STARTED|Second Washout Period||59
5293723|NCT00573170|13013358|P2|STARTED|Second Washout Period||58
5293724|NCT00573170|13013359|P1|STARTED|Second Washout Period||56
5293725|NCT00573170|13013354|P6|NOT COMPLETED|Second Treatment Period||0
5293726|NCT00573170|13013355|P5|NOT COMPLETED|Second Treatment Period||0
5293727|NCT00573170|13013356|P4|NOT COMPLETED|Second Treatment Period||0
5293728|NCT00573170|13013357|P3|NOT COMPLETED|Second Treatment Period||0
5293729|NCT00573170|13013358|P2|NOT COMPLETED|Second Treatment Period||0
5293730|NCT00573170|13013359|P1|NOT COMPLETED|Second Treatment Period||0
5293731|NCT00573170|13013354|P6|COMPLETED|Second Treatment Period||55
5293732|NCT00573170|13013355|P5|COMPLETED|Second Treatment Period||59
5293733|NCT00573170|13013356|P4|COMPLETED|Second Treatment Period||61
5293734|NCT00573170|13013357|P3|COMPLETED|Second Treatment Period||59
5293735|NCT00573170|13013358|P2|COMPLETED|Second Treatment Period||58
5293736|NCT00573170|13013359|P1|COMPLETED|Second Treatment Period||56
5293737|NCT00573170|13013354|P6|STARTED|Second Treatment Period||55
5293738|NCT00573170|13013355|P5|STARTED|Second Treatment Period||59
5293739|NCT00573170|13013356|P4|STARTED|Second Treatment Period||61
5293740|NCT00573170|13013357|P3|STARTED|Second Treatment Period||59
5293741|NCT00573170|13013358|P2|STARTED|Second Treatment Period||58
5293742|NCT00573170|13013359|P1|STARTED|Second Treatment Period||56
5293743|NCT00573170|13013354|P6|NOT COMPLETED|First Washout Period||7
5293744|NCT00573170|13013355|P5|NOT COMPLETED|First Washout Period||3
5293745|NCT00573170|13013356|P4|NOT COMPLETED|First Washout Period||5
5293746|NCT00573170|13013357|P3|NOT COMPLETED|First Washout Period||1
5293747|NCT00573170|13013358|P2|NOT COMPLETED|First Washout Period||2
5293748|NCT00573170|13013359|P1|NOT COMPLETED|First Washout Period||8
5293749|NCT00573170|13013354|P6|COMPLETED|First Washout Period||55
5293750|NCT00573170|13013355|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
5293751|NCT00573170|13013356|P4|COMPLETED|First Washout Period||61
5293752|NCT00573170|13013357|P3|COMPLETED|First Washout Period||59
5293753|NCT00573170|13013358|P2|COMPLETED|First Washout Period||58
5293754|NCT00573170|13013359|P1|COMPLETED|First Washout Period||56
5293755|NCT00573170|13013354|P6|STARTED|First Washout Period||62
5293756|NCT00573170|13013355|P5|STARTED|First Washout Period||62
5293757|NCT00573170|13013356|P4|STARTED|First Washout Period||66
5293758|NCT00573170|13013357|P3|STARTED|First Washout Period||60
5293759|NCT00573170|13013358|P2|STARTED|First Washout Period||60
5293760|NCT00573170|13013359|P1|STARTED|First Washout Period||64
5293761|NCT00573170|13013354|P6|NOT COMPLETED|First Treatment Period||0
5293762|NCT00573170|13013355|P5|NOT COMPLETED|First Treatment Period||1
5293763|NCT00573170|13013356|P4|NOT COMPLETED|First Treatment Period||0
5293764|NCT00573170|13013357|P3|NOT COMPLETED|First Treatment Period||0
5293765|NCT00573170|13013358|P2|NOT COMPLETED|First Treatment Period||0
5293766|NCT00573170|13013359|P1|NOT COMPLETED|First Treatment Period||0
5293767|NCT00573170|13013354|P6|COMPLETED|First Treatment Period||62
5293768|NCT00573170|13013355|P5|COMPLETED|First Treatment Period||62
5293769|NCT00573170|13013356|P4|COMPLETED|First Treatment Period||66
5293770|NCT00573170|13013357|P3|COMPLETED|First Treatment Period||60
5293771|NCT00573170|13013358|P2|COMPLETED|First Treatment Period||60
5293772|NCT00573170|13013359|P1|COMPLETED|First Treatment Period||64
5293773|NCT00573170|13013354|P6|STARTED|First Treatment Period||62
5293774|NCT00573170|13013355|P5|STARTED|First Treatment Period||63
5293775|NCT00573170|13013356|P4|STARTED|First Treatment Period||66
5293776|NCT00573170|13013357|P3|STARTED|First Treatment Period||60
5293777|NCT00573170|13013358|P2|STARTED|First Treatment Period||60
5293778|NCT00573170|13013359|P1|STARTED|First Treatment Period||64
5293779|NCT00573157|13013435|P2|NOT COMPLETED|Overall Study||2
5293780|NCT00573157|13013436|P1|NOT COMPLETED|Overall Study||4
5293781|NCT00573157|13013435|P2|COMPLETED|Overall Study||0
5293782|NCT00573157|13013436|P1|COMPLETED|Overall Study||0
5293783|NCT00573157|13013435|P2|STARTED|Overall Study||2
5293784|NCT00573157|13013436|P1|STARTED|Overall Study||4
5293785|NCT00573144|13013448|P2|NOT COMPLETED|Overall Study||3
5293786|NCT00573144|13013449|P1|NOT COMPLETED|Overall Study||2
5293787|NCT00573144|13013448|P2|COMPLETED|Overall Study||25
5293788|NCT00573144|13013449|P1|COMPLETED|Overall Study||28
5293789|NCT00573144|13013448|P2|STARTED|Overall Study||28
5293790|NCT00573144|13013449|P1|STARTED|Overall Study||30
5293791|NCT00573131|13013461|P2|NOT COMPLETED|Overall Study||8
5293792|NCT00573131|13013462|P1|NOT COMPLETED|Overall Study||10
5293793|NCT00573131|13013461|P2|COMPLETED|Overall Study||57
5293794|NCT00573131|13013462|P1|COMPLETED|Overall Study||62
5293795|NCT00573131|13013461|P2|STARTED|Overall Study||65
5293796|NCT00573131|13013462|P1|STARTED|Overall Study||72
5293797|NCT00573066|13013468|P1|NOT COMPLETED|Overall Study||20
5293798|NCT00573066|13013468|P1|COMPLETED|Overall Study||36
5293799|NCT00573066|13013468|P1|STARTED|Overall Study||56
5293800|NCT00572936|13013472|P6|NOT COMPLETED|Third Intervention||0
5293801|NCT00572936|13013473|P5|NOT COMPLETED|Third Intervention||0
5293802|NCT00572936|13013474|P4|NOT COMPLETED|Third Intervention||0
5293803|NCT00572936|13013475|P3|NOT COMPLETED|Third Intervention||0
5293804|NCT00572936|13013476|P2|NOT COMPLETED|Third Intervention||0
5293805|NCT00572936|13013477|P1|NOT COMPLETED|Third Intervention||0
5293806|NCT00572936|13013472|P6|COMPLETED|Third Intervention||5
5293807|NCT00572936|13013473|P5|COMPLETED|Third Intervention||3
5293808|NCT00572936|13013474|P4|COMPLETED|Third Intervention||5
5293809|NCT00572936|13013475|P3|COMPLETED|Third Intervention||4
5293810|NCT00572936|13013476|P2|COMPLETED|Third Intervention||3
5293811|NCT00572936|13013477|P1|COMPLETED|Third Intervention||4
5293812|NCT00572936|13013472|P6|STARTED|Third Intervention||5
5293813|NCT00572936|13013473|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
5293814|NCT00572936|13013474|P4|STARTED|Third Intervention||5
5293815|NCT00572936|13013475|P3|STARTED|Third Intervention||4
5293816|NCT00572936|13013476|P2|STARTED|Third Intervention||3
5293817|NCT00572936|13013477|P1|STARTED|Third Intervention||4
5293818|NCT00572936|13013472|P6|NOT COMPLETED|Second Intervention||0
5293819|NCT00572936|13013473|P5|NOT COMPLETED|Second Intervention||0
5293820|NCT00572936|13013474|P4|NOT COMPLETED|Second Intervention||0
5293821|NCT00572936|13013475|P3|NOT COMPLETED|Second Intervention||0
5293822|NCT00572936|13013476|P2|NOT COMPLETED|Second Intervention||0
5293823|NCT00572936|13013477|P1|NOT COMPLETED|Second Intervention||0
5293824|NCT00572936|13013472|P6|COMPLETED|Second Intervention||5
5293825|NCT00572936|13013473|P5|COMPLETED|Second Intervention||4
5293826|NCT00572936|13013474|P4|COMPLETED|Second Intervention||5
5293827|NCT00572936|13013475|P3|COMPLETED|Second Intervention||4
5293828|NCT00572936|13013476|P2|COMPLETED|Second Intervention||3
5293829|NCT00572936|13013477|P1|COMPLETED|Second Intervention||4
5293830|NCT00572936|13013472|P6|STARTED|Second Intervention||5
5293831|NCT00572936|13013473|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
5293832|NCT00572936|13013474|P4|STARTED|Second Intervention||5
5293833|NCT00572936|13013475|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
5293834|NCT00572936|13013476|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
5293835|NCT00572936|13013477|P1|STARTED|Second Intervention||4
5293836|NCT00572936|13013472|P6|NOT COMPLETED|First Intervention||0
5293837|NCT00572936|13013473|P5|NOT COMPLETED|First Intervention||0
5293838|NCT00572936|13013474|P4|NOT COMPLETED|First Intervention||0
5293839|NCT00572936|13013475|P3|NOT COMPLETED|First Intervention||0
5293840|NCT00572936|13013476|P2|NOT COMPLETED|First Intervention||0
5293841|NCT00572936|13013477|P1|NOT COMPLETED|First Intervention||0
5293842|NCT00572936|13013472|P6|COMPLETED|First Intervention||5
5293843|NCT00572936|13013473|P5|COMPLETED|First Intervention||5
5293844|NCT00572936|13013474|P4|COMPLETED|First Intervention||5
5293845|NCT00572936|13013475|P3|COMPLETED|First Intervention||5
5293846|NCT00572936|13013476|P2|COMPLETED|First Intervention||4
5293847|NCT00572936|13013477|P1|COMPLETED|First Intervention||4
5293848|NCT00572936|13013472|P6|STARTED|First Intervention||5
5293849|NCT00572936|13013473|P5|STARTED|First Intervention||5
5293850|NCT00572936|13013474|P4|STARTED|First Intervention||5
5293851|NCT00572936|13013475|P3|STARTED|First Intervention||5
5293852|NCT00572936|13013476|P2|STARTED|First Intervention||4
5293853|NCT00572936|13013477|P1|STARTED|First Intervention||4
5293854|NCT00572910|13013512|P11|NOT COMPLETED|Overall Study||3
5293855|NCT00572910|13013513|P10|NOT COMPLETED|Overall Study||6
5293856|NCT00572910|13013514|P9|NOT COMPLETED|Overall Study||3
5293857|NCT00572910|13013515|P8|NOT COMPLETED|Overall Study||4
5293858|NCT00572910|13013516|P7|NOT COMPLETED|Overall Study||4
5293859|NCT00572910|13013517|P6|NOT COMPLETED|Overall Study||3
5293860|NCT00572910|13013518|P5|NOT COMPLETED|Overall Study||2
5293861|NCT00572910|13013519|P4|NOT COMPLETED|Overall Study||4
5293862|NCT00572910|13013520|P3|NOT COMPLETED|Overall Study||2
5293863|NCT00572910|13013521|P2|NOT COMPLETED|Overall Study||3
5293864|NCT00572910|13013522|P1|NOT COMPLETED|Overall Study||4
5293865|NCT00572910|13013512|P11|COMPLETED|Overall Study||15
5293866|NCT00572910|13013513|P10|COMPLETED|Overall Study||13
5293867|NCT00572910|13013514|P9|COMPLETED|Overall Study||16
5293868|NCT00572910|13013515|P8|COMPLETED|Overall Study||15
5293869|NCT00572910|13013516|P7|COMPLETED|Overall Study||15
5293870|NCT00572910|13013517|P6|COMPLETED|Overall Study||16
5293871|NCT00572910|13013518|P5|COMPLETED|Overall Study||17
5293872|NCT00572910|13013519|P4|COMPLETED|Overall Study||14
5293873|NCT00572910|13013520|P3|COMPLETED|Overall Study||17
5293874|NCT00572910|13013521|P2|COMPLETED|Overall Study||15
5293875|NCT00572910|13013522|P1|COMPLETED|Overall Study||15
5293876|NCT00572910|13013512|P11|STARTED|Overall Study||18
5293877|NCT00572910|13013513|P10|STARTED|Overall Study||19
5293878|NCT00572910|13013514|P9|STARTED|Overall Study||19
5293879|NCT00572910|13013515|P8|STARTED|Overall Study||19
5293880|NCT00572910|13013516|P7|STARTED|Overall Study||19
5293881|NCT00572910|13013517|P6|STARTED|Overall Study||19
5293882|NCT00572910|13013518|P5|STARTED|Overall Study||19
5293883|NCT00572910|13013519|P4|STARTED|Overall Study||18
5293884|NCT00572910|13013520|P3|STARTED|Overall Study||19
5293885|NCT00572910|13013521|P2|STARTED|Overall Study||18
5293886|NCT00572910|13013522|P1|STARTED|Overall Study||19
5293887|NCT00572897|13013570|P2|NOT COMPLETED|Overall Study||0
5293888|NCT00572897|13013571|P1|NOT COMPLETED|Overall Study||0
5293889|NCT00572897|13013570|P2|COMPLETED|Overall Study||34
5293890|NCT00572897|13013571|P1|COMPLETED|Overall Study||32
5293891|NCT00572897|13013570|P2|STARTED|Overall Study||34
5293892|NCT00572897|13013571|P1|STARTED|Overall Study||32
5293893|NCT00572832|13013589|P2|NOT COMPLETED|Overall Study||12
5293894|NCT00572832|13013590|P1|NOT COMPLETED|Overall Study||0
5293895|NCT00572832|13013589|P2|COMPLETED|Overall Study||88
5293896|NCT00572832|13013590|P1|COMPLETED|Overall Study||100
5293897|NCT00572832|13013589|P2|STARTED|Overall Study||100
5293898|NCT00572832|13013590|P1|STARTED|Overall Study||100
5293899|NCT00572728|13013596|P1|NOT COMPLETED|Overall Study||39
5293900|NCT00572728|13013596|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
5293901|NCT00572728|13013596|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
5293902|NCT00572728|13013596|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
5293903|NCT00572728|13013596|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
5293904|NCT00572728|13013596|P1|Pathology Complete|Overall Study||51
5293905|NCT00572728|13013596|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
5293906|NCT00572728|13013596|P1|Second Chemotherapy Initiated|Overall Study||59
5293907|NCT00572728|13013596|P1|Completed FLT2 Scan|Overall Study||60
5293908|NCT00572728|13013596|P1|First Therapy Initiated|Overall Study||65
5293909|NCT00572728|13013596|P1|Completed FLT1 Scan|Overall Study||67
5293910|NCT00572728|13013596|P1|On Study|Overall Study||71
5293911|NCT00572728|13013596|P1|Did Not Withdraw|Overall Study||72
5293912|NCT00572728|13013596|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
5293913|NCT00572728|13013596|P1|Eligible|Overall Study||87
5293914|NCT00572728|13013596|P1|STARTED|Overall Study|Registered|90
5293915|NCT00572624|13013610|P2|NOT COMPLETED|Overall Study||4
5293916|NCT00572624|13013611|P1|NOT COMPLETED|Overall Study||17
5293917|NCT00572624|13013610|P2|COMPLETED|Overall Study||10
5293918|NCT00572624|13013611|P1|COMPLETED|Overall Study||20
5293919|NCT00572624|13013610|P2|STARTED|Overall Study||14
5293920|NCT00572624|13013611|P1|STARTED|Overall Study||37
5293921|NCT00572572|13013639|P2|NOT COMPLETED|Overall Study||6
5293922|NCT00572572|13013640|P1|NOT COMPLETED|Overall Study||3
5293923|NCT00572572|13013639|P2|COMPLETED|Overall Study||28
5293924|NCT00572572|13013640|P1|COMPLETED|Overall Study||32
5293925|NCT00572572|13013639|P2|STARTED|Overall Study||34
5293926|NCT00572572|13013640|P1|STARTED|Overall Study||35
5293927|NCT00572533|13013658|P2|NOT COMPLETED|Overall Study||3
5293928|NCT00572533|13013659|P1|NOT COMPLETED|Overall Study||7
5293929|NCT00572533|13013658|P2|COMPLETED|Overall Study||28
5293930|NCT00572533|13013659|P1|COMPLETED|Overall Study||24
5293931|NCT00572533|13013658|P2|STARTED|Overall Study||31
5293932|NCT00572533|13013659|P1|STARTED|Overall Study||31
5293933|NCT00572468|13013681|P2|NOT COMPLETED|Overall Study||4
5293934|NCT00572468|13013682|P1|NOT COMPLETED|Overall Study||2
5293935|NCT00572468|13013681|P2|COMPLETED|Overall Study||16
5293936|NCT00572468|13013682|P1|COMPLETED|Overall Study||20
5293937|NCT00572468|13013681|P2|STARTED|Overall Study||20
5293938|NCT00572468|13013682|P1|STARTED|Overall Study||22
5293939|NCT00572260|13013690|P1|NOT COMPLETED|Overall Study||0
5293940|NCT00572260|13013690|P1|COMPLETED|Overall Study||11
5293941|NCT00572260|13013690|P1|STARTED|Overall Study||11
5293942|NCT00572234|13013696|P2|NOT COMPLETED|Overall Study||5
5293943|NCT00572234|13013697|P1|NOT COMPLETED|Overall Study||1
5293944|NCT00572234|13013696|P2|COMPLETED|Overall Study||16
5293945|NCT00572234|13013697|P1|COMPLETED|Overall Study||18
5293946|NCT00572234|13013696|P2|STARTED|Overall Study||21
5293947|NCT00572234|13013697|P1|STARTED|Overall Study||19
5293948|NCT00572195|13013703|P1|NOT COMPLETED|Overall Study||68
5293949|NCT00572195|13013703|P1|COMPLETED|Overall Study||162
5293950|NCT00572195|13013703|P1|STARTED|Overall Study||230
5293951|NCT00572156|13013715|P4|NOT COMPLETED|Overall Study||25
5293952|NCT00572156|13013716|P3|NOT COMPLETED|Overall Study||27
5293953|NCT00572156|13013717|P2|NOT COMPLETED|Overall Study||26
5293954|NCT00572156|13013718|P1|NOT COMPLETED|Overall Study||26
5293955|NCT00572156|13013715|P4|COMPLETED|Overall Study||1
5293956|NCT00572156|13013716|P3|COMPLETED|Overall Study||0
5293957|NCT00572156|13013717|P2|COMPLETED|Overall Study||1
5293958|NCT00572156|13013718|P1|COMPLETED|Overall Study||0
5293959|NCT00572156|13013715|P4|STARTED|Overall Study||26
5293960|NCT00572156|13013716|P3|STARTED|Overall Study||27
5293961|NCT00572156|13013717|P2|STARTED|Overall Study||27
5293962|NCT00572156|13013718|P1|STARTED|Overall Study||26
5293963|NCT00572117|13013778|P2|NOT COMPLETED|Overall Study||2
5293964|NCT00572117|13013779|P1|NOT COMPLETED|Overall Study||2
5293965|NCT00572117|13013778|P2|COMPLETED|Overall Study||5
5293966|NCT00572117|13013779|P1|COMPLETED|Overall Study||3
5293967|NCT00572117|13013778|P2|STARTED|Overall Study||7
5293968|NCT00572117|13013779|P1|STARTED|Overall Study||5
5293969|NCT00572039|13013789|P2|NOT COMPLETED|Overall Study||10
5293970|NCT00572039|13013790|P1|NOT COMPLETED|Overall Study||16
5293971|NCT00572039|13013789|P2|COMPLETED|Overall Study||110
5293972|NCT00572039|13013790|P1|COMPLETED|Overall Study||105
5293973|NCT00572039|13013789|P2|STARTED|Overall Study||120
5293974|NCT00572039|13013790|P1|STARTED|Overall Study||121
5293975|NCT00571987|13013802|P1|NOT COMPLETED|Overall Study||7
5293976|NCT00571987|13013802|P1|COMPLETED|Overall Study||100
5293977|NCT00571987|13013802|P1|STARTED|Overall Study||107
5293978|NCT00571974|13013809|P2|NOT COMPLETED|Phase II||4
5293979|NCT00571974|13013810|P1|NOT COMPLETED|Phase II||0
5293980|NCT00571974|13013809|P2|COMPLETED|Phase II||17
5293981|NCT00571974|13013810|P1|COMPLETED|Phase II||0
5293982|NCT00571974|13013809|P2|STARTED|Phase II|3 participants are from phase I|21
5293983|NCT00571974|13013810|P1|STARTED|Phase II||0
5293984|NCT00571974|13013809|P2|NOT COMPLETED|Phase I||0
5293985|NCT00571974|13013810|P1|NOT COMPLETED|Phase I||0
5293986|NCT00571974|13013809|P2|COMPLETED|Phase I||0
5293987|NCT00571974|13013810|P1|COMPLETED|Phase I||9
5293988|NCT00571974|13013809|P2|STARTED|Phase I||0
5293989|NCT00571974|13013810|P1|STARTED|Phase I||9
5293990|NCT00571961|13013816|P1|NOT COMPLETED|Overall Study||0
5293991|NCT00571961|13013816|P1|COMPLETED|Overall Study||12
5293992|NCT00571961|13013816|P1|STARTED|Overall Study||12
5293993|NCT00571948|13013822|P2|NOT COMPLETED|Overall Study||14
5293994|NCT00571948|13013823|P1|NOT COMPLETED|Overall Study||11
5293995|NCT00571948|13013822|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
5293996|NCT00571948|13013823|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
5293997|NCT00571948|13013822|P2|STARTED|Overall Study||66
5293998|NCT00571948|13013823|P1|STARTED|Overall Study||66
5293999|NCT00571922|13013831|P2|NOT COMPLETED|Overall Study||36
5294000|NCT00571922|13013832|P1|NOT COMPLETED|Overall Study||36
5294001|NCT00571922|13013831|P2|COMPLETED|Overall Study||0
5294002|NCT00571922|13013832|P1|COMPLETED|Overall Study||0
5294003|NCT00571922|13013831|P2|STARTED|Overall Study||36
5294004|NCT00571922|13013832|P1|STARTED|Overall Study||36
5294005|NCT00571701|13013842|P2|NOT COMPLETED|Second Intervention 12 Months||1
5294006|NCT00571701|13013843|P1|NOT COMPLETED|Second Intervention 12 Months||3
5294007|NCT00571701|13013842|P2|COMPLETED|Second Intervention 12 Months||20
5294008|NCT00571701|13013843|P1|COMPLETED|Second Intervention 12 Months||13
5294009|NCT00571701|13013842|P2|STARTED|Second Intervention 12 Months||21
5294010|NCT00571701|13013843|P1|STARTED|Second Intervention 12 Months||16
5294011|NCT00571701|13013842|P2|NOT COMPLETED|First Intervention 12 Months||1
5294012|NCT00571701|13013843|P1|NOT COMPLETED|First Intervention 12 Months||3
5294013|NCT00571701|13013842|P2|COMPLETED|First Intervention 12 Months||21
5294014|NCT00571701|13013843|P1|COMPLETED|First Intervention 12 Months||16
5294015|NCT00571701|13013842|P2|STARTED|First Intervention 12 Months||22
5294016|NCT00571701|13013843|P1|STARTED|First Intervention 12 Months||19
5294017|NCT00571688|13013869|P2|NOT COMPLETED|Overall Study||6
5294018|NCT00571688|13013870|P1|NOT COMPLETED|Overall Study||5
5294019|NCT00571688|13013869|P2|COMPLETED|Overall Study||19
5294020|NCT00571688|13013870|P1|COMPLETED|Overall Study||20
5294021|NCT00571688|13013869|P2|STARTED|Overall Study||25
5294022|NCT00571688|13013870|P1|STARTED|Overall Study||25
5294023|NCT00571662|13013876|P1|NOT COMPLETED|Overall Study||8
5294024|NCT00571662|13013876|P1|COMPLETED|Overall Study||68
5294025|NCT00571662|13013876|P1|STARTED|Overall Study||76
5294026|NCT00571649|13013887|P2|NOT COMPLETED|Follow-up Period||528
5294027|NCT00571649|13013888|P1|NOT COMPLETED|Follow-up Period||545
5294028|NCT00571649|13013887|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
5294029|NCT00571649|13013888|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
5294030|NCT00571649|13013887|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
5294031|NCT00571649|13013888|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
5294032|NCT00571649|13013887|P2|NOT COMPLETED|Treatment Period||1004
5294033|NCT00571649|13013888|P1|NOT COMPLETED|Treatment Period||1092
5294034|NCT00571649|13013887|P2|COMPLETED|Treatment Period||3047
5294035|NCT00571649|13013888|P1|COMPLETED|Treatment Period||2958
5294036|NCT00571649|13013887|P2|Day 35|Treatment Period||3115
5294037|NCT00571649|13013888|P1|Day 35|Treatment Period||3033
5294038|NCT00571649|13013887|P2|Day 10|Treatment Period||3499
5294039|NCT00571649|13013888|P1|Day 10|Treatment Period||3454
5294040|NCT00571649|13013887|P2|Participants Received Treatment|Treatment Period||4001
5294041|NCT00571649|13013888|P1|Participants Received Treatment|Treatment Period||3997
5294042|NCT00571649|13013887|P2|STARTED|Treatment Period||4051
5294043|NCT00571649|13013888|P1|STARTED|Treatment Period||4050
5294044|NCT00571493|13013920|P7|NOT COMPLETED|Overall Study||0
5294045|NCT00571493|13013921|P6|NOT COMPLETED|Overall Study||0
5294046|NCT00571493|13013922|P5|NOT COMPLETED|Overall Study||0
5294047|NCT00571493|13013923|P4|NOT COMPLETED|Overall Study||0
5294048|NCT00571493|13013924|P3|NOT COMPLETED|Overall Study||0
5294049|NCT00571493|13013925|P2|NOT COMPLETED|Overall Study||0
5294050|NCT00571493|13013926|P1|NOT COMPLETED|Overall Study||0
5294051|NCT00571493|13013920|P7|COMPLETED|Overall Study||6
5294052|NCT00571493|13013921|P6|COMPLETED|Overall Study||12
5294053|NCT00571493|13013922|P5|COMPLETED|Overall Study||11
5294054|NCT00571493|13013923|P4|COMPLETED|Overall Study||3
5294055|NCT00571493|13013924|P3|COMPLETED|Overall Study||3
5294056|NCT00571493|13013925|P2|COMPLETED|Overall Study||4
5294057|NCT00571493|13013926|P1|COMPLETED|Overall Study||3
5294058|NCT00571493|13013920|P7|STARTED|Overall Study||6
5294059|NCT00571493|13013921|P6|STARTED|Overall Study||12
5294060|NCT00571493|13013922|P5|STARTED|Overall Study||11
5294061|NCT00571493|13013923|P4|STARTED|Overall Study||3
5294062|NCT00571493|13013924|P3|STARTED|Overall Study||3
5294063|NCT00571493|13013925|P2|STARTED|Overall Study||4
5294064|NCT00571493|13013926|P1|STARTED|Overall Study||3
5294065|NCT00571428|13013936|P2|NOT COMPLETED|Overall Study||0
5294066|NCT00571428|13013937|P1|NOT COMPLETED|Overall Study||0
5294067|NCT00571428|13013936|P2|COMPLETED|Overall Study||18
5294068|NCT00571428|13013937|P1|COMPLETED|Overall Study||15
5294069|NCT00571428|13013936|P2|STARTED|Overall Study||18
5294070|NCT00571428|13013937|P1|STARTED|Overall Study||15
5294071|NCT00571324|13013969|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
5294072|NCT00571324|13013970|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
5294073|NCT00571324|13013969|P2|COMPLETED|Intervention 2 (7 Hours)||4
5294074|NCT00571324|13013970|P1|COMPLETED|Intervention 2 (7 Hours)||5
5294075|NCT00571324|13013969|P2|STARTED|Intervention 2 (7 Hours)||4
5294076|NCT00571324|13013970|P1|STARTED|Intervention 2 (7 Hours)||5
5294077|NCT00571324|13013969|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
5294078|NCT00571324|13013970|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
5294079|NCT00571324|13013969|P2|COMPLETED|Intervention 1 (7 Hours)||4
5294080|NCT00571324|13013970|P1|COMPLETED|Intervention 1 (7 Hours)||5
5294081|NCT00571324|13013969|P2|STARTED|Intervention 1 (7 Hours)||4
5294082|NCT00571324|13013970|P1|STARTED|Intervention 1 (7 Hours)||5
5294083|NCT00571194|13013982|P1|NOT COMPLETED|Overall Study||0
5294084|NCT00571194|13013982|P1|COMPLETED|Overall Study||7
5294085|NCT00571194|13013982|P1|STARTED|Overall Study||7
5294086|NCT00571103|13013986|P1|NOT COMPLETED|Overall Study||2
5294087|NCT00571103|13013986|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
5294088|NCT00571103|13013986|P1|STARTED|Overall Study||28
5294089|NCT00571064|13013991|P1|NOT COMPLETED|Overall Study||21
5294090|NCT00571064|13013991|P1|COMPLETED|Overall Study||76
5294091|NCT00571064|13013991|P1|STARTED|Overall Study||97
5294092|NCT00571038|13014006|P2|NOT COMPLETED|Overall Study||14
5294093|NCT00571038|13014007|P1|NOT COMPLETED|Overall Study||11
5294094|NCT00571038|13014006|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
5294095|NCT00571038|13014007|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
5294096|NCT00571038|13014006|P2|18 Month Survey Only|Overall Study||163
5294097|NCT00571038|13014007|P1|18 Month Survey Only|Overall Study||199
5294098|NCT00571038|13014006|P2|6 Month Follow up|Overall Study||176
5294099|NCT00571038|13014007|P1|6 Month Follow up|Overall Study||208
5294100|NCT00571038|13014006|P2|STARTED|Overall Study||185
5294101|NCT00571038|13014007|P1|STARTED|Overall Study||219
5294102|NCT00570960|13014055|P2|NOT COMPLETED|Overall Study||0
5294103|NCT00570960|13014056|P1|NOT COMPLETED|Overall Study||0
5294104|NCT00570960|13014055|P2|COMPLETED|Overall Study||4
5294105|NCT00570960|13014056|P1|COMPLETED|Overall Study||4
5294106|NCT00570960|13014055|P2|STARTED|Overall Study||4
5294107|NCT00570960|13014056|P1|STARTED|Overall Study||4
5294108|NCT00570921|13014062|P1|NOT COMPLETED|Overall Study||2
5294109|NCT00570921|13014062|P1|COMPLETED|Overall Study||31
5294110|NCT00570921|13014062|P1|STARTED|Overall Study||33
5294111|NCT00570908|13014068|P1|NOT COMPLETED|Overall Study||7
5294112|NCT00570908|13014068|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
5294113|NCT00570908|13014068|P1|STARTED|Overall Study||12
5294114|NCT00570778|13014072|P4|NOT COMPLETED|Overall Study||4
5294115|NCT00570778|13014073|P3|NOT COMPLETED|Overall Study||7
5294116|NCT00570778|13014074|P2|NOT COMPLETED|Overall Study||4
5294117|NCT00570778|13014075|P1|NOT COMPLETED|Overall Study||4
5294118|NCT00570778|13014072|P4|COMPLETED|Overall Study||34
5294119|NCT00570778|13014073|P3|COMPLETED|Overall Study||30
5294120|NCT00570778|13014074|P2|COMPLETED|Overall Study||34
5294121|NCT00570778|13014075|P1|COMPLETED|Overall Study||37
5294122|NCT00570778|13014072|P4|Modified Intent-to-treat Population|Overall Study||37
5294123|NCT00570778|13014073|P3|Modified Intent-to-treat Population|Overall Study||35
5294124|NCT00570778|13014074|P2|Modified Intent-to-treat Population|Overall Study||37
5294125|NCT00570778|13014075|P1|Modified Intent-to-treat Population|Overall Study||40
5294126|NCT00570778|13014072|P4|Safety Population: Received Study Drug|Overall Study||38
5294127|NCT00570778|13014073|P3|Safety Population: Received Study Drug|Overall Study||36
5294128|NCT00570778|13014074|P2|Safety Population: Received Study Drug|Overall Study||38
5294129|NCT00570778|13014075|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
5294130|NCT00570778|13014072|P4|STARTED|Overall Study||38
5294131|NCT00570778|13014073|P3|STARTED|Overall Study||37
5294132|NCT00570778|13014074|P2|STARTED|Overall Study||38
5294133|NCT00570778|13014075|P1|STARTED|Overall Study||41
5294134|NCT00570765|13014096|P3|NOT COMPLETED|Overall Study||0
5294135|NCT00570765|13014097|P2|NOT COMPLETED|Overall Study||7
5294136|NCT00570765|13014098|P1|NOT COMPLETED|Overall Study||4
5294137|NCT00570765|13014096|P3|COMPLETED|Overall Study||23
5294138|NCT00570765|13014097|P2|COMPLETED|Overall Study||9
5294139|NCT00570765|13014098|P1|COMPLETED|Overall Study||16
5294140|NCT00570765|13014096|P3|STARTED|Overall Study||23
5294141|NCT00570765|13014097|P2|STARTED|Overall Study||16
5294142|NCT00570765|13014098|P1|STARTED|Overall Study||20
5294143|NCT00570739|13014116|P4|NOT COMPLETED|Overall Study||12
5294144|NCT00570739|13014117|P3|NOT COMPLETED|Overall Study||16
5294145|NCT00570739|13014118|P2|NOT COMPLETED|Overall Study||21
5294146|NCT00570739|13014119|P1|NOT COMPLETED|Overall Study||21
5294147|NCT00570739|13014116|P4|COMPLETED|Overall Study||96
5294148|NCT00570739|13014117|P3|COMPLETED|Overall Study||92
5294149|NCT00570739|13014118|P2|COMPLETED|Overall Study||124
5294150|NCT00570739|13014119|P1|COMPLETED|Overall Study||120
5294151|NCT00570739|13014116|P4|STARTED|Overall Study||108
5294152|NCT00570739|13014117|P3|STARTED|Overall Study||108
5294153|NCT00570739|13014118|P2|STARTED|Overall Study||145
5294154|NCT00570739|13014119|P1|STARTED|Overall Study||141
5294155|NCT00570713|13014271|P2|NOT COMPLETED|Overall Study||77
5294156|NCT00570713|13014272|P1|NOT COMPLETED|Overall Study||78
5294157|NCT00570713|13014271|P2|COMPLETED|Overall Study||0
5294158|NCT00570713|13014272|P1|COMPLETED|Overall Study||0
5294159|NCT00570713|13014271|P2|STARTED|Overall Study||77
5294160|NCT00570713|13014272|P1|STARTED|Overall Study||78
5294161|NCT00570700|13014282|P1|NOT COMPLETED|Overall Study||11
5294162|NCT00570700|13014282|P1|COMPLETED|Overall Study||27
5294163|NCT00570700|13014282|P1|STARTED|Overall Study||38
5294164|NCT00570687|13014290|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294165|NCT00570687|13014291|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294166|NCT00570687|13014292|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294167|NCT00570687|13014293|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294168|NCT00570687|13014294|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294169|NCT00570687|13014295|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294170|NCT00570687|13014296|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294171|NCT00570687|13014297|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294172|NCT00570687|13014298|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294173|NCT00570687|13014299|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294174|NCT00570687|13014290|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294175|NCT00570687|13014291|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294176|NCT00570687|13014292|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294177|NCT00570687|13014293|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294178|NCT00570687|13014294|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294179|NCT00570687|13014295|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
5294180|NCT00570687|13014296|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
5294181|NCT00570687|13014297|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
5294182|NCT00570687|13014298|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
5294183|NCT00570687|13014299|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
5294184|NCT00570687|13014290|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294185|NCT00570687|13014291|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294186|NCT00570687|13014292|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294187|NCT00570687|13014293|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294188|NCT00570687|13014294|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294189|NCT00570687|13014295|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
5294190|NCT00570687|13014296|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
5294191|NCT00570687|13014297|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
5294192|NCT00570687|13014298|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
5294193|NCT00570687|13014299|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
5294194|NCT00570687|13014290|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294195|NCT00570687|13014291|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294196|NCT00570687|13014292|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294197|NCT00570687|13014293|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294198|NCT00570687|13014294|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294199|NCT00570687|13014295|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294200|NCT00570687|13014296|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294201|NCT00570687|13014297|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294202|NCT00570687|13014298|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294203|NCT00570687|13014299|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294204|NCT00570687|13014290|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294205|NCT00570687|13014291|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294206|NCT00570687|13014292|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294207|NCT00570687|13014293|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294208|NCT00570687|13014294|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294209|NCT00570687|13014295|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
5294210|NCT00570687|13014296|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
5294211|NCT00570687|13014297|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
5294212|NCT00570687|13014298|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
5294213|NCT00570687|13014299|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
5294214|NCT00570687|13014290|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294215|NCT00570687|13014291|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294216|NCT00570687|13014292|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294217|NCT00570687|13014293|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294218|NCT00570687|13014294|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294219|NCT00570687|13014295|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
5294220|NCT00570687|13014296|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
5294221|NCT00570687|13014297|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
5294222|NCT00570687|13014298|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
5294223|NCT00570687|13014299|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
5294224|NCT00570687|13014290|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294225|NCT00570687|13014291|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294226|NCT00570687|13014292|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294227|NCT00570687|13014293|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294228|NCT00570687|13014294|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294229|NCT00570687|13014295|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294230|NCT00570687|13014296|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294231|NCT00570687|13014297|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294232|NCT00570687|13014298|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294233|NCT00570687|13014299|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294234|NCT00570687|13014290|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294235|NCT00570687|13014291|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294236|NCT00570687|13014292|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294237|NCT00570687|13014293|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294238|NCT00570687|13014294|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294239|NCT00570687|13014295|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
5294240|NCT00570687|13014296|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
5294241|NCT00570687|13014297|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
5294242|NCT00570687|13014298|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
5294243|NCT00570687|13014299|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
5294244|NCT00570687|13014290|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294245|NCT00570687|13014291|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294246|NCT00570687|13014292|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294247|NCT00570687|13014293|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294248|NCT00570687|13014294|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294249|NCT00570687|13014295|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
5294250|NCT00570687|13014296|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
5294251|NCT00570687|13014297|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
5294252|NCT00570687|13014298|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
5294253|NCT00570687|13014299|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
5294254|NCT00570687|13014290|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294255|NCT00570687|13014291|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294256|NCT00570687|13014292|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294257|NCT00570687|13014293|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294258|NCT00570687|13014294|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294259|NCT00570687|13014295|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294260|NCT00570687|13014296|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294261|NCT00570687|13014297|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294262|NCT00570687|13014298|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294263|NCT00570687|13014299|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294264|NCT00570687|13014290|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294265|NCT00570687|13014291|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294266|NCT00570687|13014292|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294267|NCT00570687|13014293|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294268|NCT00570687|13014294|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294269|NCT00570687|13014295|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
5294270|NCT00570687|13014296|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
5294271|NCT00570687|13014297|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
5294272|NCT00570687|13014298|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
5294273|NCT00570687|13014299|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
5294274|NCT00570687|13014290|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294275|NCT00570687|13014291|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294276|NCT00570687|13014292|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294277|NCT00570687|13014293|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294278|NCT00570687|13014294|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294279|NCT00570687|13014295|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
5294280|NCT00570687|13014296|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
5294281|NCT00570687|13014297|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
5294282|NCT00570687|13014298|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
5294283|NCT00570687|13014299|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
5294284|NCT00570687|13014290|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294285|NCT00570687|13014291|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294286|NCT00570687|13014292|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294287|NCT00570687|13014293|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294288|NCT00570687|13014294|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294289|NCT00570687|13014295|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294290|NCT00570687|13014296|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294291|NCT00570687|13014297|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294292|NCT00570687|13014298|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294293|NCT00570687|13014299|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294294|NCT00570687|13014290|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294295|NCT00570687|13014291|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294296|NCT00570687|13014292|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294297|NCT00570687|13014293|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294298|NCT00570687|13014294|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294299|NCT00570687|13014295|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294300|NCT00570687|13014296|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
5294301|NCT00570687|13014297|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
5294302|NCT00570687|13014298|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
5294303|NCT00570687|13014299|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
5294304|NCT00570687|13014290|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294305|NCT00570687|13014291|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294306|NCT00570687|13014292|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294307|NCT00570687|13014293|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294308|NCT00570687|13014294|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294309|NCT00570687|13014295|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
5294310|NCT00570687|13014296|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
5294311|NCT00570687|13014297|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
5294312|NCT00570687|13014298|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
5294313|NCT00570687|13014299|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
5294314|NCT00570687|13014290|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294315|NCT00570687|13014291|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294316|NCT00570687|13014292|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294317|NCT00570687|13014293|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294318|NCT00570687|13014294|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294319|NCT00570687|13014295|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294320|NCT00570687|13014296|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294321|NCT00570687|13014297|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294322|NCT00570687|13014298|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294323|NCT00570687|13014299|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294324|NCT00570687|13014290|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294325|NCT00570687|13014291|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294326|NCT00570687|13014292|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294327|NCT00570687|13014293|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294328|NCT00570687|13014294|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294329|NCT00570687|13014295|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
5294330|NCT00570687|13014296|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
5294331|NCT00570687|13014297|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
5294332|NCT00570687|13014298|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
5294333|NCT00570687|13014299|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
5294334|NCT00570687|13014290|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294335|NCT00570687|13014291|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294336|NCT00570687|13014292|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294337|NCT00570687|13014293|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294338|NCT00570687|13014294|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294339|NCT00570687|13014295|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
5294340|NCT00570687|13014296|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
5294341|NCT00570687|13014297|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
5294342|NCT00570687|13014298|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
5294343|NCT00570687|13014299|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
5294344|NCT00570687|13014290|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294345|NCT00570687|13014291|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294346|NCT00570687|13014292|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294347|NCT00570687|13014293|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294348|NCT00570687|13014294|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294349|NCT00570687|13014295|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294350|NCT00570687|13014296|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294351|NCT00570687|13014297|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294352|NCT00570687|13014298|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294353|NCT00570687|13014299|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294354|NCT00570687|13014290|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294355|NCT00570687|13014291|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294356|NCT00570687|13014292|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294357|NCT00570687|13014293|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294358|NCT00570687|13014294|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294359|NCT00570687|13014295|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294360|NCT00570687|13014296|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
5294361|NCT00570687|13014297|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
5294362|NCT00570687|13014298|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
5294363|NCT00570687|13014299|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
5294364|NCT00570687|13014290|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294365|NCT00570687|13014291|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294366|NCT00570687|13014292|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294367|NCT00570687|13014293|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294368|NCT00570687|13014294|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294369|NCT00570687|13014295|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
5294370|NCT00570687|13014296|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
5294371|NCT00570687|13014297|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
5294372|NCT00570687|13014298|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
5294373|NCT00570687|13014299|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
5294374|NCT00570687|13014290|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294375|NCT00570687|13014291|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294376|NCT00570687|13014292|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294377|NCT00570687|13014293|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
5294378|NCT00570687|13014294|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294379|NCT00570687|13014295|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294380|NCT00570687|13014296|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294381|NCT00570687|13014297|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294382|NCT00570687|13014298|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294383|NCT00570687|13014299|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294384|NCT00570687|13014290|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294385|NCT00570687|13014291|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294386|NCT00570687|13014292|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294387|NCT00570687|13014293|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294388|NCT00570687|13014294|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294389|NCT00570687|13014295|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294390|NCT00570687|13014296|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294391|NCT00570687|13014297|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294392|NCT00570687|13014298|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294393|NCT00570687|13014299|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
5294394|NCT00570687|13014290|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294395|NCT00570687|13014291|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294396|NCT00570687|13014292|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294397|NCT00570687|13014293|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
5294398|NCT00570687|13014294|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294399|NCT00570687|13014295|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294400|NCT00570687|13014296|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294401|NCT00570687|13014297|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294402|NCT00570687|13014298|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294403|NCT00570687|13014299|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
5294404|NCT00570687|13014290|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294405|NCT00570687|13014291|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294406|NCT00570687|13014292|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294407|NCT00570687|13014293|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294408|NCT00570687|13014294|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294409|NCT00570687|13014295|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294410|NCT00570687|13014296|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294411|NCT00570687|13014297|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294412|NCT00570687|13014298|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294413|NCT00570687|13014299|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294414|NCT00570687|13014290|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294415|NCT00570687|13014291|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294416|NCT00570687|13014292|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294417|NCT00570687|13014293|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
5294418|NCT00570687|13014294|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294419|NCT00570687|13014295|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294420|NCT00570687|13014296|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294421|NCT00570687|13014297|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294422|NCT00570687|13014298|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294423|NCT00570687|13014299|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
5294424|NCT00570687|13014290|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294425|NCT00570687|13014291|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294426|NCT00570687|13014292|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294427|NCT00570687|13014293|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
5294428|NCT00570687|13014294|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294429|NCT00570687|13014295|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294430|NCT00570687|13014296|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294431|NCT00570687|13014297|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294432|NCT00570687|13014298|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294433|NCT00570687|13014299|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
5294434|NCT00570687|13014290|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294435|NCT00570687|13014291|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
5294436|NCT00570687|13014292|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294437|NCT00570687|13014293|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294438|NCT00570687|13014294|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294752|NCT00570323|13014442|P1|NOT COMPLETED|Complete Study After Start||3
5294439|NCT00570687|13014295|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294440|NCT00570687|13014296|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294441|NCT00570687|13014297|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294442|NCT00570687|13014298|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294443|NCT00570687|13014299|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294444|NCT00570687|13014290|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294445|NCT00570687|13014291|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294446|NCT00570687|13014292|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294447|NCT00570687|13014293|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
5294448|NCT00570687|13014294|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294449|NCT00570687|13014295|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294450|NCT00570687|13014296|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294451|NCT00570687|13014297|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294452|NCT00570687|13014298|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294453|NCT00570687|13014299|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
5294454|NCT00570687|13014290|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294455|NCT00570687|13014291|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
5294456|NCT00570687|13014292|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294457|NCT00570687|13014293|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
5294458|NCT00570687|13014294|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294459|NCT00570687|13014295|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294460|NCT00570687|13014296|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294461|NCT00570687|13014297|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294462|NCT00570687|13014298|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294463|NCT00570687|13014299|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
5294464|NCT00570687|13014290|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294465|NCT00570687|13014291|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294466|NCT00570687|13014292|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294467|NCT00570687|13014293|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294468|NCT00570687|13014294|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294469|NCT00570687|13014295|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294470|NCT00570687|13014296|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294471|NCT00570687|13014297|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294472|NCT00570687|13014298|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294473|NCT00570687|13014299|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294474|NCT00570687|13014290|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294475|NCT00570687|13014291|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
5294476|NCT00570687|13014292|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294477|NCT00570687|13014293|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
5294478|NCT00570687|13014294|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294479|NCT00570687|13014295|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294480|NCT00570687|13014296|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294481|NCT00570687|13014297|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294482|NCT00570687|13014298|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294483|NCT00570687|13014299|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
5294484|NCT00570687|13014290|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294485|NCT00570687|13014291|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
5294486|NCT00570687|13014292|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294487|NCT00570687|13014293|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
5294488|NCT00570687|13014294|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294489|NCT00570687|13014295|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294490|NCT00570687|13014296|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294491|NCT00570687|13014297|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294492|NCT00570687|13014298|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294493|NCT00570687|13014299|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
5294494|NCT00570687|13014290|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
5294495|NCT00570687|13014291|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
5294496|NCT00570687|13014292|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
5294497|NCT00570687|13014293|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
5294498|NCT00570687|13014294|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
5294499|NCT00570687|13014295|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
5294500|NCT00570687|13014296|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294501|NCT00570687|13014297|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294502|NCT00570687|13014298|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294503|NCT00570687|13014299|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294504|NCT00570687|13014290|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294505|NCT00570687|13014291|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
5294506|NCT00570687|13014292|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294507|NCT00570687|13014293|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
5294508|NCT00570687|13014294|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294509|NCT00570687|13014295|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294510|NCT00570687|13014296|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294511|NCT00570687|13014297|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294512|NCT00570687|13014298|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294513|NCT00570687|13014299|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
5294514|NCT00570687|13014290|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294515|NCT00570687|13014291|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294516|NCT00570687|13014292|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294517|NCT00570687|13014293|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294518|NCT00570687|13014294|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294519|NCT00570687|13014295|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
5294520|NCT00570687|13014296|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
5294521|NCT00570687|13014297|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
5294522|NCT00570687|13014298|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
5294523|NCT00570687|13014299|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
5294524|NCT00570687|13014290|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294525|NCT00570687|13014291|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294526|NCT00570687|13014292|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294527|NCT00570687|13014293|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294528|NCT00570687|13014294|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294529|NCT00570687|13014295|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294530|NCT00570687|13014296|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294531|NCT00570687|13014297|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294532|NCT00570687|13014298|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294533|NCT00570687|13014299|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294534|NCT00570687|13014290|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294535|NCT00570687|13014291|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294536|NCT00570687|13014292|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294537|NCT00570687|13014293|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294538|NCT00570687|13014294|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294539|NCT00570687|13014295|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294540|NCT00570687|13014296|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294541|NCT00570687|13014297|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294542|NCT00570687|13014298|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294543|NCT00570687|13014299|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294544|NCT00570687|13014290|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294545|NCT00570687|13014291|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294546|NCT00570687|13014292|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294547|NCT00570687|13014293|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294548|NCT00570687|13014294|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294549|NCT00570687|13014295|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
5294550|NCT00570687|13014296|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294551|NCT00570687|13014297|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294552|NCT00570687|13014298|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294553|NCT00570687|13014299|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
5294554|NCT00570687|13014290|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294555|NCT00570687|13014291|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294556|NCT00570687|13014292|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294557|NCT00570687|13014293|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294558|NCT00570687|13014294|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294559|NCT00570687|13014295|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294560|NCT00570687|13014296|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294561|NCT00570687|13014297|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294562|NCT00570687|13014298|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294563|NCT00570687|13014299|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294564|NCT00570687|13014290|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294565|NCT00570687|13014291|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294566|NCT00570687|13014292|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294567|NCT00570687|13014293|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294568|NCT00570687|13014294|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294569|NCT00570687|13014295|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
5294570|NCT00570687|13014296|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294571|NCT00570687|13014297|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294572|NCT00570687|13014298|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294573|NCT00570687|13014299|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
5294574|NCT00570687|13014290|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294575|NCT00570687|13014291|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294576|NCT00570687|13014292|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294577|NCT00570687|13014293|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294578|NCT00570687|13014294|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294579|NCT00570687|13014295|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
5294580|NCT00570687|13014296|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
5294581|NCT00570687|13014297|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
5294582|NCT00570687|13014298|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
5294583|NCT00570687|13014299|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
5294584|NCT00570687|13014290|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294585|NCT00570687|13014291|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294586|NCT00570687|13014292|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294587|NCT00570687|13014293|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294588|NCT00570687|13014294|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294589|NCT00570687|13014295|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294590|NCT00570687|13014296|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294591|NCT00570687|13014297|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294592|NCT00570687|13014298|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294593|NCT00570687|13014299|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294594|NCT00570687|13014290|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294595|NCT00570687|13014291|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294596|NCT00570687|13014292|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294597|NCT00570687|13014293|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294598|NCT00570687|13014294|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294599|NCT00570687|13014295|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294600|NCT00570687|13014296|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294601|NCT00570687|13014297|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294602|NCT00570687|13014298|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294603|NCT00570687|13014299|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294604|NCT00570687|13014290|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294605|NCT00570687|13014291|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294606|NCT00570687|13014292|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294607|NCT00570687|13014293|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294608|NCT00570687|13014294|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294609|NCT00570687|13014295|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
5294610|NCT00570687|13014296|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294611|NCT00570687|13014297|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294612|NCT00570687|13014298|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294613|NCT00570687|13014299|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
5294614|NCT00570687|13014290|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294615|NCT00570687|13014291|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294616|NCT00570687|13014292|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294617|NCT00570687|13014293|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294618|NCT00570687|13014294|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294619|NCT00570687|13014295|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294620|NCT00570687|13014296|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294621|NCT00570687|13014297|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294622|NCT00570687|13014298|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294623|NCT00570687|13014299|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294624|NCT00570687|13014290|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294625|NCT00570687|13014291|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294626|NCT00570687|13014292|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294627|NCT00570687|13014293|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294628|NCT00570687|13014294|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294629|NCT00570687|13014295|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
5294630|NCT00570687|13014296|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294631|NCT00570687|13014297|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294632|NCT00570687|13014298|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294633|NCT00570687|13014299|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
5294634|NCT00570687|13014290|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294635|NCT00570687|13014291|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294636|NCT00570687|13014292|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294637|NCT00570687|13014293|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294638|NCT00570687|13014294|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294639|NCT00570687|13014295|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
5294640|NCT00570687|13014296|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
5294641|NCT00570687|13014297|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
5294642|NCT00570687|13014298|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
5294643|NCT00570687|13014299|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
5294644|NCT00570687|13014290|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294645|NCT00570687|13014291|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294646|NCT00570687|13014292|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294647|NCT00570687|13014293|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294648|NCT00570687|13014294|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294649|NCT00570687|13014295|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294650|NCT00570687|13014296|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294651|NCT00570687|13014297|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294652|NCT00570687|13014298|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294653|NCT00570687|13014299|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294654|NCT00570687|13014290|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294655|NCT00570687|13014291|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294656|NCT00570687|13014292|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294657|NCT00570687|13014293|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294658|NCT00570687|13014294|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294659|NCT00570687|13014295|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294660|NCT00570687|13014296|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294661|NCT00570687|13014297|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294662|NCT00570687|13014298|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294663|NCT00570687|13014299|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294664|NCT00570687|13014290|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294665|NCT00570687|13014291|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294666|NCT00570687|13014292|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294667|NCT00570687|13014293|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294668|NCT00570687|13014294|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294669|NCT00570687|13014295|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
5294670|NCT00570687|13014296|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294671|NCT00570687|13014297|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294672|NCT00570687|13014298|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294673|NCT00570687|13014299|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
5294674|NCT00570674|13014325|P7|NOT COMPLETED|Overall Study||0
5294675|NCT00570674|13014326|P6|NOT COMPLETED|Overall Study||0
5294676|NCT00570674|13014327|P5|NOT COMPLETED|Overall Study||0
5294677|NCT00570674|13014328|P4|NOT COMPLETED|Overall Study||0
5294678|NCT00570674|13014329|P3|NOT COMPLETED|Overall Study||1
5294679|NCT00570674|13014330|P2|NOT COMPLETED|Overall Study||0
5294680|NCT00570674|13014331|P1|NOT COMPLETED|Overall Study||0
5294681|NCT00570674|13014325|P7|COMPLETED|Overall Study||0
5294682|NCT00570674|13014326|P6|COMPLETED|Overall Study||10
5294683|NCT00570674|13014327|P5|COMPLETED|Overall Study||3
5294684|NCT00570674|13014328|P4|COMPLETED|Overall Study||3
5294685|NCT00570674|13014329|P3|COMPLETED|Overall Study||3
5294686|NCT00570674|13014330|P2|COMPLETED|Overall Study||3
5294687|NCT00570674|13014331|P1|COMPLETED|Overall Study||6
5294688|NCT00570674|13014325|P7|PEG Evaluable|Overall Study||0
5294689|NCT00570674|13014326|P6|PEG Evaluable|Overall Study||10
5294690|NCT00570674|13014327|P5|PEG Evaluable|Overall Study||2
5294691|NCT00570674|13014328|P4|PEG Evaluable|Overall Study||3
5294692|NCT00570674|13014329|P3|PEG Evaluable|Overall Study||3
5294693|NCT00570674|13014330|P2|PEG Evaluable|Overall Study||3
5294694|NCT00570674|13014331|P1|PEG Evaluable|Overall Study||6
5294695|NCT00570674|13014325|P7|Treated|Overall Study||0
5294696|NCT00570674|13014326|P6|Treated|Overall Study||10
5294697|NCT00570674|13014327|P5|Treated|Overall Study||3
5294698|NCT00570674|13014328|P4|Treated|Overall Study||3
5294699|NCT00570674|13014329|P3|Treated|Overall Study||3
5294700|NCT00570674|13014330|P2|Treated|Overall Study||3
5294701|NCT00570674|13014331|P1|Treated|Overall Study||6
5294702|NCT00570674|13014325|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
5294703|NCT00570674|13014326|P6|STARTED|Overall Study||10
5294704|NCT00570674|13014327|P5|STARTED|Overall Study||3
5294705|NCT00570674|13014328|P4|STARTED|Overall Study||3
5294706|NCT00570674|13014329|P3|STARTED|Overall Study||4
5294707|NCT00570674|13014330|P2|STARTED|Overall Study||3
5294708|NCT00570674|13014331|P1|STARTED|Overall Study||6
5294709|NCT00570531|13014348|P1|NOT COMPLETED|Overall Study||0
5294710|NCT00570531|13014348|P1|COMPLETED|Overall Study||6
5294711|NCT00570531|13014348|P1|STARTED|Overall Study||6
5294712|NCT00570505|13014354|P1|NOT COMPLETED|Overall Study||41
5294713|NCT00570505|13014354|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
5294714|NCT00570505|13014354|P1|STARTED|Overall Study||149
5294715|NCT00570492|13014367|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
5294716|NCT00570492|13014368|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
5294717|NCT00570492|13014369|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
5294718|NCT00570492|13014367|P3|COMPLETED|52-week Double-blind Treatment Period||186
5294719|NCT00570492|13014368|P2|COMPLETED|52-week Double-blind Treatment Period||187
5294720|NCT00570492|13014369|P1|COMPLETED|52-week Double-blind Treatment Period||0
5294721|NCT00570492|13014367|P3|STARTED|52-week Double-blind Treatment Period||237
5294722|NCT00570492|13014368|P2|STARTED|52-week Double-blind Treatment Period||237
5294723|NCT00570492|13014369|P1|STARTED|52-week Double-blind Treatment Period||0
5294724|NCT00570492|13014367|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
5294725|NCT00570492|13014368|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
5294726|NCT00570492|13014369|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
5294727|NCT00570492|13014367|P3|COMPLETED|16-week Single-blind Baseline Period||0
5294728|NCT00570492|13014368|P2|COMPLETED|16-week Single-blind Baseline Period||0
5294729|NCT00570492|13014369|P1|COMPLETED|16-week Single-blind Baseline Period||474
5294730|NCT00570492|13014367|P3|STARTED|16-week Single-blind Baseline Period||0
5294731|NCT00570492|13014368|P2|STARTED|16-week Single-blind Baseline Period||0
5294732|NCT00570492|13014369|P1|STARTED|16-week Single-blind Baseline Period||910
5294733|NCT00570401|13014407|P1|NOT COMPLETED|Overall Study||2
5294734|NCT00570401|13014407|P1|COMPLETED|Overall Study||19
5294735|NCT00570401|13014407|P1|STARTED|Overall Study||21
5294736|NCT00570362|13014413|P2|NOT COMPLETED|Overall Study||0
5294737|NCT00570362|13014414|P1|NOT COMPLETED|Overall Study||0
5294738|NCT00570362|13014413|P2|COMPLETED|Overall Study||30
5294739|NCT00570362|13014414|P1|COMPLETED|Overall Study||19
5294740|NCT00570362|13014413|P2|STARTED|Overall Study||30
5294741|NCT00570362|13014414|P1|STARTED|Overall Study||19
5294742|NCT00570349|13014423|P3|NOT COMPLETED|Overall Study||0
5294743|NCT00570349|13014424|P2|NOT COMPLETED|Overall Study||0
5294744|NCT00570349|13014425|P1|NOT COMPLETED|Overall Study||0
5294745|NCT00570349|13014423|P3|COMPLETED|Overall Study||6
5294746|NCT00570349|13014424|P2|COMPLETED|Overall Study||6
5294747|NCT00570349|13014425|P1|COMPLETED|Overall Study||6
5294748|NCT00570349|13014423|P3|STARTED|Overall Study||6
5294749|NCT00570349|13014424|P2|STARTED|Overall Study||6
5294750|NCT00570349|13014425|P1|STARTED|Overall Study||6
5294751|NCT00570323|13014441|P2|NOT COMPLETED|Complete Study After Start||1
5294753|NCT00570323|13014441|P2|COMPLETED|Complete Study After Start||34
5294754|NCT00570323|13014442|P1|COMPLETED|Complete Study After Start||31
5294755|NCT00570323|13014441|P2|STARTED|Complete Study After Start||35
5294756|NCT00570323|13014442|P1|STARTED|Complete Study After Start||34
5294757|NCT00570323|13014441|P2|NOT COMPLETED|Started Treatment After Randomization||1
5294758|NCT00570323|13014442|P1|NOT COMPLETED|Started Treatment After Randomization||2
5294759|NCT00570323|13014441|P2|COMPLETED|Started Treatment After Randomization||35
5294760|NCT00570323|13014442|P1|COMPLETED|Started Treatment After Randomization||34
5294761|NCT00570323|13014441|P2|STARTED|Started Treatment After Randomization||36
5294762|NCT00570323|13014442|P1|STARTED|Started Treatment After Randomization||36
5294763|NCT00570310|13014454|P2|NOT COMPLETED|Overall Study||6
5294764|NCT00570310|13014455|P1|NOT COMPLETED|Overall Study||2
5294765|NCT00570310|13014454|P2|COMPLETED|Overall Study||45
5294766|NCT00570310|13014455|P1|COMPLETED|Overall Study||51
5294767|NCT00570310|13014454|P2|STARTED|Overall Study||51
5294768|NCT00570310|13014455|P1|STARTED|Overall Study||53
5294769|NCT00570258|13014465|P2|NOT COMPLETED|Overall Study||15
5294770|NCT00570258|13014466|P1|NOT COMPLETED|Overall Study||12
5294771|NCT00570258|13014465|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
5294772|NCT00570258|13014466|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
5294773|NCT00570258|13014465|P2|STARTED|Overall Study||15
5294774|NCT00570258|13014466|P1|STARTED|Overall Study||12
5294775|NCT00570232|13014474|P1|NOT COMPLETED|Overall Study||23
5294776|NCT00570232|13014474|P1|COMPLETED|Overall Study||8
5294777|NCT00570232|13014474|P1|STARTED|Overall Study||31
5294778|NCT00570141|13014480|P1|NOT COMPLETED|Overall Study||3
5294779|NCT00570141|13014480|P1|COMPLETED|Overall Study||10
5294780|NCT00570141|13014480|P1|STARTED|Overall Study||13
5294781|NCT00570089|13014485|P2|NOT COMPLETED|Perod 2||0
5294782|NCT00570089|13014486|P1|NOT COMPLETED|Perod 2||0
5294783|NCT00570089|13014485|P2|COMPLETED|Perod 2||10
5294784|NCT00570089|13014486|P1|COMPLETED|Perod 2||10
5294785|NCT00570089|13014485|P2|STARTED|Perod 2||10
5294786|NCT00570089|13014486|P1|STARTED|Perod 2||10
5294787|NCT00570089|13014485|P2|NOT COMPLETED|Period 1||0
5294788|NCT00570089|13014486|P1|NOT COMPLETED|Period 1||0
5294789|NCT00570089|13014485|P2|COMPLETED|Period 1||10
5294790|NCT00570089|13014486|P1|COMPLETED|Period 1||10
5294791|NCT00570089|13014485|P2|STARTED|Period 1||10
5294792|NCT00570089|13014486|P1|STARTED|Period 1||10
5294793|NCT00570063|13014496|P2|NOT COMPLETED|Overall Study||8
5294794|NCT00570063|13014497|P1|NOT COMPLETED|Overall Study||15
5294795|NCT00570063|13014496|P2|COMPLETED|Overall Study||3
5294796|NCT00570063|13014497|P1|COMPLETED|Overall Study||9
5294797|NCT00570063|13014496|P2|STARTED|Overall Study||11
5294798|NCT00570063|13014497|P1|STARTED|Overall Study||24
5294799|NCT00570037|13014563|P2|NOT COMPLETED|Overall Study||69
5294800|NCT00570037|13014564|P1|NOT COMPLETED|Overall Study||44
5294801|NCT00570037|13014563|P2|COMPLETED|Overall Study||237
5294802|NCT00570037|13014564|P1|COMPLETED|Overall Study||194
5294803|NCT00570037|13014563|P2|STARTED|Overall Study||306
5294804|NCT00570037|13014564|P1|STARTED|Overall Study||238
5294805|NCT00569946|13014574|P1|NOT COMPLETED|Overall Study||59
5294806|NCT00569946|13014574|P1|COMPLETED|Overall Study||5
5294807|NCT00569946|13014574|P1|STARTED|Overall Study||64
5294808|NCT00569868|13014590|P1|NOT COMPLETED|Overall Study||0
5294809|NCT00569868|13014590|P1|COMPLETED|Overall Study||11
5294810|NCT00569868|13014590|P1|STARTED|Overall Study||11
5294811|NCT00569855|13014594|P1|NOT COMPLETED|Overall Study||0
5294812|NCT00569855|13014594|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
5294813|NCT00569855|13014594|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
5294814|NCT00569803|13014606|P8|NOT COMPLETED|Overall Study||1
5294815|NCT00569803|13014607|P7|NOT COMPLETED|Overall Study||0
5294816|NCT00569803|13014608|P6|NOT COMPLETED|Overall Study||0
5294817|NCT00569803|13014609|P5|NOT COMPLETED|Overall Study||0
5294818|NCT00569803|13014610|P4|NOT COMPLETED|Overall Study||1
5294819|NCT00569803|13014611|P3|NOT COMPLETED|Overall Study||0
5294820|NCT00569803|13014612|P2|NOT COMPLETED|Overall Study||0
5294821|NCT00569803|13014613|P1|NOT COMPLETED|Overall Study||1
5294822|NCT00569803|13014606|P8|COMPLETED|Overall Study||5
5294823|NCT00569803|13014607|P7|COMPLETED|Overall Study||10
5294824|NCT00569803|13014608|P6|COMPLETED|Overall Study||5
5294825|NCT00569803|13014609|P5|COMPLETED|Overall Study||5
5294826|NCT00569803|13014610|P4|COMPLETED|Overall Study||5
5294827|NCT00569803|13014611|P3|COMPLETED|Overall Study||5
5294828|NCT00569803|13014612|P2|COMPLETED|Overall Study||5
5294829|NCT00569803|13014613|P1|COMPLETED|Overall Study||4
5294830|NCT00569803|13014606|P8|STARTED|Overall Study||6
5294831|NCT00569803|13014607|P7|STARTED|Overall Study||10
5294832|NCT00569803|13014608|P6|STARTED|Overall Study||5
5294833|NCT00569803|13014609|P5|STARTED|Overall Study||5
5294834|NCT00569803|13014610|P4|STARTED|Overall Study||6
5294835|NCT00569803|13014611|P3|STARTED|Overall Study||5
5294836|NCT00569803|13014612|P2|STARTED|Overall Study||5
5294837|NCT00569803|13014613|P1|STARTED|Overall Study||5
5294838|NCT00569777|13014740|P2|NOT COMPLETED|Overall Study||3
5294839|NCT00569777|13014741|P1|NOT COMPLETED|Overall Study||10
5294840|NCT00569777|13014740|P2|COMPLETED|Overall Study||101
5294841|NCT00569777|13014741|P1|COMPLETED|Overall Study||196
5294842|NCT00569777|13014740|P2|STARTED|Overall Study||104
5294843|NCT00569777|13014741|P1|STARTED|Overall Study||206
5294844|NCT00569673|13014783|P1|NOT COMPLETED|Overall Study||0
5294845|NCT00569673|13014783|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
5294846|NCT00569673|13014783|P1|STARTED|Overall Study|Total number participants enrolled on study|71
5294847|NCT00569660|13014788|P1|NOT COMPLETED|Overall Study||0
5294848|NCT00569660|13014788|P1|COMPLETED|Overall Study||34
5294849|NCT00569660|13014788|P1|STARTED|Overall Study||34
5294850|NCT00569582|13014792|P1|NOT COMPLETED|Overall Study||16
5294851|NCT00569582|13014792|P1|COMPLETED|Overall Study||34
5294852|NCT00569582|13014792|P1|STARTED|Overall Study||50
5294853|NCT00569530|13014799|P2|NOT COMPLETED|Overall Study||0
5294854|NCT00569530|13014800|P1|NOT COMPLETED|Overall Study||0
5294855|NCT00569530|13014799|P2|COMPLETED|Overall Study||42
5294856|NCT00569530|13014800|P1|COMPLETED|Overall Study||43
5294857|NCT00569530|13014799|P2|STARTED|Overall Study||42
5294858|NCT00569530|13014800|P1|STARTED|Overall Study||43
5294859|NCT00569374|13014808|P1|NOT COMPLETED|Overall Study||4
5294860|NCT00569374|13014808|P1|COMPLETED|Overall Study||4
5294861|NCT00569374|13014808|P1|STARTED|Overall Study||8
5294862|NCT00569309|13014818|P1|NOT COMPLETED|Overall Study||0
5294863|NCT00569309|13014818|P1|COMPLETED|Overall Study||30
5294864|NCT00569309|13014818|P1|STARTED|Overall Study||30
5294865|NCT00569270|13014827|P2|NOT COMPLETED|Period: Second Intervention||0
5294866|NCT00569270|13014828|P1|NOT COMPLETED|Period: Second Intervention||0
5294867|NCT00569270|13014827|P2|COMPLETED|Period: Second Intervention||14
5294868|NCT00569270|13014828|P1|COMPLETED|Period: Second Intervention||15
5294869|NCT00569270|13014827|P2|29 Days|Period: Second Intervention||14
5294870|NCT00569270|13014828|P1|29 Days|Period: Second Intervention||15
5294871|NCT00569270|13014827|P2|STARTED|Period: Second Intervention||14
5294872|NCT00569270|13014828|P1|STARTED|Period: Second Intervention||15
5294873|NCT00569270|13014827|P2|NOT COMPLETED|Period: First Intervention||1
5294874|NCT00569270|13014828|P1|NOT COMPLETED|Period: First Intervention||0
5294875|NCT00569270|13014827|P2|COMPLETED|Period: First Intervention||14
5294876|NCT00569270|13014828|P1|COMPLETED|Period: First Intervention||15
5294877|NCT00569270|13014827|P2|STARTED|Period: First Intervention||15
5294878|NCT00569270|13014828|P1|STARTED|Period: First Intervention|randomized cross over study|15
5294879|NCT00569231|13014863|P1|NOT COMPLETED|Overall Study||7
5294880|NCT00569231|13014863|P1|COMPLETED|Overall Study||11
5294881|NCT00569231|13014863|P1|STARTED|Overall Study||18
5294882|NCT00569192|13014873|P3|NOT COMPLETED|Overall Study||25
5294883|NCT00569192|13014874|P2|NOT COMPLETED|Overall Study||20
5294884|NCT00569192|13014875|P1|NOT COMPLETED|Overall Study||23
5294885|NCT00569192|13014873|P3|COMPLETED|Overall Study||99
5294886|NCT00569192|13014874|P2|COMPLETED|Overall Study||105
5294887|NCT00569192|13014875|P1|COMPLETED|Overall Study||88
5294888|NCT00569192|13014873|P3|STARTED|Overall Study||124
5294889|NCT00569192|13014874|P2|STARTED|Overall Study||125
5294890|NCT00569192|13014875|P1|STARTED|Overall Study||111
5294891|NCT00569166|13014901|P3|NOT COMPLETED|Overall Study||4
5294892|NCT00569166|13014902|P2|NOT COMPLETED|Overall Study||6
5294893|NCT00569166|13014903|P1|NOT COMPLETED|Overall Study||9
5294894|NCT00569166|13014901|P3|COMPLETED|Overall Study||27
5294895|NCT00569166|13014902|P2|COMPLETED|Overall Study||25
5294896|NCT00569166|13014903|P1|COMPLETED|Overall Study||21
5294897|NCT00569166|13014901|P3|STARTED|Overall Study||31
5294898|NCT00569166|13014902|P2|STARTED|Overall Study||31
5294899|NCT00569166|13014903|P1|STARTED|Overall Study||30
5294900|NCT00569127|13014937|P2|NOT COMPLETED|Overall Study||213
5294901|NCT00569127|13014938|P1|NOT COMPLETED|Overall Study||214
5294902|NCT00569127|13014937|P2|COMPLETED|Overall Study||0
5294903|NCT00569127|13014938|P1|COMPLETED|Overall Study||0
5294904|NCT00569127|13014937|P2|Eligible|Overall Study||202
5294905|NCT00569127|13014938|P1|Eligible|Overall Study||200
5294906|NCT00569127|13014937|P2|STARTED|Overall Study||213
5294907|NCT00569127|13014938|P1|STARTED|Overall Study||214
5294908|NCT00569010|13014958|P4|NOT COMPLETED|Overall Study||0
5294909|NCT00569010|13014959|P3|NOT COMPLETED|Overall Study||0
5294910|NCT00569010|13014960|P2|NOT COMPLETED|Overall Study||0
5294911|NCT00569010|13014961|P1|NOT COMPLETED|Overall Study||0
5294912|NCT00569010|13014958|P4|COMPLETED|Overall Study||11
5294913|NCT00569010|13014959|P3|COMPLETED|Overall Study||11
5294914|NCT00569010|13014960|P2|COMPLETED|Overall Study||6
5294915|NCT00569010|13014961|P1|COMPLETED|Overall Study||6
5294916|NCT00569010|13014958|P4|STARTED|Overall Study||11
5294917|NCT00569010|13014959|P3|STARTED|Overall Study||11
5294918|NCT00569010|13014960|P2|STARTED|Overall Study||6
5294919|NCT00569010|13014961|P1|STARTED|Overall Study||6
5294920|NCT00568958|13014973|P2|NOT COMPLETED|Follow-Up||7
5294921|NCT00568958|13014974|P1|NOT COMPLETED|Follow-Up||9
5294922|NCT00568958|13014973|P2|COMPLETED|Follow-Up||60
5294923|NCT00568958|13014974|P1|COMPLETED|Follow-Up||52
5294924|NCT00568958|13014973|P2|STARTED|Follow-Up||67
5294925|NCT00568958|13014974|P1|STARTED|Follow-Up||61
5294926|NCT00568958|13014973|P2|NOT COMPLETED|Allocation||3
5294927|NCT00568958|13014974|P1|NOT COMPLETED|Allocation||9
5294928|NCT00568958|13014973|P2|COMPLETED|Allocation||67
5294929|NCT00568958|13014974|P1|COMPLETED|Allocation||61
5294930|NCT00568958|13014973|P2|STARTED|Allocation||70
5294931|NCT00568958|13014974|P1|STARTED|Allocation||70
5294932|NCT00568854|13014994|P2|NOT COMPLETED|Overall Study||0
5294933|NCT00568854|13014995|P1|NOT COMPLETED|Overall Study||0
5294934|NCT00568854|13014994|P2|COMPLETED|Overall Study||4
5294935|NCT00568854|13014995|P1|COMPLETED|Overall Study||6
5294936|NCT00568854|13014994|P2|STARTED|Overall Study||4
5294937|NCT00568854|13014995|P1|STARTED|Overall Study||6
5294938|NCT00568802|13015003|P1|NOT COMPLETED|Overall Study||3
5294939|NCT00568802|13015003|P1|COMPLETED|Overall Study||24
5294940|NCT00568802|13015003|P1|STARTED|Overall Study||27
5294941|NCT00568776|13015021|P4|NOT COMPLETED|Overall Study||72
5294942|NCT00568776|13015022|P3|NOT COMPLETED|Overall Study||74
5294943|NCT00568776|13015023|P2|NOT COMPLETED|Overall Study||36
5294944|NCT00568776|13015024|P1|NOT COMPLETED|Overall Study||30
5294945|NCT00568776|13015021|P4|COMPLETED|Overall Study||19
5294946|NCT00568776|13015022|P3|COMPLETED|Overall Study||15
5294947|NCT00568776|13015023|P2|COMPLETED|Overall Study||52
5294948|NCT00568776|13015024|P1|COMPLETED|Overall Study||53
5294949|NCT00568776|13015021|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
5294950|NCT00568776|13015022|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
5294951|NCT00568776|13015023|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
5294952|NCT00568776|13015024|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
5294953|NCT00568698|13015058|P1|NOT COMPLETED|Overall Study||11
5294954|NCT00568698|13015058|P1|COMPLETED|Overall Study||18
5294955|NCT00568698|13015058|P1|STARTED|Overall Study||29
5294956|NCT00568685|13015073|P3|NOT COMPLETED|Overall Study||5
5294957|NCT00568685|13015074|P2|NOT COMPLETED|Overall Study||5
5294958|NCT00568685|13015075|P1|NOT COMPLETED|Overall Study||10
5294959|NCT00568685|13015073|P3|COMPLETED|Overall Study||46
5294960|NCT00568685|13015074|P2|COMPLETED|Overall Study||46
5294961|NCT00568685|13015075|P1|COMPLETED|Overall Study||41
5294962|NCT00568685|13015073|P3|STARTED|Overall Study||51
5294963|NCT00568685|13015074|P2|STARTED|Overall Study||51
5294964|NCT00568685|13015075|P1|STARTED|Overall Study||51
5294965|NCT00568633|13015109|P2|NOT COMPLETED|Overall Study||0
5294966|NCT00568633|13015110|P1|NOT COMPLETED|Overall Study||0
5294967|NCT00568633|13015109|P2|COMPLETED|Overall Study||33
5294968|NCT00568633|13015110|P1|COMPLETED|Overall Study||25
5294969|NCT00568633|13015109|P2|STARTED|Overall Study||33
5294970|NCT00568633|13015110|P1|STARTED|Overall Study||25
5294971|NCT00568555|13015132|P2|NOT COMPLETED|Overall Study||1
5294972|NCT00568555|13015133|P1|NOT COMPLETED|Overall Study||1
5294973|NCT00568555|13015132|P2|COMPLETED|Overall Study||14
5294974|NCT00568555|13015133|P1|COMPLETED|Overall Study||15
5294975|NCT00568555|13015132|P2|STARTED|Overall Study||15
5294976|NCT00568555|13015133|P1|STARTED|Overall Study||16
5294977|NCT00568451|13015151|P4|NOT COMPLETED|Overall Study||7
5294978|NCT00568451|13015152|P3|NOT COMPLETED|Overall Study||2
5294979|NCT00568451|13015153|P2|NOT COMPLETED|Overall Study||0
5294980|NCT00568451|13015154|P1|NOT COMPLETED|Overall Study||0
5294981|NCT00568451|13015151|P4|COMPLETED|Overall Study||2
5294982|NCT00568451|13015152|P3|COMPLETED|Overall Study||0
5294983|NCT00568451|13015153|P2|COMPLETED|Overall Study||0
5294984|NCT00568451|13015154|P1|COMPLETED|Overall Study||0
5294985|NCT00568451|13015151|P4|STARTED|Overall Study||9
5294986|NCT00568451|13015152|P3|STARTED|Overall Study||2
5294987|NCT00568451|13015153|P2|STARTED|Overall Study||0
5294988|NCT00568451|13015154|P1|STARTED|Overall Study||0
5294989|NCT00568399|13015170|P1|NOT COMPLETED|Overall Study||15
5294990|NCT00568399|13015170|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
5294991|NCT00568399|13015170|P1|STARTED|Overall Study||37
5294992|NCT00568386|13015176|P2|NOT COMPLETED|Overall Study||0
5294993|NCT00568386|13015177|P1|NOT COMPLETED|Overall Study||0
5294994|NCT00568386|13015176|P2|COMPLETED|Overall Study||20
5294995|NCT00568386|13015177|P1|COMPLETED|Overall Study||20
5294996|NCT00568386|13015176|P2|STARTED|Overall Study||20
5294997|NCT00568386|13015177|P1|STARTED|Overall Study||20
5294998|NCT00568334|13015185|P2|NOT COMPLETED|Overall Study||1
5294999|NCT00568334|13015186|P1|NOT COMPLETED|Overall Study||1
5295000|NCT00568334|13015185|P2|COMPLETED|Overall Study||121
5295001|NCT00568334|13015186|P1|COMPLETED|Overall Study||121
5295002|NCT00568334|13015185|P2|STARTED|Overall Study||122
5295003|NCT00568334|13015186|P1|STARTED|Overall Study||122
5295004|NCT00568178|13015212|P6|NOT COMPLETED|Open Label Extension||80
5295005|NCT00568178|13015213|P5|NOT COMPLETED|Open Label Extension||79
5295006|NCT00568178|13015214|P4|NOT COMPLETED|Open Label Extension||0
5295007|NCT00568178|13015215|P3|NOT COMPLETED|Open Label Extension||0
5295008|NCT00568178|13015216|P2|NOT COMPLETED|Open Label Extension||0
5295009|NCT00568178|13015217|P1|NOT COMPLETED|Open Label Extension||0
5295010|NCT00568178|13015212|P6|COMPLETED|Open Label Extension||54
5295011|NCT00568178|13015213|P5|COMPLETED|Open Label Extension||55
5295012|NCT00568178|13015214|P4|COMPLETED|Open Label Extension||0
5295013|NCT00568178|13015215|P3|COMPLETED|Open Label Extension||0
5295014|NCT00568178|13015216|P2|COMPLETED|Open Label Extension||0
5295015|NCT00568178|13015217|P1|COMPLETED|Open Label Extension||0
5295016|NCT00568178|13015212|P6|STARTED|Open Label Extension||134
5295017|NCT00568178|13015213|P5|STARTED|Open Label Extension||134
5295018|NCT00568178|13015214|P4|STARTED|Open Label Extension||0
5295019|NCT00568178|13015215|P3|STARTED|Open Label Extension||0
5295020|NCT00568178|13015216|P2|STARTED|Open Label Extension||0
5295021|NCT00568178|13015217|P1|STARTED|Open Label Extension||0
5295022|NCT00568178|13015212|P6|NOT COMPLETED|Double Blind Base Study||0
5295023|NCT00568178|13015213|P5|NOT COMPLETED|Double Blind Base Study||0
5295024|NCT00568178|13015214|P4|NOT COMPLETED|Double Blind Base Study||5
5295025|NCT00568178|13015215|P3|NOT COMPLETED|Double Blind Base Study||1
5295026|NCT00568178|13015216|P2|NOT COMPLETED|Double Blind Base Study||6
5295027|NCT00568178|13015217|P1|NOT COMPLETED|Double Blind Base Study||6
5295028|NCT00568178|13015212|P6|COMPLETED|Double Blind Base Study||0
5295029|NCT00568178|13015213|P5|COMPLETED|Double Blind Base Study||0
5295030|NCT00568178|13015214|P4|COMPLETED|Double Blind Base Study||25
5295031|NCT00568178|13015215|P3|COMPLETED|Double Blind Base Study||29
5295032|NCT00568178|13015216|P2|COMPLETED|Double Blind Base Study||118
5295033|NCT00568178|13015217|P1|COMPLETED|Double Blind Base Study||116
5295034|NCT00568178|13015212|P6|STARTED|Double Blind Base Study||0
5295035|NCT00568178|13015213|P5|STARTED|Double Blind Base Study||0
5295036|NCT00568178|13015214|P4|STARTED|Double Blind Base Study||30
5295037|NCT00568178|13015215|P3|STARTED|Double Blind Base Study||30
5295038|NCT00568178|13015216|P2|STARTED|Double Blind Base Study||124
5295039|NCT00568178|13015217|P1|STARTED|Double Blind Base Study||122
5295040|NCT00568087|13015235|P2|NOT COMPLETED|Overall Study||7
5295041|NCT00568087|13015236|P1|NOT COMPLETED|Overall Study||7
5295042|NCT00568087|13015235|P2|COMPLETED|Overall Study||17
5295043|NCT00568087|13015236|P1|COMPLETED|Overall Study||15
5295044|NCT00568087|13015235|P2|Received Intervention|Overall Study||23
5295045|NCT00568087|13015236|P1|Received Intervention|Overall Study||21
5295046|NCT00568087|13015235|P2|STARTED|Overall Study||24
5295047|NCT00568087|13015236|P1|STARTED|Overall Study||22
5295048|NCT00568061|13015250|P2|NOT COMPLETED|Overall Study||2
5295049|NCT00568061|13015251|P1|NOT COMPLETED|Overall Study||5
5295050|NCT00568061|13015250|P2|COMPLETED|Overall Study||14
5295051|NCT00568061|13015251|P1|COMPLETED|Overall Study||8
5295052|NCT00568061|13015250|P2|STARTED|Overall Study||16
5295053|NCT00568061|13015251|P1|STARTED|Overall Study||13
5295054|NCT00568022|13015279|P3|NOT COMPLETED|Overall Study||0
5295055|NCT00568022|13015280|P2|NOT COMPLETED|Overall Study||0
5295056|NCT00568022|13015281|P1|NOT COMPLETED|Overall Study||0
5295057|NCT00568022|13015279|P3|COMPLETED|Overall Study||3
5295058|NCT00568022|13015280|P2|COMPLETED|Overall Study||3
5295059|NCT00568022|13015281|P1|COMPLETED|Overall Study||3
5295060|NCT00568022|13015279|P3|STARTED|Overall Study||3
5295061|NCT00568022|13015280|P2|STARTED|Overall Study||3
5295062|NCT00568022|13015281|P1|STARTED|Overall Study||3
5295063|NCT00567996|13015314|P3|NOT COMPLETED|Overall Study||70
5295064|NCT00567996|13015315|P2|NOT COMPLETED|Overall Study||50
5295065|NCT00567996|13015316|P1|NOT COMPLETED|Overall Study||44
5295066|NCT00567996|13015314|P3|COMPLETED|Overall Study||265
5295067|NCT00567996|13015315|P2|COMPLETED|Overall Study||284
5295068|NCT00567996|13015316|P1|COMPLETED|Overall Study||289
5295069|NCT00567996|13015314|P3|Intent-to-treat: Received Study Drug|Overall Study||335
5295070|NCT00567996|13015315|P2|Intent-to-treat: Received Study Drug|Overall Study||333
5295071|NCT00567996|13015316|P1|Intent-to-treat: Received Study Drug|Overall Study||330
5295072|NCT00567996|13015314|P3|STARTED|Overall Study||335
5295073|NCT00567996|13015315|P2|STARTED|Overall Study||334
5295074|NCT00567996|13015316|P1|STARTED|Overall Study|Randomized participants|333
5295075|NCT00567892|13015332|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
5295076|NCT00567892|13015333|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
5295077|NCT00567892|13015334|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
5295078|NCT00567892|13015335|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
5295079|NCT00567892|13015332|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
5295080|NCT00567892|13015333|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
5295081|NCT00567892|13015334|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
5295082|NCT00567892|13015335|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
5295083|NCT00567892|13015332|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
5295084|NCT00567892|13015333|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
5295085|NCT00567892|13015334|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
5295086|NCT00567892|13015335|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
5295087|NCT00567892|13015332|P4|NOT COMPLETED|Washout (2 Weeks)||0
5295088|NCT00567892|13015333|P3|NOT COMPLETED|Washout (2 Weeks)||0
5295089|NCT00567892|13015334|P2|NOT COMPLETED|Washout (2 Weeks)||0
5295090|NCT00567892|13015335|P1|NOT COMPLETED|Washout (2 Weeks)||0
5295091|NCT00567892|13015332|P4|COMPLETED|Washout (2 Weeks)||6
5295092|NCT00567892|13015333|P3|COMPLETED|Washout (2 Weeks)||9
5295093|NCT00567892|13015334|P2|COMPLETED|Washout (2 Weeks)||7
5295094|NCT00567892|13015335|P1|COMPLETED|Washout (2 Weeks)||7
5295095|NCT00567892|13015332|P4|STARTED|Washout (2 Weeks)||6
5295096|NCT00567892|13015333|P3|STARTED|Washout (2 Weeks)||9
5295097|NCT00567892|13015334|P2|STARTED|Washout (2 Weeks)||7
5295098|NCT00567892|13015335|P1|STARTED|Washout (2 Weeks)||7
5295099|NCT00567892|13015332|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
5295100|NCT00567892|13015333|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
5295101|NCT00567892|13015334|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
5295102|NCT00567892|13015335|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
5295103|NCT00567892|13015332|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
5295104|NCT00567892|13015333|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
5295105|NCT00567892|13015334|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
5295106|NCT00567892|13015335|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
5295107|NCT00567892|13015332|P4|STARTED|First Treatment (2 or 4 Weeks)||10
5295108|NCT00567892|13015333|P3|STARTED|First Treatment (2 or 4 Weeks)||10
5295109|NCT00567892|13015334|P2|STARTED|First Treatment (2 or 4 Weeks)||7
5295110|NCT00567892|13015335|P1|STARTED|First Treatment (2 or 4 Weeks)||7
5295111|NCT00567879|13015353|P6|NOT COMPLETED|Overall Study||3
5295112|NCT00567879|13015354|P5|NOT COMPLETED|Overall Study||12
5295113|NCT00567879|13015355|P4|NOT COMPLETED|Overall Study||6
5295114|NCT00567879|13015356|P3|NOT COMPLETED|Overall Study||21
5295115|NCT00567879|13015357|P2|NOT COMPLETED|Overall Study||7
5295116|NCT00567879|13015358|P1|NOT COMPLETED|Overall Study||7
5295117|NCT00567879|13015353|P6|COMPLETED|Overall Study||0
5295118|NCT00567879|13015354|P5|COMPLETED|Overall Study||0
5295119|NCT00567879|13015355|P4|COMPLETED|Overall Study||0
5295120|NCT00567879|13015356|P3|COMPLETED|Overall Study||0
5295121|NCT00567879|13015357|P2|COMPLETED|Overall Study||0
5295122|NCT00567879|13015358|P1|COMPLETED|Overall Study||0
5295123|NCT00567879|13015353|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
5295124|NCT00567879|13015354|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
5295125|NCT00567879|13015355|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
5295126|NCT00567879|13015356|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
5295127|NCT00567879|13015357|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
5295128|NCT00567879|13015358|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
5295129|NCT00567879|13015353|P6|STARTED|Overall Study||3
5295130|NCT00567879|13015354|P5|STARTED|Overall Study||12
5295131|NCT00567879|13015355|P4|STARTED|Overall Study||6
5295132|NCT00567879|13015356|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
5295133|NCT00567879|13015357|P2|STARTED|Overall Study||7
5295134|NCT00567879|13015358|P1|STARTED|Overall Study||7
5295135|NCT00567840|13015384|P5|NOT COMPLETED|Overall Study||0
5295136|NCT00567840|13015385|P4|NOT COMPLETED|Overall Study||1
5295137|NCT00567840|13015386|P3|NOT COMPLETED|Overall Study||1
5295138|NCT00567840|13015387|P2|NOT COMPLETED|Overall Study||0
5295139|NCT00567840|13015388|P1|NOT COMPLETED|Overall Study||2
5295140|NCT00567840|13015384|P5|COMPLETED|Overall Study||8
5295141|NCT00567840|13015385|P4|COMPLETED|Overall Study||14
5295142|NCT00567840|13015386|P3|COMPLETED|Overall Study||15
5295143|NCT00567840|13015387|P2|COMPLETED|Overall Study||15
5295144|NCT00567840|13015388|P1|COMPLETED|Overall Study||13
5295145|NCT00567840|13015384|P5|STARTED|Overall Study||8
5295146|NCT00567840|13015385|P4|STARTED|Overall Study||15
5295147|NCT00567840|13015386|P3|STARTED|Overall Study||16
5295148|NCT00567840|13015387|P2|STARTED|Overall Study||15
5295149|NCT00567840|13015388|P1|STARTED|Overall Study||15
5295150|NCT00567593|13015425|P1|NOT COMPLETED|Overall Study||2
5295151|NCT00567593|13015425|P1|COMPLETED|Overall Study||10
5295152|NCT00567593|13015425|P1|STARTED|Overall Study||12
5295153|NCT00567567|13015432|P3|NOT COMPLETED|Overall Study||278
5295154|NCT00567567|13015433|P2|NOT COMPLETED|Overall Study||134
5295155|NCT00567567|13015434|P1|NOT COMPLETED|Overall Study||152
5295156|NCT00567567|13015432|P3|COMPLETED|Overall Study||1
5295157|NCT00567567|13015433|P2|COMPLETED|Overall Study||42
5295158|NCT00567567|13015434|P1|COMPLETED|Overall Study||58
5295159|NCT00567567|13015432|P3|STARTED|Overall Study||279
5295160|NCT00567567|13015433|P2|STARTED|Overall Study||176
5295161|NCT00567567|13015434|P1|STARTED|Overall Study||210
5295162|NCT00567541|13015482|P2|NOT COMPLETED|Overall Study||1
5295163|NCT00567541|13015483|P1|NOT COMPLETED|Overall Study||0
5295164|NCT00567541|13015482|P2|COMPLETED|Overall Study||8
5295165|NCT00567541|13015483|P1|COMPLETED|Overall Study||7
5295166|NCT00567541|13015482|P2|STARTED|Overall Study||9
5295167|NCT00567541|13015483|P1|STARTED|Overall Study||7
5295168|NCT00567502|13015493|P4|NOT COMPLETED|Overall Study||87
5295169|NCT00567502|13015494|P3|NOT COMPLETED|Overall Study||908
5295170|NCT00567502|13015495|P2|NOT COMPLETED|Overall Study||33
5295171|NCT00567502|13015496|P1|NOT COMPLETED|Overall Study||241
5295172|NCT00567502|13015493|P4|COMPLETED|Overall Study||23
5295173|NCT00567502|13015494|P3|COMPLETED|Overall Study||1758
5295174|NCT00567502|13015495|P2|COMPLETED|Overall Study||108
5295175|NCT00567502|13015496|P1|COMPLETED|Overall Study||563
5295176|NCT00567502|13015493|P4|Initiated Treatment|Overall Study||38
5295177|NCT00567502|13015494|P3|Initiated Treatment|Overall Study||2666
5295178|NCT00567502|13015495|P2|Initiated Treatment|Overall Study||141
5295179|NCT00567502|13015496|P1|Initiated Treatment|Overall Study||804
5295180|NCT00567502|13015493|P4|STARTED|Overall Study||110
5295181|NCT00567502|13015494|P3|STARTED|Overall Study||2666
5295182|NCT00567502|13015495|P2|STARTED|Overall Study||141
5295183|NCT00567502|13015496|P1|STARTED|Overall Study||804
5295184|NCT00567489|13015533|P2|NOT COMPLETED|Overall Study||23
5295185|NCT00567489|13015534|P1|NOT COMPLETED|Overall Study||7
5295186|NCT00567489|13015533|P2|COMPLETED|Overall Study||101
5295187|NCT00567489|13015534|P1|COMPLETED|Overall Study||120
5295188|NCT00567489|13015533|P2|STARTED|Overall Study||124
5295189|NCT00567489|13015534|P1|STARTED|Overall Study||127
5295190|NCT00567476|13015584|P2|NOT COMPLETED|Overall Study||4
5295191|NCT00567476|13015585|P1|NOT COMPLETED|Overall Study||8
5295192|NCT00567476|13015584|P2|COMPLETED|Overall Study||34
5295193|NCT00567476|13015585|P1|COMPLETED|Overall Study||70
5295194|NCT00567476|13015584|P2|STARTED|Overall Study||38
5295195|NCT00567476|13015585|P1|STARTED|Overall Study||78
5295196|NCT00567398|13015611|P2|NOT COMPLETED|Overall Study||23
5295197|NCT00567398|13015612|P1|NOT COMPLETED|Overall Study||7
5295198|NCT00567398|13015611|P2|COMPLETED|Overall Study||101
5295199|NCT00567398|13015612|P1|COMPLETED|Overall Study||120
5295200|NCT00567398|13015611|P2|STARTED|Overall Study||124
5295201|NCT00567398|13015612|P1|STARTED|Overall Study||127
5295202|NCT00567359|13015660|P1|NOT COMPLETED|Overall Study||1
5295203|NCT00567359|13015660|P1|COMPLETED|Overall Study||99
5295204|NCT00567359|13015660|P1|STARTED|Overall Study||100
5295205|NCT00567320|13015669|P2|NOT COMPLETED|Overall Study||0
5295206|NCT00567320|13015670|P1|NOT COMPLETED|Overall Study||0
5295207|NCT00567320|13015669|P2|COMPLETED|Overall Study||18
5295208|NCT00567320|13015670|P1|COMPLETED|Overall Study||13
5295209|NCT00567320|13015669|P2|STARTED|Overall Study||18
5295210|NCT00567320|13015670|P1|STARTED|Overall Study||13
5295211|NCT00567307|13015678|P2|NOT COMPLETED|Overall Study||1
5295212|NCT00567307|13015679|P1|NOT COMPLETED|Overall Study||12
5295213|NCT00567307|13015678|P2|COMPLETED|Overall Study||104
5295214|NCT00567307|13015679|P1|COMPLETED|Overall Study||99
5295215|NCT00567307|13015678|P2|STARTED|Overall Study||105
5295216|NCT00567307|13015679|P1|STARTED|Overall Study||111
5295217|NCT00567268|13015685|P1|NOT COMPLETED|Overall Study||50
5295218|NCT00567268|13015685|P1|COMPLETED|Overall Study||1144
5295219|NCT00567268|13015685|P1|STARTED|Overall Study||1194
5295220|NCT00567255|13015736|P2|NOT COMPLETED|Overall Study||228
5295221|NCT00567255|13015737|P1|NOT COMPLETED|Overall Study||463
5295222|NCT00567255|13015736|P2|COMPLETED|Overall Study||267
5295223|NCT00567255|13015737|P1|COMPLETED|Overall Study||538
5295224|NCT00567255|13015736|P2|STARTED|Overall Study||495
5295225|NCT00567255|13015737|P1|STARTED|Overall Study||1001
5295226|NCT00567242|13015783|P2|NOT COMPLETED|Overall Study||0
5295227|NCT00567242|13015784|P1|NOT COMPLETED|Overall Study||0
5295228|NCT00567242|13015783|P2|COMPLETED|Overall Study||7
5295229|NCT00567242|13015784|P1|COMPLETED|Overall Study||7
5295230|NCT00567242|13015783|P2|STARTED|Overall Study||7
5295231|NCT00567242|13015784|P1|STARTED|Overall Study||7
5295232|NCT00567229|13015794|P1|NOT COMPLETED|Overall Study||0
5295233|NCT00567229|13015794|P1|COMPLETED|Overall Study||3
5295234|NCT00567229|13015794|P1|STARTED|Overall Study||3
5295235|NCT00567190|13015800|P2|NOT COMPLETED|Overall Study||333
5295236|NCT00567190|13015801|P1|NOT COMPLETED|Overall Study||283
5295237|NCT00567190|13015800|P2|COMPLETED|Overall Study||73
5295238|NCT00567190|13015801|P1|COMPLETED|Overall Study||119
5295239|NCT00567190|13015800|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
5295240|NCT00567190|13015801|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
5295241|NCT00567190|13015800|P2|Received at Least One Dose of Placebo|Overall Study||395
5295242|NCT00567190|13015801|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
5295243|NCT00567190|13015800|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
5295244|NCT00567190|13015801|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
5295245|NCT00567190|13015800|P2|Did Not Receive Any Study Treatment|Overall Study||2
5295246|NCT00567190|13015801|P1|Did Not Receive Any Study Treatment|Overall Study||2
5295247|NCT00567190|13015800|P2|STARTED|Overall Study||406
5295248|NCT00567190|13015801|P1|STARTED|Overall Study||402
5295249|NCT00567164|13015852|P3|NOT COMPLETED|Overall Study||72
5295250|NCT00567164|13015853|P2|NOT COMPLETED|Overall Study||73
5295251|NCT00567164|13015854|P1|NOT COMPLETED|Overall Study||546
5295252|NCT00567164|13015852|P3|COMPLETED|Overall Study||160
5295253|NCT00567164|13015853|P2|COMPLETED|Overall Study||161
5295254|NCT00567164|13015854|P1|COMPLETED|Overall Study||875
5295255|NCT00567164|13015852|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
5295256|NCT00567164|13015853|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
5295257|NCT00567164|13015854|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
5295258|NCT00567164|13015852|P3|STARTED|Overall Study||232
5295259|NCT00567164|13015853|P2|STARTED|Overall Study||234
5295260|NCT00567164|13015854|P1|STARTED|Overall Study||1421
5295261|NCT00567112|13015926|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5295262|NCT00567112|13015927|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5295263|NCT00567112|13015928|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
5295264|NCT00567112|13015926|P3|COMPLETED|Treatment Period 4 (3 Days)||3
5295265|NCT00567112|13015927|P2|COMPLETED|Treatment Period 4 (3 Days)||7
5295266|NCT00567112|13015928|P1|COMPLETED|Treatment Period 4 (3 Days)||4
5295267|NCT00567112|13015926|P3|STARTED|Treatment Period 4 (3 Days)||3
5295268|NCT00567112|13015927|P2|STARTED|Treatment Period 4 (3 Days)||7
5295269|NCT00567112|13015928|P1|STARTED|Treatment Period 4 (3 Days)||4
5295270|NCT00567112|13015926|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
5295271|NCT00567112|13015927|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
5295272|NCT00567112|13015928|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
5295273|NCT00567112|13015926|P3|COMPLETED|Washout Period 3 (3 Days)||3
5295274|NCT00567112|13015927|P2|COMPLETED|Washout Period 3 (3 Days)||7
5295275|NCT00567112|13015928|P1|COMPLETED|Washout Period 3 (3 Days)||4
5295276|NCT00567112|13015926|P3|STARTED|Washout Period 3 (3 Days)||3
5295277|NCT00567112|13015927|P2|STARTED|Washout Period 3 (3 Days)||7
5295278|NCT00567112|13015928|P1|STARTED|Washout Period 3 (3 Days)||7
5295279|NCT00567112|13015926|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5295280|NCT00567112|13015927|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5295281|NCT00567112|13015928|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
5295282|NCT00567112|13015926|P3|COMPLETED|Treatment Period 3 (3 Days)||3
5295283|NCT00567112|13015927|P2|COMPLETED|Treatment Period 3 (3 Days)||7
5295284|NCT00567112|13015928|P1|COMPLETED|Treatment Period 3 (3 Days)||7
5295285|NCT00567112|13015926|P3|STARTED|Treatment Period 3 (3 Days)||3
5295286|NCT00567112|13015927|P2|STARTED|Treatment Period 3 (3 Days)||7
5295287|NCT00567112|13015928|P1|STARTED|Treatment Period 3 (3 Days)||7
5295288|NCT00567112|13015926|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
5295289|NCT00567112|13015927|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
5295290|NCT00567112|13015928|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
5295291|NCT00567112|13015926|P3|COMPLETED|Washout Period 2 (3 Days)||3
5295292|NCT00567112|13015927|P2|COMPLETED|Washout Period 2 (3 Days)||7
5295293|NCT00567112|13015928|P1|COMPLETED|Washout Period 2 (3 Days)||7
5295294|NCT00567112|13015926|P3|STARTED|Washout Period 2 (3 Days)||3
5295295|NCT00567112|13015927|P2|STARTED|Washout Period 2 (3 Days)||7
5295296|NCT00567112|13015928|P1|STARTED|Washout Period 2 (3 Days)||7
5295297|NCT00567112|13015926|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5295298|NCT00567112|13015927|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
5295299|NCT00567112|13015928|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
5295300|NCT00567112|13015926|P3|COMPLETED|Treatment Period 2 (3 Days)||3
5295301|NCT00567112|13015927|P2|COMPLETED|Treatment Period 2 (3 Days)||7
5295302|NCT00567112|13015928|P1|COMPLETED|Treatment Period 2 (3 Days)||7
5295303|NCT00567112|13015926|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
5295304|NCT00567112|13015927|P2|STARTED|Treatment Period 2 (3 Days)||8
5295305|NCT00567112|13015928|P1|STARTED|Treatment Period 2 (3 Days)||7
5295306|NCT00567112|13015926|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
5295307|NCT00567112|13015927|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
5295308|NCT00567112|13015928|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
5295309|NCT00567112|13015926|P3|COMPLETED|Washout Period 1 (3 Days)||0
5295310|NCT00567112|13015927|P2|COMPLETED|Washout Period 1 (3 Days)||8
5295311|NCT00567112|13015928|P1|COMPLETED|Washout Period 1 (3 Days)||7
5295312|NCT00567112|13015926|P3|STARTED|Washout Period 1 (3 Days)||0
5295313|NCT00567112|13015927|P2|STARTED|Washout Period 1 (3 Days)||8
5295314|NCT00567112|13015928|P1|STARTED|Washout Period 1 (3 Days)||7
5295315|NCT00567112|13015926|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5295316|NCT00567112|13015927|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5295317|NCT00567112|13015928|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
5295318|NCT00567112|13015926|P3|COMPLETED|Treatment Period 1 (3 Days)||0
5295319|NCT00567112|13015927|P2|COMPLETED|Treatment Period 1 (3 Days)||8
5295320|NCT00567112|13015928|P1|COMPLETED|Treatment Period 1 (3 Days)||7
5295321|NCT00567112|13015926|P3|STARTED|Treatment Period 1 (3 Days)||0
5295322|NCT00567112|13015927|P2|STARTED|Treatment Period 1 (3 Days)||8
5295323|NCT00567112|13015928|P1|STARTED|Treatment Period 1 (3 Days)||7
5295324|NCT00567008|13015952|P2|NOT COMPLETED|Overall Study||1
5295325|NCT00567008|13015953|P1|NOT COMPLETED|Overall Study||1
5295326|NCT00567008|13015952|P2|COMPLETED|Overall Study||18
5295327|NCT00567008|13015953|P1|COMPLETED|Overall Study||17
5295328|NCT00567008|13015952|P2|STARTED|Overall Study||19
5295329|NCT00567008|13015953|P1|STARTED|Overall Study||18
5295330|NCT00566995|13015959|P1|NOT COMPLETED|Overall Study||7
5295331|NCT00566995|13015959|P1|COMPLETED|Overall Study||30
5295332|NCT00566995|13015959|P1|STARTED|Overall Study||37
5295333|NCT00566982|13015974|P2|NOT COMPLETED|Overall Study||69
5295334|NCT00566982|13015975|P1|NOT COMPLETED|Overall Study||8
5295335|NCT00566982|13015974|P2|COMPLETED|Overall Study||294
5295336|NCT00566982|13015975|P1|COMPLETED|Overall Study||55
5295337|NCT00566982|13015974|P2|STARTED|Overall Study||363
5295338|NCT00566982|13015975|P1|STARTED|Overall Study||63
5295339|NCT00566969|13016000|P3|NOT COMPLETED|Overall Study||12
5295340|NCT00566969|13016001|P2|NOT COMPLETED|Overall Study||9
5295341|NCT00566969|13016002|P1|NOT COMPLETED|Overall Study||15
5295342|NCT00566969|13016000|P3|COMPLETED|Overall Study||23
5295343|NCT00566969|13016001|P2|COMPLETED|Overall Study||28
5295344|NCT00566969|13016002|P1|COMPLETED|Overall Study||19
5295345|NCT00566969|13016000|P3|STARTED|Overall Study||35
5295346|NCT00566969|13016001|P2|STARTED|Overall Study||37
5295347|NCT00566969|13016002|P1|STARTED|Overall Study||34
5295348|NCT00566943|13016012|P2|NOT COMPLETED|Overall Study||0
5295349|NCT00566943|13016013|P1|NOT COMPLETED|Overall Study||0
5295350|NCT00566943|13016012|P2|COMPLETED|Overall Study||49
5295351|NCT00566943|13016013|P1|COMPLETED|Overall Study||52
5295352|NCT00566943|13016012|P2|STARTED|Overall Study||49
5295353|NCT00566943|13016013|P1|STARTED|Overall Study||52
5295354|NCT00566930|13016028|P3|NOT COMPLETED|Overall Study||1
5295355|NCT00566930|13016029|P2|NOT COMPLETED|Overall Study||4
5295356|NCT00566930|13016030|P1|NOT COMPLETED|Overall Study||2
5295357|NCT00566930|13016028|P3|COMPLETED|Overall Study||32
5295358|NCT00566930|13016029|P2|COMPLETED|Overall Study||32
5295359|NCT00566930|13016030|P1|COMPLETED|Overall Study||27
5295360|NCT00566930|13016028|P3|STARTED|Overall Study||33
5295361|NCT00566930|13016029|P2|STARTED|Overall Study||36
5295362|NCT00566930|13016030|P1|STARTED|Overall Study||29
5295363|NCT00566852|13016040|P2|NOT COMPLETED|Overall Study||198
5295364|NCT00566852|13016041|P1|NOT COMPLETED|Overall Study||207
5295365|NCT00566852|13016040|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
5295366|NCT00566852|13016041|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
5295367|NCT00566852|13016040|P2|STARTED|Overall Study||276
5295368|NCT00566852|13016041|P1|STARTED|Overall Study||278
5295369|NCT00566813|13016059|P2|NOT COMPLETED|Overall Study||0
5295370|NCT00566813|13016060|P1|NOT COMPLETED|Overall Study||0
5295371|NCT00566813|13016059|P2|COMPLETED|Overall Study||6
5295372|NCT00566813|13016060|P1|COMPLETED|Overall Study||4
5295373|NCT00566813|13016059|P2|STARTED|Overall Study||6
5295374|NCT00566813|13016060|P1|STARTED|Overall Study||4
5295375|NCT00566735|13016072|P2|NOT COMPLETED|Overall Study||7
5295376|NCT00566735|13016073|P1|NOT COMPLETED|Overall Study||2
5295377|NCT00566735|13016072|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
5295378|NCT00566735|13016073|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
5295379|NCT00566735|13016072|P2|Withdrew Before Baseline Measures|Overall Study||7
5295380|NCT00566735|13016073|P1|Withdrew Before Baseline Measures|Overall Study||2
5295381|NCT00566735|13016072|P2|STARTED|Overall Study||19
5295382|NCT00566735|13016073|P1|STARTED|Overall Study||20
5295383|NCT00566722|13016086|P3|NOT COMPLETED|Overall Study||9
5295384|NCT00566722|13016087|P2|NOT COMPLETED|Overall Study||5
5295385|NCT00566722|13016088|P1|NOT COMPLETED|Overall Study||2
5295386|NCT00566722|13016086|P3|COMPLETED|Overall Study||73
5295387|NCT00566722|13016087|P2|COMPLETED|Overall Study||24
5295388|NCT00566722|13016088|P1|COMPLETED|Overall Study||39
5295389|NCT00566722|13016086|P3|STARTED|Overall Study||82
5295390|NCT00566722|13016087|P2|STARTED|Overall Study||29
5295391|NCT00566722|13016088|P1|STARTED|Overall Study||41
5295392|NCT00566709|13016134|P2|NOT COMPLETED|Overall Study||0
5295393|NCT00566709|13016135|P1|NOT COMPLETED|Overall Study||5
5295394|NCT00566709|13016134|P2|COMPLETED|Overall Study||51
5295395|NCT00566709|13016135|P1|COMPLETED|Overall Study||46
5295396|NCT00566709|13016134|P2|STARTED|Overall Study||51
5295397|NCT00566709|13016135|P1|STARTED|Overall Study||51
5295398|NCT00566696|13016151|P1|NOT COMPLETED|Overall Study||42
5295399|NCT00566696|13016151|P1|COMPLETED|Overall Study||31
5295400|NCT00566696|13016151|P1|STARTED|Overall Study||73
5295401|NCT00566631|13016161|P1|NOT COMPLETED|Part 2: Extension Phase||82
5295402|NCT00566631|13016161|P1|COMPLETED|Part 2: Extension Phase||57
5295403|NCT00566631|13016161|P1|STARTED|Part 2: Extension Phase||139
5295404|NCT00566631|13016161|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
5295405|NCT00566631|13016161|P1|COMPLETED|Between Treatment and Extension Phase||139
5295406|NCT00566631|13016161|P1|STARTED|Between Treatment and Extension Phase||234
5295407|NCT00566631|13016161|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
5295408|NCT00566631|13016161|P1|COMPLETED|Part 1: Core Treatment Phase||234
5295409|NCT00566631|13016161|P1|STARTED|Part 1: Core Treatment Phase||294
5295410|NCT00566579|13016178|P2|NOT COMPLETED|Overall Study||0
5295411|NCT00566579|13016179|P1|NOT COMPLETED|Overall Study||0
5295412|NCT00566579|13016178|P2|COMPLETED|Overall Study||31
5295413|NCT00566579|13016179|P1|COMPLETED|Overall Study||29
5295414|NCT00566579|13016178|P2|STARTED|Overall Study||31
5295415|NCT00566579|13016179|P1|STARTED|Overall Study||29
5295416|NCT00566527|13016188|P3|NOT COMPLETED|Overall Study||78
5295417|NCT00566527|13016189|P2|NOT COMPLETED|Overall Study||66
5295418|NCT00566527|13016190|P1|NOT COMPLETED|Overall Study||17
5295419|NCT00566527|13016188|P3|COMPLETED|Overall Study||461
5295420|NCT00566527|13016189|P2|COMPLETED|Overall Study||474
5295421|NCT00566527|13016190|P1|COMPLETED|Overall Study||524
5295422|NCT00566527|13016188|P3|Received ProQuad® Dose 2|Overall Study||462
5295423|NCT00566527|13016189|P2|Received ProQuad® Dose 2|Overall Study||478
5295424|NCT00566527|13016190|P1|Received ProQuad® Dose 2|Overall Study||525
5295425|NCT00566527|13016188|P3|Received ProQuad® Dose 1|Overall Study||470
5295426|NCT00566527|13016189|P2|Received ProQuad® Dose 1|Overall Study||484
5295427|NCT00566527|13016190|P1|Received ProQuad® Dose 1|Overall Study||529
5295428|NCT00566527|13016188|P3|STARTED|Overall Study|Number randomized.|539
5295429|NCT00566527|13016189|P2|STARTED|Overall Study|Number randomized.|540
5295430|NCT00566527|13016190|P1|STARTED|Overall Study|Number randomized.|541
5295431|NCT00566501|13016231|P2|NOT COMPLETED|Overall Study||126
5295432|NCT00566501|13016232|P1|NOT COMPLETED|Overall Study||156
5295433|NCT00566501|13016231|P2|COMPLETED|Overall Study||210
5295434|NCT00566501|13016232|P1|COMPLETED|Overall Study||423
5295435|NCT00566501|13016231|P2|Not Determined|Overall Study||0
5295436|NCT00566501|13016232|P1|Not Determined|Overall Study||1
5295437|NCT00566501|13016231|P2|Other ( Not Specified)|Overall Study||21
5295438|NCT00566501|13016232|P1|Other ( Not Specified)|Overall Study||24
5295439|NCT00566501|13016231|P2|Medication Non-compliance|Overall Study||0
5295440|NCT00566501|13016232|P1|Medication Non-compliance|Overall Study||5
5295441|NCT00566501|13016231|P2|Protocol Violation|Overall Study||2
5295442|NCT00566501|13016232|P1|Protocol Violation|Overall Study||2
5295443|NCT00566501|13016231|P2|Request of Investigator or Sponsor|Overall Study||7
5295444|NCT00566501|13016232|P1|Request of Investigator or Sponsor|Overall Study||6
5295445|NCT00566501|13016231|P2|Withdraw of Consent by Subject|Overall Study||30
5295446|NCT00566501|13016232|P1|Withdraw of Consent by Subject|Overall Study||33
5295447|NCT00566501|13016231|P2|Lack of Efficacy|Overall Study||3
5295448|NCT00566501|13016232|P1|Lack of Efficacy|Overall Study||8
5295449|NCT00566501|13016231|P2|Adverse Event|Overall Study||59
5295450|NCT00566501|13016232|P1|Adverse Event|Overall Study||68
5295451|NCT00566501|13016231|P2|Discontinued|Overall Study||122
5295452|NCT00566501|13016232|P1|Discontinued|Overall Study||146
5295453|NCT00566501|13016231|P2|Safety Population|Overall Study||332
5295454|NCT00566501|13016232|P1|Safety Population|Overall Study||570
5295455|NCT00566501|13016231|P2|STARTED|Overall Study||336
5295456|NCT00566501|13016232|P1|STARTED|Overall Study||579
5295457|NCT00566462|13016240|P2|NOT COMPLETED|Overall Study||0
5295458|NCT00566462|13016241|P1|NOT COMPLETED|Overall Study||0
5295459|NCT00566462|13016240|P2|COMPLETED|Overall Study||0
5295460|NCT00566462|13016241|P1|COMPLETED|Overall Study||1
5295461|NCT00566462|13016240|P2|STARTED|Overall Study||0
5295462|NCT00566462|13016241|P1|STARTED|Overall Study||1
5295463|NCT00566254|13016251|P2|NOT COMPLETED|Overall Study||14
5295464|NCT00566254|13016252|P1|NOT COMPLETED|Overall Study||10
5295465|NCT00566254|13016251|P2|COMPLETED|Overall Study||93
5295466|NCT00566254|13016252|P1|COMPLETED|Overall Study||90
5295467|NCT00566254|13016251|P2|STARTED|Overall Study||107
5295468|NCT00566254|13016252|P1|STARTED|Overall Study||100
5295469|NCT00566228|13016266|P2|NOT COMPLETED|Overall Study||5
5295470|NCT00566228|13016267|P1|NOT COMPLETED|Overall Study||6
5295471|NCT00566228|13016266|P2|COMPLETED|Overall Study||55
5295472|NCT00566228|13016267|P1|COMPLETED|Overall Study||56
5295473|NCT00566228|13016266|P2|STARTED|Overall Study||60
5295474|NCT00566228|13016267|P1|STARTED|Overall Study||62
5295475|NCT00566150|13016285|P2|NOT COMPLETED|Overall Study||5
5295476|NCT00566150|13016286|P1|NOT COMPLETED|Overall Study||9
5295477|NCT00566150|13016285|P2|COMPLETED|Overall Study||11
5295478|NCT00566150|13016286|P1|COMPLETED|Overall Study||10
5295479|NCT00566150|13016285|P2|STARTED|Overall Study||16
5295480|NCT00566150|13016286|P1|STARTED|Overall Study||19
5295481|NCT00566111|13016300|P2|NOT COMPLETED|Overall Study||2
5295482|NCT00566111|13016301|P1|NOT COMPLETED|Overall Study||0
5295483|NCT00566111|13016300|P2|COMPLETED|Overall Study||1
5295484|NCT00566111|13016301|P1|COMPLETED|Overall Study||2
5295485|NCT00566111|13016300|P2|STARTED|Overall Study||3
5295486|NCT00566111|13016301|P1|STARTED|Overall Study||2
5295487|NCT00566098|13016315|P1|NOT COMPLETED|Administration of ASCT+MILs||18
5295488|NCT00566098|13016315|P1|COMPLETED|Administration of ASCT+MILs||4
5295489|NCT00566098|13016315|P1|STARTED|Administration of ASCT+MILs||22
5295490|NCT00566098|13016315|P1|NOT COMPLETED|Generation of MILs Product||1
5295491|NCT00566098|13016315|P1|COMPLETED|Generation of MILs Product||22
5295492|NCT00566098|13016315|P1|STARTED|Generation of MILs Product||23
5295493|NCT00566098|13016315|P1|NOT COMPLETED|Collection of MILs||2
5295494|NCT00566098|13016315|P1|COMPLETED|Collection of MILs||23
5295495|NCT00566098|13016315|P1|STARTED|Collection of MILs||25
5295496|NCT00566020|13016325|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
5295497|NCT00566020|13016326|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
5295498|NCT00566020|13016325|P2|COMPLETED|46-week Long-term Administration Phase||68
5295499|NCT00566020|13016326|P1|COMPLETED|46-week Long-term Administration Phase||0
5295500|NCT00566020|13016325|P2|STARTED|46-week Long-term Administration Phase||85
5295501|NCT00566020|13016326|P1|STARTED|46-week Long-term Administration Phase||0
5295502|NCT00566020|13016325|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
5295503|NCT00566020|13016326|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
5295504|NCT00566020|13016325|P2|COMPLETED|6-week Dosage Adjustment Phase||0
5295505|NCT00566020|13016326|P1|COMPLETED|6-week Dosage Adjustment Phase||85
5295506|NCT00566020|13016325|P2|STARTED|6-week Dosage Adjustment Phase||0
5295507|NCT00566020|13016326|P1|STARTED|6-week Dosage Adjustment Phase||92
5295508|NCT00565916|13016353|P2|NOT COMPLETED|Overall Study||0
5295509|NCT00565916|13016354|P1|NOT COMPLETED|Overall Study||0
5295510|NCT00565916|13016353|P2|COMPLETED|Overall Study||11
5295511|NCT00565916|13016354|P1|COMPLETED|Overall Study||11
5295512|NCT00565916|13016353|P2|STARTED|Overall Study||11
5295513|NCT00565916|13016354|P1|STARTED|Overall Study||11
5295514|NCT00565864|13016363|P3|NOT COMPLETED|Overall Study||11
5295515|NCT00565864|13016364|P2|NOT COMPLETED|Overall Study||12
5295516|NCT00565864|13016365|P1|NOT COMPLETED|Overall Study||12
5295517|NCT00565864|13016363|P3|COMPLETED|Overall Study||45
5295518|NCT00565864|13016364|P2|COMPLETED|Overall Study||47
5295519|NCT00565864|13016365|P1|COMPLETED|Overall Study||46
5295520|NCT00565864|13016363|P3|STARTED|Overall Study||56
5295521|NCT00565864|13016364|P2|STARTED|Overall Study||59
5295522|NCT00565864|13016365|P1|STARTED|Overall Study||58
5295523|NCT00565812|13016415|P3|NOT COMPLETED|Overall Study||130
5295524|NCT00565812|13016416|P2|NOT COMPLETED|Overall Study||135
5295525|NCT00565812|13016417|P1|NOT COMPLETED|Overall Study||144
5295526|NCT00565812|13016415|P3|COMPLETED|Overall Study||356
5295527|NCT00565812|13016416|P2|COMPLETED|Overall Study||351
5295528|NCT00565812|13016417|P1|COMPLETED|Overall Study||341
5295529|NCT00565812|13016415|P3|STARTED|Overall Study||486
5295530|NCT00565812|13016416|P2|STARTED|Overall Study||486
5295531|NCT00565812|13016417|P1|STARTED|Overall Study||485
5295532|NCT00565773|13016554|P1|NOT COMPLETED|Overall Study||2
5295533|NCT00565773|13016554|P1|COMPLETED|Overall Study||38
5295534|NCT00565773|13016554|P1|STARTED|Overall Study||40
5295535|NCT00565747|13016566|P2|NOT COMPLETED|Overall Study||73
5295536|NCT00565747|13016567|P1|NOT COMPLETED|Overall Study||67
5295537|NCT00565747|13016566|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
5295538|NCT00565747|13016567|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
5295539|NCT00565747|13016566|P2|STARTED|Overall Study||678
5295540|NCT00565747|13016567|P1|STARTED|Overall Study||654
5295541|NCT00565721|13016577|P1|NOT COMPLETED|Overall Study||17
5295542|NCT00565721|13016577|P1|COMPLETED|Overall Study||16
5295543|NCT00565721|13016577|P1|STARTED|Overall Study||33
5295544|NCT00565669|13016598|P2|NOT COMPLETED|Overall Study||0
5295545|NCT00565669|13016599|P1|NOT COMPLETED|Overall Study||0
5295546|NCT00565669|13016598|P2|COMPLETED|Overall Study||9
5295547|NCT00565669|13016599|P1|COMPLETED|Overall Study||11
5295548|NCT00565669|13016598|P2|STARTED|Overall Study||9
5295549|NCT00565669|13016599|P1|STARTED|Overall Study||11
5295550|NCT00565643|13016607|P2|NOT COMPLETED|Overall Study||0
5295551|NCT00565643|13016608|P1|NOT COMPLETED|Overall Study||0
5295552|NCT00565643|13016607|P2|COMPLETED|Overall Study||373
5295553|NCT00565643|13016608|P1|COMPLETED|Overall Study||380
5295554|NCT00565643|13016607|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
5295555|NCT00565643|13016608|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
5295556|NCT00565643|13016607|P2|Safety Data|Overall Study||373
5295557|NCT00565643|13016608|P1|Safety Data|Overall Study||380
5295558|NCT00565643|13016607|P2|STARTED|Overall Study||373
5295559|NCT00565643|13016608|P1|STARTED|Overall Study||380
5295560|NCT00565617|13016626|P1|NOT COMPLETED|Overall Study||1
5295561|NCT00565617|13016626|P1|COMPLETED|Overall Study||5
5295562|NCT00565617|13016626|P1|STARTED|Overall Study||6
5295563|NCT00565604|13016630|P1|NOT COMPLETED|Overall Study||4
5295564|NCT00565604|13016630|P1|COMPLETED|Overall Study||39
5295565|NCT00565604|13016630|P1|6 Month|Overall Study||39
5295566|NCT00565604|13016630|P1|6 Week|Overall Study||39
5295567|NCT00565604|13016630|P1|2 Week|Overall Study||41
5295568|NCT00565604|13016630|P1|7 Day|Overall Study||41
5295569|NCT00565604|13016630|P1|STARTED|Overall Study||43
5295570|NCT00565461|13016641|P4|NOT COMPLETED|Overall Study||3
5295571|NCT00565461|13016642|P3|NOT COMPLETED|Overall Study||1
5295572|NCT00565461|13016643|P2|NOT COMPLETED|Overall Study||1
5295573|NCT00565461|13016644|P1|NOT COMPLETED|Overall Study||0
5295574|NCT00565461|13016641|P4|COMPLETED|Overall Study||37
5295575|NCT00565461|13016642|P3|COMPLETED|Overall Study||39
5295576|NCT00565461|13016643|P2|COMPLETED|Overall Study||39
5295577|NCT00565461|13016644|P1|COMPLETED|Overall Study||40
5295578|NCT00565461|13016641|P4|STARTED|Overall Study||40
5295579|NCT00565461|13016642|P3|STARTED|Overall Study||40
5295580|NCT00565461|13016643|P2|STARTED|Overall Study||40
5295581|NCT00565461|13016644|P1|STARTED|Overall Study||40
5295582|NCT00565448|13016676|P2|NOT COMPLETED|Overall Study||2
5295583|NCT00565448|13016677|P1|NOT COMPLETED|Overall Study||3
5295584|NCT00565448|13016676|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
5295585|NCT00565448|13016677|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
5295586|NCT00565448|13016676|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
5295587|NCT00565448|13016677|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
5295588|NCT00565409|13016688|P4|NOT COMPLETED|Period 2 Double-Blind||59
5295589|NCT00565409|13016689|P3|NOT COMPLETED|Period 2 Double-Blind||27
5295590|NCT00565409|13016690|P2|NOT COMPLETED|Period 2 Double-Blind||21
5295591|NCT00565409|13016691|P1|NOT COMPLETED|Period 2 Double-Blind||0
5295592|NCT00565409|13016688|P4|COMPLETED|Period 2 Double-Blind||141
5295593|NCT00565409|13016689|P3|COMPLETED|Period 2 Double-Blind||175
5295594|NCT00565409|13016690|P2|COMPLETED|Period 2 Double-Blind||181
5295595|NCT00565409|13016691|P1|COMPLETED|Period 2 Double-Blind||0
5295596|NCT00565409|13016688|P4|STARTED|Period 2 Double-Blind||200
5295597|NCT00565409|13016689|P3|STARTED|Period 2 Double-Blind||202
5295598|NCT00565409|13016690|P2|STARTED|Period 2 Double-Blind||202
5295599|NCT00565409|13016691|P1|STARTED|Period 2 Double-Blind||0
5295600|NCT00565409|13016688|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
5295601|NCT00565409|13016689|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
5295602|NCT00565409|13016690|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
5295603|NCT00565409|13016691|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
5295604|NCT00565409|13016688|P4|COMPLETED|After Period 1, Prior to Period 2||0
5295605|NCT00565409|13016689|P3|COMPLETED|After Period 1, Prior to Period 2||0
5295606|NCT00565409|13016690|P2|COMPLETED|After Period 1, Prior to Period 2||0
5295607|NCT00565409|13016691|P1|COMPLETED|After Period 1, Prior to Period 2||604
5295608|NCT00565409|13016688|P4|STARTED|After Period 1, Prior to Period 2||0
5295609|NCT00565409|13016689|P3|STARTED|After Period 1, Prior to Period 2||0
5295610|NCT00565409|13016690|P2|STARTED|After Period 1, Prior to Period 2||0
5295611|NCT00565409|13016691|P1|STARTED|After Period 1, Prior to Period 2||756
5295612|NCT00565409|13016688|P4|NOT COMPLETED|Period 1 Open Label||0
5295613|NCT00565409|13016689|P3|NOT COMPLETED|Period 1 Open Label||0
5295614|NCT00565409|13016690|P2|NOT COMPLETED|Period 1 Open Label||0
5295615|NCT00565409|13016691|P1|NOT COMPLETED|Period 1 Open Label||78
5295616|NCT00565409|13016688|P4|COMPLETED|Period 1 Open Label||0
5295617|NCT00565409|13016689|P3|COMPLETED|Period 1 Open Label||0
5295618|NCT00565409|13016690|P2|COMPLETED|Period 1 Open Label||0
5295619|NCT00565409|13016691|P1|COMPLETED|Period 1 Open Label||756
5295620|NCT00565409|13016688|P4|STARTED|Period 1 Open Label||0
5295621|NCT00565409|13016689|P3|STARTED|Period 1 Open Label||0
5295622|NCT00565409|13016690|P2|STARTED|Period 1 Open Label||0
5295623|NCT00565409|13016691|P1|STARTED|Period 1 Open Label||834
5295624|NCT00565370|13016793|P1|NOT COMPLETED|Overall Study||0
5295625|NCT00565370|13016793|P1|COMPLETED|Overall Study||21
5295626|NCT00565370|13016793|P1|STARTED|Overall Study||21
5295627|NCT00565266|13016801|P1|NOT COMPLETED|Overall Study||36
5295628|NCT00565266|13016801|P1|COMPLETED|Overall Study||174
5295629|NCT00565266|13016801|P1|STARTED|Overall Study||210
5295630|NCT00565136|13016827|P1|NOT COMPLETED|Overall Study||3
5295631|NCT00565136|13016827|P1|COMPLETED|Overall Study||26
5295632|NCT00565136|13016827|P1|STARTED|Overall Study||29
5295633|NCT00565110|13016847|P2|NOT COMPLETED|Overall Study||131
5295634|NCT00565110|13016848|P1|NOT COMPLETED|Overall Study||131
5295635|NCT00565110|13016847|P2|COMPLETED|Overall Study||111
5295636|NCT00565110|13016848|P1|COMPLETED|Overall Study||99
5295637|NCT00565110|13016847|P2|12-Month|Overall Study||144
5295638|NCT00565110|13016848|P1|12-Month|Overall Study||114
5295639|NCT00565110|13016847|P2|STARTED|Overall Study||242
5295640|NCT00565110|13016848|P1|STARTED|Overall Study||230
5295641|NCT00565084|13016856|P3|NOT COMPLETED|Third Treatment Period||0
5295642|NCT00565084|13016857|P2|NOT COMPLETED|Third Treatment Period||0
5295643|NCT00565084|13016858|P1|NOT COMPLETED|Third Treatment Period||0
5295644|NCT00565084|13016856|P3|COMPLETED|Third Treatment Period||11
5295645|NCT00565084|13016857|P2|COMPLETED|Third Treatment Period||11
5295646|NCT00565084|13016858|P1|COMPLETED|Third Treatment Period||11
5295647|NCT00565084|13016856|P3|STARTED|Third Treatment Period||11
5295648|NCT00565084|13016857|P2|STARTED|Third Treatment Period||11
5295649|NCT00565084|13016858|P1|STARTED|Third Treatment Period||11
5295650|NCT00565084|13016856|P3|NOT COMPLETED|Second Treatment Period||0
5295651|NCT00565084|13016857|P2|NOT COMPLETED|Second Treatment Period||0
5295652|NCT00565084|13016858|P1|NOT COMPLETED|Second Treatment Period||0
5295653|NCT00565084|13016856|P3|COMPLETED|Second Treatment Period||11
5295654|NCT00565084|13016857|P2|COMPLETED|Second Treatment Period||11
5295655|NCT00565084|13016858|P1|COMPLETED|Second Treatment Period||11
5295656|NCT00565084|13016856|P3|STARTED|Second Treatment Period||11
5295657|NCT00565084|13016857|P2|STARTED|Second Treatment Period||11
5295658|NCT00565084|13016858|P1|STARTED|Second Treatment Period||11
5295659|NCT00565084|13016856|P3|NOT COMPLETED|First Treatment Period||0
5295660|NCT00565084|13016857|P2|NOT COMPLETED|First Treatment Period||0
5295661|NCT00565084|13016858|P1|NOT COMPLETED|First Treatment Period||0
5295662|NCT00565084|13016856|P3|COMPLETED|First Treatment Period||11
5295663|NCT00565084|13016857|P2|COMPLETED|First Treatment Period||11
5295664|NCT00565084|13016858|P1|COMPLETED|First Treatment Period||11
5295665|NCT00565084|13016856|P3|STARTED|First Treatment Period||11
5295666|NCT00565084|13016857|P2|STARTED|First Treatment Period||11
5295667|NCT00565084|13016858|P1|STARTED|First Treatment Period||11
5295668|NCT00565058|13016868|P2|NOT COMPLETED|Overall Study||0
5295669|NCT00565058|13016869|P1|NOT COMPLETED|Overall Study||1
5295670|NCT00565058|13016868|P2|COMPLETED|Overall Study||15
5295671|NCT00565058|13016869|P1|COMPLETED|Overall Study||9
5295672|NCT00565058|13016868|P2|STARTED|Overall Study||15
5295673|NCT00565058|13016869|P1|STARTED|Overall Study||10
5295674|NCT00565045|13016879|P2|NOT COMPLETED|Overall Study||3
5295675|NCT00565045|13016880|P1|NOT COMPLETED|Overall Study||1
5295676|NCT00565045|13016879|P2|COMPLETED|Overall Study||8
5295677|NCT00565045|13016880|P1|COMPLETED|Overall Study||9
5295678|NCT00565045|13016879|P2|STARTED|Overall Study||11
5295679|NCT00565045|13016880|P1|STARTED|Overall Study||10
5295680|NCT00564954|13016896|P2|NOT COMPLETED|Period 2- 1 Week||0
5295681|NCT00564954|13016897|P1|NOT COMPLETED|Period 2- 1 Week||0
5295682|NCT00564954|13016896|P2|COMPLETED|Period 2- 1 Week||42
5295683|NCT00564954|13016897|P1|COMPLETED|Period 2- 1 Week||44
5295684|NCT00564954|13016896|P2|STARTED|Period 2- 1 Week||42
5295685|NCT00564954|13016897|P1|STARTED|Period 2- 1 Week||44
5295686|NCT00564954|13016896|P2|NOT COMPLETED|Period 1- 1 Week||0
5295687|NCT00564954|13016897|P1|NOT COMPLETED|Period 1- 1 Week||0
5295688|NCT00564954|13016896|P2|COMPLETED|Period 1- 1 Week||42
5295689|NCT00564954|13016897|P1|COMPLETED|Period 1- 1 Week||44
5295690|NCT00564954|13016896|P2|STARTED|Period 1- 1 Week||42
5295691|NCT00564954|13016897|P1|STARTED|Period 1- 1 Week||44
5295692|NCT00564902|13016916|P3|NOT COMPLETED|Overall Study||4
5295693|NCT00564902|13016917|P2|NOT COMPLETED|Overall Study||4
5295694|NCT00564902|13016918|P1|NOT COMPLETED|Overall Study||1
5295695|NCT00564902|13016916|P3|COMPLETED|Overall Study||21
5295696|NCT00564902|13016917|P2|COMPLETED|Overall Study||21
5295697|NCT00564902|13016918|P1|COMPLETED|Overall Study||9
5295698|NCT00564902|13016916|P3|12 Months|Overall Study||21
5295699|NCT00564902|13016917|P2|12 Months|Overall Study||21
5295700|NCT00564902|13016918|P1|12 Months|Overall Study||9
5295701|NCT00564902|13016916|P3|8 Months|Overall Study||21
5295702|NCT00564902|13016917|P2|8 Months|Overall Study||22
5295703|NCT00564902|13016918|P1|8 Months|Overall Study||9
5295704|NCT00564902|13016916|P3|4 Months|Overall Study||23
5295705|NCT00564902|13016917|P2|4 Months|Overall Study||24
5295706|NCT00564902|13016918|P1|4 Months|Overall Study||9
5295707|NCT00564902|13016916|P3|STARTED|Overall Study||25
5295708|NCT00564902|13016917|P2|STARTED|Overall Study||25
5295709|NCT00564902|13016918|P1|STARTED|Overall Study||10
5295710|NCT00564889|13016950|P1|NOT COMPLETED|Overall Study||29
5295711|NCT00564889|13016950|P1|COMPLETED|Overall Study||6
5295712|NCT00564889|13016950|P1|STARTED|Overall Study||35
5295713|NCT00564876|13016958|P1|NOT COMPLETED|Overall Study||0
5295714|NCT00564876|13016958|P1|COMPLETED|Overall Study||2
5295715|NCT00564876|13016958|P1|STARTED|Overall Study||2
5295716|NCT00564850|13016965|P1|NOT COMPLETED|Overall Study||2
5295717|NCT00564850|13016965|P1|COMPLETED|Overall Study||35
5295718|NCT00564850|13016965|P1|STARTED|Overall Study||37
5295719|NCT00564733|13016983|P1|NOT COMPLETED|Overall Study||9
5295720|NCT00564733|13016983|P1|COMPLETED|Overall Study||46
5295721|NCT00564733|13016983|P1|STARTED|Overall Study||55
5295722|NCT00564681|13016991|P4|NOT COMPLETED|Overall Study||2
5295723|NCT00564681|13016992|P3|NOT COMPLETED|Overall Study||3
5295724|NCT00564681|13016993|P2|NOT COMPLETED|Overall Study||3
5295725|NCT00564681|13016994|P1|NOT COMPLETED|Overall Study||11
5295726|NCT00564681|13016991|P4|COMPLETED|Overall Study||19
5295727|NCT00564681|13016992|P3|COMPLETED|Overall Study||40
5295728|NCT00564681|13016993|P2|COMPLETED|Overall Study||58
5295729|NCT00564681|13016994|P1|COMPLETED|Overall Study||106
5295730|NCT00564681|13016991|P4|STARTED|Overall Study||21
5295731|NCT00564681|13016992|P3|STARTED|Overall Study||43
5295732|NCT00564681|13016993|P2|STARTED|Overall Study||61
5295733|NCT00564681|13016994|P1|STARTED|Overall Study||117
5295734|NCT00564629|13017017|P2|NOT COMPLETED|Overall Study||9
5295735|NCT00564629|13017018|P1|NOT COMPLETED|Overall Study||15
5295736|NCT00564629|13017017|P2|COMPLETED|Overall Study||45
5295737|NCT00564629|13017018|P1|COMPLETED|Overall Study||36
5295738|NCT00564629|13017017|P2|STARTED|Overall Study||54
5295739|NCT00564629|13017018|P1|STARTED|Overall Study||51
5295740|NCT00564486|13017043|P4|NOT COMPLETED|Overall Study||7
5295741|NCT00564486|13017044|P3|NOT COMPLETED|Overall Study||3
5295742|NCT00564486|13017045|P2|NOT COMPLETED|Overall Study||1
5295743|NCT00564486|13017046|P1|NOT COMPLETED|Overall Study||7
5295744|NCT00564486|13017043|P4|COMPLETED|Overall Study||60
5295745|NCT00564486|13017044|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
5295746|NCT00564486|13017045|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
5295747|NCT00564486|13017046|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
5295748|NCT00564486|13017043|P4|STARTED|Overall Study||67
5295749|NCT00564486|13017044|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
5295750|NCT00564486|13017045|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
5295751|NCT00564486|13017046|P1|STARTED|Overall Study||43
5295752|NCT00564447|13017070|P8|NOT COMPLETED|Overall Study||0
5295753|NCT00564447|13017071|P7|NOT COMPLETED|Overall Study||0
5295754|NCT00564447|13017072|P6|NOT COMPLETED|Overall Study||0
5295755|NCT00564447|13017073|P5|NOT COMPLETED|Overall Study||0
5295756|NCT00564447|13017074|P4|NOT COMPLETED|Overall Study||0
5295757|NCT00564447|13017075|P3|NOT COMPLETED|Overall Study||0
5295758|NCT00564447|13017076|P2|NOT COMPLETED|Overall Study||0
5295759|NCT00564447|13017077|P1|NOT COMPLETED|Overall Study||0
5295760|NCT00564447|13017070|P8|COMPLETED|Overall Study||6
5295761|NCT00564447|13017071|P7|COMPLETED|Overall Study||6
5295762|NCT00564447|13017072|P6|COMPLETED|Overall Study||6
5295763|NCT00564447|13017073|P5|COMPLETED|Overall Study||6
5295764|NCT00564447|13017074|P4|COMPLETED|Overall Study||6
5295765|NCT00564447|13017075|P3|COMPLETED|Overall Study||6
5295766|NCT00564447|13017076|P2|COMPLETED|Overall Study||6
5295767|NCT00564447|13017077|P1|COMPLETED|Overall Study||6
5295768|NCT00564447|13017070|P8|STARTED|Overall Study||6
5295769|NCT00564447|13017071|P7|STARTED|Overall Study||6
5295770|NCT00564447|13017072|P6|STARTED|Overall Study||6
5295771|NCT00564447|13017073|P5|STARTED|Overall Study||6
5295772|NCT00564447|13017074|P4|STARTED|Overall Study||6
5295773|NCT00564447|13017075|P3|STARTED|Overall Study||6
5295774|NCT00564447|13017076|P2|STARTED|Overall Study||6
5295775|NCT00564447|13017077|P1|STARTED|Overall Study||6
5295776|NCT00564395|13017095|P2|NOT COMPLETED|Second Intervention (10 Days)||0
5295777|NCT00564395|13017096|P1|NOT COMPLETED|Second Intervention (10 Days)||0
5295778|NCT00564395|13017095|P2|COMPLETED|Second Intervention (10 Days)||7
5295779|NCT00564395|13017096|P1|COMPLETED|Second Intervention (10 Days)||7
5295780|NCT00564395|13017095|P2|STARTED|Second Intervention (10 Days)||7
5295781|NCT00564395|13017096|P1|STARTED|Second Intervention (10 Days)||7
5295782|NCT00564395|13017095|P2|NOT COMPLETED|First Intervention (10 Days)||2
5295783|NCT00564395|13017096|P1|NOT COMPLETED|First Intervention (10 Days)||2
5295784|NCT00564395|13017095|P2|COMPLETED|First Intervention (10 Days)||7
5295785|NCT00564395|13017096|P1|COMPLETED|First Intervention (10 Days)||7
5295786|NCT00564395|13017095|P2|Received Intervention|First Intervention (10 Days)||7
5295787|NCT00564395|13017096|P1|Received Intervention|First Intervention (10 Days)||7
5295788|NCT00564395|13017095|P2|STARTED|First Intervention (10 Days)||9
5295789|NCT00564395|13017096|P1|STARTED|First Intervention (10 Days)||9
5295790|NCT00564278|13017104|P2|NOT COMPLETED|Overall Study||42
5295791|NCT00564278|13017105|P1|NOT COMPLETED|Overall Study||47
5295792|NCT00564278|13017104|P2|COMPLETED|Overall Study||56
5295793|NCT00564278|13017105|P1|COMPLETED|Overall Study||50
5295794|NCT00564278|13017104|P2|STARTED|Overall Study||98
5295795|NCT00564278|13017105|P1|STARTED|Overall Study||97
5295796|NCT00564265|13017121|P1|NOT COMPLETED|Overall Study||0
5295797|NCT00564265|13017121|P1|COMPLETED|Overall Study||24
5295798|NCT00564265|13017121|P1|STARTED|Overall Study||24
5295799|NCT00564070|13017127|P2|NOT COMPLETED|Overall Study||7
5295800|NCT00564070|13017128|P1|NOT COMPLETED|Overall Study||12
5295801|NCT00564070|13017127|P2|COMPLETED|Overall Study||38
5295802|NCT00564070|13017128|P1|COMPLETED|Overall Study||30
5295803|NCT00564070|13017127|P2|STARTED|Overall Study||45
5295804|NCT00564070|13017128|P1|STARTED|Overall Study||42
5295805|NCT00564018|13017155|P3|NOT COMPLETED|Overall Study||1
5295806|NCT00564018|13017156|P2|NOT COMPLETED|Overall Study||3
5295807|NCT00564018|13017157|P1|NOT COMPLETED|Overall Study||2
5295808|NCT00564018|13017155|P3|COMPLETED|Overall Study||11
5295809|NCT00564018|13017156|P2|COMPLETED|Overall Study||7
5295810|NCT00564018|13017157|P1|COMPLETED|Overall Study||9
5295811|NCT00564018|13017155|P3|STARTED|Overall Study||12
5295812|NCT00564018|13017156|P2|STARTED|Overall Study||10
5295813|NCT00564018|13017157|P1|STARTED|Overall Study||11
5295814|NCT00563797|13017170|P2|NOT COMPLETED|Overall Study||2
5295815|NCT00563797|13017171|P1|NOT COMPLETED|Overall Study||7
5295816|NCT00563797|13017170|P2|COMPLETED|Overall Study||8
5295817|NCT00563797|13017171|P1|COMPLETED|Overall Study||4
5295818|NCT00563797|13017170|P2|Follow-Up|Overall Study||10
5295819|NCT00563797|13017171|P1|Follow-Up|Overall Study||11
5295820|NCT00563797|13017170|P2|Received Allocated Intervention|Overall Study||10
5295821|NCT00563797|13017171|P1|Received Allocated Intervention|Overall Study||11
5295822|NCT00563797|13017170|P2|STARTED|Overall Study||10
5295823|NCT00563797|13017171|P1|STARTED|Overall Study||11
5295824|NCT00563784|13017183|P1|NOT COMPLETED|Overall Study||22
5295825|NCT00563784|13017183|P1|COMPLETED|Overall Study||46
5295826|NCT00563784|13017183|P1|STARTED|Overall Study||68
5295827|NCT00563706|13017197|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295828|NCT00563706|13017198|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295829|NCT00563706|13017199|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295830|NCT00563706|13017200|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295831|NCT00563706|13017201|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295832|NCT00563706|13017202|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295833|NCT00563706|13017203|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295834|NCT00563706|13017204|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295835|NCT00563706|13017205|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
5295836|NCT00563706|13017197|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
5295837|NCT00563706|13017198|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
5295838|NCT00563706|13017199|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
5295839|NCT00563706|13017200|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
5295840|NCT00563706|13017201|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
5295841|NCT00563706|13017202|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
5295842|NCT00563706|13017203|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
5295843|NCT00563706|13017204|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
5295844|NCT00563706|13017205|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
5295845|NCT00563706|13017197|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
5295846|NCT00563706|13017198|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
5295847|NCT00563706|13017199|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
5295848|NCT00563706|13017200|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
5295849|NCT00563706|13017201|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
5295850|NCT00563706|13017202|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
5295851|NCT00563706|13017203|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
5295852|NCT00563706|13017204|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
5295853|NCT00563706|13017205|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
5295854|NCT00563706|13017197|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
5295855|NCT00563706|13017198|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
5295856|NCT00563706|13017199|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
5295857|NCT00563706|13017200|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
5295858|NCT00563706|13017201|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
5295859|NCT00563706|13017202|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
5295860|NCT00563706|13017203|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
5295861|NCT00563706|13017204|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
5295862|NCT00563706|13017205|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
5295863|NCT00563706|13017197|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
5295864|NCT00563706|13017198|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
5295865|NCT00563706|13017199|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
5295866|NCT00563706|13017200|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
5295867|NCT00563706|13017201|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
5295868|NCT00563706|13017202|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
5295869|NCT00563706|13017203|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
5295870|NCT00563706|13017204|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
5295871|NCT00563706|13017205|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
5295872|NCT00563706|13017197|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
5295873|NCT00563706|13017198|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
5295874|NCT00563706|13017199|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
5295875|NCT00563706|13017200|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
5295876|NCT00563706|13017201|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
5295877|NCT00563706|13017202|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
5295878|NCT00563706|13017203|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
5295879|NCT00563706|13017204|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
5295880|NCT00563706|13017205|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
5295881|NCT00563576|13017308|P2|NOT COMPLETED|Overall Study||14
5295882|NCT00563576|13017309|P1|NOT COMPLETED|Overall Study||14
5295883|NCT00563576|13017308|P2|COMPLETED|Overall Study||22
5295884|NCT00563576|13017309|P1|COMPLETED|Overall Study||21
5295885|NCT00563576|13017308|P2|STARTED|Overall Study||36
5295886|NCT00563576|13017309|P1|STARTED|Overall Study||35
5295887|NCT00563381|13017323|P2|NOT COMPLETED|Overall Study||648
5295888|NCT00563381|13017324|P1|NOT COMPLETED|Overall Study||585
5295889|NCT00563381|13017323|P2|COMPLETED|Overall Study|Completed treatment|3021
5295890|NCT00563381|13017324|P1|COMPLETED|Overall Study|Completed treatment|3122
5295891|NCT00563381|13017323|P2|STARTED|Overall Study|Started treatment|3669
5295892|NCT00563381|13017324|P1|STARTED|Overall Study|Started treatment|3707
5295893|NCT00563368|13017397|P7|NOT COMPLETED|Overall Study||33
5295894|NCT00563368|13017398|P6|NOT COMPLETED|Overall Study||30
5295895|NCT00563368|13017399|P5|NOT COMPLETED|Overall Study||28
5295896|NCT00563368|13017400|P4|NOT COMPLETED|Overall Study||29
5295897|NCT00563368|13017401|P3|NOT COMPLETED|Overall Study||30
5295898|NCT00563368|13017402|P2|NOT COMPLETED|Overall Study||30
5295899|NCT00563368|13017403|P1|NOT COMPLETED|Overall Study||35
5295900|NCT00563368|13017397|P7|COMPLETED|Overall Study||75
5295901|NCT00563368|13017398|P6|COMPLETED|Overall Study||77
5295902|NCT00563368|13017399|P5|COMPLETED|Overall Study||80
5295903|NCT00563368|13017400|P4|COMPLETED|Overall Study||78
5295904|NCT00563368|13017401|P3|COMPLETED|Overall Study||78
5295905|NCT00563368|13017402|P2|COMPLETED|Overall Study||79
5295906|NCT00563368|13017403|P1|COMPLETED|Overall Study||74
5295907|NCT00563368|13017397|P7|STARTED|Overall Study||108
5295908|NCT00563368|13017398|P6|STARTED|Overall Study||107
5295909|NCT00563368|13017399|P5|STARTED|Overall Study||108
5295910|NCT00563368|13017400|P4|STARTED|Overall Study||107
5295911|NCT00563368|13017401|P3|STARTED|Overall Study||108
5295912|NCT00563368|13017402|P2|STARTED|Overall Study||109
5295913|NCT00563368|13017403|P1|STARTED|Overall Study||109
5295914|NCT00563316|13017426|P1|NOT COMPLETED|Overall Study||12
5295915|NCT00563316|13017426|P1|COMPLETED|Overall Study||16
5295916|NCT00563316|13017426|P1|Received Investigational Product|Overall Study||27
5295917|NCT00563316|13017426|P1|STARTED|Overall Study||28
5295918|NCT00563290|13017439|P2|NOT COMPLETED|Overall Study||0
5295919|NCT00563290|13017440|P1|NOT COMPLETED|Overall Study||0
5295920|NCT00563290|13017439|P2|COMPLETED|Overall Study||4
5295921|NCT00563290|13017440|P1|COMPLETED|Overall Study||3
5295922|NCT00563290|13017439|P2|STARTED|Overall Study||4
5295923|NCT00563290|13017440|P1|STARTED|Overall Study||3
5295924|NCT00563186|13017451|P2|NOT COMPLETED|Overall Study||75
5295925|NCT00563186|13017452|P1|NOT COMPLETED|Overall Study||98
5295926|NCT00563186|13017451|P2|COMPLETED|Overall Study||604
5295927|NCT00563186|13017452|P1|COMPLETED|Overall Study||910
5295928|NCT00563186|13017451|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
5295929|NCT00563186|13017452|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
5295930|NCT00562965|13017463|P2|NOT COMPLETED|Overall Study||6
5295931|NCT00562965|13017464|P1|NOT COMPLETED|Overall Study||3
5295932|NCT00562965|13017463|P2|COMPLETED|Overall Study||8
5295933|NCT00562965|13017464|P1|COMPLETED|Overall Study||12
5295934|NCT00562965|13017463|P2|Treated|Overall Study||13
5295935|NCT00562965|13017464|P1|Treated|Overall Study||15
5295936|NCT00562965|13017463|P2|STARTED|Overall Study||14
5295937|NCT00562965|13017464|P1|STARTED|Overall Study||15
5295938|NCT00562861|13017485|P2|NOT COMPLETED|Overall Study||11
5295939|NCT00562861|13017486|P1|NOT COMPLETED|Overall Study||20
5295940|NCT00562861|13017485|P2|COMPLETED|Overall Study||48
5295941|NCT00562861|13017486|P1|COMPLETED|Overall Study||40
5295942|NCT00562861|13017485|P2|STARTED|Overall Study||59
5295943|NCT00562861|13017486|P1|STARTED|Overall Study||60
5295944|NCT00562718|13017492|P1|NOT COMPLETED|Overall Study||11
5295945|NCT00562718|13017492|P1|COMPLETED|Overall Study||39
5295946|NCT00562718|13017492|P1|STARTED|Overall Study||50
5295947|NCT00562627|13017501|P3|NOT COMPLETED|Overall Study||1
5295948|NCT00562627|13017502|P2|NOT COMPLETED|Overall Study||1
5295949|NCT00562627|13017503|P1|NOT COMPLETED|Overall Study||1
5295950|NCT00562627|13017501|P3|COMPLETED|Overall Study||33
5295951|NCT00562627|13017502|P2|COMPLETED|Overall Study||33
5295952|NCT00562627|13017503|P1|COMPLETED|Overall Study||33
5295953|NCT00562627|13017501|P3|STARTED|Overall Study||34
5295954|NCT00562627|13017502|P2|STARTED|Overall Study||34
5295955|NCT00562627|13017503|P1|STARTED|Overall Study||34
5295956|NCT00562588|13017519|P2|NOT COMPLETED|Overall Study||99
5295957|NCT00562588|13017520|P1|NOT COMPLETED|Overall Study||92
5295958|NCT00562588|13017519|P2|COMPLETED|Overall Study||184
5295959|NCT00562588|13017520|P1|COMPLETED|Overall Study||168
5295960|NCT00562588|13017519|P2|STARTED|Overall Study||283
5295961|NCT00562588|13017520|P1|STARTED|Overall Study||260
5295962|NCT00562484|13017550|P2|NOT COMPLETED|Overall Study||104
5295963|NCT00562484|13017551|P1|NOT COMPLETED|Overall Study||206
5295964|NCT00562484|13017550|P2|COMPLETED|Overall Study||4907
5295965|NCT00562484|13017551|P1|COMPLETED|Overall Study||9827
5295966|NCT00562484|13017550|P2|STARTED|Overall Study||5011
5295967|NCT00562484|13017551|P1|STARTED|Overall Study||10033
5295968|NCT00562354|13017583|P2|NOT COMPLETED|Overall Study||2
5295969|NCT00562354|13017584|P1|NOT COMPLETED|Overall Study||0
5295970|NCT00562354|13017583|P2|COMPLETED|Overall Study||135
5295971|NCT00562354|13017584|P1|COMPLETED|Overall Study||134
5295972|NCT00562354|13017583|P2|Evaluable Immunogenicity Population|Overall Study||134
5295973|NCT00562354|13017584|P1|Evaluable Immunogenicity Population|Overall Study||134
5295974|NCT00562354|13017583|P2|Received Study Treatment|Overall Study||136
5295975|NCT00562354|13017584|P1|Received Study Treatment|Overall Study||134
5295976|NCT00562354|13017583|P2|STARTED|Overall Study||137
5295977|NCT00562354|13017584|P1|STARTED|Overall Study||134
5295978|NCT00562328|13017625|P1|NOT COMPLETED|Overall Study||0
5295979|NCT00562328|13017625|P1|COMPLETED|Overall Study||33
5295980|NCT00562328|13017625|P1|STARTED|Overall Study||33
5295981|NCT00562315|13017633|P1|NOT COMPLETED|Overall Study||0
5295982|NCT00562315|13017633|P1|COMPLETED|Overall Study||93
5295983|NCT00562315|13017633|P1|STARTED|Overall Study||93
5295984|NCT00562302|13017650|P2|NOT COMPLETED|Overall Study||32
5295985|NCT00562302|13017651|P1|NOT COMPLETED|Overall Study||20
5295986|NCT00562302|13017650|P2|COMPLETED|Overall Study||137
5295987|NCT00562302|13017651|P1|COMPLETED|Overall Study||150
5295988|NCT00562302|13017650|P2|STARTED|Overall Study||169
5295989|NCT00562302|13017651|P1|STARTED|Overall Study||170
5295990|NCT00562159|13017673|P2|NOT COMPLETED|Overall Study||33
5295991|NCT00562159|13017674|P1|NOT COMPLETED|Overall Study||38
5295992|NCT00562159|13017673|P2|COMPLETED|Overall Study||192
5295993|NCT00562159|13017674|P1|COMPLETED|Overall Study||175
5295994|NCT00562159|13017673|P2|STARTED|Overall Study||225
5295995|NCT00562159|13017674|P1|STARTED|Overall Study||213
5295996|NCT00562120|13017686|P4|NOT COMPLETED|Fourth Intervention Period||0
5295997|NCT00562120|13017687|P3|NOT COMPLETED|Fourth Intervention Period||0
5295998|NCT00562120|13017688|P2|NOT COMPLETED|Fourth Intervention Period||0
5295999|NCT00562120|13017689|P1|NOT COMPLETED|Fourth Intervention Period||0
5296000|NCT00562120|13017686|P4|COMPLETED|Fourth Intervention Period||5
5296001|NCT00562120|13017687|P3|COMPLETED|Fourth Intervention Period||5
5296002|NCT00562120|13017688|P2|COMPLETED|Fourth Intervention Period||5
5296003|NCT00562120|13017689|P1|COMPLETED|Fourth Intervention Period||4
5296004|NCT00562120|13017686|P4|STARTED|Fourth Intervention Period||5
5296005|NCT00562120|13017687|P3|STARTED|Fourth Intervention Period||5
5296006|NCT00562120|13017688|P2|STARTED|Fourth Intervention Period||5
5296007|NCT00562120|13017689|P1|STARTED|Fourth Intervention Period||4
5296008|NCT00562120|13017686|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
5296009|NCT00562120|13017687|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
5296010|NCT00562120|13017688|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
5296011|NCT00562120|13017689|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
5296012|NCT00562120|13017686|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
5296013|NCT00562120|13017687|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
5296014|NCT00562120|13017688|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
5296015|NCT00562120|13017689|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
5296016|NCT00562120|13017686|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
5296017|NCT00562120|13017687|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
5296018|NCT00562120|13017688|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
5296019|NCT00562120|13017689|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
5296020|NCT00562120|13017686|P4|NOT COMPLETED|Third Intervention Period||0
5296021|NCT00562120|13017687|P3|NOT COMPLETED|Third Intervention Period||0
5296022|NCT00562120|13017688|P2|NOT COMPLETED|Third Intervention Period||0
5296023|NCT00562120|13017689|P1|NOT COMPLETED|Third Intervention Period||0
5296024|NCT00562120|13017686|P4|COMPLETED|Third Intervention Period||5
5296025|NCT00562120|13017687|P3|COMPLETED|Third Intervention Period||5
5296026|NCT00562120|13017688|P2|COMPLETED|Third Intervention Period||5
5296027|NCT00562120|13017689|P1|COMPLETED|Third Intervention Period||4
5296028|NCT00562120|13017686|P4|STARTED|Third Intervention Period||5
5296029|NCT00562120|13017687|P3|STARTED|Third Intervention Period||5
5296030|NCT00562120|13017688|P2|STARTED|Third Intervention Period||5
5296031|NCT00562120|13017689|P1|STARTED|Third Intervention Period||4
5296032|NCT00562120|13017686|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
5296033|NCT00562120|13017687|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
5296034|NCT00562120|13017688|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
5296035|NCT00562120|13017689|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
5296036|NCT00562120|13017686|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
5296037|NCT00562120|13017687|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
5296038|NCT00562120|13017688|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
5296039|NCT00562120|13017689|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
5296040|NCT00562120|13017686|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
5296041|NCT00562120|13017687|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
5296042|NCT00562120|13017688|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
5296043|NCT00562120|13017689|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
5296044|NCT00562120|13017686|P4|NOT COMPLETED|Second Intervention Period||0
5296045|NCT00562120|13017687|P3|NOT COMPLETED|Second Intervention Period||0
5296046|NCT00562120|13017688|P2|NOT COMPLETED|Second Intervention Period||0
5296047|NCT00562120|13017689|P1|NOT COMPLETED|Second Intervention Period||0
5296048|NCT00562120|13017686|P4|COMPLETED|Second Intervention Period||5
5296049|NCT00562120|13017687|P3|COMPLETED|Second Intervention Period||5
5296050|NCT00562120|13017688|P2|COMPLETED|Second Intervention Period||5
5296051|NCT00562120|13017689|P1|COMPLETED|Second Intervention Period||4
5296052|NCT00562120|13017686|P4|STARTED|Second Intervention Period||5
5296053|NCT00562120|13017687|P3|STARTED|Second Intervention Period||5
5296054|NCT00562120|13017688|P2|STARTED|Second Intervention Period||5
5296055|NCT00562120|13017689|P1|STARTED|Second Intervention Period||4
5296056|NCT00562120|13017686|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
5296057|NCT00562120|13017687|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
5296058|NCT00562120|13017688|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
5296059|NCT00562120|13017689|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
5296060|NCT00562120|13017686|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
5296061|NCT00562120|13017687|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
5296062|NCT00562120|13017688|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
5296063|NCT00562120|13017689|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
5296064|NCT00562120|13017686|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
5296065|NCT00562120|13017687|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
5296066|NCT00562120|13017688|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
5296067|NCT00562120|13017689|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
5296068|NCT00562120|13017686|P4|NOT COMPLETED|First Intervention Period||0
5296069|NCT00562120|13017687|P3|NOT COMPLETED|First Intervention Period||0
5296070|NCT00562120|13017688|P2|NOT COMPLETED|First Intervention Period||0
5296071|NCT00562120|13017689|P1|NOT COMPLETED|First Intervention Period||2
5296072|NCT00562120|13017686|P4|COMPLETED|First Intervention Period||5
5296073|NCT00562120|13017687|P3|COMPLETED|First Intervention Period||5
5296074|NCT00562120|13017688|P2|COMPLETED|First Intervention Period||5
5296075|NCT00562120|13017689|P1|COMPLETED|First Intervention Period||4
5296076|NCT00562120|13017686|P4|Treated|First Intervention Period||5
5296077|NCT00562120|13017687|P3|Treated|First Intervention Period||5
5296078|NCT00562120|13017688|P2|Treated|First Intervention Period||5
5296079|NCT00562120|13017689|P1|Treated|First Intervention Period||5
5296080|NCT00562120|13017686|P4|STARTED|First Intervention Period||5
5296081|NCT00562120|13017687|P3|STARTED|First Intervention Period||5
5296082|NCT00562120|13017688|P2|STARTED|First Intervention Period||5
5296083|NCT00562120|13017689|P1|STARTED|First Intervention Period||6
5296084|NCT00562094|13017721|P1|NOT COMPLETED|Overall Study||62
5296085|NCT00562094|13017721|P1|COMPLETED|Overall Study||8554
5296086|NCT00562094|13017721|P1|STARTED|Overall Study||8616
5296087|NCT00561977|13017736|P3|NOT COMPLETED|Overall Study||2
5296088|NCT00561977|13017737|P2|NOT COMPLETED|Overall Study||3
5296089|NCT00561977|13017738|P1|NOT COMPLETED|Overall Study||0
5296090|NCT00561977|13017736|P3|COMPLETED|Overall Study||10
5296091|NCT00561977|13017737|P2|COMPLETED|Overall Study||9
5296092|NCT00561977|13017738|P1|COMPLETED|Overall Study||12
5296093|NCT00561977|13017736|P3|STARTED|Overall Study||12
5296094|NCT00561977|13017737|P2|STARTED|Overall Study||12
5296095|NCT00561977|13017738|P1|STARTED|Overall Study||12
5296096|NCT00561951|13017764|P3|NOT COMPLETED|Overall Study||32
5296097|NCT00561951|13017765|P2|NOT COMPLETED|Overall Study||34
5296098|NCT00561951|13017766|P1|NOT COMPLETED|Overall Study||33
5296099|NCT00561951|13017764|P3|COMPLETED|Overall Study||281
5296100|NCT00561951|13017765|P2|COMPLETED|Overall Study||286
5296101|NCT00561951|13017766|P1|COMPLETED|Overall Study||285
5296102|NCT00561951|13017764|P3|STARTED|Overall Study||313
5296103|NCT00561951|13017765|P2|STARTED|Overall Study||320
5296104|NCT00561951|13017766|P1|STARTED|Overall Study||318
5296105|NCT00561925|13017822|P5|NOT COMPLETED|Open-Label Extension Period||50
5296106|NCT00561925|13017823|P4|NOT COMPLETED|Open-Label Extension Period||43
5296107|NCT00561925|13017824|P3|NOT COMPLETED|Open-Label Extension Period||0
5296108|NCT00561925|13017825|P2|NOT COMPLETED|Open-Label Extension Period||0
5296109|NCT00561925|13017826|P1|NOT COMPLETED|Open-Label Extension Period||0
5296110|NCT00561925|13017822|P5|COMPLETED|Open-Label Extension Period||328
5296111|NCT00561925|13017823|P4|COMPLETED|Open-Label Extension Period||315
5296112|NCT00561925|13017824|P3|COMPLETED|Open-Label Extension Period||0
5296113|NCT00561925|13017825|P2|COMPLETED|Open-Label Extension Period||1
5296114|NCT00561925|13017826|P1|COMPLETED|Open-Label Extension Period||0
5296115|NCT00561925|13017822|P5|STARTED|Open-Label Extension Period||378
5296116|NCT00561925|13017823|P4|STARTED|Open-Label Extension Period||358
5296117|NCT00561925|13017824|P3|STARTED|Open-Label Extension Period||0
5296118|NCT00561925|13017825|P2|STARTED|Open-Label Extension Period||1
5296119|NCT00561925|13017826|P1|STARTED|Open-Label Extension Period||0
5296120|NCT00561925|13017822|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
5296121|NCT00561925|13017823|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
5296122|NCT00561925|13017824|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
5296123|NCT00561925|13017825|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
5296124|NCT00561925|13017826|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
5296125|NCT00561925|13017822|P5|COMPLETED|144-week Double-blind, Double-dummy||0
5296126|NCT00561925|13017823|P4|COMPLETED|144-week Double-blind, Double-dummy||0
5296127|NCT00561925|13017824|P3|COMPLETED|144-week Double-blind, Double-dummy||378
5296128|NCT00561925|13017825|P2|COMPLETED|144-week Double-blind, Double-dummy||358
5296129|NCT00561925|13017826|P1|COMPLETED|144-week Double-blind, Double-dummy||0
5296130|NCT00561925|13017822|P5|STARTED|144-week Double-blind, Double-dummy||0
5296131|NCT00561925|13017823|P4|STARTED|144-week Double-blind, Double-dummy||0
5296132|NCT00561925|13017824|P3|STARTED|144-week Double-blind, Double-dummy||505
5296133|NCT00561925|13017825|P2|STARTED|144-week Double-blind, Double-dummy||508
5296134|NCT00561925|13017826|P1|STARTED|144-week Double-blind, Double-dummy||0
5296135|NCT00561925|13017822|P5|NOT COMPLETED|14 Day Lead-In Period||0
5296136|NCT00561925|13017823|P4|NOT COMPLETED|14 Day Lead-In Period||0
5296137|NCT00561925|13017824|P3|NOT COMPLETED|14 Day Lead-In Period||0
5296138|NCT00561925|13017825|P2|NOT COMPLETED|14 Day Lead-In Period||0
5296139|NCT00561925|13017826|P1|NOT COMPLETED|14 Day Lead-In Period||55
5296140|NCT00561925|13017822|P5|COMPLETED|14 Day Lead-In Period||0
5296141|NCT00561925|13017823|P4|COMPLETED|14 Day Lead-In Period||0
5296142|NCT00561925|13017824|P3|COMPLETED|14 Day Lead-In Period||0
5296143|NCT00561925|13017825|P2|COMPLETED|14 Day Lead-In Period||0
5296144|NCT00561925|13017826|P1|COMPLETED|14 Day Lead-In Period||1013
5296145|NCT00561925|13017822|P5|STARTED|14 Day Lead-In Period||0
5296146|NCT00561925|13017823|P4|STARTED|14 Day Lead-In Period||0
5296147|NCT00561925|13017824|P3|STARTED|14 Day Lead-In Period||0
5296148|NCT00561925|13017825|P2|STARTED|14 Day Lead-In Period||0
5296149|NCT00561925|13017826|P1|STARTED|14 Day Lead-In Period||1068
5296150|NCT00561912|13017875|P1|NOT COMPLETED|Overall Study||1
5296151|NCT00561912|13017875|P1|COMPLETED|Overall Study||1
5296152|NCT00561912|13017875|P1|STARTED|Overall Study||2
5296153|NCT00561834|13017879|P1|NOT COMPLETED|Overall Study||0
5296154|NCT00561834|13017879|P1|COMPLETED|Overall Study||2
5296155|NCT00561834|13017879|P1|STARTED|Overall Study||2
5296156|NCT00561821|13017887|P4|NOT COMPLETED|Overall Study||3
5296157|NCT00561821|13017888|P3|NOT COMPLETED|Overall Study||2
5296158|NCT00561821|13017889|P2|NOT COMPLETED|Overall Study||6
5296159|NCT00561821|13017890|P1|NOT COMPLETED|Overall Study||5
5296160|NCT00561821|13017887|P4|COMPLETED|Overall Study||133
5296161|NCT00561821|13017888|P3|COMPLETED|Overall Study||132
5296162|NCT00561821|13017889|P2|COMPLETED|Overall Study||130
5296163|NCT00561821|13017890|P1|COMPLETED|Overall Study||127
5296164|NCT00561821|13017887|P4|Treated|Overall Study||136
5296165|NCT00561821|13017888|P3|Treated|Overall Study||133
5296166|NCT00561821|13017889|P2|Treated|Overall Study||136
5296167|NCT00561821|13017890|P1|Treated|Overall Study||132
5296168|NCT00561821|13017887|P4|STARTED|Overall Study||136
5296169|NCT00561821|13017888|P3|STARTED|Overall Study||134
5296170|NCT00561821|13017889|P2|STARTED|Overall Study||136
5296171|NCT00561821|13017890|P1|STARTED|Overall Study||132
5296172|NCT00561795|13017966|P4|NOT COMPLETED|Overall Study||0
5296173|NCT00561795|13017967|P3|NOT COMPLETED|Overall Study||0
5296174|NCT00561795|13017968|P2|NOT COMPLETED|Overall Study||6
5296175|NCT00561795|13017969|P1|NOT COMPLETED|Overall Study||4
5296176|NCT00561795|13017966|P4|COMPLETED|Overall Study||0
5296177|NCT00561795|13017967|P3|COMPLETED|Overall Study||0
5296178|NCT00561795|13017968|P2|COMPLETED|Overall Study||0
5296179|NCT00561795|13017969|P1|COMPLETED|Overall Study||2
5296180|NCT00561795|13017966|P4|STARTED|Overall Study||0
5296181|NCT00561795|13017967|P3|STARTED|Overall Study||0
5296182|NCT00561795|13017968|P2|STARTED|Overall Study||6
5296183|NCT00561795|13017969|P1|STARTED|Overall Study||6
5296184|NCT00561730|13017989|P1|NOT COMPLETED|Overall Study||9
5296185|NCT00561730|13017989|P1|COMPLETED|Overall Study||1986
5296186|NCT00561730|13017989|P1|STARTED|Overall Study||1995
5296187|NCT00561678|13018005|P2|NOT COMPLETED|Overall Study||6
5296188|NCT00561678|13018006|P1|NOT COMPLETED|Overall Study||8
5296189|NCT00561678|13018005|P2|COMPLETED|Overall Study||201
5296190|NCT00561678|13018006|P1|COMPLETED|Overall Study||189
5296191|NCT00561678|13018005|P2|STARTED|Overall Study||207
5296192|NCT00561678|13018006|P1|STARTED|Overall Study||197
5296193|NCT00561652|13018024|P2|NOT COMPLETED|Overall Study||1
5296194|NCT00561652|13018025|P1|NOT COMPLETED|Overall Study||0
5296195|NCT00561652|13018024|P2|COMPLETED|Overall Study||19
5296196|NCT00561652|13018025|P1|COMPLETED|Overall Study||10
5296197|NCT00561652|13018024|P2|STARTED|Overall Study||20
5296198|NCT00561652|13018025|P1|STARTED|Overall Study||10
5296199|NCT00561600|13018045|P2|NOT COMPLETED|Overall Study||16
5296200|NCT00561600|13018046|P1|NOT COMPLETED|Overall Study||18
5296201|NCT00561600|13018045|P2|COMPLETED|Overall Study||119
5296202|NCT00561600|13018046|P1|COMPLETED|Overall Study||112
5296203|NCT00561600|13018045|P2|STARTED|Overall Study||135
5296204|NCT00561600|13018046|P1|STARTED|Overall Study||130
5296205|NCT00561574|13018108|P2|NOT COMPLETED|Overall Study||58
5296206|NCT00561574|13018109|P1|NOT COMPLETED|Overall Study||48
5296207|NCT00561574|13018108|P2|COMPLETED|Overall Study||73
5296208|NCT00561574|13018109|P1|COMPLETED|Overall Study||80
5296209|NCT00561574|13018108|P2|STARTED|Overall Study||131
5296210|NCT00561574|13018109|P1|STARTED|Overall Study||128
5296211|NCT00561470|13018135|P2|NOT COMPLETED|Overall Study||612
5296212|NCT00561470|13018136|P1|NOT COMPLETED|Overall Study||614
5296213|NCT00561470|13018135|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
5296214|NCT00561470|13018136|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
5296215|NCT00561470|13018135|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
5296216|NCT00561470|13018136|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
5296217|NCT00561470|13018135|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
5296218|NCT00561470|13018136|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
5296219|NCT00561470|13018135|P2|TREATED|Overall Study||607
5296220|NCT00561470|13018136|P1|TREATED|Overall Study||609
5296221|NCT00561470|13018135|P2|STARTED|Overall Study||612
5296222|NCT00561470|13018136|P1|STARTED|Overall Study||614
5296223|NCT00561457|13018150|P1|NOT COMPLETED|Overall Study||24
5296224|NCT00561457|13018150|P1|COMPLETED|Overall Study||110
5296225|NCT00561457|13018150|P1|STARTED|Overall Study||134
5296226|NCT00561431|13018156|P2|NOT COMPLETED|Overall Study||0
5296227|NCT00561431|13018157|P1|NOT COMPLETED|Overall Study||0
5296228|NCT00561431|13018156|P2|COMPLETED|Overall Study||100
5296229|NCT00561431|13018157|P1|COMPLETED|Overall Study||100
5296230|NCT00561431|13018156|P2|STARTED|Overall Study||100
5296231|NCT00561431|13018157|P1|STARTED|Overall Study||100
5296232|NCT00561418|13018165|P1|NOT COMPLETED|Overall Study||0
5296233|NCT00561418|13018165|P1|COMPLETED|Overall Study||23
5296234|NCT00561418|13018165|P1|STARTED|Overall Study||23
5296235|NCT00561392|13018172|P1|NOT COMPLETED|Overall Study||53
5296236|NCT00561392|13018172|P1|COMPLETED|Overall Study||155
5296237|NCT00561392|13018172|P1|STARTED|Overall Study||208
5296238|NCT00561353|13018194|P10|NOT COMPLETED|Overall Study||2
5296239|NCT00561353|13018195|P9|NOT COMPLETED|Overall Study||7
5296240|NCT00561353|13018196|P8|NOT COMPLETED|Overall Study||4
5296241|NCT00561353|13018197|P7|NOT COMPLETED|Overall Study||6
5296242|NCT00561353|13018198|P6|NOT COMPLETED|Overall Study||6
5296243|NCT00561353|13018199|P5|NOT COMPLETED|Overall Study||1
5296244|NCT00561353|13018200|P4|NOT COMPLETED|Overall Study||6
5296245|NCT00561353|13018201|P3|NOT COMPLETED|Overall Study||3
5296246|NCT00561353|13018202|P2|NOT COMPLETED|Overall Study||3
5296247|NCT00561353|13018203|P1|NOT COMPLETED|Overall Study||5
5296248|NCT00561353|13018194|P10|COMPLETED|Overall Study||3
5296249|NCT00561353|13018195|P9|COMPLETED|Overall Study||2
5296250|NCT00561353|13018196|P8|COMPLETED|Overall Study||6
5296251|NCT00561353|13018197|P7|COMPLETED|Overall Study||3
5296252|NCT00561353|13018198|P6|COMPLETED|Overall Study||3
5296253|NCT00561353|13018199|P5|COMPLETED|Overall Study||5
5296254|NCT00561353|13018200|P4|COMPLETED|Overall Study||12
5296255|NCT00561353|13018201|P3|COMPLETED|Overall Study||10
5296256|NCT00561353|13018202|P2|COMPLETED|Overall Study||16
5296257|NCT00561353|13018203|P1|COMPLETED|Overall Study||13
5296258|NCT00561353|13018194|P10|STARTED|Overall Study||5
5296259|NCT00561353|13018195|P9|STARTED|Overall Study||9
5296260|NCT00561353|13018196|P8|STARTED|Overall Study||10
5296261|NCT00561353|13018197|P7|STARTED|Overall Study||9
5296262|NCT00561353|13018198|P6|STARTED|Overall Study||9
5296263|NCT00561353|13018199|P5|STARTED|Overall Study||6
5296264|NCT00561353|13018200|P4|STARTED|Overall Study||18
5296265|NCT00561353|13018201|P3|STARTED|Overall Study||13
5296266|NCT00561353|13018202|P2|STARTED|Overall Study||19
5296267|NCT00561353|13018203|P1|STARTED|Overall Study||18
5296268|NCT00561340|13018358|P2|NOT COMPLETED|Overall Study||0
5296269|NCT00561340|13018359|P1|NOT COMPLETED|Overall Study||6
5296270|NCT00561340|13018358|P2|COMPLETED|Overall Study||16
5296271|NCT00561340|13018359|P1|COMPLETED|Overall Study||7
5296272|NCT00561340|13018358|P2|STARTED|Overall Study||16
5296273|NCT00561340|13018359|P1|STARTED|Overall Study||13
5296274|NCT00561145|13018369|P2|NOT COMPLETED|Overall Study||0
5296275|NCT00561145|13018370|P1|NOT COMPLETED|Overall Study||0
5296276|NCT00561145|13018369|P2|COMPLETED|Overall Study||17
5296277|NCT00561145|13018370|P1|COMPLETED|Overall Study||15
5296278|NCT00561145|13018369|P2|STARTED|Overall Study||17
5296279|NCT00561145|13018370|P1|STARTED|Overall Study||15
5296280|NCT00561080|13018379|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
5296281|NCT00561080|13018380|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
5296282|NCT00561080|13018381|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
5296283|NCT00561080|13018379|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
5296284|NCT00561080|13018380|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
5296285|NCT00561080|13018381|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
5296286|NCT00561080|13018379|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296287|NCT00561080|13018380|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296288|NCT00561080|13018381|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296289|NCT00561080|13018379|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
5296290|NCT00561080|13018380|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
5296291|NCT00561080|13018381|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
5296292|NCT00561080|13018379|P3|COMPLETED|24-month Post Last Dose Follow-up||0
5296293|NCT00561080|13018380|P2|COMPLETED|24-month Post Last Dose Follow-up||0
5296294|NCT00561080|13018381|P1|COMPLETED|24-month Post Last Dose Follow-up||0
5296295|NCT00561080|13018379|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296296|NCT00561080|13018380|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296297|NCT00561080|13018381|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
5296298|NCT00561080|13018379|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
5296299|NCT00561080|13018380|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
5296300|NCT00561080|13018381|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
5296301|NCT00561080|13018379|P3|COMPLETED|12-month Post Last Dose Follow-up||215
5296302|NCT00561080|13018380|P2|COMPLETED|12-month Post Last Dose Follow-up||220
5296303|NCT00561080|13018381|P1|COMPLETED|12-month Post Last Dose Follow-up||243
5296304|NCT00561080|13018379|P3|STARTED|12-month Post Last Dose Follow-up||225
5296305|NCT00561080|13018380|P2|STARTED|12-month Post Last Dose Follow-up||229
5296306|NCT00561080|13018381|P1|STARTED|12-month Post Last Dose Follow-up||250
5296307|NCT00561080|13018379|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
5296308|NCT00561080|13018380|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
5296309|NCT00561080|13018381|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
5296310|NCT00561080|13018379|P3|COMPLETED|Vaccination Period (up to Month 4)||225
5296311|NCT00561080|13018380|P2|COMPLETED|Vaccination Period (up to Month 4)||229
5296312|NCT00561080|13018381|P1|COMPLETED|Vaccination Period (up to Month 4)||250
5296313|NCT00561080|13018379|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
5296314|NCT00561080|13018380|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
5296315|NCT00561080|13018381|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
5296316|NCT00561080|13018379|P3|STARTED|Vaccination Period (up to Month 4)||251
5296317|NCT00561080|13018380|P2|STARTED|Vaccination Period (up to Month 4)||255
5296318|NCT00561080|13018381|P1|STARTED|Vaccination Period (up to Month 4)||253
5296319|NCT00561015|13018458|P6|NOT COMPLETED|Overall Study||3
5296320|NCT00561015|13018459|P5|NOT COMPLETED|Overall Study||1
5296321|NCT00561015|13018460|P4|NOT COMPLETED|Overall Study||1
5296322|NCT00561015|13018461|P3|NOT COMPLETED|Overall Study||0
5296323|NCT00561015|13018462|P2|NOT COMPLETED|Overall Study||0
5296324|NCT00561015|13018463|P1|NOT COMPLETED|Overall Study||4
5296325|NCT00561015|13018458|P6|COMPLETED|Overall Study||6
5296326|NCT00561015|13018459|P5|COMPLETED|Overall Study||8
5296327|NCT00561015|13018460|P4|COMPLETED|Overall Study||7
5296328|NCT00561015|13018461|P3|COMPLETED|Overall Study||9
5296329|NCT00561015|13018462|P2|COMPLETED|Overall Study||5
5296330|NCT00561015|13018463|P1|COMPLETED|Overall Study||5
5296331|NCT00561015|13018458|P6|STARTED|Overall Study||9
5296332|NCT00561015|13018459|P5|STARTED|Overall Study||9
5296333|NCT00561015|13018460|P4|STARTED|Overall Study||8
5296334|NCT00561015|13018461|P3|STARTED|Overall Study||9
5296335|NCT00561015|13018462|P2|STARTED|Overall Study||5
5296336|NCT00561015|13018463|P1|STARTED|Overall Study||9
5296337|NCT00561002|13018539|P2|NOT COMPLETED|Overall Study||0
5296338|NCT00561002|13018540|P1|NOT COMPLETED|Overall Study||0
5296339|NCT00561002|13018539|P2|COMPLETED|Overall Study||9
5296340|NCT00561002|13018540|P1|COMPLETED|Overall Study||23
5296341|NCT00561002|13018539|P2|STARTED|Overall Study||9
5296342|NCT00561002|13018540|P1|STARTED|Overall Study||23
5296343|NCT00560950|13018554|P2|NOT COMPLETED|Overall Study||0
5296344|NCT00560950|13018555|P1|NOT COMPLETED|Overall Study||1
5296345|NCT00560950|13018554|P2|COMPLETED|Overall Study||71
5296346|NCT00560950|13018555|P1|COMPLETED|Overall Study||71
5296347|NCT00560950|13018554|P2|STARTED|Overall Study||71
5296348|NCT00560950|13018555|P1|STARTED|Overall Study||72
5296349|NCT00560937|13018593|P2|NOT COMPLETED|Overall Study||2
5296350|NCT00560937|13018594|P1|NOT COMPLETED|Overall Study||1
5296351|NCT00560937|13018593|P2|COMPLETED|Overall Study||9
5296441|NCT00560508|13018815|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
5296352|NCT00560937|13018594|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
5296353|NCT00560937|13018593|P2|STARTED|Overall Study||11
5296354|NCT00560937|13018594|P1|STARTED|Overall Study||10
5296355|NCT00560885|13018610|P1|NOT COMPLETED|Overall Study||8
5296356|NCT00560885|13018610|P1|COMPLETED|Overall Study||47
5296357|NCT00560885|13018610|P1|2 Year Follow-up|Overall Study||47
5296358|NCT00560885|13018610|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
5296359|NCT00560885|13018610|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
5296360|NCT00560885|13018610|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
5296361|NCT00560885|13018610|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
5296362|NCT00560885|13018610|P1|STARTED|Overall Study||55
5296363|NCT00560859|13018619|P2|NOT COMPLETED|Overall Study||24
5296364|NCT00560859|13018620|P1|NOT COMPLETED|Overall Study||32
5296365|NCT00560859|13018619|P2|COMPLETED|Overall Study||203
5296366|NCT00560859|13018620|P1|COMPLETED|Overall Study||194
5296367|NCT00560859|13018619|P2|STARTED|Overall Study||227
5296368|NCT00560859|13018620|P1|STARTED|Overall Study||226
5296369|NCT00560833|13018635|P5|NOT COMPLETED|Overall Study||42
5296370|NCT00560833|13018636|P4|NOT COMPLETED|Overall Study||31
5296371|NCT00560833|13018637|P3|NOT COMPLETED|Overall Study||39
5296372|NCT00560833|13018638|P2|NOT COMPLETED|Overall Study||26
5296373|NCT00560833|13018639|P1|NOT COMPLETED|Overall Study||44
5296374|NCT00560833|13018635|P5|COMPLETED|Overall Study||114
5296375|NCT00560833|13018636|P4|COMPLETED|Overall Study||124
5296376|NCT00560833|13018637|P3|COMPLETED|Overall Study||121
5296377|NCT00560833|13018638|P2|COMPLETED|Overall Study||129
5296378|NCT00560833|13018639|P1|COMPLETED|Overall Study||273
5296379|NCT00560833|13018635|P5|Treated|Overall Study|One participant was randomized but not treated|155
5296380|NCT00560833|13018636|P4|Treated|Overall Study||155
5296381|NCT00560833|13018637|P3|Treated|Overall Study||160
5296382|NCT00560833|13018638|P2|Treated|Overall Study|One participant was randomized but not treated|154
5296383|NCT00560833|13018639|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
5296384|NCT00560833|13018635|P5|STARTED|Overall Study||156
5296385|NCT00560833|13018636|P4|STARTED|Overall Study||155
5296386|NCT00560833|13018637|P3|STARTED|Overall Study||160
5296387|NCT00560833|13018638|P2|STARTED|Overall Study||155
5296388|NCT00560833|13018639|P1|STARTED|Overall Study||317
5296389|NCT00560794|13018671|P1|NOT COMPLETED|Overall Study||11
5296390|NCT00560794|13018671|P1|COMPLETED|Overall Study||10
5296391|NCT00560794|13018671|P1|Completed 1 Treatment Cycle|Overall Study||20
5296392|NCT00560794|13018671|P1|STARTED|Overall Study||21
5296393|NCT00560755|13018688|P1|NOT COMPLETED|Overall Study||60
5296394|NCT00560755|13018688|P1|COMPLETED|Overall Study||3328
5296395|NCT00560755|13018688|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
5296396|NCT00560755|13018688|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
5296397|NCT00560703|13018709|P2|NOT COMPLETED|Overall Study||6
5296398|NCT00560703|13018710|P1|NOT COMPLETED|Overall Study||0
5296399|NCT00560703|13018709|P2|COMPLETED|Overall Study||18
5296400|NCT00560703|13018710|P1|COMPLETED|Overall Study||46
5296401|NCT00560703|13018709|P2|STARTED|Overall Study||24
5296402|NCT00560703|13018710|P1|STARTED|Overall Study||46
5296403|NCT00560612|13018720|P2|NOT COMPLETED|Overall Study||0
5296404|NCT00560612|13018721|P1|NOT COMPLETED|Overall Study||0
5296405|NCT00560612|13018720|P2|COMPLETED|Overall Study||7
5296406|NCT00560612|13018721|P1|COMPLETED|Overall Study||5
5296407|NCT00560612|13018720|P2|STARTED|Overall Study||7
5296408|NCT00560612|13018721|P1|STARTED|Overall Study||5
5296409|NCT00560573|13018733|P6|NOT COMPLETED|Overall Study||13
5296410|NCT00560573|13018734|P5|NOT COMPLETED|Overall Study||7
5296411|NCT00560573|13018735|P4|NOT COMPLETED|Overall Study||10
5296412|NCT00560573|13018736|P3|NOT COMPLETED|Overall Study||6
5296413|NCT00560573|13018737|P2|NOT COMPLETED|Overall Study||3
5296414|NCT00560573|13018738|P1|NOT COMPLETED|Overall Study||6
5296415|NCT00560573|13018733|P6|COMPLETED|Overall Study||0
5296416|NCT00560573|13018734|P5|COMPLETED|Overall Study||1
5296417|NCT00560573|13018735|P4|COMPLETED|Overall Study||0
5296418|NCT00560573|13018736|P3|COMPLETED|Overall Study||0
5296419|NCT00560573|13018737|P2|COMPLETED|Overall Study||0
5296420|NCT00560573|13018738|P1|COMPLETED|Overall Study||0
5296421|NCT00560573|13018733|P6|Treated|Overall Study||13
5296422|NCT00560573|13018734|P5|Treated|Overall Study||7
5296423|NCT00560573|13018735|P4|Treated|Overall Study||10
5296424|NCT00560573|13018736|P3|Treated|Overall Study||6
5296425|NCT00560573|13018737|P2|Treated|Overall Study||3
5296426|NCT00560573|13018738|P1|Treated|Overall Study||6
5296427|NCT00560573|13018733|P6|STARTED|Overall Study||13
5296428|NCT00560573|13018734|P5|STARTED|Overall Study||8
5296429|NCT00560573|13018735|P4|STARTED|Overall Study||10
5296430|NCT00560573|13018736|P3|STARTED|Overall Study||6
5296431|NCT00560573|13018737|P2|STARTED|Overall Study||3
5296432|NCT00560573|13018738|P1|STARTED|Overall Study||6
5296433|NCT00560560|13018792|P2|NOT COMPLETED|Overall Study||83
5296434|NCT00560560|13018793|P1|NOT COMPLETED|Overall Study||85
5296435|NCT00560560|13018792|P2|COMPLETED|Overall Study||0
5296436|NCT00560560|13018793|P1|COMPLETED|Overall Study||0
5296437|NCT00560560|13018792|P2|STARTED|Overall Study||83
5296438|NCT00560560|13018793|P1|STARTED|Overall Study||85
5296439|NCT00560508|13018815|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
5296440|NCT00560508|13018816|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
5299099|NCT00546273|13026615|P3|STARTED|II||0
5296442|NCT00560508|13018816|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
5296443|NCT00560508|13018815|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
5296444|NCT00560508|13018816|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
5296445|NCT00560508|13018815|P2|NOT COMPLETED|12 Week Double-blind Period||3
5296446|NCT00560508|13018816|P1|NOT COMPLETED|12 Week Double-blind Period||5
5296447|NCT00560508|13018815|P2|COMPLETED|12 Week Double-blind Period||53
5296448|NCT00560508|13018816|P1|COMPLETED|12 Week Double-blind Period||51
5296449|NCT00560508|13018815|P2|STARTED|12 Week Double-blind Period||56
5296450|NCT00560508|13018816|P1|STARTED|12 Week Double-blind Period||56
5296451|NCT00560417|13018875|P2|NOT COMPLETED|Overall Study||17
5296452|NCT00560417|13018876|P1|NOT COMPLETED|Overall Study||17
5296453|NCT00560417|13018875|P2|COMPLETED|Overall Study||151
5296454|NCT00560417|13018876|P1|COMPLETED|Overall Study||154
5296455|NCT00560417|13018875|P2|Intention to Treat (ITT) Population|Overall Study||167
5296456|NCT00560417|13018876|P1|Intention to Treat (ITT) Population|Overall Study||170
5296457|NCT00560417|13018875|P2|STARTED|Overall Study||168
5296458|NCT00560417|13018876|P1|STARTED|Overall Study||171
5296459|NCT00560404|13018904|P2|NOT COMPLETED|Overall Study||21
5296460|NCT00560404|13018905|P1|NOT COMPLETED|Overall Study||36
5296461|NCT00560404|13018904|P2|COMPLETED|Overall Study||100
5296462|NCT00560404|13018905|P1|COMPLETED|Overall Study||76
5296463|NCT00560404|13018904|P2|STARTED|Overall Study||121
5296464|NCT00560404|13018905|P1|STARTED|Overall Study||112
5296465|NCT00560391|13018952|P5|NOT COMPLETED|Overall Study||2
5296466|NCT00560391|13018953|P4|NOT COMPLETED|Overall Study||1
5296467|NCT00560391|13018954|P3|NOT COMPLETED|Overall Study||0
5296468|NCT00560391|13018955|P2|NOT COMPLETED|Overall Study||0
5296469|NCT00560391|13018956|P1|NOT COMPLETED|Overall Study||0
5296470|NCT00560391|13018952|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
5296471|NCT00560391|13018953|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
5296472|NCT00560391|13018954|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
5296473|NCT00560391|13018955|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
5296474|NCT00560391|13018956|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
5296475|NCT00560391|13018952|P5|STARTED|Overall Study|Participants who received treatment|17
5296476|NCT00560391|13018953|P4|STARTED|Overall Study|Participants who received treatment|6
5296477|NCT00560391|13018954|P3|STARTED|Overall Study|Participants who received treatment|3
5296478|NCT00560391|13018955|P2|STARTED|Overall Study|Participants who received treatment|3
5296479|NCT00560391|13018956|P1|STARTED|Overall Study|Participants who received treatment|6
5296480|NCT00560352|13019012|P3|NOT COMPLETED|Overall Study||4
5296481|NCT00560352|13019013|P2|NOT COMPLETED|Overall Study||3
5296482|NCT00560352|13019014|P1|NOT COMPLETED|Overall Study||7
5296483|NCT00560352|13019012|P3|COMPLETED|Overall Study||0
5296484|NCT00560352|13019013|P2|COMPLETED|Overall Study||0
5296485|NCT00560352|13019014|P1|COMPLETED|Overall Study||0
5296486|NCT00560352|13019012|P3|STARTED|Overall Study||4
5296487|NCT00560352|13019013|P2|STARTED|Overall Study||3
5296488|NCT00560352|13019014|P1|STARTED|Overall Study||7
5296489|NCT00560313|13019031|P1|NOT COMPLETED|Overall Study||6
5296490|NCT00560313|13019031|P1|COMPLETED|Overall Study||48
5296491|NCT00560313|13019031|P1|STARTED|Overall Study||54
5296492|NCT00560235|13019058|P3|NOT COMPLETED|Phase 2||97
5296493|NCT00560235|13019059|P2|NOT COMPLETED|Phase 2||0
5296494|NCT00560235|13019060|P1|NOT COMPLETED|Phase 2||0
5296495|NCT00560235|13019058|P3|COMPLETED|Phase 2||10
5296496|NCT00560235|13019059|P2|COMPLETED|Phase 2||0
5296497|NCT00560235|13019060|P1|COMPLETED|Phase 2||0
5296498|NCT00560235|13019058|P3|STARTED|Phase 2||107
5296499|NCT00560235|13019059|P2|STARTED|Phase 2||0
5296500|NCT00560235|13019060|P1|STARTED|Phase 2||0
5296501|NCT00560235|13019058|P3|NOT COMPLETED|Phase 1B||0
5296502|NCT00560235|13019059|P2|NOT COMPLETED|Phase 1B||19
5296503|NCT00560235|13019060|P1|NOT COMPLETED|Phase 1B||0
5296504|NCT00560235|13019058|P3|COMPLETED|Phase 1B||0
5296505|NCT00560235|13019059|P2|COMPLETED|Phase 1B||2
5296506|NCT00560235|13019060|P1|COMPLETED|Phase 1B||0
5296507|NCT00560235|13019058|P3|STARTED|Phase 1B||0
5296508|NCT00560235|13019059|P2|STARTED|Phase 1B||21
5296509|NCT00560235|13019060|P1|STARTED|Phase 1B||0
5296510|NCT00560235|13019058|P3|NOT COMPLETED|Phase 1||0
5296511|NCT00560235|13019059|P2|NOT COMPLETED|Phase 1||0
5296512|NCT00560235|13019060|P1|NOT COMPLETED|Phase 1||8
5296513|NCT00560235|13019058|P3|COMPLETED|Phase 1||0
5296514|NCT00560235|13019059|P2|COMPLETED|Phase 1||0
5296515|NCT00560235|13019060|P1|COMPLETED|Phase 1||2
5296516|NCT00560235|13019058|P3|STARTED|Phase 1||0
5296517|NCT00560235|13019059|P2|STARTED|Phase 1||0
5296518|NCT00560235|13019060|P1|STARTED|Phase 1||10
5296519|NCT00560105|13019091|P2|NOT COMPLETED|Overall Study||2
5296520|NCT00560105|13019092|P1|NOT COMPLETED|Overall Study||1
5296521|NCT00560105|13019091|P2|COMPLETED|Overall Study||18
5296522|NCT00560105|13019092|P1|COMPLETED|Overall Study||19
5296523|NCT00560105|13019091|P2|STARTED|Overall Study||20
5296524|NCT00560105|13019092|P1|STARTED|Overall Study||20
5296525|NCT00560066|13019106|P2|NOT COMPLETED|Overall Study||22
5296526|NCT00560066|13019107|P1|NOT COMPLETED|Overall Study||6
5296527|NCT00560066|13019106|P2|COMPLETED|Overall Study||980
5296528|NCT00560066|13019107|P1|COMPLETED|Overall Study||390
5299100|NCT00546273|13026616|P2|STARTED|II||4
5296529|NCT00560066|13019106|P2|STARTED|Overall Study||1002
5296530|NCT00560066|13019107|P1|STARTED|Overall Study||396
5296531|NCT00559988|13019139|P2|NOT COMPLETED|Overall Study||352
5296532|NCT00559988|13019140|P1|NOT COMPLETED|Overall Study||351
5296533|NCT00559988|13019139|P2|COMPLETED|Overall Study||1009
5296534|NCT00559988|13019140|P1|COMPLETED|Overall Study||1006
5296535|NCT00559988|13019139|P2|STARTED|Overall Study||1361
5296536|NCT00559988|13019140|P1|STARTED|Overall Study||1357
5296537|NCT00559962|13019170|P8|NOT COMPLETED|Overall Study||4
5296538|NCT00559962|13019171|P7|NOT COMPLETED|Overall Study||5
5296539|NCT00559962|13019172|P6|NOT COMPLETED|Overall Study||5
5296540|NCT00559962|13019173|P5|NOT COMPLETED|Overall Study||14
5296541|NCT00559962|13019174|P4|NOT COMPLETED|Overall Study||5
5296542|NCT00559962|13019175|P3|NOT COMPLETED|Overall Study||10
5296543|NCT00559962|13019176|P2|NOT COMPLETED|Overall Study||9
5296544|NCT00559962|13019177|P1|NOT COMPLETED|Overall Study||2
5296545|NCT00559962|13019170|P8|COMPLETED|Overall Study||25
5296546|NCT00559962|13019171|P7|COMPLETED|Overall Study||28
5296547|NCT00559962|13019172|P6|COMPLETED|Overall Study||23
5296548|NCT00559962|13019173|P5|COMPLETED|Overall Study||21
5296549|NCT00559962|13019174|P4|COMPLETED|Overall Study||29
5296550|NCT00559962|13019175|P3|COMPLETED|Overall Study||24
5296551|NCT00559962|13019176|P2|COMPLETED|Overall Study||25
5296552|NCT00559962|13019177|P1|COMPLETED|Overall Study||31
5296553|NCT00559962|13019170|P8|STARTED|Overall Study||29
5296554|NCT00559962|13019171|P7|STARTED|Overall Study||33
5296555|NCT00559962|13019172|P6|STARTED|Overall Study||28
5296556|NCT00559962|13019173|P5|STARTED|Overall Study||35
5296557|NCT00559962|13019174|P4|STARTED|Overall Study||34
5296558|NCT00559962|13019175|P3|STARTED|Overall Study||34
5296559|NCT00559962|13019176|P2|STARTED|Overall Study||34
5296560|NCT00559962|13019177|P1|STARTED|Overall Study||33
5296561|NCT00559949|13019197|P1|NOT COMPLETED|Overall Study||7
5296562|NCT00559949|13019197|P1|COMPLETED|Overall Study||32
5296563|NCT00559949|13019197|P1|STARTED|Overall Study||39
5296564|NCT00559936|13019204|P1|NOT COMPLETED|Overall Study||4
5296565|NCT00559936|13019204|P1|COMPLETED|Overall Study||20
5296566|NCT00559936|13019204|P1|STARTED|Overall Study||24
5296567|NCT00559897|13019209|P1|NOT COMPLETED|Overall Study||0
5296568|NCT00559897|13019209|P1|COMPLETED|Overall Study||6
5296569|NCT00559897|13019209|P1|STARTED|Overall Study||6
5296570|NCT00559845|13019213|P1|NOT COMPLETED|Overall Study||7
5296571|NCT00559845|13019213|P1|COMPLETED|Overall Study||49
5296572|NCT00559845|13019213|P1|STARTED|Overall Study||56
5296573|NCT00559754|13019222|P1|NOT COMPLETED|Overall Study||11
5296574|NCT00559754|13019222|P1|COMPLETED|Overall Study||61
5296575|NCT00559754|13019222|P1|STARTED|Overall Study||72
5296576|NCT00559637|13019246|P1|NOT COMPLETED|Overall Study||54
5296577|NCT00559637|13019246|P1|COMPLETED|Overall Study||130
5296578|NCT00559637|13019246|P1|STARTED|Overall Study||184
5296579|NCT00559585|13019259|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
5296580|NCT00559585|13019260|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
5296581|NCT00559585|13019259|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
5296582|NCT00559585|13019260|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
5296583|NCT00559585|13019259|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
5296584|NCT00559585|13019260|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
5296585|NCT00559585|13019259|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
5296586|NCT00559585|13019260|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
5296587|NCT00559585|13019259|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
5296588|NCT00559585|13019260|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
5296589|NCT00559585|13019259|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
5296590|NCT00559585|13019260|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
5296591|NCT00559585|13019259|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
5296592|NCT00559585|13019260|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
5296593|NCT00559585|13019259|P2|COMPLETED|Double Blind ST Period Main Study||676
5296594|NCT00559585|13019260|P1|COMPLETED|Double Blind ST Period Main Study||693
5296595|NCT00559585|13019259|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
5296596|NCT00559585|13019260|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
5296597|NCT00559507|13019320|P1|NOT COMPLETED|Overall Study||3
5296598|NCT00559507|13019320|P1|COMPLETED|Overall Study||9
5296599|NCT00559507|13019320|P1|STARTED|Overall Study||12
5296600|NCT00559468|13019328|P2|NOT COMPLETED|Overall Study||1
5296601|NCT00559468|13019329|P1|NOT COMPLETED|Overall Study||0
5296602|NCT00559468|13019328|P2|COMPLETED|Overall Study||25
5296603|NCT00559468|13019329|P1|COMPLETED|Overall Study||26
5296604|NCT00559468|13019328|P2|Treated|Overall Study||25
5296605|NCT00559468|13019329|P1|Treated|Overall Study||26
5296606|NCT00559468|13019328|P2|STARTED|Overall Study||26
5296607|NCT00559468|13019329|P1|STARTED|Overall Study||26
5296608|NCT00559377|13019339|P1|NOT COMPLETED|Overall Study||9
5296609|NCT00559377|13019339|P1|COMPLETED|Overall Study||7
5296610|NCT00559377|13019339|P1|STARTED|Overall Study||16
5296611|NCT00559364|13019349|P2|NOT COMPLETED|Overall Study||0
5296612|NCT00559364|13019350|P1|NOT COMPLETED|Overall Study||1
5296613|NCT00559364|13019349|P2|COMPLETED|Overall Study||20
5296614|NCT00559364|13019350|P1|COMPLETED|Overall Study||29
5296615|NCT00559364|13019349|P2|STARTED|Overall Study||20
5296616|NCT00559364|13019350|P1|STARTED|Overall Study||30
5296617|NCT00559273|13019362|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
5296618|NCT00559273|13019363|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
5296619|NCT00559273|13019362|P2|COMPLETED|Evaluation Period (8 Weeks)||137
5296620|NCT00559273|13019363|P1|COMPLETED|Evaluation Period (8 Weeks)||141
5296621|NCT00559273|13019362|P2|STARTED|Evaluation Period (8 Weeks)||142
5296622|NCT00559273|13019363|P1|STARTED|Evaluation Period (8 Weeks)||144
5296623|NCT00559273|13019362|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
5296624|NCT00559273|13019363|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
5296625|NCT00559273|13019362|P2|COMPLETED|Correction Period (20 Weeks)||142
5296626|NCT00559273|13019363|P1|COMPLETED|Correction Period (20 Weeks)||144
5296627|NCT00559273|13019362|P2|Treated|Correction Period (20 Weeks)||154
5296628|NCT00559273|13019363|P1|Treated|Correction Period (20 Weeks)||151
5296629|NCT00559273|13019362|P2|STARTED|Correction Period (20 Weeks)||154
5296630|NCT00559273|13019363|P1|STARTED|Correction Period (20 Weeks)||153
5296631|NCT00559104|13019385|P2|NOT COMPLETED|Overall Study||0
5296632|NCT00559104|13019386|P1|NOT COMPLETED|Overall Study||9
5296633|NCT00559104|13019385|P2|COMPLETED|Overall Study||5
5296634|NCT00559104|13019386|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
5296635|NCT00559104|13019385|P2|STARTED|Overall Study||5
5296636|NCT00559104|13019386|P1|STARTED|Overall Study||55
5296637|NCT00559013|13019396|P1|NOT COMPLETED|Overall Study||0
5296638|NCT00559013|13019396|P1|COMPLETED|Overall Study||38
5296639|NCT00559013|13019396|P1|STARTED|Overall Study||38
5296640|NCT00558896|13019407|P7|NOT COMPLETED|Overall Study||24
5296641|NCT00558896|13019408|P6|NOT COMPLETED|Overall Study||52
5296642|NCT00558896|13019409|P5|NOT COMPLETED|Overall Study||23
5296643|NCT00558896|13019410|P4|NOT COMPLETED|Overall Study||12
5296644|NCT00558896|13019411|P3|NOT COMPLETED|Overall Study||5
5296645|NCT00558896|13019412|P2|NOT COMPLETED|Overall Study||7
5296646|NCT00558896|13019413|P1|NOT COMPLETED|Overall Study||21
5296647|NCT00558896|13019407|P7|COMPLETED|Overall Study||9
5296648|NCT00558896|13019408|P6|COMPLETED|Overall Study||68
5296649|NCT00558896|13019409|P5|COMPLETED|Overall Study||37
5296650|NCT00558896|13019410|P4|COMPLETED|Overall Study||23
5296651|NCT00558896|13019411|P3|COMPLETED|Overall Study||30
5296652|NCT00558896|13019412|P2|COMPLETED|Overall Study||27
5296653|NCT00558896|13019413|P1|COMPLETED|Overall Study||39
5296654|NCT00558896|13019407|P7|STARTED|Overall Study||33
5296655|NCT00558896|13019408|P6|STARTED|Overall Study||120
5296656|NCT00558896|13019409|P5|STARTED|Overall Study||60
5296657|NCT00558896|13019410|P4|STARTED|Overall Study||35
5296658|NCT00558896|13019411|P3|STARTED|Overall Study||35
5296659|NCT00558896|13019412|P2|STARTED|Overall Study||34
5296660|NCT00558896|13019413|P1|STARTED|Overall Study||60
5296661|NCT00558870|13019445|P2|NOT COMPLETED|Overall Study||0
5296662|NCT00558870|13019446|P1|NOT COMPLETED|Overall Study||0
5296663|NCT00558870|13019445|P2|COMPLETED|Overall Study||2
5296664|NCT00558870|13019446|P1|COMPLETED|Overall Study||2
5296665|NCT00558870|13019445|P2|STARTED|Overall Study||2
5296666|NCT00558870|13019446|P1|STARTED|Overall Study||2
5296667|NCT00558844|13019459|P5|NOT COMPLETED|Overall Study||1
5296668|NCT00558844|13019460|P4|NOT COMPLETED|Overall Study||0
5296669|NCT00558844|13019461|P3|NOT COMPLETED|Overall Study||1
5296670|NCT00558844|13019462|P2|NOT COMPLETED|Overall Study||0
5296671|NCT00558844|13019463|P1|NOT COMPLETED|Overall Study||3
5296672|NCT00558844|13019459|P5|COMPLETED|Overall Study||6
5296673|NCT00558844|13019460|P4|COMPLETED|Overall Study||5
5296674|NCT00558844|13019461|P3|COMPLETED|Overall Study||6
5296675|NCT00558844|13019462|P2|COMPLETED|Overall Study||7
5296676|NCT00558844|13019463|P1|COMPLETED|Overall Study||12
5296677|NCT00558844|13019459|P5|STARTED|Overall Study||7
5296678|NCT00558844|13019460|P4|STARTED|Overall Study||5
5296679|NCT00558844|13019461|P3|STARTED|Overall Study||7
5296680|NCT00558844|13019462|P2|STARTED|Overall Study||7
5296681|NCT00558844|13019463|P1|STARTED|Overall Study||15
5296682|NCT00558831|13019515|P1|NOT COMPLETED|Overall Study||1
5296683|NCT00558831|13019515|P1|COMPLETED|Overall Study||10
5296684|NCT00558831|13019515|P1|STARTED|Overall Study||11
5296685|NCT00558792|13019524|P3|NOT COMPLETED|Overall Study||0
5296686|NCT00558792|13019525|P2|NOT COMPLETED|Overall Study||0
5296687|NCT00558792|13019526|P1|NOT COMPLETED|Overall Study||0
5296688|NCT00558792|13019524|P3|COMPLETED|Overall Study||60
5296689|NCT00558792|13019525|P2|COMPLETED|Overall Study||63
5296690|NCT00558792|13019526|P1|COMPLETED|Overall Study||68
5296691|NCT00558792|13019524|P3|STARTED|Overall Study||60
5296692|NCT00558792|13019525|P2|STARTED|Overall Study||63
5296693|NCT00558792|13019526|P1|STARTED|Overall Study||68
5296694|NCT00558753|13019572|P2|NOT COMPLETED|Overall Study||7
5296695|NCT00558753|13019573|P1|NOT COMPLETED|Overall Study||5
5296696|NCT00558753|13019572|P2|COMPLETED|Overall Study||113
5296697|NCT00558753|13019573|P1|COMPLETED|Overall Study||115
5296698|NCT00558753|13019572|P2|STARTED|Overall Study||120
5296699|NCT00558753|13019573|P1|STARTED|Overall Study||120
5296700|NCT00558701|13019585|P2|NOT COMPLETED|Overall Study||4
5296701|NCT00558701|13019586|P1|NOT COMPLETED|Overall Study||1
5296702|NCT00558701|13019585|P2|COMPLETED|Overall Study||11
5296703|NCT00558701|13019586|P1|COMPLETED|Overall Study||14
5296704|NCT00558701|13019585|P2|STARTED|Overall Study||15
5296705|NCT00558701|13019586|P1|STARTED|Overall Study||15
5296706|NCT00558636|13019594|P2|NOT COMPLETED|Follow-up||7
5296707|NCT00558636|13019595|P1|NOT COMPLETED|Follow-up||12
5296708|NCT00558636|13019594|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
5296709|NCT00558636|13019595|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
5296710|NCT00558636|13019594|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
5296711|NCT00558636|13019595|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
5296712|NCT00558636|13019594|P2|NOT COMPLETED|Treatment||44
5296713|NCT00558636|13019595|P1|NOT COMPLETED|Treatment||47
5296714|NCT00558636|13019594|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
5296715|NCT00558636|13019595|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
5296716|NCT00558636|13019594|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
5296717|NCT00558636|13019595|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
5296718|NCT00558636|13019594|P2|STARTED|Treatment||44
5296719|NCT00558636|13019595|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
5296720|NCT00558571|13019617|P4|NOT COMPLETED|Overall Study||0
5296721|NCT00558571|13019618|P3|NOT COMPLETED|Overall Study||0
5296722|NCT00558571|13019619|P2|NOT COMPLETED|Overall Study||0
5296723|NCT00558571|13019620|P1|NOT COMPLETED|Overall Study||0
5296724|NCT00558571|13019617|P4|COMPLETED|Overall Study||30
5296725|NCT00558571|13019618|P3|COMPLETED|Overall Study||16
5296726|NCT00558571|13019619|P2|COMPLETED|Overall Study||16
5296727|NCT00558571|13019620|P1|COMPLETED|Overall Study||16
5296728|NCT00558571|13019617|P4|STARTED|Overall Study||30
5296729|NCT00558571|13019618|P3|STARTED|Overall Study||16
5296730|NCT00558571|13019619|P2|STARTED|Overall Study||16
5296731|NCT00558571|13019620|P1|STARTED|Overall Study||16
5296732|NCT00558558|13019695|P1|NOT COMPLETED|Overall Study||6
5296733|NCT00558558|13019695|P1|COMPLETED|Overall Study||0
5296734|NCT00558558|13019695|P1|STARTED|Overall Study||6
5296735|NCT00558519|13019699|P1|NOT COMPLETED|Overall Study||23
5296736|NCT00558519|13019699|P1|COMPLETED|Overall Study||295
5296737|NCT00558519|13019699|P1|STARTED|Overall Study||318
5296738|NCT00558467|13019709|P2|NOT COMPLETED|Overall Study||4
5296739|NCT00558467|13019710|P1|NOT COMPLETED|Overall Study||1
5296740|NCT00558467|13019709|P2|COMPLETED|Overall Study||39
5296741|NCT00558467|13019710|P1|COMPLETED|Overall Study||19
5296742|NCT00558467|13019709|P2|STARTED|Overall Study||43
5296743|NCT00558467|13019710|P1|STARTED|Overall Study||20
5296744|NCT00558428|13019770|P4|NOT COMPLETED|Overall Study||11
5296745|NCT00558428|13019771|P3|NOT COMPLETED|Overall Study||4
5296746|NCT00558428|13019772|P2|NOT COMPLETED|Overall Study||24
5296747|NCT00558428|13019773|P1|NOT COMPLETED|Overall Study||12
5296748|NCT00558428|13019770|P4|COMPLETED|Overall Study||266
5296749|NCT00558428|13019771|P3|COMPLETED|Overall Study||273
5296750|NCT00558428|13019772|P2|COMPLETED|Overall Study||252
5296751|NCT00558428|13019773|P1|COMPLETED|Overall Study||255
5296752|NCT00558428|13019770|P4|STARTED|Overall Study||277
5296753|NCT00558428|13019771|P3|STARTED|Overall Study||277
5296754|NCT00558428|13019772|P2|STARTED|Overall Study||276
5296755|NCT00558428|13019773|P1|STARTED|Overall Study||267
5296756|NCT00558363|13019813|P2|NOT COMPLETED|Overall Study||36
5296757|NCT00558363|13019814|P1|NOT COMPLETED|Overall Study||71
5296758|NCT00558363|13019813|P2|COMPLETED|Overall Study||111
5296759|NCT00558363|13019814|P1|COMPLETED|Overall Study||76
5296760|NCT00558363|13019813|P2|STARTED|Overall Study||147
5296761|NCT00558363|13019814|P1|STARTED|Overall Study||147
5296762|NCT00558285|13019869|P5|NOT COMPLETED|Overall Study||4
5296763|NCT00558285|13019870|P4|NOT COMPLETED|Overall Study||4
5296764|NCT00558285|13019871|P3|NOT COMPLETED|Overall Study||5
5296765|NCT00558285|13019872|P2|NOT COMPLETED|Overall Study||3
5296766|NCT00558285|13019873|P1|NOT COMPLETED|Overall Study||6
5296767|NCT00558285|13019869|P5|COMPLETED|Overall Study||49
5296768|NCT00558285|13019870|P4|COMPLETED|Overall Study||48
5296769|NCT00558285|13019871|P3|COMPLETED|Overall Study||46
5296770|NCT00558285|13019872|P2|COMPLETED|Overall Study||48
5296771|NCT00558285|13019873|P1|COMPLETED|Overall Study||44
5296772|NCT00558285|13019869|P5|Safety: Received Study Drug|Overall Study||53
5296773|NCT00558285|13019870|P4|Safety: Received Study Drug|Overall Study||51
5296774|NCT00558285|13019871|P3|Safety: Received Study Drug|Overall Study||51
5296775|NCT00558285|13019872|P2|Safety: Received Study Drug|Overall Study||51
5296776|NCT00558285|13019873|P1|Safety: Received Study Drug|Overall Study||49
5296777|NCT00558285|13019869|P5|STARTED|Overall Study||53
5296778|NCT00558285|13019870|P4|STARTED|Overall Study||52
5296779|NCT00558285|13019871|P3|STARTED|Overall Study||51
5296780|NCT00558285|13019872|P2|STARTED|Overall Study||51
5296781|NCT00558285|13019873|P1|STARTED|Overall Study||50
5296782|NCT00558272|13019917|P2|NOT COMPLETED|Overall Study||2
5296783|NCT00558272|13019918|P1|NOT COMPLETED|Overall Study||13
5296784|NCT00558272|13019917|P2|COMPLETED|Overall Study|4-week treatment period|68
5296785|NCT00558272|13019918|P1|COMPLETED|Overall Study|4-week treatment period|56
5296786|NCT00558272|13019917|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
5296787|NCT00558272|13019918|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
5296788|NCT00558272|13019917|P2|STARTED|Overall Study|Randomised|70
5296789|NCT00558272|13019918|P1|STARTED|Overall Study|Randomised|69
5296790|NCT00558259|13019958|P2|NOT COMPLETED|Overall Study||99
5296791|NCT00558259|13019959|P1|NOT COMPLETED|Overall Study||71
5296792|NCT00558259|13019958|P2|COMPLETED|Overall Study|Completed treatment.|563
5296793|NCT00558259|13019959|P1|COMPLETED|Overall Study|Completed treatment.|610
5296794|NCT00558259|13019958|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
5296795|NCT00558259|13019959|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
5296796|NCT00558246|13019979|P1|NOT COMPLETED|Overall Study||0
5296797|NCT00558246|13019979|P1|COMPLETED|Overall Study||79
5296798|NCT00558246|13019979|P1|STARTED|Overall Study||79
5296799|NCT00558103|13019999|P6|NOT COMPLETED|Monotherapy Extension Phase||9
5296800|NCT00558103|13020000|P5|NOT COMPLETED|Monotherapy Extension Phase||0
5296801|NCT00558103|13020001|P4|NOT COMPLETED|Monotherapy Extension Phase||0
5296802|NCT00558103|13020002|P3|NOT COMPLETED|Monotherapy Extension Phase||0
5296803|NCT00558103|13020003|P2|NOT COMPLETED|Monotherapy Extension Phase||0
5296804|NCT00558103|13020004|P1|NOT COMPLETED|Monotherapy Extension Phase||0
5296805|NCT00558103|13019999|P6|COMPLETED|Monotherapy Extension Phase||0
5296806|NCT00558103|13020000|P5|COMPLETED|Monotherapy Extension Phase||0
5296807|NCT00558103|13020001|P4|COMPLETED|Monotherapy Extension Phase||0
5296808|NCT00558103|13020002|P3|COMPLETED|Monotherapy Extension Phase||0
5296809|NCT00558103|13020003|P2|COMPLETED|Monotherapy Extension Phase||0
5296810|NCT00558103|13020004|P1|COMPLETED|Monotherapy Extension Phase||0
5296811|NCT00558103|13019999|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
5296812|NCT00558103|13020000|P5|STARTED|Monotherapy Extension Phase||0
5296813|NCT00558103|13020001|P4|STARTED|Monotherapy Extension Phase||0
5296814|NCT00558103|13020002|P3|STARTED|Monotherapy Extension Phase||0
5296815|NCT00558103|13020003|P2|STARTED|Monotherapy Extension Phase||0
5296816|NCT00558103|13020004|P1|STARTED|Monotherapy Extension Phase||0
5296817|NCT00558103|13019999|P6|NOT COMPLETED|Randomized Treatment Phase||0
5296818|NCT00558103|13020000|P5|NOT COMPLETED|Randomized Treatment Phase||5
5296819|NCT00558103|13020001|P4|NOT COMPLETED|Randomized Treatment Phase||2
5296820|NCT00558103|13020002|P3|NOT COMPLETED|Randomized Treatment Phase||3
5296821|NCT00558103|13020003|P2|NOT COMPLETED|Randomized Treatment Phase||4
5296822|NCT00558103|13020004|P1|NOT COMPLETED|Randomized Treatment Phase||5
5296823|NCT00558103|13019999|P6|COMPLETED|Randomized Treatment Phase||0
5296824|NCT00558103|13020000|P5|COMPLETED|Randomized Treatment Phase||33
5296825|NCT00558103|13020001|P4|COMPLETED|Randomized Treatment Phase||11
5296826|NCT00558103|13020002|P3|COMPLETED|Randomized Treatment Phase||33
5296827|NCT00558103|13020003|P2|COMPLETED|Randomized Treatment Phase||34
5296828|NCT00558103|13020004|P1|COMPLETED|Randomized Treatment Phase||33
5296829|NCT00558103|13019999|P6|STARTED|Randomized Treatment Phase||0
5296830|NCT00558103|13020000|P5|STARTED|Randomized Treatment Phase||38
5296831|NCT00558103|13020001|P4|STARTED|Randomized Treatment Phase||13
5296832|NCT00558103|13020002|P3|STARTED|Randomized Treatment Phase||36
5296833|NCT00558103|13020003|P2|STARTED|Randomized Treatment Phase||38
5296834|NCT00558103|13020004|P1|STARTED|Randomized Treatment Phase||38
5296835|NCT00558064|13020034|P2|NOT COMPLETED|Overall Study||5
5296836|NCT00558064|13020035|P1|NOT COMPLETED|Overall Study||5
5296837|NCT00558064|13020034|P2|COMPLETED|Overall Study||257
5296838|NCT00558064|13020035|P1|COMPLETED|Overall Study||264
5296839|NCT00558064|13020034|P2|STARTED|Overall Study||262
5296840|NCT00558064|13020035|P1|STARTED|Overall Study||269
5296841|NCT00558025|13020057|P2|NOT COMPLETED|Overall Study||3
5296842|NCT00558025|13020058|P1|NOT COMPLETED|Overall Study||4
5296843|NCT00558025|13020057|P2|COMPLETED|Overall Study||49
5296844|NCT00558025|13020058|P1|COMPLETED|Overall Study||100
5296845|NCT00558025|13020057|P2|STARTED|Overall Study||52
5296846|NCT00558025|13020058|P1|STARTED|Overall Study||104
5296847|NCT00558012|13020082|P2|NOT COMPLETED|Overall Study||18
5296848|NCT00558012|13020083|P1|NOT COMPLETED|Overall Study||25
5296849|NCT00558012|13020082|P2|COMPLETED|Overall Study||74
5296850|NCT00558012|13020083|P1|COMPLETED|Overall Study||64
5296851|NCT00558012|13020082|P2|STARTED|Overall Study||92
5296852|NCT00558012|13020083|P1|STARTED|Overall Study||89
5296853|NCT00557947|13020089|P1|NOT COMPLETED|Overall Study||0
5296854|NCT00557947|13020089|P1|COMPLETED|Overall Study||83
5296855|NCT00557947|13020089|P1|STARTED|Overall Study||83
5296856|NCT00557856|13020105|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
5296857|NCT00557856|13020106|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
5296858|NCT00557856|13020107|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
5296859|NCT00557856|13020108|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
5296860|NCT00557856|13020109|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
5296861|NCT00557856|13020110|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
5296862|NCT00557856|13020111|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
5296863|NCT00557856|13020112|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
5296864|NCT00557856|13020113|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
5296865|NCT00557856|13020105|P9|COMPLETED|Part 2: Exploratory Phase||0
5296866|NCT00557856|13020106|P8|COMPLETED|Part 2: Exploratory Phase||0
5296867|NCT00557856|13020107|P7|COMPLETED|Part 2: Exploratory Phase||0
5296868|NCT00557856|13020108|P6|COMPLETED|Part 2: Exploratory Phase||0
5296869|NCT00557856|13020109|P5|COMPLETED|Part 2: Exploratory Phase||0
5296870|NCT00557856|13020110|P4|COMPLETED|Part 2: Exploratory Phase||0
5296871|NCT00557856|13020111|P3|COMPLETED|Part 2: Exploratory Phase||0
5296872|NCT00557856|13020112|P2|COMPLETED|Part 2: Exploratory Phase||0
5296873|NCT00557856|13020113|P1|COMPLETED|Part 2: Exploratory Phase||0
5296874|NCT00557856|13020105|P9|STARTED|Part 2: Exploratory Phase||24
5296875|NCT00557856|13020106|P8|STARTED|Part 2: Exploratory Phase||0
5296876|NCT00557856|13020107|P7|STARTED|Part 2: Exploratory Phase||0
5296877|NCT00557856|13020108|P6|STARTED|Part 2: Exploratory Phase||0
5296878|NCT00557856|13020109|P5|STARTED|Part 2: Exploratory Phase||0
5296879|NCT00557856|13020110|P4|STARTED|Part 2: Exploratory Phase||0
5296880|NCT00557856|13020111|P3|STARTED|Part 2: Exploratory Phase||0
5296881|NCT00557856|13020112|P2|STARTED|Part 2: Exploratory Phase||0
5299101|NCT00546273|13026617|P1|STARTED|II||0
5296882|NCT00557856|13020113|P1|STARTED|Part 2: Exploratory Phase||0
5296883|NCT00557856|13020105|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
5296884|NCT00557856|13020106|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
5296885|NCT00557856|13020107|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
5296886|NCT00557856|13020108|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
5296887|NCT00557856|13020109|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
5296888|NCT00557856|13020110|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
5296889|NCT00557856|13020111|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
5296890|NCT00557856|13020112|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
5296891|NCT00557856|13020113|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
5296892|NCT00557856|13020105|P9|COMPLETED|Part 1: Dose Escalation Phase||0
5296893|NCT00557856|13020106|P8|COMPLETED|Part 1: Dose Escalation Phase||0
5296894|NCT00557856|13020107|P7|COMPLETED|Part 1: Dose Escalation Phase||0
5296895|NCT00557856|13020108|P6|COMPLETED|Part 1: Dose Escalation Phase||0
5296896|NCT00557856|13020109|P5|COMPLETED|Part 1: Dose Escalation Phase||0
5296897|NCT00557856|13020110|P4|COMPLETED|Part 1: Dose Escalation Phase||0
5296898|NCT00557856|13020111|P3|COMPLETED|Part 1: Dose Escalation Phase||0
5296899|NCT00557856|13020112|P2|COMPLETED|Part 1: Dose Escalation Phase||0
5296900|NCT00557856|13020113|P1|COMPLETED|Part 1: Dose Escalation Phase||0
5296901|NCT00557856|13020105|P9|Treated|Part 1: Dose Escalation Phase||0
5296902|NCT00557856|13020106|P8|Treated|Part 1: Dose Escalation Phase||6
5296903|NCT00557856|13020107|P7|Treated|Part 1: Dose Escalation Phase||7
5296904|NCT00557856|13020108|P6|Treated|Part 1: Dose Escalation Phase||8
5296905|NCT00557856|13020109|P5|Treated|Part 1: Dose Escalation Phase||4
5296906|NCT00557856|13020110|P4|Treated|Part 1: Dose Escalation Phase||3
5296907|NCT00557856|13020111|P3|Treated|Part 1: Dose Escalation Phase||6
5296908|NCT00557856|13020112|P2|Treated|Part 1: Dose Escalation Phase||5
5296909|NCT00557856|13020113|P1|Treated|Part 1: Dose Escalation Phase||5
5296910|NCT00557856|13020105|P9|STARTED|Part 1: Dose Escalation Phase||0
5296911|NCT00557856|13020106|P8|STARTED|Part 1: Dose Escalation Phase||6
5296912|NCT00557856|13020107|P7|STARTED|Part 1: Dose Escalation Phase||7
5296913|NCT00557856|13020108|P6|STARTED|Part 1: Dose Escalation Phase||8
5296914|NCT00557856|13020109|P5|STARTED|Part 1: Dose Escalation Phase||4
5296915|NCT00557856|13020110|P4|STARTED|Part 1: Dose Escalation Phase||3
5296916|NCT00557856|13020111|P3|STARTED|Part 1: Dose Escalation Phase||6
5296917|NCT00557856|13020112|P2|STARTED|Part 1: Dose Escalation Phase||5
5296918|NCT00557856|13020113|P1|STARTED|Part 1: Dose Escalation Phase||7
5296919|NCT00557830|13020312|P3|NOT COMPLETED|Treatment Phase||0
5296920|NCT00557830|13020313|P2|NOT COMPLETED|Treatment Phase||0
5296921|NCT00557830|13020314|P1|NOT COMPLETED|Treatment Phase||0
5296922|NCT00557830|13020312|P3|COMPLETED|Treatment Phase||2
5296923|NCT00557830|13020313|P2|COMPLETED|Treatment Phase||4
5296924|NCT00557830|13020314|P1|COMPLETED|Treatment Phase||0
5296925|NCT00557830|13020312|P3|STARTED|Treatment Phase||2
5296926|NCT00557830|13020313|P2|STARTED|Treatment Phase||4
5296927|NCT00557830|13020314|P1|STARTED|Treatment Phase||0
5296928|NCT00557830|13020312|P3|NOT COMPLETED|Screening Treatment Phase||0
5296929|NCT00557830|13020313|P2|NOT COMPLETED|Screening Treatment Phase||0
5296930|NCT00557830|13020314|P1|NOT COMPLETED|Screening Treatment Phase||6
5296931|NCT00557830|13020312|P3|COMPLETED|Screening Treatment Phase||0
5296932|NCT00557830|13020313|P2|COMPLETED|Screening Treatment Phase||0
5296933|NCT00557830|13020314|P1|COMPLETED|Screening Treatment Phase||6
5296934|NCT00557830|13020312|P3|STARTED|Screening Treatment Phase||0
5296935|NCT00557830|13020313|P2|STARTED|Screening Treatment Phase||0
5296936|NCT00557830|13020314|P1|STARTED|Screening Treatment Phase||12
5296937|NCT00557622|13020336|P2|NOT COMPLETED|12-Week Treatment Phase||1
5296938|NCT00557622|13020337|P1|NOT COMPLETED|12-Week Treatment Phase||0
5296939|NCT00557622|13020336|P2|COMPLETED|12-Week Treatment Phase||1
5296940|NCT00557622|13020337|P1|COMPLETED|12-Week Treatment Phase||1
5296941|NCT00557622|13020336|P2|STARTED|12-Week Treatment Phase||2
5296942|NCT00557622|13020337|P1|STARTED|12-Week Treatment Phase||1
5296943|NCT00557622|13020336|P2|NOT COMPLETED|4-Week Run-in Phase||0
5296944|NCT00557622|13020337|P1|NOT COMPLETED|4-Week Run-in Phase||2
5296945|NCT00557622|13020336|P2|COMPLETED|4-Week Run-in Phase||0
5296946|NCT00557622|13020337|P1|COMPLETED|4-Week Run-in Phase||3
5296947|NCT00557622|13020336|P2|STARTED|4-Week Run-in Phase||0
5296948|NCT00557622|13020337|P1|STARTED|4-Week Run-in Phase||5
5296949|NCT00557505|13020366|P9|NOT COMPLETED|Overall Study||17
5296950|NCT00557505|13020367|P8|NOT COMPLETED|Overall Study||5
5296951|NCT00557505|13020368|P7|NOT COMPLETED|Overall Study||3
5296952|NCT00557505|13020369|P6|NOT COMPLETED|Overall Study||3
5296953|NCT00557505|13020370|P5|NOT COMPLETED|Overall Study||2
5296954|NCT00557505|13020371|P4|NOT COMPLETED|Overall Study||3
5296955|NCT00557505|13020372|P3|NOT COMPLETED|Overall Study||4
5296956|NCT00557505|13020373|P2|NOT COMPLETED|Overall Study||3
5296957|NCT00557505|13020374|P1|NOT COMPLETED|Overall Study||3
5296958|NCT00557505|13020366|P9|COMPLETED|Overall Study||0
5296959|NCT00557505|13020367|P8|COMPLETED|Overall Study||0
5296960|NCT00557505|13020368|P7|COMPLETED|Overall Study||0
5296961|NCT00557505|13020369|P6|COMPLETED|Overall Study||0
5296962|NCT00557505|13020370|P5|COMPLETED|Overall Study||0
5296963|NCT00557505|13020371|P4|COMPLETED|Overall Study||0
5296964|NCT00557505|13020372|P3|COMPLETED|Overall Study||0
5296965|NCT00557505|13020373|P2|COMPLETED|Overall Study||0
5296966|NCT00557505|13020374|P1|COMPLETED|Overall Study||0
5296967|NCT00557505|13020366|P9|STARTED|Overall Study||17
5296968|NCT00557505|13020367|P8|STARTED|Overall Study||5
5296969|NCT00557505|13020368|P7|STARTED|Overall Study||3
5296970|NCT00557505|13020369|P6|STARTED|Overall Study||3
5296971|NCT00557505|13020370|P5|STARTED|Overall Study||2
5296972|NCT00557505|13020371|P4|STARTED|Overall Study||3
5296973|NCT00557505|13020372|P3|STARTED|Overall Study||4
5296974|NCT00557505|13020373|P2|STARTED|Overall Study||3
5296975|NCT00557505|13020374|P1|STARTED|Overall Study||3
5296976|NCT00557492|13020538|P1|NOT COMPLETED|Overall Study||1
5296977|NCT00557492|13020538|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
5296978|NCT00557492|13020538|P1|STARTED|Overall Study||59
5296979|NCT00557466|13020556|P6|NOT COMPLETED|Overall Study||6
5296980|NCT00557466|13020557|P5|NOT COMPLETED|Overall Study||3
5296981|NCT00557466|13020558|P4|NOT COMPLETED|Overall Study||4
5296982|NCT00557466|13020559|P3|NOT COMPLETED|Overall Study||6
5296983|NCT00557466|13020560|P2|NOT COMPLETED|Overall Study||5
5296984|NCT00557466|13020561|P1|NOT COMPLETED|Overall Study||4
5296985|NCT00557466|13020556|P6|COMPLETED|Overall Study||85
5296986|NCT00557466|13020557|P5|COMPLETED|Overall Study||87
5296987|NCT00557466|13020558|P4|COMPLETED|Overall Study||92
5296988|NCT00557466|13020559|P3|COMPLETED|Overall Study||95
5296989|NCT00557466|13020560|P2|COMPLETED|Overall Study||87
5296990|NCT00557466|13020561|P1|COMPLETED|Overall Study||94
5296991|NCT00557466|13020556|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
5296992|NCT00557466|13020557|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
5296993|NCT00557466|13020558|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
5296994|NCT00557466|13020559|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
5296995|NCT00557466|13020560|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
5296996|NCT00557466|13020561|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
5296997|NCT00557466|13020556|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
5296998|NCT00557466|13020557|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
5296999|NCT00557466|13020558|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
5297000|NCT00557466|13020559|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
5297001|NCT00557466|13020560|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
5297002|NCT00557466|13020561|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
5297003|NCT00557466|13020556|P6|STARTED|Overall Study||91
5297004|NCT00557466|13020557|P5|STARTED|Overall Study||90
5297005|NCT00557466|13020558|P4|STARTED|Overall Study||96
5297006|NCT00557466|13020559|P3|STARTED|Overall Study||101
5297007|NCT00557466|13020560|P2|STARTED|Overall Study||92
5297008|NCT00557466|13020561|P1|STARTED|Overall Study||98
5297009|NCT00557440|13020614|P3|NOT COMPLETED|Treatment Period 3||0
5297010|NCT00557440|13020615|P2|NOT COMPLETED|Treatment Period 3||0
5297011|NCT00557440|13020616|P1|NOT COMPLETED|Treatment Period 3||0
5297012|NCT00557440|13020614|P3|COMPLETED|Treatment Period 3||12
5297013|NCT00557440|13020615|P2|COMPLETED|Treatment Period 3||12
5297014|NCT00557440|13020616|P1|COMPLETED|Treatment Period 3||12
5297015|NCT00557440|13020614|P3|STARTED|Treatment Period 3||12
5297016|NCT00557440|13020615|P2|STARTED|Treatment Period 3||12
5297017|NCT00557440|13020616|P1|STARTED|Treatment Period 3||12
5297018|NCT00557440|13020614|P3|NOT COMPLETED|Treatment Period 2||0
5297019|NCT00557440|13020615|P2|NOT COMPLETED|Treatment Period 2||0
5297020|NCT00557440|13020616|P1|NOT COMPLETED|Treatment Period 2||0
5297021|NCT00557440|13020614|P3|COMPLETED|Treatment Period 2||12
5297022|NCT00557440|13020615|P2|COMPLETED|Treatment Period 2||12
5297023|NCT00557440|13020616|P1|COMPLETED|Treatment Period 2||12
5297024|NCT00557440|13020614|P3|STARTED|Treatment Period 2||12
5297025|NCT00557440|13020615|P2|STARTED|Treatment Period 2||12
5297026|NCT00557440|13020616|P1|STARTED|Treatment Period 2||12
5297027|NCT00557440|13020614|P3|NOT COMPLETED|Treatment Period 1||1
5297028|NCT00557440|13020615|P2|NOT COMPLETED|Treatment Period 1||0
5297029|NCT00557440|13020616|P1|NOT COMPLETED|Treatment Period 1||0
5297030|NCT00557440|13020614|P3|COMPLETED|Treatment Period 1||12
5297031|NCT00557440|13020615|P2|COMPLETED|Treatment Period 1||12
5297032|NCT00557440|13020616|P1|COMPLETED|Treatment Period 1||12
5297033|NCT00557440|13020614|P3|STARTED|Treatment Period 1||13
5297034|NCT00557440|13020615|P2|STARTED|Treatment Period 1||12
5297035|NCT00557440|13020616|P1|STARTED|Treatment Period 1||12
5297036|NCT00557362|13020640|P4|NOT COMPLETED|Overall Study||3
5297037|NCT00557362|13020641|P3|NOT COMPLETED|Overall Study||4
5297038|NCT00557362|13020642|P2|NOT COMPLETED|Overall Study||2
5297039|NCT00557362|13020643|P1|NOT COMPLETED|Overall Study||2
5297040|NCT00557362|13020640|P4|COMPLETED|Overall Study||27
5297041|NCT00557362|13020641|P3|COMPLETED|Overall Study||26
5297042|NCT00557362|13020642|P2|COMPLETED|Overall Study||28
5297043|NCT00557362|13020643|P1|COMPLETED|Overall Study||28
5297044|NCT00557362|13020640|P4|STARTED|Overall Study||30
5297045|NCT00557362|13020641|P3|STARTED|Overall Study||30
5297046|NCT00557362|13020642|P2|STARTED|Overall Study||30
5297047|NCT00557362|13020643|P1|STARTED|Overall Study||30
5297048|NCT00557349|13020661|P2|NOT COMPLETED|Overall Study||5
5297049|NCT00557349|13020662|P1|NOT COMPLETED|Overall Study||5
5297050|NCT00557349|13020661|P2|COMPLETED|Overall Study||13
5297051|NCT00557349|13020662|P1|COMPLETED|Overall Study||17
5297052|NCT00557349|13020661|P2|STARTED|Overall Study||18
5297053|NCT00557349|13020662|P1|STARTED|Overall Study|omeprazole/bicarb|22
5297054|NCT00557323|13020670|P1|NOT COMPLETED|Overall Study||7
5297055|NCT00557323|13020670|P1|COMPLETED|Overall Study||27
5297056|NCT00557323|13020670|P1|STARTED|Overall Study||34
5297057|NCT00557310|13020675|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
5297058|NCT00557310|13020675|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
5297059|NCT00557310|13020675|P1|STARTED|Extension Phase (18 - 24 Months)||30
5297060|NCT00557310|13020675|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
5297061|NCT00557310|13020675|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
5297062|NCT00557310|13020675|P1|STARTED|Main Study (0 - 18 Months)||35
5297063|NCT00557284|13020697|P2|NOT COMPLETED|Overall Study||0
5297064|NCT00557284|13020698|P1|NOT COMPLETED|Overall Study||0
5297065|NCT00557284|13020697|P2|COMPLETED|Overall Study||11
5297066|NCT00557284|13020698|P1|COMPLETED|Overall Study||9
5297067|NCT00557284|13020697|P2|STARTED|Overall Study||11
5297068|NCT00557284|13020698|P1|STARTED|Overall Study||9
5297069|NCT00557245|13020721|P3|NOT COMPLETED|Overall Study||12
5297070|NCT00557245|13020722|P2|NOT COMPLETED|Overall Study||12
5297071|NCT00557245|13020723|P1|NOT COMPLETED|Overall Study||12
5297072|NCT00557245|13020721|P3|COMPLETED|Overall Study||1574
5297073|NCT00557245|13020722|P2|COMPLETED|Overall Study||1571
5297074|NCT00557245|13020723|P1|COMPLETED|Overall Study||1577
5297075|NCT00557245|13020721|P3|STARTED|Overall Study||1586
5297076|NCT00557245|13020722|P2|STARTED|Overall Study||1583
5297077|NCT00557245|13020723|P1|STARTED|Overall Study||1589
5297078|NCT00557193|13020761|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
5297079|NCT00557193|13020762|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
5297080|NCT00557193|13020763|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
5297081|NCT00557193|13020764|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
5297082|NCT00557193|13020765|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
5297083|NCT00557193|13020766|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
5297084|NCT00557193|13020761|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
5297085|NCT00557193|13020762|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
5297086|NCT00557193|13020763|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
5297087|NCT00557193|13020764|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
5297088|NCT00557193|13020765|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
5297089|NCT00557193|13020766|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
5297090|NCT00557193|13020761|P6|STARTED|Post Induction Therapy by Tx Assignment||56
5297091|NCT00557193|13020762|P5|STARTED|Post Induction Therapy by Tx Assignment||11
5297092|NCT00557193|13020763|P4|STARTED|Post Induction Therapy by Tx Assignment||11
5297093|NCT00557193|13020764|P3|STARTED|Post Induction Therapy by Tx Assignment||54
5297094|NCT00557193|13020765|P2|STARTED|Post Induction Therapy by Tx Assignment||60
5297095|NCT00557193|13020766|P1|STARTED|Post Induction Therapy by Tx Assignment||0
5297096|NCT00557193|13020761|P6|NOT COMPLETED|Induction||0
5297097|NCT00557193|13020762|P5|NOT COMPLETED|Induction||0
5297098|NCT00557193|13020763|P4|NOT COMPLETED|Induction||0
5297099|NCT00557193|13020764|P3|NOT COMPLETED|Induction||0
5297100|NCT00557193|13020765|P2|NOT COMPLETED|Induction||0
5297101|NCT00557193|13020766|P1|NOT COMPLETED|Induction||26
5297102|NCT00557193|13020761|P6|COMPLETED|Induction||0
5297103|NCT00557193|13020762|P5|COMPLETED|Induction||0
5297104|NCT00557193|13020763|P4|COMPLETED|Induction||0
5297105|NCT00557193|13020764|P3|COMPLETED|Induction||0
5297106|NCT00557193|13020765|P2|COMPLETED|Induction||0
5297107|NCT00557193|13020766|P1|COMPLETED|Induction||192
5297108|NCT00557193|13020761|P6|STARTED|Induction||0
5297109|NCT00557193|13020762|P5|STARTED|Induction||0
5297110|NCT00557193|13020763|P4|STARTED|Induction||0
5297111|NCT00557193|13020764|P3|STARTED|Induction||0
5297112|NCT00557193|13020765|P2|STARTED|Induction||0
5297113|NCT00557193|13020766|P1|STARTED|Induction||218
5297114|NCT00557076|13020806|P2|NOT COMPLETED|Overall Study||1
5297115|NCT00557076|13020807|P1|NOT COMPLETED|Overall Study||0
5297116|NCT00557076|13020806|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
5297117|NCT00557076|13020807|P1|COMPLETED|Overall Study||8
5297118|NCT00557076|13020806|P2|STARTED|Overall Study||8
5297119|NCT00557076|13020807|P1|STARTED|Overall Study||8
5297120|NCT00556998|13020815|P1|NOT COMPLETED|Voriconazole Oral||2
5297121|NCT00556998|13020815|P1|COMPLETED|Voriconazole Oral||20
5297122|NCT00556998|13020815|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
5297123|NCT00556998|13020815|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
5297124|NCT00556998|13020815|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
5297125|NCT00556998|13020815|P1|Treated|Voriconazole Intravenous (IV)||26
5297126|NCT00556998|13020815|P1|STARTED|Voriconazole Intravenous (IV)||26
5297127|NCT00556972|13020835|P1|NOT COMPLETED|Overall Study||0
5297128|NCT00556972|13020835|P1|COMPLETED|Overall Study||4
5297129|NCT00556972|13020835|P1|STARTED|Overall Study||4
5297130|NCT00556946|13020842|P1|NOT COMPLETED|Overall Study||1
5297131|NCT00556946|13020842|P1|COMPLETED|Overall Study||16
5297132|NCT00556946|13020842|P1|STARTED|Overall Study||17
5297133|NCT00556933|13020850|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
5297134|NCT00556933|13020851|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
5297135|NCT00556933|13020852|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
5297136|NCT00556933|13020853|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
5297137|NCT00556933|13020850|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
5297138|NCT00556933|13020851|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
5297139|NCT00556933|13020852|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
5297140|NCT00556933|13020853|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
5297141|NCT00556933|13020850|P4|STARTED|CNI Withdrawal vs. Minimization||43
5297142|NCT00556933|13020851|P3|STARTED|CNI Withdrawal vs. Minimization||39
5297143|NCT00556933|13020852|P2|STARTED|CNI Withdrawal vs. Minimization||37
5297144|NCT00556933|13020853|P1|STARTED|CNI Withdrawal vs. Minimization||43
5297145|NCT00556933|13020850|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
5297146|NCT00556933|13020851|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
5297147|NCT00556933|13020852|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
5297148|NCT00556933|13020853|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
5297149|NCT00556933|13020850|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
5297150|NCT00556933|13020851|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
5297151|NCT00556933|13020852|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
5297152|NCT00556933|13020853|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
5297153|NCT00556933|13020850|P4|STARTED|Single vs. Divided-dose rATG Induction||45
5297154|NCT00556933|13020851|P3|STARTED|Single vs. Divided-dose rATG Induction||45
5297155|NCT00556933|13020852|P2|STARTED|Single vs. Divided-dose rATG Induction||45
5297156|NCT00556933|13020853|P1|STARTED|Single vs. Divided-dose rATG Induction||45
5297157|NCT00556894|13020910|P3|NOT COMPLETED|Overall Study||19
5297158|NCT00556894|13020911|P2|NOT COMPLETED|Overall Study||19
5297159|NCT00556894|13020912|P1|NOT COMPLETED|Overall Study||16
5297160|NCT00556894|13020910|P3|COMPLETED|Overall Study||65
5297161|NCT00556894|13020911|P2|COMPLETED|Overall Study||68
5297162|NCT00556894|13020912|P1|COMPLETED|Overall Study||66
5297163|NCT00556894|13020910|P3|STARTED|Overall Study||84
5297164|NCT00556894|13020911|P2|STARTED|Overall Study||87
5297165|NCT00556894|13020912|P1|STARTED|Overall Study||82
5297166|NCT00556842|13020922|P2|NOT COMPLETED|Overall Study||23
5297167|NCT00556842|13020923|P1|NOT COMPLETED|Overall Study||31
5297168|NCT00556842|13020922|P2|COMPLETED|Overall Study||723
5297169|NCT00556842|13020923|P1|COMPLETED|Overall Study||718
5297170|NCT00556842|13020922|P2|STARTED|Overall Study||746
5297171|NCT00556842|13020923|P1|STARTED|Overall Study||749
5297172|NCT00556712|13020941|P2|NOT COMPLETED|Overall Study||438
5297173|NCT00556712|13020942|P1|NOT COMPLETED|Overall Study||451
5297174|NCT00556712|13020941|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
5297175|NCT00556712|13020942|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
5297176|NCT00556712|13020941|P2|STARTED|Overall Study||438
5297177|NCT00556712|13020942|P1|STARTED|Overall Study||451
5297178|NCT00556673|13021020|P2|NOT COMPLETED|Overall Study||2
5297179|NCT00556673|13021021|P1|NOT COMPLETED|Overall Study||3
5297180|NCT00556673|13021020|P2|COMPLETED|Overall Study||13
5297181|NCT00556673|13021021|P1|COMPLETED|Overall Study||13
5297182|NCT00556673|13021020|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
5297183|NCT00556673|13021021|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
5297184|NCT00556673|13021020|P2|STARTED|Overall Study||15
5297185|NCT00556673|13021021|P1|STARTED|Overall Study||16
5297186|NCT00556543|13021057|P1|NOT COMPLETED|Overall Study||0
5297187|NCT00556543|13021057|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
5297188|NCT00556543|13021057|P1|STARTED|Overall Study||10
5297189|NCT00556504|13021075|P2|NOT COMPLETED|Overall Study||9
5297190|NCT00556504|13021076|P1|NOT COMPLETED|Overall Study||8
5297191|NCT00556504|13021075|P2|COMPLETED|Overall Study||33
5297192|NCT00556504|13021076|P1|COMPLETED|Overall Study||34
5297193|NCT00556504|13021075|P2|Safety Population|Overall Study||42
5297194|NCT00556504|13021076|P1|Safety Population|Overall Study||41
5297195|NCT00556504|13021075|P2|Intend-to Treat Population|Overall Study||42
5297196|NCT00556504|13021076|P1|Intend-to Treat Population|Overall Study||42
5297197|NCT00556504|13021075|P2|STARTED|Overall Study||42
5297198|NCT00556504|13021076|P1|STARTED|Overall Study||42
5297199|NCT00556491|13021096|P2|NOT COMPLETED|Overall Study||1
5297200|NCT00556491|13021097|P1|NOT COMPLETED|Overall Study||1
5297201|NCT00556491|13021096|P2|COMPLETED|Overall Study||19
5297202|NCT00556491|13021097|P1|COMPLETED|Overall Study||19
5297203|NCT00556491|13021096|P2|STARTED|Overall Study||20
5297204|NCT00556491|13021097|P1|STARTED|Overall Study|January 2008|20
5297205|NCT00556478|13021115|P2|NOT COMPLETED|Open-Label Phase||10
5297206|NCT00556478|13021116|P1|NOT COMPLETED|Open-Label Phase||14
5297207|NCT00556478|13021115|P2|COMPLETED|Open-Label Phase||67
5297208|NCT00556478|13021116|P1|COMPLETED|Open-Label Phase||132
5297209|NCT00556478|13021115|P2|Treated in Open-label|Open-Label Phase||71
5297210|NCT00556478|13021116|P1|Treated in Open-label|Open-Label Phase||142
5297211|NCT00556478|13021115|P2|STARTED|Open-Label Phase||77
5297212|NCT00556478|13021116|P1|STARTED|Open-Label Phase||146
5297213|NCT00556478|13021115|P2|NOT COMPLETED|Double-blind Phase||8
5297214|NCT00556478|13021116|P1|NOT COMPLETED|Double-blind Phase||21
5297215|NCT00556478|13021115|P2|COMPLETED|Double-blind Phase||77
5297216|NCT00556478|13021116|P1|COMPLETED|Double-blind Phase||150
5297217|NCT00556478|13021115|P2|ITT|Double-blind Phase||82
5297218|NCT00556478|13021116|P1|ITT|Double-blind Phase||167
5297219|NCT00556478|13021115|P2|STARTED|Double-blind Phase||85
5297220|NCT00556478|13021116|P1|STARTED|Double-blind Phase||171
5297221|NCT00556452|13021144|P3|NOT COMPLETED|Overall Study||0
5297222|NCT00556452|13021145|P2|NOT COMPLETED|Overall Study||0
5297223|NCT00556452|13021146|P1|NOT COMPLETED|Overall Study||0
5297224|NCT00556452|13021144|P3|COMPLETED|Overall Study||19
5297225|NCT00556452|13021145|P2|COMPLETED|Overall Study||21
5297226|NCT00556452|13021146|P1|COMPLETED|Overall Study||6
5297227|NCT00556452|13021144|P3|STARTED|Overall Study||19
5297228|NCT00556452|13021145|P2|STARTED|Overall Study||21
5297229|NCT00556452|13021146|P1|STARTED|Overall Study||6
5297230|NCT00556439|13021157|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
5297231|NCT00556439|13021158|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
5297232|NCT00556439|13021159|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
5297233|NCT00556439|13021160|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
5297234|NCT00556439|13021157|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
5297235|NCT00556439|13021158|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
5297236|NCT00556439|13021159|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
5297237|NCT00556439|13021160|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
5297238|NCT00556439|13021157|P4|STARTED|After Week 12 (Randomized Study Period)||15
5297239|NCT00556439|13021158|P3|STARTED|After Week 12 (Randomized Study Period)||11
5297240|NCT00556439|13021159|P2|STARTED|After Week 12 (Randomized Study Period)||21
5297241|NCT00556439|13021160|P1|STARTED|After Week 12 (Randomized Study Period)||20
5297242|NCT00556439|13021157|P4|NOT COMPLETED|Study Entry to Week 12||0
5297243|NCT00556439|13021158|P3|NOT COMPLETED|Study Entry to Week 12||8
5297244|NCT00556439|13021159|P2|NOT COMPLETED|Study Entry to Week 12||0
5297245|NCT00556439|13021160|P1|NOT COMPLETED|Study Entry to Week 12||8
5297246|NCT00556439|13021157|P4|COMPLETED|Study Entry to Week 12||0
5297247|NCT00556439|13021158|P3|COMPLETED|Study Entry to Week 12||26
5297248|NCT00556439|13021159|P2|COMPLETED|Study Entry to Week 12||0
5297249|NCT00556439|13021160|P1|COMPLETED|Study Entry to Week 12||41
5297250|NCT00556439|13021157|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
5297251|NCT00556439|13021158|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
5297252|NCT00556439|13021159|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
5297253|NCT00556439|13021160|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
5297254|NCT00556426|13021170|P1|NOT COMPLETED|Overall Study||9
5297255|NCT00556426|13021170|P1|COMPLETED|Overall Study||91
5297256|NCT00556426|13021170|P1|STARTED|Overall Study||100
5297257|NCT00556400|13021180|P2|NOT COMPLETED|Overall Study||0
5297258|NCT00556400|13021181|P1|NOT COMPLETED|Overall Study||0
5297259|NCT00556400|13021180|P2|COMPLETED|Overall Study||0
5297260|NCT00556400|13021181|P1|COMPLETED|Overall Study||1
5297261|NCT00556400|13021180|P2|STARTED|Overall Study||0
5297262|NCT00556400|13021181|P1|STARTED|Overall Study||1
5297263|NCT00556374|13021192|P2|NOT COMPLETED|Overall Study||220
5297264|NCT00556374|13021193|P1|NOT COMPLETED|Overall Study||247
5297265|NCT00556374|13021192|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
5297266|NCT00556374|13021193|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
5297267|NCT00556374|13021192|P2|Received Study Drug|Overall Study||1700
5297268|NCT00556374|13021193|P1|Received Study Drug|Overall Study||1699
5297269|NCT00556374|13021192|P2|STARTED|Overall Study||1711
5297270|NCT00556374|13021193|P1|STARTED|Overall Study||1709
5297271|NCT00556322|13021213|P2|NOT COMPLETED|Overall Study||203
5297272|NCT00556322|13021214|P1|NOT COMPLETED|Overall Study||221
5297273|NCT00556322|13021213|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
5297274|NCT00556322|13021214|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
5297275|NCT00556322|13021213|P2|STARTED|Overall Study||203
5297276|NCT00556322|13021214|P1|STARTED|Overall Study||221
5297277|NCT00556166|13021262|P1|NOT COMPLETED|Overall Study||1
5297278|NCT00556166|13021262|P1|COMPLETED|Overall Study||3
5297279|NCT00556166|13021262|P1|STARTED|Overall Study||4
5297280|NCT00556140|13021267|P1|NOT COMPLETED|Overall Study||3
5297281|NCT00556140|13021267|P1|COMPLETED|Overall Study||13
5297282|NCT00556140|13021267|P1|STARTED|Overall Study||16
5297283|NCT00556075|13021275|P3|NOT COMPLETED|Overall Study||8
5297284|NCT00556075|13021276|P2|NOT COMPLETED|Overall Study||9
5297285|NCT00556075|13021277|P1|NOT COMPLETED|Overall Study||13
5297286|NCT00556075|13021275|P3|COMPLETED|Overall Study||15
5297287|NCT00556075|13021276|P2|COMPLETED|Overall Study||13
5297288|NCT00556075|13021277|P1|COMPLETED|Overall Study||9
5297289|NCT00556075|13021275|P3|STARTED|Overall Study||23
5297290|NCT00556075|13021276|P2|STARTED|Overall Study||22
5297291|NCT00556075|13021277|P1|STARTED|Overall Study||22
5297292|NCT00556049|13021300|P1|NOT COMPLETED|Overall Study||0
5297293|NCT00556049|13021300|P1|COMPLETED|Overall Study||72
5297294|NCT00556049|13021300|P1|STARTED|Overall Study||72
5297295|NCT00555997|13021307|P4|NOT COMPLETED|Phase 2 SPCD||3
5297296|NCT00555997|13021308|P3|NOT COMPLETED|Phase 2 SPCD||7
5297297|NCT00555997|13021309|P2|NOT COMPLETED|Phase 2 SPCD||0
5297298|NCT00555997|13021310|P1|NOT COMPLETED|Phase 2 SPCD||0
5297299|NCT00555997|13021307|P4|COMPLETED|Phase 2 SPCD||22
5297300|NCT00555997|13021308|P3|COMPLETED|Phase 2 SPCD||31
5297301|NCT00555997|13021309|P2|COMPLETED|Phase 2 SPCD||0
5297302|NCT00555997|13021310|P1|COMPLETED|Phase 2 SPCD||0
5297303|NCT00555997|13021307|P4|STARTED|Phase 2 SPCD||25
5297304|NCT00555997|13021308|P3|STARTED|Phase 2 SPCD||38
5297305|NCT00555997|13021309|P2|STARTED|Phase 2 SPCD||0
5297306|NCT00555997|13021310|P1|STARTED|Phase 2 SPCD||0
5297307|NCT00555997|13021307|P4|NOT COMPLETED|Phase 1 SPCD||0
5297308|NCT00555997|13021308|P3|NOT COMPLETED|Phase 1 SPCD||0
5297309|NCT00555997|13021309|P2|NOT COMPLETED|Phase 1 SPCD||15
5297310|NCT00555997|13021310|P1|NOT COMPLETED|Phase 1 SPCD||12
5297311|NCT00555997|13021307|P4|COMPLETED|Phase 1 SPCD||0
5297312|NCT00555997|13021308|P3|COMPLETED|Phase 1 SPCD||0
5297313|NCT00555997|13021309|P2|COMPLETED|Phase 1 SPCD||76
5297314|NCT00555997|13021310|P1|COMPLETED|Phase 1 SPCD||17
5297315|NCT00555997|13021307|P4|STARTED|Phase 1 SPCD||0
5297316|NCT00555997|13021308|P3|STARTED|Phase 1 SPCD||0
5297317|NCT00555997|13021309|P2|STARTED|Phase 1 SPCD||91
5297318|NCT00555997|13021310|P1|STARTED|Phase 1 SPCD||29
5297319|NCT00555971|13021328|P2|NOT COMPLETED|Overall Study||1
5297320|NCT00555971|13021329|P1|NOT COMPLETED|Overall Study||1
5297321|NCT00555971|13021328|P2|COMPLETED|Overall Study||7
5297322|NCT00555971|13021329|P1|COMPLETED|Overall Study||4
5297323|NCT00555971|13021328|P2|STARTED|Overall Study||8
5297324|NCT00555971|13021329|P1|STARTED|Overall Study||5
5297325|NCT00555906|13021340|P5|NOT COMPLETED|Phase 2||32
5297326|NCT00555906|13021341|P4|NOT COMPLETED|Phase 2||0
5297327|NCT00555906|13021342|P3|NOT COMPLETED|Phase 2||0
5297328|NCT00555906|13021343|P2|NOT COMPLETED|Phase 2||0
5297329|NCT00555906|13021344|P1|NOT COMPLETED|Phase 2||0
5297330|NCT00555906|13021340|P5|COMPLETED|Phase 2||0
5297331|NCT00555906|13021341|P4|COMPLETED|Phase 2||0
5297332|NCT00555906|13021342|P3|COMPLETED|Phase 2||0
5297333|NCT00555906|13021343|P2|COMPLETED|Phase 2||0
5297334|NCT00555906|13021344|P1|COMPLETED|Phase 2||0
5297335|NCT00555906|13021340|P5|Treated|Phase 2||30
5297336|NCT00555906|13021341|P4|Treated|Phase 2||0
5297337|NCT00555906|13021342|P3|Treated|Phase 2||0
5297338|NCT00555906|13021343|P2|Treated|Phase 2||0
5297339|NCT00555906|13021344|P1|Treated|Phase 2||0
5297340|NCT00555906|13021340|P5|STARTED|Phase 2||32
5297341|NCT00555906|13021341|P4|STARTED|Phase 2||0
5297342|NCT00555906|13021342|P3|STARTED|Phase 2||0
5297343|NCT00555906|13021343|P2|STARTED|Phase 2||0
5297344|NCT00555906|13021344|P1|STARTED|Phase 2||0
5297345|NCT00555906|13021340|P5|NOT COMPLETED|Phase 1||0
5297346|NCT00555906|13021341|P4|NOT COMPLETED|Phase 1||5
5297347|NCT00555906|13021342|P3|NOT COMPLETED|Phase 1||7
5297348|NCT00555906|13021343|P2|NOT COMPLETED|Phase 1||6
5297349|NCT00555906|13021344|P1|NOT COMPLETED|Phase 1||3
5297350|NCT00555906|13021340|P5|COMPLETED|Phase 1||0
5297351|NCT00555906|13021341|P4|COMPLETED|Phase 1||0
5297352|NCT00555906|13021342|P3|COMPLETED|Phase 1||0
5297353|NCT00555906|13021343|P2|COMPLETED|Phase 1||0
5297354|NCT00555906|13021344|P1|COMPLETED|Phase 1||0
5297355|NCT00555906|13021340|P5|STARTED|Phase 1||0
5297356|NCT00555906|13021341|P4|STARTED|Phase 1||5
5297357|NCT00555906|13021342|P3|STARTED|Phase 1||7
5297358|NCT00555906|13021343|P2|STARTED|Phase 1||6
5297359|NCT00555906|13021344|P1|STARTED|Phase 1||3
5297360|NCT00555893|13021376|P2|NOT COMPLETED|Overall Study||0
5297361|NCT00555893|13021377|P1|NOT COMPLETED|Overall Study||0
5297362|NCT00555893|13021376|P2|COMPLETED|Overall Study||63
5297363|NCT00555893|13021377|P1|COMPLETED|Overall Study||130
5297364|NCT00555893|13021376|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
5297365|NCT00555893|13021377|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
5297366|NCT00555893|13021376|P2|STARTED|Overall Study||63
5297367|NCT00555893|13021377|P1|STARTED|Overall Study||130
5297368|NCT00555880|13021393|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5297369|NCT00555880|13021394|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
5297370|NCT00555880|13021393|P2|COMPLETED|Treatment Period 2 (1 Day)||11
5297371|NCT00555880|13021394|P1|COMPLETED|Treatment Period 2 (1 Day)||13
5297372|NCT00555880|13021393|P2|STARTED|Treatment Period 2 (1 Day)||11
5297373|NCT00555880|13021394|P1|STARTED|Treatment Period 2 (1 Day)||13
5297374|NCT00555880|13021393|P2|NOT COMPLETED|Washout (1 Day)||0
5297375|NCT00555880|13021394|P1|NOT COMPLETED|Washout (1 Day)||0
5297376|NCT00555880|13021393|P2|COMPLETED|Washout (1 Day)||11
5297377|NCT00555880|13021394|P1|COMPLETED|Washout (1 Day)||13
5297378|NCT00555880|13021393|P2|STARTED|Washout (1 Day)||11
5297379|NCT00555880|13021394|P1|STARTED|Washout (1 Day)||13
5297380|NCT00555880|13021393|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5297381|NCT00555880|13021394|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
5297382|NCT00555880|13021393|P2|COMPLETED|Treatment Period 1 (1 Day)||11
5297383|NCT00555880|13021394|P1|COMPLETED|Treatment Period 1 (1 Day)||13
5297384|NCT00555880|13021393|P2|STARTED|Treatment Period 1 (1 Day)||11
5297385|NCT00555880|13021394|P1|STARTED|Treatment Period 1 (1 Day)||13
5297386|NCT00555750|13021433|P2|NOT COMPLETED|Overall Study||0
5297387|NCT00555750|13021434|P1|NOT COMPLETED|Overall Study||0
5297388|NCT00555750|13021433|P2|COMPLETED|Overall Study||10
5297389|NCT00555750|13021434|P1|COMPLETED|Overall Study||10
5297390|NCT00555750|13021433|P2|STARTED|Overall Study||10
5297391|NCT00555750|13021434|P1|STARTED|Overall Study||10
5297392|NCT00555672|13021466|P2|NOT COMPLETED|Overall Study||10
5297393|NCT00555672|13021467|P1|NOT COMPLETED|Overall Study||24
5297394|NCT00555672|13021466|P2|COMPLETED|Overall Study||0
5297395|NCT00555672|13021467|P1|COMPLETED|Overall Study||0
5297396|NCT00555672|13021466|P2|STARTED|Overall Study||10
5297397|NCT00555672|13021467|P1|STARTED|Overall Study||24
5297398|NCT00555620|13021492|P6|NOT COMPLETED|Overall Study||22
5297399|NCT00555620|13021493|P5|NOT COMPLETED|Overall Study||3
5297400|NCT00555620|13021494|P4|NOT COMPLETED|Overall Study||23
5297401|NCT00555620|13021495|P3|NOT COMPLETED|Overall Study||15
5297402|NCT00555620|13021496|P2|NOT COMPLETED|Overall Study||7
5297403|NCT00555620|13021497|P1|NOT COMPLETED|Overall Study||6
5297404|NCT00555620|13021492|P6|COMPLETED|Overall Study||0
5297405|NCT00555620|13021493|P5|COMPLETED|Overall Study||0
5297406|NCT00555620|13021494|P4|COMPLETED|Overall Study||0
5297407|NCT00555620|13021495|P3|COMPLETED|Overall Study||0
5297408|NCT00555620|13021496|P2|COMPLETED|Overall Study||0
5297409|NCT00555620|13021497|P1|COMPLETED|Overall Study||0
5297410|NCT00555620|13021492|P6|STARTED|Overall Study||22
5297411|NCT00555620|13021493|P5|STARTED|Overall Study||3
5297412|NCT00555620|13021494|P4|STARTED|Overall Study||23
5297413|NCT00555620|13021495|P3|STARTED|Overall Study||15
5297414|NCT00555620|13021496|P2|STARTED|Overall Study||7
5297415|NCT00555620|13021497|P1|STARTED|Overall Study||6
5297416|NCT00555581|13021609|P1|NOT COMPLETED|Overall Study||6
5297417|NCT00555581|13021609|P1|COMPLETED|Overall Study||24
5297418|NCT00555581|13021609|P1|STARTED|Overall Study||30
5297419|NCT00555568|13021621|P3|NOT COMPLETED|Overall Study||16
5297420|NCT00555568|13021622|P2|NOT COMPLETED|Overall Study||16
5297421|NCT00555568|13021623|P1|NOT COMPLETED|Overall Study||26
5297422|NCT00555568|13021621|P3|COMPLETED|Overall Study||84
5297423|NCT00555568|13021622|P2|COMPLETED|Overall Study||82
5297424|NCT00555568|13021623|P1|COMPLETED|Overall Study||74
5297425|NCT00555568|13021621|P3|STARTED|Overall Study||100
5297426|NCT00555568|13021622|P2|STARTED|Overall Study||98
5297427|NCT00555568|13021623|P1|STARTED|Overall Study||100
5297428|NCT00555477|13021645|P2|NOT COMPLETED|Overall Study||13
5297429|NCT00555477|13021646|P1|NOT COMPLETED|Overall Study||2
5297430|NCT00555477|13021645|P2|COMPLETED|Overall Study||32
5297431|NCT00555477|13021646|P1|COMPLETED|Overall Study||12
5297432|NCT00555477|13021645|P2|STARTED|Overall Study||45
5297433|NCT00555477|13021646|P1|STARTED|Overall Study||14
5297434|NCT00555464|13021653|P2|NOT COMPLETED|Overall Study||3
5297435|NCT00555464|13021654|P1|NOT COMPLETED|Overall Study||0
5297436|NCT00555464|13021653|P2|COMPLETED|Overall Study||1
5297437|NCT00555464|13021654|P1|COMPLETED|Overall Study||4
5297438|NCT00555464|13021653|P2|STARTED|Overall Study||4
5297439|NCT00555464|13021654|P1|STARTED|Overall Study||4
5297440|NCT00555438|13021662|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
5297441|NCT00555438|13021662|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
5297442|NCT00555438|13021662|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
5297443|NCT00555438|13021662|P1|NOT COMPLETED|10 Days Post-operative||4
5297444|NCT00555438|13021662|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
5297445|NCT00555438|13021662|P1|STARTED|10 Days Post-operative||442
5297446|NCT00555425|13021672|P2|NOT COMPLETED|Overall Study||19
5297447|NCT00555425|13021673|P1|NOT COMPLETED|Overall Study||51
5297448|NCT00555425|13021672|P2|COMPLETED|Overall Study||37
5297449|NCT00555425|13021673|P1|COMPLETED|Overall Study||6
5297450|NCT00555425|13021672|P2|STARTED|Overall Study||56
5297451|NCT00555425|13021673|P1|STARTED|Overall Study||57
5297452|NCT00555360|13021693|P2|NOT COMPLETED|Overall Study||36
5297453|NCT00555360|13021694|P1|NOT COMPLETED|Overall Study||27
5297454|NCT00555360|13021693|P2|COMPLETED|Overall Study||153
5297455|NCT00555360|13021694|P1|COMPLETED|Overall Study||156
5297456|NCT00555360|13021693|P2|STARTED|Overall Study||189
5297457|NCT00555360|13021694|P1|STARTED|Overall Study||183
5297458|NCT00555321|13021709|P5|NOT COMPLETED|Long-term Extension Phase||26
5297459|NCT00555321|13021710|P4|NOT COMPLETED|Long-term Extension Phase||38
5297460|NCT00555321|13021711|P3|NOT COMPLETED|Long-term Extension Phase||24
5297461|NCT00555321|13021712|P2|NOT COMPLETED|Long-term Extension Phase||27
5297462|NCT00555321|13021713|P1|NOT COMPLETED|Long-term Extension Phase||30
5297463|NCT00555321|13021709|P5|COMPLETED|Long-term Extension Phase||0
5297464|NCT00555321|13021710|P4|COMPLETED|Long-term Extension Phase||0
5297465|NCT00555321|13021711|P3|COMPLETED|Long-term Extension Phase||0
5297466|NCT00555321|13021712|P2|COMPLETED|Long-term Extension Phase||0
5297467|NCT00555321|13021713|P1|COMPLETED|Long-term Extension Phase||0
5297468|NCT00555321|13021709|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
5297469|NCT00555321|13021710|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
5297470|NCT00555321|13021711|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
5297471|NCT00555321|13021712|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
5297472|NCT00555321|13021713|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
5297473|NCT00555321|13021709|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
5297474|NCT00555321|13021710|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
5297475|NCT00555321|13021711|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
5297476|NCT00555321|13021712|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
5297477|NCT00555321|13021713|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
5297478|NCT00555321|13021709|P5|COMPLETED|Treatment Phase up to 12-months||32
5297479|NCT00555321|13021710|P4|COMPLETED|Treatment Phase up to 12-months||46
5297480|NCT00555321|13021711|P3|COMPLETED|Treatment Phase up to 12-months||26
5297481|NCT00555321|13021712|P2|COMPLETED|Treatment Phase up to 12-months||29
5297482|NCT00555321|13021713|P1|COMPLETED|Treatment Phase up to 12-months||31
5297483|NCT00555321|13021709|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
5297484|NCT00555321|13021710|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
5297485|NCT00555321|13021711|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
5297486|NCT00555321|13021712|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
5297487|NCT00555321|13021713|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
5297488|NCT00555321|13021709|P5|STARTED|Treatment Phase up to 12-months||54
5297489|NCT00555321|13021710|P4|STARTED|Treatment Phase up to 12-months||53
5297490|NCT00555321|13021711|P3|STARTED|Treatment Phase up to 12-months||50
5297491|NCT00555321|13021712|P2|STARTED|Treatment Phase up to 12-months||51
5297492|NCT00555321|13021713|P1|STARTED|Treatment Phase up to 12-months||52
5297493|NCT00555217|13022017|P2|NOT COMPLETED|Overall Study||68
5297494|NCT00555217|13022018|P1|NOT COMPLETED|Overall Study||75
5297495|NCT00555217|13022017|P2|COMPLETED|Overall Study||656
5297496|NCT00555217|13022018|P1|COMPLETED|Overall Study||649
5297497|NCT00555217|13022017|P2|STARTED|Overall Study||724
5297498|NCT00555217|13022018|P1|STARTED|Overall Study||724
5297499|NCT00555152|13022030|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297500|NCT00555152|13022031|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297501|NCT00555152|13022032|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297502|NCT00555152|13022033|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297503|NCT00555152|13022030|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
5297504|NCT00555152|13022031|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297505|NCT00555152|13022032|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
5297506|NCT00555152|13022033|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297507|NCT00555152|13022030|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
5297508|NCT00555152|13022031|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
5297509|NCT00555152|13022032|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
5297510|NCT00555152|13022033|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
5297511|NCT00555152|13022030|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297512|NCT00555152|13022031|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297513|NCT00555152|13022032|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297514|NCT00555152|13022033|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297515|NCT00555152|13022030|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
5297516|NCT00555152|13022031|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297517|NCT00555152|13022032|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
5297518|NCT00555152|13022033|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
5297519|NCT00555152|13022030|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
5297520|NCT00555152|13022031|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
5297521|NCT00555152|13022032|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
5297522|NCT00555152|13022033|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
5297523|NCT00555061|13022055|P1|NOT COMPLETED|Overall Study||9
5297524|NCT00555061|13022055|P1|COMPLETED|Overall Study||78
5297525|NCT00555061|13022055|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
5297526|NCT00555048|13022062|P1|NOT COMPLETED|Overall Study||0
5297527|NCT00555048|13022062|P1|COMPLETED|Overall Study||1
5297528|NCT00555048|13022062|P1|STARTED|Overall Study||1
5297529|NCT00555009|13022074|P2|NOT COMPLETED|Overall Study||6
5297530|NCT00555009|13022075|P1|NOT COMPLETED|Overall Study||2
5297531|NCT00555009|13022074|P2|COMPLETED|Overall Study||0
5297532|NCT00555009|13022075|P1|COMPLETED|Overall Study||2
5297533|NCT00555009|13022074|P2|STARTED|Overall Study||6
5297534|NCT00555009|13022075|P1|STARTED|Overall Study||4
5297535|NCT00554996|13022097|P1|NOT COMPLETED|Overall Study||0
5297536|NCT00554996|13022097|P1|COMPLETED|Overall Study||10
5297537|NCT00554996|13022097|P1|STARTED|Overall Study||10
5297538|NCT00554970|13022105|P4|NOT COMPLETED|Period 2||0
5297539|NCT00554970|13022106|P3|NOT COMPLETED|Period 2||1
5297540|NCT00554970|13022107|P2|NOT COMPLETED|Period 2||0
5297541|NCT00554970|13022108|P1|NOT COMPLETED|Period 2||0
5297542|NCT00554970|13022105|P4|COMPLETED|Period 2||8
5297543|NCT00554970|13022106|P3|COMPLETED|Period 2||7
5297544|NCT00554970|13022107|P2|COMPLETED|Period 2||8
5297545|NCT00554970|13022108|P1|COMPLETED|Period 2||7
5297546|NCT00554970|13022105|P4|STARTED|Period 2||8
5297547|NCT00554970|13022106|P3|STARTED|Period 2||8
5297548|NCT00554970|13022107|P2|STARTED|Period 2||8
5297549|NCT00554970|13022108|P1|STARTED|Period 2||7
5297550|NCT00554970|13022105|P4|NOT COMPLETED|Period 1||0
5297551|NCT00554970|13022106|P3|NOT COMPLETED|Period 1||0
5297552|NCT00554970|13022107|P2|NOT COMPLETED|Period 1||0
5297553|NCT00554970|13022108|P1|NOT COMPLETED|Period 1||1
5297554|NCT00554970|13022105|P4|COMPLETED|Period 1||8
5297555|NCT00554970|13022106|P3|COMPLETED|Period 1||8
5297556|NCT00554970|13022107|P2|COMPLETED|Period 1||8
5297557|NCT00554970|13022108|P1|COMPLETED|Period 1||7
5297558|NCT00554970|13022105|P4|STARTED|Period 1||8
5297559|NCT00554970|13022106|P3|STARTED|Period 1||8
5297560|NCT00554970|13022107|P2|STARTED|Period 1||8
5297561|NCT00554970|13022108|P1|STARTED|Period 1||8
5297562|NCT00554853|13022140|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
5297563|NCT00554853|13022141|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
5297564|NCT00554853|13022140|P2|COMPLETED|Crossover Arm (3 Months)||55
5297565|NCT00554853|13022141|P1|COMPLETED|Crossover Arm (3 Months)||53
5297566|NCT00554853|13022140|P2|STARTED|Crossover Arm (3 Months)||57
5297567|NCT00554853|13022141|P1|STARTED|Crossover Arm (3 Months)||56
5297568|NCT00554853|13022140|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
5297569|NCT00554853|13022141|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
5297570|NCT00554853|13022140|P2|COMPLETED|Washout Period (2 Weeks)||57
5297571|NCT00554853|13022141|P1|COMPLETED|Washout Period (2 Weeks)||56
5297572|NCT00554853|13022140|P2|STARTED|Washout Period (2 Weeks)||64
5297573|NCT00554853|13022141|P1|STARTED|Washout Period (2 Weeks)||56
5297574|NCT00554853|13022140|P2|NOT COMPLETED|First Arm of Study||7
5297575|NCT00554853|13022141|P1|NOT COMPLETED|First Arm of Study||16
5297576|NCT00554853|13022140|P2|COMPLETED|First Arm of Study||64
5297577|NCT00554853|13022141|P1|COMPLETED|First Arm of Study||56
5297578|NCT00554853|13022140|P2|STARTED|First Arm of Study||71
5297579|NCT00554853|13022141|P1|STARTED|First Arm of Study||72
5297580|NCT00554840|13022155|P2|NOT COMPLETED|Overall Study||1
5297581|NCT00554840|13022156|P1|NOT COMPLETED|Overall Study||0
5297582|NCT00554840|13022155|P2|COMPLETED|Overall Study||4
5297583|NCT00554840|13022156|P1|COMPLETED|Overall Study||4
5297584|NCT00554840|13022155|P2|STARTED|Overall Study||5
5297585|NCT00554840|13022156|P1|STARTED|Overall Study||4
5297586|NCT00554801|13022174|P2|NOT COMPLETED|Overall Study||0
5297587|NCT00554801|13022175|P1|NOT COMPLETED|Overall Study||19
5297588|NCT00554801|13022174|P2|COMPLETED|Overall Study||29
5297589|NCT00554801|13022175|P1|COMPLETED|Overall Study||36
5297590|NCT00554801|13022174|P2|STARTED|Overall Study||29
5297591|NCT00554801|13022175|P1|STARTED|Overall Study||55
5297592|NCT00554788|13022186|P3|NOT COMPLETED|Overall Study||14
5297593|NCT00554788|13022187|P2|NOT COMPLETED|Overall Study||6
5297594|NCT00554788|13022188|P1|NOT COMPLETED|Overall Study||7
5297595|NCT00554788|13022186|P3|COMPLETED|Overall Study||7
5297596|NCT00554788|13022187|P2|COMPLETED|Overall Study||12
5297597|NCT00554788|13022188|P1|COMPLETED|Overall Study||14
5297598|NCT00554788|13022186|P3|STARTED|Overall Study||21
5297599|NCT00554788|13022187|P2|STARTED|Overall Study||18
5297600|NCT00554788|13022188|P1|STARTED|Overall Study||21
5297601|NCT00554749|13022200|P1|NOT COMPLETED|Overall Study||0
5297602|NCT00554749|13022200|P1|COMPLETED|Overall Study||7
5297603|NCT00554749|13022200|P1|STARTED|Overall Study||7
5297604|NCT00554671|13022207|P2|NOT COMPLETED|Overall Study||16
5297605|NCT00554671|13022208|P1|NOT COMPLETED|Overall Study||20
5297606|NCT00554671|13022207|P2|COMPLETED|Overall Study||117
5297607|NCT00554671|13022208|P1|COMPLETED|Overall Study||97
5297608|NCT00554671|13022207|P2|STARTED|Overall Study||133
5297609|NCT00554671|13022208|P1|STARTED|Overall Study||117
5297610|NCT00554619|13022220|P1|NOT COMPLETED|Overall Study||3
5297611|NCT00554619|13022220|P1|COMPLETED|Overall Study||18
5297612|NCT00554619|13022220|P1|STARTED|Overall Study||21
5297613|NCT00554515|13022232|P1|NOT COMPLETED|Overall Study||118
5297614|NCT00554515|13022232|P1|COMPLETED|Overall Study||5
5297615|NCT00554515|13022232|P1|Treated|Overall Study||120
5297616|NCT00554515|13022232|P1|STARTED|Overall Study||123
5297617|NCT00554463|13022261|P1|NOT COMPLETED|Overall Study||0
5297618|NCT00554463|13022261|P1|COMPLETED|Overall Study||5
5297619|NCT00554463|13022261|P1|STARTED|Overall Study||5
5297620|NCT00554372|13022273|P2|NOT COMPLETED|Overall Study||0
5297621|NCT00554372|13022274|P1|NOT COMPLETED|Overall Study||0
5297622|NCT00554372|13022273|P2|COMPLETED|Overall Study||16
5297623|NCT00554372|13022274|P1|COMPLETED|Overall Study||14
5297624|NCT00554372|13022273|P2|STARTED|Overall Study||16
5297625|NCT00554372|13022274|P1|STARTED|Overall Study||14
5297626|NCT00554294|13022288|P2|NOT COMPLETED|Overall Study||80
5297627|NCT00554294|13022289|P1|NOT COMPLETED|Overall Study||160
5297628|NCT00554294|13022288|P2|COMPLETED|Overall Study||1641
5297629|NCT00554294|13022289|P1|COMPLETED|Overall Study||1309
5297630|NCT00554294|13022288|P2|STARTED|Overall Study||1721
5297631|NCT00554294|13022289|P1|STARTED|Overall Study||1469
5297632|NCT00554229|13022295|P2|NOT COMPLETED|Overall Study||225
5297633|NCT00554229|13022296|P1|NOT COMPLETED|Overall Study||226
5297634|NCT00554229|13022295|P2|COMPLETED|Overall Study||70
5297635|NCT00554229|13022296|P1|COMPLETED|Overall Study||73
5297636|NCT00554229|13022295|P2|Patients Who Received Treatment|Overall Study||295
5297637|NCT00554229|13022296|P1|Patients Who Received Treatment|Overall Study||298
5297638|NCT00554229|13022295|P2|STARTED|Overall Study||295
5297639|NCT00554229|13022296|P1|STARTED|Overall Study||299
5297640|NCT00554216|13022321|P3|NOT COMPLETED|Overall Study||172
5297641|NCT00554216|13022322|P2|NOT COMPLETED|Overall Study||94
5297642|NCT00554216|13022323|P1|NOT COMPLETED|Overall Study||242
5297643|NCT00554216|13022321|P3|COMPLETED|Overall Study||340
5297644|NCT00554216|13022322|P2|COMPLETED|Overall Study||147
5297645|NCT00554216|13022323|P1|COMPLETED|Overall Study||272
5297646|NCT00554216|13022321|P3|STARTED|Overall Study||512
5297647|NCT00554216|13022322|P2|STARTED|Overall Study||241
5297648|NCT00554216|13022323|P1|STARTED|Overall Study||514
5297649|NCT00554190|13022334|P1|NOT COMPLETED|Overall Study||10
5297650|NCT00554190|13022334|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
5297651|NCT00554190|13022334|P1|STARTED|Overall Study|29 subjects treated.|29
5297652|NCT00554099|13022343|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
5297653|NCT00554099|13022344|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
5297654|NCT00554099|13022345|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
5297655|NCT00554099|13022343|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
5297656|NCT00554099|13022344|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
5297657|NCT00554099|13022345|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
5297658|NCT00554099|13022343|P3|STARTED|Non-Treatment Phase (9 Months)||27
5297659|NCT00554099|13022344|P2|STARTED|Non-Treatment Phase (9 Months)||32
5297660|NCT00554099|13022345|P1|STARTED|Non-Treatment Phase (9 Months)||29
5297661|NCT00554099|13022343|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
5297662|NCT00554099|13022344|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
5297663|NCT00554099|13022345|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
5297664|NCT00554099|13022343|P3|COMPLETED|Treatment Period (12 Weeks)||27
5297665|NCT00554099|13022344|P2|COMPLETED|Treatment Period (12 Weeks)||32
5297666|NCT00554099|13022345|P1|COMPLETED|Treatment Period (12 Weeks)||29
5297667|NCT00554099|13022343|P3|STARTED|Treatment Period (12 Weeks)||36
5297668|NCT00554099|13022344|P2|STARTED|Treatment Period (12 Weeks)||40
5297669|NCT00554099|13022345|P1|STARTED|Treatment Period (12 Weeks)||41
5297670|NCT00553969|13022378|P4|NOT COMPLETED|Overall Study||1
5297671|NCT00553969|13022379|P3|NOT COMPLETED|Overall Study||1
5297672|NCT00553969|13022380|P2|NOT COMPLETED|Overall Study||0
5297673|NCT00553969|13022381|P1|NOT COMPLETED|Overall Study||8
5297674|NCT00553969|13022378|P4|COMPLETED|Overall Study||23
5297675|NCT00553969|13022379|P3|COMPLETED|Overall Study||21
5297676|NCT00553969|13022380|P2|COMPLETED|Overall Study||24
5297677|NCT00553969|13022381|P1|COMPLETED|Overall Study||23
5297678|NCT00553969|13022378|P4|STARTED|Overall Study||24
5297679|NCT00553969|13022379|P3|STARTED|Overall Study||22
5297680|NCT00553969|13022380|P2|STARTED|Overall Study||24
5297681|NCT00553969|13022381|P1|STARTED|Overall Study||31
5297682|NCT00553839|13022391|P1|NOT COMPLETED|Overall Study||0
5297683|NCT00553839|13022391|P1|COMPLETED|Overall Study||21
5297684|NCT00553839|13022391|P1|STARTED|Overall Study||21
5297685|NCT00553787|13022400|P3|NOT COMPLETED|Overall Study||262
5297686|NCT00553787|13022401|P2|NOT COMPLETED|Overall Study||124
5297687|NCT00553787|13022402|P1|NOT COMPLETED|Overall Study||378
5297688|NCT00553787|13022400|P3|COMPLETED|Overall Study||733
5297689|NCT00553787|13022401|P2|COMPLETED|Overall Study||374
5297690|NCT00553787|13022402|P1|COMPLETED|Overall Study||616
5297691|NCT00553787|13022400|P3|STARTED|Overall Study||995
5297692|NCT00553787|13022401|P2|STARTED|Overall Study||498
5297693|NCT00553787|13022402|P1|STARTED|Overall Study||994
5297694|NCT00553735|13022413|P1|NOT COMPLETED|Overall Study||7
5297695|NCT00553735|13022413|P1|COMPLETED|Overall Study||1
5297696|NCT00553735|13022413|P1|STARTED|Overall Study||8
5297697|NCT00553696|13022434|P4|NOT COMPLETED|Overall Study||1
5297698|NCT00553696|13022435|P3|NOT COMPLETED|Overall Study||6
5297699|NCT00553696|13022436|P2|NOT COMPLETED|Overall Study||16
5297700|NCT00553696|13022437|P1|NOT COMPLETED|Overall Study||4
5297701|NCT00553696|13022434|P4|COMPLETED|Overall Study||0
5297702|NCT00553696|13022435|P3|COMPLETED|Overall Study||0
5297703|NCT00553696|13022436|P2|COMPLETED|Overall Study||0
5297704|NCT00553696|13022437|P1|COMPLETED|Overall Study||0
5297705|NCT00553696|13022434|P4|STARTED|Overall Study||1
5297706|NCT00553696|13022435|P3|STARTED|Overall Study||6
5297707|NCT00553696|13022436|P2|STARTED|Overall Study||16
5297708|NCT00553696|13022437|P1|STARTED|Overall Study||4
5297709|NCT00553644|13022475|P1|NOT COMPLETED|Overall Study||28
5297710|NCT00553644|13022475|P1|COMPLETED|Overall Study||25
5297711|NCT00553644|13022475|P1|STARTED|Overall Study||53
5297712|NCT00553631|13022484|P2|NOT COMPLETED|Overall Study||1
5297713|NCT00553631|13022485|P1|NOT COMPLETED|Overall Study||1
5297714|NCT00553631|13022484|P2|COMPLETED|Overall Study||16
5297715|NCT00553631|13022485|P1|COMPLETED|Overall Study||16
5297716|NCT00553631|13022484|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
5297717|NCT00553631|13022485|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
5297718|NCT00553605|13022507|P2|NOT COMPLETED|Overall Study||3
5297719|NCT00553605|13022508|P1|NOT COMPLETED|Overall Study||4
5297720|NCT00553605|13022507|P2|COMPLETED|Overall Study||161
5297721|NCT00553605|13022508|P1|COMPLETED|Overall Study||172
5297722|NCT00553605|13022507|P2|Treated|Overall Study||164
5297723|NCT00553605|13022508|P1|Treated|Overall Study||174
5297724|NCT00553605|13022507|P2|STARTED|Overall Study||164
5297725|NCT00553605|13022508|P1|STARTED|Overall Study||176
5297726|NCT00553540|13022534|P2|NOT COMPLETED|Overall Study||5
5297727|NCT00553540|13022535|P1|NOT COMPLETED|Overall Study||2
5297728|NCT00553540|13022534|P2|COMPLETED|Overall Study||20
5297729|NCT00553540|13022535|P1|COMPLETED|Overall Study||23
5297730|NCT00553540|13022534|P2|STARTED|Overall Study||25
5297731|NCT00553540|13022535|P1|STARTED|Overall Study||25
5297732|NCT00553514|13022546|P5|NOT COMPLETED|Overall Study||7
5297733|NCT00553514|13022547|P4|NOT COMPLETED|Overall Study||7
5297734|NCT00553514|13022548|P3|NOT COMPLETED|Overall Study||6
5297735|NCT00553514|13022549|P2|NOT COMPLETED|Overall Study||8
5297736|NCT00553514|13022550|P1|NOT COMPLETED|Overall Study||8
5297737|NCT00553514|13022546|P5|COMPLETED|Overall Study||8
5297738|NCT00553514|13022547|P4|COMPLETED|Overall Study||6
5297739|NCT00553514|13022548|P3|COMPLETED|Overall Study||9
5297740|NCT00553514|13022549|P2|COMPLETED|Overall Study||6
5297741|NCT00553514|13022550|P1|COMPLETED|Overall Study||6
5297742|NCT00553514|13022546|P5|STARTED|Overall Study||15
5297743|NCT00553514|13022547|P4|STARTED|Overall Study||13
5297744|NCT00553514|13022548|P3|STARTED|Overall Study||15
5297745|NCT00553514|13022549|P2|STARTED|Overall Study||14
5297746|NCT00553514|13022550|P1|STARTED|Overall Study||14
5297747|NCT00553501|13022587|P1|NOT COMPLETED|Overall Study||4
5297748|NCT00553501|13022587|P1|COMPLETED|Overall Study||55
5297749|NCT00553501|13022587|P1|STARTED|Overall Study||59
5297750|NCT00553475|13022596|P3|NOT COMPLETED|Overall Study||13
5297751|NCT00553475|13022597|P2|NOT COMPLETED|Overall Study||20
5297752|NCT00553475|13022598|P1|NOT COMPLETED|Overall Study||16
5297753|NCT00553475|13022596|P3|COMPLETED|Overall Study||32
5297754|NCT00553475|13022597|P2|COMPLETED|Overall Study||114
5297755|NCT00553475|13022598|P1|COMPLETED|Overall Study||119
5297756|NCT00553475|13022596|P3|STARTED|Overall Study||45
5297757|NCT00553475|13022597|P2|STARTED|Overall Study||134
5297758|NCT00553475|13022598|P1|STARTED|Overall Study||135
5297759|NCT00553462|13022720|P1|NOT COMPLETED|Overall Study||14
5297760|NCT00553462|13022720|P1|COMPLETED|Overall Study||61
5297761|NCT00553462|13022720|P1|STARTED|Overall Study||75
5297762|NCT00553436|13022726|P1|NOT COMPLETED|Overall Study||1
5297763|NCT00553436|13022726|P1|COMPLETED|Overall Study|09 April 2009|6
5297764|NCT00553436|13022726|P1|STARTED|Overall Study|20 August 2007|7
5297765|NCT00553410|13022734|P2|NOT COMPLETED|Overall Study||18
5297766|NCT00553410|13022735|P1|NOT COMPLETED|Overall Study||15
5297767|NCT00553410|13022734|P2|COMPLETED|Overall Study||2425
5297768|NCT00553410|13022735|P1|COMPLETED|Overall Study||2426
5297769|NCT00553410|13022734|P2|STARTED|Overall Study||2443
5297770|NCT00553410|13022735|P1|STARTED|Overall Study||2441
5297771|NCT00553358|13022750|P3|NOT COMPLETED|Overall Study||60
5297772|NCT00553358|13022751|P2|NOT COMPLETED|Overall Study||12
5297773|NCT00553358|13022752|P1|NOT COMPLETED|Overall Study||53
5297774|NCT00553358|13022750|P3|COMPLETED|Overall Study||92
5297775|NCT00553358|13022751|P2|COMPLETED|Overall Study||137
5297776|NCT00553358|13022752|P1|COMPLETED|Overall Study||101
5297777|NCT00553358|13022750|P3|STARTED|Overall Study||152
5297778|NCT00553358|13022751|P2|STARTED|Overall Study||149
5297779|NCT00553358|13022752|P1|STARTED|Overall Study||154
5297780|NCT00553332|13022778|P1|NOT COMPLETED|Overall Study||1
5297781|NCT00553332|13022778|P1|COMPLETED|Overall Study|evaluable for response|28
5297782|NCT00553332|13022778|P1|STARTED|Overall Study||29
5297783|NCT00553319|13022790|P3|NOT COMPLETED|Overall Study||9
5297784|NCT00553319|13022791|P2|NOT COMPLETED|Overall Study||10
5297785|NCT00553319|13022792|P1|NOT COMPLETED|Overall Study||14
5297786|NCT00553319|13022790|P3|COMPLETED|Overall Study||34
5297787|NCT00553319|13022791|P2|COMPLETED|Overall Study||30
5297788|NCT00553319|13022792|P1|COMPLETED|Overall Study||29
5297789|NCT00553319|13022790|P3|STARTED|Overall Study||43
5297790|NCT00553319|13022791|P2|STARTED|Overall Study||40
5297791|NCT00553319|13022792|P1|STARTED|Overall Study||43
5297792|NCT00553280|13022803|P1|NOT COMPLETED|Overall Study||26
5297793|NCT00553280|13022803|P1|COMPLETED|Overall Study||97
5297794|NCT00553280|13022803|P1|STARTED|Overall Study||123
5297795|NCT00553267|13022815|P3|NOT COMPLETED|Overall Study||10
5297796|NCT00553267|13022816|P2|NOT COMPLETED|Overall Study||18
5297797|NCT00553267|13022817|P1|NOT COMPLETED|Overall Study||14
5297798|NCT00553267|13022815|P3|COMPLETED|Overall Study||307
5297799|NCT00553267|13022816|P2|COMPLETED|Overall Study||297
5297800|NCT00553267|13022817|P1|COMPLETED|Overall Study||301
5297801|NCT00553267|13022815|P3|STARTED|Overall Study||317
5297802|NCT00553267|13022816|P2|STARTED|Overall Study||315
5297803|NCT00553267|13022817|P1|STARTED|Overall Study||315
5297804|NCT00553202|13022852|P1|NOT COMPLETED|Overall Study||68
5297805|NCT00553202|13022852|P1|COMPLETED|Overall Study||90
5297806|NCT00553202|13022852|P1|STARTED|Overall Study||158
5297807|NCT00553163|13022862|P2|NOT COMPLETED|Overall Study||0
5297808|NCT00553163|13022863|P1|NOT COMPLETED|Overall Study||0
5297809|NCT00553163|13022862|P2|COMPLETED|Overall Study||10
5297810|NCT00553163|13022863|P1|COMPLETED|Overall Study||16
5297811|NCT00553163|13022862|P2|STARTED|Overall Study||10
5297812|NCT00553163|13022863|P1|STARTED|Overall Study||16
5297813|NCT00553150|13022879|P4|NOT COMPLETED|Overall Study||4
5297814|NCT00553150|13022880|P3|NOT COMPLETED|Overall Study||0
5297815|NCT00553150|13022881|P2|NOT COMPLETED|Overall Study||0
5297816|NCT00553150|13022882|P1|NOT COMPLETED|Overall Study||0
5297817|NCT00553150|13022879|P4|COMPLETED|Overall Study||100
5297818|NCT00553150|13022880|P3|COMPLETED|Overall Study||6
5297819|NCT00553150|13022881|P2|COMPLETED|Overall Study||6
5297820|NCT00553150|13022882|P1|COMPLETED|Overall Study||6
5297821|NCT00553150|13022879|P4|STARTED|Overall Study||104
5297822|NCT00553150|13022880|P3|STARTED|Overall Study||6
5297823|NCT00553150|13022881|P2|STARTED|Overall Study||6
5297824|NCT00553150|13022882|P1|STARTED|Overall Study||6
5297825|NCT00553098|13022894|P1|NOT COMPLETED|Overall Study||1
5297826|NCT00553098|13022894|P1|COMPLETED|Overall Study||28
5297827|NCT00553098|13022894|P1|STARTED|Overall Study||29
5297828|NCT00552929|13022918|P10|NOT COMPLETED|Overall Study||0
5297829|NCT00552929|13022919|P9|NOT COMPLETED|Overall Study||1
5297830|NCT00552929|13022920|P8|NOT COMPLETED|Overall Study||0
5297831|NCT00552929|13022921|P7|NOT COMPLETED|Overall Study||0
5297832|NCT00552929|13022922|P6|NOT COMPLETED|Overall Study||1
5297833|NCT00552929|13022923|P5|NOT COMPLETED|Overall Study||0
5297834|NCT00552929|13022924|P4|NOT COMPLETED|Overall Study||0
5297835|NCT00552929|13022925|P3|NOT COMPLETED|Overall Study||0
5297836|NCT00552929|13022926|P2|NOT COMPLETED|Overall Study||0
5297837|NCT00552929|13022927|P1|NOT COMPLETED|Overall Study||0
5297838|NCT00552929|13022918|P10|COMPLETED|Overall Study||11
5297839|NCT00552929|13022919|P9|COMPLETED|Overall Study||9
5297840|NCT00552929|13022920|P8|COMPLETED|Overall Study||11
5297841|NCT00552929|13022921|P7|COMPLETED|Overall Study||10
5297842|NCT00552929|13022922|P6|COMPLETED|Overall Study||9
5297843|NCT00552929|13022923|P5|COMPLETED|Overall Study||10
5297844|NCT00552929|13022924|P4|COMPLETED|Overall Study||11
5297845|NCT00552929|13022925|P3|COMPLETED|Overall Study||10
5297846|NCT00552929|13022926|P2|COMPLETED|Overall Study||10
5297847|NCT00552929|13022927|P1|COMPLETED|Overall Study||9
5297848|NCT00552929|13022918|P10|Participants as Treated|Overall Study||11
5297849|NCT00552929|13022919|P9|Participants as Treated|Overall Study||10
5297850|NCT00552929|13022920|P8|Participants as Treated|Overall Study||11
5297851|NCT00552929|13022921|P7|Participants as Treated|Overall Study||10
5297852|NCT00552929|13022922|P6|Participants as Treated|Overall Study||9
5297853|NCT00552929|13022923|P5|Participants as Treated|Overall Study||10
5297854|NCT00552929|13022924|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
5297855|NCT00552929|13022925|P3|Participants as Treated|Overall Study||10
5297856|NCT00552929|13022926|P2|Participants as Treated|Overall Study||10
5297857|NCT00552929|13022927|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
5297858|NCT00552929|13022918|P10|STARTED|Overall Study||11
5297859|NCT00552929|13022919|P9|STARTED|Overall Study||10
5297860|NCT00552929|13022920|P8|STARTED|Overall Study||11
5297861|NCT00552929|13022921|P7|STARTED|Overall Study||10
5297862|NCT00552929|13022922|P6|STARTED|Overall Study||10
5297863|NCT00552929|13022923|P5|STARTED|Overall Study||10
5297864|NCT00552929|13022924|P4|STARTED|Overall Study||11
5297865|NCT00552929|13022925|P3|STARTED|Overall Study||10
5297866|NCT00552929|13022926|P2|STARTED|Overall Study||10
5297867|NCT00552929|13022927|P1|STARTED|Overall Study||9
5297868|NCT00552812|13022979|P1|NOT COMPLETED|Overall Study||20
5297869|NCT00552812|13022979|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
5297870|NCT00552812|13022979|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
5297871|NCT00552786|13022987|P2|NOT COMPLETED|Second Intervention||0
5297872|NCT00552786|13022988|P1|NOT COMPLETED|Second Intervention||0
5297873|NCT00552786|13022987|P2|COMPLETED|Second Intervention||28
5297874|NCT00552786|13022988|P1|COMPLETED|Second Intervention||25
5297875|NCT00552786|13022987|P2|STARTED|Second Intervention||28
5297876|NCT00552786|13022988|P1|STARTED|Second Intervention||25
5297877|NCT00552786|13022987|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5297878|NCT00552786|13022988|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5297879|NCT00552786|13022987|P2|COMPLETED|Washout Period of 2 Weeks||28
5297880|NCT00552786|13022988|P1|COMPLETED|Washout Period of 2 Weeks||25
5297881|NCT00552786|13022987|P2|STARTED|Washout Period of 2 Weeks||28
5297882|NCT00552786|13022988|P1|STARTED|Washout Period of 2 Weeks||25
5297883|NCT00552786|13022987|P2|NOT COMPLETED|First Intervention||0
5297884|NCT00552786|13022988|P1|NOT COMPLETED|First Intervention||0
5297885|NCT00552786|13022987|P2|COMPLETED|First Intervention||28
5297886|NCT00552786|13022988|P1|COMPLETED|First Intervention||25
5297887|NCT00552786|13022987|P2|Medication and Hearing Evaluation|First Intervention||28
5297888|NCT00552786|13022988|P1|Medication and Hearing Evaluation|First Intervention||25
5297889|NCT00552786|13022987|P2|STARTED|First Intervention||28
5297890|NCT00552786|13022988|P1|STARTED|First Intervention||25
5297891|NCT00552760|13022998|P2|NOT COMPLETED|Overall Study||33
5297892|NCT00552760|13022999|P1|NOT COMPLETED|Overall Study||26
5297893|NCT00552760|13022998|P2|COMPLETED|Overall Study||8
5297894|NCT00552760|13022999|P1|COMPLETED|Overall Study||16
5297895|NCT00552760|13022998|P2|STARTED|Overall Study||41
5297896|NCT00552760|13022999|P1|STARTED|Overall Study||42
5297897|NCT00552695|13023015|P2|NOT COMPLETED|Overall Study||0
5297898|NCT00552695|13023016|P1|NOT COMPLETED|Overall Study||0
5297899|NCT00552695|13023015|P2|COMPLETED|Overall Study|September 2007|23
5297900|NCT00552695|13023016|P1|COMPLETED|Overall Study|September 2007|22
5297901|NCT00552695|13023015|P2|STARTED|Overall Study|August 2007|23
5297902|NCT00552695|13023016|P1|STARTED|Overall Study|August 2007|22
5297903|NCT00552669|13023026|P2|NOT COMPLETED|Overall Study||7
5297904|NCT00552669|13023027|P1|NOT COMPLETED|Overall Study||3
5297905|NCT00552669|13023026|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
5297906|NCT00552669|13023027|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
5297907|NCT00552669|13023026|P2|STARTED|Overall Study|patients|100
5297908|NCT00552669|13023027|P1|STARTED|Overall Study|patients|100
5297909|NCT00552617|13023047|P10|NOT COMPLETED|Overall Study||1
5297910|NCT00552617|13023048|P9|NOT COMPLETED|Overall Study||2
5297911|NCT00552617|13023049|P8|NOT COMPLETED|Overall Study||0
5297912|NCT00552617|13023050|P7|NOT COMPLETED|Overall Study||0
5297913|NCT00552617|13023051|P6|NOT COMPLETED|Overall Study||2
5297914|NCT00552617|13023052|P5|NOT COMPLETED|Overall Study||0
5297915|NCT00552617|13023053|P4|NOT COMPLETED|Overall Study||1
5297916|NCT00552617|13023054|P3|NOT COMPLETED|Overall Study||1
5297917|NCT00552617|13023055|P2|NOT COMPLETED|Overall Study||0
5297918|NCT00552617|13023056|P1|NOT COMPLETED|Overall Study||0
5297919|NCT00552617|13023047|P10|COMPLETED|Overall Study||9
5297920|NCT00552617|13023048|P9|COMPLETED|Overall Study||8
5297921|NCT00552617|13023049|P8|COMPLETED|Overall Study||10
5297922|NCT00552617|13023050|P7|COMPLETED|Overall Study||10
5297923|NCT00552617|13023051|P6|COMPLETED|Overall Study||8
5297924|NCT00552617|13023052|P5|COMPLETED|Overall Study||10
5297925|NCT00552617|13023053|P4|COMPLETED|Overall Study||9
5297926|NCT00552617|13023054|P3|COMPLETED|Overall Study||9
5297927|NCT00552617|13023055|P2|COMPLETED|Overall Study||10
5297928|NCT00552617|13023056|P1|COMPLETED|Overall Study||10
5297929|NCT00552617|13023047|P10|Treated|Overall Study||9
5297930|NCT00552617|13023048|P9|Treated|Overall Study||10
5297931|NCT00552617|13023049|P8|Treated|Overall Study||10
5297932|NCT00552617|13023050|P7|Treated|Overall Study||10
5297933|NCT00552617|13023051|P6|Treated|Overall Study||10
5297934|NCT00552617|13023052|P5|Treated|Overall Study||10
5297935|NCT00552617|13023053|P4|Treated|Overall Study||10
5297936|NCT00552617|13023054|P3|Treated|Overall Study||9
5297937|NCT00552617|13023055|P2|Treated|Overall Study||10
5297938|NCT00552617|13023056|P1|Treated|Overall Study||10
5297939|NCT00552617|13023047|P10|STARTED|Overall Study||10
5297940|NCT00552617|13023048|P9|STARTED|Overall Study||10
5297941|NCT00552617|13023049|P8|STARTED|Overall Study||10
5297942|NCT00552617|13023050|P7|STARTED|Overall Study||10
5297943|NCT00552617|13023051|P6|STARTED|Overall Study||10
5297944|NCT00552617|13023052|P5|STARTED|Overall Study||10
5297945|NCT00552617|13023053|P4|STARTED|Overall Study||10
5297946|NCT00552617|13023054|P3|STARTED|Overall Study||10
5297947|NCT00552617|13023055|P2|STARTED|Overall Study||10
5297948|NCT00552617|13023056|P1|STARTED|Overall Study||10
5297949|NCT00552578|13023100|P2|NOT COMPLETED|Overall Study||1
5297950|NCT00552578|13023101|P1|NOT COMPLETED|Overall Study||1
5297951|NCT00552578|13023100|P2|COMPLETED|Overall Study||5
5297952|NCT00552578|13023101|P1|COMPLETED|Overall Study||5
5297953|NCT00552578|13023100|P2|STARTED|Overall Study||6
5297954|NCT00552578|13023101|P1|STARTED|Overall Study||6
5297955|NCT00552513|13023113|P2|NOT COMPLETED|Overall Study||1
5297956|NCT00552513|13023114|P1|NOT COMPLETED|Overall Study||5
5297957|NCT00552513|13023113|P2|COMPLETED|Overall Study||1437
5297958|NCT00552513|13023114|P1|COMPLETED|Overall Study||1588
5297959|NCT00552513|13023113|P2|STARTED|Overall Study||1438
5297960|NCT00552513|13023114|P1|STARTED|Overall Study||1593
5297961|NCT00552448|13023126|P2|NOT COMPLETED|Overall Study||0
5297962|NCT00552448|13023127|P1|NOT COMPLETED|Overall Study||1
5297963|NCT00552448|13023126|P2|COMPLETED|Overall Study||16
5297964|NCT00552448|13023127|P1|COMPLETED|Overall Study||19
5297965|NCT00552448|13023126|P2|STARTED|Overall Study||16
5297966|NCT00552448|13023127|P1|STARTED|Overall Study||20
5297967|NCT00552422|13023139|P1|NOT COMPLETED|Overall Study||0
5297968|NCT00552422|13023139|P1|COMPLETED|Overall Study||6
5297969|NCT00552422|13023139|P1|STARTED|Overall Study||6
5297970|NCT00552409|13023145|P2|NOT COMPLETED|Overall Study||2
5297971|NCT00552409|13023146|P1|NOT COMPLETED|Overall Study||1
5297972|NCT00552409|13023145|P2|COMPLETED|Overall Study||9
5297973|NCT00552409|13023146|P1|COMPLETED|Overall Study||10
5297974|NCT00552409|13023145|P2|STARTED|Overall Study||11
5297975|NCT00552409|13023146|P1|STARTED|Overall Study||11
5297976|NCT00552396|13023159|P7|NOT COMPLETED|Overall Study||9
5297977|NCT00552396|13023160|P6|NOT COMPLETED|Overall Study||3
5297978|NCT00552396|13023161|P5|NOT COMPLETED|Overall Study||3
5297979|NCT00552396|13023162|P4|NOT COMPLETED|Overall Study||6
5297980|NCT00552396|13023163|P3|NOT COMPLETED|Overall Study||3
5297981|NCT00552396|13023164|P2|NOT COMPLETED|Overall Study||3
5297982|NCT00552396|13023165|P1|NOT COMPLETED|Overall Study||3
5297983|NCT00552396|13023159|P7|COMPLETED|Overall Study||1
5297984|NCT00552396|13023160|P6|COMPLETED|Overall Study||0
5297985|NCT00552396|13023161|P5|COMPLETED|Overall Study||0
5297986|NCT00552396|13023162|P4|COMPLETED|Overall Study||0
5297987|NCT00552396|13023163|P3|COMPLETED|Overall Study||0
5297988|NCT00552396|13023164|P2|COMPLETED|Overall Study||0
5297989|NCT00552396|13023165|P1|COMPLETED|Overall Study||1
5297990|NCT00552396|13023159|P7|STARTED|Overall Study||10
5297991|NCT00552396|13023160|P6|STARTED|Overall Study||3
5297992|NCT00552396|13023161|P5|STARTED|Overall Study||3
5297993|NCT00552396|13023162|P4|STARTED|Overall Study||6
5297994|NCT00552396|13023163|P3|STARTED|Overall Study||3
5297995|NCT00552396|13023164|P2|STARTED|Overall Study||3
5297996|NCT00552396|13023165|P1|STARTED|Overall Study||4
5297997|NCT00552344|13023202|P1|NOT COMPLETED|Overall Study||315
5297998|NCT00552344|13023202|P1|COMPLETED|Overall Study||87
5297999|NCT00552344|13023202|P1|STARTED|Overall Study||402
5298000|NCT00552305|13023211|P1|NOT COMPLETED|Overall Study||250
5298001|NCT00552305|13023211|P1|COMPLETED|Overall Study||120
5298002|NCT00552305|13023211|P1|STARTED|Overall Study||370
5298003|NCT00552279|13023221|P2|NOT COMPLETED|Overall Study||3
5298004|NCT00552279|13023222|P1|NOT COMPLETED|Overall Study||14
5298005|NCT00552279|13023221|P2|COMPLETED|Overall Study||398
5298006|NCT00552279|13023222|P1|COMPLETED|Overall Study||389
5298007|NCT00552279|13023221|P2|STARTED|Overall Study||401
5298008|NCT00552279|13023222|P1|STARTED|Overall Study||403
5298009|NCT00552240|13023248|P2|NOT COMPLETED|Overall Study||18
5298010|NCT00552240|13023249|P1|NOT COMPLETED|Overall Study||24
5298011|NCT00552240|13023248|P2|COMPLETED|Overall Study||59
5298012|NCT00552240|13023249|P1|COMPLETED|Overall Study||51
5298013|NCT00552240|13023248|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
5298014|NCT00552240|13023249|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
5298015|NCT00552188|13023351|P2|NOT COMPLETED|Overall Study||5
5298016|NCT00552188|13023352|P1|NOT COMPLETED|Overall Study||2
5298017|NCT00552188|13023351|P2|COMPLETED|Overall Study||21
5298018|NCT00552188|13023352|P1|COMPLETED|Overall Study||24
5298019|NCT00552188|13023351|P2|STARTED|Overall Study||26
5298020|NCT00552188|13023352|P1|STARTED|Overall Study||26
5298021|NCT00552175|13023363|P3|NOT COMPLETED|Overall Study||14
5298022|NCT00552175|13023364|P2|NOT COMPLETED|Overall Study||13
5298023|NCT00552175|13023365|P1|NOT COMPLETED|Overall Study||17
5298024|NCT00552175|13023363|P3|COMPLETED|Overall Study||72
5298025|NCT00552175|13023364|P2|COMPLETED|Overall Study||73
5298026|NCT00552175|13023365|P1|COMPLETED|Overall Study||150
5298027|NCT00552175|13023363|P3|Full Analysis Set Population|Overall Study||86
5298028|NCT00552175|13023364|P2|Full Analysis Set Population|Overall Study||85
5298029|NCT00552175|13023365|P1|Full Analysis Set Population|Overall Study||167
5298030|NCT00552175|13023363|P3|STARTED|Overall Study||86
5298031|NCT00552175|13023364|P2|STARTED|Overall Study||86
5298032|NCT00552175|13023365|P1|STARTED|Overall Study||167
5298033|NCT00552110|13023405|P5|NOT COMPLETED|Overall Study||9
5298034|NCT00552110|13023406|P4|NOT COMPLETED|Overall Study||8
5298035|NCT00552110|13023407|P3|NOT COMPLETED|Overall Study||2
5298036|NCT00552110|13023408|P2|NOT COMPLETED|Overall Study||5
5298037|NCT00552110|13023409|P1|NOT COMPLETED|Overall Study||4
5298038|NCT00552110|13023405|P5|COMPLETED|Overall Study||133
5298039|NCT00552110|13023406|P4|COMPLETED|Overall Study||133
5298040|NCT00552110|13023407|P3|COMPLETED|Overall Study||137
5298041|NCT00552110|13023408|P2|COMPLETED|Overall Study||134
5298042|NCT00552110|13023409|P1|COMPLETED|Overall Study||142
5298043|NCT00552110|13023405|P5|STARTED|Overall Study||142
5298044|NCT00552110|13023406|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
5298045|NCT00552110|13023407|P3|STARTED|Overall Study||139
5298046|NCT00552110|13023408|P2|STARTED|Overall Study||139
5298047|NCT00552110|13023409|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
5298048|NCT00552084|13023428|P2|NOT COMPLETED|Overall Study||9
5298049|NCT00552084|13023429|P1|NOT COMPLETED|Overall Study||8
5298050|NCT00552084|13023428|P2|COMPLETED|Overall Study||55
5298051|NCT00552084|13023429|P1|COMPLETED|Overall Study||118
5298052|NCT00552084|13023428|P2|STARTED|Overall Study||64
5298053|NCT00552084|13023429|P1|STARTED|Overall Study||126
5298054|NCT00552071|13023437|P2|NOT COMPLETED|Overall Study||2
5298055|NCT00552071|13023438|P1|NOT COMPLETED|Overall Study||4
5298056|NCT00552071|13023437|P2|COMPLETED|Overall Study||9
5298057|NCT00552071|13023438|P1|COMPLETED|Overall Study||6
5298058|NCT00552071|13023437|P2|STARTED|Overall Study||11
5298059|NCT00552071|13023438|P1|STARTED|Overall Study||10
5298060|NCT00552058|13023448|P2|NOT COMPLETED|Overall Study||24
5298061|NCT00552058|13023449|P1|NOT COMPLETED|Overall Study||16
5298062|NCT00552058|13023448|P2|COMPLETED|Overall Study||192
5298063|NCT00552058|13023449|P1|COMPLETED|Overall Study||207
5298064|NCT00552058|13023448|P2|STARTED|Overall Study||216
5298065|NCT00552058|13023449|P1|STARTED|Overall Study||223
5298066|NCT00552032|13023489|P2|NOT COMPLETED|Overall Study||19
5298067|NCT00552032|13023490|P1|NOT COMPLETED|Overall Study||17
5298068|NCT00552032|13023489|P2|COMPLETED|Overall Study||47
5298069|NCT00552032|13023490|P1|COMPLETED|Overall Study||49
5298070|NCT00552032|13023489|P2|STARTED|Overall Study||66
5298071|NCT00552032|13023490|P1|STARTED|Overall Study||66
5298072|NCT00551759|13023534|P1|NOT COMPLETED|Overall Study||13
5298073|NCT00551759|13023534|P1|COMPLETED|Overall Study||9
5298074|NCT00551759|13023534|P1|Received Adjuvant Therapy|Overall Study||12
5298075|NCT00551759|13023534|P1|Underwent Surgery|Overall Study||17
5298076|NCT00551759|13023534|P1|Eligible and Began Treatment|Overall Study||21
5298077|NCT00551759|13023534|P1|STARTED|Overall Study||22
5298078|NCT00551746|13023540|P2|NOT COMPLETED|Overall Study||8
5298079|NCT00551746|13023541|P1|NOT COMPLETED|Overall Study||11
5298080|NCT00551746|13023540|P2|COMPLETED|Overall Study||26
5298081|NCT00551746|13023541|P1|COMPLETED|Overall Study||25
5298082|NCT00551746|13023540|P2|STARTED|Overall Study||34
5298083|NCT00551746|13023541|P1|STARTED|Overall Study||36
5298084|NCT00551707|13023552|P5|NOT COMPLETED|Overall Study||1
5298085|NCT00551707|13023553|P4|NOT COMPLETED|Overall Study||4
5298086|NCT00551707|13023554|P3|NOT COMPLETED|Overall Study||3
5298087|NCT00551707|13023555|P2|NOT COMPLETED|Overall Study||6
5298088|NCT00551707|13023556|P1|NOT COMPLETED|Overall Study||0
5298089|NCT00551707|13023552|P5|COMPLETED|Overall Study||3
5298090|NCT00551707|13023553|P4|COMPLETED|Overall Study||4
5298091|NCT00551707|13023554|P3|COMPLETED|Overall Study||10
5298092|NCT00551707|13023555|P2|COMPLETED|Overall Study||16
5298093|NCT00551707|13023556|P1|COMPLETED|Overall Study||4
5298094|NCT00551707|13023552|P5|STARTED|Overall Study||4
5298095|NCT00551707|13023553|P4|STARTED|Overall Study||8
5298096|NCT00551707|13023554|P3|STARTED|Overall Study||13
5298097|NCT00551707|13023555|P2|STARTED|Overall Study||22
5298098|NCT00551707|13023556|P1|STARTED|Overall Study||4
5298099|NCT00551642|13023575|P2|NOT COMPLETED|Overall Study||63
5298100|NCT00551642|13023576|P1|NOT COMPLETED|Overall Study||61
5298101|NCT00551642|13023575|P2|COMPLETED|Overall Study||338
5298102|NCT00551642|13023576|P1|COMPLETED|Overall Study||338
5298103|NCT00551642|13023575|P2|STARTED|Overall Study||401
5298104|NCT00551642|13023576|P1|STARTED|Overall Study||399
5298105|NCT00551525|13023582|P1|NOT COMPLETED|Overall Study||5
5298106|NCT00551525|13023582|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
5298107|NCT00551525|13023582|P1|STARTED|Overall Study||67
5298108|NCT00551460|13023591|P1|NOT COMPLETED|Overall Study||18
5298109|NCT00551460|13023591|P1|COMPLETED|Overall Study||60
5298110|NCT00551460|13023591|P1|STARTED|Overall Study||78
5298111|NCT00551421|13023597|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
5298112|NCT00551421|13023597|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
5298113|NCT00551421|13023597|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
5298114|NCT00551421|13023597|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
5298115|NCT00551421|13023597|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
5298116|NCT00551421|13023597|P1|STARTED|Original Protocol, Dose Level 1||3
5298117|NCT00551369|13023604|P1|NOT COMPLETED|Overall Study||7
5298118|NCT00551369|13023604|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
5298119|NCT00551369|13023604|P1|STARTED|Overall Study||33
5298120|NCT00551291|13023613|P1|NOT COMPLETED|Overall Study||1
5298121|NCT00551291|13023613|P1|COMPLETED|Overall Study||9
5298122|NCT00551291|13023613|P1|STARTED|Overall Study||10
5298123|NCT00551213|13023621|P2|NOT COMPLETED|Overall Study||17
5298124|NCT00551213|13023622|P1|NOT COMPLETED|Overall Study||50
5298125|NCT00551213|13023621|P2|COMPLETED|Overall Study||0
5298126|NCT00551213|13023622|P1|COMPLETED|Overall Study||0
5298127|NCT00551213|13023621|P2|Treated|Overall Study||15
5298128|NCT00551213|13023622|P1|Treated|Overall Study||49
5298129|NCT00551213|13023621|P2|STARTED|Overall Study||17
5298130|NCT00551213|13023622|P1|STARTED|Overall Study||50
5298131|NCT00551200|13023638|P1|NOT COMPLETED|Overall Study||4
5298132|NCT00551200|13023638|P1|COMPLETED|Overall Study||10
5298133|NCT00551200|13023638|P1|STARTED|Overall Study||14
5298134|NCT00551174|13023653|P2|NOT COMPLETED|Overall Study||6
5298135|NCT00551174|13023654|P1|NOT COMPLETED|Overall Study||19
5298136|NCT00551174|13023653|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
5298137|NCT00551174|13023654|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
5298138|NCT00551174|13023653|P2|STARTED|Overall Study||400
5298139|NCT00551174|13023654|P1|STARTED|Overall Study||381
5298140|NCT00551161|13023666|P1|NOT COMPLETED|Overall Study||1
5298141|NCT00551161|13023666|P1|COMPLETED|Overall Study||11
5298142|NCT00551161|13023666|P1|STARTED|Overall Study||12
5298143|NCT00551135|13023674|P4|NOT COMPLETED|Overall Study||5
5298144|NCT00551135|13023675|P3|NOT COMPLETED|Overall Study||5
5298145|NCT00551135|13023676|P2|NOT COMPLETED|Overall Study||2
5298146|NCT00551135|13023677|P1|NOT COMPLETED|Overall Study||5
5298147|NCT00551135|13023674|P4|COMPLETED|Overall Study||103
5298148|NCT00551135|13023675|P3|COMPLETED|Overall Study||98
5298149|NCT00551135|13023676|P2|COMPLETED|Overall Study||104
5298150|NCT00551135|13023677|P1|COMPLETED|Overall Study||103
5298151|NCT00551135|13023674|P4|STARTED|Overall Study||108
5298152|NCT00551135|13023675|P3|STARTED|Overall Study||103
5298153|NCT00551135|13023676|P2|STARTED|Overall Study||106
5298154|NCT00551135|13023677|P1|STARTED|Overall Study||108
5298155|NCT00551070|13023791|P1|NOT COMPLETED|Overall Study||0
5298156|NCT00551070|13023791|P1|COMPLETED|Overall Study||52
5298157|NCT00551070|13023791|P1|STARTED|Overall Study||52
5298158|NCT00551031|13023806|P5|NOT COMPLETED|Overall Study||1
5298159|NCT00551031|13023807|P4|NOT COMPLETED|Overall Study||3
5298160|NCT00551031|13023808|P3|NOT COMPLETED|Overall Study||2
5298161|NCT00551031|13023809|P2|NOT COMPLETED|Overall Study||11
5298162|NCT00551031|13023810|P1|NOT COMPLETED|Overall Study||2
5298163|NCT00551031|13023806|P5|COMPLETED|Overall Study||185
5298164|NCT00551031|13023807|P4|COMPLETED|Overall Study||317
5298165|NCT00551031|13023808|P3|COMPLETED|Overall Study||317
5298166|NCT00551031|13023809|P2|COMPLETED|Overall Study||625
5298167|NCT00551031|13023810|P1|COMPLETED|Overall Study||635
5298168|NCT00551031|13023806|P5|STARTED|Overall Study||186
5298169|NCT00551031|13023807|P4|STARTED|Overall Study||320
5298170|NCT00551031|13023808|P3|STARTED|Overall Study||319
5298171|NCT00551031|13023809|P2|STARTED|Overall Study||636
5298172|NCT00551031|13023810|P1|STARTED|Overall Study||637
5298173|NCT00550953|13023839|P2|NOT COMPLETED|Overall Study||6
5298174|NCT00550953|13023840|P1|NOT COMPLETED|Overall Study||6
5298175|NCT00550953|13023839|P2|COMPLETED|Overall Study||152
5298176|NCT00550953|13023840|P1|COMPLETED|Overall Study||150
5298177|NCT00550953|13023839|P2|STARTED|Overall Study||158
5298178|NCT00550953|13023840|P1|STARTED|Overall Study||156
5298179|NCT00550862|13023864|P4|NOT COMPLETED|Overall Study||1
5298180|NCT00550862|13023865|P3|NOT COMPLETED|Overall Study||16
5298181|NCT00550862|13023866|P2|NOT COMPLETED|Overall Study||6
5298182|NCT00550862|13023867|P1|NOT COMPLETED|Overall Study||6
5298183|NCT00550862|13023864|P4|COMPLETED|Overall Study||37
5298184|NCT00550862|13023865|P3|COMPLETED|Overall Study||25
5298185|NCT00550862|13023866|P2|COMPLETED|Overall Study||42
5298186|NCT00550862|13023867|P1|COMPLETED|Overall Study||32
5298187|NCT00550862|13023864|P4|STARTED|Overall Study||38
5298188|NCT00550862|13023865|P3|STARTED|Overall Study||41
5298189|NCT00550862|13023866|P2|STARTED|Overall Study||48
5298190|NCT00550862|13023867|P1|STARTED|Overall Study||38
5298191|NCT00550836|13023887|P2|NOT COMPLETED|Overall Study||9
5298192|NCT00550836|13023888|P1|NOT COMPLETED|Overall Study||3
5298193|NCT00550836|13023887|P2|COMPLETED|Overall Study||46
5298194|NCT00550836|13023888|P1|COMPLETED|Overall Study||46
5298195|NCT00550836|13023887|P2|STARTED|Overall Study||55
5298196|NCT00550836|13023888|P1|STARTED|Overall Study||49
5298197|NCT00550771|13023904|P2|NOT COMPLETED|Overall Study||10
5298198|NCT00550771|13023905|P1|NOT COMPLETED|Overall Study||17
5298199|NCT00550771|13023904|P2|COMPLETED|Overall Study||50
5298200|NCT00550771|13023905|P1|COMPLETED|Overall Study||104
5298201|NCT00550771|13023904|P2|STARTED|Overall Study||60
5298202|NCT00550771|13023905|P1|STARTED|Overall Study||121
5298203|NCT00550745|13023919|P2|NOT COMPLETED|Overall Study||60
5298204|NCT00550745|13023920|P1|NOT COMPLETED|Overall Study||87
5298205|NCT00550745|13023919|P2|COMPLETED|Overall Study||5939
5298206|NCT00550745|13023920|P1|COMPLETED|Overall Study||5913
5298207|NCT00550745|13023919|P2|STARTED|Overall Study||5999
5298208|NCT00550745|13023920|P1|STARTED|Overall Study||6000
5298209|NCT00550732|13023928|P1|NOT COMPLETED|Overall Study||11
5298210|NCT00550732|13023928|P1|COMPLETED|Overall Study||29
5298211|NCT00550732|13023928|P1|STARTED|Overall Study||40
5298212|NCT00550680|13023939|P1|NOT COMPLETED|Overall Study||56
5298213|NCT00550680|13023939|P1|COMPLETED|Overall Study||152
5298214|NCT00550680|13023939|P1|STARTED|Overall Study||208
5298215|NCT00550654|13023948|P1|NOT COMPLETED|Overall Study||0
5298216|NCT00550654|13023948|P1|COMPLETED|Overall Study||1
5298217|NCT00550654|13023948|P1|STARTED|Overall Study||1
5298218|NCT00550615|13023960|P4|NOT COMPLETED|Overall Study||10
5298219|NCT00550615|13023961|P3|NOT COMPLETED|Overall Study||4
5298220|NCT00550615|13023962|P2|NOT COMPLETED|Overall Study||0
5298221|NCT00550615|13023963|P1|NOT COMPLETED|Overall Study||0
5298222|NCT00550615|13023960|P4|COMPLETED|Overall Study||12
5298223|NCT00550615|13023961|P3|COMPLETED|Overall Study||6
5298224|NCT00550615|13023962|P2|COMPLETED|Overall Study||3
5298225|NCT00550615|13023963|P1|COMPLETED|Overall Study||3
5298226|NCT00550615|13023960|P4|STARTED|Overall Study||22
5298227|NCT00550615|13023961|P3|STARTED|Overall Study||10
5298228|NCT00550615|13023962|P2|STARTED|Overall Study||3
5298229|NCT00550615|13023963|P1|STARTED|Overall Study||3
5298230|NCT00550589|13023969|P1|NOT COMPLETED|Overall Study||0
5298231|NCT00550589|13023969|P1|COMPLETED|Overall Study||33
5298232|NCT00550589|13023969|P1|STARTED|Overall Study||33
5298233|NCT00550550|13023982|P2|NOT COMPLETED|Overall Study||29
5298234|NCT00550550|13023983|P1|NOT COMPLETED|Overall Study||34
5298235|NCT00550550|13023982|P2|COMPLETED|Overall Study||140
5298236|NCT00550550|13023983|P1|COMPLETED|Overall Study||142
5298237|NCT00550550|13023982|P2|Number Treated|Overall Study||169
5298238|NCT00550550|13023983|P1|Number Treated|Overall Study||175
5298239|NCT00550550|13023982|P2|STARTED|Overall Study||169
5298240|NCT00550550|13023983|P1|STARTED|Overall Study||176
5298241|NCT00550537|13023995|P1|NOT COMPLETED|Overall Study||104
5298242|NCT00550537|13023995|P1|COMPLETED|Overall Study||12
5298243|NCT00550537|13023995|P1|STARTED|Overall Study||116
5298244|NCT00550459|13024012|P2|NOT COMPLETED|Overall Study||3
5298245|NCT00550459|13024013|P1|NOT COMPLETED|Overall Study||1
5298246|NCT00550459|13024012|P2|COMPLETED|Overall Study||26
5298247|NCT00550459|13024013|P1|COMPLETED|Overall Study||27
5298248|NCT00550459|13024012|P2|STARTED|Overall Study||29
5298249|NCT00550459|13024013|P1|STARTED|Overall Study||28
5298250|NCT00550446|13024082|P11|NOT COMPLETED|Post Week 12||1
5298251|NCT00550446|13024083|P10|NOT COMPLETED|Post Week 12||7
5298252|NCT00550446|13024084|P9|NOT COMPLETED|Post Week 12||2
5298253|NCT00550446|13024085|P8|NOT COMPLETED|Post Week 12||1
5298254|NCT00550446|13024086|P7|NOT COMPLETED|Post Week 12||2
5298255|NCT00550446|13024087|P6|NOT COMPLETED|Post Week 12||1
5298256|NCT00550446|13024088|P5|NOT COMPLETED|Post Week 12||2
5298257|NCT00550446|13024089|P4|NOT COMPLETED|Post Week 12||3
5298258|NCT00550446|13024090|P3|NOT COMPLETED|Post Week 12||3
5298259|NCT00550446|13024091|P2|NOT COMPLETED|Post Week 12||2
5298260|NCT00550446|13024092|P1|NOT COMPLETED|Post Week 12||3
5298261|NCT00550446|13024082|P11|COMPLETED|Post Week 12||24
5298262|NCT00550446|13024083|P10|COMPLETED|Post Week 12||37
5298263|NCT00550446|13024084|P9|COMPLETED|Post Week 12||15
5298264|NCT00550446|13024085|P8|COMPLETED|Post Week 12||16
5298265|NCT00550446|13024086|P7|COMPLETED|Post Week 12||19
5298266|NCT00550446|13024087|P6|COMPLETED|Post Week 12||0
5298267|NCT00550446|13024088|P5|COMPLETED|Post Week 12||52
5298268|NCT00550446|13024089|P4|COMPLETED|Post Week 12||55
5298269|NCT00550446|13024090|P3|COMPLETED|Post Week 12||43
5298270|NCT00550446|13024091|P2|COMPLETED|Post Week 12||28
5298271|NCT00550446|13024092|P1|COMPLETED|Post Week 12||24
5298272|NCT00550446|13024082|P11|STARTED|Post Week 12||25
5298273|NCT00550446|13024083|P10|STARTED|Post Week 12||44
5298274|NCT00550446|13024084|P9|STARTED|Post Week 12||17
5298275|NCT00550446|13024085|P8|STARTED|Post Week 12||17
5298276|NCT00550446|13024086|P7|STARTED|Post Week 12||21
5298277|NCT00550446|13024087|P6|STARTED|Post Week 12||1
5298278|NCT00550446|13024088|P5|STARTED|Post Week 12||54
5298279|NCT00550446|13024089|P4|STARTED|Post Week 12||58
5298280|NCT00550446|13024090|P3|STARTED|Post Week 12||46
5298281|NCT00550446|13024091|P2|STARTED|Post Week 12||30
5298282|NCT00550446|13024092|P1|STARTED|Post Week 12||27
5298283|NCT00550446|13024082|P11|NOT COMPLETED|Up To Week 12||0
5298284|NCT00550446|13024083|P10|NOT COMPLETED|Up To Week 12||0
5298285|NCT00550446|13024084|P9|NOT COMPLETED|Up To Week 12||0
5298286|NCT00550446|13024085|P8|NOT COMPLETED|Up To Week 12||0
5298287|NCT00550446|13024086|P7|NOT COMPLETED|Up To Week 12||13
5298288|NCT00550446|13024087|P6|NOT COMPLETED|Up To Week 12||8
5298289|NCT00550446|13024088|P5|NOT COMPLETED|Up To Week 12||3
5298290|NCT00550446|13024089|P4|NOT COMPLETED|Up To Week 12||3
5298291|NCT00550446|13024090|P3|NOT COMPLETED|Up To Week 12||4
5298292|NCT00550446|13024091|P2|NOT COMPLETED|Up To Week 12||5
5298293|NCT00550446|13024092|P1|NOT COMPLETED|Up To Week 12||10
5298294|NCT00550446|13024082|P11|COMPLETED|Up To Week 12||0
5298295|NCT00550446|13024083|P10|COMPLETED|Up To Week 12||0
5298296|NCT00550446|13024084|P9|COMPLETED|Up To Week 12||0
5298297|NCT00550446|13024085|P8|COMPLETED|Up To Week 12||0
5298298|NCT00550446|13024086|P7|COMPLETED|Up To Week 12||46
5298299|NCT00550446|13024087|P6|COMPLETED|Up To Week 12||45
5298300|NCT00550446|13024088|P5|COMPLETED|Up To Week 12||54
5298301|NCT00550446|13024089|P4|COMPLETED|Up To Week 12||58
5298302|NCT00550446|13024090|P3|COMPLETED|Up To Week 12||46
5298303|NCT00550446|13024091|P2|COMPLETED|Up To Week 12||47
5298304|NCT00550446|13024092|P1|COMPLETED|Up To Week 12||44
5298305|NCT00550446|13024082|P11|Treated|Up To Week 12||0
5298306|NCT00550446|13024083|P10|Treated|Up To Week 12||0
5298307|NCT00550446|13024084|P9|Treated|Up To Week 12||0
5298308|NCT00550446|13024085|P8|Treated|Up To Week 12||0
5298309|NCT00550446|13024086|P7|Treated|Up To Week 12||59
5298310|NCT00550446|13024087|P6|Treated|Up To Week 12||53
5298311|NCT00550446|13024088|P5|Treated|Up To Week 12||57
5298312|NCT00550446|13024089|P4|Treated|Up To Week 12||61
5298313|NCT00550446|13024090|P3|Treated|Up To Week 12||49
5298314|NCT00550446|13024091|P2|Treated|Up To Week 12||51
5298315|NCT00550446|13024092|P1|Treated|Up To Week 12||54
5298316|NCT00550446|13024082|P11|STARTED|Up To Week 12||0
5298317|NCT00550446|13024083|P10|STARTED|Up To Week 12||0
5298318|NCT00550446|13024084|P9|STARTED|Up To Week 12||0
5298319|NCT00550446|13024085|P8|STARTED|Up To Week 12||0
5298320|NCT00550446|13024086|P7|STARTED|Up To Week 12||59
5298321|NCT00550446|13024087|P6|STARTED|Up To Week 12||53
5298322|NCT00550446|13024088|P5|STARTED|Up To Week 12||57
5298323|NCT00550446|13024089|P4|STARTED|Up To Week 12||61
5298324|NCT00550446|13024090|P3|STARTED|Up To Week 12||50
5298325|NCT00550446|13024091|P2|STARTED|Up To Week 12||52
5298326|NCT00550446|13024092|P1|STARTED|Up To Week 12||54
5298327|NCT00550420|13024524|P1|NOT COMPLETED|Overall Study||305
5298328|NCT00550420|13024524|P1|COMPLETED|Overall Study||26
5298329|NCT00550420|13024524|P1|STARTED|Overall Study||331
5298330|NCT00550407|13024547|P3|NOT COMPLETED|26-Week Randomized Phase||24
5298331|NCT00550407|13024548|P2|NOT COMPLETED|26-Week Randomized Phase||43
5298332|NCT00550407|13024549|P1|NOT COMPLETED|26-Week Randomized Phase||0
5298333|NCT00550407|13024547|P3|COMPLETED|26-Week Randomized Phase||21
5298334|NCT00550407|13024548|P2|COMPLETED|26-Week Randomized Phase||15
5298335|NCT00550407|13024549|P1|COMPLETED|26-Week Randomized Phase||0
5298336|NCT00550407|13024547|P3|STARTED|26-Week Randomized Phase||45
5298337|NCT00550407|13024548|P2|STARTED|26-Week Randomized Phase||58
5298338|NCT00550407|13024549|P1|STARTED|26-Week Randomized Phase||0
5298339|NCT00550407|13024547|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
5298340|NCT00550407|13024548|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
5298341|NCT00550407|13024549|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
5298342|NCT00550407|13024547|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
5298343|NCT00550407|13024548|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
5298344|NCT00550407|13024549|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
5298345|NCT00550407|13024547|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
5298346|NCT00550407|13024548|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
5298347|NCT00550407|13024549|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
5298348|NCT00550394|13024584|P2|NOT COMPLETED|Overall Study||13
5298349|NCT00550394|13024585|P1|NOT COMPLETED|Overall Study||12
5298350|NCT00550394|13024584|P2|COMPLETED|Overall Study||5
5298351|NCT00550394|13024585|P1|COMPLETED|Overall Study||9
5298352|NCT00550394|13024584|P2|STARTED|Overall Study||18
5298353|NCT00550394|13024585|P1|STARTED|Overall Study||21
5298354|NCT00550368|13024599|P2|NOT COMPLETED|Overall Study||0
5298355|NCT00550368|13024600|P1|NOT COMPLETED|Overall Study||0
5298356|NCT00550368|13024599|P2|COMPLETED|Overall Study||19
5298357|NCT00550368|13024600|P1|COMPLETED|Overall Study||26
5298358|NCT00550368|13024599|P2|STARTED|Overall Study||19
5298359|NCT00550368|13024600|P1|STARTED|Overall Study||26
5298360|NCT00550290|13024610|P2|NOT COMPLETED|Overall Study||0
5298361|NCT00550290|13024611|P1|NOT COMPLETED|Overall Study||0
5298362|NCT00550290|13024610|P2|COMPLETED|Overall Study||8
5298363|NCT00550290|13024611|P1|COMPLETED|Overall Study||10
5298364|NCT00550290|13024610|P2|STARTED|Overall Study||8
5298365|NCT00550290|13024611|P1|STARTED|Overall Study||10
5298366|NCT00550277|13024617|P1|NOT COMPLETED|Overall Study||9
5298367|NCT00550277|13024617|P1|COMPLETED|Overall Study||11
5298368|NCT00550277|13024617|P1|STARTED|Overall Study||20
5298369|NCT00550238|13024621|P1|NOT COMPLETED|Overall Study||459
5298370|NCT00550238|13024621|P1|COMPLETED|Overall Study||0
5298371|NCT00550238|13024621|P1|STARTED|Overall Study||459
5298372|NCT00550173|13024628|P3|NOT COMPLETED|Overall Study||73
5298373|NCT00550173|13024629|P2|NOT COMPLETED|Overall Study||63
5298374|NCT00550173|13024630|P1|NOT COMPLETED|Overall Study||72
5298375|NCT00550173|13024628|P3|COMPLETED|Overall Study||11
5298376|NCT00550173|13024629|P2|COMPLETED|Overall Study||19
5298377|NCT00550173|13024630|P1|COMPLETED|Overall Study||9
5298378|NCT00550173|13024628|P3|Not Discontinued at 18 Months|Overall Study||11
5298379|NCT00550173|13024629|P2|Not Discontinued at 18 Months|Overall Study||19
5298380|NCT00550173|13024630|P1|Not Discontinued at 18 Months|Overall Study||9
5298381|NCT00550173|13024628|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
5298382|NCT00550173|13024629|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
5298383|NCT00550173|13024630|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
5298384|NCT00550173|13024628|P3|STARTED|Overall Study||84
5298385|NCT00550173|13024629|P2|STARTED|Overall Study||82
5298386|NCT00550173|13024630|P1|STARTED|Overall Study||81
5298387|NCT00550147|13024659|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
5298388|NCT00550147|13024659|P1|COMPLETED|Quetiapine Addition Treatment Period||18
5298389|NCT00550147|13024659|P1|STARTED|Quetiapine Addition Treatment Period||24
5298390|NCT00550147|13024659|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
5298391|NCT00550147|13024659|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
5298392|NCT00550147|13024659|P1|STARTED|OROS Methylphenidate Monotherapy||30
5298393|NCT00550043|13024682|P5|NOT COMPLETED|Overall Study||1
5298394|NCT00550043|13024683|P4|NOT COMPLETED|Overall Study||2
5298395|NCT00550043|13024684|P3|NOT COMPLETED|Overall Study||1
5298396|NCT00550043|13024685|P2|NOT COMPLETED|Overall Study||3
5298397|NCT00550043|13024686|P1|NOT COMPLETED|Overall Study||0
5298398|NCT00550043|13024682|P5|COMPLETED|Overall Study||9
5298399|NCT00550043|13024683|P4|COMPLETED|Overall Study||8
5298400|NCT00550043|13024684|P3|COMPLETED|Overall Study||8
5298401|NCT00550043|13024685|P2|COMPLETED|Overall Study||9
5298402|NCT00550043|13024686|P1|COMPLETED|Overall Study||9
5298403|NCT00550043|13024682|P5|STARTED|Overall Study||10
5298404|NCT00550043|13024683|P4|STARTED|Overall Study||10
5298405|NCT00550043|13024684|P3|STARTED|Overall Study||9
5298406|NCT00550043|13024685|P2|STARTED|Overall Study||12
5298407|NCT00550043|13024686|P1|STARTED|Overall Study||9
5298408|NCT00549939|13024741|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
5298409|NCT00549939|13024742|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
5298410|NCT00549939|13024743|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
5298411|NCT00549939|13024741|P3|COMPLETED|40-week Open Label Treatment Period||78
5298412|NCT00549939|13024742|P2|COMPLETED|40-week Open Label Treatment Period||75
5298413|NCT00549939|13024743|P1|COMPLETED|40-week Open Label Treatment Period||0
5298414|NCT00549939|13024741|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
5298415|NCT00549939|13024742|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
5298416|NCT00549939|13024743|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
5298417|NCT00549939|13024741|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
5298418|NCT00549939|13024742|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
5298419|NCT00549939|13024743|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
5298420|NCT00549939|13024741|P3|COMPLETED|12-week Double Blind Treatment Period||56
5298421|NCT00549939|13024742|P2|COMPLETED|12-week Double Blind Treatment Period||55
5298422|NCT00549939|13024743|P1|COMPLETED|12-week Double Blind Treatment Period||56
5298423|NCT00549939|13024741|P3|STARTED|12-week Double Blind Treatment Period||58
5298424|NCT00549939|13024742|P2|STARTED|12-week Double Blind Treatment Period||57
5298425|NCT00549939|13024743|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
5298426|NCT00549900|13024770|P1|NOT COMPLETED|Overall Study||1
5298427|NCT00549900|13024770|P1|COMPLETED|Overall Study||29
5298428|NCT00549900|13024770|P1|STARTED|Overall Study||30
5298429|NCT00549822|13024779|P1|NOT COMPLETED|Overall Study||0
5298430|NCT00549822|13024779|P1|COMPLETED|Overall Study||3
5298431|NCT00549822|13024779|P1|STARTED|Overall Study||3
5298432|NCT00549783|13024787|P2|NOT COMPLETED|Overall Study||13
5298433|NCT00549783|13024788|P1|NOT COMPLETED|Overall Study||8
5298434|NCT00549783|13024787|P2|COMPLETED|Overall Study||122
5298435|NCT00549783|13024788|P1|COMPLETED|Overall Study||131
5298436|NCT00549783|13024787|P2|STARTED|Overall Study||135
5298437|NCT00549783|13024788|P1|STARTED|Overall Study||139
5298438|NCT00549770|13024826|P8|NOT COMPLETED|Overall Study||25
5298439|NCT00549770|13024827|P7|NOT COMPLETED|Overall Study||14
5298440|NCT00549770|13024828|P6|NOT COMPLETED|Overall Study||13
5298441|NCT00549770|13024829|P5|NOT COMPLETED|Overall Study||17
5298442|NCT00549770|13024830|P4|NOT COMPLETED|Overall Study||16
5298443|NCT00549770|13024831|P3|NOT COMPLETED|Overall Study||10
5298444|NCT00549770|13024832|P2|NOT COMPLETED|Overall Study||11
5298445|NCT00549770|13024833|P1|NOT COMPLETED|Overall Study||7
5298446|NCT00549770|13024826|P8|COMPLETED|Overall Study||148
5298447|NCT00549770|13024827|P7|COMPLETED|Overall Study||151
5298448|NCT00549770|13024828|P6|COMPLETED|Overall Study||151
5298449|NCT00549770|13024829|P5|COMPLETED|Overall Study||149
5298450|NCT00549770|13024830|P4|COMPLETED|Overall Study||147
5298451|NCT00549770|13024831|P3|COMPLETED|Overall Study||162
5298452|NCT00549770|13024832|P2|COMPLETED|Overall Study||158
5298453|NCT00549770|13024833|P1|COMPLETED|Overall Study||149
5298454|NCT00549770|13024826|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
5298455|NCT00549770|13024827|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
5298456|NCT00549770|13024828|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
5298457|NCT00549770|13024829|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
5298458|NCT00549770|13024830|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
5298459|NCT00549770|13024831|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
5298460|NCT00549770|13024832|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
5298461|NCT00549770|13024833|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
5298462|NCT00549770|13024826|P8|Intent-to-treat Population|Overall Study||172
5298463|NCT00549770|13024827|P7|Intent-to-treat Population|Overall Study||164
5298464|NCT00549770|13024828|P6|Intent-to-treat Population|Overall Study||163
5298465|NCT00549770|13024829|P5|Intent-to-treat Population|Overall Study||163
5298466|NCT00549770|13024830|P4|Intent-to-treat Population|Overall Study||163
5298467|NCT00549770|13024831|P3|Intent-to-treat Population|Overall Study||170
5298468|NCT00549770|13024832|P2|Intent-to-treat Population|Overall Study||168
5298469|NCT00549770|13024833|P1|Intent-to-treat Population|Overall Study||154
5298470|NCT00549770|13024826|P8|STARTED|Overall Study||173
5298471|NCT00549770|13024827|P7|STARTED|Overall Study||165
5298472|NCT00549770|13024828|P6|STARTED|Overall Study||164
5298473|NCT00549770|13024829|P5|STARTED|Overall Study||166
5298474|NCT00549770|13024830|P4|STARTED|Overall Study||163
5298475|NCT00549770|13024831|P3|STARTED|Overall Study||172
5298476|NCT00549770|13024832|P2|STARTED|Overall Study||169
5298477|NCT00549770|13024833|P1|STARTED|Overall Study||156
5298478|NCT00549757|13024917|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
5298479|NCT00549757|13024918|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
5298480|NCT00549757|13024917|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
5298481|NCT00549757|13024918|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
5298482|NCT00549757|13024917|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
5298483|NCT00549757|13024918|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
5298484|NCT00549757|13024917|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
5298485|NCT00549757|13024918|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
5298486|NCT00549757|13024917|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
5298487|NCT00549757|13024918|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
5298488|NCT00549757|13024917|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
5298489|NCT00549757|13024918|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
5298490|NCT00549757|13024917|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
5298491|NCT00549757|13024918|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
5298492|NCT00549757|13024917|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
5298493|NCT00549757|13024918|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
5298494|NCT00549718|13024980|P4|NOT COMPLETED|Overall Study||55
5298495|NCT00549718|13024981|P3|NOT COMPLETED|Overall Study||39
5298496|NCT00549718|13024982|P2|NOT COMPLETED|Overall Study||37
5298497|NCT00549718|13024983|P1|NOT COMPLETED|Overall Study||41
5298498|NCT00549718|13024980|P4|COMPLETED|Overall Study||73
5298499|NCT00549718|13024981|P3|COMPLETED|Overall Study||85
5298500|NCT00549718|13024982|P2|COMPLETED|Overall Study||86
5298501|NCT00549718|13024983|P1|COMPLETED|Overall Study||84
5298502|NCT00549718|13024980|P4|STARTED|Overall Study||128
5298503|NCT00549718|13024981|P3|STARTED|Overall Study||124
5298504|NCT00549718|13024982|P2|STARTED|Overall Study||123
5298505|NCT00549718|13024983|P1|STARTED|Overall Study||125
5298506|NCT00549640|13024999|P2|NOT COMPLETED|Overall Study||16
5298507|NCT00549640|13025000|P1|NOT COMPLETED|Overall Study||18
5298508|NCT00549640|13024999|P2|COMPLETED|Overall Study||24
5298509|NCT00549640|13025000|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
5298510|NCT00549640|13024999|P2|STARTED|Overall Study||40
5298511|NCT00549640|13025000|P1|STARTED|Overall Study||40
5298512|NCT00549601|13025013|P3|NOT COMPLETED|Received Study Drug||4
5298513|NCT00549601|13025014|P2|NOT COMPLETED|Received Study Drug||11
5298514|NCT00549601|13025015|P1|NOT COMPLETED|Received Study Drug||7
5298515|NCT00549601|13025013|P3|COMPLETED|Received Study Drug||45
5298516|NCT00549601|13025014|P2|COMPLETED|Received Study Drug||36
5298517|NCT00549601|13025015|P1|COMPLETED|Received Study Drug||36
5298518|NCT00549601|13025013|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
5298519|NCT00549601|13025014|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
5298520|NCT00549601|13025015|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
5298521|NCT00549601|13025013|P3|NOT COMPLETED|Randomized||2
5298522|NCT00549601|13025014|P2|NOT COMPLETED|Randomized||1
5298523|NCT00549601|13025015|P1|NOT COMPLETED|Randomized||0
5298524|NCT00549601|13025013|P3|COMPLETED|Randomized||49
5298525|NCT00549601|13025014|P2|COMPLETED|Randomized||47
5298526|NCT00549601|13025015|P1|COMPLETED|Randomized||43
5298527|NCT00549601|13025013|P3|STARTED|Randomized||51
5298528|NCT00549601|13025014|P2|STARTED|Randomized||48
5298529|NCT00549601|13025015|P1|STARTED|Randomized||43
5298530|NCT00549562|13025037|P1|NOT COMPLETED|Overall Study||2
5298531|NCT00549562|13025037|P1|COMPLETED|Overall Study||23
5298532|NCT00549562|13025037|P1|STARTED|Overall Study||25
5298533|NCT00549549|13025049|P4|NOT COMPLETED|Overall Study||25
5298534|NCT00549549|13025050|P3|NOT COMPLETED|Overall Study||17
5298535|NCT00549549|13025051|P2|NOT COMPLETED|Overall Study||22
5298536|NCT00549549|13025052|P1|NOT COMPLETED|Overall Study||24
5298537|NCT00549549|13025049|P4|COMPLETED|Overall Study||78
5298538|NCT00549549|13025050|P3|COMPLETED|Overall Study||82
5298539|NCT00549549|13025051|P2|COMPLETED|Overall Study||77
5298540|NCT00549549|13025052|P1|COMPLETED|Overall Study||77
5298541|NCT00549549|13025049|P4|Treated|Overall Study||102
5298542|NCT00549549|13025050|P3|Treated|Overall Study||98
5298543|NCT00549549|13025051|P2|Treated|Overall Study||99
5298544|NCT00549549|13025052|P1|Treated|Overall Study||101
5298545|NCT00549549|13025049|P4|STARTED|Overall Study||103
5298546|NCT00549549|13025050|P3|STARTED|Overall Study||99
5298547|NCT00549549|13025051|P2|STARTED|Overall Study||99
5298548|NCT00549549|13025052|P1|STARTED|Overall Study||101
5298549|NCT00549445|13025120|P2|NOT COMPLETED|Overall Study||17
5298550|NCT00549445|13025121|P1|NOT COMPLETED|Overall Study||15
5298551|NCT00549445|13025120|P2|COMPLETED|Overall Study||13
5298552|NCT00549445|13025121|P1|COMPLETED|Overall Study||8
5298553|NCT00549445|13025120|P2|STARTED|Overall Study||30
5298554|NCT00549445|13025121|P1|STARTED|Overall Study||23
5298555|NCT00549393|13025129|P2|NOT COMPLETED|Period 3 (6 Months)||0
5298556|NCT00549393|13025130|P1|NOT COMPLETED|Period 3 (6 Months)||0
5298557|NCT00549393|13025129|P2|COMPLETED|Period 3 (6 Months)||1326
5298558|NCT00549393|13025130|P1|COMPLETED|Period 3 (6 Months)||1103
5298559|NCT00549393|13025129|P2|Per Protocol|Period 3 (6 Months)||1326
5298560|NCT00549393|13025130|P1|Per Protocol|Period 3 (6 Months)||667
5298561|NCT00549393|13025129|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
5298562|NCT00549393|13025130|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
5298563|NCT00549393|13025129|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
5298564|NCT00549393|13025130|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
5298565|NCT00549393|13025129|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
5298566|NCT00549393|13025130|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
5298567|NCT00549393|13025129|P2|STARTED|Period 2 Washout (2 Weeks)||0
5298568|NCT00549393|13025130|P1|STARTED|Period 2 Washout (2 Weeks)||0
5298569|NCT00549393|13025129|P2|NOT COMPLETED|Period 1 (6 Months)||0
5298570|NCT00549393|13025130|P1|NOT COMPLETED|Period 1 (6 Months)||0
5298571|NCT00549393|13025129|P2|COMPLETED|Period 1 (6 Months)||1199
5298572|NCT00549393|13025130|P1|COMPLETED|Period 1 (6 Months)||1319
5298573|NCT00549393|13025129|P2|Per Protocol|Period 1 (6 Months)||1199
5298574|NCT00549393|13025130|P1|Per Protocol|Period 1 (6 Months)||880
5298575|NCT00549393|13025129|P2|STARTED|Period 1 (6 Months)|ITT|1199
5298576|NCT00549393|13025130|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
5298577|NCT00549328|13025140|P1|NOT COMPLETED|Overall Study||14
5298578|NCT00549328|13025140|P1|COMPLETED|Overall Study||0
5298579|NCT00549328|13025140|P1|STARTED|Overall Study||14
5298580|NCT00549302|13025151|P3|NOT COMPLETED|Open-Label||69
5298581|NCT00549302|13025152|P2|NOT COMPLETED|Open-Label||0
5298582|NCT00549302|13025153|P1|NOT COMPLETED|Open-Label||0
5298583|NCT00549302|13025151|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
5298584|NCT00549302|13025152|P2|COMPLETED|Open-Label||0
5298585|NCT00549302|13025153|P1|COMPLETED|Open-Label||0
5298586|NCT00549302|13025151|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
5298587|NCT00549302|13025152|P2|STARTED|Open-Label||0
5298588|NCT00549302|13025153|P1|STARTED|Open-Label||0
5298589|NCT00549302|13025151|P3|NOT COMPLETED|Double-Blind||0
5298590|NCT00549302|13025152|P2|NOT COMPLETED|Double-Blind||53
5298591|NCT00549302|13025153|P1|NOT COMPLETED|Double-Blind||11
5298592|NCT00549302|13025151|P3|COMPLETED|Double-Blind||0
5298593|NCT00549302|13025152|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
5298594|NCT00549302|13025153|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
5298595|NCT00549302|13025151|P3|Received at Least One Dose of Study Drug|Double-Blind||0
5298596|NCT00549302|13025152|P2|Received at Least One Dose of Study Drug|Double-Blind||294
5298597|NCT00549302|13025153|P1|Received at Least One Dose of Study Drug|Double-Blind||63
5298598|NCT00549302|13025151|P3|STARTED|Double-Blind||0
5298599|NCT00549302|13025152|P2|STARTED|Double-Blind||294
5298600|NCT00549302|13025153|P1|STARTED|Double-Blind||63
5298601|NCT00549198|13025165|P2|NOT COMPLETED|Overall Study||63
5298602|NCT00549198|13025166|P1|NOT COMPLETED|Overall Study||80
5298603|NCT00549198|13025165|P2|COMPLETED|Overall Study||134
5298604|NCT00549198|13025166|P1|COMPLETED|Overall Study||115
5298605|NCT00549198|13025165|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
5298606|NCT00549198|13025166|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
5298607|NCT00549172|13025288|P2|NOT COMPLETED|Overall Study||0
5298608|NCT00549172|13025289|P1|NOT COMPLETED|Overall Study||0
5298609|NCT00549172|13025288|P2|COMPLETED|Overall Study||76
5298610|NCT00549172|13025289|P1|COMPLETED|Overall Study||70
5298611|NCT00549172|13025288|P2|STARTED|Overall Study||76
5298612|NCT00549172|13025289|P1|STARTED|Overall Study||70
5298613|NCT00549055|13025303|P1|NOT COMPLETED|Overall Study||35
5298614|NCT00549055|13025303|P1|COMPLETED|Overall Study||3
5298615|NCT00549055|13025303|P1|STARTED|Overall Study||38
5298616|NCT00549042|13025315|P2|NOT COMPLETED|Double-blind Phase||90
5298617|NCT00549042|13025316|P1|NOT COMPLETED|Double-blind Phase||68
5298618|NCT00549042|13025315|P2|COMPLETED|Double-blind Phase||44
5298619|NCT00549042|13025316|P1|COMPLETED|Double-blind Phase||66
5298620|NCT00549042|13025315|P2|STARTED|Double-blind Phase||134
5298621|NCT00549042|13025316|P1|STARTED|Double-blind Phase||134
5298622|NCT00549042|13025315|P2|NOT COMPLETED|Conversion and Titration Phase||0
5298623|NCT00549042|13025316|P1|NOT COMPLETED|Conversion and Titration Phase||191
5298624|NCT00549042|13025315|P2|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
5298625|NCT00549042|13025316|P1|COMPLETED|Conversion and Titration Phase||268
5298626|NCT00549042|13025315|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
5298627|NCT00549042|13025316|P1|STARTED|Conversion and Titration Phase||459
5298628|NCT00548886|13025333|P1|NOT COMPLETED|Overall Study||0
5298629|NCT00548886|13025333|P1|COMPLETED|Overall Study||7
5298630|NCT00548886|13025333|P1|STARTED|Overall Study||7
5298631|NCT00548860|13025340|P2|NOT COMPLETED|Overall Study||175
5298632|NCT00548860|13025341|P1|NOT COMPLETED|Overall Study||136
5298633|NCT00548860|13025340|P2|COMPLETED|Overall Study||847
5298634|NCT00548860|13025341|P1|COMPLETED|Overall Study||860
5298635|NCT00548860|13025340|P2|STARTED|Overall Study||1022
5298636|NCT00548860|13025341|P1|STARTED|Overall Study||996
5298637|NCT00548847|13025347|P1|NOT COMPLETED|Overall Study||7
5298638|NCT00548847|13025347|P1|COMPLETED|Overall Study||8
5298639|NCT00548847|13025347|P1|STARTED|Overall Study||15
5298640|NCT00548808|13025354|P2|NOT COMPLETED|Overall Study||26
5298641|NCT00548808|13025355|P1|NOT COMPLETED|Overall Study||42
5298642|NCT00548808|13025354|P2|COMPLETED|Overall Study||186
5298643|NCT00548808|13025355|P1|COMPLETED|Overall Study||172
5298644|NCT00548808|13025354|P2|Per-Protocol Set|Overall Study||184
5298645|NCT00548808|13025355|P1|Per-Protocol Set|Overall Study||177
5298646|NCT00548808|13025354|P2|Full Analysis Set|Overall Study||212
5298647|NCT00548808|13025355|P1|Full Analysis Set|Overall Study||211
5298648|NCT00548808|13025354|P2|STARTED|Overall Study||212
5298649|NCT00548808|13025355|P1|STARTED|Overall Study||214
5298650|NCT00548717|13025379|P2|NOT COMPLETED|Overall Study||2
5298651|NCT00548717|13025380|P1|NOT COMPLETED|Overall Study||9
5298652|NCT00548717|13025379|P2|COMPLETED|Overall Study||0
5298653|NCT00548717|13025380|P1|COMPLETED|Overall Study||4
5298654|NCT00548717|13025379|P2|STARTED|Overall Study||2
5298655|NCT00548717|13025380|P1|STARTED|Overall Study||13
5298656|NCT00548691|13025399|P2|NOT COMPLETED|Overall Study||9
5298657|NCT00548691|13025400|P1|NOT COMPLETED|Overall Study||7
5298658|NCT00548691|13025399|P2|COMPLETED|Overall Study||250
5298659|NCT00548691|13025400|P1|COMPLETED|Overall Study||251
5298660|NCT00548691|13025399|P2|STARTED|Overall Study||259
5298661|NCT00548691|13025400|P1|STARTED|Overall Study||258
5298662|NCT00548652|13025409|P3|NOT COMPLETED|Overall Study||11
5298663|NCT00548652|13025410|P2|NOT COMPLETED|Overall Study||9
5298664|NCT00548652|13025411|P1|NOT COMPLETED|Overall Study||2
5298665|NCT00548652|13025409|P3|COMPLETED|Overall Study||34
5298666|NCT00548652|13025410|P2|COMPLETED|Overall Study||29
5298667|NCT00548652|13025411|P1|COMPLETED|Overall Study||16
5298668|NCT00548652|13025409|P3|STARTED|Overall Study||45
5298669|NCT00548652|13025410|P2|STARTED|Overall Study||38
5298670|NCT00548652|13025411|P1|STARTED|Overall Study||18
5298671|NCT00548548|13025424|P2|NOT COMPLETED|Overall Study||366
5298672|NCT00548548|13025425|P1|NOT COMPLETED|Overall Study||362
5298673|NCT00548548|13025424|P2|COMPLETED|Overall Study||21
5298674|NCT00548548|13025425|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
5298675|NCT00548548|13025424|P2|Safety Population|Overall Study||381
5298676|NCT00548548|13025425|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
5298677|NCT00548548|13025424|P2|Treated|Overall Study||384
5298678|NCT00548548|13025425|P1|Treated|Overall Study||383
5298679|NCT00548548|13025424|P2|STARTED|Overall Study||387
5298680|NCT00548548|13025425|P1|STARTED|Overall Study||387
5298681|NCT00548470|13025445|P1|NOT COMPLETED|Overall Study||2
5298682|NCT00548470|13025445|P1|COMPLETED|Overall Study||12
5298683|NCT00548470|13025445|P1|STARTED|Overall Study||14
5298684|NCT00548431|13025453|P1|NOT COMPLETED|Overall Study||0
5298685|NCT00548431|13025453|P1|COMPLETED|Overall Study||38
5298686|NCT00548431|13025453|P1|STARTED|Overall Study||38
5298687|NCT00548418|13025457|P1|NOT COMPLETED|Overall Study||0
5298688|NCT00548418|13025457|P1|COMPLETED|Overall Study||27
5298689|NCT00548418|13025457|P1|STARTED|Overall Study||27
5298690|NCT00548405|13025468|P3|NOT COMPLETED|Overall Study||9
5298691|NCT00548405|13025469|P2|NOT COMPLETED|Overall Study||20
5298692|NCT00548405|13025470|P1|NOT COMPLETED|Overall Study||56
5298693|NCT00548405|13025468|P3|COMPLETED|Overall Study||164
5298694|NCT00548405|13025469|P2|COMPLETED|Overall Study||416
5298695|NCT00548405|13025470|P1|COMPLETED|Overall Study||175
5298696|NCT00548405|13025468|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
5298697|NCT00548405|13025469|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
5298698|NCT00548405|13025470|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
5298699|NCT00548405|13025468|P3|STARTED|Overall Study|Randomized.|173
5298700|NCT00548405|13025469|P2|STARTED|Overall Study|Randomized.|436
5298701|NCT00548405|13025470|P1|STARTED|Overall Study|Randomized.|231
5298702|NCT00548340|13025491|P3|NOT COMPLETED|Overall Study||9
5298703|NCT00548340|13025492|P2|NOT COMPLETED|Overall Study||11
5298704|NCT00548340|13025493|P1|NOT COMPLETED|Overall Study||8
5298705|NCT00548340|13025491|P3|COMPLETED|Overall Study||95
5298706|NCT00548340|13025492|P2|COMPLETED|Overall Study||98
5298707|NCT00548340|13025493|P1|COMPLETED|Overall Study||101
5298708|NCT00548340|13025491|P3|STARTED|Overall Study||104
5298709|NCT00548340|13025492|P2|STARTED|Overall Study||109
5298710|NCT00548340|13025493|P1|STARTED|Overall Study||109
5298711|NCT00548327|13025512|P2|NOT COMPLETED|Overall Study||1
5298712|NCT00548327|13025513|P1|NOT COMPLETED|Overall Study||0
5298713|NCT00548327|13025512|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
5298714|NCT00548327|13025513|P1|COMPLETED|Overall Study||6
5298715|NCT00548327|13025512|P2|STARTED|Overall Study||5
5298716|NCT00548327|13025513|P1|STARTED|Overall Study||6
5298717|NCT00548262|13025531|P1|NOT COMPLETED|Overall Study||32
5298718|NCT00548262|13025531|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
5298719|NCT00548262|13025531|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
5298720|NCT00548249|13025561|P5|NOT COMPLETED|Overall Study||21
5298721|NCT00548249|13025562|P4|NOT COMPLETED|Overall Study||13
5298722|NCT00548249|13025563|P3|NOT COMPLETED|Overall Study||20
5298723|NCT00548249|13025564|P2|NOT COMPLETED|Overall Study||13
5298724|NCT00548249|13025565|P1|NOT COMPLETED|Overall Study||16
5298725|NCT00548249|13025561|P5|COMPLETED|Overall Study||7
5298726|NCT00548249|13025562|P4|COMPLETED|Overall Study||9
5298727|NCT00548249|13025563|P3|COMPLETED|Overall Study||9
5298728|NCT00548249|13025564|P2|COMPLETED|Overall Study||13
5298729|NCT00548249|13025565|P1|COMPLETED|Overall Study||10
5298730|NCT00548249|13025561|P5|STARTED|Overall Study||28
5298731|NCT00548249|13025562|P4|STARTED|Overall Study||22
5298732|NCT00548249|13025563|P3|STARTED|Overall Study||29
5298733|NCT00548249|13025564|P2|STARTED|Overall Study||26
5298734|NCT00548249|13025565|P1|STARTED|Overall Study||26
5298735|NCT00548197|13025604|P2|NOT COMPLETED|Overall Study||0
5298736|NCT00548197|13025605|P1|NOT COMPLETED|Overall Study||0
5298737|NCT00548197|13025604|P2|COMPLETED|Overall Study||22
5298738|NCT00548197|13025605|P1|COMPLETED|Overall Study||18
5298739|NCT00548197|13025604|P2|STARTED|Overall Study||22
5298740|NCT00548197|13025605|P1|STARTED|Overall Study||18
5298741|NCT00548184|13025613|P1|NOT COMPLETED|Overall Study||5
5298742|NCT00548184|13025613|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
5298743|NCT00548184|13025613|P1|STARTED|Overall Study||65
5298744|NCT00548171|13025619|P2|NOT COMPLETED|Overall Study||0
5298745|NCT00548171|13025620|P1|NOT COMPLETED|Overall Study||0
5298746|NCT00548171|13025619|P2|COMPLETED|Overall Study||39
5298747|NCT00548171|13025620|P1|COMPLETED|Overall Study||164
5298748|NCT00548171|13025619|P2|STARTED|Overall Study||39
5298749|NCT00548171|13025620|P1|STARTED|Overall Study||164
5298750|NCT00548145|13025661|P2|NOT COMPLETED|Overall Study||4
5298751|NCT00548145|13025662|P1|NOT COMPLETED|Overall Study||1
5298752|NCT00548145|13025661|P2|COMPLETED|Overall Study||16
5298753|NCT00548145|13025662|P1|COMPLETED|Overall Study||17
5298754|NCT00548145|13025661|P2|STARTED|Overall Study||20
5298755|NCT00548145|13025662|P1|STARTED|Overall Study||18
5298756|NCT00548132|13025670|P2|NOT COMPLETED|Overall Study||0
5298757|NCT00548132|13025671|P1|NOT COMPLETED|Overall Study||0
5298758|NCT00548132|13025670|P2|COMPLETED|Overall Study||554
5298759|NCT00548132|13025671|P1|COMPLETED|Overall Study||534
5298760|NCT00548132|13025670|P2|Consented to Study|Overall Study||554
5298761|NCT00548132|13025671|P1|Consented to Study|Overall Study||534
5298762|NCT00548132|13025670|P2|STARTED|Overall Study||554
5298763|NCT00548132|13025671|P1|STARTED|Overall Study||534
5298764|NCT00548093|13025681|P2|NOT COMPLETED|Overall Study||16
5298765|NCT00548093|13025682|P1|NOT COMPLETED|Overall Study||50
5298766|NCT00548093|13025681|P2|COMPLETED|Overall Study||0
5298767|NCT00548093|13025682|P1|COMPLETED|Overall Study||0
5298768|NCT00548093|13025681|P2|STARTED|Overall Study||16
5298769|NCT00548093|13025682|P1|STARTED|Overall Study||50
5298770|NCT00548041|13025712|P1|NOT COMPLETED|Overall Study||0
5298771|NCT00548041|13025712|P1|COMPLETED|Overall Study||100
5298772|NCT00548041|13025712|P1|STARTED|Overall Study||100
5298773|NCT00547911|13025720|P6|NOT COMPLETED|Overall Study||0
5298774|NCT00547911|13025721|P5|NOT COMPLETED|Overall Study||0
5298775|NCT00547911|13025722|P4|NOT COMPLETED|Overall Study||1
5298776|NCT00547911|13025723|P3|NOT COMPLETED|Overall Study||0
5298777|NCT00547911|13025724|P2|NOT COMPLETED|Overall Study||0
5298778|NCT00547911|13025725|P1|NOT COMPLETED|Overall Study||0
5298779|NCT00547911|13025720|P6|COMPLETED|Overall Study||3
5298780|NCT00547911|13025721|P5|COMPLETED|Overall Study||3
5298781|NCT00547911|13025722|P4|COMPLETED|Overall Study||1
5298782|NCT00547911|13025723|P3|COMPLETED|Overall Study||2
5298783|NCT00547911|13025724|P2|COMPLETED|Overall Study||2
5298784|NCT00547911|13025725|P1|COMPLETED|Overall Study||2
5298785|NCT00547911|13025720|P6|STARTED|Overall Study||3
5298786|NCT00547911|13025721|P5|STARTED|Overall Study||3
5298787|NCT00547911|13025722|P4|STARTED|Overall Study||2
5298788|NCT00547911|13025723|P3|STARTED|Overall Study||2
5298789|NCT00547911|13025724|P2|STARTED|Overall Study||2
5298790|NCT00547911|13025725|P1|STARTED|Overall Study||2
5298791|NCT00547703|13025756|P2|NOT COMPLETED|Overall Study||0
5298792|NCT00547703|13025757|P1|NOT COMPLETED|Overall Study||1
5298793|NCT00547703|13025756|P2|COMPLETED|Overall Study||1
5298794|NCT00547703|13025757|P1|COMPLETED|Overall Study||3
5298795|NCT00547703|13025756|P2|STARTED|Overall Study||1
5298796|NCT00547703|13025757|P1|STARTED|Overall Study||4
5298797|NCT00547638|13025765|P2|NOT COMPLETED|Overall Study||14
5298798|NCT00547638|13025766|P1|NOT COMPLETED|Overall Study||24
5298799|NCT00547638|13025765|P2|COMPLETED|Overall Study||59
5298800|NCT00547638|13025766|P1|COMPLETED|Overall Study||119
5298801|NCT00547638|13025765|P2|STARTED|Overall Study||73
5298802|NCT00547638|13025766|P1|STARTED|Overall Study||143
5298803|NCT00547534|13025782|P1|NOT COMPLETED|Overall Study||11
5298804|NCT00547534|13025782|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
5298805|NCT00547534|13025782|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
5298806|NCT00547521|13025790|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
5298807|NCT00547521|13025791|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
5298808|NCT00547521|13025790|P2|COMPLETED|Long Term Extension (LTE) Study||59
5298809|NCT00547521|13025791|P1|COMPLETED|Long Term Extension (LTE) Study||0
5298810|NCT00547521|13025790|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
5298811|NCT00547521|13025791|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
5298812|NCT00547521|13025790|P2|NOT COMPLETED|Short Term Study (4 Months)||4
5298813|NCT00547521|13025791|P1|NOT COMPLETED|Short Term Study (4 Months)||1
5298814|NCT00547521|13025790|P2|COMPLETED|Short Term Study (4 Months)||45
5298815|NCT00547521|13025791|P1|COMPLETED|Short Term Study (4 Months)||50
5298816|NCT00547521|13025790|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
5298817|NCT00547521|13025791|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
5298818|NCT00547456|13025861|P1|NOT COMPLETED|Overall Study||0
5298819|NCT00547456|13025861|P1|COMPLETED|Overall Study||20
5298820|NCT00547456|13025861|P1|STARTED|Overall Study||20
5298821|NCT00547378|13025868|P3|NOT COMPLETED|All Implanted Cohort||70
5298822|NCT00547378|13025869|P2|NOT COMPLETED|All Implanted Cohort||18
5298823|NCT00547378|13025870|P1|NOT COMPLETED|All Implanted Cohort||15
5298824|NCT00547378|13025868|P3|COMPLETED|All Implanted Cohort||111
5298825|NCT00547378|13025869|P2|COMPLETED|All Implanted Cohort||22
5298826|NCT00547378|13025870|P1|COMPLETED|All Implanted Cohort||36
5298827|NCT00547378|13025868|P3|Month 60|All Implanted Cohort||114
5298828|NCT00547378|13025869|P2|Month 60|All Implanted Cohort||23
5298829|NCT00547378|13025870|P1|Month 60|All Implanted Cohort||36
5298830|NCT00547378|13025868|P3|Month 48|All Implanted Cohort||136
5298831|NCT00547378|13025869|P2|Month 48|All Implanted Cohort||27
5298832|NCT00547378|13025870|P1|Month 48|All Implanted Cohort||38
5298833|NCT00547378|13025868|P3|Month 36|All Implanted Cohort||146
5298834|NCT00547378|13025869|P2|Month 36|All Implanted Cohort||29
5298835|NCT00547378|13025870|P1|Month 36|All Implanted Cohort||42
5298836|NCT00547378|13025868|P3|Month 24|All Implanted Cohort||161
5298837|NCT00547378|13025869|P2|Month 24|All Implanted Cohort||30
5298838|NCT00547378|13025870|P1|Month 24|All Implanted Cohort||42
5298839|NCT00547378|13025868|P3|Month 12|All Implanted Cohort||175
5298840|NCT00547378|13025869|P2|Month 12|All Implanted Cohort||32
5298841|NCT00547378|13025870|P1|Month 12|All Implanted Cohort||48
5298842|NCT00547378|13025868|P3|Month 6|All Implanted Cohort||178
5298843|NCT00547378|13025869|P2|Month 6|All Implanted Cohort||36
5298844|NCT00547378|13025870|P1|Month 6|All Implanted Cohort||50
5298845|NCT00547378|13025868|P3|Month 3|All Implanted Cohort||178
5298846|NCT00547378|13025869|P2|Month 3|All Implanted Cohort||39
5298847|NCT00547378|13025870|P1|Month 3|All Implanted Cohort||51
5298848|NCT00547378|13025868|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
5298849|NCT00547378|13025869|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
5298850|NCT00547378|13025870|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
5298851|NCT00547378|13025868|P3|NOT COMPLETED|Randomized Cohort||0
5298852|NCT00547378|13025869|P2|NOT COMPLETED|Randomized Cohort||6
5298853|NCT00547378|13025870|P1|NOT COMPLETED|Randomized Cohort||11
5298854|NCT00547378|13025868|P3|COMPLETED|Randomized Cohort||0
5298855|NCT00547378|13025869|P2|COMPLETED|Randomized Cohort||71
5298856|NCT00547378|13025870|P1|COMPLETED|Randomized Cohort||59
5298857|NCT00547378|13025868|P3|Month 6|Randomized Cohort||0
5298858|NCT00547378|13025869|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
5298859|NCT00547378|13025870|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
5298860|NCT00547378|13025868|P3|Month 3|Randomized Cohort||0
5298861|NCT00547378|13025869|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
5298862|NCT00547378|13025870|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
5298863|NCT00547378|13025868|P3|STARTED|Randomized Cohort||0
5298864|NCT00547378|13025869|P2|STARTED|Randomized Cohort||77
5298865|NCT00547378|13025870|P1|STARTED|Randomized Cohort||70
5298866|NCT00547365|13025880|P1|NOT COMPLETED|Overall Study||8
5298867|NCT00547365|13025880|P1|COMPLETED|Overall Study||2
5298868|NCT00547365|13025880|P1|STARTED|Overall Study||10
5298869|NCT00547300|13025887|P2|NOT COMPLETED|Overall Study||26
5298870|NCT00547300|13025888|P1|NOT COMPLETED|Overall Study||25
5298871|NCT00547300|13025887|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
5298872|NCT00547300|13025888|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
5298873|NCT00547300|13025887|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
5298874|NCT00547300|13025888|P1|STARTED|Overall Study||25
5298875|NCT00547248|13025902|P4|NOT COMPLETED|Overall Study||2
5298876|NCT00547248|13025903|P3|NOT COMPLETED|Overall Study||10
5298877|NCT00547248|13025904|P2|NOT COMPLETED|Overall Study||0
5298878|NCT00547248|13025905|P1|NOT COMPLETED|Overall Study||0
5298879|NCT00547248|13025902|P4|COMPLETED|Overall Study||96
5298880|NCT00547248|13025903|P3|COMPLETED|Overall Study||275
5298881|NCT00547248|13025904|P2|COMPLETED|Overall Study||93
5298882|NCT00547248|13025905|P1|COMPLETED|Overall Study||280
5298883|NCT00547248|13025902|P4|STARTED|Overall Study||98
5298884|NCT00547248|13025903|P3|STARTED|Overall Study||285
5298885|NCT00547248|13025904|P2|STARTED|Overall Study||93
5298886|NCT00547248|13025905|P1|STARTED|Overall Study||280
5298887|NCT00547157|13026023|P2|NOT COMPLETED|Overall Study||23
5298888|NCT00547157|13026024|P1|NOT COMPLETED|Overall Study||49
5298889|NCT00547157|13026023|P2|COMPLETED|Overall Study||39
5298890|NCT00547157|13026024|P1|COMPLETED|Overall Study||41
5298891|NCT00547157|13026023|P2|STARTED|Overall Study||62
5298892|NCT00547157|13026024|P1|STARTED|Overall Study||90
5298893|NCT00547118|13026042|P2|NOT COMPLETED|Overall Study||9
5298894|NCT00547118|13026043|P1|NOT COMPLETED|Overall Study||8
5298895|NCT00547118|13026042|P2|COMPLETED|Overall Study||0
5298896|NCT00547118|13026043|P1|COMPLETED|Overall Study||0
5298897|NCT00547118|13026042|P2|STARTED|Overall Study||9
5298898|NCT00547118|13026043|P1|STARTED|Overall Study||8
5298899|NCT00547105|13026075|P1|NOT COMPLETED|Overall Study||0
5298900|NCT00547105|13026075|P1|COMPLETED|Overall Study||24
5298901|NCT00547105|13026075|P1|STARTED|Overall Study||24
5298902|NCT00546910|13026087|P2|NOT COMPLETED|Overall Study||11
5298903|NCT00546910|13026088|P1|NOT COMPLETED|Overall Study||9
5298904|NCT00546910|13026087|P2|COMPLETED|Overall Study||51
5298905|NCT00546910|13026088|P1|COMPLETED|Overall Study||54
5298906|NCT00546910|13026087|P2|STARTED|Overall Study||62
5298907|NCT00546910|13026088|P1|STARTED|Overall Study||63
5298908|NCT00546897|13026108|P2|NOT COMPLETED|Overall Study||0
5298909|NCT00546897|13026109|P1|NOT COMPLETED|Overall Study||0
5298910|NCT00546897|13026108|P2|COMPLETED|Overall Study||33
5298911|NCT00546897|13026109|P1|COMPLETED|Overall Study||15
5298912|NCT00546897|13026108|P2|STARTED|Overall Study||33
5298913|NCT00546897|13026109|P1|STARTED|Overall Study||15
5298914|NCT00546884|13026147|P2|NOT COMPLETED|Overall Study||0
5298915|NCT00546884|13026148|P1|NOT COMPLETED|Overall Study||0
5298916|NCT00546884|13026147|P2|COMPLETED|Overall Study||117
5298917|NCT00546884|13026148|P1|COMPLETED|Overall Study||145
5298918|NCT00546884|13026147|P2|STARTED|Overall Study||117
5298919|NCT00546884|13026148|P1|STARTED|Overall Study||145
5298920|NCT00546871|13026154|P2|NOT COMPLETED|Study Extension Period||1
5298921|NCT00546871|13026155|P1|NOT COMPLETED|Study Extension Period||1
5298922|NCT00546871|13026154|P2|COMPLETED|Study Extension Period||25
5298923|NCT00546871|13026155|P1|COMPLETED|Study Extension Period||9
5298924|NCT00546871|13026154|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
5298925|NCT00546871|13026155|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
5298926|NCT00546871|13026154|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
5298927|NCT00546871|13026155|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
5298928|NCT00546871|13026154|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
5298929|NCT00546871|13026155|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
5298930|NCT00546871|13026154|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
5298931|NCT00546871|13026155|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
5298932|NCT00546871|13026154|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
5298933|NCT00546871|13026155|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
5298934|NCT00546871|13026154|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
5298935|NCT00546871|13026155|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
5298936|NCT00546871|13026154|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
5298937|NCT00546871|13026155|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
5298938|NCT00546871|13026154|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
5298939|NCT00546871|13026155|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
5298940|NCT00546871|13026154|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
5298941|NCT00546871|13026155|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
5298942|NCT00546871|13026154|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
5298943|NCT00546871|13026155|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
5298944|NCT00546871|13026154|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
5298945|NCT00546871|13026155|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
5298946|NCT00546871|13026154|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
5298947|NCT00546871|13026155|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
5298948|NCT00546871|13026154|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
5298949|NCT00546871|13026155|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
5298950|NCT00546819|13026260|P2|NOT COMPLETED|Overall Study||6
5298951|NCT00546819|13026261|P1|NOT COMPLETED|Overall Study||8
5298952|NCT00546819|13026260|P2|COMPLETED|Overall Study||96
5298953|NCT00546819|13026261|P1|COMPLETED|Overall Study||199
5298954|NCT00546819|13026260|P2|VACCINATED|Overall Study||100
5298955|NCT00546819|13026261|P1|VACCINATED|Overall Study||206
5298956|NCT00546819|13026260|P2|STARTED|Overall Study||102
5298957|NCT00546819|13026261|P1|STARTED|Overall Study||207
5298958|NCT00546754|13026273|P2|NOT COMPLETED|Overall Study||49
5298959|NCT00546754|13026274|P1|NOT COMPLETED|Overall Study||50
5298960|NCT00546754|13026273|P2|COMPLETED|Overall Study||334
5298961|NCT00546754|13026274|P1|COMPLETED|Overall Study||375
5298962|NCT00546754|13026273|P2|Week 12|Overall Study||334
5298963|NCT00546754|13026274|P1|Week 12|Overall Study||375
5298964|NCT00546754|13026273|P2|Week 6|Overall Study||347
5298965|NCT00546754|13026274|P1|Week 6|Overall Study||396
5298966|NCT00546754|13026273|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
5298967|NCT00546754|13026274|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
5298968|NCT00546754|13026273|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
5298969|NCT00546754|13026274|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
5298970|NCT00546728|13026306|P2|NOT COMPLETED|Overall Study||0
5298971|NCT00546728|13026307|P1|NOT COMPLETED|Overall Study||0
5298972|NCT00546728|13026306|P2|COMPLETED|Overall Study||25
5298973|NCT00546728|13026307|P1|COMPLETED|Overall Study||25
5298974|NCT00546728|13026306|P2|STARTED|Overall Study||25
5298975|NCT00546728|13026307|P1|STARTED|Overall Study||25
5298976|NCT00546715|13026317|P4|NOT COMPLETED|Overall Study||0
5298977|NCT00546715|13026318|P3|NOT COMPLETED|Overall Study||0
5298978|NCT00546715|13026319|P2|NOT COMPLETED|Overall Study||1
5298979|NCT00546715|13026320|P1|NOT COMPLETED|Overall Study||0
5298980|NCT00546715|13026317|P4|COMPLETED|Overall Study||2
5298981|NCT00546715|13026318|P3|COMPLETED|Overall Study||5
5298982|NCT00546715|13026319|P2|COMPLETED|Overall Study||4
5298983|NCT00546715|13026320|P1|COMPLETED|Overall Study||6
5298984|NCT00546715|13026317|P4|STARTED|Overall Study||2
5298985|NCT00546715|13026318|P3|STARTED|Overall Study||5
5298986|NCT00546715|13026319|P2|STARTED|Overall Study||5
5298987|NCT00546715|13026320|P1|STARTED|Overall Study||6
5298988|NCT00546637|13026375|P2|NOT COMPLETED|Overall Study||49
5298989|NCT00546637|13026376|P1|NOT COMPLETED|Overall Study||73
5298990|NCT00546637|13026375|P2|COMPLETED|Overall Study||424
5298991|NCT00546637|13026376|P1|COMPLETED|Overall Study||401
5298992|NCT00546637|13026375|P2|Received Treatment|Overall Study||472
5298993|NCT00546637|13026376|P1|Received Treatment|Overall Study||471
5298994|NCT00546637|13026375|P2|STARTED|Overall Study||473
5298995|NCT00546637|13026376|P1|STARTED|Overall Study||474
5298996|NCT00546572|13026450|P2|NOT COMPLETED|Vax 2 / Year 1||2
5298997|NCT00546572|13026451|P1|NOT COMPLETED|Vax 2 / Year 1||4
5298998|NCT00546572|13026450|P2|COMPLETED|Vax 2 / Year 1||402
5298999|NCT00546572|13026451|P1|COMPLETED|Vax 2 / Year 1||387
5299000|NCT00546572|13026450|P2|Received Vax 2|Vax 2 / Year 1||404
5299001|NCT00546572|13026451|P1|Received Vax 2|Vax 2 / Year 1||391
5299002|NCT00546572|13026450|P2|STARTED|Vax 2 / Year 1||404
5299003|NCT00546572|13026451|P1|STARTED|Vax 2 / Year 1||391
5299004|NCT00546572|13026450|P2|NOT COMPLETED|Vax 1 / Year 0||70
5299005|NCT00546572|13026451|P1|NOT COMPLETED|Vax 1 / Year 0||73
5299006|NCT00546572|13026450|P2|COMPLETED|Vax 1 / Year 0||404
5299007|NCT00546572|13026451|P1|COMPLETED|Vax 1 / Year 0||391
5299008|NCT00546572|13026450|P2|Received Vax 1|Vax 1 / Year 0||473
5299009|NCT00546572|13026451|P1|Received Vax 1|Vax 1 / Year 0||463
5299010|NCT00546572|13026450|P2|STARTED|Vax 1 / Year 0||474
5299011|NCT00546572|13026451|P1|STARTED|Vax 1 / Year 0||464
5299012|NCT00546481|13026495|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
5299013|NCT00546481|13026496|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
5299014|NCT00546481|13026497|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
5299015|NCT00546481|13026495|P3|COMPLETED|Maintenance Phase (CERA)||50
5299016|NCT00546481|13026496|P2|COMPLETED|Maintenance Phase (CERA)||0
5299017|NCT00546481|13026497|P1|COMPLETED|Maintenance Phase (CERA)||0
5299018|NCT00546481|13026495|P3|STARTED|Maintenance Phase (CERA)||54
5299019|NCT00546481|13026496|P2|STARTED|Maintenance Phase (CERA)||0
5299020|NCT00546481|13026497|P1|STARTED|Maintenance Phase (CERA)||0
5299021|NCT00546481|13026495|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
5299022|NCT00546481|13026496|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
5299023|NCT00546481|13026497|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
5299024|NCT00546481|13026495|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
5299025|NCT00546481|13026496|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
5299026|NCT00546481|13026497|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
5299027|NCT00546481|13026495|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
5299028|NCT00546481|13026496|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
5299029|NCT00546481|13026497|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
5299030|NCT00546429|13026520|P1|NOT COMPLETED|Overall Study||30
5299031|NCT00546429|13026520|P1|COMPLETED|Overall Study||32
5299032|NCT00546429|13026520|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
5299033|NCT00546390|13026526|P2|NOT COMPLETED|Overall Study||0
5299034|NCT00546390|13026527|P1|NOT COMPLETED|Overall Study||0
5299035|NCT00546390|13026526|P2|COMPLETED|Overall Study||28
5299036|NCT00546390|13026527|P1|COMPLETED|Overall Study||27
5299037|NCT00546390|13026526|P2|STARTED|Overall Study||28
5299038|NCT00546390|13026527|P1|STARTED|Overall Study||27
5299039|NCT00546377|13026535|P1|NOT COMPLETED|Overall Study||7
5299040|NCT00546377|13026535|P1|COMPLETED|Overall Study||43
5299041|NCT00546377|13026535|P1|STARTED|Overall Study||50
5299042|NCT00546364|13026543|P3|NOT COMPLETED|Overall Study||17
5299043|NCT00546364|13026544|P2|NOT COMPLETED|Overall Study||18
5299044|NCT00546364|13026545|P1|NOT COMPLETED|Overall Study||17
5299045|NCT00546364|13026543|P3|COMPLETED|Overall Study|Still on treatment|3
5299046|NCT00546364|13026544|P2|COMPLETED|Overall Study|Still on treatment|4
5299047|NCT00546364|13026545|P1|COMPLETED|Overall Study|Still on treatment|3
5299048|NCT00546364|13026543|P3|Never Treated|Overall Study||0
5299049|NCT00546364|13026544|P2|Never Treated|Overall Study||0
5299050|NCT00546364|13026545|P1|Never Treated|Overall Study||0
5299051|NCT00546364|13026543|P3|STARTED|Overall Study||20
5299052|NCT00546364|13026544|P2|STARTED|Overall Study||22
5299053|NCT00546364|13026545|P1|STARTED|Overall Study||20
5299054|NCT00546351|13026580|P1|NOT COMPLETED|Overall Study||236
5299055|NCT00546351|13026580|P1|COMPLETED|Overall Study||385
5299056|NCT00546351|13026580|P1|STARTED|Overall Study||621
5299057|NCT00546273|13026613|P5|NOT COMPLETED|IV||0
5299058|NCT00546273|13026614|P4|NOT COMPLETED|IV||0
5299059|NCT00546273|13026615|P3|NOT COMPLETED|IV||0
5299060|NCT00546273|13026616|P2|NOT COMPLETED|IV||0
5299061|NCT00546273|13026617|P1|NOT COMPLETED|IV||0
5299062|NCT00546273|13026613|P5|COMPLETED|IV||2
5299063|NCT00546273|13026614|P4|COMPLETED|IV||4
5299064|NCT00546273|13026615|P3|COMPLETED|IV||0
5299065|NCT00546273|13026616|P2|COMPLETED|IV||0
5299066|NCT00546273|13026617|P1|COMPLETED|IV||0
5299067|NCT00546273|13026613|P5|STARTED|IV||2
5299068|NCT00546273|13026614|P4|STARTED|IV||4
5299069|NCT00546273|13026615|P3|STARTED|IV||0
5299070|NCT00546273|13026616|P2|STARTED|IV||0
5299071|NCT00546273|13026617|P1|STARTED|IV||0
5299072|NCT00546273|13026613|P5|NOT COMPLETED|III||0
5299073|NCT00546273|13026614|P4|NOT COMPLETED|III||0
5299074|NCT00546273|13026615|P3|NOT COMPLETED|III||0
5299075|NCT00546273|13026616|P2|NOT COMPLETED|III||0
5299076|NCT00546273|13026617|P1|NOT COMPLETED|III||0
5299077|NCT00546273|13026613|P5|COMPLETED|III||2
5299078|NCT00546273|13026614|P4|COMPLETED|III||0
5299079|NCT00546273|13026615|P3|COMPLETED|III||4
5299080|NCT00546273|13026616|P2|COMPLETED|III||0
5299081|NCT00546273|13026617|P1|COMPLETED|III||0
5299082|NCT00546273|13026613|P5|STARTED|III||2
5299083|NCT00546273|13026614|P4|STARTED|III||0
5299084|NCT00546273|13026615|P3|STARTED|III||4
5299085|NCT00546273|13026616|P2|STARTED|III||0
5299086|NCT00546273|13026617|P1|STARTED|III||0
5299087|NCT00546273|13026613|P5|NOT COMPLETED|II||0
5299088|NCT00546273|13026614|P4|NOT COMPLETED|II||0
5299089|NCT00546273|13026615|P3|NOT COMPLETED|II||0
5299090|NCT00546273|13026616|P2|NOT COMPLETED|II||0
5299091|NCT00546273|13026617|P1|NOT COMPLETED|II||0
5299092|NCT00546273|13026613|P5|COMPLETED|II||2
5299093|NCT00546273|13026614|P4|COMPLETED|II||0
5299094|NCT00546273|13026615|P3|COMPLETED|II||0
5299095|NCT00546273|13026616|P2|COMPLETED|II||4
5299096|NCT00546273|13026617|P1|COMPLETED|II||0
5299097|NCT00546273|13026613|P5|STARTED|II||2
5299098|NCT00546273|13026614|P4|STARTED|II||0
5299102|NCT00546273|13026613|P5|NOT COMPLETED|I||0
5299103|NCT00546273|13026614|P4|NOT COMPLETED|I||0
5299104|NCT00546273|13026615|P3|NOT COMPLETED|I||0
5299105|NCT00546273|13026616|P2|NOT COMPLETED|I||0
5299106|NCT00546273|13026617|P1|NOT COMPLETED|I||0
5299107|NCT00546273|13026613|P5|COMPLETED|I||2
5299108|NCT00546273|13026614|P4|COMPLETED|I||0
5299109|NCT00546273|13026615|P3|COMPLETED|I||0
5299110|NCT00546273|13026616|P2|COMPLETED|I||0
5299111|NCT00546273|13026617|P1|COMPLETED|I||4
5299112|NCT00546273|13026613|P5|STARTED|I||2
5299113|NCT00546273|13026614|P4|STARTED|I||0
5299114|NCT00546273|13026615|P3|STARTED|I||0
5299115|NCT00546273|13026616|P2|STARTED|I||0
5299116|NCT00546273|13026617|P1|STARTED|I||4
5299117|NCT00546260|13026626|P2|NOT COMPLETED|Overall Study||2
5299118|NCT00546260|13026627|P1|NOT COMPLETED|Overall Study||8
5299119|NCT00546260|13026626|P2|COMPLETED|Overall Study||32
5299120|NCT00546260|13026627|P1|COMPLETED|Overall Study||28
5299121|NCT00546260|13026626|P2|STARTED|Overall Study||34
5299122|NCT00546260|13026627|P1|STARTED|Overall Study||36
5299123|NCT00546156|13026639|P2|NOT COMPLETED|Overall Study||1
5299124|NCT00546156|13026640|P1|NOT COMPLETED|Overall Study||14
5299125|NCT00546156|13026639|P2|COMPLETED|Overall Study||19
5299126|NCT00546156|13026640|P1|COMPLETED|Overall Study||70
5299127|NCT00546156|13026639|P2|STARTED|Overall Study||20
5299128|NCT00546156|13026640|P1|STARTED|Overall Study||84
5299129|NCT00546117|13026649|P2|NOT COMPLETED|Overall Study||0
5299130|NCT00546117|13026650|P1|NOT COMPLETED|Overall Study||4
5299131|NCT00546117|13026649|P2|COMPLETED|Overall Study||7
5299132|NCT00546117|13026650|P1|COMPLETED|Overall Study||5
5299133|NCT00546117|13026649|P2|STARTED|Overall Study||7
5299134|NCT00546117|13026650|P1|STARTED|Overall Study||9
5299135|NCT00546104|13026664|P1|NOT COMPLETED|Overall Study||0
5299136|NCT00546104|13026664|P1|COMPLETED|Overall Study||31
5299137|NCT00546104|13026664|P1|STARTED|Overall Study||31
5299138|NCT00546078|13026675|P2|NOT COMPLETED|Overall Study||7
5299139|NCT00546078|13026676|P1|NOT COMPLETED|Overall Study||4
5299140|NCT00546078|13026675|P2|COMPLETED|Overall Study||43
5299141|NCT00546078|13026676|P1|COMPLETED|Overall Study||61
5299142|NCT00546078|13026675|P2|Month 18|Overall Study||45
5299143|NCT00546078|13026676|P1|Month 18|Overall Study||61
5299144|NCT00546078|13026675|P2|STARTED|Overall Study||50
5299145|NCT00546078|13026676|P1|STARTED|Overall Study||65
5299146|NCT00546052|13026714|P1|NOT COMPLETED|Overall Study||227
5299147|NCT00546052|13026714|P1|COMPLETED|Overall Study||1511
5299148|NCT00546052|13026714|P1|Week 52|Overall Study||1511
5299149|NCT00546052|13026714|P1|Week 32|Overall Study||1583
5299150|NCT00546052|13026714|P1|Week 12|Overall Study||1650
5299151|NCT00546052|13026714|P1|Week 8|Overall Study||1680
5299152|NCT00546052|13026714|P1|Week 4|Overall Study||1714
5299153|NCT00546052|13026714|P1|STARTED|Overall Study||1738
5299154|NCT00546000|13026732|P1|NOT COMPLETED|Overall Study||4
5299155|NCT00546000|13026732|P1|COMPLETED|Overall Study||52
5299156|NCT00546000|13026732|P1|STARTED|Overall Study||56
5299157|NCT00545974|13026739|P2|NOT COMPLETED|Overall Study||3
5299158|NCT00545974|13026740|P1|NOT COMPLETED|Overall Study||2
5299159|NCT00545974|13026739|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
5299160|NCT00545974|13026740|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
5299161|NCT00545974|13026739|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
5299162|NCT00545974|13026740|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
5299163|NCT00545948|13026751|P3|NOT COMPLETED|Overall Study||7
5299164|NCT00545948|13026752|P2|NOT COMPLETED|Overall Study||1
5299165|NCT00545948|13026753|P1|NOT COMPLETED|Overall Study||1
5299166|NCT00545948|13026751|P3|COMPLETED|Overall Study||0
5299167|NCT00545948|13026752|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
5299168|NCT00545948|13026753|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
5299169|NCT00545948|13026751|P3|Assigned Treatment|Overall Study||0
5299170|NCT00545948|13026752|P2|Assigned Treatment|Overall Study||15
5299171|NCT00545948|13026753|P1|Assigned Treatment|Overall Study||9
5299172|NCT00545948|13026751|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
5299173|NCT00545948|13026752|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
5299174|NCT00545948|13026753|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
5299175|NCT00545844|13026763|P1|NOT COMPLETED|Overall Study||12
5299176|NCT00545844|13026763|P1|COMPLETED|Overall Study||301
5299177|NCT00545844|13026763|P1|STARTED|Overall Study||313
5299178|NCT00545818|13026779|P2|NOT COMPLETED|Overall Study||7
5299179|NCT00545818|13026780|P1|NOT COMPLETED|Overall Study||3
5299180|NCT00545818|13026779|P2|COMPLETED|Overall Study||39
5299181|NCT00545818|13026780|P1|COMPLETED|Overall Study||46
5299182|NCT00545818|13026779|P2|STARTED|Overall Study||46
5299183|NCT00545818|13026780|P1|STARTED|Overall Study||49
5299184|NCT00545792|13026794|P1|NOT COMPLETED|Overall Study||1
5299185|NCT00545792|13026794|P1|COMPLETED|Overall Study||20
5299186|NCT00545792|13026794|P1|STARTED|Overall Study||21
5299187|NCT00545779|13026799|P1|NOT COMPLETED|Overall Study||44
5299188|NCT00545779|13026799|P1|COMPLETED|Overall Study||633
5299189|NCT00545779|13026799|P1|STARTED|Overall Study||677
5299190|NCT00545766|13026812|P1|NOT COMPLETED|Overall Study||5
5299191|NCT00545766|13026812|P1|COMPLETED|Overall Study||36
5299192|NCT00545766|13026812|P1|STARTED|Overall Study||41
5299193|NCT00545753|13026819|P3|NOT COMPLETED|Overall Study||26
5299194|NCT00545753|13026820|P2|NOT COMPLETED|Overall Study||5
5299195|NCT00545753|13026821|P1|NOT COMPLETED|Overall Study||16
5299196|NCT00545753|13026819|P3|COMPLETED|Overall Study||230
5299197|NCT00545753|13026820|P2|COMPLETED|Overall Study||54
5299198|NCT00545753|13026821|P1|COMPLETED|Overall Study||227
5299199|NCT00545753|13026819|P3|STARTED|Overall Study||256
5299200|NCT00545753|13026820|P2|STARTED|Overall Study||59
5299201|NCT00545753|13026821|P1|STARTED|Overall Study||243
5299202|NCT00545740|13026834|P4|NOT COMPLETED|Overall Study||71
5299203|NCT00545740|13026835|P3|NOT COMPLETED|Overall Study||96
5299204|NCT00545740|13026836|P2|NOT COMPLETED|Overall Study||83
5299205|NCT00545740|13026837|P1|NOT COMPLETED|Overall Study||75
5299206|NCT00545740|13026834|P4|COMPLETED|Overall Study||78
5299207|NCT00545740|13026835|P3|COMPLETED|Overall Study||55
5299208|NCT00545740|13026836|P2|COMPLETED|Overall Study||62
5299209|NCT00545740|13026837|P1|COMPLETED|Overall Study||70
5299210|NCT00545740|13026834|P4|STARTED|Overall Study||149
5299211|NCT00545740|13026835|P3|STARTED|Overall Study||151
5299212|NCT00545740|13026836|P2|STARTED|Overall Study||145
5299213|NCT00545740|13026837|P1|STARTED|Overall Study||145
5299214|NCT00545714|13026871|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
5299215|NCT00545714|13026871|P1|COMPLETED|Maintenance Phase (36 Months)||42
5299216|NCT00545714|13026871|P1|STARTED|Maintenance Phase (36 Months)||74
5299217|NCT00545714|13026871|P1|NOT COMPLETED|Induction Phase (6 Months)||12
5299218|NCT00545714|13026871|P1|COMPLETED|Induction Phase (6 Months)||74
5299219|NCT00545714|13026871|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
5299220|NCT00545714|13026871|P1|Safety Population|Induction Phase (6 Months)||86
5299221|NCT00545714|13026871|P1|STARTED|Induction Phase (6 Months)||86
5299222|NCT00545688|13026892|P4|NOT COMPLETED|Follow-Up Period||27
5299223|NCT00545688|13026893|P3|NOT COMPLETED|Follow-Up Period||20
5299224|NCT00545688|13026894|P2|NOT COMPLETED|Follow-Up Period||19
5299225|NCT00545688|13026895|P1|NOT COMPLETED|Follow-Up Period||21
5299226|NCT00545688|13026892|P4|COMPLETED|Follow-Up Period||60
5299227|NCT00545688|13026893|P3|COMPLETED|Follow-Up Period||78
5299228|NCT00545688|13026894|P2|COMPLETED|Follow-Up Period||83
5299229|NCT00545688|13026895|P1|COMPLETED|Follow-Up Period||77
5299230|NCT00545688|13026892|P4|STARTED|Follow-Up Period||87
5299231|NCT00545688|13026893|P3|STARTED|Follow-Up Period||98
5299232|NCT00545688|13026894|P2|STARTED|Follow-Up Period||102
5299233|NCT00545688|13026895|P1|STARTED|Follow-Up Period||98
5299234|NCT00545688|13026892|P4|NOT COMPLETED|Adjuvant Treatment Period||14
5299235|NCT00545688|13026893|P3|NOT COMPLETED|Adjuvant Treatment Period||4
5299236|NCT00545688|13026894|P2|NOT COMPLETED|Adjuvant Treatment Period||8
5299237|NCT00545688|13026895|P1|NOT COMPLETED|Adjuvant Treatment Period||5
5299238|NCT00545688|13026892|P4|COMPLETED|Adjuvant Treatment Period||74
5299239|NCT00545688|13026893|P3|COMPLETED|Adjuvant Treatment Period||90
5299240|NCT00545688|13026894|P2|COMPLETED|Adjuvant Treatment Period||94
5299241|NCT00545688|13026895|P1|COMPLETED|Adjuvant Treatment Period||98
5299242|NCT00545688|13026892|P4|STARTED|Adjuvant Treatment Period||88
5299243|NCT00545688|13026893|P3|STARTED|Adjuvant Treatment Period||94
5299244|NCT00545688|13026894|P2|STARTED|Adjuvant Treatment Period||102
5299245|NCT00545688|13026895|P1|STARTED|Adjuvant Treatment Period||103
5299246|NCT00545688|13026892|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
5299247|NCT00545688|13026893|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
5299248|NCT00545688|13026894|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
5299249|NCT00545688|13026895|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
5299250|NCT00545688|13026892|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
5299251|NCT00545688|13026893|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
5299252|NCT00545688|13026894|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
5299253|NCT00545688|13026895|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
5299254|NCT00545688|13026892|P4|STARTED|Neo-Adjuvant Treatment Period||94
5299255|NCT00545688|13026893|P3|STARTED|Neo-Adjuvant Treatment Period||108
5299256|NCT00545688|13026894|P2|STARTED|Neo-Adjuvant Treatment Period||107
5299257|NCT00545688|13026895|P1|STARTED|Neo-Adjuvant Treatment Period||107
5299258|NCT00545662|13026967|P2|NOT COMPLETED|Overall Study||79
5299259|NCT00545662|13026968|P1|NOT COMPLETED|Overall Study||85
5299260|NCT00545662|13026967|P2|COMPLETED|Overall Study||528
5299261|NCT00545662|13026968|P1|COMPLETED|Overall Study||521
5299262|NCT00545662|13026967|P2|STARTED|Overall Study||607
5299263|NCT00545662|13026968|P1|STARTED|Overall Study||606
5299264|NCT00545623|13026978|P4|NOT COMPLETED|Overall Study||11
5299265|NCT00545623|13026979|P3|NOT COMPLETED|Overall Study||13
5299266|NCT00545623|13026980|P2|NOT COMPLETED|Overall Study||10
5299267|NCT00545623|13026981|P1|NOT COMPLETED|Overall Study||7
5299268|NCT00545623|13026978|P4|COMPLETED|Overall Study||23
5299269|NCT00545623|13026979|P3|COMPLETED|Overall Study||20
5299270|NCT00545623|13026980|P2|COMPLETED|Overall Study||21
5299271|NCT00545623|13026981|P1|COMPLETED|Overall Study||25
5299272|NCT00545623|13026978|P4|STARTED|Overall Study||34
5299273|NCT00545623|13026979|P3|STARTED|Overall Study||33
5299274|NCT00545623|13026980|P2|STARTED|Overall Study||31
5299275|NCT00545623|13026981|P1|STARTED|Overall Study||32
5299276|NCT00545584|13026994|P3|NOT COMPLETED|Overall Study||56
5299277|NCT00545584|13026995|P2|NOT COMPLETED|Overall Study||80
5299278|NCT00545584|13026996|P1|NOT COMPLETED|Overall Study||79
5299279|NCT00545584|13026994|P3|COMPLETED|Overall Study||250
5299280|NCT00545584|13026995|P2|COMPLETED|Overall Study||334
5299281|NCT00545584|13026996|P1|COMPLETED|Overall Study||333
5299282|NCT00545584|13026994|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
5299283|NCT00545584|13026995|P2|STARTED|Overall Study||414
5299284|NCT00545584|13026996|P1|STARTED|Overall Study||412
5299285|NCT00545571|13027007|P1|NOT COMPLETED|Overall Study||67
5299286|NCT00545571|13027007|P1|COMPLETED|Overall Study||53
5299287|NCT00545571|13027007|P1|STARTED|Overall Study||120
5299288|NCT00545532|13027022|P2|NOT COMPLETED|Overall Study||10
5299289|NCT00545532|13027023|P1|NOT COMPLETED|Overall Study||6
5299290|NCT00545532|13027022|P2|COMPLETED|Overall Study||100
5299291|NCT00545532|13027023|P1|COMPLETED|Overall Study||99
5299292|NCT00545532|13027022|P2|STARTED|Overall Study||110
5299293|NCT00545532|13027023|P1|STARTED|Overall Study||105
5299294|NCT00545506|13027105|P2|NOT COMPLETED|Overall Study||0
5299295|NCT00545506|13027106|P1|NOT COMPLETED|Overall Study||0
5299296|NCT00545506|13027105|P2|COMPLETED|Overall Study||3
5299297|NCT00545506|13027106|P1|COMPLETED|Overall Study||3
5299298|NCT00545506|13027105|P2|STARTED|Overall Study||3
5299299|NCT00545506|13027106|P1|STARTED|Overall Study||3
5299300|NCT00545441|13027114|P2|NOT COMPLETED|Overall Study||16
5299301|NCT00545441|13027115|P1|NOT COMPLETED|Overall Study||18
5299302|NCT00545441|13027114|P2|COMPLETED|Overall Study||26
5299303|NCT00545441|13027115|P1|COMPLETED|Overall Study||26
5299304|NCT00545441|13027114|P2|STARTED|Overall Study||42
5299305|NCT00545441|13027115|P1|STARTED|Overall Study||44
5299306|NCT00545402|13027123|P2|NOT COMPLETED|Overall Study||29
5299307|NCT00545402|13027124|P1|NOT COMPLETED|Overall Study||34
5299308|NCT00545402|13027123|P2|COMPLETED|Overall Study||61
5299309|NCT00545402|13027124|P1|COMPLETED|Overall Study||56
5299310|NCT00545402|13027123|P2|STARTED|Overall Study||90
5299311|NCT00545402|13027124|P1|STARTED|Overall Study||90
5299312|NCT00545363|13027142|P2|NOT COMPLETED|Overall Study||15
5299313|NCT00545363|13027143|P1|NOT COMPLETED|Overall Study||19
5299314|NCT00545363|13027142|P2|COMPLETED|Overall Study||343
5299315|NCT00545363|13027143|P1|COMPLETED|Overall Study||339
5299316|NCT00545363|13027142|P2|Treated|Overall Study||357
5299317|NCT00545363|13027143|P1|Treated|Overall Study||354
5299318|NCT00545363|13027142|P2|STARTED|Overall Study||358
5299319|NCT00545363|13027143|P1|STARTED|Overall Study||358
5299320|NCT00545298|13027158|P3|NOT COMPLETED|Overall Study||1
5299321|NCT00545298|13027159|P2|NOT COMPLETED|Overall Study||0
5299322|NCT00545298|13027160|P1|NOT COMPLETED|Overall Study||2
5299323|NCT00545298|13027158|P3|COMPLETED|Overall Study||0
5299324|NCT00545298|13027159|P2|COMPLETED|Overall Study||1
5299325|NCT00545298|13027160|P1|COMPLETED|Overall Study||0
5299326|NCT00545298|13027158|P3|STARTED|Overall Study||1
5299327|NCT00545298|13027159|P2|STARTED|Overall Study||1
5299328|NCT00545298|13027160|P1|STARTED|Overall Study||2
5299329|NCT00545272|13027177|P6|NOT COMPLETED|Overall Study||3
5299330|NCT00545272|13027178|P5|NOT COMPLETED|Overall Study||2
5299331|NCT00545272|13027179|P4|NOT COMPLETED|Overall Study||1
5299332|NCT00545272|13027180|P3|NOT COMPLETED|Overall Study||1
5299333|NCT00545272|13027181|P2|NOT COMPLETED|Overall Study||1
5299334|NCT00545272|13027182|P1|NOT COMPLETED|Overall Study||0
5299335|NCT00545272|13027177|P6|COMPLETED|Overall Study||59
5299336|NCT00545272|13027178|P5|COMPLETED|Overall Study||62
5299337|NCT00545272|13027179|P4|COMPLETED|Overall Study||71
5299338|NCT00545272|13027180|P3|COMPLETED|Overall Study||64
5299339|NCT00545272|13027181|P2|COMPLETED|Overall Study||67
5299340|NCT00545272|13027182|P1|COMPLETED|Overall Study||61
5299341|NCT00545272|13027177|P6|STARTED|Overall Study||62
5299342|NCT00545272|13027178|P5|STARTED|Overall Study||64
5299343|NCT00545272|13027179|P4|STARTED|Overall Study||72
5299344|NCT00545272|13027180|P3|STARTED|Overall Study||65
5299345|NCT00545272|13027181|P2|STARTED|Overall Study||68
5299346|NCT00545272|13027182|P1|STARTED|Overall Study||61
5299347|NCT00545233|13027234|P2|NOT COMPLETED|Overall Study||35
5299348|NCT00545233|13027235|P1|NOT COMPLETED|Overall Study||46
5299349|NCT00545233|13027234|P2|COMPLETED|Overall Study||41
5299350|NCT00545233|13027235|P1|COMPLETED|Overall Study||33
5299351|NCT00545233|13027234|P2|Intent-to-Treat (ITT)|Overall Study||73
5299352|NCT00545233|13027235|P1|Intent-to-Treat (ITT)|Overall Study||77
5299353|NCT00545233|13027234|P2|Safety Set|Overall Study||75
5299354|NCT00545233|13027235|P1|Safety Set|Overall Study||77
5299355|NCT00545233|13027234|P2|STARTED|Overall Study||76
5299356|NCT00545233|13027235|P1|STARTED|Overall Study||79
5299357|NCT00545181|13027284|P2|NOT COMPLETED|Overall Study||0
5299358|NCT00545181|13027285|P1|NOT COMPLETED|Overall Study||0
5299359|NCT00545181|13027284|P2|COMPLETED|Overall Study||25
5299360|NCT00545181|13027285|P1|COMPLETED|Overall Study||29
5299361|NCT00545181|13027284|P2|STARTED|Overall Study||25
5299362|NCT00545181|13027285|P1|STARTED|Overall Study||29
5299363|NCT00545168|13027294|P3|NOT COMPLETED|Overall Study||21
5299364|NCT00545168|13027295|P2|NOT COMPLETED|Overall Study||5
5299365|NCT00545168|13027296|P1|NOT COMPLETED|Overall Study||16
5299366|NCT00545168|13027294|P3|COMPLETED|Overall Study||193
5299367|NCT00545168|13027295|P2|COMPLETED|Overall Study||58
5299368|NCT00545168|13027296|P1|COMPLETED|Overall Study||187
5299369|NCT00545168|13027294|P3|STARTED|Overall Study||214
5299370|NCT00545168|13027295|P2|STARTED|Overall Study||63
5299371|NCT00545168|13027296|P1|STARTED|Overall Study||203
5299372|NCT00545155|13027305|P1|NOT COMPLETED|Overall Study||0
5299373|NCT00545155|13027305|P1|COMPLETED|Overall Study||187
5299374|NCT00545155|13027305|P1|STARTED|Overall Study||187
5299375|NCT00545103|13027322|P4|NOT COMPLETED|Overall Study||70
5299376|NCT00545103|13027323|P3|NOT COMPLETED|Overall Study||76
5299377|NCT00545103|13027324|P2|NOT COMPLETED|Overall Study||78
5299378|NCT00545103|13027325|P1|NOT COMPLETED|Overall Study||75
5299379|NCT00545103|13027322|P4|COMPLETED|Overall Study||76
5299380|NCT00545103|13027323|P3|COMPLETED|Overall Study||74
5299381|NCT00545103|13027324|P2|COMPLETED|Overall Study||70
5299382|NCT00545103|13027325|P1|COMPLETED|Overall Study||73
5299383|NCT00545103|13027322|P4|STARTED|Overall Study||146
5299384|NCT00545103|13027323|P3|STARTED|Overall Study||150
5299385|NCT00545103|13027324|P2|STARTED|Overall Study||148
5299386|NCT00545103|13027325|P1|STARTED|Overall Study||148
5299387|NCT00545077|13027361|P2|NOT COMPLETED|Overall Study||155
5299388|NCT00545077|13027362|P1|NOT COMPLETED|Overall Study||148
5299389|NCT00545077|13027361|P2|COMPLETED|Overall Study||36
5299390|NCT00545077|13027362|P1|COMPLETED|Overall Study||41
5299391|NCT00545077|13027361|P2|STARTED|Overall Study||191
5299392|NCT00545077|13027362|P1|STARTED|Overall Study||189
5299393|NCT00545064|13027378|P1|NOT COMPLETED|Overall Study||8
5299394|NCT00545064|13027378|P1|COMPLETED|Overall Study||170
5299395|NCT00545064|13027378|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
5299396|NCT00545064|13027378|P1|Visit 2 (Week 4)|Overall Study||169
5299397|NCT00545064|13027378|P1|Visit 1 (Baseline)|Overall Study||178
5299398|NCT00545064|13027378|P1|STARTED|Overall Study||178
5299399|NCT00545051|13027389|P2|NOT COMPLETED|Overall Study||7
5299400|NCT00545051|13027390|P1|NOT COMPLETED|Overall Study||9
5299401|NCT00545051|13027389|P2|COMPLETED|Overall Study||65
5299402|NCT00545051|13027390|P1|COMPLETED|Overall Study||59
5299403|NCT00545051|13027389|P2|STARTED|Overall Study||72
5299404|NCT00545051|13027390|P1|STARTED|Overall Study||68
5299405|NCT00545025|13027406|P2|NOT COMPLETED|Overall Study||0
5299406|NCT00545025|13027407|P1|NOT COMPLETED|Overall Study||0
5299407|NCT00545025|13027406|P2|COMPLETED|Overall Study||83
5299408|NCT00545025|13027407|P1|COMPLETED|Overall Study||160
5299409|NCT00545025|13027406|P2|STARTED|Overall Study||83
5299410|NCT00545025|13027407|P1|STARTED|Overall Study||160
5299411|NCT00544908|13027427|P1|NOT COMPLETED|Overall Study||0
5299412|NCT00544908|13027427|P1|COMPLETED|Overall Study||7
5299413|NCT00544908|13027427|P1|STARTED|Overall Study||7
5299414|NCT00544882|13027434|P3|NOT COMPLETED|Cycle 3: Follow-up||0
5299415|NCT00544882|13027435|P2|NOT COMPLETED|Cycle 3: Follow-up||2
5299416|NCT00544882|13027436|P1|NOT COMPLETED|Cycle 3: Follow-up||0
5299417|NCT00544882|13027434|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
5299418|NCT00544882|13027435|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
5299419|NCT00544882|13027436|P1|COMPLETED|Cycle 3: Follow-up||0
5299420|NCT00544882|13027434|P3|STARTED|Cycle 3: Follow-up||28
5299421|NCT00544882|13027435|P2|STARTED|Cycle 3: Follow-up||28
5299422|NCT00544882|13027436|P1|STARTED|Cycle 3: Follow-up||0
5299423|NCT00544882|13027434|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
5299424|NCT00544882|13027435|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
5299425|NCT00544882|13027436|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
5299426|NCT00544882|13027434|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
5299427|NCT00544882|13027435|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
5299428|NCT00544882|13027436|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
5299429|NCT00544882|13027434|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
5299430|NCT00544882|13027435|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
5299431|NCT00544882|13027436|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
5299432|NCT00544882|13027434|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
5299433|NCT00544882|13027435|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
5299434|NCT00544882|13027436|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
5299435|NCT00544882|13027434|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
5299436|NCT00544882|13027435|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
5299437|NCT00544882|13027436|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
5299438|NCT00544882|13027434|P3|COMPLETED|Cycle 1: Run-in Cycle||0
5299439|NCT00544882|13027435|P2|COMPLETED|Cycle 1: Run-in Cycle||0
5299440|NCT00544882|13027436|P1|COMPLETED|Cycle 1: Run-in Cycle||58
5299441|NCT00544882|13027434|P3|STARTED|Cycle 1: Run-in Cycle||0
5299442|NCT00544882|13027435|P2|STARTED|Cycle 1: Run-in Cycle||0
5299443|NCT00544882|13027436|P1|STARTED|Cycle 1: Run-in Cycle||61
5299444|NCT00544869|13027461|P3|NOT COMPLETED|Overall Study||0
5299445|NCT00544869|13027462|P2|NOT COMPLETED|Overall Study||2
5299446|NCT00544869|13027463|P1|NOT COMPLETED|Overall Study||12
5299447|NCT00544869|13027461|P3|COMPLETED|Overall Study||2
5299448|NCT00544869|13027462|P2|COMPLETED|Overall Study||12
5299449|NCT00544869|13027463|P1|COMPLETED|Overall Study||24
5299450|NCT00544869|13027461|P3|STARTED|Overall Study||2
5299451|NCT00544869|13027462|P2|STARTED|Overall Study||14
5299452|NCT00544869|13027463|P1|STARTED|Overall Study||36
5299453|NCT00544817|13027471|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
5299454|NCT00544817|13027471|P1|COMPLETED|Follow-up Systemic Therapy||9
5299455|NCT00544817|13027471|P1|STARTED|Follow-up Systemic Therapy||28
5299456|NCT00544817|13027471|P1|NOT COMPLETED|No Treatment Interval||12
5299457|NCT00544817|13027471|P1|COMPLETED|No Treatment Interval||28
5299458|NCT00544817|13027471|P1|STARTED|No Treatment Interval||40
5299459|NCT00544817|13027471|P1|NOT COMPLETED|Combined Modality||7
5299460|NCT00544817|13027471|P1|COMPLETED|Combined Modality||40
5299461|NCT00544817|13027471|P1|STARTED|Combined Modality||47
5299462|NCT00544778|13027477|P1|NOT COMPLETED|Overall Study||0
5299463|NCT00544778|13027477|P1|COMPLETED|Overall Study||7
5299464|NCT00544778|13027477|P1|STARTED|Overall Study||7
5299465|NCT00544713|13027483|P2|NOT COMPLETED|Overall Study||5
5299466|NCT00544713|13027484|P1|NOT COMPLETED|Overall Study||3
5299467|NCT00544713|13027483|P2|COMPLETED|Overall Study||109
5299468|NCT00544713|13027484|P1|COMPLETED|Overall Study||111
5299469|NCT00544713|13027483|P2|STARTED|Overall Study||114
5299470|NCT00544713|13027484|P1|STARTED|Overall Study||114
5299471|NCT00544674|13027514|P1|NOT COMPLETED|Overall Study||1
5299472|NCT00544674|13027514|P1|COMPLETED|Overall Study||4
5299473|NCT00544674|13027514|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
5299474|NCT00544648|13027520|P2|NOT COMPLETED|Overall Study||1
5299475|NCT00544648|13027521|P1|NOT COMPLETED|Overall Study||3
5299476|NCT00544648|13027520|P2|COMPLETED|Overall Study||1
5299477|NCT00544648|13027521|P1|COMPLETED|Overall Study||8
5299478|NCT00544648|13027520|P2|STARTED|Overall Study||2
5299479|NCT00544648|13027521|P1|STARTED|Overall Study||11
5299480|NCT00544557|13027535|P1|NOT COMPLETED|Overall Study||434
5299481|NCT00544557|13027535|P1|COMPLETED|Overall Study||1251
5299482|NCT00544557|13027535|P1|STARTED|Overall Study||1685
5299483|NCT00544544|13027566|P1|NOT COMPLETED|Overall Study||3
5299484|NCT00544544|13027566|P1|COMPLETED|Overall Study||11
5299485|NCT00544544|13027566|P1|STARTED|Overall Study||14
5299486|NCT00544440|13027573|P1|NOT COMPLETED|Overall Study||57
5299487|NCT00544440|13027573|P1|COMPLETED|Overall Study||0
5299488|NCT00544440|13027573|P1|STARTED|Overall Study||57
5299489|NCT00544167|13027580|P1|NOT COMPLETED|Overall Study||29
5299490|NCT00544167|13027580|P1|COMPLETED|Overall Study||16
5299491|NCT00544167|13027580|P1|STARTED|Overall Study||45
5299492|NCT00544076|13027587|P3|NOT COMPLETED|Overall Study||11
5299493|NCT00544076|13027588|P2|NOT COMPLETED|Overall Study||16
5299494|NCT00544076|13027589|P1|NOT COMPLETED|Overall Study||17
5299495|NCT00544076|13027587|P3|COMPLETED|Overall Study||20
5299496|NCT00544076|13027588|P2|COMPLETED|Overall Study||19
5299497|NCT00544076|13027589|P1|COMPLETED|Overall Study||17
5299498|NCT00544076|13027587|P3|STARTED|Overall Study||31
5299499|NCT00544076|13027588|P2|STARTED|Overall Study||35
5299500|NCT00544076|13027589|P1|STARTED|Overall Study||34
5299501|NCT00543985|13027606|P1|NOT COMPLETED|Overall Study||4
5299502|NCT00543985|13027606|P1|COMPLETED|Overall Study||32
5299503|NCT00543985|13027606|P1|STARTED|Overall Study||36
5299504|NCT00543855|13027617|P4|NOT COMPLETED|Overall Study||4
5299505|NCT00543855|13027618|P3|NOT COMPLETED|Overall Study||6
5299506|NCT00543855|13027619|P2|NOT COMPLETED|Overall Study||2
5299507|NCT00543855|13027620|P1|NOT COMPLETED|Overall Study||4
5299508|NCT00543855|13027617|P4|COMPLETED|Overall Study||30
5299509|NCT00543855|13027618|P3|COMPLETED|Overall Study||31
5299510|NCT00543855|13027619|P2|COMPLETED|Overall Study||31
5299511|NCT00543855|13027620|P1|COMPLETED|Overall Study||31
5299512|NCT00543855|13027617|P4|STARTED|Overall Study||34
5299513|NCT00543855|13027618|P3|STARTED|Overall Study||37
5299514|NCT00543855|13027619|P2|STARTED|Overall Study||33
5299515|NCT00543855|13027620|P1|STARTED|Overall Study||35
5299516|NCT00543803|13027642|P1|NOT COMPLETED|Overall Study||142
5299517|NCT00543803|13027642|P1|COMPLETED|Overall Study||192
5299518|NCT00543803|13027642|P1|STARTED|Overall Study||334
5299519|NCT00543764|13027661|P2|NOT COMPLETED|Overall Study||0
5299520|NCT00543764|13027662|P1|NOT COMPLETED|Overall Study||0
5299521|NCT00543764|13027661|P2|COMPLETED|Overall Study||50
5299522|NCT00543764|13027662|P1|COMPLETED|Overall Study||100
5299523|NCT00543764|13027661|P2|STARTED|Overall Study||50
5299524|NCT00543764|13027662|P1|STARTED|Overall Study||100
5299525|NCT00543725|13027670|P2|NOT COMPLETED|Overall Study||74
5299526|NCT00543725|13027671|P1|NOT COMPLETED|Overall Study||68
5299527|NCT00543725|13027670|P2|COMPLETED|Overall Study||264
5299528|NCT00543725|13027671|P1|COMPLETED|Overall Study||272
5299529|NCT00543725|13027670|P2|STARTED|Overall Study||338
5299530|NCT00543725|13027671|P1|STARTED|Overall Study||340
5299531|NCT00543569|13027697|P4|NOT COMPLETED|Overall Study||9
5299532|NCT00543569|13027698|P3|NOT COMPLETED|Overall Study||20
5299533|NCT00543569|13027699|P2|NOT COMPLETED|Overall Study||8
5299534|NCT00543569|13027700|P1|NOT COMPLETED|Overall Study||12
5299535|NCT00543569|13027697|P4|COMPLETED|Overall Study||72
5299536|NCT00543569|13027698|P3|COMPLETED|Overall Study||60
5299537|NCT00543569|13027699|P2|COMPLETED|Overall Study||72
5299538|NCT00543569|13027700|P1|COMPLETED|Overall Study||70
5299539|NCT00543569|13027697|P4|Received Treatment|Overall Study||78
5299540|NCT00543569|13027698|P3|Received Treatment|Overall Study||75
5299541|NCT00543569|13027699|P2|Received Treatment|Overall Study||77
5299542|NCT00543569|13027700|P1|Received Treatment|Overall Study||79
5299543|NCT00543569|13027697|P4|STARTED|Overall Study||81
5299544|NCT00543569|13027698|P3|STARTED|Overall Study||80
5299545|NCT00543569|13027699|P2|STARTED|Overall Study||80
5299546|NCT00543569|13027700|P1|STARTED|Overall Study||82
5299547|NCT00543543|13027806|P4|NOT COMPLETED|Extension Study||226
5299548|NCT00543543|13027807|P3|NOT COMPLETED|Extension Study||0
5299549|NCT00543543|13027808|P2|NOT COMPLETED|Extension Study||0
5299550|NCT00543543|13027809|P1|NOT COMPLETED|Extension Study||0
5299551|NCT00543543|13027806|P4|COMPLETED|Extension Study||2824
5299552|NCT00543543|13027807|P3|COMPLETED|Extension Study||0
5299553|NCT00543543|13027808|P2|COMPLETED|Extension Study||150
5299554|NCT00543543|13027809|P1|COMPLETED|Extension Study||0
5299555|NCT00543543|13027806|P4|STARTED|Extension Study|Cohort 2|3050
5299556|NCT00543543|13027807|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
5299557|NCT00543543|13027808|P2|STARTED|Extension Study|Cohort 1|150
5299558|NCT00543543|13027809|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
5299559|NCT00543543|13027806|P4|NOT COMPLETED|Base Study||1222
5299560|NCT00543543|13027807|P3|NOT COMPLETED|Base Study||14
5299561|NCT00543543|13027808|P2|NOT COMPLETED|Base Study||1252
5299562|NCT00543543|13027809|P1|NOT COMPLETED|Base Study||20
5299563|NCT00543543|13027806|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
5299564|NCT00543543|13027807|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
5299565|NCT00543543|13027808|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
5299566|NCT00543543|13027809|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
5299567|NCT00543543|13027806|P4|Completed 3 Vaccinations|Base Study||6934
5299568|NCT00543543|13027807|P3|Completed 3 Vaccinations|Base Study||297
5299569|NCT00543543|13027808|P2|Completed 3 Vaccinations|Base Study||6928
5299570|NCT00543543|13027809|P1|Completed 3 Vaccinations|Base Study||300
5299571|NCT00543543|13027806|P4|STARTED|Base Study||7109
5299572|NCT00543543|13027807|P3|STARTED|Base Study||310
5299573|NCT00543543|13027808|P2|STARTED|Base Study||7106
5299574|NCT00543543|13027809|P1|STARTED|Base Study||315
5299575|NCT00543439|13027853|P3|NOT COMPLETED|Period 2||2
5299576|NCT00543439|13027854|P2|NOT COMPLETED|Period 2||1
5299577|NCT00543439|13027855|P1|NOT COMPLETED|Period 2||1
5299578|NCT00543439|13027853|P3|COMPLETED|Period 2||23
5299579|NCT00543439|13027854|P2|COMPLETED|Period 2||25
5299580|NCT00543439|13027855|P1|COMPLETED|Period 2||8
5299581|NCT00543439|13027853|P3|STARTED|Period 2||25
5299582|NCT00543439|13027854|P2|STARTED|Period 2||26
5299583|NCT00543439|13027855|P1|STARTED|Period 2||9
5299584|NCT00543439|13027853|P3|NOT COMPLETED|Period 1||2
5299585|NCT00543439|13027854|P2|NOT COMPLETED|Period 1||3
5299586|NCT00543439|13027855|P1|NOT COMPLETED|Period 1||1
5299587|NCT00543439|13027853|P3|COMPLETED|Period 1||25
5299588|NCT00543439|13027854|P2|COMPLETED|Period 1||26
5299589|NCT00543439|13027855|P1|COMPLETED|Period 1||9
5299590|NCT00543439|13027853|P3|Treated|Period 1||27
5299591|NCT00543439|13027854|P2|Treated|Period 1||29
5299592|NCT00543439|13027855|P1|Treated|Period 1||9
5299593|NCT00543439|13027853|P3|STARTED|Period 1||27
5299594|NCT00543439|13027854|P2|STARTED|Period 1||29
5299595|NCT00543439|13027855|P1|STARTED|Period 1||10
5299596|NCT00543400|13027902|P4|NOT COMPLETED|Overall Study||5
5299597|NCT00543400|13027903|P3|NOT COMPLETED|Overall Study||4
5299598|NCT00543400|13027904|P2|NOT COMPLETED|Overall Study||1
5299599|NCT00543400|13027905|P1|NOT COMPLETED|Overall Study||5
5299600|NCT00543400|13027902|P4|COMPLETED|Overall Study||151
5299601|NCT00543400|13027903|P3|COMPLETED|Overall Study||148
5299602|NCT00543400|13027904|P2|COMPLETED|Overall Study||43
5299603|NCT00543400|13027905|P1|COMPLETED|Overall Study||146
5299604|NCT00543400|13027902|P4|STARTED|Overall Study||156
5299605|NCT00543400|13027903|P3|STARTED|Overall Study||152
5299606|NCT00543400|13027904|P2|STARTED|Overall Study||44
5299607|NCT00543400|13027905|P1|STARTED|Overall Study||151
5299608|NCT00543387|13027924|P11|NOT COMPLETED|Crossover Participants||3
5299609|NCT00543387|13027925|P10|NOT COMPLETED|Crossover Participants||1
5299610|NCT00543387|13027926|P9|NOT COMPLETED|Crossover Participants||0
5299611|NCT00543387|13027927|P8|NOT COMPLETED|Crossover Participants||0
5299612|NCT00543387|13027928|P7|NOT COMPLETED|Crossover Participants||0
5299613|NCT00543387|13027929|P6|NOT COMPLETED|Crossover Participants||0
5299614|NCT00543387|13027930|P5|NOT COMPLETED|Crossover Participants||0
5299615|NCT00543387|13027931|P4|NOT COMPLETED|Crossover Participants||0
5299616|NCT00543387|13027932|P3|NOT COMPLETED|Crossover Participants||0
5299617|NCT00543387|13027933|P2|NOT COMPLETED|Crossover Participants||0
5299618|NCT00543387|13027934|P1|NOT COMPLETED|Crossover Participants||0
5299619|NCT00543387|13027924|P11|COMPLETED|Crossover Participants||0
5299620|NCT00543387|13027925|P10|COMPLETED|Crossover Participants||0
5299621|NCT00543387|13027926|P9|COMPLETED|Crossover Participants||0
5299622|NCT00543387|13027927|P8|COMPLETED|Crossover Participants||0
5299623|NCT00543387|13027928|P7|COMPLETED|Crossover Participants||0
5299624|NCT00543387|13027929|P6|COMPLETED|Crossover Participants||0
5299625|NCT00543387|13027930|P5|COMPLETED|Crossover Participants||0
5299626|NCT00543387|13027931|P4|COMPLETED|Crossover Participants||0
5299627|NCT00543387|13027932|P3|COMPLETED|Crossover Participants||0
5299628|NCT00543387|13027933|P2|COMPLETED|Crossover Participants||0
5299629|NCT00543387|13027934|P1|COMPLETED|Crossover Participants||0
5299630|NCT00543387|13027924|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
5299631|NCT00543387|13027925|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
5299632|NCT00543387|13027926|P9|STARTED|Crossover Participants||0
5299633|NCT00543387|13027927|P8|STARTED|Crossover Participants||0
5299634|NCT00543387|13027928|P7|STARTED|Crossover Participants||0
5299635|NCT00543387|13027929|P6|STARTED|Crossover Participants||0
5299636|NCT00543387|13027930|P5|STARTED|Crossover Participants||0
5299637|NCT00543387|13027931|P4|STARTED|Crossover Participants||0
5299638|NCT00543387|13027932|P3|STARTED|Crossover Participants||0
5299639|NCT00543387|13027933|P2|STARTED|Crossover Participants||0
5299640|NCT00543387|13027934|P1|STARTED|Crossover Participants||0
5299641|NCT00543387|13027924|P11|NOT COMPLETED|Panel 1 + Panel 2||0
5299642|NCT00543387|13027925|P10|NOT COMPLETED|Panel 1 + Panel 2||0
5299643|NCT00543387|13027926|P9|NOT COMPLETED|Panel 1 + Panel 2||5
5299644|NCT00543387|13027927|P8|NOT COMPLETED|Panel 1 + Panel 2||6
5299645|NCT00543387|13027928|P7|NOT COMPLETED|Panel 1 + Panel 2||6
5299646|NCT00543387|13027929|P6|NOT COMPLETED|Panel 1 + Panel 2||3
5299647|NCT00543387|13027930|P5|NOT COMPLETED|Panel 1 + Panel 2||3
5299648|NCT00543387|13027931|P4|NOT COMPLETED|Panel 1 + Panel 2||3
5299649|NCT00543387|13027932|P3|NOT COMPLETED|Panel 1 + Panel 2||3
5299650|NCT00543387|13027933|P2|NOT COMPLETED|Panel 1 + Panel 2||3
5299651|NCT00543387|13027934|P1|NOT COMPLETED|Panel 1 + Panel 2||3
5299652|NCT00543387|13027924|P11|COMPLETED|Panel 1 + Panel 2||0
5299653|NCT00543387|13027925|P10|COMPLETED|Panel 1 + Panel 2||0
5299654|NCT00543387|13027926|P9|COMPLETED|Panel 1 + Panel 2||0
5299655|NCT00543387|13027927|P8|COMPLETED|Panel 1 + Panel 2||0
5299656|NCT00543387|13027928|P7|COMPLETED|Panel 1 + Panel 2||0
5299657|NCT00543387|13027929|P6|COMPLETED|Panel 1 + Panel 2||0
5299658|NCT00543387|13027930|P5|COMPLETED|Panel 1 + Panel 2||0
5299659|NCT00543387|13027931|P4|COMPLETED|Panel 1 + Panel 2||0
5299660|NCT00543387|13027932|P3|COMPLETED|Panel 1 + Panel 2||0
5299661|NCT00543387|13027933|P2|COMPLETED|Panel 1 + Panel 2||0
5299662|NCT00543387|13027934|P1|COMPLETED|Panel 1 + Panel 2||0
5299663|NCT00543387|13027924|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299664|NCT00543387|13027925|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299665|NCT00543387|13027926|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299666|NCT00543387|13027927|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299667|NCT00543387|13027928|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299668|NCT00543387|13027929|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
5299669|NCT00543387|13027930|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
5299670|NCT00543387|13027931|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299671|NCT00543387|13027932|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299672|NCT00543387|13027933|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
5299673|NCT00543387|13027934|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
5299674|NCT00543387|13027924|P11|STARTED|Panel 1 + Panel 2||0
5299675|NCT00543387|13027925|P10|STARTED|Panel 1 + Panel 2||0
5299676|NCT00543387|13027926|P9|STARTED|Panel 1 + Panel 2||5
5299677|NCT00543387|13027927|P8|STARTED|Panel 1 + Panel 2||6
5299678|NCT00543387|13027928|P7|STARTED|Panel 1 + Panel 2||6
5299679|NCT00543387|13027929|P6|STARTED|Panel 1 + Panel 2||3
5299680|NCT00543387|13027930|P5|STARTED|Panel 1 + Panel 2||3
5299681|NCT00543387|13027931|P4|STARTED|Panel 1 + Panel 2||3
5299682|NCT00543387|13027932|P3|STARTED|Panel 1 + Panel 2||3
5299683|NCT00543387|13027933|P2|STARTED|Panel 1 + Panel 2||3
5299684|NCT00543387|13027934|P1|STARTED|Panel 1 + Panel 2||3
5299685|NCT00543309|13027972|P3|NOT COMPLETED|Overall Study||0
5299686|NCT00543309|13027973|P2|NOT COMPLETED|Overall Study||1
5299687|NCT00543309|13027974|P1|NOT COMPLETED|Overall Study||0
5299688|NCT00543309|13027972|P3|COMPLETED|Overall Study||35
5299689|NCT00543309|13027973|P2|COMPLETED|Overall Study||35
5299690|NCT00543309|13027974|P1|COMPLETED|Overall Study||35
5299691|NCT00543309|13027972|P3|STARTED|Overall Study||35
5299692|NCT00543309|13027973|P2|STARTED|Overall Study||36
5299693|NCT00543309|13027974|P1|STARTED|Overall Study||35
5299694|NCT00543296|13028024|P1|NOT COMPLETED|Overall Study||7
5299695|NCT00543296|13028024|P1|COMPLETED|Overall Study||14
5299696|NCT00543296|13028024|P1|STARTED|Overall Study||21
5299697|NCT00543140|13028031|P1|NOT COMPLETED|Overall Study||72
5299698|NCT00543140|13028031|P1|COMPLETED|Overall Study||231
5299699|NCT00543140|13028031|P1|STARTED|Overall Study||303
5299700|NCT00543127|13028041|P2|NOT COMPLETED|Overall Study||87
5299701|NCT00543127|13028042|P1|NOT COMPLETED|Overall Study||130
5299702|NCT00543127|13028041|P2|COMPLETED|Overall Study||350
5299703|NCT00543127|13028042|P1|COMPLETED|Overall Study||303
5299704|NCT00543127|13028041|P2|STARTED|Overall Study||437
5299705|NCT00543127|13028042|P1|STARTED|Overall Study||433
5299706|NCT00543101|13028056|P2|NOT COMPLETED|Overall Study||0
5299707|NCT00543101|13028057|P1|NOT COMPLETED|Overall Study||0
5299708|NCT00543101|13028056|P2|COMPLETED|Overall Study||12
5299709|NCT00543101|13028057|P1|COMPLETED|Overall Study||12
5299710|NCT00543101|13028056|P2|STARTED|Overall Study||12
5299711|NCT00543101|13028057|P1|STARTED|Overall Study||12
5299712|NCT00543062|13028069|P4|NOT COMPLETED|Overall Study||1
5299713|NCT00543062|13028070|P3|NOT COMPLETED|Overall Study||3
5299714|NCT00543062|13028071|P2|NOT COMPLETED|Overall Study||1
5299715|NCT00543062|13028072|P1|NOT COMPLETED|Overall Study||2
5299716|NCT00543062|13028069|P4|COMPLETED|Overall Study||11
5299717|NCT00543062|13028070|P3|COMPLETED|Overall Study||9
5299718|NCT00543062|13028071|P2|COMPLETED|Overall Study||11
5299719|NCT00543062|13028072|P1|COMPLETED|Overall Study||10
5299720|NCT00543062|13028069|P4|STARTED|Overall Study||12
5299721|NCT00543062|13028070|P3|STARTED|Overall Study||12
5299722|NCT00543062|13028071|P2|STARTED|Overall Study||12
5299723|NCT00543062|13028072|P1|STARTED|Overall Study||12
5299724|NCT00542997|13028094|P1|NOT COMPLETED|Efficacy Period||3
5299725|NCT00542997|13028094|P1|COMPLETED|Efficacy Period||43
5299726|NCT00542997|13028094|P1|STARTED|Efficacy Period||46
5299727|NCT00542997|13028094|P1|NOT COMPLETED|Wash in / Wash Out Period||5
5299728|NCT00542997|13028094|P1|COMPLETED|Wash in / Wash Out Period||46
5299729|NCT00542997|13028094|P1|STARTED|Wash in / Wash Out Period||51
5299730|NCT00542971|13028109|P1|NOT COMPLETED|Overall Study||0
5299731|NCT00542971|13028109|P1|COMPLETED|Overall Study||75
5299732|NCT00542971|13028109|P1|STARTED|Overall Study||75
5299733|NCT00542880|13028116|P2|NOT COMPLETED|Period 3||2
5299734|NCT00542880|13028117|P1|NOT COMPLETED|Period 3||0
5299735|NCT00542880|13028116|P2|COMPLETED|Period 3||201
5299736|NCT00542880|13028117|P1|COMPLETED|Period 3||204
5299737|NCT00542880|13028116|P2|STARTED|Period 3||203
5299738|NCT00542880|13028117|P1|STARTED|Period 3||204
5299739|NCT00542880|13028116|P2|NOT COMPLETED|Period 2||10
5299740|NCT00542880|13028117|P1|NOT COMPLETED|Period 2||7
5299741|NCT00542880|13028116|P2|COMPLETED|Period 2||203
5299742|NCT00542880|13028117|P1|COMPLETED|Period 2||204
5299743|NCT00542880|13028116|P2|STARTED|Period 2||213
5299744|NCT00542880|13028117|P1|STARTED|Period 2||211
5299745|NCT00542880|13028116|P2|NOT COMPLETED|Period 1||12
5299746|NCT00542880|13028117|P1|NOT COMPLETED|Period 1||6
5299747|NCT00542880|13028116|P2|COMPLETED|Period 1||213
5299748|NCT00542880|13028117|P1|COMPLETED|Period 1||211
5299749|NCT00542880|13028116|P2|STARTED|Period 1||225
5299750|NCT00542880|13028117|P1|STARTED|Period 1|This was a cross-over study|217
5299751|NCT00542828|13028153|P1|NOT COMPLETED|Overall Study||13
5299752|NCT00542828|13028153|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
5299753|NCT00542828|13028153|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
5299754|NCT00542815|13028171|P3|NOT COMPLETED|Overall Study||32
5299755|NCT00542815|13028172|P2|NOT COMPLETED|Overall Study||32
5299756|NCT00542815|13028173|P1|NOT COMPLETED|Overall Study||106
5299757|NCT00542815|13028171|P3|COMPLETED|Overall Study||92
5299758|NCT00542815|13028172|P2|COMPLETED|Overall Study||44
5299759|NCT00542815|13028173|P1|COMPLETED|Overall Study||326
5299760|NCT00542815|13028171|P3|STARTED|Overall Study||124
5299761|NCT00542815|13028172|P2|STARTED|Overall Study||76
5299762|NCT00542815|13028173|P1|STARTED|Overall Study||432
5299763|NCT00542789|13028186|P2|NOT COMPLETED|Overall Study||78
5299764|NCT00542789|13028187|P1|NOT COMPLETED|Overall Study||41
5299765|NCT00542789|13028186|P2|COMPLETED|Overall Study||90
5299766|NCT00542789|13028187|P1|COMPLETED|Overall Study||134
5299767|NCT00542789|13028186|P2|STARTED|Overall Study|Randomised|168
5299768|NCT00542789|13028187|P1|STARTED|Overall Study|Randomised|175
5299769|NCT00542750|13028197|P1|NOT COMPLETED|Overall Study||0
5299770|NCT00542750|13028197|P1|COMPLETED|Overall Study||24
5299771|NCT00542750|13028197|P1|STARTED|Overall Study||24
5299772|NCT00542620|13028203|P2|NOT COMPLETED|Overall Study||0
5299773|NCT00542620|13028204|P1|NOT COMPLETED|Overall Study||0
5299774|NCT00542620|13028203|P2|COMPLETED|Overall Study||12
5299775|NCT00542620|13028204|P1|COMPLETED|Overall Study||13
5299776|NCT00542620|13028203|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
5299777|NCT00542620|13028204|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
5299778|NCT00542620|13028203|P2|STARTED|Overall Study||12
5299779|NCT00542620|13028204|P1|STARTED|Overall Study||13
5299780|NCT00542542|13028270|P2|NOT COMPLETED|Overall Study||0
5299781|NCT00542542|13028271|P1|NOT COMPLETED|Overall Study||0
5299782|NCT00542542|13028270|P2|COMPLETED|Overall Study||44
5299783|NCT00542542|13028271|P1|COMPLETED|Overall Study||44
5299784|NCT00542542|13028270|P2|STARTED|Overall Study||44
5299785|NCT00542542|13028271|P1|STARTED|Overall Study||44
5299786|NCT00542490|13028277|P1|NOT COMPLETED|Overall Study||2
5299787|NCT00542490|13028277|P1|COMPLETED|Overall Study||21
5299788|NCT00542490|13028277|P1|STARTED|Overall Study||23
5299789|NCT00542425|13028287|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
5299790|NCT00542425|13028288|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
5299791|NCT00542425|13028289|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
5299792|NCT00542425|13028290|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
5299793|NCT00542425|13028291|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
5299794|NCT00542425|13028287|P5|COMPLETED|Extended 24 Weeks of Treatment||13
5299795|NCT00542425|13028288|P4|COMPLETED|Extended 24 Weeks of Treatment||6
5299796|NCT00542425|13028289|P3|COMPLETED|Extended 24 Weeks of Treatment||8
5299797|NCT00542425|13028290|P2|COMPLETED|Extended 24 Weeks of Treatment||11
5299798|NCT00542425|13028291|P1|COMPLETED|Extended 24 Weeks of Treatment||10
5299799|NCT00542425|13028287|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
5299800|NCT00542425|13028288|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
5299801|NCT00542425|13028289|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
5299802|NCT00542425|13028290|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
5299803|NCT00542425|13028291|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
5299804|NCT00542425|13028287|P5|NOT COMPLETED|Initial 24 Weeks||6
5299805|NCT00542425|13028288|P4|NOT COMPLETED|Initial 24 Weeks||11
5299806|NCT00542425|13028289|P3|NOT COMPLETED|Initial 24 Weeks||7
5299807|NCT00542425|13028290|P2|NOT COMPLETED|Initial 24 Weeks||10
5299808|NCT00542425|13028291|P1|NOT COMPLETED|Initial 24 Weeks||4
5299809|NCT00542425|13028287|P5|COMPLETED|Initial 24 Weeks||39
5299810|NCT00542425|13028288|P4|COMPLETED|Initial 24 Weeks||34
5299811|NCT00542425|13028289|P3|COMPLETED|Initial 24 Weeks||36
5299812|NCT00542425|13028290|P2|COMPLETED|Initial 24 Weeks||33
5299813|NCT00542425|13028291|P1|COMPLETED|Initial 24 Weeks||42
5299814|NCT00542425|13028287|P5|STARTED|Initial 24 Weeks||45
5299815|NCT00542425|13028288|P4|STARTED|Initial 24 Weeks||45
5299816|NCT00542425|13028289|P3|STARTED|Initial 24 Weeks||43
5299817|NCT00542425|13028290|P2|STARTED|Initial 24 Weeks||43
5299818|NCT00542425|13028291|P1|STARTED|Initial 24 Weeks||46
5299819|NCT00542386|13028329|P6|NOT COMPLETED|Overall Study||50
5299820|NCT00542386|13028330|P5|NOT COMPLETED|Overall Study||40
5299821|NCT00542386|13028331|P4|NOT COMPLETED|Overall Study||38
5299822|NCT00542386|13028332|P3|NOT COMPLETED|Overall Study||33
5299823|NCT00542386|13028333|P2|NOT COMPLETED|Overall Study||28
5299824|NCT00542386|13028334|P1|NOT COMPLETED|Overall Study||43
5299825|NCT00542386|13028329|P6|COMPLETED|Overall Study||82
5299826|NCT00542386|13028330|P5|COMPLETED|Overall Study||62
5299827|NCT00542386|13028331|P4|COMPLETED|Overall Study||65
5299828|NCT00542386|13028332|P3|COMPLETED|Overall Study||66
5299829|NCT00542386|13028333|P2|COMPLETED|Overall Study||74
5299830|NCT00542386|13028334|P1|COMPLETED|Overall Study||61
5299831|NCT00542386|13028329|P6|STARTED|Overall Study||132
5299832|NCT00542386|13028330|P5|STARTED|Overall Study||102
5299833|NCT00542386|13028331|P4|STARTED|Overall Study||103
5299834|NCT00542386|13028332|P3|STARTED|Overall Study||99
5299835|NCT00542386|13028333|P2|STARTED|Overall Study||102
5299836|NCT00542386|13028334|P1|STARTED|Overall Study||104
5299837|NCT00542321|13028356|P2|NOT COMPLETED|Overall Study||1
5299838|NCT00542321|13028357|P1|NOT COMPLETED|Overall Study||0
5299839|NCT00542321|13028356|P2|COMPLETED|Overall Study||7
5299840|NCT00542321|13028357|P1|COMPLETED|Overall Study||8
5299841|NCT00542321|13028356|P2|STARTED|Overall Study||8
5299842|NCT00542321|13028357|P1|STARTED|Overall Study||8
5299843|NCT00542308|13028371|P1|NOT COMPLETED|Overall Study||0
5299844|NCT00542308|13028371|P1|COMPLETED|Overall Study||90
5299845|NCT00542308|13028371|P1|STARTED|Overall Study||90
5299846|NCT00542269|13028379|P3|NOT COMPLETED|Overall Study||6
5299847|NCT00542269|13028380|P2|NOT COMPLETED|Overall Study||6
5299848|NCT00542269|13028381|P1|NOT COMPLETED|Overall Study||13
5299849|NCT00542269|13028379|P3|COMPLETED|Overall Study||51
5299850|NCT00542269|13028380|P2|COMPLETED|Overall Study||54
5299851|NCT00542269|13028381|P1|COMPLETED|Overall Study||48
5299852|NCT00542269|13028379|P3|STARTED|Overall Study||57
5299853|NCT00542269|13028380|P2|STARTED|Overall Study||60
5299854|NCT00542269|13028381|P1|STARTED|Overall Study||61
5299855|NCT00542191|13028410|P1|NOT COMPLETED|Overall Study||3
5299856|NCT00542191|13028410|P1|COMPLETED|Overall Study||18
5299857|NCT00542191|13028410|P1|STARTED|Overall Study||21
5299858|NCT00542178|13028420|P8|NOT COMPLETED|Overall Study||85
5299859|NCT00542178|13028421|P7|NOT COMPLETED|Overall Study||87
5299860|NCT00542178|13028422|P6|NOT COMPLETED|Overall Study||89
5299861|NCT00542178|13028423|P5|NOT COMPLETED|Overall Study||64
5299862|NCT00542178|13028424|P4|NOT COMPLETED|Overall Study||62
5299863|NCT00542178|13028425|P3|NOT COMPLETED|Overall Study||74
5299864|NCT00542178|13028426|P2|NOT COMPLETED|Overall Study||80
5299865|NCT00542178|13028427|P1|NOT COMPLETED|Overall Study||75
5299866|NCT00542178|13028420|P8|COMPLETED|Overall Study||381
5299867|NCT00542178|13028421|P7|COMPLETED|Overall Study||406
5299868|NCT00542178|13028422|P6|COMPLETED|Overall Study||406
5299869|NCT00542178|13028423|P5|COMPLETED|Overall Study||400
5299870|NCT00542178|13028424|P4|COMPLETED|Overall Study||308
5299871|NCT00542178|13028425|P3|COMPLETED|Overall Study||308
5299872|NCT00542178|13028426|P2|COMPLETED|Overall Study||332
5299873|NCT00542178|13028427|P1|COMPLETED|Overall Study||315
5299874|NCT00542178|13028420|P8|STARTED|Overall Study||466
5299875|NCT00542178|13028421|P7|STARTED|Overall Study||493
5299876|NCT00542178|13028422|P6|STARTED|Overall Study||495
5299877|NCT00542178|13028423|P5|STARTED|Overall Study||464
5299878|NCT00542178|13028424|P4|STARTED|Overall Study||370
5299879|NCT00542178|13028425|P3|STARTED|Overall Study||382
5299880|NCT00542178|13028426|P2|STARTED|Overall Study||412
5299881|NCT00542178|13028427|P1|STARTED|Overall Study||390
5299882|NCT00541970|13028463|P4|NOT COMPLETED|Month 60||72
5299883|NCT00541970|13028464|P3|NOT COMPLETED|Month 60||82
5299884|NCT00541970|13028465|P2|NOT COMPLETED|Month 60||77
5299885|NCT00541970|13028466|P1|NOT COMPLETED|Month 60||78
5299886|NCT00541970|13028463|P4|COMPLETED|Month 60||167
5299887|NCT00541970|13028464|P3|COMPLETED|Month 60||158
5299888|NCT00541970|13028465|P2|COMPLETED|Month 60||164
5299889|NCT00541970|13028466|P1|COMPLETED|Month 60||162
5299890|NCT00541970|13028463|P4|STARTED|Month 60||239
5299891|NCT00541970|13028464|P3|STARTED|Month 60||240
5299892|NCT00541970|13028465|P2|STARTED|Month 60||241
5299893|NCT00541970|13028466|P1|STARTED|Month 60||240
5299894|NCT00541970|13028463|P4|NOT COMPLETED|Month 48||75
5299895|NCT00541970|13028464|P3|NOT COMPLETED|Month 48||73
5299896|NCT00541970|13028465|P2|NOT COMPLETED|Month 48||73
5299897|NCT00541970|13028466|P1|NOT COMPLETED|Month 48||71
5299898|NCT00541970|13028463|P4|COMPLETED|Month 48||164
5299899|NCT00541970|13028464|P3|COMPLETED|Month 48||167
5299900|NCT00541970|13028465|P2|COMPLETED|Month 48||168
5299901|NCT00541970|13028466|P1|COMPLETED|Month 48||169
5299902|NCT00541970|13028463|P4|STARTED|Month 48||239
5299903|NCT00541970|13028464|P3|STARTED|Month 48||240
5299904|NCT00541970|13028465|P2|STARTED|Month 48||241
5299905|NCT00541970|13028466|P1|STARTED|Month 48||240
5299906|NCT00541970|13028463|P4|NOT COMPLETED|Month 36||60
5299907|NCT00541970|13028464|P3|NOT COMPLETED|Month 36||66
5299908|NCT00541970|13028465|P2|NOT COMPLETED|Month 36||66
5299909|NCT00541970|13028466|P1|NOT COMPLETED|Month 36||61
5299910|NCT00541970|13028463|P4|COMPLETED|Month 36||179
5299911|NCT00541970|13028464|P3|COMPLETED|Month 36||174
5299912|NCT00541970|13028465|P2|COMPLETED|Month 36||175
5299913|NCT00541970|13028466|P1|COMPLETED|Month 36||179
5299914|NCT00541970|13028463|P4|STARTED|Month 36||239
5299915|NCT00541970|13028464|P3|STARTED|Month 36||240
5299916|NCT00541970|13028465|P2|STARTED|Month 36||241
5299917|NCT00541970|13028466|P1|STARTED|Month 36||240
5299918|NCT00541970|13028463|P4|NOT COMPLETED|Month 24||22
5299919|NCT00541970|13028464|P3|NOT COMPLETED|Month 24||32
5299920|NCT00541970|13028465|P2|NOT COMPLETED|Month 24||32
5299921|NCT00541970|13028466|P1|NOT COMPLETED|Month 24||29
5299922|NCT00541970|13028463|P4|COMPLETED|Month 24||217
5299923|NCT00541970|13028464|P3|COMPLETED|Month 24||208
5299924|NCT00541970|13028465|P2|COMPLETED|Month 24||209
5299925|NCT00541970|13028466|P1|COMPLETED|Month 24||211
5299926|NCT00541970|13028463|P4|STARTED|Month 24||239
5299927|NCT00541970|13028464|P3|STARTED|Month 24||240
5299928|NCT00541970|13028465|P2|STARTED|Month 24||241
5299929|NCT00541970|13028466|P1|STARTED|Month 24||240
5299930|NCT00541970|13028463|P4|NOT COMPLETED|Month 18||17
5299931|NCT00541970|13028464|P3|NOT COMPLETED|Month 18||25
5299932|NCT00541970|13028465|P2|NOT COMPLETED|Month 18||24
5299933|NCT00541970|13028466|P1|NOT COMPLETED|Month 18||14
5299934|NCT00541970|13028463|P4|COMPLETED|Month 18||222
5299935|NCT00541970|13028464|P3|COMPLETED|Month 18||215
5299936|NCT00541970|13028465|P2|COMPLETED|Month 18||217
5299937|NCT00541970|13028466|P1|COMPLETED|Month 18||226
5299938|NCT00541970|13028463|P4|STARTED|Month 18||239
5299939|NCT00541970|13028464|P3|STARTED|Month 18||240
5299940|NCT00541970|13028465|P2|STARTED|Month 18||241
5299941|NCT00541970|13028466|P1|STARTED|Month 18||240
5299942|NCT00541970|13028463|P4|NOT COMPLETED|Month 12||16
5299943|NCT00541970|13028464|P3|NOT COMPLETED|Month 12||21
5299944|NCT00541970|13028465|P2|NOT COMPLETED|Month 12||22
5299945|NCT00541970|13028466|P1|NOT COMPLETED|Month 12||12
5299946|NCT00541970|13028463|P4|COMPLETED|Month 12||223
5299947|NCT00541970|13028464|P3|COMPLETED|Month 12||219
5299948|NCT00541970|13028465|P2|COMPLETED|Month 12||219
5299949|NCT00541970|13028466|P1|COMPLETED|Month 12||228
5299950|NCT00541970|13028463|P4|STARTED|Month 12||239
5299951|NCT00541970|13028464|P3|STARTED|Month 12||240
5299952|NCT00541970|13028465|P2|STARTED|Month 12||241
5299953|NCT00541970|13028466|P1|STARTED|Month 12||240
5299954|NCT00541970|13028463|P4|NOT COMPLETED|Month 7||5
5299955|NCT00541970|13028464|P3|NOT COMPLETED|Month 7||11
5299956|NCT00541970|13028465|P2|NOT COMPLETED|Month 7||13
5299957|NCT00541970|13028466|P1|NOT COMPLETED|Month 7||9
5299958|NCT00541970|13028463|P4|COMPLETED|Month 7||234
5299959|NCT00541970|13028464|P3|COMPLETED|Month 7||229
5299960|NCT00541970|13028465|P2|COMPLETED|Month 7||228
5299961|NCT00541970|13028466|P1|COMPLETED|Month 7||231
5299962|NCT00541970|13028463|P4|STARTED|Month 7||239
5299963|NCT00541970|13028464|P3|STARTED|Month 7||240
5299964|NCT00541970|13028465|P2|STARTED|Month 7||241
5299965|NCT00541970|13028466|P1|STARTED|Month 7||240
5299966|NCT00541931|13028617|P2|NOT COMPLETED|Overall Study||4
5299967|NCT00541931|13028618|P1|NOT COMPLETED|Overall Study||5
5299968|NCT00541931|13028617|P2|COMPLETED|Overall Study||11
5299969|NCT00541931|13028618|P1|COMPLETED|Overall Study||17
5299970|NCT00541931|13028617|P2|STARTED|Overall Study||15
5299971|NCT00541931|13028618|P1|STARTED|Overall Study||22
5299972|NCT00541866|13028631|P5|NOT COMPLETED|Overall Study||15
5299973|NCT00541866|13028632|P4|NOT COMPLETED|Overall Study||16
5299974|NCT00541866|13028633|P3|NOT COMPLETED|Overall Study||15
5299975|NCT00541866|13028634|P2|NOT COMPLETED|Overall Study||18
5299976|NCT00541866|13028635|P1|NOT COMPLETED|Overall Study||34
5299977|NCT00541866|13028631|P5|COMPLETED|Overall Study||3
5299978|NCT00541866|13028632|P4|COMPLETED|Overall Study||0
5299979|NCT00541866|13028633|P3|COMPLETED|Overall Study||2
5299980|NCT00541866|13028634|P2|COMPLETED|Overall Study||0
5299981|NCT00541866|13028635|P1|COMPLETED|Overall Study||7
5299982|NCT00541866|13028631|P5|STARTED|Overall Study||18
5299983|NCT00541866|13028632|P4|STARTED|Overall Study||16
5299984|NCT00541866|13028633|P3|STARTED|Overall Study||17
5299985|NCT00541866|13028634|P2|STARTED|Overall Study||18
5299986|NCT00541866|13028635|P1|STARTED|Overall Study|41 started, but only 39 treated|41
5299987|NCT00541775|13028676|P3|NOT COMPLETED|Overall Study||8
5299988|NCT00541775|13028677|P2|NOT COMPLETED|Overall Study||2
5299989|NCT00541775|13028678|P1|NOT COMPLETED|Overall Study||9
5299990|NCT00541775|13028676|P3|COMPLETED|Overall Study||84
5299991|NCT00541775|13028677|P2|COMPLETED|Overall Study||85
5299992|NCT00541775|13028678|P1|COMPLETED|Overall Study||85
5299993|NCT00541775|13028676|P3|STARTED|Overall Study||92
5299994|NCT00541775|13028677|P2|STARTED|Overall Study||87
5299995|NCT00541775|13028678|P1|STARTED|Overall Study||94
5299996|NCT00541671|13028694|P2|NOT COMPLETED|Overall Study||0
5299997|NCT00541671|13028695|P1|NOT COMPLETED|Overall Study||0
5299998|NCT00541671|13028694|P2|COMPLETED|Overall Study||12
5299999|NCT00541671|13028695|P1|COMPLETED|Overall Study||13
5300000|NCT00541671|13028694|P2|STARTED|Overall Study||12
5300001|NCT00541671|13028695|P1|STARTED|Overall Study||13
5300002|NCT00541658|13028704|P3|NOT COMPLETED|Overall Study||68
5300003|NCT00541658|13028705|P2|NOT COMPLETED|Overall Study||73
5300004|NCT00541658|13028706|P1|NOT COMPLETED|Overall Study||60
5300005|NCT00541658|13028704|P3|COMPLETED|Overall Study||240
5300006|NCT00541658|13028705|P2|COMPLETED|Overall Study||234
5300007|NCT00541658|13028706|P1|COMPLETED|Overall Study||248
5300008|NCT00541658|13028704|P3|ITT Population|Overall Study||308
5300009|NCT00541658|13028705|P2|ITT Population|Overall Study||307
5300010|NCT00541658|13028706|P1|ITT Population|Overall Study||307
5300011|NCT00541658|13028704|P3|STARTED|Overall Study||308
5300012|NCT00541658|13028705|P2|STARTED|Overall Study||307
5300013|NCT00541658|13028706|P1|STARTED|Overall Study||308
5300014|NCT00541593|13028863|P1|NOT COMPLETED|Overall Study||0
5300015|NCT00541593|13028863|P1|COMPLETED|Overall Study||5
5300016|NCT00541593|13028863|P1|STARTED|Overall Study||5
5300017|NCT00541450|13028869|P2|NOT COMPLETED|Phase B||31
5300018|NCT00541450|13028870|P1|NOT COMPLETED|Phase B||37
5300019|NCT00541450|13028869|P2|COMPLETED|Phase B||200
5300020|NCT00541450|13028870|P1|COMPLETED|Phase B||187
5300021|NCT00541450|13028869|P2|STARTED|Phase B||231
5300022|NCT00541450|13028870|P1|STARTED|Phase B||224
5300023|NCT00541450|13028869|P2|NOT COMPLETED|Phase A||17
5300024|NCT00541450|13028870|P1|NOT COMPLETED|Phase A||20
5300025|NCT00541450|13028869|P2|COMPLETED|Phase A||231
5300026|NCT00541450|13028870|P1|COMPLETED|Phase A||224
5300027|NCT00541450|13028869|P2|STARTED|Phase A||248
5300028|NCT00541450|13028870|P1|STARTED|Phase A||244
5300029|NCT00541346|13028888|P1|NOT COMPLETED|Follow-up||1
5300030|NCT00541346|13028888|P1|COMPLETED|Follow-up||15
5300031|NCT00541346|13028888|P1|STARTED|Follow-up||16
5300032|NCT00541346|13028888|P1|NOT COMPLETED|Baseline||0
5300033|NCT00541346|13028888|P1|COMPLETED|Baseline||16
5300034|NCT00541346|13028888|P1|STARTED|Baseline||16
5300035|NCT00541307|13028902|P1|NOT COMPLETED|Overall Study||24
5300036|NCT00541307|13028902|P1|COMPLETED|Overall Study||95
5300037|NCT00541307|13028902|P1|STARTED|Overall Study||119
5300038|NCT00541242|13028912|P2|NOT COMPLETED|Treatment Period 2||7
5300039|NCT00541242|13028913|P1|NOT COMPLETED|Treatment Period 2||9
5300040|NCT00541242|13028912|P2|COMPLETED|Treatment Period 2||266
5300041|NCT00541242|13028913|P1|COMPLETED|Treatment Period 2||261
5300042|NCT00541242|13028912|P2|STARTED|Treatment Period 2||273
5300043|NCT00541242|13028913|P1|STARTED|Treatment Period 2||270
5300044|NCT00541242|13028912|P2|NOT COMPLETED|Treatment Period 1||0
5300045|NCT00541242|13028913|P1|NOT COMPLETED|Treatment Period 1||0
5300046|NCT00541242|13028912|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
5300047|NCT00541242|13028913|P1|COMPLETED|Treatment Period 1||0
5300048|NCT00541242|13028912|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
5300049|NCT00541242|13028913|P1|STARTED|Treatment Period 1||0
5300050|NCT00541229|13028927|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
5300051|NCT00541229|13028928|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
5300052|NCT00541229|13028929|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
5300053|NCT00541229|13028930|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
5300054|NCT00541229|13028931|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
5300055|NCT00541229|13028932|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
5300056|NCT00541229|13028927|P6|COMPLETED|Treatment Period III (Week 11)||4
5300057|NCT00541229|13028928|P5|COMPLETED|Treatment Period III (Week 11)||6
5300058|NCT00541229|13028929|P4|COMPLETED|Treatment Period III (Week 11)||8
5300059|NCT00541229|13028930|P3|COMPLETED|Treatment Period III (Week 11)||9
5300060|NCT00541229|13028931|P2|COMPLETED|Treatment Period III (Week 11)||8
5300061|NCT00541229|13028932|P1|COMPLETED|Treatment Period III (Week 11)||7
5300062|NCT00541229|13028927|P6|STARTED|Treatment Period III (Week 11)||5
5300063|NCT00541229|13028928|P5|STARTED|Treatment Period III (Week 11)||7
5300064|NCT00541229|13028929|P4|STARTED|Treatment Period III (Week 11)||8
5300065|NCT00541229|13028930|P3|STARTED|Treatment Period III (Week 11)||10
5300066|NCT00541229|13028931|P2|STARTED|Treatment Period III (Week 11)||8
5300067|NCT00541229|13028932|P1|STARTED|Treatment Period III (Week 11)||7
5300068|NCT00541229|13028927|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
5300069|NCT00541229|13028928|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
5300070|NCT00541229|13028929|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
5300071|NCT00541229|13028930|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
5300072|NCT00541229|13028931|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
5300073|NCT00541229|13028932|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
5300074|NCT00541229|13028927|P6|COMPLETED|Washout Period II (Week 7-10)||5
5300075|NCT00541229|13028928|P5|COMPLETED|Washout Period II (Week 7-10)||7
5300076|NCT00541229|13028929|P4|COMPLETED|Washout Period II (Week 7-10)||8
5300077|NCT00541229|13028930|P3|COMPLETED|Washout Period II (Week 7-10)||10
5300078|NCT00541229|13028931|P2|COMPLETED|Washout Period II (Week 7-10)||8
5300079|NCT00541229|13028932|P1|COMPLETED|Washout Period II (Week 7-10)||7
5300080|NCT00541229|13028927|P6|STARTED|Washout Period II (Week 7-10)||8
5300081|NCT00541229|13028928|P5|STARTED|Washout Period II (Week 7-10)||11
5300082|NCT00541229|13028929|P4|STARTED|Washout Period II (Week 7-10)||12
5300083|NCT00541229|13028930|P3|STARTED|Washout Period II (Week 7-10)||12
5300084|NCT00541229|13028931|P2|STARTED|Washout Period II (Week 7-10)||12
5300085|NCT00541229|13028932|P1|STARTED|Washout Period II (Week 7-10)||11
5300086|NCT00541229|13028927|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
5300087|NCT00541229|13028928|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
5300088|NCT00541229|13028929|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
5300089|NCT00541229|13028930|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
5300090|NCT00541229|13028931|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
5300091|NCT00541229|13028932|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
5300092|NCT00541229|13028927|P6|COMPLETED|Treatment Period II (Week 6)||8
5300093|NCT00541229|13028928|P5|COMPLETED|Treatment Period II (Week 6)||11
5300094|NCT00541229|13028929|P4|COMPLETED|Treatment Period II (Week 6)||12
5300095|NCT00541229|13028930|P3|COMPLETED|Treatment Period II (Week 6)||12
5300096|NCT00541229|13028931|P2|COMPLETED|Treatment Period II (Week 6)||12
5300097|NCT00541229|13028932|P1|COMPLETED|Treatment Period II (Week 6)||11
5300098|NCT00541229|13028927|P6|STARTED|Treatment Period II (Week 6)||11
5300099|NCT00541229|13028928|P5|STARTED|Treatment Period II (Week 6)||13
5300100|NCT00541229|13028929|P4|STARTED|Treatment Period II (Week 6)||13
5300101|NCT00541229|13028930|P3|STARTED|Treatment Period II (Week 6)||13
5300102|NCT00541229|13028931|P2|STARTED|Treatment Period II (Week 6)||13
5300103|NCT00541229|13028932|P1|STARTED|Treatment Period II (Week 6)||13
5300104|NCT00541229|13028927|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
5300105|NCT00541229|13028928|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
5300106|NCT00541229|13028929|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
5300107|NCT00541229|13028930|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
5300108|NCT00541229|13028931|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
5300109|NCT00541229|13028932|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
5300110|NCT00541229|13028927|P6|COMPLETED|Washout Period I (Week 2-5)||11
5300111|NCT00541229|13028928|P5|COMPLETED|Washout Period I (Week 2-5)||13
5300112|NCT00541229|13028929|P4|COMPLETED|Washout Period I (Week 2-5)||13
5300113|NCT00541229|13028930|P3|COMPLETED|Washout Period I (Week 2-5)||13
5300114|NCT00541229|13028931|P2|COMPLETED|Washout Period I (Week 2-5)||13
5300115|NCT00541229|13028932|P1|COMPLETED|Washout Period I (Week 2-5)||13
5300116|NCT00541229|13028927|P6|STARTED|Washout Period I (Week 2-5)||16
5300117|NCT00541229|13028928|P5|STARTED|Washout Period I (Week 2-5)||14
5300118|NCT00541229|13028929|P4|STARTED|Washout Period I (Week 2-5)||17
5300119|NCT00541229|13028930|P3|STARTED|Washout Period I (Week 2-5)||17
5300120|NCT00541229|13028931|P2|STARTED|Washout Period I (Week 2-5)||15
5300121|NCT00541229|13028932|P1|STARTED|Washout Period I (Week 2-5)||17
5300122|NCT00541229|13028927|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
5300123|NCT00541229|13028928|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
5300124|NCT00541229|13028929|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
5300125|NCT00541229|13028930|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
5300126|NCT00541229|13028931|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
5300127|NCT00541229|13028932|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
5300128|NCT00541229|13028927|P6|COMPLETED|Treatment Period I (Week 1)||16
5300129|NCT00541229|13028928|P5|COMPLETED|Treatment Period I (Week 1)||14
5300130|NCT00541229|13028929|P4|COMPLETED|Treatment Period I (Week 1)||17
5300131|NCT00541229|13028930|P3|COMPLETED|Treatment Period I (Week 1)||17
5300132|NCT00541229|13028931|P2|COMPLETED|Treatment Period I (Week 1)||15
5300133|NCT00541229|13028932|P1|COMPLETED|Treatment Period I (Week 1)||17
5300134|NCT00541229|13028927|P6|STARTED|Treatment Period I (Week 1)||18
5300135|NCT00541229|13028928|P5|STARTED|Treatment Period I (Week 1)||14
5300136|NCT00541229|13028929|P4|STARTED|Treatment Period I (Week 1)||18
5300137|NCT00541229|13028930|P3|STARTED|Treatment Period I (Week 1)||20
5300138|NCT00541229|13028931|P2|STARTED|Treatment Period I (Week 1)||16
5300139|NCT00541229|13028932|P1|STARTED|Treatment Period I (Week 1)||17
5300140|NCT00541190|13028942|P2|NOT COMPLETED|Overall Study||0
5300141|NCT00541190|13028943|P1|NOT COMPLETED|Overall Study||0
5300142|NCT00541190|13028942|P2|COMPLETED|Overall Study||11
5300143|NCT00541190|13028943|P1|COMPLETED|Overall Study||10
5300144|NCT00541190|13028942|P2|STARTED|Overall Study||11
5300145|NCT00541190|13028943|P1|STARTED|Overall Study||10
5300146|NCT00541099|13028951|P1|NOT COMPLETED|Overall Study||3
5300147|NCT00541099|13028951|P1|COMPLETED|Overall Study||8
5300148|NCT00541099|13028951|P1|STARTED|Overall Study||11
5300149|NCT00541034|13028959|P1|NOT COMPLETED|Overall Study||3
5300150|NCT00541034|13028959|P1|COMPLETED|Overall Study||46
5300151|NCT00541034|13028959|P1|STARTED|Overall Study||49
5300152|NCT00540982|13028963|P1|NOT COMPLETED|Overall Study||0
5300153|NCT00540982|13028963|P1|COMPLETED|Overall Study||47
5300154|NCT00540982|13028963|P1|Severe Liver Dysfunction|Overall Study||12
5300155|NCT00540982|13028963|P1|Moderate Liver Dysfunction|Overall Study||18
5300156|NCT00540982|13028963|P1|Mild Liver Dysfunction|Overall Study||6
5300157|NCT00540982|13028963|P1|Normal Liver Function|Overall Study||11
5300158|NCT00540982|13028963|P1|STARTED|Overall Study||47
5300159|NCT00540969|13028987|P2|NOT COMPLETED|Overall Study||0
5300160|NCT00540969|13028988|P1|NOT COMPLETED|Overall Study||0
5300161|NCT00540969|13028987|P2|COMPLETED|Overall Study||1
5300162|NCT00540969|13028988|P1|COMPLETED|Overall Study||2
5300163|NCT00540969|13028987|P2|STARTED|Overall Study||1
5300164|NCT00540969|13028988|P1|STARTED|Overall Study||2
5300165|NCT00540722|13028998|P1|NOT COMPLETED|Overall Study||0
5300166|NCT00540722|13028998|P1|COMPLETED|Overall Study||56
5300167|NCT00540722|13028998|P1|STARTED|Overall Study||56
5300168|NCT00540644|13029008|P2|NOT COMPLETED|Overall Study||9
5300169|NCT00540644|13029009|P1|NOT COMPLETED|Overall Study||9
5300170|NCT00540644|13029008|P2|COMPLETED|Overall Study||13
5300171|NCT00540644|13029009|P1|COMPLETED|Overall Study||39
5300172|NCT00540644|13029008|P2|STARTED|Overall Study||22
5300173|NCT00540644|13029009|P1|STARTED|Overall Study||48
5300174|NCT00540592|13029029|P10|NOT COMPLETED|Overall Study||2
5300175|NCT00540592|13029030|P9|NOT COMPLETED|Overall Study||1
5300176|NCT00540592|13029031|P8|NOT COMPLETED|Overall Study||1
5300177|NCT00540592|13029032|P7|NOT COMPLETED|Overall Study||0
5300178|NCT00540592|13029033|P6|NOT COMPLETED|Overall Study||0
5300179|NCT00540592|13029034|P5|NOT COMPLETED|Overall Study||1
5300180|NCT00540592|13029035|P4|NOT COMPLETED|Overall Study||1
5300181|NCT00540592|13029036|P3|NOT COMPLETED|Overall Study||1
5300182|NCT00540592|13029037|P2|NOT COMPLETED|Overall Study||1
5300183|NCT00540592|13029038|P1|NOT COMPLETED|Overall Study||2
5300184|NCT00540592|13029029|P10|COMPLETED|Overall Study||201
5300185|NCT00540592|13029030|P9|COMPLETED|Overall Study||199
5300186|NCT00540592|13029031|P8|COMPLETED|Overall Study||198
5300187|NCT00540592|13029032|P7|COMPLETED|Overall Study||198
5300188|NCT00540592|13029033|P6|COMPLETED|Overall Study||198
5300189|NCT00540592|13029034|P5|COMPLETED|Overall Study||198
5300190|NCT00540592|13029035|P4|COMPLETED|Overall Study||201
5300191|NCT00540592|13029036|P3|COMPLETED|Overall Study||201
5300192|NCT00540592|13029037|P2|COMPLETED|Overall Study||201
5300193|NCT00540592|13029038|P1|COMPLETED|Overall Study||202
5300194|NCT00540592|13029029|P10|Completed at Day 180|Overall Study||189
5300195|NCT00540592|13029030|P9|Completed at Day 180|Overall Study||198
5300196|NCT00540592|13029031|P8|Completed at Day 180|Overall Study||193
5300197|NCT00540592|13029032|P7|Completed at Day 180|Overall Study||196
5300198|NCT00540592|13029033|P6|Completed at Day 180|Overall Study||198
5300199|NCT00540592|13029034|P5|Completed at Day 180|Overall Study||195
5300200|NCT00540592|13029035|P4|Completed at Day 180|Overall Study||197
5300201|NCT00540592|13029036|P3|Completed at Day 180|Overall Study||197
5300202|NCT00540592|13029037|P2|Completed at Day 180|Overall Study||201
5300203|NCT00540592|13029038|P1|Completed at Day 180|Overall Study||200
5300204|NCT00540592|13029029|P10|STARTED|Overall Study||203
5300205|NCT00540592|13029030|P9|STARTED|Overall Study||200
5300206|NCT00540592|13029031|P8|STARTED|Overall Study||199
5300207|NCT00540592|13029032|P7|STARTED|Overall Study||198
5300208|NCT00540592|13029033|P6|STARTED|Overall Study||198
5300209|NCT00540592|13029034|P5|STARTED|Overall Study||199
5300210|NCT00540592|13029035|P4|STARTED|Overall Study||202
5300211|NCT00540592|13029036|P3|STARTED|Overall Study||202
5300212|NCT00540592|13029037|P2|STARTED|Overall Study||202
5300213|NCT00540592|13029038|P1|STARTED|Overall Study||204
5300214|NCT00540579|13029270|P1|NOT COMPLETED|Overall Study||0
5300215|NCT00540579|13029270|P1|COMPLETED|Overall Study||23
5300216|NCT00540579|13029270|P1|STARTED|Overall Study||23
5300217|NCT00540514|13029277|P2|NOT COMPLETED|Overall Study||266
5300218|NCT00540514|13029278|P1|NOT COMPLETED|Overall Study||246
5300219|NCT00540514|13029277|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
5300220|NCT00540514|13029278|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
5300221|NCT00540514|13029277|P2|Biomarker Population|Overall Study||36
5300222|NCT00540514|13029278|P1|Biomarker Population|Overall Study||35
5300223|NCT00540514|13029277|P2|Treated|Overall Study||524
5300224|NCT00540514|13029278|P1|Treated|Overall Study||514
5300225|NCT00540514|13029277|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
5300226|NCT00540514|13029278|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
5300227|NCT00540449|13029310|P2|NOT COMPLETED|Overall Study||78
5300228|NCT00540449|13029311|P1|NOT COMPLETED|Overall Study||84
5300229|NCT00540449|13029310|P2|COMPLETED|Overall Study||266
5300230|NCT00540449|13029311|P1|COMPLETED|Overall Study||262
5300231|NCT00540449|13029310|P2|STARTED|Overall Study||344
5300232|NCT00540449|13029311|P1|STARTED|Overall Study||346
5300233|NCT00540436|13029333|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
5300234|NCT00540436|13029333|P1|COMPLETED|Second 12-Week Treatment Period||21
5300235|NCT00540436|13029333|P1|STARTED|Second 12-Week Treatment Period||22
5300236|NCT00540436|13029333|P1|NOT COMPLETED|First 12-Week Treatment Period||3
5300237|NCT00540436|13029333|P1|COMPLETED|First 12-Week Treatment Period||22
5300238|NCT00540436|13029333|P1|STARTED|First 12-Week Treatment Period||25
5300239|NCT00540423|13029348|P3|NOT COMPLETED|Open-Label Treatment Period||2
5300240|NCT00540423|13029349|P2|NOT COMPLETED|Open-Label Treatment Period||0
5300241|NCT00540423|13029350|P1|NOT COMPLETED|Open-Label Treatment Period||0
5300242|NCT00540423|13029348|P3|COMPLETED|Open-Label Treatment Period||20
5300243|NCT00540423|13029349|P2|COMPLETED|Open-Label Treatment Period||0
5300244|NCT00540423|13029350|P1|COMPLETED|Open-Label Treatment Period||0
5300245|NCT00540423|13029348|P3|STARTED|Open-Label Treatment Period||22
5300246|NCT00540423|13029349|P2|STARTED|Open-Label Treatment Period||0
5300247|NCT00540423|13029350|P1|STARTED|Open-Label Treatment Period||0
5300248|NCT00540423|13029348|P3|NOT COMPLETED|Double-Blind Treatment Period||0
5300249|NCT00540423|13029349|P2|NOT COMPLETED|Double-Blind Treatment Period||1
5300250|NCT00540423|13029350|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5300251|NCT00540423|13029348|P3|COMPLETED|Double-Blind Treatment Period||0
5300252|NCT00540423|13029349|P2|COMPLETED|Double-Blind Treatment Period||14
5300253|NCT00540423|13029350|P1|COMPLETED|Double-Blind Treatment Period||8
5300254|NCT00540423|13029348|P3|STARTED|Double-Blind Treatment Period||0
5300255|NCT00540423|13029349|P2|STARTED|Double-Blind Treatment Period||15
5300256|NCT00540423|13029350|P1|STARTED|Double-Blind Treatment Period||8
5300257|NCT00540293|13029400|P1|NOT COMPLETED|Overall Study||35
5300258|NCT00540293|13029400|P1|COMPLETED|Overall Study||390
5300259|NCT00540293|13029400|P1|STARTED|Overall Study||425
5300260|NCT00540228|13029448|P5|NOT COMPLETED|Overall Study||0
5300261|NCT00540228|13029449|P4|NOT COMPLETED|Overall Study||0
5300262|NCT00540228|13029450|P3|NOT COMPLETED|Overall Study||0
5300263|NCT00540228|13029451|P2|NOT COMPLETED|Overall Study||1
5300264|NCT00540228|13029452|P1|NOT COMPLETED|Overall Study||3
5300265|NCT00540228|13029448|P5|COMPLETED|Overall Study||202
5300266|NCT00540228|13029449|P4|COMPLETED|Overall Study||202
5300267|NCT00540228|13029450|P3|COMPLETED|Overall Study||204
5300268|NCT00540228|13029451|P2|COMPLETED|Overall Study||197
5300269|NCT00540228|13029452|P1|COMPLETED|Overall Study||197
5300270|NCT00540228|13029448|P5|STARTED|Overall Study||202
5300271|NCT00540228|13029449|P4|STARTED|Overall Study||202
5300272|NCT00540228|13029450|P3|STARTED|Overall Study||204
5300273|NCT00540228|13029451|P2|STARTED|Overall Study||198
5300274|NCT00540228|13029452|P1|STARTED|Overall Study||200
5300275|NCT00540124|13029522|P3|NOT COMPLETED|Overall Study||1
5300276|NCT00540124|13029523|P2|NOT COMPLETED|Overall Study||3
5300277|NCT00540124|13029524|P1|NOT COMPLETED|Overall Study||4
5300278|NCT00540124|13029522|P3|COMPLETED|Overall Study||48
5300279|NCT00540124|13029523|P2|COMPLETED|Overall Study||48
5300280|NCT00540124|13029524|P1|COMPLETED|Overall Study||47
5300281|NCT00540124|13029522|P3|STARTED|Overall Study||49
5300282|NCT00540124|13029523|P2|STARTED|Overall Study||51
5300283|NCT00540124|13029524|P1|STARTED|Overall Study||51
5300284|NCT00540046|13029570|P2|NOT COMPLETED|Overall Study||23
5300285|NCT00540046|13029571|P1|NOT COMPLETED|Overall Study||33
5300286|NCT00540046|13029570|P2|COMPLETED|Overall Study||88
5300287|NCT00540046|13029571|P1|COMPLETED|Overall Study||71
5300288|NCT00540046|13029570|P2|STARTED|Overall Study||111
5300289|NCT00540046|13029571|P1|STARTED|Overall Study||104
5300290|NCT00540007|13029581|P2|NOT COMPLETED|Overall Study||0
5300291|NCT00540007|13029582|P1|NOT COMPLETED|Overall Study||0
5300292|NCT00540007|13029581|P2|COMPLETED|Overall Study||42
5300293|NCT00540007|13029582|P1|COMPLETED|Overall Study||38
5300294|NCT00540007|13029581|P2|STARTED|Overall Study||42
5300295|NCT00540007|13029582|P1|STARTED|Overall Study||38
5300296|NCT00539994|13029607|P3|NOT COMPLETED|Overall Study||2
5300297|NCT00539994|13029608|P2|NOT COMPLETED|Overall Study||1
5300298|NCT00539994|13029609|P1|NOT COMPLETED|Overall Study||3
5300299|NCT00539994|13029607|P3|COMPLETED|Overall Study||13
5300300|NCT00539994|13029608|P2|COMPLETED|Overall Study||18
5300301|NCT00539994|13029609|P1|COMPLETED|Overall Study||20
5300302|NCT00539994|13029607|P3|STARTED|Overall Study||15
5300303|NCT00539994|13029608|P2|STARTED|Overall Study||19
5300304|NCT00539994|13029609|P1|STARTED|Overall Study||23
5300305|NCT00539942|13029648|P2|NOT COMPLETED|Overall Study||0
5300306|NCT00539942|13029649|P1|NOT COMPLETED|Overall Study||0
5300307|NCT00539942|13029648|P2|COMPLETED|Overall Study||3
5300308|NCT00539942|13029649|P1|COMPLETED|Overall Study||4
5300309|NCT00539942|13029648|P2|STARTED|Overall Study||3
5300310|NCT00539942|13029649|P1|STARTED|Overall Study||4
5300311|NCT00539864|13029659|P2|NOT COMPLETED|Overall Study||2
5300312|NCT00539864|13029660|P1|NOT COMPLETED|Overall Study||1
5300313|NCT00539864|13029659|P2|COMPLETED|Overall Study||300
5300314|NCT00539864|13029660|P1|COMPLETED|Overall Study||299
5300315|NCT00539864|13029659|P2|STARTED|Overall Study||302
5300316|NCT00539864|13029660|P1|STARTED|Overall Study||300
5300317|NCT00539734|13029672|P1|NOT COMPLETED|Overall Study||1
5300318|NCT00539734|13029672|P1|COMPLETED|Overall Study||25
5300319|NCT00539734|13029672|P1|STARTED|Overall Study||26
5300320|NCT00539695|13029677|P1|NOT COMPLETED|Overall Study||13
5300321|NCT00539695|13029677|P1|COMPLETED|Overall Study||12
5300322|NCT00539695|13029677|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
5300323|NCT00539695|13029677|P1|STARTED|Overall Study||25
5300324|NCT00539656|13029683|P1|NOT COMPLETED|Overall Study||0
5300325|NCT00539656|13029683|P1|COMPLETED|Overall Study||3
5300326|NCT00539656|13029683|P1|STARTED|Overall Study||3
5300327|NCT00539617|13029689|P1|NOT COMPLETED|Treatment Period||0
5300328|NCT00539617|13029689|P1|COMPLETED|Treatment Period||3
5300329|NCT00539617|13029689|P1|STARTED|Treatment Period||3
5300330|NCT00539617|13029689|P1|NOT COMPLETED|Run-In Period||1
5300331|NCT00539617|13029689|P1|COMPLETED|Run-In Period||3
5300332|NCT00539617|13029689|P1|STARTED|Run-In Period||4
5300333|NCT00539617|13029689|P1|NOT COMPLETED|Pre-screening Period||3
5300334|NCT00539617|13029689|P1|COMPLETED|Pre-screening Period||4
5300335|NCT00539617|13029689|P1|STARTED|Pre-screening Period||7
5300336|NCT00539591|13029698|P3|NOT COMPLETED|Overall Study||3
5300337|NCT00539591|13029699|P2|NOT COMPLETED|Overall Study||2
5300338|NCT00539591|13029700|P1|NOT COMPLETED|Overall Study||5
5300339|NCT00539591|13029698|P3|COMPLETED|Overall Study||1
5300340|NCT00539591|13029699|P2|COMPLETED|Overall Study||0
5300341|NCT00539591|13029700|P1|COMPLETED|Overall Study||18
5300342|NCT00539591|13029698|P3|STARTED|Overall Study||4
5300343|NCT00539591|13029699|P2|STARTED|Overall Study||2
5300344|NCT00539591|13029700|P1|STARTED|Overall Study||23
5300345|NCT00539539|13029810|P2|NOT COMPLETED|Overall Study||0
5300346|NCT00539539|13029811|P1|NOT COMPLETED|Overall Study||0
5300347|NCT00539539|13029810|P2|COMPLETED|Overall Study||771
5300348|NCT00539539|13029811|P1|COMPLETED|Overall Study||815
5300349|NCT00539539|13029810|P2|STARTED|Overall Study||771
5300350|NCT00539539|13029811|P1|STARTED|Overall Study||815
5300351|NCT00539526|13029834|P3|NOT COMPLETED|Overall Study||2
5300352|NCT00539526|13029835|P2|NOT COMPLETED|Overall Study||2
5300353|NCT00539526|13029836|P1|NOT COMPLETED|Overall Study||3
5300354|NCT00539526|13029834|P3|COMPLETED|Overall Study||36
5300355|NCT00539526|13029835|P2|COMPLETED|Overall Study||31
5300356|NCT00539526|13029836|P1|COMPLETED|Overall Study||32
5300357|NCT00539526|13029834|P3|STARTED|Overall Study||38
5300358|NCT00539526|13029835|P2|STARTED|Overall Study||33
5300359|NCT00539526|13029836|P1|STARTED|Overall Study||35
5300360|NCT00539513|13029852|P2|NOT COMPLETED|Overall Study||2
5300361|NCT00539513|13029853|P1|NOT COMPLETED|Overall Study||2
5300362|NCT00539513|13029852|P2|COMPLETED|Overall Study||3
5300363|NCT00539513|13029853|P1|COMPLETED|Overall Study||3
5300364|NCT00539513|13029852|P2|Received Allocated Intervention|Overall Study||4
5300365|NCT00539513|13029853|P1|Received Allocated Intervention|Overall Study||3
5300366|NCT00539513|13029852|P2|STARTED|Overall Study||5
5300367|NCT00539513|13029853|P1|STARTED|Overall Study||5
5300368|NCT00539500|13029865|P1|NOT COMPLETED|Overall Study||3
5300369|NCT00539500|13029865|P1|COMPLETED|Overall Study||0
5300370|NCT00539500|13029865|P1|STARTED|Overall Study||3
5300371|NCT00539305|13029873|P2|NOT COMPLETED|Overall Study||2
5300372|NCT00539305|13029874|P1|NOT COMPLETED|Overall Study||1
5300373|NCT00539305|13029873|P2|COMPLETED|Overall Study||10
5300374|NCT00539305|13029874|P1|COMPLETED|Overall Study||9
5300375|NCT00539305|13029873|P2|STARTED|Overall Study||12
5300376|NCT00539305|13029874|P1|STARTED|Overall Study||10
5300377|NCT00539279|13029888|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
5300378|NCT00539279|13029889|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
5300379|NCT00539279|13029888|P2|COMPLETED|6-Month Follow-Up Assessment||22
5300380|NCT00539279|13029889|P1|COMPLETED|6-Month Follow-Up Assessment||17
5300381|NCT00539279|13029888|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
5300474|NCT00539006|13029978|P1|STARTED|Treatment Period 1||96
5300475|NCT00539006|13029975|P4|NOT COMPLETED|Pre-treatment||0
5300382|NCT00539279|13029889|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
5300383|NCT00539279|13029888|P2|NOT COMPLETED|Post-Treatment Assessment||9
5300384|NCT00539279|13029889|P1|NOT COMPLETED|Post-Treatment Assessment||12
5300385|NCT00539279|13029888|P2|COMPLETED|Post-Treatment Assessment||29
5300386|NCT00539279|13029889|P1|COMPLETED|Post-Treatment Assessment||18
5300387|NCT00539279|13029888|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
5300388|NCT00539279|13029889|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
5300389|NCT00539279|13029888|P2|NOT COMPLETED|Treatment||8
5300390|NCT00539279|13029889|P1|NOT COMPLETED|Treatment||11
5300391|NCT00539279|13029888|P2|COMPLETED|Treatment||38
5300392|NCT00539279|13029889|P1|COMPLETED|Treatment||30
5300393|NCT00539279|13029888|P2|STARTED|Treatment||46
5300394|NCT00539279|13029889|P1|STARTED|Treatment||41
5300395|NCT00539253|13029907|P1|NOT COMPLETED|Overall Study||26
5300396|NCT00539253|13029907|P1|COMPLETED|Overall Study||19
5300397|NCT00539253|13029907|P1|STARTED|Overall Study||45
5300398|NCT00539240|13029915|P3|NOT COMPLETED|Overall Study||15
5300399|NCT00539240|13029916|P2|NOT COMPLETED|Overall Study||7
5300400|NCT00539240|13029917|P1|NOT COMPLETED|Overall Study||6
5300401|NCT00539240|13029915|P3|COMPLETED|Overall Study||39
5300402|NCT00539240|13029916|P2|COMPLETED|Overall Study||48
5300403|NCT00539240|13029917|P1|COMPLETED|Overall Study||53
5300404|NCT00539240|13029915|P3|STARTED|Overall Study||54
5300405|NCT00539240|13029916|P2|STARTED|Overall Study||55
5300406|NCT00539240|13029917|P1|STARTED|Overall Study||59
5300407|NCT00539188|13029936|P2|NOT COMPLETED|Overall Study||1
5300408|NCT00539188|13029937|P1|NOT COMPLETED|Overall Study||3
5300409|NCT00539188|13029936|P2|COMPLETED|Overall Study||1
5300410|NCT00539188|13029937|P1|COMPLETED|Overall Study||1
5300411|NCT00539188|13029936|P2|Received Allocated Intervention|Overall Study||2
5300412|NCT00539188|13029937|P1|Received Allocated Intervention|Overall Study||3
5300413|NCT00539188|13029936|P2|STARTED|Overall Study||2
5300414|NCT00539188|13029937|P1|STARTED|Overall Study||4
5300415|NCT00539110|13029951|P2|NOT COMPLETED|Overall Study||0
5300416|NCT00539110|13029952|P1|NOT COMPLETED|Overall Study||0
5300417|NCT00539110|13029951|P2|COMPLETED|Overall Study||5
5300418|NCT00539110|13029952|P1|COMPLETED|Overall Study||5
5300419|NCT00539110|13029951|P2|STARTED|Overall Study||5
5300420|NCT00539110|13029952|P1|STARTED|Overall Study||5
5300421|NCT00539032|13029960|P2|NOT COMPLETED|Overall Study||1
5300422|NCT00539032|13029961|P1|NOT COMPLETED|Overall Study||2
5300423|NCT00539032|13029960|P2|COMPLETED|Overall Study||84
5300424|NCT00539032|13029961|P1|COMPLETED|Overall Study||151
5300425|NCT00539032|13029960|P2|STARTED|Overall Study||85
5300426|NCT00539032|13029961|P1|STARTED|Overall Study||153
5300427|NCT00539006|13029975|P4|NOT COMPLETED|Post-Study||0
5300428|NCT00539006|13029976|P3|NOT COMPLETED|Post-Study||0
5300429|NCT00539006|13029977|P2|NOT COMPLETED|Post-Study||0
5300430|NCT00539006|13029978|P1|NOT COMPLETED|Post-Study||0
5300431|NCT00539006|13029975|P4|COMPLETED|Post-Study||81
5300432|NCT00539006|13029976|P3|COMPLETED|Post-Study||77
5300433|NCT00539006|13029977|P2|COMPLETED|Post-Study||83
5300434|NCT00539006|13029978|P1|COMPLETED|Post-Study||75
5300435|NCT00539006|13029975|P4|STARTED|Post-Study||81
5300436|NCT00539006|13029976|P3|STARTED|Post-Study||77
5300437|NCT00539006|13029977|P2|STARTED|Post-Study||83
5300438|NCT00539006|13029978|P1|STARTED|Post-Study||75
5300439|NCT00539006|13029975|P4|NOT COMPLETED|Treatment Period 2||0
5300440|NCT00539006|13029976|P3|NOT COMPLETED|Treatment Period 2||0
5300441|NCT00539006|13029977|P2|NOT COMPLETED|Treatment Period 2||1
5300442|NCT00539006|13029978|P1|NOT COMPLETED|Treatment Period 2||1
5300443|NCT00539006|13029975|P4|COMPLETED|Treatment Period 2||81
5300444|NCT00539006|13029976|P3|COMPLETED|Treatment Period 2||77
5300445|NCT00539006|13029977|P2|COMPLETED|Treatment Period 2||83
5300446|NCT00539006|13029978|P1|COMPLETED|Treatment Period 2||75
5300447|NCT00539006|13029975|P4|STARTED|Treatment Period 2||81
5300448|NCT00539006|13029976|P3|STARTED|Treatment Period 2||77
5300449|NCT00539006|13029977|P2|STARTED|Treatment Period 2||84
5300450|NCT00539006|13029978|P1|STARTED|Treatment Period 2||76
5300451|NCT00539006|13029975|P4|NOT COMPLETED|Washout||9
5300452|NCT00539006|13029976|P3|NOT COMPLETED|Washout||16
5300453|NCT00539006|13029977|P2|NOT COMPLETED|Washout||10
5300454|NCT00539006|13029978|P1|NOT COMPLETED|Washout||20
5300455|NCT00539006|13029975|P4|COMPLETED|Washout||81
5300456|NCT00539006|13029976|P3|COMPLETED|Washout||77
5300457|NCT00539006|13029977|P2|COMPLETED|Washout||84
5300458|NCT00539006|13029978|P1|COMPLETED|Washout||76
5300459|NCT00539006|13029975|P4|STARTED|Washout||90
5300460|NCT00539006|13029976|P3|STARTED|Washout||93
5300461|NCT00539006|13029977|P2|STARTED|Washout||94
5300462|NCT00539006|13029978|P1|STARTED|Washout||96
5300463|NCT00539006|13029975|P4|NOT COMPLETED|Treatment Period 1||1
5300464|NCT00539006|13029976|P3|NOT COMPLETED|Treatment Period 1||2
5300465|NCT00539006|13029977|P2|NOT COMPLETED|Treatment Period 1||0
5300466|NCT00539006|13029978|P1|NOT COMPLETED|Treatment Period 1||0
5300467|NCT00539006|13029975|P4|COMPLETED|Treatment Period 1||90
5300468|NCT00539006|13029976|P3|COMPLETED|Treatment Period 1||93
5300469|NCT00539006|13029977|P2|COMPLETED|Treatment Period 1||94
5300470|NCT00539006|13029978|P1|COMPLETED|Treatment Period 1||96
5300471|NCT00539006|13029975|P4|STARTED|Treatment Period 1||91
5300472|NCT00539006|13029976|P3|STARTED|Treatment Period 1||95
5300473|NCT00539006|13029977|P2|STARTED|Treatment Period 1||94
5300476|NCT00539006|13029976|P3|NOT COMPLETED|Pre-treatment||0
5300477|NCT00539006|13029977|P2|NOT COMPLETED|Pre-treatment||1
5300478|NCT00539006|13029978|P1|NOT COMPLETED|Pre-treatment||0
5300479|NCT00539006|13029975|P4|COMPLETED|Pre-treatment||91
5300480|NCT00539006|13029976|P3|COMPLETED|Pre-treatment||95
5300481|NCT00539006|13029977|P2|COMPLETED|Pre-treatment||94
5300482|NCT00539006|13029978|P1|COMPLETED|Pre-treatment||96
5300483|NCT00539006|13029975|P4|STARTED|Pre-treatment||91
5300484|NCT00539006|13029976|P3|STARTED|Pre-treatment||95
5300485|NCT00539006|13029977|P2|STARTED|Pre-treatment||95
5300486|NCT00539006|13029978|P1|STARTED|Pre-treatment||96
5300487|NCT00538980|13030008|P1|NOT COMPLETED|Overall Study||10
5300488|NCT00538980|13030008|P1|COMPLETED|Overall Study||0
5300489|NCT00538980|13030008|P1|STARTED|Overall Study||10
5300490|NCT00538915|13030016|P1|NOT COMPLETED|Overall Study||11
5300491|NCT00538915|13030016|P1|COMPLETED|Overall Study||52
5300492|NCT00538915|13030016|P1|STARTED|Overall Study||63
5300493|NCT00538902|13030023|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
5300494|NCT00538902|13030024|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
5300495|NCT00538902|13030025|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
5300496|NCT00538902|13030023|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
5300497|NCT00538902|13030024|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
5300498|NCT00538902|13030025|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
5300499|NCT00538902|13030023|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
5300500|NCT00538902|13030024|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
5300501|NCT00538902|13030025|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
5300502|NCT00538902|13030023|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
5300503|NCT00538902|13030024|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
5300504|NCT00538902|13030025|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
5300505|NCT00538902|13030023|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
5300506|NCT00538902|13030024|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
5300507|NCT00538902|13030025|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
5300508|NCT00538902|13030023|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
5300509|NCT00538902|13030024|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
5300510|NCT00538902|13030025|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
5300511|NCT00538863|13030060|P1|NOT COMPLETED|Open-label Maintenance||106
5300512|NCT00538863|13030060|P1|COMPLETED|Open-label Maintenance||163
5300513|NCT00538863|13030060|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
5300514|NCT00538863|13030060|P1|NOT COMPLETED|Open-label Titration||45
5300515|NCT00538863|13030060|P1|COMPLETED|Open-label Titration||184
5300516|NCT00538863|13030060|P1|STARTED|Open-label Titration||229
5300517|NCT00538850|13030066|P3|NOT COMPLETED|Placebo - Double-blind||3
5300518|NCT00538850|13030067|P2|NOT COMPLETED|Placebo - Double-blind||0
5300519|NCT00538850|13030068|P1|NOT COMPLETED|Placebo - Double-blind||0
5300520|NCT00538850|13030066|P3|COMPLETED|Placebo - Double-blind||95
5300521|NCT00538850|13030067|P2|COMPLETED|Placebo - Double-blind||0
5300522|NCT00538850|13030068|P1|COMPLETED|Placebo - Double-blind||0
5300523|NCT00538850|13030066|P3|STARTED|Placebo - Double-blind||98
5300524|NCT00538850|13030067|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
5300525|NCT00538850|13030068|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
5300526|NCT00538850|13030066|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
5300527|NCT00538850|13030067|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
5300528|NCT00538850|13030068|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
5300529|NCT00538850|13030066|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
5300530|NCT00538850|13030067|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
5300531|NCT00538850|13030068|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
5300532|NCT00538850|13030066|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
5300533|NCT00538850|13030067|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
5300534|NCT00538850|13030068|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
5300535|NCT00538850|13030066|P3|NOT COMPLETED|Titration Period||0
5300536|NCT00538850|13030067|P2|NOT COMPLETED|Titration Period||0
5300537|NCT00538850|13030068|P1|NOT COMPLETED|Titration Period||32
5300538|NCT00538850|13030066|P3|COMPLETED|Titration Period||0
5300539|NCT00538850|13030067|P2|COMPLETED|Titration Period||0
5300540|NCT00538850|13030068|P1|COMPLETED|Titration Period||98
5300541|NCT00538850|13030066|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
5300542|NCT00538850|13030067|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
5300543|NCT00538850|13030068|P1|STARTED|Titration Period||130
5300544|NCT00538824|13030080|P1|NOT COMPLETED|Overall Study||0
5300545|NCT00538824|13030080|P1|COMPLETED|Overall Study||5
5300546|NCT00538824|13030080|P1|Progression of Disease|Overall Study||2
5300547|NCT00538824|13030080|P1|STARTED|Overall Study||5
5300548|NCT00538785|13030086|P2|NOT COMPLETED|Overall Study||17
5300549|NCT00538785|13030087|P1|NOT COMPLETED|Overall Study||19
5300550|NCT00538785|13030086|P2|COMPLETED|Overall Study||595
5300551|NCT00538785|13030087|P1|COMPLETED|Overall Study||604
5300552|NCT00538785|13030086|P2|STARTED|Overall Study||612
5300553|NCT00538785|13030087|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
5300554|NCT00538759|13030110|P2|NOT COMPLETED|Overall Study||0
5300555|NCT00538759|13030111|P1|NOT COMPLETED|Overall Study||0
5300556|NCT00538759|13030110|P2|COMPLETED|Overall Study||8
5300557|NCT00538759|13030111|P1|COMPLETED|Overall Study||13
5300558|NCT00538759|13030110|P2|STARTED|Overall Study||8
5300559|NCT00538759|13030111|P1|STARTED|Overall Study||13
5300560|NCT00538733|13030129|P1|NOT COMPLETED|Overall Study||12
5300561|NCT00538733|13030129|P1|COMPLETED|Overall Study||14
5300562|NCT00538733|13030129|P1|Removed to Pursue Alternative Theray|Overall Study||2
5300563|NCT00538733|13030129|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
5300564|NCT00538733|13030129|P1|Removed Due to Progression of Disease|Overall Study||1
5300565|NCT00538733|13030129|P1|STARTED|Overall Study||26
5300566|NCT00538642|13030138|P2|NOT COMPLETED|Overall Study||5
5300567|NCT00538642|13030139|P1|NOT COMPLETED|Overall Study||1
5300568|NCT00538642|13030138|P2|COMPLETED|Overall Study||9
5300569|NCT00538642|13030139|P1|COMPLETED|Overall Study||9
5300570|NCT00538642|13030138|P2|STARTED|Overall Study||14
5300571|NCT00538642|13030139|P1|STARTED|Overall Study||10
5300572|NCT00538629|13030179|P1|NOT COMPLETED|Overall Study||22
5300573|NCT00538629|13030179|P1|COMPLETED|Overall Study||449
5300574|NCT00538629|13030179|P1|STARTED|Overall Study||471
5300575|NCT00538616|13030226|P2|NOT COMPLETED|Overall Study||0
5300576|NCT00538616|13030227|P1|NOT COMPLETED|Overall Study||0
5300577|NCT00538616|13030226|P2|COMPLETED|Overall Study||3
5300578|NCT00538616|13030227|P1|COMPLETED|Overall Study||5
5300579|NCT00538616|13030226|P2|STARTED|Overall Study||3
5300580|NCT00538616|13030227|P1|STARTED|Overall Study||5
5300581|NCT00538590|13030235|P2|NOT COMPLETED|Overall Study||0
5300582|NCT00538590|13030236|P1|NOT COMPLETED|Overall Study||1
5300583|NCT00538590|13030235|P2|COMPLETED|Overall Study||10
5300584|NCT00538590|13030236|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
5300585|NCT00538590|13030235|P2|STARTED|Overall Study||10
5300586|NCT00538590|13030236|P1|STARTED|Overall Study||10
5300587|NCT00538512|13030253|P3|NOT COMPLETED|Overall Study||13
5300588|NCT00538512|13030254|P2|NOT COMPLETED|Overall Study||30
5300589|NCT00538512|13030255|P1|NOT COMPLETED|Overall Study||27
5300590|NCT00538512|13030253|P3|COMPLETED|Overall Study||312
5300591|NCT00538512|13030254|P2|COMPLETED|Overall Study||783
5300592|NCT00538512|13030255|P1|COMPLETED|Overall Study||787
5300593|NCT00538512|13030253|P3|STARTED|Overall Study||325
5300594|NCT00538512|13030254|P2|STARTED|Overall Study||813
5300595|NCT00538512|13030255|P1|STARTED|Overall Study||814
5300596|NCT00538473|13030274|P2|NOT COMPLETED|Overall Study||0
5300597|NCT00538473|13030275|P1|NOT COMPLETED|Overall Study||1
5300598|NCT00538473|13030274|P2|COMPLETED|Overall Study||35
5300599|NCT00538473|13030275|P1|COMPLETED|Overall Study||32
5300600|NCT00538473|13030274|P2|STARTED|Overall Study||35
5300601|NCT00538473|13030275|P1|STARTED|Overall Study||33
5300602|NCT00538434|13030311|P4|NOT COMPLETED|Overall Study||6
5300603|NCT00538434|13030312|P3|NOT COMPLETED|Overall Study||7
5300604|NCT00538434|13030313|P2|NOT COMPLETED|Overall Study||11
5300605|NCT00538434|13030314|P1|NOT COMPLETED|Overall Study||9
5300606|NCT00538434|13030311|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
5300607|NCT00538434|13030312|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
5300608|NCT00538434|13030313|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
5300609|NCT00538434|13030314|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
5300610|NCT00538434|13030311|P4|Intent-to-treat (ITT) Population|Overall Study||57
5300611|NCT00538434|13030312|P3|Intent-to-treat (ITT) Population|Overall Study||57
5300612|NCT00538434|13030313|P2|Intent-to-treat (ITT) Population|Overall Study||57
5300613|NCT00538434|13030314|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
5300614|NCT00538434|13030311|P4|STARTED|Overall Study||57
5300615|NCT00538434|13030312|P3|STARTED|Overall Study||57
5300616|NCT00538434|13030313|P2|STARTED|Overall Study||57
5300617|NCT00538434|13030314|P1|STARTED|Overall Study||56
5300618|NCT00538304|13030338|P2|NOT COMPLETED|Overall Study||5
5300619|NCT00538304|13030339|P1|NOT COMPLETED|Overall Study||7
5300620|NCT00538304|13030338|P2|COMPLETED|Overall Study||66
5300621|NCT00538304|13030339|P1|COMPLETED|Overall Study||144
5300622|NCT00538304|13030338|P2|STARTED|Overall Study||71
5300623|NCT00538304|13030339|P1|STARTED|Overall Study||151
5300624|NCT00538291|13030355|P1|NOT COMPLETED|Overall Study||3
5300625|NCT00538291|13030355|P1|COMPLETED|Overall Study||10
5300626|NCT00538291|13030355|P1|STARTED|Overall Study||13
5300627|NCT00538213|13030362|P3|NOT COMPLETED|Overall Study||0
5300628|NCT00538213|13030363|P2|NOT COMPLETED|Overall Study||0
5300629|NCT00538213|13030364|P1|NOT COMPLETED|Overall Study||0
5300630|NCT00538213|13030362|P3|COMPLETED|Overall Study||38
5300631|NCT00538213|13030363|P2|COMPLETED|Overall Study||40
5300632|NCT00538213|13030364|P1|COMPLETED|Overall Study||55
5300633|NCT00538213|13030362|P3|STARTED|Overall Study||38
5300634|NCT00538213|13030363|P2|STARTED|Overall Study||40
5300635|NCT00538213|13030364|P1|STARTED|Overall Study||55
5300636|NCT00537979|13030413|P2|NOT COMPLETED|Overall Study||20
5300637|NCT00537979|13030414|P1|NOT COMPLETED|Overall Study||6
5300638|NCT00537979|13030413|P2|COMPLETED|Overall Study||89
5300639|NCT00537979|13030414|P1|COMPLETED|Overall Study||32
5300640|NCT00537979|13030413|P2|STARTED|Overall Study||109
5300641|NCT00537979|13030414|P1|STARTED|Overall Study||38
5300642|NCT00537940|13030430|P2|NOT COMPLETED|Overall Study||179
5300643|NCT00537940|13030431|P1|NOT COMPLETED|Overall Study||183
5300644|NCT00537940|13030430|P2|COMPLETED|Overall Study||62
5300731|NCT00537407|13030587|P5|COMPLETED|Part 1 Weeks 1-4||10
5300645|NCT00537940|13030431|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
5300646|NCT00537940|13030430|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
5300647|NCT00537940|13030431|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
5300648|NCT00537940|13030430|P2|Completed Maintenance Phase|Overall Study||172
5300649|NCT00537940|13030431|P1|Completed Maintenance Phase|Overall Study||187
5300650|NCT00537940|13030430|P2|Completed Titration Phase|Overall Study||210
5300651|NCT00537940|13030431|P1|Completed Titration Phase|Overall Study||213
5300652|NCT00537940|13030430|P2|STARTED|Overall Study||241
5300653|NCT00537940|13030431|P1|STARTED|Overall Study||241
5300654|NCT00537823|13030455|P2|NOT COMPLETED|Overall Study||0
5300655|NCT00537823|13030456|P1|NOT COMPLETED|Overall Study||2
5300656|NCT00537823|13030455|P2|COMPLETED|Overall Study||2
5300657|NCT00537823|13030456|P1|COMPLETED|Overall Study||5
5300658|NCT00537823|13030455|P2|STARTED|Overall Study||2
5300659|NCT00537823|13030456|P1|STARTED|Overall Study||7
5300660|NCT00537810|13030482|P4|NOT COMPLETED|Overall Study||4
5300661|NCT00537810|13030483|P3|NOT COMPLETED|Overall Study||4
5300662|NCT00537810|13030484|P2|NOT COMPLETED|Overall Study||13
5300663|NCT00537810|13030485|P1|NOT COMPLETED|Overall Study||6
5300664|NCT00537810|13030482|P4|COMPLETED|Overall Study||22
5300665|NCT00537810|13030483|P3|COMPLETED|Overall Study||21
5300666|NCT00537810|13030484|P2|COMPLETED|Overall Study||14
5300667|NCT00537810|13030485|P1|COMPLETED|Overall Study||20
5300668|NCT00537810|13030482|P4|STARTED|Overall Study||26
5300669|NCT00537810|13030483|P3|STARTED|Overall Study||25
5300670|NCT00537810|13030484|P2|STARTED|Overall Study||27
5300671|NCT00537810|13030485|P1|STARTED|Overall Study||26
5300672|NCT00537771|13030501|P2|NOT COMPLETED|Overall Study||61
5300673|NCT00537771|13030502|P1|NOT COMPLETED|Overall Study||29
5300674|NCT00537771|13030501|P2|COMPLETED|Overall Study||114
5300675|NCT00537771|13030502|P1|COMPLETED|Overall Study||149
5300676|NCT00537771|13030501|P2|STARTED|Overall Study||175
5300677|NCT00537771|13030502|P1|STARTED|Overall Study||178
5300678|NCT00537745|13030512|P1|NOT COMPLETED|Overall Study||5
5300679|NCT00537745|13030512|P1|COMPLETED|Overall Study||9
5300680|NCT00537745|13030512|P1|Began Intervention|Overall Study||11
5300681|NCT00537745|13030512|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
5300682|NCT00537680|13030520|P3|NOT COMPLETED|Overall Study||0
5300683|NCT00537680|13030521|P2|NOT COMPLETED|Overall Study||2
5300684|NCT00537680|13030522|P1|NOT COMPLETED|Overall Study||0
5300685|NCT00537680|13030520|P3|COMPLETED|Overall Study||24
5300686|NCT00537680|13030521|P2|COMPLETED|Overall Study||22
5300687|NCT00537680|13030522|P1|COMPLETED|Overall Study||22
5300688|NCT00537680|13030520|P3|STARTED|Overall Study||24
5300689|NCT00537680|13030521|P2|STARTED|Overall Study||24
5300690|NCT00537680|13030522|P1|STARTED|Overall Study||22
5300691|NCT00537511|13030530|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
5300692|NCT00537511|13030530|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
5300693|NCT00537511|13030530|P1|STARTED|Maintenance Phase (Monotherapy)||8
5300694|NCT00537511|13030530|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
5300695|NCT00537511|13030530|P1|COMPLETED|Recovery Period (Monotherapy)||3
5300696|NCT00537511|13030530|P1|STARTED|Recovery Period (Monotherapy)||11
5300697|NCT00537511|13030530|P1|NOT COMPLETED|Extension Period (Combination)||6
5300698|NCT00537511|13030530|P1|COMPLETED|Extension Period (Combination)||11
5300699|NCT00537511|13030530|P1|STARTED|Extension Period (Combination)||17
5300700|NCT00537511|13030530|P1|NOT COMPLETED|Treatment Period (Combination)||5
5300701|NCT00537511|13030530|P1|COMPLETED|Treatment Period (Combination)||17
5300702|NCT00537511|13030530|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
5300703|NCT00537511|13030530|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
5300704|NCT00537511|13030530|P1|STARTED|Treatment Period (Combination)||22
5300705|NCT00537485|13030557|P2|NOT COMPLETED|Overall Study||10
5300706|NCT00537485|13030558|P1|NOT COMPLETED|Overall Study||15
5300707|NCT00537485|13030557|P2|COMPLETED|Overall Study||80
5300708|NCT00537485|13030558|P1|COMPLETED|Overall Study||75
5300709|NCT00537485|13030557|P2|STARTED|Overall Study||90
5300710|NCT00537485|13030558|P1|STARTED|Overall Study||90
5300711|NCT00537407|13030587|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
5300712|NCT00537407|13030588|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
5300713|NCT00537407|13030589|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
5300714|NCT00537407|13030590|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
5300715|NCT00537407|13030591|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
5300716|NCT00537407|13030587|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
5300717|NCT00537407|13030588|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
5300718|NCT00537407|13030589|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
5300719|NCT00537407|13030590|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
5300720|NCT00537407|13030591|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
5300721|NCT00537407|13030587|P5|STARTED|Part 2 Weeks 5-48 or 72||10
5300722|NCT00537407|13030588|P4|STARTED|Part 2 Weeks 5-48 or 72||10
5300723|NCT00537407|13030589|P3|STARTED|Part 2 Weeks 5-48 or 72||11
5300724|NCT00537407|13030590|P2|STARTED|Part 2 Weeks 5-48 or 72||9
5300725|NCT00537407|13030591|P1|STARTED|Part 2 Weeks 5-48 or 72||10
5300726|NCT00537407|13030587|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
5300727|NCT00537407|13030588|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
5300728|NCT00537407|13030589|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
5300729|NCT00537407|13030590|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
5300730|NCT00537407|13030591|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
5300732|NCT00537407|13030588|P4|COMPLETED|Part 1 Weeks 1-4||10
5300733|NCT00537407|13030589|P3|COMPLETED|Part 1 Weeks 1-4||11
5300734|NCT00537407|13030590|P2|COMPLETED|Part 1 Weeks 1-4||9
5300735|NCT00537407|13030591|P1|COMPLETED|Part 1 Weeks 1-4||10
5300736|NCT00537407|13030587|P5|STARTED|Part 1 Weeks 1-4||10
5300737|NCT00537407|13030588|P4|STARTED|Part 1 Weeks 1-4||10
5300738|NCT00537407|13030589|P3|STARTED|Part 1 Weeks 1-4||11
5300739|NCT00537407|13030590|P2|STARTED|Part 1 Weeks 1-4||9
5300740|NCT00537407|13030591|P1|STARTED|Part 1 Weeks 1-4||10
5300741|NCT00537394|13030631|P3|NOT COMPLETED|2nd Year of Follow-up||6
5300742|NCT00537394|13030632|P2|NOT COMPLETED|2nd Year of Follow-up||9
5300743|NCT00537394|13030633|P1|NOT COMPLETED|2nd Year of Follow-up||11
5300744|NCT00537394|13030631|P3|COMPLETED|2nd Year of Follow-up||44
5300745|NCT00537394|13030632|P2|COMPLETED|2nd Year of Follow-up||159
5300746|NCT00537394|13030633|P1|COMPLETED|2nd Year of Follow-up||158
5300747|NCT00537394|13030631|P3|STARTED|2nd Year of Follow-up||50
5300748|NCT00537394|13030632|P2|STARTED|2nd Year of Follow-up||168
5300749|NCT00537394|13030633|P1|STARTED|2nd Year of Follow-up||169
5300750|NCT00537394|13030631|P3|NOT COMPLETED|First Year of Follow-up||3
5300751|NCT00537394|13030632|P2|NOT COMPLETED|First Year of Follow-up||11
5300752|NCT00537394|13030633|P1|NOT COMPLETED|First Year of Follow-up||12
5300753|NCT00537394|13030631|P3|COMPLETED|First Year of Follow-up||50
5300754|NCT00537394|13030632|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
5300755|NCT00537394|13030633|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
5300756|NCT00537394|13030631|P3|STARTED|First Year of Follow-up||53
5300757|NCT00537394|13030632|P2|STARTED|First Year of Follow-up||179
5300758|NCT00537394|13030633|P1|STARTED|First Year of Follow-up||181
5300759|NCT00537381|13030669|P2|NOT COMPLETED|Overall Study||62
5300760|NCT00537381|13030670|P1|NOT COMPLETED|Overall Study||56
5300761|NCT00537381|13030669|P2|COMPLETED|Overall Study||4
5300762|NCT00537381|13030670|P1|COMPLETED|Overall Study||9
5300763|NCT00537381|13030669|P2|STARTED|Overall Study||66
5300764|NCT00537381|13030670|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
5300765|NCT00537329|13030690|P1|NOT COMPLETED|Overall Study||26
5300766|NCT00537329|13030690|P1|COMPLETED|Overall Study||17
5300767|NCT00537329|13030690|P1|STARTED|Overall Study||43
5300768|NCT00537316|13030710|P7|NOT COMPLETED|Part 2||2
5300769|NCT00537316|13030711|P6|NOT COMPLETED|Part 2||4
5300770|NCT00537316|13030712|P5|NOT COMPLETED|Part 2||1
5300771|NCT00537316|13030713|P4|NOT COMPLETED|Part 2||3
5300772|NCT00537316|13030714|P3|NOT COMPLETED|Part 2||32
5300773|NCT00537316|13030715|P2|NOT COMPLETED|Part 2||9
5300774|NCT00537316|13030716|P1|NOT COMPLETED|Part 2||26
5300775|NCT00537316|13030710|P7|COMPLETED|Part 2||0
5300776|NCT00537316|13030711|P6|COMPLETED|Part 2||0
5300777|NCT00537316|13030712|P5|COMPLETED|Part 2||1
5300778|NCT00537316|13030713|P4|COMPLETED|Part 2||2
5300779|NCT00537316|13030714|P3|COMPLETED|Part 2||16
5300780|NCT00537316|13030715|P2|COMPLETED|Part 2||1
5300781|NCT00537316|13030716|P1|COMPLETED|Part 2||11
5300782|NCT00537316|13030710|P7|STARTED|Part 2||2
5300783|NCT00537316|13030711|P6|STARTED|Part 2||4
5300784|NCT00537316|13030712|P5|STARTED|Part 2||2
5300785|NCT00537316|13030713|P4|STARTED|Part 2||5
5300786|NCT00537316|13030714|P3|STARTED|Part 2||48
5300787|NCT00537316|13030715|P2|STARTED|Part 2||10
5300788|NCT00537316|13030716|P1|STARTED|Part 2||37
5300789|NCT00537316|13030710|P7|NOT COMPLETED|Part 1||0
5300790|NCT00537316|13030711|P6|NOT COMPLETED|Part 1||0
5300791|NCT00537316|13030712|P5|NOT COMPLETED|Part 1||0
5300792|NCT00537316|13030713|P4|NOT COMPLETED|Part 1||0
5300793|NCT00537316|13030714|P3|NOT COMPLETED|Part 1||17
5300794|NCT00537316|13030715|P2|NOT COMPLETED|Part 1||27
5300795|NCT00537316|13030716|P1|NOT COMPLETED|Part 1||14
5300796|NCT00537316|13030710|P7|COMPLETED|Part 1||0
5300797|NCT00537316|13030711|P6|COMPLETED|Part 1||0
5300798|NCT00537316|13030712|P5|COMPLETED|Part 1||0
5300799|NCT00537316|13030713|P4|COMPLETED|Part 1||0
5300800|NCT00537316|13030714|P3|COMPLETED|Part 1||63
5300801|NCT00537316|13030715|P2|COMPLETED|Part 1||53
5300802|NCT00537316|13030716|P1|COMPLETED|Part 1||65
5300803|NCT00537316|13030710|P7|STARTED|Part 1||0
5300804|NCT00537316|13030711|P6|STARTED|Part 1||0
5300805|NCT00537316|13030712|P5|STARTED|Part 1||0
5300806|NCT00537316|13030713|P4|STARTED|Part 1||0
5300807|NCT00537316|13030714|P3|STARTED|Part 1||80
5300808|NCT00537316|13030715|P2|STARTED|Part 1||80
5300809|NCT00537316|13030716|P1|STARTED|Part 1||79
5300810|NCT00537303|13030743|P2|NOT COMPLETED|Overall Study||25
5300811|NCT00537303|13030744|P1|NOT COMPLETED|Overall Study||26
5300812|NCT00537303|13030743|P2|COMPLETED|Overall Study||125
5300813|NCT00537303|13030744|P1|COMPLETED|Overall Study||120
5300814|NCT00537303|13030743|P2|STARTED|Overall Study||150
5300815|NCT00537303|13030744|P1|STARTED|Overall Study||146
5300816|NCT00537290|13030760|P1|NOT COMPLETED|Overall Study||0
5300817|NCT00537290|13030760|P1|COMPLETED|Overall Study||19
5300818|NCT00537290|13030760|P1|STARTED|Overall Study||19
5300819|NCT00537277|13030765|P1|NOT COMPLETED|Overall Study||49
5300820|NCT00537277|13030765|P1|COMPLETED|Overall Study||112
5300821|NCT00537277|13030765|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
5300822|NCT00537277|13030765|P1|STARTED|Overall Study||161
5300823|NCT00537238|13030776|P2|NOT COMPLETED|Overall Study||173
5300824|NCT00537238|13030777|P1|NOT COMPLETED|Overall Study||174
5300825|NCT00537238|13030776|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
5300826|NCT00537238|13030777|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
5300827|NCT00537238|13030776|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
5300828|NCT00537238|13030777|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
5300829|NCT00537238|13030776|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
5300830|NCT00537238|13030777|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
5300831|NCT00537238|13030776|P2|Completed Titration Phase|Overall Study||236
5300832|NCT00537238|13030777|P1|Completed Titration Phase|Overall Study||226
5300833|NCT00537238|13030776|P2|STARTED|Overall Study||255
5300834|NCT00537238|13030777|P1|STARTED|Overall Study||254
5300835|NCT00537199|13030797|P1|NOT COMPLETED|Overall Study||1
5300836|NCT00537199|13030797|P1|COMPLETED|Overall Study||0
5300837|NCT00537199|13030797|P1|STARTED|Overall Study||1
5300838|NCT00537095|13030803|P2|NOT COMPLETED|Overall Study||57
5300839|NCT00537095|13030804|P1|NOT COMPLETED|Overall Study||51
5300840|NCT00537095|13030803|P2|COMPLETED|Overall Study||16
5300841|NCT00537095|13030804|P1|COMPLETED|Overall Study||21
5300842|NCT00537095|13030803|P2|STARTED|Overall Study||73
5300843|NCT00537095|13030804|P1|STARTED|Overall Study||72
5300844|NCT00537082|13030819|P3|NOT COMPLETED|Overall Study||6
5300845|NCT00537082|13030820|P2|NOT COMPLETED|Overall Study||9
5300846|NCT00537082|13030821|P1|NOT COMPLETED|Overall Study||9
5300847|NCT00537082|13030819|P3|COMPLETED|Overall Study||51
5300848|NCT00537082|13030820|P2|COMPLETED|Overall Study||48
5300849|NCT00537082|13030821|P1|COMPLETED|Overall Study||48
5300850|NCT00537082|13030819|P3|STARTED|Overall Study||57
5300851|NCT00537082|13030820|P2|STARTED|Overall Study||57
5300852|NCT00537082|13030821|P1|STARTED|Overall Study||57
5300853|NCT00537056|13030838|P1|NOT COMPLETED|12-month Follow-up||0
5300854|NCT00537056|13030838|P1|COMPLETED|12-month Follow-up||17
5300855|NCT00537056|13030838|P1|STARTED|12-month Follow-up||17
5300856|NCT00537056|13030838|P1|NOT COMPLETED|Interim PET/CT||5
5300857|NCT00537056|13030838|P1|COMPLETED|Interim PET/CT||12
5300858|NCT00537056|13030838|P1|STARTED|Interim PET/CT||17
5300859|NCT00537056|13030838|P1|NOT COMPLETED|Baseline PET/CT||0
5300860|NCT00537056|13030838|P1|COMPLETED|Baseline PET/CT||17
5300861|NCT00537056|13030838|P1|STARTED|Baseline PET/CT||17
5300862|NCT00537030|13030850|P1|NOT COMPLETED|Overall Study||16
5300863|NCT00537030|13030850|P1|COMPLETED|Overall Study||43
5300864|NCT00537030|13030850|P1|STARTED|Overall Study||59
5300865|NCT00537017|13030857|P1|NOT COMPLETED|Follow-up Phase||9
5300866|NCT00537017|13030857|P1|COMPLETED|Follow-up Phase||126
5300867|NCT00537017|13030857|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
5300868|NCT00537017|13030857|P1|NOT COMPLETED|Treatment Phase||34
5300869|NCT00537017|13030857|P1|COMPLETED|Treatment Phase||106
5300870|NCT00537017|13030857|P1|STARTED|Treatment Phase||140
5300871|NCT00536991|13030868|P1|NOT COMPLETED|Overall Study||13
5300872|NCT00536991|13030868|P1|COMPLETED|Overall Study||38
5300873|NCT00536991|13030868|P1|STARTED|Overall Study||51
5300874|NCT00536978|13030875|P1|NOT COMPLETED|Overall Study||22
5300875|NCT00536978|13030875|P1|COMPLETED|Overall Study||0
5300876|NCT00536978|13030875|P1|STARTED|Overall Study||22
5300877|NCT00536913|13030881|P2|NOT COMPLETED|Overall Study||0
5300878|NCT00536913|13030882|P1|NOT COMPLETED|Overall Study||0
5300879|NCT00536913|13030881|P2|COMPLETED|Overall Study||52
5300880|NCT00536913|13030882|P1|COMPLETED|Overall Study||55
5300881|NCT00536913|13030881|P2|STARTED|Overall Study||52
5300882|NCT00536913|13030882|P1|STARTED|Overall Study||55
5300883|NCT00536874|13030904|P1|NOT COMPLETED|Overall Study||4
5300884|NCT00536874|13030904|P1|COMPLETED|Overall Study||35
5300885|NCT00536874|13030904|P1|STARTED|Overall Study||39
5300886|NCT00536809|13030914|P1|NOT COMPLETED|Phase II||2
5300887|NCT00536809|13030914|P1|COMPLETED|Phase II||0
5300888|NCT00536809|13030914|P1|STARTED|Phase II||2
5300889|NCT00536809|13030914|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
5300890|NCT00536809|13030914|P1|COMPLETED|Phase I (Dose-finding Phase)||10
5300891|NCT00536809|13030914|P1|STARTED|Phase I (Dose-finding Phase)||10
5300892|NCT00536744|13030937|P2|NOT COMPLETED|Overall Study||28
5300893|NCT00536744|13030938|P1|NOT COMPLETED|Overall Study||29
5300894|NCT00536744|13030937|P2|COMPLETED|Overall Study||71
5300895|NCT00536744|13030938|P1|COMPLETED|Overall Study||78
5300896|NCT00536744|13030937|P2|STARTED|Overall Study||99
5300897|NCT00536744|13030938|P1|STARTED|Overall Study||107
5300898|NCT00536731|13030947|P3|NOT COMPLETED|Overall Study||5
5300899|NCT00536731|13030948|P2|NOT COMPLETED|Overall Study||5
5300900|NCT00536731|13030949|P1|NOT COMPLETED|Overall Study||4
5300901|NCT00536731|13030947|P3|COMPLETED|Overall Study||238
5300902|NCT00536731|13030948|P2|COMPLETED|Overall Study||241
5300903|NCT00536731|13030949|P1|COMPLETED|Overall Study||249
5300904|NCT00536731|13030947|P3|STARTED|Overall Study||243
5300905|NCT00536731|13030948|P2|STARTED|Overall Study||246
5300906|NCT00536731|13030949|P1|STARTED|Overall Study||253
5300907|NCT00536575|13030993|P1|NOT COMPLETED|Overall Study||2
5300908|NCT00536575|13030993|P1|COMPLETED|Overall Study||11
5300909|NCT00536575|13030993|P1|STARTED|Overall Study||13
5300910|NCT00536510|13030999|P2|NOT COMPLETED|Overall Study||29
5300911|NCT00536510|13031000|P1|NOT COMPLETED|Overall Study||82
5300912|NCT00536510|13030999|P2|COMPLETED|Overall Study||295
5300913|NCT00536510|13031000|P1|COMPLETED|Overall Study||240
5300914|NCT00536510|13030999|P2|STARTED|Overall Study||324
5300915|NCT00536510|13031000|P1|STARTED|Overall Study||322
5300916|NCT00536484|13031010|P2|NOT COMPLETED|Overall Study||56
5300917|NCT00536484|13031011|P1|NOT COMPLETED|Overall Study||60
5300918|NCT00536484|13031010|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
5300919|NCT00536484|13031011|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
5300920|NCT00536484|13031010|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
5300921|NCT00536484|13031011|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
5300922|NCT00536471|13031045|P4|NOT COMPLETED|Overall Study||74
5300923|NCT00536471|13031046|P3|NOT COMPLETED|Overall Study||139
5300924|NCT00536471|13031047|P2|NOT COMPLETED|Overall Study||84
5300925|NCT00536471|13031048|P1|NOT COMPLETED|Overall Study||156
5300926|NCT00536471|13031045|P4|COMPLETED|Overall Study||57
5300927|NCT00536471|13031046|P3|COMPLETED|Overall Study||122
5300928|NCT00536471|13031047|P2|COMPLETED|Overall Study||43
5300929|NCT00536471|13031048|P1|COMPLETED|Overall Study||101
5300930|NCT00536471|13031045|P4|STARTED|Overall Study||131
5300931|NCT00536471|13031046|P3|STARTED|Overall Study||261
5300932|NCT00536471|13031047|P2|STARTED|Overall Study||127
5300933|NCT00536471|13031048|P1|STARTED|Overall Study||257
5300934|NCT00536380|13031293|P3|NOT COMPLETED|Overall Study||10
5300935|NCT00536380|13031294|P2|NOT COMPLETED|Overall Study||9
5300936|NCT00536380|13031295|P1|NOT COMPLETED|Overall Study||12
5300937|NCT00536380|13031293|P3|COMPLETED|Overall Study||94
5300938|NCT00536380|13031294|P2|COMPLETED|Overall Study||95
5300939|NCT00536380|13031295|P1|COMPLETED|Overall Study||94
5300940|NCT00536380|13031293|P3|STARTED|Overall Study||104
5300941|NCT00536380|13031294|P2|STARTED|Overall Study||104
5300942|NCT00536380|13031295|P1|STARTED|Overall Study||106
5300943|NCT00536341|13031305|P2|NOT COMPLETED|Overall Study||11
5300944|NCT00536341|13031306|P1|NOT COMPLETED|Overall Study||5
5300945|NCT00536341|13031305|P2|COMPLETED|Overall Study||43
5300946|NCT00536341|13031306|P1|COMPLETED|Overall Study||5
5300947|NCT00536341|13031305|P2|STARTED|Overall Study||54
5300948|NCT00536341|13031306|P1|STARTED|Overall Study||10
5300949|NCT00536263|13031319|P3|NOT COMPLETED|Overall Study||21
5300950|NCT00536263|13031320|P2|NOT COMPLETED|Overall Study||14
5300951|NCT00536263|13031321|P1|NOT COMPLETED|Overall Study||11
5300952|NCT00536263|13031319|P3|COMPLETED|Overall Study||204
5300953|NCT00536263|13031320|P2|COMPLETED|Overall Study||207
5300954|NCT00536263|13031321|P1|COMPLETED|Overall Study||214
5300955|NCT00536263|13031319|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
5300956|NCT00536263|13031320|P2|STARTED|Overall Study||221
5300957|NCT00536263|13031321|P1|STARTED|Overall Study||225
5300958|NCT00536198|13031361|P2|NOT COMPLETED|Overall Study||39
5300959|NCT00536198|13031362|P1|NOT COMPLETED|Overall Study||37
5300960|NCT00536198|13031361|P2|COMPLETED|Overall Study||88
5300961|NCT00536198|13031362|P1|COMPLETED|Overall Study||88
5300962|NCT00536198|13031361|P2|Cycle 6|Overall Study||88
5300963|NCT00536198|13031362|P1|Cycle 6|Overall Study||88
5300964|NCT00536198|13031361|P2|Cycle 5|Overall Study||85
5300965|NCT00536198|13031362|P1|Cycle 5|Overall Study||88
5300966|NCT00536198|13031361|P2|Cycle 4|Overall Study||98
5300967|NCT00536198|13031362|P1|Cycle 4|Overall Study||95
5300968|NCT00536198|13031361|P2|Cycle 3|Overall Study||101
5300969|NCT00536198|13031362|P1|Cycle 3|Overall Study||100
5300970|NCT00536198|13031361|P2|Cycle 2|Overall Study||112
5300971|NCT00536198|13031362|P1|Cycle 2|Overall Study||104
5300972|NCT00536198|13031361|P2|Cycle 1|Overall Study||123
5300973|NCT00536198|13031362|P1|Cycle 1|Overall Study||110
5300974|NCT00536198|13031361|P2|STARTED|Overall Study||127
5300975|NCT00536198|13031362|P1|STARTED|Overall Study||125
5300976|NCT00536172|13031392|P2|NOT COMPLETED|Overall Study||9
5300977|NCT00536172|13031393|P1|NOT COMPLETED|Overall Study||14
5300978|NCT00536172|13031392|P2|COMPLETED|Overall Study||65
5300979|NCT00536172|13031393|P1|COMPLETED|Overall Study||60
5300980|NCT00536172|13031392|P2|STARTED|Overall Study||74
5300981|NCT00536172|13031393|P1|STARTED|Overall Study||74
5300982|NCT00536120|13031401|P2|NOT COMPLETED|Overall Study||3
5300983|NCT00536120|13031402|P1|NOT COMPLETED|Overall Study||6
5300984|NCT00536120|13031401|P2|COMPLETED|Overall Study||27
5300985|NCT00536120|13031402|P1|COMPLETED|Overall Study||24
5300986|NCT00536120|13031401|P2|STARTED|Overall Study||30
5300987|NCT00536120|13031402|P1|STARTED|Overall Study||30
5300988|NCT00536107|13031416|P2|NOT COMPLETED|Overall Study||6
5300989|NCT00536107|13031417|P1|NOT COMPLETED|Overall Study||8
5300990|NCT00536107|13031416|P2|COMPLETED|Overall Study||0
5300991|NCT00536107|13031417|P1|COMPLETED|Overall Study||0
5300992|NCT00536107|13031416|P2|STARTED|Overall Study||6
5300993|NCT00536107|13031417|P1|STARTED|Overall Study||8
5300994|NCT00535938|13031427|P2|NOT COMPLETED|Overall Study||462
5300995|NCT00535938|13031428|P1|NOT COMPLETED|Overall Study||391
5300996|NCT00535938|13031427|P2|COMPLETED|Overall Study||404
5300997|NCT00535938|13031428|P1|COMPLETED|Overall Study||115
5300998|NCT00535938|13031427|P2|STARTED|Overall Study||866
5300999|NCT00535938|13031428|P1|STARTED|Overall Study||506
5301000|NCT00535925|13031466|P2|NOT COMPLETED|Overall Study||8
5301001|NCT00535925|13031467|P1|NOT COMPLETED|Overall Study||19
5301002|NCT00535925|13031466|P2|COMPLETED|Overall Study||199
5301003|NCT00535925|13031467|P1|COMPLETED|Overall Study||169
5301004|NCT00535925|13031466|P2|STARTED|Overall Study||207
5301005|NCT00535925|13031467|P1|STARTED|Overall Study||188
5301006|NCT00535873|13031475|P1|NOT COMPLETED|Overall Study||0
5301007|NCT00535873|13031475|P1|COMPLETED|Overall Study||60
5301008|NCT00535873|13031475|P1|STARTED|Overall Study||60
5301009|NCT00535847|13031482|P3|NOT COMPLETED|Overall Study||2
5301010|NCT00535847|13031483|P2|NOT COMPLETED|Overall Study||14
5301011|NCT00535847|13031484|P1|NOT COMPLETED|Overall Study||22
5301012|NCT00535847|13031482|P3|COMPLETED|Overall Study||0
5301013|NCT00535847|13031483|P2|COMPLETED|Overall Study||20
5301014|NCT00535847|13031484|P1|COMPLETED|Overall Study||59
5301015|NCT00535847|13031482|P3|STARTED|Overall Study||2
5301016|NCT00535847|13031483|P2|STARTED|Overall Study||34
5301017|NCT00535847|13031484|P1|STARTED|Overall Study||81
5301018|NCT00535821|13031510|P2|NOT COMPLETED|Overall Study||0
5301019|NCT00535821|13031511|P1|NOT COMPLETED|Overall Study||0
5301020|NCT00535821|13031510|P2|COMPLETED|Overall Study||3
5301021|NCT00535821|13031511|P1|COMPLETED|Overall Study||2
5301022|NCT00535821|13031510|P2|STARTED|Overall Study||3
5301023|NCT00535821|13031511|P1|STARTED|Overall Study||2
5301024|NCT00535782|13031519|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
5301025|NCT00535782|13031520|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
5301026|NCT00535782|13031521|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
5301027|NCT00535782|13031519|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
5301028|NCT00535782|13031520|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
5301029|NCT00535782|13031521|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
5301030|NCT00535782|13031519|P3|STARTED|Part 2: 80-Week Open-label Period||124
5301031|NCT00535782|13031520|P2|STARTED|Part 2: 80-Week Open-label Period||0
5301032|NCT00535782|13031521|P1|STARTED|Part 2: 80-Week Open-label Period||0
5301033|NCT00535782|13031519|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
5301034|NCT00535782|13031520|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
5301035|NCT00535782|13031521|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
5301036|NCT00535782|13031519|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
5301037|NCT00535782|13031520|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
5301038|NCT00535782|13031521|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
5301039|NCT00535782|13031519|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
5301040|NCT00535782|13031520|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
5301041|NCT00535782|13031521|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
5301042|NCT00535782|13031519|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
5301043|NCT00535782|13031520|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
5301044|NCT00535782|13031521|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
5301045|NCT00535782|13031519|P3|STARTED|Part 1: 24-Week Double-blind Period||0
5301046|NCT00535782|13031520|P2|STARTED|Part 1: 24-Week Double-blind Period||63
5301047|NCT00535782|13031521|P1|STARTED|Part 1: 24-Week Double-blind Period||69
5301048|NCT00535769|13031538|P2|NOT COMPLETED|Overall Study||0
5301049|NCT00535769|13031539|P1|NOT COMPLETED|Overall Study||0
5301050|NCT00535769|13031538|P2|COMPLETED|Overall Study||35
5301051|NCT00535769|13031539|P1|COMPLETED|Overall Study||35
5301052|NCT00535769|13031538|P2|STARTED|Overall Study||35
5301053|NCT00535769|13031539|P1|STARTED|Overall Study||35
5301054|NCT00535743|13031572|P24|NOT COMPLETED|Overall Study||0
5301055|NCT00535743|13031573|P23|NOT COMPLETED|Overall Study||0
5301056|NCT00535743|13031574|P22|NOT COMPLETED|Overall Study||1
5301057|NCT00535743|13031575|P21|NOT COMPLETED|Overall Study||0
5301058|NCT00535743|13031576|P20|NOT COMPLETED|Overall Study||0
5301059|NCT00535743|13031577|P19|NOT COMPLETED|Overall Study||0
5301060|NCT00535743|13031578|P18|NOT COMPLETED|Overall Study||0
5301061|NCT00535743|13031579|P17|NOT COMPLETED|Overall Study||0
5301062|NCT00535743|13031580|P16|NOT COMPLETED|Overall Study||0
5301063|NCT00535743|13031581|P15|NOT COMPLETED|Overall Study||0
5301064|NCT00535743|13031582|P14|NOT COMPLETED|Overall Study||0
5301065|NCT00535743|13031583|P13|NOT COMPLETED|Overall Study||0
5301066|NCT00535743|13031584|P12|NOT COMPLETED|Overall Study||0
5301067|NCT00535743|13031585|P11|NOT COMPLETED|Overall Study||0
5301068|NCT00535743|13031586|P10|NOT COMPLETED|Overall Study||1
5301069|NCT00535743|13031587|P9|NOT COMPLETED|Overall Study||1
5301070|NCT00535743|13031588|P8|NOT COMPLETED|Overall Study||0
5301071|NCT00535743|13031589|P7|NOT COMPLETED|Overall Study||0
5301072|NCT00535743|13031590|P6|NOT COMPLETED|Overall Study||0
5301073|NCT00535743|13031591|P5|NOT COMPLETED|Overall Study||0
5301074|NCT00535743|13031592|P4|NOT COMPLETED|Overall Study||0
5301075|NCT00535743|13031593|P3|NOT COMPLETED|Overall Study||0
5301076|NCT00535743|13031594|P2|NOT COMPLETED|Overall Study||0
5301077|NCT00535743|13031595|P1|NOT COMPLETED|Overall Study||0
5301078|NCT00535743|13031572|P24|COMPLETED|Overall Study||5
5301079|NCT00535743|13031573|P23|COMPLETED|Overall Study||6
5301080|NCT00535743|13031574|P22|COMPLETED|Overall Study||4
5301081|NCT00535743|13031575|P21|COMPLETED|Overall Study||5
5301082|NCT00535743|13031576|P20|COMPLETED|Overall Study||5
5301083|NCT00535743|13031577|P19|COMPLETED|Overall Study||3
5301084|NCT00535743|13031578|P18|COMPLETED|Overall Study||11
5301085|NCT00535743|13031579|P17|COMPLETED|Overall Study||10
5301086|NCT00535743|13031580|P16|COMPLETED|Overall Study||13
5301087|NCT00535743|13031581|P15|COMPLETED|Overall Study||9
5301088|NCT00535743|13031582|P14|COMPLETED|Overall Study||10
5301089|NCT00535743|13031583|P13|COMPLETED|Overall Study||5
5301090|NCT00535743|13031584|P12|COMPLETED|Overall Study||5
5301091|NCT00535743|13031585|P11|COMPLETED|Overall Study||5
5301092|NCT00535743|13031586|P10|COMPLETED|Overall Study||4
5301093|NCT00535743|13031587|P9|COMPLETED|Overall Study||4
5301094|NCT00535743|13031588|P8|COMPLETED|Overall Study||5
5301095|NCT00535743|13031589|P7|COMPLETED|Overall Study||3
5301096|NCT00535743|13031590|P6|COMPLETED|Overall Study||10
5301097|NCT00535743|13031591|P5|COMPLETED|Overall Study||11
5301098|NCT00535743|13031592|P4|COMPLETED|Overall Study||11
5301099|NCT00535743|13031593|P3|COMPLETED|Overall Study||11
5301100|NCT00535743|13031594|P2|COMPLETED|Overall Study||11
5301101|NCT00535743|13031595|P1|COMPLETED|Overall Study||5
5301102|NCT00535743|13031572|P24|Treated|Overall Study||5
5301103|NCT00535743|13031573|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec’d 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
5301104|NCT00535743|13031574|P22|Treated|Overall Study||5
5301105|NCT00535743|13031575|P21|Treated|Overall Study||5
5301106|NCT00535743|13031576|P20|Treated|Overall Study||5
5301107|NCT00535743|13031577|P19|Treated|Overall Study||3
5301108|NCT00535743|13031578|P18|Treated|Overall Study||11
5301109|NCT00535743|13031579|P17|Treated|Overall Study||10
5301110|NCT00535743|13031580|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec’d 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
5301111|NCT00535743|13031581|P15|Treated|Overall Study||9
5301112|NCT00535743|13031582|P14|Treated|Overall Study||10
5301113|NCT00535743|13031583|P13|Treated|Overall Study||5
5301114|NCT00535743|13031584|P12|Treated|Overall Study||5
5301115|NCT00535743|13031585|P11|Treated|Overall Study||5
5301116|NCT00535743|13031586|P10|Treated|Overall Study||5
5301117|NCT00535743|13031587|P9|Treated|Overall Study||4
5301118|NCT00535743|13031588|P8|Treated|Overall Study||5
5301119|NCT00535743|13031589|P7|Treated|Overall Study||3
5301120|NCT00535743|13031590|P6|Treated|Overall Study||10
5301121|NCT00535743|13031591|P5|Treated|Overall Study||11
5301122|NCT00535743|13031592|P4|Treated|Overall Study||11
5301123|NCT00535743|13031593|P3|Treated|Overall Study||11
5301124|NCT00535743|13031594|P2|Treated|Overall Study||11
5301125|NCT00535743|13031595|P1|Treated|Overall Study||5
5301126|NCT00535743|13031572|P24|STARTED|Overall Study||5
5301127|NCT00535743|13031573|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
5301128|NCT00535743|13031574|P22|STARTED|Overall Study||5
5301129|NCT00535743|13031575|P21|STARTED|Overall Study||5
5301130|NCT00535743|13031576|P20|STARTED|Overall Study||5
5301131|NCT00535743|13031577|P19|STARTED|Overall Study||3
5301132|NCT00535743|13031578|P18|STARTED|Overall Study||11
5301133|NCT00535743|13031579|P17|STARTED|Overall Study||10
5301134|NCT00535743|13031580|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
5301135|NCT00535743|13031581|P15|STARTED|Overall Study||9
5301136|NCT00535743|13031582|P14|STARTED|Overall Study||10
5301137|NCT00535743|13031583|P13|STARTED|Overall Study||5
5301138|NCT00535743|13031584|P12|STARTED|Overall Study||5
5301139|NCT00535743|13031585|P11|STARTED|Overall Study||5
5301140|NCT00535743|13031586|P10|STARTED|Overall Study||5
5301141|NCT00535743|13031587|P9|STARTED|Overall Study||5
5301142|NCT00535743|13031588|P8|STARTED|Overall Study||5
5301143|NCT00535743|13031589|P7|STARTED|Overall Study||3
5301144|NCT00535743|13031590|P6|STARTED|Overall Study||10
5301145|NCT00535743|13031591|P5|STARTED|Overall Study||11
5301146|NCT00535743|13031592|P4|STARTED|Overall Study||11
5301147|NCT00535743|13031593|P3|STARTED|Overall Study||11
5301148|NCT00535743|13031594|P2|STARTED|Overall Study||11
5301149|NCT00535743|13031595|P1|STARTED|Overall Study||5
5301150|NCT00535730|13031719|P2|NOT COMPLETED|Overall Study||7
5301151|NCT00535730|13031720|P1|NOT COMPLETED|Overall Study||2
5301152|NCT00535730|13031719|P2|COMPLETED|Overall Study||230
5301153|NCT00535730|13031720|P1|COMPLETED|Overall Study||234
5301154|NCT00535730|13031719|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
5301155|NCT00535730|13031720|P1|STARTED|Overall Study||236
5301156|NCT00535652|13031737|P1|NOT COMPLETED|Overall Study||3
5301157|NCT00535652|13031737|P1|COMPLETED|Overall Study||20
5301158|NCT00535652|13031737|P1|STARTED|Overall Study||23
5301159|NCT00535626|13031741|P1|NOT COMPLETED|Overall Study||105
5301160|NCT00535626|13031741|P1|COMPLETED|Overall Study||85
5301161|NCT00535626|13031741|P1|STARTED|Overall Study||190
5301162|NCT00535613|13031753|P2|NOT COMPLETED|Overall Study||0
5301163|NCT00535613|13031754|P1|NOT COMPLETED|Overall Study||0
5301164|NCT00535613|13031753|P2|COMPLETED|Overall Study||50
5301165|NCT00535613|13031754|P1|COMPLETED|Overall Study||49
5301166|NCT00535613|13031753|P2|STARTED|Overall Study||50
5301167|NCT00535613|13031754|P1|STARTED|Overall Study||49
5301168|NCT00535587|13031768|P4|NOT COMPLETED|Overall Study||13
5301169|NCT00535587|13031769|P3|NOT COMPLETED|Overall Study||8
5301170|NCT00535587|13031770|P2|NOT COMPLETED|Overall Study||11
5301171|NCT00535587|13031771|P1|NOT COMPLETED|Overall Study||10
5301172|NCT00535587|13031768|P4|COMPLETED|Overall Study||41
5301173|NCT00535587|13031769|P3|COMPLETED|Overall Study||39
5301174|NCT00535587|13031770|P2|COMPLETED|Overall Study||42
5301175|NCT00535587|13031771|P1|COMPLETED|Overall Study||43
5301176|NCT00535587|13031768|P4|STARTED|Overall Study||54
5301177|NCT00535587|13031769|P3|STARTED|Overall Study||47
5301178|NCT00535587|13031770|P2|STARTED|Overall Study||53
5301179|NCT00535587|13031771|P1|STARTED|Overall Study||53
5301180|NCT00535496|13031781|P4|NOT COMPLETED|Overall Study||0
5301181|NCT00535496|13031782|P3|NOT COMPLETED|Overall Study||0
5301182|NCT00535496|13031783|P2|NOT COMPLETED|Overall Study||2
5301183|NCT00535496|13031784|P1|NOT COMPLETED|Overall Study||0
5301184|NCT00535496|13031781|P4|COMPLETED|Overall Study||31
5301185|NCT00535496|13031782|P3|COMPLETED|Overall Study||30
5301186|NCT00535496|13031783|P2|COMPLETED|Overall Study||13
5301187|NCT00535496|13031784|P1|COMPLETED|Overall Study||15
5301188|NCT00535496|13031781|P4|All-Subjects-Treated (AST) Group|Overall Study||31
5301189|NCT00535496|13031782|P3|All-Subjects-Treated (AST) Group|Overall Study||30
5301190|NCT00535496|13031783|P2|All-Subjects-Treated (AST) Group|Overall Study||14
5301191|NCT00535496|13031784|P1|All-Subjects-Treated (AST) Group|Overall Study||15
5301192|NCT00535496|13031781|P4|STARTED|Overall Study||31
5301193|NCT00535496|13031782|P3|STARTED|Overall Study||30
5301194|NCT00535496|13031783|P2|STARTED|Overall Study||15
5301195|NCT00535496|13031784|P1|STARTED|Overall Study||15
5301196|NCT00535405|13031804|P5|NOT COMPLETED|Overall Study||16
5301197|NCT00535405|13031805|P4|NOT COMPLETED|Overall Study||22
5301198|NCT00535405|13031806|P3|NOT COMPLETED|Overall Study||18
5301199|NCT00535405|13031807|P2|NOT COMPLETED|Overall Study||26
5301200|NCT00535405|13031808|P1|NOT COMPLETED|Overall Study||17
5301201|NCT00535405|13031804|P5|COMPLETED|Overall Study||241
5301202|NCT00535405|13031805|P4|COMPLETED|Overall Study||235
5301203|NCT00535405|13031806|P3|COMPLETED|Overall Study||241
5301204|NCT00535405|13031807|P2|COMPLETED|Overall Study||233
5301205|NCT00535405|13031808|P1|COMPLETED|Overall Study||240
5301206|NCT00535405|13031804|P5|STARTED|Overall Study||257
5301207|NCT00535405|13031805|P4|STARTED|Overall Study||257
5301208|NCT00535405|13031806|P3|STARTED|Overall Study||259
5301209|NCT00535405|13031807|P2|STARTED|Overall Study||259
5301210|NCT00535405|13031808|P1|STARTED|Overall Study||257
5301211|NCT00535392|13031845|P1|NOT COMPLETED|Overall Study||0
5301212|NCT00535392|13031845|P1|COMPLETED|Overall Study||33
5301213|NCT00535392|13031845|P1|STARTED|Overall Study||33
5301214|NCT00535301|13031853|P2|NOT COMPLETED|Overall Study||5
5301215|NCT00535301|13031854|P1|NOT COMPLETED|Overall Study||5
5301216|NCT00535301|13031853|P2|COMPLETED|Overall Study||33
5301217|NCT00535301|13031854|P1|COMPLETED|Overall Study||33
5301218|NCT00535301|13031853|P2|STARTED|Overall Study||38
5301219|NCT00535301|13031854|P1|STARTED|Overall Study||38
5301220|NCT00535288|13031869|P5|NOT COMPLETED|Overall Study||42
5301221|NCT00535288|13031870|P4|NOT COMPLETED|Overall Study||29
5301222|NCT00535288|13031871|P3|NOT COMPLETED|Overall Study||33
5301223|NCT00535288|13031872|P2|NOT COMPLETED|Overall Study||32
5301224|NCT00535288|13031873|P1|NOT COMPLETED|Overall Study||54
5301225|NCT00535288|13031869|P5|COMPLETED|Overall Study||116
5301226|NCT00535288|13031870|P4|COMPLETED|Overall Study||122
5301227|NCT00535288|13031871|P3|COMPLETED|Overall Study||127
5301228|NCT00535288|13031872|P2|COMPLETED|Overall Study||130
5301229|NCT00535288|13031873|P1|COMPLETED|Overall Study||260
5301230|NCT00535288|13031869|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
5301231|NCT00535288|13031870|P4|STARTED|Overall Study||151
5301232|NCT00535288|13031871|P3|STARTED|Overall Study||160
5301233|NCT00535288|13031872|P2|STARTED|Overall Study||162
5301234|NCT00535288|13031873|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
5301235|NCT00535262|13031950|P1|NOT COMPLETED|Overall Study||3
5301236|NCT00535262|13031950|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
5301237|NCT00535262|13031950|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
5301238|NCT00535236|13031964|P10|NOT COMPLETED|Overall Study||4
5301239|NCT00535236|13031965|P9|NOT COMPLETED|Overall Study||13
5301240|NCT00535236|13031966|P8|NOT COMPLETED|Overall Study||1
5301241|NCT00535236|13031967|P7|NOT COMPLETED|Overall Study||11
5301242|NCT00535236|13031968|P6|NOT COMPLETED|Overall Study||1
5301243|NCT00535236|13031969|P5|NOT COMPLETED|Overall Study||12
5301244|NCT00535236|13031970|P4|NOT COMPLETED|Overall Study||4
5301245|NCT00535236|13031971|P3|NOT COMPLETED|Overall Study||12
5301246|NCT00535236|13031972|P2|NOT COMPLETED|Overall Study||2
5301247|NCT00535236|13031973|P1|NOT COMPLETED|Overall Study||7
5301248|NCT00535236|13031964|P10|COMPLETED|Overall Study||16
5301249|NCT00535236|13031965|P9|COMPLETED|Overall Study||47
5301250|NCT00535236|13031966|P8|COMPLETED|Overall Study||18
5301251|NCT00535236|13031967|P7|COMPLETED|Overall Study||51
5301252|NCT00535236|13031968|P6|COMPLETED|Overall Study||19
5301253|NCT00535236|13031969|P5|COMPLETED|Overall Study||47
5301254|NCT00535236|13031970|P4|COMPLETED|Overall Study||6
5301255|NCT00535236|13031971|P3|COMPLETED|Overall Study||29
5301256|NCT00535236|13031972|P2|COMPLETED|Overall Study||8
5301257|NCT00535236|13031973|P1|COMPLETED|Overall Study||33
5301258|NCT00535236|13031964|P10|Vaccination 4|Overall Study||17
5301259|NCT00535236|13031965|P9|Vaccination 4|Overall Study||50
5301260|NCT00535236|13031966|P8|Vaccination 4|Overall Study||18
5301261|NCT00535236|13031967|P7|Vaccination 4|Overall Study||51
5301262|NCT00535236|13031968|P6|Vaccination 4|Overall Study||19
5301263|NCT00535236|13031969|P5|Vaccination 4|Overall Study||47
5301264|NCT00535236|13031970|P4|Vaccination 4|Overall Study||6
5301265|NCT00535236|13031971|P3|Vaccination 4|Overall Study||32
5301266|NCT00535236|13031972|P2|Vaccination 4|Overall Study||10
5301267|NCT00535236|13031973|P1|Vaccination 4|Overall Study||34
5301268|NCT00535236|13031964|P10|Vaccination 3|Overall Study||18
5301269|NCT00535236|13031965|P9|Vaccination 3|Overall Study||53
5301270|NCT00535236|13031966|P8|Vaccination 3|Overall Study||18
5301271|NCT00535236|13031967|P7|Vaccination 3|Overall Study||51
5301272|NCT00535236|13031968|P6|Vaccination 3|Overall Study||19
5301273|NCT00535236|13031969|P5|Vaccination 3|Overall Study||48
5301274|NCT00535236|13031970|P4|Vaccination 3|Overall Study||8
5301275|NCT00535236|13031971|P3|Vaccination 3|Overall Study||35
5301276|NCT00535236|13031972|P2|Vaccination 3|Overall Study||10
5301277|NCT00535236|13031973|P1|Vaccination 3|Overall Study||34
5301278|NCT00535236|13031964|P10|Vaccination 2|Overall Study||19
5301279|NCT00535236|13031965|P9|Vaccination 2|Overall Study||57
5301280|NCT00535236|13031966|P8|Vaccination 2|Overall Study||19
5301281|NCT00535236|13031967|P7|Vaccination 2|Overall Study||58
5301282|NCT00535236|13031968|P6|Vaccination 2|Overall Study||19
5301283|NCT00535236|13031969|P5|Vaccination 2|Overall Study||52
5301284|NCT00535236|13031970|P4|Vaccination 2|Overall Study||8
5301285|NCT00535236|13031971|P3|Vaccination 2|Overall Study||37
5301286|NCT00535236|13031972|P2|Vaccination 2|Overall Study||10
5301287|NCT00535236|13031973|P1|Vaccination 2|Overall Study||35
5301288|NCT00535236|13031964|P10|Vaccination 1|Overall Study||20
5301289|NCT00535236|13031965|P9|Vaccination 1|Overall Study||60
5301290|NCT00535236|13031966|P8|Vaccination 1|Overall Study||19
5301291|NCT00535236|13031967|P7|Vaccination 1|Overall Study||61
5301292|NCT00535236|13031968|P6|Vaccination 1|Overall Study||19
5301293|NCT00535236|13031969|P5|Vaccination 1|Overall Study||58
5301294|NCT00535236|13031970|P4|Vaccination 1|Overall Study||10
5301295|NCT00535236|13031971|P3|Vaccination 1|Overall Study||40
5301296|NCT00535236|13031972|P2|Vaccination 1|Overall Study||10
5301297|NCT00535236|13031973|P1|Vaccination 1|Overall Study||40
5301298|NCT00535236|13031964|P10|STARTED|Overall Study||20
5301299|NCT00535236|13031965|P9|STARTED|Overall Study||60
5301300|NCT00535236|13031966|P8|STARTED|Overall Study||19
5301301|NCT00535236|13031967|P7|STARTED|Overall Study||62
5301302|NCT00535236|13031968|P6|STARTED|Overall Study||20
5301303|NCT00535236|13031969|P5|STARTED|Overall Study||59
5301304|NCT00535236|13031970|P4|STARTED|Overall Study||10
5301305|NCT00535236|13031971|P3|STARTED|Overall Study||41
5301306|NCT00535236|13031972|P2|STARTED|Overall Study||10
5301307|NCT00535236|13031973|P1|STARTED|Overall Study||40
5301308|NCT00535223|13032033|P2|NOT COMPLETED|Overall Study||1
5301309|NCT00535223|13032034|P1|NOT COMPLETED|Overall Study||4
5301310|NCT00535223|13032033|P2|COMPLETED|Overall Study||39
5301311|NCT00535223|13032034|P1|COMPLETED|Overall Study||37
5301312|NCT00535223|13032033|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
5301313|NCT00535223|13032034|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
5301314|NCT00535145|13032042|P1|NOT COMPLETED|Phase II||15
5301315|NCT00535145|13032042|P1|COMPLETED|Phase II||69
5301316|NCT00535145|13032042|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
5301317|NCT00535145|13032042|P1|NOT COMPLETED|Phase I||29
5301318|NCT00535145|13032042|P1|COMPLETED|Phase I||85
5301319|NCT00535145|13032042|P1|STARTED|Phase I||114
5301320|NCT00535132|13032054|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
5301321|NCT00535132|13032055|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
5301322|NCT00535132|13032054|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
5301323|NCT00535132|13032055|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
5301324|NCT00535132|13032054|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
5301325|NCT00535132|13032055|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
5301326|NCT00535132|13032054|P2|NOT COMPLETED|Safety Analysis Set||2
5301327|NCT00535132|13032055|P1|NOT COMPLETED|Safety Analysis Set||2
5301328|NCT00535132|13032054|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
5301329|NCT00535132|13032055|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
5301330|NCT00535132|13032054|P2|STARTED|Safety Analysis Set||101
5301331|NCT00535132|13032055|P1|STARTED|Safety Analysis Set||100
5301332|NCT00535132|13032054|P2|NOT COMPLETED|Randomized Population||0
5301333|NCT00535132|13032055|P1|NOT COMPLETED|Randomized Population||0
5301334|NCT00535132|13032054|P2|COMPLETED|Randomized Population||101
5301335|NCT00535132|13032055|P1|COMPLETED|Randomized Population||100
5301336|NCT00535132|13032054|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
5301337|NCT00535132|13032055|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
5301338|NCT00535002|13032113|P8|NOT COMPLETED|Overall Study||0
5301339|NCT00535002|13032114|P7|NOT COMPLETED|Overall Study||0
5301340|NCT00535002|13032115|P6|NOT COMPLETED|Overall Study||0
5301341|NCT00535002|13032116|P5|NOT COMPLETED|Overall Study||0
5301342|NCT00535002|13032117|P4|NOT COMPLETED|Overall Study||0
5301343|NCT00535002|13032118|P3|NOT COMPLETED|Overall Study||0
5301344|NCT00535002|13032119|P2|NOT COMPLETED|Overall Study||0
5301345|NCT00535002|13032120|P1|NOT COMPLETED|Overall Study||0
5301346|NCT00535002|13032113|P8|COMPLETED|Overall Study||16
5301347|NCT00535002|13032114|P7|COMPLETED|Overall Study||12
5301348|NCT00535002|13032115|P6|COMPLETED|Overall Study||17
5301349|NCT00535002|13032116|P5|COMPLETED|Overall Study||9
5301350|NCT00535002|13032117|P4|COMPLETED|Overall Study||14
5301351|NCT00535002|13032118|P3|COMPLETED|Overall Study||13
5301352|NCT00535002|13032119|P2|COMPLETED|Overall Study||12
5301353|NCT00535002|13032120|P1|COMPLETED|Overall Study||19
5301354|NCT00535002|13032113|P8|STARTED|Overall Study||16
5301355|NCT00535002|13032114|P7|STARTED|Overall Study||12
5301356|NCT00535002|13032115|P6|STARTED|Overall Study||17
5301357|NCT00535002|13032116|P5|STARTED|Overall Study||9
5301358|NCT00535002|13032117|P4|STARTED|Overall Study||14
5301359|NCT00535002|13032118|P3|STARTED|Overall Study||13
5301360|NCT00535002|13032119|P2|STARTED|Overall Study||12
5301361|NCT00535002|13032120|P1|STARTED|Overall Study||19
5301362|NCT00534976|13032136|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
5301363|NCT00534976|13032137|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
5301364|NCT00534976|13032136|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
5301365|NCT00534976|13032137|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
5301366|NCT00534976|13032136|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
5301367|NCT00534976|13032137|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
5301368|NCT00534976|13032136|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
5301369|NCT00534976|13032137|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
5301370|NCT00534976|13032136|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
5301371|NCT00534976|13032137|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
5301372|NCT00534976|13032136|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
5301373|NCT00534976|13032137|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
5301374|NCT00534976|13032136|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
5301375|NCT00534976|13032137|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
5301376|NCT00534976|13032136|P2|COMPLETED|Period 1: Placebo Run-in||33
5301377|NCT00534976|13032137|P1|COMPLETED|Period 1: Placebo Run-in||33
5301378|NCT00534976|13032136|P2|STARTED|Period 1: Placebo Run-in||33
5301379|NCT00534976|13032137|P1|STARTED|Period 1: Placebo Run-in||33
5301380|NCT00534937|13032159|P2|NOT COMPLETED|Overall Study||12
5301381|NCT00534937|13032160|P1|NOT COMPLETED|Overall Study||8
5301382|NCT00534937|13032159|P2|COMPLETED|Overall Study||35
5301383|NCT00534937|13032160|P1|COMPLETED|Overall Study||34
5301384|NCT00534937|13032159|P2|STARTED|Overall Study||47
5301385|NCT00534937|13032160|P1|STARTED|Overall Study||42
5301386|NCT00534833|13032174|P2|NOT COMPLETED|Overall Study||0
5301387|NCT00534833|13032175|P1|NOT COMPLETED|Overall Study||0
5301388|NCT00534833|13032174|P2|COMPLETED|Overall Study||180
5301389|NCT00534833|13032175|P1|COMPLETED|Overall Study||182
5301390|NCT00534833|13032174|P2|STARTED|Overall Study||180
5301391|NCT00534833|13032175|P1|STARTED|Overall Study||182
5301392|NCT00534794|13032187|P2|NOT COMPLETED|Overall Study||0
5301393|NCT00534794|13032188|P1|NOT COMPLETED|Overall Study||0
5301394|NCT00534794|13032187|P2|COMPLETED|Overall Study||39
5301395|NCT00534794|13032188|P1|COMPLETED|Overall Study||40
5301396|NCT00534794|13032187|P2|STARTED|Overall Study||39
5301397|NCT00534794|13032188|P1|STARTED|Overall Study||40
5301398|NCT00534703|13032198|P2|NOT COMPLETED|Overall Study||0
5301399|NCT00534703|13032199|P1|NOT COMPLETED|Overall Study||0
5301400|NCT00534703|13032198|P2|COMPLETED|Overall Study||1
5301401|NCT00534703|13032199|P1|COMPLETED|Overall Study||4
5301402|NCT00534703|13032198|P2|STARTED|Overall Study||1
5301403|NCT00534703|13032199|P1|STARTED|Overall Study||4
5301404|NCT00534638|13032217|P2|NOT COMPLETED|Overall Study||11791
5301405|NCT00534638|13032218|P1|NOT COMPLETED|Overall Study||6491
5301406|NCT00534638|13032217|P2|COMPLETED|Overall Study||5547
5301407|NCT00534638|13032218|P1|COMPLETED|Overall Study||8346
5301408|NCT00534638|13032217|P2|STARTED|Overall Study||17338
5301409|NCT00534638|13032218|P1|STARTED|Overall Study||14837
5301410|NCT00534599|13032256|P2|NOT COMPLETED|Overall Study||32
5301411|NCT00534599|13032257|P1|NOT COMPLETED|Overall Study||57
5301412|NCT00534599|13032256|P2|COMPLETED|Overall Study||168
5301413|NCT00534599|13032257|P1|COMPLETED|Overall Study||152
5301414|NCT00534599|13032256|P2|STARTED|Overall Study|Randomized|200
5301415|NCT00534599|13032257|P1|STARTED|Overall Study|Randomized|209
5301416|NCT00534495|13032293|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
5301417|NCT00534495|13032294|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
5301418|NCT00534495|13032295|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
5301419|NCT00534495|13032293|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
5301420|NCT00534495|13032294|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
5301421|NCT00534495|13032295|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
5301422|NCT00534495|13032293|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
5301423|NCT00534495|13032294|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
5301424|NCT00534495|13032295|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
5301425|NCT00534495|13032293|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
5301426|NCT00534495|13032294|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
5301427|NCT00534495|13032295|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
5301428|NCT00534495|13032293|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
5301429|NCT00534495|13032294|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
5301430|NCT00534495|13032295|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
5301431|NCT00534495|13032293|P3|STARTED|All Active Treatment Phase Week 4-24||0
5301432|NCT00534495|13032294|P2|STARTED|All Active Treatment Phase Week 4-24||34
5301433|NCT00534495|13032295|P1|STARTED|All Active Treatment Phase Week 4-24||36
5301434|NCT00534495|13032293|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
5301435|NCT00534495|13032294|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
5301436|NCT00534495|13032295|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
5301437|NCT00534495|13032293|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
5301438|NCT00534495|13032294|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
5301439|NCT00534495|13032295|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
5301440|NCT00534495|13032293|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
5301441|NCT00534495|13032294|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
5301442|NCT00534495|13032295|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
5301443|NCT00534417|13032318|P1|NOT COMPLETED|Overall Study||0
5301444|NCT00534417|13032318|P1|COMPLETED|Overall Study||41
5301445|NCT00534417|13032318|P1|STARTED|Overall Study||41
5301446|NCT00534404|13032333|P3|NOT COMPLETED|Overall Study||242
5301447|NCT00534404|13032334|P2|NOT COMPLETED|Overall Study||143
5301448|NCT00534404|13032335|P1|NOT COMPLETED|Overall Study||180
5301449|NCT00534404|13032333|P3|COMPLETED|Overall Study||586
5301450|NCT00534404|13032334|P2|COMPLETED|Overall Study||687
5301451|NCT00534404|13032335|P1|COMPLETED|Overall Study||647
5301452|NCT00534404|13032333|P3|3-month Follow up Completed|Overall Study||593
5301453|NCT00534404|13032334|P2|3-month Follow up Completed|Overall Study||731
5301454|NCT00534404|13032335|P1|3-month Follow up Completed|Overall Study||682
5301455|NCT00534404|13032333|P3|1-month Follow up Completed|Overall Study||626
5301456|NCT00534404|13032334|P2|1-month Follow up Completed|Overall Study||781
5301457|NCT00534404|13032335|P1|1-month Follow up Completed|Overall Study||742
5301458|NCT00534404|13032333|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
5301459|NCT00534404|13032334|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
5301460|NCT00534404|13032335|P1|Completed at Least 1 Counseling Call|Overall Study||813
5301461|NCT00534404|13032333|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
5301462|NCT00534404|13032334|P2|Completed Second NRT Order|Overall Study||789
5301463|NCT00534404|13032335|P1|Completed Second NRT Order|Overall Study||640
5301464|NCT00534404|13032333|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
5301465|NCT00534404|13032334|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
5301466|NCT00534404|13032335|P1|Completed First NRT Order|Overall Study||765
5301467|NCT00534404|13032333|P3|Completed at Least 1 Online Session|Overall Study||658
5301468|NCT00534404|13032334|P2|Completed at Least 1 Online Session|Overall Study||813
5301469|NCT00534404|13032335|P1|Completed at Least 1 Online Session|Overall Study||781
5301470|NCT00534404|13032333|P3|STARTED|Overall Study||828
5301471|NCT00534404|13032334|P2|STARTED|Overall Study||830
5301472|NCT00534404|13032335|P1|STARTED|Overall Study||827
5301473|NCT00534365|13032351|P2|NOT COMPLETED|Overall Study||7
5301474|NCT00534365|13032352|P1|NOT COMPLETED|Overall Study||0
5301475|NCT00534365|13032351|P2|COMPLETED|Overall Study||129
5301476|NCT00534365|13032352|P1|COMPLETED|Overall Study||127
5301477|NCT00534365|13032351|P2|Included in Intent to Treat Analysis|Overall Study||136
5301478|NCT00534365|13032352|P1|Included in Intent to Treat Analysis|Overall Study||127
5301479|NCT00534365|13032351|P2|Follow up at 12 Months or More|Overall Study||128
5301480|NCT00534365|13032352|P1|Follow up at 12 Months or More|Overall Study||119
5301481|NCT00534365|13032351|P2|Any Follow up|Overall Study||135
5301482|NCT00534365|13032352|P1|Any Follow up|Overall Study||126
5301483|NCT00534365|13032351|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
5301484|NCT00534365|13032352|P1|Received Procedure|Overall Study||127
5301485|NCT00534365|13032351|P2|STARTED|Overall Study||136
5301486|NCT00534365|13032352|P1|STARTED|Overall Study||127
5301487|NCT00534352|13032366|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
5301488|NCT00534352|13032366|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
5301489|NCT00534352|13032366|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
5301490|NCT00534352|13032366|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
5301491|NCT00534352|13032366|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
5301492|NCT00534352|13032366|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
5301493|NCT00534352|13032366|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
5301494|NCT00534352|13032366|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
5301495|NCT00534352|13032366|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
5301496|NCT00534352|13032366|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
5301497|NCT00534352|13032366|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
5301498|NCT00534352|13032366|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
5301499|NCT00534313|13032410|P4|NOT COMPLETED|Long-term Period||33
5301500|NCT00534313|13032411|P3|NOT COMPLETED|Long-term Period||43
5301501|NCT00534313|13032412|P2|NOT COMPLETED|Long-term Period||34
5301502|NCT00534313|13032413|P1|NOT COMPLETED|Long-term Period||37
5301503|NCT00534313|13032410|P4|COMPLETED|Long-term Period||0
5301504|NCT00534313|13032411|P3|COMPLETED|Long-term Period||0
5301505|NCT00534313|13032412|P2|COMPLETED|Long-term Period||0
5301506|NCT00534313|13032413|P1|COMPLETED|Long-term Period||0
5301507|NCT00534313|13032410|P4|STARTED|Long-term Period||33
5301508|NCT00534313|13032411|P3|STARTED|Long-term Period||43
5301509|NCT00534313|13032412|P2|STARTED|Long-term Period||34
5301510|NCT00534313|13032413|P1|STARTED|Long-term Period||37
5301511|NCT00534313|13032410|P4|NOT COMPLETED|Short-term Period||9
5301512|NCT00534313|13032411|P3|NOT COMPLETED|Short-term Period||2
5301513|NCT00534313|13032412|P2|NOT COMPLETED|Short-term Period||6
5301514|NCT00534313|13032413|P1|NOT COMPLETED|Short-term Period||6
5301515|NCT00534313|13032410|P4|COMPLETED|Short-term Period|Completed the short-term study|33
5301516|NCT00534313|13032411|P3|COMPLETED|Short-term Period|Completed the short-term study|43
5301517|NCT00534313|13032412|P2|COMPLETED|Short-term Period|Completed the short-term study|34
5301518|NCT00534313|13032413|P1|COMPLETED|Short-term Period|Completed the short-term study|37
5301519|NCT00534313|13032410|P4|STARTED|Short-term Period||42
5301520|NCT00534313|13032411|P3|STARTED|Short-term Period||45
5301521|NCT00534313|13032412|P2|STARTED|Short-term Period||40
5301522|NCT00534313|13032413|P1|STARTED|Short-term Period||43
5301523|NCT00534248|13032508|P2|NOT COMPLETED|Overall Study||673
5301524|NCT00534248|13032509|P1|NOT COMPLETED|Overall Study||661
5301525|NCT00534248|13032508|P2|COMPLETED|Overall Study||10555
5301526|NCT00534248|13032509|P1|COMPLETED|Overall Study||10550
5301527|NCT00534248|13032508|P2|VACCINATED|Overall Study||11210
5301528|NCT00534248|13032509|P1|VACCINATED|Overall Study||11186
5301529|NCT00534248|13032508|P2|STARTED|Overall Study||11228
5301530|NCT00534248|13032509|P1|STARTED|Overall Study||11211
5301531|NCT00534235|13032521|P2|NOT COMPLETED|Overall Study||23
5301532|NCT00534235|13032522|P1|NOT COMPLETED|Overall Study||16
5301533|NCT00534235|13032521|P2|COMPLETED|Overall Study||192
5301534|NCT00534235|13032522|P1|COMPLETED|Overall Study||91
5301535|NCT00534235|13032521|P2|STARTED|Overall Study||215
5301536|NCT00534235|13032522|P1|STARTED|Overall Study||107
5301537|NCT00534209|13032646|P1|NOT COMPLETED|Overall Study||0
5301538|NCT00534209|13032646|P1|COMPLETED|Overall Study||1
5301539|NCT00534209|13032646|P1|STARTED|Overall Study||1
5301540|NCT00534105|13032666|P2|NOT COMPLETED|Overall Study||39
5301541|NCT00534105|13032667|P1|NOT COMPLETED|Overall Study||23
5301542|NCT00534105|13032666|P2|COMPLETED|Overall Study||20
5301543|NCT00534105|13032667|P1|COMPLETED|Overall Study||24
5301544|NCT00534105|13032666|P2|STARTED|Overall Study||59
5301545|NCT00534105|13032667|P1|STARTED|Overall Study||47
5301546|NCT00534092|13032681|P2|NOT COMPLETED|Overall Study||0
5301547|NCT00534092|13032682|P1|NOT COMPLETED|Overall Study||2
5301548|NCT00534092|13032681|P2|COMPLETED|Overall Study||14
5301549|NCT00534092|13032682|P1|COMPLETED|Overall Study||53
5301550|NCT00534092|13032681|P2|STARTED|Overall Study||14
5301551|NCT00534092|13032682|P1|STARTED|Overall Study||55
5301552|NCT00534001|13032707|P2|NOT COMPLETED|Overall Study||4
5301553|NCT00534001|13032708|P1|NOT COMPLETED|Overall Study||5
5301554|NCT00534001|13032707|P2|COMPLETED|Overall Study||43
5301555|NCT00534001|13032708|P1|COMPLETED|Overall Study||43
5301556|NCT00534001|13032707|P2|STARTED|Overall Study||47
5301557|NCT00534001|13032708|P1|STARTED|Overall Study||48
5301558|NCT00533949|13032720|P4|NOT COMPLETED|Overall Study||10
5301559|NCT00533949|13032721|P3|NOT COMPLETED|Overall Study||10
5301560|NCT00533949|13032722|P2|NOT COMPLETED|Overall Study||14
5301561|NCT00533949|13032723|P1|NOT COMPLETED|Overall Study||15
5301562|NCT00533949|13032720|P4|COMPLETED|Overall Study||100
5301563|NCT00533949|13032721|P3|COMPLETED|Overall Study||137
5301564|NCT00533949|13032722|P2|COMPLETED|Overall Study||107
5301565|NCT00533949|13032723|P1|COMPLETED|Overall Study||151
5301566|NCT00533949|13032720|P4|STARTED|Overall Study||110
5301567|NCT00533949|13032721|P3|STARTED|Overall Study||147
5301568|NCT00533949|13032722|P2|STARTED|Overall Study||121
5301569|NCT00533949|13032723|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
5301570|NCT00533897|13032764|P8|NOT COMPLETED|Long Term Extension (LTE)||25
5301571|NCT00533897|13032765|P7|NOT COMPLETED|Long Term Extension (LTE)||13
5301572|NCT00533897|13032766|P6|NOT COMPLETED|Long Term Extension (LTE)||0
5301573|NCT00533897|13032767|P5|NOT COMPLETED|Long Term Extension (LTE)||0
5301574|NCT00533897|13032768|P4|NOT COMPLETED|Long Term Extension (LTE)||0
5301575|NCT00533897|13032769|P3|NOT COMPLETED|Long Term Extension (LTE)||0
5301576|NCT00533897|13032770|P2|NOT COMPLETED|Long Term Extension (LTE)||0
5301577|NCT00533897|13032771|P1|NOT COMPLETED|Long Term Extension (LTE)||0
5301578|NCT00533897|13032764|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
5301579|NCT00533897|13032765|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
5301580|NCT00533897|13032766|P6|COMPLETED|Long Term Extension (LTE)||0
5301581|NCT00533897|13032767|P5|COMPLETED|Long Term Extension (LTE)||0
5301582|NCT00533897|13032768|P4|COMPLETED|Long Term Extension (LTE)||0
5301583|NCT00533897|13032769|P3|COMPLETED|Long Term Extension (LTE)||0
5301584|NCT00533897|13032770|P2|COMPLETED|Long Term Extension (LTE)||0
5301585|NCT00533897|13032771|P1|COMPLETED|Long Term Extension (LTE)||0
5301586|NCT00533897|13032764|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
5301587|NCT00533897|13032765|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
5301588|NCT00533897|13032766|P6|STARTED|Long Term Extension (LTE)||0
5301589|NCT00533897|13032767|P5|STARTED|Long Term Extension (LTE)||0
5301590|NCT00533897|13032768|P4|STARTED|Long Term Extension (LTE)||0
5301591|NCT00533897|13032769|P3|STARTED|Long Term Extension (LTE)||0
5301592|NCT00533897|13032770|P2|STARTED|Long Term Extension (LTE)||0
5301593|NCT00533897|13032771|P1|STARTED|Long Term Extension (LTE)||0
5301594|NCT00533897|13032764|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301595|NCT00533897|13032765|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301596|NCT00533897|13032766|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
5301597|NCT00533897|13032767|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301598|NCT00533897|13032768|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301599|NCT00533897|13032769|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301600|NCT00533897|13032770|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301601|NCT00533897|13032771|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
5301602|NCT00533897|13032764|P8|COMPLETED|Re-introduction (RI) Period 3||0
5301603|NCT00533897|13032765|P7|COMPLETED|Re-introduction (RI) Period 3||0
5301604|NCT00533897|13032766|P6|COMPLETED|Re-introduction (RI) Period 3||42
5301605|NCT00533897|13032767|P5|COMPLETED|Re-introduction (RI) Period 3||35
5301606|NCT00533897|13032768|P4|COMPLETED|Re-introduction (RI) Period 3||40
5301607|NCT00533897|13032769|P3|COMPLETED|Re-introduction (RI) Period 3||0
5301608|NCT00533897|13032770|P2|COMPLETED|Re-introduction (RI) Period 3||0
5301609|NCT00533897|13032771|P1|COMPLETED|Re-introduction (RI) Period 3||0
5301610|NCT00533897|13032764|P8|STARTED|Re-introduction (RI) Period 3||0
5301611|NCT00533897|13032765|P7|STARTED|Re-introduction (RI) Period 3||0
5301612|NCT00533897|13032766|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
5301613|NCT00533897|13032767|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
5301614|NCT00533897|13032768|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
5301615|NCT00533897|13032769|P3|STARTED|Re-introduction (RI) Period 3||0
5301616|NCT00533897|13032770|P2|STARTED|Re-introduction (RI) Period 3||0
5301617|NCT00533897|13032771|P1|STARTED|Re-introduction (RI) Period 3||0
5301618|NCT00533897|13032764|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301619|NCT00533897|13032765|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301620|NCT00533897|13032766|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301621|NCT00533897|13032767|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301622|NCT00533897|13032768|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301623|NCT00533897|13032769|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
5301624|NCT00533897|13032770|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
5301625|NCT00533897|13032771|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301626|NCT00533897|13032764|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301627|NCT00533897|13032765|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301628|NCT00533897|13032766|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301629|NCT00533897|13032767|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301630|NCT00533897|13032768|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301631|NCT00533897|13032769|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
5301632|NCT00533897|13032770|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
5301633|NCT00533897|13032771|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
5301634|NCT00533897|13032764|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301635|NCT00533897|13032765|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301636|NCT00533897|13032766|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301637|NCT00533897|13032767|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301638|NCT00533897|13032768|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301639|NCT00533897|13032769|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
5301640|NCT00533897|13032770|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
5301641|NCT00533897|13032771|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
5301642|NCT00533897|13032764|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
5301643|NCT00533897|13032765|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
5301644|NCT00533897|13032766|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
5301645|NCT00533897|13032767|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
5301646|NCT00533897|13032768|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
5301647|NCT00533897|13032769|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
5301648|NCT00533897|13032770|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
5301649|NCT00533897|13032771|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
5301650|NCT00533897|13032764|P8|COMPLETED|Lead-in (LI) Period 1||0
5301651|NCT00533897|13032765|P7|COMPLETED|Lead-in (LI) Period 1||0
5301652|NCT00533897|13032766|P6|COMPLETED|Lead-in (LI) Period 1||0
5301653|NCT00533897|13032767|P5|COMPLETED|Lead-in (LI) Period 1||0
5301654|NCT00533897|13032768|P4|COMPLETED|Lead-in (LI) Period 1||0
5301655|NCT00533897|13032769|P3|COMPLETED|Lead-in (LI) Period 1||0
5301656|NCT00533897|13032770|P2|COMPLETED|Lead-in (LI) Period 1||0
5301657|NCT00533897|13032771|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
5301658|NCT00533897|13032764|P8|STARTED|Lead-in (LI) Period 1||0
5301659|NCT00533897|13032765|P7|STARTED|Lead-in (LI) Period 1||0
5301660|NCT00533897|13032766|P6|STARTED|Lead-in (LI) Period 1||0
5301661|NCT00533897|13032767|P5|STARTED|Lead-in (LI) Period 1||0
5301662|NCT00533897|13032768|P4|STARTED|Lead-in (LI) Period 1||0
5301663|NCT00533897|13032769|P3|STARTED|Lead-in (LI) Period 1||0
5301664|NCT00533897|13032770|P2|STARTED|Lead-in (LI) Period 1||0
5301665|NCT00533897|13032771|P1|STARTED|Lead-in (LI) Period 1||167
5301666|NCT00533845|13032911|P2|NOT COMPLETED|Overall Study||0
5301667|NCT00533845|13032912|P1|NOT COMPLETED|Overall Study||1
5301668|NCT00533845|13032911|P2|COMPLETED|Overall Study||15
5301669|NCT00533845|13032912|P1|COMPLETED|Overall Study||14
5301670|NCT00533845|13032911|P2|STARTED|Overall Study||15
5301671|NCT00533845|13032912|P1|STARTED|Overall Study||15
5301672|NCT00533702|13032920|P2|NOT COMPLETED|Overall Study||2
5301673|NCT00533702|13032921|P1|NOT COMPLETED|Overall Study||5
5301674|NCT00533702|13032920|P2|COMPLETED|Overall Study||50
5301675|NCT00533702|13032921|P1|COMPLETED|Overall Study||49
5301676|NCT00533702|13032920|P2|Received Any Quantity of Study Drug|Overall Study||50
5301677|NCT00533702|13032921|P1|Received Any Quantity of Study Drug|Overall Study||52
5301678|NCT00533702|13032920|P2|STARTED|Overall Study||52
5301679|NCT00533702|13032921|P1|STARTED|Overall Study||54
5301680|NCT00533546|13032945|P1|NOT COMPLETED|Overall Study||0
5301681|NCT00533546|13032945|P1|COMPLETED|Overall Study||12
5301682|NCT00533546|13032945|P1|STARTED|Overall Study||12
5301683|NCT00533507|13032952|P1|NOT COMPLETED|Overall Study||1
5301684|NCT00533507|13032952|P1|COMPLETED|Overall Study||229
5301685|NCT00533507|13032952|P1|STARTED|Overall Study||230
5301686|NCT00533442|13032973|P2|NOT COMPLETED|Follow-up||10
5301687|NCT00533442|13032974|P1|NOT COMPLETED|Follow-up||9
5301688|NCT00533442|13032973|P2|COMPLETED|Follow-up||74
5301689|NCT00533442|13032974|P1|COMPLETED|Follow-up||77
5301690|NCT00533442|13032973|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
5301691|NCT00533442|13032974|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
5301692|NCT00533442|13032973|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
5301693|NCT00533442|13032974|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
5301694|NCT00533442|13032973|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
5301695|NCT00533442|13032974|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
5301696|NCT00533442|13032973|P2|STARTED|Allocation and Intent to Treat Analysis||84
5301697|NCT00533442|13032974|P1|STARTED|Allocation and Intent to Treat Analysis||86
5301698|NCT00533351|13032986|P2|NOT COMPLETED|Period 3||0
5301699|NCT00533351|13032987|P1|NOT COMPLETED|Period 3||0
5301700|NCT00533351|13032986|P2|COMPLETED|Period 3||0
5301701|NCT00533351|13032987|P1|COMPLETED|Period 3||3
5301702|NCT00533351|13032986|P2|STARTED|Period 3|No patients continued to Period 3|0
5301703|NCT00533351|13032987|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
5301704|NCT00533351|13032986|P2|NOT COMPLETED|Period 2||0
5301705|NCT00533351|13032987|P1|NOT COMPLETED|Period 2||0
5301706|NCT00533351|13032986|P2|COMPLETED|Period 2||1
5301707|NCT00533351|13032987|P1|COMPLETED|Period 2||5
5301708|NCT00533351|13032986|P2|STARTED|Period 2||1
5301709|NCT00533351|13032987|P1|STARTED|Period 2||5
5301710|NCT00533351|13032986|P2|NOT COMPLETED|Period 1||1
5301711|NCT00533351|13032987|P1|NOT COMPLETED|Period 1||2
5301712|NCT00533351|13032986|P2|COMPLETED|Period 1||1
5301713|NCT00533351|13032987|P1|COMPLETED|Period 1||5
5301714|NCT00533351|13032986|P2|STARTED|Period 1||2
5301715|NCT00533351|13032987|P1|STARTED|Period 1||7
5301716|NCT00533273|13032997|P2|NOT COMPLETED|Open-label||0
5301717|NCT00533273|13032998|P1|NOT COMPLETED|Open-label||6
5301718|NCT00533273|13032997|P2|COMPLETED|Open-label||0
5301719|NCT00533273|13032998|P1|COMPLETED|Open-label||58
5301720|NCT00533273|13032997|P2|STARTED|Open-label|no placebo - this phase was open label|0
5301721|NCT00533273|13032998|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
5301722|NCT00533273|13032997|P2|NOT COMPLETED|Double-blind||2
5301723|NCT00533273|13032998|P1|NOT COMPLETED|Double-blind||0
5301724|NCT00533273|13032997|P2|COMPLETED|Double-blind||19
5301725|NCT00533273|13032998|P1|COMPLETED|Double-blind||45
5301726|NCT00533273|13032997|P2|STARTED|Double-blind||21
5301727|NCT00533273|13032998|P1|STARTED|Double-blind||45
5301728|NCT00533117|13033033|P4|NOT COMPLETED|Overall Study||5
5301729|NCT00533117|13033034|P3|NOT COMPLETED|Overall Study||6
5301730|NCT00533117|13033035|P2|NOT COMPLETED|Overall Study||5
5301731|NCT00533117|13033036|P1|NOT COMPLETED|Overall Study||4
5301732|NCT00533117|13033033|P4|COMPLETED|Overall Study||13
5301733|NCT00533117|13033034|P3|COMPLETED|Overall Study||14
5301734|NCT00533117|13033035|P2|COMPLETED|Overall Study||14
5301735|NCT00533117|13033036|P1|COMPLETED|Overall Study||14
5301736|NCT00533117|13033033|P4|STARTED|Overall Study||18
5301737|NCT00533117|13033034|P3|STARTED|Overall Study||20
5301738|NCT00533117|13033035|P2|STARTED|Overall Study||19
5301739|NCT00533117|13033036|P1|STARTED|Overall Study||18
5301740|NCT00532948|13033049|P3|NOT COMPLETED|Overall Study||4
5301741|NCT00532948|13033050|P2|NOT COMPLETED|Overall Study||5
5301742|NCT00532948|13033051|P1|NOT COMPLETED|Overall Study||4
5301743|NCT00532948|13033049|P3|COMPLETED|Overall Study||2
5301744|NCT00532948|13033050|P2|COMPLETED|Overall Study||9
5301745|NCT00532948|13033051|P1|COMPLETED|Overall Study||0
5301746|NCT00532948|13033049|P3|STARTED|Overall Study||6
5301747|NCT00532948|13033050|P2|STARTED|Overall Study||14
5301748|NCT00532948|13033051|P1|STARTED|Overall Study||4
5301749|NCT00532935|13033083|P2|NOT COMPLETED|Overall Study||52
5301750|NCT00532935|13033084|P1|NOT COMPLETED|Overall Study||51
5301751|NCT00532935|13033083|P2|COMPLETED|Overall Study||204
5301752|NCT00532935|13033084|P1|COMPLETED|Overall Study||210
5301753|NCT00532935|13033083|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
5301754|NCT00532935|13033084|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
5301755|NCT00532883|13033102|P4|NOT COMPLETED|Overall Study||5
5301756|NCT00532883|13033103|P3|NOT COMPLETED|Overall Study||4
5301757|NCT00532883|13033104|P2|NOT COMPLETED|Overall Study||7
5301758|NCT00532883|13033105|P1|NOT COMPLETED|Overall Study||6
5301759|NCT00532883|13033102|P4|COMPLETED|Overall Study|Study terminated early.|6
5301760|NCT00532883|13033103|P3|COMPLETED|Overall Study|Study terminated early.|6
5301761|NCT00532883|13033104|P2|COMPLETED|Overall Study|Study terminated early.|5
5301762|NCT00532883|13033105|P1|COMPLETED|Overall Study|Study terminated early.|5
5301763|NCT00532883|13033102|P4|STARTED|Overall Study||11
5301764|NCT00532883|13033103|P3|STARTED|Overall Study||10
5301765|NCT00532883|13033104|P2|STARTED|Overall Study||12
5301766|NCT00532883|13033105|P1|STARTED|Overall Study||11
5301767|NCT00532779|13033118|P3|NOT COMPLETED|Overall Study||291
5301768|NCT00532779|13033119|P2|NOT COMPLETED|Overall Study||287
5301769|NCT00532779|13033120|P1|NOT COMPLETED|Overall Study||294
5301770|NCT00532779|13033118|P3|COMPLETED|Overall Study||290
5301771|NCT00532779|13033119|P2|COMPLETED|Overall Study||296
5301772|NCT00532779|13033120|P1|COMPLETED|Overall Study||284
5301773|NCT00532779|13033118|P3|STARTED|Overall Study||581
5301774|NCT00532779|13033119|P2|STARTED|Overall Study||583
5301775|NCT00532779|13033120|P1|STARTED|Overall Study||578
5301776|NCT00532493|13033181|P2|NOT COMPLETED|Overall Study||29
5301777|NCT00532493|13033182|P1|NOT COMPLETED|Overall Study||30
5301778|NCT00532493|13033181|P2|COMPLETED|Overall Study||123
5301779|NCT00532493|13033182|P1|COMPLETED|Overall Study||122
5301780|NCT00532493|13033181|P2|STARTED|Overall Study||152
5301781|NCT00532493|13033182|P1|STARTED|Overall Study||152
5301782|NCT00532480|13033212|P1|NOT COMPLETED|Overall Study||3
5301783|NCT00532480|13033212|P1|COMPLETED|Overall Study||7
5301784|NCT00532480|13033212|P1|STARTED|Overall Study||10
5301785|NCT00532441|13033216|P2|NOT COMPLETED|Overall Study||0
5301786|NCT00532441|13033217|P1|NOT COMPLETED|Overall Study||1
5301787|NCT00532441|13033216|P2|COMPLETED|Overall Study||11
5301788|NCT00532441|13033217|P1|COMPLETED|Overall Study||13
5301789|NCT00532441|13033216|P2|STARTED|Overall Study||11
5301790|NCT00532441|13033217|P1|STARTED|Overall Study||14
5301791|NCT00532298|13033232|P6|NOT COMPLETED|Overall Study||2
5301792|NCT00532298|13033233|P5|NOT COMPLETED|Overall Study||1
5301793|NCT00532298|13033234|P4|NOT COMPLETED|Overall Study||0
5301794|NCT00532298|13033235|P3|NOT COMPLETED|Overall Study||1
5301795|NCT00532298|13033236|P2|NOT COMPLETED|Overall Study||1
5301796|NCT00532298|13033237|P1|NOT COMPLETED|Overall Study||2
5301797|NCT00532298|13033232|P6|COMPLETED|Overall Study||261
5301798|NCT00532298|13033233|P5|COMPLETED|Overall Study||267
5301799|NCT00532298|13033234|P4|COMPLETED|Overall Study||264
5301800|NCT00532298|13033235|P3|COMPLETED|Overall Study||263
5301801|NCT00532298|13033236|P2|COMPLETED|Overall Study||265
5301802|NCT00532298|13033237|P1|COMPLETED|Overall Study||267
5301803|NCT00532298|13033232|P6|STARTED|Overall Study||263
5301804|NCT00532298|13033233|P5|STARTED|Overall Study||268
5301805|NCT00532298|13033234|P4|STARTED|Overall Study||264
5301806|NCT00532298|13033235|P3|STARTED|Overall Study||264
5301807|NCT00532298|13033236|P2|STARTED|Overall Study||266
5301808|NCT00532298|13033237|P1|STARTED|Overall Study||269
5301809|NCT00532259|13033317|P1|NOT COMPLETED|Overall Study||32
5301810|NCT00532259|13033317|P1|COMPLETED|Overall Study||40
5301811|NCT00532259|13033317|P1|STARTED|Overall Study||72
5301812|NCT00532155|13033324|P2|NOT COMPLETED|Overall Study||456
5301813|NCT00532155|13033325|P1|NOT COMPLETED|Overall Study||457
5301814|NCT00532155|13033324|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
5301815|NCT00532155|13033325|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
5301816|NCT00532155|13033324|P2|SAFETY POPULATION|Overall Study||450
5301817|NCT00532155|13033325|P1|SAFETY POPULATION|Overall Study||455
5301818|NCT00532155|13033324|P2|STARTED|Overall Study||456
5301819|NCT00532155|13033325|P1|STARTED|Overall Study||457
5301820|NCT00532129|13033339|P1|NOT COMPLETED|Follow-up Period||65
5301821|NCT00532129|13033339|P1|COMPLETED|Follow-up Period||33
5301822|NCT00532129|13033339|P1|STARTED|Follow-up Period||98
5301823|NCT00532129|13033339|P1|NOT COMPLETED|Treatment Period||49
5301824|NCT00532129|13033339|P1|COMPLETED|Treatment Period||51
5301825|NCT00532129|13033339|P1|STARTED|Treatment Period||100
5301826|NCT00531960|13033359|P2|NOT COMPLETED|Overall Study||63
5301827|NCT00531960|13033360|P1|NOT COMPLETED|Overall Study||61
5301828|NCT00531960|13033359|P2|COMPLETED|Overall Study||0
5301829|NCT00531960|13033360|P1|COMPLETED|Overall Study||0
5301830|NCT00531960|13033359|P2|STARTED|Overall Study||63
5301831|NCT00531960|13033360|P1|STARTED|Overall Study||61
5301832|NCT00531947|13033378|P2|NOT COMPLETED|Overall Study||51
5301833|NCT00531947|13033379|P1|NOT COMPLETED|Overall Study||42
5301834|NCT00531947|13033378|P2|COMPLETED|Overall Study||101
5301835|NCT00531947|13033379|P1|COMPLETED|Overall Study||114
5301836|NCT00531947|13033378|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
5301837|NCT00531947|13033379|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
5301838|NCT00531934|13033423|P2|NOT COMPLETED|Overall Study||63
5301839|NCT00531934|13033424|P1|NOT COMPLETED|Overall Study||66
5301840|NCT00531934|13033423|P2|COMPLETED|Overall Study||11
5301841|NCT00531934|13033424|P1|COMPLETED|Overall Study||7
5301842|NCT00531934|13033423|P2|STARTED|Overall Study||74
5301843|NCT00531934|13033424|P1|STARTED|Overall Study||73
5301844|NCT00531882|13033495|P3|NOT COMPLETED|Overall Study||0
5301845|NCT00531882|13033496|P2|NOT COMPLETED|Overall Study||0
5301846|NCT00531882|13033497|P1|NOT COMPLETED|Overall Study||0
5301847|NCT00531882|13033495|P3|COMPLETED|Overall Study||5
5301848|NCT00531882|13033496|P2|COMPLETED|Overall Study||10
5301849|NCT00531882|13033497|P1|COMPLETED|Overall Study||10
5301850|NCT00531882|13033495|P3|STARTED|Overall Study||5
5301851|NCT00531882|13033496|P2|STARTED|Overall Study||10
5301852|NCT00531882|13033497|P1|STARTED|Overall Study||10
5301853|NCT00531843|13033507|P2|NOT COMPLETED|Overall Study||0
5301854|NCT00531843|13033508|P1|NOT COMPLETED|Overall Study||0
5301855|NCT00531843|13033507|P2|COMPLETED|Overall Study||6
5301856|NCT00531843|13033508|P1|COMPLETED|Overall Study||81
5301857|NCT00531843|13033507|P2|STARTED|Overall Study||6
5301858|NCT00531843|13033508|P1|STARTED|Overall Study||81
5301859|NCT00531817|13033520|P2|NOT COMPLETED|Entered Extended Treatment Period||57
5301860|NCT00531817|13033521|P1|NOT COMPLETED|Entered Extended Treatment Period||137
5301861|NCT00531817|13033520|P2|COMPLETED|Entered Extended Treatment Period||113
5301862|NCT00531817|13033521|P1|COMPLETED|Entered Extended Treatment Period||206
5301863|NCT00531817|13033520|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
5301864|NCT00531817|13033521|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
5301865|NCT00531817|13033520|P2|NOT COMPLETED|Randomized||34
5301866|NCT00531817|13033521|P1|NOT COMPLETED|Randomized||59
5301867|NCT00531817|13033520|P2|COMPLETED|Randomized||173
5301868|NCT00531817|13033521|P1|COMPLETED|Randomized||353
5301869|NCT00531817|13033520|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
5301952|NCT00531284|13033728|P16|NOT COMPLETED|Overall Study||12
5301870|NCT00531817|13033521|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
5301871|NCT00531817|13033520|P2|STARTED|Randomized||207
5301872|NCT00531817|13033521|P1|STARTED|Randomized||412
5301873|NCT00531752|13033552|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
5301874|NCT00531752|13033553|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
5301875|NCT00531752|13033554|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
5301876|NCT00531752|13033555|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
5301877|NCT00531752|13033552|P4|COMPLETED|Second Double-blind Intervention Period||11
5301878|NCT00531752|13033553|P3|COMPLETED|Second Double-blind Intervention Period||9
5301879|NCT00531752|13033554|P2|COMPLETED|Second Double-blind Intervention Period||11
5301880|NCT00531752|13033555|P1|COMPLETED|Second Double-blind Intervention Period||9
5301881|NCT00531752|13033552|P4|STARTED|Second Double-blind Intervention Period||13
5301882|NCT00531752|13033553|P3|STARTED|Second Double-blind Intervention Period||9
5301883|NCT00531752|13033554|P2|STARTED|Second Double-blind Intervention Period||13
5301884|NCT00531752|13033555|P1|STARTED|Second Double-blind Intervention Period||11
5301885|NCT00531752|13033552|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5301886|NCT00531752|13033553|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5301887|NCT00531752|13033554|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5301888|NCT00531752|13033555|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
5301889|NCT00531752|13033552|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
5301890|NCT00531752|13033553|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
5301891|NCT00531752|13033554|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
5301892|NCT00531752|13033555|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
5301893|NCT00531752|13033552|P4|STARTED|Wash-out Period (at Least 7 Days)||13
5301894|NCT00531752|13033553|P3|STARTED|Wash-out Period (at Least 7 Days)||9
5301895|NCT00531752|13033554|P2|STARTED|Wash-out Period (at Least 7 Days)||13
5301896|NCT00531752|13033555|P1|STARTED|Wash-out Period (at Least 7 Days)||11
5301897|NCT00531752|13033552|P4|NOT COMPLETED|First Double-blind Intervention Period||3
5301898|NCT00531752|13033553|P3|NOT COMPLETED|First Double-blind Intervention Period||7
5301899|NCT00531752|13033554|P2|NOT COMPLETED|First Double-blind Intervention Period||4
5301900|NCT00531752|13033555|P1|NOT COMPLETED|First Double-blind Intervention Period||6
5301901|NCT00531752|13033552|P4|COMPLETED|First Double-blind Intervention Period||13
5301902|NCT00531752|13033553|P3|COMPLETED|First Double-blind Intervention Period||9
5301903|NCT00531752|13033554|P2|COMPLETED|First Double-blind Intervention Period||13
5301904|NCT00531752|13033555|P1|COMPLETED|First Double-blind Intervention Period||11
5301905|NCT00531752|13033552|P4|Treated|First Double-blind Intervention Period||16
5301906|NCT00531752|13033553|P3|Treated|First Double-blind Intervention Period||16
5301907|NCT00531752|13033554|P2|Treated|First Double-blind Intervention Period||17
5301908|NCT00531752|13033555|P1|Treated|First Double-blind Intervention Period||16
5301909|NCT00531752|13033552|P4|STARTED|First Double-blind Intervention Period||16
5301910|NCT00531752|13033553|P3|STARTED|First Double-blind Intervention Period||16
5301911|NCT00531752|13033554|P2|STARTED|First Double-blind Intervention Period||17
5301912|NCT00531752|13033555|P1|STARTED|First Double-blind Intervention Period||17
5301913|NCT00531661|13033634|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
5301914|NCT00531661|13033635|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
5301915|NCT00531661|13033634|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
5301916|NCT00531661|13033635|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
5301917|NCT00531661|13033634|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
5301918|NCT00531661|13033635|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
5301919|NCT00531661|13033634|P2|NOT COMPLETED|6 Months||26
5301920|NCT00531661|13033635|P1|NOT COMPLETED|6 Months||26
5301921|NCT00531661|13033634|P2|COMPLETED|6 Months||254
5301922|NCT00531661|13033635|P1|COMPLETED|6 Months||244
5301923|NCT00531661|13033634|P2|STARTED|6 Months||280
5301924|NCT00531661|13033635|P1|STARTED|6 Months||270
5301925|NCT00531518|13033657|P2|NOT COMPLETED|Overall Study||71
5301926|NCT00531518|13033658|P1|NOT COMPLETED|Overall Study||32
5301927|NCT00531518|13033657|P2|COMPLETED|Overall Study||134
5301928|NCT00531518|13033658|P1|COMPLETED|Overall Study||55
5301929|NCT00531518|13033657|P2|STARTED|Overall Study||205
5301930|NCT00531518|13033658|P1|STARTED|Overall Study||87
5301931|NCT00531479|13033666|P2|NOT COMPLETED|Overall Study||83
5301932|NCT00531479|13033667|P1|NOT COMPLETED|Overall Study||76
5301933|NCT00531479|13033666|P2|COMPLETED|Overall Study||146
5301934|NCT00531479|13033667|P1|COMPLETED|Overall Study||154
5301935|NCT00531479|13033666|P2|Treated|Overall Study||226
5301936|NCT00531479|13033667|P1|Treated|Overall Study||228
5301937|NCT00531479|13033666|P2|STARTED|Overall Study||229
5301938|NCT00531479|13033667|P1|STARTED|Overall Study||230
5301939|NCT00531453|13033687|P2|NOT COMPLETED|Overall Study||0
5301940|NCT00531453|13033688|P1|NOT COMPLETED|Overall Study||0
5301941|NCT00531453|13033687|P2|COMPLETED|Overall Study|10 April 2009|49
5301942|NCT00531453|13033688|P1|COMPLETED|Overall Study|10 April 2009|49
5301943|NCT00531453|13033687|P2|STARTED|Overall Study|02 October 2007|49
5301944|NCT00531453|13033688|P1|STARTED|Overall Study|02 October 2007|49
5301945|NCT00531427|13033698|P2|NOT COMPLETED|Overall Study||94
5301946|NCT00531427|13033699|P1|NOT COMPLETED|Overall Study||73
5301947|NCT00531427|13033698|P2|COMPLETED|Overall Study||191
5301948|NCT00531427|13033699|P1|COMPLETED|Overall Study||209
5301949|NCT00531427|13033698|P2|STARTED|Overall Study||285
5301950|NCT00531427|13033699|P1|STARTED|Overall Study||282
5301951|NCT00531284|13033727|P17|NOT COMPLETED|Overall Study||8
5301953|NCT00531284|13033729|P15|NOT COMPLETED|Overall Study||4
5301954|NCT00531284|13033730|P14|NOT COMPLETED|Overall Study||3
5301955|NCT00531284|13033731|P13|NOT COMPLETED|Overall Study||2
5301956|NCT00531284|13033732|P12|NOT COMPLETED|Overall Study||24
5301957|NCT00531284|13033733|P11|NOT COMPLETED|Overall Study||3
5301958|NCT00531284|13033734|P10|NOT COMPLETED|Overall Study||4
5301959|NCT00531284|13033735|P9|NOT COMPLETED|Overall Study||11
5301960|NCT00531284|13033736|P8|NOT COMPLETED|Overall Study||10
5301961|NCT00531284|13033737|P7|NOT COMPLETED|Overall Study||6
5301962|NCT00531284|13033738|P6|NOT COMPLETED|Overall Study||7
5301963|NCT00531284|13033739|P5|NOT COMPLETED|Overall Study||6
5301964|NCT00531284|13033740|P4|NOT COMPLETED|Overall Study||63
5301965|NCT00531284|13033741|P3|NOT COMPLETED|Overall Study||6
5301966|NCT00531284|13033742|P2|NOT COMPLETED|Overall Study||4
5301967|NCT00531284|13033743|P1|NOT COMPLETED|Overall Study||3
5301968|NCT00531284|13033727|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301969|NCT00531284|13033728|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
5301970|NCT00531284|13033729|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
5301971|NCT00531284|13033730|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301972|NCT00531284|13033731|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301973|NCT00531284|13033732|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301974|NCT00531284|13033733|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301975|NCT00531284|13033734|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301976|NCT00531284|13033735|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301977|NCT00531284|13033736|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301978|NCT00531284|13033737|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301979|NCT00531284|13033738|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301980|NCT00531284|13033739|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
5301981|NCT00531284|13033740|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
5301982|NCT00531284|13033741|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
5301983|NCT00531284|13033742|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
5301984|NCT00531284|13033743|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
5301985|NCT00531284|13033727|P17|STARTED|Overall Study||8
5301986|NCT00531284|13033728|P16|STARTED|Overall Study||14
5301987|NCT00531284|13033729|P15|STARTED|Overall Study||7
5301988|NCT00531284|13033730|P14|STARTED|Overall Study||3
5301989|NCT00531284|13033731|P13|STARTED|Overall Study||2
5301990|NCT00531284|13033732|P12|STARTED|Overall Study||24
5301991|NCT00531284|13033733|P11|STARTED|Overall Study||3
5301992|NCT00531284|13033734|P10|STARTED|Overall Study||4
5301993|NCT00531284|13033735|P9|STARTED|Overall Study||11
5301994|NCT00531284|13033736|P8|STARTED|Overall Study||10
5301995|NCT00531284|13033737|P7|STARTED|Overall Study||6
5301996|NCT00531284|13033738|P6|STARTED|Overall Study||7
5301997|NCT00531284|13033739|P5|STARTED|Overall Study||6
5301998|NCT00531284|13033740|P4|STARTED|Overall Study||65
5301999|NCT00531284|13033741|P3|STARTED|Overall Study||7
5302000|NCT00531284|13033742|P2|STARTED|Overall Study||4
5302001|NCT00531284|13033743|P1|STARTED|Overall Study||3
5302002|NCT00531206|13033893|P1|NOT COMPLETED|Overall Study||20
5302003|NCT00531206|13033893|P1|COMPLETED|Overall Study||45
5302004|NCT00531206|13033893|P1|STARTED|Overall Study||65
5302005|NCT00531050|13033923|P6|NOT COMPLETED|Part 2: Period 3||1
5302006|NCT00531050|13033924|P5|NOT COMPLETED|Part 2: Period 3||0
5302007|NCT00531050|13033925|P4|NOT COMPLETED|Part 2: Period 3||0
5302008|NCT00531050|13033926|P3|NOT COMPLETED|Part 2: Period 3||0
5302009|NCT00531050|13033927|P2|NOT COMPLETED|Part 2: Period 3||0
5302010|NCT00531050|13033928|P1|NOT COMPLETED|Part 2: Period 3||1
5302011|NCT00531050|13033923|P6|COMPLETED|Part 2: Period 3||3
5302012|NCT00531050|13033924|P5|COMPLETED|Part 2: Period 3||4
5302013|NCT00531050|13033925|P4|COMPLETED|Part 2: Period 3||4
5302014|NCT00531050|13033926|P3|COMPLETED|Part 2: Period 3||4
5302015|NCT00531050|13033927|P2|COMPLETED|Part 2: Period 3||4
5302016|NCT00531050|13033928|P1|COMPLETED|Part 2: Period 3||2
5302017|NCT00531050|13033923|P6|STARTED|Part 2: Period 3||4
5302018|NCT00531050|13033924|P5|STARTED|Part 2: Period 3||4
5302019|NCT00531050|13033925|P4|STARTED|Part 2: Period 3||4
5302020|NCT00531050|13033926|P3|STARTED|Part 2: Period 3||4
5302021|NCT00531050|13033927|P2|STARTED|Part 2: Period 3||4
5302022|NCT00531050|13033928|P1|STARTED|Part 2: Period 3||3
5302023|NCT00531050|13033923|P6|NOT COMPLETED|Part 2: Period 2||0
5302024|NCT00531050|13033924|P5|NOT COMPLETED|Part 2: Period 2||0
5302025|NCT00531050|13033925|P4|NOT COMPLETED|Part 2: Period 2||0
5302026|NCT00531050|13033926|P3|NOT COMPLETED|Part 2: Period 2||0
5302027|NCT00531050|13033927|P2|NOT COMPLETED|Part 2: Period 2||0
5302028|NCT00531050|13033928|P1|NOT COMPLETED|Part 2: Period 2||0
5302029|NCT00531050|13033923|P6|COMPLETED|Part 2: Period 2||4
5302030|NCT00531050|13033924|P5|COMPLETED|Part 2: Period 2||4
5302031|NCT00531050|13033925|P4|COMPLETED|Part 2: Period 2||4
5302032|NCT00531050|13033926|P3|COMPLETED|Part 2: Period 2||4
5302033|NCT00531050|13033927|P2|COMPLETED|Part 2: Period 2||4
5302034|NCT00531050|13033928|P1|COMPLETED|Part 2: Period 2||3
5302035|NCT00531050|13033923|P6|STARTED|Part 2: Period 2||4
5302036|NCT00531050|13033924|P5|STARTED|Part 2: Period 2||4
5302037|NCT00531050|13033925|P4|STARTED|Part 2: Period 2||4
5302038|NCT00531050|13033926|P3|STARTED|Part 2: Period 2||4
5302039|NCT00531050|13033927|P2|STARTED|Part 2: Period 2||4
5302040|NCT00531050|13033928|P1|STARTED|Part 2: Period 2||3
5302041|NCT00531050|13033923|P6|NOT COMPLETED|Part 2: Period 1||1
5302042|NCT00531050|13033924|P5|NOT COMPLETED|Part 2: Period 1||0
5302043|NCT00531050|13033925|P4|NOT COMPLETED|Part 2: Period 1||0
5302044|NCT00531050|13033926|P3|NOT COMPLETED|Part 2: Period 1||0
5302045|NCT00531050|13033927|P2|NOT COMPLETED|Part 2: Period 1||0
5302046|NCT00531050|13033928|P1|NOT COMPLETED|Part 2: Period 1||0
5302047|NCT00531050|13033923|P6|COMPLETED|Part 2: Period 1||4
5302048|NCT00531050|13033924|P5|COMPLETED|Part 2: Period 1||4
5302049|NCT00531050|13033925|P4|COMPLETED|Part 2: Period 1||4
5302050|NCT00531050|13033926|P3|COMPLETED|Part 2: Period 1||4
5302051|NCT00531050|13033927|P2|COMPLETED|Part 2: Period 1||4
5302052|NCT00531050|13033928|P1|COMPLETED|Part 2: Period 1||3
5302053|NCT00531050|13033923|P6|STARTED|Part 2: Period 1||5
5302054|NCT00531050|13033924|P5|STARTED|Part 2: Period 1||4
5302055|NCT00531050|13033925|P4|STARTED|Part 2: Period 1||4
5302056|NCT00531050|13033926|P3|STARTED|Part 2: Period 1||4
5302057|NCT00531050|13033927|P2|STARTED|Part 2: Period 1||4
5302058|NCT00531050|13033928|P1|STARTED|Part 2: Period 1||3
5302059|NCT00531050|13033923|P6|NOT COMPLETED|Part 1: Period 3||0
5302060|NCT00531050|13033924|P5|NOT COMPLETED|Part 1: Period 3||0
5302061|NCT00531050|13033925|P4|NOT COMPLETED|Part 1: Period 3||0
5302062|NCT00531050|13033926|P3|NOT COMPLETED|Part 1: Period 3||0
5302063|NCT00531050|13033927|P2|NOT COMPLETED|Part 1: Period 3||0
5302064|NCT00531050|13033928|P1|NOT COMPLETED|Part 1: Period 3||1
5302065|NCT00531050|13033923|P6|COMPLETED|Part 1: Period 3||5
5302066|NCT00531050|13033924|P5|COMPLETED|Part 1: Period 3||4
5302067|NCT00531050|13033925|P4|COMPLETED|Part 1: Period 3||4
5302068|NCT00531050|13033926|P3|COMPLETED|Part 1: Period 3||4
5302069|NCT00531050|13033927|P2|COMPLETED|Part 1: Period 3||4
5302070|NCT00531050|13033928|P1|COMPLETED|Part 1: Period 3||3
5302071|NCT00531050|13033923|P6|STARTED|Part 1: Period 3||5
5302072|NCT00531050|13033924|P5|STARTED|Part 1: Period 3||4
5302073|NCT00531050|13033925|P4|STARTED|Part 1: Period 3||4
5302074|NCT00531050|13033926|P3|STARTED|Part 1: Period 3||4
5302075|NCT00531050|13033927|P2|STARTED|Part 1: Period 3||4
5302076|NCT00531050|13033928|P1|STARTED|Part 1: Period 3||4
5302077|NCT00531050|13033923|P6|NOT COMPLETED|Part 1: Period 2||0
5302078|NCT00531050|13033924|P5|NOT COMPLETED|Part 1: Period 2||0
5302079|NCT00531050|13033925|P4|NOT COMPLETED|Part 1: Period 2||0
5302080|NCT00531050|13033926|P3|NOT COMPLETED|Part 1: Period 2||0
5302081|NCT00531050|13033927|P2|NOT COMPLETED|Part 1: Period 2||0
5302082|NCT00531050|13033928|P1|NOT COMPLETED|Part 1: Period 2||0
5302083|NCT00531050|13033923|P6|COMPLETED|Part 1: Period 2||5
5302084|NCT00531050|13033924|P5|COMPLETED|Part 1: Period 2||4
5302085|NCT00531050|13033925|P4|COMPLETED|Part 1: Period 2||4
5302086|NCT00531050|13033926|P3|COMPLETED|Part 1: Period 2||4
5302087|NCT00531050|13033927|P2|COMPLETED|Part 1: Period 2||4
5302088|NCT00531050|13033928|P1|COMPLETED|Part 1: Period 2||4
5302089|NCT00531050|13033923|P6|STARTED|Part 1: Period 2||5
5302090|NCT00531050|13033924|P5|STARTED|Part 1: Period 2||4
5302091|NCT00531050|13033925|P4|STARTED|Part 1: Period 2||4
5302092|NCT00531050|13033926|P3|STARTED|Part 1: Period 2||4
5302093|NCT00531050|13033927|P2|STARTED|Part 1: Period 2||4
5302094|NCT00531050|13033928|P1|STARTED|Part 1: Period 2||4
5302095|NCT00531050|13033923|P6|NOT COMPLETED|Part 1: Period 1||0
5302096|NCT00531050|13033924|P5|NOT COMPLETED|Part 1: Period 1||0
5302097|NCT00531050|13033925|P4|NOT COMPLETED|Part 1: Period 1||1
5302098|NCT00531050|13033926|P3|NOT COMPLETED|Part 1: Period 1||0
5302099|NCT00531050|13033927|P2|NOT COMPLETED|Part 1: Period 1||1
5302100|NCT00531050|13033928|P1|NOT COMPLETED|Part 1: Period 1||0
5302101|NCT00531050|13033923|P6|COMPLETED|Part 1: Period 1||5
5302102|NCT00531050|13033924|P5|COMPLETED|Part 1: Period 1||4
5302103|NCT00531050|13033925|P4|COMPLETED|Part 1: Period 1||4
5302104|NCT00531050|13033926|P3|COMPLETED|Part 1: Period 1||4
5302105|NCT00531050|13033927|P2|COMPLETED|Part 1: Period 1||4
5302106|NCT00531050|13033928|P1|COMPLETED|Part 1: Period 1||4
5302107|NCT00531050|13033923|P6|STARTED|Part 1: Period 1||5
5302108|NCT00531050|13033924|P5|STARTED|Part 1: Period 1||4
5302109|NCT00531050|13033925|P4|STARTED|Part 1: Period 1||5
5302110|NCT00531050|13033926|P3|STARTED|Part 1: Period 1||4
5302111|NCT00531050|13033927|P2|STARTED|Part 1: Period 1||5
5302112|NCT00531050|13033928|P1|STARTED|Part 1: Period 1||4
5302113|NCT00531011|13033957|P2|NOT COMPLETED|Overall Study||7
5302114|NCT00531011|13033958|P1|NOT COMPLETED|Overall Study||4
5302115|NCT00531011|13033957|P2|COMPLETED|Overall Study||90
5302116|NCT00531011|13033958|P1|COMPLETED|Overall Study||99
5302117|NCT00531011|13033957|P2|STARTED|Overall Study||97
5302118|NCT00531011|13033958|P1|STARTED|Overall Study||103
5302119|NCT00530946|13034004|P4|NOT COMPLETED|Overall Study||2
5302120|NCT00530946|13034005|P3|NOT COMPLETED|Overall Study||1
5302121|NCT00530946|13034006|P2|NOT COMPLETED|Overall Study||2
5302122|NCT00530946|13034007|P1|NOT COMPLETED|Overall Study||2
5302123|NCT00530946|13034004|P4|COMPLETED|Overall Study||38
5302124|NCT00530946|13034005|P3|COMPLETED|Overall Study||40
5302125|NCT00530946|13034006|P2|COMPLETED|Overall Study||39
5302126|NCT00530946|13034007|P1|COMPLETED|Overall Study||41
5302127|NCT00530946|13034004|P4|STARTED|Overall Study||40
5302128|NCT00530946|13034005|P3|STARTED|Overall Study||41
5302129|NCT00530946|13034006|P2|STARTED|Overall Study||41
5302130|NCT00530946|13034007|P1|STARTED|Overall Study||43
5302131|NCT00530920|13034060|P3|NOT COMPLETED|Overall Study||4
5302132|NCT00530920|13034061|P2|NOT COMPLETED|Overall Study||2
5302133|NCT00530920|13034062|P1|NOT COMPLETED|Overall Study||0
5302134|NCT00530920|13034060|P3|COMPLETED|Overall Study||24
5302135|NCT00530920|13034061|P2|COMPLETED|Overall Study||25
5302136|NCT00530920|13034062|P1|COMPLETED|Overall Study||30
5302137|NCT00530920|13034060|P3|STARTED|Overall Study||28
5302138|NCT00530920|13034061|P2|STARTED|Overall Study||27
5302139|NCT00530920|13034062|P1|STARTED|Overall Study||30
5302140|NCT00530894|13034122|P4|NOT COMPLETED|Overall Study||94
5302141|NCT00530894|13034123|P3|NOT COMPLETED|Overall Study||55
5302142|NCT00530894|13034124|P2|NOT COMPLETED|Overall Study||115
5302143|NCT00530894|13034125|P1|NOT COMPLETED|Overall Study||88
5302144|NCT00530894|13034122|P4|COMPLETED|Overall Study||85
5302145|NCT00530894|13034123|P3|COMPLETED|Overall Study||124
5302146|NCT00530894|13034124|P2|COMPLETED|Overall Study||236
5302147|NCT00530894|13034125|P1|COMPLETED|Overall Study||260
5302148|NCT00530894|13034122|P4|STARTED|Overall Study||179
5302149|NCT00530894|13034123|P3|STARTED|Overall Study||179
5302150|NCT00530894|13034124|P2|STARTED|Overall Study||351
5302151|NCT00530894|13034125|P1|STARTED|Overall Study||348
5302152|NCT00530855|13034153|P1|NOT COMPLETED|Overall Study||112
5302153|NCT00530855|13034153|P1|COMPLETED|Overall Study||210
5302154|NCT00530855|13034153|P1|STARTED|Overall Study||322
5302155|NCT00530842|13034162|P2|NOT COMPLETED|Period 2||9
5302156|NCT00530842|13034163|P1|NOT COMPLETED|Period 2||8
5302157|NCT00530842|13034162|P2|COMPLETED|Period 2||151
5302158|NCT00530842|13034163|P1|COMPLETED|Period 2||149
5302159|NCT00530842|13034162|P2|STARTED|Period 2||160
5302160|NCT00530842|13034163|P1|STARTED|Period 2||157
5302161|NCT00530842|13034162|P2|NOT COMPLETED|Period 1||11
5302162|NCT00530842|13034163|P1|NOT COMPLETED|Period 1||14
5302163|NCT00530842|13034162|P2|COMPLETED|Period 1||161
5302164|NCT00530842|13034163|P1|COMPLETED|Period 1||158
5302165|NCT00530842|13034162|P2|STARTED|Period 1||172
5302166|NCT00530842|13034163|P1|STARTED|Period 1||172
5302167|NCT00530842|13034162|P2|NOT COMPLETED|Overall Study||21
5302168|NCT00530842|13034163|P1|NOT COMPLETED|Overall Study||23
5302169|NCT00530842|13034162|P2|COMPLETED|Overall Study||151
5302170|NCT00530842|13034163|P1|COMPLETED|Overall Study||149
5302171|NCT00530842|13034162|P2|STARTED|Overall Study||172
5302172|NCT00530842|13034163|P1|STARTED|Overall Study||172
5302173|NCT00530816|13034290|P3|NOT COMPLETED|Overall Study||41
5302174|NCT00530816|13034291|P2|NOT COMPLETED|Overall Study||42
5302175|NCT00530816|13034292|P1|NOT COMPLETED|Overall Study||26
5302176|NCT00530816|13034290|P3|COMPLETED|Overall Study||29
5302177|NCT00530816|13034291|P2|COMPLETED|Overall Study||17
5302178|NCT00530816|13034292|P1|COMPLETED|Overall Study||9
5302179|NCT00530816|13034290|P3|STARTED|Overall Study||70
5302180|NCT00530816|13034291|P2|STARTED|Overall Study||59
5302181|NCT00530816|13034292|P1|STARTED|Overall Study||35
5302182|NCT00530803|13034320|P2|NOT COMPLETED|Overall Study||0
5302183|NCT00530803|13034321|P1|NOT COMPLETED|Overall Study||0
5302184|NCT00530803|13034320|P2|COMPLETED|Overall Study||50
5302185|NCT00530803|13034321|P1|COMPLETED|Overall Study||50
5302186|NCT00530803|13034320|P2|STARTED|Overall Study||50
5302187|NCT00530803|13034321|P1|STARTED|Overall Study||50
5302188|NCT00530790|13034335|P1|NOT COMPLETED|Overall Study||5
5302189|NCT00530790|13034335|P1|COMPLETED|Overall Study||30
5302190|NCT00530790|13034335|P1|STARTED|Overall Study||35
5302191|NCT00530777|13034357|P2|NOT COMPLETED|Overall Study||5
5302192|NCT00530777|13034358|P1|NOT COMPLETED|Overall Study||7
5302193|NCT00530777|13034357|P2|COMPLETED|Overall Study||69
5302194|NCT00530777|13034358|P1|COMPLETED|Overall Study||67
5302195|NCT00530777|13034357|P2|STARTED|Overall Study||74
5302196|NCT00530777|13034358|P1|STARTED|Overall Study||74
5302197|NCT00530764|13034370|P4|NOT COMPLETED|Overall Study||25
5302198|NCT00530764|13034371|P3|NOT COMPLETED|Overall Study||20
5302199|NCT00530764|13034372|P2|NOT COMPLETED|Overall Study||21
5302200|NCT00530764|13034373|P1|NOT COMPLETED|Overall Study||31
5302201|NCT00530764|13034370|P4|COMPLETED|Overall Study||66
5302202|NCT00530764|13034371|P3|COMPLETED|Overall Study||71
5302203|NCT00530764|13034372|P2|COMPLETED|Overall Study||67
5302204|NCT00530764|13034373|P1|COMPLETED|Overall Study||59
5302205|NCT00530764|13034370|P4|STARTED|Overall Study||91
5302206|NCT00530764|13034371|P3|STARTED|Overall Study||91
5302207|NCT00530764|13034372|P2|STARTED|Overall Study||88
5302208|NCT00530764|13034373|P1|STARTED|Overall Study||90
5302209|NCT00530712|13034415|P1|NOT COMPLETED|12 Month Follow-up Visit||24
5302210|NCT00530712|13034415|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
5302211|NCT00530712|13034415|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
5302212|NCT00530712|13034415|P1|NOT COMPLETED|6 Month Follow-up Visit||12
5302213|NCT00530712|13034415|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
5302214|NCT00530712|13034415|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
5302215|NCT00530712|13034415|P1|NOT COMPLETED|30 Day Follow-up Visit||7
5302216|NCT00530712|13034415|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
5302217|NCT00530712|13034415|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
5302218|NCT00530712|13034415|P1|NOT COMPLETED|Enrollment||0
5302219|NCT00530712|13034415|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
5302220|NCT00530712|13034415|P1|STARTED|Enrollment|Total Enrolled Subjects|287
5302221|NCT00530634|13034432|P1|NOT COMPLETED|Overall Study||0
5302222|NCT00530634|13034432|P1|COMPLETED|Overall Study||3
5302223|NCT00530634|13034432|P1|STARTED|Overall Study||3
5302224|NCT00530621|13034438|P2|NOT COMPLETED|Overall Study||80
5302225|NCT00530621|13034439|P1|NOT COMPLETED|Overall Study||80
5302226|NCT00530621|13034438|P2|COMPLETED|Overall Study||0
5302227|NCT00530621|13034439|P1|COMPLETED|Overall Study||0
5302228|NCT00530621|13034438|P2|Received at Least 1 Dose of Study Drug|Overall Study||80
5302229|NCT00530621|13034439|P1|Received at Least 1 Dose of Study Drug|Overall Study||79
5302230|NCT00530621|13034438|P2|STARTED|Overall Study||80
5302231|NCT00530621|13034439|P1|STARTED|Overall Study||80
5302232|NCT00530504|13034460|P1|NOT COMPLETED|Overall Study||152
5302233|NCT00530504|13034460|P1|COMPLETED|Overall Study||1348
5302234|NCT00530504|13034460|P1|STARTED|Overall Study||1500
5302235|NCT00530439|13034466|P2|NOT COMPLETED|Overall Study||26
5302236|NCT00530439|13034467|P1|NOT COMPLETED|Overall Study||30
5302237|NCT00530439|13034466|P2|COMPLETED|Overall Study||154
5302238|NCT00530439|13034467|P1|COMPLETED|Overall Study||150
5302239|NCT00530439|13034466|P2|STARTED|Overall Study||180
5302240|NCT00530439|13034467|P1|STARTED|Overall Study||180
5302241|NCT00530348|13034475|P2|NOT COMPLETED|Overall Study||19
5302242|NCT00530348|13034476|P1|NOT COMPLETED|Overall Study||22
5302243|NCT00530348|13034475|P2|COMPLETED|Overall Study||367
5302244|NCT00530348|13034476|P1|COMPLETED|Overall Study||173
5302245|NCT00530348|13034475|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
5302246|NCT00530348|13034476|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
5302247|NCT00530348|13034475|P2|STARTED|Overall Study|Randomized.|386
5302248|NCT00530348|13034476|P1|STARTED|Overall Study|Randomized.|195
5302249|NCT00530335|13034492|P1|NOT COMPLETED|Overall Study||6
5302250|NCT00530335|13034492|P1|COMPLETED|Overall Study||39
5302251|NCT00530335|13034492|P1|STARTED|Overall Study||45
5302252|NCT00530270|13034509|P2|NOT COMPLETED|Overall Study||0
5302253|NCT00530270|13034510|P1|NOT COMPLETED|Overall Study||1
5302254|NCT00530270|13034509|P2|COMPLETED|Overall Study||6
5302255|NCT00530270|13034510|P1|COMPLETED|Overall Study||5
5302256|NCT00530270|13034509|P2|STARTED|Overall Study||6
5302257|NCT00530270|13034510|P1|STARTED|Overall Study||6
5302258|NCT00530257|13034524|P1|NOT COMPLETED|Overall Study||1
5302259|NCT00530257|13034524|P1|COMPLETED|Overall Study||30
5302260|NCT00530257|13034524|P1|STARTED|Overall Study||31
5302261|NCT00530218|13034552|P1|NOT COMPLETED|Overall Study||25
5302262|NCT00530218|13034552|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
5302263|NCT00530218|13034552|P1|STARTED|Overall Study||61
5302264|NCT00530088|13034559|P1|NOT COMPLETED|Overall Study||10
5302265|NCT00530088|13034559|P1|COMPLETED|Overall Study||20
5302266|NCT00530088|13034559|P1|STARTED|Overall Study||30
5302267|NCT00530075|13034564|P1|NOT COMPLETED|Overall Study||7
5302268|NCT00530075|13034564|P1|COMPLETED|Overall Study||38
5302269|NCT00530075|13034564|P1|STARTED|Overall Study||45
5302270|NCT00530023|13034577|P2|NOT COMPLETED|Overall Study||1
5302271|NCT00530023|13034578|P1|NOT COMPLETED|Overall Study||0
5302272|NCT00530023|13034577|P2|COMPLETED|Overall Study||14
5302273|NCT00530023|13034578|P1|COMPLETED|Overall Study||14
5302274|NCT00530023|13034577|P2|STARTED|Overall Study||15
5302275|NCT00530023|13034578|P1|STARTED|Overall Study||14
5302276|NCT00529958|13034595|P3|NOT COMPLETED|5-Year Follow-up||1
5302277|NCT00529958|13034596|P2|NOT COMPLETED|5-Year Follow-up||3
5302278|NCT00529958|13034597|P1|NOT COMPLETED|5-Year Follow-up||3
5302279|NCT00529958|13034595|P3|COMPLETED|5-Year Follow-up||107
5302280|NCT00529958|13034596|P2|COMPLETED|5-Year Follow-up||105
5302281|NCT00529958|13034597|P1|COMPLETED|5-Year Follow-up||103
5302282|NCT00529958|13034595|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
5302283|NCT00529958|13034596|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
5302284|NCT00529958|13034597|P1|STARTED|5-Year Follow-up||106
5302285|NCT00529958|13034595|P3|NOT COMPLETED|2-Year Follow-up||2
5302286|NCT00529958|13034596|P2|NOT COMPLETED|2-Year Follow-up||2
5302287|NCT00529958|13034597|P1|NOT COMPLETED|2-Year Follow-up||4
5302288|NCT00529958|13034595|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
5302289|NCT00529958|13034596|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
5302290|NCT00529958|13034597|P1|COMPLETED|2-Year Follow-up||106
5302291|NCT00529958|13034595|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
5302292|NCT00529958|13034596|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
5302293|NCT00529958|13034597|P1|STARTED|2-Year Follow-up||110
5302294|NCT00529802|13034638|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
5302295|NCT00529802|13034638|P1|COMPLETED|Evaluable for Secondary Endpoint||48
5302296|NCT00529802|13034638|P1|STARTED|Evaluable for Secondary Endpoint||50
5302297|NCT00529802|13034638|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
5302298|NCT00529802|13034638|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
5302299|NCT00529802|13034638|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
5302300|NCT00529789|13034644|P1|NOT COMPLETED|Study Period IV||6
5302301|NCT00529789|13034644|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
5302302|NCT00529789|13034644|P1|STARTED|Study Period IV||48
5302303|NCT00529789|13034644|P1|NOT COMPLETED|Study Period II/III||24
5302304|NCT00529789|13034644|P1|COMPLETED|Study Period II/III||48
5302305|NCT00529789|13034644|P1|STARTED|Study Period II/III||72
5302306|NCT00529763|13034669|P3|NOT COMPLETED|Overall Study||7
5302307|NCT00529763|13034670|P2|NOT COMPLETED|Overall Study||33
5302308|NCT00529763|13034671|P1|NOT COMPLETED|Overall Study||10
5302309|NCT00529763|13034669|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
5302310|NCT00529763|13034670|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
5302311|NCT00529763|13034671|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
5302312|NCT00529763|13034669|P3|STARTED|Overall Study||59
5302313|NCT00529763|13034670|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
5302314|NCT00529763|13034671|P1|STARTED|Overall Study||25
5302315|NCT00529659|13034709|P2|NOT COMPLETED|Overall Study||23
5302316|NCT00529659|13034710|P1|NOT COMPLETED|Overall Study||11
5302317|NCT00529659|13034709|P2|COMPLETED|Overall Study||66
5302318|NCT00529659|13034710|P1|COMPLETED|Overall Study||70
5302319|NCT00529659|13034709|P2|STARTED|Overall Study||89
5302320|NCT00529659|13034710|P1|STARTED|Overall Study||81
5302321|NCT00529633|13034728|P2|NOT COMPLETED|Overall Study||1
5302322|NCT00529633|13034729|P1|NOT COMPLETED|Overall Study||1
5302323|NCT00529633|13034728|P2|COMPLETED|Overall Study||1
5302324|NCT00529633|13034729|P1|COMPLETED|Overall Study||1
5302325|NCT00529633|13034728|P2|STARTED|Overall Study||2
5302326|NCT00529633|13034729|P1|STARTED|Overall Study||2
5302327|NCT00529568|13034741|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
5302328|NCT00529568|13034742|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
5302329|NCT00529568|13034743|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
5302330|NCT00529568|13034741|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
5302331|NCT00529568|13034742|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
5302332|NCT00529568|13034743|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
5302333|NCT00529568|13034741|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
5302334|NCT00529568|13034742|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
5302335|NCT00529568|13034743|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
5302336|NCT00529568|13034741|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
5302337|NCT00529568|13034742|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
5302338|NCT00529568|13034743|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
5302339|NCT00529568|13034741|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
5302340|NCT00529568|13034742|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
5302341|NCT00529568|13034743|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
5302342|NCT00529568|13034741|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
5302343|NCT00529568|13034742|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
5302344|NCT00529568|13034743|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
5302345|NCT00529555|13034794|P3|NOT COMPLETED|Overall Study||26
5302346|NCT00529555|13034795|P2|NOT COMPLETED|Overall Study||30
5302347|NCT00529555|13034796|P1|NOT COMPLETED|Overall Study||29
5302348|NCT00529555|13034794|P3|COMPLETED|Overall Study||174
5302349|NCT00529555|13034795|P2|COMPLETED|Overall Study||172
5302350|NCT00529555|13034796|P1|COMPLETED|Overall Study||171
5302351|NCT00529555|13034794|P3|STARTED|Overall Study||200
5302352|NCT00529555|13034795|P2|STARTED|Overall Study||202
5302353|NCT00529555|13034796|P1|STARTED|Overall Study||200
5302354|NCT00529542|13034806|P2|NOT COMPLETED|Overall Study||1
5302355|NCT00529542|13034807|P1|NOT COMPLETED|Overall Study||1
5302356|NCT00529542|13034806|P2|COMPLETED|Overall Study||10
5302357|NCT00529542|13034807|P1|COMPLETED|Overall Study||8
5302358|NCT00529542|13034806|P2|STARTED|Overall Study||11
5302359|NCT00529542|13034807|P1|STARTED|Overall Study||9
5302360|NCT00529529|13034850|P3|NOT COMPLETED|Overall Study||31
5302361|NCT00529529|13034851|P2|NOT COMPLETED|Overall Study||43
5302362|NCT00529529|13034852|P1|NOT COMPLETED|Overall Study||43
5302363|NCT00529529|13034850|P3|COMPLETED|Overall Study||238
5302364|NCT00529529|13034851|P2|COMPLETED|Overall Study||225
5302365|NCT00529529|13034852|P1|COMPLETED|Overall Study||225
5302366|NCT00529529|13034850|P3|STARTED|Overall Study||269
5302367|NCT00529529|13034851|P2|STARTED|Overall Study||268
5302368|NCT00529529|13034852|P1|STARTED|Overall Study||268
5302369|NCT00529516|13034911|P3|NOT COMPLETED|Overall Study||1
5302370|NCT00529516|13034912|P2|NOT COMPLETED|Overall Study||2
5302371|NCT00529516|13034913|P1|NOT COMPLETED|Overall Study||3
5302372|NCT00529516|13034911|P3|COMPLETED|Overall Study||288
5302373|NCT00529516|13034912|P2|COMPLETED|Overall Study||486
5302374|NCT00529516|13034913|P1|COMPLETED|Overall Study||472
5302375|NCT00529516|13034911|P3|STARTED|Overall Study||289
5302376|NCT00529516|13034912|P2|STARTED|Overall Study||488
5302377|NCT00529516|13034913|P1|STARTED|Overall Study||475
5302378|NCT00529464|13034984|P3|NOT COMPLETED|Overall Study||0
5302379|NCT00529464|13034985|P2|NOT COMPLETED|Overall Study||0
5302380|NCT00529464|13034986|P1|NOT COMPLETED|Overall Study||0
5302381|NCT00529464|13034984|P3|COMPLETED|Overall Study||0
5302382|NCT00529464|13034985|P2|COMPLETED|Overall Study||0
5302383|NCT00529464|13034986|P1|COMPLETED|Overall Study||0
5302384|NCT00529464|13034984|P3|STARTED|Overall Study||0
5302385|NCT00529464|13034985|P2|STARTED|Overall Study||0
5302386|NCT00529464|13034986|P1|STARTED|Overall Study||0
5302387|NCT00529451|13034998|P4|NOT COMPLETED|Overall Study||31
5302388|NCT00529451|13034999|P3|NOT COMPLETED|Overall Study||40
5302389|NCT00529451|13035000|P2|NOT COMPLETED|Overall Study||48
5302390|NCT00529451|13035001|P1|NOT COMPLETED|Overall Study||37
5302391|NCT00529451|13034998|P4|COMPLETED|Overall Study||299
5302392|NCT00529451|13034999|P3|COMPLETED|Overall Study||292
5302393|NCT00529451|13035000|P2|COMPLETED|Overall Study||275
5302394|NCT00529451|13035001|P1|COMPLETED|Overall Study||294
5302395|NCT00529451|13034998|P4|STARTED|Overall Study||330
5302396|NCT00529451|13034999|P3|STARTED|Overall Study||332
5302397|NCT00529451|13035000|P2|STARTED|Overall Study||323
5302398|NCT00529451|13035001|P1|STARTED|Overall Study||331
5302399|NCT00529399|13035028|P3|NOT COMPLETED|Overall Study||2
5302400|NCT00529399|13035029|P2|NOT COMPLETED|Overall Study||1
5302401|NCT00529399|13035030|P1|NOT COMPLETED|Overall Study||2
5302402|NCT00529399|13035028|P3|COMPLETED|Overall Study||46
5302403|NCT00529399|13035029|P2|COMPLETED|Overall Study||48
5302404|NCT00529399|13035030|P1|COMPLETED|Overall Study||46
5302405|NCT00529399|13035028|P3|STARTED|Overall Study||48
5302406|NCT00529399|13035029|P2|STARTED|Overall Study||49
5302407|NCT00529399|13035030|P1|STARTED|Overall Study||48
5302408|NCT00529386|13035038|P1|NOT COMPLETED|Overall Study||1
5302409|NCT00529386|13035038|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
5302410|NCT00529386|13035038|P1|STARTED|Overall Study|Study has been discontinued|7
5302411|NCT00529373|13035044|P2|NOT COMPLETED|Second Extension Study||197
5302412|NCT00529373|13035045|P1|NOT COMPLETED|Second Extension Study||300
5302413|NCT00529373|13035044|P2|COMPLETED|Second Extension Study||2112
5302414|NCT00529373|13035045|P1|COMPLETED|Second Extension Study||2844
5302415|NCT00529373|13035044|P2|STARTED|Second Extension Study||2309
5302416|NCT00529373|13035045|P1|STARTED|Second Extension Study||3144
5302417|NCT00529373|13035044|P2|NOT COMPLETED|First Extension Study||1651
5302418|NCT00529373|13035045|P1|NOT COMPLETED|First Extension Study||1153
5302419|NCT00529373|13035044|P2|COMPLETED|First Extension Study||2309
5302420|NCT00529373|13035045|P1|COMPLETED|First Extension Study||3144
5302421|NCT00529373|13035044|P2|STARTED|First Extension Study||3960
5302422|NCT00529373|13035045|P1|STARTED|First Extension Study||4297
5302423|NCT00529373|13035044|P2|NOT COMPLETED|Base Study||4068
5302424|NCT00529373|13035045|P1|NOT COMPLETED|Base Study||3746
5302425|NCT00529373|13035044|P2|COMPLETED|Base Study||3960
5302426|NCT00529373|13035045|P1|COMPLETED|Base Study||4297
5302427|NCT00529373|13035044|P2|STARTED|Base Study||8028
5302428|NCT00529373|13035045|P1|STARTED|Base Study||8043
5302429|NCT00529308|13035239|P2|NOT COMPLETED|Overall Study||1
5302430|NCT00529308|13035240|P1|NOT COMPLETED|Overall Study||1
5302431|NCT00529308|13035239|P2|COMPLETED|Overall Study||10
5302432|NCT00529308|13035240|P1|COMPLETED|Overall Study||8
5302433|NCT00529308|13035239|P2|STARTED|Overall Study||11
5302434|NCT00529308|13035240|P1|STARTED|Overall Study||9
5302435|NCT00529282|13035256|P2|NOT COMPLETED|Overall Study||0
5302436|NCT00529282|13035257|P1|NOT COMPLETED|Overall Study||0
5302437|NCT00529282|13035256|P2|COMPLETED|Overall Study||2
5302438|NCT00529282|13035257|P1|COMPLETED|Overall Study||0
5302439|NCT00529282|13035256|P2|STARTED|Overall Study||2
5302440|NCT00529282|13035257|P1|STARTED|Overall Study||0
5302441|NCT00529243|13035269|P1|NOT COMPLETED|Overall Study||3
5302442|NCT00529243|13035269|P1|COMPLETED|Overall Study||49
5302443|NCT00529243|13035269|P1|STARTED|Overall Study||52
5302444|NCT00529217|13035274|P1|NOT COMPLETED|Overall Study||4
5302445|NCT00529217|13035274|P1|COMPLETED|Overall Study||8
5302446|NCT00529217|13035274|P1|STARTED|Overall Study||12
5302447|NCT00529204|13035279|P1|NOT COMPLETED|Overall Study||0
5302448|NCT00529204|13035279|P1|COMPLETED|Overall Study||1
5302449|NCT00529204|13035279|P1|STARTED|Overall Study||1
5302450|NCT00529191|13035287|P2|NOT COMPLETED|Overall Study||0
5302451|NCT00529191|13035288|P1|NOT COMPLETED|Overall Study||3
5302452|NCT00529191|13035287|P2|COMPLETED|Overall Study||13
5302453|NCT00529191|13035288|P1|COMPLETED|Overall Study||24
5302454|NCT00529191|13035287|P2|STARTED|Overall Study||13
5302455|NCT00529191|13035288|P1|STARTED|Overall Study||27
5302456|NCT00529152|13035310|P1|NOT COMPLETED|Overall Study||5
5302457|NCT00529152|13035310|P1|COMPLETED|Overall Study||95
5302458|NCT00529152|13035310|P1|STARTED|Overall Study||100
5302459|NCT00529126|13035318|P4|NOT COMPLETED|Overall Study||0
5302460|NCT00529126|13035319|P3|NOT COMPLETED|Overall Study||0
5302461|NCT00529126|13035320|P2|NOT COMPLETED|Overall Study||0
5302462|NCT00529126|13035321|P1|NOT COMPLETED|Overall Study||0
5302463|NCT00529126|13035318|P4|COMPLETED|Overall Study||26
5302464|NCT00529126|13035319|P3|COMPLETED|Overall Study||24
5302465|NCT00529126|13035320|P2|COMPLETED|Overall Study||25
5302466|NCT00529126|13035321|P1|COMPLETED|Overall Study||25
5302467|NCT00529126|13035318|P4|STARTED|Overall Study||26
5302468|NCT00529126|13035319|P3|STARTED|Overall Study||24
5302469|NCT00529126|13035320|P2|STARTED|Overall Study||25
5302470|NCT00529126|13035321|P1|STARTED|Overall Study||25
5302471|NCT00529100|13035334|P2|NOT COMPLETED|Overall Study||9
5302472|NCT00529100|13035335|P1|NOT COMPLETED|Overall Study||0
5302473|NCT00529100|13035334|P2|COMPLETED|Overall Study||24
5302474|NCT00529100|13035335|P1|COMPLETED|Overall Study||16
5302475|NCT00529100|13035334|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
5302476|NCT00529100|13035335|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
5302477|NCT00529100|13035334|P2|STARTED|Overall Study||33
5302478|NCT00529100|13035335|P1|STARTED|Overall Study||16
5302479|NCT00529087|13035352|P3|NOT COMPLETED|Overall Study||16
5302480|NCT00529087|13035353|P2|NOT COMPLETED|Overall Study||28
5302481|NCT00529087|13035354|P1|NOT COMPLETED|Overall Study||28
5302482|NCT00529087|13035352|P3|COMPLETED|Overall Study||146
5302483|NCT00529087|13035353|P2|COMPLETED|Overall Study||120
5302484|NCT00529087|13035354|P1|COMPLETED|Overall Study||122
5302485|NCT00529087|13035352|P3|STARTED|Overall Study||162
5302486|NCT00529087|13035353|P2|STARTED|Overall Study||148
5302487|NCT00529087|13035354|P1|STARTED|Overall Study||150
5302488|NCT00529035|13035418|P1|NOT COMPLETED|Overall Study||1
5302489|NCT00529035|13035418|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
5302490|NCT00529035|13035418|P1|STARTED|Overall Study|29 enrolled|29
5302491|NCT00528970|13035432|P3|NOT COMPLETED|Overall Study||20
5302492|NCT00528970|13035433|P2|NOT COMPLETED|Overall Study||15
5302493|NCT00528970|13035434|P1|NOT COMPLETED|Overall Study||14
5302494|NCT00528970|13035432|P3|COMPLETED|Overall Study||105
5302495|NCT00528970|13035433|P2|COMPLETED|Overall Study||110
5302496|NCT00528970|13035434|P1|COMPLETED|Overall Study||110
5302497|NCT00528970|13035432|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
5302498|NCT00528970|13035433|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
5302499|NCT00528970|13035434|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
5302500|NCT00528970|13035432|P3|STARTED|Overall Study||125
5302501|NCT00528970|13035433|P2|STARTED|Overall Study||125
5302502|NCT00528970|13035434|P1|STARTED|Overall Study||124
5302503|NCT00528957|13035453|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
5302504|NCT00528957|13035454|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
5302505|NCT00528957|13035453|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
5302506|NCT00528957|13035454|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
5302507|NCT00528957|13035453|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
5302508|NCT00528957|13035454|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
5302509|NCT00528957|13035453|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
5302510|NCT00528957|13035454|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
5302511|NCT00528957|13035453|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
5302512|NCT00528957|13035454|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
5302513|NCT00528957|13035453|P2|STARTED|Third Extension (Week 240 to Week 336)||37
5302514|NCT00528957|13035454|P1|STARTED|Third Extension (Week 240 to Week 336)||27
5302515|NCT00528957|13035453|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
5302516|NCT00528957|13035454|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
5302517|NCT00528957|13035453|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
5302518|NCT00528957|13035454|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
5302519|NCT00528957|13035453|P2|STARTED|Second Extension (Week 144 to Week 240)||40
5302520|NCT00528957|13035454|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
5302521|NCT00528957|13035453|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
5302522|NCT00528957|13035454|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
5302523|NCT00528957|13035453|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
5302524|NCT00528957|13035454|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
5302525|NCT00528957|13035453|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
5302526|NCT00528957|13035454|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
5302527|NCT00528957|13035453|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
5302528|NCT00528957|13035454|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
5302529|NCT00528957|13035453|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
5302530|NCT00528957|13035454|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
5302531|NCT00528957|13035453|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
5302532|NCT00528957|13035454|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
5302533|NCT00528931|13035595|P1|NOT COMPLETED|Overall Study||1
5302534|NCT00528931|13035595|P1|COMPLETED|Overall Study||15
5302535|NCT00528931|13035595|P1|STARTED|Overall Study||16
5302536|NCT00528879|13035607|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
5302537|NCT00528879|13035608|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
5302538|NCT00528879|13035609|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
5302539|NCT00528879|13035610|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
5302540|NCT00528879|13035607|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
5302541|NCT00528879|13035608|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
5302542|NCT00528879|13035609|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
5302543|NCT00528879|13035610|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
5302544|NCT00528879|13035607|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
5302545|NCT00528879|13035608|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
5302546|NCT00528879|13035609|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
5302547|NCT00528879|13035610|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
5302548|NCT00528879|13035607|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
5302549|NCT00528879|13035608|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
5302550|NCT00528879|13035609|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
5302551|NCT00528879|13035610|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
5302552|NCT00528879|13035607|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
5302553|NCT00528879|13035608|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
5302554|NCT00528879|13035609|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
5302555|NCT00528879|13035610|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
5302556|NCT00528879|13035607|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
5302557|NCT00528879|13035608|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
5302558|NCT00528879|13035609|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
5302559|NCT00528879|13035610|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
5302560|NCT00528879|13035607|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
5302561|NCT00528879|13035608|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
5302562|NCT00528879|13035609|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
5302563|NCT00528879|13035610|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
5302564|NCT00528866|13035676|P1|NOT COMPLETED|Overall Study||6
5302565|NCT00528866|13035676|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
5302566|NCT00528866|13035676|P1|STARTED|Overall Study||80
5302567|NCT00528840|13035689|P1|NOT COMPLETED|Overall Study||33
5302568|NCT00528840|13035689|P1|COMPLETED|Overall Study||168
5302569|NCT00528840|13035689|P1|STARTED|Overall Study||201
5302570|NCT00528801|13035703|P2|NOT COMPLETED|Overall Study||11
5302571|NCT00528801|13035704|P1|NOT COMPLETED|Overall Study||27
5302572|NCT00528801|13035703|P2|COMPLETED|Overall Study||41
5302573|NCT00528801|13035704|P1|COMPLETED|Overall Study||133
5302574|NCT00528801|13035703|P2|STARTED|Overall Study||52
5302575|NCT00528801|13035704|P1|STARTED|Overall Study||160
5302576|NCT00528788|13035714|P1|NOT COMPLETED|Overall Study||4
5302577|NCT00528788|13035714|P1|COMPLETED|Overall Study||20
5302578|NCT00528788|13035714|P1|STARTED|Overall Study||24
5302579|NCT00528775|13035718|P1|NOT COMPLETED|Overall Study||1
5302580|NCT00528775|13035718|P1|COMPLETED|Overall Study||5
5302581|NCT00528775|13035718|P1|STARTED|Overall Study||6
5302582|NCT00528645|13035726|P1|NOT COMPLETED|Overall Study||3
5302583|NCT00528645|13035726|P1|COMPLETED|Overall Study||20
5302584|NCT00528645|13035726|P1|STARTED|Overall Study||23
5302585|NCT00528606|13035735|P2|NOT COMPLETED|Overall Study||4
5302586|NCT00528606|13035736|P1|NOT COMPLETED|Overall Study||13
5302587|NCT00528606|13035735|P2|COMPLETED|Overall Study||100
5302588|NCT00528606|13035736|P1|COMPLETED|Overall Study||191
5302589|NCT00528606|13035735|P2|STARTED|Overall Study||104
5302590|NCT00528606|13035736|P1|STARTED|Overall Study||204
5302591|NCT00528580|13035760|P2|NOT COMPLETED|Overall Study||0
5302592|NCT00528580|13035761|P1|NOT COMPLETED|Overall Study||0
5302593|NCT00528580|13035760|P2|COMPLETED|Overall Study||34
5302594|NCT00528580|13035761|P1|COMPLETED|Overall Study||34
5302595|NCT00528580|13035760|P2|STARTED|Overall Study||34
5302596|NCT00528580|13035761|P1|STARTED|Overall Study||34
5302597|NCT00528567|13035769|P2|NOT COMPLETED|Overall Study||308
5302598|NCT00528567|13035770|P1|NOT COMPLETED|Overall Study||431
5302599|NCT00528567|13035769|P2|COMPLETED|Overall Study||982
5302600|NCT00528567|13035770|P1|COMPLETED|Overall Study||870
5302601|NCT00528567|13035769|P2|Safety Population|Overall Study||1271
5302602|NCT00528567|13035770|P1|Safety Population|Overall Study||1288
5302603|NCT00528567|13035769|P2|Intention to Treat|Overall Study||1290
5302604|NCT00528567|13035770|P1|Intention to Treat|Overall Study||1301
5302605|NCT00528567|13035769|P2|STARTED|Overall Study||1290
5302606|NCT00528567|13035770|P1|STARTED|Overall Study||1301
5302607|NCT00528541|13035810|P2|NOT COMPLETED|Overall Study||1
5302608|NCT00528541|13035811|P1|NOT COMPLETED|Overall Study||2
5302609|NCT00528541|13035810|P2|COMPLETED|Overall Study||69
5302610|NCT00528541|13035811|P1|COMPLETED|Overall Study||73
5302611|NCT00528541|13035810|P2|STARTED|Overall Study||70
5302612|NCT00528541|13035811|P1|STARTED|Overall Study||75
5302613|NCT00528528|13035837|P4|NOT COMPLETED|Overall Study||3
5302614|NCT00528528|13035838|P3|NOT COMPLETED|Overall Study||3
5302615|NCT00528528|13035839|P2|NOT COMPLETED|Overall Study||3
5302616|NCT00528528|13035840|P1|NOT COMPLETED|Overall Study||3
5302617|NCT00528528|13035837|P4|COMPLETED|Overall Study||36
5302618|NCT00528528|13035838|P3|COMPLETED|Overall Study||37
5302619|NCT00528528|13035839|P2|COMPLETED|Overall Study||39
5302620|NCT00528528|13035840|P1|COMPLETED|Overall Study||37
5302621|NCT00528528|13035837|P4|Ongoing at Time of Cut-off|Overall Study||0
5302622|NCT00528528|13035838|P3|Ongoing at Time of Cut-off|Overall Study||1
5302623|NCT00528528|13035839|P2|Ongoing at Time of Cut-off|Overall Study||0
5302624|NCT00528528|13035840|P1|Ongoing at Time of Cut-off|Overall Study||0
5302625|NCT00528528|13035837|P4|STARTED|Overall Study||39
5302626|NCT00528528|13035838|P3|STARTED|Overall Study||40
5302627|NCT00528528|13035839|P2|STARTED|Overall Study||42
5302628|NCT00528528|13035840|P1|STARTED|Overall Study||40
5302629|NCT00528450|13035874|P1|NOT COMPLETED|Overall Study||0
5302630|NCT00528450|13035874|P1|COMPLETED|Overall Study||1
5302631|NCT00528450|13035874|P1|STARTED|Overall Study||1
5302632|NCT00528424|13035878|P1|NOT COMPLETED|Overall Study||29
5302633|NCT00528424|13035878|P1|COMPLETED|Overall Study||257
5302634|NCT00528424|13035878|P1|STARTED|Overall Study||286
5302635|NCT00528411|13035893|P3|NOT COMPLETED|Overall Study||1
5302636|NCT00528411|13035894|P2|NOT COMPLETED|Overall Study||3
5302637|NCT00528411|13035895|P1|NOT COMPLETED|Overall Study||5
5302638|NCT00528411|13035893|P3|COMPLETED|Overall Study||11
5302639|NCT00528411|13035894|P2|COMPLETED|Overall Study||51
5302640|NCT00528411|13035895|P1|COMPLETED|Overall Study||52
5302641|NCT00528411|13035893|P3|STARTED|Overall Study||12
5302642|NCT00528411|13035894|P2|STARTED|Overall Study||54
5302643|NCT00528411|13035895|P1|STARTED|Overall Study||57
5302644|NCT00528398|13036018|P1|NOT COMPLETED|Overall Study||0
5302645|NCT00528398|13036018|P1|COMPLETED|Overall Study||111
5302646|NCT00528398|13036018|P1|STARTED|Overall Study||111
5302647|NCT00528372|13036032|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
5302648|NCT00528372|13036033|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
5302649|NCT00528372|13036034|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
5302650|NCT00528372|13036035|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
5302651|NCT00528372|13036036|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
5302652|NCT00528372|13036037|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
5302653|NCT00528372|13036038|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
5302654|NCT00528372|13036039|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
5302655|NCT00528372|13036040|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
5302656|NCT00528372|13036032|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
5302657|NCT00528372|13036033|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
5302658|NCT00528372|13036034|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
5302659|NCT00528372|13036035|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
5302660|NCT00528372|13036036|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
5302661|NCT00528372|13036037|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
5302662|NCT00528372|13036038|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
5302663|NCT00528372|13036039|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
5302664|NCT00528372|13036040|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
5302665|NCT00528372|13036032|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
5302666|NCT00528372|13036033|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
5302667|NCT00528372|13036034|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
5302668|NCT00528372|13036035|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
5302669|NCT00528372|13036036|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
5302670|NCT00528372|13036037|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
5302671|NCT00528372|13036038|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
5302672|NCT00528372|13036039|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
5302673|NCT00528372|13036040|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
5302674|NCT00528372|13036032|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
5302675|NCT00528372|13036033|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
5302676|NCT00528372|13036034|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
5302677|NCT00528372|13036035|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
5302678|NCT00528372|13036036|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
5302679|NCT00528372|13036037|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
5302680|NCT00528372|13036038|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
5302681|NCT00528372|13036039|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
5302682|NCT00528372|13036040|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
5302683|NCT00528372|13036032|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
5302684|NCT00528372|13036033|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
5302685|NCT00528372|13036034|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
5302686|NCT00528372|13036035|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
5302687|NCT00528372|13036036|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
5302688|NCT00528372|13036037|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
5302689|NCT00528372|13036038|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
5302690|NCT00528372|13036039|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
5302691|NCT00528372|13036040|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
5302692|NCT00528372|13036032|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
5302693|NCT00528372|13036033|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
5302694|NCT00528372|13036034|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
5302695|NCT00528372|13036035|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
5302696|NCT00528372|13036036|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
5302697|NCT00528372|13036037|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
5302698|NCT00528372|13036038|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
5302699|NCT00528372|13036039|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
5302700|NCT00528372|13036040|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
5302701|NCT00528268|13036154|P2|NOT COMPLETED|Overall Study||1
5302702|NCT00528268|13036155|P1|NOT COMPLETED|Overall Study||1
5302703|NCT00528268|13036154|P2|COMPLETED|Overall Study||7
5302704|NCT00528268|13036155|P1|COMPLETED|Overall Study||5
5302705|NCT00528268|13036154|P2|STARTED|Overall Study||8
5302706|NCT00528268|13036155|P1|STARTED|Overall Study||6
5302707|NCT00528190|13036163|P2|NOT COMPLETED|Overall Study||1
5302708|NCT00528190|13036164|P1|NOT COMPLETED|Overall Study||0
5302709|NCT00528190|13036163|P2|COMPLETED|Overall Study||16
5302710|NCT00528190|13036164|P1|COMPLETED|Overall Study||18
5302711|NCT00528190|13036163|P2|STARTED|Overall Study||17
5302712|NCT00528190|13036164|P1|STARTED|Overall Study||18
5302713|NCT00528112|13036172|P2|NOT COMPLETED|Extension Phase||157
5302714|NCT00528112|13036173|P1|NOT COMPLETED|Extension Phase||0
5302715|NCT00528112|13036172|P2|COMPLETED|Extension Phase||550
5302716|NCT00528112|13036173|P1|COMPLETED|Extension Phase||0
5302717|NCT00528112|13036172|P2|STARTED|Extension Phase||707
5302718|NCT00528112|13036173|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
5302719|NCT00528112|13036172|P2|NOT COMPLETED|Treatment up to 3 Years||583
5302720|NCT00528112|13036173|P1|NOT COMPLETED|Treatment up to 3 Years||613
5302721|NCT00528112|13036172|P2|COMPLETED|Treatment up to 3 Years||870
5302722|NCT00528112|13036173|P1|COMPLETED|Treatment up to 3 Years||819
5302723|NCT00528112|13036172|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
5302724|NCT00528112|13036173|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
5302725|NCT00528112|13036172|P2|STARTED|Treatment up to 3 Years||1453
5302726|NCT00528112|13036173|P1|STARTED|Treatment up to 3 Years||1432
5302727|NCT00528021|13036231|P4|NOT COMPLETED|Overall Study||9
5302728|NCT00528021|13036232|P3|NOT COMPLETED|Overall Study||7
5302729|NCT00528021|13036233|P2|NOT COMPLETED|Overall Study||13
5302730|NCT00528021|13036234|P1|NOT COMPLETED|Overall Study||17
5302731|NCT00528021|13036231|P4|COMPLETED|Overall Study||47
5302732|NCT00528021|13036232|P3|COMPLETED|Overall Study||49
5302733|NCT00528021|13036233|P2|COMPLETED|Overall Study||46
5302734|NCT00528021|13036234|P1|COMPLETED|Overall Study||42
5302735|NCT00528021|13036231|P4|STARTED|Overall Study||56
5302736|NCT00528021|13036232|P3|STARTED|Overall Study||56
5302737|NCT00528021|13036233|P2|STARTED|Overall Study||59
5302738|NCT00528021|13036234|P1|STARTED|Overall Study||59
5302739|NCT00527982|13036246|P2|NOT COMPLETED|Overall Study||0
5302740|NCT00527982|13036247|P1|NOT COMPLETED|Overall Study||1
5302741|NCT00527982|13036246|P2|COMPLETED|Overall Study||0
5302742|NCT00527982|13036247|P1|COMPLETED|Overall Study||0
5302743|NCT00527982|13036246|P2|STARTED|Overall Study||0
5302744|NCT00527982|13036247|P1|STARTED|Overall Study||1
5302745|NCT00527943|13036255|P2|NOT COMPLETED|Overall Study||146
5302746|NCT00527943|13036256|P1|NOT COMPLETED|Overall Study||160
5302747|NCT00527943|13036255|P2|COMPLETED|Overall Study||6327
5302748|NCT00527943|13036256|P1|COMPLETED|Overall Study||6311
5302749|NCT00527943|13036255|P2|Received Treatment|Overall Study||6446
5302750|NCT00527943|13036256|P1|Received Treatment|Overall Study||6441
5302751|NCT00527943|13036255|P2|STARTED|Overall Study||6473
5302752|NCT00527943|13036256|P1|STARTED|Overall Study||6471
5302753|NCT00527904|13036288|P1|NOT COMPLETED|Overall Study||96
5302754|NCT00527904|13036288|P1|COMPLETED|Overall Study||143
5302755|NCT00527904|13036288|P1|STARTED|Overall Study||239
5302756|NCT00527878|13036292|P2|NOT COMPLETED|Intervention 2||0
5302757|NCT00527878|13036293|P1|NOT COMPLETED|Intervention 2||0
5302758|NCT00527878|13036292|P2|COMPLETED|Intervention 2||4
5302759|NCT00527878|13036293|P1|COMPLETED|Intervention 2||5
5302760|NCT00527878|13036292|P2|STARTED|Intervention 2||4
5302761|NCT00527878|13036293|P1|STARTED|Intervention 2||5
5302762|NCT00527878|13036292|P2|NOT COMPLETED|Intervention 1||3
5302763|NCT00527878|13036293|P1|NOT COMPLETED|Intervention 1||2
5302764|NCT00527878|13036292|P2|COMPLETED|Intervention 1||4
5302765|NCT00527878|13036293|P1|COMPLETED|Intervention 1||5
5302766|NCT00527878|13036292|P2|STARTED|Intervention 1||7
5302767|NCT00527878|13036293|P1|STARTED|Intervention 1||7
5302768|NCT00527826|13036307|P2|NOT COMPLETED|Overall Study||26
5302769|NCT00527826|13036308|P1|NOT COMPLETED|Overall Study||21
5302770|NCT00527826|13036307|P2|COMPLETED|Overall Study||80
5302771|NCT00527826|13036308|P1|COMPLETED|Overall Study||87
5302772|NCT00527826|13036307|P2|STARTED|Overall Study||106
5302773|NCT00527826|13036308|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
5302774|NCT00527787|13036357|P2|NOT COMPLETED|Overall Study||63
5302775|NCT00527787|13036358|P1|NOT COMPLETED|Overall Study||38
5302776|NCT00527787|13036357|P2|COMPLETED|Overall Study||153
5302777|NCT00527787|13036358|P1|COMPLETED|Overall Study||180
5302778|NCT00527787|13036357|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
5302779|NCT00527787|13036358|P1|STARTED|Overall Study||218
5302780|NCT00527748|13036380|P1|NOT COMPLETED|Overall Study||3
5302781|NCT00527748|13036380|P1|COMPLETED|Overall Study||23
5302782|NCT00527748|13036380|P1|STARTED|Overall Study||26
5302783|NCT00527735|13036387|P3|NOT COMPLETED|Overall Study||107
5302784|NCT00527735|13036388|P2|NOT COMPLETED|Overall Study||107
5302785|NCT00527735|13036389|P1|NOT COMPLETED|Overall Study||108
5302786|NCT00527735|13036387|P3|COMPLETED|Overall Study|Still on treatment|2
5302787|NCT00527735|13036388|P2|COMPLETED|Overall Study|Still on treatment|2
5302788|NCT00527735|13036389|P1|COMPLETED|Overall Study|Still on treatment|5
5302789|NCT00527735|13036387|P3|STARTED|Overall Study|Treated|109
5302790|NCT00527735|13036388|P2|STARTED|Overall Study|Treated|109
5302791|NCT00527735|13036389|P1|STARTED|Overall Study|Treated|113
5302792|NCT00527722|13036463|P2|NOT COMPLETED|Overall Study||0
5302793|NCT00527722|13036464|P1|NOT COMPLETED|Overall Study||0
5302794|NCT00527722|13036463|P2|COMPLETED|Overall Study||25
5302795|NCT00527722|13036464|P1|COMPLETED|Overall Study||22
5302796|NCT00527722|13036463|P2|STARTED|Overall Study||25
5302797|NCT00527722|13036464|P1|STARTED|Overall Study||22
5302798|NCT00527644|13036470|P1|NOT COMPLETED|Overall Study||0
5302799|NCT00527644|13036470|P1|COMPLETED|Overall Study||14
5302800|NCT00527644|13036470|P1|STARTED|Overall Study||14
5302801|NCT00527618|13036475|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
5302802|NCT00527618|13036476|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
5302803|NCT00527618|13036475|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
5302804|NCT00527618|13036476|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
5302805|NCT00527618|13036475|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
5302806|NCT00527618|13036476|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
5302807|NCT00527618|13036475|P2|NOT COMPLETED|Week 13-14 (Washout)||0
5302808|NCT00527618|13036476|P1|NOT COMPLETED|Week 13-14 (Washout)||1
5302809|NCT00527618|13036475|P2|COMPLETED|Week 13-14 (Washout)||16
5302810|NCT00527618|13036476|P1|COMPLETED|Week 13-14 (Washout)||12
5302811|NCT00527618|13036475|P2|STARTED|Week 13-14 (Washout)||16
5302812|NCT00527618|13036476|P1|STARTED|Week 13-14 (Washout)||13
5302813|NCT00527618|13036475|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
5302814|NCT00527618|13036476|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
5302815|NCT00527618|13036475|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
5302816|NCT00527618|13036476|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
5302817|NCT00527618|13036475|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
5302818|NCT00527618|13036476|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
5302819|NCT00527605|13036491|P2|NOT COMPLETED|Overall Study||11
5302820|NCT00527605|13036492|P1|NOT COMPLETED|Overall Study||13
5302821|NCT00527605|13036491|P2|COMPLETED|Overall Study||116
5302822|NCT00527605|13036492|P1|COMPLETED|Overall Study||113
5302823|NCT00527605|13036491|P2|STARTED|Overall Study||127
5302824|NCT00527605|13036492|P1|STARTED|Overall Study||126
5302825|NCT00527592|13036528|P1|NOT COMPLETED|Overall Study||0
5302826|NCT00527592|13036528|P1|COMPLETED|Overall Study||54
5302827|NCT00527592|13036528|P1|STARTED|Overall Study||54
5302828|NCT00527566|13036534|P1|NOT COMPLETED|Overall Study||0
5302829|NCT00527566|13036534|P1|COMPLETED|Overall Study||10
5302830|NCT00527566|13036534|P1|STARTED|Overall Study||10
5302831|NCT00527514|13036543|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
5302832|NCT00527514|13036543|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
5302833|NCT00527514|13036543|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
5302834|NCT00527514|13036543|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
5302835|NCT00527514|13036543|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
5302836|NCT00527514|13036543|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
5302837|NCT00527514|13036543|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
5302838|NCT00527514|13036543|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
5302839|NCT00527514|13036543|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
5302840|NCT00527514|13036543|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
5302841|NCT00527514|13036543|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
5302842|NCT00527514|13036543|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
5302843|NCT00527488|13036559|P4|NOT COMPLETED|Overall Study||0
5302844|NCT00527488|13036560|P3|NOT COMPLETED|Overall Study||1
5302845|NCT00527488|13036561|P2|NOT COMPLETED|Overall Study||1
5302846|NCT00527488|13036562|P1|NOT COMPLETED|Overall Study||0
5302847|NCT00527488|13036559|P4|COMPLETED|Overall Study||13
5302848|NCT00527488|13036560|P3|COMPLETED|Overall Study||12
5302849|NCT00527488|13036561|P2|COMPLETED|Overall Study||12
5302850|NCT00527488|13036562|P1|COMPLETED|Overall Study||13
5302851|NCT00527488|13036559|P4|STARTED|Overall Study||13
5302852|NCT00527488|13036560|P3|STARTED|Overall Study||13
5302853|NCT00527488|13036561|P2|STARTED|Overall Study||13
5302854|NCT00527488|13036562|P1|STARTED|Overall Study||13
5302855|NCT00527475|13036638|P2|NOT COMPLETED|Overall Study||1
5302856|NCT00527475|13036639|P1|NOT COMPLETED|Overall Study||3
5302857|NCT00527475|13036638|P2|COMPLETED|Overall Study||29
5302858|NCT00527475|13036639|P1|COMPLETED|Overall Study||27
5302859|NCT00527475|13036638|P2|STARTED|Overall Study||30
5302860|NCT00527475|13036639|P1|STARTED|Overall Study||30
5302861|NCT00527423|13036645|P1|NOT COMPLETED|Overall Study||37
5302862|NCT00527423|13036645|P1|COMPLETED|Overall Study||120
5302863|NCT00527423|13036645|P1|STARTED|Overall Study||157
5302864|NCT00527397|13036651|P1|NOT COMPLETED|Overall Study||24
5302865|NCT00527397|13036651|P1|COMPLETED|Overall Study||0
5302866|NCT00527397|13036651|P1|STARTED|Overall Study||24
5302867|NCT00527332|13036677|P2|NOT COMPLETED|Overall Study||9
5302868|NCT00527332|13036678|P1|NOT COMPLETED|Overall Study||9
5302869|NCT00527332|13036677|P2|COMPLETED|Overall Study||80
5302870|NCT00527332|13036678|P1|COMPLETED|Overall Study||82
5302871|NCT00527332|13036677|P2|STARTED|Overall Study||89
5302872|NCT00527332|13036678|P1|STARTED|Overall Study||91
5302873|NCT00527319|13036687|P3|NOT COMPLETED|Overall Study||6
5302874|NCT00527319|13036688|P2|NOT COMPLETED|Overall Study||4
5302875|NCT00527319|13036689|P1|NOT COMPLETED|Overall Study||6
5302876|NCT00527319|13036687|P3|COMPLETED|Overall Study||7
5302877|NCT00527319|13036688|P2|COMPLETED|Overall Study||8
5302878|NCT00527319|13036689|P1|COMPLETED|Overall Study||6
5302879|NCT00527319|13036687|P3|STARTED|Overall Study||13
5302880|NCT00527319|13036688|P2|STARTED|Overall Study||12
5302881|NCT00527319|13036689|P1|STARTED|Overall Study||12
5302882|NCT00527124|13036702|P2|NOT COMPLETED|Overall Study||0
5302883|NCT00527124|13036703|P1|NOT COMPLETED|Overall Study||0
5302884|NCT00527124|13036702|P2|COMPLETED|Overall Study||28
5302885|NCT00527124|13036703|P1|COMPLETED|Overall Study||29
5302886|NCT00527124|13036702|P2|STARTED|Overall Study||28
5302887|NCT00527124|13036703|P1|STARTED|Overall Study||29
5302888|NCT00527111|13036719|P2|NOT COMPLETED|Overall Study||22
5302889|NCT00527111|13036720|P1|NOT COMPLETED|Overall Study||20
5302890|NCT00527111|13036719|P2|COMPLETED|Overall Study||47
5302891|NCT00527111|13036720|P1|COMPLETED|Overall Study||50
5302892|NCT00527111|13036719|P2|STARTED|Overall Study||69
5302893|NCT00527111|13036720|P1|STARTED|Overall Study||70
5302894|NCT00527098|13036736|P2|NOT COMPLETED|Overall Study||0
5302895|NCT00527098|13036737|P1|NOT COMPLETED|Overall Study||0
5302896|NCT00527098|13036736|P2|COMPLETED|Overall Study||83
5302897|NCT00527098|13036737|P1|COMPLETED|Overall Study||36
5302898|NCT00527098|13036736|P2|STARTED|Overall Study||83
5302899|NCT00527098|13036737|P1|STARTED|Overall Study||36
5302900|NCT00527072|13036742|P1|NOT COMPLETED|Overall Study||36
5302901|NCT00527072|13036742|P1|COMPLETED|Overall Study||179
5302902|NCT00527072|13036742|P1|STARTED|Overall Study||215
5302903|NCT00526994|13036751|P3|NOT COMPLETED|Overall Study||107
5302904|NCT00526994|13036752|P2|NOT COMPLETED|Overall Study||121
5302905|NCT00526994|13036753|P1|NOT COMPLETED|Overall Study||108
5302906|NCT00526994|13036751|P3|COMPLETED|Overall Study||791
5302907|NCT00526994|13036752|P2|COMPLETED|Overall Study||772
5302908|NCT00526994|13036753|P1|COMPLETED|Overall Study||801
5302909|NCT00526994|13036751|P3|STARTED|Overall Study||898
5302910|NCT00526994|13036752|P2|STARTED|Overall Study||893
5302911|NCT00526994|13036753|P1|STARTED|Overall Study||909
5302912|NCT00526890|13036770|P1|NOT COMPLETED|Overall Study||2
5302913|NCT00526890|13036770|P1|COMPLETED|Overall Study||14
5302914|NCT00526890|13036770|P1|STARTED|Overall Study||16
5302915|NCT00526799|13036782|P2|NOT COMPLETED|Overall Study||1
5302916|NCT00526799|13036783|P1|NOT COMPLETED|Overall Study||1
5302917|NCT00526799|13036782|P2|COMPLETED|Overall Study||13
5302918|NCT00526799|13036783|P1|COMPLETED|Overall Study||15
5302919|NCT00526799|13036782|P2|STARTED|Overall Study||14
5302920|NCT00526799|13036783|P1|STARTED|Overall Study||16
5302921|NCT00526669|13036791|P2|NOT COMPLETED|Combined Treatment Phase||8
5302922|NCT00526669|13036792|P1|NOT COMPLETED|Combined Treatment Phase||0
5302923|NCT00526669|13036791|P2|COMPLETED|Combined Treatment Phase||59
5302924|NCT00526669|13036792|P1|COMPLETED|Combined Treatment Phase||0
5302925|NCT00526669|13036791|P2|STARTED|Combined Treatment Phase||67
5302926|NCT00526669|13036792|P1|STARTED|Combined Treatment Phase||0
5302927|NCT00526669|13036791|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
5302928|NCT00526669|13036792|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
5302929|NCT00526669|13036791|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
5302930|NCT00526669|13036792|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
5302931|NCT00526669|13036791|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
5302932|NCT00526669|13036792|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
5302933|NCT00526656|13036821|P1|NOT COMPLETED|Overall Study||2
5302934|NCT00526656|13036821|P1|COMPLETED|Overall Study||7
5302935|NCT00526656|13036821|P1|STARTED|Overall Study||9
5302936|NCT00526630|13036827|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
5302937|NCT00526630|13036828|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
5302938|NCT00526630|13036827|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
5302939|NCT00526630|13036828|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
5302940|NCT00526630|13036827|P2|STARTED|Second Intervention Period - 12 Weeks||8
5302941|NCT00526630|13036828|P1|STARTED|Second Intervention Period - 12 Weeks||12
5302942|NCT00526630|13036827|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
5302943|NCT00526630|13036828|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
5302944|NCT00526630|13036827|P2|COMPLETED|First Intervention Period - 12 Weeks||8
5302945|NCT00526630|13036828|P1|COMPLETED|First Intervention Period - 12 Weeks||12
5302946|NCT00526630|13036827|P2|STARTED|First Intervention Period - 12 Weeks||11
5302947|NCT00526630|13036828|P1|STARTED|First Intervention Period - 12 Weeks||12
5302948|NCT00526591|13036858|P2|NOT COMPLETED|Overall Study||0
5302949|NCT00526591|13036859|P1|NOT COMPLETED|Overall Study||0
5302950|NCT00526591|13036858|P2|COMPLETED|Overall Study||9
5302951|NCT00526591|13036859|P1|COMPLETED|Overall Study||8
5302952|NCT00526591|13036858|P2|STARTED|Overall Study||9
5302953|NCT00526591|13036859|P1|STARTED|Overall Study||8
5302954|NCT00526474|13036871|P2|NOT COMPLETED|Overall Study||272
5302955|NCT00526474|13036872|P1|NOT COMPLETED|Overall Study||292
5302956|NCT00526474|13036871|P2|COMPLETED|Overall Study||12953
5302957|NCT00526474|13036872|P1|COMPLETED|Overall Study||12932
5302958|NCT00526474|13036871|P2|Received Study Drug|Overall Study||13186
5302959|NCT00526474|13036872|P1|Received Study Drug|Overall Study||13166
5302960|NCT00526474|13036871|P2|STARTED|Overall Study||13225
5302961|NCT00526474|13036872|P1|STARTED|Overall Study||13224
5302962|NCT00526331|13036940|P1|NOT COMPLETED|Overall Study||55
5302963|NCT00526331|13036940|P1|COMPLETED|Overall Study||0
5302964|NCT00526331|13036940|P1|STARTED|Overall Study||55
5302965|NCT00526292|13036944|P1|NOT COMPLETED|Overall Study||0
5302966|NCT00526292|13036944|P1|COMPLETED|Overall Study||6
5302967|NCT00526292|13036944|P1|STARTED|Overall Study||6
5302968|NCT00526227|13036948|P1|NOT COMPLETED|Overall Study||2
5302969|NCT00526227|13036948|P1|COMPLETED|Overall Study||79
5302970|NCT00526227|13036948|P1|STARTED|Overall Study||81
5302971|NCT00526188|13036953|P1|NOT COMPLETED|Overall Study||0
5302972|NCT00526188|13036953|P1|COMPLETED|Overall Study||234
5302973|NCT00526188|13036953|P1|STARTED|Overall Study||234
5302974|NCT00526162|13036959|P1|NOT COMPLETED|Overall Study||3
5302975|NCT00526162|13036959|P1|COMPLETED|Overall Study||80
5302976|NCT00526162|13036959|P1|STARTED|Overall Study||83
5302977|NCT00526123|13036969|P2|NOT COMPLETED|Overall Study||246
5302978|NCT00526123|13036970|P1|NOT COMPLETED|Overall Study||264
5302979|NCT00526123|13036969|P2|COMPLETED|Overall Study||50
5302980|NCT00526123|13036970|P1|COMPLETED|Overall Study||39
5302981|NCT00526123|13036969|P2|STARTED|Overall Study|Intent-to-Treat population|296
5302982|NCT00526123|13036970|P1|STARTED|Overall Study|Intent-to-Treat population|303
5302983|NCT00526110|13036992|P2|NOT COMPLETED|Overall Study||41
5302984|NCT00526110|13036993|P1|NOT COMPLETED|Overall Study||2
5302985|NCT00526110|13036992|P2|COMPLETED|Overall Study||4
5302986|NCT00526110|13036993|P1|COMPLETED|Overall Study||51
5302987|NCT00526110|13036992|P2|STARTED|Overall Study||45
5302988|NCT00526110|13036993|P1|STARTED|Overall Study||53
5302989|NCT00526097|13037002|P2|NOT COMPLETED|Overall Study||56
5302990|NCT00526097|13037003|P1|NOT COMPLETED|Overall Study||15
5302991|NCT00526097|13037002|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
5303081|NCT00525603|13037332|P1|NOT COMPLETED|Overall Study||0
5302992|NCT00526097|13037003|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
5302993|NCT00526097|13037002|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
5302994|NCT00526097|13037003|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
5302995|NCT00526071|13037179|P1|NOT COMPLETED|Overall Study||6
5302996|NCT00526071|13037179|P1|COMPLETED|Overall Study||17
5302997|NCT00526071|13037179|P1|Non-amenable Population; Women|Overall Study||4
5302998|NCT00526071|13037179|P1|Non-amenable Population; Men|Overall Study||3
5302999|NCT00526071|13037179|P1|Amenable Population; Women|Overall Study||5
5303000|NCT00526071|13037179|P1|Amenable Population; Men|Overall Study||11
5303001|NCT00526071|13037179|P1|Pharmacodynamic (PD) Population|Overall Study||23
5303002|NCT00526071|13037179|P1|Safety Population|Overall Study||23
5303003|NCT00526071|13037179|P1|STARTED|Overall Study||23
5303004|NCT00526058|13037190|P2|NOT COMPLETED|Period: Second Intervention||0
5303005|NCT00526058|13037191|P1|NOT COMPLETED|Period: Second Intervention||0
5303006|NCT00526058|13037190|P2|COMPLETED|Period: Second Intervention||9
5303007|NCT00526058|13037191|P1|COMPLETED|Period: Second Intervention||9
5303008|NCT00526058|13037190|P2|STARTED|Period: Second Intervention||9
5303009|NCT00526058|13037191|P1|STARTED|Period: Second Intervention||9
5303010|NCT00526058|13037190|P2|NOT COMPLETED|Period: First Intervention||0
5303011|NCT00526058|13037191|P1|NOT COMPLETED|Period: First Intervention||0
5303012|NCT00526058|13037190|P2|COMPLETED|Period: First Intervention||9
5303013|NCT00526058|13037191|P1|COMPLETED|Period: First Intervention||9
5303014|NCT00526058|13037190|P2|STARTED|Period: First Intervention||9
5303015|NCT00526058|13037191|P1|STARTED|Period: First Intervention||9
5303016|NCT00525915|13037205|P2|NOT COMPLETED|Overall Study||9
5303017|NCT00525915|13037206|P1|NOT COMPLETED|Overall Study||8
5303018|NCT00525915|13037205|P2|COMPLETED|Overall Study||54
5303019|NCT00525915|13037206|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
5303020|NCT00525915|13037205|P2|STARTED|Overall Study||63
5303021|NCT00525915|13037206|P1|STARTED|Overall Study||63
5303022|NCT00525902|13037212|P1|NOT COMPLETED|Overall Study||1
5303023|NCT00525902|13037212|P1|COMPLETED|Overall Study||30
5303024|NCT00525902|13037212|P1|50 Weeks|Overall Study||12
5303025|NCT00525902|13037212|P1|10 Weeks|Overall Study||30
5303026|NCT00525902|13037212|P1|STARTED|Overall Study||31
5303027|NCT00525876|13037219|P2|NOT COMPLETED|Overall Study||0
5303028|NCT00525876|13037220|P1|NOT COMPLETED|Overall Study||0
5303029|NCT00525876|13037219|P2|COMPLETED|Overall Study||20
5303030|NCT00525876|13037220|P1|COMPLETED|Overall Study||16
5303031|NCT00525876|13037219|P2|STARTED|Overall Study||20
5303032|NCT00525876|13037220|P1|STARTED|Overall Study||16
5303033|NCT00525837|13037226|P1|NOT COMPLETED|Overall Study||4
5303034|NCT00525837|13037226|P1|COMPLETED|Overall Study||14
5303035|NCT00525837|13037226|P1|STARTED|Overall Study||18
5303036|NCT00525824|13037236|P4|NOT COMPLETED|Overall Study||15
5303037|NCT00525824|13037237|P3|NOT COMPLETED|Overall Study||19
5303038|NCT00525824|13037238|P2|NOT COMPLETED|Overall Study||28
5303039|NCT00525824|13037239|P1|NOT COMPLETED|Overall Study||19
5303040|NCT00525824|13037236|P4|COMPLETED|Overall Study||188
5303041|NCT00525824|13037237|P3|COMPLETED|Overall Study||183
5303042|NCT00525824|13037238|P2|COMPLETED|Overall Study||186
5303043|NCT00525824|13037239|P1|COMPLETED|Overall Study||195
5303044|NCT00525824|13037236|P4|STARTED|Overall Study|Randomized population|203
5303045|NCT00525824|13037237|P3|STARTED|Overall Study|Randomized population|202
5303046|NCT00525824|13037238|P2|STARTED|Overall Study|Randomized population|214
5303047|NCT00525824|13037239|P1|STARTED|Overall Study|Randomized population|214
5303048|NCT00525798|13037303|P2|NOT COMPLETED|Overall Study||599
5303049|NCT00525798|13037304|P1|NOT COMPLETED|Overall Study||756
5303050|NCT00525798|13037303|P2|COMPLETED|Overall Study||1732
5303051|NCT00525798|13037304|P1|COMPLETED|Overall Study||1578
5303052|NCT00525798|13037303|P2|STARTED|Overall Study||2331
5303053|NCT00525798|13037304|P1|STARTED|Overall Study||2334
5303054|NCT00525785|13037312|P1|NOT COMPLETED|Overall Study||3
5303055|NCT00525785|13037312|P1|COMPLETED|Overall Study||55
5303056|NCT00525785|13037312|P1|STARTED|Overall Study||58
5303057|NCT00525733|13037318|P2|NOT COMPLETED|Overall Study||3
5303058|NCT00525733|13037319|P1|NOT COMPLETED|Overall Study||3
5303059|NCT00525733|13037318|P2|COMPLETED|Overall Study||23
5303060|NCT00525733|13037319|P1|COMPLETED|Overall Study||11
5303061|NCT00525733|13037318|P2|STARTED|Overall Study||26
5303062|NCT00525733|13037319|P1|STARTED|Overall Study||14
5303063|NCT00525629|13037325|P2|NOT COMPLETED|Second Intervention||15
5303064|NCT00525629|13037326|P1|NOT COMPLETED|Second Intervention||15
5303065|NCT00525629|13037325|P2|COMPLETED|Second Intervention||0
5303066|NCT00525629|13037326|P1|COMPLETED|Second Intervention||0
5303067|NCT00525629|13037325|P2|STARTED|Second Intervention||15
5303068|NCT00525629|13037326|P1|STARTED|Second Intervention||15
5303069|NCT00525629|13037325|P2|NOT COMPLETED|Washout||0
5303070|NCT00525629|13037326|P1|NOT COMPLETED|Washout||0
5303071|NCT00525629|13037325|P2|COMPLETED|Washout||15
5303072|NCT00525629|13037326|P1|COMPLETED|Washout||15
5303073|NCT00525629|13037325|P2|STARTED|Washout||15
5303074|NCT00525629|13037326|P1|STARTED|Washout||15
5303075|NCT00525629|13037325|P2|NOT COMPLETED|First Intervention||5
5303076|NCT00525629|13037326|P1|NOT COMPLETED|First Intervention||5
5303077|NCT00525629|13037325|P2|COMPLETED|First Intervention||15
5303078|NCT00525629|13037326|P1|COMPLETED|First Intervention||15
5303079|NCT00525629|13037325|P2|STARTED|First Intervention||20
5303080|NCT00525629|13037326|P1|STARTED|First Intervention||20
5303082|NCT00525603|13037332|P1|COMPLETED|Overall Study||60
5303083|NCT00525603|13037332|P1|STARTED|Overall Study||60
5303084|NCT00525590|13037336|P1|NOT COMPLETED|Overall Study||45
5303085|NCT00525590|13037336|P1|COMPLETED|Overall Study||14
5303086|NCT00525590|13037336|P1|STARTED|Overall Study||59
5303087|NCT00525525|13037354|P2|NOT COMPLETED|Overall Study||0
5303088|NCT00525525|13037355|P1|NOT COMPLETED|Overall Study||0
5303089|NCT00525525|13037354|P2|COMPLETED|Overall Study||15
5303090|NCT00525525|13037355|P1|COMPLETED|Overall Study||59
5303091|NCT00525525|13037354|P2|STARTED|Overall Study||15
5303092|NCT00525525|13037355|P1|STARTED|Overall Study||59
5303093|NCT00525512|13037364|P4|NOT COMPLETED|Open-Label Phase||5
5303094|NCT00525512|13037365|P3|NOT COMPLETED|Open-Label Phase||6
5303095|NCT00525512|13037366|P2|NOT COMPLETED|Open-Label Phase||0
5303096|NCT00525512|13037367|P1|NOT COMPLETED|Open-Label Phase||0
5303097|NCT00525512|13037364|P4|COMPLETED|Open-Label Phase||189
5303098|NCT00525512|13037365|P3|COMPLETED|Open-Label Phase||158
5303099|NCT00525512|13037366|P2|COMPLETED|Open-Label Phase||0
5303100|NCT00525512|13037367|P1|COMPLETED|Open-Label Phase||0
5303101|NCT00525512|13037364|P4|STARTED|Open-Label Phase||194
5303102|NCT00525512|13037365|P3|STARTED|Open-Label Phase||164
5303103|NCT00525512|13037366|P2|STARTED|Open-Label Phase||0
5303104|NCT00525512|13037367|P1|STARTED|Open-Label Phase||0
5303105|NCT00525512|13037364|P4|NOT COMPLETED|Double-Blind Phase||0
5303106|NCT00525512|13037365|P3|NOT COMPLETED|Double-Blind Phase||0
5303107|NCT00525512|13037366|P2|NOT COMPLETED|Double-Blind Phase||66
5303108|NCT00525512|13037367|P1|NOT COMPLETED|Double-Blind Phase||96
5303109|NCT00525512|13037364|P4|COMPLETED|Double-Blind Phase||0
5303110|NCT00525512|13037365|P3|COMPLETED|Double-Blind Phase||0
5303111|NCT00525512|13037366|P2|COMPLETED|Double-Blind Phase||194
5303112|NCT00525512|13037367|P1|COMPLETED|Double-Blind Phase||163
5303113|NCT00525512|13037364|P4|STARTED|Double-Blind Phase||0
5303114|NCT00525512|13037365|P3|STARTED|Double-Blind Phase||0
5303115|NCT00525512|13037366|P2|STARTED|Double-Blind Phase||260
5303116|NCT00525512|13037367|P1|STARTED|Double-Blind Phase||259
5303117|NCT00525499|13037509|P4|NOT COMPLETED|Overall Study||7
5303118|NCT00525499|13037510|P3|NOT COMPLETED|Overall Study||7
5303119|NCT00525499|13037511|P2|NOT COMPLETED|Overall Study||7
5303120|NCT00525499|13037512|P1|NOT COMPLETED|Overall Study||7
5303121|NCT00525499|13037509|P4|COMPLETED|Overall Study||39
5303122|NCT00525499|13037510|P3|COMPLETED|Overall Study||40
5303123|NCT00525499|13037511|P2|COMPLETED|Overall Study||39
5303124|NCT00525499|13037512|P1|COMPLETED|Overall Study||40
5303125|NCT00525499|13037509|P4|STARTED|Overall Study||46
5303126|NCT00525499|13037510|P3|STARTED|Overall Study||47
5303127|NCT00525499|13037511|P2|STARTED|Overall Study||46
5303128|NCT00525499|13037512|P1|STARTED|Overall Study||47
5303129|NCT00525421|13037528|P2|NOT COMPLETED|Overall Study||0
5303130|NCT00525421|13037529|P1|NOT COMPLETED|Overall Study||0
5303131|NCT00525421|13037528|P2|COMPLETED|Overall Study||10
5303132|NCT00525421|13037529|P1|COMPLETED|Overall Study||10
5303133|NCT00525421|13037528|P2|STARTED|Overall Study||10
5303134|NCT00525421|13037529|P1|STARTED|Overall Study|Enrollment started october 2007|10
5303135|NCT00525265|13037539|P2|NOT COMPLETED|Overall Study||0
5303136|NCT00525265|13037540|P1|NOT COMPLETED|Overall Study||1
5303137|NCT00525265|13037539|P2|COMPLETED|Overall Study||10
5303138|NCT00525265|13037540|P1|COMPLETED|Overall Study||9
5303139|NCT00525265|13037539|P2|STARTED|Overall Study||10
5303140|NCT00525265|13037540|P1|STARTED|Overall Study||10
5303141|NCT00525174|13037548|P2|NOT COMPLETED|Overall Study||8
5303142|NCT00525174|13037549|P1|NOT COMPLETED|Overall Study||9
5303143|NCT00525174|13037548|P2|COMPLETED|Overall Study||81
5303144|NCT00525174|13037549|P1|COMPLETED|Overall Study||88
5303145|NCT00525174|13037548|P2|STARTED|Overall Study||89
5303146|NCT00525174|13037549|P1|STARTED|Overall Study||97
5303147|NCT00525161|13037597|P1|NOT COMPLETED|Overall Study||1
5303148|NCT00525161|13037597|P1|COMPLETED|Overall Study||10
5303149|NCT00525161|13037597|P1|STARTED|Overall Study||11
5303150|NCT00525148|13037607|P4|NOT COMPLETED|Overall Study||61
5303151|NCT00525148|13037608|P3|NOT COMPLETED|Overall Study||7
5303152|NCT00525148|13037609|P2|NOT COMPLETED|Overall Study||38
5303153|NCT00525148|13037610|P1|NOT COMPLETED|Overall Study||23
5303154|NCT00525148|13037607|P4|COMPLETED|Overall Study||0
5303155|NCT00525148|13037608|P3|COMPLETED|Overall Study||0
5303156|NCT00525148|13037609|P2|COMPLETED|Overall Study||0
5303157|NCT00525148|13037610|P1|COMPLETED|Overall Study||0
5303158|NCT00525148|13037607|P4|STARTED|Overall Study|entered and treated|61
5303159|NCT00525148|13037608|P3|STARTED|Overall Study|entered and treated|7
5303160|NCT00525148|13037609|P2|STARTED|Overall Study|entered and treated|38
5303161|NCT00525148|13037610|P1|STARTED|Overall Study|entered and treated|23
5303162|NCT00525135|13037628|P1|NOT COMPLETED|Overall Study||0
5303163|NCT00525135|13037628|P1|COMPLETED|Overall Study||5
5303164|NCT00525135|13037628|P1|STARTED|Overall Study||5
5303165|NCT00525044|13037638|P2|NOT COMPLETED|Overall Study||1
5303166|NCT00525044|13037639|P1|NOT COMPLETED|Overall Study||0
5303167|NCT00525044|13037638|P2|COMPLETED|Overall Study||124
5303168|NCT00525044|13037639|P1|COMPLETED|Overall Study||124
5303169|NCT00525044|13037638|P2|STARTED|Overall Study||125
5303170|NCT00525044|13037639|P1|STARTED|Overall Study||124
5303171|NCT00525031|13037655|P2|NOT COMPLETED|Overall Study||1
5303172|NCT00525031|13037656|P1|NOT COMPLETED|Overall Study||1
5303173|NCT00525031|13037655|P2|COMPLETED|Overall Study||24
5303174|NCT00525031|13037656|P1|COMPLETED|Overall Study||26
5303175|NCT00525031|13037655|P2|STARTED|Overall Study||25
5303176|NCT00525031|13037656|P1|STARTED|Overall Study||27
5303177|NCT00524940|13037663|P1|NOT COMPLETED|Overall Study||0
5303178|NCT00524940|13037663|P1|COMPLETED|Overall Study||124
5303179|NCT00524940|13037663|P1|STARTED|Overall Study||124
5303180|NCT00524771|13037670|P2|NOT COMPLETED|Overall Study||585
5303181|NCT00524771|13037671|P1|NOT COMPLETED|Overall Study||220
5303182|NCT00524771|13037670|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
5303183|NCT00524771|13037671|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
5303184|NCT00524771|13037670|P2|STARTED|Overall Study||17016
5303185|NCT00524771|13037671|P1|STARTED|Overall Study||17084
5303186|NCT00524745|13037685|P4|NOT COMPLETED|Overall Study||22
5303187|NCT00524745|13037686|P3|NOT COMPLETED|Overall Study||29
5303188|NCT00524745|13037687|P2|NOT COMPLETED|Overall Study||13
5303189|NCT00524745|13037688|P1|NOT COMPLETED|Overall Study||34
5303190|NCT00524745|13037685|P4|COMPLETED|Overall Study||205
5303191|NCT00524745|13037686|P3|COMPLETED|Overall Study||212
5303192|NCT00524745|13037687|P2|COMPLETED|Overall Study||193
5303193|NCT00524745|13037688|P1|COMPLETED|Overall Study||195
5303194|NCT00524745|13037685|P4|STARTED|Overall Study||227
5303195|NCT00524745|13037686|P3|STARTED|Overall Study||241
5303196|NCT00524745|13037687|P2|STARTED|Overall Study||206
5303197|NCT00524745|13037688|P1|STARTED|Overall Study||229
5303198|NCT00524680|13037714|P4|NOT COMPLETED|Overall Study||6
5303199|NCT00524680|13037715|P3|NOT COMPLETED|Overall Study||3
5303200|NCT00524680|13037716|P2|NOT COMPLETED|Overall Study||1
5303201|NCT00524680|13037717|P1|NOT COMPLETED|Overall Study||3
5303202|NCT00524680|13037714|P4|COMPLETED|Overall Study||34
5303203|NCT00524680|13037715|P3|COMPLETED|Overall Study||33
5303204|NCT00524680|13037716|P2|COMPLETED|Overall Study||34
5303205|NCT00524680|13037717|P1|COMPLETED|Overall Study||34
5303206|NCT00524680|13037714|P4|STARTED|Overall Study||40
5303207|NCT00524680|13037715|P3|STARTED|Overall Study||36
5303208|NCT00524680|13037716|P2|STARTED|Overall Study||35
5303209|NCT00524680|13037717|P1|STARTED|Overall Study||37
5303210|NCT00524589|13037739|P1|NOT COMPLETED|Overall Study||18
5303211|NCT00524589|13037739|P1|COMPLETED|Overall Study||0
5303212|NCT00524589|13037739|P1|STARTED|Overall Study||18
5303213|NCT00524576|13037746|P2|NOT COMPLETED|Overall Study||0
5303214|NCT00524576|13037747|P1|NOT COMPLETED|Overall Study||0
5303215|NCT00524576|13037746|P2|COMPLETED|Overall Study||47
5303216|NCT00524576|13037747|P1|COMPLETED|Overall Study||97
5303217|NCT00524576|13037746|P2|STARTED|Overall Study||47
5303218|NCT00524576|13037747|P1|STARTED|Overall Study||97
5303219|NCT00524537|13037765|P1|NOT COMPLETED|Overall Study||2574
5303220|NCT00524537|13037765|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
5303221|NCT00524537|13037765|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
5303222|NCT00524537|13037765|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
5303223|NCT00524537|13037765|P1|Discontinued|Overall Study|Discontinued from study|2811
5303224|NCT00524537|13037765|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
5303225|NCT00524511|13037781|P2|NOT COMPLETED|Overall Study||7
5303226|NCT00524511|13037782|P1|NOT COMPLETED|Overall Study||4
5303227|NCT00524511|13037781|P2|COMPLETED|Overall Study||61
5303228|NCT00524511|13037782|P1|COMPLETED|Overall Study||64
5303229|NCT00524511|13037781|P2|STARTED|Overall Study||68
5303230|NCT00524511|13037782|P1|STARTED|Overall Study||68
5303231|NCT00524485|13037790|P1|NOT COMPLETED|Overall Study||5
5303232|NCT00524485|13037790|P1|COMPLETED|Overall Study||7
5303233|NCT00524485|13037790|P1|STARTED|Overall Study||12
5303234|NCT00524472|13037802|P2|NOT COMPLETED|Overall Study||0
5303235|NCT00524472|13037803|P1|NOT COMPLETED|Overall Study||0
5303236|NCT00524472|13037802|P2|COMPLETED|Overall Study||730
5303237|NCT00524472|13037803|P1|COMPLETED|Overall Study||709
5303238|NCT00524472|13037802|P2|STARTED|Overall Study||730
5303239|NCT00524472|13037803|P1|STARTED|Overall Study||709
5303240|NCT00524459|13037819|P1|NOT COMPLETED|Overall Study||2
5303241|NCT00524459|13037819|P1|COMPLETED|Overall Study||4
5303242|NCT00524459|13037819|P1|STARTED|Overall Study||6
5303243|NCT00524420|13037829|P2|NOT COMPLETED|Overall Study||0
5303244|NCT00524420|13037830|P1|NOT COMPLETED|Overall Study||1
5303245|NCT00524420|13037829|P2|COMPLETED|Overall Study||11
5303246|NCT00524420|13037830|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
5303247|NCT00524420|13037829|P2|STARTED|Overall Study||11
5303248|NCT00524420|13037830|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
5303249|NCT00524394|13037842|P1|NOT COMPLETED|Overall Study||1
5303250|NCT00524394|13037842|P1|COMPLETED|Overall Study||1
5303251|NCT00524394|13037842|P1|STARTED|Overall Study||2
5303252|NCT00524368|13037848|P2|NOT COMPLETED|Overall Study||48
5303253|NCT00524368|13037849|P1|NOT COMPLETED|Overall Study||41
5303254|NCT00524368|13037848|P2|COMPLETED|Overall Study||248
5303255|NCT00524368|13037849|P1|COMPLETED|Overall Study||253
5303256|NCT00524368|13037848|P2|STARTED|Overall Study||296
5303257|NCT00524368|13037849|P1|STARTED|Overall Study||294
5303258|NCT00524342|13037877|P1|NOT COMPLETED|Overall Study||0
5303259|NCT00524342|13037877|P1|COMPLETED|Overall Study||7
5303260|NCT00524342|13037877|P1|STARTED|Overall Study||7
5303261|NCT00524316|13037883|P1|NOT COMPLETED|Overall Study||16
5303262|NCT00524316|13037883|P1|COMPLETED|Overall Study||0
5303263|NCT00524316|13037883|P1|STARTED|Overall Study||16
5303264|NCT00524303|13037895|P3|NOT COMPLETED|Overall Study||18
5303265|NCT00524303|13037896|P2|NOT COMPLETED|Overall Study||10
5303266|NCT00524303|13037897|P1|NOT COMPLETED|Overall Study||12
5303267|NCT00524303|13037895|P3|COMPLETED|Overall Study||15
5303268|NCT00524303|13037896|P2|COMPLETED|Overall Study||24
5303269|NCT00524303|13037897|P1|COMPLETED|Overall Study||21
5303270|NCT00524303|13037895|P3|STARTED|Overall Study||33
5303271|NCT00524303|13037896|P2|STARTED|Overall Study||34
5303272|NCT00524303|13037897|P1|STARTED|Overall Study||33
5303273|NCT00524264|13037927|P2|NOT COMPLETED|Overall Study||27
5303274|NCT00524264|13037928|P1|NOT COMPLETED|Overall Study||20
5303275|NCT00524264|13037927|P2|COMPLETED|Overall Study||57
5303276|NCT00524264|13037928|P1|COMPLETED|Overall Study||144
5303277|NCT00524264|13037927|P2|STARTED|Overall Study||84
5303278|NCT00524264|13037928|P1|STARTED|Overall Study||164
5303279|NCT00524225|13037940|P1|NOT COMPLETED|Overall Study||0
5303280|NCT00524225|13037940|P1|COMPLETED|Overall Study||3
5303281|NCT00524225|13037940|P1|STARTED|Overall Study||3
5303282|NCT00524173|13037949|P2|NOT COMPLETED|Overall Study||2
5303283|NCT00524173|13037950|P1|NOT COMPLETED|Overall Study||5
5303284|NCT00524173|13037949|P2|COMPLETED|Overall Study||13
5303285|NCT00524173|13037950|P1|COMPLETED|Overall Study||12
5303286|NCT00524173|13037949|P2|STARTED|Overall Study||15
5303287|NCT00524173|13037950|P1|STARTED|Overall Study||17
5303288|NCT00524134|13037962|P1|NOT COMPLETED|Overall Study||2
5303289|NCT00524134|13037962|P1|COMPLETED|Overall Study||4
5303290|NCT00524134|13037962|P1|STARTED|Overall Study||6
5303291|NCT00524121|13037969|P1|NOT COMPLETED|Overall Study||19
5303292|NCT00524121|13037969|P1|COMPLETED|Overall Study||3
5303293|NCT00524121|13037969|P1|STARTED|Overall Study||22
5303294|NCT00524043|13037989|P3|NOT COMPLETED|Overall Study||31
5303295|NCT00524043|13037990|P2|NOT COMPLETED|Overall Study||28
5303296|NCT00524043|13037991|P1|NOT COMPLETED|Overall Study||30
5303297|NCT00524043|13037989|P3|COMPLETED|Overall Study||35
5303298|NCT00524043|13037990|P2|COMPLETED|Overall Study||42
5303299|NCT00524043|13037991|P1|COMPLETED|Overall Study||34
5303300|NCT00524043|13037989|P3|STARTED|Overall Study||66
5303301|NCT00524043|13037990|P2|STARTED|Overall Study||70
5303302|NCT00524043|13037991|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
5303303|NCT00524030|13038013|P2|NOT COMPLETED|Overall Study||59
5303304|NCT00524030|13038014|P1|NOT COMPLETED|Overall Study||17
5303305|NCT00524030|13038013|P2|COMPLETED|Overall Study||70
5303306|NCT00524030|13038014|P1|COMPLETED|Overall Study||15
5303307|NCT00524030|13038013|P2|Completed Taper/Titration Phase|Overall Study||70
5303308|NCT00524030|13038014|P1|Completed Taper/Titration Phase|Overall Study||15
5303309|NCT00524030|13038013|P2|Completed Double-Blind Treatment Phase|Overall Study||70
5303310|NCT00524030|13038014|P1|Completed Double-Blind Treatment Phase|Overall Study||15
5303311|NCT00524030|13038013|P2|STARTED|Overall Study||129
5303312|NCT00524030|13038014|P1|STARTED|Overall Study||32
5303313|NCT00524017|13038034|P2|NOT COMPLETED|Overall Study||1
5303314|NCT00524017|13038035|P1|NOT COMPLETED|Overall Study||0
5303315|NCT00524017|13038034|P2|COMPLETED|Overall Study||5
5303316|NCT00524017|13038035|P1|COMPLETED|Overall Study||13
5303317|NCT00524017|13038034|P2|STARTED|Overall Study||6
5303318|NCT00524017|13038035|P1|STARTED|Overall Study||13
5303319|NCT00523991|13038053|P2|NOT COMPLETED|Overall Study||27
5303320|NCT00523991|13038054|P1|NOT COMPLETED|Overall Study||21
5303321|NCT00523991|13038053|P2|COMPLETED|Overall Study||211
5303322|NCT00523991|13038054|P1|COMPLETED|Overall Study||198
5303323|NCT00523991|13038053|P2|STARTED|Overall Study||238
5303324|NCT00523991|13038054|P1|STARTED|Overall Study||219
5303325|NCT00523978|13038334|P2|NOT COMPLETED|Overall Study||8
5303326|NCT00523978|13038335|P1|NOT COMPLETED|Overall Study||9
5303327|NCT00523978|13038334|P2|COMPLETED|Overall Study||79
5303328|NCT00523978|13038335|P1|COMPLETED|Overall Study||162
5303329|NCT00523978|13038334|P2|STARTED|Overall Study||87
5303330|NCT00523978|13038335|P1|STARTED|Overall Study||171
5303331|NCT00523939|13038349|P2|NOT COMPLETED|Overall Study||0
5303332|NCT00523939|13038350|P1|NOT COMPLETED|Overall Study||0
5303333|NCT00523939|13038349|P2|COMPLETED|Overall Study||2
5303334|NCT00523939|13038350|P1|COMPLETED|Overall Study||2
5303335|NCT00523939|13038349|P2|STARTED|Overall Study||2
5303336|NCT00523939|13038350|P1|STARTED|Overall Study||2
5303337|NCT00523848|13038357|P1|NOT COMPLETED|Overall Study||24
5303338|NCT00523848|13038357|P1|COMPLETED|Overall Study||22
5303339|NCT00523848|13038357|P1|Treated With Study Therapy|Overall Study||44
5303340|NCT00523848|13038357|P1|STARTED|Overall Study||46
5303341|NCT00523809|13038363|P1|NOT COMPLETED|Overall Study||0
5303342|NCT00523809|13038363|P1|COMPLETED|Overall Study||5
5303343|NCT00523809|13038363|P1|STARTED|Overall Study||5
5303344|NCT00523744|13038367|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
5303345|NCT00523744|13038367|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
5303346|NCT00523744|13038367|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
5303347|NCT00523744|13038367|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
5303348|NCT00523744|13038367|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
5303349|NCT00523744|13038367|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
5303350|NCT00523744|13038367|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
5303351|NCT00523744|13038367|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
5303352|NCT00523744|13038367|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
5303353|NCT00523718|13038386|P2|NOT COMPLETED|Overall Study||0
5303354|NCT00523718|13038387|P1|NOT COMPLETED|Overall Study||3
5303355|NCT00523718|13038386|P2|COMPLETED|Overall Study||18
5303356|NCT00523718|13038387|P1|COMPLETED|Overall Study||17
5303357|NCT00523718|13038386|P2|STARTED|Overall Study||18
5303358|NCT00523718|13038387|P1|STARTED|Overall Study||20
5303359|NCT00523705|13038401|P2|NOT COMPLETED|Overall Study||1
5303360|NCT00523705|13038402|P1|NOT COMPLETED|Overall Study||0
5303361|NCT00523705|13038401|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
5303362|NCT00523705|13038402|P1|COMPLETED|Overall Study||7
5303363|NCT00523705|13038401|P2|STARTED|Overall Study||4
5303364|NCT00523705|13038402|P1|STARTED|Overall Study||7
5303365|NCT00523640|13038414|P1|NOT COMPLETED|Overall Study||1
5303366|NCT00523640|13038414|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
5303367|NCT00523640|13038414|P1|STARTED|Overall Study||30
5303368|NCT00523614|13038422|P2|NOT COMPLETED|Overall Study||0
5303369|NCT00523614|13038423|P1|NOT COMPLETED|Overall Study||0
5303370|NCT00523614|13038422|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
5303371|NCT00523614|13038423|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
5303372|NCT00523614|13038422|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
5303373|NCT00523614|13038423|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
5303374|NCT00523549|13038431|P2|NOT COMPLETED|Overall Study||16
5303375|NCT00523549|13038432|P1|NOT COMPLETED|Overall Study||19
5303376|NCT00523549|13038431|P2|COMPLETED|Overall Study||99
5303377|NCT00523549|13038432|P1|COMPLETED|Overall Study||95
5303378|NCT00523549|13038431|P2|STARTED|Overall Study||115
5303379|NCT00523549|13038432|P1|STARTED|Overall Study||114
5303380|NCT00523419|13038450|P1|NOT COMPLETED|Overall Study||32
5303381|NCT00523419|13038450|P1|COMPLETED|Overall Study||0
5303382|NCT00523419|13038450|P1|STARTED|Overall Study||32
5303383|NCT00523367|13038460|P1|NOT COMPLETED|Overall Study||23
5303384|NCT00523367|13038460|P1|COMPLETED|Overall Study||2
5303385|NCT00523367|13038460|P1|STARTED|Overall Study||25
5303386|NCT00523341|13038466|P2|NOT COMPLETED|Overall Study||1000
5303387|NCT00523341|13038467|P1|NOT COMPLETED|Overall Study||924
5303388|NCT00523341|13038466|P2|COMPLETED|Overall Study||1343
5303389|NCT00523341|13038467|P1|COMPLETED|Overall Study||1283
5303390|NCT00523341|13038466|P2|Received Treatment|Overall Study||2343
5303391|NCT00523341|13038467|P1|Received Treatment|Overall Study||2206
5303392|NCT00523341|13038466|P2|STARTED|Overall Study||2343
5303393|NCT00523341|13038467|P1|STARTED|Overall Study||2207
5303394|NCT00523302|13038569|P2|NOT COMPLETED|Overall Study||0
5303395|NCT00523302|13038570|P1|NOT COMPLETED|Overall Study||0
5303396|NCT00523302|13038569|P2|COMPLETED|Overall Study||10
5303397|NCT00523302|13038570|P1|COMPLETED|Overall Study||10
5303398|NCT00523302|13038569|P2|STARTED|Overall Study||10
5303399|NCT00523302|13038570|P1|STARTED|Overall Study||10
5303400|NCT00523237|13038580|P1|NOT COMPLETED|Overall Study||0
5303401|NCT00523237|13038580|P1|COMPLETED|Overall Study||14
5303402|NCT00523237|13038580|P1|STARTED|Overall Study||14
5303403|NCT00522951|13038584|P2|NOT COMPLETED|Period 2||1
5303404|NCT00522951|13038585|P1|NOT COMPLETED|Period 2||2
5303405|NCT00522951|13038584|P2|COMPLETED|Period 2||75
5303406|NCT00522951|13038585|P1|COMPLETED|Period 2||84
5303407|NCT00522951|13038584|P2|Subjects Received Treatment|Period 2||75
5303408|NCT00522951|13038585|P1|Subjects Received Treatment|Period 2||84
5303409|NCT00522951|13038584|P2|STARTED|Period 2||76
5303410|NCT00522951|13038585|P1|STARTED|Period 2||86
5303411|NCT00522951|13038584|P2|NOT COMPLETED|Washout Period||2
5303412|NCT00522951|13038585|P1|NOT COMPLETED|Washout Period||0
5303413|NCT00522951|13038584|P2|COMPLETED|Washout Period||76
5303414|NCT00522951|13038585|P1|COMPLETED|Washout Period||86
5303415|NCT00522951|13038584|P2|STARTED|Washout Period||78
5303416|NCT00522951|13038585|P1|STARTED|Washout Period||86
5303417|NCT00522951|13038584|P2|NOT COMPLETED|Period 1||1
5303418|NCT00522951|13038585|P1|NOT COMPLETED|Period 1||0
5303419|NCT00522951|13038584|P2|COMPLETED|Period 1||78
5303420|NCT00522951|13038585|P1|COMPLETED|Period 1||86
5303421|NCT00522951|13038584|P2|Received Treatment|Period 1||78
5303422|NCT00522951|13038585|P1|Received Treatment|Period 1||86
5303423|NCT00522951|13038584|P2|STARTED|Period 1||79
5303424|NCT00522951|13038585|P1|STARTED|Period 1||86
5303425|NCT00522925|13038628|P3|NOT COMPLETED|Overall Study||2
5303426|NCT00522925|13038629|P2|NOT COMPLETED|Overall Study||1
5303427|NCT00522925|13038630|P1|NOT COMPLETED|Overall Study||8
5303428|NCT00522925|13038628|P3|COMPLETED|Overall Study||36
5303429|NCT00522925|13038629|P2|COMPLETED|Overall Study||38
5303430|NCT00522925|13038630|P1|COMPLETED|Overall Study||28
5303431|NCT00522925|13038628|P3|STARTED|Overall Study||38
5303432|NCT00522925|13038629|P2|STARTED|Overall Study||39
5303433|NCT00522925|13038630|P1|STARTED|Overall Study||36
5303434|NCT00522873|13038640|P2|NOT COMPLETED|Overall Study||44
5303435|NCT00522873|13038641|P1|NOT COMPLETED|Overall Study||96
5303436|NCT00522873|13038640|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
5303437|NCT00522873|13038641|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
5303438|NCT00522873|13038640|P2|Received Treatment|Overall Study||172
5303439|NCT00522873|13038641|P1|Received Treatment|Overall Study||489
5303440|NCT00522873|13038640|P2|STARTED|Overall Study||172
5303441|NCT00522873|13038641|P1|STARTED|Overall Study||490
5303442|NCT00522795|13038650|P1|NOT COMPLETED|Overall Study||0
5303443|NCT00522795|13038650|P1|COMPLETED|Overall Study||40
5303444|NCT00522795|13038650|P1|STARTED|Overall Study||40
5303445|NCT00522626|13038654|P1|NOT COMPLETED|Overall Study||7
5303446|NCT00522626|13038654|P1|COMPLETED|Overall Study||12
5303447|NCT00522626|13038654|P1|STARTED|Overall Study||19
5303448|NCT00522548|13038660|P2|NOT COMPLETED|Overall Study||4
5303449|NCT00522548|13038661|P1|NOT COMPLETED|Overall Study||2
5303450|NCT00522548|13038660|P2|COMPLETED|Overall Study||15
5303451|NCT00522548|13038661|P1|COMPLETED|Overall Study||16
5303452|NCT00522548|13038660|P2|Completed 2/2 PK Visits|Overall Study||5
5303453|NCT00522548|13038661|P1|Completed 2/2 PK Visits|Overall Study||7
5303454|NCT00522548|13038660|P2|Completed 1/2 PK Visits|Overall Study||1
5303455|NCT00522548|13038661|P1|Completed 1/2 PK Visits|Overall Study||1
5303456|NCT00522548|13038660|P2|Completed 0/2 PK Visits|Overall Study||4
5303457|NCT00522548|13038661|P1|Completed 0/2 PK Visits|Overall Study||3
5303458|NCT00522548|13038660|P2|Consented to Pharmacokinetic Study|Overall Study||10
5303459|NCT00522548|13038661|P1|Consented to Pharmacokinetic Study|Overall Study||11
5303460|NCT00522548|13038660|P2|STARTED|Overall Study||19
5303461|NCT00522548|13038661|P1|STARTED|Overall Study||18
5303462|NCT00522457|13038689|P1|NOT COMPLETED|Overall Study||18
5303463|NCT00522457|13038689|P1|COMPLETED|Overall Study||1
5303464|NCT00522457|13038689|P1|STARTED|Overall Study||19
5303465|NCT00522431|13038695|P1|NOT COMPLETED|Overall Study||11
5303466|NCT00522431|13038695|P1|COMPLETED|Overall Study||138
5303467|NCT00522431|13038695|P1|STARTED|Overall Study||149
5303468|NCT00522418|13038702|P2|NOT COMPLETED|Overall Study||58
5303469|NCT00522418|13038703|P1|NOT COMPLETED|Overall Study||57
5303470|NCT00522418|13038702|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
5303471|NCT00522418|13038703|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
5303472|NCT00522418|13038702|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
5303473|NCT00522418|13038703|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
5303474|NCT00522418|13038702|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
5303475|NCT00522418|13038703|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
5303476|NCT00522418|13038702|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
5303477|NCT00522418|13038703|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
5303478|NCT00522418|13038702|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
5303479|NCT00522418|13038703|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
5303480|NCT00522418|13038702|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
5303481|NCT00522418|13038703|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
5303482|NCT00522418|13038702|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
5303483|NCT00522418|13038703|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
5303484|NCT00522418|13038702|P2|STARTED|Overall Study||63
5303485|NCT00522418|13038703|P1|STARTED|Overall Study||59
5303486|NCT00522392|13038751|P2|NOT COMPLETED|Overall Study||13
5303487|NCT00522392|13038752|P1|NOT COMPLETED|Overall Study||8
5303488|NCT00522392|13038751|P2|COMPLETED|Overall Study||12
5303489|NCT00522392|13038752|P1|COMPLETED|Overall Study||15
5303490|NCT00522392|13038751|P2|Pts w/ QOL Assessments Complete|Overall Study||8
5303491|NCT00522392|13038752|P1|Pts w/ QOL Assessments Complete|Overall Study||12
5303492|NCT00522392|13038751|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
5303493|NCT00522392|13038752|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
5303494|NCT00522392|13038751|P2|STARTED|Overall Study||25
5303495|NCT00522392|13038752|P1|STARTED|Overall Study||23
5303496|NCT00522379|13038769|P5|NOT COMPLETED|Overall Study||27
5303497|NCT00522379|13038770|P4|NOT COMPLETED|Overall Study||14
5303498|NCT00522379|13038771|P3|NOT COMPLETED|Overall Study||22
5303499|NCT00522379|13038772|P2|NOT COMPLETED|Overall Study||23
5303500|NCT00522379|13038773|P1|NOT COMPLETED|Overall Study||22
5303501|NCT00522379|13038769|P5|COMPLETED|Overall Study||81
5303502|NCT00522379|13038770|P4|COMPLETED|Overall Study||80
5303503|NCT00522379|13038771|P3|COMPLETED|Overall Study||82
5303504|NCT00522379|13038772|P2|COMPLETED|Overall Study||84
5303505|NCT00522379|13038773|P1|COMPLETED|Overall Study||79
5303506|NCT00522379|13038769|P5|STARTED|Overall Study||108
5303507|NCT00522379|13038770|P4|STARTED|Overall Study||94
5303508|NCT00522379|13038771|P3|STARTED|Overall Study||104
5303509|NCT00522379|13038772|P2|STARTED|Overall Study||107
5303510|NCT00522379|13038773|P1|STARTED|Overall Study||101
5303511|NCT00522301|13038875|P1|NOT COMPLETED|Overall Study||6
5303512|NCT00522301|13038875|P1|COMPLETED|Overall Study||0
5303513|NCT00522301|13038875|P1|STARTED|Overall Study||6
5303514|NCT00522275|13038879|P1|NOT COMPLETED|Overall Study||170
5303515|NCT00522275|13038879|P1|COMPLETED|Overall Study||138
5303516|NCT00522275|13038879|P1|STARTED|Overall Study||308
5303517|NCT00522171|13038889|P2|NOT COMPLETED|Overall Study||0
5303518|NCT00522171|13038890|P1|NOT COMPLETED|Overall Study||0
5303519|NCT00522171|13038889|P2|COMPLETED|Overall Study||15
5303520|NCT00522171|13038890|P1|COMPLETED|Overall Study||15
5303521|NCT00522171|13038889|P2|STARTED|Overall Study||15
5303522|NCT00522171|13038890|P1|STARTED|Overall Study||15
5303523|NCT00522041|13038900|P2|NOT COMPLETED|Overall Study||12
5303524|NCT00522041|13038901|P1|NOT COMPLETED|Overall Study||17
5303525|NCT00522041|13038900|P2|COMPLETED|Overall Study||113
5303526|NCT00522041|13038901|P1|COMPLETED|Overall Study||106
5303527|NCT00522041|13038900|P2|Received Treatment|Overall Study||124
5303528|NCT00522041|13038901|P1|Received Treatment|Overall Study||123
5303529|NCT00522041|13038900|P2|STARTED|Overall Study||125
5303530|NCT00522041|13038901|P1|STARTED|Overall Study||123
5303531|NCT00521989|13038916|P5|NOT COMPLETED|Overall Study||23
5303532|NCT00521989|13038917|P4|NOT COMPLETED|Overall Study||12
5303533|NCT00521989|13038918|P3|NOT COMPLETED|Overall Study||16
5303534|NCT00521989|13038919|P2|NOT COMPLETED|Overall Study||17
5303535|NCT00521989|13038920|P1|NOT COMPLETED|Overall Study||20
5303536|NCT00521989|13038916|P5|COMPLETED|Overall Study||35
5303537|NCT00521989|13038917|P4|COMPLETED|Overall Study||42
5303538|NCT00521989|13038918|P3|COMPLETED|Overall Study||41
5303539|NCT00521989|13038919|P2|COMPLETED|Overall Study||37
5303540|NCT00521989|13038920|P1|COMPLETED|Overall Study||36
5303541|NCT00521989|13038916|P5|STARTED|Overall Study||58
5303542|NCT00521989|13038917|P4|STARTED|Overall Study||54
5303543|NCT00521989|13038918|P3|STARTED|Overall Study||57
5303544|NCT00521989|13038919|P2|STARTED|Overall Study||54
5303545|NCT00521989|13038920|P1|STARTED|Overall Study||56
5303546|NCT00521976|13038932|P1|NOT COMPLETED|Overall Study||0
5303547|NCT00521976|13038932|P1|COMPLETED|Overall Study||871
5303548|NCT00521976|13038932|P1|STARTED|Overall Study||871
5303549|NCT00521924|13038939|P2|NOT COMPLETED|Overall Study||4
5303550|NCT00521924|13038940|P1|NOT COMPLETED|Overall Study||4
5303551|NCT00521924|13038939|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
5303552|NCT00521924|13038940|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
5303553|NCT00521924|13038939|P2|STARTED|Overall Study|Subjects randomized|4
5303554|NCT00521924|13038940|P1|STARTED|Overall Study|Subjects randomized|4
5303555|NCT00521885|13038948|P2|NOT COMPLETED|Overall Study||0
5303556|NCT00521885|13038949|P1|NOT COMPLETED|Overall Study||0
5303557|NCT00521885|13038948|P2|COMPLETED|Overall Study||0
5303558|NCT00521885|13038949|P1|COMPLETED|Overall Study||0
5303559|NCT00521885|13038948|P2|STARTED|Overall Study||0
5303560|NCT00521885|13038949|P1|STARTED|Overall Study||0
5303561|NCT00521599|13038960|P3|NOT COMPLETED|Overall Study||36
5303562|NCT00521599|13038961|P2|NOT COMPLETED|Overall Study||29
5303563|NCT00521599|13038962|P1|NOT COMPLETED|Overall Study||25
5303564|NCT00521599|13038960|P3|COMPLETED|Overall Study||100
5303565|NCT00521599|13038961|P2|COMPLETED|Overall Study||239
5303566|NCT00521599|13038962|P1|COMPLETED|Overall Study||243
5303567|NCT00521599|13038960|P3|STARTED|Overall Study||136
5303568|NCT00521599|13038961|P2|STARTED|Overall Study||268
5303569|NCT00521599|13038962|P1|STARTED|Overall Study||268
5303570|NCT00521586|13038973|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
5303571|NCT00521586|13038974|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
5303572|NCT00521586|13038973|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
5303573|NCT00521586|13038974|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
5303574|NCT00521586|13038973|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
5303575|NCT00521586|13038974|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
5303576|NCT00521586|13038973|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
5303577|NCT00521586|13038974|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
5303578|NCT00521586|13038973|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
5303579|NCT00521586|13038974|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
5303580|NCT00521586|13038973|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
5303581|NCT00521586|13038974|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
5303582|NCT00521586|13038973|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
5303583|NCT00521586|13038974|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
5303584|NCT00521586|13038973|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
5303585|NCT00521586|13038974|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
5303586|NCT00521586|13038973|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
5303587|NCT00521586|13038974|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
5303588|NCT00521586|13038973|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
5303589|NCT00521586|13038974|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
5303590|NCT00521586|13038973|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
5303591|NCT00521586|13038974|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
5303592|NCT00521586|13038973|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
5303593|NCT00521586|13038974|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
5303594|NCT00521586|13038973|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
5303595|NCT00521586|13038974|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
5303596|NCT00521586|13038973|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
5303597|NCT00521586|13038974|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
5303598|NCT00521586|13038973|P2|STARTED|Initial Vaccination (Year 0)||562
5303599|NCT00521586|13038974|P1|STARTED|Initial Vaccination (Year 0)||554
5303600|NCT00521456|13039034|P2|NOT COMPLETED|Overall Study||28
5303601|NCT00521456|13039035|P1|NOT COMPLETED|Overall Study||13
5303602|NCT00521456|13039034|P2|COMPLETED|Overall Study||59
5303603|NCT00521456|13039035|P1|COMPLETED|Overall Study||163
5303604|NCT00521456|13039034|P2|STARTED|Overall Study||87
5303605|NCT00521456|13039035|P1|STARTED|Overall Study||176
5303606|NCT00521365|13039047|P1|NOT COMPLETED|Overall Study||20
5303607|NCT00521365|13039047|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
5303608|NCT00521365|13039047|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
5303609|NCT00521365|13039047|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
5303610|NCT00521365|13039047|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
5303611|NCT00521365|13039047|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
5303612|NCT00521352|13039066|P2|NOT COMPLETED|Overall Study||3
5303613|NCT00521352|13039067|P1|NOT COMPLETED|Overall Study||1
5303614|NCT00521352|13039066|P2|COMPLETED|Overall Study||10
5303615|NCT00521352|13039067|P1|COMPLETED|Overall Study||11
5303616|NCT00521352|13039066|P2|STARTED|Overall Study||13
5303617|NCT00521352|13039067|P1|STARTED|Overall Study||12
5303618|NCT00521339|13039077|P3|NOT COMPLETED|Observational Follow Up Phase||0
5303619|NCT00521339|13039078|P2|NOT COMPLETED|Observational Follow Up Phase||0
5303620|NCT00521339|13039079|P1|NOT COMPLETED|Observational Follow Up Phase||0
5303621|NCT00521339|13039077|P3|COMPLETED|Observational Follow Up Phase||4
5303622|NCT00521339|13039078|P2|COMPLETED|Observational Follow Up Phase||4
5303623|NCT00521339|13039079|P1|COMPLETED|Observational Follow Up Phase||14
5303624|NCT00521339|13039077|P3|STARTED|Observational Follow Up Phase||4
5303625|NCT00521339|13039078|P2|STARTED|Observational Follow Up Phase||4
5303626|NCT00521339|13039079|P1|STARTED|Observational Follow Up Phase||14
5303627|NCT00521339|13039077|P3|NOT COMPLETED|Treatment Extension Phase||3
5303628|NCT00521339|13039078|P2|NOT COMPLETED|Treatment Extension Phase||0
5303629|NCT00521339|13039079|P1|NOT COMPLETED|Treatment Extension Phase||0
5303630|NCT00521339|13039077|P3|COMPLETED|Treatment Extension Phase||4
5303631|NCT00521339|13039078|P2|COMPLETED|Treatment Extension Phase||4
5303632|NCT00521339|13039079|P1|COMPLETED|Treatment Extension Phase||0
5303633|NCT00521339|13039077|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
5303634|NCT00521339|13039078|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
5303635|NCT00521339|13039079|P1|STARTED|Treatment Extension Phase||0
5303636|NCT00521339|13039077|P3|NOT COMPLETED|Treatment Phase||0
5303637|NCT00521339|13039078|P2|NOT COMPLETED|Treatment Phase||0
5303638|NCT00521339|13039079|P1|NOT COMPLETED|Treatment Phase||12
5303639|NCT00521339|13039077|P3|COMPLETED|Treatment Phase||0
5303640|NCT00521339|13039078|P2|COMPLETED|Treatment Phase||0
5303641|NCT00521339|13039079|P1|COMPLETED|Treatment Phase||19
5303642|NCT00521339|13039077|P3|Received Apremilast|Treatment Phase||0
5303643|NCT00521339|13039078|P2|Received Apremilast|Treatment Phase||0
5303644|NCT00521339|13039079|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
5303645|NCT00521339|13039077|P3|STARTED|Treatment Phase||0
5303646|NCT00521339|13039078|P2|STARTED|Treatment Phase||0
5303647|NCT00521339|13039079|P1|STARTED|Treatment Phase||31
5303648|NCT00521144|13039147|P5|NOT COMPLETED|Overall Study||7
5303649|NCT00521144|13039148|P4|NOT COMPLETED|Overall Study||1
5303650|NCT00521144|13039149|P3|NOT COMPLETED|Overall Study||2
5303651|NCT00521144|13039150|P2|NOT COMPLETED|Overall Study||3
5303652|NCT00521144|13039151|P1|NOT COMPLETED|Overall Study||4
5303653|NCT00521144|13039147|P5|COMPLETED|Overall Study||0
5303654|NCT00521144|13039148|P4|COMPLETED|Overall Study||0
5303655|NCT00521144|13039149|P3|COMPLETED|Overall Study||1
5303656|NCT00521144|13039150|P2|COMPLETED|Overall Study||2
5303657|NCT00521144|13039151|P1|COMPLETED|Overall Study||2
5303658|NCT00521144|13039147|P5|STARTED|Overall Study||7
5303659|NCT00521144|13039148|P4|STARTED|Overall Study||1
5303660|NCT00521144|13039149|P3|STARTED|Overall Study||3
5303661|NCT00521144|13039150|P2|STARTED|Overall Study||5
5303662|NCT00521144|13039151|P1|STARTED|Overall Study||6
5303663|NCT00521079|13039165|P2|NOT COMPLETED|Overall Study||5
5303664|NCT00521079|13039166|P1|NOT COMPLETED|Overall Study||14
5303665|NCT00521079|13039165|P2|COMPLETED|Overall Study||97
5303666|NCT00521079|13039166|P1|COMPLETED|Overall Study||178
5303667|NCT00521079|13039165|P2|Surgical Roll-In|Overall Study||5
5303668|NCT00521079|13039166|P1|Surgical Roll-In|Overall Study||9
5303669|NCT00521079|13039165|P2|STARTED|Overall Study||102
5303670|NCT00521079|13039166|P1|STARTED|Overall Study||192
5303671|NCT00521053|13039176|P1|NOT COMPLETED|Observation Phase||68
5303672|NCT00521053|13039176|P1|COMPLETED|Observation Phase||12
5303673|NCT00521053|13039176|P1|STARTED|Observation Phase||80
5303674|NCT00521053|13039176|P1|NOT COMPLETED|Treatment Phase||0
5303675|NCT00521053|13039176|P1|COMPLETED|Treatment Phase||80
5303676|NCT00521053|13039176|P1|Received 4 Cycles of PV-10|Treatment Phase||3
5303677|NCT00521053|13039176|P1|Received 3 Cycles of PV-10|Treatment Phase||16
5303678|NCT00521053|13039176|P1|Received 2 Cycles of PV-10|Treatment Phase||26
5303679|NCT00521053|13039176|P1|Received 1 Cycle of PV-10|Treatment Phase||35
5303680|NCT00521053|13039176|P1|STARTED|Treatment Phase||80
5303681|NCT00521014|13039186|P1|NOT COMPLETED|Overall Study||1
5303682|NCT00521014|13039186|P1|COMPLETED|Overall Study||13
5303683|NCT00521014|13039186|P1|STARTED|Overall Study||14
5303684|NCT00521001|13039190|P1|NOT COMPLETED|Overall Study||1
5303685|NCT00521001|13039190|P1|COMPLETED|Overall Study||48
5303686|NCT00521001|13039190|P1|STARTED|Overall Study||49
5303687|NCT00520975|13039199|P2|NOT COMPLETED|Overall Study||48
5303688|NCT00520975|13039200|P1|NOT COMPLETED|Overall Study||48
5303689|NCT00520975|13039199|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
5303690|NCT00520975|13039200|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
5303691|NCT00520975|13039199|P2|Treated and Reported Adverse Events Data|Overall Study||45
5303692|NCT00520975|13039200|P1|Treated and Reported Adverse Events Data|Overall Study||47
5303693|NCT00520975|13039199|P2|STARTED|Overall Study||48
5303694|NCT00520975|13039200|P1|STARTED|Overall Study||48
5303695|NCT00520936|13039232|P8|NOT COMPLETED|Overall Study||1
5303696|NCT00520936|13039233|P7|NOT COMPLETED|Overall Study||4
5303697|NCT00520936|13039234|P6|NOT COMPLETED|Overall Study||0
5303698|NCT00520936|13039235|P5|NOT COMPLETED|Overall Study||1
5303699|NCT00520936|13039236|P4|NOT COMPLETED|Overall Study||0
5303700|NCT00520936|13039237|P3|NOT COMPLETED|Overall Study||2
5303701|NCT00520936|13039238|P2|NOT COMPLETED|Overall Study||4
5303702|NCT00520936|13039239|P1|NOT COMPLETED|Overall Study||0
5303703|NCT00520936|13039232|P8|COMPLETED|Overall Study||9
5303704|NCT00520936|13039233|P7|COMPLETED|Overall Study||7
5303705|NCT00520936|13039234|P6|COMPLETED|Overall Study||10
5303706|NCT00520936|13039235|P5|COMPLETED|Overall Study||5
5303707|NCT00520936|13039236|P4|COMPLETED|Overall Study||5
5303708|NCT00520936|13039237|P3|COMPLETED|Overall Study||7
5303709|NCT00520936|13039238|P2|COMPLETED|Overall Study||7
5303710|NCT00520936|13039239|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
5303711|NCT00520936|13039232|P8|STARTED|Overall Study||10
5303712|NCT00520936|13039233|P7|STARTED|Overall Study||11
5303713|NCT00520936|13039234|P6|STARTED|Overall Study||10
5303714|NCT00520936|13039235|P5|STARTED|Overall Study||6
5303715|NCT00520936|13039236|P4|STARTED|Overall Study||5
5303716|NCT00520936|13039237|P3|STARTED|Overall Study||9
5303717|NCT00520936|13039238|P2|STARTED|Overall Study||11
5303718|NCT00520936|13039239|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
5303719|NCT00520910|13039268|P2|NOT COMPLETED|Overall Study||0
5303720|NCT00520910|13039269|P1|NOT COMPLETED|Overall Study||0
5303721|NCT00520910|13039268|P2|COMPLETED|Overall Study||5
5303722|NCT00520910|13039269|P1|COMPLETED|Overall Study||5
5303723|NCT00520910|13039268|P2|STARTED|Overall Study||5
5303724|NCT00520910|13039269|P1|STARTED|Overall Study||5
5303725|NCT00520884|13039279|P4|NOT COMPLETED|Overall Study||0
5303726|NCT00520884|13039280|P3|NOT COMPLETED|Overall Study||0
5303727|NCT00520884|13039281|P2|NOT COMPLETED|Overall Study||0
5303728|NCT00520884|13039282|P1|NOT COMPLETED|Overall Study||0
5303729|NCT00520884|13039279|P4|COMPLETED|Overall Study||3
5303730|NCT00520884|13039280|P3|COMPLETED|Overall Study||2
5303731|NCT00520884|13039281|P2|COMPLETED|Overall Study||2
5303732|NCT00520884|13039282|P1|COMPLETED|Overall Study||3
5303733|NCT00520884|13039279|P4|STARTED|Overall Study||3
5303734|NCT00520884|13039280|P3|STARTED|Overall Study||2
5303735|NCT00520884|13039281|P2|STARTED|Overall Study||2
5303736|NCT00520884|13039282|P1|STARTED|Overall Study||3
5303737|NCT00520845|13039294|P1|NOT COMPLETED|Overall Study||22
5303738|NCT00520845|13039294|P1|COMPLETED|Overall Study||1
5303739|NCT00520845|13039294|P1|STARTED|Overall Study||23
5303740|NCT00520767|13039302|P1|NOT COMPLETED|Overall Study||2
5303741|NCT00520767|13039302|P1|COMPLETED|Overall Study||33
5303742|NCT00520767|13039302|P1|STARTED|Overall Study||35
5303743|NCT00520741|13039308|P2|NOT COMPLETED|Overall Study||125
5303744|NCT00520741|13039309|P1|NOT COMPLETED|Overall Study||37
5303745|NCT00520741|13039308|P2|COMPLETED|Overall Study||194
5303746|NCT00520741|13039309|P1|COMPLETED|Overall Study||69
5303747|NCT00520741|13039308|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
5303748|NCT00520741|13039309|P1|STARTED|Overall Study||106
5303749|NCT00520676|13039327|P2|NOT COMPLETED|Overall Study||103
5303750|NCT00520676|13039328|P1|NOT COMPLETED|Overall Study||101
5303751|NCT00520676|13039327|P2|COMPLETED|Overall Study||29
5303752|NCT00520676|13039328|P1|COMPLETED|Overall Study||27
5303753|NCT00520676|13039327|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
5303754|NCT00520676|13039328|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
5303755|NCT00520676|13039327|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
5303756|NCT00520676|13039328|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
5303757|NCT00520676|13039327|P2|STARTED|Overall Study||132
5303758|NCT00520676|13039328|P1|STARTED|Overall Study||128
5303759|NCT00520572|13039354|P6|NOT COMPLETED|Overall Study||2
5303760|NCT00520572|13039355|P5|NOT COMPLETED|Overall Study||12
5303761|NCT00520572|13039356|P4|NOT COMPLETED|Overall Study||14
5303762|NCT00520572|13039357|P3|NOT COMPLETED|Overall Study||15
5303763|NCT00520572|13039358|P2|NOT COMPLETED|Overall Study||14
5303764|NCT00520572|13039359|P1|NOT COMPLETED|Overall Study||12
5303765|NCT00520572|13039354|P6|COMPLETED|Overall Study|Participants completed the study.|62
5303766|NCT00520572|13039355|P5|COMPLETED|Overall Study|Participants completed the study.|53
5303767|NCT00520572|13039356|P4|COMPLETED|Overall Study|Participants completed the study.|50
5303768|NCT00520572|13039357|P3|COMPLETED|Overall Study|Participants completed the study.|49
5303769|NCT00520572|13039358|P2|COMPLETED|Overall Study|Participants completed the study.|50
5303770|NCT00520572|13039359|P1|COMPLETED|Overall Study|Participants completed the study.|52
5303771|NCT00520572|13039354|P6|STARTED|Overall Study|Participants randomised.|64
5303772|NCT00520572|13039355|P5|STARTED|Overall Study|Participants randomised.|65
5303773|NCT00520572|13039356|P4|STARTED|Overall Study|Participants randomised.|64
5303774|NCT00520572|13039357|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
5303775|NCT00520572|13039358|P2|STARTED|Overall Study|Participants randomised.|64
5303776|NCT00520572|13039359|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
5303777|NCT00520546|13039397|P1|NOT COMPLETED|Overall Study||6
5303778|NCT00520546|13039397|P1|COMPLETED|Overall Study||38
5303779|NCT00520546|13039397|P1|STARTED|Overall Study||44
5303780|NCT00520494|13039412|P1|NOT COMPLETED|Overall Study||1
5303781|NCT00520494|13039412|P1|COMPLETED|Overall Study||17
5303782|NCT00520494|13039412|P1|STARTED|Overall Study||18
5303783|NCT00520481|13039437|P2|NOT COMPLETED|Overall Study||1
5303784|NCT00520481|13039438|P1|NOT COMPLETED|Overall Study||7
5303785|NCT00520481|13039437|P2|COMPLETED|Overall Study||9
5303786|NCT00520481|13039438|P1|COMPLETED|Overall Study||24
5303787|NCT00520481|13039437|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
5303788|NCT00520481|13039438|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
5303789|NCT00520481|13039437|P2|STARTED|Overall Study||10
5303790|NCT00520481|13039438|P1|STARTED|Overall Study||31
5303791|NCT00520468|13039458|P1|NOT COMPLETED|Overall Study||0
5303792|NCT00520468|13039458|P1|COMPLETED|Overall Study||14
5303793|NCT00520468|13039458|P1|STARTED|Overall Study||14
5303794|NCT00520403|13039462|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
5303795|NCT00520403|13039462|P1|COMPLETED|Bevacizumab Monotherapy||0
5303796|NCT00520403|13039462|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
5303797|NCT00520403|13039462|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
5303798|NCT00520403|13039462|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
5303799|NCT00520403|13039462|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
5303800|NCT00520351|13039471|P2|NOT COMPLETED|Second Intervention||0
5303801|NCT00520351|13039472|P1|NOT COMPLETED|Second Intervention||0
5303802|NCT00520351|13039471|P2|COMPLETED|Second Intervention||14
5303803|NCT00520351|13039472|P1|COMPLETED|Second Intervention||14
5303804|NCT00520351|13039471|P2|STARTED|Second Intervention||14
5303805|NCT00520351|13039472|P1|STARTED|Second Intervention||14
5303806|NCT00520351|13039471|P2|NOT COMPLETED|First Intervention||1
5303807|NCT00520351|13039472|P1|NOT COMPLETED|First Intervention||1
5303808|NCT00520351|13039471|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
5303809|NCT00520351|13039472|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
5303810|NCT00520351|13039471|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
5303811|NCT00520351|13039472|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
5303812|NCT00520299|13039487|P3|NOT COMPLETED|Overall Study||6
5303813|NCT00520299|13039488|P2|NOT COMPLETED|Overall Study||3
5303814|NCT00520299|13039489|P1|NOT COMPLETED|Overall Study||0
5303815|NCT00520299|13039487|P3|COMPLETED|Overall Study||13
5303816|NCT00520299|13039488|P2|COMPLETED|Overall Study||3
5303817|NCT00520299|13039489|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
5303818|NCT00520299|13039487|P3|STARTED|Overall Study||19
5303819|NCT00520299|13039488|P2|STARTED|Overall Study||6
5303820|NCT00520299|13039489|P1|STARTED|Overall Study||6
5303821|NCT00520286|13039520|P2|NOT COMPLETED|Overall Study||32
5303822|NCT00520286|13039521|P1|NOT COMPLETED|Overall Study||66
5303823|NCT00520286|13039520|P2|COMPLETED|Overall Study||36
5303824|NCT00520286|13039521|P1|COMPLETED|Overall Study||76
5303825|NCT00520286|13039520|P2|STARTED|Overall Study||68
5303826|NCT00520286|13039521|P1|STARTED|Overall Study||142
5303827|NCT00520234|13039531|P2|NOT COMPLETED|Overall Study||2
5303828|NCT00520234|13039532|P1|NOT COMPLETED|Overall Study||1
5303829|NCT00520234|13039531|P2|COMPLETED|Overall Study||102
5303830|NCT00520234|13039532|P1|COMPLETED|Overall Study||117
5303831|NCT00520234|13039531|P2|STARTED|Overall Study||104
5303832|NCT00520234|13039532|P1|STARTED|Overall Study||118
5303833|NCT00520130|13039544|P2|NOT COMPLETED|Overall Study||1
5303834|NCT00520130|13039545|P1|NOT COMPLETED|Overall Study||5
5303835|NCT00520130|13039544|P2|COMPLETED|Overall Study||44
5303836|NCT00520130|13039545|P1|COMPLETED|Overall Study||39
5303837|NCT00520130|13039544|P2|STARTED|Overall Study||45
5303838|NCT00520130|13039545|P1|STARTED|Overall Study||44
5303839|NCT00520039|13039587|P2|NOT COMPLETED|Overall Study||5
5303840|NCT00520039|13039588|P1|NOT COMPLETED|Overall Study||7
5303841|NCT00520039|13039587|P2|COMPLETED|Overall Study||19
5303842|NCT00520039|13039588|P1|COMPLETED|Overall Study||21
5303843|NCT00520039|13039587|P2|STARTED|Overall Study||24
5303844|NCT00520039|13039588|P1|STARTED|Overall Study||28
5303845|NCT00520013|13039601|P3|NOT COMPLETED|Overall Study||11
5303846|NCT00520013|13039602|P2|NOT COMPLETED|Overall Study||15
5303847|NCT00520013|13039603|P1|NOT COMPLETED|Overall Study||12
5303848|NCT00520013|13039601|P3|COMPLETED|Overall Study||0
5303849|NCT00520013|13039602|P2|COMPLETED|Overall Study||10
5303850|NCT00520013|13039603|P1|COMPLETED|Overall Study||11
5303851|NCT00520013|13039601|P3|Treated|Overall Study||11
5303852|NCT00520013|13039602|P2|Treated|Overall Study||25
5303853|NCT00520013|13039603|P1|Treated|Overall Study||23
5303854|NCT00520013|13039601|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
5303855|NCT00520013|13039602|P2|STARTED|Overall Study||25
5303856|NCT00520013|13039603|P1|STARTED|Overall Study||23
5303857|NCT00519896|13039613|P1|NOT COMPLETED|Overall Study||2
5303858|NCT00519896|13039613|P1|COMPLETED|Overall Study||33
5303859|NCT00519896|13039613|P1|STARTED|Overall Study||35
5303860|NCT00519831|13039619|P1|NOT COMPLETED|Overall Study||3
5303861|NCT00519831|13039619|P1|COMPLETED|Overall Study||13
5303862|NCT00519831|13039619|P1|STARTED|Overall Study||16
5303863|NCT00519818|13039626|P1|NOT COMPLETED|Overall Study||0
5303864|NCT00519818|13039626|P1|COMPLETED|Overall Study||14
5303865|NCT00519818|13039626|P1|STARTED|Overall Study||14
5303866|NCT00519779|13039636|P2|NOT COMPLETED|Overall Study||1
5303867|NCT00519779|13039637|P1|NOT COMPLETED|Overall Study||0
5303868|NCT00519779|13039636|P2|COMPLETED|Overall Study||33
5303869|NCT00519779|13039637|P1|COMPLETED|Overall Study||34
5303870|NCT00519779|13039636|P2|STARTED|Overall Study||34
5303871|NCT00519779|13039637|P1|STARTED|Overall Study||34
5303872|NCT00519649|13039653|P1|NOT COMPLETED|Overall Study||1
5303873|NCT00519649|13039653|P1|COMPLETED|Overall Study||299
5303874|NCT00519649|13039653|P1|STARTED|Overall Study||300
5303875|NCT00519636|13039666|P4|NOT COMPLETED|Post Study Period||1
5303876|NCT00519636|13039667|P3|NOT COMPLETED|Post Study Period||0
5303877|NCT00519636|13039668|P2|NOT COMPLETED|Post Study Period||0
5303878|NCT00519636|13039669|P1|NOT COMPLETED|Post Study Period||0
5303879|NCT00519636|13039666|P4|COMPLETED|Post Study Period||85
5303880|NCT00519636|13039667|P3|COMPLETED|Post Study Period||74
5303881|NCT00519636|13039668|P2|COMPLETED|Post Study Period||71
5303882|NCT00519636|13039669|P1|COMPLETED|Post Study Period||69
5303883|NCT00519636|13039666|P4|STARTED|Post Study Period||86
5303884|NCT00519636|13039667|P3|STARTED|Post Study Period||74
5303885|NCT00519636|13039668|P2|STARTED|Post Study Period||71
5303886|NCT00519636|13039669|P1|STARTED|Post Study Period||69
5303887|NCT00519636|13039666|P4|NOT COMPLETED|Treatment Period 2||2
5303888|NCT00519636|13039667|P3|NOT COMPLETED|Treatment Period 2||1
5303889|NCT00519636|13039668|P2|NOT COMPLETED|Treatment Period 2||1
5303890|NCT00519636|13039669|P1|NOT COMPLETED|Treatment Period 2||0
5303891|NCT00519636|13039666|P4|COMPLETED|Treatment Period 2||86
5303892|NCT00519636|13039667|P3|COMPLETED|Treatment Period 2||74
5303893|NCT00519636|13039668|P2|COMPLETED|Treatment Period 2||71
5303894|NCT00519636|13039669|P1|COMPLETED|Treatment Period 2||69
5303895|NCT00519636|13039666|P4|STARTED|Treatment Period 2||88
5303896|NCT00519636|13039667|P3|STARTED|Treatment Period 2||75
5303897|NCT00519636|13039668|P2|STARTED|Treatment Period 2||72
5303898|NCT00519636|13039669|P1|STARTED|Treatment Period 2||69
5303899|NCT00519636|13039666|P4|NOT COMPLETED|Washout Period||5
5303900|NCT00519636|13039667|P3|NOT COMPLETED|Washout Period||14
5303901|NCT00519636|13039668|P2|NOT COMPLETED|Washout Period||14
5303902|NCT00519636|13039669|P1|NOT COMPLETED|Washout Period||20
5303903|NCT00519636|13039666|P4|COMPLETED|Washout Period||88
5303904|NCT00519636|13039667|P3|COMPLETED|Washout Period||75
5303905|NCT00519636|13039668|P2|COMPLETED|Washout Period||72
5303906|NCT00519636|13039669|P1|COMPLETED|Washout Period||69
5303907|NCT00519636|13039666|P4|STARTED|Washout Period||93
5303908|NCT00519636|13039667|P3|STARTED|Washout Period||89
5303909|NCT00519636|13039668|P2|STARTED|Washout Period||86
5303910|NCT00519636|13039669|P1|STARTED|Washout Period||89
5303911|NCT00519636|13039666|P4|NOT COMPLETED|Treatment Period 1||0
5303912|NCT00519636|13039667|P3|NOT COMPLETED|Treatment Period 1||1
5303913|NCT00519636|13039668|P2|NOT COMPLETED|Treatment Period 1||0
5303914|NCT00519636|13039669|P1|NOT COMPLETED|Treatment Period 1||2
5303915|NCT00519636|13039666|P4|COMPLETED|Treatment Period 1||93
5303916|NCT00519636|13039667|P3|COMPLETED|Treatment Period 1||89
5303917|NCT00519636|13039668|P2|COMPLETED|Treatment Period 1||86
5303918|NCT00519636|13039669|P1|COMPLETED|Treatment Period 1||89
5303919|NCT00519636|13039666|P4|STARTED|Treatment Period 1||93
5303920|NCT00519636|13039667|P3|STARTED|Treatment Period 1||90
5303921|NCT00519636|13039668|P2|STARTED|Treatment Period 1||86
5303922|NCT00519636|13039669|P1|STARTED|Treatment Period 1||91
5303923|NCT00519623|13039699|P1|NOT COMPLETED|Overall Study||1
5303924|NCT00519623|13039699|P1|COMPLETED|Overall Study||8
5303925|NCT00519623|13039699|P1|STARTED|Overall Study||9
5303926|NCT00519584|13039708|P4|NOT COMPLETED|Overall Study||0
5303927|NCT00519584|13039709|P3|NOT COMPLETED|Overall Study||0
5303928|NCT00519584|13039710|P2|NOT COMPLETED|Overall Study||0
5303929|NCT00519584|13039711|P1|NOT COMPLETED|Overall Study||0
5303930|NCT00519584|13039708|P4|COMPLETED|Overall Study||56
5303931|NCT00519584|13039709|P3|COMPLETED|Overall Study||54
5303932|NCT00519584|13039710|P2|COMPLETED|Overall Study||54
5303933|NCT00519584|13039711|P1|COMPLETED|Overall Study||54
5303934|NCT00519584|13039708|P4|STARTED|Overall Study||56
5303935|NCT00519584|13039709|P3|STARTED|Overall Study||54
5303936|NCT00519584|13039710|P2|STARTED|Overall Study||54
5303937|NCT00519584|13039711|P1|STARTED|Overall Study||54
5303938|NCT00519532|13039733|P1|NOT COMPLETED|Overall Study||18
5303939|NCT00519532|13039733|P1|COMPLETED|Overall Study||66
5303940|NCT00519532|13039733|P1|STARTED|Overall Study||84
5303941|NCT00519428|13039743|P3|NOT COMPLETED|Overall Study||25
5303942|NCT00519428|13039744|P2|NOT COMPLETED|Overall Study||15
5303943|NCT00519428|13039745|P1|NOT COMPLETED|Overall Study||21
5303944|NCT00519428|13039743|P3|COMPLETED|Overall Study||58
5303945|NCT00519428|13039744|P2|COMPLETED|Overall Study||69
5303946|NCT00519428|13039745|P1|COMPLETED|Overall Study||57
5303947|NCT00519428|13039743|P3|STARTED|Overall Study||83
5303948|NCT00519428|13039744|P2|STARTED|Overall Study||84
5303949|NCT00519428|13039745|P1|STARTED|Overall Study||78
5303950|NCT00519376|13039765|P16|NOT COMPLETED|Treatment Period 4||0
5303951|NCT00519376|13039766|P15|NOT COMPLETED|Treatment Period 4||0
5303952|NCT00519376|13039767|P14|NOT COMPLETED|Treatment Period 4||0
5303953|NCT00519376|13039768|P13|NOT COMPLETED|Treatment Period 4||0
5303954|NCT00519376|13039769|P12|NOT COMPLETED|Treatment Period 4||0
5303955|NCT00519376|13039770|P11|NOT COMPLETED|Treatment Period 4||0
5303956|NCT00519376|13039771|P10|NOT COMPLETED|Treatment Period 4||0
5303957|NCT00519376|13039772|P9|NOT COMPLETED|Treatment Period 4||0
5303958|NCT00519376|13039773|P8|NOT COMPLETED|Treatment Period 4||0
5303959|NCT00519376|13039774|P7|NOT COMPLETED|Treatment Period 4||0
5303960|NCT00519376|13039775|P6|NOT COMPLETED|Treatment Period 4||0
5303961|NCT00519376|13039776|P5|NOT COMPLETED|Treatment Period 4||0
5303962|NCT00519376|13039777|P4|NOT COMPLETED|Treatment Period 4||0
5303963|NCT00519376|13039778|P3|NOT COMPLETED|Treatment Period 4||1
5303964|NCT00519376|13039779|P2|NOT COMPLETED|Treatment Period 4||0
5303965|NCT00519376|13039780|P1|NOT COMPLETED|Treatment Period 4||0
5303966|NCT00519376|13039765|P16|COMPLETED|Treatment Period 4||1
5303967|NCT00519376|13039766|P15|COMPLETED|Treatment Period 4||1
5303968|NCT00519376|13039767|P14|COMPLETED|Treatment Period 4||1
5303969|NCT00519376|13039768|P13|COMPLETED|Treatment Period 4||0
5303970|NCT00519376|13039769|P12|COMPLETED|Treatment Period 4||1
5303971|NCT00519376|13039770|P11|COMPLETED|Treatment Period 4||1
5303972|NCT00519376|13039771|P10|COMPLETED|Treatment Period 4||1
5303973|NCT00519376|13039772|P9|COMPLETED|Treatment Period 4||1
5303974|NCT00519376|13039773|P8|COMPLETED|Treatment Period 4||1
5303975|NCT00519376|13039774|P7|COMPLETED|Treatment Period 4||1
5303976|NCT00519376|13039775|P6|COMPLETED|Treatment Period 4||1
5303977|NCT00519376|13039776|P5|COMPLETED|Treatment Period 4||1
5303978|NCT00519376|13039777|P4|COMPLETED|Treatment Period 4||2
5303979|NCT00519376|13039778|P3|COMPLETED|Treatment Period 4||1
5303980|NCT00519376|13039779|P2|COMPLETED|Treatment Period 4||2
5303981|NCT00519376|13039780|P1|COMPLETED|Treatment Period 4||2
5303982|NCT00519376|13039765|P16|STARTED|Treatment Period 4||1
5303983|NCT00519376|13039766|P15|STARTED|Treatment Period 4||1
5303984|NCT00519376|13039767|P14|STARTED|Treatment Period 4||1
5303985|NCT00519376|13039768|P13|STARTED|Treatment Period 4||0
5303986|NCT00519376|13039769|P12|STARTED|Treatment Period 4||1
5303987|NCT00519376|13039770|P11|STARTED|Treatment Period 4||1
5303988|NCT00519376|13039771|P10|STARTED|Treatment Period 4||1
5303989|NCT00519376|13039772|P9|STARTED|Treatment Period 4||1
5303990|NCT00519376|13039773|P8|STARTED|Treatment Period 4||1
5303991|NCT00519376|13039774|P7|STARTED|Treatment Period 4||1
5303992|NCT00519376|13039775|P6|STARTED|Treatment Period 4||1
5303993|NCT00519376|13039776|P5|STARTED|Treatment Period 4||1
5303994|NCT00519376|13039777|P4|STARTED|Treatment Period 4||2
5303995|NCT00519376|13039778|P3|STARTED|Treatment Period 4||2
5303996|NCT00519376|13039779|P2|STARTED|Treatment Period 4||2
5303997|NCT00519376|13039780|P1|STARTED|Treatment Period 4||2
5303998|NCT00519376|13039765|P16|NOT COMPLETED|Washout Period 3||0
5303999|NCT00519376|13039766|P15|NOT COMPLETED|Washout Period 3||0
5304000|NCT00519376|13039767|P14|NOT COMPLETED|Washout Period 3||0
5304001|NCT00519376|13039768|P13|NOT COMPLETED|Washout Period 3||0
5304002|NCT00519376|13039769|P12|NOT COMPLETED|Washout Period 3||0
5304003|NCT00519376|13039770|P11|NOT COMPLETED|Washout Period 3||0
5304004|NCT00519376|13039771|P10|NOT COMPLETED|Washout Period 3||0
5304005|NCT00519376|13039772|P9|NOT COMPLETED|Washout Period 3||0
5304006|NCT00519376|13039773|P8|NOT COMPLETED|Washout Period 3||0
5304007|NCT00519376|13039774|P7|NOT COMPLETED|Washout Period 3||0
5304008|NCT00519376|13039775|P6|NOT COMPLETED|Washout Period 3||0
5304009|NCT00519376|13039776|P5|NOT COMPLETED|Washout Period 3||0
5304010|NCT00519376|13039777|P4|NOT COMPLETED|Washout Period 3||0
5304011|NCT00519376|13039778|P3|NOT COMPLETED|Washout Period 3||0
5304012|NCT00519376|13039779|P2|NOT COMPLETED|Washout Period 3||0
5304013|NCT00519376|13039780|P1|NOT COMPLETED|Washout Period 3||0
5304014|NCT00519376|13039765|P16|COMPLETED|Washout Period 3||1
5304015|NCT00519376|13039766|P15|COMPLETED|Washout Period 3||1
5304016|NCT00519376|13039767|P14|COMPLETED|Washout Period 3||1
5304017|NCT00519376|13039768|P13|COMPLETED|Washout Period 3||0
5304018|NCT00519376|13039769|P12|COMPLETED|Washout Period 3||1
5304019|NCT00519376|13039770|P11|COMPLETED|Washout Period 3||1
5304020|NCT00519376|13039771|P10|COMPLETED|Washout Period 3||1
5304021|NCT00519376|13039772|P9|COMPLETED|Washout Period 3||1
5304022|NCT00519376|13039773|P8|COMPLETED|Washout Period 3||1
5304023|NCT00519376|13039774|P7|COMPLETED|Washout Period 3||1
5304024|NCT00519376|13039775|P6|COMPLETED|Washout Period 3||1
5304025|NCT00519376|13039776|P5|COMPLETED|Washout Period 3||1
5304026|NCT00519376|13039777|P4|COMPLETED|Washout Period 3||2
5304027|NCT00519376|13039778|P3|COMPLETED|Washout Period 3||2
5304028|NCT00519376|13039779|P2|COMPLETED|Washout Period 3||2
5304029|NCT00519376|13039780|P1|COMPLETED|Washout Period 3||2
5304030|NCT00519376|13039765|P16|STARTED|Washout Period 3||1
5304031|NCT00519376|13039766|P15|STARTED|Washout Period 3||1
5304032|NCT00519376|13039767|P14|STARTED|Washout Period 3||1
5304033|NCT00519376|13039768|P13|STARTED|Washout Period 3||0
5304034|NCT00519376|13039769|P12|STARTED|Washout Period 3||1
5304035|NCT00519376|13039770|P11|STARTED|Washout Period 3||1
5304036|NCT00519376|13039771|P10|STARTED|Washout Period 3||1
5304037|NCT00519376|13039772|P9|STARTED|Washout Period 3||1
5304038|NCT00519376|13039773|P8|STARTED|Washout Period 3||1
5304039|NCT00519376|13039774|P7|STARTED|Washout Period 3||1
5304040|NCT00519376|13039775|P6|STARTED|Washout Period 3||1
5304041|NCT00519376|13039776|P5|STARTED|Washout Period 3||1
5304042|NCT00519376|13039777|P4|STARTED|Washout Period 3||2
5304043|NCT00519376|13039778|P3|STARTED|Washout Period 3||2
5304044|NCT00519376|13039779|P2|STARTED|Washout Period 3||2
5304045|NCT00519376|13039780|P1|STARTED|Washout Period 3||2
5304046|NCT00519376|13039765|P16|NOT COMPLETED|Treatment Period 3||0
5304047|NCT00519376|13039766|P15|NOT COMPLETED|Treatment Period 3||0
5304048|NCT00519376|13039767|P14|NOT COMPLETED|Treatment Period 3||0
5304049|NCT00519376|13039768|P13|NOT COMPLETED|Treatment Period 3||0
5304050|NCT00519376|13039769|P12|NOT COMPLETED|Treatment Period 3||0
5304051|NCT00519376|13039770|P11|NOT COMPLETED|Treatment Period 3||0
5304052|NCT00519376|13039771|P10|NOT COMPLETED|Treatment Period 3||0
5304053|NCT00519376|13039772|P9|NOT COMPLETED|Treatment Period 3||0
5304054|NCT00519376|13039773|P8|NOT COMPLETED|Treatment Period 3||0
5304055|NCT00519376|13039774|P7|NOT COMPLETED|Treatment Period 3||0
5304056|NCT00519376|13039775|P6|NOT COMPLETED|Treatment Period 3||0
5304057|NCT00519376|13039776|P5|NOT COMPLETED|Treatment Period 3||0
5304058|NCT00519376|13039777|P4|NOT COMPLETED|Treatment Period 3||0
5304059|NCT00519376|13039778|P3|NOT COMPLETED|Treatment Period 3||0
5304060|NCT00519376|13039779|P2|NOT COMPLETED|Treatment Period 3||0
5304061|NCT00519376|13039780|P1|NOT COMPLETED|Treatment Period 3||0
5304062|NCT00519376|13039765|P16|COMPLETED|Treatment Period 3||1
5304063|NCT00519376|13039766|P15|COMPLETED|Treatment Period 3||1
5304064|NCT00519376|13039767|P14|COMPLETED|Treatment Period 3||1
5304065|NCT00519376|13039768|P13|COMPLETED|Treatment Period 3||0
5304066|NCT00519376|13039769|P12|COMPLETED|Treatment Period 3||1
5304067|NCT00519376|13039770|P11|COMPLETED|Treatment Period 3||1
5304068|NCT00519376|13039771|P10|COMPLETED|Treatment Period 3||1
5304069|NCT00519376|13039772|P9|COMPLETED|Treatment Period 3||1
5304070|NCT00519376|13039773|P8|COMPLETED|Treatment Period 3||1
5304071|NCT00519376|13039774|P7|COMPLETED|Treatment Period 3||1
5304072|NCT00519376|13039775|P6|COMPLETED|Treatment Period 3||1
5304073|NCT00519376|13039776|P5|COMPLETED|Treatment Period 3||1
5304074|NCT00519376|13039777|P4|COMPLETED|Treatment Period 3||2
5304075|NCT00519376|13039778|P3|COMPLETED|Treatment Period 3||2
5304076|NCT00519376|13039779|P2|COMPLETED|Treatment Period 3||2
5304077|NCT00519376|13039780|P1|COMPLETED|Treatment Period 3||2
5304078|NCT00519376|13039765|P16|STARTED|Treatment Period 3||1
5304079|NCT00519376|13039766|P15|STARTED|Treatment Period 3||1
5304080|NCT00519376|13039767|P14|STARTED|Treatment Period 3||1
5304081|NCT00519376|13039768|P13|STARTED|Treatment Period 3||0
5304082|NCT00519376|13039769|P12|STARTED|Treatment Period 3||1
5304083|NCT00519376|13039770|P11|STARTED|Treatment Period 3||1
5304084|NCT00519376|13039771|P10|STARTED|Treatment Period 3||1
5304085|NCT00519376|13039772|P9|STARTED|Treatment Period 3||1
5304086|NCT00519376|13039773|P8|STARTED|Treatment Period 3||1
5304087|NCT00519376|13039774|P7|STARTED|Treatment Period 3||1
5304088|NCT00519376|13039775|P6|STARTED|Treatment Period 3||1
5304089|NCT00519376|13039776|P5|STARTED|Treatment Period 3||1
5304090|NCT00519376|13039777|P4|STARTED|Treatment Period 3||2
5304091|NCT00519376|13039778|P3|STARTED|Treatment Period 3||2
5304092|NCT00519376|13039779|P2|STARTED|Treatment Period 3||2
5304093|NCT00519376|13039780|P1|STARTED|Treatment Period 3||2
5304094|NCT00519376|13039765|P16|NOT COMPLETED|Washout Period 2||0
5304095|NCT00519376|13039766|P15|NOT COMPLETED|Washout Period 2||0
5304096|NCT00519376|13039767|P14|NOT COMPLETED|Washout Period 2||0
5304097|NCT00519376|13039768|P13|NOT COMPLETED|Washout Period 2||0
5304098|NCT00519376|13039769|P12|NOT COMPLETED|Washout Period 2||0
5304099|NCT00519376|13039770|P11|NOT COMPLETED|Washout Period 2||0
5304100|NCT00519376|13039771|P10|NOT COMPLETED|Washout Period 2||0
5304101|NCT00519376|13039772|P9|NOT COMPLETED|Washout Period 2||0
5304102|NCT00519376|13039773|P8|NOT COMPLETED|Washout Period 2||0
5304103|NCT00519376|13039774|P7|NOT COMPLETED|Washout Period 2||0
5304104|NCT00519376|13039775|P6|NOT COMPLETED|Washout Period 2||0
5304105|NCT00519376|13039776|P5|NOT COMPLETED|Washout Period 2||0
5304106|NCT00519376|13039777|P4|NOT COMPLETED|Washout Period 2||0
5304107|NCT00519376|13039778|P3|NOT COMPLETED|Washout Period 2||0
5304108|NCT00519376|13039779|P2|NOT COMPLETED|Washout Period 2||0
5304109|NCT00519376|13039780|P1|NOT COMPLETED|Washout Period 2||0
5304110|NCT00519376|13039765|P16|COMPLETED|Washout Period 2||1
5304111|NCT00519376|13039766|P15|COMPLETED|Washout Period 2||1
5304112|NCT00519376|13039767|P14|COMPLETED|Washout Period 2||1
5304113|NCT00519376|13039768|P13|COMPLETED|Washout Period 2||0
5304114|NCT00519376|13039769|P12|COMPLETED|Washout Period 2||1
5304115|NCT00519376|13039770|P11|COMPLETED|Washout Period 2||1
5304116|NCT00519376|13039771|P10|COMPLETED|Washout Period 2||1
5304117|NCT00519376|13039772|P9|COMPLETED|Washout Period 2||1
5304118|NCT00519376|13039773|P8|COMPLETED|Washout Period 2||1
5304119|NCT00519376|13039774|P7|COMPLETED|Washout Period 2||1
5304120|NCT00519376|13039775|P6|COMPLETED|Washout Period 2||1
5304121|NCT00519376|13039776|P5|COMPLETED|Washout Period 2||1
5304122|NCT00519376|13039777|P4|COMPLETED|Washout Period 2||2
5304123|NCT00519376|13039778|P3|COMPLETED|Washout Period 2||2
5304124|NCT00519376|13039779|P2|COMPLETED|Washout Period 2||2
5304125|NCT00519376|13039780|P1|COMPLETED|Washout Period 2||2
5304126|NCT00519376|13039765|P16|STARTED|Washout Period 2||1
5304127|NCT00519376|13039766|P15|STARTED|Washout Period 2||1
5304128|NCT00519376|13039767|P14|STARTED|Washout Period 2||1
5304129|NCT00519376|13039768|P13|STARTED|Washout Period 2||0
5304130|NCT00519376|13039769|P12|STARTED|Washout Period 2||1
5304131|NCT00519376|13039770|P11|STARTED|Washout Period 2||1
5304132|NCT00519376|13039771|P10|STARTED|Washout Period 2||1
5304133|NCT00519376|13039772|P9|STARTED|Washout Period 2||1
5304134|NCT00519376|13039773|P8|STARTED|Washout Period 2||1
5304135|NCT00519376|13039774|P7|STARTED|Washout Period 2||1
5304136|NCT00519376|13039775|P6|STARTED|Washout Period 2||1
5304137|NCT00519376|13039776|P5|STARTED|Washout Period 2||1
5304138|NCT00519376|13039777|P4|STARTED|Washout Period 2||2
5304139|NCT00519376|13039778|P3|STARTED|Washout Period 2||2
5304140|NCT00519376|13039779|P2|STARTED|Washout Period 2||2
5304141|NCT00519376|13039780|P1|STARTED|Washout Period 2||2
5304142|NCT00519376|13039765|P16|NOT COMPLETED|Treatment Period 2||0
5304143|NCT00519376|13039766|P15|NOT COMPLETED|Treatment Period 2||0
5304144|NCT00519376|13039767|P14|NOT COMPLETED|Treatment Period 2||0
5304145|NCT00519376|13039768|P13|NOT COMPLETED|Treatment Period 2||1
5304146|NCT00519376|13039769|P12|NOT COMPLETED|Treatment Period 2||0
5304147|NCT00519376|13039770|P11|NOT COMPLETED|Treatment Period 2||0
5304148|NCT00519376|13039771|P10|NOT COMPLETED|Treatment Period 2||0
5304149|NCT00519376|13039772|P9|NOT COMPLETED|Treatment Period 2||0
5304150|NCT00519376|13039773|P8|NOT COMPLETED|Treatment Period 2||0
5304151|NCT00519376|13039774|P7|NOT COMPLETED|Treatment Period 2||0
5304152|NCT00519376|13039775|P6|NOT COMPLETED|Treatment Period 2||0
5304153|NCT00519376|13039776|P5|NOT COMPLETED|Treatment Period 2||0
5304154|NCT00519376|13039777|P4|NOT COMPLETED|Treatment Period 2||0
5304155|NCT00519376|13039778|P3|NOT COMPLETED|Treatment Period 2||0
5304156|NCT00519376|13039779|P2|NOT COMPLETED|Treatment Period 2||0
5304157|NCT00519376|13039780|P1|NOT COMPLETED|Treatment Period 2||0
5304158|NCT00519376|13039765|P16|COMPLETED|Treatment Period 2||1
5304159|NCT00519376|13039766|P15|COMPLETED|Treatment Period 2||1
5304160|NCT00519376|13039767|P14|COMPLETED|Treatment Period 2||1
5304161|NCT00519376|13039768|P13|COMPLETED|Treatment Period 2||0
5304162|NCT00519376|13039769|P12|COMPLETED|Treatment Period 2||1
5304163|NCT00519376|13039770|P11|COMPLETED|Treatment Period 2||1
5304164|NCT00519376|13039771|P10|COMPLETED|Treatment Period 2||1
5304165|NCT00519376|13039772|P9|COMPLETED|Treatment Period 2||1
5304166|NCT00519376|13039773|P8|COMPLETED|Treatment Period 2||1
5304167|NCT00519376|13039774|P7|COMPLETED|Treatment Period 2||1
5304168|NCT00519376|13039775|P6|COMPLETED|Treatment Period 2||1
5304169|NCT00519376|13039776|P5|COMPLETED|Treatment Period 2||1
5304170|NCT00519376|13039777|P4|COMPLETED|Treatment Period 2||2
5304171|NCT00519376|13039778|P3|COMPLETED|Treatment Period 2||2
5304172|NCT00519376|13039779|P2|COMPLETED|Treatment Period 2||2
5304173|NCT00519376|13039780|P1|COMPLETED|Treatment Period 2||2
5304174|NCT00519376|13039765|P16|STARTED|Treatment Period 2||1
5304175|NCT00519376|13039766|P15|STARTED|Treatment Period 2||1
5304176|NCT00519376|13039767|P14|STARTED|Treatment Period 2||1
5304177|NCT00519376|13039768|P13|STARTED|Treatment Period 2||1
5304178|NCT00519376|13039769|P12|STARTED|Treatment Period 2||1
5304179|NCT00519376|13039770|P11|STARTED|Treatment Period 2||1
5304180|NCT00519376|13039771|P10|STARTED|Treatment Period 2||1
5304181|NCT00519376|13039772|P9|STARTED|Treatment Period 2||1
5304182|NCT00519376|13039773|P8|STARTED|Treatment Period 2||1
5304183|NCT00519376|13039774|P7|STARTED|Treatment Period 2||1
5304184|NCT00519376|13039775|P6|STARTED|Treatment Period 2||1
5304185|NCT00519376|13039776|P5|STARTED|Treatment Period 2||1
5304186|NCT00519376|13039777|P4|STARTED|Treatment Period 2||2
5304187|NCT00519376|13039778|P3|STARTED|Treatment Period 2||2
5304188|NCT00519376|13039779|P2|STARTED|Treatment Period 2||2
5304189|NCT00519376|13039780|P1|STARTED|Treatment Period 2||2
5304190|NCT00519376|13039765|P16|NOT COMPLETED|Washout Period 1||0
5304191|NCT00519376|13039766|P15|NOT COMPLETED|Washout Period 1||0
5304192|NCT00519376|13039767|P14|NOT COMPLETED|Washout Period 1||0
5304193|NCT00519376|13039768|P13|NOT COMPLETED|Washout Period 1||0
5304194|NCT00519376|13039769|P12|NOT COMPLETED|Washout Period 1||0
5304195|NCT00519376|13039770|P11|NOT COMPLETED|Washout Period 1||0
5304196|NCT00519376|13039771|P10|NOT COMPLETED|Washout Period 1||0
5304197|NCT00519376|13039772|P9|NOT COMPLETED|Washout Period 1||0
5304198|NCT00519376|13039773|P8|NOT COMPLETED|Washout Period 1||0
5304199|NCT00519376|13039774|P7|NOT COMPLETED|Washout Period 1||0
5304200|NCT00519376|13039775|P6|NOT COMPLETED|Washout Period 1||0
5304201|NCT00519376|13039776|P5|NOT COMPLETED|Washout Period 1||0
5304202|NCT00519376|13039777|P4|NOT COMPLETED|Washout Period 1||0
5304203|NCT00519376|13039778|P3|NOT COMPLETED|Washout Period 1||0
5304204|NCT00519376|13039779|P2|NOT COMPLETED|Washout Period 1||0
5304205|NCT00519376|13039780|P1|NOT COMPLETED|Washout Period 1||0
5304206|NCT00519376|13039765|P16|COMPLETED|Washout Period 1||1
5304207|NCT00519376|13039766|P15|COMPLETED|Washout Period 1||1
5304208|NCT00519376|13039767|P14|COMPLETED|Washout Period 1||1
5304209|NCT00519376|13039768|P13|COMPLETED|Washout Period 1||1
5304210|NCT00519376|13039769|P12|COMPLETED|Washout Period 1||1
5304211|NCT00519376|13039770|P11|COMPLETED|Washout Period 1||1
5304212|NCT00519376|13039771|P10|COMPLETED|Washout Period 1||1
5304213|NCT00519376|13039772|P9|COMPLETED|Washout Period 1||1
5304214|NCT00519376|13039773|P8|COMPLETED|Washout Period 1||1
5304215|NCT00519376|13039774|P7|COMPLETED|Washout Period 1||1
5304216|NCT00519376|13039775|P6|COMPLETED|Washout Period 1||1
5304217|NCT00519376|13039776|P5|COMPLETED|Washout Period 1||1
5304218|NCT00519376|13039777|P4|COMPLETED|Washout Period 1||2
5304219|NCT00519376|13039778|P3|COMPLETED|Washout Period 1||2
5304220|NCT00519376|13039779|P2|COMPLETED|Washout Period 1||2
5304221|NCT00519376|13039780|P1|COMPLETED|Washout Period 1||2
5304222|NCT00519376|13039765|P16|STARTED|Washout Period 1||1
5304223|NCT00519376|13039766|P15|STARTED|Washout Period 1||1
5304224|NCT00519376|13039767|P14|STARTED|Washout Period 1||1
5304225|NCT00519376|13039768|P13|STARTED|Washout Period 1||1
5304226|NCT00519376|13039769|P12|STARTED|Washout Period 1||1
5304227|NCT00519376|13039770|P11|STARTED|Washout Period 1||1
5304228|NCT00519376|13039771|P10|STARTED|Washout Period 1||1
5304229|NCT00519376|13039772|P9|STARTED|Washout Period 1||1
5304230|NCT00519376|13039773|P8|STARTED|Washout Period 1||1
5304231|NCT00519376|13039774|P7|STARTED|Washout Period 1||1
5304232|NCT00519376|13039775|P6|STARTED|Washout Period 1||1
5304233|NCT00519376|13039776|P5|STARTED|Washout Period 1||1
5304234|NCT00519376|13039777|P4|STARTED|Washout Period 1||2
5304235|NCT00519376|13039778|P3|STARTED|Washout Period 1||2
5304236|NCT00519376|13039779|P2|STARTED|Washout Period 1||2
5304237|NCT00519376|13039780|P1|STARTED|Washout Period 1||2
5304238|NCT00519376|13039765|P16|NOT COMPLETED|Treatment Period 1||0
5304239|NCT00519376|13039766|P15|NOT COMPLETED|Treatment Period 1||0
5304240|NCT00519376|13039767|P14|NOT COMPLETED|Treatment Period 1||0
5304241|NCT00519376|13039768|P13|NOT COMPLETED|Treatment Period 1||0
5304242|NCT00519376|13039769|P12|NOT COMPLETED|Treatment Period 1||0
5304243|NCT00519376|13039770|P11|NOT COMPLETED|Treatment Period 1||0
5304244|NCT00519376|13039771|P10|NOT COMPLETED|Treatment Period 1||0
5304245|NCT00519376|13039772|P9|NOT COMPLETED|Treatment Period 1||0
5304246|NCT00519376|13039773|P8|NOT COMPLETED|Treatment Period 1||0
5304247|NCT00519376|13039774|P7|NOT COMPLETED|Treatment Period 1||0
5304248|NCT00519376|13039775|P6|NOT COMPLETED|Treatment Period 1||0
5304249|NCT00519376|13039776|P5|NOT COMPLETED|Treatment Period 1||0
5304250|NCT00519376|13039777|P4|NOT COMPLETED|Treatment Period 1||0
5304251|NCT00519376|13039778|P3|NOT COMPLETED|Treatment Period 1||0
5304252|NCT00519376|13039779|P2|NOT COMPLETED|Treatment Period 1||0
5304253|NCT00519376|13039780|P1|NOT COMPLETED|Treatment Period 1||0
5304254|NCT00519376|13039765|P16|COMPLETED|Treatment Period 1||1
5304255|NCT00519376|13039766|P15|COMPLETED|Treatment Period 1||1
5304256|NCT00519376|13039767|P14|COMPLETED|Treatment Period 1||1
5304257|NCT00519376|13039768|P13|COMPLETED|Treatment Period 1||1
5304258|NCT00519376|13039769|P12|COMPLETED|Treatment Period 1||1
5304259|NCT00519376|13039770|P11|COMPLETED|Treatment Period 1||1
5304260|NCT00519376|13039771|P10|COMPLETED|Treatment Period 1||1
5304261|NCT00519376|13039772|P9|COMPLETED|Treatment Period 1||1
5304262|NCT00519376|13039773|P8|COMPLETED|Treatment Period 1||1
5304263|NCT00519376|13039774|P7|COMPLETED|Treatment Period 1||1
5304264|NCT00519376|13039775|P6|COMPLETED|Treatment Period 1||1
5304265|NCT00519376|13039776|P5|COMPLETED|Treatment Period 1||1
5304266|NCT00519376|13039777|P4|COMPLETED|Treatment Period 1||2
5304267|NCT00519376|13039778|P3|COMPLETED|Treatment Period 1||2
5304268|NCT00519376|13039779|P2|COMPLETED|Treatment Period 1||2
5304269|NCT00519376|13039780|P1|COMPLETED|Treatment Period 1||2
5304270|NCT00519376|13039765|P16|STARTED|Treatment Period 1||1
5304271|NCT00519376|13039766|P15|STARTED|Treatment Period 1||1
5304272|NCT00519376|13039767|P14|STARTED|Treatment Period 1||1
5304273|NCT00519376|13039768|P13|STARTED|Treatment Period 1||1
5304274|NCT00519376|13039769|P12|STARTED|Treatment Period 1||1
5304275|NCT00519376|13039770|P11|STARTED|Treatment Period 1||1
5304276|NCT00519376|13039771|P10|STARTED|Treatment Period 1||1
5304277|NCT00519376|13039772|P9|STARTED|Treatment Period 1||1
5304278|NCT00519376|13039773|P8|STARTED|Treatment Period 1||1
5304279|NCT00519376|13039774|P7|STARTED|Treatment Period 1||1
5304280|NCT00519376|13039775|P6|STARTED|Treatment Period 1||1
5304281|NCT00519376|13039776|P5|STARTED|Treatment Period 1||1
5304282|NCT00519376|13039777|P4|STARTED|Treatment Period 1||2
5304283|NCT00519376|13039778|P3|STARTED|Treatment Period 1||2
5304284|NCT00519376|13039779|P2|STARTED|Treatment Period 1||2
5304285|NCT00519376|13039780|P1|STARTED|Treatment Period 1||2
5304286|NCT00519285|13039904|P2|NOT COMPLETED|Overall Study||612
5304287|NCT00519285|13039905|P1|NOT COMPLETED|Overall Study||612
5304288|NCT00519285|13039904|P2|COMPLETED|Overall Study||0
5304289|NCT00519285|13039905|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
5304290|NCT00519285|13039904|P2|Still Treated at Cut-off Date|Overall Study||2
5304291|NCT00519285|13039905|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
5304292|NCT00519285|13039904|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
5304293|NCT00519285|13039905|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
5304294|NCT00519285|13039904|P2|STARTED|Overall Study|Randomized|612
5304295|NCT00519285|13039905|P1|STARTED|Overall Study|Randomized|612
5304296|NCT00519194|13039931|P1|NOT COMPLETED|Overall Study||21
5304297|NCT00519194|13039931|P1|COMPLETED|Overall Study||91
5304298|NCT00519194|13039931|P1|STARTED|Overall Study||112
5304299|NCT00519090|13039937|P2|NOT COMPLETED|Overall Study||0
5304300|NCT00519090|13039938|P1|NOT COMPLETED|Overall Study||0
5304301|NCT00519090|13039937|P2|COMPLETED|Overall Study||4
5304302|NCT00519090|13039938|P1|COMPLETED|Overall Study||2
5304303|NCT00519090|13039937|P2|STARTED|Overall Study||4
5304304|NCT00519090|13039938|P1|STARTED|Overall Study||2
5304305|NCT00519077|13039946|P1|NOT COMPLETED|Overall Study||8
5304306|NCT00519077|13039946|P1|COMPLETED|Overall Study||36
5304307|NCT00519077|13039946|P1|STARTED|Overall Study||44
5304308|NCT00518986|13039953|P2|NOT COMPLETED|Overall Study||26
5304309|NCT00518986|13039954|P1|NOT COMPLETED|Overall Study||26
5304310|NCT00518986|13039953|P2|COMPLETED|Overall Study||98
5304311|NCT00518986|13039954|P1|COMPLETED|Overall Study||99
5304312|NCT00518986|13039953|P2|STARTED|Overall Study||124
5304313|NCT00518986|13039954|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
5304314|NCT00518973|13040080|P2|NOT COMPLETED|Overall Study||2
5304315|NCT00518973|13040081|P1|NOT COMPLETED|Overall Study||3
5304316|NCT00518973|13040080|P2|COMPLETED|Overall Study||4
5304317|NCT00518973|13040081|P1|COMPLETED|Overall Study||6
5304318|NCT00518973|13040080|P2|STARTED|Overall Study||6
5304319|NCT00518973|13040081|P1|STARTED|Overall Study||9
5304320|NCT00518882|13040097|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
5304321|NCT00518882|13040098|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
5304322|NCT00518882|13040097|P2|COMPLETED|Open-Label Extension, Week 26-78||138
5304323|NCT00518882|13040098|P1|COMPLETED|Open-Label Extension, Week 26-78||161
5304324|NCT00518882|13040097|P2|STARTED|Open-Label Extension, Week 26-78||187
5304325|NCT00518882|13040098|P1|STARTED|Open-Label Extension, Week 26-78||202
5304326|NCT00518882|13040097|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
5304327|NCT00518882|13040098|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
5304328|NCT00518882|13040097|P2|COMPLETED|Double-Blind, Week 0-26||187
5304329|NCT00518882|13040098|P1|COMPLETED|Double-Blind, Week 0-26||202
5304330|NCT00518882|13040097|P2|Randomised|Double-Blind, Week 0-26||231
5304331|NCT00518882|13040098|P1|Randomised|Double-Blind, Week 0-26||233
5304332|NCT00518882|13040097|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
5304333|NCT00518882|13040098|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
5304334|NCT00518713|13040216|P4|NOT COMPLETED|Overall Study||18
5304335|NCT00518713|13040217|P3|NOT COMPLETED|Overall Study||18
5304336|NCT00518713|13040218|P2|NOT COMPLETED|Overall Study||17
5304337|NCT00518713|13040219|P1|NOT COMPLETED|Overall Study||8
5304338|NCT00518713|13040216|P4|COMPLETED|Overall Study||41
5304339|NCT00518713|13040217|P3|COMPLETED|Overall Study||41
5304340|NCT00518713|13040218|P2|COMPLETED|Overall Study||45
5304341|NCT00518713|13040219|P1|COMPLETED|Overall Study||50
5304342|NCT00518713|13040216|P4|Modified Intent-to-Treat Population|Overall Study||57
5304343|NCT00518713|13040217|P3|Modified Intent-to-Treat Population|Overall Study||49
5304344|NCT00518713|13040218|P2|Modified Intent-to-Treat Population|Overall Study||58
5304345|NCT00518713|13040219|P1|Modified Intent-to-Treat Population|Overall Study||53
5304346|NCT00518713|13040216|P4|STARTED|Overall Study||59
5304347|NCT00518713|13040217|P3|STARTED|Overall Study||59
5304348|NCT00518713|13040218|P2|STARTED|Overall Study||62
5304349|NCT00518713|13040219|P1|STARTED|Overall Study||58
5304350|NCT00518687|13040279|P2|NOT COMPLETED|Overall Study||1420
5304351|NCT00518687|13040280|P1|NOT COMPLETED|Overall Study||1437
5304352|NCT00518687|13040279|P2|COMPLETED|Overall Study||2585
5304353|NCT00518687|13040280|P1|COMPLETED|Overall Study||2568
5304354|NCT00518687|13040279|P2|Vaccinated|Overall Study||3982
5304355|NCT00518687|13040280|P1|Vaccinated|Overall Study||3981
5304356|NCT00518687|13040279|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
5304357|NCT00518687|13040280|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
5304358|NCT00518622|13040300|P8|NOT COMPLETED|Overall Study||0
5304359|NCT00518622|13040301|P7|NOT COMPLETED|Overall Study||0
5304360|NCT00518622|13040302|P6|NOT COMPLETED|Overall Study||0
5304361|NCT00518622|13040303|P5|NOT COMPLETED|Overall Study||0
5304362|NCT00518622|13040304|P4|NOT COMPLETED|Overall Study||0
5304363|NCT00518622|13040305|P3|NOT COMPLETED|Overall Study||1
5304364|NCT00518622|13040306|P2|NOT COMPLETED|Overall Study||1
5304365|NCT00518622|13040307|P1|NOT COMPLETED|Overall Study||0
5304366|NCT00518622|13040300|P8|COMPLETED|Overall Study||5
5304367|NCT00518622|13040301|P7|COMPLETED|Overall Study||4
5304368|NCT00518622|13040302|P6|COMPLETED|Overall Study||5
5304369|NCT00518622|13040303|P5|COMPLETED|Overall Study||6
5304370|NCT00518622|13040304|P4|COMPLETED|Overall Study||5
5304371|NCT00518622|13040305|P3|COMPLETED|Overall Study||5
5304372|NCT00518622|13040306|P2|COMPLETED|Overall Study||5
5304373|NCT00518622|13040307|P1|COMPLETED|Overall Study||3
5304374|NCT00518622|13040300|P8|Discontinued Therapy|Overall Study||0
5304375|NCT00518622|13040301|P7|Discontinued Therapy|Overall Study||0
5304376|NCT00518622|13040302|P6|Discontinued Therapy|Overall Study||0
5304377|NCT00518622|13040303|P5|Discontinued Therapy|Overall Study||0
5304378|NCT00518622|13040304|P4|Discontinued Therapy|Overall Study||0
5304379|NCT00518622|13040305|P3|Discontinued Therapy|Overall Study||0
5304380|NCT00518622|13040306|P2|Discontinued Therapy|Overall Study||1
5304381|NCT00518622|13040307|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
5304382|NCT00518622|13040300|P8|Completed Therapy|Overall Study||5
5304383|NCT00518622|13040301|P7|Completed Therapy|Overall Study||4
5304384|NCT00518622|13040302|P6|Completed Therapy|Overall Study||5
5304385|NCT00518622|13040303|P5|Completed Therapy|Overall Study||6
5304386|NCT00518622|13040304|P4|Completed Therapy|Overall Study||5
5304387|NCT00518622|13040305|P3|Completed Therapy|Overall Study||6
5304388|NCT00518622|13040306|P2|Completed Therapy|Overall Study||5
5304389|NCT00518622|13040307|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
5304390|NCT00518622|13040300|P8|STARTED|Overall Study||5
5304391|NCT00518622|13040301|P7|STARTED|Overall Study||4
5304392|NCT00518622|13040302|P6|STARTED|Overall Study||5
5304393|NCT00518622|13040303|P5|STARTED|Overall Study||6
5304394|NCT00518622|13040304|P4|STARTED|Overall Study||5
5304395|NCT00518622|13040305|P3|STARTED|Overall Study||6
5304396|NCT00518622|13040306|P2|STARTED|Overall Study||6
5304397|NCT00518622|13040307|P1|STARTED|Overall Study||3
5304398|NCT00518531|13040335|P2|NOT COMPLETED|Treatment Period 2||20
5304399|NCT00518531|13040336|P1|NOT COMPLETED|Treatment Period 2||3
5304400|NCT00518531|13040335|P2|COMPLETED|Treatment Period 2||95
5304401|NCT00518531|13040336|P1|COMPLETED|Treatment Period 2||103
5304402|NCT00518531|13040335|P2|Received Treatment|Treatment Period 2||110
5304403|NCT00518531|13040336|P1|Received Treatment|Treatment Period 2||106
5304404|NCT00518531|13040335|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
5304405|NCT00518531|13040336|P1|STARTED|Treatment Period 2||106
5304406|NCT00518531|13040335|P2|NOT COMPLETED|Treatment Period 1||12
5304407|NCT00518531|13040336|P1|NOT COMPLETED|Treatment Period 1||18
5304408|NCT00518531|13040335|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
5304409|NCT00518531|13040336|P1|COMPLETED|Treatment Period 1||106
5304410|NCT00518531|13040335|P2|Received Treatment|Treatment Period 1||124
5304411|NCT00518531|13040336|P1|Received Treatment|Treatment Period 1||119
5304412|NCT00518531|13040335|P2|STARTED|Treatment Period 1||126
5304413|NCT00518531|13040336|P1|STARTED|Treatment Period 1||124
5304414|NCT00518349|13040372|P2|NOT COMPLETED|Overall Study||0
5304415|NCT00518349|13040373|P1|NOT COMPLETED|Overall Study||0
5304416|NCT00518349|13040372|P2|COMPLETED|Overall Study||60
5304417|NCT00518349|13040373|P1|COMPLETED|Overall Study||60
5304418|NCT00518349|13040372|P2|STARTED|Overall Study||60
5304419|NCT00518349|13040373|P1|STARTED|Overall Study||60
5304420|NCT00518336|13040381|P2|NOT COMPLETED|Year 9||1
5304421|NCT00518336|13040382|P1|NOT COMPLETED|Year 9||5
5304422|NCT00518336|13040381|P2|COMPLETED|Year 9||212
5304423|NCT00518336|13040382|P1|COMPLETED|Year 9||219
5304424|NCT00518336|13040381|P2|STARTED|Year 9||213
5304425|NCT00518336|13040382|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
5304426|NCT00518336|13040381|P2|NOT COMPLETED|Year 8||2
5304427|NCT00518336|13040382|P1|NOT COMPLETED|Year 8||1
5304428|NCT00518336|13040381|P2|COMPLETED|Year 8||211
5304429|NCT00518336|13040382|P1|COMPLETED|Year 8||222
5304430|NCT00518336|13040381|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
5304431|NCT00518336|13040382|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
5304432|NCT00518336|13040381|P2|NOT COMPLETED|Year 7||3
5304433|NCT00518336|13040382|P1|NOT COMPLETED|Year 7||2
5304434|NCT00518336|13040381|P2|COMPLETED|Year 7||208
5304435|NCT00518336|13040382|P1|COMPLETED|Year 7||220
5304436|NCT00518336|13040381|P2|STARTED|Year 7||211
5304437|NCT00518336|13040382|P1|STARTED|Year 7||222
5304438|NCT00518323|13040548|P4|NOT COMPLETED|Overall Study||25
5304439|NCT00518323|13040549|P3|NOT COMPLETED|Overall Study||11
5304440|NCT00518323|13040550|P2|NOT COMPLETED|Overall Study||8
5304441|NCT00518323|13040551|P1|NOT COMPLETED|Overall Study||19
5304442|NCT00518323|13040548|P4|COMPLETED|Overall Study||26
5304443|NCT00518323|13040549|P3|COMPLETED|Overall Study||37
5304444|NCT00518323|13040550|P2|COMPLETED|Overall Study||40
5304445|NCT00518323|13040551|P1|COMPLETED|Overall Study||35
5304446|NCT00518323|13040548|P4|STARTED|Overall Study||51
5304447|NCT00518323|13040549|P3|STARTED|Overall Study||48
5304448|NCT00518323|13040550|P2|STARTED|Overall Study||48
5304449|NCT00518323|13040551|P1|STARTED|Overall Study||54
5304450|NCT00518284|13040581|P4|NOT COMPLETED|Overall Study||2
5304451|NCT00518284|13040582|P3|NOT COMPLETED|Overall Study||1
5304452|NCT00518284|13040583|P2|NOT COMPLETED|Overall Study||3
5304453|NCT00518284|13040584|P1|NOT COMPLETED|Overall Study||0
5304454|NCT00518284|13040581|P4|COMPLETED|Overall Study||0
5304455|NCT00518284|13040582|P3|COMPLETED|Overall Study||0
5304456|NCT00518284|13040583|P2|COMPLETED|Overall Study||0
5304457|NCT00518284|13040584|P1|COMPLETED|Overall Study||0
5304458|NCT00518284|13040581|P4|STARTED|Overall Study||2
5304459|NCT00518284|13040582|P3|STARTED|Overall Study||1
5304460|NCT00518284|13040583|P2|STARTED|Overall Study||3
5304461|NCT00518284|13040584|P1|STARTED|Overall Study||0
5304462|NCT00518206|13040640|P2|NOT COMPLETED|Overall Study||6
5304463|NCT00518206|13040641|P1|NOT COMPLETED|Overall Study||11
5304464|NCT00518206|13040640|P2|COMPLETED|Overall Study||13
5304465|NCT00518206|13040641|P1|COMPLETED|Overall Study||16
5304466|NCT00518206|13040640|P2|STARTED|Overall Study||19
5304467|NCT00518206|13040641|P1|STARTED|Overall Study||27
5304468|NCT00518180|13040658|P3|NOT COMPLETED|Overall Study||82
5304469|NCT00518180|13040659|P2|NOT COMPLETED|Overall Study||69
5304470|NCT00518180|13040660|P1|NOT COMPLETED|Overall Study||65
5304471|NCT00518180|13040658|P3|COMPLETED|Overall Study||457
5304472|NCT00518180|13040659|P2|COMPLETED|Overall Study||472
5304473|NCT00518180|13040660|P1|COMPLETED|Overall Study||475
5304474|NCT00518180|13040658|P3|STARTED|Overall Study||539
5304475|NCT00518180|13040659|P2|STARTED|Overall Study||541
5304476|NCT00518180|13040660|P1|STARTED|Overall Study||540
5304477|NCT00518154|13040702|P1|NOT COMPLETED|Overall Study||0
5304478|NCT00518154|13040702|P1|COMPLETED|Overall Study||7
5304479|NCT00518154|13040702|P1|STARTED|Overall Study||7
5304480|NCT00518115|13040716|P10|NOT COMPLETED|Overall Study||15
5304481|NCT00518115|13040717|P9|NOT COMPLETED|Overall Study||5
5304482|NCT00518115|13040718|P8|NOT COMPLETED|Overall Study||15
5304483|NCT00518115|13040719|P7|NOT COMPLETED|Overall Study||8
5304484|NCT00518115|13040720|P6|NOT COMPLETED|Overall Study||15
5304485|NCT00518115|13040721|P5|NOT COMPLETED|Overall Study||10
5304486|NCT00518115|13040722|P4|NOT COMPLETED|Overall Study||11
5304487|NCT00518115|13040723|P3|NOT COMPLETED|Overall Study||17
5304488|NCT00518115|13040724|P2|NOT COMPLETED|Overall Study||6
5304489|NCT00518115|13040725|P1|NOT COMPLETED|Overall Study||12
5304490|NCT00518115|13040716|P10|COMPLETED|Overall Study||20
5304491|NCT00518115|13040717|P9|COMPLETED|Overall Study||30
5304492|NCT00518115|13040718|P8|COMPLETED|Overall Study||20
5304493|NCT00518115|13040719|P7|COMPLETED|Overall Study||25
5304494|NCT00518115|13040720|P6|COMPLETED|Overall Study||19
5304495|NCT00518115|13040721|P5|COMPLETED|Overall Study||21
5304496|NCT00518115|13040722|P4|COMPLETED|Overall Study||24
5304497|NCT00518115|13040723|P3|COMPLETED|Overall Study||19
5304498|NCT00518115|13040724|P2|COMPLETED|Overall Study||29
5304499|NCT00518115|13040725|P1|COMPLETED|Overall Study||40
5304583|NCT00517634|13041046|P6|COMPLETED|Second Treatment Period||4
5304500|NCT00518115|13040716|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
5304501|NCT00518115|13040717|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
5304502|NCT00518115|13040718|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
5304503|NCT00518115|13040719|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
5304504|NCT00518115|13040720|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
5304505|NCT00518115|13040721|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
5304506|NCT00518115|13040722|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
5304507|NCT00518115|13040723|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
5304508|NCT00518115|13040724|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
5304509|NCT00518115|13040725|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
5304510|NCT00518115|13040716|P10|STARTED|Overall Study||35
5304511|NCT00518115|13040717|P9|STARTED|Overall Study||35
5304512|NCT00518115|13040718|P8|STARTED|Overall Study||35
5304513|NCT00518115|13040719|P7|STARTED|Overall Study||33
5304514|NCT00518115|13040720|P6|STARTED|Overall Study||34
5304515|NCT00518115|13040721|P5|STARTED|Overall Study||31
5304516|NCT00518115|13040722|P4|STARTED|Overall Study||35
5304517|NCT00518115|13040723|P3|STARTED|Overall Study||36
5304518|NCT00518115|13040724|P2|STARTED|Overall Study||35
5304519|NCT00518115|13040725|P1|STARTED|Overall Study||52
5304520|NCT00518089|13040883|P2|NOT COMPLETED|Overall Study||31
5304521|NCT00518089|13040884|P1|NOT COMPLETED|Overall Study||28
5304522|NCT00518089|13040883|P2|COMPLETED|Overall Study||398
5304523|NCT00518089|13040884|P1|COMPLETED|Overall Study||402
5304524|NCT00518089|13040883|P2|STARTED|Overall Study||429
5304525|NCT00518089|13040884|P1|STARTED|Overall Study||430
5304526|NCT00518011|13040900|P2|NOT COMPLETED|Overall Study||8
5304527|NCT00518011|13040901|P1|NOT COMPLETED|Overall Study||9
5304528|NCT00518011|13040900|P2|COMPLETED|Overall Study||0
5304529|NCT00518011|13040901|P1|COMPLETED|Overall Study||0
5304530|NCT00518011|13040900|P2|STARTED|Overall Study||8
5304531|NCT00518011|13040901|P1|STARTED|Overall Study||9
5304532|NCT00517933|13040923|P2|NOT COMPLETED|Period 2||13
5304533|NCT00517933|13040924|P1|NOT COMPLETED|Period 2||6
5304534|NCT00517933|13040923|P2|COMPLETED|Period 2||70
5304535|NCT00517933|13040924|P1|COMPLETED|Period 2||73
5304536|NCT00517933|13040923|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
5304537|NCT00517933|13040924|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
5304538|NCT00517933|13040923|P2|NOT COMPLETED|Period 1||6
5304539|NCT00517933|13040924|P1|NOT COMPLETED|Period 1||8
5304540|NCT00517933|13040923|P2|COMPLETED|Period 1||85
5304541|NCT00517933|13040924|P1|COMPLETED|Period 1||81
5304542|NCT00517933|13040923|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
5304543|NCT00517933|13040924|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
5304544|NCT00517881|13040988|P1|NOT COMPLETED|Overall Study||5
5304545|NCT00517881|13040988|P1|COMPLETED|Overall Study||24
5304546|NCT00517881|13040988|P1|STARTED|Overall Study||29
5304547|NCT00517829|13041000|P2|NOT COMPLETED|Overall Study||75
5304548|NCT00517829|13041001|P1|NOT COMPLETED|Overall Study||75
5304549|NCT00517829|13041000|P2|COMPLETED|Overall Study||0
5304550|NCT00517829|13041001|P1|COMPLETED|Overall Study||0
5304551|NCT00517829|13041000|P2|STARTED|Overall Study||75
5304552|NCT00517829|13041001|P1|STARTED|Overall Study||75
5304553|NCT00517751|13041015|P1|NOT COMPLETED|Overall Study||129
5304554|NCT00517751|13041015|P1|COMPLETED|Overall Study||33
5304555|NCT00517751|13041015|P1|STARTED|Overall Study||162
5304556|NCT00517699|13041038|P1|NOT COMPLETED|Overall Study||5
5304557|NCT00517699|13041038|P1|COMPLETED|Overall Study||0
5304558|NCT00517699|13041038|P1|STARTED|Overall Study||5
5304559|NCT00517634|13041046|P6|NOT COMPLETED|Third Treatment Period||0
5304560|NCT00517634|13041047|P5|NOT COMPLETED|Third Treatment Period||0
5304561|NCT00517634|13041048|P4|NOT COMPLETED|Third Treatment Period||0
5304562|NCT00517634|13041049|P3|NOT COMPLETED|Third Treatment Period||0
5304563|NCT00517634|13041050|P2|NOT COMPLETED|Third Treatment Period||0
5304564|NCT00517634|13041051|P1|NOT COMPLETED|Third Treatment Period||0
5304565|NCT00517634|13041046|P6|COMPLETED|Third Treatment Period||4
5304566|NCT00517634|13041047|P5|COMPLETED|Third Treatment Period||3
5304567|NCT00517634|13041048|P4|COMPLETED|Third Treatment Period||3
5304568|NCT00517634|13041049|P3|COMPLETED|Third Treatment Period||4
5304569|NCT00517634|13041050|P2|COMPLETED|Third Treatment Period||4
5304570|NCT00517634|13041051|P1|COMPLETED|Third Treatment Period||4
5304571|NCT00517634|13041046|P6|STARTED|Third Treatment Period||4
5304572|NCT00517634|13041047|P5|STARTED|Third Treatment Period||3
5304573|NCT00517634|13041048|P4|STARTED|Third Treatment Period||3
5304574|NCT00517634|13041049|P3|STARTED|Third Treatment Period||4
5304575|NCT00517634|13041050|P2|STARTED|Third Treatment Period||4
5304576|NCT00517634|13041051|P1|STARTED|Third Treatment Period||4
5304577|NCT00517634|13041046|P6|NOT COMPLETED|Second Treatment Period||0
5304578|NCT00517634|13041047|P5|NOT COMPLETED|Second Treatment Period||1
5304579|NCT00517634|13041048|P4|NOT COMPLETED|Second Treatment Period||0
5304580|NCT00517634|13041049|P3|NOT COMPLETED|Second Treatment Period||0
5304581|NCT00517634|13041050|P2|NOT COMPLETED|Second Treatment Period||0
5304582|NCT00517634|13041051|P1|NOT COMPLETED|Second Treatment Period||0
5304584|NCT00517634|13041047|P5|COMPLETED|Second Treatment Period||3
5304585|NCT00517634|13041048|P4|COMPLETED|Second Treatment Period||3
5304586|NCT00517634|13041049|P3|COMPLETED|Second Treatment Period||4
5304587|NCT00517634|13041050|P2|COMPLETED|Second Treatment Period||4
5304588|NCT00517634|13041051|P1|COMPLETED|Second Treatment Period||4
5304589|NCT00517634|13041046|P6|STARTED|Second Treatment Period||4
5304590|NCT00517634|13041047|P5|STARTED|Second Treatment Period||4
5304591|NCT00517634|13041048|P4|STARTED|Second Treatment Period||3
5304592|NCT00517634|13041049|P3|STARTED|Second Treatment Period||4
5304593|NCT00517634|13041050|P2|STARTED|Second Treatment Period||4
5304594|NCT00517634|13041051|P1|STARTED|Second Treatment Period||4
5304595|NCT00517634|13041046|P6|NOT COMPLETED|First Treatment Period||0
5304596|NCT00517634|13041047|P5|NOT COMPLETED|First Treatment Period||0
5304597|NCT00517634|13041048|P4|NOT COMPLETED|First Treatment Period||0
5304598|NCT00517634|13041049|P3|NOT COMPLETED|First Treatment Period||0
5304599|NCT00517634|13041050|P2|NOT COMPLETED|First Treatment Period||0
5304600|NCT00517634|13041051|P1|NOT COMPLETED|First Treatment Period||0
5304601|NCT00517634|13041046|P6|COMPLETED|First Treatment Period||4
5304602|NCT00517634|13041047|P5|COMPLETED|First Treatment Period||4
5304603|NCT00517634|13041048|P4|COMPLETED|First Treatment Period||3
5304604|NCT00517634|13041049|P3|COMPLETED|First Treatment Period||4
5304605|NCT00517634|13041050|P2|COMPLETED|First Treatment Period||4
5304606|NCT00517634|13041051|P1|COMPLETED|First Treatment Period||4
5304607|NCT00517634|13041046|P6|STARTED|First Treatment Period||4
5304608|NCT00517634|13041047|P5|STARTED|First Treatment Period||4
5304609|NCT00517634|13041048|P4|STARTED|First Treatment Period||3
5304610|NCT00517634|13041049|P3|STARTED|First Treatment Period||4
5304611|NCT00517634|13041050|P2|STARTED|First Treatment Period||4
5304612|NCT00517634|13041051|P1|STARTED|First Treatment Period||4
5304613|NCT00517595|13041062|P1|NOT COMPLETED|Overall Study||0
5304614|NCT00517595|13041062|P1|COMPLETED|Overall Study||48
5304615|NCT00517595|13041062|P1|STARTED|Overall Study||48
5304616|NCT00517556|13041073|P2|NOT COMPLETED|Overall Study||5
5304617|NCT00517556|13041074|P1|NOT COMPLETED|Overall Study||4
5304618|NCT00517556|13041073|P2|COMPLETED|Overall Study||14
5304619|NCT00517556|13041074|P1|COMPLETED|Overall Study||15
5304620|NCT00517556|13041073|P2|STARTED|Overall Study||19
5304621|NCT00517556|13041074|P1|STARTED|Overall Study||19
5304622|NCT00517530|13041087|P7|NOT COMPLETED|Overall Study||19
5304623|NCT00517530|13041088|P6|NOT COMPLETED|Overall Study||19
5304624|NCT00517530|13041089|P5|NOT COMPLETED|Overall Study||20
5304625|NCT00517530|13041090|P4|NOT COMPLETED|Overall Study||21
5304626|NCT00517530|13041091|P3|NOT COMPLETED|Overall Study||18
5304627|NCT00517530|13041092|P2|NOT COMPLETED|Overall Study||13
5304628|NCT00517530|13041093|P1|NOT COMPLETED|Overall Study||19
5304629|NCT00517530|13041087|P7|COMPLETED|Overall Study||1
5304630|NCT00517530|13041088|P6|COMPLETED|Overall Study||0
5304631|NCT00517530|13041089|P5|COMPLETED|Overall Study||1
5304632|NCT00517530|13041090|P4|COMPLETED|Overall Study||1
5304633|NCT00517530|13041091|P3|COMPLETED|Overall Study||0
5304634|NCT00517530|13041092|P2|COMPLETED|Overall Study||0
5304635|NCT00517530|13041093|P1|COMPLETED|Overall Study||2
5304636|NCT00517530|13041087|P7|Retreated Population|Overall Study||0
5304637|NCT00517530|13041088|P6|Retreated Population|Overall Study||2
5304638|NCT00517530|13041089|P5|Retreated Population|Overall Study||2
5304639|NCT00517530|13041090|P4|Retreated Population|Overall Study||4
5304640|NCT00517530|13041091|P3|Retreated Population|Overall Study||1
5304641|NCT00517530|13041092|P2|Retreated Population|Overall Study||2
5304642|NCT00517530|13041093|P1|Retreated Population|Overall Study||2
5304643|NCT00517530|13041087|P7|Completed Follow-up|Overall Study||1
5304644|NCT00517530|13041088|P6|Completed Follow-up|Overall Study||0
5304645|NCT00517530|13041089|P5|Completed Follow-up|Overall Study||0
5304646|NCT00517530|13041090|P4|Completed Follow-up|Overall Study||1
5304647|NCT00517530|13041091|P3|Completed Follow-up|Overall Study||0
5304648|NCT00517530|13041092|P2|Completed Follow-up|Overall Study||0
5304649|NCT00517530|13041093|P1|Completed Follow-up|Overall Study||2
5304650|NCT00517530|13041087|P7|Started Follow-up|Overall Study||19
5304651|NCT00517530|13041088|P6|Started Follow-up|Overall Study||16
5304652|NCT00517530|13041089|P5|Started Follow-up|Overall Study||17
5304653|NCT00517530|13041090|P4|Started Follow-up|Overall Study||21
5304654|NCT00517530|13041091|P3|Started Follow-up|Overall Study||17
5304655|NCT00517530|13041092|P2|Started Follow-up|Overall Study||13
5304656|NCT00517530|13041093|P1|Started Follow-up|Overall Study||20
5304657|NCT00517530|13041087|P7|Completed Treatment|Overall Study||13
5304658|NCT00517530|13041088|P6|Completed Treatment|Overall Study||9
5304659|NCT00517530|13041089|P5|Completed Treatment|Overall Study||9
5304660|NCT00517530|13041090|P4|Completed Treatment|Overall Study||18
5304661|NCT00517530|13041091|P3|Completed Treatment|Overall Study||13
5304662|NCT00517530|13041092|P2|Completed Treatment|Overall Study||13
5304663|NCT00517530|13041093|P1|Completed Treatment|Overall Study||11
5304664|NCT00517530|13041087|P7|STARTED|Overall Study||20
5304665|NCT00517530|13041088|P6|STARTED|Overall Study||19
5304666|NCT00517530|13041089|P5|STARTED|Overall Study||21
5304667|NCT00517530|13041090|P4|STARTED|Overall Study||22
5304668|NCT00517530|13041091|P3|STARTED|Overall Study||18
5304669|NCT00517530|13041092|P2|STARTED|Overall Study||13
5304670|NCT00517530|13041093|P1|STARTED|Overall Study||21
5304671|NCT00517413|13041153|P1|NOT COMPLETED|Overall Study||61
5304672|NCT00517413|13041153|P1|COMPLETED|Overall Study||102
5304673|NCT00517413|13041153|P1|STARTED|Overall Study||163
5304674|NCT00517361|13041174|P1|NOT COMPLETED|Overall Study||11
5304675|NCT00517361|13041174|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
5304676|NCT00517361|13041174|P1|STARTED|Overall Study||11
5304677|NCT00517296|13041183|P2|NOT COMPLETED|Overall Study||0
5304678|NCT00517296|13041184|P1|NOT COMPLETED|Overall Study||1
5304679|NCT00517296|13041183|P2|COMPLETED|Overall Study||11
5304680|NCT00517296|13041184|P1|COMPLETED|Overall Study||9
5304681|NCT00517296|13041183|P2|STARTED|Overall Study||11
5304682|NCT00517296|13041184|P1|STARTED|Overall Study||10
5304683|NCT00517192|13041196|P2|NOT COMPLETED|Overall Study||20
5304684|NCT00517192|13041197|P1|NOT COMPLETED|Overall Study||19
5304685|NCT00517192|13041196|P2|COMPLETED|Overall Study||0
5304686|NCT00517192|13041197|P1|COMPLETED|Overall Study||0
5304687|NCT00517192|13041196|P2|STARTED|Overall Study||20
5304688|NCT00517192|13041197|P1|STARTED|Overall Study||19
5304689|NCT00517075|13041249|P4|NOT COMPLETED|Overall Study||0
5304690|NCT00517075|13041250|P3|NOT COMPLETED|Overall Study||0
5304691|NCT00517075|13041251|P2|NOT COMPLETED|Overall Study||0
5304692|NCT00517075|13041252|P1|NOT COMPLETED|Overall Study||0
5304693|NCT00517075|13041249|P4|COMPLETED|Overall Study||0
5304694|NCT00517075|13041250|P3|COMPLETED|Overall Study||0
5304695|NCT00517075|13041251|P2|COMPLETED|Overall Study||0
5304696|NCT00517075|13041252|P1|COMPLETED|Overall Study||0
5304697|NCT00517075|13041249|P4|STARTED|Overall Study||0
5304698|NCT00517075|13041250|P3|STARTED|Overall Study||0
5304699|NCT00517075|13041251|P2|STARTED|Overall Study||0
5304700|NCT00517075|13041252|P1|STARTED|Overall Study||0
5304701|NCT00517010|13041290|P1|NOT COMPLETED|Overall Study||1
5304702|NCT00517010|13041290|P1|COMPLETED|Overall Study||5
5304703|NCT00517010|13041290|P1|STARTED|Overall Study||6
5304704|NCT00516919|13041295|P2|NOT COMPLETED|Overall Study||7
5304705|NCT00516919|13041296|P1|NOT COMPLETED|Overall Study||10
5304706|NCT00516919|13041295|P2|COMPLETED|Overall Study||32
5304707|NCT00516919|13041296|P1|COMPLETED|Overall Study||30
5304708|NCT00516919|13041295|P2|STARTED|Overall Study||39
5304709|NCT00516919|13041296|P1|STARTED|Overall Study||40
5304710|NCT00516906|13041304|P2|NOT COMPLETED|Overall Study||2
5304711|NCT00516906|13041305|P1|NOT COMPLETED|Overall Study||6
5304712|NCT00516906|13041304|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
5304713|NCT00516906|13041305|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
5304714|NCT00516906|13041304|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
5304715|NCT00516906|13041305|P1|STARTED|Overall Study||36
5304716|NCT00516893|13041315|P1|NOT COMPLETED|Overall Study||21
5304717|NCT00516893|13041315|P1|COMPLETED|Overall Study||92
5304718|NCT00516893|13041315|P1|Received Study Treatment|Overall Study||112
5304719|NCT00516893|13041315|P1|STARTED|Overall Study||113
5304720|NCT00516737|13041324|P2|NOT COMPLETED|Overall Study||8
5304721|NCT00516737|13041325|P1|NOT COMPLETED|Overall Study||11
5304722|NCT00516737|13041324|P2|COMPLETED|Overall Study||96
5304723|NCT00516737|13041325|P1|COMPLETED|Overall Study||92
5304724|NCT00516737|13041324|P2|STARTED|Overall Study||104
5304725|NCT00516737|13041325|P1|STARTED|Overall Study||103
5304726|NCT00516503|13041345|P2|NOT COMPLETED|Overall Study||0
5304727|NCT00516503|13041346|P1|NOT COMPLETED|Overall Study||0
5304728|NCT00516503|13041345|P2|COMPLETED|Overall Study||102
5304729|NCT00516503|13041346|P1|COMPLETED|Overall Study||101
5304730|NCT00516503|13041345|P2|STARTED|Overall Study||102
5304731|NCT00516503|13041346|P1|STARTED|Overall Study||101
5304732|NCT00516386|13041364|P1|NOT COMPLETED|Overall Study||6
5304733|NCT00516386|13041364|P1|COMPLETED|Overall Study||10
5304734|NCT00516386|13041364|P1|STARTED|Overall Study||16
5304735|NCT00516321|13041371|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
5304736|NCT00516321|13041372|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
5304737|NCT00516321|13041373|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
5304738|NCT00516321|13041371|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
5304739|NCT00516321|13041372|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
5304740|NCT00516321|13041373|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
5304741|NCT00516321|13041371|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
5304742|NCT00516321|13041372|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
5304743|NCT00516321|13041373|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
5304744|NCT00516321|13041371|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
5304745|NCT00516321|13041372|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
5304746|NCT00516321|13041373|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
5304747|NCT00516321|13041371|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
5304748|NCT00516321|13041372|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
5304749|NCT00516321|13041373|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
5304750|NCT00516321|13041371|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
5304751|NCT00516321|13041372|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
5304752|NCT00516321|13041373|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
5304753|NCT00516295|13041424|P3|NOT COMPLETED|Overall Study||0
5304754|NCT00516295|13041425|P2|NOT COMPLETED|Overall Study||0
5304755|NCT00516295|13041426|P1|NOT COMPLETED|Overall Study||3
5304756|NCT00516295|13041424|P3|COMPLETED|Overall Study||0
5304757|NCT00516295|13041425|P2|COMPLETED|Overall Study||0
5304758|NCT00516295|13041426|P1|COMPLETED|Overall Study||4
5304759|NCT00516295|13041424|P3|STARTED|Overall Study||0
5304760|NCT00516295|13041425|P2|STARTED|Overall Study||0
5304761|NCT00516295|13041426|P1|STARTED|Overall Study||7
5304762|NCT00516269|13041439|P2|NOT COMPLETED|Overall Study||3
5304763|NCT00516269|13041440|P1|NOT COMPLETED|Overall Study||2
5304764|NCT00516269|13041439|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
5304765|NCT00516269|13041440|P1|COMPLETED|Overall Study|2 patients had an early termination|17
5304766|NCT00516269|13041439|P2|STARTED|Overall Study||19
5304767|NCT00516269|13041440|P1|STARTED|Overall Study||19
5304768|NCT00516217|13041446|P1|NOT COMPLETED|Overall Study||0
5304769|NCT00516217|13041446|P1|COMPLETED|Overall Study||29
5304770|NCT00516217|13041446|P1|STARTED|Overall Study||29
5304771|NCT00516165|13041452|P1|NOT COMPLETED|Overall Study||0
5304772|NCT00516165|13041452|P1|COMPLETED|Overall Study||28
5304773|NCT00516165|13041452|P1|STARTED|Overall Study||28
5304774|NCT00516139|13041461|P1|NOT COMPLETED|Overall Study||38
5304775|NCT00516139|13041461|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
5304776|NCT00516139|13041461|P1|STARTED|Overall Study||122
5304777|NCT00516074|13041492|P2|NOT COMPLETED|Overall Study||3
5304778|NCT00516074|13041493|P1|NOT COMPLETED|Overall Study||6
5304779|NCT00516074|13041492|P2|COMPLETED|Overall Study||23
5304780|NCT00516074|13041493|P1|COMPLETED|Overall Study||22
5304781|NCT00516074|13041492|P2|STARTED|Overall Study||26
5304782|NCT00516074|13041493|P1|STARTED|Overall Study||28
5304783|NCT00516048|13041511|P3|NOT COMPLETED|Overall Study||1
5304784|NCT00516048|13041512|P2|NOT COMPLETED|Overall Study||2
5304785|NCT00516048|13041513|P1|NOT COMPLETED|Overall Study||0
5304786|NCT00516048|13041511|P3|COMPLETED|Overall Study||0
5304787|NCT00516048|13041512|P2|COMPLETED|Overall Study||40
5304788|NCT00516048|13041513|P1|COMPLETED|Overall Study||15
5304789|NCT00516048|13041511|P3|STARTED|Overall Study||1
5304790|NCT00516048|13041512|P2|STARTED|Overall Study||42
5304791|NCT00516048|13041513|P1|STARTED|Overall Study||15
5304792|NCT00515879|13041529|P2|NOT COMPLETED|Overall Study||20
5304793|NCT00515879|13041530|P1|NOT COMPLETED|Overall Study||25
5304794|NCT00515879|13041529|P2|COMPLETED|Overall Study||62
5304795|NCT00515879|13041530|P1|COMPLETED|Overall Study||62
5304796|NCT00515879|13041529|P2|STARTED|Overall Study||82
5304797|NCT00515879|13041530|P1|STARTED|Overall Study||87
5304798|NCT00515827|13041548|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
5304799|NCT00515827|13041549|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
5304800|NCT00515827|13041548|P2|COMPLETED|Second Intervention (12 Weeks)||25
5304801|NCT00515827|13041549|P1|COMPLETED|Second Intervention (12 Weeks)||25
5304802|NCT00515827|13041548|P2|STARTED|Second Intervention (12 Weeks)||25
5304803|NCT00515827|13041549|P1|STARTED|Second Intervention (12 Weeks)||26
5304804|NCT00515827|13041548|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
5304805|NCT00515827|13041549|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
5304806|NCT00515827|13041548|P2|COMPLETED|First Intervention (12 Weeks)||25
5304807|NCT00515827|13041549|P1|COMPLETED|First Intervention (12 Weeks)||26
5304808|NCT00515827|13041548|P2|STARTED|First Intervention (12 Weeks)||26
5304809|NCT00515827|13041549|P1|STARTED|First Intervention (12 Weeks)||27
5304810|NCT00515723|13041575|P4|NOT COMPLETED|Overall Study||6
5304811|NCT00515723|13041576|P3|NOT COMPLETED|Overall Study||1
5304812|NCT00515723|13041577|P2|NOT COMPLETED|Overall Study||1
5304813|NCT00515723|13041578|P1|NOT COMPLETED|Overall Study||5
5304814|NCT00515723|13041575|P4|COMPLETED|Overall Study||21
5304815|NCT00515723|13041576|P3|COMPLETED|Overall Study||21
5304816|NCT00515723|13041577|P2|COMPLETED|Overall Study||21
5304817|NCT00515723|13041578|P1|COMPLETED|Overall Study||20
5304818|NCT00515723|13041575|P4|STARTED|Overall Study||27
5304819|NCT00515723|13041576|P3|STARTED|Overall Study||22
5304820|NCT00515723|13041577|P2|STARTED|Overall Study||22
5304821|NCT00515723|13041578|P1|STARTED|Overall Study||25
5304822|NCT00515697|13041594|P1|NOT COMPLETED|Overall Study||0
5304823|NCT00515697|13041594|P1|COMPLETED|Overall Study||39
5304824|NCT00515697|13041594|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
5304825|NCT00515697|13041594|P1|STARTED|Overall Study||39
5304826|NCT00515671|13041607|P2|NOT COMPLETED|Overall Study||17
5304827|NCT00515671|13041608|P1|NOT COMPLETED|Overall Study||17
5304828|NCT00515671|13041607|P2|COMPLETED|Overall Study||41
5304829|NCT00515671|13041608|P1|COMPLETED|Overall Study||43
5304830|NCT00515671|13041607|P2|STARTED|Overall Study||58
5304831|NCT00515671|13041608|P1|STARTED|Overall Study||60
5304832|NCT00515619|13041616|P1|NOT COMPLETED|Overall Study||216
5304833|NCT00515619|13041616|P1|COMPLETED|Overall Study||160
5304834|NCT00515619|13041616|P1|Safety Set|Overall Study||376
5304835|NCT00515619|13041616|P1|STARTED|Overall Study||376
5304836|NCT00515541|13041628|P4|NOT COMPLETED|Overall Study||5
5304837|NCT00515541|13041629|P3|NOT COMPLETED|Overall Study||0
5304838|NCT00515541|13041630|P2|NOT COMPLETED|Overall Study||5
5304839|NCT00515541|13041631|P1|NOT COMPLETED|Overall Study||0
5304840|NCT00515541|13041628|P4|COMPLETED|Overall Study||6
5304841|NCT00515541|13041629|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
5304842|NCT00515541|13041630|P2|COMPLETED|Overall Study||7
5304843|NCT00515541|13041631|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
5304844|NCT00515541|13041628|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
5304845|NCT00515541|13041629|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
5304846|NCT00515541|13041630|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
5304847|NCT00515541|13041631|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
5304848|NCT00515541|13041628|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
5304849|NCT00515541|13041629|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
5304850|NCT00515541|13041630|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
5304851|NCT00515541|13041631|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
5304852|NCT00515541|13041628|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
5304853|NCT00515541|13041629|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
5304854|NCT00515541|13041630|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
5304855|NCT00515541|13041631|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
5304856|NCT00515541|13041628|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
5304857|NCT00515541|13041629|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
5304858|NCT00515541|13041630|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
5304859|NCT00515541|13041631|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
5304860|NCT00515541|13041628|P4|STARTED|Overall Study||11
5304861|NCT00515541|13041629|P3|STARTED|Overall Study||10
5304862|NCT00515541|13041630|P2|STARTED|Overall Study||12
5304863|NCT00515541|13041631|P1|STARTED|Overall Study||10
5304864|NCT00515502|13041653|P12|NOT COMPLETED|Treatment Period 4||0
5304865|NCT00515502|13041654|P11|NOT COMPLETED|Treatment Period 4||0
5304866|NCT00515502|13041655|P10|NOT COMPLETED|Treatment Period 4||0
5304867|NCT00515502|13041656|P9|NOT COMPLETED|Treatment Period 4||0
5304868|NCT00515502|13041657|P8|NOT COMPLETED|Treatment Period 4||0
5304869|NCT00515502|13041658|P7|NOT COMPLETED|Treatment Period 4||0
5304870|NCT00515502|13041659|P6|NOT COMPLETED|Treatment Period 4||0
5304871|NCT00515502|13041660|P5|NOT COMPLETED|Treatment Period 4||0
5304872|NCT00515502|13041661|P4|NOT COMPLETED|Treatment Period 4||0
5304873|NCT00515502|13041662|P3|NOT COMPLETED|Treatment Period 4||0
5304874|NCT00515502|13041663|P2|NOT COMPLETED|Treatment Period 4||0
5304875|NCT00515502|13041664|P1|NOT COMPLETED|Treatment Period 4||0
5304876|NCT00515502|13041653|P12|COMPLETED|Treatment Period 4||0
5304877|NCT00515502|13041654|P11|COMPLETED|Treatment Period 4||1
5304878|NCT00515502|13041655|P10|COMPLETED|Treatment Period 4||2
5304879|NCT00515502|13041656|P9|COMPLETED|Treatment Period 4||0
5304880|NCT00515502|13041657|P8|COMPLETED|Treatment Period 4||1
5304881|NCT00515502|13041658|P7|COMPLETED|Treatment Period 4||1
5304882|NCT00515502|13041659|P6|COMPLETED|Treatment Period 4||1
5304883|NCT00515502|13041660|P5|COMPLETED|Treatment Period 4||3
5304884|NCT00515502|13041661|P4|COMPLETED|Treatment Period 4||3
5304885|NCT00515502|13041662|P3|COMPLETED|Treatment Period 4||4
5304886|NCT00515502|13041663|P2|COMPLETED|Treatment Period 4||3
5304887|NCT00515502|13041664|P1|COMPLETED|Treatment Period 4||1
5304888|NCT00515502|13041653|P12|STARTED|Treatment Period 4||0
5304889|NCT00515502|13041654|P11|STARTED|Treatment Period 4||1
5304890|NCT00515502|13041655|P10|STARTED|Treatment Period 4||2
5304891|NCT00515502|13041656|P9|STARTED|Treatment Period 4||0
5304892|NCT00515502|13041657|P8|STARTED|Treatment Period 4||1
5304893|NCT00515502|13041658|P7|STARTED|Treatment Period 4||1
5304894|NCT00515502|13041659|P6|STARTED|Treatment Period 4||1
5304895|NCT00515502|13041660|P5|STARTED|Treatment Period 4||3
5304896|NCT00515502|13041661|P4|STARTED|Treatment Period 4||3
5304897|NCT00515502|13041662|P3|STARTED|Treatment Period 4||4
5304898|NCT00515502|13041663|P2|STARTED|Treatment Period 4||3
5304899|NCT00515502|13041664|P1|STARTED|Treatment Period 4||1
5304900|NCT00515502|13041653|P12|NOT COMPLETED|Washout Period 3||0
5304901|NCT00515502|13041654|P11|NOT COMPLETED|Washout Period 3||0
5304902|NCT00515502|13041655|P10|NOT COMPLETED|Washout Period 3||0
5304903|NCT00515502|13041656|P9|NOT COMPLETED|Washout Period 3||0
5304904|NCT00515502|13041657|P8|NOT COMPLETED|Washout Period 3||0
5304905|NCT00515502|13041658|P7|NOT COMPLETED|Washout Period 3||0
5304906|NCT00515502|13041659|P6|NOT COMPLETED|Washout Period 3||0
5304907|NCT00515502|13041660|P5|NOT COMPLETED|Washout Period 3||0
5304908|NCT00515502|13041661|P4|NOT COMPLETED|Washout Period 3||0
5304909|NCT00515502|13041662|P3|NOT COMPLETED|Washout Period 3||0
5304910|NCT00515502|13041663|P2|NOT COMPLETED|Washout Period 3||0
5304911|NCT00515502|13041664|P1|NOT COMPLETED|Washout Period 3||0
5304912|NCT00515502|13041653|P12|COMPLETED|Washout Period 3||0
5304913|NCT00515502|13041654|P11|COMPLETED|Washout Period 3||1
5304914|NCT00515502|13041655|P10|COMPLETED|Washout Period 3||2
5304915|NCT00515502|13041656|P9|COMPLETED|Washout Period 3||0
5304916|NCT00515502|13041657|P8|COMPLETED|Washout Period 3||1
5304917|NCT00515502|13041658|P7|COMPLETED|Washout Period 3||1
5304918|NCT00515502|13041659|P6|COMPLETED|Washout Period 3||1
5304919|NCT00515502|13041660|P5|COMPLETED|Washout Period 3||3
5304920|NCT00515502|13041661|P4|COMPLETED|Washout Period 3||3
5304921|NCT00515502|13041662|P3|COMPLETED|Washout Period 3||4
5304922|NCT00515502|13041663|P2|COMPLETED|Washout Period 3||3
5304923|NCT00515502|13041664|P1|COMPLETED|Washout Period 3||1
5304924|NCT00515502|13041653|P12|STARTED|Washout Period 3||0
5304925|NCT00515502|13041654|P11|STARTED|Washout Period 3||1
5304926|NCT00515502|13041655|P10|STARTED|Washout Period 3||2
5304927|NCT00515502|13041656|P9|STARTED|Washout Period 3||0
5304928|NCT00515502|13041657|P8|STARTED|Washout Period 3||1
5304929|NCT00515502|13041658|P7|STARTED|Washout Period 3||1
5304930|NCT00515502|13041659|P6|STARTED|Washout Period 3||1
5304931|NCT00515502|13041660|P5|STARTED|Washout Period 3||3
5304932|NCT00515502|13041661|P4|STARTED|Washout Period 3||3
5304933|NCT00515502|13041662|P3|STARTED|Washout Period 3||4
5304934|NCT00515502|13041663|P2|STARTED|Washout Period 3||3
5304935|NCT00515502|13041664|P1|STARTED|Washout Period 3||1
5304936|NCT00515502|13041653|P12|NOT COMPLETED|Treatment Period 3||0
5304937|NCT00515502|13041654|P11|NOT COMPLETED|Treatment Period 3||0
5304938|NCT00515502|13041655|P10|NOT COMPLETED|Treatment Period 3||0
5304939|NCT00515502|13041656|P9|NOT COMPLETED|Treatment Period 3||0
5304940|NCT00515502|13041657|P8|NOT COMPLETED|Treatment Period 3||0
5304941|NCT00515502|13041658|P7|NOT COMPLETED|Treatment Period 3||0
5304942|NCT00515502|13041659|P6|NOT COMPLETED|Treatment Period 3||0
5304943|NCT00515502|13041660|P5|NOT COMPLETED|Treatment Period 3||0
5304944|NCT00515502|13041661|P4|NOT COMPLETED|Treatment Period 3||0
5304945|NCT00515502|13041662|P3|NOT COMPLETED|Treatment Period 3||0
5304946|NCT00515502|13041663|P2|NOT COMPLETED|Treatment Period 3||0
5304947|NCT00515502|13041664|P1|NOT COMPLETED|Treatment Period 3||0
5304948|NCT00515502|13041653|P12|COMPLETED|Treatment Period 3||0
5304949|NCT00515502|13041654|P11|COMPLETED|Treatment Period 3||1
5304950|NCT00515502|13041655|P10|COMPLETED|Treatment Period 3||2
5304951|NCT00515502|13041656|P9|COMPLETED|Treatment Period 3||0
5304952|NCT00515502|13041657|P8|COMPLETED|Treatment Period 3||1
5304953|NCT00515502|13041658|P7|COMPLETED|Treatment Period 3||1
5304954|NCT00515502|13041659|P6|COMPLETED|Treatment Period 3||1
5304955|NCT00515502|13041660|P5|COMPLETED|Treatment Period 3||3
5304956|NCT00515502|13041661|P4|COMPLETED|Treatment Period 3||3
5304957|NCT00515502|13041662|P3|COMPLETED|Treatment Period 3||4
5304958|NCT00515502|13041663|P2|COMPLETED|Treatment Period 3||3
5304959|NCT00515502|13041664|P1|COMPLETED|Treatment Period 3||1
5304960|NCT00515502|13041653|P12|STARTED|Treatment Period 3||0
5304961|NCT00515502|13041654|P11|STARTED|Treatment Period 3||1
5304962|NCT00515502|13041655|P10|STARTED|Treatment Period 3||2
5304963|NCT00515502|13041656|P9|STARTED|Treatment Period 3||0
5304964|NCT00515502|13041657|P8|STARTED|Treatment Period 3||1
5304965|NCT00515502|13041658|P7|STARTED|Treatment Period 3||1
5304966|NCT00515502|13041659|P6|STARTED|Treatment Period 3||1
5304967|NCT00515502|13041660|P5|STARTED|Treatment Period 3||3
5304968|NCT00515502|13041661|P4|STARTED|Treatment Period 3||3
5304969|NCT00515502|13041662|P3|STARTED|Treatment Period 3||4
5304970|NCT00515502|13041663|P2|STARTED|Treatment Period 3||3
5304971|NCT00515502|13041664|P1|STARTED|Treatment Period 3||1
5304972|NCT00515502|13041653|P12|NOT COMPLETED|Washout Period 2||0
5304973|NCT00515502|13041654|P11|NOT COMPLETED|Washout Period 2||0
5304974|NCT00515502|13041655|P10|NOT COMPLETED|Washout Period 2||0
5304975|NCT00515502|13041656|P9|NOT COMPLETED|Washout Period 2||0
5304976|NCT00515502|13041657|P8|NOT COMPLETED|Washout Period 2||0
5304977|NCT00515502|13041658|P7|NOT COMPLETED|Washout Period 2||0
5304978|NCT00515502|13041659|P6|NOT COMPLETED|Washout Period 2||0
5304979|NCT00515502|13041660|P5|NOT COMPLETED|Washout Period 2||0
5304980|NCT00515502|13041661|P4|NOT COMPLETED|Washout Period 2||0
5304981|NCT00515502|13041662|P3|NOT COMPLETED|Washout Period 2||0
5304982|NCT00515502|13041663|P2|NOT COMPLETED|Washout Period 2||0
5304983|NCT00515502|13041664|P1|NOT COMPLETED|Washout Period 2||0
5304984|NCT00515502|13041653|P12|COMPLETED|Washout Period 2||0
5304985|NCT00515502|13041654|P11|COMPLETED|Washout Period 2||1
5304986|NCT00515502|13041655|P10|COMPLETED|Washout Period 2||2
5304987|NCT00515502|13041656|P9|COMPLETED|Washout Period 2||0
5304988|NCT00515502|13041657|P8|COMPLETED|Washout Period 2||1
5304989|NCT00515502|13041658|P7|COMPLETED|Washout Period 2||1
5304990|NCT00515502|13041659|P6|COMPLETED|Washout Period 2||1
5304991|NCT00515502|13041660|P5|COMPLETED|Washout Period 2||3
5304992|NCT00515502|13041661|P4|COMPLETED|Washout Period 2||3
5304993|NCT00515502|13041662|P3|COMPLETED|Washout Period 2||4
5304994|NCT00515502|13041663|P2|COMPLETED|Washout Period 2||3
5304995|NCT00515502|13041664|P1|COMPLETED|Washout Period 2||1
5304996|NCT00515502|13041653|P12|STARTED|Washout Period 2||0
5304997|NCT00515502|13041654|P11|STARTED|Washout Period 2||1
5304998|NCT00515502|13041655|P10|STARTED|Washout Period 2||2
5304999|NCT00515502|13041656|P9|STARTED|Washout Period 2||0
5305000|NCT00515502|13041657|P8|STARTED|Washout Period 2||1
5305001|NCT00515502|13041658|P7|STARTED|Washout Period 2||1
5305002|NCT00515502|13041659|P6|STARTED|Washout Period 2||1
5305003|NCT00515502|13041660|P5|STARTED|Washout Period 2||3
5305004|NCT00515502|13041661|P4|STARTED|Washout Period 2||3
5305005|NCT00515502|13041662|P3|STARTED|Washout Period 2||4
5305006|NCT00515502|13041663|P2|STARTED|Washout Period 2||3
5305007|NCT00515502|13041664|P1|STARTED|Washout Period 2||1
5305008|NCT00515502|13041653|P12|NOT COMPLETED|Treatment Period 2||0
5305009|NCT00515502|13041654|P11|NOT COMPLETED|Treatment Period 2||0
5305010|NCT00515502|13041655|P10|NOT COMPLETED|Treatment Period 2||0
5305011|NCT00515502|13041656|P9|NOT COMPLETED|Treatment Period 2||0
5305012|NCT00515502|13041657|P8|NOT COMPLETED|Treatment Period 2||0
5305013|NCT00515502|13041658|P7|NOT COMPLETED|Treatment Period 2||0
5305014|NCT00515502|13041659|P6|NOT COMPLETED|Treatment Period 2||0
5305015|NCT00515502|13041660|P5|NOT COMPLETED|Treatment Period 2||0
5305016|NCT00515502|13041661|P4|NOT COMPLETED|Treatment Period 2||0
5305017|NCT00515502|13041662|P3|NOT COMPLETED|Treatment Period 2||0
5305018|NCT00515502|13041663|P2|NOT COMPLETED|Treatment Period 2||1
5305019|NCT00515502|13041664|P1|NOT COMPLETED|Treatment Period 2||0
5305020|NCT00515502|13041653|P12|COMPLETED|Treatment Period 2||0
5305021|NCT00515502|13041654|P11|COMPLETED|Treatment Period 2||1
5305022|NCT00515502|13041655|P10|COMPLETED|Treatment Period 2||2
5305023|NCT00515502|13041656|P9|COMPLETED|Treatment Period 2||0
5305024|NCT00515502|13041657|P8|COMPLETED|Treatment Period 2||1
5305025|NCT00515502|13041658|P7|COMPLETED|Treatment Period 2||1
5305026|NCT00515502|13041659|P6|COMPLETED|Treatment Period 2||1
5305027|NCT00515502|13041660|P5|COMPLETED|Treatment Period 2||3
5305028|NCT00515502|13041661|P4|COMPLETED|Treatment Period 2||3
5305029|NCT00515502|13041662|P3|COMPLETED|Treatment Period 2||4
5305030|NCT00515502|13041663|P2|COMPLETED|Treatment Period 2||3
5305031|NCT00515502|13041664|P1|COMPLETED|Treatment Period 2||1
5305032|NCT00515502|13041653|P12|STARTED|Treatment Period 2||0
5305033|NCT00515502|13041654|P11|STARTED|Treatment Period 2||1
5305034|NCT00515502|13041655|P10|STARTED|Treatment Period 2||2
5305035|NCT00515502|13041656|P9|STARTED|Treatment Period 2||0
5305036|NCT00515502|13041657|P8|STARTED|Treatment Period 2||1
5305037|NCT00515502|13041658|P7|STARTED|Treatment Period 2||1
5305038|NCT00515502|13041659|P6|STARTED|Treatment Period 2||1
5305039|NCT00515502|13041660|P5|STARTED|Treatment Period 2||3
5305040|NCT00515502|13041661|P4|STARTED|Treatment Period 2||3
5305041|NCT00515502|13041662|P3|STARTED|Treatment Period 2||4
5305042|NCT00515502|13041663|P2|STARTED|Treatment Period 2||4
5305043|NCT00515502|13041664|P1|STARTED|Treatment Period 2||1
5305044|NCT00515502|13041653|P12|NOT COMPLETED|Washout Period 1||0
5305045|NCT00515502|13041654|P11|NOT COMPLETED|Washout Period 1||0
5305046|NCT00515502|13041655|P10|NOT COMPLETED|Washout Period 1||0
5305047|NCT00515502|13041656|P9|NOT COMPLETED|Washout Period 1||0
5305048|NCT00515502|13041657|P8|NOT COMPLETED|Washout Period 1||0
5305049|NCT00515502|13041658|P7|NOT COMPLETED|Washout Period 1||0
5305050|NCT00515502|13041659|P6|NOT COMPLETED|Washout Period 1||0
5305051|NCT00515502|13041660|P5|NOT COMPLETED|Washout Period 1||0
5305052|NCT00515502|13041661|P4|NOT COMPLETED|Washout Period 1||0
5305053|NCT00515502|13041662|P3|NOT COMPLETED|Washout Period 1||0
5305054|NCT00515502|13041663|P2|NOT COMPLETED|Washout Period 1||0
5305055|NCT00515502|13041664|P1|NOT COMPLETED|Washout Period 1||0
5305056|NCT00515502|13041653|P12|COMPLETED|Washout Period 1||0
5305057|NCT00515502|13041654|P11|COMPLETED|Washout Period 1||1
5305058|NCT00515502|13041655|P10|COMPLETED|Washout Period 1||2
5305059|NCT00515502|13041656|P9|COMPLETED|Washout Period 1||0
5305060|NCT00515502|13041657|P8|COMPLETED|Washout Period 1||1
5305061|NCT00515502|13041658|P7|COMPLETED|Washout Period 1||1
5305062|NCT00515502|13041659|P6|COMPLETED|Washout Period 1||1
5305063|NCT00515502|13041660|P5|COMPLETED|Washout Period 1||3
5305064|NCT00515502|13041661|P4|COMPLETED|Washout Period 1||3
5305065|NCT00515502|13041662|P3|COMPLETED|Washout Period 1||4
5305066|NCT00515502|13041663|P2|COMPLETED|Washout Period 1||4
5305067|NCT00515502|13041664|P1|COMPLETED|Washout Period 1||1
5305068|NCT00515502|13041653|P12|STARTED|Washout Period 1||0
5305069|NCT00515502|13041654|P11|STARTED|Washout Period 1||1
5305070|NCT00515502|13041655|P10|STARTED|Washout Period 1||2
5305071|NCT00515502|13041656|P9|STARTED|Washout Period 1||0
5305072|NCT00515502|13041657|P8|STARTED|Washout Period 1||1
5305073|NCT00515502|13041658|P7|STARTED|Washout Period 1||1
5305074|NCT00515502|13041659|P6|STARTED|Washout Period 1||1
5305075|NCT00515502|13041660|P5|STARTED|Washout Period 1||3
5305076|NCT00515502|13041661|P4|STARTED|Washout Period 1||3
5305077|NCT00515502|13041662|P3|STARTED|Washout Period 1||4
5305078|NCT00515502|13041663|P2|STARTED|Washout Period 1||4
5305079|NCT00515502|13041664|P1|STARTED|Washout Period 1||1
5305080|NCT00515502|13041653|P12|NOT COMPLETED|Treatment Period 1||1
5305081|NCT00515502|13041654|P11|NOT COMPLETED|Treatment Period 1||0
5305082|NCT00515502|13041655|P10|NOT COMPLETED|Treatment Period 1||0
5305083|NCT00515502|13041656|P9|NOT COMPLETED|Treatment Period 1||1
5305084|NCT00515502|13041657|P8|NOT COMPLETED|Treatment Period 1||0
5305085|NCT00515502|13041658|P7|NOT COMPLETED|Treatment Period 1||1
5305086|NCT00515502|13041659|P6|NOT COMPLETED|Treatment Period 1||0
5305087|NCT00515502|13041660|P5|NOT COMPLETED|Treatment Period 1||0
5305088|NCT00515502|13041661|P4|NOT COMPLETED|Treatment Period 1||0
5305089|NCT00515502|13041662|P3|NOT COMPLETED|Treatment Period 1||0
5305090|NCT00515502|13041663|P2|NOT COMPLETED|Treatment Period 1||0
5305091|NCT00515502|13041664|P1|NOT COMPLETED|Treatment Period 1||0
5305092|NCT00515502|13041653|P12|COMPLETED|Treatment Period 1||0
5305093|NCT00515502|13041654|P11|COMPLETED|Treatment Period 1||1
5305094|NCT00515502|13041655|P10|COMPLETED|Treatment Period 1||2
5305095|NCT00515502|13041656|P9|COMPLETED|Treatment Period 1||0
5305096|NCT00515502|13041657|P8|COMPLETED|Treatment Period 1||1
5305097|NCT00515502|13041658|P7|COMPLETED|Treatment Period 1||1
5305098|NCT00515502|13041659|P6|COMPLETED|Treatment Period 1||1
5305099|NCT00515502|13041660|P5|COMPLETED|Treatment Period 1||3
5305100|NCT00515502|13041661|P4|COMPLETED|Treatment Period 1||3
5305101|NCT00515502|13041662|P3|COMPLETED|Treatment Period 1||4
5305102|NCT00515502|13041663|P2|COMPLETED|Treatment Period 1||4
5305103|NCT00515502|13041664|P1|COMPLETED|Treatment Period 1||1
5305104|NCT00515502|13041653|P12|STARTED|Treatment Period 1||1
5305105|NCT00515502|13041654|P11|STARTED|Treatment Period 1||1
5305106|NCT00515502|13041655|P10|STARTED|Treatment Period 1||2
5305107|NCT00515502|13041656|P9|STARTED|Treatment Period 1||1
5305108|NCT00515502|13041657|P8|STARTED|Treatment Period 1||1
5305109|NCT00515502|13041658|P7|STARTED|Treatment Period 1||2
5305110|NCT00515502|13041659|P6|STARTED|Treatment Period 1||1
5305111|NCT00515502|13041660|P5|STARTED|Treatment Period 1||3
5305112|NCT00515502|13041661|P4|STARTED|Treatment Period 1||3
5305113|NCT00515502|13041662|P3|STARTED|Treatment Period 1||4
5305114|NCT00515502|13041663|P2|STARTED|Treatment Period 1||4
5305115|NCT00515502|13041664|P1|STARTED|Treatment Period 1||1
5305116|NCT00515463|13041824|P2|NOT COMPLETED|Overall Study||14
5305117|NCT00515463|13041825|P1|NOT COMPLETED|Overall Study||14
5305118|NCT00515463|13041824|P2|COMPLETED|Overall Study||142
5305119|NCT00515463|13041825|P1|COMPLETED|Overall Study||141
5305120|NCT00515463|13041824|P2|Received Study Medication|Overall Study||156
5305121|NCT00515463|13041825|P1|Received Study Medication|Overall Study||154
5305122|NCT00515463|13041824|P2|STARTED|Overall Study||156
5305123|NCT00515463|13041825|P1|STARTED|Overall Study||155
5305124|NCT00515437|13041979|P4|NOT COMPLETED|Overall Study||1
5305125|NCT00515437|13041980|P3|NOT COMPLETED|Overall Study||0
5305126|NCT00515437|13041981|P2|NOT COMPLETED|Overall Study||0
5305127|NCT00515437|13041982|P1|NOT COMPLETED|Overall Study||0
5305128|NCT00515437|13041979|P4|COMPLETED|Overall Study||14
5305129|NCT00515437|13041980|P3|COMPLETED|Overall Study||13
5305130|NCT00515437|13041981|P2|COMPLETED|Overall Study||12
5305131|NCT00515437|13041982|P1|COMPLETED|Overall Study||14
5305132|NCT00515437|13041979|P4|STARTED|Overall Study||15
5305133|NCT00515437|13041980|P3|STARTED|Overall Study||13
5305134|NCT00515437|13041981|P2|STARTED|Overall Study||12
5305135|NCT00515437|13041982|P1|STARTED|Overall Study||14
5305136|NCT00515411|13042007|P3|NOT COMPLETED|Overall Study||0
5305137|NCT00515411|13042008|P2|NOT COMPLETED|Overall Study||0
5305138|NCT00515411|13042009|P1|NOT COMPLETED|Overall Study||0
5305139|NCT00515411|13042007|P3|COMPLETED|Overall Study||26
5305140|NCT00515411|13042008|P2|COMPLETED|Overall Study||31
5305141|NCT00515411|13042009|P1|COMPLETED|Overall Study||54
5305142|NCT00515411|13042007|P3|STARTED|Overall Study||26
5305143|NCT00515411|13042008|P2|STARTED|Overall Study||31
5305144|NCT00515411|13042009|P1|STARTED|Overall Study||54
5305145|NCT00515294|13042024|P4|NOT COMPLETED|Overall Study||4
5305146|NCT00515294|13042025|P3|NOT COMPLETED|Overall Study||11
5305147|NCT00515294|13042026|P2|NOT COMPLETED|Overall Study||3
5305148|NCT00515294|13042027|P1|NOT COMPLETED|Overall Study||9
5305149|NCT00515294|13042024|P4|COMPLETED|Overall Study||35
5305150|NCT00515294|13042025|P3|COMPLETED|Overall Study||27
5305151|NCT00515294|13042026|P2|COMPLETED|Overall Study||36
5305152|NCT00515294|13042027|P1|COMPLETED|Overall Study||29
5305153|NCT00515294|13042024|P4|STARTED|Overall Study||39
5305154|NCT00515294|13042025|P3|STARTED|Overall Study||38
5305155|NCT00515294|13042026|P2|STARTED|Overall Study||39
5305156|NCT00515294|13042027|P1|STARTED|Overall Study||38
5305157|NCT00515216|13042041|P1|NOT COMPLETED|Overall Study||1
5305158|NCT00515216|13042041|P1|COMPLETED|Overall Study||25
5305159|NCT00515216|13042041|P1|STARTED|Overall Study||26
5305160|NCT00515203|13042065|P2|NOT COMPLETED|Overall Study||0
5305161|NCT00515203|13042066|P1|NOT COMPLETED|Overall Study||0
5305162|NCT00515203|13042065|P2|COMPLETED|Overall Study||5
5305163|NCT00515203|13042066|P1|COMPLETED|Overall Study||17
5305164|NCT00515203|13042065|P2|STARTED|Overall Study||5
5305165|NCT00515203|13042066|P1|STARTED|Overall Study||17
5305166|NCT00515177|13042084|P2|NOT COMPLETED|Overall Study||1
5305167|NCT00515177|13042085|P1|NOT COMPLETED|Overall Study||2
5305168|NCT00515177|13042084|P2|COMPLETED|Overall Study||9
5305169|NCT00515177|13042085|P1|COMPLETED|Overall Study||18
5305170|NCT00515177|13042084|P2|STARTED|Overall Study||10
5305171|NCT00515177|13042085|P1|STARTED|Overall Study||20
5305172|NCT00515112|13042103|P2|NOT COMPLETED|Overall Study||3
5305173|NCT00515112|13042104|P1|NOT COMPLETED|Overall Study||3
5305174|NCT00515112|13042103|P2|COMPLETED|Overall Study||0
5305175|NCT00515112|13042104|P1|COMPLETED|Overall Study||0
5305176|NCT00515112|13042103|P2|STARTED|Overall Study||3
5305177|NCT00515112|13042104|P1|STARTED|Overall Study||3
5305178|NCT00515099|13042114|P2|NOT COMPLETED|Overall Study||4
5305179|NCT00515099|13042115|P1|NOT COMPLETED|Overall Study||3
5305180|NCT00515099|13042114|P2|COMPLETED|Overall Study||16
5305181|NCT00515099|13042115|P1|COMPLETED|Overall Study||35
5305182|NCT00515099|13042114|P2|STARTED|Overall Study||20
5305183|NCT00515099|13042115|P1|STARTED|Overall Study||38
5305184|NCT00515086|13042137|P4|NOT COMPLETED|Overall Study||6
5305185|NCT00515086|13042138|P3|NOT COMPLETED|Overall Study||5
5305186|NCT00515086|13042139|P2|NOT COMPLETED|Overall Study||6
5305187|NCT00515086|13042140|P1|NOT COMPLETED|Overall Study||24
5305188|NCT00515086|13042137|P4|COMPLETED|Overall Study||0
5305189|NCT00515086|13042138|P3|COMPLETED|Overall Study||0
5305190|NCT00515086|13042139|P2|COMPLETED|Overall Study||0
5305191|NCT00515086|13042140|P1|COMPLETED|Overall Study||0
5305192|NCT00515086|13042137|P4|STARTED|Overall Study||6
5305193|NCT00515086|13042138|P3|STARTED|Overall Study||5
5305194|NCT00515086|13042139|P2|STARTED|Overall Study||6
5305195|NCT00515086|13042140|P1|STARTED|Overall Study||24
5305196|NCT00515073|13042167|P1|NOT COMPLETED|Overall Study||2
5305197|NCT00515073|13042167|P1|COMPLETED|Overall Study||28
5305198|NCT00515073|13042167|P1|STARTED|Overall Study||30
5305199|NCT00515034|13042175|P4|NOT COMPLETED|Overall Study||5
5305200|NCT00515034|13042176|P3|NOT COMPLETED|Overall Study||8
5305201|NCT00515034|13042177|P2|NOT COMPLETED|Overall Study||2
5305202|NCT00515034|13042178|P1|NOT COMPLETED|Overall Study||8
5305203|NCT00515034|13042175|P4|COMPLETED|Overall Study||15
5305204|NCT00515034|13042176|P3|COMPLETED|Overall Study||54
5305205|NCT00515034|13042177|P2|COMPLETED|Overall Study||13
5305206|NCT00515034|13042178|P1|COMPLETED|Overall Study||41
5305207|NCT00515034|13042175|P4|TREATED|Overall Study||19
5305208|NCT00515034|13042176|P3|TREATED|Overall Study||61
5305209|NCT00515034|13042177|P2|TREATED|Overall Study||15
5305210|NCT00515034|13042178|P1|TREATED|Overall Study||48
5305211|NCT00515034|13042175|P4|STARTED|Overall Study||20
5305212|NCT00515034|13042176|P3|STARTED|Overall Study||62
5305213|NCT00515034|13042177|P2|STARTED|Overall Study||15
5305214|NCT00515034|13042178|P1|STARTED|Overall Study||49
5305215|NCT00515021|13042198|P2|NOT COMPLETED|Overall Study||0
5305216|NCT00515021|13042199|P1|NOT COMPLETED|Overall Study||0
5305217|NCT00515021|13042198|P2|COMPLETED|Overall Study||11
5305218|NCT00515021|13042199|P1|COMPLETED|Overall Study||9
5305219|NCT00515021|13042198|P2|STARTED|Overall Study||11
5305220|NCT00515021|13042199|P1|STARTED|Overall Study||9
5305221|NCT00515008|13042209|P2|NOT COMPLETED|Overall Study||4
5305222|NCT00515008|13042210|P1|NOT COMPLETED|Overall Study||3
5305223|NCT00515008|13042209|P2|COMPLETED|Overall Study||29
5305224|NCT00515008|13042210|P1|COMPLETED|Overall Study||30
5305225|NCT00515008|13042209|P2|Completed 12 Week Evaluation|Overall Study||29
5305226|NCT00515008|13042210|P1|Completed 12 Week Evaluation|Overall Study||32
5305227|NCT00515008|13042209|P2|STARTED|Overall Study||33
5305228|NCT00515008|13042210|P1|STARTED|Overall Study||33
5305229|NCT00514943|13042234|P2|NOT COMPLETED|Stage 2||36
5305230|NCT00514943|13042235|P1|NOT COMPLETED|Stage 2||32
5305231|NCT00514943|13042234|P2|COMPLETED|Stage 2||0
5305232|NCT00514943|13042235|P1|COMPLETED|Stage 2||0
5305233|NCT00514943|13042234|P2|STARTED|Stage 2||36
5305234|NCT00514943|13042235|P1|STARTED|Stage 2||32
5305235|NCT00514943|13042234|P2|NOT COMPLETED|Stage 1||26
5305236|NCT00514943|13042235|P1|NOT COMPLETED|Stage 1||30
5305237|NCT00514943|13042234|P2|COMPLETED|Stage 1||36
5305238|NCT00514943|13042235|P1|COMPLETED|Stage 1||32
5305239|NCT00514943|13042234|P2|STARTED|Stage 1|2 randomized patients were not treated|62
5305240|NCT00514943|13042235|P1|STARTED|Stage 1|1 randomized patient was not treated|62
5305241|NCT00514917|13042293|P2|NOT COMPLETED|Overall Study||115
5305242|NCT00514917|13042294|P1|NOT COMPLETED|Overall Study||126
5305243|NCT00514917|13042293|P2|COMPLETED|Overall Study||91
5305244|NCT00514917|13042294|P1|COMPLETED|Overall Study||81
5305245|NCT00514917|13042293|P2|Testosterone-Specific Evaluable|Overall Study||124
5305246|NCT00514917|13042294|P1|Testosterone-Specific Evaluable|Overall Study||122
5305247|NCT00514917|13042293|P2|Completed Study Treatment|Overall Study||182
5305248|NCT00514917|13042294|P1|Completed Study Treatment|Overall Study||170
5305249|NCT00514917|13042293|P2|Treated|Overall Study||204
5305250|NCT00514917|13042294|P1|Treated|Overall Study||196
5305251|NCT00514917|13042293|P2|STARTED|Overall Study||206
5305252|NCT00514917|13042294|P1|STARTED|Overall Study||207
5305253|NCT00514904|13042322|P2|NOT COMPLETED|Overall Study||5
5305254|NCT00514904|13042323|P1|NOT COMPLETED|Overall Study||24
5305255|NCT00514904|13042322|P2|COMPLETED|Overall Study||371
5305256|NCT00514904|13042323|P1|COMPLETED|Overall Study||1101
5305257|NCT00514904|13042322|P2|STARTED|Overall Study||376
5305258|NCT00514904|13042323|P1|STARTED|Overall Study||1125
5305259|NCT00514852|13042359|P2|NOT COMPLETED|Overall Study||5
5305260|NCT00514852|13042360|P1|NOT COMPLETED|Overall Study||5
5305261|NCT00514852|13042359|P2|COMPLETED|Overall Study||154
5305262|NCT00514852|13042360|P1|COMPLETED|Overall Study||152
5305263|NCT00514852|13042359|P2|STARTED|Overall Study||159
5305264|NCT00514852|13042360|P1|STARTED|Overall Study||157
5305265|NCT00514813|13042388|P4|NOT COMPLETED|Overall Study||4
5305266|NCT00514813|13042389|P3|NOT COMPLETED|Overall Study||47
5305267|NCT00514813|13042390|P2|NOT COMPLETED|Overall Study||86
5305268|NCT00514813|13042391|P1|NOT COMPLETED|Overall Study||15
5305269|NCT00514813|13042388|P4|COMPLETED|Overall Study||0
5305270|NCT00514813|13042389|P3|COMPLETED|Overall Study||0
5305271|NCT00514813|13042390|P2|COMPLETED|Overall Study||0
5305272|NCT00514813|13042391|P1|COMPLETED|Overall Study||0
5305273|NCT00514813|13042388|P4|STARTED|Overall Study||4
5305274|NCT00514813|13042389|P3|STARTED|Overall Study||47
5305275|NCT00514813|13042390|P2|STARTED|Overall Study||86
5305276|NCT00514813|13042391|P1|STARTED|Overall Study||15
5305277|NCT00514735|13042411|P2|NOT COMPLETED|Overall Study||6
5305278|NCT00514735|13042412|P1|NOT COMPLETED|Overall Study||14
5305279|NCT00514735|13042411|P2|COMPLETED|Overall Study||66
5305280|NCT00514735|13042412|P1|COMPLETED|Overall Study||124
5305281|NCT00514735|13042411|P2|STARTED|Overall Study||72
5305282|NCT00514735|13042412|P1|STARTED|Overall Study||138
5305283|NCT00514709|13042432|P2|NOT COMPLETED|Overall Study||0
5305284|NCT00514709|13042433|P1|NOT COMPLETED|Overall Study||0
5305285|NCT00514709|13042432|P2|COMPLETED|Overall Study||613
5305286|NCT00514709|13042433|P1|COMPLETED|Overall Study||1230
5305287|NCT00514709|13042432|P2|STARTED|Overall Study||613
5305288|NCT00514709|13042433|P1|STARTED|Overall Study||1230
5305289|NCT00514683|13042448|P5|NOT COMPLETED|Overall Study||33
5305290|NCT00514683|13042449|P4|NOT COMPLETED|Overall Study||14
5305291|NCT00514683|13042450|P3|NOT COMPLETED|Overall Study||18
5305292|NCT00514683|13042451|P2|NOT COMPLETED|Overall Study||25
5305293|NCT00514683|13042452|P1|NOT COMPLETED|Overall Study||26
5305294|NCT00514683|13042448|P5|COMPLETED|Overall Study||53
5305295|NCT00514683|13042449|P4|COMPLETED|Overall Study||72
5305296|NCT00514683|13042450|P3|COMPLETED|Overall Study||68
5305297|NCT00514683|13042451|P2|COMPLETED|Overall Study||62
5305298|NCT00514683|13042452|P1|COMPLETED|Overall Study||61
5305299|NCT00514683|13042448|P5|STARTED|Overall Study|Randomised|86
5305300|NCT00514683|13042449|P4|STARTED|Overall Study|Randomised|86
5305301|NCT00514683|13042450|P3|STARTED|Overall Study|Randomised|86
5305302|NCT00514683|13042451|P2|STARTED|Overall Study|Randomised|87
5305303|NCT00514683|13042452|P1|STARTED|Overall Study|Randomised|87
5305304|NCT00514592|13042643|P1|NOT COMPLETED|Overall Study||0
5305305|NCT00514592|13042643|P1|COMPLETED|Overall Study||230
5305306|NCT00514592|13042643|P1|STARTED|Overall Study||230
5305307|NCT00514514|13042651|P3|NOT COMPLETED|Extension - 4 Years||21
5305308|NCT00514514|13042652|P2|NOT COMPLETED|Extension - 4 Years||22
5305309|NCT00514514|13042653|P1|NOT COMPLETED|Extension - 4 Years||37
5305310|NCT00514514|13042651|P3|COMPLETED|Extension - 4 Years||113
5305311|NCT00514514|13042652|P2|COMPLETED|Extension - 4 Years||117
5305312|NCT00514514|13042653|P1|COMPLETED|Extension - 4 Years||108
5305313|NCT00514514|13042651|P3|Non-randomized (Followed)|Extension - 4 Years||0
5305314|NCT00514514|13042652|P2|Non-randomized (Followed)|Extension - 4 Years||0
5305315|NCT00514514|13042653|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
5305316|NCT00514514|13042651|P3|STARTED|Extension - 4 Years||134
5305317|NCT00514514|13042652|P2|STARTED|Extension - 4 Years||139
5305318|NCT00514514|13042653|P1|STARTED|Extension - 4 Years||145
5305319|NCT00514514|13042651|P3|NOT COMPLETED|Randomized - 9 Month||38
5305320|NCT00514514|13042652|P2|NOT COMPLETED|Randomized - 9 Month||61
5305321|NCT00514514|13042653|P1|NOT COMPLETED|Randomized - 9 Month||39
5305322|NCT00514514|13042651|P3|COMPLETED|Randomized - 9 Month||124
5305323|NCT00514514|13042652|P2|COMPLETED|Randomized - 9 Month||110
5305324|NCT00514514|13042653|P1|COMPLETED|Randomized - 9 Month||127
5305325|NCT00514514|13042651|P3|Randomized - Received Treatment|Randomized - 9 Month||161
5305326|NCT00514514|13042652|P2|Randomized - Received Treatment|Randomized - 9 Month||171
5305327|NCT00514514|13042653|P1|Randomized - Received Treatment|Randomized - 9 Month||165
5305328|NCT00514514|13042651|P3|STARTED|Randomized - 9 Month||162
5305329|NCT00514514|13042652|P2|STARTED|Randomized - 9 Month||171
5305330|NCT00514514|13042653|P1|STARTED|Randomized - 9 Month||166
5305331|NCT00514514|13042651|P3|NOT COMPLETED|Pre-phase||0
5305332|NCT00514514|13042652|P2|NOT COMPLETED|Pre-phase||0
5305333|NCT00514514|13042653|P1|NOT COMPLETED|Pre-phase||303
5305334|NCT00514514|13042651|P3|COMPLETED|Pre-phase||0
5305335|NCT00514514|13042652|P2|COMPLETED|Pre-phase||0
5305336|NCT00514514|13042653|P1|COMPLETED|Pre-phase||499
5305337|NCT00514514|13042651|P3|STARTED|Pre-phase||0
5305338|NCT00514514|13042652|P2|STARTED|Pre-phase||0
5305339|NCT00514514|13042653|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
5305340|NCT00514501|13042697|P1|NOT COMPLETED|Overall Study||3
5305341|NCT00514501|13042697|P1|COMPLETED|Overall Study||507
5305342|NCT00514501|13042697|P1|STARTED|Overall Study||510
5305343|NCT00514449|13042705|P2|NOT COMPLETED|Overall Study||4
5305344|NCT00514449|13042706|P1|NOT COMPLETED|Overall Study||3
5305345|NCT00514449|13042705|P2|COMPLETED|Overall Study||8
5305346|NCT00514449|13042706|P1|COMPLETED|Overall Study||9
5305347|NCT00514449|13042705|P2|STARTED|Overall Study||12
5305348|NCT00514449|13042706|P1|STARTED|Overall Study||12
5305349|NCT00514215|13042716|P1|NOT COMPLETED|Overall Study||0
5305350|NCT00514215|13042716|P1|COMPLETED|Overall Study||8
5305351|NCT00514215|13042716|P1|STARTED|Overall Study||8
5305352|NCT00514137|13042723|P1|NOT COMPLETED|Overall Study||0
5305353|NCT00514137|13042723|P1|COMPLETED|Overall Study||13
5305354|NCT00514137|13042723|P1|STARTED|Overall Study||13
5305355|NCT00514020|13042730|P1|NOT COMPLETED|Overall Study||28
5305356|NCT00514020|13042730|P1|COMPLETED|Overall Study||5
5305357|NCT00514020|13042730|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
5305358|NCT00513799|13042738|P4|NOT COMPLETED|Four-Month Follow-Up||3
5305359|NCT00513799|13042739|P3|NOT COMPLETED|Four-Month Follow-Up||7
5305360|NCT00513799|13042740|P2|NOT COMPLETED|Four-Month Follow-Up||5
5305361|NCT00513799|13042741|P1|NOT COMPLETED|Four-Month Follow-Up||0
5305362|NCT00513799|13042738|P4|COMPLETED|Four-Month Follow-Up||51
5305363|NCT00513799|13042739|P3|COMPLETED|Four-Month Follow-Up||57
5305364|NCT00513799|13042740|P2|COMPLETED|Four-Month Follow-Up||57
5305365|NCT00513799|13042741|P1|COMPLETED|Four-Month Follow-Up||64
5305366|NCT00513799|13042738|P4|STARTED|Four-Month Follow-Up||54
5305367|NCT00513799|13042739|P3|STARTED|Four-Month Follow-Up||64
5305368|NCT00513799|13042740|P2|STARTED|Four-Month Follow-Up||62
5305369|NCT00513799|13042741|P1|STARTED|Four-Month Follow-Up||64
5305370|NCT00513799|13042738|P4|NOT COMPLETED|One-Month Follow-Up||21
5305371|NCT00513799|13042739|P3|NOT COMPLETED|One-Month Follow-Up||11
5305372|NCT00513799|13042740|P2|NOT COMPLETED|One-Month Follow-Up||13
5305373|NCT00513799|13042741|P1|NOT COMPLETED|One-Month Follow-Up||11
5305374|NCT00513799|13042738|P4|COMPLETED|One-Month Follow-Up||54
5305375|NCT00513799|13042739|P3|COMPLETED|One-Month Follow-Up||64
5305376|NCT00513799|13042740|P2|COMPLETED|One-Month Follow-Up||62
5305377|NCT00513799|13042741|P1|COMPLETED|One-Month Follow-Up||64
5305378|NCT00513799|13042738|P4|STARTED|One-Month Follow-Up||75
5305379|NCT00513799|13042739|P3|STARTED|One-Month Follow-Up||75
5305380|NCT00513799|13042740|P2|STARTED|One-Month Follow-Up||75
5305381|NCT00513799|13042741|P1|STARTED|One-Month Follow-Up||75
5305382|NCT00513747|13042762|P3|NOT COMPLETED|Overall Study||0
5305383|NCT00513747|13042763|P2|NOT COMPLETED|Overall Study||0
5305384|NCT00513747|13042764|P1|NOT COMPLETED|Overall Study||0
5305385|NCT00513747|13042762|P3|COMPLETED|Overall Study||55
5305386|NCT00513747|13042763|P2|COMPLETED|Overall Study||11
5305387|NCT00513747|13042764|P1|COMPLETED|Overall Study||17
5305388|NCT00513747|13042762|P3|Received at Least One Dose of Treatment|Overall Study||40
5305389|NCT00513747|13042763|P2|Received at Least One Dose of Treatment|Overall Study||11
5305390|NCT00513747|13042764|P1|Received at Least One Dose of Treatment|Overall Study||9
5305391|NCT00513747|13042762|P3|STARTED|Overall Study||55
5305392|NCT00513747|13042763|P2|STARTED|Overall Study||11
5305393|NCT00513747|13042764|P1|STARTED|Overall Study||17
5305394|NCT00513708|13042784|P3|NOT COMPLETED|Overall Study||4
5305395|NCT00513708|13042785|P2|NOT COMPLETED|Overall Study||4
5305396|NCT00513708|13042786|P1|NOT COMPLETED|Overall Study||4
5305397|NCT00513708|13042784|P3|COMPLETED|Overall Study||46
5305398|NCT00513708|13042785|P2|COMPLETED|Overall Study||46
5305399|NCT00513708|13042786|P1|COMPLETED|Overall Study||46
5305400|NCT00513708|13042784|P3|STARTED|Overall Study||50
5305401|NCT00513708|13042785|P2|STARTED|Overall Study||50
5305402|NCT00513708|13042786|P1|STARTED|Overall Study||50
5305403|NCT00513695|13042800|P1|NOT COMPLETED|Overall Study||5
5305404|NCT00513695|13042800|P1|COMPLETED|Overall Study||63
5305405|NCT00513695|13042800|P1|STARTED|Overall Study||68
5305406|NCT00513682|13042809|P1|NOT COMPLETED|Treatment Phase||0
5305407|NCT00513682|13042809|P1|COMPLETED|Treatment Phase||7
5305408|NCT00513682|13042809|P1|STARTED|Treatment Phase||7
5305409|NCT00513682|13042809|P1|NOT COMPLETED|Washout Phase||2
5305410|NCT00513682|13042809|P1|COMPLETED|Washout Phase||7
5305411|NCT00513682|13042809|P1|STARTED|Washout Phase||9
5305412|NCT00513682|13042809|P1|NOT COMPLETED|Screening Phase||0
5305413|NCT00513682|13042809|P1|COMPLETED|Screening Phase||9
5305414|NCT00513682|13042809|P1|STARTED|Screening Phase||9
5305415|NCT00513617|13042821|P3|NOT COMPLETED|Overall Study||8
5305416|NCT00513617|13042822|P2|NOT COMPLETED|Overall Study||10
5305417|NCT00513617|13042823|P1|NOT COMPLETED|Overall Study||11
5305418|NCT00513617|13042821|P3|COMPLETED|Overall Study||30
5305419|NCT00513617|13042822|P2|COMPLETED|Overall Study||25
5305420|NCT00513617|13042823|P1|COMPLETED|Overall Study||25
5305421|NCT00513617|13042821|P3|STARTED|Overall Study||38
5305422|NCT00513617|13042822|P2|STARTED|Overall Study||35
5305423|NCT00513617|13042823|P1|STARTED|Overall Study||36
5305424|NCT00513604|13042839|P5|NOT COMPLETED|Overall Study||0
5305425|NCT00513604|13042840|P4|NOT COMPLETED|Overall Study||0
5305426|NCT00513604|13042841|P3|NOT COMPLETED|Overall Study||3
5305427|NCT00513604|13042842|P2|NOT COMPLETED|Overall Study||3
5305428|NCT00513604|13042843|P1|NOT COMPLETED|Overall Study||2
5305429|NCT00513604|13042839|P5|COMPLETED|Overall Study||35
5305430|NCT00513604|13042840|P4|COMPLETED|Overall Study||34
5305431|NCT00513604|13042841|P3|COMPLETED|Overall Study||21
5305432|NCT00513604|13042842|P2|COMPLETED|Overall Study||36
5305433|NCT00513604|13042843|P1|COMPLETED|Overall Study||24
5305434|NCT00513604|13042839|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
5305435|NCT00513604|13042840|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
5305436|NCT00513604|13042841|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
5305437|NCT00513604|13042842|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
5305438|NCT00513604|13042843|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
5305439|NCT00513526|13042860|P1|NOT COMPLETED|Overall Study||17
5305440|NCT00513526|13042860|P1|COMPLETED|Overall Study||92
5305441|NCT00513526|13042860|P1|STARTED|Overall Study||109
5305442|NCT00513500|13042877|P2|NOT COMPLETED|Overall Study||54
5305443|NCT00513500|13042878|P1|NOT COMPLETED|Overall Study||41
5305444|NCT00513500|13042877|P2|COMPLETED|Overall Study||2054
5305445|NCT00513500|13042878|P1|COMPLETED|Overall Study||976
5305446|NCT00513500|13042877|P2|STARTED|Overall Study||2108
5305447|NCT00513500|13042878|P1|STARTED|Overall Study||1017
5305448|NCT00513474|13042890|P2|NOT COMPLETED|Overall Study||9
5305449|NCT00513474|13042891|P1|NOT COMPLETED|Overall Study||7
5305450|NCT00513474|13042890|P2|COMPLETED|Overall Study||12
5305451|NCT00513474|13042891|P1|COMPLETED|Overall Study||18
5305452|NCT00513474|13042890|P2|Received Rasburicase Per Protocol|Overall Study||0
5305453|NCT00513474|13042891|P1|Received Rasburicase Per Protocol|Overall Study||24
5305454|NCT00513474|13042890|P2|STARTED|Overall Study||21
5305455|NCT00513474|13042891|P1|STARTED|Overall Study||25
5305456|NCT00513461|13042905|P2|NOT COMPLETED|Overall Study||10
5305457|NCT00513461|13042906|P1|NOT COMPLETED|Overall Study||13
5305458|NCT00513461|13042905|P2|COMPLETED|Overall Study||43
5305459|NCT00513461|13042906|P1|COMPLETED|Overall Study||44
5305460|NCT00513461|13042905|P2|STARTED|Overall Study||53
5305461|NCT00513461|13042906|P1|STARTED|Overall Study||57
5305462|NCT00513435|13042940|P1|NOT COMPLETED|Overall Study||0
5305463|NCT00513435|13042940|P1|COMPLETED|Overall Study||9
5305464|NCT00513435|13042940|P1|STARTED|Overall Study||9
5305465|NCT00513409|13042947|P2|NOT COMPLETED|Overall Study||6
5305466|NCT00513409|13042948|P1|NOT COMPLETED|Overall Study||2
5305467|NCT00513409|13042947|P2|COMPLETED|Overall Study||73
5305468|NCT00513409|13042948|P1|COMPLETED|Overall Study||82
5305469|NCT00513409|13042947|P2|STARTED|Overall Study||79
5305470|NCT00513409|13042948|P1|STARTED|Overall Study||84
5305471|NCT00513370|13042974|P1|NOT COMPLETED|Overall Study||24
5305472|NCT00513370|13042974|P1|COMPLETED|Overall Study||179
5305473|NCT00513370|13042974|P1|STARTED|Overall Study||203
5305474|NCT00513357|13043004|P2|NOT COMPLETED|Overall Study||10
5305475|NCT00513357|13043005|P1|NOT COMPLETED|Overall Study||15
5305476|NCT00513357|13043004|P2|COMPLETED|Overall Study||25
5305477|NCT00513357|13043005|P1|COMPLETED|Overall Study||23
5305478|NCT00513357|13043004|P2|STARTED|Overall Study||35
5305479|NCT00513357|13043005|P1|STARTED|Overall Study||38
5305480|NCT00513344|13043011|P1|NOT COMPLETED|3rd Intervention 1 Day||0
5305481|NCT00513344|13043011|P1|COMPLETED|3rd Intervention 1 Day||5
5305482|NCT00513344|13043011|P1|STARTED|3rd Intervention 1 Day||5
5305483|NCT00513344|13043011|P1|NOT COMPLETED|Washout Period 3 Days||0
5305484|NCT00513344|13043011|P1|COMPLETED|Washout Period 3 Days||5
5305485|NCT00513344|13043011|P1|STARTED|Washout Period 3 Days||5
5305486|NCT00513344|13043011|P1|NOT COMPLETED|2nd Intervention 1 Day||0
5305487|NCT00513344|13043011|P1|COMPLETED|2nd Intervention 1 Day||5
5305488|NCT00513344|13043011|P1|STARTED|2nd Intervention 1 Day||5
5305489|NCT00513344|13043011|P1|NOT COMPLETED|Washout Period 3 Days||0
5305490|NCT00513344|13043011|P1|COMPLETED|Washout Period 3 Days||5
5305491|NCT00513344|13043011|P1|STARTED|Washout Period 3 Days||5
5305492|NCT00513344|13043011|P1|NOT COMPLETED|1st Intervention 1 Day||0
5305493|NCT00513344|13043011|P1|COMPLETED|1st Intervention 1 Day||5
5305494|NCT00513344|13043011|P1|STARTED|1st Intervention 1 Day||5
5305495|NCT00513344|13043011|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
5305496|NCT00513344|13043011|P1|COMPLETED|Diet Restriction (3 Days)||5
5305497|NCT00513344|13043011|P1|STARTED|Diet Restriction (3 Days)||5
5305498|NCT00513305|13043024|P2|NOT COMPLETED|Overall Study||27
5305499|NCT00513305|13043025|P1|NOT COMPLETED|Overall Study||28
5305500|NCT00513305|13043024|P2|COMPLETED|Overall Study||7
5305501|NCT00513305|13043025|P1|COMPLETED|Overall Study||5
5305502|NCT00513305|13043024|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
5305503|NCT00513305|13043025|P1|STARTED|Overall Study||33
5305504|NCT00513292|13043043|P2|NOT COMPLETED|Overall Study||0
5305505|NCT00513292|13043044|P1|NOT COMPLETED|Overall Study||0
5305506|NCT00513292|13043043|P2|COMPLETED|Overall Study||142
5305507|NCT00513292|13043044|P1|COMPLETED|Overall Study||138
5305508|NCT00513292|13043043|P2|STARTED|Overall Study||142
5305509|NCT00513292|13043044|P1|STARTED|Overall Study||138
5305510|NCT00513240|13043068|P2|NOT COMPLETED|Overall Study||7
5305511|NCT00513240|13043069|P1|NOT COMPLETED|Overall Study||13
5305512|NCT00513240|13043068|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
5305513|NCT00513240|13043069|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
5305514|NCT00513240|13043068|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
5305515|NCT00513240|13043069|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
5305516|NCT00513240|13043068|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
5305517|NCT00513240|13043069|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
5305518|NCT00513071|13043082|P1|NOT COMPLETED|Overall Study||5
5305519|NCT00513071|13043082|P1|COMPLETED|Overall Study||23
5305520|NCT00513071|13043082|P1|STARTED|Overall Study||28
5305521|NCT00513019|13043094|P2|NOT COMPLETED|Overall Study||5
5305522|NCT00513019|13043095|P1|NOT COMPLETED|Overall Study||5
5305523|NCT00513019|13043094|P2|COMPLETED|Overall Study||13
5305524|NCT00513019|13043095|P1|COMPLETED|Overall Study||12
5305525|NCT00513019|13043094|P2|STARTED|Overall Study||18
5305526|NCT00513019|13043095|P1|STARTED|Overall Study||17
5305527|NCT00512902|13043101|P1|NOT COMPLETED|Overall Study||8
5305528|NCT00512902|13043101|P1|COMPLETED|Overall Study||12
5305529|NCT00512902|13043101|P1|STARTED|Overall Study||20
5305530|NCT00512876|13043109|P1|NOT COMPLETED|Overall Study||4
5305531|NCT00512876|13043109|P1|COMPLETED|Overall Study||20
5305532|NCT00512876|13043109|P1|STARTED|Overall Study||24
5305533|NCT00512798|13043116|P2|NOT COMPLETED|Overall Study||27
5305534|NCT00512798|13043117|P1|NOT COMPLETED|Overall Study||19
5305535|NCT00512798|13043116|P2|COMPLETED|Overall Study||1
5305536|NCT00512798|13043117|P1|COMPLETED|Overall Study||0
5305537|NCT00512798|13043116|P2|STARTED|Overall Study||28
5305538|NCT00512798|13043117|P1|STARTED|Overall Study||19
5305539|NCT00512707|13043128|P2|NOT COMPLETED|Overall Study||12
5305540|NCT00512707|13043129|P1|NOT COMPLETED|Overall Study||10
5305541|NCT00512707|13043128|P2|COMPLETED|Overall Study||58
5305542|NCT00512707|13043129|P1|COMPLETED|Overall Study||60
5305543|NCT00512707|13043128|P2|STARTED|Overall Study||70
5305544|NCT00512707|13043129|P1|STARTED|Overall Study||70
5305545|NCT00512278|13043161|P2|NOT COMPLETED|Overall Study||17
5305546|NCT00512278|13043162|P1|NOT COMPLETED|Overall Study||28
5305547|NCT00512278|13043161|P2|COMPLETED|Overall Study||56
5305548|NCT00512278|13043162|P1|COMPLETED|Overall Study||45
5305549|NCT00512278|13043161|P2|STARTED|Overall Study||73
5305550|NCT00512278|13043162|P1|STARTED|Overall Study||73
5305551|NCT00512252|13043179|P3|NOT COMPLETED|Overall Study||3
5305552|NCT00512252|13043180|P2|NOT COMPLETED|Overall Study||0
5305553|NCT00512252|13043181|P1|NOT COMPLETED|Overall Study||0
5305554|NCT00512252|13043179|P3|COMPLETED|Overall Study||43
5305555|NCT00512252|13043180|P2|COMPLETED|Overall Study||3
5305556|NCT00512252|13043181|P1|COMPLETED|Overall Study||3
5305557|NCT00512252|13043179|P3|STARTED|Overall Study||46
5305558|NCT00512252|13043180|P2|STARTED|Overall Study||3
5305559|NCT00512252|13043181|P1|STARTED|Overall Study||3
5305560|NCT00512148|13043209|P1|NOT COMPLETED|Long Term Follow Up Period||6
5305561|NCT00512148|13043209|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
5305562|NCT00512148|13043209|P1|STARTED|Long Term Follow Up Period||6
5305563|NCT00512148|13043209|P1|NOT COMPLETED|Primay Study Period||1
5305564|NCT00512148|13043209|P1|COMPLETED|Primay Study Period||6
5305565|NCT00512148|13043209|P1|STARTED|Primay Study Period||7
5305566|NCT00512096|13043215|P1|NOT COMPLETED|Overall Study||7
5305567|NCT00512096|13043215|P1|COMPLETED|Overall Study||23
5305568|NCT00512096|13043215|P1|STARTED|Overall Study||30
5305569|NCT00511992|13043219|P1|NOT COMPLETED|Overall Study||7
5305570|NCT00511992|13043219|P1|COMPLETED|Overall Study||13
5305571|NCT00511992|13043219|P1|STARTED|Overall Study||20
5305572|NCT00511914|13043226|P2|NOT COMPLETED|Overall Study||0
5305573|NCT00511914|13043227|P1|NOT COMPLETED|Overall Study||0
5305574|NCT00511914|13043226|P2|COMPLETED|Overall Study||67
5305575|NCT00511914|13043227|P1|COMPLETED|Overall Study||68
5305576|NCT00511914|13043226|P2|STARTED|Overall Study||67
5305577|NCT00511914|13043227|P1|STARTED|Overall Study||68
5305578|NCT00511901|13043243|P2|NOT COMPLETED|Overall Study||3
5305579|NCT00511901|13043244|P1|NOT COMPLETED|Overall Study||1
5305580|NCT00511901|13043243|P2|COMPLETED|Overall Study||8
5305581|NCT00511901|13043244|P1|COMPLETED|Overall Study||10
5305582|NCT00511901|13043243|P2|STARTED|Overall Study||11
5305583|NCT00511901|13043244|P1|STARTED|Overall Study||11
5305584|NCT00511875|13043266|P2|NOT COMPLETED|Overall Study||0
5305585|NCT00511875|13043267|P1|NOT COMPLETED|Overall Study||5
5305586|NCT00511875|13043266|P2|COMPLETED|Overall Study||15
5305587|NCT00511875|13043267|P1|COMPLETED|Overall Study||10
5305588|NCT00511875|13043266|P2|STARTED|Overall Study||15
5305589|NCT00511875|13043267|P1|STARTED|Overall Study||15
5305590|NCT00511862|13043292|P3|NOT COMPLETED|Overall Study||0
5305591|NCT00511862|13043293|P2|NOT COMPLETED|Overall Study||0
5305592|NCT00511862|13043294|P1|NOT COMPLETED|Overall Study||0
5305593|NCT00511862|13043292|P3|COMPLETED|Overall Study||47
5305594|NCT00511862|13043293|P2|COMPLETED|Overall Study||43
5305595|NCT00511862|13043294|P1|COMPLETED|Overall Study||61
5305596|NCT00511862|13043292|P3|STARTED|Overall Study||47
5305597|NCT00511862|13043293|P2|STARTED|Overall Study||43
5305598|NCT00511862|13043294|P1|STARTED|Overall Study||61
5305599|NCT00511836|13043307|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
5305600|NCT00511836|13043308|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
5305601|NCT00511836|13043307|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
5305602|NCT00511836|13043308|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
5305603|NCT00511836|13043307|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
5305604|NCT00511836|13043308|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
5305605|NCT00511836|13043307|P2|NOT COMPLETED|Double-blind Period||0
5305606|NCT00511836|13043308|P1|NOT COMPLETED|Double-blind Period||1
5305607|NCT00511836|13043307|P2|COMPLETED|Double-blind Period||15
5305608|NCT00511836|13043308|P1|COMPLETED|Double-blind Period||15
5305609|NCT00511836|13043307|P2|STARTED|Double-blind Period||15
5305610|NCT00511836|13043308|P1|STARTED|Double-blind Period||16
5305611|NCT00511810|13043325|P2|NOT COMPLETED|Overall Study||5
5305612|NCT00511810|13043326|P1|NOT COMPLETED|Overall Study||1
5305613|NCT00511810|13043325|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
5305614|NCT00511810|13043326|P1|COMPLETED|Overall Study||7
5305615|NCT00511810|13043325|P2|STARTED|Overall Study||12
5305616|NCT00511810|13043326|P1|STARTED|Overall Study||8
5305617|NCT00511797|13043336|P4|NOT COMPLETED|Overall Study||15
5305618|NCT00511797|13043337|P3|NOT COMPLETED|Overall Study||11
5305619|NCT00511797|13043338|P2|NOT COMPLETED|Overall Study||8
5305620|NCT00511797|13043339|P1|NOT COMPLETED|Overall Study||7
5305621|NCT00511797|13043336|P4|COMPLETED|Overall Study||47
5305622|NCT00511797|13043337|P3|COMPLETED|Overall Study||51
5305623|NCT00511797|13043338|P2|COMPLETED|Overall Study||55
5305624|NCT00511797|13043339|P1|COMPLETED|Overall Study||55
5305625|NCT00511797|13043336|P4|Subjects Received Treatment|Overall Study|FAS|58
5305626|NCT00511797|13043337|P3|Subjects Received Treatment|Overall Study|FAS|61
5305627|NCT00511797|13043338|P2|Subjects Received Treatment|Overall Study|FAS|62
5305628|NCT00511797|13043339|P1|Subjects Received Treatment|Overall Study|FAS|61
5305629|NCT00511797|13043336|P4|Subjects Dispensed Drugs|Overall Study||59
5305630|NCT00511797|13043337|P3|Subjects Dispensed Drugs|Overall Study||61
5305631|NCT00511797|13043338|P2|Subjects Dispensed Drugs|Overall Study||63
5305632|NCT00511797|13043339|P1|Subjects Dispensed Drugs|Overall Study||61
5305633|NCT00511797|13043336|P4|STARTED|Overall Study||62
5305634|NCT00511797|13043337|P3|STARTED|Overall Study||62
5305635|NCT00511797|13043338|P2|STARTED|Overall Study||63
5305636|NCT00511797|13043339|P1|STARTED|Overall Study||62
5305637|NCT00511706|13043443|P2|NOT COMPLETED|Overall Study||5
5305638|NCT00511706|13043444|P1|NOT COMPLETED|Overall Study||8
5305639|NCT00511706|13043443|P2|COMPLETED|Overall Study||115
5305640|NCT00511706|13043444|P1|COMPLETED|Overall Study||115
5305641|NCT00511706|13043443|P2|STARTED|Overall Study||120
5305642|NCT00511706|13043444|P1|STARTED|Overall Study||123
5305643|NCT00511667|13043458|P2|NOT COMPLETED|Overall Study||3
5305644|NCT00511667|13043459|P1|NOT COMPLETED|Overall Study||12
5305645|NCT00511667|13043458|P2|COMPLETED|Overall Study||15
5305646|NCT00511667|13043459|P1|COMPLETED|Overall Study||40
5305647|NCT00511667|13043458|P2|STARTED|Overall Study||18
5305648|NCT00511667|13043459|P1|STARTED|Overall Study||52
5305649|NCT00511472|13043494|P2|NOT COMPLETED|Overall Study||6
5305650|NCT00511472|13043495|P1|NOT COMPLETED|Overall Study||3
5305651|NCT00511472|13043494|P2|COMPLETED|Overall Study||17
5305652|NCT00511472|13043495|P1|COMPLETED|Overall Study||44
5305653|NCT00511472|13043494|P2|STARTED|Overall Study||23
5305654|NCT00511472|13043495|P1|STARTED|Overall Study||47
5305655|NCT00511433|13043514|P2|NOT COMPLETED|Overall Study||1
5305656|NCT00511433|13043515|P1|NOT COMPLETED|Overall Study||6
5305657|NCT00511433|13043514|P2|COMPLETED|Overall Study||15
5305658|NCT00511433|13043515|P1|COMPLETED|Overall Study||26
5305659|NCT00511433|13043514|P2|STARTED|Overall Study||16
5305660|NCT00511433|13043515|P1|STARTED|Overall Study||32
5305661|NCT00511355|13043555|P2|NOT COMPLETED|Overall Study||9
5305662|NCT00511355|13043556|P1|NOT COMPLETED|Overall Study||7
5305663|NCT00511355|13043555|P2|COMPLETED|Overall Study||52
5305664|NCT00511355|13043556|P1|COMPLETED|Overall Study||53
5305665|NCT00511355|13043555|P2|STARTED|Overall Study||61
5305666|NCT00511355|13043556|P1|STARTED|Overall Study||60
5305667|NCT00511342|13043656|P2|NOT COMPLETED|Overall Study||22
5305668|NCT00511342|13043657|P1|NOT COMPLETED|Overall Study||13
5305669|NCT00511342|13043656|P2|COMPLETED|Overall Study||32
5305670|NCT00511342|13043657|P1|COMPLETED|Overall Study||43
5305671|NCT00511342|13043656|P2|STARTED|Overall Study||54
5305672|NCT00511342|13043657|P1|STARTED|Overall Study||56
5305673|NCT00511329|13043681|P1|NOT COMPLETED|Overall Study||0
5305674|NCT00511329|13043681|P1|COMPLETED|Overall Study||0
5305675|NCT00511329|13043681|P1|STARTED|Overall Study||0
5305676|NCT00511238|13043688|P2|NOT COMPLETED|Overall Study||226
5305677|NCT00511238|13043689|P1|NOT COMPLETED|Overall Study||42
5305678|NCT00511238|13043688|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
5305679|NCT00511238|13043689|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
5305680|NCT00511238|13043688|P2|STARTED|Overall Study||266
5305681|NCT00511238|13043689|P1|STARTED|Overall Study||46
5305682|NCT00511199|13043708|P2|NOT COMPLETED|Overall Study||125
5305683|NCT00511199|13043709|P1|NOT COMPLETED|Overall Study||449
5305684|NCT00511199|13043708|P2|COMPLETED|Overall Study||410
5305685|NCT00511199|13043709|P1|COMPLETED|Overall Study||1142
5305686|NCT00511199|13043708|P2|STARTED|Overall Study||535
5305687|NCT00511199|13043709|P1|STARTED|Overall Study||1591
5305688|NCT00511173|13043733|P1|NOT COMPLETED|Overall Study||0
5305689|NCT00511173|13043733|P1|COMPLETED|Overall Study||102
5305690|NCT00511173|13043733|P1|STARTED|Overall Study||102
5305691|NCT00511147|13043738|P1|NOT COMPLETED|Overall Study||7
5305692|NCT00511147|13043738|P1|COMPLETED|Overall Study||57
5305693|NCT00511147|13043738|P1|STARTED|Overall Study||64
5305694|NCT00511134|13043747|P2|NOT COMPLETED|Overall Study||2
5305695|NCT00511134|13043748|P1|NOT COMPLETED|Overall Study||0
5305696|NCT00511134|13043747|P2|COMPLETED|Overall Study||1
5305697|NCT00511134|13043748|P1|COMPLETED|Overall Study||1
5305698|NCT00511134|13043747|P2|STARTED|Overall Study||3
5305699|NCT00511134|13043748|P1|STARTED|Overall Study||1
5305700|NCT00511108|13043760|P4|NOT COMPLETED|Overall Study||5
5305701|NCT00511108|13043761|P3|NOT COMPLETED|Overall Study||5
5305702|NCT00511108|13043762|P2|NOT COMPLETED|Overall Study||2
5305703|NCT00511108|13043763|P1|NOT COMPLETED|Overall Study||6
5305704|NCT00511108|13043760|P4|COMPLETED|Overall Study||48
5305705|NCT00511108|13043761|P3|COMPLETED|Overall Study||47
5305706|NCT00511108|13043762|P2|COMPLETED|Overall Study||52
5305707|NCT00511108|13043763|P1|COMPLETED|Overall Study||46
5305708|NCT00511108|13043760|P4|STARTED|Overall Study||53
5305709|NCT00511108|13043761|P3|STARTED|Overall Study||52
5305710|NCT00511108|13043762|P2|STARTED|Overall Study||54
5305711|NCT00511108|13043763|P1|STARTED|Overall Study||52
5305712|NCT00511095|13043781|P1|NOT COMPLETED|Overall Study||11
5305713|NCT00511095|13043781|P1|COMPLETED|Overall Study||196
5305714|NCT00511095|13043781|P1|STARTED|Overall Study||207
5305715|NCT00511004|13043794|P3|NOT COMPLETED|Overall Study||4
5305716|NCT00511004|13043795|P2|NOT COMPLETED|Overall Study||0
5305717|NCT00511004|13043796|P1|NOT COMPLETED|Overall Study||0
5305718|NCT00511004|13043794|P3|COMPLETED|Overall Study||10
5305719|NCT00511004|13043795|P2|COMPLETED|Overall Study||13
5305720|NCT00511004|13043796|P1|COMPLETED|Overall Study||13
5305721|NCT00511004|13043794|P3|STARTED|Overall Study||14
5305722|NCT00511004|13043795|P2|STARTED|Overall Study||13
5305723|NCT00511004|13043796|P1|STARTED|Overall Study||13
5305724|NCT00510952|13043815|P2|NOT COMPLETED|Overall Study||16
5305725|NCT00510952|13043816|P1|NOT COMPLETED|Overall Study||26
5305726|NCT00510952|13043815|P2|COMPLETED|Overall Study||220
5305727|NCT00510952|13043816|P1|COMPLETED|Overall Study||209
5305728|NCT00510952|13043815|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
5305729|NCT00510952|13043816|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
5305730|NCT00510952|13043815|P2|STARTED|Overall Study||236
5305731|NCT00510952|13043816|P1|STARTED|Overall Study||235
5305732|NCT00510887|13043842|P1|NOT COMPLETED|Overall Study||1
5305733|NCT00510887|13043842|P1|COMPLETED|Overall Study||11
5305734|NCT00510887|13043842|P1|STARTED|Overall Study||12
5305735|NCT00510874|13043858|P7|NOT COMPLETED|Overall Study||1
5305736|NCT00510874|13043859|P6|NOT COMPLETED|Overall Study||0
5305737|NCT00510874|13043860|P5|NOT COMPLETED|Overall Study||7
5305738|NCT00510874|13043861|P4|NOT COMPLETED|Overall Study||3
5305739|NCT00510874|13043862|P3|NOT COMPLETED|Overall Study||1
5305740|NCT00510874|13043863|P2|NOT COMPLETED|Overall Study||4
5305741|NCT00510874|13043864|P1|NOT COMPLETED|Overall Study||3
5305742|NCT00510874|13043858|P7|COMPLETED|Overall Study|Upto Day 182|49
5305743|NCT00510874|13043859|P6|COMPLETED|Overall Study|Upto Day 182|50
5305744|NCT00510874|13043860|P5|COMPLETED|Overall Study|Upto Day 182|141
5305745|NCT00510874|13043861|P4|COMPLETED|Overall Study|Upto Day 182|148
5305746|NCT00510874|13043862|P3|COMPLETED|Overall Study|Upto Day 182|150
5305747|NCT00510874|13043863|P2|COMPLETED|Overall Study|Upto Day 182|148
5305748|NCT00510874|13043864|P1|COMPLETED|Overall Study|Upto Day 182|75
5305749|NCT00510874|13043858|P7|STARTED|Overall Study||50
5305750|NCT00510874|13043859|P6|STARTED|Overall Study||50
5305751|NCT00510874|13043860|P5|STARTED|Overall Study||148
5305752|NCT00510874|13043861|P4|STARTED|Overall Study||151
5305753|NCT00510874|13043862|P3|STARTED|Overall Study||151
5305754|NCT00510874|13043863|P2|STARTED|Overall Study||152
5305755|NCT00510874|13043864|P1|STARTED|Overall Study||78
5305756|NCT00510835|13043967|P3|NOT COMPLETED|Overall Study||2
5305757|NCT00510835|13043968|P2|NOT COMPLETED|Overall Study||2
5305758|NCT00510835|13043969|P1|NOT COMPLETED|Overall Study||6
5305759|NCT00510835|13043967|P3|COMPLETED|Overall Study||456
5305760|NCT00510835|13043968|P2|COMPLETED|Overall Study||446
5305761|NCT00510835|13043969|P1|COMPLETED|Overall Study||439
5305762|NCT00510835|13043967|P3|STARTED|Overall Study||458
5305763|NCT00510835|13043968|P2|STARTED|Overall Study||448
5305764|NCT00510835|13043969|P1|STARTED|Overall Study||445
5305765|NCT00510809|13043980|P3|NOT COMPLETED|Overall Study||0
5305766|NCT00510809|13043981|P2|NOT COMPLETED|Overall Study||0
5305767|NCT00510809|13043982|P1|NOT COMPLETED|Overall Study||0
5305768|NCT00510809|13043980|P3|COMPLETED|Overall Study||18
5305769|NCT00510809|13043981|P2|COMPLETED|Overall Study||18
5305770|NCT00510809|13043982|P1|COMPLETED|Overall Study||18
5305771|NCT00510809|13043980|P3|STARTED|Overall Study||18
5305772|NCT00510809|13043981|P2|STARTED|Overall Study||18
5305773|NCT00510809|13043982|P1|STARTED|Overall Study||18
5305774|NCT00510783|13043995|P2|NOT COMPLETED|Overall Study||29
5305775|NCT00510783|13043996|P1|NOT COMPLETED|Overall Study||31
5305776|NCT00510783|13043995|P2|COMPLETED|Overall Study||47
5305777|NCT00510783|13043996|P1|COMPLETED|Overall Study||51
5305778|NCT00510783|13043995|P2|STARTED|Overall Study||76
5305779|NCT00510783|13043996|P1|STARTED|Overall Study||82
5305780|NCT00510744|13044002|P1|NOT COMPLETED|Overall Study||0
5305781|NCT00510744|13044002|P1|COMPLETED|Overall Study||5
5305782|NCT00510744|13044002|P1|STARTED|Overall Study||5
5305783|NCT00510718|13044013|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
5305784|NCT00510718|13044014|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
5305785|NCT00510718|13044013|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
5305786|NCT00510718|13044014|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
5305787|NCT00510718|13044013|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
5305788|NCT00510718|13044014|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
5305789|NCT00510718|13044013|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
5305790|NCT00510718|13044014|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
5305791|NCT00510718|13044013|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
5305792|NCT00510718|13044014|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
5305793|NCT00510718|13044013|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
5305794|NCT00510718|13044014|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
5305795|NCT00510718|13044013|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
5305796|NCT00510718|13044014|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
5305797|NCT00510718|13044013|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
5305798|NCT00510718|13044014|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
5305799|NCT00510718|13044013|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
5305800|NCT00510718|13044014|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
5305801|NCT00510718|13044013|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
5305802|NCT00510718|13044014|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
5305803|NCT00510718|13044013|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
5305804|NCT00510718|13044014|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
5305805|NCT00510718|13044013|P2|COMPLETED|Single Dose Period: 1 Week||12
5305806|NCT00510718|13044014|P1|COMPLETED|Single Dose Period: 1 Week||15
5305807|NCT00510718|13044013|P2|600 mg/Day|Single Dose Period: 1 Week||3
5305808|NCT00510718|13044014|P1|600 mg/Day|Single Dose Period: 1 Week||0
5305809|NCT00510718|13044013|P2|480 mg/Day|Single Dose Period: 1 Week||6
5305810|NCT00510718|13044014|P1|480 mg/Day|Single Dose Period: 1 Week||0
5305811|NCT00510718|13044013|P2|360 mg/Day|Single Dose Period: 1 Week||2
5305812|NCT00510718|13044014|P1|360 mg/Day|Single Dose Period: 1 Week||4
5305813|NCT00510718|13044013|P2|240 mg/Day|Single Dose Period: 1 Week||0
5305814|NCT00510718|13044014|P1|240 mg/Day|Single Dose Period: 1 Week||3
5305815|NCT00510718|13044013|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
5305816|NCT00510718|13044014|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
5305817|NCT00510718|13044013|P2|60 mg/Day|Single Dose Period: 1 Week||0
5305818|NCT00510718|13044014|P1|60 mg/Day|Single Dose Period: 1 Week||3
5305819|NCT00510718|13044013|P2|30 mg/Day|Single Dose Period: 1 Week||0
5305820|NCT00510718|13044014|P1|30 mg/Day|Single Dose Period: 1 Week||3
5305821|NCT00510718|13044013|P2|STARTED|Single Dose Period: 1 Week||12
5305822|NCT00510718|13044014|P1|STARTED|Single Dose Period: 1 Week||15
5305823|NCT00510692|13044140|P2|NOT COMPLETED|Overall Study||3
5305824|NCT00510692|13044141|P1|NOT COMPLETED|Overall Study||2
5305825|NCT00510692|13044140|P2|COMPLETED|Overall Study||26
5305826|NCT00510692|13044141|P1|COMPLETED|Overall Study||27
5305827|NCT00510692|13044140|P2|STARTED|Overall Study||29
5305828|NCT00510692|13044141|P1|STARTED|Overall Study||29
5305829|NCT00510653|13044155|P1|NOT COMPLETED|Overall Study||11
5305830|NCT00510653|13044155|P1|COMPLETED|Overall Study||13
5305831|NCT00510653|13044155|P1|STARTED|Overall Study||24
5305832|NCT00510510|13044162|P3|NOT COMPLETED|Overall Study||17
5305833|NCT00510510|13044163|P2|NOT COMPLETED|Overall Study||9
5305834|NCT00510510|13044164|P1|NOT COMPLETED|Overall Study||5
5305835|NCT00510510|13044162|P3|COMPLETED|Overall Study||74
5305836|NCT00510510|13044163|P2|COMPLETED|Overall Study||89
5305837|NCT00510510|13044164|P1|COMPLETED|Overall Study||87
5305838|NCT00510510|13044162|P3|STARTED|Overall Study||91
5305839|NCT00510510|13044163|P2|STARTED|Overall Study||98
5305840|NCT00510510|13044164|P1|STARTED|Overall Study||92
5305841|NCT00510497|13044175|P1|NOT COMPLETED|Overall Study||3
5305842|NCT00510497|13044175|P1|COMPLETED|Overall Study||8
5305843|NCT00510497|13044175|P1|STARTED|Overall Study||11
5305844|NCT00510484|13044182|P2|NOT COMPLETED|Period 2||0
5305845|NCT00510484|13044183|P1|NOT COMPLETED|Period 2||0
5305846|NCT00510484|13044182|P2|COMPLETED|Period 2||15
5305847|NCT00510484|13044183|P1|COMPLETED|Period 2||16
5305848|NCT00510484|13044182|P2|STARTED|Period 2||15
5305849|NCT00510484|13044183|P1|STARTED|Period 2||16
5305850|NCT00510484|13044182|P2|NOT COMPLETED|Wash-out Period||1
5305851|NCT00510484|13044183|P1|NOT COMPLETED|Wash-out Period||0
5305852|NCT00510484|13044182|P2|COMPLETED|Wash-out Period||15
5305853|NCT00510484|13044183|P1|COMPLETED|Wash-out Period||16
5305854|NCT00510484|13044182|P2|STARTED|Wash-out Period||16
5305855|NCT00510484|13044183|P1|STARTED|Wash-out Period||16
5305856|NCT00510484|13044182|P2|NOT COMPLETED|Period 1||0
5305857|NCT00510484|13044183|P1|NOT COMPLETED|Period 1||0
5305858|NCT00510484|13044182|P2|COMPLETED|Period 1||16
5305859|NCT00510484|13044183|P1|COMPLETED|Period 1||16
5305860|NCT00510484|13044182|P2|STARTED|Period 1||16
5305861|NCT00510484|13044183|P1|STARTED|Period 1||16
5305862|NCT00510458|13044203|P1|NOT COMPLETED|Overall Study||47
5305863|NCT00510458|13044203|P1|COMPLETED|Overall Study||27
5305864|NCT00510458|13044203|P1|STARTED|Overall Study||74
5305865|NCT00510289|13044216|P1|NOT COMPLETED|Overall Study||12
5305866|NCT00510289|13044216|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
5305867|NCT00510289|13044216|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
5305868|NCT00510289|13044216|P1|STARTED|Overall Study|All patients who consented|19
5305869|NCT00510276|13044226|P2|NOT COMPLETED|Extension Open-Label Phase||48
5305870|NCT00510276|13044227|P1|NOT COMPLETED|Extension Open-Label Phase||33
5305871|NCT00510276|13044226|P2|COMPLETED|Extension Open-Label Phase||81
5305872|NCT00510276|13044227|P1|COMPLETED|Extension Open-Label Phase||78
5305873|NCT00510276|13044226|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
5305874|NCT00510276|13044227|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
5305875|NCT00510276|13044226|P2|NOT COMPLETED|Acute Double-Blind Phase||95
5305876|NCT00510276|13044227|P1|NOT COMPLETED|Acute Double-Blind Phase||105
5305877|NCT00510276|13044226|P2|COMPLETED|Acute Double-Blind Phase||130
5305878|NCT00510276|13044227|P1|COMPLETED|Acute Double-Blind Phase||115
5305879|NCT00510276|13044226|P2|STARTED|Acute Double-Blind Phase||225
5305880|NCT00510276|13044227|P1|STARTED|Acute Double-Blind Phase||220
5305881|NCT00510224|13044312|P1|NOT COMPLETED|Overall Study||3
5305882|NCT00510224|13044312|P1|COMPLETED|Overall Study||10
5305883|NCT00510224|13044312|P1|STARTED|Overall Study||13
5305884|NCT00510198|13044321|P2|NOT COMPLETED|Overall Study||4
5305885|NCT00510198|13044322|P1|NOT COMPLETED|Overall Study||5
5305886|NCT00510198|13044321|P2|COMPLETED|Overall Study||54
5305887|NCT00510198|13044322|P1|COMPLETED|Overall Study||54
5305888|NCT00510198|13044321|P2|STARTED|Overall Study||58
5305889|NCT00510198|13044322|P1|STARTED|Overall Study||59
5305890|NCT00510146|13044336|P2|NOT COMPLETED|Open-Label Treatment||26
5305891|NCT00510146|13044337|P1|NOT COMPLETED|Open-Label Treatment||71
5305892|NCT00510146|13044336|P2|COMPLETED|Open-Label Treatment||96
5305893|NCT00510146|13044337|P1|COMPLETED|Open-Label Treatment||196
5305894|NCT00510146|13044336|P2|STARTED|Open-Label Treatment||122
5305895|NCT00510146|13044337|P1|STARTED|Open-Label Treatment||267
5305896|NCT00510146|13044336|P2|NOT COMPLETED|Double-Blind Treatment||49
5305897|NCT00510146|13044337|P1|NOT COMPLETED|Double-Blind Treatment||76
5305898|NCT00510146|13044336|P2|COMPLETED|Double-Blind Treatment||122
5305899|NCT00510146|13044337|P1|COMPLETED|Double-Blind Treatment||267
5305900|NCT00510146|13044336|P2|STARTED|Double-Blind Treatment||171
5305901|NCT00510146|13044337|P1|STARTED|Double-Blind Treatment||343
5305902|NCT00510068|13044426|P2|NOT COMPLETED|Open-label Period||0
5305903|NCT00510068|13044427|P1|NOT COMPLETED|Open-label Period||225
5305904|NCT00510068|13044426|P2|COMPLETED|Open-label Period||0
5305905|NCT00510068|13044427|P1|COMPLETED|Open-label Period||0
5305906|NCT00510068|13044426|P2|STARTED|Open-label Period||0
5305907|NCT00510068|13044427|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
5305908|NCT00510068|13044426|P2|NOT COMPLETED|Double-blind Period||203
5305909|NCT00510068|13044427|P1|NOT COMPLETED|Double-blind Period||207
5305910|NCT00510068|13044426|P2|COMPLETED|Double-blind Period||0
5305911|NCT00510068|13044427|P1|COMPLETED|Double-blind Period||0
5305912|NCT00510068|13044426|P2|Safety Population|Double-blind Period||203
5305913|NCT00510068|13044427|P1|Safety Population|Double-blind Period||204
5305914|NCT00510068|13044426|P2|STARTED|Double-blind Period||203
5305915|NCT00510068|13044427|P1|STARTED|Double-blind Period||207
5305916|NCT00509925|13044468|P2|NOT COMPLETED|Overall Study||1
5305917|NCT00509925|13044469|P1|NOT COMPLETED|Overall Study||0
5305918|NCT00509925|13044468|P2|COMPLETED|Overall Study||10
5305919|NCT00509925|13044469|P1|COMPLETED|Overall Study||12
5305920|NCT00509925|13044468|P2|STARTED|Overall Study||11
5305921|NCT00509925|13044469|P1|STARTED|Overall Study||12
5305922|NCT00509899|13044517|P8|NOT COMPLETED|Overall Study||1
5305923|NCT00509899|13044518|P7|NOT COMPLETED|Overall Study||1
5305924|NCT00509899|13044519|P6|NOT COMPLETED|Overall Study||10
5305925|NCT00509899|13044520|P5|NOT COMPLETED|Overall Study||5
5305926|NCT00509899|13044521|P4|NOT COMPLETED|Overall Study||4
5305927|NCT00509899|13044522|P3|NOT COMPLETED|Overall Study||20
5305928|NCT00509899|13044523|P2|NOT COMPLETED|Overall Study||9
5305929|NCT00509899|13044524|P1|NOT COMPLETED|Overall Study||16
5305930|NCT00509899|13044517|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
5305931|NCT00509899|13044518|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
5305932|NCT00509899|13044519|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
5305933|NCT00509899|13044520|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
5305934|NCT00509899|13044521|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
5305935|NCT00509899|13044522|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
5305936|NCT00509899|13044523|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
5305937|NCT00509899|13044524|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
5305938|NCT00509899|13044517|P8|STARTED|Overall Study||3
5305939|NCT00509899|13044518|P7|STARTED|Overall Study||6
5305940|NCT00509899|13044519|P6|STARTED|Overall Study||22
5305941|NCT00509899|13044520|P5|STARTED|Overall Study||6
5305942|NCT00509899|13044521|P4|STARTED|Overall Study||5
5305943|NCT00509899|13044522|P3|STARTED|Overall Study||47
5305944|NCT00509899|13044523|P2|STARTED|Overall Study||35
5305945|NCT00509899|13044524|P1|STARTED|Overall Study||30
5305946|NCT00509873|13044564|P2|NOT COMPLETED|Overall Study||15
5305947|NCT00509873|13044565|P1|NOT COMPLETED|Overall Study||11
5305948|NCT00509873|13044564|P2|COMPLETED|Overall Study||276
5305949|NCT00509873|13044565|P1|COMPLETED|Overall Study||276
5305950|NCT00509873|13044564|P2|STARTED|Overall Study||291
5305951|NCT00509873|13044565|P1|STARTED|Overall Study||287
5305952|NCT00509821|13044581|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
5305953|NCT00509821|13044582|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
5305954|NCT00509821|13044581|P2|COMPLETED|Study Period 4 (Follow Up)||50
5305955|NCT00509821|13044582|P1|COMPLETED|Study Period 4 (Follow Up)||2
5305956|NCT00509821|13044581|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
5305957|NCT00509821|13044582|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
5305958|NCT00509821|13044581|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
5305959|NCT00509821|13044582|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
5305960|NCT00509821|13044581|P2|COMPLETED|Study Period 3 (Maintenance)||0
5305961|NCT00509821|13044582|P1|COMPLETED|Study Period 3 (Maintenance)||3
5305962|NCT00509821|13044581|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
5305963|NCT00509821|13044582|P1|STARTED|Study Period 3 (Maintenance)||3
5305964|NCT00509821|13044581|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
5305965|NCT00509821|13044582|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
5305966|NCT00509821|13044581|P2|COMPLETED|Study Period 2 (Radiation)||0
5305967|NCT00509821|13044582|P1|COMPLETED|Study Period 2 (Radiation)||3
5305968|NCT00509821|13044581|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
5305969|NCT00509821|13044582|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
5305970|NCT00509821|13044581|P2|NOT COMPLETED|Study Period 1 (Induction)||4
5305971|NCT00509821|13044582|P1|NOT COMPLETED|Study Period 1 (Induction)||0
5305972|NCT00509821|13044581|P2|COMPLETED|Study Period 1 (Induction)||53
5305973|NCT00509821|13044582|P1|COMPLETED|Study Period 1 (Induction)||3
5305974|NCT00509821|13044581|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
5305975|NCT00509821|13044582|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
5305976|NCT00509821|13044581|P2|STARTED|Study Period 1 (Induction)||57
5305977|NCT00509821|13044582|P1|STARTED|Study Period 1 (Induction)||3
5305978|NCT00509795|13044600|P4|NOT COMPLETED|Overall Study||27
5305979|NCT00509795|13044601|P3|NOT COMPLETED|Overall Study||27
5305980|NCT00509795|13044602|P2|NOT COMPLETED|Overall Study||11
5305981|NCT00509795|13044603|P1|NOT COMPLETED|Overall Study||22
5305982|NCT00509795|13044600|P4|COMPLETED|Overall Study||276
5305983|NCT00509795|13044601|P3|COMPLETED|Overall Study||277
5305984|NCT00509795|13044602|P2|COMPLETED|Overall Study||293
5305985|NCT00509795|13044603|P1|COMPLETED|Overall Study||284
5305986|NCT00509795|13044600|P4|Per Protocol Set (PPS) Population|Overall Study||265
5305987|NCT00509795|13044601|P3|Per Protocol Set (PPS) Population|Overall Study||270
5305988|NCT00509795|13044602|P2|Per Protocol Set (PPS) Population|Overall Study||285
5305989|NCT00509795|13044603|P1|Per Protocol Set (PPS) Population|Overall Study||269
5305990|NCT00509795|13044600|P4|Full Analysis Set (FAS) Population|Overall Study||301
5305991|NCT00509795|13044601|P3|Full Analysis Set (FAS) Population|Overall Study||301
5305992|NCT00509795|13044602|P2|Full Analysis Set (FAS) Population|Overall Study||304
5305993|NCT00509795|13044603|P1|Full Analysis Set (FAS) Population|Overall Study||304
5305994|NCT00509795|13044600|P4|Patients Received Treatment (SAF)|Overall Study||303
5305995|NCT00509795|13044601|P3|Patients Received Treatment (SAF)|Overall Study||304
5305996|NCT00509795|13044602|P2|Patients Received Treatment (SAF)|Overall Study||304
5305997|NCT00509795|13044603|P1|Patients Received Treatment (SAF)|Overall Study||304
5305998|NCT00509795|13044600|P4|STARTED|Overall Study||303
5305999|NCT00509795|13044601|P3|STARTED|Overall Study||304
5306000|NCT00509795|13044602|P2|STARTED|Overall Study||304
5306001|NCT00509795|13044603|P1|STARTED|Overall Study||306
5306002|NCT00509769|13044634|P1|NOT COMPLETED|Overall Study||91
5306003|NCT00509769|13044634|P1|COMPLETED|Overall Study||21
5306004|NCT00509769|13044634|P1|STARTED|Overall Study||112
5306005|NCT00509665|13044643|P1|NOT COMPLETED|Overall Study||0
5306006|NCT00509665|13044643|P1|COMPLETED|Overall Study||18
5306007|NCT00509665|13044643|P1|STARTED|Overall Study||18
5306008|NCT00509600|13044653|P1|NOT COMPLETED|Overall Study||1
5306009|NCT00509600|13044653|P1|COMPLETED|Overall Study||0
5306010|NCT00509600|13044653|P1|STARTED|Overall Study||1
5306011|NCT00509587|13044657|P1|NOT COMPLETED|Overall Study||0
5306012|NCT00509587|13044657|P1|COMPLETED|Overall Study||21
5306013|NCT00509587|13044657|P1|STARTED|Overall Study||21
5306014|NCT00509496|13044668|P2|NOT COMPLETED|Overall Study||0
5306015|NCT00509496|13044669|P1|NOT COMPLETED|Overall Study||0
5306016|NCT00509496|13044668|P2|COMPLETED|Overall Study||2
5306017|NCT00509496|13044669|P1|COMPLETED|Overall Study||19
5306018|NCT00509496|13044668|P2|STARTED|Overall Study||2
5306019|NCT00509496|13044669|P1|STARTED|Overall Study||19
5306020|NCT00509392|13044679|P3|NOT COMPLETED|Overall Study||0
5306021|NCT00509392|13044680|P2|NOT COMPLETED|Overall Study||0
5306022|NCT00509392|13044681|P1|NOT COMPLETED|Overall Study||0
5306023|NCT00509392|13044679|P3|COMPLETED|Overall Study||4
5306024|NCT00509392|13044680|P2|COMPLETED|Overall Study||33
5306025|NCT00509392|13044681|P1|COMPLETED|Overall Study||32
5306026|NCT00509392|13044679|P3|STARTED|Overall Study||4
5306027|NCT00509392|13044680|P2|STARTED|Overall Study||33
5306028|NCT00509392|13044681|P1|STARTED|Overall Study||32
5306029|NCT00509366|13044732|P5|NOT COMPLETED|Overall Study||0
5306030|NCT00509366|13044733|P4|NOT COMPLETED|Overall Study||0
5306031|NCT00509366|13044734|P3|NOT COMPLETED|Overall Study||1
5306032|NCT00509366|13044735|P2|NOT COMPLETED|Overall Study||1
5306033|NCT00509366|13044736|P1|NOT COMPLETED|Overall Study||1
5306034|NCT00509366|13044732|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
5306035|NCT00509366|13044733|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
5306036|NCT00509366|13044734|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
5306037|NCT00509366|13044735|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
5306038|NCT00509366|13044736|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
5306039|NCT00509366|13044732|P5|Assigned Treatment|Overall Study||0
5306040|NCT00509366|13044733|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
5306041|NCT00509366|13044734|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
5306042|NCT00509366|13044735|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
5306043|NCT00509366|13044736|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
5306044|NCT00509366|13044732|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
5306045|NCT00509366|13044733|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
5306046|NCT00509366|13044734|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
5306047|NCT00509366|13044735|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
5306048|NCT00509366|13044736|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
5306049|NCT00509288|13044749|P2|NOT COMPLETED|Overall Study||0
5306050|NCT00509288|13044750|P1|NOT COMPLETED|Overall Study||0
5306051|NCT00509288|13044749|P2|COMPLETED|Overall Study||3
5306052|NCT00509288|13044750|P1|COMPLETED|Overall Study||21
5306053|NCT00509288|13044749|P2|STARTED|Overall Study||3
5306054|NCT00509288|13044750|P1|STARTED|Overall Study||21
5306055|NCT00509262|13044760|P2|NOT COMPLETED|Overall Study||42
5306056|NCT00509262|13044761|P1|NOT COMPLETED|Overall Study||47
5306057|NCT00509262|13044760|P2|COMPLETED|Overall Study||170
5306058|NCT00509262|13044761|P1|COMPLETED|Overall Study||164
5306059|NCT00509262|13044760|P2|STARTED|Overall Study||212
5306060|NCT00509262|13044761|P1|STARTED|Overall Study||211
5306061|NCT00509249|13044773|P1|NOT COMPLETED|Overall Study||0
5306062|NCT00509249|13044773|P1|COMPLETED|Overall Study||18
5306063|NCT00509249|13044773|P1|STARTED|Overall Study||18
5306064|NCT00509236|13044779|P2|NOT COMPLETED|Overall Study||20
5306065|NCT00509236|13044780|P1|NOT COMPLETED|Overall Study||17
5306066|NCT00509236|13044779|P2|COMPLETED|Overall Study||45
5306067|NCT00509236|13044780|P1|COMPLETED|Overall Study||47
5306068|NCT00509236|13044779|P2|STARTED|Overall Study||65
5306069|NCT00509236|13044780|P1|STARTED|Overall Study||64
5306070|NCT00509223|13044795|P2|NOT COMPLETED|Overall Study||72
5306071|NCT00509223|13044796|P1|NOT COMPLETED|Overall Study||88
5306072|NCT00509223|13044795|P2|COMPLETED|Overall Study||137
5306073|NCT00509223|13044796|P1|COMPLETED|Overall Study||119
5306074|NCT00509223|13044795|P2|STARTED|Overall Study||209
5306075|NCT00509223|13044796|P1|STARTED|Overall Study||207
5306076|NCT00509197|13044804|P2|NOT COMPLETED|Overall Study||0
5306077|NCT00509197|13044805|P1|NOT COMPLETED|Overall Study||0
5306078|NCT00509197|13044804|P2|COMPLETED|Overall Study||6
5306079|NCT00509197|13044805|P1|COMPLETED|Overall Study||6
5306080|NCT00509197|13044804|P2|STARTED|Overall Study||6
5306081|NCT00509197|13044805|P1|STARTED|Overall Study||6
5306082|NCT00509171|13044819|P2|NOT COMPLETED|Overall Study||0
5306083|NCT00509171|13044820|P1|NOT COMPLETED|Overall Study||0
5306084|NCT00509171|13044819|P2|COMPLETED|Overall Study||11
5306085|NCT00509171|13044820|P1|COMPLETED|Overall Study||11
5306086|NCT00509171|13044819|P2|STARTED|Overall Study||11
5306087|NCT00509171|13044820|P1|STARTED|Overall Study||11
5306088|NCT00509106|13044828|P2|NOT COMPLETED|Overall Study||29
5306089|NCT00509106|13044829|P1|NOT COMPLETED|Overall Study||31
5306090|NCT00509106|13044828|P2|COMPLETED|Overall Study||278
5306091|NCT00509106|13044829|P1|COMPLETED|Overall Study||284
5306092|NCT00509106|13044828|P2|STARTED|Overall Study||307
5306093|NCT00509106|13044829|P1|STARTED|Overall Study||315
5306094|NCT00509093|13044835|P1|NOT COMPLETED|Overall Study||24
5306095|NCT00509093|13044835|P1|COMPLETED|Overall Study||8
5306096|NCT00509093|13044835|P1|STARTED|Overall Study||32
5306097|NCT00509067|13044845|P2|NOT COMPLETED|Overall Study||5
5306098|NCT00509067|13044846|P1|NOT COMPLETED|Overall Study||4
5306099|NCT00509067|13044845|P2|COMPLETED|Overall Study||19
5306100|NCT00509067|13044846|P1|COMPLETED|Overall Study||15
5306101|NCT00509067|13044845|P2|STARTED|Overall Study||24
5306102|NCT00509067|13044846|P1|STARTED|Overall Study||19
5306103|NCT00509041|13044856|P1|NOT COMPLETED|Overall Study||0
5306104|NCT00509041|13044856|P1|COMPLETED|Overall Study||43
5306105|NCT00509041|13044856|P1|STARTED|Overall Study||43
5306106|NCT00509028|13044865|P2|NOT COMPLETED|Overall Study||7
5306107|NCT00509028|13044866|P1|NOT COMPLETED|Overall Study||12
5306108|NCT00509028|13044865|P2|COMPLETED|Overall Study||113
5306109|NCT00509028|13044866|P1|COMPLETED|Overall Study||109
5306110|NCT00509028|13044865|P2|STARTED|Overall Study||120
5306111|NCT00509028|13044866|P1|STARTED|Overall Study||121
5306112|NCT00509002|13044898|P1|NOT COMPLETED|Overall Study||0
5306113|NCT00509002|13044898|P1|COMPLETED|Overall Study||37
5306114|NCT00509002|13044898|P1|STARTED|Overall Study||37
5306115|NCT00508924|13044906|P4|NOT COMPLETED|Overall Study||1
5306116|NCT00508924|13044907|P3|NOT COMPLETED|Overall Study||1
5306117|NCT00508924|13044908|P2|NOT COMPLETED|Overall Study||0
5306118|NCT00508924|13044909|P1|NOT COMPLETED|Overall Study||0
5306119|NCT00508924|13044906|P4|COMPLETED|Overall Study||33
5306120|NCT00508924|13044907|P3|COMPLETED|Overall Study||31
5306121|NCT00508924|13044908|P2|COMPLETED|Overall Study||38
5306122|NCT00508924|13044909|P1|COMPLETED|Overall Study||36
5306123|NCT00508924|13044906|P4|STARTED|Overall Study||34
5306124|NCT00508924|13044907|P3|STARTED|Overall Study||32
5306125|NCT00508924|13044908|P2|STARTED|Overall Study||38
5306126|NCT00508924|13044909|P1|STARTED|Overall Study||36
5306127|NCT00508872|13044923|P1|NOT COMPLETED|Overall Study||2
5306128|NCT00508872|13044923|P1|COMPLETED|Overall Study||0
5306129|NCT00508872|13044923|P1|STARTED|Overall Study||2
5306130|NCT00508820|13044929|P2|NOT COMPLETED|Overall Study||64
5306131|NCT00508820|13044930|P1|NOT COMPLETED|Overall Study||55
5306132|NCT00508820|13044929|P2|COMPLETED|Overall Study||175
5306133|NCT00508820|13044930|P1|COMPLETED|Overall Study||113
5306134|NCT00508820|13044929|P2|STARTED|Overall Study||239
5306135|NCT00508820|13044930|P1|STARTED|Overall Study||168
5306136|NCT00508755|13044940|P1|NOT COMPLETED|Overall Study||1
5306137|NCT00508755|13044940|P1|COMPLETED|Overall Study||5
5306138|NCT00508755|13044940|P1|STARTED|Overall Study||6
5306139|NCT00508742|13044948|P2|NOT COMPLETED|Period 3: Toddler Dose||15
5306140|NCT00508742|13044949|P1|NOT COMPLETED|Period 3: Toddler Dose||25
5306141|NCT00508742|13044948|P2|COMPLETED|Period 3: Toddler Dose||863
5306142|NCT00508742|13044949|P1|COMPLETED|Period 3: Toddler Dose||858
5306143|NCT00508742|13044948|P2|STARTED|Period 3: Toddler Dose||878
5306144|NCT00508742|13044949|P1|STARTED|Period 3: Toddler Dose||883
5306145|NCT00508742|13044948|P2|NOT COMPLETED|Period 2: After Infant Series||11
5306146|NCT00508742|13044949|P1|NOT COMPLETED|Period 2: After Infant Series||7
5306147|NCT00508742|13044948|P2|COMPLETED|Period 2: After Infant Series||878
5306148|NCT00508742|13044949|P1|COMPLETED|Period 2: After Infant Series||883
5306149|NCT00508742|13044948|P2|STARTED|Period 2: After Infant Series||889
5306150|NCT00508742|13044949|P1|STARTED|Period 2: After Infant Series||890
5306151|NCT00508742|13044948|P2|NOT COMPLETED|Period 1: Infant Series||45
5306152|NCT00508742|13044949|P1|NOT COMPLETED|Period 1: Infant Series||42
5306153|NCT00508742|13044948|P2|COMPLETED|Period 1: Infant Series||889
5306154|NCT00508742|13044949|P1|COMPLETED|Period 1: Infant Series||890
5306155|NCT00508742|13044948|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
5306156|NCT00508742|13044949|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
5306157|NCT00508742|13044948|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
5306158|NCT00508742|13044949|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
5306159|NCT00508742|13044948|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
5306160|NCT00508742|13044949|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
5306161|NCT00508742|13044948|P2|STARTED|Period 1: Infant Series||934
5306162|NCT00508742|13044949|P1|STARTED|Period 1: Infant Series||932
5306163|NCT00508716|13044965|P2|NOT COMPLETED|Overall Study||0
5306164|NCT00508716|13044966|P1|NOT COMPLETED|Overall Study||0
5306165|NCT00508716|13044965|P2|COMPLETED|Overall Study||63
5306166|NCT00508716|13044966|P1|COMPLETED|Overall Study||61
5306167|NCT00508716|13044965|P2|STARTED|Overall Study||63
5306168|NCT00508716|13044966|P1|STARTED|Overall Study||61
5306169|NCT00508651|13044974|P2|NOT COMPLETED|Overall Study||2
5306170|NCT00508651|13044975|P1|NOT COMPLETED|Overall Study||4
5306171|NCT00508651|13044974|P2|COMPLETED|Overall Study||8
5306172|NCT00508651|13044975|P1|COMPLETED|Overall Study||16
5306173|NCT00508651|13044974|P2|STARTED|Overall Study||10
5306174|NCT00508651|13044975|P1|STARTED|Overall Study||20
5306175|NCT00508521|13045049|P1|NOT COMPLETED|Overall Study||0
5306176|NCT00508521|13045049|P1|COMPLETED|Overall Study||4
5306177|NCT00508521|13045049|P1|STARTED|Overall Study||4
5306178|NCT00508482|13045056|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
5306179|NCT00508482|13045057|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
5306180|NCT00508482|13045058|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
5306181|NCT00508482|13045056|P3|COMPLETED|at the 12th Week of Follow-up||98
5306182|NCT00508482|13045057|P2|COMPLETED|at the 12th Week of Follow-up||96
5306183|NCT00508482|13045058|P1|COMPLETED|at the 12th Week of Follow-up||196
5306184|NCT00508482|13045056|P3|STARTED|at the 12th Week of Follow-up||98
5306185|NCT00508482|13045057|P2|STARTED|at the 12th Week of Follow-up||96
5306186|NCT00508482|13045058|P1|STARTED|at the 12th Week of Follow-up||196
5306187|NCT00508482|13045056|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
5306188|NCT00508482|13045057|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
5306189|NCT00508482|13045058|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
5306190|NCT00508482|13045056|P3|COMPLETED|at the 4th Week of Follow-up||98
5306191|NCT00508482|13045057|P2|COMPLETED|at the 4th Week of Follow-up||96
5306192|NCT00508482|13045058|P1|COMPLETED|at the 4th Week of Follow-up||196
5306193|NCT00508482|13045056|P3|STARTED|at the 4th Week of Follow-up||99
5306194|NCT00508482|13045057|P2|STARTED|at the 4th Week of Follow-up||102
5306195|NCT00508482|13045058|P1|STARTED|at the 4th Week of Follow-up||216
5306196|NCT00508482|13045056|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
5306197|NCT00508482|13045057|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
5306198|NCT00508482|13045058|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
5306199|NCT00508482|13045056|P3|COMPLETED|Over 4 Weeks of Treatment||99
5306200|NCT00508482|13045057|P2|COMPLETED|Over 4 Weeks of Treatment||102
5306201|NCT00508482|13045058|P1|COMPLETED|Over 4 Weeks of Treatment||216
5306202|NCT00508482|13045056|P3|STARTED|Over 4 Weeks of Treatment||119
5306203|NCT00508482|13045057|P2|STARTED|Over 4 Weeks of Treatment||119
5306204|NCT00508482|13045058|P1|STARTED|Over 4 Weeks of Treatment||237
5306205|NCT00508469|13045095|P2|NOT COMPLETED|Overall Study||10
5306206|NCT00508469|13045096|P1|NOT COMPLETED|Overall Study||17
5306207|NCT00508469|13045095|P2|COMPLETED|Overall Study||40
5306208|NCT00508469|13045096|P1|COMPLETED|Overall Study||35
5306209|NCT00508469|13045095|P2|STARTED|Overall Study||50
5306210|NCT00508469|13045096|P1|STARTED|Overall Study||52
5306211|NCT00508404|13045102|P1|NOT COMPLETED|Overall Study||42
5306212|NCT00508404|13045102|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
5306213|NCT00508404|13045102|P1|STARTED|Overall Study||154
5306214|NCT00508391|13045129|P2|NOT COMPLETED|Second Treatment||0
5306215|NCT00508391|13045130|P1|NOT COMPLETED|Second Treatment||2
5306216|NCT00508391|13045129|P2|COMPLETED|Second Treatment||59
5306217|NCT00508391|13045130|P1|COMPLETED|Second Treatment||52
5306218|NCT00508391|13045129|P2|STARTED|Second Treatment||59
5306219|NCT00508391|13045130|P1|STARTED|Second Treatment||54
5306220|NCT00508391|13045129|P2|NOT COMPLETED|First Treatment||3
5306221|NCT00508391|13045130|P1|NOT COMPLETED|First Treatment||6
5306222|NCT00508391|13045129|P2|COMPLETED|First Treatment||59
5306223|NCT00508391|13045130|P1|COMPLETED|First Treatment||54
5306224|NCT00508391|13045129|P2|STARTED|First Treatment||62
5306225|NCT00508391|13045130|P1|STARTED|First Treatment||60
5306226|NCT00508300|13045143|P2|NOT COMPLETED|Overall Study||4
5306227|NCT00508300|13045144|P1|NOT COMPLETED|Overall Study||2
5306228|NCT00508300|13045143|P2|COMPLETED|Overall Study||57
5306229|NCT00508300|13045144|P1|COMPLETED|Overall Study||65
5306230|NCT00508300|13045143|P2|STARTED|Overall Study||61
5306231|NCT00508300|13045144|P1|STARTED|Overall Study||67
5306232|NCT00508274|13045150|P1|NOT COMPLETED|Overall Study||2
5306233|NCT00508274|13045150|P1|COMPLETED|Overall Study||50
5306234|NCT00508274|13045150|P1|STARTED|Overall Study||52
5306235|NCT00508261|13045163|P4|NOT COMPLETED|Overall Study||1
5306236|NCT00508261|13045164|P3|NOT COMPLETED|Overall Study||6
5306237|NCT00508261|13045165|P2|NOT COMPLETED|Overall Study||8
5306238|NCT00508261|13045166|P1|NOT COMPLETED|Overall Study||3
5306239|NCT00508261|13045163|P4|COMPLETED|Overall Study||126
5306240|NCT00508261|13045164|P3|COMPLETED|Overall Study||218
5306241|NCT00508261|13045165|P2|COMPLETED|Overall Study||212
5306242|NCT00508261|13045166|P1|COMPLETED|Overall Study||219
5306243|NCT00508261|13045163|P4|STARTED|Overall Study||127
5306244|NCT00508261|13045164|P3|STARTED|Overall Study||224
5306245|NCT00508261|13045165|P2|STARTED|Overall Study||220
5306246|NCT00508261|13045166|P1|STARTED|Overall Study||222
5306247|NCT00508196|13045276|P2|NOT COMPLETED|Overall Study||0
5306248|NCT00508196|13045277|P1|NOT COMPLETED|Overall Study||0
5306249|NCT00508196|13045276|P2|COMPLETED|Overall Study||11
5306250|NCT00508196|13045277|P1|COMPLETED|Overall Study||11
5306251|NCT00508196|13045276|P2|STARTED|Overall Study||11
5306252|NCT00508196|13045277|P1|STARTED|Overall Study||11
5306253|NCT00508183|13045289|P2|NOT COMPLETED|Overall Study||8
5306254|NCT00508183|13045290|P1|NOT COMPLETED|Overall Study||9
5306255|NCT00508183|13045289|P2|COMPLETED|Overall Study||34
5306256|NCT00508183|13045290|P1|COMPLETED|Overall Study||39
5306257|NCT00508183|13045289|P2|STARTED|Overall Study||42
5306258|NCT00508183|13045290|P1|STARTED|Overall Study||48
5306259|NCT00508157|13045306|P2|NOT COMPLETED|Overall Study||3
5306260|NCT00508157|13045307|P1|NOT COMPLETED|Overall Study||2
5306261|NCT00508157|13045306|P2|COMPLETED|Overall Study||23
5306262|NCT00508157|13045307|P1|COMPLETED|Overall Study||24
5306263|NCT00508157|13045306|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
5306264|NCT00508157|13045307|P1|Safety Sample|Overall Study||26
5306265|NCT00508157|13045306|P2|Randomized Sample|Overall Study||26
5306266|NCT00508157|13045307|P1|Randomized Sample|Overall Study||26
5306267|NCT00508157|13045306|P2|STARTED|Overall Study||26
5306268|NCT00508157|13045307|P1|STARTED|Overall Study||26
5306269|NCT00508144|13045329|P1|NOT COMPLETED|Overall Study||11
5306270|NCT00508144|13045329|P1|COMPLETED|Overall Study||53
5306271|NCT00508144|13045329|P1|STARTED|Overall Study||64
5306272|NCT00508118|13045335|P2|NOT COMPLETED|Overall Study||0
5306273|NCT00508118|13045336|P1|NOT COMPLETED|Overall Study||0
5306274|NCT00508118|13045335|P2|COMPLETED|Overall Study||4
5306275|NCT00508118|13045336|P1|COMPLETED|Overall Study||3
5306276|NCT00508118|13045335|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
5306277|NCT00508118|13045336|P1|STARTED|Overall Study||3
5306278|NCT00508105|13045357|P2|NOT COMPLETED|Overall Study||6
5306279|NCT00508105|13045358|P1|NOT COMPLETED|Overall Study||4
5306280|NCT00508105|13045357|P2|COMPLETED|Overall Study||37
5306281|NCT00508105|13045358|P1|COMPLETED|Overall Study||40
5306282|NCT00508105|13045357|P2|STARTED|Overall Study||43
5306283|NCT00508105|13045358|P1|STARTED|Overall Study||44
5306284|NCT00508027|13045368|P1|NOT COMPLETED|Dose Level 3||0
5306285|NCT00508027|13045368|P1|COMPLETED|Dose Level 3||2
5306286|NCT00508027|13045368|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
5306287|NCT00508027|13045368|P1|NOT COMPLETED|Dose Level 2||4
5306288|NCT00508027|13045368|P1|COMPLETED|Dose Level 2||16
5306289|NCT00508027|13045368|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
5306290|NCT00508027|13045368|P1|NOT COMPLETED|Dose Level 1||8
5306291|NCT00508027|13045368|P1|COMPLETED|Dose Level 1||12
5306292|NCT00508027|13045368|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
5306293|NCT00508001|13045409|P3|NOT COMPLETED|Overall Study||7
5306294|NCT00508001|13045410|P2|NOT COMPLETED|Overall Study||12
5306295|NCT00508001|13045411|P1|NOT COMPLETED|Overall Study||19
5306296|NCT00508001|13045409|P3|COMPLETED|Overall Study||16
5306297|NCT00508001|13045410|P2|COMPLETED|Overall Study||13
5306298|NCT00508001|13045411|P1|COMPLETED|Overall Study||0
5306299|NCT00508001|13045409|P3|Secondary Treatment Phase|Overall Study||16
5306300|NCT00508001|13045410|P2|Secondary Treatment Phase|Overall Study||13
5306301|NCT00508001|13045411|P1|Secondary Treatment Phase|Overall Study||0
5306302|NCT00508001|13045409|P3|STARTED|Overall Study||23
5306303|NCT00508001|13045410|P2|STARTED|Overall Study||25
5306304|NCT00508001|13045411|P1|STARTED|Overall Study||19
5306305|NCT00507819|13045428|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5306306|NCT00507819|13045429|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5306307|NCT00507819|13045428|P2|COMPLETED|Second Intervention (6 Weeks)||14
5306308|NCT00507819|13045429|P1|COMPLETED|Second Intervention (6 Weeks)||13
5306309|NCT00507819|13045428|P2|STARTED|Second Intervention (6 Weeks)||14
5306310|NCT00507819|13045429|P1|STARTED|Second Intervention (6 Weeks)||13
5306311|NCT00507819|13045428|P2|NOT COMPLETED|Washout (6 Weeks)||0
5306312|NCT00507819|13045429|P1|NOT COMPLETED|Washout (6 Weeks)||1
5306313|NCT00507819|13045428|P2|COMPLETED|Washout (6 Weeks)||14
5306314|NCT00507819|13045429|P1|COMPLETED|Washout (6 Weeks)||13
5306315|NCT00507819|13045428|P2|STARTED|Washout (6 Weeks)||14
5306316|NCT00507819|13045429|P1|STARTED|Washout (6 Weeks)||14
5306317|NCT00507819|13045428|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
5306318|NCT00507819|13045429|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5306319|NCT00507819|13045428|P2|COMPLETED|First Intervention (6 Weeks)||14
5306320|NCT00507819|13045429|P1|COMPLETED|First Intervention (6 Weeks)||14
5306321|NCT00507819|13045428|P2|STARTED|First Intervention (6 Weeks)||14
5306322|NCT00507819|13045429|P1|STARTED|First Intervention (6 Weeks)||14
5306323|NCT00507767|13045441|P1|NOT COMPLETED|Overall Study||0
5306324|NCT00507767|13045441|P1|COMPLETED|Overall Study||15
5306325|NCT00507767|13045441|P1|STARTED|Overall Study||15
5306326|NCT00507689|13045448|P2|NOT COMPLETED|Randomized Period||2
5306327|NCT00507689|13045449|P1|NOT COMPLETED|Randomized Period||1
5306328|NCT00507689|13045448|P2|COMPLETED|Randomized Period||16
5306329|NCT00507689|13045449|P1|COMPLETED|Randomized Period||18
5306330|NCT00507689|13045448|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
5306331|NCT00507689|13045449|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
5306332|NCT00507689|13045448|P2|NOT COMPLETED|Pre-Randomization Period||0
5306333|NCT00507689|13045449|P1|NOT COMPLETED|Pre-Randomization Period||3
5306334|NCT00507689|13045448|P2|COMPLETED|Pre-Randomization Period||0
5306335|NCT00507689|13045449|P1|COMPLETED|Pre-Randomization Period||37
5306336|NCT00507689|13045448|P2|STARTED|Pre-Randomization Period||0
5306337|NCT00507689|13045449|P1|STARTED|Pre-Randomization Period||40
5306338|NCT00507559|13045466|P1|NOT COMPLETED|Overall Study||71
5306339|NCT00507559|13045466|P1|COMPLETED|Overall Study||84
5306340|NCT00507559|13045466|P1|STARTED|Overall Study||155
5306341|NCT00507546|13045481|P2|NOT COMPLETED|Overall Study||1
5306342|NCT00507546|13045482|P1|NOT COMPLETED|Overall Study||2
5306343|NCT00507546|13045481|P2|COMPLETED|Overall Study||3
5306344|NCT00507546|13045482|P1|COMPLETED|Overall Study||2
5306345|NCT00507546|13045481|P2|STARTED|Overall Study||4
5306346|NCT00507546|13045482|P1|STARTED|Overall Study||4
5306347|NCT00507507|13045492|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
5306348|NCT00507507|13045493|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
5306349|NCT00507507|13045492|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
5306350|NCT00507507|13045493|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
5306351|NCT00507507|13045492|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
5306352|NCT00507507|13045493|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
5306353|NCT00507507|13045492|P2|NOT COMPLETED|Treatment Period||53
5306354|NCT00507507|13045493|P1|NOT COMPLETED|Treatment Period||52
5306355|NCT00507507|13045492|P2|COMPLETED|Treatment Period||9
5306356|NCT00507507|13045493|P1|COMPLETED|Treatment Period||12
5306357|NCT00507507|13045492|P2|Completed 192 Weeks of Treatment|Treatment Period||52
5306358|NCT00507507|13045493|P1|Completed 192 Weeks of Treatment|Treatment Period||52
5306359|NCT00507507|13045492|P2|STARTED|Treatment Period||62
5306360|NCT00507507|13045493|P1|STARTED|Treatment Period||64
5306361|NCT00507455|13045528|P3|NOT COMPLETED|Overall Study||12
5306362|NCT00507455|13045529|P2|NOT COMPLETED|Overall Study||6
5306363|NCT00507455|13045530|P1|NOT COMPLETED|Overall Study||12
5306364|NCT00507455|13045528|P3|COMPLETED|Overall Study||62
5306365|NCT00507455|13045529|P2|COMPLETED|Overall Study||68
5306366|NCT00507455|13045530|P1|COMPLETED|Overall Study||62
5306367|NCT00507455|13045528|P3|STARTED|Overall Study||74
5306368|NCT00507455|13045529|P2|STARTED|Overall Study||74
5306369|NCT00507455|13045530|P1|STARTED|Overall Study||74
5306370|NCT00507442|13045593|P4|NOT COMPLETED|Overall Study||5
5306371|NCT00507442|13045594|P3|NOT COMPLETED|Overall Study||15
5306372|NCT00507442|13045595|P2|NOT COMPLETED|Overall Study||27
5306373|NCT00507442|13045596|P1|NOT COMPLETED|Overall Study||16
5306374|NCT00507442|13045593|P4|COMPLETED|Overall Study||12
5306375|NCT00507442|13045594|P3|COMPLETED|Overall Study||18
5306376|NCT00507442|13045595|P2|COMPLETED|Overall Study||39
5306377|NCT00507442|13045596|P1|COMPLETED|Overall Study||26
5306378|NCT00507442|13045593|P4|STARTED|Overall Study||17
5306379|NCT00507442|13045594|P3|STARTED|Overall Study||33
5306380|NCT00507442|13045595|P2|STARTED|Overall Study||66
5306381|NCT00507442|13045596|P1|STARTED|Overall Study||42
5306382|NCT00507429|13045648|P2|NOT COMPLETED|Maintenance Phase||0
5306383|NCT00507429|13045649|P1|NOT COMPLETED|Maintenance Phase||14
5306384|NCT00507429|13045648|P2|COMPLETED|Maintenance Phase||0
5306385|NCT00507429|13045649|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
5306386|NCT00507429|13045648|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
5306387|NCT00507429|13045649|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
5306388|NCT00507429|13045648|P2|NOT COMPLETED|Treatment Phase||18
5306389|NCT00507429|13045649|P1|NOT COMPLETED|Treatment Phase||37
5306390|NCT00507429|13045648|P2|COMPLETED|Treatment Phase||7
5306391|NCT00507429|13045649|P1|COMPLETED|Treatment Phase||18
5306392|NCT00507429|13045648|P2|STARTED|Treatment Phase|Randomized|25
5306393|NCT00507429|13045649|P1|STARTED|Treatment Phase|Randomized|55
5306394|NCT00507416|13045660|P3|NOT COMPLETED|Overall Study||114
5306395|NCT00507416|13045661|P2|NOT COMPLETED|Overall Study||125
5306396|NCT00507416|13045662|P1|NOT COMPLETED|Overall Study||118
5306397|NCT00507416|13045660|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
5306398|NCT00507416|13045661|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
5306399|NCT00507416|13045662|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
5306400|NCT00507416|13045660|P3|Completed 8 Treatment Cycles|Overall Study||69
5306401|NCT00507416|13045661|P2|Completed 8 Treatment Cycles|Overall Study||60
5306402|NCT00507416|13045662|P1|Completed 8 Treatment Cycles|Overall Study||82
5306403|NCT00507416|13045660|P3|Treated (Safety Population)|Overall Study||163
5306404|NCT00507416|13045661|P2|Treated (Safety Population)|Overall Study||158
5306405|NCT00507416|13045662|P1|Treated (Safety Population)|Overall Study||165
5306406|NCT00507416|13045660|P3|STARTED|Overall Study||167
5306407|NCT00507416|13045661|P2|STARTED|Overall Study||167
5306408|NCT00507416|13045662|P1|STARTED|Overall Study||168
5306409|NCT00507208|13045693|P2|NOT COMPLETED|Overall Study||0
5306410|NCT00507208|13045694|P1|NOT COMPLETED|Overall Study||0
5306411|NCT00507208|13045693|P2|COMPLETED|Overall Study||26
5306412|NCT00507208|13045694|P1|COMPLETED|Overall Study||27
5306413|NCT00507208|13045693|P2|Received Dynasplint in Crossover|Overall Study||3
5306414|NCT00507208|13045694|P1|Received Dynasplint in Crossover|Overall Study||0
5306415|NCT00507208|13045693|P2|STARTED|Overall Study||26
5306416|NCT00507208|13045694|P1|STARTED|Overall Study||27
5306417|NCT00507130|13045704|P4|NOT COMPLETED|Overall Study||1
5306418|NCT00507130|13045705|P3|NOT COMPLETED|Overall Study||1
5306419|NCT00507130|13045706|P2|NOT COMPLETED|Overall Study||0
5306420|NCT00507130|13045707|P1|NOT COMPLETED|Overall Study||1
5306421|NCT00507130|13045704|P4|COMPLETED|Overall Study||8
5306422|NCT00507130|13045705|P3|COMPLETED|Overall Study||8
5306423|NCT00507130|13045706|P2|COMPLETED|Overall Study||9
5306424|NCT00507130|13045707|P1|COMPLETED|Overall Study||8
5306425|NCT00507130|13045704|P4|STARTED|Overall Study||9
5306426|NCT00507130|13045705|P3|STARTED|Overall Study||9
5306427|NCT00507130|13045706|P2|STARTED|Overall Study||9
5306428|NCT00507130|13045707|P1|STARTED|Overall Study||9
5306429|NCT00506948|13045749|P1|NOT COMPLETED|Overall Study||10
5306430|NCT00506948|13045749|P1|COMPLETED|Overall Study||0
5306431|NCT00506948|13045749|P1|STARTED|Overall Study||10
5306432|NCT00506922|13045758|P5|NOT COMPLETED|Overall Study||1
5306433|NCT00506922|13045759|P4|NOT COMPLETED|Overall Study||2
5306434|NCT00506922|13045760|P3|NOT COMPLETED|Overall Study||0
5306435|NCT00506922|13045761|P2|NOT COMPLETED|Overall Study||0
5306436|NCT00506922|13045762|P1|NOT COMPLETED|Overall Study||0
5306437|NCT00506922|13045758|P5|COMPLETED|Overall Study||10
5306438|NCT00506922|13045759|P4|COMPLETED|Overall Study||61
5306439|NCT00506922|13045760|P3|COMPLETED|Overall Study||29
5306440|NCT00506922|13045761|P2|COMPLETED|Overall Study||10
5306441|NCT00506922|13045762|P1|COMPLETED|Overall Study||37
5306442|NCT00506922|13045758|P5|STARTED|Overall Study||11
5306443|NCT00506922|13045759|P4|STARTED|Overall Study||63
5306444|NCT00506922|13045760|P3|STARTED|Overall Study||29
5306445|NCT00506922|13045761|P2|STARTED|Overall Study||10
5306446|NCT00506922|13045762|P1|STARTED|Overall Study||37
5306447|NCT00506909|13045770|P1|NOT COMPLETED|Overall Study||0
5306448|NCT00506909|13045770|P1|COMPLETED|Overall Study||0
5306449|NCT00506909|13045770|P1|STARTED|Overall Study||0
5306450|NCT00506883|13045789|P3|NOT COMPLETED|Overall Study||4
5306451|NCT00506883|13045790|P2|NOT COMPLETED|Overall Study||3
5306452|NCT00506883|13045791|P1|NOT COMPLETED|Overall Study||7
5306453|NCT00506883|13045789|P3|COMPLETED|Overall Study||55
5306454|NCT00506883|13045790|P2|COMPLETED|Overall Study||71
5306455|NCT00506883|13045791|P1|COMPLETED|Overall Study||45
5306456|NCT00506883|13045789|P3|STARTED|Overall Study||59
5306457|NCT00506883|13045790|P2|STARTED|Overall Study||74
5306458|NCT00506883|13045791|P1|STARTED|Overall Study||52
5306459|NCT00506857|13045799|P1|NOT COMPLETED|Overall Study||0
5306460|NCT00506857|13045799|P1|COMPLETED|Overall Study||80
5306461|NCT00506857|13045799|P1|STARTED|Overall Study||80
5306462|NCT00506831|13045804|P1|NOT COMPLETED|Overall Study||2
5306463|NCT00506831|13045804|P1|COMPLETED|Overall Study||7
5306464|NCT00506831|13045804|P1|STARTED|Overall Study||9
5306465|NCT00506753|13045817|P2|NOT COMPLETED|Overall Study||15
5306466|NCT00506753|13045818|P1|NOT COMPLETED|Overall Study||21
5306467|NCT00506753|13045817|P2|COMPLETED|Overall Study||84
5306468|NCT00506753|13045818|P1|COMPLETED|Overall Study||79
5306469|NCT00506753|13045817|P2|STARTED|Overall Study||99
5306470|NCT00506753|13045818|P1|STARTED|Overall Study||100
5306471|NCT00506714|13045830|P2|NOT COMPLETED|Overall Study||0
5306472|NCT00506714|13045831|P1|NOT COMPLETED|Overall Study||0
5306473|NCT00506714|13045830|P2|COMPLETED|Overall Study||13
5306474|NCT00506714|13045831|P1|COMPLETED|Overall Study||13
5306475|NCT00506714|13045830|P2|STARTED|Overall Study||13
5306476|NCT00506714|13045831|P1|STARTED|Overall Study||13
5306477|NCT00506675|13045841|P2|NOT COMPLETED|Overall Study||0
5306478|NCT00506675|13045842|P1|NOT COMPLETED|Overall Study||0
5306479|NCT00506675|13045841|P2|COMPLETED|Overall Study||28
5306480|NCT00506675|13045842|P1|COMPLETED|Overall Study||27
5306481|NCT00506675|13045841|P2|STARTED|Overall Study||28
5306482|NCT00506675|13045842|P1|STARTED|Overall Study||27
5306483|NCT00506662|13045856|P2|NOT COMPLETED|Overall Study||28
5306484|NCT00506662|13045857|P1|NOT COMPLETED|Overall Study||17
5306485|NCT00506662|13045856|P2|COMPLETED|Overall Study||20
5306486|NCT00506662|13045857|P1|COMPLETED|Overall Study||21
5306487|NCT00506662|13045856|P2|STARTED|Overall Study||48
5306488|NCT00506662|13045857|P1|STARTED|Overall Study||38
5306489|NCT00506597|13045887|P1|NOT COMPLETED|Overall Study||0
5306490|NCT00506597|13045887|P1|COMPLETED|Overall Study||33
5306491|NCT00506597|13045887|P1|STARTED|Overall Study||33
5306492|NCT00506493|13045891|P1|NOT COMPLETED|Overall Study||11
5306493|NCT00506493|13045891|P1|COMPLETED|Overall Study||64
5306494|NCT00506493|13045891|P1|STARTED|Overall Study||75
5306495|NCT00506454|13045900|P2|NOT COMPLETED|Overall Study||1
5306496|NCT00506454|13045901|P1|NOT COMPLETED|Overall Study||1
5306497|NCT00506454|13045900|P2|COMPLETED|Overall Study||10
5306498|NCT00506454|13045901|P1|COMPLETED|Overall Study||10
5306499|NCT00506454|13045900|P2|STARTED|Overall Study||11
5306500|NCT00506454|13045901|P1|STARTED|Overall Study||11
5306501|NCT00506441|13045907|P2|NOT COMPLETED|Period 2; Double-blind Period||5
5306502|NCT00506441|13045908|P1|NOT COMPLETED|Period 2; Double-blind Period||3
5306503|NCT00506441|13045907|P2|COMPLETED|Period 2; Double-blind Period||79
5306504|NCT00506441|13045908|P1|COMPLETED|Period 2; Double-blind Period||82
5306505|NCT00506441|13045907|P2|STARTED|Period 2; Double-blind Period||84
5306506|NCT00506441|13045908|P1|STARTED|Period 2; Double-blind Period||85
5306507|NCT00506441|13045907|P2|NOT COMPLETED|Period 1; Open-label Period||0
5306508|NCT00506441|13045908|P1|NOT COMPLETED|Period 1; Open-label Period||76
5306509|NCT00506441|13045907|P2|COMPLETED|Period 1; Open-label Period||0
5306510|NCT00506441|13045908|P1|COMPLETED|Period 1; Open-label Period||169
5306511|NCT00506441|13045907|P2|STARTED|Period 1; Open-label Period||0
5306512|NCT00506441|13045908|P1|STARTED|Period 1; Open-label Period||245
5306513|NCT00506415|13045916|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
5306514|NCT00506415|13045917|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306515|NCT00506415|13045918|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306516|NCT00506415|13045919|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306517|NCT00506415|13045916|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
5306518|NCT00506415|13045917|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306519|NCT00506415|13045918|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306520|NCT00506415|13045919|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
5306521|NCT00506415|13045916|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
5306522|NCT00506415|13045917|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
5306523|NCT00506415|13045918|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
5306524|NCT00506415|13045919|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
5306525|NCT00506415|13045916|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
5306526|NCT00506415|13045917|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
5306527|NCT00506415|13045918|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
5306528|NCT00506415|13045919|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
5306529|NCT00506415|13045916|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
5306530|NCT00506415|13045917|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
5306531|NCT00506415|13045918|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
5306532|NCT00506415|13045919|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
5306533|NCT00506415|13045916|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
5306534|NCT00506415|13045917|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
5306535|NCT00506415|13045918|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
5306536|NCT00506415|13045919|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
5306537|NCT00506415|13045916|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306538|NCT00506415|13045917|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306539|NCT00506415|13045918|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306540|NCT00506415|13045919|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
5306541|NCT00506415|13045916|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306542|NCT00506415|13045917|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306543|NCT00506415|13045918|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
5306544|NCT00506415|13045919|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
5306545|NCT00506415|13045916|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
5306546|NCT00506415|13045917|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
5306547|NCT00506415|13045918|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
5306548|NCT00506415|13045919|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
5306549|NCT00506415|13045916|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
5306550|NCT00506415|13045917|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
5306551|NCT00506415|13045918|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
5306552|NCT00506415|13045919|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
5306553|NCT00506389|13045944|P3|NOT COMPLETED|Follow-up Period||0
5306554|NCT00506389|13045945|P2|NOT COMPLETED|Follow-up Period||0
5306555|NCT00506389|13045946|P1|NOT COMPLETED|Follow-up Period||0
5306556|NCT00506389|13045944|P3|COMPLETED|Follow-up Period||136
5306557|NCT00506389|13045945|P2|COMPLETED|Follow-up Period||138
5306558|NCT00506389|13045946|P1|COMPLETED|Follow-up Period||139
5306559|NCT00506389|13045944|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
5306560|NCT00506389|13045945|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
5306561|NCT00506389|13045946|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
5306562|NCT00506389|13045944|P3|NOT COMPLETED|In-treatment Period||12
5306563|NCT00506389|13045945|P2|NOT COMPLETED|In-treatment Period||15
5306564|NCT00506389|13045946|P1|NOT COMPLETED|In-treatment Period||26
5306565|NCT00506389|13045944|P3|COMPLETED|In-treatment Period||125
5306566|NCT00506389|13045945|P2|COMPLETED|In-treatment Period||124
5306567|NCT00506389|13045946|P1|COMPLETED|In-treatment Period||117
5306568|NCT00506389|13045944|P3|All Participants Treated|In-treatment Period||136
5306569|NCT00506389|13045945|P2|All Participants Treated|In-treatment Period||138
5306570|NCT00506389|13045946|P1|All Participants Treated|In-treatment Period||139
5306571|NCT00506389|13045944|P3|STARTED|In-treatment Period||137
5306572|NCT00506389|13045945|P2|STARTED|In-treatment Period||139
5306573|NCT00506389|13045946|P1|STARTED|In-treatment Period||143
5306574|NCT00506350|13045972|P9|NOT COMPLETED|Overall Study||5
5306575|NCT00506350|13045973|P8|NOT COMPLETED|Overall Study||5
5306576|NCT00506350|13045974|P7|NOT COMPLETED|Overall Study||2
5306577|NCT00506350|13045975|P6|NOT COMPLETED|Overall Study||2
5306578|NCT00506350|13045976|P5|NOT COMPLETED|Overall Study||10
5306579|NCT00506350|13045977|P4|NOT COMPLETED|Overall Study||2
5306580|NCT00506350|13045978|P3|NOT COMPLETED|Overall Study||6
5306581|NCT00506350|13045979|P2|NOT COMPLETED|Overall Study||3
5306582|NCT00506350|13045980|P1|NOT COMPLETED|Overall Study||3
5306583|NCT00506350|13045972|P9|COMPLETED|Overall Study||30
5306584|NCT00506350|13045973|P8|COMPLETED|Overall Study||36
5306585|NCT00506350|13045974|P7|COMPLETED|Overall Study||33
5306586|NCT00506350|13045975|P6|COMPLETED|Overall Study||38
5306587|NCT00506350|13045976|P5|COMPLETED|Overall Study||40
5306588|NCT00506350|13045977|P4|COMPLETED|Overall Study||34
5306589|NCT00506350|13045978|P3|COMPLETED|Overall Study||31
5306590|NCT00506350|13045979|P2|COMPLETED|Overall Study||37
5306591|NCT00506350|13045980|P1|COMPLETED|Overall Study||33
5306592|NCT00506350|13045972|P9|STARTED|Overall Study||35
5306593|NCT00506350|13045973|P8|STARTED|Overall Study||41
5306594|NCT00506350|13045974|P7|STARTED|Overall Study||35
5306595|NCT00506350|13045975|P6|STARTED|Overall Study||40
5306596|NCT00506350|13045976|P5|STARTED|Overall Study||50
5306597|NCT00506350|13045977|P4|STARTED|Overall Study||36
5306598|NCT00506350|13045978|P3|STARTED|Overall Study||37
5306599|NCT00506350|13045979|P2|STARTED|Overall Study||40
5306600|NCT00506350|13045980|P1|STARTED|Overall Study||36
5306601|NCT00506285|13046127|P2|NOT COMPLETED|6-month Open Label Phase||12
5306602|NCT00506285|13046128|P1|NOT COMPLETED|6-month Open Label Phase||10
5306603|NCT00506285|13046127|P2|COMPLETED|6-month Open Label Phase||19
5306604|NCT00506285|13046128|P1|COMPLETED|6-month Open Label Phase||10
5306605|NCT00506285|13046127|P2|STARTED|6-month Open Label Phase||31
5306606|NCT00506285|13046128|P1|STARTED|6-month Open Label Phase||20
5306607|NCT00506285|13046127|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
5306608|NCT00506285|13046128|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
5306609|NCT00506285|13046127|P2|COMPLETED|Double Blind Cross-Over Phase||31
5306610|NCT00506285|13046128|P1|COMPLETED|Double Blind Cross-Over Phase||20
5306611|NCT00506285|13046127|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
5306612|NCT00506285|13046128|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
5306613|NCT00506285|13046127|P2|STARTED|Double Blind Cross-Over Phase||36
5306614|NCT00506285|13046128|P1|STARTED|Double Blind Cross-Over Phase||29
5306615|NCT00506285|13046127|P2|NOT COMPLETED|3 Week Screening Phase||10
5306616|NCT00506285|13046128|P1|NOT COMPLETED|3 Week Screening Phase||17
5306617|NCT00506285|13046127|P2|COMPLETED|3 Week Screening Phase||36
5306618|NCT00506285|13046128|P1|COMPLETED|3 Week Screening Phase||29
5306619|NCT00506285|13046127|P2|STARTED|3 Week Screening Phase||46
5306620|NCT00506285|13046128|P1|STARTED|3 Week Screening Phase||46
5306621|NCT00506155|13046136|P1|NOT COMPLETED|Overall Study||0
5306622|NCT00506155|13046136|P1|COMPLETED|Overall Study||60
5306623|NCT00506155|13046136|P1|STARTED|Overall Study||60
5306624|NCT00506142|13046143|P2|NOT COMPLETED|Overall Study||19
5306625|NCT00506142|13046144|P1|NOT COMPLETED|Overall Study||35
5306626|NCT00506142|13046143|P2|COMPLETED|Overall Study||0
5306627|NCT00506142|13046144|P1|COMPLETED|Overall Study||0
5306628|NCT00506142|13046143|P2|STARTED|Overall Study||19
5306629|NCT00506142|13046144|P1|STARTED|Overall Study||35
5306630|NCT00506077|13046152|P2|NOT COMPLETED|Treatment Period 2||1
5306631|NCT00506077|13046153|P1|NOT COMPLETED|Treatment Period 2||1
5306632|NCT00506077|13046152|P2|COMPLETED|Treatment Period 2||23
5306633|NCT00506077|13046153|P1|COMPLETED|Treatment Period 2||23
5306634|NCT00506077|13046152|P2|STARTED|Treatment Period 2||24
5306635|NCT00506077|13046153|P1|STARTED|Treatment Period 2||24
5306636|NCT00506077|13046152|P2|NOT COMPLETED|Washout||0
5306637|NCT00506077|13046153|P1|NOT COMPLETED|Washout||0
5306638|NCT00506077|13046152|P2|COMPLETED|Washout||24
5306639|NCT00506077|13046153|P1|COMPLETED|Washout||24
5306640|NCT00506077|13046152|P2|STARTED|Washout||24
5306641|NCT00506077|13046153|P1|STARTED|Washout||24
5306642|NCT00506077|13046152|P2|NOT COMPLETED|Treatment Period 1||3
5306643|NCT00506077|13046153|P1|NOT COMPLETED|Treatment Period 1||4
5306644|NCT00506077|13046152|P2|COMPLETED|Treatment Period 1||24
5306645|NCT00506077|13046153|P1|COMPLETED|Treatment Period 1||24
5306646|NCT00506077|13046152|P2|STARTED|Treatment Period 1||27
5306647|NCT00506077|13046153|P1|STARTED|Treatment Period 1||28
5306648|NCT00506064|13046175|P2|NOT COMPLETED|Overall Study||0
5306649|NCT00506064|13046176|P1|NOT COMPLETED|Overall Study||0
5306650|NCT00506064|13046175|P2|COMPLETED|Overall Study||0
5306651|NCT00506064|13046176|P1|COMPLETED|Overall Study||1
5306652|NCT00506064|13046175|P2|STARTED|Overall Study||0
5306653|NCT00506064|13046176|P1|STARTED|Overall Study||1
5306654|NCT00506025|13046185|P3|NOT COMPLETED|Overall Study||0
5306655|NCT00506025|13046186|P2|NOT COMPLETED|Overall Study||0
5306656|NCT00506025|13046187|P1|NOT COMPLETED|Overall Study||0
5306657|NCT00506025|13046185|P3|COMPLETED|Overall Study||8
5306658|NCT00506025|13046186|P2|COMPLETED|Overall Study||9
5306659|NCT00506025|13046187|P1|COMPLETED|Overall Study||10
5306660|NCT00506025|13046185|P3|STARTED|Overall Study||8
5306661|NCT00506025|13046186|P2|STARTED|Overall Study||9
5306662|NCT00506025|13046187|P1|STARTED|Overall Study||10
5306663|NCT00505934|13046195|P1|NOT COMPLETED|Overall Study||3
5306664|NCT00505934|13046195|P1|COMPLETED|Overall Study||16
5306665|NCT00505934|13046195|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
5306666|NCT00505921|13046201|P1|NOT COMPLETED|Overall Study||9
5306667|NCT00505921|13046201|P1|COMPLETED|Overall Study||18
5306668|NCT00505921|13046201|P1|STARTED|Overall Study||27
5306669|NCT00505895|13046207|P2|NOT COMPLETED|Overall Study||0
5306670|NCT00505895|13046208|P1|NOT COMPLETED|Overall Study||0
5306671|NCT00505895|13046207|P2|COMPLETED|Overall Study||23
5306672|NCT00505895|13046208|P1|COMPLETED|Overall Study||27
5306673|NCT00505895|13046207|P2|STARTED|Overall Study||23
5306674|NCT00505895|13046208|P1|STARTED|Overall Study||27
5306675|NCT00505778|13046218|P2|NOT COMPLETED|Overall Study||135
5306676|NCT00505778|13046219|P1|NOT COMPLETED|Overall Study||134
5306677|NCT00505778|13046218|P2|COMPLETED|Overall Study||378
5306678|NCT00505778|13046219|P1|COMPLETED|Overall Study||380
5306679|NCT00505778|13046218|P2|Intent to Treat (ITT) Population|Overall Study||511
5306680|NCT00505778|13046219|P1|Intent to Treat (ITT) Population|Overall Study||512
5306681|NCT00505778|13046218|P2|STARTED|Overall Study||513
5306682|NCT00505778|13046219|P1|STARTED|Overall Study||514
5306683|NCT00505765|13046238|P3|NOT COMPLETED|Overall Study||3
5306684|NCT00505765|13046239|P2|NOT COMPLETED|Overall Study||3
5306685|NCT00505765|13046240|P1|NOT COMPLETED|Overall Study||2
5306686|NCT00505765|13046238|P3|COMPLETED|Overall Study||19
5306687|NCT00505765|13046239|P2|COMPLETED|Overall Study||17
5306688|NCT00505765|13046240|P1|COMPLETED|Overall Study||19
5306689|NCT00505765|13046238|P3|Mid-Point Assessment|Overall Study||21
5306690|NCT00505765|13046239|P2|Mid-Point Assessment|Overall Study||19
5306691|NCT00505765|13046240|P1|Mid-Point Assessment|Overall Study||20
5306692|NCT00505765|13046238|P3|STARTED|Overall Study||22
5306693|NCT00505765|13046239|P2|STARTED|Overall Study||20
5306694|NCT00505765|13046240|P1|STARTED|Overall Study||21
5306695|NCT00505752|13046267|P4|NOT COMPLETED|Overall Study||6
5306696|NCT00505752|13046268|P3|NOT COMPLETED|Overall Study||8
5306697|NCT00505752|13046269|P2|NOT COMPLETED|Overall Study||9
5306698|NCT00505752|13046270|P1|NOT COMPLETED|Overall Study||6
5306699|NCT00505752|13046267|P4|COMPLETED|Overall Study||126
5306700|NCT00505752|13046268|P3|COMPLETED|Overall Study||120
5306701|NCT00505752|13046269|P2|COMPLETED|Overall Study||119
5306702|NCT00505752|13046270|P1|COMPLETED|Overall Study||126
5306703|NCT00505752|13046267|P4|STARTED|Overall Study||132
5306704|NCT00505752|13046268|P3|STARTED|Overall Study||128
5306705|NCT00505752|13046269|P2|STARTED|Overall Study||128
5306706|NCT00505752|13046270|P1|STARTED|Overall Study||132
5306707|NCT00505687|13046284|P1|NOT COMPLETED|Overall Study||95
5306708|NCT00505687|13046284|P1|COMPLETED|Overall Study||91
5306709|NCT00505687|13046284|P1|STARTED|Overall Study||186
5306710|NCT00505661|13046290|P1|NOT COMPLETED|Overall Study||4
5306711|NCT00505661|13046290|P1|COMPLETED|Overall Study||12
5306712|NCT00505661|13046290|P1|STARTED|Overall Study||16
5306713|NCT00505635|13046294|P1|NOT COMPLETED|Overall Study||0
5306714|NCT00505635|13046294|P1|COMPLETED|Overall Study||5
5306715|NCT00505635|13046294|P1|STARTED|Overall Study||5
5306716|NCT00505622|13046301|P3|NOT COMPLETED|Overall Study||96
5306717|NCT00505622|13046302|P2|NOT COMPLETED|Overall Study||108
5306718|NCT00505622|13046303|P1|NOT COMPLETED|Overall Study||121
5306719|NCT00505622|13046301|P3|COMPLETED|Overall Study||0
5306720|NCT00505622|13046302|P2|COMPLETED|Overall Study||0
5306721|NCT00505622|13046303|P1|COMPLETED|Overall Study||0
5306722|NCT00505622|13046301|P3|STARTED|Overall Study||96
5306723|NCT00505622|13046302|P2|STARTED|Overall Study||108
5306724|NCT00505622|13046303|P1|STARTED|Overall Study||121
5306725|NCT00505518|13046320|P1|NOT COMPLETED|Overall Study||0
5306726|NCT00505518|13046320|P1|COMPLETED|Overall Study||9
5306727|NCT00505518|13046320|P1|STARTED|Overall Study||9
5306728|NCT00505414|13046328|P5|NOT COMPLETED|Maintenance Phase||0
5306729|NCT00505414|13046329|P4|NOT COMPLETED|Maintenance Phase||0
5306730|NCT00505414|13046330|P3|NOT COMPLETED|Maintenance Phase||8
5306731|NCT00505414|13046331|P2|NOT COMPLETED|Maintenance Phase||5
5306732|NCT00505414|13046332|P1|NOT COMPLETED|Maintenance Phase||6
5306733|NCT00505414|13046328|P5|COMPLETED|Maintenance Phase||0
5306734|NCT00505414|13046329|P4|COMPLETED|Maintenance Phase||0
5306735|NCT00505414|13046330|P3|COMPLETED|Maintenance Phase||6
5306736|NCT00505414|13046331|P2|COMPLETED|Maintenance Phase||10
5306737|NCT00505414|13046332|P1|COMPLETED|Maintenance Phase||12
5306738|NCT00505414|13046328|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
5306739|NCT00505414|13046329|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
5306740|NCT00505414|13046330|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
5306741|NCT00505414|13046331|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
5306742|NCT00505414|13046332|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
5306743|NCT00505414|13046328|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
5306744|NCT00505414|13046329|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
5306745|NCT00505414|13046330|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
5306746|NCT00505414|13046331|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
5306747|NCT00505414|13046332|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
5306748|NCT00505414|13046328|P5|NOT COMPLETED|Titration Phase||12
5306749|NCT00505414|13046329|P4|NOT COMPLETED|Titration Phase||30
5306750|NCT00505414|13046330|P3|NOT COMPLETED|Titration Phase||0
5306751|NCT00505414|13046331|P2|NOT COMPLETED|Titration Phase||0
5306752|NCT00505414|13046332|P1|NOT COMPLETED|Titration Phase||0
5306753|NCT00505414|13046328|P5|COMPLETED|Titration Phase||19
5306754|NCT00505414|13046329|P4|COMPLETED|Titration Phase||32
5306755|NCT00505414|13046330|P3|COMPLETED|Titration Phase||0
5306756|NCT00505414|13046331|P2|COMPLETED|Titration Phase||0
5306757|NCT00505414|13046332|P1|COMPLETED|Titration Phase||0
5306758|NCT00505414|13046328|P5|STARTED|Titration Phase||31
5306759|NCT00505414|13046329|P4|STARTED|Titration Phase||62
5306760|NCT00505414|13046330|P3|STARTED|Titration Phase||0
5306761|NCT00505414|13046331|P2|STARTED|Titration Phase||0
5306762|NCT00505414|13046332|P1|STARTED|Titration Phase||0
5306763|NCT00505375|13046349|P2|NOT COMPLETED|Overall Study||5
5306764|NCT00505375|13046350|P1|NOT COMPLETED|Overall Study||4
5306765|NCT00505375|13046349|P2|COMPLETED|Overall Study||30
5306766|NCT00505375|13046350|P1|COMPLETED|Overall Study||73
5306767|NCT00505375|13046349|P2|STARTED|Overall Study||35
5306768|NCT00505375|13046350|P1|STARTED|Overall Study||77
5306769|NCT00505362|13046358|P2|NOT COMPLETED|Overall Study||0
5306770|NCT00505362|13046359|P1|NOT COMPLETED|Overall Study||0
5306771|NCT00505362|13046358|P2|COMPLETED|Overall Study||28
5306772|NCT00505362|13046359|P1|COMPLETED|Overall Study||35
5306773|NCT00505362|13046358|P2|STARTED|Overall Study||28
5306774|NCT00505362|13046359|P1|STARTED|Overall Study||35
5306775|NCT00505284|13046372|P5|NOT COMPLETED|Overall Study||33
5306776|NCT00505284|13046373|P4|NOT COMPLETED|Overall Study||19
5306777|NCT00505284|13046374|P3|NOT COMPLETED|Overall Study||12
5306778|NCT00505284|13046375|P2|NOT COMPLETED|Overall Study||16
5306779|NCT00505284|13046376|P1|NOT COMPLETED|Overall Study||10
5306780|NCT00505284|13046372|P5|COMPLETED|Overall Study||37
5306781|NCT00505284|13046373|P4|COMPLETED|Overall Study||49
5306782|NCT00505284|13046374|P3|COMPLETED|Overall Study||57
5306783|NCT00505284|13046375|P2|COMPLETED|Overall Study||56
5306784|NCT00505284|13046376|P1|COMPLETED|Overall Study||63
5306785|NCT00505284|13046372|P5|STARTED|Overall Study||70
5306786|NCT00505284|13046373|P4|STARTED|Overall Study||68
5306787|NCT00505284|13046374|P3|STARTED|Overall Study||69
5306788|NCT00505284|13046375|P2|STARTED|Overall Study||72
5306789|NCT00505284|13046376|P1|STARTED|Overall Study||73
5306790|NCT00505076|13046446|P3|NOT COMPLETED|Overall Study||5
5306791|NCT00505076|13046447|P2|NOT COMPLETED|Overall Study||2
5306792|NCT00505076|13046448|P1|NOT COMPLETED|Overall Study||3
5306793|NCT00505076|13046446|P3|COMPLETED|Overall Study||17
5306794|NCT00505076|13046447|P2|COMPLETED|Overall Study||17
5306795|NCT00505076|13046448|P1|COMPLETED|Overall Study||19
5306796|NCT00505076|13046446|P3|STARTED|Overall Study||22
5306797|NCT00505076|13046447|P2|STARTED|Overall Study||19
5306798|NCT00505076|13046448|P1|STARTED|Overall Study||22
5306799|NCT00504985|13046462|P1|NOT COMPLETED|Overall Study||0
5306800|NCT00504985|13046462|P1|COMPLETED|Overall Study||14
5306801|NCT00504985|13046462|P1|STARTED|Overall Study||14
5306802|NCT00504894|13046468|P2|NOT COMPLETED|Overall Study||0
5306803|NCT00504894|13046469|P1|NOT COMPLETED|Overall Study||0
5306804|NCT00504894|13046468|P2|COMPLETED|Overall Study||18
5306805|NCT00504894|13046469|P1|COMPLETED|Overall Study||17
5306806|NCT00504894|13046468|P2|STARTED|Overall Study||18
5306807|NCT00504894|13046469|P1|STARTED|Overall Study||17
5306808|NCT00504881|13046477|P2|NOT COMPLETED|Overall Study||36
5306809|NCT00504881|13046478|P1|NOT COMPLETED|Overall Study||10
5306810|NCT00504881|13046477|P2|COMPLETED|Overall Study||323
5306811|NCT00504881|13046478|P1|COMPLETED|Overall Study||111
5306812|NCT00504881|13046477|P2|STARTED|Overall Study||359
5306813|NCT00504881|13046478|P1|STARTED|Overall Study||121
5306814|NCT00504829|13046531|P3|NOT COMPLETED|Overall Study||10
5306815|NCT00504829|13046532|P2|NOT COMPLETED|Overall Study||4
5306816|NCT00504829|13046533|P1|NOT COMPLETED|Overall Study||6
5306817|NCT00504829|13046531|P3|COMPLETED|Overall Study||63
5306818|NCT00504829|13046532|P2|COMPLETED|Overall Study||70
5306819|NCT00504829|13046533|P1|COMPLETED|Overall Study||67
5306820|NCT00504829|13046531|P3|STARTED|Overall Study||73
5306821|NCT00504829|13046532|P2|STARTED|Overall Study||74
5306822|NCT00504829|13046533|P1|STARTED|Overall Study||73
5306823|NCT00504777|13046542|P1|NOT COMPLETED|Overall Study||1
5306824|NCT00504777|13046542|P1|COMPLETED|Overall Study||35
5306825|NCT00504777|13046542|P1|STARTED|Overall Study||36
5306826|NCT00504751|13046549|P1|NOT COMPLETED|Overall Study||0
5306827|NCT00504751|13046549|P1|COMPLETED|Overall Study||15
5306828|NCT00504751|13046549|P1|STARTED|Overall Study||15
5306829|NCT00504725|13046555|P2|NOT COMPLETED|Overall Study||0
5306830|NCT00504725|13046556|P1|NOT COMPLETED|Overall Study||1
5306831|NCT00504725|13046555|P2|COMPLETED|Overall Study||20
5306832|NCT00504725|13046556|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
5306833|NCT00504725|13046555|P2|STARTED|Overall Study||20
5306834|NCT00504725|13046556|P1|STARTED|Overall Study||21
5306835|NCT00504660|13046568|P2|NOT COMPLETED|Overall Study||0
5306836|NCT00504660|13046569|P1|NOT COMPLETED|Overall Study||0
5306837|NCT00504660|13046568|P2|COMPLETED|Overall Study||43
5306838|NCT00504660|13046569|P1|COMPLETED|Overall Study||31
5306839|NCT00504660|13046568|P2|STARTED|Overall Study||43
5306840|NCT00504660|13046569|P1|STARTED|Overall Study||31
5306841|NCT00504595|13046579|P4|NOT COMPLETED|Overall Study||0
5306842|NCT00504595|13046580|P3|NOT COMPLETED|Overall Study||2
5306843|NCT00504595|13046581|P2|NOT COMPLETED|Overall Study||0
5306844|NCT00504595|13046582|P1|NOT COMPLETED|Overall Study||1
5306845|NCT00504595|13046579|P4|COMPLETED|Overall Study||10
5306846|NCT00504595|13046580|P3|COMPLETED|Overall Study||8
5306847|NCT00504595|13046581|P2|COMPLETED|Overall Study||10
5306848|NCT00504595|13046582|P1|COMPLETED|Overall Study||49
5306849|NCT00504595|13046579|P4|STARTED|Overall Study||10
5306850|NCT00504595|13046580|P3|STARTED|Overall Study||10
5306851|NCT00504595|13046581|P2|STARTED|Overall Study||10
5306852|NCT00504595|13046582|P1|STARTED|Overall Study||50
5306853|NCT00504556|13046599|P5|NOT COMPLETED|Overall Study||25
5306854|NCT00504556|13046600|P4|NOT COMPLETED|Overall Study||128
5306855|NCT00504556|13046601|P3|NOT COMPLETED|Overall Study||31
5306856|NCT00504556|13046602|P2|NOT COMPLETED|Overall Study||38
5306857|NCT00504556|13046603|P1|NOT COMPLETED|Overall Study||35
5306858|NCT00504556|13046599|P5|COMPLETED|Overall Study||226
5306859|NCT00504556|13046600|P4|COMPLETED|Overall Study||52
5306860|NCT00504556|13046601|P3|COMPLETED|Overall Study||204
5306861|NCT00504556|13046602|P2|COMPLETED|Overall Study||207
5306862|NCT00504556|13046603|P1|COMPLETED|Overall Study||200
5306863|NCT00504556|13046599|P5|Pharmacodynamic Analysis Set|Overall Study||244
5306864|NCT00504556|13046600|P4|Pharmacodynamic Analysis Set|Overall Study||170
5306865|NCT00504556|13046601|P3|Pharmacodynamic Analysis Set|Overall Study||228
5306866|NCT00504556|13046602|P2|Pharmacodynamic Analysis Set|Overall Study||236
5306867|NCT00504556|13046603|P1|Pharmacodynamic Analysis Set|Overall Study||230
5306868|NCT00504556|13046599|P5|Per Protocol Analysis Set|Overall Study||250
5306869|NCT00504556|13046600|P4|Per Protocol Analysis Set|Overall Study||180
5306870|NCT00504556|13046601|P3|Per Protocol Analysis Set|Overall Study||234
5306871|NCT00504556|13046602|P2|Per Protocol Analysis Set|Overall Study||243
5306872|NCT00504556|13046603|P1|Per Protocol Analysis Set|Overall Study||235
5306873|NCT00504556|13046599|P5|Safety Analysis Set|Overall Study||250
5306874|NCT00504556|13046600|P4|Safety Analysis Set|Overall Study||180
5306875|NCT00504556|13046601|P3|Safety Analysis Set|Overall Study||234
5306876|NCT00504556|13046602|P2|Safety Analysis Set|Overall Study||244
5306877|NCT00504556|13046603|P1|Safety Analysis Set|Overall Study||235
5306878|NCT00504556|13046599|P5|STARTED|Overall Study||251
5306879|NCT00504556|13046600|P4|STARTED|Overall Study||180
5306880|NCT00504556|13046601|P3|STARTED|Overall Study||235
5306881|NCT00504556|13046602|P2|STARTED|Overall Study||245
5306882|NCT00504556|13046603|P1|STARTED|Overall Study||235
5306883|NCT00504504|13046663|P1|NOT COMPLETED|Overall Study||0
5306884|NCT00504504|13046663|P1|COMPLETED|Overall Study||82
5306885|NCT00504504|13046663|P1|STARTED|Overall Study||82
5306886|NCT00504426|13046671|P4|NOT COMPLETED|Overall Study||0
5306887|NCT00504426|13046672|P3|NOT COMPLETED|Overall Study||4
5306888|NCT00504426|13046673|P2|NOT COMPLETED|Overall Study||1
5306889|NCT00504426|13046674|P1|NOT COMPLETED|Overall Study||3
5306890|NCT00504426|13046671|P4|COMPLETED|Overall Study||24
5306891|NCT00504426|13046672|P3|COMPLETED|Overall Study||18
5306892|NCT00504426|13046673|P2|COMPLETED|Overall Study||22
5306893|NCT00504426|13046674|P1|COMPLETED|Overall Study||29
5306894|NCT00504426|13046671|P4|STARTED|Overall Study||24
5306895|NCT00504426|13046672|P3|STARTED|Overall Study||22
5306896|NCT00504426|13046673|P2|STARTED|Overall Study||23
5306897|NCT00504426|13046674|P1|STARTED|Overall Study||32
5306898|NCT00504348|13046688|P1|NOT COMPLETED|Overall Study||8
5306899|NCT00504348|13046688|P1|COMPLETED|Overall Study||17
5306900|NCT00504348|13046688|P1|STARTED|Overall Study||25
5306901|NCT00504309|13046699|P6|NOT COMPLETED|Overall Study||0
5306902|NCT00504309|13046700|P5|NOT COMPLETED|Overall Study||1
5306903|NCT00504309|13046701|P4|NOT COMPLETED|Overall Study||0
5306904|NCT00504309|13046702|P3|NOT COMPLETED|Overall Study||1
5306905|NCT00504309|13046703|P2|NOT COMPLETED|Overall Study||0
5306906|NCT00504309|13046704|P1|NOT COMPLETED|Overall Study||0
5306907|NCT00504309|13046699|P6|COMPLETED|Overall Study||3
5306908|NCT00504309|13046700|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
5306909|NCT00504309|13046701|P4|COMPLETED|Overall Study||3
5306910|NCT00504309|13046702|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
5306911|NCT00504309|13046703|P2|COMPLETED|Overall Study||5
5306912|NCT00504309|13046704|P1|COMPLETED|Overall Study||7
5306913|NCT00504309|13046699|P6|STARTED|Overall Study||3
5306914|NCT00504309|13046700|P5|STARTED|Overall Study||8
5306915|NCT00504309|13046701|P4|STARTED|Overall Study||3
5306916|NCT00504309|13046702|P3|STARTED|Overall Study||2
5306917|NCT00504309|13046703|P2|STARTED|Overall Study||5
5306918|NCT00504309|13046704|P1|STARTED|Overall Study||7
5306919|NCT00504257|13046742|P1|NOT COMPLETED|Overall Study||4
5306920|NCT00504257|13046742|P1|COMPLETED|Overall Study||41
5306921|NCT00504257|13046742|P1|STARTED|Overall Study||45
5306922|NCT00504231|13046754|P4|NOT COMPLETED|Overall Study||0
5306923|NCT00504231|13046755|P3|NOT COMPLETED|Overall Study||1
5306924|NCT00504231|13046756|P2|NOT COMPLETED|Overall Study||0
5306925|NCT00504231|13046757|P1|NOT COMPLETED|Overall Study||0
5306926|NCT00504231|13046754|P4|COMPLETED|Overall Study||65
5306927|NCT00504231|13046755|P3|COMPLETED|Overall Study||63
5306928|NCT00504231|13046756|P2|COMPLETED|Overall Study||64
5306929|NCT00504231|13046757|P1|COMPLETED|Overall Study||65
5306930|NCT00504231|13046754|P4|STARTED|Overall Study||65
5306931|NCT00504231|13046755|P3|STARTED|Overall Study||64
5306932|NCT00504231|13046756|P2|STARTED|Overall Study||64
5306933|NCT00504231|13046757|P1|STARTED|Overall Study||65
5306934|NCT00504166|13046777|P2|NOT COMPLETED|Overall Study||14
5306935|NCT00504166|13046778|P1|NOT COMPLETED|Overall Study||6
5306936|NCT00504166|13046777|P2|COMPLETED|Overall Study||13
5306937|NCT00504166|13046778|P1|COMPLETED|Overall Study||20
5306938|NCT00504166|13046777|P2|STARTED|Overall Study||27
5306939|NCT00504166|13046778|P1|STARTED|Overall Study||26
5306940|NCT00504153|13046784|P1|NOT COMPLETED|Overall Study||6
5306941|NCT00504153|13046784|P1|COMPLETED|Overall Study||13
5306942|NCT00504153|13046784|P1|STARTED|Overall Study||19
5306943|NCT00504075|13046792|P1|NOT COMPLETED|Overall Study||8
5306944|NCT00504075|13046792|P1|COMPLETED|Overall Study||27
5306945|NCT00504075|13046792|P1|STARTED|Overall Study||35
5306946|NCT00504023|13046798|P1|NOT COMPLETED|Overall Study||0
5306947|NCT00504023|13046798|P1|COMPLETED|Overall Study||8
5306948|NCT00504023|13046798|P1|STARTED|Overall Study||8
5306949|NCT00503997|13046802|P1|NOT COMPLETED|Overall Study||8
5306950|NCT00503997|13046802|P1|COMPLETED|Overall Study||34
5306951|NCT00503997|13046802|P1|STARTED|Overall Study||42
5306952|NCT00503984|13046808|P6|NOT COMPLETED|Overall Study||0
5306953|NCT00503984|13046809|P5|NOT COMPLETED|Overall Study||1
5306954|NCT00503984|13046810|P4|NOT COMPLETED|Overall Study||0
5306955|NCT00503984|13046811|P3|NOT COMPLETED|Overall Study||0
5306956|NCT00503984|13046812|P2|NOT COMPLETED|Overall Study||2
5306957|NCT00503984|13046813|P1|NOT COMPLETED|Overall Study||0
5306958|NCT00503984|13046808|P6|COMPLETED|Overall Study||1
5306959|NCT00503984|13046809|P5|COMPLETED|Overall Study||5
5306960|NCT00503984|13046810|P4|COMPLETED|Overall Study||6
5306961|NCT00503984|13046811|P3|COMPLETED|Overall Study||3
5306962|NCT00503984|13046812|P2|COMPLETED|Overall Study||1
5306963|NCT00503984|13046813|P1|COMPLETED|Overall Study||3
5306964|NCT00503984|13046808|P6|STARTED|Overall Study||1
5306965|NCT00503984|13046809|P5|STARTED|Overall Study||6
5306966|NCT00503984|13046810|P4|STARTED|Overall Study||6
5306967|NCT00503984|13046811|P3|STARTED|Overall Study||3
5306968|NCT00503984|13046812|P2|STARTED|Overall Study||3
5306969|NCT00503984|13046813|P1|STARTED|Overall Study||3
5306970|NCT00503906|13046839|P1|NOT COMPLETED|Overall Study||1
5306971|NCT00503906|13046839|P1|COMPLETED|Overall Study||29
5306972|NCT00503906|13046839|P1|STARTED|Overall Study||30
5306973|NCT00503880|13046848|P5|NOT COMPLETED|Overall Study||0
5306974|NCT00503880|13046849|P4|NOT COMPLETED|Overall Study||0
5306975|NCT00503880|13046850|P3|NOT COMPLETED|Overall Study||0
5306976|NCT00503880|13046851|P2|NOT COMPLETED|Overall Study||0
5306977|NCT00503880|13046852|P1|NOT COMPLETED|Overall Study||2
5306978|NCT00503880|13046848|P5|COMPLETED|Overall Study||0
5306979|NCT00503880|13046849|P4|COMPLETED|Overall Study||0
5306980|NCT00503880|13046850|P3|COMPLETED|Overall Study||0
5306981|NCT00503880|13046851|P2|COMPLETED|Overall Study||0
5306982|NCT00503880|13046852|P1|COMPLETED|Overall Study||0
5306983|NCT00503880|13046848|P5|STARTED|Overall Study||0
5306984|NCT00503880|13046849|P4|STARTED|Overall Study||0
5306985|NCT00503880|13046850|P3|STARTED|Overall Study||0
5306986|NCT00503880|13046851|P2|STARTED|Overall Study||0
5306987|NCT00503880|13046852|P1|STARTED|Overall Study||2
5306988|NCT00503841|13046861|P1|NOT COMPLETED|Overall Study||44
5306989|NCT00503841|13046861|P1|COMPLETED|Overall Study||0
5306990|NCT00503841|13046861|P1|STARTED|Overall Study||44
5306991|NCT00503776|13046872|P4|NOT COMPLETED|Overall Study||2
5306992|NCT00503776|13046873|P3|NOT COMPLETED|Overall Study||2
5306993|NCT00503776|13046874|P2|NOT COMPLETED|Overall Study||0
5306994|NCT00503776|13046875|P1|NOT COMPLETED|Overall Study||1
5306995|NCT00503776|13046872|P4|COMPLETED|Overall Study||8
5306996|NCT00503776|13046873|P3|COMPLETED|Overall Study||10
5306997|NCT00503776|13046874|P2|COMPLETED|Overall Study||12
5306998|NCT00503776|13046875|P1|COMPLETED|Overall Study||7
5306999|NCT00503776|13046872|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
5307000|NCT00503776|13046873|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
5307001|NCT00503776|13046874|P2|STARTED|Overall Study||12
5307002|NCT00503776|13046875|P1|STARTED|Overall Study||8
5307003|NCT00503750|13046901|P1|NOT COMPLETED|Overall Study||0
5307004|NCT00503750|13046901|P1|COMPLETED|Overall Study||27
5307005|NCT00503750|13046901|P1|STARTED|Overall Study||27
5307006|NCT00503698|13046908|P2|NOT COMPLETED|Overall Study||355
5307007|NCT00503698|13046909|P1|NOT COMPLETED|Overall Study||357
5307008|NCT00503698|13046908|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
5307009|NCT00503698|13046909|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
5307010|NCT00503698|13046908|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
5307011|NCT00503698|13046909|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
5307012|NCT00503698|13046908|P2|STARTED|Overall Study|Randomised|355
5307013|NCT00503698|13046909|P1|STARTED|Overall Study|Randomised|357
5307014|NCT00503685|13046926|P3|NOT COMPLETED|Overall Study||2
5307015|NCT00503685|13046927|P2|NOT COMPLETED|Overall Study||3
5307016|NCT00503685|13046928|P1|NOT COMPLETED|Overall Study||0
5307017|NCT00503685|13046926|P3|COMPLETED|Overall Study||18
5307018|NCT00503685|13046927|P2|COMPLETED|Overall Study||19
5307019|NCT00503685|13046928|P1|COMPLETED|Overall Study||23
5307020|NCT00503685|13046926|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
5307021|NCT00503685|13046927|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
5307022|NCT00503685|13046928|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
5307023|NCT00503685|13046926|P3|STARTED|Overall Study||20
5307024|NCT00503685|13046927|P2|STARTED|Overall Study||22
5307025|NCT00503685|13046928|P1|STARTED|Overall Study||23
5307026|NCT00503425|13046970|P1|NOT COMPLETED|Overall Study||54
5307027|NCT00503425|13046970|P1|COMPLETED|Overall Study||161
5307028|NCT00503425|13046970|P1|STARTED|Overall Study||215
5307029|NCT00503399|13046980|P2|NOT COMPLETED|Overall Study||8
5307030|NCT00503399|13046981|P1|NOT COMPLETED|Overall Study||7
5307031|NCT00503399|13046980|P2|COMPLETED|Overall Study||39
5307032|NCT00503399|13046981|P1|COMPLETED|Overall Study||38
5307033|NCT00503399|13046980|P2|STARTED|Overall Study||47
5307034|NCT00503399|13046981|P1|STARTED|Overall Study||45
5307035|NCT00503308|13047005|P2|NOT COMPLETED|Overall Study||1
5307036|NCT00503308|13047006|P1|NOT COMPLETED|Overall Study||2
5307037|NCT00503308|13047005|P2|COMPLETED|Overall Study||134
5307038|NCT00503308|13047006|P1|COMPLETED|Overall Study||144
5307039|NCT00503308|13047005|P2|STARTED|Overall Study||135
5307040|NCT00503308|13047006|P1|STARTED|Overall Study||146
5307041|NCT00503139|13047012|P1|NOT COMPLETED|Overall Study||8
5307042|NCT00503139|13047012|P1|COMPLETED|Overall Study||676
5307043|NCT00503139|13047012|P1|STARTED|Overall Study||684
5307044|NCT00503113|13047026|P3|NOT COMPLETED|Overall Study||28
5307045|NCT00503113|13047027|P2|NOT COMPLETED|Overall Study||28
5307046|NCT00503113|13047028|P1|NOT COMPLETED|Overall Study||33
5307047|NCT00503113|13047026|P3|COMPLETED|Overall Study||241
5307048|NCT00503113|13047027|P2|COMPLETED|Overall Study||236
5307049|NCT00503113|13047028|P1|COMPLETED|Overall Study||235
5307050|NCT00503113|13047026|P3|Safety Population|Overall Study||267
5307051|NCT00503113|13047027|P2|Safety Population|Overall Study||263
5307052|NCT00503113|13047028|P1|Safety Population|Overall Study||263
5307053|NCT00503113|13047026|P3|Per Protocol Population (PP)|Overall Study||241
5307054|NCT00503113|13047027|P2|Per Protocol Population (PP)|Overall Study||243
5307055|NCT00503113|13047028|P1|Per Protocol Population (PP)|Overall Study||246
5307056|NCT00503113|13047026|P3|Intent to Treat Population (ITT)|Overall Study||268
5307057|NCT00503113|13047027|P2|Intent to Treat Population (ITT)|Overall Study||261
5307058|NCT00503113|13047028|P1|Intent to Treat Population (ITT)|Overall Study||262
5307059|NCT00503113|13047026|P3|STARTED|Overall Study||269
5307060|NCT00503113|13047027|P2|STARTED|Overall Study||264
5307061|NCT00503113|13047028|P1|STARTED|Overall Study||268
5307062|NCT00503009|13047060|P3|NOT COMPLETED|Overall Study||3
5307063|NCT00503009|13047061|P2|NOT COMPLETED|Overall Study||2
5307064|NCT00503009|13047062|P1|NOT COMPLETED|Overall Study||1
5307065|NCT00503009|13047060|P3|COMPLETED|Overall Study||3
5307066|NCT00503009|13047061|P2|COMPLETED|Overall Study||3
5307067|NCT00503009|13047062|P1|COMPLETED|Overall Study||4
5307068|NCT00503009|13047060|P3|STARTED|Overall Study||6
5307069|NCT00503009|13047061|P2|STARTED|Overall Study||5
5307070|NCT00503009|13047062|P1|STARTED|Overall Study||5
5307071|NCT00502996|13047079|P1|NOT COMPLETED|Overall Study||44
5307072|NCT00502996|13047079|P1|COMPLETED|Overall Study||188
5307073|NCT00502996|13047079|P1|STARTED|Overall Study||232
5307074|NCT00502944|13047105|P2|NOT COMPLETED|Overall Study||1766
5307075|NCT00502944|13047106|P1|NOT COMPLETED|Overall Study||1064
5307076|NCT00502944|13047105|P2|COMPLETED|Overall Study||643
5307077|NCT00502944|13047106|P1|COMPLETED|Overall Study||1382
5307078|NCT00502944|13047105|P2|STARTED|Overall Study||2409
5307079|NCT00502944|13047106|P1|STARTED|Overall Study||2446
5307080|NCT00502905|13047118|P1|NOT COMPLETED|Overall Study||0
5307081|NCT00502905|13047118|P1|COMPLETED|Overall Study||196
5307082|NCT00502905|13047118|P1|STARTED|Overall Study||196
5307083|NCT00502853|13047122|P1|NOT COMPLETED|Overall Study||0
5307084|NCT00502853|13047122|P1|COMPLETED|Overall Study||10
5307085|NCT00502853|13047122|P1|STARTED|Overall Study||10
5307086|NCT00502840|13047147|P1|NOT COMPLETED|Overall Study||100
5307087|NCT00502840|13047147|P1|COMPLETED|Overall Study||93
5307088|NCT00502840|13047147|P1|STARTED|Overall Study||193
5307089|NCT00502801|13047175|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
5307090|NCT00502801|13047175|P1|COMPLETED|End of Therapy to Test of Cure||121
5307091|NCT00502801|13047175|P1|STARTED|End of Therapy to Test of Cure||129
5307092|NCT00502801|13047175|P1|NOT COMPLETED|Treatment Period||54
5307093|NCT00502801|13047175|P1|COMPLETED|Treatment Period||129
5307094|NCT00502801|13047175|P1|STARTED|Treatment Period||183
5307095|NCT00502775|13047183|P3|NOT COMPLETED|Overall Study||13
5307096|NCT00502775|13047184|P2|NOT COMPLETED|Overall Study||15
5307097|NCT00502775|13047185|P1|NOT COMPLETED|Overall Study||10
5307098|NCT00502775|13047183|P3|COMPLETED|Overall Study||214
5307099|NCT00502775|13047184|P2|COMPLETED|Overall Study||209
5307100|NCT00502775|13047185|P1|COMPLETED|Overall Study||219
5307101|NCT00502775|13047183|P3|STARTED|Overall Study||227
5307102|NCT00502775|13047184|P2|STARTED|Overall Study||224
5307103|NCT00502775|13047185|P1|STARTED|Overall Study||229
5307104|NCT00502697|13047228|P2|NOT COMPLETED|Overall Study||12
5307105|NCT00502697|13047229|P1|NOT COMPLETED|Overall Study||13
5307106|NCT00502697|13047228|P2|COMPLETED|Overall Study||102
5307107|NCT00502697|13047229|P1|COMPLETED|Overall Study||109
5307108|NCT00502697|13047228|P2|STARTED|Overall Study||114
5307109|NCT00502697|13047229|P1|STARTED|Overall Study||122
5307110|NCT00502671|13047237|P1|NOT COMPLETED|Overall Study||77
5307111|NCT00502671|13047237|P1|COMPLETED|Overall Study||151
5307112|NCT00502671|13047237|P1|STARTED|Overall Study||228
5307113|NCT00502593|13047254|P12|NOT COMPLETED|Overall Study||0
5307114|NCT00502593|13047255|P11|NOT COMPLETED|Overall Study||2
5307115|NCT00502593|13047256|P10|NOT COMPLETED|Overall Study||0
5307116|NCT00502593|13047257|P9|NOT COMPLETED|Overall Study||6
5307117|NCT00502593|13047258|P8|NOT COMPLETED|Overall Study||0
5307118|NCT00502593|13047259|P7|NOT COMPLETED|Overall Study||5
5307119|NCT00502593|13047260|P6|NOT COMPLETED|Overall Study||0
5307120|NCT00502593|13047261|P5|NOT COMPLETED|Overall Study||4
5307121|NCT00502593|13047262|P4|NOT COMPLETED|Overall Study||4
5307122|NCT00502593|13047263|P3|NOT COMPLETED|Overall Study||10
5307123|NCT00502593|13047264|P2|NOT COMPLETED|Overall Study||2
5307124|NCT00502593|13047265|P1|NOT COMPLETED|Overall Study||3
5307125|NCT00502593|13047254|P12|COMPLETED|Overall Study||18
5307126|NCT00502593|13047255|P11|COMPLETED|Overall Study||47
5307127|NCT00502593|13047256|P10|COMPLETED|Overall Study||17
5307128|NCT00502593|13047257|P9|COMPLETED|Overall Study||43
5307129|NCT00502593|13047258|P8|COMPLETED|Overall Study||17
5307130|NCT00502593|13047259|P7|COMPLETED|Overall Study||44
5307131|NCT00502593|13047260|P6|COMPLETED|Overall Study||17
5307132|NCT00502593|13047261|P5|COMPLETED|Overall Study||47
5307133|NCT00502593|13047262|P4|COMPLETED|Overall Study||14
5307134|NCT00502593|13047263|P3|COMPLETED|Overall Study||41
5307135|NCT00502593|13047264|P2|COMPLETED|Overall Study||16
5307136|NCT00502593|13047265|P1|COMPLETED|Overall Study||48
5307137|NCT00502593|13047254|P12|STARTED|Overall Study||18
5307138|NCT00502593|13047255|P11|STARTED|Overall Study||49
5307139|NCT00502593|13047256|P10|STARTED|Overall Study||17
5307140|NCT00502593|13047257|P9|STARTED|Overall Study||49
5307141|NCT00502593|13047258|P8|STARTED|Overall Study||17
5307142|NCT00502593|13047259|P7|STARTED|Overall Study||49
5307143|NCT00502593|13047260|P6|STARTED|Overall Study||17
5307144|NCT00502593|13047261|P5|STARTED|Overall Study||51
5307145|NCT00502593|13047262|P4|STARTED|Overall Study||18
5307146|NCT00502593|13047263|P3|STARTED|Overall Study||51
5307147|NCT00502593|13047264|P2|STARTED|Overall Study||18
5307148|NCT00502593|13047265|P1|STARTED|Overall Study||51
5307149|NCT00502320|13047781|P2|NOT COMPLETED|Overall Study||7
5307150|NCT00502320|13047782|P1|NOT COMPLETED|Overall Study||6
5307151|NCT00502320|13047781|P2|COMPLETED|Overall Study||18
5307152|NCT00502320|13047782|P1|COMPLETED|Overall Study||19
5307153|NCT00502320|13047781|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
5307154|NCT00502320|13047782|P1|Screening Visit|Overall Study||25
5307155|NCT00502320|13047781|P2|STARTED|Overall Study||25
5307156|NCT00502320|13047782|P1|STARTED|Overall Study||25
5307157|NCT00502242|13047794|P2|NOT COMPLETED|Overall Study||56
5307158|NCT00502242|13047795|P1|NOT COMPLETED|Overall Study||51
5307159|NCT00502242|13047794|P2|COMPLETED|Overall Study||84
5307160|NCT00502242|13047795|P1|COMPLETED|Overall Study||104
5307161|NCT00502242|13047794|P2|STARTED|Overall Study||140
5307162|NCT00502242|13047795|P1|STARTED|Overall Study||155
5307163|NCT00502216|13047848|P2|NOT COMPLETED|Overall Study||0
5307164|NCT00502216|13047849|P1|NOT COMPLETED|Overall Study||0
5307165|NCT00502216|13047848|P2|COMPLETED|Overall Study||19
5307166|NCT00502216|13047849|P1|COMPLETED|Overall Study||21
5307167|NCT00502216|13047848|P2|STARTED|Overall Study||19
5307168|NCT00502216|13047849|P1|STARTED|Overall Study||21
5307169|NCT00502203|13047859|P1|NOT COMPLETED|Overall Study||1
5307170|NCT00502203|13047859|P1|COMPLETED|Overall Study||22
5307171|NCT00502203|13047859|P1|STARTED|Overall Study||23
5307172|NCT00501995|13047863|P1|NOT COMPLETED|Overall Study||1
5307173|NCT00501995|13047863|P1|COMPLETED|Overall Study||5
5307174|NCT00501995|13047863|P1|STARTED|Overall Study||6
5307175|NCT00501969|13047868|P1|NOT COMPLETED|Overall Study||206
5307176|NCT00501969|13047868|P1|COMPLETED|Overall Study||189
5307177|NCT00501969|13047868|P1|STARTED|Overall Study||395
5307178|NCT00501943|13047876|P2|NOT COMPLETED|Overall Study||3
5307179|NCT00501943|13047877|P1|NOT COMPLETED|Overall Study||2
5307180|NCT00501943|13047876|P2|COMPLETED|Overall Study||18
5307181|NCT00501943|13047877|P1|COMPLETED|Overall Study||20
5307182|NCT00501943|13047876|P2|STARTED|Overall Study||21
5307183|NCT00501943|13047877|P1|STARTED|Overall Study||22
5307184|NCT00501891|13047893|P1|NOT COMPLETED|Overall Study||0
5307185|NCT00501891|13047893|P1|COMPLETED|Overall Study||32
5307186|NCT00501891|13047893|P1|STARTED|Overall Study||32
5307187|NCT00501852|13047900|P1|NOT COMPLETED|Overall Study||5
5307188|NCT00501852|13047900|P1|COMPLETED|Overall Study||78
5307189|NCT00501852|13047900|P1|Tiotropium|Overall Study||55
5307190|NCT00501852|13047900|P1|Placebo|Overall Study||55
5307191|NCT00501852|13047900|P1|NVA237 100µg|Overall Study||54
5307192|NCT00501852|13047900|P1|NVA237 50µg|Overall Study||53
5307193|NCT00501852|13047900|P1|NVA237 25µg|Overall Study||51
5307194|NCT00501852|13047900|P1|NVA237 12.5µg|Overall Study||55
5307195|NCT00501852|13047900|P1|STARTED|Overall Study||83
5307196|NCT00501644|13047920|P1|NOT COMPLETED|Overall Study||5
5307197|NCT00501644|13047920|P1|COMPLETED|Overall Study||54
5307198|NCT00501644|13047920|P1|STARTED|Overall Study||59
5307199|NCT00501631|13047926|P2|NOT COMPLETED|Part B (Open-label Period)||51
5307200|NCT00501631|13047927|P1|NOT COMPLETED|Part B (Open-label Period)||53
5307201|NCT00501631|13047926|P2|COMPLETED|Part B (Open-label Period)||48
5307202|NCT00501631|13047927|P1|COMPLETED|Part B (Open-label Period)||37
5307203|NCT00501631|13047926|P2|STARTED|Part B (Open-label Period)||99
5307204|NCT00501631|13047927|P1|STARTED|Part B (Open-label Period)||90
5307205|NCT00501631|13047926|P2|NOT COMPLETED|Part A (Double-blind Period)||49
5307206|NCT00501631|13047927|P1|NOT COMPLETED|Part A (Double-blind Period)||62
5307207|NCT00501631|13047926|P2|COMPLETED|Part A (Double-blind Period)||99
5307208|NCT00501631|13047927|P1|COMPLETED|Part A (Double-blind Period)||90
5307209|NCT00501631|13047926|P2|STARTED|Part A (Double-blind Period)||148
5307210|NCT00501631|13047927|P1|STARTED|Part A (Double-blind Period)||152
5307211|NCT00501592|13047936|P3|NOT COMPLETED|Overall Study||3
5307212|NCT00501592|13047937|P2|NOT COMPLETED|Overall Study||5
5307213|NCT00501592|13047938|P1|NOT COMPLETED|Overall Study||0
5307214|NCT00501592|13047936|P3|COMPLETED|Overall Study||20
5307215|NCT00501592|13047937|P2|COMPLETED|Overall Study||16
5307216|NCT00501592|13047938|P1|COMPLETED|Overall Study||20
5307217|NCT00501592|13047936|P3|STARTED|Overall Study||23
5307218|NCT00501592|13047937|P2|STARTED|Overall Study||21
5307219|NCT00501592|13047938|P1|STARTED|Overall Study||20
5307220|NCT00501540|13047949|P1|NOT COMPLETED|Overall Study||5
5307221|NCT00501540|13047949|P1|COMPLETED|Overall Study||10
5307222|NCT00501540|13047949|P1|STARTED|Overall Study||15
5307223|NCT00501345|13047955|P1|NOT COMPLETED|Overall Study||0
5307224|NCT00501345|13047955|P1|COMPLETED|Overall Study||5
5307225|NCT00501345|13047955|P1|STARTED|Overall Study||5
5307226|NCT00501293|13047961|P2|NOT COMPLETED|Maintenance Period||28
5307227|NCT00501293|13047962|P1|NOT COMPLETED|Maintenance Period||46
5307228|NCT00501293|13047961|P2|COMPLETED|Maintenance Period||25
5307229|NCT00501293|13047962|P1|COMPLETED|Maintenance Period||63
5307230|NCT00501293|13047961|P2|STARTED|Maintenance Period||53
5307231|NCT00501293|13047962|P1|STARTED|Maintenance Period||109
5307232|NCT00501293|13047961|P2|NOT COMPLETED|Optimization Period||0
5307233|NCT00501293|13047962|P1|NOT COMPLETED|Optimization Period||1
5307234|NCT00501293|13047961|P2|COMPLETED|Optimization Period||53
5307235|NCT00501293|13047962|P1|COMPLETED|Optimization Period||109
5307236|NCT00501293|13047961|P2|STARTED|Optimization Period||53
5307237|NCT00501293|13047962|P1|STARTED|Optimization Period||110
5307238|NCT00501228|13047989|P1|NOT COMPLETED|Overall Study||1
5307239|NCT00501228|13047989|P1|COMPLETED|Overall Study||1
5307240|NCT00501228|13047989|P1|STARTED|Overall Study||2
5307241|NCT00501085|13047993|P1|NOT COMPLETED|Overall Study||432
5307242|NCT00501085|13047993|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
5307243|NCT00501085|13047993|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
5307244|NCT00501059|13048003|P2|NOT COMPLETED|Overall Study||1892
5307245|NCT00501059|13048004|P1|NOT COMPLETED|Overall Study||1868
5307246|NCT00501059|13048003|P2|COMPLETED|Overall Study||4384
5307247|NCT00501059|13048004|P1|COMPLETED|Overall Study||4402
5307248|NCT00501059|13048003|P2|STARTED|Overall Study||6276
5307249|NCT00501059|13048004|P1|STARTED|Overall Study||6270
5307250|NCT00501046|13048028|P2|NOT COMPLETED|Overall Study||294
5307251|NCT00501046|13048029|P1|NOT COMPLETED|Overall Study||270
5307252|NCT00501046|13048028|P2|COMPLETED|Overall Study||213
5307253|NCT00501046|13048029|P1|COMPLETED|Overall Study||238
5307254|NCT00501046|13048028|P2|STARTED|Overall Study||507
5307255|NCT00501046|13048029|P1|STARTED|Overall Study||508
5307256|NCT00501007|13048035|P2|NOT COMPLETED|Overall Study||25
5307257|NCT00501007|13048036|P1|NOT COMPLETED|Overall Study||29
5307258|NCT00501007|13048035|P2|COMPLETED|Overall Study||78
5307259|NCT00501007|13048036|P1|COMPLETED|Overall Study||71
5307260|NCT00501007|13048035|P2|STARTED|Overall Study||103
5307261|NCT00501007|13048036|P1|STARTED|Overall Study||100
5307262|NCT00500903|13048045|P3|NOT COMPLETED|Overall Study||20
5307263|NCT00500903|13048046|P2|NOT COMPLETED|Overall Study||2
5307264|NCT00500903|13048047|P1|NOT COMPLETED|Overall Study||65
5307265|NCT00500903|13048045|P3|COMPLETED|Overall Study||0
5307266|NCT00500903|13048046|P2|COMPLETED|Overall Study||0
5307267|NCT00500903|13048047|P1|COMPLETED|Overall Study||0
5307268|NCT00500903|13048045|P3|STARTED|Overall Study||20
5307269|NCT00500903|13048046|P2|STARTED|Overall Study||2
5307270|NCT00500903|13048047|P1|STARTED|Overall Study||65
5307271|NCT00500890|13048228|P2|NOT COMPLETED|Overall Study||0
5307272|NCT00500890|13048229|P1|NOT COMPLETED|Overall Study||0
5307273|NCT00500890|13048228|P2|COMPLETED|Overall Study||1
5307274|NCT00500890|13048229|P1|COMPLETED|Overall Study||1
5307275|NCT00500890|13048228|P2|STARTED|Overall Study||1
5307276|NCT00500890|13048229|P1|STARTED|Overall Study||1
5307277|NCT00500760|13048243|P2|NOT COMPLETED|Overall Study||24
5307278|NCT00500760|13048244|P1|NOT COMPLETED|Overall Study||43
5307279|NCT00500760|13048243|P2|COMPLETED|Overall Study||40
5307280|NCT00500760|13048244|P1|COMPLETED|Overall Study||46
5307281|NCT00500760|13048243|P2|Received Treatment|Overall Study||63
5307282|NCT00500760|13048244|P1|Received Treatment|Overall Study||87
5307283|NCT00500760|13048243|P2|STARTED|Overall Study||64
5307284|NCT00500760|13048244|P1|STARTED|Overall Study||89
5307285|NCT00500682|13048264|P2|NOT COMPLETED|Overall Study||287
5307286|NCT00500682|13048265|P1|NOT COMPLETED|Overall Study||306
5307287|NCT00500682|13048264|P2|COMPLETED|Overall Study||223
5307288|NCT00500682|13048265|P1|COMPLETED|Overall Study||204
5307289|NCT00500682|13048264|P2|STARTED|Overall Study||510
5307290|NCT00500682|13048265|P1|STARTED|Overall Study||510
5307291|NCT00500656|13048275|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
5307292|NCT00500656|13048276|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
5307293|NCT00500656|13048277|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
5307294|NCT00500656|13048278|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
5307295|NCT00500656|13048275|P4|COMPLETED|Open Label Extension (OLE) Phase||6
5307296|NCT00500656|13048276|P3|COMPLETED|Open Label Extension (OLE) Phase||1
5307297|NCT00500656|13048277|P2|COMPLETED|Open Label Extension (OLE) Phase||9
5307298|NCT00500656|13048278|P1|COMPLETED|Open Label Extension (OLE) Phase||16
5307299|NCT00500656|13048275|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
5307300|NCT00500656|13048276|P3|STARTED|Open Label Extension (OLE) Phase||2
5307301|NCT00500656|13048277|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
5307302|NCT00500656|13048278|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
5307303|NCT00500656|13048275|P4|NOT COMPLETED|Controlled Phase||8
5307304|NCT00500656|13048276|P3|NOT COMPLETED|Controlled Phase||1
5307305|NCT00500656|13048277|P2|NOT COMPLETED|Controlled Phase||10
5307306|NCT00500656|13048278|P1|NOT COMPLETED|Controlled Phase||10
5307307|NCT00500656|13048275|P4|COMPLETED|Controlled Phase||0
5307308|NCT00500656|13048276|P3|COMPLETED|Controlled Phase||2
5307309|NCT00500656|13048277|P2|COMPLETED|Controlled Phase||28
5307310|NCT00500656|13048278|P1|COMPLETED|Controlled Phase||26
5307311|NCT00500656|13048275|P4|STARTED|Controlled Phase||8
5307312|NCT00500656|13048276|P3|STARTED|Controlled Phase||3
5307313|NCT00500656|13048277|P2|STARTED|Controlled Phase||38
5307314|NCT00500656|13048278|P1|STARTED|Controlled Phase||36
5307315|NCT00500578|13048292|P2|NOT COMPLETED|Overall Study||0
5307316|NCT00500578|13048293|P1|NOT COMPLETED|Overall Study||0
5307317|NCT00500578|13048292|P2|COMPLETED|Overall Study|All completed|32
5307318|NCT00500578|13048293|P1|COMPLETED|Overall Study|All completed|18
5307319|NCT00500578|13048292|P2|STARTED|Overall Study||32
5307320|NCT00500578|13048293|P1|STARTED|Overall Study||18
5307321|NCT00500539|13048299|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
5307322|NCT00500539|13048299|P1|COMPLETED|Follow-up Period (16 Weeks)||136
5307323|NCT00500539|13048299|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
5307324|NCT00500539|13048299|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
5307325|NCT00500539|13048299|P1|COMPLETED|Treatment Period (24 Weeks)||140
5307326|NCT00500539|13048299|P1|STARTED|Treatment Period (24 Weeks)||155
5307327|NCT00500448|13048308|P2|NOT COMPLETED|Overall Study||0
5307328|NCT00500448|13048309|P1|NOT COMPLETED|Overall Study||0
5307329|NCT00500448|13048308|P2|COMPLETED|Overall Study||16
5307330|NCT00500448|13048309|P1|COMPLETED|Overall Study||14
5307331|NCT00500448|13048308|P2|STARTED|Overall Study||16
5307332|NCT00500448|13048309|P1|STARTED|Overall Study||14
5307333|NCT00500370|13048325|P2|NOT COMPLETED|Overall Study||34
5307334|NCT00500370|13048326|P1|NOT COMPLETED|Overall Study||33
5307335|NCT00500370|13048325|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
5307336|NCT00500370|13048326|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
5307337|NCT00500370|13048325|P2|Treatment Complete (Week 24)|Overall Study||54
5307338|NCT00500370|13048326|P1|Treatment Complete (Week 24)|Overall Study||48
5307339|NCT00500370|13048325|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
5307340|NCT00500370|13048326|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
5307341|NCT00500370|13048325|P2|STARTED|Overall Study||83
5307342|NCT00500370|13048326|P1|STARTED|Overall Study||80
5307343|NCT00500357|13048362|P1|NOT COMPLETED|Overall Study||1
5307344|NCT00500357|13048362|P1|COMPLETED|Overall Study||104
5307345|NCT00500357|13048362|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
5307346|NCT00500357|13048362|P1|Received 13vPnC (Vax 3)|Overall Study||105
5307347|NCT00500357|13048362|P1|STARTED|Overall Study||105
5307348|NCT00500331|13048388|P7|NOT COMPLETED|Overall Study||2
5307349|NCT00500331|13048389|P6|NOT COMPLETED|Overall Study||5
5307350|NCT00500331|13048390|P5|NOT COMPLETED|Overall Study||4
5307351|NCT00500331|13048391|P4|NOT COMPLETED|Overall Study||10
5307352|NCT00500331|13048392|P3|NOT COMPLETED|Overall Study||5
5307353|NCT00500331|13048393|P2|NOT COMPLETED|Overall Study||5
5307354|NCT00500331|13048394|P1|NOT COMPLETED|Overall Study||15
5307355|NCT00500331|13048388|P7|COMPLETED|Overall Study||46
5307356|NCT00500331|13048389|P6|COMPLETED|Overall Study||42
5307357|NCT00500331|13048390|P5|COMPLETED|Overall Study||44
5307358|NCT00500331|13048391|P4|COMPLETED|Overall Study||38
5307359|NCT00500331|13048392|P3|COMPLETED|Overall Study||43
5307360|NCT00500331|13048393|P2|COMPLETED|Overall Study||42
5307361|NCT00500331|13048394|P1|COMPLETED|Overall Study||33
5307362|NCT00500331|13048388|P7|STARTED|Overall Study||48
5307363|NCT00500331|13048389|P6|STARTED|Overall Study||47
5307364|NCT00500331|13048390|P5|STARTED|Overall Study||48
5307365|NCT00500331|13048391|P4|STARTED|Overall Study||48
5307366|NCT00500331|13048392|P3|STARTED|Overall Study||48
5307367|NCT00500331|13048393|P2|STARTED|Overall Study||47
5307368|NCT00500331|13048394|P1|STARTED|Overall Study||48
5307369|NCT00500318|13048531|P2|NOT COMPLETED|Overall Study||17
5307370|NCT00500318|13048532|P1|NOT COMPLETED|Overall Study||5
5307371|NCT00500318|13048531|P2|COMPLETED|Overall Study||78
5307372|NCT00500318|13048532|P1|COMPLETED|Overall Study||81
5307373|NCT00500318|13048531|P2|STARTED|Overall Study||95
5307374|NCT00500318|13048532|P1|STARTED|Overall Study||86
5307375|NCT00500292|13048549|P3|NOT COMPLETED|Overall Study||27
5307376|NCT00500292|13048550|P2|NOT COMPLETED|Overall Study||31
5307377|NCT00500292|13048551|P1|NOT COMPLETED|Overall Study||25
5307378|NCT00500292|13048549|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
5307379|NCT00500292|13048550|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
5307380|NCT00500292|13048551|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
5307381|NCT00500292|13048549|P3|STARTED|Overall Study|randomised patients|37
5307382|NCT00500292|13048550|P2|STARTED|Overall Study|randomised patients|35
5307383|NCT00500292|13048551|P1|STARTED|Overall Study|randomised patients|32
5307384|NCT00500240|13048561|P2|NOT COMPLETED|Overall Study||0
5307385|NCT00500240|13048562|P1|NOT COMPLETED|Overall Study||0
5307386|NCT00500240|13048561|P2|COMPLETED|Overall Study||26
5307387|NCT00500240|13048562|P1|COMPLETED|Overall Study||25
5307388|NCT00500240|13048561|P2|STARTED|Overall Study||26
5307389|NCT00500240|13048562|P1|STARTED|Overall Study||25
5307390|NCT00500149|13048572|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
5307391|NCT00500149|13048573|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
5307392|NCT00500149|13048572|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
5307393|NCT00500149|13048573|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
5307394|NCT00500149|13048572|P2|STARTED|Second Intervention (Cross-over Phase)||57
5307395|NCT00500149|13048573|P1|STARTED|Second Intervention (Cross-over Phase)||56
5307396|NCT00500149|13048572|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
5307397|NCT00500149|13048573|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
5307398|NCT00500149|13048572|P2|COMPLETED|First Intervention (Cross-over Phase)||57
5307399|NCT00500149|13048573|P1|COMPLETED|First Intervention (Cross-over Phase)||56
5307400|NCT00500149|13048572|P2|STARTED|First Intervention (Cross-over Phase)||59
5307401|NCT00500149|13048573|P1|STARTED|First Intervention (Cross-over Phase)||58
5307402|NCT00500149|13048572|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
5307403|NCT00500149|13048573|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
5307404|NCT00500149|13048572|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
5307405|NCT00500149|13048573|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
5307406|NCT00500149|13048572|P2|STARTED|Enrolled (Dose-optimization Phase)||0
5307407|NCT00500149|13048573|P1|STARTED|Enrolled (Dose-optimization Phase)||129
5307408|NCT00500110|13048581|P1|NOT COMPLETED|Overall Study||3
5307409|NCT00500110|13048581|P1|COMPLETED|Overall Study||36
5307410|NCT00500110|13048581|P1|STARTED|Overall Study||39
5307411|NCT00500071|13048585|P1|NOT COMPLETED|30-day Safety Follow-up||17
5307412|NCT00500071|13048585|P1|COMPLETED|30-day Safety Follow-up||278
5307413|NCT00500071|13048585|P1|STARTED|30-day Safety Follow-up||295
5307414|NCT00500071|13048585|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
5307415|NCT00500071|13048585|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
5307416|NCT00500071|13048585|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
5307417|NCT00500071|13048585|P1|NOT COMPLETED|Screening and Washout Phase||1
5307418|NCT00500071|13048585|P1|COMPLETED|Screening and Washout Phase||317
5307419|NCT00500071|13048585|P1|STARTED|Screening and Washout Phase||318
5307420|NCT00500045|13048594|P1|NOT COMPLETED|Overall Study||0
5307421|NCT00500045|13048594|P1|COMPLETED|Overall Study||0
5307422|NCT00500045|13048594|P1|STARTED|Overall Study||0
5307423|NCT00499915|13048601|P2|NOT COMPLETED|Overall Study||6
5307424|NCT00499915|13048602|P1|NOT COMPLETED|Overall Study||15
5307425|NCT00499915|13048601|P2|COMPLETED|Overall Study||76
5307426|NCT00499915|13048602|P1|COMPLETED|Overall Study||68
5307427|NCT00499915|13048601|P2|STARTED|Overall Study||82
5307428|NCT00499915|13048602|P1|STARTED|Overall Study||83
5307429|NCT00499889|13048608|P1|NOT COMPLETED|Overall Study||1
5307430|NCT00499889|13048608|P1|COMPLETED|Overall Study||41
5307431|NCT00499889|13048608|P1|STARTED|Overall Study||42
5307432|NCT00499863|13048616|P2|NOT COMPLETED|Overall Study||43
5307433|NCT00499863|13048617|P1|NOT COMPLETED|Overall Study||50
5307434|NCT00499863|13048616|P2|COMPLETED|Overall Study||29
5307435|NCT00499863|13048617|P1|COMPLETED|Overall Study||95
5307436|NCT00499863|13048616|P2|STARTED|Overall Study||72
5307437|NCT00499863|13048617|P1|STARTED|Overall Study||145
5307438|NCT00500266|13048645|P1|NOT COMPLETED|Overall Study||13
5307439|NCT00500266|13048645|P1|COMPLETED|Overall Study||1040
5307440|NCT00500266|13048645|P1|Treated|Overall Study||1049
5307441|NCT00500266|13048645|P1|STARTED|Overall Study||1053
5307442|NCT00499746|13048652|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
5307443|NCT00499746|13048652|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
5307444|NCT00499746|13048652|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
5307445|NCT00499746|13048652|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
5307446|NCT00499746|13048652|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
5307447|NCT00499746|13048652|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
5307448|NCT00499746|13048652|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
5307449|NCT00499746|13048652|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
5307450|NCT00499746|13048652|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
5307451|NCT00499694|13048721|P1|NOT COMPLETED|Overall Study||1
5307452|NCT00499694|13048721|P1|COMPLETED|Overall Study||30
5307453|NCT00499694|13048721|P1|STARTED|Overall Study||31
5307454|NCT00499681|13048730|P2|NOT COMPLETED|Overall Study||2
5307455|NCT00499681|13048731|P1|NOT COMPLETED|Overall Study||0
5307456|NCT00499681|13048730|P2|COMPLETED|Overall Study||0
5307457|NCT00499681|13048731|P1|COMPLETED|Overall Study||4
5307458|NCT00499681|13048730|P2|STARTED|Overall Study||2
5307459|NCT00499681|13048731|P1|STARTED|Overall Study||4
5307460|NCT00499655|13048739|P2|NOT COMPLETED|Overall Study||0
5307461|NCT00499655|13048740|P1|NOT COMPLETED|Overall Study||0
5307462|NCT00499655|13048739|P2|COMPLETED|Overall Study||54
5307463|NCT00499655|13048740|P1|COMPLETED|Overall Study||53
5307464|NCT00499655|13048739|P2|STARTED|Overall Study||54
5307465|NCT00499655|13048740|P1|STARTED|Overall Study||53
5307466|NCT00499616|13048758|P4|NOT COMPLETED|Overall Study||57
5307467|NCT00499616|13048759|P3|NOT COMPLETED|Overall Study||36
5307468|NCT00499616|13048760|P2|NOT COMPLETED|Overall Study||28
5307469|NCT00499616|13048761|P1|NOT COMPLETED|Overall Study||15
5307470|NCT00499616|13048758|P4|COMPLETED|Overall Study||0
5307471|NCT00499616|13048759|P3|COMPLETED|Overall Study||53
5307472|NCT00499616|13048760|P2|COMPLETED|Overall Study||114
5307473|NCT00499616|13048761|P1|COMPLETED|Overall Study||161
5307474|NCT00499616|13048758|P4|STARTED|Overall Study||57
5307475|NCT00499616|13048759|P3|STARTED|Overall Study||89
5307476|NCT00499616|13048760|P2|STARTED|Overall Study||142
5307477|NCT00499616|13048761|P1|STARTED|Overall Study||176
5307478|NCT00499603|13048806|P2|NOT COMPLETED|Overall Study||1
5307479|NCT00499603|13048807|P1|NOT COMPLETED|Overall Study||0
5307480|NCT00499603|13048806|P2|COMPLETED|Overall Study||22
5307481|NCT00499603|13048807|P1|COMPLETED|Overall Study||27
5307482|NCT00499603|13048806|P2|STARTED|Overall Study||23
5307483|NCT00499603|13048807|P1|STARTED|Overall Study||27
5307484|NCT00499590|13048820|P3|NOT COMPLETED|Overall Study||113
5307485|NCT00499590|13048821|P2|NOT COMPLETED|Overall Study||112
5307486|NCT00499590|13048822|P1|NOT COMPLETED|Overall Study||113
5307487|NCT00499590|13048820|P3|COMPLETED|Overall Study||0
5307488|NCT00499590|13048821|P2|COMPLETED|Overall Study||0
5307489|NCT00499590|13048822|P1|COMPLETED|Overall Study||0
5307490|NCT00499590|13048820|P3|STARTED|Overall Study||113
5307491|NCT00499590|13048821|P2|STARTED|Overall Study||112
5307492|NCT00499590|13048822|P1|STARTED|Overall Study||113
5307493|NCT00499486|13048833|P1|NOT COMPLETED|Overall Study||16
5307494|NCT00499486|13048833|P1|COMPLETED|Overall Study||31
5307495|NCT00499486|13048833|P1|STARTED|Overall Study||47
5307496|NCT00499473|13048841|P2|NOT COMPLETED|Overall Study||0
5307497|NCT00499473|13048842|P1|NOT COMPLETED|Overall Study||6
5307498|NCT00499473|13048841|P2|COMPLETED|Overall Study||4
5307499|NCT00499473|13048842|P1|COMPLETED|Overall Study|Patients evaluable|21
5307500|NCT00499473|13048841|P2|STARTED|Overall Study||4
5307501|NCT00499473|13048842|P1|STARTED|Overall Study||27
5307502|NCT00499460|13048860|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
5307503|NCT00499460|13048861|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
5307504|NCT00499460|13048860|P2|COMPLETED|Intervention 2 (30 Days)||6
5307505|NCT00499460|13048861|P1|COMPLETED|Intervention 2 (30 Days)||6
5307506|NCT00499460|13048860|P2|STARTED|Intervention 2 (30 Days)||7
5307507|NCT00499460|13048861|P1|STARTED|Intervention 2 (30 Days)||6
5307508|NCT00499460|13048860|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
5307509|NCT00499460|13048861|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
5307510|NCT00499460|13048860|P2|COMPLETED|Intervention 1 (30 Days)||7
5307511|NCT00499460|13048861|P1|COMPLETED|Intervention 1 (30 Days)||6
5307512|NCT00499460|13048860|P2|STARTED|Intervention 1 (30 Days)||7
5307513|NCT00499460|13048861|P1|STARTED|Intervention 1 (30 Days)||8
5307514|NCT00499447|13048877|P1|NOT COMPLETED|Overall Study||0
5307515|NCT00499447|13048877|P1|COMPLETED|Overall Study||13
5307516|NCT00499447|13048877|P1|STARTED|Overall Study||13
5307517|NCT00499408|13048881|P1|NOT COMPLETED|Overall Study||0
5307518|NCT00499408|13048881|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
5307519|NCT00499408|13048881|P1|STARTED|Overall Study||26
5307520|NCT00499369|13048894|P5|NOT COMPLETED|Overall Study||12
5307521|NCT00499369|13048895|P4|NOT COMPLETED|Overall Study||9
5307522|NCT00499369|13048896|P3|NOT COMPLETED|Overall Study||17
5307523|NCT00499369|13048897|P2|NOT COMPLETED|Overall Study||18
5307524|NCT00499369|13048898|P1|NOT COMPLETED|Overall Study||16
5307525|NCT00499369|13048894|P5|COMPLETED|Overall Study||0
5307526|NCT00499369|13048895|P4|COMPLETED|Overall Study||0
5307527|NCT00499369|13048896|P3|COMPLETED|Overall Study||0
5307528|NCT00499369|13048897|P2|COMPLETED|Overall Study||0
5307529|NCT00499369|13048898|P1|COMPLETED|Overall Study||0
5307530|NCT00499369|13048894|P5|Eligible|Overall Study||12
5307531|NCT00499369|13048895|P4|Eligible|Overall Study||8
5307532|NCT00499369|13048896|P3|Eligible|Overall Study||16
5307533|NCT00499369|13048897|P2|Eligible|Overall Study||16
5307534|NCT00499369|13048898|P1|Eligible|Overall Study||14
5307535|NCT00499369|13048894|P5|STARTED|Overall Study||12
5307536|NCT00499369|13048895|P4|STARTED|Overall Study||9
5307537|NCT00499369|13048896|P3|STARTED|Overall Study||17
5307538|NCT00499369|13048897|P2|STARTED|Overall Study||18
5307539|NCT00499369|13048898|P1|STARTED|Overall Study||16
5307540|NCT00499343|13048927|P2|NOT COMPLETED|Overall Study||0
5307541|NCT00499343|13048928|P1|NOT COMPLETED|Overall Study||0
5307542|NCT00499343|13048927|P2|COMPLETED|Overall Study||43
5307543|NCT00499343|13048928|P1|COMPLETED|Overall Study||41
5307544|NCT00499343|13048927|P2|STARTED|Overall Study||43
5307545|NCT00499343|13048928|P1|STARTED|Overall Study||41
5307546|NCT00499252|13048934|P1|NOT COMPLETED|Overall Study||12
5307547|NCT00499252|13048934|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
5307548|NCT00499252|13048934|P1|STARTED|Overall Study||51
5307549|NCT00499122|13048944|P1|NOT COMPLETED|Overall Study||2
5307550|NCT00499122|13048944|P1|COMPLETED|Overall Study||39
5307551|NCT00499122|13048944|P1|STARTED|Overall Study||41
5307552|NCT00499109|13048952|P2|NOT COMPLETED|Overall Study||7
5307553|NCT00499109|13048953|P1|NOT COMPLETED|Overall Study||18
5307554|NCT00499109|13048952|P2|COMPLETED|Overall Study||85
5307555|NCT00499109|13048953|P1|COMPLETED|Overall Study||165
5307556|NCT00499109|13048952|P2|STARTED|Overall Study||92
5307557|NCT00499109|13048953|P1|STARTED|Overall Study||183
5307558|NCT00499096|13048968|P2|NOT COMPLETED|Overall Study||20
5307559|NCT00499096|13048969|P1|NOT COMPLETED|Overall Study||23
5307560|NCT00499096|13048968|P2|COMPLETED|Overall Study||40
5307561|NCT00499096|13048969|P1|COMPLETED|Overall Study||35
5307562|NCT00499096|13048968|P2|STARTED|Overall Study||60
5307563|NCT00499096|13048969|P1|STARTED|Overall Study||58
5307564|NCT00499083|13048987|P1|NOT COMPLETED|Overall Study||3
5307565|NCT00499083|13048987|P1|COMPLETED|Overall Study||14
5307566|NCT00499083|13048987|P1|Participants at Moffitt Cancer Center|Overall Study||14
5307567|NCT00499083|13048987|P1|Participants at UNMC|Overall Study||3
5307568|NCT00499083|13048987|P1|STARTED|Overall Study||17
5307569|NCT00499031|13048994|P1|NOT COMPLETED|Overall Study||3
5307570|NCT00499031|13048994|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
5307571|NCT00499031|13048994|P1|STARTED|Overall Study|Total number participants enrolled on study|38
5307572|NCT00498940|13049001|P2|NOT COMPLETED|Overall Study||0
5307573|NCT00498940|13049002|P1|NOT COMPLETED|Overall Study||0
5307574|NCT00498940|13049001|P2|COMPLETED|Overall Study||31
5307575|NCT00498940|13049002|P1|COMPLETED|Overall Study||30
5307576|NCT00498940|13049001|P2|STARTED|Overall Study||31
5307577|NCT00498940|13049002|P1|STARTED|Overall Study||30
5307578|NCT00498927|13049010|P1|NOT COMPLETED|Overall Study||0
5307579|NCT00498927|13049010|P1|COMPLETED|Overall Study||47
5307580|NCT00498927|13049010|P1|STARTED|Overall Study||47
5307581|NCT00498797|13049017|P2|NOT COMPLETED|Overall Study||29
5307582|NCT00498797|13049018|P1|NOT COMPLETED|Overall Study||38
5307583|NCT00498797|13049017|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
5307584|NCT00498797|13049018|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
5307585|NCT00498797|13049017|P2|STARTED|Overall Study|randomised patients|43
5307586|NCT00498797|13049018|P1|STARTED|Overall Study|randomised patients|43
5307587|NCT00498706|13049028|P2|NOT COMPLETED|Overall Study||0
5307588|NCT00498706|13049029|P1|NOT COMPLETED|Overall Study||0
5307589|NCT00498706|13049028|P2|COMPLETED|Overall Study||162
5307590|NCT00498706|13049029|P1|COMPLETED|Overall Study||163
5307591|NCT00498706|13049028|P2|Post Treatment Week 18|Overall Study||162
5307592|NCT00498706|13049029|P1|Post Treatment Week 18|Overall Study||163
5307593|NCT00498706|13049028|P2|STARTED|Overall Study||162
5307594|NCT00498706|13049029|P1|STARTED|Overall Study||163
5307595|NCT00498628|13049043|P2|NOT COMPLETED|Overall Study||21
5307596|NCT00498628|13049044|P1|NOT COMPLETED|Overall Study||15
5307597|NCT00498628|13049043|P2|COMPLETED|Overall Study||92
5307598|NCT00498628|13049044|P1|COMPLETED|Overall Study||90
5307599|NCT00498628|13049043|P2|STARTED|Overall Study||113
5307600|NCT00498628|13049044|P1|STARTED|Overall Study||105
5307601|NCT00498615|13049076|P6|NOT COMPLETED|Placebo||0
5307602|NCT00498615|13049077|P5|NOT COMPLETED|Placebo||0
5307603|NCT00498615|13049078|P4|NOT COMPLETED|Placebo||0
5307604|NCT00498615|13049079|P3|NOT COMPLETED|Placebo||0
5307605|NCT00498615|13049080|P2|NOT COMPLETED|Placebo||0
5307606|NCT00498615|13049081|P1|NOT COMPLETED|Placebo||0
5307607|NCT00498615|13049076|P6|COMPLETED|Placebo||3
5307608|NCT00498615|13049077|P5|COMPLETED|Placebo||3
5307609|NCT00498615|13049078|P4|COMPLETED|Placebo||2
5307610|NCT00498615|13049079|P3|COMPLETED|Placebo||3
5307611|NCT00498615|13049080|P2|COMPLETED|Placebo||4
5307612|NCT00498615|13049081|P1|COMPLETED|Placebo||2
5307613|NCT00498615|13049076|P6|STARTED|Placebo||3
5307614|NCT00498615|13049077|P5|STARTED|Placebo||3
5307615|NCT00498615|13049078|P4|STARTED|Placebo||2
5307616|NCT00498615|13049079|P3|STARTED|Placebo||3
5307617|NCT00498615|13049080|P2|STARTED|Placebo||4
5307618|NCT00498615|13049081|P1|STARTED|Placebo||2
5307619|NCT00498615|13049076|P6|NOT COMPLETED|Fasudil 40mg||0
5307620|NCT00498615|13049077|P5|NOT COMPLETED|Fasudil 40mg||0
5307621|NCT00498615|13049078|P4|NOT COMPLETED|Fasudil 40mg||0
5307622|NCT00498615|13049079|P3|NOT COMPLETED|Fasudil 40mg||0
5307623|NCT00498615|13049080|P2|NOT COMPLETED|Fasudil 40mg||0
5307624|NCT00498615|13049081|P1|NOT COMPLETED|Fasudil 40mg||0
5307625|NCT00498615|13049076|P6|COMPLETED|Fasudil 40mg||3
5307626|NCT00498615|13049077|P5|COMPLETED|Fasudil 40mg||3
5307627|NCT00498615|13049078|P4|COMPLETED|Fasudil 40mg||2
5307628|NCT00498615|13049079|P3|COMPLETED|Fasudil 40mg||3
5307629|NCT00498615|13049080|P2|COMPLETED|Fasudil 40mg||4
5307630|NCT00498615|13049081|P1|COMPLETED|Fasudil 40mg||2
5307631|NCT00498615|13049076|P6|STARTED|Fasudil 40mg||3
5307632|NCT00498615|13049077|P5|STARTED|Fasudil 40mg||3
5307633|NCT00498615|13049078|P4|STARTED|Fasudil 40mg||2
5307634|NCT00498615|13049079|P3|STARTED|Fasudil 40mg||3
5307635|NCT00498615|13049080|P2|STARTED|Fasudil 40mg||4
5307636|NCT00498615|13049081|P1|STARTED|Fasudil 40mg||2
5307637|NCT00498615|13049076|P6|NOT COMPLETED|Fasudil 80mg||0
5307638|NCT00498615|13049077|P5|NOT COMPLETED|Fasudil 80mg||0
5307639|NCT00498615|13049078|P4|NOT COMPLETED|Fasudil 80mg||0
5307640|NCT00498615|13049079|P3|NOT COMPLETED|Fasudil 80mg||0
5307641|NCT00498615|13049080|P2|NOT COMPLETED|Fasudil 80mg||0
5307642|NCT00498615|13049081|P1|NOT COMPLETED|Fasudil 80mg||0
5307643|NCT00498615|13049076|P6|COMPLETED|Fasudil 80mg||3
5307644|NCT00498615|13049077|P5|COMPLETED|Fasudil 80mg||3
5307645|NCT00498615|13049078|P4|COMPLETED|Fasudil 80mg||2
5307646|NCT00498615|13049079|P3|COMPLETED|Fasudil 80mg||3
5307647|NCT00498615|13049080|P2|COMPLETED|Fasudil 80mg||4
5307648|NCT00498615|13049081|P1|COMPLETED|Fasudil 80mg||2
5307649|NCT00498615|13049076|P6|STARTED|Fasudil 80mg||3
5307650|NCT00498615|13049077|P5|STARTED|Fasudil 80mg||3
5307651|NCT00498615|13049078|P4|STARTED|Fasudil 80mg||2
5307652|NCT00498615|13049079|P3|STARTED|Fasudil 80mg||3
5307653|NCT00498615|13049080|P2|STARTED|Fasudil 80mg||4
5307654|NCT00498615|13049081|P1|STARTED|Fasudil 80mg||2
5307655|NCT00498602|13049102|P7|NOT COMPLETED|Overall Study||2
5307656|NCT00498602|13049103|P6|NOT COMPLETED|Overall Study||13
5307657|NCT00498602|13049104|P5|NOT COMPLETED|Overall Study||4
5307658|NCT00498602|13049105|P4|NOT COMPLETED|Overall Study||5
5307659|NCT00498602|13049106|P3|NOT COMPLETED|Overall Study||8
5307660|NCT00498602|13049107|P2|NOT COMPLETED|Overall Study||10
5307661|NCT00498602|13049108|P1|NOT COMPLETED|Overall Study||10
5307662|NCT00498602|13049102|P7|COMPLETED|Overall Study||15
5307663|NCT00498602|13049103|P6|COMPLETED|Overall Study||31
5307664|NCT00498602|13049104|P5|COMPLETED|Overall Study||8
5307665|NCT00498602|13049105|P4|COMPLETED|Overall Study||30
5307666|NCT00498602|13049106|P3|COMPLETED|Overall Study||32
5307667|NCT00498602|13049107|P2|COMPLETED|Overall Study||51
5307668|NCT00498602|13049108|P1|COMPLETED|Overall Study||26
5307669|NCT00498602|13049102|P7|Treated|Overall Study||17
5307670|NCT00498602|13049103|P6|Treated|Overall Study||44
5307671|NCT00498602|13049104|P5|Treated|Overall Study||12
5307672|NCT00498602|13049105|P4|Treated|Overall Study||35
5307673|NCT00498602|13049106|P3|Treated|Overall Study||40
5307674|NCT00498602|13049107|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
5307675|NCT00498602|13049108|P1|Treated|Overall Study||36
5307676|NCT00498602|13049102|P7|STARTED|Overall Study||17
5307677|NCT00498602|13049103|P6|STARTED|Overall Study||44
5307678|NCT00498602|13049104|P5|STARTED|Overall Study||12
5307679|NCT00498602|13049105|P4|STARTED|Overall Study||35
5307680|NCT00498602|13049106|P3|STARTED|Overall Study||40
5307681|NCT00498602|13049107|P2|STARTED|Overall Study||61
5307682|NCT00498602|13049108|P1|STARTED|Overall Study||36
5307683|NCT00498550|13049147|P2|NOT COMPLETED|Overall Study||1
5307684|NCT00498550|13049148|P1|NOT COMPLETED|Overall Study||0
5307685|NCT00498550|13049147|P2|COMPLETED|Overall Study||15
5307686|NCT00498550|13049148|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
5307687|NCT00498550|13049147|P2|STARTED|Overall Study||16
5307688|NCT00498550|13049148|P1|STARTED|Overall Study||15
5307689|NCT00498485|13049156|P2|NOT COMPLETED|Overall Study||5
5307690|NCT00498485|13049157|P1|NOT COMPLETED|Overall Study||1
5307691|NCT00498485|13049156|P2|COMPLETED|Overall Study||5
5307692|NCT00498485|13049157|P1|COMPLETED|Overall Study||6
5307693|NCT00498485|13049156|P2|STARTED|Overall Study||10
5307694|NCT00498485|13049157|P1|STARTED|Overall Study||7
5307695|NCT00498433|13049168|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
5307696|NCT00498433|13049169|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
5307697|NCT00498433|13049170|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
5307698|NCT00498433|13049168|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
5307699|NCT00498433|13049169|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
5307700|NCT00498433|13049170|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
5307701|NCT00498433|13049168|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
5307702|NCT00498433|13049169|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
5307703|NCT00498433|13049170|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
5307704|NCT00498433|13049168|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
5307705|NCT00498433|13049169|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
5307706|NCT00498433|13049170|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
5307707|NCT00498433|13049168|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
5307708|NCT00498433|13049169|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
5307709|NCT00498433|13049170|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
5307710|NCT00498433|13049168|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
5307711|NCT00498433|13049169|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
5307712|NCT00498433|13049170|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
5307713|NCT00498433|13049168|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307714|NCT00498433|13049169|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307715|NCT00498433|13049170|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307716|NCT00498433|13049168|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
5307717|NCT00498433|13049169|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307718|NCT00498433|13049170|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307719|NCT00498433|13049168|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
5307720|NCT00498433|13049169|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307721|NCT00498433|13049170|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
5307722|NCT00498433|13049168|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307723|NCT00498433|13049169|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307724|NCT00498433|13049170|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307725|NCT00498433|13049168|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307726|NCT00498433|13049169|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
5307727|NCT00498433|13049170|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307728|NCT00498433|13049168|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307729|NCT00498433|13049169|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
5307730|NCT00498433|13049170|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
5307731|NCT00498433|13049168|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307732|NCT00498433|13049169|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307733|NCT00498433|13049170|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307734|NCT00498433|13049168|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307735|NCT00498433|13049169|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307736|NCT00498433|13049170|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
5307737|NCT00498433|13049168|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307738|NCT00498433|13049169|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
5307739|NCT00498433|13049170|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
5307740|NCT00498368|13049215|P2|NOT COMPLETED|Overall Study||2
5307741|NCT00498368|13049216|P1|NOT COMPLETED|Overall Study||3
5307742|NCT00498368|13049215|P2|COMPLETED|Overall Study||15
5307743|NCT00498368|13049216|P1|COMPLETED|Overall Study||14
5307744|NCT00498368|13049215|P2|STARTED|Overall Study||17
5307745|NCT00498368|13049216|P1|STARTED|Overall Study||17
5307746|NCT00498355|13049228|P1|NOT COMPLETED|Overall Study||1
5307747|NCT00498355|13049228|P1|COMPLETED|Overall Study||6
5307748|NCT00498355|13049228|P1|STARTED|Overall Study||7
5307749|NCT00498186|13049236|P1|NOT COMPLETED|Overall Study||173
5307750|NCT00498186|13049236|P1|COMPLETED|Overall Study||122
5307751|NCT00498186|13049236|P1|STARTED|Overall Study||295
5307752|NCT00498173|13049243|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307753|NCT00498173|13049244|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307754|NCT00498173|13049245|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307755|NCT00498173|13049243|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
5307756|NCT00498173|13049244|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307757|NCT00498173|13049245|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307758|NCT00498173|13049243|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
5307759|NCT00498173|13049244|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307760|NCT00498173|13049245|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
5307761|NCT00498173|13049243|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
5307762|NCT00498173|13049244|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
5307763|NCT00498173|13049245|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
5307764|NCT00498173|13049243|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
5307765|NCT00498173|13049244|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
5307766|NCT00498173|13049245|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
5307767|NCT00498173|13049243|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
5307768|NCT00498173|13049244|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
5307769|NCT00498173|13049245|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
5307770|NCT00497874|13049275|P2|NOT COMPLETED|Overall Study||116
5307771|NCT00497874|13049276|P1|NOT COMPLETED|Overall Study||147
5307772|NCT00497874|13049275|P2|COMPLETED|Overall Study||343
5307773|NCT00497874|13049276|P1|COMPLETED|Overall Study||296
5307774|NCT00497874|13049275|P2|STARTED|Overall Study||459
5307775|NCT00497874|13049276|P1|STARTED|Overall Study||443
5307776|NCT00497796|13049294|P2|NOT COMPLETED|Overall Study||59
5307777|NCT00497796|13049295|P1|NOT COMPLETED|Overall Study||85
5307778|NCT00497796|13049294|P2|COMPLETED|Overall Study||101
5307779|NCT00497796|13049295|P1|COMPLETED|Overall Study||62
5307780|NCT00497796|13049294|P2|STARTED|Overall Study||160
5307781|NCT00497796|13049295|P1|STARTED|Overall Study||147
5307782|NCT00497770|13049327|P4|NOT COMPLETED|Overall Study||0
5307783|NCT00497770|13049328|P3|NOT COMPLETED|Overall Study||0
5307784|NCT00497770|13049329|P2|NOT COMPLETED|Overall Study||0
5307785|NCT00497770|13049330|P1|NOT COMPLETED|Overall Study||0
5307786|NCT00497770|13049327|P4|COMPLETED|Overall Study||28
5307787|NCT00497770|13049328|P3|COMPLETED|Overall Study||37
5307788|NCT00497770|13049329|P2|COMPLETED|Overall Study||65
5307789|NCT00497770|13049330|P1|COMPLETED|Overall Study||304
5307790|NCT00497770|13049327|P4|STARTED|Overall Study||28
5307791|NCT00497770|13049328|P3|STARTED|Overall Study||37
5307792|NCT00497770|13049329|P2|STARTED|Overall Study||65
5307793|NCT00497770|13049330|P1|STARTED|Overall Study||304
5307794|NCT00497198|13049382|P2|NOT COMPLETED|Overall Study||5
5307795|NCT00497198|13049383|P1|NOT COMPLETED|Overall Study||5
5307796|NCT00497198|13049382|P2|COMPLETED|Overall Study||86
5307797|NCT00497198|13049383|P1|COMPLETED|Overall Study||87
5307798|NCT00497198|13049382|P2|STARTED|Overall Study||91
5307799|NCT00497198|13049383|P1|STARTED|Overall Study||92
5307800|NCT00497146|13049399|P2|NOT COMPLETED|Long-term Follow-up Period||6
5307801|NCT00497146|13049400|P1|NOT COMPLETED|Long-term Follow-up Period||15
5307802|NCT00497146|13049399|P2|COMPLETED|Long-term Follow-up Period||66
5307803|NCT00497146|13049400|P1|COMPLETED|Long-term Follow-up Period||50
5307804|NCT00497146|13049399|P2|STARTED|Long-term Follow-up Period||72
5307805|NCT00497146|13049400|P1|STARTED|Long-term Follow-up Period||65
5307806|NCT00497146|13049399|P2|NOT COMPLETED|Treatment Period||21
5307807|NCT00497146|13049400|P1|NOT COMPLETED|Treatment Period||27
5307808|NCT00497146|13049399|P2|COMPLETED|Treatment Period||91
5307809|NCT00497146|13049400|P1|COMPLETED|Treatment Period||88
5307810|NCT00497146|13049399|P2|STARTED|Treatment Period||112
5307811|NCT00497146|13049400|P1|STARTED|Treatment Period||115
5307812|NCT00497081|13049442|P2|NOT COMPLETED|Overall Study||2
5307813|NCT00497081|13049443|P1|NOT COMPLETED|Overall Study||2
5307814|NCT00497081|13049442|P2|COMPLETED|Overall Study||28
5307815|NCT00497081|13049443|P1|COMPLETED|Overall Study||28
5307816|NCT00497081|13049442|P2|STARTED|Overall Study||30
5307817|NCT00497081|13049443|P1|STARTED|Overall Study||30
5307818|NCT00497055|13049455|P2|NOT COMPLETED|Overall Study||5
5307819|NCT00497055|13049456|P1|NOT COMPLETED|Overall Study||10
5307820|NCT00497055|13049455|P2|COMPLETED|Overall Study||40
5307821|NCT00497055|13049456|P1|COMPLETED|Overall Study||35
5307822|NCT00497055|13049455|P2|STARTED|Overall Study||45
5307823|NCT00497055|13049456|P1|STARTED|Overall Study||45
5307824|NCT00496964|13049468|P2|NOT COMPLETED|Overall Study||1
5307825|NCT00496964|13049469|P1|NOT COMPLETED|Overall Study||0
5307826|NCT00496964|13049468|P2|COMPLETED|Overall Study||3
5307827|NCT00496964|13049469|P1|COMPLETED|Overall Study||1
5307828|NCT00496964|13049468|P2|STARTED|Overall Study||4
5307829|NCT00496964|13049469|P1|STARTED|Overall Study||1
5307830|NCT00496873|13049487|P1|NOT COMPLETED|Overall Study||7
5307831|NCT00496873|13049487|P1|COMPLETED|Overall Study||78
5307832|NCT00496873|13049487|P1|STARTED|Overall Study||85
5307833|NCT00496860|13049496|P3|NOT COMPLETED|Overall Study||0
5307834|NCT00496860|13049497|P2|NOT COMPLETED|Overall Study||1
5307835|NCT00496860|13049498|P1|NOT COMPLETED|Overall Study||1
5307836|NCT00496860|13049496|P3|COMPLETED|Overall Study||6
5307837|NCT00496860|13049497|P2|COMPLETED|Overall Study||15
5307838|NCT00496860|13049498|P1|COMPLETED|Overall Study||3
5307839|NCT00496860|13049496|P3|STARTED|Overall Study||6
5307840|NCT00496860|13049497|P2|STARTED|Overall Study||16
5307841|NCT00496860|13049498|P1|STARTED|Overall Study||4
5307842|NCT00496834|13049520|P2|NOT COMPLETED|Overall Study||13
5307843|NCT00496834|13049521|P1|NOT COMPLETED|Overall Study||18
5307844|NCT00496834|13049520|P2|COMPLETED|Overall Study||87
5307845|NCT00496834|13049521|P1|COMPLETED|Overall Study||83
5307846|NCT00496834|13049520|P2|STARTED|Overall Study||100
5307847|NCT00496834|13049521|P1|STARTED|Overall Study||101
5307848|NCT00496808|13049533|P1|NOT COMPLETED|Overall Study||0
5307849|NCT00496808|13049533|P1|COMPLETED|Overall Study||69
5307850|NCT00496808|13049533|P1|STARTED|Overall Study||69
5307851|NCT00496782|13049540|P2|NOT COMPLETED|Overall Study||2
5307852|NCT00496782|13049541|P1|NOT COMPLETED|Overall Study||1
5307853|NCT00496782|13049540|P2|COMPLETED|Overall Study||5
5307854|NCT00496782|13049541|P1|COMPLETED|Overall Study||8
5307855|NCT00496782|13049540|P2|STARTED|Overall Study||7
5307856|NCT00496782|13049541|P1|STARTED|Overall Study||9
5307857|NCT00496769|13049575|P3|NOT COMPLETED|Open Label||1011
5307858|NCT00496769|13049576|P2|NOT COMPLETED|Open Label||0
5307859|NCT00496769|13049577|P1|NOT COMPLETED|Open Label||0
5307860|NCT00496769|13049575|P3|COMPLETED|Open Label||2264
5307861|NCT00496769|13049576|P2|COMPLETED|Open Label||0
5307862|NCT00496769|13049577|P1|COMPLETED|Open Label||0
5307863|NCT00496769|13049575|P3|STARTED|Open Label||3275
5307864|NCT00496769|13049576|P2|STARTED|Open Label||0
5307865|NCT00496769|13049577|P1|STARTED|Open Label||0
5307866|NCT00496769|13049575|P3|NOT COMPLETED|Double Blind||0
5307867|NCT00496769|13049576|P2|NOT COMPLETED|Double Blind||649
5307868|NCT00496769|13049577|P1|NOT COMPLETED|Double Blind||558
5307869|NCT00496769|13049575|P3|COMPLETED|Double Blind||0
5307870|NCT00496769|13049576|P2|COMPLETED|Double Blind||2142
5307871|NCT00496769|13049577|P1|COMPLETED|Double Blind||2249
5307872|NCT00496769|13049575|P3|Received Treatment|Double Blind||0
5307873|NCT00496769|13049576|P2|Received Treatment|Double Blind||2708
5307874|NCT00496769|13049577|P1|Received Treatment|Double Blind||2798
5307875|NCT00496769|13049575|P3|STARTED|Double Blind||0
5307876|NCT00496769|13049576|P2|STARTED|Double Blind|Randomized|2791
5307877|NCT00496769|13049577|P1|STARTED|Double Blind|Randomized|2807
5307878|NCT00496756|13049600|P1|NOT COMPLETED|Overall Study||3
5307879|NCT00496756|13049600|P1|COMPLETED|Overall Study||11
5307880|NCT00496756|13049600|P1|STARTED|Overall Study||14
5307881|NCT00496730|13049607|P2|NOT COMPLETED|Overall Study||5
5307882|NCT00496730|13049608|P1|NOT COMPLETED|Overall Study||6
5307883|NCT00496730|13049607|P2|COMPLETED|Overall Study||121
5307884|NCT00496730|13049608|P1|COMPLETED|Overall Study||124
5307885|NCT00496730|13049607|P2|STARTED|Overall Study||126
5307886|NCT00496730|13049608|P1|STARTED|Overall Study||130
5307887|NCT00496626|13049620|P2|NOT COMPLETED|Overall Study||6
5307888|NCT00496626|13049621|P1|NOT COMPLETED|Overall Study||6
5307889|NCT00496626|13049620|P2|COMPLETED|Overall Study||292
5307890|NCT00496626|13049621|P1|COMPLETED|Overall Study||296
5307891|NCT00496626|13049620|P2|STARTED|Overall Study||298
5307892|NCT00496626|13049621|P1|STARTED|Overall Study||302
5307893|NCT00496587|13049633|P1|NOT COMPLETED|Overall Study||31
5307894|NCT00496587|13049633|P1|COMPLETED|Overall Study||3
5307895|NCT00496587|13049633|P1|STARTED|Overall Study||34
5307896|NCT00496483|13049639|P1|NOT COMPLETED|Overall Study||12
5307897|NCT00496483|13049639|P1|COMPLETED|Overall Study||48
5307898|NCT00496483|13049639|P1|Dosed|Overall Study||51
5307899|NCT00496483|13049639|P1|STARTED|Overall Study||60
5307900|NCT00496470|13049656|P2|NOT COMPLETED|Overall Study||29
5307901|NCT00496470|13049657|P1|NOT COMPLETED|Overall Study||26
5307902|NCT00496470|13049656|P2|COMPLETED|Overall Study||302
5307903|NCT00496470|13049657|P1|COMPLETED|Overall Study||303
5307904|NCT00496470|13049656|P2|Received Study Medication|Overall Study||330
5307905|NCT00496470|13049657|P1|Received Study Medication|Overall Study||329
5307906|NCT00496470|13049656|P2|STARTED|Overall Study||331
5307907|NCT00496470|13049657|P1|STARTED|Overall Study||329
5307908|NCT00496379|13049735|P1|NOT COMPLETED|Overall Study||0
5307909|NCT00496379|13049735|P1|COMPLETED|Overall Study||15
5307910|NCT00496379|13049735|P1|STARTED|Overall Study||15
5307911|NCT00496366|13049743|P1|NOT COMPLETED|Overall Study||1
5307912|NCT00496366|13049743|P1|COMPLETED|Overall Study||10
5307913|NCT00496366|13049743|P1|STARTED|Overall Study||11
5307914|NCT00496340|13049748|P1|NOT COMPLETED|Overall Study||0
5307915|NCT00496340|13049748|P1|COMPLETED|Overall Study||42
5307916|NCT00496340|13049748|P1|STARTED|Overall Study||42
5307917|NCT00496262|13049761|P1|NOT COMPLETED|Overall Study||0
5307918|NCT00496262|13049761|P1|COMPLETED|Overall Study||15
5307919|NCT00496262|13049761|P1|STARTED|Overall Study||15
5307920|NCT00496197|13049774|P1|NOT COMPLETED|Overall Study||122
5307921|NCT00496197|13049774|P1|COMPLETED|Overall Study||160
5307922|NCT00496197|13049774|P1|STARTED|Overall Study||282
5307923|NCT00496080|13049801|P1|NOT COMPLETED|Overall Study||27
5307924|NCT00496080|13049801|P1|COMPLETED|Overall Study||60
5307925|NCT00496080|13049801|P1|STARTED|Overall Study||87
5307926|NCT00496054|13049811|P1|NOT COMPLETED|Overall Study||8
5307927|NCT00496054|13049811|P1|COMPLETED|Overall Study||102
5307928|NCT00496054|13049811|P1|STARTED|Overall Study||110
5307929|NCT00496015|13049843|P5|NOT COMPLETED|Overall Study||0
5307930|NCT00496015|13049844|P4|NOT COMPLETED|Overall Study||1
5307931|NCT00496015|13049845|P3|NOT COMPLETED|Overall Study||0
5307932|NCT00496015|13049846|P2|NOT COMPLETED|Overall Study||0
5307933|NCT00496015|13049847|P1|NOT COMPLETED|Overall Study||1
5307934|NCT00496015|13049843|P5|COMPLETED|Overall Study||336
5307935|NCT00496015|13049844|P4|COMPLETED|Overall Study||36
5307936|NCT00496015|13049845|P3|COMPLETED|Overall Study||172
5307937|NCT00496015|13049846|P2|COMPLETED|Overall Study||27
5307938|NCT00496015|13049847|P1|COMPLETED|Overall Study||177
5307939|NCT00496015|13049843|P5|STARTED|Overall Study||336
5307940|NCT00496015|13049844|P4|STARTED|Overall Study||37
5307941|NCT00496015|13049845|P3|STARTED|Overall Study||172
5307942|NCT00496015|13049846|P2|STARTED|Overall Study||27
5307943|NCT00496015|13049847|P1|STARTED|Overall Study||178
5307944|NCT00495820|13049971|P2|NOT COMPLETED|Overall Study||1
5307945|NCT00495820|13049972|P1|NOT COMPLETED|Overall Study||1
5307946|NCT00495820|13049971|P2|COMPLETED|Overall Study||29
5307947|NCT00495820|13049972|P1|COMPLETED|Overall Study||29
5307948|NCT00495820|13049971|P2|STARTED|Overall Study||30
5307949|NCT00495820|13049972|P1|STARTED|Overall Study||30
5307950|NCT00495794|13049984|P2|NOT COMPLETED|Overall Study||0
5307951|NCT00495794|13049985|P1|NOT COMPLETED|Overall Study||522
5307952|NCT00495794|13049984|P2|COMPLETED|Overall Study||2303
5307953|NCT00495794|13049985|P1|COMPLETED|Overall Study||1797
5307954|NCT00495794|13049984|P2|STARTED|Overall Study||2303
5307955|NCT00495794|13049985|P1|STARTED|Overall Study||2319
5307956|NCT00495755|13049995|P1|NOT COMPLETED|Overall Study||3
5307957|NCT00495755|13049995|P1|COMPLETED|Overall Study||10
5307958|NCT00495755|13049995|P1|STARTED|Overall Study||13
5307959|NCT00495716|13050002|P2|NOT COMPLETED|Overall Study||13
5307960|NCT00495716|13050003|P1|NOT COMPLETED|Overall Study||15
5307961|NCT00495716|13050002|P2|COMPLETED|Overall Study||24
5307962|NCT00495716|13050003|P1|COMPLETED|Overall Study||20
5307963|NCT00495716|13050002|P2|STARTED|Overall Study||37
5307964|NCT00495716|13050003|P1|STARTED|Overall Study||35
5307965|NCT00495677|13050016|P7|NOT COMPLETED|Stage 2 (25 Days)||0
5307966|NCT00495677|13050017|P6|NOT COMPLETED|Stage 2 (25 Days)||0
5307967|NCT00495677|13050018|P5|NOT COMPLETED|Stage 2 (25 Days)||0
5307968|NCT00495677|13050019|P4|NOT COMPLETED|Stage 2 (25 Days)||0
5307969|NCT00495677|13050020|P3|NOT COMPLETED|Stage 2 (25 Days)||0
5307970|NCT00495677|13050021|P2|NOT COMPLETED|Stage 2 (25 Days)||0
5307971|NCT00495677|13050022|P1|NOT COMPLETED|Stage 2 (25 Days)||0
5307972|NCT00495677|13050016|P7|COMPLETED|Stage 2 (25 Days)||7
5307973|NCT00495677|13050017|P6|COMPLETED|Stage 2 (25 Days)||8
5307974|NCT00495677|13050018|P5|COMPLETED|Stage 2 (25 Days)||8
5307975|NCT00495677|13050019|P4|COMPLETED|Stage 2 (25 Days)||0
5307976|NCT00495677|13050020|P3|COMPLETED|Stage 2 (25 Days)||0
5307977|NCT00495677|13050021|P2|COMPLETED|Stage 2 (25 Days)||0
5307978|NCT00495677|13050022|P1|COMPLETED|Stage 2 (25 Days)||0
5307979|NCT00495677|13050016|P7|STARTED|Stage 2 (25 Days)||7
5307980|NCT00495677|13050017|P6|STARTED|Stage 2 (25 Days)||8
5307981|NCT00495677|13050018|P5|STARTED|Stage 2 (25 Days)||8
5307982|NCT00495677|13050019|P4|STARTED|Stage 2 (25 Days)||0
5307983|NCT00495677|13050020|P3|STARTED|Stage 2 (25 Days)||0
5307984|NCT00495677|13050021|P2|STARTED|Stage 2 (25 Days)||0
5307985|NCT00495677|13050022|P1|STARTED|Stage 2 (25 Days)||0
5307986|NCT00495677|13050016|P7|NOT COMPLETED|Stage 1 (25 Days)||0
5307987|NCT00495677|13050017|P6|NOT COMPLETED|Stage 1 (25 Days)||0
5307988|NCT00495677|13050018|P5|NOT COMPLETED|Stage 1 (25 Days)||0
5307989|NCT00495677|13050019|P4|NOT COMPLETED|Stage 1 (25 Days)||0
5307990|NCT00495677|13050020|P3|NOT COMPLETED|Stage 1 (25 Days)||1
5307991|NCT00495677|13050021|P2|NOT COMPLETED|Stage 1 (25 Days)||0
5307992|NCT00495677|13050022|P1|NOT COMPLETED|Stage 1 (25 Days)||0
5307993|NCT00495677|13050016|P7|COMPLETED|Stage 1 (25 Days)||0
5307994|NCT00495677|13050017|P6|COMPLETED|Stage 1 (25 Days)||0
5307995|NCT00495677|13050018|P5|COMPLETED|Stage 1 (25 Days)||0
5307996|NCT00495677|13050019|P4|COMPLETED|Stage 1 (25 Days)||6
5307997|NCT00495677|13050020|P3|COMPLETED|Stage 1 (25 Days)||5
5307998|NCT00495677|13050021|P2|COMPLETED|Stage 1 (25 Days)||6
5307999|NCT00495677|13050022|P1|COMPLETED|Stage 1 (25 Days)||2
5308000|NCT00495677|13050016|P7|STARTED|Stage 1 (25 Days)||0
5308001|NCT00495677|13050017|P6|STARTED|Stage 1 (25 Days)||0
5308002|NCT00495677|13050018|P5|STARTED|Stage 1 (25 Days)||0
5308003|NCT00495677|13050019|P4|STARTED|Stage 1 (25 Days)||6
5308004|NCT00495677|13050020|P3|STARTED|Stage 1 (25 Days)||6
5308005|NCT00495677|13050021|P2|STARTED|Stage 1 (25 Days)||6
5308006|NCT00495677|13050022|P1|STARTED|Stage 1 (25 Days)||2
5308007|NCT00495625|13050077|P1|NOT COMPLETED|Overall Study||10
5308008|NCT00495625|13050077|P1|COMPLETED|Overall Study||23
5308009|NCT00495625|13050077|P1|STARTED|Overall Study||33
5308010|NCT00495612|13050088|P2|NOT COMPLETED|Overall Study||0
5308011|NCT00495612|13050089|P1|NOT COMPLETED|Overall Study||4
5308012|NCT00495612|13050088|P2|COMPLETED|Overall Study||33
5308013|NCT00495612|13050089|P1|COMPLETED|Overall Study||32
5308014|NCT00495612|13050088|P2|STARTED|Overall Study||33
5308015|NCT00495612|13050089|P1|STARTED|Overall Study||36
5308016|NCT00495586|13050107|P2|NOT COMPLETED|Overall Study||4
5308017|NCT00495586|13050108|P1|NOT COMPLETED|Overall Study||4
5308018|NCT00495586|13050107|P2|COMPLETED|Overall Study||158
5308019|NCT00495586|13050108|P1|COMPLETED|Overall Study||152
5308020|NCT00495586|13050107|P2|STARTED|Overall Study||162
5308021|NCT00495586|13050108|P1|STARTED|Overall Study||156
5308022|NCT00495521|13050118|P2|NOT COMPLETED|Overall Study||1
5308023|NCT00495521|13050119|P1|NOT COMPLETED|Overall Study||0
5308024|NCT00495521|13050118|P2|COMPLETED|Overall Study||0
5308025|NCT00495521|13050119|P1|COMPLETED|Overall Study||1
5308026|NCT00495521|13050118|P2|STARTED|Overall Study||1
5308027|NCT00495521|13050119|P1|STARTED|Overall Study||1
5308028|NCT00495495|13050149|P1|NOT COMPLETED|Overall Study||99
5308029|NCT00495495|13050149|P1|COMPLETED|Overall Study||295
5308030|NCT00495495|13050149|P1|STARTED|Overall Study||394
5308031|NCT00495469|13050169|P7|NOT COMPLETED|Overall Study||5
5308032|NCT00495469|13050170|P6|NOT COMPLETED|Overall Study||5
5308033|NCT00495469|13050171|P5|NOT COMPLETED|Overall Study||5
5308034|NCT00495469|13050172|P4|NOT COMPLETED|Overall Study||4
5308035|NCT00495469|13050173|P3|NOT COMPLETED|Overall Study||7
5308036|NCT00495469|13050174|P2|NOT COMPLETED|Overall Study||7
5308037|NCT00495469|13050175|P1|NOT COMPLETED|Overall Study||6
5308038|NCT00495469|13050169|P7|COMPLETED|Overall Study||30
5308039|NCT00495469|13050170|P6|COMPLETED|Overall Study||31
5308040|NCT00495469|13050171|P5|COMPLETED|Overall Study||31
5308041|NCT00495469|13050172|P4|COMPLETED|Overall Study||32
5308042|NCT00495469|13050173|P3|COMPLETED|Overall Study||27
5308043|NCT00495469|13050174|P2|COMPLETED|Overall Study||30
5308044|NCT00495469|13050175|P1|COMPLETED|Overall Study||30
5308045|NCT00495469|13050169|P7|STARTED|Overall Study||35
5308046|NCT00495469|13050170|P6|STARTED|Overall Study||36
5308047|NCT00495469|13050171|P5|STARTED|Overall Study||36
5308048|NCT00495469|13050172|P4|STARTED|Overall Study||36
5308049|NCT00495469|13050173|P3|STARTED|Overall Study||34
5308050|NCT00495469|13050174|P2|STARTED|Overall Study||37
5308051|NCT00495469|13050175|P1|STARTED|Overall Study||36
5308052|NCT00495391|13050319|P2|NOT COMPLETED|Overall Study||21
5308053|NCT00495391|13050320|P1|NOT COMPLETED|Overall Study||36
5308054|NCT00495391|13050319|P2|COMPLETED|Overall Study||1
5308055|NCT00495391|13050320|P1|COMPLETED|Overall Study||6
5308056|NCT00495391|13050319|P2|From Baseline to End of Follow up|Overall Study||1
5308057|NCT00495391|13050320|P1|From Baseline to End of Follow up|Overall Study||6
5308058|NCT00495391|13050319|P2|From Baseline to End of Treatment|Overall Study||1
5308059|NCT00495391|13050320|P1|From Baseline to End of Treatment|Overall Study||6
5308060|NCT00495391|13050319|P2|From Baseline to Week 16|Overall Study||11
5308061|NCT00495391|13050320|P1|From Baseline to Week 16|Overall Study||24
5308062|NCT00495391|13050319|P2|From Baseline to Week 8|Overall Study||20
5308063|NCT00495391|13050320|P1|From Baseline to Week 8|Overall Study||31
5308064|NCT00495391|13050319|P2|STARTED|Overall Study||22
5308065|NCT00495391|13050320|P1|STARTED|Overall Study||42
5308066|NCT00495222|13050340|P1|NOT COMPLETED|Overall Study||0
5308067|NCT00495222|13050340|P1|COMPLETED|Overall Study||9
5308068|NCT00495222|13050340|P1|STARTED|Overall Study||9
5308069|NCT00495170|13050343|P1|NOT COMPLETED|Overall Study||20
5308070|NCT00495170|13050343|P1|COMPLETED|Overall Study||64
5308071|NCT00495170|13050343|P1|STARTED|Overall Study||84
5308072|NCT00495157|13050350|P3|NOT COMPLETED|Overall Study||13
5308073|NCT00495157|13050351|P2|NOT COMPLETED|Overall Study||23
5308074|NCT00495157|13050352|P1|NOT COMPLETED|Overall Study||16
5308075|NCT00495157|13050350|P3|COMPLETED|Overall Study||101
5308076|NCT00495157|13050351|P2|COMPLETED|Overall Study||92
5308077|NCT00495157|13050352|P1|COMPLETED|Overall Study||97
5308078|NCT00495157|13050350|P3|STARTED|Overall Study||114
5308079|NCT00495157|13050351|P2|STARTED|Overall Study||115
5308080|NCT00495157|13050352|P1|STARTED|Overall Study||113
5308081|NCT00495131|13050362|P2|NOT COMPLETED|Overall Study||6
5308082|NCT00495131|13050363|P1|NOT COMPLETED|Overall Study||7
5308083|NCT00495131|13050362|P2|COMPLETED|Overall Study||148
5308084|NCT00495131|13050363|P1|COMPLETED|Overall Study||147
5308085|NCT00495131|13050362|P2|STARTED|Overall Study||154
5308086|NCT00495131|13050363|P1|STARTED|Overall Study||154
5308087|NCT00495079|13050373|P1|NOT COMPLETED|Overall Study||0
5308088|NCT00495079|13050373|P1|COMPLETED|Overall Study||65
5308089|NCT00495079|13050373|P1|STARTED|Overall Study||65
5308090|NCT00495040|13050380|P1|NOT COMPLETED|Overall Study||3
5308091|NCT00495040|13050380|P1|COMPLETED|Overall Study||35
5308092|NCT00495040|13050380|P1|STARTED|Overall Study||38
5308093|NCT00494975|13050386|P2|NOT COMPLETED|Overall Study||1
5308094|NCT00494975|13050387|P1|NOT COMPLETED|Overall Study||2
5308095|NCT00494975|13050386|P2|COMPLETED|Overall Study||10
5308096|NCT00494975|13050387|P1|COMPLETED|Overall Study||8
5308097|NCT00494975|13050386|P2|STARTED|Overall Study||11
5308098|NCT00494975|13050387|P1|STARTED|Overall Study||10
5308099|NCT00494871|13050395|P2|NOT COMPLETED|Follow-up (FU) Period||23
5308100|NCT00494871|13050396|P1|NOT COMPLETED|Follow-up (FU) Period||29
5308101|NCT00494871|13050395|P2|COMPLETED|Follow-up (FU) Period||616
5308102|NCT00494871|13050396|P1|COMPLETED|Follow-up (FU) Period||610
5308103|NCT00494871|13050395|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
5308104|NCT00494871|13050396|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
5308105|NCT00494871|13050395|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
5308106|NCT00494871|13050396|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
5308107|NCT00494871|13050395|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
5308108|NCT00494871|13050396|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
5308109|NCT00494871|13050395|P2|COMPLETED|Double-blind (DB) Treatment Period||468
5308110|NCT00494871|13050396|P1|COMPLETED|Double-blind (DB) Treatment Period||480
5308111|NCT00494871|13050395|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
5308112|NCT00494871|13050396|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
5308113|NCT00494871|13050395|P2|STARTED|Double-blind (DB) Treatment Period||640
5308114|NCT00494871|13050396|P1|STARTED|Double-blind (DB) Treatment Period||640
5308115|NCT00494806|13050428|P2|NOT COMPLETED|Overall Study||0
5308116|NCT00494806|13050429|P1|NOT COMPLETED|Overall Study||0
5308117|NCT00494806|13050428|P2|COMPLETED|Overall Study||32
5308118|NCT00494806|13050429|P1|COMPLETED|Overall Study||34
5308119|NCT00494806|13050428|P2|STARTED|Overall Study||32
5308120|NCT00494806|13050429|P1|STARTED|Overall Study||34
5308121|NCT00494780|13050437|P2|NOT COMPLETED|Overall Study||13
5308122|NCT00494780|13050438|P1|NOT COMPLETED|Overall Study||11
5308123|NCT00494780|13050437|P2|COMPLETED|Overall Study||17
5308124|NCT00494780|13050438|P1|COMPLETED|Overall Study||18
5308125|NCT00494780|13050437|P2|STARTED|Overall Study||30
5308126|NCT00494780|13050438|P1|STARTED|Overall Study||29
5308127|NCT00494676|13050476|P2|NOT COMPLETED|Second Intervention||1
5308128|NCT00494676|13050477|P1|NOT COMPLETED|Second Intervention||1
5308129|NCT00494676|13050476|P2|COMPLETED|Second Intervention||28
5308130|NCT00494676|13050477|P1|COMPLETED|Second Intervention||33
5308131|NCT00494676|13050476|P2|STARTED|Second Intervention||29
5308132|NCT00494676|13050477|P1|STARTED|Second Intervention||34
5308133|NCT00494676|13050476|P2|NOT COMPLETED|First Intervention||3
5308134|NCT00494676|13050477|P1|NOT COMPLETED|First Intervention||1
5308135|NCT00494676|13050476|P2|COMPLETED|First Intervention||29
5308136|NCT00494676|13050477|P1|COMPLETED|First Intervention||34
5308137|NCT00494676|13050476|P2|STARTED|First Intervention||32
5308138|NCT00494676|13050477|P1|STARTED|First Intervention||35
5308139|NCT00494676|13050476|P2|NOT COMPLETED|Allocation||4
5308140|NCT00494676|13050477|P1|NOT COMPLETED|Allocation||2
5308141|NCT00494676|13050476|P2|COMPLETED|Allocation||32
5308142|NCT00494676|13050477|P1|COMPLETED|Allocation||35
5308143|NCT00494676|13050476|P2|STARTED|Allocation||36
5308144|NCT00494676|13050477|P1|STARTED|Allocation||37
5308145|NCT00494585|13050484|P1|NOT COMPLETED|Overall Study||0
5308146|NCT00494585|13050484|P1|COMPLETED|Overall Study||22
5308147|NCT00494585|13050484|P1|STARTED|Overall Study||22
5308148|NCT00494507|13050492|P4|NOT COMPLETED|Open-Label Phase||5
5308149|NCT00494507|13050493|P3|NOT COMPLETED|Open-Label Phase||5
5308150|NCT00494507|13050494|P2|NOT COMPLETED|Open-Label Phase||1
5308151|NCT00494507|13050495|P1|NOT COMPLETED|Open-Label Phase||0
5308152|NCT00494507|13050492|P4|COMPLETED|Open-Label Phase||14
5308153|NCT00494507|13050493|P3|COMPLETED|Open-Label Phase||17
5308154|NCT00494507|13050494|P2|COMPLETED|Open-Label Phase||7
5308155|NCT00494507|13050495|P1|COMPLETED|Open-Label Phase||9
5308156|NCT00494507|13050492|P4|STARTED|Open-Label Phase||19
5308157|NCT00494507|13050493|P3|STARTED|Open-Label Phase||22
5308158|NCT00494507|13050494|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
5308159|NCT00494507|13050495|P1|STARTED|Open-Label Phase||9
5308160|NCT00494507|13050492|P4|NOT COMPLETED|Double-Blind Phase||1
5308161|NCT00494507|13050493|P3|NOT COMPLETED|Double-Blind Phase||2
5308162|NCT00494507|13050494|P2|NOT COMPLETED|Double-Blind Phase||0
5308163|NCT00494507|13050495|P1|NOT COMPLETED|Double-Blind Phase||3
5308164|NCT00494507|13050492|P4|COMPLETED|Double-Blind Phase||19
5308165|NCT00494507|13050493|P3|COMPLETED|Double-Blind Phase||22
5308166|NCT00494507|13050494|P2|COMPLETED|Double-Blind Phase||9
5308167|NCT00494507|13050495|P1|COMPLETED|Double-Blind Phase||9
5308168|NCT00494507|13050492|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
5308169|NCT00494507|13050493|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
5308170|NCT00494507|13050494|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
5308171|NCT00494507|13050495|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
5308172|NCT00494507|13050492|P4|STARTED|Double-Blind Phase||20
5308173|NCT00494507|13050493|P3|STARTED|Double-Blind Phase||24
5308174|NCT00494507|13050494|P2|STARTED|Double-Blind Phase||9
5308175|NCT00494507|13050495|P1|STARTED|Double-Blind Phase||12
5308176|NCT00494494|13050545|P2|NOT COMPLETED|Overall Study||0
5308177|NCT00494494|13050546|P1|NOT COMPLETED|Overall Study||0
5308178|NCT00494494|13050545|P2|COMPLETED|Overall Study||39
5308179|NCT00494494|13050546|P1|COMPLETED|Overall Study||40
5308180|NCT00494494|13050545|P2|STARTED|Overall Study||39
5308181|NCT00494494|13050546|P1|STARTED|Overall Study||40
5308182|NCT00494481|13050562|P2|NOT COMPLETED|Overall Study||24
5308183|NCT00494481|13050563|P1|NOT COMPLETED|Overall Study||29
5308184|NCT00494481|13050562|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
5308185|NCT00494481|13050563|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
5308186|NCT00494481|13050562|P2|STARTED|Overall Study|randomised patients|29
5308187|NCT00494481|13050563|P1|STARTED|Overall Study|randomised patients|35
5308188|NCT00494442|13050571|P2|NOT COMPLETED|Overall Study||16
5308189|NCT00494442|13050572|P1|NOT COMPLETED|Overall Study||17
5308190|NCT00494442|13050571|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
5308191|NCT00494442|13050572|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
5308192|NCT00494442|13050571|P2|STARTED|Overall Study|Patients received treatment|33
5308193|NCT00494442|13050572|P1|STARTED|Overall Study|Patients received treatment|24
5308194|NCT00494299|13050588|P2|NOT COMPLETED|Overall Study||229
5308195|NCT00494299|13050589|P1|NOT COMPLETED|Overall Study||229
5308196|NCT00494299|13050588|P2|COMPLETED|Overall Study||0
5308197|NCT00494299|13050589|P1|COMPLETED|Overall Study||0
5308198|NCT00494299|13050588|P2|Received Treatment|Overall Study||227
5308199|NCT00494299|13050589|P1|Received Treatment|Overall Study||229
5308200|NCT00494299|13050588|P2|STARTED|Overall Study||229
5308201|NCT00494299|13050589|P1|STARTED|Overall Study||229
5308202|NCT00494234|13050601|P2|NOT COMPLETED|Overall Study||10
5308203|NCT00494234|13050602|P1|NOT COMPLETED|Overall Study||15
5308204|NCT00494234|13050601|P2|COMPLETED|Overall Study||17
5308205|NCT00494234|13050602|P1|COMPLETED|Overall Study||12
5308206|NCT00494234|13050601|P2|STARTED|Overall Study||27
5308207|NCT00494234|13050602|P1|STARTED|Overall Study||27
5308208|NCT00494221|13050621|P3|NOT COMPLETED|Overall Study||14
5308209|NCT00494221|13050622|P2|NOT COMPLETED|Overall Study||11
5308210|NCT00494221|13050623|P1|NOT COMPLETED|Overall Study||16
5308211|NCT00494221|13050621|P3|COMPLETED|Overall Study||44
5308212|NCT00494221|13050622|P2|COMPLETED|Overall Study||45
5308213|NCT00494221|13050623|P1|COMPLETED|Overall Study||42
5308214|NCT00494221|13050621|P3|STARTED|Overall Study||58
5308215|NCT00494221|13050622|P2|STARTED|Overall Study||56
5308216|NCT00494221|13050623|P1|STARTED|Overall Study||58
5308217|NCT00494143|13050643|P6|NOT COMPLETED|Overall Study||0
5308218|NCT00494143|13050644|P5|NOT COMPLETED|Overall Study||0
5308219|NCT00494143|13050645|P4|NOT COMPLETED|Overall Study||0
5308220|NCT00494143|13050646|P3|NOT COMPLETED|Overall Study||0
5308221|NCT00494143|13050647|P2|NOT COMPLETED|Overall Study||0
5308222|NCT00494143|13050648|P1|NOT COMPLETED|Overall Study||0
5308223|NCT00494143|13050643|P6|COMPLETED|Overall Study||0
5308224|NCT00494143|13050644|P5|COMPLETED|Overall Study||1
5308225|NCT00494143|13050645|P4|COMPLETED|Overall Study||0
5308226|NCT00494143|13050646|P3|COMPLETED|Overall Study||3
5308227|NCT00494143|13050647|P2|COMPLETED|Overall Study||2
5308228|NCT00494143|13050648|P1|COMPLETED|Overall Study||1
5308229|NCT00494143|13050643|P6|STARTED|Overall Study||0
5308230|NCT00494143|13050644|P5|STARTED|Overall Study||1
5308231|NCT00494143|13050645|P4|STARTED|Overall Study||0
5308232|NCT00494143|13050646|P3|STARTED|Overall Study||3
5308233|NCT00494143|13050647|P2|STARTED|Overall Study||2
5308234|NCT00494143|13050648|P1|STARTED|Overall Study||1
5308235|NCT00494091|13050664|P2|NOT COMPLETED|Overall Study||76
5308236|NCT00494091|13050665|P1|NOT COMPLETED|Overall Study||6
5308237|NCT00494091|13050664|P2|COMPLETED|Overall Study||0
5308238|NCT00494091|13050665|P1|COMPLETED|Overall Study||0
5308239|NCT00494091|13050664|P2|STARTED|Overall Study||76
5308240|NCT00494091|13050665|P1|STARTED|Overall Study||6
5308241|NCT00494026|13050687|P1|NOT COMPLETED|Overall Study||4
5308242|NCT00494026|13050687|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
5308243|NCT00494026|13050687|P1|STARTED|Overall Study||4
5308244|NCT00494013|13050697|P2|NOT COMPLETED|Overall Study||36
5308245|NCT00494013|13050698|P1|NOT COMPLETED|Overall Study||30
5308246|NCT00494013|13050697|P2|COMPLETED|Overall Study||183
5308247|NCT00494013|13050698|P1|COMPLETED|Overall Study||193
5308248|NCT00494013|13050697|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
5308249|NCT00494013|13050698|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
5308250|NCT00494013|13050697|P2|STARTED|Overall Study||219
5308251|NCT00494013|13050698|P1|STARTED|Overall Study||223
5308252|NCT00493974|13050728|P2|NOT COMPLETED|Overall Study||14
5308253|NCT00493974|13050729|P1|NOT COMPLETED|Overall Study||13
5308254|NCT00493974|13050728|P2|COMPLETED|Overall Study||45
5308255|NCT00493974|13050729|P1|COMPLETED|Overall Study||47
5308256|NCT00493974|13050728|P2|STARTED|Overall Study||59
5308257|NCT00493974|13050729|P1|STARTED|Overall Study||60
5308258|NCT00493805|13050747|P2|NOT COMPLETED|Overall Study||0
5308259|NCT00493805|13050748|P1|NOT COMPLETED|Overall Study||0
5308260|NCT00493805|13050747|P2|COMPLETED|Overall Study||42
5308261|NCT00493805|13050748|P1|COMPLETED|Overall Study||17
5308262|NCT00493805|13050747|P2|STARTED|Overall Study||42
5308263|NCT00493805|13050748|P1|STARTED|Overall Study||17
5308264|NCT00493779|13050756|P1|NOT COMPLETED|Overall Study||1
5308265|NCT00493779|13050756|P1|COMPLETED|Overall Study|Completed follow-up phase|97
5308266|NCT00493779|13050756|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
5308267|NCT00493649|13050763|P1|NOT COMPLETED|Overall Study||82
5308268|NCT00493649|13050763|P1|COMPLETED|Overall Study||411
5308269|NCT00493649|13050763|P1|STARTED|Overall Study||493
5308270|NCT00493636|13050776|P2|NOT COMPLETED|Overall Study||2
5308271|NCT00493636|13050777|P1|NOT COMPLETED|Overall Study||2
5308272|NCT00493636|13050776|P2|COMPLETED|Overall Study||77
5308273|NCT00493636|13050777|P1|COMPLETED|Overall Study||79
5308274|NCT00493636|13050776|P2|STARTED|Overall Study||79
5308275|NCT00493636|13050777|P1|STARTED|Overall Study||81
5308276|NCT00493454|13050791|P1|NOT COMPLETED|Overall Study||1
5308277|NCT00493454|13050791|P1|COMPLETED|Overall Study||5
5308278|NCT00493454|13050791|P1|STARTED|Overall Study||6
5308279|NCT00493311|13050797|P2|NOT COMPLETED|Overall Study||2
5308280|NCT00493311|13050798|P1|NOT COMPLETED|Overall Study||2
5308281|NCT00493311|13050797|P2|COMPLETED|Overall Study||29
5308282|NCT00493311|13050798|P1|COMPLETED|Overall Study||27
5308283|NCT00493311|13050797|P2|STARTED|Overall Study||31
5308284|NCT00493311|13050798|P1|STARTED|Overall Study||29
5308285|NCT00493285|13050818|P6|NOT COMPLETED|Overall Study||0
5308286|NCT00493285|13050819|P5|NOT COMPLETED|Overall Study||1
5308287|NCT00493285|13050820|P4|NOT COMPLETED|Overall Study||0
5308288|NCT00493285|13050821|P3|NOT COMPLETED|Overall Study||0
5308289|NCT00493285|13050822|P2|NOT COMPLETED|Overall Study||0
5308290|NCT00493285|13050823|P1|NOT COMPLETED|Overall Study||0
5308291|NCT00493285|13050818|P6|COMPLETED|Overall Study||5
5308292|NCT00493285|13050819|P5|COMPLETED|Overall Study||9
5308293|NCT00493285|13050820|P4|COMPLETED|Overall Study||6
5308294|NCT00493285|13050821|P3|COMPLETED|Overall Study||9
5308295|NCT00493285|13050822|P2|COMPLETED|Overall Study||6
5308296|NCT00493285|13050823|P1|COMPLETED|Overall Study||13
5308297|NCT00493285|13050818|P6|STARTED|Overall Study||5
5308298|NCT00493285|13050819|P5|STARTED|Overall Study||10
5308299|NCT00493285|13050820|P4|STARTED|Overall Study||6
5308300|NCT00493285|13050821|P3|STARTED|Overall Study||9
5308301|NCT00493285|13050822|P2|STARTED|Overall Study||6
5308302|NCT00493285|13050823|P1|STARTED|Overall Study||13
5308303|NCT00493246|13051055|P8|NOT COMPLETED|Overall Study||0
5308304|NCT00493246|13051056|P7|NOT COMPLETED|Overall Study||1
5308305|NCT00493246|13051057|P6|NOT COMPLETED|Overall Study||1
5308306|NCT00493246|13051058|P5|NOT COMPLETED|Overall Study||1
5308307|NCT00493246|13051059|P4|NOT COMPLETED|Overall Study||0
5308308|NCT00493246|13051060|P3|NOT COMPLETED|Overall Study||0
5308309|NCT00493246|13051061|P2|NOT COMPLETED|Overall Study||0
5308310|NCT00493246|13051062|P1|NOT COMPLETED|Overall Study||0
5308311|NCT00493246|13051055|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
5308312|NCT00493246|13051056|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
5308313|NCT00493246|13051057|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
5308314|NCT00493246|13051058|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
5308315|NCT00493246|13051059|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
5308316|NCT00493246|13051060|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
5308317|NCT00493246|13051061|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
5308318|NCT00493246|13051062|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
5308319|NCT00493246|13051055|P8|STARTED|Overall Study|All subjects who were randomized.|10
5308320|NCT00493246|13051056|P7|STARTED|Overall Study|All subjects who were randomized.|12
5308321|NCT00493246|13051057|P6|STARTED|Overall Study|All subjects who were randomized.|16
5308322|NCT00493246|13051058|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
5308323|NCT00493246|13051059|P4|STARTED|Overall Study||13
5308324|NCT00493246|13051060|P3|STARTED|Overall Study||12
5308325|NCT00493246|13051061|P2|STARTED|Overall Study||1
5308326|NCT00493246|13051062|P1|STARTED|Overall Study||2
5308327|NCT00493220|13051126|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308328|NCT00493220|13051127|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308329|NCT00493220|13051128|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308330|NCT00493220|13051129|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308331|NCT00493220|13051130|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308332|NCT00493220|13051131|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
5308333|NCT00493220|13051126|P6|COMPLETED|Final 7-Day Safety Follow-up||5
5308334|NCT00493220|13051127|P5|COMPLETED|Final 7-Day Safety Follow-up||5
5308335|NCT00493220|13051128|P4|COMPLETED|Final 7-Day Safety Follow-up||5
5308336|NCT00493220|13051129|P3|COMPLETED|Final 7-Day Safety Follow-up||5
5308337|NCT00493220|13051130|P2|COMPLETED|Final 7-Day Safety Follow-up||5
5308338|NCT00493220|13051131|P1|COMPLETED|Final 7-Day Safety Follow-up||4
5308339|NCT00493220|13051126|P6|STARTED|Final 7-Day Safety Follow-up||5
5308340|NCT00493220|13051127|P5|STARTED|Final 7-Day Safety Follow-up||5
5308341|NCT00493220|13051128|P4|STARTED|Final 7-Day Safety Follow-up||5
5308342|NCT00493220|13051129|P3|STARTED|Final 7-Day Safety Follow-up||5
5308343|NCT00493220|13051130|P2|STARTED|Final 7-Day Safety Follow-up||5
5308344|NCT00493220|13051131|P1|STARTED|Final 7-Day Safety Follow-up||4
5308345|NCT00493220|13051126|P6|NOT COMPLETED|Third Intervention||0
5308346|NCT00493220|13051127|P5|NOT COMPLETED|Third Intervention||0
5308347|NCT00493220|13051128|P4|NOT COMPLETED|Third Intervention||0
5308348|NCT00493220|13051129|P3|NOT COMPLETED|Third Intervention||0
5308349|NCT00493220|13051130|P2|NOT COMPLETED|Third Intervention||0
5308350|NCT00493220|13051131|P1|NOT COMPLETED|Third Intervention||1
5308351|NCT00493220|13051126|P6|COMPLETED|Third Intervention||5
5308352|NCT00493220|13051127|P5|COMPLETED|Third Intervention||5
5308353|NCT00493220|13051128|P4|COMPLETED|Third Intervention||5
5308354|NCT00493220|13051129|P3|COMPLETED|Third Intervention||5
5308355|NCT00493220|13051130|P2|COMPLETED|Third Intervention||5
5308356|NCT00493220|13051131|P1|COMPLETED|Third Intervention||4
5308357|NCT00493220|13051126|P6|STARTED|Third Intervention||5
5308358|NCT00493220|13051127|P5|STARTED|Third Intervention||5
5308359|NCT00493220|13051128|P4|STARTED|Third Intervention||5
5308360|NCT00493220|13051129|P3|STARTED|Third Intervention||5
5308361|NCT00493220|13051130|P2|STARTED|Third Intervention||5
5308362|NCT00493220|13051131|P1|STARTED|Third Intervention||5
5308363|NCT00493220|13051126|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308364|NCT00493220|13051127|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308365|NCT00493220|13051128|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308366|NCT00493220|13051129|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308367|NCT00493220|13051130|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308368|NCT00493220|13051131|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
5308369|NCT00493220|13051126|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308370|NCT00493220|13051127|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308371|NCT00493220|13051128|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308372|NCT00493220|13051129|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308373|NCT00493220|13051130|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308374|NCT00493220|13051131|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
5308375|NCT00493220|13051126|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308376|NCT00493220|13051127|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308377|NCT00493220|13051128|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308378|NCT00493220|13051129|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308379|NCT00493220|13051130|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308380|NCT00493220|13051131|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
5308381|NCT00493220|13051126|P6|NOT COMPLETED|Second Intervention||0
5308382|NCT00493220|13051127|P5|NOT COMPLETED|Second Intervention||0
5308383|NCT00493220|13051128|P4|NOT COMPLETED|Second Intervention||0
5308384|NCT00493220|13051129|P3|NOT COMPLETED|Second Intervention||0
5308385|NCT00493220|13051130|P2|NOT COMPLETED|Second Intervention||0
5308386|NCT00493220|13051131|P1|NOT COMPLETED|Second Intervention||0
5308387|NCT00493220|13051126|P6|COMPLETED|Second Intervention||5
5308388|NCT00493220|13051127|P5|COMPLETED|Second Intervention||5
5308389|NCT00493220|13051128|P4|COMPLETED|Second Intervention||5
5308390|NCT00493220|13051129|P3|COMPLETED|Second Intervention||5
5308391|NCT00493220|13051130|P2|COMPLETED|Second Intervention||5
5308392|NCT00493220|13051131|P1|COMPLETED|Second Intervention||5
5308393|NCT00493220|13051126|P6|STARTED|Second Intervention||5
5308394|NCT00493220|13051127|P5|STARTED|Second Intervention||5
5308395|NCT00493220|13051128|P4|STARTED|Second Intervention||5
5308396|NCT00493220|13051129|P3|STARTED|Second Intervention||5
5308397|NCT00493220|13051130|P2|STARTED|Second Intervention||5
5308398|NCT00493220|13051131|P1|STARTED|Second Intervention||5
5308399|NCT00493220|13051126|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308400|NCT00493220|13051127|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308401|NCT00493220|13051128|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308402|NCT00493220|13051129|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308403|NCT00493220|13051130|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308404|NCT00493220|13051131|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
5308405|NCT00493220|13051126|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308406|NCT00493220|13051127|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308407|NCT00493220|13051128|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308408|NCT00493220|13051129|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308409|NCT00493220|13051130|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308410|NCT00493220|13051131|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
5308411|NCT00493220|13051126|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
5308412|NCT00493220|13051127|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
5308413|NCT00493220|13051128|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
5308414|NCT00493220|13051129|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
5308415|NCT00493220|13051130|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
5308416|NCT00493220|13051131|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
5308417|NCT00493220|13051126|P6|NOT COMPLETED|First Intervention||0
5308418|NCT00493220|13051127|P5|NOT COMPLETED|First Intervention||0
5308419|NCT00493220|13051128|P4|NOT COMPLETED|First Intervention||0
5308420|NCT00493220|13051129|P3|NOT COMPLETED|First Intervention||0
5308421|NCT00493220|13051130|P2|NOT COMPLETED|First Intervention||0
5308422|NCT00493220|13051131|P1|NOT COMPLETED|First Intervention||0
5308423|NCT00493220|13051126|P6|COMPLETED|First Intervention||5
5308424|NCT00493220|13051127|P5|COMPLETED|First Intervention||5
5308425|NCT00493220|13051128|P4|COMPLETED|First Intervention||5
5308426|NCT00493220|13051129|P3|COMPLETED|First Intervention||5
5308427|NCT00493220|13051130|P2|COMPLETED|First Intervention||5
5308428|NCT00493220|13051131|P1|COMPLETED|First Intervention||5
5308429|NCT00493220|13051126|P6|STARTED|First Intervention||5
5308430|NCT00493220|13051127|P5|STARTED|First Intervention||5
5308431|NCT00493220|13051128|P4|STARTED|First Intervention||5
5308432|NCT00493220|13051129|P3|STARTED|First Intervention||5
5308433|NCT00493220|13051130|P2|STARTED|First Intervention||5
5308434|NCT00493220|13051131|P1|STARTED|First Intervention||5
5308435|NCT00493181|13051148|P1|NOT COMPLETED|Overall Study||0
5308436|NCT00493181|13051148|P1|COMPLETED|Overall Study||8
5308437|NCT00493181|13051148|P1|STARTED|Overall Study||8
5308438|NCT00493064|13051152|P1|NOT COMPLETED|Overall Study||11
5308439|NCT00493064|13051152|P1|COMPLETED|Overall Study||52
5308440|NCT00493064|13051152|P1|STARTED|Overall Study||63
5308441|NCT00493038|13051159|P2|NOT COMPLETED|Follow-up||0
5308442|NCT00493038|13051160|P1|NOT COMPLETED|Follow-up||1
5308443|NCT00493038|13051159|P2|COMPLETED|Follow-up||126
5308444|NCT00493038|13051160|P1|COMPLETED|Follow-up||122
5308445|NCT00493038|13051159|P2|STARTED|Follow-up||126
5308446|NCT00493038|13051160|P1|STARTED|Follow-up||123
5308447|NCT00493038|13051159|P2|NOT COMPLETED|Treatment||20
5308448|NCT00493038|13051160|P1|NOT COMPLETED|Treatment||24
5308449|NCT00493038|13051159|P2|COMPLETED|Treatment||126
5308450|NCT00493038|13051160|P1|COMPLETED|Treatment||123
5308451|NCT00493038|13051159|P2|Test-of-Cure Visit|Treatment||126
5308452|NCT00493038|13051160|P1|Test-of-Cure Visit|Treatment||123
5308453|NCT00493038|13051159|P2|Treated With Study Medication|Treatment||142
5308454|NCT00493038|13051160|P1|Treated With Study Medication|Treatment||145
5308455|NCT00493038|13051159|P2|Randomization|Treatment||146
5308456|NCT00493038|13051160|P1|Randomization|Treatment||147
5308457|NCT00493038|13051159|P2|STARTED|Treatment||146
5308458|NCT00493038|13051160|P1|STARTED|Treatment||147
5308459|NCT00493025|13051174|P1|NOT COMPLETED|Overall Study||19
5308460|NCT00493025|13051174|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
5308461|NCT00493025|13051174|P1|STARTED|Overall Study||19
5308462|NCT00493012|13051185|P2|NOT COMPLETED|Overall Study||17
5308463|NCT00493012|13051186|P1|NOT COMPLETED|Overall Study||18
5308464|NCT00493012|13051185|P2|COMPLETED|Overall Study||83
5308465|NCT00493012|13051186|P1|COMPLETED|Overall Study||82
5308466|NCT00493012|13051185|P2|STARTED|Overall Study||100
5308467|NCT00493012|13051186|P1|STARTED|Overall Study||100
5308468|NCT00492973|13051214|P2|NOT COMPLETED|Overall Study||1
5308469|NCT00492973|13051215|P1|NOT COMPLETED|Overall Study||0
5308470|NCT00492973|13051214|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
5308471|NCT00492973|13051215|P1|COMPLETED|Overall Study||37
5308472|NCT00492973|13051214|P2|STARTED|Overall Study||39
5308473|NCT00492973|13051215|P1|STARTED|Overall Study||37
5308474|NCT00492921|13051229|P3|NOT COMPLETED|Overall Study||1
5308475|NCT00492921|13051230|P2|NOT COMPLETED|Overall Study||0
5308476|NCT00492921|13051231|P1|NOT COMPLETED|Overall Study||1
5308477|NCT00492921|13051229|P3|COMPLETED|Overall Study||2
5308478|NCT00492921|13051230|P2|COMPLETED|Overall Study||4
5308479|NCT00492921|13051231|P1|COMPLETED|Overall Study||4
5308480|NCT00492921|13051229|P3|STARTED|Overall Study||3
5308481|NCT00492921|13051230|P2|STARTED|Overall Study||4
5308482|NCT00492921|13051231|P1|STARTED|Overall Study||5
5308483|NCT00492856|13051242|P4|NOT COMPLETED|Post-consolidation||1
5308484|NCT00492856|13051243|P3|NOT COMPLETED|Post-consolidation||27
5308485|NCT00492856|13051244|P2|NOT COMPLETED|Post-consolidation||12
5308486|NCT00492856|13051245|P1|NOT COMPLETED|Post-consolidation||0
5308487|NCT00492856|13051242|P4|COMPLETED|Post-consolidation||0
5308488|NCT00492856|13051243|P3|COMPLETED|Post-consolidation||0
5308489|NCT00492856|13051244|P2|COMPLETED|Post-consolidation||29
5308490|NCT00492856|13051245|P1|COMPLETED|Post-consolidation||0
5308491|NCT00492856|13051242|P4|STARTED|Post-consolidation||1
5308492|NCT00492856|13051243|P3|STARTED|Post-consolidation||27
5308493|NCT00492856|13051244|P2|STARTED|Post-consolidation||41
5308494|NCT00492856|13051245|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
5308495|NCT00492856|13051242|P4|NOT COMPLETED|Consolidation||0
5308496|NCT00492856|13051243|P3|NOT COMPLETED|Consolidation||0
5308497|NCT00492856|13051244|P2|NOT COMPLETED|Consolidation||0
5308498|NCT00492856|13051245|P1|NOT COMPLETED|Consolidation||9
5308499|NCT00492856|13051242|P4|COMPLETED|Consolidation||0
5308500|NCT00492856|13051243|P3|COMPLETED|Consolidation||0
5308501|NCT00492856|13051244|P2|COMPLETED|Consolidation||0
5308502|NCT00492856|13051245|P1|COMPLETED|Consolidation||83
5308503|NCT00492856|13051242|P4|STARTED|Consolidation||0
5308504|NCT00492856|13051243|P3|STARTED|Consolidation||0
5308505|NCT00492856|13051244|P2|STARTED|Consolidation||0
5308506|NCT00492856|13051245|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
5308507|NCT00492856|13051242|P4|NOT COMPLETED|Induction||0
5308508|NCT00492856|13051243|P3|NOT COMPLETED|Induction||0
5308509|NCT00492856|13051244|P2|NOT COMPLETED|Induction||0
5308510|NCT00492856|13051245|P1|NOT COMPLETED|Induction||6
5308511|NCT00492856|13051242|P4|COMPLETED|Induction||0
5308512|NCT00492856|13051243|P3|COMPLETED|Induction||0
5308513|NCT00492856|13051244|P2|COMPLETED|Induction||0
5308514|NCT00492856|13051245|P1|COMPLETED|Induction||99
5308515|NCT00492856|13051242|P4|STARTED|Induction||0
5308516|NCT00492856|13051243|P3|STARTED|Induction||0
5308517|NCT00492856|13051244|P2|STARTED|Induction||0
5308518|NCT00492856|13051245|P1|STARTED|Induction||105
5308519|NCT00492752|13051259|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
5308520|NCT00492752|13051260|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
5308521|NCT00492752|13051261|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
5308522|NCT00492752|13051262|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
5308523|NCT00492752|13051259|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
5308524|NCT00492752|13051260|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
5308525|NCT00492752|13051261|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
5308526|NCT00492752|13051262|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
5308527|NCT00492752|13051259|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
5308528|NCT00492752|13051260|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
5308529|NCT00492752|13051261|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
5308530|NCT00492752|13051262|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
5308531|NCT00492752|13051259|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
5308532|NCT00492752|13051260|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
5308533|NCT00492752|13051261|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
5308534|NCT00492752|13051262|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
5308535|NCT00492752|13051259|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
5308536|NCT00492752|13051260|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
5308537|NCT00492752|13051261|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
5308538|NCT00492752|13051262|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
5308539|NCT00492752|13051259|P4|NOT COMPLETED|Double Blind Treatment||0
5308540|NCT00492752|13051260|P3|NOT COMPLETED|Double Blind Treatment||3
5308541|NCT00492752|13051261|P2|NOT COMPLETED|Double Blind Treatment||0
5308542|NCT00492752|13051262|P1|NOT COMPLETED|Double Blind Treatment||14
5308543|NCT00492752|13051259|P4|COMPLETED|Double Blind Treatment||6
5308544|NCT00492752|13051260|P3|COMPLETED|Double Blind Treatment||67
5308545|NCT00492752|13051261|P2|COMPLETED|Double Blind Treatment||16
5308546|NCT00492752|13051262|P1|COMPLETED|Double Blind Treatment||120
5308547|NCT00492752|13051259|P4|Received Treatment|Double Blind Treatment|Safety Population|6
5308548|NCT00492752|13051260|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
5308549|NCT00492752|13051261|P2|Received Treatment|Double Blind Treatment|Safety Population|16
5308550|NCT00492752|13051262|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
5308551|NCT00492752|13051259|P4|STARTED|Double Blind Treatment||6
5308552|NCT00492752|13051260|P3|STARTED|Double Blind Treatment||70
5308553|NCT00492752|13051261|P2|STARTED|Double Blind Treatment||16
5308554|NCT00492752|13051262|P1|STARTED|Double Blind Treatment||134
5308555|NCT00492726|13051297|P2|NOT COMPLETED|Overall Study||36
5308556|NCT00492726|13051298|P1|NOT COMPLETED|Overall Study||50
5308557|NCT00492726|13051297|P2|COMPLETED|Overall Study||358
5308558|NCT00492726|13051298|P1|COMPLETED|Overall Study||360
5308559|NCT00492726|13051297|P2|End of Study|Overall Study||358
5308560|NCT00492726|13051298|P1|End of Study|Overall Study||360
5308561|NCT00492726|13051297|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
5308562|NCT00492726|13051298|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
5308563|NCT00492726|13051297|P2|STARTED|Overall Study||394
5308564|NCT00492726|13051298|P1|STARTED|Overall Study||410
5308565|NCT00492648|13051324|P2|NOT COMPLETED|Month 42 (109674 Study)||0
5308566|NCT00492648|13051325|P1|NOT COMPLETED|Month 42 (109674 Study)||0
5308567|NCT00492648|13051324|P2|COMPLETED|Month 42 (109674 Study)||20
5308568|NCT00492648|13051325|P1|COMPLETED|Month 42 (109674 Study)||3
5308569|NCT00492648|13051324|P2|STARTED|Month 42 (109674 Study)||20
5308570|NCT00492648|13051325|P1|STARTED|Month 42 (109674 Study)||3
5308571|NCT00492648|13051324|P2|NOT COMPLETED|Month 30 (109671 Study)||1
5308572|NCT00492648|13051325|P1|NOT COMPLETED|Month 30 (109671 Study)||0
5308573|NCT00492648|13051324|P2|COMPLETED|Month 30 (109671 Study)||29
5308574|NCT00492648|13051325|P1|COMPLETED|Month 30 (109671 Study)||4
5308575|NCT00492648|13051324|P2|STARTED|Month 30 (109671 Study)||30
5308576|NCT00492648|13051325|P1|STARTED|Month 30 (109671 Study)||4
5308577|NCT00492622|13051351|P1|NOT COMPLETED|Overall Study||0
5308578|NCT00492622|13051351|P1|COMPLETED|Overall Study||12
5308579|NCT00492622|13051351|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
5308580|NCT00492583|13051363|P2|NOT COMPLETED|Overall Study||0
5308581|NCT00492583|13051364|P1|NOT COMPLETED|Overall Study||0
5308582|NCT00492583|13051363|P2|COMPLETED|Overall Study||87
5308583|NCT00492583|13051364|P1|COMPLETED|Overall Study||95
5308584|NCT00492583|13051363|P2|STARTED|Overall Study||87
5308585|NCT00492583|13051364|P1|STARTED|Overall Study||95
5308586|NCT00492557|13051372|P2|NOT COMPLETED|Overall Study||23
5308587|NCT00492557|13051373|P1|NOT COMPLETED|Overall Study||24
5308588|NCT00492557|13051372|P2|COMPLETED|Overall Study||557
5308589|NCT00492557|13051373|P1|COMPLETED|Overall Study||556
5308590|NCT00492557|13051372|P2|Vaccinated Dose 2|Overall Study||558
5308591|NCT00492557|13051373|P1|Vaccinated Dose 2|Overall Study||560
5308592|NCT00492557|13051372|P2|Vaccinated Dose 1|Overall Study||575
5308593|NCT00492557|13051373|P1|Vaccinated Dose 1|Overall Study||577
5308594|NCT00492557|13051372|P2|STARTED|Overall Study||580
5308595|NCT00492557|13051373|P1|STARTED|Overall Study||580
5308596|NCT00492544|13051389|P1|NOT COMPLETED|Overall Study||0
5308597|NCT00492544|13051389|P1|COMPLETED|Overall Study||100
5308598|NCT00492544|13051389|P1|STARTED|Overall Study||100
5308599|NCT00492531|13051403|P2|NOT COMPLETED|Overall Study||23
5308600|NCT00492531|13051404|P1|NOT COMPLETED|Overall Study||22
5308601|NCT00492531|13051403|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
5308602|NCT00492531|13051404|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
5308603|NCT00492531|13051403|P2|STARTED|Overall Study||37
5308604|NCT00492531|13051404|P1|STARTED|Overall Study||37
5308605|NCT00492401|13051416|P1|NOT COMPLETED|Overall Study||0
5308606|NCT00492401|13051416|P1|COMPLETED|Overall Study||55
5308607|NCT00492401|13051416|P1|STARTED|Overall Study||55
5308608|NCT00492349|13051427|P2|NOT COMPLETED|Overall Study||7
5308609|NCT00492349|13051428|P1|NOT COMPLETED|Overall Study||3
5308610|NCT00492349|13051427|P2|COMPLETED|Overall Study||27
5308611|NCT00492349|13051428|P1|COMPLETED|Overall Study||32
5308612|NCT00492349|13051427|P2|Week 8|Overall Study||27
5308613|NCT00492349|13051428|P1|Week 8|Overall Study||32
5308614|NCT00492349|13051427|P2|Week 2|Overall Study||33
5308615|NCT00492349|13051428|P1|Week 2|Overall Study||32
5308616|NCT00492349|13051427|P2|STARTED|Overall Study||34
5308617|NCT00492349|13051428|P1|STARTED|Overall Study||35
5308618|NCT00492336|13051450|P2|NOT COMPLETED|Overall Study||6
5308619|NCT00492336|13051451|P1|NOT COMPLETED|Overall Study||2
5308620|NCT00492336|13051450|P2|COMPLETED|Overall Study||23
5308621|NCT00492336|13051451|P1|COMPLETED|Overall Study||26
5308622|NCT00492336|13051450|P2|STARTED|Overall Study||29
5308623|NCT00492336|13051451|P1|STARTED|Overall Study||28
5308624|NCT00492297|13051477|P1|NOT COMPLETED|Survival Only Follow-up||59
5308625|NCT00492297|13051477|P1|COMPLETED|Survival Only Follow-up||0
5308626|NCT00492297|13051477|P1|STARTED|Survival Only Follow-up||59
5308627|NCT00492297|13051477|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
5308628|NCT00492297|13051477|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
5308629|NCT00492297|13051477|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
5308630|NCT00492297|13051477|P1|NOT COMPLETED|Treatment||5
5308631|NCT00492297|13051477|P1|COMPLETED|Treatment||78
5308632|NCT00492297|13051477|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
5308633|NCT00492297|13051477|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
5308634|NCT00492297|13051477|P1|STARTED|Treatment||83
5308635|NCT00492284|13051495|P4|NOT COMPLETED|Overall Study||10
5308636|NCT00492284|13051496|P3|NOT COMPLETED|Overall Study||6
5308637|NCT00492284|13051497|P2|NOT COMPLETED|Overall Study||4
5308638|NCT00492284|13051498|P1|NOT COMPLETED|Overall Study||1
5308639|NCT00492284|13051495|P4|COMPLETED|Overall Study||31
5308640|NCT00492284|13051496|P3|COMPLETED|Overall Study||37
5308641|NCT00492284|13051497|P2|COMPLETED|Overall Study||35
5308642|NCT00492284|13051498|P1|COMPLETED|Overall Study||38
5308643|NCT00492284|13051495|P4|STARTED|Overall Study||41
5308644|NCT00492284|13051496|P3|STARTED|Overall Study||43
5308645|NCT00492284|13051497|P2|STARTED|Overall Study||39
5308646|NCT00492284|13051498|P1|STARTED|Overall Study||39
5308647|NCT00492232|13051542|P2|NOT COMPLETED|Open-Label Treatment||0
5308648|NCT00492232|13051543|P1|NOT COMPLETED|Open-Label Treatment||1
5308649|NCT00492232|13051542|P2|COMPLETED|Open-Label Treatment||0
5308650|NCT00492232|13051543|P1|COMPLETED|Open-Label Treatment||88
5308651|NCT00492232|13051542|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
5308652|NCT00492232|13051543|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
5308653|NCT00492232|13051542|P2|NOT COMPLETED|Double-Blind Treatment||25
5308654|NCT00492232|13051543|P1|NOT COMPLETED|Double-Blind Treatment||18
5308655|NCT00492232|13051542|P2|COMPLETED|Double-Blind Treatment||45
5308656|NCT00492232|13051543|P1|COMPLETED|Double-Blind Treatment||47
5308657|NCT00492232|13051542|P2|STARTED|Double-Blind Treatment||70
5308658|NCT00492232|13051543|P1|STARTED|Double-Blind Treatment||65
5308659|NCT00492232|13051542|P2|NOT COMPLETED|Placebo Run-in||70
5308660|NCT00492232|13051543|P1|NOT COMPLETED|Placebo Run-in||0
5308661|NCT00492232|13051542|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
5308662|NCT00492232|13051543|P1|COMPLETED|Placebo Run-in||0
5308663|NCT00492232|13051542|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
5308664|NCT00492232|13051543|P1|STARTED|Placebo Run-in||0
5308665|NCT00492206|13051575|P1|NOT COMPLETED|Overall Study||0
5308666|NCT00492206|13051575|P1|COMPLETED|Overall Study||40
5308667|NCT00492206|13051575|P1|STARTED|Overall Study||40
5308668|NCT00492115|13051584|P2|NOT COMPLETED|Overall Study||4
5308669|NCT00492115|13051585|P1|NOT COMPLETED|Overall Study||3
5308670|NCT00492115|13051584|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
5308671|NCT00492115|13051585|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
5308672|NCT00492115|13051584|P2|STARTED|Overall Study||19
5308673|NCT00492115|13051585|P1|STARTED|Overall Study||19
5308674|NCT00492089|13051595|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
5308675|NCT00492089|13051596|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
5308676|NCT00492089|13051595|P2|COMPLETED|Second Intervention (6 Weeks)||6
5308677|NCT00492089|13051596|P1|COMPLETED|Second Intervention (6 Weeks)||5
5308678|NCT00492089|13051595|P2|STARTED|Second Intervention (6 Weeks)||6
5308679|NCT00492089|13051596|P1|STARTED|Second Intervention (6 Weeks)||5
5308680|NCT00492089|13051595|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
5308681|NCT00492089|13051596|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
5308682|NCT00492089|13051595|P2|COMPLETED|First Intervention (6 Weeks)||6
5308683|NCT00492089|13051596|P1|COMPLETED|First Intervention (6 Weeks)||5
5308684|NCT00492089|13051595|P2|STARTED|First Intervention (6 Weeks)||6
5308685|NCT00492089|13051596|P1|STARTED|First Intervention (6 Weeks)||5
5308686|NCT00492063|13051606|P4|NOT COMPLETED|Overall Study||10
5308687|NCT00492063|13051607|P3|NOT COMPLETED|Overall Study||11
5308688|NCT00492063|13051608|P2|NOT COMPLETED|Overall Study||14
5308689|NCT00492063|13051609|P1|NOT COMPLETED|Overall Study||10
5308690|NCT00492063|13051606|P4|COMPLETED|Overall Study||666
5308691|NCT00492063|13051607|P3|COMPLETED|Overall Study||667
5308692|NCT00492063|13051608|P2|COMPLETED|Overall Study||634
5308693|NCT00492063|13051609|P1|COMPLETED|Overall Study||642
5308694|NCT00492063|13051606|P4|STARTED|Overall Study||676
5308695|NCT00492063|13051607|P3|STARTED|Overall Study||678
5308696|NCT00492063|13051608|P2|STARTED|Overall Study||648
5308697|NCT00492063|13051609|P1|STARTED|Overall Study||652
5308698|NCT00492024|13051633|P2|NOT COMPLETED|Follow up||2
5308699|NCT00492024|13051634|P1|NOT COMPLETED|Follow up||1
5308700|NCT00492024|13051633|P2|COMPLETED|Follow up||99
5308701|NCT00492024|13051634|P1|COMPLETED|Follow up||221
5308702|NCT00492024|13051633|P2|STARTED|Follow up||101
5308703|NCT00492024|13051634|P1|STARTED|Follow up||222
5308704|NCT00492024|13051633|P2|NOT COMPLETED|Treatment||22
5308705|NCT00492024|13051634|P1|NOT COMPLETED|Treatment||29
5308706|NCT00492024|13051633|P2|COMPLETED|Treatment||101
5308707|NCT00492024|13051634|P1|COMPLETED|Treatment||222
5308708|NCT00492024|13051633|P2|STARTED|Treatment||123
5308709|NCT00492024|13051634|P1|STARTED|Treatment||251
5308710|NCT00491894|13051650|P1|NOT COMPLETED|Overall Study||34
5308711|NCT00491894|13051650|P1|COMPLETED|Overall Study||103
5308712|NCT00491894|13051650|P1|STARTED|Overall Study||137
5308713|NCT00491829|13051661|P3|NOT COMPLETED|Overall Study||75
5308714|NCT00491829|13051662|P2|NOT COMPLETED|Overall Study||114
5308715|NCT00491829|13051663|P1|NOT COMPLETED|Overall Study||95
5308716|NCT00491829|13051661|P3|COMPLETED|Overall Study||243
5308717|NCT00491829|13051662|P2|COMPLETED|Overall Study||202
5308718|NCT00491829|13051663|P1|COMPLETED|Overall Study||216
5308719|NCT00491829|13051661|P3|STARTED|Overall Study||318
5308720|NCT00491829|13051662|P2|STARTED|Overall Study||316
5308721|NCT00491829|13051663|P1|STARTED|Overall Study||311
5308722|NCT00491764|13051677|P6|NOT COMPLETED|Overall Study||9
5308723|NCT00491764|13051678|P5|NOT COMPLETED|Overall Study||3
5308724|NCT00491764|13051679|P4|NOT COMPLETED|Overall Study||8
5308725|NCT00491764|13051680|P3|NOT COMPLETED|Overall Study||8
5308726|NCT00491764|13051681|P2|NOT COMPLETED|Overall Study||7
5308727|NCT00491764|13051682|P1|NOT COMPLETED|Overall Study||5
5308728|NCT00491764|13051677|P6|COMPLETED|Overall Study||27
5308729|NCT00491764|13051678|P5|COMPLETED|Overall Study||33
5308730|NCT00491764|13051679|P4|COMPLETED|Overall Study||28
5308731|NCT00491764|13051680|P3|COMPLETED|Overall Study||28
5308732|NCT00491764|13051681|P2|COMPLETED|Overall Study||30
5308733|NCT00491764|13051682|P1|COMPLETED|Overall Study||32
5308734|NCT00491764|13051677|P6|STARTED|Overall Study||36
5308735|NCT00491764|13051678|P5|STARTED|Overall Study||36
5308736|NCT00491764|13051679|P4|STARTED|Overall Study||36
5308737|NCT00491764|13051680|P3|STARTED|Overall Study||36
5308738|NCT00491764|13051681|P2|STARTED|Overall Study||37
5308739|NCT00491764|13051682|P1|STARTED|Overall Study||37
5308740|NCT00491751|13051711|P3|NOT COMPLETED|Overall Study||0
5308741|NCT00491751|13051712|P2|NOT COMPLETED|Overall Study||0
5308742|NCT00491751|13051713|P1|NOT COMPLETED|Overall Study||0
5308743|NCT00491751|13051711|P3|COMPLETED|Overall Study||42
5308744|NCT00491751|13051712|P2|COMPLETED|Overall Study||44
5308745|NCT00491751|13051713|P1|COMPLETED|Overall Study||22
5308746|NCT00491751|13051711|P3|STARTED|Overall Study||42
5308747|NCT00491751|13051712|P2|STARTED|Overall Study||44
5308748|NCT00491751|13051713|P1|STARTED|Overall Study||22
5308749|NCT00491738|13051725|P2|NOT COMPLETED|Overall Study||0
5308750|NCT00491738|13051726|P1|NOT COMPLETED|Overall Study||0
5308751|NCT00491738|13051725|P2|COMPLETED|Overall Study||9
5308752|NCT00491738|13051726|P1|COMPLETED|Overall Study||7
5308753|NCT00491738|13051725|P2|STARTED|Overall Study||9
5308754|NCT00491738|13051726|P1|STARTED|Overall Study||7
5308755|NCT00491608|13051730|P1|NOT COMPLETED|Overall Study||3
5308756|NCT00491608|13051730|P1|COMPLETED|Overall Study||206
5308757|NCT00491608|13051730|P1|STARTED|Overall Study|Participants who received treatment|209
5308758|NCT00491556|13051741|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
5308759|NCT00491556|13051742|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
5308760|NCT00491556|13051741|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
5308761|NCT00491556|13051742|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
5308762|NCT00491556|13051741|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
5308763|NCT00491556|13051742|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
5308764|NCT00491556|13051741|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
5308765|NCT00491556|13051742|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
5308766|NCT00491556|13051741|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
5308767|NCT00491556|13051742|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
5308768|NCT00491556|13051741|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
5308769|NCT00491556|13051742|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
5308770|NCT00491556|13051741|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
5308771|NCT00491556|13051742|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
5308772|NCT00491530|13051801|P3|NOT COMPLETED|Overall Study||5
5308773|NCT00491530|13051802|P2|NOT COMPLETED|Overall Study||6
5308774|NCT00491530|13051803|P1|NOT COMPLETED|Overall Study||12
5308775|NCT00491530|13051801|P3|COMPLETED|Overall Study||81
5308776|NCT00491530|13051802|P2|COMPLETED|Overall Study||44
5308777|NCT00491530|13051803|P1|COMPLETED|Overall Study||162
5308778|NCT00491530|13051801|P3|STARTED|Overall Study||86
5308779|NCT00491530|13051802|P2|STARTED|Overall Study||50
5308780|NCT00491530|13051803|P1|STARTED|Overall Study||174
5308781|NCT00491504|13051833|P4|NOT COMPLETED|Overall Study||4
5308782|NCT00491504|13051834|P3|NOT COMPLETED|Overall Study||4
5308783|NCT00491504|13051835|P2|NOT COMPLETED|Overall Study||1
5308784|NCT00491504|13051836|P1|NOT COMPLETED|Overall Study||0
5308785|NCT00491504|13051833|P4|COMPLETED|Overall Study||73
5308786|NCT00491504|13051834|P3|COMPLETED|Overall Study||74
5308787|NCT00491504|13051835|P2|COMPLETED|Overall Study||77
5308788|NCT00491504|13051836|P1|COMPLETED|Overall Study||77
5308789|NCT00491504|13051833|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
5308790|NCT00491504|13051834|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
5308791|NCT00491504|13051835|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
5308792|NCT00491504|13051836|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
5308793|NCT00491400|13051846|P2|NOT COMPLETED|Overall Study||4
5308794|NCT00491400|13051847|P1|NOT COMPLETED|Overall Study||5
5308795|NCT00491400|13051846|P2|COMPLETED|Overall Study||9
5308796|NCT00491400|13051847|P1|COMPLETED|Overall Study||10
5308797|NCT00491400|13051846|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
5308798|NCT00491400|13051847|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
5308799|NCT00491400|13051846|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
5308800|NCT00491400|13051847|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
5308801|NCT00491400|13051846|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
5308802|NCT00491400|13051847|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
5308803|NCT00491400|13051846|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
5308804|NCT00491400|13051847|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
5308805|NCT00491400|13051846|P2|STARTED|Overall Study||13
5308806|NCT00491400|13051847|P1|STARTED|Overall Study||15
5308807|NCT00491387|13051855|P1|NOT COMPLETED|Overall Study||20
5308808|NCT00491387|13051855|P1|COMPLETED|Overall Study||4
5308809|NCT00491387|13051855|P1|Study Enrollment|Overall Study||24
5308810|NCT00491387|13051855|P1|STARTED|Overall Study||24
5308811|NCT00491374|13051861|P2|NOT COMPLETED|Overall Study||0
5308812|NCT00491374|13051862|P1|NOT COMPLETED|Overall Study||0
5308813|NCT00491374|13051861|P2|COMPLETED|Overall Study||0
5308814|NCT00491374|13051862|P1|COMPLETED|Overall Study||0
5308815|NCT00491374|13051861|P2|STARTED|Overall Study||0
5308816|NCT00491374|13051862|P1|STARTED|Overall Study||0
5308817|NCT00491322|13051870|P2|NOT COMPLETED|Overall Study||1
5308818|NCT00491322|13051871|P1|NOT COMPLETED|Overall Study||1
5308819|NCT00491322|13051870|P2|COMPLETED|Overall Study||50
5308820|NCT00491322|13051871|P1|COMPLETED|Overall Study||40
5308821|NCT00491322|13051870|P2|STARTED|Overall Study||51
5308822|NCT00491322|13051871|P1|STARTED|Overall Study||41
5308823|NCT00491244|13051879|P2|NOT COMPLETED|Overall Study||20
5308824|NCT00491244|13051880|P1|NOT COMPLETED|Overall Study||27
5308825|NCT00491244|13051879|P2|COMPLETED|Overall Study||168
5308826|NCT00491244|13051880|P1|COMPLETED|Overall Study||162
5308827|NCT00491244|13051879|P2|STARTED|Overall Study||188
5308828|NCT00491244|13051880|P1|STARTED|Overall Study||189
5308829|NCT00491179|13051890|P2|NOT COMPLETED|Overall Study||2
5308830|NCT00491179|13051891|P1|NOT COMPLETED|Overall Study||7
5308831|NCT00491179|13051890|P2|COMPLETED|Overall Study||8
5308832|NCT00491179|13051891|P1|COMPLETED|Overall Study||18
5308833|NCT00491179|13051890|P2|STARTED|Overall Study||10
5308834|NCT00491179|13051891|P1|STARTED|Overall Study||25
5308835|NCT00491075|13051899|P1|NOT COMPLETED|Overall Study||2
5308836|NCT00491075|13051899|P1|COMPLETED|Overall Study||14
5308837|NCT00491075|13051899|P1|STARTED|Overall Study||16
5308838|NCT00490971|13051905|P5|NOT COMPLETED|Maintenance||39
5308839|NCT00490971|13051906|P4|NOT COMPLETED|Maintenance||53
5308840|NCT00490971|13051907|P3|NOT COMPLETED|Maintenance||51
5308841|NCT00490971|13051908|P2|NOT COMPLETED|Maintenance||0
5308842|NCT00490971|13051909|P1|NOT COMPLETED|Maintenance||0
5308843|NCT00490971|13051905|P5|COMPLETED|Maintenance||44
5308844|NCT00490971|13051906|P4|COMPLETED|Maintenance||96
5308845|NCT00490971|13051907|P3|COMPLETED|Maintenance||96
5308846|NCT00490971|13051908|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
5308847|NCT00490971|13051909|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
5308848|NCT00490971|13051905|P5|STARTED|Maintenance||83
5308849|NCT00490971|13051906|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
5308850|NCT00490971|13051907|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
5308851|NCT00490971|13051908|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
5308852|NCT00490971|13051909|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
5308853|NCT00490971|13051905|P5|NOT COMPLETED|Acute/Continuation||0
5308854|NCT00490971|13051906|P4|NOT COMPLETED|Acute/Continuation||0
5308855|NCT00490971|13051907|P3|NOT COMPLETED|Acute/Continuation||0
5308856|NCT00490971|13051908|P2|NOT COMPLETED|Acute/Continuation||62
5308857|NCT00490971|13051909|P1|NOT COMPLETED|Acute/Continuation||306
5308858|NCT00490971|13051905|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308859|NCT00490971|13051906|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308860|NCT00490971|13051907|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308861|NCT00490971|13051908|P2|COMPLETED|Acute/Continuation||86
5308862|NCT00490971|13051909|P1|COMPLETED|Acute/Continuation||308
5308863|NCT00490971|13051905|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308864|NCT00490971|13051906|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308865|NCT00490971|13051907|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
5308866|NCT00490971|13051908|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
5308867|NCT00490971|13051909|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
5308868|NCT00490945|13051956|P5|NOT COMPLETED|Overall Study||0
5308869|NCT00490945|13051957|P4|NOT COMPLETED|Overall Study||0
5308870|NCT00490945|13051958|P3|NOT COMPLETED|Overall Study||0
5308871|NCT00490945|13051959|P2|NOT COMPLETED|Overall Study||1
5308872|NCT00490945|13051960|P1|NOT COMPLETED|Overall Study||0
5308873|NCT00490945|13051956|P5|COMPLETED|Overall Study||7
5308874|NCT00490945|13051957|P4|COMPLETED|Overall Study||7
5308875|NCT00490945|13051958|P3|COMPLETED|Overall Study||8
5308876|NCT00490945|13051959|P2|COMPLETED|Overall Study||8
5308877|NCT00490945|13051960|P1|COMPLETED|Overall Study||8
5308878|NCT00490945|13051956|P5|STARTED|Overall Study||7
5308879|NCT00490945|13051957|P4|STARTED|Overall Study||7
5308880|NCT00490945|13051958|P3|STARTED|Overall Study||8
5308881|NCT00490945|13051959|P2|STARTED|Overall Study||9
5308882|NCT00490945|13051960|P1|STARTED|Overall Study||8
5308883|NCT00490919|13051996|P3|NOT COMPLETED|Double-blind Phase||84
5308884|NCT00490919|13051997|P2|NOT COMPLETED|Double-blind Phase||86
5308885|NCT00490919|13051998|P1|NOT COMPLETED|Double-blind Phase||0
5308886|NCT00490919|13051996|P3|COMPLETED|Double-blind Phase||199
5308887|NCT00490919|13051997|P2|COMPLETED|Double-blind Phase||170
5308888|NCT00490919|13051998|P1|COMPLETED|Double-blind Phase||0
5308889|NCT00490919|13051996|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
5308890|NCT00490919|13051997|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
5308891|NCT00490919|13051998|P1|STARTED|Double-blind Phase||0
5308892|NCT00490919|13051996|P3|NOT COMPLETED|Open-label Run-in Period||0
5308893|NCT00490919|13051997|P2|NOT COMPLETED|Open-label Run-in Period||0
5308894|NCT00490919|13051998|P1|NOT COMPLETED|Open-label Run-in Period||483
5308895|NCT00490919|13051996|P3|COMPLETED|Open-label Run-in Period||0
5308896|NCT00490919|13051997|P2|COMPLETED|Open-label Run-in Period||0
5308897|NCT00490919|13051998|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
5308898|NCT00490919|13051996|P3|STARTED|Open-label Run-in Period||0
5308899|NCT00490919|13051997|P2|STARTED|Open-label Run-in Period||0
5308900|NCT00490919|13051998|P1|STARTED|Open-label Run-in Period||1024
5308901|NCT00490841|13052009|P1|NOT COMPLETED|Overall Study||13
5308902|NCT00490841|13052009|P1|COMPLETED|Overall Study||189
5308903|NCT00490841|13052009|P1|STARTED|Overall Study||202
5308904|NCT00490815|13052031|P2|NOT COMPLETED|Overall Study||9
5308905|NCT00490815|13052032|P1|NOT COMPLETED|Overall Study||8
5308906|NCT00490815|13052031|P2|COMPLETED|Overall Study||8
5308907|NCT00490815|13052032|P1|COMPLETED|Overall Study||12
5308908|NCT00490815|13052031|P2|STARTED|Overall Study||17
5308909|NCT00490815|13052032|P1|STARTED|Overall Study||20
5308910|NCT00490802|13052042|P2|NOT COMPLETED|Overall Study||2
5308911|NCT00490802|13052043|P1|NOT COMPLETED|Overall Study||1
5308912|NCT00490802|13052042|P2|COMPLETED|Overall Study||7
5308913|NCT00490802|13052043|P1|COMPLETED|Overall Study||9
5308914|NCT00490802|13052042|P2|STARTED|Overall Study||9
5308915|NCT00490802|13052043|P1|STARTED|Overall Study||10
5308916|NCT00490724|13052060|P3|NOT COMPLETED|Period II||3
5308917|NCT00490724|13052061|P2|NOT COMPLETED|Period II||1
5308918|NCT00490724|13052062|P1|NOT COMPLETED|Period II||3
5308919|NCT00490724|13052060|P3|COMPLETED|Period II||16
5308920|NCT00490724|13052061|P2|COMPLETED|Period II||19
5308921|NCT00490724|13052062|P1|COMPLETED|Period II||18
5308922|NCT00490724|13052060|P3|STARTED|Period II||19
5308923|NCT00490724|13052061|P2|STARTED|Period II||20
5308924|NCT00490724|13052062|P1|STARTED|Period II||21
5308925|NCT00490724|13052060|P3|NOT COMPLETED|Period I||1
5308926|NCT00490724|13052061|P2|NOT COMPLETED|Period I||0
5308927|NCT00490724|13052062|P1|NOT COMPLETED|Period I||0
5308928|NCT00490724|13052060|P3|COMPLETED|Period I||19
5308929|NCT00490724|13052061|P2|COMPLETED|Period I||20
5308930|NCT00490724|13052062|P1|COMPLETED|Period I||21
5308931|NCT00490724|13052060|P3|STARTED|Period I||20
5308932|NCT00490724|13052061|P2|STARTED|Period I||20
5308933|NCT00490724|13052062|P1|STARTED|Period I||21
5308934|NCT00490698|13052127|P1|NOT COMPLETED|Overall Study||10
5308935|NCT00490698|13052127|P1|COMPLETED|Overall Study||1
5308936|NCT00490698|13052127|P1|STARTED|Overall Study||11
5308937|NCT00490646|13052133|P2|NOT COMPLETED|Overall Study||2
5308938|NCT00490646|13052134|P1|NOT COMPLETED|Overall Study||2
5308939|NCT00490646|13052133|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
5308940|NCT00490646|13052134|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
5308941|NCT00490646|13052133|P2|Treated|Overall Study||24
5308942|NCT00490646|13052134|P1|Treated|Overall Study||24
5308943|NCT00490646|13052133|P2|STARTED|Overall Study||25
5308944|NCT00490646|13052134|P1|STARTED|Overall Study||25
5308945|NCT00490568|13052154|P1|NOT COMPLETED|Overall Study||1364
5308946|NCT00490568|13052154|P1|COMPLETED|Overall Study||97
5308947|NCT00490568|13052154|P1|STARTED|Overall Study||1461
5308948|NCT00490555|13052178|P4|NOT COMPLETED|Overall Study||0
5308949|NCT00490555|13052179|P3|NOT COMPLETED|Overall Study||2
5308950|NCT00490555|13052180|P2|NOT COMPLETED|Overall Study||0
5308951|NCT00490555|13052181|P1|NOT COMPLETED|Overall Study||0
5308952|NCT00490555|13052178|P4|COMPLETED|Overall Study||7
5308953|NCT00490555|13052179|P3|COMPLETED|Overall Study||7
5308954|NCT00490555|13052180|P2|COMPLETED|Overall Study||8
5308955|NCT00490555|13052181|P1|COMPLETED|Overall Study||8
5308956|NCT00490555|13052178|P4|STARTED|Overall Study||7
5308957|NCT00490555|13052179|P3|STARTED|Overall Study||9
5308958|NCT00490555|13052180|P2|STARTED|Overall Study||8
5308959|NCT00490555|13052181|P1|STARTED|Overall Study||8
5308960|NCT00490542|13052209|P2|NOT COMPLETED|Overall Study||4
5308961|NCT00490542|13052210|P1|NOT COMPLETED|Overall Study||7
5308962|NCT00490542|13052209|P2|COMPLETED|Overall Study||31
5308963|NCT00490542|13052210|P1|COMPLETED|Overall Study||31
5308964|NCT00490542|13052209|P2|STARTED|Overall Study||35
5308965|NCT00490542|13052210|P1|STARTED|Overall Study||38
5308966|NCT00490529|13052216|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
5308967|NCT00490529|13052216|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
5308968|NCT00490529|13052216|P1|STARTED|Treatment With CpG-MCL Vaccine||48
5308969|NCT00490529|13052216|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
5308970|NCT00490529|13052216|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
5308971|NCT00490529|13052216|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
5308972|NCT00490490|13052224|P1|NOT COMPLETED|Completed Assessment for TTP||3
5308973|NCT00490490|13052224|P1|COMPLETED|Completed Assessment for TTP||5
5308974|NCT00490490|13052224|P1|STARTED|Completed Assessment for TTP||8
5308975|NCT00490490|13052224|P1|NOT COMPLETED|Completed Assessment for CR||0
5308976|NCT00490490|13052224|P1|COMPLETED|Completed Assessment for CR||8
5308977|NCT00490490|13052224|P1|STARTED|Completed Assessment for CR||8
5308978|NCT00490477|13052232|P2|NOT COMPLETED|Overall Study||0
5308979|NCT00490477|13052233|P1|NOT COMPLETED|Overall Study||0
5308980|NCT00490477|13052232|P2|COMPLETED|Overall Study||8
5308981|NCT00490477|13052233|P1|COMPLETED|Overall Study||8
5308982|NCT00490477|13052232|P2|STARTED|Overall Study||8
5308983|NCT00490477|13052233|P1|STARTED|Overall Study||8
5308984|NCT00490451|13052241|P2|NOT COMPLETED|Overall Study||38
5308985|NCT00490451|13052242|P1|NOT COMPLETED|Overall Study||63
5308986|NCT00490451|13052241|P2|COMPLETED|Overall Study||0
5308987|NCT00490451|13052242|P1|COMPLETED|Overall Study||0
5308988|NCT00490451|13052241|P2|STARTED|Overall Study||38
5308989|NCT00490451|13052242|P1|STARTED|Overall Study||63
5308990|NCT00490269|13052264|P2|NOT COMPLETED|Placebo Then Dronabinol||0
5308991|NCT00490269|13052265|P1|NOT COMPLETED|Placebo Then Dronabinol||0
5308992|NCT00490269|13052264|P2|COMPLETED|Placebo Then Dronabinol||6
5308993|NCT00490269|13052265|P1|COMPLETED|Placebo Then Dronabinol||6
5308994|NCT00490269|13052264|P2|STARTED|Placebo Then Dronabinol||6
5308995|NCT00490269|13052265|P1|STARTED|Placebo Then Dronabinol||6
5308996|NCT00490269|13052264|P2|NOT COMPLETED|Dronabinol Then Placebo||0
5308997|NCT00490269|13052265|P1|NOT COMPLETED|Dronabinol Then Placebo||0
5308998|NCT00490269|13052264|P2|COMPLETED|Dronabinol Then Placebo||6
5308999|NCT00490269|13052265|P1|COMPLETED|Dronabinol Then Placebo||6
5309000|NCT00490269|13052264|P2|STARTED|Dronabinol Then Placebo||6
5309001|NCT00490269|13052265|P1|STARTED|Dronabinol Then Placebo||6
5309002|NCT00490256|13052273|P2|NOT COMPLETED|Overall Study||0
5309003|NCT00490256|13052274|P1|NOT COMPLETED|Overall Study||0
5309004|NCT00490256|13052273|P2|COMPLETED|Overall Study||7
5309005|NCT00490256|13052274|P1|COMPLETED|Overall Study||7
5309006|NCT00490256|13052273|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
5309007|NCT00490256|13052274|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
5309008|NCT00490256|13052273|P2|STARTED|Overall Study||7
5309009|NCT00490256|13052274|P1|STARTED|Overall Study||7
5309010|NCT00490139|13052284|P4|NOT COMPLETED|Overall Study||307
5309011|NCT00490139|13052285|P3|NOT COMPLETED|Overall Study||434
5309012|NCT00490139|13052286|P2|NOT COMPLETED|Overall Study||275
5309013|NCT00490139|13052287|P1|NOT COMPLETED|Overall Study||308
5309014|NCT00490139|13052284|P4|COMPLETED|Overall Study||1790
5309015|NCT00490139|13052285|P3|COMPLETED|Overall Study||1666
5309016|NCT00490139|13052286|P2|COMPLETED|Overall Study||1816
5309017|NCT00490139|13052287|P1|COMPLETED|Overall Study||1785
5309018|NCT00490139|13052284|P4|STARTED|Overall Study||2097
5309019|NCT00490139|13052285|P3|STARTED|Overall Study||2100
5309020|NCT00490139|13052286|P2|STARTED|Overall Study||2091
5309021|NCT00490139|13052287|P1|STARTED|Overall Study||2093
5309022|NCT00490100|13052317|P1|NOT COMPLETED|Overall Study||3
5309023|NCT00490100|13052317|P1|COMPLETED|Overall Study||3
5309024|NCT00490100|13052317|P1|STARTED|Overall Study||6
5309025|NCT00490061|13052322|P1|NOT COMPLETED|Overall Study||1
5309026|NCT00490061|13052322|P1|COMPLETED|Overall Study||16
5309027|NCT00490061|13052322|P1|STARTED|Overall Study||17
5309028|NCT00490035|13052331|P4|NOT COMPLETED|Overall Study||6
5309029|NCT00490035|13052332|P3|NOT COMPLETED|Overall Study||12
5309030|NCT00490035|13052333|P2|NOT COMPLETED|Overall Study||6
5309031|NCT00490035|13052334|P1|NOT COMPLETED|Overall Study||8
5309032|NCT00490035|13052331|P4|COMPLETED|Overall Study||94
5309033|NCT00490035|13052332|P3|COMPLETED|Overall Study||88
5309034|NCT00490035|13052333|P2|COMPLETED|Overall Study||93
5309035|NCT00490035|13052334|P1|COMPLETED|Overall Study||92
5309036|NCT00490035|13052331|P4|STARTED|Overall Study||100
5309037|NCT00490035|13052332|P3|STARTED|Overall Study||100
5309038|NCT00490035|13052333|P2|STARTED|Overall Study||99
5309039|NCT00490035|13052334|P1|STARTED|Overall Study||100
5309040|NCT00490022|13052434|P2|NOT COMPLETED|Overall Study||3
5309041|NCT00490022|13052435|P1|NOT COMPLETED|Overall Study||1
5309042|NCT00490022|13052434|P2|COMPLETED|Overall Study||12
5309043|NCT00490022|13052435|P1|COMPLETED|Overall Study||15
5309044|NCT00490022|13052434|P2|STARTED|Overall Study||15
5309045|NCT00490022|13052435|P1|STARTED|Overall Study||16
5309046|NCT00490009|13052443|P1|NOT COMPLETED|Overall Study||0
5309047|NCT00490009|13052443|P1|COMPLETED|Overall Study||9
5309048|NCT00490009|13052443|P1|STARTED|Overall Study||9
5309049|NCT00489970|13052452|P3|NOT COMPLETED|Persistence Year 9||5
5309050|NCT00489970|13052453|P2|NOT COMPLETED|Persistence Year 9||2
5309051|NCT00489970|13052454|P1|NOT COMPLETED|Persistence Year 9||3
5309052|NCT00489970|13052452|P3|COMPLETED|Persistence Year 9||357
5309053|NCT00489970|13052453|P2|COMPLETED|Persistence Year 9||136
5309054|NCT00489970|13052454|P1|COMPLETED|Persistence Year 9||306
5309055|NCT00489970|13052452|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
5309056|NCT00489970|13052453|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
5309057|NCT00489970|13052454|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
5309058|NCT00489970|13052452|P3|NOT COMPLETED|Persistence Year 5||0
5309059|NCT00489970|13052453|P2|NOT COMPLETED|Persistence Year 5||0
5309060|NCT00489970|13052454|P1|NOT COMPLETED|Persistence Year 5||0
5309061|NCT00489970|13052452|P3|COMPLETED|Persistence Year 5||0
5309062|NCT00489970|13052453|P2|COMPLETED|Persistence Year 5||401
5309063|NCT00489970|13052454|P1|COMPLETED|Persistence Year 5||856
5309064|NCT00489970|13052452|P3|STARTED|Persistence Year 5||0
5309065|NCT00489970|13052453|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
5309066|NCT00489970|13052454|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
5309067|NCT00489970|13052452|P3|NOT COMPLETED|Persistence Year 3||0
5309068|NCT00489970|13052453|P2|NOT COMPLETED|Persistence Year 3||0
5309069|NCT00489970|13052454|P1|NOT COMPLETED|Persistence Year 3||0
5309070|NCT00489970|13052452|P3|COMPLETED|Persistence Year 3||0
5309071|NCT00489970|13052453|P2|COMPLETED|Persistence Year 3||486
5309072|NCT00489970|13052454|P1|COMPLETED|Persistence Year 3||1019
5309073|NCT00489970|13052452|P3|STARTED|Persistence Year 3||0
5309074|NCT00489970|13052453|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
5309075|NCT00489970|13052454|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
5309076|NCT00489970|13052452|P3|NOT COMPLETED|Persistence Year 1||0
5309077|NCT00489970|13052453|P2|NOT COMPLETED|Persistence Year 1||0
5309078|NCT00489970|13052454|P1|NOT COMPLETED|Persistence Year 1||0
5309079|NCT00489970|13052452|P3|COMPLETED|Persistence Year 1||0
5309080|NCT00489970|13052453|P2|COMPLETED|Persistence Year 1||523
5309081|NCT00489970|13052454|P1|COMPLETED|Persistence Year 1||1069
5309082|NCT00489970|13052452|P3|STARTED|Persistence Year 1||0
5309083|NCT00489970|13052453|P2|STARTED|Persistence Year 1||523
5309084|NCT00489970|13052454|P1|STARTED|Persistence Year 1||1069
5309085|NCT00489918|13052558|P5|NOT COMPLETED|Overall Study||1
5309086|NCT00489918|13052559|P4|NOT COMPLETED|Overall Study||1
5309087|NCT00489918|13052560|P3|NOT COMPLETED|Overall Study||4
5309088|NCT00489918|13052561|P2|NOT COMPLETED|Overall Study||2
5309089|NCT00489918|13052562|P1|NOT COMPLETED|Overall Study||2
5309090|NCT00489918|13052558|P5|COMPLETED|Overall Study||32
5309091|NCT00489918|13052559|P4|COMPLETED|Overall Study||32
5309092|NCT00489918|13052560|P3|COMPLETED|Overall Study||28
5309093|NCT00489918|13052561|P2|COMPLETED|Overall Study||32
5309094|NCT00489918|13052562|P1|COMPLETED|Overall Study||31
5309095|NCT00489918|13052558|P5|STARTED|Overall Study||33
5309096|NCT00489918|13052559|P4|STARTED|Overall Study||33
5309097|NCT00489918|13052560|P3|STARTED|Overall Study||32
5309098|NCT00489918|13052561|P2|STARTED|Overall Study||34
5309099|NCT00489918|13052562|P1|STARTED|Overall Study||33
5309100|NCT00489866|13052596|P2|NOT COMPLETED|Overall Study||0
5309101|NCT00489866|13052597|P1|NOT COMPLETED|Overall Study||2
5309102|NCT00489866|13052596|P2|COMPLETED|Overall Study||7
5309103|NCT00489866|13052597|P1|COMPLETED|Overall Study||5
5309104|NCT00489866|13052596|P2|STARTED|Overall Study||7
5309105|NCT00489866|13052597|P1|STARTED|Overall Study||7
5309106|NCT00489853|13052611|P3|NOT COMPLETED|Follow-up Period||0
5309107|NCT00489853|13052612|P2|NOT COMPLETED|Follow-up Period||0
5309108|NCT00489853|13052613|P1|NOT COMPLETED|Follow-up Period||0
5309109|NCT00489853|13052611|P3|COMPLETED|Follow-up Period||33
5309110|NCT00489853|13052612|P2|COMPLETED|Follow-up Period||29
5309111|NCT00489853|13052613|P1|COMPLETED|Follow-up Period||29
5309112|NCT00489853|13052611|P3|STARTED|Follow-up Period||33
5309113|NCT00489853|13052612|P2|STARTED|Follow-up Period||29
5309114|NCT00489853|13052613|P1|STARTED|Follow-up Period||29
5309115|NCT00489853|13052611|P3|NOT COMPLETED|Treatment Period 3||0
5309116|NCT00489853|13052612|P2|NOT COMPLETED|Treatment Period 3||1
5309117|NCT00489853|13052613|P1|NOT COMPLETED|Treatment Period 3||0
5309118|NCT00489853|13052611|P3|COMPLETED|Treatment Period 3||33
5309119|NCT00489853|13052612|P2|COMPLETED|Treatment Period 3||29
5309120|NCT00489853|13052613|P1|COMPLETED|Treatment Period 3||29
5309121|NCT00489853|13052611|P3|STARTED|Treatment Period 3||33
5309122|NCT00489853|13052612|P2|STARTED|Treatment Period 3||30
5309123|NCT00489853|13052613|P1|STARTED|Treatment Period 3||29
5309124|NCT00489853|13052611|P3|NOT COMPLETED|Wash-out Period 2||2
5309125|NCT00489853|13052612|P2|NOT COMPLETED|Wash-out Period 2||3
5309126|NCT00489853|13052613|P1|NOT COMPLETED|Wash-out Period 2||4
5309127|NCT00489853|13052611|P3|COMPLETED|Wash-out Period 2||31
5309128|NCT00489853|13052612|P2|COMPLETED|Wash-out Period 2||32
5309129|NCT00489853|13052613|P1|COMPLETED|Wash-out Period 2||29
5309130|NCT00489853|13052611|P3|STARTED|Wash-out Period 2||33
5309131|NCT00489853|13052612|P2|STARTED|Wash-out Period 2||35
5309132|NCT00489853|13052613|P1|STARTED|Wash-out Period 2||33
5309133|NCT00489853|13052611|P3|NOT COMPLETED|Treatment Period 2||0
5309134|NCT00489853|13052612|P2|NOT COMPLETED|Treatment Period 2||0
5309135|NCT00489853|13052613|P1|NOT COMPLETED|Treatment Period 2||0
5309136|NCT00489853|13052611|P3|COMPLETED|Treatment Period 2||33
5309137|NCT00489853|13052612|P2|COMPLETED|Treatment Period 2||35
5309138|NCT00489853|13052613|P1|COMPLETED|Treatment Period 2||33
5309139|NCT00489853|13052611|P3|STARTED|Treatment Period 2||33
5309140|NCT00489853|13052612|P2|STARTED|Treatment Period 2||35
5309141|NCT00489853|13052613|P1|STARTED|Treatment Period 2||33
5309142|NCT00489853|13052611|P3|NOT COMPLETED|Wash-out Period 1||6
5309143|NCT00489853|13052612|P2|NOT COMPLETED|Wash-out Period 1||3
5309144|NCT00489853|13052613|P1|NOT COMPLETED|Wash-out Period 1||1
5309145|NCT00489853|13052611|P3|COMPLETED|Wash-out Period 1||32
5309146|NCT00489853|13052612|P2|COMPLETED|Wash-out Period 1||34
5309147|NCT00489853|13052613|P1|COMPLETED|Wash-out Period 1||35
5309148|NCT00489853|13052611|P3|STARTED|Wash-out Period 1||38
5309149|NCT00489853|13052612|P2|STARTED|Wash-out Period 1||37
5309150|NCT00489853|13052613|P1|STARTED|Wash-out Period 1||36
5309151|NCT00489853|13052611|P3|NOT COMPLETED|Treatment Period 1||0
5309152|NCT00489853|13052612|P2|NOT COMPLETED|Treatment Period 1||0
5309153|NCT00489853|13052613|P1|NOT COMPLETED|Treatment Period 1||0
5309154|NCT00489853|13052611|P3|COMPLETED|Treatment Period 1||38
5309155|NCT00489853|13052612|P2|COMPLETED|Treatment Period 1||37
5309156|NCT00489853|13052613|P1|COMPLETED|Treatment Period 1||36
5309157|NCT00489853|13052611|P3|STARTED|Treatment Period 1||38
5309158|NCT00489853|13052612|P2|STARTED|Treatment Period 1||37
5309159|NCT00489853|13052613|P1|STARTED|Treatment Period 1||36
5309160|NCT00489827|13052710|P2|NOT COMPLETED|Overall Study||2
5309161|NCT00489827|13052711|P1|NOT COMPLETED|Overall Study||2
5309162|NCT00489827|13052710|P2|COMPLETED|Overall Study||433
5309163|NCT00489827|13052711|P1|COMPLETED|Overall Study||428
5309164|NCT00489827|13052710|P2|STARTED|Overall Study||435
5309165|NCT00489827|13052711|P1|STARTED|Overall Study||430
5309166|NCT00489736|13052735|P2|NOT COMPLETED|Overall Study||69
5309167|NCT00489736|13052736|P1|NOT COMPLETED|Overall Study||96
5309168|NCT00489736|13052735|P2|COMPLETED|Overall Study|completed study drug period|186
5309169|NCT00489736|13052736|P1|COMPLETED|Overall Study|completed study drug period|153
5309170|NCT00489736|13052735|P2|STARTED|Overall Study|Randomized and treated patients|255
5309171|NCT00489736|13052736|P1|STARTED|Overall Study|Randomized and treated patients|249
5309172|NCT00489554|13052746|P1|NOT COMPLETED|Overall Study||4
5309173|NCT00489554|13052746|P1|COMPLETED|Overall Study||226
5309174|NCT00489554|13052746|P1|STARTED|Overall Study||230
5309175|NCT00489541|13052766|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
5309176|NCT00489541|13052767|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
5309177|NCT00489541|13052766|P2|COMPLETED|9-Month Angiographic Follow-up||108
5309178|NCT00489541|13052767|P1|COMPLETED|9-Month Angiographic Follow-up||197
5309179|NCT00489541|13052766|P2|STARTED|9-Month Angiographic Follow-up||125
5309180|NCT00489541|13052767|P1|STARTED|9-Month Angiographic Follow-up||224
5309181|NCT00489541|13052766|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
5309182|NCT00489541|13052767|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
5309183|NCT00489541|13052766|P2|COMPLETED|12-Month Clinical Follow-up||120
5309184|NCT00489541|13052767|P1|COMPLETED|12-Month Clinical Follow-up||215
5309185|NCT00489541|13052766|P2|STARTED|12-Month Clinical Follow-up||125
5309186|NCT00489541|13052767|P1|STARTED|12-Month Clinical Follow-up||224
5309187|NCT00489489|13052778|P3|NOT COMPLETED|Overall Study||3
5309188|NCT00489489|13052779|P2|NOT COMPLETED|Overall Study||5
5309189|NCT00489489|13052780|P1|NOT COMPLETED|Overall Study||3
5309190|NCT00489489|13052778|P3|COMPLETED|Overall Study|completed treatment period|37
5309191|NCT00489489|13052779|P2|COMPLETED|Overall Study|completed treatment period|32
5309192|NCT00489489|13052780|P1|COMPLETED|Overall Study|completed treatment period|38
5309193|NCT00489489|13052778|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
5309194|NCT00489489|13052779|P2|Treated|Overall Study||36
5309195|NCT00489489|13052780|P1|Treated|Overall Study||41
5309196|NCT00489489|13052778|P3|STARTED|Overall Study|randomized|40
5309197|NCT00489489|13052779|P2|STARTED|Overall Study|randomized|37
5309198|NCT00489489|13052780|P1|STARTED|Overall Study|randomized|41
5309199|NCT00489476|13052812|P4|NOT COMPLETED|Overall Study||0
5309200|NCT00489476|13052813|P3|NOT COMPLETED|Overall Study||0
5309201|NCT00489476|13052814|P2|NOT COMPLETED|Overall Study||1
5309202|NCT00489476|13052815|P1|NOT COMPLETED|Overall Study||0
5309203|NCT00489476|13052812|P4|COMPLETED|Overall Study||43
5309204|NCT00489476|13052813|P3|COMPLETED|Overall Study||43
5309205|NCT00489476|13052814|P2|COMPLETED|Overall Study||42
5309206|NCT00489476|13052815|P1|COMPLETED|Overall Study||39
5309207|NCT00489476|13052812|P4|STARTED|Overall Study||43
5309208|NCT00489476|13052813|P3|STARTED|Overall Study||43
5309209|NCT00489476|13052814|P2|STARTED|Overall Study||43
5309210|NCT00489476|13052815|P1|STARTED|Overall Study||39
5309211|NCT00489424|13052836|P3|NOT COMPLETED|Overall Study||5
5309212|NCT00489424|13052837|P2|NOT COMPLETED|Overall Study||5
5309213|NCT00489424|13052838|P1|NOT COMPLETED|Overall Study||4
5309214|NCT00489424|13052836|P3|COMPLETED|Overall Study||257
5309215|NCT00489424|13052837|P2|COMPLETED|Overall Study||259
5309216|NCT00489424|13052838|P1|COMPLETED|Overall Study||263
5309217|NCT00489424|13052836|P3|STARTED|Overall Study||262
5309218|NCT00489424|13052837|P2|STARTED|Overall Study||264
5309219|NCT00489424|13052838|P1|STARTED|Overall Study||267
5309220|NCT00489411|13052869|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
5309221|NCT00489411|13052870|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
5309222|NCT00489411|13052869|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
5309223|NCT00489411|13052870|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
5309224|NCT00489411|13052869|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
5309225|NCT00489411|13052870|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
5309226|NCT00489411|13052869|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
5309227|NCT00489411|13052870|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
5309228|NCT00489411|13052869|P2|COMPLETED|Washout Period (Weeks 6-7)||93
5309229|NCT00489411|13052870|P1|COMPLETED|Washout Period (Weeks 6-7)||85
5309230|NCT00489411|13052869|P2|STARTED|Washout Period (Weeks 6-7)||94
5309231|NCT00489411|13052870|P1|STARTED|Washout Period (Weeks 6-7)||87
5309232|NCT00489411|13052869|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
5309233|NCT00489411|13052870|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
5309234|NCT00489411|13052869|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
5309235|NCT00489411|13052870|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
5309236|NCT00489411|13052869|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
5309237|NCT00489411|13052870|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
5309238|NCT00489359|13052884|P2|NOT COMPLETED|Overall Study||29
5309239|NCT00489359|13052885|P1|NOT COMPLETED|Overall Study||7
5309240|NCT00489359|13052884|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
5309241|NCT00489359|13052885|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
5309242|NCT00489359|13052884|P2|STARTED|Overall Study||66
5309243|NCT00489359|13052885|P1|STARTED|Overall Study||20
5309244|NCT00489281|13052910|P2|NOT COMPLETED|Overall Study||0
5309245|NCT00489281|13052911|P1|NOT COMPLETED|Overall Study||0
5309246|NCT00489281|13052910|P2|COMPLETED|Overall Study||13
5309247|NCT00489281|13052911|P1|COMPLETED|Overall Study||29
5309248|NCT00489281|13052910|P2|STARTED|Overall Study||13
5309249|NCT00489281|13052911|P1|STARTED|Overall Study||29
5309250|NCT00489268|13052928|P5|NOT COMPLETED|Overall Study||20
5309251|NCT00489268|13052929|P4|NOT COMPLETED|Overall Study||0
5309252|NCT00489268|13052930|P3|NOT COMPLETED|Overall Study||1
5309253|NCT00489268|13052931|P2|NOT COMPLETED|Overall Study||0
5309254|NCT00489268|13052932|P1|NOT COMPLETED|Overall Study||0
5309255|NCT00489268|13052928|P5|COMPLETED|Overall Study||50
5309256|NCT00489268|13052929|P4|COMPLETED|Overall Study||11
5309257|NCT00489268|13052930|P3|COMPLETED|Overall Study||9
5309258|NCT00489268|13052931|P2|COMPLETED|Overall Study||10
5309259|NCT00489268|13052932|P1|COMPLETED|Overall Study||1
5309260|NCT00489268|13052928|P5|STARTED|Overall Study||70
5309261|NCT00489268|13052929|P4|STARTED|Overall Study||11
5309262|NCT00489268|13052930|P3|STARTED|Overall Study||10
5309263|NCT00489268|13052931|P2|STARTED|Overall Study||10
5309264|NCT00489268|13052932|P1|STARTED|Overall Study||1
5309265|NCT00489255|13052961|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
5309266|NCT00489255|13052962|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
5309267|NCT00489255|13052961|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
5309268|NCT00489255|13052962|P1|COMPLETED|Period 3: Days 57 to 84||24
5309269|NCT00489255|13052961|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
5309270|NCT00489255|13052962|P1|STARTED|Period 3: Days 57 to 84||28
5309271|NCT00489255|13052961|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
5309272|NCT00489255|13052962|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
5309273|NCT00489255|13052961|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
5309274|NCT00489255|13052962|P1|COMPLETED|Period 2: Days 29 to 56||61
5309275|NCT00489255|13052961|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
5309276|NCT00489255|13052962|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
5309277|NCT00489255|13052961|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
5309278|NCT00489255|13052962|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
5309279|NCT00489255|13052961|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
5309280|NCT00489255|13052962|P1|STARTED|Period 2: Days 29 to 56||64
5309281|NCT00489255|13052961|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
5309282|NCT00489255|13052962|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
5309283|NCT00489255|13052961|P2|COMPLETED|Period 1: Days 1 to 28||34
5309284|NCT00489255|13052962|P1|COMPLETED|Period 1: Days 1 to 28||107
5309285|NCT00489255|13052961|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
5309286|NCT00489255|13052962|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
5309287|NCT00489255|13052961|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
5309288|NCT00489255|13052962|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
5309289|NCT00489255|13052961|P2|STARTED|Period 1: Days 1 to 28||46
5309290|NCT00489255|13052962|P1|STARTED|Period 1: Days 1 to 28||136
5309291|NCT00489255|13052961|P2|NOT COMPLETED|Screening and Initial Randomization||3
5309292|NCT00489255|13052962|P1|NOT COMPLETED|Screening and Initial Randomization||9
5309293|NCT00489255|13052961|P2|COMPLETED|Screening and Initial Randomization||46
5309294|NCT00489255|13052962|P1|COMPLETED|Screening and Initial Randomization||136
5309295|NCT00489255|13052961|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
5309296|NCT00489255|13052962|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
5309297|NCT00489216|13053010|P1|NOT COMPLETED|Overall Study||1
5309298|NCT00489216|13053010|P1|COMPLETED|Overall Study||1
5309299|NCT00489216|13053010|P1|STARTED|Overall Study||2
5309300|NCT00489086|13053019|P1|NOT COMPLETED|Overall Study||23
5309301|NCT00489086|13053019|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
5309302|NCT00489086|13053019|P1|STARTED|Overall Study||36
5309303|NCT00488982|13053023|P3|NOT COMPLETED|Response to Course 3||3
5309304|NCT00488982|13053024|P2|NOT COMPLETED|Response to Course 3||1
5309305|NCT00488982|13053025|P1|NOT COMPLETED|Response to Course 3||0
5309306|NCT00488982|13053023|P3|COMPLETED|Response to Course 3||0
5309307|NCT00488982|13053024|P2|COMPLETED|Response to Course 3||1
5309308|NCT00488982|13053025|P1|COMPLETED|Response to Course 3||0
5309309|NCT00488982|13053023|P3|STARTED|Response to Course 3||3
5309310|NCT00488982|13053024|P2|STARTED|Response to Course 3||2
5309311|NCT00488982|13053025|P1|STARTED|Response to Course 3||0
5309312|NCT00488982|13053023|P3|NOT COMPLETED|Course 3||5
5309313|NCT00488982|13053024|P2|NOT COMPLETED|Course 3||2
5309314|NCT00488982|13053025|P1|NOT COMPLETED|Course 3||0
5309315|NCT00488982|13053023|P3|COMPLETED|Course 3||3
5309316|NCT00488982|13053024|P2|COMPLETED|Course 3||2
5309317|NCT00488982|13053025|P1|COMPLETED|Course 3||0
5309318|NCT00488982|13053023|P3|STARTED|Course 3||8
5309319|NCT00488982|13053024|P2|STARTED|Course 3||4
5309320|NCT00488982|13053025|P1|STARTED|Course 3||0
5309321|NCT00488982|13053023|P3|NOT COMPLETED|Course 2||5
5309322|NCT00488982|13053024|P2|NOT COMPLETED|Course 2||9
5309323|NCT00488982|13053025|P1|NOT COMPLETED|Course 2||0
5309324|NCT00488982|13053023|P3|COMPLETED|Course 2||8
5309325|NCT00488982|13053024|P2|COMPLETED|Course 2||4
5309326|NCT00488982|13053025|P1|COMPLETED|Course 2||0
5309327|NCT00488982|13053023|P3|STARTED|Course 2||13
5309328|NCT00488982|13053024|P2|STARTED|Course 2||13
5309329|NCT00488982|13053025|P1|STARTED|Course 2||0
5309330|NCT00488982|13053023|P3|NOT COMPLETED|Course 1||14
5309331|NCT00488982|13053024|P2|NOT COMPLETED|Course 1||12
5309332|NCT00488982|13053025|P1|NOT COMPLETED|Course 1||0
5309333|NCT00488982|13053023|P3|COMPLETED|Course 1||13
5309334|NCT00488982|13053024|P2|COMPLETED|Course 1||13
5309335|NCT00488982|13053025|P1|COMPLETED|Course 1||0
5309336|NCT00488982|13053023|P3|STARTED|Course 1||27
5309337|NCT00488982|13053024|P2|STARTED|Course 1||25
5309338|NCT00488982|13053025|P1|STARTED|Course 1||0
5309339|NCT00488982|13053023|P3|NOT COMPLETED|Induction Chemotherapy||0
5309340|NCT00488982|13053024|P2|NOT COMPLETED|Induction Chemotherapy||0
5309341|NCT00488982|13053025|P1|NOT COMPLETED|Induction Chemotherapy||73
5309342|NCT00488982|13053023|P3|COMPLETED|Induction Chemotherapy||0
5309343|NCT00488982|13053024|P2|COMPLETED|Induction Chemotherapy||0
5309344|NCT00488982|13053025|P1|COMPLETED|Induction Chemotherapy||52
5309345|NCT00488982|13053023|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
5309346|NCT00488982|13053024|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
5309347|NCT00488982|13053025|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
5309348|NCT00488982|13053023|P3|6 Cycles Completed|Induction Chemotherapy||0
5309349|NCT00488982|13053024|P2|6 Cycles Completed|Induction Chemotherapy||0
5309350|NCT00488982|13053025|P1|6 Cycles Completed|Induction Chemotherapy||94
5309351|NCT00488982|13053023|P3|STARTED|Induction Chemotherapy||0
5309352|NCT00488982|13053024|P2|STARTED|Induction Chemotherapy||0
5309353|NCT00488982|13053025|P1|STARTED|Induction Chemotherapy||125
5309354|NCT00488865|13053039|P1|NOT COMPLETED|Overall Study||0
5309355|NCT00488865|13053039|P1|COMPLETED|Overall Study||100
5309356|NCT00488865|13053039|P1|STARTED|Overall Study||100
5309357|NCT00488826|13053048|P3|NOT COMPLETED|Overall Study||26
5309358|NCT00488826|13053049|P2|NOT COMPLETED|Overall Study||52
5309359|NCT00488826|13053050|P1|NOT COMPLETED|Overall Study||56
5309360|NCT00488826|13053048|P3|COMPLETED|Overall Study||178
5309361|NCT00488826|13053049|P2|COMPLETED|Overall Study||244
5309362|NCT00488826|13053050|P1|COMPLETED|Overall Study||244
5309363|NCT00488826|13053048|P3|STARTED|Overall Study||204
5309364|NCT00488826|13053049|P2|STARTED|Overall Study||296
5309365|NCT00488826|13053050|P1|STARTED|Overall Study||300
5309366|NCT00488774|13053065|P4|NOT COMPLETED|Overall Study||3
5309367|NCT00488774|13053066|P3|NOT COMPLETED|Overall Study||5
5309368|NCT00488774|13053067|P2|NOT COMPLETED|Overall Study||5
5309369|NCT00488774|13053068|P1|NOT COMPLETED|Overall Study||8
5309370|NCT00488774|13053065|P4|COMPLETED|Overall Study||74
5309371|NCT00488774|13053066|P3|COMPLETED|Overall Study||70
5309372|NCT00488774|13053067|P2|COMPLETED|Overall Study||57
5309373|NCT00488774|13053068|P1|COMPLETED|Overall Study||69
5309374|NCT00488774|13053065|P4|STARTED|Overall Study||77
5309375|NCT00488774|13053066|P3|STARTED|Overall Study||75
5309376|NCT00488774|13053067|P2|STARTED|Overall Study||62
5309377|NCT00488774|13053068|P1|STARTED|Overall Study||77
5309378|NCT00488683|13053085|P3|NOT COMPLETED|Overall Study||2
5309379|NCT00488683|13053086|P2|NOT COMPLETED|Overall Study||6
5309380|NCT00488683|13053087|P1|NOT COMPLETED|Overall Study||12
5309381|NCT00488683|13053085|P3|COMPLETED|Overall Study||52
5309382|NCT00488683|13053086|P2|COMPLETED|Overall Study||48
5309383|NCT00488683|13053087|P1|COMPLETED|Overall Study||96
5309384|NCT00488683|13053085|P3|STARTED|Overall Study||54
5309385|NCT00488683|13053086|P2|STARTED|Overall Study||54
5309386|NCT00488683|13053087|P1|STARTED|Overall Study||108
5309387|NCT00488644|13053146|P1|NOT COMPLETED|Overall Study||2
5309388|NCT00488644|13053146|P1|COMPLETED|Overall Study||10
5309389|NCT00488644|13053146|P1|STARTED|Overall Study||12
5309390|NCT00488631|13053156|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
5309391|NCT00488631|13053157|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
5309392|NCT00488631|13053158|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
5309393|NCT00488631|13053159|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
5309394|NCT00488631|13053160|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309395|NCT00488631|13053161|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309396|NCT00488631|13053162|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309397|NCT00488631|13053163|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309398|NCT00488631|13053164|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309399|NCT00488631|13053165|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
5309400|NCT00488631|13053156|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
5309401|NCT00488631|13053157|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
5309402|NCT00488631|13053158|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
5309403|NCT00488631|13053159|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
5309404|NCT00488631|13053160|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309405|NCT00488631|13053161|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309406|NCT00488631|13053162|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309407|NCT00488631|13053163|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309408|NCT00488631|13053164|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309409|NCT00488631|13053165|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
5309410|NCT00488631|13053156|P10|STARTED|Open Label Study Extension (Week 54-228)||7
5309411|NCT00488631|13053157|P9|STARTED|Open Label Study Extension (Week 54-228)||470
5309412|NCT00488631|13053158|P8|STARTED|Open Label Study Extension (Week 54-228)||93
5309413|NCT00488631|13053159|P7|STARTED|Open Label Study Extension (Week 54-228)||96
5309414|NCT00488631|13053160|P6|STARTED|Open Label Study Extension (Week 54-228)||0
5309415|NCT00488631|13053161|P5|STARTED|Open Label Study Extension (Week 54-228)||0
5309416|NCT00488631|13053162|P4|STARTED|Open Label Study Extension (Week 54-228)||0
5309417|NCT00488631|13053163|P3|STARTED|Open Label Study Extension (Week 54-228)||0
5309418|NCT00488631|13053164|P2|STARTED|Open Label Study Extension (Week 54-228)||0
5309419|NCT00488631|13053165|P1|STARTED|Open Label Study Extension (Week 54-228)||0
5309420|NCT00488631|13053156|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
5309421|NCT00488631|13053157|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
5309422|NCT00488631|13053158|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
5309423|NCT00488631|13053159|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
5309424|NCT00488631|13053160|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
5309425|NCT00488631|13053161|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
5309426|NCT00488631|13053162|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
5309427|NCT00488631|13053163|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
5309428|NCT00488631|13053164|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
5309429|NCT00488631|13053165|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
5309430|NCT00488631|13053156|P10|COMPLETED|Double Blind Period (Week 0-54)||0
5309431|NCT00488631|13053157|P9|COMPLETED|Double Blind Period (Week 0-54)||0
5309432|NCT00488631|13053158|P8|COMPLETED|Double Blind Period (Week 0-54)||0
5309433|NCT00488631|13053159|P7|COMPLETED|Double Blind Period (Week 0-54)||0
5309434|NCT00488631|13053160|P6|COMPLETED|Double Blind Period (Week 0-54)||189
5309435|NCT00488631|13053161|P5|COMPLETED|Double Blind Period (Week 0-54)||127
5309436|NCT00488631|13053162|P4|COMPLETED|Double Blind Period (Week 0-54)||88
5309437|NCT00488631|13053163|P3|COMPLETED|Double Blind Period (Week 0-54)||109
5309438|NCT00488631|13053164|P2|COMPLETED|Double Blind Period (Week 0-54)||111
5309439|NCT00488631|13053165|P1|COMPLETED|Double Blind Period (Week 0-54)||113
5309440|NCT00488631|13053156|P10|STARTED|Double Blind Period (Week 0-54)||0
5309441|NCT00488631|13053157|P9|STARTED|Double Blind Period (Week 0-54)||0
5309442|NCT00488631|13053158|P8|STARTED|Double Blind Period (Week 0-54)||0
5309443|NCT00488631|13053159|P7|STARTED|Double Blind Period (Week 0-54)||0
5309444|NCT00488631|13053160|P6|STARTED|Double Blind Period (Week 0-54)||405
5309445|NCT00488631|13053161|P5|STARTED|Double Blind Period (Week 0-54)||230
5309446|NCT00488631|13053162|P4|STARTED|Double Blind Period (Week 0-54)||129
5309447|NCT00488631|13053163|P3|STARTED|Double Blind Period (Week 0-54)||154
5309448|NCT00488631|13053164|P2|STARTED|Double Blind Period (Week 0-54)||154
5309449|NCT00488631|13053165|P1|STARTED|Double Blind Period (Week 0-54)||156
5309450|NCT00488618|13053202|P2|NOT COMPLETED|Overall Study||43
5309451|NCT00488618|13053203|P1|NOT COMPLETED|Overall Study||47
5309452|NCT00488618|13053202|P2|COMPLETED|Overall Study||75
5309453|NCT00488618|13053203|P1|COMPLETED|Overall Study||73
5309454|NCT00488618|13053202|P2|Safety Population: Received Study Drug|Overall Study||118
5309455|NCT00488618|13053203|P1|Safety Population: Received Study Drug|Overall Study||118
5309456|NCT00488618|13053202|P2|STARTED|Overall Study||118
5309457|NCT00488618|13053203|P1|STARTED|Overall Study||120
5309458|NCT00488592|13053211|P1|NOT COMPLETED|Overall Study||3
5309459|NCT00488592|13053211|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
5309460|NCT00488592|13053211|P1|STARTED|Overall Study|10 subjects were accrued|10
5309461|NCT00488514|13053215|P1|NOT COMPLETED|Overall Study||293
5309462|NCT00488514|13053215|P1|COMPLETED|Overall Study||363
5309463|NCT00488514|13053215|P1|STARTED|Overall Study||656
5309464|NCT00488488|13053288|P1|NOT COMPLETED|Overall Study||268
5309465|NCT00488488|13053288|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
5309466|NCT00488488|13053288|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
5309467|NCT00488488|13053288|P1|STARTED|Overall Study||1028
5309468|NCT00488475|13053303|P1|NOT COMPLETED|Overall Study||1754
5309469|NCT00488475|13053303|P1|COMPLETED|Overall Study||3191
5309470|NCT00488475|13053303|P1|STARTED|Overall Study||4945
5309471|NCT00488345|13053332|P3|NOT COMPLETED|Overall Study||3
5309472|NCT00488345|13053333|P2|NOT COMPLETED|Overall Study||4
5309473|NCT00488345|13053334|P1|NOT COMPLETED|Overall Study||0
5309474|NCT00488345|13053332|P3|COMPLETED|Overall Study||17
5309475|NCT00488345|13053333|P2|COMPLETED|Overall Study||17
5309476|NCT00488345|13053334|P1|COMPLETED|Overall Study||17
5309477|NCT00488345|13053332|P3|STARTED|Overall Study||20
5309478|NCT00488345|13053333|P2|STARTED|Overall Study||21
5309479|NCT00488345|13053334|P1|STARTED|Overall Study||17
5309480|NCT00488319|13053360|P3|NOT COMPLETED|Overall Study||122
5309481|NCT00488319|13053361|P2|NOT COMPLETED|Overall Study||43
5309482|NCT00488319|13053362|P1|NOT COMPLETED|Overall Study||15
5309483|NCT00488319|13053360|P3|COMPLETED|Overall Study||121
5309484|NCT00488319|13053361|P2|COMPLETED|Overall Study||75
5309485|NCT00488319|13053362|P1|COMPLETED|Overall Study||24
5309486|NCT00488319|13053360|P3|STARTED|Overall Study||243
5309487|NCT00488319|13053361|P2|STARTED|Overall Study||118
5309488|NCT00488319|13053362|P1|STARTED|Overall Study||39
5309489|NCT00488293|13053449|P2|NOT COMPLETED|Overall Study||30
5309490|NCT00488293|13053450|P1|NOT COMPLETED|Overall Study||36
5309491|NCT00488293|13053449|P2|COMPLETED|Overall Study||166
5309492|NCT00488293|13053450|P1|COMPLETED|Overall Study||160
5309493|NCT00488293|13053449|P2|STARTED|Overall Study||196
5309494|NCT00488293|13053450|P1|STARTED|Overall Study||196
5309495|NCT00488059|13053474|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
5309496|NCT00488059|13053475|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309497|NCT00488059|13053476|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309498|NCT00488059|13053474|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
5309499|NCT00488059|13053475|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309500|NCT00488059|13053476|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309501|NCT00488059|13053474|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
5309502|NCT00488059|13053475|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309503|NCT00488059|13053476|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
5309504|NCT00488059|13053474|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309505|NCT00488059|13053475|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
5309506|NCT00488059|13053476|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309507|NCT00488059|13053474|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309508|NCT00488059|13053475|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
5309509|NCT00488059|13053476|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309510|NCT00488059|13053474|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309511|NCT00488059|13053475|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
5309512|NCT00488059|13053476|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
5309513|NCT00488059|13053474|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
5309514|NCT00488059|13053475|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
5309515|NCT00488059|13053476|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
5309516|NCT00488059|13053474|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
5309517|NCT00488059|13053475|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
5309518|NCT00488059|13053476|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
5309519|NCT00488059|13053474|P3|STARTED|Phase I: ENF 90mg SC BID||0
5309520|NCT00488059|13053475|P2|STARTED|Phase I: ENF 90mg SC BID||0
5309521|NCT00488059|13053476|P1|STARTED|Phase I: ENF 90mg SC BID||29
5309522|NCT00488033|13053495|P2|NOT COMPLETED|Overall Study||0
5309523|NCT00488033|13053496|P1|NOT COMPLETED|Overall Study||1
5309524|NCT00488033|13053495|P2|COMPLETED|Overall Study||452
5309525|NCT00488033|13053496|P1|COMPLETED|Overall Study||447
5309526|NCT00488033|13053495|P2|STARTED|Overall Study||452
5309527|NCT00488033|13053496|P1|STARTED|Overall Study||448
5309528|NCT00487981|13053512|P1|NOT COMPLETED|Overall Study||1
5309529|NCT00487981|13053512|P1|COMPLETED|Overall Study||0
5309530|NCT00487981|13053512|P1|STARTED|Overall Study||1
5309531|NCT00487942|13053520|P4|NOT COMPLETED|Overall Study||2
5309532|NCT00487942|13053521|P3|NOT COMPLETED|Overall Study||3
5309533|NCT00487942|13053522|P2|NOT COMPLETED|Overall Study||3
5309534|NCT00487942|13053523|P1|NOT COMPLETED|Overall Study||3
5309535|NCT00487942|13053520|P4|COMPLETED|Overall Study||13
5309536|NCT00487942|13053521|P3|COMPLETED|Overall Study||12
5309537|NCT00487942|13053522|P2|COMPLETED|Overall Study||12
5309538|NCT00487942|13053523|P1|COMPLETED|Overall Study||12
5309539|NCT00487942|13053520|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
5309540|NCT00487942|13053521|P3|STARTED|Overall Study||15
5309541|NCT00487942|13053522|P2|STARTED|Overall Study||15
5309542|NCT00487942|13053523|P1|STARTED|Overall Study||15
5309543|NCT00487825|13053907|P2|NOT COMPLETED|Overall Study||5
5309544|NCT00487825|13053908|P1|NOT COMPLETED|Overall Study||6
5309545|NCT00487825|13053907|P2|COMPLETED|Overall Study||21
5309546|NCT00487825|13053908|P1|COMPLETED|Overall Study||46
5309547|NCT00487825|13053907|P2|STARTED|Overall Study||26
5309548|NCT00487825|13053908|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
5309549|NCT00487747|13053920|P1|NOT COMPLETED|Overall Study||11
5309550|NCT00487747|13053920|P1|COMPLETED|Overall Study||7
5309551|NCT00487747|13053920|P1|STARTED|Overall Study||18
5309552|NCT00487721|13053931|P2|NOT COMPLETED|Overall Study||0
5309553|NCT00487721|13053932|P1|NOT COMPLETED|Overall Study||0
5309554|NCT00487721|13053931|P2|COMPLETED|Overall Study||6
5309555|NCT00487721|13053932|P1|COMPLETED|Overall Study||6
5309556|NCT00487721|13053931|P2|STARTED|Overall Study||6
5309557|NCT00487721|13053932|P1|STARTED|Overall Study||6
5309558|NCT00487695|13053937|P2|NOT COMPLETED|Second Procedure||3
5309559|NCT00487695|13053938|P1|NOT COMPLETED|Second Procedure||1
5309560|NCT00487695|13053937|P2|COMPLETED|Second Procedure||20
5309561|NCT00487695|13053938|P1|COMPLETED|Second Procedure||19
5309562|NCT00487695|13053937|P2|STARTED|Second Procedure||23
5309563|NCT00487695|13053938|P1|STARTED|Second Procedure||20
5309564|NCT00487695|13053937|P2|NOT COMPLETED|First Procedure||0
5309565|NCT00487695|13053938|P1|NOT COMPLETED|First Procedure||3
5309566|NCT00487695|13053937|P2|COMPLETED|First Procedure||23
5309567|NCT00487695|13053938|P1|COMPLETED|First Procedure||20
5309568|NCT00487695|13053937|P2|STARTED|First Procedure||23
5309569|NCT00487695|13053938|P1|STARTED|First Procedure||23
5309570|NCT00487669|13053954|P1|NOT COMPLETED|Overall Study||0
5309571|NCT00487669|13053954|P1|COMPLETED|Overall Study||12
5309572|NCT00487669|13053954|P1|STARTED|Overall Study||12
5309573|NCT00487578|13053966|P2|NOT COMPLETED|Overall Study||4
5309574|NCT00487578|13053967|P1|NOT COMPLETED|Overall Study||1
5309575|NCT00487578|13053966|P2|COMPLETED|Overall Study||5
5309576|NCT00487578|13053967|P1|COMPLETED|Overall Study||2
5309577|NCT00487578|13053966|P2|STARTED|Overall Study||9
5309578|NCT00487578|13053967|P1|STARTED|Overall Study||3
5309579|NCT00487565|13053983|P1|NOT COMPLETED|Overall Study||28
5309580|NCT00487565|13053983|P1|COMPLETED|Overall Study||182
5309581|NCT00487565|13053983|P1|STARTED|Overall Study||210
5309582|NCT00487552|13053987|P1|NOT COMPLETED|Overall Study||6
5309583|NCT00487552|13053987|P1|COMPLETED|Overall Study||12
5309584|NCT00487552|13053987|P1|STARTED|Overall Study||18
5309585|NCT00487539|13053996|P4|NOT COMPLETED|Overall Study||4
5309586|NCT00487539|13053997|P3|NOT COMPLETED|Overall Study||3
5309587|NCT00487539|13053998|P2|NOT COMPLETED|Overall Study||3
5309588|NCT00487539|13053999|P1|NOT COMPLETED|Overall Study||7
5309589|NCT00487539|13053996|P4|COMPLETED|Overall Study||327
5309590|NCT00487539|13053997|P3|COMPLETED|Overall Study||328
5309591|NCT00487539|13053998|P2|COMPLETED|Overall Study||69
5309592|NCT00487539|13053999|P1|COMPLETED|Overall Study||324
5309593|NCT00487539|13053996|P4|STARTED|Overall Study||331
5309594|NCT00487539|13053997|P3|STARTED|Overall Study||331
5309595|NCT00487539|13053998|P2|STARTED|Overall Study||72
5309596|NCT00487539|13053999|P1|STARTED|Overall Study||331
5309597|NCT00487461|13054020|P3|NOT COMPLETED|Overall Study||4
5309598|NCT00487461|13054021|P2|NOT COMPLETED|Overall Study||2
5309599|NCT00487461|13054022|P1|NOT COMPLETED|Overall Study||0
5309600|NCT00487461|13054020|P3|COMPLETED|Overall Study||7
5309601|NCT00487461|13054021|P2|COMPLETED|Overall Study||10
5309602|NCT00487461|13054022|P1|COMPLETED|Overall Study||2
5309603|NCT00487461|13054020|P3|STARTED|Overall Study||11
5309604|NCT00487461|13054021|P2|STARTED|Overall Study||12
5309605|NCT00487461|13054022|P1|STARTED|Overall Study||2
5309606|NCT00487435|13054033|P1|NOT COMPLETED|Overall Study||485
5309607|NCT00487435|13054033|P1|COMPLETED|Overall Study||669
5309608|NCT00487435|13054033|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
5309609|NCT00487396|13054038|P1|NOT COMPLETED|Overall Study||3
5309610|NCT00487396|13054038|P1|COMPLETED|Overall Study||95
5309611|NCT00487396|13054038|P1|STARTED|Overall Study||98
5309612|NCT00487279|13054046|P2|NOT COMPLETED|Overall Study||2
5309613|NCT00487279|13054047|P1|NOT COMPLETED|Overall Study||1
5309614|NCT00487279|13054046|P2|COMPLETED|Overall Study||35
5309615|NCT00487279|13054047|P1|COMPLETED|Overall Study||43
5309616|NCT00487279|13054046|P2|STARTED|Overall Study||37
5309617|NCT00487279|13054047|P1|STARTED|Overall Study||44
5309618|NCT00487240|13054057|P2|NOT COMPLETED|Overall Study||26
5309619|NCT00487240|13054058|P1|NOT COMPLETED|Overall Study||31
5309620|NCT00487240|13054057|P2|COMPLETED|Overall Study||166
5309621|NCT00487240|13054058|P1|COMPLETED|Overall Study||164
5309622|NCT00487240|13054057|P2|Full Analysis Set (ITT Population)|Overall Study||189
5309623|NCT00487240|13054058|P1|Full Analysis Set (ITT Population)|Overall Study||192
5309624|NCT00487240|13054057|P2|STARTED|Overall Study||192
5309625|NCT00487240|13054058|P1|STARTED|Overall Study||195
5309626|NCT00487188|13054086|P3|NOT COMPLETED|Maintenance Phase||1
5309627|NCT00487188|13054087|P2|NOT COMPLETED|Maintenance Phase||0
5309628|NCT00487188|13054088|P1|NOT COMPLETED|Maintenance Phase||3
5309629|NCT00487188|13054086|P3|COMPLETED|Maintenance Phase||8
5309630|NCT00487188|13054087|P2|COMPLETED|Maintenance Phase||8
5309631|NCT00487188|13054088|P1|COMPLETED|Maintenance Phase||7
5309632|NCT00487188|13054086|P3|STARTED|Maintenance Phase||9
5309633|NCT00487188|13054087|P2|STARTED|Maintenance Phase||8
5309634|NCT00487188|13054088|P1|STARTED|Maintenance Phase||10
5309635|NCT00487188|13054086|P3|NOT COMPLETED|Induction Phase||0
5309636|NCT00487188|13054087|P2|NOT COMPLETED|Induction Phase||7
5309637|NCT00487188|13054088|P1|NOT COMPLETED|Induction Phase||9
5309638|NCT00487188|13054086|P3|COMPLETED|Induction Phase||0
5309639|NCT00487188|13054087|P2|COMPLETED|Induction Phase||9
5309640|NCT00487188|13054088|P1|COMPLETED|Induction Phase||22
5309641|NCT00487188|13054086|P3|Safety Population|Induction Phase||0
5309642|NCT00487188|13054087|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
5309643|NCT00487188|13054088|P1|Safety Population|Induction Phase||29
5309644|NCT00487188|13054086|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
5309645|NCT00487188|13054087|P2|STARTED|Induction Phase||16
5309646|NCT00487188|13054088|P1|STARTED|Induction Phase||31
5309647|NCT00487162|13054127|P2|NOT COMPLETED|Overall Study||5
5309648|NCT00487162|13054128|P1|NOT COMPLETED|Overall Study||2
5309649|NCT00487162|13054127|P2|COMPLETED|Overall Study||21
5309650|NCT00487162|13054128|P1|COMPLETED|Overall Study||28
5309651|NCT00487162|13054127|P2|STARTED|Overall Study||26
5309652|NCT00487162|13054128|P1|STARTED|Overall Study||30
5309653|NCT00487084|13054139|P3|NOT COMPLETED|Overall Study||5
5309654|NCT00487084|13054140|P2|NOT COMPLETED|Overall Study||3
5309655|NCT00487084|13054141|P1|NOT COMPLETED|Overall Study||4
5309656|NCT00487084|13054139|P3|COMPLETED|Overall Study||28
5309657|NCT00487084|13054140|P2|COMPLETED|Overall Study||30
5309658|NCT00487084|13054141|P1|COMPLETED|Overall Study||29
5309659|NCT00487084|13054139|P3|STARTED|Overall Study||33
5309660|NCT00487084|13054140|P2|STARTED|Overall Study||33
5309661|NCT00487084|13054141|P1|STARTED|Overall Study||33
5309662|NCT00486954|13054162|P5|NOT COMPLETED|Randomized Part||14
5309663|NCT00486954|13054163|P4|NOT COMPLETED|Randomized Part||20
5309664|NCT00486954|13054164|P3|NOT COMPLETED|Randomized Part||0
5309665|NCT00486954|13054165|P2|NOT COMPLETED|Randomized Part||0
5309666|NCT00486954|13054166|P1|NOT COMPLETED|Randomized Part||0
5309667|NCT00486954|13054162|P5|COMPLETED|Randomized Part||115
5309668|NCT00486954|13054163|P4|COMPLETED|Randomized Part||112
5309669|NCT00486954|13054164|P3|COMPLETED|Randomized Part||0
5309670|NCT00486954|13054165|P2|COMPLETED|Randomized Part||0
5309671|NCT00486954|13054166|P1|COMPLETED|Randomized Part||0
5309672|NCT00486954|13054162|P5|STARTED|Randomized Part||129
5309673|NCT00486954|13054163|P4|STARTED|Randomized Part||132
5309674|NCT00486954|13054164|P3|STARTED|Randomized Part||0
5309675|NCT00486954|13054165|P2|STARTED|Randomized Part||0
5309676|NCT00486954|13054166|P1|STARTED|Randomized Part||0
5309677|NCT00486954|13054162|P5|NOT COMPLETED|Pilot Part||0
5309678|NCT00486954|13054163|P4|NOT COMPLETED|Pilot Part||0
5309679|NCT00486954|13054164|P3|NOT COMPLETED|Pilot Part||6
5309680|NCT00486954|13054165|P2|NOT COMPLETED|Pilot Part||0
5309681|NCT00486954|13054166|P1|NOT COMPLETED|Pilot Part||6
5309682|NCT00486954|13054162|P5|COMPLETED|Pilot Part||0
5309683|NCT00486954|13054163|P4|COMPLETED|Pilot Part||0
5309684|NCT00486954|13054164|P3|COMPLETED|Pilot Part||0
5309685|NCT00486954|13054165|P2|COMPLETED|Pilot Part||0
5309686|NCT00486954|13054166|P1|COMPLETED|Pilot Part||0
5309687|NCT00486954|13054162|P5|STARTED|Pilot Part||0
5309688|NCT00486954|13054163|P4|STARTED|Pilot Part||0
5309689|NCT00486954|13054164|P3|STARTED|Pilot Part||6
5309690|NCT00486954|13054165|P2|STARTED|Pilot Part||0
5309691|NCT00486954|13054166|P1|STARTED|Pilot Part||6
5309692|NCT00486902|13054264|P2|NOT COMPLETED|Overall Study||5
5309693|NCT00486902|13054265|P1|NOT COMPLETED|Overall Study||9
5309694|NCT00486902|13054264|P2|COMPLETED|Overall Study||89
5309695|NCT00486902|13054265|P1|COMPLETED|Overall Study||85
5309696|NCT00486902|13054264|P2|STARTED|Overall Study||94
5309697|NCT00486902|13054265|P1|STARTED|Overall Study||94
5309698|NCT00486863|13054287|P2|NOT COMPLETED|Overall Study||3
5309699|NCT00486863|13054288|P1|NOT COMPLETED|Overall Study||1
5309700|NCT00486863|13054287|P2|COMPLETED|Overall Study||183
5309701|NCT00486863|13054288|P1|COMPLETED|Overall Study||183
5309702|NCT00486863|13054287|P2|STARTED|Overall Study||186
5309703|NCT00486863|13054288|P1|STARTED|Overall Study||184
5309704|NCT00486837|13054332|P2|NOT COMPLETED|Overall Study||7
5309705|NCT00486837|13054333|P1|NOT COMPLETED|Overall Study||9
5309706|NCT00486837|13054332|P2|COMPLETED|Overall Study||28
5309707|NCT00486837|13054333|P1|COMPLETED|Overall Study||28
5309708|NCT00486837|13054332|P2|STARTED|Overall Study||35
5309709|NCT00486837|13054333|P1|STARTED|Overall Study||37
5309710|NCT00486824|13054351|P2|NOT COMPLETED|Overall Study||2
5309711|NCT00486824|13054352|P1|NOT COMPLETED|Overall Study||2
5309712|NCT00486824|13054351|P2|COMPLETED|Overall Study||3
5309713|NCT00486824|13054352|P1|COMPLETED|Overall Study||3
5309714|NCT00486824|13054351|P2|STARTED|Overall Study||5
5309715|NCT00486824|13054352|P1|STARTED|Overall Study||5
5309716|NCT00486811|13054373|P3|NOT COMPLETED|Overall Study||214
5309717|NCT00486811|13054374|P2|NOT COMPLETED|Overall Study||141
5309718|NCT00486811|13054375|P1|NOT COMPLETED|Overall Study||122
5309719|NCT00486811|13054373|P3|COMPLETED|Overall Study||119
5309720|NCT00486811|13054374|P2|COMPLETED|Overall Study||179
5309721|NCT00486811|13054375|P1|COMPLETED|Overall Study||215
5309722|NCT00486811|13054373|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
5309723|NCT00486811|13054374|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
5309724|NCT00486811|13054375|P1|STARTED|Overall Study||337
5309725|NCT00486759|13054418|P2|NOT COMPLETED|Safety Follow-up||118
5309726|NCT00486759|13054419|P1|NOT COMPLETED|Safety Follow-up||139
5309727|NCT00486759|13054418|P2|COMPLETED|Safety Follow-up||142
5309728|NCT00486759|13054419|P1|COMPLETED|Safety Follow-up||64
5309729|NCT00486759|13054418|P2|STARTED|Safety Follow-up||260
5309730|NCT00486759|13054419|P1|STARTED|Safety Follow-up||203
5309731|NCT00486759|13054418|P2|NOT COMPLETED|Treatment||137
5309732|NCT00486759|13054419|P1|NOT COMPLETED|Treatment||187
5309733|NCT00486759|13054418|P2|COMPLETED|Treatment||260
5309734|NCT00486759|13054419|P1|COMPLETED|Treatment||203
5309735|NCT00486759|13054418|P2|STARTED|Treatment||397
5309736|NCT00486759|13054419|P1|STARTED|Treatment||390
5309737|NCT00486720|13054431|P2|NOT COMPLETED|Overall Study||12
5309738|NCT00486720|13054432|P1|NOT COMPLETED|Overall Study||10
5309739|NCT00486720|13054431|P2|COMPLETED|Overall Study||0
5309740|NCT00486720|13054432|P1|COMPLETED|Overall Study||0
5309741|NCT00486720|13054431|P2|STARTED|Overall Study||12
5309742|NCT00486720|13054432|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
5309743|NCT00486642|13054442|P2|NOT COMPLETED|Overall Study||0
5309744|NCT00486642|13054443|P1|NOT COMPLETED|Overall Study||0
5309745|NCT00486642|13054442|P2|COMPLETED|Overall Study||13
5309746|NCT00486642|13054443|P1|COMPLETED|Overall Study||10
5309747|NCT00486642|13054442|P2|STARTED|Overall Study||13
5309748|NCT00486642|13054443|P1|STARTED|Overall Study||10
5309749|NCT00486603|13054467|P5|NOT COMPLETED|Overall Study||0
5309750|NCT00486603|13054468|P4|NOT COMPLETED|Overall Study||0
5309751|NCT00486603|13054469|P3|NOT COMPLETED|Overall Study||0
5309752|NCT00486603|13054470|P2|NOT COMPLETED|Overall Study||1
5309753|NCT00486603|13054471|P1|NOT COMPLETED|Overall Study||1
5309754|NCT00486603|13054467|P5|COMPLETED|Overall Study||76
5309755|NCT00486603|13054468|P4|COMPLETED|Overall Study||3
5309756|NCT00486603|13054469|P3|COMPLETED|Overall Study||3
5309757|NCT00486603|13054470|P2|COMPLETED|Overall Study||6
5309758|NCT00486603|13054471|P1|COMPLETED|Overall Study||2
5309759|NCT00486603|13054467|P5|STARTED|Overall Study||76
5309760|NCT00486603|13054468|P4|STARTED|Overall Study||3
5309761|NCT00486603|13054469|P3|STARTED|Overall Study||3
5309762|NCT00486603|13054470|P2|STARTED|Overall Study||7
5309763|NCT00486603|13054471|P1|STARTED|Overall Study||3
5309764|NCT00486525|13054495|P2|NOT COMPLETED|Overall Study||13
5309765|NCT00486525|13054496|P1|NOT COMPLETED|Overall Study||6
5309766|NCT00486525|13054495|P2|COMPLETED|Overall Study||87
5309767|NCT00486525|13054496|P1|COMPLETED|Overall Study||94
5309768|NCT00486525|13054495|P2|STARTED|Overall Study||100
5309769|NCT00486525|13054496|P1|STARTED|Overall Study||100
5309770|NCT00486447|13054512|P1|NOT COMPLETED|Overall Study||0
5309771|NCT00486447|13054512|P1|COMPLETED|Overall Study||249
5309772|NCT00486447|13054512|P1|STARTED|Overall Study||249
5309773|NCT00486434|13054519|P2|NOT COMPLETED|Overall Study||134
5309774|NCT00486434|13054520|P1|NOT COMPLETED|Overall Study||194
5309775|NCT00486434|13054519|P2|COMPLETED|Overall Study||454
5309776|NCT00486434|13054520|P1|COMPLETED|Overall Study||394
5309777|NCT00486434|13054519|P2|STARTED|Overall Study||588
5309778|NCT00486434|13054520|P1|STARTED|Overall Study||588
5309779|NCT00486330|13054539|P1|NOT COMPLETED|Overall Study||2
5309780|NCT00486330|13054539|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
5309781|NCT00486330|13054539|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
5309782|NCT00486291|13054545|P2|NOT COMPLETED|Overall Study||29
5309783|NCT00486291|13054546|P1|NOT COMPLETED|Overall Study||16
5309784|NCT00486291|13054545|P2|COMPLETED|Overall Study||76
5309785|NCT00486291|13054546|P1|COMPLETED|Overall Study||89
5309786|NCT00486291|13054545|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
5309787|NCT00486291|13054546|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
5309788|NCT00486278|13054554|P1|NOT COMPLETED|Overall Study||9
5309789|NCT00486278|13054554|P1|COMPLETED|Overall Study||42
5309790|NCT00486278|13054554|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
5309791|NCT00486265|13054688|P1|NOT COMPLETED|Overall Study||9
5309792|NCT00486265|13054688|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
5309793|NCT00486265|13054688|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
5309794|NCT00486252|13054692|P1|NOT COMPLETED|Overall Study||58
5309795|NCT00486252|13054692|P1|COMPLETED|Overall Study||938
5309796|NCT00486252|13054692|P1|STARTED|Overall Study||996
5309797|NCT00486226|13054707|P1|NOT COMPLETED|Overall Study||13
5309798|NCT00486226|13054707|P1|COMPLETED|Overall Study||92
5309799|NCT00486226|13054707|P1|STARTED|Overall Study||105
5309800|NCT00486044|13054717|P2|NOT COMPLETED|Overall Study||3
5309801|NCT00486044|13054718|P1|NOT COMPLETED|Overall Study||2
5309802|NCT00486044|13054717|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
5309803|NCT00486044|13054718|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
5309804|NCT00486044|13054717|P2|STARTED|Overall Study|23 in MRI sub-study|49
5309805|NCT00486044|13054718|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
5309806|NCT00486031|13054730|P1|NOT COMPLETED|Overall Study||3
5309807|NCT00486031|13054730|P1|COMPLETED|Overall Study||440
5309808|NCT00486031|13054730|P1|STARTED|Overall Study||443
5309809|NCT00486018|13054738|P3|NOT COMPLETED|Overall Study||6
5309810|NCT00486018|13054739|P2|NOT COMPLETED|Overall Study||6
5309811|NCT00486018|13054740|P1|NOT COMPLETED|Overall Study||9
5309812|NCT00486018|13054738|P3|COMPLETED|Overall Study||125
5309813|NCT00486018|13054739|P2|COMPLETED|Overall Study||128
5309814|NCT00486018|13054740|P1|COMPLETED|Overall Study||123
5309815|NCT00486018|13054738|P3|Received Drug (Safety Population)|Overall Study||130
5309816|NCT00486018|13054739|P2|Received Drug (Safety Population)|Overall Study||134
5309817|NCT00486018|13054740|P1|Received Drug (Safety Population)|Overall Study||131
5309818|NCT00486018|13054738|P3|STARTED|Overall Study||131
5309819|NCT00486018|13054739|P2|STARTED|Overall Study||134
5309820|NCT00486018|13054740|P1|STARTED|Overall Study||132
5309821|NCT00485953|13054768|P2|NOT COMPLETED|Overall Study||7
5309822|NCT00485953|13054769|P1|NOT COMPLETED|Overall Study||7
5309823|NCT00485953|13054768|P2|COMPLETED|Overall Study||47
5309824|NCT00485953|13054769|P1|COMPLETED|Overall Study||48
5309825|NCT00485953|13054768|P2|STARTED|Overall Study||54
5309826|NCT00485953|13054769|P1|STARTED|Overall Study||55
5309827|NCT00485836|13054782|P3|NOT COMPLETED|Overall Study||11
5309828|NCT00485836|13054783|P2|NOT COMPLETED|Overall Study||3
5309829|NCT00485836|13054784|P1|NOT COMPLETED|Overall Study||15
5309830|NCT00485836|13054782|P3|COMPLETED|Overall Study||119
5309831|NCT00485836|13054783|P2|COMPLETED|Overall Study||129
5309832|NCT00485836|13054784|P1|COMPLETED|Overall Study||115
5309833|NCT00485836|13054782|P3|Received Study Drug (Safety Population)|Overall Study||129
5309834|NCT00485836|13054783|P2|Received Study Drug (Safety Population)|Overall Study||132
5309835|NCT00485836|13054784|P1|Received Study Drug (Safety Population)|Overall Study||129
5309836|NCT00485836|13054782|P3|STARTED|Overall Study||130
5309837|NCT00485836|13054783|P2|STARTED|Overall Study||132
5309838|NCT00485836|13054784|P1|STARTED|Overall Study||130
5309839|NCT00485758|13054812|P2|NOT COMPLETED|Overall Study||65
5309840|NCT00485758|13054813|P1|NOT COMPLETED|Overall Study||156
5309841|NCT00485758|13054812|P2|COMPLETED|Overall Study||277
5309842|NCT00485758|13054813|P1|COMPLETED|Overall Study||298
5309843|NCT00485758|13054812|P2|STARTED|Overall Study||342
5309844|NCT00485758|13054813|P1|STARTED|Overall Study||454
5309845|NCT00485732|13054825|P2|NOT COMPLETED|Overall Study||9
5309846|NCT00485732|13054826|P1|NOT COMPLETED|Overall Study||8
5309847|NCT00485732|13054825|P2|COMPLETED|Overall Study||67
5309848|NCT00485732|13054826|P1|COMPLETED|Overall Study||141
5309849|NCT00485732|13054825|P2|STARTED|Overall Study||76
5309850|NCT00485732|13054826|P1|STARTED|Overall Study||149
5309851|NCT00485693|13054848|P2|NOT COMPLETED|Overall Study||0
5309852|NCT00485693|13054849|P1|NOT COMPLETED|Overall Study||0
5309853|NCT00485693|13054848|P2|COMPLETED|Overall Study||104
5309854|NCT00485693|13054849|P1|COMPLETED|Overall Study||34
5309855|NCT00485693|13054848|P2|STARTED|Overall Study||104
5309856|NCT00485693|13054849|P1|STARTED|Overall Study||34
5309857|NCT00485485|13054858|P1|NOT COMPLETED|Overall Study||0
5309858|NCT00485485|13054858|P1|COMPLETED|Overall Study||7
5309859|NCT00485485|13054858|P1|STARTED|Overall Study||7
5309860|NCT00485472|13054864|P2|NOT COMPLETED|Overall Study||12
5309861|NCT00485472|13054865|P1|NOT COMPLETED|Overall Study||16
5309862|NCT00485472|13054864|P2|COMPLETED|Overall Study||64
5309863|NCT00485472|13054865|P1|COMPLETED|Overall Study||57
5309864|NCT00485472|13054864|P2|Entered Maintenance Phase|Overall Study||67
5309865|NCT00485472|13054865|P1|Entered Maintenance Phase|Overall Study||65
5309866|NCT00485472|13054864|P2|STARTED|Overall Study||76
5309867|NCT00485472|13054865|P1|STARTED|Overall Study||73
5309868|NCT00485433|13054891|P4|NOT COMPLETED|Overall Study||0
5309869|NCT00485433|13054892|P3|NOT COMPLETED|Overall Study||0
5309870|NCT00485433|13054893|P2|NOT COMPLETED|Overall Study||0
5309871|NCT00485433|13054894|P1|NOT COMPLETED|Overall Study||0
5309872|NCT00485433|13054891|P4|COMPLETED|Overall Study||25
5309873|NCT00485433|13054892|P3|COMPLETED|Overall Study||24
5309874|NCT00485433|13054893|P2|COMPLETED|Overall Study||25
5309875|NCT00485433|13054894|P1|COMPLETED|Overall Study||24
5309876|NCT00485433|13054891|P4|STARTED|Overall Study||25
5309877|NCT00485433|13054892|P3|STARTED|Overall Study||24
5309878|NCT00485433|13054893|P2|STARTED|Overall Study||25
5309879|NCT00485433|13054894|P1|STARTED|Overall Study||24
5309880|NCT00485303|13054902|P1|NOT COMPLETED|Overall Study||56
5309881|NCT00485303|13054902|P1|COMPLETED|Overall Study||2
5309882|NCT00485303|13054902|P1|STARTED|Overall Study||58
5309883|NCT00485264|13054920|P6|NOT COMPLETED|Overall Study||7
5309884|NCT00485264|13054921|P5|NOT COMPLETED|Overall Study||6
5309885|NCT00485264|13054922|P4|NOT COMPLETED|Overall Study||4
5309886|NCT00485264|13054923|P3|NOT COMPLETED|Overall Study||6
5309887|NCT00485264|13054924|P2|NOT COMPLETED|Overall Study||7
5309888|NCT00485264|13054925|P1|NOT COMPLETED|Overall Study||36
5309889|NCT00485264|13054920|P6|COMPLETED|Overall Study||5
5309890|NCT00485264|13054921|P5|COMPLETED|Overall Study||9
5309891|NCT00485264|13054922|P4|COMPLETED|Overall Study||17
5309892|NCT00485264|13054923|P3|COMPLETED|Overall Study||12
5309893|NCT00485264|13054924|P2|COMPLETED|Overall Study||9
5309894|NCT00485264|13054925|P1|COMPLETED|Overall Study||35
5309895|NCT00485264|13054920|P6|Completed Week 24|Overall Study||11
5309896|NCT00485264|13054921|P5|Completed Week 24|Overall Study||14
5309897|NCT00485264|13054922|P4|Completed Week 24|Overall Study||21
5309898|NCT00485264|13054923|P3|Completed Week 24|Overall Study||18
5309899|NCT00485264|13054924|P2|Completed Week 24|Overall Study||16
5309900|NCT00485264|13054925|P1|Completed Week 24|Overall Study||67
5309901|NCT00485264|13054920|P6|STARTED|Overall Study||12
5309902|NCT00485264|13054921|P5|STARTED|Overall Study||15
5309903|NCT00485264|13054922|P4|STARTED|Overall Study||21
5309904|NCT00485264|13054923|P3|STARTED|Overall Study||18
5309905|NCT00485264|13054924|P2|STARTED|Overall Study||16
5309906|NCT00485264|13054925|P1|STARTED|Overall Study||71
5309907|NCT00485173|13055013|P2|NOT COMPLETED|Overall Study||64
5309908|NCT00485173|13055014|P1|NOT COMPLETED|Overall Study||36
5309909|NCT00485173|13055013|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
5309910|NCT00485173|13055014|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
5309911|NCT00485173|13055013|P2|STARTED|Overall Study||486
5309912|NCT00485173|13055014|P1|STARTED|Overall Study||224
5309913|NCT00485134|13055062|P8|NOT COMPLETED|Overall Study||1
5309914|NCT00485134|13055063|P7|NOT COMPLETED|Overall Study||3
5309915|NCT00485134|13055064|P6|NOT COMPLETED|Overall Study||4
5309916|NCT00485134|13055065|P5|NOT COMPLETED|Overall Study||3
5309917|NCT00485134|13055066|P4|NOT COMPLETED|Overall Study||1
5309918|NCT00485134|13055067|P3|NOT COMPLETED|Overall Study||3
5309919|NCT00485134|13055068|P2|NOT COMPLETED|Overall Study||2
5309920|NCT00485134|13055069|P1|NOT COMPLETED|Overall Study||1
5309921|NCT00485134|13055062|P8|COMPLETED|Overall Study||20
5309922|NCT00485134|13055063|P7|COMPLETED|Overall Study||28
5309923|NCT00485134|13055064|P6|COMPLETED|Overall Study||3
5309924|NCT00485134|13055065|P5|COMPLETED|Overall Study||7
5309925|NCT00485134|13055066|P4|COMPLETED|Overall Study||7
5309926|NCT00485134|13055067|P3|COMPLETED|Overall Study||9
5309927|NCT00485134|13055068|P2|COMPLETED|Overall Study||10
5309928|NCT00485134|13055069|P1|COMPLETED|Overall Study||11
5309929|NCT00485134|13055062|P8|STARTED|Overall Study||21
5309930|NCT00485134|13055063|P7|STARTED|Overall Study||31
5309931|NCT00485134|13055064|P6|STARTED|Overall Study||7
5309932|NCT00485134|13055065|P5|STARTED|Overall Study||10
5309933|NCT00485134|13055066|P4|STARTED|Overall Study||8
5309934|NCT00485134|13055067|P3|STARTED|Overall Study||12
5309935|NCT00485134|13055068|P2|STARTED|Overall Study||12
5309936|NCT00485134|13055069|P1|STARTED|Overall Study||12
5309937|NCT00485069|13055091|P2|NOT COMPLETED|Overall Study||12
5309938|NCT00485069|13055092|P1|NOT COMPLETED|Overall Study||18
5309939|NCT00485069|13055091|P2|COMPLETED|Overall Study||46
5309940|NCT00485069|13055092|P1|COMPLETED|Overall Study||47
5309941|NCT00485069|13055091|P2|STARTED|Overall Study||58
5309942|NCT00485069|13055092|P1|STARTED|Overall Study||65
5309943|NCT00484939|13055137|P2|NOT COMPLETED|Overall Study||140
5309944|NCT00484939|13055138|P1|NOT COMPLETED|Overall Study||140
5309945|NCT00484939|13055137|P2|COMPLETED|Overall Study||0
5309946|NCT00484939|13055138|P1|COMPLETED|Overall Study||0
5309947|NCT00484939|13055137|P2|STARTED|Overall Study||140
5309948|NCT00484939|13055138|P1|STARTED|Overall Study||140
5309949|NCT00484874|13055158|P1|NOT COMPLETED|Overall Study||0
5309950|NCT00484874|13055158|P1|COMPLETED|Overall Study||12
5309951|NCT00484874|13055158|P1|STARTED|Overall Study||12
5309952|NCT00484679|13055165|P1|NOT COMPLETED|Overall Study||3
5309953|NCT00484679|13055165|P1|COMPLETED|Overall Study||15
5309954|NCT00484679|13055165|P1|STARTED|Overall Study||18
5309955|NCT00484419|13055172|P3|NOT COMPLETED|Overall Study||11
5309956|NCT00484419|13055173|P2|NOT COMPLETED|Overall Study||5
5309957|NCT00484419|13055174|P1|NOT COMPLETED|Overall Study||12
5309958|NCT00484419|13055172|P3|COMPLETED|Overall Study||45
5309959|NCT00484419|13055173|P2|COMPLETED|Overall Study||51
5309960|NCT00484419|13055174|P1|COMPLETED|Overall Study||45
5309961|NCT00484419|13055172|P3|STARTED|Overall Study||56
5309962|NCT00484419|13055173|P2|STARTED|Overall Study||56
5309963|NCT00484419|13055174|P1|STARTED|Overall Study||57
5309964|NCT00484393|13055232|P2|NOT COMPLETED|Overall Study||0
5309965|NCT00484393|13055233|P1|NOT COMPLETED|Overall Study||0
5309966|NCT00484393|13055232|P2|COMPLETED|Overall Study||3
5309967|NCT00484393|13055233|P1|COMPLETED|Overall Study||4
5309968|NCT00484393|13055232|P2|STARTED|Overall Study||3
5309969|NCT00484393|13055233|P1|STARTED|Overall Study||4
5309970|NCT00484354|13055241|P2|NOT COMPLETED|Overall Study||2
5309971|NCT00484354|13055242|P1|NOT COMPLETED|Overall Study||1
5309972|NCT00484354|13055241|P2|COMPLETED|Overall Study||57
5309973|NCT00484354|13055242|P1|COMPLETED|Overall Study||63
5309974|NCT00484354|13055241|P2|STARTED|Overall Study||59
5309975|NCT00484354|13055242|P1|STARTED|Overall Study||64
5309976|NCT00484315|13055258|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
5309977|NCT00484315|13055259|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
5309978|NCT00484315|13055258|P2|COMPLETED|9-Month Angiographic Follow-up||61
5309979|NCT00484315|13055259|P1|COMPLETED|9-Month Angiographic Follow-up||228
5309980|NCT00484315|13055258|P2|STARTED|9-Month Angiographic Follow-up||74
5309981|NCT00484315|13055259|P1|STARTED|9-Month Angiographic Follow-up||256
5309982|NCT00484315|13055258|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
5309983|NCT00484315|13055259|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
5309984|NCT00484315|13055258|P2|COMPLETED|12-Month Clinical Follow-up||311
5309985|NCT00484315|13055259|P1|COMPLETED|12-Month Clinical Follow-up||914
5309986|NCT00484315|13055258|P2|STARTED|12-Month Clinical Follow-up||320
5309987|NCT00484315|13055259|P1|STARTED|12-Month Clinical Follow-up||942
5309988|NCT00484289|13055270|P3|NOT COMPLETED|Post Marketing Phase||0
5309989|NCT00484289|13055271|P2|NOT COMPLETED|Post Marketing Phase||1
5309990|NCT00484289|13055272|P1|NOT COMPLETED|Post Marketing Phase||0
5309991|NCT00484289|13055270|P3|COMPLETED|Post Marketing Phase||10
5309992|NCT00484289|13055271|P2|COMPLETED|Post Marketing Phase||141
5309993|NCT00484289|13055272|P1|COMPLETED|Post Marketing Phase||10
5309994|NCT00484289|13055270|P3|STARTED|Post Marketing Phase||10
5309995|NCT00484289|13055271|P2|STARTED|Post Marketing Phase||142
5309996|NCT00484289|13055272|P1|STARTED|Post Marketing Phase||10
5309997|NCT00484289|13055270|P3|NOT COMPLETED|Long Term Phase||16
5309998|NCT00484289|13055271|P2|NOT COMPLETED|Long Term Phase||36
5309999|NCT00484289|13055272|P1|NOT COMPLETED|Long Term Phase||3
5310000|NCT00484289|13055270|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
5310001|NCT00484289|13055271|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
5310002|NCT00484289|13055272|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
5310003|NCT00484289|13055270|P3|STARTED|Long Term Phase||26
5310004|NCT00484289|13055271|P2|STARTED|Long Term Phase||178
5310005|NCT00484289|13055272|P1|STARTED|Long Term Phase||13
5310006|NCT00484185|13055344|P1|NOT COMPLETED|Overall Study||71
5310007|NCT00484185|13055344|P1|COMPLETED|Overall Study||112
5310008|NCT00484185|13055344|P1|Treated|Overall Study||178
5310009|NCT00484185|13055344|P1|STARTED|Overall Study||183
5310010|NCT00484159|13055366|P3|NOT COMPLETED|Overall Study||0
5310011|NCT00484159|13055367|P2|NOT COMPLETED|Overall Study||1
5310012|NCT00484159|13055368|P1|NOT COMPLETED|Overall Study||1
5310013|NCT00484159|13055366|P3|COMPLETED|Overall Study||51
5310014|NCT00484159|13055367|P2|COMPLETED|Overall Study||49
5310015|NCT00484159|13055368|P1|COMPLETED|Overall Study||49
5310016|NCT00484159|13055366|P3|STARTED|Overall Study||51
5310017|NCT00484159|13055367|P2|STARTED|Overall Study||50
5310018|NCT00484159|13055368|P1|STARTED|Overall Study||50
5310019|NCT00484094|13055379|P1|NOT COMPLETED|Overall Study||42
5310020|NCT00484094|13055379|P1|COMPLETED|Overall Study||167
5310021|NCT00484094|13055379|P1|STARTED|Overall Study||209
5310022|NCT00483938|13055395|P7|NOT COMPLETED|Overall Study||40
5310023|NCT00483938|13055396|P6|NOT COMPLETED|Overall Study||8
5310024|NCT00483938|13055397|P5|NOT COMPLETED|Overall Study||2
5310025|NCT00483938|13055398|P4|NOT COMPLETED|Overall Study||6
5310026|NCT00483938|13055399|P3|NOT COMPLETED|Overall Study||0
5310027|NCT00483938|13055400|P2|NOT COMPLETED|Overall Study||19
5310028|NCT00483938|13055401|P1|NOT COMPLETED|Overall Study||5
5310029|NCT00483938|13055395|P7|COMPLETED|Overall Study||0
5310030|NCT00483938|13055396|P6|COMPLETED|Overall Study||18
5310031|NCT00483938|13055397|P5|COMPLETED|Overall Study||23
5310032|NCT00483938|13055398|P4|COMPLETED|Overall Study||25
5310033|NCT00483938|13055399|P3|COMPLETED|Overall Study||30
5310034|NCT00483938|13055400|P2|COMPLETED|Overall Study||24
5310035|NCT00483938|13055401|P1|COMPLETED|Overall Study||36
5310036|NCT00483938|13055395|P7|STARTED|Overall Study||40
5310037|NCT00483938|13055396|P6|STARTED|Overall Study||26
5310038|NCT00483938|13055397|P5|STARTED|Overall Study||25
5310039|NCT00483938|13055398|P4|STARTED|Overall Study||31
5310040|NCT00483938|13055399|P3|STARTED|Overall Study||30
5310041|NCT00483938|13055400|P2|STARTED|Overall Study||43
5310042|NCT00483938|13055401|P1|STARTED|Overall Study||41
5310043|NCT00483756|13055425|P3|NOT COMPLETED|Overall Study||52
5310044|NCT00483756|13055426|P2|NOT COMPLETED|Overall Study||50
5310045|NCT00483756|13055427|P1|NOT COMPLETED|Overall Study||33
5310046|NCT00483756|13055425|P3|COMPLETED|Overall Study||59
5310047|NCT00483756|13055426|P2|COMPLETED|Overall Study||60
5310048|NCT00483756|13055427|P1|COMPLETED|Overall Study||77
5310049|NCT00483756|13055425|P3|Treated|Overall Study||107
5310050|NCT00483756|13055426|P2|Treated|Overall Study||106
5310051|NCT00483756|13055427|P1|Treated|Overall Study||109
5310052|NCT00483756|13055425|P3|STARTED|Overall Study||111
5310053|NCT00483756|13055426|P2|STARTED|Overall Study||110
5310054|NCT00483756|13055427|P1|STARTED|Overall Study||110
5310055|NCT00483717|13055491|P2|NOT COMPLETED|Overall Study||21
5310056|NCT00483717|13055492|P1|NOT COMPLETED|Overall Study||24
5310057|NCT00483717|13055491|P2|COMPLETED|Overall Study||65
5310058|NCT00483717|13055492|P1|COMPLETED|Overall Study||63
5310059|NCT00483717|13055491|P2|STARTED|Overall Study||86
5310060|NCT00483717|13055492|P1|STARTED|Overall Study||87
5310061|NCT00483704|13055515|P3|NOT COMPLETED|Treatment||156
5310062|NCT00483704|13055516|P2|NOT COMPLETED|Treatment||129
5310063|NCT00483704|13055517|P1|NOT COMPLETED|Treatment||129
5310064|NCT00483704|13055515|P3|COMPLETED|Treatment||399
5310065|NCT00483704|13055516|P2|COMPLETED|Treatment||420
5310066|NCT00483704|13055517|P1|COMPLETED|Treatment||444
5310067|NCT00483704|13055515|P3|STARTED|Treatment||555
5310068|NCT00483704|13055516|P2|STARTED|Treatment||549
5310069|NCT00483704|13055517|P1|STARTED|Treatment||573
5310070|NCT00483704|13055515|P3|NOT COMPLETED|Randomization||91
5310071|NCT00483704|13055516|P2|NOT COMPLETED|Randomization||96
5310072|NCT00483704|13055517|P1|NOT COMPLETED|Randomization||71
5310073|NCT00483704|13055515|P3|COMPLETED|Randomization||555
5310074|NCT00483704|13055516|P2|COMPLETED|Randomization||549
5310075|NCT00483704|13055517|P1|COMPLETED|Randomization||573
5310076|NCT00483704|13055515|P3|STARTED|Randomization||646
5310077|NCT00483704|13055516|P2|STARTED|Randomization||645
5310078|NCT00483704|13055517|P1|STARTED|Randomization||644
5310079|NCT00483652|13055563|P2|NOT COMPLETED|Post-study Follow-up||0
5310080|NCT00483652|13055564|P1|NOT COMPLETED|Post-study Follow-up||0
5310081|NCT00483652|13055563|P2|COMPLETED|Post-study Follow-up||114
5310082|NCT00483652|13055564|P1|COMPLETED|Post-study Follow-up||113
5310083|NCT00483652|13055563|P2|STARTED|Post-study Follow-up||114
5310084|NCT00483652|13055564|P1|STARTED|Post-study Follow-up||113
5310085|NCT00483652|13055563|P2|NOT COMPLETED|Double-blind Treatment Period||5
5310086|NCT00483652|13055564|P1|NOT COMPLETED|Double-blind Treatment Period||7
5310087|NCT00483652|13055563|P2|COMPLETED|Double-blind Treatment Period||114
5310088|NCT00483652|13055564|P1|COMPLETED|Double-blind Treatment Period||113
5310089|NCT00483652|13055563|P2|STARTED|Double-blind Treatment Period||119
5310090|NCT00483652|13055564|P1|STARTED|Double-blind Treatment Period||120
5310091|NCT00483574|13055574|P2|NOT COMPLETED|Overall Study||13
5310092|NCT00483574|13055575|P1|NOT COMPLETED|Overall Study||102
5310093|NCT00483574|13055574|P2|COMPLETED|Overall Study||308
5310094|NCT00483574|13055575|P1|COMPLETED|Overall Study||951
5310095|NCT00483574|13055574|P2|STARTED|Overall Study||321
5310096|NCT00483574|13055575|P1|STARTED|Overall Study||1053
5310097|NCT00483561|13055583|P1|NOT COMPLETED|Overall Study||11
5310098|NCT00483561|13055583|P1|COMPLETED|Overall Study||15
5310099|NCT00483561|13055583|P1|STARTED|Overall Study||26
5310100|NCT00483548|13055590|P2|NOT COMPLETED|Overall Study||46
5310101|NCT00483548|13055591|P1|NOT COMPLETED|Overall Study||60
5310102|NCT00483548|13055590|P2|COMPLETED|Overall Study||104
5310103|NCT00483548|13055591|P1|COMPLETED|Overall Study||88
5310104|NCT00483548|13055590|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
5310105|NCT00483548|13055591|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
5310106|NCT00483548|13055590|P2|STARTED|Overall Study||150
5310107|NCT00483548|13055591|P1|STARTED|Overall Study||148
5310108|NCT00483509|13055629|P1|NOT COMPLETED|Overall Study||0
5310109|NCT00483509|13055629|P1|COMPLETED|Overall Study||28
5310110|NCT00483509|13055629|P1|STARTED|Overall Study||28
5310111|NCT00483496|13055637|P1|NOT COMPLETED|Overall Study||1
5310112|NCT00483496|13055637|P1|COMPLETED|Overall Study||15
5310113|NCT00483496|13055637|P1|STARTED|Overall Study||16
5310114|NCT00483405|13055649|P1|NOT COMPLETED|Overall Study||28
5310115|NCT00483405|13055649|P1|COMPLETED|Overall Study||0
5310116|NCT00483405|13055649|P1|STARTED|Overall Study||28
5310117|NCT00483379|13055658|P2|NOT COMPLETED|Extension Period||0
5310118|NCT00483379|13055659|P1|NOT COMPLETED|Extension Period||0
5310119|NCT00483379|13055658|P2|COMPLETED|Extension Period||2
5310120|NCT00483379|13055659|P1|COMPLETED|Extension Period||1
5310121|NCT00483379|13055658|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
5310122|NCT00483379|13055659|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
5310123|NCT00483379|13055658|P2|NOT COMPLETED|Treatment Period||0
5310124|NCT00483379|13055659|P1|NOT COMPLETED|Treatment Period||2
5310125|NCT00483379|13055658|P2|COMPLETED|Treatment Period||7
5310126|NCT00483379|13055659|P1|COMPLETED|Treatment Period||4
5310127|NCT00483379|13055658|P2|STARTED|Treatment Period||7
5310128|NCT00483379|13055659|P1|STARTED|Treatment Period||6
5310129|NCT00483327|13055695|P1|NOT COMPLETED|Overall Study||10
5310130|NCT00483327|13055695|P1|COMPLETED|Overall Study||20
5310131|NCT00483327|13055695|P1|STARTED|Overall Study||30
5310132|NCT00483262|13055706|P2|NOT COMPLETED|Overall Study||0
5310133|NCT00483262|13055707|P1|NOT COMPLETED|Overall Study||0
5310134|NCT00483262|13055706|P2|COMPLETED|Overall Study||43
5310135|NCT00483262|13055707|P1|COMPLETED|Overall Study||20
5310136|NCT00483262|13055706|P2|STARTED|Overall Study||43
5310137|NCT00483262|13055707|P1|STARTED|Overall Study||20
5310138|NCT00483223|13055717|P1|NOT COMPLETED|Overall Study||0
5310139|NCT00483223|13055717|P1|COMPLETED|Overall Study||86
5310140|NCT00483223|13055717|P1|STARTED|Overall Study||86
5310141|NCT00483184|13055727|P3|NOT COMPLETED|Overall Study||3
5310142|NCT00483184|13055728|P2|NOT COMPLETED|Overall Study||4
5310143|NCT00483184|13055729|P1|NOT COMPLETED|Overall Study||5
5310144|NCT00483184|13055727|P3|COMPLETED|Overall Study||23
5310145|NCT00483184|13055728|P2|COMPLETED|Overall Study||27
5310146|NCT00483184|13055729|P1|COMPLETED|Overall Study||22
5310147|NCT00483184|13055727|P3|STARTED|Overall Study||26
5310148|NCT00483184|13055728|P2|STARTED|Overall Study||31
5310149|NCT00483184|13055729|P1|STARTED|Overall Study||27
5310150|NCT00483119|13055739|P2|NOT COMPLETED|Overall Study||1
5310151|NCT00483119|13055740|P1|NOT COMPLETED|Overall Study||1
5310152|NCT00483119|13055739|P2|COMPLETED|Overall Study||3
5310153|NCT00483119|13055740|P1|COMPLETED|Overall Study||4
5310154|NCT00483119|13055739|P2|STARTED|Overall Study||4
5310155|NCT00483119|13055740|P1|STARTED|Overall Study||5
5310156|NCT00483041|13055754|P2|NOT COMPLETED|Overall Study||1
5310157|NCT00483041|13055755|P1|NOT COMPLETED|Overall Study||0
5310158|NCT00483041|13055754|P2|COMPLETED|Overall Study||5
5310159|NCT00483041|13055755|P1|COMPLETED|Overall Study||5
5310160|NCT00483041|13055754|P2|STARTED|Overall Study||6
5310161|NCT00483041|13055755|P1|STARTED|Overall Study||5
5310162|NCT00483002|13055785|P1|NOT COMPLETED|Overall Study||2554
5310163|NCT00483002|13055785|P1|COMPLETED|Overall Study||1165
5310164|NCT00483002|13055785|P1|STARTED|Overall Study||3719
5310165|NCT00482911|13055793|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
5310166|NCT00482911|13055794|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
5310167|NCT00482911|13055793|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
5310168|NCT00482911|13055794|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
5310169|NCT00482911|13055793|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
5310170|NCT00482911|13055794|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
5310171|NCT00482911|13055793|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
5310172|NCT00482911|13055794|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
5310173|NCT00482911|13055793|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
5310174|NCT00482911|13055794|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
5310175|NCT00482911|13055793|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
5310176|NCT00482911|13055794|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
5310177|NCT00482911|13055793|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
5310178|NCT00482911|13055794|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
5310179|NCT00482911|13055793|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
5310180|NCT00482911|13055794|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
5310181|NCT00482911|13055793|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
5310182|NCT00482911|13055794|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
5310183|NCT00482729|13055810|P2|NOT COMPLETED|Overall Study||218
5310184|NCT00482729|13055811|P1|NOT COMPLETED|Overall Study||217
5310185|NCT00482729|13055810|P2|COMPLETED|Overall Study||406
5310186|NCT00482729|13055811|P1|COMPLETED|Overall Study||409
5310187|NCT00482729|13055810|P2|Completed Phase B|Overall Study||406
5310188|NCT00482729|13055811|P1|Completed Phase B|Overall Study||409
5310189|NCT00482729|13055810|P2|Completed Phase A|Overall Study||482
5310190|NCT00482729|13055811|P1|Completed Phase A|Overall Study||484
5310191|NCT00482729|13055810|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
5310192|NCT00482729|13055811|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
5310193|NCT00482703|13055827|P2|NOT COMPLETED|Overall Study||0
5310194|NCT00482703|13055828|P1|NOT COMPLETED|Overall Study||1
5310195|NCT00482703|13055827|P2|COMPLETED|Overall Study||12
5310196|NCT00482703|13055828|P1|COMPLETED|Overall Study||10
5310197|NCT00482703|13055827|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
5310198|NCT00482703|13055828|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
5310199|NCT00482677|13055875|P2|NOT COMPLETED|Overall Study||0
5310200|NCT00482677|13055876|P1|NOT COMPLETED|Overall Study||0
5310201|NCT00482677|13055875|P2|COMPLETED|Overall Study||281
5310202|NCT00482677|13055876|P1|COMPLETED|Overall Study||281
5310203|NCT00482677|13055875|P2|STARTED|Overall Study||281
5310204|NCT00482677|13055876|P1|STARTED|Overall Study||281
5310205|NCT00482625|13055886|P1|NOT COMPLETED|Overall Study||0
5310206|NCT00482625|13055886|P1|COMPLETED|Overall Study||6
5310207|NCT00482625|13055886|P1|STARTED|Overall Study||6
5310208|NCT00482612|13055899|P4|NOT COMPLETED|Follow-up Period||8
5310209|NCT00482612|13055900|P3|NOT COMPLETED|Follow-up Period||22
5310210|NCT00482612|13055901|P2|NOT COMPLETED|Follow-up Period||18
5310211|NCT00482612|13055902|P1|NOT COMPLETED|Follow-up Period||14
5310212|NCT00482612|13055899|P4|COMPLETED|Follow-up Period||127
5310213|NCT00482612|13055900|P3|COMPLETED|Follow-up Period||106
5310214|NCT00482612|13055901|P2|COMPLETED|Follow-up Period||107
5310215|NCT00482612|13055902|P1|COMPLETED|Follow-up Period||123
5310216|NCT00482612|13055899|P4|STARTED|Follow-up Period||135
5310217|NCT00482612|13055900|P3|STARTED|Follow-up Period||128
5310218|NCT00482612|13055901|P2|STARTED|Follow-up Period||125
5310219|NCT00482612|13055902|P1|STARTED|Follow-up Period||137
5310220|NCT00482612|13055899|P4|NOT COMPLETED|In-treatment Period||0
5310221|NCT00482612|13055900|P3|NOT COMPLETED|In-treatment Period||1
5310222|NCT00482612|13055901|P2|NOT COMPLETED|In-treatment Period||0
5310223|NCT00482612|13055902|P1|NOT COMPLETED|In-treatment Period||0
5310224|NCT00482612|13055899|P4|COMPLETED|In-treatment Period||135
5310225|NCT00482612|13055900|P3|COMPLETED|In-treatment Period||128
5310226|NCT00482612|13055901|P2|COMPLETED|In-treatment Period||125
5310227|NCT00482612|13055902|P1|COMPLETED|In-treatment Period||137
5310228|NCT00482612|13055899|P4|Treated|In-treatment Period||135
5310229|NCT00482612|13055900|P3|Treated|In-treatment Period||128
5310230|NCT00482612|13055901|P2|Treated|In-treatment Period||125
5310231|NCT00482612|13055902|P1|Treated|In-treatment Period||137
5310232|NCT00482612|13055899|P4|STARTED|In-treatment Period||135
5310233|NCT00482612|13055900|P3|STARTED|In-treatment Period||129
5310234|NCT00482612|13055901|P2|STARTED|In-treatment Period||125
5310235|NCT00482612|13055902|P1|STARTED|In-treatment Period||137
5310236|NCT00482547|13055930|P2|NOT COMPLETED|Overall Study||161
5310237|NCT00482547|13055931|P1|NOT COMPLETED|Overall Study||173
5310238|NCT00482547|13055930|P2|COMPLETED|Overall Study||428
5310239|NCT00482547|13055931|P1|COMPLETED|Overall Study||426
5310240|NCT00482547|13055930|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
5310241|NCT00482547|13055931|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
5310242|NCT00482547|13055930|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
5310243|NCT00482547|13055931|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
5310244|NCT00482547|13055930|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
5310245|NCT00482547|13055931|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
5310246|NCT00482391|13055951|P1|NOT COMPLETED|Overall Study||3
5310247|NCT00482391|13055951|P1|COMPLETED|Overall Study||92
5310248|NCT00482391|13055951|P1|STARTED|Overall Study||95
5310249|NCT00482274|13055956|P1|NOT COMPLETED|Overall Study||1
5310250|NCT00482274|13055956|P1|COMPLETED|Overall Study||2
5310251|NCT00482274|13055956|P1|STARTED|Overall Study||3
5310252|NCT00482170|13055966|P2|NOT COMPLETED|Overall Study||20
5310253|NCT00482170|13055967|P1|NOT COMPLETED|Overall Study||15
5310254|NCT00482170|13055966|P2|COMPLETED|Overall Study||194
5310255|NCT00482170|13055967|P1|COMPLETED|Overall Study||192
5310256|NCT00482170|13055966|P2|Treated|Overall Study||211
5310257|NCT00482170|13055967|P1|Treated|Overall Study||207
5310258|NCT00482170|13055966|P2|STARTED|Overall Study||214
5310259|NCT00482170|13055967|P1|STARTED|Overall Study||207
5310260|NCT00482053|13056085|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
5310261|NCT00482053|13056085|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
5310262|NCT00482053|13056085|P1|STARTED|Allogeneic Peripheral Stem Cells||2
5310263|NCT00482053|13056085|P1|NOT COMPLETED|Inter-treatment Period||1
5310264|NCT00482053|13056085|P1|COMPLETED|Inter-treatment Period||2
5310265|NCT00482053|13056085|P1|STARTED|Inter-treatment Period||3
5310266|NCT00482053|13056085|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
5310267|NCT00482053|13056085|P1|COMPLETED|Autologous Peripheral Stem Cells||3
5310268|NCT00482053|13056085|P1|STARTED|Autologous Peripheral Stem Cells||3
5310269|NCT00482014|13056099|P4|NOT COMPLETED|Overall Study||23
5310270|NCT00482014|13056100|P3|NOT COMPLETED|Overall Study||11
5310271|NCT00482014|13056101|P2|NOT COMPLETED|Overall Study||6
5310272|NCT00482014|13056102|P1|NOT COMPLETED|Overall Study||7
5310273|NCT00482014|13056099|P4|COMPLETED|Overall Study||29
5310274|NCT00482014|13056100|P3|COMPLETED|Overall Study||35
5310275|NCT00482014|13056101|P2|COMPLETED|Overall Study||7
5310276|NCT00482014|13056102|P1|COMPLETED|Overall Study||2
5310277|NCT00482014|13056099|P4|STARTED|Overall Study||52
5310278|NCT00482014|13056100|P3|STARTED|Overall Study||46
5310279|NCT00482014|13056101|P2|STARTED|Overall Study||13
5310280|NCT00482014|13056102|P1|STARTED|Overall Study||9
5310281|NCT00482001|13056126|P2|NOT COMPLETED|Overall Study||1
5310282|NCT00482001|13056127|P1|NOT COMPLETED|Overall Study||1
5310283|NCT00482001|13056126|P2|COMPLETED|Overall Study||10
5310284|NCT00482001|13056127|P1|COMPLETED|Overall Study||10
5310285|NCT00482001|13056126|P2|STARTED|Overall Study||11
5310286|NCT00482001|13056127|P1|STARTED|Overall Study||11
5310287|NCT00481988|13056147|P2|NOT COMPLETED|Overall Study||1
5310288|NCT00481988|13056148|P1|NOT COMPLETED|Overall Study||1
5310289|NCT00481988|13056147|P2|COMPLETED|Overall Study||8
5310290|NCT00481988|13056148|P1|COMPLETED|Overall Study||11
5310291|NCT00481988|13056147|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
5310292|NCT00481988|13056148|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
5310293|NCT00481988|13056147|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
5310294|NCT00481988|13056148|P1|STARTED|Overall Study||12
5310295|NCT00481871|13056161|P5|NOT COMPLETED|Overall Study||0
5310296|NCT00481871|13056162|P4|NOT COMPLETED|Overall Study||0
5310297|NCT00481871|13056163|P3|NOT COMPLETED|Overall Study||1
5310298|NCT00481871|13056164|P2|NOT COMPLETED|Overall Study||0
5310299|NCT00481871|13056165|P1|NOT COMPLETED|Overall Study||0
5310300|NCT00481871|13056161|P5|COMPLETED|Overall Study||34
5310301|NCT00481871|13056162|P4|COMPLETED|Overall Study||38
5310302|NCT00481871|13056163|P3|COMPLETED|Overall Study||17
5310303|NCT00481871|13056164|P2|COMPLETED|Overall Study||10
5310304|NCT00481871|13056165|P1|COMPLETED|Overall Study||7
5310305|NCT00481871|13056161|P5|STARTED|Overall Study||34
5310306|NCT00481871|13056162|P4|STARTED|Overall Study||38
5310307|NCT00481871|13056163|P3|STARTED|Overall Study||18
5310308|NCT00481871|13056164|P2|STARTED|Overall Study||10
5310309|NCT00481871|13056165|P1|STARTED|Overall Study||7
5310310|NCT00481845|13056181|P2|NOT COMPLETED|Overall Study||0
5310311|NCT00481845|13056182|P1|NOT COMPLETED|Overall Study||0
5310312|NCT00481845|13056181|P2|COMPLETED|Overall Study||0
5310313|NCT00481845|13056182|P1|COMPLETED|Overall Study||1
5310314|NCT00481845|13056181|P2|STARTED|Overall Study||0
5310315|NCT00481845|13056182|P1|STARTED|Overall Study||1
5310316|NCT00481832|13056190|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
5310317|NCT00481832|13056190|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
5310318|NCT00481832|13056190|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
5310319|NCT00481832|13056190|P1|NOT COMPLETED|Inter-transplant Period||27
5310320|NCT00481832|13056190|P1|COMPLETED|Inter-transplant Period||13
5310321|NCT00481832|13056190|P1|STARTED|Inter-transplant Period||40
5310322|NCT00481832|13056190|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
5310323|NCT00481832|13056190|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
5310324|NCT00481832|13056190|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
5310325|NCT00481832|13056190|P1|NOT COMPLETED|Enrollment||10
5310326|NCT00481832|13056190|P1|COMPLETED|Enrollment||40
5310327|NCT00481832|13056190|P1|STARTED|Enrollment||50
5310328|NCT00481767|13056205|P2|NOT COMPLETED|Overall Study||21
5310329|NCT00481767|13056206|P1|NOT COMPLETED|Overall Study||32
5310330|NCT00481767|13056205|P2|COMPLETED|Overall Study||205
5310331|NCT00481767|13056206|P1|COMPLETED|Overall Study||418
5310332|NCT00481767|13056205|P2|STARTED|Overall Study||226
5310333|NCT00481767|13056206|P1|STARTED|Overall Study||450
5310334|NCT00481676|13056240|P2|NOT COMPLETED|Overall Study||5
5310335|NCT00481676|13056241|P1|NOT COMPLETED|Overall Study||2
5310336|NCT00481676|13056240|P2|COMPLETED|Overall Study||17
5310337|NCT00481676|13056241|P1|COMPLETED|Overall Study||25
5310338|NCT00481676|13056240|P2|STARTED|Overall Study||22
5310339|NCT00481676|13056241|P1|STARTED|Overall Study||27
5310340|NCT00481507|13056265|P2|NOT COMPLETED|Overall Study||0
5310341|NCT00481507|13056266|P1|NOT COMPLETED|Overall Study||0
5310342|NCT00481507|13056265|P2|COMPLETED|Overall Study||61
5310343|NCT00481507|13056266|P1|COMPLETED|Overall Study||64
5310344|NCT00481507|13056265|P2|STARTED|Overall Study||61
5310345|NCT00481507|13056266|P1|STARTED|Overall Study||64
5310346|NCT00481351|13056276|P2|NOT COMPLETED|Overall Study||0
5310347|NCT00481351|13056277|P1|NOT COMPLETED|Overall Study||0
5310348|NCT00481351|13056276|P2|COMPLETED|Overall Study||12
5310349|NCT00481351|13056277|P1|COMPLETED|Overall Study||13
5310350|NCT00481351|13056276|P2|STARTED|Overall Study||12
5310351|NCT00481351|13056277|P1|STARTED|Overall Study||13
5310352|NCT00481247|13056293|P2|NOT COMPLETED|Overall Study||260
5310353|NCT00481247|13056294|P1|NOT COMPLETED|Overall Study||259
5310354|NCT00481247|13056293|P2|COMPLETED|Overall Study||0
5310355|NCT00481247|13056294|P1|COMPLETED|Overall Study||0
5310356|NCT00481247|13056293|P2|Received Treatment|Overall Study||258
5310357|NCT00481247|13056294|P1|Received Treatment|Overall Study||258
5310358|NCT00481247|13056293|P2|STARTED|Overall Study|Randomized|260
5310359|NCT00481247|13056294|P1|STARTED|Overall Study|Randomized|259
5310360|NCT00481195|13056318|P2|NOT COMPLETED|Overall Study||39
5310361|NCT00481195|13056319|P1|NOT COMPLETED|Overall Study||39
5310362|NCT00481195|13056318|P2|COMPLETED|Overall Study||90
5310363|NCT00481195|13056319|P1|COMPLETED|Overall Study||89
5310364|NCT00481195|13056318|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
5310365|NCT00481195|13056319|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
5310366|NCT00481078|13056405|P2|NOT COMPLETED|Overall Study||20
5310367|NCT00481078|13056406|P1|NOT COMPLETED|Overall Study||42
5310368|NCT00481078|13056405|P2|COMPLETED|Overall Study||12
5310369|NCT00481078|13056406|P1|COMPLETED|Overall Study||20
5310370|NCT00481078|13056405|P2|STARTED|Overall Study||32
5310371|NCT00481078|13056406|P1|STARTED|Overall Study||62
5310372|NCT00481065|13056424|P8|NOT COMPLETED|Overall Study||19
5310373|NCT00481065|13056425|P7|NOT COMPLETED|Overall Study||16
5310374|NCT00481065|13056426|P6|NOT COMPLETED|Overall Study||24
5310375|NCT00481065|13056427|P5|NOT COMPLETED|Overall Study||23
5310376|NCT00481065|13056428|P4|NOT COMPLETED|Overall Study||15
5310377|NCT00481065|13056429|P3|NOT COMPLETED|Overall Study||19
5310378|NCT00481065|13056430|P2|NOT COMPLETED|Overall Study||17
5310379|NCT00481065|13056431|P1|NOT COMPLETED|Overall Study||22
5310380|NCT00481065|13056424|P8|COMPLETED|Overall Study||30
5310381|NCT00481065|13056425|P7|COMPLETED|Overall Study||34
5310382|NCT00481065|13056426|P6|COMPLETED|Overall Study||27
5310383|NCT00481065|13056427|P5|COMPLETED|Overall Study||28
5310384|NCT00481065|13056428|P4|COMPLETED|Overall Study||37
5310385|NCT00481065|13056429|P3|COMPLETED|Overall Study||32
5310386|NCT00481065|13056430|P2|COMPLETED|Overall Study||33
5310387|NCT00481065|13056431|P1|COMPLETED|Overall Study||29
5310388|NCT00481065|13056424|P8|STARTED|Overall Study||49
5310389|NCT00481065|13056425|P7|STARTED|Overall Study||50
5310390|NCT00481065|13056426|P6|STARTED|Overall Study||51
5310391|NCT00481065|13056427|P5|STARTED|Overall Study||51
5310392|NCT00481065|13056428|P4|STARTED|Overall Study||52
5310393|NCT00481065|13056429|P3|STARTED|Overall Study||51
5310394|NCT00481065|13056430|P2|STARTED|Overall Study||50
5310395|NCT00481065|13056431|P1|STARTED|Overall Study||51
5310396|NCT00480987|13056517|P1|NOT COMPLETED|Overall Study||0
5310397|NCT00480987|13056517|P1|COMPLETED|Overall Study||27
5310398|NCT00480987|13056517|P1|STARTED|Overall Study||27
5310399|NCT00480857|13056521|P1|NOT COMPLETED|Overall Study||2
5310400|NCT00480857|13056521|P1|COMPLETED|Overall Study||17
5310401|NCT00480857|13056521|P1|STARTED|Overall Study||19
5310402|NCT00480779|13056531|P2|NOT COMPLETED|Overall Study||3
5310403|NCT00480779|13056532|P1|NOT COMPLETED|Overall Study||2
5310404|NCT00480779|13056531|P2|COMPLETED|Overall Study||19
5310405|NCT00480779|13056532|P1|COMPLETED|Overall Study||24
5310406|NCT00480779|13056531|P2|STARTED|Overall Study||22
5310407|NCT00480779|13056532|P1|STARTED|Overall Study||26
5310408|NCT00480740|13056559|P3|NOT COMPLETED|Overall Study||0
5310409|NCT00480740|13056560|P2|NOT COMPLETED|Overall Study||0
5310410|NCT00480740|13056561|P1|NOT COMPLETED|Overall Study||0
5310411|NCT00480740|13056559|P3|COMPLETED|Overall Study||6
5310412|NCT00480740|13056560|P2|COMPLETED|Overall Study||9
5310413|NCT00480740|13056561|P1|COMPLETED|Overall Study||26
5310414|NCT00480740|13056559|P3|STARTED|Overall Study||6
5310415|NCT00480740|13056560|P2|STARTED|Overall Study||9
5310416|NCT00480740|13056561|P1|STARTED|Overall Study||26
5310417|NCT00480636|13056569|P1|NOT COMPLETED|Overall Study||19
5310418|NCT00480636|13056569|P1|COMPLETED|Overall Study||83
5310419|NCT00480636|13056569|P1|STARTED|Overall Study||102
5310420|NCT00480532|13056581|P4|NOT COMPLETED|Overall Study||1
5310421|NCT00480532|13056582|P3|NOT COMPLETED|Overall Study||4
5310422|NCT00480532|13056583|P2|NOT COMPLETED|Overall Study||4
5310423|NCT00480532|13056584|P1|NOT COMPLETED|Overall Study||2
5310424|NCT00480532|13056581|P4|COMPLETED|Overall Study||31
5310425|NCT00480532|13056582|P3|COMPLETED|Overall Study||29
5310426|NCT00480532|13056583|P2|COMPLETED|Overall Study||29
5310427|NCT00480532|13056584|P1|COMPLETED|Overall Study||31
5310428|NCT00480532|13056581|P4|STARTED|Overall Study||32
5310429|NCT00480532|13056582|P3|STARTED|Overall Study||33
5310430|NCT00480532|13056583|P2|STARTED|Overall Study||33
5310431|NCT00480532|13056584|P1|STARTED|Overall Study||33
5310432|NCT00480493|13056604|P2|NOT COMPLETED|Overall Study||7
5310433|NCT00480493|13056605|P1|NOT COMPLETED|Overall Study||2
5310434|NCT00480493|13056604|P2|COMPLETED|Overall Study||21
5310435|NCT00480493|13056605|P1|COMPLETED|Overall Study||30
5310436|NCT00480493|13056604|P2|Randomized|Overall Study||28
5310437|NCT00480493|13056605|P1|Randomized|Overall Study||32
5310438|NCT00480493|13056604|P2|STARTED|Overall Study||28
5310439|NCT00480493|13056605|P1|STARTED|Overall Study||32
5310440|NCT00480441|13056617|P3|NOT COMPLETED|Randomization||2
5310441|NCT00480441|13056618|P2|NOT COMPLETED|Randomization||7
5310442|NCT00480441|13056619|P1|NOT COMPLETED|Randomization||0
5310443|NCT00480441|13056617|P3|COMPLETED|Randomization||9
5310444|NCT00480441|13056618|P2|COMPLETED|Randomization||6
5310445|NCT00480441|13056619|P1|COMPLETED|Randomization||0
5310446|NCT00480441|13056617|P3|STARTED|Randomization||11
5310447|NCT00480441|13056618|P2|STARTED|Randomization||13
5310448|NCT00480441|13056619|P1|STARTED|Randomization||0
5310449|NCT00480441|13056617|P3|NOT COMPLETED|Baseline Functional MRI||0
5310450|NCT00480441|13056618|P2|NOT COMPLETED|Baseline Functional MRI||0
5310451|NCT00480441|13056619|P1|NOT COMPLETED|Baseline Functional MRI||12
5310452|NCT00480441|13056617|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
5310453|NCT00480441|13056618|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
5310454|NCT00480441|13056619|P1|COMPLETED|Baseline Functional MRI||12
5310455|NCT00480441|13056617|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
5310456|NCT00480441|13056618|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
5310457|NCT00480441|13056619|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
5310458|NCT00480441|13056617|P3|NOT COMPLETED|Screening||0
5310459|NCT00480441|13056618|P2|NOT COMPLETED|Screening||0
5310460|NCT00480441|13056619|P1|NOT COMPLETED|Screening||37
5310461|NCT00480441|13056617|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
5310462|NCT00480441|13056618|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
5310463|NCT00480441|13056619|P1|COMPLETED|Screening||24
5310464|NCT00480441|13056617|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
5310465|NCT00480441|13056618|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
5310466|NCT00480441|13056619|P1|STARTED|Screening||61
5310467|NCT00480324|13056628|P2|NOT COMPLETED|Overall Study||16
5310468|NCT00480324|13056629|P1|NOT COMPLETED|Overall Study||32
5310469|NCT00480324|13056628|P2|COMPLETED|Overall Study||241
5310470|NCT00480324|13056629|P1|COMPLETED|Overall Study||476
5310471|NCT00480324|13056628|P2|STARTED|Overall Study||257
5310472|NCT00480324|13056629|P1|STARTED|Overall Study||508
5310473|NCT00480077|13056657|P2|NOT COMPLETED|Overall Study||26
5310474|NCT00480077|13056658|P1|NOT COMPLETED|Overall Study||31
5310475|NCT00480077|13056657|P2|COMPLETED|Overall Study||141
5310476|NCT00480077|13056658|P1|COMPLETED|Overall Study||137
5310477|NCT00480077|13056657|P2|STARTED|Overall Study||167
5310478|NCT00480077|13056658|P1|STARTED|Overall Study||168
5310479|NCT00480025|13056666|P2|NOT COMPLETED|Overall Study||369
5310480|NCT00480025|13056667|P1|NOT COMPLETED|Overall Study||752
5310481|NCT00480025|13056666|P2|COMPLETED|Overall Study||388
5310482|NCT00480025|13056667|P1|COMPLETED|Overall Study||763
5310483|NCT00480025|13056666|P2|STARTED|Overall Study||757
5310484|NCT00480025|13056667|P1|STARTED|Overall Study||1515
5310485|NCT00479882|13056739|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
5310486|NCT00479882|13056740|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
5310487|NCT00479882|13056741|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
5310488|NCT00479882|13056742|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
5310489|NCT00479882|13056739|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
5310490|NCT00479882|13056740|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
5310491|NCT00479882|13056741|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
5310492|NCT00479882|13056742|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
5310493|NCT00479882|13056739|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
5310494|NCT00479882|13056740|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
5310495|NCT00479882|13056741|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
5310496|NCT00479882|13056742|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
5310497|NCT00479882|13056739|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
5310498|NCT00479882|13056740|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
5310499|NCT00479882|13056741|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
5310500|NCT00479882|13056742|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
5310501|NCT00479882|13056739|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
5310502|NCT00479882|13056740|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
5310503|NCT00479882|13056741|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
5310504|NCT00479882|13056742|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
5310505|NCT00479882|13056739|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
5310506|NCT00479882|13056740|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
5310507|NCT00479882|13056741|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
5310508|NCT00479882|13056742|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
5310509|NCT00479856|13056872|P1|NOT COMPLETED|Overall Study||3
5310510|NCT00479856|13056872|P1|COMPLETED|Overall Study||6
5310511|NCT00479856|13056872|P1|STARTED|Overall Study||9
5310512|NCT00479765|13056881|P1|NOT COMPLETED|Overall Study||4
5310513|NCT00479765|13056881|P1|COMPLETED|Overall Study||0
5310514|NCT00479765|13056881|P1|STARTED|Overall Study||4
5310515|NCT00479713|13056887|P2|NOT COMPLETED|Overall Study||9
5310516|NCT00479713|13056888|P1|NOT COMPLETED|Overall Study||13
5310517|NCT00479713|13056887|P2|COMPLETED|Overall Study||295
5310518|NCT00479713|13056888|P1|COMPLETED|Overall Study||301
5310519|NCT00479713|13056887|P2|STARTED|Overall Study||304
5310520|NCT00479713|13056888|P1|STARTED|Overall Study||314
5310521|NCT00479674|13056912|P1|NOT COMPLETED|Overall Study||41
5310522|NCT00479674|13056912|P1|COMPLETED|Overall Study||0
5310523|NCT00479674|13056912|P1|STARTED|Overall Study||41
5310524|NCT00479557|13056927|P7|NOT COMPLETED|Overall Study||2
5310525|NCT00479557|13056928|P6|NOT COMPLETED|Overall Study||13
5310526|NCT00479557|13056929|P5|NOT COMPLETED|Overall Study||4
5310527|NCT00479557|13056930|P4|NOT COMPLETED|Overall Study||5
5310528|NCT00479557|13056931|P3|NOT COMPLETED|Overall Study||8
5310529|NCT00479557|13056932|P2|NOT COMPLETED|Overall Study||10
5310530|NCT00479557|13056933|P1|NOT COMPLETED|Overall Study||10
5310531|NCT00479557|13056927|P7|COMPLETED|Overall Study||15
5310532|NCT00479557|13056928|P6|COMPLETED|Overall Study||31
5310533|NCT00479557|13056929|P5|COMPLETED|Overall Study||8
5310534|NCT00479557|13056930|P4|COMPLETED|Overall Study||30
5310535|NCT00479557|13056931|P3|COMPLETED|Overall Study||32
5310536|NCT00479557|13056932|P2|COMPLETED|Overall Study||51
5310537|NCT00479557|13056933|P1|COMPLETED|Overall Study||26
5310538|NCT00479557|13056927|P7|Treated|Overall Study||17
5310539|NCT00479557|13056928|P6|Treated|Overall Study||44
5310540|NCT00479557|13056929|P5|Treated|Overall Study||12
5310541|NCT00479557|13056930|P4|Treated|Overall Study||35
5310542|NCT00479557|13056931|P3|Treated|Overall Study||40
5310543|NCT00479557|13056932|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
5310544|NCT00479557|13056933|P1|Treated|Overall Study||36
5310545|NCT00479557|13056927|P7|STARTED|Overall Study||17
5310546|NCT00479557|13056928|P6|STARTED|Overall Study||44
5310547|NCT00479557|13056929|P5|STARTED|Overall Study||12
5310548|NCT00479557|13056930|P4|STARTED|Overall Study||35
5310549|NCT00479557|13056931|P3|STARTED|Overall Study||40
5310550|NCT00479557|13056932|P2|STARTED|Overall Study||61
5310551|NCT00479557|13056933|P1|STARTED|Overall Study||36
5310552|NCT00479466|13056976|P6|NOT COMPLETED|Overall Study||4
5310553|NCT00479466|13056977|P5|NOT COMPLETED|Overall Study||8
5310554|NCT00479466|13056978|P4|NOT COMPLETED|Overall Study||3
5310555|NCT00479466|13056979|P3|NOT COMPLETED|Overall Study||3
5310556|NCT00479466|13056980|P2|NOT COMPLETED|Overall Study||8
5310557|NCT00479466|13056981|P1|NOT COMPLETED|Overall Study||13
5310558|NCT00479466|13056976|P6|COMPLETED|Overall Study||53
5310559|NCT00479466|13056977|P5|COMPLETED|Overall Study||48
5310560|NCT00479466|13056978|P4|COMPLETED|Overall Study||55
5310561|NCT00479466|13056979|P3|COMPLETED|Overall Study||54
5310562|NCT00479466|13056980|P2|COMPLETED|Overall Study||49
5310563|NCT00479466|13056981|P1|COMPLETED|Overall Study||44
5310564|NCT00479466|13056976|P6|STARTED|Overall Study||57
5310565|NCT00479466|13056977|P5|STARTED|Overall Study||56
5310566|NCT00479466|13056978|P4|STARTED|Overall Study||58
5310567|NCT00479466|13056979|P3|STARTED|Overall Study||57
5310568|NCT00479466|13056980|P2|STARTED|Overall Study||57
5310569|NCT00479466|13056981|P1|STARTED|Overall Study||57
5310570|NCT00479401|13057010|P3|NOT COMPLETED|Overall Study||12
5310571|NCT00479401|13057011|P2|NOT COMPLETED|Overall Study||37
5310572|NCT00479401|13057012|P1|NOT COMPLETED|Overall Study||49
5310573|NCT00479401|13057010|P3|COMPLETED|Overall Study||91
5310574|NCT00479401|13057011|P2|COMPLETED|Overall Study||176
5310575|NCT00479401|13057012|P1|COMPLETED|Overall Study||174
5310576|NCT00479401|13057010|P3|STARTED|Overall Study||103
5310577|NCT00479401|13057011|P2|STARTED|Overall Study||213
5310578|NCT00479401|13057012|P1|STARTED|Overall Study||223
5310579|NCT00479388|13057067|P2|NOT COMPLETED|Overall Study||73
5310580|NCT00479388|13057068|P1|NOT COMPLETED|Overall Study||132
5310581|NCT00479388|13057067|P2|COMPLETED|Overall Study||537
5310582|NCT00479388|13057068|P1|COMPLETED|Overall Study||474
5310583|NCT00479388|13057067|P2|STARTED|Overall Study||610
5310584|NCT00479388|13057068|P1|STARTED|Overall Study||606
5310585|NCT00479336|13057082|P4|NOT COMPLETED|Overall Study||5
5310586|NCT00479336|13057083|P3|NOT COMPLETED|Overall Study||1
5310587|NCT00479336|13057084|P2|NOT COMPLETED|Overall Study||6
5310588|NCT00479336|13057085|P1|NOT COMPLETED|Overall Study||4
5310589|NCT00479336|13057082|P4|COMPLETED|Overall Study||21
5310590|NCT00479336|13057083|P3|COMPLETED|Overall Study||24
5310591|NCT00479336|13057084|P2|COMPLETED|Overall Study||20
5310592|NCT00479336|13057085|P1|COMPLETED|Overall Study||23
5310593|NCT00479336|13057082|P4|STARTED|Overall Study||26
5310594|NCT00479336|13057083|P3|STARTED|Overall Study||25
5310595|NCT00479336|13057084|P2|STARTED|Overall Study||26
5310596|NCT00479336|13057085|P1|STARTED|Overall Study||27
5310597|NCT00479258|13057101|P2|NOT COMPLETED|Overall Study||0
5310598|NCT00479258|13057102|P1|NOT COMPLETED|Overall Study||0
5310599|NCT00479258|13057101|P2|COMPLETED|Overall Study||0
5310600|NCT00479258|13057102|P1|COMPLETED|Overall Study||0
5310601|NCT00479258|13057101|P2|STARTED|Overall Study||0
5310602|NCT00479258|13057102|P1|STARTED|Overall Study||0
5310603|NCT00479232|13057108|P6|NOT COMPLETED|Overall Study||30
5310604|NCT00479232|13057109|P5|NOT COMPLETED|Overall Study||4
5310605|NCT00479232|13057110|P4|NOT COMPLETED|Overall Study||3
5310606|NCT00479232|13057111|P3|NOT COMPLETED|Overall Study||28
5310607|NCT00479232|13057112|P2|NOT COMPLETED|Overall Study||3
5310608|NCT00479232|13057113|P1|NOT COMPLETED|Overall Study||3
5310609|NCT00479232|13057108|P6|COMPLETED|Overall Study||0
5310610|NCT00479232|13057109|P5|COMPLETED|Overall Study||0
5310611|NCT00479232|13057110|P4|COMPLETED|Overall Study||0
5310612|NCT00479232|13057111|P3|COMPLETED|Overall Study||0
5310613|NCT00479232|13057112|P2|COMPLETED|Overall Study||0
5310614|NCT00479232|13057113|P1|COMPLETED|Overall Study||0
5310615|NCT00479232|13057108|P6|STARTED|Overall Study||30
5310616|NCT00479232|13057109|P5|STARTED|Overall Study||4
5310617|NCT00479232|13057110|P4|STARTED|Overall Study||3
5310618|NCT00479232|13057111|P3|STARTED|Overall Study||28
5310619|NCT00479232|13057112|P2|STARTED|Overall Study||3
5310620|NCT00479232|13057113|P1|STARTED|Overall Study||3
5310621|NCT00479154|13057133|P2|NOT COMPLETED|Overall Study||0
5310622|NCT00479154|13057134|P1|NOT COMPLETED|Overall Study||0
5310623|NCT00479154|13057133|P2|COMPLETED|Overall Study||3
5310624|NCT00479154|13057134|P1|COMPLETED|Overall Study||3
5310625|NCT00479154|13057133|P2|STARTED|Overall Study||3
5310626|NCT00479154|13057134|P1|STARTED|Overall Study||3
5310627|NCT00479089|13057142|P2|NOT COMPLETED|Overall Study||0
5310628|NCT00479089|13057143|P1|NOT COMPLETED|Overall Study||0
5310629|NCT00479089|13057142|P2|COMPLETED|Overall Study||25
5310630|NCT00479089|13057143|P1|COMPLETED|Overall Study||25
5310631|NCT00479089|13057142|P2|STARTED|Overall Study||25
5310632|NCT00479089|13057143|P1|STARTED|Overall Study||25
5310633|NCT00479037|13057155|P2|NOT COMPLETED|Overall Study||6
5310634|NCT00479037|13057156|P1|NOT COMPLETED|Overall Study||3
5310635|NCT00479037|13057155|P2|COMPLETED|Overall Study||34
5310636|NCT00479037|13057156|P1|COMPLETED|Overall Study||38
5310637|NCT00479037|13057155|P2|STARTED|Overall Study||40
5310638|NCT00479037|13057156|P1|STARTED|Overall Study||41
5310639|NCT00478933|13057166|P1|NOT COMPLETED|Overall Study||78
5310640|NCT00478933|13057166|P1|COMPLETED|Overall Study||1145
5310641|NCT00478933|13057166|P1|STARTED|Overall Study||1223
5310642|NCT00478881|13057192|P2|NOT COMPLETED|Overall Study||22
5310643|NCT00478881|13057193|P1|NOT COMPLETED|Overall Study||39
5310644|NCT00478881|13057192|P2|COMPLETED|Overall Study||176
5310645|NCT00478881|13057193|P1|COMPLETED|Overall Study||160
5310646|NCT00478881|13057192|P2|Received Medication|Overall Study||198
5310647|NCT00478881|13057193|P1|Received Medication|Overall Study||198
5310648|NCT00478881|13057192|P2|STARTED|Overall Study||198
5310649|NCT00478881|13057193|P1|STARTED|Overall Study||199
5310650|NCT00478777|13057217|P1|NOT COMPLETED|Overall Study||77
5310651|NCT00478777|13057217|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
5310652|NCT00478777|13057217|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
5310653|NCT00478777|13057217|P1|STARTED|Overall Study||150
5310654|NCT00478673|13057224|P1|NOT COMPLETED|12-Months Post-Procedure||64
5310655|NCT00478673|13057224|P1|COMPLETED|12-Months Post-Procedure||231
5310656|NCT00478673|13057224|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
5310657|NCT00478673|13057224|P1|NOT COMPLETED|30-Days Post-Procedure||10
5310658|NCT00478673|13057224|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
5310659|NCT00478673|13057224|P1|STARTED|30-Days Post-Procedure||298
5310660|NCT00478647|13057229|P1|NOT COMPLETED|Overall Study||2
5310661|NCT00478647|13057229|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
5310662|NCT00478647|13057229|P1|STARTED|Overall Study||40
5310663|NCT00478608|13057237|P1|NOT COMPLETED|Overall Study||20
5310664|NCT00478608|13057237|P1|COMPLETED|Overall Study||59
5310665|NCT00478608|13057237|P1|STARTED|Overall Study||79
5310666|NCT00478569|13057245|P1|NOT COMPLETED|Overall Study||409
5310667|NCT00478569|13057245|P1|COMPLETED|Overall Study||761
5310668|NCT00478569|13057245|P1|STARTED|Overall Study||1170
5310669|NCT00478556|13057261|P2|NOT COMPLETED|Overall Study||0
5310670|NCT00478556|13057262|P1|NOT COMPLETED|Overall Study||0
5310671|NCT00478556|13057261|P2|COMPLETED|Overall Study||149
5310672|NCT00478556|13057262|P1|COMPLETED|Overall Study||151
5310673|NCT00478556|13057261|P2|STARTED|Overall Study||149
5310674|NCT00478556|13057262|P1|STARTED|Overall Study||151
5310675|NCT00478426|13057270|P1|NOT COMPLETED|Overall Study||1
5310676|NCT00478426|13057270|P1|COMPLETED|Overall Study||33
5310677|NCT00478426|13057270|P1|STARTED|Overall Study||34
5310678|NCT00478335|13057280|P2|NOT COMPLETED|Period 2 (4 Days)||0
5310679|NCT00478335|13057281|P1|NOT COMPLETED|Period 2 (4 Days)||0
5310680|NCT00478335|13057280|P2|COMPLETED|Period 2 (4 Days)||2
5310681|NCT00478335|13057281|P1|COMPLETED|Period 2 (4 Days)||2
5310682|NCT00478335|13057280|P2|STARTED|Period 2 (4 Days)||2
5310683|NCT00478335|13057281|P1|STARTED|Period 2 (4 Days)||2
5310684|NCT00478335|13057280|P2|NOT COMPLETED|Period 1 (4 Days)||0
5310685|NCT00478335|13057281|P1|NOT COMPLETED|Period 1 (4 Days)||0
5310686|NCT00478335|13057280|P2|COMPLETED|Period 1 (4 Days)||2
5310687|NCT00478335|13057281|P1|COMPLETED|Period 1 (4 Days)||2
5310688|NCT00478335|13057280|P2|STARTED|Period 1 (4 Days)||2
5310689|NCT00478335|13057281|P1|STARTED|Period 1 (4 Days)||2
5310690|NCT00478257|13057289|P2|NOT COMPLETED|Overall Study||3
5310691|NCT00478257|13057290|P1|NOT COMPLETED|Overall Study||8
5310692|NCT00478257|13057289|P2|COMPLETED|Overall Study||13
5310693|NCT00478257|13057290|P1|COMPLETED|Overall Study||15
5310694|NCT00478257|13057289|P2|STARTED|Overall Study||16
5310695|NCT00478257|13057290|P1|STARTED|Overall Study||23
5310696|NCT00478244|13057296|P1|NOT COMPLETED|Overall Study||1
5310697|NCT00478244|13057296|P1|COMPLETED|Overall Study||6
5310698|NCT00478244|13057296|P1|STARTED|Overall Study||7
5310699|NCT00478231|13057309|P1|NOT COMPLETED|Overall Study||84
5310700|NCT00478231|13057309|P1|COMPLETED|Overall Study||125
5310701|NCT00478231|13057309|P1|Treated|Overall Study||206
5310702|NCT00478231|13057309|P1|STARTED|Overall Study||209
5310703|NCT00478218|13057330|P2|NOT COMPLETED|Overall Study||0
5310704|NCT00478218|13057331|P1|NOT COMPLETED|Overall Study||0
5310705|NCT00478218|13057330|P2|COMPLETED|Overall Study||19
5310706|NCT00478218|13057331|P1|COMPLETED|Overall Study||34
5310707|NCT00478218|13057330|P2|STARTED|Overall Study||19
5310708|NCT00478218|13057331|P1|STARTED|Overall Study||34
5310709|NCT00478205|13057345|P2|NOT COMPLETED|Overall Study||87
5310710|NCT00478205|13057346|P1|NOT COMPLETED|Overall Study||296
5310711|NCT00478205|13057345|P2|COMPLETED|Overall Study||399
5310712|NCT00478205|13057346|P1|COMPLETED|Overall Study||685
5310713|NCT00478205|13057345|P2|STARTED|Overall Study||486
5310714|NCT00478205|13057346|P1|STARTED|Overall Study||981
5310715|NCT00478192|13057361|P3|NOT COMPLETED|Overall Study||2
5310716|NCT00478192|13057362|P2|NOT COMPLETED|Overall Study||5
5310717|NCT00478192|13057363|P1|NOT COMPLETED|Overall Study||4
5310718|NCT00478192|13057361|P3|COMPLETED|Overall Study||8
5310719|NCT00478192|13057362|P2|COMPLETED|Overall Study||15
5310720|NCT00478192|13057363|P1|COMPLETED|Overall Study||16
5310721|NCT00478192|13057361|P3|End of Treatment|Overall Study||8
5310722|NCT00478192|13057362|P2|End of Treatment|Overall Study||16
5310723|NCT00478192|13057363|P1|End of Treatment|Overall Study||18
5310724|NCT00478192|13057361|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
5310725|NCT00478192|13057362|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
5310726|NCT00478192|13057363|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
5310727|NCT00478192|13057361|P3|STARTED|Overall Study||10
5310728|NCT00478192|13057362|P2|STARTED|Overall Study||20
5310729|NCT00478192|13057363|P1|STARTED|Overall Study||20
5310730|NCT00478140|13057390|P1|NOT COMPLETED|Overall Study||1
5310731|NCT00478140|13057390|P1|COMPLETED|Overall Study||3
5310732|NCT00478140|13057390|P1|STARTED|Overall Study||4
5310733|NCT00478062|13057397|P1|NOT COMPLETED|Overall Study||0
5310734|NCT00478062|13057397|P1|COMPLETED|Overall Study||1
5310735|NCT00478062|13057397|P1|STARTED|Overall Study||1
5310736|NCT00478036|13057407|P3|NOT COMPLETED|Overall Study||0
5310737|NCT00478036|13057408|P2|NOT COMPLETED|Overall Study||0
5310738|NCT00478036|13057409|P1|NOT COMPLETED|Overall Study||0
5310739|NCT00478036|13057407|P3|COMPLETED|Overall Study||14
5310740|NCT00478036|13057408|P2|COMPLETED|Overall Study||7
5310741|NCT00478036|13057409|P1|COMPLETED|Overall Study||10
5310742|NCT00478036|13057407|P3|STARTED|Overall Study||14
5310743|NCT00478036|13057408|P2|STARTED|Overall Study||7
5310744|NCT00478036|13057409|P1|STARTED|Overall Study||10
5310745|NCT00478023|13057422|P5|NOT COMPLETED|Overall Study||55
5310746|NCT00478023|13057423|P4|NOT COMPLETED|Overall Study||30
5310747|NCT00478023|13057424|P3|NOT COMPLETED|Overall Study||20
5310748|NCT00478023|13057425|P2|NOT COMPLETED|Overall Study||24
5310749|NCT00478023|13057426|P1|NOT COMPLETED|Overall Study||35
5310750|NCT00478023|13057422|P5|COMPLETED|Overall Study||114
5310751|NCT00478023|13057423|P4|COMPLETED|Overall Study||146
5310752|NCT00478023|13057424|P3|COMPLETED|Overall Study||151
5310753|NCT00478023|13057425|P2|COMPLETED|Overall Study||144
5310754|NCT00478023|13057426|P1|COMPLETED|Overall Study||135
5310755|NCT00478023|13057422|P5|STARTED|Overall Study||169
5310756|NCT00478023|13057423|P4|STARTED|Overall Study||176
5310757|NCT00478023|13057424|P3|STARTED|Overall Study||171
5310758|NCT00478023|13057425|P2|STARTED|Overall Study||168
5310759|NCT00478023|13057426|P1|STARTED|Overall Study||170
5310760|NCT00477971|13057445|P2|NOT COMPLETED|Overall Study||6
5310761|NCT00477971|13057446|P1|NOT COMPLETED|Overall Study||17
5310762|NCT00477971|13057445|P2|COMPLETED|Overall Study||49
5310763|NCT00477971|13057446|P1|COMPLETED|Overall Study||17
5310764|NCT00477971|13057445|P2|STARTED|Overall Study||55
5310765|NCT00477971|13057446|P1|STARTED|Overall Study||34
5310766|NCT00477750|13057458|P1|NOT COMPLETED|Overall Study||11
5310767|NCT00477750|13057458|P1|COMPLETED|Overall Study||15
5310768|NCT00477750|13057458|P1|STARTED|Overall Study||26
5310769|NCT00477685|13057466|P1|NOT COMPLETED|Overall Study||0
5310770|NCT00477685|13057466|P1|COMPLETED|Overall Study||10
5310771|NCT00477685|13057466|P1|STARTED|Overall Study||10
5310772|NCT00477672|13057474|P3|NOT COMPLETED|Overall Study||16
5310773|NCT00477672|13057475|P2|NOT COMPLETED|Overall Study||16
5310774|NCT00477672|13057476|P1|NOT COMPLETED|Overall Study||7
5310775|NCT00477672|13057474|P3|COMPLETED|Overall Study||83
5310776|NCT00477672|13057475|P2|COMPLETED|Overall Study||85
5310777|NCT00477672|13057476|P1|COMPLETED|Overall Study||91
5310778|NCT00477672|13057474|P3|STARTED|Overall Study||99
5310779|NCT00477672|13057475|P2|STARTED|Overall Study||101
5310780|NCT00477672|13057476|P1|STARTED|Overall Study||98
5310781|NCT00477633|13057487|P1|NOT COMPLETED|Overall Study||709
5310782|NCT00477633|13057487|P1|COMPLETED|Overall Study||991
5310783|NCT00477633|13057487|P1|STARTED|Overall Study||1700
5310784|NCT00477607|13057495|P2|NOT COMPLETED|Overall Study||7
5310785|NCT00477607|13057496|P1|NOT COMPLETED|Overall Study||7
5310786|NCT00477607|13057495|P2|COMPLETED|Overall Study||13
5310787|NCT00477607|13057496|P1|COMPLETED|Overall Study||12
5310788|NCT00477607|13057495|P2|STARTED|Overall Study||20
5310789|NCT00477607|13057496|P1|STARTED|Overall Study||19
5310790|NCT00477594|13057508|P2|NOT COMPLETED|Follow-up Period||1
5310791|NCT00477594|13057509|P1|NOT COMPLETED|Follow-up Period||3
5310792|NCT00477594|13057508|P2|COMPLETED|Follow-up Period||4
5310793|NCT00477594|13057509|P1|COMPLETED|Follow-up Period||13
5310794|NCT00477594|13057508|P2|STARTED|Follow-up Period||5
5310795|NCT00477594|13057509|P1|STARTED|Follow-up Period||16
5310796|NCT00477594|13057508|P2|NOT COMPLETED|Year 3||0
5310797|NCT00477594|13057509|P1|NOT COMPLETED|Year 3||2
5310798|NCT00477594|13057508|P2|COMPLETED|Year 3||0
5310799|NCT00477594|13057509|P1|COMPLETED|Year 3||2
5310800|NCT00477594|13057508|P2|STARTED|Year 3||0
5310801|NCT00477594|13057509|P1|STARTED|Year 3||4
5310802|NCT00477594|13057508|P2|NOT COMPLETED|Year 1 and Year 2||4
5310803|NCT00477594|13057509|P1|NOT COMPLETED|Year 1 and Year 2||9
5310804|NCT00477594|13057508|P2|COMPLETED|Year 1 and Year 2||1
5310805|NCT00477594|13057509|P1|COMPLETED|Year 1 and Year 2||7
5310806|NCT00477594|13057508|P2|STARTED|Year 1 and Year 2||5
5310807|NCT00477594|13057509|P1|STARTED|Year 1 and Year 2||16
5310808|NCT00477490|13057570|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
5310809|NCT00477490|13057571|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
5310810|NCT00477490|13057572|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
5310811|NCT00477490|13057573|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
5310812|NCT00477490|13057574|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
5310813|NCT00477490|13057575|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
5310814|NCT00477490|13057576|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
5310815|NCT00477490|13057577|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
5310816|NCT00477490|13057578|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
5310817|NCT00477490|13057570|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
5310818|NCT00477490|13057571|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
5310819|NCT00477490|13057572|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
5310820|NCT00477490|13057573|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
5310821|NCT00477490|13057574|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
5310822|NCT00477490|13057575|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
5310823|NCT00477490|13057576|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
5310824|NCT00477490|13057577|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
5310825|NCT00477490|13057578|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
5310826|NCT00477490|13057570|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
5310827|NCT00477490|13057571|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
5310828|NCT00477490|13057572|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
5310829|NCT00477490|13057573|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
5310830|NCT00477490|13057574|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
5310831|NCT00477490|13057575|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
5310832|NCT00477490|13057576|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
5310833|NCT00477490|13057577|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
5310834|NCT00477490|13057578|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
5310835|NCT00477490|13057570|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
5310836|NCT00477490|13057571|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
5310837|NCT00477490|13057572|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
5310838|NCT00477490|13057573|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
5310839|NCT00477490|13057574|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
5310840|NCT00477490|13057575|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
5310841|NCT00477490|13057576|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
5310842|NCT00477490|13057577|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
5310843|NCT00477490|13057578|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
5310844|NCT00477490|13057570|P9|COMPLETED|Part I: 4 Week Efficacy||0
5310845|NCT00477490|13057571|P8|COMPLETED|Part I: 4 Week Efficacy||0
5310846|NCT00477490|13057572|P7|COMPLETED|Part I: 4 Week Efficacy||0
5310847|NCT00477490|13057573|P6|COMPLETED|Part I: 4 Week Efficacy||0
5310848|NCT00477490|13057574|P5|COMPLETED|Part I: 4 Week Efficacy||135
5310849|NCT00477490|13057575|P4|COMPLETED|Part I: 4 Week Efficacy||138
5310850|NCT00477490|13057576|P3|COMPLETED|Part I: 4 Week Efficacy||148
5310851|NCT00477490|13057577|P2|COMPLETED|Part I: 4 Week Efficacy||144
5310852|NCT00477490|13057578|P1|COMPLETED|Part I: 4 Week Efficacy||145
5310853|NCT00477490|13057570|P9|ITT Population|Part I: 4 Week Efficacy||0
5310854|NCT00477490|13057571|P8|ITT Population|Part I: 4 Week Efficacy||0
5310855|NCT00477490|13057572|P7|ITT Population|Part I: 4 Week Efficacy||0
5310856|NCT00477490|13057573|P6|ITT Population|Part I: 4 Week Efficacy||0
5310857|NCT00477490|13057574|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
5310858|NCT00477490|13057575|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
5310859|NCT00477490|13057576|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
5310860|NCT00477490|13057577|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
5310861|NCT00477490|13057578|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
5310862|NCT00477490|13057570|P9|STARTED|Part I: 4 Week Efficacy||0
5310863|NCT00477490|13057571|P8|STARTED|Part I: 4 Week Efficacy||0
5310864|NCT00477490|13057572|P7|STARTED|Part I: 4 Week Efficacy||0
5310865|NCT00477490|13057573|P6|STARTED|Part I: 4 Week Efficacy||0
5310866|NCT00477490|13057574|P5|STARTED|Part I: 4 Week Efficacy||160
5310867|NCT00477490|13057575|P4|STARTED|Part I: 4 Week Efficacy||158
5310868|NCT00477490|13057576|P3|STARTED|Part I: 4 Week Efficacy||158
5310869|NCT00477490|13057577|P2|STARTED|Part I: 4 Week Efficacy||163
5310870|NCT00477490|13057578|P1|STARTED|Part I: 4 Week Efficacy||160
5310871|NCT00477464|13057662|P1|NOT COMPLETED|Overall Study||51
5310872|NCT00477464|13057662|P1|COMPLETED|Overall Study||0
5310873|NCT00477464|13057662|P1|STARTED|Overall Study||51
5310874|NCT00477451|13057689|P4|NOT COMPLETED|Overall Study||0
5310875|NCT00477451|13057690|P3|NOT COMPLETED|Overall Study||0
5310876|NCT00477451|13057691|P2|NOT COMPLETED|Overall Study||0
5310877|NCT00477451|13057692|P1|NOT COMPLETED|Overall Study||0
5310878|NCT00477451|13057689|P4|COMPLETED|Overall Study||2
5310879|NCT00477451|13057690|P3|COMPLETED|Overall Study||7
5310880|NCT00477451|13057691|P2|COMPLETED|Overall Study||20
5310881|NCT00477451|13057692|P1|COMPLETED|Overall Study||20
5310882|NCT00477451|13057689|P4|STARTED|Overall Study||2
5310883|NCT00477451|13057690|P3|STARTED|Overall Study||7
5310884|NCT00477451|13057691|P2|STARTED|Overall Study||20
5310885|NCT00477451|13057692|P1|STARTED|Overall Study||20
5310886|NCT00477386|13057706|P2|NOT COMPLETED|Overall Study||17
5310887|NCT00477386|13057707|P1|NOT COMPLETED|Overall Study||11
5310888|NCT00477386|13057706|P2|COMPLETED|Overall Study||0
5310889|NCT00477386|13057707|P1|COMPLETED|Overall Study||0
5310890|NCT00477386|13057706|P2|STARTED|Overall Study||17
5310891|NCT00477386|13057707|P1|STARTED|Overall Study||11
5310892|NCT00477334|13057717|P2|NOT COMPLETED|Overall Study||76
5310893|NCT00477334|13057718|P1|NOT COMPLETED|Overall Study||170
5310894|NCT00477334|13057717|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
5310895|NCT00477334|13057718|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
5310896|NCT00477334|13057717|P2|Modified Intent to Treat Population|Overall Study||78
5310897|NCT00477334|13057718|P1|Modified Intent to Treat Population|Overall Study||152
5310898|NCT00477334|13057717|P2|Participants Completing First Recurrence|Overall Study||92
5310899|NCT00477334|13057718|P1|Participants Completing First Recurrence|Overall Study||187
5310900|NCT00477334|13057717|P2|Intent to Treat Population|Overall Study||98
5310901|NCT00477334|13057718|P1|Intent to Treat Population|Overall Study||201
5310902|NCT00477334|13057717|P2|Randomized and Took Study Drug|Overall Study||98
5310903|NCT00477334|13057718|P1|Randomized and Took Study Drug|Overall Study||206
5310904|NCT00477334|13057717|P2|STARTED|Overall Study||151
5310905|NCT00477334|13057718|P1|STARTED|Overall Study||312
5310906|NCT00477295|13057744|P2|NOT COMPLETED|Overall Study||109
5310907|NCT00477295|13057745|P1|NOT COMPLETED|Overall Study||121
5310908|NCT00477295|13057744|P2|COMPLETED|Overall Study||192
5310909|NCT00477295|13057745|P1|COMPLETED|Overall Study||161
5310910|NCT00477295|13057744|P2|STARTED|Overall Study||301
5310911|NCT00477295|13057745|P1|STARTED|Overall Study||282
5310912|NCT00477269|13057773|P3|NOT COMPLETED|Open Label Extension||13
5310913|NCT00477269|13057774|P2|NOT COMPLETED|Open Label Extension||0
5310914|NCT00477269|13057775|P1|NOT COMPLETED|Open Label Extension||0
5310915|NCT00477269|13057773|P3|COMPLETED|Open Label Extension||9
5310916|NCT00477269|13057774|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
5310917|NCT00477269|13057775|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
5310918|NCT00477269|13057773|P3|STARTED|Open Label Extension||22
5310919|NCT00477269|13057774|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
5310920|NCT00477269|13057775|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
5310921|NCT00477269|13057773|P3|NOT COMPLETED|Core Study||0
5310922|NCT00477269|13057774|P2|NOT COMPLETED|Core Study||8
5310923|NCT00477269|13057775|P1|NOT COMPLETED|Core Study||9
5310924|NCT00477269|13057773|P3|COMPLETED|Core Study||0
5310925|NCT00477269|13057774|P2|COMPLETED|Core Study||23
5310926|NCT00477269|13057775|P1|COMPLETED|Core Study||19
5310927|NCT00477269|13057773|P3|STARTED|Core Study||0
5310928|NCT00477269|13057774|P2|STARTED|Core Study||31
5310929|NCT00477269|13057775|P1|STARTED|Core Study||28
5310930|NCT00477230|13057829|P2|NOT COMPLETED|Overall Study||31
5310931|NCT00477230|13057830|P1|NOT COMPLETED|Overall Study||20
5310932|NCT00477230|13057829|P2|COMPLETED|Overall Study||1
5310933|NCT00477230|13057830|P1|COMPLETED|Overall Study||12
5310934|NCT00477230|13057829|P2|STARTED|Overall Study||32
5310935|NCT00477230|13057830|P1|STARTED|Overall Study||32
5310936|NCT00477204|13057838|P2|NOT COMPLETED|Overall Study||0
5310937|NCT00477204|13057839|P1|NOT COMPLETED|Overall Study||0
5310938|NCT00477204|13057838|P2|COMPLETED|Overall Study||5
5310939|NCT00477204|13057839|P1|COMPLETED|Overall Study||4
5310940|NCT00477204|13057838|P2|STARTED|Overall Study||5
5310941|NCT00477204|13057839|P1|STARTED|Overall Study||4
5310942|NCT00477191|13057845|P1|NOT COMPLETED|Overall Study||5
5310943|NCT00477191|13057845|P1|COMPLETED|Overall Study||13
5310944|NCT00477191|13057845|P1|STARTED|Overall Study||18
5310945|NCT00477165|13057854|P2|NOT COMPLETED|Overall Study||2
5310946|NCT00477165|13057855|P1|NOT COMPLETED|Overall Study||7
5310947|NCT00477165|13057854|P2|COMPLETED|Overall Study||25
5310948|NCT00477165|13057855|P1|COMPLETED|Overall Study||20
5310949|NCT00477165|13057854|P2|STARTED|Overall Study||27
5310950|NCT00477165|13057855|P1|STARTED|Overall Study||27
5310951|NCT00477152|13057867|P1|NOT COMPLETED|Overall Study||3
5310952|NCT00477152|13057867|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
5310953|NCT00477152|13057867|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
5310954|NCT00477087|13057874|P1|NOT COMPLETED|Overall Study||0
5310955|NCT00477087|13057874|P1|COMPLETED|Overall Study||10
5310956|NCT00477087|13057874|P1|STARTED|Overall Study||10
5310957|NCT00476996|13057883|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
5310958|NCT00476996|13057884|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
5310959|NCT00476996|13057885|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
5310960|NCT00476996|13057886|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
5310961|NCT00476996|13057883|P4|COMPLETED|OLE Phase (From Week 48)||0
5310962|NCT00476996|13057884|P3|COMPLETED|OLE Phase (From Week 48)||0
5310963|NCT00476996|13057885|P2|COMPLETED|OLE Phase (From Week 48)||0
5310964|NCT00476996|13057886|P1|COMPLETED|OLE Phase (From Week 48)||0
5310965|NCT00476996|13057883|P4|STARTED|OLE Phase (From Week 48)||664
5310966|NCT00476996|13057884|P3|STARTED|OLE Phase (From Week 48)||0
5310967|NCT00476996|13057885|P2|STARTED|OLE Phase (From Week 48)||0
5310968|NCT00476996|13057886|P1|STARTED|OLE Phase (From Week 48)||0
5310969|NCT00476996|13057883|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
5310970|NCT00476996|13057884|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
5310971|NCT00476996|13057885|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
5310972|NCT00476996|13057886|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
5310973|NCT00476996|13057883|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
5310974|NCT00476996|13057884|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
5310975|NCT00476996|13057885|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
5310976|NCT00476996|13057886|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
5310977|NCT00476996|13057883|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
5310978|NCT00476996|13057884|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
5310979|NCT00476996|13057885|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
5310980|NCT00476996|13057886|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
5310981|NCT00476957|13057918|P2|NOT COMPLETED|Overall Study||193
5310982|NCT00476957|13057919|P1|NOT COMPLETED|Overall Study||176
5310983|NCT00476957|13057918|P2|COMPLETED|Overall Study||4159
5310984|NCT00476957|13057919|P1|COMPLETED|Overall Study||4181
5310985|NCT00476957|13057918|P2|STARTED|Overall Study||4352
5310986|NCT00476957|13057919|P1|STARTED|Overall Study||4357
5310987|NCT00476827|13057933|P6|NOT COMPLETED|Overall Study||0
5310988|NCT00476827|13057934|P5|NOT COMPLETED|Overall Study||0
5310989|NCT00476827|13057935|P4|NOT COMPLETED|Overall Study||0
5310990|NCT00476827|13057936|P3|NOT COMPLETED|Overall Study||0
5310991|NCT00476827|13057937|P2|NOT COMPLETED|Overall Study||0
5310992|NCT00476827|13057938|P1|NOT COMPLETED|Overall Study||0
5310993|NCT00476827|13057933|P6|COMPLETED|Overall Study||2
5310994|NCT00476827|13057934|P5|COMPLETED|Overall Study||2
5310995|NCT00476827|13057935|P4|COMPLETED|Overall Study||0
5310996|NCT00476827|13057936|P3|COMPLETED|Overall Study||1
5310997|NCT00476827|13057937|P2|COMPLETED|Overall Study||0
5310998|NCT00476827|13057938|P1|COMPLETED|Overall Study||3
5310999|NCT00476827|13057933|P6|STARTED|Overall Study||2
5311000|NCT00476827|13057934|P5|STARTED|Overall Study||2
5311001|NCT00476827|13057935|P4|STARTED|Overall Study||0
5311002|NCT00476827|13057936|P3|STARTED|Overall Study||1
5311003|NCT00476827|13057937|P2|STARTED|Overall Study||0
5311004|NCT00476827|13057938|P1|STARTED|Overall Study||3
5311005|NCT00476788|13057968|P1|NOT COMPLETED|Overall Study||3
5311006|NCT00476788|13057968|P1|COMPLETED|Overall Study||11
5311007|NCT00476788|13057968|P1|STARTED|Overall Study||14
5311008|NCT00476645|13057973|P1|NOT COMPLETED|Overall Study||0
5311009|NCT00476645|13057973|P1|COMPLETED|Overall Study||10
5311010|NCT00476645|13057973|P1|STARTED|Overall Study||10
5311011|NCT00476593|13057983|P4|NOT COMPLETED|Overall Study||22
5311012|NCT00476593|13057984|P3|NOT COMPLETED|Overall Study||8
5311013|NCT00476593|13057985|P2|NOT COMPLETED|Overall Study||2
5311014|NCT00476593|13057986|P1|NOT COMPLETED|Overall Study||10
5311015|NCT00476593|13057983|P4|COMPLETED|Overall Study||107
5311016|NCT00476593|13057984|P3|COMPLETED|Overall Study||30
5311017|NCT00476593|13057985|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
5311018|NCT00476593|13057986|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
5311019|NCT00476593|13057983|P4|STARTED|Overall Study||129
5311020|NCT00476593|13057984|P3|STARTED|Overall Study||38
5311021|NCT00476593|13057985|P2|STARTED|Overall Study||19
5311022|NCT00476593|13057986|P1|STARTED|Overall Study||32
5311023|NCT00476476|13057998|P2|NOT COMPLETED|Overall Study||24
5311024|NCT00476476|13057999|P1|NOT COMPLETED|Overall Study||2
5311025|NCT00476476|13057998|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
5311026|NCT00476476|13057999|P1|COMPLETED|Overall Study||15
5311027|NCT00476476|13057998|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
5311028|NCT00476476|13057999|P1|Response Evaluable|Overall Study||17
5311029|NCT00476476|13057998|P2|STARTED|Overall Study||24
5311030|NCT00476476|13057999|P1|STARTED|Overall Study||17
5311031|NCT00476242|13058006|P2|NOT COMPLETED|Overall Study||16
5311032|NCT00476242|13058007|P1|NOT COMPLETED|Overall Study||8
5311033|NCT00476242|13058006|P2|COMPLETED|Overall Study||12
5311034|NCT00476242|13058007|P1|COMPLETED|Overall Study||19
5311035|NCT00476242|13058006|P2|STARTED|Overall Study||28
5311036|NCT00476242|13058007|P1|STARTED|Overall Study||27
5311037|NCT00476229|13058017|P1|NOT COMPLETED|Overall Study||1
5311038|NCT00476229|13058017|P1|COMPLETED|Overall Study||19
5311039|NCT00476229|13058017|P1|STARTED|Overall Study||20
5311040|NCT00476151|13058023|P2|NOT COMPLETED|Overall Study||7
5311041|NCT00476151|13058024|P1|NOT COMPLETED|Overall Study||3
5311042|NCT00476151|13058023|P2|COMPLETED|Overall Study||107
5311043|NCT00476151|13058024|P1|COMPLETED|Overall Study||109
5311044|NCT00476151|13058023|P2|STARTED|Overall Study||114
5311045|NCT00476151|13058024|P1|STARTED|Overall Study||112
5311046|NCT00476086|13058030|P1|NOT COMPLETED|Overall Study||5
5311047|NCT00476086|13058030|P1|COMPLETED|Overall Study||15
5311048|NCT00476086|13058030|P1|Received Radiation|Overall Study||15
5311049|NCT00476086|13058030|P1|Received Chemotherapy|Overall Study||19
5311050|NCT00476086|13058030|P1|STARTED|Overall Study||20
5311051|NCT00476047|13058036|P1|NOT COMPLETED|Overall Study||1
5311052|NCT00476047|13058036|P1|COMPLETED|Overall Study||15
5311053|NCT00476047|13058036|P1|Completed Treatment|Overall Study||16
5311054|NCT00476047|13058036|P1|STARTED|Overall Study||16
5311055|NCT00476021|13058045|P2|NOT COMPLETED|Overall Study||0
5311056|NCT00476021|13058046|P1|NOT COMPLETED|Overall Study||0
5311057|NCT00476021|13058045|P2|COMPLETED|Overall Study||51
5311058|NCT00476021|13058046|P1|COMPLETED|Overall Study||51
5311059|NCT00476021|13058045|P2|STARTED|Overall Study||51
5311060|NCT00476021|13058046|P1|STARTED|Overall Study||51
5311061|NCT00476008|13058062|P2|NOT COMPLETED|Overall Study||8
5311062|NCT00476008|13058063|P1|NOT COMPLETED|Overall Study||9
5311063|NCT00476008|13058062|P2|COMPLETED|Overall Study||13
5311064|NCT00476008|13058063|P1|COMPLETED|Overall Study||13
5311065|NCT00476008|13058062|P2|6 Month Testing|Overall Study||14
5311066|NCT00476008|13058063|P1|6 Month Testing|Overall Study||15
5311067|NCT00476008|13058062|P2|STARTED|Overall Study||21
5311068|NCT00476008|13058063|P1|STARTED|Overall Study||22
5311069|NCT00475982|13058089|P2|NOT COMPLETED|Overall Study||3
5311070|NCT00475982|13058090|P1|NOT COMPLETED|Overall Study||7
5311071|NCT00475982|13058089|P2|COMPLETED|Overall Study||18
5311072|NCT00475982|13058090|P1|COMPLETED|Overall Study||16
5311073|NCT00475982|13058089|P2|STARTED|Overall Study||21
5311074|NCT00475982|13058090|P1|STARTED|Overall Study||23
5311075|NCT00475904|13058111|P3|NOT COMPLETED|Overall Study||4
5311076|NCT00475904|13058112|P2|NOT COMPLETED|Overall Study||13
5311077|NCT00475904|13058113|P1|NOT COMPLETED|Overall Study||15
5311078|NCT00475904|13058111|P3|COMPLETED|Overall Study||72
5311079|NCT00475904|13058112|P2|COMPLETED|Overall Study||131
5311080|NCT00475904|13058113|P1|COMPLETED|Overall Study||125
5311081|NCT00475904|13058111|P3|STARTED|Overall Study||76
5311082|NCT00475904|13058112|P2|STARTED|Overall Study||144
5311083|NCT00475904|13058113|P1|STARTED|Overall Study||140
5311084|NCT00475878|13058126|P2|NOT COMPLETED|Overall Study||0
5311085|NCT00475878|13058127|P1|NOT COMPLETED|Overall Study||0
5311086|NCT00475878|13058126|P2|COMPLETED|Overall Study||72
5311087|NCT00475878|13058127|P1|COMPLETED|Overall Study||75
5311088|NCT00475878|13058126|P2|STARTED|Overall Study||72
5311089|NCT00475878|13058127|P1|STARTED|Overall Study||75
5311090|NCT00475865|13058138|P3|NOT COMPLETED|Overall Study||6
5311091|NCT00475865|13058139|P2|NOT COMPLETED|Overall Study||5
5311092|NCT00475865|13058140|P1|NOT COMPLETED|Overall Study||2
5311093|NCT00475865|13058138|P3|COMPLETED|Overall Study|completed treatment period|34
5311094|NCT00475865|13058139|P2|COMPLETED|Overall Study|completed treatment period|37
5311095|NCT00475865|13058140|P1|COMPLETED|Overall Study||39
5311096|NCT00475865|13058138|P3|Treated|Overall Study||40
5311097|NCT00475865|13058139|P2|Treated|Overall Study||42
5311098|NCT00475865|13058140|P1|Treated|Overall Study|completed treatment period|41
5311099|NCT00475865|13058138|P3|STARTED|Overall Study|randomized|40
5311100|NCT00475865|13058139|P2|STARTED|Overall Study|randomized|42
5311101|NCT00475865|13058140|P1|STARTED|Overall Study|randomized|41
5311102|NCT00475852|13058170|P2|NOT COMPLETED|Overall Study||548
5311103|NCT00475852|13058171|P1|NOT COMPLETED|Overall Study||517
5311104|NCT00475852|13058170|P2|COMPLETED|Overall Study||3029
5311105|NCT00475852|13058171|P1|COMPLETED|Overall Study||3047
5311106|NCT00475852|13058170|P2|STARTED|Overall Study||3577
5311107|NCT00475852|13058171|P1|STARTED|Overall Study||3564
5311108|NCT00475787|13058201|P2|NOT COMPLETED|Overall Study||7
5311109|NCT00475787|13058202|P1|NOT COMPLETED|Overall Study||8
5311110|NCT00475787|13058201|P2|COMPLETED|Overall Study||60
5311111|NCT00475787|13058202|P1|COMPLETED|Overall Study||61
5311112|NCT00475787|13058201|P2|STARTED|Overall Study||67
5311113|NCT00475787|13058202|P1|STARTED|Overall Study||69
5311114|NCT00475735|13058222|P6|NOT COMPLETED|Treatment Period 2||1
5311115|NCT00475735|13058223|P5|NOT COMPLETED|Treatment Period 2||1
5311116|NCT00475735|13058224|P4|NOT COMPLETED|Treatment Period 2||2
5311117|NCT00475735|13058225|P3|NOT COMPLETED|Treatment Period 2||0
5311118|NCT00475735|13058226|P2|NOT COMPLETED|Treatment Period 2||1
5311119|NCT00475735|13058227|P1|NOT COMPLETED|Treatment Period 2||0
5311120|NCT00475735|13058222|P6|COMPLETED|Treatment Period 2||13
5311121|NCT00475735|13058223|P5|COMPLETED|Treatment Period 2||15
5311122|NCT00475735|13058224|P4|COMPLETED|Treatment Period 2||4
5311123|NCT00475735|13058225|P3|COMPLETED|Treatment Period 2||7
5311124|NCT00475735|13058226|P2|COMPLETED|Treatment Period 2||9
5311125|NCT00475735|13058227|P1|COMPLETED|Treatment Period 2||10
5311126|NCT00475735|13058222|P6|STARTED|Treatment Period 2||14
5311127|NCT00475735|13058223|P5|STARTED|Treatment Period 2||16
5311128|NCT00475735|13058224|P4|STARTED|Treatment Period 2||6
5311129|NCT00475735|13058225|P3|STARTED|Treatment Period 2||7
5311130|NCT00475735|13058226|P2|STARTED|Treatment Period 2||10
5311131|NCT00475735|13058227|P1|STARTED|Treatment Period 2||10
5311132|NCT00475735|13058222|P6|NOT COMPLETED|Treatment Washout||0
5311133|NCT00475735|13058223|P5|NOT COMPLETED|Treatment Washout||0
5311134|NCT00475735|13058224|P4|NOT COMPLETED|Treatment Washout||0
5311135|NCT00475735|13058225|P3|NOT COMPLETED|Treatment Washout||0
5311136|NCT00475735|13058226|P2|NOT COMPLETED|Treatment Washout||2
5311137|NCT00475735|13058227|P1|NOT COMPLETED|Treatment Washout||0
5311138|NCT00475735|13058222|P6|COMPLETED|Treatment Washout||14
5311139|NCT00475735|13058223|P5|COMPLETED|Treatment Washout||16
5311140|NCT00475735|13058224|P4|COMPLETED|Treatment Washout||6
5311141|NCT00475735|13058225|P3|COMPLETED|Treatment Washout||7
5311142|NCT00475735|13058226|P2|COMPLETED|Treatment Washout||10
5311143|NCT00475735|13058227|P1|COMPLETED|Treatment Washout||10
5311144|NCT00475735|13058222|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
5311145|NCT00475735|13058223|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
5311146|NCT00475735|13058224|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
5311147|NCT00475735|13058225|P3|STARTED|Treatment Washout||7
5311148|NCT00475735|13058226|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
5311149|NCT00475735|13058227|P1|STARTED|Treatment Washout||10
5311150|NCT00475735|13058222|P6|NOT COMPLETED|Treatment Period 1||3
5311151|NCT00475735|13058223|P5|NOT COMPLETED|Treatment Period 1||2
5311152|NCT00475735|13058224|P4|NOT COMPLETED|Treatment Period 1||2
5311153|NCT00475735|13058225|P3|NOT COMPLETED|Treatment Period 1||0
5311154|NCT00475735|13058226|P2|NOT COMPLETED|Treatment Period 1||2
5311155|NCT00475735|13058227|P1|NOT COMPLETED|Treatment Period 1||4
5311156|NCT00475735|13058222|P6|COMPLETED|Treatment Period 1||12
5311157|NCT00475735|13058223|P5|COMPLETED|Treatment Period 1||14
5311158|NCT00475735|13058224|P4|COMPLETED|Treatment Period 1||5
5311159|NCT00475735|13058225|P3|COMPLETED|Treatment Period 1||7
5311160|NCT00475735|13058226|P2|COMPLETED|Treatment Period 1||11
5311161|NCT00475735|13058227|P1|COMPLETED|Treatment Period 1||10
5311162|NCT00475735|13058222|P6|STARTED|Treatment Period 1||15
5311163|NCT00475735|13058223|P5|STARTED|Treatment Period 1||16
5311164|NCT00475735|13058224|P4|STARTED|Treatment Period 1||7
5311165|NCT00475735|13058225|P3|STARTED|Treatment Period 1||7
5311166|NCT00475735|13058226|P2|STARTED|Treatment Period 1||13
5311167|NCT00475735|13058227|P1|STARTED|Treatment Period 1||14
5311168|NCT00475722|13058240|P2|NOT COMPLETED|Overall Study||12
5311169|NCT00475722|13058241|P1|NOT COMPLETED|Overall Study||15
5311170|NCT00475722|13058240|P2|COMPLETED|Overall Study||47
5311171|NCT00475722|13058241|P1|COMPLETED|Overall Study||46
5311172|NCT00475722|13058240|P2|STARTED|Overall Study||59
5311173|NCT00475722|13058241|P1|STARTED|Overall Study||61
5311174|NCT00475709|13058247|P1|NOT COMPLETED|Overall Study||76
5311175|NCT00475709|13058247|P1|COMPLETED|Overall Study||946
5311176|NCT00475709|13058247|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
5311177|NCT00475709|13058247|P1|STARTED|Overall Study||1022
5311178|NCT00475670|13058255|P2|NOT COMPLETED|Overall Study||41
5311179|NCT00475670|13058256|P1|NOT COMPLETED|Overall Study||3
5311180|NCT00475670|13058255|P2|COMPLETED|Overall Study||0
5311181|NCT00475670|13058256|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
5311182|NCT00475670|13058255|P2|STARTED|Overall Study||41
5311183|NCT00475670|13058256|P1|STARTED|Overall Study||3
5311184|NCT00475657|13058280|P1|NOT COMPLETED|Overall Study||4
5311185|NCT00475657|13058280|P1|COMPLETED|Overall Study||1
5311186|NCT00475657|13058280|P1|STARTED|Overall Study||5
5311187|NCT00475644|13058288|P1|NOT COMPLETED|Overall Study||13
5311188|NCT00475644|13058288|P1|COMPLETED|Overall Study||53
5311189|NCT00475644|13058288|P1|Received at Least One Dose of Study Drug|Overall Study||66
5311190|NCT00475644|13058288|P1|STARTED|Overall Study||66
5311191|NCT00475501|13058300|P4|NOT COMPLETED|Overall Study||4
5311192|NCT00475501|13058301|P3|NOT COMPLETED|Overall Study||4
5311193|NCT00475501|13058302|P2|NOT COMPLETED|Overall Study||5
5311194|NCT00475501|13058303|P1|NOT COMPLETED|Overall Study||7
5311195|NCT00475501|13058300|P4|COMPLETED|Overall Study||12
5311196|NCT00475501|13058301|P3|COMPLETED|Overall Study||13
5311197|NCT00475501|13058302|P2|COMPLETED|Overall Study||8
5311198|NCT00475501|13058303|P1|COMPLETED|Overall Study||7
5311199|NCT00475501|13058300|P4|STARTED|Overall Study||16
5311200|NCT00475501|13058301|P3|STARTED|Overall Study||17
5311201|NCT00475501|13058302|P2|STARTED|Overall Study||13
5311202|NCT00475501|13058303|P1|STARTED|Overall Study||14
5311203|NCT00475423|13058353|P1|NOT COMPLETED|Overall Study||32
5311204|NCT00475423|13058353|P1|COMPLETED|Overall Study||90
5311205|NCT00475423|13058353|P1|STARTED|Overall Study||122
5311206|NCT00475332|13058374|P1|NOT COMPLETED|Overall Study||0
5311207|NCT00475332|13058374|P1|COMPLETED|Overall Study||2
5311208|NCT00475332|13058374|P1|STARTED|Overall Study||2
5311209|NCT00475319|13058382|P3|NOT COMPLETED|Overall Study||4
5311210|NCT00475319|13058383|P2|NOT COMPLETED|Overall Study||1
5311211|NCT00475319|13058384|P1|NOT COMPLETED|Overall Study||2
5311212|NCT00475319|13058382|P3|COMPLETED|Overall Study||99
5311213|NCT00475319|13058383|P2|COMPLETED|Overall Study||101
5311214|NCT00475319|13058384|P1|COMPLETED|Overall Study||101
5311215|NCT00475319|13058382|P3|STARTED|Overall Study||103
5311216|NCT00475319|13058383|P2|STARTED|Overall Study||102
5311217|NCT00475319|13058384|P1|STARTED|Overall Study||103
5311218|NCT00475306|13058399|P4|NOT COMPLETED|Overall Study||1
5311219|NCT00475306|13058400|P3|NOT COMPLETED|Overall Study||0
5311220|NCT00475306|13058401|P2|NOT COMPLETED|Overall Study||1
5311221|NCT00475306|13058402|P1|NOT COMPLETED|Overall Study||1
5311222|NCT00475306|13058399|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
5311223|NCT00475306|13058400|P3|COMPLETED|Overall Study||72
5311224|NCT00475306|13058401|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
5311225|NCT00475306|13058402|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
5311226|NCT00475306|13058399|P4|STARTED|Overall Study||72
5311227|NCT00475306|13058400|P3|STARTED|Overall Study||72
5311228|NCT00475306|13058401|P2|STARTED|Overall Study||72
5311229|NCT00475306|13058402|P1|STARTED|Overall Study||73
5311230|NCT00475241|13058418|P2|NOT COMPLETED|Overall Study||3
5311231|NCT00475241|13058419|P1|NOT COMPLETED|Overall Study||7
5311232|NCT00475241|13058418|P2|COMPLETED|Overall Study||15
5311233|NCT00475241|13058419|P1|COMPLETED|Overall Study||11
5311234|NCT00475241|13058418|P2|STARTED|Overall Study||18
5311235|NCT00475241|13058419|P1|STARTED|Overall Study||18
5311236|NCT00475228|13058433|P2|NOT COMPLETED|Overall Study||17
5311237|NCT00475228|13058434|P1|NOT COMPLETED|Overall Study||17
5311238|NCT00475228|13058433|P2|COMPLETED|Overall Study||27
5311239|NCT00475228|13058434|P1|COMPLETED|Overall Study||27
5311240|NCT00475228|13058433|P2|STARTED|Overall Study||44
5311241|NCT00475228|13058434|P1|STARTED|Overall Study||44
5311242|NCT00475215|13058446|P2|NOT COMPLETED|Overall Study||4
5311243|NCT00475215|13058447|P1|NOT COMPLETED|Overall Study||5
5311244|NCT00475215|13058446|P2|COMPLETED|Overall Study||38
5311245|NCT00475215|13058447|P1|COMPLETED|Overall Study||39
5311246|NCT00475215|13058446|P2|Treated|Overall Study||38
5311247|NCT00475215|13058447|P1|Treated|Overall Study||39
5311248|NCT00475215|13058446|P2|STARTED|Overall Study||42
5311249|NCT00475215|13058447|P1|STARTED|Overall Study||44
5311250|NCT00475176|13058473|P1|NOT COMPLETED|Overall Study||4
5311251|NCT00475176|13058473|P1|COMPLETED|Overall Study||20
5311252|NCT00475176|13058473|P1|STARTED|Overall Study||24
5311253|NCT00475150|13058480|P2|NOT COMPLETED|Overall Study||0
5311254|NCT00475150|13058481|P1|NOT COMPLETED|Overall Study||0
5311255|NCT00475150|13058480|P2|COMPLETED|Overall Study||16
5311256|NCT00475150|13058481|P1|COMPLETED|Overall Study||23
5311257|NCT00475150|13058480|P2|STARTED|Overall Study||16
5311258|NCT00475150|13058481|P1|STARTED|Overall Study||23
5311259|NCT00475085|13058498|P4|NOT COMPLETED|Overall Study||20
5311260|NCT00475085|13058499|P3|NOT COMPLETED|Overall Study||19
5311261|NCT00475085|13058500|P2|NOT COMPLETED|Overall Study||20
5311262|NCT00475085|13058501|P1|NOT COMPLETED|Overall Study||18
5311263|NCT00475085|13058498|P4|COMPLETED|Overall Study||234
5311264|NCT00475085|13058499|P3|COMPLETED|Overall Study||241
5311265|NCT00475085|13058500|P2|COMPLETED|Overall Study||234
5311266|NCT00475085|13058501|P1|COMPLETED|Overall Study||235
5311267|NCT00475085|13058498|P4|STARTED|Overall Study||254
5311268|NCT00475085|13058499|P3|STARTED|Overall Study||260
5311269|NCT00475085|13058500|P2|STARTED|Overall Study||254
5311270|NCT00475085|13058501|P1|STARTED|Overall Study||253
5311271|NCT00475033|13058513|P2|NOT COMPLETED|Toddler Dose||0
5311272|NCT00475033|13058514|P1|NOT COMPLETED|Toddler Dose||4
5311273|NCT00475033|13058513|P2|COMPLETED|Toddler Dose||282
5311274|NCT00475033|13058514|P1|COMPLETED|Toddler Dose||283
5311275|NCT00475033|13058513|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
5311276|NCT00475033|13058514|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
5311277|NCT00475033|13058513|P2|NOT COMPLETED|After the Infant Series||8
5311278|NCT00475033|13058514|P1|NOT COMPLETED|After the Infant Series||6
5311279|NCT00475033|13058513|P2|COMPLETED|After the Infant Series||282
5311280|NCT00475033|13058514|P1|COMPLETED|After the Infant Series||287
5311281|NCT00475033|13058513|P2|Withdrawn After Infant Series|After the Infant Series||8
5311282|NCT00475033|13058514|P1|Withdrawn After Infant Series|After the Infant Series||6
5311283|NCT00475033|13058513|P2|STARTED|After the Infant Series||290
5311284|NCT00475033|13058514|P1|STARTED|After the Infant Series||293
5311285|NCT00475033|13058513|P2|NOT COMPLETED|Infant Series||13
5311286|NCT00475033|13058514|P1|NOT COMPLETED|Infant Series||7
5311287|NCT00475033|13058513|P2|COMPLETED|Infant Series||290
5311288|NCT00475033|13058514|P1|COMPLETED|Infant Series||293
5311289|NCT00475033|13058513|P2|Vaccinated Dose 3|Infant Series||294
5311290|NCT00475033|13058514|P1|Vaccinated Dose 3|Infant Series||293
5311291|NCT00475033|13058513|P2|Vaccinated Dose 2|Infant Series||296
5311292|NCT00475033|13058514|P1|Vaccinated Dose 2|Infant Series||297
5311293|NCT00475033|13058513|P2|Vaccinated Dose 1|Infant Series||303
5311294|NCT00475033|13058514|P1|Vaccinated Dose 1|Infant Series||300
5311295|NCT00475033|13058513|P2|STARTED|Infant Series||303
5311296|NCT00475033|13058514|P1|STARTED|Infant Series||300
5311297|NCT00475020|13058562|P1|NOT COMPLETED|Overall Study||5
5311298|NCT00475020|13058562|P1|COMPLETED|Overall Study||58
5311299|NCT00475020|13058562|P1|STARTED|Overall Study||63
5311300|NCT00474994|13058567|P1|NOT COMPLETED|Overall Study||5
5311301|NCT00474994|13058567|P1|COMPLETED|Overall Study||48
5311302|NCT00474994|13058567|P1|STARTED|Overall Study||53
5311303|NCT00474968|13058573|P2|NOT COMPLETED|Overall Study||16
5311304|NCT00474968|13058574|P1|NOT COMPLETED|Overall Study||18
5311305|NCT00474968|13058573|P2|COMPLETED|Overall Study||355
5311306|NCT00474968|13058574|P1|COMPLETED|Overall Study||348
5311307|NCT00474968|13058573|P2|STARTED|Overall Study||371
5311308|NCT00474968|13058574|P1|STARTED|Overall Study||366
5311309|NCT00474955|13058584|P1|NOT COMPLETED|Overall Study||8
5311310|NCT00474955|13058584|P1|COMPLETED|Overall Study||19
5311311|NCT00474955|13058584|P1|STARTED|Overall Study||27
5311312|NCT00474929|13058600|P5|NOT COMPLETED|Overall Study||0
5311313|NCT00474929|13058601|P4|NOT COMPLETED|Overall Study||2
5311314|NCT00474929|13058602|P3|NOT COMPLETED|Overall Study||2
5311315|NCT00474929|13058603|P2|NOT COMPLETED|Overall Study||1
5311316|NCT00474929|13058604|P1|NOT COMPLETED|Overall Study||0
5311317|NCT00474929|13058600|P5|COMPLETED|Overall Study||77
5311318|NCT00474929|13058601|P4|COMPLETED|Overall Study||5
5311319|NCT00474929|13058602|P3|COMPLETED|Overall Study||5
5311320|NCT00474929|13058603|P2|COMPLETED|Overall Study||5
5311321|NCT00474929|13058604|P1|COMPLETED|Overall Study||6
5311322|NCT00474929|13058600|P5|STARTED|Overall Study||77
5311323|NCT00474929|13058601|P4|STARTED|Overall Study||7
5311324|NCT00474929|13058602|P3|STARTED|Overall Study||7
5311325|NCT00474929|13058603|P2|STARTED|Overall Study||6
5311326|NCT00474929|13058604|P1|STARTED|Overall Study||6
5311327|NCT00474903|13058621|P3|NOT COMPLETED|Overall Study||2
5311328|NCT00474903|13058622|P2|NOT COMPLETED|Overall Study||5
5311329|NCT00474903|13058623|P1|NOT COMPLETED|Overall Study||1
5311330|NCT00474903|13058621|P3|COMPLETED|Overall Study||43
5311331|NCT00474903|13058622|P2|COMPLETED|Overall Study||42
5311332|NCT00474903|13058623|P1|COMPLETED|Overall Study||29
5311333|NCT00474903|13058621|P3|STARTED|Overall Study||45
5311334|NCT00474903|13058622|P2|STARTED|Overall Study||47
5311335|NCT00474903|13058623|P1|STARTED|Overall Study||30
5311336|NCT00474851|13058636|P2|NOT COMPLETED|Overall Study||11
5311337|NCT00474851|13058637|P1|NOT COMPLETED|Overall Study||8
5311338|NCT00474851|13058636|P2|COMPLETED|Overall Study||16
5311339|NCT00474851|13058637|P1|COMPLETED|Overall Study||18
5311340|NCT00474851|13058636|P2|Completed Baseline|Overall Study||26
5311341|NCT00474851|13058637|P1|Completed Baseline|Overall Study||25
5311342|NCT00474851|13058636|P2|STARTED|Overall Study||27
5311343|NCT00474851|13058637|P1|STARTED|Overall Study||26
5311344|NCT00474812|13058645|P1|NOT COMPLETED|Overall Study||7
5311345|NCT00474812|13058645|P1|COMPLETED|Overall Study||44
5311346|NCT00474812|13058645|P1|STARTED|Overall Study||51
5311347|NCT00474786|13058655|P2|NOT COMPLETED|Overall Study||253
5311348|NCT00474786|13058656|P1|NOT COMPLETED|Overall Study||259
5311349|NCT00474786|13058655|P2|COMPLETED|Overall Study||0
5311350|NCT00474786|13058656|P1|COMPLETED|Overall Study||0
5311351|NCT00474786|13058655|P2|STARTED|Overall Study||253
5311352|NCT00474786|13058656|P1|STARTED|Overall Study||259
5311353|NCT00474760|13058681|P7|NOT COMPLETED|Overall Study||10
5311354|NCT00474760|13058682|P6|NOT COMPLETED|Overall Study||29
5311355|NCT00474760|13058683|P5|NOT COMPLETED|Overall Study||12
5311356|NCT00474760|13058684|P4|NOT COMPLETED|Overall Study||3
5311357|NCT00474760|13058685|P3|NOT COMPLETED|Overall Study||3
5311358|NCT00474760|13058686|P2|NOT COMPLETED|Overall Study||3
5311359|NCT00474760|13058687|P1|NOT COMPLETED|Overall Study||3
5311360|NCT00474760|13058681|P7|COMPLETED|Overall Study||1
5311361|NCT00474760|13058682|P6|COMPLETED|Overall Study||0
5311362|NCT00474760|13058683|P5|COMPLETED|Overall Study||1
5311363|NCT00474760|13058684|P4|COMPLETED|Overall Study||0
5311364|NCT00474760|13058685|P3|COMPLETED|Overall Study||0
5311365|NCT00474760|13058686|P2|COMPLETED|Overall Study||0
5311366|NCT00474760|13058687|P1|COMPLETED|Overall Study||0
5311367|NCT00474760|13058681|P7|STARTED|Overall Study||11
5311368|NCT00474760|13058682|P6|STARTED|Overall Study||29
5311369|NCT00474760|13058683|P5|STARTED|Overall Study||13
5311370|NCT00474760|13058684|P4|STARTED|Overall Study||3
5311371|NCT00474760|13058685|P3|STARTED|Overall Study||3
5311372|NCT00474760|13058686|P2|STARTED|Overall Study||3
5311373|NCT00474760|13058687|P1|STARTED|Overall Study||3
5311374|NCT00474708|13058794|P2|NOT COMPLETED|Overall Study||25
5311375|NCT00474708|13058795|P1|NOT COMPLETED|Overall Study||57
5311376|NCT00474708|13058794|P2|COMPLETED|Overall Study||342
5311377|NCT00474708|13058795|P1|COMPLETED|Overall Study||734
5311378|NCT00474708|13058794|P2|STARTED|Overall Study||367
5311379|NCT00474708|13058795|P1|STARTED|Overall Study||791
5311380|NCT00474630|13058805|P2|NOT COMPLETED|Overall Study||70
5311381|NCT00474630|13058806|P1|NOT COMPLETED|Overall Study||160
5311382|NCT00474630|13058805|P2|COMPLETED|Overall Study||100
5311383|NCT00474630|13058806|P1|COMPLETED|Overall Study||175
5311384|NCT00474630|13058805|P2|STARTED|Overall Study||170
5311385|NCT00474630|13058806|P1|STARTED|Overall Study||335
5311386|NCT00474617|13058863|P3|NOT COMPLETED|Overall Study||2
5311387|NCT00474617|13058864|P2|NOT COMPLETED|Overall Study||3
5311388|NCT00474617|13058865|P1|NOT COMPLETED|Overall Study||8
5311389|NCT00474617|13058863|P3|COMPLETED|Overall Study||40
5311390|NCT00474617|13058864|P2|COMPLETED|Overall Study||61
5311391|NCT00474617|13058865|P1|COMPLETED|Overall Study||48
5311392|NCT00474617|13058863|P3|Treated|Overall Study||40
5311393|NCT00474617|13058864|P2|Treated|Overall Study||62
5311394|NCT00474617|13058865|P1|Treated|Overall Study||48
5311395|NCT00474617|13058863|P3|STARTED|Overall Study||42
5311396|NCT00474617|13058864|P2|STARTED|Overall Study||64
5311397|NCT00474617|13058865|P1|STARTED|Overall Study||56
5311398|NCT00474539|13058899|P2|NOT COMPLETED|Toddler Dose||0
5311399|NCT00474539|13058900|P1|NOT COMPLETED|Toddler Dose||1
5311400|NCT00474539|13058899|P2|COMPLETED|Toddler Dose||220
5311401|NCT00474539|13058900|P1|COMPLETED|Toddler Dose||208
5311402|NCT00474539|13058899|P2|STARTED|Toddler Dose||220
5311403|NCT00474539|13058900|P1|STARTED|Toddler Dose||209
5311404|NCT00474539|13058899|P2|NOT COMPLETED|After Infant Series||0
5311405|NCT00474539|13058900|P1|NOT COMPLETED|After Infant Series||4
5311406|NCT00474539|13058899|P2|COMPLETED|After Infant Series||220
5311407|NCT00474539|13058900|P1|COMPLETED|After Infant Series||209
5311408|NCT00474539|13058899|P2|STARTED|After Infant Series||220
5311409|NCT00474539|13058900|P1|STARTED|After Infant Series||213
5311410|NCT00474539|13058899|P2|NOT COMPLETED|Infant Series||6
5311411|NCT00474539|13058900|P1|NOT COMPLETED|Infant Series||10
5311412|NCT00474539|13058899|P2|COMPLETED|Infant Series||220
5311413|NCT00474539|13058900|P1|COMPLETED|Infant Series||213
5311414|NCT00474539|13058899|P2|Vaccinated Dose 3|Infant Series||221
5311415|NCT00474539|13058900|P1|Vaccinated Dose 3|Infant Series||214
5311416|NCT00474539|13058899|P2|Vaccinated Dose 2|Infant Series||222
5311417|NCT00474539|13058900|P1|Vaccinated Dose 2|Infant Series||217
5311418|NCT00474539|13058899|P2|Vaccinated Dose 1|Infant Series||226
5311419|NCT00474539|13058900|P1|Vaccinated Dose 1|Infant Series||218
5311420|NCT00474539|13058899|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
5311421|NCT00474539|13058900|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
5311422|NCT00474526|13058965|P17|NOT COMPLETED|Overall Study||9
5311423|NCT00474526|13058966|P16|NOT COMPLETED|Overall Study||18
5311424|NCT00474526|13058967|P15|NOT COMPLETED|Overall Study||77
5311425|NCT00474526|13058968|P14|NOT COMPLETED|Overall Study||156
5311426|NCT00474526|13058969|P13|NOT COMPLETED|Overall Study||15
5311427|NCT00474526|13058970|P12|NOT COMPLETED|Overall Study||11
5311428|NCT00474526|13058971|P11|NOT COMPLETED|Overall Study||10
5311429|NCT00474526|13058972|P10|NOT COMPLETED|Overall Study||27
5311430|NCT00474526|13058973|P9|NOT COMPLETED|Overall Study||6
5311431|NCT00474526|13058974|P8|NOT COMPLETED|Overall Study||6
5311432|NCT00474526|13058975|P7|NOT COMPLETED|Overall Study||25
5311433|NCT00474526|13058976|P6|NOT COMPLETED|Overall Study||16
5311434|NCT00474526|13058977|P5|NOT COMPLETED|Overall Study||68
5311435|NCT00474526|13058978|P4|NOT COMPLETED|Overall Study||119
5311436|NCT00474526|13058979|P3|NOT COMPLETED|Overall Study||49
5311437|NCT00474526|13058980|P2|NOT COMPLETED|Overall Study||46
5311438|NCT00474526|13058981|P1|NOT COMPLETED|Overall Study||33
5311439|NCT00474526|13058965|P17|COMPLETED|Overall Study||174
5311440|NCT00474526|13058966|P16|COMPLETED|Overall Study||152
5311441|NCT00474526|13058967|P15|COMPLETED|Overall Study||281
5311442|NCT00474526|13058968|P14|COMPLETED|Overall Study||1270
5311443|NCT00474526|13058969|P13|COMPLETED|Overall Study||135
5311444|NCT00474526|13058970|P12|COMPLETED|Overall Study||139
5311445|NCT00474526|13058971|P11|COMPLETED|Overall Study||141
5311446|NCT00474526|13058972|P10|COMPLETED|Overall Study||121
5311447|NCT00474526|13058973|P9|COMPLETED|Overall Study||144
5311448|NCT00474526|13058974|P8|COMPLETED|Overall Study||145
5311449|NCT00474526|13058975|P7|COMPLETED|Overall Study||178
5311450|NCT00474526|13058976|P6|COMPLETED|Overall Study||54
5311451|NCT00474526|13058977|P5|COMPLETED|Overall Study||8
5311452|NCT00474526|13058978|P4|COMPLETED|Overall Study||561
5311453|NCT00474526|13058979|P3|COMPLETED|Overall Study||110
5311454|NCT00474526|13058980|P2|COMPLETED|Overall Study||120
5311455|NCT00474526|13058981|P1|COMPLETED|Overall Study||121
5311456|NCT00474526|13058965|P17|STARTED|Overall Study||183
5311457|NCT00474526|13058966|P16|STARTED|Overall Study||170
5311458|NCT00474526|13058967|P15|STARTED|Overall Study||358
5311459|NCT00474526|13058968|P14|STARTED|Overall Study||1426
5311460|NCT00474526|13058969|P13|STARTED|Overall Study||150
5311461|NCT00474526|13058970|P12|STARTED|Overall Study||150
5311462|NCT00474526|13058971|P11|STARTED|Overall Study||151
5311463|NCT00474526|13058972|P10|STARTED|Overall Study||148
5311464|NCT00474526|13058973|P9|STARTED|Overall Study||150
5311465|NCT00474526|13058974|P8|STARTED|Overall Study||151
5311466|NCT00474526|13058975|P7|STARTED|Overall Study||203
5311467|NCT00474526|13058976|P6|STARTED|Overall Study||70
5311468|NCT00474526|13058977|P5|STARTED|Overall Study||76
5311469|NCT00474526|13058978|P4|STARTED|Overall Study||680
5311470|NCT00474526|13058979|P3|STARTED|Overall Study||159
5311471|NCT00474526|13058980|P2|STARTED|Overall Study||166
5311472|NCT00474526|13058981|P1|STARTED|Overall Study||154
5311473|NCT00474487|13059146|P4|NOT COMPLETED|Overall Study||0
5311474|NCT00474487|13059147|P3|NOT COMPLETED|Overall Study||14
5311475|NCT00474487|13059148|P2|NOT COMPLETED|Overall Study||2
5311476|NCT00474487|13059149|P1|NOT COMPLETED|Overall Study||30
5311477|NCT00474487|13059146|P4|COMPLETED|Overall Study||109
5311478|NCT00474487|13059147|P3|COMPLETED|Overall Study||885
5311479|NCT00474487|13059148|P2|COMPLETED|Overall Study||215
5311480|NCT00474487|13059149|P1|COMPLETED|Overall Study||1576
5311481|NCT00474487|13059146|P4|STARTED|Overall Study||109
5311482|NCT00474487|13059147|P3|STARTED|Overall Study||899
5311483|NCT00474487|13059148|P2|STARTED|Overall Study||217
5311484|NCT00474487|13059149|P1|STARTED|Overall Study||1606
5311485|NCT00474383|13059169|P2|NOT COMPLETED|Extension||5
5311486|NCT00474383|13059170|P1|NOT COMPLETED|Extension||0
5311487|NCT00474383|13059169|P2|COMPLETED|Extension||0
5311488|NCT00474383|13059170|P1|COMPLETED|Extension||0
5311489|NCT00474383|13059169|P2|STARTED|Extension||5
5311490|NCT00474383|13059170|P1|STARTED|Extension||0
5311491|NCT00474383|13059169|P2|NOT COMPLETED|Between Main Study and Extension||0
5311492|NCT00474383|13059170|P1|NOT COMPLETED|Between Main Study and Extension||6
5311493|NCT00474383|13059169|P2|COMPLETED|Between Main Study and Extension||0
5311494|NCT00474383|13059170|P1|COMPLETED|Between Main Study and Extension||5
5311495|NCT00474383|13059169|P2|STARTED|Between Main Study and Extension||0
5311496|NCT00474383|13059170|P1|STARTED|Between Main Study and Extension||11
5311497|NCT00474383|13059169|P2|NOT COMPLETED|Main Study||0
5311498|NCT00474383|13059170|P1|NOT COMPLETED|Main Study||36
5311499|NCT00474383|13059169|P2|COMPLETED|Main Study||0
5311500|NCT00474383|13059170|P1|COMPLETED|Main Study||11
5311501|NCT00474383|13059169|P2|STARTED|Main Study||0
5311502|NCT00474383|13059170|P1|STARTED|Main Study||47
5311503|NCT00474266|13059185|P4|NOT COMPLETED|Overall Study||7
5311504|NCT00474266|13059186|P3|NOT COMPLETED|Overall Study||4
5311505|NCT00474266|13059187|P2|NOT COMPLETED|Overall Study||20
5311506|NCT00474266|13059188|P1|NOT COMPLETED|Overall Study||7
5311507|NCT00474266|13059185|P4|COMPLETED|Overall Study||118
5311508|NCT00474266|13059186|P3|COMPLETED|Overall Study||122
5311509|NCT00474266|13059187|P2|COMPLETED|Overall Study||354
5311510|NCT00474266|13059188|P1|COMPLETED|Overall Study||368
5311511|NCT00474266|13059185|P4|STARTED|Overall Study||125
5311512|NCT00474266|13059186|P3|STARTED|Overall Study||126
5311513|NCT00474266|13059187|P2|STARTED|Overall Study||374
5311514|NCT00474266|13059188|P1|STARTED|Overall Study||375
5311515|NCT00474253|13059292|P2|NOT COMPLETED|Overall Study||4
5311516|NCT00474253|13059293|P1|NOT COMPLETED|Overall Study||3
5311517|NCT00474253|13059292|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
5311518|NCT00474253|13059293|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
5311519|NCT00474253|13059292|P2|Treated|Overall Study|Based on actual treatment received.|54
5311520|NCT00474253|13059293|P1|Treated|Overall Study|Based on actual treatment received.|56
5311521|NCT00474253|13059292|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
5311522|NCT00474253|13059293|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
5311523|NCT00474240|13059317|P6|NOT COMPLETED|Overall Study||18
5311524|NCT00474240|13059318|P5|NOT COMPLETED|Overall Study||8
5311525|NCT00474240|13059319|P4|NOT COMPLETED|Overall Study||16
5311526|NCT00474240|13059320|P3|NOT COMPLETED|Overall Study||9
5311527|NCT00474240|13059321|P2|NOT COMPLETED|Overall Study||1
5311528|NCT00474240|13059322|P1|NOT COMPLETED|Overall Study||1
5311529|NCT00474240|13059317|P6|COMPLETED|Overall Study||8
5311530|NCT00474240|13059318|P5|COMPLETED|Overall Study||18
5311531|NCT00474240|13059319|P4|COMPLETED|Overall Study||10
5311532|NCT00474240|13059320|P3|COMPLETED|Overall Study||17
5311533|NCT00474240|13059321|P2|COMPLETED|Overall Study||25
5311534|NCT00474240|13059322|P1|COMPLETED|Overall Study||26
5311535|NCT00474240|13059317|P6|STARTED|Overall Study||26
5311536|NCT00474240|13059318|P5|STARTED|Overall Study||26
5311537|NCT00474240|13059319|P4|STARTED|Overall Study||26
5311538|NCT00474240|13059320|P3|STARTED|Overall Study||26
5311539|NCT00474240|13059321|P2|STARTED|Overall Study||26
5311540|NCT00474240|13059322|P1|STARTED|Overall Study||27
5311541|NCT00474201|13059342|P1|NOT COMPLETED|Overall Study||0
5311542|NCT00474201|13059342|P1|COMPLETED|Overall Study||15
5311543|NCT00474201|13059342|P1|STARTED|Overall Study||15
5311544|NCT00474188|13059347|P1|NOT COMPLETED|Overall Study||6
5311545|NCT00474188|13059347|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
5311546|NCT00474188|13059347|P1|STARTED|Overall Study||26
5311547|NCT00474175|13059357|P3|NOT COMPLETED|Overall Study||4
5311548|NCT00474175|13059358|P2|NOT COMPLETED|Overall Study||7
5311549|NCT00474175|13059359|P1|NOT COMPLETED|Overall Study||1
5311550|NCT00474175|13059357|P3|COMPLETED|Overall Study||225
5311551|NCT00474175|13059358|P2|COMPLETED|Overall Study||226
5311552|NCT00474175|13059359|P1|COMPLETED|Overall Study||114
5311553|NCT00474175|13059357|P3|Treated|Overall Study||228
5311554|NCT00474175|13059358|P2|Treated|Overall Study||233
5311555|NCT00474175|13059359|P1|Treated|Overall Study||115
5311556|NCT00474175|13059357|P3|STARTED|Overall Study||229
5311557|NCT00474175|13059358|P2|STARTED|Overall Study||233
5311558|NCT00474175|13059359|P1|STARTED|Overall Study||115
5311559|NCT00474123|13059396|P2|NOT COMPLETED|Overall Study||0
5311560|NCT00474123|13059397|P1|NOT COMPLETED|Overall Study||0
5311561|NCT00474123|13059396|P2|COMPLETED|Overall Study||40
5311562|NCT00474123|13059397|P1|COMPLETED|Overall Study||38
5311563|NCT00474123|13059396|P2|STARTED|Overall Study||40
5311564|NCT00474123|13059397|P1|STARTED|Overall Study||38
5311565|NCT00474058|13059423|P2|NOT COMPLETED|Overall Study||17
5311566|NCT00474058|13059424|P1|NOT COMPLETED|Overall Study||24
5311567|NCT00474058|13059423|P2|COMPLETED|Overall Study||80
5311568|NCT00474058|13059424|P1|COMPLETED|Overall Study||166
5311569|NCT00474058|13059423|P2|STARTED|Overall Study||97
5311570|NCT00474058|13059424|P1|STARTED|Overall Study||190
5311571|NCT00474045|13059438|P2|NOT COMPLETED|Overall Study||101
5311572|NCT00474045|13059439|P1|NOT COMPLETED|Overall Study||106
5311573|NCT00474045|13059438|P2|COMPLETED|Overall Study||136
5311574|NCT00474045|13059439|P1|COMPLETED|Overall Study||127
5311575|NCT00474045|13059438|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
5311576|NCT00474045|13059439|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
5311577|NCT00474045|13059438|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
5311578|NCT00474045|13059439|P1|Exposed-Pregnant Subjects|Overall Study||152
5311579|NCT00474045|13059438|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
5311580|NCT00474045|13059439|P1|Exposed-All Subjects|Overall Study||233
5311581|NCT00474045|13059438|P2|STARTED|Overall Study||237
5311582|NCT00474045|13059439|P1|STARTED|Overall Study||233
5311583|NCT00473889|13059539|P2|NOT COMPLETED|Overall Study||64
5311584|NCT00473889|13059540|P1|NOT COMPLETED|Overall Study||83
5311585|NCT00473889|13059539|P2|COMPLETED|Overall Study||63
5311586|NCT00473889|13059540|P1|COMPLETED|Overall Study||43
5311587|NCT00473889|13059539|P2|STARTED|Overall Study||127
5311588|NCT00473889|13059540|P1|STARTED|Overall Study||126
5311589|NCT00473876|13059552|P2|NOT COMPLETED|Overall Study||1
5311590|NCT00473876|13059553|P1|NOT COMPLETED|Overall Study||3
5311591|NCT00473876|13059552|P2|COMPLETED|Overall Study||22
5311592|NCT00473876|13059553|P1|COMPLETED|Overall Study||36
5311593|NCT00473876|13059552|P2|STARTED|Overall Study||23
5311594|NCT00473876|13059553|P1|STARTED|Overall Study||39
5311595|NCT00473837|13059563|P2|NOT COMPLETED|Overall Study||3
5311596|NCT00473837|13059564|P1|NOT COMPLETED|Overall Study||1
5311597|NCT00473837|13059563|P2|COMPLETED|Overall Study||43
5311598|NCT00473837|13059564|P1|COMPLETED|Overall Study||49
5311599|NCT00473837|13059563|P2|STARTED|Overall Study||46
5311600|NCT00473837|13059564|P1|STARTED|Overall Study||50
5311601|NCT00473824|13059572|P2|NOT COMPLETED|Overall Study||0
5311602|NCT00473824|13059573|P1|NOT COMPLETED|Overall Study||5
5311603|NCT00473824|13059572|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
5311604|NCT00473824|13059573|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
5311605|NCT00473824|13059572|P2|STARTED|Overall Study||2
5311606|NCT00473824|13059573|P1|STARTED|Overall Study||5
5311607|NCT00473746|13059584|P5|NOT COMPLETED|Period 2 (Phase 2)||27
5311608|NCT00473746|13059585|P4|NOT COMPLETED|Period 2 (Phase 2)||0
5311609|NCT00473746|13059586|P3|NOT COMPLETED|Period 2 (Phase 2)||0
5311610|NCT00473746|13059587|P2|NOT COMPLETED|Period 2 (Phase 2)||0
5311611|NCT00473746|13059588|P1|NOT COMPLETED|Period 2 (Phase 2)||0
5311612|NCT00473746|13059584|P5|COMPLETED|Period 2 (Phase 2)||6
5311613|NCT00473746|13059585|P4|COMPLETED|Period 2 (Phase 2)||0
5311614|NCT00473746|13059586|P3|COMPLETED|Period 2 (Phase 2)||0
5311615|NCT00473746|13059587|P2|COMPLETED|Period 2 (Phase 2)||0
5311616|NCT00473746|13059588|P1|COMPLETED|Period 2 (Phase 2)||0
5311617|NCT00473746|13059584|P5|STARTED|Period 2 (Phase 2)||33
5311618|NCT00473746|13059585|P4|STARTED|Period 2 (Phase 2)||0
5311619|NCT00473746|13059586|P3|STARTED|Period 2 (Phase 2)||0
5311620|NCT00473746|13059587|P2|STARTED|Period 2 (Phase 2)||0
5311621|NCT00473746|13059588|P1|STARTED|Period 2 (Phase 2)||0
5311622|NCT00473746|13059584|P5|NOT COMPLETED|Period 1 (Phase 1)||0
5311623|NCT00473746|13059585|P4|NOT COMPLETED|Period 1 (Phase 1)||10
5311624|NCT00473746|13059586|P3|NOT COMPLETED|Period 1 (Phase 1)||6
5311625|NCT00473746|13059587|P2|NOT COMPLETED|Period 1 (Phase 1)||9
5311626|NCT00473746|13059588|P1|NOT COMPLETED|Period 1 (Phase 1)||6
5311627|NCT00473746|13059584|P5|COMPLETED|Period 1 (Phase 1)||0
5311628|NCT00473746|13059585|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
5311629|NCT00473746|13059586|P3|COMPLETED|Period 1 (Phase 1)||0
5311630|NCT00473746|13059587|P2|COMPLETED|Period 1 (Phase 1)||0
5311631|NCT00473746|13059588|P1|COMPLETED|Period 1 (Phase 1)||0
5311632|NCT00473746|13059584|P5|STARTED|Period 1 (Phase 1)||0
5311633|NCT00473746|13059585|P4|STARTED|Period 1 (Phase 1)||12
5311634|NCT00473746|13059586|P3|STARTED|Period 1 (Phase 1)||6
5311635|NCT00473746|13059587|P2|STARTED|Period 1 (Phase 1)||9
5311636|NCT00473746|13059588|P1|STARTED|Period 1 (Phase 1)||6
5311637|NCT00473694|13059637|P4|NOT COMPLETED|Overall Study||7
5311638|NCT00473694|13059638|P3|NOT COMPLETED|Overall Study||5
5311639|NCT00473694|13059639|P2|NOT COMPLETED|Overall Study||4
5311640|NCT00473694|13059640|P1|NOT COMPLETED|Overall Study||11
5311641|NCT00473694|13059637|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
5311642|NCT00473694|13059638|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
5311643|NCT00473694|13059639|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
5311644|NCT00473694|13059640|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
5311645|NCT00473694|13059637|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
5311646|NCT00473694|13059638|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
5311647|NCT00473694|13059639|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
5311648|NCT00473694|13059640|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
5311649|NCT00473694|13059637|P4|STARTED|Overall Study||42
5311650|NCT00473694|13059638|P3|STARTED|Overall Study||51
5311651|NCT00473694|13059639|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
5311652|NCT00473694|13059640|P1|STARTED|Overall Study||48
5311653|NCT00473668|13059681|P3|NOT COMPLETED|Overall Study||10
5311654|NCT00473668|13059682|P2|NOT COMPLETED|Overall Study||11
5311655|NCT00473668|13059683|P1|NOT COMPLETED|Overall Study||5
5311656|NCT00473668|13059681|P3|COMPLETED|Overall Study||89
5311657|NCT00473668|13059682|P2|COMPLETED|Overall Study||89
5311658|NCT00473668|13059683|P1|COMPLETED|Overall Study||95
5311659|NCT00473668|13059681|P3|STARTED|Overall Study||99
5311660|NCT00473668|13059682|P2|STARTED|Overall Study||100
5311661|NCT00473668|13059683|P1|STARTED|Overall Study||100
5311662|NCT00473655|13059736|P3|NOT COMPLETED|Overall Study||8
5311663|NCT00473655|13059737|P2|NOT COMPLETED|Overall Study||5
5311664|NCT00473655|13059738|P1|NOT COMPLETED|Overall Study||9
5311665|NCT00473655|13059736|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
5311666|NCT00473655|13059737|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
5311667|NCT00473655|13059738|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
5311668|NCT00473655|13059736|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
5311669|NCT00473655|13059737|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
5311670|NCT00473655|13059738|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
5311671|NCT00473642|13059773|P3|NOT COMPLETED|Overall Study||2
5311672|NCT00473642|13059774|P2|NOT COMPLETED|Overall Study||1
5311673|NCT00473642|13059775|P1|NOT COMPLETED|Overall Study||2
5311674|NCT00473642|13059773|P3|COMPLETED|Overall Study||8
5311675|NCT00473642|13059774|P2|COMPLETED|Overall Study||10
5311676|NCT00473642|13059775|P1|COMPLETED|Overall Study||8
5311677|NCT00473642|13059773|P3|STARTED|Overall Study||10
5311678|NCT00473642|13059774|P2|STARTED|Overall Study||11
5311679|NCT00473642|13059775|P1|STARTED|Overall Study||10
5311680|NCT00473590|13059785|P2|NOT COMPLETED|Overall Study||38
5311681|NCT00473590|13059786|P1|NOT COMPLETED|Overall Study||45
5311682|NCT00473590|13059785|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
5311683|NCT00473590|13059786|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
5311684|NCT00473590|13059785|P2|Safety Population|Overall Study||50
5311685|NCT00473590|13059786|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
5311686|NCT00473590|13059785|P2|Treated|Overall Study||48
5311687|NCT00473590|13059786|P1|Treated|Overall Study||52
5311688|NCT00473590|13059785|P2|STARTED|Overall Study||49
5311689|NCT00473590|13059786|P1|STARTED|Overall Study||53
5311690|NCT00473564|13059802|P1|NOT COMPLETED|Overall Study||23
5311691|NCT00473564|13059802|P1|COMPLETED|Overall Study||147
5311692|NCT00473564|13059802|P1|STARTED|Overall Study||170
5311693|NCT00473512|13059812|P5|NOT COMPLETED|Period 2 (Phase 2)||2
5311694|NCT00473512|13059813|P4|NOT COMPLETED|Period 2 (Phase 2)||23
5311695|NCT00473512|13059814|P3|NOT COMPLETED|Period 2 (Phase 2)||2
5311696|NCT00473512|13059815|P2|NOT COMPLETED|Period 2 (Phase 2)||2
5311697|NCT00473512|13059816|P1|NOT COMPLETED|Period 2 (Phase 2)||1
5311698|NCT00473512|13059812|P5|COMPLETED|Period 2 (Phase 2)||0
5311699|NCT00473512|13059813|P4|COMPLETED|Period 2 (Phase 2)||0
5311700|NCT00473512|13059814|P3|COMPLETED|Period 2 (Phase 2)||0
5311701|NCT00473512|13059815|P2|COMPLETED|Period 2 (Phase 2)||0
5311702|NCT00473512|13059816|P1|COMPLETED|Period 2 (Phase 2)||0
5311703|NCT00473512|13059812|P5|STARTED|Period 2 (Phase 2)||2
5311704|NCT00473512|13059813|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
5311705|NCT00473512|13059814|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
5311706|NCT00473512|13059815|P2|STARTED|Period 2 (Phase 2)||2
5311707|NCT00473512|13059816|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
5311708|NCT00473512|13059812|P5|NOT COMPLETED|Period 1 (Phase 1)||1
5311709|NCT00473512|13059813|P4|NOT COMPLETED|Period 1 (Phase 1)||17
5311710|NCT00473512|13059814|P3|NOT COMPLETED|Period 1 (Phase 1)||0
5311711|NCT00473512|13059815|P2|NOT COMPLETED|Period 1 (Phase 1)||1
5311712|NCT00473512|13059816|P1|NOT COMPLETED|Period 1 (Phase 1)||1
5311713|NCT00473512|13059812|P5|COMPLETED|Period 1 (Phase 1)||2
5311714|NCT00473512|13059813|P4|COMPLETED|Period 1 (Phase 1)||25
5311715|NCT00473512|13059814|P3|COMPLETED|Period 1 (Phase 1)||3
5311716|NCT00473512|13059815|P2|COMPLETED|Period 1 (Phase 1)||2
5311717|NCT00473512|13059816|P1|COMPLETED|Period 1 (Phase 1)||2
5311718|NCT00473512|13059812|P5|STARTED|Period 1 (Phase 1)||3
5311719|NCT00473512|13059813|P4|STARTED|Period 1 (Phase 1)||42
5311720|NCT00473512|13059814|P3|STARTED|Period 1 (Phase 1)||3
5311721|NCT00473512|13059815|P2|STARTED|Period 1 (Phase 1)||3
5311722|NCT00473512|13059816|P1|STARTED|Period 1 (Phase 1)||3
5311723|NCT00473434|13059874|P1|NOT COMPLETED|Overall Study||32
5311724|NCT00473434|13059874|P1|COMPLETED|Overall Study||32
5311725|NCT00473434|13059874|P1|STARTED|Overall Study||64
5311726|NCT00473382|13059939|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
5311727|NCT00473382|13059940|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
5311728|NCT00473382|13059941|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
5311729|NCT00473382|13059939|P3|COMPLETED|Open-label Extension Through Month 60||2
5311730|NCT00473382|13059940|P2|COMPLETED|Open-label Extension Through Month 60||1
5311731|NCT00473382|13059941|P1|COMPLETED|Open-label Extension Through Month 60||2
5311732|NCT00473382|13059939|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
5311733|NCT00473382|13059940|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
5311734|NCT00473382|13059941|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
5311735|NCT00473382|13059939|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
5311736|NCT00473382|13059940|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
5311737|NCT00473382|13059941|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
5311738|NCT00473382|13059939|P3|COMPLETED|Open-label Extension Through Month 48||37
5311739|NCT00473382|13059940|P2|COMPLETED|Open-label Extension Through Month 48||42
5311740|NCT00473382|13059941|P1|COMPLETED|Open-label Extension Through Month 48||38
5311741|NCT00473382|13059939|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
5311742|NCT00473382|13059940|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
5311743|NCT00473382|13059941|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
5311744|NCT00473382|13059939|P3|NOT COMPLETED|Core Study||29
5311745|NCT00473382|13059940|P2|NOT COMPLETED|Core Study||27
5311746|NCT00473382|13059941|P1|NOT COMPLETED|Core Study||28
5311747|NCT00473382|13059939|P3|COMPLETED|Core Study||98
5311748|NCT00473382|13059940|P2|COMPLETED|Core Study||98
5311749|NCT00473382|13059941|P1|COMPLETED|Core Study||102
5311750|NCT00473382|13059939|P3|STARTED|Core Study||127
5311751|NCT00473382|13059940|P2|STARTED|Core Study||125
5311752|NCT00473382|13059941|P1|STARTED|Core Study||130
5311753|NCT00473330|13059999|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
5311754|NCT00473330|13060000|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
5311755|NCT00473330|13060001|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
5311756|NCT00473330|13059999|P3|COMPLETED|Open-label Extension Through Month 60||0
5311757|NCT00473330|13060000|P2|COMPLETED|Open-label Extension Through Month 60||1
5311758|NCT00473330|13060001|P1|COMPLETED|Open-label Extension Through Month 60||1
5311759|NCT00473330|13059999|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
5311760|NCT00473330|13060000|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
5311761|NCT00473330|13060001|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
5311762|NCT00473330|13059999|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
5311763|NCT00473330|13060000|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
5311764|NCT00473330|13060001|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
5311765|NCT00473330|13059999|P3|COMPLETED|Open-label Extension Through Month 48||50
5311766|NCT00473330|13060000|P2|COMPLETED|Open-label Extension Through Month 48||59
5311767|NCT00473330|13060001|P1|COMPLETED|Open-label Extension Through Month 48||63
5311768|NCT00473330|13059999|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
5311769|NCT00473330|13060000|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
5311943|NCT00471380|13060456|P2|NOT COMPLETED|Second Intervention||4
5311770|NCT00473330|13060001|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
5311771|NCT00473330|13059999|P3|NOT COMPLETED|Core Study||41
5311772|NCT00473330|13060000|P2|NOT COMPLETED|Core Study||25
5311773|NCT00473330|13060001|P1|NOT COMPLETED|Core Study||27
5311774|NCT00473330|13059999|P3|COMPLETED|Core Study||86
5311775|NCT00473330|13060000|P2|COMPLETED|Core Study||100
5311776|NCT00473330|13060001|P1|COMPLETED|Core Study||98
5311777|NCT00473330|13059999|P3|STARTED|Core Study||127
5311778|NCT00473330|13060000|P2|STARTED|Core Study||125
5311779|NCT00473330|13060001|P1|STARTED|Core Study||125
5311780|NCT00473265|13060056|P1|NOT COMPLETED|Overall Study||20
5311781|NCT00473265|13060056|P1|COMPLETED|Overall Study||48
5311782|NCT00473265|13060056|P1|STARTED|Overall Study||68
5311783|NCT00473083|13060068|P3|NOT COMPLETED|Overall Study||0
5311784|NCT00473083|13060069|P2|NOT COMPLETED|Overall Study||0
5311785|NCT00473083|13060070|P1|NOT COMPLETED|Overall Study||1
5311786|NCT00473083|13060068|P3|COMPLETED|Overall Study||50
5311787|NCT00473083|13060069|P2|COMPLETED|Overall Study||50
5311788|NCT00473083|13060070|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
5311789|NCT00473083|13060068|P3|STARTED|Overall Study||50
5311790|NCT00473083|13060069|P2|STARTED|Overall Study||50
5311791|NCT00473083|13060070|P1|STARTED|Overall Study||50
5311792|NCT00472849|13060098|P2|NOT COMPLETED|Overall Study||0
5311793|NCT00472849|13060099|P1|NOT COMPLETED|Overall Study||0
5311794|NCT00472849|13060098|P2|COMPLETED|Overall Study||78
5311795|NCT00472849|13060099|P1|COMPLETED|Overall Study||12
5311796|NCT00472849|13060098|P2|STARTED|Overall Study||78
5311797|NCT00472849|13060099|P1|STARTED|Overall Study||12
5311798|NCT00472797|13060107|P2|NOT COMPLETED|Overall Study||1
5311799|NCT00472797|13060108|P1|NOT COMPLETED|Overall Study||4
5311800|NCT00472797|13060107|P2|COMPLETED|Overall Study||112
5311801|NCT00472797|13060108|P1|COMPLETED|Overall Study||115
5311802|NCT00472797|13060107|P2|STARTED|Overall Study||113
5311803|NCT00472797|13060108|P1|STARTED|Overall Study||119
5311804|NCT00472732|13060134|P2|NOT COMPLETED|Overall Study||0
5311805|NCT00472732|13060135|P1|NOT COMPLETED|Overall Study||0
5311806|NCT00472732|13060134|P2|COMPLETED|Overall Study||22
5311807|NCT00472732|13060135|P1|COMPLETED|Overall Study||24
5311808|NCT00472732|13060134|P2|STARTED|Overall Study||22
5311809|NCT00472732|13060135|P1|STARTED|Overall Study||24
5311810|NCT00472641|13060145|P1|NOT COMPLETED|Overall Study||7
5311811|NCT00472641|13060145|P1|COMPLETED|Overall Study||18
5311812|NCT00472641|13060145|P1|STARTED|Overall Study||25
5311813|NCT00472576|13060152|P2|NOT COMPLETED|Second Intervention||0
5311814|NCT00472576|13060153|P1|NOT COMPLETED|Second Intervention||0
5311815|NCT00472576|13060152|P2|COMPLETED|Second Intervention||3
5311816|NCT00472576|13060153|P1|COMPLETED|Second Intervention||2
5311817|NCT00472576|13060152|P2|STARTED|Second Intervention||3
5311818|NCT00472576|13060153|P1|STARTED|Second Intervention||2
5311819|NCT00472576|13060152|P2|NOT COMPLETED|First Intervention||0
5311820|NCT00472576|13060153|P1|NOT COMPLETED|First Intervention||0
5311821|NCT00472576|13060152|P2|COMPLETED|First Intervention||3
5311822|NCT00472576|13060153|P1|COMPLETED|First Intervention||2
5311823|NCT00472576|13060152|P2|STARTED|First Intervention||3
5311824|NCT00472576|13060153|P1|STARTED|First Intervention||2
5311825|NCT00472446|13060165|P4|NOT COMPLETED|Overall Study||6
5311826|NCT00472446|13060166|P3|NOT COMPLETED|Overall Study||7
5311827|NCT00472446|13060167|P2|NOT COMPLETED|Overall Study||6
5311828|NCT00472446|13060168|P1|NOT COMPLETED|Overall Study||5
5311829|NCT00472446|13060165|P4|COMPLETED|Overall Study||39
5311830|NCT00472446|13060166|P3|COMPLETED|Overall Study||38
5311831|NCT00472446|13060167|P2|COMPLETED|Overall Study||41
5311832|NCT00472446|13060168|P1|COMPLETED|Overall Study||41
5311833|NCT00472446|13060165|P4|STARTED|Overall Study||45
5311834|NCT00472446|13060166|P3|STARTED|Overall Study||45
5311835|NCT00472446|13060167|P2|STARTED|Overall Study||47
5311836|NCT00472446|13060168|P1|STARTED|Overall Study||46
5311837|NCT00472420|13060198|P1|NOT COMPLETED|Follow-up Period||17
5311838|NCT00472420|13060198|P1|COMPLETED|Follow-up Period||15
5311839|NCT00472420|13060198|P1|STARTED|Follow-up Period||32
5311840|NCT00472420|13060198|P1|NOT COMPLETED|Induction Treatment Period||16
5311841|NCT00472420|13060198|P1|COMPLETED|Induction Treatment Period||32
5311842|NCT00472420|13060198|P1|STARTED|Induction Treatment Period||48
5311843|NCT00472303|13060206|P3|NOT COMPLETED|Maintenance Phase||17
5311844|NCT00472303|13060207|P2|NOT COMPLETED|Maintenance Phase||16
5311845|NCT00472303|13060208|P1|NOT COMPLETED|Maintenance Phase||17
5311846|NCT00472303|13060206|P3|COMPLETED|Maintenance Phase||95
5311847|NCT00472303|13060207|P2|COMPLETED|Maintenance Phase||93
5311848|NCT00472303|13060208|P1|COMPLETED|Maintenance Phase||89
5311849|NCT00472303|13060206|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
5311850|NCT00472303|13060207|P2|STARTED|Maintenance Phase||109
5311851|NCT00472303|13060208|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
5311852|NCT00472303|13060206|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
5311853|NCT00472303|13060207|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
5311854|NCT00472303|13060208|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
5311855|NCT00472303|13060206|P3|COMPLETED|Discontinuations After Titration Phase||0
5311856|NCT00472303|13060207|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
5311944|NCT00471380|13060457|P1|NOT COMPLETED|Second Intervention||0
5311857|NCT00472303|13060208|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
5311858|NCT00472303|13060206|P3|STARTED|Discontinuations After Titration Phase||0
5311859|NCT00472303|13060207|P2|STARTED|Discontinuations After Titration Phase||129
5311860|NCT00472303|13060208|P1|STARTED|Discontinuations After Titration Phase||279
5311861|NCT00472303|13060206|P3|NOT COMPLETED|Titration Phase||0
5311862|NCT00472303|13060207|P2|NOT COMPLETED|Titration Phase||29
5311863|NCT00472303|13060208|P1|NOT COMPLETED|Titration Phase||59
5311864|NCT00472303|13060206|P3|COMPLETED|Titration Phase||0
5311865|NCT00472303|13060207|P2|COMPLETED|Titration Phase||129
5311866|NCT00472303|13060208|P1|COMPLETED|Titration Phase||279
5311867|NCT00472303|13060206|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
5311868|NCT00472303|13060207|P2|STARTED|Titration Phase||158
5311869|NCT00472303|13060208|P1|STARTED|Titration Phase||338
5311870|NCT00472290|13060271|P1|NOT COMPLETED|Overall Study||72
5311871|NCT00472290|13060271|P1|COMPLETED|Overall Study||0
5311872|NCT00472290|13060271|P1|STARTED|Overall Study||72
5311873|NCT00472199|13060283|P2|NOT COMPLETED|Overall Study||60
5311874|NCT00472199|13060284|P1|NOT COMPLETED|Overall Study||35
5311875|NCT00472199|13060283|P2|COMPLETED|Overall Study||103
5311876|NCT00472199|13060284|P1|COMPLETED|Overall Study||131
5311877|NCT00472199|13060283|P2|STARTED|Overall Study||163
5311878|NCT00472199|13060284|P1|STARTED|Overall Study||166
5311879|NCT00472082|13060350|P1|NOT COMPLETED|Overall Study||5
5311880|NCT00472082|13060350|P1|COMPLETED|Overall Study||0
5311881|NCT00472082|13060350|P1|STARTED|Overall Study||5
5311882|NCT00472056|13060359|P4|NOT COMPLETED|Overall Study||0
5311883|NCT00472056|13060360|P3|NOT COMPLETED|Overall Study||0
5311884|NCT00472056|13060361|P2|NOT COMPLETED|Overall Study||0
5311885|NCT00472056|13060362|P1|NOT COMPLETED|Overall Study||0
5311886|NCT00472056|13060359|P4|COMPLETED|Overall Study||17
5311887|NCT00472056|13060360|P3|COMPLETED|Overall Study||32
5311888|NCT00472056|13060361|P2|COMPLETED|Overall Study||19
5311889|NCT00472056|13060362|P1|COMPLETED|Overall Study||25
5311890|NCT00472056|13060359|P4|STARTED|Overall Study||17
5311891|NCT00472056|13060360|P3|STARTED|Overall Study||32
5311892|NCT00472056|13060361|P2|STARTED|Overall Study||19
5311893|NCT00472056|13060362|P1|STARTED|Overall Study||25
5311894|NCT00472030|13060372|P2|NOT COMPLETED|Overall Study||0
5311895|NCT00472030|13060373|P1|NOT COMPLETED|Overall Study||1
5311896|NCT00472030|13060372|P2|COMPLETED|Overall Study||0
5311897|NCT00472030|13060373|P1|COMPLETED|Overall Study||1
5311898|NCT00472030|13060372|P2|STARTED|Overall Study||0
5311899|NCT00472030|13060373|P1|STARTED|Overall Study||2
5311900|NCT00471822|13060389|P1|NOT COMPLETED|Overall Study||2
5311901|NCT00471822|13060389|P1|COMPLETED|Overall Study||9705
5311902|NCT00471822|13060389|P1|Treated|Overall Study||9705
5311903|NCT00471822|13060389|P1|STARTED|Overall Study||9707
5311904|NCT00471718|13060397|P1|NOT COMPLETED|Overall Study||27
5311905|NCT00471718|13060397|P1|COMPLETED|Overall Study||0
5311906|NCT00471718|13060397|P1|STARTED|Overall Study||27
5311907|NCT00471705|13060409|P3|NOT COMPLETED|Overall Study||15
5311908|NCT00471705|13060410|P2|NOT COMPLETED|Overall Study||22
5311909|NCT00471705|13060411|P1|NOT COMPLETED|Overall Study||24
5311910|NCT00471705|13060409|P3|COMPLETED|Overall Study||134
5311911|NCT00471705|13060410|P2|COMPLETED|Overall Study||121
5311912|NCT00471705|13060411|P1|COMPLETED|Overall Study||121
5311913|NCT00471705|13060409|P3|STARTED|Overall Study||149
5311914|NCT00471705|13060410|P2|STARTED|Overall Study||143
5311915|NCT00471705|13060411|P1|STARTED|Overall Study||145
5311916|NCT00471536|13060425|P1|NOT COMPLETED|Overall Study||1
5311917|NCT00471536|13060425|P1|COMPLETED|Overall Study||18
5311918|NCT00471536|13060425|P1|STARTED|Overall Study||19
5311919|NCT00471497|13060437|P3|NOT COMPLETED|Overall Study||40
5311920|NCT00471497|13060438|P2|NOT COMPLETED|Overall Study||35
5311921|NCT00471497|13060439|P1|NOT COMPLETED|Overall Study||46
5311922|NCT00471497|13060437|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
5311923|NCT00471497|13060438|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
5311924|NCT00471497|13060439|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
5311925|NCT00471497|13060437|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
5311926|NCT00471497|13060438|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
5311927|NCT00471497|13060439|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
5311928|NCT00471497|13060437|P3|STARTED|Overall Study||281
5311929|NCT00471497|13060438|P2|STARTED|Overall Study||282
5311930|NCT00471497|13060439|P1|STARTED|Overall Study||283
5311931|NCT00471445|13060449|P2|NOT COMPLETED|Overall Study||2
5311932|NCT00471445|13060450|P1|NOT COMPLETED|Overall Study||2
5311933|NCT00471445|13060449|P2|COMPLETED|Overall Study||231
5311934|NCT00471445|13060450|P1|COMPLETED|Overall Study||227
5311935|NCT00471445|13060449|P2|STARTED|Overall Study||233
5311936|NCT00471445|13060450|P1|STARTED|Overall Study||229
5311937|NCT00471380|13060456|P2|NOT COMPLETED|Third Intervention||2
5311938|NCT00471380|13060457|P1|NOT COMPLETED|Third Intervention||1
5311939|NCT00471380|13060456|P2|COMPLETED|Third Intervention||14
5311940|NCT00471380|13060457|P1|COMPLETED|Third Intervention||17
5311941|NCT00471380|13060456|P2|STARTED|Third Intervention||16
5311942|NCT00471380|13060457|P1|STARTED|Third Intervention||18
5311945|NCT00471380|13060456|P2|COMPLETED|Second Intervention||16
5311946|NCT00471380|13060457|P1|COMPLETED|Second Intervention||18
5311947|NCT00471380|13060456|P2|STARTED|Second Intervention||20
5311948|NCT00471380|13060457|P1|STARTED|Second Intervention||18
5311949|NCT00471380|13060456|P2|NOT COMPLETED|First Intervention||4
5311950|NCT00471380|13060457|P1|NOT COMPLETED|First Intervention||4
5311951|NCT00471380|13060456|P2|COMPLETED|First Intervention||20
5311952|NCT00471380|13060457|P1|COMPLETED|First Intervention||18
5311953|NCT00471380|13060456|P2|STARTED|First Intervention||24
5311954|NCT00471380|13060457|P1|STARTED|First Intervention||22
5311955|NCT00471354|13060463|P1|NOT COMPLETED|Overall Study||52
5311956|NCT00471354|13060463|P1|COMPLETED|Overall Study||176
5311957|NCT00471354|13060463|P1|STARTED|Overall Study||228
5311958|NCT00471328|13060475|P2|NOT COMPLETED|Extension Phase||67
5311959|NCT00471328|13060476|P1|NOT COMPLETED|Extension Phase||41
5311960|NCT00471328|13060475|P2|COMPLETED|Extension Phase||0
5311961|NCT00471328|13060476|P1|COMPLETED|Extension Phase||0
5311962|NCT00471328|13060475|P2|Started:CrossOver During Extension|Extension Phase||10
5311963|NCT00471328|13060476|P1|Started:CrossOver During Extension|Extension Phase||0
5311964|NCT00471328|13060475|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
5311965|NCT00471328|13060476|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
5311966|NCT00471328|13060475|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
5311967|NCT00471328|13060476|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
5311968|NCT00471328|13060475|P2|STARTED|Extension Phase||67
5311969|NCT00471328|13060476|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
5311970|NCT00471328|13060475|P2|NOT COMPLETED|Core Phase||67
5311971|NCT00471328|13060476|P1|NOT COMPLETED|Core Phase||107
5311972|NCT00471328|13060475|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
5311973|NCT00471328|13060476|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
5311974|NCT00471328|13060475|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
5311975|NCT00471328|13060476|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
5311976|NCT00471328|13060475|P2|STARTED|Core Phase||83
5311977|NCT00471328|13060476|P1|STARTED|Core Phase||165
5311978|NCT00471315|13060495|P1|NOT COMPLETED|Overall Study||8
5311979|NCT00471315|13060495|P1|COMPLETED|Overall Study||10
5311980|NCT00471315|13060495|P1|STARTED|Overall Study||18
5311981|NCT00471276|13060500|P1|NOT COMPLETED|Overall Study||83
5311982|NCT00471276|13060500|P1|COMPLETED|Overall Study||0
5311983|NCT00471276|13060500|P1|STARTED|Overall Study||83
5311984|NCT00471237|13060530|P7|NOT COMPLETED|Overall Study||3
5311985|NCT00471237|13060531|P6|NOT COMPLETED|Overall Study||39
5311986|NCT00471237|13060532|P5|NOT COMPLETED|Overall Study||41
5311987|NCT00471237|13060533|P4|NOT COMPLETED|Overall Study||45
5311988|NCT00471237|13060534|P3|NOT COMPLETED|Overall Study||34
5311989|NCT00471237|13060535|P2|NOT COMPLETED|Overall Study||42
5311990|NCT00471237|13060536|P1|NOT COMPLETED|Overall Study||41
5311991|NCT00471237|13060530|P7|COMPLETED|Overall Study||38
5311992|NCT00471237|13060531|P6|COMPLETED|Overall Study||50
5311993|NCT00471237|13060532|P5|COMPLETED|Overall Study||46
5311994|NCT00471237|13060533|P4|COMPLETED|Overall Study||43
5311995|NCT00471237|13060534|P3|COMPLETED|Overall Study||48
5311996|NCT00471237|13060535|P2|COMPLETED|Overall Study||45
5311997|NCT00471237|13060536|P1|COMPLETED|Overall Study||49
5311998|NCT00471237|13060530|P7|STARTED|Overall Study||41
5311999|NCT00471237|13060531|P6|STARTED|Overall Study||89
5312000|NCT00471237|13060532|P5|STARTED|Overall Study||87
5312001|NCT00471237|13060533|P4|STARTED|Overall Study||88
5312002|NCT00471237|13060534|P3|STARTED|Overall Study||82
5312003|NCT00471237|13060535|P2|STARTED|Overall Study||87
5312004|NCT00471237|13060536|P1|STARTED|Overall Study||90
5312005|NCT00471146|13060686|P2|NOT COMPLETED|Overall Study||174
5312006|NCT00471146|13060687|P1|NOT COMPLETED|Overall Study||172
5312007|NCT00471146|13060686|P2|COMPLETED|Overall Study||142
5312008|NCT00471146|13060687|P1|COMPLETED|Overall Study||142
5312009|NCT00471146|13060686|P2|Treated|Overall Study||308
5312010|NCT00471146|13060687|P1|Treated|Overall Study||305
5312011|NCT00471146|13060686|P2|STARTED|Overall Study||316
5312012|NCT00471146|13060687|P1|STARTED|Overall Study||314
5312013|NCT00471107|13060712|P3|NOT COMPLETED|Overall Study||3
5312014|NCT00471107|13060713|P2|NOT COMPLETED|Overall Study||1
5312015|NCT00471107|13060714|P1|NOT COMPLETED|Overall Study||3
5312016|NCT00471107|13060712|P3|COMPLETED|Overall Study||12
5312017|NCT00471107|13060713|P2|COMPLETED|Overall Study||14
5312018|NCT00471107|13060714|P1|COMPLETED|Overall Study||12
5312019|NCT00471107|13060712|P3|STARTED|Overall Study||15
5312020|NCT00471107|13060713|P2|STARTED|Overall Study||15
5312021|NCT00471107|13060714|P1|STARTED|Overall Study||15
5312022|NCT00471081|13060724|P2|NOT COMPLETED|Extended Safety Follow-Up||13
5312023|NCT00471081|13060725|P1|NOT COMPLETED|Extended Safety Follow-Up||2
5312024|NCT00471081|13060724|P2|COMPLETED|Extended Safety Follow-Up||176
5312025|NCT00471081|13060725|P1|COMPLETED|Extended Safety Follow-Up||158
5312026|NCT00471081|13060724|P2|STARTED|Extended Safety Follow-Up||189
5312027|NCT00471081|13060725|P1|STARTED|Extended Safety Follow-Up||160
5312028|NCT00471081|13060724|P2|NOT COMPLETED|Active Phase||13
5312029|NCT00471081|13060725|P1|NOT COMPLETED|Active Phase||2
5312030|NCT00471081|13060724|P2|COMPLETED|Active Phase||176
5312031|NCT00471081|13060725|P1|COMPLETED|Active Phase||158
5312032|NCT00471081|13060724|P2|STARTED|Active Phase||189
5312033|NCT00471081|13060725|P1|STARTED|Active Phase||160
5312034|NCT00471068|13060764|P2|NOT COMPLETED|Overall Study||1
5312035|NCT00471068|13060765|P1|NOT COMPLETED|Overall Study||1
5312036|NCT00471068|13060764|P2|COMPLETED|Overall Study||24
5312037|NCT00471068|13060765|P1|COMPLETED|Overall Study||20
5312038|NCT00471068|13060764|P2|STARTED|Overall Study||25
5312039|NCT00471068|13060765|P1|STARTED|Overall Study||21
5312040|NCT00470847|13060771|P1|NOT COMPLETED|Overall Study||1
5312041|NCT00470847|13060771|P1|COMPLETED|Overall Study||34
5312042|NCT00470847|13060771|P1|STARTED|Overall Study||35
5312043|NCT00470834|13060784|P2|NOT COMPLETED|Extension Period (24 Months)||23
5312044|NCT00470834|13060785|P1|NOT COMPLETED|Extension Period (24 Months)||15
5312045|NCT00470834|13060784|P2|COMPLETED|Extension Period (24 Months)||7
5312046|NCT00470834|13060785|P1|COMPLETED|Extension Period (24 Months)||11
5312047|NCT00470834|13060784|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
5312048|NCT00470834|13060785|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
5312049|NCT00470834|13060784|P2|NOT COMPLETED|Treatment Period (18 Months)||31
5312050|NCT00470834|13060785|P1|NOT COMPLETED|Treatment Period (18 Months)||38
5312051|NCT00470834|13060784|P2|COMPLETED|Treatment Period (18 Months)||31
5312052|NCT00470834|13060785|P1|COMPLETED|Treatment Period (18 Months)||27
5312053|NCT00470834|13060784|P2|STARTED|Treatment Period (18 Months)||62
5312054|NCT00470834|13060785|P1|STARTED|Treatment Period (18 Months)||65
5312055|NCT00470626|13060799|P1|NOT COMPLETED|Overall Study||17
5312056|NCT00470626|13060799|P1|COMPLETED|Overall Study||112
5312057|NCT00470626|13060799|P1|STARTED|Overall Study||129
5312058|NCT00470600|13060807|P2|NOT COMPLETED|Overall Study||0
5312059|NCT00470600|13060808|P1|NOT COMPLETED|Overall Study||0
5312060|NCT00470600|13060807|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
5312061|NCT00470600|13060808|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
5312062|NCT00470600|13060807|P2|STARTED|Overall Study||99
5312063|NCT00470600|13060808|P1|STARTED|Overall Study||86
5312064|NCT00470548|13060820|P4|NOT COMPLETED|Overall Study||0
5312065|NCT00470548|13060821|P3|NOT COMPLETED|Overall Study||0
5312066|NCT00470548|13060822|P2|NOT COMPLETED|Overall Study||0
5312067|NCT00470548|13060823|P1|NOT COMPLETED|Overall Study||0
5312068|NCT00470548|13060820|P4|COMPLETED|Overall Study||37
5312069|NCT00470548|13060821|P3|COMPLETED|Overall Study||6
5312070|NCT00470548|13060822|P2|COMPLETED|Overall Study||3
5312071|NCT00470548|13060823|P1|COMPLETED|Overall Study||3
5312072|NCT00470548|13060820|P4|STARTED|Overall Study||37
5312073|NCT00470548|13060821|P3|STARTED|Overall Study||6
5312074|NCT00470548|13060822|P2|STARTED|Overall Study||3
5312075|NCT00470548|13060823|P1|STARTED|Overall Study||3
5312076|NCT00470535|13060841|P1|NOT COMPLETED|Overall Study||18
5312077|NCT00470535|13060841|P1|COMPLETED|Overall Study||0
5312078|NCT00470535|13060841|P1|STARTED|Overall Study||18
5312079|NCT00470470|13060850|P1|NOT COMPLETED|Overall Study||5
5312080|NCT00470470|13060850|P1|COMPLETED|Overall Study||25
5312081|NCT00470470|13060850|P1|STARTED|Overall Study||30
5312082|NCT00470418|13060857|P2|NOT COMPLETED|Overall Study||0
5312083|NCT00470418|13060858|P1|NOT COMPLETED|Overall Study||1
5312084|NCT00470418|13060857|P2|COMPLETED|Overall Study||3
5312085|NCT00470418|13060858|P1|COMPLETED|Overall Study||6
5312086|NCT00470418|13060857|P2|STARTED|Overall Study||3
5312087|NCT00470418|13060858|P1|STARTED|Overall Study||7
5312088|NCT00470392|13060868|P2|NOT COMPLETED|Overall Study||0
5312089|NCT00470392|13060869|P1|NOT COMPLETED|Overall Study||0
5312090|NCT00470392|13060868|P2|COMPLETED|Overall Study||2
5312091|NCT00470392|13060869|P1|COMPLETED|Overall Study||7
5312092|NCT00470392|13060868|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
5312093|NCT00470392|13060869|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
5312094|NCT00470366|13060879|P1|NOT COMPLETED|Overall Study||4
5312095|NCT00470366|13060879|P1|COMPLETED|Overall Study||56
5312096|NCT00470366|13060879|P1|STARTED|Overall Study||60
5312097|NCT00470301|13060886|P1|NOT COMPLETED|Overall Study||5
5312098|NCT00470301|13060886|P1|COMPLETED|Overall Study||55
5312099|NCT00470301|13060886|P1|STARTED|Overall Study||60
5312100|NCT00470275|13060890|P1|NOT COMPLETED|Overall Study||10
5312101|NCT00470275|13060890|P1|COMPLETED|Overall Study||0
5312102|NCT00470275|13060890|P1|STARTED|Overall Study||10
5312103|NCT00470262|13060896|P2|NOT COMPLETED|Overall Study||0
5312104|NCT00470262|13060897|P1|NOT COMPLETED|Overall Study||2
5312105|NCT00470262|13060896|P2|COMPLETED|Overall Study||12
5312106|NCT00470262|13060897|P1|COMPLETED|Overall Study||13
5312107|NCT00470262|13060896|P2|STARTED|Overall Study||12
5312108|NCT00470262|13060897|P1|STARTED|Overall Study||15
5312109|NCT00470184|13060905|P1|NOT COMPLETED|Overall Study||22
5312110|NCT00470184|13060905|P1|COMPLETED|Overall Study||19
5312111|NCT00470184|13060905|P1|Treated With Study Therapy|Overall Study||36
5312112|NCT00470184|13060905|P1|STARTED|Overall Study||41
5312113|NCT00470158|13060917|P5|NOT COMPLETED|Overall Study||6
5312114|NCT00470158|13060918|P4|NOT COMPLETED|Overall Study||5
5312115|NCT00470158|13060919|P3|NOT COMPLETED|Overall Study||8
5312116|NCT00470158|13060920|P2|NOT COMPLETED|Overall Study||8
5312117|NCT00470158|13060921|P1|NOT COMPLETED|Overall Study||8
5312118|NCT00470158|13060917|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
5312119|NCT00470158|13060918|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
5312120|NCT00470158|13060919|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
5312121|NCT00470158|13060920|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
5312122|NCT00470158|13060921|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
5312123|NCT00470158|13060917|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
5312124|NCT00470158|13060918|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
5312125|NCT00470158|13060919|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
5312126|NCT00470158|13060920|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
5312127|NCT00470158|13060921|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
5312128|NCT00470106|13060937|P4|NOT COMPLETED|Overall Study||2
5312129|NCT00470106|13060938|P3|NOT COMPLETED|Overall Study||7
5312130|NCT00470106|13060939|P2|NOT COMPLETED|Overall Study||5
5312131|NCT00470106|13060940|P1|NOT COMPLETED|Overall Study||3
5312132|NCT00470106|13060937|P4|COMPLETED|Overall Study||19
5312133|NCT00470106|13060938|P3|COMPLETED|Overall Study||14
5312134|NCT00470106|13060939|P2|COMPLETED|Overall Study||19
5312135|NCT00470106|13060940|P1|COMPLETED|Overall Study||16
5312136|NCT00470106|13060937|P4|STARTED|Overall Study||21
5312137|NCT00470106|13060938|P3|STARTED|Overall Study||21
5312138|NCT00470106|13060939|P2|STARTED|Overall Study||24
5312139|NCT00470106|13060940|P1|STARTED|Overall Study||19
5312140|NCT00470093|13060954|P1|NOT COMPLETED|Overall Study||2
5312141|NCT00470093|13060954|P1|COMPLETED|Overall Study||0
5312142|NCT00470093|13060954|P1|STARTED|Overall Study||2
5312143|NCT00470067|13060961|P1|NOT COMPLETED|Overall Study||7
5312144|NCT00470067|13060961|P1|COMPLETED|Overall Study||2
5312145|NCT00470067|13060961|P1|STARTED|Overall Study||9
5312146|NCT00470054|13060965|P1|NOT COMPLETED|Overall Study||1
5312147|NCT00470054|13060965|P1|COMPLETED|Overall Study||43
5312148|NCT00470054|13060965|P1|STARTED|Overall Study||44
5312149|NCT00469911|13060975|P2|NOT COMPLETED|Overall Study||0
5312150|NCT00469911|13060976|P1|NOT COMPLETED|Overall Study||0
5312151|NCT00469911|13060975|P2|COMPLETED|Overall Study||10
5312152|NCT00469911|13060976|P1|COMPLETED|Overall Study||8
5312153|NCT00469911|13060975|P2|STARTED|Overall Study||10
5312154|NCT00469911|13060976|P1|STARTED|Overall Study||8
5312155|NCT00469898|13060981|P1|NOT COMPLETED|Overall Study||25
5312156|NCT00469898|13060981|P1|COMPLETED|Overall Study||25
5312157|NCT00469898|13060981|P1|STARTED|Overall Study||50
5312158|NCT00469859|13060990|P2|NOT COMPLETED|Overall Study||2
5312159|NCT00469859|13060991|P1|NOT COMPLETED|Overall Study||0
5312160|NCT00469859|13060990|P2|COMPLETED|Overall Study||6
5312161|NCT00469859|13060991|P1|COMPLETED|Overall Study||6
5312162|NCT00469859|13060990|P2|STARTED|Overall Study||8
5312163|NCT00469859|13060991|P1|STARTED|Overall Study||6
5312164|NCT00469833|13060999|P1|NOT COMPLETED|Overall Study||2
5312165|NCT00469833|13060999|P1|COMPLETED|Overall Study||15
5312166|NCT00469833|13060999|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
5312167|NCT00469612|13061011|P2|NOT COMPLETED|Overall Study||0
5312168|NCT00469612|13061012|P1|NOT COMPLETED|Overall Study||2
5312169|NCT00469612|13061011|P2|COMPLETED|Overall Study||0
5312170|NCT00469612|13061012|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
5312171|NCT00469612|13061011|P2|STARTED|Overall Study||0
5312172|NCT00469612|13061012|P1|STARTED|Overall Study||2
5312173|NCT00469508|13061024|P2|NOT COMPLETED|Overall Study||24
5312174|NCT00469508|13061025|P1|NOT COMPLETED|Overall Study||20
5312175|NCT00469508|13061024|P2|COMPLETED|Overall Study||13
5312176|NCT00469508|13061025|P1|COMPLETED|Overall Study||14
5312177|NCT00469508|13061024|P2|STARTED|Overall Study||37
5312178|NCT00469508|13061025|P1|STARTED|Overall Study||34
5312179|NCT00469456|13061039|P2|NOT COMPLETED|Overall Study||4
5312180|NCT00469456|13061040|P1|NOT COMPLETED|Overall Study||9
5312181|NCT00469456|13061039|P2|COMPLETED|Overall Study||131
5312182|NCT00469456|13061040|P1|COMPLETED|Overall Study||120
5312183|NCT00469456|13061039|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
5312184|NCT00469456|13061040|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
5312185|NCT00469391|13061050|P2|NOT COMPLETED|Overall Study||5
5312186|NCT00469391|13061051|P1|NOT COMPLETED|Overall Study||14
5312187|NCT00469391|13061050|P2|COMPLETED|Overall Study||24
5312188|NCT00469391|13061051|P1|COMPLETED|Overall Study||13
5312189|NCT00469391|13061050|P2|Patient Preference|Overall Study||1
5312190|NCT00469391|13061051|P1|Patient Preference|Overall Study||0
5312191|NCT00469391|13061050|P2|Lost to Follow up|Overall Study||1
5312192|NCT00469391|13061051|P1|Lost to Follow up|Overall Study||0
5312193|NCT00469391|13061050|P2|Adverse Event|Overall Study||0
5312194|NCT00469391|13061051|P1|Adverse Event|Overall Study||8
5312195|NCT00469391|13061050|P2|Unsuccessful Implant Procedure|Overall Study||0
5312196|NCT00469391|13061051|P1|Unsuccessful Implant Procedure|Overall Study||4
5312197|NCT00469391|13061050|P2|Discontinued Prior to Procedure|Overall Study||3
5312198|NCT00469391|13061051|P1|Discontinued Prior to Procedure|Overall Study||2
5312199|NCT00469391|13061050|P2|STARTED|Overall Study||29
5312200|NCT00469391|13061051|P1|STARTED|Overall Study||27
5312201|NCT00469274|13061059|P2|NOT COMPLETED|Overall Study||0
5312202|NCT00469274|13061060|P1|NOT COMPLETED|Overall Study||0
5312203|NCT00469274|13061059|P2|COMPLETED|Overall Study||42
5312204|NCT00469274|13061060|P1|COMPLETED|Overall Study||44
5312205|NCT00469274|13061059|P2|STARTED|Overall Study||42
5312206|NCT00469274|13061060|P1|STARTED|Overall Study||44
5312207|NCT00469209|13061069|P3|NOT COMPLETED|Overall Study||1
5312208|NCT00469209|13061070|P2|NOT COMPLETED|Overall Study||0
5312209|NCT00469209|13061071|P1|NOT COMPLETED|Overall Study||1
5312210|NCT00469209|13061069|P3|COMPLETED|Overall Study||19
5312211|NCT00469209|13061070|P2|COMPLETED|Overall Study||20
5312212|NCT00469209|13061071|P1|COMPLETED|Overall Study||19
5312213|NCT00469209|13061069|P3|STARTED|Overall Study||20
5312214|NCT00469209|13061070|P2|STARTED|Overall Study||20
5312215|NCT00469209|13061071|P1|STARTED|Overall Study||20
5312216|NCT00469092|13061081|P2|NOT COMPLETED|Overall Study||21
5312217|NCT00469092|13061082|P1|NOT COMPLETED|Overall Study||26
5312218|NCT00469092|13061081|P2|COMPLETED|Overall Study||220
5312219|NCT00469092|13061082|P1|COMPLETED|Overall Study||213
5312220|NCT00469092|13061081|P2|Exposed to Study Drug|Overall Study||238
5312221|NCT00469092|13061082|P1|Exposed to Study Drug|Overall Study||231
5312222|NCT00469092|13061081|P2|STARTED|Overall Study||241
5312223|NCT00469092|13061082|P1|STARTED|Overall Study||239
5312224|NCT00469079|13061101|P3|NOT COMPLETED|Overall Study||19
5312225|NCT00469079|13061102|P2|NOT COMPLETED|Overall Study||22
5312226|NCT00469079|13061103|P1|NOT COMPLETED|Overall Study||9
5312227|NCT00469079|13061101|P3|COMPLETED|Overall Study||32
5312228|NCT00469079|13061102|P2|COMPLETED|Overall Study||30
5312229|NCT00469079|13061103|P1|COMPLETED|Overall Study||18
5312230|NCT00469079|13061101|P3|STARTED|Overall Study||51
5312231|NCT00469079|13061102|P2|STARTED|Overall Study||52
5312232|NCT00469079|13061103|P1|STARTED|Overall Study||27
5312233|NCT00468910|13061122|P2|NOT COMPLETED|Overall Study||3
5312234|NCT00468910|13061123|P1|NOT COMPLETED|Overall Study||4
5312235|NCT00468910|13061122|P2|COMPLETED|Overall Study||36
5312236|NCT00468910|13061123|P1|COMPLETED|Overall Study||36
5312237|NCT00468910|13061122|P2|Follow-up|Overall Study||36
5312238|NCT00468910|13061123|P1|Follow-up|Overall Study||36
5312239|NCT00468910|13061122|P2|Post-Treatment Biopsy|Overall Study||36
5312240|NCT00468910|13061123|P1|Post-Treatment Biopsy|Overall Study||36
5312241|NCT00468910|13061122|P2|Treatment|Overall Study||36
5312242|NCT00468910|13061123|P1|Treatment|Overall Study||36
5312243|NCT00468910|13061122|P2|Randomization|Overall Study||39
5312244|NCT00468910|13061123|P1|Randomization|Overall Study||40
5312245|NCT00468910|13061122|P2|STARTED|Overall Study||39
5312246|NCT00468910|13061123|P1|STARTED|Overall Study||40
5312247|NCT00468858|13061142|P3|NOT COMPLETED|Overall Study||14
5312248|NCT00468858|13061143|P2|NOT COMPLETED|Overall Study||10
5312249|NCT00468858|13061144|P1|NOT COMPLETED|Overall Study||9
5312250|NCT00468858|13061142|P3|COMPLETED|Overall Study||199
5312251|NCT00468858|13061143|P2|COMPLETED|Overall Study||202
5312252|NCT00468858|13061144|P1|COMPLETED|Overall Study||202
5312253|NCT00468858|13061142|P3|STARTED|Overall Study||213
5312254|NCT00468858|13061143|P2|STARTED|Overall Study||212
5312255|NCT00468858|13061144|P1|STARTED|Overall Study||211
5312256|NCT00468845|13061265|P3|NOT COMPLETED|Overall Study||30
5312257|NCT00468845|13061266|P2|NOT COMPLETED|Overall Study||34
5312258|NCT00468845|13061267|P1|NOT COMPLETED|Overall Study||21
5312259|NCT00468845|13061265|P3|COMPLETED|Overall Study||139
5312260|NCT00468845|13061266|P2|COMPLETED|Overall Study||136
5312261|NCT00468845|13061267|P1|COMPLETED|Overall Study||141
5312262|NCT00468845|13061265|P3|Received Treatment|Overall Study||167
5312263|NCT00468845|13061266|P2|Received Treatment|Overall Study||166
5312264|NCT00468845|13061267|P1|Received Treatment|Overall Study||161
5312265|NCT00468845|13061265|P3|STARTED|Overall Study||169
5312266|NCT00468845|13061266|P2|STARTED|Overall Study||170
5312267|NCT00468845|13061267|P1|STARTED|Overall Study||162
5312268|NCT00468819|13061404|P3|NOT COMPLETED|Overall Study||2
5312269|NCT00468819|13061405|P2|NOT COMPLETED|Overall Study||0
5312270|NCT00468819|13061406|P1|NOT COMPLETED|Overall Study||6
5312271|NCT00468819|13061404|P3|COMPLETED|Overall Study||46
5312272|NCT00468819|13061405|P2|COMPLETED|Overall Study||44
5312273|NCT00468819|13061406|P1|COMPLETED|Overall Study||42
5312274|NCT00468819|13061404|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
5312275|NCT00468819|13061405|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
5312276|NCT00468819|13061406|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
5312277|NCT00468819|13061404|P3|STARTED|Overall Study|Enrolled participants|48
5312278|NCT00468819|13061405|P2|STARTED|Overall Study|Enrolled participants|44
5312279|NCT00468819|13061406|P1|STARTED|Overall Study|Enrolled participants|48
5312280|NCT00468728|13061486|P2|NOT COMPLETED|Follow-up||31
5312281|NCT00468728|13061487|P1|NOT COMPLETED|Follow-up||34
5312282|NCT00468728|13061486|P2|COMPLETED|Follow-up||222
5312283|NCT00468728|13061487|P1|COMPLETED|Follow-up||222
5312284|NCT00468728|13061486|P2|STARTED|Follow-up||253
5312285|NCT00468728|13061487|P1|STARTED|Follow-up||256
5312286|NCT00468728|13061486|P2|NOT COMPLETED|Treatment||11
5312287|NCT00468728|13061487|P1|NOT COMPLETED|Treatment||4
5312288|NCT00468728|13061486|P2|COMPLETED|Treatment||253
5312289|NCT00468728|13061487|P1|COMPLETED|Treatment||256
5312290|NCT00468728|13061486|P2|STARTED|Treatment||264
5312291|NCT00468728|13061487|P1|STARTED|Treatment||260
5312292|NCT00468728|13061486|P2|NOT COMPLETED|Enrollment||7
5312293|NCT00468728|13061487|P1|NOT COMPLETED|Enrollment||4
5312294|NCT00468728|13061486|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
5312295|NCT00468728|13061487|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
5312296|NCT00468728|13061486|P2|STARTED|Enrollment||271
5312297|NCT00468728|13061487|P1|STARTED|Enrollment||264
5312298|NCT00468676|13061499|P2|NOT COMPLETED|Overall Study||12
5312299|NCT00468676|13061500|P1|NOT COMPLETED|Overall Study||16
5312300|NCT00468676|13061499|P2|COMPLETED|Overall Study||94
5312301|NCT00468676|13061500|P1|COMPLETED|Overall Study||92
5312302|NCT00468676|13061499|P2|STARTED|Overall Study||106
5312303|NCT00468676|13061500|P1|STARTED|Overall Study||108
5312304|NCT00468650|13061517|P1|NOT COMPLETED|Overall Study||7
5312305|NCT00468650|13061517|P1|COMPLETED|Overall Study||110
5312306|NCT00468650|13061517|P1|STARTED|Overall Study||117
5312307|NCT00468585|13061565|P4|NOT COMPLETED|Overall Study||1
5312308|NCT00468585|13061566|P3|NOT COMPLETED|Overall Study||5
5312309|NCT00468585|13061567|P2|NOT COMPLETED|Overall Study||0
5312310|NCT00468585|13061568|P1|NOT COMPLETED|Overall Study||1
5312311|NCT00468585|13061565|P4|COMPLETED|Overall Study||5
5312312|NCT00468585|13061566|P3|COMPLETED|Overall Study||45
5312313|NCT00468585|13061567|P2|COMPLETED|Overall Study||3
5312314|NCT00468585|13061568|P1|COMPLETED|Overall Study||3
5312315|NCT00468585|13061565|P4|STARTED|Overall Study||6
5312316|NCT00468585|13061566|P3|STARTED|Overall Study||50
5312317|NCT00468585|13061567|P2|STARTED|Overall Study||3
5312318|NCT00468585|13061568|P1|STARTED|Overall Study||4
5312319|NCT00468559|13061580|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
5312320|NCT00468559|13061581|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
5312321|NCT00468559|13061582|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
5312322|NCT00468559|13061580|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
5312323|NCT00468559|13061581|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
5312324|NCT00468559|13061582|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
5312325|NCT00468559|13061580|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
5312326|NCT00468559|13061581|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
5312327|NCT00468559|13061582|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
5312328|NCT00468559|13061580|P3|NOT COMPLETED|Open-label Treatment Phase||0
5312329|NCT00468559|13061581|P2|NOT COMPLETED|Open-label Treatment Phase||0
5312330|NCT00468559|13061582|P1|NOT COMPLETED|Open-label Treatment Phase||18
5312331|NCT00468559|13061580|P3|COMPLETED|Open-label Treatment Phase||0
5312332|NCT00468559|13061581|P2|COMPLETED|Open-label Treatment Phase||0
5312333|NCT00468559|13061582|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
5312334|NCT00468559|13061580|P3|STARTED|Open-label Treatment Phase||0
5312335|NCT00468559|13061581|P2|STARTED|Open-label Treatment Phase||0
5312336|NCT00468559|13061582|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
5312337|NCT00468546|13061610|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
5312338|NCT00468546|13061611|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
5312339|NCT00468546|13061610|P2|COMPLETED|Week 24 to Week 104 Analysis||83
5312340|NCT00468546|13061611|P1|COMPLETED|Week 24 to Week 104 Analysis||103
5312341|NCT00468546|13061610|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
5312342|NCT00468546|13061611|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
5312343|NCT00468546|13061610|P2|NOT COMPLETED|Week 24 Analysis||55
5312344|NCT00468546|13061611|P1|NOT COMPLETED|Week 24 Analysis||97
5312345|NCT00468546|13061610|P2|COMPLETED|Week 24 Analysis||253
5312346|NCT00468546|13061611|P1|COMPLETED|Week 24 Analysis||111
5312347|NCT00468546|13061610|P2|STARTED|Week 24 Analysis||308
5312348|NCT00468546|13061611|P1|STARTED|Week 24 Analysis||208
5312349|NCT00468481|13061641|P2|NOT COMPLETED|Overall Study||24
5312350|NCT00468481|13061642|P1|NOT COMPLETED|Overall Study||88
5312351|NCT00468481|13061641|P2|COMPLETED|Overall Study||70
5312352|NCT00468481|13061642|P1|COMPLETED|Overall Study||203
5312353|NCT00468481|13061641|P2|Subjects Treated|Overall Study||94
5312354|NCT00468481|13061642|P1|Subjects Treated|Overall Study||285
5312355|NCT00468481|13061641|P2|STARTED|Overall Study||94
5312356|NCT00468481|13061642|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
5312357|NCT00468312|13061742|P2|NOT COMPLETED|Overall Study||5
5312358|NCT00468312|13061743|P1|NOT COMPLETED|Overall Study||4
5312359|NCT00468312|13061742|P2|COMPLETED|Overall Study||204
5312360|NCT00468312|13061743|P1|COMPLETED|Overall Study||216
5312361|NCT00468312|13061742|P2|STARTED|Overall Study||209
5312362|NCT00468312|13061743|P1|STARTED|Overall Study||220
5312363|NCT00468299|13061759|P2|NOT COMPLETED|Overall Study||1
5312364|NCT00468299|13061760|P1|NOT COMPLETED|Overall Study||0
5312365|NCT00468299|13061759|P2|COMPLETED|Overall Study||7
5312366|NCT00468299|13061760|P1|COMPLETED|Overall Study||9
5312367|NCT00468299|13061759|P2|STARTED|Overall Study||8
5312368|NCT00468299|13061760|P1|STARTED|Overall Study||9
5312369|NCT00468286|13061770|P2|NOT COMPLETED|Overall Study||12
5312370|NCT00468286|13061771|P1|NOT COMPLETED|Overall Study||7
5312371|NCT00468286|13061770|P2|COMPLETED|Overall Study||54
5312372|NCT00468286|13061771|P1|COMPLETED|Overall Study||60
5312373|NCT00468286|13061770|P2|STARTED|Overall Study||66
5312374|NCT00468286|13061771|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
5312375|NCT00468208|13061793|P1|NOT COMPLETED|Overall Study||0
5312376|NCT00468208|13061793|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
5312377|NCT00468208|13061793|P1|STARTED|Overall Study||20
5312378|NCT00468169|13061803|P2|NOT COMPLETED|Overall Study||0
5312379|NCT00468169|13061804|P1|NOT COMPLETED|Overall Study||1
5312380|NCT00468169|13061803|P2|COMPLETED|Overall Study||53
5312381|NCT00468169|13061804|P1|COMPLETED|Overall Study||56
5312382|NCT00468169|13061803|P2|STARTED|Overall Study||53
5312383|NCT00468169|13061804|P1|STARTED|Overall Study||57
5312384|NCT00468143|13061820|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
5312385|NCT00468143|13061821|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
5312386|NCT00468143|13061820|P2|COMPLETED|Second Intervention (3 Weeks)||24
5312387|NCT00468143|13061821|P1|COMPLETED|Second Intervention (3 Weeks)||25
5312388|NCT00468143|13061820|P2|STARTED|Second Intervention (3 Weeks)||27
5312389|NCT00468143|13061821|P1|STARTED|Second Intervention (3 Weeks)||28
5312390|NCT00468143|13061820|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
5312391|NCT00468143|13061821|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
5312392|NCT00468143|13061820|P2|COMPLETED|First Intervention (3 Weeks)||27
5312393|NCT00468143|13061821|P1|COMPLETED|First Intervention (3 Weeks)||28
5312394|NCT00468143|13061820|P2|STARTED|First Intervention (3 Weeks)||31
5312395|NCT00468143|13061821|P1|STARTED|First Intervention (3 Weeks)||31
5312396|NCT00468104|13061835|P2|NOT COMPLETED|Second Intervention||4
5312397|NCT00468104|13061836|P1|NOT COMPLETED|Second Intervention||5
5312398|NCT00468104|13061835|P2|COMPLETED|Second Intervention||37
5312399|NCT00468104|13061836|P1|COMPLETED|Second Intervention||3
5312400|NCT00468104|13061835|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
5312401|NCT00468104|13061836|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
5312402|NCT00468104|13061835|P2|NOT COMPLETED|First Intervention||1
5312403|NCT00468104|13061836|P1|NOT COMPLETED|First Intervention||9
5312404|NCT00468104|13061835|P2|COMPLETED|First Intervention||45
5312405|NCT00468104|13061836|P1|COMPLETED|First Intervention||45
5312406|NCT00468104|13061835|P2|STARTED|First Intervention||46
5312407|NCT00468104|13061836|P1|STARTED|First Intervention||54
5312408|NCT00468052|13061853|P2|NOT COMPLETED|Overall Study||8
5312409|NCT00468052|13061854|P1|NOT COMPLETED|Overall Study||7
5312410|NCT00468052|13061853|P2|COMPLETED|Overall Study||61
5312411|NCT00468052|13061854|P1|COMPLETED|Overall Study||61
5312412|NCT00468052|13061853|P2|Target Enrollment|Overall Study||70
5312413|NCT00468052|13061854|P1|Target Enrollment|Overall Study||70
5312414|NCT00468052|13061853|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
5312415|NCT00468052|13061854|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
5312416|NCT00467961|13061872|P1|NOT COMPLETED|Overall Study||7
5312417|NCT00467961|13061872|P1|COMPLETED|Overall Study||24
5312418|NCT00467961|13061872|P1|STARTED|Overall Study||31
5312419|NCT00467896|13061876|P1|NOT COMPLETED|Overall Study||51
5312420|NCT00467896|13061876|P1|COMPLETED|Overall Study||11
5312421|NCT00467896|13061876|P1|STARTED|Overall Study||62
5312422|NCT00467870|13061902|P6|NOT COMPLETED|Overall Study||2
5312423|NCT00467870|13061903|P5|NOT COMPLETED|Overall Study||37
5312424|NCT00467870|13061904|P4|NOT COMPLETED|Overall Study||33
5312425|NCT00467870|13061905|P3|NOT COMPLETED|Overall Study||4
5312426|NCT00467870|13061906|P2|NOT COMPLETED|Overall Study||43
5312427|NCT00467870|13061907|P1|NOT COMPLETED|Overall Study||45
5312428|NCT00467870|13061902|P6|COMPLETED|Overall Study||21
5312429|NCT00467870|13061903|P5|COMPLETED|Overall Study||93
5312430|NCT00467870|13061904|P4|COMPLETED|Overall Study||79
5312431|NCT00467870|13061905|P3|COMPLETED|Overall Study||18
5312432|NCT00467870|13061906|P2|COMPLETED|Overall Study||74
5312433|NCT00467870|13061907|P1|COMPLETED|Overall Study||75
5312434|NCT00467870|13061902|P6|STARTED|Overall Study||23
5312435|NCT00467870|13061903|P5|STARTED|Overall Study||130
5312436|NCT00467870|13061904|P4|STARTED|Overall Study||112
5312437|NCT00467870|13061905|P3|STARTED|Overall Study||22
5312438|NCT00467870|13061906|P2|STARTED|Overall Study||117
5312439|NCT00467870|13061907|P1|STARTED|Overall Study||120
5312440|NCT00467857|13061950|P2|NOT COMPLETED|Overall Study||8
5312441|NCT00467857|13061951|P1|NOT COMPLETED|Overall Study||3
5312442|NCT00467857|13061950|P2|COMPLETED|Overall Study||139
5312443|NCT00467857|13061951|P1|COMPLETED|Overall Study||143
5312444|NCT00467857|13061950|P2|STARTED|Overall Study||147
5312445|NCT00467857|13061951|P1|STARTED|Overall Study||146
5312446|NCT00467844|13061986|P3|NOT COMPLETED|Overall Study||14
5312447|NCT00467844|13061987|P2|NOT COMPLETED|Overall Study||20
5312448|NCT00467844|13061988|P1|NOT COMPLETED|Overall Study||19
5312449|NCT00467844|13061986|P3|COMPLETED|Overall Study||38
5312450|NCT00467844|13061987|P2|COMPLETED|Overall Study||34
5312451|NCT00467844|13061988|P1|COMPLETED|Overall Study||34
5312452|NCT00467844|13061986|P3|STARTED|Overall Study||52
5312453|NCT00467844|13061987|P2|STARTED|Overall Study||54
5312454|NCT00467844|13061988|P1|STARTED|Overall Study||53
5312455|NCT00467831|13061999|P1|NOT COMPLETED|Overall Study||3
5312456|NCT00467831|13061999|P1|COMPLETED|Overall Study||0
5312457|NCT00467831|13061999|P1|STARTED|Overall Study||3
5312458|NCT00467779|13062018|P15|NOT COMPLETED|Stage 3||17
5312459|NCT00467779|13062019|P14|NOT COMPLETED|Stage 3||0
5312460|NCT00467779|13062020|P13|NOT COMPLETED|Stage 3||0
5312461|NCT00467779|13062021|P12|NOT COMPLETED|Stage 3||0
5312462|NCT00467779|13062022|P11|NOT COMPLETED|Stage 3||0
5312463|NCT00467779|13062023|P10|NOT COMPLETED|Stage 3||0
5312464|NCT00467779|13062024|P9|NOT COMPLETED|Stage 3||0
5312465|NCT00467779|13062025|P8|NOT COMPLETED|Stage 3||0
5312466|NCT00467779|13062026|P7|NOT COMPLETED|Stage 3||0
5312467|NCT00467779|13062027|P6|NOT COMPLETED|Stage 3||0
5312468|NCT00467779|13062028|P5|NOT COMPLETED|Stage 3||0
5312469|NCT00467779|13062029|P4|NOT COMPLETED|Stage 3||0
5312470|NCT00467779|13062030|P3|NOT COMPLETED|Stage 3||0
5312471|NCT00467779|13062031|P2|NOT COMPLETED|Stage 3||0
5312472|NCT00467779|13062032|P1|NOT COMPLETED|Stage 3||0
5312473|NCT00467779|13062018|P15|COMPLETED|Stage 3||3
5312474|NCT00467779|13062019|P14|COMPLETED|Stage 3||0
5312475|NCT00467779|13062020|P13|COMPLETED|Stage 3||0
5312476|NCT00467779|13062021|P12|COMPLETED|Stage 3||0
5312477|NCT00467779|13062022|P11|COMPLETED|Stage 3||0
5312478|NCT00467779|13062023|P10|COMPLETED|Stage 3||0
5312479|NCT00467779|13062024|P9|COMPLETED|Stage 3||0
5312480|NCT00467779|13062025|P8|COMPLETED|Stage 3||0
5312481|NCT00467779|13062026|P7|COMPLETED|Stage 3||0
5312482|NCT00467779|13062027|P6|COMPLETED|Stage 3||0
5312483|NCT00467779|13062028|P5|COMPLETED|Stage 3||0
5312484|NCT00467779|13062029|P4|COMPLETED|Stage 3||0
5312485|NCT00467779|13062030|P3|COMPLETED|Stage 3||0
5312486|NCT00467779|13062031|P2|COMPLETED|Stage 3||0
5312487|NCT00467779|13062032|P1|COMPLETED|Stage 3||0
5312488|NCT00467779|13062018|P15|STARTED|Stage 3||20
5312489|NCT00467779|13062019|P14|STARTED|Stage 3||0
5312490|NCT00467779|13062020|P13|STARTED|Stage 3||0
5312491|NCT00467779|13062021|P12|STARTED|Stage 3||0
5312492|NCT00467779|13062022|P11|STARTED|Stage 3||0
5312493|NCT00467779|13062023|P10|STARTED|Stage 3||0
5312494|NCT00467779|13062024|P9|STARTED|Stage 3||0
5312495|NCT00467779|13062025|P8|STARTED|Stage 3||0
5312496|NCT00467779|13062026|P7|STARTED|Stage 3||0
5312497|NCT00467779|13062027|P6|STARTED|Stage 3||0
5312498|NCT00467779|13062028|P5|STARTED|Stage 3||0
5312499|NCT00467779|13062029|P4|STARTED|Stage 3||0
5312500|NCT00467779|13062030|P3|STARTED|Stage 3||0
5312501|NCT00467779|13062031|P2|STARTED|Stage 3||0
5312502|NCT00467779|13062032|P1|STARTED|Stage 3||0
5312503|NCT00467779|13062018|P15|NOT COMPLETED|Stage 2A||0
5312504|NCT00467779|13062019|P14|NOT COMPLETED|Stage 2A||21
5312505|NCT00467779|13062020|P13|NOT COMPLETED|Stage 2A||0
5312506|NCT00467779|13062021|P12|NOT COMPLETED|Stage 2A||0
5312507|NCT00467779|13062022|P11|NOT COMPLETED|Stage 2A||0
5312508|NCT00467779|13062023|P10|NOT COMPLETED|Stage 2A||0
5312509|NCT00467779|13062024|P9|NOT COMPLETED|Stage 2A||0
5312510|NCT00467779|13062025|P8|NOT COMPLETED|Stage 2A||0
5312511|NCT00467779|13062026|P7|NOT COMPLETED|Stage 2A||0
5312512|NCT00467779|13062027|P6|NOT COMPLETED|Stage 2A||0
5312513|NCT00467779|13062028|P5|NOT COMPLETED|Stage 2A||0
5312514|NCT00467779|13062029|P4|NOT COMPLETED|Stage 2A||0
5312515|NCT00467779|13062030|P3|NOT COMPLETED|Stage 2A||0
5312516|NCT00467779|13062031|P2|NOT COMPLETED|Stage 2A||0
5312517|NCT00467779|13062032|P1|NOT COMPLETED|Stage 2A||0
5312518|NCT00467779|13062018|P15|COMPLETED|Stage 2A||0
5312519|NCT00467779|13062019|P14|COMPLETED|Stage 2A||1
5312520|NCT00467779|13062020|P13|COMPLETED|Stage 2A||0
5312521|NCT00467779|13062021|P12|COMPLETED|Stage 2A||0
5312522|NCT00467779|13062022|P11|COMPLETED|Stage 2A||0
5312523|NCT00467779|13062023|P10|COMPLETED|Stage 2A||0
5312524|NCT00467779|13062024|P9|COMPLETED|Stage 2A||0
5312525|NCT00467779|13062025|P8|COMPLETED|Stage 2A||0
5312526|NCT00467779|13062026|P7|COMPLETED|Stage 2A||0
5312527|NCT00467779|13062027|P6|COMPLETED|Stage 2A||0
5312528|NCT00467779|13062028|P5|COMPLETED|Stage 2A||0
5312529|NCT00467779|13062029|P4|COMPLETED|Stage 2A||0
5312530|NCT00467779|13062030|P3|COMPLETED|Stage 2A||0
5312531|NCT00467779|13062031|P2|COMPLETED|Stage 2A||0
5312532|NCT00467779|13062032|P1|COMPLETED|Stage 2A||0
5312533|NCT00467779|13062018|P15|STARTED|Stage 2A||0
5312534|NCT00467779|13062019|P14|STARTED|Stage 2A||22
5312535|NCT00467779|13062020|P13|STARTED|Stage 2A||0
5312536|NCT00467779|13062021|P12|STARTED|Stage 2A||0
5312537|NCT00467779|13062022|P11|STARTED|Stage 2A||0
5312538|NCT00467779|13062023|P10|STARTED|Stage 2A||0
5312539|NCT00467779|13062024|P9|STARTED|Stage 2A||0
5312540|NCT00467779|13062025|P8|STARTED|Stage 2A||0
5312541|NCT00467779|13062026|P7|STARTED|Stage 2A||0
5312542|NCT00467779|13062027|P6|STARTED|Stage 2A||0
5312543|NCT00467779|13062028|P5|STARTED|Stage 2A||0
5312544|NCT00467779|13062029|P4|STARTED|Stage 2A||0
5312545|NCT00467779|13062030|P3|STARTED|Stage 2A||0
5312546|NCT00467779|13062031|P2|STARTED|Stage 2A||0
5312547|NCT00467779|13062032|P1|STARTED|Stage 2A||0
5312548|NCT00467779|13062018|P15|NOT COMPLETED|Stage 2||0
5312549|NCT00467779|13062019|P14|NOT COMPLETED|Stage 2||0
5312550|NCT00467779|13062020|P13|NOT COMPLETED|Stage 2||0
5312551|NCT00467779|13062021|P12|NOT COMPLETED|Stage 2||0
5312552|NCT00467779|13062022|P11|NOT COMPLETED|Stage 2||0
5312553|NCT00467779|13062023|P10|NOT COMPLETED|Stage 2||0
5312554|NCT00467779|13062024|P9|NOT COMPLETED|Stage 2||21
5312555|NCT00467779|13062025|P8|NOT COMPLETED|Stage 2||0
5312556|NCT00467779|13062026|P7|NOT COMPLETED|Stage 2||0
5312557|NCT00467779|13062027|P6|NOT COMPLETED|Stage 2||0
5312558|NCT00467779|13062028|P5|NOT COMPLETED|Stage 2||0
5312559|NCT00467779|13062029|P4|NOT COMPLETED|Stage 2||0
5312560|NCT00467779|13062030|P3|NOT COMPLETED|Stage 2||0
5312561|NCT00467779|13062031|P2|NOT COMPLETED|Stage 2||0
5312562|NCT00467779|13062032|P1|NOT COMPLETED|Stage 2||0
5312563|NCT00467779|13062018|P15|COMPLETED|Stage 2||0
5312564|NCT00467779|13062019|P14|COMPLETED|Stage 2||0
5312565|NCT00467779|13062020|P13|COMPLETED|Stage 2||0
5312566|NCT00467779|13062021|P12|COMPLETED|Stage 2||0
5312567|NCT00467779|13062022|P11|COMPLETED|Stage 2||0
5312568|NCT00467779|13062023|P10|COMPLETED|Stage 2||0
5312569|NCT00467779|13062024|P9|COMPLETED|Stage 2||0
5312570|NCT00467779|13062025|P8|COMPLETED|Stage 2||0
5312571|NCT00467779|13062026|P7|COMPLETED|Stage 2||0
5312572|NCT00467779|13062027|P6|COMPLETED|Stage 2||0
5312573|NCT00467779|13062028|P5|COMPLETED|Stage 2||0
5312574|NCT00467779|13062029|P4|COMPLETED|Stage 2||0
5312575|NCT00467779|13062030|P3|COMPLETED|Stage 2||0
5312576|NCT00467779|13062031|P2|COMPLETED|Stage 2||0
5312577|NCT00467779|13062032|P1|COMPLETED|Stage 2||0
5312578|NCT00467779|13062018|P15|STARTED|Stage 2||0
5312579|NCT00467779|13062019|P14|STARTED|Stage 2||0
5312580|NCT00467779|13062020|P13|STARTED|Stage 2||0
5312581|NCT00467779|13062021|P12|STARTED|Stage 2||0
5312582|NCT00467779|13062022|P11|STARTED|Stage 2||0
5312583|NCT00467779|13062023|P10|STARTED|Stage 2||0
5312584|NCT00467779|13062024|P9|STARTED|Stage 2||21
5312585|NCT00467779|13062025|P8|STARTED|Stage 2||0
5312586|NCT00467779|13062026|P7|STARTED|Stage 2||0
5312587|NCT00467779|13062027|P6|STARTED|Stage 2||0
5312588|NCT00467779|13062028|P5|STARTED|Stage 2||0
5312589|NCT00467779|13062029|P4|STARTED|Stage 2||0
5312590|NCT00467779|13062030|P3|STARTED|Stage 2||0
5312591|NCT00467779|13062031|P2|STARTED|Stage 2||0
5312592|NCT00467779|13062032|P1|STARTED|Stage 2||0
5312593|NCT00467779|13062018|P15|NOT COMPLETED|Stage 1A||0
5312594|NCT00467779|13062019|P14|NOT COMPLETED|Stage 1A||0
5312595|NCT00467779|13062020|P13|NOT COMPLETED|Stage 1A||6
5312596|NCT00467779|13062021|P12|NOT COMPLETED|Stage 1A||8
5312597|NCT00467779|13062022|P11|NOT COMPLETED|Stage 1A||3
5312598|NCT00467779|13062023|P10|NOT COMPLETED|Stage 1A||3
5312599|NCT00467779|13062024|P9|NOT COMPLETED|Stage 1A||0
5312600|NCT00467779|13062025|P8|NOT COMPLETED|Stage 1A||0
5312601|NCT00467779|13062026|P7|NOT COMPLETED|Stage 1A||0
5312602|NCT00467779|13062027|P6|NOT COMPLETED|Stage 1A||0
5312603|NCT00467779|13062028|P5|NOT COMPLETED|Stage 1A||0
5312604|NCT00467779|13062029|P4|NOT COMPLETED|Stage 1A||0
5312605|NCT00467779|13062030|P3|NOT COMPLETED|Stage 1A||0
5312606|NCT00467779|13062031|P2|NOT COMPLETED|Stage 1A||0
5312607|NCT00467779|13062032|P1|NOT COMPLETED|Stage 1A||0
5312608|NCT00467779|13062018|P15|COMPLETED|Stage 1A||0
5312609|NCT00467779|13062019|P14|COMPLETED|Stage 1A||0
5312610|NCT00467779|13062020|P13|COMPLETED|Stage 1A||0
5312611|NCT00467779|13062021|P12|COMPLETED|Stage 1A||0
5312612|NCT00467779|13062022|P11|COMPLETED|Stage 1A||0
5312613|NCT00467779|13062023|P10|COMPLETED|Stage 1A||0
5312614|NCT00467779|13062024|P9|COMPLETED|Stage 1A||0
5312615|NCT00467779|13062025|P8|COMPLETED|Stage 1A||0
5312616|NCT00467779|13062026|P7|COMPLETED|Stage 1A||0
5312617|NCT00467779|13062027|P6|COMPLETED|Stage 1A||0
5312618|NCT00467779|13062028|P5|COMPLETED|Stage 1A||0
5312619|NCT00467779|13062029|P4|COMPLETED|Stage 1A||0
5312620|NCT00467779|13062030|P3|COMPLETED|Stage 1A||0
5312621|NCT00467779|13062031|P2|COMPLETED|Stage 1A||0
5312622|NCT00467779|13062032|P1|COMPLETED|Stage 1A||0
5312623|NCT00467779|13062018|P15|STARTED|Stage 1A||0
5312624|NCT00467779|13062019|P14|STARTED|Stage 1A||0
5312625|NCT00467779|13062020|P13|STARTED|Stage 1A||6
5312626|NCT00467779|13062021|P12|STARTED|Stage 1A||8
5312627|NCT00467779|13062022|P11|STARTED|Stage 1A||3
5312628|NCT00467779|13062023|P10|STARTED|Stage 1A||3
5312629|NCT00467779|13062024|P9|STARTED|Stage 1A||0
5312630|NCT00467779|13062025|P8|STARTED|Stage 1A||0
5312631|NCT00467779|13062026|P7|STARTED|Stage 1A||0
5312632|NCT00467779|13062027|P6|STARTED|Stage 1A||0
5312633|NCT00467779|13062028|P5|STARTED|Stage 1A||0
5312634|NCT00467779|13062029|P4|STARTED|Stage 1A||0
5312635|NCT00467779|13062030|P3|STARTED|Stage 1A||0
5312636|NCT00467779|13062031|P2|STARTED|Stage 1A||0
5312637|NCT00467779|13062032|P1|STARTED|Stage 1A||0
5312638|NCT00467779|13062018|P15|NOT COMPLETED|Stage 1||0
5312639|NCT00467779|13062019|P14|NOT COMPLETED|Stage 1||0
5312640|NCT00467779|13062020|P13|NOT COMPLETED|Stage 1||0
5312641|NCT00467779|13062021|P12|NOT COMPLETED|Stage 1||0
5312642|NCT00467779|13062022|P11|NOT COMPLETED|Stage 1||0
5312643|NCT00467779|13062023|P10|NOT COMPLETED|Stage 1||0
5312644|NCT00467779|13062024|P9|NOT COMPLETED|Stage 1||0
5312645|NCT00467779|13062025|P8|NOT COMPLETED|Stage 1||7
5312646|NCT00467779|13062026|P7|NOT COMPLETED|Stage 1||7
5312647|NCT00467779|13062027|P6|NOT COMPLETED|Stage 1||5
5312648|NCT00467779|13062028|P5|NOT COMPLETED|Stage 1||3
5312649|NCT00467779|13062029|P4|NOT COMPLETED|Stage 1||3
5312650|NCT00467779|13062030|P3|NOT COMPLETED|Stage 1||3
5312651|NCT00467779|13062031|P2|NOT COMPLETED|Stage 1||3
5312652|NCT00467779|13062032|P1|NOT COMPLETED|Stage 1||4
5312653|NCT00467779|13062018|P15|COMPLETED|Stage 1||0
5312654|NCT00467779|13062019|P14|COMPLETED|Stage 1||0
5312655|NCT00467779|13062020|P13|COMPLETED|Stage 1||0
5312656|NCT00467779|13062021|P12|COMPLETED|Stage 1||0
5312657|NCT00467779|13062022|P11|COMPLETED|Stage 1||0
5312658|NCT00467779|13062023|P10|COMPLETED|Stage 1||0
5312659|NCT00467779|13062024|P9|COMPLETED|Stage 1||0
5312660|NCT00467779|13062025|P8|COMPLETED|Stage 1||0
5312661|NCT00467779|13062026|P7|COMPLETED|Stage 1||0
5312662|NCT00467779|13062027|P6|COMPLETED|Stage 1||1
5312663|NCT00467779|13062028|P5|COMPLETED|Stage 1||0
5312664|NCT00467779|13062029|P4|COMPLETED|Stage 1||0
5312665|NCT00467779|13062030|P3|COMPLETED|Stage 1||0
5312666|NCT00467779|13062031|P2|COMPLETED|Stage 1||0
5312667|NCT00467779|13062032|P1|COMPLETED|Stage 1||0
5312668|NCT00467779|13062018|P15|STARTED|Stage 1||0
5312669|NCT00467779|13062019|P14|STARTED|Stage 1||0
5312670|NCT00467779|13062020|P13|STARTED|Stage 1||0
5312671|NCT00467779|13062021|P12|STARTED|Stage 1||0
5312672|NCT00467779|13062022|P11|STARTED|Stage 1||0
5312673|NCT00467779|13062023|P10|STARTED|Stage 1||0
5312674|NCT00467779|13062024|P9|STARTED|Stage 1||0
5312675|NCT00467779|13062025|P8|STARTED|Stage 1||7
5312676|NCT00467779|13062026|P7|STARTED|Stage 1||7
5312677|NCT00467779|13062027|P6|STARTED|Stage 1||6
5312678|NCT00467779|13062028|P5|STARTED|Stage 1||3
5312679|NCT00467779|13062029|P4|STARTED|Stage 1||3
5312680|NCT00467779|13062030|P3|STARTED|Stage 1||3
5312681|NCT00467779|13062031|P2|STARTED|Stage 1||3
5312682|NCT00467779|13062032|P1|STARTED|Stage 1||4
5312683|NCT00467753|13062206|P2|NOT COMPLETED|Overall Study||2
5312684|NCT00467753|13062207|P1|NOT COMPLETED|Overall Study||3
5312685|NCT00467753|13062206|P2|COMPLETED|Overall Study||0
5312686|NCT00467753|13062207|P1|COMPLETED|Overall Study||0
5312687|NCT00467753|13062206|P2|STARTED|Overall Study||2
5312688|NCT00467753|13062207|P1|STARTED|Overall Study||3
5312689|NCT00467740|13062218|P5|NOT COMPLETED|Overall Study||0
5312690|NCT00467740|13062219|P4|NOT COMPLETED|Overall Study||1
5312691|NCT00467740|13062220|P3|NOT COMPLETED|Overall Study||2
5312692|NCT00467740|13062221|P2|NOT COMPLETED|Overall Study||3
5312693|NCT00467740|13062222|P1|NOT COMPLETED|Overall Study||1
5312694|NCT00467740|13062218|P5|COMPLETED|Overall Study||61
5312695|NCT00467740|13062219|P4|COMPLETED|Overall Study||59
5312696|NCT00467740|13062220|P3|COMPLETED|Overall Study||58
5312697|NCT00467740|13062221|P2|COMPLETED|Overall Study||58
5312698|NCT00467740|13062222|P1|COMPLETED|Overall Study||53
5312699|NCT00467740|13062218|P5|STARTED|Overall Study||61
5312700|NCT00467740|13062219|P4|STARTED|Overall Study||60
5312701|NCT00467740|13062220|P3|STARTED|Overall Study||60
5312702|NCT00467740|13062221|P2|STARTED|Overall Study||61
5312703|NCT00467740|13062222|P1|STARTED|Overall Study||54
5312704|NCT00467649|13062411|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
5312705|NCT00467649|13062412|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312706|NCT00467649|13062413|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
5312707|NCT00467649|13062414|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312708|NCT00467649|13062415|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312709|NCT00467649|13062416|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312710|NCT00467649|13062411|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
5312711|NCT00467649|13062412|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
5312712|NCT00467649|13062413|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
5312713|NCT00467649|13062414|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
5312714|NCT00467649|13062415|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312715|NCT00467649|13062416|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
5312716|NCT00467649|13062411|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
5312717|NCT00467649|13062412|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
5312718|NCT00467649|13062413|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
5312719|NCT00467649|13062414|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
5312720|NCT00467649|13062415|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
5312721|NCT00467649|13062416|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
5312722|NCT00467649|13062411|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
5312723|NCT00467649|13062412|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
5312724|NCT00467649|13062413|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
5312725|NCT00467649|13062414|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
5312726|NCT00467649|13062415|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
5312727|NCT00467649|13062416|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
5312728|NCT00467649|13062411|P6|COMPLETED|Phase 1 (Randomized Population)||0
5312729|NCT00467649|13062412|P5|COMPLETED|Phase 1 (Randomized Population)||0
5312730|NCT00467649|13062413|P4|COMPLETED|Phase 1 (Randomized Population)||0
5312731|NCT00467649|13062414|P3|COMPLETED|Phase 1 (Randomized Population)||0
5312732|NCT00467649|13062415|P2|COMPLETED|Phase 1 (Randomized Population)||50
5312733|NCT00467649|13062416|P1|COMPLETED|Phase 1 (Randomized Population)||48
5312734|NCT00467649|13062411|P6|Intent to Treat|Phase 1 (Randomized Population)||0
5312735|NCT00467649|13062412|P5|Intent to Treat|Phase 1 (Randomized Population)||0
5312736|NCT00467649|13062413|P4|Intent to Treat|Phase 1 (Randomized Population)||0
5312737|NCT00467649|13062414|P3|Intent to Treat|Phase 1 (Randomized Population)||0
5312738|NCT00467649|13062415|P2|Intent to Treat|Phase 1 (Randomized Population)||56
5312739|NCT00467649|13062416|P1|Intent to Treat|Phase 1 (Randomized Population)||56
5312740|NCT00467649|13062411|P6|STARTED|Phase 1 (Randomized Population)||0
5312741|NCT00467649|13062412|P5|STARTED|Phase 1 (Randomized Population)||0
5312742|NCT00467649|13062413|P4|STARTED|Phase 1 (Randomized Population)||0
5312743|NCT00467649|13062414|P3|STARTED|Phase 1 (Randomized Population)||0
5312744|NCT00467649|13062415|P2|STARTED|Phase 1 (Randomized Population)||56
5312745|NCT00467649|13062416|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
5312746|NCT00467610|13062456|P1|NOT COMPLETED|Overall Study||1
5312747|NCT00467610|13062456|P1|COMPLETED|Overall Study||5
5312748|NCT00467610|13062456|P1|STARTED|Overall Study||6
5312749|NCT00467597|13062467|P2|NOT COMPLETED|Overall Study||0
5312750|NCT00467597|13062468|P1|NOT COMPLETED|Overall Study||2
5312751|NCT00467597|13062467|P2|COMPLETED|Overall Study||6
5312752|NCT00467597|13062468|P1|COMPLETED|Overall Study||24
5312753|NCT00467597|13062467|P2|STARTED|Overall Study||6
5312754|NCT00467597|13062468|P1|STARTED|Overall Study||26
5312755|NCT00467584|13062481|P3|NOT COMPLETED|Overall Study||1
5312756|NCT00467584|13062482|P2|NOT COMPLETED|Overall Study||5
5312757|NCT00467584|13062483|P1|NOT COMPLETED|Overall Study||4
5312758|NCT00467584|13062481|P3|COMPLETED|Overall Study||20
5312759|NCT00467584|13062482|P2|COMPLETED|Overall Study||15
5312760|NCT00467584|13062483|P1|COMPLETED|Overall Study||17
5312761|NCT00467584|13062481|P3|STARTED|Overall Study||21
5312762|NCT00467584|13062482|P2|STARTED|Overall Study||20
5312763|NCT00467584|13062483|P1|STARTED|Overall Study||21
5312764|NCT00467558|13062493|P2|NOT COMPLETED|Overall Study||0
5312765|NCT00467558|13062494|P1|NOT COMPLETED|Overall Study||2
5312766|NCT00467558|13062493|P2|COMPLETED|Overall Study||3
5312767|NCT00467558|13062494|P1|COMPLETED|Overall Study||2
5312768|NCT00467558|13062493|P2|STARTED|Overall Study||3
5312769|NCT00467558|13062494|P1|STARTED|Overall Study||4
5312770|NCT00467519|13062504|P2|NOT COMPLETED|Overall Study||23
5312771|NCT00467519|13062505|P1|NOT COMPLETED|Overall Study||14
5312772|NCT00467519|13062504|P2|COMPLETED|Overall Study||488
5312773|NCT00467519|13062505|P1|COMPLETED|Overall Study||517
5312774|NCT00467519|13062504|P2|STARTED|Overall Study||511
5312775|NCT00467519|13062505|P1|STARTED|Overall Study||531
5312776|NCT00467389|13062521|P2|NOT COMPLETED|Overall Study||0
5312777|NCT00467389|13062522|P1|NOT COMPLETED|Overall Study||0
5312778|NCT00467389|13062521|P2|COMPLETED|Overall Study||6
5312779|NCT00467389|13062522|P1|COMPLETED|Overall Study||6
5312780|NCT00467389|13062521|P2|STARTED|Overall Study||6
5312781|NCT00467389|13062522|P1|STARTED|Overall Study||6
5312782|NCT00467363|13062534|P2|NOT COMPLETED|Overall Study||70
5312783|NCT00467363|13062535|P1|NOT COMPLETED|Overall Study||80
5312784|NCT00467363|13062534|P2|COMPLETED|Overall Study||543
5312785|NCT00467363|13062535|P1|COMPLETED|Overall Study||535
5312786|NCT00467363|13062534|P2|STARTED|Overall Study||613
5312787|NCT00467363|13062535|P1|STARTED|Overall Study||615
5312788|NCT00467298|13062571|P2|NOT COMPLETED|Overall Study||6
5312789|NCT00467298|13062572|P1|NOT COMPLETED|Overall Study||4
5312790|NCT00467298|13062571|P2|COMPLETED|Overall Study||38
5312791|NCT00467298|13062572|P1|COMPLETED|Overall Study||42
5312792|NCT00467298|13062571|P2|STARTED|Overall Study||44
5312793|NCT00467298|13062572|P1|STARTED|Overall Study||46
5312794|NCT00467285|13062582|P2|NOT COMPLETED|Overall Study||4
5312795|NCT00467285|13062583|P1|NOT COMPLETED|Overall Study||4
5312796|NCT00467285|13062582|P2|COMPLETED|Overall Study||60
5312797|NCT00467285|13062583|P1|COMPLETED|Overall Study||28
5312798|NCT00467285|13062582|P2|STARTED|Overall Study||64
5312799|NCT00467285|13062583|P1|STARTED|Overall Study||32
5312800|NCT00467259|13062603|P2|NOT COMPLETED|Overall Study||242
5312801|NCT00467259|13062604|P1|NOT COMPLETED|Overall Study||75
5312802|NCT00467259|13062603|P2|COMPLETED|Overall Study||778
5312803|NCT00467259|13062604|P1|COMPLETED|Overall Study||176
5312804|NCT00467259|13062603|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
5312805|NCT00467259|13062604|P1|ITT Population|Overall Study||251
5312806|NCT00467259|13062603|P2|STARTED|Overall Study||1020
5312807|NCT00467259|13062604|P1|STARTED|Overall Study||251
5312808|NCT00467077|13062614|P1|NOT COMPLETED|Overall Study||0
5312809|NCT00467077|13062614|P1|COMPLETED|Overall Study||21
5312810|NCT00467077|13062614|P1|STARTED|Overall Study||21
5312811|NCT00467051|13062621|P1|NOT COMPLETED|Overall Study||2
5312812|NCT00467051|13062621|P1|COMPLETED|Overall Study||18
5312813|NCT00467051|13062621|P1|STARTED|Overall Study||20
5312814|NCT00467038|13062628|P2|NOT COMPLETED|Overall Study||0
5312815|NCT00467038|13062629|P1|NOT COMPLETED|Overall Study||0
5312816|NCT00467038|13062628|P2|COMPLETED|Overall Study||11
5312817|NCT00467038|13062629|P1|COMPLETED|Overall Study||11
5312818|NCT00467038|13062628|P2|STARTED|Overall Study||11
5312819|NCT00467038|13062629|P1|STARTED|Overall Study||11
5312820|NCT00466960|13062637|P1|NOT COMPLETED|Overall Study||0
5312821|NCT00466960|13062637|P1|COMPLETED|Overall Study||21
5312822|NCT00466960|13062637|P1|STARTED|Overall Study||21
5312823|NCT00466947|13062648|P2|NOT COMPLETED|Study End Analysis Period||2534
5312824|NCT00466947|13062649|P1|NOT COMPLETED|Study End Analysis Period||2496
5312825|NCT00466947|13062648|P2|COMPLETED|Study End Analysis Period||9265
5312826|NCT00466947|13062649|P1|COMPLETED|Study End Analysis Period||9302
5312827|NCT00466947|13062648|P2|STARTED|Study End Analysis Period||11799
5312828|NCT00466947|13062649|P1|STARTED|Study End Analysis Period||11798
5312829|NCT00466947|13062648|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
5312830|NCT00466947|13062649|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
5312831|NCT00466947|13062648|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
5312832|NCT00466947|13062649|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
5312833|NCT00466947|13062648|P2|Ongoing|Primary Outcome Analysis Period||11863
5312834|NCT00466947|13062649|P1|Ongoing|Primary Outcome Analysis Period||11875
5312835|NCT00466947|13062648|P2|STARTED|Primary Outcome Analysis Period||11863
5312836|NCT00466947|13062649|P1|STARTED|Primary Outcome Analysis Period||11875
5312837|NCT00466817|13062773|P2|NOT COMPLETED|Overall Study||4
5312838|NCT00466817|13062774|P1|NOT COMPLETED|Overall Study||5
5312839|NCT00466817|13062773|P2|COMPLETED|Overall Study||43
5312840|NCT00466817|13062774|P1|COMPLETED|Overall Study||44
5312841|NCT00466817|13062773|P2|STARTED|Overall Study||47
5312842|NCT00466817|13062774|P1|STARTED|Overall Study||49
5312843|NCT00466752|13062829|P2|NOT COMPLETED|Overall Study||0
5312844|NCT00466752|13062830|P1|NOT COMPLETED|Overall Study||0
5312845|NCT00466752|13062829|P2|COMPLETED|Overall Study||0
5312846|NCT00466752|13062830|P1|COMPLETED|Overall Study||5
5312847|NCT00466752|13062829|P2|STARTED|Overall Study||0
5312848|NCT00466752|13062830|P1|STARTED|Overall Study||5
5312849|NCT00466726|13062840|P1|NOT COMPLETED|Overall Study||14
5312850|NCT00466726|13062840|P1|COMPLETED|Overall Study||43
5312851|NCT00466726|13062840|P1|STARTED|Overall Study||57
5312852|NCT00466687|13062846|P1|NOT COMPLETED|Overall Study||34
5312853|NCT00466687|13062846|P1|COMPLETED|Overall Study||0
5312854|NCT00466687|13062846|P1|STARTED|Overall Study||34
5312855|NCT00466661|13062855|P2|NOT COMPLETED|Overall Study||6
5312856|NCT00466661|13062856|P1|NOT COMPLETED|Overall Study||4
5312857|NCT00466661|13062855|P2|COMPLETED|Overall Study||11
5312858|NCT00466661|13062856|P1|COMPLETED|Overall Study||12
5312859|NCT00466661|13062855|P2|At Least 1 Postrandomization Visit|Overall Study||16
5312860|NCT00466661|13062856|P1|At Least 1 Postrandomization Visit|Overall Study||14
5312861|NCT00466661|13062855|P2|STARTED|Overall Study||17
5312862|NCT00466661|13062856|P1|STARTED|Overall Study||16
5312863|NCT00466505|13062878|P1|NOT COMPLETED|Overall Study||17
5312864|NCT00466505|13062878|P1|COMPLETED|Overall Study||0
5312865|NCT00466505|13062878|P1|STARTED|Overall Study||17
5312866|NCT00466323|13062892|P2|NOT COMPLETED|Overall Study||23
5312867|NCT00466323|13062893|P1|NOT COMPLETED|Overall Study||28
5312868|NCT00466323|13062892|P2|COMPLETED|Overall Study||92
5312869|NCT00466323|13062893|P1|COMPLETED|Overall Study||89
5312870|NCT00466323|13062892|P2|STARTED|Overall Study||115
5312871|NCT00466323|13062893|P1|STARTED|Overall Study||117
5312872|NCT00466310|13062908|P3|NOT COMPLETED|Overall Study||0
5312873|NCT00466310|13062909|P2|NOT COMPLETED|Overall Study||0
5312874|NCT00466310|13062910|P1|NOT COMPLETED|Overall Study||0
5312875|NCT00466310|13062908|P3|COMPLETED|Overall Study||31
5312876|NCT00466310|13062909|P2|COMPLETED|Overall Study||20
5312877|NCT00466310|13062910|P1|COMPLETED|Overall Study||20
5312878|NCT00466310|13062908|P3|STARTED|Overall Study||31
5312879|NCT00466310|13062909|P2|STARTED|Overall Study||20
5312880|NCT00466310|13062910|P1|STARTED|Overall Study||20
5312881|NCT00466206|13062918|P1|NOT COMPLETED|Overall Study||0
5312882|NCT00466206|13062918|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
5312883|NCT00466206|13062918|P1|STARTED|Overall Study||10
5312884|NCT00466193|13062928|P2|NOT COMPLETED|Overall Study||8
5312885|NCT00466193|13062929|P1|NOT COMPLETED|Overall Study||12
5312886|NCT00466193|13062928|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
5312887|NCT00466193|13062929|P1|COMPLETED|Overall Study||138
5312888|NCT00466193|13062928|P2|STARTED|Overall Study||145
5312889|NCT00466193|13062929|P1|STARTED|Overall Study||150
5312890|NCT00466167|13062956|P3|NOT COMPLETED|Overall Study||21
5312891|NCT00466167|13062957|P2|NOT COMPLETED|Overall Study||12
5312892|NCT00466167|13062958|P1|NOT COMPLETED|Overall Study||20
5312893|NCT00466167|13062956|P3|COMPLETED|Overall Study||157
5312894|NCT00466167|13062957|P2|COMPLETED|Overall Study||163
5312895|NCT00466167|13062958|P1|COMPLETED|Overall Study||145
5312896|NCT00466167|13062956|P3|STARTED|Overall Study||178
5312897|NCT00466167|13062957|P2|STARTED|Overall Study||175
5312898|NCT00466167|13062958|P1|STARTED|Overall Study||165
5312899|NCT00465998|13063014|P1|NOT COMPLETED|Overall Study||0
5312900|NCT00465998|13063014|P1|COMPLETED|Overall Study||275
5312901|NCT00465998|13063014|P1|STARTED|Overall Study||275
5312902|NCT00465985|13063019|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
5312903|NCT00465985|13063020|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
5312904|NCT00465985|13063019|P2|COMPLETED|Part III - Open-label Treatment Period||0
5312905|NCT00465985|13063020|P1|COMPLETED|Part III - Open-label Treatment Period||29
5312906|NCT00465985|13063019|P2|STARTED|Part III - Open-label Treatment Period||0
5312907|NCT00465985|13063020|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
5312908|NCT00465985|13063019|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
5312909|NCT00465985|13063020|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
5312910|NCT00465985|13063019|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
5312911|NCT00465985|13063020|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
5312912|NCT00465985|13063019|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
5312913|NCT00465985|13063020|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
5312914|NCT00465985|13063019|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
5312915|NCT00465985|13063020|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
5312916|NCT00465985|13063019|P2|COMPLETED|Part I - Open-label Treatment Period||0
5312917|NCT00465985|13063020|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
5312918|NCT00465985|13063019|P2|STARTED|Part I - Open-label Treatment Period||0
5312919|NCT00465985|13063020|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
5312920|NCT00465972|13063043|P2|NOT COMPLETED|Overall Study||1
5312921|NCT00465972|13063044|P1|NOT COMPLETED|Overall Study||2
5312922|NCT00465972|13063043|P2|COMPLETED|Overall Study||23
5312923|NCT00465972|13063044|P1|COMPLETED|Overall Study||18
5312924|NCT00465972|13063043|P2|STARTED|Overall Study||24
5312925|NCT00465972|13063044|P1|STARTED|Overall Study||20
5312926|NCT00465894|13063054|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
5312927|NCT00465894|13063055|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
5312928|NCT00465894|13063054|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
5312929|NCT00465894|13063055|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
5312930|NCT00465894|13063054|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
5312931|NCT00465894|13063055|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
5312932|NCT00465894|13063054|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
5312933|NCT00465894|13063055|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
5312934|NCT00465894|13063054|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
5312935|NCT00465894|13063055|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
5312936|NCT00465894|13063054|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
5312937|NCT00465894|13063055|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
5312938|NCT00465894|13063054|P2|NOT COMPLETED|Treatment For 12 Weeks||3
5312939|NCT00465894|13063055|P1|NOT COMPLETED|Treatment For 12 Weeks||5
5312940|NCT00465894|13063054|P2|COMPLETED|Treatment For 12 Weeks||25
5312941|NCT00465894|13063055|P1|COMPLETED|Treatment For 12 Weeks||25
5312942|NCT00465894|13063054|P2|STARTED|Treatment For 12 Weeks||28
5312943|NCT00465894|13063055|P1|STARTED|Treatment For 12 Weeks||30
5312944|NCT00465816|13063088|P3|NOT COMPLETED|Overall Study||2
5312945|NCT00465816|13063089|P2|NOT COMPLETED|Overall Study||0
5312946|NCT00465816|13063090|P1|NOT COMPLETED|Overall Study||0
5312947|NCT00465816|13063088|P3|COMPLETED|Overall Study||120
5312948|NCT00465816|13063089|P2|COMPLETED|Overall Study||122
5312949|NCT00465816|13063090|P1|COMPLETED|Overall Study||367
5312950|NCT00465816|13063088|P3|STARTED|Overall Study||122
5312951|NCT00465816|13063089|P2|STARTED|Overall Study||122
5312952|NCT00465816|13063090|P1|STARTED|Overall Study||367
5312953|NCT00465738|13063153|P2|NOT COMPLETED|Overall Study||6
5312954|NCT00465738|13063154|P1|NOT COMPLETED|Overall Study||6
5312955|NCT00465738|13063153|P2|COMPLETED|Overall Study||89
5312956|NCT00465738|13063154|P1|COMPLETED|Overall Study||91
5312957|NCT00465738|13063153|P2|STARTED|Overall Study||95
5312958|NCT00465738|13063154|P1|STARTED|Overall Study||97
5312959|NCT00465647|13063248|P4|NOT COMPLETED|Overall Study||13
5312960|NCT00465647|13063249|P3|NOT COMPLETED|Overall Study||11
5312961|NCT00465647|13063250|P2|NOT COMPLETED|Overall Study||8
5312962|NCT00465647|13063251|P1|NOT COMPLETED|Overall Study||13
5312963|NCT00465647|13063248|P4|COMPLETED|Overall Study||12
5312964|NCT00465647|13063249|P3|COMPLETED|Overall Study||18
5312965|NCT00465647|13063250|P2|COMPLETED|Overall Study||15
5312966|NCT00465647|13063251|P1|COMPLETED|Overall Study||26
5312967|NCT00465647|13063248|P4|STARTED|Overall Study||25
5312968|NCT00465647|13063249|P3|STARTED|Overall Study||29
5312969|NCT00465647|13063250|P2|STARTED|Overall Study||23
5312970|NCT00465647|13063251|P1|STARTED|Overall Study||39
5312971|NCT00465595|13063276|P2|NOT COMPLETED|Overall Study||5
5312972|NCT00465595|13063277|P1|NOT COMPLETED|Overall Study||5
5312973|NCT00465595|13063276|P2|COMPLETED|Overall Study||24
5312974|NCT00465595|13063277|P1|COMPLETED|Overall Study||22
5312975|NCT00465595|13063276|P2|STARTED|Overall Study||29
5312976|NCT00465595|13063277|P1|STARTED|Overall Study||27
5312977|NCT00465569|13063299|P2|NOT COMPLETED|Overall Study||0
5312978|NCT00465569|13063300|P1|NOT COMPLETED|Overall Study||1
5312979|NCT00465569|13063299|P2|COMPLETED|Overall Study||7
5312980|NCT00465569|13063300|P1|COMPLETED|Overall Study||12
5312981|NCT00465569|13063299|P2|STARTED|Overall Study||7
5312982|NCT00465569|13063300|P1|STARTED|Overall Study||13
5312983|NCT00465530|13063312|P2|NOT COMPLETED|Overall Study||4
5312984|NCT00465530|13063313|P1|NOT COMPLETED|Overall Study||2
5312985|NCT00465530|13063312|P2|COMPLETED|Overall Study||15
5312986|NCT00465530|13063313|P1|COMPLETED|Overall Study||19
5312987|NCT00465530|13063312|P2|STARTED|Overall Study||19
5312988|NCT00465530|13063313|P1|STARTED|Overall Study||21
5312989|NCT00465361|13063323|P1|NOT COMPLETED|Post-Intervention Assessment||0
5312990|NCT00465361|13063323|P1|COMPLETED|Post-Intervention Assessment||3
5312991|NCT00465361|13063323|P1|STARTED|Post-Intervention Assessment||3
5312992|NCT00465361|13063323|P1|NOT COMPLETED|Baseline Assessment||4
5312993|NCT00465361|13063323|P1|COMPLETED|Baseline Assessment||3
5312994|NCT00465361|13063323|P1|STARTED|Baseline Assessment||7
5312995|NCT00465270|13063329|P2|NOT COMPLETED|Overall Study||160
5312996|NCT00465270|13063330|P1|NOT COMPLETED|Overall Study||104
5312997|NCT00465270|13063329|P2|COMPLETED|Overall Study||321
5312998|NCT00465270|13063330|P1|COMPLETED|Overall Study||395
5312999|NCT00465270|13063329|P2|STARTED|Overall Study||481
5313000|NCT00465270|13063330|P1|STARTED|Overall Study||499
5313001|NCT00465179|13063339|P1|NOT COMPLETED|Overall Study||53
5313002|NCT00465179|13063339|P1|COMPLETED|Overall Study||4
5313003|NCT00465179|13063339|P1|STARTED|Overall Study||57
5313004|NCT00465101|13063345|P1|NOT COMPLETED|Overall Study||59
5313005|NCT00465101|13063345|P1|COMPLETED|Overall Study||91
5313006|NCT00465101|13063345|P1|STARTED|Overall Study||150
5313007|NCT00465088|13063380|P2|NOT COMPLETED|Overall Study||9
5313008|NCT00465088|13063381|P1|NOT COMPLETED|Overall Study||32
5313009|NCT00465088|13063380|P2|COMPLETED|Overall Study||70
5313010|NCT00465088|13063381|P1|COMPLETED|Overall Study||82
5313011|NCT00465088|13063380|P2|STARTED|Overall Study||79
5313012|NCT00465088|13063381|P1|STARTED|Overall Study|For both arms, started means treated.|114
5313013|NCT00464945|13063415|P2|NOT COMPLETED|Toddler Dose||1
5313014|NCT00464945|13063416|P1|NOT COMPLETED|Toddler Dose||0
5313015|NCT00464945|13063415|P2|COMPLETED|Toddler Dose||130
5313016|NCT00464945|13063416|P1|COMPLETED|Toddler Dose||131
5313017|NCT00464945|13063415|P2|STARTED|Toddler Dose||131
5313018|NCT00464945|13063416|P1|STARTED|Toddler Dose||131
5313019|NCT00464945|13063415|P2|NOT COMPLETED|After Infant Series||2
5313020|NCT00464945|13063416|P1|NOT COMPLETED|After Infant Series||0
5313021|NCT00464945|13063415|P2|COMPLETED|After Infant Series||131
5313022|NCT00464945|13063416|P1|COMPLETED|After Infant Series||131
5313023|NCT00464945|13063415|P2|STARTED|After Infant Series||133
5313024|NCT00464945|13063416|P1|STARTED|After Infant Series||131
5313025|NCT00464945|13063415|P2|NOT COMPLETED|Infant Series||1
5313026|NCT00464945|13063416|P1|NOT COMPLETED|Infant Series||4
5313027|NCT00464945|13063415|P2|COMPLETED|Infant Series||133
5313028|NCT00464945|13063416|P1|COMPLETED|Infant Series||131
5313029|NCT00464945|13063415|P2|Vaccinated Dose 3|Infant Series||133
5313030|NCT00464945|13063416|P1|Vaccinated Dose 3|Infant Series||132
5313031|NCT00464945|13063415|P2|Vaccinated Dose 2|Infant Series||133
5313032|NCT00464945|13063416|P1|Vaccinated Dose 2|Infant Series||132
5313033|NCT00464945|13063415|P2|Vaccinated Dose 1|Infant Series||134
5313034|NCT00464945|13063416|P1|Vaccinated Dose 1|Infant Series||134
5313035|NCT00464945|13063415|P2|STARTED|Infant Series||134
5313036|NCT00464945|13063416|P1|STARTED|Infant Series||135
5313037|NCT00464815|13063446|P2|NOT COMPLETED|Overall Study||3
5313038|NCT00464815|13063447|P1|NOT COMPLETED|Overall Study||6
5313039|NCT00464815|13063446|P2|COMPLETED|Overall Study||254
5313040|NCT00464815|13063447|P1|COMPLETED|Overall Study||762
5313041|NCT00464815|13063446|P2|STARTED|Overall Study||257
5313042|NCT00464815|13063447|P1|STARTED|Overall Study||768
5313043|NCT00464737|13063480|P3|NOT COMPLETED|Overall Study||55
5313044|NCT00464737|13063481|P2|NOT COMPLETED|Overall Study||32
5313045|NCT00464737|13063482|P1|NOT COMPLETED|Overall Study||32
5313046|NCT00464737|13063480|P3|COMPLETED|Overall Study||19
5313047|NCT00464737|13063481|P2|COMPLETED|Overall Study||42
5313048|NCT00464737|13063482|P1|COMPLETED|Overall Study||50
5313049|NCT00464737|13063480|P3|STARTED|Overall Study||74
5313050|NCT00464737|13063481|P2|STARTED|Overall Study||74
5313051|NCT00464737|13063482|P1|STARTED|Overall Study||82
5313052|NCT00464711|13063529|P1|NOT COMPLETED|Overall Study||15
5313053|NCT00464711|13063529|P1|COMPLETED|Overall Study||25
5313054|NCT00464711|13063529|P1|STARTED|Overall Study||40
5313055|NCT00464698|13063533|P1|NOT COMPLETED|Period 3: 120mg||2
5313056|NCT00464698|13063533|P1|COMPLETED|Period 3: 120mg||12
5313057|NCT00464698|13063533|P1|STARTED|Period 3: 120mg||14
5313058|NCT00464698|13063533|P1|NOT COMPLETED|Period 2: 60 mg||0
5313059|NCT00464698|13063533|P1|COMPLETED|Period 2: 60 mg||17
5313060|NCT00464698|13063533|P1|STARTED|Period 2: 60 mg||17
5313061|NCT00464698|13063533|P1|NOT COMPLETED|Period 1: 30 mg||3
5313062|NCT00464698|13063533|P1|COMPLETED|Period 1: 30 mg||17
5313063|NCT00464698|13063533|P1|STARTED|Period 1: 30 mg||20
5313064|NCT00464685|13063545|P2|NOT COMPLETED|Overall Study||33
5313065|NCT00464685|13063546|P1|NOT COMPLETED|Overall Study||23
5313066|NCT00464685|13063545|P2|COMPLETED|Overall Study||94
5313067|NCT00464685|13063546|P1|COMPLETED|Overall Study||103
5313068|NCT00464685|13063545|P2|STARTED|Overall Study||127
5313069|NCT00464685|13063546|P1|STARTED|Overall Study||126
5313070|NCT00464672|13063562|P6|NOT COMPLETED|Overall Study||4
5313071|NCT00464672|13063563|P5|NOT COMPLETED|Overall Study||10
5313072|NCT00464672|13063564|P4|NOT COMPLETED|Overall Study||1
5313073|NCT00464672|13063565|P3|NOT COMPLETED|Overall Study||0
5313074|NCT00464672|13063566|P2|NOT COMPLETED|Overall Study||10
5313075|NCT00464672|13063567|P1|NOT COMPLETED|Overall Study||25
5313076|NCT00464672|13063562|P6|COMPLETED|Overall Study||195
5313077|NCT00464672|13063563|P5|COMPLETED|Overall Study||392
5313078|NCT00464672|13063564|P4|COMPLETED|Overall Study||199
5313079|NCT00464672|13063565|P3|COMPLETED|Overall Study||400
5313080|NCT00464672|13063566|P2|COMPLETED|Overall Study||222
5313081|NCT00464672|13063567|P1|COMPLETED|Overall Study||435
5313082|NCT00464672|13063562|P6|STARTED|Overall Study||199
5313083|NCT00464672|13063563|P5|STARTED|Overall Study||402
5313084|NCT00464672|13063564|P4|STARTED|Overall Study||200
5313085|NCT00464672|13063565|P3|STARTED|Overall Study||400
5313086|NCT00464672|13063566|P2|STARTED|Overall Study||232
5313087|NCT00464672|13063567|P1|STARTED|Overall Study||460
5313088|NCT00464646|13063639|P2|NOT COMPLETED|Overall Study||0
5313089|NCT00464646|13063640|P1|NOT COMPLETED|Overall Study||0
5313090|NCT00464646|13063639|P2|COMPLETED|Overall Study||29
5313091|NCT00464646|13063640|P1|COMPLETED|Overall Study||76
5313092|NCT00464646|13063639|P2|STARTED|Overall Study||29
5313093|NCT00464646|13063640|P1|STARTED|Overall Study||76
5313094|NCT00464620|13063646|P3|NOT COMPLETED|Overall Study||7
5313095|NCT00464620|13063647|P2|NOT COMPLETED|Overall Study||2
5313096|NCT00464620|13063648|P1|NOT COMPLETED|Overall Study||2
5313097|NCT00464620|13063646|P3|COMPLETED|Overall Study||109
5313098|NCT00464620|13063647|P2|COMPLETED|Overall Study||198
5313099|NCT00464620|13063648|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
5313100|NCT00464620|13063646|P3|STARTED|Overall Study||116
5313101|NCT00464620|13063647|P2|STARTED|Overall Study||200
5313102|NCT00464620|13063648|P1|STARTED|Overall Study||50
5313103|NCT00464568|13063675|P1|NOT COMPLETED|Overall Study||2
5313104|NCT00464568|13063675|P1|COMPLETED|Overall Study||30
5313105|NCT00464568|13063675|P1|STARTED|Overall Study||32
5313106|NCT00464542|13063748|P1|NOT COMPLETED|Post-treatment||0
5313107|NCT00464542|13063748|P1|COMPLETED|Post-treatment||10
5313108|NCT00464542|13063748|P1|STARTED|Post-treatment||10
5313109|NCT00464542|13063748|P1|NOT COMPLETED|Pre-treatment||2
5313110|NCT00464542|13063748|P1|COMPLETED|Pre-treatment||10
5313111|NCT00464542|13063748|P1|STARTED|Pre-treatment||12
5313112|NCT00464490|13063755|P2|NOT COMPLETED|Overall Study||11
5313113|NCT00464490|13063756|P1|NOT COMPLETED|Overall Study||11
5313114|NCT00464490|13063755|P2|COMPLETED|Overall Study||10
5313115|NCT00464490|13063756|P1|COMPLETED|Overall Study||10
5313116|NCT00464490|13063755|P2|STARTED|Overall Study||21
5313117|NCT00464490|13063756|P1|STARTED|Overall Study||21
5313118|NCT00464464|13063764|P2|NOT COMPLETED|Overall Study||3
5313119|NCT00464464|13063765|P1|NOT COMPLETED|Overall Study||5
5313120|NCT00464464|13063764|P2|COMPLETED|Overall Study||36
5313121|NCT00464464|13063765|P1|COMPLETED|Overall Study||36
5313122|NCT00464464|13063764|P2|STARTED|Overall Study||39
5313123|NCT00464464|13063765|P1|STARTED|Overall Study||41
5313124|NCT00464438|13063779|P2|NOT COMPLETED|Overall Study||6
5313125|NCT00464438|13063780|P1|NOT COMPLETED|Overall Study||2
5313126|NCT00464438|13063779|P2|COMPLETED|Overall Study||80
5313127|NCT00464438|13063780|P1|COMPLETED|Overall Study||83
5313128|NCT00464438|13063779|P2|STARTED|Overall Study||86
5313129|NCT00464438|13063780|P1|STARTED|Overall Study||85
5313130|NCT00464334|13063803|P11|NOT COMPLETED|Overall Study||4
5313131|NCT00464334|13063804|P10|NOT COMPLETED|Overall Study||1
5313132|NCT00464334|13063805|P9|NOT COMPLETED|Overall Study||6
5313133|NCT00464334|13063806|P8|NOT COMPLETED|Overall Study||1
5313134|NCT00464334|13063807|P7|NOT COMPLETED|Overall Study||3
5313135|NCT00464334|13063808|P6|NOT COMPLETED|Overall Study||4
5313136|NCT00464334|13063809|P5|NOT COMPLETED|Overall Study||4
5313137|NCT00464334|13063810|P4|NOT COMPLETED|Overall Study||4
5313138|NCT00464334|13063811|P3|NOT COMPLETED|Overall Study||5
5313139|NCT00464334|13063812|P2|NOT COMPLETED|Overall Study||8
5313140|NCT00464334|13063813|P1|NOT COMPLETED|Overall Study||1
5313141|NCT00464334|13063803|P11|COMPLETED|Overall Study||4
5313142|NCT00464334|13063804|P10|COMPLETED|Overall Study||4
5313143|NCT00464334|13063805|P9|COMPLETED|Overall Study||2
5313144|NCT00464334|13063806|P8|COMPLETED|Overall Study||7
5313145|NCT00464334|13063807|P7|COMPLETED|Overall Study||6
5313146|NCT00464334|13063808|P6|COMPLETED|Overall Study||3
5313147|NCT00464334|13063809|P5|COMPLETED|Overall Study||3
5313148|NCT00464334|13063810|P4|COMPLETED|Overall Study||4
5313149|NCT00464334|13063811|P3|COMPLETED|Overall Study||3
5313150|NCT00464334|13063812|P2|COMPLETED|Overall Study||5
5313151|NCT00464334|13063813|P1|COMPLETED|Overall Study||4
5313152|NCT00464334|13063803|P11|STARTED|Overall Study||8
5313153|NCT00464334|13063804|P10|STARTED|Overall Study||5
5313154|NCT00464334|13063805|P9|STARTED|Overall Study||8
5313155|NCT00464334|13063806|P8|STARTED|Overall Study||8
5313156|NCT00464334|13063807|P7|STARTED|Overall Study||9
5313157|NCT00464334|13063808|P6|STARTED|Overall Study||7
5313158|NCT00464334|13063809|P5|STARTED|Overall Study||7
5313159|NCT00464334|13063810|P4|STARTED|Overall Study||8
5313160|NCT00464334|13063811|P3|STARTED|Overall Study||8
5313161|NCT00464334|13063812|P2|STARTED|Overall Study||13
5313162|NCT00464334|13063813|P1|STARTED|Overall Study||5
5313163|NCT00464308|13063873|P3|NOT COMPLETED|Overall Study||59
5313164|NCT00464308|13063874|P2|NOT COMPLETED|Overall Study||63
5313165|NCT00464308|13063875|P1|NOT COMPLETED|Overall Study||69
5313166|NCT00464308|13063873|P3|COMPLETED|Overall Study||400
5313167|NCT00464308|13063874|P2|COMPLETED|Overall Study||406
5313168|NCT00464308|13063875|P1|COMPLETED|Overall Study||395
5313169|NCT00464308|13063873|P3|STARTED|Overall Study||459
5313170|NCT00464308|13063874|P2|STARTED|Overall Study||469
5313171|NCT00464308|13063875|P1|STARTED|Overall Study||464
5313172|NCT00464269|13063905|P4|NOT COMPLETED|Overall Study||9
5313173|NCT00464269|13063906|P3|NOT COMPLETED|Overall Study||7
5313174|NCT00464269|13063907|P2|NOT COMPLETED|Overall Study||17
5313175|NCT00464269|13063908|P1|NOT COMPLETED|Overall Study||6
5313176|NCT00464269|13063905|P4|COMPLETED|Overall Study||93
5313177|NCT00464269|13063906|P3|COMPLETED|Overall Study||93
5313178|NCT00464269|13063907|P2|COMPLETED|Overall Study||82
5313179|NCT00464269|13063908|P1|COMPLETED|Overall Study||93
5313180|NCT00464269|13063905|P4|STARTED|Overall Study||102
5313181|NCT00464269|13063906|P3|STARTED|Overall Study||100
5313182|NCT00464269|13063907|P2|STARTED|Overall Study||99
5313183|NCT00464269|13063908|P1|STARTED|Overall Study||99
5313184|NCT00464204|13064008|P2|NOT COMPLETED|Overall Study||32
5313185|NCT00464204|13064009|P1|NOT COMPLETED|Overall Study||49
5313186|NCT00464204|13064008|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
5313187|NCT00464204|13064009|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
5313188|NCT00464204|13064008|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
5313189|NCT00464204|13064009|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
5313190|NCT00464204|13064008|P2|Day 90 Follow-up Performed|Overall Study||74
5313191|NCT00464204|13064009|P1|Day 90 Follow-up Performed|Overall Study||69
5313192|NCT00464204|13064008|P2|Day 30 Follow-up Performed|Overall Study||83
5313193|NCT00464204|13064009|P1|Day 30 Follow-up Performed|Overall Study||89
5313194|NCT00464204|13064008|P2|Completed Treatment|Overall Study||83
5313195|NCT00464204|13064009|P1|Completed Treatment|Overall Study||81
5313196|NCT00464204|13064008|P2|STARTED|Overall Study||96
5313197|NCT00464204|13064009|P1|STARTED|Overall Study||100
5313198|NCT00464087|13064046|P3|NOT COMPLETED|Overall Study||29
5313199|NCT00464087|13064047|P2|NOT COMPLETED|Overall Study||0
5313200|NCT00464087|13064048|P1|NOT COMPLETED|Overall Study||0
5313201|NCT00464087|13064046|P3|COMPLETED|Overall Study||0
5313202|NCT00464087|13064047|P2|COMPLETED|Overall Study||51
5313203|NCT00464087|13064048|P1|COMPLETED|Overall Study||49
5313204|NCT00464087|13064046|P3|STARTED|Overall Study||29
5313205|NCT00464087|13064047|P2|STARTED|Overall Study||51
5313206|NCT00464087|13064048|P1|STARTED|Overall Study||49
5313207|NCT00463866|13064066|P2|NOT COMPLETED|Overall Study||340
5313208|NCT00463866|13064067|P1|NOT COMPLETED|Overall Study||309
5313209|NCT00463866|13064066|P2|COMPLETED|Overall Study||3705
5313210|NCT00463866|13064067|P1|COMPLETED|Overall Study||3699
5313211|NCT00463866|13064066|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
5313212|NCT00463866|13064067|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
5313213|NCT00463840|13064087|P1|NOT COMPLETED|Overall Study||12
5313214|NCT00463840|13064087|P1|COMPLETED|Overall Study||12
5313215|NCT00463840|13064087|P1|STARTED|Overall Study||24
5313216|NCT00463801|13064092|P1|NOT COMPLETED|Overall Study||13
5313217|NCT00463801|13064092|P1|COMPLETED|Overall Study||39
5313218|NCT00463801|13064092|P1|STARTED|Overall Study||52
5313219|NCT00463788|13064098|P2|NOT COMPLETED|Overall Study||54
5313220|NCT00463788|13064099|P1|NOT COMPLETED|Overall Study||109
5313221|NCT00463788|13064098|P2|COMPLETED|Overall Study||4
5313222|NCT00463788|13064099|P1|COMPLETED|Overall Study||6
5313223|NCT00463788|13064098|P2|Treated|Overall Study||57
5313224|NCT00463788|13064099|P1|Treated|Overall Study||114
5313225|NCT00463788|13064098|P2|STARTED|Overall Study||58
5313226|NCT00463788|13064099|P1|STARTED|Overall Study||115
5313227|NCT00463684|13064114|P1|NOT COMPLETED|Overall Study||4
5313228|NCT00463684|13064114|P1|COMPLETED|Overall Study||274
5313229|NCT00463684|13064114|P1|STARTED|Overall Study||278
5313230|NCT00463606|13064132|P3|NOT COMPLETED|Overall Study||20
5313231|NCT00463606|13064133|P2|NOT COMPLETED|Overall Study||34
5313232|NCT00463606|13064134|P1|NOT COMPLETED|Overall Study||41
5313233|NCT00463606|13064132|P3|COMPLETED|Overall Study||231
5313234|NCT00463606|13064133|P2|COMPLETED|Overall Study||220
5313235|NCT00463606|13064134|P1|COMPLETED|Overall Study||212
5313236|NCT00463606|13064132|P3|STARTED|Overall Study||251
5313237|NCT00463606|13064133|P2|STARTED|Overall Study||254
5313238|NCT00463606|13064134|P1|STARTED|Overall Study||253
5313239|NCT00463580|13064159|P2|NOT COMPLETED|Overall Study||2
5313240|NCT00463580|13064160|P1|NOT COMPLETED|Overall Study||3
5313241|NCT00463580|13064159|P2|COMPLETED|Overall Study||28
5313242|NCT00463580|13064160|P1|COMPLETED|Overall Study||27
5313243|NCT00463580|13064159|P2|STARTED|Overall Study||30
5313244|NCT00463580|13064160|P1|STARTED|Overall Study||30
5313245|NCT00463567|13064193|P7|NOT COMPLETED|Overall Study||11
5313246|NCT00463567|13064194|P6|NOT COMPLETED|Overall Study||21
5313247|NCT00463567|13064195|P5|NOT COMPLETED|Overall Study||23
5313248|NCT00463567|13064196|P4|NOT COMPLETED|Overall Study||131
5313249|NCT00463567|13064197|P3|NOT COMPLETED|Overall Study||89
5313250|NCT00463567|13064198|P2|NOT COMPLETED|Overall Study||77
5313251|NCT00463567|13064199|P1|NOT COMPLETED|Overall Study||95
5313252|NCT00463567|13064193|P7|COMPLETED|Overall Study||112
5313253|NCT00463567|13064194|P6|COMPLETED|Overall Study||102
5313254|NCT00463567|13064195|P5|COMPLETED|Overall Study||107
5313255|NCT00463567|13064196|P4|COMPLETED|Overall Study||294
5313256|NCT00463567|13064197|P3|COMPLETED|Overall Study||331
5313257|NCT00463567|13064198|P2|COMPLETED|Overall Study||341
5313258|NCT00463567|13064199|P1|COMPLETED|Overall Study||325
5313259|NCT00463567|13064193|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
5313260|NCT00463567|13064194|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
5313261|NCT00463567|13064195|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
5313262|NCT00463567|13064196|P4|Safety Population: Received Study Drug|Overall Study||418
5313263|NCT00463567|13064197|P3|Safety Population: Received Study Drug|Overall Study||415
5313264|NCT00463567|13064198|P2|Safety Population: Received Study Drug|Overall Study||416
5313265|NCT00463567|13064199|P1|Safety Population: Received Study Drug|Overall Study||416
5313266|NCT00463567|13064193|P7|STARTED|Overall Study||123
5313267|NCT00463567|13064194|P6|STARTED|Overall Study||123
5313268|NCT00463567|13064195|P5|STARTED|Overall Study||130
5313269|NCT00463567|13064196|P4|STARTED|Overall Study||425
5313270|NCT00463567|13064197|P3|STARTED|Overall Study||420
5313271|NCT00463567|13064198|P2|STARTED|Overall Study||418
5313272|NCT00463567|13064199|P1|STARTED|Overall Study|Randomized Participants|420
5313273|NCT00463476|13064232|P2|NOT COMPLETED|Overall Study||3
5313274|NCT00463476|13064233|P1|NOT COMPLETED|Overall Study||2
5313275|NCT00463476|13064232|P2|COMPLETED|Overall Study||151
5313276|NCT00463476|13064233|P1|COMPLETED|Overall Study||149
5313277|NCT00463476|13064232|P2|STARTED|Overall Study||154
5313278|NCT00463476|13064233|P1|STARTED|Overall Study||151
5313279|NCT00463437|13064253|P4|NOT COMPLETED|Overall Study||7
5313280|NCT00463437|13064254|P3|NOT COMPLETED|Overall Study||6
5313281|NCT00463437|13064255|P2|NOT COMPLETED|Overall Study||11
5313282|NCT00463437|13064256|P1|NOT COMPLETED|Overall Study||4
5313283|NCT00463437|13064253|P4|COMPLETED|Overall Study||350
5313284|NCT00463437|13064254|P3|COMPLETED|Overall Study||352
5313285|NCT00463437|13064255|P2|COMPLETED|Overall Study||352
5313286|NCT00463437|13064256|P1|COMPLETED|Overall Study||355
5313287|NCT00463437|13064253|P4|STARTED|Overall Study||357
5313288|NCT00463437|13064254|P3|STARTED|Overall Study||358
5313289|NCT00463437|13064255|P2|STARTED|Overall Study||363
5313290|NCT00463437|13064256|P1|STARTED|Overall Study||359
5313291|NCT00463385|13064322|P4|NOT COMPLETED|Overall Study||22
5313292|NCT00463385|13064323|P3|NOT COMPLETED|Overall Study||22
5313293|NCT00463385|13064324|P2|NOT COMPLETED|Overall Study||22
5313294|NCT00463385|13064325|P1|NOT COMPLETED|Overall Study||22
5313295|NCT00463385|13064322|P4|COMPLETED|Overall Study||0
5313296|NCT00463385|13064323|P3|COMPLETED|Overall Study||0
5313297|NCT00463385|13064324|P2|COMPLETED|Overall Study||0
5313298|NCT00463385|13064325|P1|COMPLETED|Overall Study||0
5313299|NCT00463385|13064322|P4|Treated|Overall Study||22
5313300|NCT00463385|13064323|P3|Treated|Overall Study||19
5313301|NCT00463385|13064324|P2|Treated|Overall Study||22
5313302|NCT00463385|13064325|P1|Treated|Overall Study||22
5313303|NCT00463385|13064322|P4|STARTED|Overall Study||22
5313304|NCT00463385|13064323|P3|STARTED|Overall Study||22
5313305|NCT00463385|13064324|P2|STARTED|Overall Study||22
5313306|NCT00463385|13064325|P1|STARTED|Overall Study||22
5313307|NCT00463346|13064377|P2|NOT COMPLETED|Overall Study||3
5313308|NCT00463346|13064378|P1|NOT COMPLETED|Overall Study||3
5313309|NCT00463346|13064377|P2|COMPLETED|Overall Study||8
5313310|NCT00463346|13064378|P1|COMPLETED|Overall Study||9
5313311|NCT00463346|13064377|P2|STARTED|Overall Study||11
5313312|NCT00463346|13064378|P1|STARTED|Overall Study||12
5313313|NCT00463229|13064388|P2|NOT COMPLETED|Overall Study||10
5313314|NCT00463229|13064389|P1|NOT COMPLETED|Overall Study||9
5313315|NCT00463229|13064388|P2|COMPLETED|Overall Study||39
5313316|NCT00463229|13064389|P1|COMPLETED|Overall Study||43
5313317|NCT00463229|13064388|P2|STARTED|Overall Study||49
5313318|NCT00463229|13064389|P1|STARTED|Overall Study||52
5313319|NCT00463060|13064409|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
5313320|NCT00463060|13064409|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
5313321|NCT00463060|13064409|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
5313322|NCT00463060|13064409|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
5313323|NCT00463060|13064409|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
5313324|NCT00463060|13064409|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
5313325|NCT00463060|13064409|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
5313326|NCT00463060|13064409|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
5313327|NCT00463060|13064409|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
5313328|NCT00463060|13064409|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
5313329|NCT00463060|13064409|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
5313330|NCT00463060|13064409|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
5313331|NCT00463060|13064409|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
5313332|NCT00463060|13064409|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
5313333|NCT00463060|13064409|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
5313334|NCT00463047|13064423|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
5313335|NCT00463047|13064424|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
5313336|NCT00463047|13064423|P2|COMPLETED|Double-Blind Treatment Period 2||88
5313337|NCT00463047|13064424|P1|COMPLETED|Double-Blind Treatment Period 2||92
5313338|NCT00463047|13064423|P2|STARTED|Double-Blind Treatment Period 2||90
5313339|NCT00463047|13064424|P1|STARTED|Double-Blind Treatment Period 2||93
5313340|NCT00463047|13064423|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
5313341|NCT00463047|13064424|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
5313342|NCT00463047|13064423|P2|COMPLETED|Double-Blind Treatment Period 1||90
5313343|NCT00463047|13064424|P1|COMPLETED|Double-Blind Treatment Period 1||93
5313344|NCT00463047|13064423|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
5313345|NCT00463047|13064424|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
5313346|NCT00463047|13064423|P2|NOT COMPLETED|Titration Period 2||23
5313347|NCT00463047|13064424|P1|NOT COMPLETED|Titration Period 2||30
5313348|NCT00463047|13064423|P2|COMPLETED|Titration Period 2||98
5313349|NCT00463047|13064424|P1|COMPLETED|Titration Period 2||93
5313350|NCT00463047|13064423|P2|STARTED|Titration Period 2||121
5313351|NCT00463047|13064424|P1|STARTED|Titration Period 2||123
5313352|NCT00463047|13064423|P2|NOT COMPLETED|Titration Period 1||39
5313353|NCT00463047|13064424|P1|NOT COMPLETED|Titration Period 1||37
5313354|NCT00463047|13064423|P2|COMPLETED|Titration Period 1||121
5313355|NCT00463047|13064424|P1|COMPLETED|Titration Period 1||123
5313356|NCT00463047|13064423|P2|STARTED|Titration Period 1||160
5313357|NCT00463047|13064424|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
5313358|NCT00462982|13064509|P1|NOT COMPLETED|Overall Study||3
5313359|NCT00462982|13064509|P1|COMPLETED|Overall Study||5
5313360|NCT00462982|13064509|P1|STARTED|Overall Study||8
5313361|NCT00462943|13064516|P3|NOT COMPLETED|Overall Study||23
5313362|NCT00462943|13064517|P2|NOT COMPLETED|Overall Study||30
5313363|NCT00462943|13064518|P1|NOT COMPLETED|Overall Study||45
5313364|NCT00462943|13064516|P3|COMPLETED|Overall Study||0
5313365|NCT00462943|13064517|P2|COMPLETED|Overall Study||1
5313366|NCT00462943|13064518|P1|COMPLETED|Overall Study||1
5313367|NCT00462943|13064516|P3|STARTED|Overall Study||23
5313368|NCT00462943|13064517|P2|STARTED|Overall Study||31
5313369|NCT00462943|13064518|P1|STARTED|Overall Study||46
5313370|NCT00462917|13064589|P4|NOT COMPLETED|Overall Study||11
5313371|NCT00462917|13064590|P3|NOT COMPLETED|Overall Study||12
5313372|NCT00462917|13064591|P2|NOT COMPLETED|Overall Study||10
5313373|NCT00462917|13064592|P1|NOT COMPLETED|Overall Study||10
5313374|NCT00462917|13064589|P4|COMPLETED|Overall Study||66
5313375|NCT00462917|13064590|P3|COMPLETED|Overall Study||54
5313376|NCT00462917|13064591|P2|COMPLETED|Overall Study||65
5313377|NCT00462917|13064592|P1|COMPLETED|Overall Study||62
5313378|NCT00462917|13064589|P4|Completed 6 Month Follow-up|Overall Study||66
5313379|NCT00462917|13064590|P3|Completed 6 Month Follow-up|Overall Study||55
5313380|NCT00462917|13064591|P2|Completed 6 Month Follow-up|Overall Study||68
5313381|NCT00462917|13064592|P1|Completed 6 Month Follow-up|Overall Study||63
5313382|NCT00462917|13064589|P4|Completed 6 Week Follow-up|Overall Study||68
5313383|NCT00462917|13064590|P3|Completed 6 Week Follow-up|Overall Study||55
5313384|NCT00462917|13064591|P2|Completed 6 Week Follow-up|Overall Study||70
5313385|NCT00462917|13064592|P1|Completed 6 Week Follow-up|Overall Study||63
5313386|NCT00462917|13064589|P4|Received Risk Information|Overall Study||68
5313387|NCT00462917|13064590|P3|Received Risk Information|Overall Study||55
5313388|NCT00462917|13064591|P2|Received Risk Information|Overall Study||70
5313389|NCT00462917|13064592|P1|Received Risk Information|Overall Study||64
5313390|NCT00462917|13064589|P4|Met With Genetic Counselor|Overall Study||71
5313391|NCT00462917|13064590|P3|Met With Genetic Counselor|Overall Study||56
5313392|NCT00462917|13064591|P2|Met With Genetic Counselor|Overall Study||71
5313393|NCT00462917|13064592|P1|Met With Genetic Counselor|Overall Study||66
5313394|NCT00462917|13064589|P4|STARTED|Overall Study||77
5313395|NCT00462917|13064590|P3|STARTED|Overall Study||66
5313396|NCT00462917|13064591|P2|STARTED|Overall Study||75
5313397|NCT00462917|13064592|P1|STARTED|Overall Study||72
5313398|NCT00462904|13064610|P1|NOT COMPLETED|Overall Study||1
5313399|NCT00462904|13064610|P1|COMPLETED|Overall Study||3
5313400|NCT00462904|13064610|P1|STARTED|Overall Study||4
5313401|NCT00462865|13064615|P1|NOT COMPLETED|Overall Study||1
5313402|NCT00462865|13064615|P1|COMPLETED|Overall Study||17
5313403|NCT00462865|13064615|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
5313404|NCT00462839|13064622|P2|NOT COMPLETED|Viewed Second||0
5313405|NCT00462839|13064623|P1|NOT COMPLETED|Viewed Second||0
5313406|NCT00462839|13064622|P2|COMPLETED|Viewed Second||53
5313407|NCT00462839|13064623|P1|COMPLETED|Viewed Second||53
5313408|NCT00462839|13064622|P2|STARTED|Viewed Second||53
5313409|NCT00462839|13064623|P1|STARTED|Viewed Second||53
5313410|NCT00462839|13064622|P2|NOT COMPLETED|Viewed First||0
5313411|NCT00462839|13064623|P1|NOT COMPLETED|Viewed First||0
5313412|NCT00462839|13064622|P2|COMPLETED|Viewed First||53
5313413|NCT00462839|13064623|P1|COMPLETED|Viewed First||53
5313414|NCT00462839|13064622|P2|STARTED|Viewed First||53
5313415|NCT00462839|13064623|P1|STARTED|Viewed First||53
5313416|NCT00462826|13064635|P1|NOT COMPLETED|Overall Study||5
5313417|NCT00462826|13064635|P1|COMPLETED|Overall Study||44
5313418|NCT00462826|13064635|P1|STARTED|Overall Study||49
5313419|NCT00462761|13064648|P1|NOT COMPLETED|Overall Study||76
5313420|NCT00462761|13064648|P1|COMPLETED|Overall Study||0
5313421|NCT00462761|13064648|P1|STARTED|Overall Study||76
5313422|NCT00462748|13064723|P3|NOT COMPLETED|Overall Study||11
5313423|NCT00462748|13064724|P2|NOT COMPLETED|Overall Study||11
5313424|NCT00462748|13064725|P1|NOT COMPLETED|Overall Study||12
5313425|NCT00462748|13064723|P3|COMPLETED|Overall Study||251
5313426|NCT00462748|13064724|P2|COMPLETED|Overall Study||252
5313427|NCT00462748|13064725|P1|COMPLETED|Overall Study||249
5313428|NCT00462748|13064723|P3|STARTED|Overall Study||262
5313429|NCT00462748|13064724|P2|STARTED|Overall Study||263
5313430|NCT00462748|13064725|P1|STARTED|Overall Study||261
5313431|NCT00462735|13064733|P1|NOT COMPLETED|Overall Study||0
5313432|NCT00462735|13064733|P1|COMPLETED|Overall Study||33
5313433|NCT00462735|13064733|P1|STARTED|Overall Study||33
5313434|NCT00462722|13064744|P3|NOT COMPLETED|Overall Study||12
5313435|NCT00462722|13064745|P2|NOT COMPLETED|Overall Study||4
5313436|NCT00462722|13064746|P1|NOT COMPLETED|Overall Study||13
5313437|NCT00462722|13064744|P3|COMPLETED|Overall Study||42
5313438|NCT00462722|13064745|P2|COMPLETED|Overall Study||51
5313439|NCT00462722|13064746|P1|COMPLETED|Overall Study||37
5313440|NCT00462722|13064744|P3|STARTED|Overall Study||54
5313441|NCT00462722|13064745|P2|STARTED|Overall Study||55
5313442|NCT00462722|13064746|P1|STARTED|Overall Study||50
5313443|NCT00462709|13064778|P1|NOT COMPLETED|Overall Study||67
5313444|NCT00462709|13064778|P1|COMPLETED|Overall Study||79
5313445|NCT00462709|13064778|P1|STARTED|Overall Study||146
5313446|NCT00462670|13064787|P2|NOT COMPLETED|Overall Study||7
5313447|NCT00462670|13064788|P1|NOT COMPLETED|Overall Study||5
5313448|NCT00462670|13064787|P2|COMPLETED|Overall Study||46
5313449|NCT00462670|13064788|P1|COMPLETED|Overall Study||52
5313450|NCT00462670|13064787|P2|STARTED|Overall Study||53
5313451|NCT00462670|13064788|P1|STARTED|Overall Study||57
5313452|NCT00462644|13064798|P2|NOT COMPLETED|Overall Study||0
5313453|NCT00462644|13064799|P1|NOT COMPLETED|Overall Study||0
5313454|NCT00462644|13064798|P2|COMPLETED|Overall Study||12
5313455|NCT00462644|13064799|P1|COMPLETED|Overall Study||18
5313456|NCT00462644|13064798|P2|STARTED|Overall Study||12
5313457|NCT00462644|13064799|P1|STARTED|Overall Study||18
5313458|NCT00462605|13064817|P1|NOT COMPLETED|Overall Study||14
5313459|NCT00462605|13064817|P1|COMPLETED|Overall Study||10
5313460|NCT00462605|13064817|P1|STARTED|Overall Study||24
5313461|NCT00462501|13064825|P1|NOT COMPLETED|Overall Study||5
5313462|NCT00462501|13064825|P1|COMPLETED|Overall Study||30
5313463|NCT00462501|13064825|P1|STARTED|Overall Study||35
5313464|NCT00462488|13064831|P2|NOT COMPLETED|Overall Study||17
5313465|NCT00462488|13064832|P1|NOT COMPLETED|Overall Study||20
5313466|NCT00462488|13064831|P2|COMPLETED|Overall Study||6
5313467|NCT00462488|13064832|P1|COMPLETED|Overall Study||3
5313468|NCT00462488|13064831|P2|Completed Maintenance 2|Overall Study||6
5313469|NCT00462488|13064832|P1|Completed Maintenance 2|Overall Study||7
5313470|NCT00462488|13064831|P2|Completed Induction 2/Maintenance 1|Overall Study||9
5313471|NCT00462488|13064832|P1|Completed Induction 2/Maintenance 1|Overall Study||18
5313472|NCT00462488|13064831|P2|Completed Induction Phase|Overall Study||23
5313473|NCT00462488|13064832|P1|Completed Induction Phase|Overall Study||22
5313474|NCT00462488|13064831|P2|STARTED|Overall Study||23
5313475|NCT00462488|13064832|P1|STARTED|Overall Study||23
5313476|NCT00462462|13064840|P2|NOT COMPLETED|Overall Study||1
5313477|NCT00462462|13064841|P1|NOT COMPLETED|Overall Study||0
5313478|NCT00462462|13064840|P2|COMPLETED|Overall Study||13
5313479|NCT00462462|13064841|P1|COMPLETED|Overall Study||17
5313480|NCT00462462|13064840|P2|STARTED|Overall Study||14
5313481|NCT00462462|13064841|P1|STARTED|Overall Study||17
5313482|NCT00462449|13064851|P2|NOT COMPLETED|Overall Study||0
5313483|NCT00462449|13064852|P1|NOT COMPLETED|Overall Study||0
5313484|NCT00462449|13064851|P2|COMPLETED|Overall Study||10
5313485|NCT00462449|13064852|P1|COMPLETED|Overall Study||13
5313486|NCT00462449|13064851|P2|STARTED|Overall Study||10
5313487|NCT00462449|13064852|P1|STARTED|Overall Study||13
5313488|NCT00462423|13064862|P1|NOT COMPLETED|Overall Study||0
5313489|NCT00462423|13064862|P1|COMPLETED|Overall Study||50
5313490|NCT00462423|13064862|P1|STARTED|Overall Study||50
5313491|NCT00462384|13064869|P1|NOT COMPLETED|Overall Study||9
5313492|NCT00462384|13064869|P1|COMPLETED|Overall Study||30
5313493|NCT00462384|13064869|P1|STARTED|Overall Study||39
5313494|NCT00462345|13064877|P1|NOT COMPLETED|Overall Study||3
5313495|NCT00462345|13064877|P1|COMPLETED|Overall Study||37
5313496|NCT00462345|13064877|P1|Completed First Course|Overall Study||38
5313497|NCT00462345|13064877|P1|STARTED|Overall Study||40
5313498|NCT00462332|13064901|P2|NOT COMPLETED|Overall Study||0
5313499|NCT00462332|13064902|P1|NOT COMPLETED|Overall Study||0
5313500|NCT00462332|13064901|P2|COMPLETED|Overall Study||41
5313501|NCT00462332|13064902|P1|COMPLETED|Overall Study||45
5313502|NCT00462332|13064901|P2|STARTED|Overall Study||41
5313503|NCT00462332|13064902|P1|STARTED|Overall Study||45
5313504|NCT00462306|13064912|P2|NOT COMPLETED|Overall Study||13
5313505|NCT00462306|13064913|P1|NOT COMPLETED|Overall Study||0
5313506|NCT00462306|13064912|P2|COMPLETED|Overall Study||490
5313507|NCT00462306|13064913|P1|COMPLETED|Overall Study||4074
5313508|NCT00462306|13064912|P2|STARTED|Overall Study||503
5313509|NCT00462306|13064913|P1|STARTED|Overall Study||4074
5313510|NCT00462280|13064925|P4|NOT COMPLETED|Overall Study||3
5313511|NCT00462280|13064926|P3|NOT COMPLETED|Overall Study||0
5313512|NCT00462280|13064927|P2|NOT COMPLETED|Overall Study||7
5313513|NCT00462280|13064928|P1|NOT COMPLETED|Overall Study||10
5313514|NCT00462280|13064925|P4|COMPLETED|Overall Study||4
5313515|NCT00462280|13064926|P3|COMPLETED|Overall Study||7
5313516|NCT00462280|13064927|P2|COMPLETED|Overall Study||25
5313517|NCT00462280|13064928|P1|COMPLETED|Overall Study||24
5313518|NCT00462280|13064925|P4|STARTED|Overall Study||7
5313519|NCT00462280|13064926|P3|STARTED|Overall Study||7
5313520|NCT00462280|13064927|P2|STARTED|Overall Study||32
5313521|NCT00462280|13064928|P1|STARTED|Overall Study||34
5313522|NCT00462228|13064988|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
5313523|NCT00462228|13064988|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
5313524|NCT00462228|13064988|P1|STARTED|No Treatment (Washout) 4 Weeks||11
5313525|NCT00462228|13064988|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
5313526|NCT00462228|13064988|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
5313527|NCT00462228|13064988|P1|STARTED|Placebo or Memantine 12 Weeks||11
5313528|NCT00462228|13064988|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
5313529|NCT00462228|13064988|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
5313530|NCT00462228|13064988|P1|STARTED|No Treatment (Washout) 4 Weeks||11
5313531|NCT00462228|13064988|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
5313532|NCT00462228|13064988|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
5313533|NCT00462228|13064988|P1|STARTED|Memantine or Placebo 12 Weeks||11
5313534|NCT00462124|13065009|P1|NOT COMPLETED|Overall Study||1
5313535|NCT00462124|13065009|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
5313536|NCT00462124|13065009|P1|STARTED|Overall Study||7
5313537|NCT00462072|13065017|P3|NOT COMPLETED|Week 10||0
5313538|NCT00462072|13065018|P2|NOT COMPLETED|Week 10||0
5313539|NCT00462072|13065019|P1|NOT COMPLETED|Week 10||0
5313540|NCT00462072|13065017|P3|COMPLETED|Week 10||9
5313541|NCT00462072|13065018|P2|COMPLETED|Week 10||12
5313542|NCT00462072|13065019|P1|COMPLETED|Week 10||10
5313543|NCT00462072|13065017|P3|STARTED|Week 10||9
5313544|NCT00462072|13065018|P2|STARTED|Week 10||12
5313545|NCT00462072|13065019|P1|STARTED|Week 10||10
5313546|NCT00462072|13065017|P3|NOT COMPLETED|Baseline (Week 0)||0
5313547|NCT00462072|13065018|P2|NOT COMPLETED|Baseline (Week 0)||0
5313548|NCT00462072|13065019|P1|NOT COMPLETED|Baseline (Week 0)||0
5313549|NCT00462072|13065017|P3|COMPLETED|Baseline (Week 0)||9
5313550|NCT00462072|13065018|P2|COMPLETED|Baseline (Week 0)||12
5313551|NCT00462072|13065019|P1|COMPLETED|Baseline (Week 0)||10
5313552|NCT00462072|13065017|P3|STARTED|Baseline (Week 0)||9
5313553|NCT00462072|13065018|P2|STARTED|Baseline (Week 0)||12
5313554|NCT00462072|13065019|P1|STARTED|Baseline (Week 0)||10
5313555|NCT00462020|13065035|P2|NOT COMPLETED|Overall Study||0
5313556|NCT00462020|13065036|P1|NOT COMPLETED|Overall Study||0
5313557|NCT00462020|13065035|P2|COMPLETED|Overall Study||50
5313558|NCT00462020|13065036|P1|COMPLETED|Overall Study||52
5313559|NCT00462020|13065035|P2|STARTED|Overall Study||50
5313560|NCT00462020|13065036|P1|STARTED|Overall Study||52
5313561|NCT00461981|13065044|P2|NOT COMPLETED|Overall Study||9
5313562|NCT00461981|13065045|P1|NOT COMPLETED|Overall Study||11
5313563|NCT00461981|13065044|P2|COMPLETED|Overall Study||42
5313564|NCT00461981|13065045|P1|COMPLETED|Overall Study||39
5313565|NCT00461981|13065044|P2|STARTED|Overall Study||51
5313566|NCT00461981|13065045|P1|STARTED|Overall Study||50
5313567|NCT00461851|13065155|P1|NOT COMPLETED|Overall Study||0
5313568|NCT00461851|13065155|P1|COMPLETED|Overall Study||17
5313569|NCT00461851|13065155|P1|STARTED|Overall Study||17
5313570|NCT00461812|13065161|P1|NOT COMPLETED|Overall Study||10
5313571|NCT00461812|13065161|P1|COMPLETED|Overall Study||0
5313572|NCT00461812|13065161|P1|STARTED|Overall Study||10
5313573|NCT00461786|13065166|P1|NOT COMPLETED|Overall Study||3
5313574|NCT00461786|13065166|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
5313575|NCT00461786|13065166|P1|STARTED|Overall Study||51
5313576|NCT00461734|13065176|P2|NOT COMPLETED|Overall Study||60
5313577|NCT00461734|13065177|P1|NOT COMPLETED|Overall Study||58
5313578|NCT00461734|13065176|P2|COMPLETED|Overall Study||60
5313579|NCT00461734|13065177|P1|COMPLETED|Overall Study||62
5313580|NCT00461734|13065176|P2|STARTED|Overall Study||120
5313581|NCT00461734|13065177|P1|STARTED|Overall Study||120
5313582|NCT00461708|13065211|P2|NOT COMPLETED|Overall Study||38
5313583|NCT00461708|13065212|P1|NOT COMPLETED|Overall Study||115
5313584|NCT00461708|13065211|P2|COMPLETED|Overall Study||0
5313585|NCT00461708|13065212|P1|COMPLETED|Overall Study||0
5313586|NCT00461708|13065211|P2|STARTED|Overall Study||38
5313587|NCT00461708|13065212|P1|STARTED|Overall Study||115
5313588|NCT00461682|13065238|P1|NOT COMPLETED|Overall Study||1
5313589|NCT00461682|13065238|P1|COMPLETED|Overall Study||0
5313590|NCT00461682|13065238|P1|STARTED|Overall Study||1
5313591|NCT00461630|13065266|P2|NOT COMPLETED|Overall Study||827
5313592|NCT00461630|13065267|P1|NOT COMPLETED|Overall Study||906
5313593|NCT00461630|13065266|P2|COMPLETED|Overall Study||12008
5313594|NCT00461630|13065267|P1|COMPLETED|Overall Study||11932
5313595|NCT00461630|13065266|P2|STARTED|Overall Study||12835
5313596|NCT00461630|13065267|P1|STARTED|Overall Study||12838
5313597|NCT00461591|13065283|P2|NOT COMPLETED|Overall Study||85
5313598|NCT00461591|13065284|P1|NOT COMPLETED|Overall Study||89
5313599|NCT00461591|13065283|P2|COMPLETED|Overall Study||311
5313600|NCT00461591|13065284|P1|COMPLETED|Overall Study||317
5313601|NCT00461591|13065283|P2|STARTED|Overall Study||396
5313602|NCT00461591|13065284|P1|STARTED|Overall Study||406
5313603|NCT00461552|13065306|P2|NOT COMPLETED|Overall Study||2
5313604|NCT00461552|13065307|P1|NOT COMPLETED|Overall Study||0
5313605|NCT00461552|13065306|P2|COMPLETED|Overall Study||5
5313606|NCT00461552|13065307|P1|COMPLETED|Overall Study||7
5313607|NCT00461552|13065306|P2|STARTED|Overall Study||7
5313608|NCT00461552|13065307|P1|STARTED|Overall Study||7
5313609|NCT00461513|13065317|P2|NOT COMPLETED|Overall Study||25
5313610|NCT00461513|13065318|P1|NOT COMPLETED|Overall Study||22
5313611|NCT00461513|13065317|P2|COMPLETED|Overall Study||172
5313612|NCT00461513|13065318|P1|COMPLETED|Overall Study||165
5313613|NCT00461513|13065317|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
5313614|NCT00461513|13065318|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
5313615|NCT00461500|13065330|P2|NOT COMPLETED|Overall Study||6
5313616|NCT00461500|13065331|P1|NOT COMPLETED|Overall Study||7
5313617|NCT00461500|13065330|P2|COMPLETED|Overall Study||38
5313618|NCT00461500|13065331|P1|COMPLETED|Overall Study||30
5313619|NCT00461500|13065330|P2|STARTED|Overall Study||44
5313620|NCT00461500|13065331|P1|STARTED|Overall Study||37
5313621|NCT00461331|13065361|P2|NOT COMPLETED|Intervention 2||0
5313622|NCT00461331|13065362|P1|NOT COMPLETED|Intervention 2||0
5313623|NCT00461331|13065361|P2|COMPLETED|Intervention 2||10
5313624|NCT00461331|13065362|P1|COMPLETED|Intervention 2||10
5313625|NCT00461331|13065361|P2|STARTED|Intervention 2||10
5313626|NCT00461331|13065362|P1|STARTED|Intervention 2||10
5313627|NCT00461331|13065361|P2|NOT COMPLETED|Washout||0
5313628|NCT00461331|13065362|P1|NOT COMPLETED|Washout||0
5313629|NCT00461331|13065361|P2|COMPLETED|Washout||10
5313630|NCT00461331|13065362|P1|COMPLETED|Washout||10
5313631|NCT00461331|13065361|P2|STARTED|Washout||10
5313632|NCT00461331|13065362|P1|STARTED|Washout||10
5313633|NCT00461331|13065361|P2|NOT COMPLETED|Intervention 1||0
5313634|NCT00461331|13065362|P1|NOT COMPLETED|Intervention 1||0
5313635|NCT00461331|13065361|P2|COMPLETED|Intervention 1||10
5313636|NCT00461331|13065362|P1|COMPLETED|Intervention 1||10
5313637|NCT00461331|13065361|P2|STARTED|Intervention 1||10
5313638|NCT00461331|13065362|P1|STARTED|Intervention 1||10
5313639|NCT00461305|13065374|P2|NOT COMPLETED|Continued Treatment||0
5313640|NCT00461305|13065375|P1|NOT COMPLETED|Continued Treatment||95
5313641|NCT00461305|13065374|P2|COMPLETED|Continued Treatment||0
5313642|NCT00461305|13065375|P1|COMPLETED|Continued Treatment||254
5313643|NCT00461305|13065374|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
5313644|NCT00461305|13065375|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
5313645|NCT00461305|13065374|P2|NOT COMPLETED|Treatment||9
5313646|NCT00461305|13065375|P1|NOT COMPLETED|Treatment||101
5313647|NCT00461305|13065374|P2|COMPLETED|Treatment||56
5313648|NCT00461305|13065375|P1|COMPLETED|Treatment||254
5313649|NCT00461305|13065374|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
5313650|NCT00461305|13065375|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
5313651|NCT00461305|13065374|P2|Subjects Dispensed Drugs|Treatment||65
5313652|NCT00461305|13065375|P1|Subjects Dispensed Drugs|Treatment||350
5313653|NCT00461305|13065374|P2|STARTED|Treatment|Enrolled|65
5313654|NCT00461305|13065375|P1|STARTED|Treatment|Enrolled|355
5313655|NCT00461292|13065438|P3|NOT COMPLETED|Treatment Cycle 2||0
5313656|NCT00461292|13065439|P2|NOT COMPLETED|Treatment Cycle 2||2
5313657|NCT00461292|13065440|P1|NOT COMPLETED|Treatment Cycle 2||5
5313658|NCT00461292|13065438|P3|COMPLETED|Treatment Cycle 2||0
5313659|NCT00461292|13065439|P2|COMPLETED|Treatment Cycle 2||72
5313660|NCT00461292|13065440|P1|COMPLETED|Treatment Cycle 2||58
5313661|NCT00461292|13065438|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
5313662|NCT00461292|13065439|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
5313663|NCT00461292|13065440|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
5313664|NCT00461292|13065438|P3|NOT COMPLETED|Treatment Cycle 1||11
5313665|NCT00461292|13065439|P2|NOT COMPLETED|Treatment Cycle 1||12
5313666|NCT00461292|13065440|P1|NOT COMPLETED|Treatment Cycle 1||15
5313667|NCT00461292|13065438|P3|COMPLETED|Treatment Cycle 1||81
5313668|NCT00461292|13065439|P2|COMPLETED|Treatment Cycle 1||80
5313669|NCT00461292|13065440|P1|COMPLETED|Treatment Cycle 1||76
5313670|NCT00461292|13065438|P3|STARTED|Treatment Cycle 1||92
5313671|NCT00461292|13065439|P2|STARTED|Treatment Cycle 1||92
5313672|NCT00461292|13065440|P1|STARTED|Treatment Cycle 1||91
5313673|NCT00461253|13065459|P2|NOT COMPLETED|Overall Study||19798
5313674|NCT00461253|13065460|P1|NOT COMPLETED|Overall Study||4980
5313675|NCT00461253|13065459|P2|COMPLETED|Overall Study|Analyzed controls|20452
5313676|NCT00461253|13065460|P1|COMPLETED|Overall Study|Analyzed cases|5113
5313677|NCT00461253|13065459|P2|STARTED|Overall Study|Identified controls|40250
5313678|NCT00461253|13065460|P1|STARTED|Overall Study|Identified cases|10093
5313679|NCT00461175|13065468|P2|NOT COMPLETED|Overall Study||365
5313680|NCT00461175|13065469|P1|NOT COMPLETED|Overall Study||522
5313681|NCT00461175|13065468|P2|COMPLETED|Overall Study||18370
5313682|NCT00461175|13065469|P1|COMPLETED|Overall Study||43078
5313683|NCT00461175|13065468|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
5313684|NCT00461175|13065469|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
5313685|NCT00461123|13065479|P2|NOT COMPLETED|Overall Study||6
5313686|NCT00461123|13065480|P1|NOT COMPLETED|Overall Study||6
5313687|NCT00461123|13065479|P2|COMPLETED|Overall Study||19
5313688|NCT00461123|13065480|P1|COMPLETED|Overall Study||19
5313689|NCT00461123|13065479|P2|STARTED|Overall Study||25
5313690|NCT00461123|13065480|P1|STARTED|Overall Study||25
5313691|NCT00461097|13065496|P2|NOT COMPLETED|Overall Study||0
5313692|NCT00461097|13065497|P1|NOT COMPLETED|Overall Study||0
5313693|NCT00461097|13065496|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
5313694|NCT00461097|13065497|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
5313695|NCT00461097|13065496|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
5313696|NCT00461097|13065497|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
5313697|NCT00461097|13065496|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
5313698|NCT00461097|13065497|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
5313699|NCT00461097|13065496|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
5313700|NCT00461097|13065497|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
5313701|NCT00461097|13065496|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
5313702|NCT00461097|13065497|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
5313703|NCT00461097|13065496|P2|STARTED|Overall Study||15
5313704|NCT00461097|13065497|P1|STARTED|Overall Study||40
5313705|NCT00461045|13065513|P1|NOT COMPLETED|Overall Study||0
5313706|NCT00461045|13065513|P1|COMPLETED|Overall Study||15
5313707|NCT00461045|13065513|P1|STARTED|Overall Study||15
5313708|NCT00461032|13065525|P2|NOT COMPLETED|Overall Study||44
5313709|NCT00461032|13065526|P1|NOT COMPLETED|Overall Study||37
5313710|NCT00461032|13065525|P2|COMPLETED|Overall Study||536
5313711|NCT00461032|13065526|P1|COMPLETED|Overall Study||545
5313712|NCT00461032|13065525|P2|STARTED|Overall Study||580
5313713|NCT00461032|13065526|P1|STARTED|Overall Study||582
5313714|NCT00460993|13065540|P2|NOT COMPLETED|Phase 2 (6 Days)||0
5313715|NCT00460993|13065541|P1|NOT COMPLETED|Phase 2 (6 Days)||0
5313716|NCT00460993|13065540|P2|COMPLETED|Phase 2 (6 Days)||17
5313717|NCT00460993|13065541|P1|COMPLETED|Phase 2 (6 Days)||14
5313718|NCT00460993|13065540|P2|STARTED|Phase 2 (6 Days)||17
5313719|NCT00460993|13065541|P1|STARTED|Phase 2 (6 Days)||14
5313720|NCT00460993|13065540|P2|NOT COMPLETED|Phase 1 (6 Days)||0
5313721|NCT00460993|13065541|P1|NOT COMPLETED|Phase 1 (6 Days)||0
5313722|NCT00460993|13065540|P2|COMPLETED|Phase 1 (6 Days)||17
5313723|NCT00460993|13065541|P1|COMPLETED|Phase 1 (6 Days)||14
5313724|NCT00460993|13065540|P2|STARTED|Phase 1 (6 Days)||17
5313725|NCT00460993|13065541|P1|STARTED|Phase 1 (6 Days)||14
5313726|NCT00460811|13065552|P5|NOT COMPLETED|Overall Study||20
5313727|NCT00460811|13065553|P4|NOT COMPLETED|Overall Study||18
5313728|NCT00460811|13065554|P3|NOT COMPLETED|Overall Study||14
5313729|NCT00460811|13065555|P2|NOT COMPLETED|Overall Study||15
5313730|NCT00460811|13065556|P1|NOT COMPLETED|Overall Study||16
5313731|NCT00460811|13065552|P5|COMPLETED|Overall Study||65
5313732|NCT00460811|13065553|P4|COMPLETED|Overall Study||71
5313733|NCT00460811|13065554|P3|COMPLETED|Overall Study||71
5313734|NCT00460811|13065555|P2|COMPLETED|Overall Study||67
5313735|NCT00460811|13065556|P1|COMPLETED|Overall Study||63
5313736|NCT00460811|13065552|P5|STARTED|Overall Study||85
5313737|NCT00460811|13065553|P4|STARTED|Overall Study||89
5313738|NCT00460811|13065554|P3|STARTED|Overall Study||85
5313739|NCT00460811|13065555|P2|STARTED|Overall Study||82
5313740|NCT00460811|13065556|P1|STARTED|Overall Study||79
5313741|NCT00460798|13065598|P1|NOT COMPLETED|Overall Study||340
5313742|NCT00460798|13065598|P1|COMPLETED|Overall Study||108
5313743|NCT00460798|13065598|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
5313744|NCT00460798|13065598|P1|STARTED|Overall Study||448
5313745|NCT00460746|13065606|P1|NOT COMPLETED|Overall Study||2
5313746|NCT00460746|13065606|P1|COMPLETED|Overall Study||8
5313747|NCT00460746|13065606|P1|STARTED|Overall Study||10
5313748|NCT00460655|13065621|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
5313749|NCT00460655|13065622|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
5313750|NCT00460655|13065623|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313751|NCT00460655|13065624|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313752|NCT00460655|13065621|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
5313753|NCT00460655|13065622|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
5313754|NCT00460655|13065623|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
5313755|NCT00460655|13065624|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
5313756|NCT00460655|13065621|P4|STARTED|Open-Label Phase (36 Weeks)||61
5313757|NCT00460655|13065622|P3|STARTED|Open-Label Phase (36 Weeks)||52
5313758|NCT00460655|13065623|P2|STARTED|Open-Label Phase (36 Weeks)||0
5313759|NCT00460655|13065624|P1|STARTED|Open-Label Phase (36 Weeks)||0
5313760|NCT00460655|13065621|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313761|NCT00460655|13065622|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313762|NCT00460655|13065623|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
5313763|NCT00460655|13065624|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
5313764|NCT00460655|13065621|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313765|NCT00460655|13065622|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313766|NCT00460655|13065623|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
5313767|NCT00460655|13065624|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
5313768|NCT00460655|13065621|P4|STARTED|Double-Blind Phase (12 Weeks)||0
5313769|NCT00460655|13065622|P3|STARTED|Double-Blind Phase (12 Weeks)||0
5313770|NCT00460655|13065623|P2|STARTED|Double-Blind Phase (12 Weeks)||62
5313771|NCT00460655|13065624|P1|STARTED|Double-Blind Phase (12 Weeks)||58
5313772|NCT00460603|13065668|P12|NOT COMPLETED|Phase 2||41
5313773|NCT00460603|13065669|P11|NOT COMPLETED|Phase 2||43
5313774|NCT00460603|13065670|P10|NOT COMPLETED|Phase 2||42
5313775|NCT00460603|13065671|P9|NOT COMPLETED|Phase 2||0
5313776|NCT00460603|13065672|P8|NOT COMPLETED|Phase 2||0
5313777|NCT00460603|13065673|P7|NOT COMPLETED|Phase 2||0
5313778|NCT00460603|13065674|P6|NOT COMPLETED|Phase 2||0
5313779|NCT00460603|13065675|P5|NOT COMPLETED|Phase 2||0
5313780|NCT00460603|13065676|P4|NOT COMPLETED|Phase 2||0
5313781|NCT00460603|13065677|P3|NOT COMPLETED|Phase 2||0
5313782|NCT00460603|13065678|P2|NOT COMPLETED|Phase 2||0
5313783|NCT00460603|13065679|P1|NOT COMPLETED|Phase 2||0
5313784|NCT00460603|13065668|P12|COMPLETED|Phase 2||0
5313785|NCT00460603|13065669|P11|COMPLETED|Phase 2||0
5313786|NCT00460603|13065670|P10|COMPLETED|Phase 2||0
5313787|NCT00460603|13065671|P9|COMPLETED|Phase 2||0
5313788|NCT00460603|13065672|P8|COMPLETED|Phase 2||0
5313789|NCT00460603|13065673|P7|COMPLETED|Phase 2||0
5313790|NCT00460603|13065674|P6|COMPLETED|Phase 2||0
5313791|NCT00460603|13065675|P5|COMPLETED|Phase 2||0
5313792|NCT00460603|13065676|P4|COMPLETED|Phase 2||0
5313793|NCT00460603|13065677|P3|COMPLETED|Phase 2||0
5313794|NCT00460603|13065678|P2|COMPLETED|Phase 2||0
5313795|NCT00460603|13065679|P1|COMPLETED|Phase 2||0
5313796|NCT00460603|13065668|P12|Treated|Phase 2||41
5313797|NCT00460603|13065669|P11|Treated|Phase 2||43
5313798|NCT00460603|13065670|P10|Treated|Phase 2||39
5313799|NCT00460603|13065671|P9|Treated|Phase 2||0
5313800|NCT00460603|13065672|P8|Treated|Phase 2||0
5313801|NCT00460603|13065673|P7|Treated|Phase 2||0
5313802|NCT00460603|13065674|P6|Treated|Phase 2||0
5313803|NCT00460603|13065675|P5|Treated|Phase 2||0
5313804|NCT00460603|13065676|P4|Treated|Phase 2||0
5313805|NCT00460603|13065677|P3|Treated|Phase 2||0
5313806|NCT00460603|13065678|P2|Treated|Phase 2||0
5313807|NCT00460603|13065679|P1|Treated|Phase 2||0
5313808|NCT00460603|13065668|P12|STARTED|Phase 2||41
5313809|NCT00460603|13065669|P11|STARTED|Phase 2||43
5313810|NCT00460603|13065670|P10|STARTED|Phase 2||42
5313811|NCT00460603|13065671|P9|STARTED|Phase 2||0
5313812|NCT00460603|13065672|P8|STARTED|Phase 2||0
5313813|NCT00460603|13065673|P7|STARTED|Phase 2||0
5313814|NCT00460603|13065674|P6|STARTED|Phase 2||0
5313815|NCT00460603|13065675|P5|STARTED|Phase 2||0
5313816|NCT00460603|13065676|P4|STARTED|Phase 2||0
5313817|NCT00460603|13065677|P3|STARTED|Phase 2||0
5313818|NCT00460603|13065678|P2|STARTED|Phase 2||0
5313819|NCT00460603|13065679|P1|STARTED|Phase 2||0
5313820|NCT00460603|13065668|P12|NOT COMPLETED|Phase 1||0
5313821|NCT00460603|13065669|P11|NOT COMPLETED|Phase 1||0
5313822|NCT00460603|13065670|P10|NOT COMPLETED|Phase 1||0
5313823|NCT00460603|13065671|P9|NOT COMPLETED|Phase 1||18
5313824|NCT00460603|13065672|P8|NOT COMPLETED|Phase 1||3
5313825|NCT00460603|13065673|P7|NOT COMPLETED|Phase 1||6
5313826|NCT00460603|13065674|P6|NOT COMPLETED|Phase 1||4
5313827|NCT00460603|13065675|P5|NOT COMPLETED|Phase 1||6
5313828|NCT00460603|13065676|P4|NOT COMPLETED|Phase 1||8
5313829|NCT00460603|13065677|P3|NOT COMPLETED|Phase 1||4
5313830|NCT00460603|13065678|P2|NOT COMPLETED|Phase 1||6
5313831|NCT00460603|13065679|P1|NOT COMPLETED|Phase 1||6
5313832|NCT00460603|13065668|P12|COMPLETED|Phase 1||0
5313833|NCT00460603|13065669|P11|COMPLETED|Phase 1||0
5313834|NCT00460603|13065670|P10|COMPLETED|Phase 1||0
5313835|NCT00460603|13065671|P9|COMPLETED|Phase 1||0
5313836|NCT00460603|13065672|P8|COMPLETED|Phase 1||0
5313837|NCT00460603|13065673|P7|COMPLETED|Phase 1||0
5313838|NCT00460603|13065674|P6|COMPLETED|Phase 1||0
5313839|NCT00460603|13065675|P5|COMPLETED|Phase 1||0
5313840|NCT00460603|13065676|P4|COMPLETED|Phase 1||0
5313841|NCT00460603|13065677|P3|COMPLETED|Phase 1||0
5313842|NCT00460603|13065678|P2|COMPLETED|Phase 1||0
5313843|NCT00460603|13065679|P1|COMPLETED|Phase 1||0
5313844|NCT00460603|13065668|P12|STARTED|Phase 1||0
5313845|NCT00460603|13065669|P11|STARTED|Phase 1||0
5313846|NCT00460603|13065670|P10|STARTED|Phase 1||0
5313847|NCT00460603|13065671|P9|STARTED|Phase 1||18
5313848|NCT00460603|13065672|P8|STARTED|Phase 1||3
5313849|NCT00460603|13065673|P7|STARTED|Phase 1||6
5313850|NCT00460603|13065674|P6|STARTED|Phase 1||4
5313851|NCT00460603|13065675|P5|STARTED|Phase 1||6
5313852|NCT00460603|13065676|P4|STARTED|Phase 1||8
5313853|NCT00460603|13065677|P3|STARTED|Phase 1||4
5313854|NCT00460603|13065678|P2|STARTED|Phase 1||6
5313855|NCT00460603|13065679|P1|STARTED|Phase 1||6
5313856|NCT00460577|13065773|P2|NOT COMPLETED|Overall Study||6
5313857|NCT00460577|13065774|P1|NOT COMPLETED|Overall Study||2
5313858|NCT00460577|13065773|P2|COMPLETED|Overall Study||24
5313859|NCT00460577|13065774|P1|COMPLETED|Overall Study||28
5313860|NCT00460577|13065773|P2|STARTED|Overall Study||30
5313861|NCT00460577|13065774|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
5313862|NCT00460564|13065792|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313863|NCT00460564|13065793|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
5313864|NCT00460564|13065794|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
5313865|NCT00460564|13065795|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
5313866|NCT00460564|13065796|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313867|NCT00460564|13065797|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313868|NCT00460564|13065798|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313869|NCT00460564|13065799|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
5313870|NCT00460564|13065792|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
5313871|NCT00460564|13065793|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
5313872|NCT00460564|13065794|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
5313873|NCT00460564|13065795|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
5313874|NCT00460564|13065796|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
5313875|NCT00460564|13065797|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
5313876|NCT00460564|13065798|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
5313877|NCT00460564|13065799|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
5313878|NCT00460564|13065792|P8|STARTED|Open-Label Phase (36 Weeks)||11
5313879|NCT00460564|13065793|P7|STARTED|Open-Label Phase (36 Weeks)||21
5313880|NCT00460564|13065794|P6|STARTED|Open-Label Phase (36 Weeks)||25
5313881|NCT00460564|13065795|P5|STARTED|Open-Label Phase (36 Weeks)||47
5313882|NCT00460564|13065796|P4|STARTED|Open-Label Phase (36 Weeks)||0
5313883|NCT00460564|13065797|P3|STARTED|Open-Label Phase (36 Weeks)||0
5313884|NCT00460564|13065798|P2|STARTED|Open-Label Phase (36 Weeks)||0
5313885|NCT00460564|13065799|P1|STARTED|Open-Label Phase (36 Weeks)||0
5313886|NCT00460564|13065792|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313887|NCT00460564|13065793|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313888|NCT00460564|13065794|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313889|NCT00460564|13065795|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313890|NCT00460564|13065796|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313891|NCT00460564|13065797|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
5313892|NCT00460564|13065798|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
5313893|NCT00460564|13065799|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
5313894|NCT00460564|13065792|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313895|NCT00460564|13065793|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313896|NCT00460564|13065794|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313897|NCT00460564|13065795|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
5313898|NCT00460564|13065796|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
5313899|NCT00460564|13065797|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
5313900|NCT00460564|13065798|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
5313901|NCT00460564|13065799|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
5313902|NCT00460564|13065792|P8|STARTED|Double-Blind Phase (12 Weeks)||0
5313903|NCT00460564|13065793|P7|STARTED|Double-Blind Phase (12 Weeks)||0
5313904|NCT00460564|13065794|P6|STARTED|Double-Blind Phase (12 Weeks)||0
5313905|NCT00460564|13065795|P5|STARTED|Double-Blind Phase (12 Weeks)||0
5313906|NCT00460564|13065796|P4|STARTED|Double-Blind Phase (12 Weeks)||11
5313907|NCT00460564|13065797|P3|STARTED|Double-Blind Phase (12 Weeks)||21
5313908|NCT00460564|13065798|P2|STARTED|Double-Blind Phase (12 Weeks)||26
5313909|NCT00460564|13065799|P1|STARTED|Double-Blind Phase (12 Weeks)||51
5313910|NCT00460551|13065893|P1|NOT COMPLETED|Overall Study||0
5313911|NCT00460551|13065893|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
5313912|NCT00460551|13065893|P1|STARTED|Overall Study||13
5313913|NCT00460525|13065900|P2|NOT COMPLETED|Overall Study||5
5313914|NCT00460525|13065901|P1|NOT COMPLETED|Overall Study||11
5313915|NCT00460525|13065900|P2|COMPLETED|Overall Study||194
5313916|NCT00460525|13065901|P1|COMPLETED|Overall Study||190
5313917|NCT00460525|13065900|P2|STARTED|Overall Study||199
5313918|NCT00460525|13065901|P1|STARTED|Overall Study||201
5313919|NCT00460434|13065943|P2|NOT COMPLETED|Overall Study||7
5313920|NCT00460434|13065944|P1|NOT COMPLETED|Overall Study||3
5313921|NCT00460434|13065943|P2|COMPLETED|Overall Study||165
5313922|NCT00460434|13065944|P1|COMPLETED|Overall Study||162
5313923|NCT00460434|13065943|P2|12 Months|Overall Study||165
5313924|NCT00460434|13065944|P1|12 Months|Overall Study||162
5313925|NCT00460434|13065943|P2|3 Months|Overall Study||171
5313926|NCT00460434|13065944|P1|3 Months|Overall Study||163
5313927|NCT00460434|13065943|P2|STARTED|Overall Study||172
5313928|NCT00460434|13065944|P1|STARTED|Overall Study||165
5313929|NCT00460421|13065973|P3|NOT COMPLETED|Overall Study||0
5313930|NCT00460421|13065974|P2|NOT COMPLETED|Overall Study||0
5313931|NCT00460421|13065975|P1|NOT COMPLETED|Overall Study||0
5313932|NCT00460421|13065973|P3|COMPLETED|Overall Study||9
5313933|NCT00460421|13065974|P2|COMPLETED|Overall Study||9
5313934|NCT00460421|13065975|P1|COMPLETED|Overall Study||9
5313935|NCT00460421|13065973|P3|STARTED|Overall Study||9
5313936|NCT00460421|13065974|P2|STARTED|Overall Study||9
5313937|NCT00460421|13065975|P1|STARTED|Overall Study||9
5313938|NCT00460408|13066023|P4|NOT COMPLETED|Overall Study||0
5313939|NCT00460408|13066024|P3|NOT COMPLETED|Overall Study||6
5313940|NCT00460408|13066025|P2|NOT COMPLETED|Overall Study||3
5313941|NCT00460408|13066026|P1|NOT COMPLETED|Overall Study||67
5313942|NCT00460408|13066023|P4|COMPLETED|Overall Study||7
5313943|NCT00460408|13066024|P3|COMPLETED|Overall Study||69
5313944|NCT00460408|13066025|P2|COMPLETED|Overall Study||13
5313945|NCT00460408|13066026|P1|COMPLETED|Overall Study||336
5313946|NCT00460408|13066023|P4|STARTED|Overall Study||7
5313947|NCT00460408|13066024|P3|STARTED|Overall Study||75
5313948|NCT00460408|13066025|P2|STARTED|Overall Study||16
5313949|NCT00460408|13066026|P1|STARTED|Overall Study||403
5313950|NCT00460265|13066063|P2|NOT COMPLETED|Overall Study||89
5313951|NCT00460265|13066064|P1|NOT COMPLETED|Overall Study||85
5313952|NCT00460265|13066063|P2|COMPLETED|Overall Study|Completed study=death|241
5313953|NCT00460265|13066064|P1|COMPLETED|Overall Study|Completed study=death|243
5313954|NCT00460265|13066063|P2|Received Study Medication|Overall Study||325
5313955|NCT00460265|13066064|P1|Received Study Medication|Overall Study||325
5313956|NCT00460265|13066063|P2|Randomized While Alive|Overall Study||330
5313957|NCT00460265|13066064|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
5313958|NCT00460265|13066063|P2|STARTED|Overall Study||330
5313959|NCT00460265|13066064|P1|STARTED|Overall Study||328
5313960|NCT00460239|13066080|P9|NOT COMPLETED|Overall Study||0
5313961|NCT00460239|13066081|P8|NOT COMPLETED|Overall Study||0
5313962|NCT00460239|13066082|P7|NOT COMPLETED|Overall Study||0
5313963|NCT00460239|13066083|P6|NOT COMPLETED|Overall Study||3
5313964|NCT00460239|13066084|P5|NOT COMPLETED|Overall Study||0
5313965|NCT00460239|13066085|P4|NOT COMPLETED|Overall Study||0
5313966|NCT00460239|13066086|P3|NOT COMPLETED|Overall Study||0
5313967|NCT00460239|13066087|P2|NOT COMPLETED|Overall Study||1
5313968|NCT00460239|13066088|P1|NOT COMPLETED|Overall Study||0
5313969|NCT00460239|13066080|P9|COMPLETED|Overall Study||1
5313970|NCT00460239|13066081|P8|COMPLETED|Overall Study||1
5313971|NCT00460239|13066082|P7|COMPLETED|Overall Study||1
5313972|NCT00460239|13066083|P6|COMPLETED|Overall Study||1
5313973|NCT00460239|13066084|P5|COMPLETED|Overall Study||1
5313974|NCT00460239|13066085|P4|COMPLETED|Overall Study||0
5313975|NCT00460239|13066086|P3|COMPLETED|Overall Study||1
5313976|NCT00460239|13066087|P2|COMPLETED|Overall Study||2
5313977|NCT00460239|13066088|P1|COMPLETED|Overall Study||0
5313978|NCT00460239|13066080|P9|STARTED|Overall Study||1
5313979|NCT00460239|13066081|P8|STARTED|Overall Study||1
5313980|NCT00460239|13066082|P7|STARTED|Overall Study||1
5313981|NCT00460239|13066083|P6|STARTED|Overall Study||4
5313982|NCT00460239|13066084|P5|STARTED|Overall Study||1
5313983|NCT00460239|13066085|P4|STARTED|Overall Study||0
5313984|NCT00460239|13066086|P3|STARTED|Overall Study||1
5313985|NCT00460239|13066087|P2|STARTED|Overall Study||3
5313986|NCT00460239|13066088|P1|STARTED|Overall Study||0
5313987|NCT00460109|13066157|P1|NOT COMPLETED|Overall Study||1
5313988|NCT00460109|13066157|P1|COMPLETED|Overall Study||23
5313989|NCT00460109|13066157|P1|STARTED|Overall Study||24
5313990|NCT00460031|13066165|P1|NOT COMPLETED|Overall Study||11
5313991|NCT00460031|13066165|P1|COMPLETED|Overall Study||23
5313992|NCT00460031|13066165|P1|STARTED|Overall Study||34
5313993|NCT00459979|13066173|P1|NOT COMPLETED|Overall Study||2
5313994|NCT00459979|13066173|P1|COMPLETED|Overall Study||28
5313995|NCT00459979|13066173|P1|STARTED|Overall Study||30
5313996|NCT00459953|13066185|P2|NOT COMPLETED|Overall Study||1
5313997|NCT00459953|13066186|P1|NOT COMPLETED|Overall Study||1
5313998|NCT00459953|13066185|P2|COMPLETED|Overall Study||70
5313999|NCT00459953|13066186|P1|COMPLETED|Overall Study||71
5314000|NCT00459953|13066185|P2|STARTED|Overall Study||71
5314001|NCT00459953|13066186|P1|STARTED|Overall Study||72
5314002|NCT00459875|13066192|P1|NOT COMPLETED|Overall Study||3
5314003|NCT00459875|13066192|P1|COMPLETED|Overall Study||21
5314004|NCT00459875|13066192|P1|STARTED|Overall Study||24
5314005|NCT00459862|13066196|P1|NOT COMPLETED|Overall Study||0
5314006|NCT00459862|13066196|P1|COMPLETED|Overall Study||34
5314007|NCT00459862|13066196|P1|STARTED|Overall Study||34
5314008|NCT00459810|13066205|P1|NOT COMPLETED|Overall Study||0
5314009|NCT00459810|13066205|P1|COMPLETED|Overall Study||21
5314010|NCT00459810|13066205|P1|STARTED|Overall Study||21
5314011|NCT00459732|13066215|P2|NOT COMPLETED|Overall Study||3
5314012|NCT00459732|13066216|P1|NOT COMPLETED|Overall Study||4
5314013|NCT00459732|13066215|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
5314014|NCT00459732|13066216|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
5314015|NCT00459732|13066215|P2|STARTED|Overall Study||17
5314016|NCT00459732|13066216|P1|STARTED|Overall Study||23
5314017|NCT00459706|13066228|P2|NOT COMPLETED|Overall Study||21
5314018|NCT00459706|13066229|P1|NOT COMPLETED|Overall Study||26
5314019|NCT00459706|13066228|P2|COMPLETED|Overall Study||294
5314020|NCT00459706|13066229|P1|COMPLETED|Overall Study||299
5314021|NCT00459706|13066228|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
5314022|NCT00459706|13066229|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
5314023|NCT00459706|13066228|P2|STARTED|Overall Study||315
5314024|NCT00459706|13066229|P1|STARTED|Overall Study||325
5314025|NCT00459667|13066372|P3|NOT COMPLETED|Overall Study||20
5314026|NCT00459667|13066373|P2|NOT COMPLETED|Overall Study||47
5314027|NCT00459667|13066374|P1|NOT COMPLETED|Overall Study||38
5314028|NCT00459667|13066372|P3|COMPLETED|Overall Study||161
5314029|NCT00459667|13066373|P2|COMPLETED|Overall Study||600
5314030|NCT00459667|13066374|P1|COMPLETED|Overall Study||554
5314031|NCT00459667|13066372|P3|Started Treatment|Overall Study||180
5314032|NCT00459667|13066373|P2|Started Treatment|Overall Study||644
5314033|NCT00459667|13066374|P1|Started Treatment|Overall Study||586
5314034|NCT00459667|13066372|P3|Study Medication Dispensed|Overall Study||180
5314035|NCT00459667|13066373|P2|Study Medication Dispensed|Overall Study||645
5314036|NCT00459667|13066374|P1|Study Medication Dispensed|Overall Study||586
5314037|NCT00459667|13066372|P3|STARTED|Overall Study||181
5314038|NCT00459667|13066373|P2|STARTED|Overall Study||647
5314039|NCT00459667|13066374|P1|STARTED|Overall Study||592
5314040|NCT00459537|13066396|P2|NOT COMPLETED|Overall Study||76
5314041|NCT00459537|13066397|P1|NOT COMPLETED|Overall Study||66
5314042|NCT00459537|13066396|P2|COMPLETED|Overall Study||446
5314043|NCT00459537|13066397|P1|COMPLETED|Overall Study||441
5314044|NCT00459537|13066396|P2|Safety Population|Overall Study||512
5314045|NCT00459537|13066397|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
5314046|NCT00459537|13066396|P2|STARTED|Overall Study||522
5314047|NCT00459537|13066397|P1|STARTED|Overall Study||507
5314048|NCT00459381|13066411|P1|NOT COMPLETED|Overall Study||0
5314049|NCT00459381|13066411|P1|COMPLETED|Overall Study||35
5314050|NCT00459381|13066411|P1|STARTED|Overall Study||35
5314051|NCT00459368|13066423|P2|NOT COMPLETED|Overall Study||329
5314052|NCT00459368|13066424|P1|NOT COMPLETED|Overall Study||295
5314053|NCT00459368|13066423|P2|COMPLETED|Overall Study||1034
5314054|NCT00459368|13066424|P1|COMPLETED|Overall Study||1040
5314055|NCT00459368|13066423|P2|STARTED|Overall Study||1363
5314056|NCT00459368|13066424|P1|STARTED|Overall Study||1335
5314057|NCT00459355|13066432|P2|NOT COMPLETED|Overall Study||18
5314058|NCT00459355|13066433|P1|NOT COMPLETED|Overall Study||20
5314059|NCT00459355|13066432|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
5314060|NCT00459355|13066433|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
5314061|NCT00459355|13066432|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
5314062|NCT00459355|13066433|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
5314063|NCT00459342|13066445|P1|NOT COMPLETED|Overall Study||1
5314064|NCT00459342|13066445|P1|COMPLETED|Overall Study||34
5314065|NCT00459342|13066445|P1|STARTED|Overall Study||35
5314066|NCT00459316|13066458|P3|NOT COMPLETED|Step 3||1
5314067|NCT00459316|13066459|P2|NOT COMPLETED|Step 3||0
5314068|NCT00459316|13066460|P1|NOT COMPLETED|Step 3||3
5314069|NCT00459316|13066458|P3|COMPLETED|Step 3||39
5314070|NCT00459316|13066459|P2|COMPLETED|Step 3||0
5314071|NCT00459316|13066460|P1|COMPLETED|Step 3||149
5314072|NCT00459316|13066458|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
5314073|NCT00459316|13066459|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
5314074|NCT00459316|13066460|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
5314075|NCT00459316|13066458|P3|NOT COMPLETED|Steps 1 & 2||2
5314076|NCT00459316|13066459|P2|NOT COMPLETED|Steps 1 & 2||7
5314077|NCT00459316|13066460|P1|NOT COMPLETED|Steps 1 & 2||21
5314078|NCT00459316|13066458|P3|COMPLETED|Steps 1 & 2||57
5314079|NCT00459316|13066459|P2|COMPLETED|Steps 1 & 2||32
5314080|NCT00459316|13066460|P1|COMPLETED|Steps 1 & 2||259
5314081|NCT00459316|13066458|P3|STARTED|Steps 1 & 2||59
5314082|NCT00459316|13066459|P2|STARTED|Steps 1 & 2||39
5314083|NCT00459316|13066460|P1|STARTED|Steps 1 & 2||280
5314084|NCT00459303|13066514|P1|NOT COMPLETED|Overall Study||0
5314085|NCT00459303|13066514|P1|COMPLETED|Overall Study||20
5314086|NCT00459303|13066514|P1|STARTED|Overall Study||20
5314087|NCT00459290|13066525|P1|NOT COMPLETED|Overall Study||5
5314088|NCT00459290|13066525|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
5314089|NCT00459290|13066525|P1|STARTED|Overall Study||24
5314090|NCT00459186|13066540|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
5314091|NCT00459186|13066540|P1|COMPLETED|Combination RAD001 + Docetaxel||15
5314092|NCT00459186|13066540|P1|STARTED|Combination RAD001 + Docetaxel||15
5314093|NCT00459186|13066540|P1|NOT COMPLETED|PET Imaging and Assessment||3
5314094|NCT00459186|13066540|P1|COMPLETED|PET Imaging and Assessment||15
5314095|NCT00459186|13066540|P1|STARTED|PET Imaging and Assessment||18
5314096|NCT00459186|13066540|P1|NOT COMPLETED|Single Agent RAD001||1
5314097|NCT00459186|13066540|P1|COMPLETED|Single Agent RAD001||18
5314098|NCT00459186|13066540|P1|STARTED|Single Agent RAD001||19
5314099|NCT00459134|13066547|P2|NOT COMPLETED|Overall Study||25
5314100|NCT00459134|13066548|P1|NOT COMPLETED|Overall Study||23
5314101|NCT00459134|13066547|P2|COMPLETED|Overall Study||67
5314102|NCT00459134|13066548|P1|COMPLETED|Overall Study||71
5314103|NCT00459134|13066547|P2|STARTED|Overall Study||92
5314104|NCT00459134|13066548|P1|STARTED|Overall Study||94
5314105|NCT00459121|13066556|P1|NOT COMPLETED|Overall Study||0
5314106|NCT00459121|13066556|P1|COMPLETED|Overall Study||2
5314107|NCT00459121|13066556|P1|STARTED|Overall Study||2
5314108|NCT00459108|13066564|P1|NOT COMPLETED|Overall Study||11
5314109|NCT00459108|13066564|P1|COMPLETED|Overall Study||14
5314110|NCT00459108|13066564|P1|STARTED|Overall Study||25
5314111|NCT00459056|13066574|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
5314112|NCT00459056|13066575|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
5314113|NCT00459056|13066574|P2|COMPLETED|Second Intervention (Final Three Months)||14
5314114|NCT00459056|13066575|P1|COMPLETED|Second Intervention (Final Three Months)||9
5314115|NCT00459056|13066574|P2|STARTED|Second Intervention (Final Three Months)||14
5314116|NCT00459056|13066575|P1|STARTED|Second Intervention (Final Three Months)||9
5314117|NCT00459056|13066574|P2|NOT COMPLETED|Washout (1 Month)||0
5314118|NCT00459056|13066575|P1|NOT COMPLETED|Washout (1 Month)||0
5314119|NCT00459056|13066574|P2|COMPLETED|Washout (1 Month)||14
5314120|NCT00459056|13066575|P1|COMPLETED|Washout (1 Month)||9
5314121|NCT00459056|13066574|P2|STARTED|Washout (1 Month)||14
5314122|NCT00459056|13066575|P1|STARTED|Washout (1 Month)||9
5314123|NCT00459056|13066574|P2|NOT COMPLETED|First Intervention (First Three Months)||1
5314124|NCT00459056|13066575|P1|NOT COMPLETED|First Intervention (First Three Months)||1
5314125|NCT00459056|13066574|P2|COMPLETED|First Intervention (First Three Months)||14
5314126|NCT00459056|13066575|P1|COMPLETED|First Intervention (First Three Months)||9
5314127|NCT00459056|13066574|P2|STARTED|First Intervention (First Three Months)||15
5314128|NCT00459056|13066575|P1|STARTED|First Intervention (First Three Months)||10
5314129|NCT00459043|13066583|P2|NOT COMPLETED|Overall Study||0
5314130|NCT00459043|13066584|P1|NOT COMPLETED|Overall Study||1
5314131|NCT00459043|13066583|P2|COMPLETED|Overall Study||15
5314132|NCT00459043|13066584|P1|COMPLETED|Overall Study||14
5314133|NCT00459043|13066583|P2|STARTED|Overall Study||15
5314134|NCT00459043|13066584|P1|STARTED|Overall Study||15
5314135|NCT00458952|13066596|P2|NOT COMPLETED|Overall Study||5
5314136|NCT00458952|13066597|P1|NOT COMPLETED|Overall Study||2
5314137|NCT00458952|13066596|P2|COMPLETED|Overall Study||9
5314138|NCT00458952|13066597|P1|COMPLETED|Overall Study||5
5314139|NCT00458952|13066596|P2|STARTED|Overall Study||14
5314140|NCT00458952|13066597|P1|STARTED|Overall Study||7
5314141|NCT00458848|13066601|P1|NOT COMPLETED|Overall Study||0
5314142|NCT00458848|13066601|P1|COMPLETED|Overall Study||51
5314143|NCT00458848|13066601|P1|STARTED|Overall Study||51
5314144|NCT00458822|13066607|P1|NOT COMPLETED|Overall Study||0
5314145|NCT00458822|13066607|P1|COMPLETED|Overall Study||40
5314146|NCT00458822|13066607|P1|STARTED|Overall Study||40
5314147|NCT00458705|13066611|P1|NOT COMPLETED|Overall Study||5
5314148|NCT00458705|13066611|P1|COMPLETED|Overall Study||40
5314149|NCT00458705|13066611|P1|STARTED|Overall Study||45
5314150|NCT00458536|13066615|P1|NOT COMPLETED|Overall Study||19
5314151|NCT00458536|13066615|P1|COMPLETED|Overall Study||19
5314152|NCT00458536|13066615|P1|STARTED|Overall Study||38
5314153|NCT00458484|13066626|P7|NOT COMPLETED|Overall Study||0
5314154|NCT00458484|13066627|P6|NOT COMPLETED|Overall Study||1
5314155|NCT00458484|13066628|P5|NOT COMPLETED|Overall Study||0
5314156|NCT00458484|13066629|P4|NOT COMPLETED|Overall Study||0
5314157|NCT00458484|13066630|P3|NOT COMPLETED|Overall Study||0
5314158|NCT00458484|13066631|P2|NOT COMPLETED|Overall Study||0
5314159|NCT00458484|13066632|P1|NOT COMPLETED|Overall Study||0
5314160|NCT00458484|13066626|P7|COMPLETED|Overall Study||3
5314161|NCT00458484|13066627|P6|COMPLETED|Overall Study||4
5314162|NCT00458484|13066628|P5|COMPLETED|Overall Study||4
5314163|NCT00458484|13066629|P4|COMPLETED|Overall Study||6
5314164|NCT00458484|13066630|P3|COMPLETED|Overall Study||3
5314165|NCT00458484|13066631|P2|COMPLETED|Overall Study||6
5314166|NCT00458484|13066632|P1|COMPLETED|Overall Study||4
5314167|NCT00458484|13066626|P7|STARTED|Overall Study||3
5314168|NCT00458484|13066627|P6|STARTED|Overall Study||5
5314169|NCT00458484|13066628|P5|STARTED|Overall Study||4
5314170|NCT00458484|13066629|P4|STARTED|Overall Study||6
5314171|NCT00458484|13066630|P3|STARTED|Overall Study||3
5314172|NCT00458484|13066631|P2|STARTED|Overall Study||6
5314173|NCT00458484|13066632|P1|STARTED|Overall Study||4
5314174|NCT00458406|13066673|P2|NOT COMPLETED|Month 3||0
5314175|NCT00458406|13066674|P1|NOT COMPLETED|Month 3||0
5314176|NCT00458406|13066673|P2|COMPLETED|Month 3||13
5314177|NCT00458406|13066674|P1|COMPLETED|Month 3||43
5314178|NCT00458406|13066673|P2|STARTED|Month 3||13
5314179|NCT00458406|13066674|P1|STARTED|Month 3||43
5314180|NCT00458406|13066673|P2|NOT COMPLETED|Month 1||0
5314181|NCT00458406|13066674|P1|NOT COMPLETED|Month 1||0
5314182|NCT00458406|13066673|P2|COMPLETED|Month 1||13
5314183|NCT00458406|13066674|P1|COMPLETED|Month 1||43
5314184|NCT00458406|13066673|P2|STARTED|Month 1||13
5314185|NCT00458406|13066674|P1|STARTED|Month 1||43
5314186|NCT00458393|13066698|P2|NOT COMPLETED|Overall Study||295
5314187|NCT00458393|13066699|P1|NOT COMPLETED|Overall Study||309
5314188|NCT00458393|13066698|P2|COMPLETED|Overall Study||953
5314189|NCT00458393|13066699|P1|COMPLETED|Overall Study||942
5314190|NCT00458393|13066698|P2|STARTED|Overall Study||1248
5314191|NCT00458393|13066699|P1|STARTED|Overall Study||1251
5314192|NCT00458341|13066747|P2|NOT COMPLETED|Cycle 2||0
5314193|NCT00458341|13066748|P1|NOT COMPLETED|Cycle 2||0
5314194|NCT00458341|13066747|P2|COMPLETED|Cycle 2||15
5314195|NCT00458341|13066748|P1|COMPLETED|Cycle 2||15
5314196|NCT00458341|13066747|P2|Received at Least 1 Dose of Study Drug|Cycle 2||15
5314197|NCT00458341|13066748|P1|Received at Least 1 Dose of Study Drug|Cycle 2||15
5314198|NCT00458341|13066747|P2|STARTED|Cycle 2||15
5314199|NCT00458341|13066748|P1|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
5314200|NCT00458341|13066747|P2|NOT COMPLETED|Cycle 1||0
5314201|NCT00458341|13066748|P1|NOT COMPLETED|Cycle 1||1
5314202|NCT00458341|13066747|P2|COMPLETED|Cycle 1||15
5314203|NCT00458341|13066748|P1|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
5314204|NCT00458341|13066747|P2|Received at Least 1 Dose of Study Drug|Cycle 1||15
5314205|NCT00458341|13066748|P1|Received at Least 1 Dose of Study Drug|Cycle 1||15
5314206|NCT00458341|13066747|P2|STARTED|Cycle 1||15
5314207|NCT00458341|13066748|P1|STARTED|Cycle 1||15
5314208|NCT00458302|13066788|P2|NOT COMPLETED|Overall Study||24
5314209|NCT00458302|13066789|P1|NOT COMPLETED|Overall Study||20
5314210|NCT00458302|13066788|P2|COMPLETED|Overall Study||103
5314211|NCT00458302|13066789|P1|COMPLETED|Overall Study||109
5314212|NCT00458302|13066788|P2|STARTED|Overall Study||127
5314213|NCT00458302|13066789|P1|STARTED|Overall Study||129
5314214|NCT00458237|13066823|P3|NOT COMPLETED|Overall Study||0
5314215|NCT00458237|13066824|P2|NOT COMPLETED|Overall Study||0
5314216|NCT00458237|13066825|P1|NOT COMPLETED|Overall Study||0
5314217|NCT00458237|13066823|P3|COMPLETED|Overall Study||5
5314218|NCT00458237|13066824|P2|COMPLETED|Overall Study||3
5314219|NCT00458237|13066825|P1|COMPLETED|Overall Study||3
5314220|NCT00458237|13066823|P3|STARTED|Overall Study||5
5314221|NCT00458237|13066824|P2|STARTED|Overall Study||3
5314222|NCT00458237|13066825|P1|STARTED|Overall Study||3
5314223|NCT00458211|13066834|P1|NOT COMPLETED|Overall Study||16
5314224|NCT00458211|13066834|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
5314225|NCT00458211|13066834|P1|STARTED|Overall Study||40
5314226|NCT00457977|13066855|P2|NOT COMPLETED|Overall Study||25
5314227|NCT00457977|13066856|P1|NOT COMPLETED|Overall Study||28
5314228|NCT00457977|13066855|P2|COMPLETED|Overall Study||66
5314229|NCT00457977|13066856|P1|COMPLETED|Overall Study||62
5314230|NCT00457977|13066855|P2|2-Year|Overall Study||66
5314231|NCT00457977|13066856|P1|2-Year|Overall Study||62
5314232|NCT00457977|13066855|P2|1-Year|Overall Study||76
5314233|NCT00457977|13066856|P1|1-Year|Overall Study||69
5314234|NCT00457977|13066855|P2|1-Month|Overall Study||87
5314235|NCT00457977|13066856|P1|1-Month|Overall Study||88
5314236|NCT00457977|13066855|P2|STARTED|Overall Study||91
5314237|NCT00457977|13066856|P1|STARTED|Overall Study||90
5314238|NCT00457951|13066867|P3|NOT COMPLETED|Overall Study||12
5314239|NCT00457951|13066868|P2|NOT COMPLETED|Overall Study||16
5314240|NCT00457951|13066869|P1|NOT COMPLETED|Overall Study||0
5314241|NCT00457951|13066867|P3|COMPLETED|Overall Study||60
5314242|NCT00457951|13066868|P2|COMPLETED|Overall Study||50
5314243|NCT00457951|13066869|P1|COMPLETED|Overall Study||13
5314244|NCT00457951|13066867|P3|STARTED|Overall Study||72
5314245|NCT00457951|13066868|P2|STARTED|Overall Study||66
5314246|NCT00457951|13066869|P1|STARTED|Overall Study||13
5314247|NCT00457821|13066884|P8|NOT COMPLETED|Part 2||1
5314248|NCT00457821|13066885|P7|NOT COMPLETED|Part 2||0
5314249|NCT00457821|13066886|P6|NOT COMPLETED|Part 2||0
5314250|NCT00457821|13066887|P5|NOT COMPLETED|Part 2||0
5314251|NCT00457821|13066888|P4|NOT COMPLETED|Part 2||0
5314252|NCT00457821|13066889|P3|NOT COMPLETED|Part 2||0
5314253|NCT00457821|13066890|P2|NOT COMPLETED|Part 2||0
5314254|NCT00457821|13066891|P1|NOT COMPLETED|Part 2||0
5314255|NCT00457821|13066884|P8|COMPLETED|Part 2||4
5314256|NCT00457821|13066885|P7|COMPLETED|Part 2||7
5314257|NCT00457821|13066886|P6|COMPLETED|Part 2||8
5314258|NCT00457821|13066887|P5|COMPLETED|Part 2||0
5314259|NCT00457821|13066888|P4|COMPLETED|Part 2||0
5314260|NCT00457821|13066889|P3|COMPLETED|Part 2||0
5314261|NCT00457821|13066890|P2|COMPLETED|Part 2||0
5314262|NCT00457821|13066891|P1|COMPLETED|Part 2||0
5314263|NCT00457821|13066884|P8|Completed Study Drug Treatment|Part 2||4
5314264|NCT00457821|13066885|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
5314265|NCT00457821|13066886|P6|Completed Study Drug Treatment|Part 2||8
5314266|NCT00457821|13066887|P5|Completed Study Drug Treatment|Part 2||0
5314267|NCT00457821|13066888|P4|Completed Study Drug Treatment|Part 2||0
5314268|NCT00457821|13066889|P3|Completed Study Drug Treatment|Part 2||0
5314269|NCT00457821|13066890|P2|Completed Study Drug Treatment|Part 2||0
5314270|NCT00457821|13066891|P1|Completed Study Drug Treatment|Part 2||0
5314271|NCT00457821|13066884|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
5314272|NCT00457821|13066885|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
5314273|NCT00457821|13066886|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
5314274|NCT00457821|13066887|P5|STARTED|Part 2|Arm in Part 1 only|0
5314275|NCT00457821|13066888|P4|STARTED|Part 2|Arm in Part 1 only|0
5314276|NCT00457821|13066889|P3|STARTED|Part 2|Arm in Part 1 only|0
5314277|NCT00457821|13066890|P2|STARTED|Part 2|Arm in Part 1 only|0
5314278|NCT00457821|13066891|P1|STARTED|Part 2|Arm in Part 1 only|0
5314279|NCT00457821|13066884|P8|NOT COMPLETED|Part 1||0
5314280|NCT00457821|13066885|P7|NOT COMPLETED|Part 1||0
5314281|NCT00457821|13066886|P6|NOT COMPLETED|Part 1||0
5314282|NCT00457821|13066887|P5|NOT COMPLETED|Part 1||0
5314283|NCT00457821|13066888|P4|NOT COMPLETED|Part 1||0
5314284|NCT00457821|13066889|P3|NOT COMPLETED|Part 1||1
5314285|NCT00457821|13066890|P2|NOT COMPLETED|Part 1||0
5314286|NCT00457821|13066891|P1|NOT COMPLETED|Part 1||0
5314287|NCT00457821|13066884|P8|COMPLETED|Part 1||0
5314288|NCT00457821|13066885|P7|COMPLETED|Part 1||0
5314289|NCT00457821|13066886|P6|COMPLETED|Part 1||0
5314290|NCT00457821|13066887|P5|COMPLETED|Part 1||4
5314291|NCT00457821|13066888|P4|COMPLETED|Part 1||4
5314292|NCT00457821|13066889|P3|COMPLETED|Part 1||4
5314293|NCT00457821|13066890|P2|COMPLETED|Part 1||4
5314294|NCT00457821|13066891|P1|COMPLETED|Part 1||4
5314295|NCT00457821|13066884|P8|STARTED|Part 1|Arm in Part 2 only|0
5314296|NCT00457821|13066885|P7|STARTED|Part 1|Arm in Part 2 only|0
5314297|NCT00457821|13066886|P6|STARTED|Part 1|Arm in Part 2 only|0
5314298|NCT00457821|13066887|P5|STARTED|Part 1|Number of subjects randomized|4
5314299|NCT00457821|13066888|P4|STARTED|Part 1|Number of subjects randomized|4
5314300|NCT00457821|13066889|P3|STARTED|Part 1|Number of subjects randomized|5
5314301|NCT00457821|13066890|P2|STARTED|Part 1|Number of subjects randomized|4
5314302|NCT00457821|13066891|P1|STARTED|Part 1|Number of subjects randomized|4
5314303|NCT00457795|13066920|P1|NOT COMPLETED|Overall Study||0
5314304|NCT00457795|13066920|P1|COMPLETED|Overall Study||15
5314305|NCT00457795|13066920|P1|STARTED|Overall Study||15
5314306|NCT00457743|13066930|P3|NOT COMPLETED|Overall Study||3
5314307|NCT00457743|13066931|P2|NOT COMPLETED|Overall Study||27
5314308|NCT00457743|13066932|P1|NOT COMPLETED|Overall Study||3
5314309|NCT00457743|13066930|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
5314310|NCT00457743|13066931|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
5314311|NCT00457743|13066932|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
5314312|NCT00457743|13066930|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
5314313|NCT00457743|13066931|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
5314314|NCT00457743|13066932|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
5314315|NCT00457743|13066930|P3|Completed Phase 1|Overall Study||3
5314316|NCT00457743|13066931|P2|Completed Phase 1|Overall Study||6
5314317|NCT00457743|13066932|P1|Completed Phase 1|Overall Study||3
5314318|NCT00457743|13066930|P3|Enrolled in Phase 1|Overall Study||3
5314319|NCT00457743|13066931|P2|Enrolled in Phase 1|Overall Study||6
5314320|NCT00457743|13066932|P1|Enrolled in Phase 1|Overall Study||3
5314321|NCT00457743|13066930|P3|STARTED|Overall Study|Overall study|3
5314322|NCT00457743|13066931|P2|STARTED|Overall Study|Overall study|30
5314323|NCT00457743|13066932|P1|STARTED|Overall Study|Overall study|3
5314324|NCT00457730|13066976|P2|NOT COMPLETED|Overall Study||1
5314325|NCT00457730|13066977|P1|NOT COMPLETED|Overall Study||4
5314326|NCT00457730|13066976|P2|COMPLETED|Overall Study||19
5314327|NCT00457730|13066977|P1|COMPLETED|Overall Study||14
5314328|NCT00457730|13066976|P2|STARTED|Overall Study||20
5314329|NCT00457730|13066977|P1|STARTED|Overall Study||18
5314330|NCT00457691|13066989|P2|NOT COMPLETED|Overall Study||382
5314331|NCT00457691|13066990|P1|NOT COMPLETED|Overall Study||386
5314332|NCT00457691|13066989|P2|COMPLETED|Overall Study||0
5314333|NCT00457691|13066990|P1|COMPLETED|Overall Study||0
5314334|NCT00457691|13066989|P2|STARTED|Overall Study||382
5314335|NCT00457691|13066990|P1|STARTED|Overall Study||386
5314336|NCT00457665|13067012|P2|NOT COMPLETED|24 Months||8
5314337|NCT00457665|13067013|P1|NOT COMPLETED|24 Months||5
5314338|NCT00457665|13067012|P2|COMPLETED|24 Months||11
5314339|NCT00457665|13067013|P1|COMPLETED|24 Months||15
5314340|NCT00457665|13067012|P2|STARTED|24 Months||19
5314341|NCT00457665|13067013|P1|STARTED|24 Months||20
5314342|NCT00457665|13067012|P2|NOT COMPLETED|12 Months||9
5314343|NCT00457665|13067013|P1|NOT COMPLETED|12 Months||8
5314344|NCT00457665|13067012|P2|COMPLETED|12 Months||19
5314345|NCT00457665|13067013|P1|COMPLETED|12 Months||20
5314346|NCT00457665|13067012|P2|STARTED|12 Months||28
5314347|NCT00457665|13067013|P1|STARTED|12 Months||28
5314348|NCT00457639|13067019|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
5314349|NCT00457639|13067020|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
5314350|NCT00457639|13067019|P2|COMPLETED|Intervention 2 (6 Months)||6
5314351|NCT00457639|13067020|P1|COMPLETED|Intervention 2 (6 Months)||6
5314352|NCT00457639|13067019|P2|STARTED|Intervention 2 (6 Months)||7
5314353|NCT00457639|13067020|P1|STARTED|Intervention 2 (6 Months)||6
5314354|NCT00457639|13067019|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
5314355|NCT00457639|13067020|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
5314356|NCT00457639|13067019|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
5314357|NCT00457639|13067020|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
5314358|NCT00457639|13067019|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
5314359|NCT00457639|13067020|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
5314360|NCT00457418|13067028|P1|NOT COMPLETED|Post PK Maintenance||28
5314361|NCT00457418|13067028|P1|COMPLETED|Post PK Maintenance||3
5314362|NCT00457418|13067028|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
5314363|NCT00457418|13067028|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
5314364|NCT00457418|13067028|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
5314365|NCT00457418|13067028|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
5314366|NCT00457392|13067040|P2|NOT COMPLETED|Overall Study||480
5314367|NCT00457392|13067041|P1|NOT COMPLETED|Overall Study||480
5314368|NCT00457392|13067040|P2|COMPLETED|Overall Study||0
5314369|NCT00457392|13067041|P1|COMPLETED|Overall Study||0
5314370|NCT00457392|13067040|P2|Treated|Overall Study||477
5314371|NCT00457392|13067041|P1|Treated|Overall Study||473
5314372|NCT00457392|13067040|P2|STARTED|Overall Study||480
5314373|NCT00457392|13067041|P1|STARTED|Overall Study||480
5314374|NCT00457366|13067059|P2|NOT COMPLETED|Overall Study||0
5314375|NCT00457366|13067060|P1|NOT COMPLETED|Overall Study||0
5314376|NCT00457366|13067059|P2|COMPLETED|Overall Study||32
5314377|NCT00457366|13067060|P1|COMPLETED|Overall Study||40
5314378|NCT00457366|13067059|P2|STARTED|Overall Study||32
5314379|NCT00457366|13067060|P1|STARTED|Overall Study||40
5314380|NCT00457301|13067068|P2|NOT COMPLETED|Overall Study||24
5314381|NCT00457301|13067069|P1|NOT COMPLETED|Overall Study||23
5314382|NCT00457301|13067068|P2|COMPLETED|Overall Study||84
5314383|NCT00457301|13067069|P1|COMPLETED|Overall Study||82
5314384|NCT00457301|13067068|P2|STARTED|Overall Study||108
5314385|NCT00457301|13067069|P1|STARTED|Overall Study||105
5314386|NCT00457249|13067083|P2|NOT COMPLETED|Overall Study||2
5314387|NCT00457249|13067084|P1|NOT COMPLETED|Overall Study||12
5314388|NCT00457249|13067083|P2|COMPLETED|Overall Study||389
5314389|NCT00457249|13067084|P1|COMPLETED|Overall Study||1158
5314390|NCT00457249|13067083|P2|STARTED|Overall Study||391
5314391|NCT00457249|13067084|P1|STARTED|Overall Study||1170
5314392|NCT00457197|13067098|P2|NOT COMPLETED|Overall Study||1
5314393|NCT00457197|13067099|P1|NOT COMPLETED|Overall Study||1
5314394|NCT00457197|13067098|P2|COMPLETED|Overall Study||44
5314395|NCT00457197|13067099|P1|COMPLETED|Overall Study||44
5314396|NCT00457197|13067098|P2|STARTED|Overall Study||45
5314397|NCT00457197|13067099|P1|STARTED|Overall Study||45
5314398|NCT00457015|13067123|P2|NOT COMPLETED|Overall Study||1
5314399|NCT00457015|13067124|P1|NOT COMPLETED|Overall Study||0
5314400|NCT00457015|13067123|P2|COMPLETED|Overall Study||47
5314401|NCT00457015|13067124|P1|COMPLETED|Overall Study||48
5314402|NCT00457015|13067123|P2|STARTED|Overall Study||48
5314403|NCT00457015|13067124|P1|STARTED|Overall Study||48
5314404|NCT00457002|13067140|P2|NOT COMPLETED|Overall Study||757
5314405|NCT00457002|13067141|P1|NOT COMPLETED|Overall Study||813
5314406|NCT00457002|13067140|P2|COMPLETED|Overall Study||2516
5314407|NCT00457002|13067141|P1|COMPLETED|Overall Study||2442
5314408|NCT00457002|13067140|P2|STARTED|Overall Study||3273
5314409|NCT00457002|13067141|P1|STARTED|Overall Study||3255
5314410|NCT00456989|13067209|P1|NOT COMPLETED|Overall Study||0
5314411|NCT00456989|13067209|P1|COMPLETED|Overall Study||39
5314412|NCT00456989|13067209|P1|STARTED|Overall Study||39
5314413|NCT00456885|13067214|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
5314414|NCT00456885|13067215|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
5314415|NCT00456885|13067214|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
5314416|NCT00456885|13067215|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
5314417|NCT00456885|13067214|P2|STARTED|Second Treatment Period, 16 Weeks||17
5314418|NCT00456885|13067215|P1|STARTED|Second Treatment Period, 16 Weeks||24
5314419|NCT00456885|13067214|P2|NOT COMPLETED|Washout, 3 Weeks||0
5314420|NCT00456885|13067215|P1|NOT COMPLETED|Washout, 3 Weeks||0
5314421|NCT00456885|13067214|P2|COMPLETED|Washout, 3 Weeks||17
5314422|NCT00456885|13067215|P1|COMPLETED|Washout, 3 Weeks||24
5314423|NCT00456885|13067214|P2|STARTED|Washout, 3 Weeks||17
5314424|NCT00456885|13067215|P1|STARTED|Washout, 3 Weeks||24
5314425|NCT00456885|13067214|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
5314426|NCT00456885|13067215|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
5314427|NCT00456885|13067214|P2|COMPLETED|First Treatment Period, 16 Weeks||17
5314428|NCT00456885|13067215|P1|COMPLETED|First Treatment Period, 16 Weeks||24
5314429|NCT00456885|13067214|P2|STARTED|First Treatment Period, 16 Weeks||17
5314430|NCT00456885|13067215|P1|STARTED|First Treatment Period, 16 Weeks||24
5314431|NCT00456846|13067246|P2|NOT COMPLETED|Overall Study||28
5314432|NCT00456846|13067247|P1|NOT COMPLETED|Overall Study||16
5314433|NCT00456846|13067246|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
5314434|NCT00456846|13067247|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
5314435|NCT00456846|13067246|P2|STARTED|Overall Study||76
5314436|NCT00456846|13067247|P1|STARTED|Overall Study||47
5314437|NCT00456807|13067269|P2|NOT COMPLETED|Overall Study||0
5314438|NCT00456807|13067270|P1|NOT COMPLETED|Overall Study||1
5314439|NCT00456807|13067269|P2|COMPLETED|Overall Study||47
5314440|NCT00456807|13067270|P1|COMPLETED|Overall Study||52
5314441|NCT00456807|13067269|P2|STARTED|Overall Study||47
5314442|NCT00456807|13067270|P1|STARTED|Overall Study||53
5314443|NCT00456755|13067288|P2|NOT COMPLETED|Overall Study||1
5314444|NCT00456755|13067289|P1|NOT COMPLETED|Overall Study||2
5314445|NCT00456755|13067288|P2|COMPLETED|Overall Study||62
5314446|NCT00456755|13067289|P1|COMPLETED|Overall Study||61
5314447|NCT00456755|13067288|P2|STARTED|Overall Study||63
5314448|NCT00456755|13067289|P1|STARTED|Overall Study||63
5314449|NCT00456625|13067297|P1|NOT COMPLETED|Overall Study||0
5314450|NCT00456625|13067297|P1|COMPLETED|Overall Study||76
5314451|NCT00456625|13067297|P1|STARTED|Overall Study||76
5314452|NCT00456612|13067303|P1|NOT COMPLETED|Overall Study||3
5314453|NCT00456612|13067303|P1|COMPLETED|Overall Study||1
5314454|NCT00456612|13067303|P1|STARTED|Overall Study||4
5314455|NCT00456599|13067308|P1|NOT COMPLETED|Overall Study||3
5314456|NCT00456599|13067308|P1|COMPLETED|Overall Study||68
5314457|NCT00456599|13067308|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
5314458|NCT00456599|13067308|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
5314459|NCT00456599|13067308|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
5314460|NCT00456599|13067308|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
5314461|NCT00456599|13067308|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
5314462|NCT00456599|13067308|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
5314463|NCT00456599|13067308|P1|STARTED|Overall Study||71
5314464|NCT00456547|13067316|P2|NOT COMPLETED|Overall Study||0
5314465|NCT00456547|13067317|P1|NOT COMPLETED|Overall Study||0
5314466|NCT00456547|13067316|P2|COMPLETED|Overall Study||12
5314467|NCT00456547|13067317|P1|COMPLETED|Overall Study||12
5314468|NCT00456547|13067316|P2|STARTED|Overall Study||12
5314469|NCT00456547|13067317|P1|STARTED|Overall Study||12
5314470|NCT00456521|13067331|P2|NOT COMPLETED|Overall Study||84
5314471|NCT00456521|13067332|P1|NOT COMPLETED|Overall Study||249
5314472|NCT00456521|13067331|P2|COMPLETED|Overall Study||118
5314473|NCT00456521|13067332|P1|COMPLETED|Overall Study||342
5314474|NCT00456521|13067331|P2|STARTED|Overall Study||202
5314475|NCT00456521|13067332|P1|STARTED|Overall Study||591
5314476|NCT00456508|13067372|P1|NOT COMPLETED|Overall Study||0
5314477|NCT00456508|13067372|P1|COMPLETED|Overall Study||147
5314478|NCT00456508|13067372|P1|STARTED|Overall Study||147
5314479|NCT00456495|13067378|P1|NOT COMPLETED|Overall Study||2
5314480|NCT00456495|13067378|P1|COMPLETED|Overall Study||3
5314481|NCT00456495|13067378|P1|STARTED|Overall Study||5
5314482|NCT00456365|13067385|P2|NOT COMPLETED|Overall Study||12
5314483|NCT00456365|13067386|P1|NOT COMPLETED|Overall Study||7
5314484|NCT00456365|13067385|P2|COMPLETED|Overall Study||42
5314485|NCT00456365|13067386|P1|COMPLETED|Overall Study||49
5314486|NCT00456365|13067385|P2|STARTED|Overall Study||54
5314487|NCT00456365|13067386|P1|STARTED|Overall Study||56
5314488|NCT00456300|13067398|P2|NOT COMPLETED|Overall Study||0
5314489|NCT00456300|13067399|P1|NOT COMPLETED|Overall Study||1
5314490|NCT00456300|13067398|P2|COMPLETED|Overall Study||4
5314491|NCT00456300|13067399|P1|COMPLETED|Overall Study||4
5314492|NCT00456300|13067398|P2|STARTED|Overall Study||4
5314493|NCT00456300|13067399|P1|STARTED|Overall Study||5
5314494|NCT00456261|13067409|P2|NOT COMPLETED|Maintenance Therapy||0
5314495|NCT00456261|13067410|P1|NOT COMPLETED|Maintenance Therapy||0
5314496|NCT00456261|13067409|P2|COMPLETED|Maintenance Therapy||29
5314497|NCT00456261|13067410|P1|COMPLETED|Maintenance Therapy||3
5314498|NCT00456261|13067409|P2|STARTED|Maintenance Therapy||29
5314499|NCT00456261|13067410|P1|STARTED|Maintenance Therapy||3
5314500|NCT00456261|13067409|P2|NOT COMPLETED|Combination Therapy||26
5314501|NCT00456261|13067410|P1|NOT COMPLETED|Combination Therapy||52
5314502|NCT00456261|13067409|P2|COMPLETED|Combination Therapy||29
5314503|NCT00456261|13067410|P1|COMPLETED|Combination Therapy||3
5314504|NCT00456261|13067409|P2|STARTED|Combination Therapy||55
5314505|NCT00456261|13067410|P1|STARTED|Combination Therapy||55
5314506|NCT00456092|13067423|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
5314507|NCT00456092|13067424|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
5314508|NCT00456092|13067425|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
5314509|NCT00456092|13067426|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
5314510|NCT00456092|13067427|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
5314511|NCT00456092|13067423|P5|COMPLETED|Treatment Phase (12 Weeks)||0
5314512|NCT00456092|13067424|P4|COMPLETED|Treatment Phase (12 Weeks)||0
5314513|NCT00456092|13067425|P3|COMPLETED|Treatment Phase (12 Weeks)||50
5314514|NCT00456092|13067426|P2|COMPLETED|Treatment Phase (12 Weeks)||55
5314515|NCT00456092|13067427|P1|COMPLETED|Treatment Phase (12 Weeks)||60
5314516|NCT00456092|13067423|P5|STARTED|Treatment Phase (12 Weeks)||0
5314517|NCT00456092|13067424|P4|STARTED|Treatment Phase (12 Weeks)||0
5314518|NCT00456092|13067425|P3|STARTED|Treatment Phase (12 Weeks)||68
5314519|NCT00456092|13067426|P2|STARTED|Treatment Phase (12 Weeks)||69
5314520|NCT00456092|13067427|P1|STARTED|Treatment Phase (12 Weeks)||67
5314521|NCT00456092|13067423|P5|NOT COMPLETED|Extension Phase||7
5314522|NCT00456092|13067424|P4|NOT COMPLETED|Extension Phase||1
5314523|NCT00456092|13067425|P3|NOT COMPLETED|Extension Phase||0
5314524|NCT00456092|13067426|P2|NOT COMPLETED|Extension Phase||4
5314525|NCT00456092|13067427|P1|NOT COMPLETED|Extension Phase||11
5314526|NCT00456092|13067423|P5|COMPLETED|Extension Phase||13
5314527|NCT00456092|13067424|P4|COMPLETED|Extension Phase||19
5314528|NCT00456092|13067425|P3|COMPLETED|Extension Phase||0
5314529|NCT00456092|13067426|P2|COMPLETED|Extension Phase||36
5314530|NCT00456092|13067427|P1|COMPLETED|Extension Phase||35
5314531|NCT00456092|13067423|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
5314532|NCT00456092|13067424|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
5314533|NCT00456092|13067425|P3|STARTED|Extension Phase||0
5314534|NCT00456092|13067426|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
5314535|NCT00456092|13067427|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
5314536|NCT00456014|13067577|P1|NOT COMPLETED|Tricyclic Phase||3
5314537|NCT00456014|13067577|P1|COMPLETED|Tricyclic Phase||1
5314538|NCT00456014|13067577|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
5314539|NCT00456014|13067577|P1|NOT COMPLETED|SSRI Phase||9
5314540|NCT00456014|13067577|P1|COMPLETED|SSRI Phase||28
5314541|NCT00456014|13067577|P1|STARTED|SSRI Phase||37
5314542|NCT00455975|13067585|P2|NOT COMPLETED|Overall Study||21
5314543|NCT00455975|13067586|P1|NOT COMPLETED|Overall Study||18
5314544|NCT00455975|13067585|P2|COMPLETED|Overall Study||40
5314545|NCT00455975|13067586|P1|COMPLETED|Overall Study||40
5314546|NCT00455975|13067585|P2|STARTED|Overall Study||61
5314547|NCT00455975|13067586|P1|STARTED|Overall Study||58
5314548|NCT00455962|13067600|P2|NOT COMPLETED|Overall Study||0
5314549|NCT00455962|13067601|P1|NOT COMPLETED|Overall Study||0
5314550|NCT00455962|13067600|P2|COMPLETED|Overall Study||13
5314551|NCT00455962|13067601|P1|COMPLETED|Overall Study||10
5314552|NCT00455962|13067600|P2|STARTED|Overall Study||13
5314553|NCT00455962|13067601|P1|STARTED|Overall Study||10
5314554|NCT00455923|13067609|P2|NOT COMPLETED|Overall Study||3
5314555|NCT00455923|13067610|P1|NOT COMPLETED|Overall Study||3
5314556|NCT00455923|13067609|P2|COMPLETED|Overall Study||47
5314557|NCT00455923|13067610|P1|COMPLETED|Overall Study||47
5314558|NCT00455923|13067609|P2|STARTED|Overall Study||50
5314559|NCT00455923|13067610|P1|STARTED|Overall Study||50
5314560|NCT00455858|13067626|P1|NOT COMPLETED|Overall Study||6
5314561|NCT00455858|13067626|P1|COMPLETED|Overall Study||81
5314562|NCT00455858|13067626|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
5314563|NCT00455741|13067636|P2|NOT COMPLETED|Overall Study||1
5314564|NCT00455741|13067637|P1|NOT COMPLETED|Overall Study||0
5314565|NCT00455741|13067636|P2|COMPLETED|Overall Study||11
5314566|NCT00455741|13067637|P1|COMPLETED|Overall Study||13
5314567|NCT00455741|13067636|P2|STARTED|Overall Study||12
5314568|NCT00455741|13067637|P1|STARTED|Overall Study||13
5314569|NCT00455702|13067655|P2|NOT COMPLETED|Overall Study||3
5314570|NCT00455702|13067656|P1|NOT COMPLETED|Overall Study||3
5314571|NCT00455702|13067655|P2|COMPLETED|Overall Study||16
5314572|NCT00455702|13067656|P1|COMPLETED|Overall Study||16
5314573|NCT00455702|13067655|P2|STARTED|Overall Study||19
5314574|NCT00455702|13067656|P1|STARTED|Overall Study||19
5314575|NCT00455689|13067666|P2|NOT COMPLETED|Overall Study||0
5314576|NCT00455689|13067667|P1|NOT COMPLETED|Overall Study||0
5314577|NCT00455689|13067666|P2|COMPLETED|Overall Study||6
5314578|NCT00455689|13067667|P1|COMPLETED|Overall Study||14
5314579|NCT00455689|13067666|P2|STARTED|Overall Study||6
5314580|NCT00455689|13067667|P1|STARTED|Overall Study||14
5314581|NCT00455663|13067677|P3|NOT COMPLETED|Overall Study||3
5314582|NCT00455663|13067678|P2|NOT COMPLETED|Overall Study||4
5314583|NCT00455663|13067679|P1|NOT COMPLETED|Overall Study||3
5314584|NCT00455663|13067677|P3|COMPLETED|Overall Study||29
5314585|NCT00455663|13067678|P2|COMPLETED|Overall Study||32
5314586|NCT00455663|13067679|P1|COMPLETED|Overall Study||34
5314587|NCT00455663|13067677|P3|STARTED|Overall Study||32
5314588|NCT00455663|13067678|P2|STARTED|Overall Study||36
5314589|NCT00455663|13067679|P1|STARTED|Overall Study||37
5314590|NCT00455650|13067698|P6|NOT COMPLETED|Week 3||0
5314591|NCT00455650|13067699|P5|NOT COMPLETED|Week 3||0
5314592|NCT00455650|13067700|P4|NOT COMPLETED|Week 3||0
5314593|NCT00455650|13067701|P3|NOT COMPLETED|Week 3||0
5314594|NCT00455650|13067702|P2|NOT COMPLETED|Week 3||0
5314595|NCT00455650|13067703|P1|NOT COMPLETED|Week 3||0
5314596|NCT00455650|13067698|P6|COMPLETED|Week 3||13
5314597|NCT00455650|13067699|P5|COMPLETED|Week 3||14
5314598|NCT00455650|13067700|P4|COMPLETED|Week 3||14
5314599|NCT00455650|13067701|P3|COMPLETED|Week 3||10
5314600|NCT00455650|13067702|P2|COMPLETED|Week 3||10
5314601|NCT00455650|13067703|P1|COMPLETED|Week 3||10
5314602|NCT00455650|13067698|P6|STARTED|Week 3||13
5314603|NCT00455650|13067699|P5|STARTED|Week 3||14
5314604|NCT00455650|13067700|P4|STARTED|Week 3||14
5314605|NCT00455650|13067701|P3|STARTED|Week 3||10
5314606|NCT00455650|13067702|P2|STARTED|Week 3||10
5314607|NCT00455650|13067703|P1|STARTED|Week 3||10
5314608|NCT00455650|13067698|P6|NOT COMPLETED|Week 2||0
5314609|NCT00455650|13067699|P5|NOT COMPLETED|Week 2||0
5314610|NCT00455650|13067700|P4|NOT COMPLETED|Week 2||0
5314611|NCT00455650|13067701|P3|NOT COMPLETED|Week 2||0
5314612|NCT00455650|13067702|P2|NOT COMPLETED|Week 2||0
5314613|NCT00455650|13067703|P1|NOT COMPLETED|Week 2||0
5314614|NCT00455650|13067698|P6|COMPLETED|Week 2||13
5314615|NCT00455650|13067699|P5|COMPLETED|Week 2||14
5314616|NCT00455650|13067700|P4|COMPLETED|Week 2||14
5314617|NCT00455650|13067701|P3|COMPLETED|Week 2||10
5314618|NCT00455650|13067702|P2|COMPLETED|Week 2||10
5314619|NCT00455650|13067703|P1|COMPLETED|Week 2||10
5314620|NCT00455650|13067698|P6|STARTED|Week 2||13
5314621|NCT00455650|13067699|P5|STARTED|Week 2||14
5314622|NCT00455650|13067700|P4|STARTED|Week 2||14
5314623|NCT00455650|13067701|P3|STARTED|Week 2||10
5314624|NCT00455650|13067702|P2|STARTED|Week 2||10
5314625|NCT00455650|13067703|P1|STARTED|Week 2||10
5314626|NCT00455650|13067698|P6|NOT COMPLETED|Week 1||0
5314627|NCT00455650|13067699|P5|NOT COMPLETED|Week 1||0
5314628|NCT00455650|13067700|P4|NOT COMPLETED|Week 1||0
5314629|NCT00455650|13067701|P3|NOT COMPLETED|Week 1||0
5314630|NCT00455650|13067702|P2|NOT COMPLETED|Week 1||0
5314631|NCT00455650|13067703|P1|NOT COMPLETED|Week 1||0
5314632|NCT00455650|13067698|P6|COMPLETED|Week 1||13
5314633|NCT00455650|13067699|P5|COMPLETED|Week 1||14
5314634|NCT00455650|13067700|P4|COMPLETED|Week 1||14
5314635|NCT00455650|13067701|P3|COMPLETED|Week 1||10
5314636|NCT00455650|13067702|P2|COMPLETED|Week 1||10
5314637|NCT00455650|13067703|P1|COMPLETED|Week 1||10
5314638|NCT00455650|13067698|P6|STARTED|Week 1||13
5314639|NCT00455650|13067699|P5|STARTED|Week 1||14
5314640|NCT00455650|13067700|P4|STARTED|Week 1||14
5314641|NCT00455650|13067701|P3|STARTED|Week 1||10
5314642|NCT00455650|13067702|P2|STARTED|Week 1||10
5314643|NCT00455650|13067703|P1|STARTED|Week 1||10
5314644|NCT00455533|13067733|P3|NOT COMPLETED|Period Two: Randomized Period||6
5314645|NCT00455533|13067734|P2|NOT COMPLETED|Period Two: Randomized Period||6
5314646|NCT00455533|13067735|P1|NOT COMPLETED|Period Two: Randomized Period||0
5314647|NCT00455533|13067733|P3|COMPLETED|Period Two: Randomized Period||138
5314648|NCT00455533|13067734|P2|COMPLETED|Period Two: Randomized Period||139
5314649|NCT00455533|13067735|P1|COMPLETED|Period Two: Randomized Period||0
5314650|NCT00455533|13067733|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
5314651|NCT00455533|13067734|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
5314652|NCT00455533|13067735|P1|STARTED|Period Two: Randomized Period||0
5314653|NCT00455533|13067733|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
5314654|NCT00455533|13067734|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
5314655|NCT00455533|13067735|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
5314656|NCT00455533|13067733|P3|COMPLETED|Period One: Initial Chemotherapy||0
5314657|NCT00455533|13067734|P2|COMPLETED|Period One: Initial Chemotherapy||0
5314658|NCT00455533|13067735|P1|COMPLETED|Period One: Initial Chemotherapy||295
5314659|NCT00455533|13067733|P3|STARTED|Period One: Initial Chemotherapy||0
5314660|NCT00455533|13067734|P2|STARTED|Period One: Initial Chemotherapy||0
5314661|NCT00455533|13067735|P1|STARTED|Period One: Initial Chemotherapy||313
5314662|NCT00455520|13067784|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
5314663|NCT00455520|13067785|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
5314664|NCT00455520|13067784|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
5314665|NCT00455520|13067785|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
5314666|NCT00455520|13067784|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
5314667|NCT00455520|13067785|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
5314668|NCT00455520|13067784|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
5314669|NCT00455520|13067785|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
5314670|NCT00455520|13067784|P2|COMPLETED|Open Label Tapentadol Extended Release||0
5314671|NCT00455520|13067785|P1|COMPLETED|Open Label Tapentadol Extended Release||395
5314672|NCT00455520|13067784|P2|STARTED|Open Label Tapentadol Extended Release||0
5314673|NCT00455520|13067785|P1|STARTED|Open Label Tapentadol Extended Release||591
5314674|NCT00455455|13067801|P2|NOT COMPLETED|Second Intervention||0
5314675|NCT00455455|13067802|P1|NOT COMPLETED|Second Intervention||0
5314676|NCT00455455|13067801|P2|COMPLETED|Second Intervention||24
5314677|NCT00455455|13067802|P1|COMPLETED|Second Intervention||24
5314678|NCT00455455|13067801|P2|STARTED|Second Intervention||24
5314679|NCT00455455|13067802|P1|STARTED|Second Intervention||24
5314680|NCT00455455|13067801|P2|NOT COMPLETED|Washout||0
5314681|NCT00455455|13067802|P1|NOT COMPLETED|Washout||1
5314682|NCT00455455|13067801|P2|COMPLETED|Washout||24
5314683|NCT00455455|13067802|P1|COMPLETED|Washout||24
5314684|NCT00455455|13067801|P2|STARTED|Washout||24
5314685|NCT00455455|13067802|P1|STARTED|Washout||25
5314686|NCT00455455|13067801|P2|NOT COMPLETED|First Intervention||0
5314687|NCT00455455|13067802|P1|NOT COMPLETED|First Intervention||0
5314688|NCT00455455|13067801|P2|COMPLETED|First Intervention||24
5314689|NCT00455455|13067802|P1|COMPLETED|First Intervention||25
5314690|NCT00455455|13067801|P2|STARTED|First Intervention||24
5314691|NCT00455455|13067802|P1|STARTED|First Intervention||25
5314692|NCT00455455|13067801|P2|NOT COMPLETED|Washout||1
5314693|NCT00455455|13067802|P1|NOT COMPLETED|Washout||0
5314694|NCT00455455|13067801|P2|COMPLETED|Washout||24
5314695|NCT00455455|13067802|P1|COMPLETED|Washout||25
5314696|NCT00455455|13067801|P2|STARTED|Washout||25
5314697|NCT00455455|13067802|P1|STARTED|Washout||25
5314698|NCT00455429|13067822|P4|NOT COMPLETED|Overall Study||14
5314699|NCT00455429|13067823|P3|NOT COMPLETED|Overall Study||1
5314700|NCT00455429|13067824|P2|NOT COMPLETED|Overall Study||5
5314701|NCT00455429|13067825|P1|NOT COMPLETED|Overall Study||2
5314702|NCT00455429|13067822|P4|COMPLETED|Overall Study||20
5314703|NCT00455429|13067823|P3|COMPLETED|Overall Study||16
5314704|NCT00455429|13067824|P2|COMPLETED|Overall Study||10
5314705|NCT00455429|13067825|P1|COMPLETED|Overall Study||16
5314706|NCT00455429|13067822|P4|Treated|Overall Study||32
5314707|NCT00455429|13067823|P3|Treated|Overall Study||17
5314708|NCT00455429|13067824|P2|Treated|Overall Study||15
5314709|NCT00455429|13067825|P1|Treated|Overall Study||18
5314710|NCT00455429|13067822|P4|STARTED|Overall Study||34
5314711|NCT00455429|13067823|P3|STARTED|Overall Study||17
5314712|NCT00455429|13067824|P2|STARTED|Overall Study||15
5314713|NCT00455429|13067825|P1|STARTED|Overall Study||18
5314714|NCT00455312|13067884|P2|NOT COMPLETED|Overall Study||1
5314715|NCT00455312|13067885|P1|NOT COMPLETED|Overall Study||0
5314716|NCT00455312|13067884|P2|COMPLETED|Overall Study||20
5314717|NCT00455312|13067885|P1|COMPLETED|Overall Study||15
5314718|NCT00455312|13067884|P2|STARTED|Overall Study||21
5314719|NCT00455312|13067885|P1|STARTED|Overall Study||15
5314720|NCT00455195|13067911|P2|NOT COMPLETED|Extension Study AGLU03206||0
5314721|NCT00455195|13067912|P1|NOT COMPLETED|Extension Study AGLU03206||0
5314722|NCT00455195|13067911|P2|COMPLETED|Extension Study AGLU03206||26
5314723|NCT00455195|13067912|P1|COMPLETED|Extension Study AGLU03206||55
5314724|NCT00455195|13067911|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
5314725|NCT00455195|13067912|P1|STARTED|Extension Study AGLU03206||55
5314726|NCT00455195|13067911|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
5314727|NCT00455195|13067912|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
5314728|NCT00455195|13067911|P2|COMPLETED|Double-blind Study AGLU02704||26
5314729|NCT00455195|13067912|P1|COMPLETED|Double-blind Study AGLU02704||55
5314730|NCT00455195|13067911|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
5314731|NCT00455195|13067912|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
5314732|NCT00455143|13067926|P1|NOT COMPLETED|Overall Study||6
5314733|NCT00455143|13067926|P1|COMPLETED|Overall Study||21
5314734|NCT00455143|13067926|P1|STARTED|Overall Study||27
5314735|NCT00455013|13067950|P3|NOT COMPLETED|Long Term Extension (LTE)||7
5314736|NCT00455013|13067951|P2|NOT COMPLETED|Long Term Extension (LTE)||3
5314737|NCT00455013|13067952|P1|NOT COMPLETED|Long Term Extension (LTE)||2
5314738|NCT00455013|13067950|P3|COMPLETED|Long Term Extension (LTE)||20
5314739|NCT00455013|13067951|P2|COMPLETED|Long Term Extension (LTE)||16
5314740|NCT00455013|13067952|P1|COMPLETED|Long Term Extension (LTE)||25
5314741|NCT00455013|13067950|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
5314742|NCT00455013|13067951|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
5314743|NCT00455013|13067952|P1|STARTED|Long Term Extension (LTE)||27
5314744|NCT00455013|13067950|P3|NOT COMPLETED|Short Term Period||2
5314745|NCT00455013|13067951|P2|NOT COMPLETED|Short Term Period||5
5314746|NCT00455013|13067952|P1|NOT COMPLETED|Short Term Period||6
5314747|NCT00455013|13067950|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
5314748|NCT00455013|13067951|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
5314749|NCT00455013|13067952|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
5314750|NCT00455013|13067950|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
5314751|NCT00455013|13067951|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
5314752|NCT00455013|13067952|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
5314753|NCT00454987|13068020|P3|NOT COMPLETED|Year 4 (NCT00454987)||0
5314754|NCT00454987|13068021|P2|NOT COMPLETED|Year 4 (NCT00454987)||0
5314755|NCT00454987|13068022|P1|NOT COMPLETED|Year 4 (NCT00454987)||0
5314756|NCT00454987|13068020|P3|COMPLETED|Year 4 (NCT00454987)||0
5314757|NCT00454987|13068021|P2|COMPLETED|Year 4 (NCT00454987)||62
5314758|NCT00454987|13068022|P1|COMPLETED|Year 4 (NCT00454987)||206
5314759|NCT00454987|13068020|P3|STARTED|Year 4 (NCT00454987)||0
5314760|NCT00454987|13068021|P2|STARTED|Year 4 (NCT00454987)||62
5314761|NCT00454987|13068022|P1|STARTED|Year 4 (NCT00454987)||206
5314762|NCT00454987|13068020|P3|NOT COMPLETED|Year 2 (NCT00454987)||0
5314763|NCT00454987|13068021|P2|NOT COMPLETED|Year 2 (NCT00454987)||0
5314764|NCT00454987|13068022|P1|NOT COMPLETED|Year 2 (NCT00454987)||0
5314765|NCT00454987|13068020|P3|COMPLETED|Year 2 (NCT00454987)||74
5314766|NCT00454987|13068021|P2|COMPLETED|Year 2 (NCT00454987)||77
5314767|NCT00454987|13068022|P1|COMPLETED|Year 2 (NCT00454987)||235
5314768|NCT00454987|13068020|P3|STARTED|Year 2 (NCT00454987)||74
5314769|NCT00454987|13068021|P2|STARTED|Year 2 (NCT00454987)||77
5314770|NCT00454987|13068022|P1|STARTED|Year 2 (NCT00454987)||235
5314771|NCT00454987|13068020|P3|NOT COMPLETED|Year 1 (NCT00454987)||0
5314772|NCT00454987|13068021|P2|NOT COMPLETED|Year 1 (NCT00454987)||0
5314773|NCT00454987|13068022|P1|NOT COMPLETED|Year 1 (NCT00454987)||0
5314774|NCT00454987|13068020|P3|COMPLETED|Year 1 (NCT00454987)||0
5314775|NCT00454987|13068021|P2|COMPLETED|Year 1 (NCT00454987)||67
5314776|NCT00454987|13068022|P1|COMPLETED|Year 1 (NCT00454987)||221
5314777|NCT00454987|13068020|P3|STARTED|Year 1 (NCT00454987)||0
5314778|NCT00454987|13068021|P2|STARTED|Year 1 (NCT00454987)||67
5314779|NCT00454987|13068022|P1|STARTED|Year 1 (NCT00454987)||221
5314780|NCT00454987|13068020|P3|NOT COMPLETED|Booster Period (NCT00258700)||0
5314781|NCT00454987|13068021|P2|NOT COMPLETED|Booster Period (NCT00258700)||1
5314782|NCT00454987|13068022|P1|NOT COMPLETED|Booster Period (NCT00258700)||2
5314783|NCT00454987|13068020|P3|COMPLETED|Booster Period (NCT00258700)||0
5314784|NCT00454987|13068021|P2|COMPLETED|Booster Period (NCT00258700)||116
5314785|NCT00454987|13068022|P1|COMPLETED|Booster Period (NCT00258700)||357
5314786|NCT00454987|13068020|P3|STARTED|Booster Period (NCT00258700)||0
5314787|NCT00454987|13068021|P2|STARTED|Booster Period (NCT00258700)||117
5314788|NCT00454987|13068022|P1|STARTED|Booster Period (NCT00258700)||359
5314789|NCT00454909|13068096|P3|NOT COMPLETED|Overall Study||2
5314790|NCT00454909|13068097|P2|NOT COMPLETED|Overall Study||3
5314791|NCT00454909|13068098|P1|NOT COMPLETED|Overall Study||7
5314792|NCT00454909|13068096|P3|COMPLETED|Overall Study||86
5314793|NCT00454909|13068097|P2|COMPLETED|Overall Study||194
5314794|NCT00454909|13068098|P1|COMPLETED|Overall Study||580
5314795|NCT00454909|13068096|P3|STARTED|Overall Study||88
5314796|NCT00454909|13068097|P2|STARTED|Overall Study||197
5314797|NCT00454909|13068098|P1|STARTED|Overall Study||587
5314798|NCT00454857|13068136|P1|NOT COMPLETED|Overall Study||54
5314799|NCT00454857|13068136|P1|COMPLETED|Overall Study||272
5314800|NCT00454857|13068136|P1|Completed ≥1 Observational Study Visit|Overall Study||319
5314801|NCT00454857|13068136|P1|Completed Retrospective Chart Review|Overall Study||324
5314802|NCT00454857|13068136|P1|STARTED|Overall Study||326
5314803|NCT00454818|13068161|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
5314804|NCT00454818|13068162|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
5314805|NCT00454818|13068163|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
5314806|NCT00454818|13068164|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
5314807|NCT00454818|13068165|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
5314808|NCT00454818|13068161|P5|COMPLETED|Phase 2: Randomized Double-blind||10
5314809|NCT00454818|13068162|P4|COMPLETED|Phase 2: Randomized Double-blind||8
5314810|NCT00454818|13068163|P3|COMPLETED|Phase 2: Randomized Double-blind||5
5314811|NCT00454818|13068164|P2|COMPLETED|Phase 2: Randomized Double-blind||6
5314812|NCT00454818|13068165|P1|COMPLETED|Phase 2: Randomized Double-blind||0
5314813|NCT00454818|13068161|P5|STARTED|Phase 2: Randomized Double-blind||14
5314814|NCT00454818|13068162|P4|STARTED|Phase 2: Randomized Double-blind||9
5314815|NCT00454818|13068163|P3|STARTED|Phase 2: Randomized Double-blind||8
5314816|NCT00454818|13068164|P2|STARTED|Phase 2: Randomized Double-blind||8
5314817|NCT00454818|13068165|P1|STARTED|Phase 2: Randomized Double-blind||0
5314818|NCT00454818|13068161|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
5314819|NCT00454818|13068162|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
5314820|NCT00454818|13068163|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
5314821|NCT00454818|13068164|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
5314822|NCT00454818|13068165|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
5314823|NCT00454818|13068161|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
5314824|NCT00454818|13068162|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
5314825|NCT00454818|13068163|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
5314826|NCT00454818|13068164|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
5314827|NCT00454818|13068165|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
5314828|NCT00454818|13068161|P5|STARTED|Phase I: Open-label Dose-escalation||0
5314829|NCT00454818|13068162|P4|STARTED|Phase I: Open-label Dose-escalation||3
5314830|NCT00454818|13068163|P3|STARTED|Phase I: Open-label Dose-escalation||3
5314831|NCT00454818|13068164|P2|STARTED|Phase I: Open-label Dose-escalation||3
5314832|NCT00454818|13068165|P1|STARTED|Phase I: Open-label Dose-escalation||3
5314833|NCT00454805|13068244|P2|NOT COMPLETED|Overall Study||23
5314834|NCT00454805|13068245|P1|NOT COMPLETED|Overall Study||26
5314835|NCT00454805|13068244|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
5314836|NCT00454805|13068245|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
5314837|NCT00454805|13068244|P2|STARTED|Overall Study|Randomised|31
5314838|NCT00454805|13068245|P1|STARTED|Overall Study|Randomised|31
5314839|NCT00454779|13068261|P2|NOT COMPLETED|Second-line Treatment Phase||3
5314840|NCT00454779|13068262|P1|NOT COMPLETED|Second-line Treatment Phase||0
5314841|NCT00454779|13068261|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
5314842|NCT00454779|13068262|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
5314843|NCT00454779|13068261|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
5314844|NCT00454779|13068262|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
5314845|NCT00454779|13068261|P2|NOT COMPLETED|First-line Treatment Phase||8
5314846|NCT00454779|13068262|P1|NOT COMPLETED|First-line Treatment Phase||5
5314847|NCT00454779|13068261|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
5314848|NCT00454779|13068262|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
5314849|NCT00454779|13068261|P2|Received Study Medication|First-line Treatment Phase||55
5314850|NCT00454779|13068262|P1|Received Study Medication|First-line Treatment Phase||56
5314851|NCT00454779|13068261|P2|STARTED|First-line Treatment Phase||57
5314852|NCT00454779|13068262|P1|STARTED|First-line Treatment Phase||56
5314853|NCT00454649|13068300|P10|NOT COMPLETED|Overall Study||5
5314854|NCT00454649|13068301|P9|NOT COMPLETED|Overall Study||20
5314855|NCT00454649|13068302|P8|NOT COMPLETED|Overall Study||19
5314856|NCT00454649|13068303|P7|NOT COMPLETED|Overall Study||9
5314857|NCT00454649|13068304|P6|NOT COMPLETED|Overall Study||7
5314858|NCT00454649|13068305|P5|NOT COMPLETED|Overall Study||1
5314859|NCT00454649|13068306|P4|NOT COMPLETED|Overall Study||6
5314860|NCT00454649|13068307|P3|NOT COMPLETED|Overall Study||19
5314861|NCT00454649|13068308|P2|NOT COMPLETED|Overall Study||4
5314862|NCT00454649|13068309|P1|NOT COMPLETED|Overall Study||3
5314863|NCT00454649|13068300|P10|COMPLETED|Overall Study||1
5314864|NCT00454649|13068301|P9|COMPLETED|Overall Study||1
5314865|NCT00454649|13068302|P8|COMPLETED|Overall Study||0
5314866|NCT00454649|13068303|P7|COMPLETED|Overall Study||0
5314867|NCT00454649|13068304|P6|COMPLETED|Overall Study||0
5314868|NCT00454649|13068305|P5|COMPLETED|Overall Study||0
5314869|NCT00454649|13068306|P4|COMPLETED|Overall Study||1
5314870|NCT00454649|13068307|P3|COMPLETED|Overall Study||1
5314871|NCT00454649|13068308|P2|COMPLETED|Overall Study||1
5314872|NCT00454649|13068309|P1|COMPLETED|Overall Study||0
5314873|NCT00454649|13068300|P10|STARTED|Overall Study||6
5314874|NCT00454649|13068301|P9|STARTED|Overall Study||21
5314875|NCT00454649|13068302|P8|STARTED|Overall Study||19
5314876|NCT00454649|13068303|P7|STARTED|Overall Study||9
5314877|NCT00454649|13068304|P6|STARTED|Overall Study||7
5314878|NCT00454649|13068305|P5|STARTED|Overall Study||1
5314879|NCT00454649|13068306|P4|STARTED|Overall Study||7
5314880|NCT00454649|13068307|P3|STARTED|Overall Study||20
5314881|NCT00454649|13068308|P2|STARTED|Overall Study||5
5314882|NCT00454649|13068309|P1|STARTED|Overall Study||3
5314883|NCT00454636|13068438|P4|NOT COMPLETED|Overall Study||32
5314884|NCT00454636|13068439|P3|NOT COMPLETED|Overall Study||20
5314885|NCT00454636|13068440|P2|NOT COMPLETED|Overall Study||23
5314886|NCT00454636|13068441|P1|NOT COMPLETED|Overall Study||31
5314887|NCT00454636|13068438|P4|COMPLETED|Overall Study||26
5314888|NCT00454636|13068439|P3|COMPLETED|Overall Study||7
5314889|NCT00454636|13068440|P2|COMPLETED|Overall Study||9
5314890|NCT00454636|13068441|P1|COMPLETED|Overall Study||10
5314891|NCT00454636|13068438|P4|STARTED|Overall Study||58
5314892|NCT00454636|13068439|P3|STARTED|Overall Study||27
5314893|NCT00454636|13068440|P2|STARTED|Overall Study||32
5314894|NCT00454636|13068441|P1|STARTED|Overall Study||41
5314895|NCT00454584|13068474|P6|NOT COMPLETED|After Controlled Period||32
5314896|NCT00454584|13068475|P5|NOT COMPLETED|After Controlled Period||12
5314897|NCT00454584|13068476|P4|NOT COMPLETED|After Controlled Period||26
5314898|NCT00454584|13068477|P3|NOT COMPLETED|After Controlled Period||0
5314899|NCT00454584|13068478|P2|NOT COMPLETED|After Controlled Period||0
5314900|NCT00454584|13068479|P1|NOT COMPLETED|After Controlled Period||0
5314901|NCT00454584|13068474|P6|COMPLETED|After Controlled Period||310
5314902|NCT00454584|13068475|P5|COMPLETED|After Controlled Period||189
5314903|NCT00454584|13068476|P4|COMPLETED|After Controlled Period||310
5314904|NCT00454584|13068477|P3|COMPLETED|After Controlled Period||0
5314905|NCT00454584|13068478|P2|COMPLETED|After Controlled Period||0
5314906|NCT00454584|13068479|P1|COMPLETED|After Controlled Period||0
5314907|NCT00454584|13068474|P6|STARTED|After Controlled Period||342
5314908|NCT00454584|13068475|P5|STARTED|After Controlled Period||201
5314909|NCT00454584|13068476|P4|STARTED|After Controlled Period||336
5314910|NCT00454584|13068477|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5314911|NCT00454584|13068478|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5314912|NCT00454584|13068479|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5314913|NCT00454584|13068474|P6|NOT COMPLETED|Controlled Period||0
5314914|NCT00454584|13068475|P5|NOT COMPLETED|Controlled Period||0
5314915|NCT00454584|13068476|P4|NOT COMPLETED|Controlled Period||0
5314916|NCT00454584|13068477|P3|NOT COMPLETED|Controlled Period||5
5314917|NCT00454584|13068478|P2|NOT COMPLETED|Controlled Period||8
5314918|NCT00454584|13068479|P1|NOT COMPLETED|Controlled Period||11
5314919|NCT00454584|13068474|P6|COMPLETED|Controlled Period||0
5314920|NCT00454584|13068475|P5|COMPLETED|Controlled Period||0
5314921|NCT00454584|13068476|P4|COMPLETED|Controlled Period||0
5314922|NCT00454584|13068477|P3|COMPLETED|Controlled Period||342
5314923|NCT00454584|13068478|P2|COMPLETED|Controlled Period||201
5314924|NCT00454584|13068479|P1|COMPLETED|Controlled Period||336
5314925|NCT00454584|13068474|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5314926|NCT00454584|13068475|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5314927|NCT00454584|13068476|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5314928|NCT00454584|13068477|P3|STARTED|Controlled Period||347
5314929|NCT00454584|13068478|P2|STARTED|Controlled Period||209
5314930|NCT00454584|13068479|P1|STARTED|Controlled Period||347
5314931|NCT00454571|13068501|P2|NOT COMPLETED|Overall Study||6
5314932|NCT00454571|13068502|P1|NOT COMPLETED|Overall Study||13
5314933|NCT00454571|13068501|P2|COMPLETED|Overall Study||13
5314934|NCT00454571|13068502|P1|COMPLETED|Overall Study||5
5314935|NCT00454571|13068501|P2|STARTED|Overall Study||19
5314936|NCT00454571|13068502|P1|STARTED|Overall Study||18
5314937|NCT00454532|13068514|P4|NOT COMPLETED|Overall Study||0
5314938|NCT00454532|13068515|P3|NOT COMPLETED|Overall Study||0
5314939|NCT00454532|13068516|P2|NOT COMPLETED|Overall Study||0
5314940|NCT00454532|13068517|P1|NOT COMPLETED|Overall Study||0
5314941|NCT00454532|13068514|P4|COMPLETED|Overall Study||7
5314942|NCT00454532|13068515|P3|COMPLETED|Overall Study||3
5314943|NCT00454532|13068516|P2|COMPLETED|Overall Study||6
5314944|NCT00454532|13068517|P1|COMPLETED|Overall Study||11
5314945|NCT00454532|13068514|P4|STARTED|Overall Study||7
5314946|NCT00454532|13068515|P3|STARTED|Overall Study||3
5314947|NCT00454532|13068516|P2|STARTED|Overall Study||6
5314948|NCT00454532|13068517|P1|STARTED|Overall Study||11
5314949|NCT00454363|13068537|P2|NOT COMPLETED|Overall Study||2
5314950|NCT00454363|13068538|P1|NOT COMPLETED|Overall Study||5
5314951|NCT00454363|13068537|P2|COMPLETED|Overall Study||29
5314952|NCT00454363|13068538|P1|COMPLETED|Overall Study||15
5314953|NCT00454363|13068537|P2|STARTED|Overall Study||31
5314954|NCT00454363|13068538|P1|STARTED|Overall Study||20
5314955|NCT00454324|13068551|P2|NOT COMPLETED|Overall Study||0
5314956|NCT00454324|13068552|P1|NOT COMPLETED|Overall Study||0
5314957|NCT00454324|13068551|P2|COMPLETED|Overall Study||13
5314958|NCT00454324|13068552|P1|COMPLETED|Overall Study||14
5314959|NCT00454324|13068551|P2|STARTED|Overall Study||13
5314960|NCT00454324|13068552|P1|STARTED|Overall Study||14
5314961|NCT00454246|13068567|P3|NOT COMPLETED|Overall Study||9
5314962|NCT00454246|13068568|P2|NOT COMPLETED|Overall Study||29
5314963|NCT00454246|13068569|P1|NOT COMPLETED|Overall Study||73
5314964|NCT00454246|13068567|P3|COMPLETED|Overall Study||0
5314965|NCT00454246|13068568|P2|COMPLETED|Overall Study||0
5314966|NCT00454246|13068569|P1|COMPLETED|Overall Study||0
5314967|NCT00454246|13068567|P3|STARTED|Overall Study||9
5314968|NCT00454246|13068568|P2|STARTED|Overall Study||29
5314969|NCT00454246|13068569|P1|STARTED|Overall Study||73
5314970|NCT00454207|13068585|P2|NOT COMPLETED|Overall Study||2
5314971|NCT00454207|13068586|P1|NOT COMPLETED|Overall Study||4
5314972|NCT00454207|13068585|P2|COMPLETED|Overall Study||21
5314973|NCT00454207|13068586|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
5314974|NCT00454207|13068585|P2|STARTED|Overall Study||23
5314975|NCT00454207|13068586|P1|STARTED|Overall Study||21
5314976|NCT00454194|13068631|P2|NOT COMPLETED|Overall Study||14
5314977|NCT00454194|13068632|P1|NOT COMPLETED|Overall Study||22
5314978|NCT00454194|13068631|P2|COMPLETED|Overall Study||37
5314979|NCT00454194|13068632|P1|COMPLETED|Overall Study||25
5314980|NCT00454194|13068631|P2|STARTED|Overall Study||51
5314981|NCT00454194|13068632|P1|STARTED|Overall Study||47
5314982|NCT00454181|13068650|P2|NOT COMPLETED|Overall Study||3
5314983|NCT00454181|13068651|P1|NOT COMPLETED|Overall Study||15
5314984|NCT00454181|13068650|P2|COMPLETED|Overall Study||11
5314985|NCT00454181|13068651|P1|COMPLETED|Overall Study||30
5314986|NCT00454181|13068650|P2|STARTED|Overall Study||14
5314987|NCT00454181|13068651|P1|STARTED|Overall Study||45
5314988|NCT00454142|13068667|P1|NOT COMPLETED|Overall Study||1
5314989|NCT00454142|13068667|P1|COMPLETED|Overall Study||32
5314990|NCT00454142|13068667|P1|STARTED|Overall Study||33
5314991|NCT00454116|13068685|P3|NOT COMPLETED|Overall Study||28
5314992|NCT00454116|13068686|P2|NOT COMPLETED|Overall Study||29
5314993|NCT00454116|13068687|P1|NOT COMPLETED|Overall Study||27
5314994|NCT00454116|13068685|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
5314995|NCT00454116|13068686|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
5315172|NCT00452790|13069159|P2|NOT COMPLETED|After Infant Series||14
5314996|NCT00454116|13068687|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
5314997|NCT00454116|13068685|P3|STARTED|Overall Study|randomised patients|35
5314998|NCT00454116|13068686|P2|STARTED|Overall Study|randomised patients|36
5314999|NCT00454116|13068687|P1|STARTED|Overall Study|randomised patients|35
5315000|NCT00454051|13068697|P2|NOT COMPLETED|Overall Study||3
5315001|NCT00454051|13068698|P1|NOT COMPLETED|Overall Study||3
5315002|NCT00454051|13068697|P2|COMPLETED|Overall Study||8
5315003|NCT00454051|13068698|P1|COMPLETED|Overall Study||17
5315004|NCT00454051|13068697|P2|STARTED|Overall Study||11
5315005|NCT00454051|13068698|P1|STARTED|Overall Study||20
5315006|NCT00453999|13068731|P3|NOT COMPLETED|Overall Study||3
5315007|NCT00453999|13068732|P2|NOT COMPLETED|Overall Study||5
5315008|NCT00453999|13068733|P1|NOT COMPLETED|Overall Study||5
5315009|NCT00453999|13068731|P3|COMPLETED|Overall Study||43
5315010|NCT00453999|13068732|P2|COMPLETED|Overall Study||41
5315011|NCT00453999|13068733|P1|COMPLETED|Overall Study||40
5315012|NCT00453999|13068731|P3|STARTED|Overall Study||46
5315013|NCT00453999|13068732|P2|STARTED|Overall Study||46
5315014|NCT00453999|13068733|P1|STARTED|Overall Study||45
5315015|NCT00453986|13068761|P5|NOT COMPLETED|Overall Study||0
5315016|NCT00453986|13068762|P4|NOT COMPLETED|Overall Study||2
5315017|NCT00453986|13068763|P3|NOT COMPLETED|Overall Study||6
5315018|NCT00453986|13068764|P2|NOT COMPLETED|Overall Study||5
5315019|NCT00453986|13068765|P1|NOT COMPLETED|Overall Study||6
5315020|NCT00453986|13068761|P5|COMPLETED|Overall Study||105
5315021|NCT00453986|13068762|P4|COMPLETED|Overall Study||310
5315022|NCT00453986|13068763|P3|COMPLETED|Overall Study||307
5315023|NCT00453986|13068764|P2|COMPLETED|Overall Study||306
5315024|NCT00453986|13068765|P1|COMPLETED|Overall Study||305
5315025|NCT00453986|13068761|P5|STARTED|Overall Study||105
5315026|NCT00453986|13068762|P4|STARTED|Overall Study||312
5315027|NCT00453986|13068763|P3|STARTED|Overall Study||313
5315028|NCT00453986|13068764|P2|STARTED|Overall Study||311
5315029|NCT00453986|13068765|P1|STARTED|Overall Study||311
5315030|NCT00453973|13068858|P2|NOT COMPLETED|Overall Study||48
5315031|NCT00453973|13068859|P1|NOT COMPLETED|Overall Study||51
5315032|NCT00453973|13068858|P2|COMPLETED|Overall Study||15
5315033|NCT00453973|13068859|P1|COMPLETED|Overall Study||0
5315034|NCT00453973|13068858|P2|STARTED|Overall Study||63
5315035|NCT00453973|13068859|P1|STARTED|Overall Study||51
5315036|NCT00453921|13068869|P4|NOT COMPLETED|Overall Study||1
5315037|NCT00453921|13068870|P3|NOT COMPLETED|Overall Study||2
5315038|NCT00453921|13068871|P2|NOT COMPLETED|Overall Study||1
5315039|NCT00453921|13068872|P1|NOT COMPLETED|Overall Study||1
5315040|NCT00453921|13068869|P4|COMPLETED|Overall Study||18
5315041|NCT00453921|13068870|P3|COMPLETED|Overall Study||18
5315042|NCT00453921|13068871|P2|COMPLETED|Overall Study||17
5315043|NCT00453921|13068872|P1|COMPLETED|Overall Study||18
5315044|NCT00453921|13068869|P4|STARTED|Overall Study||19
5315045|NCT00453921|13068870|P3|STARTED|Overall Study||20
5315046|NCT00453921|13068871|P2|STARTED|Overall Study||18
5315047|NCT00453921|13068872|P1|STARTED|Overall Study||19
5315048|NCT00453895|13068906|P1|NOT COMPLETED|Overall Study||0
5315049|NCT00453895|13068906|P1|COMPLETED|Overall Study||39
5315050|NCT00453895|13068906|P1|STARTED|Overall Study||39
5315051|NCT00453479|13068917|P3|NOT COMPLETED|Overall Study||0
5315052|NCT00453479|13068918|P2|NOT COMPLETED|Overall Study||0
5315053|NCT00453479|13068919|P1|NOT COMPLETED|Overall Study||0
5315054|NCT00453479|13068917|P3|COMPLETED|Overall Study||8
5315055|NCT00453479|13068918|P2|COMPLETED|Overall Study||9
5315056|NCT00453479|13068919|P1|COMPLETED|Overall Study||6
5315057|NCT00453479|13068917|P3|STARTED|Overall Study||8
5315058|NCT00453479|13068918|P2|STARTED|Overall Study||9
5315059|NCT00453479|13068919|P1|STARTED|Overall Study||6
5315060|NCT00453388|13068994|P4|NOT COMPLETED|Overall Study||0
5315061|NCT00453388|13068995|P3|NOT COMPLETED|Overall Study||0
5315062|NCT00453388|13068996|P2|NOT COMPLETED|Overall Study||0
5315063|NCT00453388|13068997|P1|NOT COMPLETED|Overall Study||0
5315064|NCT00453388|13068994|P4|COMPLETED|Overall Study||0
5315065|NCT00453388|13068995|P3|COMPLETED|Overall Study||1
5315066|NCT00453388|13068996|P2|COMPLETED|Overall Study||5
5315067|NCT00453388|13068997|P1|COMPLETED|Overall Study||0
5315068|NCT00453388|13068994|P4|STARTED|Overall Study||0
5315069|NCT00453388|13068995|P3|STARTED|Overall Study||1
5315070|NCT00453388|13068996|P2|STARTED|Overall Study||5
5315071|NCT00453388|13068997|P1|STARTED|Overall Study||0
5315072|NCT00453362|13069019|P1|NOT COMPLETED|Overall Study||87
5315073|NCT00453362|13069019|P1|COMPLETED|Overall Study||1
5315074|NCT00453362|13069019|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
5315075|NCT00453362|13069019|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
5315076|NCT00453362|13069019|P1|Treated With Erlotinib|Overall Study||74
5315077|NCT00453362|13069019|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
5315078|NCT00453349|13069045|P2|NOT COMPLETED|Completed Study||34
5315079|NCT00453349|13069046|P1|NOT COMPLETED|Completed Study||27
5315080|NCT00453349|13069045|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
5315081|NCT00453349|13069046|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
5315082|NCT00453349|13069045|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
5315083|NCT00453349|13069046|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
5315084|NCT00453349|13069045|P2|STARTED|Completed Study||232
5315085|NCT00453349|13069046|P1|STARTED|Completed Study||228
5315086|NCT00453349|13069045|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
5315087|NCT00453349|13069046|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
5315088|NCT00453349|13069045|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
5315089|NCT00453349|13069046|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
5315090|NCT00453349|13069045|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
5315091|NCT00453349|13069046|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
5315092|NCT00453349|13069045|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
5315093|NCT00453349|13069046|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
5315094|NCT00453349|13069045|P2|NOT COMPLETED|Randomized||23
5315095|NCT00453349|13069046|P1|NOT COMPLETED|Randomized||25
5315096|NCT00453349|13069045|P2|COMPLETED|Randomized||209
5315097|NCT00453349|13069046|P1|COMPLETED|Randomized||203
5315098|NCT00453349|13069045|P2|STARTED|Randomized||232
5315099|NCT00453349|13069046|P1|STARTED|Randomized||228
5315100|NCT00453336|13069072|P1|NOT COMPLETED|Overall Study||0
5315101|NCT00453336|13069072|P1|COMPLETED|Overall Study||45
5315102|NCT00453336|13069072|P1|STARTED|Overall Study||45
5315103|NCT00453310|13069077|P1|NOT COMPLETED|Overall Study||10
5315104|NCT00453310|13069077|P1|COMPLETED|Overall Study||0
5315105|NCT00453310|13069077|P1|STARTED|Overall Study||10
5315106|NCT00453206|13069081|P1|NOT COMPLETED|Overall Study||1
5315107|NCT00453206|13069081|P1|COMPLETED|Overall Study||65
5315108|NCT00453206|13069081|P1|STARTED|Overall Study||66
5315109|NCT00453193|13069085|P1|NOT COMPLETED|Overall Study||0
5315110|NCT00453193|13069085|P1|COMPLETED|Overall Study||24
5315111|NCT00453193|13069085|P1|STARTED|Overall Study||24
5315112|NCT00453180|13069091|P2|NOT COMPLETED|Overall Study||3
5315113|NCT00453180|13069092|P1|NOT COMPLETED|Overall Study||3
5315114|NCT00453180|13069091|P2|COMPLETED|Overall Study||12
5315115|NCT00453180|13069092|P1|COMPLETED|Overall Study||13
5315116|NCT00453180|13069091|P2|STARTED|Overall Study||15
5315117|NCT00453180|13069092|P1|STARTED|Overall Study||16
5315118|NCT00453154|13069111|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
5315119|NCT00453154|13069112|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
5315120|NCT00453154|13069113|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
5315121|NCT00453154|13069114|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
5315122|NCT00453154|13069111|P4|COMPLETED|Open Label Sunitinib Crossover||0
5315123|NCT00453154|13069112|P3|COMPLETED|Open Label Sunitinib Crossover||18
5315124|NCT00453154|13069113|P2|COMPLETED|Open Label Sunitinib Crossover||0
5315125|NCT00453154|13069114|P1|COMPLETED|Open Label Sunitinib Crossover||0
5315126|NCT00453154|13069111|P4|STARTED|Open Label Sunitinib Crossover||0
5315127|NCT00453154|13069112|P3|STARTED|Open Label Sunitinib Crossover||18
5315128|NCT00453154|13069113|P2|STARTED|Open Label Sunitinib Crossover||0
5315129|NCT00453154|13069114|P1|STARTED|Open Label Sunitinib Crossover||0
5315130|NCT00453154|13069111|P4|NOT COMPLETED|Double BIind Maintenance||49
5315131|NCT00453154|13069112|P3|NOT COMPLETED|Double BIind Maintenance||46
5315132|NCT00453154|13069113|P2|NOT COMPLETED|Double BIind Maintenance||0
5315133|NCT00453154|13069114|P1|NOT COMPLETED|Double BIind Maintenance||0
5315134|NCT00453154|13069111|P4|COMPLETED|Double BIind Maintenance||0
5315135|NCT00453154|13069112|P3|COMPLETED|Double BIind Maintenance||0
5315136|NCT00453154|13069113|P2|COMPLETED|Double BIind Maintenance||0
5315137|NCT00453154|13069114|P1|COMPLETED|Double BIind Maintenance||0
5315138|NCT00453154|13069111|P4|STARTED|Double BIind Maintenance||49
5315139|NCT00453154|13069112|P3|STARTED|Double BIind Maintenance||46
5315140|NCT00453154|13069113|P2|STARTED|Double BIind Maintenance||0
5315141|NCT00453154|13069114|P1|STARTED|Double BIind Maintenance||0
5315142|NCT00453154|13069111|P4|NOT COMPLETED|Combination Chemotherapy||0
5315143|NCT00453154|13069112|P3|NOT COMPLETED|Combination Chemotherapy||0
5315144|NCT00453154|13069113|P2|NOT COMPLETED|Combination Chemotherapy||49
5315145|NCT00453154|13069114|P1|NOT COMPLETED|Combination Chemotherapy||0
5315146|NCT00453154|13069111|P4|COMPLETED|Combination Chemotherapy||0
5315147|NCT00453154|13069112|P3|COMPLETED|Combination Chemotherapy||0
5315148|NCT00453154|13069113|P2|COMPLETED|Combination Chemotherapy||95
5315149|NCT00453154|13069114|P1|COMPLETED|Combination Chemotherapy||12
5315150|NCT00453154|13069111|P4|STARTED|Combination Chemotherapy||0
5315151|NCT00453154|13069112|P3|STARTED|Combination Chemotherapy||0
5315152|NCT00453154|13069113|P2|STARTED|Combination Chemotherapy||144
5315153|NCT00453154|13069114|P1|STARTED|Combination Chemotherapy||12
5315154|NCT00453102|13069127|P1|NOT COMPLETED|Overall Study||2
5315155|NCT00453102|13069127|P1|COMPLETED|Overall Study||16
5315156|NCT00453102|13069127|P1|STARTED|Overall Study||18
5315157|NCT00453063|13069138|P2|NOT COMPLETED|Overall Study||3
5315158|NCT00453063|13069139|P1|NOT COMPLETED|Overall Study||3
5315159|NCT00453063|13069138|P2|COMPLETED|Overall Study||212
5315160|NCT00453063|13069139|P1|COMPLETED|Overall Study||208
5315161|NCT00453063|13069138|P2|STARTED|Overall Study||215
5315162|NCT00453063|13069139|P1|STARTED|Overall Study||211
5315163|NCT00452868|13069153|P1|NOT COMPLETED|Overall Study||2
5315164|NCT00452868|13069153|P1|COMPLETED|Overall Study||11
5315165|NCT00452868|13069153|P1|STARTED|Overall Study||13
5315166|NCT00452790|13069159|P2|NOT COMPLETED|Toddler Dose||2
5315167|NCT00452790|13069160|P1|NOT COMPLETED|Toddler Dose||0
5315168|NCT00452790|13069159|P2|COMPLETED|Toddler Dose||198
5315169|NCT00452790|13069160|P1|COMPLETED|Toddler Dose||198
5315170|NCT00452790|13069159|P2|STARTED|Toddler Dose||200
5315171|NCT00452790|13069160|P1|STARTED|Toddler Dose||198
5315173|NCT00452790|13069160|P1|NOT COMPLETED|After Infant Series||21
5315174|NCT00452790|13069159|P2|COMPLETED|After Infant Series||200
5315175|NCT00452790|13069160|P1|COMPLETED|After Infant Series||198
5315176|NCT00452790|13069159|P2|STARTED|After Infant Series||214
5315177|NCT00452790|13069160|P1|STARTED|After Infant Series||219
5315178|NCT00452790|13069159|P2|NOT COMPLETED|Infant Series||141
5315179|NCT00452790|13069160|P1|NOT COMPLETED|Infant Series||135
5315180|NCT00452790|13069159|P2|COMPLETED|Infant Series||214
5315181|NCT00452790|13069160|P1|COMPLETED|Infant Series||219
5315182|NCT00452790|13069159|P2|Vaccinated Dose 3|Infant Series||218
5315183|NCT00452790|13069160|P1|Vaccinated Dose 3|Infant Series||221
5315184|NCT00452790|13069159|P2|Vaccinated Dose 2|Infant Series||300
5315185|NCT00452790|13069160|P1|Vaccinated Dose 2|Infant Series||300
5315186|NCT00452790|13069159|P2|Vaccinated Dose 1|Infant Series||353
5315187|NCT00452790|13069160|P1|Vaccinated Dose 1|Infant Series||353
5315188|NCT00452790|13069159|P2|STARTED|Infant Series||355
5315189|NCT00452790|13069160|P1|STARTED|Infant Series||354
5315190|NCT00452699|13069196|P2|NOT COMPLETED|Overall Study||73
5315191|NCT00452699|13069197|P1|NOT COMPLETED|Overall Study||81
5315192|NCT00452699|13069196|P2|COMPLETED|Overall Study||242
5315193|NCT00452699|13069197|P1|COMPLETED|Overall Study||225
5315194|NCT00452699|13069196|P2|STARTED|Overall Study||315
5315195|NCT00452699|13069197|P1|STARTED|Overall Study||306
5315196|NCT00452673|13069213|P5|NOT COMPLETED|Dose Expansion Period||21
5315197|NCT00452673|13069214|P4|NOT COMPLETED|Dose Expansion Period||0
5315198|NCT00452673|13069215|P3|NOT COMPLETED|Dose Expansion Period||0
5315199|NCT00452673|13069216|P2|NOT COMPLETED|Dose Expansion Period||0
5315200|NCT00452673|13069217|P1|NOT COMPLETED|Dose Expansion Period||0
5315201|NCT00452673|13069213|P5|COMPLETED|Dose Expansion Period||0
5315202|NCT00452673|13069214|P4|COMPLETED|Dose Expansion Period||0
5315203|NCT00452673|13069215|P3|COMPLETED|Dose Expansion Period||0
5315204|NCT00452673|13069216|P2|COMPLETED|Dose Expansion Period||0
5315205|NCT00452673|13069217|P1|COMPLETED|Dose Expansion Period||0
5315206|NCT00452673|13069213|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
5315207|NCT00452673|13069214|P4|STARTED|Dose Expansion Period||0
5315208|NCT00452673|13069215|P3|STARTED|Dose Expansion Period||0
5315209|NCT00452673|13069216|P2|STARTED|Dose Expansion Period||0
5315210|NCT00452673|13069217|P1|STARTED|Dose Expansion Period||0
5315211|NCT00452673|13069213|P5|NOT COMPLETED|Dose Escalation Period||0
5315212|NCT00452673|13069214|P4|NOT COMPLETED|Dose Escalation Period||9
5315213|NCT00452673|13069215|P3|NOT COMPLETED|Dose Escalation Period||6
5315214|NCT00452673|13069216|P2|NOT COMPLETED|Dose Escalation Period||9
5315215|NCT00452673|13069217|P1|NOT COMPLETED|Dose Escalation Period||7
5315216|NCT00452673|13069213|P5|COMPLETED|Dose Escalation Period||0
5315217|NCT00452673|13069214|P4|COMPLETED|Dose Escalation Period||0
5315218|NCT00452673|13069215|P3|COMPLETED|Dose Escalation Period||0
5315219|NCT00452673|13069216|P2|COMPLETED|Dose Escalation Period||0
5315220|NCT00452673|13069217|P1|COMPLETED|Dose Escalation Period||0
5315221|NCT00452673|13069213|P5|STARTED|Dose Escalation Period||0
5315222|NCT00452673|13069214|P4|STARTED|Dose Escalation Period||9
5315223|NCT00452673|13069215|P3|STARTED|Dose Escalation Period||6
5315224|NCT00452673|13069216|P2|STARTED|Dose Escalation Period||9
5315225|NCT00452673|13069217|P1|STARTED|Dose Escalation Period||7
5315226|NCT00452543|13069249|P2|NOT COMPLETED|Overall Study||6
5315227|NCT00452543|13069250|P1|NOT COMPLETED|Overall Study||5
5315228|NCT00452543|13069249|P2|COMPLETED|Overall Study||5
5315229|NCT00452543|13069250|P1|COMPLETED|Overall Study||7
5315230|NCT00452543|13069249|P2|STARTED|Overall Study||11
5315231|NCT00452543|13069250|P1|STARTED|Overall Study||12
5315232|NCT00452530|13069264|P2|NOT COMPLETED|Overall Study||136
5315233|NCT00452530|13069265|P1|NOT COMPLETED|Overall Study||136
5315234|NCT00452530|13069264|P2|COMPLETED|Overall Study||1393
5315235|NCT00452530|13069265|P1|COMPLETED|Overall Study||1392
5315236|NCT00452530|13069264|P2|Primary Participants|Overall Study||997
5315237|NCT00452530|13069265|P1|Primary Participants|Overall Study||976
5315238|NCT00452530|13069264|P2|Evaluable Participants|Overall Study||921
5315239|NCT00452530|13069265|P1|Evaluable Participants|Overall Study||907
5315240|NCT00452530|13069264|P2|Received Treatment|Overall Study||1508
5315241|NCT00452530|13069265|P1|Received Treatment|Overall Study||1501
5315242|NCT00452530|13069264|P2|STARTED|Overall Study|Randomized|1529
5315243|NCT00452530|13069265|P1|STARTED|Overall Study|Randomized|1528
5315244|NCT00452452|13069286|P3|NOT COMPLETED|Overall Study||1
5315245|NCT00452452|13069287|P2|NOT COMPLETED|Overall Study||0
5315246|NCT00452452|13069288|P1|NOT COMPLETED|Overall Study||2
5315247|NCT00452452|13069286|P3|COMPLETED|Overall Study||152
5315248|NCT00452452|13069287|P2|COMPLETED|Overall Study||112
5315249|NCT00452452|13069288|P1|COMPLETED|Overall Study||88
5315250|NCT00452452|13069286|P3|Vaccinated Dose 3|Overall Study||0
5315251|NCT00452452|13069287|P2|Vaccinated Dose 3|Overall Study||0
5315252|NCT00452452|13069288|P1|Vaccinated Dose 3|Overall Study||89
5315253|NCT00452452|13069286|P3|Vaccinated Dose 2|Overall Study||0
5315254|NCT00452452|13069287|P2|Vaccinated Dose 2|Overall Study||112
5315255|NCT00452452|13069288|P1|Vaccinated Dose 2|Overall Study||90
5315256|NCT00452452|13069286|P3|Vaccinated Dose 1|Overall Study||152
5315257|NCT00452452|13069287|P2|Vaccinated Dose 1|Overall Study||112
5315258|NCT00452452|13069288|P1|Vaccinated Dose 1|Overall Study||90
5315259|NCT00452452|13069286|P3|STARTED|Overall Study||153
5315260|NCT00452452|13069287|P2|STARTED|Overall Study||112
5315261|NCT00452452|13069288|P1|STARTED|Overall Study||90
5315262|NCT00452426|13069313|P2|NOT COMPLETED|Overall Study||11
5315263|NCT00452426|13069314|P1|NOT COMPLETED|Overall Study||7
5315264|NCT00452426|13069313|P2|COMPLETED|Overall Study||493
5315265|NCT00452426|13069314|P1|COMPLETED|Overall Study||489
5315266|NCT00452426|13069313|P2|STARTED|Overall Study||504
5315267|NCT00452426|13069314|P1|STARTED|Overall Study||496
5315268|NCT00452400|13069333|P5|NOT COMPLETED|Overall Study||3
5315269|NCT00452400|13069334|P4|NOT COMPLETED|Overall Study||1
5315270|NCT00452400|13069335|P3|NOT COMPLETED|Overall Study||7
5315271|NCT00452400|13069336|P2|NOT COMPLETED|Overall Study||1
5315272|NCT00452400|13069337|P1|NOT COMPLETED|Overall Study||5
5315273|NCT00452400|13069333|P5|COMPLETED|Overall Study||76
5315274|NCT00452400|13069334|P4|COMPLETED|Overall Study||85
5315275|NCT00452400|13069335|P3|COMPLETED|Overall Study||73
5315276|NCT00452400|13069336|P2|COMPLETED|Overall Study||80
5315277|NCT00452400|13069337|P1|COMPLETED|Overall Study||74
5315278|NCT00452400|13069333|P5|STARTED|Overall Study||79
5315279|NCT00452400|13069334|P4|STARTED|Overall Study||86
5315280|NCT00452400|13069335|P3|STARTED|Overall Study||80
5315281|NCT00452400|13069336|P2|STARTED|Overall Study||81
5315282|NCT00452400|13069337|P1|STARTED|Overall Study||79
5315283|NCT00452387|13069509|P1|NOT COMPLETED|Overall Study||0
5315284|NCT00452387|13069509|P1|COMPLETED|Overall Study||22
5315285|NCT00452387|13069509|P1|STARTED|Overall Study||22
5315286|NCT00452374|13069517|P1|NOT COMPLETED|Overall Study||0
5315287|NCT00452374|13069517|P1|COMPLETED|Overall Study||48
5315288|NCT00452374|13069517|P1|STARTED|Overall Study||48
5315289|NCT00452361|13069524|P2|NOT COMPLETED|Overall Study||10
5315290|NCT00452361|13069525|P1|NOT COMPLETED|Overall Study||21
5315291|NCT00452361|13069524|P2|COMPLETED|Overall Study||0
5315292|NCT00452361|13069525|P1|COMPLETED|Overall Study||0
5315293|NCT00452361|13069524|P2|STARTED|Overall Study||10
5315294|NCT00452361|13069525|P1|STARTED|Overall Study||21
5315295|NCT00452348|13069569|P2|NOT COMPLETED|Overall Study||84
5315296|NCT00452348|13069570|P1|NOT COMPLETED|Overall Study||79
5315297|NCT00452348|13069569|P2|COMPLETED|Overall Study||234
5315298|NCT00452348|13069570|P1|COMPLETED|Overall Study||231
5315299|NCT00452348|13069569|P2|STARTED|Overall Study||318
5315300|NCT00452348|13069570|P1|STARTED|Overall Study||310
5315301|NCT00452335|13069585|P3|NOT COMPLETED|Overall Study||9
5315302|NCT00452335|13069586|P2|NOT COMPLETED|Overall Study||4
5315303|NCT00452335|13069587|P1|NOT COMPLETED|Overall Study||2
5315304|NCT00452335|13069585|P3|COMPLETED|Overall Study||23
5315305|NCT00452335|13069586|P2|COMPLETED|Overall Study||61
5315306|NCT00452335|13069587|P1|COMPLETED|Overall Study||25
5315307|NCT00452335|13069585|P3|STARTED|Overall Study||32
5315308|NCT00452335|13069586|P2|STARTED|Overall Study||65
5315309|NCT00452335|13069587|P1|STARTED|Overall Study||27
5315310|NCT00452114|13069624|P2|NOT COMPLETED|Overall Study||3
5315311|NCT00452114|13069625|P1|NOT COMPLETED|Overall Study||3
5315312|NCT00452114|13069624|P2|COMPLETED|Overall Study||10
5315313|NCT00452114|13069625|P1|COMPLETED|Overall Study||12
5315314|NCT00452114|13069624|P2|STARTED|Overall Study||13
5315315|NCT00452114|13069625|P1|STARTED|Overall Study||15
5315316|NCT00451958|13069641|P5|NOT COMPLETED|CS21A (NCT00451958)||0
5315317|NCT00451958|13069642|P4|NOT COMPLETED|CS21A (NCT00451958)||39
5315318|NCT00451958|13069643|P3|NOT COMPLETED|CS21A (NCT00451958)||42
5315319|NCT00451958|13069644|P2|NOT COMPLETED|CS21A (NCT00451958)||77
5315320|NCT00451958|13069645|P1|NOT COMPLETED|CS21A (NCT00451958)||65
5315321|NCT00451958|13069641|P5|COMPLETED|CS21A (NCT00451958)||0
5315322|NCT00451958|13069642|P4|COMPLETED|CS21A (NCT00451958)||27
5315323|NCT00451958|13069643|P3|COMPLETED|CS21A (NCT00451958)||27
5315324|NCT00451958|13069644|P2|COMPLETED|CS21A (NCT00451958)||49
5315325|NCT00451958|13069645|P1|COMPLETED|CS21A (NCT00451958)||60
5315326|NCT00451958|13069641|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
5315327|NCT00451958|13069642|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
5315328|NCT00451958|13069643|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
5315329|NCT00451958|13069644|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
5315330|NCT00451958|13069645|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
5315331|NCT00451958|13069641|P5|NOT COMPLETED|CS21 (NCT00295750)||32
5315332|NCT00451958|13069642|P4|NOT COMPLETED|CS21 (NCT00295750)||0
5315333|NCT00451958|13069643|P3|NOT COMPLETED|CS21 (NCT00295750)||0
5315334|NCT00451958|13069644|P2|NOT COMPLETED|CS21 (NCT00295750)||43
5315335|NCT00451958|13069645|P1|NOT COMPLETED|CS21 (NCT00295750)||41
5315336|NCT00451958|13069641|P5|COMPLETED|CS21 (NCT00295750)||172
5315337|NCT00451958|13069642|P4|COMPLETED|CS21 (NCT00295750)||0
5315338|NCT00451958|13069643|P3|COMPLETED|CS21 (NCT00295750)||0
5315339|NCT00451958|13069644|P2|COMPLETED|CS21 (NCT00295750)||163
5315340|NCT00451958|13069645|P1|COMPLETED|CS21 (NCT00295750)||169
5315341|NCT00451958|13069641|P5|STARTED|CS21 (NCT00295750)||204
5315342|NCT00451958|13069642|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
5315343|NCT00451958|13069643|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
5315344|NCT00451958|13069644|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
5315345|NCT00451958|13069645|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
5315346|NCT00451906|13069675|P1|NOT COMPLETED|Overall Study||2239
5315347|NCT00451906|13069675|P1|COMPLETED|Overall Study||13
5315348|NCT00451906|13069675|P1|STARTED|Overall Study||2252
5315349|NCT00451698|13069685|P2|NOT COMPLETED|Overall Study||0
5315350|NCT00451698|13069686|P1|NOT COMPLETED|Overall Study||0
5315351|NCT00451698|13069685|P2|COMPLETED|Overall Study||6
5315352|NCT00451698|13069686|P1|COMPLETED|Overall Study||3
5315353|NCT00451698|13069685|P2|STARTED|Overall Study||6
5315354|NCT00451698|13069686|P1|STARTED|Overall Study||3
5315355|NCT00451555|13069703|P2|NOT COMPLETED|Overall Study||4
5315356|NCT00451555|13069704|P1|NOT COMPLETED|Overall Study||13
5315357|NCT00451555|13069703|P2|COMPLETED|Overall Study||56
5315358|NCT00451555|13069704|P1|COMPLETED|Overall Study||83
5315359|NCT00451555|13069703|P2|Death|Overall Study||0
5315360|NCT00451555|13069704|P1|Death|Overall Study||2
5315361|NCT00451555|13069703|P2|Progressive Disease|Overall Study||54
5315362|NCT00451555|13069704|P1|Progressive Disease|Overall Study||75
5315363|NCT00451555|13069703|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
5315364|NCT00451555|13069704|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
5315365|NCT00451555|13069703|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
5315366|NCT00451555|13069704|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
5315367|NCT00451555|13069703|P2|Received at Least One Dose of Study Drug|Overall Study||58
5315368|NCT00451555|13069704|P1|Received at Least One Dose of Study Drug|Overall Study||94
5315369|NCT00451555|13069703|P2|STARTED|Overall Study||60
5315370|NCT00451555|13069704|P1|STARTED|Overall Study||96
5315371|NCT00451451|13069738|P4|NOT COMPLETED|Overall Study||58
5315372|NCT00451451|13069739|P3|NOT COMPLETED|Overall Study||72
5315373|NCT00451451|13069740|P2|NOT COMPLETED|Overall Study||75
5315374|NCT00451451|13069741|P1|NOT COMPLETED|Overall Study||85
5315375|NCT00451451|13069738|P4|COMPLETED|Overall Study||292
5315376|NCT00451451|13069739|P3|COMPLETED|Overall Study||273
5315377|NCT00451451|13069740|P2|COMPLETED|Overall Study||284
5315378|NCT00451451|13069741|P1|COMPLETED|Overall Study||278
5315379|NCT00451451|13069738|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
5315380|NCT00451451|13069739|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
5315381|NCT00451451|13069740|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
5315382|NCT00451451|13069741|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
5315383|NCT00451321|13069776|P8|NOT COMPLETED|Overall Study||6
5315384|NCT00451321|13069777|P7|NOT COMPLETED|Overall Study||6
5315385|NCT00451321|13069778|P6|NOT COMPLETED|Overall Study||9
5315386|NCT00451321|13069779|P5|NOT COMPLETED|Overall Study||7
5315387|NCT00451321|13069780|P4|NOT COMPLETED|Overall Study||12
5315388|NCT00451321|13069781|P3|NOT COMPLETED|Overall Study||18
5315389|NCT00451321|13069782|P2|NOT COMPLETED|Overall Study||5
5315390|NCT00451321|13069783|P1|NOT COMPLETED|Overall Study||7
5315391|NCT00451321|13069776|P8|COMPLETED|Overall Study||0
5315392|NCT00451321|13069777|P7|COMPLETED|Overall Study||0
5315393|NCT00451321|13069778|P6|COMPLETED|Overall Study||0
5315394|NCT00451321|13069779|P5|COMPLETED|Overall Study||0
5315395|NCT00451321|13069780|P4|COMPLETED|Overall Study||7
5315396|NCT00451321|13069781|P3|COMPLETED|Overall Study||0
5315397|NCT00451321|13069782|P2|COMPLETED|Overall Study||10
5315398|NCT00451321|13069783|P1|COMPLETED|Overall Study||1
5315399|NCT00451321|13069776|P8|STARTED|Overall Study||6
5315400|NCT00451321|13069777|P7|STARTED|Overall Study||6
5315401|NCT00451321|13069778|P6|STARTED|Overall Study||9
5315402|NCT00451321|13069779|P5|STARTED|Overall Study||7
5315403|NCT00451321|13069780|P4|STARTED|Overall Study||19
5315404|NCT00451321|13069781|P3|STARTED|Overall Study||18
5315405|NCT00451321|13069782|P2|STARTED|Overall Study||15
5315406|NCT00451321|13069783|P1|STARTED|Overall Study||8
5315407|NCT00451282|13069955|P2|NOT COMPLETED|Overall Study||5
5315408|NCT00451282|13069956|P1|NOT COMPLETED|Overall Study||6
5315409|NCT00451282|13069955|P2|COMPLETED|Overall Study||34
5315410|NCT00451282|13069956|P1|COMPLETED|Overall Study||40
5315411|NCT00451282|13069955|P2|STARTED|Overall Study||39
5315412|NCT00451282|13069956|P1|STARTED|Overall Study||46
5315413|NCT00451217|13069972|P4|NOT COMPLETED|Overall Study||5
5315414|NCT00451217|13069973|P3|NOT COMPLETED|Overall Study||4
5315415|NCT00451217|13069974|P2|NOT COMPLETED|Overall Study||2
5315416|NCT00451217|13069975|P1|NOT COMPLETED|Overall Study||2
5315417|NCT00451217|13069972|P4|COMPLETED|Overall Study||44
5315418|NCT00451217|13069973|P3|COMPLETED|Overall Study||47
5315419|NCT00451217|13069974|P2|COMPLETED|Overall Study||47
5315420|NCT00451217|13069975|P1|COMPLETED|Overall Study||47
5315421|NCT00451217|13069972|P4|Treated|Overall Study||45
5315422|NCT00451217|13069973|P3|Treated|Overall Study||48
5315423|NCT00451217|13069974|P2|Treated|Overall Study||48
5315424|NCT00451217|13069975|P1|Treated|Overall Study||48
5315425|NCT00451217|13069972|P4|STARTED|Overall Study||49
5315426|NCT00451217|13069973|P3|STARTED|Overall Study||51
5315427|NCT00451217|13069974|P2|STARTED|Overall Study||49
5315428|NCT00451217|13069975|P1|STARTED|Overall Study||49
5315429|NCT00451204|13070003|P2|NOT COMPLETED|Overall Study||20
5315430|NCT00451204|13070004|P1|NOT COMPLETED|Overall Study||22
5315431|NCT00451204|13070003|P2|COMPLETED|Overall Study||56
5315432|NCT00451204|13070004|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
5315433|NCT00451204|13070003|P2|STARTED|Overall Study||76
5315434|NCT00451204|13070004|P1|STARTED|Overall Study||82
5315435|NCT00451191|13070022|P2|NOT COMPLETED|Overall Study||11
5315436|NCT00451191|13070023|P1|NOT COMPLETED|Overall Study||15
5315437|NCT00451191|13070022|P2|COMPLETED|Overall Study||55
5315438|NCT00451191|13070023|P1|COMPLETED|Overall Study||53
5315439|NCT00451191|13070022|P2|STARTED|Overall Study||66
5315440|NCT00451191|13070023|P1|STARTED|Overall Study||68
5315441|NCT00451178|13070031|P2|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
5315442|NCT00451178|13070032|P1|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
5315443|NCT00451178|13070031|P2|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
5315444|NCT00451178|13070032|P1|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
5315445|NCT00451178|13070031|P2|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
5315446|NCT00451178|13070032|P1|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
5315447|NCT00451178|13070031|P2|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
5315448|NCT00451178|13070032|P1|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
5315449|NCT00451178|13070031|P2|COMPLETED|Maintenance Therapy (up to 3 Years)||0
5315450|NCT00451178|13070032|P1|COMPLETED|Maintenance Therapy (up to 3 Years)||6
5315451|NCT00451178|13070031|P2|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
5315452|NCT00451178|13070032|P1|STARTED|Maintenance Therapy (up to 3 Years)||36
5315453|NCT00451178|13070031|P2|NOT COMPLETED|Prior to Maintenance Therapy||0
5315454|NCT00451178|13070032|P1|NOT COMPLETED|Prior to Maintenance Therapy||4
5315455|NCT00451178|13070031|P2|COMPLETED|Prior to Maintenance Therapy||0
5315456|NCT00451178|13070032|P1|COMPLETED|Prior to Maintenance Therapy||36
5315457|NCT00451178|13070031|P2|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
5315458|NCT00451178|13070032|P1|STARTED|Prior to Maintenance Therapy||40
5315459|NCT00451178|13070031|P2|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
5315460|NCT00451178|13070032|P1|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
5315461|NCT00451178|13070031|P2|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
5315462|NCT00451178|13070032|P1|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
5315463|NCT00451178|13070031|P2|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
5315464|NCT00451178|13070032|P1|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
5315465|NCT00451178|13070031|P2|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
5315466|NCT00451178|13070032|P1|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
5315467|NCT00451048|13070058|P1|NOT COMPLETED|Overall Study||0
5315468|NCT00451048|13070058|P1|COMPLETED|Overall Study||10
5315469|NCT00451048|13070058|P1|STARTED|Overall Study||10
5315470|NCT00450983|13070067|P1|NOT COMPLETED|Overall Study||0
5315471|NCT00450983|13070067|P1|COMPLETED|Overall Study||1
5315472|NCT00450983|13070067|P1|STARTED|Overall Study||1
5315473|NCT00450866|13070079|P2|NOT COMPLETED|Overall Study||3
5315474|NCT00450866|13070080|P1|NOT COMPLETED|Overall Study||7
5315475|NCT00450866|13070079|P2|COMPLETED|Overall Study||7
5315476|NCT00450866|13070080|P1|COMPLETED|Overall Study||38
5315477|NCT00450866|13070079|P2|STARTED|Overall Study||10
5315478|NCT00450866|13070080|P1|STARTED|Overall Study||45
5315479|NCT00450814|13070100|P11|NOT COMPLETED|Overall Study||0
5315480|NCT00450814|13070101|P10|NOT COMPLETED|Overall Study||1
5315481|NCT00450814|13070102|P9|NOT COMPLETED|Overall Study||0
5315482|NCT00450814|13070103|P8|NOT COMPLETED|Overall Study||0
5315483|NCT00450814|13070104|P7|NOT COMPLETED|Overall Study||0
5315484|NCT00450814|13070105|P6|NOT COMPLETED|Overall Study||1
5315485|NCT00450814|13070106|P5|NOT COMPLETED|Overall Study||1
5315486|NCT00450814|13070107|P4|NOT COMPLETED|Overall Study||1
5315487|NCT00450814|13070108|P3|NOT COMPLETED|Overall Study||0
5315488|NCT00450814|13070109|P2|NOT COMPLETED|Overall Study||0
5315489|NCT00450814|13070110|P1|NOT COMPLETED|Overall Study||0
5315490|NCT00450814|13070100|P11|COMPLETED|Overall Study||4
5315491|NCT00450814|13070101|P10|COMPLETED|Overall Study||11
5315492|NCT00450814|13070102|P9|COMPLETED|Overall Study||2
5315493|NCT00450814|13070103|P8|COMPLETED|Overall Study||3
5315494|NCT00450814|13070104|P7|COMPLETED|Overall Study||3
5315495|NCT00450814|13070105|P6|COMPLETED|Overall Study||6
5315496|NCT00450814|13070106|P5|COMPLETED|Overall Study||3
5315497|NCT00450814|13070107|P4|COMPLETED|Overall Study||3
5315498|NCT00450814|13070108|P3|COMPLETED|Overall Study||3
5315499|NCT00450814|13070109|P2|COMPLETED|Overall Study||3
5315500|NCT00450814|13070110|P1|COMPLETED|Overall Study||3
5315501|NCT00450814|13070100|P11|STARTED|Overall Study||4
5315502|NCT00450814|13070101|P10|STARTED|Overall Study||12
5315503|NCT00450814|13070102|P9|STARTED|Overall Study||2
5315504|NCT00450814|13070103|P8|STARTED|Overall Study||3
5315505|NCT00450814|13070104|P7|STARTED|Overall Study||3
5315506|NCT00450814|13070105|P6|STARTED|Overall Study||7
5315507|NCT00450814|13070106|P5|STARTED|Overall Study||4
5315508|NCT00450814|13070107|P4|STARTED|Overall Study||4
5315509|NCT00450814|13070108|P3|STARTED|Overall Study||3
5315510|NCT00450814|13070109|P2|STARTED|Overall Study||3
5315511|NCT00450814|13070110|P1|STARTED|Overall Study||3
5315512|NCT00450801|13070144|P1|NOT COMPLETED|Overall Study||1
5315513|NCT00450801|13070144|P1|COMPLETED|Overall Study||21
5315514|NCT00450801|13070144|P1|STARTED|Overall Study||22
5315515|NCT00450749|13070158|P3|NOT COMPLETED|Overall Study||2
5315516|NCT00450749|13070159|P2|NOT COMPLETED|Overall Study||1
5315517|NCT00450749|13070160|P1|NOT COMPLETED|Overall Study||0
5315518|NCT00450749|13070158|P3|COMPLETED|Overall Study||2
5315519|NCT00450749|13070159|P2|COMPLETED|Overall Study||2
5315520|NCT00450749|13070160|P1|COMPLETED|Overall Study||3
5315521|NCT00450749|13070158|P3|STARTED|Overall Study||4
5315522|NCT00450749|13070159|P2|STARTED|Overall Study||3
5315523|NCT00450749|13070160|P1|STARTED|Overall Study||3
5315524|NCT00450723|13070198|P1|NOT COMPLETED|Overall Study||5
5315525|NCT00450723|13070198|P1|COMPLETED|Overall Study||34
5315526|NCT00450723|13070198|P1|STARTED|Overall Study||39
5315527|NCT00450658|13070206|P2|NOT COMPLETED|Overall Study||90
5315528|NCT00450658|13070207|P1|NOT COMPLETED|Overall Study||143
5315529|NCT00450658|13070206|P2|COMPLETED|Overall Study||122
5315530|NCT00450658|13070207|P1|COMPLETED|Overall Study||272
5315531|NCT00450658|13070206|P2|STARTED|Overall Study||212
5315532|NCT00450658|13070207|P1|STARTED|Overall Study||415
5315533|NCT00450619|13070221|P2|NOT COMPLETED|Overall Study||1
5315534|NCT00450619|13070222|P1|NOT COMPLETED|Overall Study||4
5315535|NCT00450619|13070221|P2|COMPLETED|Overall Study||21
5315536|NCT00450619|13070222|P1|COMPLETED|Overall Study||18
5315537|NCT00450619|13070221|P2|STARTED|Overall Study||22
5315538|NCT00450619|13070222|P1|STARTED|Overall Study||22
5315539|NCT00450580|13070248|P2|NOT COMPLETED|Overall Study||16
5315540|NCT00450580|13070249|P1|NOT COMPLETED|Overall Study||16
5315541|NCT00450580|13070248|P2|COMPLETED|Overall Study||90
5315542|NCT00450580|13070249|P1|COMPLETED|Overall Study||90
5315543|NCT00450580|13070248|P2|STARTED|Overall Study||106
5315544|NCT00450580|13070249|P1|STARTED|Overall Study||106
5315545|NCT00450463|13070269|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
5315546|NCT00450463|13070270|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
5315547|NCT00450463|13070269|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
5315548|NCT00450463|13070270|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
5315549|NCT00450463|13070269|P2|STARTED|Progressed to Receive Vaccine Alone||0
5315550|NCT00450463|13070270|P1|STARTED|Progressed to Receive Vaccine Alone||11
5315551|NCT00450463|13070269|P2|NOT COMPLETED|Initial Drug Administration||0
5315552|NCT00450463|13070270|P1|NOT COMPLETED|Initial Drug Administration||0
5315553|NCT00450463|13070269|P2|COMPLETED|Initial Drug Administration||31
5315554|NCT00450463|13070270|P1|COMPLETED|Initial Drug Administration||33
5315555|NCT00450463|13070269|P2|STARTED|Initial Drug Administration||31
5315556|NCT00450463|13070270|P1|STARTED|Initial Drug Administration||33
5315557|NCT00450450|13070286|P2|NOT COMPLETED|Overall Study||3
5315558|NCT00450450|13070287|P1|NOT COMPLETED|Overall Study||5
5315559|NCT00450450|13070286|P2|COMPLETED|Overall Study||11
5315560|NCT00450450|13070287|P1|COMPLETED|Overall Study||8
5315561|NCT00450450|13070286|P2|STARTED|Overall Study||14
5315562|NCT00450450|13070287|P1|STARTED|Overall Study||13
5315563|NCT00450437|13070311|P4|NOT COMPLETED|Overall Study||11
5315564|NCT00450437|13070312|P3|NOT COMPLETED|Overall Study||24
5315565|NCT00450437|13070313|P2|NOT COMPLETED|Overall Study||16
5315566|NCT00450437|13070314|P1|NOT COMPLETED|Overall Study||46
5315567|NCT00450437|13070311|P4|COMPLETED|Overall Study||325
5315568|NCT00450437|13070312|P3|COMPLETED|Overall Study||999
5315569|NCT00450437|13070313|P2|COMPLETED|Overall Study||524
5315570|NCT00450437|13070314|P1|COMPLETED|Overall Study||1594
5315571|NCT00450437|13070311|P4|STARTED|Overall Study||336
5315572|NCT00450437|13070312|P3|STARTED|Overall Study||1023
5315573|NCT00450437|13070313|P2|STARTED|Overall Study||540
5315574|NCT00450437|13070314|P1|STARTED|Overall Study||1640
5315575|NCT00450424|13070338|P2|NOT COMPLETED|Overall Study||11
5315576|NCT00450424|13070339|P1|NOT COMPLETED|Overall Study||20
5315577|NCT00450424|13070338|P2|COMPLETED|Overall Study||106
5315578|NCT00450424|13070339|P1|COMPLETED|Overall Study||102
5315579|NCT00450424|13070338|P2|STARTED|Overall Study||117
5315580|NCT00450424|13070339|P1|STARTED|Overall Study||122
5315581|NCT00450411|13070345|P1|NOT COMPLETED|Overall Study||8
5315582|NCT00450411|13070345|P1|COMPLETED|Overall Study||92
5315583|NCT00450411|13070345|P1|STARTED|Overall Study||100
5315584|NCT00450385|13070350|P1|NOT COMPLETED|Overall Study||13
5315585|NCT00450385|13070350|P1|COMPLETED|Overall Study||44
5315586|NCT00450385|13070350|P1|STARTED|Overall Study||57
5315587|NCT00450372|13070359|P1|NOT COMPLETED|Overall Study||1
5315588|NCT00450372|13070359|P1|COMPLETED|Overall Study||37
5315589|NCT00450372|13070359|P1|STARTED|Overall Study||38
5315590|NCT00450333|13070372|P4|NOT COMPLETED|Overall Study||28
5315591|NCT00450333|13070373|P3|NOT COMPLETED|Overall Study||25
5315592|NCT00450333|13070374|P2|NOT COMPLETED|Overall Study||63
5315593|NCT00450333|13070375|P1|NOT COMPLETED|Overall Study||54
5315594|NCT00450333|13070372|P4|COMPLETED|Overall Study||74
5315595|NCT00450333|13070373|P3|COMPLETED|Overall Study||75
5315596|NCT00450333|13070374|P2|COMPLETED|Overall Study||44
5315597|NCT00450333|13070375|P1|COMPLETED|Overall Study||44
5315598|NCT00450333|13070372|P4|STARTED|Overall Study||102
5315599|NCT00450333|13070373|P3|STARTED|Overall Study||100
5315600|NCT00450333|13070374|P2|STARTED|Overall Study||107
5315601|NCT00450333|13070375|P1|STARTED|Overall Study||98
5315602|NCT00450294|13070393|P1|NOT COMPLETED|Overall Study||0
5315603|NCT00450294|13070393|P1|COMPLETED|Overall Study||10
5315604|NCT00450294|13070393|P1|STARTED|Overall Study||10
5315605|NCT00450255|13070398|P1|NOT COMPLETED|Overall Study||1
5315606|NCT00450255|13070398|P1|COMPLETED|Overall Study||40
5315607|NCT00450255|13070398|P1|STARTED|Overall Study||41
5315608|NCT00450242|13070408|P2|NOT COMPLETED|Overall Study||1
5315609|NCT00450242|13070409|P1|NOT COMPLETED|Overall Study||3
5315610|NCT00450242|13070408|P2|COMPLETED|Overall Study||6
5315611|NCT00450242|13070409|P1|COMPLETED|Overall Study||4
5315612|NCT00450242|13070408|P2|STARTED|Overall Study||7
5315613|NCT00450242|13070409|P1|STARTED|Overall Study||7
5315614|NCT00450216|13070423|P2|NOT COMPLETED|Overall Study||129
5315615|NCT00450216|13070424|P1|NOT COMPLETED|Overall Study||174
5315616|NCT00450216|13070423|P2|COMPLETED|Overall Study||170
5315617|NCT00450216|13070424|P1|COMPLETED|Overall Study||433
5315618|NCT00450216|13070423|P2|STARTED|Overall Study||299
5315619|NCT00450216|13070424|P1|STARTED|Overall Study||607
5315620|NCT00450190|13070436|P1|NOT COMPLETED|Overall Study||2
5315621|NCT00450190|13070436|P1|COMPLETED|Overall Study||18
5315622|NCT00450190|13070436|P1|STARTED|Overall Study||20
5315623|NCT00450177|13070446|P2|NOT COMPLETED|Overall Study||11
5315624|NCT00450177|13070447|P1|NOT COMPLETED|Overall Study||9
5315625|NCT00450177|13070446|P2|COMPLETED|Overall Study||92
5315626|NCT00450177|13070447|P1|COMPLETED|Overall Study||88
5315627|NCT00450177|13070446|P2|STARTED|Overall Study||103
5315628|NCT00450177|13070447|P1|STARTED|Overall Study||97
5315629|NCT00450112|13070473|P2|NOT COMPLETED|Overall Study||6
5315630|NCT00450112|13070474|P1|NOT COMPLETED|Overall Study||13
5315631|NCT00450112|13070473|P2|COMPLETED|Overall Study||71
5315632|NCT00450112|13070474|P1|COMPLETED|Overall Study||112
5315633|NCT00450112|13070473|P2|Analyzed Participants|Overall Study||74
5315634|NCT00450112|13070474|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
5315635|NCT00450112|13070473|P2|Received Injection|Overall Study||74
5315636|NCT00450112|13070474|P1|Received Injection|Overall Study||125
5315637|NCT00450112|13070473|P2|STARTED|Overall Study||77
5315638|NCT00450112|13070474|P1|STARTED|Overall Study||125
5315639|NCT00450073|13070499|P3|NOT COMPLETED|Overall Study||1
5315640|NCT00450073|13070500|P2|NOT COMPLETED|Overall Study||0
5315641|NCT00450073|13070501|P1|NOT COMPLETED|Overall Study||1
5315642|NCT00450073|13070499|P3|COMPLETED|Overall Study||9
5315643|NCT00450073|13070500|P2|COMPLETED|Overall Study||10
5315644|NCT00450073|13070501|P1|COMPLETED|Overall Study||9
5315645|NCT00450073|13070499|P3|STARTED|Overall Study||10
5315646|NCT00450073|13070500|P2|STARTED|Overall Study||10
5315647|NCT00450073|13070501|P1|STARTED|Overall Study||10
5315648|NCT00449956|13070512|P3|NOT COMPLETED|Overall Study||9
5315649|NCT00449956|13070513|P2|NOT COMPLETED|Overall Study||4
5315650|NCT00449956|13070514|P1|NOT COMPLETED|Overall Study||10
5315651|NCT00449956|13070512|P3|COMPLETED|Overall Study||184
5315652|NCT00449956|13070513|P2|COMPLETED|Overall Study||88
5315653|NCT00449956|13070514|P1|COMPLETED|Overall Study||179
5315654|NCT00449956|13070512|P3|STARTED|Overall Study||193
5315655|NCT00449956|13070513|P2|STARTED|Overall Study||92
5315656|NCT00449956|13070514|P1|STARTED|Overall Study||189
5315657|NCT00449930|13070530|P2|NOT COMPLETED|Overall Study||75
5315658|NCT00449930|13070531|P1|NOT COMPLETED|Overall Study||61
5315659|NCT00449930|13070530|P2|COMPLETED|Overall Study||447
5315660|NCT00449930|13070531|P1|COMPLETED|Overall Study||467
5315661|NCT00449930|13070530|P2|STARTED|Overall Study||522
5315662|NCT00449930|13070531|P1|STARTED|Overall Study||528
5315663|NCT00449865|13070547|P2|NOT COMPLETED|Overall Study||534
5315664|NCT00449865|13070548|P1|NOT COMPLETED|Overall Study||522
5315665|NCT00449865|13070547|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
5315666|NCT00449865|13070548|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
5315667|NCT00449865|13070547|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
5315668|NCT00449865|13070548|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
5315669|NCT00449865|13070547|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
5315670|NCT00449865|13070548|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
5315671|NCT00449865|13070547|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
5315672|NCT00449865|13070548|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
5315673|NCT00449865|13070547|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
5315674|NCT00449865|13070548|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
5315675|NCT00449865|13070547|P2|STARTED|Overall Study||874
5315676|NCT00449865|13070548|P1|STARTED|Overall Study||867
5315677|NCT00449787|13070556|P2|NOT COMPLETED|Overall Study||100
5315678|NCT00449787|13070557|P1|NOT COMPLETED|Overall Study||105
5315679|NCT00449787|13070556|P2|COMPLETED|Overall Study||98
5315680|NCT00449787|13070557|P1|COMPLETED|Overall Study||98
5315681|NCT00449787|13070556|P2|STARTED|Overall Study||198
5315682|NCT00449787|13070557|P1|STARTED|Overall Study||203
5315683|NCT00449748|13070567|P1|NOT COMPLETED|Overall Study||0
5315684|NCT00449748|13070567|P1|COMPLETED|Overall Study||10
5315685|NCT00449748|13070567|P1|STARTED|Overall Study||10
5315686|NCT00449696|13070573|P2|NOT COMPLETED|Overall Study||9
5315687|NCT00449696|13070574|P1|NOT COMPLETED|Overall Study||20
5315688|NCT00449696|13070573|P2|COMPLETED|Overall Study||119
5315689|NCT00449696|13070574|P1|COMPLETED|Overall Study||231
5315690|NCT00449696|13070573|P2|Analyzed Participants|Overall Study||128
5315691|NCT00449696|13070574|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
5315692|NCT00449696|13070573|P2|Received Injection|Overall Study||128
5315693|NCT00449696|13070574|P1|Received Injection|Overall Study||249
5315694|NCT00449696|13070573|P2|STARTED|Overall Study||128
5315695|NCT00449696|13070574|P1|STARTED|Overall Study||251
5315696|NCT00449670|13070598|P2|NOT COMPLETED|Booster Phase (Study no.109873)||3
5315697|NCT00449670|13070599|P1|NOT COMPLETED|Booster Phase (Study no.109873)||0
5315698|NCT00449670|13070598|P2|COMPLETED|Booster Phase (Study no.109873)||233
5315699|NCT00449670|13070599|P1|COMPLETED|Booster Phase (Study no.109873)||265
5315700|NCT00449670|13070598|P2|STARTED|Booster Phase (Study no.109873)||236
5315701|NCT00449670|13070599|P1|STARTED|Booster Phase (Study no.109873)||265
5315702|NCT00449670|13070598|P2|NOT COMPLETED|Primary Phase (Study no.109630)||2
5315703|NCT00449670|13070599|P1|NOT COMPLETED|Primary Phase (Study no.109630)||14
5315704|NCT00449670|13070598|P2|COMPLETED|Primary Phase (Study no.109630)||243
5315705|NCT00449670|13070599|P1|COMPLETED|Primary Phase (Study no.109630)||947
5315706|NCT00449670|13070598|P2|STARTED|Primary Phase (Study no.109630)||245
5315707|NCT00449670|13070599|P1|STARTED|Primary Phase (Study no.109630)||961
5315708|NCT00449644|13070712|P4|NOT COMPLETED|Overall Study||32
5315709|NCT00449644|13070713|P3|NOT COMPLETED|Overall Study||29
5315710|NCT00449644|13070714|P2|NOT COMPLETED|Overall Study||13
5315711|NCT00449644|13070715|P1|NOT COMPLETED|Overall Study||10
5315712|NCT00449644|13070712|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
5315713|NCT00449644|13070713|P3|COMPLETED|Overall Study||50
5315714|NCT00449644|13070714|P2|COMPLETED|Overall Study||11
5315715|NCT00449644|13070715|P1|COMPLETED|Overall Study||13
5315716|NCT00449644|13070712|P4|Rollover|Overall Study||1
5315717|NCT00449644|13070713|P3|Rollover|Overall Study||0
5315718|NCT00449644|13070714|P2|Rollover|Overall Study||0
5315719|NCT00449644|13070715|P1|Rollover|Overall Study||0
5315720|NCT00449644|13070712|P4|STARTED|Overall Study||81
5315721|NCT00449644|13070713|P3|STARTED|Overall Study||79
5315722|NCT00449644|13070714|P2|STARTED|Overall Study||24
5315723|NCT00449644|13070715|P1|STARTED|Overall Study||23
5315724|NCT00449540|13070735|P3|NOT COMPLETED|Treatment Phase||17
5315725|NCT00449540|13070736|P2|NOT COMPLETED|Treatment Phase||20
5315726|NCT00449540|13070737|P1|NOT COMPLETED|Treatment Phase||0
5315727|NCT00449540|13070735|P3|COMPLETED|Treatment Phase||82
5315728|NCT00449540|13070736|P2|COMPLETED|Treatment Phase||82
5315729|NCT00449540|13070737|P1|COMPLETED|Treatment Phase||0
5315730|NCT00449540|13070735|P3|STARTED|Treatment Phase||99
5315731|NCT00449540|13070736|P2|STARTED|Treatment Phase||102
5315732|NCT00449540|13070737|P1|STARTED|Treatment Phase||0
5315733|NCT00449540|13070735|P3|NOT COMPLETED|Pretreatment Phase||0
5315734|NCT00449540|13070736|P2|NOT COMPLETED|Pretreatment Phase||0
5315735|NCT00449540|13070737|P1|NOT COMPLETED|Pretreatment Phase||66
5315736|NCT00449540|13070735|P3|COMPLETED|Pretreatment Phase||0
5315737|NCT00449540|13070736|P2|COMPLETED|Pretreatment Phase||0
5315738|NCT00449540|13070737|P1|COMPLETED|Pretreatment Phase||201
5315739|NCT00449540|13070735|P3|STARTED|Pretreatment Phase||0
5315740|NCT00449540|13070736|P2|STARTED|Pretreatment Phase||0
5315741|NCT00449540|13070737|P1|STARTED|Pretreatment Phase||267
5315742|NCT00449176|13070754|P3|NOT COMPLETED|Overall Study||167
5315743|NCT00449176|13070755|P2|NOT COMPLETED|Overall Study||195
5315744|NCT00449176|13070756|P1|NOT COMPLETED|Overall Study||152
5315745|NCT00449176|13070754|P3|COMPLETED|Overall Study||152
5315746|NCT00449176|13070755|P2|COMPLETED|Overall Study||133
5315747|NCT00449176|13070756|P1|COMPLETED|Overall Study||166
5315748|NCT00449176|13070754|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
5315749|NCT00449176|13070755|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
5315750|NCT00449176|13070756|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
5315751|NCT00449163|13070782|P1|NOT COMPLETED|Overall Study||3
5315752|NCT00449163|13070782|P1|COMPLETED|Overall Study||22
5315753|NCT00449163|13070782|P1|STARTED|Overall Study||25
5315754|NCT00449150|13070792|P3|NOT COMPLETED|Overall Study||47
5315755|NCT00449150|13070793|P2|NOT COMPLETED|Overall Study||53
5315756|NCT00449150|13070794|P1|NOT COMPLETED|Overall Study||46
5315757|NCT00449150|13070792|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
5315758|NCT00449150|13070793|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
5315759|NCT00449150|13070794|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
5315760|NCT00449150|13070792|P3|STARTED|Overall Study||218
5315761|NCT00449150|13070793|P2|STARTED|Overall Study||230
5315762|NCT00449150|13070794|P1|STARTED|Overall Study||219
5315763|NCT00449072|13070807|P2|NOT COMPLETED|Overall Study||42
5315764|NCT00449072|13070808|P1|NOT COMPLETED|Overall Study||41
5315765|NCT00449072|13070807|P2|COMPLETED|Overall Study||109
5315766|NCT00449072|13070808|P1|COMPLETED|Overall Study||107
5315767|NCT00449072|13070807|P2|STARTED|Overall Study||151
5315768|NCT00449072|13070808|P1|STARTED|Overall Study||148
5315769|NCT00449046|13070832|P1|NOT COMPLETED|Overall Study||0
5315770|NCT00449046|13070832|P1|COMPLETED|Overall Study||40
5315771|NCT00449046|13070832|P1|STARTED|Overall Study||40
5315772|NCT00449033|13070845|P2|NOT COMPLETED|Follow-up Period||434
5315773|NCT00449033|13070846|P1|NOT COMPLETED|Follow-up Period||425
5315774|NCT00449033|13070845|P2|COMPLETED|Follow-up Period||0
5315775|NCT00449033|13070846|P1|COMPLETED|Follow-up Period||0
5315776|NCT00449033|13070845|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
5315777|NCT00449033|13070846|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
5315778|NCT00449033|13070845|P2|NOT COMPLETED|Treatment Period||452
5315779|NCT00449033|13070846|P1|NOT COMPLETED|Treatment Period||452
5315780|NCT00449033|13070845|P2|COMPLETED|Treatment Period||0
5315781|NCT00449033|13070846|P1|COMPLETED|Treatment Period||0
5315782|NCT00449033|13070845|P2|Received Treatment|Treatment Period||449
5315783|NCT00449033|13070846|P1|Received Treatment|Treatment Period||452
5315784|NCT00449033|13070845|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
5315785|NCT00449033|13070846|P1|STARTED|Treatment Period||452
5315786|NCT00448916|13070884|P4|NOT COMPLETED|Overall Study||6
5315787|NCT00448916|13070885|P3|NOT COMPLETED|Overall Study||6
5315788|NCT00448916|13070886|P2|NOT COMPLETED|Overall Study||6
5315789|NCT00448916|13070887|P1|NOT COMPLETED|Overall Study||7
5315790|NCT00448916|13070884|P4|COMPLETED|Overall Study||5
5315791|NCT00448916|13070885|P3|COMPLETED|Overall Study||6
5315792|NCT00448916|13070886|P2|COMPLETED|Overall Study||9
5315793|NCT00448916|13070887|P1|COMPLETED|Overall Study||9
5315794|NCT00448916|13070884|P4|STARTED|Overall Study||11
5315795|NCT00448916|13070885|P3|STARTED|Overall Study||12
5315796|NCT00448916|13070886|P2|STARTED|Overall Study||15
5315797|NCT00448916|13070887|P1|STARTED|Overall Study||16
5315798|NCT00448864|13070961|P3|NOT COMPLETED|Overall Study||1
5315799|NCT00448864|13070962|P2|NOT COMPLETED|Overall Study||5
5315800|NCT00448864|13070963|P1|NOT COMPLETED|Overall Study||5
5315801|NCT00448864|13070961|P3|COMPLETED|Overall Study||18
5315802|NCT00448864|13070962|P2|COMPLETED|Overall Study||24
5315803|NCT00448864|13070963|P1|COMPLETED|Overall Study||22
5315804|NCT00448864|13070961|P3|Completed Post-operative Period|Overall Study||18
5315805|NCT00448864|13070962|P2|Completed Post-operative Period|Overall Study||25
5315806|NCT00448864|13070963|P1|Completed Post-operative Period|Overall Study||26
5315807|NCT00448864|13070961|P3|Started Post-operative Period|Overall Study||18
5315808|NCT00448864|13070962|P2|Started Post-operative Period|Overall Study||25
5315809|NCT00448864|13070963|P1|Started Post-operative Period|Overall Study||26
5315810|NCT00448864|13070961|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
5315811|NCT00448864|13070962|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
5315812|NCT00448864|13070963|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
5315813|NCT00448864|13070961|P3|STARTED|Overall Study||19
5315814|NCT00448864|13070962|P2|STARTED|Overall Study||29
5315815|NCT00448864|13070963|P1|STARTED|Overall Study||27
5315816|NCT00448760|13070979|P1|NOT COMPLETED|Overall Study||3
5315817|NCT00448760|13070979|P1|COMPLETED|Overall Study||26
5315818|NCT00448760|13070979|P1|STARTED|Overall Study||29
5315819|NCT00448747|13070988|P2|NOT COMPLETED|Overall Study||0
5315820|NCT00448747|13070989|P1|NOT COMPLETED|Overall Study||1
5315821|NCT00448747|13070988|P2|COMPLETED|Overall Study||48
5315822|NCT00448747|13070989|P1|COMPLETED|Overall Study||52
5315823|NCT00448747|13070988|P2|Per Protocol Population (PPS)|Overall Study||48
5315824|NCT00448747|13070989|P1|Per Protocol Population (PPS)|Overall Study||50
5315825|NCT00448747|13070988|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
5315826|NCT00448747|13070989|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
5315827|NCT00448747|13070988|P2|Received L-ARG-GHRH|Overall Study||10
5315828|NCT00448747|13070989|P1|Received L-ARG-GHRH|Overall Study||43
5315829|NCT00448747|13070988|P2|Received AEZS-130|Overall Study||48
5315830|NCT00448747|13070989|P1|Received AEZS-130|Overall Study||52
5315831|NCT00448747|13070988|P2|Received Second Drug Administration|Overall Study||10
5315832|NCT00448747|13070989|P1|Received Second Drug Administration|Overall Study||42
5315833|NCT00448747|13070988|P2|Received First Drug Administration|Overall Study||48
5315834|NCT00448747|13070989|P1|Received First Drug Administration|Overall Study||53
5315835|NCT00448747|13070988|P2|STARTED|Overall Study||48
5315836|NCT00448747|13070989|P1|STARTED|Overall Study||53
5315837|NCT00448708|13071007|P2|NOT COMPLETED|Overall Study||31
5315838|NCT00448708|13071008|P1|NOT COMPLETED|Overall Study||35
5315839|NCT00448708|13071007|P2|COMPLETED|Overall Study||79
5315840|NCT00448708|13071008|P1|COMPLETED|Overall Study||77
5315841|NCT00448708|13071007|P2|STARTED|Overall Study||110
5315842|NCT00448708|13071008|P1|STARTED|Overall Study||112
5315843|NCT00448682|13071016|P1|NOT COMPLETED|Overall Study||0
5315844|NCT00448682|13071016|P1|COMPLETED|Overall Study||25
5315845|NCT00448682|13071016|P1|STARTED|Overall Study||25
5315846|NCT00448669|13071024|P2|NOT COMPLETED|Overall Study||198
5315847|NCT00448669|13071025|P1|NOT COMPLETED|Overall Study||218
5315848|NCT00448669|13071024|P2|COMPLETED|Overall Study||410
5315849|NCT00448669|13071025|P1|COMPLETED|Overall Study||393
5315850|NCT00448669|13071024|P2|STARTED|Overall Study||608
5315851|NCT00448669|13071025|P1|STARTED|Overall Study||611
5315852|NCT00448630|13071041|P1|NOT COMPLETED|Overall Study||27
5315853|NCT00448630|13071041|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
5315854|NCT00448630|13071041|P1|STARTED|Overall Study||328
5315855|NCT00448591|13071086|P1|NOT COMPLETED|Overall Study||2296
5315856|NCT00448591|13071086|P1|COMPLETED|Overall Study||0
5315857|NCT00448591|13071086|P1|STARTED|Overall Study||2296
5315858|NCT00448539|13071097|P2|NOT COMPLETED|Overall Study||152
5315859|NCT00448539|13071098|P1|NOT COMPLETED|Overall Study||134
5315860|NCT00448539|13071097|P2|COMPLETED|Overall Study||0
5315861|NCT00448539|13071098|P1|COMPLETED|Overall Study||0
5315862|NCT00448539|13071097|P2|STARTED|Overall Study||152
5315863|NCT00448539|13071098|P1|STARTED|Overall Study||134
5315864|NCT00448448|13071106|P2|NOT COMPLETED|Overall Study||41
5315865|NCT00448448|13071107|P1|NOT COMPLETED|Overall Study||100
5315866|NCT00448448|13071106|P2|COMPLETED|Overall Study||96
5315867|NCT00448448|13071107|P1|COMPLETED|Overall Study||146
5315868|NCT00448448|13071106|P2|STARTED|Overall Study||137
5315869|NCT00448448|13071107|P1|STARTED|Overall Study||246
5315870|NCT00448435|13071113|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
5315871|NCT00448435|13071114|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
5315872|NCT00448435|13071113|P2|COMPLETED|Extension Period - 20 Weeks||0
5315873|NCT00448435|13071114|P1|COMPLETED|Extension Period - 20 Weeks||50
5315874|NCT00448435|13071113|P2|STARTED|Extension Period - 20 Weeks||0
5315875|NCT00448435|13071114|P1|STARTED|Extension Period - 20 Weeks||50
5315876|NCT00448435|13071113|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
5315877|NCT00448435|13071114|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
5315878|NCT00448435|13071113|P2|COMPLETED|Treatment Period II - 4 Weeks||25
5315879|NCT00448435|13071114|P1|COMPLETED|Treatment Period II - 4 Weeks||25
5315880|NCT00448435|13071113|P2|STARTED|Treatment Period II - 4 Weeks||25
5315881|NCT00448435|13071114|P1|STARTED|Treatment Period II - 4 Weeks||25
5315882|NCT00448435|13071113|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
5315883|NCT00448435|13071114|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
5315884|NCT00448435|13071113|P2|COMPLETED|Washout Period - 2 Weeks||25
5315885|NCT00448435|13071114|P1|COMPLETED|Washout Period - 2 Weeks||25
5315886|NCT00448435|13071113|P2|STARTED|Washout Period - 2 Weeks||25
5315887|NCT00448435|13071114|P1|STARTED|Washout Period - 2 Weeks||26
5315888|NCT00448435|13071113|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
5315889|NCT00448435|13071114|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
5315890|NCT00448435|13071113|P2|COMPLETED|Treatment Period I - 4 Weeks||25
5315891|NCT00448435|13071114|P1|COMPLETED|Treatment Period I - 4 Weeks||26
5315892|NCT00448435|13071113|P2|STARTED|Treatment Period I - 4 Weeks||25
5315893|NCT00448435|13071114|P1|STARTED|Treatment Period I - 4 Weeks||26
5315894|NCT00448357|13071140|P1|NOT COMPLETED|Overall Study||0
5315895|NCT00448357|13071140|P1|COMPLETED|Overall Study||54
5315896|NCT00448357|13071140|P1|STARTED|Overall Study||54
5315897|NCT00448344|13071165|P2|NOT COMPLETED|Overall Study||36
5315898|NCT00448344|13071166|P1|NOT COMPLETED|Overall Study||30
5315899|NCT00448344|13071165|P2|COMPLETED|Overall Study||200
5315900|NCT00448344|13071166|P1|COMPLETED|Overall Study||205
5315901|NCT00448344|13071165|P2|STARTED|Overall Study||236
5315902|NCT00448344|13071166|P1|STARTED|Overall Study||235
5315903|NCT00448279|13071176|P2|NOT COMPLETED|Overall Study||29
5315904|NCT00448279|13071177|P1|NOT COMPLETED|Overall Study||29
5315905|NCT00448279|13071176|P2|COMPLETED|Overall Study||0
5315906|NCT00448279|13071177|P1|COMPLETED|Overall Study||0
5315907|NCT00448279|13071176|P2|STARTED|Overall Study||29
5315908|NCT00448279|13071177|P1|STARTED|Overall Study||29
5315909|NCT00448227|13071193|P1|NOT COMPLETED|Overall Study||0
5315910|NCT00448227|13071193|P1|COMPLETED|Overall Study||18
5315911|NCT00448227|13071193|P1|STARTED|Overall Study||18
5315912|NCT00448201|13071220|P1|NOT COMPLETED|Overall Study||0
5315913|NCT00448201|13071220|P1|COMPLETED|Overall Study||71
5315914|NCT00448201|13071220|P1|STARTED|Overall Study||71
5315915|NCT00448175|13071231|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
5315916|NCT00448175|13071232|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
5315917|NCT00448175|13071231|P2|COMPLETED|Continued PTNS Through 12 Months||0
5315918|NCT00448175|13071232|P1|COMPLETED|Continued PTNS Through 12 Months||25
5315919|NCT00448175|13071231|P2|STARTED|Continued PTNS Through 12 Months||0
5315920|NCT00448175|13071232|P1|STARTED|Continued PTNS Through 12 Months||35
5315921|NCT00448175|13071231|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
5315922|NCT00448175|13071232|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
5315923|NCT00448175|13071231|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
5315924|NCT00448175|13071232|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
5315925|NCT00448175|13071231|P2|STARTED|12 Weeks PTNS vs. Drug||50
5315926|NCT00448175|13071232|P1|STARTED|12 Weeks PTNS vs. Drug||50
5315927|NCT00448136|13071240|P2|NOT COMPLETED|Overall Study||8
5315928|NCT00448136|13071241|P1|NOT COMPLETED|Overall Study||4
5315929|NCT00448136|13071240|P2|COMPLETED|Overall Study||41
5315930|NCT00448136|13071241|P1|COMPLETED|Overall Study||30
5315931|NCT00448136|13071240|P2|STARTED|Overall Study||49
5315932|NCT00448136|13071241|P1|STARTED|Overall Study||34
5315933|NCT00448123|13071279|P2|NOT COMPLETED|Overall Study||12
5315934|NCT00448123|13071280|P1|NOT COMPLETED|Overall Study||15
5315935|NCT00448123|13071279|P2|COMPLETED|Overall Study||53
5315936|NCT00448123|13071280|P1|COMPLETED|Overall Study||47
5315937|NCT00448123|13071279|P2|STARTED|Overall Study||65
5315938|NCT00448123|13071280|P1|STARTED|Overall Study||62
5315939|NCT00448019|13071290|P1|NOT COMPLETED|Overall Study||7
5315940|NCT00448019|13071290|P1|COMPLETED|Overall Study||57
5315941|NCT00448019|13071290|P1|STARTED|Overall Study||64
5315942|NCT00447902|13071298|P2|NOT COMPLETED|Overall Study||6
5315943|NCT00447902|13071299|P1|NOT COMPLETED|Overall Study||4
5315944|NCT00447902|13071298|P2|COMPLETED|Overall Study||0
5315945|NCT00447902|13071299|P1|COMPLETED|Overall Study||1
5315946|NCT00447902|13071298|P2|STARTED|Overall Study||6
5315947|NCT00447902|13071299|P1|STARTED|Overall Study||5
5315948|NCT00447876|13071341|P2|NOT COMPLETED|Overall Study||4
5315949|NCT00447876|13071342|P1|NOT COMPLETED|Overall Study||3
5315950|NCT00447876|13071341|P2|COMPLETED|Overall Study||16
5315951|NCT00447876|13071342|P1|COMPLETED|Overall Study||17
5315952|NCT00447876|13071341|P2|STARTED|Overall Study||20
5315953|NCT00447876|13071342|P1|STARTED|Overall Study||20
5315954|NCT00447772|13071372|P1|NOT COMPLETED|Overall Study||27
5315955|NCT00447772|13071372|P1|COMPLETED|Overall Study||489
5315956|NCT00447772|13071372|P1|STARTED|Overall Study||516
5315957|NCT00447603|13071392|P3|NOT COMPLETED|Filter Period||15
5315958|NCT00447603|13071393|P2|NOT COMPLETED|Filter Period||4
5315959|NCT00447603|13071394|P1|NOT COMPLETED|Filter Period||0
5315960|NCT00447603|13071392|P3|COMPLETED|Filter Period||0
5315961|NCT00447603|13071393|P2|COMPLETED|Filter Period||0
5315962|NCT00447603|13071394|P1|COMPLETED|Filter Period||0
5315963|NCT00447603|13071392|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
5315964|NCT00447603|13071393|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
5315965|NCT00447603|13071394|P1|STARTED|Filter Period||0
5315966|NCT00447603|13071392|P3|NOT COMPLETED|Screening||0
5315967|NCT00447603|13071393|P2|NOT COMPLETED|Screening||0
5315968|NCT00447603|13071394|P1|NOT COMPLETED|Screening||21
5315969|NCT00447603|13071392|P3|COMPLETED|Screening||0
5315970|NCT00447603|13071393|P2|COMPLETED|Screening||0
5315971|NCT00447603|13071394|P1|COMPLETED|Screening||19
5315972|NCT00447603|13071392|P3|STARTED|Screening||0
5315973|NCT00447603|13071393|P2|STARTED|Screening||0
5315974|NCT00447603|13071394|P1|STARTED|Screening||40
5315975|NCT00447590|13071414|P1|NOT COMPLETED|Overall Study||60
5316058|NCT00447057|13071589|P2|COMPLETED|Overall Study||3
5315976|NCT00447590|13071414|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
5315977|NCT00447590|13071414|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
5315978|NCT00447499|13071423|P1|NOT COMPLETED|Overall Study||7
5315979|NCT00447499|13071423|P1|COMPLETED|Overall Study||52
5315980|NCT00447499|13071423|P1|STARTED|Overall Study||59
5315981|NCT00447421|13071433|P1|NOT COMPLETED|Overall Study||6
5315982|NCT00447421|13071433|P1|COMPLETED|Overall Study||3
5315983|NCT00447421|13071433|P1|STARTED|Overall Study||9
5315984|NCT00447382|13071445|P2|NOT COMPLETED|Overall Study||6
5315985|NCT00447382|13071446|P1|NOT COMPLETED|Overall Study||6
5315986|NCT00447382|13071445|P2|COMPLETED|Overall Study||160
5315987|NCT00447382|13071446|P1|COMPLETED|Overall Study||158
5315988|NCT00447382|13071445|P2|STARTED|Overall Study||166
5315989|NCT00447382|13071446|P1|STARTED|Overall Study||164
5315990|NCT00447330|13071498|P1|NOT COMPLETED|Overall Study||2
5315991|NCT00447330|13071498|P1|COMPLETED|Overall Study||58
5315992|NCT00447330|13071498|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
5315993|NCT00447278|13071507|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
5315994|NCT00447278|13071508|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
5315995|NCT00447278|13071507|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
5315996|NCT00447278|13071508|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
5315997|NCT00447278|13071507|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
5315998|NCT00447278|13071508|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
5315999|NCT00447278|13071507|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
5316000|NCT00447278|13071508|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
5316001|NCT00447278|13071507|P2|COMPLETED|Period II (6 Month Open-Label)||171
5316002|NCT00447278|13071508|P1|COMPLETED|Period II (6 Month Open-Label)||157
5316003|NCT00447278|13071507|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
5316004|NCT00447278|13071508|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
5316005|NCT00447278|13071507|P2|STARTED|Period II (6 Month Open-Label)||200
5316006|NCT00447278|13071508|P1|STARTED|Period II (6 Month Open-Label)||199
5316007|NCT00447265|13071529|P2|NOT COMPLETED|Overall Study||0
5316008|NCT00447265|13071530|P1|NOT COMPLETED|Overall Study||1
5316009|NCT00447265|13071529|P2|COMPLETED|Overall Study||0
5316010|NCT00447265|13071530|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
5316011|NCT00447265|13071529|P2|STARTED|Overall Study||0
5316012|NCT00447265|13071530|P1|STARTED|Overall Study||1
5316013|NCT00447226|13071543|P2|NOT COMPLETED|Double-blind Phase||3
5316014|NCT00447226|13071544|P1|NOT COMPLETED|Double-blind Phase||4
5316015|NCT00447226|13071543|P2|COMPLETED|Double-blind Phase||0
5316016|NCT00447226|13071544|P1|COMPLETED|Double-blind Phase||0
5316017|NCT00447226|13071543|P2|STARTED|Double-blind Phase||3
5316018|NCT00447226|13071544|P1|STARTED|Double-blind Phase||4
5316019|NCT00447226|13071543|P2|NOT COMPLETED|12-Week Open-label Phase||25
5316020|NCT00447226|13071544|P1|NOT COMPLETED|12-Week Open-label Phase||0
5316021|NCT00447226|13071543|P2|COMPLETED|12-Week Open-label Phase||7
5316022|NCT00447226|13071544|P1|COMPLETED|12-Week Open-label Phase||0
5316023|NCT00447226|13071543|P2|STARTED|12-Week Open-label Phase||32
5316024|NCT00447226|13071544|P1|STARTED|12-Week Open-label Phase||0
5316025|NCT00447122|13071562|P1|NOT COMPLETED|Overall Study||2
5316026|NCT00447122|13071562|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
5316027|NCT00447122|13071562|P1|STARTED|Overall Study||31
5316028|NCT00447083|13071568|P4|NOT COMPLETED|Phase II||1
5316029|NCT00447083|13071569|P3|NOT COMPLETED|Phase II||1
5316030|NCT00447083|13071570|P2|NOT COMPLETED|Phase II||0
5316031|NCT00447083|13071571|P1|NOT COMPLETED|Phase II||0
5316032|NCT00447083|13071568|P4|COMPLETED|Phase II||7
5316033|NCT00447083|13071569|P3|COMPLETED|Phase II||7
5316034|NCT00447083|13071570|P2|COMPLETED|Phase II||0
5316035|NCT00447083|13071571|P1|COMPLETED|Phase II||0
5316036|NCT00447083|13071568|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
5316037|NCT00447083|13071569|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
5316038|NCT00447083|13071570|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
5316039|NCT00447083|13071571|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
5316040|NCT00447083|13071568|P4|NOT COMPLETED|Phase I||0
5316041|NCT00447083|13071569|P3|NOT COMPLETED|Phase I||0
5316042|NCT00447083|13071570|P2|NOT COMPLETED|Phase I||0
5316043|NCT00447083|13071571|P1|NOT COMPLETED|Phase I||0
5316044|NCT00447083|13071568|P4|COMPLETED|Phase I||0
5316045|NCT00447083|13071569|P3|COMPLETED|Phase I||0
5316046|NCT00447083|13071570|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
5316047|NCT00447083|13071571|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
5316048|NCT00447083|13071568|P4|STARTED|Phase I||0
5316049|NCT00447083|13071569|P3|STARTED|Phase I||0
5316050|NCT00447083|13071570|P2|STARTED|Phase I||9
5316051|NCT00447083|13071571|P1|STARTED|Phase I||10
5316052|NCT00447057|13071587|P4|NOT COMPLETED|Overall Study||26
5316053|NCT00447057|13071588|P3|NOT COMPLETED|Overall Study||19
5316054|NCT00447057|13071589|P2|NOT COMPLETED|Overall Study||73
5316055|NCT00447057|13071590|P1|NOT COMPLETED|Overall Study||83
5316056|NCT00447057|13071587|P4|COMPLETED|Overall Study||0
5316057|NCT00447057|13071588|P3|COMPLETED|Overall Study||0
5316059|NCT00447057|13071590|P1|COMPLETED|Overall Study||0
5316060|NCT00447057|13071587|P4|STARTED|Overall Study||26
5316061|NCT00447057|13071588|P3|STARTED|Overall Study||19
5316062|NCT00447057|13071589|P2|STARTED|Overall Study||76
5316063|NCT00447057|13071590|P1|STARTED|Overall Study||83
5316064|NCT00447005|13071608|P1|NOT COMPLETED|Overall Study||12
5316065|NCT00447005|13071608|P1|COMPLETED|Overall Study||0
5316066|NCT00447005|13071608|P1|STARTED|Overall Study||12
5316067|NCT00446992|13071622|P1|NOT COMPLETED|Overall Study||16
5316068|NCT00446992|13071622|P1|COMPLETED|Overall Study|Intervention Completion|14
5316069|NCT00446992|13071622|P1|STARTED|Overall Study|Beginning of Intervention|30
5316070|NCT00446966|13071636|P2|NOT COMPLETED|Overall Study||7
5316071|NCT00446966|13071637|P1|NOT COMPLETED|Overall Study||10
5316072|NCT00446966|13071636|P2|COMPLETED|Overall Study||123
5316073|NCT00446966|13071637|P1|COMPLETED|Overall Study||120
5316074|NCT00446966|13071636|P2|STARTED|Overall Study||130
5316075|NCT00446966|13071637|P1|STARTED|Overall Study||130
5316076|NCT00446849|13071643|P1|NOT COMPLETED|Maintenance Phase||70
5316077|NCT00446849|13071643|P1|COMPLETED|Maintenance Phase||138
5316078|NCT00446849|13071643|P1|STARTED|Maintenance Phase||208
5316079|NCT00446849|13071643|P1|NOT COMPLETED|Acute Phase||82
5316080|NCT00446849|13071643|P1|COMPLETED|Acute Phase||56
5316081|NCT00446849|13071643|P1|STARTED|Acute Phase||138
5316082|NCT00446797|13071655|P2|NOT COMPLETED|Overall Study||12
5316083|NCT00446797|13071656|P1|NOT COMPLETED|Overall Study||8
5316084|NCT00446797|13071655|P2|COMPLETED|Overall Study||125
5316085|NCT00446797|13071656|P1|COMPLETED|Overall Study||133
5316086|NCT00446797|13071655|P2|STARTED|Overall Study||137
5316087|NCT00446797|13071656|P1|STARTED|Overall Study||141
5316088|NCT00446654|13071702|P2|NOT COMPLETED|Overall Study||0
5316089|NCT00446654|13071703|P1|NOT COMPLETED|Overall Study||2
5316090|NCT00446654|13071702|P2|COMPLETED|Overall Study||22
5316091|NCT00446654|13071703|P1|COMPLETED|Overall Study||19
5316092|NCT00446654|13071702|P2|STARTED|Overall Study||22
5316093|NCT00446654|13071703|P1|STARTED|Overall Study||21
5316094|NCT00446641|13071711|P2|NOT COMPLETED|Overall Study||10
5316095|NCT00446641|13071712|P1|NOT COMPLETED|Overall Study||17
5316096|NCT00446641|13071711|P2|COMPLETED|Overall Study||109
5316097|NCT00446641|13071712|P1|COMPLETED|Overall Study||108
5316098|NCT00446641|13071711|P2|STARTED|Overall Study||119
5316099|NCT00446641|13071712|P1|STARTED|Overall Study||125
5316100|NCT00446563|13071732|P2|NOT COMPLETED|Overall Study||9
5316101|NCT00446563|13071733|P1|NOT COMPLETED|Overall Study||7
5316102|NCT00446563|13071732|P2|COMPLETED|Overall Study||38
5316103|NCT00446563|13071733|P1|COMPLETED|Overall Study||36
5316104|NCT00446563|13071732|P2|STARTED|Overall Study||47
5316105|NCT00446563|13071733|P1|STARTED|Overall Study||43
5316106|NCT00446550|13071769|P2|NOT COMPLETED|Overall Study||0
5316107|NCT00446550|13071770|P1|NOT COMPLETED|Overall Study||1
5316108|NCT00446550|13071769|P2|COMPLETED|Overall Study||8
5316109|NCT00446550|13071770|P1|COMPLETED|Overall Study||10
5316110|NCT00446550|13071769|P2|PD Population|Overall Study||8
5316111|NCT00446550|13071770|P1|PD Population|Overall Study||11
5316112|NCT00446550|13071769|P2|Safety Population|Overall Study||8
5316113|NCT00446550|13071770|P1|Safety Population|Overall Study||11
5316114|NCT00446550|13071769|P2|STARTED|Overall Study||8
5316115|NCT00446550|13071770|P1|STARTED|Overall Study||11
5316116|NCT00446511|13071782|P4|NOT COMPLETED|Overall Study||6
5316117|NCT00446511|13071783|P3|NOT COMPLETED|Overall Study||7
5316118|NCT00446511|13071784|P2|NOT COMPLETED|Overall Study||2
5316119|NCT00446511|13071785|P1|NOT COMPLETED|Overall Study||10
5316120|NCT00446511|13071782|P4|COMPLETED|Overall Study||103
5316121|NCT00446511|13071783|P3|COMPLETED|Overall Study||96
5316122|NCT00446511|13071784|P2|COMPLETED|Overall Study||15
5316123|NCT00446511|13071785|P1|COMPLETED|Overall Study||11
5316124|NCT00446511|13071782|P4|STARTED|Overall Study||109
5316125|NCT00446511|13071783|P3|STARTED|Overall Study||103
5316126|NCT00446511|13071784|P2|STARTED|Overall Study||17
5316127|NCT00446511|13071785|P1|STARTED|Overall Study||21
5316128|NCT00446459|13071809|P1|NOT COMPLETED|12 Months||18
5316129|NCT00446459|13071809|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
5316130|NCT00446459|13071809|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
5316131|NCT00446459|13071809|P1|NOT COMPLETED|8 Months||12
5316132|NCT00446459|13071809|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
5316133|NCT00446459|13071809|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
5316134|NCT00446446|13071817|P1|NOT COMPLETED|Overall Study||24
5316135|NCT00446446|13071817|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
5316136|NCT00446446|13071817|P1|STARTED|Overall Study||52
5316137|NCT00446290|13071828|P1|NOT COMPLETED|Overall Study||0
5316138|NCT00446290|13071828|P1|COMPLETED|Overall Study||22
5316139|NCT00446290|13071828|P1|STARTED|Overall Study||22
5316140|NCT00446264|13071832|P1|NOT COMPLETED|Overall Study||0
5316141|NCT00446264|13071832|P1|COMPLETED|Overall Study||14
5316142|NCT00446264|13071832|P1|STARTED|Overall Study||14
5316143|NCT00446251|13071841|P1|NOT COMPLETED|Overall Study||5
5316144|NCT00446251|13071841|P1|COMPLETED|Overall Study||9
5316145|NCT00446251|13071841|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
5316146|NCT00446199|13071851|P4|NOT COMPLETED|Overall Study||30
5316147|NCT00446199|13071852|P3|NOT COMPLETED|Overall Study||27
5316148|NCT00446199|13071853|P2|NOT COMPLETED|Overall Study||20
5316149|NCT00446199|13071854|P1|NOT COMPLETED|Overall Study||23
5316150|NCT00446199|13071851|P4|COMPLETED|Overall Study||153
5316151|NCT00446199|13071852|P3|COMPLETED|Overall Study||158
5316152|NCT00446199|13071853|P2|COMPLETED|Overall Study||164
5316153|NCT00446199|13071854|P1|COMPLETED|Overall Study||160
5316154|NCT00446199|13071851|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
5316155|NCT00446199|13071852|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
5316156|NCT00446199|13071853|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
5316157|NCT00446199|13071854|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
5316158|NCT00446199|13071851|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
5316159|NCT00446199|13071852|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
5316160|NCT00446199|13071853|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
5316161|NCT00446199|13071854|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
5316162|NCT00446199|13071851|P4|STARTED|Overall Study||183
5316163|NCT00446199|13071852|P3|STARTED|Overall Study||185
5316164|NCT00446199|13071853|P2|STARTED|Overall Study||184
5316165|NCT00446199|13071854|P1|STARTED|Overall Study||183
5316166|NCT00446147|13071934|P2|NOT COMPLETED|Overall Study||14
5316167|NCT00446147|13071935|P1|NOT COMPLETED|Overall Study||15
5316168|NCT00446147|13071934|P2|COMPLETED|Overall Study||180
5316169|NCT00446147|13071935|P1|COMPLETED|Overall Study||180
5316170|NCT00446147|13071934|P2|STARTED|Overall Study||194
5316171|NCT00446147|13071935|P1|STARTED|Overall Study||195
5316172|NCT00446134|13071947|P4|NOT COMPLETED|Overall Study||45
5316173|NCT00446134|13071948|P3|NOT COMPLETED|Overall Study||43
5316174|NCT00446134|13071949|P2|NOT COMPLETED|Overall Study||45
5316175|NCT00446134|13071950|P1|NOT COMPLETED|Overall Study||34
5316176|NCT00446134|13071947|P4|COMPLETED|Overall Study||25
5316177|NCT00446134|13071948|P3|COMPLETED|Overall Study||26
5316178|NCT00446134|13071949|P2|COMPLETED|Overall Study||25
5316179|NCT00446134|13071950|P1|COMPLETED|Overall Study||35
5316180|NCT00446134|13071947|P4|STARTED|Overall Study||70
5316181|NCT00446134|13071948|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
5316182|NCT00446134|13071949|P2|STARTED|Overall Study||70
5316183|NCT00446134|13071950|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
5316184|NCT00446095|13071977|P5|NOT COMPLETED|Phase I (28 Days)||3
5316185|NCT00446095|13071978|P4|NOT COMPLETED|Phase I (28 Days)||1
5316186|NCT00446095|13071979|P3|NOT COMPLETED|Phase I (28 Days)||0
5316187|NCT00446095|13071980|P2|NOT COMPLETED|Phase I (28 Days)||0
5316188|NCT00446095|13071981|P1|NOT COMPLETED|Phase I (28 Days)||0
5316189|NCT00446095|13071977|P5|COMPLETED|Phase I (28 Days)||4
5316190|NCT00446095|13071978|P4|COMPLETED|Phase I (28 Days)||5
5316191|NCT00446095|13071979|P3|COMPLETED|Phase I (28 Days)||0
5316192|NCT00446095|13071980|P2|COMPLETED|Phase I (28 Days)||0
5316193|NCT00446095|13071981|P1|COMPLETED|Phase I (28 Days)||0
5316194|NCT00446095|13071977|P5|STARTED|Phase I (28 Days)||7
5316195|NCT00446095|13071978|P4|STARTED|Phase I (28 Days)||6
5316196|NCT00446095|13071979|P3|STARTED|Phase I (28 Days)||0
5316197|NCT00446095|13071980|P2|STARTED|Phase I (28 Days)||0
5316198|NCT00446095|13071981|P1|STARTED|Phase I (28 Days)||0
5316199|NCT00446095|13071977|P5|NOT COMPLETED|Phase II (8 Weeks)||0
5316200|NCT00446095|13071978|P4|NOT COMPLETED|Phase II (8 Weeks)||0
5316201|NCT00446095|13071979|P3|NOT COMPLETED|Phase II (8 Weeks)||3
5316202|NCT00446095|13071980|P2|NOT COMPLETED|Phase II (8 Weeks)||3
5316203|NCT00446095|13071981|P1|NOT COMPLETED|Phase II (8 Weeks)||12
5316204|NCT00446095|13071977|P5|COMPLETED|Phase II (8 Weeks)||0
5316205|NCT00446095|13071978|P4|COMPLETED|Phase II (8 Weeks)||0
5316206|NCT00446095|13071979|P3|COMPLETED|Phase II (8 Weeks)||21
5316207|NCT00446095|13071980|P2|COMPLETED|Phase II (8 Weeks)||18
5316208|NCT00446095|13071981|P1|COMPLETED|Phase II (8 Weeks)||11
5316209|NCT00446095|13071977|P5|STARTED|Phase II (8 Weeks)||0
5316210|NCT00446095|13071978|P4|STARTED|Phase II (8 Weeks)||0
5316211|NCT00446095|13071979|P3|STARTED|Phase II (8 Weeks)||24
5316212|NCT00446095|13071980|P2|STARTED|Phase II (8 Weeks)||21
5316213|NCT00446095|13071981|P1|STARTED|Phase II (8 Weeks)||23
5316214|NCT00446030|13072004|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
5316215|NCT00446030|13072005|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
5316216|NCT00446030|13072004|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
5316217|NCT00446030|13072005|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
5316218|NCT00446030|13072004|P2|STARTED|FOLLOW-UP (up to 2-years)||34
5316219|NCT00446030|13072005|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
5316220|NCT00446030|13072004|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
5316221|NCT00446030|13072005|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
5316222|NCT00446030|13072004|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
5316223|NCT00446030|13072005|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
5316224|NCT00446030|13072004|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
5316225|NCT00446030|13072005|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
5316226|NCT00446030|13072004|P2|STARTED|TREATMENT (up to 52 Weeks)||34
5316227|NCT00446030|13072005|P1|STARTED|TREATMENT (up to 52 Weeks)||93
5316228|NCT00445939|13072016|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
5316229|NCT00445939|13072017|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
5316230|NCT00445939|13072018|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
5316231|NCT00445939|13072019|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
5316232|NCT00445939|13072016|P4|COMPLETED|Period B - Week 4 - Week 8||20
5316233|NCT00445939|13072017|P3|COMPLETED|Period B - Week 4 - Week 8||0
5316234|NCT00445939|13072018|P2|COMPLETED|Period B - Week 4 - Week 8||0
5316235|NCT00445939|13072019|P1|COMPLETED|Period B - Week 4 - Week 8||14
5316236|NCT00445939|13072016|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
5316237|NCT00445939|13072017|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
5316238|NCT00445939|13072018|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
5316239|NCT00445939|13072019|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
5316240|NCT00445939|13072016|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
5316241|NCT00445939|13072017|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
5316242|NCT00445939|13072018|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
5316243|NCT00445939|13072019|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
5316244|NCT00445939|13072016|P4|COMPLETED|Period A - Week 0 - Week 4||0
5316245|NCT00445939|13072017|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
5316246|NCT00445939|13072018|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
5316247|NCT00445939|13072019|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
5316248|NCT00445939|13072016|P4|STARTED|Period A - Week 0 - Week 4||0
5316249|NCT00445939|13072017|P3|STARTED|Period A - Week 0 - Week 4||23
5316250|NCT00445939|13072018|P2|STARTED|Period A - Week 0 - Week 4||34
5316251|NCT00445939|13072019|P1|STARTED|Period A - Week 0 - Week 4||33
5316252|NCT00445887|13072044|P2|NOT COMPLETED|Overall Study||0
5316253|NCT00445887|13072045|P1|NOT COMPLETED|Overall Study||0
5316254|NCT00445887|13072044|P2|COMPLETED|Overall Study||31
5316255|NCT00445887|13072045|P1|COMPLETED|Overall Study||33
5316256|NCT00445887|13072044|P2|STARTED|Overall Study||31
5316257|NCT00445887|13072045|P1|STARTED|Overall Study||33
5316258|NCT00445848|13072067|P1|NOT COMPLETED|Overall Study||85
5316259|NCT00445848|13072067|P1|COMPLETED|Overall Study||0
5316260|NCT00445848|13072067|P1|STARTED|Overall Study||85
5316261|NCT00445770|13072077|P3|NOT COMPLETED|Overall Study||31
5316262|NCT00445770|13072078|P2|NOT COMPLETED|Overall Study||35
5316263|NCT00445770|13072079|P1|NOT COMPLETED|Overall Study||53
5316264|NCT00445770|13072077|P3|COMPLETED|Overall Study||151
5316265|NCT00445770|13072078|P2|COMPLETED|Overall Study||157
5316266|NCT00445770|13072079|P1|COMPLETED|Overall Study||123
5316267|NCT00445770|13072077|P3|STARTED|Overall Study||182
5316268|NCT00445770|13072078|P2|STARTED|Overall Study||192
5316269|NCT00445770|13072079|P1|STARTED|Overall Study||176
5316270|NCT00445744|13072146|P1|NOT COMPLETED|Overall Study||1
5316271|NCT00445744|13072146|P1|COMPLETED|Overall Study||51
5316272|NCT00445744|13072146|P1|STARTED|Overall Study||52
5316273|NCT00445705|13072155|P4|NOT COMPLETED|Overall Study||14
5316274|NCT00445705|13072156|P3|NOT COMPLETED|Overall Study||11
5316275|NCT00445705|13072157|P2|NOT COMPLETED|Overall Study||11
5316276|NCT00445705|13072158|P1|NOT COMPLETED|Overall Study||9
5316277|NCT00445705|13072155|P4|COMPLETED|Overall Study||39
5316278|NCT00445705|13072156|P3|COMPLETED|Overall Study||41
5316279|NCT00445705|13072157|P2|COMPLETED|Overall Study||42
5316280|NCT00445705|13072158|P1|COMPLETED|Overall Study||44
5316281|NCT00445705|13072155|P4|STARTED|Overall Study||53
5316282|NCT00445705|13072156|P3|STARTED|Overall Study||52
5316283|NCT00445705|13072157|P2|STARTED|Overall Study||53
5316284|NCT00445705|13072158|P1|STARTED|Overall Study||53
5316285|NCT00445692|13072180|P1|NOT COMPLETED|Overall Study||16
5316286|NCT00445692|13072180|P1|COMPLETED|Overall Study||15
5316287|NCT00445692|13072180|P1|STARTED|Overall Study||31
5316288|NCT00445679|13072190|P4|NOT COMPLETED|Overall Study||47
5316289|NCT00445679|13072191|P3|NOT COMPLETED|Overall Study||66
5316290|NCT00445679|13072192|P2|NOT COMPLETED|Overall Study||46
5316291|NCT00445679|13072193|P1|NOT COMPLETED|Overall Study||48
5316292|NCT00445679|13072190|P4|COMPLETED|Overall Study||149
5316293|NCT00445679|13072191|P3|COMPLETED|Overall Study||139
5316294|NCT00445679|13072192|P2|COMPLETED|Overall Study||157
5316295|NCT00445679|13072193|P1|COMPLETED|Overall Study||155
5316296|NCT00445679|13072190|P4|STARTED|Overall Study||196
5316297|NCT00445679|13072191|P3|STARTED|Overall Study||205
5316298|NCT00445679|13072192|P2|STARTED|Overall Study||203
5316299|NCT00445679|13072193|P1|STARTED|Overall Study||203
5316300|NCT00445601|13072229|P2|NOT COMPLETED|Overall Study||28
5316301|NCT00445601|13072230|P1|NOT COMPLETED|Overall Study||33
5316302|NCT00445601|13072229|P2|COMPLETED|Overall Study||177
5316303|NCT00445601|13072230|P1|COMPLETED|Overall Study||168
5316304|NCT00445601|13072229|P2|Received TURBT|Overall Study||193
5316305|NCT00445601|13072230|P1|Received TURBT|Overall Study||190
5316306|NCT00445601|13072229|P2|STARTED|Overall Study||205
5316307|NCT00445601|13072230|P1|STARTED|Overall Study||201
5316308|NCT00445588|13072242|P1|NOT COMPLETED|Overall Study||0
5316309|NCT00445588|13072242|P1|COMPLETED|Overall Study||56
5316310|NCT00445588|13072242|P1|STARTED|Overall Study||56
5316311|NCT00445549|13072247|P1|NOT COMPLETED|Overall Study||12
5316312|NCT00445549|13072247|P1|COMPLETED|Overall Study||0
5316313|NCT00445549|13072247|P1|STARTED|Overall Study||12
5316314|NCT00445484|13072254|P2|NOT COMPLETED|Overall Study||1
5316315|NCT00445484|13072255|P1|NOT COMPLETED|Overall Study||4
5316316|NCT00445484|13072254|P2|COMPLETED|Overall Study||10
5316317|NCT00445484|13072255|P1|COMPLETED|Overall Study||7
5316318|NCT00445484|13072254|P2|STARTED|Overall Study||11
5316319|NCT00445484|13072255|P1|STARTED|Overall Study||11
5316320|NCT00445458|13072271|P4|NOT COMPLETED|Overall Study||28
5316321|NCT00445458|13072272|P3|NOT COMPLETED|Overall Study||68
5316322|NCT00445458|13072273|P2|NOT COMPLETED|Overall Study||5
5316323|NCT00445458|13072274|P1|NOT COMPLETED|Overall Study||3
5316324|NCT00445458|13072271|P4|COMPLETED|Overall Study||3
5316325|NCT00445458|13072272|P3|COMPLETED|Overall Study||3
5316326|NCT00445458|13072273|P2|COMPLETED|Overall Study||0
5316327|NCT00445458|13072274|P1|COMPLETED|Overall Study||0
5316328|NCT00445458|13072271|P4|STARTED|Overall Study||31
5316329|NCT00445458|13072272|P3|STARTED|Overall Study||71
5316330|NCT00445458|13072273|P2|STARTED|Overall Study||5
5316331|NCT00445458|13072274|P1|STARTED|Overall Study||3
5316332|NCT00445432|13072292|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
5316333|NCT00445432|13072293|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
5316334|NCT00445432|13072294|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
5316335|NCT00445432|13072295|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
5316336|NCT00445432|13072292|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
5316337|NCT00445432|13072293|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
5316338|NCT00445432|13072294|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
5316339|NCT00445432|13072295|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
5316340|NCT00445432|13072292|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
5316341|NCT00445432|13072293|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
5316342|NCT00445432|13072294|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
5316343|NCT00445432|13072295|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
5316344|NCT00445432|13072292|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
5316345|NCT00445432|13072293|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
5316346|NCT00445432|13072294|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
5316347|NCT00445432|13072295|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
5316348|NCT00445432|13072292|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
5316349|NCT00445432|13072293|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
5316350|NCT00445432|13072294|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
5316351|NCT00445432|13072295|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
5316352|NCT00445432|13072292|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
5316353|NCT00445432|13072293|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
5316354|NCT00445432|13072294|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
5316355|NCT00445432|13072295|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
5316356|NCT00445341|13072328|P1|NOT COMPLETED|Overall Study||2
5316357|NCT00445341|13072328|P1|COMPLETED|Overall Study||26
5316358|NCT00445341|13072328|P1|STARTED|Overall Study||28
5316359|NCT00445328|13072335|P2|NOT COMPLETED|Overall Study||6
5316360|NCT00445328|13072336|P1|NOT COMPLETED|Overall Study||3
5316361|NCT00445328|13072335|P2|COMPLETED|Overall Study||36
5316362|NCT00445328|13072336|P1|COMPLETED|Overall Study||39
5316363|NCT00445328|13072335|P2|Received Treatment|Overall Study||42
5316364|NCT00445328|13072336|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
5316365|NCT00445328|13072335|P2|STARTED|Overall Study||42
5316366|NCT00445328|13072336|P1|STARTED|Overall Study||42
5316367|NCT00445315|13072359|P5|NOT COMPLETED|Overall Study||0
5316368|NCT00445315|13072360|P4|NOT COMPLETED|Overall Study||0
5316369|NCT00445315|13072361|P3|NOT COMPLETED|Overall Study||0
5316370|NCT00445315|13072362|P2|NOT COMPLETED|Overall Study||0
5316371|NCT00445315|13072363|P1|NOT COMPLETED|Overall Study||0
5316372|NCT00445315|13072359|P5|COMPLETED|Overall Study||8
5316373|NCT00445315|13072360|P4|COMPLETED|Overall Study||6
5316374|NCT00445315|13072361|P3|COMPLETED|Overall Study||6
5316375|NCT00445315|13072362|P2|COMPLETED|Overall Study||6
5316376|NCT00445315|13072363|P1|COMPLETED|Overall Study||6
5316377|NCT00445315|13072359|P5|STARTED|Overall Study||8
5316378|NCT00445315|13072360|P4|STARTED|Overall Study||6
5316379|NCT00445315|13072361|P3|STARTED|Overall Study||6
5316380|NCT00445315|13072362|P2|STARTED|Overall Study||6
5316381|NCT00445315|13072363|P1|STARTED|Overall Study||6
5316382|NCT00445302|13072457|P4|NOT COMPLETED|Overall Study||0
5316383|NCT00445302|13072458|P3|NOT COMPLETED|Overall Study||0
5316384|NCT00445302|13072459|P2|NOT COMPLETED|Overall Study||0
5316385|NCT00445302|13072460|P1|NOT COMPLETED|Overall Study||0
5316386|NCT00445302|13072457|P4|COMPLETED|Overall Study||6
5316387|NCT00445302|13072458|P3|COMPLETED|Overall Study||6
5316388|NCT00445302|13072459|P2|COMPLETED|Overall Study||5
5316389|NCT00445302|13072460|P1|COMPLETED|Overall Study||6
5316390|NCT00445302|13072457|P4|STARTED|Overall Study||6
5316391|NCT00445302|13072458|P3|STARTED|Overall Study||6
5316392|NCT00445302|13072459|P2|STARTED|Overall Study||5
5316393|NCT00445302|13072460|P1|STARTED|Overall Study||6
5316394|NCT00445263|13072488|P2|NOT COMPLETED|Overall Study||1
5316395|NCT00445263|13072489|P1|NOT COMPLETED|Overall Study||0
5316396|NCT00445263|13072488|P2|COMPLETED|Overall Study||86
5316397|NCT00445263|13072489|P1|COMPLETED|Overall Study||83
5316398|NCT00445263|13072488|P2|STARTED|Overall Study||87
5316399|NCT00445263|13072489|P1|STARTED|Overall Study||83
5316400|NCT00445224|13072497|P2|NOT COMPLETED|Combined Exercises||0
5316401|NCT00445224|13072498|P1|NOT COMPLETED|Combined Exercises||0
5316402|NCT00445224|13072497|P2|COMPLETED|Combined Exercises||13
5316403|NCT00445224|13072498|P1|COMPLETED|Combined Exercises||13
5316404|NCT00445224|13072497|P2|STARTED|Combined Exercises||13
5316405|NCT00445224|13072498|P1|STARTED|Combined Exercises||13
5316406|NCT00445224|13072497|P2|NOT COMPLETED|Specific Exercises||3
5316407|NCT00445224|13072498|P1|NOT COMPLETED|Specific Exercises||4
5316408|NCT00445224|13072497|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
5316409|NCT00445224|13072498|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
5316410|NCT00445224|13072497|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
5316411|NCT00445224|13072498|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
5316412|NCT00445224|13072497|P2|Baseline|Specific Exercises||16
5316413|NCT00445224|13072498|P1|Baseline|Specific Exercises||17
5316414|NCT00445224|13072497|P2|STARTED|Specific Exercises||16
5316415|NCT00445224|13072498|P1|STARTED|Specific Exercises||17
5316416|NCT00445211|13072510|P2|NOT COMPLETED|Overall Study||0
5316417|NCT00445211|13072511|P1|NOT COMPLETED|Overall Study||0
5316418|NCT00445211|13072510|P2|COMPLETED|Overall Study||23
5316419|NCT00445211|13072511|P1|COMPLETED|Overall Study||23
5316420|NCT00445211|13072510|P2|STARTED|Overall Study||23
5316421|NCT00445211|13072511|P1|STARTED|Overall Study||23
5316422|NCT00445146|13072525|P1|NOT COMPLETED|Overall Study||119
5316423|NCT00445146|13072525|P1|COMPLETED|Overall Study||73
5316424|NCT00445146|13072525|P1|STARTED|Overall Study||192
5316425|NCT00445003|13072547|P3|NOT COMPLETED|Overall Study||4
5316426|NCT00445003|13072548|P2|NOT COMPLETED|Overall Study||10
5316427|NCT00445003|13072549|P1|NOT COMPLETED|Overall Study||5
5316428|NCT00445003|13072547|P3|COMPLETED|Overall Study||105
5316429|NCT00445003|13072548|P2|COMPLETED|Overall Study||103
5316430|NCT00445003|13072549|P1|COMPLETED|Overall Study||118
5316431|NCT00445003|13072547|P3|STARTED|Overall Study||109
5316432|NCT00445003|13072548|P2|STARTED|Overall Study||113
5316433|NCT00445003|13072549|P1|STARTED|Overall Study||123
5316434|NCT00444951|13072581|P3|NOT COMPLETED|Overall Study||3
5316435|NCT00444951|13072582|P2|NOT COMPLETED|Overall Study||6
5316436|NCT00444951|13072583|P1|NOT COMPLETED|Overall Study||5
5316437|NCT00444951|13072581|P3|COMPLETED|Overall Study||160
5316438|NCT00444951|13072582|P2|COMPLETED|Overall Study||136
5316439|NCT00444951|13072583|P1|COMPLETED|Overall Study||140
5316440|NCT00444951|13072581|P3|STARTED|Overall Study||163
5316441|NCT00444951|13072582|P2|STARTED|Overall Study||142
5316442|NCT00444951|13072583|P1|STARTED|Overall Study||145
5316443|NCT00444925|13072600|P3|NOT COMPLETED|Double-blind Treatment Period||81
5316444|NCT00444925|13072601|P2|NOT COMPLETED|Double-blind Treatment Period||56
5316445|NCT00444925|13072602|P1|NOT COMPLETED|Double-blind Treatment Period||30
5316446|NCT00444925|13072600|P3|COMPLETED|Double-blind Treatment Period||598
5316447|NCT00444925|13072601|P2|COMPLETED|Double-blind Treatment Period||628
5316448|NCT00444925|13072602|P1|COMPLETED|Double-blind Treatment Period||304
5316449|NCT00444925|13072600|P3|STARTED|Double-blind Treatment Period||679
5316450|NCT00444925|13072601|P2|STARTED|Double-blind Treatment Period||684
5316451|NCT00444925|13072602|P1|STARTED|Double-blind Treatment Period||334
5316452|NCT00444925|13072600|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
5316453|NCT00444925|13072601|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
5316454|NCT00444925|13072602|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
5316455|NCT00444925|13072600|P3|COMPLETED|Randomized to Double-blind Treatment||679
5316456|NCT00444925|13072601|P2|COMPLETED|Randomized to Double-blind Treatment||684
5316457|NCT00444925|13072602|P1|COMPLETED|Randomized to Double-blind Treatment||334
5316458|NCT00444925|13072600|P3|STARTED|Randomized to Double-blind Treatment||685
5316459|NCT00444925|13072601|P2|STARTED|Randomized to Double-blind Treatment||690
5316460|NCT00444925|13072602|P1|STARTED|Randomized to Double-blind Treatment||337
5316461|NCT00444925|13072600|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
5316462|NCT00444925|13072601|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
5316463|NCT00444925|13072602|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
5316464|NCT00444925|13072600|P3|COMPLETED|Single-blind Placebo Run-In Period||0
5316465|NCT00444925|13072601|P2|COMPLETED|Single-blind Placebo Run-In Period||0
5316466|NCT00444925|13072602|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
5316467|NCT00444925|13072600|P3|STARTED|Single-blind Placebo Run-In Period||0
5316468|NCT00444925|13072601|P2|STARTED|Single-blind Placebo Run-In Period||0
5316469|NCT00444925|13072602|P1|STARTED|Single-blind Placebo Run-In Period||2446
5316470|NCT00444912|13072666|P2|NOT COMPLETED|Overall Study||2
5316471|NCT00444912|13072667|P1|NOT COMPLETED|Overall Study||3
5316472|NCT00444912|13072666|P2|COMPLETED|Overall Study||13
5316473|NCT00444912|13072667|P1|COMPLETED|Overall Study||12
5316474|NCT00444912|13072666|P2|Received Transplant|Overall Study||14
5316475|NCT00444912|13072667|P1|Received Transplant|Overall Study||14
5316476|NCT00444912|13072666|P2|Received Plerixafor|Overall Study||15
5316477|NCT00444912|13072667|P1|Received Plerixafor|Overall Study||15
5316478|NCT00444912|13072666|P2|STARTED|Overall Study||15
5316479|NCT00444912|13072667|P1|STARTED|Overall Study||15
5316480|NCT00444821|13072697|P2|NOT COMPLETED|Overall Study||366
5316481|NCT00444821|13072698|P1|NOT COMPLETED|Overall Study||362
5316482|NCT00444821|13072697|P2|COMPLETED|Overall Study||0
5316483|NCT00444821|13072698|P1|COMPLETED|Overall Study||0
5316484|NCT00444821|13072697|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
5316485|NCT00444821|13072698|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
5316486|NCT00444821|13072697|P2|STARTED|Overall Study||366
5316487|NCT00444821|13072698|P1|STARTED|Overall Study||362
5316488|NCT00444795|13072708|P1|NOT COMPLETED|Overall Study||3
5316489|NCT00444795|13072708|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
5316490|NCT00444795|13072708|P1|STARTED|Overall Study||620
5316491|NCT00444678|13072713|P1|NOT COMPLETED|Overall Study||31
5316492|NCT00444678|13072713|P1|COMPLETED|Overall Study||5
5316493|NCT00444678|13072713|P1|STARTED|Overall Study||36
5316494|NCT00444626|13072720|P1|NOT COMPLETED|Repeat Treatment Period||0
5316495|NCT00444626|13072720|P1|COMPLETED|Repeat Treatment Period||105
5316496|NCT00444626|13072720|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
5316497|NCT00444626|13072720|P1|NOT COMPLETED|Initial Treatment Period||12
5316498|NCT00444626|13072720|P1|COMPLETED|Initial Treatment Period||128
5316499|NCT00444626|13072720|P1|STARTED|Initial Treatment Period||140
5316500|NCT00444600|13072750|P4|NOT COMPLETED|Overall Study||10
5316501|NCT00444600|13072751|P3|NOT COMPLETED|Overall Study||10
5316502|NCT00444600|13072752|P2|NOT COMPLETED|Overall Study||16
5316503|NCT00444600|13072753|P1|NOT COMPLETED|Overall Study||19
5316504|NCT00444600|13072750|P4|COMPLETED|Overall Study|Number of eyes|176
5316505|NCT00444600|13072751|P3|COMPLETED|Overall Study|Number of eyes|178
5316506|NCT00444600|13072752|P2|COMPLETED|Overall Study|Number of eyes|171
5316507|NCT00444600|13072753|P1|COMPLETED|Overall Study|Number of eyes|274
5316508|NCT00444600|13072750|P4|STARTED|Overall Study|Number of eyes|186
5316509|NCT00444600|13072751|P3|STARTED|Overall Study|Number of eyes|188
5316510|NCT00444600|13072752|P2|STARTED|Overall Study|Number of eyes|187
5316511|NCT00444600|13072753|P1|STARTED|Overall Study|Number of eyes|293
5316512|NCT00444587|13072845|P2|NOT COMPLETED|Overall Study||15
5316513|NCT00444587|13072846|P1|NOT COMPLETED|Overall Study||83
5316514|NCT00444587|13072845|P2|COMPLETED|Overall Study||1
5316515|NCT00444587|13072846|P1|COMPLETED|Overall Study||10
5316516|NCT00444587|13072845|P2|STARTED|Overall Study||16
5316517|NCT00444587|13072846|P1|STARTED|Overall Study||93
5316518|NCT00444535|13072867|P1|NOT COMPLETED|Overall Study||24
5316519|NCT00444535|13072867|P1|COMPLETED|Overall Study||28
5316520|NCT00444535|13072867|P1|STARTED|Overall Study||52
5316521|NCT00444457|13072878|P4|NOT COMPLETED|Toddler Dose||8
5316522|NCT00444457|13072879|P3|NOT COMPLETED|Toddler Dose||4
5316523|NCT00444457|13072880|P2|NOT COMPLETED|Toddler Dose||6
5316524|NCT00444457|13072881|P1|NOT COMPLETED|Toddler Dose||7
5316525|NCT00444457|13072878|P4|COMPLETED|Toddler Dose||200
5316526|NCT00444457|13072879|P3|COMPLETED|Toddler Dose||404
5316527|NCT00444457|13072880|P2|COMPLETED|Toddler Dose||391
5316528|NCT00444457|13072881|P1|COMPLETED|Toddler Dose||408
5316529|NCT00444457|13072878|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
5316530|NCT00444457|13072879|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
5316531|NCT00444457|13072880|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
5316532|NCT00444457|13072881|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
5316533|NCT00444457|13072878|P4|NOT COMPLETED|After Infant Series||10
5316534|NCT00444457|13072879|P3|NOT COMPLETED|After Infant Series||19
5316535|NCT00444457|13072880|P2|NOT COMPLETED|After Infant Series||30
5316536|NCT00444457|13072881|P1|NOT COMPLETED|After Infant Series||20
5316537|NCT00444457|13072878|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
5316538|NCT00444457|13072879|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
5316539|NCT00444457|13072880|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
5316540|NCT00444457|13072881|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
5316541|NCT00444457|13072878|P4|STARTED|After Infant Series||218
5316542|NCT00444457|13072879|P3|STARTED|After Infant Series||427
5316543|NCT00444457|13072880|P2|STARTED|After Infant Series||427
5316544|NCT00444457|13072881|P1|STARTED|After Infant Series||435
5316545|NCT00444457|13072878|P4|NOT COMPLETED|Infant Series||28
5316546|NCT00444457|13072879|P3|NOT COMPLETED|Infant Series||61
5316547|NCT00444457|13072880|P2|NOT COMPLETED|Infant Series||61
5316548|NCT00444457|13072881|P1|NOT COMPLETED|Infant Series||54
5316549|NCT00444457|13072878|P4|COMPLETED|Infant Series||218
5316550|NCT00444457|13072879|P3|COMPLETED|Infant Series||428
5316551|NCT00444457|13072880|P2|COMPLETED|Infant Series||427
5316552|NCT00444457|13072881|P1|COMPLETED|Infant Series||435
5316553|NCT00444457|13072878|P4|Vaccinated Dose 3|Infant Series||225
5316554|NCT00444457|13072879|P3|Vaccinated Dose 3|Infant Series||438
5316555|NCT00444457|13072880|P2|Vaccinated Dose 3|Infant Series||435
5316556|NCT00444457|13072881|P1|Vaccinated Dose 3|Infant Series||442
5316557|NCT00444457|13072878|P4|Vaccinated Dose 2|Infant Series||228
5316558|NCT00444457|13072879|P3|Vaccinated Dose 2|Infant Series||455
5316559|NCT00444457|13072880|P2|Vaccinated Dose 2|Infant Series||447
5316560|NCT00444457|13072881|P1|Vaccinated Dose 2|Infant Series||455
5316561|NCT00444457|13072878|P4|Vaccinated Dose 1|Infant Series||244
5316562|NCT00444457|13072879|P3|Vaccinated Dose 1|Infant Series||485
5316563|NCT00444457|13072880|P2|Vaccinated Dose 1|Infant Series||484
5316564|NCT00444457|13072881|P1|Vaccinated Dose 1|Infant Series||486
5316565|NCT00444457|13072878|P4|STARTED|Infant Series||246
5316566|NCT00444457|13072879|P3|STARTED|Infant Series||489
5316567|NCT00444457|13072880|P2|STARTED|Infant Series||488
5316568|NCT00444457|13072881|P1|STARTED|Infant Series||489
5316569|NCT00444275|13072946|P5|NOT COMPLETED|Maintenance Treatment Phase||179
5316570|NCT00444275|13072947|P4|NOT COMPLETED|Maintenance Treatment Phase||133
5316571|NCT00444275|13072948|P3|NOT COMPLETED|Maintenance Treatment Phase||161
5316572|NCT00444275|13072949|P2|NOT COMPLETED|Maintenance Treatment Phase||0
5316573|NCT00444275|13072950|P1|NOT COMPLETED|Maintenance Treatment Phase||0
5316574|NCT00444275|13072946|P5|COMPLETED|Maintenance Treatment Phase||701
5316575|NCT00444275|13072947|P4|COMPLETED|Maintenance Treatment Phase||764
5316576|NCT00444275|13072948|P3|COMPLETED|Maintenance Treatment Phase||747
5316577|NCT00444275|13072949|P2|COMPLETED|Maintenance Treatment Phase||0
5316578|NCT00444275|13072950|P1|COMPLETED|Maintenance Treatment Phase||0
5316579|NCT00444275|13072946|P5|STARTED|Maintenance Treatment Phase||880
5316580|NCT00444275|13072947|P4|STARTED|Maintenance Treatment Phase||897
5316581|NCT00444275|13072948|P3|STARTED|Maintenance Treatment Phase||908
5316582|NCT00444275|13072949|P2|STARTED|Maintenance Treatment Phase||0
5316583|NCT00444275|13072950|P1|STARTED|Maintenance Treatment Phase||0
5316584|NCT00444275|13072946|P5|NOT COMPLETED|Initial Treatment Phase||0
5316585|NCT00444275|13072947|P4|NOT COMPLETED|Initial Treatment Phase||0
5316586|NCT00444275|13072948|P3|NOT COMPLETED|Initial Treatment Phase||0
5316587|NCT00444275|13072949|P2|NOT COMPLETED|Initial Treatment Phase||96
5316588|NCT00444275|13072950|P1|NOT COMPLETED|Initial Treatment Phase||248
5316589|NCT00444275|13072946|P5|COMPLETED|Initial Treatment Phase||0
5316590|NCT00444275|13072947|P4|COMPLETED|Initial Treatment Phase||0
5316591|NCT00444275|13072948|P3|COMPLETED|Initial Treatment Phase||0
5316592|NCT00444275|13072949|P2|COMPLETED|Initial Treatment Phase||777
5316593|NCT00444275|13072950|P1|COMPLETED|Initial Treatment Phase||1908
5316594|NCT00444275|13072946|P5|STARTED|Initial Treatment Phase||0
5316595|NCT00444275|13072947|P4|STARTED|Initial Treatment Phase||0
5316596|NCT00444275|13072948|P3|STARTED|Initial Treatment Phase||0
5316597|NCT00444275|13072949|P2|STARTED|Initial Treatment Phase||873
5316598|NCT00444275|13072950|P1|STARTED|Initial Treatment Phase||2156
5316599|NCT00444145|13073000|P1|NOT COMPLETED|Overall Study||19
5316600|NCT00444145|13073000|P1|COMPLETED|Overall Study||19
5316601|NCT00444145|13073000|P1|STARTED|Overall Study||38
5316602|NCT00444106|13073007|P3|NOT COMPLETED|Overall Study||1
5316603|NCT00444106|13073008|P2|NOT COMPLETED|Overall Study||1
5316604|NCT00444106|13073009|P1|NOT COMPLETED|Overall Study||2
5316605|NCT00444106|13073007|P3|COMPLETED|Overall Study||52
5316606|NCT00444106|13073008|P2|COMPLETED|Overall Study||52
5316607|NCT00444106|13073009|P1|COMPLETED|Overall Study||157
5316608|NCT00444106|13073007|P3|Completed Treatment Period|Overall Study||53
5316609|NCT00444106|13073008|P2|Completed Treatment Period|Overall Study||53
5316610|NCT00444106|13073009|P1|Completed Treatment Period|Overall Study||159
5316611|NCT00444106|13073007|P3|STARTED|Overall Study||53
5316612|NCT00444106|13073008|P2|STARTED|Overall Study||53
5316613|NCT00444106|13073009|P1|STARTED|Overall Study||159
5316614|NCT00444067|13073026|P2|NOT COMPLETED|Overall Study||1
5316615|NCT00444067|13073027|P1|NOT COMPLETED|Overall Study||0
5316616|NCT00444067|13073026|P2|COMPLETED|Overall Study||23
5316617|NCT00444067|13073027|P1|COMPLETED|Overall Study||74
5316618|NCT00444067|13073026|P2|STARTED|Overall Study||24
5316619|NCT00444067|13073027|P1|STARTED|Overall Study||74
5316620|NCT00444028|13073043|P6|NOT COMPLETED|Overall Study||0
5316621|NCT00444028|13073044|P5|NOT COMPLETED|Overall Study||0
5316622|NCT00444028|13073045|P4|NOT COMPLETED|Overall Study||0
5316623|NCT00444028|13073046|P3|NOT COMPLETED|Overall Study||0
5316624|NCT00444028|13073047|P2|NOT COMPLETED|Overall Study||0
5316625|NCT00444028|13073048|P1|NOT COMPLETED|Overall Study||0
5316626|NCT00444028|13073043|P6|COMPLETED|Overall Study||8
5316627|NCT00444028|13073044|P5|COMPLETED|Overall Study||7
5316628|NCT00444028|13073045|P4|COMPLETED|Overall Study||6
5316629|NCT00444028|13073046|P3|COMPLETED|Overall Study||8
5316630|NCT00444028|13073047|P2|COMPLETED|Overall Study||7
5316631|NCT00444028|13073048|P1|COMPLETED|Overall Study||14
5316632|NCT00444028|13073043|P6|STARTED|Overall Study||8
5316633|NCT00444028|13073044|P5|STARTED|Overall Study||7
5316634|NCT00444028|13073045|P4|STARTED|Overall Study||6
5316635|NCT00444028|13073046|P3|STARTED|Overall Study||8
5316636|NCT00444028|13073047|P2|STARTED|Overall Study||7
5316637|NCT00444028|13073048|P1|STARTED|Overall Study||14
5316638|NCT00443898|13073090|P4|NOT COMPLETED|Overall Study||18
5316639|NCT00443898|13073091|P3|NOT COMPLETED|Overall Study||29
5316640|NCT00443898|13073092|P2|NOT COMPLETED|Overall Study||25
5316641|NCT00443898|13073093|P1|NOT COMPLETED|Overall Study||24
5316642|NCT00443898|13073090|P4|COMPLETED|Overall Study||110
5316643|NCT00443898|13073091|P3|COMPLETED|Overall Study||107
5316644|NCT00443898|13073092|P2|COMPLETED|Overall Study||103
5316645|NCT00443898|13073093|P1|COMPLETED|Overall Study||102
5316646|NCT00443898|13073090|P4|STARTED|Overall Study||128
5316647|NCT00443898|13073091|P3|STARTED|Overall Study||136
5316648|NCT00443898|13073092|P2|STARTED|Overall Study||128
5316649|NCT00443898|13073093|P1|STARTED|Overall Study||126
5316650|NCT00443872|13073115|P1|NOT COMPLETED|Overall Study||17
5316651|NCT00443872|13073115|P1|COMPLETED|Overall Study||60
5316652|NCT00443872|13073115|P1|STARTED|Overall Study||77
5316653|NCT00443846|13073130|P2|NOT COMPLETED|Overall Study||6
5316654|NCT00443846|13073131|P1|NOT COMPLETED|Overall Study||11
5316655|NCT00443846|13073130|P2|COMPLETED|Overall Study||117
5316656|NCT00443846|13073131|P1|COMPLETED|Overall Study||113
5316657|NCT00443846|13073130|P2|Vaccinated|Overall Study||123
5316658|NCT00443846|13073131|P1|Vaccinated|Overall Study||116
5316659|NCT00443846|13073130|P2|STARTED|Overall Study||123
5316660|NCT00443846|13073131|P1|STARTED|Overall Study||124
5316661|NCT00443820|13073141|P4|NOT COMPLETED|Overall Study||17
5316662|NCT00443820|13073142|P3|NOT COMPLETED|Overall Study||18
5316663|NCT00443820|13073143|P2|NOT COMPLETED|Overall Study||19
5316664|NCT00443820|13073144|P1|NOT COMPLETED|Overall Study||21
5316665|NCT00443820|13073141|P4|COMPLETED|Overall Study||111
5316666|NCT00443820|13073142|P3|COMPLETED|Overall Study||117
5316756|NCT00443261|13073458|P1|NOT COMPLETED|Overall Study||1
5316667|NCT00443820|13073143|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
5316668|NCT00443820|13073144|P1|COMPLETED|Overall Study||112
5316669|NCT00443820|13073141|P4|Safety Population|Overall Study||126
5316670|NCT00443820|13073142|P3|Safety Population|Overall Study||134
5316671|NCT00443820|13073143|P2|Safety Population|Overall Study||129
5316672|NCT00443820|13073144|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
5316673|NCT00443820|13073141|P4|STARTED|Overall Study||128
5316674|NCT00443820|13073142|P3|STARTED|Overall Study||135
5316675|NCT00443820|13073143|P2|STARTED|Overall Study||130
5316676|NCT00443820|13073144|P1|STARTED|Overall Study||133
5316677|NCT00443781|13073166|P1|NOT COMPLETED|Overall Study||25
5316678|NCT00443781|13073166|P1|COMPLETED|Overall Study||37
5316679|NCT00443781|13073166|P1|STARTED|Overall Study||62
5316680|NCT00443755|13073172|P2|NOT COMPLETED|Overall Study||1
5316681|NCT00443755|13073173|P1|NOT COMPLETED|Overall Study||2
5316682|NCT00443755|13073172|P2|COMPLETED|Overall Study||13
5316683|NCT00443755|13073173|P1|COMPLETED|Overall Study||12
5316684|NCT00443755|13073172|P2|STARTED|Overall Study||14
5316685|NCT00443755|13073173|P1|STARTED|Overall Study||14
5316686|NCT00443729|13073207|P2|NOT COMPLETED|Overall Study||7
5316687|NCT00443729|13073208|P1|NOT COMPLETED|Overall Study||10
5316688|NCT00443729|13073207|P2|COMPLETED|Overall Study||172
5316689|NCT00443729|13073208|P1|COMPLETED|Overall Study||166
5316690|NCT00443729|13073207|P2|Treated|Overall Study||178
5316691|NCT00443729|13073208|P1|Treated|Overall Study||176
5316692|NCT00443729|13073207|P2|STARTED|Overall Study||179
5316693|NCT00443729|13073208|P1|STARTED|Overall Study||176
5316694|NCT00443703|13073256|P2|NOT COMPLETED|Overall Study||18
5316695|NCT00443703|13073257|P1|NOT COMPLETED|Overall Study||28
5316696|NCT00443703|13073256|P2|COMPLETED|Overall Study||157
5316697|NCT00443703|13073257|P1|COMPLETED|Overall Study||149
5316698|NCT00443703|13073256|P2|Treated|Overall Study||174
5316699|NCT00443703|13073257|P1|Treated|Overall Study||174
5316700|NCT00443703|13073256|P2|STARTED|Overall Study||175
5316701|NCT00443703|13073257|P1|STARTED|Overall Study||177
5316702|NCT00443651|13073309|P2|NOT COMPLETED|Overall Study||58
5316703|NCT00443651|13073310|P1|NOT COMPLETED|Overall Study||95
5316704|NCT00443651|13073309|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
5316705|NCT00443651|13073310|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
5316706|NCT00443651|13073309|P2|Week 48|Overall Study||134
5316707|NCT00443651|13073310|P1|Week 48|Overall Study||338
5316708|NCT00443651|13073309|P2|Week 24|Overall Study||160
5316709|NCT00443651|13073310|P1|Week 24|Overall Study||376
5316710|NCT00443651|13073309|P2|STARTED|Overall Study||176
5316711|NCT00443651|13073310|P1|STARTED|Overall Study||401
5316712|NCT00443599|13073330|P2|NOT COMPLETED|Overall Study||3
5316713|NCT00443599|13073331|P1|NOT COMPLETED|Overall Study||6
5316714|NCT00443599|13073330|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
5316715|NCT00443599|13073331|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
5316716|NCT00443599|13073330|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
5316717|NCT00443599|13073331|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
5316718|NCT00443560|13073365|P2|NOT COMPLETED|Overall Study||30
5316719|NCT00443560|13073366|P1|NOT COMPLETED|Overall Study||60
5316720|NCT00443560|13073365|P2|COMPLETED|Overall Study||1051
5316721|NCT00443560|13073366|P1|COMPLETED|Overall Study||1021
5316722|NCT00443560|13073365|P2|STARTED|Overall Study||1081
5316723|NCT00443560|13073366|P1|STARTED|Overall Study||1081
5316724|NCT00443547|13073380|P4|NOT COMPLETED|Overall Study||2
5316725|NCT00443547|13073381|P3|NOT COMPLETED|Overall Study||21
5316726|NCT00443547|13073382|P2|NOT COMPLETED|Overall Study||42
5316727|NCT00443547|13073383|P1|NOT COMPLETED|Overall Study||45
5316728|NCT00443547|13073380|P4|COMPLETED|Overall Study||4
5316729|NCT00443547|13073381|P3|COMPLETED|Overall Study||27
5316730|NCT00443547|13073382|P2|COMPLETED|Overall Study||46
5316731|NCT00443547|13073383|P1|COMPLETED|Overall Study||44
5316732|NCT00443547|13073380|P4|Evaluated at 12 Months|Overall Study||5
5316733|NCT00443547|13073381|P3|Evaluated at 12 Months|Overall Study||37
5316734|NCT00443547|13073382|P2|Evaluated at 12 Months|Overall Study||55
5316735|NCT00443547|13073383|P1|Evaluated at 12 Months|Overall Study||58
5316736|NCT00443547|13073380|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
5316737|NCT00443547|13073381|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
5316738|NCT00443547|13073382|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
5316739|NCT00443547|13073383|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
5316740|NCT00443534|13073401|P1|NOT COMPLETED|Overall Study||123
5316741|NCT00443534|13073401|P1|COMPLETED|Overall Study||0
5316742|NCT00443534|13073401|P1|Treated|Overall Study||122
5316743|NCT00443534|13073401|P1|STARTED|Overall Study||123
5316744|NCT00443456|13073408|P1|NOT COMPLETED|Overall Study||18
5316745|NCT00443456|13073408|P1|COMPLETED|Overall Study||116
5316746|NCT00443456|13073408|P1|STARTED|Overall Study||134
5316747|NCT00443430|13073443|P2|NOT COMPLETED|Overall Study||4
5316748|NCT00443430|13073444|P1|NOT COMPLETED|Overall Study||4
5316749|NCT00443430|13073443|P2|COMPLETED|Overall Study||38
5316750|NCT00443430|13073444|P1|COMPLETED|Overall Study||39
5316751|NCT00443430|13073443|P2|STARTED|Overall Study||42
5316752|NCT00443430|13073444|P1|STARTED|Overall Study||43
5316753|NCT00443352|13073454|P1|NOT COMPLETED|Overall Study||5
5316754|NCT00443352|13073454|P1|COMPLETED|Overall Study||22
5316755|NCT00443352|13073454|P1|STARTED|Overall Study||27
5316757|NCT00443261|13073458|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
5316758|NCT00443261|13073458|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
5316759|NCT00443261|13073458|P1|STARTED|Overall Study||1
5316760|NCT00443209|13073464|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
5316761|NCT00443209|13073465|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
5316762|NCT00443209|13073464|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
5316763|NCT00443209|13073465|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
5316764|NCT00443209|13073464|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
5316765|NCT00443209|13073465|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
5316766|NCT00443209|13073464|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
5316767|NCT00443209|13073465|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
5316768|NCT00443209|13073464|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
5316769|NCT00443209|13073465|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
5316770|NCT00443209|13073464|P2|Treated|Months 1 to 12 Treatment Period||313
5316771|NCT00443209|13073465|P1|Treated|Months 1 to 12 Treatment Period||641
5316772|NCT00443209|13073464|P2|STARTED|Months 1 to 12 Treatment Period||356
5316773|NCT00443209|13073465|P1|STARTED|Months 1 to 12 Treatment Period||712
5316774|NCT00443118|13073482|P3|NOT COMPLETED|Overall Study||0
5316775|NCT00443118|13073483|P2|NOT COMPLETED|Overall Study||1
5316776|NCT00443118|13073484|P1|NOT COMPLETED|Overall Study||4
5316777|NCT00443118|13073482|P3|COMPLETED|Overall Study||226
5316778|NCT00443118|13073483|P2|COMPLETED|Overall Study||290
5316779|NCT00443118|13073484|P1|COMPLETED|Overall Study||511
5316780|NCT00443118|13073482|P3|STARTED|Overall Study||226
5316781|NCT00443118|13073483|P2|STARTED|Overall Study||291
5316782|NCT00443118|13073484|P1|STARTED|Overall Study||515
5316783|NCT00443053|13073533|P2|NOT COMPLETED|Overall Study||33
5316784|NCT00443053|13073534|P1|NOT COMPLETED|Overall Study||21
5316785|NCT00443053|13073533|P2|COMPLETED|Overall Study||1467
5316786|NCT00443053|13073534|P1|COMPLETED|Overall Study||1481
5316787|NCT00443053|13073533|P2|STARTED|Overall Study||1500
5316788|NCT00443053|13073534|P1|STARTED|Overall Study||1502
5316789|NCT00443040|13073555|P3|NOT COMPLETED|Overall Study||1
5316790|NCT00443040|13073556|P2|NOT COMPLETED|Overall Study||0
5316791|NCT00443040|13073557|P1|NOT COMPLETED|Overall Study||4
5316792|NCT00443040|13073555|P3|COMPLETED|Overall Study||9
5316793|NCT00443040|13073556|P2|COMPLETED|Overall Study||11
5316794|NCT00443040|13073557|P1|COMPLETED|Overall Study||10
5316795|NCT00443040|13073555|P3|STARTED|Overall Study||10
5316796|NCT00443040|13073556|P2|STARTED|Overall Study||11
5316797|NCT00443040|13073557|P1|STARTED|Overall Study||14
5316798|NCT00442962|13073565|P1|NOT COMPLETED|Overall Study||8
5316799|NCT00442962|13073565|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
5316800|NCT00442962|13073565|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
5316801|NCT00442962|13073565|P1|STARTED|Overall Study||54
5316802|NCT00442936|13073583|P4|NOT COMPLETED|Overall Study||1
5316803|NCT00442936|13073584|P3|NOT COMPLETED|Overall Study||1
5316804|NCT00442936|13073585|P2|NOT COMPLETED|Overall Study||0
5316805|NCT00442936|13073586|P1|NOT COMPLETED|Overall Study||1
5316806|NCT00442936|13073583|P4|COMPLETED|Overall Study||347
5316807|NCT00442936|13073584|P3|COMPLETED|Overall Study||344
5316808|NCT00442936|13073585|P2|COMPLETED|Overall Study||354
5316809|NCT00442936|13073586|P1|COMPLETED|Overall Study||332
5316810|NCT00442936|13073583|P4|STARTED|Overall Study||348
5316811|NCT00442936|13073584|P3|STARTED|Overall Study||345
5316812|NCT00442936|13073585|P2|STARTED|Overall Study||354
5316813|NCT00442936|13073586|P1|STARTED|Overall Study||333
5316814|NCT00442897|13073634|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
5316815|NCT00442897|13073635|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
5316816|NCT00442897|13073634|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
5316817|NCT00442897|13073635|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
5316818|NCT00442897|13073634|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
5316819|NCT00442897|13073635|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
5316820|NCT00442897|13073634|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
5316821|NCT00442897|13073635|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
5316822|NCT00442897|13073634|P2|COMPLETED|Base Study (12 Week Follow-up)||99
5316823|NCT00442897|13073635|P1|COMPLETED|Base Study (12 Week Follow-up)||101
5316824|NCT00442897|13073634|P2|STARTED|Base Study (12 Week Follow-up)||111
5316825|NCT00442897|13073635|P1|STARTED|Base Study (12 Week Follow-up)||118
5316826|NCT00442767|13073643|P1|NOT COMPLETED|Overall Study||0
5316827|NCT00442767|13073643|P1|COMPLETED|Overall Study||8
5316828|NCT00442767|13073643|P1|STARTED|Overall Study||8
5316829|NCT00442702|13073653|P2|NOT COMPLETED|Evaluation Period||4
5316830|NCT00442702|13073654|P1|NOT COMPLETED|Evaluation Period||5
5316831|NCT00442702|13073653|P2|COMPLETED|Evaluation Period||107
5316832|NCT00442702|13073654|P1|COMPLETED|Evaluation Period||97
5316833|NCT00442702|13073653|P2|STARTED|Evaluation Period||111
5316834|NCT00442702|13073654|P1|STARTED|Evaluation Period||102
5316835|NCT00442702|13073653|P2|NOT COMPLETED|Titration Period||3
5316836|NCT00442702|13073654|P1|NOT COMPLETED|Titration Period||12
5316837|NCT00442702|13073653|P2|COMPLETED|Titration Period||111
5316838|NCT00442702|13073654|P1|COMPLETED|Titration Period||102
5316839|NCT00442702|13073653|P2|Safety Population|Titration Period||113
5316840|NCT00442702|13073654|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
5316841|NCT00442702|13073653|P2|STARTED|Titration Period||114
5316842|NCT00442702|13073654|P1|STARTED|Titration Period||114
5316843|NCT00442689|13073669|P3|NOT COMPLETED|Overall Study||9
5316844|NCT00442689|13073670|P2|NOT COMPLETED|Overall Study||11
5316845|NCT00442689|13073671|P1|NOT COMPLETED|Overall Study||10
5316846|NCT00442689|13073669|P3|COMPLETED|Overall Study||13
5316847|NCT00442689|13073670|P2|COMPLETED|Overall Study||13
5316848|NCT00442689|13073671|P1|COMPLETED|Overall Study||11
5316849|NCT00442689|13073669|P3|STARTED|Overall Study||22
5316850|NCT00442689|13073670|P2|STARTED|Overall Study||24
5316851|NCT00442689|13073671|P1|STARTED|Overall Study||21
5316852|NCT00442611|13073699|P2|NOT COMPLETED|Overall Study||0
5316853|NCT00442611|13073700|P1|NOT COMPLETED|Overall Study||1
5316854|NCT00442611|13073699|P2|COMPLETED|Overall Study||3
5316855|NCT00442611|13073700|P1|COMPLETED|Overall Study||6
5316856|NCT00442611|13073699|P2|STARTED|Overall Study||3
5316857|NCT00442611|13073700|P1|STARTED|Overall Study||7
5316858|NCT00442598|13073719|P3|NOT COMPLETED|Overall Study||0
5316859|NCT00442598|13073720|P2|NOT COMPLETED|Overall Study||8
5316860|NCT00442598|13073721|P1|NOT COMPLETED|Overall Study||6
5316861|NCT00442598|13073719|P3|COMPLETED|Overall Study||0
5316862|NCT00442598|13073720|P2|COMPLETED|Overall Study||2
5316863|NCT00442598|13073721|P1|COMPLETED|Overall Study||1
5316864|NCT00442598|13073719|P3|Two Cycles|Overall Study||0
5316865|NCT00442598|13073720|P2|Two Cycles|Overall Study||6
5316866|NCT00442598|13073721|P1|Two Cycles|Overall Study||5
5316867|NCT00442598|13073719|P3|STARTED|Overall Study||0
5316868|NCT00442598|13073720|P2|STARTED|Overall Study||10
5316869|NCT00442598|13073721|P1|STARTED|Overall Study||7
5316870|NCT00442572|13073739|P2|NOT COMPLETED|Overall Study||3
5316871|NCT00442572|13073740|P1|NOT COMPLETED|Overall Study||8
5316872|NCT00442572|13073739|P2|COMPLETED|Overall Study||1
5316873|NCT00442572|13073740|P1|COMPLETED|Overall Study||9
5316874|NCT00442572|13073739|P2|STARTED|Overall Study||4
5316875|NCT00442572|13073740|P1|STARTED|Overall Study||17
5316876|NCT00442559|13073780|P2|NOT COMPLETED|Overall Study||35
5316877|NCT00442559|13073781|P1|NOT COMPLETED|Overall Study||34
5316878|NCT00442559|13073780|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
5316879|NCT00442559|13073781|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
5316880|NCT00442559|13073780|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
5316881|NCT00442559|13073781|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
5316882|NCT00442559|13073780|P2|STARTED|Overall Study||91
5316883|NCT00442559|13073781|P1|STARTED|Overall Study||100
5316884|NCT00442546|13073796|P3|NOT COMPLETED|Overall Study||33
5316885|NCT00442546|13073797|P2|NOT COMPLETED|Overall Study||37
5316886|NCT00442546|13073798|P1|NOT COMPLETED|Overall Study||26
5316887|NCT00442546|13073796|P3|COMPLETED|Overall Study||71
5316888|NCT00442546|13073797|P2|COMPLETED|Overall Study||63
5316889|NCT00442546|13073798|P1|COMPLETED|Overall Study||77
5316890|NCT00442546|13073796|P3|Received Treatment|Overall Study||98
5316891|NCT00442546|13073797|P2|Received Treatment|Overall Study||96
5316892|NCT00442546|13073798|P1|Received Treatment|Overall Study||98
5316893|NCT00442546|13073796|P3|STARTED|Overall Study||104
5316894|NCT00442546|13073797|P2|STARTED|Overall Study||100
5316895|NCT00442546|13073798|P1|STARTED|Overall Study||103
5316896|NCT00442507|13073920|P1|NOT COMPLETED|Overall Study||0
5316897|NCT00442507|13073920|P1|COMPLETED|Overall Study||6
5316898|NCT00442507|13073920|P1|STARTED|Overall Study||6
5316899|NCT00442468|13073927|P1|NOT COMPLETED|Overall Study||183
5316900|NCT00442468|13073927|P1|COMPLETED|Overall Study||1100
5316901|NCT00442468|13073927|P1|STARTED|Overall Study||1283
5316902|NCT00442416|13073957|P2|NOT COMPLETED|Overall Study||39
5316903|NCT00442416|13073958|P1|NOT COMPLETED|Overall Study||37
5316904|NCT00442416|13073957|P2|COMPLETED|Overall Study||2
5316905|NCT00442416|13073958|P1|COMPLETED|Overall Study||2
5316906|NCT00442416|13073957|P2|STARTED|Overall Study||41
5316907|NCT00442416|13073958|P1|STARTED|Overall Study||39
5316908|NCT00442364|13073991|P1|NOT COMPLETED|Overall Study||0
5316909|NCT00442364|13073991|P1|COMPLETED|Overall Study||60
5316910|NCT00442364|13073991|P1|STARTED|Overall Study||60
5316911|NCT00442351|13073997|P2|NOT COMPLETED|Overall Study||6
5316912|NCT00442351|13073998|P1|NOT COMPLETED|Overall Study||7
5316913|NCT00442351|13073997|P2|COMPLETED|Overall Study||3
5316914|NCT00442351|13073998|P1|COMPLETED|Overall Study||10
5316915|NCT00442351|13073997|P2|STARTED|Overall Study||9
5316916|NCT00442351|13073998|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
5316917|NCT00442338|13074007|P3|NOT COMPLETED|Overall Study||0
5316918|NCT00442338|13074008|P2|NOT COMPLETED|Overall Study||0
5316919|NCT00442338|13074009|P1|NOT COMPLETED|Overall Study||0
5316920|NCT00442338|13074007|P3|COMPLETED|Overall Study||31
5316921|NCT00442338|13074008|P2|COMPLETED|Overall Study||30
5316922|NCT00442338|13074009|P1|COMPLETED|Overall Study||30
5316923|NCT00442338|13074007|P3|STARTED|Overall Study||31
5316924|NCT00442338|13074008|P2|STARTED|Overall Study||30
5316925|NCT00442338|13074009|P1|STARTED|Overall Study||30
5316926|NCT00442286|13074020|P2|NOT COMPLETED|Overall Study||2
5316927|NCT00442286|13074021|P1|NOT COMPLETED|Overall Study||7
5316928|NCT00442286|13074020|P2|COMPLETED|Overall Study||82
5316929|NCT00442286|13074021|P1|COMPLETED|Overall Study||174
5316930|NCT00442286|13074020|P2|12 Months|Overall Study||82
5316931|NCT00442286|13074021|P1|12 Months|Overall Study||174
5316932|NCT00442286|13074020|P2|6 Months|Overall Study||83
5316933|NCT00442286|13074021|P1|6 Months|Overall Study||177
5316934|NCT00442286|13074020|P2|STARTED|Overall Study||84
5316935|NCT00442286|13074021|P1|STARTED|Overall Study||181
5316936|NCT00442169|13074038|P6|NOT COMPLETED|Part 2||0
5316937|NCT00442169|13074039|P5|NOT COMPLETED|Part 2||0
5316938|NCT00442169|13074040|P4|NOT COMPLETED|Part 2||0
5316939|NCT00442169|13074041|P3|NOT COMPLETED|Part 2||0
5316940|NCT00442169|13074042|P2|NOT COMPLETED|Part 2||0
5316941|NCT00442169|13074043|P1|NOT COMPLETED|Part 2||0
5316942|NCT00442169|13074038|P6|COMPLETED|Part 2||57
5316943|NCT00442169|13074039|P5|COMPLETED|Part 2||25
5316944|NCT00442169|13074040|P4|COMPLETED|Part 2||0
5316945|NCT00442169|13074041|P3|COMPLETED|Part 2||0
5316946|NCT00442169|13074042|P2|COMPLETED|Part 2||0
5316947|NCT00442169|13074043|P1|COMPLETED|Part 2||0
5316948|NCT00442169|13074038|P6|STARTED|Part 2||57
5316949|NCT00442169|13074039|P5|STARTED|Part 2||25
5316950|NCT00442169|13074040|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
5316951|NCT00442169|13074041|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
5316952|NCT00442169|13074042|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
5316953|NCT00442169|13074043|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
5316954|NCT00442169|13074038|P6|NOT COMPLETED|Part 1||0
5316955|NCT00442169|13074039|P5|NOT COMPLETED|Part 1||0
5316956|NCT00442169|13074040|P4|NOT COMPLETED|Part 1||0
5316957|NCT00442169|13074041|P3|NOT COMPLETED|Part 1||0
5316958|NCT00442169|13074042|P2|NOT COMPLETED|Part 1||0
5316959|NCT00442169|13074043|P1|NOT COMPLETED|Part 1||0
5316960|NCT00442169|13074038|P6|COMPLETED|Part 1||0
5316961|NCT00442169|13074039|P5|COMPLETED|Part 1||0
5316962|NCT00442169|13074040|P4|COMPLETED|Part 1||31
5316963|NCT00442169|13074041|P3|COMPLETED|Part 1||40
5316964|NCT00442169|13074042|P2|COMPLETED|Part 1||24
5316965|NCT00442169|13074043|P1|COMPLETED|Part 1||17
5316966|NCT00442169|13074038|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
5316967|NCT00442169|13074039|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
5316968|NCT00442169|13074040|P4|STARTED|Part 1||31
5316969|NCT00442169|13074041|P3|STARTED|Part 1||40
5316970|NCT00442169|13074042|P2|STARTED|Part 1||24
5316971|NCT00442169|13074043|P1|STARTED|Part 1||17
5316972|NCT00442117|13074083|P2|NOT COMPLETED|Overall Study||38
5316973|NCT00442117|13074084|P1|NOT COMPLETED|Overall Study||38
5316974|NCT00442117|13074083|P2|COMPLETED|Overall Study||49
5316975|NCT00442117|13074084|P1|COMPLETED|Overall Study||47
5316976|NCT00442117|13074083|P2|STARTED|Overall Study||87
5316977|NCT00442117|13074084|P1|STARTED|Overall Study||85
5316978|NCT00442013|13074098|P2|NOT COMPLETED|Overall Study||17
5316979|NCT00442013|13074099|P1|NOT COMPLETED|Overall Study||26
5316980|NCT00442013|13074098|P2|COMPLETED|Overall Study||132
5316981|NCT00442013|13074099|P1|COMPLETED|Overall Study||131
5316982|NCT00442013|13074098|P2|STARTED|Overall Study||149
5316983|NCT00442013|13074099|P1|STARTED|Overall Study||157
5316984|NCT00441974|13074115|P1|NOT COMPLETED|Overall Study||128
5316985|NCT00441974|13074115|P1|COMPLETED|Overall Study||1342
5316986|NCT00441974|13074115|P1|STARTED|Overall Study||1470
5316987|NCT00441792|13074131|P2|NOT COMPLETED|Overall Study||2
5316988|NCT00441792|13074132|P1|NOT COMPLETED|Overall Study||0
5316989|NCT00441792|13074131|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
5316990|NCT00441792|13074132|P1|COMPLETED|Overall Study||59
5316991|NCT00441792|13074131|P2|STARTED|Overall Study||63
5316992|NCT00441792|13074132|P1|STARTED|Overall Study||59
5316993|NCT00441766|13074144|P4|NOT COMPLETED|Overall Study||6
5316994|NCT00441766|13074145|P3|NOT COMPLETED|Overall Study||9
5316995|NCT00441766|13074146|P2|NOT COMPLETED|Overall Study||7
5316996|NCT00441766|13074147|P1|NOT COMPLETED|Overall Study||14
5316997|NCT00441766|13074144|P4|COMPLETED|Overall Study||48
5316998|NCT00441766|13074145|P3|COMPLETED|Overall Study||44
5316999|NCT00441766|13074146|P2|COMPLETED|Overall Study||46
5317000|NCT00441766|13074147|P1|COMPLETED|Overall Study||39
5317001|NCT00441766|13074144|P4|STARTED|Overall Study||54
5317002|NCT00441766|13074145|P3|STARTED|Overall Study||53
5317003|NCT00441766|13074146|P2|STARTED|Overall Study||53
5317004|NCT00441766|13074147|P1|STARTED|Overall Study||53
5317005|NCT00441727|13074172|P3|NOT COMPLETED|Overall Study||168
5317006|NCT00441727|13074173|P2|NOT COMPLETED|Overall Study||118
5317007|NCT00441727|13074174|P1|NOT COMPLETED|Overall Study||106
5317008|NCT00441727|13074172|P3|COMPLETED|Overall Study|ITT/randomised|637
5317009|NCT00441727|13074173|P2|COMPLETED|Overall Study|ITT/randomised|686
5317010|NCT00441727|13074174|P1|COMPLETED|Overall Study|ITT/randomised|711
5317011|NCT00441727|13074172|P3|STARTED|Overall Study|ITT/randomised|805
5317012|NCT00441727|13074173|P2|STARTED|Overall Study|ITT/randomised|804
5317013|NCT00441727|13074174|P1|STARTED|Overall Study|ITT/randomised|817
5317014|NCT00441701|13074207|P10|NOT COMPLETED|Overall Study||0
5317015|NCT00441701|13074208|P9|NOT COMPLETED|Overall Study||0
5317016|NCT00441701|13074209|P8|NOT COMPLETED|Overall Study||0
5317017|NCT00441701|13074210|P7|NOT COMPLETED|Overall Study||0
5317018|NCT00441701|13074211|P6|NOT COMPLETED|Overall Study||3
5317019|NCT00441701|13074212|P5|NOT COMPLETED|Overall Study||2
5317020|NCT00441701|13074213|P4|NOT COMPLETED|Overall Study||3
5317021|NCT00441701|13074214|P3|NOT COMPLETED|Overall Study||4
5317022|NCT00441701|13074215|P2|NOT COMPLETED|Overall Study||4
5317023|NCT00441701|13074216|P1|NOT COMPLETED|Overall Study||5
5317024|NCT00441701|13074207|P10|COMPLETED|Overall Study||0
5317025|NCT00441701|13074208|P9|COMPLETED|Overall Study||0
5317026|NCT00441701|13074209|P8|COMPLETED|Overall Study||0
5317027|NCT00441701|13074210|P7|COMPLETED|Overall Study||0
5317028|NCT00441701|13074211|P6|COMPLETED|Overall Study||8
5317029|NCT00441701|13074212|P5|COMPLETED|Overall Study||20
5317030|NCT00441701|13074213|P4|COMPLETED|Overall Study||8
5317031|NCT00441701|13074214|P3|COMPLETED|Overall Study||18
5317032|NCT00441701|13074215|P2|COMPLETED|Overall Study||7
5317033|NCT00441701|13074216|P1|COMPLETED|Overall Study||17
5317034|NCT00441701|13074207|P10|STARTED|Overall Study||0
5317035|NCT00441701|13074208|P9|STARTED|Overall Study||0
5317036|NCT00441701|13074209|P8|STARTED|Overall Study||0
5317037|NCT00441701|13074210|P7|STARTED|Overall Study||0
5317038|NCT00441701|13074211|P6|STARTED|Overall Study||11
5317039|NCT00441701|13074212|P5|STARTED|Overall Study||22
5317040|NCT00441701|13074213|P4|STARTED|Overall Study||11
5317041|NCT00441701|13074214|P3|STARTED|Overall Study||22
5317042|NCT00441701|13074215|P2|STARTED|Overall Study||11
5317043|NCT00441701|13074216|P1|STARTED|Overall Study||22
5317044|NCT00441584|13074298|P1|NOT COMPLETED|Overall Study||105
5317045|NCT00441584|13074298|P1|COMPLETED|Overall Study||12
5317046|NCT00441584|13074298|P1|STARTED|Overall Study||117
5317047|NCT00441558|13074302|P1|NOT COMPLETED|Overall Study||1056
5317048|NCT00441558|13074302|P1|COMPLETED|Overall Study||667
5317049|NCT00441558|13074302|P1|STARTED|Overall Study||1723
5317050|NCT00441545|13074306|P2|NOT COMPLETED|Second Intervention||7
5317051|NCT00441545|13074307|P1|NOT COMPLETED|Second Intervention||12
5317052|NCT00441545|13074306|P2|COMPLETED|Second Intervention||68
5317053|NCT00441545|13074307|P1|COMPLETED|Second Intervention||65
5317054|NCT00441545|13074306|P2|STARTED|Second Intervention||75
5317055|NCT00441545|13074307|P1|STARTED|Second Intervention||77
5317056|NCT00441545|13074306|P2|NOT COMPLETED|Washout||0
5317057|NCT00441545|13074307|P1|NOT COMPLETED|Washout||0
5317058|NCT00441545|13074306|P2|COMPLETED|Washout||75
5317059|NCT00441545|13074307|P1|COMPLETED|Washout||77
5317060|NCT00441545|13074306|P2|STARTED|Washout||75
5317061|NCT00441545|13074307|P1|STARTED|Washout||77
5317062|NCT00441545|13074306|P2|NOT COMPLETED|First Intervention||12
5317063|NCT00441545|13074307|P1|NOT COMPLETED|First Intervention||18
5317064|NCT00441545|13074306|P2|COMPLETED|First Intervention||75
5317065|NCT00441545|13074307|P1|COMPLETED|First Intervention||77
5317066|NCT00441545|13074306|P2|STARTED|First Intervention||87
5317067|NCT00441545|13074307|P1|STARTED|First Intervention||95
5317068|NCT00441480|13074321|P2|NOT COMPLETED|Overall Study||4
5317069|NCT00441480|13074322|P1|NOT COMPLETED|Overall Study||3
5317070|NCT00441480|13074321|P2|COMPLETED|Overall Study||41
5317071|NCT00441480|13074322|P1|COMPLETED|Overall Study||43
5317072|NCT00441480|13074321|P2|STARTED|Overall Study||45
5317073|NCT00441480|13074322|P1|STARTED|Overall Study||46
5317074|NCT00441467|13074354|P1|NOT COMPLETED|Overall Study||18
5317075|NCT00441467|13074354|P1|COMPLETED|Overall Study||4
5317076|NCT00441467|13074354|P1|4 Cycles|Overall Study||7
5317077|NCT00441467|13074354|P1|2 Cycles|Overall Study||17
5317078|NCT00441467|13074354|P1|STARTED|Overall Study||22
5317079|NCT00441441|13074362|P2|NOT COMPLETED|Overall Study||14
5317080|NCT00441441|13074363|P1|NOT COMPLETED|Overall Study||11
5317081|NCT00441441|13074362|P2|COMPLETED|Overall Study||163
5317082|NCT00441441|13074363|P1|COMPLETED|Overall Study||162
5317083|NCT00441441|13074362|P2|STARTED|Overall Study||177
5317084|NCT00441441|13074363|P1|STARTED|Overall Study||173
5317085|NCT00441363|13074423|P2|NOT COMPLETED|Overall Study||15
5317086|NCT00441363|13074424|P1|NOT COMPLETED|Overall Study||17
5317087|NCT00441363|13074423|P2|COMPLETED|Overall Study||19
5317088|NCT00441363|13074424|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
5317089|NCT00441363|13074423|P2|STARTED|Overall Study||34
5317090|NCT00441363|13074424|P1|STARTED|Overall Study||32
5317091|NCT00441337|13074436|P4|NOT COMPLETED|Overall Study||21
5317092|NCT00441337|13074437|P3|NOT COMPLETED|Overall Study||6
5317093|NCT00441337|13074438|P2|NOT COMPLETED|Overall Study||6
5317094|NCT00441337|13074439|P1|NOT COMPLETED|Overall Study||6
5317095|NCT00441337|13074436|P4|COMPLETED|Overall Study||0
5317096|NCT00441337|13074437|P3|COMPLETED|Overall Study||0
5317097|NCT00441337|13074438|P2|COMPLETED|Overall Study||0
5317098|NCT00441337|13074439|P1|COMPLETED|Overall Study||0
5317099|NCT00441337|13074436|P4|STARTED|Overall Study||21
5317100|NCT00441337|13074437|P3|STARTED|Overall Study||6
5317101|NCT00441337|13074438|P2|STARTED|Overall Study||6
5317102|NCT00441337|13074439|P1|STARTED|Overall Study||6
5317103|NCT00441285|13074522|P5|NOT COMPLETED|Overall Study||0
5317104|NCT00441285|13074523|P4|NOT COMPLETED|Overall Study||0
5317105|NCT00441285|13074524|P3|NOT COMPLETED|Overall Study||0
5317106|NCT00441285|13074525|P2|NOT COMPLETED|Overall Study||0
5317107|NCT00441285|13074526|P1|NOT COMPLETED|Overall Study||0
5317108|NCT00441285|13074522|P5|COMPLETED|Overall Study||43
5317109|NCT00441285|13074523|P4|COMPLETED|Overall Study||40
5317110|NCT00441285|13074524|P3|COMPLETED|Overall Study||41
5317111|NCT00441285|13074525|P2|COMPLETED|Overall Study||16
5317112|NCT00441285|13074526|P1|COMPLETED|Overall Study||16
5317113|NCT00441285|13074522|P5|STARTED|Overall Study||43
5317114|NCT00441285|13074523|P4|STARTED|Overall Study||40
5317115|NCT00441285|13074524|P3|STARTED|Overall Study||41
5317116|NCT00441285|13074525|P2|STARTED|Overall Study||16
5317117|NCT00441285|13074526|P1|STARTED|Overall Study||16
5317118|NCT00441272|13074552|P2|NOT COMPLETED|Overall Study||25
5317119|NCT00441272|13074553|P1|NOT COMPLETED|Overall Study||25
5317120|NCT00441272|13074552|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
5317121|NCT00441272|13074553|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
5317122|NCT00441272|13074552|P2|STARTED|Overall Study||25
5317123|NCT00441272|13074553|P1|STARTED|Overall Study||25
5317124|NCT00441259|13074561|P2|NOT COMPLETED|Overall Study||0
5317125|NCT00441259|13074562|P1|NOT COMPLETED|Overall Study||0
5317126|NCT00441259|13074561|P2|COMPLETED|Overall Study||48
5317127|NCT00441259|13074562|P1|COMPLETED|Overall Study||48
5317128|NCT00441259|13074561|P2|STARTED|Overall Study||48
5317129|NCT00441259|13074562|P1|STARTED|Overall Study||48
5317130|NCT00441168|13074580|P2|NOT COMPLETED|Follow-up Period||9
5317131|NCT00441168|13074581|P1|NOT COMPLETED|Follow-up Period||12
5317132|NCT00441168|13074580|P2|COMPLETED|Follow-up Period||4
5317133|NCT00441168|13074581|P1|COMPLETED|Follow-up Period||5
5317134|NCT00441168|13074580|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
5317135|NCT00441168|13074581|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
5317136|NCT00441168|13074580|P2|NOT COMPLETED|Treatment Period||6
5317137|NCT00441168|13074581|P1|NOT COMPLETED|Treatment Period||11
5317138|NCT00441168|13074580|P2|COMPLETED|Treatment Period||7
5317139|NCT00441168|13074581|P1|COMPLETED|Treatment Period||6
5317140|NCT00441168|13074580|P2|TREATED|Treatment Period||13
5317141|NCT00441168|13074581|P1|TREATED|Treatment Period||16
5317142|NCT00441168|13074580|P2|STARTED|Treatment Period||13
5317143|NCT00441168|13074581|P1|STARTED|Treatment Period||17
5317144|NCT00441142|13074595|P4|NOT COMPLETED|Overall Study||68
5317145|NCT00441142|13074596|P3|NOT COMPLETED|Overall Study||22
5317146|NCT00441142|13074597|P2|NOT COMPLETED|Overall Study||7
5317147|NCT00441142|13074598|P1|NOT COMPLETED|Overall Study||6
5317148|NCT00441142|13074595|P4|COMPLETED|Overall Study||1
5317149|NCT00441142|13074596|P3|COMPLETED|Overall Study||7
5317150|NCT00441142|13074597|P2|COMPLETED|Overall Study||0
5317151|NCT00441142|13074598|P1|COMPLETED|Overall Study||0
5317152|NCT00441142|13074595|P4|STARTED|Overall Study||69
5317153|NCT00441142|13074596|P3|STARTED|Overall Study||29
5317154|NCT00441142|13074597|P2|STARTED|Overall Study||7
5317155|NCT00441142|13074598|P1|STARTED|Overall Study||6
5317156|NCT00441129|13074620|P2|NOT COMPLETED|Overall Study||14
5317157|NCT00441129|13074621|P1|NOT COMPLETED|Overall Study||6
5317158|NCT00441129|13074620|P2|COMPLETED|Overall Study||41
5317159|NCT00441129|13074621|P1|COMPLETED|Overall Study||54
5317160|NCT00441129|13074620|P2|STARTED|Overall Study||55
5317161|NCT00441129|13074621|P1|STARTED|Overall Study||60
5317162|NCT00441116|13074633|P2|NOT COMPLETED|Overall Study||2
5317163|NCT00441116|13074634|P1|NOT COMPLETED|Overall Study||3
5317164|NCT00441116|13074633|P2|COMPLETED|Overall Study||75
5317165|NCT00441116|13074634|P1|COMPLETED|Overall Study||73
5317166|NCT00441116|13074633|P2|STARTED|Overall Study||77
5317167|NCT00441116|13074634|P1|STARTED|Overall Study||76
5317168|NCT00441103|13074702|P2|NOT COMPLETED|Overall Study||4
5317169|NCT00441103|13074703|P1|NOT COMPLETED|Overall Study||11
5317170|NCT00441103|13074702|P2|COMPLETED|Overall Study||56
5317171|NCT00441103|13074703|P1|COMPLETED|Overall Study||109
5317172|NCT00441103|13074702|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
5317173|NCT00441103|13074703|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
5317174|NCT00441090|13074719|P5|NOT COMPLETED|Overall Study||0
5317175|NCT00441090|13074720|P4|NOT COMPLETED|Overall Study||2
5317176|NCT00441090|13074721|P3|NOT COMPLETED|Overall Study||2
5317177|NCT00441090|13074722|P2|NOT COMPLETED|Overall Study||1
5317178|NCT00441090|13074723|P1|NOT COMPLETED|Overall Study||2
5317179|NCT00441090|13074719|P5|COMPLETED|Overall Study||5
5317180|NCT00441090|13074720|P4|COMPLETED|Overall Study||13
5317181|NCT00441090|13074721|P3|COMPLETED|Overall Study||12
5317182|NCT00441090|13074722|P2|COMPLETED|Overall Study||14
5317183|NCT00441090|13074723|P1|COMPLETED|Overall Study||13
5317184|NCT00441090|13074719|P5|STARTED|Overall Study||5
5317185|NCT00441090|13074720|P4|STARTED|Overall Study||15
5317186|NCT00441090|13074721|P3|STARTED|Overall Study||14
5317187|NCT00441090|13074722|P2|STARTED|Overall Study||15
5317188|NCT00441090|13074723|P1|STARTED|Overall Study||15
5317189|NCT00441064|13074767|P2|NOT COMPLETED|Overall Study||7
5317190|NCT00441064|13074768|P1|NOT COMPLETED|Overall Study||10
5317191|NCT00441064|13074767|P2|COMPLETED|Overall Study||56
5317192|NCT00441064|13074768|P1|COMPLETED|Overall Study||59
5317193|NCT00441064|13074767|P2|Intent-to-treat (ITT) Population|Overall Study||57
5317194|NCT00441064|13074768|P1|Intent-to-treat (ITT) Population|Overall Study||61
5317195|NCT00441064|13074767|P2|Safety Population (SP)|Overall Study||63
5317196|NCT00441064|13074768|P1|Safety Population (SP)|Overall Study||69
5317197|NCT00441064|13074767|P2|STARTED|Overall Study||63
5317198|NCT00441064|13074768|P1|STARTED|Overall Study||69
5317199|NCT00441012|13074780|P2|NOT COMPLETED|Overall Study||13
5317200|NCT00441012|13074781|P1|NOT COMPLETED|Overall Study||18
5317201|NCT00441012|13074780|P2|COMPLETED|Overall Study||263
5317202|NCT00441012|13074781|P1|COMPLETED|Overall Study||252
5317203|NCT00441012|13074780|P2|Vaccination Visit 3|Overall Study||269
5317204|NCT00441012|13074781|P1|Vaccination Visit 3|Overall Study||265
5317205|NCT00441012|13074780|P2|Vaccination Visit 2|Overall Study||272
5317206|NCT00441012|13074781|P1|Vaccination Visit 2|Overall Study||267
5317207|NCT00441012|13074780|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
5317208|NCT00441012|13074781|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
5317209|NCT00441012|13074780|P2|STARTED|Overall Study||276
5317210|NCT00441012|13074781|P1|STARTED|Overall Study||270
5317211|NCT00440947|13074795|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
5317212|NCT00440947|13074796|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
5317213|NCT00440947|13074797|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
5317214|NCT00440947|13074798|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
5317215|NCT00440947|13074799|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
5317216|NCT00440947|13074795|P5|COMPLETED|Optional 60-Week Extension Phase||154
5317217|NCT00440947|13074796|P4|COMPLETED|Optional 60-Week Extension Phase||160
5317218|NCT00440947|13074797|P3|COMPLETED|Optional 60-Week Extension Phase||0
5317219|NCT00440947|13074798|P2|COMPLETED|Optional 60-Week Extension Phase||0
5317220|NCT00440947|13074799|P1|COMPLETED|Optional 60-Week Extension Phase||0
5317221|NCT00440947|13074795|P5|STARTED|Optional 60-Week Extension Phase||180
5317222|NCT00440947|13074796|P4|STARTED|Optional 60-Week Extension Phase||189
5317223|NCT00440947|13074797|P3|STARTED|Optional 60-Week Extension Phase||0
5317224|NCT00440947|13074798|P2|STARTED|Optional 60-Week Extension Phase||0
5317225|NCT00440947|13074799|P1|STARTED|Optional 60-Week Extension Phase||0
5317226|NCT00440947|13074795|P5|NOT COMPLETED|48-Week Randomization Phase||0
5317227|NCT00440947|13074796|P4|NOT COMPLETED|48-Week Randomization Phase||0
5317228|NCT00440947|13074797|P3|NOT COMPLETED|48-Week Randomization Phase||24
5317229|NCT00440947|13074798|P2|NOT COMPLETED|48-Week Randomization Phase||16
5317230|NCT00440947|13074799|P1|NOT COMPLETED|48-Week Randomization Phase||0
5317231|NCT00440947|13074795|P5|COMPLETED|48-Week Randomization Phase||0
5317232|NCT00440947|13074796|P4|COMPLETED|48-Week Randomization Phase||0
5317233|NCT00440947|13074797|P3|COMPLETED|48-Week Randomization Phase||185
5317234|NCT00440947|13074798|P2|COMPLETED|48-Week Randomization Phase||194
5317235|NCT00440947|13074799|P1|COMPLETED|48-Week Randomization Phase||0
5317236|NCT00440947|13074795|P5|STARTED|48-Week Randomization Phase||0
5317237|NCT00440947|13074796|P4|STARTED|48-Week Randomization Phase||0
5317238|NCT00440947|13074797|P3|STARTED|48-Week Randomization Phase||209
5317239|NCT00440947|13074798|P2|STARTED|48-Week Randomization Phase||210
5317240|NCT00440947|13074799|P1|STARTED|48-Week Randomization Phase||0
5317241|NCT00440947|13074795|P5|NOT COMPLETED|36-Week Induction Phase||0
5317242|NCT00440947|13074796|P4|NOT COMPLETED|36-Week Induction Phase||0
5317243|NCT00440947|13074797|P3|NOT COMPLETED|36-Week Induction Phase||0
5317244|NCT00440947|13074798|P2|NOT COMPLETED|36-Week Induction Phase||0
5317245|NCT00440947|13074799|P1|NOT COMPLETED|36-Week Induction Phase||73
5317246|NCT00440947|13074795|P5|COMPLETED|36-Week Induction Phase||0
5317247|NCT00440947|13074796|P4|COMPLETED|36-Week Induction Phase||0
5317248|NCT00440947|13074797|P3|COMPLETED|36-Week Induction Phase||0
5317249|NCT00440947|13074798|P2|COMPLETED|36-Week Induction Phase||0
5317250|NCT00440947|13074799|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
5317251|NCT00440947|13074795|P5|STARTED|36-Week Induction Phase||0
5317252|NCT00440947|13074796|P4|STARTED|36-Week Induction Phase||0
5317253|NCT00440947|13074797|P3|STARTED|36-Week Induction Phase||0
5317254|NCT00440947|13074798|P2|STARTED|36-Week Induction Phase||0
5317255|NCT00440947|13074799|P1|STARTED|36-Week Induction Phase||515
5317256|NCT00440830|13074854|P4|NOT COMPLETED|Overall Study||0
5317257|NCT00440830|13074855|P3|NOT COMPLETED|Overall Study||0
5317258|NCT00440830|13074856|P2|NOT COMPLETED|Overall Study||0
5317259|NCT00440830|13074857|P1|NOT COMPLETED|Overall Study||0
5317260|NCT00440830|13074854|P4|COMPLETED|Overall Study||10
5317261|NCT00440830|13074855|P3|COMPLETED|Overall Study||30
5317262|NCT00440830|13074856|P2|COMPLETED|Overall Study||8
5317263|NCT00440830|13074857|P1|COMPLETED|Overall Study||20
5317264|NCT00440830|13074854|P4|STARTED|Overall Study||10
5317265|NCT00440830|13074855|P3|STARTED|Overall Study||30
5317266|NCT00440830|13074856|P2|STARTED|Overall Study||8
5317267|NCT00440830|13074857|P1|STARTED|Overall Study||20
5317268|NCT00440726|13074874|P3|NOT COMPLETED|Phase 2||2
5317269|NCT00440726|13074875|P2|NOT COMPLETED|Phase 2||0
5317270|NCT00440726|13074876|P1|NOT COMPLETED|Phase 2||0
5317271|NCT00440726|13074874|P3|COMPLETED|Phase 2||20
5317272|NCT00440726|13074875|P2|COMPLETED|Phase 2||0
5317273|NCT00440726|13074876|P1|COMPLETED|Phase 2||0
5317274|NCT00440726|13074874|P3|STARTED|Phase 2||22
5317275|NCT00440726|13074875|P2|STARTED|Phase 2||0
5317276|NCT00440726|13074876|P1|STARTED|Phase 2||0
5317277|NCT00440726|13074874|P3|NOT COMPLETED|Phase 1||0
5317278|NCT00440726|13074875|P2|NOT COMPLETED|Phase 1||1
5317279|NCT00440726|13074876|P1|NOT COMPLETED|Phase 1||1
5317280|NCT00440726|13074874|P3|COMPLETED|Phase 1||0
5317281|NCT00440726|13074875|P2|COMPLETED|Phase 1||5
5317282|NCT00440726|13074876|P1|COMPLETED|Phase 1||3
5317283|NCT00440726|13074874|P3|STARTED|Phase 1||0
5317284|NCT00440726|13074875|P2|STARTED|Phase 1||6
5317285|NCT00440726|13074876|P1|STARTED|Phase 1||4
5317286|NCT00440700|13074890|P3|NOT COMPLETED|Overall Study||4
5317287|NCT00440700|13074891|P2|NOT COMPLETED|Overall Study||8
5317288|NCT00440700|13074892|P1|NOT COMPLETED|Overall Study||8
5317289|NCT00440700|13074890|P3|COMPLETED|Overall Study||120
5317290|NCT00440700|13074891|P2|COMPLETED|Overall Study||110
5317291|NCT00440700|13074892|P1|COMPLETED|Overall Study||114
5317292|NCT00440700|13074890|P3|STARTED|Overall Study||124
5317293|NCT00440700|13074891|P2|STARTED|Overall Study||118
5317294|NCT00440700|13074892|P1|STARTED|Overall Study||122
5317295|NCT00440557|13074915|P3|NOT COMPLETED|Overall Study||35
5317296|NCT00440557|13074916|P2|NOT COMPLETED|Overall Study||29
5317297|NCT00440557|13074917|P1|NOT COMPLETED|Overall Study||25
5317298|NCT00440557|13074915|P3|COMPLETED|Overall Study||90
5317299|NCT00440557|13074916|P2|COMPLETED|Overall Study||96
5317300|NCT00440557|13074917|P1|COMPLETED|Overall Study||98
5317301|NCT00440557|13074915|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
5317302|NCT00440557|13074916|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
5317303|NCT00440557|13074917|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
5317304|NCT00440531|13074949|P3|NOT COMPLETED|Overall Study||7
5317305|NCT00440531|13074950|P2|NOT COMPLETED|Overall Study||5
5317306|NCT00440531|13074951|P1|NOT COMPLETED|Overall Study||10
5317307|NCT00440531|13074949|P3|COMPLETED|Overall Study||165
5317308|NCT00440531|13074950|P2|COMPLETED|Overall Study||178
5317309|NCT00440531|13074951|P1|COMPLETED|Overall Study||175
5317310|NCT00440531|13074949|P3|Vaccination 3|Overall Study||166
5317311|NCT00440531|13074950|P2|Vaccination 3|Overall Study||178
5317312|NCT00440531|13074951|P1|Vaccination 3|Overall Study||176
5317313|NCT00440531|13074949|P3|Vaccination 2|Overall Study||171
5317314|NCT00440531|13074950|P2|Vaccination 2|Overall Study||182
5317315|NCT00440531|13074951|P1|Vaccination 2|Overall Study||181
5317316|NCT00440531|13074949|P3|Vaccination 1|Overall Study||172
5317317|NCT00440531|13074950|P2|Vaccination 1|Overall Study||183
5317318|NCT00440531|13074951|P1|Vaccination 1|Overall Study||183
5317319|NCT00440531|13074949|P3|STARTED|Overall Study||172
5317320|NCT00440531|13074950|P2|STARTED|Overall Study||183
5317321|NCT00440531|13074951|P1|STARTED|Overall Study||185
5317322|NCT00440518|13074968|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
5317323|NCT00440518|13074969|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
5317324|NCT00440518|13074970|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
5317325|NCT00440518|13074968|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
5317326|NCT00440518|13074969|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
5317327|NCT00440518|13074970|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
5317328|NCT00440518|13074968|P3|STARTED|Maintenance and Safety Follow-up Periods||70
5317329|NCT00440518|13074969|P2|STARTED|Maintenance and Safety Follow-up Periods||63
5317330|NCT00440518|13074970|P1|STARTED|Maintenance and Safety Follow-up Periods||59
5317331|NCT00440518|13074968|P3|NOT COMPLETED|Randomized /Titration Period||4
5317332|NCT00440518|13074969|P2|NOT COMPLETED|Randomized /Titration Period||9
5317333|NCT00440518|13074970|P1|NOT COMPLETED|Randomized /Titration Period||13
5317334|NCT00440518|13074968|P3|COMPLETED|Randomized /Titration Period||70
5317335|NCT00440518|13074969|P2|COMPLETED|Randomized /Titration Period||63
5317336|NCT00440518|13074970|P1|COMPLETED|Randomized /Titration Period||59
5317337|NCT00440518|13074968|P3|STARTED|Randomized /Titration Period||74
5317338|NCT00440518|13074969|P2|STARTED|Randomized /Titration Period||72
5317339|NCT00440518|13074970|P1|STARTED|Randomized /Titration Period||72
5317340|NCT00440505|13074990|P6|NOT COMPLETED|Third Intervention||0
5317341|NCT00440505|13074991|P5|NOT COMPLETED|Third Intervention||0
5317342|NCT00440505|13074992|P4|NOT COMPLETED|Third Intervention||1
5317343|NCT00440505|13074993|P3|NOT COMPLETED|Third Intervention||0
5317344|NCT00440505|13074994|P2|NOT COMPLETED|Third Intervention||0
5317345|NCT00440505|13074995|P1|NOT COMPLETED|Third Intervention||0
5317346|NCT00440505|13074990|P6|COMPLETED|Third Intervention||5
5317347|NCT00440505|13074991|P5|COMPLETED|Third Intervention||5
5317348|NCT00440505|13074992|P4|COMPLETED|Third Intervention||1
5317349|NCT00440505|13074993|P3|COMPLETED|Third Intervention||1
5317350|NCT00440505|13074994|P2|COMPLETED|Third Intervention||2
5317351|NCT00440505|13074995|P1|COMPLETED|Third Intervention||5
5317352|NCT00440505|13074990|P6|STARTED|Third Intervention||5
5317353|NCT00440505|13074991|P5|STARTED|Third Intervention||5
5317354|NCT00440505|13074992|P4|STARTED|Third Intervention||2
5317355|NCT00440505|13074993|P3|STARTED|Third Intervention||1
5317356|NCT00440505|13074994|P2|STARTED|Third Intervention||2
5317357|NCT00440505|13074995|P1|STARTED|Third Intervention||5
5317358|NCT00440505|13074990|P6|NOT COMPLETED|Second Intervention||0
5317359|NCT00440505|13074991|P5|NOT COMPLETED|Second Intervention||0
5317360|NCT00440505|13074992|P4|NOT COMPLETED|Second Intervention||0
5317361|NCT00440505|13074993|P3|NOT COMPLETED|Second Intervention||0
5317362|NCT00440505|13074994|P2|NOT COMPLETED|Second Intervention||0
5317363|NCT00440505|13074995|P1|NOT COMPLETED|Second Intervention||0
5317364|NCT00440505|13074990|P6|COMPLETED|Second Intervention||5
5317365|NCT00440505|13074991|P5|COMPLETED|Second Intervention||5
5317366|NCT00440505|13074992|P4|COMPLETED|Second Intervention||2
5317367|NCT00440505|13074993|P3|COMPLETED|Second Intervention||1
5317368|NCT00440505|13074994|P2|COMPLETED|Second Intervention||2
5317369|NCT00440505|13074995|P1|COMPLETED|Second Intervention||5
5317370|NCT00440505|13074990|P6|STARTED|Second Intervention||5
5317371|NCT00440505|13074991|P5|STARTED|Second Intervention||5
5317372|NCT00440505|13074992|P4|STARTED|Second Intervention||2
5317373|NCT00440505|13074993|P3|STARTED|Second Intervention||1
5317374|NCT00440505|13074994|P2|STARTED|Second Intervention||2
5317375|NCT00440505|13074995|P1|STARTED|Second Intervention||5
5317376|NCT00440505|13074990|P6|NOT COMPLETED|First Intervention||0
5317377|NCT00440505|13074991|P5|NOT COMPLETED|First Intervention||0
5317378|NCT00440505|13074992|P4|NOT COMPLETED|First Intervention||0
5317379|NCT00440505|13074993|P3|NOT COMPLETED|First Intervention||0
5317380|NCT00440505|13074994|P2|NOT COMPLETED|First Intervention||0
5317381|NCT00440505|13074995|P1|NOT COMPLETED|First Intervention||0
5317382|NCT00440505|13074990|P6|COMPLETED|First Intervention||5
5317383|NCT00440505|13074991|P5|COMPLETED|First Intervention||5
5317384|NCT00440505|13074992|P4|COMPLETED|First Intervention||2
5317385|NCT00440505|13074993|P3|COMPLETED|First Intervention||1
5317386|NCT00440505|13074994|P2|COMPLETED|First Intervention||2
5317387|NCT00440505|13074995|P1|COMPLETED|First Intervention||5
5317388|NCT00440505|13074990|P6|STARTED|First Intervention||5
5317389|NCT00440505|13074991|P5|STARTED|First Intervention||5
5317390|NCT00440505|13074992|P4|STARTED|First Intervention||2
5317391|NCT00440505|13074993|P3|STARTED|First Intervention||1
5317392|NCT00440505|13074994|P2|STARTED|First Intervention||2
5317393|NCT00440505|13074995|P1|STARTED|First Intervention||5
5317394|NCT00440466|13075015|P3|NOT COMPLETED|Overall Study||41
5317395|NCT00440466|13075016|P2|NOT COMPLETED|Overall Study||15
5317396|NCT00440466|13075017|P1|NOT COMPLETED|Overall Study||13
5317397|NCT00440466|13075015|P3|COMPLETED|Overall Study||174
5317398|NCT00440466|13075016|P2|COMPLETED|Overall Study||92
5317399|NCT00440466|13075017|P1|COMPLETED|Overall Study||95
5317400|NCT00440466|13075015|P3|STARTED|Overall Study||215
5317401|NCT00440466|13075016|P2|STARTED|Overall Study||107
5317402|NCT00440466|13075017|P1|STARTED|Overall Study||108
5317403|NCT00440401|13075051|P2|NOT COMPLETED|Overall Study||6
5317404|NCT00440401|13075052|P1|NOT COMPLETED|Overall Study||4
5317405|NCT00440401|13075051|P2|COMPLETED|Overall Study||54
5317406|NCT00440401|13075052|P1|COMPLETED|Overall Study||55
5317407|NCT00440401|13075051|P2|STARTED|Overall Study||60
5317408|NCT00440401|13075052|P1|STARTED|Overall Study||59
5317409|NCT00440310|13075062|P2|NOT COMPLETED|Overall Study||30
5317410|NCT00440310|13075063|P1|NOT COMPLETED|Overall Study||28
5317411|NCT00440310|13075062|P2|COMPLETED|Overall Study||209
5317412|NCT00440310|13075063|P1|COMPLETED|Overall Study||216
5317413|NCT00440310|13075062|P2|Treated|Overall Study||232
5317414|NCT00440310|13075063|P1|Treated|Overall Study||222
5317415|NCT00440310|13075062|P2|STARTED|Overall Study||239
5317416|NCT00440310|13075063|P1|STARTED|Overall Study||244
5317417|NCT00440297|13075071|P2|NOT COMPLETED|Overall Study||18
5317418|NCT00440297|13075072|P1|NOT COMPLETED|Overall Study||23
5317419|NCT00440297|13075071|P2|COMPLETED|Overall Study||120
5317420|NCT00440297|13075072|P1|COMPLETED|Overall Study||116
5317421|NCT00440297|13075071|P2|Vaccination Visit 4|Overall Study||122
5317422|NCT00440297|13075072|P1|Vaccination Visit 4|Overall Study||116
5317423|NCT00440297|13075071|P2|Vaccination Visit 3|Overall Study||125
5317424|NCT00440297|13075072|P1|Vaccination Visit 3|Overall Study||124
5317425|NCT00440297|13075071|P2|Vaccination Visit 2|Overall Study||134
5317426|NCT00440297|13075072|P1|Vaccination Visit 2|Overall Study||136
5317427|NCT00440297|13075071|P2|Vaccination Visit 1|Overall Study||138
5317428|NCT00440297|13075072|P1|Vaccination Visit 1|Overall Study||138
5317429|NCT00440297|13075071|P2|STARTED|Overall Study||138
5317430|NCT00440297|13075072|P1|STARTED|Overall Study||139
5317431|NCT00440271|13075088|P2|NOT COMPLETED|Overall Study||15
5317432|NCT00440271|13075089|P1|NOT COMPLETED|Overall Study||12
5317433|NCT00440271|13075088|P2|COMPLETED|Overall Study||3
5317434|NCT00440271|13075089|P1|COMPLETED|Overall Study||3
5317435|NCT00440271|13075088|P2|STARTED|Overall Study||18
5317436|NCT00440271|13075089|P1|STARTED|Overall Study||15
5317437|NCT00440232|13075123|P2|NOT COMPLETED|Overall Study||4
5317438|NCT00440232|13075124|P1|NOT COMPLETED|Overall Study||3
5317439|NCT00440232|13075123|P2|COMPLETED|Overall Study||34
5317440|NCT00440232|13075124|P1|COMPLETED|Overall Study||33
5317441|NCT00440232|13075123|P2|STARTED|Overall Study||38
5317442|NCT00440232|13075124|P1|STARTED|Overall Study||36
5317443|NCT00440193|13075134|P2|NOT COMPLETED|Observational Period||38
5317444|NCT00440193|13075135|P1|NOT COMPLETED|Observational Period||45
5317445|NCT00440193|13075134|P2|COMPLETED|Observational Period||1369
5317446|NCT00440193|13075135|P1|COMPLETED|Observational Period||1380
5317447|NCT00440193|13075134|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
5317448|NCT00440193|13075135|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
5317449|NCT00440193|13075134|P2|NOT COMPLETED|Treatment Period||351
5317450|NCT00440193|13075135|P1|NOT COMPLETED|Treatment Period||305
5317451|NCT00440193|13075134|P2|COMPLETED|Treatment Period||1367
5317452|NCT00440193|13075135|P1|COMPLETED|Treatment Period||1426
5317453|NCT00440193|13075134|P2|Participants Received Treatment|Treatment Period||1711
5317454|NCT00440193|13075135|P1|Participants Received Treatment|Treatment Period||1718
5317455|NCT00440193|13075134|P2|STARTED|Treatment Period||1718
5317456|NCT00440193|13075135|P1|STARTED|Treatment Period||1731
5317457|NCT00440180|13075171|P2|NOT COMPLETED|Overall Study||0
5317458|NCT00440180|13075172|P1|NOT COMPLETED|Overall Study||0
5317459|NCT00440180|13075171|P2|COMPLETED|Overall Study||10
5317460|NCT00440180|13075172|P1|COMPLETED|Overall Study||10
5317461|NCT00440180|13075171|P2|STARTED|Overall Study||10
5317462|NCT00440180|13075172|P1|STARTED|Overall Study||10
5317463|NCT00440115|13075181|P3|NOT COMPLETED|Overall Study||6
5317464|NCT00440115|13075182|P2|NOT COMPLETED|Overall Study||11
5317465|NCT00440115|13075183|P1|NOT COMPLETED|Overall Study||7
5317466|NCT00440115|13075181|P3|COMPLETED|Overall Study||244
5317467|NCT00440115|13075182|P2|COMPLETED|Overall Study||238
5317468|NCT00440115|13075183|P1|COMPLETED|Overall Study||244
5317469|NCT00440115|13075181|P3|STARTED|Overall Study||250
5317470|NCT00440115|13075182|P2|STARTED|Overall Study||249
5317471|NCT00440115|13075183|P1|STARTED|Overall Study||251
5317472|NCT00440050|13075199|P2|NOT COMPLETED|Overall Study||67
5317473|NCT00440050|13075200|P1|NOT COMPLETED|Overall Study||40
5317474|NCT00440050|13075199|P2|COMPLETED|Overall Study||171
5317475|NCT00440050|13075200|P1|COMPLETED|Overall Study||124
5317476|NCT00440050|13075199|P2|STARTED|Overall Study||238
5317477|NCT00440050|13075200|P1|STARTED|Overall Study||164
5317478|NCT00440037|13075212|P1|NOT COMPLETED|Overall Study||9
5317479|NCT00440037|13075212|P1|COMPLETED|Overall Study||35
5317480|NCT00440037|13075212|P1|STARTED|Overall Study||44
5317481|NCT00440011|13075222|P2|NOT COMPLETED|Overall Study||3
5317482|NCT00440011|13075223|P1|NOT COMPLETED|Overall Study||4
5317483|NCT00440011|13075222|P2|COMPLETED|Overall Study||132
5317484|NCT00440011|13075223|P1|COMPLETED|Overall Study||127
5317485|NCT00440011|13075222|P2|STARTED|Overall Study||135
5317486|NCT00440011|13075223|P1|STARTED|Overall Study||131
5317487|NCT00439946|13075231|P1|NOT COMPLETED|Overall Study||0
5317488|NCT00439946|13075231|P1|COMPLETED|Overall Study||8
5317489|NCT00439946|13075231|P1|STARTED|Overall Study||8
5317490|NCT00439777|13075250|P2|NOT COMPLETED|Observational Period||41
5317491|NCT00439777|13075251|P1|NOT COMPLETED|Observational Period||41
5317492|NCT00439777|13075250|P2|COMPLETED|Observational Period||2156
5317493|NCT00439777|13075251|P1|COMPLETED|Observational Period||2165
5317494|NCT00439777|13075250|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
5317495|NCT00439777|13075251|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
5317496|NCT00439777|13075250|P2|NOT COMPLETED|Treatment Period||459
5317497|NCT00439777|13075251|P1|NOT COMPLETED|Treatment Period||419
5317498|NCT00439777|13075250|P2|COMPLETED|Treatment Period||1954
5317499|NCT00439777|13075251|P1|COMPLETED|Treatment Period||2001
5317500|NCT00439777|13075250|P2|Participants Received Treatment|Treatment Period||2405
5317501|NCT00439777|13075251|P1|Participants Received Treatment|Treatment Period||2412
5317502|NCT00439777|13075250|P2|STARTED|Treatment Period||2413
5317503|NCT00439777|13075251|P1|STARTED|Treatment Period||2420
5317504|NCT00439738|13075289|P2|NOT COMPLETED|Overall Study||28
5317505|NCT00439738|13075290|P1|NOT COMPLETED|Overall Study||36
5317506|NCT00439738|13075289|P2|COMPLETED|Overall Study||178
5317507|NCT00439738|13075290|P1|COMPLETED|Overall Study||170
5317508|NCT00439738|13075289|P2|STARTED|Overall Study||206
5317509|NCT00439738|13075290|P1|STARTED|Overall Study||206
5317510|NCT00439725|13075308|P2|NOT COMPLETED|Observational Period||7
5317511|NCT00439725|13075309|P1|NOT COMPLETED|Observational Period||8
5317512|NCT00439725|13075308|P2|COMPLETED|Observational Period||553
5317513|NCT00439725|13075309|P1|COMPLETED|Observational Period||569
5317514|NCT00439725|13075308|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
5317515|NCT00439725|13075309|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
5317516|NCT00439725|13075308|P2|NOT COMPLETED|Treatment Period||246
5317517|NCT00439725|13075309|P1|NOT COMPLETED|Treatment Period||236
5317518|NCT00439725|13075308|P2|COMPLETED|Treatment Period||349
5317519|NCT00439725|13075309|P1|COMPLETED|Treatment Period||366
5317520|NCT00439725|13075308|P2|Participants Received Treatment|Treatment Period|Safety population|590
5317521|NCT00439725|13075309|P1|Participants Received Treatment|Treatment Period|Safety population|598
5317522|NCT00439725|13075308|P2|STARTED|Treatment Period||595
5317523|NCT00439725|13075309|P1|STARTED|Treatment Period||602
5317524|NCT00439673|13075353|P1|NOT COMPLETED|Overall Study||36
5317525|NCT00439673|13075353|P1|COMPLETED|Overall Study||26
5317526|NCT00439673|13075353|P1|STARTED|Overall Study||62
5317527|NCT00439647|13075360|P2|NOT COMPLETED|Overall Study||71
5317528|NCT00439647|13075361|P1|NOT COMPLETED|Overall Study||58
5317529|NCT00439647|13075360|P2|COMPLETED|Overall Study||540
5317530|NCT00439647|13075361|P1|COMPLETED|Overall Study||530
5317531|NCT00439647|13075360|P2|Modified Intent to Treat (mITT)|Overall Study||574
5317532|NCT00439647|13075361|P1|Modified Intent to Treat (mITT)|Overall Study||553
5317533|NCT00439647|13075360|P2|STARTED|Overall Study||611
5317534|NCT00439647|13075361|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
5317535|NCT00439608|13075393|P1|NOT COMPLETED|Overall Study||0
5317536|NCT00439608|13075393|P1|COMPLETED|Overall Study||60
5317537|NCT00439608|13075393|P1|STARTED|Overall Study||60
5317538|NCT00439569|13075398|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
5317539|NCT00439569|13075398|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
5317540|NCT00439569|13075398|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
5317541|NCT00439569|13075398|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
5317542|NCT00439569|13075398|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
5317543|NCT00439569|13075398|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
5317544|NCT00439556|13075412|P3|NOT COMPLETED|Overall Study||0
5317545|NCT00439556|13075413|P2|NOT COMPLETED|Overall Study||1
5317546|NCT00439556|13075414|P1|NOT COMPLETED|Overall Study||0
5317547|NCT00439556|13075412|P3|COMPLETED|Overall Study||0
5317548|NCT00439556|13075413|P2|COMPLETED|Overall Study||3
5317549|NCT00439556|13075414|P1|COMPLETED|Overall Study||36
5317550|NCT00439556|13075412|P3|STARTED|Overall Study||0
5317551|NCT00439556|13075413|P2|STARTED|Overall Study||4
5317552|NCT00439556|13075414|P1|STARTED|Overall Study||36
5317553|NCT00439517|13075427|P2|NOT COMPLETED|Overall Study||0
5317554|NCT00439517|13075428|P1|NOT COMPLETED|Overall Study||2
5317555|NCT00439517|13075427|P2|COMPLETED|Overall Study||150
5317556|NCT00439517|13075428|P1|COMPLETED|Overall Study||150
5317557|NCT00439517|13075427|P2|STARTED|Overall Study||150
5317558|NCT00439517|13075428|P1|STARTED|Overall Study||152
5317559|NCT00439465|13075450|P1|NOT COMPLETED|Overall Study||4
5317560|NCT00439465|13075450|P1|COMPLETED|Overall Study||19
5317561|NCT00439465|13075450|P1|STARTED|Overall Study||23
5317562|NCT00439413|13075462|P2|NOT COMPLETED|Overall Study||37
5317563|NCT00439413|13075463|P1|NOT COMPLETED|Overall Study||31
5317564|NCT00439413|13075462|P2|COMPLETED|Overall Study||88
5317565|NCT00439413|13075463|P1|COMPLETED|Overall Study||90
5317566|NCT00439413|13075462|P2|STARTED|Overall Study||125
5317567|NCT00439413|13075463|P1|STARTED|Overall Study||121
5317568|NCT00439374|13075473|P2|NOT COMPLETED|Overall Study||0
5317569|NCT00439374|13075474|P1|NOT COMPLETED|Overall Study||0
5317570|NCT00439374|13075473|P2|COMPLETED|Overall Study||330
5317571|NCT00439374|13075474|P1|COMPLETED|Overall Study||327
5317572|NCT00439374|13075473|P2|STARTED|Overall Study||330
5317573|NCT00439374|13075474|P1|STARTED|Overall Study||327
5317574|NCT00439335|13075534|P2|NOT COMPLETED|Overall Study||0
5317575|NCT00439335|13075535|P1|NOT COMPLETED|Overall Study||2
5317576|NCT00439335|13075534|P2|COMPLETED|Overall Study||114
5317577|NCT00439335|13075535|P1|COMPLETED|Overall Study||111
5317578|NCT00439335|13075534|P2|STARTED|Overall Study||114
5317579|NCT00439335|13075535|P1|STARTED|Overall Study||113
5317580|NCT00439309|13075567|P2|NOT COMPLETED|Follow-Up||2
5317581|NCT00439309|13075568|P1|NOT COMPLETED|Follow-Up||3
5317582|NCT00439309|13075567|P2|COMPLETED|Follow-Up||13
5317583|NCT00439309|13075568|P1|COMPLETED|Follow-Up||51
5317584|NCT00439309|13075567|P2|STARTED|Follow-Up||15
5317585|NCT00439309|13075568|P1|STARTED|Follow-Up||54
5317586|NCT00439309|13075567|P2|NOT COMPLETED|Treatment||0
5317587|NCT00439309|13075568|P1|NOT COMPLETED|Treatment||0
5317588|NCT00439309|13075567|P2|COMPLETED|Treatment||15
5317589|NCT00439309|13075568|P1|COMPLETED|Treatment||54
5317590|NCT00439309|13075567|P2|STARTED|Treatment||15
5317591|NCT00439309|13075568|P1|STARTED|Treatment||54
5317592|NCT00439270|13075587|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
5317593|NCT00439270|13075588|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
5317594|NCT00439270|13075589|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
5317595|NCT00439270|13075590|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
5317596|NCT00439270|13075591|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
5317597|NCT00439270|13075587|P5|COMPLETED|Phase 2 (51.6 Months)||0
5317598|NCT00439270|13075588|P4|COMPLETED|Phase 2 (51.6 Months)||0
5317599|NCT00439270|13075589|P3|COMPLETED|Phase 2 (51.6 Months)||0
5317600|NCT00439270|13075590|P2|COMPLETED|Phase 2 (51.6 Months)||0
5317601|NCT00439270|13075591|P1|COMPLETED|Phase 2 (51.6 Months)||0
5317602|NCT00439270|13075587|P5|STARTED|Phase 2 (51.6 Months)||0
5317603|NCT00439270|13075588|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
5317604|NCT00439270|13075589|P3|STARTED|Phase 2 (51.6 Months)||0
5317605|NCT00439270|13075590|P2|STARTED|Phase 2 (51.6 Months)||0
5317606|NCT00439270|13075591|P1|STARTED|Phase 2 (51.6 Months)||0
5317607|NCT00439270|13075587|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
5317608|NCT00439270|13075588|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
5317609|NCT00439270|13075589|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
5317610|NCT00439270|13075590|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
5317611|NCT00439270|13075591|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
5317612|NCT00439270|13075587|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
5317613|NCT00439270|13075588|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
5317614|NCT00439270|13075589|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
5317615|NCT00439270|13075590|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
5317616|NCT00439270|13075591|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
5317617|NCT00439270|13075587|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
5317618|NCT00439270|13075588|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
5317619|NCT00439270|13075589|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
5317620|NCT00439270|13075590|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
5317621|NCT00439270|13075591|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
5317622|NCT00439244|13075633|P3|NOT COMPLETED|Overall Study||7
5317623|NCT00439244|13075634|P2|NOT COMPLETED|Overall Study||6
5317624|NCT00439244|13075635|P1|NOT COMPLETED|Overall Study||11
5317625|NCT00439244|13075633|P3|COMPLETED|Overall Study||131
5317626|NCT00439244|13075634|P2|COMPLETED|Overall Study||131
5317627|NCT00439244|13075635|P1|COMPLETED|Overall Study||126
5317628|NCT00439244|13075633|P3|Safety Population|Overall Study||137
5317629|NCT00439244|13075634|P2|Safety Population|Overall Study||137
5317630|NCT00439244|13075635|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
5317631|NCT00439244|13075633|P3|STARTED|Overall Study||138
5317632|NCT00439244|13075634|P2|STARTED|Overall Study||137
5317633|NCT00439244|13075635|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
5317634|NCT00439231|13075655|P1|NOT COMPLETED|Overall Study||28
5317635|NCT00439231|13075655|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
5317636|NCT00439231|13075655|P1|STARTED|Overall Study||33
5317637|NCT00439218|13075659|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
5317638|NCT00439218|13075659|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
5317639|NCT00439218|13075659|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
5317640|NCT00439218|13075659|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
5317641|NCT00439218|13075659|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
5317642|NCT00439218|13075659|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
5317643|NCT00439179|13075674|P4|NOT COMPLETED|Overall Study||0
5317644|NCT00439179|13075675|P3|NOT COMPLETED|Overall Study||0
5317645|NCT00439179|13075676|P2|NOT COMPLETED|Overall Study||2
5317646|NCT00439179|13075677|P1|NOT COMPLETED|Overall Study||0
5317647|NCT00439179|13075674|P4|COMPLETED|Overall Study||5
5317648|NCT00439179|13075675|P3|COMPLETED|Overall Study||6
5317649|NCT00439179|13075676|P2|COMPLETED|Overall Study||11
5317650|NCT00439179|13075677|P1|COMPLETED|Overall Study||3
5317651|NCT00439179|13075674|P4|STARTED|Overall Study|2 with biliry|5
5317652|NCT00439179|13075675|P3|STARTED|Overall Study|2 with biliary|6
5317653|NCT00439179|13075676|P2|STARTED|Overall Study|2 with biliary|13
5317654|NCT00439179|13075677|P1|STARTED|Overall Study|1 with biliary|3
5317655|NCT00439140|13075694|P3|NOT COMPLETED|Treatment Cycle 2||0
5317656|NCT00439140|13075695|P2|NOT COMPLETED|Treatment Cycle 2||1
5317657|NCT00439140|13075696|P1|NOT COMPLETED|Treatment Cycle 2||2
5317658|NCT00439140|13075694|P3|COMPLETED|Treatment Cycle 2||0
5317659|NCT00439140|13075695|P2|COMPLETED|Treatment Cycle 2||6
5317660|NCT00439140|13075696|P1|COMPLETED|Treatment Cycle 2||11
5317661|NCT00439140|13075694|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
5317662|NCT00439140|13075695|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
5317663|NCT00439140|13075696|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
5317664|NCT00439140|13075694|P3|NOT COMPLETED|Treatment Cycle 1||1
5317665|NCT00439140|13075695|P2|NOT COMPLETED|Treatment Cycle 1||4
5317666|NCT00439140|13075696|P1|NOT COMPLETED|Treatment Cycle 1||1
5317667|NCT00439140|13075694|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
5317668|NCT00439140|13075695|P2|COMPLETED|Treatment Cycle 1||10
5317669|NCT00439140|13075696|P1|COMPLETED|Treatment Cycle 1||14
5317670|NCT00439140|13075694|P3|STARTED|Treatment Cycle 1||12
5317671|NCT00439140|13075695|P2|STARTED|Treatment Cycle 1||14
5317672|NCT00439140|13075696|P1|STARTED|Treatment Cycle 1||15
5317673|NCT00438971|13075725|P1|NOT COMPLETED|Overall Study||2
5317674|NCT00438971|13075725|P1|COMPLETED|Overall Study||15
5317675|NCT00438971|13075725|P1|STARTED|Overall Study||17
5317676|NCT00438932|13075740|P4|NOT COMPLETED|Overall Study||0
5317677|NCT00438932|13075741|P3|NOT COMPLETED|Overall Study||0
5317678|NCT00438932|13075742|P2|NOT COMPLETED|Overall Study||0
5317679|NCT00438932|13075743|P1|NOT COMPLETED|Overall Study||0
5317680|NCT00438932|13075740|P4|COMPLETED|Overall Study||4
5317681|NCT00438932|13075741|P3|COMPLETED|Overall Study||4
5317682|NCT00438932|13075742|P2|COMPLETED|Overall Study||4
5317683|NCT00438932|13075743|P1|COMPLETED|Overall Study||4
5317684|NCT00438932|13075740|P4|STARTED|Overall Study||4
5317685|NCT00438932|13075741|P3|STARTED|Overall Study||4
5317686|NCT00438932|13075742|P2|STARTED|Overall Study||4
5317687|NCT00438932|13075743|P1|STARTED|Overall Study||4
5317688|NCT00438880|13075759|P2|NOT COMPLETED|Overall Study||0
5317689|NCT00438880|13075760|P1|NOT COMPLETED|Overall Study||0
5317690|NCT00438880|13075759|P2|COMPLETED|Overall Study||8
5317691|NCT00438880|13075760|P1|COMPLETED|Overall Study||30
5317692|NCT00438880|13075759|P2|STARTED|Overall Study||8
5317693|NCT00438880|13075760|P1|STARTED|Overall Study||30
5317694|NCT00438854|13075772|P1|NOT COMPLETED|Overall Study||0
5317695|NCT00438854|13075772|P1|COMPLETED|Overall Study||15
5317696|NCT00438854|13075772|P1|STARTED|Overall Study||15
5317697|NCT00438815|13075779|P1|NOT COMPLETED|Overall Study||70
5317698|NCT00438815|13075779|P1|COMPLETED|Overall Study||43
5317699|NCT00438815|13075779|P1|STARTED|Overall Study||113
5317700|NCT00438802|13075792|P3|NOT COMPLETED|Overall Study||0
5317701|NCT00438802|13075793|P2|NOT COMPLETED|Overall Study||0
5317702|NCT00438802|13075794|P1|NOT COMPLETED|Overall Study||0
5317703|NCT00438802|13075792|P3|COMPLETED|Overall Study||9
5317704|NCT00438802|13075793|P2|COMPLETED|Overall Study||8
5317705|NCT00438802|13075794|P1|COMPLETED|Overall Study||6
5317706|NCT00438802|13075792|P3|STARTED|Overall Study||9
5317707|NCT00438802|13075793|P2|STARTED|Overall Study||8
5317708|NCT00438802|13075794|P1|STARTED|Overall Study||6
5317709|NCT00438750|13075808|P2|NOT COMPLETED|Overall Study||9
5317710|NCT00438750|13075809|P1|NOT COMPLETED|Overall Study||9
5317711|NCT00438750|13075808|P2|COMPLETED|Overall Study||37
5317712|NCT00438750|13075809|P1|COMPLETED|Overall Study||39
5317713|NCT00438750|13075808|P2|STARTED|Overall Study||46
5317714|NCT00438750|13075809|P1|STARTED|Overall Study||48
5317715|NCT00438672|13075829|P2|NOT COMPLETED|Overall Study||9
5317716|NCT00438672|13075830|P1|NOT COMPLETED|Overall Study||7
5317717|NCT00438672|13075829|P2|COMPLETED|Overall Study||24
5317718|NCT00438672|13075830|P1|COMPLETED|Overall Study||24
5317719|NCT00438672|13075829|P2|STARTED|Overall Study||33
5317720|NCT00438672|13075830|P1|STARTED|Overall Study||31
5317721|NCT00438659|13075840|P2|NOT COMPLETED|Overall Study||4
5317722|NCT00438659|13075841|P1|NOT COMPLETED|Overall Study||6
5317723|NCT00438659|13075840|P2|COMPLETED|Overall Study||82
5317724|NCT00438659|13075841|P1|COMPLETED|Overall Study||84
5317725|NCT00438659|13075840|P2|STARTED|Overall Study||86
5317726|NCT00438659|13075841|P1|STARTED|Overall Study||90
5317727|NCT00438633|13075865|P2|NOT COMPLETED|Overall Study||17
5317728|NCT00438633|13075866|P1|NOT COMPLETED|Overall Study||16
5317729|NCT00438633|13075865|P2|COMPLETED|Overall Study||14
5317730|NCT00438633|13075866|P1|COMPLETED|Overall Study||16
5317731|NCT00438633|13075865|P2|3-month Follow-up|Overall Study||24
5317732|NCT00438633|13075866|P1|3-month Follow-up|Overall Study||26
5317733|NCT00438633|13075865|P2|STARTED|Overall Study||31
5317734|NCT00438633|13075866|P1|STARTED|Overall Study||32
5317735|NCT00438490|13075882|P2|NOT COMPLETED|Overall Study||0
5317736|NCT00438490|13075883|P1|NOT COMPLETED|Overall Study||0
5317737|NCT00438490|13075882|P2|COMPLETED|Overall Study||9
5317738|NCT00438490|13075883|P1|COMPLETED|Overall Study||12
5317739|NCT00438490|13075882|P2|STARTED|Overall Study||9
5317740|NCT00438490|13075883|P1|STARTED|Overall Study||12
5317741|NCT00438464|13075897|P2|NOT COMPLETED|Overall Study||7
5317742|NCT00438464|13075898|P1|NOT COMPLETED|Overall Study||14
5317743|NCT00438464|13075897|P2|COMPLETED|Overall Study||94
5317744|NCT00438464|13075898|P1|COMPLETED|Overall Study||89
5317745|NCT00438464|13075897|P2|Received Assigned Intervention|Overall Study||94
5317746|NCT00438464|13075898|P1|Received Assigned Intervention|Overall Study||89
5317747|NCT00438464|13075897|P2|STARTED|Overall Study||101
5317748|NCT00438464|13075898|P1|STARTED|Overall Study||103
5317749|NCT00438451|13075953|P3|NOT COMPLETED|Overall Study||53
5317750|NCT00438451|13075954|P2|NOT COMPLETED|Overall Study||66
5317751|NCT00438451|13075955|P1|NOT COMPLETED|Overall Study||47
5317752|NCT00438451|13075953|P3|COMPLETED|Overall Study||65
5317753|NCT00438451|13075954|P2|COMPLETED|Overall Study||55
5317754|NCT00438451|13075955|P1|COMPLETED|Overall Study||75
5317755|NCT00438451|13075953|P3|Maintenance Phase (Week 7-58)|Overall Study||93
5317756|NCT00438451|13075954|P2|Maintenance Phase (Week 7-58)|Overall Study||89
5317757|NCT00438451|13075955|P1|Maintenance Phase (Week 7-58)|Overall Study||93
5317758|NCT00438451|13075953|P3|ITT Population|Overall Study||117
5317759|NCT00438451|13075954|P2|ITT Population|Overall Study||120
5317760|NCT00438451|13075955|P1|ITT Population|Overall Study||122
5317761|NCT00438451|13075953|P3|Safety Population|Overall Study||117
5317762|NCT00438451|13075954|P2|Safety Population|Overall Study||121
5317763|NCT00438451|13075955|P1|Safety Population|Overall Study||122
5317764|NCT00438451|13075953|P3|STARTED|Overall Study||118
5317765|NCT00438451|13075954|P2|STARTED|Overall Study||121
5317766|NCT00438451|13075955|P1|STARTED|Overall Study||122
5317767|NCT00438399|13075999|P6|NOT COMPLETED|Overall Study||6
5317768|NCT00438399|13076000|P5|NOT COMPLETED|Overall Study||3
5317769|NCT00438399|13076001|P4|NOT COMPLETED|Overall Study||4
5317770|NCT00438399|13076002|P3|NOT COMPLETED|Overall Study||7
5317771|NCT00438399|13076003|P2|NOT COMPLETED|Overall Study||8
5317772|NCT00438399|13076004|P1|NOT COMPLETED|Overall Study||8
5317773|NCT00438399|13075999|P6|COMPLETED|Overall Study||31
5317774|NCT00438399|13076000|P5|COMPLETED|Overall Study||30
5317775|NCT00438399|13076001|P4|COMPLETED|Overall Study||32
5317776|NCT00438399|13076002|P3|COMPLETED|Overall Study||28
5317777|NCT00438399|13076003|P2|COMPLETED|Overall Study||32
5317778|NCT00438399|13076004|P1|COMPLETED|Overall Study||30
5317779|NCT00438399|13075999|P6|TREATED & ANALYZED|Overall Study||31
5317780|NCT00438399|13076000|P5|TREATED & ANALYZED|Overall Study||30
5317781|NCT00438399|13076001|P4|TREATED & ANALYZED|Overall Study||32
5317782|NCT00438399|13076002|P3|TREATED & ANALYZED|Overall Study||28
5317783|NCT00438399|13076003|P2|TREATED & ANALYZED|Overall Study||32
5317784|NCT00438399|13076004|P1|TREATED & ANALYZED|Overall Study||30
5317785|NCT00438399|13075999|P6|STARTED|Overall Study||37
5317786|NCT00438399|13076000|P5|STARTED|Overall Study||33
5317787|NCT00438399|13076001|P4|STARTED|Overall Study||36
5317788|NCT00438399|13076002|P3|STARTED|Overall Study||35
5317789|NCT00438399|13076003|P2|STARTED|Overall Study||40
5317790|NCT00438399|13076004|P1|STARTED|Overall Study||38
5317791|NCT00438360|13076015|P2|NOT COMPLETED|Overall Study||43
5317792|NCT00438360|13076016|P1|NOT COMPLETED|Overall Study||72
5317793|NCT00438360|13076015|P2|COMPLETED|Overall Study||38
5317794|NCT00438360|13076016|P1|COMPLETED|Overall Study||90
5317795|NCT00438360|13076015|P2|Intention to Treat (ITT) Population|Overall Study||79
5317796|NCT00438360|13076016|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
5317797|NCT00438360|13076015|P2|STARTED|Overall Study||81
5317798|NCT00438360|13076016|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
5317799|NCT00438256|13076030|P4|NOT COMPLETED|Overall Study||9
5317800|NCT00438256|13076031|P3|NOT COMPLETED|Overall Study||1
5317801|NCT00438256|13076032|P2|NOT COMPLETED|Overall Study||1
5317802|NCT00438256|13076033|P1|NOT COMPLETED|Overall Study||2
5317803|NCT00438256|13076030|P4|COMPLETED|Overall Study||32
5317804|NCT00438256|13076031|P3|COMPLETED|Overall Study||2
5317805|NCT00438256|13076032|P2|COMPLETED|Overall Study||2
5317806|NCT00438256|13076033|P1|COMPLETED|Overall Study||1
5317807|NCT00438256|13076030|P4|Surgical Resection|Overall Study||34
5317808|NCT00438256|13076031|P3|Surgical Resection|Overall Study||2
5317809|NCT00438256|13076032|P2|Surgical Resection|Overall Study||2
5317810|NCT00438256|13076033|P1|Surgical Resection|Overall Study||1
5317811|NCT00438256|13076030|P4|STARTED|Overall Study||41
5317812|NCT00438256|13076031|P3|STARTED|Overall Study||3
5317813|NCT00438256|13076032|P2|STARTED|Overall Study||3
5317814|NCT00438256|13076033|P1|STARTED|Overall Study||3
5317815|NCT00438204|13076049|P1|NOT COMPLETED|Overall Study||0
5317816|NCT00438204|13076049|P1|COMPLETED|Overall Study||39
5317817|NCT00438204|13076049|P1|STARTED|Overall Study||39
5317818|NCT00438191|13076059|P2|NOT COMPLETED|Overall Study||14
5317819|NCT00438191|13076060|P1|NOT COMPLETED|Overall Study||11
5317820|NCT00438191|13076059|P2|COMPLETED|Overall Study||26
5317821|NCT00438191|13076060|P1|COMPLETED|Overall Study||32
5317822|NCT00438191|13076059|P2|STARTED|Overall Study||40
5317823|NCT00438191|13076060|P1|STARTED|Overall Study||43
5317824|NCT00438100|13076074|P2|NOT COMPLETED|Overall Study||4
5317825|NCT00438100|13076075|P1|NOT COMPLETED|Overall Study||2
5317826|NCT00438100|13076074|P2|COMPLETED|Overall Study||65
5317827|NCT00438100|13076075|P1|COMPLETED|Overall Study||71
5317828|NCT00438100|13076074|P2|STARTED|Overall Study||69
5317829|NCT00438100|13076075|P1|STARTED|Overall Study||73
5317830|NCT00437983|13076083|P2|NOT COMPLETED|Overall Study||13
5317831|NCT00437983|13076084|P1|NOT COMPLETED|Overall Study||13
5317832|NCT00437983|13076083|P2|COMPLETED|Overall Study||65
5317833|NCT00437983|13076084|P1|COMPLETED|Overall Study||66
5317834|NCT00437983|13076083|P2|STARTED|Overall Study||78
5317835|NCT00437983|13076084|P1|STARTED|Overall Study||79
5317836|NCT00437658|13076097|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
5317837|NCT00437658|13076098|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
5317838|NCT00437658|13076099|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
5317839|NCT00437658|13076097|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
5317840|NCT00437658|13076098|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
5317841|NCT00437658|13076099|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
5317842|NCT00437658|13076097|P3|STARTED|Post-treatment Period (24 Weeks)||51
5317843|NCT00437658|13076098|P2|STARTED|Post-treatment Period (24 Weeks)||62
5317844|NCT00437658|13076099|P1|STARTED|Post-treatment Period (24 Weeks)||56
5317845|NCT00437658|13076097|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
5317846|NCT00437658|13076098|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
5317847|NCT00437658|13076099|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
5317848|NCT00437658|13076097|P3|COMPLETED|Treatment Period (24 Weeks)||51
5317849|NCT00437658|13076098|P2|COMPLETED|Treatment Period (24 Weeks)||62
5317850|NCT00437658|13076099|P1|COMPLETED|Treatment Period (24 Weeks)||56
5317851|NCT00437658|13076097|P3|Received Study Drug|Treatment Period (24 Weeks)||84
5317852|NCT00437658|13076098|P2|Received Study Drug|Treatment Period (24 Weeks)||84
5317853|NCT00437658|13076099|P1|Received Study Drug|Treatment Period (24 Weeks)||84
5317854|NCT00437658|13076097|P3|STARTED|Treatment Period (24 Weeks)||84
5317855|NCT00437658|13076098|P2|STARTED|Treatment Period (24 Weeks)||84
5317856|NCT00437658|13076099|P1|STARTED|Treatment Period (24 Weeks)||84
5317857|NCT00437645|13076193|P2|NOT COMPLETED|Overall Study||115
5317858|NCT00437645|13076194|P1|NOT COMPLETED|Overall Study||35
5317859|NCT00437645|13076193|P2|COMPLETED|Overall Study||476
5317860|NCT00437645|13076194|P1|COMPLETED|Overall Study||557
5317861|NCT00437645|13076193|P2|STARTED|Overall Study||591
5317862|NCT00437645|13076194|P1|STARTED|Overall Study||592
5317863|NCT00437489|13076210|P2|NOT COMPLETED|Overall Study||22
5317864|NCT00437489|13076211|P1|NOT COMPLETED|Overall Study||23
5317865|NCT00437489|13076210|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
5317866|NCT00437489|13076211|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
5317867|NCT00437489|13076210|P2|STARTED|Overall Study||24
5317868|NCT00437489|13076211|P1|STARTED|Overall Study||25
5317869|NCT00437398|13076223|P1|NOT COMPLETED|Overall Study||0
5317870|NCT00437398|13076223|P1|COMPLETED|Overall Study||2
5317871|NCT00437398|13076223|P1|STARTED|Overall Study||2
5317872|NCT00437281|13076248|P20|NOT COMPLETED|Overall Study||1
5317873|NCT00437281|13076249|P19|NOT COMPLETED|Overall Study||1
5317874|NCT00437281|13076250|P18|NOT COMPLETED|Overall Study||0
5317875|NCT00437281|13076251|P17|NOT COMPLETED|Overall Study||0
5317876|NCT00437281|13076252|P16|NOT COMPLETED|Overall Study||0
5317877|NCT00437281|13076253|P15|NOT COMPLETED|Overall Study||1
5317878|NCT00437281|13076254|P14|NOT COMPLETED|Overall Study||1
5317879|NCT00437281|13076255|P13|NOT COMPLETED|Overall Study||0
5317880|NCT00437281|13076256|P12|NOT COMPLETED|Overall Study||0
5317881|NCT00437281|13076257|P11|NOT COMPLETED|Overall Study||0
5317882|NCT00437281|13076258|P10|NOT COMPLETED|Overall Study||1
5317883|NCT00437281|13076259|P9|NOT COMPLETED|Overall Study||0
5317884|NCT00437281|13076260|P8|NOT COMPLETED|Overall Study||0
5317885|NCT00437281|13076261|P7|NOT COMPLETED|Overall Study||0
5317886|NCT00437281|13076262|P6|NOT COMPLETED|Overall Study||1
5317887|NCT00437281|13076263|P5|NOT COMPLETED|Overall Study||0
5317888|NCT00437281|13076264|P4|NOT COMPLETED|Overall Study||1
5317889|NCT00437281|13076265|P3|NOT COMPLETED|Overall Study||0
5317890|NCT00437281|13076266|P2|NOT COMPLETED|Overall Study||0
5317891|NCT00437281|13076267|P1|NOT COMPLETED|Overall Study||0
5317892|NCT00437281|13076248|P20|COMPLETED|Overall Study||2
5317893|NCT00437281|13076249|P19|COMPLETED|Overall Study||1
5317894|NCT00437281|13076250|P18|COMPLETED|Overall Study||4
5317895|NCT00437281|13076251|P17|COMPLETED|Overall Study||3
5317896|NCT00437281|13076252|P16|COMPLETED|Overall Study||3
5317897|NCT00437281|13076253|P15|COMPLETED|Overall Study||4
5317898|NCT00437281|13076254|P14|COMPLETED|Overall Study||2
5317899|NCT00437281|13076255|P13|COMPLETED|Overall Study||2
5317900|NCT00437281|13076256|P12|COMPLETED|Overall Study||3
5317901|NCT00437281|13076257|P11|COMPLETED|Overall Study||3
5317902|NCT00437281|13076258|P10|COMPLETED|Overall Study||4
5317903|NCT00437281|13076259|P9|COMPLETED|Overall Study||3
5317904|NCT00437281|13076260|P8|COMPLETED|Overall Study||3
5317905|NCT00437281|13076261|P7|COMPLETED|Overall Study||3
5317906|NCT00437281|13076262|P6|COMPLETED|Overall Study||3
5317907|NCT00437281|13076263|P5|COMPLETED|Overall Study||4
5317908|NCT00437281|13076264|P4|COMPLETED|Overall Study||2
5317909|NCT00437281|13076265|P3|COMPLETED|Overall Study||3
5317910|NCT00437281|13076266|P2|COMPLETED|Overall Study||3
5317911|NCT00437281|13076267|P1|COMPLETED|Overall Study||3
5317912|NCT00437281|13076248|P20|STARTED|Overall Study||3
5317913|NCT00437281|13076249|P19|STARTED|Overall Study||2
5317914|NCT00437281|13076250|P18|STARTED|Overall Study||4
5317915|NCT00437281|13076251|P17|STARTED|Overall Study||3
5317916|NCT00437281|13076252|P16|STARTED|Overall Study||3
5317917|NCT00437281|13076253|P15|STARTED|Overall Study||5
5317918|NCT00437281|13076254|P14|STARTED|Overall Study||3
5317919|NCT00437281|13076255|P13|STARTED|Overall Study||2
5317920|NCT00437281|13076256|P12|STARTED|Overall Study||3
5317921|NCT00437281|13076257|P11|STARTED|Overall Study||3
5317922|NCT00437281|13076258|P10|STARTED|Overall Study||5
5317923|NCT00437281|13076259|P9|STARTED|Overall Study||3
5317924|NCT00437281|13076260|P8|STARTED|Overall Study||3
5317925|NCT00437281|13076261|P7|STARTED|Overall Study||3
5317926|NCT00437281|13076262|P6|STARTED|Overall Study||4
5317927|NCT00437281|13076263|P5|STARTED|Overall Study||4
5317928|NCT00437281|13076264|P4|STARTED|Overall Study||3
5317929|NCT00437281|13076265|P3|STARTED|Overall Study||3
5317930|NCT00437281|13076266|P2|STARTED|Overall Study||3
5317931|NCT00437281|13076267|P1|STARTED|Overall Study||3
5317932|NCT00437268|13076563|P2|NOT COMPLETED|Overall Study||13
5317933|NCT00437268|13076564|P1|NOT COMPLETED|Overall Study||13
5317934|NCT00437268|13076563|P2|COMPLETED|Overall Study||0
5317935|NCT00437268|13076564|P1|COMPLETED|Overall Study||0
5317936|NCT00437268|13076563|P2|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
5317937|NCT00437268|13076564|P1|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
5317938|NCT00437268|13076563|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
5317939|NCT00437268|13076564|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
5317940|NCT00437268|13076563|P2|STARTED|Overall Study||13
5317941|NCT00437268|13076564|P1|STARTED|Overall Study||13
5317942|NCT00437203|13076590|P10|NOT COMPLETED|Overall Study||4
5317943|NCT00437203|13076591|P9|NOT COMPLETED|Overall Study||3
5317944|NCT00437203|13076592|P8|NOT COMPLETED|Overall Study||3
5317945|NCT00437203|13076593|P7|NOT COMPLETED|Overall Study||7
5317946|NCT00437203|13076594|P6|NOT COMPLETED|Overall Study||3
5317947|NCT00437203|13076595|P5|NOT COMPLETED|Overall Study||3
5317948|NCT00437203|13076596|P4|NOT COMPLETED|Overall Study||3
5317949|NCT00437203|13076597|P3|NOT COMPLETED|Overall Study||3
5317950|NCT00437203|13076598|P2|NOT COMPLETED|Overall Study||8
5317951|NCT00437203|13076599|P1|NOT COMPLETED|Overall Study||6
5317952|NCT00437203|13076590|P10|COMPLETED|Overall Study||0
5317953|NCT00437203|13076591|P9|COMPLETED|Overall Study||0
5317954|NCT00437203|13076592|P8|COMPLETED|Overall Study||0
5317955|NCT00437203|13076593|P7|COMPLETED|Overall Study||0
5317956|NCT00437203|13076594|P6|COMPLETED|Overall Study||0
5317957|NCT00437203|13076595|P5|COMPLETED|Overall Study||0
5317958|NCT00437203|13076596|P4|COMPLETED|Overall Study||0
5317959|NCT00437203|13076597|P3|COMPLETED|Overall Study||0
5317960|NCT00437203|13076598|P2|COMPLETED|Overall Study||0
5317961|NCT00437203|13076599|P1|COMPLETED|Overall Study||0
5317962|NCT00437203|13076590|P10|STARTED|Overall Study||4
5317963|NCT00437203|13076591|P9|STARTED|Overall Study||3
5317964|NCT00437203|13076592|P8|STARTED|Overall Study||3
5317965|NCT00437203|13076593|P7|STARTED|Overall Study||7
5317966|NCT00437203|13076594|P6|STARTED|Overall Study||3
5317967|NCT00437203|13076595|P5|STARTED|Overall Study||3
5317968|NCT00437203|13076596|P4|STARTED|Overall Study||3
5317969|NCT00437203|13076597|P3|STARTED|Overall Study||3
5317970|NCT00437203|13076598|P2|STARTED|Overall Study||8
5317971|NCT00437203|13076599|P1|STARTED|Overall Study||6
5317972|NCT00437125|13076703|P1|NOT COMPLETED|Overall Study||32
5317973|NCT00437125|13076703|P1|COMPLETED|Overall Study||119
5317974|NCT00437125|13076703|P1|STARTED|Overall Study||151
5317975|NCT00437073|13076724|P2|NOT COMPLETED|Overall Study||1
5317976|NCT00437073|13076725|P1|NOT COMPLETED|Overall Study||1
5317977|NCT00437073|13076724|P2|COMPLETED|Overall Study||8
5317978|NCT00437073|13076725|P1|COMPLETED|Overall Study||12
5317979|NCT00437073|13076724|P2|STARTED|Overall Study||9
5317980|NCT00437073|13076725|P1|STARTED|Overall Study||13
5317981|NCT00437034|13076753|P1|NOT COMPLETED|Overall Study||6
5317982|NCT00437034|13076753|P1|COMPLETED|Overall Study||0
5317983|NCT00437034|13076753|P1|STARTED|Overall Study||6
5317984|NCT00436982|13076759|P2|NOT COMPLETED|Overall Study||4
5317985|NCT00436982|13076760|P1|NOT COMPLETED|Overall Study||4
5317986|NCT00436982|13076759|P2|COMPLETED|Overall Study||26
5317987|NCT00436982|13076760|P1|COMPLETED|Overall Study||26
5317988|NCT00436982|13076759|P2|STARTED|Overall Study||30
5317989|NCT00436982|13076760|P1|STARTED|Overall Study||30
5317990|NCT00436969|13076782|P2|NOT COMPLETED|Overall Study||52
5317991|NCT00436969|13076783|P1|NOT COMPLETED|Overall Study||22
5317992|NCT00436969|13076782|P2|COMPLETED|Overall Study||134
5317993|NCT00436969|13076783|P1|COMPLETED|Overall Study||66
5317994|NCT00436969|13076782|P2|Randomized But Not Treated|Overall Study||3
5317995|NCT00436969|13076783|P1|Randomized But Not Treated|Overall Study||1
5317996|NCT00436969|13076782|P2|STARTED|Overall Study||186
5317997|NCT00436969|13076783|P1|STARTED|Overall Study||88
5317998|NCT00436956|13076831|P2|NOT COMPLETED|Overall Study||0
5317999|NCT00436956|13076832|P1|NOT COMPLETED|Overall Study||1
5318000|NCT00436956|13076831|P2|COMPLETED|Overall Study||23
5318001|NCT00436956|13076832|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
5318002|NCT00436956|13076831|P2|STARTED|Overall Study||23
5318003|NCT00436956|13076832|P1|STARTED|Overall Study||36
5318004|NCT00436917|13076846|P1|NOT COMPLETED|Overall Study||21
5318005|NCT00436917|13076846|P1|COMPLETED|Overall Study||32
5318089|NCT00436618|13076966|P1|STARTED|Overall Study||114
5318006|NCT00436917|13076846|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
5318007|NCT00436904|13076861|P1|NOT COMPLETED|Overall Study||0
5318008|NCT00436904|13076861|P1|COMPLETED|Overall Study||30
5318009|NCT00436904|13076861|P1|STARTED|Overall Study||30
5318010|NCT00436852|13076872|P2|NOT COMPLETED|Overall Study||45
5318011|NCT00436852|13076873|P1|NOT COMPLETED|Overall Study||35
5318012|NCT00436852|13076872|P2|COMPLETED|Overall Study||2
5318013|NCT00436852|13076873|P1|COMPLETED|Overall Study||10
5318014|NCT00436852|13076872|P2|STARTED|Overall Study||47
5318015|NCT00436852|13076873|P1|STARTED|Overall Study||45
5318016|NCT00436826|13076892|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
5318017|NCT00436826|13076893|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
5318018|NCT00436826|13076894|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318019|NCT00436826|13076895|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318020|NCT00436826|13076896|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318021|NCT00436826|13076897|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318022|NCT00436826|13076892|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318023|NCT00436826|13076893|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
5318024|NCT00436826|13076894|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318025|NCT00436826|13076895|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318026|NCT00436826|13076896|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318027|NCT00436826|13076897|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
5318028|NCT00436826|13076892|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
5318029|NCT00436826|13076893|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
5318030|NCT00436826|13076894|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
5318031|NCT00436826|13076895|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
5318032|NCT00436826|13076896|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
5318033|NCT00436826|13076897|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
5318034|NCT00436826|13076892|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318035|NCT00436826|13076893|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318036|NCT00436826|13076894|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
5318037|NCT00436826|13076895|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
5318038|NCT00436826|13076896|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318039|NCT00436826|13076897|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318040|NCT00436826|13076892|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318041|NCT00436826|13076893|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318042|NCT00436826|13076894|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
5318043|NCT00436826|13076895|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
5318044|NCT00436826|13076896|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318045|NCT00436826|13076897|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
5318046|NCT00436826|13076892|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
5318047|NCT00436826|13076893|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
5318048|NCT00436826|13076894|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
5318049|NCT00436826|13076895|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
5318050|NCT00436826|13076896|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
5318051|NCT00436826|13076897|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
5318052|NCT00436826|13076892|P6|NOT COMPLETED|Double Blind Period||0
5318053|NCT00436826|13076893|P5|NOT COMPLETED|Double Blind Period||0
5318054|NCT00436826|13076894|P4|NOT COMPLETED|Double Blind Period||0
5318055|NCT00436826|13076895|P3|NOT COMPLETED|Double Blind Period||0
5318056|NCT00436826|13076896|P2|NOT COMPLETED|Double Blind Period||11
5318057|NCT00436826|13076897|P1|NOT COMPLETED|Double Blind Period||13
5318058|NCT00436826|13076892|P6|COMPLETED|Double Blind Period||0
5318059|NCT00436826|13076893|P5|COMPLETED|Double Blind Period||0
5318060|NCT00436826|13076894|P4|COMPLETED|Double Blind Period||0
5318061|NCT00436826|13076895|P3|COMPLETED|Double Blind Period||0
5318062|NCT00436826|13076896|P2|COMPLETED|Double Blind Period||37
5318063|NCT00436826|13076897|P1|COMPLETED|Double Blind Period||111
5318064|NCT00436826|13076892|P6|STARTED|Double Blind Period||0
5318065|NCT00436826|13076893|P5|STARTED|Double Blind Period||0
5318066|NCT00436826|13076894|P4|STARTED|Double Blind Period||0
5318067|NCT00436826|13076895|P3|STARTED|Double Blind Period||0
5318068|NCT00436826|13076896|P2|STARTED|Double Blind Period||48
5318069|NCT00436826|13076897|P1|STARTED|Double Blind Period||124
5318070|NCT00436748|13076919|P2|NOT COMPLETED|Overall Study||12
5318071|NCT00436748|13076920|P1|NOT COMPLETED|Overall Study||11
5318072|NCT00436748|13076919|P2|COMPLETED|Overall Study||45
5318073|NCT00436748|13076920|P1|COMPLETED|Overall Study||48
5318074|NCT00436748|13076919|P2|Received Treatment|Overall Study||56
5318075|NCT00436748|13076920|P1|Received Treatment|Overall Study||58
5318076|NCT00436748|13076919|P2|STARTED|Overall Study||57
5318077|NCT00436748|13076920|P1|STARTED|Overall Study||59
5318078|NCT00436644|13076954|P1|NOT COMPLETED|Overall Study||3
5318079|NCT00436644|13076954|P1|COMPLETED|Overall Study||15
5318080|NCT00436644|13076954|P1|STARTED|Overall Study||18
5318081|NCT00436618|13076964|P3|NOT COMPLETED|Overall Study||61
5318082|NCT00436618|13076965|P2|NOT COMPLETED|Overall Study||27
5318083|NCT00436618|13076966|P1|NOT COMPLETED|Overall Study||30
5318084|NCT00436618|13076964|P3|COMPLETED|Overall Study||46
5318085|NCT00436618|13076965|P2|COMPLETED|Overall Study||28
5318086|NCT00436618|13076966|P1|COMPLETED|Overall Study||84
5318087|NCT00436618|13076964|P3|STARTED|Overall Study||107
5318088|NCT00436618|13076965|P2|STARTED|Overall Study||55
5318090|NCT00436605|13076983|P1|NOT COMPLETED|Overall Study||3
5318091|NCT00436605|13076983|P1|COMPLETED|Overall Study||36
5318092|NCT00436605|13076983|P1|STARTED|Overall Study||39
5318093|NCT00436566|13076988|P1|NOT COMPLETED|Overall Study||3
5318094|NCT00436566|13076988|P1|COMPLETED|Overall Study||109
5318095|NCT00436566|13076988|P1|STARTED|Overall Study||112
5318096|NCT00436553|13076995|P3|NOT COMPLETED|Overall Study||10
5318097|NCT00436553|13076996|P2|NOT COMPLETED|Overall Study||12
5318098|NCT00436553|13076997|P1|NOT COMPLETED|Overall Study||13
5318099|NCT00436553|13076995|P3|COMPLETED|Overall Study||102
5318100|NCT00436553|13076996|P2|COMPLETED|Overall Study||93
5318101|NCT00436553|13076997|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
5318102|NCT00436553|13076995|P3|STARTED|Overall Study||112
5318103|NCT00436553|13076996|P2|STARTED|Overall Study||105
5318104|NCT00436553|13076997|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
5318105|NCT00436501|13077018|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
5318106|NCT00436501|13077019|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
5318107|NCT00436501|13077018|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
5318108|NCT00436501|13077019|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
5318109|NCT00436501|13077018|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
5318110|NCT00436501|13077019|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
5318111|NCT00436501|13077018|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
5318112|NCT00436501|13077019|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
5318113|NCT00436501|13077018|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
5318114|NCT00436501|13077019|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
5318115|NCT00436501|13077018|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
5318116|NCT00436501|13077019|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
5318117|NCT00436501|13077018|P2|NOT COMPLETED|Complete Study Participation||0
5318118|NCT00436501|13077019|P1|NOT COMPLETED|Complete Study Participation||0
5318119|NCT00436501|13077018|P2|COMPLETED|Complete Study Participation||49
5318120|NCT00436501|13077019|P1|COMPLETED|Complete Study Participation||9
5318121|NCT00436501|13077018|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
5318122|NCT00436501|13077019|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
5318123|NCT00436475|13077038|P4|NOT COMPLETED|Overall Study||2
5318124|NCT00436475|13077039|P3|NOT COMPLETED|Overall Study||1
5318125|NCT00436475|13077040|P2|NOT COMPLETED|Overall Study||1
5318126|NCT00436475|13077041|P1|NOT COMPLETED|Overall Study||0
5318127|NCT00436475|13077038|P4|COMPLETED|Overall Study||22
5318128|NCT00436475|13077039|P3|COMPLETED|Overall Study||21
5318129|NCT00436475|13077040|P2|COMPLETED|Overall Study||22
5318130|NCT00436475|13077041|P1|COMPLETED|Overall Study||23
5318131|NCT00436475|13077038|P4|STARTED|Overall Study||24
5318132|NCT00436475|13077039|P3|STARTED|Overall Study||22
5318133|NCT00436475|13077040|P2|STARTED|Overall Study||23
5318134|NCT00436475|13077041|P1|STARTED|Overall Study||23
5318135|NCT00436436|13077055|P1|NOT COMPLETED|Overall Study||12
5318136|NCT00436436|13077055|P1|COMPLETED|Overall Study||0
5318137|NCT00436436|13077055|P1|STARTED|Overall Study||12
5318138|NCT00436345|13077066|P2|NOT COMPLETED|Overall Study||0
5318139|NCT00436345|13077067|P1|NOT COMPLETED|Overall Study||3
5318140|NCT00436345|13077066|P2|COMPLETED|Overall Study||18
5318141|NCT00436345|13077067|P1|COMPLETED|Overall Study||18
5318142|NCT00436345|13077066|P2|STARTED|Overall Study||18
5318143|NCT00436345|13077067|P1|STARTED|Overall Study||21
5318144|NCT00436332|13077120|P1|NOT COMPLETED|Overall Study||83
5318145|NCT00436332|13077120|P1|COMPLETED|Overall Study||1
5318146|NCT00436332|13077120|P1|Eligible and Began Protocol Therapy|Overall Study||79
5318147|NCT00436332|13077120|P1|Eligible|Overall Study||82
5318148|NCT00436332|13077120|P1|STARTED|Overall Study||84
5318149|NCT00436215|13077127|P1|NOT COMPLETED|Overall Study||4
5318150|NCT00436215|13077127|P1|COMPLETED|Overall Study||51
5318151|NCT00436215|13077127|P1|STARTED|Overall Study||55
5318152|NCT00436163|13077133|P1|NOT COMPLETED|Overall Study||3
5318153|NCT00436163|13077133|P1|COMPLETED|Overall Study||36
5318154|NCT00436163|13077133|P1|STARTED|Overall Study||39
5318155|NCT00436046|13077147|P3|NOT COMPLETED|Overall Study||0
5318156|NCT00436046|13077148|P2|NOT COMPLETED|Overall Study||0
5318157|NCT00436046|13077149|P1|NOT COMPLETED|Overall Study||0
5318158|NCT00436046|13077147|P3|COMPLETED|Overall Study||31
5318159|NCT00436046|13077148|P2|COMPLETED|Overall Study||32
5318160|NCT00436046|13077149|P1|COMPLETED|Overall Study||32
5318161|NCT00436046|13077147|P3|STARTED|Overall Study||31
5318162|NCT00436046|13077148|P2|STARTED|Overall Study||32
5318163|NCT00436046|13077149|P1|STARTED|Overall Study||32
5318164|NCT00436007|13077181|P3|NOT COMPLETED|Overall Study||23
5318165|NCT00436007|13077182|P2|NOT COMPLETED|Overall Study||14
5318166|NCT00436007|13077183|P1|NOT COMPLETED|Overall Study||19
5318167|NCT00436007|13077181|P3|COMPLETED|Overall Study||148
5318168|NCT00436007|13077182|P2|COMPLETED|Overall Study||156
5318169|NCT00436007|13077183|P1|COMPLETED|Overall Study||151
5318170|NCT00436007|13077181|P3|STARTED|Overall Study||171
5318171|NCT00436007|13077182|P2|STARTED|Overall Study||170
5318172|NCT00436007|13077183|P1|STARTED|Overall Study||170
5318173|NCT00435994|13077231|P3|NOT COMPLETED|Overall Study||0
5318174|NCT00435994|13077232|P2|NOT COMPLETED|Overall Study||0
5318175|NCT00435994|13077233|P1|NOT COMPLETED|Overall Study||7
5318176|NCT00435994|13077231|P3|COMPLETED|Overall Study||12
5318177|NCT00435994|13077232|P2|COMPLETED|Overall Study||25
5318178|NCT00435994|13077233|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
5318179|NCT00435994|13077231|P3|STARTED|Overall Study||12
5318180|NCT00435994|13077232|P2|STARTED|Overall Study||25
5318181|NCT00435994|13077233|P1|STARTED|Overall Study||22
5318182|NCT00435942|13077244|P2|NOT COMPLETED|Overall Study||27
5318183|NCT00435942|13077245|P1|NOT COMPLETED|Overall Study||23
5318184|NCT00435942|13077244|P2|COMPLETED|Overall Study||33
5318185|NCT00435942|13077245|P1|COMPLETED|Overall Study||97
5318186|NCT00435942|13077244|P2|STARTED|Overall Study||60
5318187|NCT00435942|13077245|P1|STARTED|Overall Study||120
5318188|NCT00435929|13077254|P2|NOT COMPLETED|Overall Study||0
5318189|NCT00435929|13077255|P1|NOT COMPLETED|Overall Study||0
5318190|NCT00435929|13077254|P2|COMPLETED|Overall Study||9
5318191|NCT00435929|13077255|P1|COMPLETED|Overall Study||7
5318192|NCT00435929|13077254|P2|STARTED|Overall Study||9
5318193|NCT00435929|13077255|P1|STARTED|Overall Study||7
5318194|NCT00435825|13077285|P4|NOT COMPLETED|Overall Study||16
5318195|NCT00435825|13077286|P3|NOT COMPLETED|Overall Study||11
5318196|NCT00435825|13077287|P2|NOT COMPLETED|Overall Study||12
5318197|NCT00435825|13077288|P1|NOT COMPLETED|Overall Study||18
5318198|NCT00435825|13077285|P4|COMPLETED|Overall Study||120
5318199|NCT00435825|13077286|P3|COMPLETED|Overall Study||127
5318200|NCT00435825|13077287|P2|COMPLETED|Overall Study||124
5318201|NCT00435825|13077288|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
5318202|NCT00435825|13077285|P4|Completed 48 Weeks Treatment|Overall Study||117
5318203|NCT00435825|13077286|P3|Completed 48 Weeks Treatment|Overall Study||124
5318204|NCT00435825|13077287|P2|Completed 48 Weeks Treatment|Overall Study||0
5318205|NCT00435825|13077288|P1|Completed 48 Weeks Treatment|Overall Study||0
5318206|NCT00435825|13077285|P4|Completed 24 Weeks Treatment|Overall Study||131
5318207|NCT00435825|13077286|P3|Completed 24 Weeks Treatment|Overall Study||134
5318208|NCT00435825|13077287|P2|Completed 24 Weeks Treatment|Overall Study||126
5318209|NCT00435825|13077288|P1|Completed 24 Weeks Treatment|Overall Study||128
5318210|NCT00435825|13077285|P4|Entered Follow-up|Overall Study||133
5318211|NCT00435825|13077286|P3|Entered Follow-up|Overall Study||135
5318212|NCT00435825|13077287|P2|Entered Follow-up|Overall Study||132
5318213|NCT00435825|13077288|P1|Entered Follow-up|Overall Study||140
5318214|NCT00435825|13077285|P4|Received Study Drug|Overall Study||136
5318215|NCT00435825|13077286|P3|Received Study Drug|Overall Study||136
5318216|NCT00435825|13077287|P2|Received Study Drug|Overall Study||136
5318217|NCT00435825|13077288|P1|Received Study Drug|Overall Study||140
5318218|NCT00435825|13077285|P4|STARTED|Overall Study||136
5318219|NCT00435825|13077286|P3|STARTED|Overall Study||138
5318220|NCT00435825|13077287|P2|STARTED|Overall Study||136
5318221|NCT00435825|13077288|P1|STARTED|Overall Study||141
5318222|NCT00435812|13077344|P2|NOT COMPLETED|Overall Study||18
5318223|NCT00435812|13077345|P1|NOT COMPLETED|Overall Study||63
5318224|NCT00435812|13077344|P2|COMPLETED|Overall Study||590
5318225|NCT00435812|13077345|P1|COMPLETED|Overall Study||1757
5318226|NCT00435812|13077344|P2|STARTED|Overall Study||608
5318227|NCT00435812|13077345|P1|STARTED|Overall Study||1820
5318228|NCT00435591|13077357|P4|NOT COMPLETED|Overall Study||11
5318229|NCT00435591|13077358|P3|NOT COMPLETED|Overall Study||5
5318230|NCT00435591|13077359|P2|NOT COMPLETED|Overall Study||4
5318231|NCT00435591|13077360|P1|NOT COMPLETED|Overall Study||7
5318232|NCT00435591|13077357|P4|COMPLETED|Overall Study||19
5318233|NCT00435591|13077358|P3|COMPLETED|Overall Study||25
5318234|NCT00435591|13077359|P2|COMPLETED|Overall Study||27
5318235|NCT00435591|13077360|P1|COMPLETED|Overall Study||23
5318236|NCT00435591|13077357|P4|End of Treatment|Overall Study||23
5318237|NCT00435591|13077358|P3|End of Treatment|Overall Study||27
5318238|NCT00435591|13077359|P2|End of Treatment|Overall Study||27
5318239|NCT00435591|13077360|P1|End of Treatment|Overall Study||25
5318240|NCT00435591|13077357|P4|Full Analysis Set|Overall Study||29
5318241|NCT00435591|13077358|P3|Full Analysis Set|Overall Study||30
5318242|NCT00435591|13077359|P2|Full Analysis Set|Overall Study||29
5318243|NCT00435591|13077360|P1|Full Analysis Set|Overall Study||28
5318244|NCT00435591|13077357|P4|Safety Analysis Set|Overall Study||29
5318245|NCT00435591|13077358|P3|Safety Analysis Set|Overall Study||30
5318246|NCT00435591|13077359|P2|Safety Analysis Set|Overall Study||30
5318247|NCT00435591|13077360|P1|Safety Analysis Set|Overall Study||28
5318248|NCT00435591|13077357|P4|STARTED|Overall Study||30
5318249|NCT00435591|13077358|P3|STARTED|Overall Study||30
5318250|NCT00435591|13077359|P2|STARTED|Overall Study||31
5318251|NCT00435591|13077360|P1|STARTED|Overall Study||30
5318252|NCT00435539|13077390|P5|NOT COMPLETED|Overall Study||0
5318253|NCT00435539|13077391|P4|NOT COMPLETED|Overall Study||0
5318254|NCT00435539|13077392|P3|NOT COMPLETED|Overall Study||0
5318255|NCT00435539|13077393|P2|NOT COMPLETED|Overall Study||0
5318256|NCT00435539|13077394|P1|NOT COMPLETED|Overall Study||0
5318257|NCT00435539|13077390|P5|COMPLETED|Overall Study||12
5318258|NCT00435539|13077391|P4|COMPLETED|Overall Study||12
5318259|NCT00435539|13077392|P3|COMPLETED|Overall Study||11
5318260|NCT00435539|13077393|P2|COMPLETED|Overall Study||13
5318261|NCT00435539|13077394|P1|COMPLETED|Overall Study||12
5318262|NCT00435539|13077390|P5|STARTED|Overall Study||12
5318263|NCT00435539|13077391|P4|STARTED|Overall Study||12
5318264|NCT00435539|13077392|P3|STARTED|Overall Study||11
5318265|NCT00435539|13077393|P2|STARTED|Overall Study||13
5318266|NCT00435539|13077394|P1|STARTED|Overall Study||12
5318267|NCT00435487|13077411|P2|NOT COMPLETED|Overall Study||15
5318268|NCT00435487|13077412|P1|NOT COMPLETED|Overall Study||12
5318269|NCT00435487|13077411|P2|COMPLETED|Overall Study||71
5318270|NCT00435487|13077412|P1|COMPLETED|Overall Study||76
5318271|NCT00435487|13077411|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
5318272|NCT00435487|13077412|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
5318273|NCT00435487|13077411|P2|STARTED|Overall Study||86
5318274|NCT00435487|13077412|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
5318275|NCT00435461|13077431|P3|NOT COMPLETED|Overall Study||24
5318276|NCT00435461|13077432|P2|NOT COMPLETED|Overall Study||14
5318277|NCT00435461|13077433|P1|NOT COMPLETED|Overall Study||23
5318278|NCT00435461|13077431|P3|COMPLETED|Overall Study||287
5318279|NCT00435461|13077432|P2|COMPLETED|Overall Study||298
5318280|NCT00435461|13077433|P1|COMPLETED|Overall Study||290
5318281|NCT00435461|13077431|P3|STARTED|Overall Study||311
5318282|NCT00435461|13077432|P2|STARTED|Overall Study||312
5318283|NCT00435461|13077433|P1|STARTED|Overall Study||313
5318284|NCT00435409|13077470|P3|NOT COMPLETED|Overall Study||78
5318285|NCT00435409|13077471|P2|NOT COMPLETED|Overall Study||143
5318286|NCT00435409|13077472|P1|NOT COMPLETED|Overall Study||221
5318287|NCT00435409|13077470|P3|COMPLETED|Overall Study||0
5318288|NCT00435409|13077471|P2|COMPLETED|Overall Study||0
5318289|NCT00435409|13077472|P1|COMPLETED|Overall Study||0
5318290|NCT00435409|13077470|P3|Treated|Overall Study||78
5318291|NCT00435409|13077471|P2|Treated|Overall Study||139
5318292|NCT00435409|13077472|P1|Treated|Overall Study||217
5318293|NCT00435409|13077470|P3|STARTED|Overall Study||78
5318294|NCT00435409|13077471|P2|STARTED|Overall Study||143
5318295|NCT00435409|13077472|P1|STARTED|Overall Study||221
5318296|NCT00435370|13077494|P2|NOT COMPLETED|Overall Study||20
5318297|NCT00435370|13077495|P1|NOT COMPLETED|Overall Study||22
5318298|NCT00435370|13077494|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
5318299|NCT00435370|13077495|P1|COMPLETED|Overall Study||68
5318300|NCT00435370|13077494|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
5318301|NCT00435370|13077495|P1|STARTED|Overall Study||90
5318302|NCT00435188|13077503|P2|NOT COMPLETED|Overall Study||23
5318303|NCT00435188|13077504|P1|NOT COMPLETED|Overall Study||22
5318304|NCT00435188|13077503|P2|COMPLETED|Overall Study||176
5318305|NCT00435188|13077504|P1|COMPLETED|Overall Study||177
5318306|NCT00435188|13077503|P2|STARTED|Overall Study||199
5318307|NCT00435188|13077504|P1|STARTED|Overall Study||199
5318308|NCT00435162|13077547|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
5318309|NCT00435162|13077548|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
5318310|NCT00435162|13077549|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
5318311|NCT00435162|13077550|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
5318312|NCT00435162|13077551|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
5318313|NCT00435162|13077552|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
5318314|NCT00435162|13077547|P6|COMPLETED|Period 2 (2 Weeks)||15
5318315|NCT00435162|13077548|P5|COMPLETED|Period 2 (2 Weeks)||15
5318316|NCT00435162|13077549|P4|COMPLETED|Period 2 (2 Weeks)||8
5318317|NCT00435162|13077550|P3|COMPLETED|Period 2 (2 Weeks)||6
5318318|NCT00435162|13077551|P2|COMPLETED|Period 2 (2 Weeks)||14
5318319|NCT00435162|13077552|P1|COMPLETED|Period 2 (2 Weeks)||15
5318320|NCT00435162|13077547|P6|STARTED|Period 2 (2 Weeks)||15
5318321|NCT00435162|13077548|P5|STARTED|Period 2 (2 Weeks)||15
5318322|NCT00435162|13077549|P4|STARTED|Period 2 (2 Weeks)||8
5318323|NCT00435162|13077550|P3|STARTED|Period 2 (2 Weeks)||6
5318324|NCT00435162|13077551|P2|STARTED|Period 2 (2 Weeks)||15
5318325|NCT00435162|13077552|P1|STARTED|Period 2 (2 Weeks)||15
5318326|NCT00435162|13077547|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
5318327|NCT00435162|13077548|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
5318328|NCT00435162|13077549|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
5318329|NCT00435162|13077550|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
5318330|NCT00435162|13077551|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
5318331|NCT00435162|13077552|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
5318332|NCT00435162|13077547|P6|COMPLETED|Period 1 (6 Weeks)||15
5318333|NCT00435162|13077548|P5|COMPLETED|Period 1 (6 Weeks)||15
5318334|NCT00435162|13077549|P4|COMPLETED|Period 1 (6 Weeks)||8
5318335|NCT00435162|13077550|P3|COMPLETED|Period 1 (6 Weeks)||6
5318336|NCT00435162|13077551|P2|COMPLETED|Period 1 (6 Weeks)||15
5318337|NCT00435162|13077552|P1|COMPLETED|Period 1 (6 Weeks)||15
5318338|NCT00435162|13077547|P6|STARTED|Period 1 (6 Weeks)||15
5318339|NCT00435162|13077548|P5|STARTED|Period 1 (6 Weeks)||15
5318340|NCT00435162|13077549|P4|STARTED|Period 1 (6 Weeks)||8
5318341|NCT00435162|13077550|P3|STARTED|Period 1 (6 Weeks)||6
5318342|NCT00435162|13077551|P2|STARTED|Period 1 (6 Weeks)||15
5318343|NCT00435162|13077552|P1|STARTED|Period 1 (6 Weeks)||15
5318344|NCT00435045|13077572|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
5318345|NCT00435045|13077573|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
5318346|NCT00435045|13077572|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
5318347|NCT00435045|13077573|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
5318348|NCT00435045|13077572|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
5318349|NCT00435045|13077573|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
5318350|NCT00435045|13077572|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
5318351|NCT00435045|13077573|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
5318352|NCT00435045|13077572|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
5318353|NCT00435045|13077573|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
5318354|NCT00435045|13077572|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
5318355|NCT00435045|13077573|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
5318356|NCT00435045|13077572|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
5318357|NCT00435045|13077573|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
5318358|NCT00435045|13077572|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
5318359|NCT00435045|13077573|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
5318360|NCT00435045|13077572|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
5318361|NCT00435045|13077573|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
5318362|NCT00435019|13077629|P2|NOT COMPLETED|Overall Study||10
5318363|NCT00435019|13077630|P1|NOT COMPLETED|Overall Study||13
5318364|NCT00435019|13077629|P2|COMPLETED|Overall Study||161
5318365|NCT00435019|13077630|P1|COMPLETED|Overall Study||164
5318366|NCT00435019|13077629|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
5318367|NCT00435019|13077630|P1|Exposed to Study Drug|Overall Study||177
5318368|NCT00435019|13077629|P2|STARTED|Overall Study|Randomised|171
5318369|NCT00435019|13077630|P1|STARTED|Overall Study|Randomised|177
5318370|NCT00434993|13077642|P2|NOT COMPLETED|Overall Study||0
5318371|NCT00434993|13077643|P1|NOT COMPLETED|Overall Study||0
5318372|NCT00434993|13077642|P2|COMPLETED|Overall Study||130
5318373|NCT00434993|13077643|P1|COMPLETED|Overall Study||152
5318374|NCT00434993|13077642|P2|STARTED|Overall Study||130
5318375|NCT00434993|13077643|P1|STARTED|Overall Study||152
5318376|NCT00434967|13077671|P4|NOT COMPLETED|Overall Study||14
5318377|NCT00434967|13077672|P3|NOT COMPLETED|Overall Study||9
5318378|NCT00434967|13077673|P2|NOT COMPLETED|Overall Study||8
5318379|NCT00434967|13077674|P1|NOT COMPLETED|Overall Study||7
5318380|NCT00434967|13077671|P4|COMPLETED|Overall Study||478
5318381|NCT00434967|13077672|P3|COMPLETED|Overall Study||461
5318382|NCT00434967|13077673|P2|COMPLETED|Overall Study||457
5318383|NCT00434967|13077674|P1|COMPLETED|Overall Study||90
5318384|NCT00434967|13077671|P4|STARTED|Overall Study||492
5318385|NCT00434967|13077672|P3|STARTED|Overall Study||470
5318386|NCT00434967|13077673|P2|STARTED|Overall Study||465
5318387|NCT00434967|13077674|P1|STARTED|Overall Study||97
5318388|NCT00434954|13077694|P2|NOT COMPLETED|Overall Study||71
5318389|NCT00434954|13077695|P1|NOT COMPLETED|Overall Study||82
5318390|NCT00434954|13077694|P2|COMPLETED|Overall Study||175
5318391|NCT00434954|13077695|P1|COMPLETED|Overall Study||166
5318392|NCT00434954|13077694|P2|Completed - Previous Treatment MET + SU|Overall Study||38
5318393|NCT00434954|13077695|P1|Completed - Previous Treatment MET + SU|Overall Study||31
5318394|NCT00434954|13077694|P2|Completed - Previous Treatment MET Only|Overall Study||137
5318395|NCT00434954|13077695|P1|Completed - Previous Treatment MET Only|Overall Study||135
5318396|NCT00434954|13077694|P2|FAS - Previous Treatment MET + SU|Overall Study||60
5318397|NCT00434954|13077695|P1|FAS - Previous Treatment MET + SU|Overall Study||66
5318398|NCT00434954|13077694|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
5318399|NCT00434954|13077695|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
5318400|NCT00434954|13077694|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
5318401|NCT00434954|13077695|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
5318402|NCT00434954|13077694|P2|Started - Previous Treatment MET + SU|Overall Study||65
5318403|NCT00434954|13077695|P1|Started - Previous Treatment MET + SU|Overall Study||66
5318404|NCT00434954|13077694|P2|Started - Previous Treatment MET Only|Overall Study||181
5318405|NCT00434954|13077695|P1|Started - Previous Treatment MET Only|Overall Study||182
5318406|NCT00434954|13077694|P2|STARTED|Overall Study||246
5318407|NCT00434954|13077695|P1|STARTED|Overall Study||248
5318408|NCT00434876|13077725|P2|NOT COMPLETED|Overall Study||1
5318409|NCT00434876|13077726|P1|NOT COMPLETED|Overall Study||1
5318410|NCT00434876|13077725|P2|COMPLETED|Overall Study||10
5318411|NCT00434876|13077726|P1|COMPLETED|Overall Study||10
5318412|NCT00434876|13077725|P2|STARTED|Overall Study||11
5318413|NCT00434876|13077726|P1|STARTED|Overall Study||11
5318414|NCT00434759|13077740|P2|NOT COMPLETED|Overall Study||5
5318415|NCT00434759|13077741|P1|NOT COMPLETED|Overall Study||24
5318416|NCT00434759|13077740|P2|COMPLETED|Overall Study||38
5318417|NCT00434759|13077741|P1|COMPLETED|Overall Study||22
5318418|NCT00434759|13077740|P2|STARTED|Overall Study||43
5318419|NCT00434759|13077741|P1|STARTED|Overall Study||46
5318420|NCT00434642|13077757|P2|NOT COMPLETED|Open-label Treatment Phase||11
5318421|NCT00434642|13077758|P1|NOT COMPLETED|Open-label Treatment Phase||0
5318422|NCT00434642|13077757|P2|COMPLETED|Open-label Treatment Phase||1
5318423|NCT00434642|13077758|P1|COMPLETED|Open-label Treatment Phase||0
5318424|NCT00434642|13077757|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
5318425|NCT00434642|13077758|P1|STARTED|Open-label Treatment Phase||0
5318426|NCT00434642|13077757|P2|NOT COMPLETED|Blinded Treatment Phase||229
5318427|NCT00434642|13077758|P1|NOT COMPLETED|Blinded Treatment Phase||242
5318428|NCT00434642|13077757|P2|COMPLETED|Blinded Treatment Phase||13
5318429|NCT00434642|13077758|P1|COMPLETED|Blinded Treatment Phase||0
5318430|NCT00434642|13077757|P2|STARTED|Blinded Treatment Phase||242
5318431|NCT00434642|13077758|P1|STARTED|Blinded Treatment Phase||242
5318432|NCT00434590|13077776|P2|NOT COMPLETED|Overall Study||5
5318433|NCT00434590|13077777|P1|NOT COMPLETED|Overall Study||5
5318434|NCT00434590|13077776|P2|COMPLETED|Overall Study||0
5318435|NCT00434590|13077777|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
5318436|NCT00434590|13077776|P2|STARTED|Overall Study||5
5318437|NCT00434590|13077777|P1|STARTED|Overall Study||5
5318438|NCT00434577|13077788|P5|NOT COMPLETED|Month 36||0
5318439|NCT00434577|13077789|P4|NOT COMPLETED|Month 36||0
5318440|NCT00434577|13077790|P3|NOT COMPLETED|Month 36||0
5318441|NCT00434577|13077791|P2|NOT COMPLETED|Month 36||0
5318442|NCT00434577|13077792|P1|NOT COMPLETED|Month 36||0
5318443|NCT00434577|13077788|P5|COMPLETED|Month 36||47
5318444|NCT00434577|13077789|P4|COMPLETED|Month 36||155
5318445|NCT00434577|13077790|P3|COMPLETED|Month 36||150
5318446|NCT00434577|13077791|P2|COMPLETED|Month 36||147
5318447|NCT00434577|13077792|P1|COMPLETED|Month 36||147
5318448|NCT00434577|13077788|P5|STARTED|Month 36||47
5318449|NCT00434577|13077789|P4|STARTED|Month 36||155
5318450|NCT00434577|13077790|P3|STARTED|Month 36||150
5318451|NCT00434577|13077791|P2|STARTED|Month 36||147
5318452|NCT00434577|13077792|P1|STARTED|Month 36||147
5318453|NCT00434577|13077788|P5|NOT COMPLETED|Month 24||0
5318454|NCT00434577|13077789|P4|NOT COMPLETED|Month 24||0
5318455|NCT00434577|13077790|P3|NOT COMPLETED|Month 24||0
5318456|NCT00434577|13077791|P2|NOT COMPLETED|Month 24||0
5318457|NCT00434577|13077792|P1|NOT COMPLETED|Month 24||0
5318458|NCT00434577|13077788|P5|COMPLETED|Month 24||49
5318459|NCT00434577|13077789|P4|COMPLETED|Month 24||157
5318460|NCT00434577|13077790|P3|COMPLETED|Month 24||154
5318461|NCT00434577|13077791|P2|COMPLETED|Month 24||155
5318462|NCT00434577|13077792|P1|COMPLETED|Month 24||150
5318463|NCT00434577|13077788|P5|STARTED|Month 24||49
5318464|NCT00434577|13077789|P4|STARTED|Month 24||157
5318465|NCT00434577|13077790|P3|STARTED|Month 24||154
5318466|NCT00434577|13077791|P2|STARTED|Month 24||155
5318467|NCT00434577|13077792|P1|STARTED|Month 24||150
5318468|NCT00434577|13077788|P5|NOT COMPLETED|Month 12||0
5318469|NCT00434577|13077789|P4|NOT COMPLETED|Month 12||0
5318470|NCT00434577|13077790|P3|NOT COMPLETED|Month 12||0
5318471|NCT00434577|13077791|P2|NOT COMPLETED|Month 12||0
5318472|NCT00434577|13077792|P1|NOT COMPLETED|Month 12||0
5318473|NCT00434577|13077788|P5|COMPLETED|Month 12||50
5318474|NCT00434577|13077789|P4|COMPLETED|Month 12||161
5318475|NCT00434577|13077790|P3|COMPLETED|Month 12||159
5318476|NCT00434577|13077791|P2|COMPLETED|Month 12||159
5318477|NCT00434577|13077792|P1|COMPLETED|Month 12||156
5318478|NCT00434577|13077788|P5|STARTED|Month 12||50
5318479|NCT00434577|13077789|P4|STARTED|Month 12||161
5318480|NCT00434577|13077790|P3|STARTED|Month 12||159
5318481|NCT00434577|13077791|P2|STARTED|Month 12||159
5318482|NCT00434577|13077792|P1|STARTED|Month 12||156
5318483|NCT00434577|13077788|P5|NOT COMPLETED|Months 0-3||3
5318484|NCT00434577|13077789|P4|NOT COMPLETED|Months 0-3||1
5318485|NCT00434577|13077790|P3|NOT COMPLETED|Months 0-3||4
5318486|NCT00434577|13077791|P2|NOT COMPLETED|Months 0-3||2
5318487|NCT00434577|13077792|P1|NOT COMPLETED|Months 0-3||3
5318488|NCT00434577|13077788|P5|COMPLETED|Months 0-3||51
5318489|NCT00434577|13077789|P4|COMPLETED|Months 0-3||164
5318490|NCT00434577|13077790|P3|COMPLETED|Months 0-3||161
5318491|NCT00434577|13077791|P2|COMPLETED|Months 0-3||164
5318492|NCT00434577|13077792|P1|COMPLETED|Months 0-3||161
5318493|NCT00434577|13077788|P5|STARTED|Months 0-3||54
5318494|NCT00434577|13077789|P4|STARTED|Months 0-3||165
5318495|NCT00434577|13077790|P3|STARTED|Months 0-3||165
5318496|NCT00434577|13077791|P2|STARTED|Months 0-3||166
5318497|NCT00434577|13077792|P1|STARTED|Months 0-3||164
5318498|NCT00434512|13077970|P6|NOT COMPLETED|Overall Study||1
5318499|NCT00434512|13077971|P5|NOT COMPLETED|Overall Study||1
5318500|NCT00434512|13077972|P4|NOT COMPLETED|Overall Study||1
5318501|NCT00434512|13077973|P3|NOT COMPLETED|Overall Study||0
5318502|NCT00434512|13077974|P2|NOT COMPLETED|Overall Study||1
5318503|NCT00434512|13077975|P1|NOT COMPLETED|Overall Study||0
5318504|NCT00434512|13077970|P6|COMPLETED|Overall Study||49
5318505|NCT00434512|13077971|P5|COMPLETED|Overall Study||49
5318506|NCT00434512|13077972|P4|COMPLETED|Overall Study||49
5318507|NCT00434512|13077973|P3|COMPLETED|Overall Study||10
5318508|NCT00434512|13077974|P2|COMPLETED|Overall Study||9
5318509|NCT00434512|13077975|P1|COMPLETED|Overall Study||10
5318510|NCT00434512|13077970|P6|STARTED|Overall Study||50
5318511|NCT00434512|13077971|P5|STARTED|Overall Study||50
5318512|NCT00434512|13077972|P4|STARTED|Overall Study||50
5318513|NCT00434512|13077973|P3|STARTED|Overall Study||10
5318514|NCT00434512|13077974|P2|STARTED|Overall Study||10
5318515|NCT00434512|13077975|P1|STARTED|Overall Study||10
5318516|NCT00434434|13078076|P3|NOT COMPLETED|Overall Study||1
5318517|NCT00434434|13078077|P2|NOT COMPLETED|Overall Study||0
5318518|NCT00434434|13078078|P1|NOT COMPLETED|Overall Study||2
5318519|NCT00434434|13078076|P3|COMPLETED|Overall Study||13
5318520|NCT00434434|13078077|P2|COMPLETED|Overall Study||24
5318521|NCT00434434|13078078|P1|COMPLETED|Overall Study||21
5318522|NCT00434434|13078076|P3|STARTED|Overall Study||14
5318523|NCT00434434|13078077|P2|STARTED|Overall Study||24
5318524|NCT00434434|13078078|P1|STARTED|Overall Study||23
5318525|NCT00434421|13078089|P1|NOT COMPLETED|Overall Study||2
5318526|NCT00434421|13078089|P1|COMPLETED|Overall Study||26
5318527|NCT00434421|13078089|P1|STARTED|Overall Study||28
5318528|NCT00434356|13078095|P2|NOT COMPLETED|Overall Study||23
5318529|NCT00434356|13078096|P1|NOT COMPLETED|Overall Study||23
5318530|NCT00434356|13078095|P2|COMPLETED|Overall Study||0
5318531|NCT00434356|13078096|P1|COMPLETED|Overall Study||0
5318532|NCT00434356|13078095|P2|STARTED|Overall Study||23
5318533|NCT00434356|13078096|P1|STARTED|Overall Study||23
5318534|NCT00434330|13078117|P6|NOT COMPLETED|Overall Study||1
5318535|NCT00434330|13078118|P5|NOT COMPLETED|Overall Study||1
5318536|NCT00434330|13078119|P4|NOT COMPLETED|Overall Study||2
5318537|NCT00434330|13078120|P3|NOT COMPLETED|Overall Study||3
5318538|NCT00434330|13078121|P2|NOT COMPLETED|Overall Study||0
5318539|NCT00434330|13078122|P1|NOT COMPLETED|Overall Study||1
5318540|NCT00434330|13078117|P6|COMPLETED|Overall Study||14
5318541|NCT00434330|13078118|P5|COMPLETED|Overall Study||14
5318542|NCT00434330|13078119|P4|COMPLETED|Overall Study||13
5318543|NCT00434330|13078120|P3|COMPLETED|Overall Study||13
5318544|NCT00434330|13078121|P2|COMPLETED|Overall Study||15
5318545|NCT00434330|13078122|P1|COMPLETED|Overall Study||14
5318546|NCT00434330|13078117|P6|STARTED|Overall Study||15
5318547|NCT00434330|13078118|P5|STARTED|Overall Study||15
5318548|NCT00434330|13078119|P4|STARTED|Overall Study||15
5318549|NCT00434330|13078120|P3|STARTED|Overall Study||16
5318550|NCT00434330|13078121|P2|STARTED|Overall Study||15
5318551|NCT00434330|13078122|P1|STARTED|Overall Study||15
5318552|NCT00434304|13078154|P1|NOT COMPLETED|Overall Study||20
5318553|NCT00434304|13078154|P1|COMPLETED|Overall Study||42
5318554|NCT00434304|13078154|P1|STARTED|Overall Study||62
5318555|NCT00434278|13078192|P2|NOT COMPLETED|Overall Study||0
5318556|NCT00434278|13078193|P1|NOT COMPLETED|Overall Study||2
5318557|NCT00434278|13078192|P2|COMPLETED|Overall Study||13
5318558|NCT00434278|13078193|P1|COMPLETED|Overall Study||12
5318559|NCT00434278|13078192|P2|STARTED|Overall Study||13
5318560|NCT00434278|13078193|P1|STARTED|Overall Study||14
5318561|NCT00434252|13078203|P2|NOT COMPLETED|Overall Study||131
5318562|NCT00434252|13078204|P1|NOT COMPLETED|Overall Study||64
5318563|NCT00434252|13078203|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
5318564|NCT00434252|13078204|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
5318565|NCT00434252|13078203|P2|Treated|Overall Study||143
5318566|NCT00434252|13078204|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
5318567|NCT00434252|13078203|P2|STARTED|Overall Study||143
5318568|NCT00434252|13078204|P1|STARTED|Overall Study||71
5318569|NCT00434226|13078226|P2|NOT COMPLETED|Overall Study||26
5318570|NCT00434226|13078227|P1|NOT COMPLETED|Overall Study||30
5318571|NCT00434226|13078226|P2|COMPLETED|Overall Study||0
5318572|NCT00434226|13078227|P1|COMPLETED|Overall Study||0
5318573|NCT00434226|13078226|P2|STARTED|Overall Study||26
5318574|NCT00434226|13078227|P1|STARTED|Overall Study||30
5318575|NCT00434213|13078238|P1|NOT COMPLETED|Overall Study||49
5318576|NCT00434213|13078238|P1|COMPLETED|Overall Study||260
5318577|NCT00434213|13078238|P1|STARTED|Overall Study||309
5318578|NCT00434161|13078246|P3|NOT COMPLETED|Overall Study||11
5318579|NCT00434161|13078247|P2|NOT COMPLETED|Overall Study||3
5318580|NCT00434161|13078248|P1|NOT COMPLETED|Overall Study||10
5318581|NCT00434161|13078246|P3|COMPLETED|Overall Study||104
5318582|NCT00434161|13078247|P2|COMPLETED|Overall Study||54
5318583|NCT00434161|13078248|P1|COMPLETED|Overall Study||99
5318584|NCT00434161|13078246|P3|STARTED|Overall Study||115
5318585|NCT00434161|13078247|P2|STARTED|Overall Study||57
5318586|NCT00434161|13078248|P1|STARTED|Overall Study||109
5318587|NCT00434148|13078292|P2|NOT COMPLETED|Overall Study||73
5318588|NCT00434148|13078293|P1|NOT COMPLETED|Overall Study||69
5318589|NCT00434148|13078292|P2|COMPLETED|Overall Study||7
5318590|NCT00434148|13078293|P1|COMPLETED|Overall Study||13
5318591|NCT00434148|13078292|P2|Completed Month 12; Entered Extension|Overall Study||32
5318592|NCT00434148|13078293|P1|Completed Month 12; Entered Extension|Overall Study||26
5318593|NCT00434148|13078292|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
5318594|NCT00434148|13078293|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
5318595|NCT00434148|13078292|P2|Completed Month 12|Overall Study||39
5318596|NCT00434148|13078293|P1|Completed Month 12|Overall Study||39
5318597|NCT00434148|13078292|P2|STARTED|Overall Study||80
5318598|NCT00434148|13078293|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
5318599|NCT00434122|13078329|P2|NOT COMPLETED|Overall Study||7
5318600|NCT00434122|13078330|P1|NOT COMPLETED|Overall Study||6
5318601|NCT00434122|13078329|P2|COMPLETED|Overall Study||36
5318602|NCT00434122|13078330|P1|COMPLETED|Overall Study||36
5318603|NCT00434122|13078329|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
5318604|NCT00434122|13078330|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
5318605|NCT00434122|13078329|P2|STARTED|Overall Study|Randomised|43
5318606|NCT00434122|13078330|P1|STARTED|Overall Study|Randomised|42
5318607|NCT00434109|13078339|P1|NOT COMPLETED|Overall Study||18
5318608|NCT00434109|13078339|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
5318609|NCT00434109|13078339|P1|STARTED|Overall Study||39
5318610|NCT00434057|13078348|P1|NOT COMPLETED|Overall Study||1
5318611|NCT00434057|13078348|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
5318612|NCT00434057|13078348|P1|STARTED|Overall Study||1383
5318613|NCT00434018|13078354|P2|NOT COMPLETED|Overall Study||12
5318614|NCT00434018|13078355|P1|NOT COMPLETED|Overall Study||17
5318615|NCT00434018|13078354|P2|COMPLETED|Overall Study||57
5318616|NCT00434018|13078355|P1|COMPLETED|Overall Study||52
5318617|NCT00434018|13078354|P2|STARTED|Overall Study||69
5318618|NCT00434018|13078355|P1|STARTED|Overall Study||69
5318619|NCT00433992|13078373|P2|NOT COMPLETED|Overall Study||8
5318620|NCT00433992|13078374|P1|NOT COMPLETED|Overall Study||9
5318621|NCT00433992|13078373|P2|COMPLETED|Overall Study||20
5318622|NCT00433992|13078374|P1|COMPLETED|Overall Study||19
5318623|NCT00433992|13078373|P2|STARTED|Overall Study||28
5318624|NCT00433992|13078374|P1|STARTED|Overall Study||28
5318625|NCT00433966|13078386|P4|NOT COMPLETED|Stent Intervention/Randomization||62
5318626|NCT00433966|13078387|P3|NOT COMPLETED|Stent Intervention/Randomization||154
5318627|NCT00433966|13078388|P2|NOT COMPLETED|Stent Intervention/Randomization||0
5318628|NCT00433966|13078389|P1|NOT COMPLETED|Stent Intervention/Randomization||0
5318629|NCT00433966|13078386|P4|COMPLETED|Stent Intervention/Randomization||687
5318630|NCT00433966|13078387|P3|COMPLETED|Stent Intervention/Randomization||2103
5318631|NCT00433966|13078388|P2|COMPLETED|Stent Intervention/Randomization||0
5318632|NCT00433966|13078389|P1|COMPLETED|Stent Intervention/Randomization||0
5318633|NCT00433966|13078386|P4|3-Year Follow-up|Stent Intervention/Randomization||687
5318634|NCT00433966|13078387|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
5318635|NCT00433966|13078388|P2|3-Year Follow-up|Stent Intervention/Randomization||0
5318636|NCT00433966|13078389|P1|3-Year Follow-up|Stent Intervention/Randomization||0
5318637|NCT00433966|13078386|P4|1-Year Follow-up|Stent Intervention/Randomization||715
5318638|NCT00433966|13078387|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
5318639|NCT00433966|13078388|P2|1-Year Follow-up|Stent Intervention/Randomization||0
5318640|NCT00433966|13078389|P1|1-Year Follow-up|Stent Intervention/Randomization||0
5318641|NCT00433966|13078386|P4|STARTED|Stent Intervention/Randomization||749
5318642|NCT00433966|13078387|P3|STARTED|Stent Intervention/Randomization||2257
5318643|NCT00433966|13078388|P2|STARTED|Stent Intervention/Randomization||0
5318644|NCT00433966|13078389|P1|STARTED|Stent Intervention/Randomization||0
5318645|NCT00433966|13078386|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
5318646|NCT00433966|13078387|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
5318647|NCT00433966|13078388|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
5318648|NCT00433966|13078389|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
5318649|NCT00433966|13078386|P4|COMPLETED|Pharmacology Intervention/Randomization||0
5318650|NCT00433966|13078387|P3|COMPLETED|Pharmacology Intervention/Randomization||0
5318651|NCT00433966|13078388|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
5318652|NCT00433966|13078389|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
5318653|NCT00433966|13078386|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
5318654|NCT00433966|13078387|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
5318655|NCT00433966|13078388|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
5318656|NCT00433966|13078389|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
5318657|NCT00433966|13078386|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
5318658|NCT00433966|13078387|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
5318659|NCT00433966|13078388|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
5318660|NCT00433966|13078389|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
5318661|NCT00433966|13078386|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
5318662|NCT00433966|13078387|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
5318663|NCT00433966|13078388|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
5318664|NCT00433966|13078389|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
5318665|NCT00433966|13078386|P4|STARTED|Pharmacology Intervention/Randomization||0
5318666|NCT00433966|13078387|P3|STARTED|Pharmacology Intervention/Randomization||0
5318667|NCT00433966|13078388|P2|STARTED|Pharmacology Intervention/Randomization||1802
5318668|NCT00433966|13078389|P1|STARTED|Pharmacology Intervention/Randomization||1800
5318669|NCT00433914|13078411|P2|NOT COMPLETED|Overall Study||3
5318670|NCT00433914|13078412|P1|NOT COMPLETED|Overall Study||0
5318671|NCT00433914|13078411|P2|COMPLETED|Overall Study||27
5318672|NCT00433914|13078412|P1|COMPLETED|Overall Study||30
5318673|NCT00433914|13078411|P2|STARTED|Overall Study||30
5318674|NCT00433914|13078412|P1|STARTED|Overall Study||30
5318675|NCT00433836|13078432|P2|NOT COMPLETED|Overall Study||6
5318676|NCT00433836|13078433|P1|NOT COMPLETED|Overall Study||13
5318677|NCT00433836|13078432|P2|COMPLETED|Overall Study||143
5318678|NCT00433836|13078433|P1|COMPLETED|Overall Study||138
5318679|NCT00433836|13078432|P2|STARTED|Overall Study||149
5318680|NCT00433836|13078433|P1|STARTED|Overall Study||151
5318681|NCT00433771|13078445|P1|NOT COMPLETED|Overall Study||19
5318682|NCT00433771|13078445|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
5318683|NCT00433771|13078445|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
5318684|NCT00433745|13078461|P1|NOT COMPLETED|Overall Study||0
5318685|NCT00433745|13078461|P1|COMPLETED|Overall Study||4
5318686|NCT00433745|13078461|P1|STARTED|Overall Study||4
5318687|NCT00433654|13078468|P2|NOT COMPLETED|Overall Study||5
5318688|NCT00433654|13078469|P1|NOT COMPLETED|Overall Study||15
5318689|NCT00433654|13078468|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
5318690|NCT00433654|13078469|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
5318691|NCT00433654|13078468|P2|STARTED|Overall Study||206
5318692|NCT00433654|13078469|P1|STARTED|Overall Study||258
5318693|NCT00433550|13078503|P3|NOT COMPLETED|Overall Study||0
5318694|NCT00433550|13078504|P2|NOT COMPLETED|Overall Study||0
5318695|NCT00433550|13078505|P1|NOT COMPLETED|Overall Study||0
5318696|NCT00433550|13078503|P3|COMPLETED|Overall Study||6
5318697|NCT00433550|13078504|P2|COMPLETED|Overall Study||10
5318698|NCT00433550|13078505|P1|COMPLETED|Overall Study||17
5318699|NCT00433550|13078503|P3|STARTED|Overall Study||6
5318700|NCT00433550|13078504|P2|STARTED|Overall Study||10
5318701|NCT00433550|13078505|P1|STARTED|Overall Study||17
5318702|NCT00433537|13078515|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
5318703|NCT00433537|13078516|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
5318704|NCT00433537|13078517|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
5318705|NCT00433537|13078515|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
5318706|NCT00433537|13078516|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
5318707|NCT00433537|13078517|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
5318708|NCT00433537|13078515|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
5318709|NCT00433537|13078516|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
5318710|NCT00433537|13078517|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
5318711|NCT00433537|13078515|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
5318712|NCT00433537|13078516|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
5318713|NCT00433537|13078517|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
5318714|NCT00433537|13078515|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
5318715|NCT00433537|13078516|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
5318716|NCT00433537|13078517|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
5318717|NCT00433537|13078515|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
5318718|NCT00433537|13078516|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
5318719|NCT00433537|13078517|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
5318720|NCT00433537|13078515|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
5318721|NCT00433537|13078516|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
5318722|NCT00433537|13078517|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
5318723|NCT00433537|13078515|P3|STARTED|Step 1 - VcR-CVAD Induction||10
5318724|NCT00433537|13078516|P2|STARTED|Step 1 - VcR-CVAD Induction||22
5318725|NCT00433537|13078517|P1|STARTED|Step 1 - VcR-CVAD Induction||45
5318726|NCT00433511|13078529|P3|NOT COMPLETED|Step 2 (Arm D)||491
5318727|NCT00433511|13078530|P2|NOT COMPLETED|Step 2 (Arm D)||0
5318728|NCT00433511|13078531|P1|NOT COMPLETED|Step 2 (Arm D)||0
5318729|NCT00433511|13078529|P3|COMPLETED|Step 2 (Arm D)||825
5318730|NCT00433511|13078530|P2|COMPLETED|Step 2 (Arm D)||0
5318731|NCT00433511|13078531|P1|COMPLETED|Step 2 (Arm D)||0
5318732|NCT00433511|13078529|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
5318733|NCT00433511|13078530|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
5318734|NCT00433511|13078531|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
5318735|NCT00433511|13078529|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
5318736|NCT00433511|13078530|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
5318737|NCT00433511|13078531|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
5318738|NCT00433511|13078529|P3|NOT COMPLETED|Step 1||390
5318739|NCT00433511|13078530|P2|NOT COMPLETED|Step 1||385
5318740|NCT00433511|13078531|P1|NOT COMPLETED|Step 1||136
5318741|NCT00433511|13078529|P3|COMPLETED|Step 1||1618
5318742|NCT00433511|13078530|P2|COMPLETED|Step 1||1601
5318743|NCT00433511|13078531|P1|COMPLETED|Step 1||864
5318744|NCT00433511|13078529|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
5318745|NCT00433511|13078530|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
5318746|NCT00433511|13078531|P1|Patients in Genetic Ancestry Analysis|Step 1||575
5318747|NCT00433511|13078529|P3|Patients Who Received Treatment|Step 1||1942
5318748|NCT00433511|13078530|P2|Patients Who Received Treatment|Step 1||1922
5318749|NCT00433511|13078531|P1|Patients Who Received Treatment|Step 1||972
5318750|NCT00433511|13078529|P3|STARTED|Step 1||2008
5318751|NCT00433511|13078530|P2|STARTED|Step 1||1986
5318752|NCT00433511|13078531|P1|STARTED|Step 1||1000
5318753|NCT00433446|13078545|P1|NOT COMPLETED|Overall Study||61
5318754|NCT00433446|13078545|P1|COMPLETED|Overall Study||1
5318755|NCT00433446|13078545|P1|Eligible and Began Protocol Therapy|Overall Study||53
5318756|NCT00433446|13078545|P1|Eligible|Overall Study||53
5318757|NCT00433446|13078545|P1|STARTED|Overall Study||62
5318758|NCT00433381|13078555|P2|NOT COMPLETED|Overall Study||3
5318759|NCT00433381|13078556|P1|NOT COMPLETED|Overall Study||3
5318760|NCT00433381|13078555|P2|COMPLETED|Overall Study||57
5318761|NCT00433381|13078556|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
5318762|NCT00433381|13078555|P2|STARTED|Overall Study||60
5318763|NCT00433381|13078556|P1|STARTED|Overall Study||63
5318764|NCT00433329|13078575|P1|NOT COMPLETED|Overall Study||21
5318765|NCT00433329|13078575|P1|COMPLETED|Overall Study||79
5318766|NCT00433329|13078575|P1|STARTED|Overall Study||100
5318767|NCT00433290|13078581|P2|NOT COMPLETED|Overall Study||17
5318768|NCT00433290|13078582|P1|NOT COMPLETED|Overall Study||35
5318769|NCT00433290|13078581|P2|COMPLETED|Overall Study||111
5318770|NCT00433290|13078582|P1|COMPLETED|Overall Study||93
5318771|NCT00433290|13078581|P2|STARTED|Overall Study||128
5318772|NCT00433290|13078582|P1|STARTED|Overall Study||128
5318773|NCT00433199|13078651|P2|NOT COMPLETED|Open-Label Period||34
5318774|NCT00433199|13078652|P1|NOT COMPLETED|Open-Label Period||0
5318775|NCT00433199|13078651|P2|COMPLETED|Open-Label Period||185
5318776|NCT00433199|13078652|P1|COMPLETED|Open-Label Period||0
5318777|NCT00433199|13078651|P2|STARTED|Open-Label Period||219
5318778|NCT00433199|13078652|P1|STARTED|Open-Label Period||0
5318779|NCT00433199|13078651|P2|NOT COMPLETED|Double-Blind Period||66
5318780|NCT00433199|13078652|P1|NOT COMPLETED|Double-Blind Period||12
5318781|NCT00433199|13078651|P2|COMPLETED|Double-Blind Period||168
5318782|NCT00433199|13078652|P1|COMPLETED|Double-Blind Period||28
5318783|NCT00433199|13078651|P2|STARTED|Double-Blind Period||234
5318784|NCT00433199|13078652|P1|STARTED|Double-Blind Period||40
5318785|NCT00433160|13078672|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
5318786|NCT00433160|13078673|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
5318787|NCT00433160|13078672|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
5318788|NCT00433160|13078673|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
5318789|NCT00433160|13078672|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
5318790|NCT00433160|13078673|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
5318791|NCT00433160|13078672|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
5318792|NCT00433160|13078673|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
5318793|NCT00433160|13078672|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
5318794|NCT00433160|13078673|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
5318795|NCT00433160|13078672|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
5318796|NCT00433160|13078673|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
5318797|NCT00433160|13078672|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
5318798|NCT00433160|13078673|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
5318799|NCT00433160|13078672|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
5318800|NCT00433160|13078673|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
5318801|NCT00433160|13078672|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
5318802|NCT00433160|13078673|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
5318803|NCT00433160|13078672|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
5318804|NCT00433160|13078673|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
5318805|NCT00433160|13078672|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
5318806|NCT00433160|13078673|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
5318807|NCT00433160|13078672|P2|STARTED|52-Week Double-Blind (DB) Period||70
5318808|NCT00433160|13078673|P1|STARTED|52-Week Double-Blind (DB) Period||137
5318809|NCT00433147|13078725|P4|NOT COMPLETED|Overall Study||0
5318810|NCT00433147|13078726|P3|NOT COMPLETED|Overall Study||0
5318811|NCT00433147|13078727|P2|NOT COMPLETED|Overall Study||1
5318812|NCT00433147|13078728|P1|NOT COMPLETED|Overall Study||0
5318813|NCT00433147|13078725|P4|COMPLETED|Overall Study||7
5318814|NCT00433147|13078726|P3|COMPLETED|Overall Study||9
5318815|NCT00433147|13078727|P2|COMPLETED|Overall Study||6
5318816|NCT00433147|13078728|P1|COMPLETED|Overall Study||7
5318817|NCT00433147|13078725|P4|Received at Least One Dose of Study Drug|Overall Study||7
5318818|NCT00433147|13078726|P3|Received at Least One Dose of Study Drug|Overall Study||9
5318819|NCT00433147|13078727|P2|Received at Least One Dose of Study Drug|Overall Study||7
5318820|NCT00433147|13078728|P1|Received at Least One Dose of Study Drug|Overall Study||7
5318821|NCT00433147|13078725|P4|PD Population|Overall Study||7
5318822|NCT00433147|13078726|P3|PD Population|Overall Study||9
5318823|NCT00433147|13078727|P2|PD Population|Overall Study||6
5318824|NCT00433147|13078728|P1|PD Population|Overall Study||7
5318825|NCT00433147|13078725|P4|Safety Population|Overall Study||7
5318826|NCT00433147|13078726|P3|Safety Population|Overall Study||9
5318827|NCT00433147|13078727|P2|Safety Population|Overall Study||7
5318828|NCT00433147|13078728|P1|Safety Population|Overall Study||7
5318829|NCT00433147|13078725|P4|STARTED|Overall Study||7
5318830|NCT00433147|13078726|P3|STARTED|Overall Study||9
5318831|NCT00433147|13078727|P2|STARTED|Overall Study||7
5318832|NCT00433147|13078728|P1|STARTED|Overall Study||7
5318833|NCT00433017|13078744|P2|NOT COMPLETED|Overall Study||101
5318834|NCT00433017|13078745|P1|NOT COMPLETED|Overall Study||96
5318835|NCT00433017|13078744|P2|COMPLETED|Overall Study||32
5318836|NCT00433017|13078745|P1|COMPLETED|Overall Study||26
5318837|NCT00433017|13078744|P2|Completed 12 Month Phase|Overall Study||126
5318838|NCT00433017|13078745|P1|Completed 12 Month Phase|Overall Study||114
5318839|NCT00433017|13078744|P2|STARTED|Overall Study||133
5318840|NCT00433017|13078745|P1|STARTED|Overall Study||122
5318841|NCT00433004|13078761|P2|NOT COMPLETED|Overall Study||7
5318842|NCT00433004|13078762|P1|NOT COMPLETED|Overall Study||5
5318843|NCT00433004|13078761|P2|COMPLETED|Overall Study||16
5318844|NCT00433004|13078762|P1|COMPLETED|Overall Study||22
5318845|NCT00433004|13078761|P2|STARTED|Overall Study||23
5318846|NCT00433004|13078762|P1|STARTED|Overall Study||27
5318847|NCT00432991|13078774|P2|NOT COMPLETED|Overall Study||12
5318848|NCT00432991|13078775|P1|NOT COMPLETED|Overall Study||7
5318849|NCT00432991|13078774|P2|COMPLETED|Overall Study||19
5318850|NCT00432991|13078775|P1|COMPLETED|Overall Study||15
5318851|NCT00432991|13078774|P2|STARTED|Overall Study||31
5318852|NCT00432991|13078775|P1|STARTED|Overall Study||22
5318853|NCT00432965|13078787|P2|NOT COMPLETED|Overall Study||86
5318854|NCT00432965|13078788|P1|NOT COMPLETED|Overall Study||94
5318855|NCT00432965|13078787|P2|COMPLETED|Overall Study||80
5318856|NCT00432965|13078788|P1|COMPLETED|Overall Study||75
5318857|NCT00432965|13078787|P2|STARTED|Overall Study||166
5318858|NCT00432965|13078788|P1|STARTED|Overall Study||169
5318859|NCT00432835|13078796|P2|NOT COMPLETED|Overall Study||7
5318860|NCT00432835|13078797|P1|NOT COMPLETED|Overall Study||6
5318861|NCT00432835|13078796|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
5318862|NCT00432835|13078797|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
5318863|NCT00432835|13078796|P2|Completed 2nd Intervention|Overall Study||23
5318864|NCT00432835|13078797|P1|Completed 2nd Intervention|Overall Study||22
5318865|NCT00432835|13078796|P2|Completed 1st Intervention|Overall Study||23
5318866|NCT00432835|13078797|P1|Completed 1st Intervention|Overall Study||22
5318867|NCT00432835|13078796|P2|STARTED|Overall Study||30
5318868|NCT00432835|13078797|P1|STARTED|Overall Study||28
5318869|NCT00432809|13078810|P3|NOT COMPLETED|2 Year Sub-study||1
5318870|NCT00432809|13078811|P2|NOT COMPLETED|2 Year Sub-study||2
5318871|NCT00432809|13078812|P1|NOT COMPLETED|2 Year Sub-study||3
5318872|NCT00432809|13078810|P3|COMPLETED|2 Year Sub-study||19
5318873|NCT00432809|13078811|P2|COMPLETED|2 Year Sub-study||18
5318874|NCT00432809|13078812|P1|COMPLETED|2 Year Sub-study||17
5318875|NCT00432809|13078810|P3|STARTED|2 Year Sub-study||20
5318876|NCT00432809|13078811|P2|STARTED|2 Year Sub-study||20
5318877|NCT00432809|13078812|P1|STARTED|2 Year Sub-study||20
5318878|NCT00432809|13078810|P3|NOT COMPLETED|1 Year Follow-up||1
5318879|NCT00432809|13078811|P2|NOT COMPLETED|1 Year Follow-up||0
5318880|NCT00432809|13078812|P1|NOT COMPLETED|1 Year Follow-up||9
5318881|NCT00432809|13078810|P3|COMPLETED|1 Year Follow-up||49
5318882|NCT00432809|13078811|P2|COMPLETED|1 Year Follow-up||50
5318883|NCT00432809|13078812|P1|COMPLETED|1 Year Follow-up||41
5318884|NCT00432809|13078810|P3|STARTED|1 Year Follow-up||50
5318885|NCT00432809|13078811|P2|STARTED|1 Year Follow-up||50
5318886|NCT00432809|13078812|P1|STARTED|1 Year Follow-up||50
5318887|NCT00432744|13078885|P2|NOT COMPLETED|Months 7 - 12||1
5318888|NCT00432744|13078886|P1|NOT COMPLETED|Months 7 - 12||1
5318889|NCT00432744|13078885|P2|COMPLETED|Months 7 - 12||7
5318890|NCT00432744|13078886|P1|COMPLETED|Months 7 - 12||6
5318891|NCT00432744|13078885|P2|STARTED|Months 7 - 12||8
5318892|NCT00432744|13078886|P1|STARTED|Months 7 - 12||7
5318893|NCT00432744|13078885|P2|NOT COMPLETED|Months 0-6||4
5318894|NCT00432744|13078886|P1|NOT COMPLETED|Months 0-6||5
5318895|NCT00432744|13078885|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
5318896|NCT00432744|13078886|P1|COMPLETED|Months 0-6||7
5318897|NCT00432744|13078885|P2|STARTED|Months 0-6||12
5318898|NCT00432744|13078886|P1|STARTED|Months 0-6||12
5318899|NCT00432679|13078898|P2|NOT COMPLETED|Overall Study||3
5318900|NCT00432679|13078899|P1|NOT COMPLETED|Overall Study||5
5318901|NCT00432679|13078898|P2|COMPLETED|Overall Study||72
5318902|NCT00432679|13078899|P1|COMPLETED|Overall Study||69
5318903|NCT00432679|13078898|P2|STARTED|Overall Study||75
5318904|NCT00432679|13078899|P1|STARTED|Overall Study||74
5318905|NCT00432666|13078923|P2|NOT COMPLETED|Open-Label Extension Period||0
5318906|NCT00432666|13078924|P1|NOT COMPLETED|Open-Label Extension Period||25
5318907|NCT00432666|13078923|P2|COMPLETED|Open-Label Extension Period||0
5318908|NCT00432666|13078924|P1|COMPLETED|Open-Label Extension Period||120
5318909|NCT00432666|13078923|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
5318910|NCT00432666|13078924|P1|STARTED|Open-Label Extension Period||145
5318911|NCT00432666|13078923|P2|NOT COMPLETED|Main Period||1
5318912|NCT00432666|13078924|P1|NOT COMPLETED|Main Period||2
5318913|NCT00432666|13078923|P2|COMPLETED|Main Period||74
5318914|NCT00432666|13078924|P1|COMPLETED|Main Period||71
5318915|NCT00432666|13078923|P2|STARTED|Main Period||75
5318916|NCT00432666|13078924|P1|STARTED|Main Period||73
5318917|NCT00432601|13079088|P2|NOT COMPLETED|Time 2 to Time 3||22
5318918|NCT00432601|13079089|P1|NOT COMPLETED|Time 2 to Time 3||19
5318919|NCT00432601|13079088|P2|COMPLETED|Time 2 to Time 3||122
5318920|NCT00432601|13079089|P1|COMPLETED|Time 2 to Time 3||122
5318921|NCT00432601|13079088|P2|STARTED|Time 2 to Time 3||144
5318922|NCT00432601|13079089|P1|STARTED|Time 2 to Time 3||141
5318923|NCT00432601|13079088|P2|NOT COMPLETED|Time 1 to Time 2||368
5318924|NCT00432601|13079089|P1|NOT COMPLETED|Time 1 to Time 2||369
5318925|NCT00432601|13079088|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
5318926|NCT00432601|13079089|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
5318927|NCT00432601|13079088|P2|STARTED|Time 1 to Time 2||512
5318928|NCT00432601|13079089|P1|STARTED|Time 1 to Time 2||510
5318929|NCT00432562|13079097|P2|NOT COMPLETED|Overall Study||0
5318930|NCT00432562|13079098|P1|NOT COMPLETED|Overall Study||3
5318931|NCT00432562|13079097|P2|COMPLETED|Overall Study||15
5318932|NCT00432562|13079098|P1|COMPLETED|Overall Study||13
5318933|NCT00432562|13079097|P2|STARTED|Overall Study||15
5318934|NCT00432562|13079098|P1|STARTED|Overall Study||16
5318935|NCT00432458|13079124|P2|NOT COMPLETED|Overall Study||1
5318936|NCT00432458|13079125|P1|NOT COMPLETED|Overall Study||5
5318937|NCT00432458|13079124|P2|COMPLETED|Overall Study||32
5318938|NCT00432458|13079125|P1|COMPLETED|Overall Study||30
5318939|NCT00432458|13079124|P2|STARTED|Overall Study||33
5318940|NCT00432458|13079125|P1|STARTED|Overall Study||35
5318941|NCT00432445|13079143|P1|NOT COMPLETED|Overall Study||0
5318942|NCT00432445|13079143|P1|COMPLETED|Overall Study||2
5318943|NCT00432445|13079143|P1|STARTED|Overall Study||2
5318944|NCT00432380|13079150|P3|NOT COMPLETED|Overall Study||1
5318945|NCT00432380|13079151|P2|NOT COMPLETED|Overall Study||4
5318946|NCT00432380|13079152|P1|NOT COMPLETED|Overall Study||4
5318947|NCT00432380|13079150|P3|COMPLETED|Overall Study||74
5318948|NCT00432380|13079151|P2|COMPLETED|Overall Study||146
5318949|NCT00432380|13079152|P1|COMPLETED|Overall Study||146
5318950|NCT00432380|13079150|P3|STARTED|Overall Study||75
5318951|NCT00432380|13079151|P2|STARTED|Overall Study||150
5318952|NCT00432380|13079152|P1|STARTED|Overall Study||150
5318953|NCT00432341|13079178|P2|NOT COMPLETED|Overall Study||0
5318954|NCT00432341|13079179|P1|NOT COMPLETED|Overall Study||0
5318955|NCT00432341|13079178|P2|COMPLETED|Overall Study||30
5318956|NCT00432341|13079179|P1|COMPLETED|Overall Study||24
5318957|NCT00432341|13079178|P2|STARTED|Overall Study||30
5318958|NCT00432341|13079179|P1|STARTED|Overall Study||24
5318959|NCT00432276|13079205|P2|NOT COMPLETED|Overall Study||156
5318960|NCT00432276|13079206|P1|NOT COMPLETED|Overall Study||121
5318961|NCT00432276|13079205|P2|COMPLETED|Overall Study||243
5318962|NCT00432276|13079206|P1|COMPLETED|Overall Study||283
5318963|NCT00432276|13079205|P2|Per Protocol Set|Overall Study||306
5318964|NCT00432276|13079206|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
5318965|NCT00432276|13079205|P2|STARTED|Overall Study||399
5318966|NCT00432276|13079206|P1|STARTED|Overall Study||404
5318967|NCT00432237|13079296|P4|NOT COMPLETED|Overall Study||124
5318968|NCT00432237|13079297|P3|NOT COMPLETED|Overall Study||109
5318969|NCT00432237|13079298|P2|NOT COMPLETED|Overall Study||101
5318970|NCT00432237|13079299|P1|NOT COMPLETED|Overall Study||67
5318971|NCT00432237|13079296|P4|COMPLETED|Overall Study||366
5318972|NCT00432237|13079297|P3|COMPLETED|Overall Study||375
5318973|NCT00432237|13079298|P2|COMPLETED|Overall Study||384
5318974|NCT00432237|13079299|P1|COMPLETED|Overall Study||177
5318975|NCT00432237|13079296|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
5318976|NCT00432237|13079297|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
5318977|NCT00432237|13079298|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
5318978|NCT00432237|13079299|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
5318979|NCT00432237|13079296|P4|Completed--With Data|Overall Study||365
5318980|NCT00432237|13079297|P3|Completed--With Data|Overall Study||370
5318981|NCT00432237|13079298|P2|Completed--With Data|Overall Study||381
5318982|NCT00432237|13079299|P1|Completed--With Data|Overall Study||176
5318983|NCT00432237|13079296|P4|STARTED|Overall Study||490
5318984|NCT00432237|13079297|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
5318985|NCT00432237|13079298|P2|STARTED|Overall Study||485
5318986|NCT00432237|13079299|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
5318987|NCT00432172|13079341|P4|NOT COMPLETED|Overall Study||7
5318988|NCT00432172|13079342|P3|NOT COMPLETED|Overall Study||11
5318989|NCT00432172|13079343|P2|NOT COMPLETED|Overall Study||7
5318990|NCT00432172|13079344|P1|NOT COMPLETED|Overall Study||6
5318991|NCT00432172|13079341|P4|COMPLETED|Overall Study||41
5318992|NCT00432172|13079342|P3|COMPLETED|Overall Study||35
5318993|NCT00432172|13079343|P2|COMPLETED|Overall Study||41
5318994|NCT00432172|13079344|P1|COMPLETED|Overall Study||41
5318995|NCT00432172|13079341|P4|STARTED|Overall Study||48
5318996|NCT00432172|13079342|P3|STARTED|Overall Study||46
5318997|NCT00432172|13079343|P2|STARTED|Overall Study||48
5318998|NCT00432172|13079344|P1|STARTED|Overall Study||47
5318999|NCT00432159|13079369|P5|NOT COMPLETED|Overall Study||10
5319000|NCT00432159|13079370|P4|NOT COMPLETED|Overall Study||5
5319001|NCT00432159|13079371|P3|NOT COMPLETED|Overall Study||4
5319002|NCT00432159|13079372|P2|NOT COMPLETED|Overall Study||30
5319003|NCT00432159|13079373|P1|NOT COMPLETED|Overall Study||22
5319004|NCT00432159|13079369|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
5319005|NCT00432159|13079370|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
5319006|NCT00432159|13079371|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
5319007|NCT00432159|13079372|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
5319008|NCT00432159|13079373|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
5319009|NCT00432159|13079369|P5|STARTED|Overall Study||89
5319010|NCT00432159|13079370|P4|STARTED|Overall Study||20
5319011|NCT00432159|13079371|P3|STARTED|Overall Study||39
5319012|NCT00432159|13079372|P2|STARTED|Overall Study||167
5319013|NCT00432159|13079373|P1|STARTED|Overall Study||185
5319014|NCT00432042|13079480|P3|NOT COMPLETED|Overall Study||2
5319015|NCT00432042|13079481|P2|NOT COMPLETED|Overall Study||1
5319016|NCT00432042|13079482|P1|NOT COMPLETED|Overall Study||7
5319017|NCT00432042|13079480|P3|COMPLETED|Overall Study||239
5319018|NCT00432042|13079481|P2|COMPLETED|Overall Study||234
5319019|NCT00432042|13079482|P1|COMPLETED|Overall Study||472
5319020|NCT00432042|13079480|P3|Vaccinated|Overall Study||240
5319021|NCT00432042|13079481|P2|Vaccinated|Overall Study||235
5319022|NCT00432042|13079482|P1|Vaccinated|Overall Study||477
5319023|NCT00432042|13079480|P3|STARTED|Overall Study|Number randomized.|241
5319024|NCT00432042|13079481|P2|STARTED|Overall Study|Number randomized.|235
5319025|NCT00432042|13079482|P1|STARTED|Overall Study|Number randomized.|479
5319026|NCT00431964|13079495|P2|NOT COMPLETED|Overall Study||8
5319027|NCT00431964|13079496|P1|NOT COMPLETED|Overall Study||6
5319028|NCT00431964|13079495|P2|COMPLETED|Overall Study||124
5319029|NCT00431964|13079496|P1|COMPLETED|Overall Study||125
5319030|NCT00431964|13079495|P2|Withdrew From Study|Overall Study||5
5319031|NCT00431964|13079496|P1|Withdrew From Study|Overall Study||6
5319032|NCT00431964|13079495|P2|Did Not Receive Drug|Overall Study||3
5319033|NCT00431964|13079496|P1|Did Not Receive Drug|Overall Study||0
5319034|NCT00431964|13079495|P2|Randomized/Received Drug|Overall Study||129
5319035|NCT00431964|13079496|P1|Randomized/Received Drug|Overall Study||131
5319036|NCT00431964|13079495|P2|STARTED|Overall Study||132
5319037|NCT00431964|13079496|P1|STARTED|Overall Study||131
5319038|NCT00431951|13079506|P4|NOT COMPLETED|Overall Study||2
5319039|NCT00431951|13079507|P3|NOT COMPLETED|Overall Study||2
5319040|NCT00431951|13079508|P2|NOT COMPLETED|Overall Study||2
5319041|NCT00431951|13079509|P1|NOT COMPLETED|Overall Study||1
5319042|NCT00431951|13079506|P4|COMPLETED|Overall Study||4
5319043|NCT00431951|13079507|P3|COMPLETED|Overall Study||6
5319044|NCT00431951|13079508|P2|COMPLETED|Overall Study||6
5319045|NCT00431951|13079509|P1|COMPLETED|Overall Study||7
5319046|NCT00431951|13079506|P4|STARTED|Overall Study||6
5319047|NCT00431951|13079507|P3|STARTED|Overall Study||8
5319048|NCT00431951|13079508|P2|STARTED|Overall Study||8
5319049|NCT00431951|13079509|P1|STARTED|Overall Study||8
5319050|NCT00431847|13079571|P5|NOT COMPLETED|Overall Study||1
5319051|NCT00431847|13079572|P4|NOT COMPLETED|Overall Study||14
5319052|NCT00431847|13079573|P3|NOT COMPLETED|Overall Study||4
5319053|NCT00431847|13079574|P2|NOT COMPLETED|Overall Study||3
5319054|NCT00431847|13079575|P1|NOT COMPLETED|Overall Study||6
5319055|NCT00431847|13079571|P5|COMPLETED|Overall Study||0
5319056|NCT00431847|13079572|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
5319057|NCT00431847|13079573|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
5319058|NCT00431847|13079574|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
5319059|NCT00431847|13079575|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
5319060|NCT00431847|13079571|P5|STARTED|Overall Study||1
5319061|NCT00431847|13079572|P4|STARTED|Overall Study||184
5319062|NCT00431847|13079573|P3|STARTED|Overall Study||24
5319063|NCT00431847|13079574|P2|STARTED|Overall Study||45
5319064|NCT00431847|13079575|P1|STARTED|Overall Study||132
5319065|NCT00431834|13079649|P1|NOT COMPLETED|Overall Study||13
5319066|NCT00431834|13079649|P1|COMPLETED|Overall Study||62
5319067|NCT00431834|13079649|P1|STARTED|Overall Study||75
5319068|NCT00431626|13079658|P2|NOT COMPLETED|Overall Study||0
5319069|NCT00431626|13079659|P1|NOT COMPLETED|Overall Study||0
5319070|NCT00431626|13079658|P2|COMPLETED|Overall Study||0
5319071|NCT00431626|13079659|P1|COMPLETED|Overall Study||4
5319072|NCT00431626|13079658|P2|STARTED|Overall Study||0
5319073|NCT00431626|13079659|P1|STARTED|Overall Study||4
5319074|NCT00431496|13079665|P1|NOT COMPLETED|Overall Study||11
5319075|NCT00431496|13079665|P1|COMPLETED|Overall Study||60
5319076|NCT00431496|13079665|P1|STARTED|Overall Study||71
5319077|NCT00431444|13079676|P2|NOT COMPLETED|Overall Study||7
5319078|NCT00431444|13079677|P1|NOT COMPLETED|Overall Study||5
5319079|NCT00431444|13079676|P2|COMPLETED|Overall Study||46
5319080|NCT00431444|13079677|P1|COMPLETED|Overall Study||51
5319081|NCT00431444|13079676|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
5319082|NCT00431444|13079677|P1|STARTED|Overall Study||56
5319083|NCT00431184|13079703|P2|NOT COMPLETED|Second Intervention (Day 2)||0
5319084|NCT00431184|13079704|P1|NOT COMPLETED|Second Intervention (Day 2)||0
5319085|NCT00431184|13079703|P2|COMPLETED|Second Intervention (Day 2)||9
5319086|NCT00431184|13079704|P1|COMPLETED|Second Intervention (Day 2)||10
5319087|NCT00431184|13079703|P2|STARTED|Second Intervention (Day 2)||9
5319088|NCT00431184|13079704|P1|STARTED|Second Intervention (Day 2)||10
5319089|NCT00431184|13079703|P2|NOT COMPLETED|1st Intervention (Day 1)||0
5319090|NCT00431184|13079704|P1|NOT COMPLETED|1st Intervention (Day 1)||0
5319091|NCT00431184|13079703|P2|COMPLETED|1st Intervention (Day 1)||9
5319092|NCT00431184|13079704|P1|COMPLETED|1st Intervention (Day 1)||10
5319093|NCT00431184|13079703|P2|STARTED|1st Intervention (Day 1)||9
5319094|NCT00431184|13079704|P1|STARTED|1st Intervention (Day 1)||10
5319095|NCT00431132|13079712|P1|NOT COMPLETED|Overall Study||44
5319096|NCT00431132|13079712|P1|COMPLETED|Overall Study||292
5319097|NCT00431132|13079712|P1|STARTED|Overall Study||336
5319098|NCT00431067|13079717|P1|NOT COMPLETED|Overall Study||41
5319099|NCT00431067|13079717|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
5319100|NCT00431067|13079717|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
5319101|NCT00431041|13079727|P2|NOT COMPLETED|Overall Study||24
5319102|NCT00431041|13079728|P1|NOT COMPLETED|Overall Study||16
5319103|NCT00431041|13079727|P2|COMPLETED|Overall Study||40
5319104|NCT00431041|13079728|P1|COMPLETED|Overall Study||52
5319105|NCT00431041|13079727|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
5319106|NCT00431041|13079728|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
5319107|NCT00430989|13079742|P2|NOT COMPLETED|Overall Study||60
5319108|NCT00430989|13079743|P1|NOT COMPLETED|Overall Study||60
5319109|NCT00430989|13079742|P2|COMPLETED|Overall Study||3509
5319110|NCT00430989|13079743|P1|COMPLETED|Overall Study||3483
5319111|NCT00430989|13079742|P2|STARTED|Overall Study||3569
5319112|NCT00430989|13079743|P1|STARTED|Overall Study||3543
5319113|NCT00430950|13079763|P2|NOT COMPLETED|Overall Study||13
5319114|NCT00430950|13079764|P1|NOT COMPLETED|Overall Study||13
5319115|NCT00430950|13079763|P2|COMPLETED|Overall Study||495
5319116|NCT00430950|13079764|P1|COMPLETED|Overall Study||489
5319117|NCT00430950|13079763|P2|STARTED|Overall Study||508
5319118|NCT00430950|13079764|P1|STARTED|Overall Study||502
5319119|NCT00430937|13079778|P2|NOT COMPLETED|Overall Study||28
5319120|NCT00430937|13079779|P1|NOT COMPLETED|Overall Study||27
5319121|NCT00430937|13079778|P2|COMPLETED|Overall Study||64
5319122|NCT00430937|13079779|P1|COMPLETED|Overall Study||70
5319123|NCT00430937|13079778|P2|STARTED|Overall Study||92
5319124|NCT00430937|13079779|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
5319125|NCT00430781|13079790|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
5319126|NCT00430781|13079791|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
5319127|NCT00430781|13079792|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
5319128|NCT00430781|13079790|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
5319129|NCT00430781|13079791|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
5319130|NCT00430781|13079792|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
5319131|NCT00430781|13079790|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
5319132|NCT00430781|13079791|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
5319133|NCT00430781|13079792|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
5319134|NCT00430781|13079790|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
5319135|NCT00430781|13079791|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
5319136|NCT00430781|13079792|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
5319137|NCT00430781|13079790|P3|COMPLETED|Final Analysis; 31 July 2008||26
5319138|NCT00430781|13079791|P2|COMPLETED|Final Analysis; 31 July 2008||39
5319139|NCT00430781|13079792|P1|COMPLETED|Final Analysis; 31 July 2008||0
5319140|NCT00430781|13079790|P3|Ongoing|Final Analysis; 31 July 2008||32
5319141|NCT00430781|13079791|P2|Ongoing|Final Analysis; 31 July 2008||29
5319142|NCT00430781|13079792|P1|Ongoing|Final Analysis; 31 July 2008||0
5319143|NCT00430781|13079790|P3|STARTED|Final Analysis; 31 July 2008||74
5319144|NCT00430781|13079791|P2|STARTED|Final Analysis; 31 July 2008||78
5319145|NCT00430781|13079792|P1|STARTED|Final Analysis; 31 July 2008||0
5319146|NCT00430781|13079790|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
5319147|NCT00430781|13079791|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
5319148|NCT00430781|13079792|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
5319149|NCT00430781|13079790|P3|COMPLETED|Interim Analysis; 11 February 2008||0
5319150|NCT00430781|13079791|P2|COMPLETED|Interim Analysis; 11 February 2008||0
5319151|NCT00430781|13079792|P1|COMPLETED|Interim Analysis; 11 February 2008||0
5319152|NCT00430781|13079790|P3|Ongoing|Interim Analysis; 11 February 2008||25
5319153|NCT00430781|13079791|P2|Ongoing|Interim Analysis; 11 February 2008||20
5319154|NCT00430781|13079792|P1|Ongoing|Interim Analysis; 11 February 2008||23
5319155|NCT00430781|13079790|P3|STARTED|Interim Analysis; 11 February 2008||60
5319156|NCT00430781|13079791|P2|STARTED|Interim Analysis; 11 February 2008||58
5319157|NCT00430781|13079792|P1|STARTED|Interim Analysis; 11 February 2008||59
5319158|NCT00430768|13079818|P3|NOT COMPLETED|Overall Study||0
5319159|NCT00430768|13079819|P2|NOT COMPLETED|Overall Study||0
5319160|NCT00430768|13079820|P1|NOT COMPLETED|Overall Study||0
5319161|NCT00430768|13079818|P3|COMPLETED|Overall Study||3
5319162|NCT00430768|13079819|P2|COMPLETED|Overall Study||3
5319163|NCT00430768|13079820|P1|COMPLETED|Overall Study||3
5319164|NCT00430768|13079818|P3|STARTED|Overall Study||3
5319165|NCT00430768|13079819|P2|STARTED|Overall Study||3
5319166|NCT00430768|13079820|P1|STARTED|Overall Study||3
5319167|NCT00430755|13079834|P1|NOT COMPLETED|Overall Study||53
5319168|NCT00430755|13079834|P1|COMPLETED|Overall Study||45
5319169|NCT00430755|13079834|P1|STARTED|Overall Study||98
5319170|NCT00430716|13079841|P3|NOT COMPLETED|Open Label Phase||7
5319171|NCT00430716|13079842|P2|NOT COMPLETED|Open Label Phase||7
5319172|NCT00430716|13079843|P1|NOT COMPLETED|Open Label Phase||9
5319173|NCT00430716|13079841|P3|COMPLETED|Open Label Phase||32
5319174|NCT00430716|13079842|P2|COMPLETED|Open Label Phase||31
5319175|NCT00430716|13079843|P1|COMPLETED|Open Label Phase||27
5319176|NCT00430716|13079841|P3|STARTED|Open Label Phase||39
5319177|NCT00430716|13079842|P2|STARTED|Open Label Phase||38
5319178|NCT00430716|13079843|P1|STARTED|Open Label Phase||36
5319179|NCT00430716|13079841|P3|NOT COMPLETED|Double Blind Phase||6
5319180|NCT00430716|13079842|P2|NOT COMPLETED|Double Blind Phase||5
5319181|NCT00430716|13079843|P1|NOT COMPLETED|Double Blind Phase||6
5319182|NCT00430716|13079841|P3|COMPLETED|Double Blind Phase||39
5319183|NCT00430716|13079842|P2|COMPLETED|Double Blind Phase||38
5319184|NCT00430716|13079843|P1|COMPLETED|Double Blind Phase||36
5319185|NCT00430716|13079841|P3|Treated|Double Blind Phase||45
5319186|NCT00430716|13079842|P2|Treated|Double Blind Phase||43
5319187|NCT00430716|13079843|P1|Treated|Double Blind Phase||41
5319188|NCT00430716|13079841|P3|STARTED|Double Blind Phase||45
5319189|NCT00430716|13079842|P2|STARTED|Double Blind Phase||43
5319190|NCT00430716|13079843|P1|STARTED|Double Blind Phase||42
5319191|NCT00430677|13079875|P3|NOT COMPLETED|Long-term Extension Period||63
5319192|NCT00430677|13079876|P2|NOT COMPLETED|Long-term Extension Period||58
5319193|NCT00430677|13079877|P1|NOT COMPLETED|Long-term Extension Period||60
5319194|NCT00430677|13079875|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
5319195|NCT00430677|13079876|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
5319196|NCT00430677|13079877|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
5319197|NCT00430677|13079875|P3|STARTED|Long-term Extension Period||74
5319198|NCT00430677|13079876|P2|STARTED|Long-term Extension Period||67
5319199|NCT00430677|13079877|P1|STARTED|Long-term Extension Period||70
5319200|NCT00430677|13079875|P3|NOT COMPLETED|Short-term Period||22
5319201|NCT00430677|13079876|P2|NOT COMPLETED|Short-term Period||25
5319202|NCT00430677|13079877|P1|NOT COMPLETED|Short-term Period||23
5319203|NCT00430677|13079875|P3|COMPLETED|Short-term Period|Completed the short-term period|78
5319204|NCT00430677|13079876|P2|COMPLETED|Short-term Period|Completed the short-term period|74
5319205|NCT00430677|13079877|P1|COMPLETED|Short-term Period|Completed the short-term period|76
5319206|NCT00430677|13079875|P3|STARTED|Short-term Period||100
5319207|NCT00430677|13079876|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
5319208|NCT00430677|13079877|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
5319209|NCT00430638|13080000|P2|NOT COMPLETED|Overall Study||48
5319210|NCT00430638|13080001|P1|NOT COMPLETED|Overall Study||78
5319211|NCT00430638|13080000|P2|COMPLETED|Overall Study||92
5319212|NCT00430638|13080001|P1|COMPLETED|Overall Study||60
5319213|NCT00430638|13080000|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
5319214|NCT00430638|13080001|P1|STARTED|Overall Study||138
5319215|NCT00430625|13080019|P2|NOT COMPLETED|Overall Study||0
5319216|NCT00430625|13080020|P1|NOT COMPLETED|Overall Study||0
5319217|NCT00430625|13080019|P2|COMPLETED|Overall Study||12
5319218|NCT00430625|13080020|P1|COMPLETED|Overall Study||13
5319219|NCT00430625|13080019|P2|STARTED|Overall Study||12
5319220|NCT00430625|13080020|P1|STARTED|Overall Study||13
5319221|NCT00430573|13080036|P1|NOT COMPLETED|Overall Study||5
5319222|NCT00430573|13080036|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
5319223|NCT00430573|13080036|P1|STARTED|Overall Study||10
5319224|NCT00430521|13080049|P8|NOT COMPLETED|Overall Study||12
5319225|NCT00430521|13080050|P7|NOT COMPLETED|Overall Study||10
5319226|NCT00430521|13080051|P6|NOT COMPLETED|Overall Study||5
5319227|NCT00430521|13080052|P5|NOT COMPLETED|Overall Study||5
5319228|NCT00430521|13080053|P4|NOT COMPLETED|Overall Study||8
5319229|NCT00430521|13080054|P3|NOT COMPLETED|Overall Study||3
5319230|NCT00430521|13080055|P2|NOT COMPLETED|Overall Study||9
5319231|NCT00430521|13080056|P1|NOT COMPLETED|Overall Study||11
5319232|NCT00430521|13080049|P8|COMPLETED|Overall Study||51
5319233|NCT00430521|13080050|P7|COMPLETED|Overall Study||55
5319234|NCT00430521|13080051|P6|COMPLETED|Overall Study||59
5319235|NCT00430521|13080052|P5|COMPLETED|Overall Study||59
5319236|NCT00430521|13080053|P4|COMPLETED|Overall Study||55
5319237|NCT00430521|13080054|P3|COMPLETED|Overall Study||61
5319238|NCT00430521|13080055|P2|COMPLETED|Overall Study||57
5319239|NCT00430521|13080056|P1|COMPLETED|Overall Study||52
5319240|NCT00430521|13080049|P8|STARTED|Overall Study||63
5319241|NCT00430521|13080050|P7|STARTED|Overall Study||65
5319242|NCT00430521|13080051|P6|STARTED|Overall Study||64
5319243|NCT00430521|13080052|P5|STARTED|Overall Study||64
5319244|NCT00430521|13080053|P4|STARTED|Overall Study||63
5319245|NCT00430521|13080054|P3|STARTED|Overall Study||64
5319246|NCT00430521|13080055|P2|STARTED|Overall Study||66
5319247|NCT00430521|13080056|P1|STARTED|Overall Study||63
5319248|NCT00430508|13080298|P4|NOT COMPLETED|Overall Study||5
5319249|NCT00430508|13080299|P3|NOT COMPLETED|Overall Study||13
5319250|NCT00430508|13080300|P2|NOT COMPLETED|Overall Study||6
5319251|NCT00430508|13080301|P1|NOT COMPLETED|Overall Study||3
5319252|NCT00430508|13080298|P4|COMPLETED|Overall Study||269
5319253|NCT00430508|13080299|P3|COMPLETED|Overall Study||266
5319254|NCT00430508|13080300|P2|COMPLETED|Overall Study||272
5319255|NCT00430508|13080301|P1|COMPLETED|Overall Study||137
5319256|NCT00430508|13080298|P4|STARTED|Overall Study||274
5319257|NCT00430508|13080299|P3|STARTED|Overall Study||279
5319258|NCT00430508|13080300|P2|STARTED|Overall Study||278
5319259|NCT00430508|13080301|P1|STARTED|Overall Study||140
5319260|NCT00430495|13080339|P4|NOT COMPLETED|Overall Study||4
5319261|NCT00430495|13080340|P3|NOT COMPLETED|Overall Study||13
5319262|NCT00430495|13080341|P2|NOT COMPLETED|Overall Study||7
5319263|NCT00430495|13080342|P1|NOT COMPLETED|Overall Study||14
5319264|NCT00430495|13080339|P4|COMPLETED|Overall Study||60
5319265|NCT00430495|13080340|P3|COMPLETED|Overall Study||49
5319266|NCT00430495|13080341|P2|COMPLETED|Overall Study||59
5319267|NCT00430495|13080342|P1|COMPLETED|Overall Study||50
5319268|NCT00430495|13080339|P4|Treated|Overall Study||64
5319269|NCT00430495|13080340|P3|Treated|Overall Study||62
5319270|NCT00430495|13080341|P2|Treated|Overall Study||66
5319271|NCT00430495|13080342|P1|Treated|Overall Study||62
5319272|NCT00430495|13080339|P4|STARTED|Overall Study||64
5319273|NCT00430495|13080340|P3|STARTED|Overall Study||62
5319274|NCT00430495|13080341|P2|STARTED|Overall Study||66
5319275|NCT00430495|13080342|P1|STARTED|Overall Study||64
5319276|NCT00430482|13080382|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
5319277|NCT00430482|13080383|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
5319278|NCT00430482|13080382|P2|COMPLETED|Completed 2 Follow-Up Visits||20
5319279|NCT00430482|13080383|P1|COMPLETED|Completed 2 Follow-Up Visits||29
5319280|NCT00430482|13080382|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
5319281|NCT00430482|13080383|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
5319282|NCT00430482|13080382|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
5319283|NCT00430482|13080383|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
5319284|NCT00430482|13080382|P2|STARTED|Completed 2 Follow-Up Visits||26
5319285|NCT00430482|13080383|P1|STARTED|Completed 2 Follow-Up Visits||34
5319286|NCT00430482|13080382|P2|NOT COMPLETED|Completed Treatment||11
5319287|NCT00430482|13080383|P1|NOT COMPLETED|Completed Treatment||7
5319288|NCT00430482|13080382|P2|COMPLETED|Completed Treatment||26
5319289|NCT00430482|13080383|P1|COMPLETED|Completed Treatment||34
5319290|NCT00430482|13080382|P2|Completed ASI at Midpoint|Completed Treatment||29
5319291|NCT00430482|13080383|P1|Completed ASI at Midpoint|Completed Treatment||35
5319292|NCT00430482|13080382|P2|STARTED|Completed Treatment||37
5319293|NCT00430482|13080383|P1|STARTED|Completed Treatment||41
5319294|NCT00430352|13080391|P1|NOT COMPLETED|Overall Study||138
5319295|NCT00430352|13080391|P1|COMPLETED|Overall Study||407
5319296|NCT00430352|13080391|P1|STARTED|Overall Study||545
5319297|NCT00430300|13080409|P4|NOT COMPLETED|Overall Study||2
5319298|NCT00430300|13080410|P3|NOT COMPLETED|Overall Study||6
5319299|NCT00430300|13080411|P2|NOT COMPLETED|Overall Study||2
5319300|NCT00430300|13080412|P1|NOT COMPLETED|Overall Study||2
5319301|NCT00430300|13080409|P4|COMPLETED|Overall Study||15
5319302|NCT00430300|13080410|P3|COMPLETED|Overall Study||29
5319303|NCT00430300|13080411|P2|COMPLETED|Overall Study||16
5319304|NCT00430300|13080412|P1|COMPLETED|Overall Study||15
5319305|NCT00430300|13080409|P4|STARTED|Overall Study||17
5319306|NCT00430300|13080410|P3|STARTED|Overall Study||35
5319307|NCT00430300|13080411|P2|STARTED|Overall Study||18
5319308|NCT00430300|13080412|P1|STARTED|Overall Study||17
5319309|NCT00430248|13080517|P3|NOT COMPLETED|Overall Study||135
5319310|NCT00430248|13080518|P2|NOT COMPLETED|Overall Study||158
5319311|NCT00430248|13080519|P1|NOT COMPLETED|Overall Study||125
5319312|NCT00430248|13080517|P3|COMPLETED|Overall Study||621
5319313|NCT00430248|13080518|P2|COMPLETED|Overall Study||598
5319314|NCT00430248|13080519|P1|COMPLETED|Overall Study||632
5319315|NCT00430248|13080517|P3|STARTED|Overall Study||756
5319316|NCT00430248|13080518|P2|STARTED|Overall Study||756
5319317|NCT00430248|13080519|P1|STARTED|Overall Study||757
5319318|NCT00430183|13080577|P2|NOT COMPLETED|Overall Study||0
5319319|NCT00430183|13080578|P1|NOT COMPLETED|Overall Study||0
5319320|NCT00430183|13080577|P2|COMPLETED|Overall Study||397
5319321|NCT00430183|13080578|P1|COMPLETED|Overall Study||391
5319322|NCT00430183|13080577|P2|STARTED|Overall Study||397
5319323|NCT00430183|13080578|P1|STARTED|Overall Study||391
5319324|NCT00430092|13080587|P3|NOT COMPLETED|Overall Study||57
5319325|NCT00430092|13080588|P2|NOT COMPLETED|Overall Study||4
5319326|NCT00430092|13080589|P1|NOT COMPLETED|Overall Study||6
5319327|NCT00430092|13080587|P3|COMPLETED|Overall Study||56
5319328|NCT00430092|13080588|P2|COMPLETED|Overall Study||48
5319329|NCT00430092|13080589|P1|COMPLETED|Overall Study||48
5319330|NCT00430092|13080587|P3|STARTED|Overall Study||113
5319331|NCT00430092|13080588|P2|STARTED|Overall Study||52
5319332|NCT00430092|13080589|P1|STARTED|Overall Study||54
5319333|NCT00430027|13080594|P1|NOT COMPLETED|Overall Study||8
5319334|NCT00430027|13080594|P1|COMPLETED|Overall Study||0
5319335|NCT00430027|13080594|P1|STARTED|Overall Study||8
5319336|NCT00429949|13080598|P1|NOT COMPLETED|Overall Study||0
5319337|NCT00429949|13080598|P1|COMPLETED|Overall Study||21
5319338|NCT00429949|13080598|P1|STARTED|Overall Study||21
5319339|NCT00429923|13080611|P3|NOT COMPLETED|Overall Study||39
5319340|NCT00429923|13080612|P2|NOT COMPLETED|Overall Study||4
5319341|NCT00429923|13080613|P1|NOT COMPLETED|Overall Study||5
5319342|NCT00429923|13080611|P3|COMPLETED|Overall Study||68
5319343|NCT00429923|13080612|P2|COMPLETED|Overall Study||51
5319344|NCT00429923|13080613|P1|COMPLETED|Overall Study||52
5319345|NCT00429923|13080611|P3|STARTED|Overall Study||107
5319346|NCT00429923|13080612|P2|STARTED|Overall Study||55
5319347|NCT00429923|13080613|P1|STARTED|Overall Study||57
5319348|NCT00429793|13080618|P1|NOT COMPLETED|Overall Study||6
5319349|NCT00429793|13080618|P1|COMPLETED|Overall Study||54
5319350|NCT00429793|13080618|P1|STARTED|Overall Study||60
5319351|NCT00429702|13080634|P2|NOT COMPLETED|Overall Study||0
5319352|NCT00429702|13080635|P1|NOT COMPLETED|Overall Study||0
5319353|NCT00429702|13080634|P2|COMPLETED|Overall Study||4
5319354|NCT00429702|13080635|P1|COMPLETED|Overall Study||3
5319355|NCT00429702|13080634|P2|STARTED|Overall Study||4
5319356|NCT00429702|13080635|P1|STARTED|Overall Study||3
5319357|NCT00429663|13080645|P2|NOT COMPLETED|Overall Study||39
5319358|NCT00429663|13080646|P1|NOT COMPLETED|Overall Study||36
5319359|NCT00429663|13080645|P2|COMPLETED|Overall Study||41
5319360|NCT00429663|13080646|P1|COMPLETED|Overall Study||40
5319361|NCT00429663|13080645|P2|STARTED|Overall Study||80
5319362|NCT00429663|13080646|P1|STARTED|Overall Study||76
5319363|NCT00429572|13080660|P1|NOT COMPLETED|Overall Study||1
5319364|NCT00429572|13080660|P1|COMPLETED|Overall Study||18
5319365|NCT00429572|13080660|P1|STARTED|Overall Study||19
5319366|NCT00429507|13080668|P1|NOT COMPLETED|Overall Study||0
5319367|NCT00429507|13080668|P1|COMPLETED|Overall Study||12
5319368|NCT00429507|13080668|P1|STARTED|Overall Study||12
5319369|NCT00429494|13080672|P1|NOT COMPLETED|Overall Study||15
5319370|NCT00429494|13080672|P1|COMPLETED|Overall Study||44
5319371|NCT00429494|13080672|P1|STARTED|Overall Study||59
5319372|NCT00429416|13080676|P1|NOT COMPLETED|Overall Study||1
5319373|NCT00429416|13080676|P1|COMPLETED|Overall Study||13
5319374|NCT00429416|13080676|P1|STARTED|Overall Study||14
5319375|NCT00429403|13080686|P2|NOT COMPLETED|Overall Study||0
5319376|NCT00429403|13080687|P1|NOT COMPLETED|Overall Study||0
5319377|NCT00429403|13080686|P2|COMPLETED|Overall Study||0
5319378|NCT00429403|13080687|P1|COMPLETED|Overall Study||1
5319379|NCT00429403|13080686|P2|STARTED|Overall Study||0
5319380|NCT00429403|13080687|P1|STARTED|Overall Study||1
5319381|NCT00429364|13080695|P2|NOT COMPLETED|Overall Study||33
5319382|NCT00429364|13080696|P1|NOT COMPLETED|Overall Study||32
5319383|NCT00429364|13080695|P2|COMPLETED|Overall Study||272
5319384|NCT00429364|13080696|P1|COMPLETED|Overall Study||271
5319385|NCT00429364|13080695|P2|STARTED|Overall Study||305
5319386|NCT00429364|13080696|P1|STARTED|Overall Study||303
5319387|NCT00429299|13080755|P3|NOT COMPLETED|Overall Study||4
5319388|NCT00429299|13080756|P2|NOT COMPLETED|Overall Study||7
5319389|NCT00429299|13080757|P1|NOT COMPLETED|Overall Study||4
5319390|NCT00429299|13080755|P3|COMPLETED|Overall Study||42
5319391|NCT00429299|13080756|P2|COMPLETED|Overall Study||32
5319392|NCT00429299|13080757|P1|COMPLETED|Overall Study||32
5319393|NCT00429299|13080755|P3|STARTED|Overall Study||46
5319394|NCT00429299|13080756|P2|STARTED|Overall Study||39
5319395|NCT00429299|13080757|P1|STARTED|Overall Study||36
5319396|NCT00429273|13080789|P3|NOT COMPLETED|Overall Study||9
5319397|NCT00429273|13080790|P2|NOT COMPLETED|Overall Study||8
5319398|NCT00429273|13080791|P1|NOT COMPLETED|Overall Study||8
5319399|NCT00429273|13080789|P3|COMPLETED|Overall Study||61
5319400|NCT00429273|13080790|P2|COMPLETED|Overall Study||61
5319401|NCT00429273|13080791|P1|COMPLETED|Overall Study||60
5319402|NCT00429273|13080789|P3|STARTED|Overall Study||70
5319403|NCT00429273|13080790|P2|STARTED|Overall Study||69
5319404|NCT00429273|13080791|P1|STARTED|Overall Study||68
5319405|NCT00429182|13080799|P1|NOT COMPLETED|Overall Study||7
5319406|NCT00429182|13080799|P1|COMPLETED|Overall Study||25
5319407|NCT00429182|13080799|P1|STARTED|Overall Study||32
5319408|NCT00429169|13080806|P2|NOT COMPLETED|Overall Study||2
5319409|NCT00429169|13080807|P1|NOT COMPLETED|Overall Study||2
5319410|NCT00429169|13080806|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
5319411|NCT00429169|13080807|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
5319412|NCT00429169|13080806|P2|STARTED|Overall Study||40
5319413|NCT00429169|13080807|P1|STARTED|Overall Study||38
5319414|NCT00429143|13080819|P1|NOT COMPLETED|Overall Study||0
5319415|NCT00429143|13080819|P1|COMPLETED|Overall Study||27
5319416|NCT00429143|13080819|P1|STARTED|Overall Study||27
5319417|NCT00429104|13080827|P1|NOT COMPLETED|Overall Study||1
5319418|NCT00429104|13080827|P1|COMPLETED|Overall Study||17
5319419|NCT00429104|13080827|P1|STARTED|Overall Study||18
5319420|NCT00429026|13080832|P1|NOT COMPLETED|Overall Study||40
5319421|NCT00429026|13080832|P1|COMPLETED|Overall Study||0
5319422|NCT00429026|13080832|P1|STARTED|Overall Study||40
5319423|NCT00428974|13080840|P4|NOT COMPLETED|Overall Study||3
5319424|NCT00428974|13080841|P3|NOT COMPLETED|Overall Study||1
5319425|NCT00428974|13080842|P2|NOT COMPLETED|Overall Study||0
5319426|NCT00428974|13080843|P1|NOT COMPLETED|Overall Study||8
5319427|NCT00428974|13080840|P4|COMPLETED|Overall Study||16
5319428|NCT00428974|13080841|P3|COMPLETED|Overall Study||14
5319429|NCT00428974|13080842|P2|COMPLETED|Overall Study||17
5319430|NCT00428974|13080843|P1|COMPLETED|Overall Study||17
5319431|NCT00428974|13080840|P4|STARTED|Overall Study||19
5319432|NCT00428974|13080841|P3|STARTED|Overall Study||15
5319433|NCT00428974|13080842|P2|STARTED|Overall Study||17
5319434|NCT00428974|13080843|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
5319435|NCT00428948|13080859|P2|NOT COMPLETED|Overall Study||67
5319436|NCT00428948|13080860|P1|NOT COMPLETED|Overall Study||221
5319437|NCT00428948|13080859|P2|COMPLETED|Overall Study||417
5319438|NCT00428948|13080860|P1|COMPLETED|Overall Study||740
5319439|NCT00428948|13080859|P2|Received Treatment|Overall Study||483
5319440|NCT00428948|13080860|P1|Received Treatment|Overall Study||961
5319441|NCT00428948|13080859|P2|STARTED|Overall Study||484
5319442|NCT00428948|13080860|P1|STARTED|Overall Study||961
5319443|NCT00428922|13080878|P1|NOT COMPLETED|Overall Study||0
5319444|NCT00428922|13080878|P1|COMPLETED|Overall Study||26
5319445|NCT00428922|13080878|P1|STARTED|Overall Study||26
5319446|NCT00428844|13080888|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
5319447|NCT00428844|13080889|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
5319448|NCT00428844|13080890|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
5319449|NCT00428844|13080888|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
5319450|NCT00428844|13080889|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
5319451|NCT00428844|13080890|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
5319452|NCT00428844|13080888|P3|STARTED|Completed Test of Cure (TOC) Visit||19
5319453|NCT00428844|13080889|P2|STARTED|Completed Test of Cure (TOC) Visit||18
5319454|NCT00428844|13080890|P1|STARTED|Completed Test of Cure (TOC) Visit||23
5319455|NCT00428844|13080888|P3|NOT COMPLETED|Completed Study Drug Treatment||7
5319456|NCT00428844|13080889|P2|NOT COMPLETED|Completed Study Drug Treatment||6
5319457|NCT00428844|13080890|P1|NOT COMPLETED|Completed Study Drug Treatment||2
5319458|NCT00428844|13080888|P3|COMPLETED|Completed Study Drug Treatment||19
5319459|NCT00428844|13080889|P2|COMPLETED|Completed Study Drug Treatment||18
5319460|NCT00428844|13080890|P1|COMPLETED|Completed Study Drug Treatment||23
5319461|NCT00428844|13080888|P3|Received First Dose|Completed Study Drug Treatment||25
5319462|NCT00428844|13080889|P2|Received First Dose|Completed Study Drug Treatment||24
5319463|NCT00428844|13080890|P1|Received First Dose|Completed Study Drug Treatment||25
5319464|NCT00428844|13080888|P3|STARTED|Completed Study Drug Treatment||26
5319465|NCT00428844|13080889|P2|STARTED|Completed Study Drug Treatment||24
5319466|NCT00428844|13080890|P1|STARTED|Completed Study Drug Treatment||25
5319467|NCT00428792|13080913|P2|NOT COMPLETED|Overall Study||4
5319468|NCT00428792|13080914|P1|NOT COMPLETED|Overall Study||1
5319469|NCT00428792|13080913|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
5319470|NCT00428792|13080914|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
5319471|NCT00428792|13080913|P2|STARTED|Overall Study||70
5319472|NCT00428792|13080914|P1|STARTED|Overall Study||80
5319473|NCT00428610|13080941|P3|NOT COMPLETED|Overall Study||32
5319474|NCT00428610|13080942|P2|NOT COMPLETED|Overall Study||18
5319475|NCT00428610|13080943|P1|NOT COMPLETED|Overall Study||53
5319476|NCT00428610|13080941|P3|COMPLETED|Overall Study||0
5319477|NCT00428610|13080942|P2|COMPLETED|Overall Study||0
5319478|NCT00428610|13080943|P1|COMPLETED|Overall Study||0
5319479|NCT00428610|13080941|P3|Received at Least One Dose of Study Drug|Overall Study||32
5319480|NCT00428610|13080942|P2|Received at Least One Dose of Study Drug|Overall Study||18
5319481|NCT00428610|13080943|P1|Received at Least One Dose of Study Drug|Overall Study||53
5319482|NCT00428610|13080941|P3|STARTED|Overall Study||32
5319483|NCT00428610|13080942|P2|STARTED|Overall Study||18
5319484|NCT00428610|13080943|P1|STARTED|Overall Study||53
5319485|NCT00428597|13080977|P2|NOT COMPLETED|Overall Study||85
5319486|NCT00428597|13080978|P1|NOT COMPLETED|Overall Study||86
5319487|NCT00428597|13080977|P2|COMPLETED|Overall Study||0
5319488|NCT00428597|13080978|P1|COMPLETED|Overall Study||0
5319489|NCT00428597|13080977|P2|Received Treatment|Overall Study||82
5319490|NCT00428597|13080978|P1|Received Treatment|Overall Study||83
5319491|NCT00428597|13080977|P2|STARTED|Overall Study||85
5319492|NCT00428597|13080978|P1|STARTED|Overall Study||86
5319493|NCT00428584|13081020|P2|NOT COMPLETED|Extension Phase||29
5319494|NCT00428584|13081021|P1|NOT COMPLETED|Extension Phase||21
5319495|NCT00428584|13081020|P2|COMPLETED|Extension Phase||34
5319496|NCT00428584|13081021|P1|COMPLETED|Extension Phase||35
5319497|NCT00428584|13081020|P2|STARTED|Extension Phase||63
5319498|NCT00428584|13081021|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
5319499|NCT00428584|13081020|P2|NOT COMPLETED|Comparative Phase||1
5319500|NCT00428584|13081021|P1|NOT COMPLETED|Comparative Phase||9
5319501|NCT00428584|13081020|P2|COMPLETED|Comparative Phase||63
5319502|NCT00428584|13081021|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
5319503|NCT00428584|13081020|P2|STARTED|Comparative Phase||64
5319504|NCT00428584|13081021|P1|STARTED|Comparative Phase||65
5319505|NCT00428441|13081045|P1|NOT COMPLETED|Overall Study||1
5319506|NCT00428441|13081045|P1|COMPLETED|Overall Study||74
5319507|NCT00428441|13081045|P1|STARTED|Overall Study||75
5319508|NCT00428389|13081051|P2|NOT COMPLETED|Extension Phase||26
5319509|NCT00428389|13081052|P1|NOT COMPLETED|Extension Phase||32
5319510|NCT00428389|13081051|P2|COMPLETED|Extension Phase||91
5319511|NCT00428389|13081052|P1|COMPLETED|Extension Phase||85
5319512|NCT00428389|13081051|P2|STARTED|Extension Phase||117
5319513|NCT00428389|13081052|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
5319514|NCT00428389|13081051|P2|NOT COMPLETED|Core Phase||11
5319515|NCT00428389|13081052|P1|NOT COMPLETED|Core Phase||11
5319516|NCT00428389|13081051|P2|COMPLETED|Core Phase||120
5319517|NCT00428389|13081052|P1|COMPLETED|Core Phase||120
5319518|NCT00428389|13081051|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
5319519|NCT00428389|13081052|P1|Intent-to-treat Population|Core Phase||131
5319520|NCT00428389|13081051|P2|STARTED|Core Phase||131
5319521|NCT00428389|13081052|P1|STARTED|Core Phase||131
5319522|NCT00428298|13081072|P2|NOT COMPLETED|Overall Study||11
5319523|NCT00428298|13081073|P1|NOT COMPLETED|Overall Study||14
5319524|NCT00428298|13081072|P2|COMPLETED|Overall Study||19
5319525|NCT00428298|13081073|P1|COMPLETED|Overall Study||16
5319526|NCT00428298|13081072|P2|Second RBANS at Study Exit|Overall Study||3
5319527|NCT00428298|13081073|P1|Second RBANS at Study Exit|Overall Study||3
5319528|NCT00428298|13081072|P2|STARTED|Overall Study||30
5319529|NCT00428298|13081073|P1|STARTED|Overall Study||30
5319530|NCT00428246|13081086|P3|NOT COMPLETED|Overall Study||1
5319531|NCT00428246|13081087|P2|NOT COMPLETED|Overall Study||0
5319532|NCT00428246|13081088|P1|NOT COMPLETED|Overall Study||1
5319533|NCT00428246|13081086|P3|COMPLETED|Overall Study||7
5319534|NCT00428246|13081087|P2|COMPLETED|Overall Study||8
5319535|NCT00428246|13081088|P1|COMPLETED|Overall Study||7
5319536|NCT00428246|13081086|P3|STARTED|Overall Study||8
5319537|NCT00428246|13081087|P2|STARTED|Overall Study||8
5319538|NCT00428246|13081088|P1|STARTED|Overall Study||8
5319539|NCT00428220|13081096|P1|NOT COMPLETED|Overall Study||223
5319540|NCT00428220|13081096|P1|COMPLETED|Overall Study||0
5319541|NCT00428220|13081096|P1|STARTED|Overall Study||223
5319542|NCT00428207|13081112|P2|NOT COMPLETED|Overall Study||0
5319543|NCT00428207|13081113|P1|NOT COMPLETED|Overall Study||0
5319544|NCT00428207|13081112|P2|COMPLETED|Overall Study||2
5319545|NCT00428207|13081113|P1|COMPLETED|Overall Study||2
5319546|NCT00428207|13081112|P2|STARTED|Overall Study||2
5319547|NCT00428207|13081113|P1|STARTED|Overall Study||2
5319548|NCT00428116|13081121|P2|NOT COMPLETED|Overall Study||0
5319549|NCT00428116|13081122|P1|NOT COMPLETED|Overall Study||3
5319550|NCT00428116|13081121|P2|COMPLETED|Overall Study||21
5319551|NCT00428116|13081122|P1|COMPLETED|Overall Study||18
5319552|NCT00428116|13081121|P2|STARTED|Overall Study||21
5319553|NCT00428116|13081122|P1|STARTED|Overall Study||21
5319554|NCT00428090|13081134|P4|NOT COMPLETED|Overall Study||28
5319555|NCT00428090|13081135|P3|NOT COMPLETED|Overall Study||38
5319556|NCT00428090|13081136|P2|NOT COMPLETED|Overall Study||31
5319557|NCT00428090|13081137|P1|NOT COMPLETED|Overall Study||34
5319558|NCT00428090|13081134|P4|COMPLETED|Overall Study||55
5319559|NCT00428090|13081135|P3|COMPLETED|Overall Study||127
5319560|NCT00428090|13081136|P2|COMPLETED|Overall Study||135
5319561|NCT00428090|13081137|P1|COMPLETED|Overall Study||131
5319562|NCT00428090|13081134|P4|STARTED|Overall Study||83
5319563|NCT00428090|13081135|P3|STARTED|Overall Study||165
5319564|NCT00428090|13081136|P2|STARTED|Overall Study||166
5319565|NCT00428090|13081137|P1|STARTED|Overall Study||165
5319566|NCT00428077|13081251|P1|NOT COMPLETED|Overall Study||0
5319567|NCT00428077|13081251|P1|COMPLETED|Overall Study||4
5319568|NCT00428077|13081251|P1|STARTED|Overall Study||4
5319569|NCT00427999|13081255|P1|NOT COMPLETED|Overall Study||32
5319570|NCT00427999|13081255|P1|COMPLETED|Overall Study||33
5319571|NCT00427999|13081255|P1|Extension Follow-up|Overall Study||19
5319572|NCT00427999|13081255|P1|Intent to Treat (ITT)|Overall Study||61
5319573|NCT00427999|13081255|P1|STARTED|Overall Study||65
5319574|NCT00427973|13081264|P1|NOT COMPLETED|Overall Study||0
5319575|NCT00427973|13081264|P1|COMPLETED|Overall Study||17
5319576|NCT00427973|13081264|P1|STARTED|Overall Study||17
5319577|NCT00427960|13081273|P2|NOT COMPLETED|Overall Study||4
5319578|NCT00427960|13081274|P1|NOT COMPLETED|Overall Study||2
5319579|NCT00427960|13081273|P2|COMPLETED|Overall Study||21
5319580|NCT00427960|13081274|P1|COMPLETED|Overall Study||28
5319581|NCT00427960|13081273|P2|STARTED|Overall Study||25
5319582|NCT00427960|13081274|P1|STARTED|Overall Study||30
5319583|NCT00427934|13081312|P4|NOT COMPLETED|Overall Study||15
5319584|NCT00427934|13081313|P3|NOT COMPLETED|Overall Study||23
5319585|NCT00427934|13081314|P2|NOT COMPLETED|Overall Study||0
5319586|NCT00427934|13081315|P1|NOT COMPLETED|Overall Study||1
5319587|NCT00427934|13081312|P4|COMPLETED|Overall Study||19
5319588|NCT00427934|13081313|P3|COMPLETED|Overall Study||55
5319589|NCT00427934|13081314|P2|COMPLETED|Overall Study||8
5319590|NCT00427934|13081315|P1|COMPLETED|Overall Study||7
5319591|NCT00427934|13081312|P4|Treated|Overall Study||33
5319592|NCT00427934|13081313|P3|Treated|Overall Study||77
5319593|NCT00427934|13081314|P2|Treated|Overall Study||8
5319594|NCT00427934|13081315|P1|Treated|Overall Study||8
5319595|NCT00427934|13081312|P4|STARTED|Overall Study||34
5319596|NCT00427934|13081313|P3|STARTED|Overall Study||78
5319597|NCT00427934|13081314|P2|STARTED|Overall Study||8
5319598|NCT00427934|13081315|P1|STARTED|Overall Study||8
5319599|NCT00427921|13081383|P1|NOT COMPLETED|Overall Study||50
5319600|NCT00427921|13081383|P1|COMPLETED|Overall Study||254
5319601|NCT00427921|13081383|P1|STARTED|Overall Study||304
5319602|NCT00427908|13081406|P4|NOT COMPLETED|Persistence Phase Year 5||0
5319603|NCT00427908|13081407|P3|NOT COMPLETED|Persistence Phase Year 5||0
5319604|NCT00427908|13081408|P2|NOT COMPLETED|Persistence Phase Year 5||0
5319605|NCT00427908|13081409|P1|NOT COMPLETED|Persistence Phase Year 5||0
5319606|NCT00427908|13081406|P4|COMPLETED|Persistence Phase Year 5||13
5319607|NCT00427908|13081407|P3|COMPLETED|Persistence Phase Year 5||12
5319608|NCT00427908|13081408|P2|COMPLETED|Persistence Phase Year 5||99
5319609|NCT00427908|13081409|P1|COMPLETED|Persistence Phase Year 5||52
5319610|NCT00427908|13081406|P4|STARTED|Persistence Phase Year 5||13
5319611|NCT00427908|13081407|P3|STARTED|Persistence Phase Year 5||12
5319612|NCT00427908|13081408|P2|STARTED|Persistence Phase Year 5||99
5319613|NCT00427908|13081409|P1|STARTED|Persistence Phase Year 5||52
5319614|NCT00427908|13081406|P4|NOT COMPLETED|Persistence Phase Year 4||0
5319615|NCT00427908|13081407|P3|NOT COMPLETED|Persistence Phase Year 4||0
5319616|NCT00427908|13081408|P2|NOT COMPLETED|Persistence Phase Year 4||0
5319617|NCT00427908|13081409|P1|NOT COMPLETED|Persistence Phase Year 4||0
5319618|NCT00427908|13081406|P4|COMPLETED|Persistence Phase Year 4||32
5319619|NCT00427908|13081407|P3|COMPLETED|Persistence Phase Year 4||34
5319620|NCT00427908|13081408|P2|COMPLETED|Persistence Phase Year 4||192
5319621|NCT00427908|13081409|P1|COMPLETED|Persistence Phase Year 4||165
5319622|NCT00427908|13081406|P4|STARTED|Persistence Phase Year 4||32
5319623|NCT00427908|13081407|P3|STARTED|Persistence Phase Year 4||34
5319624|NCT00427908|13081408|P2|STARTED|Persistence Phase Year 4||192
5319625|NCT00427908|13081409|P1|STARTED|Persistence Phase Year 4||165
5319626|NCT00427908|13081406|P4|NOT COMPLETED|Persistence Phase Year 3||0
5319627|NCT00427908|13081407|P3|NOT COMPLETED|Persistence Phase Year 3||0
5319628|NCT00427908|13081408|P2|NOT COMPLETED|Persistence Phase Year 3||0
5319629|NCT00427908|13081409|P1|NOT COMPLETED|Persistence Phase Year 3||0
5319630|NCT00427908|13081406|P4|COMPLETED|Persistence Phase Year 3||38
5319631|NCT00427908|13081407|P3|COMPLETED|Persistence Phase Year 3||38
5319632|NCT00427908|13081408|P2|COMPLETED|Persistence Phase Year 3||201
5319633|NCT00427908|13081409|P1|COMPLETED|Persistence Phase Year 3||185
5319634|NCT00427908|13081406|P4|STARTED|Persistence Phase Year 3||38
5319635|NCT00427908|13081407|P3|STARTED|Persistence Phase Year 3||38
5319636|NCT00427908|13081408|P2|STARTED|Persistence Phase Year 3||201
5319637|NCT00427908|13081409|P1|STARTED|Persistence Phase Year 3||185
5319638|NCT00427908|13081406|P4|NOT COMPLETED|Persistence Phase Year 2||0
5319639|NCT00427908|13081407|P3|NOT COMPLETED|Persistence Phase Year 2||0
5319640|NCT00427908|13081408|P2|NOT COMPLETED|Persistence Phase Year 2||0
5319641|NCT00427908|13081409|P1|NOT COMPLETED|Persistence Phase Year 2||0
5319642|NCT00427908|13081406|P4|COMPLETED|Persistence Phase Year 2||61
5319643|NCT00427908|13081407|P3|COMPLETED|Persistence Phase Year 2||53
5319644|NCT00427908|13081408|P2|COMPLETED|Persistence Phase Year 2||215
5319645|NCT00427908|13081409|P1|COMPLETED|Persistence Phase Year 2||208
5319646|NCT00427908|13081406|P4|STARTED|Persistence Phase Year 2||61
5319647|NCT00427908|13081407|P3|STARTED|Persistence Phase Year 2||53
5319648|NCT00427908|13081408|P2|STARTED|Persistence Phase Year 2||215
5319649|NCT00427908|13081409|P1|STARTED|Persistence Phase Year 2||208
5319650|NCT00427908|13081406|P4|NOT COMPLETED|Persistence Phase Year 1||0
5319651|NCT00427908|13081407|P3|NOT COMPLETED|Persistence Phase Year 1||0
5319652|NCT00427908|13081408|P2|NOT COMPLETED|Persistence Phase Year 1||0
5319653|NCT00427908|13081409|P1|NOT COMPLETED|Persistence Phase Year 1||0
5319654|NCT00427908|13081406|P4|COMPLETED|Persistence Phase Year 1||78
5319655|NCT00427908|13081407|P3|COMPLETED|Persistence Phase Year 1||71
5319656|NCT00427908|13081408|P2|COMPLETED|Persistence Phase Year 1||221
5319657|NCT00427908|13081409|P1|COMPLETED|Persistence Phase Year 1||222
5319658|NCT00427908|13081406|P4|STARTED|Persistence Phase Year 1||78
5319659|NCT00427908|13081407|P3|STARTED|Persistence Phase Year 1||71
5319660|NCT00427908|13081408|P2|STARTED|Persistence Phase Year 1||221
5319661|NCT00427908|13081409|P1|STARTED|Persistence Phase Year 1||222
5319662|NCT00427908|13081406|P4|NOT COMPLETED|Primary Phase||0
5319663|NCT00427908|13081407|P3|NOT COMPLETED|Primary Phase||3
5319664|NCT00427908|13081408|P2|NOT COMPLETED|Primary Phase||3
5319665|NCT00427908|13081409|P1|NOT COMPLETED|Primary Phase||5
5319666|NCT00427908|13081406|P4|COMPLETED|Primary Phase||78
5319667|NCT00427908|13081407|P3|COMPLETED|Primary Phase||72
5319668|NCT00427908|13081408|P2|COMPLETED|Primary Phase||228
5319669|NCT00427908|13081409|P1|COMPLETED|Primary Phase||224
5319670|NCT00427908|13081406|P4|STARTED|Primary Phase||78
5319671|NCT00427908|13081407|P3|STARTED|Primary Phase||75
5319672|NCT00427908|13081408|P2|STARTED|Primary Phase||231
5319673|NCT00427908|13081409|P1|STARTED|Primary Phase||229
5319674|NCT00427895|13081609|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
5319675|NCT00427895|13081610|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319676|NCT00427895|13081611|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319677|NCT00427895|13081612|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
5319678|NCT00427895|13081613|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319679|NCT00427895|13081614|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319680|NCT00427895|13081615|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319681|NCT00427895|13081616|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
5319682|NCT00427895|13081609|P8|COMPLETED|Vax 2/Year 3 to 4||212
5319683|NCT00427895|13081610|P7|COMPLETED|Vax 2/Year 3 to 4||189
5319684|NCT00427895|13081611|P6|COMPLETED|Vax 2/Year 3 to 4||108
5319685|NCT00427895|13081612|P5|COMPLETED|Vax 2/Year 3 to 4||107
5319686|NCT00427895|13081613|P4|COMPLETED|Vax 2/Year 3 to 4||0
5319687|NCT00427895|13081614|P3|COMPLETED|Vax 2/Year 3 to 4||0
5319688|NCT00427895|13081615|P2|COMPLETED|Vax 2/Year 3 to 4||0
5319689|NCT00427895|13081616|P1|COMPLETED|Vax 2/Year 3 to 4||0
5319690|NCT00427895|13081609|P8|STARTED|Vax 2/Year 3 to 4||214
5319691|NCT00427895|13081610|P7|STARTED|Vax 2/Year 3 to 4||189
5319692|NCT00427895|13081611|P6|STARTED|Vax 2/Year 3 to 4||108
5319693|NCT00427895|13081612|P5|STARTED|Vax 2/Year 3 to 4||108
5319694|NCT00427895|13081613|P4|STARTED|Vax 2/Year 3 to 4||0
5319695|NCT00427895|13081614|P3|STARTED|Vax 2/Year 3 to 4||0
5319696|NCT00427895|13081615|P2|STARTED|Vax 2/Year 3 to 4||0
5319697|NCT00427895|13081616|P1|STARTED|Vax 2/Year 3 to 4||0
5319698|NCT00427895|13081609|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319699|NCT00427895|13081610|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319700|NCT00427895|13081611|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319701|NCT00427895|13081612|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319702|NCT00427895|13081613|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
5319703|NCT00427895|13081614|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
5319704|NCT00427895|13081615|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
5319705|NCT00427895|13081616|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
5319706|NCT00427895|13081609|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319707|NCT00427895|13081610|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319708|NCT00427895|13081611|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319709|NCT00427895|13081612|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319710|NCT00427895|13081613|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
5319711|NCT00427895|13081614|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
5319712|NCT00427895|13081615|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
5319713|NCT00427895|13081616|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
5319714|NCT00427895|13081609|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
5319715|NCT00427895|13081610|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
5319716|NCT00427895|13081611|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
5319717|NCT00427895|13081612|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
5319718|NCT00427895|13081613|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
5319719|NCT00427895|13081614|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
5319720|NCT00427895|13081615|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
5319721|NCT00427895|13081616|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
5319722|NCT00427895|13081609|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
5319723|NCT00427895|13081610|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
5319724|NCT00427895|13081611|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
5319725|NCT00427895|13081612|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
5319726|NCT00427895|13081613|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
5319727|NCT00427895|13081614|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
5319728|NCT00427895|13081615|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
5319729|NCT00427895|13081616|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
5319730|NCT00427895|13081609|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
5319731|NCT00427895|13081610|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
5319732|NCT00427895|13081611|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
5319733|NCT00427895|13081612|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
5319734|NCT00427895|13081613|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
5319735|NCT00427895|13081614|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
5319736|NCT00427895|13081615|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
5319737|NCT00427895|13081616|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
5319738|NCT00427895|13081609|P8|STARTED|Vax 1/Year 1 Follow-up||0
5319739|NCT00427895|13081610|P7|STARTED|Vax 1/Year 1 Follow-up||0
5319740|NCT00427895|13081611|P6|STARTED|Vax 1/Year 1 Follow-up||0
5319741|NCT00427895|13081612|P5|STARTED|Vax 1/Year 1 Follow-up||0
5319742|NCT00427895|13081613|P4|STARTED|Vax 1/Year 1 Follow-up||502
5319743|NCT00427895|13081614|P3|STARTED|Vax 1/Year 1 Follow-up||392
5319744|NCT00427895|13081615|P2|STARTED|Vax 1/Year 1 Follow-up||411
5319745|NCT00427895|13081616|P1|STARTED|Vax 1/Year 1 Follow-up||411
5319746|NCT00427895|13081609|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319747|NCT00427895|13081610|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319748|NCT00427895|13081611|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319749|NCT00427895|13081612|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319750|NCT00427895|13081613|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
5319751|NCT00427895|13081614|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319752|NCT00427895|13081615|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319753|NCT00427895|13081616|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
5319754|NCT00427895|13081609|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
5319755|NCT00427895|13081610|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
5319756|NCT00427895|13081611|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
5319757|NCT00427895|13081612|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
5319758|NCT00427895|13081613|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
5319759|NCT00427895|13081614|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
5319760|NCT00427895|13081615|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
5319761|NCT00427895|13081616|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
5319762|NCT00427895|13081609|P8|STARTED|Between 6-Month Follow-up - Year 1||0
5319763|NCT00427895|13081610|P7|STARTED|Between 6-Month Follow-up - Year 1||0
5319764|NCT00427895|13081611|P6|STARTED|Between 6-Month Follow-up - Year 1||0
5319765|NCT00427895|13081612|P5|STARTED|Between 6-Month Follow-up - Year 1||0
5319766|NCT00427895|13081613|P4|STARTED|Between 6-Month Follow-up - Year 1||854
5319767|NCT00427895|13081614|P3|STARTED|Between 6-Month Follow-up - Year 1||392
5319768|NCT00427895|13081615|P2|STARTED|Between 6-Month Follow-up - Year 1||411
5319769|NCT00427895|13081616|P1|STARTED|Between 6-Month Follow-up - Year 1||411
5319770|NCT00427895|13081609|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319771|NCT00427895|13081610|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319772|NCT00427895|13081611|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319773|NCT00427895|13081612|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319774|NCT00427895|13081613|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
5319775|NCT00427895|13081614|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
5319776|NCT00427895|13081615|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
5319777|NCT00427895|13081616|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
5319778|NCT00427895|13081609|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319779|NCT00427895|13081610|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319780|NCT00427895|13081611|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319781|NCT00427895|13081612|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
5319782|NCT00427895|13081613|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
5319783|NCT00427895|13081614|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
5319784|NCT00427895|13081615|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
5319785|NCT00427895|13081616|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
5319786|NCT00427895|13081609|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
5319787|NCT00427895|13081610|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
5319788|NCT00427895|13081611|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
5319789|NCT00427895|13081612|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
5319790|NCT00427895|13081613|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
5319791|NCT00427895|13081614|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
5319792|NCT00427895|13081615|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
5319793|NCT00427895|13081616|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
5319794|NCT00427895|13081609|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
5319795|NCT00427895|13081610|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
5319796|NCT00427895|13081611|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
5319797|NCT00427895|13081612|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
5319798|NCT00427895|13081613|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
5319799|NCT00427895|13081614|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
5319800|NCT00427895|13081615|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
5319801|NCT00427895|13081616|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
5319802|NCT00427804|13081673|P2|NOT COMPLETED|Overall Study||0
5319803|NCT00427804|13081674|P1|NOT COMPLETED|Overall Study||0
5319804|NCT00427804|13081673|P2|COMPLETED|Overall Study||5
5319805|NCT00427804|13081674|P1|COMPLETED|Overall Study||4
5319806|NCT00427804|13081673|P2|STARTED|Overall Study||5
5319807|NCT00427804|13081674|P1|STARTED|Overall Study||4
5319808|NCT00427791|13081682|P2|NOT COMPLETED|Overall Study||0
5319809|NCT00427791|13081683|P1|NOT COMPLETED|Overall Study||0
5319810|NCT00427791|13081682|P2|COMPLETED|Overall Study||13
5319811|NCT00427791|13081683|P1|COMPLETED|Overall Study||10
5319812|NCT00427791|13081682|P2|STARTED|Overall Study||13
5319813|NCT00427791|13081683|P1|STARTED|Overall Study||10
5319814|NCT00427778|13081691|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
5319815|NCT00427778|13081692|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5319816|NCT00427778|13081691|P2|COMPLETED|Second Intervention (4 Weeks)||14
5319817|NCT00427778|13081692|P1|COMPLETED|Second Intervention (4 Weeks)||10
5319818|NCT00427778|13081691|P2|STARTED|Second Intervention (4 Weeks)||14
5319819|NCT00427778|13081692|P1|STARTED|Second Intervention (4 Weeks)||10
5319820|NCT00427778|13081691|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
5319821|NCT00427778|13081692|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
5319822|NCT00427778|13081691|P2|COMPLETED|Wash Out (2 Weeks)||14
5319823|NCT00427778|13081692|P1|COMPLETED|Wash Out (2 Weeks)||10
5319824|NCT00427778|13081691|P2|STARTED|Wash Out (2 Weeks)||14
5319825|NCT00427778|13081692|P1|STARTED|Wash Out (2 Weeks)||10
5319826|NCT00427778|13081691|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
5319827|NCT00427778|13081692|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
5319828|NCT00427778|13081691|P2|COMPLETED|First Intervention (4 Weeks)||14
5319829|NCT00427778|13081692|P1|COMPLETED|First Intervention (4 Weeks)||10
5319830|NCT00427778|13081691|P2|STARTED|First Intervention (4 Weeks)||15
5319831|NCT00427778|13081692|P1|STARTED|First Intervention (4 Weeks)||14
5319832|NCT00427765|13081711|P1|NOT COMPLETED|Overall Study||0
5319833|NCT00427765|13081711|P1|COMPLETED|Overall Study||164
5319834|NCT00427765|13081711|P1|STARTED|Overall Study||164
5319835|NCT00427700|13081717|P2|NOT COMPLETED|Overall Study||11
5319836|NCT00427700|13081718|P1|NOT COMPLETED|Overall Study||3
5319837|NCT00427700|13081717|P2|COMPLETED|Overall Study||31
5319838|NCT00427700|13081718|P1|COMPLETED|Overall Study||37
5319839|NCT00427700|13081717|P2|STARTED|Overall Study||42
5319840|NCT00427700|13081718|P1|STARTED|Overall Study||40
5319841|NCT00427661|13081726|P1|NOT COMPLETED|Overall Study||0
5319842|NCT00427661|13081726|P1|COMPLETED|Overall Study||8
5319843|NCT00427661|13081726|P1|STARTED|Overall Study||8
5319844|NCT00427648|13081734|P2|NOT COMPLETED|Overall Study||3
5319845|NCT00427648|13081735|P1|NOT COMPLETED|Overall Study||1
5319846|NCT00427648|13081734|P2|COMPLETED|Overall Study||7
5319847|NCT00427648|13081735|P1|COMPLETED|Overall Study||11
5319848|NCT00427648|13081734|P2|STARTED|Overall Study||10
5319849|NCT00427648|13081735|P1|STARTED|Overall Study||12
5319850|NCT00427635|13081755|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
5319851|NCT00427635|13081756|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
5319852|NCT00427635|13081755|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
5319853|NCT00427635|13081756|P1|COMPLETED|Study Completion to Safety Follow-up||25
5319854|NCT00427635|13081755|P2|STARTED|Study Completion to Safety Follow-up||26
5319855|NCT00427635|13081756|P1|STARTED|Study Completion to Safety Follow-up||25
5319856|NCT00427635|13081755|P2|NOT COMPLETED|Treatment Phase||0
5319857|NCT00427635|13081756|P1|NOT COMPLETED|Treatment Phase||1
5319858|NCT00427635|13081755|P2|COMPLETED|Treatment Phase|ITT population|26
5319859|NCT00427635|13081756|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
5319860|NCT00427635|13081755|P2|STARTED|Treatment Phase|Randomised|26
5319861|NCT00427635|13081756|P1|STARTED|Treatment Phase|Randomised|26
5319862|NCT00427557|13081784|P1|NOT COMPLETED|Overall Study||0
5319863|NCT00427557|13081784|P1|COMPLETED|Overall Study||30
5319864|NCT00427557|13081784|P1|STARTED|Overall Study||30
5319865|NCT00427349|13081788|P1|NOT COMPLETED|Overall Study||46
5319866|NCT00427349|13081788|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
5319867|NCT00427349|13081788|P1|Eligible and Treated|Overall Study||44
5319868|NCT00427349|13081788|P1|Treated|Overall Study||45
5319869|NCT00427349|13081788|P1|Eligible|Overall Study||45
5319870|NCT00427349|13081788|P1|STARTED|Overall Study||46
5319871|NCT00427336|13081794|P1|NOT COMPLETED|Overall Study||0
5319872|NCT00427336|13081794|P1|COMPLETED|Overall Study||9
5319873|NCT00427336|13081794|P1|STARTED|Overall Study||9
5319874|NCT00427297|13081800|P2|NOT COMPLETED|Overall Study||0
5319875|NCT00427297|13081801|P1|NOT COMPLETED|Overall Study||0
5319876|NCT00427297|13081800|P2|COMPLETED|Overall Study||17
5319877|NCT00427297|13081801|P1|COMPLETED|Overall Study||17
5319878|NCT00427297|13081800|P2|STARTED|Overall Study||17
5319879|NCT00427297|13081801|P1|STARTED|Overall Study||17
5319880|NCT00427193|13081815|P2|NOT COMPLETED|Overall Study||4
5319881|NCT00427193|13081816|P1|NOT COMPLETED|Overall Study||26
5319882|NCT00427193|13081815|P2|COMPLETED|Overall Study||71
5319883|NCT00427193|13081816|P1|COMPLETED|Overall Study||117
5319884|NCT00427193|13081815|P2|STARTED|Overall Study||75
5319885|NCT00427193|13081816|P1|STARTED|Overall Study||143
5319886|NCT00427037|13081836|P2|NOT COMPLETED|Overall Study||7
5319887|NCT00427037|13081837|P1|NOT COMPLETED|Overall Study||7
5319888|NCT00427037|13081836|P2|COMPLETED|Overall Study||10
5319889|NCT00427037|13081837|P1|COMPLETED|Overall Study||10
5319890|NCT00427037|13081836|P2|STARTED|Overall Study||17
5319891|NCT00427037|13081837|P1|STARTED|Overall Study||17
5319892|NCT00427011|13081845|P1|NOT COMPLETED|Overall Study||25
5319893|NCT00427011|13081845|P1|COMPLETED|Overall Study||0
5319894|NCT00427011|13081845|P1|STARTED|Overall Study||25
5319895|NCT00426855|13081856|P1|NOT COMPLETED|Overall Study||0
5319896|NCT00426855|13081856|P1|COMPLETED|Overall Study||12
5319897|NCT00426855|13081856|P1|STARTED|Overall Study||12
5319898|NCT00426842|13081860|P1|NOT COMPLETED|Overall Study||1
5319899|NCT00426842|13081860|P1|COMPLETED|Overall Study||10
5319900|NCT00426842|13081860|P1|STARTED|Overall Study||11
5319901|NCT00426764|13081866|P1|NOT COMPLETED|Overall Study||131
5319902|NCT00426764|13081866|P1|COMPLETED|Overall Study||0
5319903|NCT00426764|13081866|P1|Discontinued at End of or After Cycle 6|Overall Study||33
5319904|NCT00426764|13081866|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
5319905|NCT00426764|13081866|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
5319906|NCT00426751|13081883|P2|NOT COMPLETED|Overall Study||20
5319907|NCT00426751|13081884|P1|NOT COMPLETED|Overall Study||22
5319908|NCT00426751|13081883|P2|COMPLETED|Overall Study||183
5319909|NCT00426751|13081884|P1|COMPLETED|Overall Study||204
5319910|NCT00426751|13081883|P2|STARTED|Overall Study||203
5319911|NCT00426751|13081884|P1|STARTED|Overall Study||226
5319912|NCT00426660|13081928|P1|NOT COMPLETED|Overall Study||131
5319913|NCT00426660|13081928|P1|COMPLETED|Overall Study||916
5319914|NCT00426660|13081928|P1|Safety Analysis Set|Overall Study||1032
5319915|NCT00426660|13081928|P1|Treated|Overall Study||1032
5319916|NCT00426660|13081928|P1|STARTED|Overall Study||1047
5319917|NCT00426556|13081959|P4|NOT COMPLETED|Phase II - Extension Phase||23
5319918|NCT00426556|13081960|P3|NOT COMPLETED|Phase II - Extension Phase||0
5319919|NCT00426556|13081961|P2|NOT COMPLETED|Phase II - Extension Phase||0
5319920|NCT00426556|13081962|P1|NOT COMPLETED|Phase II - Extension Phase||0
5319921|NCT00426556|13081959|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
5319922|NCT00426556|13081960|P3|COMPLETED|Phase II - Extension Phase||0
5319923|NCT00426556|13081961|P2|COMPLETED|Phase II - Extension Phase||0
5319924|NCT00426556|13081962|P1|COMPLETED|Phase II - Extension Phase||0
5319925|NCT00426556|13081959|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
5319926|NCT00426556|13081960|P3|STARTED|Phase II - Extension Phase||0
5319927|NCT00426556|13081961|P2|STARTED|Phase II - Extension Phase||0
5319928|NCT00426556|13081962|P1|STARTED|Phase II - Extension Phase||0
5319929|NCT00426556|13081959|P4|NOT COMPLETED|Phase II - Core Phase||27
5319930|NCT00426556|13081960|P3|NOT COMPLETED|Phase II - Core Phase||0
5319931|NCT00426556|13081961|P2|NOT COMPLETED|Phase II - Core Phase||0
5319932|NCT00426556|13081962|P1|NOT COMPLETED|Phase II - Core Phase||0
5319933|NCT00426556|13081959|P4|COMPLETED|Phase II - Core Phase||28
5319934|NCT00426556|13081960|P3|COMPLETED|Phase II - Core Phase||0
5319935|NCT00426556|13081961|P2|COMPLETED|Phase II - Core Phase||0
5319936|NCT00426556|13081962|P1|COMPLETED|Phase II - Core Phase||0
5319937|NCT00426556|13081959|P4|STARTED|Phase II - Core Phase||55
5319938|NCT00426556|13081960|P3|STARTED|Phase II - Core Phase||0
5319939|NCT00426556|13081961|P2|STARTED|Phase II - Core Phase||0
5319940|NCT00426556|13081962|P1|STARTED|Phase II - Core Phase||0
5319941|NCT00426556|13081959|P4|NOT COMPLETED|Phase I - Extension Phase||0
5319942|NCT00426556|13081960|P3|NOT COMPLETED|Phase I - Extension Phase||7
5319943|NCT00426556|13081961|P2|NOT COMPLETED|Phase I - Extension Phase||6
5319944|NCT00426556|13081962|P1|NOT COMPLETED|Phase I - Extension Phase||5
5319945|NCT00426556|13081959|P4|COMPLETED|Phase I - Extension Phase||0
5319946|NCT00426556|13081960|P3|COMPLETED|Phase I - Extension Phase||0
5319947|NCT00426556|13081961|P2|COMPLETED|Phase I - Extension Phase||1
5319948|NCT00426556|13081962|P1|COMPLETED|Phase I - Extension Phase||0
5319949|NCT00426556|13081959|P4|STARTED|Phase I - Extension Phase||0
5319950|NCT00426556|13081960|P3|STARTED|Phase I - Extension Phase||7
5319951|NCT00426556|13081961|P2|STARTED|Phase I - Extension Phase||7
5319952|NCT00426556|13081962|P1|STARTED|Phase I - Extension Phase||5
5319953|NCT00426556|13081959|P4|NOT COMPLETED|Phase I - Core Phase||0
5319954|NCT00426556|13081960|P3|NOT COMPLETED|Phase I - Core Phase||3
5319955|NCT00426556|13081961|P2|NOT COMPLETED|Phase I - Core Phase||10
5319956|NCT00426556|13081962|P1|NOT COMPLETED|Phase I - Core Phase||1
5319957|NCT00426556|13081959|P4|COMPLETED|Phase I - Core Phase||0
5319958|NCT00426556|13081960|P3|COMPLETED|Phase I - Core Phase||7
5319959|NCT00426556|13081961|P2|COMPLETED|Phase I - Core Phase||7
5319960|NCT00426556|13081962|P1|COMPLETED|Phase I - Core Phase||5
5319961|NCT00426556|13081959|P4|STARTED|Phase I - Core Phase||0
5319962|NCT00426556|13081960|P3|STARTED|Phase I - Core Phase||10
5319963|NCT00426556|13081961|P2|STARTED|Phase I - Core Phase||17
5319964|NCT00426556|13081962|P1|STARTED|Phase I - Core Phase||6
5319965|NCT00426361|13081987|P3|NOT COMPLETED|Overall Study||5
5319966|NCT00426361|13081988|P2|NOT COMPLETED|Overall Study||5
5319967|NCT00426361|13081989|P1|NOT COMPLETED|Overall Study||4
5319968|NCT00426361|13081987|P3|COMPLETED|Overall Study||243
5319969|NCT00426361|13081988|P2|COMPLETED|Overall Study||250
5319970|NCT00426361|13081989|P1|COMPLETED|Overall Study||244
5319971|NCT00426361|13081987|P3|STARTED|Overall Study||248
5319972|NCT00426361|13081988|P2|STARTED|Overall Study||255
5319973|NCT00426361|13081989|P1|STARTED|Overall Study||248
5319974|NCT00426283|13082041|P2|NOT COMPLETED|Overall Study||1
5319975|NCT00426283|13082042|P1|NOT COMPLETED|Overall Study||5
5319976|NCT00426283|13082041|P2|COMPLETED|Overall Study||13
5319977|NCT00426283|13082042|P1|COMPLETED|Overall Study||23
5319978|NCT00426283|13082041|P2|STARTED|Overall Study||14
5319979|NCT00426283|13082042|P1|STARTED|Overall Study||28
5319980|NCT00426270|13082048|P1|NOT COMPLETED|Overall Study||6
5319981|NCT00426270|13082048|P1|COMPLETED|Overall Study||110
5319982|NCT00426270|13082048|P1|STARTED|Overall Study||116
5319983|NCT00426231|13082058|P2|NOT COMPLETED|Overall Study||12
5319984|NCT00426231|13082059|P1|NOT COMPLETED|Overall Study||9
5319985|NCT00426231|13082058|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
5319986|NCT00426231|13082059|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
5319987|NCT00426231|13082058|P2|STARTED|Overall Study||37
5319988|NCT00426231|13082059|P1|STARTED|Overall Study||36
5319989|NCT00426153|13082069|P2|NOT COMPLETED|Overall Study||0
5319990|NCT00426153|13082070|P1|NOT COMPLETED|Overall Study||0
5319991|NCT00426153|13082069|P2|COMPLETED|Overall Study||14
5319992|NCT00426153|13082070|P1|COMPLETED|Overall Study||28
5319993|NCT00426153|13082069|P2|STARTED|Overall Study||14
5319994|NCT00426153|13082070|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
5319995|NCT00426127|13082082|P1|NOT COMPLETED|Overall Study||2
5319996|NCT00426127|13082082|P1|COMPLETED|Overall Study||0
5319997|NCT00426127|13082082|P1|STARTED|Overall Study||2
5319998|NCT00425945|13082090|P2|NOT COMPLETED|Overall Study||5
5319999|NCT00425945|13082091|P1|NOT COMPLETED|Overall Study||4
5320000|NCT00425945|13082090|P2|COMPLETED|Overall Study||61
5320001|NCT00425945|13082091|P1|COMPLETED|Overall Study||60
5320002|NCT00425945|13082090|P2|STARTED|Overall Study||66
5320003|NCT00425945|13082091|P1|STARTED|Overall Study||64
5320004|NCT00425854|13082129|P2|NOT COMPLETED|Overall Study||21
5320005|NCT00425854|13082130|P1|NOT COMPLETED|Overall Study||29
5320006|NCT00425854|13082129|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
5320007|NCT00425854|13082130|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
5320008|NCT00425854|13082129|P2|STARTED|Overall Study|Treated|21
5320009|NCT00425854|13082130|P1|STARTED|Overall Study|Treated|29
5320010|NCT00425802|13082151|P1|NOT COMPLETED|Overall Study||0
5320011|NCT00425802|13082151|P1|COMPLETED|Overall Study||61
5320012|NCT00425802|13082151|P1|STARTED|Overall Study||61
5320013|NCT00425750|13082163|P1|NOT COMPLETED|Overall Study||25
5320014|NCT00425750|13082163|P1|COMPLETED|Overall Study||0
5320015|NCT00425750|13082163|P1|STARTED|Overall Study||25
5320016|NCT00425698|13082171|P2|NOT COMPLETED|Overall Study||2
5320017|NCT00425698|13082172|P1|NOT COMPLETED|Overall Study||3
5320018|NCT00425698|13082171|P2|COMPLETED|Overall Study||42
5320019|NCT00425698|13082172|P1|COMPLETED|Overall Study||41
5320020|NCT00425698|13082171|P2|STARTED|Overall Study||44
5320021|NCT00425698|13082172|P1|STARTED|Overall Study||44
5320022|NCT00425672|13082178|P1|NOT COMPLETED|Overall Study||1
5320023|NCT00425672|13082178|P1|COMPLETED|Overall Study||14
5320024|NCT00425672|13082178|P1|STARTED|Overall Study||15
5320025|NCT00425607|13082187|P1|NOT COMPLETED|Overall Study||2
5320026|NCT00425607|13082187|P1|COMPLETED|Overall Study||27
5320027|NCT00425607|13082187|P1|Received Treatment|Overall Study||28
5320028|NCT00425607|13082187|P1|STARTED|Overall Study||29
5320029|NCT00425503|13082191|P1|NOT COMPLETED|Overall Study||3
5320030|NCT00425503|13082191|P1|COMPLETED|Overall Study||37
5320031|NCT00425503|13082191|P1|STARTED|Overall Study||40
5320032|NCT00425477|13082195|P1|NOT COMPLETED|Overall Study||13
5320033|NCT00425477|13082195|P1|COMPLETED|Overall Study||13
5320034|NCT00425477|13082195|P1|STARTED|Overall Study||26
5320035|NCT00425438|13082203|P2|NOT COMPLETED|Overall Study||27
5320036|NCT00425438|13082204|P1|NOT COMPLETED|Overall Study||25
5320037|NCT00425438|13082203|P2|COMPLETED|Overall Study||0
5320038|NCT00425438|13082204|P1|COMPLETED|Overall Study||0
5320039|NCT00425438|13082203|P2|STARTED|Overall Study||27
5320040|NCT00425438|13082204|P1|STARTED|Overall Study||25
5320041|NCT00425386|13082220|P1|NOT COMPLETED|Overall Study||3
5320042|NCT00425386|13082220|P1|COMPLETED|Overall Study||43
5320043|NCT00425386|13082220|P1|STARTED|Overall Study||46
5320044|NCT00425373|13082238|P9|NOT COMPLETED|Overall Study||18
5320045|NCT00425373|13082239|P8|NOT COMPLETED|Overall Study||10
5320046|NCT00425373|13082240|P7|NOT COMPLETED|Overall Study||7
5320047|NCT00425373|13082241|P6|NOT COMPLETED|Overall Study||9
5320048|NCT00425373|13082242|P5|NOT COMPLETED|Overall Study||10
5320049|NCT00425373|13082243|P4|NOT COMPLETED|Overall Study||2
5320050|NCT00425373|13082244|P3|NOT COMPLETED|Overall Study||3
5320051|NCT00425373|13082245|P2|NOT COMPLETED|Overall Study||3
5320052|NCT00425373|13082246|P1|NOT COMPLETED|Overall Study||5
5320053|NCT00425373|13082238|P9|COMPLETED|Overall Study||148
5320054|NCT00425373|13082239|P8|COMPLETED|Overall Study||151
5320055|NCT00425373|13082240|P7|COMPLETED|Overall Study||154
5320056|NCT00425373|13082241|P6|COMPLETED|Overall Study||154
5320057|NCT00425373|13082242|P5|COMPLETED|Overall Study||159
5320058|NCT00425373|13082243|P4|COMPLETED|Overall Study||160
5320059|NCT00425373|13082244|P3|COMPLETED|Overall Study||157
5320060|NCT00425373|13082245|P2|COMPLETED|Overall Study||164
5320061|NCT00425373|13082246|P1|COMPLETED|Overall Study||154
5320062|NCT00425373|13082238|P9|STARTED|Overall Study||166
5320063|NCT00425373|13082239|P8|STARTED|Overall Study||161
5320064|NCT00425373|13082240|P7|STARTED|Overall Study||161
5320065|NCT00425373|13082241|P6|STARTED|Overall Study||163
5320066|NCT00425373|13082242|P5|STARTED|Overall Study||169
5320067|NCT00425373|13082243|P4|STARTED|Overall Study||162
5320068|NCT00425373|13082244|P3|STARTED|Overall Study||160
5320069|NCT00425373|13082245|P2|STARTED|Overall Study||167
5320070|NCT00425373|13082246|P1|STARTED|Overall Study||159
5320071|NCT00425308|13082304|P2|NOT COMPLETED|Overall Study||1
5320072|NCT00425308|13082305|P1|NOT COMPLETED|Overall Study||4
5320073|NCT00425308|13082304|P2|COMPLETED|Overall Study||14
5320074|NCT00425308|13082305|P1|COMPLETED|Overall Study||11
5320075|NCT00425308|13082304|P2|STARTED|Overall Study||15
5320076|NCT00425308|13082305|P1|STARTED|Overall Study||15
5320077|NCT00425269|13082335|P2|NOT COMPLETED|Overall Study||20
5320078|NCT00425269|13082336|P1|NOT COMPLETED|Overall Study||19
5320079|NCT00425269|13082335|P2|COMPLETED|Overall Study||77
5320080|NCT00425269|13082336|P1|COMPLETED|Overall Study||82
5320081|NCT00425269|13082335|P2|STARTED|Overall Study||97
5320082|NCT00425269|13082336|P1|STARTED|Overall Study||101
5320083|NCT00425113|13082414|P2|NOT COMPLETED|Overall Study||2
5320084|NCT00425113|13082415|P1|NOT COMPLETED|Overall Study||2
5320085|NCT00425113|13082414|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
5320086|NCT00425113|13082415|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
5320087|NCT00425113|13082414|P2|Exposed to Study Drug|Overall Study||17
5320088|NCT00425113|13082415|P1|Exposed to Study Drug|Overall Study||16
5320089|NCT00425113|13082414|P2|STARTED|Overall Study||18
5320090|NCT00425113|13082415|P1|STARTED|Overall Study||17
5320091|NCT00425100|13082423|P1|NOT COMPLETED|Overall Study||53
5320092|NCT00425100|13082423|P1|COMPLETED|Overall Study||463
5320093|NCT00425100|13082423|P1|STARTED|Overall Study||516
5320094|NCT00425061|13082467|P7|NOT COMPLETED|Overall Study||19
5320095|NCT00425061|13082468|P6|NOT COMPLETED|Overall Study||4
5320096|NCT00425061|13082469|P5|NOT COMPLETED|Overall Study||26
5320097|NCT00425061|13082470|P4|NOT COMPLETED|Overall Study||2
5320098|NCT00425061|13082471|P3|NOT COMPLETED|Overall Study||0
5320099|NCT00425061|13082472|P2|NOT COMPLETED|Overall Study||2
5320100|NCT00425061|13082473|P1|NOT COMPLETED|Overall Study||2
5320101|NCT00425061|13082467|P7|COMPLETED|Overall Study||26
5320102|NCT00425061|13082468|P6|COMPLETED|Overall Study||0
5320103|NCT00425061|13082469|P5|COMPLETED|Overall Study||19
5320104|NCT00425061|13082470|P4|COMPLETED|Overall Study||14
5320105|NCT00425061|13082471|P3|COMPLETED|Overall Study||16
5320106|NCT00425061|13082472|P2|COMPLETED|Overall Study||15
5320107|NCT00425061|13082473|P1|COMPLETED|Overall Study||14
5320108|NCT00425061|13082467|P7|STARTED|Overall Study||45
5320109|NCT00425061|13082468|P6|STARTED|Overall Study||4
5320110|NCT00425061|13082469|P5|STARTED|Overall Study||45
5320111|NCT00425061|13082470|P4|STARTED|Overall Study||16
5320112|NCT00425061|13082471|P3|STARTED|Overall Study||16
5320113|NCT00425061|13082472|P2|STARTED|Overall Study||17
5320114|NCT00425061|13082473|P1|STARTED|Overall Study||16
5320115|NCT00424840|13082589|P3|NOT COMPLETED|Overall Study||0
5320116|NCT00424840|13082590|P2|NOT COMPLETED|Overall Study||0
5320117|NCT00424840|13082591|P1|NOT COMPLETED|Overall Study||0
5320118|NCT00424840|13082589|P3|COMPLETED|Overall Study||5
5320119|NCT00424840|13082590|P2|COMPLETED|Overall Study||4
5320120|NCT00424840|13082591|P1|COMPLETED|Overall Study||3
5320121|NCT00424840|13082589|P3|STARTED|Overall Study||5
5320122|NCT00424840|13082590|P2|STARTED|Overall Study||4
5320123|NCT00424840|13082591|P1|STARTED|Overall Study||3
5320124|NCT00424827|13082597|P1|NOT COMPLETED|Overall Study||1
5320125|NCT00424827|13082597|P1|COMPLETED|Overall Study||10
5320126|NCT00424827|13082597|P1|STARTED|Overall Study||11
5320127|NCT00424775|13082605|P2|NOT COMPLETED|Overall Study||0
5320128|NCT00424775|13082606|P1|NOT COMPLETED|Overall Study||3
5320129|NCT00424775|13082605|P2|COMPLETED|Overall Study||0
5320130|NCT00424775|13082606|P1|COMPLETED|Overall Study||0
5320131|NCT00424775|13082605|P2|STARTED|Overall Study||0
5320132|NCT00424775|13082606|P1|STARTED|Overall Study||3
5320133|NCT00424762|13082616|P2|NOT COMPLETED|Overall Study||22
5320134|NCT00424762|13082617|P1|NOT COMPLETED|Overall Study||20
5320135|NCT00424762|13082616|P2|COMPLETED|Overall Study||54
5320136|NCT00424762|13082617|P1|COMPLETED|Overall Study||54
5320137|NCT00424762|13082616|P2|STARTED|Overall Study||76
5320138|NCT00424762|13082617|P1|STARTED|Overall Study||74
5320139|NCT00424749|13082627|P1|NOT COMPLETED|Overall Study||1
5320140|NCT00424749|13082627|P1|COMPLETED|Overall Study||3
5320141|NCT00424749|13082627|P1|STARTED|Overall Study||4
5320142|NCT00424645|13082634|P2|NOT COMPLETED|Overall Study||0
5320143|NCT00424645|13082635|P1|NOT COMPLETED|Overall Study||1
5320144|NCT00424645|13082634|P2|COMPLETED|Overall Study||0
5320145|NCT00424645|13082635|P1|COMPLETED|Overall Study||2
5320146|NCT00424645|13082634|P2|STARTED|Overall Study||0
5320147|NCT00424645|13082635|P1|STARTED|Overall Study||3
5320148|NCT00424632|13082643|P10|NOT COMPLETED|Overall Study||6
5320149|NCT00424632|13082644|P9|NOT COMPLETED|Overall Study||16
5320150|NCT00424632|13082645|P8|NOT COMPLETED|Overall Study||3
5320151|NCT00424632|13082646|P7|NOT COMPLETED|Overall Study||7
5320152|NCT00424632|13082647|P6|NOT COMPLETED|Overall Study||15
5320153|NCT00424632|13082648|P5|NOT COMPLETED|Overall Study||3
5320154|NCT00424632|13082649|P4|NOT COMPLETED|Overall Study||4
5320155|NCT00424632|13082650|P3|NOT COMPLETED|Overall Study||1
5320156|NCT00424632|13082651|P2|NOT COMPLETED|Overall Study||1
5320157|NCT00424632|13082652|P1|NOT COMPLETED|Overall Study||1
5320158|NCT00424632|13082643|P10|COMPLETED|Overall Study||0
5320159|NCT00424632|13082644|P9|COMPLETED|Overall Study||0
5320160|NCT00424632|13082645|P8|COMPLETED|Overall Study||0
5320161|NCT00424632|13082646|P7|COMPLETED|Overall Study||0
5320162|NCT00424632|13082647|P6|COMPLETED|Overall Study||0
5320163|NCT00424632|13082648|P5|COMPLETED|Overall Study||0
5320164|NCT00424632|13082649|P4|COMPLETED|Overall Study||0
5320165|NCT00424632|13082650|P3|COMPLETED|Overall Study||0
5320166|NCT00424632|13082651|P2|COMPLETED|Overall Study||0
5320167|NCT00424632|13082652|P1|COMPLETED|Overall Study||0
5320168|NCT00424632|13082643|P10|STARTED|Overall Study||6
5320169|NCT00424632|13082644|P9|STARTED|Overall Study||16
5320170|NCT00424632|13082645|P8|STARTED|Overall Study||3
5320171|NCT00424632|13082646|P7|STARTED|Overall Study||7
5320172|NCT00424632|13082647|P6|STARTED|Overall Study||15
5320173|NCT00424632|13082648|P5|STARTED|Overall Study||3
5320174|NCT00424632|13082649|P4|STARTED|Overall Study||4
5320175|NCT00424632|13082650|P3|STARTED|Overall Study||1
5320176|NCT00424632|13082651|P2|STARTED|Overall Study||1
5320177|NCT00424632|13082652|P1|STARTED|Overall Study||1
5320178|NCT00424619|13082786|P3|NOT COMPLETED|3 Month||0
5320179|NCT00424619|13082787|P2|NOT COMPLETED|3 Month||0
5320180|NCT00424619|13082788|P1|NOT COMPLETED|3 Month||0
5320181|NCT00424619|13082786|P3|COMPLETED|3 Month||17
5320182|NCT00424619|13082787|P2|COMPLETED|3 Month||18
5320183|NCT00424619|13082788|P1|COMPLETED|3 Month||12
5320184|NCT00424619|13082786|P3|STARTED|3 Month||17
5320185|NCT00424619|13082787|P2|STARTED|3 Month||18
5320186|NCT00424619|13082788|P1|STARTED|3 Month||12
5320187|NCT00424619|13082786|P3|NOT COMPLETED|4 Week||0
5320188|NCT00424619|13082787|P2|NOT COMPLETED|4 Week||0
5320189|NCT00424619|13082788|P1|NOT COMPLETED|4 Week||0
5320190|NCT00424619|13082786|P3|COMPLETED|4 Week||17
5320191|NCT00424619|13082787|P2|COMPLETED|4 Week||17
5320192|NCT00424619|13082788|P1|COMPLETED|4 Week||18
5320193|NCT00424619|13082786|P3|STARTED|4 Week||17
5320194|NCT00424619|13082787|P2|STARTED|4 Week||17
5320195|NCT00424619|13082788|P1|STARTED|4 Week||18
5320196|NCT00424619|13082786|P3|NOT COMPLETED|Baseline||1
5320197|NCT00424619|13082787|P2|NOT COMPLETED|Baseline||0
5320198|NCT00424619|13082788|P1|NOT COMPLETED|Baseline||0
5320199|NCT00424619|13082786|P3|COMPLETED|Baseline||20
5320200|NCT00424619|13082787|P2|COMPLETED|Baseline||22
5320201|NCT00424619|13082788|P1|COMPLETED|Baseline||22
5320202|NCT00424619|13082786|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
5320203|NCT00424619|13082787|P2|STARTED|Baseline||22
5320204|NCT00424619|13082788|P1|STARTED|Baseline||22
5320205|NCT00424593|13082822|P2|NOT COMPLETED|Dose-Blind Extension Period||0
5320206|NCT00424593|13082823|P1|NOT COMPLETED|Dose-Blind Extension Period||64
5320207|NCT00424593|13082822|P2|COMPLETED|Dose-Blind Extension Period||0
5320208|NCT00424593|13082823|P1|COMPLETED|Dose-Blind Extension Period||117
5320209|NCT00424593|13082822|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
5320210|NCT00424593|13082823|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
5320211|NCT00424593|13082822|P2|NOT COMPLETED|Acute Double-Blind Period||23
5320212|NCT00424593|13082823|P1|NOT COMPLETED|Acute Double-Blind Period||31
5320213|NCT00424593|13082822|P2|COMPLETED|Acute Double-Blind Period||98
5320214|NCT00424593|13082823|P1|COMPLETED|Acute Double-Blind Period||84
5320215|NCT00424593|13082822|P2|STARTED|Acute Double-Blind Period||121
5320216|NCT00424593|13082823|P1|STARTED|Acute Double-Blind Period||115
5320217|NCT00424554|13082869|P2|NOT COMPLETED|Overall Study||0
5320218|NCT00424554|13082870|P1|NOT COMPLETED|Overall Study||0
5320219|NCT00424554|13082869|P2|COMPLETED|Overall Study||6
5320220|NCT00424554|13082870|P1|COMPLETED|Overall Study||34
5320221|NCT00424554|13082869|P2|STARTED|Overall Study||6
5320222|NCT00424554|13082870|P1|STARTED|Overall Study||34
5320223|NCT00424528|13082887|P3|NOT COMPLETED|Overall Study||4
5320224|NCT00424528|13082888|P2|NOT COMPLETED|Overall Study||4
5320225|NCT00424528|13082889|P1|NOT COMPLETED|Overall Study||5
5320226|NCT00424528|13082887|P3|COMPLETED|Overall Study||74
5320227|NCT00424528|13082888|P2|COMPLETED|Overall Study||76
5320228|NCT00424528|13082889|P1|COMPLETED|Overall Study||71
5320229|NCT00424528|13082887|P3|STARTED|Overall Study||78
5320230|NCT00424528|13082888|P2|STARTED|Overall Study||80
5320231|NCT00424528|13082889|P1|STARTED|Overall Study||76
5320232|NCT00424515|13082944|P2|NOT COMPLETED|Overall Study||13
5320233|NCT00424515|13082945|P1|NOT COMPLETED|Overall Study||11
5320234|NCT00424515|13082944|P2|COMPLETED|Overall Study||0
5320235|NCT00424515|13082945|P1|COMPLETED|Overall Study||0
5320236|NCT00424515|13082944|P2|STARTED|Overall Study||13
5320237|NCT00424515|13082945|P1|STARTED|Overall Study||11
5320238|NCT00424502|13082955|P1|NOT COMPLETED|Overall Study||0
5320239|NCT00424502|13082955|P1|COMPLETED|Overall Study||20
5320240|NCT00424502|13082955|P1|STARTED|Overall Study||20
5320241|NCT00424489|13082964|P1|NOT COMPLETED|Overall Study||3
5320242|NCT00424489|13082964|P1|COMPLETED|Overall Study||6
5320243|NCT00424489|13082964|P1|STARTED|Overall Study||9
5320244|NCT00424476|13082971|P3|NOT COMPLETED|Overall Study||49
5320245|NCT00424476|13082972|P2|NOT COMPLETED|Overall Study||48
5320246|NCT00424476|13082973|P1|NOT COMPLETED|Overall Study||61
5320247|NCT00424476|13082971|P3|COMPLETED|Overall Study||241
5320248|NCT00424476|13082972|P2|COMPLETED|Overall Study||240
5320249|NCT00424476|13082973|P1|COMPLETED|Overall Study||226
5320250|NCT00424476|13082971|P3|STARTED|Overall Study||290
5320251|NCT00424476|13082972|P2|STARTED|Overall Study||288
5320252|NCT00424476|13082973|P1|STARTED|Overall Study||287
5320253|NCT00424463|13082999|P3|NOT COMPLETED|Overall Study||16
5320254|NCT00424463|13083000|P2|NOT COMPLETED|Overall Study||14
5320255|NCT00424463|13083001|P1|NOT COMPLETED|Overall Study||7
5320256|NCT00424463|13082999|P3|COMPLETED|Overall Study||72
5320257|NCT00424463|13083000|P2|COMPLETED|Overall Study||34
5320258|NCT00424463|13083001|P1|COMPLETED|Overall Study||38
5320259|NCT00424463|13082999|P3|STARTED|Overall Study||88
5320260|NCT00424463|13083000|P2|STARTED|Overall Study||48
5320261|NCT00424463|13083001|P1|STARTED|Overall Study||45
5320262|NCT00424398|13083030|P3|NOT COMPLETED|Overall Study||0
5320263|NCT00424398|13083031|P2|NOT COMPLETED|Overall Study||1
5320264|NCT00424398|13083032|P1|NOT COMPLETED|Overall Study||3
5320265|NCT00424398|13083030|P3|COMPLETED|Overall Study||36
5320266|NCT00424398|13083031|P2|COMPLETED|Overall Study||35
5320267|NCT00424398|13083032|P1|COMPLETED|Overall Study||32
5320268|NCT00424398|13083030|P3|STARTED|Overall Study||36
5320269|NCT00424398|13083031|P2|STARTED|Overall Study||36
5320270|NCT00424398|13083032|P1|STARTED|Overall Study||35
5320271|NCT00424385|13083076|P1|NOT COMPLETED|Cohort 1||1
5320272|NCT00424385|13083076|P1|COMPLETED|Cohort 1||4
5320273|NCT00424385|13083076|P1|STARTED|Cohort 1||5
5320274|NCT00424385|13083076|P1|NOT COMPLETED|Cohort 0||6
5320275|NCT00424385|13083076|P1|COMPLETED|Cohort 0||6
5320276|NCT00424385|13083076|P1|STARTED|Cohort 0||12
5320277|NCT00424372|13083083|P1|NOT COMPLETED|Overall Study||31
5320278|NCT00424372|13083083|P1|COMPLETED|Overall Study||95
5320279|NCT00424372|13083083|P1|STARTED|Overall Study||126
5320280|NCT00424346|13083095|P4|NOT COMPLETED|Extension Phase||55
5320281|NCT00424346|13083096|P3|NOT COMPLETED|Extension Phase||55
5320282|NCT00424346|13083097|P2|NOT COMPLETED|Extension Phase||102
5320283|NCT00424346|13083098|P1|NOT COMPLETED|Extension Phase||0
5320284|NCT00424346|13083095|P4|COMPLETED|Extension Phase||3
5320285|NCT00424346|13083096|P3|COMPLETED|Extension Phase||4
5320286|NCT00424346|13083097|P2|COMPLETED|Extension Phase||8
5320287|NCT00424346|13083098|P1|COMPLETED|Extension Phase||0
5320288|NCT00424346|13083095|P4|STARTED|Extension Phase||58
5320289|NCT00424346|13083096|P3|STARTED|Extension Phase||59
5320290|NCT00424346|13083097|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
5320291|NCT00424346|13083098|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
5320292|NCT00424346|13083095|P4|NOT COMPLETED|Core Study||7
5320293|NCT00424346|13083096|P3|NOT COMPLETED|Core Study||4
5320294|NCT00424346|13083097|P2|NOT COMPLETED|Core Study||8
5320295|NCT00424346|13083098|P1|NOT COMPLETED|Core Study||9
5320296|NCT00424346|13083095|P4|COMPLETED|Core Study||63
5320297|NCT00424346|13083096|P3|COMPLETED|Core Study||65
5320298|NCT00424346|13083097|P2|COMPLETED|Core Study||56
5320299|NCT00424346|13083098|P1|COMPLETED|Core Study||62
5320300|NCT00424346|13083095|P4|STARTED|Core Study||70
5320301|NCT00424346|13083096|P3|STARTED|Core Study||69
5320302|NCT00424346|13083097|P2|STARTED|Core Study||64
5320303|NCT00424346|13083098|P1|STARTED|Core Study||71
5320304|NCT00424294|13083213|P2|NOT COMPLETED|Overall Study||15
5320305|NCT00424294|13083214|P1|NOT COMPLETED|Overall Study||8
5320306|NCT00424294|13083213|P2|COMPLETED|Overall Study||19
5320307|NCT00424294|13083214|P1|COMPLETED|Overall Study||28
5320308|NCT00424294|13083213|P2|Treated|Overall Study||34
5320309|NCT00424294|13083214|P1|Treated|Overall Study||35
5320310|NCT00424294|13083213|P2|STARTED|Overall Study||34
5320311|NCT00424294|13083214|P1|STARTED|Overall Study||36
5320312|NCT00424268|13083264|P2|NOT COMPLETED|Overall Study||39
5320313|NCT00424268|13083265|P1|NOT COMPLETED|Overall Study||62
5320314|NCT00424268|13083264|P2|COMPLETED|Overall Study||333
5320315|NCT00424268|13083265|P1|COMPLETED|Overall Study||309
5320316|NCT00424268|13083264|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
5320317|NCT00424268|13083265|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
5320318|NCT00424255|13083281|P2|NOT COMPLETED|Overall Study||346
5320319|NCT00424255|13083282|P1|NOT COMPLETED|Overall Study||342
5320320|NCT00424255|13083281|P2|COMPLETED|Overall Study||0
5320321|NCT00424255|13083282|P1|COMPLETED|Overall Study||0
5320322|NCT00424255|13083281|P2|STARTED|Overall Study||346
5320323|NCT00424255|13083282|P1|STARTED|Overall Study||342
5320324|NCT00424190|13083330|P2|NOT COMPLETED|Overall Study||30
5320325|NCT00424190|13083331|P1|NOT COMPLETED|Overall Study||22
5320326|NCT00424190|13083330|P2|COMPLETED|Overall Study||317
5320327|NCT00424190|13083331|P1|COMPLETED|Overall Study||329
5320328|NCT00424190|13083330|P2|STARTED|Overall Study||347
5320329|NCT00424190|13083331|P1|STARTED|Overall Study||351
5320330|NCT00424177|13083337|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
5320331|NCT00424177|13083337|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
5320332|NCT00424177|13083337|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
5320333|NCT00424177|13083337|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
5320334|NCT00424177|13083337|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
5320335|NCT00424177|13083337|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
5320336|NCT00424177|13083337|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
5320337|NCT00424177|13083337|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
5320338|NCT00424177|13083337|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
5320339|NCT00424047|13083366|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
5320340|NCT00424047|13083367|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
5320341|NCT00424047|13083366|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
5320342|NCT00424047|13083367|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
5320343|NCT00424047|13083366|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
5320344|NCT00424047|13083367|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
5320345|NCT00424047|13083366|P2|NOT COMPLETED|On Study at Time of Unblinding||167
5320346|NCT00424047|13083367|P1|NOT COMPLETED|On Study at Time of Unblinding||155
5320347|NCT00424047|13083366|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
5320348|NCT00424047|13083367|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
5320349|NCT00424047|13083366|P2|STARTED|On Study at Time of Unblinding||175
5320350|NCT00424047|13083367|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
5320351|NCT00424047|13083366|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
5320352|NCT00424047|13083367|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
5320353|NCT00424047|13083366|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
5320354|NCT00424047|13083367|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
5320355|NCT00424047|13083366|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
5320356|NCT00424047|13083367|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
5320357|NCT00424047|13083366|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
5320358|NCT00424047|13083367|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
5320359|NCT00424047|13083366|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
5320360|NCT00424047|13083367|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
5320361|NCT00424021|13083399|P4|NOT COMPLETED|AMB-220-E Study Period||10
5320362|NCT00424021|13083400|P3|NOT COMPLETED|AMB-220-E Study Period||5
5320363|NCT00424021|13083401|P2|NOT COMPLETED|AMB-220-E Study Period||2
5320364|NCT00424021|13083402|P1|NOT COMPLETED|AMB-220-E Study Period||1
5320365|NCT00424021|13083399|P4|COMPLETED|AMB-220-E Study Period||16
5320366|NCT00424021|13083400|P3|COMPLETED|AMB-220-E Study Period||14
5320367|NCT00424021|13083401|P2|COMPLETED|AMB-220-E Study Period||5
5320368|NCT00424021|13083402|P1|COMPLETED|AMB-220-E Study Period||1
5320369|NCT00424021|13083399|P4|STARTED|AMB-220-E Study Period||26
5320370|NCT00424021|13083400|P3|STARTED|AMB-220-E Study Period||19
5320371|NCT00424021|13083401|P2|STARTED|AMB-220-E Study Period||7
5320372|NCT00424021|13083402|P1|STARTED|AMB-220-E Study Period||2
5320373|NCT00424021|13083399|P4|NOT COMPLETED|NCT00046319 Study Period||1
5320374|NCT00424021|13083400|P3|NOT COMPLETED|NCT00046319 Study Period||1
5320375|NCT00424021|13083401|P2|NOT COMPLETED|NCT00046319 Study Period||3
5320376|NCT00424021|13083402|P1|NOT COMPLETED|NCT00046319 Study Period||1
5320377|NCT00424021|13083399|P4|COMPLETED|NCT00046319 Study Period||12
5320378|NCT00424021|13083400|P3|COMPLETED|NCT00046319 Study Period||15
5320379|NCT00424021|13083401|P2|COMPLETED|NCT00046319 Study Period||16
5320380|NCT00424021|13083402|P1|COMPLETED|NCT00046319 Study Period||15
5320381|NCT00424021|13083399|P4|STARTED|NCT00046319 Study Period||13
5320382|NCT00424021|13083400|P3|STARTED|NCT00046319 Study Period||16
5320383|NCT00424021|13083401|P2|STARTED|NCT00046319 Study Period||19
5320384|NCT00424021|13083402|P1|STARTED|NCT00046319 Study Period||16
5320385|NCT00424008|13083445|P2|NOT COMPLETED|Overall Study||335
5320386|NCT00424008|13083446|P1|NOT COMPLETED|Overall Study||349
5320387|NCT00424008|13083445|P2|COMPLETED|Overall Study||16
5320388|NCT00424008|13083446|P1|COMPLETED|Overall Study||22
5320389|NCT00424008|13083445|P2|STARTED|Overall Study||351
5320390|NCT00424008|13083446|P1|STARTED|Overall Study||371
5320391|NCT00423943|13083461|P2|NOT COMPLETED|Overall Study||1
5320392|NCT00423943|13083462|P1|NOT COMPLETED|Overall Study||3
5320393|NCT00423943|13083461|P2|COMPLETED|Overall Study||13
5320394|NCT00423943|13083462|P1|COMPLETED|Overall Study||16
5320395|NCT00423943|13083461|P2|STARTED|Overall Study||14
5320396|NCT00423943|13083462|P1|STARTED|Overall Study||19
5320397|NCT00423930|13083476|P1|NOT COMPLETED|Overall Study||2
5320398|NCT00423930|13083476|P1|COMPLETED|Overall Study||42
5320399|NCT00423930|13083476|P1|STARTED|Overall Study||44
5320400|NCT00423917|13083481|P1|NOT COMPLETED|Overall Study||3
5320401|NCT00423917|13083481|P1|COMPLETED|Overall Study||33
5320402|NCT00423917|13083481|P1|STARTED|Overall Study||36
5320403|NCT00423891|13083494|P3|NOT COMPLETED|Post-Dosing Follow Up||2
5320404|NCT00423891|13083495|P2|NOT COMPLETED|Post-Dosing Follow Up||3
5320405|NCT00423891|13083496|P1|NOT COMPLETED|Post-Dosing Follow Up||2
5320406|NCT00423891|13083494|P3|COMPLETED|Post-Dosing Follow Up||3
5320407|NCT00423891|13083495|P2|COMPLETED|Post-Dosing Follow Up||15
5320408|NCT00423891|13083496|P1|COMPLETED|Post-Dosing Follow Up||20
5320409|NCT00423891|13083494|P3|STARTED|Post-Dosing Follow Up||5
5320410|NCT00423891|13083495|P2|STARTED|Post-Dosing Follow Up||18
5320411|NCT00423891|13083496|P1|STARTED|Post-Dosing Follow Up||22
5320412|NCT00423891|13083494|P3|NOT COMPLETED|Treatment||0
5320413|NCT00423891|13083495|P2|NOT COMPLETED|Treatment||0
5320414|NCT00423891|13083496|P1|NOT COMPLETED|Treatment||2
5320415|NCT00423891|13083494|P3|COMPLETED|Treatment||5
5320416|NCT00423891|13083495|P2|COMPLETED|Treatment||19
5320417|NCT00423891|13083496|P1|COMPLETED|Treatment||22
5320418|NCT00423891|13083494|P3|STARTED|Treatment||5
5320419|NCT00423891|13083495|P2|STARTED|Treatment||19
5320420|NCT00423891|13083496|P1|STARTED|Treatment||24
5320421|NCT00423891|13083494|P3|NOT COMPLETED|Enrolled||3
5320422|NCT00423891|13083495|P2|NOT COMPLETED|Enrolled||2
5320423|NCT00423891|13083496|P1|NOT COMPLETED|Enrolled||11
5320424|NCT00423891|13083494|P3|COMPLETED|Enrolled||5
5320425|NCT00423891|13083495|P2|COMPLETED|Enrolled||19
5320426|NCT00423891|13083496|P1|COMPLETED|Enrolled||24
5320427|NCT00423891|13083494|P3|STARTED|Enrolled||8
5320428|NCT00423891|13083495|P2|STARTED|Enrolled||21
5320429|NCT00423891|13083496|P1|STARTED|Enrolled||35
5320430|NCT00423878|13083565|P2|NOT COMPLETED|Overall Study||8
5320431|NCT00423878|13083566|P1|NOT COMPLETED|Overall Study||20
5320432|NCT00423878|13083565|P2|COMPLETED|Overall Study||98
5320433|NCT00423878|13083566|P1|COMPLETED|Overall Study||89
5320434|NCT00423878|13083565|P2|STARTED|Overall Study||106
5320435|NCT00423878|13083566|P1|STARTED|Overall Study||109
5320436|NCT00423852|13083574|P1|NOT COMPLETED|Overall Study||3
5320437|NCT00423852|13083574|P1|COMPLETED|Overall Study||23
5320438|NCT00423852|13083574|P1|STARTED|Overall Study||26
5320439|NCT00423813|13083582|P3|NOT COMPLETED|Overall Study||74
5320440|NCT00423813|13083583|P2|NOT COMPLETED|Overall Study||66
5320441|NCT00423813|13083584|P1|NOT COMPLETED|Overall Study||57
5320442|NCT00423813|13083582|P3|COMPLETED|Overall Study||116
5320443|NCT00423813|13083583|P2|COMPLETED|Overall Study||129
5320444|NCT00423813|13083584|P1|COMPLETED|Overall Study||131
5320445|NCT00423813|13083582|P3|Treated|Overall Study||189
5320446|NCT00423813|13083583|P2|Treated|Overall Study||194
5320447|NCT00423813|13083584|P1|Treated|Overall Study||188
5320448|NCT00423813|13083582|P3|STARTED|Overall Study||190
5320449|NCT00423813|13083583|P2|STARTED|Overall Study||195
5320450|NCT00423813|13083584|P1|STARTED|Overall Study||188
5320451|NCT00423800|13083594|P2|NOT COMPLETED|Overall Study||1
5320452|NCT00423800|13083595|P1|NOT COMPLETED|Overall Study||0
5320453|NCT00423800|13083594|P2|COMPLETED|Overall Study||1
5320454|NCT00423800|13083595|P1|COMPLETED|Overall Study||3
5320455|NCT00423800|13083594|P2|STARTED|Overall Study||2
5320456|NCT00423800|13083595|P1|STARTED|Overall Study||3
5320457|NCT00423735|13083607|P3|NOT COMPLETED|Overall Study||0
5320458|NCT00423735|13083608|P2|NOT COMPLETED|Overall Study||6
5320459|NCT00423735|13083609|P1|NOT COMPLETED|Overall Study||8
5320460|NCT00423735|13083607|P3|COMPLETED|Overall Study||0
5320461|NCT00423735|13083608|P2|COMPLETED|Overall Study||29
5320462|NCT00423735|13083609|P1|COMPLETED|Overall Study||21
5320463|NCT00423735|13083607|P3|STARTED|Overall Study||0
5320464|NCT00423735|13083608|P2|STARTED|Overall Study||35
5320465|NCT00423735|13083609|P1|STARTED|Overall Study||29
5320466|NCT00423722|13083632|P2|NOT COMPLETED|Overall Study||13
5320467|NCT00423722|13083633|P1|NOT COMPLETED|Overall Study||14
5320468|NCT00423722|13083632|P2|COMPLETED|Overall Study||53
5320469|NCT00423722|13083633|P1|COMPLETED|Overall Study||49
5320470|NCT00423722|13083632|P2|STARTED|Overall Study||66
5320471|NCT00423722|13083633|P1|STARTED|Overall Study||63
5320472|NCT00423683|13083655|P2|NOT COMPLETED|Overall Study||0
5320473|NCT00423683|13083656|P1|NOT COMPLETED|Overall Study||1
5320474|NCT00423683|13083655|P2|COMPLETED|Overall Study||33
5320475|NCT00423683|13083656|P1|COMPLETED|Overall Study||30
5320476|NCT00423683|13083655|P2|STARTED|Overall Study||33
5320477|NCT00423683|13083656|P1|STARTED|Overall Study||31
5320478|NCT00423670|13083675|P8|NOT COMPLETED|Follow-up Period||3
5320479|NCT00423670|13083676|P7|NOT COMPLETED|Follow-up Period||9
5320480|NCT00423670|13083677|P6|NOT COMPLETED|Follow-up Period||0
5320481|NCT00423670|13083678|P5|NOT COMPLETED|Follow-up Period||2
5320482|NCT00423670|13083679|P4|NOT COMPLETED|Follow-up Period||5
5320483|NCT00423670|13083680|P3|NOT COMPLETED|Follow-up Period||11
5320484|NCT00423670|13083681|P2|NOT COMPLETED|Follow-up Period||16
5320485|NCT00423670|13083682|P1|NOT COMPLETED|Follow-up Period||3
5320486|NCT00423670|13083675|P8|COMPLETED|Follow-up Period||32
5320487|NCT00423670|13083676|P7|COMPLETED|Follow-up Period||41
5320488|NCT00423670|13083677|P6|COMPLETED|Follow-up Period||14
5320489|NCT00423670|13083678|P5|COMPLETED|Follow-up Period||89
5320490|NCT00423670|13083679|P4|COMPLETED|Follow-up Period||91
5320491|NCT00423670|13083680|P3|COMPLETED|Follow-up Period||85
5320492|NCT00423670|13083681|P2|COMPLETED|Follow-up Period||84
5320493|NCT00423670|13083682|P1|COMPLETED|Follow-up Period||94
5320494|NCT00423670|13083675|P8|STARTED|Follow-up Period||35
5320495|NCT00423670|13083676|P7|STARTED|Follow-up Period||50
5320496|NCT00423670|13083677|P6|STARTED|Follow-up Period||14
5320497|NCT00423670|13083678|P5|STARTED|Follow-up Period||91
5320498|NCT00423670|13083679|P4|STARTED|Follow-up Period||96
5320499|NCT00423670|13083680|P3|STARTED|Follow-up Period||96
5320500|NCT00423670|13083681|P2|STARTED|Follow-up Period||100
5320501|NCT00423670|13083682|P1|STARTED|Follow-up Period||97
5320502|NCT00423670|13083675|P8|NOT COMPLETED|Treatment Period||21
5320503|NCT00423670|13083676|P7|NOT COMPLETED|Treatment Period||31
5320504|NCT00423670|13083677|P6|NOT COMPLETED|Treatment Period||8
5320505|NCT00423670|13083678|P5|NOT COMPLETED|Treatment Period||27
5320506|NCT00423670|13083679|P4|NOT COMPLETED|Treatment Period||40
5320507|NCT00423670|13083680|P3|NOT COMPLETED|Treatment Period||27
5320508|NCT00423670|13083681|P2|NOT COMPLETED|Treatment Period||30
5320509|NCT00423670|13083682|P1|NOT COMPLETED|Treatment Period||52
5320510|NCT00423670|13083675|P8|COMPLETED|Treatment Period||15
5320511|NCT00423670|13083676|P7|COMPLETED|Treatment Period||28
5320512|NCT00423670|13083677|P6|COMPLETED|Treatment Period||8
5320513|NCT00423670|13083678|P5|COMPLETED|Treatment Period||76
5320514|NCT00423670|13083679|P4|COMPLETED|Treatment Period||63
5320515|NCT00423670|13083680|P3|COMPLETED|Treatment Period||76
5320516|NCT00423670|13083681|P2|COMPLETED|Treatment Period||77
5320517|NCT00423670|13083682|P1|COMPLETED|Treatment Period||52
5320518|NCT00423670|13083675|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
5320519|NCT00423670|13083676|P7|STARTED|Treatment Period||59
5320520|NCT00423670|13083677|P6|STARTED|Treatment Period||16
5320521|NCT00423670|13083678|P5|STARTED|Treatment Period||103
5320522|NCT00423670|13083679|P4|STARTED|Treatment Period||103
5320523|NCT00423670|13083680|P3|STARTED|Treatment Period||103
5320524|NCT00423670|13083681|P2|STARTED|Treatment Period||107
5320525|NCT00423670|13083682|P1|STARTED|Treatment Period||104
5320526|NCT00423657|13083740|P2|NOT COMPLETED|Overall Study||25
5320527|NCT00423657|13083741|P1|NOT COMPLETED|Overall Study||26
5320528|NCT00423657|13083740|P2|COMPLETED|Overall Study||313
5320529|NCT00423657|13083741|P1|COMPLETED|Overall Study||316
5320530|NCT00423657|13083740|P2|STARTED|Overall Study||338
5320531|NCT00423657|13083741|P1|STARTED|Overall Study||342
5320532|NCT00423605|13083747|P1|NOT COMPLETED|Overall Study||241
5320533|NCT00423605|13083747|P1|COMPLETED|Overall Study||319
5320534|NCT00423605|13083747|P1|STARTED|Overall Study||560
5320535|NCT00423592|13083751|P1|NOT COMPLETED|Overall Study||7
5320536|NCT00423592|13083751|P1|COMPLETED|Overall Study|Completed study|29
5320537|NCT00423592|13083751|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
5320538|NCT00423592|13083751|P1|STARTED|Overall Study|Enrolled|36
5320539|NCT00423579|13083772|P2|NOT COMPLETED|Overall Study||4
5320540|NCT00423579|13083773|P1|NOT COMPLETED|Overall Study||4
5320541|NCT00423579|13083772|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
5320542|NCT00423579|13083773|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
5320543|NCT00423579|13083772|P2|STARTED|Overall Study||60
5320544|NCT00423579|13083773|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
5320545|NCT00423488|13083781|P2|NOT COMPLETED|Overall Study||1
5320546|NCT00423488|13083782|P1|NOT COMPLETED|Overall Study||5
5320547|NCT00423488|13083781|P2|COMPLETED|Overall Study||50
5320548|NCT00423488|13083782|P1|COMPLETED|Overall Study||37
5320549|NCT00423488|13083781|P2|STARTED|Overall Study||51
5320550|NCT00423488|13083782|P1|STARTED|Overall Study||42
5320551|NCT00423449|13083788|P5|NOT COMPLETED|Overall Study||7
5320552|NCT00423449|13083789|P4|NOT COMPLETED|Overall Study||22
5320553|NCT00423449|13083790|P3|NOT COMPLETED|Overall Study||15
5320554|NCT00423449|13083791|P2|NOT COMPLETED|Overall Study||4
5320555|NCT00423449|13083792|P1|NOT COMPLETED|Overall Study||3
5320556|NCT00423449|13083788|P5|COMPLETED|Overall Study||0
5320557|NCT00423449|13083789|P4|COMPLETED|Overall Study||5
5320558|NCT00423449|13083790|P3|COMPLETED|Overall Study||2
5320559|NCT00423449|13083791|P2|COMPLETED|Overall Study||2
5320560|NCT00423449|13083792|P1|COMPLETED|Overall Study||1
5320561|NCT00423449|13083788|P5|STARTED|Overall Study||7
5320562|NCT00423449|13083789|P4|STARTED|Overall Study||27
5320563|NCT00423449|13083790|P3|STARTED|Overall Study||17
5320564|NCT00423449|13083791|P2|STARTED|Overall Study||6
5320565|NCT00423449|13083792|P1|STARTED|Overall Study||4
5320566|NCT00423436|13083817|P2|NOT COMPLETED|Overall Study||0
5320567|NCT00423436|13083818|P1|NOT COMPLETED|Overall Study||0
5320568|NCT00423436|13083817|P2|COMPLETED|Overall Study||33
5320569|NCT00423436|13083818|P1|COMPLETED|Overall Study||35
5320570|NCT00423436|13083817|P2|STARTED|Overall Study||33
5320571|NCT00423436|13083818|P1|STARTED|Overall Study||35
5320572|NCT00423358|13083826|P2|NOT COMPLETED|Overall Study||0
5320573|NCT00423358|13083827|P1|NOT COMPLETED|Overall Study||0
5320574|NCT00423358|13083826|P2|COMPLETED|Overall Study||11
5320575|NCT00423358|13083827|P1|COMPLETED|Overall Study||11
5320576|NCT00423358|13083826|P2|STARTED|Overall Study||11
5320577|NCT00423358|13083827|P1|STARTED|Overall Study||11
5320578|NCT00423332|13083839|P2|NOT COMPLETED|Overall Study||7
5320579|NCT00423332|13083840|P1|NOT COMPLETED|Overall Study||9
5320580|NCT00423332|13083839|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
5320581|NCT00423332|13083840|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
5320582|NCT00423332|13083839|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
5320583|NCT00423332|13083840|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
5320584|NCT00423332|13083839|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
5320585|NCT00423332|13083840|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
5320586|NCT00423332|13083839|P2|STARTED|Overall Study|Number randomised|18
5320587|NCT00423332|13083840|P1|STARTED|Overall Study|Randomised|53
5320588|NCT00423319|13083859|P2|NOT COMPLETED|Overall Study||252
5320589|NCT00423319|13083860|P1|NOT COMPLETED|Overall Study||224
5320590|NCT00423319|13083859|P2|COMPLETED|Overall Study||2447
5320591|NCT00423319|13083860|P1|COMPLETED|Overall Study||2484
5320592|NCT00423319|13083859|P2|Participants Who Received Treatment|Overall Study||2659
5320593|NCT00423319|13083860|P1|Participants Who Received Treatment|Overall Study||2673
5320594|NCT00423319|13083859|P2|STARTED|Overall Study|Randomized|2699
5320595|NCT00423319|13083860|P1|STARTED|Overall Study|Randomized|2708
5320596|NCT00423293|13083892|P1|NOT COMPLETED|Overall Study||11
5320597|NCT00423293|13083892|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
5320598|NCT00423293|13083892|P1|STARTED|Overall Study||63
5320599|NCT00423267|13083909|P2|NOT COMPLETED|Period B||0
5320600|NCT00423267|13083910|P1|NOT COMPLETED|Period B||0
5320601|NCT00423267|13083909|P2|COMPLETED|Period B||0
5320602|NCT00423267|13083910|P1|COMPLETED|Period B||12
5320603|NCT00423267|13083909|P2|STARTED|Period B||0
5320604|NCT00423267|13083910|P1|STARTED|Period B||12
5320605|NCT00423267|13083909|P2|NOT COMPLETED|Period A||1
5320606|NCT00423267|13083910|P1|NOT COMPLETED|Period A||2
5320607|NCT00423267|13083909|P2|COMPLETED|Period A||6
5320608|NCT00423267|13083910|P1|COMPLETED|Period A||7
5320609|NCT00423267|13083909|P2|STARTED|Period A||7
5320610|NCT00423267|13083910|P1|STARTED|Period A||9
5320611|NCT00423189|13083930|P3|NOT COMPLETED|Overall Study||0
5320612|NCT00423189|13083931|P2|NOT COMPLETED|Overall Study||1
5320613|NCT00423189|13083932|P1|NOT COMPLETED|Overall Study||0
5320614|NCT00423189|13083930|P3|COMPLETED|Overall Study||2
5320615|NCT00423189|13083931|P2|COMPLETED|Overall Study||2
5320616|NCT00423189|13083932|P1|COMPLETED|Overall Study||2
5320617|NCT00423189|13083930|P3|STARTED|Overall Study||2
5320618|NCT00423189|13083931|P2|STARTED|Overall Study||3
5320619|NCT00423189|13083932|P1|STARTED|Overall Study||2
5320620|NCT00423176|13083954|P2|NOT COMPLETED|Overall Study||29
5320621|NCT00423176|13083955|P1|NOT COMPLETED|Overall Study||16
5320622|NCT00423176|13083954|P2|COMPLETED|Overall Study||94
5320623|NCT00423176|13083955|P1|COMPLETED|Overall Study||98
5320624|NCT00423176|13083954|P2|STARTED|Overall Study||123
5320625|NCT00423176|13083955|P1|STARTED|Overall Study||114
5320626|NCT00423150|13083963|P1|NOT COMPLETED|Overall Study||86
5320627|NCT00423150|13083963|P1|COMPLETED|Overall Study||0
5320628|NCT00423150|13083963|P1|STARTED|Overall Study||86
5320629|NCT00423098|13083969|P2|NOT COMPLETED|Overall Study||4
5320630|NCT00423098|13083970|P1|NOT COMPLETED|Overall Study||3
5320631|NCT00423098|13083969|P2|COMPLETED|Overall Study||35
5320632|NCT00423098|13083970|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
5320633|NCT00423098|13083969|P2|STARTED|Overall Study||39
5320634|NCT00423098|13083970|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
5320635|NCT00423085|13083997|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
5320636|NCT00423085|13083998|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
5320637|NCT00423085|13083999|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
5320638|NCT00423085|13084000|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
5320639|NCT00423085|13083997|P4|COMPLETED|52-Week Open-Label Extension Phase||474
5320640|NCT00423085|13083998|P3|COMPLETED|52-Week Open-Label Extension Phase||0
5320641|NCT00423085|13083999|P2|COMPLETED|52-Week Open-Label Extension Phase||0
5320642|NCT00423085|13084000|P1|COMPLETED|52-Week Open-Label Extension Phase||0
5320643|NCT00423085|13083997|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
5320644|NCT00423085|13083998|P3|STARTED|52-Week Open-Label Extension Phase||0
5320645|NCT00423085|13083999|P2|STARTED|52-Week Open-Label Extension Phase||0
5320646|NCT00423085|13084000|P1|STARTED|52-Week Open-Label Extension Phase||0
5320647|NCT00423085|13083997|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
5320648|NCT00423085|13083998|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
5320649|NCT00423085|13083999|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
5320650|NCT00423085|13084000|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
5320651|NCT00423085|13083997|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
5320652|NCT00423085|13083998|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
5320653|NCT00423085|13083999|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
5320654|NCT00423085|13084000|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
5320655|NCT00423085|13083997|P4|STARTED|24-Week Double-Blind Treatment Phase||0
5320656|NCT00423085|13083998|P3|STARTED|24-Week Double-Blind Treatment Phase||287
5320657|NCT00423085|13083999|P2|STARTED|24-Week Double-Blind Treatment Phase||284
5320658|NCT00423085|13084000|P1|STARTED|24-Week Double-Blind Treatment Phase||288
5320659|NCT00423046|13084029|P2|NOT COMPLETED|Overall Study||345
5320660|NCT00423046|13084030|P1|NOT COMPLETED|Overall Study||340
5320661|NCT00423046|13084029|P2|COMPLETED|Overall Study|Completed until Month 60|208
5320662|NCT00423046|13084030|P1|COMPLETED|Overall Study|Completed until Month 60|213
5320663|NCT00423046|13084029|P2|STARTED|Overall Study||553
5320664|NCT00423046|13084030|P1|STARTED|Overall Study||553
5320665|NCT00422942|13084096|P1|NOT COMPLETED|Overall Study||3
5320666|NCT00422942|13084096|P1|COMPLETED|Overall Study||0
5320667|NCT00422942|13084096|P1|STARTED|Overall Study||3
5320668|NCT00422903|13084115|P2|NOT COMPLETED|Overall Study||5
5320669|NCT00422903|13084116|P1|NOT COMPLETED|Overall Study||4
5320670|NCT00422903|13084115|P2|COMPLETED|Overall Study||38
5320671|NCT00422903|13084116|P1|COMPLETED|Overall Study||45
5320672|NCT00422903|13084115|P2|STARTED|Overall Study||43
5320673|NCT00422903|13084116|P1|STARTED|Overall Study||49
5320674|NCT00422812|13084144|P4|NOT COMPLETED|Overall Study||2
5320675|NCT00422812|13084145|P3|NOT COMPLETED|Overall Study||2
5320676|NCT00422812|13084146|P2|NOT COMPLETED|Overall Study||1
5320677|NCT00422812|13084147|P1|NOT COMPLETED|Overall Study||0
5320678|NCT00422812|13084144|P4|COMPLETED|Overall Study||103
5320679|NCT00422812|13084145|P3|COMPLETED|Overall Study||91
5320680|NCT00422812|13084146|P2|COMPLETED|Overall Study||103
5320681|NCT00422812|13084147|P1|COMPLETED|Overall Study||98
5320682|NCT00422812|13084144|P4|STARTED|Overall Study||105
5320683|NCT00422812|13084145|P3|STARTED|Overall Study||93
5320684|NCT00422812|13084146|P2|STARTED|Overall Study||104
5320685|NCT00422812|13084147|P1|STARTED|Overall Study||98
5320686|NCT00422799|13084165|P1|NOT COMPLETED|Overall Study||13
5320687|NCT00422799|13084165|P1|COMPLETED|Overall Study||50
5320688|NCT00422799|13084165|P1|STARTED|Overall Study||63
5320689|NCT00422734|13084174|P2|NOT COMPLETED|Overall Study||21
5320690|NCT00422734|13084175|P1|NOT COMPLETED|Overall Study||14
5320691|NCT00422734|13084174|P2|COMPLETED|Overall Study||243
5320692|NCT00422734|13084175|P1|COMPLETED|Overall Study||64
5320693|NCT00422734|13084174|P2|STARTED|Overall Study||264
5320694|NCT00422734|13084175|P1|STARTED|Overall Study||78
5320695|NCT00422695|13084209|P2|NOT COMPLETED|Overall Study||0
5320696|NCT00422695|13084210|P1|NOT COMPLETED|Overall Study||0
5320697|NCT00422695|13084209|P2|COMPLETED|Overall Study||38
5320698|NCT00422695|13084210|P1|COMPLETED|Overall Study||105
5320699|NCT00422695|13084209|P2|STARTED|Overall Study||38
5320700|NCT00422695|13084210|P1|STARTED|Overall Study||105
5320701|NCT00422669|13084221|P3|NOT COMPLETED|Overall Study||7
5320702|NCT00422669|13084222|P2|NOT COMPLETED|Overall Study||100
5320703|NCT00422669|13084223|P1|NOT COMPLETED|Overall Study||98
5320704|NCT00422669|13084221|P3|COMPLETED|Overall Study||0
5320705|NCT00422669|13084222|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
5320706|NCT00422669|13084223|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
5320707|NCT00422669|13084221|P3|STARTED|Overall Study||7
5320708|NCT00422669|13084222|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
5320709|NCT00422669|13084223|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
5320710|NCT00422656|13084244|P1|NOT COMPLETED|Overall Study||0
5320711|NCT00422656|13084244|P1|COMPLETED|Overall Study||37
5320712|NCT00422656|13084244|P1|STARTED|Overall Study||37
5320713|NCT00422591|13084251|P1|NOT COMPLETED|Overall Study||6
5320714|NCT00422591|13084251|P1|COMPLETED|Overall Study||169
5320715|NCT00422591|13084251|P1|STARTED|Overall Study||175
5320716|NCT00422513|13084259|P2|NOT COMPLETED|Overall Study||106
5320717|NCT00422513|13084260|P1|NOT COMPLETED|Overall Study||107
5320718|NCT00422513|13084259|P2|COMPLETED|Overall Study||24
5320719|NCT00422513|13084260|P1|COMPLETED|Overall Study||23
5320720|NCT00422513|13084259|P2|STARTED|Overall Study||130
5320721|NCT00422513|13084260|P1|STARTED|Overall Study||130
5320722|NCT00422448|13084272|P1|NOT COMPLETED|Overall Study||0
5320723|NCT00422448|13084272|P1|COMPLETED|Overall Study||43
5320724|NCT00422448|13084272|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
5320725|NCT00422422|13084277|P1|NOT COMPLETED|Overall Study||10
5320726|NCT00422422|13084277|P1|COMPLETED|Overall Study||90
5320727|NCT00422422|13084277|P1|STARTED|Overall Study||100
5320728|NCT00422383|13084294|P5|NOT COMPLETED|Overall Study||3
5320729|NCT00422383|13084295|P4|NOT COMPLETED|Overall Study||2
5320730|NCT00422383|13084296|P3|NOT COMPLETED|Overall Study||4
5320731|NCT00422383|13084297|P2|NOT COMPLETED|Overall Study||14
5320732|NCT00422383|13084298|P1|NOT COMPLETED|Overall Study||15
5320733|NCT00422383|13084294|P5|COMPLETED|Overall Study||22
5320734|NCT00422383|13084295|P4|COMPLETED|Overall Study||4
5320735|NCT00422383|13084296|P3|COMPLETED|Overall Study||89
5320736|NCT00422383|13084297|P2|COMPLETED|Overall Study||106
5320737|NCT00422383|13084298|P1|COMPLETED|Overall Study||119
5320738|NCT00422383|13084294|P5|STARTED|Overall Study||25
5320739|NCT00422383|13084295|P4|STARTED|Overall Study||6
5320740|NCT00422383|13084296|P3|STARTED|Overall Study||93
5320741|NCT00422383|13084297|P2|STARTED|Overall Study||120
5320742|NCT00422383|13084298|P1|STARTED|Overall Study||134
5320743|NCT00422292|13084441|P4|NOT COMPLETED|Overall Study||24
5320744|NCT00422292|13084442|P3|NOT COMPLETED|Overall Study||22
5320745|NCT00422292|13084443|P2|NOT COMPLETED|Overall Study||66
5320746|NCT00422292|13084444|P1|NOT COMPLETED|Overall Study||18
5320747|NCT00422292|13084441|P4|COMPLETED|Overall Study||452
5320748|NCT00422292|13084442|P3|COMPLETED|Overall Study||224
5320749|NCT00422292|13084443|P2|COMPLETED|Overall Study||598
5320750|NCT00422292|13084444|P1|COMPLETED|Overall Study||239
5320751|NCT00422292|13084441|P4|STARTED|Overall Study||476
5320752|NCT00422292|13084442|P3|STARTED|Overall Study||246
5320753|NCT00422292|13084443|P2|STARTED|Overall Study||664
5320754|NCT00422292|13084444|P1|STARTED|Overall Study||257
5320755|NCT00422279|13084472|P2|NOT COMPLETED|Overall Study||0
5320756|NCT00422279|13084473|P1|NOT COMPLETED|Overall Study||0
5320757|NCT00422279|13084472|P2|COMPLETED|Overall Study||2
5320758|NCT00422279|13084473|P1|COMPLETED|Overall Study||2
5320759|NCT00422279|13084472|P2|24 Month After Loading Period|Overall Study||2
5320760|NCT00422279|13084473|P1|24 Month After Loading Period|Overall Study||2
5320761|NCT00422279|13084472|P2|STARTED|Overall Study||2
5320762|NCT00422279|13084473|P1|STARTED|Overall Study||2
5320763|NCT00422227|13084483|P2|NOT COMPLETED|Overall Study||15
5320764|NCT00422227|13084484|P1|NOT COMPLETED|Overall Study||4
5320765|NCT00422227|13084483|P2|COMPLETED|Overall Study||88
5320766|NCT00422227|13084484|P1|COMPLETED|Overall Study||193
5320767|NCT00422227|13084483|P2|STARTED|Overall Study||103
5320768|NCT00422227|13084484|P1|STARTED|Overall Study||197
5320769|NCT00422201|13084508|P1|NOT COMPLETED|Overall Study||11
5320770|NCT00422201|13084508|P1|COMPLETED|Overall Study||7
5320771|NCT00422201|13084508|P1|STARTED|Overall Study||18
5320772|NCT00422162|13084515|P2|NOT COMPLETED|Overall Study||30
5320773|NCT00422162|13084516|P1|NOT COMPLETED|Overall Study||24
5320774|NCT00422162|13084515|P2|COMPLETED|Overall Study||142
5320775|NCT00422162|13084516|P1|COMPLETED|Overall Study||143
5320776|NCT00422162|13084515|P2|Received Treatment|Overall Study||171
5320777|NCT00422162|13084516|P1|Received Treatment|Overall Study||167
5320778|NCT00422162|13084515|P2|STARTED|Overall Study||172
5320779|NCT00422162|13084516|P1|STARTED|Overall Study||167
5320780|NCT00422097|13084576|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320781|NCT00422097|13084577|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320782|NCT00422097|13084578|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320783|NCT00422097|13084579|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320784|NCT00422097|13084580|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320785|NCT00422097|13084581|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320786|NCT00422097|13084582|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320787|NCT00422097|13084583|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
5320788|NCT00422097|13084576|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
5320789|NCT00422097|13084577|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
5320790|NCT00422097|13084578|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
5320791|NCT00422097|13084579|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
5320792|NCT00422097|13084580|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
5320793|NCT00422097|13084581|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
5320794|NCT00422097|13084582|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
5320795|NCT00422097|13084583|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
5320796|NCT00422097|13084576|P8|STARTED|Ixabepilone With Famotidine or Food||7
5320797|NCT00422097|13084577|P7|STARTED|Ixabepilone With Famotidine or Food||8
5320798|NCT00422097|13084578|P6|STARTED|Ixabepilone With Famotidine or Food||0
5320799|NCT00422097|13084579|P5|STARTED|Ixabepilone With Famotidine or Food||0
5320800|NCT00422097|13084580|P4|STARTED|Ixabepilone With Famotidine or Food||0
5320801|NCT00422097|13084581|P3|STARTED|Ixabepilone With Famotidine or Food||0
5320802|NCT00422097|13084582|P2|STARTED|Ixabepilone With Famotidine or Food||0
5320803|NCT00422097|13084583|P1|STARTED|Ixabepilone With Famotidine or Food||0
5320804|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 6||0
5320805|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 6||0
5320806|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 6||0
5320807|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 6||0
5320808|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 6||0
5320809|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 6||0
5320810|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 6||0
5320811|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 6||0
5320812|NCT00422097|13084576|P8|COMPLETED|Dose Level 6||0
5320813|NCT00422097|13084577|P7|COMPLETED|Dose Level 6||0
5320814|NCT00422097|13084578|P6|COMPLETED|Dose Level 6||6
5320815|NCT00422097|13084579|P5|COMPLETED|Dose Level 6||0
5320816|NCT00422097|13084580|P4|COMPLETED|Dose Level 6||0
5320817|NCT00422097|13084581|P3|COMPLETED|Dose Level 6||0
5320818|NCT00422097|13084582|P2|COMPLETED|Dose Level 6||0
5320819|NCT00422097|13084583|P1|COMPLETED|Dose Level 6||0
5320820|NCT00422097|13084576|P8|STARTED|Dose Level 6||0
5320821|NCT00422097|13084577|P7|STARTED|Dose Level 6||0
5320822|NCT00422097|13084578|P6|STARTED|Dose Level 6||6
5320823|NCT00422097|13084579|P5|STARTED|Dose Level 6||0
5320824|NCT00422097|13084580|P4|STARTED|Dose Level 6||0
5320825|NCT00422097|13084581|P3|STARTED|Dose Level 6||0
5320826|NCT00422097|13084582|P2|STARTED|Dose Level 6||0
5320827|NCT00422097|13084583|P1|STARTED|Dose Level 6||0
5320828|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 5||0
5320829|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 5||0
5320830|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 5||0
5320831|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 5||0
5320832|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 5||0
5320833|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 5||0
5320834|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 5||0
5320835|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 5||0
5320836|NCT00422097|13084576|P8|COMPLETED|Dose Level 5||0
5320837|NCT00422097|13084577|P7|COMPLETED|Dose Level 5||0
5320838|NCT00422097|13084578|P6|COMPLETED|Dose Level 5||0
5320839|NCT00422097|13084579|P5|COMPLETED|Dose Level 5||23
5320840|NCT00422097|13084580|P4|COMPLETED|Dose Level 5||0
5320841|NCT00422097|13084581|P3|COMPLETED|Dose Level 5||0
5320842|NCT00422097|13084582|P2|COMPLETED|Dose Level 5||0
5320843|NCT00422097|13084583|P1|COMPLETED|Dose Level 5||0
5320844|NCT00422097|13084576|P8|STARTED|Dose Level 5||0
5320845|NCT00422097|13084577|P7|STARTED|Dose Level 5||0
5320846|NCT00422097|13084578|P6|STARTED|Dose Level 5||0
5320847|NCT00422097|13084579|P5|STARTED|Dose Level 5||23
5320848|NCT00422097|13084580|P4|STARTED|Dose Level 5||0
5320849|NCT00422097|13084581|P3|STARTED|Dose Level 5||0
5320850|NCT00422097|13084582|P2|STARTED|Dose Level 5||0
5320851|NCT00422097|13084583|P1|STARTED|Dose Level 5||0
5320852|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 4||0
5320853|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 4||0
5320854|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 4||0
5320855|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 4||0
5320856|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 4||0
5320857|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 4||0
5320858|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 4||0
5320859|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 4||0
5320860|NCT00422097|13084576|P8|COMPLETED|Dose Level 4||0
5320861|NCT00422097|13084577|P7|COMPLETED|Dose Level 4||0
5320862|NCT00422097|13084578|P6|COMPLETED|Dose Level 4||0
5320863|NCT00422097|13084579|P5|COMPLETED|Dose Level 4||0
5320864|NCT00422097|13084580|P4|COMPLETED|Dose Level 4||3
5320865|NCT00422097|13084581|P3|COMPLETED|Dose Level 4||0
5320866|NCT00422097|13084582|P2|COMPLETED|Dose Level 4||0
5320867|NCT00422097|13084583|P1|COMPLETED|Dose Level 4||0
5320868|NCT00422097|13084576|P8|STARTED|Dose Level 4||0
5320869|NCT00422097|13084577|P7|STARTED|Dose Level 4||0
5320870|NCT00422097|13084578|P6|STARTED|Dose Level 4||0
5320871|NCT00422097|13084579|P5|STARTED|Dose Level 4||0
5320872|NCT00422097|13084580|P4|STARTED|Dose Level 4||3
5320873|NCT00422097|13084581|P3|STARTED|Dose Level 4||0
5320874|NCT00422097|13084582|P2|STARTED|Dose Level 4||0
5320875|NCT00422097|13084583|P1|STARTED|Dose Level 4||0
5320876|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 3||0
5320877|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 3||0
5320878|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 3||0
5320879|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 3||0
5320880|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 3||0
5320881|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 3||0
5320882|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 3||0
5320883|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 3||0
5320884|NCT00422097|13084576|P8|COMPLETED|Dose Level 3||0
5320885|NCT00422097|13084577|P7|COMPLETED|Dose Level 3||0
5320886|NCT00422097|13084578|P6|COMPLETED|Dose Level 3||0
5320887|NCT00422097|13084579|P5|COMPLETED|Dose Level 3||0
5320888|NCT00422097|13084580|P4|COMPLETED|Dose Level 3||0
5320889|NCT00422097|13084581|P3|COMPLETED|Dose Level 3||3
5320890|NCT00422097|13084582|P2|COMPLETED|Dose Level 3||0
5320891|NCT00422097|13084583|P1|COMPLETED|Dose Level 3||0
5320892|NCT00422097|13084576|P8|STARTED|Dose Level 3||0
5320893|NCT00422097|13084577|P7|STARTED|Dose Level 3||0
5320894|NCT00422097|13084578|P6|STARTED|Dose Level 3||0
5320895|NCT00422097|13084579|P5|STARTED|Dose Level 3||0
5320896|NCT00422097|13084580|P4|STARTED|Dose Level 3||0
5320897|NCT00422097|13084581|P3|STARTED|Dose Level 3||3
5320898|NCT00422097|13084582|P2|STARTED|Dose Level 3||0
5320899|NCT00422097|13084583|P1|STARTED|Dose Level 3||0
5320900|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 2||0
5320901|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 2||0
5320902|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 2||0
5320903|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 2||0
5320904|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 2||0
5320905|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 2||0
5320906|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 2||1
5320907|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 2||0
5320908|NCT00422097|13084576|P8|COMPLETED|Dose Level 2||0
5320909|NCT00422097|13084577|P7|COMPLETED|Dose Level 2||0
5320910|NCT00422097|13084578|P6|COMPLETED|Dose Level 2||0
5320911|NCT00422097|13084579|P5|COMPLETED|Dose Level 2||0
5320912|NCT00422097|13084580|P4|COMPLETED|Dose Level 2||0
5320913|NCT00422097|13084581|P3|COMPLETED|Dose Level 2||0
5320914|NCT00422097|13084582|P2|COMPLETED|Dose Level 2||5
5320915|NCT00422097|13084583|P1|COMPLETED|Dose Level 2||0
5320916|NCT00422097|13084576|P8|STARTED|Dose Level 2||0
5320917|NCT00422097|13084577|P7|STARTED|Dose Level 2||0
5320918|NCT00422097|13084578|P6|STARTED|Dose Level 2||0
5320919|NCT00422097|13084579|P5|STARTED|Dose Level 2||0
5320920|NCT00422097|13084580|P4|STARTED|Dose Level 2||0
5320921|NCT00422097|13084581|P3|STARTED|Dose Level 2||0
5320922|NCT00422097|13084582|P2|STARTED|Dose Level 2||6
5320923|NCT00422097|13084583|P1|STARTED|Dose Level 2||0
5320924|NCT00422097|13084576|P8|NOT COMPLETED|Dose Level 1||0
5320925|NCT00422097|13084577|P7|NOT COMPLETED|Dose Level 1||0
5320926|NCT00422097|13084578|P6|NOT COMPLETED|Dose Level 1||0
5320927|NCT00422097|13084579|P5|NOT COMPLETED|Dose Level 1||0
5320928|NCT00422097|13084580|P4|NOT COMPLETED|Dose Level 1||0
5320929|NCT00422097|13084581|P3|NOT COMPLETED|Dose Level 1||0
5320930|NCT00422097|13084582|P2|NOT COMPLETED|Dose Level 1||0
5320931|NCT00422097|13084583|P1|NOT COMPLETED|Dose Level 1||0
5320932|NCT00422097|13084576|P8|COMPLETED|Dose Level 1||0
5320933|NCT00422097|13084577|P7|COMPLETED|Dose Level 1||0
5320934|NCT00422097|13084578|P6|COMPLETED|Dose Level 1||0
5320935|NCT00422097|13084579|P5|COMPLETED|Dose Level 1||0
5320936|NCT00422097|13084580|P4|COMPLETED|Dose Level 1||0
5320937|NCT00422097|13084581|P3|COMPLETED|Dose Level 1||0
5320938|NCT00422097|13084582|P2|COMPLETED|Dose Level 1||0
5320939|NCT00422097|13084583|P1|COMPLETED|Dose Level 1||3
5320940|NCT00422097|13084576|P8|STARTED|Dose Level 1||0
5320941|NCT00422097|13084577|P7|STARTED|Dose Level 1||0
5320942|NCT00422097|13084578|P6|STARTED|Dose Level 1||0
5320943|NCT00422097|13084579|P5|STARTED|Dose Level 1||0
5320944|NCT00422097|13084580|P4|STARTED|Dose Level 1||0
5320945|NCT00422097|13084581|P3|STARTED|Dose Level 1||0
5320946|NCT00422097|13084582|P2|STARTED|Dose Level 1||0
5320947|NCT00422097|13084583|P1|STARTED|Dose Level 1||3
5320948|NCT00422058|13084648|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
5320949|NCT00422058|13084649|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
5320950|NCT00422058|13084650|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
5320951|NCT00422058|13084651|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
5320952|NCT00422058|13084652|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
5320953|NCT00422058|13084653|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
5320954|NCT00422058|13084648|P6|COMPLETED|Open-Label Extension, Week 20-104||45
5320955|NCT00422058|13084649|P5|COMPLETED|Open-Label Extension, Week 20-104||47
5320956|NCT00422058|13084650|P4|COMPLETED|Open-Label Extension, Week 20-104||45
5320957|NCT00422058|13084651|P3|COMPLETED|Open-Label Extension, Week 20-104||38
5320958|NCT00422058|13084652|P2|COMPLETED|Open-Label Extension, Week 20-104||46
5320959|NCT00422058|13084653|P1|COMPLETED|Open-Label Extension, Week 20-104||47
5320960|NCT00422058|13084648|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
5320961|NCT00422058|13084649|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
5320962|NCT00422058|13084650|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
5320963|NCT00422058|13084651|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
5320964|NCT00422058|13084652|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
5320965|NCT00422058|13084653|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
5320966|NCT00422058|13084648|P6|STARTED|Open-Label Extension, Week 20-104||79
5320967|NCT00422058|13084649|P5|STARTED|Open-Label Extension, Week 20-104||82
5320968|NCT00422058|13084650|P4|STARTED|Open-Label Extension, Week 20-104||73
5320969|NCT00422058|13084651|P3|STARTED|Open-Label Extension, Week 20-104||74
5320970|NCT00422058|13084652|P2|STARTED|Open-Label Extension, Week 20-104||85
5320971|NCT00422058|13084653|P1|STARTED|Open-Label Extension, Week 20-104||79
5320972|NCT00422058|13084648|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
5320973|NCT00422058|13084649|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
5320974|NCT00422058|13084650|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
5320975|NCT00422058|13084651|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
5320976|NCT00422058|13084652|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
5320977|NCT00422058|13084653|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
5320978|NCT00422058|13084648|P6|COMPLETED|Double-Blind, Week 0-20||79
5320979|NCT00422058|13084649|P5|COMPLETED|Double-Blind, Week 0-20||82
5320980|NCT00422058|13084650|P4|COMPLETED|Double-Blind, Week 0-20||73
5320981|NCT00422058|13084651|P3|COMPLETED|Double-Blind, Week 0-20||74
5320982|NCT00422058|13084652|P2|COMPLETED|Double-Blind, Week 0-20||85
5320983|NCT00422058|13084653|P1|COMPLETED|Double-Blind, Week 0-20||79
5320984|NCT00422058|13084648|P6|STARTED|Double-Blind, Week 0-20||95
5320985|NCT00422058|13084649|P5|STARTED|Double-Blind, Week 0-20||93
5320986|NCT00422058|13084650|P4|STARTED|Double-Blind, Week 0-20||93
5320987|NCT00422058|13084651|P3|STARTED|Double-Blind, Week 0-20||90
5320988|NCT00422058|13084652|P2|STARTED|Double-Blind, Week 0-20||95
5320989|NCT00422058|13084653|P1|STARTED|Double-Blind, Week 0-20||98
5320990|NCT00422032|13084783|P2|NOT COMPLETED|Overall Study||0
5320991|NCT00422032|13084784|P1|NOT COMPLETED|Overall Study||0
5320992|NCT00422032|13084783|P2|COMPLETED|Overall Study||21
5320993|NCT00422032|13084784|P1|COMPLETED|Overall Study||37
5320994|NCT00422032|13084783|P2|STARTED|Overall Study||21
5320995|NCT00422032|13084784|P1|STARTED|Overall Study||37
5320996|NCT00421993|13084794|P4|NOT COMPLETED|Overall Study||57
5320997|NCT00421993|13084795|P3|NOT COMPLETED|Overall Study||52
5320998|NCT00421993|13084796|P2|NOT COMPLETED|Overall Study||49
5320999|NCT00421993|13084797|P1|NOT COMPLETED|Overall Study||53
5321000|NCT00421993|13084794|P4|COMPLETED|Overall Study||361
5321001|NCT00421993|13084795|P3|COMPLETED|Overall Study||363
5321002|NCT00421993|13084796|P2|COMPLETED|Overall Study||369
5321003|NCT00421993|13084797|P1|COMPLETED|Overall Study||366
5321004|NCT00421993|13084794|P4|STARTED|Overall Study||418
5321005|NCT00421993|13084795|P3|STARTED|Overall Study||415
5321006|NCT00421993|13084796|P2|STARTED|Overall Study||418
5321007|NCT00421993|13084797|P1|STARTED|Overall Study||419
5321008|NCT00421954|13084827|P1|NOT COMPLETED|Overall Study||0
5321009|NCT00421954|13084827|P1|COMPLETED|Overall Study||0
5321010|NCT00421954|13084827|P1|STARTED|Overall Study||0
5321011|NCT00421928|13084834|P3|NOT COMPLETED|Overall Study||134
5321012|NCT00421928|13084835|P2|NOT COMPLETED|Overall Study||224
5321013|NCT00421928|13084836|P1|NOT COMPLETED|Overall Study||163
5321014|NCT00421928|13084834|P3|COMPLETED|Overall Study||203
5321015|NCT00421928|13084835|P2|COMPLETED|Overall Study||118
5321016|NCT00421928|13084836|P1|COMPLETED|Overall Study||181
5321017|NCT00421928|13084834|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
5321018|NCT00421928|13084835|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
5321019|NCT00421928|13084836|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
5321020|NCT00421889|13084871|P9|NOT COMPLETED|Overall Study||11
5321021|NCT00421889|13084872|P8|NOT COMPLETED|Overall Study||2
5321022|NCT00421889|13084873|P7|NOT COMPLETED|Overall Study||4
5321023|NCT00421889|13084874|P6|NOT COMPLETED|Overall Study||35
5321024|NCT00421889|13084875|P5|NOT COMPLETED|Overall Study||6
5321025|NCT00421889|13084876|P4|NOT COMPLETED|Overall Study||4
5321026|NCT00421889|13084877|P3|NOT COMPLETED|Overall Study||3
5321027|NCT00421889|13084878|P2|NOT COMPLETED|Overall Study||5
5321028|NCT00421889|13084879|P1|NOT COMPLETED|Overall Study||5
5321029|NCT00421889|13084871|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
5321030|NCT00421889|13084872|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
5321031|NCT00421889|13084873|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
5321032|NCT00421889|13084874|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
5321033|NCT00421889|13084875|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
5321034|NCT00421889|13084876|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
5321035|NCT00421889|13084877|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
5321036|NCT00421889|13084878|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
5321037|NCT00421889|13084879|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
5321038|NCT00421889|13084871|P9|STARTED|Overall Study||15
5321039|NCT00421889|13084872|P8|STARTED|Overall Study||3
5321040|NCT00421889|13084873|P7|STARTED|Overall Study||4
5321041|NCT00421889|13084874|P6|STARTED|Overall Study||35
5321042|NCT00421889|13084875|P5|STARTED|Overall Study||6
5321043|NCT00421889|13084876|P4|STARTED|Overall Study||4
5321044|NCT00421889|13084877|P3|STARTED|Overall Study||3
5321045|NCT00421889|13084878|P2|STARTED|Overall Study||5
5321046|NCT00421889|13084879|P1|STARTED|Overall Study||5
5321047|NCT00421733|13084924|P3|NOT COMPLETED|Overall Study||20
5321048|NCT00421733|13084925|P2|NOT COMPLETED|Overall Study||26
5321049|NCT00421733|13084926|P1|NOT COMPLETED|Overall Study||15
5321050|NCT00421733|13084924|P3|COMPLETED|Overall Study||73
5321051|NCT00421733|13084925|P2|COMPLETED|Overall Study||69
5321052|NCT00421733|13084926|P1|COMPLETED|Overall Study||78
5321053|NCT00421733|13084924|P3|STARTED|Overall Study||93
5321054|NCT00421733|13084925|P2|STARTED|Overall Study||95
5321055|NCT00421733|13084926|P1|STARTED|Overall Study||93
5321056|NCT00421707|13084946|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
5321057|NCT00421707|13084947|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
5321058|NCT00421707|13084946|P2|COMPLETED|Period 3:Treatment Period 2||49
5321059|NCT00421707|13084947|P1|COMPLETED|Period 3:Treatment Period 2||53
5321060|NCT00421707|13084946|P2|STARTED|Period 3:Treatment Period 2||52
5321061|NCT00421707|13084947|P1|STARTED|Period 3:Treatment Period 2||55
5321062|NCT00421707|13084946|P2|NOT COMPLETED|Period 2: Washout||4
5321063|NCT00421707|13084947|P1|NOT COMPLETED|Period 2: Washout||1
5321064|NCT00421707|13084946|P2|COMPLETED|Period 2: Washout||52
5321065|NCT00421707|13084947|P1|COMPLETED|Period 2: Washout||55
5321066|NCT00421707|13084946|P2|STARTED|Period 2: Washout||56
5321067|NCT00421707|13084947|P1|STARTED|Period 2: Washout||56
5321068|NCT00421707|13084946|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
5321069|NCT00421707|13084947|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
5321070|NCT00421707|13084946|P2|COMPLETED|Period 1: Treatment Period 1||56
5321071|NCT00421707|13084947|P1|COMPLETED|Period 1: Treatment Period 1||56
5321072|NCT00421707|13084946|P2|STARTED|Period 1: Treatment Period 1||65
5321073|NCT00421707|13084947|P1|STARTED|Period 1: Treatment Period 1||67
5321074|NCT00421603|13084989|P2|NOT COMPLETED|Overall Study||12
5321075|NCT00421603|13084990|P1|NOT COMPLETED|Overall Study||11
5321076|NCT00421603|13084989|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
5321077|NCT00421603|13084990|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
5321078|NCT00421603|13084989|P2|STARTED|Overall Study||42
5321079|NCT00421603|13084990|P1|STARTED|Overall Study||39
5321080|NCT00421408|13084998|P2|NOT COMPLETED|Overall Study||45
5321081|NCT00421408|13084999|P1|NOT COMPLETED|Overall Study||42
5321082|NCT00421408|13084998|P2|COMPLETED|Overall Study||61
5321083|NCT00421408|13084999|P1|COMPLETED|Overall Study||60
5321084|NCT00421408|13084998|P2|STARTED|Overall Study||106
5321085|NCT00421408|13084999|P1|STARTED|Overall Study||102
5321086|NCT00421343|13085017|P1|NOT COMPLETED|Overall Study||6
5321087|NCT00421343|13085017|P1|COMPLETED|Overall Study||23
5321088|NCT00421343|13085017|P1|STARTED|Overall Study||29
5321089|NCT00421174|13085023|P2|NOT COMPLETED|Overall Study||1
5321090|NCT00421174|13085024|P1|NOT COMPLETED|Overall Study||2
5321091|NCT00421174|13085023|P2|COMPLETED|Overall Study||18
5321092|NCT00421174|13085024|P1|COMPLETED|Overall Study||16
5321093|NCT00421174|13085023|P2|STARTED|Overall Study||19
5321094|NCT00421174|13085024|P1|STARTED|Overall Study||18
5321095|NCT00421148|13085072|P20|NOT COMPLETED|Overall Study||0
5321096|NCT00421148|13085073|P19|NOT COMPLETED|Overall Study||1
5321097|NCT00421148|13085074|P18|NOT COMPLETED|Overall Study||2
5321098|NCT00421148|13085075|P17|NOT COMPLETED|Overall Study||0
5321099|NCT00421148|13085076|P16|NOT COMPLETED|Overall Study||0
5321100|NCT00421148|13085077|P15|NOT COMPLETED|Overall Study||0
5321101|NCT00421148|13085078|P14|NOT COMPLETED|Overall Study||0
5321102|NCT00421148|13085079|P13|NOT COMPLETED|Overall Study||0
5321103|NCT00421148|13085080|P12|NOT COMPLETED|Overall Study||0
5321104|NCT00421148|13085081|P11|NOT COMPLETED|Overall Study||0
5321105|NCT00421148|13085082|P10|NOT COMPLETED|Overall Study||0
5321106|NCT00421148|13085083|P9|NOT COMPLETED|Overall Study||0
5321107|NCT00421148|13085084|P8|NOT COMPLETED|Overall Study||0
5321108|NCT00421148|13085085|P7|NOT COMPLETED|Overall Study||0
5321109|NCT00421148|13085086|P6|NOT COMPLETED|Overall Study||1
5321110|NCT00421148|13085087|P5|NOT COMPLETED|Overall Study||0
5321111|NCT00421148|13085088|P4|NOT COMPLETED|Overall Study||0
5321112|NCT00421148|13085089|P3|NOT COMPLETED|Overall Study||0
5321113|NCT00421148|13085090|P2|NOT COMPLETED|Overall Study||0
5321114|NCT00421148|13085091|P1|NOT COMPLETED|Overall Study||0
5321115|NCT00421148|13085072|P20|COMPLETED|Overall Study||6
5321116|NCT00421148|13085073|P19|COMPLETED|Overall Study||5
5321117|NCT00421148|13085074|P18|COMPLETED|Overall Study||4
5321118|NCT00421148|13085075|P17|COMPLETED|Overall Study||6
5321119|NCT00421148|13085076|P16|COMPLETED|Overall Study||6
5321120|NCT00421148|13085077|P15|COMPLETED|Overall Study||6
5321121|NCT00421148|13085078|P14|COMPLETED|Overall Study||6
5321122|NCT00421148|13085079|P13|COMPLETED|Overall Study||6
5321123|NCT00421148|13085080|P12|COMPLETED|Overall Study||6
5321124|NCT00421148|13085081|P11|COMPLETED|Overall Study||6
5321125|NCT00421148|13085082|P10|COMPLETED|Overall Study||5
5321126|NCT00421148|13085083|P9|COMPLETED|Overall Study||5
5321127|NCT00421148|13085084|P8|COMPLETED|Overall Study||5
5321128|NCT00421148|13085085|P7|COMPLETED|Overall Study||6
5321129|NCT00421148|13085086|P6|COMPLETED|Overall Study||4
5321130|NCT00421148|13085087|P5|COMPLETED|Overall Study||1
5321131|NCT00421148|13085088|P4|COMPLETED|Overall Study||1
5321132|NCT00421148|13085089|P3|COMPLETED|Overall Study||2
5321133|NCT00421148|13085090|P2|COMPLETED|Overall Study||2
5321134|NCT00421148|13085091|P1|COMPLETED|Overall Study||2
5321135|NCT00421148|13085072|P20|Treated|Overall Study||6
5321136|NCT00421148|13085073|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
5321137|NCT00421148|13085074|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
5321138|NCT00421148|13085075|P17|Treated|Overall Study||6
5321139|NCT00421148|13085076|P16|Treated|Overall Study||6
5321140|NCT00421148|13085077|P15|Treated|Overall Study||6
5321141|NCT00421148|13085078|P14|Treated|Overall Study||6
5321142|NCT00421148|13085079|P13|Treated|Overall Study||6
5321143|NCT00421148|13085080|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
5321144|NCT00421148|13085081|P11|Treated|Overall Study||6
5321145|NCT00421148|13085082|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
5321146|NCT00421148|13085083|P9|Treated|Overall Study||5
5321147|NCT00421148|13085084|P8|Treated|Overall Study||5
5321148|NCT00421148|13085085|P7|Treated|Overall Study||6
5321149|NCT00421148|13085086|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
5321150|NCT00421148|13085087|P5|Treated|Overall Study||1
5321151|NCT00421148|13085088|P4|Treated|Overall Study||1
5321152|NCT00421148|13085089|P3|Treated|Overall Study||2
5321153|NCT00421148|13085090|P2|Treated|Overall Study||2
5321154|NCT00421148|13085091|P1|Treated|Overall Study||2
5321155|NCT00421148|13085072|P20|STARTED|Overall Study||6
5321156|NCT00421148|13085073|P19|STARTED|Overall Study||6
5321157|NCT00421148|13085074|P18|STARTED|Overall Study||6
5321158|NCT00421148|13085075|P17|STARTED|Overall Study||6
5321159|NCT00421148|13085076|P16|STARTED|Overall Study||6
5321160|NCT00421148|13085077|P15|STARTED|Overall Study||6
5321161|NCT00421148|13085078|P14|STARTED|Overall Study||6
5321162|NCT00421148|13085079|P13|STARTED|Overall Study||6
5321163|NCT00421148|13085080|P12|STARTED|Overall Study||6
5321164|NCT00421148|13085081|P11|STARTED|Overall Study||6
5321165|NCT00421148|13085082|P10|STARTED|Overall Study||5
5321166|NCT00421148|13085083|P9|STARTED|Overall Study||5
5321167|NCT00421148|13085084|P8|STARTED|Overall Study||5
5321168|NCT00421148|13085085|P7|STARTED|Overall Study||6
5321169|NCT00421148|13085086|P6|STARTED|Overall Study||5
5321170|NCT00421148|13085087|P5|STARTED|Overall Study||1
5321171|NCT00421148|13085088|P4|STARTED|Overall Study||1
5321172|NCT00421148|13085089|P3|STARTED|Overall Study||2
5321173|NCT00421148|13085090|P2|STARTED|Overall Study||2
5321174|NCT00421148|13085091|P1|STARTED|Overall Study||2
5321175|NCT00420992|13085175|P2|NOT COMPLETED|Maintenance Phase||75
5321176|NCT00420992|13085176|P1|NOT COMPLETED|Maintenance Phase||61
5321177|NCT00420992|13085175|P2|COMPLETED|Maintenance Phase||98
5321178|NCT00420992|13085176|P1|COMPLETED|Maintenance Phase||110
5321179|NCT00420992|13085175|P2|STARTED|Maintenance Phase||173
5321180|NCT00420992|13085176|P1|STARTED|Maintenance Phase||171
5321181|NCT00420992|13085175|P2|NOT COMPLETED|Titration Phase||0
5321182|NCT00420992|13085176|P1|NOT COMPLETED|Titration Phase||203
5321183|NCT00420992|13085175|P2|COMPLETED|Titration Phase||0
5321184|NCT00420992|13085176|P1|COMPLETED|Titration Phase||344
5321185|NCT00420992|13085175|P2|STARTED|Titration Phase||0
5321186|NCT00420992|13085176|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
5321187|NCT00420927|13085190|P7|NOT COMPLETED|Period 2||53
5321188|NCT00420927|13085191|P6|NOT COMPLETED|Period 2||15
5321189|NCT00420927|13085192|P5|NOT COMPLETED|Period 2||43
5321190|NCT00420927|13085193|P4|NOT COMPLETED|Period 2||10
5321191|NCT00420927|13085194|P3|NOT COMPLETED|Period 2||13
5321192|NCT00420927|13085195|P2|NOT COMPLETED|Period 2||0
5321193|NCT00420927|13085196|P1|NOT COMPLETED|Period 2||0
5321194|NCT00420927|13085190|P7|COMPLETED|Period 2||295
5321195|NCT00420927|13085191|P6|COMPLETED|Period 2||97
5321196|NCT00420927|13085192|P5|COMPLETED|Period 2||216
5321197|NCT00420927|13085193|P4|COMPLETED|Period 2||95
5321198|NCT00420927|13085194|P3|COMPLETED|Period 2||89
5321199|NCT00420927|13085195|P2|COMPLETED|Period 2||0
5321200|NCT00420927|13085196|P1|COMPLETED|Period 2||0
5321201|NCT00420927|13085190|P7|STARTED|Period 2||348
5321202|NCT00420927|13085191|P6|STARTED|Period 2||112
5321203|NCT00420927|13085192|P5|STARTED|Period 2||259
5321204|NCT00420927|13085193|P4|STARTED|Period 2||105
5321205|NCT00420927|13085194|P3|STARTED|Period 2||102
5321206|NCT00420927|13085195|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
5321207|NCT00420927|13085196|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
5321208|NCT00420927|13085190|P7|NOT COMPLETED|Period 1||0
5321209|NCT00420927|13085191|P6|NOT COMPLETED|Period 1||0
5321210|NCT00420927|13085192|P5|NOT COMPLETED|Period 1||0
5321211|NCT00420927|13085193|P4|NOT COMPLETED|Period 1||0
5321212|NCT00420927|13085194|P3|NOT COMPLETED|Period 1||0
5321213|NCT00420927|13085195|P2|NOT COMPLETED|Period 1||57
5321214|NCT00420927|13085196|P1|NOT COMPLETED|Period 1||49
5321215|NCT00420927|13085190|P7|COMPLETED|Period 1||0
5321216|NCT00420927|13085191|P6|COMPLETED|Period 1||0
5321217|NCT00420927|13085192|P5|COMPLETED|Period 1||0
5321218|NCT00420927|13085193|P4|COMPLETED|Period 1||0
5321219|NCT00420927|13085194|P3|COMPLETED|Period 1||0
5321220|NCT00420927|13085195|P2|COMPLETED|Period 1||460
5321221|NCT00420927|13085196|P1|COMPLETED|Period 1||466
5321222|NCT00420927|13085190|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
5321223|NCT00420927|13085191|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
5321224|NCT00420927|13085192|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
5321225|NCT00420927|13085193|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
5321226|NCT00420927|13085194|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
5321227|NCT00420927|13085195|P2|STARTED|Period 1||517
5321228|NCT00420927|13085196|P1|STARTED|Period 1||515
5321229|NCT00420849|13085300|P1|NOT COMPLETED|Overall Study||331
5321230|NCT00420849|13085300|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
5321231|NCT00420849|13085300|P1|STARTED|Overall Study||587
5321232|NCT00420784|13085369|P4|NOT COMPLETED|Overall Study||78
5321233|NCT00420784|13085370|P3|NOT COMPLETED|Overall Study||53
5321234|NCT00420784|13085371|P2|NOT COMPLETED|Overall Study||58
5321235|NCT00420784|13085372|P1|NOT COMPLETED|Overall Study||29
5321236|NCT00420784|13085369|P4|COMPLETED|Overall Study||36
5321237|NCT00420784|13085370|P3|COMPLETED|Overall Study||58
5321238|NCT00420784|13085371|P2|COMPLETED|Overall Study||55
5321239|NCT00420784|13085372|P1|COMPLETED|Overall Study||86
5321240|NCT00420784|13085369|P4|STARTED|Overall Study||114
5321241|NCT00420784|13085370|P3|STARTED|Overall Study||111
5321242|NCT00420784|13085371|P2|STARTED|Overall Study||113
5321243|NCT00420784|13085372|P1|STARTED|Overall Study||115
5321244|NCT00420771|13085401|P2|NOT COMPLETED|Overall Study||4
5321245|NCT00420771|13085402|P1|NOT COMPLETED|Overall Study||3
5321246|NCT00420771|13085401|P2|COMPLETED|Overall Study||7
5321247|NCT00420771|13085402|P1|COMPLETED|Overall Study||5
5321248|NCT00420771|13085401|P2|STARTED|Overall Study||11
5321249|NCT00420771|13085402|P1|STARTED|Overall Study||8
5321250|NCT00420745|13085410|P2|NOT COMPLETED|Overall Study||6
5321251|NCT00420745|13085411|P1|NOT COMPLETED|Overall Study||15
5321252|NCT00420745|13085410|P2|COMPLETED|Overall Study||333
5321253|NCT00420745|13085411|P1|COMPLETED|Overall Study||655
5321254|NCT00420745|13085410|P2|STARTED|Overall Study||339
5321255|NCT00420745|13085411|P1|STARTED|Overall Study||670
5321256|NCT00420641|13085430|P3|NOT COMPLETED|Overall Study||44
5321257|NCT00420641|13085431|P2|NOT COMPLETED|Overall Study||72
5321258|NCT00420641|13085432|P1|NOT COMPLETED|Overall Study||45
5321259|NCT00420641|13085430|P3|COMPLETED|Overall Study||128
5321260|NCT00420641|13085431|P2|COMPLETED|Overall Study||100
5321261|NCT00420641|13085432|P1|COMPLETED|Overall Study||115
5321262|NCT00420641|13085430|P3|STARTED|Overall Study||172
5321263|NCT00420641|13085431|P2|STARTED|Overall Study||172
5321264|NCT00420641|13085432|P1|STARTED|Overall Study||160
5321265|NCT00420628|13085508|P2|NOT COMPLETED|Overall Study||4
5321266|NCT00420628|13085509|P1|NOT COMPLETED|Overall Study||9
5321267|NCT00420628|13085508|P2|COMPLETED|Overall Study||32
5321268|NCT00420628|13085509|P1|COMPLETED|Overall Study||63
5321269|NCT00420628|13085508|P2|STARTED|Overall Study||36
5321270|NCT00420628|13085509|P1|STARTED|Overall Study||72
5321271|NCT00420511|13085525|P2|NOT COMPLETED|Overall Study||1
5321272|NCT00420511|13085526|P1|NOT COMPLETED|Overall Study||2
5321273|NCT00420511|13085525|P2|COMPLETED|Overall Study||10
5321274|NCT00420511|13085526|P1|COMPLETED|Overall Study||8
5321275|NCT00420511|13085525|P2|STARTED|Overall Study||11
5321276|NCT00420511|13085526|P1|STARTED|Overall Study||10
5321277|NCT00420459|13085536|P1|NOT COMPLETED|Overall Study||0
5321278|NCT00420459|13085536|P1|COMPLETED|Overall Study||12
5321279|NCT00420459|13085536|P1|STARTED|Overall Study||12
5321280|NCT00420420|13085547|P2|NOT COMPLETED|Overall Study||4
5321281|NCT00420420|13085548|P1|NOT COMPLETED|Overall Study||8
5321282|NCT00420420|13085547|P2|COMPLETED|Overall Study||67
5321283|NCT00420420|13085548|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
5321284|NCT00420420|13085547|P2|STARTED|Overall Study|Number of patients randomized.|71
5321285|NCT00420420|13085548|P1|STARTED|Overall Study|Number of patients randomized.|73
5321286|NCT00420407|13085566|P2|NOT COMPLETED|Overall Study||6
5321287|NCT00420407|13085567|P1|NOT COMPLETED|Overall Study||4
5321288|NCT00420407|13085566|P2|COMPLETED|Overall Study||34
5321289|NCT00420407|13085567|P1|COMPLETED|Overall Study||37
5321290|NCT00420407|13085566|P2|STARTED|Overall Study||40
5321291|NCT00420407|13085567|P1|STARTED|Overall Study||41
5321292|NCT00420342|13085577|P3|NOT COMPLETED|Overall Study||1
5321293|NCT00420342|13085578|P2|NOT COMPLETED|Overall Study||2
5321294|NCT00420342|13085579|P1|NOT COMPLETED|Overall Study||1
5321295|NCT00420342|13085577|P3|COMPLETED|Overall Study||28
5321296|NCT00420342|13085578|P2|COMPLETED|Overall Study||31
5321297|NCT00420342|13085579|P1|COMPLETED|Overall Study||29
5321298|NCT00420342|13085577|P3|Received Treatment|Overall Study||29
5321299|NCT00420342|13085578|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
5321300|NCT00420342|13085579|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
5321301|NCT00420342|13085577|P3|STARTED|Overall Study||29
5321302|NCT00420342|13085578|P2|STARTED|Overall Study||33
5321303|NCT00420342|13085579|P1|STARTED|Overall Study||30
5321304|NCT00420316|13085622|P2|NOT COMPLETED|Overall Study||9
5321305|NCT00420316|13085623|P1|NOT COMPLETED|Overall Study||12
5321306|NCT00420316|13085622|P2|COMPLETED|Overall Study||522
5321307|NCT00420316|13085623|P1|COMPLETED|Overall Study||1070
5321308|NCT00420316|13085622|P2|STARTED|Overall Study||531
5321309|NCT00420316|13085623|P1|STARTED|Overall Study||1082
5321310|NCT00420303|13085647|P2|NOT COMPLETED|Overall Study||4
5321311|NCT00420303|13085648|P1|NOT COMPLETED|Overall Study||1
5321312|NCT00420303|13085647|P2|COMPLETED|Overall Study||8
5321313|NCT00420303|13085648|P1|COMPLETED|Overall Study||11
5321314|NCT00420303|13085647|P2|STARTED|Overall Study||12
5321315|NCT00420303|13085648|P1|STARTED|Overall Study||12
5321316|NCT00420290|13085660|P2|NOT COMPLETED|Overall Study||4
5321317|NCT00420290|13085661|P1|NOT COMPLETED|Overall Study||4
5321318|NCT00420290|13085660|P2|COMPLETED|Overall Study||7
5321319|NCT00420290|13085661|P1|COMPLETED|Overall Study||7
5321320|NCT00420290|13085660|P2|STARTED|Overall Study||11
5321321|NCT00420290|13085661|P1|STARTED|Overall Study||11
5321322|NCT00420238|13085677|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
5321323|NCT00420238|13085678|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
5321324|NCT00420238|13085677|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
5321325|NCT00420238|13085678|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
5321326|NCT00420238|13085677|P2|STARTED|12 Week Open-Label Treatment Period 2||39
5321327|NCT00420238|13085678|P1|STARTED|12 Week Open-Label Treatment Period 2||38
5321328|NCT00420238|13085677|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
5321329|NCT00420238|13085678|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
5321330|NCT00420238|13085677|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
5321331|NCT00420238|13085678|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
5321332|NCT00420238|13085677|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
5321333|NCT00420238|13085678|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
5321334|NCT00420212|13085817|P3|NOT COMPLETED|Overall Study||96
5321335|NCT00420212|13085818|P2|NOT COMPLETED|Overall Study||95
5321336|NCT00420212|13085819|P1|NOT COMPLETED|Overall Study||91
5321337|NCT00420212|13085817|P3|COMPLETED|Overall Study||320
5321338|NCT00420212|13085818|P2|COMPLETED|Overall Study||315
5321339|NCT00420212|13085819|P1|COMPLETED|Overall Study||317
5321340|NCT00420212|13085817|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
5321341|NCT00420212|13085818|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
5321342|NCT00420212|13085819|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
5321343|NCT00420199|13085845|P2|NOT COMPLETED|Overall Study||0
5321344|NCT00420199|13085846|P1|NOT COMPLETED|Overall Study||1
5321345|NCT00420199|13085845|P2|COMPLETED|Overall Study||23
5321346|NCT00420199|13085846|P1|COMPLETED|Overall Study||26
5321347|NCT00420199|13085845|P2|STARTED|Overall Study||23
5321348|NCT00420199|13085846|P1|STARTED|Overall Study||27
5321349|NCT00420147|13085901|P2|NOT COMPLETED|Overall Study||0
5321350|NCT00420147|13085902|P1|NOT COMPLETED|Overall Study||0
5321351|NCT00420147|13085901|P2|COMPLETED|Overall Study||19
5321352|NCT00420147|13085902|P1|COMPLETED|Overall Study||19
5321353|NCT00420147|13085901|P2|STARTED|Overall Study||19
5321354|NCT00420147|13085902|P1|STARTED|Overall Study||19
5321355|NCT00420095|13085912|P2|NOT COMPLETED|Overall Study||1
5321356|NCT00420095|13085913|P1|NOT COMPLETED|Overall Study||3
5321357|NCT00420095|13085912|P2|COMPLETED|Overall Study||59
5321358|NCT00420095|13085913|P1|COMPLETED|Overall Study||54
5321359|NCT00420095|13085912|P2|STARTED|Overall Study||60
5321360|NCT00420095|13085913|P1|STARTED|Overall Study||57
5321361|NCT00420056|13085931|P1|NOT COMPLETED|Overall Study||17
5321362|NCT00420056|13085931|P1|COMPLETED|Overall Study||0
5321363|NCT00420056|13085931|P1|STARTED|Overall Study||17
5321364|NCT00420017|13085955|P2|NOT COMPLETED|Overall Study||0
5321365|NCT00420017|13085956|P1|NOT COMPLETED|Overall Study||2
5321366|NCT00420017|13085955|P2|COMPLETED|Overall Study||40
5321367|NCT00420017|13085956|P1|COMPLETED|Overall Study|40 completed analysis|38
5321368|NCT00420017|13085955|P2|STARTED|Overall Study||40
5321369|NCT00420017|13085956|P1|STARTED|Overall Study||40
5321370|NCT00420004|13085971|P3|NOT COMPLETED|Overall Study||32
5321371|NCT00420004|13085972|P2|NOT COMPLETED|Overall Study||71
5321372|NCT00420004|13085973|P1|NOT COMPLETED|Overall Study||129
5321373|NCT00420004|13085971|P3|COMPLETED|Overall Study||30
5321374|NCT00420004|13085972|P2|COMPLETED|Overall Study||67
5321375|NCT00420004|13085973|P1|COMPLETED|Overall Study||140
5321376|NCT00420004|13085971|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
5321377|NCT00420004|13085972|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
5321378|NCT00420004|13085973|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
5321379|NCT00420004|13085971|P3|STARTED|Overall Study||62
5321380|NCT00420004|13085972|P2|STARTED|Overall Study||138
5321381|NCT00420004|13085973|P1|STARTED|Overall Study||269
5321382|NCT00419952|13086038|P2|NOT COMPLETED|Overall Study||125
5321383|NCT00419952|13086039|P1|NOT COMPLETED|Overall Study||149
5321384|NCT00419952|13086038|P2|COMPLETED|Overall Study||240
5321385|NCT00419952|13086039|P1|COMPLETED|Overall Study||228
5321386|NCT00419952|13086038|P2|STARTED|Overall Study||365
5321387|NCT00419952|13086039|P1|STARTED|Overall Study||377
5321388|NCT00419926|13086073|P2|NOT COMPLETED|Overall Study||10
5321389|NCT00419926|13086074|P1|NOT COMPLETED|Overall Study||14
5321390|NCT00419926|13086073|P2|COMPLETED|Overall Study||148
5321391|NCT00419926|13086074|P1|COMPLETED|Overall Study||141
5321392|NCT00419926|13086073|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
5321393|NCT00419926|13086074|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
5321394|NCT00419770|13086090|P2|NOT COMPLETED|Overall Study||1
5321395|NCT00419770|13086091|P1|NOT COMPLETED|Overall Study||5
5321396|NCT00419770|13086090|P2|COMPLETED|Overall Study||8
5321397|NCT00419770|13086091|P1|COMPLETED|Overall Study||6
5321398|NCT00419770|13086090|P2|STARTED|Overall Study||9
5321399|NCT00419770|13086091|P1|STARTED|Overall Study||11
5321400|NCT00419757|13086099|P2|NOT COMPLETED|Overall Study||21
5321401|NCT00419757|13086100|P1|NOT COMPLETED|Overall Study||18
5321402|NCT00419757|13086099|P2|COMPLETED|Overall Study|Randomized patients|102
5321403|NCT00419757|13086100|P1|COMPLETED|Overall Study|Randomized patients|109
5321404|NCT00419757|13086099|P2|STARTED|Overall Study|Randomized patients|123
5321405|NCT00419757|13086100|P1|STARTED|Overall Study|Randomized patients|127
5321406|NCT00419744|13086139|P3|NOT COMPLETED|Overall Study||133
5321407|NCT00419744|13086140|P2|NOT COMPLETED|Overall Study||118
5321408|NCT00419744|13086141|P1|NOT COMPLETED|Overall Study||117
5321409|NCT00419744|13086139|P3|COMPLETED|Overall Study||271
5321410|NCT00419744|13086140|P2|COMPLETED|Overall Study||290
5321411|NCT00419744|13086141|P1|COMPLETED|Overall Study||290
5321412|NCT00419744|13086139|P3|STARTED|Overall Study||404
5321413|NCT00419744|13086140|P2|STARTED|Overall Study||408
5321414|NCT00419744|13086141|P1|STARTED|Overall Study||407
5321415|NCT00419666|13086170|P1|NOT COMPLETED|Overall Study||0
5321416|NCT00419666|13086170|P1|COMPLETED|Overall Study||25
5321417|NCT00419666|13086170|P1|STARTED|Overall Study||25
5321418|NCT00419562|13086184|P2|NOT COMPLETED|Overall Study||31
5321419|NCT00419562|13086185|P1|NOT COMPLETED|Overall Study||33
5321420|NCT00419562|13086184|P2|COMPLETED|Overall Study||246
5321421|NCT00419562|13086185|P1|COMPLETED|Overall Study||250
5321422|NCT00419562|13086184|P2|STARTED|Overall Study||277
5321423|NCT00419562|13086185|P1|STARTED|Overall Study||283
5321424|NCT00419445|13086198|P3|NOT COMPLETED|Overall Study||1
5321425|NCT00419445|13086199|P2|NOT COMPLETED|Overall Study||2
5321426|NCT00419445|13086200|P1|NOT COMPLETED|Overall Study||1
5321427|NCT00419445|13086198|P3|COMPLETED|Overall Study||7
5321428|NCT00419445|13086199|P2|COMPLETED|Overall Study||14
5321429|NCT00419445|13086200|P1|COMPLETED|Overall Study||7
5321430|NCT00419445|13086198|P3|STARTED|Overall Study||8
5321431|NCT00419445|13086199|P2|STARTED|Overall Study||16
5321432|NCT00419445|13086200|P1|STARTED|Overall Study||8
5321433|NCT00419393|13086208|P1|NOT COMPLETED|Overall Study||24
5321434|NCT00419393|13086208|P1|COMPLETED|Overall Study||166
5321435|NCT00419393|13086208|P1|STARTED|Overall Study|One subject did not receive medication|190
5321436|NCT00419380|13086218|P2|NOT COMPLETED|Overall Study||10
5321437|NCT00419380|13086219|P1|NOT COMPLETED|Overall Study||1
5321438|NCT00419380|13086218|P2|COMPLETED|Overall Study||12
5321439|NCT00419380|13086219|P1|COMPLETED|Overall Study||18
5321440|NCT00419380|13086218|P2|STARTED|Overall Study||22
5321441|NCT00419380|13086219|P1|STARTED|Overall Study||19
5321442|NCT00419341|13086227|P1|NOT COMPLETED|Efficacy Period||10
5321443|NCT00419341|13086227|P1|COMPLETED|Efficacy Period||28
5321444|NCT00419341|13086227|P1|STARTED|Efficacy Period||38
5321445|NCT00419341|13086227|P1|NOT COMPLETED|Wash in/Wash Out Period||11
5321446|NCT00419341|13086227|P1|COMPLETED|Wash in/Wash Out Period||38
5321447|NCT00419341|13086227|P1|STARTED|Wash in/Wash Out Period||49
5321448|NCT00419315|13086250|P2|NOT COMPLETED|Overall Study||0
5321449|NCT00419315|13086251|P1|NOT COMPLETED|Overall Study||0
5321450|NCT00419315|13086250|P2|COMPLETED|Overall Study||78
5321451|NCT00419315|13086251|P1|COMPLETED|Overall Study||85
5321452|NCT00419315|13086250|P2|STARTED|Overall Study||78
5321453|NCT00419315|13086251|P1|STARTED|Overall Study||85
5321454|NCT00419263|13086262|P3|NOT COMPLETED|Overall Study||3
5321455|NCT00419263|13086263|P2|NOT COMPLETED|Overall Study||2
5321456|NCT00419263|13086264|P1|NOT COMPLETED|Overall Study||3
5321457|NCT00419263|13086262|P3|COMPLETED|Overall Study||112
5321458|NCT00419263|13086263|P2|COMPLETED|Overall Study||112
5321459|NCT00419263|13086264|P1|COMPLETED|Overall Study||112
5321460|NCT00419263|13086262|P3|STARTED|Overall Study||115
5321461|NCT00419263|13086263|P2|STARTED|Overall Study||114
5321462|NCT00419263|13086264|P1|STARTED|Overall Study||115
5321463|NCT00419159|13086293|P2|NOT COMPLETED|Overall Study||100
5321464|NCT00419159|13086294|P1|NOT COMPLETED|Overall Study||99
5321465|NCT00419159|13086293|P2|COMPLETED|Overall Study||0
5321466|NCT00419159|13086294|P1|COMPLETED|Overall Study||0
5321467|NCT00419159|13086293|P2|STARTED|Overall Study||100
5321468|NCT00419159|13086294|P1|STARTED|Overall Study|Full Analysis Set|99
5321469|NCT00419120|13086324|P1|NOT COMPLETED|Long Term Follow up Period||10
5321470|NCT00419120|13086324|P1|COMPLETED|Long Term Follow up Period||0
5321471|NCT00419120|13086324|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
5321472|NCT00419120|13086324|P1|NOT COMPLETED|Primary Study Period||0
5321473|NCT00419120|13086324|P1|COMPLETED|Primary Study Period||10
5321474|NCT00419120|13086324|P1|STARTED|Primary Study Period||10
5321475|NCT00419094|13086331|P2|NOT COMPLETED|Overall Study||30
5321476|NCT00419094|13086332|P1|NOT COMPLETED|Overall Study||7
5321477|NCT00419094|13086331|P2|COMPLETED|Overall Study||141
5321478|NCT00419094|13086332|P1|COMPLETED|Overall Study||50
5321479|NCT00419094|13086331|P2|STARTED|Overall Study||171
5321480|NCT00419094|13086332|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
5321481|NCT00419003|13086346|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
5321482|NCT00419003|13086347|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
5321483|NCT00419003|13086346|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
5321484|NCT00419003|13086347|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
5321485|NCT00419003|13086346|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
5321486|NCT00419003|13086347|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
5321487|NCT00419003|13086346|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
5321488|NCT00419003|13086347|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
5321489|NCT00419003|13086346|P2|COMPLETED|Phase I, Ketamine Infusion||7
5321490|NCT00419003|13086347|P1|COMPLETED|Phase I, Ketamine Infusion||7
5321491|NCT00419003|13086346|P2|STARTED|Phase I, Ketamine Infusion||13
5321492|NCT00419003|13086347|P1|STARTED|Phase I, Ketamine Infusion||13
5321493|NCT00418977|13086358|P2|NOT COMPLETED|Overall Study||3
5321494|NCT00418977|13086359|P1|NOT COMPLETED|Overall Study||3
5321495|NCT00418977|13086358|P2|COMPLETED|Overall Study||13
5321496|NCT00418977|13086359|P1|COMPLETED|Overall Study||40
5321497|NCT00418977|13086358|P2|STARTED|Overall Study||16
5321498|NCT00418977|13086359|P1|STARTED|Overall Study||43
5321499|NCT00418964|13086376|P3|NOT COMPLETED|Overall Study||6
5321500|NCT00418964|13086377|P2|NOT COMPLETED|Overall Study||3
5321501|NCT00418964|13086378|P1|NOT COMPLETED|Overall Study||1
5321502|NCT00418964|13086376|P3|COMPLETED|Overall Study||14
5321503|NCT00418964|13086377|P2|COMPLETED|Overall Study||17
5321504|NCT00418964|13086378|P1|COMPLETED|Overall Study||21
5321505|NCT00418964|13086376|P3|STARTED|Overall Study||20
5321506|NCT00418964|13086377|P2|STARTED|Overall Study||20
5321507|NCT00418964|13086378|P1|STARTED|Overall Study||22
5321508|NCT00418951|13086389|P3|NOT COMPLETED|Overall Study||0
5321509|NCT00418951|13086390|P2|NOT COMPLETED|Overall Study||0
5321510|NCT00418951|13086391|P1|NOT COMPLETED|Overall Study||0
5321511|NCT00418951|13086389|P3|COMPLETED|Overall Study||40
5321512|NCT00418951|13086390|P2|COMPLETED|Overall Study||33
5321513|NCT00418951|13086391|P1|COMPLETED|Overall Study||39
5321514|NCT00418951|13086389|P3|STARTED|Overall Study||40
5321515|NCT00418951|13086390|P2|STARTED|Overall Study||33
5321516|NCT00418951|13086391|P1|STARTED|Overall Study||39
5321517|NCT00418938|13086401|P2|NOT COMPLETED|Overall Study||23
5321518|NCT00418938|13086402|P1|NOT COMPLETED|Overall Study||24
5321519|NCT00418938|13086401|P2|COMPLETED|Overall Study||108
5321520|NCT00418938|13086402|P1|COMPLETED|Overall Study||109
5321521|NCT00418938|13086401|P2|STARTED|Overall Study||131
5321522|NCT00418938|13086402|P1|STARTED|Overall Study||133
5321523|NCT00418886|13086422|P2|NOT COMPLETED|Overall Study||255
5321524|NCT00418886|13086423|P1|NOT COMPLETED|Overall Study||226
5321525|NCT00418886|13086422|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
5321526|NCT00418886|13086423|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
5321527|NCT00418886|13086422|P2|STARTED|Overall Study|randomised patients|278
5321528|NCT00418886|13086423|P1|STARTED|Overall Study|randomised patients|256
5321529|NCT00418834|13086449|P2|NOT COMPLETED|Overall Study||20
5321530|NCT00418834|13086450|P1|NOT COMPLETED|Overall Study||23
5321531|NCT00418834|13086449|P2|COMPLETED|Overall Study||507
5321532|NCT00418834|13086450|P1|COMPLETED|Overall Study||503
5321533|NCT00418834|13086449|P2|STARTED|Overall Study||527
5321534|NCT00418834|13086450|P1|STARTED|Overall Study||526
5321535|NCT00418717|13086510|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
5321536|NCT00418717|13086510|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
5321537|NCT00418717|13086510|P1|STARTED|Treatment Period B - Weeks 5-12||41
5321538|NCT00418717|13086510|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
5321539|NCT00418717|13086510|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
5321540|NCT00418717|13086510|P1|STARTED|Treatment Period A - Weeks 1-4||42
5321541|NCT00418691|13086518|P3|NOT COMPLETED|Overall Study||5
5321542|NCT00418691|13086519|P2|NOT COMPLETED|Overall Study||2
5321543|NCT00418691|13086520|P1|NOT COMPLETED|Overall Study||2
5321544|NCT00418691|13086518|P3|COMPLETED|Overall Study||5
5321545|NCT00418691|13086519|P2|COMPLETED|Overall Study||10
5321546|NCT00418691|13086520|P1|COMPLETED|Overall Study||9
5321547|NCT00418691|13086518|P3|STARTED|Overall Study||10
5321548|NCT00418691|13086519|P2|STARTED|Overall Study||12
5321549|NCT00418691|13086520|P1|STARTED|Overall Study||11
5321550|NCT00418665|13086531|P3|NOT COMPLETED|Treatment Extension||2
5321551|NCT00418665|13086532|P2|NOT COMPLETED|Treatment Extension||4
5321552|NCT00418665|13086533|P1|NOT COMPLETED|Treatment Extension||6
5321553|NCT00418665|13086531|P3|COMPLETED|Treatment Extension||7
5321554|NCT00418665|13086532|P2|COMPLETED|Treatment Extension||4
5321555|NCT00418665|13086533|P1|COMPLETED|Treatment Extension||1
5321556|NCT00418665|13086531|P3|STARTED|Treatment Extension||9
5321557|NCT00418665|13086532|P2|STARTED|Treatment Extension||8
5321558|NCT00418665|13086533|P1|STARTED|Treatment Extension||7
5321559|NCT00418665|13086531|P3|NOT COMPLETED|Treatment Period||4
5321560|NCT00418665|13086532|P2|NOT COMPLETED|Treatment Period||6
5321561|NCT00418665|13086533|P1|NOT COMPLETED|Treatment Period||5
5321562|NCT00418665|13086531|P3|COMPLETED|Treatment Period||9
5321563|NCT00418665|13086532|P2|COMPLETED|Treatment Period||8
5321564|NCT00418665|13086533|P1|COMPLETED|Treatment Period||7
5321565|NCT00418665|13086531|P3|Received Study Medication|Treatment Period||13
5321566|NCT00418665|13086532|P2|Received Study Medication|Treatment Period||13
5321567|NCT00418665|13086533|P1|Received Study Medication|Treatment Period||11
5321568|NCT00418665|13086531|P3|STARTED|Treatment Period||13
5321569|NCT00418665|13086532|P2|STARTED|Treatment Period||14
5321570|NCT00418665|13086533|P1|STARTED|Treatment Period||12
5321571|NCT00418574|13086552|P2|NOT COMPLETED|Overall Study||23
5321572|NCT00418574|13086553|P1|NOT COMPLETED|Overall Study||48
5321573|NCT00418574|13086552|P2|COMPLETED|Overall Study||272
5321574|NCT00418574|13086553|P1|COMPLETED|Overall Study||545
5321575|NCT00418574|13086552|P2|TREATED|Overall Study||294
5321576|NCT00418574|13086553|P1|TREATED|Overall Study||592
5321577|NCT00418574|13086552|P2|STARTED|Overall Study||295
5321578|NCT00418574|13086553|P1|STARTED|Overall Study||593
5321579|NCT00418561|13086567|P3|NOT COMPLETED|Overall Study||0
5321580|NCT00418561|13086568|P2|NOT COMPLETED|Overall Study||1
5321581|NCT00418561|13086569|P1|NOT COMPLETED|Overall Study||0
5321582|NCT00418561|13086567|P3|COMPLETED|Overall Study||4
5321583|NCT00418561|13086568|P2|COMPLETED|Overall Study||4
5321584|NCT00418561|13086569|P1|COMPLETED|Overall Study||4
5321585|NCT00418561|13086567|P3|STARTED|Overall Study||4
5321586|NCT00418561|13086568|P2|STARTED|Overall Study||5
5321587|NCT00418561|13086569|P1|STARTED|Overall Study||4
5321588|NCT00418522|13086639|P2|NOT COMPLETED|Overall Study||42
5321589|NCT00418522|13086640|P1|NOT COMPLETED|Overall Study||83
5321590|NCT00418522|13086639|P2|COMPLETED|Overall Study||152
5321591|NCT00418522|13086640|P1|COMPLETED|Overall Study||136
5321592|NCT00418522|13086639|P2|Received Treatment|Overall Study||190
5321593|NCT00418522|13086640|P1|Received Treatment|Overall Study||212
5321594|NCT00418522|13086639|P2|STARTED|Overall Study||194
5321595|NCT00418522|13086640|P1|STARTED|Overall Study||219
5321596|NCT00418457|13086686|P2|NOT COMPLETED|Overall Study||0
5321597|NCT00418457|13086687|P1|NOT COMPLETED|Overall Study||0
5321598|NCT00418457|13086686|P2|COMPLETED|Overall Study||1043
5321599|NCT00418457|13086687|P1|COMPLETED|Overall Study||1065
5321600|NCT00418457|13086686|P2|STARTED|Overall Study||1043
5321601|NCT00418457|13086687|P1|STARTED|Overall Study||1065
5321602|NCT00418379|13086704|P3|NOT COMPLETED|Year 5||3
5321603|NCT00418379|13086705|P2|NOT COMPLETED|Year 5||5
5321604|NCT00418379|13086706|P1|NOT COMPLETED|Year 5||2
5321605|NCT00418379|13086704|P3|COMPLETED|Year 5||131
5321606|NCT00418379|13086705|P2|COMPLETED|Year 5||115
5321607|NCT00418379|13086706|P1|COMPLETED|Year 5||126
5321608|NCT00418379|13086704|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
5321609|NCT00418379|13086705|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
5321610|NCT00418379|13086706|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
5321611|NCT00418379|13086704|P3|NOT COMPLETED|Year 4||2
5321612|NCT00418379|13086705|P2|NOT COMPLETED|Year 4||5
5321613|NCT00418379|13086706|P1|NOT COMPLETED|Year 4||3
5321614|NCT00418379|13086704|P3|COMPLETED|Year 4||154
5321615|NCT00418379|13086705|P2|COMPLETED|Year 4||136
5321616|NCT00418379|13086706|P1|COMPLETED|Year 4||142
5321617|NCT00418379|13086704|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
5321618|NCT00418379|13086705|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
5321619|NCT00418379|13086706|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
5321620|NCT00418379|13086704|P3|NOT COMPLETED|Year 3||3
5321621|NCT00418379|13086705|P2|NOT COMPLETED|Year 3||2
5321622|NCT00418379|13086706|P1|NOT COMPLETED|Year 3||3
5321623|NCT00418379|13086704|P3|COMPLETED|Year 3||163
5321624|NCT00418379|13086705|P2|COMPLETED|Year 3||146
5321625|NCT00418379|13086706|P1|COMPLETED|Year 3||148
5321626|NCT00418379|13086704|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
5321627|NCT00418379|13086705|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
5321628|NCT00418379|13086706|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
5321629|NCT00418379|13086704|P3|NOT COMPLETED|Year 2||10
5321630|NCT00418379|13086705|P2|NOT COMPLETED|Year 2||4
5321631|NCT00418379|13086706|P1|NOT COMPLETED|Year 2||8
5321632|NCT00418379|13086704|P3|COMPLETED|Year 2||172
5321633|NCT00418379|13086705|P2|COMPLETED|Year 2||155
5321634|NCT00418379|13086706|P1|COMPLETED|Year 2||159
5321635|NCT00418379|13086704|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
5321636|NCT00418379|13086705|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
5321637|NCT00418379|13086706|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
5321638|NCT00418379|13086704|P3|NOT COMPLETED|Year 1||15
5321639|NCT00418379|13086705|P2|NOT COMPLETED|Year 1||28
5321640|NCT00418379|13086706|P1|NOT COMPLETED|Year 1||18
5321641|NCT00418379|13086704|P3|COMPLETED|Year 1||204
5321642|NCT00418379|13086705|P2|COMPLETED|Year 1||179
5321643|NCT00418379|13086706|P1|COMPLETED|Year 1||189
5321644|NCT00418379|13086704|P3|STARTED|Year 1||219
5321645|NCT00418379|13086705|P2|STARTED|Year 1||207
5321646|NCT00418379|13086706|P1|STARTED|Year 1||207
5321647|NCT00418314|13086716|P2|NOT COMPLETED|Overall Study||2
5321648|NCT00418314|13086717|P1|NOT COMPLETED|Overall Study||1
5321649|NCT00418314|13086716|P2|COMPLETED|Overall Study||828
5321650|NCT00418314|13086717|P1|COMPLETED|Overall Study||816
5321651|NCT00418314|13086716|P2|STARTED|Overall Study||830
5321652|NCT00418314|13086717|P1|STARTED|Overall Study||817
5321653|NCT00418262|13086727|P1|NOT COMPLETED|Visits 8 Thru 10||5
5321654|NCT00418262|13086727|P1|COMPLETED|Visits 8 Thru 10||11
5321655|NCT00418262|13086727|P1|STARTED|Visits 8 Thru 10||16
5321656|NCT00418262|13086727|P1|NOT COMPLETED|Visits 5 Thru 8||9
5321657|NCT00418262|13086727|P1|COMPLETED|Visits 5 Thru 8||16
5321658|NCT00418262|13086727|P1|STARTED|Visits 5 Thru 8||25
5321659|NCT00418262|13086727|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
5321660|NCT00418262|13086727|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
5321661|NCT00418262|13086727|P1|STARTED|Visits 1 (Baseline) Thru 5||27
5321662|NCT00418184|13086747|P2|NOT COMPLETED|Open-label Phase||5
5321663|NCT00418184|13086748|P1|NOT COMPLETED|Open-label Phase||5
5321664|NCT00418184|13086747|P2|COMPLETED|Open-label Phase|5 dropped out|43
5321665|NCT00418184|13086748|P1|COMPLETED|Open-label Phase|5 dropped out|97
5321666|NCT00418184|13086747|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
5321667|NCT00418184|13086748|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
5321668|NCT00418184|13086747|P2|NOT COMPLETED|Double-blind Phase||11
5321669|NCT00418184|13086748|P1|NOT COMPLETED|Double-blind Phase||27
5321670|NCT00418184|13086747|P2|COMPLETED|Double-blind Phase||52
5321671|NCT00418184|13086748|P1|COMPLETED|Double-blind Phase||110
5321672|NCT00418184|13086747|P2|STARTED|Double-blind Phase||63
5321673|NCT00418184|13086748|P1|STARTED|Double-blind Phase||137
5321674|NCT00418145|13086756|P1|NOT COMPLETED|Overall Study||6
5321675|NCT00418145|13086756|P1|COMPLETED|Overall Study||10
5321676|NCT00418145|13086756|P1|STARTED|Overall Study||16
5321677|NCT00418093|13086768|P1|NOT COMPLETED|Overall Study||0
5321678|NCT00418093|13086768|P1|COMPLETED|Overall Study||19
5321679|NCT00418093|13086768|P1|Completed Study|Overall Study||19
5321680|NCT00418093|13086768|P1|STARTED|Overall Study||19
5321681|NCT00418028|13086777|P2|NOT COMPLETED|Overall Study||1
5321682|NCT00418028|13086778|P1|NOT COMPLETED|Overall Study||2
5321683|NCT00418028|13086777|P2|COMPLETED|Overall Study||97
5321684|NCT00418028|13086778|P1|COMPLETED|Overall Study||95
5321685|NCT00418028|13086777|P2|STARTED|Overall Study||98
5321686|NCT00418028|13086778|P1|STARTED|Overall Study||97
5321687|NCT00418015|13086800|P4|NOT COMPLETED|Overall Study||0
5321688|NCT00418015|13086801|P3|NOT COMPLETED|Overall Study||0
5321689|NCT00418015|13086802|P2|NOT COMPLETED|Overall Study||0
5321690|NCT00418015|13086803|P1|NOT COMPLETED|Overall Study||0
5321691|NCT00418015|13086800|P4|COMPLETED|Overall Study||25
5321692|NCT00418015|13086801|P3|COMPLETED|Overall Study||78
5321693|NCT00418015|13086802|P2|COMPLETED|Overall Study||46
5321694|NCT00418015|13086803|P1|COMPLETED|Overall Study||144
5321695|NCT00418015|13086800|P4|STARTED|Overall Study||25
5321696|NCT00418015|13086801|P3|STARTED|Overall Study||78
5321697|NCT00418015|13086802|P2|STARTED|Overall Study||46
5321698|NCT00418015|13086803|P1|STARTED|Overall Study||144
5321699|NCT00417989|13086831|P2|NOT COMPLETED|Overall Study||22
5321700|NCT00417989|13086832|P1|NOT COMPLETED|Overall Study||20
5321701|NCT00417989|13086831|P2|COMPLETED|Overall Study||219
5321702|NCT00417989|13086832|P1|COMPLETED|Overall Study||224
5321703|NCT00417989|13086831|P2|STARTED|Overall Study||241
5321704|NCT00417989|13086832|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
5321705|NCT00417976|13086854|P1|NOT COMPLETED|Overall Study||3
5321706|NCT00417976|13086854|P1|COMPLETED|Overall Study||39
5321707|NCT00417976|13086854|P1|STARTED|Overall Study||42
5321708|NCT00417963|13086859|P1|NOT COMPLETED|Overall Study||41
5321709|NCT00417963|13086859|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
5321710|NCT00417963|13086859|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
5321711|NCT00417885|13086876|P1|NOT COMPLETED|Overall Study||6
5321712|NCT00417885|13086876|P1|COMPLETED|Overall Study||0
5321713|NCT00417885|13086876|P1|STARTED|Overall Study||6
5321714|NCT00417859|13086887|P2|NOT COMPLETED|Overall Study||1
5321715|NCT00417859|13086888|P1|NOT COMPLETED|Overall Study||0
5321716|NCT00417859|13086887|P2|COMPLETED|Overall Study||29
5321717|NCT00417859|13086888|P1|COMPLETED|Overall Study||26
5321718|NCT00417859|13086887|P2|STARTED|Overall Study||30
5321719|NCT00417859|13086888|P1|STARTED|Overall Study||26
5321720|NCT00417612|13086902|P2|NOT COMPLETED|Overall Study||3
5321721|NCT00417612|13086903|P1|NOT COMPLETED|Overall Study||3
5321722|NCT00417612|13086902|P2|COMPLETED|Overall Study||8
5321723|NCT00417612|13086903|P1|COMPLETED|Overall Study||19
5321724|NCT00417612|13086902|P2|STARTED|Overall Study||11
5321725|NCT00417612|13086903|P1|STARTED|Overall Study||22
5321726|NCT00417482|13086929|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
5321727|NCT00417482|13086930|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
5321728|NCT00417482|13086931|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
5321729|NCT00417482|13086929|P3|COMPLETED|Phase B 2nd 16 Weeks||10
5321730|NCT00417482|13086930|P2|COMPLETED|Phase B 2nd 16 Weeks||14
5321731|NCT00417482|13086931|P1|COMPLETED|Phase B 2nd 16 Weeks||10
5321732|NCT00417482|13086929|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
5321733|NCT00417482|13086930|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
5321734|NCT00417482|13086931|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
5321735|NCT00417482|13086929|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
5321736|NCT00417482|13086930|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
5321737|NCT00417482|13086931|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
5321738|NCT00417482|13086929|P3|COMPLETED|Phase B 1st 16 Weeks||13
5321739|NCT00417482|13086930|P2|COMPLETED|Phase B 1st 16 Weeks||27
5321740|NCT00417482|13086931|P1|COMPLETED|Phase B 1st 16 Weeks||13
5321741|NCT00417482|13086929|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
5321742|NCT00417482|13086930|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
5321743|NCT00417482|13086931|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
5321744|NCT00417417|13086957|P2|NOT COMPLETED|Overall Study||0
5321745|NCT00417417|13086958|P1|NOT COMPLETED|Overall Study||0
5321746|NCT00417417|13086957|P2|COMPLETED|Overall Study||6
5321747|NCT00417417|13086958|P1|COMPLETED|Overall Study||4
5321748|NCT00417417|13086957|P2|STARTED|Overall Study||6
5321749|NCT00417417|13086958|P1|STARTED|Overall Study||4
5321750|NCT00417274|13086966|P1|NOT COMPLETED|Overall Study||0
5321751|NCT00417274|13086966|P1|COMPLETED|Overall Study||31
5321752|NCT00417274|13086966|P1|STARTED|Overall Study||31
5321753|NCT00417248|13086970|P1|NOT COMPLETED|Overall Study||8
5321754|NCT00417248|13086970|P1|COMPLETED|Overall Study||0
5321755|NCT00417248|13086970|P1|STARTED|Overall Study||8
5321756|NCT00417170|13086977|P2|NOT COMPLETED|Overall Study||3
5321757|NCT00417170|13086978|P1|NOT COMPLETED|Overall Study||2
5321758|NCT00417170|13086977|P2|COMPLETED|Overall Study||22
5321759|NCT00417170|13086978|P1|COMPLETED|Overall Study||21
5321760|NCT00417170|13086977|P2|Pharmacodynamics Population|Overall Study||23
5321761|NCT00417170|13086978|P1|Pharmacodynamics Population|Overall Study||21
5321762|NCT00417170|13086977|P2|STARTED|Overall Study||25
5321763|NCT00417170|13086978|P1|STARTED|Overall Study|"Started indicates Safety population."|23
5321764|NCT00417079|13086994|P2|NOT COMPLETED|Overall Study||273
5321765|NCT00417079|13086995|P1|NOT COMPLETED|Overall Study||331
5321766|NCT00417079|13086994|P2|COMPLETED|Overall Study|Randomized patients|105
5321767|NCT00417079|13086995|P1|COMPLETED|Overall Study|Randomized patients|46
5321768|NCT00417079|13086994|P2|STARTED|Overall Study|Randomized patients|378
5321769|NCT00417079|13086995|P1|STARTED|Overall Study|Randomized patients|377
5321770|NCT00417027|13087018|P3|NOT COMPLETED|Overall Study||5
5321771|NCT00417027|13087019|P2|NOT COMPLETED|Overall Study||5
5321772|NCT00417027|13087020|P1|NOT COMPLETED|Overall Study||0
5321773|NCT00417027|13087018|P3|COMPLETED|Overall Study||54
5321774|NCT00417027|13087019|P2|COMPLETED|Overall Study||60
5321775|NCT00417027|13087020|P1|COMPLETED|Overall Study||66
5321776|NCT00417027|13087018|P3|STARTED|Overall Study||59
5321777|NCT00417027|13087019|P2|STARTED|Overall Study||65
5321778|NCT00417027|13087020|P1|STARTED|Overall Study||66
5321779|NCT00416949|13087046|P1|NOT COMPLETED|Overall Study||5
5321780|NCT00416949|13087046|P1|COMPLETED|Overall Study||4
5321781|NCT00416949|13087046|P1|STARTED|Overall Study||9
5321782|NCT00416884|13087050|P1|NOT COMPLETED|Overall Study||1
5321783|NCT00416884|13087050|P1|COMPLETED|Overall Study||0
5321784|NCT00416884|13087050|P1|STARTED|Overall Study||1
5321785|NCT00416793|13087054|P1|NOT COMPLETED|Overall Study||0
5321786|NCT00416793|13087054|P1|COMPLETED|Overall Study||9
5321787|NCT00416793|13087054|P1|STARTED|Overall Study||9
5321788|NCT00416715|13087059|P1|NOT COMPLETED|Overall Study||15
5321789|NCT00416715|13087059|P1|COMPLETED|Overall Study||85
5321790|NCT00416715|13087059|P1|STARTED|Overall Study||100
5321791|NCT00416624|13087070|P4|NOT COMPLETED|Overall Study||17
5321792|NCT00416624|13087071|P3|NOT COMPLETED|Overall Study||18
5321793|NCT00416624|13087072|P2|NOT COMPLETED|Overall Study||27
5321794|NCT00416624|13087073|P1|NOT COMPLETED|Overall Study||22
5321795|NCT00416624|13087070|P4|COMPLETED|Overall Study||40
5321796|NCT00416624|13087071|P3|COMPLETED|Overall Study||40
5321797|NCT00416624|13087072|P2|COMPLETED|Overall Study||33
5321798|NCT00416624|13087073|P1|COMPLETED|Overall Study||39
5321799|NCT00416624|13087070|P4|STARTED|Overall Study||57
5321800|NCT00416624|13087071|P3|STARTED|Overall Study||58
5321801|NCT00416624|13087072|P2|STARTED|Overall Study||60
5321802|NCT00416624|13087073|P1|STARTED|Overall Study||61
5321803|NCT00416598|13087127|P1|NOT COMPLETED|Decitabine Maintenance||72
5321804|NCT00416598|13087127|P1|COMPLETED|Decitabine Maintenance||62
5321805|NCT00416598|13087127|P1|STARTED|Decitabine Maintenance||134
5321806|NCT00416598|13087127|P1|NOT COMPLETED|Induction & Intensification||412
5321807|NCT00416598|13087127|P1|COMPLETED|Induction & Intensification||134
5321808|NCT00416598|13087127|P1|STARTED|Induction & Intensification||546
5321809|NCT00416572|13087135|P3|NOT COMPLETED|Overall Study||8
5321810|NCT00416572|13087136|P2|NOT COMPLETED|Overall Study||7
5321811|NCT00416572|13087137|P1|NOT COMPLETED|Overall Study||13
5321812|NCT00416572|13087135|P3|COMPLETED|Overall Study||76
5321813|NCT00416572|13087136|P2|COMPLETED|Overall Study||78
5321814|NCT00416572|13087137|P1|COMPLETED|Overall Study||70
5321815|NCT00416572|13087135|P3|STARTED|Overall Study||84
5321816|NCT00416572|13087136|P2|STARTED|Overall Study||85
5321817|NCT00416572|13087137|P1|STARTED|Overall Study||83
5321818|NCT00416520|13087153|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
5321819|NCT00416520|13087154|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
5321820|NCT00416520|13087155|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
5321821|NCT00416520|13087156|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
5321822|NCT00416520|13087153|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
5321823|NCT00416520|13087154|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
5321824|NCT00416520|13087155|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
5321825|NCT00416520|13087156|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
5321826|NCT00416520|13087153|P4|STARTED|Placebo-controlled Withdrawal Period||54
5321827|NCT00416520|13087154|P3|STARTED|Placebo-controlled Withdrawal Period||50
5321828|NCT00416520|13087155|P2|STARTED|Placebo-controlled Withdrawal Period||0
5321829|NCT00416520|13087156|P1|STARTED|Placebo-controlled Withdrawal Period||0
5321830|NCT00416520|13087153|P4|NOT COMPLETED|Open-label Period||0
5321831|NCT00416520|13087154|P3|NOT COMPLETED|Open-label Period||0
5321832|NCT00416520|13087155|P2|NOT COMPLETED|Open-label Period||32
5321833|NCT00416520|13087156|P1|NOT COMPLETED|Open-label Period||60
5321834|NCT00416520|13087153|P4|COMPLETED|Open-label Period||0
5321835|NCT00416520|13087154|P3|COMPLETED|Open-label Period||0
5321836|NCT00416520|13087155|P2|COMPLETED|Open-label Period||139
5321837|NCT00416520|13087156|P1|COMPLETED|Open-label Period||105
5321838|NCT00416520|13087153|P4|STARTED|Open-label Period||0
5321839|NCT00416520|13087154|P3|STARTED|Open-label Period||0
5321840|NCT00416520|13087155|P2|STARTED|Open-label Period||171
5321841|NCT00416520|13087156|P1|STARTED|Open-label Period||165
5321842|NCT00416494|13087168|P2|NOT COMPLETED|Overall Study||0
5321843|NCT00416494|13087169|P1|NOT COMPLETED|Overall Study||0
5321844|NCT00416494|13087168|P2|COMPLETED|Overall Study||31
5321845|NCT00416494|13087169|P1|COMPLETED|Overall Study||19
5321846|NCT00416494|13087168|P2|STARTED|Overall Study||31
5321847|NCT00416494|13087169|P1|STARTED|Overall Study||19
5321848|NCT00416455|13087185|P2|NOT COMPLETED|Overall Study||8
5321849|NCT00416455|13087186|P1|NOT COMPLETED|Overall Study||16
5321850|NCT00416455|13087185|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
5321851|NCT00416455|13087186|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
5321852|NCT00416455|13087185|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
5321853|NCT00416455|13087186|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
5321854|NCT00416312|13087221|P1|NOT COMPLETED|Overall Study||2
5321855|NCT00416312|13087221|P1|COMPLETED|Overall Study||7
5321856|NCT00416312|13087221|P1|Patient-specific Dosimetry|Overall Study||9
5321857|NCT00416312|13087221|P1|Conventional Dosimetry|Overall Study||9
5321858|NCT00416312|13087221|P1|STARTED|Overall Study||9
5321859|NCT00416195|13087227|P2|NOT COMPLETED|Overall Study||4
5321860|NCT00416195|13087228|P1|NOT COMPLETED|Overall Study||2
5321861|NCT00416195|13087227|P2|COMPLETED|Overall Study||34
5321862|NCT00416195|13087228|P1|COMPLETED|Overall Study||8
5321863|NCT00416195|13087227|P2|STARTED|Overall Study||38
5321864|NCT00416195|13087228|P1|STARTED|Overall Study||10
5321865|NCT00416182|13087238|P2|NOT COMPLETED|Overall Study||2
5321866|NCT00416182|13087239|P1|NOT COMPLETED|Overall Study||3
5321867|NCT00416182|13087238|P2|COMPLETED|Overall Study||6
5321868|NCT00416182|13087239|P1|COMPLETED|Overall Study||5
5321869|NCT00416182|13087238|P2|STARTED|Overall Study||8
5321870|NCT00416182|13087239|P1|STARTED|Overall Study||8
5321871|NCT00416078|13087253|P2|NOT COMPLETED|Overall Study||8
5321872|NCT00416078|13087254|P1|NOT COMPLETED|Overall Study||11
5321873|NCT00416078|13087253|P2|COMPLETED|Overall Study||16
5321874|NCT00416078|13087254|P1|COMPLETED|Overall Study||18
5321875|NCT00416078|13087253|P2|STARTED|Overall Study||24
5321876|NCT00416078|13087254|P1|STARTED|Overall Study||29
5321877|NCT00415909|13087270|P1|NOT COMPLETED|Overall Study||3
5321878|NCT00415909|13087270|P1|COMPLETED|Overall Study||0
5321879|NCT00415909|13087270|P1|STARTED|Overall Study||3
5321880|NCT00415870|13087276|P2|NOT COMPLETED|Overall Study||7
5321881|NCT00415870|13087277|P1|NOT COMPLETED|Overall Study||6
5321882|NCT00415870|13087276|P2|COMPLETED|Overall Study||26
5321883|NCT00415870|13087277|P1|COMPLETED|Overall Study||26
5321884|NCT00415870|13087276|P2|STARTED|Overall Study||33
5321885|NCT00415870|13087277|P1|STARTED|Overall Study||32
5321886|NCT00415857|13087289|P2|NOT COMPLETED|Overall Study||0
5321887|NCT00415857|13087290|P1|NOT COMPLETED|Overall Study||0
5321888|NCT00415857|13087289|P2|COMPLETED|Overall Study||3
5321889|NCT00415857|13087290|P1|COMPLETED|Overall Study||2
5321890|NCT00415857|13087289|P2|STARTED|Overall Study||3
5321891|NCT00415857|13087290|P1|STARTED|Overall Study||2
5321892|NCT00415636|13087304|P6|NOT COMPLETED|Overall Study||2
5321893|NCT00415636|13087305|P5|NOT COMPLETED|Overall Study||2
5321894|NCT00415636|13087306|P4|NOT COMPLETED|Overall Study||6
5321895|NCT00415636|13087307|P3|NOT COMPLETED|Overall Study||1
5321896|NCT00415636|13087308|P2|NOT COMPLETED|Overall Study||0
5321897|NCT00415636|13087309|P1|NOT COMPLETED|Overall Study||1
5321898|NCT00415636|13087304|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
5321988|NCT00414973|13087503|P4|STARTED|Overall Study||11
5321899|NCT00415636|13087305|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
5321900|NCT00415636|13087306|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
5321901|NCT00415636|13087307|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
5321902|NCT00415636|13087308|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
5321903|NCT00415636|13087309|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
5321904|NCT00415636|13087304|P6|STARTED|Overall Study||3
5321905|NCT00415636|13087305|P5|STARTED|Overall Study||6
5321906|NCT00415636|13087306|P4|STARTED|Overall Study||13
5321907|NCT00415636|13087307|P3|STARTED|Overall Study||3
5321908|NCT00415636|13087308|P2|STARTED|Overall Study||3
5321909|NCT00415636|13087309|P1|STARTED|Overall Study||3
5321910|NCT00415623|13087343|P2|NOT COMPLETED|Overall Study||5
5321911|NCT00415623|13087344|P1|NOT COMPLETED|Overall Study||5
5321912|NCT00415623|13087343|P2|COMPLETED|Overall Study||146
5321913|NCT00415623|13087344|P1|COMPLETED|Overall Study||149
5321914|NCT00415623|13087343|P2|STARTED|Overall Study||151
5321915|NCT00415623|13087344|P1|STARTED|Overall Study||154
5321916|NCT00415610|13087371|P3|NOT COMPLETED|Overall Study||5
5321917|NCT00415610|13087372|P2|NOT COMPLETED|Overall Study||2
5321918|NCT00415610|13087373|P1|NOT COMPLETED|Overall Study||3
5321919|NCT00415610|13087371|P3|COMPLETED|Overall Study||17
5321920|NCT00415610|13087372|P2|COMPLETED|Overall Study||18
5321921|NCT00415610|13087373|P1|COMPLETED|Overall Study||15
5321922|NCT00415610|13087371|P3|STARTED|Overall Study||22
5321923|NCT00415610|13087372|P2|STARTED|Overall Study||20
5321924|NCT00415610|13087373|P1|STARTED|Overall Study||18
5321925|NCT00415597|13087393|P1|NOT COMPLETED|Treatment||305
5321926|NCT00415597|13087393|P1|COMPLETED|Treatment||160
5321927|NCT00415597|13087393|P1|STARTED|Treatment||465
5321928|NCT00415597|13087393|P1|NOT COMPLETED|Enrollment||2
5321929|NCT00415597|13087393|P1|COMPLETED|Enrollment||465
5321930|NCT00415597|13087393|P1|STARTED|Enrollment||467
5321931|NCT00415532|13087401|P2|NOT COMPLETED|Safety Follow Up Period||12
5321932|NCT00415532|13087402|P1|NOT COMPLETED|Safety Follow Up Period||9
5321933|NCT00415532|13087401|P2|COMPLETED|Safety Follow Up Period||18
5321934|NCT00415532|13087402|P1|COMPLETED|Safety Follow Up Period||34
5321935|NCT00415532|13087401|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
5321936|NCT00415532|13087402|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
5321937|NCT00415532|13087401|P2|NOT COMPLETED|Treatment Period||15
5321938|NCT00415532|13087402|P1|NOT COMPLETED|Treatment Period||17
5321939|NCT00415532|13087401|P2|COMPLETED|Treatment Period||142
5321940|NCT00415532|13087402|P1|COMPLETED|Treatment Period||60
5321941|NCT00415532|13087401|P2|Switched to Romiplostim Group|Treatment Period||0
5321942|NCT00415532|13087402|P1|Switched to Romiplostim Group|Treatment Period||2
5321943|NCT00415532|13087401|P2|Received Treatment|Treatment Period||154
5321944|NCT00415532|13087402|P1|Received Treatment|Treatment Period||75
5321945|NCT00415532|13087401|P2|STARTED|Treatment Period||157
5321946|NCT00415532|13087402|P1|STARTED|Treatment Period||77
5321947|NCT00415519|13087424|P2|NOT COMPLETED|Overall Study||0
5321948|NCT00415519|13087425|P1|NOT COMPLETED|Overall Study||4
5321949|NCT00415519|13087424|P2|COMPLETED|Overall Study||12
5321950|NCT00415519|13087425|P1|COMPLETED|Overall Study||9
5321951|NCT00415519|13087424|P2|STARTED|Overall Study||12
5321952|NCT00415519|13087425|P1|STARTED|Overall Study||13
5321953|NCT00415506|13087445|P2|NOT COMPLETED|Overall Study||1
5321954|NCT00415506|13087446|P1|NOT COMPLETED|Overall Study||3
5321955|NCT00415506|13087445|P2|COMPLETED|Overall Study||9
5321956|NCT00415506|13087446|P1|COMPLETED|Overall Study||9
5321957|NCT00415506|13087445|P2|STARTED|Overall Study||10
5321958|NCT00415506|13087446|P1|STARTED|Overall Study||12
5321959|NCT00415493|13087456|P2|NOT COMPLETED|Overall Study||0
5321960|NCT00415493|13087457|P1|NOT COMPLETED|Overall Study||0
5321961|NCT00415493|13087456|P2|COMPLETED|Overall Study||12
5321962|NCT00415493|13087457|P1|COMPLETED|Overall Study||12
5321963|NCT00415493|13087456|P2|STARTED|Overall Study||12
5321964|NCT00415493|13087457|P1|STARTED|Overall Study||12
5321965|NCT00415194|13087465|P2|NOT COMPLETED|Overall Study||342
5321966|NCT00415194|13087466|P1|NOT COMPLETED|Overall Study||328
5321967|NCT00415194|13087465|P2|COMPLETED|Overall Study||55
5321968|NCT00415194|13087466|P1|COMPLETED|Overall Study||70
5321969|NCT00415194|13087465|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
5321970|NCT00415194|13087466|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
5321971|NCT00415194|13087465|P2|STARTED|Overall Study||397
5321972|NCT00415194|13087466|P1|STARTED|Overall Study||398
5321973|NCT00415168|13087482|P1|NOT COMPLETED|Overall Study||52
5321974|NCT00415168|13087482|P1|COMPLETED|Overall Study||1
5321975|NCT00415168|13087482|P1|Completed Treatment|Overall Study||15
5321976|NCT00415168|13087482|P1|STARTED|Overall Study||53
5321977|NCT00415051|13087492|P1|NOT COMPLETED|Overall Study||1
5321978|NCT00415051|13087492|P1|COMPLETED|Overall Study||19
5321979|NCT00415051|13087492|P1|STARTED|Overall Study||20
5321980|NCT00414973|13087503|P4|NOT COMPLETED|Overall Study||0
5321981|NCT00414973|13087504|P3|NOT COMPLETED|Overall Study||3
5321982|NCT00414973|13087505|P2|NOT COMPLETED|Overall Study||10
5321983|NCT00414973|13087506|P1|NOT COMPLETED|Overall Study||28
5321984|NCT00414973|13087503|P4|COMPLETED|Overall Study||11
5321985|NCT00414973|13087504|P3|COMPLETED|Overall Study||21
5321986|NCT00414973|13087505|P2|COMPLETED|Overall Study||99
5321987|NCT00414973|13087506|P1|COMPLETED|Overall Study||190
5321989|NCT00414973|13087504|P3|STARTED|Overall Study||24
5321990|NCT00414973|13087505|P2|STARTED|Overall Study||109
5321991|NCT00414973|13087506|P1|STARTED|Overall Study||218
5321992|NCT00414908|13087526|P2|NOT COMPLETED|Overall Study||1
5321993|NCT00414908|13087527|P1|NOT COMPLETED|Overall Study||1
5321994|NCT00414908|13087526|P2|COMPLETED|Overall Study||28
5321995|NCT00414908|13087527|P1|COMPLETED|Overall Study||24
5321996|NCT00414908|13087526|P2|STARTED|Overall Study||29
5321997|NCT00414908|13087527|P1|STARTED|Overall Study||25
5321998|NCT00414817|13087551|P2|NOT COMPLETED|Overall Study||3016
5321999|NCT00414817|13087552|P1|NOT COMPLETED|Overall Study||3130
5322000|NCT00414817|13087551|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
5322001|NCT00414817|13087552|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
5322002|NCT00414817|13087551|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
5322003|NCT00414817|13087552|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
5322004|NCT00414817|13087551|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
5322005|NCT00414817|13087552|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
5322006|NCT00414817|13087551|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
5322007|NCT00414817|13087552|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
5322008|NCT00414817|13087551|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
5322009|NCT00414817|13087552|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
5322010|NCT00414817|13087551|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
5322011|NCT00414817|13087552|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
5322012|NCT00414817|13087551|P2|STARTED|Overall Study||7031
5322013|NCT00414817|13087552|P1|STARTED|Overall Study||7033
5322014|NCT00414726|13087564|P2|NOT COMPLETED|Overall Study||1
5322015|NCT00414726|13087565|P1|NOT COMPLETED|Overall Study||0
5322016|NCT00414726|13087564|P2|COMPLETED|Overall Study||41
5322017|NCT00414726|13087565|P1|COMPLETED|Overall Study||43
5322018|NCT00414726|13087564|P2|STARTED|Overall Study||42
5322019|NCT00414726|13087565|P1|STARTED|Overall Study||43
5322020|NCT00414700|13087575|P2|NOT COMPLETED|Overall Study||3
5322021|NCT00414700|13087576|P1|NOT COMPLETED|Overall Study||6
5322022|NCT00414700|13087575|P2|COMPLETED|Overall Study||58
5322023|NCT00414700|13087576|P1|COMPLETED|Overall Study||51
5322024|NCT00414700|13087575|P2|STARTED|Overall Study||61
5322025|NCT00414700|13087576|P1|STARTED|Overall Study||57
5322026|NCT00414661|13087600|P4|NOT COMPLETED|Overall Study||3
5322027|NCT00414661|13087601|P3|NOT COMPLETED|Overall Study||2
5322028|NCT00414661|13087602|P2|NOT COMPLETED|Overall Study||14
5322029|NCT00414661|13087603|P1|NOT COMPLETED|Overall Study||14
5322030|NCT00414661|13087600|P4|COMPLETED|Overall Study||0
5322031|NCT00414661|13087601|P3|COMPLETED|Overall Study||20
5322032|NCT00414661|13087602|P2|COMPLETED|Overall Study||75
5322033|NCT00414661|13087603|P1|COMPLETED|Overall Study||34
5322034|NCT00414661|13087600|P4|STARTED|Overall Study||3
5322035|NCT00414661|13087601|P3|STARTED|Overall Study||22
5322036|NCT00414661|13087602|P2|STARTED|Overall Study||89
5322037|NCT00414661|13087603|P1|STARTED|Overall Study||48
5322038|NCT00414635|13087627|P2|NOT COMPLETED|Overall Study||2
5322039|NCT00414635|13087628|P1|NOT COMPLETED|Overall Study||5
5322040|NCT00414635|13087627|P2|COMPLETED|Overall Study||28
5322041|NCT00414635|13087628|P1|COMPLETED|Overall Study||25
5322042|NCT00414635|13087627|P2|STARTED|Overall Study||30
5322043|NCT00414635|13087628|P1|STARTED|Overall Study||30
5322044|NCT00414609|13087648|P3|NOT COMPLETED|Extension Study||57
5322045|NCT00414609|13087649|P2|NOT COMPLETED|Extension Study||0
5322046|NCT00414609|13087650|P1|NOT COMPLETED|Extension Study||0
5322047|NCT00414609|13087648|P3|COMPLETED|Extension Study||365
5322048|NCT00414609|13087649|P2|COMPLETED|Extension Study||0
5322049|NCT00414609|13087650|P1|COMPLETED|Extension Study||0
5322050|NCT00414609|13087648|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
5322051|NCT00414609|13087649|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
5322052|NCT00414609|13087650|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
5322053|NCT00414609|13087648|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
5322054|NCT00414609|13087649|P2|STARTED|Extension Study||0
5322055|NCT00414609|13087650|P1|STARTED|Extension Study||0
5322056|NCT00414609|13087648|P3|NOT COMPLETED|Core Study||0
5322057|NCT00414609|13087649|P2|NOT COMPLETED|Core Study||45
5322058|NCT00414609|13087650|P1|NOT COMPLETED|Core Study||34
5322059|NCT00414609|13087648|P3|COMPLETED|Core Study||0
5322060|NCT00414609|13087649|P2|COMPLETED|Core Study||378
5322061|NCT00414609|13087650|P1|COMPLETED|Core Study||363
5322062|NCT00414609|13087648|P3|Echocardiogram Evaluable Set|Core Study||0
5322063|NCT00414609|13087649|P2|Echocardiogram Evaluable Set|Core Study||343
5322064|NCT00414609|13087650|P1|Echocardiogram Evaluable Set|Core Study||330
5322065|NCT00414609|13087648|P3|Received Study Drug|Core Study||0
5322066|NCT00414609|13087649|P2|Received Study Drug|Core Study||422
5322067|NCT00414609|13087650|P1|Received Study Drug|Core Study||397
5322068|NCT00414609|13087648|P3|STARTED|Core Study||0
5322069|NCT00414609|13087649|P2|STARTED|Core Study||423
5322070|NCT00414609|13087650|P1|STARTED|Core Study||397
5322071|NCT00414596|13087673|P1|NOT COMPLETED|Overall Study||2
5322072|NCT00414596|13087673|P1|COMPLETED|Overall Study|April 2007|18
5322073|NCT00414596|13087673|P1|STARTED|Overall Study|December 2006|20
5322074|NCT00414544|13087682|P1|NOT COMPLETED|Overall Study||14
5322075|NCT00414544|13087682|P1|COMPLETED|Overall Study||131
5322076|NCT00414544|13087682|P1|STARTED|Overall Study||145
5322077|NCT00414518|13087690|P2|NOT COMPLETED|Overall Study||0
5322078|NCT00414518|13087691|P1|NOT COMPLETED|Overall Study||0
5322079|NCT00414518|13087690|P2|COMPLETED|Overall Study||9
5322080|NCT00414518|13087691|P1|COMPLETED|Overall Study||7
5322081|NCT00414518|13087690|P2|STARTED|Overall Study||9
5322082|NCT00414518|13087691|P1|STARTED|Overall Study||7
5322083|NCT00414466|13087705|P4|NOT COMPLETED|Overall Study||1
5322084|NCT00414466|13087706|P3|NOT COMPLETED|Overall Study||1
5322085|NCT00414466|13087707|P2|NOT COMPLETED|Overall Study||0
5322086|NCT00414466|13087708|P1|NOT COMPLETED|Overall Study||2
5322087|NCT00414466|13087705|P4|COMPLETED|Overall Study||42
5322088|NCT00414466|13087706|P3|COMPLETED|Overall Study||40
5322089|NCT00414466|13087707|P2|COMPLETED|Overall Study||42
5322090|NCT00414466|13087708|P1|COMPLETED|Overall Study||42
5322091|NCT00414466|13087705|P4|STARTED|Overall Study||43
5322092|NCT00414466|13087706|P3|STARTED|Overall Study||41
5322093|NCT00414466|13087707|P2|STARTED|Overall Study||42
5322094|NCT00414466|13087708|P1|STARTED|Overall Study||44
5322095|NCT00414453|13087726|P1|NOT COMPLETED|Overall Study||16
5322096|NCT00414453|13087726|P1|COMPLETED|Overall Study||3
5322097|NCT00414453|13087726|P1|STARTED|Overall Study||19
5322098|NCT00414440|13087774|P2|NOT COMPLETED|Extension Period||140
5322099|NCT00414440|13087775|P1|NOT COMPLETED|Extension Period||150
5322100|NCT00414440|13087774|P2|COMPLETED|Extension Period|Extension|77
5322101|NCT00414440|13087775|P1|COMPLETED|Extension Period|Extension|64
5322102|NCT00414440|13087774|P2|STARTED|Extension Period|Extension|217
5322103|NCT00414440|13087775|P1|STARTED|Extension Period|Extension|214
5322104|NCT00414440|13087774|P2|NOT COMPLETED|Core Period||32
5322105|NCT00414440|13087775|P1|NOT COMPLETED|Core Period||70
5322106|NCT00414440|13087774|P2|COMPLETED|Core Period|Core period|185
5322107|NCT00414440|13087775|P1|COMPLETED|Core Period|Core period|144
5322108|NCT00414440|13087774|P2|STARTED|Core Period|Core period|217
5322109|NCT00414440|13087775|P1|STARTED|Core Period|Core period|214
5322110|NCT00414388|13087789|P1|NOT COMPLETED|Overall Study||1
5322111|NCT00414388|13087789|P1|COMPLETED|Overall Study||21
5322112|NCT00414388|13087789|P1|STARTED|Overall Study||22
5322113|NCT00414310|13087797|P2|NOT COMPLETED|Overall Study||0
5322114|NCT00414310|13087798|P1|NOT COMPLETED|Overall Study||1
5322115|NCT00414310|13087797|P2|COMPLETED|Overall Study||79
5322116|NCT00414310|13087798|P1|COMPLETED|Overall Study||70
5322117|NCT00414310|13087797|P2|STARTED|Overall Study||79
5322118|NCT00414310|13087798|P1|STARTED|Overall Study||71
5322119|NCT00414271|13087808|P1|NOT COMPLETED|Overall Study||0
5322120|NCT00414271|13087808|P1|COMPLETED|Overall Study||18
5322121|NCT00414271|13087808|P1|STARTED|Overall Study||18
5322122|NCT00414206|13087819|P3|NOT COMPLETED|Overall Study||55
5322123|NCT00414206|13087820|P2|NOT COMPLETED|Overall Study||56
5322124|NCT00414206|13087821|P1|NOT COMPLETED|Overall Study||58
5322125|NCT00414206|13087819|P3|COMPLETED|Overall Study||59
5322126|NCT00414206|13087820|P2|COMPLETED|Overall Study||58
5322127|NCT00414206|13087821|P1|COMPLETED|Overall Study||57
5322128|NCT00414206|13087819|P3|STARTED|Overall Study||114
5322129|NCT00414206|13087820|P2|STARTED|Overall Study||114
5322130|NCT00414206|13087821|P1|STARTED|Overall Study||115
5322131|NCT00414167|13087831|P2|NOT COMPLETED|Overall Study||3
5322132|NCT00414167|13087832|P1|NOT COMPLETED|Overall Study||4
5322133|NCT00414167|13087831|P2|COMPLETED|Overall Study||27
5322134|NCT00414167|13087832|P1|COMPLETED|Overall Study||27
5322135|NCT00414167|13087831|P2|STARTED|Overall Study||30
5322136|NCT00414167|13087832|P1|STARTED|Overall Study||31
5322137|NCT00414076|13087842|P2|NOT COMPLETED|Overall Study||5
5322138|NCT00414076|13087843|P1|NOT COMPLETED|Overall Study||3
5322139|NCT00414076|13087842|P2|COMPLETED|Overall Study||0
5322140|NCT00414076|13087843|P1|COMPLETED|Overall Study||1
5322141|NCT00414076|13087842|P2|STARTED|Overall Study||5
5322142|NCT00414076|13087843|P1|STARTED|Overall Study||4
5322143|NCT00414050|13087853|P4|NOT COMPLETED|Overall Study||8
5322144|NCT00414050|13087854|P3|NOT COMPLETED|Overall Study||6
5322145|NCT00414050|13087855|P2|NOT COMPLETED|Overall Study||8
5322146|NCT00414050|13087856|P1|NOT COMPLETED|Overall Study||9
5322147|NCT00414050|13087853|P4|COMPLETED|Overall Study||423
5322148|NCT00414050|13087854|P3|COMPLETED|Overall Study||423
5322149|NCT00414050|13087855|P2|COMPLETED|Overall Study||419
5322150|NCT00414050|13087856|P1|COMPLETED|Overall Study||422
5322151|NCT00414050|13087853|P4|Received Vaccination 3|Overall Study||424
5322152|NCT00414050|13087854|P3|Received Vaccination 3|Overall Study||425
5322153|NCT00414050|13087855|P2|Received Vaccination 3|Overall Study||419
5322154|NCT00414050|13087856|P1|Received Vaccination 3|Overall Study||424
5322155|NCT00414050|13087853|P4|Received Vaccination 2|Overall Study||425
5322156|NCT00414050|13087854|P3|Received Vaccination 2|Overall Study||425
5322157|NCT00414050|13087855|P2|Received Vaccination 2|Overall Study||421
5322158|NCT00414050|13087856|P1|Received Vaccination 2|Overall Study||425
5322159|NCT00414050|13087853|P4|Received Vaccination 1|Overall Study||431
5322160|NCT00414050|13087854|P3|Received Vaccination 1|Overall Study||429
5322161|NCT00414050|13087855|P2|Received Vaccination 1|Overall Study||426
5322162|NCT00414050|13087856|P1|Received Vaccination 1|Overall Study||431
5322163|NCT00414050|13087853|P4|STARTED|Overall Study||431
5322164|NCT00414050|13087854|P3|STARTED|Overall Study||429
5322165|NCT00414050|13087855|P2|STARTED|Overall Study||427
5322166|NCT00414050|13087856|P1|STARTED|Overall Study||431
5322167|NCT00414011|13087870|P1|NOT COMPLETED|Overall Study||5
5322168|NCT00414011|13087870|P1|COMPLETED|Overall Study||35
5322169|NCT00414011|13087870|P1|STARTED|Overall Study||40
5322170|NCT00413972|13087879|P4|NOT COMPLETED|Overall Study||3
5322171|NCT00413972|13087880|P3|NOT COMPLETED|Overall Study||10
5322172|NCT00413972|13087881|P2|NOT COMPLETED|Overall Study||8
5322173|NCT00413972|13087882|P1|NOT COMPLETED|Overall Study||7
5322174|NCT00413972|13087879|P4|COMPLETED|Overall Study||95
5322175|NCT00413972|13087880|P3|COMPLETED|Overall Study||88
5322176|NCT00413972|13087881|P2|COMPLETED|Overall Study||90
5322177|NCT00413972|13087882|P1|COMPLETED|Overall Study||91
5322178|NCT00413972|13087879|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
5322179|NCT00413972|13087880|P3|STARTED|Overall Study||98
5322180|NCT00413972|13087881|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
5322181|NCT00413972|13087882|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
5322182|NCT00413959|13087892|P1|NOT COMPLETED|Overall Study||1
5322183|NCT00413959|13087892|P1|COMPLETED|Overall Study||11
5322184|NCT00413959|13087892|P1|STARTED|Overall Study||12
5322185|NCT00413920|13087899|P2|NOT COMPLETED|Overall Study||28
5322186|NCT00413920|13087900|P1|NOT COMPLETED|Overall Study||28
5322187|NCT00413920|13087899|P2|COMPLETED|Overall Study||82
5322188|NCT00413920|13087900|P1|COMPLETED|Overall Study||84
5322189|NCT00413920|13087899|P2|STARTED|Overall Study||110
5322190|NCT00413920|13087900|P1|STARTED|Overall Study||112
5322191|NCT00413894|13087915|P1|NOT COMPLETED|Overall Study||80
5322192|NCT00413894|13087915|P1|COMPLETED|Overall Study||344
5322193|NCT00413894|13087915|P1|STARTED|Overall Study||424
5322194|NCT00413777|13087932|P2|NOT COMPLETED|Extension Period||0
5322195|NCT00413777|13087933|P1|NOT COMPLETED|Extension Period||0
5322196|NCT00413777|13087932|P2|COMPLETED|Extension Period||18
5322197|NCT00413777|13087933|P1|COMPLETED|Extension Period||17
5322198|NCT00413777|13087932|P2|STARTED|Extension Period||18
5322199|NCT00413777|13087933|P1|STARTED|Extension Period||17
5322200|NCT00413777|13087932|P2|NOT COMPLETED|Fixed-dose Period||3
5322201|NCT00413777|13087933|P1|NOT COMPLETED|Fixed-dose Period||4
5322202|NCT00413777|13087932|P2|COMPLETED|Fixed-dose Period||21
5322203|NCT00413777|13087933|P1|COMPLETED|Fixed-dose Period||18
5322204|NCT00413777|13087932|P2|STARTED|Fixed-dose Period||24
5322205|NCT00413777|13087933|P1|STARTED|Fixed-dose Period||22
5322206|NCT00413699|13087981|P3|NOT COMPLETED|Extension Period||5
5322207|NCT00413699|13087982|P2|NOT COMPLETED|Extension Period||0
5322208|NCT00413699|13087983|P1|NOT COMPLETED|Extension Period||0
5322209|NCT00413699|13087981|P3|COMPLETED|Extension Period||43
5322210|NCT00413699|13087982|P2|COMPLETED|Extension Period||0
5322211|NCT00413699|13087983|P1|COMPLETED|Extension Period||0
5322212|NCT00413699|13087981|P3|STARTED|Extension Period||48
5322213|NCT00413699|13087982|P2|STARTED|Extension Period||0
5322214|NCT00413699|13087983|P1|STARTED|Extension Period||0
5322215|NCT00413699|13087981|P3|NOT COMPLETED|Initial Period||0
5322216|NCT00413699|13087982|P2|NOT COMPLETED|Initial Period||1705
5322217|NCT00413699|13087983|P1|NOT COMPLETED|Initial Period||639
5322218|NCT00413699|13087981|P3|COMPLETED|Initial Period||0
5322219|NCT00413699|13087982|P2|COMPLETED|Initial Period||1653
5322220|NCT00413699|13087983|P1|COMPLETED|Initial Period||484
5322221|NCT00413699|13087981|P3|STARTED|Initial Period||0
5322222|NCT00413699|13087982|P2|STARTED|Initial Period||3358
5322223|NCT00413699|13087983|P1|STARTED|Initial Period||1123
5322224|NCT00413660|13088065|P11|NOT COMPLETED|Post Week 12||1
5322225|NCT00413660|13088066|P10|NOT COMPLETED|Post Week 12||1
5322226|NCT00413660|13088067|P9|NOT COMPLETED|Post Week 12||0
5322227|NCT00413660|13088068|P8|NOT COMPLETED|Post Week 12||0
5322228|NCT00413660|13088069|P7|NOT COMPLETED|Post Week 12||3
5322229|NCT00413660|13088070|P6|NOT COMPLETED|Post Week 12||3
5322230|NCT00413660|13088071|P5|NOT COMPLETED|Post Week 12||6
5322231|NCT00413660|13088072|P4|NOT COMPLETED|Post Week 12||1
5322232|NCT00413660|13088073|P3|NOT COMPLETED|Post Week 12||8
5322233|NCT00413660|13088074|P2|NOT COMPLETED|Post Week 12||4
5322234|NCT00413660|13088075|P1|NOT COMPLETED|Post Week 12||3
5322235|NCT00413660|13088065|P11|COMPLETED|Post Week 12||17
5322236|NCT00413660|13088066|P10|COMPLETED|Post Week 12||12
5322237|NCT00413660|13088067|P9|COMPLETED|Post Week 12||13
5322238|NCT00413660|13088068|P8|COMPLETED|Post Week 12||21
5322239|NCT00413660|13088069|P7|COMPLETED|Post Week 12||37
5322240|NCT00413660|13088070|P6|COMPLETED|Post Week 12||54
5322241|NCT00413660|13088071|P5|COMPLETED|Post Week 12||60
5322242|NCT00413660|13088072|P4|COMPLETED|Post Week 12||66
5322243|NCT00413660|13088073|P3|COMPLETED|Post Week 12||56
5322244|NCT00413660|13088074|P2|COMPLETED|Post Week 12||44
5322245|NCT00413660|13088075|P1|COMPLETED|Post Week 12||40
5322246|NCT00413660|13088065|P11|STARTED|Post Week 12||18
5322247|NCT00413660|13088066|P10|STARTED|Post Week 12||13
5322248|NCT00413660|13088067|P9|STARTED|Post Week 12||13
5322249|NCT00413660|13088068|P8|STARTED|Post Week 12||21
5322250|NCT00413660|13088069|P7|STARTED|Post Week 12||40
5322251|NCT00413660|13088070|P6|STARTED|Post Week 12||57
5322252|NCT00413660|13088071|P5|STARTED|Post Week 12||66
5322253|NCT00413660|13088072|P4|STARTED|Post Week 12||67
5322254|NCT00413660|13088073|P3|STARTED|Post Week 12||64
5322255|NCT00413660|13088074|P2|STARTED|Post Week 12||48
5322256|NCT00413660|13088075|P1|STARTED|Post Week 12||43
5322257|NCT00413660|13088065|P11|NOT COMPLETED|Up To Week 12||0
5322258|NCT00413660|13088066|P10|NOT COMPLETED|Up To Week 12||0
5322259|NCT00413660|13088067|P9|NOT COMPLETED|Up To Week 12||0
5322260|NCT00413660|13088068|P8|NOT COMPLETED|Up To Week 12||0
5322261|NCT00413660|13088069|P7|NOT COMPLETED|Up To Week 12||11
5322262|NCT00413660|13088070|P6|NOT COMPLETED|Up To Week 12||10
5322263|NCT00413660|13088071|P5|NOT COMPLETED|Up To Week 12||9
5322264|NCT00413660|13088072|P4|NOT COMPLETED|Up To Week 12||8
5322265|NCT00413660|13088073|P3|NOT COMPLETED|Up To Week 12||7
5322266|NCT00413660|13088074|P2|NOT COMPLETED|Up To Week 12||7
5322267|NCT00413660|13088075|P1|NOT COMPLETED|Up To Week 12||7
5322268|NCT00413660|13088065|P11|COMPLETED|Up To Week 12||0
5322269|NCT00413660|13088066|P10|COMPLETED|Up To Week 12||0
5322270|NCT00413660|13088067|P9|COMPLETED|Up To Week 12||0
5322271|NCT00413660|13088068|P8|COMPLETED|Up To Week 12||0
5322272|NCT00413660|13088069|P7|COMPLETED|Up To Week 12||58
5322273|NCT00413660|13088070|P6|COMPLETED|Up To Week 12||70
5322274|NCT00413660|13088071|P5|COMPLETED|Up To Week 12||66
5322275|NCT00413660|13088072|P4|COMPLETED|Up To Week 12||67
5322276|NCT00413660|13088073|P3|COMPLETED|Up To Week 12||64
5322277|NCT00413660|13088074|P2|COMPLETED|Up To Week 12||61
5322278|NCT00413660|13088075|P1|COMPLETED|Up To Week 12||64
5322279|NCT00413660|13088065|P11|Treated|Up To Week 12||0
5322280|NCT00413660|13088066|P10|Treated|Up To Week 12||0
5322281|NCT00413660|13088067|P9|Treated|Up To Week 12||0
5322282|NCT00413660|13088068|P8|Treated|Up To Week 12||0
5322283|NCT00413660|13088069|P7|Treated|Up To Week 12||69
5322284|NCT00413660|13088070|P6|Treated|Up To Week 12||80
5322285|NCT00413660|13088071|P5|Treated|Up To Week 12||75
5322286|NCT00413660|13088072|P4|Treated|Up To Week 12||74
5322287|NCT00413660|13088073|P3|Treated|Up To Week 12||71
5322288|NCT00413660|13088074|P2|Treated|Up To Week 12||68
5322289|NCT00413660|13088075|P1|Treated|Up To Week 12||70
5322290|NCT00413660|13088065|P11|STARTED|Up To Week 12||0
5322291|NCT00413660|13088066|P10|STARTED|Up To Week 12||0
5322292|NCT00413660|13088067|P9|STARTED|Up To Week 12||0
5322293|NCT00413660|13088068|P8|STARTED|Up To Week 12||0
5322294|NCT00413660|13088069|P7|STARTED|Up To Week 12||69
5322295|NCT00413660|13088070|P6|STARTED|Up To Week 12||80
5322296|NCT00413660|13088071|P5|STARTED|Up To Week 12||75
5322297|NCT00413660|13088072|P4|STARTED|Up To Week 12||75
5322298|NCT00413660|13088073|P3|STARTED|Up To Week 12||71
5322299|NCT00413660|13088074|P2|STARTED|Up To Week 12||68
5322300|NCT00413660|13088075|P1|STARTED|Up To Week 12||71
5322301|NCT00413634|13088423|P2|NOT COMPLETED|Overall Study||0
5322302|NCT00413634|13088424|P1|NOT COMPLETED|Overall Study||0
5322303|NCT00413634|13088423|P2|COMPLETED|Overall Study||12
5322304|NCT00413634|13088424|P1|COMPLETED|Overall Study||12
5322305|NCT00413634|13088423|P2|STARTED|Overall Study||12
5322306|NCT00413634|13088424|P1|STARTED|Overall Study||12
5322307|NCT00413582|13088462|P2|NOT COMPLETED|Overall Study||0
5322308|NCT00413582|13088463|P1|NOT COMPLETED|Overall Study||0
5322309|NCT00413582|13088462|P2|COMPLETED|Overall Study|all enrolled completed|55
5322310|NCT00413582|13088463|P1|COMPLETED|Overall Study|all enrolled completed|55
5322311|NCT00413582|13088462|P2|Completion of Study|Overall Study|all enrolled completed|55
5322312|NCT00413582|13088463|P1|Completion of Study|Overall Study|all enrolled completed|55
5322313|NCT00413582|13088462|P2|STARTED|Overall Study|all enrolled completed|55
5322314|NCT00413582|13088463|P1|STARTED|Overall Study|all enrolled completed|55
5322315|NCT00413478|13088471|P1|NOT COMPLETED|Overall Study||0
5322316|NCT00413478|13088471|P1|COMPLETED|Overall Study||9
5322317|NCT00413478|13088471|P1|STARTED|Overall Study||9
5322318|NCT00413413|13088478|P3|NOT COMPLETED|Double-Blind||18
5322319|NCT00413413|13088479|P2|NOT COMPLETED|Double-Blind||14
5322320|NCT00413413|13088480|P1|NOT COMPLETED|Double-Blind||15
5322321|NCT00413413|13088478|P3|COMPLETED|Double-Blind||285
5322322|NCT00413413|13088479|P2|COMPLETED|Double-Blind||293
5322323|NCT00413413|13088480|P1|COMPLETED|Double-Blind||293
5322324|NCT00413413|13088478|P3|STARTED|Double-Blind||303
5322325|NCT00413413|13088479|P2|STARTED|Double-Blind||307
5322326|NCT00413413|13088480|P1|STARTED|Double-Blind||308
5322327|NCT00413413|13088478|P3|NOT COMPLETED|Single-Blind||0
5322328|NCT00413413|13088479|P2|NOT COMPLETED|Single-Blind||216
5322329|NCT00413413|13088480|P1|NOT COMPLETED|Single-Blind||0
5322330|NCT00413413|13088478|P3|COMPLETED|Single-Blind||0
5322331|NCT00413413|13088479|P2|COMPLETED|Single-Blind||918
5322332|NCT00413413|13088480|P1|COMPLETED|Single-Blind||0
5322333|NCT00413413|13088478|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
5322334|NCT00413413|13088479|P2|STARTED|Single-Blind||1134
5322335|NCT00413413|13088480|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
5322336|NCT00413400|13088502|P2|NOT COMPLETED|Overall Study||4
5322337|NCT00413400|13088503|P1|NOT COMPLETED|Overall Study||2
5322338|NCT00413400|13088502|P2|COMPLETED|Overall Study||12
5322339|NCT00413400|13088503|P1|COMPLETED|Overall Study||22
5322340|NCT00413400|13088502|P2|3 Month Visit|Overall Study||12
5322341|NCT00413400|13088503|P1|3 Month Visit|Overall Study||22
5322342|NCT00413400|13088502|P2|STARTED|Overall Study||16
5322343|NCT00413400|13088503|P1|STARTED|Overall Study||24
5322344|NCT00413374|13088533|P2|NOT COMPLETED|Overall Study||0
5322345|NCT00413374|13088534|P1|NOT COMPLETED|Overall Study||6
5322346|NCT00413374|13088533|P2|COMPLETED|Overall Study||80
5322347|NCT00413374|13088534|P1|COMPLETED|Overall Study||34
5322348|NCT00413374|13088533|P2|STARTED|Overall Study||80
5322349|NCT00413374|13088534|P1|STARTED|Overall Study||40
5322350|NCT00413335|13088546|P2|NOT COMPLETED|Overall Study||0
5322351|NCT00413335|13088547|P1|NOT COMPLETED|Overall Study||0
5322352|NCT00413335|13088546|P2|COMPLETED|Overall Study||9
5322353|NCT00413335|13088547|P1|COMPLETED|Overall Study||12
5322354|NCT00413335|13088546|P2|STARTED|Overall Study||9
5322355|NCT00413335|13088547|P1|STARTED|Overall Study||12
5322356|NCT00413283|13088565|P4|NOT COMPLETED|Overall Study||4
5322357|NCT00413283|13088566|P3|NOT COMPLETED|Overall Study||2
5322358|NCT00413283|13088567|P2|NOT COMPLETED|Overall Study||3
5322359|NCT00413283|13088568|P1|NOT COMPLETED|Overall Study||1
5322360|NCT00413283|13088565|P4|COMPLETED|Overall Study||13
5322361|NCT00413283|13088566|P3|COMPLETED|Overall Study||16
5322362|NCT00413283|13088567|P2|COMPLETED|Overall Study||13
5322363|NCT00413283|13088568|P1|COMPLETED|Overall Study||11
5322364|NCT00413283|13088565|P4|Received Study Drug|Overall Study||16
5322365|NCT00413283|13088566|P3|Received Study Drug|Overall Study||18
5322366|NCT00413283|13088567|P2|Received Study Drug|Overall Study||16
5322367|NCT00413283|13088568|P1|Received Study Drug|Overall Study||12
5322368|NCT00413283|13088565|P4|STARTED|Overall Study||17
5322369|NCT00413283|13088566|P3|STARTED|Overall Study||18
5322370|NCT00413283|13088567|P2|STARTED|Overall Study||16
5322371|NCT00413283|13088568|P1|STARTED|Overall Study||12
5322372|NCT00413244|13088600|P2|NOT COMPLETED|Overall Study||1
5322373|NCT00413244|13088601|P1|NOT COMPLETED|Overall Study||10
5322374|NCT00413244|13088600|P2|COMPLETED|Overall Study||19
5322375|NCT00413244|13088601|P1|COMPLETED|Overall Study||21
5322376|NCT00413244|13088600|P2|STARTED|Overall Study||20
5322377|NCT00413244|13088601|P1|STARTED|Overall Study||31
5322378|NCT00413231|13088629|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
5322379|NCT00413231|13088629|P1|COMPLETED|365-day to 60-month Post Treatment||93
5322380|NCT00413231|13088629|P1|STARTED|365-day to 60-month Post Treatment||139
5322381|NCT00413231|13088629|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
5322382|NCT00413231|13088629|P1|COMPLETED|30-day to 365-day Post Treatment||139
5322383|NCT00413231|13088629|P1|STARTED|30-day to 365-day Post Treatment||152
5322384|NCT00413231|13088629|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
5322385|NCT00413231|13088629|P1|COMPLETED|0 to 30-day Post Treatment||152
5322386|NCT00413231|13088629|P1|STARTED|0 to 30-day Post Treatment||160
5322387|NCT00413218|13088661|P2|NOT COMPLETED|Overall Study||96
5322388|NCT00413218|13088662|P1|NOT COMPLETED|Overall Study||103
5322389|NCT00413218|13088661|P2|COMPLETED|Overall Study||131
5322390|NCT00413218|13088662|P1|COMPLETED|Overall Study||120
5322391|NCT00413218|13088661|P2|Intent to Treat Population (ITT)|Overall Study||219
5322392|NCT00413218|13088662|P1|Intent to Treat Population (ITT)|Overall Study||221
5322393|NCT00413218|13088661|P2|STARTED|Overall Study||227
5322394|NCT00413218|13088662|P1|STARTED|Overall Study||223
5322395|NCT00413192|13088688|P4|NOT COMPLETED|Overall Study||32
5322396|NCT00413192|13088689|P3|NOT COMPLETED|Overall Study||19
5322397|NCT00413192|13088690|P2|NOT COMPLETED|Overall Study||40
5322398|NCT00413192|13088691|P1|NOT COMPLETED|Overall Study||37
5322399|NCT00413192|13088688|P4|COMPLETED|Overall Study||0
5322400|NCT00413192|13088689|P3|COMPLETED|Overall Study||0
5322401|NCT00413192|13088690|P2|COMPLETED|Overall Study||0
5322402|NCT00413192|13088691|P1|COMPLETED|Overall Study||0
5322403|NCT00413192|13088688|P4|STARTED|Overall Study||32
5322404|NCT00413192|13088689|P3|STARTED|Overall Study||19
5322405|NCT00413192|13088690|P2|STARTED|Overall Study||40
5322406|NCT00413192|13088691|P1|STARTED|Overall Study||37
5322407|NCT00413166|13088732|P3|NOT COMPLETED|Overall Study||0
5322408|NCT00413166|13088733|P2|NOT COMPLETED|Overall Study||0
5322409|NCT00413166|13088734|P1|NOT COMPLETED|Overall Study||0
5322410|NCT00413166|13088732|P3|COMPLETED|Overall Study||16
5322411|NCT00413166|13088733|P2|COMPLETED|Overall Study||5
5322412|NCT00413166|13088734|P1|COMPLETED|Overall Study||57
5322413|NCT00413166|13088732|P3|STARTED|Overall Study||16
5322414|NCT00413166|13088733|P2|STARTED|Overall Study||5
5322415|NCT00413166|13088734|P1|STARTED|Overall Study||57
5322416|NCT00413153|13088744|P2|NOT COMPLETED|Overall Study||1
5322417|NCT00413153|13088745|P1|NOT COMPLETED|Overall Study||2
5322418|NCT00413153|13088744|P2|COMPLETED|Overall Study||7
5322419|NCT00413153|13088745|P1|COMPLETED|Overall Study||5
5322420|NCT00413153|13088744|P2|STARTED|Overall Study||8
5322421|NCT00413153|13088745|P1|STARTED|Overall Study||7
5322422|NCT00413062|13088769|P2|NOT COMPLETED|Overall Study||210
5322423|NCT00413062|13088770|P1|NOT COMPLETED|Overall Study||678
5322424|NCT00413062|13088769|P2|COMPLETED|Overall Study||344
5322425|NCT00413062|13088770|P1|COMPLETED|Overall Study||988
5322426|NCT00413062|13088769|P2|STARTED|Overall Study||554
5322427|NCT00413062|13088770|P1|STARTED|Overall Study||1666
5322428|NCT00413049|13088796|P2|NOT COMPLETED|Overall Study||18
5322429|NCT00413049|13088797|P1|NOT COMPLETED|Overall Study||24
5322430|NCT00413049|13088796|P2|COMPLETED|Overall Study||331
5322431|NCT00413049|13088797|P1|COMPLETED|Overall Study||325
5322432|NCT00413049|13088796|P2|STARTED|Overall Study||349
5322433|NCT00413049|13088797|P1|STARTED|Overall Study||349
5322434|NCT00413036|13088813|P1|NOT COMPLETED|Overall Study||217
5322435|NCT00413036|13088813|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
5322436|NCT00413036|13088813|P1|STARTED|Overall Study||217
5322437|NCT00413010|13088823|P2|NOT COMPLETED|Overall Study||63
5322438|NCT00413010|13088824|P1|NOT COMPLETED|Overall Study||72
5322439|NCT00413010|13088823|P2|COMPLETED|Overall Study||113
5322440|NCT00413010|13088824|P1|COMPLETED|Overall Study||108
5322441|NCT00413010|13088823|P2|STARTED|Overall Study||176
5322442|NCT00413010|13088824|P1|STARTED|Overall Study||180
5322443|NCT00412984|13088846|P2|NOT COMPLETED|Overall Study||2493
5322444|NCT00412984|13088847|P1|NOT COMPLETED|Overall Study||2310
5322445|NCT00412984|13088846|P2|COMPLETED|Overall Study||6588
5322446|NCT00412984|13088847|P1|COMPLETED|Overall Study||6810
5322447|NCT00412984|13088846|P2|STARTED|Overall Study|Randomized participants|9081
5322448|NCT00412984|13088847|P1|STARTED|Overall Study|Randomized participants|9120
5322449|NCT00412971|13088891|P2|NOT COMPLETED|Overall Study||10
5322450|NCT00412971|13088892|P1|NOT COMPLETED|Overall Study||30
5322451|NCT00412971|13088891|P2|COMPLETED|Overall Study||108
5322452|NCT00412971|13088892|P1|COMPLETED|Overall Study||85
5322453|NCT00412971|13088891|P2|STARTED|Overall Study||118
5322454|NCT00412971|13088892|P1|STARTED|Overall Study||115
5322455|NCT00412958|13088905|P4|NOT COMPLETED|Overall Study||1
5322456|NCT00412958|13088906|P3|NOT COMPLETED|Overall Study||0
5322457|NCT00412958|13088907|P2|NOT COMPLETED|Overall Study||4
5322458|NCT00412958|13088908|P1|NOT COMPLETED|Overall Study||3
5322459|NCT00412958|13088905|P4|COMPLETED|Overall Study||30
5322460|NCT00412958|13088906|P3|COMPLETED|Overall Study||32
5322461|NCT00412958|13088907|P2|COMPLETED|Overall Study||29
5322462|NCT00412958|13088908|P1|COMPLETED|Overall Study||26
5322463|NCT00412958|13088905|P4|STARTED|Overall Study||31
5322464|NCT00412958|13088906|P3|STARTED|Overall Study||32
5322465|NCT00412958|13088907|P2|STARTED|Overall Study||33
5322466|NCT00412958|13088908|P1|STARTED|Overall Study||29
5322467|NCT00412932|13088918|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
5322468|NCT00412932|13088918|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
5322469|NCT00412932|13088918|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
5322470|NCT00412932|13088918|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
5322471|NCT00412932|13088918|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
5322472|NCT00412932|13088918|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
5322473|NCT00412932|13088918|P1|NOT COMPLETED|Olmesartan 40 mg||8
5322474|NCT00412932|13088918|P1|COMPLETED|Olmesartan 40 mg||161
5322475|NCT00412932|13088918|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
5322476|NCT00412932|13088918|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
5322477|NCT00412932|13088918|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
5322478|NCT00412932|13088918|P1|STARTED|Olmesartan (Olm) 20 mg||178
5322479|NCT00412893|13088929|P2|NOT COMPLETED|Overall Study||144
5322480|NCT00412893|13088930|P1|NOT COMPLETED|Overall Study||145
5322481|NCT00412893|13088929|P2|COMPLETED|Overall Study|Defined as completed treatment|120
5322482|NCT00412893|13088930|P1|COMPLETED|Overall Study|Defined as completed treatment|118
5322483|NCT00412893|13088929|P2|Received Treatment|Overall Study||258
5322484|NCT00412893|13088930|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
5322485|NCT00412893|13088929|P2|STARTED|Overall Study||264
5322486|NCT00412893|13088930|P1|STARTED|Overall Study||263
5322487|NCT00412867|13088956|P1|NOT COMPLETED|Overall Study||0
5322488|NCT00412867|13088956|P1|COMPLETED|Overall Study||58
5322489|NCT00412867|13088956|P1|STARTED|Overall Study||58
5322490|NCT00412854|13088968|P2|NOT COMPLETED|Overall Study||16
5322491|NCT00412854|13088969|P1|NOT COMPLETED|Overall Study||14
5322492|NCT00412854|13088968|P2|COMPLETED|Overall Study||314
5322493|NCT00412854|13088969|P1|COMPLETED|Overall Study||316
5322494|NCT00412854|13088968|P2|STARTED|Overall Study||330
5322495|NCT00412854|13088969|P1|STARTED|Overall Study||330
5322496|NCT00412841|13088997|P2|NOT COMPLETED|Overall Study||5
5322497|NCT00412841|13088998|P1|NOT COMPLETED|Overall Study||10
5322498|NCT00412841|13088997|P2|COMPLETED|Overall Study||16
5322499|NCT00412841|13088998|P1|COMPLETED|Overall Study||12
5322500|NCT00412841|13088997|P2|STARTED|Overall Study||21
5322501|NCT00412841|13088998|P1|STARTED|Overall Study||22
5322502|NCT00412750|13089013|P3|NOT COMPLETED|Overall Study||23
5322503|NCT00412750|13089014|P2|NOT COMPLETED|Overall Study||21
5322504|NCT00412750|13089015|P1|NOT COMPLETED|Overall Study||31
5322505|NCT00412750|13089013|P3|COMPLETED|Overall Study||31
5322506|NCT00412750|13089014|P2|COMPLETED|Overall Study||34
5322507|NCT00412750|13089015|P1|COMPLETED|Overall Study||19
5322508|NCT00412750|13089013|P3|STARTED|Overall Study||54
5322509|NCT00412750|13089014|P2|STARTED|Overall Study||55
5322510|NCT00412750|13089015|P1|STARTED|Overall Study||50
5322511|NCT00412737|13089040|P2|NOT COMPLETED|Overall Study||6
5322512|NCT00412737|13089041|P1|NOT COMPLETED|Overall Study||16
5322513|NCT00412737|13089040|P2|COMPLETED|Overall Study||232
5322514|NCT00412737|13089041|P1|COMPLETED|Overall Study||221
5322515|NCT00412737|13089040|P2|STARTED|Overall Study||238
5322516|NCT00412737|13089041|P1|STARTED|Overall Study||237
5322517|NCT00412607|13089059|P1|NOT COMPLETED|Overall Study||104
5322518|NCT00412607|13089059|P1|COMPLETED|Overall Study||145
5322519|NCT00412607|13089059|P1|Started Study Catheter|Overall Study||233
5322520|NCT00412607|13089059|P1|STARTED|Overall Study||249
5322521|NCT00412542|13089072|P2|NOT COMPLETED|Overall Study||3
5322522|NCT00412542|13089073|P1|NOT COMPLETED|Overall Study||0
5322523|NCT00412542|13089072|P2|COMPLETED|Overall Study||42
5322524|NCT00412542|13089073|P1|COMPLETED|Overall Study||33
5322525|NCT00412542|13089072|P2|STARTED|Overall Study||45
5322526|NCT00412542|13089073|P1|STARTED|Overall Study||33
5322527|NCT00412529|13089079|P2|NOT COMPLETED|Overall Study||0
5322528|NCT00412529|13089080|P1|NOT COMPLETED|Overall Study||0
5322529|NCT00412529|13089079|P2|COMPLETED|Overall Study||21
5322530|NCT00412529|13089080|P1|COMPLETED|Overall Study||23
5322531|NCT00412529|13089079|P2|STARTED|Overall Study||21
5322532|NCT00412529|13089080|P1|STARTED|Overall Study||23
5322533|NCT00412516|13089103|P3|NOT COMPLETED|Overall Study||0
5322534|NCT00412516|13089104|P2|NOT COMPLETED|Overall Study||0
5322535|NCT00412516|13089105|P1|NOT COMPLETED|Overall Study||0
5322536|NCT00412516|13089103|P3|COMPLETED|Overall Study||214
5322537|NCT00412516|13089104|P2|COMPLETED|Overall Study||212
5322538|NCT00412516|13089105|P1|COMPLETED|Overall Study||93
5322539|NCT00412516|13089103|P3|STARTED|Overall Study||214
5322540|NCT00412516|13089104|P2|STARTED|Overall Study||212
5322541|NCT00412516|13089105|P1|STARTED|Overall Study||93
5322542|NCT00412464|13089122|P1|NOT COMPLETED|Overall Study||0
5322543|NCT00412464|13089122|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
5322544|NCT00412464|13089122|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
5322545|NCT00412451|13089134|P4|NOT COMPLETED|Overall Study||2
5322546|NCT00412451|13089135|P3|NOT COMPLETED|Overall Study||1
5322547|NCT00412451|13089136|P2|NOT COMPLETED|Overall Study||0
5322548|NCT00412451|13089137|P1|NOT COMPLETED|Overall Study||0
5322549|NCT00412451|13089134|P4|COMPLETED|Overall Study||11
5322550|NCT00412451|13089135|P3|COMPLETED|Overall Study||14
5322551|NCT00412451|13089136|P2|COMPLETED|Overall Study||15
5322552|NCT00412451|13089137|P1|COMPLETED|Overall Study||8
5322553|NCT00412451|13089134|P4|STARTED|Overall Study||13
5322554|NCT00412451|13089135|P3|STARTED|Overall Study||15
5322555|NCT00412451|13089136|P2|STARTED|Overall Study||15
5322556|NCT00412451|13089137|P1|STARTED|Overall Study||8
5322557|NCT00412425|13089149|P2|NOT COMPLETED|Overall Study||0
5322558|NCT00412425|13089150|P1|NOT COMPLETED|Overall Study||0
5322559|NCT00412425|13089149|P2|COMPLETED|Overall Study||15
5322560|NCT00412425|13089150|P1|COMPLETED|Overall Study||15
5322561|NCT00412425|13089149|P2|STARTED|Overall Study||15
5322562|NCT00412425|13089150|P1|STARTED|Overall Study||15
5322563|NCT00412373|13089158|P2|NOT COMPLETED|Overall Study||77
5322564|NCT00412373|13089159|P1|NOT COMPLETED|Overall Study||41
5322565|NCT00412373|13089158|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
5322566|NCT00412373|13089159|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
5322567|NCT00412373|13089158|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
5322568|NCT00412373|13089159|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
5322569|NCT00412360|13089201|P2|NOT COMPLETED|Overall Study||3
5322570|NCT00412360|13089202|P1|NOT COMPLETED|Overall Study||1
5322571|NCT00412360|13089201|P2|COMPLETED|Overall Study||108
5322572|NCT00412360|13089202|P1|COMPLETED|Overall Study||112
5322573|NCT00412360|13089201|P2|STARTED|Overall Study||111
5322574|NCT00412360|13089202|P1|STARTED|Overall Study||113
5322575|NCT00412243|13089226|P1|NOT COMPLETED|Overall Study||0
5322576|NCT00412243|13089226|P1|COMPLETED|Overall Study||50
5322577|NCT00412243|13089226|P1|STARTED|Overall Study||50
5322578|NCT00412217|13089232|P2|NOT COMPLETED|Overall Study||48
5322579|NCT00412217|13089233|P1|NOT COMPLETED|Overall Study||46
5322580|NCT00412217|13089232|P2|COMPLETED|Overall Study||0
5322581|NCT00412217|13089233|P1|COMPLETED|Overall Study||0
5322582|NCT00412217|13089232|P2|STARTED|Overall Study||48
5322583|NCT00412217|13089233|P1|STARTED|Overall Study||46
5322584|NCT00412113|13089247|P2|NOT COMPLETED|Overall Study||15
5322585|NCT00412113|13089248|P1|NOT COMPLETED|Overall Study||12
5322586|NCT00412113|13089247|P2|COMPLETED|Overall Study|15-April-2008|107
5322587|NCT00412113|13089248|P1|COMPLETED|Overall Study|15-April-2008|111
5322588|NCT00412113|13089247|P2|Received Treatment|Overall Study||122
5322589|NCT00412113|13089248|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
5322590|NCT00412113|13089247|P2|STARTED|Overall Study|15-January-2007|122
5322591|NCT00412113|13089248|P1|STARTED|Overall Study|15-January-2007|123
5322592|NCT00412087|13089302|P2|NOT COMPLETED|Overall Study||65
5322593|NCT00412087|13089303|P1|NOT COMPLETED|Overall Study||62
5322594|NCT00412087|13089302|P2|COMPLETED|Overall Study||66
5322595|NCT00412087|13089303|P1|COMPLETED|Overall Study||72
5322596|NCT00412087|13089302|P2|STARTED|Overall Study||131
5322597|NCT00412087|13089303|P1|STARTED|Overall Study||134
5322598|NCT00412074|13089314|P3|NOT COMPLETED|Overall Study||67
5322599|NCT00412074|13089315|P2|NOT COMPLETED|Overall Study||22
5322600|NCT00412074|13089316|P1|NOT COMPLETED|Overall Study||77
5322601|NCT00412074|13089314|P3|COMPLETED|Overall Study||128
5322602|NCT00412074|13089315|P2|COMPLETED|Overall Study||44
5322603|NCT00412074|13089316|P1|COMPLETED|Overall Study||122
5322604|NCT00412074|13089314|P3|STARTED|Overall Study||195
5322605|NCT00412074|13089315|P2|STARTED|Overall Study||66
5322606|NCT00412074|13089316|P1|STARTED|Overall Study||199
5322607|NCT00412061|13089332|P2|NOT COMPLETED|Open Label Phase||170
5322608|NCT00412061|13089333|P1|NOT COMPLETED|Open Label Phase||0
5322609|NCT00412061|13089332|P2|COMPLETED|Open Label Phase||0
5322610|NCT00412061|13089333|P1|COMPLETED|Open Label Phase||0
5322611|NCT00412061|13089332|P2|STARTED|Open Label Phase||170
5322612|NCT00412061|13089333|P1|STARTED|Open Label Phase||0
5322613|NCT00412061|13089332|P2|NOT COMPLETED|Double Blind Phase||213
5322614|NCT00412061|13089333|P1|NOT COMPLETED|Double Blind Phase||216
5322615|NCT00412061|13089332|P2|COMPLETED|Double Blind Phase||0
5322616|NCT00412061|13089333|P1|COMPLETED|Double Blind Phase||0
5322617|NCT00412061|13089332|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
5322618|NCT00412061|13089333|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
5322619|NCT00412061|13089332|P2|STARTED|Double Blind Phase||213
5322620|NCT00412061|13089333|P1|STARTED|Double Blind Phase||216
5322621|NCT00411788|13089351|P1|NOT COMPLETED|Overall Study||2
5322622|NCT00411788|13089351|P1|COMPLETED|Overall Study||9
5322623|NCT00411788|13089351|P1|STARTED|Overall Study||11
5322624|NCT00411762|13089360|P1|NOT COMPLETED|Overall Study||5
5322625|NCT00411762|13089360|P1|COMPLETED|Overall Study||20
5322626|NCT00411762|13089360|P1|STARTED|Overall Study||25
5322627|NCT00411749|13089367|P2|NOT COMPLETED|Overall Study||0
5322628|NCT00411749|13089368|P1|NOT COMPLETED|Overall Study||0
5322629|NCT00411749|13089367|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
5322630|NCT00411749|13089368|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
5322631|NCT00411749|13089367|P2|Vaccinated|Overall Study||25
5322632|NCT00411749|13089368|P1|Vaccinated|Overall Study||82
5322633|NCT00411749|13089367|P2|STARTED|Overall Study||25
5322634|NCT00411749|13089368|P1|STARTED|Overall Study||82
5322635|NCT00411671|13089384|P1|NOT COMPLETED|Overall Study||20
5322636|NCT00411671|13089384|P1|COMPLETED|Overall Study||85
5322637|NCT00411671|13089384|P1|STARTED|Overall Study||105
5322638|NCT00411645|13089392|P2|NOT COMPLETED|Overall Study||164
5322639|NCT00411645|13089393|P1|NOT COMPLETED|Overall Study||81
5322640|NCT00411645|13089392|P2|COMPLETED|Overall Study||290
5322641|NCT00411645|13089393|P1|COMPLETED|Overall Study||146
5322642|NCT00411645|13089392|P2|STARTED|Overall Study||454
5322643|NCT00411645|13089393|P1|STARTED|Overall Study||227
5322644|NCT00411632|13089417|P1|NOT COMPLETED|Overall Study||1
5322645|NCT00411632|13089417|P1|COMPLETED|Overall Study||36
5322646|NCT00411632|13089417|P1|STARTED|Overall Study||37
5322647|NCT00411619|13089421|P1|NOT COMPLETED|Overall Study||6
5322648|NCT00411619|13089421|P1|COMPLETED|Overall Study||22
5322649|NCT00411619|13089421|P1|STARTED|Overall Study||28
5322650|NCT00411554|13089428|P2|NOT COMPLETED|Overall Study||9
5322651|NCT00411554|13089429|P1|NOT COMPLETED|Overall Study||8
5322652|NCT00411554|13089428|P2|COMPLETED|Overall Study||147
5322653|NCT00411554|13089429|P1|COMPLETED|Overall Study||155
5322654|NCT00411554|13089428|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
5322655|NCT00411554|13089429|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
5322656|NCT00411463|13089441|P2|NOT COMPLETED|Overall Study||3
5322657|NCT00411463|13089442|P1|NOT COMPLETED|Overall Study||3
5322658|NCT00411463|13089441|P2|COMPLETED|Overall Study||8
5322659|NCT00411463|13089442|P1|COMPLETED|Overall Study||11
5322660|NCT00411463|13089441|P2|STARTED|Overall Study||11
5322661|NCT00411463|13089442|P1|STARTED|Overall Study||14
5322662|NCT00411450|13089455|P1|NOT COMPLETED|Overall Study||3
5322663|NCT00411450|13089455|P1|COMPLETED|Overall Study|Ended second-line treatment|113
5322664|NCT00411450|13089455|P1|Received Treatment|Overall Study||115
5322665|NCT00411450|13089455|P1|STARTED|Overall Study||116
5322666|NCT00411411|13089483|P2|NOT COMPLETED|Overall Study||0
5322667|NCT00411411|13089484|P1|NOT COMPLETED|Overall Study||0
5322668|NCT00411411|13089483|P2|COMPLETED|Overall Study||25
5322669|NCT00411411|13089484|P1|COMPLETED|Overall Study||24
5322670|NCT00411411|13089483|P2|STARTED|Overall Study||25
5322671|NCT00411411|13089484|P1|STARTED|Overall Study||24
5322672|NCT00411398|13089492|P1|NOT COMPLETED|Overall Study||5
5322673|NCT00411398|13089492|P1|COMPLETED|Overall Study||10
5322674|NCT00411398|13089492|P1|STARTED|Overall Study||15
5322675|NCT00411216|13089498|P2|NOT COMPLETED|Overall Study||2
5322676|NCT00411216|13089499|P1|NOT COMPLETED|Overall Study||0
5322677|NCT00411216|13089498|P2|COMPLETED|Overall Study||8
5322678|NCT00411216|13089499|P1|COMPLETED|Overall Study||13
5322679|NCT00411216|13089498|P2|STARTED|Overall Study||10
5322680|NCT00411216|13089499|P1|STARTED|Overall Study||13
5322681|NCT00411151|13089505|P1|NOT COMPLETED|Overall Study||47
5322682|NCT00411151|13089505|P1|COMPLETED|Overall Study||5
5322683|NCT00411151|13089505|P1|STARTED|Overall Study||52
5322684|NCT00411086|13089515|P1|NOT COMPLETED|Overall Study||0
5322685|NCT00411086|13089515|P1|COMPLETED|Overall Study||52
5322686|NCT00411086|13089515|P1|STARTED|Overall Study||52
5322687|NCT00410904|13089523|P2|NOT COMPLETED|Overall Study||0
5322688|NCT00410904|13089524|P1|NOT COMPLETED|Overall Study||0
5322689|NCT00410904|13089523|P2|COMPLETED|Overall Study||20
5322690|NCT00410904|13089524|P1|COMPLETED|Overall Study||40
5322691|NCT00410904|13089523|P2|STARTED|Overall Study||20
5322692|NCT00410904|13089524|P1|STARTED|Overall Study||40
5322693|NCT00410891|13089532|P1|NOT COMPLETED|Overall Study||0
5322694|NCT00410891|13089532|P1|COMPLETED|Overall Study||129
5322695|NCT00410891|13089532|P1|STARTED|Overall Study||129
5322696|NCT00410826|13089538|P2|NOT COMPLETED|Overall Study||4
5322697|NCT00410826|13089539|P1|NOT COMPLETED|Overall Study||9
5322698|NCT00410826|13089538|P2|COMPLETED|Overall Study||95
5322699|NCT00410826|13089539|P1|COMPLETED|Overall Study||96
5322700|NCT00410826|13089538|P2|STARTED|Overall Study||99
5322701|NCT00410826|13089539|P1|STARTED|Overall Study||105
5322702|NCT00410813|13089549|P2|NOT COMPLETED|Overall Study||42
5322703|NCT00410813|13089550|P1|NOT COMPLETED|Overall Study||43
5322704|NCT00410813|13089549|P2|COMPLETED|Overall Study||0
5322705|NCT00410813|13089550|P1|COMPLETED|Overall Study|Patients treated until progression.|0
5322706|NCT00410813|13089549|P2|Eligible|Overall Study||38
5322707|NCT00410813|13089550|P1|Eligible|Overall Study||41
5322708|NCT00410813|13089549|P2|STARTED|Overall Study||42
5322709|NCT00410813|13089550|P1|STARTED|Overall Study||43
5322710|NCT00410761|13089587|P2|NOT COMPLETED|Overall Study||72
5322711|NCT00410761|13089588|P1|NOT COMPLETED|Overall Study||120
5322712|NCT00410761|13089587|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
5322713|NCT00410761|13089588|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
5322714|NCT00410761|13089587|P2|STARTED|Overall Study|randomised patients|100
5322715|NCT00410761|13089588|P1|STARTED|Overall Study|randomised patients|231
5322716|NCT00410605|13089608|P1|NOT COMPLETED|Overall Study||25
5322717|NCT00410605|13089608|P1|COMPLETED|Overall Study||14
5322718|NCT00410605|13089608|P1|STARTED|Overall Study||39
5322719|NCT00410514|13089620|P3|NOT COMPLETED|Overall Study||7
5322720|NCT00410514|13089621|P2|NOT COMPLETED|Overall Study||3
5322721|NCT00410514|13089622|P1|NOT COMPLETED|Overall Study||2
5322722|NCT00410514|13089620|P3|COMPLETED|Overall Study||58
5322723|NCT00410514|13089621|P2|COMPLETED|Overall Study||67
5322724|NCT00410514|13089622|P1|COMPLETED|Overall Study||63
5322725|NCT00410514|13089620|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
5322726|NCT00410514|13089621|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
5322727|NCT00410514|13089622|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
5322728|NCT00410514|13089620|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
5322729|NCT00410514|13089621|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
5322730|NCT00410514|13089622|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
5322731|NCT00410514|13089620|P3|STARTED|Overall Study||65
5322732|NCT00410514|13089621|P2|STARTED|Overall Study||70
5322733|NCT00410514|13089622|P1|STARTED|Overall Study||65
5322734|NCT00410488|13089683|P2|NOT COMPLETED|Overall Study||0
5322735|NCT00410488|13089684|P1|NOT COMPLETED|Overall Study||0
5322736|NCT00410488|13089683|P2|COMPLETED|Overall Study||34
5322737|NCT00410488|13089684|P1|COMPLETED|Overall Study||16
5322738|NCT00410488|13089683|P2|STARTED|Overall Study||34
5322739|NCT00410488|13089684|P1|STARTED|Overall Study||16
5322740|NCT00410423|13089689|P4|NOT COMPLETED|Phase 2||0
5322741|NCT00410423|13089690|P3|NOT COMPLETED|Phase 2||0
5322742|NCT00410423|13089691|P2|NOT COMPLETED|Phase 2||0
5322743|NCT00410423|13089692|P1|NOT COMPLETED|Phase 2||0
5322744|NCT00410423|13089689|P4|COMPLETED|Phase 2||44
5322745|NCT00410423|13089690|P3|COMPLETED|Phase 2||0
5322746|NCT00410423|13089691|P2|COMPLETED|Phase 2||0
5322747|NCT00410423|13089692|P1|COMPLETED|Phase 2||0
5322748|NCT00410423|13089689|P4|STARTED|Phase 2||44
5322749|NCT00410423|13089690|P3|STARTED|Phase 2||0
5322750|NCT00410423|13089691|P2|STARTED|Phase 2||0
5322751|NCT00410423|13089692|P1|STARTED|Phase 2||0
5322752|NCT00410423|13089689|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
5322753|NCT00410423|13089690|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
5322754|NCT00410423|13089691|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
5322755|NCT00410423|13089692|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
5322756|NCT00410423|13089689|P4|COMPLETED|Phase 1 - Dose Level 3||0
5322757|NCT00410423|13089690|P3|COMPLETED|Phase 1 - Dose Level 3||3
5322758|NCT00410423|13089691|P2|COMPLETED|Phase 1 - Dose Level 3||0
5322759|NCT00410423|13089692|P1|COMPLETED|Phase 1 - Dose Level 3||0
5322760|NCT00410423|13089689|P4|STARTED|Phase 1 - Dose Level 3||0
5322761|NCT00410423|13089690|P3|STARTED|Phase 1 - Dose Level 3||3
5322762|NCT00410423|13089691|P2|STARTED|Phase 1 - Dose Level 3||0
5322763|NCT00410423|13089692|P1|STARTED|Phase 1 - Dose Level 3||0
5322764|NCT00410423|13089689|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
5322765|NCT00410423|13089690|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
5322766|NCT00410423|13089691|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
5322767|NCT00410423|13089692|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
5322768|NCT00410423|13089689|P4|COMPLETED|Phase 1 - Dose Level 2||0
5322769|NCT00410423|13089690|P3|COMPLETED|Phase 1 - Dose Level 2||0
5322770|NCT00410423|13089691|P2|COMPLETED|Phase 1 - Dose Level 2||5
5322771|NCT00410423|13089692|P1|COMPLETED|Phase 1 - Dose Level 2||0
5322772|NCT00410423|13089689|P4|STARTED|Phase 1 - Dose Level 2||0
5322773|NCT00410423|13089690|P3|STARTED|Phase 1 - Dose Level 2||0
5322774|NCT00410423|13089691|P2|STARTED|Phase 1 - Dose Level 2||5
5322775|NCT00410423|13089692|P1|STARTED|Phase 1 - Dose Level 2||0
5322776|NCT00410423|13089689|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
5322777|NCT00410423|13089690|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
5322778|NCT00410423|13089691|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
5322779|NCT00410423|13089692|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
5322780|NCT00410423|13089689|P4|COMPLETED|Phase 1 - Dose Level 1||0
5322781|NCT00410423|13089690|P3|COMPLETED|Phase 1 - Dose Level 1||0
5322782|NCT00410423|13089691|P2|COMPLETED|Phase 1 - Dose Level 1||0
5322783|NCT00410423|13089692|P1|COMPLETED|Phase 1 - Dose Level 1||3
5322784|NCT00410423|13089689|P4|STARTED|Phase 1 - Dose Level 1||0
5322785|NCT00410423|13089690|P3|STARTED|Phase 1 - Dose Level 1||0
5322786|NCT00410423|13089691|P2|STARTED|Phase 1 - Dose Level 1||0
5322787|NCT00410423|13089692|P1|STARTED|Phase 1 - Dose Level 1||3
5322788|NCT00410410|13089705|P9|NOT COMPLETED|Open-Label Period (OL)||349
5322789|NCT00410410|13089706|P8|NOT COMPLETED|Open-Label Period (OL)||0
5322790|NCT00410410|13089707|P7|NOT COMPLETED|Open-Label Period (OL)||0
5322791|NCT00410410|13089708|P6|NOT COMPLETED|Open-Label Period (OL)||0
5322792|NCT00410410|13089709|P5|NOT COMPLETED|Open-Label Period (OL)||0
5322793|NCT00410410|13089710|P4|NOT COMPLETED|Open-Label Period (OL)||0
5322794|NCT00410410|13089711|P3|NOT COMPLETED|Open-Label Period (OL)||0
5322795|NCT00410410|13089712|P2|NOT COMPLETED|Open-Label Period (OL)||0
5322796|NCT00410410|13089713|P1|NOT COMPLETED|Open-Label Period (OL)||0
5322797|NCT00410410|13089705|P9|COMPLETED|Open-Label Period (OL)||0
5322798|NCT00410410|13089706|P8|COMPLETED|Open-Label Period (OL)||0
5322799|NCT00410410|13089707|P7|COMPLETED|Open-Label Period (OL)||0
5322800|NCT00410410|13089708|P6|COMPLETED|Open-Label Period (OL)||0
5322801|NCT00410410|13089709|P5|COMPLETED|Open-Label Period (OL)||0
5322802|NCT00410410|13089710|P4|COMPLETED|Open-Label Period (OL)||0
5322803|NCT00410410|13089711|P3|COMPLETED|Open-Label Period (OL)||0
5322804|NCT00410410|13089712|P2|COMPLETED|Open-Label Period (OL)||0
5322805|NCT00410410|13089713|P1|COMPLETED|Open-Label Period (OL)||0
5322806|NCT00410410|13089705|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
5322807|NCT00410410|13089706|P8|STARTED|Open-Label Period (OL)||0
5322808|NCT00410410|13089707|P7|STARTED|Open-Label Period (OL)||0
5322809|NCT00410410|13089708|P6|STARTED|Open-Label Period (OL)||0
5322810|NCT00410410|13089709|P5|STARTED|Open-Label Period (OL)||0
5322811|NCT00410410|13089710|P4|STARTED|Open-Label Period (OL)||0
5322812|NCT00410410|13089711|P3|STARTED|Open-Label Period (OL)||0
5322813|NCT00410410|13089712|P2|STARTED|Open-Label Period (OL)||0
5322814|NCT00410410|13089713|P1|STARTED|Open-Label Period (OL)||0
5322815|NCT00410410|13089705|P9|NOT COMPLETED|Maintenance Period (MP)||0
5322816|NCT00410410|13089706|P8|NOT COMPLETED|Maintenance Period (MP)||55
5322817|NCT00410410|13089707|P7|NOT COMPLETED|Maintenance Period (MP)||50
5322818|NCT00410410|13089708|P6|NOT COMPLETED|Maintenance Period (MP)||0
5322819|NCT00410410|13089709|P5|NOT COMPLETED|Maintenance Period (MP)||0
5322820|NCT00410410|13089710|P4|NOT COMPLETED|Maintenance Period (MP)||0
5322821|NCT00410410|13089711|P3|NOT COMPLETED|Maintenance Period (MP)||0
5322822|NCT00410410|13089712|P2|NOT COMPLETED|Maintenance Period (MP)||0
5322823|NCT00410410|13089713|P1|NOT COMPLETED|Maintenance Period (MP)||0
5322824|NCT00410410|13089705|P9|COMPLETED|Maintenance Period (MP)||0
5322825|NCT00410410|13089706|P8|COMPLETED|Maintenance Period (MP)||11
5322826|NCT00410410|13089707|P7|COMPLETED|Maintenance Period (MP)||15
5322827|NCT00410410|13089708|P6|COMPLETED|Maintenance Period (MP)||0
5322828|NCT00410410|13089709|P5|COMPLETED|Maintenance Period (MP)||0
5322829|NCT00410410|13089710|P4|COMPLETED|Maintenance Period (MP)||0
5322830|NCT00410410|13089711|P3|COMPLETED|Maintenance Period (MP)||0
5322831|NCT00410410|13089712|P2|COMPLETED|Maintenance Period (MP)||0
5322832|NCT00410410|13089713|P1|COMPLETED|Maintenance Period (MP)||0
5322833|NCT00410410|13089705|P9|STARTED|Maintenance Period (MP)||0
5322834|NCT00410410|13089706|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
5322835|NCT00410410|13089707|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
5322836|NCT00410410|13089708|P6|STARTED|Maintenance Period (MP)||0
5322837|NCT00410410|13089709|P5|STARTED|Maintenance Period (MP)||0
5322838|NCT00410410|13089710|P4|STARTED|Maintenance Period (MP)||0
5322839|NCT00410410|13089711|P3|STARTED|Maintenance Period (MP)||0
5322840|NCT00410410|13089712|P2|STARTED|Maintenance Period (MP)||0
5322841|NCT00410410|13089713|P1|STARTED|Maintenance Period (MP)||0
5322842|NCT00410410|13089705|P9|NOT COMPLETED|Induction Period (IP)||0
5322843|NCT00410410|13089706|P8|NOT COMPLETED|Induction Period (IP)||0
5322844|NCT00410410|13089707|P7|NOT COMPLETED|Induction Period (IP)||0
5322845|NCT00410410|13089708|P6|NOT COMPLETED|Induction Period (IP)||29
5322846|NCT00410410|13089709|P5|NOT COMPLETED|Induction Period (IP)||32
5322847|NCT00410410|13089710|P4|NOT COMPLETED|Induction Period (IP)||20
5322848|NCT00410410|13089711|P3|NOT COMPLETED|Induction Period (IP)||17
5322849|NCT00410410|13089712|P2|NOT COMPLETED|Induction Period (IP)||35
5322850|NCT00410410|13089713|P1|NOT COMPLETED|Induction Period (IP)||35
5322851|NCT00410410|13089705|P9|COMPLETED|Induction Period (IP)||0
5322852|NCT00410410|13089706|P8|COMPLETED|Induction Period (IP)||0
5322853|NCT00410410|13089707|P7|COMPLETED|Induction Period (IP)||0
5322854|NCT00410410|13089708|P6|COMPLETED|Induction Period (IP)||21
5322855|NCT00410410|13089709|P5|COMPLETED|Induction Period (IP)||19
5322856|NCT00410410|13089710|P4|COMPLETED|Induction Period (IP)||120
5322857|NCT00410410|13089711|P3|COMPLETED|Induction Period (IP)||53
5322858|NCT00410410|13089712|P2|COMPLETED|Induction Period (IP)||104
5322859|NCT00410410|13089713|P1|COMPLETED|Induction Period (IP)||106
5322860|NCT00410410|13089705|P9|STARTED|Induction Period (IP)||0
5322861|NCT00410410|13089706|P8|STARTED|Induction Period (IP)||0
5322862|NCT00410410|13089707|P7|STARTED|Induction Period (IP)||0
5322863|NCT00410410|13089708|P6|STARTED|Induction Period (IP)||50
5322864|NCT00410410|13089709|P5|STARTED|Induction Period (IP)||51
5322865|NCT00410410|13089710|P4|STARTED|Induction Period (IP)||140
5322866|NCT00410410|13089711|P3|STARTED|Induction Period (IP)||70
5322867|NCT00410410|13089712|P2|STARTED|Induction Period (IP)||139
5322868|NCT00410410|13089713|P1|STARTED|Induction Period (IP)||141
5322869|NCT00410384|13089874|P3|NOT COMPLETED|Overall Study||82
5322870|NCT00410384|13089875|P2|NOT COMPLETED|Overall Study||72
5322871|NCT00410384|13089876|P1|NOT COMPLETED|Overall Study||89
5322872|NCT00410384|13089874|P3|COMPLETED|Overall Study||191
5322873|NCT00410384|13089875|P2|COMPLETED|Overall Study||199
5322874|NCT00410384|13089876|P1|COMPLETED|Overall Study||186
5322875|NCT00410384|13089874|P3|STARTED|Overall Study||273
5322876|NCT00410384|13089875|P2|STARTED|Overall Study||271
5322877|NCT00410384|13089876|P1|STARTED|Overall Study||275
5322878|NCT00410280|13089904|P2|NOT COMPLETED|Overall Study||0
5322879|NCT00410280|13089905|P1|NOT COMPLETED|Overall Study||0
5322880|NCT00410280|13089904|P2|COMPLETED|Overall Study||13
5322881|NCT00410280|13089905|P1|COMPLETED|Overall Study||14
5322882|NCT00410280|13089904|P2|STARTED|Overall Study||13
5322883|NCT00410280|13089905|P1|STARTED|Overall Study||14
5322884|NCT00410202|13089949|P3|NOT COMPLETED|Off-treatment Follow up||12
5322885|NCT00410202|13089950|P2|NOT COMPLETED|Off-treatment Follow up||8
5322886|NCT00410202|13089951|P1|NOT COMPLETED|Off-treatment Follow up||14
5322887|NCT00410202|13089949|P3|COMPLETED|Off-treatment Follow up||2
5322888|NCT00410202|13089950|P2|COMPLETED|Off-treatment Follow up||0
5322889|NCT00410202|13089951|P1|COMPLETED|Off-treatment Follow up||1
5322890|NCT00410202|13089949|P3|STARTED|Off-treatment Follow up||14
5322891|NCT00410202|13089950|P2|STARTED|Off-treatment Follow up||8
5322892|NCT00410202|13089951|P1|STARTED|Off-treatment Follow up||15
5322893|NCT00410202|13089949|P3|NOT COMPLETED|On-Treatment||71
5322894|NCT00410202|13089950|P2|NOT COMPLETED|On-Treatment||79
5322895|NCT00410202|13089951|P1|NOT COMPLETED|On-Treatment||75
5322896|NCT00410202|13089949|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
5322897|NCT00410202|13089950|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
5322898|NCT00410202|13089951|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
5322899|NCT00410202|13089949|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
5322900|NCT00410202|13089950|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
5322901|NCT00410202|13089951|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
5322902|NCT00410202|13089949|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
5322903|NCT00410202|13089950|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
5322904|NCT00410202|13089951|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
5322905|NCT00410202|13089949|P3|STARTED|On-Treatment||137
5322906|NCT00410202|13089950|P2|STARTED|On-Treatment||140
5322907|NCT00410202|13089951|P1|STARTED|On-Treatment||138
5322908|NCT00410189|13090031|P1|NOT COMPLETED|Overall Study||0
5322909|NCT00410189|13090031|P1|COMPLETED|Overall Study||54
5322910|NCT00410189|13090031|P1|STARTED|Overall Study||54
5322911|NCT00410163|13090038|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
5322912|NCT00410163|13090039|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
5322913|NCT00410163|13090038|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
5322914|NCT00410163|13090039|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
5322915|NCT00410163|13090038|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
5322916|NCT00410163|13090039|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
5322917|NCT00410163|13090038|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
5322918|NCT00410163|13090039|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
5322919|NCT00410163|13090038|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
5322920|NCT00410163|13090039|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
5322921|NCT00410163|13090038|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
5322922|NCT00410163|13090039|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
5322923|NCT00410150|13090083|P2|NOT COMPLETED|Overall Study||3
5322924|NCT00410150|13090084|P1|NOT COMPLETED|Overall Study||2
5322925|NCT00410150|13090083|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
5322926|NCT00410150|13090084|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
5322927|NCT00410150|13090083|P2|STARTED|Overall Study||20
5322928|NCT00410150|13090084|P1|STARTED|Overall Study||22
5322929|NCT00410124|13090092|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
5322930|NCT00410124|13090093|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
5322931|NCT00410124|13090092|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
5322932|NCT00410124|13090093|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
5322933|NCT00410124|13090092|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
5322934|NCT00410124|13090093|P1|STARTED|Extension Phase - Open Label (45 Months)||67
5322935|NCT00410124|13090092|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
5322936|NCT00410124|13090093|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
5322937|NCT00410124|13090092|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
5322938|NCT00410124|13090093|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
5322939|NCT00410124|13090092|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
5322940|NCT00410124|13090093|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
5322941|NCT00410124|13090092|P2|Ongoing|Core Phase Double Blind (15 Months)||4
5322942|NCT00410124|13090093|P1|Ongoing|Core Phase Double Blind (15 Months)||13
5322943|NCT00410124|13090092|P2|STARTED|Core Phase Double Blind (15 Months)||139
5322944|NCT00410124|13090093|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
5322945|NCT00410072|13090124|P2|NOT COMPLETED|After Week 48 to Week 96||11
5322946|NCT00410072|13090125|P1|NOT COMPLETED|After Week 48 to Week 96||6
5322947|NCT00410072|13090124|P2|COMPLETED|After Week 48 to Week 96||174
5322948|NCT00410072|13090125|P1|COMPLETED|After Week 48 to Week 96||170
5322949|NCT00410072|13090124|P2|STARTED|After Week 48 to Week 96||185
5322950|NCT00410072|13090125|P1|STARTED|After Week 48 to Week 96||176
5322951|NCT00410072|13090124|P2|NOT COMPLETED|Day 1 to Week 48||12
5322952|NCT00410072|13090125|P1|NOT COMPLETED|Day 1 to Week 48||6
5322953|NCT00410072|13090124|P2|COMPLETED|Day 1 to Week 48||185
5322954|NCT00410072|13090125|P1|COMPLETED|Day 1 to Week 48||176
5322955|NCT00410072|13090124|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
5322956|NCT00410072|13090125|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
5322957|NCT00410059|13090161|P1|NOT COMPLETED|Overall Study||0
5322958|NCT00410059|13090161|P1|COMPLETED|Overall Study||59
5322959|NCT00410059|13090161|P1|STARTED|Overall Study||59
5322960|NCT00410046|13090165|P1|NOT COMPLETED|Overall Study||5
5322961|NCT00410046|13090165|P1|COMPLETED|Overall Study||79
5322962|NCT00410046|13090165|P1|STARTED|Overall Study||84
5322963|NCT00409838|13090196|P2|NOT COMPLETED|Long-term Extension Period||0
5322964|NCT00409838|13090197|P1|NOT COMPLETED|Long-term Extension Period||18
5322965|NCT00409838|13090196|P2|COMPLETED|Long-term Extension Period||0
5322966|NCT00409838|13090197|P1|COMPLETED|Long-term Extension Period||87
5322967|NCT00409838|13090196|P2|STARTED|Long-term Extension Period||0
5322968|NCT00409838|13090197|P1|STARTED|Long-term Extension Period||105
5322969|NCT00409838|13090196|P2|NOT COMPLETED|Short-term Period||5
5322970|NCT00409838|13090197|P1|NOT COMPLETED|Short-term Period||3
5322971|NCT00409838|13090196|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
5322972|NCT00409838|13090197|P1|COMPLETED|Short-term Period||53
5322973|NCT00409838|13090196|P2|Treated (Baseline) Population|Short-term Period||57
5322974|NCT00409838|13090197|P1|Treated (Baseline) Population|Short-term Period||55
5322975|NCT00409838|13090196|P2|STARTED|Short-term Period|Randomized|57
5322976|NCT00409838|13090197|P1|STARTED|Short-term Period|Randomized|56
5322977|NCT00409825|13090258|P1|NOT COMPLETED|Overall Study||0
5322978|NCT00409825|13090258|P1|COMPLETED|Overall Study||61
5322979|NCT00409825|13090258|P1|STARTED|Overall Study||61
5322980|NCT00409786|13090262|P1|NOT COMPLETED|Overall Study||3
5322981|NCT00409786|13090262|P1|COMPLETED|Overall Study||47
5322982|NCT00409786|13090262|P1|STARTED|Overall Study||50
5322983|NCT00409773|13090271|P5|NOT COMPLETED|Overall Study||10
5322984|NCT00409773|13090272|P4|NOT COMPLETED|Overall Study||12
5322985|NCT00409773|13090273|P3|NOT COMPLETED|Overall Study||9
5322986|NCT00409773|13090274|P2|NOT COMPLETED|Overall Study||7
5322987|NCT00409773|13090275|P1|NOT COMPLETED|Overall Study||9
5322988|NCT00409773|13090271|P5|COMPLETED|Overall Study||218
5322989|NCT00409773|13090272|P4|COMPLETED|Overall Study||216
5322990|NCT00409773|13090273|P3|COMPLETED|Overall Study||220
5322991|NCT00409773|13090274|P2|COMPLETED|Overall Study||222
5322992|NCT00409773|13090275|P1|COMPLETED|Overall Study||220
5322993|NCT00409773|13090271|P5|STARTED|Overall Study||228
5322994|NCT00409773|13090272|P4|STARTED|Overall Study||228
5322995|NCT00409773|13090273|P3|STARTED|Overall Study||229
5322996|NCT00409773|13090274|P2|STARTED|Overall Study||229
5322997|NCT00409773|13090275|P1|STARTED|Overall Study||229
5322998|NCT00409747|13090357|P1|NOT COMPLETED|Overall Study||1
5322999|NCT00409747|13090357|P1|COMPLETED|Overall Study||10
5323000|NCT00409747|13090357|P1|STARTED|Overall Study||11
5323001|NCT00409708|13090364|P2|NOT COMPLETED|Washout||10
5323002|NCT00409708|13090365|P1|NOT COMPLETED|Washout||21
5323003|NCT00409708|13090364|P2|COMPLETED|Washout||29
5323004|NCT00409708|13090365|P1|COMPLETED|Washout||17
5323005|NCT00409708|13090364|P2|STARTED|Washout||39
5323006|NCT00409708|13090365|P1|STARTED|Washout||38
5323007|NCT00409708|13090364|P2|NOT COMPLETED|Treatment||17
5323008|NCT00409708|13090365|P1|NOT COMPLETED|Treatment||15
5323009|NCT00409708|13090364|P2|COMPLETED|Treatment||39
5323010|NCT00409708|13090365|P1|COMPLETED|Treatment||38
5323011|NCT00409708|13090364|P2|STARTED|Treatment||56
5323012|NCT00409708|13090365|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
5323013|NCT00409682|13090386|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
5323014|NCT00409682|13090387|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
5323015|NCT00409682|13090388|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
5323016|NCT00409682|13090386|P3|COMPLETED|EOW Double-blind Maintenance Period||66
5323017|NCT00409682|13090387|P2|COMPLETED|EOW Double-blind Maintenance Period||58
5323018|NCT00409682|13090388|P1|COMPLETED|EOW Double-blind Maintenance Period||0
5323019|NCT00409682|13090386|P3|STARTED|EOW Double-blind Maintenance Period||93
5323020|NCT00409682|13090387|P2|STARTED|EOW Double-blind Maintenance Period||95
5323021|NCT00409682|13090388|P1|STARTED|EOW Double-blind Maintenance Period||0
5323022|NCT00409682|13090386|P3|NOT COMPLETED|Open-label Induction Period||0
5323023|NCT00409682|13090387|P2|NOT COMPLETED|Open-label Induction Period||0
5323024|NCT00409682|13090388|P1|NOT COMPLETED|Open-label Induction Period||4
5323025|NCT00409682|13090386|P3|COMPLETED|Open-label Induction Period||0
5323026|NCT00409682|13090387|P2|COMPLETED|Open-label Induction Period||0
5323027|NCT00409682|13090388|P1|COMPLETED|Open-label Induction Period||188
5323028|NCT00409682|13090386|P3|STARTED|Open-label Induction Period||0
5323029|NCT00409682|13090387|P2|STARTED|Open-label Induction Period||0
5323030|NCT00409682|13090388|P1|STARTED|Open-label Induction Period||192
5323031|NCT00409617|13090405|P1|NOT COMPLETED|Overall Study||160
5323032|NCT00409617|13090405|P1|COMPLETED|Overall Study||785
5323033|NCT00409617|13090405|P1|STARTED|Overall Study||945
5323034|NCT00409578|13090421|P4|NOT COMPLETED|Overall Study||67
5323035|NCT00409578|13090422|P3|NOT COMPLETED|Overall Study||54
5323036|NCT00409578|13090423|P2|NOT COMPLETED|Overall Study||70
5323037|NCT00409578|13090424|P1|NOT COMPLETED|Overall Study||52
5323038|NCT00409578|13090421|P4|COMPLETED|Overall Study||214
5323039|NCT00409578|13090422|P3|COMPLETED|Overall Study||215
5323040|NCT00409578|13090423|P2|COMPLETED|Overall Study||201
5323041|NCT00409578|13090424|P1|COMPLETED|Overall Study||228
5323042|NCT00409578|13090421|P4|STARTED|Overall Study||281
5323043|NCT00409578|13090422|P3|STARTED|Overall Study||269
5323044|NCT00409578|13090423|P2|STARTED|Overall Study||271
5323045|NCT00409578|13090424|P1|STARTED|Overall Study||280
5323046|NCT00409565|13090446|P1|NOT COMPLETED|Overall Study||1
5323047|NCT00409565|13090446|P1|COMPLETED|Overall Study||45
5323048|NCT00409565|13090446|P1|Overall Response Rate|Overall Study||7
5323049|NCT00409565|13090446|P1|STARTED|Overall Study||46
5323050|NCT00409539|13090459|P5|NOT COMPLETED|Overall Study||25
5323051|NCT00409539|13090460|P4|NOT COMPLETED|Overall Study||12
5323052|NCT00409539|13090461|P3|NOT COMPLETED|Overall Study||14
5323053|NCT00409539|13090462|P2|NOT COMPLETED|Overall Study||11
5323054|NCT00409539|13090463|P1|NOT COMPLETED|Overall Study||11
5323055|NCT00409539|13090459|P5|COMPLETED|Overall Study||85
5323056|NCT00409539|13090460|P4|COMPLETED|Overall Study||97
5323057|NCT00409539|13090461|P3|COMPLETED|Overall Study||95
5323058|NCT00409539|13090462|P2|COMPLETED|Overall Study||100
5323059|NCT00409539|13090463|P1|COMPLETED|Overall Study||100
5323060|NCT00409539|13090459|P5|STARTED|Overall Study||110
5323061|NCT00409539|13090460|P4|STARTED|Overall Study||109
5323062|NCT00409539|13090461|P3|STARTED|Overall Study||109
5323063|NCT00409539|13090462|P2|STARTED|Overall Study||111
5323064|NCT00409539|13090463|P1|STARTED|Overall Study||111
5323065|NCT00409409|13090482|P2|NOT COMPLETED|Overall Study||4
5323066|NCT00409409|13090483|P1|NOT COMPLETED|Overall Study||8
5323067|NCT00409409|13090482|P2|COMPLETED|Overall Study||135
5323068|NCT00409409|13090483|P1|COMPLETED|Overall Study||131
5323069|NCT00409409|13090482|P2|STARTED|Overall Study||139
5323070|NCT00409409|13090483|P1|STARTED|Overall Study||139
5323071|NCT00409344|13090491|P2|NOT COMPLETED|Overall Study||0
5323072|NCT00409344|13090492|P1|NOT COMPLETED|Overall Study||0
5323073|NCT00409344|13090491|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
5323074|NCT00409344|13090492|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
5323075|NCT00409344|13090491|P2|STARTED|Overall Study|No participants enrolled|0
5323076|NCT00409344|13090492|P1|STARTED|Overall Study|No participants enrolled|0
5323077|NCT00409331|13090510|P1|NOT COMPLETED|Overall Study||1
5323078|NCT00409331|13090510|P1|COMPLETED|Overall Study||0
5323079|NCT00409331|13090510|P1|STARTED|Overall Study||1
5323080|NCT00409292|13090514|P1|NOT COMPLETED|Overall Study||0
5323081|NCT00409292|13090514|P1|COMPLETED|Overall Study||33
5323082|NCT00409292|13090514|P1|STARTED|Overall Study||33
5323083|NCT00409240|13090523|P2|NOT COMPLETED|Overall Study||1
5323084|NCT00409240|13090524|P1|NOT COMPLETED|Overall Study||3
5323085|NCT00409240|13090523|P2|COMPLETED|Overall Study||49
5323086|NCT00409240|13090524|P1|COMPLETED|Overall Study||50
5323087|NCT00409240|13090523|P2|STARTED|Overall Study||50
5323088|NCT00409240|13090524|P1|STARTED|Overall Study||53
5323089|NCT00409188|13090532|P2|NOT COMPLETED|Overall Study||175
5323090|NCT00409188|13090533|P1|NOT COMPLETED|Overall Study||383
5323091|NCT00409188|13090532|P2|COMPLETED|Overall Study||332
5323092|NCT00409188|13090533|P1|COMPLETED|Overall Study||623
5323093|NCT00409188|13090532|P2|STARTED|Overall Study||507
5323094|NCT00409188|13090533|P1|STARTED|Overall Study||1006
5323095|NCT00409175|13090549|P2|NOT COMPLETED|Overall Study||19
5323096|NCT00409175|13090550|P1|NOT COMPLETED|Overall Study||18
5323097|NCT00409175|13090549|P2|COMPLETED|Overall Study||44
5323098|NCT00409175|13090550|P1|COMPLETED|Overall Study||47
5323099|NCT00409175|13090549|P2|STARTED|Overall Study||63
5323100|NCT00409175|13090550|P1|STARTED|Overall Study||65
5323101|NCT00409006|13090576|P2|NOT COMPLETED|Overall Study||12
5323102|NCT00409006|13090577|P1|NOT COMPLETED|Overall Study||20
5323103|NCT00409006|13090576|P2|COMPLETED|Overall Study||19
5323104|NCT00409006|13090577|P1|COMPLETED|Overall Study||19
5323105|NCT00409006|13090576|P2|STARTED|Overall Study||31
5323106|NCT00409006|13090577|P1|STARTED|Overall Study||39
5323107|NCT00408993|13090593|P2|NOT COMPLETED|Overall Study||17
5323108|NCT00408993|13090594|P1|NOT COMPLETED|Overall Study||19
5323109|NCT00408993|13090593|P2|COMPLETED|Overall Study||92
5323110|NCT00408993|13090594|P1|COMPLETED|Overall Study||87
5323111|NCT00408993|13090593|P2|STARTED|Overall Study||109
5323112|NCT00408993|13090594|P1|STARTED|Overall Study||106
5323113|NCT00408928|13090626|P1|NOT COMPLETED|Overall Study||3
5323114|NCT00408928|13090626|P1|COMPLETED|Overall Study||8
5323115|NCT00408928|13090626|P1|STARTED|Overall Study||11
5323116|NCT00408902|13090631|P1|NOT COMPLETED|Overall Study||10
5323117|NCT00408902|13090631|P1|COMPLETED|Overall Study||0
5323118|NCT00408902|13090631|P1|STARTED|Overall Study||10
5323119|NCT00408876|13090641|P4|NOT COMPLETED|Overall Study||35
5323120|NCT00408876|13090642|P3|NOT COMPLETED|Overall Study||50
5323121|NCT00408876|13090643|P2|NOT COMPLETED|Overall Study||36
5323122|NCT00408876|13090644|P1|NOT COMPLETED|Overall Study||16
5323123|NCT00408876|13090641|P4|COMPLETED|Overall Study||82
5323124|NCT00408876|13090642|P3|COMPLETED|Overall Study||62
5323125|NCT00408876|13090643|P2|COMPLETED|Overall Study||80
5323126|NCT00408876|13090644|P1|COMPLETED|Overall Study||43
5323127|NCT00408876|13090641|P4|STARTED|Overall Study||117
5323128|NCT00408876|13090642|P3|STARTED|Overall Study||112
5323129|NCT00408876|13090643|P2|STARTED|Overall Study||116
5323130|NCT00408876|13090644|P1|STARTED|Overall Study||59
5323131|NCT00408694|13090894|P1|NOT COMPLETED|Overall Study||2
5323132|NCT00408694|13090894|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
5323133|NCT00408694|13090894|P1|STARTED|Overall Study||46
5323134|NCT00408681|13090906|P1|NOT COMPLETED|Overall Study||9
5323222|NCT00408421|13091044|P2|STARTED|Treatment Re-Randomization||46
5323135|NCT00408681|13090906|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
5323136|NCT00408681|13090906|P1|STARTED|Overall Study||20
5323137|NCT00408629|13090925|P2|NOT COMPLETED|Overall Study||125
5323138|NCT00408629|13090926|P1|NOT COMPLETED|Overall Study||97
5323139|NCT00408629|13090925|P2|COMPLETED|Overall Study||135
5323140|NCT00408629|13090926|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
5323141|NCT00408629|13090925|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
5323142|NCT00408629|13090926|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
5323143|NCT00408603|13090968|P3|NOT COMPLETED|Overall Study||40
5323144|NCT00408603|13090969|P2|NOT COMPLETED|Overall Study||2
5323145|NCT00408603|13090970|P1|NOT COMPLETED|Overall Study||4
5323146|NCT00408603|13090968|P3|COMPLETED|Overall Study||35
5323147|NCT00408603|13090969|P2|COMPLETED|Overall Study||37
5323148|NCT00408603|13090970|P1|COMPLETED|Overall Study||65
5323149|NCT00408603|13090968|P3|STARTED|Overall Study||75
5323150|NCT00408603|13090969|P2|STARTED|Overall Study||39
5323151|NCT00408603|13090970|P1|STARTED|Overall Study||69
5323152|NCT00408590|13090986|P9|NOT COMPLETED|Overall Study||0
5323153|NCT00408590|13090987|P8|NOT COMPLETED|Overall Study||0
5323154|NCT00408590|13090988|P7|NOT COMPLETED|Overall Study||0
5323155|NCT00408590|13090989|P6|NOT COMPLETED|Overall Study||0
5323156|NCT00408590|13090990|P5|NOT COMPLETED|Overall Study||0
5323157|NCT00408590|13090991|P4|NOT COMPLETED|Overall Study||0
5323158|NCT00408590|13090992|P3|NOT COMPLETED|Overall Study||0
5323159|NCT00408590|13090993|P2|NOT COMPLETED|Overall Study||0
5323160|NCT00408590|13090994|P1|NOT COMPLETED|Overall Study||0
5323161|NCT00408590|13090986|P9|COMPLETED|Overall Study||13
5323162|NCT00408590|13090987|P8|COMPLETED|Overall Study||3
5323163|NCT00408590|13090988|P7|COMPLETED|Overall Study||3
5323164|NCT00408590|13090989|P6|COMPLETED|Overall Study||3
5323165|NCT00408590|13090990|P5|COMPLETED|Overall Study||3
5323166|NCT00408590|13090991|P4|COMPLETED|Overall Study||3
5323167|NCT00408590|13090992|P3|COMPLETED|Overall Study||3
5323168|NCT00408590|13090993|P2|COMPLETED|Overall Study||3
5323169|NCT00408590|13090994|P1|COMPLETED|Overall Study||3
5323170|NCT00408590|13090986|P9|STARTED|Overall Study||13
5323171|NCT00408590|13090987|P8|STARTED|Overall Study||3
5323172|NCT00408590|13090988|P7|STARTED|Overall Study||3
5323173|NCT00408590|13090989|P6|STARTED|Overall Study||3
5323174|NCT00408590|13090990|P5|STARTED|Overall Study||3
5323175|NCT00408590|13090991|P4|STARTED|Overall Study||3
5323176|NCT00408590|13090992|P3|STARTED|Overall Study||3
5323177|NCT00408590|13090993|P2|STARTED|Overall Study||3
5323178|NCT00408590|13090994|P1|STARTED|Overall Study||3
5323179|NCT00408564|13091013|P1|NOT COMPLETED|Overall Study||0
5323180|NCT00408564|13091013|P1|COMPLETED|Overall Study||39
5323181|NCT00408564|13091013|P1|STARTED|Overall Study||39
5323182|NCT00408499|13091022|P5|NOT COMPLETED|Phase II- MTD Expansion||20
5323183|NCT00408499|13091023|P4|NOT COMPLETED|Phase II- MTD Expansion||0
5323184|NCT00408499|13091024|P3|NOT COMPLETED|Phase II- MTD Expansion||0
5323185|NCT00408499|13091025|P2|NOT COMPLETED|Phase II- MTD Expansion||0
5323186|NCT00408499|13091026|P1|NOT COMPLETED|Phase II- MTD Expansion||0
5323187|NCT00408499|13091022|P5|COMPLETED|Phase II- MTD Expansion||24
5323188|NCT00408499|13091023|P4|COMPLETED|Phase II- MTD Expansion||0
5323189|NCT00408499|13091024|P3|COMPLETED|Phase II- MTD Expansion||0
5323190|NCT00408499|13091025|P2|COMPLETED|Phase II- MTD Expansion||0
5323191|NCT00408499|13091026|P1|COMPLETED|Phase II- MTD Expansion||0
5323192|NCT00408499|13091022|P5|STARTED|Phase II- MTD Expansion||44
5323193|NCT00408499|13091023|P4|STARTED|Phase II- MTD Expansion||0
5323194|NCT00408499|13091024|P3|STARTED|Phase II- MTD Expansion||0
5323195|NCT00408499|13091025|P2|STARTED|Phase II- MTD Expansion||0
5323196|NCT00408499|13091026|P1|STARTED|Phase II- MTD Expansion||0
5323197|NCT00408499|13091022|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
5323198|NCT00408499|13091023|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
5323199|NCT00408499|13091024|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
5323200|NCT00408499|13091025|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
5323201|NCT00408499|13091026|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
5323202|NCT00408499|13091022|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
5323203|NCT00408499|13091023|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
5323204|NCT00408499|13091024|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
5323205|NCT00408499|13091025|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
5323206|NCT00408499|13091026|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
5323207|NCT00408499|13091022|P5|STARTED|Phase 1: Dose Levels 1-4||0
5323208|NCT00408499|13091023|P4|STARTED|Phase 1: Dose Levels 1-4||6
5323209|NCT00408499|13091024|P3|STARTED|Phase 1: Dose Levels 1-4||3
5323210|NCT00408499|13091025|P2|STARTED|Phase 1: Dose Levels 1-4||7
5323211|NCT00408499|13091026|P1|STARTED|Phase 1: Dose Levels 1-4||4
5323212|NCT00408460|13091035|P1|NOT COMPLETED|Overall Study||0
5323213|NCT00408460|13091035|P1|COMPLETED|Overall Study||34
5323214|NCT00408460|13091035|P1|STARTED|Overall Study||34
5323215|NCT00408421|13091043|P3|NOT COMPLETED|Treatment Re-Randomization||5
5323216|NCT00408421|13091044|P2|NOT COMPLETED|Treatment Re-Randomization||7
5323217|NCT00408421|13091045|P1|NOT COMPLETED|Treatment Re-Randomization||7
5323218|NCT00408421|13091043|P3|COMPLETED|Treatment Re-Randomization||38
5323219|NCT00408421|13091044|P2|COMPLETED|Treatment Re-Randomization||39
5323220|NCT00408421|13091045|P1|COMPLETED|Treatment Re-Randomization||96
5323221|NCT00408421|13091043|P3|STARTED|Treatment Re-Randomization||43
5323223|NCT00408421|13091045|P1|STARTED|Treatment Re-Randomization||103
5323224|NCT00408421|13091043|P3|NOT COMPLETED|Treatment Initial Randomization||0
5323225|NCT00408421|13091044|P2|NOT COMPLETED|Treatment Initial Randomization||22
5323226|NCT00408421|13091045|P1|NOT COMPLETED|Treatment Initial Randomization||17
5323227|NCT00408421|13091043|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
5323228|NCT00408421|13091044|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
5323229|NCT00408421|13091045|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
5323230|NCT00408421|13091043|P3|STARTED|Treatment Initial Randomization||0
5323231|NCT00408421|13091044|P2|STARTED|Treatment Initial Randomization||111
5323232|NCT00408421|13091045|P1|STARTED|Treatment Initial Randomization||120
5323233|NCT00408408|13091125|P6|NOT COMPLETED|Overall Study||3
5323234|NCT00408408|13091126|P5|NOT COMPLETED|Overall Study||5
5323235|NCT00408408|13091127|P4|NOT COMPLETED|Overall Study||7
5323236|NCT00408408|13091128|P3|NOT COMPLETED|Overall Study||0
5323237|NCT00408408|13091129|P2|NOT COMPLETED|Overall Study||3
5323238|NCT00408408|13091130|P1|NOT COMPLETED|Overall Study||2
5323239|NCT00408408|13091125|P6|COMPLETED|Overall Study||201
5323240|NCT00408408|13091126|P5|COMPLETED|Overall Study||192
5323241|NCT00408408|13091127|P4|COMPLETED|Overall Study||194
5323242|NCT00408408|13091128|P3|COMPLETED|Overall Study||204
5323243|NCT00408408|13091129|P2|COMPLETED|Overall Study||196
5323244|NCT00408408|13091130|P1|COMPLETED|Overall Study||199
5323245|NCT00408408|13091125|P6|STARTED|Overall Study||204
5323246|NCT00408408|13091126|P5|STARTED|Overall Study||197
5323247|NCT00408408|13091127|P4|STARTED|Overall Study||201
5323248|NCT00408408|13091128|P3|STARTED|Overall Study||204
5323249|NCT00408408|13091129|P2|STARTED|Overall Study||199
5323250|NCT00408408|13091130|P1|STARTED|Overall Study||201
5323251|NCT00408317|13091192|P2|NOT COMPLETED|Second Intervention Period||2
5323252|NCT00408317|13091193|P1|NOT COMPLETED|Second Intervention Period||2
5323253|NCT00408317|13091192|P2|COMPLETED|Second Intervention Period||14
5323254|NCT00408317|13091193|P1|COMPLETED|Second Intervention Period||12
5323255|NCT00408317|13091192|P2|STARTED|Second Intervention Period||16
5323256|NCT00408317|13091193|P1|STARTED|Second Intervention Period||14
5323257|NCT00408317|13091192|P2|NOT COMPLETED|First Intervention Period||1
5323258|NCT00408317|13091193|P1|NOT COMPLETED|First Intervention Period||0
5323259|NCT00408317|13091192|P2|COMPLETED|First Intervention Period||16
5323260|NCT00408317|13091193|P1|COMPLETED|First Intervention Period||14
5323261|NCT00408317|13091192|P2|STARTED|First Intervention Period||17
5323262|NCT00408317|13091193|P1|STARTED|First Intervention Period||14
5323263|NCT00408200|13091207|P2|NOT COMPLETED|Overall Study||0
5323264|NCT00408200|13091208|P1|NOT COMPLETED|Overall Study||0
5323265|NCT00408200|13091207|P2|COMPLETED|Overall Study||53
5323266|NCT00408200|13091208|P1|COMPLETED|Overall Study||57
5323267|NCT00408200|13091207|P2|STARTED|Overall Study||53
5323268|NCT00408200|13091208|P1|STARTED|Overall Study||57
5323269|NCT00408070|13091216|P1|NOT COMPLETED|Overall Study||0
5323270|NCT00408070|13091216|P1|COMPLETED|Overall Study||5
5323271|NCT00408070|13091216|P1|STARTED|Overall Study||5
5323272|NCT00408005|13091226|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
5323273|NCT00408005|13091227|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
5323274|NCT00408005|13091228|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
5323275|NCT00408005|13091229|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
5323276|NCT00408005|13091230|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
5323277|NCT00408005|13091231|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
5323278|NCT00408005|13091232|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
5323279|NCT00408005|13091233|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
5323280|NCT00408005|13091226|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
5323281|NCT00408005|13091227|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
5323282|NCT00408005|13091228|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
5323283|NCT00408005|13091229|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
5323284|NCT00408005|13091230|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
5323285|NCT00408005|13091231|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
5323286|NCT00408005|13091232|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
5323287|NCT00408005|13091233|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
5323288|NCT00408005|13091226|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
5323289|NCT00408005|13091227|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323290|NCT00408005|13091228|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323291|NCT00408005|13091229|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323292|NCT00408005|13091230|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323293|NCT00408005|13091231|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323294|NCT00408005|13091232|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323295|NCT00408005|13091233|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
5323296|NCT00408005|13091226|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
5323297|NCT00408005|13091227|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
5323298|NCT00408005|13091228|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323299|NCT00408005|13091229|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323300|NCT00408005|13091230|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323301|NCT00408005|13091231|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323302|NCT00408005|13091232|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323303|NCT00408005|13091233|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
5323304|NCT00408005|13091226|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323305|NCT00408005|13091227|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
5323306|NCT00408005|13091228|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323307|NCT00408005|13091229|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323308|NCT00408005|13091230|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323309|NCT00408005|13091231|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323310|NCT00408005|13091232|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323311|NCT00408005|13091233|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
5323312|NCT00408005|13091226|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323313|NCT00408005|13091227|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323314|NCT00408005|13091228|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
5323315|NCT00408005|13091229|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323316|NCT00408005|13091230|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323317|NCT00408005|13091231|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323318|NCT00408005|13091232|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323319|NCT00408005|13091233|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
5323320|NCT00408005|13091226|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323321|NCT00408005|13091227|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323322|NCT00408005|13091228|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
5323323|NCT00408005|13091229|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
5323324|NCT00408005|13091230|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323325|NCT00408005|13091231|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323326|NCT00408005|13091232|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323327|NCT00408005|13091233|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
5323328|NCT00408005|13091226|P8|High Risk|Post Induction Therapy by Tx Assignment||0
5323329|NCT00408005|13091227|P7|High Risk|Post Induction Therapy by Tx Assignment||0
5323330|NCT00408005|13091228|P6|High Risk|Post Induction Therapy by Tx Assignment||52
5323331|NCT00408005|13091229|P5|High Risk|Post Induction Therapy by Tx Assignment||55
5323332|NCT00408005|13091230|P4|High Risk|Post Induction Therapy by Tx Assignment||52
5323333|NCT00408005|13091231|P3|High Risk|Post Induction Therapy by Tx Assignment||56
5323334|NCT00408005|13091232|P2|High Risk|Post Induction Therapy by Tx Assignment||0
5323335|NCT00408005|13091233|P1|High Risk|Post Induction Therapy by Tx Assignment||0
5323336|NCT00408005|13091226|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
5323337|NCT00408005|13091227|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
5323338|NCT00408005|13091228|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
5323339|NCT00408005|13091229|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
5323340|NCT00408005|13091230|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
5323341|NCT00408005|13091231|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
5323342|NCT00408005|13091232|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
5323343|NCT00408005|13091233|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
5323344|NCT00408005|13091226|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
5323345|NCT00408005|13091227|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
5323346|NCT00408005|13091228|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
5323347|NCT00408005|13091229|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
5323348|NCT00408005|13091230|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
5323349|NCT00408005|13091231|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
5323350|NCT00408005|13091232|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
5323351|NCT00408005|13091233|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
5323352|NCT00408005|13091226|P8|STARTED|Post Induction Therapy by Tx Assignment||62
5323353|NCT00408005|13091227|P7|STARTED|Post Induction Therapy by Tx Assignment||143
5323354|NCT00408005|13091228|P6|STARTED|Post Induction Therapy by Tx Assignment||219
5323355|NCT00408005|13091229|P5|STARTED|Post Induction Therapy by Tx Assignment||451
5323356|NCT00408005|13091230|P4|STARTED|Post Induction Therapy by Tx Assignment||147
5323357|NCT00408005|13091231|P3|STARTED|Post Induction Therapy by Tx Assignment||372
5323358|NCT00408005|13091232|P2|STARTED|Post Induction Therapy by Tx Assignment||0
5323359|NCT00408005|13091233|P1|STARTED|Post Induction Therapy by Tx Assignment||0
5323360|NCT00408005|13091226|P8|NOT COMPLETED|Induction||0
5323361|NCT00408005|13091227|P7|NOT COMPLETED|Induction||0
5323362|NCT00408005|13091228|P6|NOT COMPLETED|Induction||0
5323363|NCT00408005|13091229|P5|NOT COMPLETED|Induction||0
5323364|NCT00408005|13091230|P4|NOT COMPLETED|Induction||0
5323365|NCT00408005|13091231|P3|NOT COMPLETED|Induction||0
5323366|NCT00408005|13091232|P2|NOT COMPLETED|Induction||94
5323367|NCT00408005|13091233|P1|NOT COMPLETED|Induction||407
5323368|NCT00408005|13091226|P8|COMPLETED|Induction||0
5323369|NCT00408005|13091227|P7|COMPLETED|Induction||0
5323370|NCT00408005|13091228|P6|COMPLETED|Induction||0
5323371|NCT00408005|13091229|P5|COMPLETED|Induction||0
5323372|NCT00408005|13091230|P4|COMPLETED|Induction||0
5323373|NCT00408005|13091231|P3|COMPLETED|Induction||0
5323374|NCT00408005|13091232|P2|COMPLETED|Induction||205
5323375|NCT00408005|13091233|P1|COMPLETED|Induction||1189
5323376|NCT00408005|13091226|P8|STARTED|Induction||0
5323377|NCT00408005|13091227|P7|STARTED|Induction||0
5323378|NCT00408005|13091228|P6|STARTED|Induction||0
5323379|NCT00408005|13091229|P5|STARTED|Induction||0
5323380|NCT00408005|13091230|P4|STARTED|Induction||0
5323381|NCT00408005|13091231|P3|STARTED|Induction||0
5323382|NCT00408005|13091232|P2|STARTED|Induction||299
5323383|NCT00408005|13091233|P1|STARTED|Induction||1596
5323384|NCT00407966|13091263|P1|NOT COMPLETED|Overall Study||0
5323385|NCT00407966|13091263|P1|COMPLETED|Overall Study||45
5323386|NCT00407966|13091263|P1|CR|Overall Study||30
5323387|NCT00407966|13091263|P1|STARTED|Overall Study||45
5323388|NCT00407888|13091267|P1|NOT COMPLETED|Overall Study||0
5323389|NCT00407888|13091267|P1|COMPLETED|Overall Study||60
5323390|NCT00407888|13091267|P1|STARTED|Overall Study||60
5323391|NCT00407797|13091275|P1|NOT COMPLETED|Overall Study||18
5323392|NCT00407797|13091275|P1|COMPLETED|Overall Study||118
5323393|NCT00407797|13091275|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
5323394|NCT00407797|13091275|P1|STARTED|Overall Study||136
5323395|NCT00407758|13091290|P1|NOT COMPLETED|Overall Study||1
5323396|NCT00407758|13091290|P1|COMPLETED|Overall Study||27
5323397|NCT00407758|13091290|P1|STARTED|Overall Study||28
5323398|NCT00407745|13091303|P2|NOT COMPLETED|Overall Study||17
5323399|NCT00407745|13091304|P1|NOT COMPLETED|Overall Study||19
5323400|NCT00407745|13091303|P2|COMPLETED|Overall Study||91
5323401|NCT00407745|13091304|P1|COMPLETED|Overall Study||93
5323402|NCT00407745|13091303|P2|Treated|Overall Study||107
5323403|NCT00407745|13091304|P1|Treated|Overall Study||112
5323404|NCT00407745|13091303|P2|STARTED|Overall Study||108
5323405|NCT00407745|13091304|P1|STARTED|Overall Study||112
5323406|NCT00407654|13091376|P1|NOT COMPLETED|Overall Study||0
5323407|NCT00407654|13091376|P1|COMPLETED|Overall Study||75
5323408|NCT00407654|13091376|P1|STARTED|Overall Study||75
5323409|NCT00407563|13091390|P1|NOT COMPLETED|Overall Study||1
5323410|NCT00407563|13091390|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
5323411|NCT00407563|13091390|P1|STARTED|Overall Study||48
5323412|NCT00407550|13091400|P2|NOT COMPLETED|Overall Study||4
5323413|NCT00407550|13091401|P1|NOT COMPLETED|Overall Study||3
5323414|NCT00407550|13091400|P2|COMPLETED|Overall Study||5
5323415|NCT00407550|13091401|P1|COMPLETED|Overall Study||7
5323416|NCT00407550|13091400|P2|STARTED|Overall Study||9
5323417|NCT00407550|13091401|P1|STARTED|Overall Study||10
5323418|NCT00407537|13091415|P2|NOT COMPLETED|Overall Study||44
5323419|NCT00407537|13091416|P1|NOT COMPLETED|Overall Study||93
5323420|NCT00407537|13091415|P2|COMPLETED|Overall Study||638
5323421|NCT00407537|13091416|P1|COMPLETED|Overall Study||686
5323422|NCT00407537|13091415|P2|Eligible for Efficacy Analysis|Overall Study||657
5323423|NCT00407537|13091416|P1|Eligible for Efficacy Analysis|Overall Study||760
5323424|NCT00407537|13091415|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
5323425|NCT00407537|13091416|P1|STARTED|Overall Study||779
5323426|NCT00407511|13091464|P1|NOT COMPLETED|Overall Study||22
5323427|NCT00407511|13091464|P1|COMPLETED|Overall Study||99
5323428|NCT00407511|13091464|P1|STARTED|Overall Study||121
5323429|NCT00407485|13091478|P1|NOT COMPLETED|Overall Study||0
5323430|NCT00407485|13091478|P1|COMPLETED|Overall Study||22
5323431|NCT00407485|13091478|P1|STARTED|Overall Study||22
5323432|NCT00407420|13091485|P2|NOT COMPLETED|Overall Study||6
5323433|NCT00407420|13091486|P1|NOT COMPLETED|Overall Study||9
5323434|NCT00407420|13091485|P2|COMPLETED|Overall Study||46
5323435|NCT00407420|13091486|P1|COMPLETED|Overall Study||45
5323436|NCT00407420|13091485|P2|STARTED|Overall Study||52
5323437|NCT00407420|13091486|P1|STARTED|Overall Study||54
5323438|NCT00407381|13091501|P3|NOT COMPLETED|Overall Study||2
5323439|NCT00407381|13091502|P2|NOT COMPLETED|Overall Study||4
5323440|NCT00407381|13091503|P1|NOT COMPLETED|Overall Study||3
5323441|NCT00407381|13091501|P3|COMPLETED|Overall Study||40
5323442|NCT00407381|13091502|P2|COMPLETED|Overall Study||38
5323443|NCT00407381|13091503|P1|COMPLETED|Overall Study||39
5323444|NCT00407381|13091501|P3|STARTED|Overall Study||42
5323445|NCT00407381|13091502|P2|STARTED|Overall Study||42
5323446|NCT00407381|13091503|P1|STARTED|Overall Study||42
5323447|NCT00407355|13091513|P2|NOT COMPLETED|Overall Study||11
5323448|NCT00407355|13091514|P1|NOT COMPLETED|Overall Study||10
5323449|NCT00407355|13091513|P2|COMPLETED|Overall Study||9
5323450|NCT00407355|13091514|P1|COMPLETED|Overall Study||10
5323451|NCT00407355|13091513|P2|STARTED|Overall Study||20
5323452|NCT00407355|13091514|P1|STARTED|Overall Study||20
5323453|NCT00407030|13091525|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
5323454|NCT00407030|13091526|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
5323455|NCT00407030|13091527|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
5323456|NCT00407030|13091525|P3|COMPLETED|Extension Period - up to 68 Weeks||0
5323457|NCT00407030|13091526|P2|COMPLETED|Extension Period - up to 68 Weeks||74
5323458|NCT00407030|13091527|P1|COMPLETED|Extension Period - up to 68 Weeks||84
5323459|NCT00407030|13091525|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
5323460|NCT00407030|13091526|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
5323461|NCT00407030|13091527|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
5323462|NCT00407030|13091525|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
5323463|NCT00407030|13091526|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
5323464|NCT00407030|13091527|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
5323465|NCT00407030|13091525|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
5323466|NCT00407030|13091526|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
5323467|NCT00407030|13091527|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
5323468|NCT00407030|13091525|P3|STARTED|Main Period - 8 to 20 Weeks||74
5323469|NCT00407030|13091526|P2|STARTED|Main Period - 8 to 20 Weeks||78
5323470|NCT00407030|13091527|P1|STARTED|Main Period - 8 to 20 Weeks||81
5323471|NCT00406848|13091555|P2|NOT COMPLETED|Overall Study||54
5323472|NCT00406848|13091556|P1|NOT COMPLETED|Overall Study||93
5323473|NCT00406848|13091555|P2|COMPLETED|Overall Study||67
5323474|NCT00406848|13091556|P1|COMPLETED|Overall Study||156
5323475|NCT00406848|13091555|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
5323476|NCT00406848|13091556|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
5323477|NCT00406783|13091620|P2|NOT COMPLETED|Overall Study||15
5323478|NCT00406783|13091621|P1|NOT COMPLETED|Overall Study||14
5323479|NCT00406783|13091620|P2|COMPLETED|Overall Study||256
5323480|NCT00406783|13091621|P1|COMPLETED|Overall Study||262
5323481|NCT00406783|13091620|P2|STARTED|Overall Study||271
5323482|NCT00406783|13091621|P1|STARTED|Overall Study||276
5323483|NCT00406718|13091636|P3|NOT COMPLETED|Overall Study||8
5323484|NCT00406718|13091637|P2|NOT COMPLETED|Overall Study||14
5323485|NCT00406718|13091638|P1|NOT COMPLETED|Overall Study||4
5323486|NCT00406718|13091636|P3|COMPLETED|Overall Study||39
5323487|NCT00406718|13091637|P2|COMPLETED|Overall Study||34
5323488|NCT00406718|13091638|P1|COMPLETED|Overall Study||43
5323489|NCT00406718|13091636|P3|STARTED|Overall Study||47
5323490|NCT00406718|13091637|P2|STARTED|Overall Study||48
5323491|NCT00406718|13091638|P1|STARTED|Overall Study||47
5323492|NCT00406692|13091652|P1|NOT COMPLETED|Overall Study||7
5323493|NCT00406692|13091652|P1|COMPLETED|Overall Study||9
5323494|NCT00406692|13091652|P1|STARTED|Overall Study||16
5323495|NCT00406653|13091662|P7|NOT COMPLETED|Open-Label Period||324
5323496|NCT00406653|13091663|P6|NOT COMPLETED|Open-Label Period||0
5323497|NCT00406653|13091664|P5|NOT COMPLETED|Open-Label Period||0
5323498|NCT00406653|13091665|P4|NOT COMPLETED|Open-Label Period||0
5323499|NCT00406653|13091666|P3|NOT COMPLETED|Open-Label Period||0
5323500|NCT00406653|13091667|P2|NOT COMPLETED|Open-Label Period||0
5323501|NCT00406653|13091668|P1|NOT COMPLETED|Open-Label Period||0
5323502|NCT00406653|13091662|P7|COMPLETED|Open-Label Period||0
5323503|NCT00406653|13091663|P6|COMPLETED|Open-Label Period||0
5323504|NCT00406653|13091664|P5|COMPLETED|Open-Label Period||0
5323505|NCT00406653|13091665|P4|COMPLETED|Open-Label Period||0
5323506|NCT00406653|13091666|P3|COMPLETED|Open-Label Period||0
5323507|NCT00406653|13091667|P2|COMPLETED|Open-Label Period||0
5323508|NCT00406653|13091668|P1|COMPLETED|Open-Label Period||0
5323509|NCT00406653|13091662|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
5323510|NCT00406653|13091663|P6|STARTED|Open-Label Period||0
5323511|NCT00406653|13091664|P5|STARTED|Open-Label Period||0
5323512|NCT00406653|13091665|P4|STARTED|Open-Label Period||0
5323513|NCT00406653|13091666|P3|STARTED|Open-Label Period||0
5323514|NCT00406653|13091667|P2|STARTED|Open-Label Period||0
5323515|NCT00406653|13091668|P1|STARTED|Open-Label Period||0
5323516|NCT00406653|13091662|P7|NOT COMPLETED|Maintenance Period||0
5323517|NCT00406653|13091663|P6|NOT COMPLETED|Maintenance Period||36
5323518|NCT00406653|13091664|P5|NOT COMPLETED|Maintenance Period||30
5323519|NCT00406653|13091665|P4|NOT COMPLETED|Maintenance Period||0
5323520|NCT00406653|13091666|P3|NOT COMPLETED|Maintenance Period||0
5323521|NCT00406653|13091667|P2|NOT COMPLETED|Maintenance Period||0
5323522|NCT00406653|13091668|P1|NOT COMPLETED|Maintenance Period||0
5323523|NCT00406653|13091662|P7|COMPLETED|Maintenance Period||0
5323524|NCT00406653|13091663|P6|COMPLETED|Maintenance Period||10
5323525|NCT00406653|13091664|P5|COMPLETED|Maintenance Period||14
5323526|NCT00406653|13091665|P4|COMPLETED|Maintenance Period||0
5323527|NCT00406653|13091666|P3|COMPLETED|Maintenance Period||0
5323528|NCT00406653|13091667|P2|COMPLETED|Maintenance Period||0
5323529|NCT00406653|13091668|P1|COMPLETED|Maintenance Period||0
5323530|NCT00406653|13091662|P7|STARTED|Maintenance Period||0
5323531|NCT00406653|13091663|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
5323532|NCT00406653|13091664|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
5323533|NCT00406653|13091665|P4|STARTED|Maintenance Period||0
5323534|NCT00406653|13091666|P3|STARTED|Maintenance Period||0
5323535|NCT00406653|13091667|P2|STARTED|Maintenance Period||0
5323536|NCT00406653|13091668|P1|STARTED|Maintenance Period||0
5323537|NCT00406653|13091662|P7|NOT COMPLETED|Induction Period||0
5323538|NCT00406653|13091663|P6|NOT COMPLETED|Induction Period||0
5323539|NCT00406653|13091664|P5|NOT COMPLETED|Induction Period||0
5323540|NCT00406653|13091665|P4|NOT COMPLETED|Induction Period||26
5323541|NCT00406653|13091666|P3|NOT COMPLETED|Induction Period||18
5323542|NCT00406653|13091667|P2|NOT COMPLETED|Induction Period||34
5323543|NCT00406653|13091668|P1|NOT COMPLETED|Induction Period||15
5323544|NCT00406653|13091662|P7|COMPLETED|Induction Period||0
5323545|NCT00406653|13091663|P6|COMPLETED|Induction Period||0
5323546|NCT00406653|13091664|P5|COMPLETED|Induction Period||0
5323547|NCT00406653|13091665|P4|COMPLETED|Induction Period||102
5323548|NCT00406653|13091666|P3|COMPLETED|Induction Period||112
5323549|NCT00406653|13091667|P2|COMPLETED|Induction Period||94
5323550|NCT00406653|13091668|P1|COMPLETED|Induction Period||50
5323551|NCT00406653|13091662|P7|STARTED|Induction Period||0
5323552|NCT00406653|13091663|P6|STARTED|Induction Period||0
5323553|NCT00406653|13091664|P5|STARTED|Induction Period||0
5323554|NCT00406653|13091665|P4|STARTED|Induction Period||128
5323555|NCT00406653|13091666|P3|STARTED|Induction Period||130
5323556|NCT00406653|13091667|P2|STARTED|Induction Period||128
5323557|NCT00406653|13091668|P1|STARTED|Induction Period||65
5323558|NCT00406640|13091749|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
5323559|NCT00406640|13091750|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
5323560|NCT00406640|13091749|P2|COMPLETED|OL Extension Phase for Non-Responders||36
5323561|NCT00406640|13091750|P1|COMPLETED|OL Extension Phase for Non-Responders||47
5323562|NCT00406640|13091749|P2|STARTED|OL Extension Phase for Non-Responders||60
5323563|NCT00406640|13091750|P1|STARTED|OL Extension Phase for Non-Responders||69
5323564|NCT00406640|13091749|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
5323565|NCT00406640|13091750|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
5323566|NCT00406640|13091749|P2|COMPLETED|DB Continuation Phase for Responders||151
5323567|NCT00406640|13091750|P1|COMPLETED|DB Continuation Phase for Responders||139
5323568|NCT00406640|13091749|P2|STARTED|DB Continuation Phase for Responders||188
5323569|NCT00406640|13091750|P1|STARTED|DB Continuation Phase for Responders||172
5323570|NCT00406640|13091749|P2|NOT COMPLETED|Acute Phase||43
5323571|NCT00406640|13091750|P1|NOT COMPLETED|Acute Phase||51
5323572|NCT00406640|13091749|P2|COMPLETED|Acute Phase||256
5323573|NCT00406640|13091750|P1|COMPLETED|Acute Phase||245
5323574|NCT00406640|13091749|P2|STARTED|Acute Phase||299
5323575|NCT00406640|13091750|P1|STARTED|Acute Phase||296
5323576|NCT00406393|13091782|P2|NOT COMPLETED|Overall Study||1
5323577|NCT00406393|13091783|P1|NOT COMPLETED|Overall Study||2
5323578|NCT00406393|13091782|P2|COMPLETED|Overall Study||152
5323579|NCT00406393|13091783|P1|COMPLETED|Overall Study||149
5323580|NCT00406393|13091782|P2|STARTED|Overall Study||153
5323581|NCT00406393|13091783|P1|STARTED|Overall Study||151
5323582|NCT00406367|13091813|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
5323583|NCT00406367|13091814|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
5323584|NCT00406367|13091813|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
5323585|NCT00406367|13091814|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
5323586|NCT00406367|13091813|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
5323587|NCT00406367|13091814|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
5323588|NCT00406367|13091813|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
5323589|NCT00406367|13091814|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
5323590|NCT00406367|13091813|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
5323591|NCT00406367|13091814|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
5323592|NCT00406367|13091813|P2|STARTED|Main Period - 6 to 20 Weeks||34
5323593|NCT00406367|13091814|P1|STARTED|Main Period - 6 to 20 Weeks||75
5323594|NCT00406354|13091829|P3|NOT COMPLETED|All Randomized and Treated Patients||22
5323595|NCT00406354|13091830|P2|NOT COMPLETED|All Randomized and Treated Patients||13
5323596|NCT00406354|13091831|P1|NOT COMPLETED|All Randomized and Treated Patients||16
5323597|NCT00406354|13091829|P3|COMPLETED|All Randomized and Treated Patients||37
5323598|NCT00406354|13091830|P2|COMPLETED|All Randomized and Treated Patients||48
5323599|NCT00406354|13091831|P1|COMPLETED|All Randomized and Treated Patients||44
5323600|NCT00406354|13091829|P3|STARTED|All Randomized and Treated Patients||59
5323601|NCT00406354|13091830|P2|STARTED|All Randomized and Treated Patients||61
5323602|NCT00406354|13091831|P1|STARTED|All Randomized and Treated Patients||60
5323603|NCT00406354|13091829|P3|NOT COMPLETED|All Randomized Patients||1
5323604|NCT00406354|13091830|P2|NOT COMPLETED|All Randomized Patients||0
5323605|NCT00406354|13091831|P1|NOT COMPLETED|All Randomized Patients||0
5323606|NCT00406354|13091829|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
5323607|NCT00406354|13091830|P2|COMPLETED|All Randomized Patients||61
5323608|NCT00406354|13091831|P1|COMPLETED|All Randomized Patients||60
5323609|NCT00406354|13091829|P3|STARTED|All Randomized Patients||60
5323610|NCT00406354|13091830|P2|STARTED|All Randomized Patients||61
5323611|NCT00406354|13091831|P1|STARTED|All Randomized Patients||60
5323612|NCT00406315|13091902|P1|NOT COMPLETED|Overall Study||141
5323613|NCT00406315|13091902|P1|COMPLETED|Overall Study||100
5323614|NCT00406315|13091902|P1|STARTED|Overall Study|Started = Treated|241
5323615|NCT00406276|13091920|P1|NOT COMPLETED|Overall Study||4
5323616|NCT00406276|13091920|P1|COMPLETED|Overall Study||24
5323617|NCT00406276|13091920|P1|STARTED|Overall Study||28
5323618|NCT00406133|13091929|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
5323619|NCT00406133|13091930|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
5323620|NCT00406133|13091931|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
5323621|NCT00406133|13091932|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
5323622|NCT00406133|13091929|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
5323623|NCT00406133|13091930|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
5323624|NCT00406133|13091931|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
5323625|NCT00406133|13091932|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
5323626|NCT00406133|13091929|P4|STARTED|Phase 2 (Second 26 Week Period)||60
5323627|NCT00406133|13091930|P3|STARTED|Phase 2 (Second 26 Week Period)||67
5323628|NCT00406133|13091931|P2|STARTED|Phase 2 (Second 26 Week Period)||155
5323629|NCT00406133|13091932|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
5323630|NCT00406133|13091929|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
5323631|NCT00406133|13091930|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
5323632|NCT00406133|13091931|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
5323633|NCT00406133|13091932|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
5323634|NCT00406133|13091929|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
5323635|NCT00406133|13091930|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
5323636|NCT00406133|13091931|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
5323637|NCT00406133|13091932|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
5323638|NCT00406133|13091929|P4|STARTED|Phase 1 (First 26 Week Period)||62
5323639|NCT00406133|13091930|P3|STARTED|Phase 1 (First 26 Week Period)||67
5323640|NCT00406133|13091931|P2|STARTED|Phase 1 (First 26 Week Period)||157
5323641|NCT00406133|13091932|P1|STARTED|Phase 1 (First 26 Week Period)||165
5323642|NCT00406107|13091996|P2|NOT COMPLETED|Overall Study||1
5323643|NCT00406107|13091997|P1|NOT COMPLETED|Overall Study||1
5323644|NCT00406107|13091996|P2|COMPLETED|Overall Study||4
5323645|NCT00406107|13091997|P1|COMPLETED|Overall Study||14
5323646|NCT00406107|13091996|P2|STARTED|Overall Study||5
5323647|NCT00406107|13091997|P1|STARTED|Overall Study||15
5323648|NCT00406029|13092012|P5|NOT COMPLETED|Overall Study||8
5323649|NCT00406029|13092013|P4|NOT COMPLETED|Overall Study||17
5323650|NCT00406029|13092014|P3|NOT COMPLETED|Overall Study||10
5323651|NCT00406029|13092015|P2|NOT COMPLETED|Overall Study||8
5323652|NCT00406029|13092016|P1|NOT COMPLETED|Overall Study||16
5323653|NCT00406029|13092012|P5|COMPLETED|Overall Study||41
5323654|NCT00406029|13092013|P4|COMPLETED|Overall Study||40
5323655|NCT00406029|13092014|P3|COMPLETED|Overall Study||39
5323656|NCT00406029|13092015|P2|COMPLETED|Overall Study||41
5323657|NCT00406029|13092016|P1|COMPLETED|Overall Study||33
5323658|NCT00406029|13092012|P5|Treated|Overall Study||47
5323659|NCT00406029|13092013|P4|Treated|Overall Study||54
5323660|NCT00406029|13092014|P3|Treated|Overall Study||47
5323661|NCT00406029|13092015|P2|Treated|Overall Study||49
5323662|NCT00406029|13092016|P1|Treated|Overall Study||49
5323663|NCT00406029|13092012|P5|STARTED|Overall Study||49
5323664|NCT00406029|13092013|P4|STARTED|Overall Study||57
5323665|NCT00406029|13092014|P3|STARTED|Overall Study||49
5323666|NCT00406029|13092015|P2|STARTED|Overall Study||49
5323667|NCT00406029|13092016|P1|STARTED|Overall Study||49
5323668|NCT00405964|13092120|P2|NOT COMPLETED|Overall Study||95
5323669|NCT00405964|13092121|P1|NOT COMPLETED|Overall Study||59
5323670|NCT00405964|13092120|P2|COMPLETED|Overall Study||261
5323671|NCT00405964|13092121|P1|COMPLETED|Overall Study||301
5323672|NCT00405964|13092120|P2|STARTED|Overall Study||356
5323673|NCT00405964|13092121|P1|STARTED|Overall Study||360
5323674|NCT00405938|13092133|P2|NOT COMPLETED|Overall Study||0
5323675|NCT00405938|13092134|P1|NOT COMPLETED|Overall Study||0
5323676|NCT00405938|13092133|P2|COMPLETED|Overall Study||41
5323677|NCT00405938|13092134|P1|COMPLETED|Overall Study||38
5323678|NCT00405938|13092133|P2|STARTED|Overall Study||41
5323679|NCT00405938|13092134|P1|STARTED|Overall Study||38
5323680|NCT00405912|13092143|P3|NOT COMPLETED|Overall Study||16
5323681|NCT00405912|13092144|P2|NOT COMPLETED|Overall Study||19
5323682|NCT00405912|13092145|P1|NOT COMPLETED|Overall Study||16
5323683|NCT00405912|13092143|P3|COMPLETED|Overall Study||23
5323684|NCT00405912|13092144|P2|COMPLETED|Overall Study||21
5323685|NCT00405912|13092145|P1|COMPLETED|Overall Study||23
5323686|NCT00405912|13092143|P3|STARTED|Overall Study||39
5323687|NCT00405912|13092144|P2|STARTED|Overall Study||40
5323688|NCT00405912|13092145|P1|STARTED|Overall Study||39
5323689|NCT00405821|13092158|P2|NOT COMPLETED|Overall Study||22
5323690|NCT00405821|13092159|P1|NOT COMPLETED|Overall Study||22
5323691|NCT00405821|13092158|P2|COMPLETED|Overall Study||198
5323692|NCT00405821|13092159|P1|COMPLETED|Overall Study||198
5323693|NCT00405821|13092158|P2|STARTED|Overall Study||220
5323694|NCT00405821|13092159|P1|STARTED|Overall Study||220
5323695|NCT00405756|13092172|P3|NOT COMPLETED|Follow-up||88
5323696|NCT00405756|13092173|P2|NOT COMPLETED|Follow-up||90
5323697|NCT00405756|13092174|P1|NOT COMPLETED|Follow-up||75
5323698|NCT00405756|13092172|P3|COMPLETED|Follow-up||0
5323699|NCT00405756|13092173|P2|COMPLETED|Follow-up||0
5323700|NCT00405756|13092174|P1|COMPLETED|Follow-up||0
5323701|NCT00405756|13092172|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
5323702|NCT00405756|13092173|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
5323703|NCT00405756|13092174|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
5323704|NCT00405756|13092172|P3|NOT COMPLETED|Open-label Extension||72
5323705|NCT00405756|13092173|P2|NOT COMPLETED|Open-label Extension||47
5323706|NCT00405756|13092174|P1|NOT COMPLETED|Open-label Extension||19
5323707|NCT00405756|13092172|P3|COMPLETED|Open-label Extension||0
5323708|NCT00405756|13092173|P2|COMPLETED|Open-label Extension||0
5323709|NCT00405756|13092174|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
5323710|NCT00405756|13092172|P3|STARTED|Open-label Extension||72
5323711|NCT00405756|13092173|P2|STARTED|Open-label Extension||47
5323712|NCT00405756|13092174|P1|STARTED|Open-label Extension||19
5323713|NCT00405756|13092172|P3|NOT COMPLETED|Double-blind Treatment||154
5323714|NCT00405756|13092173|P2|NOT COMPLETED|Double-blind Treatment||153
5323715|NCT00405756|13092174|P1|NOT COMPLETED|Double-blind Treatment||152
5323716|NCT00405756|13092172|P3|COMPLETED|Double-blind Treatment||0
5323717|NCT00405756|13092173|P2|COMPLETED|Double-blind Treatment||0
5323718|NCT00405756|13092174|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
5323719|NCT00405756|13092172|P3|Safety Population|Double-blind Treatment||153
5323720|NCT00405756|13092173|P2|Safety Population|Double-blind Treatment||152
5323721|NCT00405756|13092174|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
5323722|NCT00405756|13092172|P3|STARTED|Double-blind Treatment||154
5323723|NCT00405756|13092173|P2|STARTED|Double-blind Treatment||153
5323724|NCT00405756|13092174|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
5323725|NCT00405704|13092264|P2|NOT COMPLETED|Overall Study||46
5323726|NCT00405704|13092265|P1|NOT COMPLETED|Overall Study||41
5323727|NCT00405704|13092264|P2|COMPLETED|Overall Study||259
5323728|NCT00405704|13092265|P1|COMPLETED|Overall Study||261
5323729|NCT00405704|13092264|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
5323730|NCT00405704|13092265|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
5323731|NCT00405704|13092264|P2|Recurrent UTI With E. Coli|Overall Study||57
5323732|NCT00405704|13092265|P1|Recurrent UTI With E. Coli|Overall Study||30
5323733|NCT00405704|13092264|P2|Outcome Stool Assessed|Overall Study||210
5323734|NCT00405704|13092265|P1|Outcome Stool Assessed|Overall Study||203
5323735|NCT00405704|13092264|P2|Completed Assessments for New Scarring|Overall Study||227
5323736|NCT00405704|13092265|P1|Completed Assessments for New Scarring|Overall Study||220
5323737|NCT00405704|13092264|P2|Completed Outcome Renal Scan|Overall Study||235
5323738|NCT00405704|13092265|P1|Completed Outcome Renal Scan|Overall Study||227
5323739|NCT00405704|13092264|P2|STARTED|Overall Study||305
5323740|NCT00405704|13092265|P1|STARTED|Overall Study||302
5323741|NCT00405652|13092285|P1|NOT COMPLETED|Overall Study||4
5323742|NCT00405652|13092285|P1|COMPLETED|Overall Study||30
5323743|NCT00405652|13092285|P1|STARTED|Overall Study||34
5323744|NCT00405639|13092292|P2|NOT COMPLETED|Overall Study||0
5323745|NCT00405639|13092293|P1|NOT COMPLETED|Overall Study||3
5323746|NCT00405639|13092292|P2|COMPLETED|Overall Study||12
5323747|NCT00405639|13092293|P1|COMPLETED|Overall Study||22
5323748|NCT00405639|13092292|P2|STARTED|Overall Study||12
5323749|NCT00405639|13092293|P1|STARTED|Overall Study||25
5323750|NCT00405587|13092309|P4|NOT COMPLETED|Overall Study||20
5323751|NCT00405587|13092310|P3|NOT COMPLETED|Overall Study||22
5323752|NCT00405587|13092311|P2|NOT COMPLETED|Overall Study||28
5323753|NCT00405587|13092312|P1|NOT COMPLETED|Overall Study||26
5323754|NCT00405587|13092309|P4|COMPLETED|Overall Study||1
5323755|NCT00405587|13092310|P3|COMPLETED|Overall Study||10
5323756|NCT00405587|13092311|P2|COMPLETED|Overall Study||2
5323757|NCT00405587|13092312|P1|COMPLETED|Overall Study||0
5323758|NCT00405587|13092309|P4|STARTED|Overall Study||21
5323759|NCT00405587|13092310|P3|STARTED|Overall Study||32
5323760|NCT00405587|13092311|P2|STARTED|Overall Study||30
5323761|NCT00405587|13092312|P1|STARTED|Overall Study||26
5323762|NCT00405548|13092430|P2|NOT COMPLETED|Overall Study||1
5323763|NCT00405548|13092431|P1|NOT COMPLETED|Overall Study||4
5323764|NCT00405548|13092430|P2|COMPLETED|Overall Study||12
5323765|NCT00405548|13092431|P1|COMPLETED|Overall Study||24
5323766|NCT00405548|13092430|P2|STARTED|Overall Study||13
5323767|NCT00405548|13092431|P1|STARTED|Overall Study||28
5323768|NCT00405522|13092445|P2|NOT COMPLETED|Overall Study||0
5323769|NCT00405522|13092446|P1|NOT COMPLETED|Overall Study||0
5323770|NCT00405522|13092445|P2|COMPLETED|Overall Study||17
5323771|NCT00405522|13092446|P1|COMPLETED|Overall Study||17
5323772|NCT00405522|13092445|P2|STARTED|Overall Study||17
5323773|NCT00405522|13092446|P1|STARTED|Overall Study||17
5323774|NCT00405509|13092458|P2|NOT COMPLETED|Overall Study||0
5323775|NCT00405509|13092459|P1|NOT COMPLETED|Overall Study||0
5323776|NCT00405509|13092458|P2|COMPLETED|Overall Study||22
5323777|NCT00405509|13092459|P1|COMPLETED|Overall Study||11
5323778|NCT00405509|13092458|P2|STARTED|Overall Study||22
5323779|NCT00405509|13092459|P1|STARTED|Overall Study||11
5323780|NCT00405392|13092475|P2|NOT COMPLETED|Overall Study||27
5323781|NCT00405392|13092476|P1|NOT COMPLETED|Overall Study||30
5323782|NCT00405392|13092475|P2|COMPLETED|Overall Study||155
5323783|NCT00405392|13092476|P1|COMPLETED|Overall Study||153
5323784|NCT00405392|13092475|P2|STARTED|Overall Study||182
5323785|NCT00405392|13092476|P1|STARTED|Overall Study||183
5323786|NCT00405353|13092486|P1|NOT COMPLETED|Overall Study||0
5323787|NCT00405353|13092486|P1|COMPLETED|Overall Study||10
5323788|NCT00405353|13092486|P1|STARTED|Overall Study||10
5323789|NCT00405288|13092492|P2|NOT COMPLETED|Overall Study||0
5323790|NCT00405288|13092493|P1|NOT COMPLETED|Overall Study||0
5323791|NCT00405288|13092492|P2|COMPLETED|Overall Study||204
5323792|NCT00405288|13092493|P1|COMPLETED|Overall Study||204
5323793|NCT00405288|13092492|P2|STARTED|Overall Study||204
5323794|NCT00405288|13092493|P1|STARTED|Overall Study||204
5323795|NCT00405275|13092523|P2|NOT COMPLETED|Overall Study||19
5323796|NCT00405275|13092524|P1|NOT COMPLETED|Overall Study||23
5323797|NCT00405275|13092523|P2|COMPLETED|Overall Study||156
5323798|NCT00405275|13092524|P1|COMPLETED|Overall Study||155
5323799|NCT00405275|13092523|P2|24 Week (Switch)|Overall Study||44
5323800|NCT00405275|13092524|P1|24 Week (Switch)|Overall Study||44
5323801|NCT00405275|13092523|P2|24 Week (no Switch)|Overall Study||121
5323802|NCT00405275|13092524|P1|24 Week (no Switch)|Overall Study||119
5323803|NCT00405275|13092523|P2|24 Weeks (Total)|Overall Study||165
5323804|NCT00405275|13092524|P1|24 Weeks (Total)|Overall Study||163
5323805|NCT00405275|13092523|P2|STARTED|Overall Study||175
5323806|NCT00405275|13092524|P1|STARTED|Overall Study||178
5323807|NCT00405067|13092533|P3|NOT COMPLETED|Overall Study||5
5323808|NCT00405067|13092534|P2|NOT COMPLETED|Overall Study||9
5323809|NCT00405067|13092535|P1|NOT COMPLETED|Overall Study||4
5323810|NCT00405067|13092533|P3|COMPLETED|Overall Study||24
5323811|NCT00405067|13092534|P2|COMPLETED|Overall Study||19
5323812|NCT00405067|13092535|P1|COMPLETED|Overall Study||24
5323813|NCT00405067|13092533|P3|STARTED|Overall Study||29
5323814|NCT00405067|13092534|P2|STARTED|Overall Study||28
5323815|NCT00405067|13092535|P1|STARTED|Overall Study||28
5323816|NCT00404924|13092572|P2|NOT COMPLETED|Overall Study||306
5323817|NCT00404924|13092573|P1|NOT COMPLETED|Overall Study||603
5323818|NCT00404924|13092572|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
5323819|NCT00404924|13092573|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
5323820|NCT00404924|13092572|P2|STARTED|Overall Study|randomised patients|307
5323821|NCT00404924|13092573|P1|STARTED|Overall Study|randomised patients|617
5323822|NCT00404820|13092591|P2|NOT COMPLETED|Overall Study||24
5323823|NCT00404820|13092592|P1|NOT COMPLETED|Overall Study||19
5323824|NCT00404820|13092591|P2|COMPLETED|Overall Study||172
5323825|NCT00404820|13092592|P1|COMPLETED|Overall Study||389
5323826|NCT00404820|13092591|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
5323827|NCT00404820|13092592|P1|Started Treatment|Overall Study||408
5323828|NCT00404820|13092591|P2|STARTED|Overall Study||196
5323829|NCT00404820|13092592|P1|STARTED|Overall Study||408
5323830|NCT00404768|13092614|P4|NOT COMPLETED|Part C||14
5323831|NCT00404768|13092615|P3|NOT COMPLETED|Part C||8
5323832|NCT00404768|13092616|P2|NOT COMPLETED|Part C||0
5323833|NCT00404768|13092617|P1|NOT COMPLETED|Part C||0
5323834|NCT00404768|13092614|P4|COMPLETED|Part C||20
5323835|NCT00404768|13092615|P3|COMPLETED|Part C||22
5323836|NCT00404768|13092616|P2|COMPLETED|Part C||0
5323837|NCT00404768|13092617|P1|COMPLETED|Part C||0
5323838|NCT00404768|13092614|P4|STARTED|Part C||34
5323839|NCT00404768|13092615|P3|STARTED|Part C||30
5323840|NCT00404768|13092616|P2|STARTED|Part C||0
5323841|NCT00404768|13092617|P1|STARTED|Part C||0
5323842|NCT00404768|13092614|P4|NOT COMPLETED|Part A and B||0
5323843|NCT00404768|13092615|P3|NOT COMPLETED|Part A and B||0
5323844|NCT00404768|13092616|P2|NOT COMPLETED|Part A and B||1
5323845|NCT00404768|13092617|P1|NOT COMPLETED|Part A and B||1
5323846|NCT00404768|13092614|P4|COMPLETED|Part A and B||0
5323847|NCT00404768|13092615|P3|COMPLETED|Part A and B||0
5323848|NCT00404768|13092616|P2|COMPLETED|Part A and B||8
5323849|NCT00404768|13092617|P1|COMPLETED|Part A and B||19
5323850|NCT00404768|13092614|P4|STARTED|Part A and B||0
5323851|NCT00404768|13092615|P3|STARTED|Part A and B||0
5323852|NCT00404768|13092616|P2|STARTED|Part A and B||9
5323853|NCT00404768|13092617|P1|STARTED|Part A and B||20
5323854|NCT00404755|13092678|P1|NOT COMPLETED|Phase III (Imipramine)||0
5323855|NCT00404755|13092678|P1|COMPLETED|Phase III (Imipramine)||3
5323856|NCT00404755|13092678|P1|STARTED|Phase III (Imipramine)||3
5323857|NCT00404755|13092678|P1|NOT COMPLETED|Phase II (Escitalopram)||2
5323858|NCT00404755|13092678|P1|COMPLETED|Phase II (Escitalopram)||9
5323859|NCT00404755|13092678|P1|STARTED|Phase II (Escitalopram)||11
5323860|NCT00404755|13092678|P1|NOT COMPLETED|Phase I (Bupropion)||4
5323861|NCT00404755|13092678|P1|COMPLETED|Phase I (Bupropion)||13
5323862|NCT00404755|13092678|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
5323863|NCT00404651|13092693|P4|NOT COMPLETED|Overall Study||21
5323864|NCT00404651|13092694|P3|NOT COMPLETED|Overall Study||45
5323865|NCT00404651|13092695|P2|NOT COMPLETED|Overall Study||28
5323866|NCT00404651|13092696|P1|NOT COMPLETED|Overall Study||39
5323867|NCT00404651|13092693|P4|COMPLETED|Overall Study||146
5323868|NCT00404651|13092694|P3|COMPLETED|Overall Study||294
5323869|NCT00404651|13092695|P2|COMPLETED|Overall Study||315
5323870|NCT00404651|13092696|P1|COMPLETED|Overall Study||301
5323871|NCT00404651|13092693|P4|STARTED|Overall Study||167
5323872|NCT00404651|13092694|P3|STARTED|Overall Study||339
5323873|NCT00404651|13092695|P2|STARTED|Overall Study||343
5323874|NCT00404651|13092696|P1|STARTED|Overall Study||340
5323875|NCT00404547|13092724|P2|NOT COMPLETED|Overall Study||25
5323876|NCT00404547|13092725|P1|NOT COMPLETED|Overall Study||90
5323877|NCT00404547|13092724|P2|COMPLETED|Overall Study||334
5323878|NCT00404547|13092725|P1|COMPLETED|Overall Study||672
5323879|NCT00404547|13092724|P2|STARTED|Overall Study||359
5323880|NCT00404547|13092725|P1|STARTED|Overall Study||762
5323881|NCT00404495|13092735|P2|NOT COMPLETED|Overall Study||11
5323882|NCT00404495|13092736|P1|NOT COMPLETED|Overall Study||44
5323883|NCT00404495|13092735|P2|COMPLETED|Overall Study||6
5323884|NCT00404495|13092736|P1|COMPLETED|Overall Study||22
5323885|NCT00404495|13092735|P2|STARTED|Overall Study||17
5323886|NCT00404495|13092736|P1|STARTED|Overall Study||66
5323887|NCT00404352|13092755|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
5323888|NCT00404352|13092756|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
5323889|NCT00404352|13092757|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
5323890|NCT00404352|13092758|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323891|NCT00404352|13092759|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323892|NCT00404352|13092760|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323893|NCT00404352|13092761|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323894|NCT00404352|13092762|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323895|NCT00404352|13092763|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
5323896|NCT00404352|13092755|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
5323897|NCT00404352|13092756|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
5323898|NCT00404352|13092757|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
5323899|NCT00404352|13092758|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
5323900|NCT00404352|13092759|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
5323901|NCT00404352|13092760|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
5323902|NCT00404352|13092761|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
5323903|NCT00404352|13092762|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
5323904|NCT00404352|13092763|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
5323905|NCT00404352|13092755|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
5323906|NCT00404352|13092756|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
5323907|NCT00404352|13092757|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
5323908|NCT00404352|13092758|P6|STARTED|Open Label Extension (up to 36 Months)||0
5323909|NCT00404352|13092759|P5|STARTED|Open Label Extension (up to 36 Months)||0
5323910|NCT00404352|13092760|P4|STARTED|Open Label Extension (up to 36 Months)||0
5323911|NCT00404352|13092761|P3|STARTED|Open Label Extension (up to 36 Months)||0
5323912|NCT00404352|13092762|P2|STARTED|Open Label Extension (up to 36 Months)||0
5323913|NCT00404352|13092763|P1|STARTED|Open Label Extension (up to 36 Months)||0
5323914|NCT00404352|13092755|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
5323915|NCT00404352|13092756|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
5323916|NCT00404352|13092757|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
5323917|NCT00404352|13092758|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
5323918|NCT00404352|13092759|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
5323919|NCT00404352|13092760|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
5323920|NCT00404352|13092761|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
5323921|NCT00404352|13092762|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
5323922|NCT00404352|13092763|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
5323923|NCT00404352|13092755|P9|COMPLETED|Open Label (up to 24 Month)||0
5323924|NCT00404352|13092756|P8|COMPLETED|Open Label (up to 24 Month)||0
5323925|NCT00404352|13092757|P7|COMPLETED|Open Label (up to 24 Month)||0
5323926|NCT00404352|13092758|P6|COMPLETED|Open Label (up to 24 Month)||52
5323927|NCT00404352|13092759|P5|COMPLETED|Open Label (up to 24 Month)||28
5323928|NCT00404352|13092760|P4|COMPLETED|Open Label (up to 24 Month)||28
5323929|NCT00404352|13092761|P3|COMPLETED|Open Label (up to 24 Month)||0
5323930|NCT00404352|13092762|P2|COMPLETED|Open Label (up to 24 Month)||0
5323931|NCT00404352|13092763|P1|COMPLETED|Open Label (up to 24 Month)||0
5323932|NCT00404352|13092755|P9|STARTED|Open Label (up to 24 Month)||0
5323933|NCT00404352|13092756|P8|STARTED|Open Label (up to 24 Month)||0
5323934|NCT00404352|13092757|P7|STARTED|Open Label (up to 24 Month)||0
5323935|NCT00404352|13092758|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
5323936|NCT00404352|13092759|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
5323937|NCT00404352|13092760|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
5323938|NCT00404352|13092761|P3|STARTED|Open Label (up to 24 Month)||0
5323939|NCT00404352|13092762|P2|STARTED|Open Label (up to 24 Month)||0
5323940|NCT00404352|13092763|P1|STARTED|Open Label (up to 24 Month)||0
5323941|NCT00404352|13092755|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323942|NCT00404352|13092756|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323943|NCT00404352|13092757|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323944|NCT00404352|13092758|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323945|NCT00404352|13092759|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323946|NCT00404352|13092760|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
5323947|NCT00404352|13092761|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
5323948|NCT00404352|13092762|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
5323949|NCT00404352|13092763|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
5323950|NCT00404352|13092755|P9|COMPLETED|Double Blind (up to 24 Month)||0
5323951|NCT00404352|13092756|P8|COMPLETED|Double Blind (up to 24 Month)||0
5323952|NCT00404352|13092757|P7|COMPLETED|Double Blind (up to 24 Month)||0
5323953|NCT00404352|13092758|P6|COMPLETED|Double Blind (up to 24 Month)||0
5323954|NCT00404352|13092759|P5|COMPLETED|Double Blind (up to 24 Month)||0
5323955|NCT00404352|13092760|P4|COMPLETED|Double Blind (up to 24 Month)||0
5323956|NCT00404352|13092761|P3|COMPLETED|Double Blind (up to 24 Month)||92
5323957|NCT00404352|13092762|P2|COMPLETED|Double Blind (up to 24 Month)||128
5323958|NCT00404352|13092763|P1|COMPLETED|Double Blind (up to 24 Month)||119
5323959|NCT00404352|13092755|P9|Treated|Double Blind (up to 24 Month)||0
5323960|NCT00404352|13092756|P8|Treated|Double Blind (up to 24 Month)||0
5323961|NCT00404352|13092757|P7|Treated|Double Blind (up to 24 Month)||0
5323962|NCT00404352|13092758|P6|Treated|Double Blind (up to 24 Month)||0
5323963|NCT00404352|13092759|P5|Treated|Double Blind (up to 24 Month)||0
5323964|NCT00404352|13092760|P4|Treated|Double Blind (up to 24 Month)||0
5323965|NCT00404352|13092761|P3|Treated|Double Blind (up to 24 Month)||171
5323966|NCT00404352|13092762|P2|Treated|Double Blind (up to 24 Month)||173
5323967|NCT00404352|13092763|P1|Treated|Double Blind (up to 24 Month)||171
5323968|NCT00404352|13092755|P9|STARTED|Double Blind (up to 24 Month)||0
5323969|NCT00404352|13092756|P8|STARTED|Double Blind (up to 24 Month)||0
5323970|NCT00404352|13092757|P7|STARTED|Double Blind (up to 24 Month)||0
5323971|NCT00404352|13092758|P6|STARTED|Double Blind (up to 24 Month)||0
5323972|NCT00404352|13092759|P5|STARTED|Double Blind (up to 24 Month)||0
5323973|NCT00404352|13092760|P4|STARTED|Double Blind (up to 24 Month)||0
5323974|NCT00404352|13092761|P3|STARTED|Double Blind (up to 24 Month)||171
5323975|NCT00404352|13092762|P2|STARTED|Double Blind (up to 24 Month)||175
5323976|NCT00404352|13092763|P1|STARTED|Double Blind (up to 24 Month)||171
5323977|NCT00404248|13092798|P9|NOT COMPLETED|Overall Study||0
5323978|NCT00404248|13092799|P8|NOT COMPLETED|Overall Study||0
5323979|NCT00404248|13092800|P7|NOT COMPLETED|Overall Study||0
5323980|NCT00404248|13092801|P6|NOT COMPLETED|Overall Study||0
5323981|NCT00404248|13092802|P5|NOT COMPLETED|Overall Study||0
5323982|NCT00404248|13092803|P4|NOT COMPLETED|Overall Study||0
5323983|NCT00404248|13092804|P3|NOT COMPLETED|Overall Study||0
5323984|NCT00404248|13092805|P2|NOT COMPLETED|Overall Study||1
5323985|NCT00404248|13092806|P1|NOT COMPLETED|Overall Study||0
5323986|NCT00404248|13092798|P9|COMPLETED|Overall Study||3
5323987|NCT00404248|13092799|P8|COMPLETED|Overall Study||6
5323988|NCT00404248|13092800|P7|COMPLETED|Overall Study||6
5323989|NCT00404248|13092801|P6|COMPLETED|Overall Study||3
5323990|NCT00404248|13092802|P5|COMPLETED|Overall Study||3
5323991|NCT00404248|13092803|P4|COMPLETED|Overall Study||2
5323992|NCT00404248|13092804|P3|COMPLETED|Overall Study||5
5323993|NCT00404248|13092805|P2|COMPLETED|Overall Study||3
5323994|NCT00404248|13092806|P1|COMPLETED|Overall Study||3
5323995|NCT00404248|13092798|P9|STARTED|Overall Study||3
5323996|NCT00404248|13092799|P8|STARTED|Overall Study||6
5323997|NCT00404248|13092800|P7|STARTED|Overall Study||6
5323998|NCT00404248|13092801|P6|STARTED|Overall Study||3
5323999|NCT00404248|13092802|P5|STARTED|Overall Study||3
5324000|NCT00404248|13092803|P4|STARTED|Overall Study||2
5324001|NCT00404248|13092804|P3|STARTED|Overall Study||5
5324002|NCT00404248|13092805|P2|STARTED|Overall Study||4
5324003|NCT00404248|13092806|P1|STARTED|Overall Study||3
5324004|NCT00404235|13092839|P2|NOT COMPLETED|Overall Study||2
5324005|NCT00404235|13092840|P1|NOT COMPLETED|Overall Study||1
5324006|NCT00404235|13092839|P2|COMPLETED|Overall Study||39
5324007|NCT00404235|13092840|P1|COMPLETED|Overall Study||34
5324008|NCT00404235|13092839|P2|STARTED|Overall Study||41
5324009|NCT00404235|13092840|P1|STARTED|Overall Study||35
5324010|NCT00404092|13092858|P4|NOT COMPLETED|Overall Study||0
5324011|NCT00404092|13092859|P3|NOT COMPLETED|Overall Study||1
5324012|NCT00404092|13092860|P2|NOT COMPLETED|Overall Study||0
5324013|NCT00404092|13092861|P1|NOT COMPLETED|Overall Study||1
5324014|NCT00404092|13092858|P4|COMPLETED|Overall Study||20
5324015|NCT00404092|13092859|P3|COMPLETED|Overall Study||8
5324016|NCT00404092|13092860|P2|COMPLETED|Overall Study||8
5324017|NCT00404092|13092861|P1|COMPLETED|Overall Study||8
5324018|NCT00404092|13092858|P4|STARTED|Overall Study||20
5324019|NCT00404092|13092859|P3|STARTED|Overall Study||9
5324020|NCT00404092|13092860|P2|STARTED|Overall Study||8
5324021|NCT00404092|13092861|P1|STARTED|Overall Study||9
5324022|NCT00404079|13092877|P2|NOT COMPLETED|Overall Study||20
5324023|NCT00404079|13092878|P1|NOT COMPLETED|Overall Study||22
5324024|NCT00404079|13092877|P2|COMPLETED|Overall Study||105
5324025|NCT00404079|13092878|P1|COMPLETED|Overall Study||103
5324026|NCT00404079|13092877|P2|STARTED|Overall Study||125
5324027|NCT00404079|13092878|P1|STARTED|Overall Study||125
5324028|NCT00404066|13092884|P1|NOT COMPLETED|Overall Study||3
5324029|NCT00404066|13092884|P1|COMPLETED|Overall Study||18
5324030|NCT00404066|13092884|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
5324031|NCT00403845|13092889|P4|NOT COMPLETED|Treatment Period 4||0
5324032|NCT00403845|13092890|P3|NOT COMPLETED|Treatment Period 4||0
5324033|NCT00403845|13092891|P2|NOT COMPLETED|Treatment Period 4||0
5324034|NCT00403845|13092892|P1|NOT COMPLETED|Treatment Period 4||0
5324035|NCT00403845|13092889|P4|COMPLETED|Treatment Period 4||11
5324036|NCT00403845|13092890|P3|COMPLETED|Treatment Period 4||11
5324037|NCT00403845|13092891|P2|COMPLETED|Treatment Period 4||13
5324038|NCT00403845|13092892|P1|COMPLETED|Treatment Period 4||10
5324039|NCT00403845|13092889|P4|STARTED|Treatment Period 4||11
5324040|NCT00403845|13092890|P3|STARTED|Treatment Period 4||11
5324041|NCT00403845|13092891|P2|STARTED|Treatment Period 4||13
5324042|NCT00403845|13092892|P1|STARTED|Treatment Period 4||10
5324043|NCT00403845|13092889|P4|NOT COMPLETED|Treatment Period 3||2
5324044|NCT00403845|13092890|P3|NOT COMPLETED|Treatment Period 3||0
5324045|NCT00403845|13092891|P2|NOT COMPLETED|Treatment Period 3||0
5324046|NCT00403845|13092892|P1|NOT COMPLETED|Treatment Period 3||0
5324047|NCT00403845|13092889|P4|COMPLETED|Treatment Period 3||11
5324048|NCT00403845|13092890|P3|COMPLETED|Treatment Period 3||11
5324049|NCT00403845|13092891|P2|COMPLETED|Treatment Period 3||13
5324050|NCT00403845|13092892|P1|COMPLETED|Treatment Period 3||10
5324051|NCT00403845|13092889|P4|STARTED|Treatment Period 3||13
5324052|NCT00403845|13092890|P3|STARTED|Treatment Period 3||11
5324053|NCT00403845|13092891|P2|STARTED|Treatment Period 3||13
5324054|NCT00403845|13092892|P1|STARTED|Treatment Period 3||10
5324055|NCT00403845|13092889|P4|NOT COMPLETED|Treatment Period 2||0
5324056|NCT00403845|13092890|P3|NOT COMPLETED|Treatment Period 2||0
5324057|NCT00403845|13092891|P2|NOT COMPLETED|Treatment Period 2||0
5324058|NCT00403845|13092892|P1|NOT COMPLETED|Treatment Period 2||1
5324059|NCT00403845|13092889|P4|COMPLETED|Treatment Period 2||13
5324060|NCT00403845|13092890|P3|COMPLETED|Treatment Period 2||11
5324061|NCT00403845|13092891|P2|COMPLETED|Treatment Period 2||13
5324062|NCT00403845|13092892|P1|COMPLETED|Treatment Period 2||10
5324063|NCT00403845|13092889|P4|STARTED|Treatment Period 2||13
5324064|NCT00403845|13092890|P3|STARTED|Treatment Period 2||11
5324065|NCT00403845|13092891|P2|STARTED|Treatment Period 2||13
5324066|NCT00403845|13092892|P1|STARTED|Treatment Period 2||11
5324067|NCT00403845|13092889|P4|NOT COMPLETED|Treatment Period 1||1
5324068|NCT00403845|13092890|P3|NOT COMPLETED|Treatment Period 1||0
5324069|NCT00403845|13092891|P2|NOT COMPLETED|Treatment Period 1||0
5324070|NCT00403845|13092892|P1|NOT COMPLETED|Treatment Period 1||1
5324071|NCT00403845|13092889|P4|COMPLETED|Treatment Period 1||13
5324072|NCT00403845|13092890|P3|COMPLETED|Treatment Period 1||11
5324073|NCT00403845|13092891|P2|COMPLETED|Treatment Period 1||13
5324074|NCT00403845|13092892|P1|COMPLETED|Treatment Period 1||11
5324075|NCT00403845|13092889|P4|STARTED|Treatment Period 1||14
5324076|NCT00403845|13092890|P3|STARTED|Treatment Period 1||11
5324077|NCT00403845|13092891|P2|STARTED|Treatment Period 1||13
5324078|NCT00403845|13092892|P1|STARTED|Treatment Period 1||12
5324079|NCT00403767|13092916|P2|NOT COMPLETED|Overall Study||2468
5324080|NCT00403767|13092917|P1|NOT COMPLETED|Overall Study||2520
5324081|NCT00403767|13092916|P2|COMPLETED|Overall Study||4657
5324082|NCT00403767|13092917|P1|COMPLETED|Overall Study||4591
5324083|NCT00403767|13092916|P2|STARTED|Overall Study||7125
5324084|NCT00403767|13092917|P1|STARTED|Overall Study||7111
5324085|NCT00403754|13092941|P4|NOT COMPLETED|Open Label: Salmeterol||0
5324086|NCT00403754|13092942|P3|NOT COMPLETED|Open Label: Salmeterol||0
5324087|NCT00403754|13092943|P2|NOT COMPLETED|Open Label: Salmeterol||0
5324088|NCT00403754|13092944|P1|NOT COMPLETED|Open Label: Salmeterol||0
5324089|NCT00403754|13092941|P4|COMPLETED|Open Label: Salmeterol||11
5324090|NCT00403754|13092942|P3|COMPLETED|Open Label: Salmeterol||8
5324091|NCT00403754|13092943|P2|COMPLETED|Open Label: Salmeterol||9
5324092|NCT00403754|13092944|P1|COMPLETED|Open Label: Salmeterol||11
5324093|NCT00403754|13092941|P4|STARTED|Open Label: Salmeterol||11
5324094|NCT00403754|13092942|P3|STARTED|Open Label: Salmeterol||8
5324095|NCT00403754|13092943|P2|STARTED|Open Label: Salmeterol||9
5324096|NCT00403754|13092944|P1|STARTED|Open Label: Salmeterol||11
5324097|NCT00403754|13092941|P4|NOT COMPLETED|Core Treatment Period 4||0
5324098|NCT00403754|13092942|P3|NOT COMPLETED|Core Treatment Period 4||0
5324099|NCT00403754|13092943|P2|NOT COMPLETED|Core Treatment Period 4||0
5324100|NCT00403754|13092944|P1|NOT COMPLETED|Core Treatment Period 4||0
5324101|NCT00403754|13092941|P4|COMPLETED|Core Treatment Period 4||11
5324102|NCT00403754|13092942|P3|COMPLETED|Core Treatment Period 4||8
5324103|NCT00403754|13092943|P2|COMPLETED|Core Treatment Period 4||9
5324104|NCT00403754|13092944|P1|COMPLETED|Core Treatment Period 4||11
5324105|NCT00403754|13092941|P4|STARTED|Core Treatment Period 4||11
5324106|NCT00403754|13092942|P3|STARTED|Core Treatment Period 4||8
5324107|NCT00403754|13092943|P2|STARTED|Core Treatment Period 4||9
5324108|NCT00403754|13092944|P1|STARTED|Core Treatment Period 4||11
5324109|NCT00403754|13092941|P4|NOT COMPLETED|Core Treatment Period 3||0
5324110|NCT00403754|13092942|P3|NOT COMPLETED|Core Treatment Period 3||0
5324111|NCT00403754|13092943|P2|NOT COMPLETED|Core Treatment Period 3||0
5324112|NCT00403754|13092944|P1|NOT COMPLETED|Core Treatment Period 3||0
5324113|NCT00403754|13092941|P4|COMPLETED|Core Treatment Period 3||11
5324114|NCT00403754|13092942|P3|COMPLETED|Core Treatment Period 3||8
5324115|NCT00403754|13092943|P2|COMPLETED|Core Treatment Period 3||9
5324116|NCT00403754|13092944|P1|COMPLETED|Core Treatment Period 3||11
5324117|NCT00403754|13092941|P4|STARTED|Core Treatment Period 3||11
5324118|NCT00403754|13092942|P3|STARTED|Core Treatment Period 3||8
5324119|NCT00403754|13092943|P2|STARTED|Core Treatment Period 3||9
5324120|NCT00403754|13092944|P1|STARTED|Core Treatment Period 3||11
5324121|NCT00403754|13092941|P4|NOT COMPLETED|Core Treatment Period 2||0
5324122|NCT00403754|13092942|P3|NOT COMPLETED|Core Treatment Period 2||1
5324123|NCT00403754|13092943|P2|NOT COMPLETED|Core Treatment Period 2||0
5324124|NCT00403754|13092944|P1|NOT COMPLETED|Core Treatment Period 2||0
5324125|NCT00403754|13092941|P4|COMPLETED|Core Treatment Period 2||11
5324126|NCT00403754|13092942|P3|COMPLETED|Core Treatment Period 2||8
5324127|NCT00403754|13092943|P2|COMPLETED|Core Treatment Period 2||9
5324128|NCT00403754|13092944|P1|COMPLETED|Core Treatment Period 2||11
5324129|NCT00403754|13092941|P4|STARTED|Core Treatment Period 2||11
5324130|NCT00403754|13092942|P3|STARTED|Core Treatment Period 2||9
5324131|NCT00403754|13092943|P2|STARTED|Core Treatment Period 2||9
5324132|NCT00403754|13092944|P1|STARTED|Core Treatment Period 2||11
5324133|NCT00403754|13092941|P4|NOT COMPLETED|Core Treatment Period 1||0
5324134|NCT00403754|13092942|P3|NOT COMPLETED|Core Treatment Period 1||0
5324135|NCT00403754|13092943|P2|NOT COMPLETED|Core Treatment Period 1||1
5324136|NCT00403754|13092944|P1|NOT COMPLETED|Core Treatment Period 1||0
5324137|NCT00403754|13092941|P4|COMPLETED|Core Treatment Period 1||11
5324138|NCT00403754|13092942|P3|COMPLETED|Core Treatment Period 1||9
5324139|NCT00403754|13092943|P2|COMPLETED|Core Treatment Period 1||9
5324140|NCT00403754|13092944|P1|COMPLETED|Core Treatment Period 1||11
5324141|NCT00403754|13092941|P4|STARTED|Core Treatment Period 1||11
5324142|NCT00403754|13092942|P3|STARTED|Core Treatment Period 1||9
5324143|NCT00403754|13092943|P2|STARTED|Core Treatment Period 1||10
5324144|NCT00403754|13092944|P1|STARTED|Core Treatment Period 1||11
5324145|NCT00403585|13092971|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
5324146|NCT00403585|13092971|P1|COMPLETED|Open-Label Phase; Extension Study||74
5324147|NCT00403585|13092971|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
5324148|NCT00403585|13092971|P1|NOT COMPLETED|Initial Treatment Phase||2
5324149|NCT00403585|13092971|P1|COMPLETED|Initial Treatment Phase||102
5324150|NCT00403585|13092971|P1|STARTED|Initial Treatment Phase||104
5324151|NCT00403546|13092982|P3|NOT COMPLETED|Randomized Trial||16
5324152|NCT00403546|13092983|P2|NOT COMPLETED|Randomized Trial||17
5324153|NCT00403546|13092984|P1|NOT COMPLETED|Randomized Trial||0
5324154|NCT00403546|13092982|P3|COMPLETED|Randomized Trial||21
5324155|NCT00403546|13092983|P2|COMPLETED|Randomized Trial||21
5324156|NCT00403546|13092984|P1|COMPLETED|Randomized Trial||0
5324157|NCT00403546|13092982|P3|STARTED|Randomized Trial||37
5324158|NCT00403546|13092983|P2|STARTED|Randomized Trial||38
5324159|NCT00403546|13092984|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
5324160|NCT00403546|13092982|P3|NOT COMPLETED|Screening Phase||0
5324161|NCT00403546|13092983|P2|NOT COMPLETED|Screening Phase||0
5324162|NCT00403546|13092984|P1|NOT COMPLETED|Screening Phase||28
5324163|NCT00403546|13092982|P3|COMPLETED|Screening Phase||0
5324164|NCT00403546|13092983|P2|COMPLETED|Screening Phase||0
5324165|NCT00403546|13092984|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
5324166|NCT00403546|13092982|P3|STARTED|Screening Phase||0
5324167|NCT00403546|13092983|P2|STARTED|Screening Phase||0
5324168|NCT00403546|13092984|P1|STARTED|Screening Phase||103
5324169|NCT00403546|13092982|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
5324170|NCT00403546|13092983|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
5324171|NCT00403546|13092984|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
5324172|NCT00403546|13092982|P3|COMPLETED|Signed Informed Consent/Open-Label||0
5324173|NCT00403546|13092983|P2|COMPLETED|Signed Informed Consent/Open-Label||0
5324174|NCT00403546|13092984|P1|COMPLETED|Signed Informed Consent/Open-Label||103
5324175|NCT00403546|13092982|P3|STARTED|Signed Informed Consent/Open-Label||0
5324176|NCT00403546|13092983|P2|STARTED|Signed Informed Consent/Open-Label||0
5324177|NCT00403546|13092984|P1|STARTED|Signed Informed Consent/Open-Label||131
5324178|NCT00403481|13093024|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
5324179|NCT00403481|13093024|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
5324180|NCT00403481|13093024|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
5324181|NCT00403481|13093024|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
5324182|NCT00403481|13093024|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
5324183|NCT00403481|13093024|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
5324184|NCT00403481|13093024|P1|NOT COMPLETED|Olm 40 mg||5
5324185|NCT00403481|13093024|P1|COMPLETED|Olm 40 mg||177
5324186|NCT00403481|13093024|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
5324187|NCT00403481|13093024|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
5324188|NCT00403481|13093024|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
5324189|NCT00403481|13093024|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
5324190|NCT00403455|13093039|P1|NOT COMPLETED|Overall Study||1
5324191|NCT00403455|13093039|P1|COMPLETED|Overall Study||37
5324192|NCT00403455|13093039|P1|STARTED|Overall Study||38
5324193|NCT00403403|13093045|P2|NOT COMPLETED|Overall Study||0
5324194|NCT00403403|13093046|P1|NOT COMPLETED|Overall Study||0
5324195|NCT00403403|13093045|P2|COMPLETED|Overall Study||52
5324196|NCT00403403|13093046|P1|COMPLETED|Overall Study||50
5324197|NCT00403403|13093045|P2|Safety-Evaluable Patients|Overall Study||51
5324198|NCT00403403|13093046|P1|Safety-Evaluable Patients|Overall Study||47
5324199|NCT00403403|13093045|P2|STARTED|Overall Study||52
5324200|NCT00403403|13093046|P1|STARTED|Overall Study||50
5324201|NCT00403390|13093062|P2|NOT COMPLETED|Overall Study||0
5324202|NCT00403390|13093063|P1|NOT COMPLETED|Overall Study||3
5324203|NCT00403390|13093062|P2|COMPLETED|Overall Study||18
5324204|NCT00403390|13093063|P1|COMPLETED|Overall Study||13
5324205|NCT00403390|13093062|P2|STARTED|Overall Study||18
5324206|NCT00403390|13093063|P1|STARTED|Overall Study||16
5324207|NCT00403273|13093071|P2|NOT COMPLETED|Overall Study||4
5324208|NCT00403273|13093072|P1|NOT COMPLETED|Overall Study||3
5324209|NCT00403273|13093071|P2|COMPLETED|Overall Study||25
5324210|NCT00403273|13093072|P1|COMPLETED|Overall Study||22
5324211|NCT00403273|13093071|P2|STARTED|Overall Study||29
5324212|NCT00403273|13093072|P1|STARTED|Overall Study||25
5324213|NCT00403234|13093114|P4|NOT COMPLETED|Overall Study||0
5324214|NCT00403234|13093115|P3|NOT COMPLETED|Overall Study||1
5324215|NCT00403234|13093116|P2|NOT COMPLETED|Overall Study||1
5324216|NCT00403234|13093117|P1|NOT COMPLETED|Overall Study||1
5324217|NCT00403234|13093114|P4|COMPLETED|Overall Study||2
5324218|NCT00403234|13093115|P3|COMPLETED|Overall Study||2
5324219|NCT00403234|13093116|P2|COMPLETED|Overall Study||2
5324220|NCT00403234|13093117|P1|COMPLETED|Overall Study||1
5324221|NCT00403234|13093114|P4|STARTED|Overall Study||2
5324222|NCT00403234|13093115|P3|STARTED|Overall Study||3
5324223|NCT00403234|13093116|P2|STARTED|Overall Study||3
5324224|NCT00403234|13093117|P1|STARTED|Overall Study||2
5324225|NCT00403130|13093127|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
5324226|NCT00403130|13093127|P1|COMPLETED|Survival Follow-up up to 6 Years||16
5324227|NCT00403130|13093127|P1|STARTED|Survival Follow-up up to 6 Years||26
5324228|NCT00403130|13093127|P1|NOT COMPLETED|2 Years From Start of Treatment||5
5324229|NCT00403130|13093127|P1|COMPLETED|2 Years From Start of Treatment||26
5324230|NCT00403130|13093127|P1|STARTED|2 Years From Start of Treatment||31
5324231|NCT00403117|13093134|P1|NOT COMPLETED|Overall Study||20
5324232|NCT00403117|13093134|P1|COMPLETED|Overall Study||29
5324233|NCT00403117|13093134|P1|STARTED|Overall Study||49
5324234|NCT00402987|13093180|P4|NOT COMPLETED|Overall Study||0
5324235|NCT00402987|13093181|P3|NOT COMPLETED|Overall Study||1
5324236|NCT00402987|13093182|P2|NOT COMPLETED|Overall Study||0
5324237|NCT00402987|13093183|P1|NOT COMPLETED|Overall Study||0
5324238|NCT00402987|13093180|P4|COMPLETED|Overall Study||89
5324239|NCT00402987|13093181|P3|COMPLETED|Overall Study||44
5324240|NCT00402987|13093182|P2|COMPLETED|Overall Study||45
5324241|NCT00402987|13093183|P1|COMPLETED|Overall Study||90
5324242|NCT00402987|13093180|P4|STARTED|Overall Study||89
5324243|NCT00402987|13093181|P3|STARTED|Overall Study||45
5324244|NCT00402987|13093182|P2|STARTED|Overall Study||45
5324245|NCT00402987|13093183|P1|STARTED|Overall Study||90
5324246|NCT00402896|13093345|P1|NOT COMPLETED|Overall Study||0
5324247|NCT00402896|13093345|P1|COMPLETED|Overall Study||20
5324248|NCT00402896|13093345|P1|STARTED|Overall Study||20
5324249|NCT00402883|13093349|P1|NOT COMPLETED|Maintenance Therapy||0
5324250|NCT00402883|13093349|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
5324251|NCT00402883|13093349|P1|STARTED|Maintenance Therapy||5
5324252|NCT00402883|13093349|P1|NOT COMPLETED|Consolidation Therapy||0
5324253|NCT00402883|13093349|P1|COMPLETED|Consolidation Therapy||5
5324254|NCT00402883|13093349|P1|STARTED|Consolidation Therapy||5
5324255|NCT00402883|13093349|P1|NOT COMPLETED|Induction Therapy||0
5324256|NCT00402883|13093349|P1|COMPLETED|Induction Therapy||5
5324257|NCT00402883|13093349|P1|STARTED|Induction Therapy||5
5324258|NCT00402831|13093355|P2|NOT COMPLETED|Overall Study||3
5324259|NCT00402831|13093356|P1|NOT COMPLETED|Overall Study||1
5324260|NCT00402831|13093355|P2|COMPLETED|Overall Study||200
5324261|NCT00402831|13093356|P1|COMPLETED|Overall Study||201
5324262|NCT00402831|13093355|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
5324263|NCT00402831|13093356|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
5324264|NCT00402831|13093355|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
5324265|NCT00402831|13093356|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
5324266|NCT00402831|13093355|P2|STARTED|Overall Study||203
5324267|NCT00402831|13093356|P1|STARTED|Overall Study||202
5324268|NCT00402779|13093390|P2|NOT COMPLETED|Overall Study||76
5324269|NCT00402779|13093391|P1|NOT COMPLETED|Overall Study||77
5324270|NCT00402779|13093390|P2|COMPLETED|Overall Study||75
5324271|NCT00402779|13093391|P1|COMPLETED|Overall Study||75
5324272|NCT00402779|13093390|P2|STARTED|Overall Study||151
5324273|NCT00402779|13093391|P1|STARTED|Overall Study||152
5324274|NCT00402740|13093397|P1|NOT COMPLETED|Overall Study||80
5324275|NCT00402740|13093397|P1|COMPLETED|Overall Study||242
5324276|NCT00402740|13093397|P1|STARTED|Overall Study||322
5324277|NCT00402727|13093409|P2|NOT COMPLETED|Overall Study||34
5324278|NCT00402727|13093410|P1|NOT COMPLETED|Overall Study||42
5324279|NCT00402727|13093409|P2|COMPLETED|Overall Study||347
5324280|NCT00402727|13093410|P1|COMPLETED|Overall Study||390
5324281|NCT00402727|13093409|P2|Achieving Test Of Cure (TOC)|Overall Study||347
5324282|NCT00402727|13093410|P1|Achieving Test Of Cure (TOC)|Overall Study||390
5324283|NCT00402727|13093409|P2|Achieving End Of Treatment (EOT)|Overall Study||355
5324284|NCT00402727|13093410|P1|Achieving End Of Treatment (EOT)|Overall Study||408
5324285|NCT00402727|13093409|P2|STARTED|Overall Study||381
5324286|NCT00402727|13093410|P1|STARTED|Overall Study||432
5324287|NCT00402714|13093440|P2|NOT COMPLETED|Overall Study||0
5324288|NCT00402714|13093441|P1|NOT COMPLETED|Overall Study||0
5324289|NCT00402714|13093440|P2|COMPLETED|Overall Study||11
5324290|NCT00402714|13093441|P1|COMPLETED|Overall Study||3
5324291|NCT00402714|13093440|P2|STARTED|Overall Study||11
5324292|NCT00402714|13093441|P1|STARTED|Overall Study||3
5324293|NCT00402688|13093452|P3|NOT COMPLETED|Overall Study||15
5324294|NCT00402688|13093453|P2|NOT COMPLETED|Overall Study||16
5324295|NCT00402688|13093454|P1|NOT COMPLETED|Overall Study||21
5324296|NCT00402688|13093452|P3|COMPLETED|Overall Study||65
5324297|NCT00402688|13093453|P2|COMPLETED|Overall Study||65
5324298|NCT00402688|13093454|P1|COMPLETED|Overall Study||60
5324299|NCT00402688|13093452|P3|STARTED|Overall Study||80
5324300|NCT00402688|13093453|P2|STARTED|Overall Study||81
5324301|NCT00402688|13093454|P1|STARTED|Overall Study||81
5324302|NCT00402649|13093477|P1|NOT COMPLETED|Overall Study||2
5324303|NCT00402649|13093477|P1|COMPLETED|Overall Study||33
5324304|NCT00402649|13093477|P1|STARTED|Overall Study||35
5324305|NCT00402597|13093492|P5|NOT COMPLETED|Overall Study||124
5324306|NCT00402597|13093493|P4|NOT COMPLETED|Overall Study||74
5324307|NCT00402597|13093494|P3|NOT COMPLETED|Overall Study||212
5324308|NCT00402597|13093495|P2|NOT COMPLETED|Overall Study||46
5324309|NCT00402597|13093496|P1|NOT COMPLETED|Overall Study||191
5324310|NCT00402597|13093492|P5|COMPLETED|Overall Study||479
5324311|NCT00402597|13093493|P4|COMPLETED|Overall Study||279
5324312|NCT00402597|13093494|P3|COMPLETED|Overall Study||834
5324313|NCT00402597|13093495|P2|COMPLETED|Overall Study||261
5324314|NCT00402597|13093496|P1|COMPLETED|Overall Study||962
5324315|NCT00402597|13093492|P5|STARTED|Overall Study||603
5324316|NCT00402597|13093493|P4|STARTED|Overall Study||353
5324317|NCT00402597|13093494|P3|STARTED|Overall Study||1046
5324318|NCT00402597|13093495|P2|STARTED|Overall Study||307
5324319|NCT00402597|13093496|P1|STARTED|Overall Study||1153
5324320|NCT00402363|13093537|P4|NOT COMPLETED|Overall Study||10
5324321|NCT00402363|13093538|P3|NOT COMPLETED|Overall Study||6
5324322|NCT00402363|13093539|P2|NOT COMPLETED|Overall Study||30
5324323|NCT00402363|13093540|P1|NOT COMPLETED|Overall Study||33
5324324|NCT00402363|13093537|P4|COMPLETED|Overall Study||45
5324325|NCT00402363|13093538|P3|COMPLETED|Overall Study||60
5324326|NCT00402363|13093539|P2|COMPLETED|Overall Study||246
5324327|NCT00402363|13093540|P1|COMPLETED|Overall Study||233
5324328|NCT00402363|13093537|P4|STARTED|Overall Study||55
5324329|NCT00402363|13093538|P3|STARTED|Overall Study||66
5324330|NCT00402363|13093539|P2|STARTED|Overall Study||276
5324331|NCT00402363|13093540|P1|STARTED|Overall Study||266
5324332|NCT00402337|13093603|P5|NOT COMPLETED|Overall Study||8
5324333|NCT00402337|13093604|P4|NOT COMPLETED|Overall Study||12
5324334|NCT00402337|13093605|P3|NOT COMPLETED|Overall Study||4
5324335|NCT00402337|13093606|P2|NOT COMPLETED|Overall Study||6
5324336|NCT00402337|13093607|P1|NOT COMPLETED|Overall Study||5
5324337|NCT00402337|13093603|P5|COMPLETED|Overall Study||61
5324338|NCT00402337|13093604|P4|COMPLETED|Overall Study||51
5324339|NCT00402337|13093605|P3|COMPLETED|Overall Study||58
5324340|NCT00402337|13093606|P2|COMPLETED|Overall Study||51
5324341|NCT00402337|13093607|P1|COMPLETED|Overall Study||54
5324342|NCT00402337|13093603|P5|STARTED|Overall Study||69
5324343|NCT00402337|13093604|P4|STARTED|Overall Study||63
5324344|NCT00402337|13093605|P3|STARTED|Overall Study||62
5324345|NCT00402337|13093606|P2|STARTED|Overall Study||57
5324346|NCT00402337|13093607|P1|STARTED|Overall Study||59
5324347|NCT00402324|13093646|P2|NOT COMPLETED|Overall Study||41
5324348|NCT00402324|13093647|P1|NOT COMPLETED|Overall Study||43
5324349|NCT00402324|13093646|P2|COMPLETED|Overall Study||60
5324350|NCT00402324|13093647|P1|COMPLETED|Overall Study||58
5324351|NCT00402324|13093646|P2|STARTED|Overall Study||101
5324352|NCT00402324|13093647|P1|STARTED|Overall Study||101
5324353|NCT00402285|13093680|P3|NOT COMPLETED|Overall Study||2
5324354|NCT00402285|13093681|P2|NOT COMPLETED|Overall Study||6
5324355|NCT00402285|13093682|P1|NOT COMPLETED|Overall Study||7
5324356|NCT00402285|13093680|P3|COMPLETED|Overall Study||26
5324357|NCT00402285|13093681|P2|COMPLETED|Overall Study||21
5324358|NCT00402285|13093682|P1|COMPLETED|Overall Study||22
5324359|NCT00402285|13093680|P3|STARTED|Overall Study||28
5324360|NCT00402285|13093681|P2|STARTED|Overall Study||27
5324361|NCT00402285|13093682|P1|STARTED|Overall Study||29
5324362|NCT00402246|13093690|P2|NOT COMPLETED|Overall Study||234
5324363|NCT00402246|13093691|P1|NOT COMPLETED|Overall Study||220
5324364|NCT00402246|13093690|P2|COMPLETED|Overall Study||749
5324365|NCT00402246|13093691|P1|COMPLETED|Overall Study||794
5324366|NCT00402246|13093690|P2|STARTED|Overall Study||983
5324367|NCT00402246|13093691|P1|STARTED|Overall Study||1014
5324368|NCT00402233|13093725|P4|NOT COMPLETED|Overall Study||11
5324369|NCT00402233|13093726|P3|NOT COMPLETED|Overall Study||11
5324370|NCT00402233|13093727|P2|NOT COMPLETED|Overall Study||10
5324371|NCT00402233|13093728|P1|NOT COMPLETED|Overall Study||5
5324372|NCT00402233|13093725|P4|COMPLETED|Overall Study||62
5324373|NCT00402233|13093726|P3|COMPLETED|Overall Study||70
5324374|NCT00402233|13093727|P2|COMPLETED|Overall Study||70
5324375|NCT00402233|13093728|P1|COMPLETED|Overall Study||72
5324376|NCT00402233|13093725|P4|STARTED|Overall Study||73
5324377|NCT00402233|13093726|P3|STARTED|Overall Study||81
5324378|NCT00402233|13093727|P2|STARTED|Overall Study||80
5324379|NCT00402233|13093728|P1|STARTED|Overall Study||77
5324380|NCT00402194|13093752|P2|NOT COMPLETED|Overall Study||0
5324381|NCT00402194|13093753|P1|NOT COMPLETED|Overall Study||0
5324382|NCT00402194|13093752|P2|COMPLETED|Overall Study||8
5324383|NCT00402194|13093753|P1|COMPLETED|Overall Study||9
5324384|NCT00402194|13093752|P2|STARTED|Overall Study||8
5324385|NCT00402194|13093753|P1|STARTED|Overall Study||9
5324386|NCT00402168|13093763|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
5324387|NCT00402168|13093764|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
5324388|NCT00402168|13093763|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
5324389|NCT00402168|13093764|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
5324390|NCT00402168|13093763|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
5324391|NCT00402168|13093764|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
5324392|NCT00402168|13093763|P2|NOT COMPLETED|Long Term (LT)||17
5324393|NCT00402168|13093764|P1|NOT COMPLETED|Long Term (LT)||11
5324394|NCT00402168|13093763|P2|COMPLETED|Long Term (LT)||64
5324395|NCT00402168|13093764|P1|COMPLETED|Long Term (LT)||70
5324396|NCT00402168|13093763|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
5324397|NCT00402168|13093764|P1|STARTED|Long Term (LT)||81
5324398|NCT00402168|13093763|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
5324399|NCT00402168|13093764|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
5324400|NCT00402168|13093763|P2|COMPLETED|Treatment (up to 12 Months)||86
5324401|NCT00402168|13093764|P1|COMPLETED|Treatment (up to 12 Months)||81
5324402|NCT00402168|13093763|P2|STARTED|Treatment (up to 12 Months)||88
5324403|NCT00402168|13093764|P1|STARTED|Treatment (up to 12 Months)||83
5324404|NCT00402168|13093763|P2|NOT COMPLETED|Randomized||1
5324405|NCT00402168|13093764|P1|NOT COMPLETED|Randomized||1
5324406|NCT00402168|13093763|P2|COMPLETED|Randomized||88
5324407|NCT00402168|13093764|P1|COMPLETED|Randomized||83
5324408|NCT00402168|13093763|P2|STARTED|Randomized||89
5324409|NCT00402168|13093764|P1|STARTED|Randomized||84
5324410|NCT00402103|13093821|P2|NOT COMPLETED|Overall Study||13
5324411|NCT00402103|13093822|P1|NOT COMPLETED|Overall Study||91
5324412|NCT00402103|13093821|P2|COMPLETED|Overall Study||73
5324413|NCT00402103|13093822|P1|COMPLETED|Overall Study||379
5324414|NCT00402103|13093821|P2|STARTED|Overall Study||86
5324415|NCT00402103|13093822|P1|STARTED|Overall Study||470
5324416|NCT00402051|13093838|P2|NOT COMPLETED|Overall Study||35
5324417|NCT00402051|13093839|P1|NOT COMPLETED|Overall Study||38
5324418|NCT00402051|13093838|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
5324419|NCT00402051|13093839|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
5324420|NCT00402051|13093838|P2|Received Treatment|Overall Study||65
5324421|NCT00402051|13093839|P1|Received Treatment|Overall Study||65
5324422|NCT00402051|13093838|P2|STARTED|Overall Study||67
5324423|NCT00402051|13093839|P1|STARTED|Overall Study||66
5324424|NCT00402025|13093856|P3|NOT COMPLETED|Overall Study||10
5324425|NCT00402025|13093857|P2|NOT COMPLETED|Overall Study||3
5324426|NCT00402025|13093858|P1|NOT COMPLETED|Overall Study||2
5324427|NCT00402025|13093856|P3|COMPLETED|Overall Study||0
5324428|NCT00402025|13093857|P2|COMPLETED|Overall Study||1
5324429|NCT00402025|13093858|P1|COMPLETED|Overall Study||1
5324430|NCT00402025|13093856|P3|STARTED|Overall Study||10
5324431|NCT00402025|13093857|P2|STARTED|Overall Study||4
5324432|NCT00402025|13093858|P1|STARTED|Overall Study||3
5324433|NCT00401973|13093884|P3|NOT COMPLETED|Overall Study||23
5324434|NCT00401973|13093885|P2|NOT COMPLETED|Overall Study||26
5324435|NCT00401973|13093886|P1|NOT COMPLETED|Overall Study||11
5324436|NCT00401973|13093884|P3|COMPLETED|Overall Study||50
5324437|NCT00401973|13093885|P2|COMPLETED|Overall Study||50
5324438|NCT00401973|13093886|P1|COMPLETED|Overall Study||39
5324439|NCT00401973|13093884|P3|STARTED|Overall Study||73
5324440|NCT00401973|13093885|P2|STARTED|Overall Study||76
5324441|NCT00401973|13093886|P1|STARTED|Overall Study||50
5324442|NCT00401960|13093925|P2|NOT COMPLETED|Overall Study||0
5324443|NCT00401960|13093926|P1|NOT COMPLETED|Overall Study||5
5324444|NCT00401960|13093925|P2|COMPLETED|Overall Study||1
5324445|NCT00401960|13093926|P1|COMPLETED|Overall Study||0
5324446|NCT00401960|13093925|P2|STARTED|Overall Study||1
5324447|NCT00401960|13093926|P1|STARTED|Overall Study||5
5324448|NCT00401882|13093936|P2|NOT COMPLETED|Overall Study||0
5324449|NCT00401882|13093937|P1|NOT COMPLETED|Overall Study||0
5324450|NCT00401882|13093936|P2|COMPLETED|Overall Study||5
5324451|NCT00401882|13093937|P1|COMPLETED|Overall Study||2
5324452|NCT00401882|13093936|P2|STARTED|Overall Study||5
5324453|NCT00401882|13093937|P1|STARTED|Overall Study||2
5324454|NCT00401843|13093956|P3|NOT COMPLETED|Overall Study||142
5324455|NCT00401843|13093957|P2|NOT COMPLETED|Overall Study||144
5324456|NCT00401843|13093958|P1|NOT COMPLETED|Overall Study||21
5324457|NCT00401843|13093956|P3|COMPLETED|Overall Study||0
5324458|NCT00401843|13093957|P2|COMPLETED|Overall Study||0
5324459|NCT00401843|13093958|P1|COMPLETED|Overall Study||0
5324460|NCT00401843|13093956|P3|Treated|Overall Study||139
5324461|NCT00401843|13093957|P2|Treated|Overall Study||142
5324462|NCT00401843|13093958|P1|Treated|Overall Study||21
5324463|NCT00401843|13093956|P3|STARTED|Overall Study||142
5324464|NCT00401843|13093957|P2|STARTED|Overall Study||144
5324465|NCT00401843|13093958|P1|STARTED|Overall Study||21
5324466|NCT00401830|13093976|P2|NOT COMPLETED|Overall Study||32
5324467|NCT00401830|13093977|P1|NOT COMPLETED|Overall Study||31
5324468|NCT00401830|13093976|P2|COMPLETED|Overall Study||46
5324469|NCT00401830|13093977|P1|COMPLETED|Overall Study||50
5324470|NCT00401830|13093976|P2|STARTED|Overall Study||78
5324471|NCT00401830|13093977|P1|STARTED|Overall Study||81
5324472|NCT00401817|13094009|P1|NOT COMPLETED|Overall Study||0
5324473|NCT00401817|13094009|P1|COMPLETED|Overall Study||11
5324474|NCT00401817|13094009|P1|STARTED|Overall Study||11
5324475|NCT00401778|13094019|P3|NOT COMPLETED|Overall Study||1
5324476|NCT00401778|13094020|P2|NOT COMPLETED|Overall Study||1
5324477|NCT00401778|13094021|P1|NOT COMPLETED|Overall Study||1
5324478|NCT00401778|13094019|P3|COMPLETED|Overall Study||10
5324479|NCT00401778|13094020|P2|COMPLETED|Overall Study||11
5324480|NCT00401778|13094021|P1|COMPLETED|Overall Study||9
5324481|NCT00401778|13094019|P3|STARTED|Overall Study||11
5324482|NCT00401778|13094020|P2|STARTED|Overall Study||12
5324483|NCT00401778|13094021|P1|STARTED|Overall Study||10
5324484|NCT00401752|13094035|P2|NOT COMPLETED|Overall Study||18
5324485|NCT00401752|13094036|P1|NOT COMPLETED|Overall Study||10
5324486|NCT00401752|13094035|P2|COMPLETED|Overall Study||94
5324487|NCT00401752|13094036|P1|COMPLETED|Overall Study||97
5324488|NCT00401752|13094035|P2|Patients Included in Per-Protocol Popula|Overall Study||99
5324489|NCT00401752|13094036|P1|Patients Included in Per-Protocol Popula|Overall Study||100
5324490|NCT00401752|13094035|P2|Patients Included in Safety Population|Overall Study||110
5324491|NCT00401752|13094036|P1|Patients Included in Safety Population|Overall Study||107
5324492|NCT00401752|13094035|P2|Patients Included in ITT Population|Overall Study||111
5324493|NCT00401752|13094036|P1|Patients Included in ITT Population|Overall Study||106
5324494|NCT00401752|13094035|P2|Number of Patients Received Treatment|Overall Study||111
5324495|NCT00401752|13094036|P1|Number of Patients Received Treatment|Overall Study||107
5324496|NCT00401752|13094035|P2|STARTED|Overall Study||112
5324497|NCT00401752|13094036|P1|STARTED|Overall Study||107
5324498|NCT00401726|13094054|P2|NOT COMPLETED|Overall Study||112
5324499|NCT00401726|13094055|P1|NOT COMPLETED|Overall Study||97
5324500|NCT00401726|13094054|P2|COMPLETED|Overall Study||156
5324501|NCT00401726|13094055|P1|COMPLETED|Overall Study||172
5324502|NCT00401726|13094054|P2|STARTED|Overall Study||268
5324503|NCT00401726|13094055|P1|STARTED|Overall Study||269
5324504|NCT00401622|13094077|P2|NOT COMPLETED|Overall Study||43
5324505|NCT00401622|13094078|P1|NOT COMPLETED|Overall Study||34
5324506|NCT00401622|13094077|P2|COMPLETED|Overall Study||117
5324507|NCT00401622|13094078|P1|COMPLETED|Overall Study||126
5324508|NCT00401622|13094077|P2|STARTED|Overall Study||160
5324509|NCT00401622|13094078|P1|STARTED|Overall Study||160
5324510|NCT00401544|13094090|P4|NOT COMPLETED|Overall Study||16
5324511|NCT00401544|13094091|P3|NOT COMPLETED|Overall Study||12
5324512|NCT00401544|13094092|P2|NOT COMPLETED|Overall Study||18
5324513|NCT00401544|13094093|P1|NOT COMPLETED|Overall Study||18
5324514|NCT00401544|13094090|P4|COMPLETED|Overall Study||44
5324515|NCT00401544|13094091|P3|COMPLETED|Overall Study||48
5324516|NCT00401544|13094092|P2|COMPLETED|Overall Study||44
5324517|NCT00401544|13094093|P1|COMPLETED|Overall Study||38
5324518|NCT00401544|13094090|P4|STARTED|Overall Study|Randomized and treated|60
5324519|NCT00401544|13094091|P3|STARTED|Overall Study|Randomized and treated|60
5324520|NCT00401544|13094092|P2|STARTED|Overall Study|Randomized and treated|62
5324521|NCT00401544|13094093|P1|STARTED|Overall Study|Randomized and treated|56
5324522|NCT00401531|13094133|P2|NOT COMPLETED|Overall Study||10
5324523|NCT00401531|13094134|P1|NOT COMPLETED|Overall Study||9
5324524|NCT00401531|13094133|P2|COMPLETED|Overall Study||196
5324525|NCT00401531|13094134|P1|COMPLETED|Overall Study||197
5324526|NCT00401531|13094133|P2|STARTED|Overall Study||206
5324527|NCT00401531|13094134|P1|STARTED|Overall Study||206
5324528|NCT00401414|13094153|P3|NOT COMPLETED|Overall Study||0
5324529|NCT00401414|13094154|P2|NOT COMPLETED|Overall Study||0
5324530|NCT00401414|13094155|P1|NOT COMPLETED|Overall Study||0
5324531|NCT00401414|13094153|P3|COMPLETED|Overall Study||79
5324532|NCT00401414|13094154|P2|COMPLETED|Overall Study||147
5324533|NCT00401414|13094155|P1|COMPLETED|Overall Study||118
5324534|NCT00401414|13094153|P3|STARTED|Overall Study||79
5324535|NCT00401414|13094154|P2|STARTED|Overall Study||147
5324536|NCT00401414|13094155|P1|STARTED|Overall Study||118
5324537|NCT00401401|13094179|P4|NOT COMPLETED|Overall Study||3
5324538|NCT00401401|13094180|P3|NOT COMPLETED|Overall Study||1
5324539|NCT00401401|13094181|P2|NOT COMPLETED|Overall Study||0
5324540|NCT00401401|13094182|P1|NOT COMPLETED|Overall Study||0
5324541|NCT00401401|13094179|P4|COMPLETED|Overall Study||9
5324542|NCT00401401|13094180|P3|COMPLETED|Overall Study||5
5324543|NCT00401401|13094181|P2|COMPLETED|Overall Study||6
5324544|NCT00401401|13094182|P1|COMPLETED|Overall Study||6
5324545|NCT00401401|13094179|P4|STARTED|Overall Study||12
5324546|NCT00401401|13094180|P3|STARTED|Overall Study||6
5324547|NCT00401401|13094181|P2|STARTED|Overall Study||6
5324548|NCT00401401|13094182|P1|STARTED|Overall Study||6
5324549|NCT00401375|13094207|P3|NOT COMPLETED|Overall Study||25
5324550|NCT00401375|13094208|P2|NOT COMPLETED|Overall Study||25
5324551|NCT00401375|13094209|P1|NOT COMPLETED|Overall Study||22
5324552|NCT00401375|13094207|P3|COMPLETED|Overall Study||149
5324553|NCT00401375|13094208|P2|COMPLETED|Overall Study||151
5324554|NCT00401375|13094209|P1|COMPLETED|Overall Study||152
5324555|NCT00401375|13094207|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
5324556|NCT00401375|13094208|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
5324557|NCT00401375|13094209|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
5324558|NCT00401375|13094207|P3|STARTED|Overall Study||174
5324559|NCT00401375|13094208|P2|STARTED|Overall Study||176
5324560|NCT00401375|13094209|P1|STARTED|Overall Study||174
5324561|NCT00401258|13094226|P1|NOT COMPLETED|Overall Study||7
5324562|NCT00401258|13094226|P1|COMPLETED|Overall Study||8
5324563|NCT00401258|13094226|P1|STARTED|Overall Study||15
5324564|NCT00401245|13094241|P8|NOT COMPLETED|Double Blind Tapering Phase||7
5324565|NCT00401245|13094242|P7|NOT COMPLETED|Double Blind Tapering Phase||7
5324566|NCT00401245|13094243|P6|NOT COMPLETED|Double Blind Tapering Phase||4
5324567|NCT00401245|13094244|P5|NOT COMPLETED|Double Blind Tapering Phase||4
5324568|NCT00401245|13094245|P4|NOT COMPLETED|Double Blind Tapering Phase||0
5324569|NCT00401245|13094246|P3|NOT COMPLETED|Double Blind Tapering Phase||0
5324570|NCT00401245|13094247|P2|NOT COMPLETED|Double Blind Tapering Phase||0
5324571|NCT00401245|13094248|P1|NOT COMPLETED|Double Blind Tapering Phase||0
5324572|NCT00401245|13094241|P8|COMPLETED|Double Blind Tapering Phase||95
5324573|NCT00401245|13094242|P7|COMPLETED|Double Blind Tapering Phase||80
5324574|NCT00401245|13094243|P6|COMPLETED|Double Blind Tapering Phase||90
5324575|NCT00401245|13094244|P5|COMPLETED|Double Blind Tapering Phase||97
5324576|NCT00401245|13094245|P4|COMPLETED|Double Blind Tapering Phase||0
5324577|NCT00401245|13094246|P3|COMPLETED|Double Blind Tapering Phase||0
5324578|NCT00401245|13094247|P2|COMPLETED|Double Blind Tapering Phase||0
5324579|NCT00401245|13094248|P1|COMPLETED|Double Blind Tapering Phase||0
5324580|NCT00401245|13094241|P8|STARTED|Double Blind Tapering Phase||102
5324581|NCT00401245|13094242|P7|STARTED|Double Blind Tapering Phase||87
5324582|NCT00401245|13094243|P6|STARTED|Double Blind Tapering Phase||94
5324583|NCT00401245|13094244|P5|STARTED|Double Blind Tapering Phase||101
5324584|NCT00401245|13094245|P4|STARTED|Double Blind Tapering Phase||0
5324585|NCT00401245|13094246|P3|STARTED|Double Blind Tapering Phase||0
5324586|NCT00401245|13094247|P2|STARTED|Double Blind Tapering Phase||0
5324587|NCT00401245|13094248|P1|STARTED|Double Blind Tapering Phase||0
5324588|NCT00401245|13094241|P8|NOT COMPLETED|Open Label Phase||0
5324589|NCT00401245|13094242|P7|NOT COMPLETED|Open Label Phase||0
5324590|NCT00401245|13094243|P6|NOT COMPLETED|Open Label Phase||0
5324591|NCT00401245|13094244|P5|NOT COMPLETED|Open Label Phase||0
5324592|NCT00401245|13094245|P4|NOT COMPLETED|Open Label Phase||21
5324593|NCT00401245|13094246|P3|NOT COMPLETED|Open Label Phase||23
5324594|NCT00401245|13094247|P2|NOT COMPLETED|Open Label Phase||35
5324595|NCT00401245|13094248|P1|NOT COMPLETED|Open Label Phase||21
5324596|NCT00401245|13094241|P8|COMPLETED|Open Label Phase||0
5324597|NCT00401245|13094242|P7|COMPLETED|Open Label Phase||0
5324598|NCT00401245|13094243|P6|COMPLETED|Open Label Phase||0
5324599|NCT00401245|13094244|P5|COMPLETED|Open Label Phase||0
5324600|NCT00401245|13094245|P4|COMPLETED|Open Label Phase||84
5324601|NCT00401245|13094246|P3|COMPLETED|Open Label Phase||95
5324602|NCT00401245|13094247|P2|COMPLETED|Open Label Phase||81
5324603|NCT00401245|13094248|P1|COMPLETED|Open Label Phase||101
5324604|NCT00401245|13094241|P8|STARTED|Open Label Phase||0
5324605|NCT00401245|13094242|P7|STARTED|Open Label Phase||0
5324606|NCT00401245|13094243|P6|STARTED|Open Label Phase||0
5324607|NCT00401245|13094244|P5|STARTED|Open Label Phase||0
5324608|NCT00401245|13094245|P4|STARTED|Open Label Phase||105
5324609|NCT00401245|13094246|P3|STARTED|Open Label Phase||118
5324610|NCT00401245|13094247|P2|STARTED|Open Label Phase||116
5324611|NCT00401245|13094248|P1|STARTED|Open Label Phase||122
5324612|NCT00401245|13094241|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
5324613|NCT00401245|13094242|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
5324614|NCT00401245|13094243|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
5324615|NCT00401245|13094244|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
5324616|NCT00401245|13094245|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
5324617|NCT00401245|13094246|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
5324618|NCT00401245|13094247|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
5324619|NCT00401245|13094248|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
5324620|NCT00401245|13094241|P8|COMPLETED|Between Titration and Open Label Phase||0
5324621|NCT00401245|13094242|P7|COMPLETED|Between Titration and Open Label Phase||0
5324622|NCT00401245|13094243|P6|COMPLETED|Between Titration and Open Label Phase||0
5324623|NCT00401245|13094244|P5|COMPLETED|Between Titration and Open Label Phase||0
5324624|NCT00401245|13094245|P4|COMPLETED|Between Titration and Open Label Phase||105
5324625|NCT00401245|13094246|P3|COMPLETED|Between Titration and Open Label Phase||118
5324626|NCT00401245|13094247|P2|COMPLETED|Between Titration and Open Label Phase||116
5324627|NCT00401245|13094248|P1|COMPLETED|Between Titration and Open Label Phase||122
5324628|NCT00401245|13094241|P8|STARTED|Between Titration and Open Label Phase||0
5324629|NCT00401245|13094242|P7|STARTED|Between Titration and Open Label Phase||0
5324630|NCT00401245|13094243|P6|STARTED|Between Titration and Open Label Phase||0
5324631|NCT00401245|13094244|P5|STARTED|Between Titration and Open Label Phase||0
5324632|NCT00401245|13094245|P4|STARTED|Between Titration and Open Label Phase||107
5324633|NCT00401245|13094246|P3|STARTED|Between Titration and Open Label Phase||118
5324634|NCT00401245|13094247|P2|STARTED|Between Titration and Open Label Phase||118
5324635|NCT00401245|13094248|P1|STARTED|Between Titration and Open Label Phase||122
5324636|NCT00401245|13094241|P8|NOT COMPLETED|Double Blind Titration Phase||0
5324637|NCT00401245|13094242|P7|NOT COMPLETED|Double Blind Titration Phase||0
5324638|NCT00401245|13094243|P6|NOT COMPLETED|Double Blind Titration Phase||0
5324639|NCT00401245|13094244|P5|NOT COMPLETED|Double Blind Titration Phase||0
5324640|NCT00401245|13094245|P4|NOT COMPLETED|Double Blind Titration Phase||15
5324641|NCT00401245|13094246|P3|NOT COMPLETED|Double Blind Titration Phase||6
5324642|NCT00401245|13094247|P2|NOT COMPLETED|Double Blind Titration Phase||3
5324643|NCT00401245|13094248|P1|NOT COMPLETED|Double Blind Titration Phase||4
5324644|NCT00401245|13094241|P8|COMPLETED|Double Blind Titration Phase||0
5324645|NCT00401245|13094242|P7|COMPLETED|Double Blind Titration Phase||0
5324646|NCT00401245|13094243|P6|COMPLETED|Double Blind Titration Phase||0
5324647|NCT00401245|13094244|P5|COMPLETED|Double Blind Titration Phase||0
5324648|NCT00401245|13094245|P4|COMPLETED|Double Blind Titration Phase||107
5324649|NCT00401245|13094246|P3|COMPLETED|Double Blind Titration Phase||118
5324650|NCT00401245|13094247|P2|COMPLETED|Double Blind Titration Phase||118
5324651|NCT00401245|13094248|P1|COMPLETED|Double Blind Titration Phase||122
5324652|NCT00401245|13094241|P8|STARTED|Double Blind Titration Phase||0
5324653|NCT00401245|13094242|P7|STARTED|Double Blind Titration Phase||0
5324654|NCT00401245|13094243|P6|STARTED|Double Blind Titration Phase||0
5324655|NCT00401245|13094244|P5|STARTED|Double Blind Titration Phase||0
5324656|NCT00401245|13094245|P4|STARTED|Double Blind Titration Phase||122
5324657|NCT00401245|13094246|P3|STARTED|Double Blind Titration Phase||124
5324658|NCT00401245|13094247|P2|STARTED|Double Blind Titration Phase||121
5324659|NCT00401245|13094248|P1|STARTED|Double Blind Titration Phase||126
5324660|NCT00401193|13094316|P3|NOT COMPLETED|Overall Study||6
5324661|NCT00401193|13094317|P2|NOT COMPLETED|Overall Study||11
5324662|NCT00401193|13094318|P1|NOT COMPLETED|Overall Study||15
5324663|NCT00401193|13094316|P3|COMPLETED|Overall Study||63
5324664|NCT00401193|13094317|P2|COMPLETED|Overall Study||106
5324665|NCT00401193|13094318|P1|COMPLETED|Overall Study||103
5324666|NCT00401193|13094316|P3|Modified Intent to Treat Population|Overall Study||67
5324667|NCT00401193|13094317|P2|Modified Intent to Treat Population|Overall Study||115
5324668|NCT00401193|13094318|P1|Modified Intent to Treat Population|Overall Study||112
5324669|NCT00401193|13094316|P3|Intent to Treat Population|Overall Study||67
5324670|NCT00401193|13094317|P2|Intent to Treat Population|Overall Study||115
5324671|NCT00401193|13094318|P1|Intent to Treat Population|Overall Study||115
5324672|NCT00401193|13094316|P3|STARTED|Overall Study||69
5324673|NCT00401193|13094317|P2|STARTED|Overall Study||117
5324674|NCT00401193|13094318|P1|STARTED|Overall Study||118
5324675|NCT00401102|13094332|P1|NOT COMPLETED|Overall Study||7
5324676|NCT00401102|13094332|P1|COMPLETED|Overall Study||5
5324677|NCT00401102|13094332|P1|STARTED|Overall Study||12
5324678|NCT00400985|13094336|P1|NOT COMPLETED|Overall Study||52
5324679|NCT00400985|13094336|P1|COMPLETED|Overall Study||449
5324680|NCT00400985|13094336|P1|STARTED|Overall Study||501
5324681|NCT00400946|13094345|P5|NOT COMPLETED|Overall Study||38
5324682|NCT00400946|13094346|P4|NOT COMPLETED|Overall Study||47
5324683|NCT00400946|13094347|P3|NOT COMPLETED|Overall Study||2
5324684|NCT00400946|13094348|P2|NOT COMPLETED|Overall Study||11
5324685|NCT00400946|13094349|P1|NOT COMPLETED|Overall Study||14
5324686|NCT00400946|13094345|P5|COMPLETED|Overall Study||206
5324687|NCT00400946|13094346|P4|COMPLETED|Overall Study||4
5324688|NCT00400946|13094347|P3|COMPLETED|Overall Study||40
5324689|NCT00400946|13094348|P2|COMPLETED|Overall Study||221
5324690|NCT00400946|13094349|P1|COMPLETED|Overall Study||217
5324691|NCT00400946|13094345|P5|Eligible and Treated|Overall Study||243
5324692|NCT00400946|13094346|P4|Eligible and Treated|Overall Study||46
5324693|NCT00400946|13094347|P3|Eligible and Treated|Overall Study||42
5324694|NCT00400946|13094348|P2|Eligible and Treated|Overall Study||232
5324695|NCT00400946|13094349|P1|Eligible and Treated|Overall Study||231
5324696|NCT00400946|13094345|P5|Evaluable for Day 32 MRD|Overall Study||168
5324697|NCT00400946|13094346|P4|Evaluable for Day 32 MRD|Overall Study||12
5324698|NCT00400946|13094347|P3|Evaluable for Day 32 MRD|Overall Study||33
5324699|NCT00400946|13094348|P2|Evaluable for Day 32 MRD|Overall Study||167
5324700|NCT00400946|13094349|P1|Evaluable for Day 32 MRD|Overall Study||166
5324701|NCT00400946|13094345|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
5324702|NCT00400946|13094346|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
5324703|NCT00400946|13094347|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
5324704|NCT00400946|13094348|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
5324705|NCT00400946|13094349|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
5324706|NCT00400946|13094345|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
5324707|NCT00400946|13094346|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
5324708|NCT00400946|13094347|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
5324709|NCT00400946|13094348|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
5324710|NCT00400946|13094349|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
5324711|NCT00400946|13094345|P5|STARTED|Overall Study||244
5324712|NCT00400946|13094346|P4|STARTED|Overall Study||51
5324713|NCT00400946|13094347|P3|STARTED|Overall Study||42
5324714|NCT00400946|13094348|P2|STARTED|Overall Study||232
5324715|NCT00400946|13094349|P1|STARTED|Overall Study||231
5324716|NCT00400881|13094377|P2|NOT COMPLETED|Overall Study||0
5324717|NCT00400881|13094378|P1|NOT COMPLETED|Overall Study||0
5324718|NCT00400881|13094377|P2|COMPLETED|Overall Study||60
5324719|NCT00400881|13094378|P1|COMPLETED|Overall Study||62
5324720|NCT00400881|13094377|P2|STARTED|Overall Study||60
5324721|NCT00400881|13094378|P1|STARTED|Overall Study||62
5324722|NCT00400829|13094386|P1|NOT COMPLETED|Overall Study||0
5324723|NCT00400829|13094386|P1|COMPLETED|Overall Study||66
5324724|NCT00400829|13094386|P1|STARTED|Overall Study||66
5324725|NCT00400803|13094392|P1|NOT COMPLETED|Overall Study||0
5324726|NCT00400803|13094392|P1|COMPLETED|Overall Study||35
5324727|NCT00400803|13094392|P1|STARTED|Overall Study||35
5324728|NCT00400764|13094408|P5|NOT COMPLETED|Phase II||11
5324729|NCT00400764|13094409|P4|NOT COMPLETED|Phase II||26
5324730|NCT00400764|13094410|P3|NOT COMPLETED|Phase II||23
5324731|NCT00400764|13094411|P2|NOT COMPLETED|Phase II||0
5324732|NCT00400764|13094412|P1|NOT COMPLETED|Phase II||0
5324733|NCT00400764|13094408|P5|COMPLETED|Phase II||0
5324734|NCT00400764|13094409|P4|COMPLETED|Phase II||0
5324735|NCT00400764|13094410|P3|COMPLETED|Phase II||0
5324736|NCT00400764|13094411|P2|COMPLETED|Phase II||0
5324737|NCT00400764|13094412|P1|COMPLETED|Phase II||0
5324738|NCT00400764|13094408|P5|Treated|Phase II||11
5324739|NCT00400764|13094409|P4|Treated|Phase II||26
5324740|NCT00400764|13094410|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
5324741|NCT00400764|13094411|P2|Treated|Phase II||0
5324742|NCT00400764|13094412|P1|Treated|Phase II||0
5324743|NCT00400764|13094408|P5|STARTED|Phase II||11
5324744|NCT00400764|13094409|P4|STARTED|Phase II||26
5324745|NCT00400764|13094410|P3|STARTED|Phase II||23
5324746|NCT00400764|13094411|P2|STARTED|Phase II||0
5324747|NCT00400764|13094412|P1|STARTED|Phase II||0
5324748|NCT00400764|13094408|P5|NOT COMPLETED|Phase Ib||0
5324749|NCT00400764|13094409|P4|NOT COMPLETED|Phase Ib||0
5324750|NCT00400764|13094410|P3|NOT COMPLETED|Phase Ib||0
5324751|NCT00400764|13094411|P2|NOT COMPLETED|Phase Ib||4
5324752|NCT00400764|13094412|P1|NOT COMPLETED|Phase Ib||6
5324753|NCT00400764|13094408|P5|COMPLETED|Phase Ib||0
5324754|NCT00400764|13094409|P4|COMPLETED|Phase Ib||0
5324755|NCT00400764|13094410|P3|COMPLETED|Phase Ib||0
5324756|NCT00400764|13094411|P2|COMPLETED|Phase Ib||2
5324757|NCT00400764|13094412|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
5324758|NCT00400764|13094408|P5|Treated|Phase Ib||0
5324759|NCT00400764|13094409|P4|Treated|Phase Ib||0
5324760|NCT00400764|13094410|P3|Treated|Phase Ib||0
5324761|NCT00400764|13094411|P2|Treated|Phase Ib||6
5324762|NCT00400764|13094412|P1|Treated|Phase Ib||6
5324763|NCT00400764|13094408|P5|STARTED|Phase Ib||0
5324764|NCT00400764|13094409|P4|STARTED|Phase Ib||0
5324765|NCT00400764|13094410|P3|STARTED|Phase Ib||0
5324766|NCT00400764|13094411|P2|STARTED|Phase Ib||6
5324767|NCT00400764|13094412|P1|STARTED|Phase Ib||6
5324768|NCT00400712|13094465|P2|NOT COMPLETED|Overall Study||16
5324769|NCT00400712|13094466|P1|NOT COMPLETED|Overall Study||17
5324770|NCT00400712|13094465|P2|COMPLETED|Overall Study||35
5324771|NCT00400712|13094466|P1|COMPLETED|Overall Study||35
5324772|NCT00400712|13094465|P2|STARTED|Overall Study||51
5324773|NCT00400712|13094466|P1|STARTED|Overall Study||52
5324774|NCT00400686|13094484|P1|NOT COMPLETED|Overall Study||0
5324775|NCT00400686|13094484|P1|COMPLETED|Overall Study||31
5324776|NCT00400686|13094484|P1|STARTED|Overall Study||31
5324777|NCT00400634|13094492|P2|NOT COMPLETED|Overall Study||1
5324778|NCT00400634|13094493|P1|NOT COMPLETED|Overall Study||4
5324779|NCT00400634|13094492|P2|COMPLETED|Overall Study||19
5324780|NCT00400634|13094493|P1|COMPLETED|Overall Study||34
5324781|NCT00400634|13094492|P2|STARTED|Overall Study||20
5324782|NCT00400634|13094493|P1|STARTED|Overall Study||38
5324783|NCT00400569|13094501|P1|NOT COMPLETED|Overall Study||1
5324784|NCT00400569|13094501|P1|COMPLETED|Overall Study||47
5324785|NCT00400569|13094501|P1|STARTED|Overall Study||48
5324786|NCT00400517|13094512|P1|NOT COMPLETED|Overall Study||2
5324787|NCT00400517|13094512|P1|COMPLETED|Overall Study||26
5324788|NCT00400517|13094512|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
5324789|NCT00400439|13094521|P2|NOT COMPLETED|Overall Study||2
5324790|NCT00400439|13094522|P1|NOT COMPLETED|Overall Study||5
5324791|NCT00400439|13094521|P2|COMPLETED|Overall Study||23
5324792|NCT00400439|13094522|P1|COMPLETED|Overall Study||47
5324793|NCT00400439|13094521|P2|STARTED|Overall Study||25
5324794|NCT00400439|13094522|P1|STARTED|Overall Study||52
5324795|NCT00400400|13094532|P2|NOT COMPLETED|Overall Study||15
5324796|NCT00400400|13094533|P1|NOT COMPLETED|Overall Study||14
5324797|NCT00400400|13094532|P2|COMPLETED|Overall Study||185
5324798|NCT00400400|13094533|P1|COMPLETED|Overall Study||186
5324799|NCT00400400|13094532|P2|Intent-to-Treat Population|Overall Study||197
5324800|NCT00400400|13094533|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
5324801|NCT00400400|13094532|P2|STARTED|Overall Study||200
5324802|NCT00400400|13094533|P1|STARTED|Overall Study||200
5324803|NCT00400205|13094551|P1|NOT COMPLETED|Overall Study||5
5324804|NCT00400205|13094551|P1|COMPLETED|Overall Study||9
5324805|NCT00400205|13094551|P1|STARTED|Overall Study||14
5324806|NCT00400179|13094558|P2|NOT COMPLETED|Overall Study||18
5324807|NCT00400179|13094559|P1|NOT COMPLETED|Overall Study||6
5324808|NCT00400179|13094558|P2|COMPLETED|Overall Study||508
5324809|NCT00400179|13094559|P1|COMPLETED|Overall Study|Received Treatment|521
5324810|NCT00400179|13094558|P2|STARTED|Overall Study||526
5324811|NCT00400179|13094559|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
5324812|NCT00400153|13094576|P3|NOT COMPLETED|Overall Study||61
5324813|NCT00400153|13094577|P2|NOT COMPLETED|Overall Study||55
5324814|NCT00400153|13094578|P1|NOT COMPLETED|Overall Study||48
5324815|NCT00400153|13094576|P3|COMPLETED|Overall Study||422
5324816|NCT00400153|13094577|P2|COMPLETED|Overall Study||436
5324817|NCT00400153|13094578|P1|COMPLETED|Overall Study||438
5324818|NCT00400153|13094576|P3|STARTED|Overall Study||483
5324819|NCT00400153|13094577|P2|STARTED|Overall Study||491
5324820|NCT00400153|13094578|P1|STARTED|Overall Study||486
5324821|NCT00399893|13094825|P2|NOT COMPLETED|Overall Study||0
5324822|NCT00399893|13094826|P1|NOT COMPLETED|Overall Study||1
5324823|NCT00399893|13094825|P2|COMPLETED|Overall Study||3
5324824|NCT00399893|13094826|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
5324825|NCT00399893|13094825|P2|STARTED|Overall Study||3
5324826|NCT00399893|13094826|P1|STARTED|Overall Study||2
5324827|NCT00399880|13094854|P2|NOT COMPLETED|Overall Study||0
5324828|NCT00399880|13094855|P1|NOT COMPLETED|Overall Study||0
5324829|NCT00399880|13094854|P2|COMPLETED|Overall Study||65
5324830|NCT00399880|13094855|P1|COMPLETED|Overall Study||65
5324831|NCT00399880|13094854|P2|STARTED|Overall Study||65
5324832|NCT00399880|13094855|P1|STARTED|Overall Study||65
5324833|NCT00399802|13094865|P2|NOT COMPLETED|Overall Study||3
5324834|NCT00399802|13094866|P1|NOT COMPLETED|Overall Study||0
5324835|NCT00399802|13094865|P2|COMPLETED|Overall Study||26
5324836|NCT00399802|13094866|P1|COMPLETED|Overall Study||14
5324837|NCT00399802|13094865|P2|STARTED|Overall Study||29
5324838|NCT00399802|13094866|P1|STARTED|Overall Study||14
5324839|NCT00399763|13094880|P2|NOT COMPLETED|Overall Study||3
5324840|NCT00399763|13094881|P1|NOT COMPLETED|Overall Study||2
5324841|NCT00399763|13094880|P2|COMPLETED|Overall Study||32
5324842|NCT00399763|13094881|P1|COMPLETED|Overall Study||33
5324843|NCT00399763|13094880|P2|STARTED|Overall Study||35
5324844|NCT00399763|13094881|P1|STARTED|Overall Study||35
5324845|NCT00399568|13094893|P2|NOT COMPLETED|Overall Study||9
5324846|NCT00399568|13094894|P1|NOT COMPLETED|Overall Study||12
5324847|NCT00399568|13094893|P2|COMPLETED|Overall Study||156
5324848|NCT00399568|13094894|P1|COMPLETED|Overall Study||154
5324849|NCT00399568|13094893|P2|STARTED|Overall Study||165
5324850|NCT00399568|13094894|P1|STARTED|Overall Study||166
5324851|NCT00399542|13094908|P2|NOT COMPLETED|Overall Study||43
5324852|NCT00399542|13094909|P1|NOT COMPLETED|Overall Study||84
5324853|NCT00399542|13094908|P2|COMPLETED|Overall Study||151
5324854|NCT00399542|13094909|P1|COMPLETED|Overall Study||303
5324855|NCT00399542|13094908|P2|STARTED|Overall Study||194
5324856|NCT00399542|13094909|P1|STARTED|Overall Study||387
5324857|NCT00399529|13094971|P1|NOT COMPLETED|Overall Study||2
5324858|NCT00399529|13094971|P1|COMPLETED|Overall Study||20
5324859|NCT00399529|13094971|P1|STARTED|Overall Study||22
5324860|NCT00399516|13094977|P1|NOT COMPLETED|Overall Study||2
5324861|NCT00399516|13094977|P1|COMPLETED|Overall Study||19
5324862|NCT00399516|13094977|P1|STARTED|Overall Study||21
5324863|NCT00399360|13094985|P4|NOT COMPLETED|Overall Study||6
5324864|NCT00399360|13094986|P3|NOT COMPLETED|Overall Study||3
5324865|NCT00399360|13094987|P2|NOT COMPLETED|Overall Study||3
5324866|NCT00399360|13094988|P1|NOT COMPLETED|Overall Study||2
5324867|NCT00399360|13094985|P4|COMPLETED|Overall Study||9
5324868|NCT00399360|13094986|P3|COMPLETED|Overall Study||10
5324869|NCT00399360|13094987|P2|COMPLETED|Overall Study||8
5324870|NCT00399360|13094988|P1|COMPLETED|Overall Study||9
5324871|NCT00399360|13094985|P4|STARTED|Overall Study||15
5324872|NCT00399360|13094986|P3|STARTED|Overall Study||13
5324873|NCT00399360|13094987|P2|STARTED|Overall Study||11
5324874|NCT00399360|13094988|P1|STARTED|Overall Study||11
5324875|NCT00399308|13095037|P3|NOT COMPLETED|Overall Study||1
5324876|NCT00399308|13095038|P2|NOT COMPLETED|Overall Study||0
5324877|NCT00399308|13095039|P1|NOT COMPLETED|Overall Study||0
5324878|NCT00399308|13095037|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
5324879|NCT00399308|13095038|P2|COMPLETED|Overall Study||15
5324880|NCT00399308|13095039|P1|COMPLETED|Overall Study||13
5324881|NCT00399308|13095037|P3|STARTED|Overall Study||12
5324882|NCT00399308|13095038|P2|STARTED|Overall Study||15
5324883|NCT00399308|13095039|P1|STARTED|Overall Study||13
5324884|NCT00399035|13095059|P3|NOT COMPLETED|Overall Study||252
5324885|NCT00399035|13095060|P2|NOT COMPLETED|Overall Study||158
5324886|NCT00399035|13095061|P1|NOT COMPLETED|Overall Study||313
5324887|NCT00399035|13095059|P3|COMPLETED|Overall Study||106
5324888|NCT00399035|13095060|P2|COMPLETED|Overall Study||58
5324889|NCT00399035|13095061|P1|COMPLETED|Overall Study||189
5324890|NCT00399035|13095059|P3|STARTED|Overall Study||358
5324891|NCT00399035|13095060|P2|STARTED|Overall Study||216
5324892|NCT00399035|13095061|P1|STARTED|Overall Study||502
5324893|NCT00398983|13095082|P2|NOT COMPLETED|Overall Study||0
5324894|NCT00398983|13095083|P1|NOT COMPLETED|Overall Study||0
5324895|NCT00398983|13095082|P2|COMPLETED|Overall Study||25
5324896|NCT00398983|13095083|P1|COMPLETED|Overall Study||20
5324897|NCT00398983|13095082|P2|STARTED|Overall Study||25
5324898|NCT00398983|13095083|P1|STARTED|Overall Study||20
5324899|NCT00398918|13095089|P1|NOT COMPLETED|Overall Study||0
5324900|NCT00398918|13095089|P1|COMPLETED|Overall Study||10
5324901|NCT00398918|13095089|P1|STARTED|Overall Study||10
5324902|NCT00398866|13095097|P3|NOT COMPLETED|Overall Study||8
5324903|NCT00398866|13095098|P2|NOT COMPLETED|Overall Study||8
5324904|NCT00398866|13095099|P1|NOT COMPLETED|Overall Study||14
5324905|NCT00398866|13095097|P3|COMPLETED|Overall Study||58
5324906|NCT00398866|13095098|P2|COMPLETED|Overall Study||60
5324907|NCT00398866|13095099|P1|COMPLETED|Overall Study||52
5324908|NCT00398866|13095097|P3|STARTED|Overall Study||66
5324909|NCT00398866|13095098|P2|STARTED|Overall Study||68
5324910|NCT00398866|13095099|P1|STARTED|Overall Study||66
5324911|NCT00398632|13095110|P1|NOT COMPLETED|Overall Study||2
5324912|NCT00398632|13095110|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
5324913|NCT00398632|13095110|P1|STARTED|Overall Study||6
5324914|NCT00398567|13095118|P3|NOT COMPLETED|Overall Study||34
5324915|NCT00398567|13095119|P2|NOT COMPLETED|Overall Study||4
5324916|NCT00398567|13095120|P1|NOT COMPLETED|Overall Study||4
5324917|NCT00398567|13095118|P3|COMPLETED|Overall Study||3
5324918|NCT00398567|13095119|P2|COMPLETED|Overall Study||0
5324919|NCT00398567|13095120|P1|COMPLETED|Overall Study||0
5324920|NCT00398567|13095118|P3|STARTED|Overall Study||37
5324921|NCT00398567|13095119|P2|STARTED|Overall Study||4
5324922|NCT00398567|13095120|P1|STARTED|Overall Study||4
5324923|NCT00398476|13095132|P2|NOT COMPLETED|Treatment Period 2||0
5324924|NCT00398476|13095133|P1|NOT COMPLETED|Treatment Period 2||0
5324925|NCT00398476|13095132|P2|COMPLETED|Treatment Period 2||64
5324926|NCT00398476|13095133|P1|COMPLETED|Treatment Period 2||63
5324927|NCT00398476|13095132|P2|STARTED|Treatment Period 2||64
5324928|NCT00398476|13095133|P1|STARTED|Treatment Period 2||63
5324929|NCT00398476|13095132|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
5324930|NCT00398476|13095133|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
5324931|NCT00398476|13095132|P2|COMPLETED|Washout Period (20 Minutes)||64
5324932|NCT00398476|13095133|P1|COMPLETED|Washout Period (20 Minutes)||63
5324933|NCT00398476|13095132|P2|STARTED|Washout Period (20 Minutes)||64
5324934|NCT00398476|13095133|P1|STARTED|Washout Period (20 Minutes)||63
5324935|NCT00398476|13095132|P2|NOT COMPLETED|Treatment Period 1||0
5324936|NCT00398476|13095133|P1|NOT COMPLETED|Treatment Period 1||0
5324937|NCT00398476|13095132|P2|COMPLETED|Treatment Period 1||64
5324938|NCT00398476|13095133|P1|COMPLETED|Treatment Period 1||63
5324939|NCT00398476|13095132|P2|STARTED|Treatment Period 1||64
5324940|NCT00398476|13095133|P1|STARTED|Treatment Period 1||63
5324941|NCT00398411|13095174|P2|NOT COMPLETED|Overall Study||1
5324942|NCT00398411|13095175|P1|NOT COMPLETED|Overall Study||0
5324943|NCT00398411|13095174|P2|COMPLETED|Overall Study||31
5324944|NCT00398411|13095175|P1|COMPLETED|Overall Study||34
5324945|NCT00398411|13095174|P2|STARTED|Overall Study||32
5324946|NCT00398411|13095175|P1|STARTED|Overall Study||34
5324947|NCT00398398|13095191|P1|NOT COMPLETED|Overall Study||0
5324948|NCT00398398|13095191|P1|COMPLETED|Overall Study||44
5324949|NCT00398398|13095191|P1|STARTED|Overall Study||44
5324950|NCT00398320|13095198|P1|NOT COMPLETED|Overall Study||6
5324951|NCT00398320|13095198|P1|COMPLETED|Overall Study||34
5324952|NCT00398320|13095198|P1|STARTED|Overall Study||40
5324953|NCT00398216|13095211|P5|NOT COMPLETED|Overall Study||15
5324954|NCT00398216|13095212|P4|NOT COMPLETED|Overall Study||22
5324955|NCT00398216|13095213|P3|NOT COMPLETED|Overall Study||21
5324956|NCT00398216|13095214|P2|NOT COMPLETED|Overall Study||19
5324957|NCT00398216|13095215|P1|NOT COMPLETED|Overall Study||11
5324958|NCT00398216|13095211|P5|COMPLETED|Overall Study||157
5324959|NCT00398216|13095212|P4|COMPLETED|Overall Study||155
5324960|NCT00398216|13095213|P3|COMPLETED|Overall Study||164
5324961|NCT00398216|13095214|P2|COMPLETED|Overall Study||151
5324962|NCT00398216|13095215|P1|COMPLETED|Overall Study||181
5324963|NCT00398216|13095211|P5|STARTED|Overall Study||172
5324964|NCT00398216|13095212|P4|STARTED|Overall Study||177
5324965|NCT00398216|13095213|P3|STARTED|Overall Study||185
5324966|NCT00398216|13095214|P2|STARTED|Overall Study||170
5324967|NCT00398216|13095215|P1|STARTED|Overall Study||192
5324968|NCT00398138|13095242|P1|NOT COMPLETED|Overall Study||2
5324969|NCT00398138|13095242|P1|COMPLETED|Overall Study||10
5324970|NCT00398138|13095242|P1|STARTED|Overall Study||12
5324971|NCT00398112|13095247|P1|NOT COMPLETED|Overall Study||18
5324972|NCT00398112|13095247|P1|COMPLETED|Overall Study||0
5324973|NCT00398112|13095247|P1|STARTED|Overall Study||18
5324974|NCT00398086|13095258|P3|NOT COMPLETED|Overall Study||2
5324975|NCT00398086|13095259|P2|NOT COMPLETED|Overall Study||23
5324976|NCT00398086|13095260|P1|NOT COMPLETED|Overall Study||9
5324977|NCT00398086|13095258|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
5324978|NCT00398086|13095259|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
5324979|NCT00398086|13095260|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
5324980|NCT00398086|13095258|P3|Phase 1, Dose Escalation Population|Overall Study||3
5324981|NCT00398086|13095259|P2|Phase 1, Dose Escalation Population|Overall Study||7
5324982|NCT00398086|13095260|P1|Phase 1, Dose Escalation Population|Overall Study||20
5324983|NCT00398086|13095258|P3|STARTED|Overall Study||3
5324984|NCT00398086|13095259|P2|STARTED|Overall Study||44
5324985|NCT00398086|13095260|P1|STARTED|Overall Study||20
5324986|NCT00398073|13095294|P2|NOT COMPLETED|Overall Study||0
5324987|NCT00398073|13095295|P1|NOT COMPLETED|Overall Study||1
5324988|NCT00398073|13095294|P2|COMPLETED|Overall Study||17
5324989|NCT00398073|13095295|P1|COMPLETED|Overall Study||17
5324990|NCT00398073|13095294|P2|STARTED|Overall Study||17
5324991|NCT00398073|13095295|P1|STARTED|Overall Study||18
5324992|NCT00398047|13095305|P1|NOT COMPLETED|Overall Study||3
5324993|NCT00398047|13095305|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
5324994|NCT00398047|13095305|P1|STARTED|Overall Study||3
5324995|NCT00397982|13095315|P1|NOT COMPLETED|Overall Study||4
5324996|NCT00397982|13095315|P1|COMPLETED|Overall Study||13
5324997|NCT00397982|13095315|P1|STARTED|Overall Study||17
5324998|NCT00397943|13095329|P5|NOT COMPLETED|Overall Study||0
5324999|NCT00397943|13095330|P4|NOT COMPLETED|Overall Study||0
5325000|NCT00397943|13095331|P3|NOT COMPLETED|Overall Study||0
5325001|NCT00397943|13095332|P2|NOT COMPLETED|Overall Study||9
5325002|NCT00397943|13095333|P1|NOT COMPLETED|Overall Study||12
5325003|NCT00397943|13095329|P5|COMPLETED|Overall Study||10
5325004|NCT00397943|13095330|P4|COMPLETED|Overall Study||10
5325005|NCT00397943|13095331|P3|COMPLETED|Overall Study||10
5325006|NCT00397943|13095332|P2|COMPLETED|Overall Study||31
5325007|NCT00397943|13095333|P1|COMPLETED|Overall Study||28
5325008|NCT00397943|13095329|P5|STARTED|Overall Study||10
5325009|NCT00397943|13095330|P4|STARTED|Overall Study||10
5325010|NCT00397943|13095331|P3|STARTED|Overall Study||10
5325011|NCT00397943|13095332|P2|STARTED|Overall Study||40
5325012|NCT00397943|13095333|P1|STARTED|Overall Study||40
5325013|NCT00397930|13095489|P2|NOT COMPLETED|Overall Study||51
5325014|NCT00397930|13095490|P1|NOT COMPLETED|Overall Study||38
5325015|NCT00397930|13095489|P2|COMPLETED|Overall Study||153
5325016|NCT00397930|13095490|P1|COMPLETED|Overall Study||168
5325017|NCT00397930|13095489|P2|STARTED|Overall Study||204
5325018|NCT00397930|13095490|P1|STARTED|Overall Study||206
5325019|NCT00397904|13095496|P1|NOT COMPLETED|Overall Study||0
5325020|NCT00397904|13095496|P1|COMPLETED|Overall Study||16
5325021|NCT00397904|13095496|P1|STARTED|Overall Study||16
5325022|NCT00397891|13095505|P5|NOT COMPLETED|Overall Study||1
5325023|NCT00397891|13095506|P4|NOT COMPLETED|Overall Study||0
5325024|NCT00397891|13095507|P3|NOT COMPLETED|Overall Study||0
5325025|NCT00397891|13095508|P2|NOT COMPLETED|Overall Study||0
5325026|NCT00397891|13095509|P1|NOT COMPLETED|Overall Study||1
5325027|NCT00397891|13095505|P5|COMPLETED|Overall Study||7
5325028|NCT00397891|13095506|P4|COMPLETED|Overall Study||6
5325029|NCT00397891|13095507|P3|COMPLETED|Overall Study||6
5325030|NCT00397891|13095508|P2|COMPLETED|Overall Study||6
5325031|NCT00397891|13095509|P1|COMPLETED|Overall Study||5
5325032|NCT00397891|13095505|P5|STARTED|Overall Study||8
5325033|NCT00397891|13095506|P4|STARTED|Overall Study||6
5325034|NCT00397891|13095507|P3|STARTED|Overall Study||6
5325035|NCT00397891|13095508|P2|STARTED|Overall Study||6
5325036|NCT00397891|13095509|P1|STARTED|Overall Study||6
5325037|NCT00397878|13095607|P1|NOT COMPLETED|Overall Study||0
5325038|NCT00397878|13095607|P1|COMPLETED|Overall Study||10
5325039|NCT00397878|13095607|P1|STARTED|Overall Study||10
5325040|NCT00397839|13095616|P2|NOT COMPLETED|Overall Study||18
5325041|NCT00397839|13095617|P1|NOT COMPLETED|Overall Study||7
5325042|NCT00397839|13095616|P2|COMPLETED|Overall Study||69
5325043|NCT00397839|13095617|P1|COMPLETED|Overall Study||41
5325044|NCT00397839|13095616|P2|STARTED|Overall Study||87
5325045|NCT00397839|13095617|P1|STARTED|Overall Study||48
5325046|NCT00397813|13095637|P6|NOT COMPLETED|Overall Study||0
5325047|NCT00397813|13095638|P5|NOT COMPLETED|Overall Study||0
5325048|NCT00397813|13095639|P4|NOT COMPLETED|Overall Study||0
5325049|NCT00397813|13095640|P3|NOT COMPLETED|Overall Study||0
5325050|NCT00397813|13095641|P2|NOT COMPLETED|Overall Study||0
5325051|NCT00397813|13095642|P1|NOT COMPLETED|Overall Study||0
5325052|NCT00397813|13095637|P6|COMPLETED|Overall Study||24
5325053|NCT00397813|13095638|P5|COMPLETED|Overall Study||5
5325054|NCT00397813|13095639|P4|COMPLETED|Overall Study||12
5325055|NCT00397813|13095640|P3|COMPLETED|Overall Study||0
5325056|NCT00397813|13095641|P2|COMPLETED|Overall Study||0
5325057|NCT00397813|13095642|P1|COMPLETED|Overall Study||36
5325058|NCT00397813|13095637|P6|STARTED|Overall Study||24
5325059|NCT00397813|13095638|P5|STARTED|Overall Study||5
5325060|NCT00397813|13095639|P4|STARTED|Overall Study||12
5325061|NCT00397813|13095640|P3|STARTED|Overall Study||0
5325062|NCT00397813|13095641|P2|STARTED|Overall Study||0
5325063|NCT00397813|13095642|P1|STARTED|Overall Study||36
5325064|NCT00397631|13095682|P2|NOT COMPLETED|Overall Study||44
5325065|NCT00397631|13095683|P1|NOT COMPLETED|Overall Study||30
5325066|NCT00397631|13095682|P2|COMPLETED|Overall Study||215
5325067|NCT00397631|13095683|P1|COMPLETED|Overall Study||231
5325068|NCT00397631|13095682|P2|STARTED|Overall Study||259
5325069|NCT00397631|13095683|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
5325070|NCT00397579|13095693|P1|NOT COMPLETED|Overall Study||0
5325071|NCT00397579|13095693|P1|COMPLETED|Overall Study||11
5325072|NCT00397579|13095693|P1|STARTED|Overall Study||11
5325073|NCT00397540|13095699|P2|NOT COMPLETED|Overall Study||0
5325074|NCT00397540|13095700|P1|NOT COMPLETED|Overall Study||1
5325075|NCT00397540|13095699|P2|COMPLETED|Overall Study||85
5325076|NCT00397540|13095700|P1|COMPLETED|Overall Study||59
5325077|NCT00397540|13095699|P2|STARTED|Overall Study||85
5325078|NCT00397540|13095700|P1|STARTED|Overall Study||60
5325079|NCT00397514|13095708|P1|NOT COMPLETED|Overall Study||9
5325080|NCT00397514|13095708|P1|COMPLETED|Overall Study||25
5325081|NCT00397514|13095708|P1|STARTED|Overall Study||34
5325082|NCT00397488|13095718|P1|NOT COMPLETED|Overall Study||7
5325083|NCT00397488|13095718|P1|COMPLETED|Overall Study||71
5325084|NCT00397488|13095718|P1|STARTED|Overall Study||78
5325085|NCT00397462|13095725|P3|NOT COMPLETED|Overall Study||0
5325086|NCT00397462|13095726|P2|NOT COMPLETED|Overall Study||0
5325087|NCT00397462|13095727|P1|NOT COMPLETED|Overall Study||0
5325088|NCT00397462|13095725|P3|COMPLETED|Overall Study||15
5325089|NCT00397462|13095726|P2|COMPLETED|Overall Study||13
5325090|NCT00397462|13095727|P1|COMPLETED|Overall Study||16
5325091|NCT00397462|13095725|P3|STARTED|Overall Study||15
5325092|NCT00397462|13095726|P2|STARTED|Overall Study||13
5325093|NCT00397462|13095727|P1|STARTED|Overall Study||16
5325094|NCT00397254|13095738|P2|NOT COMPLETED|Overall Study||2
5325095|NCT00397254|13095739|P1|NOT COMPLETED|Overall Study||2
5325096|NCT00397254|13095738|P2|COMPLETED|Overall Study||74
5325097|NCT00397254|13095739|P1|COMPLETED|Overall Study||77
5325098|NCT00397254|13095738|P2|STARTED|Overall Study||76
5325099|NCT00397254|13095739|P1|STARTED|Overall Study||79
5325100|NCT00397215|13095761|P4|NOT COMPLETED|Month 24 (Day 720)||0
5325101|NCT00397215|13095762|P3|NOT COMPLETED|Month 24 (Day 720)||0
5325102|NCT00397215|13095763|P2|NOT COMPLETED|Month 24 (Day 720)||0
5325103|NCT00397215|13095764|P1|NOT COMPLETED|Month 24 (Day 720)||0
5325104|NCT00397215|13095761|P4|COMPLETED|Month 24 (Day 720)||36
5325105|NCT00397215|13095762|P3|COMPLETED|Month 24 (Day 720)||117
5325106|NCT00397215|13095763|P2|COMPLETED|Month 24 (Day 720)||45
5325107|NCT00397215|13095764|P1|COMPLETED|Month 24 (Day 720)||122
5325108|NCT00397215|13095761|P4|STARTED|Month 24 (Day 720)||36
5325109|NCT00397215|13095762|P3|STARTED|Month 24 (Day 720)||117
5325110|NCT00397215|13095763|P2|STARTED|Month 24 (Day 720)||45
5325111|NCT00397215|13095764|P1|STARTED|Month 24 (Day 720)||122
5325112|NCT00397215|13095761|P4|NOT COMPLETED|Month 12 (Day 360)||0
5325113|NCT00397215|13095762|P3|NOT COMPLETED|Month 12 (Day 360)||0
5325114|NCT00397215|13095763|P2|NOT COMPLETED|Month 12 (Day 360)||0
5325115|NCT00397215|13095764|P1|NOT COMPLETED|Month 12 (Day 360)||0
5325116|NCT00397215|13095761|P4|COMPLETED|Month 12 (Day 360)||42
5325117|NCT00397215|13095762|P3|COMPLETED|Month 12 (Day 360)||125
5325118|NCT00397215|13095763|P2|COMPLETED|Month 12 (Day 360)||48
5325119|NCT00397215|13095764|P1|COMPLETED|Month 12 (Day 360)||130
5325120|NCT00397215|13095761|P4|STARTED|Month 12 (Day 360)||42
5325121|NCT00397215|13095762|P3|STARTED|Month 12 (Day 360)||125
5325122|NCT00397215|13095763|P2|STARTED|Month 12 (Day 360)||48
5325123|NCT00397215|13095764|P1|STARTED|Month 12 (Day 360)||130
5325124|NCT00397215|13095761|P4|NOT COMPLETED|Month 6 (Day 180)||0
5325125|NCT00397215|13095762|P3|NOT COMPLETED|Month 6 (Day 180)||5
5325126|NCT00397215|13095763|P2|NOT COMPLETED|Month 6 (Day 180)||3
5325127|NCT00397215|13095764|P1|NOT COMPLETED|Month 6 (Day 180)||2
5325128|NCT00397215|13095761|P4|COMPLETED|Month 6 (Day 180)||51
5325129|NCT00397215|13095762|P3|COMPLETED|Month 6 (Day 180)||153
5325130|NCT00397215|13095763|P2|COMPLETED|Month 6 (Day 180)||55
5325131|NCT00397215|13095764|P1|COMPLETED|Month 6 (Day 180)||162
5325132|NCT00397215|13095761|P4|STARTED|Month 6 (Day 180)||51
5325133|NCT00397215|13095762|P3|STARTED|Month 6 (Day 180)||158
5325134|NCT00397215|13095763|P2|STARTED|Month 6 (Day 180)||58
5325135|NCT00397215|13095764|P1|STARTED|Month 6 (Day 180)||164
5325136|NCT00397215|13095761|P4|NOT COMPLETED|Month 0 (Day 0)||4
5325137|NCT00397215|13095762|P3|NOT COMPLETED|Month 0 (Day 0)||6
5325138|NCT00397215|13095763|P2|NOT COMPLETED|Month 0 (Day 0)||5
5325139|NCT00397215|13095764|P1|NOT COMPLETED|Month 0 (Day 0)||7
5325140|NCT00397215|13095761|P4|COMPLETED|Month 0 (Day 0)||48
5325141|NCT00397215|13095762|P3|COMPLETED|Month 0 (Day 0)||153
5325142|NCT00397215|13095763|P2|COMPLETED|Month 0 (Day 0)||56
5325143|NCT00397215|13095764|P1|COMPLETED|Month 0 (Day 0)||158
5325144|NCT00397215|13095761|P4|STARTED|Month 0 (Day 0)||52
5325145|NCT00397215|13095762|P3|STARTED|Month 0 (Day 0)||159
5325146|NCT00397215|13095763|P2|STARTED|Month 0 (Day 0)||61
5325147|NCT00397215|13095764|P1|STARTED|Month 0 (Day 0)||165
5325148|NCT00397189|13095900|P2|NOT COMPLETED|Extension Period||43
5325149|NCT00397189|13095901|P1|NOT COMPLETED|Extension Period||113
5325150|NCT00397189|13095900|P2|COMPLETED|Extension Period||134
5325151|NCT00397189|13095901|P1|COMPLETED|Extension Period||421
5325152|NCT00397189|13095900|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
5325153|NCT00397189|13095901|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
5325154|NCT00397189|13095900|P2|NOT COMPLETED|3 Weeks Period||22
5325155|NCT00397189|13095901|P1|NOT COMPLETED|3 Weeks Period||21
5325156|NCT00397189|13095900|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
5325157|NCT00397189|13095901|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
5325158|NCT00397189|13095900|P2|STARTED|3 Weeks Period||395
5325159|NCT00397189|13095901|P1|STARTED|3 Weeks Period||394
5325160|NCT00397150|13095911|P2|NOT COMPLETED|Overall Study||145
5325161|NCT00397150|13095912|P1|NOT COMPLETED|Overall Study||135
5325162|NCT00397150|13095911|P2|COMPLETED|Overall Study||1111
5325163|NCT00397150|13095912|P1|COMPLETED|Overall Study||1188
5325164|NCT00397150|13095911|P2|STARTED|Overall Study||1256
5325165|NCT00397150|13095912|P1|STARTED|Overall Study||1323
5325166|NCT00397046|13095928|P4|NOT COMPLETED|Overall Study||5
5325167|NCT00397046|13095929|P3|NOT COMPLETED|Overall Study||10
5325168|NCT00397046|13095930|P2|NOT COMPLETED|Overall Study||3
5325169|NCT00397046|13095931|P1|NOT COMPLETED|Overall Study||3
5325170|NCT00397046|13095928|P4|COMPLETED|Overall Study||0
5325171|NCT00397046|13095929|P3|COMPLETED|Overall Study||0
5325172|NCT00397046|13095930|P2|COMPLETED|Overall Study||0
5325173|NCT00397046|13095931|P1|COMPLETED|Overall Study||0
5325174|NCT00397046|13095928|P4|STARTED|Overall Study||5
5325175|NCT00397046|13095929|P3|STARTED|Overall Study||10
5325176|NCT00397046|13095930|P2|STARTED|Overall Study||3
5325177|NCT00397046|13095931|P1|STARTED|Overall Study||3
5325178|NCT00397033|13095953|P3|NOT COMPLETED|Overall Study||23
5325179|NCT00397033|13095954|P2|NOT COMPLETED|Overall Study||37
5325180|NCT00397033|13095955|P1|NOT COMPLETED|Overall Study||44
5325181|NCT00397033|13095953|P3|COMPLETED|Overall Study||77
5325182|NCT00397033|13095954|P2|COMPLETED|Overall Study||72
5325183|NCT00397033|13095955|P1|COMPLETED|Overall Study||63
5325184|NCT00397033|13095953|P3|ITT Population|Overall Study||98
5325185|NCT00397033|13095954|P2|ITT Population|Overall Study||105
5325186|NCT00397033|13095955|P1|ITT Population|Overall Study||107
5325187|NCT00397033|13095953|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
5325188|NCT00397033|13095954|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
5325189|NCT00397033|13095955|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
5325190|NCT00397033|13095953|P3|STARTED|Overall Study||100
5325191|NCT00397033|13095954|P2|STARTED|Overall Study||109
5325192|NCT00397033|13095955|P1|STARTED|Overall Study||107
5325193|NCT00397020|13096016|P2|NOT COMPLETED|Overall Study||1
5325194|NCT00397020|13096017|P1|NOT COMPLETED|Overall Study||1
5325195|NCT00397020|13096016|P2|COMPLETED|Overall Study||15
5325196|NCT00397020|13096017|P1|COMPLETED|Overall Study||13
5325197|NCT00397020|13096016|P2|STARTED|Overall Study||16
5325198|NCT00397020|13096017|P1|STARTED|Overall Study||14
5325199|NCT00396981|13096025|P2|NOT COMPLETED|Overall Study||9
5325200|NCT00396981|13096026|P1|NOT COMPLETED|Overall Study||15
5325201|NCT00396981|13096025|P2|COMPLETED|Overall Study||306
5325202|NCT00396981|13096026|P1|COMPLETED|Overall Study||296
5325203|NCT00396981|13096025|P2|STARTED|Overall Study||315
5325204|NCT00396981|13096026|P1|STARTED|Overall Study||311
5325205|NCT00396877|13096046|P2|NOT COMPLETED|Overall Study||8
5325206|NCT00396877|13096047|P1|NOT COMPLETED|Overall Study||6
5325207|NCT00396877|13096046|P2|COMPLETED|Overall Study|Completed follow-up|459
5325208|NCT00396877|13096047|P1|COMPLETED|Overall Study|Completed follow-up|433
5325209|NCT00396877|13096046|P2|Completed Treatment|Overall Study||352
5325210|NCT00396877|13096047|P1|Completed Treatment|Overall Study||356
5325211|NCT00396877|13096046|P2|Treated|Overall Study||464
5325212|NCT00396877|13096047|P1|Treated|Overall Study||436
5325213|NCT00396877|13096046|P2|STARTED|Overall Study|Randomized|467
5325214|NCT00396877|13096047|P1|STARTED|Overall Study|Randomized|439
5325215|NCT00396812|13096057|P1|NOT COMPLETED|Overall Study||1
5325216|NCT00396812|13096057|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
5325217|NCT00396812|13096057|P1|STARTED|Overall Study||4
5325218|NCT00396656|13096069|P2|NOT COMPLETED|Second Treatment Period||1
5325219|NCT00396656|13096070|P1|NOT COMPLETED|Second Treatment Period||0
5325220|NCT00396656|13096069|P2|COMPLETED|Second Treatment Period||12
5325221|NCT00396656|13096070|P1|COMPLETED|Second Treatment Period||15
5325222|NCT00396656|13096069|P2|STARTED|Second Treatment Period||13
5325223|NCT00396656|13096070|P1|STARTED|Second Treatment Period||15
5325224|NCT00396656|13096069|P2|NOT COMPLETED|First Treatment Period||2
5325225|NCT00396656|13096070|P1|NOT COMPLETED|First Treatment Period||0
5325226|NCT00396656|13096069|P2|COMPLETED|First Treatment Period||13
5325227|NCT00396656|13096070|P1|COMPLETED|First Treatment Period||15
5325228|NCT00396656|13096069|P2|STARTED|First Treatment Period||15
5325229|NCT00396656|13096070|P1|STARTED|First Treatment Period||15
5325230|NCT00396630|13096088|P2|NOT COMPLETED|Overall Study||5
5325231|NCT00396630|13096089|P1|NOT COMPLETED|Overall Study||5
5325232|NCT00396630|13096088|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
5325233|NCT00396630|13096089|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
5325234|NCT00396630|13096088|P2|STARTED|Overall Study||100
5325235|NCT00396630|13096089|P1|STARTED|Overall Study||100
5325236|NCT00396591|13096109|P1|NOT COMPLETED|Overall Study||16
5325237|NCT00396591|13096109|P1|COMPLETED|Overall Study||0
5325238|NCT00396591|13096109|P1|STARTED|Overall Study||16
5325239|NCT00396565|13096122|P3|NOT COMPLETED|Overall Study||17
5325240|NCT00396565|13096123|P2|NOT COMPLETED|Overall Study||91
5325241|NCT00396565|13096124|P1|NOT COMPLETED|Overall Study||48
5325242|NCT00396565|13096122|P3|COMPLETED|Overall Study||30
5325243|NCT00396565|13096123|P2|COMPLETED|Overall Study||47
5325244|NCT00396565|13096124|P1|COMPLETED|Overall Study||88
5325245|NCT00396565|13096122|P3|STARTED|Overall Study||47
5325246|NCT00396565|13096123|P2|STARTED|Overall Study||138
5325247|NCT00396565|13096124|P1|STARTED|Overall Study||136
5325248|NCT00396409|13096149|P2|NOT COMPLETED|Period 2 - 2008||2
5325249|NCT00396409|13096150|P1|NOT COMPLETED|Period 2 - 2008||7
5325250|NCT00396409|13096149|P2|COMPLETED|Period 2 - 2008||53
5325251|NCT00396409|13096150|P1|COMPLETED|Period 2 - 2008||52
5325252|NCT00396409|13096149|P2|STARTED|Period 2 - 2008||55
5325253|NCT00396409|13096150|P1|STARTED|Period 2 - 2008||59
5325254|NCT00396409|13096149|P2|NOT COMPLETED|Between Period 1 and Period 2||2
5325255|NCT00396409|13096150|P1|NOT COMPLETED|Between Period 1 and Period 2||3
5325256|NCT00396409|13096149|P2|COMPLETED|Between Period 1 and Period 2||55
5325257|NCT00396409|13096150|P1|COMPLETED|Between Period 1 and Period 2||59
5325258|NCT00396409|13096149|P2|STARTED|Between Period 1 and Period 2||57
5325259|NCT00396409|13096150|P1|STARTED|Between Period 1 and Period 2||62
5325260|NCT00396409|13096149|P2|NOT COMPLETED|Period 1 - 2007||6
5325261|NCT00396409|13096150|P1|NOT COMPLETED|Period 1 - 2007||3
5325262|NCT00396409|13096149|P2|COMPLETED|Period 1 - 2007||57
5325263|NCT00396409|13096150|P1|COMPLETED|Period 1 - 2007||62
5325264|NCT00396409|13096149|P2|STARTED|Period 1 - 2007||63
5325265|NCT00396409|13096150|P1|STARTED|Period 1 - 2007||65
5325266|NCT00396383|13096180|P1|NOT COMPLETED|Overall Study||3
5325267|NCT00396383|13096180|P1|COMPLETED|Overall Study||6
5325268|NCT00396383|13096180|P1|STARTED|Overall Study||9
5325269|NCT00396331|13096193|P1|NOT COMPLETED|Overall Study||32
5325270|NCT00396331|13096193|P1|COMPLETED|Overall Study||68
5325271|NCT00396331|13096193|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
5325272|NCT00396331|13096193|P1|Number of Participants Treated|Overall Study||100
5325273|NCT00396331|13096193|P1|STARTED|Overall Study||100
5325274|NCT00396318|13096246|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
5325275|NCT00396318|13096246|P1|COMPLETED|7-Day Post-Treatment Contact||240
5325276|NCT00396318|13096246|P1|STARTED|7-Day Post-Treatment Contact||241
5325277|NCT00396318|13096246|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
5325278|NCT00396318|13096246|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
5325279|NCT00396318|13096246|P1|STARTED|48- to 96-Hour Follow-Up Period||246
5325280|NCT00396318|13096246|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
5325281|NCT00396318|13096246|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
5325282|NCT00396318|13096246|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
5325283|NCT00396292|13096259|P2|NOT COMPLETED|Overall Study||16
5325284|NCT00396292|13096260|P1|NOT COMPLETED|Overall Study||9
5325285|NCT00396292|13096259|P2|COMPLETED|Overall Study||162
5325286|NCT00396292|13096260|P1|COMPLETED|Overall Study||165
5325287|NCT00396292|13096259|P2|STARTED|Overall Study||178
5325288|NCT00396292|13096260|P1|STARTED|Overall Study||174
5325289|NCT00396279|13096266|P1|NOT COMPLETED|Overall Study||30
5325290|NCT00396279|13096266|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
5325291|NCT00396279|13096266|P1|STARTED|Overall Study||37
5325292|NCT00396266|13096277|P2|NOT COMPLETED|Overall Study||0
5325293|NCT00396266|13096278|P1|NOT COMPLETED|Overall Study||0
5325294|NCT00396266|13096277|P2|COMPLETED|Overall Study||14
5325295|NCT00396266|13096278|P1|COMPLETED|Overall Study||8
5325296|NCT00396266|13096277|P2|STARTED|Overall Study||14
5325297|NCT00396266|13096278|P1|STARTED|Overall Study||8
5325298|NCT00396253|13096299|P1|NOT COMPLETED|Overall Study||13
5325299|NCT00396253|13096299|P1|COMPLETED|Overall Study||210
5325300|NCT00396253|13096299|P1|STARTED|Overall Study||223
5325301|NCT00396201|13096311|P1|NOT COMPLETED|Follow-up Period||0
5325302|NCT00396201|13096311|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
5325303|NCT00396201|13096311|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
5325304|NCT00396201|13096311|P1|NOT COMPLETED|Treatment Period||0
5325305|NCT00396201|13096311|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
5325306|NCT00396201|13096311|P1|STARTED|Treatment Period||22
5325307|NCT00396162|13096330|P2|NOT COMPLETED|Overall Study||3
5325308|NCT00396162|13096331|P1|NOT COMPLETED|Overall Study||2
5325309|NCT00396162|13096330|P2|COMPLETED|Overall Study||35
5325310|NCT00396162|13096331|P1|COMPLETED|Overall Study||37
5325311|NCT00396162|13096330|P2|STARTED|Overall Study||38
5325312|NCT00396162|13096331|P1|STARTED|Overall Study||39
5325313|NCT00396136|13096343|P1|NOT COMPLETED|Overall Study||125
5325314|NCT00396136|13096343|P1|COMPLETED|Overall Study||96
5325315|NCT00396136|13096343|P1|STARTED|Overall Study||221
5325316|NCT00396097|13096350|P2|NOT COMPLETED|Overall Study||46
5325317|NCT00396097|13096351|P1|NOT COMPLETED|Overall Study||26
5325318|NCT00396097|13096350|P2|COMPLETED|Overall Study||156
5325319|NCT00396097|13096351|P1|COMPLETED|Overall Study||88
5325320|NCT00396097|13096350|P2|STARTED|Overall Study||202
5325321|NCT00396097|13096351|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
5325322|NCT00396084|13096379|P6|NOT COMPLETED|Overall Study||2
5325323|NCT00396084|13096380|P5|NOT COMPLETED|Overall Study||1
5325324|NCT00396084|13096381|P4|NOT COMPLETED|Overall Study||1
5325325|NCT00396084|13096382|P3|NOT COMPLETED|Overall Study||0
5325326|NCT00396084|13096383|P2|NOT COMPLETED|Overall Study||0
5325327|NCT00396084|13096384|P1|NOT COMPLETED|Overall Study||0
5325328|NCT00396084|13096379|P6|COMPLETED|Overall Study||18
5325329|NCT00396084|13096380|P5|COMPLETED|Overall Study||9
5325330|NCT00396084|13096381|P4|COMPLETED|Overall Study||9
5325331|NCT00396084|13096382|P3|COMPLETED|Overall Study||10
5325332|NCT00396084|13096383|P2|COMPLETED|Overall Study||10
5325333|NCT00396084|13096384|P1|COMPLETED|Overall Study||10
5325334|NCT00396084|13096379|P6|STARTED|Overall Study||20
5325335|NCT00396084|13096380|P5|STARTED|Overall Study||10
5325336|NCT00396084|13096381|P4|STARTED|Overall Study||10
5325337|NCT00396084|13096382|P3|STARTED|Overall Study||10
5325338|NCT00396084|13096383|P2|STARTED|Overall Study||10
5325339|NCT00396084|13096384|P1|STARTED|Overall Study||10
5325340|NCT00396032|13096459|P2|NOT COMPLETED|Overall Study||5
5325341|NCT00396032|13096460|P1|NOT COMPLETED|Overall Study||4
5325342|NCT00396032|13096459|P2|COMPLETED|Overall Study||71
5325343|NCT00396032|13096460|P1|COMPLETED|Overall Study||70
5325344|NCT00396032|13096459|P2|STARTED|Overall Study||76
5325345|NCT00396032|13096460|P1|STARTED|Overall Study||74
5325346|NCT00396019|13096477|P3|NOT COMPLETED|Overall Study||1
5325347|NCT00396019|13096478|P2|NOT COMPLETED|Overall Study||3
5325348|NCT00396019|13096479|P1|NOT COMPLETED|Overall Study||0
5325349|NCT00396019|13096477|P3|COMPLETED|Overall Study||29
5325350|NCT00396019|13096478|P2|COMPLETED|Overall Study||26
5325351|NCT00396019|13096479|P1|COMPLETED|Overall Study||27
5325352|NCT00396019|13096477|P3|STARTED|Overall Study||30
5325353|NCT00396019|13096478|P2|STARTED|Overall Study||29
5325354|NCT00396019|13096479|P1|STARTED|Overall Study||27
5325355|NCT00396006|13096489|P1|NOT COMPLETED|Overall Study||0
5325356|NCT00396006|13096489|P1|COMPLETED|Overall Study||13
5325357|NCT00396006|13096489|P1|STARTED|Overall Study||13
5325358|NCT00395993|13096506|P2|NOT COMPLETED|Overall Study||19
5325359|NCT00395993|13096507|P1|NOT COMPLETED|Overall Study||35
5325360|NCT00395993|13096506|P2|COMPLETED|Overall Study||212
5325361|NCT00395993|13096507|P1|COMPLETED|Overall Study||211
5325362|NCT00395993|13096506|P2|STARTED|Overall Study||231
5325363|NCT00395993|13096507|P1|STARTED|Overall Study||246
5325364|NCT00395967|13096513|P1|NOT COMPLETED|Follow-up Period||2
5325365|NCT00395967|13096513|P1|COMPLETED|Follow-up Period||3
5325366|NCT00395967|13096513|P1|STARTED|Follow-up Period|Participants who had transplants.|5
5325367|NCT00395967|13096513|P1|NOT COMPLETED|Treatment Period||1
5325368|NCT00395967|13096513|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
5325369|NCT00395967|13096513|P1|STARTED|Treatment Period||5
5325370|NCT00395876|13096524|P2|NOT COMPLETED|Overall Study||0
5325371|NCT00395876|13096525|P1|NOT COMPLETED|Overall Study||3
5325372|NCT00395876|13096524|P2|COMPLETED|Overall Study||50
5325373|NCT00395876|13096525|P1|COMPLETED|Overall Study||47
5325374|NCT00395876|13096524|P2|STARTED|Overall Study||50
5325375|NCT00395876|13096525|P1|STARTED|Overall Study||50
5325376|NCT00395863|13096553|P2|NOT COMPLETED|Overall Study||3
5325377|NCT00395863|13096554|P1|NOT COMPLETED|Overall Study||2
5325378|NCT00395863|13096553|P2|COMPLETED|Overall Study||20
5325379|NCT00395863|13096554|P1|COMPLETED|Overall Study||21
5325380|NCT00395863|13096553|P2|STARTED|Overall Study||23
5325381|NCT00395863|13096554|P1|STARTED|Overall Study||23
5325382|NCT00395850|13096589|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
5325383|NCT00395850|13096590|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
5325384|NCT00395850|13096591|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
5325385|NCT00395850|13096592|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
5325386|NCT00395850|13096589|P4|COMPLETED|Disulfiram/Placebo Treatment||8
5325387|NCT00395850|13096590|P3|COMPLETED|Disulfiram/Placebo Treatment||5
5325388|NCT00395850|13096591|P2|COMPLETED|Disulfiram/Placebo Treatment||9
5325389|NCT00395850|13096592|P1|COMPLETED|Disulfiram/Placebo Treatment||11
5325390|NCT00395850|13096589|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
5325391|NCT00395850|13096590|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
5325392|NCT00395850|13096591|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
5325393|NCT00395850|13096592|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
5325394|NCT00395850|13096589|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
5325395|NCT00395850|13096590|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
5325396|NCT00395850|13096591|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
5325397|NCT00395850|13096592|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
5325398|NCT00395850|13096589|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
5325399|NCT00395850|13096590|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
5325400|NCT00395850|13096591|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
5325401|NCT00395850|13096592|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
5325402|NCT00395850|13096589|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
5325403|NCT00395850|13096590|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
5325404|NCT00395850|13096591|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
5325405|NCT00395850|13096592|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
5325406|NCT00395850|13096589|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
5325407|NCT00395850|13096590|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
5325408|NCT00395850|13096591|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
5325409|NCT00395850|13096592|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
5325410|NCT00395850|13096589|P4|COMPLETED|Pre-randomization Baseline/Induction||0
5325411|NCT00395850|13096590|P3|COMPLETED|Pre-randomization Baseline/Induction||0
5325412|NCT00395850|13096591|P2|COMPLETED|Pre-randomization Baseline/Induction||0
5325413|NCT00395850|13096592|P1|COMPLETED|Pre-randomization Baseline/Induction||107
5325414|NCT00395850|13096589|P4|STARTED|Pre-randomization Baseline/Induction||0
5325415|NCT00395850|13096590|P3|STARTED|Pre-randomization Baseline/Induction||0
5325416|NCT00395850|13096591|P2|STARTED|Pre-randomization Baseline/Induction||0
5325417|NCT00395850|13096592|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
5325418|NCT00395746|13096609|P3|NOT COMPLETED|Overall Study||22
5325419|NCT00395746|13096610|P2|NOT COMPLETED|Overall Study||4
5325420|NCT00395746|13096611|P1|NOT COMPLETED|Overall Study||10
5325421|NCT00395746|13096609|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
5325422|NCT00395746|13096610|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
5325423|NCT00395746|13096611|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
5325424|NCT00395746|13096609|P3|STARTED|Overall Study|Exposed to study drug|88
5325425|NCT00395746|13096610|P2|STARTED|Overall Study|Exposed to study drug|88
5325426|NCT00395746|13096611|P1|STARTED|Overall Study|Exposed to study drug|88
5325427|NCT00395733|13096657|P2|NOT COMPLETED|Period 2||5
5325428|NCT00395733|13096658|P1|NOT COMPLETED|Period 2||2
5325429|NCT00395733|13096657|P2|COMPLETED|Period 2||37
5325430|NCT00395733|13096658|P1|COMPLETED|Period 2||39
5325431|NCT00395733|13096657|P2|STARTED|Period 2||42
5325432|NCT00395733|13096658|P1|STARTED|Period 2||41
5325433|NCT00395733|13096657|P2|NOT COMPLETED|Period 1||0
5325434|NCT00395733|13096658|P1|NOT COMPLETED|Period 1||0
5325435|NCT00395733|13096657|P2|COMPLETED|Period 1||42
5325436|NCT00395733|13096658|P1|COMPLETED|Period 1||41
5325437|NCT00395733|13096657|P2|STARTED|Period 1||42
5325438|NCT00395733|13096658|P1|STARTED|Period 1||41
5325439|NCT00395694|13096682|P2|NOT COMPLETED|Continuation Phase||13
5325440|NCT00395694|13096683|P1|NOT COMPLETED|Continuation Phase||15
5325441|NCT00395694|13096682|P2|COMPLETED|Continuation Phase||35
5325442|NCT00395694|13096683|P1|COMPLETED|Continuation Phase||34
5325443|NCT00395694|13096682|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
5325444|NCT00395694|13096683|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
5325445|NCT00395694|13096682|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
5325446|NCT00395694|13096683|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
5325447|NCT00395694|13096682|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
5325448|NCT00395694|13096683|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
5325449|NCT00395694|13096682|P2|STARTED|Escalation Phase + Maintenance Phase||51
5325450|NCT00395694|13096683|P1|STARTED|Escalation Phase + Maintenance Phase||51
5325451|NCT00395642|13096714|P1|NOT COMPLETED|Overall Study||13
5325452|NCT00395642|13096714|P1|COMPLETED|Overall Study||53
5325453|NCT00395642|13096714|P1|STARTED|Overall Study||66
5325454|NCT00395629|13096721|P3|NOT COMPLETED|Extension Study||3
5325455|NCT00395629|13096722|P2|NOT COMPLETED|Extension Study||0
5325456|NCT00395629|13096723|P1|NOT COMPLETED|Extension Study||0
5325457|NCT00395629|13096721|P3|COMPLETED|Extension Study||8
5325458|NCT00395629|13096722|P2|COMPLETED|Extension Study||6
5325459|NCT00395629|13096723|P1|COMPLETED|Extension Study||9
5325460|NCT00395629|13096721|P3|STARTED|Extension Study||11
5325461|NCT00395629|13096722|P2|STARTED|Extension Study||6
5325462|NCT00395629|13096723|P1|STARTED|Extension Study||9
5325463|NCT00395629|13096721|P3|NOT COMPLETED|Core Study||7
5325464|NCT00395629|13096722|P2|NOT COMPLETED|Core Study||4
5325465|NCT00395629|13096723|P1|NOT COMPLETED|Core Study||1
5325466|NCT00395629|13096721|P3|COMPLETED|Core Study||16
5325467|NCT00395629|13096722|P2|COMPLETED|Core Study||11
5325468|NCT00395629|13096723|P1|COMPLETED|Core Study||10
5325469|NCT00395629|13096721|P3|STARTED|Core Study||23
5325470|NCT00395629|13096722|P2|STARTED|Core Study||15
5325471|NCT00395629|13096723|P1|STARTED|Core Study||11
5325472|NCT00395538|13096740|P3|NOT COMPLETED|Overall Study||23
5325473|NCT00395538|13096741|P2|NOT COMPLETED|Overall Study||13
5325474|NCT00395538|13096742|P1|NOT COMPLETED|Overall Study||3
5325475|NCT00395538|13096740|P3|COMPLETED|Overall Study||0
5325476|NCT00395538|13096741|P2|COMPLETED|Overall Study||2
5325477|NCT00395538|13096742|P1|COMPLETED|Overall Study||5
5325478|NCT00395538|13096740|P3|Completed Bone Biopsy Year 4|Overall Study||1
5325479|NCT00395538|13096741|P2|Completed Bone Biopsy Year 4|Overall Study||1
5325480|NCT00395538|13096742|P1|Completed Bone Biopsy Year 4|Overall Study||0
5325481|NCT00395538|13096740|P3|Completed Bone Biopsy Year 2|Overall Study||3
5325482|NCT00395538|13096741|P2|Completed Bone Biopsy Year 2|Overall Study||2
5325483|NCT00395538|13096742|P1|Completed Bone Biopsy Year 2|Overall Study||0
5325484|NCT00395538|13096740|P3|Completed Bone Biopsy Year 1|Overall Study||4
5325485|NCT00395538|13096741|P2|Completed Bone Biopsy Year 1|Overall Study||1
5325486|NCT00395538|13096742|P1|Completed Bone Biopsy Year 1|Overall Study||0
5325487|NCT00395538|13096740|P3|Randomized to Bone Biospy Year 4|Overall Study||8
5325488|NCT00395538|13096741|P2|Randomized to Bone Biospy Year 4|Overall Study||2
5325489|NCT00395538|13096742|P1|Randomized to Bone Biospy Year 4|Overall Study||0
5325490|NCT00395538|13096740|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
5325491|NCT00395538|13096741|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
5325492|NCT00395538|13096742|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
5325493|NCT00395538|13096740|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
5325494|NCT00395538|13096741|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
5325495|NCT00395538|13096742|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
5325496|NCT00395538|13096740|P3|Received HPTH on New Protocol|Overall Study||19
5325497|NCT00395538|13096741|P2|Received HPTH on New Protocol|Overall Study||5
5325498|NCT00395538|13096742|P1|Received HPTH on New Protocol|Overall Study||7
5325499|NCT00395538|13096740|P3|Signed Consent to the New Protocol|Overall Study||23
5325500|NCT00395538|13096741|P2|Signed Consent to the New Protocol|Overall Study||5
5325501|NCT00395538|13096742|P1|Signed Consent to the New Protocol|Overall Study||7
5325502|NCT00395538|13096740|P3|STARTED|Overall Study||23
5325503|NCT00395538|13096741|P2|STARTED|Overall Study||15
5325504|NCT00395538|13096742|P1|STARTED|Overall Study||8
5325505|NCT00395512|13096815|P4|NOT COMPLETED|Overall Study||38
5325506|NCT00395512|13096816|P3|NOT COMPLETED|Overall Study||28
5325507|NCT00395512|13096817|P2|NOT COMPLETED|Overall Study||37
5325508|NCT00395512|13096818|P1|NOT COMPLETED|Overall Study||38
5325509|NCT00395512|13096815|P4|COMPLETED|Overall Study||126
5325510|NCT00395512|13096816|P3|COMPLETED|Overall Study||136
5325511|NCT00395512|13096817|P2|COMPLETED|Overall Study||126
5325512|NCT00395512|13096818|P1|COMPLETED|Overall Study||126
5325513|NCT00395512|13096815|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
5325514|NCT00395512|13096816|P3|Safety Set|Overall Study||164
5325515|NCT00395512|13096817|P2|Safety Set|Overall Study||163
5325516|NCT00395512|13096818|P1|Safety Set|Overall Study||164
5325517|NCT00395512|13096815|P4|STARTED|Overall Study||164
5325518|NCT00395512|13096816|P3|STARTED|Overall Study||164
5325519|NCT00395512|13096817|P2|STARTED|Overall Study||163
5325520|NCT00395512|13096818|P1|STARTED|Overall Study||164
5325521|NCT00395486|13096990|P2|NOT COMPLETED|Overall Study||5
5325522|NCT00395486|13096991|P1|NOT COMPLETED|Overall Study||6
5325523|NCT00395486|13096990|P2|COMPLETED|Overall Study|Completed subjects|121
5325524|NCT00395486|13096991|P1|COMPLETED|Overall Study|Completed subjects|126
5325525|NCT00395486|13096990|P2|STARTED|Overall Study|Randomized subjects|126
5325526|NCT00395486|13096991|P1|STARTED|Overall Study|Randomized subjects|132
5325527|NCT00395460|13097021|P2|NOT COMPLETED|Overall Study||0
5325528|NCT00395460|13097022|P1|NOT COMPLETED|Overall Study||1
5325529|NCT00395460|13097021|P2|COMPLETED|Overall Study||75
5325530|NCT00395460|13097022|P1|COMPLETED|Overall Study||71
5325531|NCT00395460|13097021|P2|Received Treatment|Overall Study||75
5325532|NCT00395460|13097022|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
5325533|NCT00395460|13097021|P2|STARTED|Overall Study||75
5325534|NCT00395460|13097022|P1|STARTED|Overall Study||72
5325535|NCT00395447|13097046|P2|NOT COMPLETED|Overall Study||111
5325536|NCT00395447|13097047|P1|NOT COMPLETED|Overall Study||121
5325537|NCT00395447|13097046|P2|COMPLETED|Overall Study||602
5325538|NCT00395447|13097047|P1|COMPLETED|Overall Study||910
5325539|NCT00395447|13097046|P2|STARTED|Overall Study||713
5325540|NCT00395447|13097047|P1|STARTED|Overall Study||1031
5325541|NCT00395343|13097055|P2|NOT COMPLETED|Overall Study||36
5325542|NCT00395343|13097056|P1|NOT COMPLETED|Overall Study||41
5325543|NCT00395343|13097055|P2|COMPLETED|Overall Study||283
5325544|NCT00395343|13097056|P1|COMPLETED|Overall Study||281
5325545|NCT00395343|13097055|P2|STARTED|Overall Study||319
5325546|NCT00395343|13097056|P1|STARTED|Overall Study||322
5325547|NCT00395304|13097074|P6|NOT COMPLETED|Treatment Period 3||1
5325548|NCT00395304|13097075|P5|NOT COMPLETED|Treatment Period 3||0
5325549|NCT00395304|13097076|P4|NOT COMPLETED|Treatment Period 3||2
5325550|NCT00395304|13097077|P3|NOT COMPLETED|Treatment Period 3||0
5325551|NCT00395304|13097078|P2|NOT COMPLETED|Treatment Period 3||2
5325552|NCT00395304|13097079|P1|NOT COMPLETED|Treatment Period 3||1
5325553|NCT00395304|13097074|P6|COMPLETED|Treatment Period 3||27
5325554|NCT00395304|13097075|P5|COMPLETED|Treatment Period 3||27
5325555|NCT00395304|13097076|P4|COMPLETED|Treatment Period 3||25
5325556|NCT00395304|13097077|P3|COMPLETED|Treatment Period 3||29
5325557|NCT00395304|13097078|P2|COMPLETED|Treatment Period 3||20
5325558|NCT00395304|13097079|P1|COMPLETED|Treatment Period 3||29
5325559|NCT00395304|13097074|P6|STARTED|Treatment Period 3||28
5325560|NCT00395304|13097075|P5|STARTED|Treatment Period 3||27
5325561|NCT00395304|13097076|P4|STARTED|Treatment Period 3||27
5325562|NCT00395304|13097077|P3|STARTED|Treatment Period 3||29
5325563|NCT00395304|13097078|P2|STARTED|Treatment Period 3||22
5325564|NCT00395304|13097079|P1|STARTED|Treatment Period 3||30
5325565|NCT00395304|13097074|P6|NOT COMPLETED|Treatment Period 2||2
5325566|NCT00395304|13097075|P5|NOT COMPLETED|Treatment Period 2||0
5325567|NCT00395304|13097076|P4|NOT COMPLETED|Treatment Period 2||1
5325568|NCT00395304|13097077|P3|NOT COMPLETED|Treatment Period 2||1
5325569|NCT00395304|13097078|P2|NOT COMPLETED|Treatment Period 2||4
5325570|NCT00395304|13097079|P1|NOT COMPLETED|Treatment Period 2||0
5325571|NCT00395304|13097074|P6|COMPLETED|Treatment Period 2||28
5325572|NCT00395304|13097075|P5|COMPLETED|Treatment Period 2||27
5325573|NCT00395304|13097076|P4|COMPLETED|Treatment Period 2||27
5325574|NCT00395304|13097077|P3|COMPLETED|Treatment Period 2||29
5325575|NCT00395304|13097078|P2|COMPLETED|Treatment Period 2||22
5325576|NCT00395304|13097079|P1|COMPLETED|Treatment Period 2||30
5325577|NCT00395304|13097074|P6|STARTED|Treatment Period 2||30
5325578|NCT00395304|13097075|P5|STARTED|Treatment Period 2||27
5325579|NCT00395304|13097076|P4|STARTED|Treatment Period 2||28
5325580|NCT00395304|13097077|P3|STARTED|Treatment Period 2||30
5325581|NCT00395304|13097078|P2|STARTED|Treatment Period 2||26
5325582|NCT00395304|13097079|P1|STARTED|Treatment Period 2||30
5325583|NCT00395304|13097074|P6|NOT COMPLETED|Treatment Period 1||2
5325584|NCT00395304|13097075|P5|NOT COMPLETED|Treatment Period 1||1
5325585|NCT00395304|13097076|P4|NOT COMPLETED|Treatment Period 1||3
5325586|NCT00395304|13097077|P3|NOT COMPLETED|Treatment Period 1||0
5325587|NCT00395304|13097078|P2|NOT COMPLETED|Treatment Period 1||4
5325588|NCT00395304|13097079|P1|NOT COMPLETED|Treatment Period 1||1
5325589|NCT00395304|13097074|P6|COMPLETED|Treatment Period 1||30
5325590|NCT00395304|13097075|P5|COMPLETED|Treatment Period 1||27
5325591|NCT00395304|13097076|P4|COMPLETED|Treatment Period 1||28
5325592|NCT00395304|13097077|P3|COMPLETED|Treatment Period 1||30
5325593|NCT00395304|13097078|P2|COMPLETED|Treatment Period 1||26
5325594|NCT00395304|13097079|P1|COMPLETED|Treatment Period 1||30
5325595|NCT00395304|13097074|P6|STARTED|Treatment Period 1||32
5325596|NCT00395304|13097075|P5|STARTED|Treatment Period 1||28
5325597|NCT00395304|13097076|P4|STARTED|Treatment Period 1||31
5325598|NCT00395304|13097077|P3|STARTED|Treatment Period 1||30
5325599|NCT00395304|13097078|P2|STARTED|Treatment Period 1||30
5325600|NCT00395304|13097079|P1|STARTED|Treatment Period 1||31
5325601|NCT00395291|13097122|P2|NOT COMPLETED|Second Intervention||0
5325602|NCT00395291|13097123|P1|NOT COMPLETED|Second Intervention||0
5325603|NCT00395291|13097122|P2|COMPLETED|Second Intervention||9
5325604|NCT00395291|13097123|P1|COMPLETED|Second Intervention||13
5325605|NCT00395291|13097122|P2|STARTED|Second Intervention||9
5325606|NCT00395291|13097123|P1|STARTED|Second Intervention||13
5325607|NCT00395291|13097122|P2|NOT COMPLETED|Washout Period for 30 Days||0
5325608|NCT00395291|13097123|P1|NOT COMPLETED|Washout Period for 30 Days||2
5325609|NCT00395291|13097122|P2|COMPLETED|Washout Period for 30 Days||9
5325610|NCT00395291|13097123|P1|COMPLETED|Washout Period for 30 Days||13
5325611|NCT00395291|13097122|P2|STARTED|Washout Period for 30 Days||9
5325612|NCT00395291|13097123|P1|STARTED|Washout Period for 30 Days||15
5325613|NCT00395291|13097122|P2|NOT COMPLETED|First Intervention||0
5325614|NCT00395291|13097123|P1|NOT COMPLETED|First Intervention||2
5325615|NCT00395291|13097122|P2|COMPLETED|First Intervention||9
5325616|NCT00395291|13097123|P1|COMPLETED|First Intervention||15
5325617|NCT00395291|13097122|P2|STARTED|First Intervention||9
5325618|NCT00395291|13097123|P1|STARTED|First Intervention||17
5325619|NCT00395226|13097155|P2|NOT COMPLETED|Overall Study||5
5325620|NCT00395226|13097156|P1|NOT COMPLETED|Overall Study||4
5325621|NCT00395226|13097155|P2|COMPLETED|Overall Study||22
5325622|NCT00395226|13097156|P1|COMPLETED|Overall Study||22
5325623|NCT00395226|13097155|P2|STARTED|Overall Study||27
5325624|NCT00395226|13097156|P1|STARTED|Overall Study||26
5325625|NCT00395161|13097164|P2|NOT COMPLETED|Overall Study||0
5325626|NCT00395161|13097165|P1|NOT COMPLETED|Overall Study||0
5325627|NCT00395161|13097164|P2|COMPLETED|Overall Study||144
5325628|NCT00395161|13097165|P1|COMPLETED|Overall Study||149
5325629|NCT00395161|13097164|P2|STARTED|Overall Study||144
5325630|NCT00395161|13097165|P1|STARTED|Overall Study||149
5325631|NCT00395135|13097181|P5|NOT COMPLETED|Year 2||190
5325632|NCT00395135|13097182|P4|NOT COMPLETED|Year 2||88
5325633|NCT00395135|13097183|P3|NOT COMPLETED|Year 2||147
5325634|NCT00395135|13097184|P2|NOT COMPLETED|Year 2||0
5325635|NCT00395135|13097185|P1|NOT COMPLETED|Year 2||0
5325636|NCT00395135|13097181|P5|COMPLETED|Year 2||507
5325637|NCT00395135|13097182|P4|COMPLETED|Year 2||195
5325638|NCT00395135|13097183|P3|COMPLETED|Year 2||426
5325639|NCT00395135|13097184|P2|COMPLETED|Year 2||0
5325640|NCT00395135|13097185|P1|COMPLETED|Year 2||0
5325641|NCT00395135|13097181|P5|STARTED|Year 2||697
5325642|NCT00395135|13097182|P4|STARTED|Year 2||283
5325643|NCT00395135|13097183|P3|STARTED|Year 2||573
5325644|NCT00395135|13097184|P2|STARTED|Year 2||0
5325645|NCT00395135|13097185|P1|STARTED|Year 2||0
5325646|NCT00395135|13097181|P5|NOT COMPLETED|Year 1||0
5325647|NCT00395135|13097182|P4|NOT COMPLETED|Year 1||0
5325648|NCT00395135|13097183|P3|NOT COMPLETED|Year 1||0
5325649|NCT00395135|13097184|P2|NOT COMPLETED|Year 1||871
5325650|NCT00395135|13097185|P1|NOT COMPLETED|Year 1||712
5325651|NCT00395135|13097181|P5|COMPLETED|Year 1||0
5325652|NCT00395135|13097182|P4|COMPLETED|Year 1||0
5325653|NCT00395135|13097183|P3|COMPLETED|Year 1||0
5325654|NCT00395135|13097184|P2|COMPLETED|Year 1||716
5325655|NCT00395135|13097185|P1|COMPLETED|Year 1||883
5325656|NCT00395135|13097181|P5|STARTED|Year 1||0
5325657|NCT00395135|13097182|P4|STARTED|Year 1||0
5325658|NCT00395135|13097183|P3|STARTED|Year 1||0
5325659|NCT00395135|13097184|P2|STARTED|Year 1||1587
5325660|NCT00395135|13097185|P1|STARTED|Year 1||1595
5325661|NCT00395083|13097203|P2|NOT COMPLETED|Overall Study||8
5325662|NCT00395083|13097204|P1|NOT COMPLETED|Overall Study||10
5325663|NCT00395083|13097203|P2|COMPLETED|Overall Study||201
5325664|NCT00395083|13097204|P1|COMPLETED|Overall Study||207
5325665|NCT00395083|13097203|P2|STARTED|Overall Study||209
5325666|NCT00395083|13097204|P1|STARTED|Overall Study||217
5325667|NCT00395057|13097220|P4|NOT COMPLETED|Overall Study||33
5325668|NCT00395057|13097221|P3|NOT COMPLETED|Overall Study||33
5325669|NCT00395057|13097222|P2|NOT COMPLETED|Overall Study||34
5325670|NCT00395057|13097223|P1|NOT COMPLETED|Overall Study||32
5325671|NCT00395057|13097220|P4|COMPLETED|Overall Study||1
5325672|NCT00395057|13097221|P3|COMPLETED|Overall Study||2
5325673|NCT00395057|13097222|P2|COMPLETED|Overall Study||1
5325674|NCT00395057|13097223|P1|COMPLETED|Overall Study||2
5325675|NCT00395057|13097220|P4|STARTED|Overall Study||34
5325676|NCT00395057|13097221|P3|STARTED|Overall Study||35
5325677|NCT00395057|13097222|P2|STARTED|Overall Study||35
5325678|NCT00395057|13097223|P1|STARTED|Overall Study||34
5325679|NCT00395044|13097251|P2|NOT COMPLETED|Overall Study||14
5325680|NCT00395044|13097252|P1|NOT COMPLETED|Overall Study||18
5325681|NCT00395044|13097251|P2|COMPLETED|Overall Study||11
5325682|NCT00395044|13097252|P1|COMPLETED|Overall Study||7
5325683|NCT00395044|13097251|P2|STARTED|Overall Study||25
5325684|NCT00395044|13097252|P1|STARTED|Overall Study||25
5325685|NCT00395018|13097270|P1|NOT COMPLETED|Off-Treatment Follow-up||4
5325686|NCT00395018|13097270|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
5325687|NCT00395018|13097270|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
5325688|NCT00395018|13097270|P1|NOT COMPLETED|On-Treatment||10
5325689|NCT00395018|13097270|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
5325690|NCT00395018|13097270|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
5325691|NCT00395018|13097270|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
5325692|NCT00395018|13097270|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
5325693|NCT00394953|13097291|P2|NOT COMPLETED|Second Treatment Period||74
5325694|NCT00394953|13097292|P1|NOT COMPLETED|Second Treatment Period||29
5325695|NCT00394953|13097291|P2|COMPLETED|Second Treatment Period||148
5325696|NCT00394953|13097292|P1|COMPLETED|Second Treatment Period||187
5325697|NCT00394953|13097291|P2|STARTED|Second Treatment Period||222
5325698|NCT00394953|13097292|P1|STARTED|Second Treatment Period||216
5325699|NCT00394953|13097291|P2|NOT COMPLETED|First Treatment Period||22
5325700|NCT00394953|13097292|P1|NOT COMPLETED|First Treatment Period||29
5325701|NCT00394953|13097291|P2|COMPLETED|First Treatment Period||222
5325702|NCT00394953|13097292|P1|COMPLETED|First Treatment Period||216
5325703|NCT00394953|13097291|P2|STARTED|First Treatment Period||244
5325704|NCT00394953|13097292|P1|STARTED|First Treatment Period||245
5325705|NCT00394914|13097310|P3|NOT COMPLETED|Treatment Period||6
5325706|NCT00394914|13097311|P2|NOT COMPLETED|Treatment Period||10
5325707|NCT00394914|13097312|P1|NOT COMPLETED|Treatment Period||0
5325708|NCT00394914|13097310|P3|COMPLETED|Treatment Period||151
5325709|NCT00394914|13097311|P2|COMPLETED|Treatment Period||144
5325710|NCT00394914|13097312|P1|COMPLETED|Treatment Period||0
5325711|NCT00394914|13097310|P3|STARTED|Treatment Period||157
5325712|NCT00394914|13097311|P2|STARTED|Treatment Period||154
5325713|NCT00394914|13097312|P1|STARTED|Treatment Period||0
5325714|NCT00394914|13097310|P3|NOT COMPLETED|Pre-exposure Period||0
5325715|NCT00394914|13097311|P2|NOT COMPLETED|Pre-exposure Period||0
5325716|NCT00394914|13097312|P1|NOT COMPLETED|Pre-exposure Period||0
5325717|NCT00394914|13097310|P3|COMPLETED|Pre-exposure Period||0
5325718|NCT00394914|13097311|P2|COMPLETED|Pre-exposure Period||0
5325719|NCT00394914|13097312|P1|COMPLETED|Pre-exposure Period||311
5325720|NCT00394914|13097310|P3|STARTED|Pre-exposure Period||0
5325721|NCT00394914|13097311|P2|STARTED|Pre-exposure Period||0
5325722|NCT00394914|13097312|P1|STARTED|Pre-exposure Period||311
5325723|NCT00394914|13097310|P3|NOT COMPLETED|Screening Period||0
5325724|NCT00394914|13097311|P2|NOT COMPLETED|Screening Period||0
5325725|NCT00394914|13097312|P1|NOT COMPLETED|Screening Period||0
5325726|NCT00394914|13097310|P3|COMPLETED|Screening Period||0
5325727|NCT00394914|13097311|P2|COMPLETED|Screening Period||0
5325728|NCT00394914|13097312|P1|COMPLETED|Screening Period||311
5325729|NCT00394914|13097310|P3|STARTED|Screening Period||0
5325730|NCT00394914|13097311|P2|STARTED|Screening Period||0
5325731|NCT00394914|13097312|P1|STARTED|Screening Period||311
5325732|NCT00394901|13097340|P4|NOT COMPLETED|Double-blind Phase||27
5325733|NCT00394901|13097341|P3|NOT COMPLETED|Double-blind Phase||18
5325734|NCT00394901|13097342|P2|NOT COMPLETED|Double-blind Phase||14
5325735|NCT00394901|13097343|P1|NOT COMPLETED|Double-blind Phase||15
5325736|NCT00394901|13097340|P4|COMPLETED|Double-blind Phase||70
5325737|NCT00394901|13097341|P3|COMPLETED|Double-blind Phase||71
5325738|NCT00394901|13097342|P2|COMPLETED|Double-blind Phase||73
5325739|NCT00394901|13097343|P1|COMPLETED|Double-blind Phase||83
5325740|NCT00394901|13097340|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
5325741|NCT00394901|13097341|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
5325742|NCT00394901|13097342|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
5325743|NCT00394901|13097343|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
5325744|NCT00394901|13097340|P4|NOT COMPLETED|Baseline Phase||0
5325745|NCT00394901|13097341|P3|NOT COMPLETED|Baseline Phase||1
5325746|NCT00394901|13097342|P2|NOT COMPLETED|Baseline Phase||0
5325747|NCT00394901|13097343|P1|NOT COMPLETED|Baseline Phase||0
5325748|NCT00394901|13097340|P4|COMPLETED|Baseline Phase||97
5325749|NCT00394901|13097341|P3|COMPLETED|Baseline Phase||89
5325750|NCT00394901|13097342|P2|COMPLETED|Baseline Phase||87
5325751|NCT00394901|13097343|P1|COMPLETED|Baseline Phase||98
5325752|NCT00394901|13097340|P4|STARTED|Baseline Phase|Subjects randomized|97
5325753|NCT00394901|13097341|P3|STARTED|Baseline Phase|Subjects randomized|90
5325754|NCT00394901|13097342|P2|STARTED|Baseline Phase|Subjects randomized|87
5325755|NCT00394901|13097343|P1|STARTED|Baseline Phase|Subjects randomized|98
5325756|NCT00394888|13097571|P3|NOT COMPLETED|Overall Study||0
5325757|NCT00394888|13097572|P2|NOT COMPLETED|Overall Study||0
5325758|NCT00394888|13097573|P1|NOT COMPLETED|Overall Study||0
5325759|NCT00394888|13097571|P3|COMPLETED|Overall Study||201
5325760|NCT00394888|13097572|P2|COMPLETED|Overall Study||48
5325761|NCT00394888|13097573|P1|COMPLETED|Overall Study||108
5325762|NCT00394888|13097571|P3|STARTED|Overall Study||201
5325763|NCT00394888|13097572|P2|STARTED|Overall Study||48
5325764|NCT00394888|13097573|P1|STARTED|Overall Study||108
5325765|NCT00394836|13097586|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
5325766|NCT00394836|13097587|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
5325767|NCT00394836|13097586|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
5325768|NCT00394836|13097587|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
5325769|NCT00394836|13097586|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
5325770|NCT00394836|13097587|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
5325771|NCT00394836|13097586|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
5325772|NCT00394836|13097587|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
5325773|NCT00394836|13097586|P2|COMPLETED|Teatment or Follow-up Phase||8
5325774|NCT00394836|13097587|P1|COMPLETED|Teatment or Follow-up Phase||2
5325775|NCT00394836|13097586|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
5325776|NCT00394836|13097587|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
5325777|NCT00394836|13097586|P2|STARTED|Teatment or Follow-up Phase||86
5325778|NCT00394836|13097587|P1|STARTED|Teatment or Follow-up Phase||30
5325779|NCT00394771|13097633|P4|NOT COMPLETED|Overall Study||39
5325780|NCT00394771|13097634|P3|NOT COMPLETED|Overall Study||47
5325781|NCT00394771|13097635|P2|NOT COMPLETED|Overall Study||34
5325782|NCT00394771|13097636|P1|NOT COMPLETED|Overall Study||41
5325783|NCT00394771|13097633|P4|COMPLETED|Overall Study||109
5325784|NCT00394771|13097634|P3|COMPLETED|Overall Study||96
5325785|NCT00394771|13097635|P2|COMPLETED|Overall Study||102
5325786|NCT00394771|13097636|P1|COMPLETED|Overall Study||99
5325787|NCT00394771|13097633|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
5325788|NCT00394771|13097634|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
5325789|NCT00394771|13097635|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
5325790|NCT00394771|13097636|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
5325791|NCT00394771|13097633|P4|STARTED|Overall Study|Safety population of treated participants|148
5325792|NCT00394771|13097634|P3|STARTED|Overall Study|Safety population of treated participants|143
5325793|NCT00394771|13097635|P2|STARTED|Overall Study|Safety population of treated participants|136
5325794|NCT00394771|13097636|P1|STARTED|Overall Study|Safety population of treated participants|140
5325795|NCT00394706|13097706|P8|NOT COMPLETED|Overall Study||0
5325796|NCT00394706|13097707|P7|NOT COMPLETED|Overall Study||3
5325797|NCT00394706|13097708|P6|NOT COMPLETED|Overall Study||7
5325798|NCT00394706|13097709|P5|NOT COMPLETED|Overall Study||2
5325799|NCT00394706|13097710|P4|NOT COMPLETED|Overall Study||1
5325800|NCT00394706|13097711|P3|NOT COMPLETED|Overall Study||9
5325801|NCT00394706|13097712|P2|NOT COMPLETED|Overall Study||2
5325802|NCT00394706|13097713|P1|NOT COMPLETED|Overall Study||4
5325803|NCT00394706|13097706|P8|COMPLETED|Overall Study||851
5325804|NCT00394706|13097707|P7|COMPLETED|Overall Study||926
5325805|NCT00394706|13097708|P6|COMPLETED|Overall Study||1377
5325806|NCT00394706|13097709|P5|COMPLETED|Overall Study||1634
5325807|NCT00394706|13097710|P4|COMPLETED|Overall Study||1632
5325808|NCT00394706|13097711|P3|COMPLETED|Overall Study||1615
5325809|NCT00394706|13097712|P2|COMPLETED|Overall Study||1860
5325810|NCT00394706|13097713|P1|COMPLETED|Overall Study||1815
5325811|NCT00394706|13097706|P8|STARTED|Overall Study||851
5325812|NCT00394706|13097707|P7|STARTED|Overall Study||929
5325813|NCT00394706|13097708|P6|STARTED|Overall Study||1384
5325814|NCT00394706|13097709|P5|STARTED|Overall Study||1636
5325815|NCT00394706|13097710|P4|STARTED|Overall Study||1633
5325816|NCT00394706|13097711|P3|STARTED|Overall Study||1624
5325817|NCT00394706|13097712|P2|STARTED|Overall Study||1862
5325818|NCT00394706|13097713|P1|STARTED|Overall Study||1819
5325819|NCT00394654|13097745|P2|NOT COMPLETED|Overall Study||0
5325820|NCT00394654|13097746|P1|NOT COMPLETED|Overall Study||2
5325821|NCT00394654|13097745|P2|COMPLETED|Overall Study||15
5325822|NCT00394654|13097746|P1|COMPLETED|Overall Study||13
5325823|NCT00394654|13097745|P2|STARTED|Overall Study||15
5325824|NCT00394654|13097746|P1|STARTED|Overall Study||15
5325825|NCT00394589|13097811|P3|NOT COMPLETED|Overall Study||7
5325826|NCT00394589|13097812|P2|NOT COMPLETED|Overall Study||3
5325827|NCT00394589|13097813|P1|NOT COMPLETED|Overall Study||8
5325828|NCT00394589|13097811|P3|COMPLETED|Overall Study||11
5325829|NCT00394589|13097812|P2|COMPLETED|Overall Study||8
5325830|NCT00394589|13097813|P1|COMPLETED|Overall Study||6
5325831|NCT00394589|13097811|P3|STARTED|Overall Study||18
5325832|NCT00394589|13097812|P2|STARTED|Overall Study||11
5325833|NCT00394589|13097813|P1|STARTED|Overall Study||14
5325834|NCT00394524|13097823|P2|NOT COMPLETED|Overall Study||4
5325835|NCT00394524|13097824|P1|NOT COMPLETED|Overall Study||3
5325836|NCT00394524|13097823|P2|COMPLETED|Overall Study||76
5325837|NCT00394524|13097824|P1|COMPLETED|Overall Study||77
5325838|NCT00394524|13097823|P2|STARTED|Overall Study||80
5325839|NCT00394524|13097824|P1|STARTED|Overall Study||80
5325840|NCT00394472|13097838|P2|NOT COMPLETED|Overall Study||11
5325841|NCT00394472|13097839|P1|NOT COMPLETED|Overall Study||9
5325842|NCT00394472|13097838|P2|COMPLETED|Overall Study||111
5325843|NCT00394472|13097839|P1|COMPLETED|Overall Study||113
5325844|NCT00394472|13097838|P2|STARTED|Overall Study||122
5325845|NCT00394472|13097839|P1|STARTED|Overall Study||122
5325846|NCT00394433|13097847|P1|NOT COMPLETED|Overall Study||3
5325847|NCT00394433|13097847|P1|COMPLETED|Overall Study||35
5325848|NCT00394433|13097847|P1|Evaluable and Treated|Overall Study||35
5325849|NCT00394433|13097847|P1|STARTED|Overall Study||38
5325850|NCT00394355|13097858|P4|NOT COMPLETED|Overall Study||31
5325851|NCT00394355|13097859|P3|NOT COMPLETED|Overall Study||38
5325852|NCT00394355|13097860|P2|NOT COMPLETED|Overall Study||34
5325853|NCT00394355|13097861|P1|NOT COMPLETED|Overall Study||35
5325854|NCT00394355|13097858|P4|COMPLETED|Overall Study||111
5325855|NCT00394355|13097859|P3|COMPLETED|Overall Study||109
5325856|NCT00394355|13097860|P2|COMPLETED|Overall Study||103
5325857|NCT00394355|13097861|P1|COMPLETED|Overall Study||105
5325858|NCT00394355|13097858|P4|STARTED|Overall Study||142
5325859|NCT00394355|13097859|P3|STARTED|Overall Study||147
5325860|NCT00394355|13097860|P2|STARTED|Overall Study||137
5325861|NCT00394355|13097861|P1|STARTED|Overall Study||140
5325862|NCT00394329|13097887|P4|NOT COMPLETED|Overall Study||24
5325863|NCT00394329|13097888|P3|NOT COMPLETED|Overall Study||13
5325864|NCT00394329|13097889|P2|NOT COMPLETED|Overall Study||9
5325865|NCT00394329|13097890|P1|NOT COMPLETED|Overall Study||8
5325866|NCT00394329|13097887|P4|COMPLETED|Overall Study||50
5325867|NCT00394329|13097888|P3|COMPLETED|Overall Study||58
5325868|NCT00394329|13097889|P2|COMPLETED|Overall Study||63
5325869|NCT00394329|13097890|P1|COMPLETED|Overall Study||63
5325870|NCT00394329|13097887|P4|STARTED|Overall Study||74
5325871|NCT00394329|13097888|P3|STARTED|Overall Study||71
5325872|NCT00394329|13097889|P2|STARTED|Overall Study||72
5325873|NCT00394329|13097890|P1|STARTED|Overall Study||71
5325874|NCT00394277|13097940|P4|NOT COMPLETED|Overall Study||125
5325875|NCT00394277|13097941|P3|NOT COMPLETED|Overall Study||120
5325876|NCT00394277|13097942|P2|NOT COMPLETED|Overall Study||60
5325877|NCT00394277|13097943|P1|NOT COMPLETED|Overall Study||58
5325878|NCT00394277|13097940|P4|COMPLETED|Overall Study||266
5325879|NCT00394277|13097941|P3|COMPLETED|Overall Study||273
5325880|NCT00394277|13097942|P2|COMPLETED|Overall Study||136
5325881|NCT00394277|13097943|P1|COMPLETED|Overall Study||137
5325882|NCT00394277|13097940|P4|STARTED|Overall Study||391
5325883|NCT00394277|13097941|P3|STARTED|Overall Study||393
5325884|NCT00394277|13097942|P2|STARTED|Overall Study||196
5325885|NCT00394277|13097943|P1|STARTED|Overall Study||195
5325886|NCT00394251|13097967|P2|NOT COMPLETED|Overall Study||38
5325887|NCT00394251|13097968|P1|NOT COMPLETED|Overall Study||37
5325888|NCT00394251|13097967|P2|COMPLETED|Overall Study||61
5325889|NCT00394251|13097968|P1|COMPLETED|Overall Study||61
5325890|NCT00394251|13097967|P2|At Least One Dose of Taxane|Overall Study||93
5325891|NCT00394251|13097968|P1|At Least One Dose of Taxane|Overall Study||93
5325892|NCT00394251|13097967|P2|STARTED|Overall Study||99
5325893|NCT00394251|13097968|P1|STARTED|Overall Study||98
5325894|NCT00394212|13097996|P2|NOT COMPLETED|Overall Study||1
5325895|NCT00394212|13097997|P1|NOT COMPLETED|Overall Study||7
5325896|NCT00394212|13097996|P2|COMPLETED|Overall Study||26
5325897|NCT00394212|13097997|P1|COMPLETED|Overall Study||43
5325898|NCT00394212|13097996|P2|6 Month Follow-up|Overall Study||26
5325899|NCT00394212|13097997|P1|6 Month Follow-up|Overall Study||43
5325900|NCT00394212|13097996|P2|3 Month Follow-up|Overall Study||26
5325901|NCT00394212|13097997|P1|3 Month Follow-up|Overall Study||45
5325902|NCT00394212|13097996|P2|6 Week Follow-up|Overall Study||26
5325903|NCT00394212|13097997|P1|6 Week Follow-up|Overall Study||45
5325904|NCT00394212|13097996|P2|STARTED|Overall Study||27
5325905|NCT00394212|13097997|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
5325906|NCT00394095|13098011|P2|NOT COMPLETED|Overall Study||0
5325907|NCT00394095|13098012|P1|NOT COMPLETED|Overall Study||1
5325908|NCT00394095|13098011|P2|COMPLETED|Overall Study||14
5325909|NCT00394095|13098012|P1|COMPLETED|Overall Study||16
5325910|NCT00394095|13098011|P2|Screened|Overall Study||14
5325911|NCT00394095|13098012|P1|Screened|Overall Study||17
5325912|NCT00394095|13098011|P2|STARTED|Overall Study||14
5325913|NCT00394095|13098012|P1|STARTED|Overall Study||17
5325914|NCT00394082|13098020|P1|NOT COMPLETED|Overall Study||26
5325915|NCT00394082|13098020|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
5325916|NCT00394082|13098020|P1|At Least One Response Assessment|Overall Study||43
5325917|NCT00394082|13098020|P1|STARTED|Overall Study||50
5325918|NCT00393978|13098031|P2|NOT COMPLETED|Overall Study||20
5325919|NCT00393978|13098032|P1|NOT COMPLETED|Overall Study||16
5325920|NCT00393978|13098031|P2|COMPLETED|Overall Study||18
5325921|NCT00393978|13098032|P1|COMPLETED|Overall Study||21
5325922|NCT00393978|13098031|P2|STARTED|Overall Study||38
5325923|NCT00393978|13098032|P1|STARTED|Overall Study||37
5325924|NCT00393939|13098042|P2|NOT COMPLETED|Overall Study||297
5325925|NCT00393939|13098043|P1|NOT COMPLETED|Overall Study||296
5325926|NCT00393939|13098042|P2|COMPLETED|Overall Study||0
5325927|NCT00393939|13098043|P1|COMPLETED|Overall Study||0
5325928|NCT00393939|13098042|P2|Treated|Overall Study||293
5325929|NCT00393939|13098043|P1|Treated|Overall Study||295
5325930|NCT00393939|13098042|P2|STARTED|Overall Study||297
5325931|NCT00393939|13098043|P1|STARTED|Overall Study||296
5325932|NCT00393913|13098061|P1|NOT COMPLETED|CPAP Withdrawal||0
5325933|NCT00393913|13098061|P1|COMPLETED|CPAP Withdrawal||42
5325934|NCT00393913|13098061|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
5325935|NCT00393913|13098061|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
5325936|NCT00393913|13098061|P1|NOT COMPLETED|CPAP||7
5325937|NCT00393913|13098061|P1|COMPLETED|CPAP||93
5325938|NCT00393913|13098061|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
5325939|NCT00393913|13098061|P1|NOT COMPLETED|Initial Assessment||37
5325940|NCT00393913|13098061|P1|COMPLETED|Initial Assessment||107
5325941|NCT00393913|13098061|P1|STARTED|Initial Assessment||144
5325942|NCT00393887|13098069|P2|NOT COMPLETED|Overall Study||9
5325943|NCT00393887|13098070|P1|NOT COMPLETED|Overall Study||16
5325944|NCT00393887|13098069|P2|COMPLETED|Overall Study||41
5325945|NCT00393887|13098070|P1|COMPLETED|Overall Study||34
5325946|NCT00393887|13098069|P2|1 Year|Overall Study||50
5325947|NCT00393887|13098070|P1|1 Year|Overall Study||45
5325948|NCT00393887|13098069|P2|STARTED|Overall Study||50
5325949|NCT00393887|13098070|P1|STARTED|Overall Study||50
5325950|NCT00393874|13098079|P3|NOT COMPLETED|Overall Study||2
5325951|NCT00393874|13098080|P2|NOT COMPLETED|Overall Study||4
5325952|NCT00393874|13098081|P1|NOT COMPLETED|Overall Study||3
5325953|NCT00393874|13098079|P3|COMPLETED|Overall Study||13
5325954|NCT00393874|13098080|P2|COMPLETED|Overall Study||13
5325955|NCT00393874|13098081|P1|COMPLETED|Overall Study||15
5325956|NCT00393874|13098079|P3|STARTED|Overall Study||15
5325957|NCT00393874|13098080|P2|STARTED|Overall Study||17
5325958|NCT00393874|13098081|P1|STARTED|Overall Study||18
5325959|NCT00393861|13098098|P1|NOT COMPLETED|Overall Study||26
5325960|NCT00393861|13098098|P1|COMPLETED|Overall Study||3
5325961|NCT00393861|13098098|P1|STARTED|Overall Study||29
5325962|NCT00393848|13098109|P4|NOT COMPLETED|Overall Study||1
5325963|NCT00393848|13098110|P3|NOT COMPLETED|Overall Study||2
5325964|NCT00393848|13098111|P2|NOT COMPLETED|Overall Study||0
5325965|NCT00393848|13098112|P1|NOT COMPLETED|Overall Study||0
5325966|NCT00393848|13098109|P4|COMPLETED|Overall Study||8
5325967|NCT00393848|13098110|P3|COMPLETED|Overall Study||4
5325968|NCT00393848|13098111|P2|COMPLETED|Overall Study||9
5325969|NCT00393848|13098112|P1|COMPLETED|Overall Study||16
5325970|NCT00393848|13098109|P4|STARTED|Overall Study||9
5325971|NCT00393848|13098110|P3|STARTED|Overall Study||6
5325972|NCT00393848|13098111|P2|STARTED|Overall Study||9
5325973|NCT00393848|13098112|P1|STARTED|Overall Study||16
5325974|NCT00393796|13098126|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
5325975|NCT00393796|13098127|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
5325976|NCT00393796|13098126|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
5325977|NCT00393796|13098127|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
5325978|NCT00393796|13098126|P2|STARTED|Open Label Period - Placebo to SUTENT||16
5325979|NCT00393796|13098127|P1|STARTED|Open Label Period - Placebo to SUTENT||0
5325980|NCT00393796|13098126|P2|NOT COMPLETED|Double Blind Period||0
5325981|NCT00393796|13098127|P1|NOT COMPLETED|Double Blind Period||0
5325982|NCT00393796|13098126|P2|COMPLETED|Double Blind Period||28
5325983|NCT00393796|13098127|P1|COMPLETED|Double Blind Period||26
5325984|NCT00393796|13098126|P2|STARTED|Double Blind Period||28
5325985|NCT00393796|13098127|P1|STARTED|Double Blind Period||26
5325986|NCT00393718|13098135|P2|NOT COMPLETED|Overall Study||22
5325987|NCT00393718|13098136|P1|NOT COMPLETED|Overall Study||43
5325988|NCT00393718|13098135|P2|COMPLETED|Overall Study||110
5325989|NCT00393718|13098136|P1|COMPLETED|Overall Study||225
5325990|NCT00393718|13098135|P2|STARTED|Overall Study||132
5325991|NCT00393718|13098136|P1|STARTED|Overall Study||268
5325992|NCT00393705|13098168|P2|NOT COMPLETED|Overall Study||23
5325993|NCT00393705|13098169|P1|NOT COMPLETED|Overall Study||23
5325994|NCT00393705|13098168|P2|COMPLETED|Overall Study||128
5325995|NCT00393705|13098169|P1|COMPLETED|Overall Study||128
5325996|NCT00393705|13098168|P2|Received at Least One Dose of Study Drug|Overall Study||139
5325997|NCT00393705|13098169|P1|Received at Least One Dose of Study Drug|Overall Study||139
5325998|NCT00393705|13098168|P2|STARTED|Overall Study||151
5325999|NCT00393705|13098169|P1|STARTED|Overall Study||151
5326000|NCT00393523|13098198|P5|NOT COMPLETED|Overall Study||1
5326001|NCT00393523|13098199|P4|NOT COMPLETED|Overall Study||6
5326002|NCT00393523|13098200|P3|NOT COMPLETED|Overall Study||4
5326003|NCT00393523|13098201|P2|NOT COMPLETED|Overall Study||9
5326004|NCT00393523|13098202|P1|NOT COMPLETED|Overall Study||12
5326005|NCT00393523|13098198|P5|COMPLETED|Overall Study||19
5326006|NCT00393523|13098199|P4|COMPLETED|Overall Study||348
5326007|NCT00393523|13098200|P3|COMPLETED|Overall Study||349
5326008|NCT00393523|13098201|P2|COMPLETED|Overall Study||366
5326009|NCT00393523|13098202|P1|COMPLETED|Overall Study||364
5326010|NCT00393523|13098198|P5|Vaccination Visit 1|Overall Study||20
5326011|NCT00393523|13098199|P4|Vaccination Visit 1|Overall Study||352
5326012|NCT00393523|13098200|P3|Vaccination Visit 1|Overall Study||349
5326013|NCT00393523|13098201|P2|Vaccination Visit 1|Overall Study||375
5326014|NCT00393523|13098202|P1|Vaccination Visit 1|Overall Study||374
5326015|NCT00393523|13098198|P5|STARTED|Overall Study||20
5326016|NCT00393523|13098199|P4|STARTED|Overall Study||354
5326017|NCT00393523|13098200|P3|STARTED|Overall Study||353
5326018|NCT00393523|13098201|P2|STARTED|Overall Study||375
5326019|NCT00393523|13098202|P1|STARTED|Overall Study||376
5326020|NCT00393510|13098219|P2|NOT COMPLETED|Overall Study||9
5326021|NCT00393510|13098220|P1|NOT COMPLETED|Overall Study||3
5326022|NCT00393510|13098219|P2|COMPLETED|Overall Study||31
5326023|NCT00393510|13098220|P1|COMPLETED|Overall Study||37
5326024|NCT00393510|13098219|P2|STARTED|Overall Study||40
5326025|NCT00393510|13098220|P1|STARTED|Overall Study||40
5326026|NCT00393484|13098232|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
5326027|NCT00393484|13098233|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
5326028|NCT00393484|13098232|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
5326029|NCT00393484|13098233|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
5326030|NCT00393484|13098232|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
5326031|NCT00393484|13098233|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
5326032|NCT00393484|13098232|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
5326033|NCT00393484|13098233|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
5326034|NCT00393484|13098232|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
5326035|NCT00393484|13098233|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
5326036|NCT00393484|13098232|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
5326037|NCT00393484|13098233|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
5326038|NCT00393484|13098232|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
5326039|NCT00393484|13098233|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
5326040|NCT00393484|13098232|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
5326041|NCT00393484|13098233|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
5326042|NCT00393484|13098232|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
5326043|NCT00393484|13098233|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
5326044|NCT00393458|13098269|P4|NOT COMPLETED|Overall Study||137
5326045|NCT00393458|13098270|P3|NOT COMPLETED|Overall Study||112
5326046|NCT00393458|13098271|P2|NOT COMPLETED|Overall Study||102
5326047|NCT00393458|13098272|P1|NOT COMPLETED|Overall Study||99
5326048|NCT00393458|13098269|P4|COMPLETED|Overall Study||295
5326049|NCT00393458|13098270|P3|COMPLETED|Overall Study||323
5326050|NCT00393458|13098271|P2|COMPLETED|Overall Study||326
5326051|NCT00393458|13098272|P1|COMPLETED|Overall Study||338
5326052|NCT00393458|13098269|P4|Exposed to Study Medication or Placebo|Overall Study||432
5326053|NCT00393458|13098270|P3|Exposed to Study Medication or Placebo|Overall Study||434
5326054|NCT00393458|13098271|P2|Exposed to Study Medication or Placebo|Overall Study||425
5326055|NCT00393458|13098272|P1|Exposed to Study Medication or Placebo|Overall Study||437
5326056|NCT00393458|13098269|P4|STARTED|Overall Study||432
5326057|NCT00393458|13098270|P3|STARTED|Overall Study||435
5326058|NCT00393458|13098271|P2|STARTED|Overall Study||428
5326059|NCT00393458|13098272|P1|STARTED|Overall Study||437
5326060|NCT00393380|13098286|P1|NOT COMPLETED|Overall Study||0
5326061|NCT00393380|13098286|P1|COMPLETED|Overall Study||13
5326062|NCT00393380|13098286|P1|STARTED|Overall Study||13
5326063|NCT00393367|13098299|P2|NOT COMPLETED|Overall Study||7
5326064|NCT00393367|13098300|P1|NOT COMPLETED|Overall Study||2
5326065|NCT00393367|13098299|P2|COMPLETED|Overall Study||81
5326066|NCT00393367|13098300|P1|COMPLETED|Overall Study||89
5326067|NCT00393367|13098299|P2|STARTED|Overall Study||88
5326068|NCT00393367|13098300|P1|STARTED|Overall Study||91
5326069|NCT00393094|13098328|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
5326070|NCT00393094|13098328|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
5326071|NCT00393094|13098328|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
5326072|NCT00393094|13098328|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
5326073|NCT00393094|13098328|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
5326074|NCT00393094|13098328|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
5326075|NCT00393068|13098335|P1|NOT COMPLETED|Overall Study||18
5326076|NCT00393068|13098335|P1|COMPLETED|Overall Study||44
5326077|NCT00393068|13098335|P1|STARTED|Overall Study||62
5326078|NCT00393042|13098339|P2|NOT COMPLETED|Second Intervetion||8
5326079|NCT00393042|13098340|P1|NOT COMPLETED|Second Intervetion||2
5326080|NCT00393042|13098339|P2|COMPLETED|Second Intervetion||19
5326081|NCT00393042|13098340|P1|COMPLETED|Second Intervetion||24
5326082|NCT00393042|13098339|P2|Completed 25/30 mg Dosage|Second Intervetion||20
5326083|NCT00393042|13098340|P1|Completed 25/30 mg Dosage|Second Intervetion||24
5326084|NCT00393042|13098339|P2|Completed the 20mg Dosage|Second Intervetion||21
5326085|NCT00393042|13098340|P1|Completed the 20mg Dosage|Second Intervetion||24
5326086|NCT00393042|13098339|P2|Completed 10 mg Dosage|Second Intervetion||24
5326087|NCT00393042|13098340|P1|Completed 10 mg Dosage|Second Intervetion||26
5326088|NCT00393042|13098339|P2|Completed Placebo Dosage|Second Intervetion||21
5326089|NCT00393042|13098340|P1|Completed Placebo Dosage|Second Intervetion||25
5326090|NCT00393042|13098339|P2|STARTED|Second Intervetion||27
5326091|NCT00393042|13098340|P1|STARTED|Second Intervetion||26
5326092|NCT00393042|13098339|P2|NOT COMPLETED|First Intervention||6
5326093|NCT00393042|13098340|P1|NOT COMPLETED|First Intervention||5
5326094|NCT00393042|13098339|P2|COMPLETED|First Intervention||27
5326095|NCT00393042|13098340|P1|COMPLETED|First Intervention||26
5326096|NCT00393042|13098339|P2|Completed 25/30mg Dosage|First Intervention||27
5326097|NCT00393042|13098340|P1|Completed 25/30mg Dosage|First Intervention||27
5326098|NCT00393042|13098339|P2|Completed 20 mg Dosage|First Intervention||28
5326099|NCT00393042|13098340|P1|Completed 20 mg Dosage|First Intervention||26
5326100|NCT00393042|13098339|P2|Completed 10mg Dosage|First Intervention||29
5326101|NCT00393042|13098340|P1|Completed 10mg Dosage|First Intervention||29
5326102|NCT00393042|13098339|P2|Completed the Placebo Dosage|First Intervention||29
5326103|NCT00393042|13098340|P1|Completed the Placebo Dosage|First Intervention||27
5326104|NCT00393042|13098339|P2|STARTED|First Intervention||33
5326105|NCT00393042|13098340|P1|STARTED|First Intervention||31
5326106|NCT00393029|13098412|P2|NOT COMPLETED|Overall Study||1
5326107|NCT00393029|13098413|P1|NOT COMPLETED|Overall Study||0
5326108|NCT00393029|13098412|P2|COMPLETED|Overall Study||9
5326109|NCT00393029|13098413|P1|COMPLETED|Overall Study||2
5326110|NCT00393029|13098412|P2|STARTED|Overall Study||10
5326111|NCT00393029|13098413|P1|STARTED|Overall Study||2
5326112|NCT00392990|13098424|P2|NOT COMPLETED|Follow up for 2 Years||0
5326113|NCT00392990|13098425|P1|NOT COMPLETED|Follow up for 2 Years||4
5326114|NCT00392990|13098424|P2|COMPLETED|Follow up for 2 Years||5
5326115|NCT00392990|13098425|P1|COMPLETED|Follow up for 2 Years||16
5326116|NCT00392990|13098424|P2|STARTED|Follow up for 2 Years||5
5326117|NCT00392990|13098425|P1|STARTED|Follow up for 2 Years||20
5326118|NCT00392990|13098424|P2|NOT COMPLETED|Treatment on Study||1
5326119|NCT00392990|13098425|P1|NOT COMPLETED|Treatment on Study||3
5326120|NCT00392990|13098424|P2|COMPLETED|Treatment on Study||4
5326121|NCT00392990|13098425|P1|COMPLETED|Treatment on Study||17
5326122|NCT00392990|13098424|P2|STARTED|Treatment on Study||5
5326123|NCT00392990|13098425|P1|STARTED|Treatment on Study||20
5326124|NCT00392951|13098437|P1|NOT COMPLETED|Overall Study||0
5326125|NCT00392951|13098437|P1|COMPLETED|Overall Study||30
5326126|NCT00392951|13098437|P1|STARTED|Overall Study||30
5326127|NCT00392925|13098449|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
5326128|NCT00392925|13098450|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
5326218|NCT00392392|13098666|P1|COMPLETED|Overall Study||9
5326129|NCT00392925|13098451|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
5326130|NCT00392925|13098452|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
5326131|NCT00392925|13098449|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
5326132|NCT00392925|13098450|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
5326133|NCT00392925|13098451|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
5326134|NCT00392925|13098452|P1|COMPLETED|Randomization to Treatment Group Period||0
5326135|NCT00392925|13098449|P4|STARTED|Randomization to Treatment Group Period||56
5326136|NCT00392925|13098450|P3|STARTED|Randomization to Treatment Group Period||56
5326137|NCT00392925|13098451|P2|STARTED|Randomization to Treatment Group Period||27
5326138|NCT00392925|13098452|P1|STARTED|Randomization to Treatment Group Period||0
5326139|NCT00392925|13098449|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326140|NCT00392925|13098450|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326141|NCT00392925|13098451|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326142|NCT00392925|13098452|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
5326143|NCT00392925|13098449|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326144|NCT00392925|13098450|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326145|NCT00392925|13098451|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
5326146|NCT00392925|13098452|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
5326147|NCT00392925|13098449|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
5326148|NCT00392925|13098450|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
5326149|NCT00392925|13098451|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
5326150|NCT00392925|13098452|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
5326151|NCT00392860|13098540|P3|NOT COMPLETED|Overall Study||0
5326152|NCT00392860|13098541|P2|NOT COMPLETED|Overall Study||0
5326153|NCT00392860|13098542|P1|NOT COMPLETED|Overall Study||0
5326154|NCT00392860|13098540|P3|COMPLETED|Overall Study||1
5326155|NCT00392860|13098541|P2|COMPLETED|Overall Study||0
5326156|NCT00392860|13098542|P1|COMPLETED|Overall Study||3
5326157|NCT00392860|13098540|P3|STARTED|Overall Study||1
5326158|NCT00392860|13098541|P2|STARTED|Overall Study||0
5326159|NCT00392860|13098542|P1|STARTED|Overall Study||3
5326160|NCT00392834|13098550|P2|NOT COMPLETED|Overall Study||0
5326161|NCT00392834|13098551|P1|NOT COMPLETED|Overall Study||0
5326162|NCT00392834|13098550|P2|COMPLETED|Overall Study||32
5326163|NCT00392834|13098551|P1|COMPLETED|Overall Study||2
5326164|NCT00392834|13098550|P2|STARTED|Overall Study||32
5326165|NCT00392834|13098551|P1|STARTED|Overall Study||2
5326166|NCT00392821|13098557|P1|NOT COMPLETED|Overall Study||19
5326167|NCT00392821|13098557|P1|COMPLETED|Overall Study||59
5326168|NCT00392821|13098557|P1|STARTED|Overall Study||78
5326169|NCT00392808|13098566|P4|NOT COMPLETED|Overall Study||4
5326170|NCT00392808|13098567|P3|NOT COMPLETED|Overall Study||2
5326171|NCT00392808|13098568|P2|NOT COMPLETED|Overall Study||3
5326172|NCT00392808|13098569|P1|NOT COMPLETED|Overall Study||6
5326173|NCT00392808|13098566|P4|COMPLETED|Overall Study||100
5326174|NCT00392808|13098567|P3|COMPLETED|Overall Study||107
5326175|NCT00392808|13098568|P2|COMPLETED|Overall Study||86
5326176|NCT00392808|13098569|P1|COMPLETED|Overall Study||81
5326177|NCT00392808|13098566|P4|STARTED|Overall Study||104
5326178|NCT00392808|13098567|P3|STARTED|Overall Study||109
5326179|NCT00392808|13098568|P2|STARTED|Overall Study||89
5326180|NCT00392808|13098569|P1|STARTED|Overall Study||87
5326181|NCT00392782|13098583|P1|NOT COMPLETED|Overall Study||0
5326182|NCT00392782|13098583|P1|COMPLETED|Overall Study||24
5326183|NCT00392782|13098583|P1|STARTED|Overall Study||24
5326184|NCT00392769|13098593|P1|NOT COMPLETED|Overall Study||10
5326185|NCT00392769|13098593|P1|COMPLETED|Overall Study||23
5326186|NCT00392769|13098593|P1|STARTED|Overall Study||33
5326187|NCT00392704|13098597|P1|NOT COMPLETED|Combined Modality Therapy||5
5326188|NCT00392704|13098597|P1|COMPLETED|Combined Modality Therapy||49
5326189|NCT00392704|13098597|P1|STARTED|Combined Modality Therapy||54
5326190|NCT00392704|13098597|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
5326191|NCT00392704|13098597|P1|COMPLETED|Neoadjuvant Chemotherapy||54
5326192|NCT00392704|13098597|P1|STARTED|Neoadjuvant Chemotherapy||60
5326193|NCT00392678|13098606|P4|NOT COMPLETED|Overall Study||1
5326194|NCT00392678|13098607|P3|NOT COMPLETED|Overall Study||2
5326195|NCT00392678|13098608|P2|NOT COMPLETED|Overall Study||1
5326196|NCT00392678|13098609|P1|NOT COMPLETED|Overall Study||0
5326197|NCT00392678|13098606|P4|COMPLETED|Overall Study||26
5326198|NCT00392678|13098607|P3|COMPLETED|Overall Study||25
5326199|NCT00392678|13098608|P2|COMPLETED|Overall Study||26
5326200|NCT00392678|13098609|P1|COMPLETED|Overall Study||27
5326201|NCT00392678|13098606|P4|STARTED|Overall Study||27
5326202|NCT00392678|13098607|P3|STARTED|Overall Study||27
5326203|NCT00392678|13098608|P2|STARTED|Overall Study||27
5326204|NCT00392678|13098609|P1|STARTED|Overall Study||27
5326205|NCT00392665|13098645|P2|NOT COMPLETED|Overall Study||15
5326206|NCT00392665|13098646|P1|NOT COMPLETED|Overall Study||17
5326207|NCT00392665|13098645|P2|COMPLETED|Overall Study||3
5326208|NCT00392665|13098646|P1|COMPLETED|Overall Study||1
5326209|NCT00392665|13098645|P2|STARTED|Overall Study||18
5326210|NCT00392665|13098646|P1|STARTED|Overall Study||18
5326211|NCT00392496|13098658|P1|NOT COMPLETED|Overall Study||0
5326212|NCT00392496|13098658|P1|COMPLETED|Overall Study||19
5326213|NCT00392496|13098658|P1|STARTED|Overall Study||19
5326214|NCT00392444|13098662|P1|NOT COMPLETED|Overall Study||0
5326215|NCT00392444|13098662|P1|COMPLETED|Overall Study||39
5326216|NCT00392444|13098662|P1|STARTED|Overall Study||39
5326217|NCT00392392|13098666|P1|NOT COMPLETED|Overall Study||20
5326219|NCT00392392|13098666|P1|STARTED|Overall Study||29
5326220|NCT00392379|13098672|P2|NOT COMPLETED|Overall Study||38
5326221|NCT00392379|13098673|P1|NOT COMPLETED|Overall Study||22
5326222|NCT00392379|13098672|P2|COMPLETED|Overall Study|Medication period|96
5326223|NCT00392379|13098673|P1|COMPLETED|Overall Study|Medication period|114
5326224|NCT00392379|13098672|P2|STARTED|Overall Study|Medication period|134
5326225|NCT00392379|13098673|P1|STARTED|Overall Study|Medication period|136
5326226|NCT00392288|13098686|P3|NOT COMPLETED|Overall Study||17
5326227|NCT00392288|13098687|P2|NOT COMPLETED|Overall Study||22
5326228|NCT00392288|13098688|P1|NOT COMPLETED|Overall Study||32
5326229|NCT00392288|13098686|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
5326230|NCT00392288|13098687|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
5326231|NCT00392288|13098688|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
5326232|NCT00392288|13098686|P3|Treatment Period|Overall Study||175
5326233|NCT00392288|13098687|P2|Treatment Period|Overall Study||174
5326234|NCT00392288|13098688|P1|Treatment Period|Overall Study||172
5326235|NCT00392288|13098686|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
5326236|NCT00392288|13098687|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
5326237|NCT00392288|13098688|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
5326238|NCT00392236|13098704|P2|NOT COMPLETED|Overall Study||6
5326239|NCT00392236|13098705|P1|NOT COMPLETED|Overall Study||12
5326240|NCT00392236|13098704|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
5326241|NCT00392236|13098705|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
5326242|NCT00392236|13098704|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
5326243|NCT00392236|13098705|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
5326244|NCT00392223|13098713|P2|NOT COMPLETED|Overall Study||13
5326245|NCT00392223|13098714|P1|NOT COMPLETED|Overall Study||9
5326246|NCT00392223|13098713|P2|COMPLETED|Overall Study||47
5326247|NCT00392223|13098714|P1|COMPLETED|Overall Study||49
5326248|NCT00392223|13098713|P2|STARTED|Overall Study||60
5326249|NCT00392223|13098714|P1|STARTED|Overall Study||58
5326250|NCT00392210|13098732|P2|NOT COMPLETED|Second Voiding Trial||0
5326251|NCT00392210|13098733|P1|NOT COMPLETED|Second Voiding Trial||0
5326252|NCT00392210|13098732|P2|COMPLETED|Second Voiding Trial||31
5326253|NCT00392210|13098733|P1|COMPLETED|Second Voiding Trial||34
5326254|NCT00392210|13098732|P2|STARTED|Second Voiding Trial||31
5326255|NCT00392210|13098733|P1|STARTED|Second Voiding Trial||34
5326256|NCT00392210|13098732|P2|NOT COMPLETED|First Voiding Trial||2
5326257|NCT00392210|13098733|P1|NOT COMPLETED|First Voiding Trial||2
5326258|NCT00392210|13098732|P2|COMPLETED|First Voiding Trial||31
5326259|NCT00392210|13098733|P1|COMPLETED|First Voiding Trial||34
5326260|NCT00392210|13098732|P2|STARTED|First Voiding Trial||33
5326261|NCT00392210|13098733|P1|STARTED|First Voiding Trial||36
5326262|NCT00392197|13098741|P2|NOT COMPLETED|Overall Study||30
5326263|NCT00392197|13098742|P1|NOT COMPLETED|Overall Study||21
5326264|NCT00392197|13098741|P2|COMPLETED|Overall Study||33
5326265|NCT00392197|13098742|P1|COMPLETED|Overall Study||27
5326266|NCT00392197|13098741|P2|STARTED|Overall Study||63
5326267|NCT00392197|13098742|P1|STARTED|Overall Study||48
5326268|NCT00392171|13098750|P1|NOT COMPLETED|Overall Study||105
5326269|NCT00392171|13098750|P1|COMPLETED|Overall Study||15
5326270|NCT00392171|13098750|P1|STARTED|Overall Study||120
5326271|NCT00392054|13098756|P2|NOT COMPLETED|Overall Study||0
5326272|NCT00392054|13098757|P1|NOT COMPLETED|Overall Study||0
5326273|NCT00392054|13098756|P2|COMPLETED|Overall Study||61
5326274|NCT00392054|13098757|P1|COMPLETED|Overall Study||66
5326275|NCT00392054|13098756|P2|Received Allocated Intervention|Overall Study||60
5326276|NCT00392054|13098757|P1|Received Allocated Intervention|Overall Study||65
5326277|NCT00392054|13098756|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
5326278|NCT00392054|13098757|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
5326279|NCT00391989|13098777|P1|NOT COMPLETED|Overall Study||2
5326280|NCT00391989|13098777|P1|COMPLETED|Overall Study||53
5326281|NCT00391989|13098777|P1|STARTED|Overall Study||55
5326282|NCT00391976|13098784|P3|NOT COMPLETED|Overall Study||35
5326283|NCT00391976|13098785|P2|NOT COMPLETED|Overall Study||25
5326284|NCT00391976|13098786|P1|NOT COMPLETED|Overall Study||27
5326285|NCT00391976|13098784|P3|COMPLETED|Overall Study||0
5326286|NCT00391976|13098785|P2|COMPLETED|Overall Study||18
5326287|NCT00391976|13098786|P1|COMPLETED|Overall Study||18
5326288|NCT00391976|13098784|P3|Safety Population|Overall Study||35
5326289|NCT00391976|13098785|P2|Safety Population|Overall Study||43
5326290|NCT00391976|13098786|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
5326291|NCT00391976|13098784|P3|Randomized|Overall Study||0
5326292|NCT00391976|13098785|P2|Randomized|Overall Study||43
5326293|NCT00391976|13098786|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
5326294|NCT00391976|13098784|P3|STARTED|Overall Study||35
5326295|NCT00391976|13098785|P2|STARTED|Overall Study||43
5326296|NCT00391976|13098786|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
5326297|NCT00391898|13098810|P2|NOT COMPLETED|Overall Study||10
5326298|NCT00391898|13098811|P1|NOT COMPLETED|Overall Study||11
5326299|NCT00391898|13098810|P2|COMPLETED|Overall Study||39
5326300|NCT00391898|13098811|P1|COMPLETED|Overall Study||35
5326301|NCT00391898|13098810|P2|STARTED|Overall Study||49
5326302|NCT00391898|13098811|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
5326303|NCT00391872|13098831|P2|NOT COMPLETED|Overall Study||255
5326304|NCT00391872|13098832|P1|NOT COMPLETED|Overall Study||307
5326305|NCT00391872|13098831|P2|COMPLETED|Overall Study||9036
5326306|NCT00391872|13098832|P1|COMPLETED|Overall Study||9026
5326307|NCT00391872|13098831|P2|STARTED|Overall Study||9291
5326308|NCT00391872|13098832|P1|STARTED|Overall Study||9333
5326309|NCT00391846|13098870|P2|NOT COMPLETED|Overall Study||7
5326310|NCT00391846|13098871|P1|NOT COMPLETED|Overall Study||8
5326311|NCT00391846|13098870|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
5326312|NCT00391846|13098871|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
5326313|NCT00391846|13098870|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
5326314|NCT00391846|13098871|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
5326315|NCT00391807|13098891|P1|NOT COMPLETED|Overall Study||715
5326316|NCT00391807|13098891|P1|COMPLETED|Overall Study||968
5326317|NCT00391807|13098891|P1|STARTED|Overall Study||1683
5326318|NCT00391768|13098918|P7|NOT COMPLETED|Overall Study||4
5326319|NCT00391768|13098919|P6|NOT COMPLETED|Overall Study||3
5326320|NCT00391768|13098920|P5|NOT COMPLETED|Overall Study||2
5326321|NCT00391768|13098921|P4|NOT COMPLETED|Overall Study||1
5326322|NCT00391768|13098922|P3|NOT COMPLETED|Overall Study||1
5326323|NCT00391768|13098923|P2|NOT COMPLETED|Overall Study||0
5326324|NCT00391768|13098924|P1|NOT COMPLETED|Overall Study||0
5326325|NCT00391768|13098918|P7|COMPLETED|Overall Study||19
5326326|NCT00391768|13098919|P6|COMPLETED|Overall Study||7
5326327|NCT00391768|13098920|P5|COMPLETED|Overall Study||22
5326328|NCT00391768|13098921|P4|COMPLETED|Overall Study||7
5326329|NCT00391768|13098922|P3|COMPLETED|Overall Study||6
5326330|NCT00391768|13098923|P2|COMPLETED|Overall Study||3
5326331|NCT00391768|13098924|P1|COMPLETED|Overall Study||12
5326332|NCT00391768|13098918|P7|STARTED|Overall Study||23
5326333|NCT00391768|13098919|P6|STARTED|Overall Study||10
5326334|NCT00391768|13098920|P5|STARTED|Overall Study||24
5326335|NCT00391768|13098921|P4|STARTED|Overall Study||8
5326336|NCT00391768|13098922|P3|STARTED|Overall Study||7
5326337|NCT00391768|13098923|P2|STARTED|Overall Study||3
5326338|NCT00391768|13098924|P1|STARTED|Overall Study||12
5326339|NCT00391716|13098992|P3|NOT COMPLETED|Overall Study||19
5326340|NCT00391716|13098993|P2|NOT COMPLETED|Overall Study||19
5326341|NCT00391716|13098994|P1|NOT COMPLETED|Overall Study||27
5326342|NCT00391716|13098992|P3|COMPLETED|Overall Study||30
5326343|NCT00391716|13098993|P2|COMPLETED|Overall Study||28
5326344|NCT00391716|13098994|P1|COMPLETED|Overall Study||27
5326345|NCT00391716|13098992|P3|STARTED|Overall Study||49
5326346|NCT00391716|13098993|P2|STARTED|Overall Study||47
5326347|NCT00391716|13098994|P1|STARTED|Overall Study||54
5326348|NCT00391625|13099011|P1|NOT COMPLETED|Month 84||0
5326349|NCT00391625|13099011|P1|COMPLETED|Month 84||8
5326350|NCT00391625|13099011|P1|STARTED|Month 84||8
5326351|NCT00391625|13099011|P1|NOT COMPLETED|Month 50||1
5326352|NCT00391625|13099011|P1|COMPLETED|Month 50||8
5326353|NCT00391625|13099011|P1|STARTED|Month 50||9
5326354|NCT00391625|13099011|P1|NOT COMPLETED|Month 14||1
5326355|NCT00391625|13099011|P1|COMPLETED|Month 14||9
5326356|NCT00391625|13099011|P1|STARTED|Month 14||10
5326357|NCT00391625|13099011|P1|NOT COMPLETED|Baseline||0
5326358|NCT00391625|13099011|P1|COMPLETED|Baseline||10
5326359|NCT00391625|13099011|P1|STARTED|Baseline||10
5326360|NCT00391599|13099053|P2|NOT COMPLETED|Overall Study||0
5326361|NCT00391599|13099054|P1|NOT COMPLETED|Overall Study||0
5326362|NCT00391599|13099053|P2|COMPLETED|Overall Study||65
5326363|NCT00391599|13099054|P1|COMPLETED|Overall Study||65
5326364|NCT00391599|13099053|P2|STARTED|Overall Study||65
5326365|NCT00391599|13099054|P1|STARTED|Overall Study||65
5326366|NCT00391586|13099064|P1|NOT COMPLETED|Overall Study||24
5326367|NCT00391586|13099064|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
5326368|NCT00391586|13099064|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
5326369|NCT00391586|13099064|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
5326370|NCT00391586|13099064|P1|STARTED|Overall Study||45
5326371|NCT00391469|13099073|P2|NOT COMPLETED|Overall Study||0
5326372|NCT00391469|13099074|P1|NOT COMPLETED|Overall Study||0
5326373|NCT00391469|13099073|P2|COMPLETED|Overall Study||671
5326374|NCT00391469|13099074|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
5326375|NCT00391469|13099073|P2|STARTED|Overall Study||671
5326376|NCT00391469|13099074|P1|STARTED|Overall Study||688
5326377|NCT00391443|13099088|P2|NOT COMPLETED|Overall Study||0
5326378|NCT00391443|13099089|P1|NOT COMPLETED|Overall Study||0
5326379|NCT00391443|13099088|P2|COMPLETED|Overall Study||407
5326380|NCT00391443|13099089|P1|COMPLETED|Overall Study||209
5326381|NCT00391443|13099088|P2|STARTED|Overall Study||407
5326382|NCT00391443|13099089|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
5326383|NCT00391391|13099101|P4|NOT COMPLETED|Overall Study||19
5326384|NCT00391391|13099102|P3|NOT COMPLETED|Overall Study||23
5326385|NCT00391391|13099103|P2|NOT COMPLETED|Overall Study||10
5326386|NCT00391391|13099104|P1|NOT COMPLETED|Overall Study||9
5326387|NCT00391391|13099101|P4|COMPLETED|Overall Study||145
5326388|NCT00391391|13099102|P3|COMPLETED|Overall Study||138
5326389|NCT00391391|13099103|P2|COMPLETED|Overall Study||87
5326390|NCT00391391|13099104|P1|COMPLETED|Overall Study||89
5326391|NCT00391391|13099101|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
5326392|NCT00391391|13099102|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
5326393|NCT00391391|13099103|P2|STARTED|Overall Study||97
5326394|NCT00391391|13099104|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
5326395|NCT00391365|13099136|P2|NOT COMPLETED|Overall Study||19
5326396|NCT00391365|13099137|P1|NOT COMPLETED|Overall Study||25
5326397|NCT00391365|13099136|P2|COMPLETED|Overall Study||151
5326398|NCT00391365|13099137|P1|COMPLETED|Overall Study||78
5326399|NCT00391365|13099136|P2|STARTED|Overall Study||170
5326400|NCT00391365|13099137|P1|STARTED|Overall Study||103
5326401|NCT00391274|13099149|P2|NOT COMPLETED|Overall Study||57
5326402|NCT00391274|13099150|P1|NOT COMPLETED|Overall Study||61
5326403|NCT00391274|13099149|P2|COMPLETED|Overall Study||47
5326404|NCT00391274|13099150|P1|COMPLETED|Overall Study||46
5326405|NCT00391274|13099149|P2|Received at Least One Dose of Study Drug|Overall Study||102
5326406|NCT00391274|13099150|P1|Received at Least One Dose of Study Drug|Overall Study||106
5326407|NCT00391274|13099149|P2|STARTED|Overall Study||104
5326408|NCT00391274|13099150|P1|STARTED|Overall Study||107
5326409|NCT00391222|13099169|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
5326410|NCT00391222|13099170|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
5326411|NCT00391222|13099171|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
5326412|NCT00391222|13099172|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
5326413|NCT00391222|13099169|P4|COMPLETED|Period III (Double-Blind Treatment)||0
5326414|NCT00391222|13099170|P3|COMPLETED|Period III (Double-Blind Treatment)||108
5326415|NCT00391222|13099171|P2|COMPLETED|Period III (Double-Blind Treatment)||113
5326416|NCT00391222|13099172|P1|COMPLETED|Period III (Double-Blind Treatment)||104
5326417|NCT00391222|13099169|P4|STARTED|Period III (Double-Blind Treatment)||0
5326418|NCT00391222|13099170|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
5326419|NCT00391222|13099171|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
5326420|NCT00391222|13099172|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
5326421|NCT00391222|13099169|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
5326422|NCT00391222|13099170|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
5326423|NCT00391222|13099171|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
5326424|NCT00391222|13099172|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
5326425|NCT00391222|13099169|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
5326426|NCT00391222|13099170|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
5326427|NCT00391222|13099171|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
5326428|NCT00391222|13099172|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
5326429|NCT00391222|13099169|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
5326430|NCT00391222|13099170|P3|STARTED|Period II (Open-label Risperidone LAI)||0
5326431|NCT00391222|13099171|P2|STARTED|Period II (Open-label Risperidone LAI)||0
5326432|NCT00391222|13099172|P1|STARTED|Period II (Open-label Risperidone LAI)||0
5326433|NCT00391092|13099198|P2|NOT COMPLETED|Overall Study||216
5326434|NCT00391092|13099199|P1|NOT COMPLETED|Overall Study||208
5326435|NCT00391092|13099198|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
5326436|NCT00391092|13099199|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
5326437|NCT00391092|13099198|P2|Received Treatment|Overall Study||215
5326438|NCT00391092|13099199|P1|Received Treatment|Overall Study||206
5326439|NCT00391092|13099198|P2|STARTED|Overall Study||216
5326440|NCT00391092|13099199|P1|STARTED|Overall Study||208
5326441|NCT00391079|13099219|P2|NOT COMPLETED|Overall Study||16
5326442|NCT00391079|13099220|P1|NOT COMPLETED|Overall Study||26
5326443|NCT00391079|13099219|P2|COMPLETED|Overall Study||156
5326444|NCT00391079|13099220|P1|COMPLETED|Overall Study||141
5326445|NCT00391079|13099219|P2|STARTED|Overall Study||172
5326446|NCT00391079|13099220|P1|STARTED|Overall Study||167
5326447|NCT00391053|13099242|P4|NOT COMPLETED|Overall Study||10
5326448|NCT00391053|13099243|P3|NOT COMPLETED|Overall Study||2
5326449|NCT00391053|13099244|P2|NOT COMPLETED|Overall Study||1
5326450|NCT00391053|13099245|P1|NOT COMPLETED|Overall Study||9
5326451|NCT00391053|13099242|P4|COMPLETED|Overall Study||1252
5326452|NCT00391053|13099243|P3|COMPLETED|Overall Study||868
5326453|NCT00391053|13099244|P2|COMPLETED|Overall Study||847
5326454|NCT00391053|13099245|P1|COMPLETED|Overall Study||848
5326455|NCT00391053|13099242|P4|STARTED|Overall Study||1262
5326456|NCT00391053|13099243|P3|STARTED|Overall Study||870
5326457|NCT00391053|13099244|P2|STARTED|Overall Study||848
5326458|NCT00391053|13099245|P1|STARTED|Overall Study||857
5326459|NCT00391027|13099269|P2|NOT COMPLETED|Overall Study||12
5326460|NCT00391027|13099270|P1|NOT COMPLETED|Overall Study||25
5326461|NCT00391027|13099269|P2|COMPLETED|Overall Study||110
5326462|NCT00391027|13099270|P1|COMPLETED|Overall Study||110
5326463|NCT00391027|13099269|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
5326464|NCT00391027|13099270|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
5326465|NCT00390949|13099310|P2|NOT COMPLETED|Overall Study||2128
5326466|NCT00390949|13099311|P1|NOT COMPLETED|Overall Study||2098
5326467|NCT00390949|13099310|P2|COMPLETED|Overall Study||2664
5326468|NCT00390949|13099311|P1|COMPLETED|Overall Study||2564
5326469|NCT00390949|13099310|P2|STARTED|Overall Study||4792
5326470|NCT00390949|13099311|P1|STARTED|Overall Study||4662
5326471|NCT00390910|13099320|P3|NOT COMPLETED|Overall Study||10
5326472|NCT00390910|13099321|P2|NOT COMPLETED|Overall Study||4
5326473|NCT00390910|13099322|P1|NOT COMPLETED|Overall Study||2
5326474|NCT00390910|13099320|P3|COMPLETED|Overall Study||139
5326475|NCT00390910|13099321|P2|COMPLETED|Overall Study||83
5326476|NCT00390910|13099322|P1|COMPLETED|Overall Study||48
5326477|NCT00390910|13099320|P3|STARTED|Overall Study||149
5326478|NCT00390910|13099321|P2|STARTED|Overall Study||87
5326479|NCT00390910|13099322|P1|STARTED|Overall Study||50
5326480|NCT00390884|13099410|P2|NOT COMPLETED|Overall Study||2
5326481|NCT00390884|13099411|P1|NOT COMPLETED|Overall Study||2
5326482|NCT00390884|13099410|P2|COMPLETED|Overall Study||55
5326483|NCT00390884|13099411|P1|COMPLETED|Overall Study||114
5326484|NCT00390884|13099410|P2|STARTED|Overall Study||57
5326485|NCT00390884|13099411|P1|STARTED|Overall Study||116
5326486|NCT00390858|13099423|P2|NOT COMPLETED|Overall Study||7
5326487|NCT00390858|13099424|P1|NOT COMPLETED|Overall Study||9
5326488|NCT00390858|13099423|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
5326489|NCT00390858|13099424|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
5326490|NCT00390858|13099423|P2|Completed Core & Entered Extension Study|Overall Study||20
5326491|NCT00390858|13099424|P1|Completed Core & Entered Extension Study|Overall Study||19
5326492|NCT00390858|13099423|P2|STARTED|Overall Study|20 Participants started the Core Study|20
5326493|NCT00390858|13099424|P1|STARTED|Overall Study|20 participants started the Core Study|20
5326494|NCT00390806|13099438|P2|NOT COMPLETED|Overall Study||32
5326495|NCT00390806|13099439|P1|NOT COMPLETED|Overall Study||30
5326496|NCT00390806|13099438|P2|COMPLETED|Overall Study||204
5326497|NCT00390806|13099439|P1|COMPLETED|Overall Study||206
5326498|NCT00390806|13099438|P2|Ongoing|Overall Study||2
5326499|NCT00390806|13099439|P1|Ongoing|Overall Study||4
5326500|NCT00390806|13099438|P2|STARTED|Overall Study||236
5326501|NCT00390806|13099439|P1|STARTED|Overall Study||236
5326502|NCT00390780|13099507|P2|NOT COMPLETED|Overall Study||27
5326503|NCT00390780|13099508|P1|NOT COMPLETED|Overall Study||23
5326504|NCT00390780|13099507|P2|COMPLETED|Overall Study||260
5326505|NCT00390780|13099508|P1|COMPLETED|Overall Study||268
5326506|NCT00390780|13099507|P2|Treatment|Overall Study||287
5326507|NCT00390780|13099508|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
5326508|NCT00390780|13099507|P2|STARTED|Overall Study||287
5326509|NCT00390780|13099508|P1|STARTED|Overall Study||291
5326510|NCT00390689|13099541|P3|NOT COMPLETED|Overall Study||3
5326511|NCT00390689|13099542|P2|NOT COMPLETED|Overall Study||5
5326512|NCT00390689|13099543|P1|NOT COMPLETED|Overall Study||5
5326513|NCT00390689|13099541|P3|COMPLETED|Overall Study||50
5326514|NCT00390689|13099542|P2|COMPLETED|Overall Study||48
5326515|NCT00390689|13099543|P1|COMPLETED|Overall Study||43
5326516|NCT00390689|13099541|P3|STARTED|Overall Study||53
5326517|NCT00390689|13099542|P2|STARTED|Overall Study||53
5326518|NCT00390689|13099543|P1|STARTED|Overall Study||48
5326519|NCT00390611|13099603|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
5326520|NCT00390611|13099604|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
5326521|NCT00390611|13099603|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
5326522|NCT00390611|13099604|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
5326523|NCT00390611|13099603|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
5326524|NCT00390611|13099604|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
5326525|NCT00390611|13099603|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
5326526|NCT00390611|13099604|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
5326527|NCT00390611|13099603|P2|COMPLETED|6 Cycles of Study Treatment||37
5326528|NCT00390611|13099604|P1|COMPLETED|6 Cycles of Study Treatment||34
5326529|NCT00390611|13099603|P2|STARTED|6 Cycles of Study Treatment||42
5326530|NCT00390611|13099604|P1|STARTED|6 Cycles of Study Treatment||43
5326531|NCT00390572|13099618|P2|NOT COMPLETED|Overall Study||5
5326532|NCT00390572|13099619|P1|NOT COMPLETED|Overall Study||8
5326533|NCT00390572|13099618|P2|COMPLETED|Overall Study||64
5326534|NCT00390572|13099619|P1|COMPLETED|Overall Study||60
5326535|NCT00390572|13099618|P2|STARTED|Overall Study||69
5326536|NCT00390572|13099619|P1|STARTED|Overall Study||68
5326537|NCT00390559|13099633|P1|NOT COMPLETED|Overall Study||44
5326538|NCT00390559|13099633|P1|COMPLETED|Overall Study||80
5326539|NCT00390559|13099633|P1|ActiveP/PlaceboC|Overall Study||90
5326540|NCT00390559|13099633|P1|PlaceboP/PlaceboC|Overall Study||93
5326541|NCT00390559|13099633|P1|ActiveP/ActiveC|Overall Study||87
5326542|NCT00390559|13099633|P1|Received PlaceboP/Active C|Overall Study||93
5326543|NCT00390559|13099633|P1|STARTED|Overall Study||124
5326544|NCT00390546|13099645|P2|NOT COMPLETED|Overall Study||5
5326545|NCT00390546|13099646|P1|NOT COMPLETED|Overall Study||6
5326546|NCT00390546|13099645|P2|COMPLETED|Overall Study||34
5326547|NCT00390546|13099646|P1|COMPLETED|Overall Study||27
5326548|NCT00390546|13099645|P2|STARTED|Overall Study||39
5326549|NCT00390546|13099646|P1|STARTED|Overall Study||33
5326550|NCT00390468|13099656|P1|NOT COMPLETED|Overall Study||3
5326551|NCT00390468|13099656|P1|COMPLETED|Overall Study||15
5326552|NCT00390468|13099656|P1|STARTED|Overall Study||18
5326553|NCT00390455|13099662|P2|NOT COMPLETED|Overall Study||23
5326554|NCT00390455|13099663|P1|NOT COMPLETED|Overall Study||32
5326555|NCT00390455|13099662|P2|COMPLETED|Overall Study||124
5326556|NCT00390455|13099663|P1|COMPLETED|Overall Study||116
5326557|NCT00390455|13099662|P2|STARTED|Overall Study||147
5326558|NCT00390455|13099663|P1|STARTED|Overall Study||148
5326559|NCT00390429|13099684|P4|NOT COMPLETED|Overall Study||0
5326560|NCT00390429|13099685|P3|NOT COMPLETED|Overall Study||0
5326561|NCT00390429|13099686|P2|NOT COMPLETED|Overall Study||0
5326562|NCT00390429|13099687|P1|NOT COMPLETED|Overall Study||0
5326563|NCT00390429|13099684|P4|COMPLETED|Overall Study||39
5326564|NCT00390429|13099685|P3|COMPLETED|Overall Study||25
5326565|NCT00390429|13099686|P2|COMPLETED|Overall Study||12
5326566|NCT00390429|13099687|P1|COMPLETED|Overall Study||5
5326567|NCT00390429|13099684|P4|STARTED|Overall Study||39
5326568|NCT00390429|13099685|P3|STARTED|Overall Study||25
5326569|NCT00390429|13099686|P2|STARTED|Overall Study||12
5326570|NCT00390429|13099687|P1|STARTED|Overall Study||5
5326571|NCT00390416|13099708|P1|NOT COMPLETED|Overall Study||4
5326572|NCT00390416|13099708|P1|COMPLETED|Overall Study||44
5326573|NCT00390416|13099708|P1|STARTED|Overall Study||48
5326574|NCT00390364|13099714|P1|NOT COMPLETED|Overall Study||0
5326575|NCT00390364|13099714|P1|COMPLETED|Overall Study||1
5326576|NCT00390364|13099714|P1|STARTED|Overall Study||1
5326577|NCT00390325|13099720|P2|NOT COMPLETED|Overall Study||0
5326578|NCT00390325|13099721|P1|NOT COMPLETED|Overall Study||0
5326579|NCT00390325|13099720|P2|COMPLETED|Overall Study||16
5326580|NCT00390325|13099721|P1|COMPLETED|Overall Study||5
5326581|NCT00390325|13099720|P2|STARTED|Overall Study||16
5326582|NCT00390325|13099721|P1|STARTED|Overall Study||5
5326583|NCT00390299|13099746|P5|NOT COMPLETED|Overall Study||0
5326584|NCT00390299|13099747|P4|NOT COMPLETED|Overall Study||0
5326585|NCT00390299|13099748|P3|NOT COMPLETED|Overall Study||0
5326586|NCT00390299|13099749|P2|NOT COMPLETED|Overall Study||0
5326587|NCT00390299|13099750|P1|NOT COMPLETED|Overall Study||1
5326588|NCT00390299|13099746|P5|COMPLETED|Overall Study||10
5326589|NCT00390299|13099747|P4|COMPLETED|Overall Study||3
5326590|NCT00390299|13099748|P3|COMPLETED|Overall Study||3
5326591|NCT00390299|13099749|P2|COMPLETED|Overall Study||3
5326592|NCT00390299|13099750|P1|COMPLETED|Overall Study||3
5326593|NCT00390299|13099746|P5|STARTED|Overall Study||10
5326594|NCT00390299|13099747|P4|STARTED|Overall Study||3
5326595|NCT00390299|13099748|P3|STARTED|Overall Study||3
5326596|NCT00390299|13099749|P2|STARTED|Overall Study||3
5326597|NCT00390299|13099750|P1|STARTED|Overall Study||4
5326598|NCT00390234|13099770|P1|NOT COMPLETED|Overall Study||0
5326599|NCT00390234|13099770|P1|COMPLETED|Overall Study||63
5326600|NCT00390234|13099770|P1|STARTED|Overall Study||63
5326601|NCT00390221|13099781|P3|NOT COMPLETED|Overall Study||15
5326602|NCT00390221|13099782|P2|NOT COMPLETED|Overall Study||20
5326603|NCT00390221|13099783|P1|NOT COMPLETED|Overall Study||18
5326604|NCT00390221|13099781|P3|COMPLETED|Overall Study||194
5326605|NCT00390221|13099782|P2|COMPLETED|Overall Study||188
5326606|NCT00390221|13099783|P1|COMPLETED|Overall Study||186
5326607|NCT00390221|13099781|P3|STARTED|Overall Study||209
5326608|NCT00390221|13099782|P2|STARTED|Overall Study||208
5326609|NCT00390221|13099783|P1|STARTED|Overall Study||204
5326610|NCT00390182|13099804|P1|NOT COMPLETED|Overall Study||5
5326611|NCT00390182|13099804|P1|COMPLETED|Overall Study||33
5326612|NCT00390182|13099804|P1|STARTED|Overall Study||38
5326613|NCT00390013|13099813|P4|NOT COMPLETED|Phase 2 Second Treatment||0
5326614|NCT00390013|13099814|P3|NOT COMPLETED|Phase 2 Second Treatment||0
5326615|NCT00390013|13099815|P2|NOT COMPLETED|Phase 2 Second Treatment||0
5326616|NCT00390013|13099816|P1|NOT COMPLETED|Phase 2 Second Treatment||0
5326617|NCT00390013|13099813|P4|COMPLETED|Phase 2 Second Treatment||0
5326618|NCT00390013|13099814|P3|COMPLETED|Phase 2 Second Treatment||0
5326619|NCT00390013|13099815|P2|COMPLETED|Phase 2 Second Treatment||1
5326620|NCT00390013|13099816|P1|COMPLETED|Phase 2 Second Treatment||2
5326621|NCT00390013|13099813|P4|STARTED|Phase 2 Second Treatment||0
5326622|NCT00390013|13099814|P3|STARTED|Phase 2 Second Treatment||0
5326623|NCT00390013|13099815|P2|STARTED|Phase 2 Second Treatment||1
5326624|NCT00390013|13099816|P1|STARTED|Phase 2 Second Treatment||2
5326625|NCT00390013|13099813|P4|NOT COMPLETED|Phase 2 First Treatment||0
5326626|NCT00390013|13099814|P3|NOT COMPLETED|Phase 2 First Treatment||0
5326627|NCT00390013|13099815|P2|NOT COMPLETED|Phase 2 First Treatment||1
5326628|NCT00390013|13099816|P1|NOT COMPLETED|Phase 2 First Treatment||1
5326629|NCT00390013|13099813|P4|COMPLETED|Phase 2 First Treatment||0
5326630|NCT00390013|13099814|P3|COMPLETED|Phase 2 First Treatment||0
5326631|NCT00390013|13099815|P2|COMPLETED|Phase 2 First Treatment||1
5326632|NCT00390013|13099816|P1|COMPLETED|Phase 2 First Treatment||2
5326633|NCT00390013|13099813|P4|STARTED|Phase 2 First Treatment||0
5326634|NCT00390013|13099814|P3|STARTED|Phase 2 First Treatment||0
5326635|NCT00390013|13099815|P2|STARTED|Phase 2 First Treatment||2
5326636|NCT00390013|13099816|P1|STARTED|Phase 2 First Treatment||3
5326637|NCT00390013|13099813|P4|NOT COMPLETED|Phase 1||1
5326638|NCT00390013|13099814|P3|NOT COMPLETED|Phase 1||0
5326639|NCT00390013|13099815|P2|NOT COMPLETED|Phase 1||0
5326640|NCT00390013|13099816|P1|NOT COMPLETED|Phase 1||0
5326641|NCT00390013|13099813|P4|COMPLETED|Phase 1||1
5326642|NCT00390013|13099814|P3|COMPLETED|Phase 1||2
5326643|NCT00390013|13099815|P2|COMPLETED|Phase 1||0
5326644|NCT00390013|13099816|P1|COMPLETED|Phase 1||0
5326645|NCT00390013|13099813|P4|STARTED|Phase 1||2
5326646|NCT00390013|13099814|P3|STARTED|Phase 1||2
5326647|NCT00390013|13099815|P2|STARTED|Phase 1||0
5326648|NCT00390013|13099816|P1|STARTED|Phase 1||0
5326649|NCT00389974|13099822|P1|NOT COMPLETED|Overall Study||0
5326650|NCT00389974|13099822|P1|COMPLETED|Overall Study||19
5326651|NCT00389974|13099822|P1|STARTED|Overall Study||19
5326652|NCT00389857|13099828|P2|NOT COMPLETED|Overall Study||0
5326653|NCT00389857|13099829|P1|NOT COMPLETED|Overall Study||0
5326654|NCT00389857|13099828|P2|COMPLETED|Overall Study||17
5326655|NCT00389857|13099829|P1|COMPLETED|Overall Study||14
5326656|NCT00389857|13099828|P2|STARTED|Overall Study||17
5326657|NCT00389857|13099829|P1|STARTED|Overall Study||14
5326658|NCT00389831|13099841|P2|NOT COMPLETED|Overall Study||7
5326659|NCT00389831|13099842|P1|NOT COMPLETED|Overall Study||0
5326660|NCT00389831|13099841|P2|COMPLETED|Overall Study||27
5326661|NCT00389831|13099842|P1|COMPLETED|Overall Study||10
5326662|NCT00389831|13099841|P2|STARTED|Overall Study||34
5326663|NCT00389831|13099842|P1|STARTED|Overall Study||10
5326664|NCT00389818|13099868|P1|NOT COMPLETED|Overall Study||3
5326665|NCT00389818|13099868|P1|COMPLETED|Overall Study||40
5326666|NCT00389818|13099868|P1|STARTED|Overall Study||43
5326667|NCT00389805|13099874|P2|NOT COMPLETED|Phase II||0
5326668|NCT00389805|13099875|P1|NOT COMPLETED|Phase II||0
5326669|NCT00389805|13099874|P2|COMPLETED|Phase II||0
5326670|NCT00389805|13099875|P1|COMPLETED|Phase II||0
5326671|NCT00389805|13099874|P2|STARTED|Phase II|The Phase II study was not conducted.|0
5326672|NCT00389805|13099875|P1|STARTED|Phase II|The Phase II study was not conducted.|0
5326673|NCT00389805|13099874|P2|NOT COMPLETED|Phase I||0
5326674|NCT00389805|13099875|P1|NOT COMPLETED|Phase I||0
5326675|NCT00389805|13099874|P2|COMPLETED|Phase I||12
5326676|NCT00389805|13099875|P1|COMPLETED|Phase I||15
5326677|NCT00389805|13099874|P2|STARTED|Phase I||12
5326678|NCT00389805|13099875|P1|STARTED|Phase I||15
5326679|NCT00389597|13099905|P4|NOT COMPLETED|Overall Study||6
5326680|NCT00389597|13099906|P3|NOT COMPLETED|Overall Study||4
5326681|NCT00389597|13099907|P2|NOT COMPLETED|Overall Study||6
5326682|NCT00389597|13099908|P1|NOT COMPLETED|Overall Study||8
5326683|NCT00389597|13099905|P4|COMPLETED|Overall Study||99
5326684|NCT00389597|13099906|P3|COMPLETED|Overall Study||221
5326685|NCT00389597|13099907|P2|COMPLETED|Overall Study||75
5326686|NCT00389597|13099908|P1|COMPLETED|Overall Study||156
5326687|NCT00389597|13099905|P4|24 mo|Overall Study||99
5326688|NCT00389597|13099906|P3|24 mo|Overall Study||221
5326689|NCT00389597|13099907|P2|24 mo|Overall Study||75
5326690|NCT00389597|13099908|P1|24 mo|Overall Study||156
5326691|NCT00389597|13099905|P4|STARTED|Overall Study||105
5326692|NCT00389597|13099906|P3|STARTED|Overall Study||225
5326693|NCT00389597|13099907|P2|STARTED|Overall Study||81
5326694|NCT00389597|13099908|P1|STARTED|Overall Study||164
5326695|NCT00389532|13099920|P2|NOT COMPLETED|Overall Study||0
5326696|NCT00389532|13099921|P1|NOT COMPLETED|Overall Study||0
5326697|NCT00389532|13099920|P2|COMPLETED|Overall Study||56
5326698|NCT00389532|13099921|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
5326699|NCT00389532|13099920|P2|STARTED|Overall Study||56
5326700|NCT00389532|13099921|P1|STARTED|Overall Study||60
5326701|NCT00389519|13099933|P4|NOT COMPLETED|Treated||4
5326702|NCT00389519|13099934|P3|NOT COMPLETED|Treated||0
5326703|NCT00389519|13099935|P2|NOT COMPLETED|Treated||1
5326704|NCT00389519|13099936|P1|NOT COMPLETED|Treated||2
5326705|NCT00389519|13099933|P4|COMPLETED|Treated||76
5326706|NCT00389519|13099934|P3|COMPLETED|Treated||40
5326707|NCT00389519|13099935|P2|COMPLETED|Treated||40
5326708|NCT00389519|13099936|P1|COMPLETED|Treated||79
5326709|NCT00389519|13099933|P4|STARTED|Treated||80
5326710|NCT00389519|13099934|P3|STARTED|Treated||40
5326711|NCT00389519|13099935|P2|STARTED|Treated||41
5326712|NCT00389519|13099936|P1|STARTED|Treated||81
5326713|NCT00389519|13099933|P4|NOT COMPLETED|Randomized||0
5326714|NCT00389519|13099934|P3|NOT COMPLETED|Randomized||0
5326715|NCT00389519|13099935|P2|NOT COMPLETED|Randomized||0
5326716|NCT00389519|13099936|P1|NOT COMPLETED|Randomized||2
5326717|NCT00389519|13099933|P4|COMPLETED|Randomized||80
5326718|NCT00389519|13099934|P3|COMPLETED|Randomized||40
5326719|NCT00389519|13099935|P2|COMPLETED|Randomized||41
5326720|NCT00389519|13099936|P1|COMPLETED|Randomized||81
5326721|NCT00389519|13099933|P4|STARTED|Randomized||80
5326722|NCT00389519|13099934|P3|STARTED|Randomized||40
5326723|NCT00389519|13099935|P2|STARTED|Randomized||41
5326724|NCT00389519|13099936|P1|STARTED|Randomized||83
5326725|NCT00389519|13099933|P4|NOT COMPLETED|Placebo Run-In||0
5326726|NCT00389519|13099934|P3|NOT COMPLETED|Placebo Run-In||0
5326727|NCT00389519|13099935|P2|NOT COMPLETED|Placebo Run-In||0
5326728|NCT00389519|13099936|P1|NOT COMPLETED|Placebo Run-In||178
5326729|NCT00389519|13099933|P4|COMPLETED|Placebo Run-In||0
5326730|NCT00389519|13099934|P3|COMPLETED|Placebo Run-In||0
5326731|NCT00389519|13099935|P2|COMPLETED|Placebo Run-In||0
5326732|NCT00389519|13099936|P1|COMPLETED|Placebo Run-In||244
5326733|NCT00389519|13099933|P4|STARTED|Placebo Run-In||0
5326734|NCT00389519|13099934|P3|STARTED|Placebo Run-In||0
5326735|NCT00389519|13099935|P2|STARTED|Placebo Run-In||0
5326736|NCT00389519|13099936|P1|STARTED|Placebo Run-In||422
5326737|NCT00389493|13099965|P3|NOT COMPLETED|Overall Study||3
5326738|NCT00389493|13099966|P2|NOT COMPLETED|Overall Study||8
5326739|NCT00389493|13099967|P1|NOT COMPLETED|Overall Study||3
5326740|NCT00389493|13099965|P3|COMPLETED|Overall Study||17
5326741|NCT00389493|13099966|P2|COMPLETED|Overall Study||32
5326742|NCT00389493|13099967|P1|COMPLETED|Overall Study||37
5326743|NCT00389493|13099965|P3|STARTED|Overall Study||20
5326744|NCT00389493|13099966|P2|STARTED|Overall Study||40
5326745|NCT00389493|13099967|P1|STARTED|Overall Study||40
5326746|NCT00389467|13099991|P4|NOT COMPLETED|Overall Study||0
5326747|NCT00389467|13099992|P3|NOT COMPLETED|Overall Study||0
5326748|NCT00389467|13099993|P2|NOT COMPLETED|Overall Study||0
5326749|NCT00389467|13099994|P1|NOT COMPLETED|Overall Study||0
5326750|NCT00389467|13099991|P4|COMPLETED|Overall Study||20
5326751|NCT00389467|13099992|P3|COMPLETED|Overall Study||30
5326752|NCT00389467|13099993|P2|COMPLETED|Overall Study||34
5326753|NCT00389467|13099994|P1|COMPLETED|Overall Study||34
5326754|NCT00389467|13099991|P4|STARTED|Overall Study||20
5326755|NCT00389467|13099992|P3|STARTED|Overall Study||30
5326756|NCT00389467|13099993|P2|STARTED|Overall Study||34
5326757|NCT00389467|13099994|P1|STARTED|Overall Study||34
5326758|NCT00389441|13100013|P1|NOT COMPLETED|Overall Study||52
5326759|NCT00389441|13100013|P1|COMPLETED|Overall Study||0
5326760|NCT00389441|13100013|P1|STARTED|Overall Study||52
5326761|NCT00389324|13100022|P1|NOT COMPLETED|Subcutaneous Phase||7
5326762|NCT00389324|13100022|P1|COMPLETED|Subcutaneous Phase||25
5326763|NCT00389324|13100022|P1|STARTED|Subcutaneous Phase||32
5326764|NCT00389324|13100022|P1|NOT COMPLETED|Intravenous Phase||0
5326765|NCT00389324|13100022|P1|COMPLETED|Intravenous Phase||32
5326766|NCT00389324|13100022|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
5326767|NCT00389324|13100022|P1|NOT COMPLETED|Run-In Phase||3
5326768|NCT00389324|13100022|P1|COMPLETED|Run-In Phase||18
5326769|NCT00389324|13100022|P1|STARTED|Run-In Phase||21
5326770|NCT00389207|13100032|P3|NOT COMPLETED|Overall Study||41
5326771|NCT00389207|13100033|P2|NOT COMPLETED|Overall Study||72
5326772|NCT00389207|13100034|P1|NOT COMPLETED|Overall Study||63
5326773|NCT00389207|13100032|P3|COMPLETED|Overall Study||152
5326774|NCT00389207|13100033|P2|COMPLETED|Overall Study||116
5326775|NCT00389207|13100034|P1|COMPLETED|Overall Study||125
5326776|NCT00389207|13100032|P3|STARTED|Overall Study||193
5326777|NCT00389207|13100033|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
5326778|NCT00389207|13100034|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
5326779|NCT00389168|13100138|P2|NOT COMPLETED|Overall Study||5
5326780|NCT00389168|13100139|P1|NOT COMPLETED|Overall Study||9
5326781|NCT00389168|13100138|P2|COMPLETED|Overall Study||53
5326782|NCT00389168|13100139|P1|COMPLETED|Overall Study||47
5326783|NCT00389168|13100138|P2|STARTED|Overall Study||58
5326784|NCT00389168|13100139|P1|STARTED|Overall Study||56
5326785|NCT00389064|13100157|P2|NOT COMPLETED|Overall Study||59
5326786|NCT00389064|13100158|P1|NOT COMPLETED|Overall Study||45
5326787|NCT00389064|13100157|P2|COMPLETED|Overall Study||168
5326788|NCT00389064|13100158|P1|COMPLETED|Overall Study||178
5326789|NCT00389064|13100157|P2|STARTED|Overall Study||227
5326790|NCT00389064|13100158|P1|STARTED|Overall Study||223
5326791|NCT00388973|13100186|P2|NOT COMPLETED|Overall Study||58
5326792|NCT00388973|13100187|P1|NOT COMPLETED|Overall Study||56
5326793|NCT00388973|13100186|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
5326794|NCT00388973|13100187|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
5326795|NCT00388973|13100186|P2|Completed Study|Overall Study||114
5326796|NCT00388973|13100187|P1|Completed Study|Overall Study||110
5326797|NCT00388973|13100186|P2|STARTED|Overall Study|Randomized|172
5326798|NCT00388973|13100187|P1|STARTED|Overall Study|Randomized|166
5326799|NCT00388947|13100207|P1|NOT COMPLETED|Overall Study||47
5326800|NCT00388947|13100207|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
5326801|NCT00388947|13100207|P1|STARTED|Overall Study||1590
5326802|NCT00388804|13100214|P2|NOT COMPLETED|Overall Study||0
5326803|NCT00388804|13100215|P1|NOT COMPLETED|Overall Study||0
5326804|NCT00388804|13100214|P2|COMPLETED|Overall Study||21
5326805|NCT00388804|13100215|P1|COMPLETED|Overall Study||17
5326806|NCT00388804|13100214|P2|STARTED|Overall Study||21
5326807|NCT00388804|13100215|P1|STARTED|Overall Study||17
5326808|NCT00388726|13100223|P2|NOT COMPLETED|Overall Study||244
5326809|NCT00388726|13100224|P1|NOT COMPLETED|Overall Study||484
5326810|NCT00388726|13100223|P2|COMPLETED|Overall Study||10
5326811|NCT00388726|13100224|P1|COMPLETED|Overall Study||24
5326812|NCT00388726|13100223|P2|STARTED|Overall Study||254
5326813|NCT00388726|13100224|P1|STARTED|Overall Study||508
5326814|NCT00388674|13100240|P2|NOT COMPLETED|End of Study||2169
5326815|NCT00388674|13100241|P1|NOT COMPLETED|End of Study||1734
5326816|NCT00388674|13100240|P2|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|3993
5326817|NCT00388674|13100241|P1|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|4482
5326818|NCT00388674|13100240|P2|STARTED|End of Study||6162
5326819|NCT00388674|13100241|P1|STARTED|End of Study||6216
5326820|NCT00388674|13100240|P2|NOT COMPLETED|Initial Treatment||2586
5326821|NCT00388674|13100241|P1|NOT COMPLETED|Initial Treatment||1828
5326822|NCT00388674|13100240|P2|COMPLETED|Initial Treatment|Completed=discontinued initial treatment reason of “successful treatment” or “end of study”|3576
5326823|NCT00388674|13100241|P1|COMPLETED|Initial Treatment|Completed=Reason of ‘successful treatment’, ‘other: successful treatment’ or ‘other: end of study’|4388
5326824|NCT00388674|13100240|P2|STARTED|Initial Treatment||6162
5326825|NCT00388674|13100241|P1|STARTED|Initial Treatment||6216
5326826|NCT00388583|13100259|P2|NOT COMPLETED|Overall Study||4
5326827|NCT00388583|13100260|P1|NOT COMPLETED|Overall Study||6
5326828|NCT00388583|13100259|P2|COMPLETED|Overall Study||406
5326829|NCT00388583|13100260|P1|COMPLETED|Overall Study||401
5326830|NCT00388583|13100259|P2|STARTED|Overall Study||410
5326831|NCT00388583|13100260|P1|STARTED|Overall Study||407
5326832|NCT00388505|13100274|P2|NOT COMPLETED|Overall Study||38
5326833|NCT00388505|13100275|P1|NOT COMPLETED|Overall Study||83
5326834|NCT00388505|13100274|P2|COMPLETED|Overall Study||171
5326835|NCT00388505|13100275|P1|COMPLETED|Overall Study||225
5326836|NCT00388505|13100274|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
5326837|NCT00388505|13100275|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
5326838|NCT00388453|13100300|P3|NOT COMPLETED|Overall Study||0
5326839|NCT00388453|13100301|P2|NOT COMPLETED|Overall Study||0
5326840|NCT00388453|13100302|P1|NOT COMPLETED|Overall Study||0
5326841|NCT00388453|13100300|P3|COMPLETED|Overall Study||10
5326842|NCT00388453|13100301|P2|COMPLETED|Overall Study||17
5326843|NCT00388453|13100302|P1|COMPLETED|Overall Study||20
5326844|NCT00388453|13100300|P3|STARTED|Overall Study||10
5326845|NCT00388453|13100301|P2|STARTED|Overall Study||17
5326846|NCT00388453|13100302|P1|STARTED|Overall Study||20
5326847|NCT00388414|13100321|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
5326848|NCT00388414|13100322|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
5326849|NCT00388414|13100321|P2|COMPLETED|Second Intervention (8 Weeks)||7
5326850|NCT00388414|13100322|P1|COMPLETED|Second Intervention (8 Weeks)||7
5326851|NCT00388414|13100321|P2|STARTED|Second Intervention (8 Weeks)||7
5326852|NCT00388414|13100322|P1|STARTED|Second Intervention (8 Weeks)||7
5326853|NCT00388414|13100321|P2|NOT COMPLETED|Washout (1 Week)||0
5326854|NCT00388414|13100322|P1|NOT COMPLETED|Washout (1 Week)||0
5326855|NCT00388414|13100321|P2|COMPLETED|Washout (1 Week)||7
5326856|NCT00388414|13100322|P1|COMPLETED|Washout (1 Week)||7
5326857|NCT00388414|13100321|P2|STARTED|Washout (1 Week)||7
5326858|NCT00388414|13100322|P1|STARTED|Washout (1 Week)||7
5326859|NCT00388414|13100321|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
5326860|NCT00388414|13100322|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
5326861|NCT00388414|13100321|P2|COMPLETED|First Intervention (8 Weeks)||7
5326862|NCT00388414|13100322|P1|COMPLETED|First Intervention (8 Weeks)||7
5326863|NCT00388414|13100321|P2|STARTED|First Intervention (8 Weeks)||7
5326864|NCT00388414|13100322|P1|STARTED|First Intervention (8 Weeks)||7
5326865|NCT00388362|13100330|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
5326866|NCT00388362|13100330|P1|COMPLETED|Remained on Study Median of 514 Days||21
5326867|NCT00388362|13100330|P1|STARTED|Remained on Study Median of 514 Days||23
5326868|NCT00388362|13100330|P1|NOT COMPLETED|Enrolled||13
5326869|NCT00388362|13100330|P1|COMPLETED|Enrolled||23
5326870|NCT00388362|13100330|P1|STARTED|Enrolled||36
5326871|NCT00388349|13100335|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
5326872|NCT00388349|13100336|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
5326873|NCT00388349|13100335|P2|COMPLETED|Phase 2 Dose Expansion||0
5326874|NCT00388349|13100336|P1|COMPLETED|Phase 2 Dose Expansion||139
5326875|NCT00388349|13100335|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
5326876|NCT00388349|13100336|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
5326877|NCT00388349|13100335|P2|NOT COMPLETED|Phase I Dose Escalation||3
5326878|NCT00388349|13100336|P1|NOT COMPLETED|Phase I Dose Escalation||0
5326879|NCT00388349|13100335|P2|COMPLETED|Phase I Dose Escalation||1
5326880|NCT00388349|13100336|P1|COMPLETED|Phase I Dose Escalation||3
5326881|NCT00388349|13100335|P2|STARTED|Phase I Dose Escalation||4
5326882|NCT00388349|13100336|P1|STARTED|Phase I Dose Escalation||3
5326883|NCT00388297|13100349|P4|NOT COMPLETED|Overall Study||8
5326884|NCT00388297|13100350|P3|NOT COMPLETED|Overall Study||11
5326885|NCT00388297|13100351|P2|NOT COMPLETED|Overall Study||12
5326886|NCT00388297|13100352|P1|NOT COMPLETED|Overall Study||16
5326887|NCT00388297|13100349|P4|COMPLETED|Overall Study||253
5326888|NCT00388297|13100350|P3|COMPLETED|Overall Study||254
5326889|NCT00388297|13100351|P2|COMPLETED|Overall Study||326
5326890|NCT00388297|13100352|P1|COMPLETED|Overall Study||323
5326891|NCT00388297|13100349|P4|STARTED|Overall Study||261
5326892|NCT00388297|13100350|P3|STARTED|Overall Study||265
5326893|NCT00388297|13100351|P2|STARTED|Overall Study||338
5326894|NCT00388297|13100352|P1|STARTED|Overall Study||339
5326895|NCT00388154|13100462|P1|NOT COMPLETED|Overall Study||1
5326896|NCT00388154|13100462|P1|COMPLETED|Overall Study||20
5326897|NCT00388154|13100462|P1|STARTED|Overall Study||21
5326898|NCT00388037|13100467|P1|NOT COMPLETED|Overall Study||1
5326899|NCT00388037|13100467|P1|COMPLETED|Overall Study||30
5326900|NCT00388037|13100467|P1|STARTED|Overall Study||31
5326901|NCT00387959|13100471|P1|NOT COMPLETED|Overall Study||1
5326902|NCT00387959|13100471|P1|COMPLETED|Overall Study||16
5326903|NCT00387959|13100471|P1|STARTED|Overall Study||17
5326904|NCT00387894|13100475|P1|NOT COMPLETED|Overall Study||1
5326905|NCT00387894|13100475|P1|COMPLETED|Overall Study||5
5326906|NCT00387894|13100475|P1|STARTED|Overall Study||6
5326907|NCT00387881|13100482|P2|NOT COMPLETED|Overall Study||102
5326908|NCT00387881|13100483|P1|NOT COMPLETED|Overall Study||89
5326909|NCT00387881|13100482|P2|COMPLETED|Overall Study||243
5326910|NCT00387881|13100483|P1|COMPLETED|Overall Study||245
5326911|NCT00387881|13100482|P2|STARTED|Overall Study||345
5326912|NCT00387881|13100483|P1|STARTED|Overall Study||334
5326913|NCT00387829|13100507|P2|NOT COMPLETED|Intent-to-treat Population||30
5326914|NCT00387829|13100508|P1|NOT COMPLETED|Intent-to-treat Population||38
5326915|NCT00387829|13100507|P2|COMPLETED|Intent-to-treat Population||136
5326916|NCT00387829|13100508|P1|COMPLETED|Intent-to-treat Population||139
5326917|NCT00387829|13100507|P2|STARTED|Intent-to-treat Population||166
5326918|NCT00387829|13100508|P1|STARTED|Intent-to-treat Population||177
5326919|NCT00387829|13100507|P2|NOT COMPLETED|Safety Population||33
5326920|NCT00387829|13100508|P1|NOT COMPLETED|Safety Population||39
5326921|NCT00387829|13100507|P2|COMPLETED|Safety Population||136
5326922|NCT00387829|13100508|P1|COMPLETED|Safety Population||139
5326923|NCT00387829|13100507|P2|STARTED|Safety Population||169
5326924|NCT00387829|13100508|P1|STARTED|Safety Population||178
5326925|NCT00387790|13100516|P1|NOT COMPLETED|Overall Study||14
5326926|NCT00387790|13100516|P1|COMPLETED|Overall Study||50
5326927|NCT00387790|13100516|P1|STARTED|Overall Study||64
5326928|NCT00387764|13100522|P1|NOT COMPLETED|Overall Study||31
5326929|NCT00387764|13100522|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
5326930|NCT00387764|13100522|P1|STARTED|Overall Study||80
5326931|NCT00387751|13100540|P1|NOT COMPLETED|Overall Study||0
5326932|NCT00387751|13100540|P1|COMPLETED|Overall Study||14
5326933|NCT00387751|13100540|P1|STARTED|Overall Study||14
5326934|NCT00387725|13100550|P4|NOT COMPLETED|Overall Study||2
5326935|NCT00387725|13100551|P3|NOT COMPLETED|Overall Study||2
5326936|NCT00387725|13100552|P2|NOT COMPLETED|Overall Study||1
5326937|NCT00387725|13100553|P1|NOT COMPLETED|Overall Study||1
5326938|NCT00387725|13100550|P4|COMPLETED|Overall Study||43
5326939|NCT00387725|13100551|P3|COMPLETED|Overall Study||43
5326940|NCT00387725|13100552|P2|COMPLETED|Overall Study||15
5326941|NCT00387725|13100553|P1|COMPLETED|Overall Study||20
5326942|NCT00387725|13100550|P4|STARTED|Overall Study||45
5326943|NCT00387725|13100551|P3|STARTED|Overall Study||45
5326944|NCT00387725|13100552|P2|STARTED|Overall Study||16
5326945|NCT00387725|13100553|P1|STARTED|Overall Study||21
5326946|NCT00387712|13100573|P2|NOT COMPLETED|Overall Study||36
5326947|NCT00387712|13100574|P1|NOT COMPLETED|Overall Study||29
5326948|NCT00387712|13100573|P2|COMPLETED|Overall Study||16
5326949|NCT00387712|13100574|P1|COMPLETED|Overall Study||18
5326950|NCT00387712|13100573|P2|STARTED|Overall Study||52
5326951|NCT00387712|13100574|P1|STARTED|Overall Study||47
5326952|NCT00387673|13100584|P3|NOT COMPLETED|Overall Study||0
5326953|NCT00387673|13100585|P2|NOT COMPLETED|Overall Study||0
5326954|NCT00387673|13100586|P1|NOT COMPLETED|Overall Study||0
5326955|NCT00387673|13100584|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326956|NCT00387673|13100585|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326957|NCT00387673|13100586|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326958|NCT00387673|13100584|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326959|NCT00387673|13100585|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326960|NCT00387673|13100586|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
5326961|NCT00387660|13100594|P2|NOT COMPLETED|Overall Study||0
5326962|NCT00387660|13100595|P1|NOT COMPLETED|Overall Study||0
5326963|NCT00387660|13100594|P2|COMPLETED|Overall Study||40
5326964|NCT00387660|13100595|P1|COMPLETED|Overall Study||40
5326965|NCT00387660|13100594|P2|STARTED|Overall Study||40
5326966|NCT00387660|13100595|P1|STARTED|Overall Study||40
5326967|NCT00387647|13100605|P1|NOT COMPLETED|Overall Study||18
5326968|NCT00387647|13100605|P1|COMPLETED|Overall Study||6
5326969|NCT00387647|13100605|P1|STARTED|Overall Study||24
5326970|NCT00387621|13100614|P2|NOT COMPLETED|Second Intervention||0
5326971|NCT00387621|13100615|P1|NOT COMPLETED|Second Intervention||0
5326972|NCT00387621|13100614|P2|COMPLETED|Second Intervention||29
5326973|NCT00387621|13100615|P1|COMPLETED|Second Intervention||29
5326974|NCT00387621|13100614|P2|STARTED|Second Intervention||29
5326975|NCT00387621|13100615|P1|STARTED|Second Intervention||29
5326976|NCT00387621|13100614|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
5326977|NCT00387621|13100615|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
5326978|NCT00387621|13100614|P2|COMPLETED|Washout Period of 2 Weeks||29
5326979|NCT00387621|13100615|P1|COMPLETED|Washout Period of 2 Weeks||29
5326980|NCT00387621|13100614|P2|STARTED|Washout Period of 2 Weeks||29
5326981|NCT00387621|13100615|P1|STARTED|Washout Period of 2 Weeks||29
5326982|NCT00387621|13100614|P2|NOT COMPLETED|First Intervention||0
5326983|NCT00387621|13100615|P1|NOT COMPLETED|First Intervention||0
5326984|NCT00387621|13100614|P2|COMPLETED|First Intervention||29
5326985|NCT00387621|13100615|P1|COMPLETED|First Intervention||29
5326986|NCT00387621|13100614|P2|STARTED|First Intervention||29
5326987|NCT00387621|13100615|P1|STARTED|First Intervention||29
5326988|NCT00387465|13100648|P3|NOT COMPLETED|Overall Study||0
5326989|NCT00387465|13100649|P2|NOT COMPLETED|Overall Study||1
5326990|NCT00387465|13100650|P1|NOT COMPLETED|Overall Study||0
5326991|NCT00387465|13100648|P3|COMPLETED|Overall Study||35
5326992|NCT00387465|13100649|P2|COMPLETED|Overall Study||6
5326993|NCT00387465|13100650|P1|COMPLETED|Overall Study||3
5326994|NCT00387465|13100648|P3|STARTED|Overall Study||35
5326995|NCT00387465|13100649|P2|STARTED|Overall Study||7
5326996|NCT00387465|13100650|P1|STARTED|Overall Study||3
5326997|NCT00387426|13100667|P1|NOT COMPLETED|Overall Study||14
5326998|NCT00387426|13100667|P1|COMPLETED|Overall Study||0
5326999|NCT00387426|13100667|P1|STARTED|Overall Study||14
5327000|NCT00387348|13100674|P3|NOT COMPLETED|Overall Study||4
5327001|NCT00387348|13100675|P2|NOT COMPLETED|Overall Study||3
5327002|NCT00387348|13100676|P1|NOT COMPLETED|Overall Study||3
5327003|NCT00387348|13100674|P3|COMPLETED|Overall Study||7
5327004|NCT00387348|13100675|P2|COMPLETED|Overall Study||2
5327005|NCT00387348|13100676|P1|COMPLETED|Overall Study||5
5327006|NCT00387348|13100674|P3|STARTED|Overall Study||11
5327007|NCT00387348|13100675|P2|STARTED|Overall Study||5
5327008|NCT00387348|13100676|P1|STARTED|Overall Study||8
5327009|NCT00387335|13100692|P2|NOT COMPLETED|Overall Study||0
5327010|NCT00387335|13100693|P1|NOT COMPLETED|Overall Study||0
5327011|NCT00387335|13100692|P2|COMPLETED|Overall Study||7
5327012|NCT00387335|13100693|P1|COMPLETED|Overall Study||15
5327013|NCT00387335|13100692|P2|STARTED|Overall Study||7
5327014|NCT00387335|13100693|P1|STARTED|Overall Study||15
5327015|NCT00387153|13100705|P1|NOT COMPLETED|Overall Study||8
5327016|NCT00387153|13100705|P1|COMPLETED|Overall Study||0
5327017|NCT00387153|13100705|P1|STARTED|Overall Study||8
5327018|NCT00387127|13100711|P2|NOT COMPLETED|Overall Study||34
5327019|NCT00387127|13100712|P1|NOT COMPLETED|Overall Study||33
5327020|NCT00387127|13100711|P2|COMPLETED|Overall Study||0
5327021|NCT00387127|13100712|P1|COMPLETED|Overall Study||0
5327022|NCT00387127|13100711|P2|STARTED|Overall Study||34
5327023|NCT00387127|13100712|P1|STARTED|Overall Study||33
5327024|NCT00387088|13100754|P2|NOT COMPLETED|Overall Study||373
5327025|NCT00387088|13100755|P1|NOT COMPLETED|Overall Study||318
5327026|NCT00387088|13100754|P2|COMPLETED|Overall Study||1629
5327027|NCT00387088|13100755|P1|COMPLETED|Overall Study||1671
5327028|NCT00387088|13100754|P2|STARTED|Overall Study||2002
5327029|NCT00387088|13100755|P1|STARTED|Overall Study||1989
5327030|NCT00387036|13100799|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
5327031|NCT00387036|13100800|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
5327032|NCT00387036|13100799|P2|COMPLETED|2-Week Crossover Second Intervention||6
5327033|NCT00387036|13100800|P1|COMPLETED|2-Week Crossover Second Intervention||6
5327034|NCT00387036|13100799|P2|STARTED|2-Week Crossover Second Intervention||6
5327035|NCT00387036|13100800|P1|STARTED|2-Week Crossover Second Intervention||6
5327036|NCT00387036|13100799|P2|NOT COMPLETED|2-Week Placebo Washout||0
5327037|NCT00387036|13100800|P1|NOT COMPLETED|2-Week Placebo Washout||0
5327038|NCT00387036|13100799|P2|COMPLETED|2-Week Placebo Washout||6
5327039|NCT00387036|13100800|P1|COMPLETED|2-Week Placebo Washout||6
5327040|NCT00387036|13100799|P2|STARTED|2-Week Placebo Washout||6
5327041|NCT00387036|13100800|P1|STARTED|2-Week Placebo Washout||6
5327042|NCT00387036|13100799|P2|NOT COMPLETED|2-Week First Intervention||0
5327043|NCT00387036|13100800|P1|NOT COMPLETED|2-Week First Intervention||0
5327044|NCT00387036|13100799|P2|COMPLETED|2-Week First Intervention||6
5327045|NCT00387036|13100800|P1|COMPLETED|2-Week First Intervention||6
5327046|NCT00387036|13100799|P2|STARTED|2-Week First Intervention||6
5327047|NCT00387036|13100800|P1|STARTED|2-Week First Intervention||6
5327048|NCT00387023|13100808|P1|NOT COMPLETED|Overall Study||0
5327049|NCT00387023|13100808|P1|COMPLETED|Overall Study||12
5327050|NCT00387023|13100808|P1|STARTED|Overall Study||12
5327051|NCT00387010|13100812|P1|NOT COMPLETED|Treatment Period||11
5327052|NCT00387010|13100812|P1|COMPLETED|Treatment Period||169
5327053|NCT00387010|13100812|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
5327054|NCT00387010|13100812|P1|STARTED|Treatment Period||180
5327055|NCT00387010|13100812|P1|NOT COMPLETED|Dose Titration Period||38
5327056|NCT00387010|13100812|P1|COMPLETED|Dose Titration Period||180
5327057|NCT00387010|13100812|P1|STARTED|Dose Titration Period||218
5327058|NCT00386880|13100833|P2|NOT COMPLETED|Overall Study||0
5327059|NCT00386880|13100834|P1|NOT COMPLETED|Overall Study||0
5327060|NCT00386880|13100833|P2|COMPLETED|Overall Study||8
5327061|NCT00386880|13100834|P1|COMPLETED|Overall Study||30
5327062|NCT00386880|13100833|P2|STARTED|Overall Study||8
5327063|NCT00386880|13100834|P1|STARTED|Overall Study||30
5327064|NCT00386776|13100839|P1|NOT COMPLETED|Overall Study||8
5327065|NCT00386776|13100839|P1|COMPLETED|Overall Study||32
5327066|NCT00386776|13100839|P1|STARTED|Overall Study||40
5327067|NCT00386607|13100849|P2|NOT COMPLETED|Extension||17
5327068|NCT00386607|13100850|P1|NOT COMPLETED|Extension||0
5327069|NCT00386607|13100849|P2|COMPLETED|Extension||145
5327070|NCT00386607|13100850|P1|COMPLETED|Extension||0
5327071|NCT00386607|13100849|P2|STARTED|Extension||162
5327072|NCT00386607|13100850|P1|STARTED|Extension||0
5327073|NCT00386607|13100849|P2|NOT COMPLETED|Core||0
5327074|NCT00386607|13100850|P1|NOT COMPLETED|Core||115
5327075|NCT00386607|13100849|P2|COMPLETED|Core||0
5327076|NCT00386607|13100850|P1|COMPLETED|Core||486
5327077|NCT00386607|13100849|P2|STARTED|Core||0
5327078|NCT00386607|13100850|P1|STARTED|Core||601
5327079|NCT00386477|13100868|P2|NOT COMPLETED|Overall Study||0
5327080|NCT00386477|13100869|P1|NOT COMPLETED|Overall Study||0
5327081|NCT00386477|13100868|P2|COMPLETED|Overall Study||145
5327082|NCT00386477|13100869|P1|COMPLETED|Overall Study||155
5327083|NCT00386477|13100868|P2|STARTED|Overall Study||145
5327084|NCT00386477|13100869|P1|STARTED|Overall Study||155
5327085|NCT00386425|13100878|P3|NOT COMPLETED|Overall Study||0
5327086|NCT00386425|13100879|P2|NOT COMPLETED|Overall Study||1
5327087|NCT00386425|13100880|P1|NOT COMPLETED|Overall Study||3
5327088|NCT00386425|13100878|P3|COMPLETED|Overall Study||53
5327089|NCT00386425|13100879|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
5327090|NCT00386425|13100880|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
5327091|NCT00386425|13100878|P3|Received Study Drug|Overall Study||53
5327092|NCT00386425|13100879|P2|Received Study Drug|Overall Study||206
5327093|NCT00386425|13100880|P1|Received Study Drug|Overall Study||227
5327094|NCT00386425|13100878|P3|STARTED|Overall Study||53
5327095|NCT00386425|13100879|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
5327096|NCT00386425|13100880|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
5327097|NCT00386360|13100906|P2|NOT COMPLETED|Overall Study||17
5327098|NCT00386360|13100907|P1|NOT COMPLETED|Overall Study||9
5327099|NCT00386360|13100906|P2|COMPLETED|Overall Study||95
5327100|NCT00386360|13100907|P1|COMPLETED|Overall Study||40
5327101|NCT00386360|13100906|P2|Primary Efficacy|Overall Study||77
5327102|NCT00386360|13100907|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
5327103|NCT00386360|13100906|P2|Intent to Treat Population (ITT)|Overall Study||110
5327104|NCT00386360|13100907|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
5327105|NCT00386360|13100906|P2|STARTED|Overall Study||112
5327106|NCT00386360|13100907|P1|STARTED|Overall Study||49
5327107|NCT00386334|13100941|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
5327108|NCT00386334|13100942|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
5327109|NCT00386334|13100941|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
5327110|NCT00386334|13100942|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
5327111|NCT00386334|13100941|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
5327112|NCT00386334|13100942|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
5327113|NCT00386334|13100941|P2|NOT COMPLETED|Double Blind Period||47
5327114|NCT00386334|13100942|P1|NOT COMPLETED|Double Blind Period||46
5327115|NCT00386334|13100941|P2|COMPLETED|Double Blind Period||147
5327116|NCT00386334|13100942|P1|COMPLETED|Double Blind Period||148
5327117|NCT00386334|13100941|P2|STARTED|Double Blind Period||194
5327118|NCT00386334|13100942|P1|STARTED|Double Blind Period||194
5327119|NCT00386308|13101086|P2|NOT COMPLETED|Overall Study||19
5327120|NCT00386308|13101087|P1|NOT COMPLETED|Overall Study||29
5327121|NCT00386308|13101086|P2|COMPLETED|Overall Study||54
5327122|NCT00386308|13101087|P1|COMPLETED|Overall Study||94
5327123|NCT00386308|13101086|P2|Modified Intent to Treat Population|Overall Study||72
5327124|NCT00386308|13101087|P1|Modified Intent to Treat Population|Overall Study||115
5327125|NCT00386308|13101086|P2|Intent to Treat Population|Overall Study||72
5327126|NCT00386308|13101087|P1|Intent to Treat Population|Overall Study||117
5327127|NCT00386308|13101086|P2|STARTED|Overall Study||73
5327128|NCT00386308|13101087|P1|STARTED|Overall Study||123
5327129|NCT00386256|13101103|P4|NOT COMPLETED|Overall Study||0
5327130|NCT00386256|13101104|P3|NOT COMPLETED|Overall Study||0
5327131|NCT00386256|13101105|P2|NOT COMPLETED|Overall Study||0
5327132|NCT00386256|13101106|P1|NOT COMPLETED|Overall Study||0
5327133|NCT00386256|13101103|P4|COMPLETED|Overall Study||3
5327134|NCT00386256|13101104|P3|COMPLETED|Overall Study||4
5327135|NCT00386256|13101105|P2|COMPLETED|Overall Study||15
5327136|NCT00386256|13101106|P1|COMPLETED|Overall Study||16
5327137|NCT00386256|13101103|P4|STARTED|Overall Study||3
5327138|NCT00386256|13101104|P3|STARTED|Overall Study||4
5327139|NCT00386256|13101105|P2|STARTED|Overall Study||15
5327140|NCT00386256|13101106|P1|STARTED|Overall Study||16
5327141|NCT00386243|13101122|P2|NOT COMPLETED|Overall Study||13
5327142|NCT00386243|13101123|P1|NOT COMPLETED|Overall Study||7
5327143|NCT00386243|13101122|P2|COMPLETED|Overall Study||108
5327144|NCT00386243|13101123|P1|COMPLETED|Overall Study||114
5327145|NCT00386243|13101122|P2|STARTED|Overall Study||121
5327146|NCT00386243|13101123|P1|STARTED|Overall Study||121
5327147|NCT00386152|13101144|P3|NOT COMPLETED|Overall Study||33
5327148|NCT00386152|13101145|P2|NOT COMPLETED|Overall Study||40
5327149|NCT00386152|13101146|P1|NOT COMPLETED|Overall Study||44
5327150|NCT00386152|13101144|P3|COMPLETED|Overall Study||42
5327151|NCT00386152|13101145|P2|COMPLETED|Overall Study||37
5327152|NCT00386152|13101146|P1|COMPLETED|Overall Study||31
5327153|NCT00386152|13101144|P3|STARTED|Overall Study|number of subjects treated|75
5327154|NCT00386152|13101145|P2|STARTED|Overall Study|number of subjects treated|77
5327155|NCT00386152|13101146|P1|STARTED|Overall Study|number of subjects treated|75
5327156|NCT00386100|13101165|P2|NOT COMPLETED|Overall Study||131
5327157|NCT00386100|13101166|P1|NOT COMPLETED|Overall Study||154
5327158|NCT00386100|13101165|P2|COMPLETED|Overall Study||217
5327159|NCT00386100|13101166|P1|COMPLETED|Overall Study||186
5327160|NCT00386100|13101165|P2|STARTED|Overall Study||348
5327161|NCT00386100|13101166|P1|STARTED|Overall Study||340
5327162|NCT00386022|13101230|P2|NOT COMPLETED|Plus Estrogen||1
5327163|NCT00386022|13101231|P1|NOT COMPLETED|Plus Estrogen||2
5327164|NCT00386022|13101230|P2|COMPLETED|Plus Estrogen||8
5327165|NCT00386022|13101231|P1|COMPLETED|Plus Estrogen||8
5327166|NCT00386022|13101230|P2|All Doses GnRH|Plus Estrogen||8
5327167|NCT00386022|13101231|P1|All Doses GnRH|Plus Estrogen||8
5327168|NCT00386022|13101230|P2|Estrogen Patch|Plus Estrogen||9
5327169|NCT00386022|13101231|P1|Estrogen Patch|Plus Estrogen||8
5327170|NCT00386022|13101230|P2|STARTED|Plus Estrogen||9
5327171|NCT00386022|13101231|P1|STARTED|Plus Estrogen||10
5327172|NCT00386022|13101230|P2|NOT COMPLETED|Baseline||0
5327173|NCT00386022|13101231|P1|NOT COMPLETED|Baseline||0
5327174|NCT00386022|13101230|P2|COMPLETED|Baseline||9
5327175|NCT00386022|13101231|P1|COMPLETED|Baseline||10
5327176|NCT00386022|13101230|P2|All Doses of GnRH|Baseline||9
5327177|NCT00386022|13101231|P1|All Doses of GnRH|Baseline||10
5327178|NCT00386022|13101230|P2|STARTED|Baseline||9
5327179|NCT00386022|13101231|P1|STARTED|Baseline||10
5327180|NCT00386009|13101241|P2|NOT COMPLETED|Overall Study||10
5327181|NCT00386009|13101242|P1|NOT COMPLETED|Overall Study||9
5327182|NCT00386009|13101241|P2|COMPLETED|Overall Study||89
5327183|NCT00386009|13101242|P1|COMPLETED|Overall Study||92
5327184|NCT00386009|13101241|P2|STARTED|Overall Study||99
5327185|NCT00386009|13101242|P1|STARTED|Overall Study||101
5327186|NCT00385996|13101280|P1|NOT COMPLETED|Overall Study||0
5327187|NCT00385996|13101280|P1|COMPLETED|Overall Study||22
5327188|NCT00385996|13101280|P1|STARTED|Overall Study||22
5327189|NCT00385944|13101289|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
5327190|NCT00385944|13101290|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
5327191|NCT00385944|13101291|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
5327192|NCT00385944|13101289|P3|COMPLETED|2nd Maintenance Dose Period||0
5327193|NCT00385944|13101290|P2|COMPLETED|2nd Maintenance Dose Period||19
5327194|NCT00385944|13101291|P1|COMPLETED|2nd Maintenance Dose Period||22
5327195|NCT00385944|13101289|P3|STARTED|2nd Maintenance Dose Period||0
5327196|NCT00385944|13101290|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
5327197|NCT00385944|13101291|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
5327198|NCT00385944|13101289|P3|NOT COMPLETED|1st Maintenance Dose Period||0
5327199|NCT00385944|13101290|P2|NOT COMPLETED|1st Maintenance Dose Period||1
5327200|NCT00385944|13101291|P1|NOT COMPLETED|1st Maintenance Dose Period||4
5327201|NCT00385944|13101289|P3|COMPLETED|1st Maintenance Dose Period||0
5327202|NCT00385944|13101290|P2|COMPLETED|1st Maintenance Dose Period||24
5327203|NCT00385944|13101291|P1|COMPLETED|1st Maintenance Dose Period||25
5327204|NCT00385944|13101289|P3|STARTED|1st Maintenance Dose Period||0
5327205|NCT00385944|13101290|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
5327206|NCT00385944|13101291|P1|STARTED|1st Maintenance Dose Period||29
5327207|NCT00385944|13101289|P3|NOT COMPLETED|Loading Dose||0
5327208|NCT00385944|13101290|P2|NOT COMPLETED|Loading Dose||0
5327209|NCT00385944|13101291|P1|NOT COMPLETED|Loading Dose||0
5327210|NCT00385944|13101289|P3|COMPLETED|Loading Dose||56
5327211|NCT00385944|13101290|P2|COMPLETED|Loading Dose||0
5327212|NCT00385944|13101291|P1|COMPLETED|Loading Dose||0
5327213|NCT00385944|13101289|P3|STARTED|Loading Dose||56
5327214|NCT00385944|13101290|P2|STARTED|Loading Dose||0
5327215|NCT00385944|13101291|P1|STARTED|Loading Dose||0
5327216|NCT00385918|13101334|P3|NOT COMPLETED|Intervention Phase After Randomization||0
5327217|NCT00385918|13101335|P2|NOT COMPLETED|Intervention Phase After Randomization||0
5327218|NCT00385918|13101336|P1|NOT COMPLETED|Intervention Phase After Randomization||3
5327219|NCT00385918|13101334|P3|COMPLETED|Intervention Phase After Randomization||0
5327220|NCT00385918|13101335|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
5327221|NCT00385918|13101336|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
5327222|NCT00385918|13101334|P3|STARTED|Intervention Phase After Randomization||0
5327223|NCT00385918|13101335|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
5327224|NCT00385918|13101336|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
5327225|NCT00385918|13101334|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
5327226|NCT00385918|13101335|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
5327227|NCT00385918|13101336|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
5327228|NCT00385918|13101334|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
5327229|NCT00385918|13101335|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
5327230|NCT00385918|13101336|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
5327231|NCT00385918|13101334|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
5327232|NCT00385918|13101335|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
5327233|NCT00385918|13101336|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
5327234|NCT00385918|13101334|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
5327235|NCT00385918|13101335|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
5327236|NCT00385918|13101336|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
5327237|NCT00385918|13101334|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
5327238|NCT00385918|13101335|P2|STARTED|Feasibility & Baseline Measurement Phase||0
5327239|NCT00385918|13101336|P1|STARTED|Feasibility & Baseline Measurement Phase||0
5327240|NCT00385840|13101360|P2|NOT COMPLETED|Overall Study||14
5327241|NCT00385840|13101361|P1|NOT COMPLETED|Overall Study||4
5327242|NCT00385840|13101360|P2|COMPLETED|Overall Study||531
5327243|NCT00385840|13101361|P1|COMPLETED|Overall Study||129
5327244|NCT00385840|13101360|P2|STARTED|Overall Study||545
5327245|NCT00385840|13101361|P1|STARTED|Overall Study||133
5327246|NCT00385827|13101384|P3|NOT COMPLETED|Part 2||48
5327247|NCT00385827|13101385|P2|NOT COMPLETED|Part 2||33
5327248|NCT00385827|13101386|P1|NOT COMPLETED|Part 2||0
5327249|NCT00385827|13101384|P3|COMPLETED|Part 2||0
5327250|NCT00385827|13101385|P2|COMPLETED|Part 2||16
5327251|NCT00385827|13101386|P1|COMPLETED|Part 2||0
5327252|NCT00385827|13101384|P3|Treated|Part 2||46
5327253|NCT00385827|13101385|P2|Treated|Part 2||47
5327254|NCT00385827|13101386|P1|Treated|Part 2||0
5327255|NCT00385827|13101384|P3|STARTED|Part 2||48
5327256|NCT00385827|13101385|P2|STARTED|Part 2||49
5327257|NCT00385827|13101386|P1|STARTED|Part 2||0
5327258|NCT00385827|13101384|P3|NOT COMPLETED|Part 1||0
5327259|NCT00385827|13101385|P2|NOT COMPLETED|Part 1||0
5327260|NCT00385827|13101386|P1|NOT COMPLETED|Part 1||9
5327261|NCT00385827|13101384|P3|COMPLETED|Part 1||0
5327262|NCT00385827|13101385|P2|COMPLETED|Part 1||0
5327263|NCT00385827|13101386|P1|COMPLETED|Part 1||0
5327264|NCT00385827|13101384|P3|Treated|Part 1||0
5327265|NCT00385827|13101385|P2|Treated|Part 1||0
5327266|NCT00385827|13101386|P1|Treated|Part 1||9
5327267|NCT00385827|13101384|P3|STARTED|Part 1||0
5327268|NCT00385827|13101385|P2|STARTED|Part 1||0
5327269|NCT00385827|13101386|P1|STARTED|Part 1||9
5327270|NCT00385801|13101408|P2|NOT COMPLETED|Overall Study||8
5327271|NCT00385801|13101409|P1|NOT COMPLETED|Overall Study||9
5327272|NCT00385801|13101408|P2|COMPLETED|Overall Study||8
5327273|NCT00385801|13101409|P1|COMPLETED|Overall Study||6
5327274|NCT00385801|13101408|P2|STARTED|Overall Study||16
5327275|NCT00385801|13101409|P1|STARTED|Overall Study||15
5327276|NCT00385788|13101423|P2|NOT COMPLETED|Overall Study||0
5327277|NCT00385788|13101424|P1|NOT COMPLETED|Overall Study||0
5327278|NCT00385788|13101423|P2|COMPLETED|Overall Study||40
5327279|NCT00385788|13101424|P1|COMPLETED|Overall Study||12
5327280|NCT00385788|13101423|P2|STARTED|Overall Study||40
5327281|NCT00385788|13101424|P1|STARTED|Overall Study||12
5327282|NCT00385762|13101430|P1|NOT COMPLETED|Overall Study||2
5327283|NCT00385762|13101430|P1|COMPLETED|Overall Study||33
5327284|NCT00385762|13101430|P1|STARTED|Overall Study||35
5327285|NCT00385736|13101440|P3|NOT COMPLETED|Safety Analysis Set||80
5327286|NCT00385736|13101441|P2|NOT COMPLETED|Safety Analysis Set||44
5327287|NCT00385736|13101442|P1|NOT COMPLETED|Safety Analysis Set||70
5327288|NCT00385736|13101440|P3|COMPLETED|Safety Analysis Set||143
5327289|NCT00385736|13101441|P2|COMPLETED|Safety Analysis Set||86
5327290|NCT00385736|13101442|P1|COMPLETED|Safety Analysis Set||153
5327291|NCT00385736|13101440|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
5327292|NCT00385736|13101441|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
5327293|NCT00385736|13101442|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
5327294|NCT00385736|13101440|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
5327295|NCT00385736|13101441|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
5327296|NCT00385736|13101442|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
5327297|NCT00385736|13101440|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
5327298|NCT00385736|13101441|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
5327299|NCT00385736|13101442|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
5327300|NCT00385736|13101440|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
5327301|NCT00385736|13101441|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
5327302|NCT00385736|13101442|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
5327303|NCT00385736|13101440|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
5327304|NCT00385736|13101441|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
5327305|NCT00385736|13101442|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
5327306|NCT00385736|13101440|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
5327307|NCT00385736|13101441|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
5327308|NCT00385736|13101442|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
5327309|NCT00385736|13101440|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
5327310|NCT00385736|13101441|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
5327311|NCT00385736|13101442|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
5327312|NCT00385723|13101487|P3|NOT COMPLETED|Overall Study||2
5327313|NCT00385723|13101488|P2|NOT COMPLETED|Overall Study||1
5327314|NCT00385723|13101489|P1|NOT COMPLETED|Overall Study||2
5327315|NCT00385723|13101487|P3|COMPLETED|Overall Study||44
5327316|NCT00385723|13101488|P2|COMPLETED|Overall Study||45
5327317|NCT00385723|13101489|P1|COMPLETED|Overall Study||44
5327318|NCT00385723|13101487|P3|STARTED|Overall Study||46
5327319|NCT00385723|13101488|P2|STARTED|Overall Study||46
5327320|NCT00385723|13101489|P1|STARTED|Overall Study||46
5327321|NCT00385684|13101503|P2|NOT COMPLETED|PHASE B||0
5327322|NCT00385684|13101504|P1|NOT COMPLETED|PHASE B||0
5327323|NCT00385684|13101503|P2|COMPLETED|PHASE B||3
5327324|NCT00385684|13101504|P1|COMPLETED|PHASE B||5
5327325|NCT00385684|13101503|P2|STARTED|PHASE B||3
5327326|NCT00385684|13101504|P1|STARTED|PHASE B||5
5327327|NCT00385684|13101503|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
5327328|NCT00385684|13101504|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
5327329|NCT00385684|13101503|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
5327330|NCT00385684|13101504|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
5327331|NCT00385684|13101503|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
5327332|NCT00385684|13101504|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
5327333|NCT00385684|13101503|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
5327334|NCT00385684|13101504|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
5327335|NCT00385684|13101503|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
5327336|NCT00385684|13101504|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
5327337|NCT00385684|13101503|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
5327338|NCT00385684|13101504|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
5327339|NCT00385671|13101513|P3|NOT COMPLETED|Overall Study||36
5327340|NCT00385671|13101514|P2|NOT COMPLETED|Overall Study||51
5327341|NCT00385671|13101515|P1|NOT COMPLETED|Overall Study||38
5327342|NCT00385671|13101513|P3|COMPLETED|Overall Study||99
5327343|NCT00385671|13101514|P2|COMPLETED|Overall Study||87
5327344|NCT00385671|13101515|P1|COMPLETED|Overall Study||96
5327345|NCT00385671|13101513|P3|STARTED|Overall Study||135
5327346|NCT00385671|13101514|P2|STARTED|Overall Study||138
5327347|NCT00385671|13101515|P1|STARTED|Overall Study||134
5327348|NCT00385593|13101671|P2|NOT COMPLETED|Overall Study||37
5327349|NCT00385593|13101672|P1|NOT COMPLETED|Overall Study||58
5327350|NCT00385593|13101671|P2|COMPLETED|Overall Study||289
5327351|NCT00385593|13101672|P1|COMPLETED|Overall Study||270
5327352|NCT00385593|13101671|P2|STARTED|Overall Study||326
5327353|NCT00385593|13101672|P1|STARTED|Overall Study||328
5327354|NCT00385580|13101690|P2|NOT COMPLETED|Overall Study||0
5327355|NCT00385580|13101691|P1|NOT COMPLETED|Overall Study||0
5327356|NCT00385580|13101690|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
5327357|NCT00385580|13101691|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
5327358|NCT00385580|13101690|P2|STARTED|Overall Study|Number of participants treated.|47
5327359|NCT00385580|13101691|P1|STARTED|Overall Study|Number of participants treated.|48
5327360|NCT00385541|13101782|P2|NOT COMPLETED|Overall Study||1
5327361|NCT00385541|13101783|P1|NOT COMPLETED|Overall Study||0
5327362|NCT00385541|13101782|P2|COMPLETED|Overall Study||24
5327363|NCT00385541|13101783|P1|COMPLETED|Overall Study||25
5327364|NCT00385541|13101782|P2|STARTED|Overall Study||25
5327365|NCT00385541|13101783|P1|STARTED|Overall Study||25
5327366|NCT00385515|13101799|P2|NOT COMPLETED|Overall Study||3
5327367|NCT00385515|13101800|P1|NOT COMPLETED|Overall Study||4
5327368|NCT00385515|13101799|P2|COMPLETED|Overall Study||21
5327369|NCT00385515|13101800|P1|COMPLETED|Overall Study||53
5327370|NCT00385515|13101799|P2|STARTED|Overall Study||24
5327371|NCT00385515|13101800|P1|STARTED|Overall Study||57
5327372|NCT00385268|13101808|P2|NOT COMPLETED|Overall Study||8
5327373|NCT00385268|13101809|P1|NOT COMPLETED|Overall Study||16
5327374|NCT00385268|13101808|P2|COMPLETED|Overall Study||18
5327375|NCT00385268|13101809|P1|COMPLETED|Overall Study||18
5327376|NCT00385268|13101808|P2|STARTED|Overall Study||26
5327377|NCT00385268|13101809|P1|STARTED|Overall Study||34
5327378|NCT00385255|13101817|P2|NOT COMPLETED|Overall Study||73
5327379|NCT00385255|13101818|P1|NOT COMPLETED|Overall Study||21
5327380|NCT00385255|13101817|P2|COMPLETED|Overall Study||785
5327381|NCT00385255|13101818|P1|COMPLETED|Overall Study||839
5327382|NCT00385255|13101817|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
5327383|NCT00385255|13101818|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
5327384|NCT00385255|13101817|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
5327385|NCT00385255|13101818|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
5327386|NCT00385255|13101817|P2|STARTED|Overall Study||858
5327387|NCT00385255|13101818|P1|STARTED|Overall Study||860
5327388|NCT00385216|13101882|P2|NOT COMPLETED|Second Intervention||0
5327389|NCT00385216|13101883|P1|NOT COMPLETED|Second Intervention||0
5327390|NCT00385216|13101882|P2|COMPLETED|Second Intervention||9
5327391|NCT00385216|13101883|P1|COMPLETED|Second Intervention||11
5327392|NCT00385216|13101882|P2|STARTED|Second Intervention||9
5327393|NCT00385216|13101883|P1|STARTED|Second Intervention||11
5327394|NCT00385216|13101882|P2|NOT COMPLETED|First Intervention||0
5327395|NCT00385216|13101883|P1|NOT COMPLETED|First Intervention||0
5327396|NCT00385216|13101882|P2|COMPLETED|First Intervention||9
5327397|NCT00385216|13101883|P1|COMPLETED|First Intervention||11
5327398|NCT00385216|13101882|P2|STARTED|First Intervention||9
5327399|NCT00385216|13101883|P1|STARTED|First Intervention||11
5327400|NCT00385203|13101897|P2|NOT COMPLETED|Overall Study||7
5327401|NCT00385203|13101898|P1|NOT COMPLETED|Overall Study||26
5327402|NCT00385203|13101897|P2|COMPLETED|Overall Study||3
5327403|NCT00385203|13101898|P1|COMPLETED|Overall Study||0
5327404|NCT00385203|13101897|P2|STARTED|Overall Study||10
5327405|NCT00385203|13101898|P1|STARTED|Overall Study||26
5327406|NCT00385138|13101918|P2|NOT COMPLETED|Overall Study||28
5327407|NCT00385138|13101919|P1|NOT COMPLETED|Overall Study||30
5327408|NCT00385138|13101918|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
5327409|NCT00385138|13101919|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
5327410|NCT00385138|13101918|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
5327411|NCT00385138|13101919|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
5327412|NCT00385138|13101918|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
5327413|NCT00385138|13101919|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
5327414|NCT00385138|13101918|P2|Intent-to-treat (ITT)|Overall Study||2669
5327415|NCT00385138|13101919|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
5327416|NCT00385138|13101918|P2|STARTED|Overall Study||2669
5327417|NCT00385138|13101919|P1|STARTED|Overall Study||2695
5327418|NCT00385008|13101965|P2|NOT COMPLETED|Overall Study||0
5327419|NCT00385008|13101966|P1|NOT COMPLETED|Overall Study||0
5327420|NCT00385008|13101965|P2|COMPLETED|Overall Study||10
5327421|NCT00385008|13101966|P1|COMPLETED|Overall Study||10
5327422|NCT00385008|13101965|P2|In Presence of Migraine|Overall Study||5
5327423|NCT00385008|13101966|P1|In Presence of Migraine|Overall Study||5
5327424|NCT00385008|13101965|P2|In Absence of Migraine|Overall Study||10
5327425|NCT00385008|13101966|P1|In Absence of Migraine|Overall Study||10
5327426|NCT00385008|13101965|P2|STARTED|Overall Study||10
5327427|NCT00385008|13101966|P1|STARTED|Overall Study||10
5327428|NCT00384956|13101986|P1|NOT COMPLETED|Overall Study||3
5327429|NCT00384956|13101986|P1|COMPLETED|Overall Study||22
5327430|NCT00384956|13101986|P1|STARTED|Overall Study||25
5327431|NCT00384930|13102003|P5|NOT COMPLETED|Overall Study||47
5327432|NCT00384930|13102004|P4|NOT COMPLETED|Overall Study||41
5327433|NCT00384930|13102005|P3|NOT COMPLETED|Overall Study||30
5327434|NCT00384930|13102006|P2|NOT COMPLETED|Overall Study||27
5327435|NCT00384930|13102007|P1|NOT COMPLETED|Overall Study||27
5327436|NCT00384930|13102003|P5|COMPLETED|Overall Study||162
5327437|NCT00384930|13102004|P4|COMPLETED|Overall Study||175
5327438|NCT00384930|13102005|P3|COMPLETED|Overall Study||182
5327439|NCT00384930|13102006|P2|COMPLETED|Overall Study||182
5327440|NCT00384930|13102007|P1|COMPLETED|Overall Study||185
5327441|NCT00384930|13102003|P5|Received Double-Blind Study Drug|Overall Study||209
5327442|NCT00384930|13102004|P4|Received Double-Blind Study Drug|Overall Study||216
5327443|NCT00384930|13102005|P3|Received Double-Blind Study Drug|Overall Study||212
5327444|NCT00384930|13102006|P2|Received Double-Blind Study Drug|Overall Study||208
5327445|NCT00384930|13102007|P1|Received Double-Blind Study Drug|Overall Study||211
5327446|NCT00384930|13102003|P5|STARTED|Overall Study||209
5327447|NCT00384930|13102004|P4|STARTED|Overall Study||216
5327448|NCT00384930|13102005|P3|STARTED|Overall Study||212
5327449|NCT00384930|13102006|P2|STARTED|Overall Study||209
5327450|NCT00384930|13102007|P1|STARTED|Overall Study||212
5327451|NCT00384865|13102065|P4|NOT COMPLETED|Overall Study||0
5327452|NCT00384865|13102066|P3|NOT COMPLETED|Overall Study||0
5327453|NCT00384865|13102067|P2|NOT COMPLETED|Overall Study||0
5327454|NCT00384865|13102068|P1|NOT COMPLETED|Overall Study||0
5327455|NCT00384865|13102065|P4|COMPLETED|Overall Study||16
5327456|NCT00384865|13102066|P3|COMPLETED|Overall Study||16
5327457|NCT00384865|13102067|P2|COMPLETED|Overall Study||16
5327458|NCT00384865|13102068|P1|COMPLETED|Overall Study||16
5327459|NCT00384865|13102065|P4|Completed Six Month Assessment|Overall Study||11
5327460|NCT00384865|13102066|P3|Completed Six Month Assessment|Overall Study||15
5327461|NCT00384865|13102067|P2|Completed Six Month Assessment|Overall Study||12
5327462|NCT00384865|13102068|P1|Completed Six Month Assessment|Overall Study||11
5327463|NCT00384865|13102065|P4|STARTED|Overall Study||16
5327464|NCT00384865|13102066|P3|STARTED|Overall Study||16
5327465|NCT00384865|13102067|P2|STARTED|Overall Study||16
5327466|NCT00384865|13102068|P1|STARTED|Overall Study||16
5327467|NCT00384839|13102086|P1|NOT COMPLETED|Overall Study||8
5327468|NCT00384839|13102086|P1|COMPLETED|Overall Study||28
5327469|NCT00384839|13102086|P1|STARTED|Overall Study||36
5327470|NCT00384813|13102097|P2|NOT COMPLETED|Overall Study||0
5327471|NCT00384813|13102098|P1|NOT COMPLETED|Overall Study||2
5327472|NCT00384813|13102097|P2|COMPLETED|Overall Study||20
5327473|NCT00384813|13102098|P1|COMPLETED|Overall Study||21
5327474|NCT00384813|13102097|P2|STARTED|Overall Study||20
5327475|NCT00384813|13102098|P1|STARTED|Overall Study||23
5327476|NCT00384774|13102111|P7|NOT COMPLETED|Overall Study||0
5327477|NCT00384774|13102112|P6|NOT COMPLETED|Overall Study||0
5327478|NCT00384774|13102113|P5|NOT COMPLETED|Overall Study||0
5327479|NCT00384774|13102114|P4|NOT COMPLETED|Overall Study||0
5327480|NCT00384774|13102115|P3|NOT COMPLETED|Overall Study||0
5327481|NCT00384774|13102116|P2|NOT COMPLETED|Overall Study||0
5327482|NCT00384774|13102117|P1|NOT COMPLETED|Overall Study||0
5327483|NCT00384774|13102111|P7|COMPLETED|Overall Study||4
5327484|NCT00384774|13102112|P6|COMPLETED|Overall Study||16
5327485|NCT00384774|13102113|P5|COMPLETED|Overall Study||28
5327486|NCT00384774|13102114|P4|COMPLETED|Overall Study||24
5327487|NCT00384774|13102115|P3|COMPLETED|Overall Study||12
5327488|NCT00384774|13102116|P2|COMPLETED|Overall Study||4
5327489|NCT00384774|13102117|P1|COMPLETED|Overall Study||42
5327490|NCT00384774|13102111|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
5327491|NCT00384774|13102112|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
5327492|NCT00384774|13102113|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
5327493|NCT00384774|13102114|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
5327494|NCT00384774|13102115|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
5327495|NCT00384774|13102116|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
5327496|NCT00384774|13102117|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
5327497|NCT00384774|13102111|P7|STARTED|Overall Study||4
5327498|NCT00384774|13102112|P6|STARTED|Overall Study||16
5327499|NCT00384774|13102113|P5|STARTED|Overall Study||28
5327500|NCT00384774|13102114|P4|STARTED|Overall Study||24
5327501|NCT00384774|13102115|P3|STARTED|Overall Study||12
5327502|NCT00384774|13102116|P2|STARTED|Overall Study||4
5327503|NCT00384774|13102117|P1|STARTED|Overall Study||42
5327504|NCT00384748|13102191|P2|NOT COMPLETED|Overall Study||0
5327505|NCT00384748|13102192|P1|NOT COMPLETED|Overall Study||0
5327506|NCT00384748|13102191|P2|COMPLETED|Overall Study||23
5327507|NCT00384748|13102192|P1|COMPLETED|Overall Study||25
5327508|NCT00384748|13102191|P2|STARTED|Overall Study||23
5327509|NCT00384748|13102192|P1|STARTED|Overall Study||25
5327510|NCT00384670|13102198|P1|NOT COMPLETED|Overall Study||0
5327511|NCT00384670|13102198|P1|COMPLETED|Overall Study||7
5327512|NCT00384670|13102198|P1|STARTED|Overall Study||7
5327513|NCT00384449|13102208|P1|NOT COMPLETED|Overall Study||0
5327514|NCT00384449|13102208|P1|COMPLETED|Overall Study||1
5327515|NCT00384449|13102208|P1|STARTED|Overall Study||1
5327516|NCT00384397|13102219|P3|NOT COMPLETED|Overall Study||33
5327517|NCT00384397|13102220|P2|NOT COMPLETED|Overall Study||46
5327518|NCT00384397|13102221|P1|NOT COMPLETED|Overall Study||32
5327519|NCT00384397|13102219|P3|COMPLETED|Overall Study||385
5327520|NCT00384397|13102220|P2|COMPLETED|Overall Study||247
5327521|NCT00384397|13102221|P1|COMPLETED|Overall Study||375
5327522|NCT00384397|13102219|P3|STARTED|Overall Study||418
5327523|NCT00384397|13102220|P2|STARTED|Overall Study||293
5327524|NCT00384397|13102221|P1|STARTED|Overall Study||407
5327525|NCT00384332|13102240|P2|NOT COMPLETED|Overall Study||0
5327526|NCT00384332|13102241|P1|NOT COMPLETED|Overall Study||4
5327527|NCT00384332|13102240|P2|COMPLETED|Overall Study||10
5327528|NCT00384332|13102241|P1|COMPLETED|Overall Study||9
5327529|NCT00384332|13102240|P2|STARTED|Overall Study||10
5327530|NCT00384332|13102241|P1|STARTED|Overall Study||13
5327531|NCT00384293|13102251|P3|NOT COMPLETED|Post-randomization Period||219
5327532|NCT00384293|13102252|P2|NOT COMPLETED|Post-randomization Period||214
5327533|NCT00384293|13102253|P1|NOT COMPLETED|Post-randomization Period||0
5327534|NCT00384293|13102251|P3|COMPLETED|Post-randomization Period||0
5327535|NCT00384293|13102252|P2|COMPLETED|Post-randomization Period||0
5327536|NCT00384293|13102253|P1|COMPLETED|Post-randomization Period||0
5327537|NCT00384293|13102251|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
5327538|NCT00384293|13102252|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
5327539|NCT00384293|13102253|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
5327540|NCT00384293|13102251|P3|STARTED|Post-randomization Period||219
5327541|NCT00384293|13102252|P2|STARTED|Post-randomization Period||214
5327542|NCT00384293|13102253|P1|STARTED|Post-randomization Period||0
5327543|NCT00384293|13102251|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
5327544|NCT00384293|13102252|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
5327545|NCT00384293|13102253|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
5327546|NCT00384293|13102251|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
5327547|NCT00384293|13102252|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
5327548|NCT00384293|13102253|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
5327549|NCT00384293|13102251|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
5327550|NCT00384293|13102252|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
5327551|NCT00384293|13102253|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
5327552|NCT00384293|13102251|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
5327553|NCT00384293|13102252|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
5327554|NCT00384293|13102253|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
5327555|NCT00384293|13102251|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
5327556|NCT00384293|13102252|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
5327557|NCT00384293|13102253|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
5327558|NCT00384241|13102266|P2|NOT COMPLETED|Overall Study||0
5327559|NCT00384241|13102267|P1|NOT COMPLETED|Overall Study||0
5327560|NCT00384241|13102266|P2|COMPLETED|Overall Study||599
5327561|NCT00384241|13102267|P1|COMPLETED|Overall Study||500
5327562|NCT00384241|13102266|P2|STARTED|Overall Study||599
5327563|NCT00384241|13102267|P1|STARTED|Overall Study||500
5327564|NCT00384189|13102277|P4|NOT COMPLETED|Overall Study||40
5327565|NCT00384189|13102278|P3|NOT COMPLETED|Overall Study||58
5327566|NCT00384189|13102279|P2|NOT COMPLETED|Overall Study||57
5327567|NCT00384189|13102280|P1|NOT COMPLETED|Overall Study||50
5327568|NCT00384189|13102277|P4|COMPLETED|Overall Study||110
5327569|NCT00384189|13102278|P3|COMPLETED|Overall Study||255
5327570|NCT00384189|13102279|P2|COMPLETED|Overall Study||255
5327571|NCT00384189|13102280|P1|COMPLETED|Overall Study||255
5327572|NCT00384189|13102277|P4|Actual Treatment Received|Overall Study||146
5327573|NCT00384189|13102278|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
5327574|NCT00384189|13102279|P2|Actual Treatment Received|Overall Study||312
5327575|NCT00384189|13102280|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
5327576|NCT00384189|13102277|P4|Randomized, Not Treated|Overall Study||4
5327577|NCT00384189|13102278|P3|Randomized, Not Treated|Overall Study||2
5327578|NCT00384189|13102279|P2|Randomized, Not Treated|Overall Study||0
5327579|NCT00384189|13102280|P1|Randomized, Not Treated|Overall Study||1
5327580|NCT00384189|13102277|P4|STARTED|Overall Study||150
5327581|NCT00384189|13102278|P3|STARTED|Overall Study||313
5327582|NCT00384189|13102279|P2|STARTED|Overall Study||312
5327583|NCT00384189|13102280|P1|STARTED|Overall Study||305
5327584|NCT00384176|13102341|P3|NOT COMPLETED|Overall Study||132
5327585|NCT00384176|13102342|P2|NOT COMPLETED|Overall Study||319
5327586|NCT00384176|13102343|P1|NOT COMPLETED|Overall Study||312
5327587|NCT00384176|13102341|P3|COMPLETED|Overall Study||60
5327588|NCT00384176|13102342|P2|COMPLETED|Overall Study||394
5327589|NCT00384176|13102343|P1|COMPLETED|Overall Study||397
5327590|NCT00384176|13102341|P3|STARTED|Overall Study||192
5327591|NCT00384176|13102342|P2|STARTED|Overall Study||713
5327592|NCT00384176|13102343|P1|STARTED|Overall Study||709
5327593|NCT00384085|13102369|P3|NOT COMPLETED|Overall Study||56
5327594|NCT00384085|13102370|P2|NOT COMPLETED|Overall Study||46
5327595|NCT00384085|13102371|P1|NOT COMPLETED|Overall Study||39
5327596|NCT00384085|13102369|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
5327597|NCT00384085|13102370|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
5327598|NCT00384085|13102371|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
5327599|NCT00384085|13102369|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
5327600|NCT00384085|13102370|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
5327601|NCT00384085|13102371|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
5327602|NCT00384085|13102369|P3|Treated (Safety Population)|Overall Study||194
5327603|NCT00384085|13102370|P2|Treated (Safety Population)|Overall Study||194
5327604|NCT00384085|13102371|P1|Treated (Safety Population)|Overall Study||194
5327605|NCT00384085|13102369|P3|Intent-To-Treat (ITT)|Overall Study||197
5327606|NCT00384085|13102370|P2|Intent-To-Treat (ITT)|Overall Study||196
5327607|NCT00384085|13102371|P1|Intent-To-Treat (ITT)|Overall Study||195
5327608|NCT00384085|13102369|P3|STARTED|Overall Study|Randomized|197
5327609|NCT00384085|13102370|P2|STARTED|Overall Study|Randomized|196
5327610|NCT00384085|13102371|P1|STARTED|Overall Study|Randomized|195
5327611|NCT00384059|13102397|P2|NOT COMPLETED|Toddler Dose||2
5327612|NCT00384059|13102398|P1|NOT COMPLETED|Toddler Dose||1
5327613|NCT00384059|13102397|P2|COMPLETED|Toddler Dose||120
5327614|NCT00384059|13102398|P1|COMPLETED|Toddler Dose||130
5327615|NCT00384059|13102397|P2|STARTED|Toddler Dose||122
5327616|NCT00384059|13102398|P1|STARTED|Toddler Dose||131
5327617|NCT00384059|13102397|P2|NOT COMPLETED|After Infant Series||10
5327618|NCT00384059|13102398|P1|NOT COMPLETED|After Infant Series||4
5327619|NCT00384059|13102397|P2|COMPLETED|After Infant Series||122
5327620|NCT00384059|13102398|P1|COMPLETED|After Infant Series||131
5327621|NCT00384059|13102397|P2|STARTED|After Infant Series||132
5327622|NCT00384059|13102398|P1|STARTED|After Infant Series||135
5327623|NCT00384059|13102397|P2|NOT COMPLETED|Infant Series||13
5327624|NCT00384059|13102398|P1|NOT COMPLETED|Infant Series||6
5327625|NCT00384059|13102397|P2|COMPLETED|Infant Series||132
5327626|NCT00384059|13102398|P1|COMPLETED|Infant Series||135
5327627|NCT00384059|13102397|P2|Vaccinated Dose 2|Infant Series||135
5327628|NCT00384059|13102398|P1|Vaccinated Dose 2|Infant Series||136
5327629|NCT00384059|13102397|P2|Vaccinated Dose 1|Infant Series||139
5327630|NCT00384059|13102398|P1|Vaccinated Dose 1|Infant Series||139
5327631|NCT00384059|13102397|P2|STARTED|Infant Series||145
5327632|NCT00384059|13102398|P1|STARTED|Infant Series||141
5327633|NCT00384033|13102448|P4|NOT COMPLETED|Overall Study||40
5327634|NCT00384033|13102449|P3|NOT COMPLETED|Overall Study||43
5327635|NCT00384033|13102450|P2|NOT COMPLETED|Overall Study||35
5327636|NCT00384033|13102451|P1|NOT COMPLETED|Overall Study||41
5327637|NCT00384033|13102448|P4|COMPLETED|Overall Study||119
5327638|NCT00384033|13102449|P3|COMPLETED|Overall Study||117
5327639|NCT00384033|13102450|P2|COMPLETED|Overall Study||120
5327640|NCT00384033|13102451|P1|COMPLETED|Overall Study||123
5327641|NCT00384033|13102448|P4|Treated|Overall Study||157
5327642|NCT00384033|13102449|P3|Treated|Overall Study||150
5327643|NCT00384033|13102450|P2|Treated|Overall Study||148
5327644|NCT00384033|13102451|P1|Treated|Overall Study||161
5327645|NCT00384033|13102448|P4|STARTED|Overall Study||159
5327646|NCT00384033|13102449|P3|STARTED|Overall Study||160
5327647|NCT00384033|13102450|P2|STARTED|Overall Study||155
5327648|NCT00384033|13102451|P1|STARTED|Overall Study||164
5327649|NCT00383942|13102495|P2|NOT COMPLETED|Overall Study||0
5327650|NCT00383942|13102496|P1|NOT COMPLETED|Overall Study||0
5327651|NCT00383942|13102495|P2|COMPLETED|Overall Study||40
5327652|NCT00383942|13102496|P1|COMPLETED|Overall Study||40
5327653|NCT00383942|13102495|P2|STARTED|Overall Study||40
5327654|NCT00383942|13102496|P1|STARTED|Overall Study||40
5327655|NCT00383786|13102504|P2|NOT COMPLETED|Overall Study||12
5327656|NCT00383786|13102505|P1|NOT COMPLETED|Overall Study||4
5327657|NCT00383786|13102504|P2|COMPLETED|Overall Study||13
5327658|NCT00383786|13102505|P1|COMPLETED|Overall Study||18
5327659|NCT00383786|13102504|P2|STARTED|Overall Study||25
5327660|NCT00383786|13102505|P1|STARTED|Overall Study||22
5327661|NCT00383760|13102511|P1|NOT COMPLETED|Overall Study||0
5327662|NCT00383760|13102511|P1|COMPLETED|Overall Study||15
5327663|NCT00383760|13102511|P1|STARTED|Overall Study||15
5327664|NCT00383747|13102527|P4|NOT COMPLETED|Visit 2||0
5327665|NCT00383747|13102528|P3|NOT COMPLETED|Visit 2||0
5327666|NCT00383747|13102529|P2|NOT COMPLETED|Visit 2||0
5327667|NCT00383747|13102530|P1|NOT COMPLETED|Visit 2||0
5327668|NCT00383747|13102527|P4|COMPLETED|Visit 2||16
5327669|NCT00383747|13102528|P3|COMPLETED|Visit 2||16
5327670|NCT00383747|13102529|P2|COMPLETED|Visit 2||14
5327671|NCT00383747|13102530|P1|COMPLETED|Visit 2||14
5327672|NCT00383747|13102527|P4|STARTED|Visit 2||16
5327673|NCT00383747|13102528|P3|STARTED|Visit 2||16
5327674|NCT00383747|13102529|P2|STARTED|Visit 2||14
5327675|NCT00383747|13102530|P1|STARTED|Visit 2||14
5327676|NCT00383747|13102527|P4|NOT COMPLETED|Visit 1||0
5327677|NCT00383747|13102528|P3|NOT COMPLETED|Visit 1||0
5327678|NCT00383747|13102529|P2|NOT COMPLETED|Visit 1||0
5327679|NCT00383747|13102530|P1|NOT COMPLETED|Visit 1||0
5327680|NCT00383747|13102527|P4|COMPLETED|Visit 1||16
5327681|NCT00383747|13102528|P3|COMPLETED|Visit 1||16
5327682|NCT00383747|13102529|P2|COMPLETED|Visit 1||14
5327683|NCT00383747|13102530|P1|COMPLETED|Visit 1||14
5327684|NCT00383747|13102527|P4|STARTED|Visit 1||16
5327685|NCT00383747|13102528|P3|STARTED|Visit 1||16
5327686|NCT00383747|13102529|P2|STARTED|Visit 1||14
5327687|NCT00383747|13102530|P1|STARTED|Visit 1||14
5327688|NCT00383721|13102555|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
5327689|NCT00383721|13102556|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
5327690|NCT00383721|13102557|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
5327691|NCT00383721|13102558|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
5327692|NCT00383721|13102559|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
5327693|NCT00383721|13102555|P5|COMPLETED|26-Week Treatment Safety Extension||8
5327694|NCT00383721|13102556|P4|COMPLETED|26-Week Treatment Safety Extension||131
5327695|NCT00383721|13102557|P3|COMPLETED|26-Week Treatment Safety Extension||126
5327696|NCT00383721|13102558|P2|COMPLETED|26-Week Treatment Safety Extension||136
5327697|NCT00383721|13102559|P1|COMPLETED|26-Week Treatment Safety Extension||126
5327698|NCT00383721|13102555|P5|STARTED|26-Week Treatment Safety Extension||8
5327699|NCT00383721|13102556|P4|STARTED|26-Week Treatment Safety Extension||148
5327700|NCT00383721|13102557|P3|STARTED|26-Week Treatment Safety Extension||149
5327701|NCT00383721|13102558|P2|STARTED|26-Week Treatment Safety Extension||153
5327702|NCT00383721|13102559|P1|STARTED|26-Week Treatment Safety Extension||145
5327703|NCT00383721|13102555|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
5327704|NCT00383721|13102556|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
5327705|NCT00383721|13102557|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
5327706|NCT00383721|13102558|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
5327707|NCT00383721|13102559|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
5327708|NCT00383721|13102555|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
5327709|NCT00383721|13102556|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
5327710|NCT00383721|13102557|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
5327711|NCT00383721|13102558|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
5327712|NCT00383721|13102559|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
5327713|NCT00383721|13102555|P5|STARTED|26-Week Double-Blind Treatment Period||236
5327714|NCT00383721|13102556|P4|STARTED|26-Week Double-Blind Treatment Period||243
5327715|NCT00383721|13102557|P3|STARTED|26-Week Double-Blind Treatment Period||253
5327716|NCT00383721|13102558|P2|STARTED|26-Week Double-Blind Treatment Period||239
5327717|NCT00383721|13102559|P1|STARTED|26-Week Double-Blind Treatment Period||225
5327718|NCT00383708|13102596|P1|NOT COMPLETED|Co-administration Period||5
5327719|NCT00383708|13102596|P1|COMPLETED|Co-administration Period||52
5327720|NCT00383708|13102596|P1|STARTED|Co-administration Period||57
5327721|NCT00383708|13102596|P1|NOT COMPLETED|Run-in Period||7
5327722|NCT00383708|13102596|P1|COMPLETED|Run-in Period||85
5327723|NCT00383708|13102596|P1|STARTED|Run-in Period||92
5327724|NCT00383708|13102596|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
5327725|NCT00383708|13102596|P1|COMPLETED|Enrolment Through Start Treatment||92
5327726|NCT00383708|13102596|P1|STARTED|Enrolment Through Start Treatment||125
5327727|NCT00383643|13102633|P3|NOT COMPLETED|Overall Study||1
5327728|NCT00383643|13102634|P2|NOT COMPLETED|Overall Study||1
5327729|NCT00383643|13102635|P1|NOT COMPLETED|Overall Study||1
5327730|NCT00383643|13102633|P3|COMPLETED|Overall Study||13
5327731|NCT00383643|13102634|P2|COMPLETED|Overall Study||15
5327732|NCT00383643|13102635|P1|COMPLETED|Overall Study||17
5327733|NCT00383643|13102633|P3|STARTED|Overall Study||14
5327734|NCT00383643|13102634|P2|STARTED|Overall Study||16
5327735|NCT00383643|13102635|P1|STARTED|Overall Study||18
5327736|NCT00383630|13102655|P1|NOT COMPLETED|Overall Study||0
5327737|NCT00383630|13102655|P1|COMPLETED|Overall Study||1
5327738|NCT00383630|13102655|P1|STARTED|Overall Study||1
5327739|NCT00383565|13102661|P1|NOT COMPLETED|Overall Study||0
5327740|NCT00383565|13102661|P1|COMPLETED|Overall Study||9
5327741|NCT00383565|13102661|P1|STARTED|Overall Study||9
5327742|NCT00383552|13102671|P4|NOT COMPLETED|Overall Study||72
5327743|NCT00383552|13102672|P3|NOT COMPLETED|Overall Study||61
5327744|NCT00383552|13102673|P2|NOT COMPLETED|Overall Study||41
5327745|NCT00383552|13102674|P1|NOT COMPLETED|Overall Study||36
5327746|NCT00383552|13102671|P4|COMPLETED|Overall Study||116
5327747|NCT00383552|13102672|P3|COMPLETED|Overall Study||127
5327748|NCT00383552|13102673|P2|COMPLETED|Overall Study||147
5327749|NCT00383552|13102674|P1|COMPLETED|Overall Study||146
5327750|NCT00383552|13102671|P4|STARTED|Overall Study||188
5327751|NCT00383552|13102672|P3|STARTED|Overall Study||188
5327752|NCT00383552|13102673|P2|STARTED|Overall Study||188
5327753|NCT00383552|13102674|P1|STARTED|Overall Study||182
5327754|NCT00383500|13102716|P3|NOT COMPLETED|Overall Study||2
5327755|NCT00383500|13102717|P2|NOT COMPLETED|Overall Study||3
5327756|NCT00383500|13102718|P1|NOT COMPLETED|Overall Study||8
5327757|NCT00383500|13102716|P3|COMPLETED|Overall Study||22
5327758|NCT00383500|13102717|P2|COMPLETED|Overall Study||21
5327759|NCT00383500|13102718|P1|COMPLETED|Overall Study||19
5327760|NCT00383500|13102716|P3|STARTED|Overall Study||24
5327761|NCT00383500|13102717|P2|STARTED|Overall Study||24
5327762|NCT00383500|13102718|P1|STARTED|Overall Study||27
5327763|NCT00383448|13102729|P1|NOT COMPLETED|Overall Study||0
5327764|NCT00383448|13102729|P1|COMPLETED|Overall Study||38
5327765|NCT00383448|13102729|P1|STARTED|Overall Study||38
5327766|NCT00383435|13102742|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
5327767|NCT00383435|13102743|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
5327768|NCT00383435|13102744|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
5327769|NCT00383435|13102745|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
5327770|NCT00383435|13102746|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
5327771|NCT00383435|13102742|P5|COMPLETED|26-Week Treatment Safety Extension||10
5327772|NCT00383435|13102743|P4|COMPLETED|26-Week Treatment Safety Extension||116
5327773|NCT00383435|13102744|P3|COMPLETED|26-Week Treatment Safety Extension||108
5327774|NCT00383435|13102745|P2|COMPLETED|26-Week Treatment Safety Extension||121
5327775|NCT00383435|13102746|P1|COMPLETED|26-Week Treatment Safety Extension||117
5327776|NCT00383435|13102742|P5|STARTED|26-Week Treatment Safety Extension||13
5327777|NCT00383435|13102743|P4|STARTED|26-Week Treatment Safety Extension||131
5327778|NCT00383435|13102744|P3|STARTED|26-Week Treatment Safety Extension||124
5327779|NCT00383435|13102745|P2|STARTED|26-Week Treatment Safety Extension||130
5327780|NCT00383435|13102746|P1|STARTED|26-Week Treatment Safety Extension||131
5327781|NCT00383435|13102742|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
5327782|NCT00383435|13102743|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
5327783|NCT00383435|13102744|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
5327784|NCT00383435|13102745|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
5327785|NCT00383435|13102746|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
5327786|NCT00383435|13102742|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
5327787|NCT00383435|13102743|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
5327788|NCT00383435|13102744|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
5327789|NCT00383435|13102745|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
5327790|NCT00383435|13102746|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
5327791|NCT00383435|13102742|P5|STARTED|26-Week Double-Blind Treatment Period||212
5327792|NCT00383435|13102743|P4|STARTED|26-Week Double-Blind Treatment Period||209
5327793|NCT00383435|13102744|P3|STARTED|26-Week Double-Blind Treatment Period||210
5327794|NCT00383435|13102745|P2|STARTED|26-Week Double-Blind Treatment Period||207
5327795|NCT00383435|13102746|P1|STARTED|26-Week Double-Blind Treatment Period||217
5327796|NCT00383331|13102785|P2|NOT COMPLETED|Overall Study||1
5327797|NCT00383331|13102786|P1|NOT COMPLETED|Overall Study||0
5327798|NCT00383331|13102785|P2|COMPLETED|Overall Study||8
5327799|NCT00383331|13102786|P1|COMPLETED|Overall Study||10
5327800|NCT00383331|13102785|P2|STARTED|Overall Study||9
5327801|NCT00383331|13102786|P1|STARTED|Overall Study||10
5327802|NCT00383292|13102805|P3|NOT COMPLETED|Overall Study||8
5327803|NCT00383292|13102806|P2|NOT COMPLETED|Overall Study||6
5327804|NCT00383292|13102807|P1|NOT COMPLETED|Overall Study||15
5327805|NCT00383292|13102805|P3|COMPLETED|Overall Study||22
5327806|NCT00383292|13102806|P2|COMPLETED|Overall Study||26
5327807|NCT00383292|13102807|P1|COMPLETED|Overall Study||53
5327808|NCT00383292|13102805|P3|Received at Least One Dose of Study Drug|Overall Study||30
5327809|NCT00383292|13102806|P2|Received at Least One Dose of Study Drug|Overall Study||32
5327810|NCT00383292|13102807|P1|Received at Least One Dose of Study Drug|Overall Study||68
5327811|NCT00383292|13102805|P3|STARTED|Overall Study||30
5327812|NCT00383292|13102806|P2|STARTED|Overall Study||32
5327813|NCT00383292|13102807|P1|STARTED|Overall Study||68
5327814|NCT00383266|13102835|P1|NOT COMPLETED|Overall Study||0
5327815|NCT00383266|13102835|P1|COMPLETED|Overall Study||9
5327816|NCT00383266|13102835|P1|STARTED|Overall Study||9
5327817|NCT00383240|13102848|P4|NOT COMPLETED|Overall Study||77
5327818|NCT00383240|13102849|P3|NOT COMPLETED|Overall Study||85
5327819|NCT00383240|13102850|P2|NOT COMPLETED|Overall Study||33
5327820|NCT00383240|13102851|P1|NOT COMPLETED|Overall Study||35
5327821|NCT00383240|13102848|P4|COMPLETED|Overall Study||119
5327822|NCT00383240|13102849|P3|COMPLETED|Overall Study||117
5327823|NCT00383240|13102850|P2|COMPLETED|Overall Study||159
5327824|NCT00383240|13102851|P1|COMPLETED|Overall Study||156
5327825|NCT00383240|13102848|P4|STARTED|Overall Study||196
5327826|NCT00383240|13102849|P3|STARTED|Overall Study||202
5327827|NCT00383240|13102850|P2|STARTED|Overall Study||192
5327828|NCT00383240|13102851|P1|STARTED|Overall Study||191
5327829|NCT00383162|13102882|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
5327830|NCT00383162|13102883|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
5327831|NCT00383162|13102882|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
5327832|NCT00383162|13102883|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
5327833|NCT00383162|13102882|P2|STARTED|Migraine Attack 2 (Period 2)||73
5327834|NCT00383162|13102883|P1|STARTED|Migraine Attack 2 (Period 2)||67
5327835|NCT00383162|13102882|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
5327836|NCT00383162|13102883|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
5327837|NCT00383162|13102882|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
5327838|NCT00383162|13102883|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
5327839|NCT00383162|13102882|P2|STARTED|Migraine Attack 1 (Period 1)||86
5327840|NCT00383162|13102883|P1|STARTED|Migraine Attack 1 (Period 1)||87
5327841|NCT00383149|13102925|P1|NOT COMPLETED|Overall Study||54
5327842|NCT00383149|13102925|P1|COMPLETED|Overall Study||0
5327843|NCT00383149|13102925|P1|STARTED|Overall Study||54
5327844|NCT00383123|13102944|P2|NOT COMPLETED|Overall Study||86
5327845|NCT00383123|13102945|P1|NOT COMPLETED|Overall Study||111
5327846|NCT00383123|13102944|P2|COMPLETED|Overall Study||1124
5327847|NCT00383123|13102945|P1|COMPLETED|Overall Study||2004
5327848|NCT00383123|13102944|P2|STARTED|Overall Study||1210
5327849|NCT00383123|13102945|P1|STARTED|Overall Study||2115
5327850|NCT00383110|13102967|P2|NOT COMPLETED|Overall Study||0
5327851|NCT00383110|13102968|P1|NOT COMPLETED|Overall Study||0
5327852|NCT00383110|13102967|P2|COMPLETED|Overall Study||150
5327853|NCT00383110|13102968|P1|COMPLETED|Overall Study||150
5327854|NCT00383110|13102967|P2|STARTED|Overall Study||150
5327855|NCT00383110|13102968|P1|STARTED|Overall Study||150
5327856|NCT00383084|13102986|P2|NOT COMPLETED|Overall Study||10
5327857|NCT00383084|13102987|P1|NOT COMPLETED|Overall Study||12
5327858|NCT00383084|13102986|P2|COMPLETED|Overall Study||28
5327859|NCT00383084|13102987|P1|COMPLETED|Overall Study||34
5327860|NCT00383084|13102986|P2|STARTED|Overall Study||38
5327861|NCT00383084|13102987|P1|STARTED|Overall Study||46
5327862|NCT00383071|13103003|P4|NOT COMPLETED|Overall Study||3
5327863|NCT00383071|13103004|P3|NOT COMPLETED|Overall Study||7
5327864|NCT00383071|13103005|P2|NOT COMPLETED|Overall Study||4
5327865|NCT00383071|13103006|P1|NOT COMPLETED|Overall Study||0
5327866|NCT00383071|13103003|P4|COMPLETED|Overall Study||22
5327867|NCT00383071|13103004|P3|COMPLETED|Overall Study||44
5327868|NCT00383071|13103005|P2|COMPLETED|Overall Study||21
5327869|NCT00383071|13103006|P1|COMPLETED|Overall Study||25
5327870|NCT00383071|13103003|P4|STARTED|Overall Study||25
5327871|NCT00383071|13103004|P3|STARTED|Overall Study||51
5327872|NCT00383071|13103005|P2|STARTED|Overall Study||25
5327873|NCT00383071|13103006|P1|STARTED|Overall Study||25
5327874|NCT00383019|13103018|P2|NOT COMPLETED|Overall Study||2
5327875|NCT00383019|13103019|P1|NOT COMPLETED|Overall Study||5
5327876|NCT00383019|13103018|P2|COMPLETED|Overall Study||143
5327877|NCT00383019|13103019|P1|COMPLETED|Overall Study||139
5327878|NCT00383019|13103018|P2|STARTED|Overall Study||145
5327879|NCT00383019|13103019|P1|STARTED|Overall Study||144
5327880|NCT00382993|13103041|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
5327881|NCT00382993|13103042|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
5327882|NCT00382993|13103041|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
5327883|NCT00382993|13103042|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
5327884|NCT00382993|13103041|P2|STARTED|Migraine Attack 2 (Period 2)||67
5327885|NCT00382993|13103042|P1|STARTED|Migraine Attack 2 (Period 2)||70
5327886|NCT00382993|13103041|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
5327887|NCT00382993|13103042|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
5327888|NCT00382993|13103041|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
5327889|NCT00382993|13103042|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
5327890|NCT00382993|13103041|P2|STARTED|Migraine Attack 1 (Period 1)||85
5327891|NCT00382993|13103042|P1|STARTED|Migraine Attack 1 (Period 1)||84
5327892|NCT00382967|13103086|P2|NOT COMPLETED|Overall Study||1
5327893|NCT00382967|13103087|P1|NOT COMPLETED|Overall Study||1
5327894|NCT00382967|13103086|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
5327895|NCT00382967|13103087|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
5327896|NCT00382967|13103086|P2|STARTED|Overall Study||138
5327897|NCT00382967|13103087|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
5327898|NCT00382928|13103097|P2|NOT COMPLETED|Overall Study||0
5327899|NCT00382928|13103098|P1|NOT COMPLETED|Overall Study||0
5327900|NCT00382928|13103097|P2|COMPLETED|Overall Study||95
5327901|NCT00382928|13103098|P1|COMPLETED|Overall Study||97
5327902|NCT00382928|13103097|P2|STARTED|Overall Study||95
5327903|NCT00382928|13103098|P1|STARTED|Overall Study||97
5327904|NCT00382863|13103112|P2|NOT COMPLETED|Overall Study||36
5327905|NCT00382863|13103113|P1|NOT COMPLETED|Overall Study||15
5327906|NCT00382863|13103112|P2|COMPLETED|Overall Study||78
5327907|NCT00382863|13103113|P1|COMPLETED|Overall Study||81
5327908|NCT00382863|13103112|P2|STARTED|Overall Study||114
5327909|NCT00382863|13103113|P1|STARTED|Overall Study||96
5327910|NCT00382824|13103169|P2|NOT COMPLETED|Overall Study||13
5327911|NCT00382824|13103170|P1|NOT COMPLETED|Overall Study||12
5327912|NCT00382824|13103169|P2|COMPLETED|Overall Study||16
5327913|NCT00382824|13103170|P1|COMPLETED|Overall Study||20
5327914|NCT00382824|13103169|P2|STARTED|Overall Study||29
5327915|NCT00382824|13103170|P1|STARTED|Overall Study||32
5327916|NCT00382785|13103186|P2|NOT COMPLETED|Overall Study||0
5327917|NCT00382785|13103187|P1|NOT COMPLETED|Overall Study||0
5327918|NCT00382785|13103186|P2|COMPLETED|Overall Study||26
5327919|NCT00382785|13103187|P1|COMPLETED|Overall Study||25
5327920|NCT00382785|13103186|P2|STARTED|Overall Study||26
5327921|NCT00382785|13103187|P1|STARTED|Overall Study||25
5327922|NCT00382733|13103197|P5|NOT COMPLETED|Overall Study||0
5327923|NCT00382733|13103198|P4|NOT COMPLETED|Overall Study||0
5327924|NCT00382733|13103199|P3|NOT COMPLETED|Overall Study||0
5327925|NCT00382733|13103200|P2|NOT COMPLETED|Overall Study||1
5327926|NCT00382733|13103201|P1|NOT COMPLETED|Overall Study||0
5327927|NCT00382733|13103197|P5|COMPLETED|Overall Study||2
5327928|NCT00382733|13103198|P4|COMPLETED|Overall Study||14
5327929|NCT00382733|13103199|P3|COMPLETED|Overall Study||3
5327930|NCT00382733|13103200|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
5327931|NCT00382733|13103201|P1|COMPLETED|Overall Study||3
5327932|NCT00382733|13103197|P5|STARTED|Overall Study||2
5327933|NCT00382733|13103198|P4|STARTED|Overall Study||14
5327934|NCT00382733|13103199|P3|STARTED|Overall Study||3
5327935|NCT00382733|13103200|P2|STARTED|Overall Study||4
5327936|NCT00382733|13103201|P1|STARTED|Overall Study||3
5327937|NCT00382720|13103222|P3|NOT COMPLETED|Overall Study||86
5327938|NCT00382720|13103223|P2|NOT COMPLETED|Overall Study||89
5327939|NCT00382720|13103224|P1|NOT COMPLETED|Overall Study||79
5327940|NCT00382720|13103222|P3|COMPLETED|Overall Study||0
5327941|NCT00382720|13103223|P2|COMPLETED|Overall Study||0
5327942|NCT00382720|13103224|P1|COMPLETED|Overall Study||0
5327943|NCT00382720|13103222|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
5327944|NCT00382720|13103223|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
5327945|NCT00382720|13103224|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
5327946|NCT00382720|13103222|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
5327947|NCT00382720|13103223|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
5327948|NCT00382720|13103224|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
5327949|NCT00382720|13103222|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
5327950|NCT00382720|13103223|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
5327951|NCT00382720|13103224|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
5327952|NCT00382720|13103222|P3|STARTED|Overall Study||86
5327953|NCT00382720|13103223|P2|STARTED|Overall Study||89
5327954|NCT00382720|13103224|P1|STARTED|Overall Study||79
5327955|NCT00382590|13103240|P2|NOT COMPLETED|Overall Study||0
5327956|NCT00382590|13103241|P1|NOT COMPLETED|Overall Study||0
5327957|NCT00382590|13103240|P2|COMPLETED|Overall Study||6
5327958|NCT00382590|13103241|P1|COMPLETED|Overall Study||4
5327959|NCT00382590|13103240|P2|STARTED|Overall Study||6
5327960|NCT00382590|13103241|P1|STARTED|Overall Study||4
5327961|NCT00382408|13103249|P2|NOT COMPLETED|Overall Study||54
5327962|NCT00382408|13103250|P1|NOT COMPLETED|Overall Study||144
5327963|NCT00382408|13103249|P2|COMPLETED|Overall Study||955
5327964|NCT00382408|13103250|P1|COMPLETED|Overall Study||2887
5327965|NCT00382408|13103249|P2|STARTED|Overall Study||1009
5327966|NCT00382408|13103250|P1|STARTED|Overall Study||3031
5327967|NCT00382291|13103277|P3|NOT COMPLETED|Overall Study||8
5327968|NCT00382291|13103278|P2|NOT COMPLETED|Overall Study||7
5327969|NCT00382291|13103279|P1|NOT COMPLETED|Overall Study||4
5327970|NCT00382291|13103277|P3|COMPLETED|Overall Study||13
5327971|NCT00382291|13103278|P2|COMPLETED|Overall Study||10
5327972|NCT00382291|13103279|P1|COMPLETED|Overall Study||14
5327973|NCT00382291|13103277|P3|STARTED|Overall Study||21
5327974|NCT00382291|13103278|P2|STARTED|Overall Study||17
5327975|NCT00382291|13103279|P1|STARTED|Overall Study||18
5327976|NCT00382265|13103292|P2|NOT COMPLETED|Overall Study||6
5327977|NCT00382265|13103293|P1|NOT COMPLETED|Overall Study||9
5327978|NCT00382265|13103292|P2|COMPLETED|Overall Study||239
5327979|NCT00382265|13103293|P1|COMPLETED|Overall Study||258
5327980|NCT00382265|13103292|P2|STARTED|Overall Study||245
5327981|NCT00382265|13103293|P1|STARTED|Overall Study||267
5327982|NCT00382174|13103311|P3|NOT COMPLETED|Overall Study||21
5327983|NCT00382174|13103312|P2|NOT COMPLETED|Overall Study||17
5327984|NCT00382174|13103313|P1|NOT COMPLETED|Overall Study||4
5327985|NCT00382174|13103311|P3|COMPLETED|Overall Study||51
5327986|NCT00382174|13103312|P2|COMPLETED|Overall Study||37
5327987|NCT00382174|13103313|P1|COMPLETED|Overall Study||14
5327988|NCT00382174|13103311|P3|STARTED|Overall Study||72
5327989|NCT00382174|13103312|P2|STARTED|Overall Study||54
5327990|NCT00382174|13103313|P1|STARTED|Overall Study||18
5327991|NCT00382148|13103326|P2|NOT COMPLETED|Overall Study||0
5327992|NCT00382148|13103327|P1|NOT COMPLETED|Overall Study||1
5327993|NCT00382148|13103326|P2|COMPLETED|Overall Study||7
5327994|NCT00382148|13103327|P1|COMPLETED|Overall Study||3
5327995|NCT00382148|13103326|P2|STARTED|Overall Study||7
5327996|NCT00382148|13103327|P1|STARTED|Overall Study||4
5327997|NCT00382109|13103341|P2|NOT COMPLETED|Overall Study||4
5327998|NCT00382109|13103342|P1|NOT COMPLETED|Overall Study||12
5327999|NCT00382109|13103341|P2|COMPLETED|Overall Study||66
5328000|NCT00382109|13103342|P1|COMPLETED|Overall Study||64
5328001|NCT00382109|13103341|P2|STARTED|Overall Study||70
5328002|NCT00382109|13103342|P1|STARTED|Overall Study||76
5328003|NCT00382031|13103364|P2|NOT COMPLETED|Overall Study||0
5328004|NCT00382031|13103365|P1|NOT COMPLETED|Overall Study||0
5328005|NCT00382031|13103364|P2|COMPLETED|Overall Study||95
5328006|NCT00382031|13103365|P1|COMPLETED|Overall Study||191
5328007|NCT00382031|13103364|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
5328008|NCT00382031|13103365|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
5328009|NCT00382018|13103381|P4|NOT COMPLETED|Overall Study||59
5328010|NCT00382018|13103382|P3|NOT COMPLETED|Overall Study||64
5328011|NCT00382018|13103383|P2|NOT COMPLETED|Overall Study||165
5328012|NCT00382018|13103384|P1|NOT COMPLETED|Overall Study||0
5328013|NCT00382018|13103381|P4|COMPLETED|Overall Study||0
5328014|NCT00382018|13103382|P3|COMPLETED|Overall Study||0
5328015|NCT00382018|13103383|P2|COMPLETED|Overall Study||0
5328016|NCT00382018|13103384|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
5328017|NCT00382018|13103381|P4|STARTED|Overall Study||59
5328018|NCT00382018|13103382|P3|STARTED|Overall Study||64
5328019|NCT00382018|13103383|P2|STARTED|Overall Study||165
5328020|NCT00382018|13103384|P1|STARTED|Overall Study||276
5328021|NCT00381966|13103402|P1|NOT COMPLETED|Overall Study||0
5328022|NCT00381966|13103402|P1|COMPLETED|Overall Study||5
5328023|NCT00381966|13103402|P1|STARTED|Overall Study||5
5328024|NCT00381940|13103407|P1|NOT COMPLETED|Overall Study||5
5328025|NCT00381940|13103407|P1|COMPLETED|Overall Study||21
5328026|NCT00381940|13103407|P1|STARTED|Overall Study||26
5328027|NCT00381888|13103411|P1|NOT COMPLETED|Overall Study||17
5328028|NCT00381888|13103411|P1|COMPLETED|Overall Study||27
5328029|NCT00381888|13103411|P1|STARTED|Overall Study||44
5328030|NCT00381862|13103416|P1|NOT COMPLETED|Overall Study||10
5328031|NCT00381862|13103416|P1|COMPLETED|Overall Study||44
5328032|NCT00381862|13103416|P1|STARTED|Overall Study||54
5328033|NCT00381849|13103422|P2|NOT COMPLETED|Open-label||0
5328034|NCT00381849|13103423|P1|NOT COMPLETED|Open-label||0
5328035|NCT00381849|13103422|P2|COMPLETED|Open-label||9
5328036|NCT00381849|13103423|P1|COMPLETED|Open-label||10
5328037|NCT00381849|13103422|P2|STARTED|Open-label||9
5328038|NCT00381849|13103423|P1|STARTED|Open-label||10
5328039|NCT00381849|13103422|P2|NOT COMPLETED|Second Intervention||0
5328040|NCT00381849|13103423|P1|NOT COMPLETED|Second Intervention||0
5328041|NCT00381849|13103422|P2|COMPLETED|Second Intervention||9
5328042|NCT00381849|13103423|P1|COMPLETED|Second Intervention||10
5328043|NCT00381849|13103422|P2|STARTED|Second Intervention||9
5328044|NCT00381849|13103423|P1|STARTED|Second Intervention||10
5328045|NCT00381849|13103422|P2|NOT COMPLETED|Wash Out||1
5328046|NCT00381849|13103423|P1|NOT COMPLETED|Wash Out||0
5328047|NCT00381849|13103422|P2|COMPLETED|Wash Out||9
5328048|NCT00381849|13103423|P1|COMPLETED|Wash Out||10
5328049|NCT00381849|13103422|P2|STARTED|Wash Out||10
5328050|NCT00381849|13103423|P1|STARTED|Wash Out||10
5328051|NCT00381849|13103422|P2|NOT COMPLETED|First Intervention||0
5328052|NCT00381849|13103423|P1|NOT COMPLETED|First Intervention||0
5328053|NCT00381849|13103422|P2|COMPLETED|First Intervention||10
5328054|NCT00381849|13103423|P1|COMPLETED|First Intervention||10
5328055|NCT00381849|13103422|P2|STARTED|First Intervention||10
5328056|NCT00381849|13103423|P1|STARTED|First Intervention||10
5328057|NCT00381810|13103441|P1|NOT COMPLETED|B Cell Follow-up||7
5328058|NCT00381810|13103441|P1|COMPLETED|B Cell Follow-up||0
5328059|NCT00381810|13103441|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
5328060|NCT00381810|13103441|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
5328061|NCT00381810|13103441|P1|COMPLETED|Treatment and Safety Follow-up||16
5328062|NCT00381810|13103441|P1|STARTED|Treatment and Safety Follow-up||31
5328063|NCT00381797|13103450|P5|NOT COMPLETED|Overall Study||2
5328064|NCT00381797|13103451|P4|NOT COMPLETED|Overall Study||1
5328065|NCT00381797|13103452|P3|NOT COMPLETED|Overall Study||0
5328066|NCT00381797|13103453|P2|NOT COMPLETED|Overall Study||1
5328067|NCT00381797|13103454|P1|NOT COMPLETED|Overall Study||1
5328068|NCT00381797|13103450|P5|COMPLETED|Overall Study||35
5328069|NCT00381797|13103451|P4|COMPLETED|Overall Study||14
5328070|NCT00381797|13103452|P3|COMPLETED|Overall Study||10
5328071|NCT00381797|13103453|P2|COMPLETED|Overall Study||16
5328072|NCT00381797|13103454|P1|COMPLETED|Overall Study||17
5328073|NCT00381797|13103450|P5|STARTED|Overall Study||37
5328074|NCT00381797|13103451|P4|STARTED|Overall Study||15
5328075|NCT00381797|13103452|P3|STARTED|Overall Study||10
5328076|NCT00381797|13103453|P2|STARTED|Overall Study||17
5328077|NCT00381797|13103454|P1|STARTED|Overall Study||18
5328078|NCT00381706|13103529|P3|NOT COMPLETED|Overall Study||1
5328079|NCT00381706|13103530|P2|NOT COMPLETED|Overall Study||2
5328080|NCT00381706|13103531|P1|NOT COMPLETED|Overall Study||7
5328081|NCT00381706|13103529|P3|COMPLETED|Overall Study||79
5328082|NCT00381706|13103530|P2|COMPLETED|Overall Study||81
5328083|NCT00381706|13103531|P1|COMPLETED|Overall Study||75
5328084|NCT00381706|13103529|P3|STARTED|Overall Study||80
5328085|NCT00381706|13103530|P2|STARTED|Overall Study||83
5328086|NCT00381706|13103531|P1|STARTED|Overall Study||82
5328087|NCT00381693|13103554|P1|NOT COMPLETED|Overall Study||8
5328088|NCT00381693|13103554|P1|COMPLETED|Overall Study||2
5328089|NCT00381693|13103554|P1|STARTED|Overall Study||10
5328090|NCT00381680|13103563|P2|NOT COMPLETED|Overall Study||50
5328091|NCT00381680|13103564|P1|NOT COMPLETED|Overall Study||125
5328092|NCT00381680|13103563|P2|COMPLETED|Overall Study||19
5328093|NCT00381680|13103564|P1|COMPLETED|Overall Study||81
5328094|NCT00381680|13103563|P2|STARTED|Overall Study||69
5328095|NCT00381680|13103564|P1|STARTED|Overall Study||206
5328096|NCT00381641|13103581|P2|NOT COMPLETED|Overall Study||2
5328097|NCT00381641|13103582|P1|NOT COMPLETED|Overall Study||0
5328098|NCT00381641|13103581|P2|COMPLETED|Overall Study||23
5328099|NCT00381641|13103582|P1|COMPLETED|Overall Study||38
5328100|NCT00381641|13103581|P2|STARTED|Overall Study||25
5328101|NCT00381641|13103582|P1|STARTED|Overall Study||38
5328102|NCT00381628|13103598|P4|NOT COMPLETED|Overall Study||0
5328103|NCT00381628|13103599|P3|NOT COMPLETED|Overall Study||0
5328104|NCT00381628|13103600|P2|NOT COMPLETED|Overall Study||0
5328105|NCT00381628|13103601|P1|NOT COMPLETED|Overall Study||0
5328106|NCT00381628|13103598|P4|COMPLETED|Overall Study||14
5328107|NCT00381628|13103599|P3|COMPLETED|Overall Study||0
5328108|NCT00381628|13103600|P2|COMPLETED|Overall Study||27
5328109|NCT00381628|13103601|P1|COMPLETED|Overall Study||18
5328110|NCT00381628|13103598|P4|STARTED|Overall Study||14
5328111|NCT00381628|13103599|P3|STARTED|Overall Study||0
5328112|NCT00381628|13103600|P2|STARTED|Overall Study||27
5328113|NCT00381628|13103601|P1|STARTED|Overall Study||18
5328114|NCT00381615|13103615|P4|NOT COMPLETED|Overall Study||2
5328115|NCT00381615|13103616|P3|NOT COMPLETED|Overall Study||1
5328116|NCT00381615|13103617|P2|NOT COMPLETED|Overall Study||5
5328117|NCT00381615|13103618|P1|NOT COMPLETED|Overall Study||4
5328118|NCT00381615|13103615|P4|COMPLETED|Overall Study||22
5328119|NCT00381615|13103616|P3|COMPLETED|Overall Study||24
5328120|NCT00381615|13103617|P2|COMPLETED|Overall Study||45
5328121|NCT00381615|13103618|P1|COMPLETED|Overall Study||44
5328122|NCT00381615|13103615|P4|STARTED|Overall Study||24
5328123|NCT00381615|13103616|P3|STARTED|Overall Study||25
5328124|NCT00381615|13103617|P2|STARTED|Overall Study||50
5328125|NCT00381615|13103618|P1|STARTED|Overall Study||48
5328126|NCT00381563|13103670|P2|NOT COMPLETED|Overall Study||6
5328127|NCT00381563|13103671|P1|NOT COMPLETED|Overall Study||7
5328128|NCT00381563|13103670|P2|COMPLETED|Overall Study||33
5328129|NCT00381563|13103671|P1|COMPLETED|Overall Study||34
5328130|NCT00381563|13103670|P2|STARTED|Overall Study||39
5328131|NCT00381563|13103671|P1|STARTED|Overall Study||41
5328132|NCT00381550|13103678|P1|NOT COMPLETED|Overall Study||0
5328133|NCT00381550|13103678|P1|COMPLETED|Overall Study||35
5328134|NCT00381550|13103678|P1|STARTED|Overall Study||35
5328135|NCT00381485|13103686|P4|NOT COMPLETED|Double-Blind Treatment Period||33
5328136|NCT00381485|13103687|P3|NOT COMPLETED|Double-Blind Treatment Period||25
5328137|NCT00381485|13103688|P2|NOT COMPLETED|Double-Blind Treatment Period||27
5328138|NCT00381485|13103689|P1|NOT COMPLETED|Double-Blind Treatment Period||0
5328139|NCT00381485|13103686|P4|COMPLETED|Double-Blind Treatment Period||207
5328140|NCT00381485|13103687|P3|COMPLETED|Double-Blind Treatment Period||208
5328141|NCT00381485|13103688|P2|COMPLETED|Double-Blind Treatment Period||228
5328142|NCT00381485|13103689|P1|COMPLETED|Double-Blind Treatment Period||0
5328143|NCT00381485|13103686|P4|STARTED|Double-Blind Treatment Period||240
5328144|NCT00381485|13103687|P3|STARTED|Double-Blind Treatment Period||233
5328145|NCT00381485|13103688|P2|STARTED|Double-Blind Treatment Period||255
5328146|NCT00381485|13103689|P1|STARTED|Double-Blind Treatment Period||0
5328147|NCT00381485|13103686|P4|NOT COMPLETED|Open-Label Run-In Period||0
5328148|NCT00381485|13103687|P3|NOT COMPLETED|Open-Label Run-In Period||0
5328149|NCT00381485|13103688|P2|NOT COMPLETED|Open-Label Run-In Period||0
5328150|NCT00381485|13103689|P1|NOT COMPLETED|Open-Label Run-In Period||106
5328151|NCT00381485|13103686|P4|COMPLETED|Open-Label Run-In Period||0
5328152|NCT00381485|13103687|P3|COMPLETED|Open-Label Run-In Period||0
5328153|NCT00381485|13103688|P2|COMPLETED|Open-Label Run-In Period||0
5328154|NCT00381485|13103689|P1|COMPLETED|Open-Label Run-In Period||728
5328155|NCT00381485|13103686|P4|STARTED|Open-Label Run-In Period||0
5328156|NCT00381485|13103687|P3|STARTED|Open-Label Run-In Period||0
5328157|NCT00381485|13103688|P2|STARTED|Open-Label Run-In Period||0
5328158|NCT00381485|13103689|P1|STARTED|Open-Label Run-In Period||834
5328159|NCT00381381|13103707|P1|NOT COMPLETED|Overall Study||64
5328160|NCT00381381|13103707|P1|COMPLETED|Overall Study||135
5328161|NCT00381381|13103707|P1|STARTED|Overall Study||199
5328162|NCT00381303|13103716|P2|NOT COMPLETED|Overall Study||33
5328163|NCT00381303|13103717|P1|NOT COMPLETED|Overall Study||94
5328164|NCT00381303|13103716|P2|COMPLETED|Overall Study||109
5328165|NCT00381303|13103717|P1|COMPLETED|Overall Study||193
5328166|NCT00381303|13103716|P2|STARTED|Overall Study||142
5328167|NCT00381303|13103717|P1|STARTED|Overall Study||287
5328168|NCT00381238|13103777|P1|NOT COMPLETED|Overall Study||12
5328169|NCT00381238|13103777|P1|COMPLETED|Overall Study||21
5328170|NCT00381238|13103777|P1|STARTED|Overall Study||33
5328171|NCT00381095|13103793|P2|NOT COMPLETED|Overall Study||21
5328172|NCT00381095|13103794|P1|NOT COMPLETED|Overall Study||13
5328173|NCT00381095|13103793|P2|COMPLETED|Overall Study||59
5328174|NCT00381095|13103794|P1|COMPLETED|Overall Study||59
5328175|NCT00381095|13103793|P2|STARTED|Overall Study||80
5328176|NCT00381095|13103794|P1|STARTED|Overall Study||72
5328177|NCT00381043|13103826|P2|NOT COMPLETED|Overall Study||8
5328178|NCT00381043|13103827|P1|NOT COMPLETED|Overall Study||12
5328179|NCT00381043|13103826|P2|COMPLETED|Overall Study||41
5328180|NCT00381043|13103827|P1|COMPLETED|Overall Study||39
5328181|NCT00381043|13103826|P2|STARTED|Overall Study||49
5328182|NCT00381043|13103827|P1|STARTED|Overall Study||51
5328183|NCT00381004|13103845|P1|NOT COMPLETED|Overall Study||0
5328184|NCT00381004|13103845|P1|COMPLETED|Overall Study||60
5328185|NCT00381004|13103845|P1|STARTED|Overall Study||60
5328186|NCT00380978|13103853|P2|NOT COMPLETED|Overall Study||10
5328187|NCT00380978|13103854|P1|NOT COMPLETED|Overall Study||2
5328188|NCT00380978|13103853|P2|COMPLETED|Overall Study||400
5328189|NCT00380978|13103854|P1|COMPLETED|Overall Study||406
5328190|NCT00380978|13103853|P2|STARTED|Overall Study||410
5328191|NCT00380978|13103854|P1|STARTED|Overall Study||408
5328192|NCT00380874|13103876|P2|NOT COMPLETED|Overall Study||10
5328193|NCT00380874|13103877|P1|NOT COMPLETED|Overall Study||13
5328194|NCT00380874|13103876|P2|COMPLETED|Overall Study||19
5328195|NCT00380874|13103877|P1|COMPLETED|Overall Study||19
5328196|NCT00380874|13103876|P2|STARTED|Overall Study||29
5328197|NCT00380874|13103877|P1|STARTED|Overall Study||32
5328198|NCT00380861|13103895|P2|NOT COMPLETED|Overall Study||17
5328199|NCT00380861|13103896|P1|NOT COMPLETED|Overall Study||18
5328200|NCT00380861|13103895|P2|COMPLETED|Overall Study||74
5328201|NCT00380861|13103896|P1|COMPLETED|Overall Study||75
5328202|NCT00380861|13103895|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
5328203|NCT00380861|13103896|P1|STARTED|Overall Study||93
5328204|NCT00380744|13103909|P7|NOT COMPLETED|Overall Study||1
5328205|NCT00380744|13103910|P6|NOT COMPLETED|Overall Study||0
5328206|NCT00380744|13103911|P5|NOT COMPLETED|Overall Study||0
5328207|NCT00380744|13103912|P4|NOT COMPLETED|Overall Study||0
5328208|NCT00380744|13103913|P3|NOT COMPLETED|Overall Study||0
5328209|NCT00380744|13103914|P2|NOT COMPLETED|Overall Study||0
5328210|NCT00380744|13103915|P1|NOT COMPLETED|Overall Study||1
5328211|NCT00380744|13103909|P7|COMPLETED|Overall Study||24
5328212|NCT00380744|13103910|P6|COMPLETED|Overall Study||25
5328213|NCT00380744|13103911|P5|COMPLETED|Overall Study||23
5328214|NCT00380744|13103912|P4|COMPLETED|Overall Study||4
5328215|NCT00380744|13103913|P3|COMPLETED|Overall Study||20
5328216|NCT00380744|13103914|P2|COMPLETED|Overall Study||4
5328217|NCT00380744|13103915|P1|COMPLETED|Overall Study||19
5328218|NCT00380744|13103909|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
5328219|NCT00380744|13103910|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
5328220|NCT00380744|13103911|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
5328221|NCT00380744|13103912|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
5328222|NCT00380744|13103913|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
5328223|NCT00380744|13103914|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
5328224|NCT00380744|13103915|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
5328225|NCT00380744|13103909|P7|STARTED|Overall Study||25
5328226|NCT00380744|13103910|P6|STARTED|Overall Study||25
5328227|NCT00380744|13103911|P5|STARTED|Overall Study||23
5328228|NCT00380744|13103912|P4|STARTED|Overall Study||4
5328229|NCT00380744|13103913|P3|STARTED|Overall Study||20
5328230|NCT00380744|13103914|P2|STARTED|Overall Study||4
5328231|NCT00380744|13103915|P1|STARTED|Overall Study||20
5328232|NCT00380718|13103965|P1|NOT COMPLETED|Overall Study||18
5328233|NCT00380718|13103965|P1|COMPLETED|Overall Study||15
5328234|NCT00380718|13103965|P1|Received Escalated Dose in Cycle 2|Overall Study||25
5328325|NCT00379821|13104313|P4|STARTED|Overall Study||160
5328235|NCT00380718|13103965|P1|Received at Least One Dose of Study Drug|Overall Study||33
5328236|NCT00380718|13103965|P1|STARTED|Overall Study||33
5328237|NCT00380692|13103977|P2|NOT COMPLETED|Study Period III - Open Label||12
5328238|NCT00380692|13103978|P1|NOT COMPLETED|Study Period III - Open Label||6
5328239|NCT00380692|13103977|P2|COMPLETED|Study Period III - Open Label||34
5328240|NCT00380692|13103978|P1|COMPLETED|Study Period III - Open Label||36
5328241|NCT00380692|13103977|P2|STARTED|Study Period III - Open Label||46
5328242|NCT00380692|13103978|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
5328243|NCT00380692|13103977|P2|NOT COMPLETED|Study Period II - Double Blind||3
5328244|NCT00380692|13103978|P1|NOT COMPLETED|Study Period II - Double Blind||5
5328245|NCT00380692|13103977|P2|COMPLETED|Study Period II - Double Blind||46
5328246|NCT00380692|13103978|P1|COMPLETED|Study Period II - Double Blind||43
5328247|NCT00380692|13103977|P2|STARTED|Study Period II - Double Blind||49
5328248|NCT00380692|13103978|P1|STARTED|Study Period II - Double Blind||48
5328249|NCT00380588|13104026|P2|NOT COMPLETED|Overall Study||40
5328250|NCT00380588|13104027|P1|NOT COMPLETED|Overall Study||39
5328251|NCT00380588|13104026|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
5328252|NCT00380588|13104027|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
5328253|NCT00380588|13104026|P2|Received at Least One Dose of Study Drug|Overall Study||42
5328254|NCT00380588|13104027|P1|Received at Least One Dose of Study Drug|Overall Study||41
5328255|NCT00380588|13104026|P2|STARTED|Overall Study||42
5328256|NCT00380588|13104027|P1|STARTED|Overall Study||42
5328257|NCT00380393|13104041|P2|NOT COMPLETED|Month 14||56
5328258|NCT00380393|13104042|P1|NOT COMPLETED|Month 14||57
5328259|NCT00380393|13104041|P2|COMPLETED|Month 14||391
5328260|NCT00380393|13104042|P1|COMPLETED|Month 14||390
5328261|NCT00380393|13104041|P2|STARTED|Month 14||447
5328262|NCT00380393|13104042|P1|STARTED|Month 14||447
5328263|NCT00380393|13104041|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
5328264|NCT00380393|13104042|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
5328265|NCT00380393|13104041|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
5328266|NCT00380393|13104042|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
5328267|NCT00380393|13104041|P2|STARTED|Month 8 (Cross-sectional Visit)||447
5328268|NCT00380393|13104042|P1|STARTED|Month 8 (Cross-sectional Visit)||447
5328269|NCT00380367|13104090|P1|NOT COMPLETED|Overall Study||2
5328270|NCT00380367|13104090|P1|COMPLETED|Overall Study||108
5328271|NCT00380367|13104090|P1|STARTED|Overall Study||110
5328272|NCT00380250|13104097|P2|NOT COMPLETED|Overall Study||55
5328273|NCT00380250|13104098|P1|NOT COMPLETED|Overall Study||99
5328274|NCT00380250|13104097|P2|COMPLETED|Overall Study||139
5328275|NCT00380250|13104098|P1|COMPLETED|Overall Study||297
5328276|NCT00380250|13104097|P2|STARTED|Overall Study||194
5328277|NCT00380250|13104098|P1|STARTED|Overall Study||396
5328278|NCT00380081|13104166|P6|NOT COMPLETED|Overall Study||1
5328279|NCT00380081|13104167|P5|NOT COMPLETED|Overall Study||1
5328280|NCT00380081|13104168|P4|NOT COMPLETED|Overall Study||0
5328281|NCT00380081|13104169|P3|NOT COMPLETED|Overall Study||0
5328282|NCT00380081|13104170|P2|NOT COMPLETED|Overall Study||0
5328283|NCT00380081|13104171|P1|NOT COMPLETED|Overall Study||0
5328284|NCT00380081|13104166|P6|COMPLETED|Overall Study||13
5328285|NCT00380081|13104167|P5|COMPLETED|Overall Study||12
5328286|NCT00380081|13104168|P4|COMPLETED|Overall Study||15
5328287|NCT00380081|13104169|P3|COMPLETED|Overall Study||13
5328288|NCT00380081|13104170|P2|COMPLETED|Overall Study||13
5328289|NCT00380081|13104171|P1|COMPLETED|Overall Study||14
5328290|NCT00380081|13104166|P6|STARTED|Overall Study||14
5328291|NCT00380081|13104167|P5|STARTED|Overall Study||13
5328292|NCT00380081|13104168|P4|STARTED|Overall Study||15
5328293|NCT00380081|13104169|P3|STARTED|Overall Study||13
5328294|NCT00380081|13104170|P2|STARTED|Overall Study||13
5328295|NCT00380081|13104171|P1|STARTED|Overall Study||14
5328296|NCT00380068|13104221|P1|NOT COMPLETED|Overall Study||69
5328297|NCT00380068|13104221|P1|COMPLETED|Overall Study||155
5328298|NCT00380068|13104221|P1|STARTED|Overall Study||224
5328299|NCT00380029|13104241|P1|NOT COMPLETED|Overall Study||0
5328300|NCT00380029|13104241|P1|COMPLETED|Overall Study||20
5328301|NCT00380029|13104241|P1|STARTED|Overall Study||20
5328302|NCT00379912|13104253|P2|NOT COMPLETED|Overall Study||0
5328303|NCT00379912|13104254|P1|NOT COMPLETED|Overall Study||1
5328304|NCT00379912|13104253|P2|COMPLETED|Overall Study||8
5328305|NCT00379912|13104254|P1|COMPLETED|Overall Study||6
5328306|NCT00379912|13104253|P2|STARTED|Overall Study||8
5328307|NCT00379912|13104254|P1|STARTED|Overall Study||7
5328308|NCT00379899|13104276|P2|NOT COMPLETED|Overall Study||40
5328309|NCT00379899|13104277|P1|NOT COMPLETED|Overall Study||40
5328310|NCT00379899|13104276|P2|COMPLETED|Overall Study||140
5328311|NCT00379899|13104277|P1|COMPLETED|Overall Study||140
5328312|NCT00379899|13104276|P2|STARTED|Overall Study||180
5328313|NCT00379899|13104277|P1|STARTED|Overall Study||180
5328314|NCT00379834|13104305|P1|NOT COMPLETED|Overall Study||2
5328315|NCT00379834|13104305|P1|COMPLETED|Overall Study||8
5328316|NCT00379834|13104305|P1|STARTED|Overall Study||10
5328317|NCT00379821|13104313|P4|NOT COMPLETED|Overall Study||79
5328318|NCT00379821|13104314|P3|NOT COMPLETED|Overall Study||67
5328319|NCT00379821|13104315|P2|NOT COMPLETED|Overall Study||89
5328320|NCT00379821|13104316|P1|NOT COMPLETED|Overall Study||73
5328321|NCT00379821|13104313|P4|COMPLETED|Overall Study||81
5328322|NCT00379821|13104314|P3|COMPLETED|Overall Study||93
5328323|NCT00379821|13104315|P2|COMPLETED|Overall Study||71
5328324|NCT00379821|13104316|P1|COMPLETED|Overall Study||87
5328326|NCT00379821|13104314|P3|STARTED|Overall Study||160
5328327|NCT00379821|13104315|P2|STARTED|Overall Study||160
5328328|NCT00379821|13104316|P1|STARTED|Overall Study||160
5328329|NCT00379808|13104457|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
5328330|NCT00379808|13104458|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
5328331|NCT00379808|13104457|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
5328332|NCT00379808|13104458|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
5328333|NCT00379808|13104457|P2|STARTED|Intervention Period 2 (4 Weeks)||11
5328334|NCT00379808|13104458|P1|STARTED|Intervention Period 2 (4 Weeks)||11
5328335|NCT00379808|13104457|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
5328336|NCT00379808|13104458|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
5328337|NCT00379808|13104457|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
5328338|NCT00379808|13104458|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
5328339|NCT00379808|13104457|P2|STARTED|Intervention Period 1 (4 Weeks)||11
5328340|NCT00379808|13104458|P1|STARTED|Intervention Period 1 (4 Weeks)||11
5328341|NCT00379795|13104479|P5|NOT COMPLETED|Overall Study||49
5328342|NCT00379795|13104480|P4|NOT COMPLETED|Overall Study||68
5328343|NCT00379795|13104481|P3|NOT COMPLETED|Overall Study||93
5328344|NCT00379795|13104482|P2|NOT COMPLETED|Overall Study||51
5328345|NCT00379795|13104483|P1|NOT COMPLETED|Overall Study||476
5328346|NCT00379795|13104479|P5|COMPLETED|Overall Study||14
5328347|NCT00379795|13104480|P4|COMPLETED|Overall Study||6
5328348|NCT00379795|13104481|P3|COMPLETED|Overall Study||23
5328349|NCT00379795|13104482|P2|COMPLETED|Overall Study||23
5328350|NCT00379795|13104483|P1|COMPLETED|Overall Study||50
5328351|NCT00379795|13104479|P5|Received Ranibizumab in Extension Study|Overall Study||0
5328352|NCT00379795|13104480|P4|Received Ranibizumab in Extension Study|Overall Study||55
5328353|NCT00379795|13104481|P3|Received Ranibizumab in Extension Study|Overall Study||113
5328354|NCT00379795|13104482|P2|Received Ranibizumab in Extension Study|Overall Study||41
5328355|NCT00379795|13104483|P1|Received Ranibizumab in Extension Study|Overall Study||377
5328356|NCT00379795|13104479|P5|STARTED|Overall Study||63
5328357|NCT00379795|13104480|P4|STARTED|Overall Study||74
5328358|NCT00379795|13104481|P3|STARTED|Overall Study||116
5328359|NCT00379795|13104482|P2|STARTED|Overall Study||74
5328360|NCT00379795|13104483|P1|STARTED|Overall Study||526
5328361|NCT00379769|13104513|P6|NOT COMPLETED|Observational Follow-up||148
5328362|NCT00379769|13104514|P5|NOT COMPLETED|Observational Follow-up||149
5328363|NCT00379769|13104515|P4|NOT COMPLETED|Observational Follow-up||0
5328364|NCT00379769|13104516|P3|NOT COMPLETED|Observational Follow-up||0
5328365|NCT00379769|13104517|P2|NOT COMPLETED|Observational Follow-up||0
5328366|NCT00379769|13104518|P1|NOT COMPLETED|Observational Follow-up||0
5328367|NCT00379769|13104513|P6|COMPLETED|Observational Follow-up||1102
5328368|NCT00379769|13104514|P5|COMPLETED|Observational Follow-up||1131
5328369|NCT00379769|13104515|P4|COMPLETED|Observational Follow-up||0
5328370|NCT00379769|13104516|P3|COMPLETED|Observational Follow-up||0
5328371|NCT00379769|13104517|P2|COMPLETED|Observational Follow-up||0
5328372|NCT00379769|13104518|P1|COMPLETED|Observational Follow-up||0
5328373|NCT00379769|13104513|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
5328374|NCT00379769|13104514|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
5328375|NCT00379769|13104515|P4|STARTED|Observational Follow-up||0
5328376|NCT00379769|13104516|P3|STARTED|Observational Follow-up||0
5328377|NCT00379769|13104517|P2|STARTED|Observational Follow-up||0
5328378|NCT00379769|13104518|P1|STARTED|Observational Follow-up||0
5328379|NCT00379769|13104513|P6|NOT COMPLETED|Main Study||0
5328380|NCT00379769|13104514|P5|NOT COMPLETED|Main Study||0
5328381|NCT00379769|13104515|P4|NOT COMPLETED|Main Study||230
5328382|NCT00379769|13104516|P3|NOT COMPLETED|Main Study||207
5328383|NCT00379769|13104517|P2|NOT COMPLETED|Main Study||199
5328384|NCT00379769|13104518|P1|NOT COMPLETED|Main Study||178
5328385|NCT00379769|13104513|P6|COMPLETED|Main Study||0
5328386|NCT00379769|13104514|P5|COMPLETED|Main Study||0
5328387|NCT00379769|13104515|P4|COMPLETED|Main Study||892
5328388|NCT00379769|13104516|P3|COMPLETED|Main Study||896
5328389|NCT00379769|13104517|P2|COMPLETED|Main Study||906
5328390|NCT00379769|13104518|P1|COMPLETED|Main Study||939
5328391|NCT00379769|13104513|P6|STARTED|Main Study||0
5328392|NCT00379769|13104514|P5|STARTED|Main Study||0
5328393|NCT00379769|13104515|P4|STARTED|Main Study||1122
5328394|NCT00379769|13104516|P3|STARTED|Main Study||1103
5328395|NCT00379769|13104517|P2|STARTED|Main Study||1105
5328396|NCT00379769|13104518|P1|STARTED|Main Study||1117
5328397|NCT00379639|13104677|P5|NOT COMPLETED|Overall Study||6
5328398|NCT00379639|13104678|P4|NOT COMPLETED|Overall Study||6
5328399|NCT00379639|13104679|P3|NOT COMPLETED|Overall Study||9
5328400|NCT00379639|13104680|P2|NOT COMPLETED|Overall Study||5
5328401|NCT00379639|13104681|P1|NOT COMPLETED|Overall Study||3
5328402|NCT00379639|13104677|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
5328403|NCT00379639|13104678|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
5328404|NCT00379639|13104679|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
5328405|NCT00379639|13104680|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
5328406|NCT00379639|13104681|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
5328407|NCT00379639|13104677|P5|Completed 6 Cycles of Therapy|Overall Study||0
5328408|NCT00379639|13104678|P4|Completed 6 Cycles of Therapy|Overall Study||0
5328409|NCT00379639|13104679|P3|Completed 6 Cycles of Therapy|Overall Study||1
5328410|NCT00379639|13104680|P2|Completed 6 Cycles of Therapy|Overall Study||2
5328411|NCT00379639|13104681|P1|Completed 6 Cycles of Therapy|Overall Study||4
5328412|NCT00379639|13104677|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
5328413|NCT00379639|13104678|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
5328414|NCT00379639|13104679|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
5328415|NCT00379639|13104680|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
5328416|NCT00379639|13104681|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
5328417|NCT00379639|13104677|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
5328418|NCT00379639|13104678|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
5328419|NCT00379639|13104679|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
5328420|NCT00379639|13104680|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
5328421|NCT00379639|13104681|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
5328422|NCT00379587|13104703|P1|NOT COMPLETED|Overall Study||2
5328423|NCT00379587|13104703|P1|COMPLETED|Overall Study||63
5328424|NCT00379587|13104703|P1|STARTED|Overall Study||65
5328425|NCT00379574|13104710|P1|NOT COMPLETED|Overall Study||0
5328426|NCT00379574|13104710|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
5328427|NCT00379574|13104710|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
5328428|NCT00379353|13104717|P2|NOT COMPLETED|Overall Study||6
5328429|NCT00379353|13104718|P1|NOT COMPLETED|Overall Study||11
5328430|NCT00379353|13104717|P2|COMPLETED|Overall Study||9
5328431|NCT00379353|13104718|P1|COMPLETED|Overall Study||5
5328432|NCT00379353|13104717|P2|STARTED|Overall Study||15
5328433|NCT00379353|13104718|P1|STARTED|Overall Study||16
5328434|NCT00379340|13104753|P5|NOT COMPLETED|Overall Study||14
5328435|NCT00379340|13104754|P4|NOT COMPLETED|Overall Study||13
5328436|NCT00379340|13104755|P3|NOT COMPLETED|Overall Study||2
5328437|NCT00379340|13104756|P2|NOT COMPLETED|Overall Study||3
5328438|NCT00379340|13104757|P1|NOT COMPLETED|Overall Study||13
5328439|NCT00379340|13104753|P5|COMPLETED|Overall Study||9
5328440|NCT00379340|13104754|P4|COMPLETED|Overall Study||37
5328441|NCT00379340|13104755|P3|COMPLETED|Overall Study||50
5328442|NCT00379340|13104756|P2|COMPLETED|Overall Study||132
5328443|NCT00379340|13104757|P1|COMPLETED|Overall Study||107
5328444|NCT00379340|13104753|P5|STARTED|Overall Study||23
5328445|NCT00379340|13104754|P4|STARTED|Overall Study||50
5328446|NCT00379340|13104755|P3|STARTED|Overall Study||52
5328447|NCT00379340|13104756|P2|STARTED|Overall Study||135
5328448|NCT00379340|13104757|P1|STARTED|Overall Study||120
5328449|NCT00379288|13104774|P4|NOT COMPLETED|Overall Study||8
5328450|NCT00379288|13104775|P3|NOT COMPLETED|Overall Study||10
5328451|NCT00379288|13104776|P2|NOT COMPLETED|Overall Study||22
5328452|NCT00379288|13104777|P1|NOT COMPLETED|Overall Study||19
5328453|NCT00379288|13104774|P4|COMPLETED|Overall Study||57
5328454|NCT00379288|13104775|P3|COMPLETED|Overall Study||58
5328455|NCT00379288|13104776|P2|COMPLETED|Overall Study||108
5328456|NCT00379288|13104777|P1|COMPLETED|Overall Study||122
5328457|NCT00379288|13104774|P4|STARTED|Overall Study||65
5328458|NCT00379288|13104775|P3|STARTED|Overall Study||68
5328459|NCT00379288|13104776|P2|STARTED|Overall Study||130
5328460|NCT00379288|13104777|P1|STARTED|Overall Study||141
5328461|NCT00379236|13104789|P3|NOT COMPLETED|Open-label Extension||55
5328462|NCT00379236|13104790|P2|NOT COMPLETED|Open-label Extension||0
5328463|NCT00379236|13104791|P1|NOT COMPLETED|Open-label Extension||0
5328464|NCT00379236|13104789|P3|COMPLETED|Open-label Extension||378
5328465|NCT00379236|13104790|P2|COMPLETED|Open-label Extension||0
5328466|NCT00379236|13104791|P1|COMPLETED|Open-label Extension||0
5328467|NCT00379236|13104789|P3|STARTED|Open-label Extension||433
5328468|NCT00379236|13104790|P2|STARTED|Open-label Extension||0
5328469|NCT00379236|13104791|P1|STARTED|Open-label Extension||0
5328470|NCT00379236|13104789|P3|NOT COMPLETED|Double-blind||0
5328471|NCT00379236|13104790|P2|NOT COMPLETED|Double-blind||36
5328472|NCT00379236|13104791|P1|NOT COMPLETED|Double-blind||36
5328473|NCT00379236|13104789|P3|COMPLETED|Double-blind||0
5328474|NCT00379236|13104790|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
5328475|NCT00379236|13104791|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
5328476|NCT00379236|13104789|P3|STARTED|Double-blind||0
5328477|NCT00379236|13104790|P2|STARTED|Double-blind||295
5328478|NCT00379236|13104791|P1|STARTED|Double-blind||293
5328479|NCT00379210|13104836|P2|NOT COMPLETED|Overall Study||7
5328480|NCT00379210|13104837|P1|NOT COMPLETED|Overall Study||10
5328481|NCT00379210|13104836|P2|COMPLETED|Overall Study||23
5328482|NCT00379210|13104837|P1|COMPLETED|Overall Study||20
5328483|NCT00379210|13104836|P2|STARTED|Overall Study||30
5328484|NCT00379210|13104837|P1|STARTED|Overall Study||30
5328485|NCT00379197|13104843|P1|NOT COMPLETED|Overall Study||5
5328486|NCT00379197|13104843|P1|COMPLETED|Overall Study||8
5328487|NCT00379197|13104843|P1|STARTED|Overall Study||13
5328488|NCT00379145|13104848|P1|NOT COMPLETED|Overall Study||0
5328489|NCT00379145|13104848|P1|COMPLETED|Overall Study||20
5328490|NCT00379145|13104848|P1|STARTED|Overall Study||20
5328491|NCT00379080|13104860|P3|NOT COMPLETED|Overall Study||0
5328492|NCT00379080|13104861|P2|NOT COMPLETED|Overall Study||4
5328493|NCT00379080|13104862|P1|NOT COMPLETED|Overall Study||0
5328494|NCT00379080|13104860|P3|COMPLETED|Overall Study||31
5328495|NCT00379080|13104861|P2|COMPLETED|Overall Study||15
5328496|NCT00379080|13104862|P1|COMPLETED|Overall Study||6
5328497|NCT00379080|13104860|P3|STARTED|Overall Study||31
5328498|NCT00379080|13104861|P2|STARTED|Overall Study||19
5328499|NCT00379080|13104862|P1|STARTED|Overall Study||6
5328500|NCT00378898|13104907|P2|NOT COMPLETED|Overall Study||6
5328501|NCT00378898|13104908|P1|NOT COMPLETED|Overall Study||11
5328502|NCT00378898|13104907|P2|COMPLETED|Overall Study||11
5328503|NCT00378898|13104908|P1|COMPLETED|Overall Study||11
5328504|NCT00378898|13104907|P2|STARTED|Overall Study||17
5328505|NCT00378898|13104908|P1|STARTED|Overall Study||22
5328506|NCT00378703|13104920|P4|NOT COMPLETED|Overall Study||91
5328507|NCT00378703|13104921|P3|NOT COMPLETED|Overall Study||90
5328508|NCT00378703|13104922|P2|NOT COMPLETED|Overall Study||91
5328509|NCT00378703|13104923|P1|NOT COMPLETED|Overall Study||89
5328510|NCT00378703|13104920|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
5328511|NCT00378703|13104921|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
5328512|NCT00378703|13104922|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
5328513|NCT00378703|13104923|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
5328514|NCT00378703|13104920|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
5328515|NCT00378703|13104921|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
5328516|NCT00378703|13104922|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
5328517|NCT00378703|13104923|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
5328518|NCT00378703|13104920|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
5328519|NCT00378703|13104921|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
5328520|NCT00378703|13104922|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
5328521|NCT00378703|13104923|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
5328522|NCT00378703|13104920|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
5328523|NCT00378703|13104921|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
5328524|NCT00378703|13104922|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
5328525|NCT00378703|13104923|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
5328526|NCT00378599|13104945|P1|NOT COMPLETED|Overall Study||52
5328527|NCT00378599|13104945|P1|COMPLETED|Overall Study||73
5328528|NCT00378599|13104945|P1|STARTED|Overall Study||125
5328529|NCT00378573|13104949|P1|NOT COMPLETED|Follow-up||14
5328530|NCT00378573|13104949|P1|COMPLETED|Follow-up||3
5328531|NCT00378573|13104949|P1|STARTED|Follow-up||17
5328532|NCT00378573|13104949|P1|NOT COMPLETED|Treatment Period||17
5328533|NCT00378573|13104949|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
5328534|NCT00378573|13104949|P1|STARTED|Treatment Period||17
5328535|NCT00378560|13104957|P2|NOT COMPLETED|Overall Study||58
5328536|NCT00378560|13104958|P1|NOT COMPLETED|Overall Study||56
5328537|NCT00378560|13104957|P2|COMPLETED|Overall Study||454
5328538|NCT00378560|13104958|P1|COMPLETED|Overall Study||453
5328539|NCT00378560|13104957|P2|Vaccinated|Overall Study||512
5328540|NCT00378560|13104958|P1|Vaccinated|Overall Study||509
5328541|NCT00378560|13104957|P2|STARTED|Overall Study||512
5328542|NCT00378560|13104958|P1|STARTED|Overall Study||509
5328543|NCT00378534|13104972|P1|NOT COMPLETED|Overall Study||60
5328544|NCT00378534|13104972|P1|COMPLETED|Overall Study|Transplantation Recipients|55
5328545|NCT00378534|13104972|P1|STARTED|Overall Study||115
5328546|NCT00378508|13104978|P2|NOT COMPLETED|Overall Study||3
5328547|NCT00378508|13104979|P1|NOT COMPLETED|Overall Study||2
5328548|NCT00378508|13104978|P2|COMPLETED|Overall Study||31
5328549|NCT00378508|13104979|P1|COMPLETED|Overall Study||27
5328550|NCT00378508|13104978|P2|Received Intervention/Placebo|Overall Study||31
5328551|NCT00378508|13104979|P1|Received Intervention/Placebo|Overall Study||28
5328552|NCT00378508|13104978|P2|Randomized|Overall Study||34
5328553|NCT00378508|13104979|P1|Randomized|Overall Study||29
5328554|NCT00378508|13104978|P2|STARTED|Overall Study||34
5328555|NCT00378508|13104979|P1|STARTED|Overall Study||29
5328556|NCT00378378|13104998|P3|NOT COMPLETED|Overall Study||2
5328557|NCT00378378|13104999|P2|NOT COMPLETED|Overall Study||1
5328558|NCT00378378|13105000|P1|NOT COMPLETED|Overall Study||0
5328559|NCT00378378|13104998|P3|COMPLETED|Overall Study||24
5328560|NCT00378378|13104999|P2|COMPLETED|Overall Study||49
5328561|NCT00378378|13105000|P1|COMPLETED|Overall Study||51
5328562|NCT00378378|13104998|P3|STARTED|Overall Study||26
5328563|NCT00378378|13104999|P2|STARTED|Overall Study||50
5328564|NCT00378378|13105000|P1|STARTED|Overall Study||51
5328565|NCT00378352|13105013|P6|NOT COMPLETED|Efficacy Phase||7
5328566|NCT00378352|13105014|P5|NOT COMPLETED|Efficacy Phase||11
5328567|NCT00378352|13105015|P4|NOT COMPLETED|Efficacy Phase||0
5328568|NCT00378352|13105016|P3|NOT COMPLETED|Efficacy Phase||0
5328569|NCT00378352|13105017|P2|NOT COMPLETED|Efficacy Phase||0
5328570|NCT00378352|13105018|P1|NOT COMPLETED|Efficacy Phase||0
5328571|NCT00378352|13105013|P6|COMPLETED|Efficacy Phase||59
5328572|NCT00378352|13105014|P5|COMPLETED|Efficacy Phase||54
5328573|NCT00378352|13105015|P4|COMPLETED|Efficacy Phase||0
5328574|NCT00378352|13105016|P3|COMPLETED|Efficacy Phase||0
5328575|NCT00378352|13105017|P2|COMPLETED|Efficacy Phase||0
5328576|NCT00378352|13105018|P1|COMPLETED|Efficacy Phase||0
5328577|NCT00378352|13105013|P6|Safety Analysis|Efficacy Phase||64
5328578|NCT00378352|13105014|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
5328579|NCT00378352|13105015|P4|Safety Analysis|Efficacy Phase||0
5328580|NCT00378352|13105016|P3|Safety Analysis|Efficacy Phase||0
5328581|NCT00378352|13105017|P2|Safety Analysis|Efficacy Phase||0
5328582|NCT00378352|13105018|P1|Safety Analysis|Efficacy Phase||0
5328583|NCT00378352|13105013|P6|STARTED|Efficacy Phase||66
5328584|NCT00378352|13105014|P5|STARTED|Efficacy Phase||65
5328585|NCT00378352|13105015|P4|STARTED|Efficacy Phase||0
5328586|NCT00378352|13105016|P3|STARTED|Efficacy Phase||0
5328587|NCT00378352|13105017|P2|STARTED|Efficacy Phase||0
5328588|NCT00378352|13105018|P1|STARTED|Efficacy Phase||0
5328589|NCT00378352|13105013|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
5328590|NCT00378352|13105014|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
5328591|NCT00378352|13105015|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
5328592|NCT00378352|13105016|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
5328593|NCT00378352|13105017|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
5328594|NCT00378352|13105018|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
5328595|NCT00378352|13105013|P6|COMPLETED|Dose Escalation 60,000 Units||0
5328596|NCT00378352|13105014|P5|COMPLETED|Dose Escalation 60,000 Units||0
5328597|NCT00378352|13105015|P4|COMPLETED|Dose Escalation 60,000 Units||10
5328598|NCT00378352|13105016|P3|COMPLETED|Dose Escalation 60,000 Units||17
5328599|NCT00378352|13105017|P2|COMPLETED|Dose Escalation 60,000 Units||0
5328600|NCT00378352|13105018|P1|COMPLETED|Dose Escalation 60,000 Units||0
5328601|NCT00378352|13105013|P6|Safety Analysis|Dose Escalation 60,000 Units||0
5328602|NCT00378352|13105014|P5|Safety Analysis|Dose Escalation 60,000 Units||0
5328603|NCT00378352|13105015|P4|Safety Analysis|Dose Escalation 60,000 Units||11
5328604|NCT00378352|13105016|P3|Safety Analysis|Dose Escalation 60,000 Units||19
5328605|NCT00378352|13105017|P2|Safety Analysis|Dose Escalation 60,000 Units||0
5328606|NCT00378352|13105018|P1|Safety Analysis|Dose Escalation 60,000 Units||0
5328607|NCT00378352|13105013|P6|STARTED|Dose Escalation 60,000 Units||0
5328608|NCT00378352|13105014|P5|STARTED|Dose Escalation 60,000 Units||0
5328609|NCT00378352|13105015|P4|STARTED|Dose Escalation 60,000 Units||11
5328610|NCT00378352|13105016|P3|STARTED|Dose Escalation 60,000 Units||20
5328611|NCT00378352|13105017|P2|STARTED|Dose Escalation 60,000 Units||0
5328612|NCT00378352|13105018|P1|STARTED|Dose Escalation 60,000 Units||0
5328613|NCT00378352|13105013|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
5328614|NCT00378352|13105014|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
5328615|NCT00378352|13105015|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
5328616|NCT00378352|13105016|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
5328617|NCT00378352|13105017|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
5328618|NCT00378352|13105018|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
5328619|NCT00378352|13105013|P6|COMPLETED|Dose Escalation 30,000 Units||0
5328620|NCT00378352|13105014|P5|COMPLETED|Dose Escalation 30,000 Units||0
5328621|NCT00378352|13105015|P4|COMPLETED|Dose Escalation 30,000 Units||9
5328622|NCT00378352|13105016|P3|COMPLETED|Dose Escalation 30,000 Units||0
5328623|NCT00378352|13105017|P2|COMPLETED|Dose Escalation 30,000 Units||16
5328624|NCT00378352|13105018|P1|COMPLETED|Dose Escalation 30,000 Units||0
5328625|NCT00378352|13105013|P6|Safety Analysis|Dose Escalation 30,000 Units||0
5328626|NCT00378352|13105014|P5|Safety Analysis|Dose Escalation 30,000 Units||0
5328627|NCT00378352|13105015|P4|Safety Analysis|Dose Escalation 30,000 Units||11
5328628|NCT00378352|13105016|P3|Safety Analysis|Dose Escalation 30,000 Units||0
5328629|NCT00378352|13105017|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
5328630|NCT00378352|13105018|P1|Safety Analysis|Dose Escalation 30,000 Units||0
5328631|NCT00378352|13105013|P6|STARTED|Dose Escalation 30,000 Units||0
5328632|NCT00378352|13105014|P5|STARTED|Dose Escalation 30,000 Units||0
5328633|NCT00378352|13105015|P4|STARTED|Dose Escalation 30,000 Units||11
5328634|NCT00378352|13105016|P3|STARTED|Dose Escalation 30,000 Units||0
5328635|NCT00378352|13105017|P2|STARTED|Dose Escalation 30,000 Units||19
5328636|NCT00378352|13105018|P1|STARTED|Dose Escalation 30,000 Units||0
5328637|NCT00378352|13105013|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
5328638|NCT00378352|13105014|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
5328639|NCT00378352|13105015|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
5328640|NCT00378352|13105016|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
5328641|NCT00378352|13105017|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
5328642|NCT00378352|13105018|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
5328643|NCT00378352|13105013|P6|COMPLETED|Dose Escalation 15,000 Units||0
5328644|NCT00378352|13105014|P5|COMPLETED|Dose Escalation 15,000 Units||0
5328645|NCT00378352|13105015|P4|COMPLETED|Dose Escalation 15,000 Units||10
5328646|NCT00378352|13105016|P3|COMPLETED|Dose Escalation 15,000 Units||0
5328647|NCT00378352|13105017|P2|COMPLETED|Dose Escalation 15,000 Units||0
5328648|NCT00378352|13105018|P1|COMPLETED|Dose Escalation 15,000 Units||15
5328649|NCT00378352|13105013|P6|Safety Analysis|Dose Escalation 15,000 Units||0
5328650|NCT00378352|13105014|P5|Safety Analysis|Dose Escalation 15,000 Units||0
5328651|NCT00378352|13105015|P4|Safety Analysis|Dose Escalation 15,000 Units||11
5328652|NCT00378352|13105016|P3|Safety Analysis|Dose Escalation 15,000 Units||0
5328653|NCT00378352|13105017|P2|Safety Analysis|Dose Escalation 15,000 Units||0
5328654|NCT00378352|13105018|P1|Safety Analysis|Dose Escalation 15,000 Units||19
5328655|NCT00378352|13105013|P6|STARTED|Dose Escalation 15,000 Units||0
5328656|NCT00378352|13105014|P5|STARTED|Dose Escalation 15,000 Units||0
5328657|NCT00378352|13105015|P4|STARTED|Dose Escalation 15,000 Units||11
5328658|NCT00378352|13105016|P3|STARTED|Dose Escalation 15,000 Units||0
5328659|NCT00378352|13105017|P2|STARTED|Dose Escalation 15,000 Units||0
5328660|NCT00378352|13105018|P1|STARTED|Dose Escalation 15,000 Units||20
5328661|NCT00378326|13105040|P1|NOT COMPLETED|Overall Study||0
5328662|NCT00378326|13105040|P1|COMPLETED|Overall Study||26
5328663|NCT00378326|13105040|P1|STARTED|Overall Study||26
5328664|NCT00378209|13105046|P1|NOT COMPLETED|Overall Study||22
5328665|NCT00378209|13105046|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
5328666|NCT00378209|13105046|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
5328667|NCT00378105|13105056|P2|NOT COMPLETED|Overall Study||30
5328668|NCT00378105|13105057|P1|NOT COMPLETED|Overall Study||20
5328669|NCT00378105|13105056|P2|COMPLETED|Overall Study||5
5328670|NCT00378105|13105057|P1|COMPLETED|Overall Study||11
5328671|NCT00378105|13105056|P2|STARTED|Overall Study||35
5328672|NCT00378105|13105057|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
5328673|NCT00378079|13105069|P3|NOT COMPLETED|Overall Study||0
5328674|NCT00378079|13105070|P2|NOT COMPLETED|Overall Study||1
5328675|NCT00378079|13105071|P1|NOT COMPLETED|Overall Study||6
5328676|NCT00378079|13105069|P3|COMPLETED|Overall Study||71
5328677|NCT00378079|13105070|P2|COMPLETED|Overall Study||69
5328678|NCT00378079|13105071|P1|COMPLETED|Overall Study||64
5328679|NCT00378079|13105069|P3|STARTED|Overall Study||71
5328680|NCT00378079|13105070|P2|STARTED|Overall Study||70
5328681|NCT00378079|13105071|P1|STARTED|Overall Study||70
5328682|NCT00378014|13105093|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
5328683|NCT00378014|13105094|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
5328684|NCT00378014|13105093|P2|COMPLETED|Extension (Month 12 to Month 59)||26
5328685|NCT00378014|13105094|P1|COMPLETED|Extension (Month 12 to Month 59)||27
5328686|NCT00378014|13105093|P2|STARTED|Extension (Month 12 to Month 59)||40
5328687|NCT00378014|13105094|P1|STARTED|Extension (Month 12 to Month 59)||41
5328688|NCT00378014|13105093|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
5328689|NCT00378014|13105094|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
5328690|NCT00378014|13105093|P2|COMPLETED|Core (Randomization to Month 11)||90
5328691|NCT00378014|13105094|P1|COMPLETED|Core (Randomization to Month 11)||87
5328692|NCT00378014|13105093|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
5328693|NCT00378014|13105094|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
5328694|NCT00378014|13105093|P2|STARTED|Core (Randomization to Month 11)||102
5328695|NCT00378014|13105094|P1|STARTED|Core (Randomization to Month 11)||101
5328696|NCT00377962|13105120|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
5328697|NCT00377962|13105121|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
5328698|NCT00377962|13105120|P2|COMPLETED|Extension Study: 12-24 Months||123
5328699|NCT00377962|13105121|P1|COMPLETED|Extension Study: 12-24 Months||98
5328700|NCT00377962|13105120|P2|STARTED|Extension Study: 12-24 Months||127
5328701|NCT00377962|13105121|P1|STARTED|Extension Study: 12-24 Months||108
5328702|NCT00377962|13105120|P2|NOT COMPLETED|Core Study: 0-12 Months||9
5328703|NCT00377962|13105121|P1|NOT COMPLETED|Core Study: 0-12 Months||28
5328704|NCT00377962|13105120|P2|COMPLETED|Core Study: 0-12 Months||133
5328705|NCT00377962|13105121|P1|COMPLETED|Core Study: 0-12 Months||112
5328706|NCT00377962|13105120|P2|STARTED|Core Study: 0-12 Months||142
5328707|NCT00377962|13105121|P1|STARTED|Core Study: 0-12 Months||140
5328708|NCT00377858|13105157|P2|NOT COMPLETED|Overall Study||27
5328709|NCT00377858|13105158|P1|NOT COMPLETED|Overall Study||31
5328710|NCT00377858|13105157|P2|COMPLETED|Overall Study||215
5328711|NCT00377858|13105158|P1|COMPLETED|Overall Study||211
5328712|NCT00377858|13105157|P2|Had at Least One Post-Baseline Value|Overall Study||240
5328713|NCT00377858|13105158|P1|Had at Least One Post-Baseline Value|Overall Study||239
5328714|NCT00377858|13105157|P2|STARTED|Overall Study||242
5328715|NCT00377858|13105158|P1|STARTED|Overall Study||242
5328716|NCT00377832|13105188|P2|NOT COMPLETED|Overall Study||0
5328717|NCT00377832|13105189|P1|NOT COMPLETED|Overall Study||0
5328718|NCT00377832|13105188|P2|COMPLETED|Overall Study||6
5328719|NCT00377832|13105189|P1|COMPLETED|Overall Study||7
5328720|NCT00377832|13105188|P2|STARTED|Overall Study||6
5328721|NCT00377832|13105189|P1|STARTED|Overall Study||7
5328722|NCT00377819|13105211|P2|NOT COMPLETED|Overall Study||10
5328723|NCT00377819|13105212|P1|NOT COMPLETED|Overall Study||13
5328724|NCT00377819|13105211|P2|COMPLETED|Overall Study||243
5328725|NCT00377819|13105212|P1|COMPLETED|Overall Study||238
5328726|NCT00377819|13105211|P2|Received Study Medication|Overall Study||253
5328727|NCT00377819|13105212|P1|Received Study Medication|Overall Study||249
5328728|NCT00377819|13105211|P2|STARTED|Overall Study||253
5328729|NCT00377819|13105212|P1|STARTED|Overall Study||251
5328730|NCT00377741|13105224|P2|NOT COMPLETED|Overall Study||0
5328731|NCT00377741|13105225|P1|NOT COMPLETED|Overall Study||0
5328732|NCT00377741|13105224|P2|COMPLETED|Overall Study||15
5328733|NCT00377741|13105225|P1|COMPLETED|Overall Study||16
5328734|NCT00377741|13105224|P2|STARTED|Overall Study||15
5328735|NCT00377741|13105225|P1|STARTED|Overall Study||16
5328736|NCT00377676|13105241|P2|NOT COMPLETED|Overall Study||322
5328737|NCT00377676|13105242|P1|NOT COMPLETED|Overall Study||961
5328738|NCT00377676|13105241|P2|COMPLETED|Overall Study||694
5328739|NCT00377676|13105242|P1|COMPLETED|Overall Study||1093
5328740|NCT00377676|13105241|P2|STARTED|Overall Study||1016
5328741|NCT00377676|13105242|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
5328742|NCT00377637|13105258|P4|NOT COMPLETED|Maintenance Phase||57
5328743|NCT00377637|13105259|P3|NOT COMPLETED|Maintenance Phase||43
5328744|NCT00377637|13105260|P2|NOT COMPLETED|Maintenance Phase||0
5328745|NCT00377637|13105261|P1|NOT COMPLETED|Maintenance Phase||0
5328746|NCT00377637|13105258|P4|COMPLETED|Maintenance Phase||54
5328747|NCT00377637|13105259|P3|COMPLETED|Maintenance Phase||73
5328748|NCT00377637|13105260|P2|COMPLETED|Maintenance Phase||0
5328749|NCT00377637|13105261|P1|COMPLETED|Maintenance Phase||0
5328750|NCT00377637|13105258|P4|STARTED|Maintenance Phase||111
5328751|NCT00377637|13105259|P3|STARTED|Maintenance Phase||116
5328752|NCT00377637|13105260|P2|STARTED|Maintenance Phase||0
5328753|NCT00377637|13105261|P1|STARTED|Maintenance Phase||0
5328754|NCT00377637|13105258|P4|NOT COMPLETED|Induction Phase||0
5328755|NCT00377637|13105259|P3|NOT COMPLETED|Induction Phase||0
5328756|NCT00377637|13105260|P2|NOT COMPLETED|Induction Phase||35
5328757|NCT00377637|13105261|P1|NOT COMPLETED|Induction Phase||29
5328758|NCT00377637|13105258|P4|COMPLETED|Induction Phase||0
5328759|NCT00377637|13105259|P3|COMPLETED|Induction Phase||0
5328760|NCT00377637|13105260|P2|COMPLETED|Induction Phase||150
5328761|NCT00377637|13105261|P1|COMPLETED|Induction Phase||156
5328762|NCT00377637|13105258|P4|Safety Population|Induction Phase||0
5328763|NCT00377637|13105259|P3|Safety Population|Induction Phase||0
5328764|NCT00377637|13105260|P2|Safety Population|Induction Phase||184
5328765|NCT00377637|13105261|P1|Safety Population|Induction Phase||180
5328766|NCT00377637|13105258|P4|STARTED|Induction Phase||0
5328767|NCT00377637|13105259|P3|STARTED|Induction Phase||0
5328768|NCT00377637|13105260|P2|STARTED|Induction Phase|Intent-To-Treat|185
5328769|NCT00377637|13105261|P1|STARTED|Induction Phase|Intent-To-Treat|185
5328770|NCT00377611|13105297|P2|NOT COMPLETED|Overall Study||33
5328771|NCT00377611|13105298|P1|NOT COMPLETED|Overall Study||22
5328772|NCT00377611|13105297|P2|COMPLETED|Overall Study||1974
5328773|NCT00377611|13105298|P1|COMPLETED|Overall Study||1025
5328774|NCT00377611|13105297|P2|STARTED|Overall Study||2007
5328775|NCT00377611|13105298|P1|STARTED|Overall Study||1047
5328776|NCT00377572|13105361|P2|NOT COMPLETED|Overall Study||54
5328777|NCT00377572|13105362|P1|NOT COMPLETED|Overall Study||53
5328778|NCT00377572|13105361|P2|COMPLETED|Overall Study||157
5328779|NCT00377572|13105362|P1|COMPLETED|Overall Study||155
5328780|NCT00377572|13105361|P2|STARTED|Overall Study||211
5328781|NCT00377572|13105362|P1|STARTED|Overall Study||208
5328782|NCT00377520|13105400|P1|NOT COMPLETED|Overall Study||1
5328783|NCT00377520|13105400|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
5328784|NCT00377520|13105400|P1|STARTED|Overall Study||27
5328785|NCT00377455|13105405|P1|NOT COMPLETED|Overall Study||1
5328786|NCT00377455|13105405|P1|COMPLETED|Overall Study||4
5328787|NCT00377455|13105405|P1|STARTED|Overall Study||5
5328788|NCT00377429|13105413|P1|NOT COMPLETED|Overall Study||15
5328789|NCT00377429|13105413|P1|COMPLETED|Overall Study|Completed main study|32
5328790|NCT00377429|13105413|P1|STARTED|Overall Study|Treated|47
5328791|NCT00377403|13105424|P2|NOT COMPLETED|Overall Study||7
5328792|NCT00377403|13105425|P1|NOT COMPLETED|Overall Study||4
5328793|NCT00377403|13105424|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
5328794|NCT00377403|13105425|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
5328795|NCT00377403|13105424|P2|Day 28 Assessment|Overall Study||77
5328796|NCT00377403|13105425|P1|Day 28 Assessment|Overall Study||82
5328797|NCT00377403|13105424|P2|Day 10 Assessment|Overall Study||71
5328798|NCT00377403|13105425|P1|Day 10 Assessment|Overall Study||81
5328799|NCT00377403|13105424|P2|Day 7 Assessment|Overall Study||75
5328800|NCT00377403|13105425|P1|Day 7 Assessment|Overall Study||80
5328801|NCT00377403|13105424|P2|Day -3 Assessment|Overall Study||74
5328802|NCT00377403|13105425|P1|Day -3 Assessment|Overall Study||81
5328803|NCT00377403|13105424|P2|STARTED|Overall Study||81
5328804|NCT00377403|13105425|P1|STARTED|Overall Study||85
5328805|NCT00377364|13105433|P2|NOT COMPLETED|Overall Study||0
5328806|NCT00377364|13105434|P1|NOT COMPLETED|Overall Study||2
5328807|NCT00377364|13105433|P2|COMPLETED|Overall Study||14
5328808|NCT00377364|13105434|P1|COMPLETED|Overall Study||14
5328809|NCT00377364|13105433|P2|STARTED|Overall Study||14
5328810|NCT00377364|13105434|P1|STARTED|Overall Study||16
5328811|NCT00377312|13105460|P2|NOT COMPLETED|Overall Study||1
5328812|NCT00377312|13105461|P1|NOT COMPLETED|Overall Study||1
5328813|NCT00377312|13105460|P2|COMPLETED|Overall Study||4
5328814|NCT00377312|13105461|P1|COMPLETED|Overall Study||5
5328815|NCT00377312|13105460|P2|STARTED|Overall Study||5
5328816|NCT00377312|13105461|P1|STARTED|Overall Study||6
5328817|NCT00377299|13105493|P2|NOT COMPLETED|Overall Study||24
5328818|NCT00377299|13105494|P1|NOT COMPLETED|Overall Study||19
5328819|NCT00377299|13105493|P2|COMPLETED|Overall Study||4
5328820|NCT00377299|13105494|P1|COMPLETED|Overall Study||13
5328821|NCT00377299|13105493|P2|STARTED|Overall Study||28
5328822|NCT00377299|13105494|P1|STARTED|Overall Study||32
5328823|NCT00377260|13105510|P2|NOT COMPLETED|Overall Study||5
5328824|NCT00377260|13105511|P1|NOT COMPLETED|Overall Study||2
5328825|NCT00377260|13105510|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
5328826|NCT00377260|13105511|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
5328827|NCT00377260|13105510|P2|STARTED|Overall Study||147
5328828|NCT00377260|13105511|P1|STARTED|Overall Study||144
5328829|NCT00377234|13105565|P2|NOT COMPLETED|Overall Study||31
5328830|NCT00377234|13105566|P1|NOT COMPLETED|Overall Study||34
5328831|NCT00377234|13105565|P2|COMPLETED|Overall Study||145
5328832|NCT00377234|13105566|P1|COMPLETED|Overall Study||146
5328833|NCT00377234|13105565|P2|Safety Analysis Set: Risedronate|Overall Study||174
5328834|NCT00377234|13105566|P1|Safety Analysis Set: Risedronate|Overall Study||153
5328835|NCT00377234|13105565|P2|Safety Analysis Set: Ibandronate|Overall Study||150
5328836|NCT00377234|13105566|P1|Safety Analysis Set: Ibandronate|Overall Study||177
5328837|NCT00377234|13105565|P2|Safety Analysis Set: Period 2|Overall Study||150
5328838|NCT00377234|13105566|P1|Safety Analysis Set: Period 2|Overall Study||153
5328839|NCT00377234|13105565|P2|Safety Analysis Set: Period 1|Overall Study||174
5328840|NCT00377234|13105566|P1|Safety Analysis Set: Period 1|Overall Study||177
5328841|NCT00377234|13105565|P2|Received Treatment|Overall Study||174
5328842|NCT00377234|13105566|P1|Received Treatment|Overall Study||177
5328843|NCT00377234|13105565|P2|Did Not Receive Study Treatment|Overall Study||2
5328844|NCT00377234|13105566|P1|Did Not Receive Study Treatment|Overall Study||3
5328845|NCT00377234|13105565|P2|Randomized|Overall Study||176
5328846|NCT00377234|13105566|P1|Randomized|Overall Study||180
5328847|NCT00377234|13105565|P2|STARTED|Overall Study||176
5328848|NCT00377234|13105566|P1|STARTED|Overall Study||180
5328849|NCT00377156|13105584|P2|NOT COMPLETED|Overall Study||54
5328850|NCT00377156|13105585|P1|NOT COMPLETED|Overall Study||48
5328851|NCT00377156|13105584|P2|COMPLETED|Overall Study||48
5328852|NCT00377156|13105585|P1|COMPLETED|Overall Study||63
5328853|NCT00377156|13105584|P2|STARTED|Overall Study||102
5328854|NCT00377156|13105585|P1|STARTED|Overall Study||111
5328855|NCT00376961|13105599|P2|NOT COMPLETED|Maintenance||23
5328856|NCT00376961|13105600|P1|NOT COMPLETED|Maintenance||0
5328857|NCT00376961|13105599|P2|COMPLETED|Maintenance||27
5328858|NCT00376961|13105600|P1|COMPLETED|Maintenance||0
5328859|NCT00376961|13105599|P2|Eligible|Maintenance||47
5328860|NCT00376961|13105600|P1|Eligible|Maintenance||0
5328861|NCT00376961|13105599|P2|STARTED|Maintenance||50
5328862|NCT00376961|13105600|P1|STARTED|Maintenance||0
5328863|NCT00376961|13105599|P2|NOT COMPLETED|Initial Registration||0
5328864|NCT00376961|13105600|P1|NOT COMPLETED|Initial Registration||7
5328865|NCT00376961|13105599|P2|COMPLETED|Initial Registration||0
5328866|NCT00376961|13105600|P1|COMPLETED|Initial Registration||61
5328867|NCT00376961|13105599|P2|Eligible|Initial Registration||0
5328868|NCT00376961|13105600|P1|Eligible|Initial Registration||65
5328869|NCT00376961|13105599|P2|STARTED|Initial Registration||0
5328870|NCT00376961|13105600|P1|STARTED|Initial Registration||68
5328871|NCT00376948|13105609|P1|NOT COMPLETED|Overall Study||0
5328872|NCT00376948|13105609|P1|COMPLETED|Overall Study||20
5328873|NCT00376948|13105609|P1|STARTED|Overall Study||20
5328874|NCT00376935|13105618|P4|NOT COMPLETED|Overall Study||0
5328875|NCT00376935|13105619|P3|NOT COMPLETED|Overall Study||0
5328876|NCT00376935|13105620|P2|NOT COMPLETED|Overall Study||0
5328877|NCT00376935|13105621|P1|NOT COMPLETED|Overall Study||0
5328878|NCT00376935|13105618|P4|COMPLETED|Overall Study||24
5328879|NCT00376935|13105619|P3|COMPLETED|Overall Study||25
5328880|NCT00376935|13105620|P2|COMPLETED|Overall Study||25
5328881|NCT00376935|13105621|P1|COMPLETED|Overall Study||25
5328882|NCT00376935|13105618|P4|STARTED|Overall Study||24
5328883|NCT00376935|13105619|P3|STARTED|Overall Study||25
5328884|NCT00376935|13105620|P2|STARTED|Overall Study||25
5328885|NCT00376935|13105621|P1|STARTED|Overall Study||25
5328886|NCT00376805|13105659|P1|NOT COMPLETED|Overall Study||0
5328887|NCT00376805|13105659|P1|COMPLETED|Overall Study||6
5328888|NCT00376805|13105659|P1|STARTED|Overall Study||6
5328889|NCT00376688|13105666|P1|NOT COMPLETED|Overall Study||4
5328890|NCT00376688|13105666|P1|COMPLETED|Overall Study||27
5328891|NCT00376688|13105666|P1|STARTED|Overall Study||31
5328892|NCT00376675|13105672|P2|NOT COMPLETED|Overall Study||14
5328893|NCT00376675|13105673|P1|NOT COMPLETED|Overall Study||20
5328894|NCT00376675|13105672|P2|COMPLETED|Overall Study||56
5328895|NCT00376675|13105673|P1|COMPLETED|Overall Study||49
5328896|NCT00376675|13105672|P2|STARTED|Overall Study||70
5328897|NCT00376675|13105673|P1|STARTED|Overall Study||69
5328898|NCT00376597|13105697|P2|NOT COMPLETED|Overall Study||3
5328899|NCT00376597|13105698|P1|NOT COMPLETED|Overall Study||11
5328900|NCT00376597|13105697|P2|COMPLETED|Overall Study||312
5328901|NCT00376597|13105698|P1|COMPLETED|Overall Study||242
5328902|NCT00376597|13105697|P2|STARTED|Overall Study||315
5328903|NCT00376597|13105698|P1|STARTED|Overall Study||253
5328904|NCT00376558|13105712|P2|NOT COMPLETED|Overall Study||0
5328905|NCT00376558|13105713|P1|NOT COMPLETED|Overall Study||0
5328906|NCT00376558|13105712|P2|COMPLETED|Overall Study||25
5328907|NCT00376558|13105713|P1|COMPLETED|Overall Study||25
5328908|NCT00376558|13105712|P2|STARTED|Overall Study||25
5328909|NCT00376558|13105713|P1|STARTED|Overall Study||25
5328910|NCT00376532|13105722|P2|NOT COMPLETED|Overall Study||6
5328911|NCT00376532|13105723|P1|NOT COMPLETED|Overall Study||6
5328912|NCT00376532|13105722|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
5328913|NCT00376532|13105723|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
5328914|NCT00376532|13105722|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
5328915|NCT00376532|13105723|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
5328916|NCT00376506|13105733|P2|NOT COMPLETED|Overall Study||2
5328917|NCT00376506|13105734|P1|NOT COMPLETED|Overall Study||0
5328918|NCT00376506|13105733|P2|COMPLETED|Overall Study||4
5328919|NCT00376506|13105734|P1|COMPLETED|Overall Study||4
5328920|NCT00376506|13105733|P2|STARTED|Overall Study||6
5328921|NCT00376506|13105734|P1|STARTED|Overall Study||4
5328922|NCT00376363|13105752|P2|NOT COMPLETED|Overall Study||46
5328923|NCT00376363|13105753|P1|NOT COMPLETED|Overall Study||56
5328924|NCT00376363|13105752|P2|COMPLETED|Overall Study||87
5328925|NCT00376363|13105753|P1|COMPLETED|Overall Study||87
5328926|NCT00376363|13105752|P2|STARTED|Overall Study||133
5328927|NCT00376363|13105753|P1|STARTED|Overall Study||143
5328928|NCT00376259|13105765|P2|NOT COMPLETED|Overall Study||21
5328929|NCT00376259|13105766|P1|NOT COMPLETED|Overall Study||22
5328930|NCT00376259|13105765|P2|COMPLETED|Overall Study||0
5328931|NCT00376259|13105766|P1|COMPLETED|Overall Study||0
5328932|NCT00376259|13105765|P2|Received Study Drug|Overall Study||21
5328933|NCT00376259|13105766|P1|Received Study Drug|Overall Study||21
5328934|NCT00376259|13105765|P2|STARTED|Overall Study||21
5328935|NCT00376259|13105766|P1|STARTED|Overall Study||22
5328936|NCT00376246|13105778|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
5328937|NCT00376246|13105779|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
5328938|NCT00376246|13105778|P2|COMPLETED|Second Intervention (2 Weeks)||12
5328939|NCT00376246|13105779|P1|COMPLETED|Second Intervention (2 Weeks)||10
5328940|NCT00376246|13105778|P2|STARTED|Second Intervention (2 Weeks)||12
5328941|NCT00376246|13105779|P1|STARTED|Second Intervention (2 Weeks)||10
5328942|NCT00376246|13105778|P2|NOT COMPLETED|Washout (2 Weeks)||0
5328943|NCT00376246|13105779|P1|NOT COMPLETED|Washout (2 Weeks)||0
5328944|NCT00376246|13105778|P2|COMPLETED|Washout (2 Weeks)||12
5328945|NCT00376246|13105779|P1|COMPLETED|Washout (2 Weeks)||10
5328946|NCT00376246|13105778|P2|STARTED|Washout (2 Weeks)||12
5328947|NCT00376246|13105779|P1|STARTED|Washout (2 Weeks)||10
5328948|NCT00376246|13105778|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
5328949|NCT00376246|13105779|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
5328950|NCT00376246|13105778|P2|COMPLETED|First Intervention (2 Weeks)||12
5328951|NCT00376246|13105779|P1|COMPLETED|First Intervention (2 Weeks)||10
5328952|NCT00376246|13105778|P2|STARTED|First Intervention (2 Weeks)||14
5328953|NCT00376246|13105779|P1|STARTED|First Intervention (2 Weeks)||14
5328954|NCT00376220|13105789|P2|NOT COMPLETED|Overall Study||12
5328955|NCT00376220|13105790|P1|NOT COMPLETED|Overall Study||10
5328956|NCT00376220|13105789|P2|COMPLETED|Overall Study||35
5328957|NCT00376220|13105790|P1|COMPLETED|Overall Study||37
5328958|NCT00376220|13105789|P2|STARTED|Overall Study||47
5328959|NCT00376220|13105790|P1|STARTED|Overall Study||47
5328960|NCT00376168|13105798|P2|NOT COMPLETED|Overall Study||1
5328961|NCT00376168|13105799|P1|NOT COMPLETED|Overall Study||2
5328962|NCT00376168|13105798|P2|COMPLETED|Overall Study||15
5328963|NCT00376168|13105799|P1|COMPLETED|Overall Study||14
5328964|NCT00376168|13105798|P2|STARTED|Overall Study|One patient randomized but not treated|16
5328965|NCT00376168|13105799|P1|STARTED|Overall Study||16
5328966|NCT00375999|13105813|P1|NOT COMPLETED|Overall Study||2
5328967|NCT00375999|13105813|P1|COMPLETED|Overall Study||32
5328968|NCT00375999|13105813|P1|STARTED|Overall Study||34
5328969|NCT00375973|13105819|P2|NOT COMPLETED|Overall Study||2
5328970|NCT00375973|13105820|P1|NOT COMPLETED|Overall Study||10
5328971|NCT00375973|13105819|P2|COMPLETED|Overall Study||28
5328972|NCT00375973|13105820|P1|COMPLETED|Overall Study||20
5328973|NCT00375973|13105819|P2|STARTED|Overall Study||30
5328974|NCT00375973|13105820|P1|STARTED|Overall Study||30
5328975|NCT00375934|13105840|P2|NOT COMPLETED|Overall Study||6
5328976|NCT00375934|13105841|P1|NOT COMPLETED|Overall Study||3
5328977|NCT00375934|13105840|P2|COMPLETED|Overall Study||95
5328978|NCT00375934|13105841|P1|COMPLETED|Overall Study||96
5328979|NCT00375934|13105840|P2|STARTED|Overall Study||101
5328980|NCT00375934|13105841|P1|STARTED|Overall Study||99
5328981|NCT00375830|13105870|P3|NOT COMPLETED|Overall Study||0
5328982|NCT00375830|13105871|P2|NOT COMPLETED|Overall Study||0
5328983|NCT00375830|13105872|P1|NOT COMPLETED|Overall Study||0
5328984|NCT00375830|13105870|P3|COMPLETED|Overall Study||74
5328985|NCT00375830|13105871|P2|COMPLETED|Overall Study||30
5328986|NCT00375830|13105872|P1|COMPLETED|Overall Study||10
5328987|NCT00375830|13105870|P3|STARTED|Overall Study||74
5328988|NCT00375830|13105871|P2|STARTED|Overall Study||30
5328989|NCT00375830|13105872|P1|STARTED|Overall Study||10
5328990|NCT00375752|13105899|P2|NOT COMPLETED|Overall Study||15
5328991|NCT00375752|13105900|P1|NOT COMPLETED|Overall Study||12
5328992|NCT00375752|13105899|P2|COMPLETED|Overall Study||74
5328993|NCT00375752|13105900|P1|COMPLETED|Overall Study||67
5328994|NCT00375752|13105899|P2|STARTED|Overall Study||89
5328995|NCT00375752|13105900|P1|STARTED|Overall Study||79
5328996|NCT00375713|13105916|P2|NOT COMPLETED|Overall Study||23
5328997|NCT00375713|13105917|P1|NOT COMPLETED|Overall Study||20
5328998|NCT00375713|13105916|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
5328999|NCT00375713|13105917|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
5329000|NCT00375713|13105916|P2|STARTED|Overall Study|Randomized population (N=234).|234
5329001|NCT00375713|13105917|P1|STARTED|Overall Study|Randomized population (N=232).|232
5329002|NCT00375674|13105931|P2|NOT COMPLETED|Overall Study||141
5329003|NCT00375674|13105932|P1|NOT COMPLETED|Overall Study||144
5329004|NCT00375674|13105931|P2|COMPLETED|Overall Study||165
5329005|NCT00375674|13105932|P1|COMPLETED|Overall Study||165
5329006|NCT00375674|13105931|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
5329095|NCT00374556|13106253|P1|COMPLETED|Overall Study||13
5329007|NCT00375674|13105932|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
5329008|NCT00375674|13105931|P2|Intent-to-Treat Population|Overall Study||306
5329009|NCT00375674|13105932|P1|Intent-to-Treat Population|Overall Study||309
5329010|NCT00375674|13105931|P2|STARTED|Overall Study||306
5329011|NCT00375674|13105932|P1|STARTED|Overall Study||309
5329012|NCT00375609|13105961|P3|NOT COMPLETED|Overall Study||1
5329013|NCT00375609|13105962|P2|NOT COMPLETED|Overall Study||7
5329014|NCT00375609|13105963|P1|NOT COMPLETED|Overall Study||4
5329015|NCT00375609|13105961|P3|COMPLETED|Overall Study||42
5329016|NCT00375609|13105962|P2|COMPLETED|Overall Study||77
5329017|NCT00375609|13105963|P1|COMPLETED|Overall Study||84
5329018|NCT00375609|13105961|P3|STARTED|Overall Study||43
5329019|NCT00375609|13105962|P2|STARTED|Overall Study||84
5329020|NCT00375609|13105963|P1|STARTED|Overall Study||88
5329021|NCT00375518|13105979|P2|NOT COMPLETED|Overall Study||17
5329022|NCT00375518|13105980|P1|NOT COMPLETED|Overall Study||8
5329023|NCT00375518|13105979|P2|COMPLETED|Overall Study||65
5329024|NCT00375518|13105980|P1|COMPLETED|Overall Study||72
5329025|NCT00375518|13105979|P2|STARTED|Overall Study||82
5329026|NCT00375518|13105980|P1|STARTED|Overall Study||80
5329027|NCT00375505|13105988|P2|NOT COMPLETED|Overall Study||2
5329028|NCT00375505|13105989|P1|NOT COMPLETED|Overall Study||1
5329029|NCT00375505|13105988|P2|COMPLETED|Overall Study||32
5329030|NCT00375505|13105989|P1|COMPLETED|Overall Study||35
5329031|NCT00375505|13105988|P2|STARTED|Overall Study||34
5329032|NCT00375505|13105989|P1|STARTED|Overall Study||36
5329033|NCT00375492|13106033|P2|NOT COMPLETED|Overall Study||26
5329034|NCT00375492|13106034|P1|NOT COMPLETED|Overall Study||26
5329035|NCT00375492|13106033|P2|COMPLETED|Overall Study||72
5329036|NCT00375492|13106034|P1|COMPLETED|Overall Study||70
5329037|NCT00375492|13106033|P2|STARTED|Overall Study||98
5329038|NCT00375492|13106034|P1|STARTED|Overall Study||96
5329039|NCT00375427|13106064|P2|NOT COMPLETED|Overall Study||74
5329040|NCT00375427|13106065|P1|NOT COMPLETED|Overall Study||60
5329041|NCT00375427|13106064|P2|COMPLETED|Overall Study||142
5329042|NCT00375427|13106065|P1|COMPLETED|Overall Study||149
5329043|NCT00375427|13106064|P2|STARTED|Overall Study||216
5329044|NCT00375427|13106065|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
5329045|NCT00375219|13106090|P3|NOT COMPLETED|Overall Study||21
5329046|NCT00375219|13106091|P2|NOT COMPLETED|Overall Study||20
5329047|NCT00375219|13106092|P1|NOT COMPLETED|Overall Study||59
5329048|NCT00375219|13106090|P3|COMPLETED|Overall Study||0
5329049|NCT00375219|13106091|P2|COMPLETED|Overall Study||0
5329050|NCT00375219|13106092|P1|COMPLETED|Overall Study||3
5329051|NCT00375219|13106090|P3|STARTED|Overall Study||21
5329052|NCT00375219|13106091|P2|STARTED|Overall Study||20
5329053|NCT00375219|13106092|P1|STARTED|Overall Study||62
5329054|NCT00375167|13106160|P2|NOT COMPLETED|Overall Study||0
5329055|NCT00375167|13106161|P1|NOT COMPLETED|Overall Study||0
5329056|NCT00375167|13106160|P2|COMPLETED|Overall Study||17
5329057|NCT00375167|13106161|P1|COMPLETED|Overall Study||16
5329058|NCT00375167|13106160|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
5329059|NCT00375167|13106161|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
5329060|NCT00374907|13106175|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
5329061|NCT00374907|13106176|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
5329062|NCT00374907|13106175|P2|COMPLETED|116-Week Short-term + Long-term Period||2
5329063|NCT00374907|13106176|P1|COMPLETED|116-Week Short-term + Long-term Period||7
5329064|NCT00374907|13106175|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
5329065|NCT00374907|13106176|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
5329066|NCT00374907|13106175|P2|STARTED|116-Week Short-term + Long-term Period||16
5329067|NCT00374907|13106176|P1|STARTED|116-Week Short-term + Long-term Period||20
5329068|NCT00374907|13106175|P2|NOT COMPLETED|12-Week Short-term Period||1
5329069|NCT00374907|13106176|P1|NOT COMPLETED|12-Week Short-term Period||3
5329070|NCT00374907|13106175|P2|COMPLETED|12-Week Short-term Period||15
5329071|NCT00374907|13106176|P1|COMPLETED|12-Week Short-term Period||17
5329072|NCT00374907|13106175|P2|STARTED|12-Week Short-term Period||16
5329073|NCT00374907|13106176|P1|STARTED|12-Week Short-term Period||20
5329074|NCT00374868|13106188|P1|NOT COMPLETED|Overall Study||36
5329075|NCT00374868|13106188|P1|COMPLETED|Overall Study||2
5329076|NCT00374868|13106188|P1|STARTED|Overall Study||38
5329077|NCT00374842|13106202|P3|NOT COMPLETED|Overall Study||0
5329078|NCT00374842|13106203|P2|NOT COMPLETED|Overall Study||0
5329079|NCT00374842|13106204|P1|NOT COMPLETED|Overall Study||0
5329080|NCT00374842|13106202|P3|COMPLETED|Overall Study||100
5329081|NCT00374842|13106203|P2|COMPLETED|Overall Study||100
5329082|NCT00374842|13106204|P1|COMPLETED|Overall Study||100
5329083|NCT00374842|13106202|P3|STARTED|Overall Study||100
5329084|NCT00374842|13106203|P2|STARTED|Overall Study||100
5329085|NCT00374842|13106204|P1|STARTED|Overall Study||100
5329086|NCT00374803|13106235|P2|NOT COMPLETED|Overall Study||0
5329087|NCT00374803|13106236|P1|NOT COMPLETED|Overall Study||0
5329088|NCT00374803|13106235|P2|COMPLETED|Overall Study||23
5329089|NCT00374803|13106236|P1|COMPLETED|Overall Study||22
5329090|NCT00374803|13106235|P2|STARTED|Overall Study||23
5329091|NCT00374803|13106236|P1|STARTED|Overall Study||22
5329092|NCT00374556|13106252|P2|NOT COMPLETED|Overall Study||1
5329093|NCT00374556|13106253|P1|NOT COMPLETED|Overall Study||1
5329094|NCT00374556|13106252|P2|COMPLETED|Overall Study||15
5329096|NCT00374556|13106252|P2|STARTED|Overall Study||16
5329097|NCT00374556|13106253|P1|STARTED|Overall Study||14
5329098|NCT00374543|13106305|P2|NOT COMPLETED|Overall Study||0
5329099|NCT00374543|13106306|P1|NOT COMPLETED|Overall Study||0
5329100|NCT00374543|13106305|P2|COMPLETED|Overall Study||1
5329101|NCT00374543|13106306|P1|COMPLETED|Overall Study||2
5329102|NCT00374543|13106305|P2|STARTED|Overall Study||1
5329103|NCT00374543|13106306|P1|STARTED|Overall Study||2
5329104|NCT00374452|13106314|P2|NOT COMPLETED|Overall Study||5
5329105|NCT00374452|13106315|P1|NOT COMPLETED|Overall Study||5
5329106|NCT00374452|13106314|P2|COMPLETED|Overall Study||43
5329107|NCT00374452|13106315|P1|COMPLETED|Overall Study||29
5329108|NCT00374452|13106314|P2|Intervention Started|Overall Study||46
5329109|NCT00374452|13106315|P1|Intervention Started|Overall Study||30
5329110|NCT00374452|13106314|P2|STARTED|Overall Study||48
5329111|NCT00374452|13106315|P1|STARTED|Overall Study||34
5329112|NCT00374335|13106321|P1|NOT COMPLETED|Overall Study||0
5329113|NCT00374335|13106321|P1|COMPLETED|Overall Study||261
5329114|NCT00374335|13106321|P1|STARTED|Overall Study||261
5329115|NCT00374322|13106328|P2|NOT COMPLETED|Overall Study||1304
5329116|NCT00374322|13106329|P1|NOT COMPLETED|Overall Study||1257
5329117|NCT00374322|13106328|P2|COMPLETED|Overall Study||278
5329118|NCT00374322|13106329|P1|COMPLETED|Overall Study||322
5329119|NCT00374322|13106328|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
5329120|NCT00374322|13106329|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
5329121|NCT00374322|13106328|P2|STARTED|Overall Study||1582
5329122|NCT00374322|13106329|P1|STARTED|Overall Study||1579
5329123|NCT00374244|13106367|P2|NOT COMPLETED|Overall Study||0
5329124|NCT00374244|13106368|P1|NOT COMPLETED|Overall Study||0
5329125|NCT00374244|13106367|P2|COMPLETED|Overall Study||14
5329126|NCT00374244|13106368|P1|COMPLETED|Overall Study||14
5329127|NCT00374244|13106367|P2|STARTED|Overall Study||14
5329128|NCT00374244|13106368|P1|STARTED|Overall Study||14
5329129|NCT00374231|13106414|P1|NOT COMPLETED|Overall Study||0
5329130|NCT00374231|13106414|P1|COMPLETED|Overall Study||40
5329131|NCT00374231|13106414|P1|STARTED|Overall Study||40
5329132|NCT00374140|13106420|P1|NOT COMPLETED|Overall Study||2
5329133|NCT00374140|13106420|P1|COMPLETED|Overall Study||38
5329134|NCT00374140|13106420|P1|STARTED|Overall Study||40
5329135|NCT00374127|13106427|P1|NOT COMPLETED|Overall Study||11
5329136|NCT00374127|13106427|P1|COMPLETED|Overall Study||24
5329137|NCT00374127|13106427|P1|STARTED|Overall Study||35
5329138|NCT00374088|13106463|P2|NOT COMPLETED|Overall Study||1
5329139|NCT00374088|13106464|P1|NOT COMPLETED|Overall Study||1
5329140|NCT00374088|13106463|P2|COMPLETED|Overall Study||10
5329141|NCT00374088|13106464|P1|COMPLETED|Overall Study||9
5329142|NCT00374088|13106463|P2|STARTED|Overall Study||11
5329143|NCT00374088|13106464|P1|STARTED|Overall Study||10
5329144|NCT00373958|13106476|P2|NOT COMPLETED|Toddler Dose||38
5329145|NCT00373958|13106477|P1|NOT COMPLETED|Toddler Dose||30
5329146|NCT00373958|13106476|P2|COMPLETED|Toddler Dose||252
5329147|NCT00373958|13106477|P1|COMPLETED|Toddler Dose||264
5329148|NCT00373958|13106476|P2|Vaccinated Toddler Dose|Toddler Dose||265
5329149|NCT00373958|13106477|P1|Vaccinated Toddler Dose|Toddler Dose||272
5329150|NCT00373958|13106476|P2|Withdrawn After Infant Series|Toddler Dose||25
5329151|NCT00373958|13106477|P1|Withdrawn After Infant Series|Toddler Dose||22
5329152|NCT00373958|13106476|P2|STARTED|Toddler Dose||290
5329153|NCT00373958|13106477|P1|STARTED|Toddler Dose||294
5329154|NCT00373958|13106476|P2|NOT COMPLETED|Infant Series||42
5329155|NCT00373958|13106477|P1|NOT COMPLETED|Infant Series||40
5329156|NCT00373958|13106476|P2|COMPLETED|Infant Series||290
5329157|NCT00373958|13106477|P1|COMPLETED|Infant Series||294
5329158|NCT00373958|13106476|P2|Vaccinated Dose 3|Infant Series||300
5329159|NCT00373958|13106477|P1|Vaccinated Dose 3|Infant Series||298
5329160|NCT00373958|13106476|P2|Vaccinated Dose 2|Infant Series||305
5329161|NCT00373958|13106477|P1|Vaccinated Dose 2|Infant Series||309
5329162|NCT00373958|13106476|P2|Vaccinated Dose 1|Infant Series||331
5329163|NCT00373958|13106477|P1|Vaccinated Dose 1|Infant Series||332
5329164|NCT00373958|13106476|P2|STARTED|Infant Series||332
5329165|NCT00373958|13106477|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
5329166|NCT00373880|13106525|P1|NOT COMPLETED|Overall Study||18
5329167|NCT00373880|13106525|P1|COMPLETED|Overall Study||8
5329168|NCT00373880|13106525|P1|STARTED|Overall Study||26
5329169|NCT00373698|13106555|P2|NOT COMPLETED|Overall Study||0
5329170|NCT00373698|13106556|P1|NOT COMPLETED|Overall Study||11
5329171|NCT00373698|13106555|P2|COMPLETED|Overall Study||99
5329172|NCT00373698|13106556|P1|COMPLETED|Overall Study||85
5329173|NCT00373698|13106555|P2|STARTED|Overall Study||99
5329174|NCT00373698|13106556|P1|STARTED|Overall Study||96
5329175|NCT00373685|13106570|P2|NOT COMPLETED|Overall Study||1421
5329176|NCT00373685|13106571|P1|NOT COMPLETED|Overall Study||1439
5329177|NCT00373685|13106570|P2|COMPLETED|Overall Study||2611
5329178|NCT00373685|13106571|P1|COMPLETED|Overall Study||2596
5329179|NCT00373685|13106570|P2|Treated|Overall Study||3955
5329180|NCT00373685|13106571|P1|Treated|Overall Study||3984
5329181|NCT00373685|13106570|P2|STARTED|Overall Study||4032
5329182|NCT00373685|13106571|P1|STARTED|Overall Study||4035
5329183|NCT00373529|13106605|P1|NOT COMPLETED|Overall Study||108
5329184|NCT00373529|13106605|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
5329185|NCT00373529|13106605|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
5329186|NCT00373529|13106605|P1|STARTED|Overall Study||116
5329187|NCT00373490|13106617|P2|NOT COMPLETED|Overall Study||6
5329188|NCT00373490|13106618|P1|NOT COMPLETED|Overall Study||9
5329189|NCT00373490|13106617|P2|COMPLETED|Overall Study||0
5329190|NCT00373490|13106618|P1|COMPLETED|Overall Study||1
5329191|NCT00373490|13106617|P2|STARTED|Overall Study||6
5329192|NCT00373490|13106618|P1|STARTED|Overall Study||10
5329193|NCT00373425|13106641|P5|NOT COMPLETED|Overall Study||72
5329194|NCT00373425|13106642|P4|NOT COMPLETED|Overall Study||11
5329195|NCT00373425|13106643|P3|NOT COMPLETED|Overall Study||134
5329196|NCT00373425|13106644|P2|NOT COMPLETED|Overall Study||153
5329197|NCT00373425|13106645|P1|NOT COMPLETED|Overall Study||370
5329198|NCT00373425|13106641|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
5329199|NCT00373425|13106642|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
5329200|NCT00373425|13106643|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
5329201|NCT00373425|13106644|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
5329202|NCT00373425|13106645|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
5329203|NCT00373425|13106641|P5|Received Treatment|Overall Study||132
5329204|NCT00373425|13106642|P4|Received Treatment|Overall Study||7
5329205|NCT00373425|13106643|P3|Received Treatment|Overall Study||134
5329206|NCT00373425|13106644|P2|Received Treatment|Overall Study||342
5329207|NCT00373425|13106645|P1|Received Treatment|Overall Study||612
5329208|NCT00373425|13106641|P5|STARTED|Overall Study||132
5329209|NCT00373425|13106642|P4|STARTED|Overall Study||11
5329210|NCT00373425|13106643|P3|STARTED|Overall Study||134
5329211|NCT00373425|13106644|P2|STARTED|Overall Study||350
5329212|NCT00373425|13106645|P1|STARTED|Overall Study||623
5329213|NCT00373399|13106670|P6|NOT COMPLETED|Overall Study||0
5329214|NCT00373399|13106671|P5|NOT COMPLETED|Overall Study||0
5329215|NCT00373399|13106672|P4|NOT COMPLETED|Overall Study||0
5329216|NCT00373399|13106673|P3|NOT COMPLETED|Overall Study||0
5329217|NCT00373399|13106674|P2|NOT COMPLETED|Overall Study||0
5329218|NCT00373399|13106675|P1|NOT COMPLETED|Overall Study||0
5329219|NCT00373399|13106670|P6|COMPLETED|Overall Study||7
5329220|NCT00373399|13106671|P5|COMPLETED|Overall Study||7
5329221|NCT00373399|13106672|P4|COMPLETED|Overall Study||6
5329222|NCT00373399|13106673|P3|COMPLETED|Overall Study||4
5329223|NCT00373399|13106674|P2|COMPLETED|Overall Study||7
5329224|NCT00373399|13106675|P1|COMPLETED|Overall Study||5
5329225|NCT00373399|13106670|P6|STARTED|Overall Study||7
5329226|NCT00373399|13106671|P5|STARTED|Overall Study||7
5329227|NCT00373399|13106672|P4|STARTED|Overall Study||6
5329228|NCT00373399|13106673|P3|STARTED|Overall Study||4
5329229|NCT00373399|13106674|P2|STARTED|Overall Study||7
5329230|NCT00373399|13106675|P1|STARTED|Overall Study||5
5329231|NCT00373386|13106683|P1|NOT COMPLETED|Overall Study||0
5329232|NCT00373386|13106683|P1|COMPLETED|Overall Study||9
5329233|NCT00373386|13106683|P1|STARTED|Overall Study||9
5329234|NCT00373360|13106693|P1|NOT COMPLETED|Overall Study||0
5329235|NCT00373360|13106693|P1|COMPLETED|Overall Study||10
5329236|NCT00373360|13106693|P1|STARTED|Overall Study||10
5329237|NCT00373334|13106724|P3|NOT COMPLETED|Overall Study||13
5329238|NCT00373334|13106725|P2|NOT COMPLETED|Overall Study||18
5329239|NCT00373334|13106726|P1|NOT COMPLETED|Overall Study||10
5329240|NCT00373334|13106724|P3|COMPLETED|Overall Study||32
5329241|NCT00373334|13106725|P2|COMPLETED|Overall Study||32
5329242|NCT00373334|13106726|P1|COMPLETED|Overall Study||33
5329243|NCT00373334|13106724|P3|STARTED|Overall Study||45
5329244|NCT00373334|13106725|P2|STARTED|Overall Study||50
5329245|NCT00373334|13106726|P1|STARTED|Overall Study||43
5329246|NCT00373295|13106740|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
5329247|NCT00373295|13106741|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
5329248|NCT00373295|13106742|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
5329249|NCT00373295|13106743|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
5329250|NCT00373295|13106744|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
5329251|NCT00373295|13106745|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
5329252|NCT00373295|13106740|P6|COMPLETED|Intervention 3 (8 Days)||2
5329253|NCT00373295|13106741|P5|COMPLETED|Intervention 3 (8 Days)||2
5329254|NCT00373295|13106742|P4|COMPLETED|Intervention 3 (8 Days)||2
5329255|NCT00373295|13106743|P3|COMPLETED|Intervention 3 (8 Days)||1
5329256|NCT00373295|13106744|P2|COMPLETED|Intervention 3 (8 Days)||1
5329257|NCT00373295|13106745|P1|COMPLETED|Intervention 3 (8 Days)||2
5329258|NCT00373295|13106740|P6|STARTED|Intervention 3 (8 Days)||2
5329259|NCT00373295|13106741|P5|STARTED|Intervention 3 (8 Days)||2
5329260|NCT00373295|13106742|P4|STARTED|Intervention 3 (8 Days)||2
5329261|NCT00373295|13106743|P3|STARTED|Intervention 3 (8 Days)||1
5329262|NCT00373295|13106744|P2|STARTED|Intervention 3 (8 Days)||1
5329263|NCT00373295|13106745|P1|STARTED|Intervention 3 (8 Days)||2
5329264|NCT00373295|13106740|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
5329265|NCT00373295|13106741|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
5329266|NCT00373295|13106742|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
5329267|NCT00373295|13106743|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
5329268|NCT00373295|13106744|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
5329269|NCT00373295|13106745|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
5329270|NCT00373295|13106740|P6|COMPLETED|Intervention 2 (8 Days)||2
5329271|NCT00373295|13106741|P5|COMPLETED|Intervention 2 (8 Days)||2
5329272|NCT00373295|13106742|P4|COMPLETED|Intervention 2 (8 Days)||2
5329273|NCT00373295|13106743|P3|COMPLETED|Intervention 2 (8 Days)||1
5329274|NCT00373295|13106744|P2|COMPLETED|Intervention 2 (8 Days)||1
5329275|NCT00373295|13106745|P1|COMPLETED|Intervention 2 (8 Days)||2
5329276|NCT00373295|13106740|P6|STARTED|Intervention 2 (8 Days)||2
5329277|NCT00373295|13106741|P5|STARTED|Intervention 2 (8 Days)||2
5329278|NCT00373295|13106742|P4|STARTED|Intervention 2 (8 Days)||2
5329279|NCT00373295|13106743|P3|STARTED|Intervention 2 (8 Days)||1
5329280|NCT00373295|13106744|P2|STARTED|Intervention 2 (8 Days)||1
5329281|NCT00373295|13106745|P1|STARTED|Intervention 2 (8 Days)||2
5329282|NCT00373295|13106740|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
5329283|NCT00373295|13106741|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
5329284|NCT00373295|13106742|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
5329285|NCT00373295|13106743|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
5329286|NCT00373295|13106744|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
5329287|NCT00373295|13106745|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
5329288|NCT00373295|13106740|P6|COMPLETED|Intervention 1 (8 Days)||2
5329289|NCT00373295|13106741|P5|COMPLETED|Intervention 1 (8 Days)||2
5329290|NCT00373295|13106742|P4|COMPLETED|Intervention 1 (8 Days)||2
5329291|NCT00373295|13106743|P3|COMPLETED|Intervention 1 (8 Days)||1
5329292|NCT00373295|13106744|P2|COMPLETED|Intervention 1 (8 Days)||1
5329293|NCT00373295|13106745|P1|COMPLETED|Intervention 1 (8 Days)||2
5329294|NCT00373295|13106740|P6|STARTED|Intervention 1 (8 Days)||2
5329295|NCT00373295|13106741|P5|STARTED|Intervention 1 (8 Days)||3
5329296|NCT00373295|13106742|P4|STARTED|Intervention 1 (8 Days)||2
5329297|NCT00373295|13106743|P3|STARTED|Intervention 1 (8 Days)||1
5329298|NCT00373295|13106744|P2|STARTED|Intervention 1 (8 Days)||3
5329299|NCT00373295|13106745|P1|STARTED|Intervention 1 (8 Days)||2
5329300|NCT00373269|13106755|P2|NOT COMPLETED|Overall Study||0
5329301|NCT00373269|13106756|P1|NOT COMPLETED|Overall Study||0
5329302|NCT00373269|13106755|P2|COMPLETED|Overall Study||10
5329303|NCT00373269|13106756|P1|COMPLETED|Overall Study||11
5329304|NCT00373269|13106755|P2|STARTED|Overall Study||10
5329305|NCT00373269|13106756|P1|STARTED|Overall Study||11
5329306|NCT00373256|13106766|P2|NOT COMPLETED|Overall Study||247
5329307|NCT00373256|13106767|P1|NOT COMPLETED|Overall Study||241
5329308|NCT00373256|13106766|P2|COMPLETED|Overall Study||0
5329309|NCT00373256|13106767|P1|COMPLETED|Overall Study||0
5329310|NCT00373256|13106766|P2|Treated|Overall Study||236
5329311|NCT00373256|13106767|P1|Treated|Overall Study||235
5329312|NCT00373256|13106766|P2|STARTED|Overall Study||247
5329313|NCT00373256|13106767|P1|STARTED|Overall Study||241
5329314|NCT00373113|13106793|P2|NOT COMPLETED|Overall Study||244
5329315|NCT00373113|13106794|P1|NOT COMPLETED|Overall Study||238
5329316|NCT00373113|13106793|P2|COMPLETED|Overall Study||0
5329317|NCT00373113|13106794|P1|COMPLETED|Overall Study||0
5329318|NCT00373113|13106793|P2|Received Treatment|Overall Study||240
5329319|NCT00373113|13106794|P1|Received Treatment|Overall Study||238
5329320|NCT00373113|13106793|P2|STARTED|Overall Study||244
5329321|NCT00373113|13106794|P1|STARTED|Overall Study||238
5329322|NCT00372996|13106816|P4|NOT COMPLETED|Overall Study||20
5329323|NCT00372996|13106817|P3|NOT COMPLETED|Overall Study||28
5329324|NCT00372996|13106818|P2|NOT COMPLETED|Overall Study||14
5329325|NCT00372996|13106819|P1|NOT COMPLETED|Overall Study||37
5329326|NCT00372996|13106816|P4|COMPLETED|Overall Study||23
5329327|NCT00372996|13106817|P3|COMPLETED|Overall Study||33
5329328|NCT00372996|13106818|P2|COMPLETED|Overall Study||22
5329329|NCT00372996|13106819|P1|COMPLETED|Overall Study||42
5329330|NCT00372996|13106816|P4|STARTED|Overall Study||43
5329331|NCT00372996|13106817|P3|STARTED|Overall Study||61
5329332|NCT00372996|13106818|P2|STARTED|Overall Study||36
5329333|NCT00372996|13106819|P1|STARTED|Overall Study||79
5329334|NCT00372970|13106845|P2|NOT COMPLETED|Overall Study||0
5329335|NCT00372970|13106846|P1|NOT COMPLETED|Overall Study||0
5329336|NCT00372970|13106845|P2|COMPLETED|Overall Study||16
5329337|NCT00372970|13106846|P1|COMPLETED|Overall Study||16
5329338|NCT00372970|13106845|P2|STARTED|Overall Study||16
5329339|NCT00372970|13106846|P1|STARTED|Overall Study||16
5329340|NCT00372957|13106855|P3|NOT COMPLETED|Overall Study||0
5329341|NCT00372957|13106856|P2|NOT COMPLETED|Overall Study||0
5329342|NCT00372957|13106857|P1|NOT COMPLETED|Overall Study||0
5329343|NCT00372957|13106855|P3|COMPLETED|Overall Study||10
5329344|NCT00372957|13106856|P2|COMPLETED|Overall Study||10
5329345|NCT00372957|13106857|P1|COMPLETED|Overall Study||10
5329346|NCT00372957|13106855|P3|STARTED|Overall Study||10
5329347|NCT00372957|13106856|P2|STARTED|Overall Study||10
5329348|NCT00372957|13106857|P1|STARTED|Overall Study||10
5329349|NCT00372905|13106904|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
5329350|NCT00372905|13106905|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
5329351|NCT00372905|13106906|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
5329352|NCT00372905|13106907|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
5329353|NCT00372905|13106904|P4|COMPLETED|Follow up Until Relapse or Progression||5
5329354|NCT00372905|13106905|P3|COMPLETED|Follow up Until Relapse or Progression||3
5329355|NCT00372905|13106906|P2|COMPLETED|Follow up Until Relapse or Progression||2
5329356|NCT00372905|13106907|P1|COMPLETED|Follow up Until Relapse or Progression||3
5329357|NCT00372905|13106904|P4|STARTED|Follow up Until Relapse or Progression||8
5329358|NCT00372905|13106905|P3|STARTED|Follow up Until Relapse or Progression||3
5329359|NCT00372905|13106906|P2|STARTED|Follow up Until Relapse or Progression||3
5329360|NCT00372905|13106907|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
5329361|NCT00372905|13106904|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
5329362|NCT00372905|13106905|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329363|NCT00372905|13106906|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329364|NCT00372905|13106907|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329365|NCT00372905|13106904|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
5329366|NCT00372905|13106905|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329367|NCT00372905|13106906|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329368|NCT00372905|13106907|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
5329369|NCT00372905|13106904|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
5329370|NCT00372905|13106905|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
5329371|NCT00372905|13106906|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
5329372|NCT00372905|13106907|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
5329373|NCT00372905|13106904|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
5329374|NCT00372905|13106905|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
5329375|NCT00372905|13106906|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
5329376|NCT00372905|13106907|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
5329377|NCT00372905|13106904|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
5329378|NCT00372905|13106905|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
5329379|NCT00372905|13106906|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
5329380|NCT00372905|13106907|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
5329381|NCT00372905|13106904|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
5329382|NCT00372905|13106905|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
5329383|NCT00372905|13106906|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
5329384|NCT00372905|13106907|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
5329385|NCT00372905|13106904|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329386|NCT00372905|13106905|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
5329387|NCT00372905|13106906|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329388|NCT00372905|13106907|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329389|NCT00372905|13106904|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329390|NCT00372905|13106905|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
5329391|NCT00372905|13106906|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329392|NCT00372905|13106907|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
5329393|NCT00372905|13106904|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
5329394|NCT00372905|13106905|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
5329395|NCT00372905|13106906|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
5329396|NCT00372905|13106907|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
5329397|NCT00372905|13106904|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
5329398|NCT00372905|13106905|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
5329399|NCT00372905|13106906|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
5329400|NCT00372905|13106907|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
5329401|NCT00372905|13106904|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
5329402|NCT00372905|13106905|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
5329403|NCT00372905|13106906|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
5329404|NCT00372905|13106907|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
5329405|NCT00372905|13106904|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
5329406|NCT00372905|13106905|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
5329407|NCT00372905|13106906|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
5329408|NCT00372905|13106907|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
5329409|NCT00372905|13106904|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329410|NCT00372905|13106905|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329411|NCT00372905|13106906|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329412|NCT00372905|13106907|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329413|NCT00372905|13106904|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329414|NCT00372905|13106905|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329415|NCT00372905|13106906|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
5329416|NCT00372905|13106907|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
5329417|NCT00372905|13106904|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
5329418|NCT00372905|13106905|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
5329419|NCT00372905|13106906|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
5329420|NCT00372905|13106907|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
5329421|NCT00372905|13106904|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
5329422|NCT00372905|13106905|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
5329423|NCT00372905|13106906|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
5329424|NCT00372905|13106907|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
5329425|NCT00372905|13106904|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
5329426|NCT00372905|13106905|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
5329427|NCT00372905|13106906|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
5329428|NCT00372905|13106907|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
5329429|NCT00372905|13106904|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
5329430|NCT00372905|13106905|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
5329431|NCT00372905|13106906|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
5329432|NCT00372905|13106907|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
5329433|NCT00372905|13106904|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329434|NCT00372905|13106905|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329435|NCT00372905|13106906|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329436|NCT00372905|13106907|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
5329437|NCT00372905|13106904|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329438|NCT00372905|13106905|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329439|NCT00372905|13106906|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
5329440|NCT00372905|13106907|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
5329441|NCT00372905|13106904|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
5329442|NCT00372905|13106905|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
5329443|NCT00372905|13106906|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
5329444|NCT00372905|13106907|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
5329445|NCT00372905|13106904|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
5329446|NCT00372905|13106905|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
5329447|NCT00372905|13106906|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
5329448|NCT00372905|13106907|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
5329449|NCT00372905|13106904|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
5329450|NCT00372905|13106905|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
5329451|NCT00372905|13106906|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
5329452|NCT00372905|13106907|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
5329453|NCT00372905|13106904|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
5329454|NCT00372905|13106905|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
5329455|NCT00372905|13106906|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
5329456|NCT00372905|13106907|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
5329457|NCT00372775|13106919|P1|NOT COMPLETED|Overall Study||63
5329458|NCT00372775|13106919|P1|COMPLETED|Overall Study||3
5329459|NCT00372775|13106919|P1|Received Treatment|Overall Study||64
5329460|NCT00372775|13106919|P1|STARTED|Overall Study||66
5329461|NCT00372697|13106941|P2|NOT COMPLETED|Overall Study||1
5329462|NCT00372697|13106942|P1|NOT COMPLETED|Overall Study||1
5329463|NCT00372697|13106941|P2|COMPLETED|Overall Study||11
5329464|NCT00372697|13106942|P1|COMPLETED|Overall Study||15
5329465|NCT00372697|13106941|P2|STARTED|Overall Study||12
5329466|NCT00372697|13106942|P1|STARTED|Overall Study||16
5329467|NCT00372619|13106967|P7|NOT COMPLETED|Overall Study||0
5329468|NCT00372619|13106968|P6|NOT COMPLETED|Overall Study||3
5329469|NCT00372619|13106969|P5|NOT COMPLETED|Overall Study||0
5329470|NCT00372619|13106970|P4|NOT COMPLETED|Overall Study||0
5329471|NCT00372619|13106971|P3|NOT COMPLETED|Overall Study||0
5329472|NCT00372619|13106972|P2|NOT COMPLETED|Overall Study||0
5329473|NCT00372619|13106973|P1|NOT COMPLETED|Overall Study||0
5329474|NCT00372619|13106967|P7|COMPLETED|Overall Study||2
5329475|NCT00372619|13106968|P6|COMPLETED|Overall Study||39
5329476|NCT00372619|13106969|P5|COMPLETED|Overall Study||7
5329477|NCT00372619|13106970|P4|COMPLETED|Overall Study||10
5329478|NCT00372619|13106971|P3|COMPLETED|Overall Study||3
5329479|NCT00372619|13106972|P2|COMPLETED|Overall Study||2
5329480|NCT00372619|13106973|P1|COMPLETED|Overall Study||8
5329481|NCT00372619|13106967|P7|STARTED|Overall Study||2
5329482|NCT00372619|13106968|P6|STARTED|Overall Study||42
5329483|NCT00372619|13106969|P5|STARTED|Overall Study||7
5329484|NCT00372619|13106970|P4|STARTED|Overall Study||10
5329485|NCT00372619|13106971|P3|STARTED|Overall Study||3
5329486|NCT00372619|13106972|P2|STARTED|Overall Study||2
5329487|NCT00372619|13106973|P1|STARTED|Overall Study||8
5329488|NCT00372593|13107006|P3|NOT COMPLETED|Overall Study||4
5329489|NCT00372593|13107007|P2|NOT COMPLETED|Overall Study||198
5329490|NCT00372593|13107008|P1|NOT COMPLETED|Overall Study||204
5329491|NCT00372593|13107006|P3|COMPLETED|Overall Study||3
5329492|NCT00372593|13107007|P2|COMPLETED|Overall Study||334
5329493|NCT00372593|13107008|P1|COMPLETED|Overall Study||327
5329494|NCT00372593|13107006|P3|STARTED|Overall Study||7
5329495|NCT00372593|13107007|P2|STARTED|Overall Study||532
5329496|NCT00372593|13107008|P1|STARTED|Overall Study||531
5329497|NCT00372567|13107037|P3|NOT COMPLETED|Phase 3 Study||12
5329498|NCT00372567|13107038|P2|NOT COMPLETED|Phase 3 Study||26
5329499|NCT00372567|13107039|P1|NOT COMPLETED|Phase 3 Study||31
5329500|NCT00372567|13107037|P3|COMPLETED|Phase 3 Study||0
5329501|NCT00372567|13107038|P2|COMPLETED|Phase 3 Study||0
5329502|NCT00372567|13107039|P1|COMPLETED|Phase 3 Study||0
5329503|NCT00372567|13107037|P3|Received Treatment|Phase 3 Study||12
5329504|NCT00372567|13107038|P2|Received Treatment|Phase 3 Study||25
5329505|NCT00372567|13107039|P1|Received Treatment|Phase 3 Study||31
5329506|NCT00372567|13107037|P3|STARTED|Phase 3 Study||12
5329507|NCT00372567|13107038|P2|STARTED|Phase 3 Study||26
5329508|NCT00372567|13107039|P1|STARTED|Phase 3 Study||31
5329509|NCT00372567|13107037|P3|NOT COMPLETED|Phase 1 Sub-study||0
5329510|NCT00372567|13107038|P2|NOT COMPLETED|Phase 1 Sub-study||0
5329511|NCT00372567|13107039|P1|NOT COMPLETED|Phase 1 Sub-study||0
5329512|NCT00372567|13107037|P3|COMPLETED|Phase 1 Sub-study||12
5329513|NCT00372567|13107038|P2|COMPLETED|Phase 1 Sub-study||0
5329514|NCT00372567|13107039|P1|COMPLETED|Phase 1 Sub-study||0
5329515|NCT00372567|13107037|P3|STARTED|Phase 1 Sub-study||12
5329516|NCT00372567|13107038|P2|STARTED|Phase 1 Sub-study||0
5329517|NCT00372567|13107039|P1|STARTED|Phase 1 Sub-study||0
5329518|NCT00372528|13107067|P1|NOT COMPLETED|Overall Study||21
5329519|NCT00372528|13107067|P1|COMPLETED|Overall Study||0
5329520|NCT00372528|13107067|P1|STARTED|Overall Study||21
5329521|NCT00372489|13107072|P1|NOT COMPLETED|Overall Study||79
5329522|NCT00372489|13107072|P1|COMPLETED|Overall Study||2
5329523|NCT00372489|13107072|P1|STARTED|Overall Study||81
5329524|NCT00372424|13107076|P1|NOT COMPLETED|Overall Study||26
5329525|NCT00372424|13107076|P1|COMPLETED|Overall Study||0
5329526|NCT00372424|13107076|P1|Treated|Overall Study||25
5329527|NCT00372424|13107076|P1|STARTED|Overall Study||26
5329528|NCT00372411|13107090|P3|NOT COMPLETED|Overall Study||3
5329529|NCT00372411|13107091|P2|NOT COMPLETED|Overall Study||8
5329530|NCT00372411|13107092|P1|NOT COMPLETED|Overall Study||5
5329531|NCT00372411|13107090|P3|COMPLETED|Overall Study||25
5329532|NCT00372411|13107091|P2|COMPLETED|Overall Study||42
5329533|NCT00372411|13107092|P1|COMPLETED|Overall Study||44
5329534|NCT00372411|13107090|P3|STARTED|Overall Study||28
5329535|NCT00372411|13107091|P2|STARTED|Overall Study||50
5329536|NCT00372411|13107092|P1|STARTED|Overall Study||49
5329537|NCT00372385|13107116|P4|NOT COMPLETED|Overall Study||8
5329538|NCT00372385|13107117|P3|NOT COMPLETED|Overall Study||10
5329539|NCT00372385|13107118|P2|NOT COMPLETED|Overall Study||20
5329540|NCT00372385|13107119|P1|NOT COMPLETED|Overall Study||33
5329541|NCT00372385|13107116|P4|COMPLETED|Overall Study||70
5329542|NCT00372385|13107117|P3|COMPLETED|Overall Study||72
5329543|NCT00372385|13107118|P2|COMPLETED|Overall Study||61
5329544|NCT00372385|13107119|P1|COMPLETED|Overall Study||49
5329545|NCT00372385|13107116|P4|STARTED|Overall Study||78
5329546|NCT00372385|13107117|P3|STARTED|Overall Study||82
5329547|NCT00372385|13107118|P2|STARTED|Overall Study||81
5329548|NCT00372385|13107119|P1|STARTED|Overall Study||82
5329549|NCT00372255|13107148|P2|NOT COMPLETED|Overall Study||1
5329550|NCT00372255|13107149|P1|NOT COMPLETED|Overall Study||2
5329551|NCT00372255|13107148|P2|COMPLETED|Overall Study||113
5329552|NCT00372255|13107149|P1|COMPLETED|Overall Study||108
5329553|NCT00372255|13107148|P2|STARTED|Overall Study||114
5329554|NCT00372255|13107149|P1|STARTED|Overall Study||110
5329555|NCT00372229|13107171|P2|NOT COMPLETED|Follow-Up Phase||52
5329556|NCT00372229|13107172|P1|NOT COMPLETED|Follow-Up Phase||46
5329557|NCT00372229|13107171|P2|COMPLETED|Follow-Up Phase||70
5329558|NCT00372229|13107172|P1|COMPLETED|Follow-Up Phase||71
5329559|NCT00372229|13107171|P2|STARTED|Follow-Up Phase||122
5329560|NCT00372229|13107172|P1|STARTED|Follow-Up Phase||117
5329561|NCT00372229|13107171|P2|NOT COMPLETED|Study Phase||29
5329562|NCT00372229|13107172|P1|NOT COMPLETED|Study Phase||31
5329563|NCT00372229|13107171|P2|COMPLETED|Study Phase||122
5329564|NCT00372229|13107172|P1|COMPLETED|Study Phase||117
5329565|NCT00372229|13107171|P2|STARTED|Study Phase||151
5329566|NCT00372229|13107172|P1|STARTED|Study Phase||148
5329567|NCT00372190|13107262|P2|NOT COMPLETED|Overall Study||1
5329568|NCT00372190|13107263|P1|NOT COMPLETED|Overall Study||3
5329569|NCT00372190|13107262|P2|COMPLETED|Overall Study||96
5329570|NCT00372190|13107263|P1|COMPLETED|Overall Study||90
5329571|NCT00372190|13107262|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
5329572|NCT00372190|13107263|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
5329573|NCT00372112|13107279|P4|NOT COMPLETED|Overall Study||4
5329574|NCT00372112|13107280|P3|NOT COMPLETED|Overall Study||4
5329575|NCT00372112|13107281|P2|NOT COMPLETED|Overall Study||1
5329576|NCT00372112|13107282|P1|NOT COMPLETED|Overall Study||1
5329577|NCT00372112|13107279|P4|COMPLETED|Overall Study||14
5329578|NCT00372112|13107280|P3|COMPLETED|Overall Study||13
5329579|NCT00372112|13107281|P2|COMPLETED|Overall Study||15
5329580|NCT00372112|13107282|P1|COMPLETED|Overall Study||16
5329581|NCT00372112|13107279|P4|STARTED|Overall Study||18
5329582|NCT00372112|13107280|P3|STARTED|Overall Study||17
5329583|NCT00372112|13107281|P2|STARTED|Overall Study||16
5329584|NCT00372112|13107282|P1|STARTED|Overall Study||17
5329585|NCT00372060|13107413|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
5329586|NCT00372060|13107414|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
5329587|NCT00372060|13107413|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
5329588|NCT00372060|13107414|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
5329589|NCT00372060|13107413|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
5329590|NCT00372060|13107414|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
5329591|NCT00372060|13107413|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
5329592|NCT00372060|13107414|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
5329593|NCT00372060|13107413|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
5329594|NCT00372060|13107414|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
5329595|NCT00372060|13107413|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
5329596|NCT00372060|13107414|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
5329597|NCT00371865|13107429|P2|NOT COMPLETED|Overall Study||14
5329598|NCT00371865|13107430|P1|NOT COMPLETED|Overall Study||15
5329599|NCT00371865|13107429|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
5329600|NCT00371865|13107430|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
5329601|NCT00371865|13107429|P2|STARTED|Overall Study||57
5329602|NCT00371865|13107430|P1|STARTED|Overall Study||57
5329603|NCT00371839|13107447|P3|NOT COMPLETED|Overall Study||2
5329604|NCT00371839|13107448|P2|NOT COMPLETED|Overall Study||7
5329605|NCT00371839|13107449|P1|NOT COMPLETED|Overall Study||17
5329606|NCT00371839|13107447|P3|COMPLETED|Overall Study||7
5329607|NCT00371839|13107448|P2|COMPLETED|Overall Study||13
5329608|NCT00371839|13107449|P1|COMPLETED|Overall Study||32
5329609|NCT00371839|13107447|P3|STARTED|Overall Study||9
5329610|NCT00371839|13107448|P2|STARTED|Overall Study||20
5329611|NCT00371839|13107449|P1|STARTED|Overall Study||49
5329612|NCT00371826|13107458|P3|NOT COMPLETED|Extension Phase (24 Months)||2
5329613|NCT00371826|13107459|P2|NOT COMPLETED|Extension Phase (24 Months)||10
5329614|NCT00371826|13107460|P1|NOT COMPLETED|Extension Phase (24 Months)||5
5329615|NCT00371826|13107458|P3|COMPLETED|Extension Phase (24 Months)||3
5329616|NCT00371826|13107459|P2|COMPLETED|Extension Phase (24 Months)||29
5329617|NCT00371826|13107460|P1|COMPLETED|Extension Phase (24 Months)||18
5329618|NCT00371826|13107458|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
5329619|NCT00371826|13107459|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
5329620|NCT00371826|13107460|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
5329621|NCT00371826|13107458|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
5329622|NCT00371826|13107459|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
5329623|NCT00371826|13107460|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
5329624|NCT00371826|13107458|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
5329625|NCT00371826|13107459|P2|STARTED|Extension Phase (24 Months)||39
5329626|NCT00371826|13107460|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
5329627|NCT00371826|13107458|P3|NOT COMPLETED|Core Phase (12 Months)||24
5329628|NCT00371826|13107459|P2|NOT COMPLETED|Core Phase (12 Months)||8
5329629|NCT00371826|13107460|P1|NOT COMPLETED|Core Phase (12 Months)||24
5329630|NCT00371826|13107458|P3|COMPLETED|Core Phase (12 Months)||6
5329631|NCT00371826|13107459|P2|COMPLETED|Core Phase (12 Months)||39
5329632|NCT00371826|13107460|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
5329633|NCT00371826|13107458|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
5329634|NCT00371826|13107459|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
5329635|NCT00371826|13107460|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
5329636|NCT00371826|13107458|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
5329637|NCT00371826|13107459|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
5329638|NCT00371826|13107460|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
5329639|NCT00371826|13107458|P3|STARTED|Core Phase (12 Months)||30
5329640|NCT00371826|13107459|P2|STARTED|Core Phase (12 Months)||47
5329641|NCT00371826|13107460|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
5329642|NCT00371787|13107584|P2|NOT COMPLETED|Overall Study||1
5329643|NCT00371787|13107585|P1|NOT COMPLETED|Overall Study||3
5329644|NCT00371787|13107584|P2|COMPLETED|Overall Study||11
5329645|NCT00371787|13107585|P1|COMPLETED|Overall Study||23
5329646|NCT00371787|13107584|P2|STARTED|Overall Study||12
5329647|NCT00371787|13107585|P1|STARTED|Overall Study||26
5329648|NCT00371761|13107599|P2|NOT COMPLETED|Overall Study||10
5329649|NCT00371761|13107600|P1|NOT COMPLETED|Overall Study||8
5329650|NCT00371761|13107599|P2|COMPLETED|Overall Study||2
5329651|NCT00371761|13107600|P1|COMPLETED|Overall Study||5
5329652|NCT00371761|13107599|P2|STARTED|Overall Study||12
5329653|NCT00371761|13107600|P1|STARTED|Overall Study||13
5329654|NCT00371683|13107608|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
5329655|NCT00371683|13107609|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
5329656|NCT00371683|13107608|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
5329657|NCT00371683|13107609|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
5329658|NCT00371683|13107608|P2|STARTED|Follow-Up Period - Randomized Patients||1533
5329659|NCT00371683|13107609|P1|STARTED|Follow-Up Period - Randomized Patients||1553
5329660|NCT00371683|13107608|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
5329661|NCT00371683|13107609|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
5329662|NCT00371683|13107608|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
5329663|NCT00371683|13107609|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
5329664|NCT00371683|13107608|P2|STARTED|DB Treatment Period-Randomized Patients||1596
5329665|NCT00371683|13107609|P1|STARTED|DB Treatment Period-Randomized Patients||1599
5329666|NCT00371644|13107663|P2|NOT COMPLETED|Overall Study||13
5329667|NCT00371644|13107664|P1|NOT COMPLETED|Overall Study||28
5329668|NCT00371644|13107663|P2|COMPLETED|Overall Study||44
5329669|NCT00371644|13107664|P1|COMPLETED|Overall Study||44
5329670|NCT00371644|13107663|P2|STARTED|Overall Study||57
5329671|NCT00371644|13107664|P1|STARTED|Overall Study||72
5329672|NCT00371631|13107670|P1|NOT COMPLETED|Overall Study||0
5329673|NCT00371631|13107670|P1|COMPLETED|Overall Study||13
5329674|NCT00371631|13107670|P1|STARTED|Overall Study||13
5329675|NCT00371566|13107677|P2|NOT COMPLETED|Follow Up Phase||7
5329676|NCT00371566|13107678|P1|NOT COMPLETED|Follow Up Phase||3
5329677|NCT00371566|13107677|P2|COMPLETED|Follow Up Phase||58
5329678|NCT00371566|13107678|P1|COMPLETED|Follow Up Phase||28
5329679|NCT00371566|13107677|P2|STARTED|Follow Up Phase||65
5329680|NCT00371566|13107678|P1|STARTED|Follow Up Phase||31
5329681|NCT00371566|13107677|P2|NOT COMPLETED|Chemoradiation Phase||3
5329682|NCT00371566|13107678|P1|NOT COMPLETED|Chemoradiation Phase||5
5329683|NCT00371566|13107677|P2|COMPLETED|Chemoradiation Phase||65
5329684|NCT00371566|13107678|P1|COMPLETED|Chemoradiation Phase||31
5329685|NCT00371566|13107677|P2|STARTED|Chemoradiation Phase||68
5329686|NCT00371566|13107678|P1|STARTED|Chemoradiation Phase||36
5329687|NCT00371566|13107677|P2|NOT COMPLETED|Treatment Phase||3
5329688|NCT00371566|13107678|P1|NOT COMPLETED|Treatment Phase||0
5329689|NCT00371566|13107677|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
5329690|NCT00371566|13107678|P1|COMPLETED|Treatment Phase||36
5329691|NCT00371566|13107677|P2|STARTED|Treatment Phase||71
5329692|NCT00371566|13107678|P1|STARTED|Treatment Phase||36
5329693|NCT00371540|13107750|P2|NOT COMPLETED|Overall Study||9
5329694|NCT00371540|13107751|P1|NOT COMPLETED|Overall Study||10
5329695|NCT00371540|13107750|P2|COMPLETED|Overall Study||87
5329696|NCT00371540|13107751|P1|COMPLETED|Overall Study||102
5329697|NCT00371540|13107750|P2|STARTED|Overall Study||96
5329698|NCT00371540|13107751|P1|STARTED|Overall Study||112
5329699|NCT00371462|13107763|P2|NOT COMPLETED|Overall Study||8
5329700|NCT00371462|13107764|P1|NOT COMPLETED|Overall Study||8
5329701|NCT00371462|13107763|P2|COMPLETED|Overall Study||27
5329702|NCT00371462|13107764|P1|COMPLETED|Overall Study||27
5329703|NCT00371462|13107763|P2|STARTED|Overall Study||35
5329704|NCT00371462|13107764|P1|STARTED|Overall Study||35
5329705|NCT00371449|13107770|P1|NOT COMPLETED|Overall Study||0
5329706|NCT00371449|13107770|P1|COMPLETED|Overall Study||120
5329707|NCT00371449|13107770|P1|STARTED|Overall Study||120
5329708|NCT00371436|13107781|P2|NOT COMPLETED|Overall Study||21
5329709|NCT00371436|13107782|P1|NOT COMPLETED|Overall Study||34
5329710|NCT00371436|13107781|P2|COMPLETED|Overall Study||68
5329711|NCT00371436|13107782|P1|COMPLETED|Overall Study||58
5329712|NCT00371436|13107781|P2|STARTED|Overall Study||89
5329713|NCT00371436|13107782|P1|STARTED|Overall Study||92
5329714|NCT00371397|13107788|P12|NOT COMPLETED|Session 3||0
5329715|NCT00371397|13107789|P11|NOT COMPLETED|Session 3||0
5329716|NCT00371397|13107790|P10|NOT COMPLETED|Session 3||0
5329717|NCT00371397|13107791|P9|NOT COMPLETED|Session 3||0
5329718|NCT00371397|13107792|P8|NOT COMPLETED|Session 3||0
5329719|NCT00371397|13107793|P7|NOT COMPLETED|Session 3||0
5329720|NCT00371397|13107794|P6|NOT COMPLETED|Session 3||0
5329721|NCT00371397|13107795|P5|NOT COMPLETED|Session 3||0
5329722|NCT00371397|13107796|P4|NOT COMPLETED|Session 3||0
5329723|NCT00371397|13107797|P3|NOT COMPLETED|Session 3||0
5329724|NCT00371397|13107798|P2|NOT COMPLETED|Session 3||0
5329725|NCT00371397|13107799|P1|NOT COMPLETED|Session 3||0
5329726|NCT00371397|13107788|P12|COMPLETED|Session 3||2
5329727|NCT00371397|13107789|P11|COMPLETED|Session 3||4
5329728|NCT00371397|13107790|P10|COMPLETED|Session 3||5
5329729|NCT00371397|13107791|P9|COMPLETED|Session 3||6
5329730|NCT00371397|13107792|P8|COMPLETED|Session 3||4
5329731|NCT00371397|13107793|P7|COMPLETED|Session 3||4
5329732|NCT00371397|13107794|P6|COMPLETED|Session 3||4
5329733|NCT00371397|13107795|P5|COMPLETED|Session 3||3
5329734|NCT00371397|13107796|P4|COMPLETED|Session 3||2
5329735|NCT00371397|13107797|P3|COMPLETED|Session 3||5
5329736|NCT00371397|13107798|P2|COMPLETED|Session 3||7
5329737|NCT00371397|13107799|P1|COMPLETED|Session 3||4
5329738|NCT00371397|13107788|P12|STARTED|Session 3||2
5329739|NCT00371397|13107789|P11|STARTED|Session 3||4
5329740|NCT00371397|13107790|P10|STARTED|Session 3||5
5329741|NCT00371397|13107791|P9|STARTED|Session 3||6
5329742|NCT00371397|13107792|P8|STARTED|Session 3||4
5329743|NCT00371397|13107793|P7|STARTED|Session 3||4
5329744|NCT00371397|13107794|P6|STARTED|Session 3||4
5329745|NCT00371397|13107795|P5|STARTED|Session 3||3
5329746|NCT00371397|13107796|P4|STARTED|Session 3||2
5329747|NCT00371397|13107797|P3|STARTED|Session 3||5
5329748|NCT00371397|13107798|P2|STARTED|Session 3||7
5329749|NCT00371397|13107799|P1|STARTED|Session 3||4
5329750|NCT00371397|13107788|P12|NOT COMPLETED|Session 2||0
5329751|NCT00371397|13107789|P11|NOT COMPLETED|Session 2||0
5329752|NCT00371397|13107790|P10|NOT COMPLETED|Session 2||0
5329753|NCT00371397|13107791|P9|NOT COMPLETED|Session 2||0
5329754|NCT00371397|13107792|P8|NOT COMPLETED|Session 2||0
5329755|NCT00371397|13107793|P7|NOT COMPLETED|Session 2||0
5329756|NCT00371397|13107794|P6|NOT COMPLETED|Session 2||0
5329757|NCT00371397|13107795|P5|NOT COMPLETED|Session 2||0
5329758|NCT00371397|13107796|P4|NOT COMPLETED|Session 2||0
5329759|NCT00371397|13107797|P3|NOT COMPLETED|Session 2||0
5329760|NCT00371397|13107798|P2|NOT COMPLETED|Session 2||0
5329761|NCT00371397|13107799|P1|NOT COMPLETED|Session 2||0
5329762|NCT00371397|13107788|P12|COMPLETED|Session 2||2
5329763|NCT00371397|13107789|P11|COMPLETED|Session 2||4
5329764|NCT00371397|13107790|P10|COMPLETED|Session 2||5
5329765|NCT00371397|13107791|P9|COMPLETED|Session 2||6
5329766|NCT00371397|13107792|P8|COMPLETED|Session 2||4
5329767|NCT00371397|13107793|P7|COMPLETED|Session 2||4
5329768|NCT00371397|13107794|P6|COMPLETED|Session 2||4
5329769|NCT00371397|13107795|P5|COMPLETED|Session 2||3
5329770|NCT00371397|13107796|P4|COMPLETED|Session 2||2
5329771|NCT00371397|13107797|P3|COMPLETED|Session 2||5
5329772|NCT00371397|13107798|P2|COMPLETED|Session 2||7
5329773|NCT00371397|13107799|P1|COMPLETED|Session 2||4
5329774|NCT00371397|13107788|P12|STARTED|Session 2||2
5329775|NCT00371397|13107789|P11|STARTED|Session 2||4
5329776|NCT00371397|13107790|P10|STARTED|Session 2||5
5329777|NCT00371397|13107791|P9|STARTED|Session 2||6
5329778|NCT00371397|13107792|P8|STARTED|Session 2||4
5329779|NCT00371397|13107793|P7|STARTED|Session 2||4
5329780|NCT00371397|13107794|P6|STARTED|Session 2||4
5329781|NCT00371397|13107795|P5|STARTED|Session 2||3
5329782|NCT00371397|13107796|P4|STARTED|Session 2||2
5329783|NCT00371397|13107797|P3|STARTED|Session 2||5
5329784|NCT00371397|13107798|P2|STARTED|Session 2||7
5329785|NCT00371397|13107799|P1|STARTED|Session 2||4
5329786|NCT00371397|13107788|P12|NOT COMPLETED|Session 1||0
5329787|NCT00371397|13107789|P11|NOT COMPLETED|Session 1||0
5329788|NCT00371397|13107790|P10|NOT COMPLETED|Session 1||0
5329789|NCT00371397|13107791|P9|NOT COMPLETED|Session 1||0
5329790|NCT00371397|13107792|P8|NOT COMPLETED|Session 1||1
5329791|NCT00371397|13107793|P7|NOT COMPLETED|Session 1||0
5329792|NCT00371397|13107794|P6|NOT COMPLETED|Session 1||0
5329793|NCT00371397|13107795|P5|NOT COMPLETED|Session 1||0
5329794|NCT00371397|13107796|P4|NOT COMPLETED|Session 1||0
5329795|NCT00371397|13107797|P3|NOT COMPLETED|Session 1||0
5329796|NCT00371397|13107798|P2|NOT COMPLETED|Session 1||0
5329797|NCT00371397|13107799|P1|NOT COMPLETED|Session 1||1
5329798|NCT00371397|13107788|P12|COMPLETED|Session 1||2
5329799|NCT00371397|13107789|P11|COMPLETED|Session 1||4
5329800|NCT00371397|13107790|P10|COMPLETED|Session 1||5
5329801|NCT00371397|13107791|P9|COMPLETED|Session 1||6
5329802|NCT00371397|13107792|P8|COMPLETED|Session 1||4
5329803|NCT00371397|13107793|P7|COMPLETED|Session 1||4
5329804|NCT00371397|13107794|P6|COMPLETED|Session 1||4
5329805|NCT00371397|13107795|P5|COMPLETED|Session 1||3
5329806|NCT00371397|13107796|P4|COMPLETED|Session 1||2
5329807|NCT00371397|13107797|P3|COMPLETED|Session 1||5
5329808|NCT00371397|13107798|P2|COMPLETED|Session 1||7
5329809|NCT00371397|13107799|P1|COMPLETED|Session 1||4
5329810|NCT00371397|13107788|P12|STARTED|Session 1||2
5329811|NCT00371397|13107789|P11|STARTED|Session 1||4
5329812|NCT00371397|13107790|P10|STARTED|Session 1||5
5329813|NCT00371397|13107791|P9|STARTED|Session 1||6
5329814|NCT00371397|13107792|P8|STARTED|Session 1||5
5329815|NCT00371397|13107793|P7|STARTED|Session 1||4
5329816|NCT00371397|13107794|P6|STARTED|Session 1||4
5329817|NCT00371397|13107795|P5|STARTED|Session 1||3
5329818|NCT00371397|13107796|P4|STARTED|Session 1||2
5329819|NCT00371397|13107797|P3|STARTED|Session 1||5
5329820|NCT00371397|13107798|P2|STARTED|Session 1||7
5329821|NCT00371397|13107799|P1|STARTED|Session 1||5
5329822|NCT00371345|13107807|P2|NOT COMPLETED|Overall Study||46
5329823|NCT00371345|13107808|P1|NOT COMPLETED|Overall Study||24
5329824|NCT00371345|13107807|P2|COMPLETED|Overall Study||0
5329825|NCT00371345|13107808|P1|COMPLETED|Overall Study||0
5329826|NCT00371345|13107807|P2|STARTED|Overall Study||46
5329827|NCT00371345|13107808|P1|STARTED|Overall Study||24
5329828|NCT00371293|13107868|P3|NOT COMPLETED|Overall Study||16
5329829|NCT00371293|13107869|P2|NOT COMPLETED|Overall Study||19
5329830|NCT00371293|13107870|P1|NOT COMPLETED|Overall Study||10
5329831|NCT00371293|13107868|P3|COMPLETED|Overall Study||46
5329832|NCT00371293|13107869|P2|COMPLETED|Overall Study||42
5329833|NCT00371293|13107870|P1|COMPLETED|Overall Study||48
5329834|NCT00371293|13107868|P3|STARTED|Overall Study||62
5329835|NCT00371293|13107869|P2|STARTED|Overall Study||61
5329836|NCT00371293|13107870|P1|STARTED|Overall Study||58
5329837|NCT00371267|13107892|P2|NOT COMPLETED|Overall Study||18
5329838|NCT00371267|13107893|P1|NOT COMPLETED|Overall Study||9
5329839|NCT00371267|13107892|P2|COMPLETED|Overall Study||32
5329840|NCT00371267|13107893|P1|COMPLETED|Overall Study||39
5329841|NCT00371267|13107892|P2|STARTED|Overall Study||50
5329842|NCT00371267|13107893|P1|STARTED|Overall Study||48
5329843|NCT00371254|13107909|P2|NOT COMPLETED|Overall Study||21
5329844|NCT00371254|13107910|P1|NOT COMPLETED|Overall Study||23
5329845|NCT00371254|13107909|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
5329846|NCT00371254|13107910|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
5329847|NCT00371254|13107909|P2|STARTED|Overall Study|Number of participants treated|21
5329848|NCT00371254|13107910|P1|STARTED|Overall Study|Number of participants treated|23
5329849|NCT00371176|13107962|P2|NOT COMPLETED|Overall Study||8
5329850|NCT00371176|13107963|P1|NOT COMPLETED|Overall Study||5
5329851|NCT00371176|13107962|P2|COMPLETED|Overall Study||5
5329852|NCT00371176|13107963|P1|COMPLETED|Overall Study||8
5329853|NCT00371176|13107962|P2|Completed Treatment|Overall Study||9
5329854|NCT00371176|13107963|P1|Completed Treatment|Overall Study||10
5329855|NCT00371176|13107962|P2|STARTED|Overall Study||13
5329856|NCT00371176|13107963|P1|STARTED|Overall Study||13
5329857|NCT00371150|13107993|P2|NOT COMPLETED|Overall Study||2
5329858|NCT00371150|13107994|P1|NOT COMPLETED|Overall Study||3
5329859|NCT00371150|13107993|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
5329860|NCT00371150|13107994|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
5329861|NCT00371150|13107993|P2|Discontinued at or After Week 48 Visit|Overall Study||1
5329862|NCT00371150|13107994|P1|Discontinued at or After Week 48 Visit|Overall Study||2
5329863|NCT00371150|13107993|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
5329864|NCT00371150|13107994|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
5329865|NCT00371150|13107993|P2|STARTED|Overall Study||6
5329866|NCT00371150|13107994|P1|STARTED|Overall Study||40
5329867|NCT00371137|13108029|P3|NOT COMPLETED|Overall Study||79
5329868|NCT00371137|13108030|P2|NOT COMPLETED|Overall Study||63
5329869|NCT00371137|13108031|P1|NOT COMPLETED|Overall Study||72
5329870|NCT00371137|13108029|P3|COMPLETED|Overall Study||104
5329871|NCT00371137|13108030|P2|COMPLETED|Overall Study||119
5329872|NCT00371137|13108031|P1|COMPLETED|Overall Study||111
5329873|NCT00371137|13108029|P3|Treated|Overall Study||182
5329874|NCT00371137|13108030|P2|Treated|Overall Study||182
5329875|NCT00371137|13108031|P1|Treated|Overall Study||183
5329876|NCT00371137|13108029|P3|STARTED|Overall Study||183
5329877|NCT00371137|13108030|P2|STARTED|Overall Study||182
5329878|NCT00371137|13108031|P1|STARTED|Overall Study||183
5329879|NCT00370994|13108041|P2|NOT COMPLETED|Overall Study||0
5329880|NCT00370994|13108042|P1|NOT COMPLETED|Overall Study||0
5329881|NCT00370994|13108041|P2|COMPLETED|Overall Study||60
5329882|NCT00370994|13108042|P1|COMPLETED|Overall Study||60
5329883|NCT00370994|13108041|P2|STARTED|Overall Study||60
5329884|NCT00370994|13108042|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
5329885|NCT00370838|13108052|P2|NOT COMPLETED|Taper||0
5329886|NCT00370838|13108053|P1|NOT COMPLETED|Taper||0
5329887|NCT00370838|13108052|P2|COMPLETED|Taper||3
5329888|NCT00370838|13108053|P1|COMPLETED|Taper||7
5329889|NCT00370838|13108052|P2|STARTED|Taper||3
5329890|NCT00370838|13108053|P1|STARTED|Taper||7
5329891|NCT00370838|13108052|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
5329892|NCT00370838|13108053|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
5329893|NCT00370838|13108052|P2|COMPLETED|Period 2 (Days 65-107)||3
5329894|NCT00370838|13108053|P1|COMPLETED|Period 2 (Days 65-107)||7
5329895|NCT00370838|13108052|P2|STARTED|Period 2 (Days 65-107)||3
5329896|NCT00370838|13108053|P1|STARTED|Period 2 (Days 65-107)||7
5329897|NCT00370838|13108052|P2|NOT COMPLETED|Washout (Days 51-64)||0
5329898|NCT00370838|13108053|P1|NOT COMPLETED|Washout (Days 51-64)||0
5329899|NCT00370838|13108052|P2|COMPLETED|Washout (Days 51-64)||3
5329900|NCT00370838|13108053|P1|COMPLETED|Washout (Days 51-64)||7
5329901|NCT00370838|13108052|P2|STARTED|Washout (Days 51-64)||3
5329902|NCT00370838|13108053|P1|STARTED|Washout (Days 51-64)||7
5329903|NCT00370838|13108052|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
5329904|NCT00370838|13108053|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
5329905|NCT00370838|13108052|P2|COMPLETED|Period 1 (Days 8-50)||3
5329906|NCT00370838|13108053|P1|COMPLETED|Period 1 (Days 8-50)||7
5329907|NCT00370838|13108052|P2|STARTED|Period 1 (Days 8-50)||3
5329908|NCT00370838|13108053|P1|STARTED|Period 1 (Days 8-50)||7
5329909|NCT00370682|13108074|P3|NOT COMPLETED|Overall Study||1
5329910|NCT00370682|13108075|P2|NOT COMPLETED|Overall Study||3
5329911|NCT00370682|13108076|P1|NOT COMPLETED|Overall Study||0
5329912|NCT00370682|13108074|P3|COMPLETED|Overall Study||39
5329913|NCT00370682|13108075|P2|COMPLETED|Overall Study||37
5329914|NCT00370682|13108076|P1|COMPLETED|Overall Study||40
5329915|NCT00370682|13108074|P3|STARTED|Overall Study||40
5329916|NCT00370682|13108075|P2|STARTED|Overall Study||40
5329917|NCT00370682|13108076|P1|STARTED|Overall Study||40
5329918|NCT00370552|13108118|P3|NOT COMPLETED|Overall Study||32
5329919|NCT00370552|13108119|P2|NOT COMPLETED|Overall Study||45
5329920|NCT00370552|13108120|P1|NOT COMPLETED|Overall Study||46
5329921|NCT00370552|13108118|P3|COMPLETED|Overall Study||0
5329922|NCT00370552|13108119|P2|COMPLETED|Overall Study||0
5329923|NCT00370552|13108120|P1|COMPLETED|Overall Study||0
5329924|NCT00370552|13108118|P3|STARTED|Overall Study|Randomized|32
5329925|NCT00370552|13108119|P2|STARTED|Overall Study|Randomized|45
5329926|NCT00370552|13108120|P1|STARTED|Overall Study|Randomized|46
5329927|NCT00370396|13108161|P3|NOT COMPLETED|Overall Study||1
5329928|NCT00370396|13108162|P2|NOT COMPLETED|Overall Study||1
5329929|NCT00370396|13108163|P1|NOT COMPLETED|Overall Study||11
5329930|NCT00370396|13108161|P3|COMPLETED|Overall Study||282
5329931|NCT00370396|13108162|P2|COMPLETED|Overall Study||91
5329932|NCT00370396|13108163|P1|COMPLETED|Overall Study||726
5329933|NCT00370396|13108161|P3|STARTED|Overall Study||283
5329934|NCT00370396|13108162|P2|STARTED|Overall Study||92
5329935|NCT00370396|13108163|P1|STARTED|Overall Study||737
5329936|NCT00370331|13108217|P2|NOT COMPLETED|Overall Study||23
5329937|NCT00370331|13108218|P1|NOT COMPLETED|Overall Study||7
5329938|NCT00370331|13108217|P2|COMPLETED|Overall Study||112
5329939|NCT00370331|13108218|P1|COMPLETED|Overall Study||55
5329940|NCT00370331|13108217|P2|STARTED|Overall Study||135
5329941|NCT00370331|13108218|P1|STARTED|Overall Study||62
5329942|NCT00370292|13108244|P1|NOT COMPLETED|Overall Study||13
5329943|NCT00370292|13108244|P1|COMPLETED|Overall Study||6
5329944|NCT00370292|13108244|P1|STARTED|Overall Study||19
5329945|NCT00370149|13108257|P2|NOT COMPLETED|Overall Study||19
5329946|NCT00370149|13108258|P1|NOT COMPLETED|Overall Study||19
5329947|NCT00370149|13108257|P2|COMPLETED|Overall Study||142
5329948|NCT00370149|13108258|P1|COMPLETED|Overall Study||146
5329949|NCT00370149|13108257|P2|STARTED|Overall Study||161
5329950|NCT00370149|13108258|P1|STARTED|Overall Study||165
5329951|NCT00370071|13108268|P1|NOT COMPLETED|Overall Study||2
5329952|NCT00370071|13108268|P1|COMPLETED|Overall Study||37
5329953|NCT00370071|13108268|P1|STARTED|Overall Study||39
5329954|NCT00370032|13108285|P2|NOT COMPLETED|Follow-up Period||0
5329955|NCT00370032|13108286|P1|NOT COMPLETED|Follow-up Period||1
5329956|NCT00370032|13108285|P2|COMPLETED|Follow-up Period||22
5329957|NCT00370032|13108286|P1|COMPLETED|Follow-up Period||22
5329958|NCT00370032|13108285|P2|STARTED|Follow-up Period||22
5329959|NCT00370032|13108286|P1|STARTED|Follow-up Period||23
5329960|NCT00370032|13108285|P2|NOT COMPLETED|Treatment Period 2||0
5329961|NCT00370032|13108286|P1|NOT COMPLETED|Treatment Period 2||0
5329962|NCT00370032|13108285|P2|COMPLETED|Treatment Period 2||22
5329963|NCT00370032|13108286|P1|COMPLETED|Treatment Period 2||23
5329964|NCT00370032|13108285|P2|STARTED|Treatment Period 2||22
5329965|NCT00370032|13108286|P1|STARTED|Treatment Period 2||23
5329966|NCT00370032|13108285|P2|NOT COMPLETED|Washout Period||2
5329967|NCT00370032|13108286|P1|NOT COMPLETED|Washout Period||1
5329968|NCT00370032|13108285|P2|COMPLETED|Washout Period||22
5329969|NCT00370032|13108286|P1|COMPLETED|Washout Period||23
5329970|NCT00370032|13108285|P2|STARTED|Washout Period||24
5329971|NCT00370032|13108286|P1|STARTED|Washout Period||24
5329972|NCT00370032|13108285|P2|NOT COMPLETED|Treatment Period 1||1
5329973|NCT00370032|13108286|P1|NOT COMPLETED|Treatment Period 1||0
5329974|NCT00370032|13108285|P2|COMPLETED|Treatment Period 1||24
5329975|NCT00370032|13108286|P1|COMPLETED|Treatment Period 1||24
5329976|NCT00370032|13108285|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
5329977|NCT00370032|13108286|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
5329978|NCT00369967|13108306|P2|NOT COMPLETED|Overall Study||12
5329979|NCT00369967|13108307|P1|NOT COMPLETED|Overall Study||23
5329980|NCT00369967|13108306|P2|COMPLETED|Overall Study||5
5329981|NCT00369967|13108307|P1|COMPLETED|Overall Study||8
5329982|NCT00369967|13108306|P2|STARTED|Overall Study||17
5329983|NCT00369967|13108307|P1|STARTED|Overall Study||31
5329984|NCT00369941|13108325|P2|NOT COMPLETED|Overall Study||100
5329985|NCT00369941|13108326|P1|NOT COMPLETED|Overall Study||72
5329986|NCT00369941|13108325|P2|COMPLETED|Overall Study||184
5329987|NCT00369941|13108326|P1|COMPLETED|Overall Study||210
5329988|NCT00369941|13108325|P2|Treated|Overall Study||282
5329989|NCT00369941|13108326|P1|Treated|Overall Study||281
5329990|NCT00369941|13108325|P2|STARTED|Overall Study||284
5329991|NCT00369941|13108326|P1|STARTED|Overall Study||282
5329992|NCT00369928|13108479|P3|NOT COMPLETED|Overall Study||20
5329993|NCT00369928|13108480|P2|NOT COMPLETED|Overall Study||16
5329994|NCT00369928|13108481|P1|NOT COMPLETED|Overall Study||8
5329995|NCT00369928|13108479|P3|COMPLETED|Overall Study||66
5329996|NCT00369928|13108480|P2|COMPLETED|Overall Study||69
5329997|NCT00369928|13108481|P1|COMPLETED|Overall Study||77
5329998|NCT00369928|13108479|P3|STARTED|Overall Study||86
5329999|NCT00369928|13108480|P2|STARTED|Overall Study||85
5330000|NCT00369928|13108481|P1|STARTED|Overall Study||85
5330001|NCT00369915|13108491|P2|NOT COMPLETED|Overall Study||3
5330002|NCT00369915|13108492|P1|NOT COMPLETED|Overall Study||6
5330003|NCT00369915|13108491|P2|COMPLETED|Overall Study||4
5330004|NCT00369915|13108492|P1|COMPLETED|Overall Study||4
5330005|NCT00369915|13108491|P2|STARTED|Overall Study||7
5330006|NCT00369915|13108492|P1|STARTED|Overall Study||10
5330007|NCT00369824|13108506|P6|NOT COMPLETED|Overall Study||11
5330008|NCT00369824|13108507|P5|NOT COMPLETED|Overall Study||18
5330009|NCT00369824|13108508|P4|NOT COMPLETED|Overall Study||15
5330010|NCT00369824|13108509|P3|NOT COMPLETED|Overall Study||12
5330011|NCT00369824|13108510|P2|NOT COMPLETED|Overall Study||19
5330012|NCT00369824|13108511|P1|NOT COMPLETED|Overall Study||15
5330013|NCT00369824|13108506|P6|COMPLETED|Overall Study||204
5330014|NCT00369824|13108507|P5|COMPLETED|Overall Study||196
5330015|NCT00369824|13108508|P4|COMPLETED|Overall Study||199
5330016|NCT00369824|13108509|P3|COMPLETED|Overall Study||202
5330017|NCT00369824|13108510|P2|COMPLETED|Overall Study||195
5330018|NCT00369824|13108511|P1|COMPLETED|Overall Study||197
5330019|NCT00369824|13108506|P6|STARTED|Overall Study||215
5330020|NCT00369824|13108507|P5|STARTED|Overall Study||214
5330021|NCT00369824|13108508|P4|STARTED|Overall Study||214
5330022|NCT00369824|13108509|P3|STARTED|Overall Study||214
5330023|NCT00369824|13108510|P2|STARTED|Overall Study||214
5330024|NCT00369824|13108511|P1|STARTED|Overall Study||212
5330025|NCT00369785|13108611|P2|NOT COMPLETED|Overall Study||25
5330026|NCT00369785|13108612|P1|NOT COMPLETED|Overall Study||27
5330027|NCT00369785|13108611|P2|COMPLETED|Overall Study||74
5330028|NCT00369785|13108612|P1|COMPLETED|Overall Study||72
5330029|NCT00369785|13108611|P2|STARTED|Overall Study||99
5330030|NCT00369785|13108612|P1|STARTED|Overall Study||99
5330031|NCT00369746|13108622|P2|NOT COMPLETED|Overall Study||0
5330032|NCT00369746|13108623|P1|NOT COMPLETED|Overall Study||0
5330033|NCT00369746|13108622|P2|COMPLETED|Overall Study||536
5330034|NCT00369746|13108623|P1|COMPLETED|Overall Study||138
5330035|NCT00369746|13108622|P2|STARTED|Overall Study||536
5330036|NCT00369746|13108623|P1|STARTED|Overall Study||138
5330037|NCT00369707|13108633|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
5330038|NCT00369707|13108633|P1|COMPLETED|Follow up for 2 Years After Treatment||38
5330039|NCT00369707|13108633|P1|STARTED|Follow up for 2 Years After Treatment||41
5330040|NCT00369707|13108633|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
5330041|NCT00369707|13108633|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
5330042|NCT00369707|13108633|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
5330043|NCT00369707|13108633|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
5330044|NCT00369707|13108633|P1|COMPLETED|Induction Part B (2 Cycles)||35
5330045|NCT00369707|13108633|P1|STARTED|Induction Part B (2 Cycles)||42
5330046|NCT00369707|13108633|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
5330047|NCT00369707|13108633|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
5330048|NCT00369707|13108633|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
5330049|NCT00369681|13108646|P1|NOT COMPLETED|Overall Study||1
5330050|NCT00369681|13108646|P1|COMPLETED|Overall Study||49
5330051|NCT00369681|13108646|P1|STARTED|Overall Study||50
5330052|NCT00369668|13108656|P3|NOT COMPLETED|Overall Study||7
5330053|NCT00369668|13108657|P2|NOT COMPLETED|Overall Study||5
5330054|NCT00369668|13108658|P1|NOT COMPLETED|Overall Study||4
5330055|NCT00369668|13108656|P3|COMPLETED|Overall Study||3
5330056|NCT00369668|13108657|P2|COMPLETED|Overall Study||5
5330057|NCT00369668|13108658|P1|COMPLETED|Overall Study||6
5330058|NCT00369668|13108656|P3|STARTED|Overall Study||10
5330059|NCT00369668|13108657|P2|STARTED|Overall Study||10
5330060|NCT00369668|13108658|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
5330061|NCT00369655|13108672|P1|NOT COMPLETED|Overall Study||2
5330062|NCT00369655|13108672|P1|COMPLETED|Overall Study||19
5330063|NCT00369655|13108672|P1|STARTED|Overall Study||21
5330064|NCT00369629|13108681|P4|NOT COMPLETED|Follow up for 1 Year||0
5330065|NCT00369629|13108682|P3|NOT COMPLETED|Follow up for 1 Year||3
5330066|NCT00369629|13108683|P2|NOT COMPLETED|Follow up for 1 Year||2
5330067|NCT00369629|13108684|P1|NOT COMPLETED|Follow up for 1 Year||2
5330068|NCT00369629|13108681|P4|COMPLETED|Follow up for 1 Year||0
5330069|NCT00369629|13108682|P3|COMPLETED|Follow up for 1 Year||2
5330070|NCT00369629|13108683|P2|COMPLETED|Follow up for 1 Year||1
5330071|NCT00369629|13108684|P1|COMPLETED|Follow up for 1 Year||4
5330072|NCT00369629|13108681|P4|STARTED|Follow up for 1 Year||0
5330073|NCT00369629|13108682|P3|STARTED|Follow up for 1 Year||5
5330074|NCT00369629|13108683|P2|STARTED|Follow up for 1 Year||3
5330075|NCT00369629|13108684|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
5330076|NCT00369629|13108681|P4|NOT COMPLETED|Completed 4 More Cycles||0
5330077|NCT00369629|13108682|P3|NOT COMPLETED|Completed 4 More Cycles||2
5330078|NCT00369629|13108683|P2|NOT COMPLETED|Completed 4 More Cycles||2
5330079|NCT00369629|13108684|P1|NOT COMPLETED|Completed 4 More Cycles||4
5330080|NCT00369629|13108681|P4|COMPLETED|Completed 4 More Cycles||0
5330081|NCT00369629|13108682|P3|COMPLETED|Completed 4 More Cycles||0
5330082|NCT00369629|13108683|P2|COMPLETED|Completed 4 More Cycles||0
5330083|NCT00369629|13108684|P1|COMPLETED|Completed 4 More Cycles||0
5330084|NCT00369629|13108681|P4|STARTED|Completed 4 More Cycles||0
5330085|NCT00369629|13108682|P3|STARTED|Completed 4 More Cycles||2
5330086|NCT00369629|13108683|P2|STARTED|Completed 4 More Cycles||2
5330087|NCT00369629|13108684|P1|STARTED|Completed 4 More Cycles||4
5330088|NCT00369629|13108681|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
5330089|NCT00369629|13108682|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
5330090|NCT00369629|13108683|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
5330091|NCT00369629|13108684|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
5330092|NCT00369629|13108681|P4|COMPLETED|Moved on to 4 More Cycles||0
5330093|NCT00369629|13108682|P3|COMPLETED|Moved on to 4 More Cycles||2
5330094|NCT00369629|13108683|P2|COMPLETED|Moved on to 4 More Cycles||2
5330095|NCT00369629|13108684|P1|COMPLETED|Moved on to 4 More Cycles||4
5330096|NCT00369629|13108681|P4|STARTED|Moved on to 4 More Cycles||0
5330097|NCT00369629|13108682|P3|STARTED|Moved on to 4 More Cycles||3
5330098|NCT00369629|13108683|P2|STARTED|Moved on to 4 More Cycles||2
5330099|NCT00369629|13108684|P1|STARTED|Moved on to 4 More Cycles||4
5330100|NCT00369629|13108681|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
5330101|NCT00369629|13108682|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
5330102|NCT00369629|13108683|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
5330103|NCT00369629|13108684|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
5330104|NCT00369629|13108681|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
5330105|NCT00369629|13108682|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
5330106|NCT00369629|13108683|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
5330107|NCT00369629|13108684|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
5330108|NCT00369629|13108681|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
5330109|NCT00369629|13108682|P3|STARTED|Treated 2 Cycles/Reached First Response||5
5330110|NCT00369629|13108683|P2|STARTED|Treated 2 Cycles/Reached First Response||3
5330111|NCT00369629|13108684|P1|STARTED|Treated 2 Cycles/Reached First Response||6
5330112|NCT00369590|13108696|P2|NOT COMPLETED|Overall Study||0
5330113|NCT00369590|13108697|P1|NOT COMPLETED|Overall Study||0
5330114|NCT00369590|13108696|P2|COMPLETED|Overall Study||42
5330115|NCT00369590|13108697|P1|COMPLETED|Overall Study||16
5330116|NCT00369590|13108696|P2|STARTED|Overall Study||42
5330117|NCT00369590|13108697|P1|STARTED|Overall Study||16
5330118|NCT00369577|13108715|P3|NOT COMPLETED|Overall Study||1
5330119|NCT00369577|13108716|P2|NOT COMPLETED|Overall Study||0
5330120|NCT00369577|13108717|P1|NOT COMPLETED|Overall Study||0
5330121|NCT00369577|13108715|P3|COMPLETED|Overall Study||40
5330122|NCT00369577|13108716|P2|COMPLETED|Overall Study||45
5330123|NCT00369577|13108717|P1|COMPLETED|Overall Study||43
5330124|NCT00369577|13108715|P3|STARTED|Overall Study||41
5330125|NCT00369577|13108716|P2|STARTED|Overall Study||45
5330126|NCT00369577|13108717|P1|STARTED|Overall Study||43
5330127|NCT00369564|13108736|P2|NOT COMPLETED|Overall Study||23
5330128|NCT00369564|13108737|P1|NOT COMPLETED|Overall Study||43
5330129|NCT00369564|13108736|P2|COMPLETED|Overall Study||100
5330130|NCT00369564|13108737|P1|COMPLETED|Overall Study||84
5330131|NCT00369564|13108736|P2|STARTED|Overall Study||123
5330132|NCT00369564|13108737|P1|STARTED|Overall Study||127
5330133|NCT00369512|13108743|P1|NOT COMPLETED|Overall Study||0
5330134|NCT00369512|13108743|P1|COMPLETED|Overall Study||15
5330135|NCT00369512|13108743|P1|STARTED|Overall Study||15
5330136|NCT00369486|13108754|P5|NOT COMPLETED|34-Week Visit||3
5330137|NCT00369486|13108755|P4|NOT COMPLETED|34-Week Visit||3
5330138|NCT00369486|13108756|P3|NOT COMPLETED|34-Week Visit||1
5330139|NCT00369486|13108757|P2|NOT COMPLETED|34-Week Visit||1
5330140|NCT00369486|13108758|P1|NOT COMPLETED|34-Week Visit||0
5330141|NCT00369486|13108754|P5|COMPLETED|34-Week Visit|Number of eyes|22
5330142|NCT00369486|13108755|P4|COMPLETED|34-Week Visit|Number of eyes|19
5330143|NCT00369486|13108756|P3|COMPLETED|34-Week Visit|Number of eyes|22
5330144|NCT00369486|13108757|P2|COMPLETED|34-Week Visit|Number of eyes|20
5330145|NCT00369486|13108758|P1|COMPLETED|34-Week Visit|Number of eyes|38
5330146|NCT00369486|13108754|P5|STARTED|34-Week Visit|Number of eyes that|25
5330147|NCT00369486|13108755|P4|STARTED|34-Week Visit|Number of eyes|22
5330148|NCT00369486|13108756|P3|STARTED|34-Week Visit|Number of eyes|23
5330149|NCT00369486|13108757|P2|STARTED|34-Week Visit|Number of eyes|21
5330150|NCT00369486|13108758|P1|STARTED|34-Week Visit|Number of eyes|38
5330151|NCT00369486|13108754|P5|NOT COMPLETED|17-Week Visit||1
5330152|NCT00369486|13108755|P4|NOT COMPLETED|17-Week Visit||1
5330153|NCT00369486|13108756|P3|NOT COMPLETED|17-Week Visit||1
5330154|NCT00369486|13108757|P2|NOT COMPLETED|17-Week Visit||0
5330155|NCT00369486|13108758|P1|NOT COMPLETED|17-Week Visit||0
5330156|NCT00369486|13108754|P5|COMPLETED|17-Week Visit|Number of eyes|24
5330157|NCT00369486|13108755|P4|COMPLETED|17-Week Visit|Number of eyes|21
5330158|NCT00369486|13108756|P3|COMPLETED|17-Week Visit|Number of eyes|22
5330159|NCT00369486|13108757|P2|COMPLETED|17-Week Visit|Number of eyes|21
5330160|NCT00369486|13108758|P1|COMPLETED|17-Week Visit|Number of eyes|38
5330161|NCT00369486|13108754|P5|STARTED|17-Week Visit|Number of eyes|25
5330162|NCT00369486|13108755|P4|STARTED|17-Week Visit|Number of eyes|22
5330163|NCT00369486|13108756|P3|STARTED|17-Week Visit|Number of eyes|23
5330164|NCT00369486|13108757|P2|STARTED|17-Week Visit|Number of eyes|21
5330165|NCT00369486|13108758|P1|STARTED|17-Week Visit|Number of eyes|38
5330166|NCT00369486|13108754|P5|NOT COMPLETED|8-Week Visit||1
5330167|NCT00369486|13108755|P4|NOT COMPLETED|8-Week Visit||1
5330168|NCT00369486|13108756|P3|NOT COMPLETED|8-Week Visit||0
5330169|NCT00369486|13108757|P2|NOT COMPLETED|8-Week Visit||1
5330170|NCT00369486|13108758|P1|NOT COMPLETED|8-Week Visit||0
5330171|NCT00369486|13108754|P5|COMPLETED|8-Week Visit|Number of eyes|24
5330172|NCT00369486|13108755|P4|COMPLETED|8-Week Visit|Number of eyes|21
5330173|NCT00369486|13108756|P3|COMPLETED|8-Week Visit|Number of eyes|22
5330174|NCT00369486|13108757|P2|COMPLETED|8-Week Visit|Number of eyes|20
5330175|NCT00369486|13108758|P1|COMPLETED|8-Week Visit|Number of eyes|38
5330176|NCT00369486|13108754|P5|STARTED|8-Week Visit|Number of eyes|25
5330177|NCT00369486|13108755|P4|STARTED|8-Week Visit|Number of eyes|22
5330178|NCT00369486|13108756|P3|STARTED|8-Week Visit|Number of eyes|22
5330179|NCT00369486|13108757|P2|STARTED|8-Week Visit|Number of eyes|21
5330180|NCT00369486|13108758|P1|STARTED|8-Week Visit|Number of eyes|38
5330181|NCT00369486|13108754|P5|NOT COMPLETED|4-Week Visit||1
5330182|NCT00369486|13108755|P4|NOT COMPLETED|4-Week Visit||2
5330183|NCT00369486|13108756|P3|NOT COMPLETED|4-Week Visit||1
5330184|NCT00369486|13108757|P2|NOT COMPLETED|4-Week Visit||2
5330185|NCT00369486|13108758|P1|NOT COMPLETED|4-Week Visit||2
5330186|NCT00369486|13108754|P5|COMPLETED|4-Week Visit|Number of eyes|24
5330187|NCT00369486|13108755|P4|COMPLETED|4-Week Visit|Number of eyes|20
5330188|NCT00369486|13108756|P3|COMPLETED|4-Week Visit|Number of eyes|22
5330189|NCT00369486|13108757|P2|COMPLETED|4-Week Visit|Number of eyes;|19
5330190|NCT00369486|13108758|P1|COMPLETED|4-Week Visit|Number of eyes|36
5330191|NCT00369486|13108754|P5|STARTED|4-Week Visit|Number of eyes|25
5330192|NCT00369486|13108755|P4|STARTED|4-Week Visit|Number of eyes|22
5330193|NCT00369486|13108756|P3|STARTED|4-Week Visit|Number of eyes|23
5330194|NCT00369486|13108757|P2|STARTED|4-Week Visit|Number of eyes|21
5330195|NCT00369486|13108758|P1|STARTED|4-Week Visit|Number of eyes|38
5330196|NCT00369382|13108797|P2|NOT COMPLETED|Overall Study||3
5330197|NCT00369382|13108798|P1|NOT COMPLETED|Overall Study||10
5330198|NCT00369382|13108797|P2|COMPLETED|Overall Study||54
5330199|NCT00369382|13108798|P1|COMPLETED|Overall Study||49
5330200|NCT00369382|13108797|P2|Completed Assigned Treatment Regimen|Overall Study||33
5330201|NCT00369382|13108798|P1|Completed Assigned Treatment Regimen|Overall Study||48
5330202|NCT00369382|13108797|P2|Received Treatment|Overall Study||57
5330203|NCT00369382|13108798|P1|Received Treatment|Overall Study||57
5330204|NCT00369382|13108797|P2|STARTED|Overall Study||57
5330205|NCT00369382|13108798|P1|STARTED|Overall Study||59
5330206|NCT00369343|13108831|P2|NOT COMPLETED|Open-label Phase||30
5330207|NCT00369343|13108832|P1|NOT COMPLETED|Open-label Phase||57
5330208|NCT00369343|13108831|P2|COMPLETED|Open-label Phase||79
5330209|NCT00369343|13108832|P1|COMPLETED|Open-label Phase||155
5330210|NCT00369343|13108831|P2|STARTED|Open-label Phase||109
5330211|NCT00369343|13108832|P1|STARTED|Open-label Phase||212
5330212|NCT00369343|13108831|P2|NOT COMPLETED|Double-blind Phase||16
5330213|NCT00369343|13108832|P1|NOT COMPLETED|Double-blind Phase||44
5330214|NCT00369343|13108831|P2|COMPLETED|Double-blind Phase||109
5330215|NCT00369343|13108832|P1|COMPLETED|Double-blind Phase||212
5330216|NCT00369343|13108831|P2|STARTED|Double-blind Phase||125
5330217|NCT00369343|13108832|P1|STARTED|Double-blind Phase||256
5330218|NCT00369317|13108865|P1|NOT COMPLETED|Overall Study||20
5330219|NCT00369317|13108865|P1|COMPLETED|Overall Study||185
5330220|NCT00369317|13108865|P1|STARTED|Overall Study||205
5330221|NCT00369278|13108881|P2|NOT COMPLETED|Overall Study||21
5330222|NCT00369278|13108882|P1|NOT COMPLETED|Overall Study||24
5330223|NCT00369278|13108881|P2|COMPLETED|Overall Study||44
5330224|NCT00369278|13108882|P1|COMPLETED|Overall Study||39
5330225|NCT00369278|13108881|P2|STARTED|Overall Study||65
5330226|NCT00369278|13108882|P1|STARTED|Overall Study||63
5330227|NCT00369265|13108898|P2|NOT COMPLETED|Overall Study||7
5330228|NCT00369265|13108899|P1|NOT COMPLETED|Overall Study||4
5330229|NCT00369265|13108898|P2|COMPLETED|Overall Study||0
5330230|NCT00369265|13108899|P1|COMPLETED|Overall Study||0
5330231|NCT00369265|13108898|P2|STARTED|Overall Study||7
5330232|NCT00369265|13108899|P1|STARTED|Overall Study||4
5330233|NCT00369226|13108907|P2|NOT COMPLETED|Phase II (45 Days)||0
5330234|NCT00369226|13108908|P1|NOT COMPLETED|Phase II (45 Days)||0
5330235|NCT00369226|13108907|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
5330236|NCT00369226|13108908|P1|COMPLETED|Phase II (45 Days)||0
5330237|NCT00369226|13108907|P2|STARTED|Phase II (45 Days)||32
5330238|NCT00369226|13108908|P1|STARTED|Phase II (45 Days)||0
5330239|NCT00369226|13108907|P2|NOT COMPLETED|Phase I (45 Days)||0
5330240|NCT00369226|13108908|P1|NOT COMPLETED|Phase I (45 Days)||0
5330241|NCT00369226|13108907|P2|COMPLETED|Phase I (45 Days)||0
5330242|NCT00369226|13108908|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
5330243|NCT00369226|13108907|P2|STARTED|Phase I (45 Days)||0
5330244|NCT00369226|13108908|P1|STARTED|Phase I (45 Days)||13
5330245|NCT00369161|13108920|P2|NOT COMPLETED|Overall Study||24
5330246|NCT00369161|13108921|P1|NOT COMPLETED|Overall Study||27
5330247|NCT00369161|13108920|P2|COMPLETED|Overall Study||95
5330248|NCT00369161|13108921|P1|COMPLETED|Overall Study||82
5330249|NCT00369161|13108920|P2|Intention to Treat (ITT)|Overall Study||117
5330250|NCT00369161|13108921|P1|Intention to Treat (ITT)|Overall Study||107
5330251|NCT00369161|13108920|P2|STARTED|Overall Study||119
5330252|NCT00369161|13108921|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
5330253|NCT00369122|13108931|P1|NOT COMPLETED|Overall Study||11
5330254|NCT00369122|13108931|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
5330255|NCT00369122|13108931|P1|STARTED|Overall Study||60
5330256|NCT00368992|13108938|P1|NOT COMPLETED|Overall Study||110
5330257|NCT00368992|13108938|P1|COMPLETED|Overall Study||0
5330258|NCT00368992|13108938|P1|STARTED|Overall Study||110
5330259|NCT00368979|13108947|P2|NOT COMPLETED|Overall Study||30
5330260|NCT00368979|13108948|P1|NOT COMPLETED|Overall Study||25
5330261|NCT00368979|13108947|P2|COMPLETED|Overall Study||163
5330262|NCT00368979|13108948|P1|COMPLETED|Overall Study||160
5330263|NCT00368979|13108947|P2|STARTED|Overall Study||193
5330264|NCT00368979|13108948|P1|STARTED|Overall Study||185
5330265|NCT00368966|13108964|P2|NOT COMPLETED|Toddler Dose||3
5330266|NCT00368966|13108965|P1|NOT COMPLETED|Toddler Dose||1
5330267|NCT00368966|13108964|P2|COMPLETED|Toddler Dose||286
5330268|NCT00368966|13108965|P1|COMPLETED|Toddler Dose||292
5330269|NCT00368966|13108964|P2|STARTED|Toddler Dose||289
5330270|NCT00368966|13108965|P1|STARTED|Toddler Dose||293
5330271|NCT00368966|13108964|P2|NOT COMPLETED|After Infant||5
5330272|NCT00368966|13108965|P1|NOT COMPLETED|After Infant||6
5330273|NCT00368966|13108964|P2|COMPLETED|After Infant||289
5330274|NCT00368966|13108965|P1|COMPLETED|After Infant||293
5330275|NCT00368966|13108964|P2|STARTED|After Infant||294
5330276|NCT00368966|13108965|P1|STARTED|After Infant||299
5330277|NCT00368966|13108964|P2|NOT COMPLETED|Infant Series||10
5330278|NCT00368966|13108965|P1|NOT COMPLETED|Infant Series||16
5330279|NCT00368966|13108964|P2|COMPLETED|Infant Series||294
5330280|NCT00368966|13108965|P1|COMPLETED|Infant Series||299
5330281|NCT00368966|13108964|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
5330282|NCT00368966|13108965|P1|Vaccinated Dose 3|Infant Series||301
5330283|NCT00368966|13108964|P2|Vaccinated Dose 2|Infant Series||298
5330284|NCT00368966|13108965|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
5330285|NCT00368966|13108964|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
5330286|NCT00368966|13108965|P1|Vaccinated Dose 1|Infant Series||314
5330287|NCT00368966|13108964|P2|STARTED|Infant Series||304
5330288|NCT00368966|13108965|P1|STARTED|Infant Series||315
5330289|NCT00368940|13109021|P2|NOT COMPLETED|Completed 12-wk Treatment||5
5330290|NCT00368940|13109022|P1|NOT COMPLETED|Completed 12-wk Treatment||6
5330291|NCT00368940|13109021|P2|COMPLETED|Completed 12-wk Treatment||32
5330292|NCT00368940|13109022|P1|COMPLETED|Completed 12-wk Treatment||31
5330293|NCT00368940|13109021|P2|STARTED|Completed 12-wk Treatment||37
5330294|NCT00368940|13109022|P1|STARTED|Completed 12-wk Treatment||37
5330295|NCT00368940|13109021|P2|NOT COMPLETED|Intention-to-Treat||0
5330296|NCT00368940|13109022|P1|NOT COMPLETED|Intention-to-Treat||0
5330297|NCT00368940|13109021|P2|COMPLETED|Intention-to-Treat||37
5330298|NCT00368940|13109022|P1|COMPLETED|Intention-to-Treat||37
5330299|NCT00368940|13109021|P2|STARTED|Intention-to-Treat||37
5330300|NCT00368940|13109022|P1|STARTED|Intention-to-Treat||37
5330301|NCT00368927|13109036|P2|NOT COMPLETED|Overall Study||3
5330302|NCT00368927|13109037|P1|NOT COMPLETED|Overall Study||5
5330303|NCT00368927|13109036|P2|COMPLETED|Overall Study||27
5330304|NCT00368927|13109037|P1|COMPLETED|Overall Study||26
5330305|NCT00368927|13109036|P2|STARTED|Overall Study||30
5330306|NCT00368927|13109037|P1|STARTED|Overall Study||31
5330307|NCT00368875|13109045|P2|NOT COMPLETED|Overall Study||48
5330308|NCT00368875|13109046|P1|NOT COMPLETED|Overall Study||6
5330309|NCT00368875|13109045|P2|COMPLETED|Overall Study||0
5330310|NCT00368875|13109046|P1|COMPLETED|Overall Study||0
5330311|NCT00368875|13109045|P2|STARTED|Overall Study||48
5330312|NCT00368875|13109046|P1|STARTED|Overall Study||6
5330313|NCT00368849|13109054|P2|NOT COMPLETED|Overall Study||2
5330314|NCT00368849|13109055|P1|NOT COMPLETED|Overall Study||0
5330315|NCT00368849|13109054|P2|COMPLETED|Overall Study||8
5330316|NCT00368849|13109055|P1|COMPLETED|Overall Study||10
5330317|NCT00368849|13109054|P2|STARTED|Overall Study||10
5330318|NCT00368849|13109055|P1|STARTED|Overall Study||10
5330319|NCT00368745|13109071|P2|NOT COMPLETED|Double-blind Treatment Period||31
5330320|NCT00368745|13109072|P1|NOT COMPLETED|Double-blind Treatment Period||26
5330321|NCT00368745|13109071|P2|COMPLETED|Double-blind Treatment Period||19
5330322|NCT00368745|13109072|P1|COMPLETED|Double-blind Treatment Period||30
5330323|NCT00368745|13109071|P2|STARTED|Double-blind Treatment Period||50
5330324|NCT00368745|13109072|P1|STARTED|Double-blind Treatment Period||56
5330325|NCT00368745|13109071|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
5330326|NCT00368745|13109072|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
5330327|NCT00368745|13109071|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
5330328|NCT00368745|13109072|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
5330329|NCT00368745|13109071|P2|STARTED|Randomized to Double-blind Treatment||51
5330330|NCT00368745|13109072|P1|STARTED|Randomized to Double-blind Treatment||57
5330331|NCT00368654|13109106|P4|NOT COMPLETED|Overall Study||3
5330332|NCT00368654|13109107|P3|NOT COMPLETED|Overall Study||3
5330333|NCT00368654|13109108|P2|NOT COMPLETED|Overall Study||3
5330334|NCT00368654|13109109|P1|NOT COMPLETED|Overall Study||3
5330335|NCT00368654|13109106|P4|COMPLETED|Overall Study||0
5330336|NCT00368654|13109107|P3|COMPLETED|Overall Study||0
5330337|NCT00368654|13109108|P2|COMPLETED|Overall Study||0
5330338|NCT00368654|13109109|P1|COMPLETED|Overall Study||0
5330339|NCT00368654|13109106|P4|STARTED|Overall Study||3
5330340|NCT00368654|13109107|P3|STARTED|Overall Study||3
5330341|NCT00368654|13109108|P2|STARTED|Overall Study||3
5330342|NCT00368654|13109109|P1|STARTED|Overall Study||3
5330343|NCT00368641|13109125|P2|NOT COMPLETED|Overall Study||6
5330344|NCT00368641|13109126|P1|NOT COMPLETED|Overall Study||6
5330345|NCT00368641|13109125|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
5330346|NCT00368641|13109126|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
5330347|NCT00368641|13109125|P2|STARTED|Overall Study||6
5330348|NCT00368641|13109126|P1|STARTED|Overall Study||6
5330349|NCT00368550|13109134|P2|NOT COMPLETED|Overall Study||23
5330350|NCT00368550|13109135|P1|NOT COMPLETED|Overall Study||28
5330351|NCT00368550|13109134|P2|COMPLETED|Overall Study||48
5330352|NCT00368550|13109135|P1|COMPLETED|Overall Study||35
5330353|NCT00368550|13109134|P2|STARTED|Overall Study||71
5330354|NCT00368550|13109135|P1|STARTED|Overall Study||63
5330355|NCT00368537|13109147|P2|NOT COMPLETED|Baseline Participants||24
5330356|NCT00368537|13109148|P1|NOT COMPLETED|Baseline Participants||24
5330357|NCT00368537|13109147|P2|COMPLETED|Baseline Participants||239
5330358|NCT00368537|13109148|P1|COMPLETED|Baseline Participants||244
5330359|NCT00368537|13109147|P2|STARTED|Baseline Participants||263
5330360|NCT00368537|13109148|P1|STARTED|Baseline Participants||268
5330361|NCT00368537|13109147|P2|NOT COMPLETED|Randomization||6
5330362|NCT00368537|13109148|P1|NOT COMPLETED|Randomization||13
5330363|NCT00368537|13109147|P2|COMPLETED|Randomization||263
5330364|NCT00368537|13109148|P1|COMPLETED|Randomization||268
5330365|NCT00368537|13109147|P2|STARTED|Randomization||269
5330366|NCT00368537|13109148|P1|STARTED|Randomization||281
5330367|NCT00368472|13109162|P1|NOT COMPLETED|Overall Study||105
5330368|NCT00368472|13109162|P1|COMPLETED|Overall Study||33
5330369|NCT00368472|13109162|P1|STARTED|Overall Study||138
5330370|NCT00368459|13109170|P2|NOT COMPLETED|Overall Study||1
5330371|NCT00368459|13109171|P1|NOT COMPLETED|Overall Study||2
5330372|NCT00368459|13109170|P2|COMPLETED|Overall Study||20
5330373|NCT00368459|13109171|P1|COMPLETED|Overall Study||19
5330374|NCT00368459|13109170|P2|STARTED|Overall Study||21
5330375|NCT00368459|13109171|P1|STARTED|Overall Study||21
5330376|NCT00368355|13109197|P2|NOT COMPLETED|Overall Study||17
5330377|NCT00368355|13109198|P1|NOT COMPLETED|Overall Study||11
5330378|NCT00368355|13109197|P2|COMPLETED|Overall Study||11
5330379|NCT00368355|13109198|P1|COMPLETED|Overall Study||7
5330380|NCT00368355|13109197|P2|STARTED|Overall Study||28
5330381|NCT00368355|13109198|P1|STARTED|Overall Study||18
5330382|NCT00368316|13109214|P2|NOT COMPLETED|Overall Study||46
5330383|NCT00368316|13109215|P1|NOT COMPLETED|Overall Study||42
5330384|NCT00368316|13109214|P2|COMPLETED|Overall Study||1319
5330385|NCT00368316|13109215|P1|COMPLETED|Overall Study||1392
5330386|NCT00368316|13109214|P2|STARTED|Overall Study||1365
5330387|NCT00368316|13109215|P1|STARTED|Overall Study||1434
5330388|NCT00368290|13109227|P2|NOT COMPLETED|Overall Study||10
5330389|NCT00368290|13109228|P1|NOT COMPLETED|Overall Study||13
5330390|NCT00368290|13109227|P2|COMPLETED|Overall Study||37
5330391|NCT00368290|13109228|P1|COMPLETED|Overall Study||34
5330392|NCT00368290|13109227|P2|STARTED|Overall Study||47
5330393|NCT00368290|13109228|P1|STARTED|Overall Study||47
5330394|NCT00368277|13109238|P2|NOT COMPLETED|Overall Study||108
5330395|NCT00368277|13109239|P1|NOT COMPLETED|Overall Study||113
5330396|NCT00368277|13109238|P2|COMPLETED|Overall Study||336
5330397|NCT00368277|13109239|P1|COMPLETED|Overall Study||344
5330398|NCT00368277|13109238|P2|STARTED|Overall Study||444
5330399|NCT00368277|13109239|P1|STARTED|Overall Study||457
5330400|NCT00368251|13109254|P3|NOT COMPLETED|Overall Study||1
5330401|NCT00368251|13109255|P2|NOT COMPLETED|Overall Study||0
5330402|NCT00368251|13109256|P1|NOT COMPLETED|Overall Study||1
5330403|NCT00368251|13109254|P3|COMPLETED|Overall Study||17
5330404|NCT00368251|13109255|P2|COMPLETED|Overall Study||20
5330405|NCT00368251|13109256|P1|COMPLETED|Overall Study||17
5330406|NCT00368251|13109254|P3|STARTED|Overall Study||18
5330407|NCT00368251|13109255|P2|STARTED|Overall Study||20
5330408|NCT00368251|13109256|P1|STARTED|Overall Study||18
5330409|NCT00368108|13109279|P3|NOT COMPLETED|Overall Study||68
5330410|NCT00368108|13109280|P2|NOT COMPLETED|Overall Study||53
5330411|NCT00368108|13109281|P1|NOT COMPLETED|Overall Study||64
5330412|NCT00368108|13109279|P3|COMPLETED|Overall Study||182
5330413|NCT00368108|13109280|P2|COMPLETED|Overall Study||198
5330414|NCT00368108|13109281|P1|COMPLETED|Overall Study||187
5330415|NCT00368108|13109279|P3|STARTED|Overall Study||250
5330416|NCT00368108|13109280|P2|STARTED|Overall Study||251
5330417|NCT00368108|13109281|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
5330418|NCT00368069|13109300|P2|NOT COMPLETED|Overall Study||7
5330419|NCT00368069|13109301|P1|NOT COMPLETED|Overall Study||8
5330420|NCT00368069|13109300|P2|COMPLETED|Overall Study||72
5330421|NCT00368069|13109301|P1|COMPLETED|Overall Study||71
5330422|NCT00368069|13109300|P2|STARTED|Overall Study||79
5330423|NCT00368069|13109301|P1|STARTED|Overall Study||79
5330424|NCT00367991|13109319|P2|NOT COMPLETED|Overall Study||2
5330425|NCT00367991|13109320|P1|NOT COMPLETED|Overall Study||2
5330426|NCT00367991|13109319|P2|COMPLETED|Overall Study||13
5330427|NCT00367991|13109320|P1|COMPLETED|Overall Study||27
5330428|NCT00367991|13109319|P2|STARTED|Overall Study||15
5330429|NCT00367991|13109320|P1|STARTED|Overall Study||29
5330430|NCT00367835|13109338|P2|NOT COMPLETED|Overall Study||31
5330431|NCT00367835|13109339|P1|NOT COMPLETED|Overall Study||29
5330432|NCT00367835|13109338|P2|COMPLETED|Overall Study||48
5330433|NCT00367835|13109339|P1|COMPLETED|Overall Study||109
5330434|NCT00367835|13109338|P2|STARTED|Overall Study||79
5330435|NCT00367835|13109339|P1|STARTED|Overall Study||138
5330436|NCT00367770|13109365|P1|NOT COMPLETED|Overall Study||2
5330437|NCT00367770|13109365|P1|COMPLETED|Overall Study||35
5330438|NCT00367770|13109365|P1|STARTED|Overall Study||37
5330439|NCT00367744|13109373|P2|NOT COMPLETED|Overall Study||5
5330440|NCT00367744|13109374|P1|NOT COMPLETED|Overall Study||4
5330441|NCT00367744|13109373|P2|COMPLETED|Overall Study||32
5330442|NCT00367744|13109374|P1|COMPLETED|Overall Study||30
5330443|NCT00367744|13109373|P2|STARTED|Overall Study||37
5330444|NCT00367744|13109374|P1|STARTED|Overall Study||34
5330445|NCT00367679|13109382|P1|NOT COMPLETED|Overall Study||0
5330446|NCT00367679|13109382|P1|COMPLETED|Overall Study||35
5330447|NCT00367679|13109382|P1|STARTED|Overall Study||35
5330448|NCT00367640|13109403|P4|NOT COMPLETED|Overall Study||10
5330449|NCT00367640|13109404|P3|NOT COMPLETED|Overall Study||19
5330450|NCT00367640|13109405|P2|NOT COMPLETED|Overall Study||22
5330451|NCT00367640|13109406|P1|NOT COMPLETED|Overall Study||18
5330452|NCT00367640|13109403|P4|COMPLETED|Overall Study||146
5330453|NCT00367640|13109404|P3|COMPLETED|Overall Study||141
5330454|NCT00367640|13109405|P2|COMPLETED|Overall Study||133
5330455|NCT00367640|13109406|P1|COMPLETED|Overall Study||139
5330456|NCT00367640|13109403|P4|STARTED|Overall Study||156
5330457|NCT00367640|13109404|P3|STARTED|Overall Study||160
5330458|NCT00367640|13109405|P2|STARTED|Overall Study||155
5330459|NCT00367640|13109406|P1|STARTED|Overall Study||157
5330460|NCT00367601|13109416|P1|NOT COMPLETED|Overall Study||0
5330461|NCT00367601|13109416|P1|COMPLETED|Overall Study||25
5330462|NCT00367601|13109416|P1|STARTED|Overall Study||25
5330463|NCT00367484|13109422|P1|NOT COMPLETED|Overall Study||17
5330464|NCT00367484|13109422|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
5330465|NCT00367484|13109422|P1|STARTED|Overall Study||460
5330466|NCT00367458|13109428|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
5330467|NCT00367458|13109429|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
5330468|NCT00367458|13109428|P2|COMPLETED|Second Intervention - 8 Weeks||12
5330469|NCT00367458|13109429|P1|COMPLETED|Second Intervention - 8 Weeks||10
5330470|NCT00367458|13109428|P2|STARTED|Second Intervention - 8 Weeks||12
5330471|NCT00367458|13109429|P1|STARTED|Second Intervention - 8 Weeks||10
5330472|NCT00367458|13109428|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
5330473|NCT00367458|13109429|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
5330474|NCT00367458|13109428|P2|COMPLETED|Washout Period - 4-6 Weeks||12
5330475|NCT00367458|13109429|P1|COMPLETED|Washout Period - 4-6 Weeks||10
5330476|NCT00367458|13109428|P2|STARTED|Washout Period - 4-6 Weeks||12
5330477|NCT00367458|13109429|P1|STARTED|Washout Period - 4-6 Weeks||10
5330478|NCT00367458|13109428|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
5330479|NCT00367458|13109429|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
5330480|NCT00367458|13109428|P2|COMPLETED|First Intervention - 8 Weeks||12
5330481|NCT00367458|13109429|P1|COMPLETED|First Intervention - 8 Weeks||10
5330482|NCT00367458|13109428|P2|STARTED|First Intervention - 8 Weeks||12
5330483|NCT00367458|13109429|P1|STARTED|First Intervention - 8 Weeks||12
5330484|NCT00367432|13109443|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
5330485|NCT00367432|13109444|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
5330486|NCT00367432|13109443|P2|COMPLETED|Second Period (up to 54 Months)||69
5330487|NCT00367432|13109444|P1|COMPLETED|Second Period (up to 54 Months)||188
5330488|NCT00367432|13109443|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
5330489|NCT00367432|13109444|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
5330490|NCT00367432|13109443|P2|NOT COMPLETED|First Period (16 Weeks)||0
5330491|NCT00367432|13109444|P1|NOT COMPLETED|First Period (16 Weeks)||38
5330492|NCT00367432|13109443|P2|COMPLETED|First Period (16 Weeks)||0
5330493|NCT00367432|13109444|P1|COMPLETED|First Period (16 Weeks)||275
5330494|NCT00367432|13109443|P2|STARTED|First Period (16 Weeks)||0
5330495|NCT00367432|13109444|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
5330496|NCT00367380|13109459|P3|NOT COMPLETED|Overall Study||0
5330497|NCT00367380|13109460|P2|NOT COMPLETED|Overall Study||0
5330498|NCT00367380|13109461|P1|NOT COMPLETED|Overall Study||0
5330499|NCT00367380|13109459|P3|COMPLETED|Overall Study||6
5330500|NCT00367380|13109460|P2|COMPLETED|Overall Study||6
5330501|NCT00367380|13109461|P1|COMPLETED|Overall Study||6
5330502|NCT00367380|13109459|P3|STARTED|Overall Study||6
5330503|NCT00367380|13109460|P2|STARTED|Overall Study||6
5330504|NCT00367380|13109461|P1|STARTED|Overall Study||6
5330505|NCT00367341|13109471|P2|NOT COMPLETED|Overall Study||0
5330506|NCT00367341|13109472|P1|NOT COMPLETED|Overall Study||2
5330507|NCT00367341|13109471|P2|COMPLETED|Overall Study||40
5330508|NCT00367341|13109472|P1|COMPLETED|Overall Study||40
5330509|NCT00367341|13109471|P2|STARTED|Overall Study||40
5330510|NCT00367341|13109472|P1|STARTED|Overall Study||42
5330511|NCT00367237|13109482|P2|NOT COMPLETED|Overall Study||11
5330512|NCT00367237|13109483|P1|NOT COMPLETED|Overall Study||10
5330513|NCT00367237|13109482|P2|COMPLETED|Overall Study||47
5330514|NCT00367237|13109483|P1|COMPLETED|Overall Study||47
5330515|NCT00367237|13109482|P2|STARTED|Overall Study|Number of subjects randomized|58
5330516|NCT00367237|13109483|P1|STARTED|Overall Study|Number of subjects randomized|57
5330517|NCT00367133|13109492|P3|NOT COMPLETED|3 Years||18
5330518|NCT00367133|13109493|P2|NOT COMPLETED|3 Years||23
5330519|NCT00367133|13109494|P1|NOT COMPLETED|3 Years||28
5330520|NCT00367133|13109492|P3|COMPLETED|3 Years||98
5330521|NCT00367133|13109493|P2|COMPLETED|3 Years||93
5330522|NCT00367133|13109494|P1|COMPLETED|3 Years||115
5330523|NCT00367133|13109492|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
5330524|NCT00367133|13109493|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
5330525|NCT00367133|13109494|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
5330526|NCT00367133|13109492|P3|NOT COMPLETED|2 Years||49
5330527|NCT00367133|13109493|P2|NOT COMPLETED|2 Years||36
5330528|NCT00367133|13109494|P1|NOT COMPLETED|2 Years||58
5330529|NCT00367133|13109492|P3|COMPLETED|2 Years||205
5330530|NCT00367133|13109493|P2|COMPLETED|2 Years||220
5330531|NCT00367133|13109494|P1|COMPLETED|2 Years||272
5330532|NCT00367133|13109492|P3|STARTED|2 Years|Number of Eyes|254
5330533|NCT00367133|13109493|P2|STARTED|2 Years|Number of Eyes|256
5330534|NCT00367133|13109494|P1|STARTED|2 Years|Number of Eyes|330
5330535|NCT00367055|13109546|P2|NOT COMPLETED|Overall Study||11
5330536|NCT00367055|13109547|P1|NOT COMPLETED|Overall Study||11
5330537|NCT00367055|13109546|P2|COMPLETED|Overall Study||30
5330538|NCT00367055|13109547|P1|COMPLETED|Overall Study||32
5330539|NCT00367055|13109546|P2|STARTED|Overall Study||41
5330540|NCT00367055|13109547|P1|STARTED|Overall Study||43
5330541|NCT00367003|13109561|P1|NOT COMPLETED|Overall Study||9
5330542|NCT00367003|13109561|P1|COMPLETED|Overall Study||28
5330543|NCT00367003|13109561|P1|STARTED|Overall Study||37
5330544|NCT00366899|13109567|P2|NOT COMPLETED|Toddler Dose||1
5330545|NCT00366899|13109568|P1|NOT COMPLETED|Toddler Dose||2
5330546|NCT00366899|13109567|P2|COMPLETED|Toddler Dose||281
5330547|NCT00366899|13109568|P1|COMPLETED|Toddler Dose||285
5330548|NCT00366899|13109567|P2|STARTED|Toddler Dose||282
5330549|NCT00366899|13109568|P1|STARTED|Toddler Dose||287
5330550|NCT00366899|13109567|P2|NOT COMPLETED|After Infant Series||9
5330551|NCT00366899|13109568|P1|NOT COMPLETED|After Infant Series||7
5330552|NCT00366899|13109567|P2|COMPLETED|After Infant Series||282
5330553|NCT00366899|13109568|P1|COMPLETED|After Infant Series||287
5330554|NCT00366899|13109567|P2|STARTED|After Infant Series||291
5330555|NCT00366899|13109568|P1|STARTED|After Infant Series||294
5330556|NCT00366899|13109567|P2|NOT COMPLETED|Infant Series||12
5330557|NCT00366899|13109568|P1|NOT COMPLETED|Infant Series||9
5330558|NCT00366899|13109567|P2|COMPLETED|Infant Series||291
5330559|NCT00366899|13109568|P1|COMPLETED|Infant Series||294
5330560|NCT00366899|13109567|P2|Vaccinated Dose 2|Infant Series||293
5330561|NCT00366899|13109568|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
5330562|NCT00366899|13109567|P2|Vaccinated Dose 1|Infant Series||302
5330563|NCT00366899|13109568|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
5330564|NCT00366899|13109567|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
5330565|NCT00366899|13109568|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
5330566|NCT00366678|13109628|P3|NOT COMPLETED|Toddler Dose||0
5330567|NCT00366678|13109629|P2|NOT COMPLETED|Toddler Dose||1
5330568|NCT00366678|13109630|P1|NOT COMPLETED|Toddler Dose||5
5330569|NCT00366678|13109628|P3|COMPLETED|Toddler Dose||137
5330570|NCT00366678|13109629|P2|COMPLETED|Toddler Dose||151
5330571|NCT00366678|13109630|P1|COMPLETED|Toddler Dose||268
5330572|NCT00366678|13109628|P3|STARTED|Toddler Dose||137
5330573|NCT00366678|13109629|P2|STARTED|Toddler Dose||152
5330574|NCT00366678|13109630|P1|STARTED|Toddler Dose||273
5330575|NCT00366678|13109628|P3|NOT COMPLETED|After Infant||0
5330576|NCT00366678|13109629|P2|NOT COMPLETED|After Infant||10
5330577|NCT00366678|13109630|P1|NOT COMPLETED|After Infant||17
5330578|NCT00366678|13109628|P3|COMPLETED|After Infant||0
5330579|NCT00366678|13109629|P2|COMPLETED|After Infant||289
5330580|NCT00366678|13109630|P1|COMPLETED|After Infant||273
5330581|NCT00366678|13109628|P3|STARTED|After Infant||0
5330582|NCT00366678|13109629|P2|STARTED|After Infant||299
5330583|NCT00366678|13109630|P1|STARTED|After Infant||290
5330584|NCT00366678|13109628|P3|NOT COMPLETED|Infant Series||0
5330585|NCT00366678|13109629|P2|NOT COMPLETED|Infant Series||10
5330586|NCT00366678|13109630|P1|NOT COMPLETED|Infant Series||14
5330587|NCT00366678|13109628|P3|COMPLETED|Infant Series||0
5330588|NCT00366678|13109629|P2|COMPLETED|Infant Series||299
5330589|NCT00366678|13109630|P1|COMPLETED|Infant Series||290
5330590|NCT00366678|13109628|P3|Vaccinated Dose 3|Infant Series||0
5330591|NCT00366678|13109629|P2|Vaccinated Dose 3|Infant Series||302
5330592|NCT00366678|13109630|P1|Vaccinated Dose 3|Infant Series||291
5330593|NCT00366678|13109628|P3|Vaccinated Dose 2|Infant Series||0
5330594|NCT00366678|13109629|P2|Vaccinated Dose 2|Infant Series||304
5330595|NCT00366678|13109630|P1|Vaccinated Dose 2|Infant Series||295
5330596|NCT00366678|13109628|P3|Vaccinated Dose 1|Infant Series||0
5330597|NCT00366678|13109629|P2|Vaccinated Dose 1|Infant Series||309
5330598|NCT00366678|13109630|P1|Vaccinated Dose 1|Infant Series||302
5330599|NCT00366678|13109628|P3|STARTED|Infant Series||0
5330600|NCT00366678|13109629|P2|STARTED|Infant Series||309
5330601|NCT00366678|13109630|P1|STARTED|Infant Series||304
5330602|NCT00366626|13109697|P2|NOT COMPLETED|Overall Study||0
5330603|NCT00366626|13109698|P1|NOT COMPLETED|Overall Study||0
5330604|NCT00366626|13109697|P2|COMPLETED|Overall Study||45
5330605|NCT00366626|13109698|P1|COMPLETED|Overall Study||38
5330606|NCT00366626|13109697|P2|STARTED|Overall Study||45
5330607|NCT00366626|13109698|P1|STARTED|Overall Study||38
5330608|NCT00366548|13109712|P2|NOT COMPLETED|Toddler Dose||0
5330609|NCT00366548|13109713|P1|NOT COMPLETED|Toddler Dose||0
5330610|NCT00366548|13109712|P2|COMPLETED|Toddler Dose||244
5330611|NCT00366548|13109713|P1|COMPLETED|Toddler Dose||240
5330612|NCT00366548|13109712|P2|STARTED|Toddler Dose||244
5330613|NCT00366548|13109713|P1|STARTED|Toddler Dose||240
5330614|NCT00366548|13109712|P2|NOT COMPLETED|After Infant Series||1
5330615|NCT00366548|13109713|P1|NOT COMPLETED|After Infant Series||6
5330616|NCT00366548|13109712|P2|COMPLETED|After Infant Series||244
5330617|NCT00366548|13109713|P1|COMPLETED|After Infant Series||240
5330618|NCT00366548|13109712|P2|STARTED|After Infant Series||245
5330619|NCT00366548|13109713|P1|STARTED|After Infant Series||246
5330620|NCT00366548|13109712|P2|NOT COMPLETED|Infant Series||5
5330621|NCT00366548|13109713|P1|NOT COMPLETED|Infant Series||4
5330622|NCT00366548|13109712|P2|COMPLETED|Infant Series||245
5330623|NCT00366548|13109713|P1|COMPLETED|Infant Series||246
5330624|NCT00366548|13109712|P2|Vaccinated Dose 3|Infant Series||247
5330625|NCT00366548|13109713|P1|Vaccinated Dose 3|Infant Series||246
5330626|NCT00366548|13109712|P2|Vaccinated Dose 2|Infant Series||249
5330627|NCT00366548|13109713|P1|Vaccinated Dose 2|Infant Series||246
5330628|NCT00366548|13109712|P2|Vaccinated Dose 1|Infant Series||250
5330629|NCT00366548|13109713|P1|Vaccinated Dose 1|Infant Series||250
5330630|NCT00366548|13109712|P2|STARTED|Infant Series||250
5330631|NCT00366548|13109713|P1|STARTED|Infant Series||250
5330632|NCT00366535|13109749|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
5330633|NCT00366535|13109750|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
5330634|NCT00366535|13109749|P2|COMPLETED|Second Phase: 12 Weeks||18
5330635|NCT00366535|13109750|P1|COMPLETED|Second Phase: 12 Weeks||21
5330636|NCT00366535|13109749|P2|STARTED|Second Phase: 12 Weeks||21
5330637|NCT00366535|13109750|P1|STARTED|Second Phase: 12 Weeks||24
5330638|NCT00366535|13109749|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
5330639|NCT00366535|13109750|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
5330640|NCT00366535|13109749|P2|COMPLETED|Washout Period (at Least a Week)||21
5330641|NCT00366535|13109750|P1|COMPLETED|Washout Period (at Least a Week)||24
5330642|NCT00366535|13109749|P2|STARTED|Washout Period (at Least a Week)||21
5330643|NCT00366535|13109750|P1|STARTED|Washout Period (at Least a Week)||24
5330644|NCT00366535|13109749|P2|NOT COMPLETED|First Phase: 12 Weeks||8
5330645|NCT00366535|13109750|P1|NOT COMPLETED|First Phase: 12 Weeks||3
5330646|NCT00366535|13109749|P2|COMPLETED|First Phase: 12 Weeks||21
5330647|NCT00366535|13109750|P1|COMPLETED|First Phase: 12 Weeks||24
5330648|NCT00366535|13109749|P2|STARTED|First Phase: 12 Weeks||29
5330649|NCT00366535|13109750|P1|STARTED|First Phase: 12 Weeks||27
5330650|NCT00366457|13109764|P1|NOT COMPLETED|Overall Study||2
5330651|NCT00366457|13109764|P1|COMPLETED|Overall Study||30
5330652|NCT00366457|13109764|P1|STARTED|Overall Study||32
5330653|NCT00366444|13109773|P2|NOT COMPLETED|Overall Study||2
5330654|NCT00366444|13109774|P1|NOT COMPLETED|Overall Study||1
5330655|NCT00366444|13109773|P2|COMPLETED|Overall Study||97
5330656|NCT00366444|13109774|P1|COMPLETED|Overall Study||101
5330657|NCT00366444|13109773|P2|STARTED|Overall Study||99
5330658|NCT00366444|13109774|P1|STARTED|Overall Study||102
5330659|NCT00366340|13109802|P2|NOT COMPLETED|Toddler Dose||1
5330660|NCT00366340|13109803|P1|NOT COMPLETED|Toddler Dose||1
5330661|NCT00366340|13109802|P2|COMPLETED|Toddler Dose||286
5330662|NCT00366340|13109803|P1|COMPLETED|Toddler Dose||289
5330663|NCT00366340|13109802|P2|STARTED|Toddler Dose||287
5330664|NCT00366340|13109803|P1|STARTED|Toddler Dose||290
5330665|NCT00366340|13109802|P2|NOT COMPLETED|After the Infant Series||6
5330666|NCT00366340|13109803|P1|NOT COMPLETED|After the Infant Series||3
5330667|NCT00366340|13109802|P2|COMPLETED|After the Infant Series||287
5330668|NCT00366340|13109803|P1|COMPLETED|After the Infant Series||290
5330669|NCT00366340|13109802|P2|STARTED|After the Infant Series||293
5330670|NCT00366340|13109803|P1|STARTED|After the Infant Series||293
5330671|NCT00366340|13109802|P2|NOT COMPLETED|Infant Series||10
5330672|NCT00366340|13109803|P1|NOT COMPLETED|Infant Series||8
5330673|NCT00366340|13109802|P2|COMPLETED|Infant Series||293
5330674|NCT00366340|13109803|P1|COMPLETED|Infant Series||293
5330675|NCT00366340|13109802|P2|Vaccinated Dose 3|Infant Series||293
5330676|NCT00366340|13109803|P1|Vaccinated Dose 3|Infant Series||294
5330677|NCT00366340|13109802|P2|Vaccinated Dose 2|Infant Series||297
5330678|NCT00366340|13109803|P1|Vaccinated Dose 2|Infant Series||296
5330679|NCT00366340|13109802|P2|Vaccinated Dose 1|Infant Series||303
5330680|NCT00366340|13109803|P1|Vaccinated Dose 1|Infant Series||300
5330681|NCT00366340|13109802|P2|STARTED|Infant Series||303
5330682|NCT00366340|13109803|P1|STARTED|Infant Series||301
5330683|NCT00366301|13109861|P4|NOT COMPLETED|Overall Study||8
5330684|NCT00366301|13109862|P3|NOT COMPLETED|Overall Study||4
5330685|NCT00366301|13109863|P2|NOT COMPLETED|Overall Study||6
5330686|NCT00366301|13109864|P1|NOT COMPLETED|Overall Study||8
5330687|NCT00366301|13109861|P4|COMPLETED|Overall Study||116
5330688|NCT00366301|13109862|P3|COMPLETED|Overall Study||122
5330689|NCT00366301|13109863|P2|COMPLETED|Overall Study||120
5330690|NCT00366301|13109864|P1|COMPLETED|Overall Study||116
5330691|NCT00366301|13109861|P4|Either 6W or 14W CRP Obtained|Overall Study||119
5330692|NCT00366301|13109862|P3|Either 6W or 14W CRP Obtained|Overall Study||124
5330693|NCT00366301|13109863|P2|Either 6W or 14W CRP Obtained|Overall Study||124
5330694|NCT00366301|13109864|P1|Either 6W or 14W CRP Obtained|Overall Study||120
5330695|NCT00366301|13109861|P4|STARTED|Overall Study||124
5330696|NCT00366301|13109862|P3|STARTED|Overall Study||126
5330697|NCT00366301|13109863|P2|STARTED|Overall Study||126
5330698|NCT00366301|13109864|P1|STARTED|Overall Study||124
5330699|NCT00366275|13109874|P1|NOT COMPLETED|Overall Study||6
5330700|NCT00366275|13109874|P1|COMPLETED|Overall Study||58
5330701|NCT00366275|13109874|P1|STARTED|Overall Study||64
5330702|NCT00366249|13109880|P2|NOT COMPLETED|Overall Study||78
5330703|NCT00366249|13109881|P1|NOT COMPLETED|Overall Study||131
5330704|NCT00366249|13109880|P2|COMPLETED|Overall Study||430
5330705|NCT00366249|13109881|P1|COMPLETED|Overall Study||422
5330706|NCT00366249|13109880|P2|STARTED|Overall Study||508
5330707|NCT00366249|13109881|P1|STARTED|Overall Study||553
5330708|NCT00366106|13109895|P1|NOT COMPLETED|Overall Study||0
5330709|NCT00366106|13109895|P1|COMPLETED|Overall Study||32
5330710|NCT00366106|13109895|P1|STARTED|Overall Study||32
5330711|NCT00366028|13109904|P2|NOT COMPLETED|Overall Study||0
5330712|NCT00366028|13109905|P1|NOT COMPLETED|Overall Study||0
5330713|NCT00366028|13109904|P2|COMPLETED|Overall Study||735
5330714|NCT00366028|13109905|P1|COMPLETED|Overall Study||889
5330715|NCT00366028|13109904|P2|STARTED|Overall Study||735
5330716|NCT00366028|13109905|P1|STARTED|Overall Study||889
5330717|NCT00365989|13109913|P1|NOT COMPLETED|Overall Study||2
5330718|NCT00365989|13109913|P1|COMPLETED|Overall Study||48
5330719|NCT00365989|13109913|P1|STARTED|Overall Study||50
5330720|NCT00365976|13109921|P2|NOT COMPLETED|Overall Study||5
5330721|NCT00365976|13109922|P1|NOT COMPLETED|Overall Study||1
5330722|NCT00365976|13109921|P2|COMPLETED|Overall Study||20
5330723|NCT00365976|13109922|P1|COMPLETED|Overall Study||32
5330724|NCT00365976|13109921|P2|STARTED|Overall Study||25
5330725|NCT00365976|13109922|P1|STARTED|Overall Study||33
5330726|NCT00365872|13109953|P3|NOT COMPLETED|Overall Study||0
5330727|NCT00365872|13109954|P2|NOT COMPLETED|Overall Study||0
5330728|NCT00365872|13109955|P1|NOT COMPLETED|Overall Study||0
5330729|NCT00365872|13109953|P3|COMPLETED|Overall Study||6
5330730|NCT00365872|13109954|P2|COMPLETED|Overall Study||6
5330731|NCT00365872|13109955|P1|COMPLETED|Overall Study||5
5330732|NCT00365872|13109953|P3|STARTED|Overall Study||6
5330733|NCT00365872|13109954|P2|STARTED|Overall Study||6
5330734|NCT00365872|13109955|P1|STARTED|Overall Study||5
5330735|NCT00365859|13109968|P4|NOT COMPLETED|Overall Study||131
5330736|NCT00365859|13109969|P3|NOT COMPLETED|Overall Study||67
5330737|NCT00365859|13109970|P2|NOT COMPLETED|Overall Study||33
5330738|NCT00365859|13109971|P1|NOT COMPLETED|Overall Study||31
5330739|NCT00365859|13109968|P4|COMPLETED|Overall Study||199
5330740|NCT00365859|13109969|P3|COMPLETED|Overall Study||107
5330741|NCT00365859|13109970|P2|COMPLETED|Overall Study||37
5330742|NCT00365859|13109971|P1|COMPLETED|Overall Study||55
5330743|NCT00365859|13109968|P4|Efficacy Population|Overall Study||322
5330744|NCT00365859|13109969|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
5330745|NCT00365859|13109970|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
5330746|NCT00365859|13109971|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
5330747|NCT00365859|13109968|P4|Safety Population|Overall Study||330
5330748|NCT00365859|13109969|P3|Safety Population|Overall Study||174
5330749|NCT00365859|13109970|P2|Safety Population|Overall Study||70
5330750|NCT00365859|13109971|P1|Safety Population|Overall Study||86
5330751|NCT00365859|13109968|P4|STARTED|Overall Study||330
5330752|NCT00365859|13109969|P3|STARTED|Overall Study||174
5330753|NCT00365859|13109970|P2|STARTED|Overall Study||70
5330754|NCT00365859|13109971|P1|STARTED|Overall Study||86
5330755|NCT00365846|13110060|P1|NOT COMPLETED|Overall Study||1
5330756|NCT00365846|13110060|P1|COMPLETED|Overall Study||28
5330757|NCT00365846|13110060|P1|STARTED|Overall Study||29
5330758|NCT00365794|13110069|P1|NOT COMPLETED|Overall Study||2
5330759|NCT00365794|13110069|P1|COMPLETED|Overall Study||20
5330760|NCT00365794|13110069|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
5330761|NCT00365768|13110084|P2|NOT COMPLETED|Overall Study||0
5330762|NCT00365768|13110085|P1|NOT COMPLETED|Overall Study||0
5330763|NCT00365768|13110084|P2|COMPLETED|Overall Study||25
5330764|NCT00365768|13110085|P1|COMPLETED|Overall Study||24
5330765|NCT00365768|13110084|P2|STARTED|Overall Study||25
5330766|NCT00365768|13110085|P1|STARTED|Overall Study||24
5330767|NCT00365716|13110098|P7|NOT COMPLETED|Extension 2||10
5330768|NCT00365716|13110099|P6|NOT COMPLETED|Extension 2||0
5330769|NCT00365716|13110100|P5|NOT COMPLETED|Extension 2||0
5330770|NCT00365716|13110101|P4|NOT COMPLETED|Extension 2||0
5330771|NCT00365716|13110102|P3|NOT COMPLETED|Extension 2||0
5330772|NCT00365716|13110103|P2|NOT COMPLETED|Extension 2||0
5330773|NCT00365716|13110104|P1|NOT COMPLETED|Extension 2||0
5330774|NCT00365716|13110098|P7|COMPLETED|Extension 2||7
5330775|NCT00365716|13110099|P6|COMPLETED|Extension 2||0
5330776|NCT00365716|13110100|P5|COMPLETED|Extension 2||0
5330777|NCT00365716|13110101|P4|COMPLETED|Extension 2||0
5330778|NCT00365716|13110102|P3|COMPLETED|Extension 2||0
5330779|NCT00365716|13110103|P2|COMPLETED|Extension 2||0
5330780|NCT00365716|13110104|P1|COMPLETED|Extension 2||0
5330781|NCT00365716|13110098|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
5330782|NCT00365716|13110099|P6|STARTED|Extension 2||0
5330783|NCT00365716|13110100|P5|STARTED|Extension 2||0
5330784|NCT00365716|13110101|P4|STARTED|Extension 2||0
5330785|NCT00365716|13110102|P3|STARTED|Extension 2||0
5330786|NCT00365716|13110103|P2|STARTED|Extension 2||0
5330787|NCT00365716|13110104|P1|STARTED|Extension 2||0
5330788|NCT00365716|13110098|P7|NOT COMPLETED|Extension 1||0
5330789|NCT00365716|13110099|P6|NOT COMPLETED|Extension 1||22
5330790|NCT00365716|13110100|P5|NOT COMPLETED|Extension 1||0
5330791|NCT00365716|13110101|P4|NOT COMPLETED|Extension 1||0
5330792|NCT00365716|13110102|P3|NOT COMPLETED|Extension 1||0
5330793|NCT00365716|13110103|P2|NOT COMPLETED|Extension 1||0
5330794|NCT00365716|13110104|P1|NOT COMPLETED|Extension 1||0
5330795|NCT00365716|13110098|P7|COMPLETED|Extension 1||0
5330796|NCT00365716|13110099|P6|COMPLETED|Extension 1||219
5330797|NCT00365716|13110100|P5|COMPLETED|Extension 1||0
5330798|NCT00365716|13110101|P4|COMPLETED|Extension 1||0
5330799|NCT00365716|13110102|P3|COMPLETED|Extension 1||0
5330800|NCT00365716|13110103|P2|COMPLETED|Extension 1||0
5330801|NCT00365716|13110104|P1|COMPLETED|Extension 1||0
5330802|NCT00365716|13110098|P7|STARTED|Extension 1||0
5330803|NCT00365716|13110099|P6|STARTED|Extension 1||241
5330804|NCT00365716|13110100|P5|STARTED|Extension 1||0
5330805|NCT00365716|13110101|P4|STARTED|Extension 1||0
5330806|NCT00365716|13110102|P3|STARTED|Extension 1||0
5330807|NCT00365716|13110103|P2|STARTED|Extension 1||0
5330808|NCT00365716|13110104|P1|STARTED|Extension 1||0
5330809|NCT00365716|13110098|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
5330810|NCT00365716|13110099|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
5330811|NCT00365716|13110100|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
5330812|NCT00365716|13110101|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
5330813|NCT00365716|13110102|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
5330814|NCT00365716|13110103|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
5330815|NCT00365716|13110104|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
5330816|NCT00365716|13110098|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
5330817|NCT00365716|13110099|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
5330818|NCT00365716|13110100|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
5330819|NCT00365716|13110101|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
5330820|NCT00365716|13110102|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
5330821|NCT00365716|13110103|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
5330822|NCT00365716|13110104|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
5330823|NCT00365716|13110098|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
5330824|NCT00365716|13110099|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
5330825|NCT00365716|13110100|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
5330826|NCT00365716|13110101|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
5330827|NCT00365716|13110102|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
5330828|NCT00365716|13110103|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
5330829|NCT00365716|13110104|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
5330830|NCT00365716|13110098|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
5330831|NCT00365716|13110099|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
5330832|NCT00365716|13110100|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
5330833|NCT00365716|13110101|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
5330834|NCT00365716|13110102|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
5330835|NCT00365716|13110103|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
5330836|NCT00365716|13110104|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
5330837|NCT00365716|13110098|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
5330838|NCT00365716|13110099|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
5330839|NCT00365716|13110100|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
5330840|NCT00365716|13110101|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
5330841|NCT00365716|13110102|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
5330842|NCT00365716|13110103|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
5330843|NCT00365716|13110104|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
5330844|NCT00365716|13110098|P7|STARTED|Base Study (Day 1 to Month 7)||0
5330845|NCT00365716|13110099|P6|STARTED|Base Study (Day 1 to Month 7)||0
5330846|NCT00365716|13110100|P5|STARTED|Base Study (Day 1 to Month 7)||146
5330847|NCT00365716|13110101|P4|STARTED|Base Study (Day 1 to Month 7)||146
5330848|NCT00365716|13110102|P3|STARTED|Base Study (Day 1 to Month 7)||292
5330849|NCT00365716|13110103|P2|STARTED|Base Study (Day 1 to Month 7)||284
5330850|NCT00365716|13110104|P1|STARTED|Base Study (Day 1 to Month 7)||290
5330851|NCT00365599|13110119|P1|NOT COMPLETED|Overall Study||0
5330852|NCT00365599|13110119|P1|COMPLETED|Overall Study||43
5330853|NCT00365599|13110119|P1|STARTED|Overall Study||43
5330854|NCT00365547|13110125|P1|NOT COMPLETED|Overall Study||3
5330855|NCT00365547|13110125|P1|COMPLETED|Overall Study||43
5330856|NCT00365547|13110125|P1|STARTED|Overall Study||46
5330857|NCT00365508|13110135|P2|NOT COMPLETED|Overall Study||154
5330858|NCT00365508|13110136|P1|NOT COMPLETED|Overall Study||139
5330859|NCT00365508|13110135|P2|COMPLETED|Overall Study||167
5330860|NCT00365508|13110136|P1|COMPLETED|Overall Study||182
5330861|NCT00365508|13110135|P2|STARTED|Overall Study||321
5330862|NCT00365508|13110136|P1|STARTED|Overall Study||321
5330863|NCT00365456|13110144|P2|NOT COMPLETED|Trial Period III (12 Months)||5
5330864|NCT00365456|13110145|P1|NOT COMPLETED|Trial Period III (12 Months)||18
5330865|NCT00365456|13110144|P2|COMPLETED|Trial Period III (12 Months)||127
5330866|NCT00365456|13110145|P1|COMPLETED|Trial Period III (12 Months)||118
5330867|NCT00365456|13110144|P2|STARTED|Trial Period III (12 Months)||132
5330868|NCT00365456|13110145|P1|STARTED|Trial Period III (12 Months)||136
5330869|NCT00365456|13110144|P2|NOT COMPLETED|Trial Period II (12 Months)||14
5330870|NCT00365456|13110145|P1|NOT COMPLETED|Trial Period II (12 Months)||0
5330871|NCT00365456|13110144|P2|COMPLETED|Trial Period II (12 Months)||268
5330872|NCT00365456|13110145|P1|COMPLETED|Trial Period II (12 Months)||0
5330873|NCT00365456|13110144|P2|STARTED|Trial Period II (12 Months)||282
5330874|NCT00365456|13110145|P1|STARTED|Trial Period II (12 Months)||0
5330875|NCT00365456|13110144|P2|NOT COMPLETED|Trial Period I (12 Months)||0
5330876|NCT00365456|13110145|P1|NOT COMPLETED|Trial Period I (12 Months)||125
5330877|NCT00365456|13110144|P2|COMPLETED|Trial Period I (12 Months)||0
5330878|NCT00365456|13110145|P1|COMPLETED|Trial Period I (12 Months)||282
5330879|NCT00365456|13110144|P2|STARTED|Trial Period I (12 Months)||0
5330880|NCT00365456|13110145|P1|STARTED|Trial Period I (12 Months)||407
5330881|NCT00365417|13110151|P1|NOT COMPLETED|Overall Study||0
5330882|NCT00365417|13110151|P1|COMPLETED|Overall Study||45
5330883|NCT00365417|13110151|P1|STARTED|Overall Study||45
5330884|NCT00365391|13110162|P1|NOT COMPLETED|Overall Study||0
5330885|NCT00365391|13110162|P1|COMPLETED|Overall Study||27
5330886|NCT00365391|13110162|P1|STARTED|Overall Study||27
5330887|NCT00365378|13110172|P3|NOT COMPLETED|Extension||197
5330888|NCT00365378|13110173|P2|NOT COMPLETED|Extension||0
5330889|NCT00365378|13110174|P1|NOT COMPLETED|Extension||0
5330890|NCT00365378|13110172|P3|COMPLETED|Extension||203
5330891|NCT00365378|13110173|P2|COMPLETED|Extension||0
5330892|NCT00365378|13110174|P1|COMPLETED|Extension||0
5330893|NCT00365378|13110172|P3|STARTED|Extension||400
5330894|NCT00365378|13110173|P2|STARTED|Extension||0
5330895|NCT00365378|13110174|P1|STARTED|Extension||0
5330896|NCT00365378|13110172|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
5330897|NCT00365378|13110173|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
5330898|NCT00365378|13110174|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
5330899|NCT00365378|13110172|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
5330900|NCT00365378|13110173|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
5330901|NCT00365378|13110174|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
5330902|NCT00365378|13110172|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
5330903|NCT00365378|13110173|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
5330904|NCT00365378|13110174|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
5330905|NCT00365378|13110172|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
5330906|NCT00365378|13110173|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
5330907|NCT00365378|13110174|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
5330908|NCT00365378|13110172|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
5330909|NCT00365378|13110173|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
5330910|NCT00365378|13110174|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
5330911|NCT00365378|13110172|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
5330912|NCT00365378|13110173|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
5330913|NCT00365378|13110174|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
5330914|NCT00365378|13110172|P3|STARTED|Vaccination (Day 1 to Month 7)||0
5330915|NCT00365378|13110173|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
5330916|NCT00365378|13110174|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
5330917|NCT00365365|13110188|P3|NOT COMPLETED|Overall Study||15
5330918|NCT00365365|13110189|P2|NOT COMPLETED|Overall Study||36
5330919|NCT00365365|13110190|P1|NOT COMPLETED|Overall Study||34
5330920|NCT00365365|13110188|P3|COMPLETED|Overall Study||44
5330921|NCT00365365|13110189|P2|COMPLETED|Overall Study||41
5330922|NCT00365365|13110190|P1|COMPLETED|Overall Study||44
5330923|NCT00365365|13110188|P3|COMPLETED TREATMENT|Overall Study||45
5330924|NCT00365365|13110189|P2|COMPLETED TREATMENT|Overall Study||36
5330925|NCT00365365|13110190|P1|COMPLETED TREATMENT|Overall Study||38
5330926|NCT00365365|13110188|P3|TREATED (SAFETY POPULATION)|Overall Study||59
5330927|NCT00365365|13110189|P2|TREATED (SAFETY POPULATION)|Overall Study||75
5330928|NCT00365365|13110190|P1|TREATED (SAFETY POPULATION)|Overall Study||78
5330929|NCT00365365|13110188|P3|STARTED|Overall Study||59
5330930|NCT00365365|13110189|P2|STARTED|Overall Study||77
5330931|NCT00365365|13110190|P1|STARTED|Overall Study||78
5330932|NCT00365352|13110207|P3|NOT COMPLETED|Overall Study||15
5330933|NCT00365352|13110208|P2|NOT COMPLETED|Overall Study||11
5330934|NCT00365352|13110209|P1|NOT COMPLETED|Overall Study||20
5330935|NCT00365352|13110207|P3|COMPLETED|Overall Study||98
5330936|NCT00365352|13110208|P2|COMPLETED|Overall Study||104
5330937|NCT00365352|13110209|P1|COMPLETED|Overall Study||77
5330938|NCT00365352|13110207|P3|Modified Intent-to-Treat Population|Overall Study||111
5330939|NCT00365352|13110208|P2|Modified Intent-to-Treat Population|Overall Study||114
5330940|NCT00365352|13110209|P1|Modified Intent-to-Treat Population|Overall Study||96
5330941|NCT00365352|13110207|P3|Safety Population|Overall Study||111
5330942|NCT00365352|13110208|P2|Safety Population|Overall Study||115
5330943|NCT00365352|13110209|P1|Safety Population|Overall Study||96
5330944|NCT00365352|13110207|P3|STARTED|Overall Study||113
5330945|NCT00365352|13110208|P2|STARTED|Overall Study||115
5330946|NCT00365352|13110209|P1|STARTED|Overall Study||97
5330947|NCT00365300|13110293|P2|NOT COMPLETED|Double-blind Phase||9
5330948|NCT00365300|13110294|P1|NOT COMPLETED|Double-blind Phase||11
5330949|NCT00365300|13110293|P2|COMPLETED|Double-blind Phase||45
5330950|NCT00365300|13110294|P1|COMPLETED|Double-blind Phase||43
5330951|NCT00365300|13110293|P2|STARTED|Double-blind Phase||54
5330952|NCT00365300|13110294|P1|STARTED|Double-blind Phase||54
5330953|NCT00365300|13110293|P2|NOT COMPLETED|Open-label Phase||0
5330954|NCT00365300|13110294|P1|NOT COMPLETED|Open-label Phase||22
5330955|NCT00365300|13110293|P2|COMPLETED|Open-label Phase||0
5330956|NCT00365300|13110294|P1|COMPLETED|Open-label Phase||107
5330957|NCT00365300|13110293|P2|STARTED|Open-label Phase||0
5330958|NCT00365300|13110294|P1|STARTED|Open-label Phase||129
5330959|NCT00365274|13110303|P1|NOT COMPLETED|Overall Study||0
5330960|NCT00365274|13110303|P1|COMPLETED|Overall Study||6
5330961|NCT00365274|13110303|P1|STARTED|Overall Study||6
5330962|NCT00365261|13110309|P2|NOT COMPLETED|Overall Study||3
5330963|NCT00365261|13110310|P1|NOT COMPLETED|Overall Study||3
5330964|NCT00365261|13110309|P2|COMPLETED|Overall Study||19
5330965|NCT00365261|13110310|P1|COMPLETED|Overall Study||20
5330966|NCT00365261|13110309|P2|STARTED|Overall Study||22
5330967|NCT00365261|13110310|P1|STARTED|Overall Study||23
5330968|NCT00365209|13110320|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
5330969|NCT00365209|13110320|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
5330970|NCT00365209|13110320|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
5330971|NCT00365209|13110320|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
5330972|NCT00365209|13110320|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
5330973|NCT00365209|13110320|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
5330974|NCT00365144|13110349|P1|NOT COMPLETED|Overall Study||0
5330975|NCT00365144|13110349|P1|COMPLETED|Overall Study||36
5330976|NCT00365144|13110349|P1|STARTED|Overall Study||36
5330977|NCT00365105|13110359|P2|NOT COMPLETED|Overall Study||8
5330978|NCT00365105|13110360|P1|NOT COMPLETED|Overall Study||5
5330979|NCT00365105|13110359|P2|COMPLETED|Overall Study||124
5330980|NCT00365105|13110360|P1|COMPLETED|Overall Study||124
5330981|NCT00365105|13110359|P2|Eligible With Adverse Event Data|Overall Study||124
5330982|NCT00365105|13110360|P1|Eligible With Adverse Event Data|Overall Study||123
5330983|NCT00365105|13110359|P2|Eligible|Overall Study||124
5330984|NCT00365105|13110360|P1|Eligible|Overall Study||124
5330985|NCT00365105|13110359|P2|STARTED|Overall Study||132
5330986|NCT00365105|13110360|P1|STARTED|Overall Study||129
5330987|NCT00365053|13110376|P1|NOT COMPLETED|Overall Study||0
5330988|NCT00365053|13110376|P1|COMPLETED|Overall Study||13
5330989|NCT00365053|13110376|P1|STARTED|Overall Study||13
5330990|NCT00364949|13110387|P2|NOT COMPLETED|Overall Study||0
5330991|NCT00364949|13110388|P1|NOT COMPLETED|Overall Study||0
5330992|NCT00364949|13110387|P2|COMPLETED|Overall Study||39
5330993|NCT00364949|13110388|P1|COMPLETED|Overall Study||31
5330994|NCT00364949|13110387|P2|STARTED|Overall Study||39
5330995|NCT00364949|13110388|P1|STARTED|Overall Study||31
5330996|NCT00364923|13110406|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
5330997|NCT00364923|13110406|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
5330998|NCT00364923|13110406|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
5330999|NCT00364923|13110406|P1|NOT COMPLETED|Treatment With Pralatrexate||4
5331000|NCT00364923|13110406|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
5331001|NCT00364923|13110406|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
5331002|NCT00364858|13110415|P2|NOT COMPLETED|Overall Study||22
5331003|NCT00364858|13110416|P1|NOT COMPLETED|Overall Study||7
5331004|NCT00364858|13110415|P2|COMPLETED|Overall Study||40
5331005|NCT00364858|13110416|P1|COMPLETED|Overall Study||26
5331006|NCT00364858|13110415|P2|STARTED|Overall Study||62
5331007|NCT00364858|13110416|P1|STARTED|Overall Study||33
5331008|NCT00364845|13110431|P2|NOT COMPLETED|Overall Study||11
5331009|NCT00364845|13110432|P1|NOT COMPLETED|Overall Study||11
5331010|NCT00364845|13110431|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
5331011|NCT00364845|13110432|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
5331012|NCT00364845|13110431|P2|STARTED|Overall Study||23
5331013|NCT00364845|13110432|P1|STARTED|Overall Study||28
5331014|NCT00364832|13110453|P12|NOT COMPLETED|Extension Year 2||3
5331015|NCT00364832|13110454|P11|NOT COMPLETED|Extension Year 2||5
5331016|NCT00364832|13110455|P10|NOT COMPLETED|Extension Year 2||5
5331017|NCT00364832|13110456|P9|NOT COMPLETED|Extension Year 2||0
5331018|NCT00364832|13110457|P8|NOT COMPLETED|Extension Year 2||0
5331019|NCT00364832|13110458|P7|NOT COMPLETED|Extension Year 2||0
5331020|NCT00364832|13110459|P6|NOT COMPLETED|Extension Year 2||0
5331021|NCT00364832|13110460|P5|NOT COMPLETED|Extension Year 2||0
5331022|NCT00364832|13110461|P4|NOT COMPLETED|Extension Year 2||0
5331023|NCT00364832|13110462|P3|NOT COMPLETED|Extension Year 2||0
5331024|NCT00364832|13110463|P2|NOT COMPLETED|Extension Year 2||0
5331025|NCT00364832|13110464|P1|NOT COMPLETED|Extension Year 2||0
5331026|NCT00364832|13110453|P12|COMPLETED|Extension Year 2||11
5331027|NCT00364832|13110454|P11|COMPLETED|Extension Year 2||9
5331028|NCT00364832|13110455|P10|COMPLETED|Extension Year 2||9
5331029|NCT00364832|13110456|P9|COMPLETED|Extension Year 2||0
5331030|NCT00364832|13110457|P8|COMPLETED|Extension Year 2||0
5331031|NCT00364832|13110458|P7|COMPLETED|Extension Year 2||0
5331032|NCT00364832|13110459|P6|COMPLETED|Extension Year 2||0
5331033|NCT00364832|13110460|P5|COMPLETED|Extension Year 2||0
5331034|NCT00364832|13110461|P4|COMPLETED|Extension Year 2||0
5331035|NCT00364832|13110462|P3|COMPLETED|Extension Year 2||0
5331036|NCT00364832|13110463|P2|COMPLETED|Extension Year 2||0
5331037|NCT00364832|13110464|P1|COMPLETED|Extension Year 2||0
5331038|NCT00364832|13110453|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
5331039|NCT00364832|13110454|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
5331040|NCT00364832|13110455|P10|STARTED|Extension Year 2||14
5331041|NCT00364832|13110456|P9|STARTED|Extension Year 2||0
5331042|NCT00364832|13110457|P8|STARTED|Extension Year 2||0
5331043|NCT00364832|13110458|P7|STARTED|Extension Year 2||0
5331044|NCT00364832|13110459|P6|STARTED|Extension Year 2||0
5331045|NCT00364832|13110460|P5|STARTED|Extension Year 2||0
5331046|NCT00364832|13110461|P4|STARTED|Extension Year 2||0
5331047|NCT00364832|13110462|P3|STARTED|Extension Year 2||0
5331048|NCT00364832|13110463|P2|STARTED|Extension Year 2||0
5331049|NCT00364832|13110464|P1|STARTED|Extension Year 2||0
5331050|NCT00364832|13110453|P12|NOT COMPLETED|Extension Year 1||10
5331051|NCT00364832|13110454|P11|NOT COMPLETED|Extension Year 1||2
5331052|NCT00364832|13110455|P10|NOT COMPLETED|Extension Year 1||4
5331053|NCT00364832|13110456|P9|NOT COMPLETED|Extension Year 1||0
5331054|NCT00364832|13110457|P8|NOT COMPLETED|Extension Year 1||0
5331055|NCT00364832|13110458|P7|NOT COMPLETED|Extension Year 1||0
5331056|NCT00364832|13110459|P6|NOT COMPLETED|Extension Year 1||0
5331057|NCT00364832|13110460|P5|NOT COMPLETED|Extension Year 1||0
5331058|NCT00364832|13110461|P4|NOT COMPLETED|Extension Year 1||0
5331059|NCT00364832|13110462|P3|NOT COMPLETED|Extension Year 1||0
5331060|NCT00364832|13110463|P2|NOT COMPLETED|Extension Year 1||0
5331061|NCT00364832|13110464|P1|NOT COMPLETED|Extension Year 1||0
5331062|NCT00364832|13110453|P12|COMPLETED|Extension Year 1||17
5331063|NCT00364832|13110454|P11|COMPLETED|Extension Year 1||15
5331064|NCT00364832|13110455|P10|COMPLETED|Extension Year 1||14
5331065|NCT00364832|13110456|P9|COMPLETED|Extension Year 1||0
5331066|NCT00364832|13110457|P8|COMPLETED|Extension Year 1||0
5331067|NCT00364832|13110458|P7|COMPLETED|Extension Year 1||0
5331068|NCT00364832|13110459|P6|COMPLETED|Extension Year 1||0
5331069|NCT00364832|13110460|P5|COMPLETED|Extension Year 1||0
5331070|NCT00364832|13110461|P4|COMPLETED|Extension Year 1||0
5331071|NCT00364832|13110462|P3|COMPLETED|Extension Year 1||0
5331072|NCT00364832|13110463|P2|COMPLETED|Extension Year 1||0
5331073|NCT00364832|13110464|P1|COMPLETED|Extension Year 1||0
5331074|NCT00364832|13110453|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
5331075|NCT00364832|13110454|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
5331076|NCT00364832|13110455|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
5331077|NCT00364832|13110456|P9|STARTED|Extension Year 1||0
5331078|NCT00364832|13110457|P8|STARTED|Extension Year 1||0
5331079|NCT00364832|13110458|P7|STARTED|Extension Year 1||0
5331080|NCT00364832|13110459|P6|STARTED|Extension Year 1||0
5331081|NCT00364832|13110460|P5|STARTED|Extension Year 1||0
5331082|NCT00364832|13110461|P4|STARTED|Extension Year 1||0
5331083|NCT00364832|13110462|P3|STARTED|Extension Year 1||0
5331084|NCT00364832|13110463|P2|STARTED|Extension Year 1||0
5331085|NCT00364832|13110464|P1|STARTED|Extension Year 1||0
5331086|NCT00364832|13110453|P12|NOT COMPLETED|Core Period||0
5331087|NCT00364832|13110454|P11|NOT COMPLETED|Core Period||0
5331088|NCT00364832|13110455|P10|NOT COMPLETED|Core Period||0
5331089|NCT00364832|13110456|P9|NOT COMPLETED|Core Period||0
5331090|NCT00364832|13110457|P8|NOT COMPLETED|Core Period||1
5331091|NCT00364832|13110458|P7|NOT COMPLETED|Core Period||4
5331092|NCT00364832|13110459|P6|NOT COMPLETED|Core Period||0
5331093|NCT00364832|13110460|P5|NOT COMPLETED|Core Period||0
5331094|NCT00364832|13110461|P4|NOT COMPLETED|Core Period||1
5331095|NCT00364832|13110462|P3|NOT COMPLETED|Core Period||1
5331096|NCT00364832|13110463|P2|NOT COMPLETED|Core Period||2
5331097|NCT00364832|13110464|P1|NOT COMPLETED|Core Period||2
5331098|NCT00364832|13110453|P12|COMPLETED|Core Period||0
5331099|NCT00364832|13110454|P11|COMPLETED|Core Period||0
5331100|NCT00364832|13110455|P10|COMPLETED|Core Period||0
5331101|NCT00364832|13110456|P9|COMPLETED|Core Period||16
5331102|NCT00364832|13110457|P8|COMPLETED|Core Period||14
5331103|NCT00364832|13110458|P7|COMPLETED|Core Period||12
5331104|NCT00364832|13110459|P6|COMPLETED|Core Period||12
5331105|NCT00364832|13110460|P5|COMPLETED|Core Period||16
5331106|NCT00364832|13110461|P4|COMPLETED|Core Period||15
5331107|NCT00364832|13110462|P3|COMPLETED|Core Period||14
5331108|NCT00364832|13110463|P2|COMPLETED|Core Period||13
5331109|NCT00364832|13110464|P1|COMPLETED|Core Period||14
5331110|NCT00364832|13110453|P12|STARTED|Core Period||0
5331111|NCT00364832|13110454|P11|STARTED|Core Period||0
5331112|NCT00364832|13110455|P10|STARTED|Core Period||0
5331113|NCT00364832|13110456|P9|STARTED|Core Period||16
5331114|NCT00364832|13110457|P8|STARTED|Core Period||15
5331115|NCT00364832|13110458|P7|STARTED|Core Period||16
5331116|NCT00364832|13110459|P6|STARTED|Core Period||12
5331117|NCT00364832|13110460|P5|STARTED|Core Period||16
5331118|NCT00364832|13110461|P4|STARTED|Core Period||16
5331119|NCT00364832|13110462|P3|STARTED|Core Period||15
5331120|NCT00364832|13110463|P2|STARTED|Core Period||15
5331121|NCT00364832|13110464|P1|STARTED|Core Period||16
5331122|NCT00364819|13110517|P1|NOT COMPLETED|Overall Study||0
5331123|NCT00364819|13110517|P1|COMPLETED|Overall Study||6
5331124|NCT00364819|13110517|P1|STARTED|Overall Study||6
5331125|NCT00364793|13110529|P4|NOT COMPLETED|Overall Study||3
5331126|NCT00364793|13110530|P3|NOT COMPLETED|Overall Study||4
5331127|NCT00364793|13110531|P2|NOT COMPLETED|Overall Study||5
5331128|NCT00364793|13110532|P1|NOT COMPLETED|Overall Study||8
5331129|NCT00364793|13110529|P4|COMPLETED|Overall Study||5
5331130|NCT00364793|13110530|P3|COMPLETED|Overall Study||0
5331131|NCT00364793|13110531|P2|COMPLETED|Overall Study||5
5331132|NCT00364793|13110532|P1|COMPLETED|Overall Study||7
5331133|NCT00364793|13110529|P4|STARTED|Overall Study||8
5331134|NCT00364793|13110530|P3|STARTED|Overall Study||4
5331135|NCT00364793|13110531|P2|STARTED|Overall Study||10
5331136|NCT00364793|13110532|P1|STARTED|Overall Study||15
5331137|NCT00364689|13110669|P1|NOT COMPLETED|Overall Study||1
5331138|NCT00364689|13110669|P1|COMPLETED|Overall Study||12
5331139|NCT00364689|13110669|P1|STARTED|Overall Study||13
5331140|NCT00364611|13110689|P2|NOT COMPLETED|Overall Study||21
5331141|NCT00364611|13110690|P1|NOT COMPLETED|Overall Study||51
5331142|NCT00364611|13110689|P2|COMPLETED|Overall Study||0
5331143|NCT00364611|13110690|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
5331144|NCT00364611|13110689|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
5331145|NCT00364611|13110690|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
5331146|NCT00364611|13110689|P2|STARTED|Overall Study||21
5331147|NCT00364611|13110690|P1|STARTED|Overall Study||52
5331148|NCT00364533|13110713|P5|NOT COMPLETED|Overall Study||51
5331149|NCT00364533|13110714|P4|NOT COMPLETED|Overall Study||31
5331150|NCT00364533|13110715|P3|NOT COMPLETED|Overall Study||45
5331151|NCT00364533|13110716|P2|NOT COMPLETED|Overall Study||40
5331152|NCT00364533|13110717|P1|NOT COMPLETED|Overall Study||42
5331153|NCT00364533|13110713|P5|COMPLETED|Overall Study||24
5331154|NCT00364533|13110714|P4|COMPLETED|Overall Study||36
5331155|NCT00364533|13110715|P3|COMPLETED|Overall Study||30
5331156|NCT00364533|13110716|P2|COMPLETED|Overall Study||31
5331157|NCT00364533|13110717|P1|COMPLETED|Overall Study||35
5331158|NCT00364533|13110713|P5|STARTED|Overall Study||75
5331159|NCT00364533|13110714|P4|STARTED|Overall Study||67
5331160|NCT00364533|13110715|P3|STARTED|Overall Study||75
5331161|NCT00364533|13110716|P2|STARTED|Overall Study||71
5331162|NCT00364533|13110717|P1|STARTED|Overall Study||77
5331163|NCT00364377|13110741|P2|NOT COMPLETED|Overall Study||0
5331164|NCT00364377|13110742|P1|NOT COMPLETED|Overall Study||0
5331165|NCT00364377|13110741|P2|COMPLETED|Overall Study||11
5331166|NCT00364377|13110742|P1|COMPLETED|Overall Study||11
5331167|NCT00364377|13110741|P2|STARTED|Overall Study||11
5331168|NCT00364377|13110742|P1|STARTED|Overall Study||11
5331169|NCT00364351|13110750|P2|NOT COMPLETED|Overall Study||583
5331170|NCT00364351|13110751|P1|NOT COMPLETED|Overall Study||592
5331171|NCT00364351|13110750|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
5331172|NCT00364351|13110751|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
5331173|NCT00364351|13110750|P2|STARTED|Overall Study|randomised patients|617
5331174|NCT00364351|13110751|P1|STARTED|Overall Study|randomised patients|623
5331175|NCT00364286|13110769|P1|NOT COMPLETED|Overall Study||3
5331176|NCT00364286|13110769|P1|COMPLETED|Overall Study||14
5331177|NCT00364286|13110769|P1|STARTED|Overall Study||17
5331178|NCT00364182|13110776|P3|NOT COMPLETED|Fourth Intervention||0
5331179|NCT00364182|13110777|P2|NOT COMPLETED|Fourth Intervention||0
5331180|NCT00364182|13110778|P1|NOT COMPLETED|Fourth Intervention||0
5331181|NCT00364182|13110776|P3|COMPLETED|Fourth Intervention||22
5331182|NCT00364182|13110777|P2|COMPLETED|Fourth Intervention||19
5331183|NCT00364182|13110778|P1|COMPLETED|Fourth Intervention||0
5331184|NCT00364182|13110776|P3|STARTED|Fourth Intervention||22
5331185|NCT00364182|13110777|P2|STARTED|Fourth Intervention||19
5331186|NCT00364182|13110778|P1|STARTED|Fourth Intervention||0
5331187|NCT00364182|13110776|P3|NOT COMPLETED|Third Intervention||1
5331188|NCT00364182|13110777|P2|NOT COMPLETED|Third Intervention||1
5331189|NCT00364182|13110778|P1|NOT COMPLETED|Third Intervention||0
5331190|NCT00364182|13110776|P3|COMPLETED|Third Intervention||22
5331191|NCT00364182|13110777|P2|COMPLETED|Third Intervention||19
5331192|NCT00364182|13110778|P1|COMPLETED|Third Intervention||0
5331193|NCT00364182|13110776|P3|STARTED|Third Intervention||23
5331194|NCT00364182|13110777|P2|STARTED|Third Intervention||20
5331195|NCT00364182|13110778|P1|STARTED|Third Intervention||0
5331196|NCT00364182|13110776|P3|NOT COMPLETED|Second Intervention||2
5331197|NCT00364182|13110777|P2|NOT COMPLETED|Second Intervention||2
5331198|NCT00364182|13110778|P1|NOT COMPLETED|Second Intervention||0
5331199|NCT00364182|13110776|P3|COMPLETED|Second Intervention||23
5331200|NCT00364182|13110777|P2|COMPLETED|Second Intervention||20
5331201|NCT00364182|13110778|P1|COMPLETED|Second Intervention||0
5331202|NCT00364182|13110776|P3|Randomized|Second Intervention||25
5331203|NCT00364182|13110777|P2|Randomized|Second Intervention||22
5331204|NCT00364182|13110778|P1|Randomized|Second Intervention||0
5331205|NCT00364182|13110776|P3|STARTED|Second Intervention||25
5331206|NCT00364182|13110777|P2|STARTED|Second Intervention||22
5331207|NCT00364182|13110778|P1|STARTED|Second Intervention||0
5331208|NCT00364182|13110776|P3|NOT COMPLETED|First Intervention||0
5331209|NCT00364182|13110777|P2|NOT COMPLETED|First Intervention||0
5331210|NCT00364182|13110778|P1|NOT COMPLETED|First Intervention||3
5331211|NCT00364182|13110776|P3|COMPLETED|First Intervention||25
5331212|NCT00364182|13110777|P2|COMPLETED|First Intervention||22
5331213|NCT00364182|13110778|P1|COMPLETED|First Intervention||0
5331214|NCT00364182|13110776|P3|STARTED|First Intervention||25
5331215|NCT00364182|13110777|P2|STARTED|First Intervention||22
5331216|NCT00364182|13110778|P1|STARTED|First Intervention||3
5331217|NCT00364156|13110812|P2|NOT COMPLETED|Overall Study||81
5331218|NCT00364156|13110813|P1|NOT COMPLETED|Overall Study||79
5331219|NCT00364156|13110812|P2|COMPLETED|Overall Study||205
5331220|NCT00364156|13110813|P1|COMPLETED|Overall Study||203
5331221|NCT00364156|13110812|P2|STARTED|Overall Study||286
5331222|NCT00364156|13110813|P1|STARTED|Overall Study||282
5331223|NCT00364130|13110821|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
5331224|NCT00364130|13110822|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
5331225|NCT00364130|13110821|P2|COMPLETED|Post Intervention Follow-up Period||50
5331226|NCT00364130|13110822|P1|COMPLETED|Post Intervention Follow-up Period||55
5331227|NCT00364130|13110821|P2|STARTED|Post Intervention Follow-up Period||61
5331228|NCT00364130|13110822|P1|STARTED|Post Intervention Follow-up Period||60
5331229|NCT00364130|13110821|P2|NOT COMPLETED|Intervention Period||8
5331230|NCT00364130|13110822|P1|NOT COMPLETED|Intervention Period||9
5331231|NCT00364130|13110821|P2|COMPLETED|Intervention Period||61
5331232|NCT00364130|13110822|P1|COMPLETED|Intervention Period||60
5331233|NCT00364130|13110821|P2|STARTED|Intervention Period||69
5331234|NCT00364130|13110822|P1|STARTED|Intervention Period||69
5331235|NCT00364013|13110844|P2|NOT COMPLETED|Overall Study||95
5331236|NCT00364013|13110845|P1|NOT COMPLETED|Overall Study||101
5331237|NCT00364013|13110844|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
5331238|NCT00364013|13110845|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
5331239|NCT00364013|13110844|P2|Received Study Drug|Overall Study||583
5331240|NCT00364013|13110845|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
5331241|NCT00364013|13110844|P2|STARTED|Overall Study||590
5331242|NCT00364013|13110845|P1|STARTED|Overall Study||593
5331243|NCT00363896|13110873|P2|NOT COMPLETED|Overall Study||47
5331244|NCT00363896|13110874|P1|NOT COMPLETED|Overall Study||89
5331245|NCT00363896|13110873|P2|COMPLETED|Overall Study||169
5331246|NCT00363896|13110874|P1|COMPLETED|Overall Study||538
5331247|NCT00363896|13110873|P2|STARTED|Overall Study||216
5331248|NCT00363896|13110874|P1|STARTED|Overall Study||627
5331249|NCT00363883|13110886|P1|NOT COMPLETED|Overall Study||0
5331250|NCT00363883|13110886|P1|COMPLETED|Overall Study||14
5331251|NCT00363883|13110886|P1|STARTED|Overall Study||14
5331252|NCT00363805|13110895|P3|NOT COMPLETED|Overall Study||3
5331253|NCT00363805|13110896|P2|NOT COMPLETED|Overall Study||6
5331254|NCT00363805|13110897|P1|NOT COMPLETED|Overall Study||4
5331255|NCT00363805|13110895|P3|COMPLETED|Overall Study||70
5331256|NCT00363805|13110896|P2|COMPLETED|Overall Study||57
5331257|NCT00363805|13110897|P1|COMPLETED|Overall Study||38
5331258|NCT00363805|13110895|P3|STARTED|Overall Study||73
5331259|NCT00363805|13110896|P2|STARTED|Overall Study||63
5331260|NCT00363805|13110897|P1|STARTED|Overall Study||42
5331261|NCT00363779|13110908|P1|NOT COMPLETED|Overall Study||0
5331262|NCT00363779|13110908|P1|COMPLETED|Overall Study||5
5331263|NCT00363779|13110908|P1|STARTED|Overall Study||5
5331264|NCT00363766|13110915|P2|NOT COMPLETED|Overall Study||20
5331265|NCT00363766|13110916|P1|NOT COMPLETED|Overall Study||32
5331266|NCT00363766|13110915|P2|COMPLETED|Overall Study||0
5331267|NCT00363766|13110916|P1|COMPLETED|Overall Study||0
5331268|NCT00363766|13110915|P2|STARTED|Overall Study||20
5331269|NCT00363766|13110916|P1|STARTED|Overall Study||32
5331270|NCT00363675|13110936|P1|NOT COMPLETED|Overall Study||0
5331271|NCT00363675|13110936|P1|COMPLETED|Overall Study||3
5331272|NCT00363675|13110936|P1|Completed Testing|Overall Study||3
5331273|NCT00363675|13110936|P1|STARTED|Overall Study||3
5331274|NCT00363649|13110945|P2|NOT COMPLETED|Overall Study||1
5331275|NCT00363649|13110946|P1|NOT COMPLETED|Overall Study||7
5331276|NCT00363649|13110945|P2|COMPLETED|Overall Study||15
5331277|NCT00363649|13110946|P1|COMPLETED|Overall Study||11
5331278|NCT00363649|13110945|P2|Did Not Cross Over|Overall Study||3
5331279|NCT00363649|13110946|P1|Did Not Cross Over|Overall Study||2
5331280|NCT00363649|13110945|P2|Crossed Over to Arm A|Overall Study||12
5331281|NCT00363649|13110946|P1|Crossed Over to Arm A|Overall Study||0
5331282|NCT00363649|13110945|P2|Crossed Over to Arm B|Overall Study||0
5331283|NCT00363649|13110946|P1|Crossed Over to Arm B|Overall Study||9
5331284|NCT00363649|13110945|P2|STARTED|Overall Study||16
5331285|NCT00363649|13110946|P1|STARTED|Overall Study||18
5331286|NCT00363545|13110962|P2|NOT COMPLETED|Overall Study||57
5331287|NCT00363545|13110963|P1|NOT COMPLETED|Overall Study||44
5331288|NCT00363545|13110962|P2|COMPLETED|Overall Study||581
5331289|NCT00363545|13110963|P1|COMPLETED|Overall Study||592
5331290|NCT00363545|13110962|P2|STARTED|Overall Study||638
5331291|NCT00363545|13110963|P1|STARTED|Overall Study||636
5331292|NCT00363480|13110981|P1|NOT COMPLETED|Overall Study||17
5331293|NCT00363480|13110981|P1|COMPLETED|Overall Study||204
5331294|NCT00363480|13110981|P1|STARTED|Overall Study||221
5331295|NCT00363467|13111001|P1|NOT COMPLETED|Overall Study||1
5331296|NCT00363467|13111001|P1|COMPLETED|Overall Study||2
5331297|NCT00363467|13111001|P1|STARTED|Overall Study||3
5331298|NCT00363415|13111011|P2|NOT COMPLETED|Overall Study||249
5331299|NCT00363415|13111012|P1|NOT COMPLETED|Overall Study||361
5331300|NCT00363415|13111011|P2|COMPLETED|Overall Study||206
5331301|NCT00363415|13111012|P1|COMPLETED|Overall Study||92
5331302|NCT00363415|13111011|P2|Received at Least One Dose of Study Drug|Overall Study||447
5331303|NCT00363415|13111012|P1|Received at Least One Dose of Study Drug|Overall Study||433
5331304|NCT00363415|13111011|P2|STARTED|Overall Study||455
5331305|NCT00363415|13111012|P1|STARTED|Overall Study||453
5331306|NCT00363311|13111030|P2|NOT COMPLETED|Overall Study||45
5331307|NCT00363311|13111031|P1|NOT COMPLETED|Overall Study||76
5331308|NCT00363311|13111030|P2|COMPLETED|Overall Study||102
5331309|NCT00363311|13111031|P1|COMPLETED|Overall Study||79
5331310|NCT00363311|13111030|P2|STARTED|Overall Study||147
5331311|NCT00363311|13111031|P1|STARTED|Overall Study||155
5331312|NCT00363298|13111097|P2|NOT COMPLETED|4-week Study Continuation Phase||0
5331313|NCT00363298|13111098|P1|NOT COMPLETED|4-week Study Continuation Phase||1
5331314|NCT00363298|13111097|P2|COMPLETED|4-week Study Continuation Phase||7
5331315|NCT00363298|13111098|P1|COMPLETED|4-week Study Continuation Phase||5
5331316|NCT00363298|13111097|P2|STARTED|4-week Study Continuation Phase||7
5331317|NCT00363298|13111098|P1|STARTED|4-week Study Continuation Phase||6
5331318|NCT00363298|13111097|P2|NOT COMPLETED|First Study Week||5
5331319|NCT00363298|13111098|P1|NOT COMPLETED|First Study Week||6
5331320|NCT00363298|13111097|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
5331321|NCT00363298|13111098|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
5331322|NCT00363298|13111097|P2|STARTED|First Study Week||12
5331323|NCT00363298|13111098|P1|STARTED|First Study Week||12
5331324|NCT00363246|13111106|P1|NOT COMPLETED|Overall Study||97
5331325|NCT00363246|13111106|P1|COMPLETED|Overall Study||669
5331326|NCT00363246|13111106|P1|STARTED|Overall Study||766
5331327|NCT00363168|13111113|P2|NOT COMPLETED|Overall Study||0
5331328|NCT00363168|13111114|P1|NOT COMPLETED|Overall Study||0
5331329|NCT00363168|13111113|P2|COMPLETED|Overall Study||2
5331330|NCT00363168|13111114|P1|COMPLETED|Overall Study||5
5331331|NCT00363168|13111113|P2|STARTED|Overall Study||2
5331332|NCT00363168|13111114|P1|STARTED|Overall Study||5
5331333|NCT00363142|13111124|P2|NOT COMPLETED|Overall Study||3
5331334|NCT00363142|13111125|P1|NOT COMPLETED|Overall Study||7
5331335|NCT00363142|13111124|P2|COMPLETED|Overall Study||66
5331336|NCT00363142|13111125|P1|COMPLETED|Overall Study||133
5331337|NCT00363142|13111124|P2|STARTED|Overall Study||69
5331338|NCT00363142|13111125|P1|STARTED|Overall Study||140
5331339|NCT00363129|13111154|P2|NOT COMPLETED|Overall Study||33
5331340|NCT00363129|13111155|P1|NOT COMPLETED|Overall Study||29
5331341|NCT00363129|13111154|P2|COMPLETED|Overall Study||60
5331342|NCT00363129|13111155|P1|COMPLETED|Overall Study||67
5331343|NCT00363129|13111154|P2|STARTED|Overall Study||93
5331344|NCT00363129|13111155|P1|STARTED|Overall Study||96
5331345|NCT00363077|13111171|P2|NOT COMPLETED|Overall Study||0
5331346|NCT00363077|13111172|P1|NOT COMPLETED|Overall Study||0
5331347|NCT00363077|13111171|P2|COMPLETED|Overall Study||75
5331348|NCT00363077|13111172|P1|COMPLETED|Overall Study||75
5331349|NCT00363077|13111171|P2|STARTED|Overall Study||75
5331350|NCT00363077|13111172|P1|STARTED|Overall Study||75
5331351|NCT00363051|13111198|P2|NOT COMPLETED|Overall Study||22
5331352|NCT00363051|13111199|P1|NOT COMPLETED|Overall Study||38
5331353|NCT00363051|13111198|P2|COMPLETED|Overall Study||23
5331354|NCT00363051|13111199|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
5331355|NCT00363051|13111198|P2|STARTED|Overall Study||45
5331356|NCT00363051|13111199|P1|STARTED|Overall Study||115
5331357|NCT00363038|13111216|P1|NOT COMPLETED|Overall Study||0
5331358|NCT00363038|13111216|P1|COMPLETED|Overall Study||16
5331359|NCT00363038|13111216|P1|STARTED|Overall Study||16
5331360|NCT00362882|13111222|P2|NOT COMPLETED|Overall Study||0
5331361|NCT00362882|13111223|P1|NOT COMPLETED|Overall Study||0
5331362|NCT00362882|13111222|P2|COMPLETED|Overall Study||41
5331363|NCT00362882|13111223|P1|COMPLETED|Overall Study||40
5331364|NCT00362882|13111222|P2|STARTED|Overall Study||41
5331365|NCT00362882|13111223|P1|STARTED|Overall Study||40
5331366|NCT00362817|13111235|P1|NOT COMPLETED|Overall Study||0
5331367|NCT00362817|13111235|P1|COMPLETED|Overall Study||17
5331368|NCT00362817|13111235|P1|STARTED|Overall Study||17
5331369|NCT00362648|13111248|P4|NOT COMPLETED|Overall Study||11
5331370|NCT00362648|13111249|P3|NOT COMPLETED|Overall Study||9
5331371|NCT00362648|13111250|P2|NOT COMPLETED|Overall Study||134
5331372|NCT00362648|13111251|P1|NOT COMPLETED|Overall Study||126
5331373|NCT00362648|13111248|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
5331374|NCT00362648|13111249|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
5331375|NCT00362648|13111250|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
5331376|NCT00362648|13111251|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
5331377|NCT00362648|13111248|P4|Vaccinated at Visit 3|Overall Study||1007
5331378|NCT00362648|13111249|P3|Vaccinated at Visit 3|Overall Study||1009
5331379|NCT00362648|13111250|P2|Vaccinated at Visit 3|Overall Study||2612
5331380|NCT00362648|13111251|P1|Vaccinated at Visit 3|Overall Study||2613
5331381|NCT00362648|13111248|P4|Vaccinated at Visit 2|Overall Study||1009
5331382|NCT00362648|13111249|P3|Vaccinated at Visit 2|Overall Study||1013
5331383|NCT00362648|13111250|P2|Vaccinated at Visit 2|Overall Study||2666
5331384|NCT00362648|13111251|P1|Vaccinated at Visit 2|Overall Study||2657
5331385|NCT00362648|13111248|P4|Vaccinated at Visit 1|Overall Study||1018
5331386|NCT00362648|13111249|P3|Vaccinated at Visit 1|Overall Study||1018
5331387|NCT00362648|13111250|P2|Vaccinated at Visit 1|Overall Study||2735
5331388|NCT00362648|13111251|P1|Vaccinated at Visit 1|Overall Study||2733
5331389|NCT00362648|13111248|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
5331390|NCT00362648|13111249|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
5331391|NCT00362648|13111250|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
5331392|NCT00362648|13111251|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
5331393|NCT00362609|13111269|P2|NOT COMPLETED|Overall Study||2
5331394|NCT00362609|13111270|P1|NOT COMPLETED|Overall Study||0
5331395|NCT00362609|13111269|P2|COMPLETED|Overall Study||38
5331396|NCT00362609|13111270|P1|COMPLETED|Overall Study||19
5331397|NCT00362609|13111269|P2|STARTED|Overall Study||40
5331398|NCT00362609|13111270|P1|STARTED|Overall Study||19
5331399|NCT00362466|13111284|P2|NOT COMPLETED|Overall Study||0
5331400|NCT00362466|13111285|P1|NOT COMPLETED|Overall Study||0
5331401|NCT00362466|13111284|P2|COMPLETED|Overall Study||1
5331402|NCT00362466|13111285|P1|COMPLETED|Overall Study||2
5331403|NCT00362466|13111284|P2|STARTED|Overall Study||1
5331404|NCT00362466|13111285|P1|STARTED|Overall Study||2
5331405|NCT00362453|13111307|P2|NOT COMPLETED|Overall Study||0
5331406|NCT00362453|13111308|P1|NOT COMPLETED|Overall Study||0
5331407|NCT00362453|13111307|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
5331408|NCT00362453|13111308|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
5331409|NCT00362453|13111307|P2|STARTED|Overall Study||20
5331410|NCT00362453|13111308|P1|STARTED|Overall Study||20
5331411|NCT00362440|13111340|P2|NOT COMPLETED|Overall Study||1
5331412|NCT00362440|13111341|P1|NOT COMPLETED|Overall Study||2
5331413|NCT00362440|13111340|P2|COMPLETED|Overall Study||3
5331414|NCT00362440|13111341|P1|COMPLETED|Overall Study||3
5331415|NCT00362440|13111340|P2|STARTED|Overall Study||4
5331416|NCT00362440|13111341|P1|STARTED|Overall Study||5
5331417|NCT00362414|13111351|P1|NOT COMPLETED|Overall Study||3
5331418|NCT00362414|13111351|P1|COMPLETED|Overall Study||12
5331419|NCT00362414|13111351|P1|STARTED|Overall Study||15
5331420|NCT00362401|13111371|P3|NOT COMPLETED|Overall Study||0
5331421|NCT00362401|13111372|P2|NOT COMPLETED|Overall Study||0
5331422|NCT00362401|13111373|P1|NOT COMPLETED|Overall Study||0
5331423|NCT00362401|13111371|P3|COMPLETED|Overall Study||40
5331424|NCT00362401|13111372|P2|COMPLETED|Overall Study||29
5331425|NCT00362401|13111373|P1|COMPLETED|Overall Study||15
5331426|NCT00362401|13111371|P3|STARTED|Overall Study||40
5331427|NCT00362401|13111372|P2|STARTED|Overall Study||29
5331428|NCT00362401|13111373|P1|STARTED|Overall Study||15
5331429|NCT00362375|13111380|P2|NOT COMPLETED|Overall Study||35
5331430|NCT00362375|13111381|P1|NOT COMPLETED|Overall Study||40
5331431|NCT00362375|13111380|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
5331432|NCT00362375|13111381|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
5331433|NCT00362375|13111380|P2|STARTED|Overall Study|Number eligible and randomized|152
5331434|NCT00362375|13111381|P1|STARTED|Overall Study|Number eligible and randomized|161
5331435|NCT00362336|13111398|P3|NOT COMPLETED|Overall Study||3
5331436|NCT00362336|13111399|P2|NOT COMPLETED|Overall Study||7
5331437|NCT00362336|13111400|P1|NOT COMPLETED|Overall Study||10
5331438|NCT00362336|13111398|P3|COMPLETED|Overall Study||134
5331439|NCT00362336|13111399|P2|COMPLETED|Overall Study||235
5331440|NCT00362336|13111400|P1|COMPLETED|Overall Study||233
5331441|NCT00362336|13111398|P3|STARTED|Overall Study||137
5331442|NCT00362336|13111399|P2|STARTED|Overall Study||242
5331443|NCT00362336|13111400|P1|STARTED|Overall Study||243
5331444|NCT00362297|13111428|P2|NOT COMPLETED|Treatment 2||0
5331445|NCT00362297|13111429|P1|NOT COMPLETED|Treatment 2||0
5331446|NCT00362297|13111428|P2|COMPLETED|Treatment 2||11
5331447|NCT00362297|13111429|P1|COMPLETED|Treatment 2||16
5331448|NCT00362297|13111428|P2|STARTED|Treatment 2||11
5331449|NCT00362297|13111429|P1|STARTED|Treatment 2||16
5331450|NCT00362297|13111428|P2|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
5331451|NCT00362297|13111429|P1|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
5331452|NCT00362297|13111428|P2|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
5331453|NCT00362297|13111429|P1|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
5331454|NCT00362297|13111428|P2|STARTED|Treatment 1 (Initial Drug Assignment)||15
5331455|NCT00362297|13111429|P1|STARTED|Treatment 1 (Initial Drug Assignment)||16
5331456|NCT00362232|13111437|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
5331457|NCT00362232|13111438|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
5331458|NCT00362232|13111437|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
5331459|NCT00362232|13111438|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
5331460|NCT00362232|13111437|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
5331461|NCT00362232|13111438|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
5331462|NCT00362232|13111437|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
5331463|NCT00362232|13111438|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
5331464|NCT00362232|13111437|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
5331465|NCT00362232|13111438|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
5331466|NCT00362232|13111437|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
5331467|NCT00362232|13111438|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
5331468|NCT00362232|13111437|P2|STARTED|Treatment (12 +/- 2 Days)||1564
5331469|NCT00362232|13111438|P1|STARTED|Treatment (12 +/- 2 Days)||1584
5331470|NCT00362180|13111483|P9|NOT COMPLETED|20 Week Safety Follow-up||0
5331471|NCT00362180|13111484|P8|NOT COMPLETED|20 Week Safety Follow-up||0
5331472|NCT00362180|13111485|P7|NOT COMPLETED|20 Week Safety Follow-up||0
5331473|NCT00362180|13111486|P6|NOT COMPLETED|20 Week Safety Follow-up||0
5331474|NCT00362180|13111487|P5|NOT COMPLETED|20 Week Safety Follow-up||0
5331475|NCT00362180|13111488|P4|NOT COMPLETED|20 Week Safety Follow-up||0
5331476|NCT00362180|13111489|P3|NOT COMPLETED|20 Week Safety Follow-up||0
5331477|NCT00362180|13111490|P2|NOT COMPLETED|20 Week Safety Follow-up||0
5331478|NCT00362180|13111491|P1|NOT COMPLETED|20 Week Safety Follow-up||0
5331479|NCT00362180|13111483|P9|COMPLETED|20 Week Safety Follow-up||1
5331480|NCT00362180|13111484|P8|COMPLETED|20 Week Safety Follow-up||3
5331481|NCT00362180|13111485|P7|COMPLETED|20 Week Safety Follow-up||0
5331482|NCT00362180|13111486|P6|COMPLETED|20 Week Safety Follow-up||9
5331483|NCT00362180|13111487|P5|COMPLETED|20 Week Safety Follow-up||11
5331484|NCT00362180|13111488|P4|COMPLETED|20 Week Safety Follow-up||0
5331485|NCT00362180|13111489|P3|COMPLETED|20 Week Safety Follow-up||1
5331486|NCT00362180|13111490|P2|COMPLETED|20 Week Safety Follow-up||2
5331487|NCT00362180|13111491|P1|COMPLETED|20 Week Safety Follow-up||3
5331488|NCT00362180|13111483|P9|STARTED|20 Week Safety Follow-up||1
5331489|NCT00362180|13111484|P8|STARTED|20 Week Safety Follow-up||3
5331490|NCT00362180|13111485|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
5331491|NCT00362180|13111486|P6|STARTED|20 Week Safety Follow-up||9
5331492|NCT00362180|13111487|P5|STARTED|20 Week Safety Follow-up||11
5331493|NCT00362180|13111488|P4|STARTED|20 Week Safety Follow-up||0
5331494|NCT00362180|13111489|P3|STARTED|20 Week Safety Follow-up||1
5331495|NCT00362180|13111490|P2|STARTED|20 Week Safety Follow-up||2
5331496|NCT00362180|13111491|P1|STARTED|20 Week Safety Follow-up||3
5331497|NCT00362180|13111483|P9|NOT COMPLETED|Treated Period||0
5331498|NCT00362180|13111484|P8|NOT COMPLETED|Treated Period||1
5331499|NCT00362180|13111485|P7|NOT COMPLETED|Treated Period||0
5331500|NCT00362180|13111486|P6|NOT COMPLETED|Treated Period||1
5331501|NCT00362180|13111487|P5|NOT COMPLETED|Treated Period||0
5331502|NCT00362180|13111488|P4|NOT COMPLETED|Treated Period||0
5331503|NCT00362180|13111489|P3|NOT COMPLETED|Treated Period||0
5331504|NCT00362180|13111490|P2|NOT COMPLETED|Treated Period||0
5331505|NCT00362180|13111491|P1|NOT COMPLETED|Treated Period||1
5331506|NCT00362180|13111483|P9|COMPLETED|Treated Period||1
5331507|NCT00362180|13111484|P8|COMPLETED|Treated Period||2
5331508|NCT00362180|13111485|P7|COMPLETED|Treated Period||6
5331509|NCT00362180|13111486|P6|COMPLETED|Treated Period||9
5331510|NCT00362180|13111487|P5|COMPLETED|Treated Period||11
5331511|NCT00362180|13111488|P4|COMPLETED|Treated Period||0
5331512|NCT00362180|13111489|P3|COMPLETED|Treated Period||1
5331513|NCT00362180|13111490|P2|COMPLETED|Treated Period||2
5331514|NCT00362180|13111491|P1|COMPLETED|Treated Period||3
5331515|NCT00362180|13111483|P9|STARTED|Treated Period||1
5331516|NCT00362180|13111484|P8|STARTED|Treated Period||3
5331517|NCT00362180|13111485|P7|STARTED|Treated Period||6
5331518|NCT00362180|13111486|P6|STARTED|Treated Period||10
5331519|NCT00362180|13111487|P5|STARTED|Treated Period||11
5331520|NCT00362180|13111488|P4|STARTED|Treated Period||0
5331521|NCT00362180|13111489|P3|STARTED|Treated Period||1
5331522|NCT00362180|13111490|P2|STARTED|Treated Period||2
5331523|NCT00362180|13111491|P1|STARTED|Treated Period||4
5331524|NCT00362128|13111552|P1|NOT COMPLETED|Overall Study||0
5331525|NCT00362128|13111552|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
5331526|NCT00362128|13111552|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
5331527|NCT00362115|13111563|P7|NOT COMPLETED|Overall Study||12
5331528|NCT00362115|13111564|P6|NOT COMPLETED|Overall Study||7
5331529|NCT00362115|13111565|P5|NOT COMPLETED|Overall Study||7
5331530|NCT00362115|13111566|P4|NOT COMPLETED|Overall Study||4
5331531|NCT00362115|13111567|P3|NOT COMPLETED|Overall Study||7
5331532|NCT00362115|13111568|P2|NOT COMPLETED|Overall Study||6
5331533|NCT00362115|13111569|P1|NOT COMPLETED|Overall Study||2
5331534|NCT00362115|13111563|P7|COMPLETED|Overall Study||52
5331535|NCT00362115|13111564|P6|COMPLETED|Overall Study||57
5331536|NCT00362115|13111565|P5|COMPLETED|Overall Study||57
5331537|NCT00362115|13111566|P4|COMPLETED|Overall Study||59
5331538|NCT00362115|13111567|P3|COMPLETED|Overall Study||57
5331539|NCT00362115|13111568|P2|COMPLETED|Overall Study||59
5331540|NCT00362115|13111569|P1|COMPLETED|Overall Study||63
5331541|NCT00362115|13111563|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
5331542|NCT00362115|13111564|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
5331543|NCT00362115|13111565|P5|STARTED|Overall Study||64
5331544|NCT00362115|13111566|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
5331545|NCT00362115|13111567|P3|STARTED|Overall Study||64
5331546|NCT00362115|13111568|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
5331547|NCT00362115|13111569|P1|STARTED|Overall Study||65
5331548|NCT00361972|13111720|P2|NOT COMPLETED|Overall Study||0
5331549|NCT00361972|13111721|P1|NOT COMPLETED|Overall Study||0
5331550|NCT00361972|13111720|P2|COMPLETED|Overall Study||9
5331551|NCT00361972|13111721|P1|COMPLETED|Overall Study||8
5331552|NCT00361972|13111720|P2|STARTED|Overall Study||9
5331553|NCT00361972|13111721|P1|STARTED|Overall Study||8
5331554|NCT00361712|13111731|P2|NOT COMPLETED|Overall Study||0
5331555|NCT00361712|13111732|P1|NOT COMPLETED|Overall Study||0
5331556|NCT00361712|13111731|P2|COMPLETED|Overall Study||21
5331557|NCT00361712|13111732|P1|COMPLETED|Overall Study||20
5331558|NCT00361712|13111731|P2|STARTED|Overall Study||21
5331559|NCT00361712|13111732|P1|STARTED|Overall Study||20
5331560|NCT00361634|13111742|P1|NOT COMPLETED|Overall Study||2
5331561|NCT00361634|13111742|P1|COMPLETED|Overall Study||12
5331562|NCT00361634|13111742|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
5331563|NCT00361634|13111742|P1|STARTED|Overall Study||14
5331564|NCT00361595|13111760|P1|NOT COMPLETED|Overall Study||0
5331565|NCT00361595|13111760|P1|COMPLETED|Overall Study||35
5331566|NCT00361595|13111760|P1|STARTED|Overall Study||35
5331567|NCT00361569|13111771|P4|NOT COMPLETED|Overall Study||21
5331568|NCT00361569|13111772|P3|NOT COMPLETED|Overall Study||18
5331569|NCT00361569|13111773|P2|NOT COMPLETED|Overall Study||11
5331570|NCT00361569|13111774|P1|NOT COMPLETED|Overall Study||12
5331571|NCT00361569|13111771|P4|COMPLETED|Overall Study||135
5331572|NCT00361569|13111772|P3|COMPLETED|Overall Study||137
5331573|NCT00361569|13111773|P2|COMPLETED|Overall Study||150
5331574|NCT00361569|13111774|P1|COMPLETED|Overall Study||138
5331575|NCT00361569|13111771|P4|STARTED|Overall Study||156
5331576|NCT00361569|13111772|P3|STARTED|Overall Study||155
5331577|NCT00361569|13111773|P2|STARTED|Overall Study||161
5331578|NCT00361569|13111774|P1|STARTED|Overall Study||150
5331579|NCT00361504|13111798|P2|NOT COMPLETED|Overall Study||145
5331580|NCT00361504|13111799|P1|NOT COMPLETED|Overall Study||481
5331581|NCT00361504|13111798|P2|COMPLETED|Overall Study||78
5331582|NCT00361504|13111799|P1|COMPLETED|Overall Study||413
5331583|NCT00361504|13111798|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
5331584|NCT00361504|13111799|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
5331585|NCT00361439|13111809|P2|NOT COMPLETED|Overall Study||0
5331586|NCT00361439|13111810|P1|NOT COMPLETED|Overall Study||0
5331587|NCT00361439|13111809|P2|COMPLETED|Overall Study||9
5331588|NCT00361439|13111810|P1|COMPLETED|Overall Study||8
5331589|NCT00361439|13111809|P2|STARTED|Overall Study||9
5331590|NCT00361439|13111810|P1|STARTED|Overall Study||8
5331591|NCT00361374|13111825|P3|NOT COMPLETED|Overall Study||12
5331592|NCT00361374|13111826|P2|NOT COMPLETED|Overall Study||15
5331593|NCT00361374|13111827|P1|NOT COMPLETED|Overall Study||15
5331594|NCT00361374|13111825|P3|COMPLETED|Overall Study||53
5331595|NCT00361374|13111826|P2|COMPLETED|Overall Study||50
5331596|NCT00361374|13111827|P1|COMPLETED|Overall Study||51
5331597|NCT00361374|13111825|P3|STARTED|Overall Study||65
5331598|NCT00361374|13111826|P2|STARTED|Overall Study||65
5331599|NCT00361374|13111827|P1|STARTED|Overall Study||66
5331600|NCT00361335|13111840|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
5331601|NCT00361335|13111841|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
5331602|NCT00361335|13111842|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
5331603|NCT00361335|13111843|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
5331604|NCT00361335|13111844|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
5331605|NCT00361335|13111845|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
5331606|NCT00361335|13111846|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
5331607|NCT00361335|13111840|P7|COMPLETED|SC Period: Week E0 to Week E24||164
5331608|NCT00361335|13111841|P6|COMPLETED|SC Period: Week E0 to Week E24||23
5331609|NCT00361335|13111842|P5|COMPLETED|SC Period: Week E0 to Week E24||3
5331610|NCT00361335|13111843|P4|COMPLETED|SC Period: Week E0 to Week E24||59
5331611|NCT00361335|13111844|P3|COMPLETED|SC Period: Week E0 to Week E24||99
5331612|NCT00361335|13111845|P2|COMPLETED|SC Period: Week E0 to Week E24||56
5331613|NCT00361335|13111846|P1|COMPLETED|SC Period: Week E0 to Week E24||80
5331614|NCT00361335|13111840|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
5331615|NCT00361335|13111841|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
5331616|NCT00361335|13111842|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
5331617|NCT00361335|13111843|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
5331618|NCT00361335|13111844|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
5331619|NCT00361335|13111845|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
5331620|NCT00361335|13111846|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
5331621|NCT00361335|13111840|P7|NOT COMPLETED|IV Period: Baseline to E0||0
5331622|NCT00361335|13111841|P6|NOT COMPLETED|IV Period: Baseline to E0||0
5331623|NCT00361335|13111842|P5|NOT COMPLETED|IV Period: Baseline to E0||24
5331624|NCT00361335|13111843|P4|NOT COMPLETED|IV Period: Baseline to E0||27
5331625|NCT00361335|13111844|P3|NOT COMPLETED|IV Period: Baseline to E0||21
5331626|NCT00361335|13111845|P2|NOT COMPLETED|IV Period: Baseline to E0||29
5331627|NCT00361335|13111846|P1|NOT COMPLETED|IV Period: Baseline to E0||20
5331628|NCT00361335|13111840|P7|COMPLETED|IV Period: Baseline to E0||0
5331629|NCT00361335|13111841|P6|COMPLETED|IV Period: Baseline to E0||0
5331630|NCT00361335|13111842|P5|COMPLETED|IV Period: Baseline to E0||105
5331631|NCT00361335|13111843|P4|COMPLETED|IV Period: Baseline to E0||102
5331632|NCT00361335|13111844|P3|COMPLETED|IV Period: Baseline to E0||107
5331633|NCT00361335|13111845|P2|COMPLETED|IV Period: Baseline to E0||99
5331634|NCT00361335|13111846|P1|COMPLETED|IV Period: Baseline to E0||109
5331635|NCT00361335|13111840|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
5331636|NCT00361335|13111841|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
5331637|NCT00361335|13111842|P5|STARTED|IV Period: Baseline to E0||129
5331638|NCT00361335|13111843|P4|STARTED|IV Period: Baseline to E0||129
5331639|NCT00361335|13111844|P3|STARTED|IV Period: Baseline to E0||128
5331640|NCT00361335|13111845|P2|STARTED|IV Period: Baseline to E0||128
5331641|NCT00361335|13111846|P1|STARTED|IV Period: Baseline to E0||129
5331642|NCT00361296|13111890|P1|NOT COMPLETED|Overall Study||3
5331643|NCT00361296|13111890|P1|COMPLETED|Overall Study||2
5331644|NCT00361296|13111890|P1|STARTED|Overall Study||5
5331645|NCT00361283|13111897|P1|NOT COMPLETED|Overall Study||27
5331646|NCT00361283|13111897|P1|COMPLETED|Overall Study||81
5331647|NCT00361283|13111897|P1|STARTED|Overall Study||108
5331648|NCT00361270|13111905|P4|NOT COMPLETED|Overall Study||13
5331649|NCT00361270|13111906|P3|NOT COMPLETED|Overall Study||10
5331650|NCT00361270|13111907|P2|NOT COMPLETED|Overall Study||14
5331651|NCT00361270|13111908|P1|NOT COMPLETED|Overall Study||24
5331652|NCT00361270|13111905|P4|COMPLETED|Overall Study||25
5331653|NCT00361270|13111906|P3|COMPLETED|Overall Study||25
5331654|NCT00361270|13111907|P2|COMPLETED|Overall Study||25
5331655|NCT00361270|13111908|P1|COMPLETED|Overall Study||25
5331656|NCT00361270|13111905|P4|STARTED|Overall Study||38
5331657|NCT00361270|13111906|P3|STARTED|Overall Study||35
5331658|NCT00361270|13111907|P2|STARTED|Overall Study||39
5331659|NCT00361270|13111908|P1|STARTED|Overall Study||49
5331660|NCT00361257|13111928|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
5331661|NCT00361257|13111929|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
5331662|NCT00361257|13111928|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
5331663|NCT00361257|13111929|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
5331664|NCT00361257|13111928|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
5331665|NCT00361257|13111929|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
5331666|NCT00361257|13111928|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
5331667|NCT00361257|13111929|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
5331668|NCT00361257|13111928|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
5331669|NCT00361257|13111929|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
5331670|NCT00361257|13111928|P2|STARTED|Step 1: Minocycline vs. Placebo||55
5331671|NCT00361257|13111929|P1|STARTED|Step 1: Minocycline vs. Placebo||52
5331672|NCT00361231|13111981|P1|NOT COMPLETED|Overall Study||34
5331673|NCT00361231|13111981|P1|COMPLETED|Overall Study||1
5331674|NCT00361231|13111981|P1|STARTED|Overall Study||35
5331675|NCT00361218|13111986|P1|NOT COMPLETED|Overall Study||23
5331676|NCT00361218|13111986|P1|COMPLETED|Overall Study||30
5331677|NCT00361218|13111986|P1|Completed Baseline Assessment|Overall Study||47
5331678|NCT00361218|13111986|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
5331679|NCT00361140|13111994|P3|NOT COMPLETED|Overall Study||0
5331680|NCT00361140|13111995|P2|NOT COMPLETED|Overall Study||0
5331681|NCT00361140|13111996|P1|NOT COMPLETED|Overall Study||0
5331682|NCT00361140|13111994|P3|COMPLETED|Overall Study||3
5331683|NCT00361140|13111995|P2|COMPLETED|Overall Study||29
5331684|NCT00361140|13111996|P1|COMPLETED|Overall Study||40
5331685|NCT00361140|13111994|P3|STARTED|Overall Study||3
5331686|NCT00361140|13111995|P2|STARTED|Overall Study||29
5331687|NCT00361140|13111996|P1|STARTED|Overall Study||40
5331688|NCT00360971|13112009|P2|NOT COMPLETED|Overall Study||0
5331689|NCT00360971|13112010|P1|NOT COMPLETED|Overall Study||0
5331690|NCT00360971|13112009|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
5331691|NCT00360971|13112010|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
5331692|NCT00360971|13112009|P2|STARTED|Overall Study||11
5331693|NCT00360971|13112010|P1|STARTED|Overall Study||10
5331694|NCT00360828|13112026|P1|NOT COMPLETED|Overall Study||1
5331695|NCT00360828|13112026|P1|COMPLETED|Overall Study||9
5331696|NCT00360828|13112026|P1|STARTED|Overall Study||10
5331697|NCT00360724|13112036|P2|NOT COMPLETED|Overall Study||4
5331698|NCT00360724|13112037|P1|NOT COMPLETED|Overall Study||4
5331699|NCT00360724|13112036|P2|COMPLETED|Overall Study||28
5331700|NCT00360724|13112037|P1|COMPLETED|Overall Study||29
5331701|NCT00360724|13112036|P2|STARTED|Overall Study||32
5331702|NCT00360724|13112037|P1|STARTED|Overall Study||33
5331703|NCT00360698|13112065|P2|NOT COMPLETED|Treatment Period||1
5331704|NCT00360698|13112066|P1|NOT COMPLETED|Treatment Period||1
5331705|NCT00360698|13112065|P2|COMPLETED|Treatment Period||56
5331706|NCT00360698|13112066|P1|COMPLETED|Treatment Period||48
5331707|NCT00360698|13112065|P2|STARTED|Treatment Period||57
5331708|NCT00360698|13112066|P1|STARTED|Treatment Period||49
5331709|NCT00360698|13112065|P2|NOT COMPLETED|Run-In||10
5331710|NCT00360698|13112066|P1|NOT COMPLETED|Run-In||0
5331711|NCT00360698|13112065|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
5331712|NCT00360698|13112066|P1|COMPLETED|Run-In||0
5331713|NCT00360698|13112065|P2|STARTED|Run-In||135
5331714|NCT00360698|13112066|P1|STARTED|Run-In||0
5331715|NCT00360685|13112094|P2|NOT COMPLETED|Overall Study||0
5331716|NCT00360685|13112095|P1|NOT COMPLETED|Overall Study||0
5331717|NCT00360685|13112094|P2|COMPLETED|Overall Study||42
5331718|NCT00360685|13112095|P1|COMPLETED|Overall Study||47
5331719|NCT00360685|13112094|P2|STARTED|Overall Study||42
5331720|NCT00360685|13112095|P1|STARTED|Overall Study||47
5331721|NCT00360672|13112105|P1|NOT COMPLETED|Overall Study||0
5331722|NCT00360672|13112105|P1|COMPLETED|Overall Study||27
5331723|NCT00360672|13112105|P1|STARTED|Overall Study||27
5331724|NCT00360568|13112111|P2|NOT COMPLETED|Overall Study||5
5331725|NCT00360568|13112112|P1|NOT COMPLETED|Overall Study||2
5331726|NCT00360568|13112111|P2|COMPLETED|Overall Study||24
5331727|NCT00360568|13112112|P1|COMPLETED|Overall Study||31
5331728|NCT00360568|13112111|P2|STARTED|Overall Study||29
5331729|NCT00360568|13112112|P1|STARTED|Overall Study||33
5331730|NCT00360555|13112223|P4|NOT COMPLETED|Overall Study||112
5331731|NCT00360555|13112224|P3|NOT COMPLETED|Overall Study||145
5331732|NCT00360555|13112225|P2|NOT COMPLETED|Overall Study||134
5331733|NCT00360555|13112226|P1|NOT COMPLETED|Overall Study||122
5331734|NCT00360555|13112223|P4|COMPLETED|Overall Study||287
5331735|NCT00360555|13112224|P3|COMPLETED|Overall Study||251
5331736|NCT00360555|13112225|P2|COMPLETED|Overall Study||259
5331737|NCT00360555|13112226|P1|COMPLETED|Overall Study||274
5331738|NCT00360555|13112223|P4|STARTED|Overall Study||399
5331739|NCT00360555|13112224|P3|STARTED|Overall Study||396
5331740|NCT00360555|13112225|P2|STARTED|Overall Study||393
5331741|NCT00360555|13112226|P1|STARTED|Overall Study||396
5331742|NCT00360529|13112243|P3|NOT COMPLETED|Overall Study||91
5331743|NCT00360529|13112244|P2|NOT COMPLETED|Overall Study||65
5331744|NCT00360529|13112245|P1|NOT COMPLETED|Overall Study||61
5331745|NCT00360529|13112243|P3|COMPLETED|Overall Study||199
5331746|NCT00360529|13112244|P2|COMPLETED|Overall Study||230
5331747|NCT00360529|13112245|P1|COMPLETED|Overall Study||234
5331748|NCT00360529|13112243|P3|STARTED|Overall Study||290
5331749|NCT00360529|13112244|P2|STARTED|Overall Study||295
5331750|NCT00360529|13112245|P1|STARTED|Overall Study||295
5331751|NCT00360490|13112273|P2|NOT COMPLETED|Overall Study||11
5331752|NCT00360490|13112274|P1|NOT COMPLETED|Overall Study||9
5331753|NCT00360490|13112273|P2|COMPLETED|Overall Study||72
5331754|NCT00360490|13112274|P1|COMPLETED|Overall Study||73
5331755|NCT00360490|13112273|P2|STARTED|Overall Study||83
5331756|NCT00360490|13112274|P1|STARTED|Overall Study||82
5331757|NCT00360412|13112309|P2|NOT COMPLETED|Overall Study||662
5331758|NCT00360412|13112310|P1|NOT COMPLETED|Overall Study||333
5331759|NCT00360412|13112309|P2|COMPLETED|Overall Study||2
5331760|NCT00360412|13112310|P1|COMPLETED|Overall Study||0
5331761|NCT00360412|13112309|P2|STARTED|Overall Study||664
5331762|NCT00360412|13112310|P1|STARTED|Overall Study||333
5331763|NCT00360399|13112325|P3|NOT COMPLETED|Overall Study||46
5331764|NCT00360399|13112326|P2|NOT COMPLETED|Overall Study||36
5331765|NCT00360399|13112327|P1|NOT COMPLETED|Overall Study||28
5331766|NCT00360399|13112325|P3|COMPLETED|Overall Study||69
5331767|NCT00360399|13112326|P2|COMPLETED|Overall Study||79
5331768|NCT00360399|13112327|P1|COMPLETED|Overall Study||86
5331769|NCT00360399|13112325|P3|Had Post-randomization Assessment|Overall Study||105
5331770|NCT00360399|13112326|P2|Had Post-randomization Assessment|Overall Study||106
5331771|NCT00360399|13112327|P1|Had Post-randomization Assessment|Overall Study||105
5331772|NCT00360399|13112325|P3|STARTED|Overall Study||115
5331773|NCT00360399|13112326|P2|STARTED|Overall Study||115
5331774|NCT00360399|13112327|P1|STARTED|Overall Study||114
5331775|NCT00360360|13112350|P1|NOT COMPLETED|Overall Study||6
5331776|NCT00360360|13112350|P1|COMPLETED|Overall Study||54
5331777|NCT00360360|13112350|P1|STARTED|Overall Study||60
5331778|NCT00360334|13112357|P2|NOT COMPLETED|Overall Study||13
5331779|NCT00360334|13112358|P1|NOT COMPLETED|Overall Study||19
5331780|NCT00360334|13112357|P2|COMPLETED|Overall Study||104
5331781|NCT00360334|13112358|P1|COMPLETED|Overall Study||99
5331782|NCT00360334|13112357|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
5331783|NCT00360334|13112358|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
5331784|NCT00360334|13112357|P2|STARTED|Overall Study||117
5331785|NCT00360334|13112358|P1|STARTED|Overall Study||118
5331786|NCT00360308|13112421|P3|NOT COMPLETED|Overall Study||88
5331787|NCT00360308|13112422|P2|NOT COMPLETED|Overall Study||79
5331788|NCT00360308|13112423|P1|NOT COMPLETED|Overall Study||76
5331789|NCT00360308|13112421|P3|COMPLETED|Overall Study||154
5331790|NCT00360308|13112422|P2|COMPLETED|Overall Study||155
5331791|NCT00360308|13112423|P1|COMPLETED|Overall Study||171
5331792|NCT00360308|13112421|P3|STARTED|Overall Study||242
5331793|NCT00360308|13112422|P2|STARTED|Overall Study||234
5331794|NCT00360308|13112423|P1|STARTED|Overall Study||247
5331795|NCT00360282|13112440|P4|NOT COMPLETED|Second Intervention||0
5331796|NCT00360282|13112441|P3|NOT COMPLETED|Second Intervention||0
5331797|NCT00360282|13112442|P2|NOT COMPLETED|Second Intervention||1
5331798|NCT00360282|13112443|P1|NOT COMPLETED|Second Intervention||0
5331799|NCT00360282|13112440|P4|COMPLETED|Second Intervention||6
5331800|NCT00360282|13112441|P3|COMPLETED|Second Intervention||6
5331801|NCT00360282|13112442|P2|COMPLETED|Second Intervention||7
5331802|NCT00360282|13112443|P1|COMPLETED|Second Intervention||6
5331803|NCT00360282|13112440|P4|STARTED|Second Intervention||6
5331804|NCT00360282|13112441|P3|STARTED|Second Intervention||6
5331805|NCT00360282|13112442|P2|STARTED|Second Intervention||8
5331806|NCT00360282|13112443|P1|STARTED|Second Intervention||6
5331807|NCT00360282|13112440|P4|NOT COMPLETED|Washout 1-3 Weeks||0
5331808|NCT00360282|13112441|P3|NOT COMPLETED|Washout 1-3 Weeks||1
5331809|NCT00360282|13112442|P2|NOT COMPLETED|Washout 1-3 Weeks||0
5331810|NCT00360282|13112443|P1|NOT COMPLETED|Washout 1-3 Weeks||0
5331811|NCT00360282|13112440|P4|COMPLETED|Washout 1-3 Weeks||6
5331812|NCT00360282|13112441|P3|COMPLETED|Washout 1-3 Weeks||6
5331813|NCT00360282|13112442|P2|COMPLETED|Washout 1-3 Weeks||8
5331814|NCT00360282|13112443|P1|COMPLETED|Washout 1-3 Weeks||6
5331815|NCT00360282|13112440|P4|STARTED|Washout 1-3 Weeks||6
5331816|NCT00360282|13112441|P3|STARTED|Washout 1-3 Weeks||7
5331817|NCT00360282|13112442|P2|STARTED|Washout 1-3 Weeks||8
5331818|NCT00360282|13112443|P1|STARTED|Washout 1-3 Weeks||6
5331819|NCT00360282|13112440|P4|NOT COMPLETED|First Intervention||0
5331820|NCT00360282|13112441|P3|NOT COMPLETED|First Intervention||0
5331821|NCT00360282|13112442|P2|NOT COMPLETED|First Intervention||0
5331822|NCT00360282|13112443|P1|NOT COMPLETED|First Intervention||0
5331823|NCT00360282|13112440|P4|COMPLETED|First Intervention||6
5331824|NCT00360282|13112441|P3|COMPLETED|First Intervention||7
5331825|NCT00360282|13112442|P2|COMPLETED|First Intervention||8
5331826|NCT00360282|13112443|P1|COMPLETED|First Intervention||6
5331827|NCT00360282|13112440|P4|STARTED|First Intervention||6
5331828|NCT00360282|13112441|P3|STARTED|First Intervention||7
5331829|NCT00360282|13112442|P2|STARTED|First Intervention||8
5331830|NCT00360282|13112443|P1|STARTED|First Intervention||6
5331831|NCT00360269|13112455|P2|NOT COMPLETED|Overall Study||12
5331832|NCT00360269|13112456|P1|NOT COMPLETED|Overall Study||10
5331833|NCT00360269|13112455|P2|COMPLETED|Overall Study||7
5331834|NCT00360269|13112456|P1|COMPLETED|Overall Study||9
5331835|NCT00360269|13112455|P2|STARTED|Overall Study||19
5331836|NCT00360269|13112456|P1|STARTED|Overall Study||19
5331837|NCT00360243|13112474|P4|NOT COMPLETED|Overall Study||125
5331838|NCT00360243|13112475|P3|NOT COMPLETED|Overall Study||156
5331839|NCT00360243|13112476|P2|NOT COMPLETED|Overall Study||120
5331840|NCT00360243|13112477|P1|NOT COMPLETED|Overall Study||102
5331841|NCT00360243|13112474|P4|COMPLETED|Overall Study||224
5331842|NCT00360243|13112475|P3|COMPLETED|Overall Study||180
5331843|NCT00360243|13112476|P2|COMPLETED|Overall Study||243
5331844|NCT00360243|13112477|P1|COMPLETED|Overall Study||235
5331845|NCT00360243|13112474|P4|STARTED|Overall Study||349
5331846|NCT00360243|13112475|P3|STARTED|Overall Study||336
5331847|NCT00360243|13112476|P2|STARTED|Overall Study||363
5331848|NCT00360243|13112477|P1|STARTED|Overall Study||337
5331849|NCT00360230|13112498|P7|NOT COMPLETED|Overall Study||2
5331850|NCT00360230|13112499|P6|NOT COMPLETED|Overall Study||4
5331851|NCT00360230|13112500|P5|NOT COMPLETED|Overall Study||5
5331852|NCT00360230|13112501|P4|NOT COMPLETED|Overall Study||2
5331853|NCT00360230|13112502|P3|NOT COMPLETED|Overall Study||3
5331854|NCT00360230|13112503|P2|NOT COMPLETED|Overall Study||3
5331855|NCT00360230|13112504|P1|NOT COMPLETED|Overall Study||6
5331856|NCT00360230|13112498|P7|COMPLETED|Overall Study||43
5331857|NCT00360230|13112499|P6|COMPLETED|Overall Study||86
5331858|NCT00360230|13112500|P5|COMPLETED|Overall Study||85
5331859|NCT00360230|13112501|P4|COMPLETED|Overall Study||88
5331860|NCT00360230|13112502|P3|COMPLETED|Overall Study||42
5331861|NCT00360230|13112503|P2|COMPLETED|Overall Study||87
5331862|NCT00360230|13112504|P1|COMPLETED|Overall Study||84
5331863|NCT00360230|13112498|P7|STARTED|Overall Study||45
5331864|NCT00360230|13112499|P6|STARTED|Overall Study||90
5331865|NCT00360230|13112500|P5|STARTED|Overall Study||90
5331866|NCT00360230|13112501|P4|STARTED|Overall Study||90
5331867|NCT00360230|13112502|P3|STARTED|Overall Study||45
5331868|NCT00360230|13112503|P2|STARTED|Overall Study||90
5331869|NCT00360230|13112504|P1|STARTED|Overall Study||90
5331870|NCT00360126|13112555|P1|NOT COMPLETED|Overall Study||0
5331871|NCT00360126|13112555|P1|COMPLETED|Overall Study||11
5331872|NCT00360126|13112555|P1|STARTED|Overall Study||11
5331873|NCT00360009|13112562|P3|NOT COMPLETED|Overall Study||3
5331874|NCT00360009|13112563|P2|NOT COMPLETED|Overall Study||4
5331875|NCT00360009|13112564|P1|NOT COMPLETED|Overall Study||0
5331876|NCT00360009|13112562|P3|COMPLETED|Overall Study||23
5331877|NCT00360009|13112563|P2|COMPLETED|Overall Study||22
5331878|NCT00360009|13112564|P1|COMPLETED|Overall Study||10
5331879|NCT00360009|13112562|P3|STARTED|Overall Study||26
5331880|NCT00360009|13112563|P2|STARTED|Overall Study||26
5331881|NCT00360009|13112564|P1|STARTED|Overall Study||10
5331882|NCT00359983|13112605|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
5331883|NCT00359983|13112606|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
5331884|NCT00359983|13112607|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
5331885|NCT00359983|13112605|P3|COMPLETED|Year 5 Persistence Follow-up||42
5331886|NCT00359983|13112606|P2|COMPLETED|Year 5 Persistence Follow-up||44
5331887|NCT00359983|13112607|P1|COMPLETED|Year 5 Persistence Follow-up||95
5331888|NCT00359983|13112605|P3|STARTED|Year 5 Persistence Follow-up||42
5331889|NCT00359983|13112606|P2|STARTED|Year 5 Persistence Follow-up||44
5331890|NCT00359983|13112607|P1|STARTED|Year 5 Persistence Follow-up||95
5331891|NCT00359983|13112605|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
5331892|NCT00359983|13112606|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
5331893|NCT00359983|13112607|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
5331894|NCT00359983|13112605|P3|COMPLETED|Year 3 Persistence Follow-up||51
5331895|NCT00359983|13112606|P2|COMPLETED|Year 3 Persistence Follow-up||47
5331896|NCT00359983|13112607|P1|COMPLETED|Year 3 Persistence Follow-up||103
5331897|NCT00359983|13112605|P3|STARTED|Year 3 Persistence Follow-up||51
5331898|NCT00359983|13112606|P2|STARTED|Year 3 Persistence Follow-up||47
5331899|NCT00359983|13112607|P1|STARTED|Year 3 Persistence Follow-up||103
5331900|NCT00359983|13112605|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
5331901|NCT00359983|13112606|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
5331902|NCT00359983|13112607|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
5331903|NCT00359983|13112605|P3|COMPLETED|Year 1 Persistence Follow-up||62
5331904|NCT00359983|13112606|P2|COMPLETED|Year 1 Persistence Follow-up||70
5331905|NCT00359983|13112607|P1|COMPLETED|Year 1 Persistence Follow-up||138
5331906|NCT00359983|13112605|P3|STARTED|Year 1 Persistence Follow-up||62
5331907|NCT00359983|13112606|P2|STARTED|Year 1 Persistence Follow-up||70
5331908|NCT00359983|13112607|P1|STARTED|Year 1 Persistence Follow-up||138
5331909|NCT00359944|13112642|P3|NOT COMPLETED|Overall Study||19
5331910|NCT00359944|13112643|P2|NOT COMPLETED|Overall Study||19
5331911|NCT00359944|13112644|P1|NOT COMPLETED|Overall Study||16
5331912|NCT00359944|13112642|P3|COMPLETED|Overall Study||38
5331913|NCT00359944|13112643|P2|COMPLETED|Overall Study||28
5331914|NCT00359944|13112644|P1|COMPLETED|Overall Study||34
5331915|NCT00359944|13112642|P3|STARTED|Overall Study||57
5331916|NCT00359944|13112643|P2|STARTED|Overall Study||47
5331917|NCT00359944|13112644|P1|STARTED|Overall Study||50
5331918|NCT00359801|13112660|P2|NOT COMPLETED|Overall Study||220
5331919|NCT00359801|13112661|P1|NOT COMPLETED|Overall Study||305
5331920|NCT00359801|13112660|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
5331921|NCT00359801|13112661|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
5331922|NCT00359801|13112660|P2|STARTED|Overall Study||989
5331923|NCT00359801|13112661|P1|STARTED|Overall Study||987
5331924|NCT00359788|13112695|P2|NOT COMPLETED|Overall Study||17
5331925|NCT00359788|13112696|P1|NOT COMPLETED|Overall Study||23
5331926|NCT00359788|13112695|P2|COMPLETED|Overall Study||159
5331927|NCT00359788|13112696|P1|COMPLETED|Overall Study||150
5331928|NCT00359788|13112695|P2|STARTED|Overall Study||176
5331929|NCT00359788|13112696|P1|STARTED|Overall Study||173
5331930|NCT00359762|13112930|P5|NOT COMPLETED|Period I||0
5331931|NCT00359762|13112931|P4|NOT COMPLETED|Period I||0
5331932|NCT00359762|13112932|P3|NOT COMPLETED|Period I||0
5331933|NCT00359762|13112933|P2|NOT COMPLETED|Period I||0
5331934|NCT00359762|13112934|P1|NOT COMPLETED|Period I||0
5331935|NCT00359762|13112930|P5|COMPLETED|Period I||0
5331936|NCT00359762|13112931|P4|COMPLETED|Period I||0
5331937|NCT00359762|13112932|P3|COMPLETED|Period I||0
5331938|NCT00359762|13112933|P2|COMPLETED|Period I||0
5331939|NCT00359762|13112934|P1|COMPLETED|Period I||0
5331940|NCT00359762|13112930|P5|STARTED|Period I||0
5331941|NCT00359762|13112931|P4|STARTED|Period I||0
5331942|NCT00359762|13112932|P3|STARTED|Period I||0
5331943|NCT00359762|13112933|P2|STARTED|Period I||0
5331944|NCT00359762|13112934|P1|STARTED|Period I||0
5331945|NCT00359762|13112930|P5|NOT COMPLETED|Period III||0
5331946|NCT00359762|13112931|P4|NOT COMPLETED|Period III||65
5331947|NCT00359762|13112932|P3|NOT COMPLETED|Period III||30
5331948|NCT00359762|13112933|P2|NOT COMPLETED|Period III||29
5331949|NCT00359762|13112934|P1|NOT COMPLETED|Period III||0
5331950|NCT00359762|13112930|P5|COMPLETED|Period III||0
5331951|NCT00359762|13112931|P4|COMPLETED|Period III||101
5331952|NCT00359762|13112932|P3|COMPLETED|Period III||47
5331953|NCT00359762|13112933|P2|COMPLETED|Period III||48
5331954|NCT00359762|13112934|P1|COMPLETED|Period III||0
5331955|NCT00359762|13112930|P5|Extension ITT Efficacy Population|Period III||0
5331956|NCT00359762|13112931|P4|Extension ITT Efficacy Population|Period III||164
5331957|NCT00359762|13112932|P3|Extension ITT Efficacy Population|Period III||75
5331958|NCT00359762|13112933|P2|Extension ITT Efficacy Population|Period III||73
5331959|NCT00359762|13112934|P1|Extension ITT Efficacy Population|Period III||0
5331960|NCT00359762|13112930|P5|Extension ITT Safety Population|Period III||0
5331961|NCT00359762|13112931|P4|Extension ITT Safety Population|Period III||166
5331962|NCT00359762|13112932|P3|Extension ITT Safety Population|Period III||76
5331963|NCT00359762|13112933|P2|Extension ITT Safety Population|Period III||74
5331964|NCT00359762|13112934|P1|Extension ITT Safety Population|Period III||0
5331965|NCT00359762|13112930|P5|STARTED|Period III||0
5331966|NCT00359762|13112931|P4|STARTED|Period III||166
5331967|NCT00359762|13112932|P3|STARTED|Period III||77
5331968|NCT00359762|13112933|P2|STARTED|Period III||77
5331969|NCT00359762|13112934|P1|STARTED|Period III||0
5331970|NCT00359762|13112930|P5|NOT COMPLETED|Period II||174
5331971|NCT00359762|13112931|P4|NOT COMPLETED|Period II||0
5331972|NCT00359762|13112932|P3|NOT COMPLETED|Period II||0
5331973|NCT00359762|13112933|P2|NOT COMPLETED|Period II||0
5331974|NCT00359762|13112934|P1|NOT COMPLETED|Period II||128
5331975|NCT00359762|13112930|P5|COMPLETED|Period II||341
5331976|NCT00359762|13112931|P4|COMPLETED|Period II||0
5331977|NCT00359762|13112932|P3|COMPLETED|Period II||0
5331978|NCT00359762|13112933|P2|COMPLETED|Period II||0
5331979|NCT00359762|13112934|P1|COMPLETED|Period II||386
5331980|NCT00359762|13112930|P5|Without Treatment Failure|Period II||138
5331981|NCT00359762|13112931|P4|Without Treatment Failure|Period II||0
5331982|NCT00359762|13112932|P3|Without Treatment Failure|Period II||0
5331983|NCT00359762|13112933|P2|Without Treatment Failure|Period II||0
5331984|NCT00359762|13112934|P1|Without Treatment Failure|Period II||124
5331985|NCT00359762|13112930|P5|Met Primary Endpoint|Period II||203
5331986|NCT00359762|13112931|P4|Met Primary Endpoint|Period II||0
5331987|NCT00359762|13112932|P3|Met Primary Endpoint|Period II||0
5331988|NCT00359762|13112933|P2|Met Primary Endpoint|Period II||0
5331989|NCT00359762|13112934|P1|Met Primary Endpoint|Period II||262
5331990|NCT00359762|13112930|P5|ITT Efficacy Population|Period II||490
5331991|NCT00359762|13112931|P4|ITT Efficacy Population|Period II||0
5331992|NCT00359762|13112932|P3|ITT Efficacy Population|Period II||0
5331993|NCT00359762|13112933|P2|ITT Efficacy Population|Period II||0
5331994|NCT00359762|13112934|P1|ITT Efficacy Population|Period II||487
5331995|NCT00359762|13112930|P5|Intent to Treat (ITT) Safety Population|Period II||511
5331996|NCT00359762|13112931|P4|Intent to Treat (ITT) Safety Population|Period II||0
5331997|NCT00359762|13112932|P3|Intent to Treat (ITT) Safety Population|Period II||0
5331998|NCT00359762|13112933|P2|Intent to Treat (ITT) Safety Population|Period II||0
5331999|NCT00359762|13112934|P1|Intent to Treat (ITT) Safety Population|Period II||508
5332000|NCT00359762|13112930|P5|STARTED|Period II||515
5332001|NCT00359762|13112931|P4|STARTED|Period II||0
5332002|NCT00359762|13112932|P3|STARTED|Period II||0
5332003|NCT00359762|13112933|P2|STARTED|Period II||0
5332004|NCT00359762|13112934|P1|STARTED|Period II||514
5332005|NCT00359736|13112997|P2|NOT COMPLETED|Overall Study||0
5332006|NCT00359736|13112998|P1|NOT COMPLETED|Overall Study||0
5332007|NCT00359736|13112997|P2|COMPLETED|Overall Study||15
5332008|NCT00359736|13112998|P1|COMPLETED|Overall Study||14
5332009|NCT00359736|13112997|P2|STARTED|Overall Study||15
5332010|NCT00359736|13112998|P1|STARTED|Overall Study||14
5332011|NCT00359632|13113008|P2|NOT COMPLETED|Overall Study||0
5332012|NCT00359632|13113009|P1|NOT COMPLETED|Overall Study||4
5332013|NCT00359632|13113008|P2|COMPLETED|Overall Study||9
5332014|NCT00359632|13113009|P1|COMPLETED|Overall Study||20
5332015|NCT00359632|13113008|P2|STARTED|Overall Study||9
5332016|NCT00359632|13113009|P1|STARTED|Overall Study||24
5332017|NCT00359619|13113023|P7|NOT COMPLETED|Overall Study||4
5332018|NCT00359619|13113024|P6|NOT COMPLETED|Overall Study||5
5332019|NCT00359619|13113025|P5|NOT COMPLETED|Overall Study||3
5332020|NCT00359619|13113026|P4|NOT COMPLETED|Overall Study||3
5332021|NCT00359619|13113027|P3|NOT COMPLETED|Overall Study||7
5332022|NCT00359619|13113028|P2|NOT COMPLETED|Overall Study||5
5332023|NCT00359619|13113029|P1|NOT COMPLETED|Overall Study||8
5332024|NCT00359619|13113023|P7|COMPLETED|Overall Study||46
5332025|NCT00359619|13113024|P6|COMPLETED|Overall Study||45
5332026|NCT00359619|13113025|P5|COMPLETED|Overall Study||45
5332027|NCT00359619|13113026|P4|COMPLETED|Overall Study||45
5332028|NCT00359619|13113027|P3|COMPLETED|Overall Study||42
5332029|NCT00359619|13113028|P2|COMPLETED|Overall Study||45
5332030|NCT00359619|13113029|P1|COMPLETED|Overall Study||80
5332031|NCT00359619|13113023|P7|STARTED|Overall Study||50
5332032|NCT00359619|13113024|P6|STARTED|Overall Study||50
5332033|NCT00359619|13113025|P5|STARTED|Overall Study||48
5332034|NCT00359619|13113026|P4|STARTED|Overall Study||48
5332035|NCT00359619|13113027|P3|STARTED|Overall Study||49
5332036|NCT00359619|13113028|P2|STARTED|Overall Study||50
5332037|NCT00359619|13113029|P1|STARTED|Overall Study||88
5332038|NCT00359424|13113159|P2|NOT COMPLETED|Overall Study||67
5332039|NCT00359424|13113160|P1|NOT COMPLETED|Overall Study||130
5332040|NCT00359424|13113159|P2|COMPLETED|Overall Study||155
5332041|NCT00359424|13113160|P1|COMPLETED|Overall Study||304
5332042|NCT00359424|13113159|P2|270 Day Follow up|Overall Study||159
5332043|NCT00359424|13113160|P1|270 Day Follow up|Overall Study||313
5332044|NCT00359424|13113159|P2|180 Day Follow up|Overall Study||167
5332045|NCT00359424|13113160|P1|180 Day Follow up|Overall Study||325
5332046|NCT00359424|13113159|P2|90 Day Follow up|Overall Study||172
5332047|NCT00359424|13113160|P1|90 Day Follow up|Overall Study||343
5332048|NCT00359424|13113159|P2|STARTED|Overall Study||222
5332049|NCT00359424|13113160|P1|STARTED|Overall Study||434
5332050|NCT00359281|13113199|P9|NOT COMPLETED|Overall Study||0
5332051|NCT00359281|13113200|P8|NOT COMPLETED|Overall Study||0
5332052|NCT00359281|13113201|P7|NOT COMPLETED|Overall Study||2
5332053|NCT00359281|13113202|P6|NOT COMPLETED|Overall Study||0
5332054|NCT00359281|13113203|P5|NOT COMPLETED|Overall Study||0
5332055|NCT00359281|13113204|P4|NOT COMPLETED|Overall Study||0
5332056|NCT00359281|13113205|P3|NOT COMPLETED|Overall Study||0
5332057|NCT00359281|13113206|P2|NOT COMPLETED|Overall Study||0
5332058|NCT00359281|13113207|P1|NOT COMPLETED|Overall Study||1
5332059|NCT00359281|13113199|P9|COMPLETED|Overall Study||20
5332060|NCT00359281|13113200|P8|COMPLETED|Overall Study||15
5332061|NCT00359281|13113201|P7|COMPLETED|Overall Study||16
5332062|NCT00359281|13113202|P6|COMPLETED|Overall Study||15
5332063|NCT00359281|13113203|P5|COMPLETED|Overall Study||10
5332064|NCT00359281|13113204|P4|COMPLETED|Overall Study||10
5332065|NCT00359281|13113205|P3|COMPLETED|Overall Study||10
5332066|NCT00359281|13113206|P2|COMPLETED|Overall Study||15
5332067|NCT00359281|13113207|P1|COMPLETED|Overall Study||15
5332068|NCT00359281|13113199|P9|STARTED|Overall Study||20
5332069|NCT00359281|13113200|P8|STARTED|Overall Study||15
5332070|NCT00359281|13113201|P7|STARTED|Overall Study||18
5332071|NCT00359281|13113202|P6|STARTED|Overall Study||15
5332072|NCT00359281|13113203|P5|STARTED|Overall Study||10
5332073|NCT00359281|13113204|P4|STARTED|Overall Study||10
5332074|NCT00359281|13113205|P3|STARTED|Overall Study||10
5332075|NCT00359281|13113206|P2|STARTED|Overall Study||15
5332076|NCT00359281|13113207|P1|STARTED|Overall Study||16
5332077|NCT00359216|13113239|P2|NOT COMPLETED|Overall Study||1
5332078|NCT00359216|13113240|P1|NOT COMPLETED|Overall Study||0
5332079|NCT00359216|13113239|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
5332080|NCT00359216|13113240|P1|COMPLETED|Overall Study||20
5332081|NCT00359216|13113239|P2|STARTED|Overall Study||10
5332082|NCT00359216|13113240|P1|STARTED|Overall Study||20
5332083|NCT00359203|13113248|P2|NOT COMPLETED|Overall Study||0
5332084|NCT00359203|13113249|P1|NOT COMPLETED|Overall Study||0
5332085|NCT00359203|13113248|P2|COMPLETED|Overall Study||38
5332086|NCT00359203|13113249|P1|COMPLETED|Overall Study||39
5332087|NCT00359203|13113248|P2|STARTED|Overall Study||38
5332088|NCT00359203|13113249|P1|STARTED|Overall Study||39
5332089|NCT00359138|13113258|P3|NOT COMPLETED|Overall Study||0
5332090|NCT00359138|13113259|P2|NOT COMPLETED|Overall Study||0
5332091|NCT00359138|13113260|P1|NOT COMPLETED|Overall Study||0
5332092|NCT00359138|13113258|P3|COMPLETED|Overall Study||12
5332093|NCT00359138|13113259|P2|COMPLETED|Overall Study||12
5332094|NCT00359138|13113260|P1|COMPLETED|Overall Study||12
5332095|NCT00359138|13113258|P3|STARTED|Overall Study||12
5332096|NCT00359138|13113259|P2|STARTED|Overall Study||12
5332097|NCT00359138|13113260|P1|STARTED|Overall Study||12
5332098|NCT00359073|13113270|P2|NOT COMPLETED|Overall Study||2
5332099|NCT00359073|13113271|P1|NOT COMPLETED|Overall Study||4
5332100|NCT00359073|13113270|P2|COMPLETED|Overall Study||11
5332101|NCT00359073|13113271|P1|COMPLETED|Overall Study||8
5332102|NCT00359073|13113270|P2|STARTED|Overall Study||13
5332103|NCT00359073|13113271|P1|STARTED|Overall Study||12
5332104|NCT00359021|13113283|P2|NOT COMPLETED|Overall Study||52
5332105|NCT00359021|13113284|P1|NOT COMPLETED|Overall Study||81
5332106|NCT00359021|13113283|P2|COMPLETED|Overall Study||195
5332107|NCT00359021|13113284|P1|COMPLETED|Overall Study||175
5332108|NCT00359021|13113283|P2|STARTED|Overall Study||247
5332109|NCT00359021|13113284|P1|STARTED|Overall Study||256
5332110|NCT00358956|13113296|P1|NOT COMPLETED|Overall Study||8
5332111|NCT00358956|13113296|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
5332112|NCT00358956|13113296|P1|STARTED|Overall Study||19
5332113|NCT00358917|13113308|P2|NOT COMPLETED|Overall Study||69
5332114|NCT00358917|13113309|P1|NOT COMPLETED|Overall Study||66
5332115|NCT00358917|13113308|P2|COMPLETED|Overall Study||230
5332116|NCT00358917|13113309|P1|COMPLETED|Overall Study||234
5332117|NCT00358917|13113308|P2|STARTED|Overall Study||299
5332118|NCT00358917|13113309|P1|STARTED|Overall Study||300
5332119|NCT00358826|13113327|P8|NOT COMPLETED|MDCT Substudy||0
5332120|NCT00358826|13113328|P7|NOT COMPLETED|MDCT Substudy||0
5332121|NCT00358826|13113329|P6|NOT COMPLETED|MDCT Substudy||2
5332122|NCT00358826|13113330|P5|NOT COMPLETED|MDCT Substudy||1
5332123|NCT00358826|13113331|P4|NOT COMPLETED|MDCT Substudy||0
5332124|NCT00358826|13113332|P3|NOT COMPLETED|MDCT Substudy||0
5332125|NCT00358826|13113333|P2|NOT COMPLETED|MDCT Substudy||0
5332126|NCT00358826|13113334|P1|NOT COMPLETED|MDCT Substudy||0
5332127|NCT00358826|13113327|P8|COMPLETED|MDCT Substudy||27
5332128|NCT00358826|13113328|P7|COMPLETED|MDCT Substudy||19
5332129|NCT00358826|13113329|P6|COMPLETED|MDCT Substudy||20
5332130|NCT00358826|13113330|P5|COMPLETED|MDCT Substudy||24
5332131|NCT00358826|13113331|P4|COMPLETED|MDCT Substudy||0
5332132|NCT00358826|13113332|P3|COMPLETED|MDCT Substudy||0
5332133|NCT00358826|13113333|P2|COMPLETED|MDCT Substudy||0
5332134|NCT00358826|13113334|P1|COMPLETED|MDCT Substudy||0
5332135|NCT00358826|13113327|P8|STARTED|MDCT Substudy||27
5332136|NCT00358826|13113328|P7|STARTED|MDCT Substudy||19
5332137|NCT00358826|13113329|P6|STARTED|MDCT Substudy||22
5332138|NCT00358826|13113330|P5|STARTED|MDCT Substudy||25
5332139|NCT00358826|13113331|P4|STARTED|MDCT Substudy||0
5332140|NCT00358826|13113332|P3|STARTED|MDCT Substudy||0
5332141|NCT00358826|13113333|P2|STARTED|MDCT Substudy||0
5332142|NCT00358826|13113334|P1|STARTED|MDCT Substudy||0
5332143|NCT00358826|13113327|P8|NOT COMPLETED|Core Study||0
5332144|NCT00358826|13113328|P7|NOT COMPLETED|Core Study||0
5332145|NCT00358826|13113329|P6|NOT COMPLETED|Core Study||0
5332146|NCT00358826|13113330|P5|NOT COMPLETED|Core Study||0
5332147|NCT00358826|13113331|P4|NOT COMPLETED|Core Study||2
5332148|NCT00358826|13113332|P3|NOT COMPLETED|Core Study||2
5332149|NCT00358826|13113333|P2|NOT COMPLETED|Core Study||5
5332150|NCT00358826|13113334|P1|NOT COMPLETED|Core Study||3
5332151|NCT00358826|13113327|P8|COMPLETED|Core Study||0
5332152|NCT00358826|13113328|P7|COMPLETED|Core Study||0
5332153|NCT00358826|13113329|P6|COMPLETED|Core Study||0
5332154|NCT00358826|13113330|P5|COMPLETED|Core Study||0
5332155|NCT00358826|13113331|P4|COMPLETED|Core Study||50
5332156|NCT00358826|13113332|P3|COMPLETED|Core Study||42
5332157|NCT00358826|13113333|P2|COMPLETED|Core Study||41
5332158|NCT00358826|13113334|P1|COMPLETED|Core Study||46
5332159|NCT00358826|13113327|P8|STARTED|Core Study||0
5332160|NCT00358826|13113328|P7|STARTED|Core Study||0
5332161|NCT00358826|13113329|P6|STARTED|Core Study||0
5332162|NCT00358826|13113330|P5|STARTED|Core Study||0
5332163|NCT00358826|13113331|P4|STARTED|Core Study||52
5332164|NCT00358826|13113332|P3|STARTED|Core Study||44
5332165|NCT00358826|13113333|P2|STARTED|Core Study||46
5332166|NCT00358826|13113334|P1|STARTED|Core Study||49
5332167|NCT00358735|13113370|P2|NOT COMPLETED|Overall Study||17
5332168|NCT00358735|13113371|P1|NOT COMPLETED|Overall Study||8
5332169|NCT00358735|13113370|P2|COMPLETED|Overall Study|Efficacy|190
5332170|NCT00358735|13113371|P1|COMPLETED|Overall Study|Efficacy|196
5332171|NCT00358735|13113370|P2|Not Completed Safety|Overall Study||13
5332172|NCT00358735|13113371|P1|Not Completed Safety|Overall Study||6
5332173|NCT00358735|13113370|P2|Completed Safety|Overall Study||194
5332174|NCT00358735|13113371|P1|Completed Safety|Overall Study||198
5332175|NCT00358735|13113370|P2|STARTED|Overall Study||207
5332176|NCT00358735|13113371|P1|STARTED|Overall Study||204
5332177|NCT00358670|13113401|P2|NOT COMPLETED|Overall Study||219
5332178|NCT00358670|13113402|P1|NOT COMPLETED|Overall Study||222
5332179|NCT00358670|13113401|P2|COMPLETED|Overall Study||0
5332180|NCT00358670|13113402|P1|COMPLETED|Overall Study||0
5332181|NCT00358670|13113401|P2|STARTED|Overall Study||219
5332182|NCT00358670|13113402|P1|STARTED|Overall Study||222
5332183|NCT00358644|13113416|P1|NOT COMPLETED|Overall Study||50
5332184|NCT00358644|13113416|P1|COMPLETED|Overall Study||5
5332185|NCT00358644|13113416|P1|STARTED|Overall Study||55
5332186|NCT00358579|13113422|P2|NOT COMPLETED|Overall Study||0
5332187|NCT00358579|13113423|P1|NOT COMPLETED|Overall Study||0
5332188|NCT00358579|13113422|P2|COMPLETED|Overall Study||374
5332189|NCT00358579|13113423|P1|COMPLETED|Overall Study||353
5332190|NCT00358579|13113422|P2|STARTED|Overall Study||374
5332191|NCT00358579|13113423|P1|STARTED|Overall Study||353
5332192|NCT00358527|13113439|P2|NOT COMPLETED|Overall Study||3
5332193|NCT00358527|13113440|P1|NOT COMPLETED|Overall Study||13
5332194|NCT00358527|13113439|P2|COMPLETED|Overall Study||131
5332195|NCT00358527|13113440|P1|COMPLETED|Overall Study||254
5332196|NCT00358527|13113439|P2|STARTED|Overall Study||134
5332197|NCT00358527|13113440|P1|STARTED|Overall Study||267
5332198|NCT00358501|13113450|P2|NOT COMPLETED|Overall Study||0
5332199|NCT00358501|13113451|P1|NOT COMPLETED|Overall Study||0
5332200|NCT00358501|13113450|P2|COMPLETED|Overall Study||32
5332201|NCT00358501|13113451|P1|COMPLETED|Overall Study||102
5332202|NCT00358501|13113450|P2|STARTED|Overall Study||32
5332203|NCT00358501|13113451|P1|STARTED|Overall Study||102
5332204|NCT00358462|13113466|P2|NOT COMPLETED|Overall Study||64
5332205|NCT00358462|13113467|P1|NOT COMPLETED|Overall Study||59
5332206|NCT00358462|13113466|P2|COMPLETED|Overall Study||238
5332207|NCT00358462|13113467|P1|COMPLETED|Overall Study||245
5332208|NCT00358462|13113466|P2|STARTED|Overall Study||302
5332209|NCT00358462|13113467|P1|STARTED|Overall Study||304
5332210|NCT00358449|13113490|P3|NOT COMPLETED|Overall Study||2
5332211|NCT00358449|13113491|P2|NOT COMPLETED|Overall Study||1
5332212|NCT00358449|13113492|P1|NOT COMPLETED|Overall Study||4
5332213|NCT00358449|13113490|P3|COMPLETED|Overall Study||18
5332214|NCT00358449|13113491|P2|COMPLETED|Overall Study||19
5332215|NCT00358449|13113492|P1|COMPLETED|Overall Study||15
5332216|NCT00358449|13113490|P3|STARTED|Overall Study||20
5332217|NCT00358449|13113491|P2|STARTED|Overall Study||20
5332218|NCT00358449|13113492|P1|STARTED|Overall Study||19
5332219|NCT00358436|13113595|P2|NOT COMPLETED|Overall Study||86
5332220|NCT00358436|13113596|P1|NOT COMPLETED|Overall Study||154
5332221|NCT00358436|13113595|P2|COMPLETED|Overall Study||118
5332222|NCT00358436|13113596|P1|COMPLETED|Overall Study||446
5332223|NCT00358436|13113595|P2|STARTED|Overall Study||204
5332224|NCT00358436|13113596|P1|STARTED|Overall Study||600
5332225|NCT00358332|13113612|P4|NOT COMPLETED|Overall Study||0
5332226|NCT00358332|13113613|P3|NOT COMPLETED|Overall Study||1
5332227|NCT00358332|13113614|P2|NOT COMPLETED|Overall Study||3
5332228|NCT00358332|13113615|P1|NOT COMPLETED|Overall Study||0
5332229|NCT00358332|13113612|P4|COMPLETED|Overall Study||25
5332230|NCT00358332|13113613|P3|COMPLETED|Overall Study||29
5332231|NCT00358332|13113614|P2|COMPLETED|Overall Study||27
5332232|NCT00358332|13113615|P1|COMPLETED|Overall Study||15
5332233|NCT00358332|13113612|P4|STARTED|Overall Study||25
5332234|NCT00358332|13113613|P3|STARTED|Overall Study||30
5332235|NCT00358332|13113614|P2|STARTED|Overall Study||30
5332236|NCT00358332|13113615|P1|STARTED|Overall Study||15
5332237|NCT00358215|13113667|P2|NOT COMPLETED|Overall Study||652
5332238|NCT00358215|13113668|P1|NOT COMPLETED|Overall Study||679
5332239|NCT00358215|13113667|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
5332240|NCT00358215|13113668|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
5332241|NCT00358215|13113667|P2|Received Investigational Product|Overall Study||1133
5332242|NCT00358215|13113668|P1|Received Investigational Product|Overall Study||1140
5332243|NCT00358215|13113667|P2|STARTED|Overall Study||1136
5332244|NCT00358215|13113668|P1|STARTED|Overall Study||1142
5332245|NCT00358150|13113682|P1|NOT COMPLETED|Overall Study||7
5332246|NCT00358150|13113682|P1|COMPLETED|Overall Study||19
5332247|NCT00358150|13113682|P1|STARTED|Overall Study||26
5332248|NCT00358007|13113704|P1|NOT COMPLETED|Overall Study||2
5332249|NCT00358007|13113704|P1|COMPLETED|Overall Study||28
5332250|NCT00358007|13113704|P1|STARTED|Overall Study||30
5332251|NCT00357994|13113711|P2|NOT COMPLETED|Overall Study||3
5332252|NCT00357994|13113712|P1|NOT COMPLETED|Overall Study||2
5332253|NCT00357994|13113711|P2|COMPLETED|Overall Study||31
5332254|NCT00357994|13113712|P1|COMPLETED|Overall Study||35
5332255|NCT00357994|13113711|P2|STARTED|Overall Study||34
5332256|NCT00357994|13113712|P1|STARTED|Overall Study||37
5332257|NCT00357968|13113766|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
5332258|NCT00357968|13113767|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
5332259|NCT00357968|13113766|P2|COMPLETED|Crossover Maintenance Dose Phase||55
5332260|NCT00357968|13113767|P1|COMPLETED|Crossover Maintenance Dose Phase||54
5332261|NCT00357968|13113766|P2|STARTED|Crossover Maintenance Dose Phase||55
5332262|NCT00357968|13113767|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
5332263|NCT00357968|13113766|P2|NOT COMPLETED|First Maintenance Dose Phase||44
5332264|NCT00357968|13113767|P1|NOT COMPLETED|First Maintenance Dose Phase||48
5332265|NCT00357968|13113766|P2|COMPLETED|First Maintenance Dose Phase||55
5332266|NCT00357968|13113767|P1|COMPLETED|First Maintenance Dose Phase||54
5332267|NCT00357968|13113766|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
5332268|NCT00357968|13113767|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
5332269|NCT00357968|13113766|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
5332270|NCT00357968|13113767|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
5332271|NCT00357968|13113766|P2|Received Loading Dose|First Maintenance Dose Phase||99
5332272|NCT00357968|13113767|P1|Received Loading Dose|First Maintenance Dose Phase||102
5332273|NCT00357968|13113766|P2|STARTED|First Maintenance Dose Phase||99
5332274|NCT00357968|13113767|P1|STARTED|First Maintenance Dose Phase||102
5332275|NCT00357955|13113811|P2|NOT COMPLETED|Overall Study||3
5332276|NCT00357955|13113812|P1|NOT COMPLETED|Overall Study||6
5332277|NCT00357955|13113811|P2|COMPLETED|Overall Study||51
5332278|NCT00357955|13113812|P1|COMPLETED|Overall Study||58
5332279|NCT00357955|13113811|P2|STARTED|Overall Study||54
5332280|NCT00357955|13113812|P1|STARTED|Overall Study||64
5332281|NCT00357903|13113820|P2|NOT COMPLETED|Overall Study||43
5332282|NCT00357903|13113821|P1|NOT COMPLETED|Overall Study||363
5332283|NCT00357903|13113820|P2|COMPLETED|Overall Study||15
5332284|NCT00357903|13113821|P1|COMPLETED|Overall Study||218
5332285|NCT00357903|13113820|P2|STARTED|Overall Study||58
5332286|NCT00357903|13113821|P1|STARTED|Overall Study||581
5332287|NCT00357877|13113861|P2|NOT COMPLETED|Overall Study||30
5332288|NCT00357877|13113862|P1|NOT COMPLETED|Overall Study||26
5332289|NCT00357877|13113861|P2|COMPLETED|Overall Study||460
5332290|NCT00357877|13113862|P1|COMPLETED|Overall Study||467
5332291|NCT00357877|13113861|P2|STARTED|Overall Study||490
5332292|NCT00357877|13113862|P1|STARTED|Overall Study||493
5332293|NCT00357760|13113876|P2|NOT COMPLETED|Overall Study||35
5332294|NCT00357760|13113877|P1|NOT COMPLETED|Overall Study||59
5332295|NCT00357760|13113876|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
5332296|NCT00357760|13113877|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
5332297|NCT00357760|13113876|P2|Patients Who Undergo Dose Escalation|Overall Study||16
5332388|NCT00357032|13114102|P1|STARTED|Overall Study||12
5332298|NCT00357760|13113877|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
5332299|NCT00357760|13113876|P2|Eligible and Treated Patients|Overall Study||32
5332300|NCT00357760|13113877|P1|Eligible and Treated Patients|Overall Study||57
5332301|NCT00357760|13113876|P2|Patients Who Started Treatment|Overall Study||34
5332302|NCT00357760|13113877|P1|Patients Who Started Treatment|Overall Study||57
5332303|NCT00357760|13113876|P2|STARTED|Overall Study||35
5332304|NCT00357760|13113877|P1|STARTED|Overall Study||59
5332305|NCT00357734|13113887|P1|NOT COMPLETED|Overall Study||4
5332306|NCT00357734|13113887|P1|COMPLETED|Overall Study||10
5332307|NCT00357734|13113887|P1|Patient Received 500 mg of ZD1839|Overall Study||1
5332308|NCT00357734|13113887|P1|Patients Received 250 mg of ZD1839|Overall Study||13
5332309|NCT00357734|13113887|P1|STARTED|Overall Study||14
5332310|NCT00357656|13113898|P2|NOT COMPLETED|Overall Study||3
5332311|NCT00357656|13113899|P1|NOT COMPLETED|Overall Study||0
5332312|NCT00357656|13113898|P2|COMPLETED|Overall Study||29
5332313|NCT00357656|13113899|P1|COMPLETED|Overall Study||31
5332314|NCT00357656|13113898|P2|STARTED|Overall Study||32
5332315|NCT00357656|13113899|P1|STARTED|Overall Study||31
5332316|NCT00357552|13113950|P1|NOT COMPLETED|Weeks 24 to 104||5
5332317|NCT00357552|13113950|P1|COMPLETED|Weeks 24 to 104||117
5332318|NCT00357552|13113950|P1|STARTED|Weeks 24 to 104||122
5332319|NCT00357552|13113950|P1|NOT COMPLETED|Weeks 0 to 24||1
5332320|NCT00357552|13113950|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
5332321|NCT00357552|13113950|P1|STARTED|Weeks 0 to 24||123
5332322|NCT00357552|13113950|P1|NOT COMPLETED|Screening||84
5332323|NCT00357552|13113950|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
5332324|NCT00357552|13113950|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
5332325|NCT00357500|13113965|P1|NOT COMPLETED|Overall Study||77
5332326|NCT00357500|13113965|P1|COMPLETED|Overall Study||24
5332327|NCT00357500|13113965|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
5332328|NCT00357500|13113965|P1|STARTED|Overall Study||101
5332329|NCT00357396|13113974|P2|NOT COMPLETED|Overall Study||0
5332330|NCT00357396|13113975|P1|NOT COMPLETED|Overall Study||1
5332331|NCT00357396|13113974|P2|COMPLETED|Overall Study||4
5332332|NCT00357396|13113975|P1|COMPLETED|Overall Study||5
5332333|NCT00357396|13113974|P2|STARTED|Overall Study||4
5332334|NCT00357396|13113975|P1|STARTED|Overall Study||6
5332335|NCT00357370|13113983|P3|NOT COMPLETED|Cohort 2||2
5332336|NCT00357370|13113984|P2|NOT COMPLETED|Cohort 2||7
5332337|NCT00357370|13113985|P1|NOT COMPLETED|Cohort 2||2
5332338|NCT00357370|13113983|P3|COMPLETED|Cohort 2||22
5332339|NCT00357370|13113984|P2|COMPLETED|Cohort 2||16
5332340|NCT00357370|13113985|P1|COMPLETED|Cohort 2||22
5332341|NCT00357370|13113983|P3|STARTED|Cohort 2||24
5332342|NCT00357370|13113984|P2|STARTED|Cohort 2||23
5332343|NCT00357370|13113985|P1|STARTED|Cohort 2||24
5332344|NCT00357370|13113983|P3|NOT COMPLETED|Cohort 1||0
5332345|NCT00357370|13113984|P2|NOT COMPLETED|Cohort 1||0
5332346|NCT00357370|13113985|P1|NOT COMPLETED|Cohort 1||0
5332347|NCT00357370|13113983|P3|COMPLETED|Cohort 1||0
5332348|NCT00357370|13113984|P2|COMPLETED|Cohort 1||0
5332349|NCT00357370|13113985|P1|COMPLETED|Cohort 1||4
5332350|NCT00357370|13113983|P3|STARTED|Cohort 1||0
5332351|NCT00357370|13113984|P2|STARTED|Cohort 1||0
5332352|NCT00357370|13113985|P1|STARTED|Cohort 1||4
5332353|NCT00357331|13114010|P2|NOT COMPLETED|Overall Study||0
5332354|NCT00357331|13114011|P1|NOT COMPLETED|Overall Study||0
5332355|NCT00357331|13114010|P2|COMPLETED|Overall Study||41
5332356|NCT00357331|13114011|P1|COMPLETED|Overall Study||42
5332357|NCT00357331|13114010|P2|STARTED|Overall Study||41
5332358|NCT00357331|13114011|P1|STARTED|Overall Study||42
5332359|NCT00357214|13114025|P4|NOT COMPLETED|Overall Study||1
5332360|NCT00357214|13114026|P3|NOT COMPLETED|Overall Study||0
5332361|NCT00357214|13114027|P2|NOT COMPLETED|Overall Study||4
5332362|NCT00357214|13114028|P1|NOT COMPLETED|Overall Study||4
5332363|NCT00357214|13114025|P4|COMPLETED|Overall Study||42
5332364|NCT00357214|13114026|P3|COMPLETED|Overall Study||42
5332365|NCT00357214|13114027|P2|COMPLETED|Overall Study||39
5332366|NCT00357214|13114028|P1|COMPLETED|Overall Study||39
5332367|NCT00357214|13114025|P4|STARTED|Overall Study||43
5332368|NCT00357214|13114026|P3|STARTED|Overall Study||42
5332369|NCT00357214|13114027|P2|STARTED|Overall Study||43
5332370|NCT00357214|13114028|P1|STARTED|Overall Study||43
5332371|NCT00357162|13114038|P1|NOT COMPLETED|Overall Study||0
5332372|NCT00357162|13114038|P1|COMPLETED|Overall Study||21
5332373|NCT00357162|13114038|P1|STARTED|Overall Study||21
5332374|NCT00357110|13114048|P2|NOT COMPLETED|Overall Study||5
5332375|NCT00357110|13114049|P1|NOT COMPLETED|Overall Study||5
5332376|NCT00357110|13114048|P2|COMPLETED|Overall Study||2
5332377|NCT00357110|13114049|P1|COMPLETED|Overall Study||1
5332378|NCT00357110|13114048|P2|STARTED|Overall Study||7
5332379|NCT00357110|13114049|P1|STARTED|Overall Study||6
5332380|NCT00357097|13114057|P2|NOT COMPLETED|Overall Study||29
5332381|NCT00357097|13114058|P1|NOT COMPLETED|Overall Study||54
5332382|NCT00357097|13114057|P2|COMPLETED|Overall Study||38
5332383|NCT00357097|13114058|P1|COMPLETED|Overall Study||145
5332384|NCT00357097|13114057|P2|STARTED|Overall Study||67
5332385|NCT00357097|13114058|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
5332386|NCT00357032|13114102|P1|NOT COMPLETED|Overall Study||0
5332387|NCT00357032|13114102|P1|COMPLETED|Overall Study||12
5332389|NCT00357006|13114112|P3|NOT COMPLETED|Overall Study||3
5332390|NCT00357006|13114113|P2|NOT COMPLETED|Overall Study||5
5332391|NCT00357006|13114114|P1|NOT COMPLETED|Overall Study||2
5332392|NCT00357006|13114112|P3|COMPLETED|Overall Study||59
5332393|NCT00357006|13114113|P2|COMPLETED|Overall Study||51
5332394|NCT00357006|13114114|P1|COMPLETED|Overall Study||60
5332395|NCT00357006|13114112|P3|STARTED|Overall Study||62
5332396|NCT00357006|13114113|P2|STARTED|Overall Study||56
5332397|NCT00357006|13114114|P1|STARTED|Overall Study||62
5332398|NCT00356993|13114122|P1|NOT COMPLETED|Overall Study||3921
5332399|NCT00356993|13114122|P1|COMPLETED|Overall Study||2088
5332400|NCT00356993|13114122|P1|STARTED|Overall Study||6009
5332401|NCT00356915|13114129|P3|NOT COMPLETED|Overall Study||42
5332402|NCT00356915|13114130|P2|NOT COMPLETED|Overall Study||94
5332403|NCT00356915|13114131|P1|NOT COMPLETED|Overall Study||76
5332404|NCT00356915|13114129|P3|COMPLETED|Overall Study||156
5332405|NCT00356915|13114130|P2|COMPLETED|Overall Study||496
5332406|NCT00356915|13114131|P1|COMPLETED|Overall Study||517
5332407|NCT00356915|13114129|P3|STARTED|Overall Study||198
5332408|NCT00356915|13114130|P2|STARTED|Overall Study||590
5332409|NCT00356915|13114131|P1|STARTED|Overall Study||593
5332410|NCT00356889|13114148|P1|NOT COMPLETED|Overall Study||3
5332411|NCT00356889|13114148|P1|COMPLETED|Overall Study||53
5332412|NCT00356889|13114148|P1|STARTED|Overall Study||56
5332413|NCT00356863|13114157|P2|NOT COMPLETED|Overall Study||75
5332414|NCT00356863|13114158|P1|NOT COMPLETED|Overall Study||92
5332415|NCT00356863|13114157|P2|COMPLETED|Overall Study||445
5332416|NCT00356863|13114158|P1|COMPLETED|Overall Study||412
5332417|NCT00356863|13114157|P2|STARTED|Overall Study||520
5332418|NCT00356863|13114158|P1|STARTED|Overall Study||504
5332419|NCT00356811|13114184|P1|NOT COMPLETED|Overall Study||49
5332420|NCT00356811|13114184|P1|COMPLETED|Overall Study||8
5332421|NCT00356811|13114184|P1|STARTED|Overall Study||57
5332422|NCT00356759|13114199|P2|NOT COMPLETED|Overall Study||10
5332423|NCT00356759|13114200|P1|NOT COMPLETED|Overall Study||14
5332424|NCT00356759|13114199|P2|COMPLETED|Overall Study||114
5332425|NCT00356759|13114200|P1|COMPLETED|Overall Study||112
5332426|NCT00356759|13114199|P2|STARTED|Overall Study||124
5332427|NCT00356759|13114200|P1|STARTED|Overall Study||126
5332428|NCT00356603|13114218|P2|NOT COMPLETED|Overall Study||3
5332429|NCT00356603|13114219|P1|NOT COMPLETED|Overall Study||6
5332430|NCT00356603|13114218|P2|COMPLETED|Overall Study||33
5332431|NCT00356603|13114219|P1|COMPLETED|Overall Study||33
5332432|NCT00356603|13114218|P2|STARTED|Overall Study||36
5332433|NCT00356603|13114219|P1|STARTED|Overall Study||39
5332434|NCT00356590|13114233|P1|NOT COMPLETED|Overall Study||274
5332435|NCT00356590|13114233|P1|COMPLETED|Overall Study||194
5332436|NCT00356590|13114233|P1|STARTED|Overall Study||468
5332437|NCT00356525|13114269|P4|NOT COMPLETED|Overall Study||9
5332438|NCT00356525|13114270|P3|NOT COMPLETED|Overall Study||7
5332439|NCT00356525|13114271|P2|NOT COMPLETED|Overall Study||11
5332440|NCT00356525|13114272|P1|NOT COMPLETED|Overall Study||14
5332441|NCT00356525|13114269|P4|COMPLETED|Overall Study||0
5332442|NCT00356525|13114270|P3|COMPLETED|Overall Study||0
5332443|NCT00356525|13114271|P2|COMPLETED|Overall Study||0
5332444|NCT00356525|13114272|P1|COMPLETED|Overall Study||0
5332445|NCT00356525|13114269|P4|STARTED|Overall Study||9
5332446|NCT00356525|13114270|P3|STARTED|Overall Study||7
5332447|NCT00356525|13114271|P2|STARTED|Overall Study||11
5332448|NCT00356525|13114272|P1|STARTED|Overall Study||14
5332449|NCT00356434|13114300|P2|NOT COMPLETED|Overall Study||0
5332450|NCT00356434|13114301|P1|NOT COMPLETED|Overall Study||0
5332451|NCT00356434|13114300|P2|COMPLETED|Overall Study||7
5332452|NCT00356434|13114301|P1|COMPLETED|Overall Study||4
5332453|NCT00356434|13114300|P2|STARTED|Overall Study||7
5332454|NCT00356434|13114301|P1|STARTED|Overall Study||4
5332455|NCT00356421|13114313|P2|NOT COMPLETED|Overall Study||17
5332456|NCT00356421|13114314|P1|NOT COMPLETED|Overall Study||32
5332457|NCT00356421|13114313|P2|COMPLETED|Overall Study||3
5332458|NCT00356421|13114314|P1|COMPLETED|Overall Study||6
5332459|NCT00356421|13114313|P2|STARTED|Overall Study||20
5332460|NCT00356421|13114314|P1|STARTED|Overall Study||38
5332461|NCT00356408|13114354|P1|NOT COMPLETED|Overall Study||60
5332462|NCT00356408|13114354|P1|COMPLETED|Overall Study||43
5332463|NCT00356408|13114354|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
5332464|NCT00356369|13114371|P2|NOT COMPLETED|Year 5||0
5332465|NCT00356369|13114372|P1|NOT COMPLETED|Year 5||0
5332466|NCT00356369|13114371|P2|COMPLETED|Year 5||105
5332467|NCT00356369|13114372|P1|COMPLETED|Year 5||299
5332468|NCT00356369|13114371|P2|STARTED|Year 5||105
5332469|NCT00356369|13114372|P1|STARTED|Year 5||299
5332470|NCT00356369|13114371|P2|NOT COMPLETED|Year 4||0
5332471|NCT00356369|13114372|P1|NOT COMPLETED|Year 4||0
5332472|NCT00356369|13114371|P2|COMPLETED|Year 4||109
5332473|NCT00356369|13114372|P1|COMPLETED|Year 4||317
5332474|NCT00356369|13114371|P2|STARTED|Year 4||109
5332475|NCT00356369|13114372|P1|STARTED|Year 4||317
5332476|NCT00356369|13114371|P2|NOT COMPLETED|Year 3||0
5332477|NCT00356369|13114372|P1|NOT COMPLETED|Year 3||0
5332478|NCT00356369|13114371|P2|COMPLETED|Year 3||116
5332479|NCT00356369|13114372|P1|COMPLETED|Year 3||344
5332480|NCT00356369|13114371|P2|STARTED|Year 3||116
5332481|NCT00356369|13114372|P1|STARTED|Year 3||344
5332482|NCT00356369|13114371|P2|NOT COMPLETED|Year 2||0
5332483|NCT00356369|13114372|P1|NOT COMPLETED|Year 2||0
5332484|NCT00356369|13114371|P2|COMPLETED|Year 2||117
5332485|NCT00356369|13114372|P1|COMPLETED|Year 2||354
5332486|NCT00356369|13114371|P2|STARTED|Year 2||117
5332487|NCT00356369|13114372|P1|STARTED|Year 2||354
5332488|NCT00356369|13114371|P2|NOT COMPLETED|Year 1||0
5332489|NCT00356369|13114372|P1|NOT COMPLETED|Year 1||0
5332490|NCT00356369|13114371|P2|COMPLETED|Year 1||121
5332491|NCT00356369|13114372|P1|COMPLETED|Year 1||364
5332492|NCT00356369|13114371|P2|STARTED|Year 1||121
5332493|NCT00356369|13114372|P1|STARTED|Year 1||364
5332494|NCT00356369|13114371|P2|NOT COMPLETED|Active Phase||1
5332495|NCT00356369|13114372|P1|NOT COMPLETED|Active Phase||2
5332496|NCT00356369|13114371|P2|COMPLETED|Active Phase||125
5332497|NCT00356369|13114372|P1|COMPLETED|Active Phase||372
5332498|NCT00356369|13114371|P2|STARTED|Active Phase||126
5332499|NCT00356369|13114372|P1|STARTED|Active Phase||374
5332500|NCT00356304|13114442|P2|NOT COMPLETED|Overall Study||4
5332501|NCT00356304|13114443|P1|NOT COMPLETED|Overall Study||2
5332502|NCT00356304|13114442|P2|COMPLETED|Overall Study||20
5332503|NCT00356304|13114443|P1|COMPLETED|Overall Study||24
5332504|NCT00356304|13114442|P2|STARTED|Overall Study||24
5332505|NCT00356304|13114443|P1|STARTED|Overall Study||26
5332506|NCT00356278|13114454|P3|NOT COMPLETED|Overall Study||19
5332507|NCT00356278|13114455|P2|NOT COMPLETED|Overall Study||15
5332508|NCT00356278|13114456|P1|NOT COMPLETED|Overall Study||25
5332509|NCT00356278|13114454|P3|COMPLETED|Overall Study||34
5332510|NCT00356278|13114455|P2|COMPLETED|Overall Study||35
5332511|NCT00356278|13114456|P1|COMPLETED|Overall Study||28
5332512|NCT00356278|13114454|P3|STARTED|Overall Study||53
5332513|NCT00356278|13114455|P2|STARTED|Overall Study||50
5332514|NCT00356278|13114456|P1|STARTED|Overall Study||53
5332515|NCT00356265|13114494|P3|NOT COMPLETED|Overall Study||1
5332516|NCT00356265|13114495|P2|NOT COMPLETED|Overall Study||0
5332517|NCT00356265|13114496|P1|NOT COMPLETED|Overall Study||0
5332518|NCT00356265|13114494|P3|COMPLETED|Overall Study||5
5332519|NCT00356265|13114495|P2|COMPLETED|Overall Study||2
5332520|NCT00356265|13114496|P1|COMPLETED|Overall Study||7
5332521|NCT00356265|13114494|P3|STARTED|Overall Study||6
5332522|NCT00356265|13114495|P2|STARTED|Overall Study||2
5332523|NCT00356265|13114496|P1|STARTED|Overall Study||7
5332524|NCT00356200|13114508|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
5332525|NCT00356200|13114509|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
5332526|NCT00356200|13114508|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
5332527|NCT00356200|13114509|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
5332528|NCT00356200|13114508|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
5332529|NCT00356200|13114509|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
5332530|NCT00356200|13114508|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
5332531|NCT00356200|13114509|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
5332532|NCT00356200|13114508|P2|COMPLETED|Cohort 1: 10 ug/ml||0
5332533|NCT00356200|13114509|P1|COMPLETED|Cohort 1: 10 ug/ml||4
5332534|NCT00356200|13114508|P2|STARTED|Cohort 1: 10 ug/ml||0
5332535|NCT00356200|13114509|P1|STARTED|Cohort 1: 10 ug/ml||5
5332536|NCT00356187|13114523|P2|NOT COMPLETED|Overall Study||0
5332537|NCT00356187|13114524|P1|NOT COMPLETED|Overall Study||0
5332538|NCT00356187|13114523|P2|COMPLETED|Overall Study||0
5332539|NCT00356187|13114524|P1|COMPLETED|Overall Study||0
5332540|NCT00356187|13114523|P2|STARTED|Overall Study||0
5332541|NCT00356187|13114524|P1|STARTED|Overall Study||0
5332542|NCT00356148|13114538|P2|NOT COMPLETED|Overall Study||1
5332543|NCT00356148|13114539|P1|NOT COMPLETED|Overall Study||2
5332544|NCT00356148|13114538|P2|COMPLETED|Overall Study||182
5332545|NCT00356148|13114539|P1|COMPLETED|Overall Study||187
5332546|NCT00356148|13114538|P2|STARTED|Overall Study||183
5332547|NCT00356148|13114539|P1|STARTED|Overall Study||189
5332548|NCT00356135|13114550|P3|NOT COMPLETED|Overall Study||5
5332549|NCT00356135|13114551|P2|NOT COMPLETED|Overall Study||2
5332550|NCT00356135|13114552|P1|NOT COMPLETED|Overall Study||4
5332551|NCT00356135|13114550|P3|COMPLETED|Overall Study||39
5332552|NCT00356135|13114551|P2|COMPLETED|Overall Study||46
5332553|NCT00356135|13114552|P1|COMPLETED|Overall Study||43
5332554|NCT00356135|13114550|P3|STARTED|Overall Study||44
5332555|NCT00356135|13114551|P2|STARTED|Overall Study||48
5332556|NCT00356135|13114552|P1|STARTED|Overall Study||47
5332557|NCT00356122|13114574|P1|NOT COMPLETED|FOLLOW-UP||41
5332558|NCT00356122|13114574|P1|COMPLETED|FOLLOW-UP||12
5332559|NCT00356122|13114574|P1|STARTED|FOLLOW-UP||53
5332560|NCT00356122|13114574|P1|NOT COMPLETED|TREATMENT||45
5332561|NCT00356122|13114574|P1|COMPLETED|TREATMENT||8
5332562|NCT00356122|13114574|P1|STARTED|TREATMENT||53
5332563|NCT00356057|13114585|P3|NOT COMPLETED|Overall Study||12
5332564|NCT00356057|13114586|P2|NOT COMPLETED|Overall Study||14
5332565|NCT00356057|13114587|P1|NOT COMPLETED|Overall Study||13
5332566|NCT00356057|13114585|P3|COMPLETED|Overall Study||22
5332567|NCT00356057|13114586|P2|COMPLETED|Overall Study||47
5332568|NCT00356057|13114587|P1|COMPLETED|Overall Study||45
5332569|NCT00356057|13114585|P3|IMPLANTED|Overall Study||25
5332570|NCT00356057|13114586|P2|IMPLANTED|Overall Study||52
5332571|NCT00356057|13114587|P1|IMPLANTED|Overall Study||49
5332572|NCT00356057|13114585|P3|STARTED|Overall Study||34
5332573|NCT00356057|13114586|P2|STARTED|Overall Study||61
5332574|NCT00356057|13114587|P1|STARTED|Overall Study||58
5332575|NCT00356031|13114625|P1|NOT COMPLETED|Overall Study||0
5332576|NCT00356031|13114625|P1|COMPLETED|Overall Study||20
5332577|NCT00356031|13114625|P1|STARTED|Overall Study||20
5332578|NCT00355914|13114636|P2|NOT COMPLETED|Overall Study||0
5332579|NCT00355914|13114637|P1|NOT COMPLETED|Overall Study||0
5332580|NCT00355914|13114636|P2|COMPLETED|Overall Study||60
5332581|NCT00355914|13114637|P1|COMPLETED|Overall Study||60
5332582|NCT00355914|13114636|P2|STARTED|Overall Study||60
5332583|NCT00355914|13114637|P1|STARTED|Overall Study||60
5332584|NCT00355797|13114648|P3|NOT COMPLETED|Overall Study||142
5332585|NCT00355797|13114649|P2|NOT COMPLETED|Overall Study||148
5332586|NCT00355797|13114650|P1|NOT COMPLETED|Overall Study||240
5332587|NCT00355797|13114648|P3|COMPLETED|Overall Study||239
5332588|NCT00355797|13114649|P2|COMPLETED|Overall Study||221
5332589|NCT00355797|13114650|P1|COMPLETED|Overall Study||501
5332590|NCT00355797|13114648|P3|STARTED|Overall Study||381
5332591|NCT00355797|13114649|P2|STARTED|Overall Study||369
5332592|NCT00355797|13114650|P1|STARTED|Overall Study||741
5332593|NCT00355784|13114682|P3|NOT COMPLETED|Overall Study||2
5332594|NCT00355784|13114683|P2|NOT COMPLETED|Overall Study||0
5332595|NCT00355784|13114684|P1|NOT COMPLETED|Overall Study||0
5332596|NCT00355784|13114682|P3|COMPLETED|Overall Study||5
5332597|NCT00355784|13114683|P2|COMPLETED|Overall Study||8
5332598|NCT00355784|13114684|P1|COMPLETED|Overall Study||9
5332599|NCT00355784|13114682|P3|STARTED|Overall Study||7
5332600|NCT00355784|13114683|P2|STARTED|Overall Study||8
5332601|NCT00355784|13114684|P1|STARTED|Overall Study||9
5332602|NCT00355706|13114718|P2|NOT COMPLETED|Overall Study||0
5332603|NCT00355706|13114719|P1|NOT COMPLETED|Overall Study||0
5332604|NCT00355706|13114718|P2|COMPLETED|Overall Study||50
5332605|NCT00355706|13114719|P1|COMPLETED|Overall Study||50
5332606|NCT00355706|13114718|P2|STARTED|Overall Study||50
5332607|NCT00355706|13114719|P1|STARTED|Overall Study||50
5332608|NCT00355615|13114733|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
5332609|NCT00355615|13114734|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
5332610|NCT00355615|13114735|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
5332611|NCT00355615|13114736|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
5332612|NCT00355615|13114737|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
5332613|NCT00355615|13114733|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
5332614|NCT00355615|13114734|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
5332615|NCT00355615|13114735|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
5332616|NCT00355615|13114736|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
5332617|NCT00355615|13114737|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
5332618|NCT00355615|13114733|P5|STARTED|40-week Rosuvastatin Open Label Period||173
5332619|NCT00355615|13114734|P4|STARTED|40-week Rosuvastatin Open Label Period||0
5332620|NCT00355615|13114735|P3|STARTED|40-week Rosuvastatin Open Label Period||0
5332621|NCT00355615|13114736|P2|STARTED|40-week Rosuvastatin Open Label Period||0
5332622|NCT00355615|13114737|P1|STARTED|40-week Rosuvastatin Open Label Period||0
5332623|NCT00355615|13114733|P5|NOT COMPLETED|Randomized Double Blind Period||0
5332624|NCT00355615|13114734|P4|NOT COMPLETED|Randomized Double Blind Period||1
5332625|NCT00355615|13114735|P3|NOT COMPLETED|Randomized Double Blind Period||1
5332626|NCT00355615|13114736|P2|NOT COMPLETED|Randomized Double Blind Period||0
5332627|NCT00355615|13114737|P1|NOT COMPLETED|Randomized Double Blind Period||1
5332628|NCT00355615|13114733|P5|COMPLETED|Randomized Double Blind Period||0
5332629|NCT00355615|13114734|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
5332630|NCT00355615|13114735|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
5332631|NCT00355615|13114736|P2|COMPLETED|Randomized Double Blind Period||44
5332632|NCT00355615|13114737|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
5332633|NCT00355615|13114733|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
5332634|NCT00355615|13114734|P4|STARTED|Randomized Double Blind Period||46
5332635|NCT00355615|13114735|P3|STARTED|Randomized Double Blind Period||45
5332636|NCT00355615|13114736|P2|STARTED|Randomized Double Blind Period||44
5332637|NCT00355615|13114737|P1|STARTED|Randomized Double Blind Period||42
5332638|NCT00355472|13114796|P1|NOT COMPLETED|Overall Study||1
5332639|NCT00355472|13114796|P1|COMPLETED|Overall Study||15
5332640|NCT00355472|13114796|P1|STARTED|Overall Study||16
5332641|NCT00355394|13114823|P2|NOT COMPLETED|Overall Study||0
5332642|NCT00355394|13114824|P1|NOT COMPLETED|Overall Study||0
5332643|NCT00355394|13114823|P2|COMPLETED|Overall Study||16
5332644|NCT00355394|13114824|P1|COMPLETED|Overall Study||15
5332645|NCT00355394|13114823|P2|STARTED|Overall Study||16
5332646|NCT00355394|13114824|P1|STARTED|Overall Study||15
5332647|NCT00355368|13114842|P2|NOT COMPLETED|Overall Study||9
5332648|NCT00355368|13114843|P1|NOT COMPLETED|Overall Study||10
5332649|NCT00355368|13114842|P2|COMPLETED|Overall Study||201
5332650|NCT00355368|13114843|P1|COMPLETED|Overall Study||200
5332651|NCT00355368|13114842|P2|STARTED|Overall Study||210
5332652|NCT00355368|13114843|P1|STARTED|Overall Study||210
5332653|NCT00355342|13114857|P2|NOT COMPLETED|Overall Study||36
5332654|NCT00355342|13114858|P1|NOT COMPLETED|Overall Study||39
5332655|NCT00355342|13114857|P2|COMPLETED|Overall Study||56
5332656|NCT00355342|13114858|P1|COMPLETED|Overall Study||55
5332657|NCT00355342|13114857|P2|STARTED|Overall Study||92
5332658|NCT00355342|13114858|P1|STARTED|Overall Study||94
5332659|NCT00355199|13114868|P2|NOT COMPLETED|Overall Study||4
5332660|NCT00355199|13114869|P1|NOT COMPLETED|Overall Study||7
5332661|NCT00355199|13114868|P2|COMPLETED|Overall Study||122
5332662|NCT00355199|13114869|P1|COMPLETED|Overall Study||113
5332663|NCT00355199|13114868|P2|STARTED|Overall Study||126
5332664|NCT00355199|13114869|P1|STARTED|Overall Study||120
5332665|NCT00355147|13114885|P2|NOT COMPLETED|Overall Study||20
5332666|NCT00355147|13114886|P1|NOT COMPLETED|Overall Study||18
5332667|NCT00355147|13114885|P2|COMPLETED|Overall Study||67
5332668|NCT00355147|13114886|P1|COMPLETED|Overall Study||69
5332669|NCT00355147|13114885|P2|STARTED|Overall Study||87
5332670|NCT00355147|13114886|P1|STARTED|Overall Study||87
5332671|NCT00355134|13114905|P5|NOT COMPLETED|Extension Phase||19
5332672|NCT00355134|13114906|P4|NOT COMPLETED|Extension Phase||16
5332673|NCT00355134|13114907|P3|NOT COMPLETED|Extension Phase||0
5332674|NCT00355134|13114908|P2|NOT COMPLETED|Extension Phase||37
5332675|NCT00355134|13114909|P1|NOT COMPLETED|Extension Phase||31
5332676|NCT00355134|13114905|P5|COMPLETED|Extension Phase||88
5332677|NCT00355134|13114906|P4|COMPLETED|Extension Phase||89
5332678|NCT00355134|13114907|P3|COMPLETED|Extension Phase||0
5332679|NCT00355134|13114908|P2|COMPLETED|Extension Phase||180
5332680|NCT00355134|13114909|P1|COMPLETED|Extension Phase||172
5332681|NCT00355134|13114905|P5|STARTED|Extension Phase||107
5332682|NCT00355134|13114906|P4|STARTED|Extension Phase||105
5332683|NCT00355134|13114907|P3|STARTED|Extension Phase||0
5332684|NCT00355134|13114908|P2|STARTED|Extension Phase||217
5332685|NCT00355134|13114909|P1|STARTED|Extension Phase||203
5332686|NCT00355134|13114905|P5|NOT COMPLETED|Core Phase||0
5332687|NCT00355134|13114906|P4|NOT COMPLETED|Core Phase||0
5332688|NCT00355134|13114907|P3|NOT COMPLETED|Core Phase||100
5332689|NCT00355134|13114908|P2|NOT COMPLETED|Core Phase||86
5332690|NCT00355134|13114909|P1|NOT COMPLETED|Core Phase||119
5332691|NCT00355134|13114905|P5|COMPLETED|Core Phase||0
5332692|NCT00355134|13114906|P4|COMPLETED|Core Phase||0
5332693|NCT00355134|13114907|P3|COMPLETED|Core Phase||255
5332694|NCT00355134|13114908|P2|COMPLETED|Core Phase||272
5332695|NCT00355134|13114909|P1|COMPLETED|Core Phase||251
5332696|NCT00355134|13114905|P5|STARTED|Core Phase||0
5332697|NCT00355134|13114906|P4|STARTED|Core Phase||0
5332698|NCT00355134|13114907|P3|STARTED|Core Phase||355
5332699|NCT00355134|13114908|P2|STARTED|Core Phase||358
5332700|NCT00355134|13114909|P1|STARTED|Core Phase||370
5332701|NCT00355121|13114952|P3|NOT COMPLETED|Overall Study||5
5332702|NCT00355121|13114953|P2|NOT COMPLETED|Overall Study||29
5332703|NCT00355121|13114954|P1|NOT COMPLETED|Overall Study||21
5332704|NCT00355121|13114952|P3|COMPLETED|Overall Study||170
5332705|NCT00355121|13114953|P2|COMPLETED|Overall Study||324
5332706|NCT00355121|13114954|P1|COMPLETED|Overall Study||332
5332707|NCT00355121|13114952|P3|STARTED|Overall Study||175
5332708|NCT00355121|13114953|P2|STARTED|Overall Study||353
5332709|NCT00355121|13114954|P1|STARTED|Overall Study||353
5332710|NCT00355082|13114985|P3|NOT COMPLETED|Continuation Phase||3
5332711|NCT00355082|13114986|P2|NOT COMPLETED|Continuation Phase||0
5332712|NCT00355082|13114987|P1|NOT COMPLETED|Continuation Phase||24
5332713|NCT00355082|13114985|P3|COMPLETED|Continuation Phase||8
5332714|NCT00355082|13114986|P2|COMPLETED|Continuation Phase||0
5332715|NCT00355082|13114987|P1|COMPLETED|Continuation Phase||160
5332716|NCT00355082|13114985|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
5332717|NCT00355082|13114986|P2|STARTED|Continuation Phase||0
5332718|NCT00355082|13114987|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
5332719|NCT00355082|13114985|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
5332720|NCT00355082|13114986|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
5332721|NCT00355082|13114987|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
5332722|NCT00355082|13114985|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
5332723|NCT00355082|13114986|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
5332724|NCT00355082|13114987|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
5332725|NCT00355082|13114985|P3|STARTED|Double-Blind (DB) Treatment Phase||0
5332726|NCT00355082|13114986|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
5332727|NCT00355082|13114987|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
5332728|NCT00355056|13115009|P2|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
5332729|NCT00355056|13115010|P1|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
5332730|NCT00355056|13115009|P2|COMPLETED|Optional Patent Foramen Ovale Closure||84
5332731|NCT00355056|13115010|P1|COMPLETED|Optional Patent Foramen Ovale Closure||0
5332732|NCT00355056|13115009|P2|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
5332733|NCT00355056|13115010|P1|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
5332734|NCT00355056|13115009|P2|NOT COMPLETED|Randomization Period||6
5332735|NCT00355056|13115010|P1|NOT COMPLETED|Randomization Period||4
5332736|NCT00355056|13115009|P2|COMPLETED|Randomization Period||117
5332737|NCT00355056|13115010|P1|COMPLETED|Randomization Period||103
5332738|NCT00355056|13115009|P2|STARTED|Randomization Period||123
5332739|NCT00355056|13115010|P1|STARTED|Randomization Period||107
5332740|NCT00355030|13115040|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
5332741|NCT00355030|13115041|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
5332742|NCT00355030|13115040|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
5332743|NCT00355030|13115041|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
5332744|NCT00355030|13115040|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
5332745|NCT00355030|13115041|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
5332746|NCT00355030|13115040|P2|NOT COMPLETED|Study Period 1 Treatment||44
5332747|NCT00355030|13115041|P1|NOT COMPLETED|Study Period 1 Treatment||45
5332748|NCT00355030|13115040|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
5332837|NCT00354029|13115275|P2|COMPLETED|Overall Study||38
5332749|NCT00355030|13115041|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
5332750|NCT00355030|13115040|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
5332751|NCT00355030|13115041|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
5332752|NCT00355030|13115040|P2|STARTED|Study Period 1 Treatment||45
5332753|NCT00355030|13115041|P1|STARTED|Study Period 1 Treatment||46
5332754|NCT00354978|13115063|P1|NOT COMPLETED|Overall Study||0
5332755|NCT00354978|13115063|P1|COMPLETED|Overall Study||43
5332756|NCT00354978|13115063|P1|STARTED|Overall Study||43
5332757|NCT00354913|13115067|P1|NOT COMPLETED|Overall Study||0
5332758|NCT00354913|13115067|P1|COMPLETED|Overall Study||21
5332759|NCT00354913|13115067|P1|STARTED|Overall Study||21
5332760|NCT00354887|13115074|P1|NOT COMPLETED|Overall Study||1
5332761|NCT00354887|13115074|P1|COMPLETED|Overall Study||29
5332762|NCT00354887|13115074|P1|STARTED|Overall Study||30
5332763|NCT00354835|13115080|P2|NOT COMPLETED|Overall Study||61
5332764|NCT00354835|13115081|P1|NOT COMPLETED|Overall Study||52
5332765|NCT00354835|13115080|P2|COMPLETED|Overall Study||181
5332766|NCT00354835|13115081|P1|COMPLETED|Overall Study||187
5332767|NCT00354835|13115080|P2|STARTED|Overall Study||242
5332768|NCT00354835|13115081|P1|STARTED|Overall Study||239
5332769|NCT00354770|13115113|P2|NOT COMPLETED|Overall Study||3
5332770|NCT00354770|13115114|P1|NOT COMPLETED|Overall Study||3
5332771|NCT00354770|13115113|P2|COMPLETED|Overall Study||22
5332772|NCT00354770|13115114|P1|COMPLETED|Overall Study||22
5332773|NCT00354770|13115113|P2|STARTED|Overall Study||25
5332774|NCT00354770|13115114|P1|STARTED|Overall Study||25
5332775|NCT00354744|13115120|P1|NOT COMPLETED|Overall Study||42
5332776|NCT00354744|13115120|P1|COMPLETED|Overall Study||67
5332777|NCT00354744|13115120|P1|STARTED|Overall Study||109
5332778|NCT00354679|13115126|P1|NOT COMPLETED|Overall Study||1
5332779|NCT00354679|13115126|P1|COMPLETED|Overall Study||33
5332780|NCT00354679|13115126|P1|STARTED|Overall Study||34
5332781|NCT00354640|13115130|P1|NOT COMPLETED|Overall Study||0
5332782|NCT00354640|13115130|P1|COMPLETED|Overall Study||11
5332783|NCT00354640|13115130|P1|STARTED|Overall Study||11
5332784|NCT00354614|13115135|P1|NOT COMPLETED|Overall Study||28
5332785|NCT00354614|13115135|P1|COMPLETED|Overall Study||53
5332786|NCT00354614|13115135|P1|STARTED|Overall Study||81
5332787|NCT00354601|13115139|P1|NOT COMPLETED|Overall Study||2
5332788|NCT00354601|13115139|P1|COMPLETED|Overall Study||0
5332789|NCT00354601|13115139|P1|STARTED|Overall Study||2
5332790|NCT00354484|13115148|P2|NOT COMPLETED|Overall Study||3
5332791|NCT00354484|13115149|P1|NOT COMPLETED|Overall Study||4
5332792|NCT00354484|13115148|P2|COMPLETED|Overall Study||144
5332793|NCT00354484|13115149|P1|COMPLETED|Overall Study||138
5332794|NCT00354484|13115148|P2|STARTED|Overall Study||147
5332795|NCT00354484|13115149|P1|STARTED|Overall Study||142
5332796|NCT00354432|13115159|P4|NOT COMPLETED|Overall Study||10
5332797|NCT00354432|13115160|P3|NOT COMPLETED|Overall Study||10
5332798|NCT00354432|13115161|P2|NOT COMPLETED|Overall Study||8
5332799|NCT00354432|13115162|P1|NOT COMPLETED|Overall Study||6
5332800|NCT00354432|13115159|P4|COMPLETED|Overall Study||20
5332801|NCT00354432|13115160|P3|COMPLETED|Overall Study||20
5332802|NCT00354432|13115161|P2|COMPLETED|Overall Study||22
5332803|NCT00354432|13115162|P1|COMPLETED|Overall Study||24
5332804|NCT00354432|13115159|P4|STARTED|Overall Study||30
5332805|NCT00354432|13115160|P3|STARTED|Overall Study||30
5332806|NCT00354432|13115161|P2|STARTED|Overall Study||30
5332807|NCT00354432|13115162|P1|STARTED|Overall Study||30
5332808|NCT00354341|13115178|P2|NOT COMPLETED|Overall Study||7
5332809|NCT00354341|13115179|P1|NOT COMPLETED|Overall Study||3
5332810|NCT00354341|13115178|P2|COMPLETED|Overall Study||75
5332811|NCT00354341|13115179|P1|COMPLETED|Overall Study||85
5332812|NCT00354341|13115178|P2|STARTED|Overall Study||82
5332813|NCT00354341|13115179|P1|STARTED|Overall Study||88
5332814|NCT00354224|13115195|P1|NOT COMPLETED|Overall Study||0
5332815|NCT00354224|13115195|P1|COMPLETED|Overall Study||10
5332816|NCT00354224|13115195|P1|STARTED|Overall Study||10
5332817|NCT00354172|13115201|P1|NOT COMPLETED|Overall Study||1
5332818|NCT00354172|13115201|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
5332819|NCT00354172|13115201|P1|STARTED|Overall Study||16
5332820|NCT00354159|13115221|P2|NOT COMPLETED|Long-term Follow-up||176
5332821|NCT00354159|13115222|P1|NOT COMPLETED|Long-term Follow-up||180
5332822|NCT00354159|13115221|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
5332823|NCT00354159|13115222|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
5332824|NCT00354159|13115221|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
5332825|NCT00354159|13115222|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
5332826|NCT00354159|13115221|P2|NOT COMPLETED|Randomized Study Period||22
5332827|NCT00354159|13115222|P1|NOT COMPLETED|Randomized Study Period||22
5332828|NCT00354159|13115221|P2|COMPLETED|Randomized Study Period||176
5332829|NCT00354159|13115222|P1|COMPLETED|Randomized Study Period||180
5332830|NCT00354159|13115221|P2|STARTED|Randomized Study Period||198
5332831|NCT00354159|13115222|P1|STARTED|Randomized Study Period||202
5332832|NCT00354107|13115265|P1|NOT COMPLETED|Overall Study||5
5332833|NCT00354107|13115265|P1|COMPLETED|Overall Study||0
5332834|NCT00354107|13115265|P1|STARTED|Overall Study||5
5332835|NCT00354029|13115275|P2|NOT COMPLETED|Overall Study||2
5332836|NCT00354029|13115276|P1|NOT COMPLETED|Overall Study||4
5332838|NCT00354029|13115276|P1|COMPLETED|Overall Study||39
5332839|NCT00354029|13115275|P2|STARTED|Overall Study||40
5332840|NCT00354029|13115276|P1|STARTED|Overall Study||43
5332841|NCT00353977|13115282|P1|NOT COMPLETED|Overall Study||0
5332842|NCT00353977|13115282|P1|COMPLETED|Overall Study||38
5332843|NCT00353977|13115282|P1|STARTED|Overall Study||38
5332844|NCT00353873|13115288|P2|NOT COMPLETED|Overall Study||3
5332845|NCT00353873|13115289|P1|NOT COMPLETED|Overall Study||6
5332846|NCT00353873|13115288|P2|COMPLETED|Overall Study||147
5332847|NCT00353873|13115289|P1|COMPLETED|Overall Study||147
5332848|NCT00353873|13115288|P2|STARTED|Overall Study||150
5332849|NCT00353873|13115289|P1|STARTED|Overall Study||153
5332850|NCT00353834|13115303|P2|NOT COMPLETED|Overall Study||0
5332851|NCT00353834|13115304|P1|NOT COMPLETED|Overall Study||0
5332852|NCT00353834|13115303|P2|COMPLETED|Overall Study||27
5332853|NCT00353834|13115304|P1|COMPLETED|Overall Study||26
5332854|NCT00353834|13115303|P2|STARTED|Overall Study||27
5332855|NCT00353834|13115304|P1|STARTED|Overall Study||26
5332856|NCT00353795|13115312|P1|NOT COMPLETED|Overall Study||0
5332857|NCT00353795|13115312|P1|COMPLETED|Overall Study||179
5332858|NCT00353795|13115312|P1|STARTED|Overall Study||179
5332859|NCT00353704|13115318|P2|NOT COMPLETED|Overall Study||1
5332860|NCT00353704|13115319|P1|NOT COMPLETED|Overall Study||3
5332861|NCT00353704|13115318|P2|COMPLETED|Overall Study||24
5332862|NCT00353704|13115319|P1|COMPLETED|Overall Study||22
5332863|NCT00353704|13115318|P2|STARTED|Overall Study||25
5332864|NCT00353704|13115319|P1|STARTED|Overall Study||25
5332865|NCT00353652|13115329|P8|NOT COMPLETED|Third Intervention – 3 Months||0
5332866|NCT00353652|13115330|P7|NOT COMPLETED|Third Intervention – 3 Months||0
5332867|NCT00353652|13115331|P6|NOT COMPLETED|Third Intervention – 3 Months||0
5332868|NCT00353652|13115332|P5|NOT COMPLETED|Third Intervention – 3 Months||0
5332869|NCT00353652|13115333|P4|NOT COMPLETED|Third Intervention – 3 Months||1
5332870|NCT00353652|13115334|P3|NOT COMPLETED|Third Intervention – 3 Months||0
5332871|NCT00353652|13115335|P2|NOT COMPLETED|Third Intervention – 3 Months||0
5332872|NCT00353652|13115336|P1|NOT COMPLETED|Third Intervention – 3 Months||0
5332873|NCT00353652|13115329|P8|COMPLETED|Third Intervention – 3 Months||0
5332874|NCT00353652|13115330|P7|COMPLETED|Third Intervention – 3 Months||1
5332875|NCT00353652|13115331|P6|COMPLETED|Third Intervention – 3 Months||0
5332876|NCT00353652|13115332|P5|COMPLETED|Third Intervention – 3 Months||3
5332877|NCT00353652|13115333|P4|COMPLETED|Third Intervention – 3 Months||6
5332878|NCT00353652|13115334|P3|COMPLETED|Third Intervention – 3 Months||6
5332879|NCT00353652|13115335|P2|COMPLETED|Third Intervention – 3 Months||0
5332880|NCT00353652|13115336|P1|COMPLETED|Third Intervention – 3 Months||0
5332881|NCT00353652|13115329|P8|STARTED|Third Intervention – 3 Months||0
5332882|NCT00353652|13115330|P7|STARTED|Third Intervention – 3 Months||1
5332883|NCT00353652|13115331|P6|STARTED|Third Intervention – 3 Months||0
5332884|NCT00353652|13115332|P5|STARTED|Third Intervention – 3 Months||3
5332885|NCT00353652|13115333|P4|STARTED|Third Intervention – 3 Months||7
5332886|NCT00353652|13115334|P3|STARTED|Third Intervention – 3 Months||6
5332887|NCT00353652|13115335|P2|STARTED|Third Intervention – 3 Months||0
5332888|NCT00353652|13115336|P1|STARTED|Third Intervention – 3 Months||0
5332889|NCT00353652|13115329|P8|NOT COMPLETED|Second Intervention – 3 Months||0
5332890|NCT00353652|13115330|P7|NOT COMPLETED|Second Intervention – 3 Months||0
5332891|NCT00353652|13115331|P6|NOT COMPLETED|Second Intervention – 3 Months||0
5332892|NCT00353652|13115332|P5|NOT COMPLETED|Second Intervention – 3 Months||0
5332893|NCT00353652|13115333|P4|NOT COMPLETED|Second Intervention – 3 Months||0
5332894|NCT00353652|13115334|P3|NOT COMPLETED|Second Intervention – 3 Months||0
5332895|NCT00353652|13115335|P2|NOT COMPLETED|Second Intervention – 3 Months||0
5332896|NCT00353652|13115336|P1|NOT COMPLETED|Second Intervention – 3 Months||0
5332897|NCT00353652|13115329|P8|COMPLETED|Second Intervention – 3 Months||0
5332898|NCT00353652|13115330|P7|COMPLETED|Second Intervention – 3 Months||1
5332899|NCT00353652|13115331|P6|COMPLETED|Second Intervention – 3 Months||0
5332900|NCT00353652|13115332|P5|COMPLETED|Second Intervention – 3 Months||3
5332901|NCT00353652|13115333|P4|COMPLETED|Second Intervention – 3 Months||7
5332902|NCT00353652|13115334|P3|COMPLETED|Second Intervention – 3 Months||6
5332903|NCT00353652|13115335|P2|COMPLETED|Second Intervention – 3 Months||11
5332904|NCT00353652|13115336|P1|COMPLETED|Second Intervention – 3 Months||12
5332905|NCT00353652|13115329|P8|STARTED|Second Intervention – 3 Months||0
5332906|NCT00353652|13115330|P7|STARTED|Second Intervention – 3 Months||1
5332907|NCT00353652|13115331|P6|STARTED|Second Intervention – 3 Months||0
5332908|NCT00353652|13115332|P5|STARTED|Second Intervention – 3 Months||3
5332909|NCT00353652|13115333|P4|STARTED|Second Intervention – 3 Months||7
5332910|NCT00353652|13115334|P3|STARTED|Second Intervention – 3 Months||6
5332911|NCT00353652|13115335|P2|STARTED|Second Intervention – 3 Months||11
5332912|NCT00353652|13115336|P1|STARTED|Second Intervention – 3 Months||12
5332913|NCT00353652|13115329|P8|NOT COMPLETED|First Intervention – 3 Months||0
5332914|NCT00353652|13115330|P7|NOT COMPLETED|First Intervention – 3 Months||0
5332915|NCT00353652|13115331|P6|NOT COMPLETED|First Intervention – 3 Months||0
5332916|NCT00353652|13115332|P5|NOT COMPLETED|First Intervention – 3 Months||0
5332917|NCT00353652|13115333|P4|NOT COMPLETED|First Intervention – 3 Months||0
5332918|NCT00353652|13115334|P3|NOT COMPLETED|First Intervention – 3 Months||0
5332919|NCT00353652|13115335|P2|NOT COMPLETED|First Intervention – 3 Months||4
5332920|NCT00353652|13115336|P1|NOT COMPLETED|First Intervention – 3 Months||3
5332921|NCT00353652|13115329|P8|COMPLETED|First Intervention – 3 Months||0
5332922|NCT00353652|13115330|P7|COMPLETED|First Intervention – 3 Months||1
5332923|NCT00353652|13115331|P6|COMPLETED|First Intervention – 3 Months||0
5332924|NCT00353652|13115332|P5|COMPLETED|First Intervention – 3 Months||3
5332925|NCT00353652|13115333|P4|COMPLETED|First Intervention – 3 Months||7
5332926|NCT00353652|13115334|P3|COMPLETED|First Intervention – 3 Months||6
5332927|NCT00353652|13115335|P2|COMPLETED|First Intervention – 3 Months||11
5332928|NCT00353652|13115336|P1|COMPLETED|First Intervention – 3 Months||12
5332929|NCT00353652|13115329|P8|STARTED|First Intervention – 3 Months||0
5332930|NCT00353652|13115330|P7|STARTED|First Intervention – 3 Months||1
5332931|NCT00353652|13115331|P6|STARTED|First Intervention – 3 Months||0
5332932|NCT00353652|13115332|P5|STARTED|First Intervention – 3 Months||3
5332933|NCT00353652|13115333|P4|STARTED|First Intervention – 3 Months||7
5332934|NCT00353652|13115334|P3|STARTED|First Intervention – 3 Months||6
5332935|NCT00353652|13115335|P2|STARTED|First Intervention – 3 Months||15
5332936|NCT00353652|13115336|P1|STARTED|First Intervention – 3 Months||15
5332937|NCT00353522|13115370|P2|NOT COMPLETED|Overall Study||9
5332938|NCT00353522|13115371|P1|NOT COMPLETED|Overall Study||15
5332939|NCT00353522|13115370|P2|COMPLETED|Overall Study||37
5332940|NCT00353522|13115371|P1|COMPLETED|Overall Study||74
5332941|NCT00353522|13115370|P2|STARTED|Overall Study||46
5332942|NCT00353522|13115371|P1|STARTED|Overall Study||89
5332943|NCT00353496|13115389|P2|NOT COMPLETED|Overall Study||17
5332944|NCT00353496|13115390|P1|NOT COMPLETED|Overall Study||16
5332945|NCT00353496|13115389|P2|COMPLETED|Overall Study||86
5332946|NCT00353496|13115390|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
5332947|NCT00353496|13115389|P2|STARTED|Overall Study||103
5332948|NCT00353496|13115390|P1|STARTED|Overall Study||101
5332949|NCT00353431|13115407|P2|NOT COMPLETED|Overall Study||0
5332950|NCT00353431|13115408|P1|NOT COMPLETED|Overall Study||0
5332951|NCT00353431|13115407|P2|COMPLETED|Overall Study||67
5332952|NCT00353431|13115408|P1|COMPLETED|Overall Study||63
5332953|NCT00353431|13115407|P2|STARTED|Overall Study||67
5332954|NCT00353431|13115408|P1|STARTED|Overall Study||63
5332955|NCT00353418|13115424|P2|NOT COMPLETED|Overall Study||158
5332956|NCT00353418|13115425|P1|NOT COMPLETED|Overall Study||83
5332957|NCT00353418|13115424|P2|COMPLETED|Overall Study||119
5332958|NCT00353418|13115425|P1|COMPLETED|Overall Study||55
5332959|NCT00353418|13115424|P2|STARTED|Overall Study||277
5332960|NCT00353418|13115425|P1|STARTED|Overall Study||138
5332961|NCT00353366|13115443|P1|NOT COMPLETED|Overall Study||143
5332962|NCT00353366|13115443|P1|COMPLETED|Overall Study||1289
5332963|NCT00353366|13115443|P1|STARTED|Overall Study||1432
5332964|NCT00353301|13115450|P1|NOT COMPLETED|Overall Study||0
5332965|NCT00353301|13115450|P1|COMPLETED|Overall Study||25
5332966|NCT00353301|13115450|P1|STARTED|Overall Study||25
5332967|NCT00353275|13115457|P2|NOT COMPLETED|Overall Study||0
5332968|NCT00353275|13115458|P1|NOT COMPLETED|Overall Study||0
5332969|NCT00353275|13115457|P2|COMPLETED|Overall Study||3
5332970|NCT00353275|13115458|P1|COMPLETED|Overall Study||2
5332971|NCT00353275|13115457|P2|STARTED|Overall Study||3
5332972|NCT00353275|13115458|P1|STARTED|Overall Study||2
5332973|NCT00353262|13115470|P1|NOT COMPLETED|Overall Study||29
5332974|NCT00353262|13115470|P1|COMPLETED|Overall Study||7
5332975|NCT00353262|13115470|P1|STARTED|Overall Study||36
5332976|NCT00353119|13115489|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
5332977|NCT00353119|13115490|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
5332978|NCT00353119|13115489|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
5332979|NCT00353119|13115490|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
5332980|NCT00353119|13115489|P2|STARTED|Second Intervention Week 12 to Week 28||10
5332981|NCT00353119|13115490|P1|STARTED|Second Intervention Week 12 to Week 28||5
5332982|NCT00353119|13115489|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
5332983|NCT00353119|13115490|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
5332984|NCT00353119|13115489|P2|COMPLETED|First Intervention Day 0 to Week 12||10
5332985|NCT00353119|13115490|P1|COMPLETED|First Intervention Day 0 to Week 12||5
5332986|NCT00353119|13115489|P2|STARTED|First Intervention Day 0 to Week 12||10
5332987|NCT00353119|13115490|P1|STARTED|First Intervention Day 0 to Week 12||5
5332988|NCT00352911|13115502|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
5332989|NCT00352911|13115503|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
5332990|NCT00352911|13115502|P2|COMPLETED|300mg Twice Daily (14 Days)||3
5332991|NCT00352911|13115503|P1|COMPLETED|300mg Twice Daily (14 Days)||15
5332992|NCT00352911|13115502|P2|STARTED|300mg Twice Daily (14 Days)||3
5332993|NCT00352911|13115503|P1|STARTED|300mg Twice Daily (14 Days)||16
5332994|NCT00352911|13115502|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
5332995|NCT00352911|13115503|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
5332996|NCT00352911|13115502|P2|COMPLETED|150mg Twice Daily (14 Days)||3
5332997|NCT00352911|13115503|P1|COMPLETED|150mg Twice Daily (14 Days)||16
5332998|NCT00352911|13115502|P2|STARTED|150mg Twice Daily (14 Days)||3
5332999|NCT00352911|13115503|P1|STARTED|150mg Twice Daily (14 Days)||16
5333000|NCT00352885|13115511|P2|NOT COMPLETED|Overall Study||7
5333001|NCT00352885|13115512|P1|NOT COMPLETED|Overall Study||6
5333002|NCT00352885|13115511|P2|COMPLETED|Overall Study||4
5333003|NCT00352885|13115512|P1|COMPLETED|Overall Study||3
5333004|NCT00352885|13115511|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
5333005|NCT00352885|13115512|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
5333006|NCT00352885|13115511|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
5333007|NCT00352885|13115512|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
5333008|NCT00352885|13115511|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
5333009|NCT00352885|13115512|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
5333010|NCT00352885|13115511|P2|STARTED|Overall Study||11
5333011|NCT00352885|13115512|P1|STARTED|Overall Study||9
5333012|NCT00352846|13115530|P2|NOT COMPLETED|Overall Study||13
5333013|NCT00352846|13115531|P1|NOT COMPLETED|Overall Study||8
5333014|NCT00352846|13115530|P2|COMPLETED|Overall Study||24
5333015|NCT00352846|13115531|P1|COMPLETED|Overall Study||29
5333016|NCT00352846|13115530|P2|STARTED|Overall Study||37
5333017|NCT00352846|13115531|P1|STARTED|Overall Study||37
5333018|NCT00352794|13115537|P1|NOT COMPLETED|Overall Study||0
5333019|NCT00352794|13115537|P1|COMPLETED|Overall Study||40
5333020|NCT00352794|13115537|P1|STARTED|Overall Study||40
5333021|NCT00352781|13115541|P1|NOT COMPLETED|Overall Study||883
5333022|NCT00352781|13115541|P1|COMPLETED|Overall Study||884
5333023|NCT00352781|13115541|P1|STARTED|Overall Study||1767
5333024|NCT00352755|13115546|P1|NOT COMPLETED|Overall Study||2
5333025|NCT00352755|13115546|P1|COMPLETED|Overall Study||16
5333026|NCT00352755|13115546|P1|STARTED|Overall Study||18
5333027|NCT00352690|13115556|P2|NOT COMPLETED|Overall Study||0
5333028|NCT00352690|13115557|P1|NOT COMPLETED|Overall Study||2
5333029|NCT00352690|13115556|P2|COMPLETED|Overall Study||0
5333030|NCT00352690|13115557|P1|COMPLETED|Overall Study||8
5333031|NCT00352690|13115556|P2|STARTED|Overall Study||0
5333032|NCT00352690|13115557|P1|STARTED|Overall Study||10
5333033|NCT00352664|13115577|P2|NOT COMPLETED|Overall Study||0
5333034|NCT00352664|13115578|P1|NOT COMPLETED|Overall Study||7
5333035|NCT00352664|13115577|P2|COMPLETED|Overall Study||0
5333036|NCT00352664|13115578|P1|COMPLETED|Overall Study||20
5333037|NCT00352664|13115577|P2|STARTED|Overall Study||0
5333038|NCT00352664|13115578|P1|STARTED|Overall Study||27
5333039|NCT00352612|13115586|P2|NOT COMPLETED|Overall Study||0
5333040|NCT00352612|13115587|P1|NOT COMPLETED|Overall Study||0
5333041|NCT00352612|13115586|P2|COMPLETED|Overall Study||100
5333042|NCT00352612|13115587|P1|COMPLETED|Overall Study||100
5333043|NCT00352612|13115586|P2|STARTED|Overall Study||100
5333044|NCT00352612|13115587|P1|STARTED|Overall Study||100
5333045|NCT00352534|13115595|P7|NOT COMPLETED|Final Risk Group Assignment||39
5333046|NCT00352534|13115596|P6|NOT COMPLETED|Final Risk Group Assignment||45
5333047|NCT00352534|13115597|P5|NOT COMPLETED|Final Risk Group Assignment||1
5333048|NCT00352534|13115598|P4|NOT COMPLETED|Final Risk Group Assignment||3
5333049|NCT00352534|13115599|P3|NOT COMPLETED|Final Risk Group Assignment||3
5333050|NCT00352534|13115600|P2|NOT COMPLETED|Final Risk Group Assignment||0
5333051|NCT00352534|13115601|P1|NOT COMPLETED|Final Risk Group Assignment||0
5333052|NCT00352534|13115595|P7|COMPLETED|Final Risk Group Assignment||1
5333053|NCT00352534|13115596|P6|COMPLETED|Final Risk Group Assignment||503
5333054|NCT00352534|13115597|P5|COMPLETED|Final Risk Group Assignment||31
5333055|NCT00352534|13115598|P4|COMPLETED|Final Risk Group Assignment||49
5333056|NCT00352534|13115599|P3|COMPLETED|Final Risk Group Assignment||116
5333057|NCT00352534|13115600|P2|COMPLETED|Final Risk Group Assignment||0
5333058|NCT00352534|13115601|P1|COMPLETED|Final Risk Group Assignment||0
5333059|NCT00352534|13115595|P7|STARTED|Final Risk Group Assignment||40
5333060|NCT00352534|13115596|P6|STARTED|Final Risk Group Assignment||548
5333061|NCT00352534|13115597|P5|STARTED|Final Risk Group Assignment||32
5333062|NCT00352534|13115598|P4|STARTED|Final Risk Group Assignment||52
5333063|NCT00352534|13115599|P3|STARTED|Final Risk Group Assignment||119
5333064|NCT00352534|13115600|P2|STARTED|Final Risk Group Assignment||0
5333065|NCT00352534|13115601|P1|STARTED|Final Risk Group Assignment||0
5333066|NCT00352534|13115595|P7|NOT COMPLETED|Initial Staging||0
5333067|NCT00352534|13115596|P6|NOT COMPLETED|Initial Staging||0
5333068|NCT00352534|13115597|P5|NOT COMPLETED|Initial Staging||0
5333069|NCT00352534|13115598|P4|NOT COMPLETED|Initial Staging||0
5333070|NCT00352534|13115599|P3|NOT COMPLETED|Initial Staging||0
5333071|NCT00352534|13115600|P2|NOT COMPLETED|Initial Staging||9
5333072|NCT00352534|13115601|P1|NOT COMPLETED|Initial Staging||8
5333073|NCT00352534|13115595|P7|COMPLETED|Initial Staging||0
5333074|NCT00352534|13115596|P6|COMPLETED|Initial Staging||0
5333075|NCT00352534|13115597|P5|COMPLETED|Initial Staging||0
5333076|NCT00352534|13115598|P4|COMPLETED|Initial Staging||0
5333077|NCT00352534|13115599|P3|COMPLETED|Initial Staging||0
5333078|NCT00352534|13115600|P2|COMPLETED|Initial Staging||588
5333079|NCT00352534|13115601|P1|COMPLETED|Initial Staging||203
5333080|NCT00352534|13115595|P7|STARTED|Initial Staging||0
5333081|NCT00352534|13115596|P6|STARTED|Initial Staging||0
5333082|NCT00352534|13115597|P5|STARTED|Initial Staging||0
5333083|NCT00352534|13115598|P4|STARTED|Initial Staging||0
5333084|NCT00352534|13115599|P3|STARTED|Initial Staging||0
5333085|NCT00352534|13115600|P2|STARTED|Initial Staging||597
5333086|NCT00352534|13115601|P1|STARTED|Initial Staging||211
5333087|NCT00352417|13115618|P2|NOT COMPLETED|Overall Study||5
5333088|NCT00352417|13115619|P1|NOT COMPLETED|Overall Study||5
5333089|NCT00352417|13115618|P2|COMPLETED|Overall Study||21
5333090|NCT00352417|13115619|P1|COMPLETED|Overall Study||19
5333091|NCT00352417|13115618|P2|STARTED|Overall Study||26
5333092|NCT00352417|13115619|P1|STARTED|Overall Study||24
5333093|NCT00352365|13115633|P1|NOT COMPLETED|Maintenance Therapy||12
5333094|NCT00352365|13115633|P1|COMPLETED|Maintenance Therapy||0
5333095|NCT00352365|13115633|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
5333096|NCT00352365|13115633|P1|STARTED|Maintenance Therapy||12
5333097|NCT00352365|13115633|P1|NOT COMPLETED|Induction Therapy||27
5333098|NCT00352365|13115633|P1|COMPLETED|Induction Therapy||14
5333099|NCT00352365|13115633|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
5333100|NCT00352365|13115633|P1|Eligible|Induction Therapy||38
5333101|NCT00352365|13115633|P1|STARTED|Induction Therapy||41
5333102|NCT00352118|13115643|P1|NOT COMPLETED|Overall Study||4
5333103|NCT00352118|13115643|P1|COMPLETED|Overall Study||0
5333104|NCT00352118|13115643|P1|STARTED|Overall Study||4
5333105|NCT00352105|13115653|P1|NOT COMPLETED|Overall Study||40
5333106|NCT00352105|13115653|P1|COMPLETED|Overall Study||20
5333107|NCT00352105|13115653|P1|STARTED|Overall Study||60
5333108|NCT00352053|13115664|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
5333109|NCT00352053|13115665|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
5333110|NCT00352053|13115664|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
5333111|NCT00352053|13115665|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
5333112|NCT00352053|13115664|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
5333113|NCT00352053|13115665|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
5333114|NCT00352053|13115664|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
5333115|NCT00352053|13115665|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
5333116|NCT00352053|13115664|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
5333117|NCT00352053|13115665|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
5333118|NCT00352053|13115664|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
5333119|NCT00352053|13115665|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
5333120|NCT00352053|13115664|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
5333121|NCT00352053|13115665|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
5333122|NCT00352053|13115664|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
5333123|NCT00352053|13115665|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
5333124|NCT00352053|13115664|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
5333125|NCT00352053|13115665|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
5333126|NCT00352053|13115664|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
5333127|NCT00352053|13115665|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
5333128|NCT00352053|13115664|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
5333129|NCT00352053|13115665|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
5333130|NCT00352053|13115664|P2|STARTED|Double-Blind Phase (Through Week 48)||42
5333131|NCT00352053|13115665|P1|STARTED|Double-Blind Phase (Through Week 48)||45
5333132|NCT00352027|13115832|P1|NOT COMPLETED|Overall Study||3
5333133|NCT00352027|13115832|P1|COMPLETED|Overall Study||77
5333134|NCT00352027|13115832|P1|STARTED|Overall Study||80
5333135|NCT00352001|13116101|P1|NOT COMPLETED|Overall Study||0
5333136|NCT00352001|13116101|P1|COMPLETED|Overall Study||37
5333137|NCT00352001|13116101|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
5333138|NCT00352001|13116101|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
5333139|NCT00352001|13116101|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
5333140|NCT00352001|13116101|P1|STARTED|Overall Study||37
5333141|NCT00351936|13116112|P1|NOT COMPLETED|Overall Study||0
5333142|NCT00351936|13116112|P1|COMPLETED|Overall Study||15
5333143|NCT00351936|13116112|P1|STARTED|Overall Study||15
5333144|NCT00351819|13116131|P2|NOT COMPLETED|Overall Study||12
5333145|NCT00351819|13116132|P1|NOT COMPLETED|Overall Study||7
5333146|NCT00351819|13116131|P2|COMPLETED|Overall Study||29
5333147|NCT00351819|13116132|P1|COMPLETED|Overall Study||36
5333148|NCT00351819|13116131|P2|STARTED|Overall Study||41
5333149|NCT00351819|13116132|P1|STARTED|Overall Study||43
5333150|NCT00351741|13116182|P2|NOT COMPLETED|Overall Study||0
5333151|NCT00351741|13116183|P1|NOT COMPLETED|Overall Study||0
5333152|NCT00351741|13116182|P2|COMPLETED|Overall Study||31
5333153|NCT00351741|13116183|P1|COMPLETED|Overall Study||31
5333154|NCT00351741|13116182|P2|STARTED|Overall Study||31
5333155|NCT00351741|13116183|P1|STARTED|Overall Study||31
5333156|NCT00351533|13116203|P2|NOT COMPLETED|Overall Study||5
5333157|NCT00351533|13116204|P1|NOT COMPLETED|Overall Study||2
5333158|NCT00351533|13116203|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
5333159|NCT00351533|13116204|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
5333160|NCT00351533|13116203|P2|STARTED|Overall Study||49
5333161|NCT00351533|13116204|P1|STARTED|Overall Study||41
5333162|NCT00351468|13116264|P1|NOT COMPLETED|Overall Study||167
5333163|NCT00351468|13116264|P1|COMPLETED|Overall Study||135
5333164|NCT00351468|13116264|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
5333165|NCT00351468|13116264|P1|Subjects From TRA108057 Repeat|Overall Study||43
5333166|NCT00351468|13116264|P1|Subjects From TRA102537 Raise|Overall Study||146
5333167|NCT00351468|13116264|P1|Subjects From TRA100773B|Overall Study||61
5333168|NCT00351468|13116264|P1|Subjects From TRA100773A|Overall Study||51
5333169|NCT00351468|13116264|P1|STARTED|Overall Study||302
5333170|NCT00351416|13116281|P2|NOT COMPLETED|Overall Study||0
5333171|NCT00351416|13116282|P1|NOT COMPLETED|Overall Study||0
5333172|NCT00351416|13116281|P2|COMPLETED|Overall Study||9
5333173|NCT00351416|13116282|P1|COMPLETED|Overall Study||6
5333174|NCT00351416|13116281|P2|STARTED|Overall Study||9
5333175|NCT00351416|13116282|P1|STARTED|Overall Study||6
5333176|NCT00351377|13116288|P1|NOT COMPLETED|Overall Study||7
5333177|NCT00351377|13116288|P1|COMPLETED|Overall Study||104
5333178|NCT00351377|13116288|P1|STARTED|Overall Study||111
5333179|NCT00351351|13116302|P2|NOT COMPLETED|Overall Study||4
5333180|NCT00351351|13116303|P1|NOT COMPLETED|Overall Study||9
5333181|NCT00351351|13116302|P2|COMPLETED|Overall Study||32
5333182|NCT00351351|13116303|P1|COMPLETED|Overall Study||25
5333183|NCT00351351|13116302|P2|STARTED|Overall Study||36
5333184|NCT00351351|13116303|P1|STARTED|Overall Study||34
5333185|NCT00351299|13116311|P2|NOT COMPLETED|Overall Study||0
5333186|NCT00351299|13116312|P1|NOT COMPLETED|Overall Study||0
5333187|NCT00351299|13116311|P2|COMPLETED|Overall Study||28
5333188|NCT00351299|13116312|P1|COMPLETED|Overall Study||25
5333189|NCT00351299|13116311|P2|STARTED|Overall Study||28
5333190|NCT00351299|13116312|P1|STARTED|Overall Study||25
5333191|NCT00351273|13116329|P3|NOT COMPLETED|Overall Study||5
5333192|NCT00351273|13116330|P2|NOT COMPLETED|Overall Study||2
5333193|NCT00351273|13116331|P1|NOT COMPLETED|Overall Study||1
5333194|NCT00351273|13116329|P3|COMPLETED|Overall Study||10
5333195|NCT00351273|13116330|P2|COMPLETED|Overall Study||10
5333196|NCT00351273|13116331|P1|COMPLETED|Overall Study||14
5333197|NCT00351273|13116329|P3|STARTED|Overall Study||15
5333198|NCT00351273|13116330|P2|STARTED|Overall Study||12
5333199|NCT00351273|13116331|P1|STARTED|Overall Study||15
5333200|NCT00351039|13116354|P1|NOT COMPLETED|Overall Study||0
5333201|NCT00351039|13116354|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
5333202|NCT00351039|13116354|P1|STARTED|Overall Study||8
5333203|NCT00351000|13116363|P1|NOT COMPLETED|Overall Study||3
5333204|NCT00351000|13116363|P1|COMPLETED|Overall Study||21
5333205|NCT00351000|13116363|P1|STARTED|Overall Study||24
5333206|NCT00350870|13116374|P4|NOT COMPLETED|Overall Study||15
5333207|NCT00350870|13116375|P3|NOT COMPLETED|Overall Study||16
5333208|NCT00350870|13116376|P2|NOT COMPLETED|Overall Study||17
5333209|NCT00350870|13116377|P1|NOT COMPLETED|Overall Study||22
5333210|NCT00350870|13116374|P4|COMPLETED|Overall Study||7
5333211|NCT00350870|13116375|P3|COMPLETED|Overall Study||6
5333212|NCT00350870|13116376|P2|COMPLETED|Overall Study||11
5333213|NCT00350870|13116377|P1|COMPLETED|Overall Study||5
5333214|NCT00350870|13116374|P4|Had at Least 1 Day of Med|Overall Study||19
5333215|NCT00350870|13116375|P3|Had at Least 1 Day of Med|Overall Study||18
5333216|NCT00350870|13116376|P2|Had at Least 1 Day of Med|Overall Study||24
5333217|NCT00350870|13116377|P1|Had at Least 1 Day of Med|Overall Study||19
5333218|NCT00350870|13116374|P4|STARTED|Overall Study||22
5333219|NCT00350870|13116375|P3|STARTED|Overall Study||22
5333220|NCT00350870|13116376|P2|STARTED|Overall Study||28
5333221|NCT00350870|13116377|P1|STARTED|Overall Study||27
5333222|NCT00350844|13116391|P1|NOT COMPLETED|Overall Study||1
5333223|NCT00350844|13116391|P1|COMPLETED|Overall Study||5
5333224|NCT00350844|13116391|P1|STARTED|Overall Study||6
5333225|NCT00350792|13116395|P1|NOT COMPLETED|Overall Study||33
5333226|NCT00350792|13116395|P1|COMPLETED|Overall Study||29
5333227|NCT00350792|13116395|P1|STARTED|Overall Study||62
5333228|NCT00350779|13116405|P2|NOT COMPLETED|Overall Study||21
5333229|NCT00350779|13116406|P1|NOT COMPLETED|Overall Study||22
5333230|NCT00350779|13116405|P2|COMPLETED|Overall Study||71
5333231|NCT00350779|13116406|P1|COMPLETED|Overall Study||148
5333232|NCT00350779|13116405|P2|STARTED|Overall Study||92
5333233|NCT00350779|13116406|P1|STARTED|Overall Study||170
5333234|NCT00350727|13116427|P3|NOT COMPLETED|Phase II||22
5333235|NCT00350727|13116428|P2|NOT COMPLETED|Phase II||19
5333236|NCT00350727|13116429|P1|NOT COMPLETED|Phase II||0
5333237|NCT00350727|13116427|P3|COMPLETED|Phase II||0
5333238|NCT00350727|13116428|P2|COMPLETED|Phase II||0
5333239|NCT00350727|13116429|P1|COMPLETED|Phase II||0
5333240|NCT00350727|13116427|P3|STARTED|Phase II||22
5333241|NCT00350727|13116428|P2|STARTED|Phase II||19
5333242|NCT00350727|13116429|P1|STARTED|Phase II||0
5333243|NCT00350727|13116427|P3|NOT COMPLETED|Phase I: Dose Escalation||0
5333244|NCT00350727|13116428|P2|NOT COMPLETED|Phase I: Dose Escalation||0
5333245|NCT00350727|13116429|P1|NOT COMPLETED|Phase I: Dose Escalation||34
5333246|NCT00350727|13116427|P3|COMPLETED|Phase I: Dose Escalation||0
5333247|NCT00350727|13116428|P2|COMPLETED|Phase I: Dose Escalation||0
5333248|NCT00350727|13116429|P1|COMPLETED|Phase I: Dose Escalation||0
5333249|NCT00350727|13116427|P3|STARTED|Phase I: Dose Escalation||0
5333250|NCT00350727|13116428|P2|STARTED|Phase I: Dose Escalation||0
5333251|NCT00350727|13116429|P1|STARTED|Phase I: Dose Escalation||34
5333252|NCT00350636|13116573|P2|NOT COMPLETED|Overall Study||45
5333253|NCT00350636|13116574|P1|NOT COMPLETED|Overall Study||43
5333254|NCT00350636|13116573|P2|COMPLETED|Overall Study||355
5333255|NCT00350636|13116574|P1|COMPLETED|Overall Study||346
5333256|NCT00350636|13116573|P2|STARTED|Overall Study||400
5333257|NCT00350636|13116574|P1|STARTED|Overall Study||389
5333258|NCT00350623|13116593|P3|NOT COMPLETED|Overall Study||6
5333259|NCT00350623|13116594|P2|NOT COMPLETED|Overall Study||4
5333260|NCT00350623|13116595|P1|NOT COMPLETED|Overall Study||8
5333261|NCT00350623|13116593|P3|COMPLETED|Overall Study||62
5333262|NCT00350623|13116594|P2|COMPLETED|Overall Study||67
5333263|NCT00350623|13116595|P1|COMPLETED|Overall Study||63
5333264|NCT00350623|13116593|P3|STARTED|Overall Study||68
5333265|NCT00350623|13116594|P2|STARTED|Overall Study||71
5333266|NCT00350623|13116595|P1|STARTED|Overall Study||71
5333267|NCT00350545|13116603|P1|NOT COMPLETED|Overall Study||2
5333268|NCT00350545|13116603|P1|COMPLETED|Overall Study||35
5333269|NCT00350545|13116603|P1|STARTED|Overall Study||37
5333270|NCT00350532|13116613|P2|NOT COMPLETED|Overall Study||0
5333271|NCT00350532|13116614|P1|NOT COMPLETED|Overall Study||0
5333272|NCT00350532|13116613|P2|COMPLETED|Overall Study||19
5333273|NCT00350532|13116614|P1|COMPLETED|Overall Study||24
5333274|NCT00350532|13116613|P2|STARTED|Overall Study||19
5333275|NCT00350532|13116614|P1|STARTED|Overall Study||24
5333276|NCT00350519|13116622|P2|NOT COMPLETED|Overall Study||6
5333277|NCT00350519|13116623|P1|NOT COMPLETED|Overall Study||4
5333278|NCT00350519|13116622|P2|COMPLETED|Overall Study||13
5333279|NCT00350519|13116623|P1|COMPLETED|Overall Study||14
5333280|NCT00350519|13116622|P2|STARTED|Overall Study||19
5333281|NCT00350519|13116623|P1|STARTED|Overall Study||18
5333282|NCT00350402|13116637|P2|NOT COMPLETED|Overall Study||1
5333283|NCT00350402|13116638|P1|NOT COMPLETED|Overall Study||1
5333284|NCT00350402|13116637|P2|COMPLETED|Overall Study||20
5333285|NCT00350402|13116638|P1|COMPLETED|Overall Study||20
5333286|NCT00350402|13116637|P2|STARTED|Overall Study||21
5333287|NCT00350402|13116638|P1|STARTED|Overall Study||21
5333288|NCT00350363|13116650|P1|NOT COMPLETED|Overall Study||0
5333289|NCT00350363|13116650|P1|COMPLETED|Overall Study||60
5333290|NCT00350363|13116650|P1|STARTED|Overall Study||60
5333291|NCT00350337|13116658|P4|NOT COMPLETED|Overall Study||0
5333292|NCT00350337|13116659|P3|NOT COMPLETED|Overall Study||3
5333293|NCT00350337|13116660|P2|NOT COMPLETED|Overall Study||3
5333294|NCT00350337|13116661|P1|NOT COMPLETED|Overall Study||5
5333295|NCT00350337|13116658|P4|COMPLETED|Overall Study||21
5333296|NCT00350337|13116659|P3|COMPLETED|Overall Study||18
5333297|NCT00350337|13116660|P2|COMPLETED|Overall Study||19
5333298|NCT00350337|13116661|P1|COMPLETED|Overall Study||17
5333299|NCT00350337|13116658|P4|STARTED|Overall Study||21
5333300|NCT00350337|13116659|P3|STARTED|Overall Study||21
5333301|NCT00350337|13116660|P2|STARTED|Overall Study||22
5333302|NCT00350337|13116661|P1|STARTED|Overall Study||22
5333303|NCT00350272|13116711|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
5333304|NCT00350272|13116712|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
5333305|NCT00350272|13116711|P2|COMPLETED|Open-Label 84 Week Treatment||27
5333306|NCT00350272|13116712|P1|COMPLETED|Open-Label 84 Week Treatment||21
5333307|NCT00350272|13116711|P2|STARTED|Open-Label 84 Week Treatment||35
5333308|NCT00350272|13116712|P1|STARTED|Open-Label 84 Week Treatment||30
5333309|NCT00350272|13116711|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
5333310|NCT00350272|13116712|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
5333311|NCT00350272|13116711|P2|COMPLETED|Blinded 12 Week Treatment||35
5333312|NCT00350272|13116712|P1|COMPLETED|Blinded 12 Week Treatment||30
5333313|NCT00350272|13116711|P2|STARTED|Blinded 12 Week Treatment||37
5333314|NCT00350272|13116712|P1|STARTED|Blinded 12 Week Treatment||39
5333315|NCT00350220|13116722|P2|NOT COMPLETED|Overall Study||0
5333316|NCT00350220|13116723|P1|NOT COMPLETED|Overall Study||0
5333317|NCT00350220|13116722|P2|COMPLETED|Overall Study||30
5333318|NCT00350220|13116723|P1|COMPLETED|Overall Study||30
5333319|NCT00350220|13116722|P2|STARTED|Overall Study||30
5333320|NCT00350220|13116723|P1|STARTED|Overall Study||30
5333321|NCT00350207|13116734|P3|NOT COMPLETED|Overall Study||7
5333322|NCT00350207|13116735|P2|NOT COMPLETED|Overall Study||6
5333323|NCT00350207|13116736|P1|NOT COMPLETED|Overall Study||8
5333324|NCT00350207|13116734|P3|COMPLETED|Overall Study||119
5333325|NCT00350207|13116735|P2|COMPLETED|Overall Study||128
5333326|NCT00350207|13116736|P1|COMPLETED|Overall Study||120
5333327|NCT00350207|13116734|P3|STARTED|Overall Study||126
5333328|NCT00350207|13116735|P2|STARTED|Overall Study||134
5333329|NCT00350207|13116736|P1|STARTED|Overall Study||128
5333330|NCT00350142|13116930|P1|NOT COMPLETED|Overall Study||0
5333331|NCT00350142|13116930|P1|COMPLETED|Overall Study||20
5333332|NCT00350142|13116930|P1|STARTED|Overall Study||20
5333333|NCT00350025|13116937|P2|NOT COMPLETED|Overall Study||2
5333334|NCT00350025|13116938|P1|NOT COMPLETED|Overall Study||0
5333335|NCT00350025|13116937|P2|COMPLETED|Overall Study||28
5333336|NCT00350025|13116938|P1|COMPLETED|Overall Study||11
5333337|NCT00350025|13116937|P2|STARTED|Overall Study||30
5333338|NCT00350025|13116938|P1|STARTED|Overall Study||11
5333339|NCT00349973|13116948|P2|NOT COMPLETED|Overall Study||3
5333340|NCT00349973|13116949|P1|NOT COMPLETED|Overall Study||4
5333341|NCT00349973|13116948|P2|COMPLETED|Overall Study||5
5333342|NCT00349973|13116949|P1|COMPLETED|Overall Study||8
5333343|NCT00349973|13116948|P2|STARTED|Overall Study||8
5333344|NCT00349973|13116949|P1|STARTED|Overall Study||12
5333345|NCT00349921|13116963|P4|NOT COMPLETED|Second Spinal Injection||0
5333346|NCT00349921|13116964|P3|NOT COMPLETED|Second Spinal Injection||0
5333347|NCT00349921|13116965|P2|NOT COMPLETED|Second Spinal Injection||0
5333348|NCT00349921|13116966|P1|NOT COMPLETED|Second Spinal Injection||0
5333349|NCT00349921|13116963|P4|COMPLETED|Second Spinal Injection||1
5333350|NCT00349921|13116964|P3|COMPLETED|Second Spinal Injection||0
5333351|NCT00349921|13116965|P2|COMPLETED|Second Spinal Injection||10
5333352|NCT00349921|13116966|P1|COMPLETED|Second Spinal Injection||9
5333353|NCT00349921|13116963|P4|STARTED|Second Spinal Injection||1
5333354|NCT00349921|13116964|P3|STARTED|Second Spinal Injection||0
5333355|NCT00349921|13116965|P2|STARTED|Second Spinal Injection||10
5333356|NCT00349921|13116966|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
5333357|NCT00349921|13116963|P4|NOT COMPLETED|First Spinal Injection||0
5333358|NCT00349921|13116964|P3|NOT COMPLETED|First Spinal Injection||1
5333359|NCT00349921|13116965|P2|NOT COMPLETED|First Spinal Injection||0
5333360|NCT00349921|13116966|P1|NOT COMPLETED|First Spinal Injection||1
5333361|NCT00349921|13116963|P4|COMPLETED|First Spinal Injection||1
5333362|NCT00349921|13116964|P3|COMPLETED|First Spinal Injection||0
5333363|NCT00349921|13116965|P2|COMPLETED|First Spinal Injection||10
5333364|NCT00349921|13116966|P1|COMPLETED|First Spinal Injection||9
5333365|NCT00349921|13116963|P4|STARTED|First Spinal Injection||1
5333366|NCT00349921|13116964|P3|STARTED|First Spinal Injection||1
5333367|NCT00349921|13116965|P2|STARTED|First Spinal Injection||10
5333368|NCT00349921|13116966|P1|STARTED|First Spinal Injection||10
5333369|NCT00349908|13116977|P2|NOT COMPLETED|Overall Study||4
5333370|NCT00349908|13116978|P1|NOT COMPLETED|Overall Study||0
5333371|NCT00349908|13116977|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
5333372|NCT00349908|13116978|P1|COMPLETED|Overall Study||10
5333373|NCT00349908|13116977|P2|STARTED|Overall Study||10
5333374|NCT00349908|13116978|P1|STARTED|Overall Study||10
5333375|NCT00349778|13116996|P1|NOT COMPLETED|Overall Study||0
5333376|NCT00349778|13116996|P1|COMPLETED|Overall Study||102
5333377|NCT00349778|13116996|P1|STARTED|Overall Study||102
5333378|NCT00349752|13117004|P2|NOT COMPLETED|Overall Study||64
5333379|NCT00349752|13117005|P1|NOT COMPLETED|Overall Study||59
5333380|NCT00349752|13117004|P2|COMPLETED|Overall Study||23
5333381|NCT00349752|13117005|P1|COMPLETED|Overall Study||28
5333382|NCT00349752|13117004|P2|STARTED|Overall Study||87
5333383|NCT00349752|13117005|P1|STARTED|Overall Study||87
5333384|NCT00349713|13117034|P3|NOT COMPLETED|Overall Study||0
5333385|NCT00349713|13117035|P2|NOT COMPLETED|Overall Study||0
5333386|NCT00349713|13117036|P1|NOT COMPLETED|Overall Study||0
5333387|NCT00349713|13117034|P3|COMPLETED|Overall Study||20
5333388|NCT00349713|13117035|P2|COMPLETED|Overall Study||20
5333389|NCT00349713|13117036|P1|COMPLETED|Overall Study||20
5333390|NCT00349713|13117034|P3|STARTED|Overall Study||20
5333391|NCT00349713|13117035|P2|STARTED|Overall Study||20
5333392|NCT00349713|13117036|P1|STARTED|Overall Study||20
5333393|NCT00349622|13117058|P2|NOT COMPLETED|Overall Study||96
5333394|NCT00349622|13117059|P1|NOT COMPLETED|Overall Study||178
5333395|NCT00349622|13117058|P2|COMPLETED|Overall Study||77
5333396|NCT00349622|13117059|P1|COMPLETED|Overall Study||162
5333397|NCT00349622|13117058|P2|STARTED|Overall Study||173
5333398|NCT00349622|13117059|P1|STARTED|Overall Study||340
5333399|NCT00349466|13117077|P2|NOT COMPLETED|Overall Study||3
5333400|NCT00349466|13117078|P1|NOT COMPLETED|Overall Study||9
5333401|NCT00349466|13117077|P2|COMPLETED|Overall Study||35
5333402|NCT00349466|13117078|P1|COMPLETED|Overall Study||33
5333403|NCT00349466|13117077|P2|STARTED|Overall Study||38
5333404|NCT00349466|13117078|P1|STARTED|Overall Study||42
5333405|NCT00349388|13117086|P2|NOT COMPLETED|Overall Study||0
5333406|NCT00349388|13117087|P1|NOT COMPLETED|Overall Study||0
5333407|NCT00349388|13117086|P2|COMPLETED|Overall Study||1
5333408|NCT00349388|13117087|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
5333409|NCT00349388|13117086|P2|STARTED|Overall Study||1
5333410|NCT00349388|13117087|P1|STARTED|Overall Study|no patients enrolled|0
5333411|NCT00349349|13117098|P3|NOT COMPLETED|Overall Study||6
5333412|NCT00349349|13117099|P2|NOT COMPLETED|Overall Study||62
5333413|NCT00349349|13117100|P1|NOT COMPLETED|Overall Study||53
5333414|NCT00349349|13117098|P3|COMPLETED|Overall Study||10
5333415|NCT00349349|13117099|P2|COMPLETED|Overall Study||50
5333416|NCT00349349|13117100|P1|COMPLETED|Overall Study||42
5333417|NCT00349349|13117098|P3|STARTED|Overall Study||16
5333418|NCT00349349|13117099|P2|STARTED|Overall Study||112
5333419|NCT00349349|13117100|P1|STARTED|Overall Study||95
5333420|NCT00349336|13117166|P2|NOT COMPLETED|Overall Study||14
5333421|NCT00349336|13117167|P1|NOT COMPLETED|Overall Study||13
5333422|NCT00349336|13117166|P2|COMPLETED|Overall Study||18
5333423|NCT00349336|13117167|P1|COMPLETED|Overall Study||19
5333424|NCT00349336|13117166|P2|STARTED|Overall Study||32
5333425|NCT00349336|13117167|P1|STARTED|Overall Study||32
5333426|NCT00348933|13117189|P1|NOT COMPLETED|Overall Study||25
5333427|NCT00348933|13117189|P1|COMPLETED|Overall Study||65
5333428|NCT00348933|13117189|P1|STARTED|Overall Study||90
5333429|NCT00348881|13117197|P2|NOT COMPLETED|Overall Study||12
5333430|NCT00348881|13117198|P1|NOT COMPLETED|Overall Study||17
5333431|NCT00348881|13117197|P2|COMPLETED|Overall Study||697
5333432|NCT00348881|13117198|P1|COMPLETED|Overall Study||1407
5333433|NCT00348881|13117197|P2|STARTED|Overall Study||709
5333434|NCT00348881|13117198|P1|STARTED|Overall Study||1424
5333435|NCT00348816|13117210|P1|NOT COMPLETED|Overall Study||1
5333436|NCT00348816|13117210|P1|COMPLETED|Overall Study||19
5333437|NCT00348816|13117210|P1|STARTED|Overall Study||20
5333438|NCT00348790|13117217|P1|NOT COMPLETED|Completed Treatment||25
5333439|NCT00348790|13117217|P1|COMPLETED|Completed Treatment||0
5333440|NCT00348790|13117217|P1|STARTED|Completed Treatment||25
5333441|NCT00348790|13117217|P1|NOT COMPLETED|Began Treatment||0
5333442|NCT00348790|13117217|P1|COMPLETED|Began Treatment||25
5333443|NCT00348790|13117217|P1|STARTED|Began Treatment||25
5333444|NCT00348686|13117229|P1|NOT COMPLETED|Overall Study||66
5333445|NCT00348686|13117229|P1|COMPLETED|Overall Study||249
5333446|NCT00348686|13117229|P1|STARTED|Overall Study||315
5333447|NCT00348673|13117246|P9|NOT COMPLETED|Stage 2||0
5333448|NCT00348673|13117247|P8|NOT COMPLETED|Stage 2||0
5333449|NCT00348673|13117248|P7|NOT COMPLETED|Stage 2||0
5333450|NCT00348673|13117249|P6|NOT COMPLETED|Stage 2||0
5333451|NCT00348673|13117250|P5|NOT COMPLETED|Stage 2||0
5333452|NCT00348673|13117251|P4|NOT COMPLETED|Stage 2||0
5333453|NCT00348673|13117252|P3|NOT COMPLETED|Stage 2||0
5333454|NCT00348673|13117253|P2|NOT COMPLETED|Stage 2||0
5333455|NCT00348673|13117254|P1|NOT COMPLETED|Stage 2||0
5333456|NCT00348673|13117246|P9|COMPLETED|Stage 2||2
5333457|NCT00348673|13117247|P8|COMPLETED|Stage 2||6
5333458|NCT00348673|13117248|P7|COMPLETED|Stage 2||6
5333459|NCT00348673|13117249|P6|COMPLETED|Stage 2||6
5333460|NCT00348673|13117250|P5|COMPLETED|Stage 2||0
5333461|NCT00348673|13117251|P4|COMPLETED|Stage 2||0
5333462|NCT00348673|13117252|P3|COMPLETED|Stage 2||0
5333463|NCT00348673|13117253|P2|COMPLETED|Stage 2||0
5333464|NCT00348673|13117254|P1|COMPLETED|Stage 2||0
5333465|NCT00348673|13117246|P9|STARTED|Stage 2||2
5333466|NCT00348673|13117247|P8|STARTED|Stage 2||6
5333467|NCT00348673|13117248|P7|STARTED|Stage 2||6
5333468|NCT00348673|13117249|P6|STARTED|Stage 2||6
5333469|NCT00348673|13117250|P5|STARTED|Stage 2||0
5333470|NCT00348673|13117251|P4|STARTED|Stage 2||0
5333471|NCT00348673|13117252|P3|STARTED|Stage 2||0
5333472|NCT00348673|13117253|P2|STARTED|Stage 2||0
5333473|NCT00348673|13117254|P1|STARTED|Stage 2||0
5333474|NCT00348673|13117246|P9|NOT COMPLETED|Stage 1||0
5333475|NCT00348673|13117247|P8|NOT COMPLETED|Stage 1||0
5333476|NCT00348673|13117248|P7|NOT COMPLETED|Stage 1||0
5333477|NCT00348673|13117249|P6|NOT COMPLETED|Stage 1||0
5333478|NCT00348673|13117250|P5|NOT COMPLETED|Stage 1||0
5333479|NCT00348673|13117251|P4|NOT COMPLETED|Stage 1||0
5333480|NCT00348673|13117252|P3|NOT COMPLETED|Stage 1||1
5333481|NCT00348673|13117253|P2|NOT COMPLETED|Stage 1||0
5333482|NCT00348673|13117254|P1|NOT COMPLETED|Stage 1||0
5333483|NCT00348673|13117246|P9|COMPLETED|Stage 1||0
5333484|NCT00348673|13117247|P8|COMPLETED|Stage 1||0
5333485|NCT00348673|13117248|P7|COMPLETED|Stage 1||0
5333486|NCT00348673|13117249|P6|COMPLETED|Stage 1||0
5333487|NCT00348673|13117250|P5|COMPLETED|Stage 1||4
5333488|NCT00348673|13117251|P4|COMPLETED|Stage 1||6
5333489|NCT00348673|13117252|P3|COMPLETED|Stage 1||6
5333490|NCT00348673|13117253|P2|COMPLETED|Stage 1||6
5333491|NCT00348673|13117254|P1|COMPLETED|Stage 1||6
5333492|NCT00348673|13117246|P9|Treated|Stage 1||0
5333493|NCT00348673|13117247|P8|Treated|Stage 1||0
5333494|NCT00348673|13117248|P7|Treated|Stage 1||0
5333495|NCT00348673|13117249|P6|Treated|Stage 1||0
5333496|NCT00348673|13117250|P5|Treated|Stage 1||4
5333497|NCT00348673|13117251|P4|Treated|Stage 1||6
5333498|NCT00348673|13117252|P3|Treated|Stage 1||6
5333499|NCT00348673|13117253|P2|Treated|Stage 1||6
5333500|NCT00348673|13117254|P1|Treated|Stage 1||6
5333501|NCT00348673|13117246|P9|STARTED|Stage 1||0
5333502|NCT00348673|13117247|P8|STARTED|Stage 1||0
5333503|NCT00348673|13117248|P7|STARTED|Stage 1||0
5333504|NCT00348673|13117249|P6|STARTED|Stage 1||0
5333505|NCT00348673|13117250|P5|STARTED|Stage 1||4
5333506|NCT00348673|13117251|P4|STARTED|Stage 1||6
5333507|NCT00348673|13117252|P3|STARTED|Stage 1||7
5333508|NCT00348673|13117253|P2|STARTED|Stage 1||6
5333509|NCT00348673|13117254|P1|STARTED|Stage 1||6
5333510|NCT00348595|13117303|P2|NOT COMPLETED|Overall Study||8
5333511|NCT00348595|13117304|P1|NOT COMPLETED|Overall Study||5
5333512|NCT00348595|13117303|P2|COMPLETED|Overall Study||26
5333513|NCT00348595|13117304|P1|COMPLETED|Overall Study||21
5333514|NCT00348595|13117303|P2|STARTED|Overall Study||34
5333515|NCT00348595|13117304|P1|STARTED|Overall Study||26
5333516|NCT00348556|13117316|P1|NOT COMPLETED|Overall Study||1
5333517|NCT00348556|13117316|P1|COMPLETED|Overall Study||3
5333518|NCT00348556|13117316|P1|STARTED|Overall Study||4
5333519|NCT00348374|13117323|P2|NOT COMPLETED|Overall Study||32
5333520|NCT00348374|13117324|P1|NOT COMPLETED|Overall Study||19
5333521|NCT00348374|13117323|P2|COMPLETED|Overall Study||71
5333522|NCT00348374|13117324|P1|COMPLETED|Overall Study||69
5333523|NCT00348374|13117323|P2|Received Study Treatment|Overall Study||96
5333524|NCT00348374|13117324|P1|Received Study Treatment|Overall Study||88
5333525|NCT00348374|13117323|P2|STARTED|Overall Study||103
5333526|NCT00348374|13117324|P1|STARTED|Overall Study||88
5333527|NCT00348348|13117371|P2|NOT COMPLETED|Overall Study||27
5333528|NCT00348348|13117372|P1|NOT COMPLETED|Overall Study||25
5333529|NCT00348348|13117371|P2|COMPLETED|Overall Study||555
5333530|NCT00348348|13117372|P1|COMPLETED|Overall Study||554
5333531|NCT00348348|13117371|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
5333532|NCT00348348|13117372|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
5333533|NCT00348309|13117387|P3|NOT COMPLETED|Overall Study||143
5333534|NCT00348309|13117388|P2|NOT COMPLETED|Overall Study||98
5333535|NCT00348309|13117389|P1|NOT COMPLETED|Overall Study||134
5333536|NCT00348309|13117387|P3|COMPLETED|Overall Study||346
5333537|NCT00348309|13117388|P2|COMPLETED|Overall Study||396
5333538|NCT00348309|13117389|P1|COMPLETED|Overall Study||362
5333539|NCT00348309|13117387|P3|STARTED|Overall Study||489
5333540|NCT00348309|13117388|P2|STARTED|Overall Study||494
5333541|NCT00348309|13117389|P1|STARTED|Overall Study||496
5333542|NCT00348283|13117462|P2|NOT COMPLETED|Open Label||34
5333543|NCT00348283|13117463|P1|NOT COMPLETED|Open Label||0
5333544|NCT00348283|13117462|P2|COMPLETED|Open Label||66
5333545|NCT00348283|13117463|P1|COMPLETED|Open Label||0
5333546|NCT00348283|13117462|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
5333547|NCT00348283|13117463|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
5333548|NCT00348283|13117462|P2|NOT COMPLETED|Double Blind||10
5333549|NCT00348283|13117463|P1|NOT COMPLETED|Double Blind||5
5333550|NCT00348283|13117462|P2|COMPLETED|Double Blind||54
5333551|NCT00348283|13117463|P1|COMPLETED|Double Blind||60
5333635|NCT00347360|13117671|P12|COMPLETED|Overall Study||37
5333552|NCT00348283|13117462|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
5333553|NCT00348283|13117463|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
5333554|NCT00348283|13117462|P2|NOT COMPLETED|Induction||6
5333555|NCT00348283|13117463|P1|NOT COMPLETED|Induction||0
5333556|NCT00348283|13117462|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
5333557|NCT00348283|13117463|P1|COMPLETED|Induction||0
5333558|NCT00348283|13117462|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
5333559|NCT00348283|13117463|P1|STARTED|Induction||0
5333560|NCT00348140|13117482|P3|NOT COMPLETED|Overall Study||163
5333561|NCT00348140|13117483|P2|NOT COMPLETED|Overall Study||139
5333562|NCT00348140|13117484|P1|NOT COMPLETED|Overall Study||126
5333563|NCT00348140|13117482|P3|COMPLETED|Overall Study||328
5333564|NCT00348140|13117483|P2|COMPLETED|Overall Study||351
5333565|NCT00348140|13117484|P1|COMPLETED|Overall Study||361
5333566|NCT00348140|13117482|P3|STARTED|Overall Study||491
5333567|NCT00348140|13117483|P2|STARTED|Overall Study||490
5333568|NCT00348140|13117484|P1|STARTED|Overall Study||487
5333569|NCT00347958|13117582|P1|NOT COMPLETED|Overall Study||4
5333570|NCT00347958|13117582|P1|COMPLETED|Overall Study||540
5333571|NCT00347958|13117582|P1|STARTED|Overall Study||544
5333572|NCT00347932|13117591|P2|NOT COMPLETED|Overall Study||52
5333573|NCT00347932|13117592|P1|NOT COMPLETED|Overall Study||31
5333574|NCT00347932|13117591|P2|COMPLETED|Overall Study||430
5333575|NCT00347932|13117592|P1|COMPLETED|Overall Study||444
5333576|NCT00347932|13117591|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
5333577|NCT00347932|13117592|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
5333578|NCT00347919|13117607|P3|NOT COMPLETED|Overall Study||38
5333579|NCT00347919|13117608|P2|NOT COMPLETED|Overall Study||76
5333580|NCT00347919|13117609|P1|NOT COMPLETED|Overall Study||71
5333581|NCT00347919|13117607|P3|COMPLETED|Overall Study||2
5333582|NCT00347919|13117608|P2|COMPLETED|Overall Study||0
5333583|NCT00347919|13117609|P1|COMPLETED|Overall Study||2
5333584|NCT00347919|13117607|P3|STARTED|Overall Study|Safety Population|40
5333585|NCT00347919|13117608|P2|STARTED|Overall Study|Safety Population|76
5333586|NCT00347919|13117609|P1|STARTED|Overall Study|Safety Population|73
5333587|NCT00347776|13117632|P3|NOT COMPLETED|12 Month Follow-up||19
5333588|NCT00347776|13117633|P2|NOT COMPLETED|12 Month Follow-up||16
5333589|NCT00347776|13117634|P1|NOT COMPLETED|12 Month Follow-up||23
5333590|NCT00347776|13117632|P3|COMPLETED|12 Month Follow-up||436
5333591|NCT00347776|13117633|P2|COMPLETED|12 Month Follow-up||446
5333592|NCT00347776|13117634|P1|COMPLETED|12 Month Follow-up||425
5333593|NCT00347776|13117632|P3|STARTED|12 Month Follow-up||455
5333594|NCT00347776|13117633|P2|STARTED|12 Month Follow-up||462
5333595|NCT00347776|13117634|P1|STARTED|12 Month Follow-up||448
5333596|NCT00347776|13117632|P3|NOT COMPLETED|6 Month Follow-up||18
5333597|NCT00347776|13117633|P2|NOT COMPLETED|6 Month Follow-up||13
5333598|NCT00347776|13117634|P1|NOT COMPLETED|6 Month Follow-up||22
5333599|NCT00347776|13117632|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
5333600|NCT00347776|13117633|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
5333601|NCT00347776|13117634|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
5333602|NCT00347776|13117632|P3|STARTED|6 Month Follow-up||473
5333603|NCT00347776|13117633|P2|STARTED|6 Month Follow-up||475
5333604|NCT00347776|13117634|P1|STARTED|6 Month Follow-up||470
5333605|NCT00347776|13117632|P3|NOT COMPLETED|1.5 Month Follow-up||12
5333606|NCT00347776|13117633|P2|NOT COMPLETED|1.5 Month Follow-up||8
5333607|NCT00347776|13117634|P1|NOT COMPLETED|1.5 Month Follow-up||14
5333608|NCT00347776|13117632|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
5333609|NCT00347776|13117633|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
5333610|NCT00347776|13117634|P1|COMPLETED|1.5 Month Follow-up||470
5333611|NCT00347776|13117632|P3|STARTED|1.5 Month Follow-up||485
5333612|NCT00347776|13117633|P2|STARTED|1.5 Month Follow-up||483
5333613|NCT00347776|13117634|P1|STARTED|1.5 Month Follow-up||484
5333614|NCT00347438|13117646|P1|NOT COMPLETED|Overall Study||2
5333615|NCT00347438|13117646|P1|COMPLETED|Overall Study||16
5333616|NCT00347438|13117646|P1|STARTED|Overall Study||18
5333617|NCT00347360|13117668|P15|NOT COMPLETED|Overall Study||4
5333618|NCT00347360|13117669|P14|NOT COMPLETED|Overall Study||8
5333619|NCT00347360|13117670|P13|NOT COMPLETED|Overall Study||10
5333620|NCT00347360|13117671|P12|NOT COMPLETED|Overall Study||6
5333621|NCT00347360|13117672|P11|NOT COMPLETED|Overall Study||5
5333622|NCT00347360|13117673|P10|NOT COMPLETED|Overall Study||9
5333623|NCT00347360|13117674|P9|NOT COMPLETED|Overall Study||6
5333624|NCT00347360|13117675|P8|NOT COMPLETED|Overall Study||3
5333625|NCT00347360|13117676|P7|NOT COMPLETED|Overall Study||7
5333626|NCT00347360|13117677|P6|NOT COMPLETED|Overall Study||8
5333627|NCT00347360|13117678|P5|NOT COMPLETED|Overall Study||5
5333628|NCT00347360|13117679|P4|NOT COMPLETED|Overall Study||13
5333629|NCT00347360|13117680|P3|NOT COMPLETED|Overall Study||6
5333630|NCT00347360|13117681|P2|NOT COMPLETED|Overall Study||8
5333631|NCT00347360|13117682|P1|NOT COMPLETED|Overall Study||5
5333632|NCT00347360|13117668|P15|COMPLETED|Overall Study||39
5333633|NCT00347360|13117669|P14|COMPLETED|Overall Study||36
5333634|NCT00347360|13117670|P13|COMPLETED|Overall Study||34
5333636|NCT00347360|13117672|P11|COMPLETED|Overall Study||39
5333637|NCT00347360|13117673|P10|COMPLETED|Overall Study||35
5333638|NCT00347360|13117674|P9|COMPLETED|Overall Study||38
5333639|NCT00347360|13117675|P8|COMPLETED|Overall Study||40
5333640|NCT00347360|13117676|P7|COMPLETED|Overall Study||37
5333641|NCT00347360|13117677|P6|COMPLETED|Overall Study||36
5333642|NCT00347360|13117678|P5|COMPLETED|Overall Study||39
5333643|NCT00347360|13117679|P4|COMPLETED|Overall Study||30
5333644|NCT00347360|13117680|P3|COMPLETED|Overall Study||37
5333645|NCT00347360|13117681|P2|COMPLETED|Overall Study||35
5333646|NCT00347360|13117682|P1|COMPLETED|Overall Study||39
5333647|NCT00347360|13117668|P15|STARTED|Overall Study||43
5333648|NCT00347360|13117669|P14|STARTED|Overall Study||44
5333649|NCT00347360|13117670|P13|STARTED|Overall Study||44
5333650|NCT00347360|13117671|P12|STARTED|Overall Study||43
5333651|NCT00347360|13117672|P11|STARTED|Overall Study||44
5333652|NCT00347360|13117673|P10|STARTED|Overall Study||44
5333653|NCT00347360|13117674|P9|STARTED|Overall Study||44
5333654|NCT00347360|13117675|P8|STARTED|Overall Study||43
5333655|NCT00347360|13117676|P7|STARTED|Overall Study||44
5333656|NCT00347360|13117677|P6|STARTED|Overall Study||44
5333657|NCT00347360|13117678|P5|STARTED|Overall Study||44
5333658|NCT00347360|13117679|P4|STARTED|Overall Study||43
5333659|NCT00347360|13117680|P3|STARTED|Overall Study||43
5333660|NCT00347360|13117681|P2|STARTED|Overall Study||43
5333661|NCT00347360|13117682|P1|STARTED|Overall Study||44
5333662|NCT00347308|13117864|P1|NOT COMPLETED|Overall Study||0
5333663|NCT00347308|13117864|P1|COMPLETED|Overall Study||40
5333664|NCT00347308|13117864|P1|STARTED|Overall Study||40
5333665|NCT00347269|13117870|P2|NOT COMPLETED|Overall Study||106
5333666|NCT00347269|13117871|P1|NOT COMPLETED|Overall Study||94
5333667|NCT00347269|13117870|P2|COMPLETED|Overall Study||395
5333668|NCT00347269|13117871|P1|COMPLETED|Overall Study||409
5333669|NCT00347269|13117870|P2|STARTED|Overall Study||501
5333670|NCT00347269|13117871|P1|STARTED|Overall Study||503
5333671|NCT00347022|13117879|P2|NOT COMPLETED|Overall Study||5
5333672|NCT00347022|13117880|P1|NOT COMPLETED|Overall Study||12
5333673|NCT00347022|13117879|P2|COMPLETED|Overall Study||66
5333674|NCT00347022|13117880|P1|COMPLETED|Overall Study||62
5333675|NCT00347022|13117879|P2|STARTED|Overall Study||71
5333676|NCT00347022|13117880|P1|STARTED|Overall Study||74
5333677|NCT00347009|13117886|P1|NOT COMPLETED|Overall Study||27
5333678|NCT00347009|13117886|P1|COMPLETED|Overall Study||128
5333679|NCT00347009|13117886|P1|STARTED|Overall Study||155
5333680|NCT00346905|13117903|P1|NOT COMPLETED|Overall Study||4
5333681|NCT00346905|13117903|P1|COMPLETED|Overall Study||12
5333682|NCT00346905|13117903|P1|STARTED|Overall Study||16
5333683|NCT00346775|13117907|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
5333684|NCT00346775|13117908|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
5333685|NCT00346775|13117907|P2|COMPLETED|Period 3: Intervention Period 2||45
5333686|NCT00346775|13117908|P1|COMPLETED|Period 3: Intervention Period 2||44
5333687|NCT00346775|13117907|P2|STARTED|Period 3: Intervention Period 2||45
5333688|NCT00346775|13117908|P1|STARTED|Period 3: Intervention Period 2||44
5333689|NCT00346775|13117907|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5333690|NCT00346775|13117908|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5333691|NCT00346775|13117907|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
5333692|NCT00346775|13117908|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
5333693|NCT00346775|13117907|P2|STARTED|Period 2: Washout Period (7 Days)||45
5333694|NCT00346775|13117908|P1|STARTED|Period 2: Washout Period (7 Days)||44
5333695|NCT00346775|13117907|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
5333696|NCT00346775|13117908|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
5333697|NCT00346775|13117907|P2|COMPLETED|Period 1: Intervention Period 1||45
5333698|NCT00346775|13117908|P1|COMPLETED|Period 1: Intervention Period 1||44
5333699|NCT00346775|13117907|P2|STARTED|Period 1: Intervention Period 1||48
5333700|NCT00346775|13117908|P1|STARTED|Period 1: Intervention Period 1||49
5333701|NCT00346697|13117920|P2|NOT COMPLETED|Overall Study||1
5333702|NCT00346697|13117921|P1|NOT COMPLETED|Overall Study||0
5333703|NCT00346697|13117920|P2|COMPLETED|Overall Study||23
5333704|NCT00346697|13117921|P1|COMPLETED|Overall Study||24
5333705|NCT00346697|13117920|P2|STARTED|Overall Study||24
5333706|NCT00346697|13117921|P1|STARTED|Overall Study||24
5333707|NCT00346632|13117957|P10|NOT COMPLETED|Overall Study||3
5333708|NCT00346632|13117958|P9|NOT COMPLETED|Overall Study||4
5333709|NCT00346632|13117959|P8|NOT COMPLETED|Overall Study||4
5333710|NCT00346632|13117960|P7|NOT COMPLETED|Overall Study||5
5333711|NCT00346632|13117961|P6|NOT COMPLETED|Overall Study||2
5333712|NCT00346632|13117962|P5|NOT COMPLETED|Overall Study||4
5333713|NCT00346632|13117963|P4|NOT COMPLETED|Overall Study||3
5333714|NCT00346632|13117964|P3|NOT COMPLETED|Overall Study||6
5333715|NCT00346632|13117965|P2|NOT COMPLETED|Overall Study||3
5333716|NCT00346632|13117966|P1|NOT COMPLETED|Overall Study||3
5333717|NCT00346632|13117957|P10|COMPLETED|Overall Study||0
5333718|NCT00346632|13117958|P9|COMPLETED|Overall Study||0
5333719|NCT00346632|13117959|P8|COMPLETED|Overall Study||0
5333720|NCT00346632|13117960|P7|COMPLETED|Overall Study||0
5333721|NCT00346632|13117961|P6|COMPLETED|Overall Study||0
5333722|NCT00346632|13117962|P5|COMPLETED|Overall Study||0
5333723|NCT00346632|13117963|P4|COMPLETED|Overall Study||0
5333724|NCT00346632|13117964|P3|COMPLETED|Overall Study||0
5333725|NCT00346632|13117965|P2|COMPLETED|Overall Study||0
5333726|NCT00346632|13117966|P1|COMPLETED|Overall Study||0
5333727|NCT00346632|13117957|P10|STARTED|Overall Study||3
5333728|NCT00346632|13117958|P9|STARTED|Overall Study||4
5333729|NCT00346632|13117959|P8|STARTED|Overall Study||4
5333730|NCT00346632|13117960|P7|STARTED|Overall Study||5
5333731|NCT00346632|13117961|P6|STARTED|Overall Study||2
5333732|NCT00346632|13117962|P5|STARTED|Overall Study||4
5333733|NCT00346632|13117963|P4|STARTED|Overall Study||3
5333734|NCT00346632|13117964|P3|STARTED|Overall Study||6
5333735|NCT00346632|13117965|P2|STARTED|Overall Study||3
5333736|NCT00346632|13117966|P1|STARTED|Overall Study||3
5333737|NCT00346476|13118109|P1|NOT COMPLETED|Overall Study||0
5333738|NCT00346476|13118109|P1|COMPLETED|Overall Study||1250
5333739|NCT00346476|13118109|P1|STARTED|Overall Study||1250
5333740|NCT00346398|13118116|P2|NOT COMPLETED|Overall Study||2
5333741|NCT00346398|13118117|P1|NOT COMPLETED|Overall Study||3
5333742|NCT00346398|13118116|P2|COMPLETED|Overall Study||24
5333743|NCT00346398|13118117|P1|COMPLETED|Overall Study||22
5333744|NCT00346398|13118116|P2|STARTED|Overall Study||26
5333745|NCT00346398|13118117|P1|STARTED|Overall Study||25
5333746|NCT00346333|13118129|P2|NOT COMPLETED|Overall Study||8
5333747|NCT00346333|13118130|P1|NOT COMPLETED|Overall Study||5
5333748|NCT00346333|13118129|P2|COMPLETED|Overall Study||111
5333749|NCT00346333|13118130|P1|COMPLETED|Overall Study||116
5333750|NCT00346333|13118129|P2|STARTED|Overall Study||119
5333751|NCT00346333|13118130|P1|STARTED|Overall Study||121
5333752|NCT00346268|13118146|P2|NOT COMPLETED|Overall Study||3
5333753|NCT00346268|13118147|P1|NOT COMPLETED|Overall Study||2
5333754|NCT00346268|13118146|P2|COMPLETED|Overall Study||50
5333755|NCT00346268|13118147|P1|COMPLETED|Overall Study||50
5333756|NCT00346268|13118146|P2|STARTED|Overall Study||53
5333757|NCT00346268|13118147|P1|STARTED|Overall Study||52
5333758|NCT00346216|13118182|P3|NOT COMPLETED|Overall Study||2348
5333759|NCT00346216|13118183|P2|NOT COMPLETED|Overall Study||2460
5333760|NCT00346216|13118184|P1|NOT COMPLETED|Overall Study||2408
5333761|NCT00346216|13118182|P3|COMPLETED|Overall Study||5621
5333762|NCT00346216|13118183|P2|COMPLETED|Overall Study||5580
5333763|NCT00346216|13118184|P1|COMPLETED|Overall Study||5664
5333764|NCT00346216|13118182|P3|STARTED|Overall Study||7969
5333765|NCT00346216|13118183|P2|STARTED|Overall Study||8040
5333766|NCT00346216|13118184|P1|STARTED|Overall Study||8072
5333767|NCT00346164|13118205|P4|NOT COMPLETED|Overall Study||106
5333768|NCT00346164|13118206|P3|NOT COMPLETED|Overall Study||26
5333769|NCT00346164|13118207|P2|NOT COMPLETED|Overall Study||7
5333770|NCT00346164|13118208|P1|NOT COMPLETED|Overall Study||17
5333771|NCT00346164|13118205|P4|COMPLETED|Overall Study||117
5333772|NCT00346164|13118206|P3|COMPLETED|Overall Study||96
5333773|NCT00346164|13118207|P2|COMPLETED|Overall Study||14
5333774|NCT00346164|13118208|P1|COMPLETED|Overall Study||205
5333775|NCT00346164|13118205|P4|STARTED|Overall Study||223
5333776|NCT00346164|13118206|P3|STARTED|Overall Study||122
5333777|NCT00346164|13118207|P2|STARTED|Overall Study||21
5333778|NCT00346164|13118208|P1|STARTED|Overall Study||222
5333779|NCT00346151|13118243|P1|NOT COMPLETED|Overall Study||3
5333780|NCT00346151|13118243|P1|COMPLETED|Overall Study||2
5333781|NCT00346151|13118243|P1|STARTED|Overall Study||5
5333782|NCT00346073|13118263|P2|NOT COMPLETED|Overall Study||24
5333783|NCT00346073|13118264|P1|NOT COMPLETED|Overall Study||41
5333784|NCT00346073|13118263|P2|COMPLETED|Overall Study||738
5333785|NCT00346073|13118264|P1|COMPLETED|Overall Study||1481
5333786|NCT00346073|13118263|P2|STARTED|Overall Study||762
5333787|NCT00346073|13118264|P1|STARTED|Overall Study||1522
5333788|NCT00346034|13118298|P1|NOT COMPLETED|Overall Study||57
5333789|NCT00346034|13118298|P1|COMPLETED|Overall Study||300
5333790|NCT00346034|13118298|P1|STARTED|Overall Study||357
5333791|NCT00345969|13118305|P2|NOT COMPLETED|Overall Study||2
5333792|NCT00345969|13118306|P1|NOT COMPLETED|Overall Study||1
5333793|NCT00345969|13118305|P2|COMPLETED|Overall Study||11
5333794|NCT00345969|13118306|P1|COMPLETED|Overall Study||11
5333795|NCT00345969|13118305|P2|STARTED|Overall Study||13
5333796|NCT00345969|13118306|P1|STARTED|Overall Study||12
5333797|NCT00345878|13118338|P2|NOT COMPLETED|Overall Study||1
5333798|NCT00345878|13118339|P1|NOT COMPLETED|Overall Study||4
5333799|NCT00345878|13118338|P2|COMPLETED|Overall Study||135
5333800|NCT00345878|13118339|P1|COMPLETED|Overall Study||131
5333801|NCT00345878|13118338|P2|STARTED|Overall Study||136
5333802|NCT00345878|13118339|P1|STARTED|Overall Study||135
5333803|NCT00345865|13118360|P5|NOT COMPLETED|Overall Study||0
5333804|NCT00345865|13118361|P4|NOT COMPLETED|Overall Study||0
5333805|NCT00345865|13118362|P3|NOT COMPLETED|Overall Study||0
5333806|NCT00345865|13118363|P2|NOT COMPLETED|Overall Study||0
5333807|NCT00345865|13118364|P1|NOT COMPLETED|Overall Study||0
5333808|NCT00345865|13118360|P5|COMPLETED|Overall Study||146
5333809|NCT00345865|13118361|P4|COMPLETED|Overall Study||5
5333810|NCT00345865|13118362|P3|COMPLETED|Overall Study||2
5333811|NCT00345865|13118363|P2|COMPLETED|Overall Study||149
5333812|NCT00345865|13118364|P1|COMPLETED|Overall Study||171
5333813|NCT00345865|13118360|P5|STARTED|Overall Study||146
5333814|NCT00345865|13118361|P4|STARTED|Overall Study||5
5333815|NCT00345865|13118362|P3|STARTED|Overall Study||2
5333816|NCT00345865|13118363|P2|STARTED|Overall Study||149
5333817|NCT00345865|13118364|P1|STARTED|Overall Study||171
5333818|NCT00345839|13118398|P2|NOT COMPLETED|Overall Study||159
5333819|NCT00345839|13118399|P1|NOT COMPLETED|Overall Study||149
5333820|NCT00345839|13118398|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
5333821|NCT00345839|13118399|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
5333822|NCT00345839|13118398|P2|STARTED|Overall Study|Randomized to placebo|1935
5333823|NCT00345839|13118399|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
5333824|NCT00345683|13118425|P2|NOT COMPLETED|Overall Study||9
5333825|NCT00345683|13118426|P1|NOT COMPLETED|Overall Study||25
5333826|NCT00345683|13118425|P2|COMPLETED|Overall Study||1001
5333827|NCT00345683|13118426|P1|COMPLETED|Overall Study||2985
5333828|NCT00345683|13118425|P2|STARTED|Overall Study||1010
5333829|NCT00345683|13118426|P1|STARTED|Overall Study||3010
5333830|NCT00345631|13118449|P3|NOT COMPLETED|Overall Study||6
5333831|NCT00345631|13118450|P2|NOT COMPLETED|Overall Study||8
5333832|NCT00345631|13118451|P1|NOT COMPLETED|Overall Study||4
5333833|NCT00345631|13118449|P3|COMPLETED|Overall Study||128
5333834|NCT00345631|13118450|P2|COMPLETED|Overall Study||259
5333835|NCT00345631|13118451|P1|COMPLETED|Overall Study||83
5333836|NCT00345631|13118449|P3|STARTED|Overall Study||134
5333837|NCT00345631|13118450|P2|STARTED|Overall Study||267
5333838|NCT00345631|13118451|P1|STARTED|Overall Study||87
5333839|NCT00345605|13118483|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
5333840|NCT00345605|13118484|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
5333841|NCT00345605|13118483|P2|COMPLETED|Arm 2, Opposite Treatment||6
5333842|NCT00345605|13118484|P1|COMPLETED|Arm 2, Opposite Treatment||5
5333843|NCT00345605|13118483|P2|STARTED|Arm 2, Opposite Treatment||6
5333844|NCT00345605|13118484|P1|STARTED|Arm 2, Opposite Treatment||6
5333845|NCT00345605|13118483|P2|NOT COMPLETED|Crossover Wash-out||0
5333846|NCT00345605|13118484|P1|NOT COMPLETED|Crossover Wash-out||0
5333847|NCT00345605|13118483|P2|COMPLETED|Crossover Wash-out||6
5333848|NCT00345605|13118484|P1|COMPLETED|Crossover Wash-out||6
5333849|NCT00345605|13118483|P2|STARTED|Crossover Wash-out||6
5333850|NCT00345605|13118484|P1|STARTED|Crossover Wash-out||6
5333851|NCT00345605|13118483|P2|NOT COMPLETED|Interval||0
5333852|NCT00345605|13118484|P1|NOT COMPLETED|Interval||0
5333853|NCT00345605|13118483|P2|COMPLETED|Interval||6
5333854|NCT00345605|13118484|P1|COMPLETED|Interval||6
5333855|NCT00345605|13118483|P2|STARTED|Interval||6
5333856|NCT00345605|13118484|P1|STARTED|Interval||6
5333857|NCT00345605|13118483|P2|NOT COMPLETED|Arm 1||1
5333858|NCT00345605|13118484|P1|NOT COMPLETED|Arm 1||0
5333859|NCT00345605|13118483|P2|COMPLETED|Arm 1||5
5333860|NCT00345605|13118484|P1|COMPLETED|Arm 1||6
5333861|NCT00345605|13118483|P2|STARTED|Arm 1||6
5333862|NCT00345605|13118484|P1|STARTED|Arm 1||6
5333863|NCT00345605|13118483|P2|NOT COMPLETED|Initial Washout||0
5333864|NCT00345605|13118484|P1|NOT COMPLETED|Initial Washout||0
5333865|NCT00345605|13118483|P2|COMPLETED|Initial Washout||6
5333866|NCT00345605|13118484|P1|COMPLETED|Initial Washout||6
5333867|NCT00345605|13118483|P2|STARTED|Initial Washout||6
5333868|NCT00345605|13118484|P1|STARTED|Initial Washout||6
5333869|NCT00345592|13118504|P2|NOT COMPLETED|Overall Study||24
5333870|NCT00345592|13118505|P1|NOT COMPLETED|Overall Study||25
5333871|NCT00345592|13118504|P2|COMPLETED|Overall Study||173
5333872|NCT00345592|13118505|P1|COMPLETED|Overall Study||174
5333873|NCT00345592|13118504|P2|STARTED|Overall Study||197
5333874|NCT00345592|13118505|P1|STARTED|Overall Study||199
5333875|NCT00345579|13118513|P2|NOT COMPLETED|Overall Study||65
5333876|NCT00345579|13118514|P1|NOT COMPLETED|Overall Study||164
5333877|NCT00345579|13118513|P2|COMPLETED|Overall Study||1048
5333878|NCT00345579|13118514|P1|COMPLETED|Overall Study||3114
5333879|NCT00345579|13118513|P2|STARTED|Overall Study||1113
5333880|NCT00345579|13118514|P1|STARTED|Overall Study||3278
5333881|NCT00345540|13118534|P1|NOT COMPLETED|Overall Study||1
5333882|NCT00345540|13118534|P1|COMPLETED|Overall Study||15
5333883|NCT00345540|13118534|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
5333884|NCT00345397|13118540|P1|NOT COMPLETED|Overall Study||1
5333885|NCT00345397|13118540|P1|COMPLETED|Overall Study||6
5333886|NCT00345397|13118540|P1|STARTED|Overall Study||7
5333887|NCT00345384|13118547|P2|NOT COMPLETED|Overall Study||0
5333888|NCT00345384|13118548|P1|NOT COMPLETED|Overall Study||0
5333889|NCT00345384|13118547|P2|COMPLETED|Overall Study||19
5333890|NCT00345384|13118548|P1|COMPLETED|Overall Study||19
5333891|NCT00345384|13118547|P2|STARTED|Overall Study||19
5333892|NCT00345384|13118548|P1|STARTED|Overall Study||19
5333893|NCT00345371|13118558|P2|NOT COMPLETED|Overall Study||33
5333894|NCT00345371|13118559|P1|NOT COMPLETED|Overall Study||30
5333895|NCT00345371|13118558|P2|COMPLETED|Overall Study||38
5333896|NCT00345371|13118559|P1|COMPLETED|Overall Study||39
5333897|NCT00345371|13118558|P2|STARTED|Overall Study||71
5333898|NCT00345371|13118559|P1|STARTED|Overall Study||69
5333899|NCT00345358|13118571|P4|NOT COMPLETED|Booster Vaccination Phase||0
5333900|NCT00345358|13118572|P3|NOT COMPLETED|Booster Vaccination Phase||0
5333901|NCT00345358|13118573|P2|NOT COMPLETED|Booster Vaccination Phase||0
5333902|NCT00345358|13118574|P1|NOT COMPLETED|Booster Vaccination Phase||4
5333903|NCT00345358|13118571|P4|COMPLETED|Booster Vaccination Phase||0
5333904|NCT00345358|13118572|P3|COMPLETED|Booster Vaccination Phase||0
5333905|NCT00345358|13118573|P2|COMPLETED|Booster Vaccination Phase||145
5333906|NCT00345358|13118574|P1|COMPLETED|Booster Vaccination Phase||141
5333907|NCT00345358|13118571|P4|STARTED|Booster Vaccination Phase||0
5333908|NCT00345358|13118572|P3|STARTED|Booster Vaccination Phase||0
5333909|NCT00345358|13118573|P2|STARTED|Booster Vaccination Phase||145
5333910|NCT00345358|13118574|P1|STARTED|Booster Vaccination Phase||145
5333911|NCT00345358|13118571|P4|NOT COMPLETED|Primary Vaccination Phase||2
5333912|NCT00345358|13118572|P3|NOT COMPLETED|Primary Vaccination Phase||8
5333913|NCT00345358|13118573|P2|NOT COMPLETED|Primary Vaccination Phase||4
5333914|NCT00345358|13118574|P1|NOT COMPLETED|Primary Vaccination Phase||5
5333915|NCT00345358|13118571|P4|COMPLETED|Primary Vaccination Phase||148
5333916|NCT00345358|13118572|P3|COMPLETED|Primary Vaccination Phase||142
5333917|NCT00345358|13118573|P2|COMPLETED|Primary Vaccination Phase||146
5333918|NCT00345358|13118574|P1|COMPLETED|Primary Vaccination Phase||145
5333919|NCT00345358|13118571|P4|STARTED|Primary Vaccination Phase||150
5333920|NCT00345358|13118572|P3|STARTED|Primary Vaccination Phase||150
5333921|NCT00345358|13118573|P2|STARTED|Primary Vaccination Phase||150
5333922|NCT00345358|13118574|P1|STARTED|Primary Vaccination Phase||150
5333923|NCT00345345|13118649|P1|NOT COMPLETED|Overall Study||2
5333924|NCT00345345|13118649|P1|COMPLETED|Overall Study||27
5333925|NCT00345345|13118649|P1|STARTED|Overall Study||29
5333926|NCT00345332|13118655|P2|NOT COMPLETED|Overall Study||0
5333927|NCT00345332|13118656|P1|NOT COMPLETED|Overall Study||0
5333928|NCT00345332|13118655|P2|COMPLETED|Overall Study||20
5333929|NCT00345332|13118656|P1|COMPLETED|Overall Study||11
5333930|NCT00345332|13118655|P2|STARTED|Overall Study||20
5333931|NCT00345332|13118656|P1|STARTED|Overall Study||11
5333932|NCT00345293|13118664|P2|NOT COMPLETED|Overall Study||0
5333933|NCT00345293|13118665|P1|NOT COMPLETED|Overall Study||2
5333934|NCT00345293|13118664|P2|COMPLETED|Overall Study||3
5333935|NCT00345293|13118665|P1|COMPLETED|Overall Study||8
5333936|NCT00345293|13118664|P2|STARTED|Overall Study||3
5333937|NCT00345293|13118665|P1|STARTED|Overall Study||10
5333938|NCT00345254|13118674|P2|NOT COMPLETED|Overall Study||0
5333939|NCT00345254|13118675|P1|NOT COMPLETED|Overall Study||0
5333940|NCT00345254|13118674|P2|COMPLETED|Overall Study||30
5333941|NCT00345254|13118675|P1|COMPLETED|Overall Study||30
5333942|NCT00345254|13118674|P2|STARTED|Overall Study||30
5333943|NCT00345254|13118675|P1|STARTED|Overall Study||30
5333944|NCT00345176|13118685|P4|NOT COMPLETED|Overall Study||10
5333945|NCT00345176|13118686|P3|NOT COMPLETED|Overall Study||6
5333946|NCT00345176|13118687|P2|NOT COMPLETED|Overall Study||6
5333947|NCT00345176|13118688|P1|NOT COMPLETED|Overall Study||5
5333948|NCT00345176|13118685|P4|COMPLETED|Overall Study||1069
5333949|NCT00345176|13118686|P3|COMPLETED|Overall Study||1062
5333950|NCT00345176|13118687|P2|COMPLETED|Overall Study||1038
5333951|NCT00345176|13118688|P1|COMPLETED|Overall Study||1007
5333952|NCT00345176|13118685|P4|STARTED|Overall Study||1079
5333953|NCT00345176|13118686|P3|STARTED|Overall Study||1068
5333954|NCT00345176|13118687|P2|STARTED|Overall Study||1044
5333955|NCT00345176|13118688|P1|STARTED|Overall Study||1012
5333956|NCT00345046|13118711|P3|NOT COMPLETED|Overall Study||2
5333957|NCT00345046|13118712|P2|NOT COMPLETED|Overall Study||1
5333958|NCT00345046|13118713|P1|NOT COMPLETED|Overall Study||1
5333959|NCT00345046|13118711|P3|COMPLETED|Overall Study||14
5333960|NCT00345046|13118712|P2|COMPLETED|Overall Study||21
5333961|NCT00345046|13118713|P1|COMPLETED|Overall Study||17
5333962|NCT00345046|13118711|P3|STARTED|Overall Study||16
5333963|NCT00345046|13118712|P2|STARTED|Overall Study||22
5333964|NCT00345046|13118713|P1|STARTED|Overall Study||18
5333965|NCT00345033|13118723|P2|NOT COMPLETED|Overall Study||4
5333966|NCT00345033|13118724|P1|NOT COMPLETED|Overall Study||4
5333967|NCT00345033|13118723|P2|COMPLETED|Overall Study||14
5333968|NCT00345033|13118724|P1|COMPLETED|Overall Study||16
5333969|NCT00345033|13118723|P2|STARTED|Overall Study||18
5333970|NCT00345033|13118724|P1|STARTED|Overall Study||20
5333971|NCT00344968|13118743|P3|NOT COMPLETED|Overall Study||116
5333972|NCT00344968|13118744|P2|NOT COMPLETED|Overall Study||102
5333973|NCT00344968|13118745|P1|NOT COMPLETED|Overall Study||59
5333974|NCT00344968|13118743|P3|COMPLETED|Overall Study||279
5333975|NCT00344968|13118744|P2|COMPLETED|Overall Study||274
5333976|NCT00344968|13118745|P1|COMPLETED|Overall Study||126
5333977|NCT00344968|13118743|P3|STARTED|Overall Study||395
5333978|NCT00344968|13118744|P2|STARTED|Overall Study||376
5333979|NCT00344968|13118745|P1|STARTED|Overall Study||185
5333980|NCT00344773|13118756|P1|NOT COMPLETED|Overall Study||21
5333981|NCT00344773|13118756|P1|COMPLETED|Overall Study||25
5333982|NCT00344773|13118756|P1|STARTED|Overall Study||46
5333983|NCT00344682|13118764|P2|NOT COMPLETED|Overall Study||1
5333984|NCT00344682|13118765|P1|NOT COMPLETED|Overall Study||4
5333985|NCT00344682|13118764|P2|COMPLETED|Overall Study||14
5333986|NCT00344682|13118765|P1|COMPLETED|Overall Study||12
5333987|NCT00344682|13118764|P2|STARTED|Overall Study||15
5333988|NCT00344682|13118765|P1|STARTED|Overall Study||16
5333989|NCT00344500|13118779|P3|NOT COMPLETED|Overall Study||2
5333990|NCT00344500|13118780|P2|NOT COMPLETED|Overall Study||35
5333991|NCT00344500|13118781|P1|NOT COMPLETED|Overall Study||23
5333992|NCT00344500|13118779|P3|COMPLETED|Overall Study||12
5333993|NCT00344500|13118780|P2|COMPLETED|Overall Study||25
5333994|NCT00344500|13118781|P1|COMPLETED|Overall Study||25
5333995|NCT00344500|13118779|P3|STARTED|Overall Study||14
5333996|NCT00344500|13118780|P2|STARTED|Overall Study||60
5333997|NCT00344500|13118781|P1|STARTED|Overall Study||48
5333998|NCT00344487|13118792|P1|NOT COMPLETED|Overall Study||1
5333999|NCT00344487|13118792|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
5334000|NCT00344487|13118792|P1|STARTED|Overall Study||3
5334001|NCT00344461|13118796|P1|NOT COMPLETED|Overall Study||21
5334002|NCT00344461|13118796|P1|COMPLETED|Overall Study||33
5334003|NCT00344461|13118796|P1|STARTED|Overall Study||54
5334004|NCT00344448|13118807|P2|NOT COMPLETED|Open Label||1
5334005|NCT00344448|13118808|P1|NOT COMPLETED|Open Label||2
5334006|NCT00344448|13118807|P2|COMPLETED|Open Label||2
5334007|NCT00344448|13118808|P1|COMPLETED|Open Label||2
5334008|NCT00344448|13118807|P2|STARTED|Open Label||3
5334009|NCT00344448|13118808|P1|STARTED|Open Label||4
5334010|NCT00344448|13118807|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
5334011|NCT00344448|13118808|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
5334012|NCT00344448|13118807|P2|COMPLETED|Double Blind, Placebo Controlled||3
5334013|NCT00344448|13118808|P1|COMPLETED|Double Blind, Placebo Controlled||4
5334014|NCT00344448|13118807|P2|STARTED|Double Blind, Placebo Controlled||3
5334015|NCT00344448|13118808|P1|STARTED|Double Blind, Placebo Controlled||6
5334016|NCT00344448|13118807|P2|NOT COMPLETED|Screening||1
5334017|NCT00344448|13118808|P1|NOT COMPLETED|Screening||0
5334018|NCT00344448|13118807|P2|COMPLETED|Screening||3
5334019|NCT00344448|13118808|P1|COMPLETED|Screening||6
5334020|NCT00344448|13118807|P2|STARTED|Screening||4
5334021|NCT00344448|13118808|P1|STARTED|Screening|No randomization during the screening phase|6
5334022|NCT00344370|13118816|P2|NOT COMPLETED|Overall Study||3
5334023|NCT00344370|13118817|P1|NOT COMPLETED|Overall Study||15
5334024|NCT00344370|13118816|P2|COMPLETED|Overall Study||68
5334025|NCT00344370|13118817|P1|COMPLETED|Overall Study||128
5334026|NCT00344370|13118816|P2|STARTED|Overall Study||71
5334027|NCT00344370|13118817|P1|STARTED|Overall Study||143
5334028|NCT00344318|13118829|P4|NOT COMPLETED|Overall Study||3
5334029|NCT00344318|13118830|P3|NOT COMPLETED|Overall Study||1
5334030|NCT00344318|13118831|P2|NOT COMPLETED|Overall Study||5
5334031|NCT00344318|13118832|P1|NOT COMPLETED|Overall Study||4
5334032|NCT00344318|13118829|P4|COMPLETED|Overall Study||100
5334033|NCT00344318|13118830|P3|COMPLETED|Overall Study||99
5334034|NCT00344318|13118831|P2|COMPLETED|Overall Study||298
5334035|NCT00344318|13118832|P1|COMPLETED|Overall Study||296
5334036|NCT00344318|13118829|P4|STARTED|Overall Study||103
5334037|NCT00344318|13118830|P3|STARTED|Overall Study||100
5334038|NCT00344318|13118831|P2|STARTED|Overall Study||303
5334039|NCT00344318|13118832|P1|STARTED|Overall Study||300
5334040|NCT00344305|13118954|P2|NOT COMPLETED|Overall Study||1
5334041|NCT00344305|13118955|P1|NOT COMPLETED|Overall Study||2
5334042|NCT00344305|13118954|P2|COMPLETED|Overall Study||99
5334043|NCT00344305|13118955|P1|COMPLETED|Overall Study||98
5334044|NCT00344305|13118954|P2|STARTED|Overall Study||100
5334045|NCT00344305|13118955|P1|STARTED|Overall Study||100
5334046|NCT00344175|13118992|P2|NOT COMPLETED|Overall Study||10
5334047|NCT00344175|13118993|P1|NOT COMPLETED|Overall Study||12
5334048|NCT00344175|13118992|P2|COMPLETED|Overall Study||47
5334049|NCT00344175|13118993|P1|COMPLETED|Overall Study||109
5334050|NCT00344175|13118992|P2|STARTED|Overall Study||57
5334051|NCT00344175|13118993|P1|STARTED|Overall Study||121
5334052|NCT00344032|13119005|P2|NOT COMPLETED|Overall Study||10
5334053|NCT00344032|13119006|P1|NOT COMPLETED|Overall Study||14
5334054|NCT00344032|13119005|P2|COMPLETED|Overall Study||168
5334055|NCT00344032|13119006|P1|COMPLETED|Overall Study||162
5334056|NCT00344032|13119005|P2|STARTED|Overall Study||178
5334057|NCT00344032|13119006|P1|STARTED|Overall Study||176
5334058|NCT00344019|13119025|P3|NOT COMPLETED|Overall Study||74
5334059|NCT00344019|13119026|P2|NOT COMPLETED|Overall Study||0
5334060|NCT00344019|13119027|P1|NOT COMPLETED|Overall Study||0
5334061|NCT00344019|13119025|P3|COMPLETED|Overall Study||0
5334062|NCT00344019|13119026|P2|COMPLETED|Overall Study||11
5334063|NCT00344019|13119027|P1|COMPLETED|Overall Study||12
5334064|NCT00344019|13119025|P3|STARTED|Overall Study||74
5334065|NCT00344019|13119026|P2|STARTED|Overall Study||11
5334066|NCT00344019|13119027|P1|STARTED|Overall Study||12
5334067|NCT00343915|13119045|P2|NOT COMPLETED|Month 66 Follow-up||0
5334068|NCT00343915|13119046|P1|NOT COMPLETED|Month 66 Follow-up||0
5334069|NCT00343915|13119045|P2|COMPLETED|Month 66 Follow-up||76
5334070|NCT00343915|13119046|P1|COMPLETED|Month 66 Follow-up||158
5334071|NCT00343915|13119045|P2|STARTED|Month 66 Follow-up||76
5334072|NCT00343915|13119046|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
5334073|NCT00343915|13119045|P2|NOT COMPLETED|Month 54 Follow-up||0
5334074|NCT00343915|13119046|P1|NOT COMPLETED|Month 54 Follow-up||0
5334075|NCT00343915|13119045|P2|COMPLETED|Month 54 Follow-up||79
5334076|NCT00343915|13119046|P1|COMPLETED|Month 54 Follow-up||166
5334077|NCT00343915|13119045|P2|STARTED|Month 54 Follow-up||79
5334078|NCT00343915|13119046|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
5334079|NCT00343915|13119045|P2|NOT COMPLETED|Month 42 Follow-up||0
5334080|NCT00343915|13119046|P1|NOT COMPLETED|Month 42 Follow-up||0
5334081|NCT00343915|13119045|P2|COMPLETED|Month 42 Follow-up||84
5334082|NCT00343915|13119046|P1|COMPLETED|Month 42 Follow-up||174
5334083|NCT00343915|13119045|P2|STARTED|Month 42 Follow-up||84
5334084|NCT00343915|13119046|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
5334085|NCT00343915|13119045|P2|NOT COMPLETED|Month 30 Follow-up||0
5334086|NCT00343915|13119046|P1|NOT COMPLETED|Month 30 Follow-up||0
5334087|NCT00343915|13119045|P2|COMPLETED|Month 30 Follow-up||88
5334088|NCT00343915|13119046|P1|COMPLETED|Month 30 Follow-up||179
5334089|NCT00343915|13119045|P2|STARTED|Month 30 Follow-up||88
5334090|NCT00343915|13119046|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
5334091|NCT00343915|13119045|P2|NOT COMPLETED|Primary Study||3
5334092|NCT00343915|13119046|P1|NOT COMPLETED|Primary Study||4
5334093|NCT00343915|13119045|P2|COMPLETED|Primary Study||123
5334094|NCT00343915|13119046|P1|COMPLETED|Primary Study||254
5334095|NCT00343915|13119045|P2|STARTED|Primary Study||126
5334096|NCT00343915|13119046|P1|STARTED|Primary Study||258
5334097|NCT00343889|13119072|P2|NOT COMPLETED|Overall Study||1
5334098|NCT00343889|13119073|P1|NOT COMPLETED|Overall Study||3
5334099|NCT00343889|13119072|P2|COMPLETED|Overall Study||188
5334100|NCT00343889|13119073|P1|COMPLETED|Overall Study||187
5334101|NCT00343889|13119072|P2|STARTED|Overall Study||189
5334102|NCT00343889|13119073|P1|STARTED|Overall Study||190
5334103|NCT00343863|13119091|P2|NOT COMPLETED|Overall Study||0
5334104|NCT00343863|13119092|P1|NOT COMPLETED|Overall Study||0
5334105|NCT00343863|13119091|P2|COMPLETED|Overall Study||34
5334106|NCT00343863|13119092|P1|COMPLETED|Overall Study||7
5334107|NCT00343863|13119091|P2|STARTED|Overall Study||34
5334108|NCT00343863|13119092|P1|STARTED|Overall Study||7
5334109|NCT00343785|13119114|P1|NOT COMPLETED|Overall Study||0
5334110|NCT00343785|13119114|P1|COMPLETED|Overall Study||21
5334111|NCT00343785|13119114|P1|STARTED|Overall Study||21
5334112|NCT00343564|13119131|P11|NOT COMPLETED|Overall Study||0
5334113|NCT00343564|13119132|P10|NOT COMPLETED|Overall Study||0
5334114|NCT00343564|13119133|P9|NOT COMPLETED|Overall Study||0
5334115|NCT00343564|13119134|P8|NOT COMPLETED|Overall Study||0
5334116|NCT00343564|13119135|P7|NOT COMPLETED|Overall Study||0
5334117|NCT00343564|13119136|P6|NOT COMPLETED|Overall Study||0
5334118|NCT00343564|13119137|P5|NOT COMPLETED|Overall Study||0
5334119|NCT00343564|13119138|P4|NOT COMPLETED|Overall Study||0
5334120|NCT00343564|13119139|P3|NOT COMPLETED|Overall Study||0
5334121|NCT00343564|13119140|P2|NOT COMPLETED|Overall Study||0
5334122|NCT00343564|13119141|P1|NOT COMPLETED|Overall Study||0
5334123|NCT00343564|13119131|P11|COMPLETED|Overall Study||8
5334124|NCT00343564|13119132|P10|COMPLETED|Overall Study||8
5334125|NCT00343564|13119133|P9|COMPLETED|Overall Study||3
5334126|NCT00343564|13119134|P8|COMPLETED|Overall Study||3
5334127|NCT00343564|13119135|P7|COMPLETED|Overall Study||4
5334128|NCT00343564|13119136|P6|COMPLETED|Overall Study||9
5334129|NCT00343564|13119137|P5|COMPLETED|Overall Study||10
5334130|NCT00343564|13119138|P4|COMPLETED|Overall Study||7
5334131|NCT00343564|13119139|P3|COMPLETED|Overall Study||3
5334132|NCT00343564|13119140|P2|COMPLETED|Overall Study||7
5334133|NCT00343564|13119141|P1|COMPLETED|Overall Study||6
5334134|NCT00343564|13119131|P11|STARTED|Overall Study||8
5334135|NCT00343564|13119132|P10|STARTED|Overall Study||8
5334136|NCT00343564|13119133|P9|STARTED|Overall Study||3
5334137|NCT00343564|13119134|P8|STARTED|Overall Study||3
5334138|NCT00343564|13119135|P7|STARTED|Overall Study||4
5334139|NCT00343564|13119136|P6|STARTED|Overall Study||9
5334140|NCT00343564|13119137|P5|STARTED|Overall Study||10
5334141|NCT00343564|13119138|P4|STARTED|Overall Study||7
5334142|NCT00343564|13119139|P3|STARTED|Overall Study||3
5334143|NCT00343564|13119140|P2|STARTED|Overall Study||7
5334144|NCT00343564|13119141|P1|STARTED|Overall Study||6
5334145|NCT00343512|13119237|P1|NOT COMPLETED|Overall Study||2
5334146|NCT00343512|13119237|P1|COMPLETED|Overall Study||32
5334147|NCT00343512|13119237|P1|STARTED|Overall Study||34
5334148|NCT00343460|13119249|P3|NOT COMPLETED|Cycle 2 - 4||0
5334149|NCT00343460|13119250|P2|NOT COMPLETED|Cycle 2 - 4||50
5334150|NCT00343460|13119251|P1|NOT COMPLETED|Cycle 2 - 4||56
5334151|NCT00343460|13119249|P3|COMPLETED|Cycle 2 - 4||0
5334152|NCT00343460|13119250|P2|COMPLETED|Cycle 2 - 4||515
5334153|NCT00343460|13119251|P1|COMPLETED|Cycle 2 - 4||528
5334154|NCT00343460|13119249|P3|STARTED|Cycle 2 - 4||0
5334155|NCT00343460|13119250|P2|STARTED|Cycle 2 - 4||565
5334156|NCT00343460|13119251|P1|STARTED|Cycle 2 - 4||584
5334157|NCT00343460|13119249|P3|NOT COMPLETED|Cycle 1||18
5334158|NCT00343460|13119250|P2|NOT COMPLETED|Cycle 1||22
5334159|NCT00343460|13119251|P1|NOT COMPLETED|Cycle 1||22
5334160|NCT00343460|13119249|P3|COMPLETED|Cycle 1||454
5334161|NCT00343460|13119250|P2|COMPLETED|Cycle 1||459
5334162|NCT00343460|13119251|P1|COMPLETED|Cycle 1||453
5334163|NCT00343460|13119249|P3|STARTED|Cycle 1||472
5334164|NCT00343460|13119250|P2|STARTED|Cycle 1||481
5334165|NCT00343460|13119251|P1|STARTED|Cycle 1||475
5334166|NCT00343382|13119325|P3|NOT COMPLETED|Overall Study||17
5334167|NCT00343382|13119326|P2|NOT COMPLETED|Overall Study||14
5334168|NCT00343382|13119327|P1|NOT COMPLETED|Overall Study||4
5334169|NCT00343382|13119325|P3|COMPLETED|Overall Study||49
5334170|NCT00343382|13119326|P2|COMPLETED|Overall Study||51
5334171|NCT00343382|13119327|P1|COMPLETED|Overall Study||60
5334172|NCT00343382|13119325|P3|STARTED|Overall Study||66
5334173|NCT00343382|13119326|P2|STARTED|Overall Study||65
5334174|NCT00343382|13119327|P1|STARTED|Overall Study||64
5334175|NCT00343291|13119346|P2|NOT COMPLETED|Overall Study||56
5334176|NCT00343291|13119347|P1|NOT COMPLETED|Overall Study||57
5334177|NCT00343291|13119346|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
5334178|NCT00343291|13119347|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
5334179|NCT00343291|13119346|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
5334180|NCT00343291|13119347|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
5334181|NCT00343291|13119346|P2|STARTED|Overall Study||61
5334182|NCT00343291|13119347|P1|STARTED|Overall Study||60
5334183|NCT00343252|13119363|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
5334184|NCT00343252|13119364|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
5334185|NCT00343252|13119363|P2|COMPLETED|18 Months (All Treated Participants)||269
5334186|NCT00343252|13119364|P1|COMPLETED|18 Months (All Treated Participants)||259
5334187|NCT00343252|13119363|P2|STARTED|18 Months (All Treated Participants)||350
5334188|NCT00343252|13119364|P1|STARTED|18 Months (All Treated Participants)||360
5334189|NCT00343252|13119363|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
5334190|NCT00343252|13119364|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
5334191|NCT00343252|13119363|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
5334192|NCT00343252|13119364|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
5334193|NCT00343252|13119363|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
5334194|NCT00343252|13119364|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
5334195|NCT00343252|13119363|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
5334196|NCT00343252|13119364|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
5334197|NCT00343252|13119363|P2|COMPLETED|6 Months (All Treated Participants)||306
5334198|NCT00343252|13119364|P1|COMPLETED|6 Months (All Treated Participants)||304
5334199|NCT00343252|13119363|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
5334200|NCT00343252|13119364|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
5334201|NCT00343252|13119363|P2|NOT COMPLETED|All Randomized Participants||82
5334202|NCT00343252|13119364|P1|NOT COMPLETED|All Randomized Participants||102
5334203|NCT00343252|13119363|P2|COMPLETED|All Randomized Participants||269
5334204|NCT00343252|13119364|P1|COMPLETED|All Randomized Participants||259
5334205|NCT00343252|13119363|P2|STARTED|All Randomized Participants||351
5334206|NCT00343252|13119364|P1|STARTED|All Randomized Participants||361
5334207|NCT00343083|13119410|P1|NOT COMPLETED|Overall Study||21
5334208|NCT00343083|13119410|P1|COMPLETED|Overall Study||22
5334209|NCT00343083|13119410|P1|STARTED|Overall Study||43
5334210|NCT00343044|13119419|P1|NOT COMPLETED|Overall Study||0
5334211|NCT00343044|13119419|P1|COMPLETED|Overall Study||40
5334212|NCT00343044|13119419|P1|STARTED|Overall Study||40
5334213|NCT00342628|13119429|P3|NOT COMPLETED|Overall Study||19
5334214|NCT00342628|13119430|P2|NOT COMPLETED|Overall Study||21
5334215|NCT00342628|13119431|P1|NOT COMPLETED|Overall Study||20
5334216|NCT00342628|13119429|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
5334217|NCT00342628|13119430|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
5334218|NCT00342628|13119431|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
5334219|NCT00342628|13119429|P3|STARTED|Overall Study||100
5334220|NCT00342628|13119430|P2|STARTED|Overall Study||101
5334221|NCT00342628|13119431|P1|STARTED|Overall Study||100
5334222|NCT00342563|13119452|P4|NOT COMPLETED|Overall Study||6
5334223|NCT00342563|13119453|P3|NOT COMPLETED|Overall Study||14
5334224|NCT00342563|13119454|P2|NOT COMPLETED|Overall Study||8
5334225|NCT00342563|13119455|P1|NOT COMPLETED|Overall Study||6
5334226|NCT00342563|13119452|P4|COMPLETED|Overall Study||22
5334227|NCT00342563|13119453|P3|COMPLETED|Overall Study||26
5334228|NCT00342563|13119454|P2|COMPLETED|Overall Study||19
5334229|NCT00342563|13119455|P1|COMPLETED|Overall Study||35
5334230|NCT00342563|13119452|P4|STARTED|Overall Study||28
5334231|NCT00342563|13119453|P3|STARTED|Overall Study||40
5334232|NCT00342563|13119454|P2|STARTED|Overall Study||27
5334233|NCT00342563|13119455|P1|STARTED|Overall Study||41
5334234|NCT00342355|13119475|P4|NOT COMPLETED|Overall Study||0
5334235|NCT00342355|13119476|P3|NOT COMPLETED|Overall Study||0
5334236|NCT00342355|13119477|P2|NOT COMPLETED|Overall Study||0
5334237|NCT00342355|13119478|P1|NOT COMPLETED|Overall Study||0
5334238|NCT00342355|13119475|P4|COMPLETED|Overall Study||443
5334239|NCT00342355|13119476|P3|COMPLETED|Overall Study||444
5334240|NCT00342355|13119477|P2|COMPLETED|Overall Study||440
5334241|NCT00342355|13119478|P1|COMPLETED|Overall Study||444
5334242|NCT00342355|13119475|P4|STARTED|Overall Study||443
5334243|NCT00342355|13119476|P3|STARTED|Overall Study||444
5334244|NCT00342355|13119477|P2|STARTED|Overall Study||440
5334245|NCT00342355|13119478|P1|STARTED|Overall Study||444
5334246|NCT00340834|13119497|P5|NOT COMPLETED|Extension Phase of Study||44
5334247|NCT00340834|13119498|P4|NOT COMPLETED|Extension Phase of Study||53
5334248|NCT00340834|13119499|P3|NOT COMPLETED|Extension Phase of Study||0
5334249|NCT00340834|13119500|P2|NOT COMPLETED|Extension Phase of Study||76
5334250|NCT00340834|13119501|P1|NOT COMPLETED|Extension Phase of Study||85
5334251|NCT00340834|13119497|P5|COMPLETED|Extension Phase of Study||123
5334252|NCT00340834|13119498|P4|COMPLETED|Extension Phase of Study||123
5334253|NCT00340834|13119499|P3|COMPLETED|Extension Phase of Study||0
5334254|NCT00340834|13119500|P2|COMPLETED|Extension Phase of Study||281
5334255|NCT00340834|13119501|P1|COMPLETED|Extension Phase of Study||245
5334256|NCT00340834|13119497|P5|Received Study Drug|Extension Phase of Study||167
5334257|NCT00340834|13119498|P4|Received Study Drug|Extension Phase of Study||174
5334258|NCT00340834|13119499|P3|Received Study Drug|Extension Phase of Study||0
5334259|NCT00340834|13119500|P2|Received Study Drug|Extension Phase of Study||356
5334260|NCT00340834|13119501|P1|Received Study Drug|Extension Phase of Study||330
5334261|NCT00340834|13119497|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
5334262|NCT00340834|13119498|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
5334263|NCT00340834|13119499|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
5334264|NCT00340834|13119500|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
5334265|NCT00340834|13119501|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
5334266|NCT00340834|13119497|P5|NOT COMPLETED|Core Phase of Study||0
5334267|NCT00340834|13119498|P4|NOT COMPLETED|Core Phase of Study||0
5334268|NCT00340834|13119499|P3|NOT COMPLETED|Core Phase of Study||49
5334269|NCT00340834|13119500|P2|NOT COMPLETED|Core Phase of Study||33
5334270|NCT00340834|13119501|P1|NOT COMPLETED|Core Phase of Study||57
5334271|NCT00340834|13119497|P5|COMPLETED|Core Phase of Study||0
5334272|NCT00340834|13119498|P4|COMPLETED|Core Phase of Study||0
5334273|NCT00340834|13119499|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
5334274|NCT00340834|13119500|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
5334275|NCT00340834|13119501|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
5334276|NCT00340834|13119497|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
5334277|NCT00340834|13119498|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
5334278|NCT00340834|13119499|P3|STARTED|Core Phase of Study||435
5334279|NCT00340834|13119500|P2|STARTED|Core Phase of Study||431
5334280|NCT00340834|13119501|P1|STARTED|Core Phase of Study||426
5334281|NCT00340704|13119535|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
5334282|NCT00340704|13119536|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
5334283|NCT00340704|13119537|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
5334284|NCT00340704|13119538|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
5334285|NCT00340704|13119539|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
5334286|NCT00340704|13119540|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
5334287|NCT00340704|13119541|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334288|NCT00340704|13119542|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334289|NCT00340704|13119543|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334290|NCT00340704|13119535|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334291|NCT00340704|13119536|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
5334292|NCT00340704|13119537|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
5334293|NCT00340704|13119538|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
5334294|NCT00340704|13119539|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
5334295|NCT00340704|13119540|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
5334296|NCT00340704|13119541|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334297|NCT00340704|13119542|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334298|NCT00340704|13119543|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
5334299|NCT00340704|13119535|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334300|NCT00340704|13119536|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334301|NCT00340704|13119537|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334302|NCT00340704|13119538|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
5334303|NCT00340704|13119539|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
5334304|NCT00340704|13119540|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
5334305|NCT00340704|13119541|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334306|NCT00340704|13119542|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334307|NCT00340704|13119543|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
5334308|NCT00340704|13119535|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
5334309|NCT00340704|13119536|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
5334310|NCT00340704|13119537|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
5334311|NCT00340704|13119538|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
5334312|NCT00340704|13119539|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
5334313|NCT00340704|13119540|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
5334314|NCT00340704|13119541|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
5334315|NCT00340704|13119542|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
5334316|NCT00340704|13119543|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
5334317|NCT00340704|13119535|P9|NOT COMPLETED|PK Study||0
5334318|NCT00340704|13119536|P8|NOT COMPLETED|PK Study||0
5334319|NCT00340704|13119537|P7|NOT COMPLETED|PK Study||0
5334320|NCT00340704|13119538|P6|NOT COMPLETED|PK Study||0
5334321|NCT00340704|13119539|P5|NOT COMPLETED|PK Study||0
5334322|NCT00340704|13119540|P4|NOT COMPLETED|PK Study||0
5334323|NCT00340704|13119541|P3|NOT COMPLETED|PK Study||1
5334324|NCT00340704|13119542|P2|NOT COMPLETED|PK Study||1
5334325|NCT00340704|13119543|P1|NOT COMPLETED|PK Study||0
5334326|NCT00340704|13119535|P9|COMPLETED|PK Study||0
5334327|NCT00340704|13119536|P8|COMPLETED|PK Study||0
5334328|NCT00340704|13119537|P7|COMPLETED|PK Study||0
5334329|NCT00340704|13119538|P6|COMPLETED|PK Study||0
5334330|NCT00340704|13119539|P5|COMPLETED|PK Study||0
5334331|NCT00340704|13119540|P4|COMPLETED|PK Study||0
5334332|NCT00340704|13119541|P3|COMPLETED|PK Study||10
5334333|NCT00340704|13119542|P2|COMPLETED|PK Study||9
5334334|NCT00340704|13119543|P1|COMPLETED|PK Study||10
5334335|NCT00340704|13119535|P9|STARTED|PK Study||0
5334336|NCT00340704|13119536|P8|STARTED|PK Study||0
5334337|NCT00340704|13119537|P7|STARTED|PK Study||0
5334338|NCT00340704|13119538|P6|STARTED|PK Study||0
5334339|NCT00340704|13119539|P5|STARTED|PK Study||0
5334340|NCT00340704|13119540|P4|STARTED|PK Study||0
5334341|NCT00340704|13119541|P3|STARTED|PK Study||11
5334342|NCT00340704|13119542|P2|STARTED|PK Study||10
5334343|NCT00340704|13119543|P1|STARTED|PK Study||10
5334344|NCT00340678|13119649|P4|NOT COMPLETED|Overall Study||0
5334345|NCT00340678|13119650|P3|NOT COMPLETED|Overall Study||0
5334346|NCT00340678|13119651|P2|NOT COMPLETED|Overall Study||0
5334347|NCT00340678|13119652|P1|NOT COMPLETED|Overall Study||1
5334348|NCT00340678|13119649|P4|COMPLETED|Overall Study||39
5334349|NCT00340678|13119650|P3|COMPLETED|Overall Study||39
5334350|NCT00340678|13119651|P2|COMPLETED|Overall Study||46
5334351|NCT00340678|13119652|P1|COMPLETED|Overall Study||45
5334352|NCT00340678|13119649|P4|STARTED|Overall Study||39
5334353|NCT00340678|13119650|P3|STARTED|Overall Study||39
5334354|NCT00340678|13119651|P2|STARTED|Overall Study||46
5334355|NCT00340678|13119652|P1|STARTED|Overall Study||46
5334356|NCT00340379|13119666|P2|NOT COMPLETED|Overall Study||9
5334357|NCT00340379|13119667|P1|NOT COMPLETED|Overall Study||8
5334358|NCT00340379|13119666|P2|COMPLETED|Overall Study||28
5334359|NCT00340379|13119667|P1|COMPLETED|Overall Study||27
5334360|NCT00340379|13119666|P2|STARTED|Overall Study||37
5334361|NCT00340379|13119667|P1|STARTED|Overall Study||35
5334362|NCT00339833|13119679|P2|NOT COMPLETED|Overall Study||8
5334363|NCT00339833|13119680|P1|NOT COMPLETED|Overall Study||6
5334364|NCT00339833|13119679|P2|COMPLETED|Overall Study||18
5334365|NCT00339833|13119680|P1|COMPLETED|Overall Study||22
5334366|NCT00339833|13119679|P2|STARTED|Overall Study||26
5334367|NCT00339833|13119680|P1|STARTED|Overall Study||28
5334368|NCT00339183|13119690|P2|NOT COMPLETED|Overall Study||105
5334369|NCT00339183|13119691|P1|NOT COMPLETED|Overall Study||121
5334370|NCT00339183|13119690|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
5334371|NCT00339183|13119691|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
5334372|NCT00339183|13119690|P2|Received Study Drug|Overall Study||593
5334373|NCT00339183|13119691|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
5334374|NCT00339183|13119690|P2|STARTED|Overall Study||595
5334375|NCT00339183|13119691|P1|STARTED|Overall Study||591
5334376|NCT00339144|13119720|P3|NOT COMPLETED|Overall Study||4
5334377|NCT00339144|13119721|P2|NOT COMPLETED|Overall Study||3
5334378|NCT00339144|13119722|P1|NOT COMPLETED|Overall Study||9
5334379|NCT00339144|13119720|P3|COMPLETED|Overall Study||0
5334380|NCT00339144|13119721|P2|COMPLETED|Overall Study||0
5334381|NCT00339144|13119722|P1|COMPLETED|Overall Study||0
5334382|NCT00339144|13119720|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
5334383|NCT00339144|13119721|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
5334384|NCT00339144|13119722|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
5334385|NCT00339079|13119808|P4|NOT COMPLETED|Overall Study||24
5334386|NCT00339079|13119809|P3|NOT COMPLETED|Overall Study||18
5334387|NCT00339079|13119810|P2|NOT COMPLETED|Overall Study||23
5334388|NCT00339079|13119811|P1|NOT COMPLETED|Overall Study||33
5334389|NCT00339079|13119808|P4|COMPLETED|Overall Study||29
5334390|NCT00339079|13119809|P3|COMPLETED|Overall Study||27
5334391|NCT00339079|13119810|P2|COMPLETED|Overall Study||21
5334392|NCT00339079|13119811|P1|COMPLETED|Overall Study||20
5334393|NCT00339079|13119808|P4|STARTED|Overall Study||53
5334394|NCT00339079|13119809|P3|STARTED|Overall Study||45
5334395|NCT00339079|13119810|P2|STARTED|Overall Study||44
5334396|NCT00339079|13119811|P1|STARTED|Overall Study||53
5334397|NCT00339040|13119827|P2|NOT COMPLETED|Stage II||2
5334398|NCT00339040|13119828|P1|NOT COMPLETED|Stage II||10
5334399|NCT00339040|13119827|P2|COMPLETED|Stage II||27
5334400|NCT00339040|13119828|P1|COMPLETED|Stage II||84
5334401|NCT00339040|13119827|P2|Vaccination 6 at Week 120|Stage II||27
5334402|NCT00339040|13119828|P1|Vaccination 6 at Week 120|Stage II||0
5334403|NCT00339040|13119827|P2|Vaccination 5 at Week 104|Stage II||28
5334404|NCT00339040|13119828|P1|Vaccination 5 at Week 104|Stage II||0
5334405|NCT00339040|13119827|P2|Vaccination 4 at Week 96|Stage II||29
5334406|NCT00339040|13119828|P1|Vaccination 4 at Week 96|Stage II||84
5334407|NCT00339040|13119827|P2|STARTED|Stage II||29
5334408|NCT00339040|13119828|P1|STARTED|Stage II||94
5334409|NCT00339040|13119827|P2|NOT COMPLETED|Stage I||1
5334410|NCT00339040|13119828|P1|NOT COMPLETED|Stage I||2
5334411|NCT00339040|13119827|P2|COMPLETED|Stage I||29
5334412|NCT00339040|13119828|P1|COMPLETED|Stage I||94
5334413|NCT00339040|13119827|P2|Vaccination 3 at Week 24|Stage I||30
5334414|NCT00339040|13119828|P1|Vaccination 3 at Week 24|Stage I||94
5334415|NCT00339040|13119827|P2|Vaccination 2 at Week 8|Stage I||30
5334416|NCT00339040|13119828|P1|Vaccination 2 at Week 8|Stage I||95
5334417|NCT00339040|13119827|P2|Vaccination 1 at Week 0|Stage I||30
5334418|NCT00339040|13119828|P1|Vaccination 1 at Week 0|Stage I||96
5334419|NCT00339040|13119827|P2|STARTED|Stage I||30
5334420|NCT00339040|13119828|P1|STARTED|Stage I||96
5334421|NCT00338988|13119846|P1|NOT COMPLETED|Overall Study||1
5334422|NCT00338988|13119846|P1|COMPLETED|Overall Study||43
5334423|NCT00338988|13119846|P1|STARTED|Overall Study||44
5334424|NCT00338962|13119855|P4|NOT COMPLETED|Overall Study||3
5334425|NCT00338962|13119856|P3|NOT COMPLETED|Overall Study||6
5334426|NCT00338962|13119857|P2|NOT COMPLETED|Overall Study||4
5334427|NCT00338962|13119858|P1|NOT COMPLETED|Overall Study||8
5334428|NCT00338962|13119855|P4|COMPLETED|Overall Study||21
5334429|NCT00338962|13119856|P3|COMPLETED|Overall Study||16
5334430|NCT00338962|13119857|P2|COMPLETED|Overall Study||16
5334431|NCT00338962|13119858|P1|COMPLETED|Overall Study||14
5334432|NCT00338962|13119855|P4|STARTED|Overall Study||24
5334433|NCT00338962|13119856|P3|STARTED|Overall Study||22
5334434|NCT00338962|13119857|P2|STARTED|Overall Study||20
5334435|NCT00338962|13119858|P1|STARTED|Overall Study||22
5334436|NCT00338884|13119880|P1|NOT COMPLETED|Overall Study||78
5334437|NCT00338884|13119880|P1|COMPLETED|Overall Study||42
5334438|NCT00338884|13119880|P1|Received Treatment|Overall Study||119
5334439|NCT00338884|13119880|P1|STARTED|Overall Study||120
5334440|NCT00338806|13119914|P2|NOT COMPLETED|Follow-up||3
5334441|NCT00338806|13119915|P1|NOT COMPLETED|Follow-up||1
5334442|NCT00338806|13119914|P2|COMPLETED|Follow-up||1
5334443|NCT00338806|13119915|P1|COMPLETED|Follow-up||1
5334444|NCT00338806|13119914|P2|STARTED|Follow-up||4
5334445|NCT00338806|13119915|P1|STARTED|Follow-up||2
5334446|NCT00338806|13119914|P2|NOT COMPLETED|Acute Phase||1
5334447|NCT00338806|13119915|P1|NOT COMPLETED|Acute Phase||0
5334448|NCT00338806|13119914|P2|COMPLETED|Acute Phase||4
5334449|NCT00338806|13119915|P1|COMPLETED|Acute Phase||2
5334450|NCT00338806|13119914|P2|STARTED|Acute Phase||5
5334451|NCT00338806|13119915|P1|STARTED|Acute Phase||2
5334452|NCT00338741|13119977|P2|NOT COMPLETED|Overall Study||0
5334453|NCT00338741|13119978|P1|NOT COMPLETED|Overall Study||2
5334454|NCT00338741|13119977|P2|COMPLETED|Overall Study||2
5334455|NCT00338741|13119978|P1|COMPLETED|Overall Study||32
5334456|NCT00338741|13119977|P2|STARTED|Overall Study||2
5334457|NCT00338741|13119978|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
5334458|NCT00338728|13119986|P1|NOT COMPLETED|Overall Study||14
5334459|NCT00338728|13119986|P1|COMPLETED|Overall Study||45
5334460|NCT00338728|13119986|P1|STARTED|Overall Study||59
5334461|NCT00338598|13119993|P2|NOT COMPLETED|Overall Study||2
5334462|NCT00338598|13119994|P1|NOT COMPLETED|Overall Study||0
5334463|NCT00338598|13119993|P2|COMPLETED|Overall Study||8
5334464|NCT00338598|13119994|P1|COMPLETED|Overall Study||10
5334465|NCT00338598|13119993|P2|STARTED|Overall Study||10
5334466|NCT00338598|13119994|P1|STARTED|Overall Study||10
5334467|NCT00338455|13120014|P2|NOT COMPLETED|Overall Study||1
5334468|NCT00338455|13120015|P1|NOT COMPLETED|Overall Study||3
5334469|NCT00338455|13120014|P2|COMPLETED|Overall Study||6
5334470|NCT00338455|13120015|P1|COMPLETED|Overall Study||6
5334471|NCT00338455|13120014|P2|Administered Study Drug|Overall Study||7
5334472|NCT00338455|13120015|P1|Administered Study Drug|Overall Study||8
5334473|NCT00338455|13120014|P2|STARTED|Overall Study||7
5334474|NCT00338455|13120015|P1|STARTED|Overall Study||9
5334475|NCT00338286|13120029|P2|NOT COMPLETED|Overall Study||213
5334476|NCT00338286|13120030|P1|NOT COMPLETED|Overall Study||233
5334477|NCT00338286|13120029|P2|COMPLETED|Overall Study||837
5334478|NCT00338286|13120030|P1|COMPLETED|Overall Study||815
5334479|NCT00338286|13120029|P2|STARTED|Overall Study||1050
5334480|NCT00338286|13120030|P1|STARTED|Overall Study||1048
5334481|NCT00338104|13120047|P3|NOT COMPLETED|Overall Study||3
5334482|NCT00338104|13120048|P2|NOT COMPLETED|Overall Study||1
5334483|NCT00338104|13120049|P1|NOT COMPLETED|Overall Study||2
5334484|NCT00338104|13120047|P3|COMPLETED|Overall Study||22
5334485|NCT00338104|13120048|P2|COMPLETED|Overall Study||24
5334486|NCT00338104|13120049|P1|COMPLETED|Overall Study||23
5334487|NCT00338104|13120047|P3|STARTED|Overall Study||25
5334488|NCT00338104|13120048|P2|STARTED|Overall Study||25
5334489|NCT00338104|13120049|P1|STARTED|Overall Study||25
5334490|NCT00338039|13120060|P1|NOT COMPLETED|Overall Study||0
5334491|NCT00338039|13120060|P1|COMPLETED|Overall Study||69
5334492|NCT00338039|13120060|P1|STARTED|Overall Study||69
5334493|NCT00337987|13120065|P1|NOT COMPLETED|Overall Study||0
5334494|NCT00337987|13120065|P1|COMPLETED|Overall Study||49
5334495|NCT00337987|13120065|P1|STARTED|Overall Study||49
5334496|NCT00337935|13120072|P2|NOT COMPLETED|Overall Study||27
5334497|NCT00337935|13120073|P1|NOT COMPLETED|Overall Study||10
5334498|NCT00337935|13120072|P2|COMPLETED|Overall Study||91
5334499|NCT00337935|13120073|P1|COMPLETED|Overall Study||29
5334500|NCT00337935|13120072|P2|STARTED|Overall Study||118
5334501|NCT00337935|13120073|P1|STARTED|Overall Study||39
5334502|NCT00337818|13120086|P3|NOT COMPLETED|Overall Study||107
5334503|NCT00337818|13120087|P2|NOT COMPLETED|Overall Study||91
5334504|NCT00337818|13120088|P1|NOT COMPLETED|Overall Study||289
5334505|NCT00337818|13120086|P3|COMPLETED|Overall Study||51
5334506|NCT00337818|13120087|P2|COMPLETED|Overall Study||63
5334507|NCT00337818|13120088|P1|COMPLETED|Overall Study||169
5334508|NCT00337818|13120086|P3|STARTED|Overall Study||158
5334509|NCT00337818|13120087|P2|STARTED|Overall Study||154
5334510|NCT00337818|13120088|P1|STARTED|Overall Study||458
5334511|NCT00337779|13120110|P2|NOT COMPLETED|Overall Study||79
5334512|NCT00337779|13120111|P1|NOT COMPLETED|Overall Study||52
5334513|NCT00337779|13120110|P2|COMPLETED|Overall Study||490
5334514|NCT00337779|13120111|P1|COMPLETED|Overall Study||534
5334515|NCT00337779|13120110|P2|STARTED|Overall Study||569
5334516|NCT00337779|13120111|P1|STARTED|Overall Study||586
5334517|NCT00337727|13120123|P2|NOT COMPLETED|Overall Study||12
5334518|NCT00337727|13120124|P1|NOT COMPLETED|Overall Study||18
5334519|NCT00337727|13120123|P2|COMPLETED|Overall Study||406
5334520|NCT00337727|13120124|P1|COMPLETED|Overall Study||412
5334521|NCT00337727|13120123|P2|STARTED|Overall Study||418
5334522|NCT00337727|13120124|P1|STARTED|Overall Study||430
5334523|NCT00337675|13120135|P3|NOT COMPLETED|Overall Study||99
5334524|NCT00337675|13120136|P2|NOT COMPLETED|Overall Study||103
5334525|NCT00337675|13120137|P1|NOT COMPLETED|Overall Study||97
5334526|NCT00337675|13120135|P3|COMPLETED|Overall Study||492
5334527|NCT00337675|13120136|P2|COMPLETED|Overall Study||488
5334528|NCT00337675|13120137|P1|COMPLETED|Overall Study||492
5334529|NCT00337675|13120135|P3|STARTED|Overall Study||591
5334530|NCT00337675|13120136|P2|STARTED|Overall Study||591
5334531|NCT00337675|13120137|P1|STARTED|Overall Study||589
5334532|NCT00337662|13120154|P4|NOT COMPLETED|Study Period III||0
5334533|NCT00337662|13120155|P3|NOT COMPLETED|Study Period III||44
5334534|NCT00337662|13120156|P2|NOT COMPLETED|Study Period III||58
5334535|NCT00337662|13120157|P1|NOT COMPLETED|Study Period III||60
5334536|NCT00337662|13120154|P4|COMPLETED|Study Period III||0
5334537|NCT00337662|13120155|P3|COMPLETED|Study Period III||100
5334538|NCT00337662|13120156|P2|COMPLETED|Study Period III||134
5334539|NCT00337662|13120157|P1|COMPLETED|Study Period III||126
5334540|NCT00337662|13120154|P4|STARTED|Study Period III||0
5334541|NCT00337662|13120155|P3|STARTED|Study Period III||144
5334542|NCT00337662|13120156|P2|STARTED|Study Period III||192
5334543|NCT00337662|13120157|P1|STARTED|Study Period III||186
5334544|NCT00337662|13120154|P4|NOT COMPLETED|Study Period II||106
5334545|NCT00337662|13120155|P3|NOT COMPLETED|Study Period II||0
5334546|NCT00337662|13120156|P2|NOT COMPLETED|Study Period II||0
5334547|NCT00337662|13120157|P1|NOT COMPLETED|Study Period II||0
5334548|NCT00337662|13120154|P4|COMPLETED|Study Period II||522
5334549|NCT00337662|13120155|P3|COMPLETED|Study Period II||0
5334550|NCT00337662|13120156|P2|COMPLETED|Study Period II||0
5334551|NCT00337662|13120157|P1|COMPLETED|Study Period II||0
5334552|NCT00337662|13120154|P4|STARTED|Study Period II||628
5334553|NCT00337662|13120155|P3|STARTED|Study Period II||0
5334554|NCT00337662|13120156|P2|STARTED|Study Period II||0
5334555|NCT00337662|13120157|P1|STARTED|Study Period II||0
5334556|NCT00337610|13120211|P2|NOT COMPLETED|Overall Study||14
5334557|NCT00337610|13120212|P1|NOT COMPLETED|Overall Study||17
5334558|NCT00337610|13120211|P2|COMPLETED|Overall Study||80
5334559|NCT00337610|13120212|P1|COMPLETED|Overall Study||79
5334560|NCT00337610|13120211|P2|Completed Week 18|Overall Study||82
5334561|NCT00337610|13120212|P1|Completed Week 18|Overall Study||89
5334562|NCT00337610|13120211|P2|STARTED|Overall Study||94
5334563|NCT00337610|13120212|P1|STARTED|Overall Study||96
5334564|NCT00337571|13120228|P4|NOT COMPLETED|Overall Study||7
5334565|NCT00337571|13120229|P3|NOT COMPLETED|Overall Study||10
5334566|NCT00337571|13120230|P2|NOT COMPLETED|Overall Study||9
5334567|NCT00337571|13120231|P1|NOT COMPLETED|Overall Study||14
5334568|NCT00337571|13120228|P4|COMPLETED|Overall Study||47
5334569|NCT00337571|13120229|P3|COMPLETED|Overall Study||49
5334570|NCT00337571|13120230|P2|COMPLETED|Overall Study||44
5334571|NCT00337571|13120231|P1|COMPLETED|Overall Study||38
5334572|NCT00337571|13120228|P4|STARTED|Overall Study||54
5334573|NCT00337571|13120229|P3|STARTED|Overall Study||59
5334574|NCT00337571|13120230|P2|STARTED|Overall Study||53
5334575|NCT00337571|13120231|P1|STARTED|Overall Study||52
5334576|NCT00337467|13120269|P1|NOT COMPLETED|Overall Study||10
5334577|NCT00337467|13120269|P1|COMPLETED|Overall Study||51
5334578|NCT00337467|13120269|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
5334579|NCT00337467|13120269|P1|STARTED|Overall Study||61
5334580|NCT00337428|13120288|P2|NOT COMPLETED|Overall Study||3
5334581|NCT00337428|13120289|P1|NOT COMPLETED|Overall Study||4
5334582|NCT00337428|13120288|P2|COMPLETED|Overall Study||421
5334583|NCT00337428|13120289|P1|COMPLETED|Overall Study||415
5334584|NCT00337428|13120288|P2|STARTED|Overall Study||424
5334585|NCT00337428|13120289|P1|STARTED|Overall Study||419
5334586|NCT00337350|13120329|P2|NOT COMPLETED|Overall Study||1
5334587|NCT00337350|13120330|P1|NOT COMPLETED|Overall Study||1
5334588|NCT00337350|13120329|P2|COMPLETED|Overall Study||10
5334589|NCT00337350|13120330|P1|COMPLETED|Overall Study||8
5334590|NCT00337350|13120329|P2|STARTED|Overall Study||11
5334591|NCT00337350|13120330|P1|STARTED|Overall Study||9
5334592|NCT00337285|13120340|P1|NOT COMPLETED|Overall Study||158
5334593|NCT00337285|13120340|P1|COMPLETED|Overall Study||191
5334594|NCT00337285|13120340|P1|STARTED|Overall Study||349
5334595|NCT00337272|13120348|P2|NOT COMPLETED|Withdrawal Period||1
5334596|NCT00337272|13120349|P1|NOT COMPLETED|Withdrawal Period||0
5334597|NCT00337272|13120348|P2|COMPLETED|Withdrawal Period||6
5334598|NCT00337272|13120349|P1|COMPLETED|Withdrawal Period||6
5334599|NCT00337272|13120348|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
5334600|NCT00337272|13120349|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
5334601|NCT00337272|13120348|P2|NOT COMPLETED|Treatment Period||2
5334602|NCT00337272|13120349|P1|NOT COMPLETED|Treatment Period||1
5334603|NCT00337272|13120348|P2|COMPLETED|Treatment Period||7
5334604|NCT00337272|13120349|P1|COMPLETED|Treatment Period||6
5334605|NCT00337272|13120348|P2|Randomization|Treatment Period||9
5334606|NCT00337272|13120349|P1|Randomization|Treatment Period||7
5334607|NCT00337272|13120348|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
5334608|NCT00337272|13120349|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
5334609|NCT00337272|13120348|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
5334610|NCT00337272|13120349|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
5334611|NCT00337272|13120348|P2|COMPLETED|Screening Period (Pre-randomization)||0
5334612|NCT00337272|13120349|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
5334613|NCT00337272|13120348|P2|STARTED|Screening Period (Pre-randomization)||0
5334614|NCT00337272|13120349|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
5334615|NCT00337207|13120369|P1|NOT COMPLETED|Overall Study||3
5334616|NCT00337207|13120369|P1|COMPLETED|Overall Study||52
5334617|NCT00337207|13120369|P1|STARTED|Overall Study||55
5334618|NCT00337194|13120377|P2|NOT COMPLETED|Overall Study||4
5334619|NCT00337194|13120378|P1|NOT COMPLETED|Overall Study||12
5334620|NCT00337194|13120377|P2|COMPLETED|Overall Study||3
5334621|NCT00337194|13120378|P1|COMPLETED|Overall Study||11
5334622|NCT00337194|13120377|P2|STARTED|Overall Study||7
5334623|NCT00337194|13120378|P1|STARTED|Overall Study||23
5334624|NCT00337181|13120395|P2|NOT COMPLETED|Overall Study||0
5334625|NCT00337181|13120396|P1|NOT COMPLETED|Overall Study||0
5334626|NCT00337181|13120395|P2|COMPLETED|Overall Study||65
5334627|NCT00337181|13120396|P1|COMPLETED|Overall Study||49
5334628|NCT00337181|13120395|P2|STARTED|Overall Study||65
5334629|NCT00337181|13120396|P1|STARTED|Overall Study||49
5334630|NCT00337168|13120402|P1|NOT COMPLETED|Overall Study||8
5334631|NCT00337168|13120402|P1|COMPLETED|Overall Study||29
5334632|NCT00337168|13120402|P1|Eligible and Treated|Overall Study||36
5334633|NCT00337168|13120402|P1|Eligible|Overall Study||37
5334634|NCT00337168|13120402|P1|STARTED|Overall Study||37
5334635|NCT00337129|13120409|P1|NOT COMPLETED|Overall Study||40
5334636|NCT00337129|13120409|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
5334637|NCT00337129|13120409|P1|STARTED|Overall Study||40
5334638|NCT00337103|13120418|P2|NOT COMPLETED|Overall Study||548
5334639|NCT00337103|13120419|P1|NOT COMPLETED|Overall Study||554
5334640|NCT00337103|13120418|P2|COMPLETED|Overall Study||0
5334641|NCT00337103|13120419|P1|COMPLETED|Overall Study||0
5334642|NCT00337103|13120418|P2|Treated (Safety Population)|Overall Study||546
5334643|NCT00337103|13120419|P1|Treated (Safety Population)|Overall Study||544
5334644|NCT00337103|13120418|P2|STARTED|Overall Study||548
5334645|NCT00337103|13120419|P1|STARTED|Overall Study||554
5334646|NCT00337077|13120453|P3|NOT COMPLETED|Overall Study||25
5334647|NCT00337077|13120454|P2|NOT COMPLETED|Overall Study||53
5334648|NCT00337077|13120455|P1|NOT COMPLETED|Overall Study||43
5334649|NCT00337077|13120453|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
5334650|NCT00337077|13120454|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
5334651|NCT00337077|13120455|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
5334652|NCT00337077|13120453|P3|Patients With Measurable Disease|Overall Study||13
5334653|NCT00337077|13120454|P2|Patients With Measurable Disease|Overall Study||38
5334654|NCT00337077|13120455|P1|Patients With Measurable Disease|Overall Study||26
5334655|NCT00337077|13120453|P3|Eligible and Treated|Overall Study||24
5334656|NCT00337077|13120454|P2|Eligible and Treated|Overall Study||51
5334657|NCT00337077|13120455|P1|Eligible and Treated|Overall Study||41
5334658|NCT00337077|13120453|P3|Toxicity Assessed|Overall Study||25
5334659|NCT00337077|13120454|P2|Toxicity Assessed|Overall Study||51
5334660|NCT00337077|13120455|P1|Toxicity Assessed|Overall Study||42
5334661|NCT00337077|13120453|P3|Treated|Overall Study||25
5334662|NCT00337077|13120454|P2|Treated|Overall Study||52
5334663|NCT00337077|13120455|P1|Treated|Overall Study||42
5334664|NCT00337077|13120453|P3|STARTED|Overall Study||25
5334665|NCT00337077|13120454|P2|STARTED|Overall Study||53
5334666|NCT00337077|13120455|P1|STARTED|Overall Study||43
5334667|NCT00336973|13120464|P1|NOT COMPLETED|Overall Study||33
5334668|NCT00336973|13120464|P1|COMPLETED|Overall Study||33
5334669|NCT00336973|13120464|P1|STARTED|Overall Study||66
5334670|NCT00336895|13120470|P1|NOT COMPLETED|Overall Study||4
5334671|NCT00336895|13120470|P1|COMPLETED|Overall Study||26
5334672|NCT00336895|13120470|P1|STARTED|Overall Study||30
5334673|NCT00336856|13120476|P1|NOT COMPLETED|Overall Study||4
5334674|NCT00336856|13120476|P1|COMPLETED|Overall Study||31
5334675|NCT00336856|13120476|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
5334676|NCT00336817|13120484|P2|NOT COMPLETED|Overall Study||2
5334677|NCT00336817|13120485|P1|NOT COMPLETED|Overall Study||1
5334678|NCT00336817|13120484|P2|COMPLETED|Overall Study||13
5334679|NCT00336817|13120485|P1|COMPLETED|Overall Study||14
5334680|NCT00336817|13120484|P2|STARTED|Overall Study||15
5334681|NCT00336817|13120485|P1|STARTED|Overall Study||15
5334682|NCT00336700|13120515|P1|NOT COMPLETED|Overall Study||0
5334683|NCT00336700|13120515|P1|COMPLETED|Overall Study||25
5334684|NCT00336700|13120515|P1|STARTED|Overall Study||25
5334685|NCT00336583|13120524|P1|NOT COMPLETED|Overall Study||2
5334686|NCT00336583|13120524|P1|COMPLETED|Overall Study||25
5334687|NCT00336583|13120524|P1|STARTED|Overall Study||27
5334688|NCT00336544|13120531|P2|NOT COMPLETED|Overall Study||22
5334689|NCT00336544|13120532|P1|NOT COMPLETED|Overall Study||19
5334690|NCT00336544|13120531|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
5334691|NCT00336544|13120532|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
5334692|NCT00336544|13120531|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
5334693|NCT00336544|13120532|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
5334694|NCT00336505|13120546|P2|NOT COMPLETED|Overall Study||27
5334695|NCT00336505|13120547|P1|NOT COMPLETED|Overall Study||37
5334696|NCT00336505|13120546|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
5334697|NCT00336505|13120547|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
5334698|NCT00336505|13120546|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
5334699|NCT00336505|13120547|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
5334700|NCT00336492|13120562|P3|NOT COMPLETED|Overall Study||11
5334701|NCT00336492|13120563|P2|NOT COMPLETED|Overall Study||4
5334702|NCT00336492|13120564|P1|NOT COMPLETED|Overall Study||15
5334703|NCT00336492|13120562|P3|COMPLETED|Overall Study||12
5334704|NCT00336492|13120563|P2|COMPLETED|Overall Study||18
5334705|NCT00336492|13120564|P1|COMPLETED|Overall Study||0
5334706|NCT00336492|13120562|P3|STARTED|Overall Study||23
5334707|NCT00336492|13120563|P2|STARTED|Overall Study||22
5334708|NCT00336492|13120564|P1|STARTED|Overall Study||15
5334709|NCT00336479|13120576|P4|NOT COMPLETED|Overall Study||4
5334710|NCT00336479|13120577|P3|NOT COMPLETED|Overall Study||26
5334711|NCT00336479|13120578|P2|NOT COMPLETED|Overall Study||25
5334712|NCT00336479|13120579|P1|NOT COMPLETED|Overall Study||37
5334713|NCT00336479|13120576|P4|COMPLETED|Overall Study||13
5334714|NCT00336479|13120577|P3|COMPLETED|Overall Study||53
5334715|NCT00336479|13120578|P2|COMPLETED|Overall Study||54
5334716|NCT00336479|13120579|P1|COMPLETED|Overall Study||38
5334717|NCT00336479|13120576|P4|STARTED|Overall Study||17
5334718|NCT00336479|13120577|P3|STARTED|Overall Study||79
5334719|NCT00336479|13120578|P2|STARTED|Overall Study||79
5334720|NCT00336479|13120579|P1|STARTED|Overall Study||75
5334721|NCT00336323|13120607|P5|NOT COMPLETED|Overall Study||3
5334722|NCT00336323|13120608|P4|NOT COMPLETED|Overall Study||0
5334723|NCT00336323|13120609|P3|NOT COMPLETED|Overall Study||1
5334724|NCT00336323|13120610|P2|NOT COMPLETED|Overall Study||1
5334725|NCT00336323|13120611|P1|NOT COMPLETED|Overall Study||0
5334726|NCT00336323|13120607|P5|COMPLETED|Overall Study||19
5334727|NCT00336323|13120608|P4|COMPLETED|Overall Study||22
5334728|NCT00336323|13120609|P3|COMPLETED|Overall Study||23
5334729|NCT00336323|13120610|P2|COMPLETED|Overall Study||21
5334730|NCT00336323|13120611|P1|COMPLETED|Overall Study||19
5334731|NCT00336323|13120607|P5|24 Week Visit|Overall Study||19
5334732|NCT00336323|13120608|P4|24 Week Visit|Overall Study||22
5334733|NCT00336323|13120609|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
5334734|NCT00336323|13120610|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
5334735|NCT00336323|13120611|P1|24 Week Visit|Overall Study||18
5334736|NCT00336323|13120607|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
5334737|NCT00336323|13120608|P4|18 Week Visit|Overall Study||21
5334738|NCT00336323|13120609|P3|18 Week Visit|Overall Study||23
5334739|NCT00336323|13120610|P2|18 Week Visit|Overall Study||22
5334740|NCT00336323|13120611|P1|18 Week Visit|Overall Study||19
5334741|NCT00336323|13120607|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
5334742|NCT00336323|13120608|P4|12 Week Visit|Overall Study||22
5334743|NCT00336323|13120609|P3|12 Week Visit|Overall Study||24
5334744|NCT00336323|13120610|P2|12 Week Visit|Overall Study||21
5334745|NCT00336323|13120611|P1|12 Week Visit|Overall Study||19
5334746|NCT00336323|13120607|P5|9 Week Visit|Overall Study||19
5334747|NCT00336323|13120608|P4|9 Week Visit|Overall Study||21
5334748|NCT00336323|13120609|P3|9 Week Visit|Overall Study||23
5334749|NCT00336323|13120610|P2|9 Week Visit|Overall Study||21
5334750|NCT00336323|13120611|P1|9 Week Visit|Overall Study||18
5334751|NCT00336323|13120607|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
5334752|NCT00336323|13120608|P4|6 Week Visit|Overall Study||22
5334753|NCT00336323|13120609|P3|6 Week Visit|Overall Study||24
5334754|NCT00336323|13120610|P2|6 Week Visit|Overall Study||22
5334755|NCT00336323|13120611|P1|6 Week Visit|Overall Study||18
5334756|NCT00336323|13120607|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
5334757|NCT00336323|13120608|P4|3 Week Visit|Overall Study||22
5334758|NCT00336323|13120609|P3|3 Week Visit|Overall Study||24
5334759|NCT00336323|13120610|P2|3 Week Visit|Overall Study||21
5334760|NCT00336323|13120611|P1|3 Week Visit|Overall Study||18
5334761|NCT00336323|13120607|P5|STARTED|Overall Study||22
5334762|NCT00336323|13120608|P4|STARTED|Overall Study||22
5334763|NCT00336323|13120609|P3|STARTED|Overall Study||24
5334764|NCT00336323|13120610|P2|STARTED|Overall Study||22
5334765|NCT00336323|13120611|P1|STARTED|Overall Study||19
5334766|NCT00336284|13120668|P2|NOT COMPLETED|Overall Study||151
5334767|NCT00336284|13120669|P1|NOT COMPLETED|Overall Study||236
5334768|NCT00336284|13120668|P2|COMPLETED|Overall Study||322
5334769|NCT00336284|13120669|P1|COMPLETED|Overall Study||741
5334770|NCT00336284|13120668|P2|STARTED|Overall Study||473
5334771|NCT00336284|13120669|P1|STARTED|Overall Study||977
5334772|NCT00336232|13120681|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
5334773|NCT00336232|13120681|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
5334774|NCT00336232|13120681|P1|STARTED|High Vitamin K (500mcg Daily)||42
5334775|NCT00336232|13120681|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
5334776|NCT00336232|13120681|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
5334777|NCT00336232|13120681|P1|STARTED|Low Vitamin K (10mcg Daily)||42
5334778|NCT00336232|13120681|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
5334779|NCT00336232|13120681|P1|COMPLETED|Baseline (200mcg Daily)||42
5334780|NCT00336232|13120681|P1|STARTED|Baseline (200mcg Daily)||59
5334781|NCT00336024|13120687|P2|NOT COMPLETED|Overall Study||19
5334782|NCT00336024|13120688|P1|NOT COMPLETED|Overall Study||20
5334783|NCT00336024|13120687|P2|COMPLETED|Overall Study||26
5334784|NCT00336024|13120688|P1|COMPLETED|Overall Study||26
5334785|NCT00336024|13120687|P2|STARTED|Overall Study||45
5334786|NCT00336024|13120688|P1|STARTED|Overall Study||46
5334787|NCT00335972|13120724|P2|NOT COMPLETED|Overall Study||3
5334788|NCT00335972|13120725|P1|NOT COMPLETED|Overall Study||0
5334789|NCT00335972|13120724|P2|COMPLETED|Overall Study||68
5334790|NCT00335972|13120725|P1|COMPLETED|Overall Study||71
5334791|NCT00335972|13120724|P2|STARTED|Overall Study||71
5334792|NCT00335972|13120725|P1|STARTED|Overall Study||71
5334793|NCT00335959|13120735|P1|NOT COMPLETED|Overall Study||3
5334794|NCT00335959|13120735|P1|COMPLETED|Overall Study||4
5334795|NCT00335959|13120735|P1|Eligible and Began Protocol Therapy|Overall Study||6
5334796|NCT00335959|13120735|P1|Eligible|Overall Study||6
5334797|NCT00335959|13120735|P1|STARTED|Overall Study||7
5334798|NCT00335829|13120740|P1|NOT COMPLETED|Overall Study||3
5334799|NCT00335829|13120740|P1|COMPLETED|Overall Study||23
5334800|NCT00335829|13120740|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
5334801|NCT00335829|13120740|P1|Received Bevacizumab|Overall Study||26
5334802|NCT00335829|13120740|P1|STARTED|Overall Study||26
5334803|NCT00335777|13120754|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
5334804|NCT00335777|13120754|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
5334805|NCT00335777|13120754|P1|STARTED|Treated 2 Headaches Per Protocol||35
5334806|NCT00335777|13120754|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
5334807|NCT00335777|13120754|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
5334808|NCT00335777|13120754|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
5334809|NCT00335764|13120764|P5|NOT COMPLETED|Overall Study||1
5334810|NCT00335764|13120765|P4|NOT COMPLETED|Overall Study||0
5334811|NCT00335764|13120766|P3|NOT COMPLETED|Overall Study||0
5334812|NCT00335764|13120767|P2|NOT COMPLETED|Overall Study||0
5334813|NCT00335764|13120768|P1|NOT COMPLETED|Overall Study||1
5334814|NCT00335764|13120764|P5|COMPLETED|Overall Study||18
5334815|NCT00335764|13120765|P4|COMPLETED|Overall Study||19
5334816|NCT00335764|13120766|P3|COMPLETED|Overall Study||24
5334817|NCT00335764|13120767|P2|COMPLETED|Overall Study||13
5334818|NCT00335764|13120768|P1|COMPLETED|Overall Study||16
5334819|NCT00335764|13120764|P5|STARTED|Overall Study||19
5334820|NCT00335764|13120765|P4|STARTED|Overall Study||19
5334821|NCT00335764|13120766|P3|STARTED|Overall Study||24
5334822|NCT00335764|13120767|P2|STARTED|Overall Study||13
5334823|NCT00335764|13120768|P1|STARTED|Overall Study||17
5334824|NCT00335738|13120817|P2|NOT COMPLETED|Overall Study||4
5334825|NCT00335738|13120818|P1|NOT COMPLETED|Overall Study||11
5334826|NCT00335738|13120817|P2|COMPLETED|Overall Study||219
5334827|NCT00335738|13120818|P1|COMPLETED|Overall Study||97
5334828|NCT00335738|13120817|P2|STARTED|Overall Study||223
5334829|NCT00335738|13120818|P1|STARTED|Overall Study||108
5334830|NCT00335725|13120835|P2|NOT COMPLETED|Overall Study||5
5334831|NCT00335725|13120836|P1|NOT COMPLETED|Overall Study||4
5334832|NCT00335725|13120835|P2|COMPLETED|Overall Study||71
5334833|NCT00335725|13120836|P1|COMPLETED|Overall Study||71
5334834|NCT00335725|13120835|P2|STARTED|Overall Study||76
5334835|NCT00335725|13120836|P1|STARTED|Overall Study||75
5334836|NCT00335556|13120850|P6|NOT COMPLETED|Overall Study||1
5334837|NCT00335556|13120851|P5|NOT COMPLETED|Overall Study||1
5334838|NCT00335556|13120852|P4|NOT COMPLETED|Overall Study||5
5334839|NCT00335556|13120853|P3|NOT COMPLETED|Overall Study||5
5334840|NCT00335556|13120854|P2|NOT COMPLETED|Overall Study||34
5334841|NCT00335556|13120855|P1|NOT COMPLETED|Overall Study||2
5334842|NCT00335556|13120850|P6|COMPLETED|Overall Study||29
5334843|NCT00335556|13120851|P5|COMPLETED|Overall Study||77
5334844|NCT00335556|13120852|P4|COMPLETED|Overall Study||5
5334845|NCT00335556|13120853|P3|COMPLETED|Overall Study||2
5334846|NCT00335556|13120854|P2|COMPLETED|Overall Study||64
5334847|NCT00335556|13120855|P1|COMPLETED|Overall Study||66
5334848|NCT00335556|13120850|P6|STARTED|Overall Study||30
5334849|NCT00335556|13120851|P5|STARTED|Overall Study||78
5334850|NCT00335556|13120852|P4|STARTED|Overall Study||10
5334851|NCT00335556|13120853|P3|STARTED|Overall Study||7
5334852|NCT00335556|13120854|P2|STARTED|Overall Study||98
5334853|NCT00335556|13120855|P1|STARTED|Overall Study||68
5334854|NCT00335517|13120876|P1|NOT COMPLETED|Overall Study||2
5334855|NCT00335517|13120876|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
5334856|NCT00335517|13120876|P1|STARTED|Overall Study||100
5334857|NCT00335504|13120884|P4|NOT COMPLETED|Overall Study||0
5334858|NCT00335504|13120885|P3|NOT COMPLETED|Overall Study||0
5334859|NCT00335504|13120886|P2|NOT COMPLETED|Overall Study||0
5334860|NCT00335504|13120887|P1|NOT COMPLETED|Overall Study||0
5334861|NCT00335504|13120884|P4|COMPLETED|Overall Study||22
5334862|NCT00335504|13120885|P3|COMPLETED|Overall Study||20
5334863|NCT00335504|13120886|P2|COMPLETED|Overall Study||21
5334864|NCT00335504|13120887|P1|COMPLETED|Overall Study||22
5334865|NCT00335504|13120884|P4|STARTED|Overall Study||22
5334866|NCT00335504|13120885|P3|STARTED|Overall Study||20
5334867|NCT00335504|13120886|P2|STARTED|Overall Study||21
5334868|NCT00335504|13120887|P1|STARTED|Overall Study||22
5334869|NCT00335478|13120909|P1|NOT COMPLETED|Overall Study||24
5334870|NCT00335478|13120909|P1|COMPLETED|Overall Study||30
5334871|NCT00335478|13120909|P1|STARTED|Overall Study||54
5334872|NCT00335452|13120917|P4|NOT COMPLETED|Overall Study||131
5334873|NCT00335452|13120918|P3|NOT COMPLETED|Overall Study||159
5334874|NCT00335452|13120919|P2|NOT COMPLETED|Overall Study||147
5334875|NCT00335452|13120920|P1|NOT COMPLETED|Overall Study||158
5334876|NCT00335452|13120917|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
5334877|NCT00335452|13120918|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
5334878|NCT00335452|13120919|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
5334879|NCT00335452|13120920|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
5334880|NCT00335452|13120917|P4|TREATED WITH ASA|Overall Study||6247
5334881|NCT00335452|13120918|P3|TREATED WITH ASA|Overall Study||6261
5334882|NCT00335452|13120919|P2|TREATED WITH ASA|Overall Study||6251
5334883|NCT00335452|13120920|P1|TREATED WITH ASA|Overall Study||6302
5334884|NCT00335452|13120917|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
5334885|NCT00335452|13120918|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
5334886|NCT00335452|13120919|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
5334887|NCT00335452|13120920|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
5334888|NCT00335452|13120917|P4|STARTED|Overall Study|Randomized|6253
5334889|NCT00335452|13120918|P3|STARTED|Overall Study|Randomized|6267
5334890|NCT00335452|13120919|P2|STARTED|Overall Study|Randomized|6254
5334891|NCT00335452|13120920|P1|STARTED|Overall Study|Randomized|6312
5334892|NCT00335322|13120945|P3|NOT COMPLETED|Overall Study||2
5334893|NCT00335322|13120946|P2|NOT COMPLETED|Overall Study||2
5334894|NCT00335322|13120947|P1|NOT COMPLETED|Overall Study||1
5334895|NCT00335322|13120945|P3|COMPLETED|Overall Study||103
5334896|NCT00335322|13120946|P2|COMPLETED|Overall Study||105
5334897|NCT00335322|13120947|P1|COMPLETED|Overall Study||114
5334898|NCT00335322|13120945|P3|STARTED|Overall Study||105
5334899|NCT00335322|13120946|P2|STARTED|Overall Study||107
5334900|NCT00335322|13120947|P1|STARTED|Overall Study||115
5334901|NCT00335283|13120960|P2|NOT COMPLETED|Overall Study||5
5334902|NCT00335283|13120961|P1|NOT COMPLETED|Overall Study||6
5334903|NCT00335283|13120960|P2|COMPLETED|Overall Study||34
5334904|NCT00335283|13120961|P1|COMPLETED|Overall Study||30
5334905|NCT00335283|13120960|P2|STARTED|Overall Study||39
5334906|NCT00335283|13120961|P1|STARTED|Overall Study||36
5334907|NCT00335257|13120976|P3|NOT COMPLETED|Overall Study||0
5334908|NCT00335257|13120977|P2|NOT COMPLETED|Overall Study||0
5334909|NCT00335257|13120978|P1|NOT COMPLETED|Overall Study||0
5334910|NCT00335257|13120976|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
5334911|NCT00335257|13120977|P2|COMPLETED|Overall Study||9377
5334912|NCT00335257|13120978|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
5334913|NCT00335257|13120976|P3|STARTED|Overall Study||60190
5334914|NCT00335257|13120977|P2|STARTED|Overall Study||9377
5334915|NCT00335257|13120978|P1|STARTED|Overall Study||15542
5334916|NCT00335153|13120995|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
5334917|NCT00335153|13120995|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
5334918|NCT00335153|13120995|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
5334919|NCT00335153|13120995|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
5334920|NCT00335153|13120995|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
5334921|NCT00335153|13120995|P1|STARTED|Nasojejunal (NJ) Test Period||354
5334922|NCT00335140|13121032|P1|NOT COMPLETED|Overall Study||1
5334923|NCT00335140|13121032|P1|COMPLETED|Overall Study||25
5334924|NCT00335140|13121032|P1|Treated|Overall Study||25
5334925|NCT00335140|13121032|P1|Eligible|Overall Study||25
5334926|NCT00335140|13121032|P1|STARTED|Overall Study||26
5334927|NCT00334958|13121038|P2|NOT COMPLETED|Overall Study||24
5334928|NCT00334958|13121039|P1|NOT COMPLETED|Overall Study||37
5334929|NCT00334958|13121038|P2|COMPLETED|Overall Study||156
5334930|NCT00334958|13121039|P1|COMPLETED|Overall Study||139
5334931|NCT00334958|13121038|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
5334932|NCT00334958|13121039|P1|STARTED|Overall Study||176
5334933|NCT00334893|13121053|P2|NOT COMPLETED|Overall Study||0
5334934|NCT00334893|13121054|P1|NOT COMPLETED|Overall Study||1
5334935|NCT00334893|13121053|P2|COMPLETED|Overall Study||37
5334936|NCT00334893|13121054|P1|COMPLETED|Overall Study||36
5334937|NCT00334893|13121053|P2|STARTED|Overall Study||37
5334938|NCT00334893|13121054|P1|STARTED|Overall Study||37
5334939|NCT00334815|13121064|P2|NOT COMPLETED|Overall Study||10
5334940|NCT00334815|13121065|P1|NOT COMPLETED|Overall Study||7
5334941|NCT00334815|13121064|P2|COMPLETED|Overall Study||3
5334942|NCT00334815|13121065|P1|COMPLETED|Overall Study||9
5334943|NCT00334815|13121064|P2|STARTED|Overall Study||13
5334944|NCT00334815|13121065|P1|STARTED|Overall Study||16
5334945|NCT00334802|13121079|P2|NOT COMPLETED|Overall Study||40
5334946|NCT00334802|13121080|P1|NOT COMPLETED|Overall Study||6
5334947|NCT00334802|13121079|P2|COMPLETED|Overall Study||16
5334948|NCT00334802|13121080|P1|COMPLETED|Overall Study||0
5334949|NCT00334802|13121079|P2|STARTED|Overall Study||56
5334950|NCT00334802|13121080|P1|STARTED|Overall Study||6
5334951|NCT00334737|13121100|P3|NOT COMPLETED|Follow up Phase||6
5334952|NCT00334737|13121101|P2|NOT COMPLETED|Follow up Phase||3
5334953|NCT00334737|13121102|P1|NOT COMPLETED|Follow up Phase||5
5334954|NCT00334737|13121100|P3|COMPLETED|Follow up Phase||24
5334955|NCT00334737|13121101|P2|COMPLETED|Follow up Phase||29
5334956|NCT00334737|13121102|P1|COMPLETED|Follow up Phase||27
5334957|NCT00334737|13121100|P3|STARTED|Follow up Phase||30
5334958|NCT00334737|13121101|P2|STARTED|Follow up Phase||32
5334959|NCT00334737|13121102|P1|STARTED|Follow up Phase||32
5334960|NCT00334737|13121100|P3|NOT COMPLETED|Hospital Phase||4
5334961|NCT00334737|13121101|P2|NOT COMPLETED|Hospital Phase||2
5334962|NCT00334737|13121102|P1|NOT COMPLETED|Hospital Phase||2
5334963|NCT00334737|13121100|P3|COMPLETED|Hospital Phase||30
5334964|NCT00334737|13121101|P2|COMPLETED|Hospital Phase||32
5334965|NCT00334737|13121102|P1|COMPLETED|Hospital Phase||32
5334966|NCT00334737|13121100|P3|STARTED|Hospital Phase||34
5334967|NCT00334737|13121101|P2|STARTED|Hospital Phase||34
5334968|NCT00334737|13121102|P1|STARTED|Hospital Phase||34
5334969|NCT00334633|13121137|P3|NOT COMPLETED|Overall Study||82
5334970|NCT00334633|13121138|P2|NOT COMPLETED|Overall Study||82
5334971|NCT00334633|13121139|P1|NOT COMPLETED|Overall Study||80
5334972|NCT00334633|13121137|P3|COMPLETED|Overall Study||114
5334973|NCT00334633|13121138|P2|COMPLETED|Overall Study||118
5334974|NCT00334633|13121139|P1|COMPLETED|Overall Study||117
5334975|NCT00334633|13121137|P3|STARTED|Overall Study||196
5334976|NCT00334633|13121138|P2|STARTED|Overall Study||200
5334977|NCT00334633|13121139|P1|STARTED|Overall Study||197
5334978|NCT00334542|13121150|P1|NOT COMPLETED|Overall Study||5
5334979|NCT00334542|13121150|P1|COMPLETED|Overall Study||45
5334980|NCT00334542|13121150|P1|STARTED|Overall Study||50
5334981|NCT00334295|13121157|P1|NOT COMPLETED|Overall Study||5
5334982|NCT00334295|13121157|P1|COMPLETED|Overall Study||30
5334983|NCT00334295|13121157|P1|STARTED|Overall Study||35
5334984|NCT00334282|13121167|P2|NOT COMPLETED|Overall Study||108
5334985|NCT00334282|13121168|P1|NOT COMPLETED|Overall Study||222
5334986|NCT00334282|13121167|P2|COMPLETED|Overall Study||37
5334987|NCT00334282|13121168|P1|COMPLETED|Overall Study||68
5334988|NCT00334282|13121167|P2|STARTED|Overall Study||145
5334989|NCT00334282|13121168|P1|STARTED|Overall Study||290
5334990|NCT00334204|13121191|P1|NOT COMPLETED|Overall Study||2
5334991|NCT00334204|13121191|P1|COMPLETED|Overall Study||56
5334992|NCT00334204|13121191|P1|STARTED|Overall Study||58
5334993|NCT00334113|13121199|P2|NOT COMPLETED|Overall Study||3
5334994|NCT00334113|13121200|P1|NOT COMPLETED|Overall Study||2
5334995|NCT00334113|13121199|P2|COMPLETED|Overall Study||31
5334996|NCT00334113|13121200|P1|COMPLETED|Overall Study||30
5334997|NCT00334113|13121199|P2|STARTED|Overall Study||34
5334998|NCT00334113|13121200|P1|STARTED|Overall Study||32
5334999|NCT00334074|13121206|P1|NOT COMPLETED|Overall Study||0
5335000|NCT00334074|13121206|P1|COMPLETED|Overall Study||30
5335001|NCT00334074|13121206|P1|STARTED|Overall Study||30
5335002|NCT00334061|13121211|P1|NOT COMPLETED|Overall Study||0
5335003|NCT00334061|13121211|P1|COMPLETED|Overall Study|November 2007|125
5335004|NCT00334061|13121211|P1|STARTED|Overall Study|June 2006|125
5335005|NCT00333983|13121223|P3|NOT COMPLETED|Overall Study||2
5335006|NCT00333983|13121224|P2|NOT COMPLETED|Overall Study||5
5335007|NCT00333983|13121225|P1|NOT COMPLETED|Overall Study||3
5335008|NCT00333983|13121223|P3|COMPLETED|Overall Study||19
5335009|NCT00333983|13121224|P2|COMPLETED|Overall Study||16
5335010|NCT00333983|13121225|P1|COMPLETED|Overall Study||17
5335011|NCT00333983|13121223|P3|STARTED|Overall Study||21
5335012|NCT00333983|13121224|P2|STARTED|Overall Study||21
5335013|NCT00333983|13121225|P1|STARTED|Overall Study||20
5335014|NCT00333970|13121235|P2|NOT COMPLETED|Overall Study||7
5335015|NCT00333970|13121236|P1|NOT COMPLETED|Overall Study||13
5335016|NCT00333970|13121235|P2|COMPLETED|Overall Study||18
5335017|NCT00333970|13121236|P1|COMPLETED|Overall Study||37
5335018|NCT00333970|13121235|P2|STARTED|Overall Study||25
5335019|NCT00333970|13121236|P1|STARTED|Overall Study||50
5335020|NCT00333879|13121242|P1|NOT COMPLETED|Overall Study||0
5335021|NCT00333879|13121242|P1|COMPLETED|Overall Study||4
5335022|NCT00333879|13121242|P1|STARTED|Overall Study||4
5335023|NCT00333866|13121251|P4|NOT COMPLETED|Overall Study||66
5335024|NCT00333866|13121252|P3|NOT COMPLETED|Overall Study||51
5335025|NCT00333866|13121253|P2|NOT COMPLETED|Overall Study||64
5335026|NCT00333866|13121254|P1|NOT COMPLETED|Overall Study||48
5335027|NCT00333866|13121251|P4|COMPLETED|Overall Study||121
5335028|NCT00333866|13121252|P3|COMPLETED|Overall Study||133
5335029|NCT00333866|13121253|P2|COMPLETED|Overall Study||123
5335030|NCT00333866|13121254|P1|COMPLETED|Overall Study||141
5335031|NCT00333866|13121251|P4|TREATED|Overall Study||186
5335032|NCT00333866|13121252|P3|TREATED|Overall Study||182
5335033|NCT00333866|13121253|P2|TREATED|Overall Study||184
5335034|NCT00333866|13121254|P1|TREATED|Overall Study||184
5335035|NCT00333866|13121251|P4|STARTED|Overall Study||187
5335036|NCT00333866|13121252|P3|STARTED|Overall Study||184
5335037|NCT00333866|13121253|P2|STARTED|Overall Study||187
5335038|NCT00333866|13121254|P1|STARTED|Overall Study||189
5335039|NCT00333840|13121314|P4|NOT COMPLETED|Second-line Treatment Period||188
5335040|NCT00333840|13121315|P3|NOT COMPLETED|Second-line Treatment Period||14
5335041|NCT00333840|13121316|P2|NOT COMPLETED|Second-line Treatment Period||0
5335042|NCT00333840|13121317|P1|NOT COMPLETED|Second-line Treatment Period||0
5335043|NCT00333840|13121314|P4|COMPLETED|Second-line Treatment Period||175
5335044|NCT00333840|13121315|P3|COMPLETED|Second-line Treatment Period||0
5335045|NCT00333840|13121316|P2|COMPLETED|Second-line Treatment Period||0
5335046|NCT00333840|13121317|P1|COMPLETED|Second-line Treatment Period||0
5335047|NCT00333840|13121314|P4|STARTED|Second-line Treatment Period||363
5335048|NCT00333840|13121315|P3|STARTED|Second-line Treatment Period||14
5335049|NCT00333840|13121316|P2|STARTED|Second-line Treatment Period||0
5335050|NCT00333840|13121317|P1|STARTED|Second-line Treatment Period||0
5335051|NCT00333840|13121314|P4|NOT COMPLETED|First-line Treatment Period||0
5335052|NCT00333840|13121315|P3|NOT COMPLETED|First-line Treatment Period||0
5335053|NCT00333840|13121316|P2|NOT COMPLETED|First-line Treatment Period||546
5335054|NCT00333840|13121317|P1|NOT COMPLETED|First-line Treatment Period||286
5335055|NCT00333840|13121314|P4|COMPLETED|First-line Treatment Period||0
5335056|NCT00333840|13121315|P3|COMPLETED|First-line Treatment Period||0
5335057|NCT00333840|13121316|P2|COMPLETED|First-line Treatment Period||7
5335058|NCT00333840|13121317|P1|COMPLETED|First-line Treatment Period||267
5335059|NCT00333840|13121314|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
5335060|NCT00333840|13121315|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
5335061|NCT00333840|13121316|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
5335062|NCT00333840|13121317|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
5335063|NCT00333840|13121314|P4|STARTED|First-line Treatment Period||0
5335064|NCT00333840|13121315|P3|STARTED|First-line Treatment Period||0
5335065|NCT00333840|13121316|P2|STARTED|First-line Treatment Period||553
5335066|NCT00333840|13121317|P1|STARTED|First-line Treatment Period||553
5335067|NCT00333814|13121345|P3|NOT COMPLETED|Overall Study||5
5335068|NCT00333814|13121346|P2|NOT COMPLETED|Overall Study||4
5335069|NCT00333814|13121347|P1|NOT COMPLETED|Overall Study||3
5335070|NCT00333814|13121345|P3|COMPLETED|Overall Study||71
5335071|NCT00333814|13121346|P2|COMPLETED|Overall Study||73
5335072|NCT00333814|13121347|P1|COMPLETED|Overall Study||73
5335073|NCT00333814|13121345|P3|STARTED|Overall Study||76
5335074|NCT00333814|13121346|P2|STARTED|Overall Study||77
5335075|NCT00333814|13121347|P1|STARTED|Overall Study||76
5335076|NCT00333801|13121363|P2|NOT COMPLETED|Overall Study||6
5335077|NCT00333801|13121364|P1|NOT COMPLETED|Overall Study||8
5335078|NCT00333801|13121363|P2|COMPLETED|Overall Study||36
5335079|NCT00333801|13121364|P1|COMPLETED|Overall Study||35
5335080|NCT00333801|13121363|P2|STARTED|Overall Study||42
5335081|NCT00333801|13121364|P1|STARTED|Overall Study||43
5335082|NCT00333788|13121382|P1|NOT COMPLETED|Overall Study||162
5335083|NCT00333788|13121382|P1|COMPLETED|Overall Study||71
5335084|NCT00333788|13121382|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
5335085|NCT00333775|13121412|P3|NOT COMPLETED|Overall Study||247
5335086|NCT00333775|13121413|P2|NOT COMPLETED|Overall Study||248
5335087|NCT00333775|13121414|P1|NOT COMPLETED|Overall Study||241
5335088|NCT00333775|13121412|P3|COMPLETED|Overall Study||0
5335089|NCT00333775|13121413|P2|COMPLETED|Overall Study||0
5335090|NCT00333775|13121414|P1|COMPLETED|Overall Study||0
5335091|NCT00333775|13121412|P3|Received Treatment|Overall Study||245
5335092|NCT00333775|13121413|P2|Received Treatment|Overall Study||247
5335093|NCT00333775|13121414|P1|Received Treatment|Overall Study||238
5335094|NCT00333775|13121412|P3|STARTED|Overall Study||247
5335095|NCT00333775|13121413|P2|STARTED|Overall Study||248
5335096|NCT00333775|13121414|P1|STARTED|Overall Study||241
5335097|NCT00333762|13121434|P1|NOT COMPLETED|Overall Study||4
5335098|NCT00333762|13121434|P1|COMPLETED|Overall Study||0
5335099|NCT00333762|13121434|P1|STARTED|Overall Study||4
5335100|NCT00333710|13121441|P3|NOT COMPLETED|Overall Study||1
5335101|NCT00333710|13121442|P2|NOT COMPLETED|Overall Study||4
5335102|NCT00333710|13121443|P1|NOT COMPLETED|Overall Study||11
5335103|NCT00333710|13121441|P3|COMPLETED|Overall Study||15
5335104|NCT00333710|13121442|P2|COMPLETED|Overall Study||14
5335105|NCT00333710|13121443|P1|COMPLETED|Overall Study||8
5335106|NCT00333710|13121441|P3|STARTED|Overall Study||16
5335107|NCT00333710|13121442|P2|STARTED|Overall Study||18
5335108|NCT00333710|13121443|P1|STARTED|Overall Study||19
5335109|NCT00333619|13121453|P2|NOT COMPLETED|Overall Study||10
5335110|NCT00333619|13121454|P1|NOT COMPLETED|Overall Study||21
5335111|NCT00333619|13121453|P2|COMPLETED|Overall Study||99
5335112|NCT00333619|13121454|P1|COMPLETED|Overall Study||89
5335113|NCT00333619|13121453|P2|3-month Follow-up|Overall Study||105
5335114|NCT00333619|13121454|P1|3-month Follow-up|Overall Study||101
5335115|NCT00333619|13121453|P2|Post-treatment|Overall Study||109
5335116|NCT00333619|13121454|P1|Post-treatment|Overall Study||109
5335117|NCT00333619|13121453|P2|STARTED|Overall Study||109
5335118|NCT00333619|13121454|P1|STARTED|Overall Study||110
5335119|NCT00333606|13121464|P2|NOT COMPLETED|Overall Study||0
5335120|NCT00333606|13121465|P1|NOT COMPLETED|Overall Study||0
5335121|NCT00333606|13121464|P2|COMPLETED|Overall Study||30
5335122|NCT00333606|13121465|P1|COMPLETED|Overall Study||30
5335123|NCT00333606|13121464|P2|STARTED|Overall Study||30
5335124|NCT00333606|13121465|P1|STARTED|Overall Study||30
5335125|NCT00333437|13121473|P1|NOT COMPLETED|Overall Study||0
5335126|NCT00333437|13121473|P1|COMPLETED|Overall Study||7
5335127|NCT00333437|13121473|P1|STARTED|Overall Study||7
5335128|NCT00333359|13121483|P2|NOT COMPLETED|Overall Study||122
5335129|NCT00333359|13121484|P1|NOT COMPLETED|Overall Study||73
5335130|NCT00333359|13121483|P2|COMPLETED|Overall Study||260
5335131|NCT00333359|13121484|P1|COMPLETED|Overall Study||126
5335132|NCT00333359|13121483|P2|STARTED|Overall Study||382
5335133|NCT00333359|13121484|P1|STARTED|Overall Study||199
5335134|NCT00333229|13121527|P2|NOT COMPLETED|Overall Study||1
5335135|NCT00333229|13121528|P1|NOT COMPLETED|Overall Study||0
5335136|NCT00333229|13121527|P2|COMPLETED|Overall Study||4
5335137|NCT00333229|13121528|P1|COMPLETED|Overall Study||6
5335138|NCT00333229|13121527|P2|STARTED|Overall Study||5
5335139|NCT00333229|13121528|P1|STARTED|Overall Study||6
5335140|NCT00333177|13121546|P4|NOT COMPLETED|Overall Study||2
5335141|NCT00333177|13121547|P3|NOT COMPLETED|Overall Study||1
5335142|NCT00333177|13121548|P2|NOT COMPLETED|Overall Study||1
5335143|NCT00333177|13121549|P1|NOT COMPLETED|Overall Study||0
5335144|NCT00333177|13121546|P4|COMPLETED|Overall Study||12
5335145|NCT00333177|13121547|P3|COMPLETED|Overall Study||16
5335146|NCT00333177|13121548|P2|COMPLETED|Overall Study||16
5335147|NCT00333177|13121549|P1|COMPLETED|Overall Study||12
5335148|NCT00333177|13121546|P4|Received Intervention|Overall Study||12
5335149|NCT00333177|13121547|P3|Received Intervention|Overall Study||16
5335150|NCT00333177|13121548|P2|Received Intervention|Overall Study||16
5335151|NCT00333177|13121549|P1|Received Intervention|Overall Study||12
5335152|NCT00333177|13121546|P4|STARTED|Overall Study||14
5335153|NCT00333177|13121547|P3|STARTED|Overall Study||17
5335154|NCT00333177|13121548|P2|STARTED|Overall Study||17
5335155|NCT00333177|13121549|P1|STARTED|Overall Study||12
5335156|NCT00333138|13121598|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
5335157|NCT00333138|13121599|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
5335158|NCT00333138|13121600|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
5335159|NCT00333138|13121598|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
5335160|NCT00333138|13121599|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
5335161|NCT00333138|13121600|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
5335162|NCT00333138|13121598|P3|STARTED|Extension Study (Month6 to End of Study)||80
5335163|NCT00333138|13121599|P2|STARTED|Extension Study (Month6 to End of Study)||87
5335164|NCT00333138|13121600|P1|STARTED|Extension Study (Month6 to End of Study)||83
5335165|NCT00333138|13121598|P3|NOT COMPLETED|Core Study (6 Months)||12
5335166|NCT00333138|13121599|P2|NOT COMPLETED|Core Study (6 Months)||6
5335167|NCT00333138|13121600|P1|NOT COMPLETED|Core Study (6 Months)||7
5335168|NCT00333138|13121598|P3|COMPLETED|Core Study (6 Months)||82
5335169|NCT00333138|13121599|P2|COMPLETED|Core Study (6 Months)||88
5335170|NCT00333138|13121600|P1|COMPLETED|Core Study (6 Months)||86
5335171|NCT00333138|13121598|P3|STARTED|Core Study (6 Months)||94
5335172|NCT00333138|13121599|P2|STARTED|Core Study (6 Months)||94
5335173|NCT00333138|13121600|P1|STARTED|Core Study (6 Months)||93
5335174|NCT00332839|13121639|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
5335175|NCT00332839|13121640|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
5335176|NCT00332839|13121639|P2|COMPLETED|Follow-up (Months 12 - 60)||31
5335177|NCT00332839|13121640|P1|COMPLETED|Follow-up (Months 12 - 60)||29
5335178|NCT00332839|13121639|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
5335179|NCT00332839|13121640|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
5335180|NCT00332839|13121639|P2|NOT COMPLETED|Core (Months 0 - 12)||18
5335181|NCT00332839|13121640|P1|NOT COMPLETED|Core (Months 0 - 12)||10
5335182|NCT00332839|13121639|P2|COMPLETED|Core (Months 0 - 12)||28
5335183|NCT00332839|13121640|P1|COMPLETED|Core (Months 0 - 12)||37
5335184|NCT00332839|13121639|P2|Safety Set|Core (Months 0 - 12)||46
5335185|NCT00332839|13121640|P1|Safety Set|Core (Months 0 - 12)||47
5335186|NCT00332839|13121639|P2|STARTED|Core (Months 0 - 12)||46
5335187|NCT00332839|13121640|P1|STARTED|Core (Months 0 - 12)||47
5335188|NCT00332722|13121660|P2|NOT COMPLETED|Overall Study||0
5335189|NCT00332722|13121661|P1|NOT COMPLETED|Overall Study||0
5335190|NCT00332722|13121660|P2|COMPLETED|Overall Study||60
5335191|NCT00332722|13121661|P1|COMPLETED|Overall Study||60
5335192|NCT00332722|13121660|P2|STARTED|Overall Study||60
5335193|NCT00332722|13121661|P1|STARTED|Overall Study||60
5335194|NCT00332709|13121671|P2|NOT COMPLETED|Overall Study||20
5335195|NCT00332709|13121672|P1|NOT COMPLETED|Overall Study||16
5335196|NCT00332709|13121671|P2|COMPLETED|Overall Study||21
5335197|NCT00332709|13121672|P1|COMPLETED|Overall Study||24
5335198|NCT00332709|13121671|P2|STARTED|Overall Study||41
5335199|NCT00332709|13121672|P1|STARTED|Overall Study||40
5335200|NCT00332696|13121696|P2|NOT COMPLETED|Overall Study||30
5335201|NCT00332696|13121697|P1|NOT COMPLETED|Overall Study||30
5335202|NCT00332696|13121696|P2|COMPLETED|Overall Study||2
5335203|NCT00332696|13121697|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
5335204|NCT00332696|13121696|P2|Completed Day 14 Visit|Overall Study||15
5335205|NCT00332696|13121697|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
5335206|NCT00332696|13121696|P2|STARTED|Overall Study||32
5335207|NCT00332696|13121697|P1|STARTED|Overall Study||32
5335208|NCT00332644|13121729|P6|NOT COMPLETED|Overall Study||15
5335209|NCT00332644|13121730|P5|NOT COMPLETED|Overall Study||12
5335210|NCT00332644|13121731|P4|NOT COMPLETED|Overall Study||20
5335211|NCT00332644|13121732|P3|NOT COMPLETED|Overall Study||9
5335212|NCT00332644|13121733|P2|NOT COMPLETED|Overall Study||22
5335213|NCT00332644|13121734|P1|NOT COMPLETED|Overall Study||12
5335214|NCT00332644|13121729|P6|COMPLETED|Overall Study||174
5335215|NCT00332644|13121730|P5|COMPLETED|Overall Study||250
5335216|NCT00332644|13121731|P4|COMPLETED|Overall Study||244
5335217|NCT00332644|13121732|P3|COMPLETED|Overall Study||258
5335218|NCT00332644|13121733|P2|COMPLETED|Overall Study||238
5335219|NCT00332644|13121734|P1|COMPLETED|Overall Study||250
5335220|NCT00332644|13121729|P6|STARTED|Overall Study||189
5335221|NCT00332644|13121730|P5|STARTED|Overall Study||262
5335222|NCT00332644|13121731|P4|STARTED|Overall Study||264
5335223|NCT00332644|13121732|P3|STARTED|Overall Study||267
5335224|NCT00332644|13121733|P2|STARTED|Overall Study||260
5335225|NCT00332644|13121734|P1|STARTED|Overall Study||262
5335226|NCT00332605|13121751|P3|NOT COMPLETED|Overall Study||8
5335227|NCT00332605|13121752|P2|NOT COMPLETED|Overall Study||2
5335228|NCT00332605|13121753|P1|NOT COMPLETED|Overall Study||2
5335229|NCT00332605|13121751|P3|COMPLETED|Overall Study||9
5335230|NCT00332605|13121752|P2|COMPLETED|Overall Study||12
5335231|NCT00332605|13121753|P1|COMPLETED|Overall Study||12
5335232|NCT00332605|13121751|P3|STARTED|Overall Study||17
5335233|NCT00332605|13121752|P2|STARTED|Overall Study||14
5335234|NCT00332605|13121753|P1|STARTED|Overall Study||14
5335235|NCT00332579|13121763|P2|NOT COMPLETED|Overall Study||1
5335236|NCT00332579|13121764|P1|NOT COMPLETED|Overall Study||1
5335237|NCT00332579|13121763|P2|COMPLETED|Overall Study||12
5335238|NCT00332579|13121764|P1|COMPLETED|Overall Study||11
5335239|NCT00332579|13121763|P2|STARTED|Overall Study||13
5335240|NCT00332579|13121764|P1|STARTED|Overall Study||12
5335241|NCT00332488|13121773|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
5335242|NCT00332488|13121774|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
5335243|NCT00332488|13121775|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
5335244|NCT00332488|13121773|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
5335245|NCT00332488|13121774|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
5335246|NCT00332488|13121775|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
5335247|NCT00332488|13121773|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
5335248|NCT00332488|13121774|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
5335249|NCT00332488|13121775|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
5335250|NCT00332488|13121773|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
5335251|NCT00332488|13121774|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
5335252|NCT00332488|13121775|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
5335253|NCT00332488|13121773|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
5335254|NCT00332488|13121774|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
5335255|NCT00332488|13121775|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
5335256|NCT00332488|13121773|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
5335257|NCT00332488|13121774|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
5335258|NCT00332488|13121775|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
5335259|NCT00332462|13121787|P1|NOT COMPLETED|Overall Study||16
5335260|NCT00332462|13121787|P1|COMPLETED|Overall Study||18
5335261|NCT00332462|13121787|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
5335262|NCT00332462|13121787|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
5335263|NCT00332462|13121787|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
5335264|NCT00332332|13121794|P1|NOT COMPLETED|Overall Study||68
5335265|NCT00332332|13121794|P1|COMPLETED|Overall Study||178
5335266|NCT00332332|13121794|P1|Received Study Medication|Overall Study||230
5335267|NCT00332332|13121794|P1|STARTED|Overall Study||246
5335268|NCT00332241|13121803|P2|NOT COMPLETED|Overall Study||8
5335269|NCT00332241|13121804|P1|NOT COMPLETED|Overall Study||15
5335270|NCT00332241|13121803|P2|COMPLETED|Overall Study||39
5335271|NCT00332241|13121804|P1|COMPLETED|Overall Study||36
5335272|NCT00332241|13121803|P2|STARTED|Overall Study||47
5335273|NCT00332241|13121804|P1|STARTED|Overall Study||51
5335274|NCT00332202|13121826|P2|NOT COMPLETED|Overall Study||125
5335275|NCT00332202|13121827|P1|NOT COMPLETED|Overall Study||241
5335276|NCT00332202|13121826|P2|COMPLETED|Overall Study||129
5335277|NCT00332202|13121827|P1|COMPLETED|Overall Study||263
5335278|NCT00332202|13121826|P2|Received At Least One Dose of Study Drug|Overall Study||249
5335279|NCT00332202|13121827|P1|Received At Least One Dose of Study Drug|Overall Study||493
5335280|NCT00332202|13121826|P2|STARTED|Overall Study||254
5335281|NCT00332202|13121827|P1|STARTED|Overall Study||504
5335282|NCT00332189|13121856|P1|NOT COMPLETED|Overall Study||21
5335283|NCT00332189|13121856|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
5335284|NCT00332189|13121856|P1|STARTED|Overall Study||111
5335285|NCT00332163|13121863|P2|NOT COMPLETED|Overall Study||0
5335286|NCT00332163|13121864|P1|NOT COMPLETED|Overall Study||0
5335287|NCT00332163|13121863|P2|COMPLETED|Overall Study||47
5335288|NCT00332163|13121864|P1|COMPLETED|Overall Study||48
5335289|NCT00332163|13121863|P2|Received Treatment|Overall Study||47
5335290|NCT00332163|13121864|P1|Received Treatment|Overall Study||48
5335291|NCT00332163|13121863|P2|STARTED|Overall Study||47
5335292|NCT00332163|13121864|P1|STARTED|Overall Study||48
5335293|NCT00331864|13121898|P2|NOT COMPLETED|Overall Study||4
5335294|NCT00331864|13121899|P1|NOT COMPLETED|Overall Study||58
5335295|NCT00331864|13121898|P2|COMPLETED|Overall Study||14
5335296|NCT00331864|13121899|P1|COMPLETED|Overall Study||455
5335297|NCT00331864|13121898|P2|STARTED|Overall Study||18
5335298|NCT00331864|13121899|P1|STARTED|Overall Study||513
5335299|NCT00331799|13121918|P1|NOT COMPLETED|Overall Study||3
5335300|NCT00331799|13121918|P1|COMPLETED|Overall Study||15
5335301|NCT00331799|13121918|P1|STARTED|Overall Study||18
5335302|NCT00331773|13121924|P2|NOT COMPLETED|Overall Study||7
5335303|NCT00331773|13121925|P1|NOT COMPLETED|Overall Study||16
5335304|NCT00331773|13121924|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
5335305|NCT00331773|13121925|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
5335306|NCT00331773|13121924|P2|STARTED|Overall Study||557
5335307|NCT00331773|13121925|P1|STARTED|Overall Study||558
5335308|NCT00331760|13121955|P2|NOT COMPLETED|Overall Study||8
5335309|NCT00331760|13121956|P1|NOT COMPLETED|Overall Study||15
5335310|NCT00331760|13121955|P2|COMPLETED|Overall Study||40
5335311|NCT00331760|13121956|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
5335312|NCT00331760|13121955|P2|STARTED|Overall Study||48
5335313|NCT00331760|13121956|P1|STARTED|Overall Study||58
5335314|NCT00331682|13121977|P1|NOT COMPLETED|Overall Study||1
5335315|NCT00331682|13121977|P1|COMPLETED|Overall Study||9
5335316|NCT00331682|13121977|P1|STARTED|Overall Study||10
5335317|NCT00331630|13121983|P1|NOT COMPLETED|Follow up for 5 Years||29
5335318|NCT00331630|13121983|P1|COMPLETED|Follow up for 5 Years||0
5335319|NCT00331630|13121983|P1|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
5335320|NCT00331630|13121983|P1|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
5335321|NCT00331630|13121983|P1|COMPLETED|Evaluated for and Completed SOC Surgery||28
5335322|NCT00331630|13121983|P1|STARTED|Evaluated for and Completed SOC Surgery||30
5335323|NCT00331630|13121983|P1|NOT COMPLETED|Treatment on Study||0
5335324|NCT00331630|13121983|P1|COMPLETED|Treatment on Study||30
5335325|NCT00331630|13121983|P1|Completed 4 Cycles|Treatment on Study||30
5335326|NCT00331630|13121983|P1|Completed 1st Cycle|Treatment on Study||30
5335327|NCT00331630|13121983|P1|STARTED|Treatment on Study||30
5335328|NCT00331552|13121995|P2|NOT COMPLETED|Period 3: Phase II||0
5335329|NCT00331552|13121996|P1|NOT COMPLETED|Period 3: Phase II||2
5335330|NCT00331552|13121995|P2|COMPLETED|Period 3: Phase II||0
5335331|NCT00331552|13121996|P1|COMPLETED|Period 3: Phase II||22
5335332|NCT00331552|13121995|P2|STARTED|Period 3: Phase II||0
5335333|NCT00331552|13121996|P1|STARTED|Period 3: Phase II||24
5335334|NCT00331552|13121995|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
5335335|NCT00331552|13121996|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
5335336|NCT00331552|13121995|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
5335337|NCT00331552|13121996|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
5335338|NCT00331552|13121995|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
5335339|NCT00331552|13121996|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
5335340|NCT00331552|13121995|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
5335341|NCT00331552|13121996|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
5335342|NCT00331552|13121995|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
5335343|NCT00331552|13121996|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
5335344|NCT00331552|13121995|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
5335345|NCT00331552|13121996|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
5335346|NCT00331422|13122010|P1|NOT COMPLETED|Overall Study||5
5335347|NCT00331422|13122010|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
5335348|NCT00331422|13122010|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
5335349|NCT00331409|13122019|P1|NOT COMPLETED|Overall Study||4
5335350|NCT00331409|13122019|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
5335351|NCT00331409|13122019|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
5335352|NCT00331344|13122027|P9|NOT COMPLETED|Phase II||4
5335353|NCT00331344|13122028|P8|NOT COMPLETED|Phase II||0
5335354|NCT00331344|13122029|P7|NOT COMPLETED|Phase II||0
5335355|NCT00331344|13122030|P6|NOT COMPLETED|Phase II||0
5335356|NCT00331344|13122031|P5|NOT COMPLETED|Phase II||0
5335357|NCT00331344|13122032|P4|NOT COMPLETED|Phase II||0
5335358|NCT00331344|13122033|P3|NOT COMPLETED|Phase II||0
5335359|NCT00331344|13122034|P2|NOT COMPLETED|Phase II||0
5335360|NCT00331344|13122035|P1|NOT COMPLETED|Phase II||0
5335361|NCT00331344|13122027|P9|COMPLETED|Phase II||48
5335362|NCT00331344|13122028|P8|COMPLETED|Phase II||6
5335363|NCT00331344|13122029|P7|COMPLETED|Phase II||0
5335364|NCT00331344|13122030|P6|COMPLETED|Phase II||0
5335365|NCT00331344|13122031|P5|COMPLETED|Phase II||0
5335366|NCT00331344|13122032|P4|COMPLETED|Phase II||0
5335367|NCT00331344|13122033|P3|COMPLETED|Phase II||0
5335368|NCT00331344|13122034|P2|COMPLETED|Phase II||0
5335369|NCT00331344|13122035|P1|COMPLETED|Phase II||0
5335370|NCT00331344|13122027|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
5335371|NCT00331344|13122028|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
5335372|NCT00331344|13122029|P7|STARTED|Phase II||0
5335373|NCT00331344|13122030|P6|STARTED|Phase II||0
5335374|NCT00331344|13122031|P5|STARTED|Phase II||0
5335375|NCT00331344|13122032|P4|STARTED|Phase II||0
5335376|NCT00331344|13122033|P3|STARTED|Phase II||0
5335377|NCT00331344|13122034|P2|STARTED|Phase II||0
5335378|NCT00331344|13122035|P1|STARTED|Phase II||0
5335379|NCT00331344|13122027|P9|NOT COMPLETED|Phase I||0
5335380|NCT00331344|13122028|P8|NOT COMPLETED|Phase I||1
5335381|NCT00331344|13122029|P7|NOT COMPLETED|Phase I||0
5335382|NCT00331344|13122030|P6|NOT COMPLETED|Phase I||2
5335383|NCT00331344|13122031|P5|NOT COMPLETED|Phase I||2
5335384|NCT00331344|13122032|P4|NOT COMPLETED|Phase I||1
5335385|NCT00331344|13122033|P3|NOT COMPLETED|Phase I||0
5335386|NCT00331344|13122034|P2|NOT COMPLETED|Phase I||0
5335387|NCT00331344|13122035|P1|NOT COMPLETED|Phase I||0
5335388|NCT00331344|13122027|P9|COMPLETED|Phase I||0
5335389|NCT00331344|13122028|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
5335390|NCT00331344|13122029|P7|COMPLETED|Phase I||4
5335391|NCT00331344|13122030|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
5335392|NCT00331344|13122031|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
5335393|NCT00331344|13122032|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
5335394|NCT00331344|13122033|P3|COMPLETED|Phase I||3
5335395|NCT00331344|13122034|P2|COMPLETED|Phase I||3
5335396|NCT00331344|13122035|P1|COMPLETED|Phase I||3
5335397|NCT00331344|13122027|P9|STARTED|Phase I||0
5335398|NCT00331344|13122028|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
5335399|NCT00331344|13122029|P7|STARTED|Phase I||4
5335400|NCT00331344|13122030|P6|STARTED|Phase I||5
5335401|NCT00331344|13122031|P5|STARTED|Phase I||6
5335402|NCT00331344|13122032|P4|STARTED|Phase I||6
5335403|NCT00331344|13122033|P3|STARTED|Phase I||3
5335404|NCT00331344|13122034|P2|STARTED|Phase I||3
5335405|NCT00331344|13122035|P1|STARTED|Phase I||3
5335406|NCT00331162|13122051|P2|NOT COMPLETED|Overall Study||0
5335407|NCT00331162|13122052|P1|NOT COMPLETED|Overall Study||0
5335408|NCT00331162|13122051|P2|COMPLETED|Overall Study||109
5335409|NCT00331162|13122052|P1|COMPLETED|Overall Study||113
5335410|NCT00331162|13122051|P2|STARTED|Overall Study||109
5335411|NCT00331162|13122052|P1|STARTED|Overall Study||113
5335412|NCT00331006|13122072|P1|NOT COMPLETED|Follow-Up Phase II||3
5335413|NCT00331006|13122072|P1|COMPLETED|Follow-Up Phase II||11
5335414|NCT00331006|13122072|P1|STARTED|Follow-Up Phase II||14
5335415|NCT00331006|13122072|P1|NOT COMPLETED|Follow-Up Phase I||1
5335416|NCT00331006|13122072|P1|COMPLETED|Follow-Up Phase I||14
5335417|NCT00331006|13122072|P1|STARTED|Follow-Up Phase I||15
5335418|NCT00331006|13122072|P1|NOT COMPLETED|Treatment Phase||1
5335419|NCT00331006|13122072|P1|COMPLETED|Treatment Phase||15
5335420|NCT00331006|13122072|P1|STARTED|Treatment Phase||16
5335421|NCT00331006|13122072|P1|NOT COMPLETED|Screening Phase||7
5335422|NCT00331006|13122072|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
5335423|NCT00331006|13122072|P1|STARTED|Screening Phase||23
5335424|NCT00330967|13122085|P2|NOT COMPLETED|Overall Study||14
5335425|NCT00330967|13122086|P1|NOT COMPLETED|Overall Study||0
5335426|NCT00330967|13122085|P2|COMPLETED|Overall Study||11
5335427|NCT00330967|13122086|P1|COMPLETED|Overall Study||0
5335428|NCT00330967|13122085|P2|STARTED|Overall Study||25
5335429|NCT00330967|13122086|P1|STARTED|Overall Study||0
5335430|NCT00330928|13122097|P1|NOT COMPLETED|Overall Study||17
5335431|NCT00330928|13122097|P1|COMPLETED|Overall Study||89
5335432|NCT00330928|13122097|P1|1 Year Phone Contact|Overall Study||89
5335433|NCT00330928|13122097|P1|7 Day Phone Contact|Overall Study||99
5335434|NCT00330928|13122097|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
5335435|NCT00330915|13122102|P1|NOT COMPLETED|Overall Study||0
5335436|NCT00330915|13122102|P1|COMPLETED|Overall Study||37
5335437|NCT00330915|13122102|P1|STARTED|Overall Study||37
5335438|NCT00330876|13122109|P2|NOT COMPLETED|Overall Study||13
5335439|NCT00330876|13122110|P1|NOT COMPLETED|Overall Study||71
5335440|NCT00330876|13122109|P2|COMPLETED|Overall Study||77
5335441|NCT00330876|13122110|P1|COMPLETED|Overall Study||378
5335442|NCT00330876|13122109|P2|STARTED|Overall Study||90
5335443|NCT00330876|13122110|P1|STARTED|Overall Study||449
5335444|NCT00330863|13122120|P2|NOT COMPLETED|Overall Study||80
5335445|NCT00330863|13122121|P1|NOT COMPLETED|Overall Study||81
5335446|NCT00330863|13122120|P2|COMPLETED|Overall Study||72
5335447|NCT00330863|13122121|P1|COMPLETED|Overall Study||72
5335448|NCT00330863|13122120|P2|STARTED|Overall Study||152
5335449|NCT00330863|13122121|P1|STARTED|Overall Study||153
5335450|NCT00330759|13122139|P2|NOT COMPLETED|Overall Study||706
5335451|NCT00330759|13122140|P1|NOT COMPLETED|Overall Study||712
5335452|NCT00330759|13122139|P2|COMPLETED|Overall Study||180
5335453|NCT00330759|13122140|P1|COMPLETED|Overall Study||178
5335454|NCT00330759|13122139|P2|Received Investigational Product|Overall Study||878
5335455|NCT00330759|13122140|P1|Received Investigational Product|Overall Study||878
5335456|NCT00330759|13122139|P2|STARTED|Overall Study||886
5335457|NCT00330759|13122140|P1|STARTED|Overall Study||890
5335458|NCT00330733|13122152|P2|NOT COMPLETED|Overall Study||5
5335459|NCT00330733|13122153|P1|NOT COMPLETED|Overall Study||7
5335460|NCT00330733|13122152|P2|COMPLETED|Overall Study||29
5335461|NCT00330733|13122153|P1|COMPLETED|Overall Study||30
5335462|NCT00330733|13122152|P2|Received Study Medication|Overall Study||34
5335463|NCT00330733|13122153|P1|Received Study Medication|Overall Study||36
5335464|NCT00330733|13122152|P2|STARTED|Overall Study||34
5335465|NCT00330733|13122153|P1|STARTED|Overall Study||37
5335466|NCT00330681|13122173|P2|NOT COMPLETED|Overall Study||14
5335467|NCT00330681|13122174|P1|NOT COMPLETED|Overall Study||9
5335468|NCT00330681|13122173|P2|COMPLETED|Overall Study||90
5335469|NCT00330681|13122174|P1|COMPLETED|Overall Study||93
5335470|NCT00330681|13122173|P2|STARTED|Overall Study||104
5335471|NCT00330681|13122174|P1|STARTED|Overall Study||102
5335472|NCT00330668|13122196|P1|NOT COMPLETED|QD Dosing Period||78
5335473|NCT00330668|13122196|P1|COMPLETED|QD Dosing Period||0
5335474|NCT00330668|13122196|P1|STARTED|QD Dosing Period||78
5335475|NCT00330668|13122196|P1|NOT COMPLETED|BID Dosing Period||36
5335476|NCT00330668|13122196|P1|COMPLETED|BID Dosing Period||78
5335477|NCT00330668|13122196|P1|STARTED|BID Dosing Period||114
5335478|NCT00330616|13122204|P1|NOT COMPLETED|Overall Study||21
5335479|NCT00330616|13122204|P1|COMPLETED|Overall Study||14
5335480|NCT00330616|13122204|P1|STARTED|Overall Study||35
5335481|NCT00330564|13122223|P1|NOT COMPLETED|Overall Study||0
5335482|NCT00330564|13122223|P1|COMPLETED|Overall Study||15
5335483|NCT00330564|13122223|P1|STARTED|Overall Study||15
5335484|NCT00330551|13122230|P2|NOT COMPLETED|Overall Study||16
5335485|NCT00330551|13122231|P1|NOT COMPLETED|Overall Study||10
5335486|NCT00330551|13122230|P2|COMPLETED|Overall Study||27
5335487|NCT00330551|13122231|P1|COMPLETED|Overall Study||30
5335488|NCT00330551|13122230|P2|STARTED|Overall Study||43
5335489|NCT00330551|13122231|P1|STARTED|Overall Study||40
5335490|NCT00330460|13122255|P2|NOT COMPLETED|Overall Study||33
5335491|NCT00330460|13122256|P1|NOT COMPLETED|Overall Study||42
5335492|NCT00330460|13122255|P2|COMPLETED|Overall Study||561
5335493|NCT00330460|13122256|P1|COMPLETED|Overall Study||553
5335494|NCT00330460|13122255|P2|STARTED|Overall Study||594
5335495|NCT00330460|13122256|P1|STARTED|Overall Study||595
5335496|NCT00330421|13122270|P2|NOT COMPLETED|Overall Study||0
5335497|NCT00330421|13122271|P1|NOT COMPLETED|Overall Study||0
5335498|NCT00330421|13122270|P2|COMPLETED|Overall Study||0
5335499|NCT00330421|13122271|P1|COMPLETED|Overall Study||15
5335500|NCT00330421|13122270|P2|STARTED|Overall Study||0
5335501|NCT00330421|13122271|P1|STARTED|Overall Study||15
5335502|NCT00330382|13122277|P2|NOT COMPLETED|Overall Study||17
5335503|NCT00330382|13122278|P1|NOT COMPLETED|Overall Study||24
5335504|NCT00330382|13122277|P2|COMPLETED|Overall Study||48
5335505|NCT00330382|13122278|P1|COMPLETED|Overall Study||43
5335506|NCT00330382|13122277|P2|STARTED|Overall Study||65
5335507|NCT00330382|13122278|P1|STARTED|Overall Study||67
5335508|NCT00330343|13122299|P1|NOT COMPLETED|Overall Study||5
5335509|NCT00330343|13122299|P1|COMPLETED|Overall Study||59
5335510|NCT00330343|13122299|P1|STARTED|Overall Study||64
5335511|NCT00330187|13122307|P4|NOT COMPLETED|Overall Study||14
5335512|NCT00330187|13122308|P3|NOT COMPLETED|Overall Study||18
5335513|NCT00330187|13122309|P2|NOT COMPLETED|Overall Study||18
5335514|NCT00330187|13122310|P1|NOT COMPLETED|Overall Study||20
5335515|NCT00330187|13122307|P4|COMPLETED|Overall Study||18
5335516|NCT00330187|13122308|P3|COMPLETED|Overall Study||11
5335517|NCT00330187|13122309|P2|COMPLETED|Overall Study||18
5335518|NCT00330187|13122310|P1|COMPLETED|Overall Study||17
5335519|NCT00330187|13122307|P4|STARTED|Overall Study||32
5335520|NCT00330187|13122308|P3|STARTED|Overall Study||29
5335521|NCT00330187|13122309|P2|STARTED|Overall Study||36
5335522|NCT00330187|13122310|P1|STARTED|Overall Study||37
5335523|NCT00330174|13122322|P2|NOT COMPLETED|Overall Study||19
5335524|NCT00330174|13122323|P1|NOT COMPLETED|Overall Study||22
5335525|NCT00330174|13122322|P2|COMPLETED|Overall Study||26
5335526|NCT00330174|13122323|P1|COMPLETED|Overall Study||23
5335527|NCT00330174|13122322|P2|STARTED|Overall Study||45
5335528|NCT00330174|13122323|P1|STARTED|Overall Study||45
5335529|NCT00330161|13122335|P1|NOT COMPLETED|Overall Study||0
5335530|NCT00330161|13122335|P1|COMPLETED|Overall Study||29
5335531|NCT00330161|13122335|P1|STARTED|Overall Study||29
5335532|NCT00329901|13122347|P3|NOT COMPLETED|Overall Study||4
5335533|NCT00329901|13122348|P2|NOT COMPLETED|Overall Study||5
5335534|NCT00329901|13122349|P1|NOT COMPLETED|Overall Study||9
5335535|NCT00329901|13122347|P3|COMPLETED|Overall Study||353
5335536|NCT00329901|13122348|P2|COMPLETED|Overall Study||349
5335537|NCT00329901|13122349|P1|COMPLETED|Overall Study||352
5335538|NCT00329901|13122347|P3|STARTED|Overall Study||357
5335539|NCT00329901|13122348|P2|STARTED|Overall Study||354
5335540|NCT00329901|13122349|P1|STARTED|Overall Study||361
5335541|NCT00329849|13122379|P2|NOT COMPLETED|Overall Study||4
5335542|NCT00329849|13122380|P1|NOT COMPLETED|Overall Study||6
5335543|NCT00329849|13122379|P2|COMPLETED|Overall Study||546
5335544|NCT00329849|13122380|P1|COMPLETED|Overall Study||944
5335545|NCT00329849|13122379|P2|STARTED|Overall Study||550
5335546|NCT00329849|13122380|P1|STARTED|Overall Study||950
5335547|NCT00329836|13122400|P1|NOT COMPLETED|Overall Study||0
5335548|NCT00329836|13122400|P1|COMPLETED|Overall Study||41
5335549|NCT00329836|13122400|P1|STARTED|Overall Study||41
5335550|NCT00329797|13122406|P2|NOT COMPLETED|Overall Study||6
5335551|NCT00329797|13122407|P1|NOT COMPLETED|Overall Study||7
5335552|NCT00329797|13122406|P2|COMPLETED|Overall Study||46
5335553|NCT00329797|13122407|P1|COMPLETED|Overall Study||50
5335554|NCT00329797|13122406|P2|STARTED|Overall Study||52
5335555|NCT00329797|13122407|P1|STARTED|Overall Study||57
5335556|NCT00329784|13122423|P4|NOT COMPLETED|Overall Study||0
5335557|NCT00329784|13122424|P3|NOT COMPLETED|Overall Study||0
5335558|NCT00329784|13122425|P2|NOT COMPLETED|Overall Study||5
5335559|NCT00329784|13122426|P1|NOT COMPLETED|Overall Study||5
5335560|NCT00329784|13122423|P4|COMPLETED|Overall Study||47
5335561|NCT00329784|13122424|P3|COMPLETED|Overall Study||51
5335562|NCT00329784|13122425|P2|COMPLETED|Overall Study||267
5335563|NCT00329784|13122426|P1|COMPLETED|Overall Study||265
5335564|NCT00329784|13122423|P4|STARTED|Overall Study||47
5335565|NCT00329784|13122424|P3|STARTED|Overall Study||51
5335566|NCT00329784|13122425|P2|STARTED|Overall Study||272
5335567|NCT00329784|13122426|P1|STARTED|Overall Study||270
5335568|NCT00329771|13122448|P1|NOT COMPLETED|Overall Study||3
5335569|NCT00329771|13122448|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
5335570|NCT00329771|13122448|P1|STARTED|Overall Study||28
5335571|NCT00329745|13122454|P2|NOT COMPLETED|Overall Study||102
5335572|NCT00329745|13122455|P1|NOT COMPLETED|Overall Study||87
5335573|NCT00329745|13122454|P2|COMPLETED|Overall Study||4226
5335574|NCT00329745|13122455|P1|COMPLETED|Overall Study||4272
5335575|NCT00329745|13122454|P2|STARTED|Overall Study||4328
5335576|NCT00329745|13122455|P1|STARTED|Overall Study||4359
5335577|NCT00329732|13122465|P2|NOT COMPLETED|Overall Study||0
5335578|NCT00329732|13122466|P1|NOT COMPLETED|Overall Study||0
5335579|NCT00329732|13122465|P2|COMPLETED|Overall Study||0
5335580|NCT00329732|13122466|P1|COMPLETED|Overall Study||2
5335581|NCT00329732|13122465|P2|STARTED|Overall Study||0
5335582|NCT00329732|13122466|P1|STARTED|Overall Study||2
5335583|NCT00329719|13122475|P4|NOT COMPLETED|Overall Study||1
5335584|NCT00329719|13122476|P3|NOT COMPLETED|Overall Study||0
5335585|NCT00329719|13122477|P2|NOT COMPLETED|Overall Study||0
5335586|NCT00329719|13122478|P1|NOT COMPLETED|Overall Study||0
5335587|NCT00329719|13122475|P4|COMPLETED|Overall Study||44
5335588|NCT00329719|13122476|P3|COMPLETED|Overall Study||9
5335589|NCT00329719|13122477|P2|COMPLETED|Overall Study||49
5335590|NCT00329719|13122478|P1|COMPLETED|Overall Study||12
5335591|NCT00329719|13122475|P4|STARTED|Overall Study||45
5335592|NCT00329719|13122476|P3|STARTED|Overall Study||9
5335593|NCT00329719|13122477|P2|STARTED|Overall Study||49
5335594|NCT00329719|13122478|P1|STARTED|Overall Study||12
5335595|NCT00329641|13122500|P1|NOT COMPLETED|Overall Study||6
5335596|NCT00329641|13122500|P1|COMPLETED|Overall Study||19
5335597|NCT00329641|13122500|P1|Eligible and Received Treatment|Overall Study||24
5335598|NCT00329641|13122500|P1|Eligible|Overall Study||25
5335599|NCT00329641|13122500|P1|STARTED|Overall Study||25
5335600|NCT00329602|13122509|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
5335601|NCT00329602|13122510|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
5335602|NCT00329602|13122511|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
5335603|NCT00329602|13122509|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
5335604|NCT00329602|13122510|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
5335605|NCT00329602|13122511|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
5335606|NCT00329602|13122509|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
5335607|NCT00329602|13122510|P2|STARTED|40-Week Open-Label Treatment Phase||0
5335608|NCT00329602|13122511|P1|STARTED|40-Week Open-Label Treatment Phase||0
5335609|NCT00329602|13122509|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
5335610|NCT00329602|13122510|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
5335611|NCT00329602|13122511|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
5335612|NCT00329602|13122509|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
5335613|NCT00329602|13122510|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
5335614|NCT00329602|13122511|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
5335615|NCT00329602|13122509|P3|STARTED|26-Week Double-Blind Treatment Phase||0
5335616|NCT00329602|13122510|P2|STARTED|26-Week Double-Blind Treatment Phase||197
5335617|NCT00329602|13122511|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
5335618|NCT00329550|13122549|P3|NOT COMPLETED|Overall Study||4
5335619|NCT00329550|13122550|P2|NOT COMPLETED|Overall Study||4
5335620|NCT00329550|13122551|P1|NOT COMPLETED|Overall Study||4
5335621|NCT00329550|13122549|P3|COMPLETED|Overall Study||12
5335622|NCT00329550|13122550|P2|COMPLETED|Overall Study||11
5335623|NCT00329550|13122551|P1|COMPLETED|Overall Study||5
5335624|NCT00329550|13122549|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
5335625|NCT00329550|13122550|P2|STARTED|Overall Study||15
5335626|NCT00329550|13122551|P1|STARTED|Overall Study||9
5335627|NCT00329524|13122798|P1|NOT COMPLETED|Overall Study||0
5335628|NCT00329524|13122798|P1|COMPLETED|Overall Study||5
5335629|NCT00329524|13122798|P1|STARTED|Overall Study||5
5335630|NCT00329433|13122806|P2|NOT COMPLETED|Overall Study||0
5335631|NCT00329433|13122807|P1|NOT COMPLETED|Overall Study||0
5335632|NCT00329433|13122806|P2|COMPLETED|Overall Study||59
5335633|NCT00329433|13122807|P1|COMPLETED|Overall Study||61
5335634|NCT00329433|13122806|P2|STARTED|Overall Study||59
5335635|NCT00329433|13122807|P1|STARTED|Overall Study||61
5335636|NCT00329420|13122820|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
5335637|NCT00329420|13122821|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
5335638|NCT00329420|13122822|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
5335639|NCT00329420|13122820|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
5335640|NCT00329420|13122821|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
5335641|NCT00329420|13122822|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
5335642|NCT00329420|13122820|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
5335643|NCT00329420|13122821|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
5335644|NCT00329420|13122822|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
5335645|NCT00329420|13122820|P3|NOT COMPLETED|Re-induction Phase||8
5335646|NCT00329420|13122821|P2|NOT COMPLETED|Re-induction Phase||6
5335647|NCT00329420|13122822|P1|NOT COMPLETED|Re-induction Phase||6
5335648|NCT00329420|13122820|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
5335649|NCT00329420|13122821|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
5335650|NCT00329420|13122822|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
5335651|NCT00329420|13122820|P3|STARTED|Re-induction Phase||15
5335652|NCT00329420|13122821|P2|STARTED|Re-induction Phase||13
5335653|NCT00329420|13122822|P1|STARTED|Re-induction Phase||18
5335654|NCT00329407|13123201|P1|NOT COMPLETED|Overall Study||1
5335655|NCT00329407|13123201|P1|COMPLETED|Overall Study||9
5335656|NCT00329407|13123201|P1|STARTED|Overall Study||10
5335657|NCT00329303|13123208|P2|NOT COMPLETED|Overall Study||2
5335658|NCT00329303|13123209|P1|NOT COMPLETED|Overall Study||2
5335659|NCT00329303|13123208|P2|COMPLETED|Overall Study||35
5335660|NCT00329303|13123209|P1|COMPLETED|Overall Study||32
5335661|NCT00329303|13123208|P2|STARTED|Overall Study||37
5335662|NCT00329303|13123209|P1|STARTED|Overall Study||34
5335663|NCT00329238|13123371|P2|NOT COMPLETED|Overall Study||281
5335664|NCT00329238|13123372|P1|NOT COMPLETED|Overall Study||276
5335665|NCT00329238|13123371|P2|COMPLETED|Overall Study||1145
5335666|NCT00329238|13123372|P1|COMPLETED|Overall Study||1154
5335667|NCT00329238|13123371|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
5335668|NCT00329238|13123372|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
5335669|NCT00329160|13123408|P1|NOT COMPLETED|Overall Study||88
5335670|NCT00329160|13123408|P1|COMPLETED|Overall Study||126
5335671|NCT00329160|13123408|P1|Treatment Period|Overall Study||214
5335672|NCT00329160|13123408|P1|Observation Period|Overall Study||214
5335673|NCT00329160|13123408|P1|STARTED|Overall Study||214
5335674|NCT00329108|13123417|P2|NOT COMPLETED|Overall Study||12
5335675|NCT00329108|13123418|P1|NOT COMPLETED|Overall Study||10
5335676|NCT00329108|13123417|P2|COMPLETED|Overall Study||2
5335677|NCT00329108|13123418|P1|COMPLETED|Overall Study||5
5335678|NCT00329108|13123417|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
5335679|NCT00329108|13123418|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
5335680|NCT00329030|13123426|P2|NOT COMPLETED|Overall Study||6
5335681|NCT00329030|13123427|P1|NOT COMPLETED|Overall Study||8
5335682|NCT00329030|13123426|P2|COMPLETED|Overall Study||107
5335683|NCT00329030|13123427|P1|COMPLETED|Overall Study||103
5335684|NCT00329030|13123426|P2|STARTED|Overall Study||113
5335685|NCT00329030|13123427|P1|STARTED|Overall Study||111
5335686|NCT00328926|13123458|P3|NOT COMPLETED|Overall Study||2
5335687|NCT00328926|13123459|P2|NOT COMPLETED|Overall Study||3
5335688|NCT00328926|13123460|P1|NOT COMPLETED|Overall Study||2
5335689|NCT00328926|13123458|P3|COMPLETED|Overall Study||1
5335690|NCT00328926|13123459|P2|COMPLETED|Overall Study||0
5335691|NCT00328926|13123460|P1|COMPLETED|Overall Study||3
5335692|NCT00328926|13123458|P3|STARTED|Overall Study||3
5335693|NCT00328926|13123459|P2|STARTED|Overall Study||3
5335694|NCT00328926|13123460|P1|STARTED|Overall Study||5
5335695|NCT00328861|13123476|P2|NOT COMPLETED|Overall Study||0
5335696|NCT00328861|13123477|P1|NOT COMPLETED|Overall Study||0
5335697|NCT00328861|13123476|P2|COMPLETED|Overall Study||1
5335698|NCT00328861|13123477|P1|COMPLETED|Overall Study||7
5335699|NCT00328861|13123476|P2|STARTED|Overall Study||1
5335700|NCT00328861|13123477|P1|STARTED|Overall Study||7
5335701|NCT00328783|13123485|P1|NOT COMPLETED|Overall Study||26
5335702|NCT00328783|13123485|P1|COMPLETED|Overall Study||86
5335703|NCT00328783|13123485|P1|STARTED|Overall Study||112
5335704|NCT00328770|13123493|P1|NOT COMPLETED|Overall Study||0
5335705|NCT00328770|13123493|P1|COMPLETED|Overall Study||70
5335706|NCT00328770|13123493|P1|STARTED|Overall Study||70
5335707|NCT00328627|13123511|P12|NOT COMPLETED|Overall Study||16
5335708|NCT00328627|13123512|P11|NOT COMPLETED|Overall Study||18
5335709|NCT00328627|13123513|P10|NOT COMPLETED|Overall Study||32
5335710|NCT00328627|13123514|P9|NOT COMPLETED|Overall Study||17
5335711|NCT00328627|13123515|P8|NOT COMPLETED|Overall Study||14
5335712|NCT00328627|13123516|P7|NOT COMPLETED|Overall Study||35
5335713|NCT00328627|13123517|P6|NOT COMPLETED|Overall Study||20
5335714|NCT00328627|13123518|P5|NOT COMPLETED|Overall Study||15
5335715|NCT00328627|13123519|P4|NOT COMPLETED|Overall Study||37
5335716|NCT00328627|13123520|P3|NOT COMPLETED|Overall Study||28
5335717|NCT00328627|13123521|P2|NOT COMPLETED|Overall Study||31
5335718|NCT00328627|13123522|P1|NOT COMPLETED|Overall Study||59
5335719|NCT00328627|13123511|P12|COMPLETED|Overall Study||114
5335720|NCT00328627|13123512|P11|COMPLETED|Overall Study||112
5335721|NCT00328627|13123513|P10|COMPLETED|Overall Study||97
5335722|NCT00328627|13123514|P9|COMPLETED|Overall Study||113
5335723|NCT00328627|13123515|P8|COMPLETED|Overall Study||116
5335724|NCT00328627|13123516|P7|COMPLETED|Overall Study||94
5335725|NCT00328627|13123517|P6|COMPLETED|Overall Study||110
5335726|NCT00328627|13123518|P5|COMPLETED|Overall Study||115
5335727|NCT00328627|13123519|P4|COMPLETED|Overall Study||93
5335728|NCT00328627|13123520|P3|COMPLETED|Overall Study||101
5335729|NCT00328627|13123521|P2|COMPLETED|Overall Study||97
5335730|NCT00328627|13123522|P1|COMPLETED|Overall Study||70
5335731|NCT00328627|13123511|P12|Safety Set|Overall Study||130
5335732|NCT00328627|13123512|P11|Safety Set|Overall Study||130
5335733|NCT00328627|13123513|P10|Safety Set|Overall Study||129
5335734|NCT00328627|13123514|P9|Safety Set|Overall Study||130
5335735|NCT00328627|13123515|P8|Safety Set|Overall Study||130
5335736|NCT00328627|13123516|P7|Safety Set|Overall Study||129
5335737|NCT00328627|13123517|P6|Safety Set|Overall Study||130
5335738|NCT00328627|13123518|P5|Safety Set|Overall Study||130
5335739|NCT00328627|13123519|P4|Safety Set|Overall Study||129
5335740|NCT00328627|13123520|P3|Safety Set|Overall Study||129
5335741|NCT00328627|13123521|P2|Safety Set|Overall Study||128
5335742|NCT00328627|13123522|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
5335743|NCT00328627|13123511|P12|STARTED|Overall Study||130
5335744|NCT00328627|13123512|P11|STARTED|Overall Study||130
5335745|NCT00328627|13123513|P10|STARTED|Overall Study||129
5335746|NCT00328627|13123514|P9|STARTED|Overall Study||130
5335747|NCT00328627|13123515|P8|STARTED|Overall Study||130
5335748|NCT00328627|13123516|P7|STARTED|Overall Study||129
5335749|NCT00328627|13123517|P6|STARTED|Overall Study||130
5335750|NCT00328627|13123518|P5|STARTED|Overall Study||130
5335751|NCT00328627|13123519|P4|STARTED|Overall Study||130
5335752|NCT00328627|13123520|P3|STARTED|Overall Study||129
5335753|NCT00328627|13123521|P2|STARTED|Overall Study||128
5335754|NCT00328627|13123522|P1|STARTED|Overall Study||129
5335755|NCT00328614|13125045|P6|NOT COMPLETED|Overall Study||1
5335756|NCT00328614|13125046|P5|NOT COMPLETED|Overall Study||1
5335757|NCT00328614|13125047|P4|NOT COMPLETED|Overall Study||1
5335758|NCT00328614|13125048|P3|NOT COMPLETED|Overall Study||0
5335759|NCT00328614|13125049|P2|NOT COMPLETED|Overall Study||0
5335760|NCT00328614|13125050|P1|NOT COMPLETED|Overall Study||0
5335761|NCT00328614|13125045|P6|COMPLETED|Overall Study||5
5335762|NCT00328614|13125046|P5|COMPLETED|Overall Study||5
5335763|NCT00328614|13125047|P4|COMPLETED|Overall Study||5
5335764|NCT00328614|13125048|P3|COMPLETED|Overall Study||6
5335765|NCT00328614|13125049|P2|COMPLETED|Overall Study||4
5335766|NCT00328614|13125050|P1|COMPLETED|Overall Study||4
5335767|NCT00328614|13125045|P6|STARTED|Overall Study||6
5335768|NCT00328614|13125046|P5|STARTED|Overall Study||6
5335769|NCT00328614|13125047|P4|STARTED|Overall Study||6
5335770|NCT00328614|13125048|P3|STARTED|Overall Study||6
5335771|NCT00328614|13125049|P2|STARTED|Overall Study||4
5335772|NCT00328614|13125050|P1|STARTED|Overall Study||4
5335773|NCT00328562|13125059|P1|NOT COMPLETED|Overall Study||1
5335774|NCT00328562|13125059|P1|COMPLETED|Overall Study||12
5335775|NCT00328562|13125059|P1|STARTED|Overall Study||13
5335776|NCT00328510|13125068|P2|NOT COMPLETED|Overall Study||4
5335777|NCT00328510|13125069|P1|NOT COMPLETED|Overall Study||10
5335778|NCT00328510|13125068|P2|COMPLETED|Overall Study||37
5335779|NCT00328510|13125069|P1|COMPLETED|Overall Study||32
5335780|NCT00328510|13125068|P2|STARTED|Overall Study||41
5335781|NCT00328510|13125069|P1|STARTED|Overall Study||42
5335782|NCT00328263|13125077|P2|NOT COMPLETED|Overall Study||4
5335783|NCT00328263|13125078|P1|NOT COMPLETED|Overall Study||3
5335784|NCT00328263|13125077|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
5335785|NCT00328263|13125078|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
5335786|NCT00328263|13125077|P2|STARTED|Overall Study||221
5335787|NCT00328263|13125078|P1|STARTED|Overall Study||216
5335788|NCT00328198|13125084|P1|NOT COMPLETED|Follow-up||35
5335789|NCT00328198|13125084|P1|COMPLETED|Follow-up||43
5335790|NCT00328198|13125084|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
5335791|NCT00328198|13125084|P1|NOT COMPLETED|Treatment||38
5335792|NCT00328198|13125084|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
5335793|NCT00328198|13125084|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
5335794|NCT00328172|13125099|P5|NOT COMPLETED|Overall Study||5
5335795|NCT00328172|13125100|P4|NOT COMPLETED|Overall Study||13
5335796|NCT00328172|13125101|P3|NOT COMPLETED|Overall Study||10
5335797|NCT00328172|13125102|P2|NOT COMPLETED|Overall Study||14
5335798|NCT00328172|13125103|P1|NOT COMPLETED|Overall Study||22
5335799|NCT00328172|13125099|P5|COMPLETED|Overall Study||60
5335800|NCT00328172|13125100|P4|COMPLETED|Overall Study||42
5335801|NCT00328172|13125101|P3|COMPLETED|Overall Study||47
5335802|NCT00328172|13125102|P2|COMPLETED|Overall Study||44
5335803|NCT00328172|13125103|P1|COMPLETED|Overall Study||45
5335804|NCT00328172|13125099|P5|STARTED|Overall Study||65
5335805|NCT00328172|13125100|P4|STARTED|Overall Study||55
5335806|NCT00328172|13125101|P3|STARTED|Overall Study||57
5335807|NCT00328172|13125102|P2|STARTED|Overall Study||58
5335808|NCT00328172|13125103|P1|STARTED|Overall Study||67
5335809|NCT00328094|13125127|P2|NOT COMPLETED|Overall Study||3
5335810|NCT00328094|13125128|P1|NOT COMPLETED|Overall Study||3
5335811|NCT00328094|13125127|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
5335812|NCT00328094|13125128|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
5335813|NCT00328094|13125127|P2|STARTED|Overall Study||125
5335814|NCT00328094|13125128|P1|STARTED|Overall Study||117
5335815|NCT00328042|13125138|P2|NOT COMPLETED|Overall Study||2
5335816|NCT00328042|13125139|P1|NOT COMPLETED|Overall Study||0
5335817|NCT00328042|13125138|P2|COMPLETED|Overall Study||63
5335818|NCT00328042|13125139|P1|COMPLETED|Overall Study||69
5335819|NCT00328042|13125138|P2|STARTED|Overall Study||65
5335820|NCT00328042|13125139|P1|STARTED|Overall Study||69
5335821|NCT00328016|13125149|P2|NOT COMPLETED|Overall Study||0
5335822|NCT00328016|13125150|P1|NOT COMPLETED|Overall Study||0
5335823|NCT00328016|13125149|P2|COMPLETED|Overall Study||21
5335824|NCT00328016|13125150|P1|COMPLETED|Overall Study||23
5335825|NCT00328016|13125149|P2|STARTED|Overall Study||21
5335826|NCT00328016|13125150|P1|STARTED|Overall Study||23
5335827|NCT00327717|13125162|P2|NOT COMPLETED|Overall Study||14
5335828|NCT00327717|13125163|P1|NOT COMPLETED|Overall Study||9
5335829|NCT00327717|13125162|P2|COMPLETED|Overall Study||106
5335830|NCT00327717|13125163|P1|COMPLETED|Overall Study||111
5335831|NCT00327717|13125162|P2|STARTED|Overall Study||120
5335832|NCT00327717|13125163|P1|STARTED|Overall Study||120
5335833|NCT00327470|13125189|P2|NOT COMPLETED|Overall Study||63
5335834|NCT00327470|13125190|P1|NOT COMPLETED|Overall Study||29
5335835|NCT00327470|13125189|P2|COMPLETED|Overall Study||118
5335836|NCT00327470|13125190|P1|COMPLETED|Overall Study||78
5335837|NCT00327470|13125189|P2|Treated|Overall Study||179
5335838|NCT00327470|13125190|P1|Treated|Overall Study||107
5335839|NCT00327470|13125189|P2|STARTED|Overall Study||181
5335840|NCT00327470|13125190|P1|STARTED|Overall Study||107
5335841|NCT00327444|13125210|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
5335842|NCT00327444|13125211|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
5335843|NCT00327444|13125210|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
5335844|NCT00327444|13125211|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
5335845|NCT00327444|13125210|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
5335846|NCT00327444|13125211|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
5335847|NCT00327444|13125210|P2|STARTED|Open Label Treatment (OL) Period||10
5335848|NCT00327444|13125211|P1|STARTED|Open Label Treatment (OL) Period||11
5335849|NCT00327444|13125210|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
5335850|NCT00327444|13125211|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
5335851|NCT00327444|13125210|P2|COMPLETED|Double Blind Treatment (DB) Period||0
5335852|NCT00327444|13125211|P1|COMPLETED|Double Blind Treatment (DB) Period||0
5335853|NCT00327444|13125210|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
5335854|NCT00327444|13125211|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
5335855|NCT00327444|13125210|P2|STARTED|Double Blind Treatment (DB) Period||29
5335856|NCT00327444|13125211|P1|STARTED|Double Blind Treatment (DB) Period||26
5335857|NCT00327392|13125223|P1|NOT COMPLETED|Overall Study||0
5335858|NCT00327392|13125223|P1|COMPLETED|Overall Study||123
5335859|NCT00327392|13125223|P1|STARTED|Overall Study||123
5335860|NCT00327340|13125229|P2|NOT COMPLETED|Overall Study||30
5335861|NCT00327340|13125230|P1|NOT COMPLETED|Overall Study||15
5335862|NCT00327340|13125229|P2|COMPLETED|Overall Study||16
5335863|NCT00327340|13125230|P1|COMPLETED|Overall Study||8
5335864|NCT00327340|13125229|P2|STARTED|Overall Study||46
5335865|NCT00327340|13125230|P1|STARTED|Overall Study||23
5335866|NCT00327171|13125244|P2|NOT COMPLETED|Overall Study||109
5335867|NCT00327171|13125245|P1|NOT COMPLETED|Overall Study||108
5335954|NCT00326716|13125470|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
5335868|NCT00327171|13125244|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
5335869|NCT00327171|13125245|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
5335870|NCT00327171|13125244|P2|STARTED|Overall Study||109
5335871|NCT00327171|13125245|P1|STARTED|Overall Study||109
5335872|NCT00327015|13125277|P4|NOT COMPLETED|Overall Study||109
5335873|NCT00327015|13125278|P3|NOT COMPLETED|Overall Study||126
5335874|NCT00327015|13125279|P2|NOT COMPLETED|Overall Study||92
5335875|NCT00327015|13125280|P1|NOT COMPLETED|Overall Study||91
5335876|NCT00327015|13125277|P4|COMPLETED|Overall Study||219
5335877|NCT00327015|13125278|P3|COMPLETED|Overall Study||209
5335878|NCT00327015|13125279|P2|COMPLETED|Overall Study||231
5335879|NCT00327015|13125280|P1|COMPLETED|Overall Study||229
5335880|NCT00327015|13125277|P4|Completed Study Without Being Rescued|Overall Study||144
5335881|NCT00327015|13125278|P3|Completed Study Without Being Rescued|Overall Study||113
5335882|NCT00327015|13125279|P2|Completed Study Without Being Rescued|Overall Study||177
5335883|NCT00327015|13125280|P1|Completed Study Without Being Rescued|Overall Study||179
5335884|NCT00327015|13125277|P4|STARTED|Overall Study||328
5335885|NCT00327015|13125278|P3|STARTED|Overall Study||335
5335886|NCT00327015|13125279|P2|STARTED|Overall Study||323
5335887|NCT00327015|13125280|P1|STARTED|Overall Study||320
5335888|NCT00326963|13125322|P1|NOT COMPLETED|Overall Study||33
5335889|NCT00326963|13125322|P1|COMPLETED|Overall Study||107
5335890|NCT00326963|13125322|P1|STARTED|Overall Study||140
5335891|NCT00326950|13125342|P1|NOT COMPLETED|Overall Study||1
5335892|NCT00326950|13125342|P1|COMPLETED|Overall Study||14
5335893|NCT00326950|13125342|P1|STARTED|Overall Study||15
5335894|NCT00326924|13125349|P2|NOT COMPLETED|Overall Study||1
5335895|NCT00326924|13125350|P1|NOT COMPLETED|Overall Study||1
5335896|NCT00326924|13125349|P2|COMPLETED|Overall Study||188
5335897|NCT00326924|13125350|P1|COMPLETED|Overall Study||187
5335898|NCT00326924|13125349|P2|STARTED|Overall Study||189
5335899|NCT00326924|13125350|P1|STARTED|Overall Study||188
5335900|NCT00326911|13125364|P2|NOT COMPLETED|Overall Study||2
5335901|NCT00326911|13125365|P1|NOT COMPLETED|Overall Study||1
5335902|NCT00326911|13125364|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
5335903|NCT00326911|13125365|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
5335904|NCT00326911|13125364|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
5335905|NCT00326911|13125365|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
5335906|NCT00326898|13125418|P3|NOT COMPLETED|Overall Study||203
5335907|NCT00326898|13125419|P2|NOT COMPLETED|Overall Study||343
5335908|NCT00326898|13125420|P1|NOT COMPLETED|Overall Study||351
5335909|NCT00326898|13125418|P3|COMPLETED|Overall Study||444
5335910|NCT00326898|13125419|P2|COMPLETED|Overall Study||306
5335911|NCT00326898|13125420|P1|COMPLETED|Overall Study||296
5335912|NCT00326898|13125418|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
5335913|NCT00326898|13125419|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
5335914|NCT00326898|13125420|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
5335915|NCT00326898|13125418|P3|Patients With Clear Cell Histology|Overall Study||540
5335916|NCT00326898|13125419|P2|Patients With Clear Cell Histology|Overall Study||540
5335917|NCT00326898|13125420|P1|Patients With Clear Cell Histology|Overall Study||542
5335918|NCT00326898|13125418|P3|Patients With Toxicity Data|Overall Study||626
5335919|NCT00326898|13125419|P2|Patients With Toxicity Data|Overall Study||628
5335920|NCT00326898|13125420|P1|Patients With Toxicity Data|Overall Study||625
5335921|NCT00326898|13125418|P3|STARTED|Overall Study||647
5335922|NCT00326898|13125419|P2|STARTED|Overall Study||649
5335923|NCT00326898|13125420|P1|STARTED|Overall Study||647
5335924|NCT00326885|13125437|P1|NOT COMPLETED|Overall Study||7
5335925|NCT00326885|13125437|P1|COMPLETED|Overall Study||25
5335926|NCT00326885|13125437|P1|STARTED|Overall Study||32
5335927|NCT00326872|13125446|P1|NOT COMPLETED|Overall Study||0
5335928|NCT00326872|13125446|P1|COMPLETED|Overall Study||26
5335929|NCT00326872|13125446|P1|STARTED|Overall Study||26
5335930|NCT00326781|13125457|P2|NOT COMPLETED|Overall Study||32
5335931|NCT00326781|13125458|P1|NOT COMPLETED|Overall Study||42
5335932|NCT00326781|13125457|P2|COMPLETED|Overall Study||298
5335933|NCT00326781|13125458|P1|COMPLETED|Overall Study||302
5335934|NCT00326781|13125457|P2|STARTED|Overall Study||330
5335935|NCT00326781|13125458|P1|STARTED|Overall Study||344
5335936|NCT00326716|13125468|P4|NOT COMPLETED|Infants||0
5335937|NCT00326716|13125469|P3|NOT COMPLETED|Infants||0
5335938|NCT00326716|13125470|P2|NOT COMPLETED|Infants||0
5335939|NCT00326716|13125471|P1|NOT COMPLETED|Infants||0
5335940|NCT00326716|13125468|P4|COMPLETED|Infants||20
5335941|NCT00326716|13125469|P3|COMPLETED|Infants||20
5335942|NCT00326716|13125470|P2|COMPLETED|Infants||0
5335943|NCT00326716|13125471|P1|COMPLETED|Infants||0
5335944|NCT00326716|13125468|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
5335945|NCT00326716|13125469|P3|STARTED|Infants|All infants were followed.|20
5335946|NCT00326716|13125470|P2|STARTED|Infants||0
5335947|NCT00326716|13125471|P1|STARTED|Infants||0
5335948|NCT00326716|13125468|P4|NOT COMPLETED|Pre-Natal Mothers||0
5335949|NCT00326716|13125469|P3|NOT COMPLETED|Pre-Natal Mothers||0
5335950|NCT00326716|13125470|P2|NOT COMPLETED|Pre-Natal Mothers||2
5335951|NCT00326716|13125471|P1|NOT COMPLETED|Pre-Natal Mothers||1
5335952|NCT00326716|13125468|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
5335953|NCT00326716|13125469|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
5335955|NCT00326716|13125471|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
5335956|NCT00326716|13125468|P4|STARTED|Pre-Natal Mothers||0
5335957|NCT00326716|13125469|P3|STARTED|Pre-Natal Mothers||0
5335958|NCT00326716|13125470|P2|STARTED|Pre-Natal Mothers||21
5335959|NCT00326716|13125471|P1|STARTED|Pre-Natal Mothers||20
5335960|NCT00326612|13125543|P2|NOT COMPLETED|Overall Study||137
5335961|NCT00326612|13125544|P1|NOT COMPLETED|Overall Study||129
5335962|NCT00326612|13125543|P2|COMPLETED|Overall Study||42
5335963|NCT00326612|13125544|P1|COMPLETED|Overall Study||50
5335964|NCT00326612|13125543|P2|STARTED|Overall Study||179
5335965|NCT00326612|13125544|P1|STARTED|Overall Study||179
5335966|NCT00326599|13125566|P4|NOT COMPLETED|Overall Study||19
5335967|NCT00326599|13125567|P3|NOT COMPLETED|Overall Study||53
5335968|NCT00326599|13125568|P2|NOT COMPLETED|Overall Study||1
5335969|NCT00326599|13125569|P1|NOT COMPLETED|Overall Study||6
5335970|NCT00326599|13125566|P4|COMPLETED|Overall Study||10
5335971|NCT00326599|13125567|P3|COMPLETED|Overall Study||5
5335972|NCT00326599|13125568|P2|COMPLETED|Overall Study||2
5335973|NCT00326599|13125569|P1|COMPLETED|Overall Study||0
5335974|NCT00326599|13125566|P4|STARTED|Overall Study||29
5335975|NCT00326599|13125567|P3|STARTED|Overall Study||58
5335976|NCT00326599|13125568|P2|STARTED|Overall Study||3
5335977|NCT00326599|13125569|P1|STARTED|Overall Study||6
5335978|NCT00326495|13125588|P1|NOT COMPLETED|Overall Study||5
5335979|NCT00326495|13125588|P1|COMPLETED|Overall Study||46
5335980|NCT00326495|13125588|P1|STARTED|Overall Study||51
5335981|NCT00326417|13125595|P4|NOT COMPLETED|Overall Study||3
5335982|NCT00326417|13125596|P3|NOT COMPLETED|Overall Study||1
5335983|NCT00326417|13125597|P2|NOT COMPLETED|Overall Study||0
5335984|NCT00326417|13125598|P1|NOT COMPLETED|Overall Study||14
5335985|NCT00326417|13125595|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
5335986|NCT00326417|13125596|P3|COMPLETED|Overall Study||38
5335987|NCT00326417|13125597|P2|COMPLETED|Overall Study||41
5335988|NCT00326417|13125598|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
5335989|NCT00326417|13125595|P4|Phase II|Overall Study||0
5335990|NCT00326417|13125596|P3|Phase II|Overall Study||33
5335991|NCT00326417|13125597|P2|Phase II|Overall Study||35
5335992|NCT00326417|13125598|P1|Phase II|Overall Study||8
5335993|NCT00326417|13125595|P4|Phase I|Overall Study||3
5335994|NCT00326417|13125596|P3|Phase I|Overall Study||6
5335995|NCT00326417|13125597|P2|Phase I|Overall Study||6
5335996|NCT00326417|13125598|P1|Phase I|Overall Study||6
5335997|NCT00326417|13125595|P4|STARTED|Overall Study||3
5335998|NCT00326417|13125596|P3|STARTED|Overall Study||39
5335999|NCT00326417|13125597|P2|STARTED|Overall Study||41
5336000|NCT00326417|13125598|P1|STARTED|Overall Study||14
5336001|NCT00326209|13125614|P1|NOT COMPLETED|Overall Study||282
5336002|NCT00326209|13125614|P1|COMPLETED|Overall Study||111
5336003|NCT00326209|13125614|P1|Safety Population|Overall Study||388
5336004|NCT00326209|13125614|P1|STARTED|Overall Study||393
5336005|NCT00326196|13125623|P2|NOT COMPLETED|Overall Study||0
5336006|NCT00326196|13125624|P1|NOT COMPLETED|Overall Study||0
5336007|NCT00326196|13125623|P2|COMPLETED|Overall Study||97
5336008|NCT00326196|13125624|P1|COMPLETED|Overall Study||101
5336009|NCT00326196|13125623|P2|STARTED|Overall Study||97
5336010|NCT00326196|13125624|P1|STARTED|Overall Study||101
5336011|NCT00326183|13125632|P2|NOT COMPLETED|Overall Study||83
5336012|NCT00326183|13125633|P1|NOT COMPLETED|Overall Study||200
5336013|NCT00326183|13125632|P2|COMPLETED|Overall Study||264
5336014|NCT00326183|13125633|P1|COMPLETED|Overall Study||1253
5336015|NCT00326183|13125632|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
5336016|NCT00326183|13125633|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
5336017|NCT00326183|13125632|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
5336018|NCT00326183|13125633|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
5336019|NCT00326183|13125632|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
5336020|NCT00326183|13125633|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
5336021|NCT00326183|13125632|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
5336022|NCT00326183|13125633|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
5336023|NCT00326183|13125632|P2|STARTED|Overall Study||347
5336024|NCT00326183|13125633|P1|STARTED|Overall Study||1453
5336025|NCT00326170|13125659|P1|NOT COMPLETED|Overall Study||0
5336026|NCT00326170|13125659|P1|COMPLETED|Overall Study||34
5336027|NCT00326170|13125659|P1|STARTED|Overall Study||34
5336028|NCT00326118|13125665|P2|NOT COMPLETED|Year 5 Follow up||0
5336029|NCT00326118|13125666|P1|NOT COMPLETED|Year 5 Follow up||0
5336030|NCT00326118|13125665|P2|COMPLETED|Year 5 Follow up||78
5336031|NCT00326118|13125666|P1|COMPLETED|Year 5 Follow up||217
5336032|NCT00326118|13125665|P2|STARTED|Year 5 Follow up||78
5336033|NCT00326118|13125666|P1|STARTED|Year 5 Follow up||217
5336034|NCT00326118|13125665|P2|NOT COMPLETED|Year 4 Follow-up||0
5336035|NCT00326118|13125666|P1|NOT COMPLETED|Year 4 Follow-up||0
5336036|NCT00326118|13125665|P2|COMPLETED|Year 4 Follow-up||80
5336037|NCT00326118|13125666|P1|COMPLETED|Year 4 Follow-up||228
5336038|NCT00326118|13125665|P2|STARTED|Year 4 Follow-up||80
5336039|NCT00326118|13125666|P1|STARTED|Year 4 Follow-up||228
5336040|NCT00326118|13125665|P2|NOT COMPLETED|Year 3 Follow-up||0
5336041|NCT00326118|13125666|P1|NOT COMPLETED|Year 3 Follow-up||0
5336042|NCT00326118|13125665|P2|COMPLETED|Year 3 Follow-up||89
5336043|NCT00326118|13125666|P1|COMPLETED|Year 3 Follow-up||256
5336044|NCT00326118|13125665|P2|STARTED|Year 3 Follow-up||89
5336045|NCT00326118|13125666|P1|STARTED|Year 3 Follow-up||256
5336046|NCT00326118|13125665|P2|NOT COMPLETED|Year 2 Follow-up||0
5336047|NCT00326118|13125666|P1|NOT COMPLETED|Year 2 Follow-up||0
5336048|NCT00326118|13125665|P2|COMPLETED|Year 2 Follow-up||92
5336049|NCT00326118|13125666|P1|COMPLETED|Year 2 Follow-up||270
5336050|NCT00326118|13125665|P2|STARTED|Year 2 Follow-up||92
5336051|NCT00326118|13125666|P1|STARTED|Year 2 Follow-up||270
5336052|NCT00326118|13125665|P2|NOT COMPLETED|Year 1 Follow-up||0
5336053|NCT00326118|13125666|P1|NOT COMPLETED|Year 1 Follow-up||0
5336054|NCT00326118|13125665|P2|COMPLETED|Year 1 Follow-up||100
5336055|NCT00326118|13125666|P1|COMPLETED|Year 1 Follow-up||295
5336056|NCT00326118|13125665|P2|STARTED|Year 1 Follow-up||100
5336057|NCT00326118|13125666|P1|STARTED|Year 1 Follow-up||295
5336058|NCT00326118|13125665|P2|NOT COMPLETED|Active Phase||1
5336059|NCT00326118|13125666|P1|NOT COMPLETED|Active Phase||4
5336060|NCT00326118|13125665|P2|COMPLETED|Active Phase||108
5336061|NCT00326118|13125666|P1|COMPLETED|Active Phase||320
5336062|NCT00326118|13125665|P2|STARTED|Active Phase||109
5336063|NCT00326118|13125666|P1|STARTED|Active Phase||324
5336064|NCT00326001|13125702|P2|NOT COMPLETED|Overall Study||8
5336065|NCT00326001|13125703|P1|NOT COMPLETED|Overall Study||7
5336066|NCT00326001|13125702|P2|COMPLETED|Overall Study||219
5336067|NCT00326001|13125703|P1|COMPLETED|Overall Study||229
5336068|NCT00326001|13125702|P2|STARTED|Overall Study||227
5336069|NCT00326001|13125703|P1|STARTED|Overall Study||236
5336070|NCT00325897|13125717|P2|NOT COMPLETED|Overall Study||13
5336071|NCT00325897|13125718|P1|NOT COMPLETED|Overall Study||12
5336072|NCT00325897|13125717|P2|COMPLETED|Overall Study||559
5336073|NCT00325897|13125718|P1|COMPLETED|Overall Study||558
5336074|NCT00325897|13125717|P2|STARTED|Overall Study||572
5336075|NCT00325897|13125718|P1|STARTED|Overall Study||570
5336076|NCT00325819|13125738|P2|NOT COMPLETED|Overall Study||13
5336077|NCT00325819|13125739|P1|NOT COMPLETED|Overall Study||9
5336078|NCT00325819|13125738|P2|COMPLETED|Overall Study||176
5336079|NCT00325819|13125739|P1|COMPLETED|Overall Study||176
5336080|NCT00325819|13125738|P2|STARTED|Overall Study||189
5336081|NCT00325819|13125739|P1|STARTED|Overall Study||185
5336082|NCT00325780|13125759|P1|NOT COMPLETED|Overall Study||155
5336083|NCT00325780|13125759|P1|COMPLETED|Overall Study||1200
5336084|NCT00325780|13125759|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
5336085|NCT00325780|13125759|P1|STARTED|Overall Study||1355
5336086|NCT00325754|13125766|P2|NOT COMPLETED|Overall Study||1
5336087|NCT00325754|13125767|P1|NOT COMPLETED|Overall Study||4
5336088|NCT00325754|13125766|P2|COMPLETED|Overall Study||10
5336089|NCT00325754|13125767|P1|COMPLETED|Overall Study||7
5336090|NCT00325754|13125766|P2|STARTED|Overall Study||11
5336091|NCT00325754|13125767|P1|STARTED|Overall Study||11
5336092|NCT00325598|13125783|P2|NOT COMPLETED|Overall Study||0
5336093|NCT00325598|13125784|P1|NOT COMPLETED|Overall Study||0
5336094|NCT00325598|13125783|P2|COMPLETED|Overall Study||50
5336095|NCT00325598|13125784|P1|COMPLETED|Overall Study||50
5336096|NCT00325598|13125783|P2|STARTED|Overall Study||50
5336097|NCT00325598|13125784|P1|STARTED|Overall Study||50
5336098|NCT00325572|13125810|P2|NOT COMPLETED|PHASE ii||0
5336099|NCT00325572|13125811|P1|NOT COMPLETED|PHASE ii||0
5336100|NCT00325572|13125810|P2|COMPLETED|PHASE ii||0
5336101|NCT00325572|13125811|P1|COMPLETED|PHASE ii||0
5336102|NCT00325572|13125810|P2|STARTED|PHASE ii||0
5336103|NCT00325572|13125811|P1|STARTED|PHASE ii||0
5336104|NCT00325572|13125810|P2|NOT COMPLETED|PHASE I||0
5336105|NCT00325572|13125811|P1|NOT COMPLETED|PHASE I||0
5336106|NCT00325572|13125810|P2|COMPLETED|PHASE I||44
5336107|NCT00325572|13125811|P1|COMPLETED|PHASE I||45
5336108|NCT00325572|13125810|P2|STARTED|PHASE I||44
5336109|NCT00325572|13125811|P1|STARTED|PHASE I||45
5336110|NCT00325468|13125822|P5|NOT COMPLETED|Overall Study||8
5336111|NCT00325468|13125823|P4|NOT COMPLETED|Overall Study||34
5336112|NCT00325468|13125824|P3|NOT COMPLETED|Overall Study||4
5336113|NCT00325468|13125825|P2|NOT COMPLETED|Overall Study||5
5336114|NCT00325468|13125826|P1|NOT COMPLETED|Overall Study||11
5336115|NCT00325468|13125822|P5|COMPLETED|Overall Study||14
5336116|NCT00325468|13125823|P4|COMPLETED|Overall Study||90
5336117|NCT00325468|13125824|P3|COMPLETED|Overall Study||10
5336118|NCT00325468|13125825|P2|COMPLETED|Overall Study||12
5336119|NCT00325468|13125826|P1|COMPLETED|Overall Study||12
5336120|NCT00325468|13125822|P5|STARTED|Overall Study||22
5336121|NCT00325468|13125823|P4|STARTED|Overall Study||124
5336122|NCT00325468|13125824|P3|STARTED|Overall Study||14
5336123|NCT00325468|13125825|P2|STARTED|Overall Study||17
5336124|NCT00325468|13125826|P1|STARTED|Overall Study||23
5336125|NCT00325442|13125861|P2|NOT COMPLETED|Overall Study||21
5336126|NCT00325442|13125862|P1|NOT COMPLETED|Overall Study||9
5336127|NCT00325442|13125861|P2|COMPLETED|Overall Study||153
5336128|NCT00325442|13125862|P1|COMPLETED|Overall Study||167
5336129|NCT00325442|13125861|P2|STARTED|Overall Study||174
5336130|NCT00325442|13125862|P1|STARTED|Overall Study||176
5336131|NCT00325416|13125909|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
5336132|NCT00325416|13125910|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
5336133|NCT00325416|13125909|P2|COMPLETED|Phase II: Treatment at MTD||40
5336134|NCT00325416|13125910|P1|COMPLETED|Phase II: Treatment at MTD||78
5336135|NCT00325416|13125909|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
5336136|NCT00325416|13125910|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
5336137|NCT00325416|13125909|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
5336138|NCT00325416|13125910|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
5336139|NCT00325416|13125909|P2|STARTED|Phase II: Treatment at MTD||42
5336140|NCT00325416|13125910|P1|STARTED|Phase II: Treatment at MTD||78
5336141|NCT00325416|13125909|P2|NOT COMPLETED|Phase I: Dose Escalation||16
5336142|NCT00325416|13125910|P1|NOT COMPLETED|Phase I: Dose Escalation||22
5336143|NCT00325416|13125909|P2|COMPLETED|Phase I: Dose Escalation||44
5336144|NCT00325416|13125910|P1|COMPLETED|Phase I: Dose Escalation||48
5336145|NCT00325416|13125909|P2|STARTED|Phase I: Dose Escalation||60
5336146|NCT00325416|13125910|P1|STARTED|Phase I: Dose Escalation||70
5336147|NCT00325403|13125924|P2|NOT COMPLETED|Overall Study||51
5336148|NCT00325403|13125925|P1|NOT COMPLETED|Overall Study||18
5336149|NCT00325403|13125924|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
5336150|NCT00325403|13125925|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
5336151|NCT00325403|13125924|P2|STARTED|Overall Study||233
5336152|NCT00325403|13125925|P1|STARTED|Overall Study||116
5336153|NCT00325234|13125963|P2|NOT COMPLETED|Overall Study||66
5336154|NCT00325234|13125964|P1|NOT COMPLETED|Overall Study||69
5336155|NCT00325234|13125963|P2|COMPLETED|Overall Study||0
5336156|NCT00325234|13125964|P1|COMPLETED|Overall Study||0
5336157|NCT00325234|13125963|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
5336158|NCT00325234|13125964|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
5336159|NCT00325234|13125963|P2|STARTED|Overall Study||66
5336160|NCT00325234|13125964|P1|STARTED|Overall Study||69
5336161|NCT00325195|13125983|P3|NOT COMPLETED|Received Intervention: ITT Population||4
5336162|NCT00325195|13125984|P2|NOT COMPLETED|Received Intervention: ITT Population||25
5336163|NCT00325195|13125985|P1|NOT COMPLETED|Received Intervention: ITT Population||26
5336164|NCT00325195|13125983|P3|COMPLETED|Received Intervention: ITT Population||39
5336165|NCT00325195|13125984|P2|COMPLETED|Received Intervention: ITT Population||59
5336166|NCT00325195|13125985|P1|COMPLETED|Received Intervention: ITT Population||59
5336167|NCT00325195|13125983|P3|STARTED|Received Intervention: ITT Population||43
5336168|NCT00325195|13125984|P2|STARTED|Received Intervention: ITT Population||84
5336169|NCT00325195|13125985|P1|STARTED|Received Intervention: ITT Population||85
5336170|NCT00325195|13125983|P3|NOT COMPLETED|Randomized||3
5336171|NCT00325195|13125984|P2|NOT COMPLETED|Randomized||5
5336172|NCT00325195|13125985|P1|NOT COMPLETED|Randomized||5
5336173|NCT00325195|13125983|P3|COMPLETED|Randomized||43
5336174|NCT00325195|13125984|P2|COMPLETED|Randomized||84
5336175|NCT00325195|13125985|P1|COMPLETED|Randomized||85
5336176|NCT00325195|13125983|P3|STARTED|Randomized||46
5336177|NCT00325195|13125984|P2|STARTED|Randomized||89
5336178|NCT00325195|13125985|P1|STARTED|Randomized||90
5336179|NCT00325156|13126008|P1|NOT COMPLETED|Overall Study||112
5336180|NCT00325156|13126008|P1|COMPLETED|Overall Study||2478
5336181|NCT00325156|13126008|P1|STARTED|Overall Study||2590
5336182|NCT00325143|13126015|P1|NOT COMPLETED|Overall Study||26
5336183|NCT00325143|13126015|P1|COMPLETED|Overall Study||676
5336184|NCT00325143|13126015|P1|STARTED|Overall Study||702
5336185|NCT00325130|13126025|P2|NOT COMPLETED|Overall Study||30
5336186|NCT00325130|13126026|P1|NOT COMPLETED|Overall Study||19
5336187|NCT00325130|13126025|P2|COMPLETED|Overall Study||494
5336188|NCT00325130|13126026|P1|COMPLETED|Overall Study||499
5336189|NCT00325130|13126025|P2|STARTED|Overall Study||524
5336190|NCT00325130|13126026|P1|STARTED|Overall Study||518
5336191|NCT00325078|13126069|P3|NOT COMPLETED|Overall Study||2
5336192|NCT00325078|13126070|P2|NOT COMPLETED|Overall Study||5
5336193|NCT00325078|13126071|P1|NOT COMPLETED|Overall Study||5
5336194|NCT00325078|13126069|P3|COMPLETED|Overall Study||23
5336195|NCT00325078|13126070|P2|COMPLETED|Overall Study||2
5336196|NCT00325078|13126071|P1|COMPLETED|Overall Study||3
5336197|NCT00325078|13126069|P3|STARTED|Overall Study||25
5336198|NCT00325078|13126070|P2|STARTED|Overall Study||7
5336199|NCT00325078|13126071|P1|STARTED|Overall Study||8
5336200|NCT00325039|13126083|P2|NOT COMPLETED|Overall Study||14
5336201|NCT00325039|13126084|P1|NOT COMPLETED|Overall Study||18
5336202|NCT00325039|13126083|P2|COMPLETED|Overall Study||285
5336203|NCT00325039|13126084|P1|COMPLETED|Overall Study||280
5336204|NCT00325039|13126083|P2|STARTED|Overall Study||299
5336205|NCT00325039|13126084|P1|STARTED|Overall Study||298
5336206|NCT00324987|13126100|P2|NOT COMPLETED|Overall Study||6
5336207|NCT00324987|13126101|P1|NOT COMPLETED|Overall Study||6
5336208|NCT00324987|13126100|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
5336209|NCT00324987|13126101|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
5336210|NCT00324987|13126100|P2|STARTED|Overall Study||6
5336211|NCT00324987|13126101|P1|STARTED|Overall Study||6
5336212|NCT00324961|13126115|P1|NOT COMPLETED|Overall Study||43
5336213|NCT00324961|13126115|P1|COMPLETED|Overall Study||490
5336214|NCT00324961|13126115|P1|STARTED|Overall Study||533
5336215|NCT00324896|13126130|P2|NOT COMPLETED|Overall Study||8
5336216|NCT00324896|13126131|P1|NOT COMPLETED|Overall Study||3
5336217|NCT00324896|13126130|P2|COMPLETED|Overall Study||7
5336218|NCT00324896|13126131|P1|COMPLETED|Overall Study||12
5336219|NCT00324896|13126130|P2|STARTED|Overall Study||15
5336220|NCT00324896|13126131|P1|STARTED|Overall Study||15
5336221|NCT00324870|13126139|P1|NOT COMPLETED|Overall Study||0
5336222|NCT00324870|13126139|P1|COMPLETED|Overall Study||37
5336223|NCT00324870|13126139|P1|STARTED|Overall Study||37
5336224|NCT00324857|13126147|P4|NOT COMPLETED|Overall Study||5
5336225|NCT00324857|13126148|P3|NOT COMPLETED|Overall Study||7
5336226|NCT00324857|13126149|P2|NOT COMPLETED|Overall Study||6
5336227|NCT00324857|13126150|P1|NOT COMPLETED|Overall Study||6
5336228|NCT00324857|13126147|P4|COMPLETED|Overall Study||158
5336229|NCT00324857|13126148|P3|COMPLETED|Overall Study||158
5336230|NCT00324857|13126149|P2|COMPLETED|Overall Study||162
5336231|NCT00324857|13126150|P1|COMPLETED|Overall Study||161
5336232|NCT00324857|13126147|P4|STARTED|Overall Study||163
5336233|NCT00324857|13126148|P3|STARTED|Overall Study||165
5336234|NCT00324857|13126149|P2|STARTED|Overall Study||168
5336235|NCT00324857|13126150|P1|STARTED|Overall Study||167
5336236|NCT00324805|13126166|P2|NOT COMPLETED|Overall Study||483
5336237|NCT00324805|13126167|P1|NOT COMPLETED|Overall Study||150
5336238|NCT00324805|13126166|P2|COMPLETED|Overall Study||269
5336239|NCT00324805|13126167|P1|COMPLETED|Overall Study||599
5336240|NCT00324805|13126166|P2|Started Assigned Therapy|Overall Study||735
5336241|NCT00324805|13126167|P1|Started Assigned Therapy|Overall Study||737
5336242|NCT00324805|13126166|P2|STARTED|Overall Study||752
5336243|NCT00324805|13126167|P1|STARTED|Overall Study||749
5336244|NCT00324753|13126181|P2|NOT COMPLETED|Overall Study||0
5336245|NCT00324753|13126182|P1|NOT COMPLETED|Overall Study||0
5336246|NCT00324753|13126181|P2|COMPLETED|Overall Study||264
5336247|NCT00324753|13126182|P1|COMPLETED|Overall Study||190
5336248|NCT00324753|13126181|P2|STARTED|Overall Study||264
5336249|NCT00324753|13126182|P1|STARTED|Overall Study||190
5336250|NCT00324740|13126192|P3|NOT COMPLETED|Overall Study||1
5336251|NCT00324740|13126193|P2|NOT COMPLETED|Overall Study||0
5336252|NCT00324740|13126194|P1|NOT COMPLETED|Overall Study||1
5336253|NCT00324740|13126192|P3|COMPLETED|Overall Study||3
5336254|NCT00324740|13126193|P2|COMPLETED|Overall Study||3
5336255|NCT00324740|13126194|P1|COMPLETED|Overall Study||6
5336256|NCT00324740|13126192|P3|STARTED|Overall Study||4
5336257|NCT00324740|13126193|P2|STARTED|Overall Study||3
5336258|NCT00324740|13126194|P1|STARTED|Overall Study||7
5336259|NCT00324701|13126203|P2|NOT COMPLETED|Overall Study||17
5336260|NCT00324701|13126204|P1|NOT COMPLETED|Overall Study||20
5336261|NCT00324701|13126203|P2|COMPLETED|Overall Study||104
5336262|NCT00324701|13126204|P1|COMPLETED|Overall Study||100
5336263|NCT00324701|13126203|P2|Week 8 Assessment|Overall Study||107
5336264|NCT00324701|13126204|P1|Week 8 Assessment|Overall Study||108
5336265|NCT00324701|13126203|P2|STARTED|Overall Study||121
5336266|NCT00324701|13126204|P1|STARTED|Overall Study||120
5336267|NCT00324675|13126214|P2|NOT COMPLETED|Overall Study||0
5336268|NCT00324675|13126215|P1|NOT COMPLETED|Overall Study||1
5336269|NCT00324675|13126214|P2|COMPLETED|Overall Study||14
5336270|NCT00324675|13126215|P1|COMPLETED|Overall Study||13
5336271|NCT00324675|13126214|P2|STARTED|Overall Study||14
5336272|NCT00324675|13126215|P1|STARTED|Overall Study||14
5336273|NCT00324649|13126223|P2|NOT COMPLETED|Overall Study||5
5336274|NCT00324649|13126224|P1|NOT COMPLETED|Overall Study||2
5336275|NCT00324649|13126223|P2|COMPLETED|Overall Study||36
5336276|NCT00324649|13126224|P1|COMPLETED|Overall Study||37
5336277|NCT00324649|13126223|P2|STARTED|Overall Study||41
5336278|NCT00324649|13126224|P1|STARTED|Overall Study||39
5336279|NCT00324415|13126264|P1|NOT COMPLETED|Overall Study||0
5336280|NCT00324415|13126264|P1|COMPLETED|Overall Study||45
5336281|NCT00324415|13126264|P1|STARTED|Overall Study||45
5336282|NCT00324350|13126279|P2|NOT COMPLETED|Overall Study||0
5336283|NCT00324350|13126280|P1|NOT COMPLETED|Overall Study||0
5336284|NCT00324350|13126279|P2|COMPLETED|Overall Study||3632
5336285|NCT00324350|13126280|P1|COMPLETED|Overall Study||3655
5336286|NCT00324350|13126279|P2|Falls Follow-Up|Overall Study||3418
5336287|NCT00324350|13126280|P1|Falls Follow-Up|Overall Study||3364
5336288|NCT00324350|13126279|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
5336289|NCT00324350|13126280|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
5336290|NCT00324350|13126279|P2|STARTED|Overall Study||3632
5336291|NCT00324350|13126280|P1|STARTED|Overall Study||3655
5336292|NCT00324272|13126294|P4|NOT COMPLETED|Overall Study||0
5336293|NCT00324272|13126295|P3|NOT COMPLETED|Overall Study||0
5336294|NCT00324272|13126296|P2|NOT COMPLETED|Overall Study||0
5336295|NCT00324272|13126297|P1|NOT COMPLETED|Overall Study||0
5336296|NCT00324272|13126294|P4|COMPLETED|Overall Study||18
5336297|NCT00324272|13126295|P3|COMPLETED|Overall Study||18
5336298|NCT00324272|13126296|P2|COMPLETED|Overall Study||20
5336299|NCT00324272|13126297|P1|COMPLETED|Overall Study||18
5336300|NCT00324272|13126294|P4|STARTED|Overall Study||18
5336301|NCT00324272|13126295|P3|STARTED|Overall Study||18
5336302|NCT00324272|13126296|P2|STARTED|Overall Study||20
5336303|NCT00324272|13126297|P1|STARTED|Overall Study||18
5336304|NCT00324259|13126333|P2|NOT COMPLETED|Overall Study||0
5336305|NCT00324259|13126334|P1|NOT COMPLETED|Overall Study||0
5336306|NCT00324259|13126333|P2|COMPLETED|Overall Study||32
5336307|NCT00324259|13126334|P1|COMPLETED|Overall Study||34
5336308|NCT00324259|13126333|P2|STARTED|Overall Study||32
5336309|NCT00324259|13126334|P1|STARTED|Overall Study||34
5336310|NCT00324233|13126355|P2|NOT COMPLETED|Second Period||7
5336311|NCT00324233|13126356|P1|NOT COMPLETED|Second Period||5
5336312|NCT00324233|13126355|P2|COMPLETED|Second Period||11
5336313|NCT00324233|13126356|P1|COMPLETED|Second Period||12
5336314|NCT00324233|13126355|P2|STARTED|Second Period||18
5336315|NCT00324233|13126356|P1|STARTED|Second Period||17
5336316|NCT00324233|13126355|P2|NOT COMPLETED|First Period||0
5336317|NCT00324233|13126356|P1|NOT COMPLETED|First Period||1
5336318|NCT00324233|13126355|P2|COMPLETED|First Period||18
5336319|NCT00324233|13126356|P1|COMPLETED|First Period||17
5336320|NCT00324233|13126355|P2|STARTED|First Period||18
5336321|NCT00324233|13126356|P1|STARTED|First Period||18
5336322|NCT00324168|13126364|P2|NOT COMPLETED|Overall Study||30
5336323|NCT00324168|13126365|P1|NOT COMPLETED|Overall Study||28
5336324|NCT00324168|13126364|P2|COMPLETED|Overall Study||220
5336325|NCT00324168|13126365|P1|COMPLETED|Overall Study||222
5336326|NCT00324168|13126364|P2|STARTED|Overall Study||250
5336327|NCT00324168|13126365|P1|STARTED|Overall Study||250
5336328|NCT00324155|13126393|P2|NOT COMPLETED|Follow-up Phase||6
5336329|NCT00324155|13126394|P1|NOT COMPLETED|Follow-up Phase||11
5336330|NCT00324155|13126393|P2|COMPLETED|Follow-up Phase||245
5336331|NCT00324155|13126394|P1|COMPLETED|Follow-up Phase||236
5336332|NCT00324155|13126393|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
5336333|NCT00324155|13126394|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
5336334|NCT00324155|13126393|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
5336335|NCT00324155|13126394|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
5336336|NCT00324155|13126393|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
5336337|NCT00324155|13126394|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
5336338|NCT00324155|13126393|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
5336339|NCT00324155|13126394|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
5336340|NCT00324155|13126393|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
5336341|NCT00324155|13126394|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
5336342|NCT00324155|13126393|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
5336343|NCT00324155|13126394|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
5336344|NCT00324155|13126393|P2|STARTED|Received Treatment in Induction Phase||251
5336345|NCT00324155|13126394|P1|STARTED|Received Treatment in Induction Phase||247
5336346|NCT00324155|13126393|P2|NOT COMPLETED|Enrolled and Randomized||1
5336347|NCT00324155|13126394|P1|NOT COMPLETED|Enrolled and Randomized||3
5336348|NCT00324155|13126393|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
5336349|NCT00324155|13126394|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
5336350|NCT00324155|13126393|P2|STARTED|Enrolled and Randomized||252
5336351|NCT00324155|13126394|P1|STARTED|Enrolled and Randomized||250
5336352|NCT00324116|13126424|P1|NOT COMPLETED|Overall Study||32
5336353|NCT00324116|13126424|P1|COMPLETED|Overall Study||49
5336354|NCT00324116|13126424|P1|STARTED|Overall Study|subjects received treatment|81
5336355|NCT00324038|13126436|P2|NOT COMPLETED|Overall Study||51
5336356|NCT00324038|13126437|P1|NOT COMPLETED|Overall Study||49
5336357|NCT00324038|13126436|P2|COMPLETED|Overall Study||58
5336358|NCT00324038|13126437|P1|COMPLETED|Overall Study||61
5336359|NCT00324038|13126436|P2|STARTED|Overall Study||109
5336360|NCT00324038|13126437|P1|STARTED|Overall Study||110
5336361|NCT00323882|13126448|P5|NOT COMPLETED|Overall Study||32
5336362|NCT00323882|13126449|P4|NOT COMPLETED|Overall Study||7
5336363|NCT00323882|13126450|P3|NOT COMPLETED|Overall Study||13
5336364|NCT00323882|13126451|P2|NOT COMPLETED|Overall Study||6
5336365|NCT00323882|13126452|P1|NOT COMPLETED|Overall Study||8
5336366|NCT00323882|13126448|P5|COMPLETED|Overall Study||2
5336367|NCT00323882|13126449|P4|COMPLETED|Overall Study||0
5336368|NCT00323882|13126450|P3|COMPLETED|Overall Study||3
5336369|NCT00323882|13126451|P2|COMPLETED|Overall Study||0
5336370|NCT00323882|13126452|P1|COMPLETED|Overall Study||0
5336371|NCT00323882|13126448|P5|STARTED|Overall Study||34
5336372|NCT00323882|13126449|P4|STARTED|Overall Study||7
5336373|NCT00323882|13126450|P3|STARTED|Overall Study||16
5336374|NCT00323882|13126451|P2|STARTED|Overall Study||6
5336375|NCT00323882|13126452|P1|STARTED|Overall Study||8
5336376|NCT00323869|13126523|P1|NOT COMPLETED|Overall Study||1
5336377|NCT00323869|13126523|P1|COMPLETED|Overall Study||47
5336378|NCT00323869|13126523|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
5336379|NCT00323869|13126523|P1|STARTED|Overall Study|Enrollment|48
5336380|NCT00323739|13126535|P1|NOT COMPLETED|Overall Study||0
5336381|NCT00323739|13126535|P1|COMPLETED|Overall Study||80
5336382|NCT00323739|13126535|P1|STARTED|Overall Study||80
5336383|NCT00323635|13126542|P2|NOT COMPLETED|Overall Study||0
5336384|NCT00323635|13126543|P1|NOT COMPLETED|Overall Study||0
5336385|NCT00323635|13126542|P2|COMPLETED|Overall Study||9
5336386|NCT00323635|13126543|P1|COMPLETED|Overall Study||10
5336387|NCT00323635|13126542|P2|STARTED|Overall Study||9
5336388|NCT00323635|13126543|P1|STARTED|Overall Study||10
5336389|NCT00323622|13126579|P8|NOT COMPLETED|Overall Study||15
5336390|NCT00323622|13126580|P7|NOT COMPLETED|Overall Study||5
5336391|NCT00323622|13126581|P6|NOT COMPLETED|Overall Study||74
5336392|NCT00323622|13126582|P5|NOT COMPLETED|Overall Study||39
5336393|NCT00323622|13126583|P4|NOT COMPLETED|Overall Study||12
5336394|NCT00323622|13126584|P3|NOT COMPLETED|Overall Study||4
5336395|NCT00323622|13126585|P2|NOT COMPLETED|Overall Study||92
5336396|NCT00323622|13126586|P1|NOT COMPLETED|Overall Study||31
5336397|NCT00323622|13126579|P8|COMPLETED|Overall Study||125
5336398|NCT00323622|13126580|P7|COMPLETED|Overall Study||38
5336399|NCT00323622|13126581|P6|COMPLETED|Overall Study||454
5336400|NCT00323622|13126582|P5|COMPLETED|Overall Study||120
5336401|NCT00323622|13126583|P4|COMPLETED|Overall Study||122
5336402|NCT00323622|13126584|P3|COMPLETED|Overall Study||38
5336403|NCT00323622|13126585|P2|COMPLETED|Overall Study||423
5336404|NCT00323622|13126586|P1|COMPLETED|Overall Study||145
5336405|NCT00323622|13126579|P8|STARTED|Overall Study||140
5336406|NCT00323622|13126580|P7|STARTED|Overall Study||43
5336407|NCT00323622|13126581|P6|STARTED|Overall Study||528
5336408|NCT00323622|13126582|P5|STARTED|Overall Study||159
5336409|NCT00323622|13126583|P4|STARTED|Overall Study||134
5336410|NCT00323622|13126584|P3|STARTED|Overall Study||42
5336411|NCT00323622|13126585|P2|STARTED|Overall Study||515
5336412|NCT00323622|13126586|P1|STARTED|Overall Study||176
5336413|NCT00323609|13126628|P4|NOT COMPLETED|Overall Study||15
5336414|NCT00323609|13126629|P3|NOT COMPLETED|Overall Study||8
5336415|NCT00323609|13126630|P2|NOT COMPLETED|Overall Study||99
5336416|NCT00323609|13126631|P1|NOT COMPLETED|Overall Study||91
5336417|NCT00323609|13126628|P4|COMPLETED|Overall Study||0
5336418|NCT00323609|13126629|P3|COMPLETED|Overall Study||0
5336419|NCT00323609|13126630|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
5336420|NCT00323609|13126631|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
5336421|NCT00323609|13126628|P4|STARTED|Overall Study||15
5336422|NCT00323609|13126629|P3|STARTED|Overall Study||8
5336423|NCT00323609|13126630|P2|STARTED|Overall Study||190
5336424|NCT00323609|13126631|P1|STARTED|Overall Study||191
5336425|NCT00323557|13126667|P2|NOT COMPLETED|Overall Study||0
5336426|NCT00323557|13126668|P1|NOT COMPLETED|Overall Study||1
5336427|NCT00323557|13126667|P2|COMPLETED|Overall Study||7
5336428|NCT00323557|13126668|P1|COMPLETED|Overall Study||24
5336429|NCT00323557|13126667|P2|STARTED|Overall Study||7
5336430|NCT00323557|13126668|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
5336431|NCT00323492|13126677|P3|NOT COMPLETED|Study Phase 2||1
5336432|NCT00323492|13126678|P2|NOT COMPLETED|Study Phase 2||1
5336433|NCT00323492|13126679|P1|NOT COMPLETED|Study Phase 2||4
5336434|NCT00323492|13126677|P3|COMPLETED|Study Phase 2||24
5336435|NCT00323492|13126678|P2|COMPLETED|Study Phase 2||17
5336436|NCT00323492|13126679|P1|COMPLETED|Study Phase 2||40
5336437|NCT00323492|13126677|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
5336438|NCT00323492|13126678|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
5336439|NCT00323492|13126679|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
5336440|NCT00323492|13126677|P3|NOT COMPLETED|Study Phase 1||0
5336441|NCT00323492|13126678|P2|NOT COMPLETED|Study Phase 1||0
5336442|NCT00323492|13126679|P1|NOT COMPLETED|Study Phase 1||2
5336443|NCT00323492|13126677|P3|COMPLETED|Study Phase 1||0
5336444|NCT00323492|13126678|P2|COMPLETED|Study Phase 1||45
5336445|NCT00323492|13126679|P1|COMPLETED|Study Phase 1||45
5336446|NCT00323492|13126677|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
5336447|NCT00323492|13126678|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
5336448|NCT00323492|13126679|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
5336449|NCT00323492|13126677|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
5336450|NCT00323492|13126678|P2|STARTED|Study Phase 1||45
5336451|NCT00323492|13126679|P1|STARTED|Study Phase 1||47
5336452|NCT00323479|13126710|P1|NOT COMPLETED|Overall Study||8
5336453|NCT00323479|13126710|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
5336454|NCT00323479|13126710|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
5336455|NCT00323479|13126710|P1|STARTED|Overall Study||114
5336456|NCT00323453|13126721|P2|NOT COMPLETED|Overall Study||0
5336457|NCT00323453|13126722|P1|NOT COMPLETED|Overall Study||0
5336458|NCT00323453|13126721|P2|COMPLETED|Overall Study||48
5336459|NCT00323453|13126722|P1|COMPLETED|Overall Study||61
5336460|NCT00323453|13126721|P2|STARTED|Overall Study||48
5336461|NCT00323453|13126722|P1|STARTED|Overall Study||61
5336462|NCT00323427|13126730|P2|NOT COMPLETED|Overall Study||23
5336463|NCT00323427|13126731|P1|NOT COMPLETED|Overall Study||31
5336464|NCT00323427|13126730|P2|COMPLETED|Overall Study||43
5336465|NCT00323427|13126731|P1|COMPLETED|Overall Study||38
5336466|NCT00323427|13126730|P2|STARTED|Overall Study||66
5336467|NCT00323427|13126731|P1|STARTED|Overall Study||69
5336468|NCT00323414|13126743|P2|NOT COMPLETED|Overall Study||1
5336469|NCT00323414|13126744|P1|NOT COMPLETED|Overall Study||0
5336470|NCT00323414|13126743|P2|COMPLETED|Overall Study||18
5336471|NCT00323414|13126744|P1|COMPLETED|Overall Study||18
5336472|NCT00323414|13126743|P2|STARTED|Overall Study||19
5336473|NCT00323414|13126744|P1|STARTED|Overall Study||18
5336474|NCT00323362|13126760|P1|NOT COMPLETED|Overall Study||0
5336475|NCT00323362|13126760|P1|COMPLETED|Overall Study||17
5336476|NCT00323362|13126760|P1|STARTED|Overall Study||17
5336477|NCT00323310|13126766|P1|NOT COMPLETED|Overall Study||3
5336478|NCT00323310|13126766|P1|COMPLETED|Overall Study||89
5336479|NCT00323310|13126766|P1|STARTED|Overall Study||92
5336480|NCT00323297|13126781|P2|NOT COMPLETED|Part B (Open-label)||12
5336481|NCT00323297|13126782|P1|NOT COMPLETED|Part B (Open-label)||9
5336482|NCT00323297|13126781|P2|COMPLETED|Part B (Open-label)||31
5336483|NCT00323297|13126782|P1|COMPLETED|Part B (Open-label)||39
5336484|NCT00323297|13126781|P2|STARTED|Part B (Open-label)||43
5336485|NCT00323297|13126782|P1|STARTED|Part B (Open-label)||48
5336486|NCT00323297|13126781|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
5336487|NCT00323297|13126782|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
5336488|NCT00323297|13126781|P2|COMPLETED|Part A (Double Blind Randomized)||43
5336489|NCT00323297|13126782|P1|COMPLETED|Part A (Double Blind Randomized)||48
5336490|NCT00323297|13126781|P2|STARTED|Part A (Double Blind Randomized)||50
5336491|NCT00323297|13126782|P1|STARTED|Part A (Double Blind Randomized)||53
5336492|NCT00323284|13126800|P2|NOT COMPLETED|24 Months Follow-up||22
5336493|NCT00323284|13126801|P1|NOT COMPLETED|24 Months Follow-up||18
5336494|NCT00323284|13126800|P2|COMPLETED|24 Months Follow-up||101
5336495|NCT00323284|13126801|P1|COMPLETED|24 Months Follow-up||98
5336496|NCT00323284|13126800|P2|STARTED|24 Months Follow-up||123
5336497|NCT00323284|13126801|P1|STARTED|24 Months Follow-up||116
5336498|NCT00323284|13126800|P2|NOT COMPLETED|12 Months Follow-up||9
5336499|NCT00323284|13126801|P1|NOT COMPLETED|12 Months Follow-up||5
5336500|NCT00323284|13126800|P2|COMPLETED|12 Months Follow-up||114
5336501|NCT00323284|13126801|P1|COMPLETED|12 Months Follow-up||111
5336502|NCT00323284|13126800|P2|STARTED|12 Months Follow-up||123
5336503|NCT00323284|13126801|P1|STARTED|12 Months Follow-up||116
5336504|NCT00323271|13126811|P2|NOT COMPLETED|Overall Study||3
5336505|NCT00323271|13126812|P1|NOT COMPLETED|Overall Study||2
5336506|NCT00323271|13126811|P2|COMPLETED|Overall Study||9
5336507|NCT00323271|13126812|P1|COMPLETED|Overall Study||11
5336508|NCT00323271|13126811|P2|STARTED|Overall Study||12
5336509|NCT00323271|13126812|P1|STARTED|Overall Study||13
5336510|NCT00323258|13126822|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
5336511|NCT00323258|13126823|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
5336512|NCT00323258|13126822|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
5336513|NCT00323258|13126823|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
5336514|NCT00323258|13126822|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
5336515|NCT00323258|13126823|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
5336516|NCT00323258|13126822|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
5336517|NCT00323258|13126823|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
5336518|NCT00323258|13126822|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
5336519|NCT00323258|13126823|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
5336520|NCT00323258|13126822|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
5336521|NCT00323258|13126823|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
5336522|NCT00323193|13126839|P2|NOT COMPLETED|Overall Study||15
5336523|NCT00323193|13126840|P1|NOT COMPLETED|Overall Study||23
5336524|NCT00323193|13126839|P2|COMPLETED|Overall Study||41
5336525|NCT00323193|13126840|P1|COMPLETED|Overall Study||30
5336526|NCT00323193|13126839|P2|STARTED|Overall Study||56
5336527|NCT00323193|13126840|P1|STARTED|Overall Study||53
5336528|NCT00323115|13126848|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
5336529|NCT00323115|13126848|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
5336530|NCT00323115|13126848|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
5336531|NCT00323115|13126848|P1|NOT COMPLETED|Vaccine Administration||1
5336532|NCT00323115|13126848|P1|COMPLETED|Vaccine Administration||10
5336533|NCT00323115|13126848|P1|STARTED|Vaccine Administration||11
5336534|NCT00323063|13126875|P2|NOT COMPLETED|Overall Study||0
5336535|NCT00323063|13126876|P1|NOT COMPLETED|Overall Study||2
5336536|NCT00323063|13126875|P2|COMPLETED|Overall Study||23
5336537|NCT00323063|13126876|P1|COMPLETED|Overall Study||24
5336538|NCT00323063|13126875|P2|STARTED|Overall Study||23
5336539|NCT00323063|13126876|P1|STARTED|Overall Study||26
5336540|NCT00323037|13126888|P2|NOT COMPLETED|Overall Study||27
5336541|NCT00323037|13126889|P1|NOT COMPLETED|Overall Study||33
5336542|NCT00323037|13126888|P2|COMPLETED|Overall Study||126
5336543|NCT00323037|13126889|P1|COMPLETED|Overall Study||132
5336544|NCT00323037|13126888|P2|STARTED|Overall Study|Number randomized|153
5336545|NCT00323037|13126889|P1|STARTED|Overall Study|Number randomized|165
5336546|NCT00322881|13126893|P1|NOT COMPLETED|Overall Study||5
5336547|NCT00322881|13126893|P1|COMPLETED|Overall Study||7
5336548|NCT00322881|13126893|P1|STARTED|Overall Study||12
5336549|NCT00322868|13126897|P1|NOT COMPLETED|Overall Study||1
5336550|NCT00322868|13126897|P1|COMPLETED|Overall Study||20
5336551|NCT00322868|13126897|P1|STARTED|Overall Study||21
5336552|NCT00322855|13126916|P1|NOT COMPLETED|Overall Study||0
5336553|NCT00322855|13126916|P1|COMPLETED|Overall Study||1
5336554|NCT00322855|13126916|P1|STARTED|Overall Study||1
5336555|NCT00322842|13126922|P2|NOT COMPLETED|Overall Study||2
5336556|NCT00322842|13126923|P1|NOT COMPLETED|Overall Study||2
5336557|NCT00322842|13126922|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
5336558|NCT00322842|13126923|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
5336559|NCT00322842|13126922|P2|STARTED|Overall Study||31
5336560|NCT00322842|13126923|P1|STARTED|Overall Study||4
5336561|NCT00322777|13126950|P2|NOT COMPLETED|Overall Study||0
5336562|NCT00322777|13126951|P1|NOT COMPLETED|Overall Study||0
5336563|NCT00322777|13126950|P2|COMPLETED|Overall Study||45
5336564|NCT00322777|13126951|P1|COMPLETED|Overall Study||39
5336565|NCT00322777|13126950|P2|Data Collection at Week 24|Overall Study||45
5336566|NCT00322777|13126951|P1|Data Collection at Week 24|Overall Study||39
5336567|NCT00322777|13126950|P2|Data Collection at Week 16|Overall Study||45
5336568|NCT00322777|13126951|P1|Data Collection at Week 16|Overall Study||39
5336569|NCT00322777|13126950|P2|Data Collection at Week 8|Overall Study||45
5336570|NCT00322777|13126951|P1|Data Collection at Week 8|Overall Study||39
5336571|NCT00322777|13126950|P2|"Data Collection at BASELINE|"|Overall Study||45
5336572|NCT00322777|13126951|P1|"Data Collection at BASELINE|"|Overall Study||39
5336573|NCT00322777|13126950|P2|STARTED|Overall Study||45
5336574|NCT00322777|13126951|P1|STARTED|Overall Study||39
5336575|NCT00322712|13126961|P1|NOT COMPLETED|Overall Study||1
5336576|NCT00322712|13126961|P1|COMPLETED|Overall Study||11
5336577|NCT00322712|13126961|P1|STARTED|Overall Study||12
5336578|NCT00322621|13126965|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
5336579|NCT00322621|13126966|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
5336580|NCT00322621|13126967|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
5336581|NCT00322621|13126965|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
5336582|NCT00322621|13126966|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
5336583|NCT00322621|13126967|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
5336584|NCT00322621|13126965|P3|STARTED|Period III - Maintenance / Rescue Phase||69
5336585|NCT00322621|13126966|P2|STARTED|Period III - Maintenance / Rescue Phase||115
5336586|NCT00322621|13126967|P1|STARTED|Period III - Maintenance / Rescue Phase||0
5336587|NCT00322621|13126965|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
5336588|NCT00322621|13126966|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
5336589|NCT00322621|13126967|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
5336590|NCT00322621|13126965|P3|COMPLETED|Period II - Acute Therapy Phase||0
5336591|NCT00322621|13126966|P2|COMPLETED|Period II - Acute Therapy Phase||0
5336592|NCT00322621|13126967|P1|COMPLETED|Period II - Acute Therapy Phase||184
5336593|NCT00322621|13126965|P3|STARTED|Period II - Acute Therapy Phase||0
5336594|NCT00322621|13126966|P2|STARTED|Period II - Acute Therapy Phase||0
5336595|NCT00322621|13126967|P1|STARTED|Period II - Acute Therapy Phase||216
5336596|NCT00322556|13127019|P1|NOT COMPLETED|Overall Study||12
5336597|NCT00322556|13127019|P1|COMPLETED|Overall Study||43
5336598|NCT00322556|13127019|P1|STARTED|Overall Study||55
5336599|NCT00322491|13127035|P2|NOT COMPLETED|Overall Study||2
5336600|NCT00322491|13127036|P1|NOT COMPLETED|Overall Study||2
5336601|NCT00322491|13127035|P2|COMPLETED|Overall Study||24
5336602|NCT00322491|13127036|P1|COMPLETED|Overall Study||21
5336603|NCT00322491|13127035|P2|STARTED|Overall Study||26
5336604|NCT00322491|13127036|P1|STARTED|Overall Study||23
5336605|NCT00322465|13127062|P4|NOT COMPLETED|Overall Study||26
5336606|NCT00322465|13127063|P3|NOT COMPLETED|Overall Study||26
5336607|NCT00322465|13127064|P2|NOT COMPLETED|Overall Study||24
5336608|NCT00322465|13127065|P1|NOT COMPLETED|Overall Study||20
5336609|NCT00322465|13127062|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
5336610|NCT00322465|13127063|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
5336611|NCT00322465|13127064|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
5336612|NCT00322465|13127065|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
5336613|NCT00322465|13127062|P4|STARTED|Overall Study|Randomized|79
5336614|NCT00322465|13127063|P3|STARTED|Overall Study|Randomized|77
5336615|NCT00322465|13127064|P2|STARTED|Overall Study|Randomized|73
5336616|NCT00322465|13127065|P1|STARTED|Overall Study|Randomized|76
5336617|NCT00322452|13127126|P2|NOT COMPLETED|Overall Study||276
5336618|NCT00322452|13127127|P1|NOT COMPLETED|Overall Study||247
5336619|NCT00322452|13127126|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
5336620|NCT00322452|13127127|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
5336621|NCT00322452|13127126|P2|STARTED|Overall Study|Number of patients randomized|608
5336622|NCT00322452|13127127|P1|STARTED|Overall Study|Number of patients randomized|609
5336623|NCT00322439|13127163|P1|NOT COMPLETED|Overall Study||1056
5336624|NCT00322439|13127163|P1|COMPLETED|Overall Study||1455
5336625|NCT00322439|13127163|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
5336626|NCT00322439|13127163|P1|STARTED|Overall Study||2511
5336627|NCT00322387|13127178|P2|NOT COMPLETED|Follow-up Period||3
5336628|NCT00322387|13127179|P1|NOT COMPLETED|Follow-up Period||2
5336629|NCT00322387|13127178|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
5336630|NCT00322387|13127179|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
5336631|NCT00322387|13127178|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
5336632|NCT00322387|13127179|P1|STARTED|Follow-up Period|Participants who had transplants|14
5336633|NCT00322387|13127178|P2|NOT COMPLETED|Treatment Period||1
5336634|NCT00322387|13127179|P1|NOT COMPLETED|Treatment Period||0
5336635|NCT00322387|13127178|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
5336636|NCT00322387|13127179|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
5336637|NCT00322387|13127178|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
5336638|NCT00322387|13127179|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
5336639|NCT00322374|13127213|P4|NOT COMPLETED|Second Escalation||0
5336640|NCT00322374|13127214|P3|NOT COMPLETED|Second Escalation||6
5336641|NCT00322374|13127215|P2|NOT COMPLETED|Second Escalation||0
5336642|NCT00322374|13127216|P1|NOT COMPLETED|Second Escalation||0
5336643|NCT00322374|13127213|P4|COMPLETED|Second Escalation||0
5336644|NCT00322374|13127214|P3|COMPLETED|Second Escalation||0
5336645|NCT00322374|13127215|P2|COMPLETED|Second Escalation||0
5336646|NCT00322374|13127216|P1|COMPLETED|Second Escalation||0
5336647|NCT00322374|13127213|P4|STARTED|Second Escalation||0
5336648|NCT00322374|13127214|P3|STARTED|Second Escalation||6
5336649|NCT00322374|13127215|P2|STARTED|Second Escalation||0
5336650|NCT00322374|13127216|P1|STARTED|Second Escalation||0
5336651|NCT00322374|13127213|P4|NOT COMPLETED|First Escalation||0
5336652|NCT00322374|13127214|P3|NOT COMPLETED|First Escalation||0
5336653|NCT00322374|13127215|P2|NOT COMPLETED|First Escalation||30
5336654|NCT00322374|13127216|P1|NOT COMPLETED|First Escalation||0
5336655|NCT00322374|13127213|P4|COMPLETED|First Escalation||0
5336656|NCT00322374|13127214|P3|COMPLETED|First Escalation||0
5336657|NCT00322374|13127215|P2|COMPLETED|First Escalation||0
5336658|NCT00322374|13127216|P1|COMPLETED|First Escalation||0
5336659|NCT00322374|13127213|P4|STARTED|First Escalation||0
5336660|NCT00322374|13127214|P3|STARTED|First Escalation||0
5336661|NCT00322374|13127215|P2|STARTED|First Escalation||30
5336662|NCT00322374|13127216|P1|STARTED|First Escalation||0
5336663|NCT00322374|13127213|P4|NOT COMPLETED|Starting Dose||0
5336664|NCT00322374|13127214|P3|NOT COMPLETED|Starting Dose||0
5336665|NCT00322374|13127215|P2|NOT COMPLETED|Starting Dose||0
5336666|NCT00322374|13127216|P1|NOT COMPLETED|Starting Dose||6
5336667|NCT00322374|13127213|P4|COMPLETED|Starting Dose||0
5336668|NCT00322374|13127214|P3|COMPLETED|Starting Dose||0
5336669|NCT00322374|13127215|P2|COMPLETED|Starting Dose||0
5336670|NCT00322374|13127216|P1|COMPLETED|Starting Dose||0
5336671|NCT00322374|13127213|P4|STARTED|Starting Dose||0
5336672|NCT00322374|13127214|P3|STARTED|Starting Dose||0
5336673|NCT00322374|13127215|P2|STARTED|Starting Dose||0
5336674|NCT00322374|13127216|P1|STARTED|Starting Dose||6
5336675|NCT00322374|13127213|P4|NOT COMPLETED|Enrollment||0
5336676|NCT00322374|13127214|P3|NOT COMPLETED|Enrollment||0
5336677|NCT00322374|13127215|P2|NOT COMPLETED|Enrollment||0
5336678|NCT00322374|13127216|P1|NOT COMPLETED|Enrollment||0
5336679|NCT00322374|13127213|P4|COMPLETED|Enrollment||42
5336680|NCT00322374|13127214|P3|COMPLETED|Enrollment||0
5336681|NCT00322374|13127215|P2|COMPLETED|Enrollment||0
5336682|NCT00322374|13127216|P1|COMPLETED|Enrollment||0
5336683|NCT00322374|13127213|P4|STARTED|Enrollment||42
5336684|NCT00322374|13127214|P3|STARTED|Enrollment||0
5336685|NCT00322374|13127215|P2|STARTED|Enrollment||0
5336686|NCT00322374|13127216|P1|STARTED|Enrollment||0
5336687|NCT00322348|13127266|P2|NOT COMPLETED|Overall Study||33
5336688|NCT00322348|13127267|P1|NOT COMPLETED|Overall Study||37
5336689|NCT00322348|13127266|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
5336690|NCT00322348|13127267|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
5336691|NCT00322348|13127266|P2|Received Study Treatment|Overall Study||48
5336692|NCT00322348|13127267|P1|Received Study Treatment|Overall Study||50
5336693|NCT00322348|13127266|P2|STARTED|Overall Study||49
5336694|NCT00322348|13127267|P1|STARTED|Overall Study||49
5336695|NCT00322335|13127286|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
5336696|NCT00322335|13127287|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
5336697|NCT00322335|13127288|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
5336698|NCT00322335|13127286|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
5336699|NCT00322335|13127287|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
5336700|NCT00322335|13127288|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
5336701|NCT00322335|13127286|P3|STARTED|Subjects 66 Months After Booster Dose||53
5336702|NCT00322335|13127287|P2|STARTED|Subjects 66 Months After Booster Dose||104
5336703|NCT00322335|13127288|P1|STARTED|Subjects 66 Months After Booster Dose||48
5336704|NCT00322335|13127286|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
5336705|NCT00322335|13127287|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
5336706|NCT00322335|13127288|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
5336707|NCT00322335|13127286|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
5336708|NCT00322335|13127287|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
5336709|NCT00322335|13127288|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
5336710|NCT00322335|13127286|P3|STARTED|Subjects 54 Months After Booster Dose||56
5336711|NCT00322335|13127287|P2|STARTED|Subjects 54 Months After Booster Dose||108
5336712|NCT00322335|13127288|P1|STARTED|Subjects 54 Months After Booster Dose||50
5336713|NCT00322335|13127286|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
5336714|NCT00322335|13127287|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
5336715|NCT00322335|13127288|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
5336716|NCT00322335|13127286|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
5336717|NCT00322335|13127287|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
5336718|NCT00322335|13127288|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
5336719|NCT00322335|13127286|P3|STARTED|Subjects 42 Months After Booster Dose||56
5336720|NCT00322335|13127287|P2|STARTED|Subjects 42 Months After Booster Dose||113
5336721|NCT00322335|13127288|P1|STARTED|Subjects 42 Months After Booster Dose||51
5336722|NCT00322335|13127286|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
5336723|NCT00322335|13127287|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
5336724|NCT00322335|13127288|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
5336725|NCT00322335|13127286|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
5336726|NCT00322335|13127287|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
5336727|NCT00322335|13127288|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
5336728|NCT00322335|13127286|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
5336729|NCT00322335|13127287|P2|STARTED|Subjects 30 Months After Booster Dose||119
5336730|NCT00322335|13127288|P1|STARTED|Subjects 30 Months After Booster Dose||54
5336731|NCT00322335|13127286|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
5336732|NCT00322335|13127287|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
5336733|NCT00322335|13127288|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
5336734|NCT00322335|13127286|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
5336735|NCT00322335|13127287|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
5336736|NCT00322335|13127288|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
5336737|NCT00322335|13127286|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
5336738|NCT00322335|13127287|P2|STARTED|Subjects 18 Months After Booster Dose||123
5336739|NCT00322335|13127288|P1|STARTED|Subjects 18 Months After Booster Dose||58
5336740|NCT00322309|13127328|P2|NOT COMPLETED|Overall Study||4
5336741|NCT00322309|13127329|P1|NOT COMPLETED|Overall Study||2
5336742|NCT00322309|13127328|P2|COMPLETED|Overall Study||9
5336743|NCT00322309|13127329|P1|COMPLETED|Overall Study||9
5336744|NCT00322309|13127328|P2|STARTED|Overall Study||13
5336745|NCT00322309|13127329|P1|STARTED|Overall Study||11
5336746|NCT00322231|13127345|P2|NOT COMPLETED|Period 2||0
5336747|NCT00322231|13127346|P1|NOT COMPLETED|Period 2||0
5336748|NCT00322231|13127345|P2|COMPLETED|Period 2||49
5336749|NCT00322231|13127346|P1|COMPLETED|Period 2||51
5336750|NCT00322231|13127345|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
5336751|NCT00322231|13127346|P1|STARTED|Period 2||51
5336752|NCT00322231|13127345|P2|NOT COMPLETED|Period 1||0
5336753|NCT00322231|13127346|P1|NOT COMPLETED|Period 1||0
5336754|NCT00322231|13127345|P2|COMPLETED|Period 1||50
5336755|NCT00322231|13127346|P1|COMPLETED|Period 1||51
5336756|NCT00322231|13127345|P2|STARTED|Period 1||50
5336757|NCT00322231|13127346|P1|STARTED|Period 1||51
5336758|NCT00322153|13127358|P2|NOT COMPLETED|Overall Study||69
5336759|NCT00322153|13127359|P1|NOT COMPLETED|Overall Study||63
5336760|NCT00322153|13127358|P2|COMPLETED|Overall Study||273
5336761|NCT00322153|13127359|P1|COMPLETED|Overall Study||272
5336762|NCT00322153|13127358|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
5336763|NCT00322153|13127359|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
5336764|NCT00322153|13127358|P2|STARTED|Overall Study|Randomized to Memantine ER|342
5336765|NCT00322153|13127359|P1|STARTED|Overall Study|Randomized to placebo|335
5336766|NCT00322101|13127371|P2|NOT COMPLETED|Overall Study||0
5336767|NCT00322101|13127372|P1|NOT COMPLETED|Overall Study||0
5336768|NCT00322101|13127371|P2|COMPLETED|Overall Study||11
5336769|NCT00322101|13127372|P1|COMPLETED|Overall Study||14
5336770|NCT00322101|13127371|P2|STARTED|Overall Study||11
5336771|NCT00322101|13127372|P1|STARTED|Overall Study||14
5336772|NCT00322049|13127392|P4|NOT COMPLETED|Overall Study||1
5336773|NCT00322049|13127393|P3|NOT COMPLETED|Overall Study||0
5336774|NCT00322049|13127394|P2|NOT COMPLETED|Overall Study||1
5336775|NCT00322049|13127395|P1|NOT COMPLETED|Overall Study||0
5336776|NCT00322049|13127392|P4|COMPLETED|Overall Study||16
5336777|NCT00322049|13127393|P3|COMPLETED|Overall Study||20
5336778|NCT00322049|13127394|P2|COMPLETED|Overall Study||9
5336779|NCT00322049|13127395|P1|COMPLETED|Overall Study||4
5336780|NCT00322049|13127392|P4|STARTED|Overall Study||17
5336781|NCT00322049|13127393|P3|STARTED|Overall Study||20
5336782|NCT00322049|13127394|P2|STARTED|Overall Study||10
5336783|NCT00322049|13127395|P1|STARTED|Overall Study||4
5336784|NCT00321984|13127428|P3|NOT COMPLETED|Overall Study||26
5336785|NCT00321984|13127429|P2|NOT COMPLETED|Overall Study||21
5336786|NCT00321984|13127430|P1|NOT COMPLETED|Overall Study||27
5336787|NCT00321984|13127428|P3|COMPLETED|Overall Study||289
5336788|NCT00321984|13127429|P2|COMPLETED|Overall Study||294
5336789|NCT00321984|13127430|P1|COMPLETED|Overall Study||290
5336790|NCT00321984|13127428|P3|STARTED|Overall Study||315
5336791|NCT00321984|13127429|P2|STARTED|Overall Study||315
5336792|NCT00321984|13127430|P1|STARTED|Overall Study||317
5336793|NCT00321971|13127449|P2|NOT COMPLETED|Overall Study||11
5336794|NCT00321971|13127450|P1|NOT COMPLETED|Overall Study||8
5336795|NCT00321971|13127449|P2|COMPLETED|Overall Study||26
5336796|NCT00321971|13127450|P1|COMPLETED|Overall Study||28
5336797|NCT00321971|13127449|P2|STARTED|Overall Study||37
5336798|NCT00321971|13127450|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
5336799|NCT00321932|13127458|P2|NOT COMPLETED|Overall Study||21
5336800|NCT00321932|13127459|P1|NOT COMPLETED|Overall Study||10
5336801|NCT00321932|13127458|P2|COMPLETED|Overall Study||11
5336802|NCT00321932|13127459|P1|COMPLETED|Overall Study||19
5336803|NCT00321932|13127458|P2|STARTED|Overall Study||32
5336804|NCT00321932|13127459|P1|STARTED|Overall Study||29
5336805|NCT00321919|13127483|P2|NOT COMPLETED|Overall Study||52
5336806|NCT00321919|13127484|P1|NOT COMPLETED|Overall Study||75
5336807|NCT00321919|13127483|P2|COMPLETED|Overall Study||250
5336808|NCT00321919|13127484|P1|COMPLETED|Overall Study||226
5336809|NCT00321919|13127483|P2|STARTED|Overall Study||302
5336810|NCT00321919|13127484|P1|STARTED|Overall Study||301
5336811|NCT00321906|13127526|P2|NOT COMPLETED|Overall Study||56
5336812|NCT00321906|13127527|P1|NOT COMPLETED|Overall Study||46
5336813|NCT00321906|13127526|P2|COMPLETED|Overall Study||31
5336814|NCT00321906|13127527|P1|COMPLETED|Overall Study||48
5336815|NCT00321906|13127526|P2|STARTED|Overall Study||87
5336816|NCT00321906|13127527|P1|STARTED|Overall Study||94
5336817|NCT00321893|13127549|P2|NOT COMPLETED|Overall Study||14
5336818|NCT00321893|13127550|P1|NOT COMPLETED|Overall Study||24
5336819|NCT00321893|13127549|P2|COMPLETED|Overall Study||87
5336820|NCT00321893|13127550|P1|COMPLETED|Overall Study||77
5336821|NCT00321893|13127549|P2|STARTED|Overall Study||101
5336822|NCT00321893|13127550|P1|STARTED|Overall Study||101
5336823|NCT00321854|13127564|P2|NOT COMPLETED|Overall Study||82
5336824|NCT00321854|13127565|P1|NOT COMPLETED|Overall Study||63
5336825|NCT00321854|13127564|P2|COMPLETED|Overall Study||192
5336826|NCT00321854|13127565|P1|COMPLETED|Overall Study||198
5336827|NCT00321854|13127564|P2|STARTED|Overall Study||274
5336828|NCT00321854|13127565|P1|STARTED|Overall Study||261
5336829|NCT00321828|13127683|P1|NOT COMPLETED|Overall Study||4
5336830|NCT00321828|13127683|P1|COMPLETED|Overall Study||86
5336831|NCT00321828|13127683|P1|STARTED|Overall Study||90
5336832|NCT00321789|13127689|P2|NOT COMPLETED|Overall Study||16
5336833|NCT00321789|13127690|P1|NOT COMPLETED|Overall Study||15
5336834|NCT00321789|13127689|P2|COMPLETED|Overall Study||112
5336835|NCT00321789|13127690|P1|COMPLETED|Overall Study||112
5336836|NCT00321789|13127689|P2|STARTED|Overall Study||128
5336837|NCT00321789|13127690|P1|STARTED|Overall Study||127
5336838|NCT00321763|13127722|P4|NOT COMPLETED|Overall Study||5
5336839|NCT00321763|13127723|P3|NOT COMPLETED|Overall Study||6
5336840|NCT00321763|13127724|P2|NOT COMPLETED|Overall Study||2
5336841|NCT00321763|13127725|P1|NOT COMPLETED|Overall Study||6
5336842|NCT00321763|13127722|P4|COMPLETED|Overall Study||565
5336843|NCT00321763|13127723|P3|COMPLETED|Overall Study||848
5336844|NCT00321763|13127724|P2|COMPLETED|Overall Study||848
5336845|NCT00321763|13127725|P1|COMPLETED|Overall Study||844
5336846|NCT00321763|13127722|P4|STARTED|Overall Study||570
5336847|NCT00321763|13127723|P3|STARTED|Overall Study||854
5336848|NCT00321763|13127724|P2|STARTED|Overall Study||850
5336849|NCT00321763|13127725|P1|STARTED|Overall Study||850
5336850|NCT00321737|13127785|P3|NOT COMPLETED|Overall Study||54
5336851|NCT00321737|13127786|P2|NOT COMPLETED|Overall Study||48
5336852|NCT00321737|13127787|P1|NOT COMPLETED|Overall Study||122
5336853|NCT00321737|13127785|P3|COMPLETED|Overall Study||104
5336854|NCT00321737|13127786|P2|COMPLETED|Overall Study||92
5336855|NCT00321737|13127787|P1|COMPLETED|Overall Study||25
5336856|NCT00321737|13127785|P3|STARTED|Overall Study||158
5336857|NCT00321737|13127786|P2|STARTED|Overall Study||140
5336858|NCT00321737|13127787|P1|STARTED|Overall Study||147
5336859|NCT00321711|13127815|P5|NOT COMPLETED|Part B||5
5336860|NCT00321711|13127816|P4|NOT COMPLETED|Part B||6
5336861|NCT00321711|13127817|P3|NOT COMPLETED|Part B||0
5336862|NCT00321711|13127818|P2|NOT COMPLETED|Part B||0
5336863|NCT00321711|13127819|P1|NOT COMPLETED|Part B||0
5336864|NCT00321711|13127815|P5|COMPLETED|Part B||10
5336865|NCT00321711|13127816|P4|COMPLETED|Part B||8
5336866|NCT00321711|13127817|P3|COMPLETED|Part B||0
5336867|NCT00321711|13127818|P2|COMPLETED|Part B||0
5336868|NCT00321711|13127819|P1|COMPLETED|Part B||0
5336869|NCT00321711|13127815|P5|STARTED|Part B||15
5336870|NCT00321711|13127816|P4|STARTED|Part B||14
5336871|NCT00321711|13127817|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
5336872|NCT00321711|13127818|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
5336873|NCT00321711|13127819|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
5336874|NCT00321711|13127815|P5|NOT COMPLETED|Part A||0
5336875|NCT00321711|13127816|P4|NOT COMPLETED|Part A||0
5336876|NCT00321711|13127817|P3|NOT COMPLETED|Part A||11
5336877|NCT00321711|13127818|P2|NOT COMPLETED|Part A||10
5336878|NCT00321711|13127819|P1|NOT COMPLETED|Part A||5
5336879|NCT00321711|13127815|P5|COMPLETED|Part A||0
5336880|NCT00321711|13127816|P4|COMPLETED|Part A||0
5336881|NCT00321711|13127817|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
5336882|NCT00321711|13127818|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
5336883|NCT00321711|13127819|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
5336884|NCT00321711|13127815|P5|STARTED|Part A||0
5336885|NCT00321711|13127816|P4|STARTED|Part A||0
5336886|NCT00321711|13127817|P3|STARTED|Part A||14
5336887|NCT00321711|13127818|P2|STARTED|Part A||13
5336888|NCT00321711|13127819|P1|STARTED|Part A||13
5336889|NCT00321698|13127851|P5|NOT COMPLETED|Phase II, MTD Dose||0
5336890|NCT00321698|13127852|P4|NOT COMPLETED|Phase II, MTD Dose||0
5336891|NCT00321698|13127853|P3|NOT COMPLETED|Phase II, MTD Dose||0
5336892|NCT00321698|13127854|P2|NOT COMPLETED|Phase II, MTD Dose||0
5336893|NCT00321698|13127855|P1|NOT COMPLETED|Phase II, MTD Dose||0
5336894|NCT00321698|13127851|P5|COMPLETED|Phase II, MTD Dose||13
5336895|NCT00321698|13127852|P4|COMPLETED|Phase II, MTD Dose||0
5336896|NCT00321698|13127853|P3|COMPLETED|Phase II, MTD Dose||0
5336897|NCT00321698|13127854|P2|COMPLETED|Phase II, MTD Dose||0
5336898|NCT00321698|13127855|P1|COMPLETED|Phase II, MTD Dose||0
5336899|NCT00321698|13127851|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
5336900|NCT00321698|13127852|P4|STARTED|Phase II, MTD Dose||0
5336901|NCT00321698|13127853|P3|STARTED|Phase II, MTD Dose||0
5336902|NCT00321698|13127854|P2|STARTED|Phase II, MTD Dose||0
5336903|NCT00321698|13127855|P1|STARTED|Phase II, MTD Dose||0
5336904|NCT00321698|13127851|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336905|NCT00321698|13127852|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336906|NCT00321698|13127853|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336907|NCT00321698|13127854|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336908|NCT00321698|13127855|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336909|NCT00321698|13127851|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
5336910|NCT00321698|13127852|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
5336911|NCT00321698|13127853|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
5336912|NCT00321698|13127854|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
5336913|NCT00321698|13127855|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
5336914|NCT00321698|13127851|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
5336915|NCT00321698|13127852|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
5336916|NCT00321698|13127853|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
5336917|NCT00321698|13127854|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
5336918|NCT00321698|13127855|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
5336919|NCT00321685|13127869|P1|NOT COMPLETED|Overall Study||39
5336920|NCT00321685|13127869|P1|COMPLETED|Overall Study||18
5336921|NCT00321685|13127869|P1|Eligible and Treated|Overall Study||53
5336922|NCT00321685|13127869|P1|Started Protocol Therapy|Overall Study||55
5336923|NCT00321685|13127869|P1|Eligible|Overall Study||55
5336924|NCT00321685|13127869|P1|STARTED|Overall Study||57
5336925|NCT00321672|13127881|P4|NOT COMPLETED|Overall Study||2
5336926|NCT00321672|13127882|P3|NOT COMPLETED|Overall Study||11
5336927|NCT00321672|13127883|P2|NOT COMPLETED|Overall Study||8
5336928|NCT00321672|13127884|P1|NOT COMPLETED|Overall Study||12
5336929|NCT00321672|13127881|P4|COMPLETED|Overall Study||71
5336930|NCT00321672|13127882|P3|COMPLETED|Overall Study||156
5336931|NCT00321672|13127883|P2|COMPLETED|Overall Study||81
5336932|NCT00321672|13127884|P1|COMPLETED|Overall Study||153
5336933|NCT00321672|13127881|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
5336934|NCT00321672|13127882|P3|STARTED|Overall Study||167
5336935|NCT00321672|13127883|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
5336936|NCT00321672|13127884|P1|STARTED|Overall Study||165
5336937|NCT00321646|13127910|P1|NOT COMPLETED|Prostatectomy||0
5336938|NCT00321646|13127910|P1|COMPLETED|Prostatectomy||37
5336939|NCT00321646|13127910|P1|STARTED|Prostatectomy||37
5336940|NCT00321646|13127910|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
5336941|NCT00321646|13127910|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
5336942|NCT00321646|13127910|P1|STARTED|Neoadjuvant Chemotherapy||42
5336943|NCT00321620|13127917|P2|NOT COMPLETED|Overall Study||722
5336944|NCT00321620|13127918|P1|NOT COMPLETED|Overall Study||743
5336945|NCT00321620|13127917|P2|COMPLETED|Overall Study||228
5336946|NCT00321620|13127918|P1|COMPLETED|Overall Study||208
5336947|NCT00321620|13127917|P2|Received Investigational Product|Overall Study||942
5336948|NCT00321620|13127918|P1|Received Investigational Product|Overall Study||946
5336949|NCT00321620|13127917|P2|STARTED|Overall Study||950
5336950|NCT00321620|13127918|P1|STARTED|Overall Study||951
5336951|NCT00321594|13127930|P5|NOT COMPLETED|Phase II, MTD Dose||0
5336952|NCT00321594|13127931|P4|NOT COMPLETED|Phase II, MTD Dose||0
5336953|NCT00321594|13127932|P3|NOT COMPLETED|Phase II, MTD Dose||0
5336954|NCT00321594|13127933|P2|NOT COMPLETED|Phase II, MTD Dose||0
5336955|NCT00321594|13127934|P1|NOT COMPLETED|Phase II, MTD Dose||0
5336956|NCT00321594|13127930|P5|COMPLETED|Phase II, MTD Dose||36
5336957|NCT00321594|13127931|P4|COMPLETED|Phase II, MTD Dose||6
5336958|NCT00321594|13127932|P3|COMPLETED|Phase II, MTD Dose||0
5336959|NCT00321594|13127933|P2|COMPLETED|Phase II, MTD Dose||0
5336960|NCT00321594|13127934|P1|COMPLETED|Phase II, MTD Dose||0
5336961|NCT00321594|13127930|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
5336962|NCT00321594|13127931|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
5336963|NCT00321594|13127932|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
5336964|NCT00321594|13127933|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
5336965|NCT00321594|13127934|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
5336966|NCT00321594|13127930|P5|NOT COMPLETED|Phase I, Level 1-4||0
5336967|NCT00321594|13127931|P4|NOT COMPLETED|Phase I, Level 1-4||0
5336968|NCT00321594|13127932|P3|NOT COMPLETED|Phase I, Level 1-4||0
5336969|NCT00321594|13127933|P2|NOT COMPLETED|Phase I, Level 1-4||0
5336970|NCT00321594|13127934|P1|NOT COMPLETED|Phase I, Level 1-4||0
5336971|NCT00321594|13127930|P5|COMPLETED|Phase I, Level 1-4||0
5336972|NCT00321594|13127931|P4|COMPLETED|Phase I, Level 1-4||6
5336973|NCT00321594|13127932|P3|COMPLETED|Phase I, Level 1-4||6
5336974|NCT00321594|13127933|P2|COMPLETED|Phase I, Level 1-4||3
5336975|NCT00321594|13127934|P1|COMPLETED|Phase I, Level 1-4||3
5336976|NCT00321594|13127930|P5|STARTED|Phase I, Level 1-4||0
5336977|NCT00321594|13127931|P4|STARTED|Phase I, Level 1-4||6
5336978|NCT00321594|13127932|P3|STARTED|Phase I, Level 1-4||6
5336979|NCT00321594|13127933|P2|STARTED|Phase I, Level 1-4||3
5336980|NCT00321594|13127934|P1|STARTED|Phase I, Level 1-4||3
5336981|NCT00321555|13127946|P1|NOT COMPLETED|Overall Study||6
5336982|NCT00321555|13127946|P1|COMPLETED|Overall Study||9
5336983|NCT00321555|13127946|P1|STARTED|Overall Study||15
5336984|NCT00321464|13127954|P2|NOT COMPLETED|Overall Study||558
5336985|NCT00321464|13127955|P1|NOT COMPLETED|Overall Study||559
5336986|NCT00321464|13127954|P2|COMPLETED|Overall Study||468
5336987|NCT00321464|13127955|P1|COMPLETED|Overall Study||461
5336988|NCT00321464|13127954|P2|Received Investigational Product|Overall Study||1019
5336989|NCT00321464|13127955|P1|Received Investigational Product|Overall Study||1014
5336990|NCT00321464|13127954|P2|STARTED|Overall Study||1026
5336991|NCT00321464|13127955|P1|STARTED|Overall Study||1020
5336992|NCT00321373|13127968|P3|NOT COMPLETED|Overall Study||3
5336993|NCT00321373|13127969|P2|NOT COMPLETED|Overall Study||0
5336994|NCT00321373|13127970|P1|NOT COMPLETED|Overall Study||2
5336995|NCT00321373|13127968|P3|COMPLETED|Overall Study||404
5336996|NCT00321373|13127969|P2|COMPLETED|Overall Study||406
5336997|NCT00321373|13127970|P1|COMPLETED|Overall Study||405
5336998|NCT00321373|13127968|P3|STARTED|Overall Study||407
5336999|NCT00321373|13127969|P2|STARTED|Overall Study||406
5337000|NCT00321373|13127970|P1|STARTED|Overall Study||407
5337001|NCT00321321|13127993|P1|NOT COMPLETED|Overall Study||0
5337002|NCT00321321|13127993|P1|COMPLETED|Overall Study||12
5337003|NCT00321321|13127993|P1|STARTED|Overall Study||12
5337004|NCT00321269|13127999|P2|NOT COMPLETED|Overall Study||6
5337005|NCT00321269|13128000|P1|NOT COMPLETED|Overall Study||8
5337006|NCT00321269|13127999|P2|COMPLETED|Overall Study||68
5337007|NCT00321269|13128000|P1|COMPLETED|Overall Study||66
5337008|NCT00321269|13127999|P2|STARTED|Overall Study||74
5337009|NCT00321269|13128000|P1|STARTED|Overall Study||74
5337010|NCT00321048|13128010|P2|NOT COMPLETED|Overall Study||8
5337011|NCT00321048|13128011|P1|NOT COMPLETED|Overall Study||6
5337012|NCT00321048|13128010|P2|COMPLETED|Overall Study||21
5337013|NCT00321048|13128011|P1|COMPLETED|Overall Study||22
5337014|NCT00321048|13128010|P2|STARTED|Overall Study||29
5337015|NCT00321048|13128011|P1|STARTED|Overall Study||28
5337016|NCT00320801|13128019|P4|NOT COMPLETED|Extension Phase||48
5337017|NCT00320801|13128020|P3|NOT COMPLETED|Extension Phase||0
5337018|NCT00320801|13128021|P2|NOT COMPLETED|Extension Phase||0
5337019|NCT00320801|13128022|P1|NOT COMPLETED|Extension Phase||0
5337020|NCT00320801|13128019|P4|COMPLETED|Extension Phase||7
5337021|NCT00320801|13128020|P3|COMPLETED|Extension Phase||0
5337022|NCT00320801|13128021|P2|COMPLETED|Extension Phase||0
5337023|NCT00320801|13128022|P1|COMPLETED|Extension Phase||0
5337024|NCT00320801|13128019|P4|STARTED|Extension Phase||55
5337025|NCT00320801|13128020|P3|STARTED|Extension Phase||0
5337026|NCT00320801|13128021|P2|STARTED|Extension Phase||0
5337027|NCT00320801|13128022|P1|STARTED|Extension Phase||0
5337028|NCT00320801|13128019|P4|NOT COMPLETED|Double-blind Phase||0
5337029|NCT00320801|13128020|P3|NOT COMPLETED|Double-blind Phase||14
5337030|NCT00320801|13128021|P2|NOT COMPLETED|Double-blind Phase||11
5337031|NCT00320801|13128022|P1|NOT COMPLETED|Double-blind Phase||0
5337032|NCT00320801|13128019|P4|COMPLETED|Double-blind Phase||0
5337033|NCT00320801|13128020|P3|COMPLETED|Double-blind Phase||35
5337034|NCT00320801|13128021|P2|COMPLETED|Double-blind Phase||36
5337035|NCT00320801|13128022|P1|COMPLETED|Double-blind Phase||0
5337036|NCT00320801|13128019|P4|STARTED|Double-blind Phase||0
5337037|NCT00320801|13128020|P3|STARTED|Double-blind Phase||49
5337038|NCT00320801|13128021|P2|STARTED|Double-blind Phase||47
5337039|NCT00320801|13128022|P1|STARTED|Double-blind Phase||0
5337040|NCT00320801|13128019|P4|NOT COMPLETED|Open-label Run-in Period||0
5337041|NCT00320801|13128020|P3|NOT COMPLETED|Open-label Run-in Period||0
5337042|NCT00320801|13128021|P2|NOT COMPLETED|Open-label Run-in Period||0
5337043|NCT00320801|13128022|P1|NOT COMPLETED|Open-label Run-in Period||92
5337044|NCT00320801|13128019|P4|COMPLETED|Open-label Run-in Period||0
5337045|NCT00320801|13128020|P3|COMPLETED|Open-label Run-in Period||0
5337046|NCT00320801|13128021|P2|COMPLETED|Open-label Run-in Period||0
5337047|NCT00320801|13128022|P1|COMPLETED|Open-label Run-in Period||96
5337048|NCT00320801|13128019|P4|STARTED|Open-label Run-in Period||0
5337049|NCT00320801|13128020|P3|STARTED|Open-label Run-in Period||0
5337050|NCT00320801|13128021|P2|STARTED|Open-label Run-in Period||0
5337051|NCT00320801|13128022|P1|STARTED|Open-label Run-in Period||188
5337052|NCT00320788|13128037|P5|NOT COMPLETED|Overall Study||5
5337053|NCT00320788|13128038|P4|NOT COMPLETED|Overall Study||5
5337054|NCT00320788|13128039|P3|NOT COMPLETED|Overall Study||3
5337055|NCT00320788|13128040|P2|NOT COMPLETED|Overall Study||6
5337056|NCT00320788|13128041|P1|NOT COMPLETED|Overall Study||6
5337057|NCT00320788|13128037|P5|COMPLETED|Overall Study||26
5337058|NCT00320788|13128038|P4|COMPLETED|Overall Study||27
5337059|NCT00320788|13128039|P3|COMPLETED|Overall Study||29
5337060|NCT00320788|13128040|P2|COMPLETED|Overall Study||26
5337061|NCT00320788|13128041|P1|COMPLETED|Overall Study||26
5337062|NCT00320788|13128037|P5|Participants Received Treatment (SAF)|Overall Study||31
5337063|NCT00320788|13128038|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
5337064|NCT00320788|13128039|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
5337065|NCT00320788|13128040|P2|Participants Received Treatment (SAF)|Overall Study||32
5337066|NCT00320788|13128041|P1|Participants Received Treatment (SAF)|Overall Study||32
5337067|NCT00320788|13128037|P5|STARTED|Overall Study||31
5337068|NCT00320788|13128038|P4|STARTED|Overall Study|Participants Randomized|32
5337069|NCT00320788|13128039|P3|STARTED|Overall Study||32
5337070|NCT00320788|13128040|P2|STARTED|Overall Study||32
5337071|NCT00320788|13128041|P1|STARTED|Overall Study||32
5337072|NCT00320749|13128084|P3|NOT COMPLETED|Overall Study||9
5337073|NCT00320749|13128085|P2|NOT COMPLETED|Overall Study||2
5337074|NCT00320749|13128086|P1|NOT COMPLETED|Overall Study||0
5337075|NCT00320749|13128084|P3|COMPLETED|Overall Study||1
5337076|NCT00320749|13128085|P2|COMPLETED|Overall Study||6
5337077|NCT00320749|13128086|P1|COMPLETED|Overall Study||3
5337078|NCT00320749|13128084|P3|STARTED|Overall Study||10
5337079|NCT00320749|13128085|P2|STARTED|Overall Study||8
5337080|NCT00320749|13128086|P1|STARTED|Overall Study||3
5337081|NCT00320710|13128095|P3|NOT COMPLETED|Overall Study||5
5337082|NCT00320710|13128096|P2|NOT COMPLETED|Overall Study||76
5337083|NCT00320710|13128097|P1|NOT COMPLETED|Overall Study||94
5337084|NCT00320710|13128095|P3|COMPLETED|Overall Study||8
5337085|NCT00320710|13128096|P2|COMPLETED|Overall Study||127
5337086|NCT00320710|13128097|P1|COMPLETED|Overall Study||106
5337087|NCT00320710|13128095|P3|Treated (Safety Set)|Overall Study||13
5337088|NCT00320710|13128096|P2|Treated (Safety Set)|Overall Study||202
5337089|NCT00320710|13128097|P1|Treated (Safety Set)|Overall Study||198
5337090|NCT00320710|13128095|P3|STARTED|Overall Study||13
5337091|NCT00320710|13128096|P2|STARTED|Overall Study||203
5337092|NCT00320710|13128097|P1|STARTED|Overall Study||200
5337093|NCT00320671|13128120|P2|NOT COMPLETED|Overall Study||38
5337094|NCT00320671|13128121|P1|NOT COMPLETED|Overall Study||33
5337095|NCT00320671|13128120|P2|COMPLETED|Overall Study||58
5337096|NCT00320671|13128121|P1|COMPLETED|Overall Study||69
5337097|NCT00320671|13128120|P2|STARTED|Overall Study||96
5337098|NCT00320671|13128121|P1|STARTED|Overall Study||102
5337099|NCT00320606|13128127|P1|NOT COMPLETED|Overall Study||3
5337100|NCT00320606|13128127|P1|COMPLETED|Overall Study||17
5337101|NCT00320606|13128127|P1|STARTED|Overall Study||20
5337102|NCT00320593|13128143|P2|NOT COMPLETED|Overall Study||1
5337103|NCT00320593|13128144|P1|NOT COMPLETED|Overall Study||7
5337104|NCT00320593|13128143|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
5337105|NCT00320593|13128144|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
5337106|NCT00320593|13128143|P2|STARTED|Overall Study||59
5337107|NCT00320593|13128144|P1|STARTED|Overall Study||59
5337108|NCT00320541|13128168|P2|NOT COMPLETED|Overall Study||57
5337109|NCT00320541|13128169|P1|NOT COMPLETED|Overall Study||50
5337110|NCT00320541|13128168|P2|COMPLETED|Overall Study||36
5337111|NCT00320541|13128169|P1|COMPLETED|Overall Study||44
5337112|NCT00320541|13128168|P2|STARTED|Overall Study||93
5337113|NCT00320541|13128169|P1|STARTED|Overall Study||94
5337114|NCT00320528|13128196|P3|NOT COMPLETED|Study Period III||106
5337115|NCT00320528|13128197|P2|NOT COMPLETED|Study Period III||31
5337116|NCT00320528|13128198|P1|NOT COMPLETED|Study Period III||87
5337117|NCT00320528|13128196|P3|COMPLETED|Study Period III||2
5337118|NCT00320528|13128197|P2|COMPLETED|Study Period III||0
5337119|NCT00320528|13128198|P1|COMPLETED|Study Period III||0
5337120|NCT00320528|13128196|P3|STARTED|Study Period III||108
5337121|NCT00320528|13128197|P2|STARTED|Study Period III||31
5337122|NCT00320528|13128198|P1|STARTED|Study Period III||87
5337123|NCT00320528|13128196|P3|NOT COMPLETED|Study Period II||22
5337124|NCT00320528|13128197|P2|NOT COMPLETED|Study Period II||10
5337125|NCT00320528|13128198|P1|NOT COMPLETED|Study Period II||11
5337126|NCT00320528|13128196|P3|COMPLETED|Study Period II||108
5337127|NCT00320528|13128197|P2|COMPLETED|Study Period II||31
5337128|NCT00320528|13128198|P1|COMPLETED|Study Period II||87
5337129|NCT00320528|13128196|P3|Received at Least One Dose of Study Drug|Study Period II||128
5337130|NCT00320528|13128197|P2|Received at Least One Dose of Study Drug|Study Period II||38
5337131|NCT00320528|13128198|P1|Received at Least One Dose of Study Drug|Study Period II||97
5337132|NCT00320528|13128196|P3|STARTED|Study Period II||130
5337133|NCT00320528|13128197|P2|STARTED|Study Period II||41
5337134|NCT00320528|13128198|P1|STARTED|Study Period II||98
5337135|NCT00320515|13128233|P1|NOT COMPLETED|Overall Study||49
5337136|NCT00320515|13128233|P1|COMPLETED|Overall Study||20
5337137|NCT00320515|13128233|P1|STARTED|Overall Study||69
5337138|NCT00320489|13128242|P2|NOT COMPLETED|Overall Study||136
5337139|NCT00320489|13128243|P1|NOT COMPLETED|Overall Study||145
5337140|NCT00320489|13128242|P2|COMPLETED|Overall Study||124
5337141|NCT00320489|13128243|P1|COMPLETED|Overall Study||119
5337142|NCT00320489|13128242|P2|STARTED|Overall Study||260
5337143|NCT00320489|13128243|P1|STARTED|Overall Study||264
5337144|NCT00320424|13128299|P1|NOT COMPLETED|Overall Study||6
5337145|NCT00320424|13128299|P1|COMPLETED|Overall Study||42
5337146|NCT00320424|13128299|P1|STARTED|Overall Study||48
5337147|NCT00320411|13128313|P1|NOT COMPLETED|Overall Study||4
5337148|NCT00320411|13128313|P1|COMPLETED|Overall Study||58
5337149|NCT00320411|13128313|P1|STARTED|Overall Study||62
5337150|NCT00320398|13128336|P2|NOT COMPLETED|Overall Study||4
5337151|NCT00320398|13128337|P1|NOT COMPLETED|Overall Study||2
5337152|NCT00320398|13128336|P2|COMPLETED|Overall Study||52
5337153|NCT00320398|13128337|P1|COMPLETED|Overall Study||56
5337154|NCT00320398|13128336|P2|STARTED|Overall Study||56
5337155|NCT00320398|13128337|P1|STARTED|Overall Study||58
5337156|NCT00320385|13128365|P2|NOT COMPLETED|Overall Study||22
5337157|NCT00320385|13128366|P1|NOT COMPLETED|Overall Study||18
5337158|NCT00320385|13128365|P2|COMPLETED|Overall Study||126
5337159|NCT00320385|13128366|P1|COMPLETED|Overall Study||130
5337160|NCT00320385|13128365|P2|STARTED|Overall Study||148
5337161|NCT00320385|13128366|P1|STARTED|Overall Study||148
5337162|NCT00320372|13128389|P2|NOT COMPLETED|Overall Study||163
5337163|NCT00320372|13128390|P1|NOT COMPLETED|Overall Study||195
5337164|NCT00320372|13128389|P2|COMPLETED|Overall Study||138
5337165|NCT00320372|13128390|P1|COMPLETED|Overall Study||299
5337166|NCT00320372|13128389|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
5337167|NCT00320372|13128390|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
5337168|NCT00320372|13128389|P2|VNS Therapy D-23 Original|Overall Study||0
5337169|NCT00320372|13128390|P1|VNS Therapy D-23 Original|Overall Study||335
5337170|NCT00320372|13128389|P2|STARTED|Overall Study||301
5337171|NCT00320372|13128390|P1|STARTED|Overall Study||494
5337172|NCT00320281|13128417|P2|NOT COMPLETED|Overall Study||0
5337173|NCT00320281|13128418|P1|NOT COMPLETED|Overall Study||0
5337174|NCT00320281|13128417|P2|COMPLETED|Overall Study||9
5337175|NCT00320281|13128418|P1|COMPLETED|Overall Study||10
5337176|NCT00320281|13128417|P2|STARTED|Overall Study||9
5337177|NCT00320281|13128418|P1|STARTED|Overall Study||10
5337178|NCT00320255|13128430|P6|NOT COMPLETED|Overall Study||0
5337179|NCT00320255|13128431|P5|NOT COMPLETED|Overall Study||0
5337180|NCT00320255|13128432|P4|NOT COMPLETED|Overall Study||8
5337181|NCT00320255|13128433|P3|NOT COMPLETED|Overall Study||6
5337182|NCT00320255|13128434|P2|NOT COMPLETED|Overall Study||7
5337183|NCT00320255|13128435|P1|NOT COMPLETED|Overall Study||11
5337184|NCT00320255|13128430|P6|COMPLETED|Overall Study||3
5337185|NCT00320255|13128431|P5|COMPLETED|Overall Study||2
5337186|NCT00320255|13128432|P4|COMPLETED|Overall Study||25
5337187|NCT00320255|13128433|P3|COMPLETED|Overall Study||24
5337188|NCT00320255|13128434|P2|COMPLETED|Overall Study||25
5337189|NCT00320255|13128435|P1|COMPLETED|Overall Study||19
5337190|NCT00320255|13128430|P6|Received Treatment|Overall Study||3
5337191|NCT00320255|13128431|P5|Received Treatment|Overall Study||2
5337192|NCT00320255|13128432|P4|Received Treatment|Overall Study||32
5337193|NCT00320255|13128433|P3|Received Treatment|Overall Study||29
5337194|NCT00320255|13128434|P2|Received Treatment|Overall Study||32
5337195|NCT00320255|13128435|P1|Received Treatment|Overall Study||29
5337196|NCT00320255|13128430|P6|STARTED|Overall Study||3
5337197|NCT00320255|13128431|P5|STARTED|Overall Study||2
5337198|NCT00320255|13128432|P4|STARTED|Overall Study||33
5337199|NCT00320255|13128433|P3|STARTED|Overall Study||30
5337200|NCT00320255|13128434|P2|STARTED|Overall Study||32
5337201|NCT00320255|13128435|P1|STARTED|Overall Study||30
5337202|NCT00320242|13128515|P2|NOT COMPLETED|Overall Study||4
5337203|NCT00320242|13128516|P1|NOT COMPLETED|Overall Study||2
5337204|NCT00320242|13128515|P2|COMPLETED|Overall Study||12
5337205|NCT00320242|13128516|P1|COMPLETED|Overall Study||14
5337206|NCT00320242|13128515|P2|STARTED|Overall Study||16
5337207|NCT00320242|13128516|P1|STARTED|Overall Study||16
5337208|NCT00320216|13128528|P5|NOT COMPLETED|Overall Study||6
5337209|NCT00320216|13128529|P4|NOT COMPLETED|Overall Study||3
5337210|NCT00320216|13128530|P3|NOT COMPLETED|Overall Study||6
5337211|NCT00320216|13128531|P2|NOT COMPLETED|Overall Study||10
5337212|NCT00320216|13128532|P1|NOT COMPLETED|Overall Study||16
5337213|NCT00320216|13128528|P5|COMPLETED|Overall Study||58
5337214|NCT00320216|13128529|P4|COMPLETED|Overall Study||61
5337215|NCT00320216|13128530|P3|COMPLETED|Overall Study||58
5337216|NCT00320216|13128531|P2|COMPLETED|Overall Study||54
5337217|NCT00320216|13128532|P1|COMPLETED|Overall Study||48
5337218|NCT00320216|13128528|P5|STARTED|Overall Study||64
5337219|NCT00320216|13128529|P4|STARTED|Overall Study||64
5337220|NCT00320216|13128530|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
5337221|NCT00320216|13128531|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
5337222|NCT00320216|13128532|P1|STARTED|Overall Study||64
5337223|NCT00320190|13128566|P2|NOT COMPLETED|Long-term (12-month) Extension||2
5337224|NCT00320190|13128567|P1|NOT COMPLETED|Long-term (12-month) Extension||9
5337225|NCT00320190|13128566|P2|COMPLETED|Long-term (12-month) Extension||1
5337226|NCT00320190|13128567|P1|COMPLETED|Long-term (12-month) Extension||2
5337227|NCT00320190|13128566|P2|STARTED|Long-term (12-month) Extension||3
5337228|NCT00320190|13128567|P1|STARTED|Long-term (12-month) Extension||11
5337229|NCT00320190|13128566|P2|NOT COMPLETED|First 12 Months||10
5337230|NCT00320190|13128567|P1|NOT COMPLETED|First 12 Months||8
5337231|NCT00320190|13128566|P2|COMPLETED|First 12 Months||3
5337232|NCT00320190|13128567|P1|COMPLETED|First 12 Months||11
5337233|NCT00320190|13128566|P2|STARTED|First 12 Months||13
5337234|NCT00320190|13128567|P1|STARTED|First 12 Months||19
5337235|NCT00320112|13128587|P2|NOT COMPLETED|Overall Study||5
5337236|NCT00320112|13128588|P1|NOT COMPLETED|Overall Study||8
5337237|NCT00320112|13128587|P2|COMPLETED|Overall Study||114
5337238|NCT00320112|13128588|P1|COMPLETED|Overall Study||117
5337239|NCT00320112|13128587|P2|STARTED|Overall Study||119
5337240|NCT00320112|13128588|P1|STARTED|Overall Study||125
5337241|NCT00319982|13128602|P2|NOT COMPLETED|Overall Study||0
5337242|NCT00319982|13128603|P1|NOT COMPLETED|Overall Study||1
5337243|NCT00319982|13128602|P2|COMPLETED|Overall Study||20
5337244|NCT00319982|13128603|P1|COMPLETED|Overall Study||18
5337245|NCT00319982|13128602|P2|STARTED|Overall Study||20
5337246|NCT00319982|13128603|P1|STARTED|Overall Study||19
5337247|NCT00319956|13128623|P2|NOT COMPLETED|Overall Study||24
5337248|NCT00319956|13128624|P1|NOT COMPLETED|Overall Study||20
5337249|NCT00319956|13128623|P2|COMPLETED|Overall Study||85
5337250|NCT00319956|13128624|P1|COMPLETED|Overall Study||91
5337251|NCT00319956|13128623|P2|STARTED|Overall Study||109
5337252|NCT00319956|13128624|P1|STARTED|Overall Study||111
5337253|NCT00319839|13128636|P1|NOT COMPLETED|Overall Study||6
5337254|NCT00319839|13128636|P1|COMPLETED|Overall Study||1
5337255|NCT00319839|13128636|P1|STARTED|Overall Study||7
5337256|NCT00319748|13128642|P1|NOT COMPLETED|Overall Study||0
5337257|NCT00319748|13128642|P1|COMPLETED|Overall Study||13
5337258|NCT00319748|13128642|P1|STARTED|Overall Study||13
5337259|NCT00319735|13128652|P1|NOT COMPLETED|Overall Study||2
5337260|NCT00319735|13128652|P1|COMPLETED|Overall Study||39
5337261|NCT00319735|13128652|P1|STARTED|Overall Study||41
5337262|NCT00319696|13128665|P1|NOT COMPLETED|Overall Study||60
5337263|NCT00319696|13128665|P1|COMPLETED|Overall Study||56
5337264|NCT00319696|13128665|P1|STARTED|Overall Study||116
5337265|NCT00319644|13128691|P2|NOT COMPLETED|Overall Study||0
5337266|NCT00319644|13128692|P1|NOT COMPLETED|Overall Study||0
5337267|NCT00319644|13128691|P2|COMPLETED|Overall Study||16
5337268|NCT00319644|13128692|P1|COMPLETED|Overall Study||21
5337269|NCT00319644|13128691|P2|STARTED|Overall Study||16
5337270|NCT00319644|13128692|P1|STARTED|Overall Study||21
5337271|NCT00319592|13128702|P2|NOT COMPLETED|Overall Study||1
5337272|NCT00319592|13128703|P1|NOT COMPLETED|Overall Study||1
5337273|NCT00319592|13128702|P2|COMPLETED|Overall Study||29
5337274|NCT00319592|13128703|P1|COMPLETED|Overall Study||29
5337275|NCT00319592|13128702|P2|STARTED|Overall Study||30
5337276|NCT00319592|13128703|P1|STARTED|Overall Study||30
5337277|NCT00319553|13128719|P2|NOT COMPLETED|Overall Study||4
5337278|NCT00319553|13128720|P1|NOT COMPLETED|Overall Study||4
5337279|NCT00319553|13128719|P2|COMPLETED|Overall Study||317
5337280|NCT00319553|13128720|P1|COMPLETED|Overall Study||319
5337281|NCT00319553|13128719|P2|STARTED|Overall Study||321
5337282|NCT00319553|13128720|P1|STARTED|Overall Study||323
5337283|NCT00319501|13128734|P2|NOT COMPLETED|Open-label Extension Period||0
5337284|NCT00319501|13128735|P1|NOT COMPLETED|Open-label Extension Period||51
5337285|NCT00319501|13128734|P2|COMPLETED|Open-label Extension Period||0
5337286|NCT00319501|13128735|P1|COMPLETED|Open-label Extension Period||0
5337287|NCT00319501|13128734|P2|Received Treatment|Open-label Extension Period||0
5337288|NCT00319501|13128735|P1|Received Treatment|Open-label Extension Period||33
5337289|NCT00319501|13128734|P2|STARTED|Open-label Extension Period||0
5337290|NCT00319501|13128735|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
5337291|NCT00319501|13128734|P2|NOT COMPLETED|Open-label Period||0
5337292|NCT00319501|13128735|P1|NOT COMPLETED|Open-label Period||116
5337293|NCT00319501|13128734|P2|COMPLETED|Open-label Period||0
5337294|NCT00319501|13128735|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
5337295|NCT00319501|13128734|P2|Received Treatment|Open-label Period||0
5337296|NCT00319501|13128735|P1|Received Treatment|Open-label Period||128
5337297|NCT00319501|13128734|P2|STARTED|Open-label Period||0
5337298|NCT00319501|13128735|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
5337299|NCT00319501|13128734|P2|NOT COMPLETED|Double-blind Period||32
5337300|NCT00319501|13128735|P1|NOT COMPLETED|Double-blind Period||43
5337301|NCT00319501|13128734|P2|COMPLETED|Double-blind Period||78
5337302|NCT00319501|13128735|P1|COMPLETED|Double-blind Period||81
5337303|NCT00319501|13128734|P2|Received Treatment|Double-blind Period||81
5337304|NCT00319501|13128735|P1|Received Treatment|Double-blind Period||82
5337305|NCT00319501|13128734|P2|STARTED|Double-blind Period|Randomized participants|110
5337306|NCT00319501|13128735|P1|STARTED|Double-blind Period|Randomized participants|124
5337307|NCT00319449|13128761|P2|NOT COMPLETED|Overall Study||0
5337308|NCT00319449|13128762|P1|NOT COMPLETED|Overall Study||2
5337309|NCT00319449|13128761|P2|COMPLETED|Overall Study||12
5337310|NCT00319449|13128762|P1|COMPLETED|Overall Study||8
5337311|NCT00319449|13128761|P2|STARTED|Overall Study||12
5337312|NCT00319449|13128762|P1|STARTED|Overall Study||10
5337313|NCT00319436|13128774|P2|NOT COMPLETED|Overall Study||7
5337314|NCT00319436|13128775|P1|NOT COMPLETED|Overall Study||6
5337315|NCT00319436|13128774|P2|COMPLETED|Overall Study||17
5337316|NCT00319436|13128775|P1|COMPLETED|Overall Study||17
5337317|NCT00319436|13128774|P2|STARTED|Overall Study||24
5337318|NCT00319436|13128775|P1|STARTED|Overall Study||23
5337319|NCT00319254|13128793|P1|NOT COMPLETED|Overall Study||54
5337320|NCT00319254|13128793|P1|COMPLETED|Overall Study||21
5337321|NCT00319254|13128793|P1|Treated|Overall Study||73
5337322|NCT00319254|13128793|P1|STARTED|Overall Study||75
5337323|NCT00319111|13128806|P1|NOT COMPLETED|Overall Study||47
5337324|NCT00319111|13128806|P1|COMPLETED|Overall Study||104
5337325|NCT00319111|13128806|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
5337326|NCT00319098|13128820|P2|NOT COMPLETED|Overall Study||32
5337327|NCT00319098|13128821|P1|NOT COMPLETED|Overall Study||135
5337328|NCT00319098|13128820|P2|COMPLETED|Overall Study||1237
5337329|NCT00319098|13128821|P1|COMPLETED|Overall Study||3667
5337330|NCT00319098|13128820|P2|STARTED|Overall Study||1269
5337331|NCT00319098|13128821|P1|STARTED|Overall Study||3802
5337332|NCT00319046|13128879|P1|NOT COMPLETED|Overall Study||8
5337333|NCT00319046|13128879|P1|COMPLETED|Overall Study||34
5337334|NCT00319046|13128879|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
5337335|NCT00319020|13128888|P2|NOT COMPLETED|Overall Study||13
5337336|NCT00319020|13128889|P1|NOT COMPLETED|Overall Study||7
5337337|NCT00319020|13128888|P2|COMPLETED|Overall Study||8
5337338|NCT00319020|13128889|P1|COMPLETED|Overall Study||8
5337339|NCT00319020|13128888|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
5337340|NCT00319020|13128889|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
5337341|NCT00319020|13128888|P2|STARTED|Overall Study||21
5337342|NCT00319020|13128889|P1|STARTED|Overall Study||15
5337343|NCT00318929|13128918|P1|NOT COMPLETED|Overall Study||0
5337344|NCT00318929|13128918|P1|COMPLETED|Overall Study||14
5337345|NCT00318929|13128918|P1|STARTED|Overall Study||14
5337346|NCT00318812|13128927|P2|NOT COMPLETED|Overall Study||0
5337347|NCT00318812|13128928|P1|NOT COMPLETED|Overall Study||0
5337348|NCT00318812|13128927|P2|COMPLETED|Overall Study||22
5337349|NCT00318812|13128928|P1|COMPLETED|Overall Study||18
5337350|NCT00318812|13128927|P2|STARTED|Overall Study||22
5337351|NCT00318812|13128928|P1|STARTED|Overall Study||18
5337352|NCT00318708|13128940|P2|NOT COMPLETED|Overall Study||5
5337353|NCT00318708|13128941|P1|NOT COMPLETED|Overall Study||8
5337354|NCT00318708|13128940|P2|COMPLETED|Overall Study||40
5337355|NCT00318708|13128941|P1|COMPLETED|Overall Study||39
5337356|NCT00318708|13128940|P2|8-week Milestone|Overall Study||42
5337357|NCT00318708|13128941|P1|8-week Milestone|Overall Study||42
5337358|NCT00318708|13128940|P2|STARTED|Overall Study||45
5337359|NCT00318708|13128941|P1|STARTED|Overall Study||47
5337360|NCT00318656|13128961|P2|NOT COMPLETED|Overall Study||2
5337361|NCT00318656|13128962|P1|NOT COMPLETED|Overall Study||0
5337362|NCT00318656|13128961|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
5337363|NCT00318656|13128962|P1|COMPLETED|Overall Study||12
5337364|NCT00318656|13128961|P2|STARTED|Overall Study||11
5337365|NCT00318656|13128962|P1|STARTED|Overall Study||12
5337366|NCT00318591|13129000|P2|NOT COMPLETED|Overall Study||45
5337367|NCT00318591|13129001|P1|NOT COMPLETED|Overall Study||60
5337368|NCT00318591|13129000|P2|COMPLETED|Overall Study||69
5337369|NCT00318591|13129001|P1|COMPLETED|Overall Study||45
5337370|NCT00318591|13129000|P2|STARTED|Overall Study||114
5337371|NCT00318591|13129001|P1|STARTED|Overall Study||105
5337372|NCT00318565|13129019|P1|NOT COMPLETED|Overall Study||24
5337373|NCT00318565|13129019|P1|COMPLETED|Overall Study||267
5337374|NCT00318565|13129019|P1|STARTED|Overall Study||291
5337375|NCT00318474|13129026|P2|NOT COMPLETED|Overall Study||17
5337376|NCT00318474|13129027|P1|NOT COMPLETED|Overall Study||18
5337377|NCT00318474|13129026|P2|COMPLETED|Overall Study||10
5337378|NCT00318474|13129027|P1|COMPLETED|Overall Study||7
5337379|NCT00318474|13129026|P2|STARTED|Overall Study||27
5337380|NCT00318474|13129027|P1|STARTED|Overall Study||25
5337381|NCT00318461|13129038|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
5337382|NCT00318461|13129039|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
5337383|NCT00318461|13129040|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
5337384|NCT00318461|13129041|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
5337385|NCT00318461|13129042|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
5337386|NCT00318461|13129038|P5|COMPLETED|Open-Label Extension, 18 Months||113
5337387|NCT00318461|13129039|P4|COMPLETED|Open-Label Extension, 18 Months||31
5337388|NCT00318461|13129040|P3|COMPLETED|Open-Label Extension, 18 Months||118
5337389|NCT00318461|13129041|P2|COMPLETED|Open-Label Extension, 18 Months||137
5337390|NCT00318461|13129042|P1|COMPLETED|Open-Label Extension, 18 Months||130
5337391|NCT00318461|13129038|P5|STARTED|Open-Label Extension, 18 Months||210
5337392|NCT00318461|13129039|P4|STARTED|Open-Label Extension, 18 Months||74
5337393|NCT00318461|13129040|P3|STARTED|Open-Label Extension, 18 Months||191
5337394|NCT00318461|13129041|P2|STARTED|Open-Label Extension, 18 Months||197
5337395|NCT00318461|13129042|P1|STARTED|Open-Label Extension, 18 Months||208
5337396|NCT00318461|13129038|P5|NOT COMPLETED|Double-Blind, 6 Months||34
5337397|NCT00318461|13129039|P4|NOT COMPLETED|Double-Blind, 6 Months||48
5337398|NCT00318461|13129040|P3|NOT COMPLETED|Double-Blind, 6 Months||51
5337399|NCT00318461|13129041|P2|NOT COMPLETED|Double-Blind, 6 Months||44
5337400|NCT00318461|13129042|P1|NOT COMPLETED|Double-Blind, 6 Months||34
5337401|NCT00318461|13129038|P5|COMPLETED|Double-Blind, 6 Months||210
5337402|NCT00318461|13129039|P4|COMPLETED|Double-Blind, 6 Months||74
5337403|NCT00318461|13129040|P3|COMPLETED|Double-Blind, 6 Months||191
5337404|NCT00318461|13129041|P2|COMPLETED|Double-Blind, 6 Months||197
5337405|NCT00318461|13129042|P1|COMPLETED|Double-Blind, 6 Months||208
5337406|NCT00318461|13129038|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
5337407|NCT00318461|13129039|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
5337408|NCT00318461|13129040|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
5337409|NCT00318461|13129041|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
5337410|NCT00318461|13129042|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
5337411|NCT00318461|13129038|P5|STARTED|Double-Blind, 6 Months|Randomised|244
5337412|NCT00318461|13129039|P4|STARTED|Double-Blind, 6 Months|Randomised|122
5337413|NCT00318461|13129040|P3|STARTED|Double-Blind, 6 Months|Randomised|242
5337414|NCT00318461|13129041|P2|STARTED|Double-Blind, 6 Months|Randomised|241
5337415|NCT00318461|13129042|P1|STARTED|Double-Blind, 6 Months|Randomised|242
5337416|NCT00318409|13129121|P2|NOT COMPLETED|Overall Study||1
5337417|NCT00318409|13129122|P1|NOT COMPLETED|Overall Study||2
5337418|NCT00318409|13129121|P2|COMPLETED|Overall Study||9
5337419|NCT00318409|13129122|P1|COMPLETED|Overall Study||18
5337420|NCT00318409|13129121|P2|STARTED|Overall Study||10
5337421|NCT00318409|13129122|P1|STARTED|Overall Study||20
5337422|NCT00318370|13129141|P3|NOT COMPLETED|Period 3||33
5337423|NCT00318370|13129142|P2|NOT COMPLETED|Period 3||0
5337424|NCT00318370|13129143|P1|NOT COMPLETED|Period 3||0
5337425|NCT00318370|13129141|P3|COMPLETED|Period 3||3
5337426|NCT00318370|13129142|P2|COMPLETED|Period 3||0
5337427|NCT00318370|13129143|P1|COMPLETED|Period 3||0
5337428|NCT00318370|13129141|P3|STARTED|Period 3||36
5337429|NCT00318370|13129142|P2|STARTED|Period 3||0
5337430|NCT00318370|13129143|P1|STARTED|Period 3||0
5337431|NCT00318370|13129141|P3|NOT COMPLETED|Period 2||0
5337432|NCT00318370|13129142|P2|NOT COMPLETED|Period 2||11
5337433|NCT00318370|13129143|P1|NOT COMPLETED|Period 2||0
5337434|NCT00318370|13129141|P3|COMPLETED|Period 2||0
5337435|NCT00318370|13129142|P2|COMPLETED|Period 2||36
5337436|NCT00318370|13129143|P1|COMPLETED|Period 2||0
5337437|NCT00318370|13129141|P3|STARTED|Period 2||0
5337438|NCT00318370|13129142|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
5337439|NCT00318370|13129143|P1|STARTED|Period 2||0
5337440|NCT00318370|13129141|P3|NOT COMPLETED|Period 1||0
5337441|NCT00318370|13129142|P2|NOT COMPLETED|Period 1||0
5337442|NCT00318370|13129143|P1|NOT COMPLETED|Period 1||7
5337443|NCT00318370|13129141|P3|COMPLETED|Period 1||0
5337444|NCT00318370|13129142|P2|COMPLETED|Period 1||0
5337445|NCT00318370|13129143|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
5337446|NCT00318370|13129141|P3|STARTED|Period 1||0
5337447|NCT00318370|13129142|P2|STARTED|Period 1||0
5337448|NCT00318370|13129143|P1|STARTED|Period 1||28
5337449|NCT00318357|13129155|P2|NOT COMPLETED|Overall Study||32
5337450|NCT00318357|13129156|P1|NOT COMPLETED|Overall Study||39
5337451|NCT00318357|13129155|P2|COMPLETED|Overall Study||104
5337452|NCT00318357|13129156|P1|COMPLETED|Overall Study||134
5337453|NCT00318357|13129155|P2|STARTED|Overall Study||136
5337454|NCT00318357|13129156|P1|STARTED|Overall Study||173
5337455|NCT00318292|13129164|P2|NOT COMPLETED|Overall Study||0
5337456|NCT00318292|13129165|P1|NOT COMPLETED|Overall Study||0
5337457|NCT00318292|13129164|P2|COMPLETED|Overall Study||45
5337458|NCT00318292|13129165|P1|COMPLETED|Overall Study||45
5337459|NCT00318292|13129164|P2|STARTED|Overall Study||45
5337460|NCT00318292|13129165|P1|STARTED|Overall Study||45
5337461|NCT00318149|13129177|P6|NOT COMPLETED|Overall Study||2
5337462|NCT00318149|13129178|P5|NOT COMPLETED|Overall Study||0
5337463|NCT00318149|13129179|P4|NOT COMPLETED|Overall Study||0
5337464|NCT00318149|13129180|P3|NOT COMPLETED|Overall Study||0
5337465|NCT00318149|13129181|P2|NOT COMPLETED|Overall Study||0
5337466|NCT00318149|13129182|P1|NOT COMPLETED|Overall Study||0
5337467|NCT00318149|13129177|P6|COMPLETED|Overall Study||73
5337468|NCT00318149|13129178|P5|COMPLETED|Overall Study||75
5337469|NCT00318149|13129179|P4|COMPLETED|Overall Study||75
5337470|NCT00318149|13129180|P3|COMPLETED|Overall Study||75
5337471|NCT00318149|13129181|P2|COMPLETED|Overall Study||50
5337472|NCT00318149|13129182|P1|COMPLETED|Overall Study||75
5337473|NCT00318149|13129177|P6|STARTED|Overall Study||75
5337474|NCT00318149|13129178|P5|STARTED|Overall Study||75
5337475|NCT00318149|13129179|P4|STARTED|Overall Study||75
5337476|NCT00318149|13129180|P3|STARTED|Overall Study||75
5337477|NCT00318149|13129181|P2|STARTED|Overall Study||50
5337478|NCT00318149|13129182|P1|STARTED|Overall Study||75
5337479|NCT00318136|13129268|P1|NOT COMPLETED|Overall Study||45
5337480|NCT00318136|13129268|P1|COMPLETED|Overall Study||2
5337481|NCT00318136|13129268|P1|STARTED|Overall Study||47
5337482|NCT00317941|13129277|P3|NOT COMPLETED|Overall Study||8
5337483|NCT00317941|13129278|P2|NOT COMPLETED|Overall Study||5
5337484|NCT00317941|13129279|P1|NOT COMPLETED|Overall Study||7
5337485|NCT00317941|13129277|P3|COMPLETED|Overall Study||60
5337486|NCT00317941|13129278|P2|COMPLETED|Overall Study||74
5337487|NCT00317941|13129279|P1|COMPLETED|Overall Study||66
5337488|NCT00317941|13129277|P3|Fulfilled Requirements PP Population|Overall Study||63
5337489|NCT00317941|13129278|P2|Fulfilled Requirements PP Population|Overall Study||76
5337490|NCT00317941|13129279|P1|Fulfilled Requirements PP Population|Overall Study||66
5337491|NCT00317941|13129277|P3|Fulfilled Requirement Safety Population|Overall Study||65
5337492|NCT00317941|13129278|P2|Fulfilled Requirement Safety Population|Overall Study||77
5337493|NCT00317941|13129279|P1|Fulfilled Requirement Safety Population|Overall Study||73
5337494|NCT00317941|13129277|P3|Participants Received Treatment|Overall Study||68
5337495|NCT00317941|13129278|P2|Participants Received Treatment|Overall Study||79
5337496|NCT00317941|13129279|P1|Participants Received Treatment|Overall Study||73
5337497|NCT00317941|13129277|P3|STARTED|Overall Study||68
5337498|NCT00317941|13129278|P2|STARTED|Overall Study||79
5337499|NCT00317941|13129279|P1|STARTED|Overall Study||73
5337500|NCT00317720|13129320|P2|NOT COMPLETED|Overall Study||0
5337501|NCT00317720|13129321|P1|NOT COMPLETED|Overall Study||0
5337502|NCT00317720|13129320|P2|COMPLETED|Overall Study||7
5337503|NCT00317720|13129321|P1|COMPLETED|Overall Study||40
5337504|NCT00317720|13129320|P2|STARTED|Overall Study||7
5337505|NCT00317720|13129321|P1|STARTED|Overall Study||40
5337506|NCT00317642|13129328|P2|NOT COMPLETED|Overall Study||135
5337507|NCT00317642|13129329|P1|NOT COMPLETED|Overall Study||122
5337508|NCT00317642|13129328|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
5337509|NCT00317642|13129329|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
5337510|NCT00317642|13129328|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
5337511|NCT00317642|13129329|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
5337512|NCT00317642|13129328|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
5337513|NCT00317642|13129329|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
5337514|NCT00317642|13129328|P2|STARTED|Overall Study||163
5337515|NCT00317642|13129329|P1|STARTED|Overall Study||163
5337516|NCT00317473|13129408|P6|NOT COMPLETED|Overall Study||3
5337517|NCT00317473|13129409|P5|NOT COMPLETED|Overall Study||8
5337518|NCT00317473|13129410|P4|NOT COMPLETED|Overall Study||2
5337519|NCT00317473|13129411|P3|NOT COMPLETED|Overall Study||3
5337520|NCT00317473|13129412|P2|NOT COMPLETED|Overall Study||3
5337521|NCT00317473|13129413|P1|NOT COMPLETED|Overall Study||4
5337522|NCT00317473|13129408|P6|COMPLETED|Overall Study||12
5337523|NCT00317473|13129409|P5|COMPLETED|Overall Study||22
5337524|NCT00317473|13129410|P4|COMPLETED|Overall Study||13
5337525|NCT00317473|13129411|P3|COMPLETED|Overall Study||27
5337526|NCT00317473|13129412|P2|COMPLETED|Overall Study||12
5337527|NCT00317473|13129413|P1|COMPLETED|Overall Study||26
5337528|NCT00317473|13129408|P6|STARTED|Overall Study||15
5337529|NCT00317473|13129409|P5|STARTED|Overall Study||30
5337530|NCT00317473|13129410|P4|STARTED|Overall Study||15
5337531|NCT00317473|13129411|P3|STARTED|Overall Study||30
5337532|NCT00317473|13129412|P2|STARTED|Overall Study||15
5337533|NCT00317473|13129413|P1|STARTED|Overall Study||30
5337534|NCT00317239|13129439|P2|NOT COMPLETED|Overall Study||19
5337535|NCT00317239|13129440|P1|NOT COMPLETED|Overall Study||13
5337536|NCT00317239|13129439|P2|COMPLETED|Overall Study||84
5337537|NCT00317239|13129440|P1|COMPLETED|Overall Study||134
5337538|NCT00317239|13129439|P2|STARTED|Overall Study||103
5337539|NCT00317239|13129440|P1|STARTED|Overall Study||147
5337540|NCT00317226|13129446|P1|NOT COMPLETED|Overall Study||23
5337541|NCT00317226|13129446|P1|COMPLETED|Overall Study||104
5337542|NCT00317226|13129446|P1|STARTED|Overall Study||127
5337543|NCT00317109|13129452|P2|NOT COMPLETED|Overall Study||0
5337544|NCT00317109|13129453|P1|NOT COMPLETED|Overall Study||3
5337545|NCT00317109|13129452|P2|COMPLETED|Overall Study||84
5337546|NCT00317109|13129453|P1|COMPLETED|Overall Study||81
5337547|NCT00317109|13129452|P2|STARTED|Overall Study||84
5337548|NCT00317109|13129453|P1|STARTED|Overall Study||84
5337549|NCT00317044|13129490|P3|NOT COMPLETED|Overall Study||45
5337550|NCT00317044|13129491|P2|NOT COMPLETED|Overall Study||40
5337551|NCT00317044|13129492|P1|NOT COMPLETED|Overall Study||48
5337552|NCT00317044|13129490|P3|COMPLETED|Overall Study||283
5337553|NCT00317044|13129491|P2|COMPLETED|Overall Study||273
5337554|NCT00317044|13129492|P1|COMPLETED|Overall Study||272
5337555|NCT00317044|13129490|P3|STARTED|Overall Study||328
5337556|NCT00317044|13129491|P2|STARTED|Overall Study||313
5337557|NCT00317044|13129492|P1|STARTED|Overall Study||320
5337558|NCT00316914|13129538|P2|NOT COMPLETED|Overall Study||36
5337559|NCT00316914|13129539|P1|NOT COMPLETED|Overall Study||33
5337560|NCT00316914|13129538|P2|COMPLETED|Overall Study||16
5337561|NCT00316914|13129539|P1|COMPLETED|Overall Study||17
5337562|NCT00316914|13129538|P2|STARTED|Overall Study||52
5337563|NCT00316914|13129539|P1|STARTED|Overall Study||50
5337564|NCT00316888|13129569|P2|NOT COMPLETED|Overall Study||8
5337565|NCT00316888|13129570|P1|NOT COMPLETED|Overall Study||6
5337566|NCT00316888|13129569|P2|COMPLETED|Overall Study||27
5337567|NCT00316888|13129570|P1|COMPLETED|Overall Study||22
5337568|NCT00316888|13129569|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
5337569|NCT00316888|13129570|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
5337570|NCT00316888|13129569|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
5337571|NCT00316888|13129570|P1|Started Induction Chemotherapy|Overall Study||28
5337572|NCT00316888|13129569|P2|Treated|Overall Study||34
5337573|NCT00316888|13129570|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
5337574|NCT00316888|13129569|P2|Eligible|Overall Study||35
5337575|NCT00316888|13129570|P1|Eligible|Overall Study||28
5337576|NCT00316888|13129569|P2|STARTED|Overall Study||35
5337577|NCT00316888|13129570|P1|STARTED|Overall Study||28
5337578|NCT00316862|13129584|P1|NOT COMPLETED|Overall Study||0
5337579|NCT00316862|13129584|P1|COMPLETED|Overall Study||82
5337580|NCT00316862|13129584|P1|STARTED|Overall Study||82
5337581|NCT00316719|13129592|P2|NOT COMPLETED|Overall Study||6
5337582|NCT00316719|13129593|P1|NOT COMPLETED|Overall Study||2
5337583|NCT00316719|13129592|P2|COMPLETED|Overall Study||47
5337584|NCT00316719|13129593|P1|COMPLETED|Overall Study||50
5337585|NCT00316719|13129592|P2|STARTED|Overall Study||53
5337586|NCT00316719|13129593|P1|STARTED|Overall Study||52
5337587|NCT00316706|13129619|P2|NOT COMPLETED|Overall Study||48
5337588|NCT00316706|13129620|P1|NOT COMPLETED|Overall Study||38
5337589|NCT00316706|13129619|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
5337590|NCT00316706|13129620|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
5337591|NCT00316706|13129619|P2|STARTED|Overall Study||619
5337592|NCT00316706|13129620|P1|STARTED|Overall Study||626
5337593|NCT00316693|13129636|P2|NOT COMPLETED|Overall Study||85
5337594|NCT00316693|13129637|P1|NOT COMPLETED|Overall Study||77
5337595|NCT00316693|13129636|P2|COMPLETED|Overall Study||436
5337596|NCT00316693|13129637|P1|COMPLETED|Overall Study||442
5337597|NCT00316693|13129636|P2|STARTED|Overall Study||521
5337598|NCT00316693|13129637|P1|STARTED|Overall Study||519
5337599|NCT00316602|13129679|P2|NOT COMPLETED|Overall Study||25
5337600|NCT00316602|13129680|P1|NOT COMPLETED|Overall Study||10
5337601|NCT00316602|13129679|P2|COMPLETED|Overall Study||325
5337602|NCT00316602|13129680|P1|COMPLETED|Overall Study||272
5337603|NCT00316602|13129679|P2|STARTED|Overall Study||350
5337604|NCT00316602|13129680|P1|STARTED|Overall Study||282
5337605|NCT00316589|13129712|P4|NOT COMPLETED|Overall Study||5
5337606|NCT00316589|13129713|P3|NOT COMPLETED|Overall Study||1
5337607|NCT00316589|13129714|P2|NOT COMPLETED|Overall Study||24
5337608|NCT00316589|13129715|P1|NOT COMPLETED|Overall Study||1
5337609|NCT00316589|13129712|P4|COMPLETED|Overall Study||127
5337610|NCT00316589|13129713|P3|COMPLETED|Overall Study||8
5337611|NCT00316589|13129714|P2|COMPLETED|Overall Study||328
5337612|NCT00316589|13129715|P1|COMPLETED|Overall Study||87
5337613|NCT00316589|13129712|P4|STARTED|Overall Study||132
5337614|NCT00316589|13129713|P3|STARTED|Overall Study||9
5337615|NCT00316589|13129714|P2|STARTED|Overall Study||352
5337616|NCT00316589|13129715|P1|STARTED|Overall Study||88
5337617|NCT00316524|13129783|P4|NOT COMPLETED|Overall Study||0
5337618|NCT00316524|13129784|P3|NOT COMPLETED|Overall Study||6
5337619|NCT00316524|13129785|P2|NOT COMPLETED|Overall Study||8
5337620|NCT00316524|13129786|P1|NOT COMPLETED|Overall Study||8
5337621|NCT00316524|13129783|P4|COMPLETED|Overall Study||200
5337622|NCT00316524|13129784|P3|COMPLETED|Overall Study||175
5337623|NCT00316524|13129785|P2|COMPLETED|Overall Study||173
5337624|NCT00316524|13129786|P1|COMPLETED|Overall Study||175
5337625|NCT00316524|13129783|P4|STARTED|Overall Study||200
5337626|NCT00316524|13129784|P3|STARTED|Overall Study||181
5337627|NCT00316524|13129785|P2|STARTED|Overall Study||181
5337628|NCT00316524|13129786|P1|STARTED|Overall Study||183
5337629|NCT00316355|13129838|P2|NOT COMPLETED|Overall Study||7
5337630|NCT00316355|13129839|P1|NOT COMPLETED|Overall Study||5
5337631|NCT00316355|13129838|P2|COMPLETED|Overall Study||12
5337632|NCT00316355|13129839|P1|COMPLETED|Overall Study||10
5337633|NCT00316355|13129838|P2|Started Treatment|Overall Study||18
5337634|NCT00316355|13129839|P1|Started Treatment|Overall Study||12
5337635|NCT00316355|13129838|P2|STARTED|Overall Study||19
5337636|NCT00316355|13129839|P1|STARTED|Overall Study||15
5337637|NCT00316303|13129849|P2|NOT COMPLETED|Overall Study||16
5337638|NCT00316303|13129850|P1|NOT COMPLETED|Overall Study||11
5337639|NCT00316303|13129849|P2|COMPLETED|Overall Study||102
5337640|NCT00316303|13129850|P1|COMPLETED|Overall Study||107
5337641|NCT00316303|13129849|P2|STARTED|Overall Study||118
5337642|NCT00316303|13129850|P1|STARTED|Overall Study||118
5337643|NCT00316277|13129866|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
5337644|NCT00316277|13129867|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
5337645|NCT00316277|13129866|P2|COMPLETED|Phase 2 (24 Weeks)||161
5337646|NCT00316277|13129867|P1|COMPLETED|Phase 2 (24 Weeks)||161
5337647|NCT00316277|13129866|P2|STARTED|Phase 2 (24 Weeks)||180
5337648|NCT00316277|13129867|P1|STARTED|Phase 2 (24 Weeks)||180
5337649|NCT00316277|13129866|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
5337650|NCT00316277|13129867|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
5337651|NCT00316277|13129866|P2|COMPLETED|Phase 1 (12 Weeks)||24
5337652|NCT00316277|13129867|P1|COMPLETED|Phase 1 (12 Weeks)||19
5337653|NCT00316277|13129866|P2|STARTED|Phase 1 (12 Weeks)||324
5337654|NCT00316277|13129867|P1|STARTED|Phase 1 (12 Weeks)||329
5337655|NCT00316264|13129888|P3|NOT COMPLETED|Overall Study||6
5337656|NCT00316264|13129889|P2|NOT COMPLETED|Overall Study||7
5337657|NCT00316264|13129890|P1|NOT COMPLETED|Overall Study||6
5337658|NCT00316264|13129888|P3|COMPLETED|Overall Study||87
5337659|NCT00316264|13129889|P2|COMPLETED|Overall Study||77
5337660|NCT00316264|13129890|P1|COMPLETED|Overall Study||77
5337661|NCT00316264|13129888|P3|STARTED|Overall Study||93
5337662|NCT00316264|13129889|P2|STARTED|Overall Study||84
5337663|NCT00316264|13129890|P1|STARTED|Overall Study||83
5337664|NCT00316225|13129958|P1|NOT COMPLETED|Overall Study||25
5337665|NCT00316225|13129958|P1|COMPLETED|Overall Study||6
5337666|NCT00316225|13129958|P1|STARTED|Overall Study||31
5337667|NCT00316199|13129967|P1|NOT COMPLETED|Overall Study||12
5337668|NCT00316199|13129967|P1|COMPLETED|Overall Study||48
5337669|NCT00316199|13129967|P1|STARTED|Overall Study||60
5337670|NCT00316186|13129975|P1|NOT COMPLETED|Overall Study||12
5337671|NCT00316186|13129975|P1|COMPLETED|Overall Study||21
5337672|NCT00316186|13129975|P1|STARTED|Overall Study||33
5337673|NCT00316173|13129989|P2|NOT COMPLETED|Treatment Phase||42
5337674|NCT00316173|13129990|P1|NOT COMPLETED|Treatment Phase||0
5337675|NCT00316173|13129989|P2|COMPLETED|Treatment Phase||13
5337676|NCT00316173|13129990|P1|COMPLETED|Treatment Phase||0
5337677|NCT00316173|13129989|P2|STARTED|Treatment Phase||55
5337678|NCT00316173|13129990|P1|STARTED|Treatment Phase||0
5337679|NCT00316173|13129989|P2|NOT COMPLETED|Run-in Phase||0
5337680|NCT00316173|13129990|P1|NOT COMPLETED|Run-in Phase||7
5337681|NCT00316173|13129989|P2|COMPLETED|Run-in Phase||0
5337682|NCT00316173|13129990|P1|COMPLETED|Run-in Phase||15
5337683|NCT00316173|13129989|P2|STARTED|Run-in Phase||0
5337684|NCT00316173|13129990|P1|STARTED|Run-in Phase||22
5337685|NCT00316121|13130003|P2|NOT COMPLETED|Overall Study||9
5337686|NCT00316121|13130004|P1|NOT COMPLETED|Overall Study||22
5337687|NCT00316121|13130003|P2|COMPLETED|Overall Study||37
5337688|NCT00316121|13130004|P1|COMPLETED|Overall Study||70
5337689|NCT00316121|13130003|P2|STARTED|Overall Study||46
5337690|NCT00316121|13130004|P1|STARTED|Overall Study||92
5337691|NCT00316082|13130015|P5|NOT COMPLETED|Overall Study||26
5337692|NCT00316082|13130016|P4|NOT COMPLETED|Overall Study||26
5337693|NCT00316082|13130017|P3|NOT COMPLETED|Overall Study||27
5337694|NCT00316082|13130018|P2|NOT COMPLETED|Overall Study||22
5337695|NCT00316082|13130019|P1|NOT COMPLETED|Overall Study||33
5337696|NCT00316082|13130015|P5|COMPLETED|Overall Study||48
5337697|NCT00316082|13130016|P4|COMPLETED|Overall Study||46
5337698|NCT00316082|13130017|P3|COMPLETED|Overall Study||44
5337699|NCT00316082|13130018|P2|COMPLETED|Overall Study||52
5337700|NCT00316082|13130019|P1|COMPLETED|Overall Study||41
5337701|NCT00316082|13130015|P5|Completed Study Without Being Rescued|Overall Study||31
5337702|NCT00316082|13130016|P4|Completed Study Without Being Rescued|Overall Study||27
5337703|NCT00316082|13130017|P3|Completed Study Without Being Rescued|Overall Study||29
5337704|NCT00316082|13130018|P2|Completed Study Without Being Rescued|Overall Study||35
5337705|NCT00316082|13130019|P1|Completed Study Without Being Rescued|Overall Study||25
5337706|NCT00316082|13130015|P5|STARTED|Overall Study||74
5337707|NCT00316082|13130016|P4|STARTED|Overall Study||72
5337708|NCT00316082|13130017|P3|STARTED|Overall Study||71
5337709|NCT00316082|13130018|P2|STARTED|Overall Study||74
5337710|NCT00316082|13130019|P1|STARTED|Overall Study||74
5337711|NCT00316017|13130050|P3|NOT COMPLETED|Overall Study||19
5337712|NCT00316017|13130051|P2|NOT COMPLETED|Overall Study||13
5337713|NCT00316017|13130052|P1|NOT COMPLETED|Overall Study||11
5337714|NCT00316017|13130050|P3|COMPLETED|Overall Study||376
5337715|NCT00316017|13130051|P2|COMPLETED|Overall Study||256
5337716|NCT00316017|13130052|P1|COMPLETED|Overall Study||220
5337717|NCT00316017|13130050|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
5337718|NCT00316017|13130051|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
5337719|NCT00316017|13130052|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
5337720|NCT00316004|13130126|P3|NOT COMPLETED|Overall Study||21
5337721|NCT00316004|13130127|P2|NOT COMPLETED|Overall Study||14
5337722|NCT00316004|13130128|P1|NOT COMPLETED|Overall Study||14
5337723|NCT00316004|13130126|P3|COMPLETED|Overall Study||582
5337724|NCT00316004|13130127|P2|COMPLETED|Overall Study||341
5337725|NCT00316004|13130128|P1|COMPLETED|Overall Study||359
5337726|NCT00316004|13130126|P3|STARTED|Overall Study||603
5337727|NCT00316004|13130127|P2|STARTED|Overall Study||355
5337728|NCT00316004|13130128|P1|STARTED|Overall Study||373
5337729|NCT00315939|13130183|P2|NOT COMPLETED|Admission 3 (3 Months)||2
5337730|NCT00315939|13130184|P1|NOT COMPLETED|Admission 3 (3 Months)||4
5337731|NCT00315939|13130183|P2|COMPLETED|Admission 3 (3 Months)||49
5337732|NCT00315939|13130184|P1|COMPLETED|Admission 3 (3 Months)||48
5337733|NCT00315939|13130183|P2|STARTED|Admission 3 (3 Months)||51
5337734|NCT00315939|13130184|P1|STARTED|Admission 3 (3 Months)||52
5337735|NCT00315939|13130183|P2|NOT COMPLETED|Admission 2 (3 Months)||4
5337736|NCT00315939|13130184|P1|NOT COMPLETED|Admission 2 (3 Months)||4
5337737|NCT00315939|13130183|P2|COMPLETED|Admission 2 (3 Months)||51
5337738|NCT00315939|13130184|P1|COMPLETED|Admission 2 (3 Months)||52
5337739|NCT00315939|13130183|P2|STARTED|Admission 2 (3 Months)||55
5337740|NCT00315939|13130184|P1|STARTED|Admission 2 (3 Months)||56
5337741|NCT00315939|13130183|P2|NOT COMPLETED|Admission 1 (3 Months)||6
5337742|NCT00315939|13130184|P1|NOT COMPLETED|Admission 1 (3 Months)||3
5337743|NCT00315939|13130183|P2|COMPLETED|Admission 1 (3 Months)||55
5337744|NCT00315939|13130184|P1|COMPLETED|Admission 1 (3 Months)||56
5337745|NCT00315939|13130183|P2|STARTED|Admission 1 (3 Months)||61
5337746|NCT00315939|13130184|P1|STARTED|Admission 1 (3 Months)||59
5337747|NCT00315822|13130192|P2|NOT COMPLETED|Overall Study||0
5337748|NCT00315822|13130193|P1|NOT COMPLETED|Overall Study||0
5337749|NCT00315822|13130192|P2|COMPLETED|Overall Study||202
5337750|NCT00315822|13130193|P1|COMPLETED|Overall Study||198
5337751|NCT00315822|13130192|P2|STARTED|Overall Study||202
5337752|NCT00315822|13130193|P1|STARTED|Overall Study||198
5337753|NCT00315731|13130199|P1|NOT COMPLETED|Overall Study||6
5337754|NCT00315731|13130199|P1|COMPLETED|Overall Study||9
5337755|NCT00315731|13130199|P1|STARTED|Overall Study||15
5337756|NCT00315705|13130227|P1|NOT COMPLETED|Phase 2||25
5337757|NCT00315705|13130227|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
5337758|NCT00315705|13130227|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
5337759|NCT00315705|13130227|P1|NOT COMPLETED|Phase 1||25
5337760|NCT00315705|13130227|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
5337761|NCT00315705|13130227|P1|STARTED|Phase 1||25
5337762|NCT00315627|13130264|P1|NOT COMPLETED|Overall Study||0
5337763|NCT00315627|13130264|P1|COMPLETED|Overall Study||3
5337764|NCT00315627|13130264|P1|STARTED|Overall Study||3
5337765|NCT00315614|13130272|P1|NOT COMPLETED|Overall Study||0
5337766|NCT00315614|13130272|P1|COMPLETED|Overall Study||3
5337767|NCT00315614|13130272|P1|STARTED|Overall Study||3
5337768|NCT00315588|13130279|P1|NOT COMPLETED|Overall Study||0
5337769|NCT00315588|13130279|P1|COMPLETED|Overall Study||7
5337770|NCT00315588|13130279|P1|STARTED|Overall Study||7
5337771|NCT00315458|13130288|P4|NOT COMPLETED|Overall Study||29
5337772|NCT00315458|13130289|P3|NOT COMPLETED|Overall Study||52
5337773|NCT00315458|13130290|P2|NOT COMPLETED|Overall Study||12
5337774|NCT00315458|13130291|P1|NOT COMPLETED|Overall Study||3
5337775|NCT00315458|13130288|P4|COMPLETED|Overall Study||10
5337776|NCT00315458|13130289|P3|COMPLETED|Overall Study||107
5337777|NCT00315458|13130290|P2|COMPLETED|Overall Study||44
5337778|NCT00315458|13130291|P1|COMPLETED|Overall Study||48
5337779|NCT00315458|13130288|P4|STARTED|Overall Study||39
5337780|NCT00315458|13130289|P3|STARTED|Overall Study||159
5337781|NCT00315458|13130290|P2|STARTED|Overall Study||56
5337782|NCT00315458|13130291|P1|STARTED|Overall Study||51
5337783|NCT00315445|13130304|P3|NOT COMPLETED|Overall Study||24
5337784|NCT00315445|13130305|P2|NOT COMPLETED|Overall Study||16
5337785|NCT00315445|13130306|P1|NOT COMPLETED|Overall Study||27
5337786|NCT00315445|13130304|P3|COMPLETED|Overall Study||22
5337787|NCT00315445|13130305|P2|COMPLETED|Overall Study||27
5337788|NCT00315445|13130306|P1|COMPLETED|Overall Study||18
5337789|NCT00315445|13130304|P3|STARTED|Overall Study||46
5337790|NCT00315445|13130305|P2|STARTED|Overall Study||43
5337791|NCT00315445|13130306|P1|STARTED|Overall Study||45
5337792|NCT00315341|13130379|P2|NOT COMPLETED|Overall Study||138
5337793|NCT00315341|13130380|P1|NOT COMPLETED|Overall Study||400
5337794|NCT00315341|13130379|P2|COMPLETED|Overall Study||391
5337795|NCT00315341|13130380|P1|COMPLETED|Overall Study||340
5337796|NCT00315341|13130379|P2|STARTED|Overall Study||529
5337797|NCT00315341|13130380|P1|STARTED|Overall Study||740
5337798|NCT00315328|13130390|P4|NOT COMPLETED|Overall Study||2
5337799|NCT00315328|13130391|P3|NOT COMPLETED|Overall Study||5
5337800|NCT00315328|13130392|P2|NOT COMPLETED|Overall Study||7
5337801|NCT00315328|13130393|P1|NOT COMPLETED|Overall Study||14
5337802|NCT00315328|13130390|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
5337803|NCT00315328|13130391|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
5337804|NCT00315328|13130392|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
5337805|NCT00315328|13130393|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
5337806|NCT00315328|13130390|P4|5 Week Visit|Overall Study||19
5337807|NCT00315328|13130391|P3|5 Week Visit|Overall Study||17
5337808|NCT00315328|13130392|P2|5 Week Visit|Overall Study||89
5337809|NCT00315328|13130393|P1|5 Week Visit|Overall Study||91
5337810|NCT00315328|13130390|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
5337811|NCT00315328|13130391|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
5337812|NCT00315328|13130392|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
5337813|NCT00315328|13130393|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
5337814|NCT00315302|13130463|P4|NOT COMPLETED|Overall Study||3
5337815|NCT00315302|13130464|P3|NOT COMPLETED|Overall Study||2
5337816|NCT00315302|13130465|P2|NOT COMPLETED|Overall Study||2
5337817|NCT00315302|13130466|P1|NOT COMPLETED|Overall Study||6
5337818|NCT00315302|13130463|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
5337819|NCT00315302|13130464|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
5337820|NCT00315302|13130465|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
5337821|NCT00315302|13130466|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
5337822|NCT00315302|13130463|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
5337823|NCT00315302|13130464|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
5337824|NCT00315302|13130465|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
5337825|NCT00315302|13130466|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
5337826|NCT00315302|13130463|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
5337827|NCT00315302|13130464|P3|18 Week Primary Outcome Visit|Overall Study||24
5337828|NCT00315302|13130465|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
5337829|NCT00315302|13130466|P1|18 Week Primary Outcome Visit|Overall Study||84
5337830|NCT00315302|13130463|P4|10 Week Visit|Overall Study||29
5337831|NCT00315302|13130464|P3|10 Week Visit|Overall Study||24
5337832|NCT00315302|13130465|P2|10 Week Visit|Overall Study||85
5337833|NCT00315302|13130466|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
5337834|NCT00315302|13130463|P4|5 Week Visit|Overall Study||30
5337835|NCT00315302|13130464|P3|5 Week Visit|Overall Study||26
5337836|NCT00315302|13130465|P2|5 Week Visit|Overall Study||86
5337837|NCT00315302|13130466|P1|5 Week Visit|Overall Study||85
5337838|NCT00315302|13130463|P4|STARTED|Overall Study||34
5337839|NCT00315302|13130464|P3|STARTED|Overall Study||26
5337840|NCT00315302|13130465|P2|STARTED|Overall Study||90
5337841|NCT00315302|13130466|P1|STARTED|Overall Study||90
5337842|NCT00315146|13130512|P4|NOT COMPLETED|Overall Study||0
5337843|NCT00315146|13130513|P3|NOT COMPLETED|Overall Study||2
5337844|NCT00315146|13130514|P2|NOT COMPLETED|Overall Study||3
5337845|NCT00315146|13130515|P1|NOT COMPLETED|Overall Study||2
5337846|NCT00315146|13130512|P4|COMPLETED|Overall Study||22
5337847|NCT00315146|13130513|P3|COMPLETED|Overall Study||20
5337848|NCT00315146|13130514|P2|COMPLETED|Overall Study||19
5337849|NCT00315146|13130515|P1|COMPLETED|Overall Study||20
5337850|NCT00315146|13130512|P4|STARTED|Overall Study||22
5337851|NCT00315146|13130513|P3|STARTED|Overall Study||22
5337852|NCT00315146|13130514|P2|STARTED|Overall Study||22
5337853|NCT00315146|13130515|P1|STARTED|Overall Study||22
5337854|NCT00315120|13130533|P4|NOT COMPLETED|Overall Study||0
5337855|NCT00315120|13130534|P3|NOT COMPLETED|Overall Study||0
5337856|NCT00315120|13130535|P2|NOT COMPLETED|Overall Study||0
5337857|NCT00315120|13130536|P1|NOT COMPLETED|Overall Study||0
5337858|NCT00315120|13130533|P4|COMPLETED|Overall Study||107
5337859|NCT00315120|13130534|P3|COMPLETED|Overall Study||115
5337860|NCT00315120|13130535|P2|COMPLETED|Overall Study||118
5337861|NCT00315120|13130536|P1|COMPLETED|Overall Study||115
5337862|NCT00315120|13130533|P4|STARTED|Overall Study||107
5337863|NCT00315120|13130534|P3|STARTED|Overall Study||115
5337864|NCT00315120|13130535|P2|STARTED|Overall Study||118
5337865|NCT00315120|13130536|P1|STARTED|Overall Study||115
5337866|NCT00315055|13130596|P2|NOT COMPLETED|Overall Study||5
5337867|NCT00315055|13130597|P1|NOT COMPLETED|Overall Study||3
5337868|NCT00315055|13130596|P2|COMPLETED|Overall Study||150
5337869|NCT00315055|13130597|P1|COMPLETED|Overall Study||152
5337870|NCT00315055|13130596|P2|STARTED|Overall Study||155
5337871|NCT00315055|13130597|P1|STARTED|Overall Study||155
5337872|NCT00314951|13130615|P2|NOT COMPLETED|Follow-up||34
5337873|NCT00314951|13130616|P1|NOT COMPLETED|Follow-up||44
5337874|NCT00314951|13130615|P2|COMPLETED|Follow-up||255
5337875|NCT00314951|13130616|P1|COMPLETED|Follow-up||263
5337876|NCT00314951|13130615|P2|STARTED|Follow-up||289
5337877|NCT00314951|13130616|P1|STARTED|Follow-up||307
5337878|NCT00314951|13130615|P2|NOT COMPLETED|Treatment||11
5337879|NCT00314951|13130616|P1|NOT COMPLETED|Treatment||16
5337880|NCT00314951|13130615|P2|COMPLETED|Treatment||289
5337881|NCT00314951|13130616|P1|COMPLETED|Treatment||307
5337882|NCT00314951|13130615|P2|STARTED|Treatment||300
5337883|NCT00314951|13130616|P1|STARTED|Treatment||323
5337884|NCT00314951|13130615|P2|NOT COMPLETED|Enrollment||6
5337885|NCT00314951|13130616|P1|NOT COMPLETED|Enrollment||0
5337886|NCT00314951|13130615|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
5337887|NCT00314951|13130616|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
5337888|NCT00314951|13130615|P2|STARTED|Enrollment||306
5337889|NCT00314951|13130616|P1|STARTED|Enrollment||323
5337890|NCT00314808|13130626|P1|NOT COMPLETED|Overall Study||8
5337891|NCT00314808|13130626|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
5337892|NCT00314808|13130626|P1|STARTED|Overall Study||33
5337893|NCT00314795|13130634|P1|NOT COMPLETED|Overall Study||20
5337894|NCT00314795|13130634|P1|COMPLETED|Overall Study||2
5337895|NCT00314795|13130634|P1|STARTED|Overall Study||22
5337896|NCT00314574|13130644|P2|NOT COMPLETED|Overall Study||83
5337897|NCT00314574|13130645|P1|NOT COMPLETED|Overall Study||94
5337898|NCT00314574|13130644|P2|COMPLETED|Overall Study||344
5337899|NCT00314574|13130645|P1|COMPLETED|Overall Study||329
5337900|NCT00314574|13130644|P2|Safety Population|Overall Study||428
5337901|NCT00314574|13130645|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
5337902|NCT00314574|13130644|P2|Received at Least One Dose of Study Drug|Overall Study||427
5337903|NCT00314574|13130645|P1|Received at Least One Dose of Study Drug|Overall Study||421
5337904|NCT00314574|13130644|P2|STARTED|Overall Study||427
5337905|NCT00314574|13130645|P1|STARTED|Overall Study||423
5337906|NCT00314366|13130661|P2|NOT COMPLETED|Overall Study||0
5337907|NCT00314366|13130662|P1|NOT COMPLETED|Overall Study||1
5337908|NCT00314366|13130661|P2|COMPLETED|Overall Study||10
5337909|NCT00314366|13130662|P1|COMPLETED|Overall Study||10
5337910|NCT00314366|13130661|P2|STARTED|Overall Study||10
5337911|NCT00314366|13130662|P1|STARTED|Overall Study||11
5337912|NCT00314353|13130692|P2|NOT COMPLETED|Follow-up||0
5337913|NCT00314353|13130693|P1|NOT COMPLETED|Follow-up||0
5337914|NCT00314353|13130692|P2|COMPLETED|Follow-up||0
5337915|NCT00314353|13130693|P1|COMPLETED|Follow-up||3
5337916|NCT00314353|13130692|P2|STARTED|Follow-up||0
5337917|NCT00314353|13130693|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
5337918|NCT00314353|13130692|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
5337919|NCT00314353|13130693|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
5337920|NCT00314353|13130692|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
5337921|NCT00314353|13130693|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
5337922|NCT00314353|13130692|P2|STARTED|Protocol Therapy (8 Cycles)||3
5337923|NCT00314353|13130693|P1|STARTED|Protocol Therapy (8 Cycles)||4
5337924|NCT00314340|13130707|P1|NOT COMPLETED|Overall Study||1
5337925|NCT00314340|13130707|P1|COMPLETED|Overall Study||11
5337926|NCT00314340|13130707|P1|Placebo|Overall Study||12
5337927|NCT00314340|13130707|P1|Hydrocodone Plus APAP|Overall Study||12
5337928|NCT00314340|13130707|P1|ER Morphine|Overall Study||11
5337929|NCT00314340|13130707|P1|STARTED|Overall Study||12
5337930|NCT00314327|13130713|P1|NOT COMPLETED|Overall Study||1
5337931|NCT00314327|13130713|P1|COMPLETED|Overall Study||0
5337932|NCT00314327|13130713|P1|STARTED|Overall Study||1
5337933|NCT00314262|13130718|P1|NOT COMPLETED|Overall Study||5
5337934|NCT00314262|13130718|P1|COMPLETED|Overall Study||7
5337935|NCT00314262|13130718|P1|STARTED|Overall Study||12
5337936|NCT00314249|13130726|P2|NOT COMPLETED|Overall Study||163
5337937|NCT00314249|13130727|P1|NOT COMPLETED|Overall Study||152
5337938|NCT00314249|13130726|P2|COMPLETED|Overall Study||353
5337939|NCT00314249|13130727|P1|COMPLETED|Overall Study||357
5337940|NCT00314249|13130726|P2|STARTED|Overall Study||516
5337941|NCT00314249|13130727|P1|STARTED|Overall Study||509
5337942|NCT00314236|13130745|P2|NOT COMPLETED|Overall Study||2
5337943|NCT00314236|13130746|P1|NOT COMPLETED|Overall Study||0
5337944|NCT00314236|13130745|P2|COMPLETED|Overall Study||37
5337945|NCT00314236|13130746|P1|COMPLETED|Overall Study||41
5337946|NCT00314236|13130745|P2|STARTED|Overall Study||39
5337947|NCT00314236|13130746|P1|STARTED|Overall Study||41
5337948|NCT00314145|13130760|P2|NOT COMPLETED|Overall Study||29
5337949|NCT00314145|13130761|P1|NOT COMPLETED|Overall Study||21
5337950|NCT00314145|13130760|P2|COMPLETED|Overall Study||381
5337951|NCT00314145|13130761|P1|COMPLETED|Overall Study||389
5337952|NCT00314145|13130760|P2|STARTED|Overall Study||410
5337953|NCT00314145|13130761|P1|STARTED|Overall Study||410
5337954|NCT00314132|13130775|P2|NOT COMPLETED|Overall Study||18
5337955|NCT00314132|13130776|P1|NOT COMPLETED|Overall Study||8
5337956|NCT00314132|13130775|P2|COMPLETED|Overall Study||1583
5337957|NCT00314132|13130776|P1|COMPLETED|Overall Study||395
5337958|NCT00314132|13130775|P2|STARTED|Overall Study||1601
5337959|NCT00314132|13130776|P1|STARTED|Overall Study||403
5337960|NCT00314106|13130786|P2|NOT COMPLETED|Overall Study||0
5337961|NCT00314106|13130787|P1|NOT COMPLETED|Overall Study||0
5337962|NCT00314106|13130786|P2|COMPLETED|Overall Study||8
5337963|NCT00314106|13130787|P1|COMPLETED|Overall Study||18
5337964|NCT00314106|13130786|P2|STARTED|Overall Study||8
5337965|NCT00314106|13130787|P1|STARTED|Overall Study||18
5337966|NCT00314093|13130795|P1|NOT COMPLETED|Overall Study||0
5337967|NCT00314093|13130795|P1|COMPLETED|Overall Study||0
5337968|NCT00314093|13130795|P1|STARTED|Overall Study||0
5337969|NCT00313911|13130803|P2|NOT COMPLETED|Overall Study||41
5337970|NCT00313911|13130804|P1|NOT COMPLETED|Overall Study||94
5337971|NCT00313911|13130803|P2|COMPLETED|Overall Study||670
5337972|NCT00313911|13130804|P1|COMPLETED|Overall Study||1328
5337973|NCT00313911|13130803|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
5337974|NCT00313911|13130804|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
5337975|NCT00313846|13130818|P2|NOT COMPLETED|Overall Study||11
5337976|NCT00313846|13130819|P1|NOT COMPLETED|Overall Study||5
5337977|NCT00313846|13130818|P2|COMPLETED|Overall Study||153
5337978|NCT00313846|13130819|P1|COMPLETED|Overall Study||157
5337979|NCT00313846|13130818|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
5337980|NCT00313846|13130819|P1|STARTED|Overall Study||162
5337981|NCT00313820|13130830|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
5337982|NCT00313820|13130831|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
5337983|NCT00313820|13130830|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
5337984|NCT00313820|13130831|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
5337985|NCT00313820|13130830|P2|STARTED|Pregabalin or Placebo Treatment Period||109
5337986|NCT00313820|13130831|P1|STARTED|Pregabalin or Placebo Treatment Period||110
5337987|NCT00313820|13130830|P2|NOT COMPLETED|Assigned to Treatment||0
5337988|NCT00313820|13130831|P1|NOT COMPLETED|Assigned to Treatment||1
5337989|NCT00313820|13130830|P2|COMPLETED|Assigned to Treatment||109
5337990|NCT00313820|13130831|P1|COMPLETED|Assigned to Treatment||110
5337991|NCT00313820|13130830|P2|STARTED|Assigned to Treatment||109
5337992|NCT00313820|13130831|P1|STARTED|Assigned to Treatment||111
5337993|NCT00313781|13130869|P3|NOT COMPLETED|After Crossover||27
5337994|NCT00313781|13130870|P2|NOT COMPLETED|After Crossover||0
5337995|NCT00313781|13130871|P1|NOT COMPLETED|After Crossover||0
5337996|NCT00313781|13130869|P3|COMPLETED|After Crossover||10
5337997|NCT00313781|13130870|P2|COMPLETED|After Crossover||0
5337998|NCT00313781|13130871|P1|COMPLETED|After Crossover||0
5337999|NCT00313781|13130869|P3|STARTED|After Crossover||37
5338000|NCT00313781|13130870|P2|STARTED|After Crossover||0
5338001|NCT00313781|13130871|P1|STARTED|After Crossover||0
5338002|NCT00313781|13130869|P3|NOT COMPLETED|Before Crossover||0
5338003|NCT00313781|13130870|P2|NOT COMPLETED|Before Crossover||79
5338004|NCT00313781|13130871|P1|NOT COMPLETED|Before Crossover||75
5338005|NCT00313781|13130869|P3|COMPLETED|Before Crossover||0
5338006|NCT00313781|13130870|P2|COMPLETED|Before Crossover||23
5338007|NCT00313781|13130871|P1|COMPLETED|Before Crossover||27
5338008|NCT00313781|13130869|P3|Treated|Before Crossover||0
5338009|NCT00313781|13130870|P2|Treated|Before Crossover||102
5338010|NCT00313781|13130871|P1|Treated|Before Crossover||97
5338011|NCT00313781|13130869|P3|STARTED|Before Crossover||0
5338012|NCT00313781|13130870|P2|STARTED|Before Crossover||102
5338013|NCT00313781|13130871|P1|STARTED|Before Crossover||102
5338014|NCT00313729|13130905|P1|NOT COMPLETED|Overall Study||0
5338015|NCT00313729|13130905|P1|COMPLETED|Overall Study||120
5338016|NCT00313729|13130905|P1|STARTED|Overall Study||120
5338017|NCT00313716|13130917|P6|NOT COMPLETED|Overall Study||13
5338018|NCT00313716|13130918|P5|NOT COMPLETED|Overall Study||6
5338019|NCT00313716|13130919|P4|NOT COMPLETED|Overall Study||4
5338020|NCT00313716|13130920|P3|NOT COMPLETED|Overall Study||12
5338021|NCT00313716|13130921|P2|NOT COMPLETED|Overall Study||8
5338022|NCT00313716|13130922|P1|NOT COMPLETED|Overall Study||5
5338023|NCT00313716|13130917|P6|COMPLETED|Overall Study||35
5338024|NCT00313716|13130918|P5|COMPLETED|Overall Study||27
5338025|NCT00313716|13130919|P4|COMPLETED|Overall Study||16
5338026|NCT00313716|13130920|P3|COMPLETED|Overall Study||38
5338027|NCT00313716|13130921|P2|COMPLETED|Overall Study||23
5338028|NCT00313716|13130922|P1|COMPLETED|Overall Study||13
5338029|NCT00313716|13130917|P6|STARTED|Overall Study||48
5338030|NCT00313716|13130918|P5|STARTED|Overall Study||33
5338031|NCT00313716|13130919|P4|STARTED|Overall Study||20
5338032|NCT00313716|13130920|P3|STARTED|Overall Study||50
5338033|NCT00313716|13130921|P2|STARTED|Overall Study||31
5338034|NCT00313716|13130922|P1|STARTED|Overall Study||18
5338035|NCT00313703|13130949|P4|NOT COMPLETED|Overall Study||12
5338036|NCT00313703|13130950|P3|NOT COMPLETED|Overall Study||5
5338037|NCT00313703|13130951|P2|NOT COMPLETED|Overall Study||2
5338038|NCT00313703|13130952|P1|NOT COMPLETED|Overall Study||11
5338039|NCT00313703|13130949|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
5338040|NCT00313703|13130950|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
5338041|NCT00313703|13130951|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
5338042|NCT00313703|13130952|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
5338043|NCT00313703|13130949|P4|STARTED|Overall Study||12
5338044|NCT00313703|13130950|P3|STARTED|Overall Study||77
5338045|NCT00313703|13130951|P2|STARTED|Overall Study||34
5338046|NCT00313703|13130952|P1|STARTED|Overall Study||186
5338047|NCT00313612|13130968|P2|NOT COMPLETED|Overall Study||1
5338048|NCT00313612|13130969|P1|NOT COMPLETED|Overall Study||0
5338049|NCT00313612|13130968|P2|COMPLETED|Overall Study||19
5338050|NCT00313612|13130969|P1|COMPLETED|Overall Study||19
5338051|NCT00313612|13130968|P2|STARTED|Overall Study||20
5338052|NCT00313612|13130969|P1|STARTED|Overall Study||19
5338053|NCT00313586|13130981|P4|NOT COMPLETED|Overall Study||23
5338054|NCT00313586|13130982|P3|NOT COMPLETED|Overall Study||24
5338055|NCT00313586|13130983|P2|NOT COMPLETED|Overall Study||70
5338056|NCT00313586|13130984|P1|NOT COMPLETED|Overall Study||70
5338057|NCT00313586|13130981|P4|COMPLETED|Overall Study||0
5338058|NCT00313586|13130982|P3|COMPLETED|Overall Study||0
5338059|NCT00313586|13130983|P2|COMPLETED|Overall Study||5
5338060|NCT00313586|13130984|P1|COMPLETED|Overall Study||5
5338061|NCT00313586|13130981|P4|Treated|Overall Study||23
5338062|NCT00313586|13130982|P3|Treated|Overall Study||24
5338063|NCT00313586|13130983|P2|Treated|Overall Study||75
5338064|NCT00313586|13130984|P1|Treated|Overall Study||74
5338065|NCT00313586|13130981|P4|STARTED|Overall Study||23
5338066|NCT00313586|13130982|P3|STARTED|Overall Study||24
5338067|NCT00313586|13130983|P2|STARTED|Overall Study||75
5338068|NCT00313586|13130984|P1|STARTED|Overall Study||75
5338069|NCT00313560|13130992|P1|NOT COMPLETED|Overall Study||0
5338070|NCT00313560|13130992|P1|COMPLETED|Overall Study||48
5338071|NCT00313560|13130992|P1|STARTED|Overall Study||48
5338072|NCT00313443|13131001|P1|NOT COMPLETED|Overall Study||0
5338073|NCT00313443|13131001|P1|COMPLETED|Overall Study||30
5338074|NCT00313443|13131001|P1|STARTED|Overall Study||30
5338075|NCT00313313|13131012|P3|NOT COMPLETED|Overall Study||82
5338076|NCT00313313|13131013|P2|NOT COMPLETED|Overall Study||66
5338077|NCT00313313|13131014|P1|NOT COMPLETED|Overall Study||63
5338078|NCT00313313|13131012|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
5338079|NCT00313313|13131013|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
5338080|NCT00313313|13131014|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
5338081|NCT00313313|13131012|P3|STARTED|Overall Study||267
5338082|NCT00313313|13131013|P2|STARTED|Overall Study||253
5338083|NCT00313313|13131014|P1|STARTED|Overall Study||248
5338084|NCT00313300|13131036|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
5338085|NCT00313300|13131037|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
5338086|NCT00313300|13131038|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
5338087|NCT00313300|13131039|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
5338088|NCT00313300|13131040|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
5338089|NCT00313300|13131036|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
5338090|NCT00313300|13131037|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
5338091|NCT00313300|13131038|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
5338092|NCT00313300|13131039|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
5338093|NCT00313300|13131040|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
5338094|NCT00313300|13131036|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
5338095|NCT00313300|13131037|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
5338096|NCT00313300|13131038|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
5338097|NCT00313300|13131039|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
5338098|NCT00313300|13131040|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
5338099|NCT00313300|13131036|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
5338100|NCT00313300|13131037|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
5338101|NCT00313300|13131038|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
5338102|NCT00313300|13131039|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
5338103|NCT00313300|13131040|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
5338104|NCT00313300|13131036|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
5338105|NCT00313300|13131037|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
5338106|NCT00313300|13131038|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
5338107|NCT00313300|13131039|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
5338108|NCT00313300|13131040|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
5338109|NCT00313300|13131036|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
5338110|NCT00313300|13131037|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
5338111|NCT00313300|13131038|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
5338112|NCT00313300|13131039|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
5338113|NCT00313300|13131040|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
5338114|NCT00313300|13131036|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
5338115|NCT00313300|13131037|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
5338116|NCT00313300|13131038|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
5338117|NCT00313300|13131039|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
5338118|NCT00313300|13131040|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
5338119|NCT00313300|13131036|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
5338120|NCT00313300|13131037|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
5338121|NCT00313300|13131038|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
5338122|NCT00313300|13131039|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
5338123|NCT00313300|13131040|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
5338124|NCT00313300|13131036|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
5338125|NCT00313300|13131037|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
5338126|NCT00313300|13131038|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
5338127|NCT00313300|13131039|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
5338128|NCT00313300|13131040|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
5338129|NCT00313300|13131036|P5|STARTED|Randomized in Phase B (26 Weeks)||221
5338130|NCT00313300|13131037|P4|STARTED|Randomized in Phase B (26 Weeks)||248
5338131|NCT00313300|13131038|P3|STARTED|Randomized in Phase B (26 Weeks)||134
5338132|NCT00313300|13131039|P2|STARTED|Randomized in Phase B (26 Weeks)||138
5338133|NCT00313300|13131040|P1|STARTED|Randomized in Phase B (26 Weeks)||427
5338134|NCT00313300|13131036|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
5338135|NCT00313300|13131037|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
5338136|NCT00313300|13131038|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
5338137|NCT00313300|13131039|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
5338138|NCT00313300|13131040|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
5338139|NCT00313300|13131036|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
5338140|NCT00313300|13131037|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
5338141|NCT00313300|13131038|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
5338142|NCT00313300|13131039|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
5338143|NCT00313300|13131040|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
5338144|NCT00313300|13131036|P5|STARTED|Randomized in Phase A (26 Weeks)||0
5338145|NCT00313300|13131037|P4|STARTED|Randomized in Phase A (26 Weeks)||0
5338146|NCT00313300|13131038|P3|STARTED|Randomized in Phase A (26 Weeks)||184
5338147|NCT00313300|13131039|P2|STARTED|Randomized in Phase A (26 Weeks)||179
5338148|NCT00313300|13131040|P1|STARTED|Randomized in Phase A (26 Weeks)||184
5338149|NCT00313209|13131092|P2|NOT COMPLETED|Overall Study||82
5338150|NCT00313209|13131093|P1|NOT COMPLETED|Overall Study||107
5338151|NCT00313209|13131092|P2|COMPLETED|Overall Study||385
5338152|NCT00313209|13131093|P1|COMPLETED|Overall Study||359
5338153|NCT00313209|13131092|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
5338154|NCT00313209|13131093|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
5338155|NCT00313170|13131110|P3|NOT COMPLETED|Overall Study||32
5338156|NCT00313170|13131111|P2|NOT COMPLETED|Overall Study||34
5338157|NCT00313170|13131112|P1|NOT COMPLETED|Overall Study||36
5338158|NCT00313170|13131110|P3|COMPLETED|Overall Study||14
5338159|NCT00313170|13131111|P2|COMPLETED|Overall Study||17
5338160|NCT00313170|13131112|P1|COMPLETED|Overall Study||11
5338161|NCT00313170|13131110|P3|STARTED|Overall Study||46
5338162|NCT00313170|13131111|P2|STARTED|Overall Study||51
5338163|NCT00313170|13131112|P1|STARTED|Overall Study||47
5338164|NCT00313144|13131131|P1|NOT COMPLETED|Overall Study||110
5338165|NCT00313144|13131131|P1|COMPLETED|Overall Study||17
5338166|NCT00313144|13131131|P1|STARTED|Overall Study||127
5338167|NCT00313014|13131218|P3|NOT COMPLETED|Overall Study||61
5338168|NCT00313014|13131219|P2|NOT COMPLETED|Overall Study||73
5338169|NCT00313014|13131220|P1|NOT COMPLETED|Overall Study||93
5338170|NCT00313014|13131218|P3|COMPLETED|Overall Study||159
5338171|NCT00313014|13131219|P2|COMPLETED|Overall Study||146
5338172|NCT00313014|13131220|P1|COMPLETED|Overall Study||128
5338173|NCT00313014|13131218|P3|STARTED|Overall Study||220
5338174|NCT00313014|13131219|P2|STARTED|Overall Study||219
5338175|NCT00313014|13131220|P1|STARTED|Overall Study||221
5338176|NCT00312923|13131240|P2|NOT COMPLETED|Overall Study||6
5338177|NCT00312923|13131241|P1|NOT COMPLETED|Overall Study||9
5338178|NCT00312923|13131240|P2|COMPLETED|Overall Study||20
5338179|NCT00312923|13131241|P1|COMPLETED|Overall Study||19
5338180|NCT00312923|13131240|P2|STARTED|Overall Study||26
5338181|NCT00312923|13131241|P1|STARTED|Overall Study||28
5338182|NCT00312897|13131251|P2|NOT COMPLETED|Overall Study||6
5338183|NCT00312897|13131252|P1|NOT COMPLETED|Overall Study||6
5338184|NCT00312897|13131251|P2|COMPLETED|Overall Study||18
5338185|NCT00312897|13131252|P1|COMPLETED|Overall Study||21
5338186|NCT00312897|13131251|P2|STARTED|Overall Study||24
5338187|NCT00312897|13131252|P1|STARTED|Overall Study||27
5338188|NCT00312884|13131262|P2|NOT COMPLETED|Overall Study||12
5338189|NCT00312884|13131263|P1|NOT COMPLETED|Overall Study||17
5338190|NCT00312884|13131262|P2|COMPLETED|Overall Study||79
5338191|NCT00312884|13131263|P1|COMPLETED|Overall Study||74
5338192|NCT00312884|13131262|P2|STARTED|Overall Study||91
5338193|NCT00312884|13131263|P1|STARTED|Overall Study||91
5338194|NCT00312858|13131277|P2|NOT COMPLETED|Overall Study||93
5338195|NCT00312858|13131278|P1|NOT COMPLETED|Overall Study||68
5338196|NCT00312858|13131277|P2|COMPLETED|Overall Study||230
5338197|NCT00312858|13131278|P1|COMPLETED|Overall Study||262
5338198|NCT00312858|13131277|P2|Visit 4|Overall Study||240
5338199|NCT00312858|13131278|P1|Visit 4|Overall Study||262
5338200|NCT00312858|13131277|P2|Visit 3|Overall Study||261
5338201|NCT00312858|13131278|P1|Visit 3|Overall Study||273
5338202|NCT00312858|13131277|P2|Visit 2|Overall Study||294
5338203|NCT00312858|13131278|P1|Visit 2|Overall Study||305
5338204|NCT00312858|13131277|P2|Visit 1|Overall Study||323
5338205|NCT00312858|13131278|P1|Visit 1|Overall Study||330
5338206|NCT00312858|13131277|P2|STARTED|Overall Study||323
5338207|NCT00312858|13131278|P1|STARTED|Overall Study||330
5338208|NCT00312845|13131332|P2|NOT COMPLETED|Overall Study||95
5338209|NCT00312845|13131333|P1|NOT COMPLETED|Overall Study||99
5338210|NCT00312845|13131332|P2|COMPLETED|Overall Study||245
5338211|NCT00312845|13131333|P1|COMPLETED|Overall Study||237
5338212|NCT00312845|13131332|P2|STARTED|Overall Study||340
5338213|NCT00312845|13131333|P1|STARTED|Overall Study||336
5338214|NCT00312728|13131341|P1|NOT COMPLETED|Overall Study||110
5338215|NCT00312728|13131341|P1|COMPLETED|Overall Study||5
5338216|NCT00312728|13131341|P1|STARTED|Overall Study||115
5338217|NCT00312702|13131353|P3|NOT COMPLETED|Challenge Phase||0
5338218|NCT00312702|13131354|P2|NOT COMPLETED|Challenge Phase||0
5338219|NCT00312702|13131355|P1|NOT COMPLETED|Challenge Phase||0
5338220|NCT00312702|13131353|P3|COMPLETED|Challenge Phase||1
5338221|NCT00312702|13131354|P2|COMPLETED|Challenge Phase||12
5338222|NCT00312702|13131355|P1|COMPLETED|Challenge Phase||0
5338223|NCT00312702|13131353|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
5338224|NCT00312702|13131354|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
5338225|NCT00312702|13131355|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
5338226|NCT00312702|13131353|P3|NOT COMPLETED|Immunization Phase||0
5338227|NCT00312702|13131354|P2|NOT COMPLETED|Immunization Phase||1
5338228|NCT00312702|13131355|P1|NOT COMPLETED|Immunization Phase||0
5338229|NCT00312702|13131353|P3|COMPLETED|Immunization Phase||0
5338230|NCT00312702|13131354|P2|COMPLETED|Immunization Phase||12
5338231|NCT00312702|13131355|P1|COMPLETED|Immunization Phase||5
5338232|NCT00312702|13131353|P3|STARTED|Immunization Phase||0
5338233|NCT00312702|13131354|P2|STARTED|Immunization Phase||13
5338234|NCT00312702|13131355|P1|STARTED|Immunization Phase||5
5338235|NCT00312663|13131368|P3|NOT COMPLETED|Challenge Phase||0
5338236|NCT00312663|13131369|P2|NOT COMPLETED|Challenge Phase||0
5338237|NCT00312663|13131370|P1|NOT COMPLETED|Challenge Phase||0
5338238|NCT00312663|13131368|P3|COMPLETED|Challenge Phase||6
5338239|NCT00312663|13131369|P2|COMPLETED|Challenge Phase||10
5338240|NCT00312663|13131370|P1|COMPLETED|Challenge Phase||0
5338241|NCT00312663|13131368|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
5338242|NCT00312663|13131369|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
5338243|NCT00312663|13131370|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
5338244|NCT00312663|13131368|P3|NOT COMPLETED|Immunization Phase||0
5338245|NCT00312663|13131369|P2|NOT COMPLETED|Immunization Phase||1
5338246|NCT00312663|13131370|P1|NOT COMPLETED|Immunization Phase||0
5338247|NCT00312663|13131368|P3|COMPLETED|Immunization Phase||0
5338248|NCT00312663|13131369|P2|COMPLETED|Immunization Phase||12
5338249|NCT00312663|13131370|P1|COMPLETED|Immunization Phase||5
5338250|NCT00312663|13131368|P3|STARTED|Immunization Phase||0
5338251|NCT00312663|13131369|P2|STARTED|Immunization Phase||13
5338252|NCT00312663|13131370|P1|STARTED|Immunization Phase||5
5338253|NCT00312572|13131383|P2|NOT COMPLETED|Overall Study||21
5338254|NCT00312572|13131384|P1|NOT COMPLETED|Overall Study||16
5338255|NCT00312572|13131383|P2|COMPLETED|Overall Study||82
5338256|NCT00312572|13131384|P1|COMPLETED|Overall Study||85
5338257|NCT00312572|13131383|P2|STARTED|Overall Study||103
5338258|NCT00312572|13131384|P1|STARTED|Overall Study||101
5338259|NCT00312494|13131395|P3|NOT COMPLETED|Overall Study||43
5338260|NCT00312494|13131396|P2|NOT COMPLETED|Overall Study||58
5338261|NCT00312494|13131397|P1|NOT COMPLETED|Overall Study||71
5338262|NCT00312494|13131395|P3|COMPLETED|Overall Study||179
5338263|NCT00312494|13131396|P2|COMPLETED|Overall Study||168
5338264|NCT00312494|13131397|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
5338265|NCT00312494|13131395|P3|Received Study Treatment|Overall Study||217
5338266|NCT00312494|13131396|P2|Received Study Treatment|Overall Study||216
5338267|NCT00312494|13131397|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
5338268|NCT00312494|13131395|P3|STARTED|Overall Study||222
5338269|NCT00312494|13131396|P2|STARTED|Overall Study||226
5338270|NCT00312494|13131397|P1|STARTED|Overall Study||232
5338271|NCT00312377|13131431|P2|NOT COMPLETED|Overall Study||668
5338272|NCT00312377|13131432|P1|NOT COMPLETED|Overall Study||644
5338273|NCT00312377|13131431|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
5338274|NCT00312377|13131432|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
5338275|NCT00312377|13131431|P2|STARTED|Overall Study|randomised patients|697
5338276|NCT00312377|13131432|P1|STARTED|Overall Study|randomised patients|694
5338277|NCT00312338|13131456|P2|NOT COMPLETED|Overall Study||3
5338278|NCT00312338|13131457|P1|NOT COMPLETED|Overall Study||22
5338279|NCT00312338|13131456|P2|COMPLETED|Overall Study||54
5338280|NCT00312338|13131457|P1|COMPLETED|Overall Study||83
5338281|NCT00312338|13131456|P2|STARTED|Overall Study||57
5338282|NCT00312338|13131457|P1|STARTED|Overall Study||105
5338283|NCT00312221|13131470|P4|NOT COMPLETED|Double-blind Phase||70
5338284|NCT00312221|13131471|P3|NOT COMPLETED|Double-blind Phase||72
5338285|NCT00312221|13131472|P2|NOT COMPLETED|Double-blind Phase||59
5338286|NCT00312221|13131473|P1|NOT COMPLETED|Double-blind Phase||0
5338287|NCT00312221|13131470|P4|COMPLETED|Double-blind Phase||63
5338288|NCT00312221|13131471|P3|COMPLETED|Double-blind Phase||77
5338289|NCT00312221|13131472|P2|COMPLETED|Double-blind Phase||77
5338290|NCT00312221|13131473|P1|COMPLETED|Double-blind Phase||0
5338291|NCT00312221|13131470|P4|STARTED|Double-blind Phase||133
5338292|NCT00312221|13131471|P3|STARTED|Double-blind Phase||149
5338293|NCT00312221|13131472|P2|STARTED|Double-blind Phase||136
5338294|NCT00312221|13131473|P1|STARTED|Double-blind Phase||0
5338295|NCT00312221|13131470|P4|NOT COMPLETED|Open-label Run-in Period||0
5338296|NCT00312221|13131471|P3|NOT COMPLETED|Open-label Run-in Period||0
5338297|NCT00312221|13131472|P2|NOT COMPLETED|Open-label Run-in Period||0
5338298|NCT00312221|13131473|P1|NOT COMPLETED|Open-label Run-in Period||234
5338299|NCT00312221|13131470|P4|COMPLETED|Open-label Run-in Period||0
5338300|NCT00312221|13131471|P3|COMPLETED|Open-label Run-in Period||0
5338301|NCT00312221|13131472|P2|COMPLETED|Open-label Run-in Period||0
5338302|NCT00312221|13131473|P1|COMPLETED|Open-label Run-in Period||418
5338303|NCT00312221|13131470|P4|STARTED|Open-label Run-in Period||0
5338304|NCT00312221|13131471|P3|STARTED|Open-label Run-in Period||0
5338305|NCT00312221|13131472|P2|STARTED|Open-label Run-in Period||0
5338306|NCT00312221|13131473|P1|STARTED|Open-label Run-in Period||652
5338307|NCT00312208|13131493|P2|NOT COMPLETED|Overall Study||123
5338308|NCT00312208|13131494|P1|NOT COMPLETED|Overall Study||172
5338309|NCT00312208|13131493|P2|COMPLETED|Overall Study||1526
5338310|NCT00312208|13131494|P1|COMPLETED|Overall Study||1477
5338311|NCT00312208|13131493|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
5338312|NCT00312208|13131494|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
5338313|NCT00312195|13131504|P2|NOT COMPLETED|Overall Study||6
5338314|NCT00312195|13131505|P1|NOT COMPLETED|Overall Study||6
5338315|NCT00312195|13131504|P2|COMPLETED|Overall Study||123
5338316|NCT00312195|13131505|P1|COMPLETED|Overall Study||132
5338317|NCT00312195|13131504|P2|STARTED|Overall Study||129
5338318|NCT00312195|13131505|P1|STARTED|Overall Study||138
5338319|NCT00311766|13131521|P2|NOT COMPLETED|Overall Study||5
5338320|NCT00311766|13131522|P1|NOT COMPLETED|Overall Study||0
5338321|NCT00311766|13131521|P2|COMPLETED|Overall Study||17
5338322|NCT00311766|13131522|P1|COMPLETED|Overall Study||8
5338323|NCT00311766|13131521|P2|STARTED|Overall Study||22
5338324|NCT00311766|13131522|P1|STARTED|Overall Study||8
5338325|NCT00311623|13131533|P3|NOT COMPLETED|Overall Study||2
5338326|NCT00311623|13131534|P2|NOT COMPLETED|Overall Study||0
5338327|NCT00311623|13131535|P1|NOT COMPLETED|Overall Study||0
5338328|NCT00311623|13131533|P3|COMPLETED|Overall Study||0
5338329|NCT00311623|13131534|P2|COMPLETED|Overall Study||20
5338330|NCT00311623|13131535|P1|COMPLETED|Overall Study||10
5338331|NCT00311623|13131533|P3|STARTED|Overall Study||2
5338332|NCT00311623|13131534|P2|STARTED|Overall Study||20
5338333|NCT00311623|13131535|P1|STARTED|Overall Study||10
5338334|NCT00311584|13131577|P2|NOT COMPLETED|Overall Study||23
5338335|NCT00311584|13131578|P1|NOT COMPLETED|Overall Study||20
5338336|NCT00311584|13131577|P2|COMPLETED|Overall Study||7
5338337|NCT00311584|13131578|P1|COMPLETED|Overall Study||9
5338338|NCT00311584|13131577|P2|STARTED|Overall Study||30
5338339|NCT00311584|13131578|P1|STARTED|Overall Study||29
5338340|NCT00311402|13131586|P2|NOT COMPLETED|Overall Study||177
5338341|NCT00311402|13131587|P1|NOT COMPLETED|Overall Study||210
5338342|NCT00311402|13131586|P2|COMPLETED|Overall Study||462
5338343|NCT00311402|13131587|P1|COMPLETED|Overall Study||445
5338344|NCT00311402|13131586|P2|STARTED|Overall Study||639
5338345|NCT00311402|13131587|P1|STARTED|Overall Study||655
5338346|NCT00311376|13131614|P3|NOT COMPLETED|Treatment Cycle 2||0
5338347|NCT00311376|13131615|P2|NOT COMPLETED|Treatment Cycle 2||13
5338348|NCT00311376|13131616|P1|NOT COMPLETED|Treatment Cycle 2||9
5338349|NCT00311376|13131614|P3|COMPLETED|Treatment Cycle 2||0
5338350|NCT00311376|13131615|P2|COMPLETED|Treatment Cycle 2||112
5338351|NCT00311376|13131616|P1|COMPLETED|Treatment Cycle 2||106
5338352|NCT00311376|13131614|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
5338353|NCT00311376|13131615|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
5338354|NCT00311376|13131616|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
5338355|NCT00311376|13131614|P3|NOT COMPLETED|Treatment Cycle 1||17
5338356|NCT00311376|13131615|P2|NOT COMPLETED|Treatment Cycle 1||17
5338357|NCT00311376|13131616|P1|NOT COMPLETED|Treatment Cycle 1||27
5338358|NCT00311376|13131614|P3|COMPLETED|Treatment Cycle 1||132
5338359|NCT00311376|13131615|P2|COMPLETED|Treatment Cycle 1||118
5338360|NCT00311376|13131616|P1|COMPLETED|Treatment Cycle 1||105
5338361|NCT00311376|13131614|P3|STARTED|Treatment Cycle 1||149
5338362|NCT00311376|13131615|P2|STARTED|Treatment Cycle 1||135
5338363|NCT00311376|13131616|P1|STARTED|Treatment Cycle 1||132
5338364|NCT00311363|13131636|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
5338365|NCT00311363|13131637|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
5338366|NCT00311363|13131638|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
5338367|NCT00311363|13131636|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
5338368|NCT00311363|13131637|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
5338369|NCT00311363|13131638|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
5338370|NCT00311363|13131636|P3|STARTED|12-Week Double-Blind Treatment Period||96
5338371|NCT00311363|13131637|P2|STARTED|12-Week Double-Blind Treatment Period||98
5338372|NCT00311363|13131638|P1|STARTED|12-Week Double-Blind Treatment Period||0
5338373|NCT00311363|13131636|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
5338374|NCT00311363|13131637|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
5338375|NCT00311363|13131638|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
5338376|NCT00311363|13131636|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
5338377|NCT00311363|13131637|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
5338378|NCT00311363|13131638|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
5338379|NCT00311363|13131636|P3|STARTED|24-Week Single-Blind Treatment Period||0
5338380|NCT00311363|13131637|P2|STARTED|24-Week Single-Blind Treatment Period||0
5338381|NCT00311363|13131638|P1|STARTED|24-Week Single-Blind Treatment Period||327
5338382|NCT00311311|13131698|P2|NOT COMPLETED|Overall Study||9
5338383|NCT00311311|13131699|P1|NOT COMPLETED|Overall Study||8
5338384|NCT00311311|13131698|P2|COMPLETED|Overall Study||26
5338385|NCT00311311|13131699|P1|COMPLETED|Overall Study||29
5338386|NCT00311311|13131698|P2|STARTED|Overall Study||35
5338387|NCT00311311|13131699|P1|STARTED|Overall Study||37
5338388|NCT00311181|13131749|P1|NOT COMPLETED|Overall Study||96
5338389|NCT00311181|13131749|P1|COMPLETED|Overall Study||121
5338390|NCT00311181|13131749|P1|STARTED|Overall Study||217
5338391|NCT00311155|13131755|P1|NOT COMPLETED|Overall Study||93
5338392|NCT00311155|13131755|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
5338393|NCT00311155|13131755|P1|STARTED|Overall Study||694
5338394|NCT00310856|13131767|P3|NOT COMPLETED|Overall Study||8
5338395|NCT00310856|13131768|P2|NOT COMPLETED|Overall Study||5
5338396|NCT00310856|13131769|P1|NOT COMPLETED|Overall Study||5
5338397|NCT00310856|13131767|P3|COMPLETED|Overall Study||42
5338398|NCT00310856|13131768|P2|COMPLETED|Overall Study||56
5338399|NCT00310856|13131769|P1|COMPLETED|Overall Study||59
5338400|NCT00310856|13131767|P3|STARTED|Overall Study||50
5338401|NCT00310856|13131768|P2|STARTED|Overall Study||61
5338402|NCT00310856|13131769|P1|STARTED|Overall Study||64
5338403|NCT00310817|13131793|P4|NOT COMPLETED|Overall Study||8
5338404|NCT00310817|13131794|P3|NOT COMPLETED|Overall Study||8
5338405|NCT00310817|13131795|P2|NOT COMPLETED|Overall Study||8
5338406|NCT00310817|13131796|P1|NOT COMPLETED|Overall Study||11
5338407|NCT00310817|13131793|P4|COMPLETED|Overall Study||74
5338408|NCT00310817|13131794|P3|COMPLETED|Overall Study||120
5338409|NCT00310817|13131795|P2|COMPLETED|Overall Study||198
5338410|NCT00310817|13131796|P1|COMPLETED|Overall Study||196
5338411|NCT00310817|13131793|P4|STARTED|Overall Study||82
5338412|NCT00310817|13131794|P3|STARTED|Overall Study||128
5338413|NCT00310817|13131795|P2|STARTED|Overall Study||206
5338414|NCT00310817|13131796|P1|STARTED|Overall Study||207
5338415|NCT00310804|13131884|P2|NOT COMPLETED|Overall Study||0
5338416|NCT00310804|13131885|P1|NOT COMPLETED|Overall Study||5
5338417|NCT00310804|13131884|P2|COMPLETED|Overall Study||171
5338418|NCT00310804|13131885|P1|COMPLETED|Overall Study||1024
5338419|NCT00310804|13131884|P2|STARTED|Overall Study||171
5338420|NCT00310804|13131885|P1|STARTED|Overall Study||1029
5338421|NCT00310791|13131920|P2|NOT COMPLETED|Overall Study||10
5338422|NCT00310791|13131921|P1|NOT COMPLETED|Overall Study||10
5338423|NCT00310791|13131920|P2|COMPLETED|Overall Study||30
5338424|NCT00310791|13131921|P1|COMPLETED|Overall Study||30
5338425|NCT00310791|13131920|P2|STARTED|Overall Study||40
5338426|NCT00310791|13131921|P1|STARTED|Overall Study||40
5338427|NCT00310466|13131929|P2|NOT COMPLETED|Overall Study||12
5338428|NCT00310466|13131930|P1|NOT COMPLETED|Overall Study||18
5338429|NCT00310466|13131929|P2|COMPLETED|Overall Study||101
5338430|NCT00310466|13131930|P1|COMPLETED|Overall Study||95
5338431|NCT00310466|13131929|P2|STARTED|Overall Study||113
5338432|NCT00310466|13131930|P1|STARTED|Overall Study||113
5338433|NCT00310440|13131944|P2|NOT COMPLETED|Overall Study||13
5338434|NCT00310440|13131945|P1|NOT COMPLETED|Overall Study||26
5338435|NCT00310440|13131944|P2|COMPLETED|Overall Study||141
5338436|NCT00310440|13131945|P1|COMPLETED|Overall Study||139
5338437|NCT00310440|13131944|P2|STARTED|Overall Study||154
5338438|NCT00310440|13131945|P1|STARTED|Overall Study||165
5338439|NCT00310427|13131971|P2|NOT COMPLETED|Overall Study||1
5338440|NCT00310427|13131972|P1|NOT COMPLETED|Overall Study||2
5338441|NCT00310427|13131971|P2|COMPLETED|Overall Study||25
5338442|NCT00310427|13131972|P1|COMPLETED|Overall Study||25
5338443|NCT00310427|13131971|P2|STARTED|Overall Study||26
5338444|NCT00310427|13131972|P1|STARTED|Overall Study||27
5338445|NCT00310401|13131994|P2|NOT COMPLETED|Overall Study||0
5338446|NCT00310401|13131995|P1|NOT COMPLETED|Overall Study||0
5338447|NCT00310401|13131994|P2|COMPLETED|Overall Study||246
5338448|NCT00310401|13131995|P1|COMPLETED|Overall Study||260
5338449|NCT00310401|13131994|P2|STARTED|Overall Study||246
5338450|NCT00310401|13131995|P1|STARTED|Overall Study||260
5338451|NCT00310388|13132009|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
5338452|NCT00310388|13132010|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
5338453|NCT00310388|13132009|P2|COMPLETED|Safety Follow-up Continuation Phase||13
5338454|NCT00310388|13132010|P1|COMPLETED|Safety Follow-up Continuation Phase||0
5338455|NCT00310388|13132009|P2|STARTED|Safety Follow-up Continuation Phase||26
5338456|NCT00310388|13132010|P1|STARTED|Safety Follow-up Continuation Phase||0
5338457|NCT00310388|13132009|P2|NOT COMPLETED|Primary Reporting Phase||0
5338458|NCT00310388|13132010|P1|NOT COMPLETED|Primary Reporting Phase||346
5338459|NCT00310388|13132009|P2|COMPLETED|Primary Reporting Phase||0
5338460|NCT00310388|13132010|P1|COMPLETED|Primary Reporting Phase||30
5338461|NCT00310388|13132009|P2|STARTED|Primary Reporting Phase||0
5338462|NCT00310388|13132010|P1|STARTED|Primary Reporting Phase||376
5338463|NCT00310375|13132052|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
5338464|NCT00310375|13132053|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
5338465|NCT00310375|13132054|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
5338466|NCT00310375|13132052|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
5338467|NCT00310375|13132053|P2|COMPLETED|Safety Follow-up Continuation Phase||0
5338468|NCT00310375|13132054|P1|COMPLETED|Safety Follow-up Continuation Phase||0
5338469|NCT00310375|13132052|P3|STARTED|Safety Follow-up Continuation Phase||19
5338470|NCT00310375|13132053|P2|STARTED|Safety Follow-up Continuation Phase||0
5338471|NCT00310375|13132054|P1|STARTED|Safety Follow-up Continuation Phase||0
5338472|NCT00310375|13132052|P3|NOT COMPLETED|Primary Reporting Phase||0
5338473|NCT00310375|13132053|P2|NOT COMPLETED|Primary Reporting Phase||68
5338474|NCT00310375|13132054|P1|NOT COMPLETED|Primary Reporting Phase||91
5338475|NCT00310375|13132052|P3|COMPLETED|Primary Reporting Phase||0
5338476|NCT00310375|13132053|P2|COMPLETED|Primary Reporting Phase||11
5338477|NCT00310375|13132054|P1|COMPLETED|Primary Reporting Phase||11
5338478|NCT00310375|13132052|P3|STARTED|Primary Reporting Phase||0
5338479|NCT00310375|13132053|P2|STARTED|Primary Reporting Phase||79
5338480|NCT00310375|13132054|P1|STARTED|Primary Reporting Phase||102
5338481|NCT00310362|13132099|P3|NOT COMPLETED|Overall Study||0
5338482|NCT00310362|13132100|P2|NOT COMPLETED|Overall Study||0
5338483|NCT00310362|13132101|P1|NOT COMPLETED|Overall Study||0
5338484|NCT00310362|13132099|P3|COMPLETED|Overall Study||1206
5338485|NCT00310362|13132100|P2|COMPLETED|Overall Study||1205
5338486|NCT00310362|13132101|P1|COMPLETED|Overall Study||1199
5338487|NCT00310362|13132099|P3|STARTED|Overall Study||1206
5338488|NCT00310362|13132100|P2|STARTED|Overall Study||1205
5338489|NCT00310362|13132101|P1|STARTED|Overall Study||1199
5338490|NCT00310310|13132120|P2|NOT COMPLETED|Overall Study||20
5338491|NCT00310310|13132121|P1|NOT COMPLETED|Overall Study||30
5338492|NCT00310310|13132120|P2|COMPLETED|Overall Study||100
5338493|NCT00310310|13132121|P1|COMPLETED|Overall Study||90
5338494|NCT00310310|13132120|P2|STARTED|Overall Study||120
5338495|NCT00310310|13132121|P1|STARTED|Overall Study||120
5338496|NCT00310180|13132149|P4|NOT COMPLETED|Overall Study||348
5338497|NCT00310180|13132150|P3|NOT COMPLETED|Overall Study||137
5338498|NCT00310180|13132151|P2|NOT COMPLETED|Overall Study||59
5338499|NCT00310180|13132152|P1|NOT COMPLETED|Overall Study||10
5338500|NCT00310180|13132149|P4|COMPLETED|Overall Study||1389
5338501|NCT00310180|13132150|P3|COMPLETED|Overall Study||3312
5338502|NCT00310180|13132151|P2|COMPLETED|Overall Study||3399
5338503|NCT00310180|13132152|P1|COMPLETED|Overall Study||1619
5338504|NCT00310180|13132149|P4|No Follow-up Data|Overall Study||245
5338505|NCT00310180|13132150|P3|No Follow-up Data|Overall Study||131
5338506|NCT00310180|13132151|P2|No Follow-up Data|Overall Study||55
5338507|NCT00310180|13132152|P1|No Follow-up Data|Overall Study||7
5338508|NCT00310180|13132149|P4|Ineligible|Overall Study||7
5338509|NCT00310180|13132150|P3|Ineligible|Overall Study||6
5338510|NCT00310180|13132151|P2|Ineligible|Overall Study||4
5338511|NCT00310180|13132152|P1|Ineligible|Overall Study||3
5338512|NCT00310180|13132149|P4|No On-study Data|Overall Study||172
5338513|NCT00310180|13132150|P3|No On-study Data|Overall Study||10
5338514|NCT00310180|13132151|P2|No On-study Data|Overall Study||2
5338515|NCT00310180|13132152|P1|No On-study Data|Overall Study||0
5338516|NCT00310180|13132149|P4|STARTED|Overall Study||1737
5338517|NCT00310180|13132150|P3|STARTED|Overall Study||3449
5338518|NCT00310180|13132151|P2|STARTED|Overall Study||3458
5338519|NCT00310180|13132152|P1|STARTED|Overall Study||1629
5338520|NCT00310076|13132182|P1|NOT COMPLETED|Overall Study||3
5338521|NCT00310076|13132182|P1|COMPLETED|Overall Study||26
5338522|NCT00310076|13132182|P1|STARTED|Overall Study||29
5338523|NCT00310050|13132188|P1|NOT COMPLETED|Overall Study||1
5338524|NCT00310050|13132188|P1|COMPLETED|Overall Study||3
5338525|NCT00310050|13132188|P1|STARTED|Overall Study||4
5338526|NCT00310037|13132199|P2|NOT COMPLETED|Overall Study||17
5338527|NCT00310037|13132200|P1|NOT COMPLETED|Overall Study||18
5338528|NCT00310037|13132199|P2|COMPLETED|Overall Study||33
5338529|NCT00310037|13132200|P1|COMPLETED|Overall Study||34
5338530|NCT00310037|13132199|P2|STARTED|Overall Study||50
5338531|NCT00310037|13132200|P1|STARTED|Overall Study||52
5338532|NCT00309985|13132214|P2|NOT COMPLETED|Overall Study||1
5338533|NCT00309985|13132215|P1|NOT COMPLETED|Overall Study||62
5338534|NCT00309985|13132214|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
5338535|NCT00309985|13132215|P1|COMPLETED|Overall Study||335
5338536|NCT00309985|13132214|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
5338537|NCT00309985|13132215|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
5338538|NCT00309985|13132214|P2|Toxicity Analysis|Overall Study||392
5338539|NCT00309985|13132215|P1|Toxicity Analysis|Overall Study||390
5338540|NCT00309985|13132214|P2|STARTED|Overall Study||393
5338541|NCT00309985|13132215|P1|STARTED|Overall Study||397
5338542|NCT00309959|13132231|P1|NOT COMPLETED|Overall Study||2
5338543|NCT00309959|13132231|P1|COMPLETED|Overall Study||35
5338544|NCT00309959|13132231|P1|STARTED|Overall Study||37
5338545|NCT00309946|13132240|P1|NOT COMPLETED|Overall Study||1
5338546|NCT00309946|13132240|P1|COMPLETED|Overall Study||50
5338547|NCT00309946|13132240|P1|STARTED|Overall Study||51
5338548|NCT00309907|13132246|P1|NOT COMPLETED|Overall Study||20
5338549|NCT00309907|13132246|P1|COMPLETED|Overall Study||19
5338550|NCT00309907|13132246|P1|STARTED|Overall Study||39
5338551|NCT00309777|13132259|P4|NOT COMPLETED|Overall Study||4
5338552|NCT00309777|13132260|P3|NOT COMPLETED|Overall Study||19
5338553|NCT00309777|13132261|P2|NOT COMPLETED|Overall Study||9
5338554|NCT00309777|13132262|P1|NOT COMPLETED|Overall Study||23
5338555|NCT00309777|13132259|P4|COMPLETED|Overall Study||107
5338556|NCT00309777|13132260|P3|COMPLETED|Overall Study||304
5338557|NCT00309777|13132261|P2|COMPLETED|Overall Study||99
5338558|NCT00309777|13132262|P1|COMPLETED|Overall Study||292
5338559|NCT00309777|13132259|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
5338560|NCT00309777|13132260|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
5338561|NCT00309777|13132261|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
5338562|NCT00309777|13132262|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
5338563|NCT00309777|13132259|P4|STARTED|Overall Study||111
5338564|NCT00309777|13132260|P3|STARTED|Overall Study||323
5338565|NCT00309777|13132261|P2|STARTED|Overall Study||108
5338566|NCT00309777|13132262|P1|STARTED|Overall Study||315
5338567|NCT00309751|13132278|P2|NOT COMPLETED|Overall Study||15
5338568|NCT00309751|13132279|P1|NOT COMPLETED|Overall Study||31
5338569|NCT00309751|13132278|P2|COMPLETED|Overall Study||124
5338570|NCT00309751|13132279|P1|COMPLETED|Overall Study||248
5338571|NCT00309751|13132278|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
5338572|NCT00309751|13132279|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
5338573|NCT00309751|13132278|P2|STARTED|Overall Study||139
5338574|NCT00309751|13132279|P1|STARTED|Overall Study||279
5338575|NCT00309738|13132289|P2|NOT COMPLETED|Overall Study||12
5338576|NCT00309738|13132290|P1|NOT COMPLETED|Overall Study||13
5338577|NCT00309738|13132289|P2|COMPLETED|Overall Study||107
5338578|NCT00309738|13132290|P1|COMPLETED|Overall Study||223
5338579|NCT00309738|13132289|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
5338580|NCT00309738|13132290|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
5338581|NCT00309738|13132289|P2|STARTED|Overall Study||119
5338582|NCT00309738|13132290|P1|STARTED|Overall Study||236
5338583|NCT00309608|13132303|P5|NOT COMPLETED|Overall Study||4
5338584|NCT00309608|13132304|P4|NOT COMPLETED|Overall Study||6
5338585|NCT00309608|13132305|P3|NOT COMPLETED|Overall Study||10
5338586|NCT00309608|13132306|P2|NOT COMPLETED|Overall Study||13
5338587|NCT00309608|13132307|P1|NOT COMPLETED|Overall Study||14
5338588|NCT00309608|13132303|P5|COMPLETED|Overall Study||61
5338589|NCT00309608|13132304|P4|COMPLETED|Overall Study||60
5338590|NCT00309608|13132305|P3|COMPLETED|Overall Study||56
5338591|NCT00309608|13132306|P2|COMPLETED|Overall Study||52
5338592|NCT00309608|13132307|P1|COMPLETED|Overall Study||57
5338593|NCT00309608|13132303|P5|STARTED|Overall Study||65
5338594|NCT00309608|13132304|P4|STARTED|Overall Study||66
5338595|NCT00309608|13132305|P3|STARTED|Overall Study||66
5338596|NCT00309608|13132306|P2|STARTED|Overall Study||65
5338597|NCT00309608|13132307|P1|STARTED|Overall Study||71
5338598|NCT00309465|13132334|P6|NOT COMPLETED|Overall Study||0
5338599|NCT00309465|13132335|P5|NOT COMPLETED|Overall Study||0
5338600|NCT00309465|13132336|P4|NOT COMPLETED|Overall Study||1
5338601|NCT00309465|13132337|P3|NOT COMPLETED|Overall Study||0
5338602|NCT00309465|13132338|P2|NOT COMPLETED|Overall Study||0
5338603|NCT00309465|13132339|P1|NOT COMPLETED|Overall Study||0
5338604|NCT00309465|13132334|P6|COMPLETED|Overall Study||76
5338605|NCT00309465|13132335|P5|COMPLETED|Overall Study||76
5338606|NCT00309465|13132336|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
5338607|NCT00309465|13132337|P3|COMPLETED|Overall Study||58
5338608|NCT00309465|13132338|P2|COMPLETED|Overall Study||58
5338609|NCT00309465|13132339|P1|COMPLETED|Overall Study||58
5338610|NCT00309465|13132334|P6|STARTED|Overall Study||76
5338611|NCT00309465|13132335|P5|STARTED|Overall Study||76
5338612|NCT00309465|13132336|P4|STARTED|Overall Study||76
5338613|NCT00309465|13132337|P3|STARTED|Overall Study||58
5338614|NCT00309465|13132338|P2|STARTED|Overall Study||58
5338615|NCT00309465|13132339|P1|STARTED|Overall Study||58
5338616|NCT00309452|13132355|P2|NOT COMPLETED|Overall Study||0
5338617|NCT00309452|13132356|P1|NOT COMPLETED|Overall Study||3
5338618|NCT00309452|13132355|P2|COMPLETED|Overall Study||60
5338619|NCT00309452|13132356|P1|COMPLETED|Overall Study||57
5338620|NCT00309452|13132355|P2|STARTED|Overall Study||60
5338621|NCT00309452|13132356|P1|STARTED|Overall Study||60
5338622|NCT00309387|13132384|P2|NOT COMPLETED|Overall Study||159
5338623|NCT00309387|13132385|P1|NOT COMPLETED|Overall Study||142
5338624|NCT00309387|13132384|P2|COMPLETED|Overall Study||351
5338625|NCT00309387|13132385|P1|COMPLETED|Overall Study||368
5338626|NCT00309387|13132384|P2|STARTED|Overall Study||510
5338627|NCT00309387|13132385|P1|STARTED|Overall Study||510
5338628|NCT00309244|13132403|P2|NOT COMPLETED|Overall Study||97
5338629|NCT00309244|13132404|P1|NOT COMPLETED|Overall Study||118
5338630|NCT00309244|13132403|P2|COMPLETED|Overall Study||246
5338631|NCT00309244|13132404|P1|COMPLETED|Overall Study||216
5338632|NCT00309244|13132403|P2|STARTED|Overall Study||343
5338633|NCT00309244|13132404|P1|STARTED|Overall Study||334
5338634|NCT00309166|13132426|P2|NOT COMPLETED|Overall Study||3
5338635|NCT00309166|13132427|P1|NOT COMPLETED|Overall Study||5
5338636|NCT00309166|13132426|P2|COMPLETED|Overall Study||86
5338637|NCT00309166|13132427|P1|COMPLETED|Overall Study||176
5338638|NCT00309166|13132426|P2|STARTED|Overall Study||89
5338639|NCT00309166|13132427|P1|STARTED|Overall Study||181
5338640|NCT00309140|13132453|P1|NOT COMPLETED|Overall Study||0
5338641|NCT00309140|13132453|P1|COMPLETED|Overall Study||23
5338642|NCT00309140|13132453|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
5338643|NCT00309140|13132453|P1|STARTED|Overall Study||23
5338644|NCT00308997|13132461|P2|NOT COMPLETED|Overall Study||1
5338645|NCT00308997|13132462|P1|NOT COMPLETED|Overall Study||1
5338646|NCT00308997|13132461|P2|COMPLETED|Overall Study||28
5338647|NCT00308997|13132462|P1|COMPLETED|Overall Study||55
5338648|NCT00308997|13132461|P2|STARTED|Overall Study||29
5338649|NCT00308997|13132462|P1|STARTED|Overall Study||56
5338650|NCT00308737|13132481|P3|NOT COMPLETED|Overall Study||37
5338651|NCT00308737|13132482|P2|NOT COMPLETED|Overall Study||289
5338652|NCT00308737|13132483|P1|NOT COMPLETED|Overall Study||463
5338653|NCT00308737|13132481|P3|COMPLETED|Overall Study||127
5338654|NCT00308737|13132482|P2|COMPLETED|Overall Study||662
5338655|NCT00308737|13132483|P1|COMPLETED|Overall Study||475
5338656|NCT00308737|13132481|P3|STARTED|Overall Study||164
5338657|NCT00308737|13132482|P2|STARTED|Overall Study||951
5338658|NCT00308737|13132483|P1|STARTED|Overall Study||938
5338659|NCT00308711|13132523|P3|NOT COMPLETED|Overall Study||5
5338660|NCT00308711|13132524|P2|NOT COMPLETED|Overall Study||4
5338661|NCT00308711|13132525|P1|NOT COMPLETED|Overall Study||2
5338662|NCT00308711|13132523|P3|COMPLETED|Overall Study||431
5338663|NCT00308711|13132524|P2|COMPLETED|Overall Study||440
5338664|NCT00308711|13132525|P1|COMPLETED|Overall Study||426
5338665|NCT00308711|13132523|P3|STARTED|Overall Study||436
5338666|NCT00308711|13132524|P2|STARTED|Overall Study||444
5338667|NCT00308711|13132525|P1|STARTED|Overall Study||428
5338668|NCT00308620|13132560|P3|NOT COMPLETED|Overall Study||1
5338669|NCT00308620|13132561|P2|NOT COMPLETED|Overall Study||1
5338670|NCT00308620|13132562|P1|NOT COMPLETED|Overall Study||1
5338671|NCT00308620|13132560|P3|COMPLETED|Overall Study||5
5338672|NCT00308620|13132561|P2|COMPLETED|Overall Study||3
5338673|NCT00308620|13132562|P1|COMPLETED|Overall Study||2
5338674|NCT00308620|13132560|P3|STARTED|Overall Study||6
5338675|NCT00308620|13132561|P2|STARTED|Overall Study||4
5338676|NCT00308620|13132562|P1|STARTED|Overall Study||3
5338677|NCT00308581|13132571|P3|NOT COMPLETED|Randomized Maintenance Phase||0
5338678|NCT00308581|13132572|P2|NOT COMPLETED|Randomized Maintenance Phase||103
5338679|NCT00308581|13132573|P1|NOT COMPLETED|Randomized Maintenance Phase||105
5338680|NCT00308581|13132571|P3|COMPLETED|Randomized Maintenance Phase||0
5338681|NCT00308581|13132572|P2|COMPLETED|Randomized Maintenance Phase||83
5338682|NCT00308581|13132573|P1|COMPLETED|Randomized Maintenance Phase||82
5338683|NCT00308581|13132571|P3|STARTED|Randomized Maintenance Phase||0
5338684|NCT00308581|13132572|P2|STARTED|Randomized Maintenance Phase||186
5338685|NCT00308581|13132573|P1|STARTED|Randomized Maintenance Phase||187
5338686|NCT00308581|13132571|P3|NOT COMPLETED|Induction Phase||166
5338687|NCT00308581|13132572|P2|NOT COMPLETED|Induction Phase||0
5338688|NCT00308581|13132573|P1|NOT COMPLETED|Induction Phase||0
5338689|NCT00308581|13132571|P3|COMPLETED|Induction Phase||373
5338690|NCT00308581|13132572|P2|COMPLETED|Induction Phase|Not applicable in this period|0
5338691|NCT00308581|13132573|P1|COMPLETED|Induction Phase|Not applicable in this period|0
5338692|NCT00308581|13132571|P3|STARTED|Induction Phase||539
5338693|NCT00308581|13132572|P2|STARTED|Induction Phase|Not applicable in this period|0
5338694|NCT00308581|13132573|P1|STARTED|Induction Phase|Not applicable in this period|0
5338695|NCT00308555|13132699|P2|NOT COMPLETED|Overall Study||0
5338696|NCT00308555|13132700|P1|NOT COMPLETED|Overall Study||3
5338697|NCT00308555|13132699|P2|COMPLETED|Overall Study||11
5338698|NCT00308555|13132700|P1|COMPLETED|Overall Study||10
5338699|NCT00308555|13132699|P2|STARTED|Overall Study||11
5338700|NCT00308555|13132700|P1|STARTED|Overall Study||13
5338701|NCT00308516|13132708|P2|NOT COMPLETED|Overall Study||21
5338702|NCT00308516|13132709|P1|NOT COMPLETED|Overall Study||29
5338703|NCT00308516|13132708|P2|COMPLETED|Overall Study||10
5338704|NCT00308516|13132709|P1|COMPLETED|Overall Study||6
5338705|NCT00308516|13132708|P2|STARTED|Overall Study||31
5338706|NCT00308516|13132709|P1|STARTED|Overall Study||35
5338707|NCT00308308|13132717|P2|NOT COMPLETED|Overall Study||68
5338708|NCT00308308|13132718|P1|NOT COMPLETED|Overall Study||103
5338709|NCT00308308|13132717|P2|COMPLETED|Overall Study||220
5338710|NCT00308308|13132718|P1|COMPLETED|Overall Study||198
5338711|NCT00308308|13132717|P2|STARTED|Overall Study||288
5338712|NCT00308308|13132718|P1|STARTED|Overall Study||301
5338713|NCT00308282|13132742|P4|NOT COMPLETED|Overall Study||2
5338714|NCT00308282|13132743|P3|NOT COMPLETED|Overall Study||1
5338715|NCT00308282|13132744|P2|NOT COMPLETED|Overall Study||4
5338716|NCT00308282|13132745|P1|NOT COMPLETED|Overall Study||3
5338717|NCT00308282|13132742|P4|COMPLETED|Overall Study||32
5338718|NCT00308282|13132743|P3|COMPLETED|Overall Study||33
5338719|NCT00308282|13132744|P2|COMPLETED|Overall Study||30
5338720|NCT00308282|13132745|P1|COMPLETED|Overall Study||31
5338721|NCT00308282|13132742|P4|Received at Least One Dose of Study Drug|Overall Study||34
5338722|NCT00308282|13132743|P3|Received at Least One Dose of Study Drug|Overall Study||34
5338723|NCT00308282|13132744|P2|Received at Least One Dose of Study Drug|Overall Study||34
5338724|NCT00308282|13132745|P1|Received at Least One Dose of Study Drug|Overall Study||34
5338725|NCT00308282|13132742|P4|STARTED|Overall Study||34
5338726|NCT00308282|13132743|P3|STARTED|Overall Study||34
5338727|NCT00308282|13132744|P2|STARTED|Overall Study||34
5338728|NCT00308282|13132745|P1|STARTED|Overall Study||34
5338729|NCT00308230|13132785|P3|NOT COMPLETED|Overall Study||0
5338730|NCT00308230|13132786|P2|NOT COMPLETED|Overall Study||0
5338731|NCT00308230|13132787|P1|NOT COMPLETED|Overall Study||0
5338732|NCT00308230|13132785|P3|COMPLETED|Overall Study||20
5338733|NCT00308230|13132786|P2|COMPLETED|Overall Study||8
5338734|NCT00308230|13132787|P1|COMPLETED|Overall Study||6
5338735|NCT00308230|13132785|P3|STARTED|Overall Study||20
5338736|NCT00308230|13132786|P2|STARTED|Overall Study||8
5338737|NCT00308230|13132787|P1|STARTED|Overall Study||6
5338738|NCT00308139|13132797|P2|NOT COMPLETED|Overall Study||87
5338739|NCT00308139|13132798|P1|NOT COMPLETED|Overall Study||94
5338740|NCT00308139|13132797|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
5338741|NCT00308139|13132798|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
5338742|NCT00308139|13132797|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
5338743|NCT00308139|13132798|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
5338744|NCT00308139|13132797|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
5338745|NCT00308139|13132798|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
5338746|NCT00308139|13132797|P2|Pharmacokinetics Population|Overall Study||0
5338747|NCT00308139|13132798|P1|Pharmacokinetics Population|Overall Study||129
5338748|NCT00308139|13132797|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
5338749|NCT00308139|13132798|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
5338750|NCT00308139|13132797|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
5338751|NCT00308139|13132798|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
5338752|NCT00308139|13132797|P2|STARTED|Overall Study||151
5338753|NCT00308139|13132798|P1|STARTED|Overall Study||152
5338754|NCT00308113|13132872|P4|NOT COMPLETED|Overall Study||1
5338755|NCT00308113|13132873|P3|NOT COMPLETED|Overall Study||0
5338756|NCT00308113|13132874|P2|NOT COMPLETED|Overall Study||0
5338757|NCT00308113|13132875|P1|NOT COMPLETED|Overall Study||0
5338758|NCT00308113|13132872|P4|COMPLETED|Overall Study||1
5338759|NCT00308113|13132873|P3|COMPLETED|Overall Study||1
5338760|NCT00308113|13132874|P2|COMPLETED|Overall Study||0
5338761|NCT00308113|13132875|P1|COMPLETED|Overall Study||0
5338762|NCT00308113|13132872|P4|STARTED|Overall Study||2
5338763|NCT00308113|13132873|P3|STARTED|Overall Study||1
5338764|NCT00308113|13132874|P2|STARTED|Overall Study||0
5338765|NCT00308113|13132875|P1|STARTED|Overall Study||0
5338766|NCT00308087|13132895|P2|NOT COMPLETED|Overall Study||37
5338767|NCT00308087|13132896|P1|NOT COMPLETED|Overall Study||36
5338768|NCT00308087|13132895|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
5338769|NCT00308087|13132896|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
5338770|NCT00308087|13132895|P2|STARTED|Overall Study||38
5338771|NCT00308087|13132896|P1|STARTED|Overall Study||37
5338772|NCT00308074|13132912|P1|NOT COMPLETED|Overall Study||1
5338773|NCT00308074|13132912|P1|COMPLETED|Overall Study||13
5338774|NCT00308074|13132912|P1|STARTED|Overall Study||14
5338775|NCT00308061|13132921|P2|NOT COMPLETED|Overall Study||0
5338776|NCT00308061|13132922|P1|NOT COMPLETED|Overall Study||0
5338777|NCT00308061|13132921|P2|COMPLETED|Overall Study||20
5338778|NCT00308061|13132922|P1|COMPLETED|Overall Study||20
5338779|NCT00308061|13132921|P2|STARTED|Overall Study||20
5338780|NCT00308061|13132922|P1|STARTED|Overall Study||20
5338781|NCT00307931|13132929|P1|NOT COMPLETED|Overall Study||1
5338782|NCT00307931|13132929|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
5338783|NCT00307931|13132929|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
5338784|NCT00307801|13132946|P2|NOT COMPLETED|Overall Study||17
5338785|NCT00307801|13132947|P1|NOT COMPLETED|Overall Study||32
5338786|NCT00307801|13132946|P2|COMPLETED|Overall Study||65
5338787|NCT00307801|13132947|P1|COMPLETED|Overall Study||117
5338788|NCT00307801|13132946|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
5338789|NCT00307801|13132947|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
5338790|NCT00307801|13132946|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
5338791|NCT00307801|13132947|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
5338792|NCT00307801|13132946|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
5338793|NCT00307801|13132947|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
5338794|NCT00307801|13132946|P2|Subjects Received Treatment|Overall Study||81
5338795|NCT00307801|13132947|P1|Subjects Received Treatment|Overall Study||145
5338796|NCT00307801|13132946|P2|STARTED|Overall Study||82
5338797|NCT00307801|13132947|P1|STARTED|Overall Study||149
5338798|NCT00307736|13133059|P4|NOT COMPLETED|Overall Study||3
5338799|NCT00307736|13133060|P3|NOT COMPLETED|Overall Study||3
5338800|NCT00307736|13133061|P2|NOT COMPLETED|Overall Study||0
5338801|NCT00307736|13133062|P1|NOT COMPLETED|Overall Study||0
5338802|NCT00307736|13133059|P4|COMPLETED|Overall Study||20
5338803|NCT00307736|13133060|P3|COMPLETED|Overall Study||0
5338804|NCT00307736|13133061|P2|COMPLETED|Overall Study||3
5338805|NCT00307736|13133062|P1|COMPLETED|Overall Study||3
5338806|NCT00307736|13133059|P4|STARTED|Overall Study||23
5338807|NCT00307736|13133060|P3|STARTED|Overall Study||3
5338808|NCT00307736|13133061|P2|STARTED|Overall Study||3
5338809|NCT00307736|13133062|P1|STARTED|Overall Study||3
5338810|NCT00307684|13133073|P3|NOT COMPLETED|Double Blind Phase||0
5338811|NCT00307684|13133074|P2|NOT COMPLETED|Double Blind Phase||5
5338812|NCT00307684|13133075|P1|NOT COMPLETED|Double Blind Phase||2
5338813|NCT00307684|13133073|P3|COMPLETED|Double Blind Phase||0
5338814|NCT00307684|13133074|P2|COMPLETED|Double Blind Phase||17
5338815|NCT00307684|13133075|P1|COMPLETED|Double Blind Phase||21
5338816|NCT00307684|13133073|P3|STARTED|Double Blind Phase||0
5338817|NCT00307684|13133074|P2|STARTED|Double Blind Phase||22
5338818|NCT00307684|13133075|P1|STARTED|Double Blind Phase||23
5338819|NCT00307684|13133073|P3|NOT COMPLETED|Open Label Phase||56
5338820|NCT00307684|13133074|P2|NOT COMPLETED|Open Label Phase||0
5338821|NCT00307684|13133075|P1|NOT COMPLETED|Open Label Phase||0
5338822|NCT00307684|13133073|P3|COMPLETED|Open Label Phase||99
5338823|NCT00307684|13133074|P2|COMPLETED|Open Label Phase||0
5338824|NCT00307684|13133075|P1|COMPLETED|Open Label Phase||0
5338825|NCT00307684|13133073|P3|STARTED|Open Label Phase|1 screening failure|155
5338826|NCT00307684|13133074|P2|STARTED|Open Label Phase||0
5338827|NCT00307684|13133075|P1|STARTED|Open Label Phase||0
5338828|NCT00307489|13133103|P2|NOT COMPLETED|Week 48 Through Week 168||6
5338829|NCT00307489|13133104|P1|NOT COMPLETED|Week 48 Through Week 168||6
5338830|NCT00307489|13133103|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
5338831|NCT00307489|13133104|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
5338832|NCT00307489|13133103|P2|STARTED|Week 48 Through Week 168||50
5338833|NCT00307489|13133104|P1|STARTED|Week 48 Through Week 168||52
5338834|NCT00307489|13133103|P2|NOT COMPLETED|Baseline Through Week 48||2
5338835|NCT00307489|13133104|P1|NOT COMPLETED|Baseline Through Week 48||1
5338836|NCT00307489|13133103|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
5338837|NCT00307489|13133104|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
5338838|NCT00307489|13133103|P2|STARTED|Baseline Through Week 48||52
5338839|NCT00307489|13133104|P1|STARTED|Baseline Through Week 48||53
5338840|NCT00307437|13133149|P7|NOT COMPLETED|After Controlled Period||113
5338841|NCT00307437|13133150|P6|NOT COMPLETED|After Controlled Period||122
5338842|NCT00307437|13133151|P5|NOT COMPLETED|After Controlled Period||55
5338843|NCT00307437|13133152|P4|NOT COMPLETED|After Controlled Period||58
5338844|NCT00307437|13133153|P3|NOT COMPLETED|After Controlled Period||0
5338845|NCT00307437|13133154|P2|NOT COMPLETED|After Controlled Period||0
5338846|NCT00307437|13133155|P1|NOT COMPLETED|After Controlled Period||0
5338847|NCT00307437|13133149|P7|COMPLETED|After Controlled Period||289
5338848|NCT00307437|13133150|P6|COMPLETED|After Controlled Period||281
5338849|NCT00307437|13133151|P5|COMPLETED|After Controlled Period||140
5338850|NCT00307437|13133152|P4|COMPLETED|After Controlled Period||139
5338851|NCT00307437|13133153|P3|COMPLETED|After Controlled Period||0
5338852|NCT00307437|13133154|P2|COMPLETED|After Controlled Period||0
5338853|NCT00307437|13133155|P1|COMPLETED|After Controlled Period||0
5338854|NCT00307437|13133149|P7|STARTED|After Controlled Period||402
5338855|NCT00307437|13133150|P6|STARTED|After Controlled Period||403
5338856|NCT00307437|13133151|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
5338857|NCT00307437|13133152|P4|STARTED|After Controlled Period||197
5338858|NCT00307437|13133153|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5338859|NCT00307437|13133154|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5338860|NCT00307437|13133155|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
5338861|NCT00307437|13133149|P7|NOT COMPLETED|Controlled Period||0
5338862|NCT00307437|13133150|P6|NOT COMPLETED|Controlled Period||0
5338863|NCT00307437|13133151|P5|NOT COMPLETED|Controlled Period||0
5338864|NCT00307437|13133152|P4|NOT COMPLETED|Controlled Period||0
5338865|NCT00307437|13133153|P3|NOT COMPLETED|Controlled Period||9
5338866|NCT00307437|13133154|P2|NOT COMPLETED|Controlled Period||6
5338867|NCT00307437|13133155|P1|NOT COMPLETED|Controlled Period||16
5338868|NCT00307437|13133149|P7|COMPLETED|Controlled Period||0
5338869|NCT00307437|13133150|P6|COMPLETED|Controlled Period||0
5338870|NCT00307437|13133151|P5|COMPLETED|Controlled Period||0
5338871|NCT00307437|13133152|P4|COMPLETED|Controlled Period||0
5338872|NCT00307437|13133153|P3|COMPLETED|Controlled Period||402
5338873|NCT00307437|13133154|P2|COMPLETED|Controlled Period||403
5338874|NCT00307437|13133155|P1|COMPLETED|Controlled Period||394
5338875|NCT00307437|13133149|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5338876|NCT00307437|13133150|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5338877|NCT00307437|13133151|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5338878|NCT00307437|13133152|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
5338879|NCT00307437|13133153|P3|STARTED|Controlled Period||411
5338880|NCT00307437|13133154|P2|STARTED|Controlled Period||409
5338881|NCT00307437|13133155|P1|STARTED|Controlled Period||410
5338882|NCT00307333|13133181|P2|NOT COMPLETED|Overall Study||3
5338883|NCT00307333|13133182|P1|NOT COMPLETED|Overall Study||11
5338884|NCT00307333|13133181|P2|COMPLETED|Overall Study||1489
5338885|NCT00307333|13133182|P1|COMPLETED|Overall Study||1500
5338886|NCT00307333|13133181|P2|STARTED|Overall Study||1492
5338887|NCT00307333|13133182|P1|STARTED|Overall Study||1511
5338888|NCT00307294|13133194|P1|NOT COMPLETED|Overall Study||1
5338889|NCT00307294|13133194|P1|COMPLETED|Overall Study||39
5338890|NCT00307294|13133194|P1|STARTED|Overall Study||40
5338891|NCT00307164|13133203|P2|NOT COMPLETED|Overall Study||14
5338892|NCT00307164|13133204|P1|NOT COMPLETED|Overall Study||15
5338893|NCT00307164|13133203|P2|COMPLETED|Overall Study||68
5338894|NCT00307164|13133204|P1|COMPLETED|Overall Study||68
5338895|NCT00307164|13133203|P2|STARTED|Overall Study||82
5338896|NCT00307164|13133204|P1|STARTED|Overall Study||83
5338897|NCT00307151|13133244|P4|NOT COMPLETED|Overall Study||11
5338898|NCT00307151|13133245|P3|NOT COMPLETED|Overall Study||20
5338899|NCT00307151|13133246|P2|NOT COMPLETED|Overall Study||7
5338900|NCT00307151|13133247|P1|NOT COMPLETED|Overall Study||11
5338901|NCT00307151|13133244|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
5338902|NCT00307151|13133245|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
5338903|NCT00307151|13133246|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
5338904|NCT00307151|13133247|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
5338905|NCT00307151|13133244|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
5338906|NCT00307151|13133245|P3|STARTED|Overall Study||147
5338907|NCT00307151|13133246|P2|STARTED|Overall Study||82
5338908|NCT00307151|13133247|P1|STARTED|Overall Study||82
5338909|NCT00307125|13133291|P3|NOT COMPLETED|Pilot Phase||1
5338910|NCT00307125|13133292|P2|NOT COMPLETED|Pilot Phase||2
5338911|NCT00307125|13133293|P1|NOT COMPLETED|Pilot Phase||0
5338912|NCT00307125|13133291|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
5338913|NCT00307125|13133292|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
5338914|NCT00307125|13133293|P1|COMPLETED|Pilot Phase||0
5338915|NCT00307125|13133291|P3|STARTED|Pilot Phase||7
5338916|NCT00307125|13133292|P2|STARTED|Pilot Phase||15
5338917|NCT00307125|13133293|P1|STARTED|Pilot Phase||0
5338918|NCT00307125|13133291|P3|NOT COMPLETED|Screening Phase||0
5338919|NCT00307125|13133292|P2|NOT COMPLETED|Screening Phase||0
5338920|NCT00307125|13133293|P1|NOT COMPLETED|Screening Phase||454
5338921|NCT00307125|13133291|P3|COMPLETED|Screening Phase||0
5338922|NCT00307125|13133292|P2|COMPLETED|Screening Phase||0
5338923|NCT00307125|13133293|P1|COMPLETED|Screening Phase||303
5338924|NCT00307125|13133291|P3|STARTED|Screening Phase||0
5338925|NCT00307125|13133292|P2|STARTED|Screening Phase||0
5338926|NCT00307125|13133293|P1|STARTED|Screening Phase||757
5338927|NCT00307086|13133315|P1|NOT COMPLETED|Overall Study||5
5338928|NCT00307086|13133315|P1|COMPLETED|Overall Study||25
5338929|NCT00307086|13133315|P1|STARTED|Overall Study||30
5338930|NCT00307047|13133321|P2|NOT COMPLETED|Overall Study||49
5338931|NCT00307047|13133322|P1|NOT COMPLETED|Overall Study||69
5338932|NCT00307047|13133321|P2|COMPLETED|Overall Study||1180
5338933|NCT00307047|13133322|P1|COMPLETED|Overall Study||2389
5338934|NCT00307047|13133321|P2|STARTED|Overall Study||1229
5338935|NCT00307047|13133322|P1|STARTED|Overall Study||2458
5338936|NCT00307034|13133460|P2|NOT COMPLETED|Overall Study||7
5338937|NCT00307034|13133461|P1|NOT COMPLETED|Overall Study||2
5338938|NCT00307034|13133460|P2|COMPLETED|Overall Study||169
5338939|NCT00307034|13133461|P1|COMPLETED|Overall Study||173
5338940|NCT00307034|13133460|P2|STARTED|Overall Study||176
5338941|NCT00307034|13133461|P1|STARTED|Overall Study||175
5338942|NCT00306995|13133506|P7|NOT COMPLETED|Study Part II for Subset 2||0
5338943|NCT00306995|13133507|P6|NOT COMPLETED|Study Part II for Subset 2||0
5338944|NCT00306995|13133508|P5|NOT COMPLETED|Study Part II for Subset 2||0
5338945|NCT00306995|13133509|P4|NOT COMPLETED|Study Part II for Subset 2||0
5338946|NCT00306995|13133510|P3|NOT COMPLETED|Study Part II for Subset 2||0
5338947|NCT00306995|13133511|P2|NOT COMPLETED|Study Part II for Subset 2||1
5338948|NCT00306995|13133512|P1|NOT COMPLETED|Study Part II for Subset 2||0
5338949|NCT00306995|13133506|P7|COMPLETED|Study Part II for Subset 2||24
5338950|NCT00306995|13133507|P6|COMPLETED|Study Part II for Subset 2||26
5338951|NCT00306995|13133508|P5|COMPLETED|Study Part II for Subset 2||23
5338952|NCT00306995|13133509|P4|COMPLETED|Study Part II for Subset 2||22
5338953|NCT00306995|13133510|P3|COMPLETED|Study Part II for Subset 2||23
5338954|NCT00306995|13133511|P2|COMPLETED|Study Part II for Subset 2||23
5338955|NCT00306995|13133512|P1|COMPLETED|Study Part II for Subset 2||23
5338956|NCT00306995|13133506|P7|STARTED|Study Part II for Subset 2||24
5338957|NCT00306995|13133507|P6|STARTED|Study Part II for Subset 2||26
5338958|NCT00306995|13133508|P5|STARTED|Study Part II for Subset 2||23
5338959|NCT00306995|13133509|P4|STARTED|Study Part II for Subset 2||22
5338960|NCT00306995|13133510|P3|STARTED|Study Part II for Subset 2||23
5338961|NCT00306995|13133511|P2|STARTED|Study Part II for Subset 2||24
5338962|NCT00306995|13133512|P1|STARTED|Study Part II for Subset 2||23
5338963|NCT00306995|13133506|P7|NOT COMPLETED|Study Part II for Subset 1||0
5338964|NCT00306995|13133507|P6|NOT COMPLETED|Study Part II for Subset 1||0
5338965|NCT00306995|13133508|P5|NOT COMPLETED|Study Part II for Subset 1||0
5338966|NCT00306995|13133509|P4|NOT COMPLETED|Study Part II for Subset 1||0
5338967|NCT00306995|13133510|P3|NOT COMPLETED|Study Part II for Subset 1||0
5338968|NCT00306995|13133511|P2|NOT COMPLETED|Study Part II for Subset 1||0
5338969|NCT00306995|13133512|P1|NOT COMPLETED|Study Part II for Subset 1||0
5338970|NCT00306995|13133506|P7|COMPLETED|Study Part II for Subset 1||23
5338971|NCT00306995|13133507|P6|COMPLETED|Study Part II for Subset 1||26
5338972|NCT00306995|13133508|P5|COMPLETED|Study Part II for Subset 1||27
5338973|NCT00306995|13133509|P4|COMPLETED|Study Part II for Subset 1||27
5338974|NCT00306995|13133510|P3|COMPLETED|Study Part II for Subset 1||27
5338975|NCT00306995|13133511|P2|COMPLETED|Study Part II for Subset 1||26
5338976|NCT00306995|13133512|P1|COMPLETED|Study Part II for Subset 1||27
5338977|NCT00306995|13133506|P7|STARTED|Study Part II for Subset 1||23
5338978|NCT00306995|13133507|P6|STARTED|Study Part II for Subset 1||26
5338979|NCT00306995|13133508|P5|STARTED|Study Part II for Subset 1||27
5338980|NCT00306995|13133509|P4|STARTED|Study Part II for Subset 1||27
5338981|NCT00306995|13133510|P3|STARTED|Study Part II for Subset 1||27
5338982|NCT00306995|13133511|P2|STARTED|Study Part II for Subset 1||26
5338983|NCT00306995|13133512|P1|STARTED|Study Part II for Subset 1||27
5338984|NCT00306995|13133506|P7|NOT COMPLETED|Study Part I||1
5338985|NCT00306995|13133507|P6|NOT COMPLETED|Study Part I||0
5338986|NCT00306995|13133508|P5|NOT COMPLETED|Study Part I||0
5338987|NCT00306995|13133509|P4|NOT COMPLETED|Study Part I||0
5338988|NCT00306995|13133510|P3|NOT COMPLETED|Study Part I||0
5338989|NCT00306995|13133511|P2|NOT COMPLETED|Study Part I||0
5338990|NCT00306995|13133512|P1|NOT COMPLETED|Study Part I||0
5338991|NCT00306995|13133506|P7|COMPLETED|Study Part I||54
5338992|NCT00306995|13133507|P6|COMPLETED|Study Part I||55
5338993|NCT00306995|13133508|P5|COMPLETED|Study Part I||55
5338994|NCT00306995|13133509|P4|COMPLETED|Study Part I||55
5338995|NCT00306995|13133510|P3|COMPLETED|Study Part I||55
5338996|NCT00306995|13133511|P2|COMPLETED|Study Part I||55
5338997|NCT00306995|13133512|P1|COMPLETED|Study Part I||55
5338998|NCT00306995|13133506|P7|STARTED|Study Part I||55
5338999|NCT00306995|13133507|P6|STARTED|Study Part I||55
5339000|NCT00306995|13133508|P5|STARTED|Study Part I||55
5339001|NCT00306995|13133509|P4|STARTED|Study Part I||55
5339002|NCT00306995|13133510|P3|STARTED|Study Part I||55
5339003|NCT00306995|13133511|P2|STARTED|Study Part I||55
5339004|NCT00306995|13133512|P1|STARTED|Study Part I||55
5339005|NCT00306917|13133894|P2|NOT COMPLETED|Overall Study||109
5339006|NCT00306917|13133895|P1|NOT COMPLETED|Overall Study||108
5339007|NCT00306917|13133894|P2|COMPLETED|Overall Study||15
5339008|NCT00306917|13133895|P1|COMPLETED|Overall Study||13
5339009|NCT00306917|13133894|P2|60 Month Follow up|Overall Study||15
5339010|NCT00306917|13133895|P1|60 Month Follow up|Overall Study||13
5339011|NCT00306917|13133894|P2|48 Month Follow up|Overall Study||22
5339012|NCT00306917|13133895|P1|48 Month Follow up|Overall Study||29
5339013|NCT00306917|13133894|P2|36 Month Follow up|Overall Study||42
5339014|NCT00306917|13133895|P1|36 Month Follow up|Overall Study||56
5339015|NCT00306917|13133894|P2|24 Month Follow up|Overall Study||71
5339016|NCT00306917|13133895|P1|24 Month Follow up|Overall Study||60
5339017|NCT00306917|13133894|P2|12 Month Follow|Overall Study||94
5339018|NCT00306917|13133895|P1|12 Month Follow|Overall Study||86
5339019|NCT00306917|13133894|P2|Postoperative to 6 Month Follow up|Overall Study||100
5339020|NCT00306917|13133895|P1|Postoperative to 6 Month Follow up|Overall Study||93
5339021|NCT00306917|13133894|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
5339022|NCT00306917|13133895|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
5339023|NCT00306891|13133905|P4|NOT COMPLETED|Part B||17
5339024|NCT00306891|13133906|P3|NOT COMPLETED|Part B||11
5339025|NCT00306891|13133907|P2|NOT COMPLETED|Part B||0
5339026|NCT00306891|13133908|P1|NOT COMPLETED|Part B||0
5339027|NCT00306891|13133905|P4|COMPLETED|Part B||14
5339028|NCT00306891|13133906|P3|COMPLETED|Part B||5
5339029|NCT00306891|13133907|P2|COMPLETED|Part B||0
5339030|NCT00306891|13133908|P1|COMPLETED|Part B||0
5339031|NCT00306891|13133905|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
5339032|NCT00306891|13133906|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
5339033|NCT00306891|13133907|P2|STARTED|Part B||0
5339034|NCT00306891|13133908|P1|STARTED|Part B||0
5339035|NCT00306891|13133905|P4|NOT COMPLETED|Part A||0
5339036|NCT00306891|13133906|P3|NOT COMPLETED|Part A||0
5339037|NCT00306891|13133907|P2|NOT COMPLETED|Part A||6
5339038|NCT00306891|13133908|P1|NOT COMPLETED|Part A||5
5339039|NCT00306891|13133905|P4|COMPLETED|Part A||0
5339040|NCT00306891|13133906|P3|COMPLETED|Part A||0
5339041|NCT00306891|13133907|P2|COMPLETED|Part A||16
5339042|NCT00306891|13133908|P1|COMPLETED|Part A||18
5339043|NCT00306891|13133905|P4|STARTED|Part A||0
5339044|NCT00306891|13133906|P3|STARTED|Part A||0
5339045|NCT00306891|13133907|P2|STARTED|Part A||22
5339046|NCT00306891|13133908|P1|STARTED|Part A||23
5339047|NCT00306852|13133931|P2|NOT COMPLETED|Overall Study||38
5339048|NCT00306852|13133932|P1|NOT COMPLETED|Overall Study||29
5339049|NCT00306852|13133931|P2|COMPLETED|Overall Study||69
5339050|NCT00306852|13133932|P1|COMPLETED|Overall Study||76
5339051|NCT00306852|13133931|P2|STARTED|Overall Study||107
5339052|NCT00306852|13133932|P1|STARTED|Overall Study||105
5339053|NCT00306787|13133950|P2|NOT COMPLETED|Overall Study||241
5339054|NCT00306787|13133951|P1|NOT COMPLETED|Overall Study||234
5339055|NCT00306787|13133950|P2|COMPLETED|Overall Study||359
5339056|NCT00306787|13133951|P1|COMPLETED|Overall Study||345
5339057|NCT00306787|13133950|P2|Intent to Treat (ITT) Population|Overall Study||381
5339058|NCT00306787|13133951|P1|Intent to Treat (ITT) Population|Overall Study||370
5339059|NCT00306787|13133950|P2|Received Study Drug (Safety Population)|Overall Study||385
5339060|NCT00306787|13133951|P1|Received Study Drug (Safety Population)|Overall Study||371
5339061|NCT00306787|13133950|P2|STARTED|Overall Study||600
5339062|NCT00306787|13133951|P1|STARTED|Overall Study||579
5339063|NCT00306670|13133969|P2|NOT COMPLETED|Overall Study||2
5339064|NCT00306670|13133970|P1|NOT COMPLETED|Overall Study||0
5339065|NCT00306670|13133969|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
5339066|NCT00306670|13133970|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
5339067|NCT00306670|13133969|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
5339068|NCT00306670|13133970|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
5339069|NCT00306592|13133976|P2|NOT COMPLETED|Overall Study||58
5339070|NCT00306592|13133977|P1|NOT COMPLETED|Overall Study||31
5339071|NCT00306592|13133976|P2|COMPLETED|Overall Study||632
5339072|NCT00306592|13133977|P1|COMPLETED|Overall Study||373
5339073|NCT00306592|13133976|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
5339074|NCT00306592|13133977|P1|Entered 101-MS-321 Extension Study|Overall Study||22
5339075|NCT00306592|13133976|P2|Completed at 48 Weeks|Overall Study||632
5339076|NCT00306592|13133977|P1|Completed at 48 Weeks|Overall Study||81
5339077|NCT00306592|13133976|P2|Completed Between 24 and 48 Weeks|Overall Study||0
5339078|NCT00306592|13133977|P1|Completed Between 24 and 48 Weeks|Overall Study||85
5339079|NCT00306592|13133976|P2|Completed at 24 Weeks|Overall Study||0
5339080|NCT00306592|13133977|P1|Completed at 24 Weeks|Overall Study||207
5339081|NCT00306592|13133976|P2|STARTED|Overall Study||690
5339082|NCT00306592|13133977|P1|STARTED|Overall Study||404
5339083|NCT00306527|13133987|P4|NOT COMPLETED|Overall Study||6
5339084|NCT00306527|13133988|P3|NOT COMPLETED|Overall Study||5
5339085|NCT00306527|13133989|P2|NOT COMPLETED|Overall Study||7
5339086|NCT00306527|13133990|P1|NOT COMPLETED|Overall Study||6
5339087|NCT00306527|13133987|P4|COMPLETED|Overall Study||590
5339088|NCT00306527|13133988|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
5339089|NCT00306527|13133989|P2|COMPLETED|Overall Study||527
5339090|NCT00306527|13133990|P1|COMPLETED|Overall Study||527
5339091|NCT00306527|13133987|P4|STARTED|Overall Study||596
5339092|NCT00306527|13133988|P3|STARTED|Overall Study||572
5339093|NCT00306527|13133989|P2|STARTED|Overall Study||534
5339094|NCT00306527|13133990|P1|STARTED|Overall Study||533
5339095|NCT00306488|13134044|P1|NOT COMPLETED|Overall Study||1
5339096|NCT00306488|13134044|P1|COMPLETED|Overall Study||10
5339097|NCT00306488|13134044|P1|STARTED|Overall Study||11
5339098|NCT00306384|13134062|P3|NOT COMPLETED|Overall Study||277
5339099|NCT00306384|13134063|P2|NOT COMPLETED|Overall Study||508
5339100|NCT00306384|13134064|P1|NOT COMPLETED|Overall Study||542
5339101|NCT00306384|13134062|P3|COMPLETED|Overall Study||251
5339102|NCT00306384|13134063|P2|COMPLETED|Overall Study||891
5339103|NCT00306384|13134064|P1|COMPLETED|Overall Study||854
5339104|NCT00306384|13134062|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
5339105|NCT00306384|13134063|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
5339106|NCT00306384|13134064|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
5339107|NCT00306384|13134062|P3|STARTED|Overall Study||528
5339108|NCT00306384|13134063|P2|STARTED|Overall Study||1399
5339109|NCT00306384|13134064|P1|STARTED|Overall Study||1396
5339110|NCT00306293|13134096|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
5339111|NCT00306293|13134097|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
5339112|NCT00306293|13134096|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
5339113|NCT00306293|13134097|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
5339114|NCT00306293|13134096|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
5339115|NCT00306293|13134097|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
5339116|NCT00306293|13134096|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
5339117|NCT00306293|13134097|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
5339118|NCT00306293|13134096|P2|COMPLETED|Washout (Day 61 to Day 66)||27
5339119|NCT00306293|13134097|P1|COMPLETED|Washout (Day 61 to Day 66)||27
5339120|NCT00306293|13134096|P2|STARTED|Washout (Day 61 to Day 66)||27
5339121|NCT00306293|13134097|P1|STARTED|Washout (Day 61 to Day 66)||27
5339122|NCT00306293|13134096|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
5339123|NCT00306293|13134097|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
5339124|NCT00306293|13134096|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
5339125|NCT00306293|13134097|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
5339126|NCT00306293|13134096|P2|STARTED|Period 1 (Day 1 to Day 60)||35
5339127|NCT00306293|13134097|P1|STARTED|Period 1 (Day 1 to Day 60)||35
5339128|NCT00306202|13134118|P3|NOT COMPLETED|Overall Study||0
5339129|NCT00306202|13134119|P2|NOT COMPLETED|Overall Study||1
5339130|NCT00306202|13134120|P1|NOT COMPLETED|Overall Study||6
5339131|NCT00306202|13134118|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
5339132|NCT00306202|13134119|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
5339133|NCT00306202|13134120|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
5339134|NCT00306202|13134118|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
5339135|NCT00306202|13134119|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
5339136|NCT00306202|13134120|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
5339137|NCT00306189|13134280|P4|NOT COMPLETED|Overall Study||5
5339138|NCT00306189|13134281|P3|NOT COMPLETED|Overall Study||11
5339139|NCT00306189|13134282|P2|NOT COMPLETED|Overall Study||6
5339140|NCT00306189|13134283|P1|NOT COMPLETED|Overall Study||9
5339141|NCT00306189|13134280|P4|COMPLETED|Overall Study||52
5339142|NCT00306189|13134281|P3|COMPLETED|Overall Study||45
5339143|NCT00306189|13134282|P2|COMPLETED|Overall Study||50
5339144|NCT00306189|13134283|P1|COMPLETED|Overall Study||48
5339145|NCT00306189|13134280|P4|STARTED|Overall Study||57
5339146|NCT00306189|13134281|P3|STARTED|Overall Study||56
5339147|NCT00306189|13134282|P2|STARTED|Overall Study||56
5339148|NCT00306189|13134283|P1|STARTED|Overall Study||57
5339149|NCT00306163|13134295|P2|NOT COMPLETED|Overall Study||0
5339150|NCT00306163|13134296|P1|NOT COMPLETED|Overall Study||0
5339151|NCT00306163|13134295|P2|COMPLETED|Overall Study||18
5339152|NCT00306163|13134296|P1|COMPLETED|Overall Study||19
5339153|NCT00306163|13134295|P2|STARTED|Overall Study||18
5339154|NCT00306163|13134296|P1|STARTED|Overall Study||19
5339155|NCT00305942|13134302|P1|NOT COMPLETED|Overall Study||38
5339156|NCT00305942|13134302|P1|COMPLETED|Overall Study||23
5339157|NCT00305942|13134302|P1|STARTED|Overall Study||61
5339158|NCT00305877|13134310|P2|NOT COMPLETED|Overall Study||34
5339159|NCT00305877|13134311|P1|NOT COMPLETED|Overall Study||24
5339160|NCT00305877|13134310|P2|COMPLETED|Overall Study||34
5339161|NCT00305877|13134311|P1|COMPLETED|Overall Study||45
5339162|NCT00305877|13134310|P2|Included in Efficacy Analysis|Overall Study||62
5339163|NCT00305877|13134311|P1|Included in Efficacy Analysis|Overall Study||65
5339164|NCT00305877|13134310|P2|Eligible|Overall Study||66
5339165|NCT00305877|13134311|P1|Eligible|Overall Study||66
5339166|NCT00305877|13134310|P2|Treated|Overall Study||63
5339167|NCT00305877|13134311|P1|Treated|Overall Study||67
5339168|NCT00305877|13134310|P2|STARTED|Overall Study||68
5339169|NCT00305877|13134311|P1|STARTED|Overall Study||69
5339170|NCT00305864|13134325|P4|NOT COMPLETED|Overall Study||13
5339171|NCT00305864|13134326|P3|NOT COMPLETED|Overall Study||1
5339172|NCT00305864|13134327|P2|NOT COMPLETED|Overall Study||1
5339173|NCT00305864|13134328|P1|NOT COMPLETED|Overall Study||0
5339174|NCT00305864|13134325|P4|COMPLETED|Overall Study||81
5339175|NCT00305864|13134326|P3|COMPLETED|Overall Study||6
5339176|NCT00305864|13134327|P2|COMPLETED|Overall Study||9
5339177|NCT00305864|13134328|P1|COMPLETED|Overall Study||7
5339178|NCT00305864|13134325|P4|STARTED|Overall Study||94
5339179|NCT00305864|13134326|P3|STARTED|Overall Study||7
5339180|NCT00305864|13134327|P2|STARTED|Overall Study||10
5339181|NCT00305864|13134328|P1|STARTED|Overall Study||7
5339182|NCT00305773|13134341|P2|NOT COMPLETED|Overall Study||18
5339183|NCT00305773|13134342|P1|NOT COMPLETED|Overall Study||14
5339184|NCT00305773|13134341|P2|COMPLETED|Overall Study||4
5339185|NCT00305773|13134342|P1|COMPLETED|Overall Study||1
5339186|NCT00305773|13134341|P2|STARTED|Overall Study||22
5339187|NCT00305773|13134342|P1|STARTED|Overall Study||15
5339188|NCT00305760|13134356|P1|NOT COMPLETED|Overall Study||47
5339189|NCT00305760|13134356|P1|COMPLETED|Overall Study||13
5339190|NCT00305760|13134356|P1|STARTED|Overall Study||60
5339191|NCT00305695|13134362|P2|NOT COMPLETED|Overall Study||27
5339192|NCT00305695|13134363|P1|NOT COMPLETED|Overall Study||41
5339193|NCT00305695|13134362|P2|COMPLETED|Overall Study||52
5339194|NCT00305695|13134363|P1|COMPLETED|Overall Study||40
5339195|NCT00305695|13134362|P2|STARTED|Overall Study||79
5339196|NCT00305695|13134363|P1|STARTED|Overall Study||81
5339197|NCT00305643|13134377|P2|NOT COMPLETED|Overall Study||0
5339198|NCT00305643|13134378|P1|NOT COMPLETED|Overall Study||0
5339199|NCT00305643|13134377|P2|COMPLETED|Overall Study||5
5339200|NCT00305643|13134378|P1|COMPLETED|Overall Study||6
5339201|NCT00305643|13134377|P2|STARTED|Overall Study||5
5339202|NCT00305643|13134378|P1|STARTED|Overall Study||6
5339203|NCT00305604|13134388|P2|NOT COMPLETED|Overall Study||47
5339204|NCT00305604|13134389|P1|NOT COMPLETED|Overall Study||32
5339205|NCT00305604|13134388|P2|COMPLETED|Overall Study||57
5339206|NCT00305604|13134389|P1|COMPLETED|Overall Study||70
5339207|NCT00305604|13134388|P2|STARTED|Overall Study||104
5339208|NCT00305604|13134389|P1|STARTED|Overall Study||102
5339209|NCT00305578|13134403|P2|NOT COMPLETED|Overall Study||2
5339210|NCT00305578|13134404|P1|NOT COMPLETED|Overall Study||3
5339211|NCT00305578|13134403|P2|COMPLETED|Overall Study||12
5339212|NCT00305578|13134404|P1|COMPLETED|Overall Study||12
5339213|NCT00305578|13134403|P2|STARTED|Overall Study||14
5339214|NCT00305578|13134404|P1|STARTED|Overall Study||15
5339215|NCT00305565|13134413|P3|NOT COMPLETED|Overall Study (ITT Population)||5
5339216|NCT00305565|13134414|P2|NOT COMPLETED|Overall Study (ITT Population)||11
5339217|NCT00305565|13134415|P1|NOT COMPLETED|Overall Study (ITT Population)||13
5339218|NCT00305565|13134413|P3|COMPLETED|Overall Study (ITT Population)||102
5339219|NCT00305565|13134414|P2|COMPLETED|Overall Study (ITT Population)||90
5339220|NCT00305565|13134415|P1|COMPLETED|Overall Study (ITT Population)||89
5339221|NCT00305565|13134413|P3|STARTED|Overall Study (ITT Population)||107
5339222|NCT00305565|13134414|P2|STARTED|Overall Study (ITT Population)||101
5339223|NCT00305565|13134415|P1|STARTED|Overall Study (ITT Population)||102
5339224|NCT00305565|13134413|P3|NOT COMPLETED|Overall Study (Safety Population)||7
5339225|NCT00305565|13134414|P2|NOT COMPLETED|Overall Study (Safety Population)||12
5339226|NCT00305565|13134415|P1|NOT COMPLETED|Overall Study (Safety Population)||14
5339227|NCT00305565|13134413|P3|COMPLETED|Overall Study (Safety Population)||106
5339228|NCT00305565|13134414|P2|COMPLETED|Overall Study (Safety Population)||95
5339229|NCT00305565|13134415|P1|COMPLETED|Overall Study (Safety Population)||97
5339230|NCT00305565|13134413|P3|STARTED|Overall Study (Safety Population)||113
5339231|NCT00305565|13134414|P2|STARTED|Overall Study (Safety Population)||107
5339232|NCT00305565|13134415|P1|STARTED|Overall Study (Safety Population)||111
5339233|NCT00305448|13134533|P3|NOT COMPLETED|Overall Study||33
5339234|NCT00305448|13134534|P2|NOT COMPLETED|Overall Study||34
5339235|NCT00305448|13134535|P1|NOT COMPLETED|Overall Study||31
5339236|NCT00305448|13134533|P3|COMPLETED|Overall Study||14
5339237|NCT00305448|13134534|P2|COMPLETED|Overall Study||17
5339238|NCT00305448|13134535|P1|COMPLETED|Overall Study||14
5339239|NCT00305448|13134533|P3|STARTED|Overall Study||47
5339240|NCT00305448|13134534|P2|STARTED|Overall Study||51
5339241|NCT00305448|13134535|P1|STARTED|Overall Study||45
5339242|NCT00305344|13134551|P1|NOT COMPLETED|Overall Study||0
5339243|NCT00305344|13134551|P1|COMPLETED|Overall Study||23
5339244|NCT00305344|13134551|P1|STARTED|Overall Study||23
5339245|NCT00305253|13134557|P2|NOT COMPLETED|Overall Study||1
5339246|NCT00305253|13134558|P1|NOT COMPLETED|Overall Study||0
5339247|NCT00305253|13134557|P2|COMPLETED|Overall Study||558
5339248|NCT00305253|13134558|P1|COMPLETED|Overall Study||432
5339249|NCT00305253|13134557|P2|STARTED|Overall Study||559
5339250|NCT00305253|13134558|P1|STARTED|Overall Study||432
5339251|NCT00305227|13134570|P2|NOT COMPLETED|Overall Study||6
5339252|NCT00305227|13134571|P1|NOT COMPLETED|Overall Study||7
5339253|NCT00305227|13134570|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
5339254|NCT00305227|13134571|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
5339255|NCT00305227|13134570|P2|STARTED|Overall Study||50
5339256|NCT00305227|13134571|P1|STARTED|Overall Study||50
5339257|NCT00305162|13134579|P2|NOT COMPLETED|1 Year Follow-up Period||65
5339258|NCT00305162|13134580|P1|NOT COMPLETED|1 Year Follow-up Period||55
5339259|NCT00305162|13134579|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
5339260|NCT00305162|13134580|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
5339261|NCT00305162|13134579|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
5339262|NCT00305162|13134580|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
5339263|NCT00305162|13134579|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
5339264|NCT00305162|13134580|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
5339265|NCT00305162|13134579|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
5339266|NCT00305162|13134580|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
5339267|NCT00305162|13134579|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
5339268|NCT00305162|13134580|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
5339269|NCT00305162|13134579|P2|STARTED|1 Year Follow-up Period||4447
5339270|NCT00305162|13134580|P1|STARTED|1 Year Follow-up Period||4435
5339271|NCT00305162|13134579|P2|NOT COMPLETED|30-day Follow-up Period||63
5339272|NCT00305162|13134580|P1|NOT COMPLETED|30-day Follow-up Period||62
5339273|NCT00305162|13134579|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
5339274|NCT00305162|13134580|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
5339275|NCT00305162|13134579|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
5339276|NCT00305162|13134580|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
5339277|NCT00305162|13134579|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
5339354|NCT00304746|13134740|P2|STARTED|Overall Study||50
5339278|NCT00305162|13134580|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
5339279|NCT00305162|13134579|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
5339280|NCT00305162|13134580|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
5339281|NCT00305162|13134579|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
5339282|NCT00305162|13134580|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
5339283|NCT00305162|13134579|P2|STARTED|30-day Follow-up Period||4447
5339284|NCT00305162|13134580|P1|STARTED|30-day Follow-up Period||4435
5339285|NCT00305162|13134579|P2|NOT COMPLETED|48 Hour Follow-up Period||16
5339286|NCT00305162|13134580|P1|NOT COMPLETED|48 Hour Follow-up Period||20
5339287|NCT00305162|13134579|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
5339288|NCT00305162|13134580|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
5339289|NCT00305162|13134579|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
5339290|NCT00305162|13134580|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
5339291|NCT00305162|13134579|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
5339292|NCT00305162|13134580|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
5339293|NCT00305162|13134579|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
5339294|NCT00305162|13134580|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
5339295|NCT00305162|13134579|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
5339296|NCT00305162|13134580|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
5339297|NCT00305162|13134579|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
5339298|NCT00305162|13134580|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
5339299|NCT00305162|13134579|P2|STARTED|48 Hour Follow-up Period||4447
5339300|NCT00305162|13134580|P1|STARTED|48 Hour Follow-up Period||4435
5339301|NCT00305110|13134618|P1|NOT COMPLETED|Overall Study||29
5339302|NCT00305110|13134618|P1|COMPLETED|Overall Study||269
5339303|NCT00305110|13134618|P1|All Necessary Data Collected|Overall Study||269
5339304|NCT00305110|13134618|P1|STARTED|Overall Study||298
5339305|NCT00305084|13134632|P5|NOT COMPLETED|Overall Study||0
5339306|NCT00305084|13134633|P4|NOT COMPLETED|Overall Study||0
5339307|NCT00305084|13134634|P3|NOT COMPLETED|Overall Study||0
5339308|NCT00305084|13134635|P2|NOT COMPLETED|Overall Study||0
5339309|NCT00305084|13134636|P1|NOT COMPLETED|Overall Study||0
5339310|NCT00305084|13134632|P5|COMPLETED|Overall Study||3
5339311|NCT00305084|13134633|P4|COMPLETED|Overall Study||3
5339312|NCT00305084|13134634|P3|COMPLETED|Overall Study||3
5339313|NCT00305084|13134635|P2|COMPLETED|Overall Study||3
5339314|NCT00305084|13134636|P1|COMPLETED|Overall Study||3
5339315|NCT00305084|13134632|P5|STARTED|Overall Study||3
5339316|NCT00305084|13134633|P4|STARTED|Overall Study||3
5339317|NCT00305084|13134634|P3|STARTED|Overall Study||3
5339318|NCT00305084|13134635|P2|STARTED|Overall Study||3
5339319|NCT00305084|13134636|P1|STARTED|Overall Study||3
5339320|NCT00305058|13134691|P2|NOT COMPLETED|Overall Study||4
5339321|NCT00305058|13134692|P1|NOT COMPLETED|Overall Study||7
5339322|NCT00305058|13134691|P2|COMPLETED|Overall Study||93
5339323|NCT00305058|13134692|P1|COMPLETED|Overall Study||90
5339324|NCT00305058|13134691|P2|Data Collection Forms Filed for Analysis|Overall Study||93
5339325|NCT00305058|13134692|P1|Data Collection Forms Filed for Analysis|Overall Study||90
5339326|NCT00305058|13134691|P2|All Outcome Data Collected|Overall Study||95
5339327|NCT00305058|13134692|P1|All Outcome Data Collected|Overall Study||93
5339328|NCT00305058|13134691|P2|Inclusion/Exclusion Verification|Overall Study||97
5339329|NCT00305058|13134692|P1|Inclusion/Exclusion Verification|Overall Study||96
5339330|NCT00305058|13134691|P2|STARTED|Overall Study||97
5339331|NCT00305058|13134692|P1|STARTED|Overall Study||97
5339332|NCT00304954|13134708|P4|NOT COMPLETED|Overall Study||0
5339333|NCT00304954|13134709|P3|NOT COMPLETED|Overall Study||1
5339334|NCT00304954|13134710|P2|NOT COMPLETED|Overall Study||0
5339335|NCT00304954|13134711|P1|NOT COMPLETED|Overall Study||1
5339336|NCT00304954|13134708|P4|COMPLETED|Overall Study||3
5339337|NCT00304954|13134709|P3|COMPLETED|Overall Study||2
5339338|NCT00304954|13134710|P2|COMPLETED|Overall Study||3
5339339|NCT00304954|13134711|P1|COMPLETED|Overall Study||3
5339340|NCT00304954|13134708|P4|STARTED|Overall Study||3
5339341|NCT00304954|13134709|P3|STARTED|Overall Study||3
5339342|NCT00304954|13134710|P2|STARTED|Overall Study||3
5339343|NCT00304954|13134711|P1|STARTED|Overall Study||4
5339344|NCT00304915|13134731|P2|NOT COMPLETED|Overall Study||16
5339345|NCT00304915|13134732|P1|NOT COMPLETED|Overall Study||18
5339346|NCT00304915|13134731|P2|COMPLETED|Overall Study||110
5339347|NCT00304915|13134732|P1|COMPLETED|Overall Study||105
5339348|NCT00304915|13134731|P2|STARTED|Overall Study||126
5339349|NCT00304915|13134732|P1|STARTED|Overall Study||123
5339350|NCT00304746|13134740|P2|NOT COMPLETED|Overall Study||0
5339351|NCT00304746|13134741|P1|NOT COMPLETED|Overall Study||0
5339352|NCT00304746|13134740|P2|COMPLETED|Overall Study||50
5339353|NCT00304746|13134741|P1|COMPLETED|Overall Study||50
5339355|NCT00304746|13134741|P1|STARTED|Overall Study||50
5339356|NCT00304707|13134751|P2|NOT COMPLETED|Overall Study||6
5339357|NCT00304707|13134752|P1|NOT COMPLETED|Overall Study||7
5339358|NCT00304707|13134751|P2|COMPLETED|Overall Study||64
5339359|NCT00304707|13134752|P1|COMPLETED|Overall Study||66
5339360|NCT00304707|13134751|P2|STARTED|Overall Study||70
5339361|NCT00304707|13134752|P1|STARTED|Overall Study||73
5339362|NCT00304512|13134761|P3|NOT COMPLETED|Extension Period||0
5339363|NCT00304512|13134762|P2|NOT COMPLETED|Extension Period||0
5339364|NCT00304512|13134763|P1|NOT COMPLETED|Extension Period||0
5339365|NCT00304512|13134761|P3|COMPLETED|Extension Period||3
5339366|NCT00304512|13134762|P2|COMPLETED|Extension Period||4
5339367|NCT00304512|13134763|P1|COMPLETED|Extension Period||2
5339368|NCT00304512|13134761|P3|STARTED|Extension Period||3
5339369|NCT00304512|13134762|P2|STARTED|Extension Period||4
5339370|NCT00304512|13134763|P1|STARTED|Extension Period||2
5339371|NCT00304512|13134761|P3|NOT COMPLETED|Treatment Period||0
5339372|NCT00304512|13134762|P2|NOT COMPLETED|Treatment Period||0
5339373|NCT00304512|13134763|P1|NOT COMPLETED|Treatment Period||0
5339374|NCT00304512|13134761|P3|COMPLETED|Treatment Period||3
5339375|NCT00304512|13134762|P2|COMPLETED|Treatment Period||4
5339376|NCT00304512|13134763|P1|COMPLETED|Treatment Period||2
5339377|NCT00304512|13134761|P3|Pharmacodynamic (PD) Population|Treatment Period||3
5339378|NCT00304512|13134762|P2|Pharmacodynamic (PD) Population|Treatment Period||4
5339379|NCT00304512|13134763|P1|Pharmacodynamic (PD) Population|Treatment Period||2
5339380|NCT00304512|13134761|P3|Pharmacokinetic (PK) Population|Treatment Period||3
5339381|NCT00304512|13134762|P2|Pharmacokinetic (PK) Population|Treatment Period||4
5339382|NCT00304512|13134763|P1|Pharmacokinetic (PK) Population|Treatment Period||2
5339383|NCT00304512|13134761|P3|Safety Population|Treatment Period||3
5339384|NCT00304512|13134762|P2|Safety Population|Treatment Period||4
5339385|NCT00304512|13134763|P1|Safety Population|Treatment Period||2
5339386|NCT00304512|13134761|P3|STARTED|Treatment Period||3
5339387|NCT00304512|13134762|P2|STARTED|Treatment Period||4
5339388|NCT00304512|13134763|P1|STARTED|Treatment Period||2
5339389|NCT00304356|13134777|P1|NOT COMPLETED|Nitazoxanide||5
5339390|NCT00304356|13134777|P1|COMPLETED|Nitazoxanide||22
5339391|NCT00304356|13134777|P1|STARTED|Nitazoxanide||27
5339392|NCT00304356|13134777|P1|NOT COMPLETED|Nitazoxanide||5
5339393|NCT00304356|13134777|P1|COMPLETED|Nitazoxanide||22
5339394|NCT00304356|13134777|P1|STARTED|Nitazoxanide||27
5339395|NCT00304278|13134781|P1|NOT COMPLETED|Overall Study||2
5339396|NCT00304278|13134781|P1|COMPLETED|Overall Study||19
5339397|NCT00304278|13134781|P1|STARTED|Overall Study||21
5339398|NCT00304265|13134788|P2|NOT COMPLETED|Overall Study||0
5339399|NCT00304265|13134789|P1|NOT COMPLETED|Overall Study||0
5339400|NCT00304265|13134788|P2|COMPLETED|Overall Study||98
5339401|NCT00304265|13134789|P1|COMPLETED|Overall Study||117
5339402|NCT00304265|13134788|P2|STARTED|Overall Study||98
5339403|NCT00304265|13134789|P1|STARTED|Overall Study||117
5339404|NCT00304187|13134797|P2|NOT COMPLETED|Overall Study||1
5339405|NCT00304187|13134798|P1|NOT COMPLETED|Overall Study||2
5339406|NCT00304187|13134797|P2|COMPLETED|Overall Study||13
5339407|NCT00304187|13134798|P1|COMPLETED|Overall Study||13
5339408|NCT00304187|13134797|P2|STARTED|Overall Study||14
5339409|NCT00304187|13134798|P1|STARTED|Overall Study||15
5339410|NCT00304161|13134808|P2|NOT COMPLETED|Overall Study||6
5339411|NCT00304161|13134809|P1|NOT COMPLETED|Overall Study||6
5339412|NCT00304161|13134808|P2|COMPLETED|Overall Study||21
5339413|NCT00304161|13134809|P1|COMPLETED|Overall Study||22
5339414|NCT00304161|13134808|P2|STARTED|Overall Study||27
5339415|NCT00304161|13134809|P1|STARTED|Overall Study||28
5339416|NCT00304096|13134819|P2|NOT COMPLETED|Overall Study||0
5339417|NCT00304096|13134820|P1|NOT COMPLETED|Overall Study||0
5339418|NCT00304096|13134819|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
5339419|NCT00304096|13134820|P1|COMPLETED|Overall Study||6
5339420|NCT00304096|13134819|P2|STARTED|Overall Study||5
5339421|NCT00304096|13134820|P1|STARTED|Overall Study||6
5339422|NCT00304083|13134830|P2|NOT COMPLETED|Overall Study||8
5339423|NCT00304083|13134831|P1|NOT COMPLETED|Overall Study||22
5339424|NCT00304083|13134830|P2|COMPLETED|Overall Study||6
5339425|NCT00304083|13134831|P1|COMPLETED|Overall Study||12
5339426|NCT00304083|13134830|P2|Patients Had Neither RT or Surgery|Overall Study||1
5339427|NCT00304083|13134831|P1|Patients Had Neither RT or Surgery|Overall Study||6
5339428|NCT00304083|13134830|P2|Patients Treated With RT Only|Overall Study||2
5339429|NCT00304083|13134831|P1|Patients Treated With RT Only|Overall Study||4
5339430|NCT00304083|13134830|P2|Patients Treated With Surgery and RT|Overall Study||1
5339431|NCT00304083|13134831|P1|Patients Treated With Surgery and RT|Overall Study||5
5339432|NCT00304083|13134830|P2|Patients Treated With Surgery|Overall Study||3
5339433|NCT00304083|13134831|P1|Patients Treated With Surgery|Overall Study||7
5339434|NCT00304083|13134830|P2|Completed 4 Cycles|Overall Study||7
5339435|NCT00304083|13134831|P1|Completed 4 Cycles|Overall Study||22
5339436|NCT00304083|13134830|P2|STARTED|Overall Study||14
5339437|NCT00304083|13134831|P1|STARTED|Overall Study||34
5339438|NCT00304070|13134850|P3|NOT COMPLETED|Overall Study||12
5339439|NCT00304070|13134851|P2|NOT COMPLETED|Overall Study||7
5339440|NCT00304070|13134852|P1|NOT COMPLETED|Overall Study||3
5339441|NCT00304070|13134850|P3|COMPLETED|Overall Study||27
5339442|NCT00304070|13134851|P2|COMPLETED|Overall Study||8
5339443|NCT00304070|13134852|P1|COMPLETED|Overall Study||21
5339444|NCT00304070|13134850|P3|STARTED|Overall Study||39
5339445|NCT00304070|13134851|P2|STARTED|Overall Study||15
5339446|NCT00304070|13134852|P1|STARTED|Overall Study||24
5339447|NCT00304031|13134867|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
5339448|NCT00304031|13134868|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
5339449|NCT00304031|13134869|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
5339450|NCT00304031|13134867|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
5339451|NCT00304031|13134868|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
5339452|NCT00304031|13134869|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
5339453|NCT00304031|13134867|P3|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
5339454|NCT00304031|13134868|P2|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
5339455|NCT00304031|13134869|P1|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
5339456|NCT00304031|13134867|P3|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
5339457|NCT00304031|13134868|P2|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
5339458|NCT00304031|13134869|P1|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
5339459|NCT00304031|13134867|P3|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
5339460|NCT00304031|13134868|P2|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
5339461|NCT00304031|13134869|P1|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
5339462|NCT00304031|13134867|P3|Eligible Population|Randomization to Adjuvant TMZ Arm||420
5339463|NCT00304031|13134868|P2|Eligible Population|Randomization to Adjuvant TMZ Arm||411
5339464|NCT00304031|13134869|P1|Eligible Population|Randomization to Adjuvant TMZ Arm||0
5339465|NCT00304031|13134867|P3|STARTED|Randomization to Adjuvant TMZ Arm||422
5339466|NCT00304031|13134868|P2|STARTED|Randomization to Adjuvant TMZ Arm||411
5339467|NCT00304031|13134869|P1|STARTED|Randomization to Adjuvant TMZ Arm||0
5339468|NCT00304031|13134867|P3|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
5339469|NCT00304031|13134868|P2|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
5339470|NCT00304031|13134869|P1|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
5339471|NCT00304031|13134867|P3|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
5339472|NCT00304031|13134868|P2|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
5339473|NCT00304031|13134869|P1|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
5339474|NCT00304031|13134867|P3|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
5339475|NCT00304031|13134868|P2|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
5339476|NCT00304031|13134869|P1|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
5339477|NCT00304031|13134867|P3|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
5339478|NCT00304031|13134868|P2|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
5339479|NCT00304031|13134869|P1|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
5339480|NCT00304031|13134867|P3|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
5339481|NCT00304031|13134868|P2|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
5339482|NCT00304031|13134869|P1|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
5339483|NCT00303979|13134922|P3|NOT COMPLETED|Overall Study||0
5339484|NCT00303979|13134923|P2|NOT COMPLETED|Overall Study||0
5339485|NCT00303979|13134924|P1|NOT COMPLETED|Overall Study||7572
5339486|NCT00303979|13134922|P3|COMPLETED|Overall Study|at 18 months|9641
5339487|NCT00303979|13134923|P2|COMPLETED|Overall Study|at 6 months|9992
5339488|NCT00303979|13134924|P1|COMPLETED|Overall Study|at 24 Months|7605
5339489|NCT00303979|13134922|P3|STARTED|Overall Study|at 18 months|9641
5339490|NCT00303979|13134923|P2|STARTED|Overall Study|at 6 months|9992
5339491|NCT00303979|13134924|P1|STARTED|Overall Study|at baseline|15177
5339492|NCT00303966|13134942|P1|NOT COMPLETED|Overall Study||0
5339493|NCT00303966|13134942|P1|COMPLETED|Overall Study||5
5339494|NCT00303966|13134942|P1|STARTED|Overall Study||5
5339495|NCT00303953|13134951|P1|NOT COMPLETED|Overall Study||19
5339496|NCT00303953|13134951|P1|COMPLETED|Overall Study||3
5339497|NCT00303953|13134951|P1|Eligible and Treated|Overall Study||20
5339498|NCT00303953|13134951|P1|Eligible|Overall Study||21
5339499|NCT00303953|13134951|P1|STARTED|Overall Study||22
5339500|NCT00303901|13134957|P1|NOT COMPLETED|Overall Study||0
5339501|NCT00303901|13134957|P1|COMPLETED|Overall Study||40
5339502|NCT00303901|13134957|P1|STARTED|Overall Study||40
5339503|NCT00303862|13134963|P1|NOT COMPLETED|Overall Study||0
5339504|NCT00303862|13134963|P1|COMPLETED|Overall Study||10
5339505|NCT00303862|13134963|P1|STARTED|Overall Study||10
5339506|NCT00303823|13134972|P2|NOT COMPLETED|Overall Study||10
5339507|NCT00303823|13134973|P1|NOT COMPLETED|Overall Study||15
5339508|NCT00303823|13134972|P2|COMPLETED|Overall Study||38
5339509|NCT00303823|13134973|P1|COMPLETED|Overall Study||35
5339510|NCT00303823|13134972|P2|STARTED|Overall Study||48
5339511|NCT00303823|13134973|P1|STARTED|Overall Study||50
5339512|NCT00303719|13134987|P2|NOT COMPLETED|Overall Study||37
5339513|NCT00303719|13134988|P1|NOT COMPLETED|Overall Study||0
5339514|NCT00303719|13134987|P2|COMPLETED|Overall Study||292
5339515|NCT00303719|13134988|P1|COMPLETED|Overall Study||13
5339516|NCT00303719|13134987|P2|STARTED|Overall Study||329
5339517|NCT00303719|13134988|P1|STARTED|Overall Study||13
5339518|NCT00303667|13135004|P2|NOT COMPLETED|Overall Study||4
5339519|NCT00303667|13135005|P1|NOT COMPLETED|Overall Study||0
5339520|NCT00303667|13135004|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
5339521|NCT00303667|13135005|P1|COMPLETED|Overall Study||8
5339522|NCT00303667|13135004|P2|STARTED|Overall Study||39
5339523|NCT00303667|13135005|P1|STARTED|Overall Study||8
5339524|NCT00303628|13135029|P2|NOT COMPLETED|Overall Study||73
5339525|NCT00303628|13135030|P1|NOT COMPLETED|Overall Study||50
5339526|NCT00303628|13135029|P2|COMPLETED|Overall Study||106
5339527|NCT00303628|13135030|P1|COMPLETED|Overall Study||126
5339528|NCT00303628|13135029|P2|Treated|Overall Study||174
5339529|NCT00303628|13135030|P1|Treated|Overall Study||173
5339530|NCT00303628|13135029|P2|Eligible|Overall Study||177
5339531|NCT00303628|13135030|P1|Eligible|Overall Study||171
5339532|NCT00303628|13135029|P2|STARTED|Overall Study||179
5339533|NCT00303628|13135030|P1|STARTED|Overall Study||176
5339534|NCT00303602|13135048|P2|NOT COMPLETED|Overall Study||15
5339535|NCT00303602|13135049|P1|NOT COMPLETED|Overall Study||19
5339536|NCT00303602|13135048|P2|COMPLETED|Overall Study||50
5339537|NCT00303602|13135049|P1|COMPLETED|Overall Study||65
5339538|NCT00303602|13135048|P2|STARTED|Overall Study||65
5339539|NCT00303602|13135049|P1|STARTED|Overall Study||84
5339540|NCT00303511|13135089|P1|NOT COMPLETED|Overall Study||0
5339541|NCT00303511|13135089|P1|COMPLETED|Overall Study||10
5339542|NCT00303511|13135089|P1|STARTED|Overall Study||10
5339543|NCT00303485|13135095|P2|NOT COMPLETED|Overall Study||2
5339544|NCT00303485|13135096|P1|NOT COMPLETED|Overall Study||1
5339545|NCT00303485|13135095|P2|COMPLETED|Overall Study||15
5339546|NCT00303485|13135096|P1|COMPLETED|Overall Study||48
5339547|NCT00303485|13135095|P2|STARTED|Overall Study||17
5339548|NCT00303485|13135096|P1|STARTED|Overall Study||49
5339549|NCT00303472|13135127|P7|NOT COMPLETED|Treatment Extension (Optional)||0
5339550|NCT00303472|13135128|P6|NOT COMPLETED|Treatment Extension (Optional)||1
5339551|NCT00303472|13135129|P5|NOT COMPLETED|Treatment Extension (Optional)||4
5339552|NCT00303472|13135130|P4|NOT COMPLETED|Treatment Extension (Optional)||8
5339553|NCT00303472|13135131|P3|NOT COMPLETED|Treatment Extension (Optional)||9
5339554|NCT00303472|13135132|P2|NOT COMPLETED|Treatment Extension (Optional)||6
5339555|NCT00303472|13135133|P1|NOT COMPLETED|Treatment Extension (Optional)||5
5339556|NCT00303472|13135127|P7|COMPLETED|Treatment Extension (Optional)||1
5339557|NCT00303472|13135128|P6|COMPLETED|Treatment Extension (Optional)||4
5339558|NCT00303472|13135129|P5|COMPLETED|Treatment Extension (Optional)||1
5339559|NCT00303472|13135130|P4|COMPLETED|Treatment Extension (Optional)||5
5339560|NCT00303472|13135131|P3|COMPLETED|Treatment Extension (Optional)||2
5339561|NCT00303472|13135132|P2|COMPLETED|Treatment Extension (Optional)||5
5339562|NCT00303472|13135133|P1|COMPLETED|Treatment Extension (Optional)||1
5339563|NCT00303472|13135127|P7|STARTED|Treatment Extension (Optional)||1
5339564|NCT00303472|13135128|P6|STARTED|Treatment Extension (Optional)||5
5339565|NCT00303472|13135129|P5|STARTED|Treatment Extension (Optional)||5
5339566|NCT00303472|13135130|P4|STARTED|Treatment Extension (Optional)||13
5339567|NCT00303472|13135131|P3|STARTED|Treatment Extension (Optional)||11
5339568|NCT00303472|13135132|P2|STARTED|Treatment Extension (Optional)||11
5339569|NCT00303472|13135133|P1|STARTED|Treatment Extension (Optional)||6
5339570|NCT00303472|13135127|P7|NOT COMPLETED|Treatment Period||2
5339571|NCT00303472|13135128|P6|NOT COMPLETED|Treatment Period||1
5339572|NCT00303472|13135129|P5|NOT COMPLETED|Treatment Period||3
5339573|NCT00303472|13135130|P4|NOT COMPLETED|Treatment Period||2
5339574|NCT00303472|13135131|P3|NOT COMPLETED|Treatment Period||0
5339575|NCT00303472|13135132|P2|NOT COMPLETED|Treatment Period||0
5339576|NCT00303472|13135133|P1|NOT COMPLETED|Treatment Period||0
5339577|NCT00303472|13135127|P7|COMPLETED|Treatment Period||3
5339578|NCT00303472|13135128|P6|COMPLETED|Treatment Period||11
5339579|NCT00303472|13135129|P5|COMPLETED|Treatment Period||8
5339580|NCT00303472|13135130|P4|COMPLETED|Treatment Period||14
5339581|NCT00303472|13135131|P3|COMPLETED|Treatment Period||11
5339582|NCT00303472|13135132|P2|COMPLETED|Treatment Period||11
5339583|NCT00303472|13135133|P1|COMPLETED|Treatment Period||6
5339584|NCT00303472|13135127|P7|STARTED|Treatment Period||5
5339585|NCT00303472|13135128|P6|STARTED|Treatment Period||12
5339586|NCT00303472|13135129|P5|STARTED|Treatment Period||11
5339587|NCT00303472|13135130|P4|STARTED|Treatment Period||16
5339588|NCT00303472|13135131|P3|STARTED|Treatment Period||11
5339589|NCT00303472|13135132|P2|STARTED|Treatment Period||11
5339590|NCT00303472|13135133|P1|STARTED|Treatment Period||6
5339591|NCT00303459|13135193|P2|NOT COMPLETED|Overall Study||89
5339592|NCT00303459|13135194|P1|NOT COMPLETED|Overall Study||83
5339593|NCT00303459|13135193|P2|COMPLETED|Overall Study||86
5339594|NCT00303459|13135194|P1|COMPLETED|Overall Study||76
5339595|NCT00303459|13135193|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
5339596|NCT00303459|13135194|P1|STARTED|Overall Study||159
5339597|NCT00303446|13135220|P2|NOT COMPLETED|Overall Study||4
5339598|NCT00303446|13135221|P1|NOT COMPLETED|Overall Study||2
5339599|NCT00303446|13135220|P2|COMPLETED|Overall Study||21
5339600|NCT00303446|13135221|P1|COMPLETED|Overall Study||23
5339601|NCT00303446|13135220|P2|STARTED|Overall Study||25
5339602|NCT00303446|13135221|P1|STARTED|Overall Study||25
5339603|NCT00303329|13135257|P2|NOT COMPLETED|Overall Study||62
5339604|NCT00303329|13135258|P1|NOT COMPLETED|Overall Study||35
5339605|NCT00303329|13135257|P2|COMPLETED|Overall Study||37
5339606|NCT00303329|13135258|P1|COMPLETED|Overall Study||50
5339607|NCT00303329|13135257|P2|STARTED|Overall Study||99
5339608|NCT00303329|13135258|P1|STARTED|Overall Study||85
5339609|NCT00303316|13135272|P2|NOT COMPLETED|Overall Study||3
5339610|NCT00303316|13135273|P1|NOT COMPLETED|Overall Study||2
5339611|NCT00303316|13135272|P2|COMPLETED|Overall Study||223
5339612|NCT00303316|13135273|P1|COMPLETED|Overall Study||230
5339613|NCT00303316|13135272|P2|STARTED|Overall Study||226
5339614|NCT00303316|13135273|P1|STARTED|Overall Study||232
5339615|NCT00303186|13135285|P1|NOT COMPLETED|Overall Study||52
5339616|NCT00303186|13135285|P1|COMPLETED|Overall Study||55
5339617|NCT00303186|13135285|P1|STARTED|Overall Study||107
5339618|NCT00303108|13135319|P3|NOT COMPLETED|Overall Study||16
5339619|NCT00303108|13135320|P2|NOT COMPLETED|Overall Study||9
5339620|NCT00303108|13135321|P1|NOT COMPLETED|Overall Study||12
5339621|NCT00303108|13135319|P3|COMPLETED|Overall Study||31
5339622|NCT00303108|13135320|P2|COMPLETED|Overall Study||37
5339623|NCT00303108|13135321|P1|COMPLETED|Overall Study||31
5339624|NCT00303108|13135319|P3|STARTED|Overall Study||47
5339625|NCT00303108|13135320|P2|STARTED|Overall Study||46
5339626|NCT00303108|13135321|P1|STARTED|Overall Study||43
5339627|NCT00303069|13135341|P4|NOT COMPLETED|Overall Study||2
5339628|NCT00303069|13135342|P3|NOT COMPLETED|Overall Study||1
5339629|NCT00303069|13135343|P2|NOT COMPLETED|Overall Study||0
5339630|NCT00303069|13135344|P1|NOT COMPLETED|Overall Study||2
5339631|NCT00303069|13135341|P4|COMPLETED|Overall Study||29
5339632|NCT00303069|13135342|P3|COMPLETED|Overall Study||33
5339633|NCT00303069|13135343|P2|COMPLETED|Overall Study||28
5339634|NCT00303069|13135344|P1|COMPLETED|Overall Study||29
5339635|NCT00303069|13135341|P4|STARTED|Overall Study||31
5339636|NCT00303069|13135342|P3|STARTED|Overall Study||34
5339637|NCT00303069|13135343|P2|STARTED|Overall Study||28
5339638|NCT00303069|13135344|P1|STARTED|Overall Study||31
5339639|NCT00302952|13135364|P2|NOT COMPLETED|Overall Study||5
5339640|NCT00302952|13135365|P1|NOT COMPLETED|Overall Study||3
5339641|NCT00302952|13135364|P2|COMPLETED|Overall Study||25
5339642|NCT00302952|13135365|P1|COMPLETED|Overall Study||31
5339643|NCT00302952|13135364|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
5339644|NCT00302952|13135365|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
5339645|NCT00302952|13135364|P2|Started Intent-to-Treat (ITT)|Overall Study||30
5339646|NCT00302952|13135365|P1|Started Intent-to-Treat (ITT)|Overall Study||34
5339647|NCT00302952|13135364|P2|STARTED|Overall Study||30
5339648|NCT00302952|13135365|P1|STARTED|Overall Study||34
5339649|NCT00302848|13135402|P3|NOT COMPLETED|Overall Study||579
5339650|NCT00302848|13135403|P2|NOT COMPLETED|Overall Study||419
5339651|NCT00302848|13135404|P1|NOT COMPLETED|Overall Study||401
5339652|NCT00302848|13135402|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
5339653|NCT00302848|13135403|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
5339654|NCT00302848|13135404|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
5339655|NCT00302848|13135402|P3|STARTED|Overall Study||26341
5339656|NCT00302848|13135403|P2|STARTED|Overall Study||15428
5339657|NCT00302848|13135404|P1|STARTED|Overall Study||16534
5339658|NCT00302731|13135415|P4|NOT COMPLETED|Overall Study||0
5339659|NCT00302731|13135416|P3|NOT COMPLETED|Overall Study||3
5339660|NCT00302731|13135417|P2|NOT COMPLETED|Overall Study||5
5339661|NCT00302731|13135418|P1|NOT COMPLETED|Overall Study||4
5339662|NCT00302731|13135415|P4|COMPLETED|Overall Study||4
5339663|NCT00302731|13135416|P3|COMPLETED|Overall Study||2
5339664|NCT00302731|13135417|P2|COMPLETED|Overall Study||1
5339665|NCT00302731|13135418|P1|COMPLETED|Overall Study||2
5339666|NCT00302731|13135415|P4|STARTED|Overall Study||4
5339667|NCT00302731|13135416|P3|STARTED|Overall Study||5
5339668|NCT00302731|13135417|P2|STARTED|Overall Study||6
5339669|NCT00302731|13135418|P1|STARTED|Overall Study||6
5339670|NCT00302718|13135444|P4|NOT COMPLETED|Overall Study||2
5339671|NCT00302718|13135445|P3|NOT COMPLETED|Overall Study||2
5339672|NCT00302718|13135446|P2|NOT COMPLETED|Overall Study||1
5339673|NCT00302718|13135447|P1|NOT COMPLETED|Overall Study||1
5339674|NCT00302718|13135444|P4|COMPLETED|Overall Study||19
5339675|NCT00302718|13135445|P3|COMPLETED|Overall Study||19
5339676|NCT00302718|13135446|P2|COMPLETED|Overall Study||20
5339677|NCT00302718|13135447|P1|COMPLETED|Overall Study||19
5339678|NCT00302718|13135444|P4|STARTED|Overall Study||21
5339679|NCT00302718|13135445|P3|STARTED|Overall Study||21
5339680|NCT00302718|13135446|P2|STARTED|Overall Study||21
5339681|NCT00302718|13135447|P1|STARTED|Overall Study||20
5339682|NCT00302458|13135513|P1|NOT COMPLETED|Overall Study||3
5339683|NCT00302458|13135513|P1|COMPLETED|Overall Study||26
5339684|NCT00302458|13135513|P1|STARTED|Overall Study||29
5339685|NCT00302328|13135524|P3|NOT COMPLETED|Overall Study||0
5339686|NCT00302328|13135525|P2|NOT COMPLETED|Overall Study||1
5339687|NCT00302328|13135526|P1|NOT COMPLETED|Overall Study||0
5339688|NCT00302328|13135524|P3|COMPLETED|Overall Study||18
5339689|NCT00302328|13135525|P2|COMPLETED|Overall Study|developed cancer during the study|34
5339690|NCT00302328|13135526|P1|COMPLETED|Overall Study||25
5339691|NCT00302328|13135524|P3|STARTED|Overall Study||18
5339692|NCT00302328|13135525|P2|STARTED|Overall Study||35
5339693|NCT00302328|13135526|P1|STARTED|Overall Study||25
5339694|NCT00302211|13135543|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
5339695|NCT00302211|13135544|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
5339696|NCT00302211|13135545|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
5339697|NCT00302211|13135546|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
5339698|NCT00302211|13135547|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
5339699|NCT00302211|13135543|P5|COMPLETED|Open Label-Patients From Double-Blind||24
5339700|NCT00302211|13135544|P4|COMPLETED|Open Label-Patients From Double-Blind||18
5339701|NCT00302211|13135545|P3|COMPLETED|Open Label-Patients From Double-Blind||0
5339702|NCT00302211|13135546|P2|COMPLETED|Open Label-Patients From Double-Blind||0
5339703|NCT00302211|13135547|P1|COMPLETED|Open Label-Patients From Double-Blind||0
5339704|NCT00302211|13135543|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
5339705|NCT00302211|13135544|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
5339706|NCT00302211|13135545|P3|STARTED|Open Label-Patients From Double-Blind||0
5339707|NCT00302211|13135546|P2|STARTED|Open Label-Patients From Double-Blind||0
5339708|NCT00302211|13135547|P1|STARTED|Open Label-Patients From Double-Blind||0
5339709|NCT00302211|13135543|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
5339710|NCT00302211|13135544|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
5339711|NCT00302211|13135545|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
5339712|NCT00302211|13135546|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
5339713|NCT00302211|13135547|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
5339714|NCT00302211|13135543|P5|COMPLETED|Double Blind Period (New Patients)||0
5339715|NCT00302211|13135544|P4|COMPLETED|Double Blind Period (New Patients)||0
5339716|NCT00302211|13135545|P3|COMPLETED|Double Blind Period (New Patients)||10
5339717|NCT00302211|13135546|P2|COMPLETED|Double Blind Period (New Patients)||25
5339718|NCT00302211|13135547|P1|COMPLETED|Double Blind Period (New Patients)||23
5339719|NCT00302211|13135543|P5|STARTED|Double Blind Period (New Patients)||0
5339720|NCT00302211|13135544|P4|STARTED|Double Blind Period (New Patients)||0
5339721|NCT00302211|13135545|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
5339722|NCT00302211|13135546|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
5339723|NCT00302211|13135547|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
5339724|NCT00302159|13135573|P1|NOT COMPLETED|Overall Study||2
5339725|NCT00302159|13135573|P1|COMPLETED|Overall Study||41
5339726|NCT00302159|13135573|P1|STARTED|Overall Study||43
5339727|NCT00302133|13135584|P2|NOT COMPLETED|Overall Study||4
5339728|NCT00302133|13135585|P1|NOT COMPLETED|Overall Study||4
5339729|NCT00302133|13135584|P2|COMPLETED|Overall Study||5
5339730|NCT00302133|13135585|P1|COMPLETED|Overall Study||5
5339731|NCT00302133|13135584|P2|STARTED|Overall Study||9
5339732|NCT00302133|13135585|P1|STARTED|Overall Study||9
5339733|NCT00302107|13135595|P2|NOT COMPLETED|Overall Study||9
5339734|NCT00302107|13135596|P1|NOT COMPLETED|Overall Study||8
5339735|NCT00302107|13135595|P2|COMPLETED|Overall Study||30
5339736|NCT00302107|13135596|P1|COMPLETED|Overall Study||31
5339737|NCT00302107|13135595|P2|STARTED|Overall Study||39
5339738|NCT00302107|13135596|P1|STARTED|Overall Study||39
5339739|NCT00302081|13135605|P3|NOT COMPLETED|Overall Study||52
5339740|NCT00302081|13135606|P2|NOT COMPLETED|Overall Study||43
5339741|NCT00302081|13135607|P1|NOT COMPLETED|Overall Study||56
5339742|NCT00302081|13135605|P3|COMPLETED|Overall Study||178
5339743|NCT00302081|13135606|P2|COMPLETED|Overall Study||186
5339744|NCT00302081|13135607|P1|COMPLETED|Overall Study||181
5339745|NCT00302081|13135605|P3|STARTED|Overall Study||230
5339746|NCT00302081|13135606|P2|STARTED|Overall Study||229
5339747|NCT00302081|13135607|P1|STARTED|Overall Study||237
5339748|NCT00302068|13135618|P3|NOT COMPLETED|Overall Study||1
5339749|NCT00302068|13135619|P2|NOT COMPLETED|Overall Study||4
5339750|NCT00302068|13135620|P1|NOT COMPLETED|Overall Study||1
5339751|NCT00302068|13135618|P3|COMPLETED|Overall Study||23
5339752|NCT00302068|13135619|P2|COMPLETED|Overall Study||36
5339753|NCT00302068|13135620|P1|COMPLETED|Overall Study||36
5339754|NCT00302068|13135618|P3|STARTED|Overall Study||24
5339755|NCT00302068|13135619|P2|STARTED|Overall Study||40
5339756|NCT00302068|13135620|P1|STARTED|Overall Study||37
5339757|NCT00302055|13135648|P2|NOT COMPLETED|Overall Study||13
5339758|NCT00302055|13135649|P1|NOT COMPLETED|Overall Study||9
5339759|NCT00302055|13135648|P2|COMPLETED|Overall Study||36
5339760|NCT00302055|13135649|P1|COMPLETED|Overall Study||14
5339761|NCT00302055|13135648|P2|STARTED|Overall Study||49
5339762|NCT00302055|13135649|P1|STARTED|Overall Study||23
5339763|NCT00302042|13135657|P2|NOT COMPLETED|Overall Study||8
5339764|NCT00302042|13135658|P1|NOT COMPLETED|Overall Study||7
5339765|NCT00302042|13135657|P2|COMPLETED|Overall Study||38
5339766|NCT00302042|13135658|P1|COMPLETED|Overall Study||39
5339767|NCT00302042|13135657|P2|STARTED|Overall Study||46
5339768|NCT00302042|13135658|P1|STARTED|Overall Study||46
5339769|NCT00302003|13135664|P1|NOT COMPLETED|Overall Study||80
5339770|NCT00302003|13135664|P1|COMPLETED|Overall Study||207
5339771|NCT00302003|13135664|P1|STARTED|Overall Study||287
5339772|NCT00301964|13135671|P1|NOT COMPLETED|Overall Study||4
5339773|NCT00301964|13135671|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
5339774|NCT00301964|13135671|P1|STARTED|Overall Study||56
5339775|NCT00301873|13135686|P1|NOT COMPLETED|Overall Study||0
5339776|NCT00301873|13135686|P1|COMPLETED|Overall Study||59
5339777|NCT00301873|13135686|P1|STARTED|Overall Study||59
5339778|NCT00301834|13135692|P1|NOT COMPLETED|Overall Study||1
5339779|NCT00301834|13135692|P1|COMPLETED|Overall Study||34
5339780|NCT00301834|13135692|P1|STARTED|Overall Study||35
5339781|NCT00301821|13135701|P1|NOT COMPLETED|Overall Study||26
5339782|NCT00301821|13135701|P1|COMPLETED|Overall Study||81
5339783|NCT00301821|13135701|P1|STARTED|Overall Study||107
5339784|NCT00301808|13135708|P1|NOT COMPLETED|Overall Study||12
5339785|NCT00301808|13135708|P1|COMPLETED|Overall Study||17
5339786|NCT00301808|13135708|P1|STARTED|Overall Study||29
5339787|NCT00301756|13135715|P1|NOT COMPLETED|Overall Study||0
5339788|NCT00301756|13135715|P1|COMPLETED|Overall Study||32
5339789|NCT00301756|13135715|P1|STARTED|Overall Study||32
5339790|NCT00301418|13135727|P1|NOT COMPLETED|Overall Study||0
5339791|NCT00301418|13135727|P1|COMPLETED|Overall Study||11
5339792|NCT00301418|13135727|P1|STARTED|Overall Study||11
5339793|NCT00301366|13135733|P1|NOT COMPLETED|Overall Study||1
5339794|NCT00301366|13135733|P1|COMPLETED|Overall Study||37
5339795|NCT00301366|13135733|P1|STARTED|Overall Study||38
5339796|NCT00301262|13135739|P2|NOT COMPLETED|Open Label Phase (OL)||2
5339797|NCT00301262|13135740|P1|NOT COMPLETED|Open Label Phase (OL)||4
5339798|NCT00301262|13135739|P2|COMPLETED|Open Label Phase (OL)||67
5339799|NCT00301262|13135740|P1|COMPLETED|Open Label Phase (OL)||79
5339800|NCT00301262|13135739|P2|STARTED|Open Label Phase (OL)||69
5339801|NCT00301262|13135740|P1|STARTED|Open Label Phase (OL)||83
5339802|NCT00301262|13135739|P2|NOT COMPLETED|Double Blind Phase (DB)||13
5339803|NCT00301262|13135740|P1|NOT COMPLETED|Double Blind Phase (DB)||10
5339804|NCT00301262|13135739|P2|COMPLETED|Double Blind Phase (DB)||69
5339805|NCT00301262|13135740|P1|COMPLETED|Double Blind Phase (DB)||84
5339806|NCT00301262|13135739|P2|STARTED|Double Blind Phase (DB)||82
5339807|NCT00301262|13135740|P1|STARTED|Double Blind Phase (DB)||94
5339808|NCT00301080|13135898|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339809|NCT00301080|13135899|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339810|NCT00301080|13135900|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339811|NCT00301080|13135901|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339812|NCT00301080|13135902|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339813|NCT00301080|13135898|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339814|NCT00301080|13135899|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339815|NCT00301080|13135900|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339816|NCT00301080|13135901|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339817|NCT00301080|13135902|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
5339818|NCT00301080|13135898|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
5339819|NCT00301080|13135899|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
5339820|NCT00301080|13135900|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
5339821|NCT00301080|13135901|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
5339822|NCT00301080|13135902|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
5339823|NCT00301080|13135898|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339824|NCT00301080|13135899|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339825|NCT00301080|13135900|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339826|NCT00301080|13135901|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339827|NCT00301080|13135902|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
5339828|NCT00301080|13135898|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339829|NCT00301080|13135899|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339830|NCT00301080|13135900|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
5339831|NCT00301080|13135901|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
5339832|NCT00301080|13135902|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
5339833|NCT00301080|13135898|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
5339834|NCT00301080|13135899|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
5339835|NCT00301080|13135900|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
5339836|NCT00301080|13135901|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
5339837|NCT00301080|13135902|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
5339838|NCT00301080|13135898|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
5339839|NCT00301080|13135899|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
5339840|NCT00301080|13135900|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
5339841|NCT00301080|13135901|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
5339842|NCT00301080|13135902|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
5339843|NCT00301080|13135898|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
5339844|NCT00301080|13135899|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
5339845|NCT00301080|13135900|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
5339846|NCT00301080|13135901|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
5339847|NCT00301080|13135902|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
5339848|NCT00301067|13135931|P4|NOT COMPLETED|Follow up Until Death||1
5339849|NCT00301067|13135932|P3|NOT COMPLETED|Follow up Until Death||0
5339850|NCT00301067|13135933|P2|NOT COMPLETED|Follow up Until Death||0
5339851|NCT00301067|13135934|P1|NOT COMPLETED|Follow up Until Death||1
5339852|NCT00301067|13135931|P4|COMPLETED|Follow up Until Death||2
5339853|NCT00301067|13135932|P3|COMPLETED|Follow up Until Death||3
5339854|NCT00301067|13135933|P2|COMPLETED|Follow up Until Death||3
5339855|NCT00301067|13135934|P1|COMPLETED|Follow up Until Death||3
5339856|NCT00301067|13135931|P4|STARTED|Follow up Until Death||3
5339857|NCT00301067|13135932|P3|STARTED|Follow up Until Death||3
5339858|NCT00301067|13135933|P2|STARTED|Follow up Until Death||3
5339859|NCT00301067|13135934|P1|STARTED|Follow up Until Death||4
5339860|NCT00301067|13135931|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
5339861|NCT00301067|13135932|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
5339862|NCT00301067|13135933|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
5339863|NCT00301067|13135934|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
5339864|NCT00301067|13135931|P4|COMPLETED|Completed 12 Cycles of Treatment||0
5339865|NCT00301067|13135932|P3|COMPLETED|Completed 12 Cycles of Treatment||0
5339866|NCT00301067|13135933|P2|COMPLETED|Completed 12 Cycles of Treatment||0
5339867|NCT00301067|13135934|P1|COMPLETED|Completed 12 Cycles of Treatment||0
5339868|NCT00301067|13135931|P4|STARTED|Completed 12 Cycles of Treatment||2
5339869|NCT00301067|13135932|P3|STARTED|Completed 12 Cycles of Treatment||0
5339870|NCT00301067|13135933|P2|STARTED|Completed 12 Cycles of Treatment||1
5339871|NCT00301067|13135934|P1|STARTED|Completed 12 Cycles of Treatment||0
5339872|NCT00301067|13135931|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
5339873|NCT00301067|13135932|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
5339874|NCT00301067|13135933|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
5339875|NCT00301067|13135934|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
5339876|NCT00301067|13135931|P4|COMPLETED|Completed 4 Cycles of Treatment||2
5339877|NCT00301067|13135932|P3|COMPLETED|Completed 4 Cycles of Treatment||0
5339878|NCT00301067|13135933|P2|COMPLETED|Completed 4 Cycles of Treatment||1
5339879|NCT00301067|13135934|P1|COMPLETED|Completed 4 Cycles of Treatment||0
5339880|NCT00301067|13135931|P4|STARTED|Completed 4 Cycles of Treatment||7
5339881|NCT00301067|13135932|P3|STARTED|Completed 4 Cycles of Treatment||2
5339882|NCT00301067|13135933|P2|STARTED|Completed 4 Cycles of Treatment||2
5339883|NCT00301067|13135934|P1|STARTED|Completed 4 Cycles of Treatment||1
5339884|NCT00301067|13135931|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
5339885|NCT00301067|13135932|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
5339886|NCT00301067|13135933|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
5339887|NCT00301067|13135934|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
5339888|NCT00301067|13135931|P4|COMPLETED|Reached 1st Response/2 Cycles||7
5339889|NCT00301067|13135932|P3|COMPLETED|Reached 1st Response/2 Cycles||2
5339890|NCT00301067|13135933|P2|COMPLETED|Reached 1st Response/2 Cycles||2
5339891|NCT00301067|13135934|P1|COMPLETED|Reached 1st Response/2 Cycles||1
5339892|NCT00301067|13135931|P4|STARTED|Reached 1st Response/2 Cycles||9
5339893|NCT00301067|13135932|P3|STARTED|Reached 1st Response/2 Cycles||3
5339894|NCT00301067|13135933|P2|STARTED|Reached 1st Response/2 Cycles||3
5339895|NCT00301067|13135934|P1|STARTED|Reached 1st Response/2 Cycles||3
5339896|NCT00301067|13135931|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
5339897|NCT00301067|13135932|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
5339898|NCT00301067|13135933|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
5339899|NCT00301067|13135934|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
5339900|NCT00301067|13135931|P4|COMPLETED|Completed DLT Period/1st Cycle||9
5339901|NCT00301067|13135932|P3|COMPLETED|Completed DLT Period/1st Cycle||3
5339902|NCT00301067|13135933|P2|COMPLETED|Completed DLT Period/1st Cycle||3
5339903|NCT00301067|13135934|P1|COMPLETED|Completed DLT Period/1st Cycle||3
5339904|NCT00301067|13135931|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
5339905|NCT00301067|13135932|P3|STARTED|Completed DLT Period/1st Cycle||3
5339906|NCT00301067|13135933|P2|STARTED|Completed DLT Period/1st Cycle||3
5339907|NCT00301067|13135934|P1|STARTED|Completed DLT Period/1st Cycle||4
5339908|NCT00301028|13135953|P1|NOT COMPLETED|Overall Study||0
5339909|NCT00301028|13135953|P1|COMPLETED|Overall Study||47
5339910|NCT00301028|13135953|P1|STARTED|Overall Study||47
5339911|NCT00300885|13135959|P2|NOT COMPLETED|Follow-up||195
5339912|NCT00300885|13135960|P1|NOT COMPLETED|Follow-up||178
5339913|NCT00300885|13135959|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
5339914|NCT00300885|13135960|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
5339915|NCT00300885|13135959|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
5339916|NCT00300885|13135960|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
5339917|NCT00300885|13135959|P2|NOT COMPLETED|Treatment||374
5339918|NCT00300885|13135960|P1|NOT COMPLETED|Treatment||373
5339919|NCT00300885|13135959|P2|COMPLETED|Treatment||88
5339920|NCT00300885|13135960|P1|COMPLETED|Treatment||91
5339921|NCT00300885|13135959|P2|Received Treatment|Treatment||459
5339922|NCT00300885|13135960|P1|Received Treatment|Treatment||463
5339923|NCT00300885|13135959|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
5339924|NCT00300885|13135960|P1|STARTED|Treatment||464
5339925|NCT00300781|13135978|P2|NOT COMPLETED|Overall Study||62
5339926|NCT00300781|13135979|P1|NOT COMPLETED|Overall Study||63
5339927|NCT00300781|13135978|P2|COMPLETED|Overall Study||8
5339928|NCT00300781|13135979|P1|COMPLETED|Overall Study||3
5339929|NCT00300781|13135978|P2|STARTED|Overall Study||70
5339930|NCT00300781|13135979|P1|STARTED|Overall Study||66
5339931|NCT00300755|13135994|P3|NOT COMPLETED|Overall Study||2
5339932|NCT00300755|13135995|P2|NOT COMPLETED|Overall Study||4
5339933|NCT00300755|13135996|P1|NOT COMPLETED|Overall Study||1
5339934|NCT00300755|13135994|P3|COMPLETED|Overall Study||19
5339935|NCT00300755|13135995|P2|COMPLETED|Overall Study||17
5339936|NCT00300755|13135996|P1|COMPLETED|Overall Study||17
5339937|NCT00300755|13135994|P3|STARTED|Overall Study||21
5339938|NCT00300755|13135995|P2|STARTED|Overall Study||21
5339939|NCT00300755|13135996|P1|STARTED|Overall Study||18
5339940|NCT00300742|13136013|P1|NOT COMPLETED|Overall Study||2
5339941|NCT00300742|13136013|P1|COMPLETED|Overall Study||3
5339942|NCT00300742|13136013|P1|STARTED|Overall Study||5
5339943|NCT00300677|13136021|P1|NOT COMPLETED|Overall Study||0
5339944|NCT00300677|13136021|P1|COMPLETED|Overall Study||12
5339945|NCT00300677|13136021|P1|STARTED|Overall Study||12
5339946|NCT00300495|13136030|P2|NOT COMPLETED|Overall Study||1
5339947|NCT00300495|13136031|P1|NOT COMPLETED|Overall Study||4
5339948|NCT00300495|13136030|P2|COMPLETED|Overall Study||8
5339949|NCT00300495|13136031|P1|COMPLETED|Overall Study||6
5339950|NCT00300495|13136030|P2|STARTED|Overall Study||9
5339951|NCT00300495|13136031|P1|STARTED|Overall Study||10
5339952|NCT00300482|13136045|P6|NOT COMPLETED|Overall Study||16
5339953|NCT00300482|13136046|P5|NOT COMPLETED|Overall Study||23
5339954|NCT00300482|13136047|P4|NOT COMPLETED|Overall Study||24
5339955|NCT00300482|13136048|P3|NOT COMPLETED|Overall Study||51
5339956|NCT00300482|13136049|P2|NOT COMPLETED|Overall Study||41
5339957|NCT00300482|13136050|P1|NOT COMPLETED|Overall Study||41
5339958|NCT00300482|13136045|P6|COMPLETED|Overall Study||115
5339959|NCT00300482|13136046|P5|COMPLETED|Overall Study||243
5339960|NCT00300482|13136047|P4|COMPLETED|Overall Study||237
5339961|NCT00300482|13136048|P3|COMPLETED|Overall Study||208
5339962|NCT00300482|13136049|P2|COMPLETED|Overall Study||220
5339963|NCT00300482|13136050|P1|COMPLETED|Overall Study||220
5339964|NCT00300482|13136045|P6|STARTED|Overall Study||131
5339965|NCT00300482|13136046|P5|STARTED|Overall Study||266
5339966|NCT00300482|13136047|P4|STARTED|Overall Study||261
5339967|NCT00300482|13136048|P3|STARTED|Overall Study||259
5339968|NCT00300482|13136049|P2|STARTED|Overall Study||261
5339969|NCT00300482|13136050|P1|STARTED|Overall Study|"For all arms, started means treated."|261
5339970|NCT00300469|13136112|P6|NOT COMPLETED|Overall Study||9
5339971|NCT00300469|13136113|P5|NOT COMPLETED|Overall Study||14
5339972|NCT00300469|13136114|P4|NOT COMPLETED|Overall Study||9
5339973|NCT00300469|13136115|P3|NOT COMPLETED|Overall Study||17
5339974|NCT00300469|13136116|P2|NOT COMPLETED|Overall Study||21
5339975|NCT00300469|13136117|P1|NOT COMPLETED|Overall Study||21
5339976|NCT00300469|13136112|P6|COMPLETED|Overall Study||46
5339977|NCT00300469|13136113|P5|COMPLETED|Overall Study||95
5339978|NCT00300469|13136114|P4|COMPLETED|Overall Study||104
5339979|NCT00300469|13136115|P3|COMPLETED|Overall Study||95
5339980|NCT00300469|13136116|P2|COMPLETED|Overall Study||89
5339981|NCT00300469|13136117|P1|COMPLETED|Overall Study||89
5339982|NCT00300469|13136112|P6|STARTED|Overall Study||55
5339983|NCT00300469|13136113|P5|STARTED|Overall Study||109
5339984|NCT00300469|13136114|P4|STARTED|Overall Study||113
5339985|NCT00300469|13136115|P3|STARTED|Overall Study||112
5339986|NCT00300469|13136116|P2|STARTED|Overall Study||110
5339987|NCT00300469|13136117|P1|STARTED|Overall Study|"For all arms, started means treated."|110
5339988|NCT00300456|13136179|P6|NOT COMPLETED|Overall Study||11
5339989|NCT00300456|13136180|P5|NOT COMPLETED|Overall Study||17
5339990|NCT00300456|13136181|P4|NOT COMPLETED|Overall Study||14
5339991|NCT00300456|13136182|P3|NOT COMPLETED|Overall Study||21
5339992|NCT00300456|13136183|P2|NOT COMPLETED|Overall Study||16
5339993|NCT00300456|13136184|P1|NOT COMPLETED|Overall Study||16
5339994|NCT00300456|13136179|P6|COMPLETED|Overall Study||48
5339995|NCT00300456|13136180|P5|COMPLETED|Overall Study||99
5339996|NCT00300456|13136181|P4|COMPLETED|Overall Study||105
5339997|NCT00300456|13136182|P3|COMPLETED|Overall Study||98
5339998|NCT00300456|13136183|P2|COMPLETED|Overall Study||102
5339999|NCT00300456|13136184|P1|COMPLETED|Overall Study||103
5340000|NCT00300456|13136179|P6|STARTED|Overall Study||59
5340001|NCT00300456|13136180|P5|STARTED|Overall Study||116
5340002|NCT00300456|13136181|P4|STARTED|Overall Study||119
5340003|NCT00300456|13136182|P3|STARTED|Overall Study||119
5340004|NCT00300456|13136183|P2|STARTED|Overall Study||118
5340005|NCT00300456|13136184|P1|STARTED|Overall Study|"For all arms, started means treated."|119
5340006|NCT00300430|13136243|P3|NOT COMPLETED|Overall Study||151
5340007|NCT00300430|13136244|P2|NOT COMPLETED|Overall Study||169
5340008|NCT00300430|13136245|P1|NOT COMPLETED|Overall Study||367
5340009|NCT00300430|13136243|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
5340010|NCT00300430|13136244|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
5340011|NCT00300430|13136245|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
5340012|NCT00300430|13136243|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
5340013|NCT00300430|13136244|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
5340014|NCT00300430|13136245|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
5340015|NCT00300391|13136279|P2|NOT COMPLETED|Overall Study||0
5340016|NCT00300391|13136280|P1|NOT COMPLETED|Overall Study||0
5340017|NCT00300391|13136279|P2|COMPLETED|Overall Study||14
5340018|NCT00300391|13136280|P1|COMPLETED|Overall Study||16
5340019|NCT00300391|13136279|P2|STARTED|Overall Study||14
5340020|NCT00300391|13136280|P1|STARTED|Overall Study||16
5340021|NCT00300365|13136298|P2|NOT COMPLETED|Overall Study||2
5340022|NCT00300365|13136299|P1|NOT COMPLETED|Overall Study||4
5340023|NCT00300365|13136298|P2|COMPLETED|Overall Study||38
5340024|NCT00300365|13136299|P1|COMPLETED|Overall Study||34
5340025|NCT00300365|13136298|P2|STARTED|Overall Study||40
5340026|NCT00300365|13136299|P1|STARTED|Overall Study||38
5340027|NCT00300274|13136308|P3|NOT COMPLETED|Overall Study||45
5340028|NCT00300274|13136309|P2|NOT COMPLETED|Overall Study||27
5340029|NCT00300274|13136310|P1|NOT COMPLETED|Overall Study||46
5340030|NCT00300274|13136308|P3|COMPLETED|Overall Study||226
5340031|NCT00300274|13136309|P2|COMPLETED|Overall Study||141
5340032|NCT00300274|13136310|P1|COMPLETED|Overall Study||236
5340033|NCT00300274|13136308|P3|Completed 12 Month|Overall Study||248
5340034|NCT00300274|13136309|P2|Completed 12 Month|Overall Study||149
5340035|NCT00300274|13136310|P1|Completed 12 Month|Overall Study||250
5340036|NCT00300274|13136308|P3|STARTED|Overall Study||271
5340037|NCT00300274|13136309|P2|STARTED|Overall Study||168
5340038|NCT00300274|13136310|P1|STARTED|Overall Study||282
5340039|NCT00300235|13136350|P5|NOT COMPLETED|Overall Study||0
5340040|NCT00300235|13136351|P4|NOT COMPLETED|Overall Study||0
5340041|NCT00300235|13136352|P3|NOT COMPLETED|Overall Study||0
5340042|NCT00300235|13136353|P2|NOT COMPLETED|Overall Study||0
5340043|NCT00300235|13136354|P1|NOT COMPLETED|Overall Study||0
5340044|NCT00300235|13136350|P5|COMPLETED|Overall Study||251
5340045|NCT00300235|13136351|P4|COMPLETED|Overall Study||362
5340046|NCT00300235|13136352|P3|COMPLETED|Overall Study||398
5340047|NCT00300235|13136353|P2|COMPLETED|Overall Study||240
5340048|NCT00300235|13136354|P1|COMPLETED|Overall Study||208
5340049|NCT00300235|13136350|P5|STARTED|Overall Study||251
5340050|NCT00300235|13136351|P4|STARTED|Overall Study||362
5340051|NCT00300235|13136352|P3|STARTED|Overall Study||398
5340052|NCT00300235|13136353|P2|STARTED|Overall Study||240
5340053|NCT00300235|13136354|P1|STARTED|Overall Study||208
5340054|NCT00299988|13136368|P2|NOT COMPLETED|Overall Study||0
5340055|NCT00299988|13136369|P1|NOT COMPLETED|Overall Study||0
5340056|NCT00299988|13136368|P2|COMPLETED|Overall Study||8
5340057|NCT00299988|13136369|P1|COMPLETED|Overall Study||16
5340058|NCT00299988|13136368|P2|STARTED|Overall Study||8
5340059|NCT00299988|13136369|P1|STARTED|Overall Study||16
5340060|NCT00299975|13136380|P3|NOT COMPLETED|Overall Study||8
5340061|NCT00299975|13136381|P2|NOT COMPLETED|Overall Study||1
5340062|NCT00299975|13136382|P1|NOT COMPLETED|Overall Study||3
5340063|NCT00299975|13136380|P3|COMPLETED|Overall Study||25
5340064|NCT00299975|13136381|P2|COMPLETED|Overall Study||31
5340065|NCT00299975|13136382|P1|COMPLETED|Overall Study||29
5340066|NCT00299975|13136380|P3|Received Allocated Intervention|Overall Study||32
5340067|NCT00299975|13136381|P2|Received Allocated Intervention|Overall Study||32
5340068|NCT00299975|13136382|P1|Received Allocated Intervention|Overall Study||32
5340069|NCT00299975|13136380|P3|STARTED|Overall Study||33
5340070|NCT00299975|13136381|P2|STARTED|Overall Study||32
5340071|NCT00299975|13136382|P1|STARTED|Overall Study||32
5340072|NCT00299741|13136432|P1|NOT COMPLETED|Overall Study||0
5340073|NCT00299741|13136432|P1|COMPLETED|Overall Study||36
5340074|NCT00299741|13136432|P1|STARTED|Overall Study||36
5340075|NCT00299702|13136439|P2|NOT COMPLETED|Overall Study||50
5340076|NCT00299702|13136440|P1|NOT COMPLETED|Overall Study||53
5340077|NCT00299702|13136439|P2|COMPLETED|Overall Study||126
5340078|NCT00299702|13136440|P1|COMPLETED|Overall Study||126
5340079|NCT00299702|13136439|P2|STARTED|Overall Study||176
5340080|NCT00299702|13136440|P1|STARTED|Overall Study||179
5340081|NCT00299689|13136448|P1|NOT COMPLETED|Overall Study||0
5340082|NCT00299689|13136448|P1|COMPLETED|Overall Study||69
5340083|NCT00299689|13136448|P1|STARTED|Overall Study||69
5340084|NCT00299546|13136455|P3|NOT COMPLETED|Overall Study||86
5340085|NCT00299546|13136456|P2|NOT COMPLETED|Overall Study||92
5340086|NCT00299546|13136457|P1|NOT COMPLETED|Overall Study||100
5340087|NCT00299546|13136455|P3|COMPLETED|Overall Study||67
5340088|NCT00299546|13136456|P2|COMPLETED|Overall Study||61
5340089|NCT00299546|13136457|P1|COMPLETED|Overall Study||55
5340090|NCT00299546|13136455|P3|STARTED|Overall Study||153
5340091|NCT00299546|13136456|P2|STARTED|Overall Study||153
5340092|NCT00299546|13136457|P1|STARTED|Overall Study||155
5340093|NCT00299494|13136488|P6|NOT COMPLETED|Overall Study||26
5340094|NCT00299494|13136489|P5|NOT COMPLETED|Overall Study||27
5340095|NCT00299494|13136490|P4|NOT COMPLETED|Overall Study||10
5340096|NCT00299494|13136491|P3|NOT COMPLETED|Overall Study||4
5340097|NCT00299494|13136492|P2|NOT COMPLETED|Overall Study||1
5340098|NCT00299494|13136493|P1|NOT COMPLETED|Overall Study||3
5340099|NCT00299494|13136488|P6|COMPLETED|Overall Study||4
5340100|NCT00299494|13136489|P5|COMPLETED|Overall Study||13
5340101|NCT00299494|13136490|P4|COMPLETED|Overall Study||24
5340102|NCT00299494|13136491|P3|COMPLETED|Overall Study||3
5340103|NCT00299494|13136492|P2|COMPLETED|Overall Study||2
5340104|NCT00299494|13136493|P1|COMPLETED|Overall Study||2
5340105|NCT00299494|13136488|P6|STARTED|Overall Study||30
5340106|NCT00299494|13136489|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
5340107|NCT00299494|13136490|P4|STARTED|Overall Study||34
5340108|NCT00299494|13136491|P3|STARTED|Overall Study||7
5340109|NCT00299494|13136492|P2|STARTED|Overall Study||3
5340110|NCT00299494|13136493|P1|STARTED|Overall Study||5
5340111|NCT00299416|13136596|P1|NOT COMPLETED|Overall Study||0
5340112|NCT00299416|13136596|P1|COMPLETED|Overall Study||30
5340113|NCT00299416|13136596|P1|STARTED|Overall Study||30
5340114|NCT00299221|13136604|P2|NOT COMPLETED|Overall Study||0
5340115|NCT00299221|13136605|P1|NOT COMPLETED|Overall Study||0
5340116|NCT00299221|13136604|P2|COMPLETED|Overall Study||71
5340117|NCT00299221|13136605|P1|COMPLETED|Overall Study||79
5340118|NCT00299221|13136604|P2|STARTED|Overall Study||71
5340119|NCT00299221|13136605|P1|STARTED|Overall Study||79
5340120|NCT00299156|13136622|P3|NOT COMPLETED|Period 2 (Randomized)||0
5340121|NCT00299156|13136623|P2|NOT COMPLETED|Period 2 (Randomized)||1
5340122|NCT00299156|13136624|P1|NOT COMPLETED|Period 2 (Randomized)||0
5340123|NCT00299156|13136622|P3|COMPLETED|Period 2 (Randomized)||16
5340124|NCT00299156|13136623|P2|COMPLETED|Period 2 (Randomized)||16
5340125|NCT00299156|13136624|P1|COMPLETED|Period 2 (Randomized)||0
5340126|NCT00299156|13136622|P3|STARTED|Period 2 (Randomized)||16
5340127|NCT00299156|13136623|P2|STARTED|Period 2 (Randomized)||17
5340128|NCT00299156|13136624|P1|STARTED|Period 2 (Randomized)||0
5340129|NCT00299156|13136622|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
5340130|NCT00299156|13136623|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
5340131|NCT00299156|13136624|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
5340132|NCT00299156|13136622|P3|COMPLETED|Period 1 (Non-Randomized)||0
5340133|NCT00299156|13136623|P2|COMPLETED|Period 1 (Non-Randomized)||0
5340134|NCT00299156|13136624|P1|COMPLETED|Period 1 (Non-Randomized)||32
5340135|NCT00299156|13136622|P3|STARTED|Period 1 (Non-Randomized)||0
5340136|NCT00299156|13136623|P2|STARTED|Period 1 (Non-Randomized)||0
5340137|NCT00299156|13136624|P1|STARTED|Period 1 (Non-Randomized)||32
5340138|NCT00299130|13136635|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
5340139|NCT00299130|13136636|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
5340140|NCT00299130|13136637|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
5340141|NCT00299130|13136635|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
5340142|NCT00299130|13136636|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
5340143|NCT00299130|13136637|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
5340144|NCT00299130|13136635|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
5340145|NCT00299130|13136636|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
5340146|NCT00299130|13136637|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
5340147|NCT00299130|13136635|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
5340148|NCT00299130|13136636|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
5340149|NCT00299130|13136637|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
5340150|NCT00299130|13136635|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
5340151|NCT00299130|13136636|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
5340152|NCT00299130|13136637|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
5340153|NCT00299130|13136635|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
5340154|NCT00299130|13136636|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
5340155|NCT00299130|13136637|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
5340156|NCT00299130|13136635|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
5340157|NCT00299130|13136636|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
5340158|NCT00299130|13136637|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
5340159|NCT00299130|13136635|P3|COMPLETED|Treatment Period (up to 5 Years)||121
5340160|NCT00299130|13136636|P2|COMPLETED|Treatment Period (up to 5 Years)||125
5340161|NCT00299130|13136637|P1|COMPLETED|Treatment Period (up to 5 Years)||119
5340162|NCT00299130|13136635|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
5340163|NCT00299130|13136636|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
5340164|NCT00299130|13136637|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
5340165|NCT00299130|13136635|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
5340166|NCT00299130|13136636|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
5340167|NCT00299130|13136637|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
5340168|NCT00299130|13136635|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
5340169|NCT00299130|13136636|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
5340170|NCT00299130|13136637|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
5340171|NCT00299130|13136635|P3|Treated|Treatment Period (up to 5 Years)||170
5340172|NCT00299130|13136636|P2|Treated|Treatment Period (up to 5 Years)||167
5340173|NCT00299130|13136637|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
5340174|NCT00299130|13136635|P3|STARTED|Treatment Period (up to 5 Years)||171
5340175|NCT00299130|13136636|P2|STARTED|Treatment Period (up to 5 Years)||168
5340176|NCT00299130|13136637|P1|STARTED|Treatment Period (up to 5 Years)||172
5340177|NCT00299104|13136742|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
5340178|NCT00299104|13136743|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
5340179|NCT00299104|13136744|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
5340180|NCT00299104|13136742|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
5340181|NCT00299104|13136743|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
5340182|NCT00299104|13136744|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
5340183|NCT00299104|13136742|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
5340184|NCT00299104|13136743|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
5340185|NCT00299104|13136744|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
5340186|NCT00299104|13136742|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
5340187|NCT00299104|13136743|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
5340188|NCT00299104|13136744|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
5340189|NCT00299104|13136742|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
5340190|NCT00299104|13136743|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
5340191|NCT00299104|13136744|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
5340192|NCT00299104|13136742|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
5340193|NCT00299104|13136743|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
5340194|NCT00299104|13136744|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
5340195|NCT00299104|13136742|P3|NOT COMPLETED|Treatment Period||172
5340196|NCT00299104|13136743|P2|NOT COMPLETED|Treatment Period||175
5340197|NCT00299104|13136744|P1|NOT COMPLETED|Treatment Period||189
5340198|NCT00299104|13136742|P3|COMPLETED|Treatment Period||80
5340199|NCT00299104|13136743|P2|COMPLETED|Treatment Period||77
5340200|NCT00299104|13136744|P1|COMPLETED|Treatment Period|Completed Week 152|62
5340201|NCT00299104|13136742|P3|Completed Week 104|Treatment Period||216
5340202|NCT00299104|13136743|P2|Completed Week 104|Treatment Period||213
5340203|NCT00299104|13136744|P1|Completed Week 104|Treatment Period||178
5340204|NCT00299104|13136742|P3|Completed Week 52|Treatment Period||232
5340205|NCT00299104|13136743|P2|Completed Week 52|Treatment Period||227
5340206|NCT00299104|13136744|P1|Completed Week 52|Treatment Period||213
5340207|NCT00299104|13136742|P3|Completed Week 24|Treatment Period||241
5340208|NCT00299104|13136743|P2|Completed Week 24|Treatment Period||240
5340209|NCT00299104|13136744|P1|Completed Week 24|Treatment Period||227
5340210|NCT00299104|13136742|P3|Safety/ITT: Received Study Drug|Treatment Period||250
5340211|NCT00299104|13136743|P2|Safety/ITT: Received Study Drug|Treatment Period||249
5340212|NCT00299104|13136744|P1|Safety/ITT: Received Study Drug|Treatment Period||249
5340213|NCT00299104|13136742|P3|STARTED|Treatment Period||252
5340214|NCT00299104|13136743|P2|STARTED|Treatment Period||252
5340215|NCT00299104|13136744|P1|STARTED|Treatment Period||251
5340216|NCT00299000|13136841|P2|NOT COMPLETED|Overall Study||0
5340217|NCT00299000|13136842|P1|NOT COMPLETED|Overall Study||0
5340218|NCT00299000|13136841|P2|COMPLETED|Overall Study||2
5340219|NCT00299000|13136842|P1|COMPLETED|Overall Study||2
5340220|NCT00299000|13136841|P2|STARTED|Overall Study||2
5340221|NCT00299000|13136842|P1|STARTED|Overall Study||2
5340222|NCT00298896|13136854|P1|NOT COMPLETED|Overall Study||50
5340223|NCT00298896|13136854|P1|COMPLETED|Overall Study||5
5340224|NCT00298896|13136854|P1|STARTED|Overall Study||55
5340225|NCT00298831|13136859|P1|NOT COMPLETED|Overall Study||32
5340226|NCT00298831|13136859|P1|COMPLETED|Overall Study||192
5340227|NCT00298831|13136859|P1|Treated|Overall Study||197
5340228|NCT00298831|13136859|P1|STARTED|Overall Study||224
5340229|NCT00298766|13136868|P1|NOT COMPLETED|Overall Study||46
5340230|NCT00298766|13136868|P1|COMPLETED|Overall Study||24
5340231|NCT00298766|13136868|P1|STARTED|Overall Study||70
5340232|NCT00298740|13136877|P1|NOT COMPLETED|Overall Study||9
5340233|NCT00298740|13136877|P1|COMPLETED|Overall Study||3
5340234|NCT00298740|13136877|P1|STARTED|Overall Study||12
5340235|NCT00298610|13136881|P1|NOT COMPLETED|Overall Study||0
5340236|NCT00298610|13136881|P1|COMPLETED|Overall Study||30
5340237|NCT00298610|13136881|P1|STARTED|Overall Study||30
5340238|NCT00298558|13136895|P4|NOT COMPLETED|10th Annual (A10)||163
5340239|NCT00298558|13136896|P3|NOT COMPLETED|10th Annual (A10)||171
5340240|NCT00298558|13136897|P2|NOT COMPLETED|10th Annual (A10)||153
5340241|NCT00298558|13136898|P1|NOT COMPLETED|10th Annual (A10)||172
5340242|NCT00298558|13136895|P4|COMPLETED|10th Annual (A10)||285
5340243|NCT00298558|13136896|P3|COMPLETED|10th Annual (A10)||319
5340244|NCT00298558|13136897|P2|COMPLETED|10th Annual (A10)||316
5340245|NCT00298558|13136898|P1|COMPLETED|10th Annual (A10)||300
5340246|NCT00298558|13136895|P4|STARTED|10th Annual (A10)||448
5340247|NCT00298558|13136896|P3|STARTED|10th Annual (A10)||490
5340248|NCT00298558|13136897|P2|STARTED|10th Annual (A10)||469
5340249|NCT00298558|13136898|P1|STARTED|10th Annual (A10)||472
5340250|NCT00298558|13136895|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
5340251|NCT00298558|13136896|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
5340252|NCT00298558|13136897|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
5340253|NCT00298558|13136898|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
5340254|NCT00298558|13136895|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
5340255|NCT00298558|13136896|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
5340256|NCT00298558|13136897|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
5340257|NCT00298558|13136898|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
5340258|NCT00298558|13136895|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
5340259|NCT00298558|13136896|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
5340260|NCT00298558|13136897|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
5340261|NCT00298558|13136898|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
5340262|NCT00298558|13136895|P4|NOT COMPLETED|3rd Annual Booster||0
5340263|NCT00298558|13136896|P3|NOT COMPLETED|3rd Annual Booster||140
5340264|NCT00298558|13136897|P2|NOT COMPLETED|3rd Annual Booster||128
5340265|NCT00298558|13136898|P1|NOT COMPLETED|3rd Annual Booster||122
5340266|NCT00298558|13136895|P4|COMPLETED|3rd Annual Booster||0
5340267|NCT00298558|13136896|P3|COMPLETED|3rd Annual Booster||230
5340268|NCT00298558|13136897|P2|COMPLETED|3rd Annual Booster||243
5340269|NCT00298558|13136898|P1|COMPLETED|3rd Annual Booster||250
5340270|NCT00298558|13136895|P4|STARTED|3rd Annual Booster||0
5340271|NCT00298558|13136896|P3|STARTED|3rd Annual Booster||370
5340272|NCT00298558|13136897|P2|STARTED|3rd Annual Booster||371
5340273|NCT00298558|13136898|P1|STARTED|3rd Annual Booster||372
5340274|NCT00298558|13136895|P4|NOT COMPLETED|2nd Annual (A2)||32
5340275|NCT00298558|13136896|P3|NOT COMPLETED|2nd Annual (A2)||27
5340276|NCT00298558|13136897|P2|NOT COMPLETED|2nd Annual (A2)||11
5340277|NCT00298558|13136898|P1|NOT COMPLETED|2nd Annual (A2)||22
5340278|NCT00298558|13136895|P4|COMPLETED|2nd Annual (A2)||552
5340279|NCT00298558|13136896|P3|COMPLETED|2nd Annual (A2)||574
5340280|NCT00298558|13136897|P2|COMPLETED|2nd Annual (A2)||555
5340281|NCT00298558|13136898|P1|COMPLETED|2nd Annual (A2)||563
5340282|NCT00298558|13136895|P4|STARTED|2nd Annual (A2)||584
5340283|NCT00298558|13136896|P3|STARTED|2nd Annual (A2)||601
5340284|NCT00298558|13136897|P2|STARTED|2nd Annual (A2)||566
5340285|NCT00298558|13136898|P1|STARTED|2nd Annual (A2)||585
5340286|NCT00298558|13136895|P4|NOT COMPLETED|1st Annual (A1)||55
5340287|NCT00298558|13136896|P3|NOT COMPLETED|1st Annual (A1)||52
5340288|NCT00298558|13136897|P2|NOT COMPLETED|1st Annual (A1)||63
5340289|NCT00298558|13136898|P1|NOT COMPLETED|1st Annual (A1)||55
5340290|NCT00298558|13136895|P4|COMPLETED|1st Annual (A1)||584
5340291|NCT00298558|13136896|P3|COMPLETED|1st Annual (A1)||601
5340292|NCT00298558|13136897|P2|COMPLETED|1st Annual (A1)||566
5340293|NCT00298558|13136898|P1|COMPLETED|1st Annual (A1)||585
5340294|NCT00298558|13136895|P4|STARTED|1st Annual (A1)||639
5340295|NCT00298558|13136896|P3|STARTED|1st Annual (A1)||653
5340296|NCT00298558|13136897|P2|STARTED|1st Annual (A1)||629
5340297|NCT00298558|13136898|P1|STARTED|1st Annual (A1)||640
5340298|NCT00298558|13136895|P4|NOT COMPLETED|Booster||0
5340299|NCT00298558|13136896|P3|NOT COMPLETED|Booster||75
5340300|NCT00298558|13136897|P2|NOT COMPLETED|Booster||70
5340301|NCT00298558|13136898|P1|NOT COMPLETED|Booster||89
5340302|NCT00298558|13136895|P4|COMPLETED|Booster||0
5340303|NCT00298558|13136896|P3|COMPLETED|Booster||295
5340304|NCT00298558|13136897|P2|COMPLETED|Booster||301
5340305|NCT00298558|13136898|P1|COMPLETED|Booster||283
5340306|NCT00298558|13136895|P4|STARTED|Booster||0
5340307|NCT00298558|13136896|P3|STARTED|Booster||370
5340308|NCT00298558|13136897|P2|STARTED|Booster||371
5340309|NCT00298558|13136898|P1|STARTED|Booster||372
5340310|NCT00298558|13136895|P4|NOT COMPLETED|Immediate Post Test||65
5340311|NCT00298558|13136896|P3|NOT COMPLETED|Immediate Post Test||59
5340312|NCT00298558|13136897|P2|NOT COMPLETED|Immediate Post Test||76
5340313|NCT00298558|13136898|P1|NOT COMPLETED|Immediate Post Test||71
5340314|NCT00298558|13136895|P4|COMPLETED|Immediate Post Test||639
5340315|NCT00298558|13136896|P3|COMPLETED|Immediate Post Test||653
5340316|NCT00298558|13136897|P2|COMPLETED|Immediate Post Test||629
5340317|NCT00298558|13136898|P1|COMPLETED|Immediate Post Test||640
5340318|NCT00298558|13136895|P4|STARTED|Immediate Post Test||704
5340319|NCT00298558|13136896|P3|STARTED|Immediate Post Test||712
5340320|NCT00298558|13136897|P2|STARTED|Immediate Post Test||705
5340321|NCT00298558|13136898|P1|STARTED|Immediate Post Test||711
5340322|NCT00298558|13136895|P4|NOT COMPLETED|Intervention||419
5340323|NCT00298558|13136896|P3|NOT COMPLETED|Intervention||75
5340324|NCT00298558|13136897|P2|NOT COMPLETED|Intervention||78
5340325|NCT00298558|13136898|P1|NOT COMPLETED|Intervention||91
5340326|NCT00298558|13136895|P4|COMPLETED|Intervention||285
5340327|NCT00298558|13136896|P3|COMPLETED|Intervention||637
5340328|NCT00298558|13136897|P2|COMPLETED|Intervention||627
5340329|NCT00298558|13136898|P1|COMPLETED|Intervention||620
5340330|NCT00298558|13136895|P4|STARTED|Intervention||704
5340331|NCT00298558|13136896|P3|STARTED|Intervention||712
5340332|NCT00298558|13136897|P2|STARTED|Intervention||705
5340333|NCT00298558|13136898|P1|STARTED|Intervention||711
5340334|NCT00298558|13136895|P4|NOT COMPLETED|Baseline||0
5340335|NCT00298558|13136896|P3|NOT COMPLETED|Baseline||0
5340336|NCT00298558|13136897|P2|NOT COMPLETED|Baseline||0
5340337|NCT00298558|13136898|P1|NOT COMPLETED|Baseline||0
5340338|NCT00298558|13136895|P4|COMPLETED|Baseline||704
5340339|NCT00298558|13136896|P3|COMPLETED|Baseline||712
5340340|NCT00298558|13136897|P2|COMPLETED|Baseline||705
5340341|NCT00298558|13136898|P1|COMPLETED|Baseline||711
5340342|NCT00298558|13136895|P4|STARTED|Baseline||704
5340343|NCT00298558|13136896|P3|STARTED|Baseline||712
5340344|NCT00298558|13136897|P2|STARTED|Baseline||705
5340345|NCT00298558|13136898|P1|STARTED|Baseline||711
5340346|NCT00298389|13136931|P3|NOT COMPLETED|Overall Study||0
5340347|NCT00298389|13136932|P2|NOT COMPLETED|Overall Study||0
5340348|NCT00298389|13136933|P1|NOT COMPLETED|Overall Study||0
5340349|NCT00298389|13136931|P3|COMPLETED|Overall Study||19
5340350|NCT00298389|13136932|P2|COMPLETED|Overall Study||17
5340351|NCT00298389|13136933|P1|COMPLETED|Overall Study||20
5340352|NCT00298389|13136931|P3|STARTED|Overall Study||19
5340353|NCT00298389|13136932|P2|STARTED|Overall Study||17
5340354|NCT00298389|13136933|P1|STARTED|Overall Study||20
5340355|NCT00298363|13136947|P3|NOT COMPLETED|Overall Study||6
5340356|NCT00298363|13136948|P2|NOT COMPLETED|Overall Study||8
5340357|NCT00298363|13136949|P1|NOT COMPLETED|Overall Study||17
5340358|NCT00298363|13136947|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
5340359|NCT00298363|13136948|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
5340360|NCT00298363|13136949|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
5340361|NCT00298363|13136947|P3|STARTED|Overall Study||22
5340362|NCT00298363|13136948|P2|STARTED|Overall Study||45
5340363|NCT00298363|13136949|P1|STARTED|Overall Study||45
5340364|NCT00298272|13137107|P2|NOT COMPLETED|Safety Follow-up Phase||4
5340365|NCT00298272|13137108|P1|NOT COMPLETED|Safety Follow-up Phase||4
5340366|NCT00298272|13137107|P2|COMPLETED|Safety Follow-up Phase||13
5340367|NCT00298272|13137108|P1|COMPLETED|Safety Follow-up Phase||18
5340368|NCT00298272|13137107|P2|STARTED|Safety Follow-up Phase||17
5340369|NCT00298272|13137108|P1|STARTED|Safety Follow-up Phase||22
5340370|NCT00298272|13137107|P2|NOT COMPLETED|Open Label Retreatment Phase||4
5340371|NCT00298272|13137108|P1|NOT COMPLETED|Open Label Retreatment Phase||9
5340372|NCT00298272|13137107|P2|COMPLETED|Open Label Retreatment Phase||12
5340373|NCT00298272|13137108|P1|COMPLETED|Open Label Retreatment Phase||13
5340374|NCT00298272|13137107|P2|Completed to Week 56|Open Label Retreatment Phase||12
5340375|NCT00298272|13137108|P1|Completed to Week 56|Open Label Retreatment Phase||13
5340376|NCT00298272|13137107|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
5340377|NCT00298272|13137108|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
5340378|NCT00298272|13137107|P2|STARTED|Open Label Retreatment Phase||16
5340379|NCT00298272|13137108|P1|STARTED|Open Label Retreatment Phase||22
5340380|NCT00298272|13137107|P2|NOT COMPLETED|Double-blind Phase||0
5340381|NCT00298272|13137108|P1|NOT COMPLETED|Double-blind Phase||8
5340382|NCT00298272|13137107|P2|COMPLETED|Double-blind Phase||18
5340383|NCT00298272|13137108|P1|COMPLETED|Double-blind Phase||28
5340384|NCT00298272|13137107|P2|Completed to Week 56|Double-blind Phase||3
5340385|NCT00298272|13137108|P1|Completed to Week 56|Double-blind Phase||8
5340386|NCT00298272|13137107|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
5340387|NCT00298272|13137108|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
5340388|NCT00298272|13137107|P2|Safety Population|Double-blind Phase||18
5340389|NCT00298272|13137108|P1|Safety Population|Double-blind Phase|received treatment|33
5340390|NCT00298272|13137107|P2|STARTED|Double-blind Phase||18
5340391|NCT00298272|13137108|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
5340392|NCT00298233|13137131|P4|NOT COMPLETED|Overall Study||0
5340393|NCT00298233|13137132|P3|NOT COMPLETED|Overall Study||0
5340394|NCT00298233|13137133|P2|NOT COMPLETED|Overall Study||0
5340395|NCT00298233|13137134|P1|NOT COMPLETED|Overall Study||0
5340396|NCT00298233|13137131|P4|COMPLETED|Overall Study||124
5340397|NCT00298233|13137132|P3|COMPLETED|Overall Study||122
5340398|NCT00298233|13137133|P2|COMPLETED|Overall Study||41
5340399|NCT00298233|13137134|P1|COMPLETED|Overall Study||39
5340400|NCT00298233|13137131|P4|STARTED|Overall Study||124
5340401|NCT00298233|13137132|P3|STARTED|Overall Study||122
5340402|NCT00298233|13137133|P2|STARTED|Overall Study||41
5340403|NCT00298233|13137134|P1|STARTED|Overall Study||39
5340404|NCT00298155|13137153|P3|NOT COMPLETED|Overall Study||0
5340405|NCT00298155|13137154|P2|NOT COMPLETED|Overall Study||0
5340406|NCT00298155|13137155|P1|NOT COMPLETED|Overall Study||0
5340407|NCT00298155|13137153|P3|COMPLETED|Overall Study||13
5340408|NCT00298155|13137154|P2|COMPLETED|Overall Study||10
5340409|NCT00298155|13137155|P1|COMPLETED|Overall Study||12
5340410|NCT00298155|13137153|P3|STARTED|Overall Study||13
5340411|NCT00298155|13137154|P2|STARTED|Overall Study||10
5340412|NCT00298155|13137155|P1|STARTED|Overall Study||12
5340413|NCT00298090|13137166|P1|NOT COMPLETED|Overall Study||18
5340414|NCT00298090|13137166|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
5340415|NCT00298090|13137166|P1|STARTED|Overall Study||47
5340416|NCT00298038|13137172|P2|NOT COMPLETED|Overall Study||93
5340417|NCT00298038|13137173|P1|NOT COMPLETED|Overall Study||52
5340418|NCT00298038|13137172|P2|COMPLETED|Overall Study||66
5340419|NCT00298038|13137173|P1|COMPLETED|Overall Study||88
5340420|NCT00298038|13137172|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
5340421|NCT00298038|13137173|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
5340422|NCT00298038|13137172|P2|STARTED|Overall Study||159
5340423|NCT00298038|13137173|P1|STARTED|Overall Study||140
5340424|NCT00297830|13137192|P3|NOT COMPLETED|12 Month Visit||0
5340425|NCT00297830|13137193|P2|NOT COMPLETED|12 Month Visit||6
5340426|NCT00297830|13137194|P1|NOT COMPLETED|12 Month Visit||1
5340427|NCT00297830|13137192|P3|COMPLETED|12 Month Visit||24
5340428|NCT00297830|13137193|P2|COMPLETED|12 Month Visit||35
5340429|NCT00297830|13137194|P1|COMPLETED|12 Month Visit||37
5340430|NCT00297830|13137192|P3|STARTED|12 Month Visit||24
5340431|NCT00297830|13137193|P2|STARTED|12 Month Visit||41
5340432|NCT00297830|13137194|P1|STARTED|12 Month Visit||38
5340433|NCT00297830|13137192|P3|NOT COMPLETED|6 Month Visit||3
5340434|NCT00297830|13137193|P2|NOT COMPLETED|6 Month Visit||2
5340435|NCT00297830|13137194|P1|NOT COMPLETED|6 Month Visit||3
5340436|NCT00297830|13137192|P3|COMPLETED|6 Month Visit||24
5340437|NCT00297830|13137193|P2|COMPLETED|6 Month Visit||41
5340438|NCT00297830|13137194|P1|COMPLETED|6 Month Visit||38
5340439|NCT00297830|13137192|P3|STARTED|6 Month Visit||27
5340440|NCT00297830|13137193|P2|STARTED|6 Month Visit||43
5340441|NCT00297830|13137194|P1|STARTED|6 Month Visit||41
5340442|NCT00297830|13137192|P3|NOT COMPLETED|Baseline||0
5340443|NCT00297830|13137193|P2|NOT COMPLETED|Baseline||0
5340444|NCT00297830|13137194|P1|NOT COMPLETED|Baseline||0
5340445|NCT00297830|13137192|P3|COMPLETED|Baseline||27
5340446|NCT00297830|13137193|P2|COMPLETED|Baseline||43
5340447|NCT00297830|13137194|P1|COMPLETED|Baseline||41
5340448|NCT00297830|13137192|P3|STARTED|Baseline||27
5340449|NCT00297830|13137193|P2|STARTED|Baseline||43
5340450|NCT00297830|13137194|P1|STARTED|Baseline||41
5340451|NCT00297778|13137213|P2|NOT COMPLETED|Overall Study||20
5340452|NCT00297778|13137214|P1|NOT COMPLETED|Overall Study||19
5340453|NCT00297778|13137213|P2|COMPLETED|Overall Study||124
5340454|NCT00297778|13137214|P1|COMPLETED|Overall Study||133
5340455|NCT00297778|13137213|P2|STARTED|Overall Study||144
5340456|NCT00297778|13137214|P1|STARTED|Overall Study||152
5340457|NCT00297648|13137248|P1|NOT COMPLETED|Overall Study||36
5340458|NCT00297648|13137248|P1|COMPLETED|Overall Study||53
5340459|NCT00297648|13137248|P1|STARTED|Overall Study||89
5340460|NCT00297596|13137287|P1|NOT COMPLETED|Overall Study||0
5340461|NCT00297596|13137287|P1|COMPLETED|Overall Study||25
5340462|NCT00297596|13137287|P1|STARTED|Overall Study||25
5340463|NCT00297492|13137294|P3|NOT COMPLETED|6 Month Follow-up||27
5340464|NCT00297492|13137295|P2|NOT COMPLETED|6 Month Follow-up||49
5340465|NCT00297492|13137296|P1|NOT COMPLETED|6 Month Follow-up||63
5340466|NCT00297492|13137294|P3|COMPLETED|6 Month Follow-up||118
5340467|NCT00297492|13137295|P2|COMPLETED|6 Month Follow-up||237
5340468|NCT00297492|13137296|P1|COMPLETED|6 Month Follow-up||227
5340469|NCT00297492|13137294|P3|STARTED|6 Month Follow-up||145
5340470|NCT00297492|13137295|P2|STARTED|6 Month Follow-up||286
5340471|NCT00297492|13137296|P1|STARTED|6 Month Follow-up||290
5340472|NCT00297492|13137294|P3|NOT COMPLETED|Set Quit Date||5
5340473|NCT00297492|13137295|P2|NOT COMPLETED|Set Quit Date||13
5340474|NCT00297492|13137296|P1|NOT COMPLETED|Set Quit Date||7
5340475|NCT00297492|13137294|P3|COMPLETED|Set Quit Date||145
5340476|NCT00297492|13137295|P2|COMPLETED|Set Quit Date||286
5340477|NCT00297492|13137296|P1|COMPLETED|Set Quit Date||290
5340478|NCT00297492|13137294|P3|STARTED|Set Quit Date||150
5340479|NCT00297492|13137295|P2|STARTED|Set Quit Date||299
5340480|NCT00297492|13137296|P1|STARTED|Set Quit Date||297
5340481|NCT00297479|13137307|P3|NOT COMPLETED|Overall Study||51
5340482|NCT00297479|13137308|P2|NOT COMPLETED|Overall Study||54
5340483|NCT00297479|13137309|P1|NOT COMPLETED|Overall Study||37
5340484|NCT00297479|13137307|P3|COMPLETED|Overall Study||103
5340485|NCT00297479|13137308|P2|COMPLETED|Overall Study||101
5340486|NCT00297479|13137309|P1|COMPLETED|Overall Study||66
5340487|NCT00297479|13137307|P3|26- Week Follow Up|Overall Study||103
5340488|NCT00297479|13137308|P2|26- Week Follow Up|Overall Study||101
5340489|NCT00297479|13137309|P1|26- Week Follow Up|Overall Study||66
5340490|NCT00297479|13137307|P3|4-Week Follow Up|Overall Study||128
5340491|NCT00297479|13137308|P2|4-Week Follow Up|Overall Study||132
5340492|NCT00297479|13137309|P1|4-Week Follow Up|Overall Study||78
5340493|NCT00297479|13137307|P3|STARTED|Overall Study||154
5340494|NCT00297479|13137308|P2|STARTED|Overall Study||155
5340495|NCT00297479|13137309|P1|STARTED|Overall Study||103
5340496|NCT00297427|13137328|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
5340497|NCT00297427|13137329|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
5340498|NCT00297427|13137328|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
5340499|NCT00297427|13137329|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
5340500|NCT00297427|13137328|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
5340501|NCT00297427|13137329|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
5340502|NCT00297427|13137328|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
5340503|NCT00297427|13137329|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
5340504|NCT00297427|13137328|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
5340505|NCT00297427|13137329|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
5340506|NCT00297427|13137328|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
5340507|NCT00297427|13137329|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
5340508|NCT00297427|13137328|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
5340509|NCT00297427|13137329|P1|STARTED|Phase 2: Optional Crossover for Sham||54
5340510|NCT00297427|13137328|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
5340511|NCT00297427|13137329|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
5340512|NCT00297427|13137328|P2|COMPLETED|Phase 1: Initial Intervention||54
5340513|NCT00297427|13137329|P1|COMPLETED|Phase 1: Initial Intervention||56
5340514|NCT00297427|13137328|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
5340515|NCT00297427|13137329|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
5340516|NCT00297258|13137370|P1|NOT COMPLETED|Overall Study||142
5340517|NCT00297258|13137370|P1|COMPLETED|Overall Study||0
5340518|NCT00297258|13137370|P1|STARTED|Overall Study||142
5340519|NCT00297232|13137389|P1|NOT COMPLETED|Overall Study||605
5340520|NCT00297232|13137389|P1|COMPLETED|Overall Study||489
5340521|NCT00297232|13137389|P1|STARTED|Overall Study||1094
5340522|NCT00297167|13137395|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
5340523|NCT00297167|13137396|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
5340524|NCT00297167|13137397|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
5340525|NCT00297167|13137395|P3|COMPLETED|Open-label Dose Normalization Period 2||31
5340526|NCT00297167|13137396|P2|COMPLETED|Open-label Dose Normalization Period 2||0
5340527|NCT00297167|13137397|P1|COMPLETED|Open-label Dose Normalization Period 2||0
5340528|NCT00297167|13137395|P3|STARTED|Open-label Dose Normalization Period 2||31
5340529|NCT00297167|13137396|P2|STARTED|Open-label Dose Normalization Period 2||0
5340530|NCT00297167|13137397|P1|STARTED|Open-label Dose Normalization Period 2||0
5340531|NCT00297167|13137395|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
5340532|NCT00297167|13137396|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
5340533|NCT00297167|13137397|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
5340534|NCT00297167|13137395|P3|COMPLETED|Second Double-blind Intervention Period||0
5340535|NCT00297167|13137396|P2|COMPLETED|Second Double-blind Intervention Period||15
5340536|NCT00297167|13137397|P1|COMPLETED|Second Double-blind Intervention Period||16
5340537|NCT00297167|13137395|P3|STARTED|Second Double-blind Intervention Period||0
5340538|NCT00297167|13137396|P2|STARTED|Second Double-blind Intervention Period||15
5340539|NCT00297167|13137397|P1|STARTED|Second Double-blind Intervention Period||17
5340540|NCT00297167|13137395|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
5340541|NCT00297167|13137396|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
5340542|NCT00297167|13137397|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
5340543|NCT00297167|13137395|P3|COMPLETED|Open-label Dose Normalization Period 1||32
5340544|NCT00297167|13137396|P2|COMPLETED|Open-label Dose Normalization Period 1||0
5340545|NCT00297167|13137397|P1|COMPLETED|Open-label Dose Normalization Period 1||0
5340546|NCT00297167|13137395|P3|STARTED|Open-label Dose Normalization Period 1||33
5340547|NCT00297167|13137396|P2|STARTED|Open-label Dose Normalization Period 1||0
5340548|NCT00297167|13137397|P1|STARTED|Open-label Dose Normalization Period 1||0
5340549|NCT00297167|13137395|P3|NOT COMPLETED|First Double-blind Intervention Period||0
5340550|NCT00297167|13137396|P2|NOT COMPLETED|First Double-blind Intervention Period||0
5340551|NCT00297167|13137397|P1|NOT COMPLETED|First Double-blind Intervention Period||0
5340552|NCT00297167|13137395|P3|COMPLETED|First Double-blind Intervention Period||0
5340553|NCT00297167|13137396|P2|COMPLETED|First Double-blind Intervention Period||16
5340554|NCT00297167|13137397|P1|COMPLETED|First Double-blind Intervention Period||17
5340555|NCT00297167|13137395|P3|STARTED|First Double-blind Intervention Period||0
5340556|NCT00297167|13137396|P2|STARTED|First Double-blind Intervention Period||16
5340557|NCT00297167|13137397|P1|STARTED|First Double-blind Intervention Period||17
5340558|NCT00297115|13137423|P2|NOT COMPLETED|Overall Study||246
5340559|NCT00297115|13137424|P1|NOT COMPLETED|Overall Study||245
5340560|NCT00297115|13137423|P2|COMPLETED|Overall Study||550
5340561|NCT00297115|13137424|P1|COMPLETED|Overall Study||527
5340562|NCT00297115|13137423|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
5340563|NCT00297115|13137424|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
5340564|NCT00297102|13137442|P2|NOT COMPLETED|Overall Study||233
5340565|NCT00297102|13137443|P1|NOT COMPLETED|Overall Study||263
5340566|NCT00297102|13137442|P2|COMPLETED|Overall Study||525
5340567|NCT00297102|13137443|P1|COMPLETED|Overall Study||502
5340568|NCT00297102|13137442|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
5340569|NCT00297102|13137443|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
5340570|NCT00297037|13137461|P2|NOT COMPLETED|Overall Study||0
5340571|NCT00297037|13137462|P1|NOT COMPLETED|Overall Study||2
5340572|NCT00297037|13137461|P2|COMPLETED|Overall Study||11
5340573|NCT00297037|13137462|P1|COMPLETED|Overall Study||8
5340574|NCT00297037|13137461|P2|STARTED|Overall Study||11
5340575|NCT00297037|13137462|P1|STARTED|Overall Study||10
5340576|NCT00296816|13137474|P1|NOT COMPLETED|Overall Study||74
5340577|NCT00296816|13137474|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
5340578|NCT00296816|13137474|P1|STARTED|Overall Study||132
5340579|NCT00296725|13137486|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
5340580|NCT00296725|13137486|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
5340581|NCT00296725|13137486|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
5340582|NCT00296725|13137486|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
5340583|NCT00296725|13137486|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
5340584|NCT00296725|13137486|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
5340585|NCT00296647|13137499|P5|NOT COMPLETED|Overall Study||20
5340586|NCT00296647|13137500|P4|NOT COMPLETED|Overall Study||17
5340587|NCT00296647|13137501|P3|NOT COMPLETED|Overall Study||34
5340588|NCT00296647|13137502|P2|NOT COMPLETED|Overall Study||28
5340589|NCT00296647|13137503|P1|NOT COMPLETED|Overall Study||32
5340590|NCT00296647|13137499|P5|COMPLETED|Overall Study||248
5340591|NCT00296647|13137500|P4|COMPLETED|Overall Study||262
5340592|NCT00296647|13137501|P3|COMPLETED|Overall Study||222
5340593|NCT00296647|13137502|P2|COMPLETED|Overall Study||233
5340594|NCT00296647|13137503|P1|COMPLETED|Overall Study||250
5340595|NCT00296647|13137499|P5|STARTED|Overall Study||268
5340596|NCT00296647|13137500|P4|STARTED|Overall Study||279
5340597|NCT00296647|13137501|P3|STARTED|Overall Study||256
5340598|NCT00296647|13137502|P2|STARTED|Overall Study||261
5340599|NCT00296647|13137503|P1|STARTED|Overall Study||282
5340600|NCT00296517|13137517|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
5340601|NCT00296517|13137518|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
5340602|NCT00296517|13137517|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
5340603|NCT00296517|13137518|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
5340604|NCT00296517|13137517|P2|STARTED|Dose Level 3 - Weeks 3-12||161
5340605|NCT00296517|13137518|P1|STARTED|Dose Level 3 - Weeks 3-12||157
5340606|NCT00296517|13137517|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
5340607|NCT00296517|13137518|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
5340608|NCT00296517|13137517|P2|COMPLETED|Dose Level 2 - Week 2||161
5340609|NCT00296517|13137518|P1|COMPLETED|Dose Level 2 - Week 2||157
5340610|NCT00296517|13137517|P2|STARTED|Dose Level 2 - Week 2||166
5340611|NCT00296517|13137518|P1|STARTED|Dose Level 2 - Week 2||159
5340612|NCT00296517|13137517|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
5340613|NCT00296517|13137518|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
5340614|NCT00296517|13137517|P2|COMPLETED|Dose Level 1 - Week 1||166
5340615|NCT00296517|13137518|P1|COMPLETED|Dose Level 1 - Week 1||159
5340616|NCT00296517|13137517|P2|STARTED|Dose Level 1 - Week 1||166
5340617|NCT00296517|13137518|P1|STARTED|Dose Level 1 - Week 1||159
5340618|NCT00296504|13137554|P9|NOT COMPLETED|Final Analysis||21
5340619|NCT00296504|13137555|P8|NOT COMPLETED|Final Analysis||0
5340620|NCT00296504|13137556|P7|NOT COMPLETED|Final Analysis||0
5340621|NCT00296504|13137557|P6|NOT COMPLETED|Final Analysis||0
5340622|NCT00296504|13137558|P5|NOT COMPLETED|Final Analysis||0
5340623|NCT00296504|13137559|P4|NOT COMPLETED|Final Analysis||0
5340624|NCT00296504|13137560|P3|NOT COMPLETED|Final Analysis||0
5340625|NCT00296504|13137561|P2|NOT COMPLETED|Final Analysis||0
5340626|NCT00296504|13137562|P1|NOT COMPLETED|Final Analysis||0
5340627|NCT00296504|13137554|P9|COMPLETED|Final Analysis||90
5340628|NCT00296504|13137555|P8|COMPLETED|Final Analysis||0
5340629|NCT00296504|13137556|P7|COMPLETED|Final Analysis||0
5340630|NCT00296504|13137557|P6|COMPLETED|Final Analysis||0
5340631|NCT00296504|13137558|P5|COMPLETED|Final Analysis||0
5340632|NCT00296504|13137559|P4|COMPLETED|Final Analysis||0
5340633|NCT00296504|13137560|P3|COMPLETED|Final Analysis||0
5340634|NCT00296504|13137561|P2|COMPLETED|Final Analysis||0
5340635|NCT00296504|13137562|P1|COMPLETED|Final Analysis||0
5340636|NCT00296504|13137554|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
5340637|NCT00296504|13137555|P8|STARTED|Final Analysis||0
5340638|NCT00296504|13137556|P7|STARTED|Final Analysis||0
5340639|NCT00296504|13137557|P6|STARTED|Final Analysis||0
5340640|NCT00296504|13137558|P5|STARTED|Final Analysis||0
5340641|NCT00296504|13137559|P4|STARTED|Final Analysis||0
5340642|NCT00296504|13137560|P3|STARTED|Final Analysis||0
5340643|NCT00296504|13137561|P2|STARTED|Final Analysis||0
5340644|NCT00296504|13137562|P1|STARTED|Final Analysis||0
5340645|NCT00296504|13137554|P9|NOT COMPLETED|Interim Analysis||0
5340646|NCT00296504|13137555|P8|NOT COMPLETED|Interim Analysis||49
5340647|NCT00296504|13137556|P7|NOT COMPLETED|Interim Analysis||74
5340648|NCT00296504|13137557|P6|NOT COMPLETED|Interim Analysis||37
5340649|NCT00296504|13137558|P5|NOT COMPLETED|Interim Analysis||37
5340650|NCT00296504|13137559|P4|NOT COMPLETED|Interim Analysis||43
5340651|NCT00296504|13137560|P3|NOT COMPLETED|Interim Analysis||105
5340652|NCT00296504|13137561|P2|NOT COMPLETED|Interim Analysis||18
5340653|NCT00296504|13137562|P1|NOT COMPLETED|Interim Analysis||76
5340654|NCT00296504|13137554|P9|COMPLETED|Interim Analysis||0
5340655|NCT00296504|13137555|P8|COMPLETED|Interim Analysis||37
5340656|NCT00296504|13137556|P7|COMPLETED|Interim Analysis||30
5340657|NCT00296504|13137557|P6|COMPLETED|Interim Analysis||41
5340658|NCT00296504|13137558|P5|COMPLETED|Interim Analysis||36
5340659|NCT00296504|13137559|P4|COMPLETED|Interim Analysis||11
5340660|NCT00296504|13137560|P3|COMPLETED|Interim Analysis||116
5340661|NCT00296504|13137561|P2|COMPLETED|Interim Analysis||0
5340662|NCT00296504|13137562|P1|COMPLETED|Interim Analysis||43
5340663|NCT00296504|13137554|P9|Ongoing|Interim Analysis||0
5340664|NCT00296504|13137555|P8|Ongoing|Interim Analysis||1
5340665|NCT00296504|13137556|P7|Ongoing|Interim Analysis||30
5340666|NCT00296504|13137557|P6|Ongoing|Interim Analysis||0
5340667|NCT00296504|13137558|P5|Ongoing|Interim Analysis||0
5340668|NCT00296504|13137559|P4|Ongoing|Interim Analysis||22
5340669|NCT00296504|13137560|P3|Ongoing|Interim Analysis||16
5340670|NCT00296504|13137561|P2|Ongoing|Interim Analysis||12
5340671|NCT00296504|13137562|P1|Ongoing|Interim Analysis||32
5340672|NCT00296504|13137554|P9|STARTED|Interim Analysis||0
5340673|NCT00296504|13137555|P8|STARTED|Interim Analysis||86
5340674|NCT00296504|13137556|P7|STARTED|Interim Analysis||104
5340675|NCT00296504|13137557|P6|STARTED|Interim Analysis||78
5340676|NCT00296504|13137558|P5|STARTED|Interim Analysis||73
5340677|NCT00296504|13137559|P4|STARTED|Interim Analysis||54
5340678|NCT00296504|13137560|P3|STARTED|Interim Analysis||221
5340679|NCT00296504|13137561|P2|STARTED|Interim Analysis||18
5340680|NCT00296504|13137562|P1|STARTED|Interim Analysis||119
5340681|NCT00296491|13137655|P4|NOT COMPLETED|Overall Study||43
5340682|NCT00296491|13137656|P3|NOT COMPLETED|Overall Study||43
5340683|NCT00296491|13137657|P2|NOT COMPLETED|Overall Study||53
5340684|NCT00296491|13137658|P1|NOT COMPLETED|Overall Study||42
5340685|NCT00296491|13137655|P4|COMPLETED|Overall Study||138
5340686|NCT00296491|13137656|P3|COMPLETED|Overall Study||137
5340687|NCT00296491|13137657|P2|COMPLETED|Overall Study||129
5340688|NCT00296491|13137658|P1|COMPLETED|Overall Study||140
5340689|NCT00296491|13137655|P4|STARTED|Overall Study||181
5340690|NCT00296491|13137656|P3|STARTED|Overall Study||180
5340691|NCT00296491|13137657|P2|STARTED|Overall Study||182
5340692|NCT00296491|13137658|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
5340693|NCT00296400|13137687|P3|NOT COMPLETED|Overall Study||13
5340694|NCT00296400|13137688|P2|NOT COMPLETED|Overall Study||18
5340695|NCT00296400|13137689|P1|NOT COMPLETED|Overall Study||17
5340696|NCT00296400|13137687|P3|COMPLETED|Overall Study||67
5340697|NCT00296400|13137688|P2|COMPLETED|Overall Study||69
5340698|NCT00296400|13137689|P1|COMPLETED|Overall Study||53
5340699|NCT00296400|13137687|P3|STARTED|Overall Study||80
5340700|NCT00296400|13137688|P2|STARTED|Overall Study||87
5340701|NCT00296400|13137689|P1|STARTED|Overall Study||70
5340702|NCT00296374|13137913|P3|NOT COMPLETED|Overall Study||29
5340703|NCT00296374|13137914|P2|NOT COMPLETED|Overall Study||23
5340704|NCT00296374|13137915|P1|NOT COMPLETED|Overall Study||25
5340705|NCT00296374|13137913|P3|COMPLETED|Overall Study||82
5340706|NCT00296374|13137914|P2|COMPLETED|Overall Study||101
5340707|NCT00296374|13137915|P1|COMPLETED|Overall Study||93
5340708|NCT00296374|13137913|P3|STARTED|Overall Study||111
5340709|NCT00296374|13137914|P2|STARTED|Overall Study||124
5340710|NCT00296374|13137915|P1|STARTED|Overall Study||118
5340711|NCT00296335|13138138|P2|NOT COMPLETED|Overall Study||122
5340712|NCT00296335|13138139|P1|NOT COMPLETED|Overall Study||30
5340713|NCT00296335|13138138|P2|COMPLETED|Overall Study||309
5340714|NCT00296335|13138139|P1|COMPLETED|Overall Study||394
5340715|NCT00296335|13138138|P2|STARTED|Overall Study||431
5340716|NCT00296335|13138139|P1|STARTED|Overall Study||424
5340717|NCT00296322|13138151|P2|NOT COMPLETED|Overall Study||79
5340718|NCT00296322|13138152|P1|NOT COMPLETED|Overall Study||21
5340719|NCT00296322|13138151|P2|COMPLETED|Overall Study||184
5340720|NCT00296322|13138152|P1|COMPLETED|Overall Study||237
5340721|NCT00296322|13138151|P2|STARTED|Overall Study||263
5340722|NCT00296322|13138152|P1|STARTED|Overall Study||258
5340723|NCT00296296|13138164|P2|NOT COMPLETED|Overall Study||13
5340724|NCT00296296|13138165|P1|NOT COMPLETED|Overall Study||2
5340725|NCT00296296|13138164|P2|COMPLETED|Overall Study||5
5340726|NCT00296296|13138165|P1|COMPLETED|Overall Study||9
5340727|NCT00296296|13138164|P2|STARTED|Overall Study||18
5340728|NCT00296296|13138165|P1|STARTED|Overall Study||11
5340729|NCT00296244|13138179|P2|NOT COMPLETED|Overall Study||1
5340730|NCT00296244|13138180|P1|NOT COMPLETED|Overall Study||0
5340731|NCT00296244|13138179|P2|COMPLETED|Overall Study||19
5340732|NCT00296244|13138180|P1|COMPLETED|Overall Study||20
5340733|NCT00296244|13138179|P2|STARTED|Overall Study||20
5340734|NCT00296244|13138180|P1|STARTED|Overall Study||20
5340735|NCT00296231|13138196|P1|NOT COMPLETED|Overall Study||0
5340736|NCT00296231|13138196|P1|COMPLETED|Overall Study||14
5340737|NCT00296231|13138196|P1|STARTED|Overall Study||14
5340738|NCT00296192|13138206|P5|NOT COMPLETED|Overall Study||0
5340739|NCT00296192|13138207|P4|NOT COMPLETED|Overall Study||0
5340740|NCT00296192|13138208|P3|NOT COMPLETED|Overall Study||0
5340741|NCT00296192|13138209|P2|NOT COMPLETED|Overall Study||0
5340742|NCT00296192|13138210|P1|NOT COMPLETED|Overall Study||0
5340743|NCT00296192|13138206|P5|COMPLETED|Overall Study||16
5340744|NCT00296192|13138207|P4|COMPLETED|Overall Study||17
5340745|NCT00296192|13138208|P3|COMPLETED|Overall Study||16
5340746|NCT00296192|13138209|P2|COMPLETED|Overall Study||16
5340747|NCT00296192|13138210|P1|COMPLETED|Overall Study||17
5340748|NCT00296192|13138206|P5|STARTED|Overall Study||16
5340749|NCT00296192|13138207|P4|STARTED|Overall Study||17
5340750|NCT00296192|13138208|P3|STARTED|Overall Study||16
5340751|NCT00296192|13138209|P2|STARTED|Overall Study||16
5340752|NCT00296192|13138210|P1|STARTED|Overall Study||17
5340753|NCT00296140|13138244|P2|NOT COMPLETED|Overall Study||0
5340754|NCT00296140|13138245|P1|NOT COMPLETED|Overall Study||3
5340755|NCT00296140|13138244|P2|COMPLETED|Overall Study||33
5340756|NCT00296140|13138245|P1|COMPLETED|Overall Study||30
5340757|NCT00296140|13138244|P2|STARTED|Overall Study||33
5340758|NCT00296140|13138245|P1|STARTED|Overall Study||33
5340759|NCT00296036|13138257|P6|NOT COMPLETED|Overall Study||4
5340760|NCT00296036|13138258|P5|NOT COMPLETED|Overall Study||2
5340761|NCT00296036|13138259|P4|NOT COMPLETED|Overall Study||1
5340762|NCT00296036|13138260|P3|NOT COMPLETED|Overall Study||2
5340763|NCT00296036|13138261|P2|NOT COMPLETED|Overall Study||0
5340764|NCT00296036|13138262|P1|NOT COMPLETED|Overall Study||1
5340765|NCT00296036|13138257|P6|COMPLETED|Overall Study||28
5340766|NCT00296036|13138258|P5|COMPLETED|Overall Study||31
5340767|NCT00296036|13138259|P4|COMPLETED|Overall Study||16
5340768|NCT00296036|13138260|P3|COMPLETED|Overall Study||16
5340769|NCT00296036|13138261|P2|COMPLETED|Overall Study||18
5340770|NCT00296036|13138262|P1|COMPLETED|Overall Study||18
5340771|NCT00296036|13138257|P6|STARTED|Overall Study||32
5340772|NCT00296036|13138258|P5|STARTED|Overall Study||33
5340773|NCT00296036|13138259|P4|STARTED|Overall Study||17
5340774|NCT00296036|13138260|P3|STARTED|Overall Study||18
5340775|NCT00296036|13138261|P2|STARTED|Overall Study||18
5340776|NCT00296036|13138262|P1|STARTED|Overall Study||19
5340777|NCT00295932|13138299|P11|NOT COMPLETED|Overall Study||1
5340778|NCT00295932|13138300|P10|NOT COMPLETED|Overall Study||0
5340779|NCT00295932|13138301|P9|NOT COMPLETED|Overall Study||0
5340780|NCT00295932|13138302|P8|NOT COMPLETED|Overall Study||0
5340781|NCT00295932|13138303|P7|NOT COMPLETED|Overall Study||0
5340782|NCT00295932|13138304|P6|NOT COMPLETED|Overall Study||0
5340783|NCT00295932|13138305|P5|NOT COMPLETED|Overall Study||0
5340784|NCT00295932|13138306|P4|NOT COMPLETED|Overall Study||0
5340785|NCT00295932|13138307|P3|NOT COMPLETED|Overall Study||0
5340786|NCT00295932|13138308|P2|NOT COMPLETED|Overall Study||0
5340787|NCT00295932|13138309|P1|NOT COMPLETED|Overall Study||0
5340788|NCT00295932|13138299|P11|COMPLETED|Overall Study||12
5340789|NCT00295932|13138300|P10|COMPLETED|Overall Study||12
5340790|NCT00295932|13138301|P9|COMPLETED|Overall Study||10
5340791|NCT00295932|13138302|P8|COMPLETED|Overall Study||4
5340792|NCT00295932|13138303|P7|COMPLETED|Overall Study||3
5340793|NCT00295932|13138304|P6|COMPLETED|Overall Study||18
5340794|NCT00295932|13138305|P5|COMPLETED|Overall Study||2
5340795|NCT00295932|13138306|P4|COMPLETED|Overall Study||4
5340796|NCT00295932|13138307|P3|COMPLETED|Overall Study||3
5340797|NCT00295932|13138308|P2|COMPLETED|Overall Study||6
5340798|NCT00295932|13138309|P1|COMPLETED|Overall Study||4
5340799|NCT00295932|13138299|P11|STARTED|Overall Study||13
5340800|NCT00295932|13138300|P10|STARTED|Overall Study||12
5340801|NCT00295932|13138301|P9|STARTED|Overall Study||10
5340802|NCT00295932|13138302|P8|STARTED|Overall Study||4
5340803|NCT00295932|13138303|P7|STARTED|Overall Study||3
5340804|NCT00295932|13138304|P6|STARTED|Overall Study||18
5340805|NCT00295932|13138305|P5|STARTED|Overall Study||2
5340806|NCT00295932|13138306|P4|STARTED|Overall Study||4
5340807|NCT00295932|13138307|P3|STARTED|Overall Study||3
5340808|NCT00295932|13138308|P2|STARTED|Overall Study||6
5340809|NCT00295932|13138309|P1|STARTED|Overall Study||4
5340810|NCT00295880|13138343|P1|NOT COMPLETED|Overall Study||2
5340811|NCT00295880|13138343|P1|COMPLETED|Overall Study||10
5340812|NCT00295880|13138343|P1|STARTED|Overall Study||12
5340813|NCT00295867|13138354|P1|NOT COMPLETED|Overall Study||11
5340814|NCT00295867|13138354|P1|COMPLETED|Overall Study||34
5340815|NCT00295867|13138354|P1|STARTED|Overall Study||45
5340816|NCT00295854|13138363|P3|NOT COMPLETED|Overall Study||15
5340817|NCT00295854|13138364|P2|NOT COMPLETED|Overall Study||21
5340818|NCT00295854|13138365|P1|NOT COMPLETED|Overall Study||18
5340819|NCT00295854|13138363|P3|COMPLETED|Overall Study||87
5340820|NCT00295854|13138364|P2|COMPLETED|Overall Study||87
5340821|NCT00295854|13138365|P1|COMPLETED|Overall Study||77
5340822|NCT00295854|13138363|P3|ITT Population (N=296)|Overall Study||99
5340823|NCT00295854|13138364|P2|ITT Population (N=296)|Overall Study||105
5340824|NCT00295854|13138365|P1|ITT Population (N=296)|Overall Study||92
5340825|NCT00295854|13138363|P3|Safety Population (N=304)|Overall Study||101
5340826|NCT00295854|13138364|P2|Safety Population (N=304)|Overall Study||108
5340827|NCT00295854|13138365|P1|Safety Population (N=304)|Overall Study||95
5340828|NCT00295854|13138363|P3|STARTED|Overall Study||102
5340829|NCT00295854|13138364|P2|STARTED|Overall Study||108
5340830|NCT00295854|13138365|P1|STARTED|Overall Study||95
5340831|NCT00295750|13138379|P3|NOT COMPLETED|Overall Study||32
5340832|NCT00295750|13138380|P2|NOT COMPLETED|Overall Study||41
5340833|NCT00295750|13138381|P1|NOT COMPLETED|Overall Study||43
5340834|NCT00295750|13138379|P3|COMPLETED|Overall Study||172
5340835|NCT00295750|13138380|P2|COMPLETED|Overall Study||169
5340836|NCT00295750|13138381|P1|COMPLETED|Overall Study||163
5340837|NCT00295750|13138379|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
5340838|NCT00295750|13138380|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
5340839|NCT00295750|13138381|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
5340840|NCT00295750|13138379|P3|STARTED|Overall Study|randomized|204
5340841|NCT00295750|13138380|P2|STARTED|Overall Study|randomized|210
5340842|NCT00295750|13138381|P1|STARTED|Overall Study|randomized|206
5340843|NCT00295633|13138416|P3|NOT COMPLETED|Overall Study||76
5340844|NCT00295633|13138417|P2|NOT COMPLETED|Overall Study||67
5340845|NCT00295633|13138418|P1|NOT COMPLETED|Overall Study||62
5340846|NCT00295633|13138416|P3|COMPLETED|Overall Study||108
5340847|NCT00295633|13138417|P2|COMPLETED|Overall Study||119
5340848|NCT00295633|13138418|P1|COMPLETED|Overall Study||133
5340849|NCT00295633|13138416|P3|Completed Study Without Being Rescued|Overall Study||51
5340850|NCT00295633|13138417|P2|Completed Study Without Being Rescued|Overall Study||82
5340851|NCT00295633|13138418|P1|Completed Study Without Being Rescued|Overall Study||88
5340852|NCT00295633|13138416|P3|STARTED|Overall Study||184
5340853|NCT00295633|13138417|P2|STARTED|Overall Study||186
5340854|NCT00295633|13138418|P1|STARTED|Overall Study||195
5340855|NCT00295620|13138437|P2|NOT COMPLETED|Overall Study||896
5340856|NCT00295620|13138438|P1|NOT COMPLETED|Overall Study||872
5340857|NCT00295620|13138437|P2|COMPLETED|Overall Study||842
5340858|NCT00295620|13138438|P1|COMPLETED|Overall Study||860
5340859|NCT00295620|13138437|P2|Safety Analysis Set|Overall Study||1710
5340860|NCT00295620|13138438|P1|Safety Analysis Set|Overall Study||1705
5340861|NCT00295620|13138437|P2|STARTED|Overall Study||1738
5340862|NCT00295620|13138438|P1|STARTED|Overall Study||1732
5340863|NCT00295503|13138452|P1|NOT COMPLETED|Overall Study||0
5340864|NCT00295503|13138452|P1|COMPLETED|Overall Study||53
5340865|NCT00295503|13138452|P1|STARTED|Overall Study||53
5340866|NCT00295490|13138462|P4|NOT COMPLETED|Overall Study||5
5340867|NCT00295490|13138463|P3|NOT COMPLETED|Overall Study||4
5340868|NCT00295490|13138464|P2|NOT COMPLETED|Overall Study||4
5340869|NCT00295490|13138465|P1|NOT COMPLETED|Overall Study||1
5340870|NCT00295490|13138462|P4|COMPLETED|Overall Study||12
5340871|NCT00295490|13138463|P3|COMPLETED|Overall Study||12
5340872|NCT00295490|13138464|P2|COMPLETED|Overall Study||15
5340873|NCT00295490|13138465|P1|COMPLETED|Overall Study||14
5340874|NCT00295490|13138462|P4|STARTED|Overall Study||17
5340875|NCT00295490|13138463|P3|STARTED|Overall Study||16
5340876|NCT00295490|13138464|P2|STARTED|Overall Study||19
5340877|NCT00295490|13138465|P1|STARTED|Overall Study||15
5340878|NCT00295061|13138505|P2|NOT COMPLETED|Overall Study||0
5340879|NCT00295061|13138506|P1|NOT COMPLETED|Overall Study||0
5340880|NCT00295061|13138505|P2|COMPLETED|Overall Study||12
5340881|NCT00295061|13138506|P1|COMPLETED|Overall Study||12
5340882|NCT00295061|13138505|P2|STARTED|Overall Study||12
5340883|NCT00295061|13138506|P1|STARTED|Overall Study||12
5340884|NCT00295022|13138515|P3|NOT COMPLETED|Overall Study||5
5340885|NCT00295022|13138516|P2|NOT COMPLETED|Overall Study||1
5340886|NCT00295022|13138517|P1|NOT COMPLETED|Overall Study||1
5340887|NCT00295022|13138515|P3|COMPLETED|Overall Study||151
5340888|NCT00295022|13138516|P2|COMPLETED|Overall Study||156
5340889|NCT00295022|13138517|P1|COMPLETED|Overall Study||104
5340890|NCT00295022|13138515|P3|STARTED|Overall Study||156
5340891|NCT00295022|13138516|P2|STARTED|Overall Study||157
5340892|NCT00295022|13138517|P1|STARTED|Overall Study||105
5340893|NCT00295009|13138606|P6|NOT COMPLETED|Overall Study||269
5340894|NCT00295009|13138607|P5|NOT COMPLETED|Overall Study||58
5340895|NCT00295009|13138608|P4|NOT COMPLETED|Overall Study||25
5340896|NCT00295009|13138609|P3|NOT COMPLETED|Overall Study||12
5340897|NCT00295009|13138610|P2|NOT COMPLETED|Overall Study||49
5340898|NCT00295009|13138611|P1|NOT COMPLETED|Overall Study||41
5340899|NCT00295009|13138606|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
5340900|NCT00295009|13138607|P5|COMPLETED|Overall Study|Completed 60 month visit|116
5340901|NCT00295009|13138608|P4|COMPLETED|Overall Study|Completed 60 month visit|57
5340902|NCT00295009|13138609|P3|COMPLETED|Overall Study|Completed 60 month visit|39
5340903|NCT00295009|13138610|P2|COMPLETED|Overall Study|Completed 60 month visit|134
5340904|NCT00295009|13138611|P1|COMPLETED|Overall Study|Completed 60 month visit|52
5340905|NCT00295009|13138606|P6|Completed 24 Month Analysis|Overall Study||198
5340906|NCT00295009|13138607|P5|Completed 24 Month Analysis|Overall Study||133
5340907|NCT00295009|13138608|P4|Completed 24 Month Analysis|Overall Study||60
5340908|NCT00295009|13138609|P3|Completed 24 Month Analysis|Overall Study||45
5340909|NCT00295009|13138610|P2|Completed 24 Month Analysis|Overall Study||148
5340910|NCT00295009|13138611|P1|Completed 24 Month Analysis|Overall Study||71
5340911|NCT00295009|13138606|P6|Treated|Overall Study||259
5340912|NCT00295009|13138607|P5|Treated|Overall Study||165
5340913|NCT00295009|13138608|P4|Treated|Overall Study||72
5340914|NCT00295009|13138609|P3|Treated|Overall Study||50
5340915|NCT00295009|13138610|P2|Treated|Overall Study||162
5340916|NCT00295009|13138611|P1|Treated|Overall Study||80
5340917|NCT00295009|13138606|P6|STARTED|Overall Study||269
5340918|NCT00295009|13138607|P5|STARTED|Overall Study||174
5340919|NCT00295009|13138608|P4|STARTED|Overall Study||82
5340920|NCT00295009|13138609|P3|STARTED|Overall Study||51
5340921|NCT00295009|13138610|P2|STARTED|Overall Study||183
5340922|NCT00295009|13138611|P1|STARTED|Overall Study||93
5340923|NCT00294762|13138633|P2|NOT COMPLETED|Overall Study||3
5340924|NCT00294762|13138634|P1|NOT COMPLETED|Overall Study||3
5340925|NCT00294762|13138633|P2|COMPLETED|Overall Study||68
5340926|NCT00294762|13138634|P1|COMPLETED|Overall Study||69
5340927|NCT00294762|13138633|P2|STARTED|Overall Study||71
5340928|NCT00294762|13138634|P1|STARTED|Overall Study||72
5340929|NCT00294723|13138653|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
5340930|NCT00294723|13138654|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
5340931|NCT00294723|13138655|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
5340932|NCT00294723|13138653|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
5340933|NCT00294723|13138654|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
5340934|NCT00294723|13138655|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
5340935|NCT00294723|13138653|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
5340936|NCT00294723|13138654|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
5340937|NCT00294723|13138655|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
5340938|NCT00294723|13138653|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
5340939|NCT00294723|13138654|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
5340940|NCT00294723|13138655|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
5340941|NCT00294723|13138653|P3|COMPLETED|Open-Label Extension 52 Weeks||97
5340942|NCT00294723|13138654|P2|COMPLETED|Open-Label Extension 52 Weeks||110
5340943|NCT00294723|13138655|P1|COMPLETED|Open-Label Extension 52 Weeks||114
5340944|NCT00294723|13138653|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
5340945|NCT00294723|13138654|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
5340946|NCT00294723|13138655|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
5340947|NCT00294723|13138653|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
5340948|NCT00294723|13138654|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
5340949|NCT00294723|13138655|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
5340950|NCT00294723|13138653|P3|COMPLETED|Double-Blind Period 52 Weeks||152
5340951|NCT00294723|13138654|P2|COMPLETED|Double-Blind Period 52 Weeks||162
5340952|NCT00294723|13138655|P1|COMPLETED|Double-Blind Period 52 Weeks||173
5340953|NCT00294723|13138653|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
5340954|NCT00294723|13138654|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
5340955|NCT00294723|13138655|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
5340956|NCT00294723|13138653|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
5340957|NCT00294723|13138654|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
5340958|NCT00294723|13138655|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
5340959|NCT00294684|13138716|P2|NOT COMPLETED|Overall Study||8
5340960|NCT00294684|13138717|P1|NOT COMPLETED|Overall Study||5
5340961|NCT00294684|13138716|P2|COMPLETED|Overall Study||62
5340962|NCT00294684|13138717|P1|COMPLETED|Overall Study||65
5340963|NCT00294684|13138716|P2|STARTED|Overall Study||70
5340964|NCT00294684|13138717|P1|STARTED|Overall Study||70
5340965|NCT00294671|13138757|P2|NOT COMPLETED|Overall Study||40
5340966|NCT00294671|13138758|P1|NOT COMPLETED|Overall Study||27
5340967|NCT00294671|13138757|P2|COMPLETED|Overall Study||26
5340968|NCT00294671|13138758|P1|COMPLETED|Overall Study||37
5340969|NCT00294671|13138757|P2|STARTED|Overall Study||66
5340970|NCT00294671|13138758|P1|STARTED|Overall Study||64
5340971|NCT00294658|13138774|P2|NOT COMPLETED|Overall Study||9
5340972|NCT00294658|13138775|P1|NOT COMPLETED|Overall Study||6
5340973|NCT00294658|13138774|P2|COMPLETED|Overall Study||51
5340974|NCT00294658|13138775|P1|COMPLETED|Overall Study||60
5340975|NCT00294658|13138774|P2|STARTED|Overall Study||60
5340976|NCT00294658|13138775|P1|STARTED|Overall Study||66
5340977|NCT00294645|13138839|P2|NOT COMPLETED|Overall Study||92
5340978|NCT00294645|13138840|P1|NOT COMPLETED|Overall Study||48
5340979|NCT00294645|13138839|P2|COMPLETED|Overall Study||510
5340980|NCT00294645|13138840|P1|COMPLETED|Overall Study||247
5340981|NCT00294645|13138839|P2|STARTED|Overall Study||602
5340982|NCT00294645|13138840|P1|STARTED|Overall Study||295
5340983|NCT00294632|13138874|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
5340984|NCT00294632|13138875|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
5340985|NCT00294632|13138874|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
5340986|NCT00294632|13138875|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
5340987|NCT00294632|13138874|P2|STARTED|Phase II: 20 mg Lenalidomide||38
5340988|NCT00294632|13138875|P1|STARTED|Phase II: 20 mg Lenalidomide||6
5340989|NCT00294632|13138874|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
5340990|NCT00294632|13138875|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
5340991|NCT00294632|13138874|P2|COMPLETED|Phase I Dose Escalation Period||0
5340992|NCT00294632|13138875|P1|COMPLETED|Phase I Dose Escalation Period||14
5340993|NCT00294632|13138874|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
5340994|NCT00294632|13138875|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
5340995|NCT00294632|13138874|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
5340996|NCT00294632|13138875|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
5340997|NCT00294632|13138874|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
5340998|NCT00294632|13138875|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
5340999|NCT00294632|13138874|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
5341000|NCT00294632|13138875|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
5341001|NCT00294632|13138874|P2|STARTED|Phase I Dose Escalation Period||0
5341002|NCT00294632|13138875|P1|STARTED|Phase I Dose Escalation Period||14
5341003|NCT00294554|13138884|P2|NOT COMPLETED|Overall Study||2
5341004|NCT00294554|13138885|P1|NOT COMPLETED|Overall Study||0
5341005|NCT00294554|13138884|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
5341006|NCT00294554|13138885|P1|COMPLETED|Overall Study||10
5341007|NCT00294554|13138884|P2|STARTED|Overall Study||10
5341008|NCT00294554|13138885|P1|STARTED|Overall Study||10
5341009|NCT00294515|13138895|P2|NOT COMPLETED|Overall Study||28
5341010|NCT00294515|13138896|P1|NOT COMPLETED|Overall Study||34
5341011|NCT00294515|13138895|P2|COMPLETED|Overall Study||132
5341012|NCT00294515|13138896|P1|COMPLETED|Overall Study||132
5341013|NCT00294515|13138895|P2|STARTED|Overall Study|Randomized|160
5341014|NCT00294515|13138896|P1|STARTED|Overall Study|Randomized|166
5341015|NCT00294398|13138912|P2|NOT COMPLETED|Overall Study||26
5341016|NCT00294398|13138913|P1|NOT COMPLETED|Overall Study||21
5341017|NCT00294398|13138912|P2|COMPLETED|Overall Study||48
5341018|NCT00294398|13138913|P1|COMPLETED|Overall Study||57
5341019|NCT00294398|13138912|P2|STARTED|Overall Study||74
5341020|NCT00294398|13138913|P1|STARTED|Overall Study||78
5341021|NCT00294060|13138921|P1|NOT COMPLETED|Overall Study||1173
5341022|NCT00294060|13138921|P1|COMPLETED|Overall Study||840
5341023|NCT00294060|13138921|P1|STARTED|Overall Study||2013
5341024|NCT00294047|13138929|P2|NOT COMPLETED|Month 84||989
5341025|NCT00294047|13138930|P1|NOT COMPLETED|Month 84||973
5341026|NCT00294047|13138929|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
5341027|NCT00294047|13138930|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
5341028|NCT00294047|13138929|P2|STARTED|Month 84||2870
5341029|NCT00294047|13138930|P1|STARTED|Month 84||2877
5341030|NCT00294047|13138929|P2|NOT COMPLETED|Month 48||433
5341031|NCT00294047|13138930|P1|NOT COMPLETED|Month 48||425
5341032|NCT00294047|13138929|P2|COMPLETED|Month 48||2438
5341033|NCT00294047|13138930|P1|COMPLETED|Month 48||2456
5341034|NCT00294047|13138929|P2|Participated up to Month 48|Month 48||2281
5341035|NCT00294047|13138930|P1|Participated up to Month 48|Month 48||2305
5341036|NCT00294047|13138929|P2|STARTED|Month 48||2871
5341037|NCT00294047|13138930|P1|STARTED|Month 48||2881
5341038|NCT00293813|13139035|P3|NOT COMPLETED|Overall Study||8
5341039|NCT00293813|13139036|P2|NOT COMPLETED|Overall Study||9
5341040|NCT00293813|13139037|P1|NOT COMPLETED|Overall Study||13
5341041|NCT00293813|13139035|P3|COMPLETED|Overall Study||74
5341042|NCT00293813|13139036|P2|COMPLETED|Overall Study||74
5341043|NCT00293813|13139037|P1|COMPLETED|Overall Study||69
5341044|NCT00293813|13139035|P3|STARTED|Overall Study||82
5341045|NCT00293813|13139036|P2|STARTED|Overall Study||83
5341046|NCT00293813|13139037|P1|STARTED|Overall Study||82
5341047|NCT00293722|13139048|P1|NOT COMPLETED|Overall Study||427
5341048|NCT00293722|13139048|P1|COMPLETED|Overall Study||864
5341049|NCT00293722|13139048|P1|STARTED|Overall Study||1291
5341050|NCT00293709|13139062|P1|NOT COMPLETED|Overall Study||47
5341051|NCT00293709|13139062|P1|COMPLETED|Overall Study||102
5341052|NCT00293709|13139062|P1|STARTED|Overall Study||149
5341053|NCT00293579|13139076|P1|NOT COMPLETED|Overall Study||1
5341054|NCT00293579|13139076|P1|COMPLETED|Overall Study||4
5341055|NCT00293579|13139076|P1|STARTED|Overall Study||5
5341056|NCT00293540|13139085|P2|NOT COMPLETED|Overall Study||8
5341057|NCT00293540|13139086|P1|NOT COMPLETED|Overall Study||7
5341058|NCT00293540|13139085|P2|COMPLETED|Overall Study||119
5341059|NCT00293540|13139086|P1|COMPLETED|Overall Study||115
5341060|NCT00293540|13139085|P2|STARTED|Overall Study||127
5341061|NCT00293540|13139086|P1|STARTED|Overall Study||122
5341062|NCT00293462|13139095|P3|NOT COMPLETED|Overall Study||10
5341063|NCT00293462|13139096|P2|NOT COMPLETED|Overall Study||8
5341064|NCT00293462|13139097|P1|NOT COMPLETED|Overall Study||7
5341065|NCT00293462|13139095|P3|COMPLETED|Overall Study||21
5341066|NCT00293462|13139096|P2|COMPLETED|Overall Study||21
5341067|NCT00293462|13139097|P1|COMPLETED|Overall Study||24
5341068|NCT00293462|13139095|P3|STARTED|Overall Study||31
5341069|NCT00293462|13139096|P2|STARTED|Overall Study||29
5341070|NCT00293462|13139097|P1|STARTED|Overall Study||31
5341071|NCT00293397|13139116|P1|NOT COMPLETED|Overall Study||2
5341072|NCT00293397|13139116|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
5341073|NCT00293397|13139116|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
5341074|NCT00293397|13139116|P1|STARTED|Overall Study||20
5341075|NCT00293384|13139126|P1|NOT COMPLETED|Overall Study||5
5341076|NCT00293384|13139126|P1|COMPLETED|Overall Study||35
5341077|NCT00293384|13139126|P1|STARTED|Overall Study||40
5341078|NCT00293293|13139135|P2|NOT COMPLETED|Overall Study||2
5341079|NCT00293293|13139136|P1|NOT COMPLETED|Overall Study||2
5341080|NCT00293293|13139135|P2|COMPLETED|Overall Study||21
5341081|NCT00293293|13139136|P1|COMPLETED|Overall Study||18
5341082|NCT00293293|13139135|P2|STARTED|Overall Study||23
5341083|NCT00293293|13139136|P1|STARTED|Overall Study||20
5341084|NCT00293267|13139164|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
5341085|NCT00293267|13139165|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
5341086|NCT00293267|13139164|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
5341087|NCT00293267|13139165|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
5341088|NCT00293267|13139164|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
5341089|NCT00293267|13139165|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
5341090|NCT00293267|13139164|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
5341091|NCT00293267|13139165|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
5341092|NCT00293267|13139164|P2|COMPLETED|Extension - Open-Label Week 157-240||26
5341093|NCT00293267|13139165|P1|COMPLETED|Extension - Open-Label Week 157-240||111
5341094|NCT00293267|13139164|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
5341095|NCT00293267|13139165|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
5341096|NCT00293267|13139164|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
5341097|NCT00293267|13139165|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
5341098|NCT00293267|13139164|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
5341099|NCT00293267|13139165|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
5341100|NCT00293267|13139164|P2|STARTED|Extension - Double-Blind Week 49-156||50
5341101|NCT00293267|13139165|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
5341102|NCT00293267|13139164|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
5341103|NCT00293267|13139165|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
5341104|NCT00293267|13139164|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
5341105|NCT00293267|13139165|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
5341106|NCT00293267|13139164|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
5341107|NCT00293267|13139165|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
5341108|NCT00293267|13139164|P2|Treated|Primary Study - Double-Blind Week 0-48||118
5341109|NCT00293267|13139165|P1|Treated|Primary Study - Double-Blind Week 0-48||232
5341110|NCT00293267|13139164|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
5341111|NCT00293267|13139165|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
5341112|NCT00293254|13139205|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
5341113|NCT00293254|13139206|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
5341114|NCT00293254|13139205|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
5341115|NCT00293254|13139206|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
5341116|NCT00293254|13139205|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
5341117|NCT00293254|13139206|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
5341118|NCT00293254|13139205|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
5341119|NCT00293254|13139206|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
5341120|NCT00293254|13139205|P2|COMPLETED|Extension - Open-Label Week 157-240||18
5341121|NCT00293254|13139206|P1|COMPLETED|Extension - Open-Label Week 157-240||110
5341122|NCT00293254|13139205|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
5341123|NCT00293254|13139206|P1|STARTED|Extension - Open-Label Week 157-240||120
5341124|NCT00293254|13139205|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
5341125|NCT00293254|13139206|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
5341126|NCT00293254|13139205|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
5341127|NCT00293254|13139206|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
5341128|NCT00293254|13139205|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
5341129|NCT00293254|13139206|P1|STARTED|Extension - Double-Blind Week 49-156||177
5341130|NCT00293254|13139205|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
5341131|NCT00293254|13139206|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
5341132|NCT00293254|13139205|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
5341133|NCT00293254|13139206|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
5341134|NCT00293254|13139205|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
5341135|NCT00293254|13139206|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
5341136|NCT00293254|13139205|P2|Treated|Primary Study - Double-Blind Week 0-48||119
5341137|NCT00293254|13139206|P1|Treated|Primary Study - Double-Blind Week 0-48||230
5341138|NCT00293254|13139205|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
5341139|NCT00293254|13139206|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
5341140|NCT00293241|13139246|P2|NOT COMPLETED|Overall Study||41
5341141|NCT00293241|13139247|P1|NOT COMPLETED|Overall Study||36
5341142|NCT00293241|13139246|P2|COMPLETED|Overall Study||265
5341143|NCT00293241|13139247|P1|COMPLETED|Overall Study||263
5341144|NCT00293241|13139246|P2|STARTED|Overall Study||306
5341145|NCT00293241|13139247|P1|STARTED|Overall Study||299
5341146|NCT00293059|13139291|P2|NOT COMPLETED|Overall Study||19
5341147|NCT00293059|13139292|P1|NOT COMPLETED|Overall Study||35
5341148|NCT00293059|13139291|P2|COMPLETED|Overall Study||51
5341149|NCT00293059|13139292|P1|COMPLETED|Overall Study||85
5341231|NCT00292227|13139627|P1|STARTED|Cross-over Period 2 (Day 39)||65
5341150|NCT00293059|13139291|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
5341151|NCT00293059|13139292|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
5341152|NCT00293059|13139291|P2|Cycle 3/Treatment Day 84|Overall Study||55
5341153|NCT00293059|13139292|P1|Cycle 3/Treatment Day 84|Overall Study||100
5341154|NCT00293059|13139291|P2|Cycle 1/Treatment Day 28|Overall Study||64
5341155|NCT00293059|13139292|P1|Cycle 1/Treatment Day 28|Overall Study||115
5341156|NCT00293059|13139291|P2|Subjects Received Treatment|Overall Study||66
5341157|NCT00293059|13139292|P1|Subjects Received Treatment|Overall Study||119
5341158|NCT00293059|13139291|P2|STARTED|Overall Study||70
5341159|NCT00293059|13139292|P1|STARTED|Overall Study||120
5341160|NCT00293033|13139404|P1|NOT COMPLETED|Double-blind Treatment Period||12
5341161|NCT00293033|13139404|P1|COMPLETED|Double-blind Treatment Period||70
5341162|NCT00293033|13139404|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
5341163|NCT00293033|13139404|P1|NOT COMPLETED|Open-label Titration Period||69
5341164|NCT00293033|13139404|P1|COMPLETED|Open-label Titration Period||82
5341165|NCT00293033|13139404|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
5341166|NCT00293020|13139507|P1|NOT COMPLETED|Overall Study||162
5341167|NCT00293020|13139507|P1|COMPLETED|Overall Study||82
5341168|NCT00293020|13139507|P1|STARTED|Overall Study||244
5341169|NCT00292981|13139511|P1|NOT COMPLETED|Overall Study||39
5341170|NCT00292981|13139511|P1|COMPLETED|Overall Study||18
5341171|NCT00292981|13139511|P1|STARTED|Overall Study||57
5341172|NCT00292942|13139522|P4|NOT COMPLETED|Overall Study||1
5341173|NCT00292942|13139523|P3|NOT COMPLETED|Overall Study||1
5341174|NCT00292942|13139524|P2|NOT COMPLETED|Overall Study||0
5341175|NCT00292942|13139525|P1|NOT COMPLETED|Overall Study||0
5341176|NCT00292942|13139522|P4|COMPLETED|Overall Study||6
5341177|NCT00292942|13139523|P3|COMPLETED|Overall Study||6
5341178|NCT00292942|13139524|P2|COMPLETED|Overall Study||6
5341179|NCT00292942|13139525|P1|COMPLETED|Overall Study||6
5341180|NCT00292942|13139522|P4|STARTED|Overall Study||7
5341181|NCT00292942|13139523|P3|STARTED|Overall Study||7
5341182|NCT00292942|13139524|P2|STARTED|Overall Study||6
5341183|NCT00292942|13139525|P1|STARTED|Overall Study||6
5341184|NCT00292591|13139559|P3|NOT COMPLETED|Overall Study||58
5341185|NCT00292591|13139560|P2|NOT COMPLETED|Overall Study||56
5341186|NCT00292591|13139561|P1|NOT COMPLETED|Overall Study||64
5341187|NCT00292591|13139559|P3|COMPLETED|Overall Study||110
5341188|NCT00292591|13139560|P2|COMPLETED|Overall Study||111
5341189|NCT00292591|13139561|P1|COMPLETED|Overall Study||102
5341190|NCT00292591|13139559|P3|STARTED|Overall Study||168
5341191|NCT00292591|13139560|P2|STARTED|Overall Study||167
5341192|NCT00292591|13139561|P1|STARTED|Overall Study||166
5341193|NCT00292461|13139571|P2|NOT COMPLETED|Overall Study||6
5341194|NCT00292461|13139572|P1|NOT COMPLETED|Overall Study||10
5341195|NCT00292461|13139571|P2|COMPLETED|Overall Study||24
5341196|NCT00292461|13139572|P1|COMPLETED|Overall Study||24
5341197|NCT00292461|13139571|P2|STARTED|Overall Study||30
5341198|NCT00292461|13139572|P1|STARTED|Overall Study||34
5341199|NCT00292370|13139587|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
5341200|NCT00292370|13139588|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
5341201|NCT00292370|13139589|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
5341202|NCT00292370|13139587|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
5341203|NCT00292370|13139588|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
5341204|NCT00292370|13139589|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
5341205|NCT00292370|13139587|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
5341206|NCT00292370|13139588|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
5341207|NCT00292370|13139589|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
5341208|NCT00292370|13139587|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
5341209|NCT00292370|13139588|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
5341210|NCT00292370|13139589|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
5341211|NCT00292370|13139587|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
5341212|NCT00292370|13139588|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
5341213|NCT00292370|13139589|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
5341214|NCT00292370|13139587|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
5341215|NCT00292370|13139588|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
5341216|NCT00292370|13139589|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
5341217|NCT00292318|13139614|P2|NOT COMPLETED|Overall Study||1
5341218|NCT00292318|13139615|P1|NOT COMPLETED|Overall Study||2
5341219|NCT00292318|13139614|P2|COMPLETED|Overall Study||2
5341220|NCT00292318|13139615|P1|COMPLETED|Overall Study||2
5341221|NCT00292318|13139614|P2|STARTED|Overall Study||3
5341222|NCT00292318|13139615|P1|STARTED|Overall Study||4
5341223|NCT00292227|13139625|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
5341224|NCT00292227|13139626|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
5341225|NCT00292227|13139627|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
5341226|NCT00292227|13139625|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
5341227|NCT00292227|13139626|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
5341228|NCT00292227|13139627|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
5341229|NCT00292227|13139625|P3|STARTED|Cross-over Period 2 (Day 39)||30
5341230|NCT00292227|13139626|P2|STARTED|Cross-over Period 2 (Day 39)||31
5341232|NCT00292227|13139625|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
5341233|NCT00292227|13139626|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
5341234|NCT00292227|13139627|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
5341235|NCT00292227|13139625|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
5341236|NCT00292227|13139626|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
5341237|NCT00292227|13139627|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
5341238|NCT00292227|13139625|P3|STARTED|Cross-over Period 1 (Day 32)||30
5341239|NCT00292227|13139626|P2|STARTED|Cross-over Period 1 (Day 32)||31
5341240|NCT00292227|13139627|P1|STARTED|Cross-over Period 1 (Day 32)||65
5341241|NCT00292227|13139625|P3|NOT COMPLETED|Patch Period||3
5341242|NCT00292227|13139626|P2|NOT COMPLETED|Patch Period||0
5341243|NCT00292227|13139627|P1|NOT COMPLETED|Patch Period||1
5341244|NCT00292227|13139625|P3|COMPLETED|Patch Period||30
5341245|NCT00292227|13139626|P2|COMPLETED|Patch Period||31
5341246|NCT00292227|13139627|P1|COMPLETED|Patch Period||65
5341247|NCT00292227|13139625|P3|STARTED|Patch Period||33
5341248|NCT00292227|13139626|P2|STARTED|Patch Period||31
5341249|NCT00292227|13139627|P1|STARTED|Patch Period||66
5341250|NCT00292188|13139709|P3|NOT COMPLETED|Double-Blind||29
5341251|NCT00292188|13139710|P2|NOT COMPLETED|Double-Blind||31
5341252|NCT00292188|13139711|P1|NOT COMPLETED|Double-Blind||0
5341253|NCT00292188|13139709|P3|COMPLETED|Double-Blind||98
5341254|NCT00292188|13139710|P2|COMPLETED|Double-Blind||96
5341255|NCT00292188|13139711|P1|COMPLETED|Double-Blind||0
5341256|NCT00292188|13139709|P3|STARTED|Double-Blind||127
5341257|NCT00292188|13139710|P2|STARTED|Double-Blind||127
5341258|NCT00292188|13139711|P1|STARTED|Double-Blind||0
5341259|NCT00292188|13139709|P3|NOT COMPLETED|Single-Blind||0
5341260|NCT00292188|13139710|P2|NOT COMPLETED|Single-Blind||0
5341261|NCT00292188|13139711|P1|NOT COMPLETED|Single-Blind||114
5341262|NCT00292188|13139709|P3|COMPLETED|Single-Blind||0
5341263|NCT00292188|13139710|P2|COMPLETED|Single-Blind||0
5341264|NCT00292188|13139711|P1|COMPLETED|Single-Blind||254
5341265|NCT00292188|13139709|P3|Received Treatment|Single-Blind||0
5341266|NCT00292188|13139710|P2|Received Treatment|Single-Blind||0
5341267|NCT00292188|13139711|P1|Received Treatment|Single-Blind||367
5341268|NCT00292188|13139709|P3|STARTED|Single-Blind||0
5341269|NCT00292188|13139710|P2|STARTED|Single-Blind||0
5341270|NCT00292188|13139711|P1|STARTED|Single-Blind||368
5341271|NCT00292162|13139772|P2|NOT COMPLETED|Overall Study||2
5341272|NCT00292162|13139773|P1|NOT COMPLETED|Overall Study||1
5341273|NCT00292162|13139772|P2|COMPLETED|Overall Study||20
5341274|NCT00292162|13139773|P1|COMPLETED|Overall Study||18
5341275|NCT00292162|13139772|P2|STARTED|Overall Study||22
5341276|NCT00292162|13139773|P1|STARTED|Overall Study||19
5341277|NCT00291876|13139789|P1|NOT COMPLETED|Month 246||0
5341278|NCT00291876|13139789|P1|COMPLETED|Month 246||116
5341279|NCT00291876|13139789|P1|STARTED|Month 246||116
5341280|NCT00291876|13139789|P1|NOT COMPLETED|Month 234||0
5341281|NCT00291876|13139789|P1|COMPLETED|Month 234||110
5341282|NCT00291876|13139789|P1|STARTED|Month 234||110
5341283|NCT00291876|13139789|P1|NOT COMPLETED|Month 222||0
5341284|NCT00291876|13139789|P1|COMPLETED|Month 222||114
5341285|NCT00291876|13139789|P1|STARTED|Month 222||114
5341286|NCT00291876|13139789|P1|NOT COMPLETED|Month 210||0
5341287|NCT00291876|13139789|P1|COMPLETED|Month 210||124
5341288|NCT00291876|13139789|P1|STARTED|Month 210||124
5341289|NCT00291876|13139789|P1|NOT COMPLETED|Month 198||0
5341290|NCT00291876|13139789|P1|COMPLETED|Month 198||135
5341291|NCT00291876|13139789|P1|STARTED|Month 198||135
5341292|NCT00291876|13139789|P1|NOT COMPLETED|Month 186||0
5341293|NCT00291876|13139789|P1|COMPLETED|Month 186||129
5341294|NCT00291876|13139789|P1|STARTED|Month 186||129
5341295|NCT00291876|13139789|P1|NOT COMPLETED|Month 174||0
5341296|NCT00291876|13139789|P1|COMPLETED|Month 174||127
5341297|NCT00291876|13139789|P1|STARTED|Month 174||127
5341298|NCT00291876|13139789|P1|NOT COMPLETED|Month 162||0
5341299|NCT00291876|13139789|P1|COMPLETED|Month 162||127
5341300|NCT00291876|13139789|P1|STARTED|Month 162||127
5341301|NCT00291876|13139789|P1|NOT COMPLETED|Month 150||0
5341302|NCT00291876|13139789|P1|COMPLETED|Month 150||117
5341303|NCT00291876|13139789|P1|STARTED|Month 150||117
5341304|NCT00291876|13139789|P1|NOT COMPLETED|Month 138||0
5341305|NCT00291876|13139789|P1|COMPLETED|Month 138||107
5341306|NCT00291876|13139789|P1|STARTED|Month 138||107
5341307|NCT00291694|13139803|P2|NOT COMPLETED|Overall Study||5
5341308|NCT00291694|13139804|P1|NOT COMPLETED|Overall Study||3
5341309|NCT00291694|13139803|P2|COMPLETED|Overall Study||43
5341310|NCT00291694|13139804|P1|COMPLETED|Overall Study||21
5341311|NCT00291694|13139803|P2|STARTED|Overall Study||48
5341312|NCT00291694|13139804|P1|STARTED|Overall Study||24
5341313|NCT00291655|13139818|P1|NOT COMPLETED|Overall Study||15
5341314|NCT00291655|13139818|P1|COMPLETED|Overall Study||115
5341315|NCT00291655|13139818|P1|STARTED|Overall Study||130
5341316|NCT00291642|13139828|P5|NOT COMPLETED|Overall Study||1
5341317|NCT00291642|13139829|P4|NOT COMPLETED|Overall Study||0
5341318|NCT00291642|13139830|P3|NOT COMPLETED|Overall Study||2
5341319|NCT00291642|13139831|P2|NOT COMPLETED|Overall Study||0
5341320|NCT00291642|13139832|P1|NOT COMPLETED|Overall Study||2
5341321|NCT00291642|13139828|P5|COMPLETED|Overall Study||118
5341322|NCT00291642|13139829|P4|COMPLETED|Overall Study||119
5341323|NCT00291642|13139830|P3|COMPLETED|Overall Study||117
5341324|NCT00291642|13139831|P2|COMPLETED|Overall Study||116
5341325|NCT00291642|13139832|P1|COMPLETED|Overall Study||76
5341326|NCT00291642|13139828|P5|STARTED|Overall Study||119
5341327|NCT00291642|13139829|P4|STARTED|Overall Study||119
5341328|NCT00291642|13139830|P3|STARTED|Overall Study||119
5341329|NCT00291642|13139831|P2|STARTED|Overall Study||116
5341330|NCT00291642|13139832|P1|STARTED|Overall Study||78
5341331|NCT00291577|13139884|P1|NOT COMPLETED|Overall Study||21
5341332|NCT00291577|13139884|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
5341333|NCT00291577|13139884|P1|STARTED|Overall Study||22
5341334|NCT00291551|13139903|P1|NOT COMPLETED|Overall Study||13
5341335|NCT00291551|13139903|P1|COMPLETED|Overall Study||26
5341336|NCT00291551|13139903|P1|STARTED|Overall Study||39
5341337|NCT00291343|13139920|P2|NOT COMPLETED|Overall Study||0
5341338|NCT00291343|13139921|P1|NOT COMPLETED|Overall Study||0
5341339|NCT00291343|13139920|P2|COMPLETED|Overall Study||93
5341340|NCT00291343|13139921|P1|COMPLETED|Overall Study||203
5341341|NCT00291343|13139920|P2|STARTED|Overall Study||93
5341342|NCT00291343|13139921|P1|STARTED|Overall Study||203
5341343|NCT00291330|13139951|P2|NOT COMPLETED|Overall Study||97
5341344|NCT00291330|13139952|P1|NOT COMPLETED|Overall Study||101
5341345|NCT00291330|13139951|P2|COMPLETED|Overall Study|Completed planned observation time|1169
5341346|NCT00291330|13139952|P1|COMPLETED|Overall Study|Completed planned observation time|1172
5341347|NCT00291330|13139951|P2|STARTED|Overall Study|Started Treatment|1266
5341348|NCT00291330|13139952|P1|STARTED|Overall Study|Started Treatment|1273
5341349|NCT00291317|13139974|P1|NOT COMPLETED|Overall Study||0
5341350|NCT00291317|13139974|P1|COMPLETED|Overall Study||6
5341351|NCT00291317|13139974|P1|STARTED|Overall Study||6
5341352|NCT00291226|13139981|P2|NOT COMPLETED|Overall Study||1
5341353|NCT00291226|13139982|P1|NOT COMPLETED|Overall Study||1
5341354|NCT00291226|13139981|P2|COMPLETED|Overall Study||3
5341355|NCT00291226|13139982|P1|COMPLETED|Overall Study||3
5341356|NCT00291226|13139981|P2|STARTED|Overall Study||4
5341357|NCT00291226|13139982|P1|STARTED|Overall Study||4
5341358|NCT00291187|13139994|P4|NOT COMPLETED|Overall Study||0
5341359|NCT00291187|13139995|P3|NOT COMPLETED|Overall Study||1
5341360|NCT00291187|13139996|P2|NOT COMPLETED|Overall Study||0
5341361|NCT00291187|13139997|P1|NOT COMPLETED|Overall Study||0
5341362|NCT00291187|13139994|P4|COMPLETED|Overall Study||106
5341363|NCT00291187|13139995|P3|COMPLETED|Overall Study||102
5341364|NCT00291187|13139996|P2|COMPLETED|Overall Study||100
5341365|NCT00291187|13139997|P1|COMPLETED|Overall Study||103
5341366|NCT00291187|13139994|P4|STARTED|Overall Study||106
5341367|NCT00291187|13139995|P3|STARTED|Overall Study||103
5341368|NCT00291187|13139996|P2|STARTED|Overall Study||100
5341369|NCT00291187|13139997|P1|STARTED|Overall Study||103
5341370|NCT00291161|13140023|P4|NOT COMPLETED|Overall Study||65
5341371|NCT00291161|13140024|P3|NOT COMPLETED|Overall Study||93
5341372|NCT00291161|13140025|P2|NOT COMPLETED|Overall Study||58
5341373|NCT00291161|13140026|P1|NOT COMPLETED|Overall Study||81
5341374|NCT00291161|13140023|P4|COMPLETED|Overall Study||122
5341375|NCT00291161|13140024|P3|COMPLETED|Overall Study||206
5341376|NCT00291161|13140025|P2|COMPLETED|Overall Study||134
5341377|NCT00291161|13140026|P1|COMPLETED|Overall Study||235
5341378|NCT00291161|13140023|P4|STARTED|Overall Study||187
5341379|NCT00291161|13140024|P3|STARTED|Overall Study||299
5341380|NCT00291161|13140025|P2|STARTED|Overall Study||192
5341381|NCT00291161|13140026|P1|STARTED|Overall Study||316
5341382|NCT00291135|13140034|P1|NOT COMPLETED|Overall Study||0
5341383|NCT00291135|13140034|P1|COMPLETED|Overall Study||42
5341384|NCT00291135|13140034|P1|STARTED|Overall Study||42
5341385|NCT00291018|13140041|P3|NOT COMPLETED|Overall Study||43
5341386|NCT00291018|13140042|P2|NOT COMPLETED|Overall Study||42
5341387|NCT00291018|13140043|P1|NOT COMPLETED|Overall Study||25
5341388|NCT00291018|13140041|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
5341389|NCT00291018|13140042|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
5341390|NCT00291018|13140043|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
5341391|NCT00291018|13140041|P3|Evaluated at 24 Months|Overall Study||105
5341392|NCT00291018|13140042|P2|Evaluated at 24 Months|Overall Study||92
5341393|NCT00291018|13140043|P1|Evaluated at 24 Months|Overall Study||99
5341394|NCT00291018|13140041|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
5341395|NCT00291018|13140042|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
5341396|NCT00291018|13140043|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
5341397|NCT00290888|13140083|P2|NOT COMPLETED|Overall Study||1
5341398|NCT00290888|13140084|P1|NOT COMPLETED|Overall Study||3
5341399|NCT00290888|13140083|P2|COMPLETED|Overall Study||44
5341400|NCT00290888|13140084|P1|COMPLETED|Overall Study||38
5341401|NCT00290888|13140083|P2|STARTED|Overall Study||45
5341402|NCT00290888|13140084|P1|STARTED|Overall Study||41
5341403|NCT00290810|13140092|P1|NOT COMPLETED|Overall Study||0
5341404|NCT00290810|13140092|P1|COMPLETED|Overall Study||12
5341405|NCT00290810|13140092|P1|STARTED|Overall Study||12
5341406|NCT00290771|13140101|P2|NOT COMPLETED|Overall Study||97
5341407|NCT00290771|13140102|P1|NOT COMPLETED|Overall Study||127
5341408|NCT00290771|13140101|P2|COMPLETED|Overall Study||3
5341409|NCT00290771|13140102|P1|COMPLETED|Overall Study||4
5341410|NCT00290771|13140101|P2|STARTED|Overall Study||100
5341411|NCT00290771|13140102|P1|STARTED|Overall Study||131
5341412|NCT00290758|13140126|P2|NOT COMPLETED|Post Intervention rFNA||5
5341413|NCT00290758|13140127|P1|NOT COMPLETED|Post Intervention rFNA||6
5341414|NCT00290758|13140126|P2|COMPLETED|Post Intervention rFNA||49
5341415|NCT00290758|13140127|P1|COMPLETED|Post Intervention rFNA||49
5341416|NCT00290758|13140126|P2|STARTED|Post Intervention rFNA||54
5341417|NCT00290758|13140127|P1|STARTED|Post Intervention rFNA||55
5341418|NCT00290758|13140126|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
5341419|NCT00290758|13140127|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
5341420|NCT00290758|13140126|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
5341421|NCT00290758|13140127|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
5341422|NCT00290758|13140126|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
5341423|NCT00290758|13140127|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
5341424|NCT00290758|13140126|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
5341425|NCT00290758|13140127|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
5341426|NCT00290758|13140126|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
5341427|NCT00290758|13140127|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
5341428|NCT00290758|13140126|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
5341429|NCT00290758|13140127|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
5341430|NCT00290758|13140126|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
5341431|NCT00290758|13140127|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
5341432|NCT00290732|13140149|P5|NOT COMPLETED|Overall Study||0
5341433|NCT00290732|13140150|P4|NOT COMPLETED|Overall Study||0
5341434|NCT00290732|13140151|P3|NOT COMPLETED|Overall Study||1
5341435|NCT00290732|13140152|P2|NOT COMPLETED|Overall Study||1
5341436|NCT00290732|13140153|P1|NOT COMPLETED|Overall Study||0
5341437|NCT00290732|13140149|P5|COMPLETED|Overall Study||3
5341438|NCT00290732|13140150|P4|COMPLETED|Overall Study||6
5341439|NCT00290732|13140151|P3|COMPLETED|Overall Study||3
5341440|NCT00290732|13140152|P2|COMPLETED|Overall Study||3
5341441|NCT00290732|13140153|P1|COMPLETED|Overall Study||3
5341442|NCT00290732|13140149|P5|STARTED|Overall Study||3
5341443|NCT00290732|13140150|P4|STARTED|Overall Study||6
5341444|NCT00290732|13140151|P3|STARTED|Overall Study||4
5341445|NCT00290732|13140152|P2|STARTED|Overall Study||4
5341446|NCT00290732|13140153|P1|STARTED|Overall Study||3
5341447|NCT00290706|13140175|P4|NOT COMPLETED|Overall Study||12
5341448|NCT00290706|13140176|P3|NOT COMPLETED|Overall Study||6
5341449|NCT00290706|13140177|P2|NOT COMPLETED|Overall Study||6
5341450|NCT00290706|13140178|P1|NOT COMPLETED|Overall Study||5
5341451|NCT00290706|13140175|P4|COMPLETED|Overall Study||2
5341452|NCT00290706|13140176|P3|COMPLETED|Overall Study||1
5341453|NCT00290706|13140177|P2|COMPLETED|Overall Study||0
5341454|NCT00290706|13140178|P1|COMPLETED|Overall Study||0
5341455|NCT00290706|13140175|P4|Reached 1st Response/Cycle 3|Overall Study||2
5341456|NCT00290706|13140176|P3|Reached 1st Response/Cycle 3|Overall Study||1
5341457|NCT00290706|13140177|P2|Reached 1st Response/Cycle 3|Overall Study||0
5341458|NCT00290706|13140178|P1|Reached 1st Response/Cycle 3|Overall Study||0
5341459|NCT00290706|13140175|P4|Attempted1st Cycle|Overall Study||14
5341460|NCT00290706|13140176|P3|Attempted1st Cycle|Overall Study||7
5341461|NCT00290706|13140177|P2|Attempted1st Cycle|Overall Study||6
5341462|NCT00290706|13140178|P1|Attempted1st Cycle|Overall Study||5
5341463|NCT00290706|13140175|P4|STARTED|Overall Study||14
5341464|NCT00290706|13140176|P3|STARTED|Overall Study||7
5341465|NCT00290706|13140177|P2|STARTED|Overall Study||6
5341466|NCT00290706|13140178|P1|STARTED|Overall Study||5
5341467|NCT00290693|13140197|P1|NOT COMPLETED|Overall Study||2
5341468|NCT00290693|13140197|P1|COMPLETED|Overall Study||43
5341469|NCT00290693|13140197|P1|STARTED|Overall Study||45
5341470|NCT00290654|13140205|P1|NOT COMPLETED|Overall Study||0
5341471|NCT00290654|13140205|P1|COMPLETED|Overall Study||41
5341472|NCT00290654|13140205|P1|STARTED|Overall Study||41
5341473|NCT00290615|13140216|P1|NOT COMPLETED|Overall Study||0
5341474|NCT00290615|13140216|P1|COMPLETED|Overall Study||30
5341475|NCT00290615|13140216|P1|STARTED|Overall Study||30
5341476|NCT00290589|13140225|P2|NOT COMPLETED|Overall Study||2
5341477|NCT00290589|13140226|P1|NOT COMPLETED|Overall Study||2
5341478|NCT00290589|13140225|P2|COMPLETED|Overall Study||41
5341479|NCT00290589|13140226|P1|COMPLETED|Overall Study||37
5341480|NCT00290589|13140225|P2|STARTED|Overall Study||43
5341481|NCT00290589|13140226|P1|STARTED|Overall Study||39
5341482|NCT00290537|13140236|P2|NOT COMPLETED|Overall Study||0
5341483|NCT00290537|13140237|P1|NOT COMPLETED|Overall Study||0
5341484|NCT00290537|13140236|P2|COMPLETED|Overall Study||0
5341485|NCT00290537|13140237|P1|COMPLETED|Overall Study||4
5341486|NCT00290537|13140236|P2|STARTED|Overall Study||0
5341487|NCT00290537|13140237|P1|STARTED|Overall Study||4
5341488|NCT00290498|13140244|P2|NOT COMPLETED|Overall Study||0
5341489|NCT00290498|13140245|P1|NOT COMPLETED|Overall Study||8
5341490|NCT00290498|13140244|P2|COMPLETED|Overall Study||10
5341491|NCT00290498|13140245|P1|COMPLETED|Overall Study||41
5341492|NCT00290498|13140244|P2|STARTED|Overall Study||10
5341493|NCT00290498|13140245|P1|STARTED|Overall Study||49
5341494|NCT00290472|13140256|P3|NOT COMPLETED|Overall Study||0
5341495|NCT00290472|13140257|P2|NOT COMPLETED|Overall Study||0
5341496|NCT00290472|13140258|P1|NOT COMPLETED|Overall Study||0
5341497|NCT00290472|13140256|P3|COMPLETED|Overall Study||18
5341498|NCT00290472|13140257|P2|COMPLETED|Overall Study||39
5341499|NCT00290472|13140258|P1|COMPLETED|Overall Study||32
5341500|NCT00290472|13140256|P3|STARTED|Overall Study||18
5341501|NCT00290472|13140257|P2|STARTED|Overall Study||39
5341502|NCT00290472|13140258|P1|STARTED|Overall Study||32
5341503|NCT00290407|13140270|P1|NOT COMPLETED|Overall Study||2
5341504|NCT00290407|13140270|P1|COMPLETED|Overall Study||0
5341505|NCT00290407|13140270|P1|STARTED|Overall Study||2
5341506|NCT00290355|13140277|P2|NOT COMPLETED|Overall Study||5
5341507|NCT00290355|13140278|P1|NOT COMPLETED|Overall Study||17
5341508|NCT00290355|13140277|P2|COMPLETED|Overall Study||55
5341509|NCT00290355|13140278|P1|COMPLETED|Overall Study||105
5341510|NCT00290355|13140277|P2|STARTED|Overall Study||60
5341511|NCT00290355|13140278|P1|STARTED|Overall Study||122
5341512|NCT00290342|13140322|P2|NOT COMPLETED|Overall Study||5
5341513|NCT00290342|13140323|P1|NOT COMPLETED|Overall Study||7
5341514|NCT00290342|13140322|P2|COMPLETED|Overall Study||223
5341515|NCT00290342|13140323|P1|COMPLETED|Overall Study||217
5341516|NCT00290342|13140322|P2|STARTED|Overall Study||228
5341517|NCT00290342|13140323|P1|STARTED|Overall Study||224
5341518|NCT00290329|13140354|P3|NOT COMPLETED|Overall Study||0
5341519|NCT00290329|13140355|P2|NOT COMPLETED|Overall Study||0
5341520|NCT00290329|13140356|P1|NOT COMPLETED|Overall Study||0
5341521|NCT00290329|13140354|P3|COMPLETED|Overall Study||61
5341522|NCT00290329|13140355|P2|COMPLETED|Overall Study||86
5341523|NCT00290329|13140356|P1|COMPLETED|Overall Study||102
5341524|NCT00290329|13140354|P3|STARTED|Overall Study||61
5341525|NCT00290329|13140355|P2|STARTED|Overall Study||86
5341526|NCT00290329|13140356|P1|STARTED|Overall Study||102
5341527|NCT00290290|13140378|P2|NOT COMPLETED|Overall Study||18
5341528|NCT00290290|13140379|P1|NOT COMPLETED|Overall Study||18
5341529|NCT00290290|13140378|P2|COMPLETED|Overall Study||391
5341530|NCT00290290|13140379|P1|COMPLETED|Overall Study||422
5341531|NCT00290290|13140378|P2|STARTED|Overall Study||409
5341532|NCT00290290|13140379|P1|STARTED|Overall Study||440
5341533|NCT00290251|13140385|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
5341534|NCT00290251|13140386|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
5341535|NCT00290251|13140387|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
5341536|NCT00290251|13140385|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
5341537|NCT00290251|13140386|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
5341538|NCT00290251|13140387|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
5341539|NCT00290251|13140385|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
5341540|NCT00290251|13140386|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
5341541|NCT00290251|13140387|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
5341542|NCT00290251|13140385|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
5341543|NCT00290251|13140386|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
5341544|NCT00290251|13140387|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
5341545|NCT00290251|13140385|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
5341546|NCT00290251|13140386|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
5341547|NCT00290251|13140387|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
5341548|NCT00290251|13140385|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
5341549|NCT00290251|13140386|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
5341550|NCT00290251|13140387|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
5341551|NCT00290251|13140385|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
5341552|NCT00290251|13140386|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
5341553|NCT00290251|13140387|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
5341554|NCT00290251|13140385|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
5341555|NCT00290251|13140386|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
5341556|NCT00290251|13140387|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
5341557|NCT00290251|13140385|P3|STARTED|Treatment 1 (Months 1 - 3)||14
5341558|NCT00290251|13140386|P2|STARTED|Treatment 1 (Months 1 - 3)||14
5341559|NCT00290251|13140387|P1|STARTED|Treatment 1 (Months 1 - 3)||14
5341560|NCT00290238|13140399|P2|NOT COMPLETED|Overall Study||41
5341561|NCT00290238|13140400|P1|NOT COMPLETED|Overall Study||42
5341562|NCT00290238|13140399|P2|COMPLETED|Overall Study||24
5341563|NCT00290238|13140400|P1|COMPLETED|Overall Study||15
5341564|NCT00290238|13140399|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
5341565|NCT00290238|13140400|P1|STARTED|Overall Study||57
5341566|NCT00290199|13140410|P2|NOT COMPLETED|Overall Study||0
5341567|NCT00290199|13140411|P1|NOT COMPLETED|Overall Study||0
5341568|NCT00290199|13140410|P2|COMPLETED|Overall Study||82
5341569|NCT00290199|13140411|P1|COMPLETED|Overall Study||87
5341570|NCT00290199|13140410|P2|STARTED|Overall Study||82
5341571|NCT00290199|13140411|P1|STARTED|Overall Study||87
5341572|NCT00290186|13140425|P2|NOT COMPLETED|Overall Study||5
5341573|NCT00290186|13140426|P1|NOT COMPLETED|Overall Study||5
5341574|NCT00290186|13140425|P2|COMPLETED|Overall Study||19
5341575|NCT00290186|13140426|P1|COMPLETED|Overall Study||20
5341576|NCT00290186|13140425|P2|Completed 6-month Followup Assessments|Overall Study||19
5341577|NCT00290186|13140426|P1|Completed 6-month Followup Assessments|Overall Study||20
5341578|NCT00290186|13140425|P2|Completed 3-month Followup Assessments|Overall Study||21
5341579|NCT00290186|13140426|P1|Completed 3-month Followup Assessments|Overall Study||20
5341580|NCT00290186|13140425|P2|Completed Post-treatment Assessments|Overall Study||22
5341581|NCT00290186|13140426|P1|Completed Post-treatment Assessments|Overall Study||24
5341582|NCT00290186|13140425|P2|Completed 8 Weeks of Treatment|Overall Study||22
5341583|NCT00290186|13140426|P1|Completed 8 Weeks of Treatment|Overall Study||24
5341584|NCT00290186|13140425|P2|Completed Baseline Assessments|Overall Study||24
5341585|NCT00290186|13140426|P1|Completed Baseline Assessments|Overall Study||25
5341586|NCT00290186|13140425|P2|STARTED|Overall Study||24
5341587|NCT00290186|13140426|P1|STARTED|Overall Study||25
5341588|NCT00290147|13140466|P2|NOT COMPLETED|Overall Study||0
5341589|NCT00290147|13140467|P1|NOT COMPLETED|Overall Study||0
5341590|NCT00290147|13140466|P2|COMPLETED|Overall Study||12
5341591|NCT00290147|13140467|P1|COMPLETED|Overall Study||10
5341592|NCT00290147|13140466|P2|STARTED|Overall Study||12
5341593|NCT00290147|13140467|P1|STARTED|Overall Study||10
5341594|NCT00289991|13140477|P2|NOT COMPLETED|Overall Study||80
5341595|NCT00289991|13140478|P1|NOT COMPLETED|Overall Study||58
5341596|NCT00289991|13140477|P2|COMPLETED|Overall Study||175
5341597|NCT00289991|13140478|P1|COMPLETED|Overall Study||176
5341598|NCT00289991|13140477|P2|STARTED|Overall Study||255
5341599|NCT00289991|13140478|P1|STARTED|Overall Study||234
5341600|NCT00289978|13140503|P3|NOT COMPLETED|Overall Study||86
5341601|NCT00289978|13140504|P2|NOT COMPLETED|Overall Study||56
5341602|NCT00289978|13140505|P1|NOT COMPLETED|Overall Study||97
5341603|NCT00289978|13140503|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
5341604|NCT00289978|13140504|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
5341605|NCT00289978|13140505|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
5341606|NCT00289978|13140503|P3|STARTED|Overall Study||418
5341607|NCT00289978|13140504|P2|STARTED|Overall Study||425
5341608|NCT00289978|13140505|P1|STARTED|Overall Study||429
5341609|NCT00289913|13140524|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
5341610|NCT00289913|13140525|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
5341611|NCT00289913|13140526|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
5341612|NCT00289913|13140527|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
5341613|NCT00289913|13140528|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
5341614|NCT00289913|13140524|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
5341615|NCT00289913|13140525|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
5341616|NCT00289913|13140526|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
5341617|NCT00289913|13140527|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
5341618|NCT00289913|13140528|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
5341619|NCT00289913|13140524|P5|STARTED|Visit 4 (Stage I and Stage II)||597
5341620|NCT00289913|13140525|P4|STARTED|Visit 4 (Stage I and Stage II)||131
5341621|NCT00289913|13140526|P3|STARTED|Visit 4 (Stage I and Stage II)||138
5341622|NCT00289913|13140527|P2|STARTED|Visit 4 (Stage I and Stage II)||106
5341623|NCT00289913|13140528|P1|STARTED|Visit 4 (Stage I and Stage II)||122
5341624|NCT00289913|13140524|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
5341625|NCT00289913|13140525|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
5341626|NCT00289913|13140526|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
5341627|NCT00289913|13140527|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
5341628|NCT00289913|13140528|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
5341629|NCT00289913|13140524|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
5341630|NCT00289913|13140525|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
5341631|NCT00289913|13140526|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
5341632|NCT00289913|13140527|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
5341633|NCT00289913|13140528|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
5341634|NCT00289913|13140524|P5|STARTED|Visit 3 (Stage I and Stage II)||605
5341635|NCT00289913|13140525|P4|STARTED|Visit 3 (Stage I and Stage II)||135
5341636|NCT00289913|13140526|P3|STARTED|Visit 3 (Stage I and Stage II)||140
5341637|NCT00289913|13140527|P2|STARTED|Visit 3 (Stage I and Stage II)||114
5341638|NCT00289913|13140528|P1|STARTED|Visit 3 (Stage I and Stage II)||131
5341639|NCT00289913|13140524|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
5341640|NCT00289913|13140525|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
5341641|NCT00289913|13140526|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
5341642|NCT00289913|13140527|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
5341643|NCT00289913|13140528|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
5341644|NCT00289913|13140524|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
5341645|NCT00289913|13140525|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
5341646|NCT00289913|13140526|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
5341647|NCT00289913|13140527|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
5341648|NCT00289913|13140528|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
5341649|NCT00289913|13140524|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
5341650|NCT00289913|13140525|P4|STARTED|Visit 2 (Stage I and Stage II)||141
5341651|NCT00289913|13140526|P3|STARTED|Visit 2 (Stage I and Stage II)||150
5341652|NCT00289913|13140527|P2|STARTED|Visit 2 (Stage I and Stage II)||135
5341653|NCT00289913|13140528|P1|STARTED|Visit 2 (Stage I and Stage II)||146
5341654|NCT00289913|13140524|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
5341655|NCT00289913|13140525|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
5341656|NCT00289913|13140526|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
5341657|NCT00289913|13140527|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
5341658|NCT00289913|13140528|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
5341659|NCT00289913|13140524|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
5341660|NCT00289913|13140525|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
5341661|NCT00289913|13140526|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
5341662|NCT00289913|13140527|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
5341663|NCT00289913|13140528|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
5341664|NCT00289913|13140524|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
5341665|NCT00289913|13140525|P4|STARTED|Visit 1 (Stage I and Stage II)||152
5341666|NCT00289913|13140526|P3|STARTED|Visit 1 (Stage I and Stage II)||159
5341667|NCT00289913|13140527|P2|STARTED|Visit 1 (Stage I and Stage II)||151
5341668|NCT00289913|13140528|P1|STARTED|Visit 1 (Stage I and Stage II)||155
5341669|NCT00289900|13140559|P6|NOT COMPLETED|Overall Study||61
5341670|NCT00289900|13140560|P5|NOT COMPLETED|Overall Study||45
5341671|NCT00289900|13140561|P4|NOT COMPLETED|Overall Study||59
5341672|NCT00289900|13140562|P3|NOT COMPLETED|Overall Study||33
5341673|NCT00289900|13140563|P2|NOT COMPLETED|Overall Study||120
5341674|NCT00289900|13140564|P1|NOT COMPLETED|Overall Study||68
5341675|NCT00289900|13140559|P6|COMPLETED|Overall Study||372
5341676|NCT00289900|13140560|P5|COMPLETED|Overall Study||392
5341677|NCT00289900|13140561|P4|COMPLETED|Overall Study||380
5341678|NCT00289900|13140562|P3|COMPLETED|Overall Study||265
5341679|NCT00289900|13140563|P2|COMPLETED|Overall Study||316
5341680|NCT00289900|13140564|P1|COMPLETED|Overall Study||229
5341681|NCT00289900|13140559|P6|Treated|Overall Study||433
5341682|NCT00289900|13140560|P5|Treated|Overall Study||437
5341683|NCT00289900|13140561|P4|Treated|Overall Study||439
5341684|NCT00289900|13140562|P3|Treated|Overall Study||298
5341685|NCT00289900|13140563|P2|Treated|Overall Study||435
5341686|NCT00289900|13140564|P1|Treated|Overall Study||297
5341687|NCT00289900|13140559|P6|STARTED|Overall Study||433
5341688|NCT00289900|13140560|P5|STARTED|Overall Study||437
5341689|NCT00289900|13140561|P4|STARTED|Overall Study||439
5341690|NCT00289900|13140562|P3|STARTED|Overall Study||298
5341691|NCT00289900|13140563|P2|STARTED|Overall Study||436
5341692|NCT00289900|13140564|P1|STARTED|Overall Study||297
5341693|NCT00289887|13140668|P2|NOT COMPLETED|Overall Study||29
5341694|NCT00289887|13140669|P1|NOT COMPLETED|Overall Study||22
5341695|NCT00289887|13140668|P2|COMPLETED|Overall Study||105
5341696|NCT00289887|13140669|P1|COMPLETED|Overall Study||105
5341697|NCT00289887|13140668|P2|STARTED|Overall Study||134
5341698|NCT00289887|13140669|P1|STARTED|Overall Study||127
5341699|NCT00289874|13140687|P2|NOT COMPLETED|Overall Study||8
5341700|NCT00289874|13140688|P1|NOT COMPLETED|Overall Study||6
5341701|NCT00289874|13140687|P2|COMPLETED|Overall Study||210
5341702|NCT00289874|13140688|P1|COMPLETED|Overall Study||197
5341703|NCT00289874|13140687|P2|STARTED|Overall Study||218
5341704|NCT00289874|13140688|P1|STARTED|Overall Study||203
5341705|NCT00289848|13140698|P2|NOT COMPLETED|Overall Study||45
5341706|NCT00289848|13140699|P1|NOT COMPLETED|Overall Study||46
5341707|NCT00289848|13140698|P2|COMPLETED|Overall Study||133
5341708|NCT00289848|13140699|P1|COMPLETED|Overall Study||306
5341709|NCT00289848|13140698|P2|STARTED|Overall Study||178
5341710|NCT00289848|13140699|P1|STARTED|Overall Study||352
5341711|NCT00289783|13140711|P2|NOT COMPLETED|Fourth Dose Phase||24
5341712|NCT00289783|13140712|P1|NOT COMPLETED|Fourth Dose Phase||87
5341713|NCT00289783|13140711|P2|COMPLETED|Fourth Dose Phase||899
5341714|NCT00289783|13140712|P1|COMPLETED|Fourth Dose Phase||2682
5341715|NCT00289783|13140711|P2|STARTED|Fourth Dose Phase||923
5341716|NCT00289783|13140712|P1|STARTED|Fourth Dose Phase||2769
5341717|NCT00289783|13140711|P2|NOT COMPLETED|Primary Phase||83
5341718|NCT00289783|13140712|P1|NOT COMPLETED|Primary Phase||248
5341719|NCT00289783|13140711|P2|COMPLETED|Primary Phase||961
5341720|NCT00289783|13140712|P1|COMPLETED|Primary Phase||2888
5341721|NCT00289783|13140711|P2|STARTED|Primary Phase||1044
5341722|NCT00289783|13140712|P1|STARTED|Primary Phase||3136
5341723|NCT00289770|13140890|P1|NOT COMPLETED|Year 15||1
5341724|NCT00289770|13140890|P1|COMPLETED|Year 15||49
5341725|NCT00289770|13140890|P1|STARTED|Year 15||50
5341726|NCT00289770|13140890|P1|NOT COMPLETED|Year 14||0
5341727|NCT00289770|13140890|P1|COMPLETED|Year 14||43
5341728|NCT00289770|13140890|P1|STARTED|Year 14||43
5341729|NCT00289770|13140890|P1|NOT COMPLETED|Year 13||0
5341730|NCT00289770|13140890|P1|COMPLETED|Year 13||37
5341731|NCT00289770|13140890|P1|STARTED|Year 13||37
5341732|NCT00289770|13140890|P1|NOT COMPLETED|Year 12||0
5341733|NCT00289770|13140890|P1|COMPLETED|Year 12||40
5341734|NCT00289770|13140890|P1|STARTED|Year 12||40
5341735|NCT00289770|13140890|P1|NOT COMPLETED|Year 11||0
5341736|NCT00289770|13140890|P1|COMPLETED|Year 11||37
5341737|NCT00289770|13140890|P1|STARTED|Year 11||37
5341738|NCT00289757|13140902|P1|NOT COMPLETED|Overall Study||0
5341739|NCT00289757|13140902|P1|COMPLETED|Overall Study||78
5341740|NCT00289757|13140902|P1|STARTED|Overall Study||78
5341741|NCT00289744|13140913|P3|NOT COMPLETED|Additional Dose Phase||0
5341742|NCT00289744|13140914|P2|NOT COMPLETED|Additional Dose Phase||0
5341743|NCT00289744|13140915|P1|NOT COMPLETED|Additional Dose Phase||0
5341744|NCT00289744|13140913|P3|COMPLETED|Additional Dose Phase||6
5341745|NCT00289744|13140914|P2|COMPLETED|Additional Dose Phase||19
5341746|NCT00289744|13140915|P1|COMPLETED|Additional Dose Phase||0
5341747|NCT00289744|13140913|P3|STARTED|Additional Dose Phase||6
5341748|NCT00289744|13140914|P2|STARTED|Additional Dose Phase||19
5341749|NCT00289744|13140915|P1|STARTED|Additional Dose Phase||0
5341750|NCT00289744|13140913|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
5341751|NCT00289744|13140914|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
5341752|NCT00289744|13140915|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
5341753|NCT00289744|13140913|P3|COMPLETED|Year 10 Long-term Follow-up||0
5341754|NCT00289744|13140914|P2|COMPLETED|Year 10 Long-term Follow-up||0
5341755|NCT00289744|13140915|P1|COMPLETED|Year 10 Long-term Follow-up||171
5341756|NCT00289744|13140913|P3|STARTED|Year 10 Long-term Follow-up||0
5341757|NCT00289744|13140914|P2|STARTED|Year 10 Long-term Follow-up||0
5341758|NCT00289744|13140915|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
5341759|NCT00289744|13140913|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
5341760|NCT00289744|13140914|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
5341761|NCT00289744|13140915|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
5341762|NCT00289744|13140913|P3|COMPLETED|Year 9 Long-term Follow-up||0
5341763|NCT00289744|13140914|P2|COMPLETED|Year 9 Long-term Follow-up||0
5341764|NCT00289744|13140915|P1|COMPLETED|Year 9 Long-term Follow-up||173
5341765|NCT00289744|13140913|P3|STARTED|Year 9 Long-term Follow-up||0
5341766|NCT00289744|13140914|P2|STARTED|Year 9 Long-term Follow-up||0
5341767|NCT00289744|13140915|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
5341768|NCT00289744|13140913|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
5341769|NCT00289744|13140914|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
5341770|NCT00289744|13140915|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
5341771|NCT00289744|13140913|P3|COMPLETED|Year 8 Long-term Follow-up||0
5341772|NCT00289744|13140914|P2|COMPLETED|Year 8 Long-term Follow-up||0
5341773|NCT00289744|13140915|P1|COMPLETED|Year 8 Long-term Follow-up||174
5341774|NCT00289744|13140913|P3|STARTED|Year 8 Long-term Follow-up||0
5341775|NCT00289744|13140914|P2|STARTED|Year 8 Long-term Follow-up||0
5341776|NCT00289744|13140915|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
5341777|NCT00289744|13140913|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
5341778|NCT00289744|13140914|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
5341779|NCT00289744|13140915|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
5341780|NCT00289744|13140913|P3|COMPLETED|Year 7 Long-term Follow-up||0
5341781|NCT00289744|13140914|P2|COMPLETED|Year 7 Long-term Follow-up||0
5341782|NCT00289744|13140915|P1|COMPLETED|Year 7 Long-term Follow-up||175
5341783|NCT00289744|13140913|P3|STARTED|Year 7 Long-term Follow-up||0
5341784|NCT00289744|13140914|P2|STARTED|Year 7 Long-term Follow-up||0
5341785|NCT00289744|13140915|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
5341786|NCT00289744|13140913|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
5341787|NCT00289744|13140914|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
5341788|NCT00289744|13140915|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
5341789|NCT00289744|13140913|P3|COMPLETED|Year 6 Long-term Follow-up||0
5341790|NCT00289744|13140914|P2|COMPLETED|Year 6 Long-term Follow-up||0
5341791|NCT00289744|13140915|P1|COMPLETED|Year 6 Long-term Follow-up||178
5341792|NCT00289744|13140913|P3|STARTED|Year 6 Long-term Follow-up||0
5341793|NCT00289744|13140914|P2|STARTED|Year 6 Long-term Follow-up||0
5341794|NCT00289744|13140915|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
5341795|NCT00289731|13140936|P3|NOT COMPLETED|Overall Study||2
5341796|NCT00289731|13140937|P2|NOT COMPLETED|Overall Study||2
5341797|NCT00289731|13140938|P1|NOT COMPLETED|Overall Study||2
5341798|NCT00289731|13140936|P3|COMPLETED|Overall Study||195
5341799|NCT00289731|13140937|P2|COMPLETED|Overall Study||198
5341800|NCT00289731|13140938|P1|COMPLETED|Overall Study||197
5341801|NCT00289731|13140936|P3|STARTED|Overall Study||197
5341802|NCT00289731|13140937|P2|STARTED|Overall Study||200
5341803|NCT00289731|13140938|P1|STARTED|Overall Study||199
5341804|NCT00289718|13141030|P1|NOT COMPLETED|Overall Study||0
5341805|NCT00289718|13141030|P1|COMPLETED|Overall Study||51
5341806|NCT00289718|13141030|P1|STARTED|Overall Study||51
5341807|NCT00289653|13141045|P1|NOT COMPLETED|Overall Study||11
5341808|NCT00289653|13141045|P1|COMPLETED|Overall Study||12
5341809|NCT00289653|13141045|P1|STARTED|Overall Study||23
5341810|NCT00289536|13141050|P3|NOT COMPLETED|Period 3||1
5341811|NCT00289536|13141051|P2|NOT COMPLETED|Period 3||0
5341812|NCT00289536|13141052|P1|NOT COMPLETED|Period 3||0
5341813|NCT00289536|13141050|P3|COMPLETED|Period 3||9
5341814|NCT00289536|13141051|P2|COMPLETED|Period 3||9
5341815|NCT00289536|13141052|P1|COMPLETED|Period 3||7
5341816|NCT00289536|13141050|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
5341817|NCT00289536|13141051|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
5341818|NCT00289536|13141052|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
5341819|NCT00289536|13141050|P3|NOT COMPLETED|Period 2||0
5341820|NCT00289536|13141051|P2|NOT COMPLETED|Period 2||0
5341821|NCT00289536|13141052|P1|NOT COMPLETED|Period 2||0
5341822|NCT00289536|13141050|P3|COMPLETED|Period 2||7
5341823|NCT00289536|13141051|P2|COMPLETED|Period 2||9
5341824|NCT00289536|13141052|P1|COMPLETED|Period 2||10
5341825|NCT00289536|13141050|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
5341826|NCT00289536|13141051|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
5341827|NCT00289536|13141052|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
5341828|NCT00289536|13141050|P3|NOT COMPLETED|Period 1||0
5341829|NCT00289536|13141051|P2|NOT COMPLETED|Period 1||0
5341830|NCT00289536|13141052|P1|NOT COMPLETED|Period 1||0
5341831|NCT00289536|13141050|P3|COMPLETED|Period 1||9
5341832|NCT00289536|13141051|P2|COMPLETED|Period 1||8
5341833|NCT00289536|13141052|P1|COMPLETED|Period 1||9
5341834|NCT00289536|13141050|P3|STARTED|Period 1||9
5341835|NCT00289536|13141051|P2|STARTED|Period 1||8
5341836|NCT00289536|13141052|P1|STARTED|Period 1||9
5341837|NCT00289471|13141091|P1|NOT COMPLETED|Overall Study||0
5341838|NCT00289471|13141091|P1|COMPLETED|Overall Study||630
5341839|NCT00289471|13141091|P1|STARTED|Overall Study||630
5341840|NCT00289458|13141098|P3|NOT COMPLETED|Overall Study||6
5341841|NCT00289458|13141099|P2|NOT COMPLETED|Overall Study||6
5341842|NCT00289458|13141100|P1|NOT COMPLETED|Overall Study||6
5341843|NCT00289458|13141098|P3|COMPLETED|Overall Study||22
5341844|NCT00289458|13141099|P2|COMPLETED|Overall Study||20
5341845|NCT00289458|13141100|P1|COMPLETED|Overall Study||19
5341846|NCT00289458|13141098|P3|STARTED|Overall Study||28
5341847|NCT00289458|13141099|P2|STARTED|Overall Study||26
5341848|NCT00289458|13141100|P1|STARTED|Overall Study||25
5341849|NCT00289341|13141125|P2|NOT COMPLETED|Overall Study||0
5341850|NCT00289341|13141126|P1|NOT COMPLETED|Overall Study||0
5341851|NCT00289341|13141125|P2|COMPLETED|Overall Study||12
5341852|NCT00289341|13141126|P1|COMPLETED|Overall Study||12
5341853|NCT00289341|13141125|P2|STARTED|Overall Study||12
5341854|NCT00289341|13141126|P1|STARTED|Overall Study||12
5341855|NCT00289315|13141139|P3|NOT COMPLETED|Overall Study||140
5341856|NCT00289315|13141140|P2|NOT COMPLETED|Overall Study||122
5341857|NCT00289315|13141141|P1|NOT COMPLETED|Overall Study||101
5341858|NCT00289315|13141139|P3|COMPLETED|Overall Study||447
5341859|NCT00289315|13141140|P2|COMPLETED|Overall Study||638
5341860|NCT00289315|13141141|P1|COMPLETED|Overall Study||612
5341861|NCT00289315|13141139|P3|STARTED|Overall Study||587
5341862|NCT00289315|13141140|P2|STARTED|Overall Study||760
5341863|NCT00289315|13141141|P1|STARTED|Overall Study||713
5341864|NCT00289289|13141161|P3|NOT COMPLETED|Overall Study||49
5341865|NCT00289289|13141162|P2|NOT COMPLETED|Overall Study||10
5341866|NCT00289289|13141163|P1|NOT COMPLETED|Overall Study||19
5341867|NCT00289289|13141161|P3|COMPLETED|Overall Study||95
5341868|NCT00289289|13141162|P2|COMPLETED|Overall Study||114
5341869|NCT00289289|13141163|P1|COMPLETED|Overall Study||113
5341870|NCT00289289|13141161|P3|STARTED|Overall Study||144
5341871|NCT00289289|13141162|P2|STARTED|Overall Study||124
5341872|NCT00289289|13141163|P1|STARTED|Overall Study||132
5341873|NCT00289276|13141178|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
5341874|NCT00289276|13141179|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
5341875|NCT00289276|13141178|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
5341876|NCT00289276|13141179|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
5341877|NCT00289276|13141178|P2|STARTED|Second Part of FAST Study (Expansion)||109
5341878|NCT00289276|13141179|P1|STARTED|Second Part of FAST Study (Expansion)||0
5341879|NCT00289276|13141178|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
5341880|NCT00289276|13141179|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
5341881|NCT00289276|13141178|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
5341882|NCT00289276|13141179|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
5341883|NCT00289276|13141178|P2|STARTED|First Part of FAST Study (Pivotal)||0
5341884|NCT00289276|13141179|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
5341885|NCT00289211|13141194|P3|NOT COMPLETED|Overall Study||10
5341886|NCT00289211|13141195|P2|NOT COMPLETED|Overall Study||1
5341887|NCT00289211|13141196|P1|NOT COMPLETED|Overall Study||0
5341888|NCT00289211|13141194|P3|COMPLETED|Overall Study||2
5341889|NCT00289211|13141195|P2|COMPLETED|Overall Study||34
5341890|NCT00289211|13141196|P1|COMPLETED|Overall Study||36
5341891|NCT00289211|13141194|P3|STARTED|Overall Study||12
5341892|NCT00289211|13141195|P2|STARTED|Overall Study||35
5341893|NCT00289211|13141196|P1|STARTED|Overall Study||36
5341894|NCT00289198|13141214|P2|NOT COMPLETED|Overall Study||30
5341895|NCT00289198|13141215|P1|NOT COMPLETED|Overall Study||31
5341896|NCT00289198|13141214|P2|COMPLETED|Overall Study||121
5341897|NCT00289198|13141215|P1|COMPLETED|Overall Study||120
5341898|NCT00289198|13141214|P2|STARTED|Overall Study||151
5341899|NCT00289198|13141215|P1|STARTED|Overall Study||151
5341900|NCT00289185|13141265|P2|NOT COMPLETED|Overall Study||26
5341901|NCT00289185|13141266|P1|NOT COMPLETED|Overall Study||28
5341902|NCT00289185|13141265|P2|COMPLETED|Overall Study||144
5341903|NCT00289185|13141266|P1|COMPLETED|Overall Study||142
5341904|NCT00289185|13141265|P2|STARTED|Overall Study||170
5341905|NCT00289185|13141266|P1|STARTED|Overall Study||170
5341906|NCT00289133|13141313|P2|NOT COMPLETED|Overall Study||298
5341907|NCT00289133|13141314|P1|NOT COMPLETED|Overall Study||272
5341908|NCT00289133|13141313|P2|COMPLETED|Overall Study||179
5341909|NCT00289133|13141314|P1|COMPLETED|Overall Study||189
5341910|NCT00289133|13141313|P2|STARTED|Overall Study||477
5341911|NCT00289133|13141314|P1|STARTED|Overall Study||461
5341912|NCT00289120|13141336|P1|NOT COMPLETED|Overall Study||0
5341913|NCT00289120|13141336|P1|COMPLETED|Overall Study||13
5341914|NCT00289120|13141336|P1|STARTED|Overall Study||13
5341915|NCT00289107|13141354|P2|NOT COMPLETED|Overall Study||44
5341916|NCT00289107|13141355|P1|NOT COMPLETED|Overall Study||53
5341917|NCT00289107|13141354|P2|COMPLETED|Overall Study||28
5341918|NCT00289107|13141355|P1|COMPLETED|Overall Study||24
5341919|NCT00289107|13141354|P2|STARTED|Overall Study||72
5341920|NCT00289107|13141355|P1|STARTED|Overall Study||77
5341921|NCT00289094|13141363|P2|NOT COMPLETED|Overall Study||47
5341922|NCT00289094|13141364|P1|NOT COMPLETED|Overall Study||47
5341923|NCT00289094|13141363|P2|COMPLETED|Overall Study||2
5341924|NCT00289094|13141364|P1|COMPLETED|Overall Study||3
5341925|NCT00289094|13141363|P2|STARTED|Overall Study||49
5341926|NCT00289094|13141364|P1|STARTED|Overall Study||50
5341927|NCT00289016|13141370|P1|NOT COMPLETED|Overall Study||37
5341928|NCT00289016|13141370|P1|COMPLETED|Overall Study||13
5341929|NCT00289016|13141370|P1|STARTED|Overall Study||50
5341930|NCT00288912|13141382|P3|NOT COMPLETED|Overall Study||28
5341931|NCT00288912|13141383|P2|NOT COMPLETED|Overall Study||17
5341932|NCT00288912|13141384|P1|NOT COMPLETED|Overall Study||17
5341933|NCT00288912|13141382|P3|COMPLETED|Overall Study||146
5341934|NCT00288912|13141383|P2|COMPLETED|Overall Study||157
5341935|NCT00288912|13141384|P1|COMPLETED|Overall Study||158
5341936|NCT00288912|13141382|P3|STARTED|Overall Study||174
5341937|NCT00288912|13141383|P2|STARTED|Overall Study||174
5341938|NCT00288912|13141384|P1|STARTED|Overall Study||175
5341939|NCT00288886|13141403|P2|NOT COMPLETED|Overall Study||11
5341940|NCT00288886|13141404|P1|NOT COMPLETED|Overall Study||11
5341941|NCT00288886|13141403|P2|COMPLETED|Overall Study||81
5341942|NCT00288886|13141404|P1|COMPLETED|Overall Study||80
5341943|NCT00288886|13141403|P2|12-month Follow Up|Overall Study||81
5341944|NCT00288886|13141404|P1|12-month Follow Up|Overall Study||80
5341945|NCT00288886|13141403|P2|6-month Follow Up|Overall Study||84
5341946|NCT00288886|13141404|P1|6-month Follow Up|Overall Study||85
5341947|NCT00288886|13141403|P2|3-month Follow Up|Overall Study||85
5341948|NCT00288886|13141404|P1|3-month Follow Up|Overall Study||82
5341949|NCT00288886|13141403|P2|STARTED|Overall Study||92
5341950|NCT00288886|13141404|P1|STARTED|Overall Study||91
5341951|NCT00288860|13141424|P2|NOT COMPLETED|Overall Study||97
5341952|NCT00288860|13141425|P1|NOT COMPLETED|Overall Study||102
5341953|NCT00288860|13141424|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
5341954|NCT00288860|13141425|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
5341955|NCT00288860|13141424|P2|Completed 12 Month fu Survey|Overall Study||281
5341956|NCT00288860|13141425|P1|Completed 12 Month fu Survey|Overall Study||257
5341957|NCT00288860|13141424|P2|Completed 4 Month fu Survey|Overall Study||299
5341958|NCT00288860|13141425|P1|Completed 4 Month fu Survey|Overall Study||275
5341959|NCT00288860|13141424|P2|Completed Intake Survey|Overall Study||417
5341960|NCT00288860|13141425|P1|Completed Intake Survey|Overall Study||408
5341961|NCT00288860|13141424|P2|STARTED|Overall Study||425
5341962|NCT00288860|13141425|P1|STARTED|Overall Study||412
5341963|NCT00288704|13141438|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
5341964|NCT00288704|13141439|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
5341965|NCT00288704|13141440|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
5341966|NCT00288704|13141438|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
5341967|NCT00288704|13141439|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
5341968|NCT00288704|13141440|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
5341969|NCT00288704|13141438|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
5341970|NCT00288704|13141439|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
5341971|NCT00288704|13141440|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
5341972|NCT00288704|13141438|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
5341973|NCT00288704|13141439|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
5341974|NCT00288704|13141440|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
5341975|NCT00288704|13141438|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
5341976|NCT00288704|13141439|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
5341977|NCT00288704|13141440|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
5341978|NCT00288704|13141438|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
5341979|NCT00288704|13141439|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
5341980|NCT00288704|13141440|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
5341981|NCT00288704|13141438|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
5341982|NCT00288704|13141439|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
5341983|NCT00288704|13141440|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
5341984|NCT00288704|13141438|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
5341985|NCT00288704|13141439|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
5341986|NCT00288704|13141440|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
5341987|NCT00288704|13141438|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
5341988|NCT00288704|13141439|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
5341989|NCT00288704|13141440|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
5341990|NCT00288639|13141467|P1|NOT COMPLETED|Overall Study||12
5341991|NCT00288639|13141467|P1|COMPLETED|Overall Study||86
5341992|NCT00288639|13141467|P1|STARTED|Overall Study||98
5341993|NCT00288626|13141484|P1|NOT COMPLETED|Overall Study||7
5341994|NCT00288626|13141484|P1|COMPLETED|Overall Study||17
5341995|NCT00288626|13141484|P1|STARTED|Overall Study||24
5341996|NCT00288600|13141509|P2|NOT COMPLETED|Overall Study||0
5341997|NCT00288600|13141510|P1|NOT COMPLETED|Overall Study||0
5341998|NCT00288600|13141509|P2|COMPLETED|Overall Study||46
5341999|NCT00288600|13141510|P1|COMPLETED|Overall Study||46
5342000|NCT00288600|13141509|P2|STARTED|Overall Study||46
5342001|NCT00288600|13141510|P1|STARTED|Overall Study||46
5342002|NCT00288587|13141518|P2|NOT COMPLETED|Overall Study||10
5342003|NCT00288587|13141519|P1|NOT COMPLETED|Overall Study||5
5342004|NCT00288587|13141518|P2|COMPLETED|Overall Study||7
5342005|NCT00288587|13141519|P1|COMPLETED|Overall Study||14
5342006|NCT00288587|13141518|P2|STARTED|Overall Study||17
5342007|NCT00288587|13141519|P1|STARTED|Overall Study||19
5342008|NCT00288574|13141535|P2|NOT COMPLETED|Overall Study||0
5342009|NCT00288574|13141536|P1|NOT COMPLETED|Overall Study||0
5342010|NCT00288574|13141535|P2|COMPLETED|Overall Study||44
5342011|NCT00288574|13141536|P1|COMPLETED|Overall Study||49
5342012|NCT00288574|13141535|P2|STARTED|Overall Study||44
5342013|NCT00288574|13141536|P1|STARTED|Overall Study||49
5342014|NCT00288509|13141562|P1|NOT COMPLETED|Treatment Cycle 4||8
5342015|NCT00288509|13141562|P1|COMPLETED|Treatment Cycle 4||80
5342016|NCT00288509|13141562|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
5342017|NCT00288509|13141562|P1|NOT COMPLETED|Treatment Cycle 3||5
5342018|NCT00288509|13141562|P1|COMPLETED|Treatment Cycle 3||91
5342019|NCT00288509|13141562|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
5342020|NCT00288509|13141562|P1|NOT COMPLETED|Treatment Cycle 2||3
5342021|NCT00288509|13141562|P1|COMPLETED|Treatment Cycle 2||97
5342022|NCT00288509|13141562|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
5342023|NCT00288509|13141562|P1|NOT COMPLETED|Treatment Cycle 1||6
5342024|NCT00288509|13141562|P1|COMPLETED|Treatment Cycle 1||102
5342025|NCT00288509|13141562|P1|STARTED|Treatment Cycle 1||108
5342026|NCT00288366|13141571|P2|NOT COMPLETED|Overall Study||0
5342027|NCT00288366|13141572|P1|NOT COMPLETED|Overall Study||0
5342028|NCT00288366|13141571|P2|COMPLETED|Overall Study||26
5342029|NCT00288366|13141572|P1|COMPLETED|Overall Study||23
5342030|NCT00288366|13141571|P2|STARTED|Overall Study||26
5342031|NCT00288366|13141572|P1|STARTED|Overall Study||23
5342032|NCT00288080|13141580|P2|NOT COMPLETED|Overall Study||23
5342033|NCT00288080|13141581|P1|NOT COMPLETED|Overall Study||26
5342034|NCT00288080|13141580|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
5342035|NCT00288080|13141581|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
5342036|NCT00288080|13141580|P2|STARTED|Overall Study||305
5342037|NCT00288080|13141581|P1|STARTED|Overall Study||307
5342038|NCT00288067|13141597|P1|NOT COMPLETED|Overall Study||0
5342039|NCT00288067|13141597|P1|COMPLETED|Overall Study||32
5342040|NCT00288067|13141597|P1|STARTED|Overall Study||32
5342041|NCT00288054|13141603|P1|NOT COMPLETED|Overall Study||24
5342042|NCT00288054|13141603|P1|COMPLETED|Overall Study||0
5342043|NCT00288054|13141603|P1|STARTED|Overall Study||24
5342044|NCT00288015|13141611|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
5342045|NCT00288015|13141611|P1|COMPLETED|Follow up for Survival x 2 Years||3
5342046|NCT00288015|13141611|P1|STARTED|Follow up for Survival x 2 Years||29
5342047|NCT00288015|13141611|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
5342048|NCT00288015|13141611|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
5342049|NCT00288015|13141611|P1|STARTED|Continued Bevacizumab Cycle 3+||26
5342050|NCT00288015|13141611|P1|NOT COMPLETED|First Response Assessment||4
5342051|NCT00288015|13141611|P1|COMPLETED|First Response Assessment||26
5342052|NCT00288015|13141611|P1|STARTED|First Response Assessment||30
5342053|NCT00288015|13141611|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
5342054|NCT00288015|13141611|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
5342055|NCT00288015|13141611|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
5342056|NCT00288015|13141611|P1|NOT COMPLETED|Registered to Study||0
5342057|NCT00288015|13141611|P1|COMPLETED|Registered to Study||32
5342058|NCT00288015|13141611|P1|STARTED|Registered to Study||32
5342059|NCT00287989|13141623|P3|NOT COMPLETED|Overall Study||0
5342060|NCT00287989|13141624|P2|NOT COMPLETED|Overall Study||0
5342061|NCT00287989|13141625|P1|NOT COMPLETED|Overall Study||0
5342062|NCT00287989|13141623|P3|COMPLETED|Overall Study||29
5342063|NCT00287989|13141624|P2|COMPLETED|Overall Study||29
5342064|NCT00287989|13141625|P1|COMPLETED|Overall Study||28
5342065|NCT00287989|13141623|P3|STARTED|Overall Study||29
5342066|NCT00287989|13141624|P2|STARTED|Overall Study||29
5342067|NCT00287989|13141625|P1|STARTED|Overall Study||28
5342068|NCT00287872|13141636|P1|NOT COMPLETED|Overall Study||0
5342069|NCT00287872|13141636|P1|COMPLETED|Overall Study||30
5342070|NCT00287872|13141636|P1|STARTED|Overall Study||30
5342071|NCT00287729|13141646|P2|NOT COMPLETED|Overall Study||31
5342072|NCT00287729|13141647|P1|NOT COMPLETED|Overall Study||34
5342073|NCT00287729|13141646|P2|COMPLETED|Overall Study||142
5342074|NCT00287729|13141647|P1|COMPLETED|Overall Study||137
5342075|NCT00287729|13141646|P2|STARTED|Overall Study||173
5342076|NCT00287729|13141647|P1|STARTED|Overall Study||171
5342077|NCT00287716|13141670|P3|NOT COMPLETED|Overall Study||31
5342078|NCT00287716|13141671|P2|NOT COMPLETED|Overall Study||17
5342079|NCT00287716|13141672|P1|NOT COMPLETED|Overall Study||38
5342080|NCT00287716|13141670|P3|COMPLETED|Overall Study||143
5342081|NCT00287716|13141671|P2|COMPLETED|Overall Study||70
5342082|NCT00287716|13141672|P1|COMPLETED|Overall Study||136
5342083|NCT00287716|13141670|P3|STARTED|Overall Study||174
5342084|NCT00287716|13141671|P2|STARTED|Overall Study||87
5342085|NCT00287716|13141672|P1|STARTED|Overall Study||174
5342086|NCT00287690|13141703|P2|NOT COMPLETED|Overall Study||26
5342087|NCT00287690|13141704|P1|NOT COMPLETED|Overall Study||20
5342088|NCT00287690|13141703|P2|COMPLETED|Overall Study||12
5342089|NCT00287690|13141704|P1|COMPLETED|Overall Study||13
5342090|NCT00287690|13141703|P2|STARTED|Overall Study||38
5342091|NCT00287690|13141704|P1|STARTED|Overall Study||33
5342092|NCT00287586|13141716|P2|NOT COMPLETED|Overall Study||52
5342093|NCT00287586|13141717|P1|NOT COMPLETED|Overall Study||45
5342094|NCT00287586|13141716|P2|COMPLETED|Overall Study||100
5342095|NCT00287586|13141717|P1|COMPLETED|Overall Study||111
5342096|NCT00287586|13141716|P2|Intent-to-treat: Received Study Drug|Overall Study||151
5342097|NCT00287586|13141717|P1|Intent-to-treat: Received Study Drug|Overall Study||155
5342098|NCT00287586|13141716|P2|STARTED|Overall Study||152
5342099|NCT00287586|13141717|P1|STARTED|Overall Study||156
5342100|NCT00287469|13141755|P2|NOT COMPLETED|Overall Study||214
5342101|NCT00287469|13141756|P1|NOT COMPLETED|Overall Study||220
5342102|NCT00287469|13141755|P2|COMPLETED|Overall Study||786
5342103|NCT00287469|13141756|P1|COMPLETED|Overall Study||780
5342104|NCT00287469|13141755|P2|STARTED|Overall Study||1000
5342105|NCT00287469|13141756|P1|STARTED|Overall Study||1000
5342106|NCT00287365|13141766|P1|NOT COMPLETED|Overall Study||13
5342107|NCT00287365|13141766|P1|COMPLETED|Overall Study||12
5342108|NCT00287365|13141766|P1|STARTED|Overall Study||25
5342109|NCT00287339|13141777|P2|NOT COMPLETED|Overall Study||0
5342110|NCT00287339|13141778|P1|NOT COMPLETED|Overall Study||0
5342111|NCT00287339|13141777|P2|COMPLETED|Overall Study||18
5342112|NCT00287339|13141778|P1|COMPLETED|Overall Study||22
5342113|NCT00287339|13141777|P2|STARTED|Overall Study||18
5342114|NCT00287339|13141778|P1|STARTED|Overall Study||22
5342115|NCT00287287|13141784|P1|NOT COMPLETED|Overall Study||0
5342116|NCT00287287|13141784|P1|COMPLETED|Overall Study||25
5342117|NCT00287287|13141784|P1|STARTED|Overall Study||25
5342118|NCT00287222|13141788|P1|NOT COMPLETED|Overall Study||0
5342119|NCT00287222|13141788|P1|COMPLETED|Overall Study||21
5342120|NCT00287222|13141788|P1|STARTED|Overall Study||21
5342121|NCT00287118|13141792|P1|NOT COMPLETED|Overall Study||52
5342122|NCT00287118|13141792|P1|COMPLETED|Overall Study||137
5342123|NCT00287118|13141792|P1|STARTED|Overall Study||189
5342124|NCT00287079|13141798|P2|NOT COMPLETED|Overall Study||1
5342125|NCT00287079|13141799|P1|NOT COMPLETED|Overall Study||22
5342126|NCT00287079|13141798|P2|COMPLETED|Overall Study||2
5342127|NCT00287079|13141799|P1|COMPLETED|Overall Study||10
5342128|NCT00287079|13141798|P2|STARTED|Overall Study||3
5342129|NCT00287079|13141799|P1|STARTED|Overall Study||32
5342130|NCT00287053|13141811|P2|NOT COMPLETED|Overall Study||1
5342131|NCT00287053|13141812|P1|NOT COMPLETED|Overall Study||4
5342132|NCT00287053|13141811|P2|COMPLETED|Overall Study||26
5342133|NCT00287053|13141812|P1|COMPLETED|Overall Study||26
5342134|NCT00287053|13141811|P2|STARTED|Overall Study||27
5342135|NCT00287053|13141812|P1|STARTED|Overall Study||30
5342136|NCT00286949|13141818|P1|NOT COMPLETED|Overall Study||0
5342137|NCT00286949|13141818|P1|COMPLETED|Overall Study||12
5342138|NCT00286949|13141818|P1|STARTED|Overall Study||12
5342139|NCT00286754|13141827|P3|NOT COMPLETED|Overall Study||10
5342140|NCT00286754|13141828|P2|NOT COMPLETED|Overall Study||18
5342141|NCT00286754|13141829|P1|NOT COMPLETED|Overall Study||20
5342142|NCT00286754|13141827|P3|COMPLETED|Overall Study||170
5342143|NCT00286754|13141828|P2|COMPLETED|Overall Study||159
5342144|NCT00286754|13141829|P1|COMPLETED|Overall Study||156
5342145|NCT00286754|13141827|P3|STARTED|Overall Study||180
5342146|NCT00286754|13141828|P2|STARTED|Overall Study||177
5342147|NCT00286754|13141829|P1|STARTED|Overall Study||176
5342148|NCT00286741|13141863|P2|NOT COMPLETED|Overall Study||17
5342149|NCT00286741|13141864|P1|NOT COMPLETED|Overall Study||11
5342150|NCT00286741|13141863|P2|COMPLETED|Overall Study||89
5342151|NCT00286741|13141864|P1|COMPLETED|Overall Study||122
5342152|NCT00286741|13141863|P2|STARTED|Overall Study||106
5342153|NCT00286741|13141864|P1|STARTED|Overall Study||133
5342154|NCT00286728|13141876|P2|NOT COMPLETED|Overall Study||29
5342155|NCT00286728|13141877|P1|NOT COMPLETED|Overall Study||36
5342156|NCT00286728|13141876|P2|COMPLETED|Overall Study||116
5342157|NCT00286728|13141877|P1|COMPLETED|Overall Study||106
5342158|NCT00286728|13141876|P2|STARTED|Overall Study||145
5342159|NCT00286728|13141877|P1|STARTED|Overall Study||142
5342160|NCT00286494|13141888|P3|NOT COMPLETED|Overall Study||39
5342161|NCT00286494|13141889|P2|NOT COMPLETED|Overall Study||44
5342162|NCT00286494|13141890|P1|NOT COMPLETED|Overall Study||26
5342163|NCT00286494|13141888|P3|COMPLETED|Overall Study||160
5342164|NCT00286494|13141889|P2|COMPLETED|Overall Study||153
5342165|NCT00286494|13141890|P1|COMPLETED|Overall Study||71
5342166|NCT00286494|13141888|P3|STARTED|Overall Study||199
5342167|NCT00286494|13141889|P2|STARTED|Overall Study||197
5342168|NCT00286494|13141890|P1|STARTED|Overall Study||97
5342169|NCT00286468|13142051|P3|NOT COMPLETED|Overall Study||50
5342170|NCT00286468|13142052|P2|NOT COMPLETED|Overall Study||50
5342171|NCT00286468|13142053|P1|NOT COMPLETED|Overall Study||37
5342172|NCT00286468|13142051|P3|COMPLETED|Overall Study||148
5342173|NCT00286468|13142052|P2|COMPLETED|Overall Study||153
5342174|NCT00286468|13142053|P1|COMPLETED|Overall Study||62
5342175|NCT00286468|13142051|P3|STARTED|Overall Study||198
5342176|NCT00286468|13142052|P2|STARTED|Overall Study||203
5342177|NCT00286468|13142053|P1|STARTED|Overall Study||99
5342178|NCT00286455|13142214|P3|NOT COMPLETED|Overall Study||24
5342179|NCT00286455|13142215|P2|NOT COMPLETED|Overall Study||28
5342180|NCT00286455|13142216|P1|NOT COMPLETED|Overall Study||25
5342181|NCT00286455|13142214|P3|COMPLETED|Overall Study||107
5342182|NCT00286455|13142215|P2|COMPLETED|Overall Study||105
5342183|NCT00286455|13142216|P1|COMPLETED|Overall Study||40
5342184|NCT00286455|13142214|P3|STARTED|Overall Study||131
5342185|NCT00286455|13142215|P2|STARTED|Overall Study||133
5342186|NCT00286455|13142216|P1|STARTED|Overall Study||65
5342187|NCT00286442|13142395|P3|NOT COMPLETED|Overall Study||32
5342188|NCT00286442|13142396|P2|NOT COMPLETED|Overall Study||45
5342189|NCT00286442|13142397|P1|NOT COMPLETED|Overall Study||37
5342190|NCT00286442|13142395|P3|COMPLETED|Overall Study||72
5342191|NCT00286442|13142396|P2|COMPLETED|Overall Study||165
5342192|NCT00286442|13142397|P1|COMPLETED|Overall Study||176
5342193|NCT00286442|13142395|P3|STARTED|Overall Study||104
5342194|NCT00286442|13142396|P2|STARTED|Overall Study||210
5342195|NCT00286442|13142397|P1|STARTED|Overall Study||213
5342196|NCT00286429|13142558|P3|NOT COMPLETED|Overall Study||52
5342197|NCT00286429|13142559|P2|NOT COMPLETED|Overall Study||48
5342198|NCT00286429|13142560|P1|NOT COMPLETED|Overall Study||75
5342199|NCT00286429|13142558|P3|COMPLETED|Overall Study||77
5342200|NCT00286429|13142559|P2|COMPLETED|Overall Study||83
5342201|NCT00286429|13142560|P1|COMPLETED|Overall Study||55
5342202|NCT00286429|13142558|P3|STARTED|Overall Study||129
5342203|NCT00286429|13142559|P2|STARTED|Overall Study||131
5342204|NCT00286429|13142560|P1|STARTED|Overall Study||130
5342205|NCT00286325|13142664|P1|NOT COMPLETED|Overall Study||0
5342206|NCT00286325|13142664|P1|COMPLETED|Overall Study||8
5342207|NCT00286325|13142664|P1|STARTED|Overall Study||8
5342208|NCT00286221|13142676|P4|NOT COMPLETED|Overall Study||6
5342209|NCT00286221|13142677|P3|NOT COMPLETED|Overall Study||9
5342210|NCT00286221|13142678|P2|NOT COMPLETED|Overall Study||5
5342211|NCT00286221|13142679|P1|NOT COMPLETED|Overall Study||10
5342212|NCT00286221|13142676|P4|COMPLETED|Overall Study||34
5342213|NCT00286221|13142677|P3|COMPLETED|Overall Study||31
5342214|NCT00286221|13142678|P2|COMPLETED|Overall Study||35
5342215|NCT00286221|13142679|P1|COMPLETED|Overall Study||29
5342216|NCT00286221|13142676|P4|STARTED|Overall Study||40
5342217|NCT00286221|13142677|P3|STARTED|Overall Study||40
5342218|NCT00286221|13142678|P2|STARTED|Overall Study||40
5342219|NCT00286221|13142679|P1|STARTED|Overall Study||39
5342220|NCT00286182|13142695|P2|NOT COMPLETED|Overall Study||3
5342221|NCT00286182|13142696|P1|NOT COMPLETED|Overall Study||5
5342222|NCT00286182|13142695|P2|COMPLETED|Overall Study||25
5342223|NCT00286182|13142696|P1|COMPLETED|Overall Study||23
5342224|NCT00286182|13142695|P2|STARTED|Overall Study||28
5342225|NCT00286182|13142696|P1|STARTED|Overall Study||28
5342226|NCT00286156|13142705|P3|NOT COMPLETED|Overall Study||1
5342227|NCT00286156|13142706|P2|NOT COMPLETED|Overall Study||1
5342228|NCT00286156|13142707|P1|NOT COMPLETED|Overall Study||2
5342229|NCT00286156|13142705|P3|COMPLETED|Overall Study||9
5342230|NCT00286156|13142706|P2|COMPLETED|Overall Study||9
5342231|NCT00286156|13142707|P1|COMPLETED|Overall Study||8
5342232|NCT00286156|13142705|P3|STARTED|Overall Study||10
5342233|NCT00286156|13142706|P2|STARTED|Overall Study||10
5342234|NCT00286156|13142707|P1|STARTED|Overall Study||10
5342235|NCT00286091|13142720|P2|NOT COMPLETED|Open-label Treatment Phase||71
5342236|NCT00286091|13142721|P1|NOT COMPLETED|Open-label Treatment Phase||77
5342237|NCT00286091|13142720|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
5342238|NCT00286091|13142721|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
5342239|NCT00286091|13142720|P2|Received Treatment|Open-label Treatment Phase||101
5342240|NCT00286091|13142721|P1|Received Treatment|Open-label Treatment Phase||109
5342241|NCT00286091|13142720|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
5342242|NCT00286091|13142721|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
5342243|NCT00286091|13142720|P2|NOT COMPLETED|Double-blind Treatment Phase||593
5342244|NCT00286091|13142721|P1|NOT COMPLETED|Double-blind Treatment Phase||584
5342245|NCT00286091|13142720|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
5342246|NCT00286091|13142721|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
5342247|NCT00286091|13142720|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
5342248|NCT00286091|13142721|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
5342249|NCT00286091|13142720|P2|Received Treatment|Double-blind Treatment Phase||716
5342250|NCT00286091|13142721|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
5342251|NCT00286091|13142720|P2|STARTED|Double-blind Treatment Phase||716
5342252|NCT00286091|13142721|P1|STARTED|Double-blind Treatment Phase||716
5342253|NCT00286078|13142735|P2|NOT COMPLETED|Overall Study||34
5342254|NCT00286078|13142736|P1|NOT COMPLETED|Overall Study||32
5342255|NCT00286078|13142735|P2|COMPLETED|Overall Study||34
5342256|NCT00286078|13142736|P1|COMPLETED|Overall Study||40
5342257|NCT00286078|13142735|P2|12 Weeks|Overall Study||62
5342258|NCT00286078|13142736|P1|12 Weeks|Overall Study||63
5342259|NCT00286078|13142735|P2|STARTED|Overall Study||68
5342260|NCT00286078|13142736|P1|STARTED|Overall Study||72
5342261|NCT00285857|13142744|P1|NOT COMPLETED|Overall Study||4
5342262|NCT00285857|13142744|P1|COMPLETED|Overall Study||26
5342263|NCT00285857|13142744|P1|STARTED|Overall Study||30
5342264|NCT00285818|13142757|P2|NOT COMPLETED|Overall Study||2
5342265|NCT00285818|13142758|P1|NOT COMPLETED|Overall Study||4
5342266|NCT00285818|13142757|P2|COMPLETED|Overall Study||3
5342267|NCT00285818|13142758|P1|COMPLETED|Overall Study||2
5342268|NCT00285818|13142757|P2|STARTED|Overall Study||5
5342269|NCT00285818|13142758|P1|STARTED|Overall Study||6
5342270|NCT00285779|13142766|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
5342271|NCT00285779|13142767|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
5342272|NCT00285779|13142766|P2|COMPLETED|Follow-up Period (wk 24-32)||10
5342273|NCT00285779|13142767|P1|COMPLETED|Follow-up Period (wk 24-32)||8
5342274|NCT00285779|13142766|P2|STARTED|Follow-up Period (wk 24-32)||10
5342275|NCT00285779|13142767|P1|STARTED|Follow-up Period (wk 24-32)||9
5342276|NCT00285779|13142766|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
5342277|NCT00285779|13142767|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
5342278|NCT00285779|13142766|P2|COMPLETED|Open Label Period (wk 12-24)||10
5342279|NCT00285779|13142767|P1|COMPLETED|Open Label Period (wk 12-24)||9
5342280|NCT00285779|13142766|P2|STARTED|Open Label Period (wk 12-24)||12
5342281|NCT00285779|13142767|P1|STARTED|Open Label Period (wk 12-24)||11
5342282|NCT00285779|13142766|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
5342283|NCT00285779|13142767|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
5342284|NCT00285779|13142766|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
5342285|NCT00285779|13142767|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
5342286|NCT00285779|13142766|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
5342287|NCT00285779|13142767|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
5342288|NCT00285649|13142803|P3|NOT COMPLETED|Overall Study||6
5342289|NCT00285649|13142804|P2|NOT COMPLETED|Overall Study||6
5342290|NCT00285649|13142805|P1|NOT COMPLETED|Overall Study||9
5342291|NCT00285649|13142803|P3|COMPLETED|Overall Study||42
5342292|NCT00285649|13142804|P2|COMPLETED|Overall Study||66
5342293|NCT00285649|13142805|P1|COMPLETED|Overall Study||63
5342294|NCT00285649|13142803|P3|STARTED|Overall Study||48
5342295|NCT00285649|13142804|P2|STARTED|Overall Study||72
5342296|NCT00285649|13142805|P1|STARTED|Overall Study||72
5342297|NCT00285584|13142815|P2|NOT COMPLETED|Month 9||3
5342298|NCT00285584|13142816|P1|NOT COMPLETED|Month 9||1
5342299|NCT00285584|13142815|P2|COMPLETED|Month 9||14
5342300|NCT00285584|13142816|P1|COMPLETED|Month 9||15
5342301|NCT00285584|13142815|P2|STARTED|Month 9||17
5342302|NCT00285584|13142816|P1|STARTED|Month 9||16
5342303|NCT00285584|13142815|P2|NOT COMPLETED|Month 6||1
5342304|NCT00285584|13142816|P1|NOT COMPLETED|Month 6||0
5342305|NCT00285584|13142815|P2|COMPLETED|Month 6||17
5342306|NCT00285584|13142816|P1|COMPLETED|Month 6||16
5342307|NCT00285584|13142815|P2|STARTED|Month 6||18
5342308|NCT00285584|13142816|P1|STARTED|Month 6||16
5342309|NCT00285584|13142815|P2|NOT COMPLETED|Month 3||3
5342310|NCT00285584|13142816|P1|NOT COMPLETED|Month 3||4
5342311|NCT00285584|13142815|P2|COMPLETED|Month 3||18
5342312|NCT00285584|13142816|P1|COMPLETED|Month 3||16
5342313|NCT00285584|13142815|P2|STARTED|Month 3||21
5342314|NCT00285584|13142816|P1|STARTED|Month 3||20
5342315|NCT00285584|13142815|P2|NOT COMPLETED|Enrollment (Month 0)||0
5342316|NCT00285584|13142816|P1|NOT COMPLETED|Enrollment (Month 0)||0
5342317|NCT00285584|13142815|P2|COMPLETED|Enrollment (Month 0)||21
5342318|NCT00285584|13142816|P1|COMPLETED|Enrollment (Month 0)||20
5342319|NCT00285584|13142815|P2|STARTED|Enrollment (Month 0)||21
5342320|NCT00285584|13142816|P1|STARTED|Enrollment (Month 0)||20
5342321|NCT00285467|13142830|P2|NOT COMPLETED|Overall Study||0
5342322|NCT00285467|13142831|P1|NOT COMPLETED|Overall Study||0
5342323|NCT00285467|13142830|P2|COMPLETED|Overall Study||22
5342324|NCT00285467|13142831|P1|COMPLETED|Overall Study||25
5342325|NCT00285467|13142830|P2|STARTED|Overall Study||22
5342326|NCT00285467|13142831|P1|STARTED|Overall Study||25
5342327|NCT00285246|13142839|P1|NOT COMPLETED|Overall Study||48
5342328|NCT00285246|13142839|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
5342329|NCT00285246|13142839|P1|STARTED|Overall Study||838
5342330|NCT00285207|13142848|P2|NOT COMPLETED|Overall Study||6
5342331|NCT00285207|13142849|P1|NOT COMPLETED|Overall Study||9
5342332|NCT00285207|13142848|P2|COMPLETED|Overall Study||71
5342333|NCT00285207|13142849|P1|COMPLETED|Overall Study||61
5342334|NCT00285207|13142848|P2|Treated|Overall Study||75
5342335|NCT00285207|13142849|P1|Treated|Overall Study||63
5342336|NCT00285207|13142848|P2|STARTED|Overall Study||77
5342337|NCT00285207|13142849|P1|STARTED|Overall Study||70
5342338|NCT00285012|13142857|P2|NOT COMPLETED|Received Study Tx||94
5342339|NCT00285012|13142858|P1|NOT COMPLETED|Received Study Tx||72
5342340|NCT00285012|13142857|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
5342341|NCT00285012|13142858|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
5342342|NCT00285012|13142857|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
5342343|NCT00285012|13142858|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
5342344|NCT00285012|13142857|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
5342345|NCT00285012|13142858|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
5342346|NCT00285012|13142857|P2|STARTED|Received Study Tx||251
5342347|NCT00285012|13142858|P1|STARTED|Received Study Tx||248
5342348|NCT00285012|13142857|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
5342349|NCT00285012|13142858|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
5342350|NCT00285012|13142857|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
5342351|NCT00285012|13142858|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
5342352|NCT00285012|13142857|P2|STARTED|Assigned to Study Treatment (Tx)||254
5342353|NCT00285012|13142858|P1|STARTED|Assigned to Study Treatment (Tx)||250
5342354|NCT00284934|13142884|P2|NOT COMPLETED|Overall Study||3
5342355|NCT00284934|13142885|P1|NOT COMPLETED|Overall Study||4
5342356|NCT00284934|13142884|P2|COMPLETED|Overall Study||43
5342357|NCT00284934|13142885|P1|COMPLETED|Overall Study||44
5342358|NCT00284934|13142884|P2|Intent-to-treat Population (ITT)|Overall Study||45
5342359|NCT00284934|13142885|P1|Intent-to-treat Population (ITT)|Overall Study||47
5342360|NCT00284934|13142884|P2|STARTED|Overall Study||46
5342361|NCT00284934|13142885|P1|STARTED|Overall Study||48
5342362|NCT00284856|13142900|P3|NOT COMPLETED|Overall Study||60
5342363|NCT00284856|13142901|P2|NOT COMPLETED|Overall Study||50
5342364|NCT00284856|13142902|P1|NOT COMPLETED|Overall Study||51
5342365|NCT00284856|13142900|P3|COMPLETED|Overall Study||276
5342366|NCT00284856|13142901|P2|COMPLETED|Overall Study||286
5342367|NCT00284856|13142902|P1|COMPLETED|Overall Study||296
5342368|NCT00284856|13142900|P3|STARTED|Overall Study||336
5342369|NCT00284856|13142901|P2|STARTED|Overall Study||336
5342370|NCT00284856|13142902|P1|STARTED|Overall Study||347
5342371|NCT00284739|13142918|P2|NOT COMPLETED|Overall Study||0
5342372|NCT00284739|13142919|P1|NOT COMPLETED|Overall Study||0
5342373|NCT00284739|13142918|P2|COMPLETED|Overall Study||9
5342374|NCT00284739|13142919|P1|COMPLETED|Overall Study||11
5342375|NCT00284739|13142918|P2|STARTED|Overall Study||9
5342376|NCT00284739|13142919|P1|STARTED|Overall Study||11
5342377|NCT00284557|13142931|P2|NOT COMPLETED|Overall Study||13
5342378|NCT00284557|13142932|P1|NOT COMPLETED|Overall Study||9
5342379|NCT00284557|13142931|P2|COMPLETED|Overall Study||50
5342380|NCT00284557|13142932|P1|COMPLETED|Overall Study||58
5342381|NCT00284557|13142931|P2|STARTED|Overall Study||63
5342382|NCT00284557|13142932|P1|STARTED|Overall Study||67
5342383|NCT00284518|13142944|P4|NOT COMPLETED|Overall Study||33
5342384|NCT00284518|13142945|P3|NOT COMPLETED|Overall Study||28
5342385|NCT00284518|13142946|P2|NOT COMPLETED|Overall Study||28
5342386|NCT00284518|13142947|P1|NOT COMPLETED|Overall Study||26
5342387|NCT00284518|13142944|P4|COMPLETED|Overall Study||61
5342388|NCT00284518|13142945|P3|COMPLETED|Overall Study||67
5342389|NCT00284518|13142946|P2|COMPLETED|Overall Study||66
5342390|NCT00284518|13142947|P1|COMPLETED|Overall Study||71
5342391|NCT00284518|13142944|P4|STARTED|Overall Study||94
5342392|NCT00284518|13142945|P3|STARTED|Overall Study||95
5342393|NCT00284518|13142946|P2|STARTED|Overall Study||94
5342394|NCT00284518|13142947|P1|STARTED|Overall Study||97
5342395|NCT00284180|13142987|P2|NOT COMPLETED|Overall Study||4
5342396|NCT00284180|13142988|P1|NOT COMPLETED|Overall Study||0
5342397|NCT00284180|13142987|P2|COMPLETED|Overall Study||17
5342398|NCT00284180|13142988|P1|COMPLETED|Overall Study||11
5342399|NCT00284180|13142987|P2|STARTED|Overall Study||21
5342400|NCT00284180|13142988|P1|STARTED|Overall Study||11
5342401|NCT00284154|13142994|P1|NOT COMPLETED|Overall Study||42
5342402|NCT00284154|13142994|P1|COMPLETED|Overall Study||9
5342403|NCT00284154|13142994|P1|STARTED|Overall Study||51
5342404|NCT00284141|13143001|P1|NOT COMPLETED|Overall Study||98
5342405|NCT00284141|13143001|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
5342406|NCT00284141|13143001|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
5342407|NCT00284141|13143001|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
5342408|NCT00284141|13143001|P1|STARTED|Overall Study||98
5342409|NCT00284089|13143024|P4|NOT COMPLETED|Extension Phase||12
5342410|NCT00284089|13143025|P3|NOT COMPLETED|Extension Phase||6
5342411|NCT00284089|13143026|P2|NOT COMPLETED|Extension Phase||0
5342412|NCT00284089|13143027|P1|NOT COMPLETED|Extension Phase||2
5342413|NCT00284089|13143024|P4|COMPLETED|Extension Phase||21
5342414|NCT00284089|13143025|P3|COMPLETED|Extension Phase||22
5342415|NCT00284089|13143026|P2|COMPLETED|Extension Phase||6
5342416|NCT00284089|13143027|P1|COMPLETED|Extension Phase||1
5342417|NCT00284089|13143024|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
5342418|NCT00284089|13143025|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
5342419|NCT00284089|13143026|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
5342420|NCT00284089|13143027|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
5342421|NCT00284089|13143024|P4|NOT COMPLETED|Multiple Dose Phase||4
5342422|NCT00284089|13143025|P3|NOT COMPLETED|Multiple Dose Phase||4
5342423|NCT00284089|13143026|P2|NOT COMPLETED|Multiple Dose Phase||0
5342424|NCT00284089|13143027|P1|NOT COMPLETED|Multiple Dose Phase||1
5342425|NCT00284089|13143024|P4|COMPLETED|Multiple Dose Phase||37
5342426|NCT00284089|13143025|P3|COMPLETED|Multiple Dose Phase||31
5342427|NCT00284089|13143026|P2|COMPLETED|Multiple Dose Phase||6
5342428|NCT00284089|13143027|P1|COMPLETED|Multiple Dose Phase||4
5342429|NCT00284089|13143024|P4|STARTED|Multiple Dose Phase||41
5342430|NCT00284089|13143025|P3|STARTED|Multiple Dose Phase||35
5342431|NCT00284089|13143026|P2|STARTED|Multiple Dose Phase||6
5342432|NCT00284089|13143027|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
5342433|NCT00284089|13143024|P4|NOT COMPLETED|Single Dose Phase||0
5342434|NCT00284089|13143025|P3|NOT COMPLETED|Single Dose Phase||0
5342435|NCT00284089|13143026|P2|NOT COMPLETED|Single Dose Phase||0
5342436|NCT00284089|13143027|P1|NOT COMPLETED|Single Dose Phase||0
5342437|NCT00284089|13143024|P4|COMPLETED|Single Dose Phase||0
5342438|NCT00284089|13143025|P3|COMPLETED|Single Dose Phase||0
5342439|NCT00284089|13143026|P2|COMPLETED|Single Dose Phase||6
5342440|NCT00284089|13143027|P1|COMPLETED|Single Dose Phase||6
5342441|NCT00284089|13143024|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
5342442|NCT00284089|13143025|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
5342443|NCT00284089|13143026|P2|STARTED|Single Dose Phase||6
5342444|NCT00284089|13143027|P1|STARTED|Single Dose Phase||6
5342445|NCT00284050|13143056|P3|NOT COMPLETED|Overall Study||9
5342446|NCT00284050|13143057|P2|NOT COMPLETED|Overall Study||5
5342447|NCT00284050|13143058|P1|NOT COMPLETED|Overall Study||5
5342448|NCT00284050|13143056|P3|COMPLETED|Overall Study||40
5342449|NCT00284050|13143057|P2|COMPLETED|Overall Study||46
5342450|NCT00284050|13143058|P1|COMPLETED|Overall Study||46
5342451|NCT00284050|13143056|P3|STARTED|Overall Study||49
5342452|NCT00284050|13143057|P2|STARTED|Overall Study||51
5342453|NCT00284050|13143058|P1|STARTED|Overall Study||51
5342454|NCT00283959|13143072|P1|NOT COMPLETED|Extension Period||1
5342455|NCT00283959|13143072|P1|COMPLETED|Extension Period||3
5342456|NCT00283959|13143072|P1|STARTED|Extension Period||4
5342457|NCT00283959|13143072|P1|NOT COMPLETED|Treatment Period||0
5342458|NCT00283959|13143072|P1|COMPLETED|Treatment Period||4
5342459|NCT00283959|13143072|P1|Pharmacodynamics (PD) Population|Treatment Period||4
5342460|NCT00283959|13143072|P1|Safety Population|Treatment Period||4
5342461|NCT00283959|13143072|P1|STARTED|Treatment Period||4
5342462|NCT00283933|13143077|P1|NOT COMPLETED|Extension Period||0
5342463|NCT00283933|13143077|P1|COMPLETED|Extension Period||5
5342464|NCT00283933|13143077|P1|STARTED|Extension Period||5
5342465|NCT00283933|13143077|P1|NOT COMPLETED|Treatment Period||0
5342466|NCT00283933|13143077|P1|COMPLETED|Treatment Period||5
5342467|NCT00283933|13143077|P1|Pharmacodynamic (PD) Population|Treatment Period||5
5342468|NCT00283933|13143077|P1|Safety Population|Treatment Period||5
5342469|NCT00283933|13143077|P1|STARTED|Treatment Period||5
5342470|NCT00283868|13143084|P2|NOT COMPLETED|Overall Study||8
5342471|NCT00283868|13143085|P1|NOT COMPLETED|Overall Study||7
5342472|NCT00283868|13143084|P2|COMPLETED|Overall Study||103
5342473|NCT00283868|13143085|P1|COMPLETED|Overall Study||104
5342474|NCT00283868|13143084|P2|STARTED|Overall Study||111
5342475|NCT00283868|13143085|P1|STARTED|Overall Study||111
5342476|NCT00283842|13143102|P5|NOT COMPLETED|Overall Study||15
5342477|NCT00283842|13143103|P4|NOT COMPLETED|Overall Study||27
5342478|NCT00283842|13143104|P3|NOT COMPLETED|Overall Study||31
5342479|NCT00283842|13143105|P2|NOT COMPLETED|Overall Study||18
5342480|NCT00283842|13143106|P1|NOT COMPLETED|Overall Study||12
5342481|NCT00283842|13143102|P5|COMPLETED|Overall Study||75
5342482|NCT00283842|13143103|P4|COMPLETED|Overall Study||42
5342483|NCT00283842|13143104|P3|COMPLETED|Overall Study||68
5342484|NCT00283842|13143105|P2|COMPLETED|Overall Study||69
5342485|NCT00283842|13143106|P1|COMPLETED|Overall Study||51
5342486|NCT00283842|13143102|P5|STARTED|Overall Study||90
5342487|NCT00283842|13143103|P4|STARTED|Overall Study||69
5342488|NCT00283842|13143104|P3|STARTED|Overall Study||99
5342489|NCT00283842|13143105|P2|STARTED|Overall Study||87
5342490|NCT00283842|13143106|P1|STARTED|Overall Study||63
5342491|NCT00283816|13143125|P2|NOT COMPLETED|Overall Study||2
5342492|NCT00283816|13143126|P1|NOT COMPLETED|Overall Study||2
5342493|NCT00283816|13143125|P2|COMPLETED|Overall Study||16
5342494|NCT00283816|13143126|P1|COMPLETED|Overall Study||16
5342495|NCT00283816|13143125|P2|STARTED|Overall Study||18
5342496|NCT00283816|13143126|P1|STARTED|Overall Study||18
5342497|NCT00283803|13143138|P1|NOT COMPLETED|Overall Study||13
5342498|NCT00283803|13143138|P1|COMPLETED|Overall Study||19
5342499|NCT00283803|13143138|P1|STARTED|Overall Study||32
5342500|NCT00283712|13143146|P2|NOT COMPLETED|Overall Study||1
5342501|NCT00283712|13143147|P1|NOT COMPLETED|Overall Study||0
5342502|NCT00283712|13143146|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
5342503|NCT00283712|13143147|P1|COMPLETED|Overall Study||10
5342504|NCT00283712|13143146|P2|Per-Protocol Sample|Overall Study||7
5342505|NCT00283712|13143147|P1|Per-Protocol Sample|Overall Study||6
5342506|NCT00283712|13143146|P2|Safety Sample|Overall Study||10
5342507|NCT00283712|13143147|P1|Safety Sample|Overall Study||10
5342508|NCT00283712|13143146|P2|Intent-to-treat Sample|Overall Study||10
5342509|NCT00283712|13143147|P1|Intent-to-treat Sample|Overall Study||10
5342510|NCT00283712|13143146|P2|STARTED|Overall Study||10
5342511|NCT00283712|13143147|P1|STARTED|Overall Study||10
5342512|NCT00283686|13143185|P4|NOT COMPLETED|Overall Study||32
5342513|NCT00283686|13143186|P3|NOT COMPLETED|Overall Study||33
5342514|NCT00283686|13143187|P2|NOT COMPLETED|Overall Study||41
5342515|NCT00283686|13143188|P1|NOT COMPLETED|Overall Study||29
5342516|NCT00283686|13143185|P4|COMPLETED|Overall Study||109
5342517|NCT00283686|13143186|P3|COMPLETED|Overall Study||111
5342518|NCT00283686|13143187|P2|COMPLETED|Overall Study||92
5342519|NCT00283686|13143188|P1|COMPLETED|Overall Study||111
5342520|NCT00283686|13143185|P4|STARTED|Overall Study||141
5342521|NCT00283686|13143186|P3|STARTED|Overall Study||144
5342522|NCT00283686|13143187|P2|STARTED|Overall Study||133
5342523|NCT00283686|13143188|P1|STARTED|Overall Study||140
5342524|NCT00283595|13143232|P2|NOT COMPLETED|Overall Study||2
5342525|NCT00283595|13143233|P1|NOT COMPLETED|Overall Study||1
5342526|NCT00283595|13143232|P2|COMPLETED|Overall Study||9
5342527|NCT00283595|13143233|P1|COMPLETED|Overall Study||9
5342528|NCT00283595|13143232|P2|STARTED|Overall Study||11
5342529|NCT00283595|13143233|P1|STARTED|Overall Study||10
5342530|NCT00283504|13143243|P2|NOT COMPLETED|Overall Study||0
5342531|NCT00283504|13143244|P1|NOT COMPLETED|Overall Study||0
5342532|NCT00283504|13143243|P2|COMPLETED|Overall Study||6
5342533|NCT00283504|13143244|P1|COMPLETED|Overall Study||7
5342534|NCT00283504|13143243|P2|STARTED|Overall Study||6
5342535|NCT00283504|13143244|P1|STARTED|Overall Study||7
5342536|NCT00283439|13143258|P4|NOT COMPLETED|Overall Study||9
5342537|NCT00283439|13143259|P3|NOT COMPLETED|Overall Study||11
5342538|NCT00283439|13143260|P2|NOT COMPLETED|Overall Study||11
5342539|NCT00283439|13143261|P1|NOT COMPLETED|Overall Study||8
5342540|NCT00283439|13143258|P4|COMPLETED|Overall Study||0
5342541|NCT00283439|13143259|P3|COMPLETED|Overall Study||0
5342542|NCT00283439|13143260|P2|COMPLETED|Overall Study||0
5342543|NCT00283439|13143261|P1|COMPLETED|Overall Study||0
5342544|NCT00283439|13143258|P4|STARTED|Overall Study||9
5342545|NCT00283439|13143259|P3|STARTED|Overall Study||11
5342546|NCT00283439|13143260|P2|STARTED|Overall Study||11
5342547|NCT00283439|13143261|P1|STARTED|Overall Study||8
5342548|NCT00283400|13143287|P4|NOT COMPLETED|Overall Study||0
5342549|NCT00283400|13143288|P3|NOT COMPLETED|Overall Study||1
5342550|NCT00283400|13143289|P2|NOT COMPLETED|Overall Study||1
5342551|NCT00283400|13143290|P1|NOT COMPLETED|Overall Study||2
5342552|NCT00283400|13143287|P4|COMPLETED|Overall Study||0
5342553|NCT00283400|13143288|P3|COMPLETED|Overall Study||6
5342554|NCT00283400|13143289|P2|COMPLETED|Overall Study||19
5342555|NCT00283400|13143290|P1|COMPLETED|Overall Study||18
5342556|NCT00283400|13143287|P4|STARTED|Overall Study||0
5342557|NCT00283400|13143288|P3|STARTED|Overall Study||7
5342558|NCT00283400|13143289|P2|STARTED|Overall Study||20
5342559|NCT00283400|13143290|P1|STARTED|Overall Study||20
5342560|NCT00283387|13143308|P2|NOT COMPLETED|Second Intervention||0
5342561|NCT00283387|13143309|P1|NOT COMPLETED|Second Intervention||0
5342562|NCT00283387|13143308|P2|COMPLETED|Second Intervention||5
5342563|NCT00283387|13143309|P1|COMPLETED|Second Intervention||5
5342564|NCT00283387|13143308|P2|STARTED|Second Intervention||5
5342565|NCT00283387|13143309|P1|STARTED|Second Intervention||5
5342566|NCT00283387|13143308|P2|NOT COMPLETED|Washout Period of 2 Months||0
5342567|NCT00283387|13143309|P1|NOT COMPLETED|Washout Period of 2 Months||0
5342568|NCT00283387|13143308|P2|COMPLETED|Washout Period of 2 Months||5
5342569|NCT00283387|13143309|P1|COMPLETED|Washout Period of 2 Months||5
5342570|NCT00283387|13143308|P2|STARTED|Washout Period of 2 Months||5
5342571|NCT00283387|13143309|P1|STARTED|Washout Period of 2 Months||5
5342572|NCT00283387|13143308|P2|NOT COMPLETED|First Intervention||2
5342573|NCT00283387|13143309|P1|NOT COMPLETED|First Intervention||1
5342574|NCT00283387|13143308|P2|COMPLETED|First Intervention||5
5342575|NCT00283387|13143309|P1|COMPLETED|First Intervention||5
5342576|NCT00283387|13143308|P2|STARTED|First Intervention||7
5342577|NCT00283387|13143309|P1|STARTED|First Intervention||6
5342578|NCT00283296|13143315|P1|NOT COMPLETED|Overall Study||5
5342579|NCT00283296|13143315|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
5342580|NCT00283296|13143315|P1|STARTED|Overall Study||14
5342581|NCT00283283|13143325|P4|NOT COMPLETED|Overall Study||0
5342582|NCT00283283|13143326|P3|NOT COMPLETED|Overall Study||0
5342583|NCT00283283|13143327|P2|NOT COMPLETED|Overall Study||0
5342584|NCT00283283|13143328|P1|NOT COMPLETED|Overall Study||0
5342585|NCT00283283|13143325|P4|COMPLETED|Overall Study||276
5342586|NCT00283283|13143326|P3|COMPLETED|Overall Study||280
5342587|NCT00283283|13143327|P2|COMPLETED|Overall Study||284
5342588|NCT00283283|13143328|P1|COMPLETED|Overall Study||274
5342589|NCT00283283|13143325|P4|STARTED|Overall Study||276
5342590|NCT00283283|13143326|P3|STARTED|Overall Study||280
5342591|NCT00283283|13143327|P2|STARTED|Overall Study||284
5342592|NCT00283283|13143328|P1|STARTED|Overall Study||274
5342593|NCT00283244|13143346|P3|NOT COMPLETED|Overall Study||51
5342594|NCT00283244|13143347|P2|NOT COMPLETED|Overall Study||51
5342595|NCT00283244|13143348|P1|NOT COMPLETED|Overall Study||18
5342596|NCT00283244|13143346|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
5342597|NCT00283244|13143347|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
5342598|NCT00283244|13143348|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
5342599|NCT00283244|13143346|P3|STARTED|Overall Study||51
5342600|NCT00283244|13143347|P2|STARTED|Overall Study||51
5342601|NCT00283244|13143348|P1|STARTED|Overall Study||44
5342602|NCT00283075|13143368|P2|NOT COMPLETED|Overall Study||0
5342603|NCT00283075|13143369|P1|NOT COMPLETED|Overall Study||0
5342604|NCT00283075|13143368|P2|COMPLETED|Overall Study||6
5342605|NCT00283075|13143369|P1|COMPLETED|Overall Study||25
5342606|NCT00283075|13143368|P2|STARTED|Overall Study||6
5342607|NCT00283075|13143369|P1|STARTED|Overall Study||25
5342608|NCT00283062|13143384|P4|NOT COMPLETED|Overall Study||49
5342609|NCT00283062|13143385|P3|NOT COMPLETED|Overall Study||41
5342610|NCT00283062|13143386|P2|NOT COMPLETED|Overall Study||7
5342611|NCT00283062|13143387|P1|NOT COMPLETED|Overall Study||12
5342612|NCT00283062|13143384|P4|COMPLETED|Overall Study||13
5342613|NCT00283062|13143385|P3|COMPLETED|Overall Study||15
5342614|NCT00283062|13143386|P2|COMPLETED|Overall Study||48
5342615|NCT00283062|13143387|P1|COMPLETED|Overall Study||43
5342616|NCT00283062|13143384|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
5342617|NCT00283062|13143385|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
5342618|NCT00283062|13143386|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
5342619|NCT00283062|13143387|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
5342620|NCT00283062|13143384|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
5342621|NCT00283062|13143385|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
5342622|NCT00283062|13143386|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
5342623|NCT00283062|13143387|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
5342624|NCT00283062|13143384|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
5342625|NCT00283062|13143385|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
5342626|NCT00283062|13143386|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
5342627|NCT00283062|13143387|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
5342628|NCT00283062|13143384|P4|STARTED|Overall Study||62
5342629|NCT00283062|13143385|P3|STARTED|Overall Study||56
5342630|NCT00283062|13143386|P2|STARTED|Overall Study||55
5342631|NCT00283062|13143387|P1|STARTED|Overall Study||55
5342632|NCT00283049|13143420|P3|NOT COMPLETED|Overall Study||54
5342633|NCT00283049|13143421|P2|NOT COMPLETED|Overall Study||45
5342634|NCT00283049|13143422|P1|NOT COMPLETED|Overall Study||58
5342635|NCT00283049|13143420|P3|COMPLETED|Overall Study||76
5342636|NCT00283049|13143421|P2|COMPLETED|Overall Study||83
5342637|NCT00283049|13143422|P1|COMPLETED|Overall Study||70
5342638|NCT00283049|13143420|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
5342639|NCT00283049|13143421|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
5342640|NCT00283049|13143422|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
5342641|NCT00282984|13143450|P2|NOT COMPLETED|Overall Study||61
5342642|NCT00282984|13143451|P1|NOT COMPLETED|Overall Study||51
5342643|NCT00282984|13143450|P2|COMPLETED|Overall Study||289
5342644|NCT00282984|13143451|P1|COMPLETED|Overall Study||302
5342645|NCT00282984|13143450|P2|STARTED|Overall Study||350
5342646|NCT00282984|13143451|P1|STARTED|Overall Study||353
5342647|NCT00282971|13143477|P2|NOT COMPLETED|Overall Study||22
5342648|NCT00282971|13143478|P1|NOT COMPLETED|Overall Study||34
5342649|NCT00282971|13143477|P2|COMPLETED|Overall Study||149
5342650|NCT00282971|13143478|P1|COMPLETED|Overall Study||146
5342651|NCT00282971|13143477|P2|STARTED|Overall Study||171
5342652|NCT00282971|13143478|P1|STARTED|Overall Study||180
5342653|NCT00282919|13143488|P1|NOT COMPLETED|Overall Study||7
5342654|NCT00282919|13143488|P1|COMPLETED|Overall Study||103
5342655|NCT00282919|13143488|P1|STARTED|Overall Study||110
5342656|NCT00282867|13143503|P3|NOT COMPLETED|Overall Study||0
5342657|NCT00282867|13143504|P2|NOT COMPLETED|Overall Study||1
5342658|NCT00282867|13143505|P1|NOT COMPLETED|Overall Study||1
5342659|NCT00282867|13143503|P3|COMPLETED|Overall Study||25
5342660|NCT00282867|13143504|P2|COMPLETED|Overall Study||24
5342661|NCT00282867|13143505|P1|COMPLETED|Overall Study||23
5342662|NCT00282867|13143503|P3|STARTED|Overall Study||25
5342663|NCT00282867|13143504|P2|STARTED|Overall Study||25
5342664|NCT00282867|13143505|P1|STARTED|Overall Study||24
5342665|NCT00282841|13143519|P1|NOT COMPLETED|Overall Study||0
5342666|NCT00282841|13143519|P1|COMPLETED|Overall Study||61
5342667|NCT00282841|13143519|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
5342668|NCT00282828|13143527|P3|NOT COMPLETED|Overall Study||9
5342669|NCT00282828|13143528|P2|NOT COMPLETED|Overall Study||12
5342670|NCT00282828|13143529|P1|NOT COMPLETED|Overall Study||6
5342671|NCT00282828|13143527|P3|COMPLETED|Overall Study||50
5342672|NCT00282828|13143528|P2|COMPLETED|Overall Study||47
5342673|NCT00282828|13143529|P1|COMPLETED|Overall Study||57
5342674|NCT00282828|13143527|P3|STARTED|Overall Study||59
5342675|NCT00282828|13143528|P2|STARTED|Overall Study||59
5342676|NCT00282828|13143529|P1|STARTED|Overall Study||63
5342677|NCT00282815|13143542|P2|NOT COMPLETED|Overall Study||6
5342678|NCT00282815|13143543|P1|NOT COMPLETED|Overall Study||7
5342679|NCT00282815|13143542|P2|COMPLETED|Overall Study||11
5342680|NCT00282815|13143543|P1|COMPLETED|Overall Study||8
5342681|NCT00282815|13143542|P2|STARTED|Overall Study||17
5342682|NCT00282815|13143543|P1|STARTED|Overall Study||15
5342683|NCT00282672|13143556|P4|NOT COMPLETED|5 Year: Follow up||5
5342684|NCT00282672|13143557|P3|NOT COMPLETED|5 Year: Follow up||0
5342685|NCT00282672|13143558|P2|NOT COMPLETED|5 Year: Follow up||5
5342686|NCT00282672|13143559|P1|NOT COMPLETED|5 Year: Follow up||1
5342687|NCT00282672|13143556|P4|COMPLETED|5 Year: Follow up||20
5342688|NCT00282672|13143557|P3|COMPLETED|5 Year: Follow up||12
5342689|NCT00282672|13143558|P2|COMPLETED|5 Year: Follow up||27
5342690|NCT00282672|13143559|P1|COMPLETED|5 Year: Follow up||14
5342691|NCT00282672|13143556|P4|STARTED|5 Year: Follow up|11 withdrew|25
5342692|NCT00282672|13143557|P3|STARTED|5 Year: Follow up|3 withdrew|12
5342693|NCT00282672|13143558|P2|STARTED|5 Year: Follow up|7 withdrew|32
5342694|NCT00282672|13143559|P1|STARTED|5 Year: Follow up|1 withdrew|15
5342695|NCT00282672|13143556|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
5342696|NCT00282672|13143557|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
5342697|NCT00282672|13143558|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
5342698|NCT00282672|13143559|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
5342699|NCT00282672|13143556|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
5342700|NCT00282672|13143557|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
5342701|NCT00282672|13143558|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
5342702|NCT00282672|13143559|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
5342703|NCT00282672|13143556|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
5342704|NCT00282672|13143557|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
5342705|NCT00282672|13143558|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
5342706|NCT00282672|13143559|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
5342707|NCT00282672|13143556|P4|NOT COMPLETED|1 Year||4
5342708|NCT00282672|13143557|P3|NOT COMPLETED|1 Year||1
5342709|NCT00282672|13143558|P2|NOT COMPLETED|1 Year||2
5342710|NCT00282672|13143559|P1|NOT COMPLETED|1 Year||3
5342711|NCT00282672|13143556|P4|COMPLETED|1 Year||38
5342712|NCT00282672|13143557|P3|COMPLETED|1 Year||20
5342713|NCT00282672|13143558|P2|COMPLETED|1 Year||40
5342714|NCT00282672|13143559|P1|COMPLETED|1 Year||19
5342715|NCT00282672|13143556|P4|STARTED|1 Year||42
5342716|NCT00282672|13143557|P3|STARTED|1 Year||21
5342717|NCT00282672|13143558|P2|STARTED|1 Year||42
5342718|NCT00282672|13143559|P1|STARTED|1 Year||22
5342719|NCT00282568|13143607|P1|NOT COMPLETED|Extended Treatment Period||24
5342720|NCT00282568|13143607|P1|COMPLETED|Extended Treatment Period||42
5342721|NCT00282568|13143607|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
5342722|NCT00282568|13143607|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
5342723|NCT00282568|13143607|P1|COMPLETED|Pharmacokinetic Treatment Period||67
5342724|NCT00282568|13143607|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
5342725|NCT00282568|13143607|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
5342726|NCT00282568|13143607|P1|STARTED|Pharmacokinetic Treatment Period||70
5342727|NCT00282464|13143633|P2|NOT COMPLETED|Overall Study||62
5342728|NCT00282464|13143634|P1|NOT COMPLETED|Overall Study||73
5342729|NCT00282464|13143633|P2|COMPLETED|Overall Study||134
5342730|NCT00282464|13143634|P1|COMPLETED|Overall Study||112
5342731|NCT00282464|13143633|P2|STARTED|Overall Study||196
5342732|NCT00282464|13143634|P1|STARTED|Overall Study||185
5342733|NCT00282438|13143684|P2|NOT COMPLETED|Overall Study||1
5342734|NCT00282438|13143685|P1|NOT COMPLETED|Overall Study||1
5342735|NCT00282438|13143684|P2|COMPLETED|Overall Study||0
5342736|NCT00282438|13143685|P1|COMPLETED|Overall Study||0
5342737|NCT00282438|13143684|P2|STARTED|Overall Study||1
5342738|NCT00282438|13143685|P1|STARTED|Overall Study||1
5342739|NCT00282412|13143695|P1|NOT COMPLETED|Overall Study||2
5342740|NCT00282412|13143695|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
5342741|NCT00282412|13143695|P1|STARTED|Overall Study||4
5342742|NCT00282347|13143701|P2|NOT COMPLETED|B Cell Follow-up Period||0
5342743|NCT00282347|13143702|P1|NOT COMPLETED|B Cell Follow-up Period||5
5342744|NCT00282347|13143701|P2|COMPLETED|B Cell Follow-up Period||4
5342745|NCT00282347|13143702|P1|COMPLETED|B Cell Follow-up Period||15
5342746|NCT00282347|13143701|P2|STARTED|B Cell Follow-up Period||4
5342747|NCT00282347|13143702|P1|STARTED|B Cell Follow-up Period||20
5342748|NCT00282347|13143701|P2|NOT COMPLETED|Safety Follow-up Period||6
5342749|NCT00282347|13143702|P1|NOT COMPLETED|Safety Follow-up Period||3
5342750|NCT00282347|13143701|P2|COMPLETED|Safety Follow-up Period||57
5342751|NCT00282347|13143702|P1|COMPLETED|Safety Follow-up Period||64
5342752|NCT00282347|13143701|P2|STARTED|Safety Follow-up Period||63
5342753|NCT00282347|13143702|P1|STARTED|Safety Follow-up Period||67
5342754|NCT00282347|13143701|P2|NOT COMPLETED|Treatment Period||9
5342755|NCT00282347|13143702|P1|NOT COMPLETED|Treatment Period||5
5342756|NCT00282347|13143701|P2|COMPLETED|Treatment Period||63
5342757|NCT00282347|13143702|P1|COMPLETED|Treatment Period||67
5342758|NCT00282347|13143701|P2|STARTED|Treatment Period||72
5342759|NCT00282347|13143702|P1|STARTED|Treatment Period||72
5342760|NCT00282334|13143728|P2|NOT COMPLETED|Overall Study||5
5342761|NCT00282334|13143729|P1|NOT COMPLETED|Overall Study||8
5342762|NCT00282334|13143728|P2|COMPLETED|Overall Study||118
5342763|NCT00282334|13143729|P1|COMPLETED|Overall Study||105
5342764|NCT00282334|13143728|P2|STARTED|Overall Study||123
5342765|NCT00282334|13143729|P1|STARTED|Overall Study||113
5342766|NCT00282308|13143737|P3|NOT COMPLETED|Safety Follow-up Period||19
5342767|NCT00282308|13143738|P2|NOT COMPLETED|Safety Follow-up Period||0
5342768|NCT00282308|13143739|P1|NOT COMPLETED|Safety Follow-up Period||0
5342769|NCT00282308|13143737|P3|COMPLETED|Safety Follow-up Period||81
5342770|NCT00282308|13143738|P2|COMPLETED|Safety Follow-up Period||0
5342771|NCT00282308|13143739|P1|COMPLETED|Safety Follow-up Period||0
5342772|NCT00282308|13143737|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
5342773|NCT00282308|13143738|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
5342774|NCT00282308|13143739|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
5342775|NCT00282308|13143737|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
5342776|NCT00282308|13143738|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
5342777|NCT00282308|13143739|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
5342778|NCT00282308|13143737|P3|COMPLETED|Optional Extension Re-treatment Period||72
5342779|NCT00282308|13143738|P2|COMPLETED|Optional Extension Re-treatment Period||0
5342780|NCT00282308|13143739|P1|COMPLETED|Optional Extension Re-treatment Period||0
5342781|NCT00282308|13143737|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
5342782|NCT00282308|13143738|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
5342783|NCT00282308|13143739|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
5342784|NCT00282308|13143737|P3|NOT COMPLETED|Treatment Period||0
5342785|NCT00282308|13143738|P2|NOT COMPLETED|Treatment Period||6
5342786|NCT00282308|13143739|P1|NOT COMPLETED|Treatment Period||4
5342787|NCT00282308|13143737|P3|COMPLETED|Treatment Period||0
5342788|NCT00282308|13143738|P2|COMPLETED|Treatment Period||28
5342789|NCT00282308|13143739|P1|COMPLETED|Treatment Period||65
5342790|NCT00282308|13143737|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
5342791|NCT00282308|13143738|P2|STARTED|Treatment Period||34
5342792|NCT00282308|13143739|P1|STARTED|Treatment Period||69
5342793|NCT00282295|13143769|P3|NOT COMPLETED|Overall Study||8
5342794|NCT00282295|13143770|P2|NOT COMPLETED|Overall Study||17
5342795|NCT00282295|13143771|P1|NOT COMPLETED|Overall Study||3
5342796|NCT00282295|13143769|P3|COMPLETED|Overall Study||441
5342797|NCT00282295|13143770|P2|COMPLETED|Overall Study||429
5342798|NCT00282295|13143771|P1|COMPLETED|Overall Study||443
5342799|NCT00282295|13143769|P3|STARTED|Overall Study||449
5342800|NCT00282295|13143770|P2|STARTED|Overall Study||446
5342801|NCT00282295|13143771|P1|STARTED|Overall Study||446
5342802|NCT00282282|13143820|P1|NOT COMPLETED|Overall Study||0
5342803|NCT00282282|13143820|P1|COMPLETED|Overall Study||29
5342804|NCT00282282|13143820|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
5342805|NCT00282256|13143826|P1|NOT COMPLETED|Extension Treatment Period||2
5342806|NCT00282256|13143826|P1|COMPLETED|Extension Treatment Period||16
5342807|NCT00282256|13143826|P1|STARTED|Extension Treatment Period||18
5342808|NCT00282256|13143826|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
5342809|NCT00282256|13143826|P1|COMPLETED|Pharmacokinetic Treatment Period||18
5342810|NCT00282256|13143826|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
5342811|NCT00282256|13143826|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
5342812|NCT00282256|13143826|P1|STARTED|Pharmacokinetic Treatment Period||19
5342813|NCT00282243|13143847|P1|NOT COMPLETED|Extension Treatment Period||22
5342814|NCT00282243|13143847|P1|COMPLETED|Extension Treatment Period||43
5342815|NCT00282243|13143847|P1|STARTED|Extension Treatment Period||65
5342816|NCT00282243|13143847|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
5342817|NCT00282243|13143847|P1|COMPLETED|Pharmacokinetic Treatment Period||65
5342818|NCT00282243|13143847|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
5342819|NCT00282243|13143847|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
5342820|NCT00282243|13143847|P1|STARTED|Pharmacokinetic Treatment Period||70
5342821|NCT00282152|13143873|P2|NOT COMPLETED|Overall Study||0
5342822|NCT00282152|13143874|P1|NOT COMPLETED|Overall Study||1
5342823|NCT00282152|13143873|P2|COMPLETED|Overall Study||15
5342824|NCT00282152|13143874|P1|COMPLETED|Overall Study||14
5342825|NCT00282152|13143873|P2|STARTED|Overall Study||15
5342826|NCT00282152|13143874|P1|STARTED|Overall Study||15
5342827|NCT00282113|13143895|P3|NOT COMPLETED|Overall Study||0
5342828|NCT00282113|13143896|P2|NOT COMPLETED|Overall Study||0
5342829|NCT00282113|13143897|P1|NOT COMPLETED|Overall Study||1
5342830|NCT00282113|13143895|P3|COMPLETED|Overall Study||29
5342831|NCT00282113|13143896|P2|COMPLETED|Overall Study||30
5342832|NCT00282113|13143897|P1|COMPLETED|Overall Study||30
5342833|NCT00282113|13143895|P3|STARTED|Overall Study||29
5342834|NCT00282113|13143896|P2|STARTED|Overall Study||30
5342835|NCT00282113|13143897|P1|STARTED|Overall Study||31
5342836|NCT00282087|13143911|P1|NOT COMPLETED|Overall Study||1
5342837|NCT00282087|13143911|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
5342838|NCT00282087|13143911|P1|STARTED|Overall Study||47
5342839|NCT00282048|13143924|P1|NOT COMPLETED|Overall Study||62
5342840|NCT00282048|13143924|P1|COMPLETED|Overall Study||0
5342841|NCT00282048|13143924|P1|STARTED|Overall Study||62
5342842|NCT00281957|13143938|P2|NOT COMPLETED|Overall Study||42
5342843|NCT00281957|13143939|P1|NOT COMPLETED|Overall Study||67
5342844|NCT00281957|13143938|P2|COMPLETED|Overall Study||0
5342845|NCT00281957|13143939|P1|COMPLETED|Overall Study||0
5342846|NCT00281957|13143938|P2|Eligible and Received Treatment|Overall Study||39
5342847|NCT00281957|13143939|P1|Eligible and Received Treatment|Overall Study||63
5342848|NCT00281957|13143938|P2|Eligible|Overall Study||40
5342849|NCT00281957|13143939|P1|Eligible|Overall Study||66
5342850|NCT00281957|13143938|P2|STARTED|Overall Study||42
5342851|NCT00281957|13143939|P1|STARTED|Overall Study||67
5342852|NCT00281918|13143953|P2|NOT COMPLETED|Overall Study||108
5342853|NCT00281918|13143954|P1|NOT COMPLETED|Overall Study||142
5342854|NCT00281918|13143953|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
5342855|NCT00281918|13143954|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
5342856|NCT00281918|13143953|P2|Safety Population; Received Study Drug|Overall Study||402
5342857|NCT00281918|13143954|P1|Safety Population; Received Study Drug|Overall Study||398
5342858|NCT00281918|13143953|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
5342859|NCT00281918|13143954|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
5342860|NCT00281879|13143988|P8|NOT COMPLETED|Overall Study||1
5342861|NCT00281879|13143989|P7|NOT COMPLETED|Overall Study||0
5342862|NCT00281879|13143990|P6|NOT COMPLETED|Overall Study||9
5342863|NCT00281879|13143991|P5|NOT COMPLETED|Overall Study||6
5342864|NCT00281879|13143992|P4|NOT COMPLETED|Overall Study||0
5342865|NCT00281879|13143993|P3|NOT COMPLETED|Overall Study||20
5342866|NCT00281879|13143994|P2|NOT COMPLETED|Overall Study||36
5342867|NCT00281879|13143995|P1|NOT COMPLETED|Overall Study||128
5342868|NCT00281879|13143988|P8|COMPLETED|Overall Study||0
5342869|NCT00281879|13143989|P7|COMPLETED|Overall Study||0
5342870|NCT00281879|13143990|P6|COMPLETED|Overall Study||0
5342871|NCT00281879|13143991|P5|COMPLETED|Overall Study||0
5342872|NCT00281879|13143992|P4|COMPLETED|Overall Study||0
5342873|NCT00281879|13143993|P3|COMPLETED|Overall Study||0
5342874|NCT00281879|13143994|P2|COMPLETED|Overall Study||0
5342875|NCT00281879|13143995|P1|COMPLETED|Overall Study||0
5342876|NCT00281879|13143988|P8|STARTED|Overall Study||1
5342877|NCT00281879|13143989|P7|STARTED|Overall Study||0
5342878|NCT00281879|13143990|P6|STARTED|Overall Study||9
5342879|NCT00281879|13143991|P5|STARTED|Overall Study||6
5342880|NCT00281879|13143992|P4|STARTED|Overall Study||0
5342881|NCT00281879|13143993|P3|STARTED|Overall Study||20
5342882|NCT00281879|13143994|P2|STARTED|Overall Study||36
5342883|NCT00281879|13143995|P1|STARTED|Overall Study||128
5342884|NCT00281840|13144013|P1|NOT COMPLETED|Overall Study||25
5342885|NCT00281840|13144013|P1|COMPLETED|Overall Study||5
5342886|NCT00281840|13144013|P1|STARTED|Overall Study||30
5342887|NCT00281827|13144018|P1|NOT COMPLETED|Overall Study||0
5342888|NCT00281827|13144018|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
5342889|NCT00281827|13144018|P1|STARTED|Overall Study||22
5342890|NCT00281697|13144029|P2|NOT COMPLETED|Overall Study||197
5342891|NCT00281697|13144030|P1|NOT COMPLETED|Overall Study||401
5342892|NCT00281697|13144029|P2|COMPLETED|Overall Study||28
5342893|NCT00281697|13144030|P1|COMPLETED|Overall Study||58
5342894|NCT00281697|13144029|P2|STARTED|Overall Study||225
5342895|NCT00281697|13144030|P1|STARTED|Overall Study||459
5342896|NCT00281684|13144050|P4|NOT COMPLETED|Overall Study||0
5342897|NCT00281684|13144051|P3|NOT COMPLETED|Overall Study||1
5342898|NCT00281684|13144052|P2|NOT COMPLETED|Overall Study||0
5342899|NCT00281684|13144053|P1|NOT COMPLETED|Overall Study||1
5342900|NCT00281684|13144050|P4|COMPLETED|Overall Study||38
5342901|NCT00281684|13144051|P3|COMPLETED|Overall Study||33
5342902|NCT00281684|13144052|P2|COMPLETED|Overall Study||36
5342903|NCT00281684|13144053|P1|COMPLETED|Overall Study||36
5342904|NCT00281684|13144050|P4|STARTED|Overall Study||38
5342905|NCT00281684|13144051|P3|STARTED|Overall Study||34
5342906|NCT00281684|13144052|P2|STARTED|Overall Study||36
5342907|NCT00281684|13144053|P1|STARTED|Overall Study||37
5342908|NCT00281658|13144127|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
5342909|NCT00281658|13144128|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
5342910|NCT00281658|13144129|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
5342911|NCT00281658|13144127|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
5342912|NCT00281658|13144128|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
5342913|NCT00281658|13144129|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
5342914|NCT00281658|13144127|P3|STARTED|Open-label Monotherapy Extension Phase||149
5342915|NCT00281658|13144128|P2|STARTED|Open-label Monotherapy Extension Phase||0
5342916|NCT00281658|13144129|P1|STARTED|Open-label Monotherapy Extension Phase||0
5342917|NCT00281658|13144127|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
5342918|NCT00281658|13144128|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
5342919|NCT00281658|13144129|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
5342920|NCT00281658|13144127|P3|COMPLETED|Double-blind, Randomized Phase||0
5342921|NCT00281658|13144128|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
5342922|NCT00281658|13144129|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
5342923|NCT00281658|13144127|P3|STARTED|Double-blind, Randomized Phase||0
5342924|NCT00281658|13144128|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
5342925|NCT00281658|13144129|P1|STARTED|Double-blind, Randomized Phase||222
5342926|NCT00281632|13144146|P1|NOT COMPLETED|Overall Study||36
5342927|NCT00281632|13144146|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
5342928|NCT00281632|13144146|P1|STARTED|Overall Study||36
5342929|NCT00281580|13144188|P16|NOT COMPLETED|Overall Study||13
5342930|NCT00281580|13144189|P15|NOT COMPLETED|Overall Study||7
5342931|NCT00281580|13144190|P14|NOT COMPLETED|Overall Study||7
5342932|NCT00281580|13144191|P13|NOT COMPLETED|Overall Study||13
5342933|NCT00281580|13144192|P12|NOT COMPLETED|Overall Study||10
5342934|NCT00281580|13144193|P11|NOT COMPLETED|Overall Study||4
5342935|NCT00281580|13144194|P10|NOT COMPLETED|Overall Study||12
5342936|NCT00281580|13144195|P9|NOT COMPLETED|Overall Study||8
5342937|NCT00281580|13144196|P8|NOT COMPLETED|Overall Study||1
5342938|NCT00281580|13144197|P7|NOT COMPLETED|Overall Study||5
5342939|NCT00281580|13144198|P6|NOT COMPLETED|Overall Study||3
5342940|NCT00281580|13144199|P5|NOT COMPLETED|Overall Study||4
5342941|NCT00281580|13144200|P4|NOT COMPLETED|Overall Study||17
5342942|NCT00281580|13144201|P3|NOT COMPLETED|Overall Study||5
5342943|NCT00281580|13144202|P2|NOT COMPLETED|Overall Study||1
5342944|NCT00281580|13144203|P1|NOT COMPLETED|Overall Study||7
5342945|NCT00281580|13144188|P16|COMPLETED|Overall Study||116
5342946|NCT00281580|13144189|P15|COMPLETED|Overall Study||133
5342947|NCT00281580|13144190|P14|COMPLETED|Overall Study||43
5342948|NCT00281580|13144191|P13|COMPLETED|Overall Study||129
5342949|NCT00281580|13144192|P12|COMPLETED|Overall Study||136
5342950|NCT00281580|13144193|P11|COMPLETED|Overall Study||44
5342951|NCT00281580|13144194|P10|COMPLETED|Overall Study||117
5342952|NCT00281580|13144195|P9|COMPLETED|Overall Study||135
5342953|NCT00281580|13144196|P8|COMPLETED|Overall Study||46
5342954|NCT00281580|13144197|P7|COMPLETED|Overall Study||39
5342955|NCT00281580|13144198|P6|COMPLETED|Overall Study||43
5342956|NCT00281580|13144199|P5|COMPLETED|Overall Study||40
5342957|NCT00281580|13144200|P4|COMPLETED|Overall Study||118
5342958|NCT00281580|13144201|P3|COMPLETED|Overall Study||125
5342959|NCT00281580|13144202|P2|COMPLETED|Overall Study||41
5342960|NCT00281580|13144203|P1|COMPLETED|Overall Study||39
5342961|NCT00281580|13144188|P16|STARTED|Overall Study||129
5342962|NCT00281580|13144189|P15|STARTED|Overall Study||140
5342963|NCT00281580|13144190|P14|STARTED|Overall Study||50
5342964|NCT00281580|13144191|P13|STARTED|Overall Study||142
5342965|NCT00281580|13144192|P12|STARTED|Overall Study||146
5342966|NCT00281580|13144193|P11|STARTED|Overall Study||48
5342967|NCT00281580|13144194|P10|STARTED|Overall Study||129
5342968|NCT00281580|13144195|P9|STARTED|Overall Study||143
5342969|NCT00281580|13144196|P8|STARTED|Overall Study||47
5342970|NCT00281580|13144197|P7|STARTED|Overall Study||44
5342971|NCT00281580|13144198|P6|STARTED|Overall Study||46
5342972|NCT00281580|13144199|P5|STARTED|Overall Study||44
5342973|NCT00281580|13144200|P4|STARTED|Overall Study||135
5342974|NCT00281580|13144201|P3|STARTED|Overall Study||130
5342975|NCT00281580|13144202|P2|STARTED|Overall Study||42
5342976|NCT00281580|13144203|P1|STARTED|Overall Study||46
5342977|NCT00281528|13144550|P3|NOT COMPLETED|Overall Study||79
5342978|NCT00281528|13144551|P2|NOT COMPLETED|Overall Study||54
5342979|NCT00281528|13144552|P1|NOT COMPLETED|Overall Study||75
5342980|NCT00281528|13144550|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
5342981|NCT00281528|13144551|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
5342982|NCT00281528|13144552|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
5342983|NCT00281528|13144550|P3|STARTED|Overall Study||79
5342984|NCT00281528|13144551|P2|STARTED|Overall Study||54
5342985|NCT00281528|13144552|P1|STARTED|Overall Study||75
5342986|NCT00281463|13144596|P1|NOT COMPLETED|Overall Study||0
5342987|NCT00281463|13144596|P1|COMPLETED|Overall Study||45
5342988|NCT00281463|13144596|P1|STARTED|Overall Study||45
5342989|NCT00281320|13144603|P2|NOT COMPLETED|Overall Study||21
5342990|NCT00281320|13144604|P1|NOT COMPLETED|Overall Study||25
5342991|NCT00281320|13144603|P2|COMPLETED|Overall Study||40
5342992|NCT00281320|13144604|P1|COMPLETED|Overall Study||36
5342993|NCT00281320|13144603|P2|STARTED|Overall Study||61
5342994|NCT00281320|13144604|P1|STARTED|Overall Study||61
5342995|NCT00281099|13144626|P2|NOT COMPLETED|Overall Study||222
5342996|NCT00281099|13144627|P1|NOT COMPLETED|Overall Study||205
5342997|NCT00281099|13144626|P2|COMPLETED|Overall Study||296
5342998|NCT00281099|13144627|P1|COMPLETED|Overall Study||308
5342999|NCT00281099|13144626|P2|STARTED|Overall Study||518
5343000|NCT00281099|13144627|P1|STARTED|Overall Study||513
5343001|NCT00281021|13144668|P1|NOT COMPLETED|Overall Study||2
5343002|NCT00281021|13144668|P1|COMPLETED|Overall Study||24
5343003|NCT00281021|13144668|P1|STARTED|Overall Study||26
5343004|NCT00280917|13144676|P4|NOT COMPLETED|Overall Study||2
5343005|NCT00280917|13144677|P3|NOT COMPLETED|Overall Study||6
5343006|NCT00280917|13144678|P2|NOT COMPLETED|Overall Study||6
5343007|NCT00280917|13144679|P1|NOT COMPLETED|Overall Study||2
5343008|NCT00280917|13144676|P4|COMPLETED|Overall Study||61
5343009|NCT00280917|13144677|P3|COMPLETED|Overall Study||57
5343010|NCT00280917|13144678|P2|COMPLETED|Overall Study||57
5343011|NCT00280917|13144679|P1|COMPLETED|Overall Study||63
5343012|NCT00280917|13144676|P4|STARTED|Overall Study||63
5343013|NCT00280917|13144677|P3|STARTED|Overall Study||63
5343014|NCT00280917|13144678|P2|STARTED|Overall Study||63
5343015|NCT00280917|13144679|P1|STARTED|Overall Study||65
5343016|NCT00280904|13144689|P1|NOT COMPLETED|Overall Study||0
5343017|NCT00280904|13144689|P1|COMPLETED|Overall Study||433
5343018|NCT00280904|13144689|P1|STARTED|Overall Study||433
5343019|NCT00280826|13144694|P1|NOT COMPLETED|Overall Study||0
5343020|NCT00280826|13144694|P1|COMPLETED|Overall Study||6
5343021|NCT00280826|13144694|P1|STARTED|Overall Study||6
5343022|NCT00280748|13144702|P1|NOT COMPLETED|Overall Study||4
5343023|NCT00280748|13144702|P1|COMPLETED|Overall Study||6
5343024|NCT00280748|13144702|P1|STARTED|Overall Study||10
5343025|NCT00280735|13144712|P1|NOT COMPLETED|Overall Study||18
5343026|NCT00280735|13144712|P1|COMPLETED|Overall Study||57
5343027|NCT00280735|13144712|P1|Received Adequate Exposure|Overall Study||57
5343028|NCT00280735|13144712|P1|Received Treatment|Overall Study||72
5343029|NCT00280735|13144712|P1|STARTED|Overall Study||75
5343030|NCT00280683|13144724|P2|NOT COMPLETED|Overall Study||3
5343031|NCT00280683|13144725|P1|NOT COMPLETED|Overall Study||2
5343032|NCT00280683|13144724|P2|COMPLETED|Overall Study||7
5343033|NCT00280683|13144725|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
5343034|NCT00280683|13144724|P2|STARTED|Overall Study||10
5343035|NCT00280683|13144725|P1|STARTED|Overall Study||10
5343036|NCT00280566|13144735|P3|NOT COMPLETED|Period 2 Double Blind||57
5343037|NCT00280566|13144736|P2|NOT COMPLETED|Period 2 Double Blind||43
5343038|NCT00280566|13144737|P1|NOT COMPLETED|Period 2 Double Blind||0
5343039|NCT00280566|13144735|P3|COMPLETED|Period 2 Double Blind||54
5343040|NCT00280566|13144736|P2|COMPLETED|Period 2 Double Blind||84
5343041|NCT00280566|13144737|P1|COMPLETED|Period 2 Double Blind||0
5343042|NCT00280566|13144735|P3|STARTED|Period 2 Double Blind||111
5343043|NCT00280566|13144736|P2|STARTED|Period 2 Double Blind||127
5343044|NCT00280566|13144737|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
5343045|NCT00280566|13144735|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
5343046|NCT00280566|13144736|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
5343047|NCT00280566|13144737|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
5343048|NCT00280566|13144735|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
5343049|NCT00280566|13144736|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
5343050|NCT00280566|13144737|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
5343051|NCT00280566|13144735|P3|STARTED|Period 1 Open Label Ziprasidone||0
5343052|NCT00280566|13144736|P2|STARTED|Period 1 Open Label Ziprasidone||0
5343053|NCT00280566|13144737|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
5343054|NCT00280397|13144762|P1|NOT COMPLETED|Overall Study||1
5343055|NCT00280397|13144762|P1|COMPLETED|Overall Study||26
5343056|NCT00280397|13144762|P1|STARTED|Overall Study||27
5343057|NCT00280384|13144777|P8|NOT COMPLETED|Overall Study||0
5343058|NCT00280384|13144778|P7|NOT COMPLETED|Overall Study||0
5343059|NCT00280384|13144779|P6|NOT COMPLETED|Overall Study||0
5343060|NCT00280384|13144780|P5|NOT COMPLETED|Overall Study||0
5343061|NCT00280384|13144781|P4|NOT COMPLETED|Overall Study||0
5343062|NCT00280384|13144782|P3|NOT COMPLETED|Overall Study||0
5343063|NCT00280384|13144783|P2|NOT COMPLETED|Overall Study||0
5343064|NCT00280384|13144784|P1|NOT COMPLETED|Overall Study||0
5343065|NCT00280384|13144777|P8|COMPLETED|Overall Study||6
5343066|NCT00280384|13144778|P7|COMPLETED|Overall Study||6
5343067|NCT00280384|13144779|P6|COMPLETED|Overall Study||6
5343068|NCT00280384|13144780|P5|COMPLETED|Overall Study||6
5343069|NCT00280384|13144781|P4|COMPLETED|Overall Study||6
5343070|NCT00280384|13144782|P3|COMPLETED|Overall Study||6
5343071|NCT00280384|13144783|P2|COMPLETED|Overall Study||6
5343072|NCT00280384|13144784|P1|COMPLETED|Overall Study||6
5343073|NCT00280384|13144777|P8|STARTED|Overall Study||6
5343074|NCT00280384|13144778|P7|STARTED|Overall Study||6
5343075|NCT00280384|13144779|P6|STARTED|Overall Study||6
5343076|NCT00280384|13144780|P5|STARTED|Overall Study||6
5343077|NCT00280384|13144781|P4|STARTED|Overall Study||6
5343078|NCT00280384|13144782|P3|STARTED|Overall Study||6
5343079|NCT00280384|13144783|P2|STARTED|Overall Study||6
5343080|NCT00280384|13144784|P1|STARTED|Overall Study||6
5343081|NCT00280293|13144828|P2|NOT COMPLETED|Overall Study||23
5343082|NCT00280293|13144829|P1|NOT COMPLETED|Overall Study||26
5343083|NCT00280293|13144828|P2|COMPLETED|Overall Study||34
5343084|NCT00280293|13144829|P1|COMPLETED|Overall Study||29
5343085|NCT00280293|13144828|P2|STARTED|Overall Study||57
5343086|NCT00280293|13144829|P1|STARTED|Overall Study||55
5343087|NCT00280241|13144841|P1|NOT COMPLETED|Overall Study||10
5343088|NCT00280241|13144841|P1|COMPLETED|Overall Study||55
5343089|NCT00280241|13144841|P1|STARTED|Overall Study||65
5343090|NCT00280150|13144852|P4|NOT COMPLETED|Overall Study||10
5343091|NCT00280150|13144853|P3|NOT COMPLETED|Overall Study||5
5343092|NCT00280150|13144854|P2|NOT COMPLETED|Overall Study||1
5343093|NCT00280150|13144855|P1|NOT COMPLETED|Overall Study||3
5343094|NCT00280150|13144852|P4|COMPLETED|Overall Study||20
5343095|NCT00280150|13144853|P3|COMPLETED|Overall Study||1
5343096|NCT00280150|13144854|P2|COMPLETED|Overall Study||4
5343097|NCT00280150|13144855|P1|COMPLETED|Overall Study||2
5343098|NCT00280150|13144852|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
5343099|NCT00280150|13144853|P3|Consolidation Therapy|Overall Study||3
5343100|NCT00280150|13144854|P2|Consolidation Therapy|Overall Study||5
5343101|NCT00280150|13144855|P1|Consolidation Therapy|Overall Study||2
5343102|NCT00280150|13144852|P4|Cohort Induction|Overall Study||30
5343103|NCT00280150|13144853|P3|Cohort Induction|Overall Study||6
5343104|NCT00280150|13144854|P2|Cohort Induction|Overall Study||5
5343105|NCT00280150|13144855|P1|Cohort Induction|Overall Study||5
5343106|NCT00280150|13144852|P4|STARTED|Overall Study||30
5343107|NCT00280150|13144853|P3|STARTED|Overall Study||6
5343108|NCT00280150|13144854|P2|STARTED|Overall Study||5
5343109|NCT00280150|13144855|P1|STARTED|Overall Study||5
5343110|NCT00280059|13144870|P2|NOT COMPLETED|Extension Phase||38
5343111|NCT00280059|13144871|P1|NOT COMPLETED|Extension Phase||49
5343112|NCT00280059|13144870|P2|COMPLETED|Extension Phase||177
5343113|NCT00280059|13144871|P1|COMPLETED|Extension Phase||145
5343114|NCT00280059|13144870|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
5343115|NCT00280059|13144871|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
5343116|NCT00280059|13144870|P2|NOT COMPLETED|Efficacy Assessment Phase||80
5343117|NCT00280059|13144871|P1|NOT COMPLETED|Efficacy Assessment Phase||94
5343118|NCT00280059|13144870|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
5343119|NCT00280059|13144871|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
5343120|NCT00280059|13144870|P2|STARTED|Efficacy Assessment Phase||330
5343121|NCT00280059|13144871|P1|STARTED|Efficacy Assessment Phase||330
5343122|NCT00279955|13144920|P3|NOT COMPLETED|Overall Study||0
5343123|NCT00279955|13144921|P2|NOT COMPLETED|Overall Study||0
5343124|NCT00279955|13144922|P1|NOT COMPLETED|Overall Study||0
5343125|NCT00279955|13144920|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
5343126|NCT00279955|13144921|P2|COMPLETED|Overall Study||486
5343127|NCT00279955|13144922|P1|COMPLETED|Overall Study||157
5343128|NCT00279955|13144920|P3|STARTED|Overall Study||358
5343129|NCT00279955|13144921|P2|STARTED|Overall Study||486
5343130|NCT00279955|13144922|P1|STARTED|Overall Study||157
5343131|NCT00279916|13144935|P2|NOT COMPLETED|Overall Study||5
5343132|NCT00279916|13144936|P1|NOT COMPLETED|Overall Study||7
5343133|NCT00279916|13144935|P2|COMPLETED|Overall Study||41
5343134|NCT00279916|13144936|P1|COMPLETED|Overall Study||38
5343135|NCT00279916|13144935|P2|STARTED|Overall Study||46
5343136|NCT00279916|13144936|P1|STARTED|Overall Study||45
5343137|NCT00279812|13144962|P6|NOT COMPLETED|Overall Study||1
5343138|NCT00279812|13144963|P5|NOT COMPLETED|Overall Study||3
5343139|NCT00279812|13144964|P4|NOT COMPLETED|Overall Study||0
5343140|NCT00279812|13144965|P3|NOT COMPLETED|Overall Study||3
5343141|NCT00279812|13144966|P2|NOT COMPLETED|Overall Study||6
5343142|NCT00279812|13144967|P1|NOT COMPLETED|Overall Study||1
5343143|NCT00279812|13144962|P6|COMPLETED|Overall Study||18
5343144|NCT00279812|13144963|P5|COMPLETED|Overall Study||17
5343145|NCT00279812|13144964|P4|COMPLETED|Overall Study||23
5343146|NCT00279812|13144965|P3|COMPLETED|Overall Study||21
5343147|NCT00279812|13144966|P2|COMPLETED|Overall Study||20
5343148|NCT00279812|13144967|P1|COMPLETED|Overall Study||20
5343149|NCT00279812|13144962|P6|STARTED|Overall Study||19
5343150|NCT00279812|13144963|P5|STARTED|Overall Study||20
5343151|NCT00279812|13144964|P4|STARTED|Overall Study||23
5343152|NCT00279812|13144965|P3|STARTED|Overall Study||24
5343153|NCT00279812|13144966|P2|STARTED|Overall Study||26
5343154|NCT00279812|13144967|P1|STARTED|Overall Study||21
5343155|NCT00279708|13144995|P2|NOT COMPLETED|Overall Study||4
5343156|NCT00279708|13144996|P1|NOT COMPLETED|Overall Study||3
5343157|NCT00279708|13144995|P2|COMPLETED|Overall Study||24
5343158|NCT00279708|13144996|P1|COMPLETED|Overall Study||24
5343159|NCT00279708|13144995|P2|STARTED|Overall Study||28
5343160|NCT00279708|13144996|P1|STARTED|Overall Study|"Started meaning randomized"|27
5343161|NCT00279591|13145004|P2|NOT COMPLETED|Overall Study||0
5343162|NCT00279591|13145005|P1|NOT COMPLETED|Overall Study||0
5343163|NCT00279591|13145004|P2|COMPLETED|Overall Study||46
5343164|NCT00279591|13145005|P1|COMPLETED|Overall Study||48
5343165|NCT00279591|13145004|P2|STARTED|Overall Study||46
5343166|NCT00279591|13145005|P1|STARTED|Overall Study||48
5343167|NCT00279500|13145019|P1|NOT COMPLETED|Overall Study||0
5343168|NCT00279500|13145019|P1|COMPLETED|Overall Study|6 patients treated|6
5343169|NCT00279500|13145019|P1|STARTED|Overall Study|6 patients treated|6
5343170|NCT00279409|13145025|P2|NOT COMPLETED|Overall Study||0
5343171|NCT00279409|13145026|P1|NOT COMPLETED|Overall Study||0
5343172|NCT00279409|13145025|P2|COMPLETED|Overall Study||0
5343173|NCT00279409|13145026|P1|COMPLETED|Overall Study||0
5343174|NCT00279409|13145025|P2|STARTED|Overall Study||0
5343175|NCT00279409|13145026|P1|STARTED|Overall Study||0
5343176|NCT00279305|13145034|P2|NOT COMPLETED|Overall Study||1
5343177|NCT00279305|13145035|P1|NOT COMPLETED|Overall Study||8
5343178|NCT00279305|13145034|P2|COMPLETED|Overall Study||29
5343179|NCT00279305|13145035|P1|COMPLETED|Overall Study||49
5343180|NCT00279305|13145034|P2|STARTED|Overall Study||30
5343181|NCT00279305|13145035|P1|STARTED|Overall Study||57
5343182|NCT00279214|13145043|P2|NOT COMPLETED|Overall Study||2
5343183|NCT00279214|13145044|P1|NOT COMPLETED|Overall Study||3
5343184|NCT00279214|13145043|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
5343185|NCT00279214|13145044|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
5343186|NCT00279214|13145043|P2|STARTED|Overall Study||21
5343187|NCT00279214|13145044|P1|STARTED|Overall Study||22
5343188|NCT00279201|13145074|P6|NOT COMPLETED|Intensification Addendum||37
5343189|NCT00279201|13145075|P5|NOT COMPLETED|Intensification Addendum||29
5343190|NCT00279201|13145076|P4|NOT COMPLETED|Intensification Addendum||28
5343191|NCT00279201|13145077|P3|NOT COMPLETED|Intensification Addendum||23
5343192|NCT00279201|13145078|P2|NOT COMPLETED|Intensification Addendum||0
5343193|NCT00279201|13145079|P1|NOT COMPLETED|Intensification Addendum||0
5343194|NCT00279201|13145074|P6|COMPLETED|Intensification Addendum||162
5343195|NCT00279201|13145075|P5|COMPLETED|Intensification Addendum||142
5343196|NCT00279201|13145076|P4|COMPLETED|Intensification Addendum||172
5343197|NCT00279201|13145077|P3|COMPLETED|Intensification Addendum||151
5343198|NCT00279201|13145078|P2|COMPLETED|Intensification Addendum||0
5343199|NCT00279201|13145079|P1|COMPLETED|Intensification Addendum||0
5343200|NCT00279201|13145074|P6|STARTED|Intensification Addendum||199
5343201|NCT00279201|13145075|P5|STARTED|Intensification Addendum||171
5343202|NCT00279201|13145076|P4|STARTED|Intensification Addendum||200
5343203|NCT00279201|13145077|P3|STARTED|Intensification Addendum||174
5343204|NCT00279201|13145078|P2|STARTED|Intensification Addendum||0
5343205|NCT00279201|13145079|P1|STARTED|Intensification Addendum||0
5343206|NCT00279201|13145074|P6|NOT COMPLETED|Maintenance||0
5343207|NCT00279201|13145075|P5|NOT COMPLETED|Maintenance||0
5343208|NCT00279201|13145076|P4|NOT COMPLETED|Maintenance||0
5343209|NCT00279201|13145077|P3|NOT COMPLETED|Maintenance||0
5343210|NCT00279201|13145078|P2|NOT COMPLETED|Maintenance||234
5343211|NCT00279201|13145079|P1|NOT COMPLETED|Maintenance||231
5343212|NCT00279201|13145074|P6|COMPLETED|Maintenance||0
5343213|NCT00279201|13145075|P5|COMPLETED|Maintenance||0
5343214|NCT00279201|13145076|P4|COMPLETED|Maintenance||0
5343215|NCT00279201|13145077|P3|COMPLETED|Maintenance||0
5343216|NCT00279201|13145078|P2|COMPLETED|Maintenance||239
5343217|NCT00279201|13145079|P1|COMPLETED|Maintenance||188
5343218|NCT00279201|13145074|P6|STARTED|Maintenance||0
5343219|NCT00279201|13145075|P5|STARTED|Maintenance||0
5343220|NCT00279201|13145076|P4|STARTED|Maintenance||0
5343221|NCT00279201|13145077|P3|STARTED|Maintenance||0
5343222|NCT00279201|13145078|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
5343223|NCT00279201|13145079|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
5343224|NCT00279201|13145074|P6|NOT COMPLETED|Initiation||0
5343225|NCT00279201|13145075|P5|NOT COMPLETED|Initiation||0
5343226|NCT00279201|13145076|P4|NOT COMPLETED|Initiation||0
5343227|NCT00279201|13145077|P3|NOT COMPLETED|Initiation||0
5343228|NCT00279201|13145078|P2|NOT COMPLETED|Initiation||145
5343229|NCT00279201|13145079|P1|NOT COMPLETED|Initiation||128
5343230|NCT00279201|13145074|P6|COMPLETED|Initiation||0
5343231|NCT00279201|13145075|P5|COMPLETED|Initiation||0
5343232|NCT00279201|13145076|P4|COMPLETED|Initiation||0
5343233|NCT00279201|13145077|P3|COMPLETED|Initiation||0
5343234|NCT00279201|13145078|P2|COMPLETED|Initiation||900
5343235|NCT00279201|13145079|P1|COMPLETED|Initiation||918
5343236|NCT00279201|13145074|P6|STARTED|Initiation||0
5343237|NCT00279201|13145075|P5|STARTED|Initiation||0
5343238|NCT00279201|13145076|P4|STARTED|Initiation||0
5343239|NCT00279201|13145077|P3|STARTED|Initiation||0
5343240|NCT00279201|13145078|P2|STARTED|Initiation||1045
5343241|NCT00279201|13145079|P1|STARTED|Initiation||1046
5343242|NCT00278993|13145223|P1|NOT COMPLETED|Overall Study||107
5343243|NCT00278993|13145223|P1|COMPLETED|Overall Study||1
5343244|NCT00278993|13145223|P1|STARTED|Overall Study||108
5343245|NCT00278954|13145231|P1|NOT COMPLETED|Overall Study||5
5343246|NCT00278954|13145231|P1|COMPLETED|Overall Study||45
5343247|NCT00278954|13145231|P1|STARTED|Overall Study||50
5343248|NCT00278915|13145239|P1|NOT COMPLETED|Overall Study||1
5343249|NCT00278915|13145239|P1|COMPLETED|Overall Study||29
5343250|NCT00278915|13145239|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
5343251|NCT00278889|13145275|P3|NOT COMPLETED|Overall Study||20
5343252|NCT00278889|13145276|P2|NOT COMPLETED|Overall Study||27
5343253|NCT00278889|13145277|P1|NOT COMPLETED|Overall Study||25
5343254|NCT00278889|13145275|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
5343255|NCT00278889|13145276|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
5343256|NCT00278889|13145277|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
5343257|NCT00278889|13145275|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
5343258|NCT00278889|13145276|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
5343259|NCT00278889|13145277|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
5343260|NCT00278889|13145275|P3|STARTED|Overall Study|Randomised|68
5343261|NCT00278889|13145276|P2|STARTED|Overall Study|Randomised|74
5343262|NCT00278889|13145277|P1|STARTED|Overall Study|Randomised|73
5343263|NCT00278876|13145303|P1|NOT COMPLETED|Overall Study||9
5343264|NCT00278876|13145303|P1|COMPLETED|Overall Study||38
5343265|NCT00278876|13145303|P1|STARTED|Overall Study||47
5343266|NCT00278863|13145311|P2|NOT COMPLETED|Overall Study||2
5343267|NCT00278863|13145312|P1|NOT COMPLETED|Overall Study||5
5343268|NCT00278863|13145311|P2|COMPLETED|Overall Study||45
5343269|NCT00278863|13145312|P1|COMPLETED|Overall Study||44
5343270|NCT00278863|13145311|P2|STARTED|Overall Study||47
5343271|NCT00278863|13145312|P1|STARTED|Overall Study||49
5343272|NCT00278655|13145320|P1|NOT COMPLETED|Overall Study||0
5343273|NCT00278655|13145320|P1|COMPLETED|Overall Study||21
5343274|NCT00278655|13145320|P1|STARTED|Overall Study||21
5343275|NCT00278629|13145325|P1|NOT COMPLETED|Overall Study||14
5343276|NCT00278629|13145325|P1|COMPLETED|Overall Study||66
5343277|NCT00278629|13145325|P1|STARTED|Overall Study||80
5343278|NCT00278564|13145332|P1|NOT COMPLETED|Overall Study||4
5343279|NCT00278564|13145332|P1|COMPLETED|Overall Study||3
5343280|NCT00278564|13145332|P1|STARTED|Overall Study||7
5343281|NCT00278538|13145336|P1|NOT COMPLETED|Overall Study||2
5343282|NCT00278538|13145336|P1|COMPLETED|Overall Study||30
5343283|NCT00278538|13145336|P1|STARTED|Overall Study||32
5343284|NCT00278525|13145342|P2|NOT COMPLETED|Overall Study||0
5343285|NCT00278525|13145343|P1|NOT COMPLETED|Overall Study||0
5343286|NCT00278525|13145342|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
5343287|NCT00278525|13145343|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
5343288|NCT00278525|13145342|P2|STARTED|Overall Study||10
5343289|NCT00278525|13145343|P1|STARTED|Overall Study||9
5343290|NCT00278512|13145353|P2|NOT COMPLETED|Overall Study||0
5343291|NCT00278512|13145354|P1|NOT COMPLETED|Overall Study||1
5343292|NCT00278512|13145353|P2|COMPLETED|Overall Study||0
5343293|NCT00278512|13145354|P1|COMPLETED|Overall Study||6
5343294|NCT00278512|13145353|P2|STARTED|Overall Study||0
5343295|NCT00278512|13145354|P1|STARTED|Overall Study||7
5343296|NCT00278473|13145362|P2|NOT COMPLETED|Overall Study||3
5343297|NCT00278473|13145363|P1|NOT COMPLETED|Overall Study||4
5343298|NCT00278473|13145362|P2|COMPLETED|Overall Study||40
5343299|NCT00278473|13145363|P1|COMPLETED|Overall Study||41
5343300|NCT00278473|13145362|P2|STARTED|Overall Study||43
5343301|NCT00278473|13145363|P1|STARTED|Overall Study||45
5343302|NCT00278395|13145379|P1|NOT COMPLETED|Overall Study||3
5343303|NCT00278395|13145379|P1|COMPLETED|Overall Study||11
5343304|NCT00278395|13145379|P1|STARTED|Overall Study||14
5343305|NCT00278343|13145386|P1|NOT COMPLETED|Overall Study||0
5343306|NCT00278343|13145386|P1|COMPLETED|Overall Study||74
5343307|NCT00278343|13145386|P1|STARTED|Overall Study||74
5343308|NCT00278200|13145397|P2|NOT COMPLETED|Overall Study||4
5343309|NCT00278200|13145398|P1|NOT COMPLETED|Overall Study||1
5343310|NCT00278200|13145397|P2|COMPLETED|Overall Study||8
5343311|NCT00278200|13145398|P1|COMPLETED|Overall Study||1
5343312|NCT00278200|13145397|P2|STARTED|Overall Study||12
5343313|NCT00278200|13145398|P1|STARTED|Overall Study||2
5343314|NCT00278161|13145407|P1|NOT COMPLETED|Overall Study||11
5343315|NCT00278161|13145407|P1|COMPLETED|Overall Study||70
5343316|NCT00278161|13145407|P1|STARTED|Overall Study||81
5343317|NCT00278148|13145413|P3|NOT COMPLETED|Phase II - Expansion Phase||6
5343318|NCT00278148|13145414|P2|NOT COMPLETED|Phase II - Expansion Phase||0
5343319|NCT00278148|13145415|P1|NOT COMPLETED|Phase II - Expansion Phase||0
5343320|NCT00278148|13145413|P3|COMPLETED|Phase II - Expansion Phase||20
5343321|NCT00278148|13145414|P2|COMPLETED|Phase II - Expansion Phase||0
5343322|NCT00278148|13145415|P1|COMPLETED|Phase II - Expansion Phase||0
5343323|NCT00278148|13145413|P3|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
5343324|NCT00278148|13145414|P2|STARTED|Phase II - Expansion Phase||0
5343325|NCT00278148|13145415|P1|STARTED|Phase II - Expansion Phase||0
5343326|NCT00278148|13145413|P3|NOT COMPLETED|Phase I - Dose Escalation||0
5343327|NCT00278148|13145414|P2|NOT COMPLETED|Phase I - Dose Escalation||0
5343328|NCT00278148|13145415|P1|NOT COMPLETED|Phase I - Dose Escalation||0
5343329|NCT00278148|13145413|P3|COMPLETED|Phase I - Dose Escalation||3
5343330|NCT00278148|13145414|P2|COMPLETED|Phase I - Dose Escalation||2
5343331|NCT00278148|13145415|P1|COMPLETED|Phase I - Dose Escalation||4
5343332|NCT00278148|13145413|P3|STARTED|Phase I - Dose Escalation||3
5343333|NCT00278148|13145414|P2|STARTED|Phase I - Dose Escalation||2
5343334|NCT00278148|13145415|P1|STARTED|Phase I - Dose Escalation||4
5343335|NCT00278109|13145427|P1|NOT COMPLETED|Overall Study||4
5343336|NCT00278109|13145427|P1|COMPLETED|Overall Study||21
5343337|NCT00278109|13145427|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
5343338|NCT00278109|13145427|P1|STARTED|Overall Study||25
5343339|NCT00277524|13145431|P4|NOT COMPLETED|Overall Study||0
5343340|NCT00277524|13145432|P3|NOT COMPLETED|Overall Study||0
5343341|NCT00277524|13145433|P2|NOT COMPLETED|Overall Study||0
5343342|NCT00277524|13145434|P1|NOT COMPLETED|Overall Study||0
5343343|NCT00277524|13145431|P4|COMPLETED|Overall Study||850
5343344|NCT00277524|13145432|P3|COMPLETED|Overall Study||1088
5343345|NCT00277524|13145433|P2|COMPLETED|Overall Study||324
5343346|NCT00277524|13145434|P1|COMPLETED|Overall Study||621
5343347|NCT00277524|13145431|P4|STARTED|Overall Study||850
5343348|NCT00277524|13145432|P3|STARTED|Overall Study||1088
5343349|NCT00277524|13145433|P2|STARTED|Overall Study||324
5343350|NCT00277524|13145434|P1|STARTED|Overall Study||621
5343351|NCT00277446|13145452|P1|NOT COMPLETED|Overall Study||0
5343352|NCT00277446|13145452|P1|COMPLETED|Overall Study||13
5343353|NCT00277446|13145452|P1|STARTED|Overall Study||13
5343354|NCT00277394|13145460|P2|NOT COMPLETED|Overall Study||24
5343355|NCT00277394|13145461|P1|NOT COMPLETED|Overall Study||37
5343356|NCT00277394|13145460|P2|COMPLETED|Overall Study||246
5343357|NCT00277394|13145461|P1|COMPLETED|Overall Study||232
5343358|NCT00277394|13145460|P2|STARTED|Overall Study||270
5343359|NCT00277394|13145461|P1|STARTED|Overall Study||269
5343360|NCT00277355|13145473|P2|NOT COMPLETED|Overall Study||5
5343361|NCT00277355|13145474|P1|NOT COMPLETED|Overall Study||14
5343362|NCT00277355|13145473|P2|COMPLETED|Overall Study||22
5343363|NCT00277355|13145474|P1|COMPLETED|Overall Study||73
5343364|NCT00277355|13145473|P2|STARTED|Overall Study||27
5343365|NCT00277355|13145474|P1|STARTED|Overall Study||87
5343366|NCT00277212|13145482|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
5343367|NCT00277212|13145483|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
5343368|NCT00277212|13145484|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
5343369|NCT00277212|13145482|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
5343370|NCT00277212|13145483|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
5343371|NCT00277212|13145484|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
5343372|NCT00277212|13145482|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
5343373|NCT00277212|13145483|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
5343374|NCT00277212|13145484|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
5343375|NCT00277212|13145482|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
5343376|NCT00277212|13145483|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
5343377|NCT00277212|13145484|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
5343378|NCT00277212|13145482|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
5343379|NCT00277212|13145483|P2|STARTED|Phase 2 - Double-Blind Treatment||173
5343380|NCT00277212|13145484|P1|STARTED|Phase 2 - Double-Blind Treatment||0
5343381|NCT00277212|13145482|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
5343382|NCT00277212|13145483|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
5343383|NCT00277212|13145484|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
5343384|NCT00277212|13145482|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
5343385|NCT00277212|13145483|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
5343386|NCT00277212|13145484|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
5343387|NCT00277212|13145482|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
5343388|NCT00277212|13145483|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
5343389|NCT00277212|13145484|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
5343390|NCT00277212|13145482|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
5343391|NCT00277212|13145483|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
5343392|NCT00277212|13145484|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
5343393|NCT00277212|13145482|P3|STARTED|Phase 1 - Single-Blind Treatment||0
5343394|NCT00277212|13145483|P2|STARTED|Phase 1 - Single-Blind Treatment||0
5343395|NCT00277212|13145484|P1|STARTED|Phase 1 - Single-Blind Treatment||787
5343396|NCT00277095|13145522|P1|NOT COMPLETED|Overall Study||21
5343397|NCT00277095|13145522|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
5343398|NCT00277095|13145522|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
5343399|NCT00276861|13145526|P1|NOT COMPLETED|Overall Study||0
5343400|NCT00276861|13145526|P1|COMPLETED|Overall Study||10
5343401|NCT00276861|13145526|P1|STARTED|Overall Study||10
5343402|NCT00276744|13145531|P1|NOT COMPLETED|PART B||0
5343403|NCT00276744|13145531|P1|COMPLETED|PART B||0
5343404|NCT00276744|13145531|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
5343405|NCT00276744|13145531|P1|NOT COMPLETED|PART A||98
5343406|NCT00276744|13145531|P1|COMPLETED|PART A||142
5343407|NCT00276744|13145531|P1|STARTED|PART A||240
5343408|NCT00276614|13145535|P1|NOT COMPLETED|Overall Study||3
5343409|NCT00276614|13145535|P1|COMPLETED|Overall Study||1
5343410|NCT00276614|13145535|P1|STARTED|Overall Study||4
5343411|NCT00276549|13145539|P1|NOT COMPLETED|Overall Study||0
5343412|NCT00276549|13145539|P1|COMPLETED|Overall Study||35
5343413|NCT00276549|13145539|P1|STARTED|Overall Study||35
5343414|NCT00276484|13145546|P2|NOT COMPLETED|Overall Study||13
5343415|NCT00276484|13145547|P1|NOT COMPLETED|Overall Study||9
5343416|NCT00276484|13145546|P2|COMPLETED|Overall Study||278
5343417|NCT00276484|13145547|P1|COMPLETED|Overall Study||279
5343418|NCT00276484|13145546|P2|STARTED|Overall Study||291
5343419|NCT00276484|13145547|P1|STARTED|Overall Study||288
5343420|NCT00276458|13145579|P2|NOT COMPLETED|Overall Study||7
5343421|NCT00276458|13145580|P1|NOT COMPLETED|Overall Study||6
5343422|NCT00276458|13145579|P2|COMPLETED|Overall Study||91
5343423|NCT00276458|13145580|P1|COMPLETED|Overall Study||92
5343424|NCT00276458|13145579|P2|STARTED|Overall Study||98
5343425|NCT00276458|13145580|P1|STARTED|Overall Study||98
5343426|NCT00276419|13145614|P2|NOT COMPLETED|Second Intervention||0
5343427|NCT00276419|13145615|P1|NOT COMPLETED|Second Intervention||0
5343428|NCT00276419|13145614|P2|COMPLETED|Second Intervention||8
5343429|NCT00276419|13145615|P1|COMPLETED|Second Intervention||7
5343430|NCT00276419|13145614|P2|STARTED|Second Intervention||8
5343431|NCT00276419|13145615|P1|STARTED|Second Intervention||7
5343432|NCT00276419|13145614|P2|NOT COMPLETED|Wash-out Phase||0
5343433|NCT00276419|13145615|P1|NOT COMPLETED|Wash-out Phase||0
5343434|NCT00276419|13145614|P2|COMPLETED|Wash-out Phase||8
5343435|NCT00276419|13145615|P1|COMPLETED|Wash-out Phase||7
5343436|NCT00276419|13145614|P2|STARTED|Wash-out Phase||8
5343437|NCT00276419|13145615|P1|STARTED|Wash-out Phase||7
5343438|NCT00276419|13145614|P2|NOT COMPLETED|First Intervention||2
5343439|NCT00276419|13145615|P1|NOT COMPLETED|First Intervention||1
5343440|NCT00276419|13145614|P2|COMPLETED|First Intervention||8
5343441|NCT00276419|13145615|P1|COMPLETED|First Intervention||7
5343442|NCT00276419|13145614|P2|STARTED|First Intervention||10
5343443|NCT00276419|13145615|P1|STARTED|First Intervention||8
5343444|NCT00276406|13145627|P2|NOT COMPLETED|Overall Study||0
5343445|NCT00276406|13145628|P1|NOT COMPLETED|Overall Study||0
5343446|NCT00276406|13145627|P2|COMPLETED|Overall Study||14
5343447|NCT00276406|13145628|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
5343448|NCT00276406|13145627|P2|STARTED|Overall Study||14
5343449|NCT00276406|13145628|P1|STARTED|Overall Study||16
5343450|NCT00276380|13145658|P2|NOT COMPLETED|Overall Study||14
5343451|NCT00276380|13145659|P1|NOT COMPLETED|Overall Study||14
5343452|NCT00276380|13145658|P2|COMPLETED|Overall Study||88
5343453|NCT00276380|13145659|P1|COMPLETED|Overall Study||88
5343454|NCT00276380|13145658|P2|STARTED|Overall Study||102
5343455|NCT00276380|13145659|P1|STARTED|Overall Study||102
5343456|NCT00276250|13145680|P3|NOT COMPLETED|Overall Study||0
5343457|NCT00276250|13145681|P2|NOT COMPLETED|Overall Study||0
5343458|NCT00276250|13145682|P1|NOT COMPLETED|Overall Study||0
5343459|NCT00276250|13145680|P3|COMPLETED|Overall Study||0
5343460|NCT00276250|13145681|P2|COMPLETED|Overall Study||1
5343461|NCT00276250|13145682|P1|COMPLETED|Overall Study||4
5343462|NCT00276250|13145680|P3|STARTED|Overall Study||0
5343463|NCT00276250|13145681|P2|STARTED|Overall Study||1
5343464|NCT00276250|13145682|P1|STARTED|Overall Study||4
5343465|NCT00276159|13145714|P1|NOT COMPLETED|Overall Study||6
5343466|NCT00276159|13145714|P1|COMPLETED|Overall Study||0
5343467|NCT00276159|13145714|P1|STARTED|Overall Study||6
5343468|NCT00276094|13145724|P3|NOT COMPLETED|Overall Study||38
5343469|NCT00276094|13145725|P2|NOT COMPLETED|Overall Study||42
5343470|NCT00276094|13145726|P1|NOT COMPLETED|Overall Study||57
5343471|NCT00276094|13145724|P3|COMPLETED|Overall Study||230
5343472|NCT00276094|13145725|P2|COMPLETED|Overall Study||234
5343473|NCT00276094|13145726|P1|COMPLETED|Overall Study||225
5343474|NCT00276094|13145724|P3|STARTED|Overall Study||268
5343475|NCT00276094|13145725|P2|STARTED|Overall Study||276
5343476|NCT00276094|13145726|P1|STARTED|Overall Study||282
5343477|NCT00276016|13145779|P6|NOT COMPLETED|Intervention 3||0
5343478|NCT00276016|13145780|P5|NOT COMPLETED|Intervention 3||0
5343479|NCT00276016|13145781|P4|NOT COMPLETED|Intervention 3||0
5343480|NCT00276016|13145782|P3|NOT COMPLETED|Intervention 3||0
5343481|NCT00276016|13145783|P2|NOT COMPLETED|Intervention 3||0
5343482|NCT00276016|13145784|P1|NOT COMPLETED|Intervention 3||0
5343483|NCT00276016|13145779|P6|COMPLETED|Intervention 3||6
5343484|NCT00276016|13145780|P5|COMPLETED|Intervention 3||6
5343485|NCT00276016|13145781|P4|COMPLETED|Intervention 3||6
5343486|NCT00276016|13145782|P3|COMPLETED|Intervention 3||7
5343487|NCT00276016|13145783|P2|COMPLETED|Intervention 3||6
5343488|NCT00276016|13145784|P1|COMPLETED|Intervention 3||7
5343489|NCT00276016|13145779|P6|STARTED|Intervention 3||6
5343490|NCT00276016|13145780|P5|STARTED|Intervention 3||6
5343491|NCT00276016|13145781|P4|STARTED|Intervention 3||6
5343492|NCT00276016|13145782|P3|STARTED|Intervention 3||7
5343493|NCT00276016|13145783|P2|STARTED|Intervention 3||6
5343494|NCT00276016|13145784|P1|STARTED|Intervention 3||7
5343495|NCT00276016|13145779|P6|NOT COMPLETED|Wash Out 2||0
5343496|NCT00276016|13145780|P5|NOT COMPLETED|Wash Out 2||0
5343497|NCT00276016|13145781|P4|NOT COMPLETED|Wash Out 2||0
5343498|NCT00276016|13145782|P3|NOT COMPLETED|Wash Out 2||0
5343499|NCT00276016|13145783|P2|NOT COMPLETED|Wash Out 2||0
5343500|NCT00276016|13145784|P1|NOT COMPLETED|Wash Out 2||0
5343501|NCT00276016|13145779|P6|COMPLETED|Wash Out 2||6
5343502|NCT00276016|13145780|P5|COMPLETED|Wash Out 2||6
5343503|NCT00276016|13145781|P4|COMPLETED|Wash Out 2||6
5343504|NCT00276016|13145782|P3|COMPLETED|Wash Out 2||7
5343505|NCT00276016|13145783|P2|COMPLETED|Wash Out 2||6
5343506|NCT00276016|13145784|P1|COMPLETED|Wash Out 2||7
5343507|NCT00276016|13145779|P6|STARTED|Wash Out 2||6
5343508|NCT00276016|13145780|P5|STARTED|Wash Out 2||6
5343509|NCT00276016|13145781|P4|STARTED|Wash Out 2||6
5343510|NCT00276016|13145782|P3|STARTED|Wash Out 2||7
5343511|NCT00276016|13145783|P2|STARTED|Wash Out 2||6
5343512|NCT00276016|13145784|P1|STARTED|Wash Out 2||7
5343513|NCT00276016|13145779|P6|NOT COMPLETED|Intervention 2||0
5343514|NCT00276016|13145780|P5|NOT COMPLETED|Intervention 2||0
5343515|NCT00276016|13145781|P4|NOT COMPLETED|Intervention 2||0
5343516|NCT00276016|13145782|P3|NOT COMPLETED|Intervention 2||0
5343517|NCT00276016|13145783|P2|NOT COMPLETED|Intervention 2||0
5343518|NCT00276016|13145784|P1|NOT COMPLETED|Intervention 2||0
5343519|NCT00276016|13145779|P6|COMPLETED|Intervention 2||6
5343520|NCT00276016|13145780|P5|COMPLETED|Intervention 2||6
5343521|NCT00276016|13145781|P4|COMPLETED|Intervention 2||6
5343522|NCT00276016|13145782|P3|COMPLETED|Intervention 2||7
5343523|NCT00276016|13145783|P2|COMPLETED|Intervention 2||6
5343524|NCT00276016|13145784|P1|COMPLETED|Intervention 2||7
5343525|NCT00276016|13145779|P6|STARTED|Intervention 2||6
5343526|NCT00276016|13145780|P5|STARTED|Intervention 2||6
5343527|NCT00276016|13145781|P4|STARTED|Intervention 2||6
5343528|NCT00276016|13145782|P3|STARTED|Intervention 2||7
5343529|NCT00276016|13145783|P2|STARTED|Intervention 2||6
5343530|NCT00276016|13145784|P1|STARTED|Intervention 2||7
5343531|NCT00276016|13145779|P6|NOT COMPLETED|Wash Out 1||0
5343532|NCT00276016|13145780|P5|NOT COMPLETED|Wash Out 1||0
5343533|NCT00276016|13145781|P4|NOT COMPLETED|Wash Out 1||0
5343534|NCT00276016|13145782|P3|NOT COMPLETED|Wash Out 1||0
5343535|NCT00276016|13145783|P2|NOT COMPLETED|Wash Out 1||0
5343536|NCT00276016|13145784|P1|NOT COMPLETED|Wash Out 1||0
5343537|NCT00276016|13145779|P6|COMPLETED|Wash Out 1||6
5343538|NCT00276016|13145780|P5|COMPLETED|Wash Out 1||6
5343539|NCT00276016|13145781|P4|COMPLETED|Wash Out 1||6
5343540|NCT00276016|13145782|P3|COMPLETED|Wash Out 1||7
5343541|NCT00276016|13145783|P2|COMPLETED|Wash Out 1||6
5343542|NCT00276016|13145784|P1|COMPLETED|Wash Out 1||7
5343543|NCT00276016|13145779|P6|STARTED|Wash Out 1||6
5343544|NCT00276016|13145780|P5|STARTED|Wash Out 1||6
5343545|NCT00276016|13145781|P4|STARTED|Wash Out 1||6
5343546|NCT00276016|13145782|P3|STARTED|Wash Out 1||7
5343547|NCT00276016|13145783|P2|STARTED|Wash Out 1||6
5343548|NCT00276016|13145784|P1|STARTED|Wash Out 1||7
5343549|NCT00276016|13145779|P6|NOT COMPLETED|Intervention 1||0
5343550|NCT00276016|13145780|P5|NOT COMPLETED|Intervention 1||0
5343551|NCT00276016|13145781|P4|NOT COMPLETED|Intervention 1||0
5343552|NCT00276016|13145782|P3|NOT COMPLETED|Intervention 1||0
5343553|NCT00276016|13145783|P2|NOT COMPLETED|Intervention 1||1
5343554|NCT00276016|13145784|P1|NOT COMPLETED|Intervention 1||0
5343555|NCT00276016|13145779|P6|COMPLETED|Intervention 1||6
5343556|NCT00276016|13145780|P5|COMPLETED|Intervention 1||6
5343557|NCT00276016|13145781|P4|COMPLETED|Intervention 1||6
5343558|NCT00276016|13145782|P3|COMPLETED|Intervention 1||7
5343559|NCT00276016|13145783|P2|COMPLETED|Intervention 1||6
5343560|NCT00276016|13145784|P1|COMPLETED|Intervention 1||7
5343561|NCT00276016|13145779|P6|STARTED|Intervention 1||6
5343562|NCT00276016|13145780|P5|STARTED|Intervention 1||6
5343563|NCT00276016|13145781|P4|STARTED|Intervention 1||6
5343564|NCT00276016|13145782|P3|STARTED|Intervention 1||7
5343565|NCT00276016|13145783|P2|STARTED|Intervention 1||7
5343566|NCT00276016|13145784|P1|STARTED|Intervention 1||7
5343567|NCT00275834|13145796|P3|NOT COMPLETED|Overall Study||1
5343568|NCT00275834|13145797|P2|NOT COMPLETED|Overall Study||3
5343569|NCT00275834|13145798|P1|NOT COMPLETED|Overall Study||3
5343570|NCT00275834|13145796|P3|COMPLETED|Overall Study||74
5343571|NCT00275834|13145797|P2|COMPLETED|Overall Study||73
5343572|NCT00275834|13145798|P1|COMPLETED|Overall Study||71
5343573|NCT00275834|13145796|P3|Completed Study While on Study Drug|Overall Study||62
5343574|NCT00275834|13145797|P2|Completed Study While on Study Drug|Overall Study||51
5343575|NCT00275834|13145798|P1|Completed Study While on Study Drug|Overall Study||54
5343576|NCT00275834|13145796|P3|STARTED|Overall Study||75
5343577|NCT00275834|13145797|P2|STARTED|Overall Study||76
5343578|NCT00275834|13145798|P1|STARTED|Overall Study||74
5343579|NCT00275821|13145830|P3|NOT COMPLETED|Overall Study||12
5343580|NCT00275821|13145831|P2|NOT COMPLETED|Overall Study||23
5343581|NCT00275821|13145832|P1|NOT COMPLETED|Overall Study||14
5343582|NCT00275821|13145830|P3|COMPLETED|Overall Study||103
5343583|NCT00275821|13145831|P2|COMPLETED|Overall Study||95
5343584|NCT00275821|13145832|P1|COMPLETED|Overall Study||106
5343585|NCT00275821|13145830|P3|STARTED|Overall Study||115
5343586|NCT00275821|13145831|P2|STARTED|Overall Study||118
5343587|NCT00275821|13145832|P1|STARTED|Overall Study||120
5343588|NCT00275561|13145851|P2|NOT COMPLETED|Overall Study||6
5343589|NCT00275561|13145852|P1|NOT COMPLETED|Overall Study||2
5343590|NCT00275561|13145851|P2|COMPLETED|Overall Study||15
5343591|NCT00275561|13145852|P1|COMPLETED|Overall Study||19
5343592|NCT00275561|13145851|P2|STARTED|Overall Study||21
5343593|NCT00275561|13145852|P1|STARTED|Overall Study||21
5343594|NCT00275509|13145864|P2|NOT COMPLETED|Overall Study||1
5343595|NCT00275509|13145865|P1|NOT COMPLETED|Overall Study||0
5343596|NCT00275509|13145864|P2|COMPLETED|Overall Study||25
5343597|NCT00275509|13145865|P1|COMPLETED|Overall Study||30
5343598|NCT00275509|13145864|P2|STARTED|Overall Study||26
5343599|NCT00275509|13145865|P1|STARTED|Overall Study||30
5343600|NCT00275392|13145877|P2|NOT COMPLETED|Overall Study||2
5343601|NCT00275392|13145878|P1|NOT COMPLETED|Overall Study||0
5343602|NCT00275392|13145877|P2|COMPLETED|Overall Study||17
5343603|NCT00275392|13145878|P1|COMPLETED|Overall Study||20
5343604|NCT00275392|13145877|P2|STARTED|Overall Study||19
5343605|NCT00275392|13145878|P1|STARTED|Overall Study||20
5343606|NCT00275340|13145888|P2|NOT COMPLETED|Overall Study||4
5343607|NCT00275340|13145889|P1|NOT COMPLETED|Overall Study||2
5343608|NCT00275340|13145888|P2|COMPLETED|Overall Study||45
5343609|NCT00275340|13145889|P1|COMPLETED|Overall Study||50
5343610|NCT00275340|13145888|P2|STARTED|Overall Study||49
5343611|NCT00275340|13145889|P1|STARTED|Overall Study||52
5343612|NCT00275301|13145893|P1|NOT COMPLETED|Overall Study||5
5343613|NCT00275301|13145893|P1|COMPLETED|Overall Study||14
5343614|NCT00275301|13145893|P1|STARTED|Overall Study||19
5343615|NCT00275275|13145900|P3|NOT COMPLETED|Overall Study||6
5343616|NCT00275275|13145901|P2|NOT COMPLETED|Overall Study||2
5343617|NCT00275275|13145902|P1|NOT COMPLETED|Overall Study||6
5343618|NCT00275275|13145900|P3|COMPLETED|Overall Study||15
5343619|NCT00275275|13145901|P2|COMPLETED|Overall Study||18
5343620|NCT00275275|13145902|P1|COMPLETED|Overall Study||14
5343621|NCT00275275|13145900|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
5343622|NCT00275275|13145901|P2|STARTED|Overall Study||20
5343623|NCT00275275|13145902|P1|STARTED|Overall Study||20
5343624|NCT00275262|13145912|P2|NOT COMPLETED|Overall Study||9
5343625|NCT00275262|13145913|P1|NOT COMPLETED|Overall Study||6
5343626|NCT00275262|13145912|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
5343627|NCT00275262|13145913|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
5343628|NCT00275262|13145912|P2|STARTED|Overall Study||13
5343629|NCT00275262|13145913|P1|STARTED|Overall Study||12
5343630|NCT00275028|13145927|P1|NOT COMPLETED|Overall Study||47
5343631|NCT00275028|13145927|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
5343632|NCT00275028|13145927|P1|STARTED|Overall Study||47
5343633|NCT00275002|13145934|P2|NOT COMPLETED|Overall Study||16
5343634|NCT00275002|13145935|P1|NOT COMPLETED|Overall Study||22
5343635|NCT00275002|13145934|P2|COMPLETED|Overall Study||0
5343636|NCT00275002|13145935|P1|COMPLETED|Overall Study||3
5343637|NCT00275002|13145934|P2|STARTED|Overall Study||16
5343638|NCT00275002|13145935|P1|STARTED|Overall Study||25
5343639|NCT00274937|13145943|P1|NOT COMPLETED|Overall Study||20
5343640|NCT00274937|13145943|P1|COMPLETED|Overall Study||91
5343641|NCT00274937|13145943|P1|STARTED|Overall Study||111
5343642|NCT00274924|13145955|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
5343643|NCT00274924|13145956|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
5343644|NCT00274924|13145957|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
5343645|NCT00274924|13145955|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
5343646|NCT00274924|13145956|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
5343647|NCT00274924|13145957|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
5343648|NCT00274924|13145955|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
5343649|NCT00274924|13145956|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
5343650|NCT00274924|13145957|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
5343651|NCT00274924|13145955|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
5343652|NCT00274924|13145956|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
5343653|NCT00274924|13145957|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
5343654|NCT00274924|13145955|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
5343655|NCT00274924|13145956|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
5343656|NCT00274924|13145957|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
5343657|NCT00274924|13145955|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
5343658|NCT00274924|13145956|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
5343659|NCT00274924|13145957|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
5343660|NCT00274924|13145955|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
5343661|NCT00274924|13145956|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
5343662|NCT00274924|13145957|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
5343663|NCT00274924|13145955|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
5343664|NCT00274924|13145956|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
5343665|NCT00274924|13145957|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
5343666|NCT00274924|13145955|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
5343667|NCT00274924|13145956|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
5343668|NCT00274924|13145957|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
5343669|NCT00274846|13145966|P1|NOT COMPLETED|Overall Study||1
5343670|NCT00274846|13145966|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
5343671|NCT00274846|13145966|P1|STARTED|Overall Study||21
5343672|NCT00274781|13145974|P1|NOT COMPLETED|Overall Study||0
5343673|NCT00274781|13145974|P1|COMPLETED|Overall Study||30
5343674|NCT00274781|13145974|P1|STARTED|Overall Study||30
5343675|NCT00274768|13145980|P1|NOT COMPLETED|Overall Study||0
5343676|NCT00274768|13145980|P1|COMPLETED|Overall Study||26
5343677|NCT00274768|13145980|P1|STARTED|Overall Study||26
5343678|NCT00274742|13145995|P6|NOT COMPLETED|Overall Study||3
5343679|NCT00274742|13145996|P5|NOT COMPLETED|Overall Study||16
5343680|NCT00274742|13145997|P4|NOT COMPLETED|Overall Study||5
5343681|NCT00274742|13145998|P3|NOT COMPLETED|Overall Study||2
5343682|NCT00274742|13145999|P2|NOT COMPLETED|Overall Study||8
5343683|NCT00274742|13146000|P1|NOT COMPLETED|Overall Study||0
5343684|NCT00274742|13145995|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
5343685|NCT00274742|13145996|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
5343686|NCT00274742|13145997|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
5343687|NCT00274742|13145998|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
5343688|NCT00274742|13145999|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
5343689|NCT00274742|13146000|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
5343690|NCT00274742|13145995|P6|STARTED|Overall Study||4
5343691|NCT00274742|13145996|P5|STARTED|Overall Study||32
5343692|NCT00274742|13145997|P4|STARTED|Overall Study||9
5343693|NCT00274742|13145998|P3|STARTED|Overall Study||6
5343694|NCT00274742|13145999|P2|STARTED|Overall Study||13
5343695|NCT00274742|13146000|P1|STARTED|Overall Study||12
5343696|NCT00274716|13146038|P6|NOT COMPLETED|Phase B||1
5343697|NCT00274716|13146039|P5|NOT COMPLETED|Phase B||0
5343698|NCT00274716|13146040|P4|NOT COMPLETED|Phase B||1
5343699|NCT00274716|13146041|P3|NOT COMPLETED|Phase B||3
5343700|NCT00274716|13146042|P2|NOT COMPLETED|Phase B||4
5343701|NCT00274716|13146043|P1|NOT COMPLETED|Phase B||1
5343702|NCT00274716|13146038|P6|COMPLETED|Phase B||14
5343703|NCT00274716|13146039|P5|COMPLETED|Phase B||16
5343704|NCT00274716|13146040|P4|COMPLETED|Phase B||41
5343705|NCT00274716|13146041|P3|COMPLETED|Phase B||41
5343706|NCT00274716|13146042|P2|COMPLETED|Phase B||40
5343707|NCT00274716|13146043|P1|COMPLETED|Phase B||42
5343708|NCT00274716|13146038|P6|STARTED|Phase B||15
5343709|NCT00274716|13146039|P5|STARTED|Phase B||16
5343710|NCT00274716|13146040|P4|STARTED|Phase B||42
5343711|NCT00274716|13146041|P3|STARTED|Phase B||44
5343712|NCT00274716|13146042|P2|STARTED|Phase B||44
5343713|NCT00274716|13146043|P1|STARTED|Phase B||43
5343714|NCT00274716|13146038|P6|NOT COMPLETED|Phase A||4
5343715|NCT00274716|13146039|P5|NOT COMPLETED|Phase A||3
5343716|NCT00274716|13146040|P4|NOT COMPLETED|Phase A||9
5343717|NCT00274716|13146041|P3|NOT COMPLETED|Phase A||8
5343718|NCT00274716|13146042|P2|NOT COMPLETED|Phase A||10
5343719|NCT00274716|13146043|P1|NOT COMPLETED|Phase A||11
5343720|NCT00274716|13146038|P6|COMPLETED|Phase A||15
5343721|NCT00274716|13146039|P5|COMPLETED|Phase A||16
5343722|NCT00274716|13146040|P4|COMPLETED|Phase A||42
5343723|NCT00274716|13146041|P3|COMPLETED|Phase A||44
5343724|NCT00274716|13146042|P2|COMPLETED|Phase A||44
5343725|NCT00274716|13146043|P1|COMPLETED|Phase A||43
5343726|NCT00274716|13146038|P6|STARTED|Phase A||19
5343727|NCT00274716|13146039|P5|STARTED|Phase A||19
5343728|NCT00274716|13146040|P4|STARTED|Phase A||51
5343729|NCT00274716|13146041|P3|STARTED|Phase A||52
5343730|NCT00274716|13146042|P2|STARTED|Phase A||54
5343731|NCT00274716|13146043|P1|STARTED|Phase A||54
5343732|NCT00274651|13146105|P2|NOT COMPLETED|Overall Study||20
5343733|NCT00274651|13146106|P1|NOT COMPLETED|Overall Study||28
5343734|NCT00274651|13146105|P2|COMPLETED|Overall Study||4
5343735|NCT00274651|13146106|P1|COMPLETED|Overall Study||1
5343736|NCT00274651|13146105|P2|STARTED|Overall Study||24
5343737|NCT00274651|13146106|P1|STARTED|Overall Study||29
5343738|NCT00274625|13146121|P2|NOT COMPLETED|Overall Study||62
5343739|NCT00274625|13146122|P1|NOT COMPLETED|Overall Study||60
5343740|NCT00274625|13146121|P2|COMPLETED|Overall Study||141
5343741|NCT00274625|13146122|P1|COMPLETED|Overall Study||139
5343742|NCT00274625|13146121|P2|STARTED|Overall Study||203
5343743|NCT00274625|13146122|P1|STARTED|Overall Study||199
5343744|NCT00274469|13146130|P2|NOT COMPLETED|Overall Study||93
5343745|NCT00274469|13146131|P1|NOT COMPLETED|Overall Study||79
5343746|NCT00274469|13146130|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
5343747|NCT00274469|13146131|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
5343748|NCT00274469|13146130|P2|STARTED|Overall Study|Number of patients randomized|103
5343749|NCT00274469|13146131|P1|STARTED|Overall Study|Number of patients randomized|102
5343750|NCT00274456|13146151|P4|NOT COMPLETED|Overall Study||45
5343751|NCT00274456|13146152|P3|NOT COMPLETED|Overall Study||35
5343752|NCT00274456|13146153|P2|NOT COMPLETED|Overall Study||27
5343753|NCT00274456|13146154|P1|NOT COMPLETED|Overall Study||37
5343754|NCT00274456|13146151|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
5343755|NCT00274456|13146152|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
5343756|NCT00274456|13146153|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
5343757|NCT00274456|13146154|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
5343758|NCT00274456|13146151|P4|At Least One Response Assessment|Overall Study||70
5343759|NCT00274456|13146152|P3|At Least One Response Assessment|Overall Study||73
5343760|NCT00274456|13146153|P2|At Least One Response Assessment|Overall Study||76
5343761|NCT00274456|13146154|P1|At Least One Response Assessment|Overall Study||73
5343762|NCT00274456|13146151|P4|STARTED|Overall Study||74
5343763|NCT00274456|13146152|P3|STARTED|Overall Study||74
5343764|NCT00274456|13146153|P2|STARTED|Overall Study||76
5343765|NCT00274456|13146154|P1|STARTED|Overall Study||76
5343766|NCT00274287|13146196|P1|NOT COMPLETED|Overall Study||2
5343767|NCT00274287|13146196|P1|COMPLETED|Overall Study||13
5343768|NCT00274287|13146196|P1|STARTED|Overall Study||15
5343769|NCT00274261|13146206|P2|NOT COMPLETED|Overall Study||337
5343770|NCT00274261|13146207|P1|NOT COMPLETED|Overall Study||489
5343771|NCT00274261|13146206|P2|COMPLETED|Overall Study||296
5343772|NCT00274261|13146207|P1|COMPLETED|Overall Study||443
5343773|NCT00274261|13146206|P2|STARTED|Overall Study||633
5343774|NCT00274261|13146207|P1|STARTED|Overall Study||932
5343775|NCT00273910|13146221|P6|NOT COMPLETED|Overall Study||0
5343776|NCT00273910|13146222|P5|NOT COMPLETED|Overall Study||0
5343777|NCT00273910|13146223|P4|NOT COMPLETED|Overall Study||0
5343778|NCT00273910|13146224|P3|NOT COMPLETED|Overall Study||0
5343779|NCT00273910|13146225|P2|NOT COMPLETED|Overall Study||0
5343780|NCT00273910|13146226|P1|NOT COMPLETED|Overall Study||0
5343781|NCT00273910|13146221|P6|COMPLETED|Overall Study||14
5343782|NCT00273910|13146222|P5|COMPLETED|Overall Study||15
5343783|NCT00273910|13146223|P4|COMPLETED|Overall Study||19
5343784|NCT00273910|13146224|P3|COMPLETED|Overall Study||18
5343785|NCT00273910|13146225|P2|COMPLETED|Overall Study||19
5343786|NCT00273910|13146226|P1|COMPLETED|Overall Study||19
5343787|NCT00273910|13146221|P6|STARTED|Overall Study||14
5343788|NCT00273910|13146222|P5|STARTED|Overall Study||15
5343789|NCT00273910|13146223|P4|STARTED|Overall Study||19
5343790|NCT00273910|13146224|P3|STARTED|Overall Study||18
5343791|NCT00273910|13146225|P2|STARTED|Overall Study||19
5343792|NCT00273910|13146226|P1|STARTED|Overall Study||19
5343793|NCT00273858|13146246|P1|NOT COMPLETED|Overall Study||537
5343794|NCT00273858|13146246|P1|COMPLETED|Overall Study||343
5343795|NCT00273858|13146246|P1|STARTED|Overall Study||880
5343796|NCT00273793|13146261|P6|NOT COMPLETED|Overall Study||0
5343797|NCT00273793|13146262|P5|NOT COMPLETED|Overall Study||0
5343798|NCT00273793|13146263|P4|NOT COMPLETED|Overall Study||0
5343799|NCT00273793|13146264|P3|NOT COMPLETED|Overall Study||0
5343800|NCT00273793|13146265|P2|NOT COMPLETED|Overall Study||0
5343801|NCT00273793|13146266|P1|NOT COMPLETED|Overall Study||0
5343802|NCT00273793|13146261|P6|COMPLETED|Overall Study||29
5343803|NCT00273793|13146262|P5|COMPLETED|Overall Study||58
5343804|NCT00273793|13146263|P4|COMPLETED|Overall Study||60
5343805|NCT00273793|13146264|P3|COMPLETED|Overall Study||18
5343806|NCT00273793|13146265|P2|COMPLETED|Overall Study||38
5343807|NCT00273793|13146266|P1|COMPLETED|Overall Study||36
5343808|NCT00273793|13146261|P6|STARTED|Overall Study||29
5343809|NCT00273793|13146262|P5|STARTED|Overall Study||58
5343810|NCT00273793|13146263|P4|STARTED|Overall Study||60
5343811|NCT00273793|13146264|P3|STARTED|Overall Study||18
5343812|NCT00273793|13146265|P2|STARTED|Overall Study||38
5343813|NCT00273793|13146266|P1|STARTED|Overall Study||36
5343814|NCT00273754|13146288|P2|NOT COMPLETED|Overall Study||0
5343815|NCT00273754|13146289|P1|NOT COMPLETED|Overall Study||0
5343816|NCT00273754|13146288|P2|COMPLETED|Overall Study||36
5343817|NCT00273754|13146289|P1|COMPLETED|Overall Study||36
5343818|NCT00273754|13146288|P2|STARTED|Overall Study||36
5343819|NCT00273754|13146289|P1|STARTED|Overall Study||36
5343820|NCT00273182|13146305|P1|NOT COMPLETED|Overall Study||985
5343821|NCT00273182|13146305|P1|COMPLETED|Overall Study||1014
5343822|NCT00273182|13146305|P1|STARTED|Overall Study||1999
5343823|NCT00273052|13146315|P2|NOT COMPLETED|Overall Study||88
5343824|NCT00273052|13146316|P1|NOT COMPLETED|Overall Study||69
5343825|NCT00273052|13146315|P2|COMPLETED|Overall Study||190
5343826|NCT00273052|13146316|P1|COMPLETED|Overall Study||221
5343827|NCT00273052|13146315|P2|STARTED|Overall Study||278
5343828|NCT00273052|13146316|P1|STARTED|Overall Study||290
5343829|NCT00272987|13146351|P3|NOT COMPLETED|Overall Study||19
5343830|NCT00272987|13146352|P2|NOT COMPLETED|Overall Study||14
5343831|NCT00272987|13146353|P1|NOT COMPLETED|Overall Study||21
5343832|NCT00272987|13146351|P3|COMPLETED|Overall Study||1
5343833|NCT00272987|13146352|P2|COMPLETED|Overall Study||0
5343834|NCT00272987|13146353|P1|COMPLETED|Overall Study||8
5343835|NCT00272987|13146351|P3|Ongoing|Overall Study||15
5343836|NCT00272987|13146352|P2|Ongoing|Overall Study||14
5343837|NCT00272987|13146353|P1|Ongoing|Overall Study||20
5343838|NCT00272987|13146351|P3|STARTED|Overall Study||20
5343839|NCT00272987|13146352|P2|STARTED|Overall Study||14
5343840|NCT00272987|13146353|P1|STARTED|Overall Study||29
5343841|NCT00272961|13146417|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
5343842|NCT00272961|13146418|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
5343843|NCT00272961|13146419|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
5343844|NCT00272961|13146420|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
5343845|NCT00272961|13146421|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
5343846|NCT00272961|13146417|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
5343847|NCT00272961|13146418|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
5343848|NCT00272961|13146419|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
5343849|NCT00272961|13146420|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
5343850|NCT00272961|13146421|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
5343851|NCT00272961|13146417|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
5343852|NCT00272961|13146418|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
5343853|NCT00272961|13146419|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
5343854|NCT00272961|13146420|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
5343855|NCT00272961|13146421|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
5343856|NCT00272961|13146417|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343857|NCT00272961|13146418|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343858|NCT00272961|13146419|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343859|NCT00272961|13146420|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343860|NCT00272961|13146421|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
5343861|NCT00272961|13146417|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343862|NCT00272961|13146418|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343863|NCT00272961|13146419|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343864|NCT00272961|13146420|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
5343865|NCT00272961|13146421|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
5343866|NCT00272961|13146417|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
5343867|NCT00272961|13146418|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
5343868|NCT00272961|13146419|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
5343869|NCT00272961|13146420|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
5343870|NCT00272961|13146421|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
5343871|NCT00272844|13146478|P1|NOT COMPLETED|Overall Study||5
5343872|NCT00272844|13146478|P1|COMPLETED|Overall Study||18
5343873|NCT00272844|13146478|P1|STARTED|Overall Study||23
5343874|NCT00272792|13146486|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
5343875|NCT00272792|13146487|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
5343876|NCT00272792|13146486|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
5343877|NCT00272792|13146487|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
5343878|NCT00272792|13146486|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
5343879|NCT00272792|13146487|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
5343880|NCT00272792|13146486|P2|NOT COMPLETED|Part 1: Responsiveness||0
5343881|NCT00272792|13146487|P1|NOT COMPLETED|Part 1: Responsiveness||1
5343882|NCT00272792|13146486|P2|COMPLETED|Part 1: Responsiveness||0
5343883|NCT00272792|13146487|P1|COMPLETED|Part 1: Responsiveness||89
5343884|NCT00272792|13146486|P2|STARTED|Part 1: Responsiveness||0
5343885|NCT00272792|13146487|P1|STARTED|Part 1: Responsiveness||90
5343886|NCT00272779|13146497|P2|NOT COMPLETED|Baseline Through Week 96||136
5343887|NCT00272779|13146498|P1|NOT COMPLETED|Baseline Through Week 96||139
5343888|NCT00272779|13146497|P2|COMPLETED|Baseline Through Week 96||307
5343889|NCT00272779|13146498|P1|COMPLETED|Baseline Through Week 96||301
5343890|NCT00272779|13146497|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
5343891|NCT00272779|13146498|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
5343892|NCT00272779|13146497|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
5343893|NCT00272779|13146498|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
5343894|NCT00272779|13146497|P2|NOT COMPLETED|Baseline Through Week 48||443
5343895|NCT00272779|13146498|P1|NOT COMPLETED|Baseline Through Week 48||440
5343896|NCT00272779|13146497|P2|COMPLETED|Baseline Through Week 48||0
5343897|NCT00272779|13146498|P1|COMPLETED|Baseline Through Week 48||0
5343898|NCT00272779|13146497|P2|STILL ON TREATMENT|Baseline Through Week 48||368
5343899|NCT00272779|13146498|P1|STILL ON TREATMENT|Baseline Through Week 48||385
5343900|NCT00272779|13146497|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
5343901|NCT00272779|13146498|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
5343902|NCT00272779|13146497|P2|Discontinued Before Week 48|Baseline Through Week 48||58
5343903|NCT00272779|13146498|P1|Discontinued Before Week 48|Baseline Through Week 48||39
5343904|NCT00272779|13146497|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
5343905|NCT00272779|13146498|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
5343906|NCT00272779|13146497|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
5343907|NCT00272779|13146498|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
5343908|NCT00272779|13146497|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
5343909|NCT00272779|13146498|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
5343910|NCT00272337|13146682|P5|NOT COMPLETED|Overall Study||0
5343911|NCT00272337|13146683|P4|NOT COMPLETED|Overall Study||0
5343912|NCT00272337|13146684|P3|NOT COMPLETED|Overall Study||0
5343913|NCT00272337|13146685|P2|NOT COMPLETED|Overall Study||0
5343914|NCT00272337|13146686|P1|NOT COMPLETED|Overall Study||0
5343915|NCT00272337|13146682|P5|COMPLETED|Overall Study||8
5343916|NCT00272337|13146683|P4|COMPLETED|Overall Study||7
5343917|NCT00272337|13146684|P3|COMPLETED|Overall Study||7
5343918|NCT00272337|13146685|P2|COMPLETED|Overall Study||7
5343919|NCT00272337|13146686|P1|COMPLETED|Overall Study||8
5343920|NCT00272337|13146682|P5|STARTED|Overall Study||8
5343921|NCT00272337|13146683|P4|STARTED|Overall Study||7
5343922|NCT00272337|13146684|P3|STARTED|Overall Study||7
5343923|NCT00272337|13146685|P2|STARTED|Overall Study||7
5343924|NCT00272337|13146686|P1|STARTED|Overall Study||8
5343925|NCT00272311|13146713|P5|NOT COMPLETED|Overall Study||0
5343926|NCT00272311|13146714|P4|NOT COMPLETED|Overall Study||0
5343927|NCT00272311|13146715|P3|NOT COMPLETED|Overall Study||0
5343928|NCT00272311|13146716|P2|NOT COMPLETED|Overall Study||0
5343929|NCT00272311|13146717|P1|NOT COMPLETED|Overall Study||0
5343930|NCT00272311|13146713|P5|COMPLETED|Overall Study||14
5343931|NCT00272311|13146714|P4|COMPLETED|Overall Study||14
5343932|NCT00272311|13146715|P3|COMPLETED|Overall Study||14
5343933|NCT00272311|13146716|P2|COMPLETED|Overall Study||14
5343934|NCT00272311|13146717|P1|COMPLETED|Overall Study||14
5343935|NCT00272311|13146713|P5|STARTED|Overall Study||14
5343936|NCT00272311|13146714|P4|STARTED|Overall Study||14
5343937|NCT00272311|13146715|P3|STARTED|Overall Study||14
5343938|NCT00272311|13146716|P2|STARTED|Overall Study||14
5343939|NCT00272311|13146717|P1|STARTED|Overall Study||14
5343940|NCT00272168|13146741|P2|NOT COMPLETED|Overall Study||10
5343941|NCT00272168|13146742|P1|NOT COMPLETED|Overall Study||10
5343942|NCT00272168|13146741|P2|COMPLETED|Overall Study||31
5343943|NCT00272168|13146742|P1|COMPLETED|Overall Study||37
5343944|NCT00272168|13146741|P2|STARTED|Overall Study||41
5343945|NCT00272168|13146742|P1|STARTED|Overall Study||47
5343946|NCT00272038|13146758|P1|NOT COMPLETED|Overall Study||7
5343947|NCT00272038|13146758|P1|COMPLETED|Overall Study||22
5343948|NCT00272038|13146758|P1|STARTED|Overall Study||29
5343949|NCT00271947|13146764|P1|NOT COMPLETED|Overall Study||1
5343950|NCT00271947|13146764|P1|COMPLETED|Overall Study||0
5343951|NCT00271947|13146764|P1|STARTED|Overall Study||1
5343952|NCT00271856|13146770|P2|NOT COMPLETED|Overall Study||18
5343953|NCT00271856|13146771|P1|NOT COMPLETED|Overall Study||11
5343954|NCT00271856|13146770|P2|COMPLETED|Overall Study||70
5343955|NCT00271856|13146771|P1|COMPLETED|Overall Study||78
5343956|NCT00271856|13146770|P2|STARTED|Overall Study||88
5343957|NCT00271856|13146771|P1|STARTED|Overall Study||89
5343958|NCT00271817|13146790|P3|NOT COMPLETED|Part 2||84
5343959|NCT00271817|13146791|P2|NOT COMPLETED|Part 2||32
5343960|NCT00271817|13146792|P1|NOT COMPLETED|Part 2||0
5343961|NCT00271817|13146790|P3|COMPLETED|Part 2||401
5343962|NCT00271817|13146791|P2|COMPLETED|Part 2||234
5343963|NCT00271817|13146792|P1|COMPLETED|Part 2||0
5343964|NCT00271817|13146790|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
5343965|NCT00271817|13146791|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
5343966|NCT00271817|13146792|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
5343967|NCT00271817|13146790|P3|NOT COMPLETED|Part 1||285
5343968|NCT00271817|13146791|P2|NOT COMPLETED|Part 1||59
5343969|NCT00271817|13146792|P1|NOT COMPLETED|Part 1||106
5343970|NCT00271817|13146790|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
5343971|NCT00271817|13146791|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
5343972|NCT00271817|13146792|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
5343973|NCT00271817|13146790|P3|STARTED|Part 1||676
5343974|NCT00271817|13146791|P2|STARTED|Part 1||272
5343975|NCT00271817|13146792|P1|STARTED|Part 1||272
5343976|NCT00271739|13146821|P2|NOT COMPLETED|Overall Study||105
5343977|NCT00271739|13146822|P1|NOT COMPLETED|Overall Study||115
5343978|NCT00271739|13146821|P2|COMPLETED|Overall Study||716
5343979|NCT00271739|13146822|P1|COMPLETED|Overall Study||729
5343980|NCT00271739|13146821|P2|STARTED|Overall Study||821
5343981|NCT00271739|13146822|P1|STARTED|Overall Study||844
5343982|NCT00271609|13146834|P2|NOT COMPLETED|Overall Study||3
5343983|NCT00271609|13146835|P1|NOT COMPLETED|Overall Study||13
5343984|NCT00271609|13146834|P2|COMPLETED|Overall Study||29
5343985|NCT00271609|13146835|P1|COMPLETED|Overall Study||43
5343986|NCT00271609|13146834|P2|STARTED|Overall Study||32
5343987|NCT00271609|13146835|P1|STARTED|Overall Study||56
5343988|NCT00271596|13146845|P2|NOT COMPLETED|Overall Study||1
5343989|NCT00271596|13146846|P1|NOT COMPLETED|Overall Study||1
5343990|NCT00271596|13146845|P2|COMPLETED|Overall Study||15
5343991|NCT00271596|13146846|P1|COMPLETED|Overall Study||16
5343992|NCT00271596|13146845|P2|STARTED|Overall Study||16
5343993|NCT00271596|13146846|P1|STARTED|Overall Study||17
5343994|NCT00271570|13146872|P2|NOT COMPLETED|Overall Study||0
5343995|NCT00271570|13146873|P1|NOT COMPLETED|Overall Study||0
5343996|NCT00271570|13146872|P2|COMPLETED|Overall Study||12
5343997|NCT00271570|13146873|P1|COMPLETED|Overall Study||12
5343998|NCT00271570|13146872|P2|STARTED|Overall Study||12
5343999|NCT00271570|13146873|P1|STARTED|Overall Study||12
5344000|NCT00271544|13146881|P1|NOT COMPLETED|Overall Study||20
5344001|NCT00271544|13146881|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
5344002|NCT00271544|13146881|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
5344003|NCT00271544|13146881|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
5344004|NCT00271544|13146881|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
5344005|NCT00271505|13146902|P1|NOT COMPLETED|Overall Study||5
5344006|NCT00271505|13146902|P1|COMPLETED|Overall Study||38
5344007|NCT00271505|13146902|P1|STARTED|Overall Study||43
5344008|NCT00271375|13146911|P3|NOT COMPLETED|Overall Study||0
5344009|NCT00271375|13146912|P2|NOT COMPLETED|Overall Study||0
5344010|NCT00271375|13146913|P1|NOT COMPLETED|Overall Study||0
5344011|NCT00271375|13146911|P3|COMPLETED|Overall Study||57
5344012|NCT00271375|13146912|P2|COMPLETED|Overall Study||83
5344013|NCT00271375|13146913|P1|COMPLETED|Overall Study||114
5344014|NCT00271375|13146911|P3|STARTED|Overall Study||57
5344015|NCT00271375|13146912|P2|STARTED|Overall Study||83
5344016|NCT00271375|13146913|P1|STARTED|Overall Study||114
5344017|NCT00271219|13146951|P2|NOT COMPLETED|Overall Study||28
5344018|NCT00271219|13146952|P1|NOT COMPLETED|Overall Study||16
5344019|NCT00271219|13146951|P2|COMPLETED|Overall Study||58
5344020|NCT00271219|13146952|P1|COMPLETED|Overall Study||73
5344021|NCT00271219|13146951|P2|STARTED|Overall Study||86
5344022|NCT00271219|13146952|P1|STARTED|Overall Study||89
5344023|NCT00271154|13146978|P2|NOT COMPLETED|Overall Study||0
5344024|NCT00271154|13146979|P1|NOT COMPLETED|Overall Study||0
5344025|NCT00271154|13146978|P2|COMPLETED|Overall Study||419
5344026|NCT00271154|13146979|P1|COMPLETED|Overall Study||191
5344027|NCT00271154|13146978|P2|STARTED|Overall Study||419
5344028|NCT00271154|13146979|P1|STARTED|Overall Study||191
5344029|NCT00271102|13146990|P2|NOT COMPLETED|Overall Study||5
5344030|NCT00271102|13146991|P1|NOT COMPLETED|Overall Study||5
5344031|NCT00271102|13146990|P2|COMPLETED|Overall Study||30
5344032|NCT00271102|13146991|P1|COMPLETED|Overall Study||30
5344033|NCT00271102|13146990|P2|STARTED|Overall Study||35
5344034|NCT00271102|13146991|P1|STARTED|Overall Study||35
5344035|NCT00271024|13147001|P4|NOT COMPLETED|Overall Study||24
5344036|NCT00271024|13147002|P3|NOT COMPLETED|Overall Study||23
5344037|NCT00271024|13147003|P2|NOT COMPLETED|Overall Study||26
5344038|NCT00271024|13147004|P1|NOT COMPLETED|Overall Study||22
5344039|NCT00271024|13147001|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
5344040|NCT00271024|13147002|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
5344041|NCT00271024|13147003|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
5344042|NCT00271024|13147004|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
5344043|NCT00271024|13147001|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
5344044|NCT00271024|13147002|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
5344045|NCT00271024|13147003|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
5344046|NCT00271024|13147004|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
5344047|NCT00271024|13147001|P4|STARTED|Overall Study||88
5344048|NCT00271024|13147002|P3|STARTED|Overall Study||88
5344049|NCT00271024|13147003|P2|STARTED|Overall Study||77
5344050|NCT00271024|13147004|P1|STARTED|Overall Study||80
5344051|NCT00271011|13147046|P1|NOT COMPLETED|Overall Study||0
5344052|NCT00271011|13147046|P1|COMPLETED|Overall Study||13
5344053|NCT00271011|13147046|P1|STARTED|Overall Study||13
5344054|NCT00270998|13147054|P3|NOT COMPLETED|12 Month Follow-up||21
5344055|NCT00270998|13147055|P2|NOT COMPLETED|12 Month Follow-up||25
5344056|NCT00270998|13147056|P1|NOT COMPLETED|12 Month Follow-up||14
5344057|NCT00270998|13147054|P3|COMPLETED|12 Month Follow-up||111
5344058|NCT00270998|13147055|P2|COMPLETED|12 Month Follow-up||99
5344059|NCT00270998|13147056|P1|COMPLETED|12 Month Follow-up||96
5344060|NCT00270998|13147054|P3|STARTED|12 Month Follow-up||132
5344061|NCT00270998|13147055|P2|STARTED|12 Month Follow-up||124
5344062|NCT00270998|13147056|P1|STARTED|12 Month Follow-up||110
5344063|NCT00270998|13147054|P3|NOT COMPLETED|3 Month Follow-up||18
5344064|NCT00270998|13147055|P2|NOT COMPLETED|3 Month Follow-up||22
5344065|NCT00270998|13147056|P1|NOT COMPLETED|3 Month Follow-up||39
5344066|NCT00270998|13147054|P3|COMPLETED|3 Month Follow-up||132
5344067|NCT00270998|13147055|P2|COMPLETED|3 Month Follow-up||124
5344068|NCT00270998|13147056|P1|COMPLETED|3 Month Follow-up||110
5344069|NCT00270998|13147054|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
5344070|NCT00270998|13147055|P2|STARTED|3 Month Follow-up||146
5344071|NCT00270998|13147056|P1|STARTED|3 Month Follow-up||149
5344072|NCT00270894|13147085|P1|NOT COMPLETED|Overall Study||2
5344073|NCT00270894|13147085|P1|COMPLETED|Overall Study||28
5344074|NCT00270894|13147085|P1|STARTED|Overall Study||30
5344075|NCT00270855|13147097|P2|NOT COMPLETED|Overall Study||8
5344076|NCT00270855|13147098|P1|NOT COMPLETED|Overall Study||8
5344077|NCT00270855|13147097|P2|COMPLETED|Overall Study||6
5344078|NCT00270855|13147098|P1|COMPLETED|Overall Study||7
5344079|NCT00270855|13147097|P2|STARTED|Overall Study||14
5344080|NCT00270855|13147098|P1|STARTED|Overall Study||15
5344081|NCT00270842|13147157|P3|NOT COMPLETED|Overall Study||16
5344082|NCT00270842|13147158|P2|NOT COMPLETED|Overall Study||16
5344083|NCT00270842|13147159|P1|NOT COMPLETED|Overall Study||15
5344084|NCT00270842|13147157|P3|COMPLETED|Overall Study||18
5344085|NCT00270842|13147158|P2|COMPLETED|Overall Study||18
5344086|NCT00270842|13147159|P1|COMPLETED|Overall Study||18
5344087|NCT00270842|13147157|P3|STARTED|Overall Study||34
5344088|NCT00270842|13147158|P2|STARTED|Overall Study||34
5344089|NCT00270842|13147159|P1|STARTED|Overall Study||33
5344090|NCT00270790|13147170|P1|NOT COMPLETED|Overall Study||5
5344091|NCT00270790|13147170|P1|COMPLETED|Overall Study||16
5344092|NCT00270790|13147170|P1|STARTED|Overall Study||21
5344093|NCT00270634|13147179|P4|NOT COMPLETED|Overall Study||5
5344094|NCT00270634|13147180|P3|NOT COMPLETED|Overall Study||22
5344095|NCT00270634|13147181|P2|NOT COMPLETED|Overall Study||13
5344096|NCT00270634|13147182|P1|NOT COMPLETED|Overall Study||17
5344097|NCT00270634|13147179|P4|COMPLETED|Overall Study||81
5344098|NCT00270634|13147180|P3|COMPLETED|Overall Study||62
5344099|NCT00270634|13147181|P2|COMPLETED|Overall Study||64
5344100|NCT00270634|13147182|P1|COMPLETED|Overall Study||70
5344101|NCT00270634|13147179|P4|STARTED|Overall Study||86
5344102|NCT00270634|13147180|P3|STARTED|Overall Study||84
5344103|NCT00270634|13147181|P2|STARTED|Overall Study||77
5344104|NCT00270634|13147182|P1|STARTED|Overall Study||87
5344105|NCT00270296|13147219|P3|NOT COMPLETED|Overall Study||61
5344106|NCT00270296|13147220|P2|NOT COMPLETED|Overall Study||90
5344107|NCT00270296|13147221|P1|NOT COMPLETED|Overall Study||99
5344108|NCT00270296|13147219|P3|COMPLETED|Overall Study||109
5344109|NCT00270296|13147220|P2|COMPLETED|Overall Study||185
5344110|NCT00270296|13147221|P1|COMPLETED|Overall Study||186
5344111|NCT00270296|13147219|P3|STARTED|Overall Study||170
5344112|NCT00270296|13147220|P2|STARTED|Overall Study||275
5344113|NCT00270296|13147221|P1|STARTED|Overall Study||285
5344114|NCT00270257|13147234|P2|NOT COMPLETED|Overall Study||424
5344115|NCT00270257|13147235|P1|NOT COMPLETED|Overall Study||412
5344116|NCT00270257|13147234|P2|COMPLETED|Overall Study||204
5344117|NCT00270257|13147235|P1|COMPLETED|Overall Study||211
5344118|NCT00270257|13147234|P2|Visit 104|Overall Study||204
5344119|NCT00270257|13147235|P1|Visit 104|Overall Study||211
5344120|NCT00270257|13147234|P2|Week 78|Overall Study||285
5344121|NCT00270257|13147235|P1|Week 78|Overall Study||283
5344122|NCT00270257|13147234|P2|Week 52|Overall Study||340
5344123|NCT00270257|13147235|P1|Week 52|Overall Study||362
5344124|NCT00270257|13147234|P2|Week 26|Overall Study||440
5344125|NCT00270257|13147235|P1|Week 26|Overall Study||460
5344126|NCT00270257|13147234|P2|Week 8|Overall Study||443
5344127|NCT00270257|13147235|P1|Week 8|Overall Study||510
5344220|NCT00268905|13147602|P1|COMPLETED|Overall Study||0
5344128|NCT00270257|13147234|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
5344129|NCT00270257|13147235|P1|STARTED|Overall Study||623
5344130|NCT00270231|13147253|P2|NOT COMPLETED|Second Intervention||1
5344131|NCT00270231|13147254|P1|NOT COMPLETED|Second Intervention||0
5344132|NCT00270231|13147253|P2|COMPLETED|Second Intervention||30
5344133|NCT00270231|13147254|P1|COMPLETED|Second Intervention||30
5344134|NCT00270231|13147253|P2|STARTED|Second Intervention||31
5344135|NCT00270231|13147254|P1|STARTED|Second Intervention||30
5344136|NCT00270231|13147253|P2|NOT COMPLETED|Washout Period||0
5344137|NCT00270231|13147254|P1|NOT COMPLETED|Washout Period||1
5344138|NCT00270231|13147253|P2|COMPLETED|Washout Period||31
5344139|NCT00270231|13147254|P1|COMPLETED|Washout Period||30
5344140|NCT00270231|13147253|P2|STARTED|Washout Period||31
5344141|NCT00270231|13147254|P1|STARTED|Washout Period||31
5344142|NCT00270231|13147253|P2|NOT COMPLETED|First Intervention||1
5344143|NCT00270231|13147254|P1|NOT COMPLETED|First Intervention||1
5344144|NCT00270231|13147253|P2|COMPLETED|First Intervention||31
5344145|NCT00270231|13147254|P1|COMPLETED|First Intervention||31
5344146|NCT00270231|13147253|P2|STARTED|First Intervention||32
5344147|NCT00270231|13147254|P1|STARTED|First Intervention||32
5344148|NCT00270205|13147264|P4|NOT COMPLETED|Overall Study||1
5344149|NCT00270205|13147265|P3|NOT COMPLETED|Overall Study||0
5344150|NCT00270205|13147266|P2|NOT COMPLETED|Overall Study||0
5344151|NCT00270205|13147267|P1|NOT COMPLETED|Overall Study||1
5344152|NCT00270205|13147264|P4|COMPLETED|Overall Study||6
5344153|NCT00270205|13147265|P3|COMPLETED|Overall Study||6
5344154|NCT00270205|13147266|P2|COMPLETED|Overall Study||6
5344155|NCT00270205|13147267|P1|COMPLETED|Overall Study||5
5344156|NCT00270205|13147264|P4|STARTED|Overall Study||7
5344157|NCT00270205|13147265|P3|STARTED|Overall Study||6
5344158|NCT00270205|13147266|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
5344159|NCT00270205|13147267|P1|STARTED|Overall Study||6
5344160|NCT00269919|13147385|P1|NOT COMPLETED|Overall Study||27
5344161|NCT00269919|13147385|P1|COMPLETED|Overall Study||13
5344162|NCT00269919|13147385|P1|Treated|Overall Study||39
5344163|NCT00269919|13147385|P1|STARTED|Overall Study||40
5344164|NCT00269633|13147404|P2|NOT COMPLETED|Overall Study||0
5344165|NCT00269633|13147405|P1|NOT COMPLETED|Overall Study||1
5344166|NCT00269633|13147404|P2|COMPLETED|Overall Study||5
5344167|NCT00269633|13147405|P1|COMPLETED|Overall Study||3
5344168|NCT00269633|13147404|P2|STARTED|Overall Study||5
5344169|NCT00269633|13147405|P1|STARTED|Overall Study||4
5344170|NCT00269477|13147415|P4|NOT COMPLETED|Overall Study||0
5344171|NCT00269477|13147416|P3|NOT COMPLETED|Overall Study||1
5344172|NCT00269477|13147417|P2|NOT COMPLETED|Overall Study||6
5344173|NCT00269477|13147418|P1|NOT COMPLETED|Overall Study||5
5344174|NCT00269477|13147415|P4|COMPLETED|Overall Study||60
5344175|NCT00269477|13147416|P3|COMPLETED|Overall Study||57
5344176|NCT00269477|13147417|P2|COMPLETED|Overall Study||12
5344177|NCT00269477|13147418|P1|COMPLETED|Overall Study||4
5344178|NCT00269477|13147415|P4|STARTED|Overall Study||60
5344179|NCT00269477|13147416|P3|STARTED|Overall Study||58
5344180|NCT00269477|13147417|P2|STARTED|Overall Study||18
5344181|NCT00269477|13147418|P1|STARTED|Overall Study||9
5344182|NCT00269399|13147434|P2|NOT COMPLETED|Overall Study||27
5344183|NCT00269399|13147435|P1|NOT COMPLETED|Overall Study||41
5344184|NCT00269399|13147434|P2|COMPLETED|Overall Study||91
5344185|NCT00269399|13147435|P1|COMPLETED|Overall Study||78
5344186|NCT00269399|13147434|P2|STARTED|Overall Study||118
5344187|NCT00269399|13147435|P1|STARTED|Overall Study||119
5344188|NCT00269152|13147445|P2|NOT COMPLETED|Overall Study||10
5344189|NCT00269152|13147446|P1|NOT COMPLETED|Overall Study||18
5344190|NCT00269152|13147445|P2|COMPLETED|Overall Study||49
5344191|NCT00269152|13147446|P1|COMPLETED|Overall Study||45
5344192|NCT00269152|13147445|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
5344193|NCT00269152|13147446|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
5344194|NCT00269113|13147462|P2|NOT COMPLETED|Overall Study||37
5344195|NCT00269113|13147463|P1|NOT COMPLETED|Overall Study||74
5344196|NCT00269113|13147462|P2|COMPLETED|Overall Study||146
5344197|NCT00269113|13147463|P1|COMPLETED|Overall Study||103
5344198|NCT00269113|13147462|P2|STARTED|Overall Study||183
5344199|NCT00269113|13147463|P1|STARTED|Overall Study||177
5344200|NCT00269087|13147481|P1|NOT COMPLETED|Overall Study||34
5344201|NCT00269087|13147481|P1|COMPLETED|Overall Study||88
5344202|NCT00269087|13147481|P1|STARTED|Overall Study||122
5344203|NCT00268996|13147511|P2|NOT COMPLETED|Overall Study||20
5344204|NCT00268996|13147512|P1|NOT COMPLETED|Overall Study||21
5344205|NCT00268996|13147511|P2|COMPLETED|Overall Study||152
5344206|NCT00268996|13147512|P1|COMPLETED|Overall Study||130
5344207|NCT00268996|13147511|P2|STARTED|Overall Study||172
5344208|NCT00268996|13147512|P1|STARTED|Overall Study||151
5344209|NCT00268983|13147556|P2|NOT COMPLETED|Overall Study||0
5344210|NCT00268983|13147557|P1|NOT COMPLETED|Overall Study||3
5344211|NCT00268983|13147556|P2|COMPLETED|Overall Study||8
5344212|NCT00268983|13147557|P1|COMPLETED|Overall Study||3
5344213|NCT00268983|13147556|P2|STARTED|Overall Study||8
5344214|NCT00268983|13147557|P1|STARTED|Overall Study||6
5344215|NCT00268905|13147600|P3|NOT COMPLETED|Overall Study||12
5344216|NCT00268905|13147601|P2|NOT COMPLETED|Overall Study||9
5344217|NCT00268905|13147602|P1|NOT COMPLETED|Overall Study||43
5344218|NCT00268905|13147600|P3|COMPLETED|Overall Study||0
5344219|NCT00268905|13147601|P2|COMPLETED|Overall Study||0
5344221|NCT00268905|13147600|P3|STARTED|Overall Study||12
5344222|NCT00268905|13147601|P2|STARTED|Overall Study||9
5344223|NCT00268905|13147602|P1|STARTED|Overall Study||43
5344224|NCT00268892|13147619|P3|NOT COMPLETED|Overall Study||39
5344225|NCT00268892|13147620|P2|NOT COMPLETED|Overall Study||42
5344226|NCT00268892|13147621|P1|NOT COMPLETED|Overall Study||39
5344227|NCT00268892|13147619|P3|COMPLETED|Overall Study||54
5344228|NCT00268892|13147620|P2|COMPLETED|Overall Study||53
5344229|NCT00268892|13147621|P1|COMPLETED|Overall Study||51
5344230|NCT00268892|13147619|P3|Switched to Higher Dose|Overall Study||76
5344231|NCT00268892|13147620|P2|Switched to Higher Dose|Overall Study||68
5344232|NCT00268892|13147621|P1|Switched to Higher Dose|Overall Study||59
5344233|NCT00268892|13147619|P3|STARTED|Overall Study||93
5344234|NCT00268892|13147620|P2|STARTED|Overall Study||95
5344235|NCT00268892|13147621|P1|STARTED|Overall Study||90
5344236|NCT00268762|13147632|P1|NOT COMPLETED|Overall Study||0
5344237|NCT00268762|13147632|P1|COMPLETED|Overall Study||65
5344238|NCT00268762|13147632|P1|STARTED|Overall Study||65
5344239|NCT00268463|13147640|P2|NOT COMPLETED|Overall Study||12
5344240|NCT00268463|13147641|P1|NOT COMPLETED|Overall Study||10
5344241|NCT00268463|13147640|P2|COMPLETED|Overall Study||0
5344242|NCT00268463|13147641|P1|COMPLETED|Overall Study||0
5344243|NCT00268463|13147640|P2|STARTED|Overall Study||12
5344244|NCT00268463|13147641|P1|STARTED|Overall Study||10
5344245|NCT00268450|13147647|P1|NOT COMPLETED|Overall Study||0
5344246|NCT00268450|13147647|P1|COMPLETED|Overall Study||21
5344247|NCT00268450|13147647|P1|STARTED|Overall Study||21
5344248|NCT00268437|13147657|P1|NOT COMPLETED|Overall Study||1
5344249|NCT00268437|13147657|P1|COMPLETED|Overall Study||26
5344250|NCT00268437|13147657|P1|STARTED|Overall Study||27
5344251|NCT00268346|13147664|P2|NOT COMPLETED|Overall Study||3
5344252|NCT00268346|13147665|P1|NOT COMPLETED|Overall Study||0
5344253|NCT00268346|13147664|P2|COMPLETED|Overall Study||37
5344254|NCT00268346|13147665|P1|COMPLETED|Overall Study||18
5344255|NCT00268346|13147664|P2|Started Treatment|Overall Study||40
5344256|NCT00268346|13147665|P1|Started Treatment|Overall Study||18
5344257|NCT00268346|13147664|P2|STARTED|Overall Study||40
5344258|NCT00268346|13147665|P1|STARTED|Overall Study||18
5344259|NCT00268242|13147671|P1|NOT COMPLETED|Overall Study||1
5344260|NCT00268242|13147671|P1|COMPLETED|Overall Study||23
5344261|NCT00268242|13147671|P1|STARTED|Overall Study||24
5344262|NCT00268203|13147680|P1|NOT COMPLETED|Overall Study||647
5344263|NCT00268203|13147680|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
5344264|NCT00268203|13147680|P1|Completed 2 Years of Follow-up|Overall Study||62
5344265|NCT00268203|13147680|P1|STARTED|Overall Study||765
5344266|NCT00267969|13147694|P7|NOT COMPLETED|After Controlled Period||72
5344267|NCT00267969|13147695|P6|NOT COMPLETED|After Controlled Period||82
5344268|NCT00267969|13147696|P5|NOT COMPLETED|After Controlled Period||35
5344269|NCT00267969|13147697|P4|NOT COMPLETED|After Controlled Period||36
5344270|NCT00267969|13147698|P3|NOT COMPLETED|After Controlled Period||0
5344271|NCT00267969|13147699|P2|NOT COMPLETED|After Controlled Period||0
5344272|NCT00267969|13147700|P1|NOT COMPLETED|After Controlled Period||0
5344273|NCT00267969|13147694|P7|COMPLETED|After Controlled Period||173
5344274|NCT00267969|13147695|P6|COMPLETED|After Controlled Period||172
5344275|NCT00267969|13147696|P5|COMPLETED|After Controlled Period||85
5344276|NCT00267969|13147697|P4|COMPLETED|After Controlled Period||87
5344277|NCT00267969|13147698|P3|COMPLETED|After Controlled Period||0
5344278|NCT00267969|13147699|P2|COMPLETED|After Controlled Period||0
5344279|NCT00267969|13147700|P1|COMPLETED|After Controlled Period||0
5344280|NCT00267969|13147694|P7|STARTED|After Controlled Period||245
5344281|NCT00267969|13147695|P6|STARTED|After Controlled Period||254
5344282|NCT00267969|13147696|P5|STARTED|After Controlled Period||120
5344283|NCT00267969|13147697|P4|STARTED|After Controlled Period||123
5344284|NCT00267969|13147698|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5344285|NCT00267969|13147699|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5344286|NCT00267969|13147700|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5344287|NCT00267969|13147694|P7|NOT COMPLETED|Controlled Period||0
5344288|NCT00267969|13147695|P6|NOT COMPLETED|Controlled Period||0
5344289|NCT00267969|13147696|P5|NOT COMPLETED|Controlled Period||0
5344290|NCT00267969|13147697|P4|NOT COMPLETED|Controlled Period||0
5344291|NCT00267969|13147698|P3|NOT COMPLETED|Controlled Period||11
5344292|NCT00267969|13147699|P2|NOT COMPLETED|Controlled Period||1
5344293|NCT00267969|13147700|P1|NOT COMPLETED|Controlled Period||12
5344294|NCT00267969|13147694|P7|COMPLETED|Controlled Period||0
5344295|NCT00267969|13147695|P6|COMPLETED|Controlled Period||0
5344296|NCT00267969|13147696|P5|COMPLETED|Controlled Period||0
5344297|NCT00267969|13147697|P4|COMPLETED|Controlled Period||0
5344298|NCT00267969|13147698|P3|COMPLETED|Controlled Period||245
5344299|NCT00267969|13147699|P2|COMPLETED|Controlled Period||254
5344300|NCT00267969|13147700|P1|COMPLETED|Controlled Period||243
5344301|NCT00267969|13147694|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344302|NCT00267969|13147695|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344303|NCT00267969|13147696|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344304|NCT00267969|13147697|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344393|NCT00267293|13147842|P2|COMPLETED|Overall Study||20
5344305|NCT00267969|13147698|P3|STARTED|Controlled Period|Number of patients randomized|256
5344306|NCT00267969|13147699|P2|STARTED|Controlled Period|Number of patients randomized|255
5344307|NCT00267969|13147700|P1|STARTED|Controlled Period|Number of patients randomized|255
5344308|NCT00267956|13147726|P4|NOT COMPLETED|After Controlled Period||2
5344309|NCT00267956|13147727|P3|NOT COMPLETED|After Controlled Period||5
5344310|NCT00267956|13147728|P2|NOT COMPLETED|After Controlled Period||0
5344311|NCT00267956|13147729|P1|NOT COMPLETED|After Controlled Period||0
5344312|NCT00267956|13147726|P4|COMPLETED|After Controlled Period||70
5344313|NCT00267956|13147727|P3|COMPLETED|After Controlled Period||52
5344314|NCT00267956|13147728|P2|COMPLETED|After Controlled Period||0
5344315|NCT00267956|13147729|P1|COMPLETED|After Controlled Period||0
5344316|NCT00267956|13147726|P4|STARTED|After Controlled Period||72
5344317|NCT00267956|13147727|P3|STARTED|After Controlled Period||57
5344318|NCT00267956|13147728|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5344319|NCT00267956|13147729|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
5344320|NCT00267956|13147726|P4|NOT COMPLETED|Controlled Period||0
5344321|NCT00267956|13147727|P3|NOT COMPLETED|Controlled Period||0
5344322|NCT00267956|13147728|P2|NOT COMPLETED|Controlled Period||4
5344323|NCT00267956|13147729|P1|NOT COMPLETED|Controlled Period||13
5344324|NCT00267956|13147726|P4|COMPLETED|Controlled Period||0
5344325|NCT00267956|13147727|P3|COMPLETED|Controlled Period||0
5344326|NCT00267956|13147728|P2|COMPLETED|Controlled Period||72
5344327|NCT00267956|13147729|P1|COMPLETED|Controlled Period||57
5344328|NCT00267956|13147726|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344329|NCT00267956|13147727|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
5344330|NCT00267956|13147728|P2|STARTED|Controlled Period||76
5344331|NCT00267956|13147729|P1|STARTED|Controlled Period||70
5344332|NCT00267865|13147747|P1|NOT COMPLETED|Consolidation Treatment||0
5344333|NCT00267865|13147747|P1|COMPLETED|Consolidation Treatment||5
5344334|NCT00267865|13147747|P1|STARTED|Consolidation Treatment||5
5344335|NCT00267865|13147747|P1|NOT COMPLETED|Induction Treatment||3
5344336|NCT00267865|13147747|P1|COMPLETED|Induction Treatment||9
5344337|NCT00267865|13147747|P1|STARTED|Induction Treatment||12
5344338|NCT00267774|13147758|P2|NOT COMPLETED|Overall Study||0
5344339|NCT00267774|13147759|P1|NOT COMPLETED|Overall Study||0
5344340|NCT00267774|13147758|P2|COMPLETED|Overall Study||496
5344341|NCT00267774|13147759|P1|COMPLETED|Overall Study||509
5344342|NCT00267774|13147758|P2|STARTED|Overall Study||496
5344343|NCT00267774|13147759|P1|STARTED|Overall Study||509
5344344|NCT00267748|13147770|P3|NOT COMPLETED|Randomized Period||132
5344345|NCT00267748|13147771|P2|NOT COMPLETED|Randomized Period||127
5344346|NCT00267748|13147772|P1|NOT COMPLETED|Randomized Period||0
5344347|NCT00267748|13147770|P3|COMPLETED|Randomized Period||14
5344348|NCT00267748|13147771|P2|COMPLETED|Randomized Period||19
5344349|NCT00267748|13147772|P1|COMPLETED|Randomized Period||0
5344350|NCT00267748|13147770|P3|Treated|Randomized Period||143
5344351|NCT00267748|13147771|P2|Treated|Randomized Period||146
5344352|NCT00267748|13147772|P1|Treated|Randomized Period||0
5344353|NCT00267748|13147770|P3|STARTED|Randomized Period||146
5344354|NCT00267748|13147771|P2|STARTED|Randomized Period||146
5344355|NCT00267748|13147772|P1|STARTED|Randomized Period||0
5344356|NCT00267748|13147770|P3|NOT COMPLETED|Non-randomized Period||0
5344357|NCT00267748|13147771|P2|NOT COMPLETED|Non-randomized Period||0
5344358|NCT00267748|13147772|P1|NOT COMPLETED|Non-randomized Period||23
5344359|NCT00267748|13147770|P3|COMPLETED|Non-randomized Period||0
5344360|NCT00267748|13147771|P2|COMPLETED|Non-randomized Period||0
5344361|NCT00267748|13147772|P1|COMPLETED|Non-randomized Period||2
5344362|NCT00267748|13147770|P3|STARTED|Non-randomized Period||0
5344363|NCT00267748|13147771|P2|STARTED|Non-randomized Period||0
5344364|NCT00267748|13147772|P1|STARTED|Non-randomized Period||25
5344365|NCT00267696|13147789|P1|NOT COMPLETED|Overall Study||0
5344366|NCT00267696|13147789|P1|COMPLETED|Overall Study||45
5344367|NCT00267696|13147789|P1|STARTED|Overall Study||45
5344368|NCT00267670|13147796|P2|NOT COMPLETED|Overall Study||0
5344369|NCT00267670|13147797|P1|NOT COMPLETED|Overall Study||4
5344370|NCT00267670|13147796|P2|COMPLETED|Overall Study||7
5344371|NCT00267670|13147797|P1|COMPLETED|Overall Study||15
5344372|NCT00267670|13147796|P2|STARTED|Overall Study||7
5344373|NCT00267670|13147797|P1|STARTED|Overall Study||19
5344374|NCT00267644|13147811|P2|NOT COMPLETED|Overall Study||0
5344375|NCT00267644|13147812|P1|NOT COMPLETED|Overall Study||0
5344376|NCT00267644|13147811|P2|COMPLETED|Overall Study||63
5344377|NCT00267644|13147812|P1|COMPLETED|Overall Study||13
5344378|NCT00267644|13147811|P2|STARTED|Overall Study||63
5344379|NCT00267644|13147812|P1|STARTED|Overall Study||13
5344380|NCT00267631|13147822|P2|NOT COMPLETED|Overall Study||0
5344381|NCT00267631|13147823|P1|NOT COMPLETED|Overall Study||0
5344382|NCT00267631|13147822|P2|COMPLETED|Overall Study||3031
5344383|NCT00267631|13147823|P1|COMPLETED|Overall Study||2361
5344384|NCT00267631|13147822|P2|STARTED|Overall Study||3031
5344385|NCT00267631|13147823|P1|STARTED|Overall Study||2361
5344386|NCT00267488|13147829|P1|NOT COMPLETED|Overall Study||11
5344387|NCT00267488|13147829|P1|COMPLETED|Overall Study||26
5344388|NCT00267488|13147829|P1|STARTED|Overall Study||37
5344389|NCT00267293|13147841|P3|NOT COMPLETED|Overall Study||0
5344390|NCT00267293|13147842|P2|NOT COMPLETED|Overall Study||0
5344391|NCT00267293|13147843|P1|NOT COMPLETED|Overall Study||0
5344392|NCT00267293|13147841|P3|COMPLETED|Overall Study||20
5344394|NCT00267293|13147843|P1|COMPLETED|Overall Study||20
5344395|NCT00267293|13147841|P3|STARTED|Overall Study||20
5344396|NCT00267293|13147842|P2|STARTED|Overall Study||20
5344397|NCT00267293|13147843|P1|STARTED|Overall Study||20
5344398|NCT00267202|13147853|P2|NOT COMPLETED|Overall Study||34
5344399|NCT00267202|13147854|P1|NOT COMPLETED|Overall Study||53
5344400|NCT00267202|13147853|P2|COMPLETED|Overall Study||105
5344401|NCT00267202|13147854|P1|COMPLETED|Overall Study||83
5344402|NCT00267202|13147853|P2|STARTED|Overall Study||139
5344403|NCT00267202|13147854|P1|STARTED|Overall Study||136
5344404|NCT00267189|13147875|P2|NOT COMPLETED|Overall Study||1
5344405|NCT00267189|13147876|P1|NOT COMPLETED|Overall Study||5
5344406|NCT00267189|13147875|P2|COMPLETED|Overall Study||72
5344407|NCT00267189|13147876|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
5344408|NCT00267189|13147875|P2|Completed Study Medication|Overall Study||72
5344409|NCT00267189|13147876|P1|Completed Study Medication|Overall Study||54
5344410|NCT00267189|13147875|P2|STARTED|Overall Study||73
5344411|NCT00267189|13147876|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
5344412|NCT00267150|13147886|P1|NOT COMPLETED|Overall Study||1
5344413|NCT00267150|13147886|P1|COMPLETED|Overall Study||30
5344414|NCT00267150|13147886|P1|STARTED|Overall Study||31
5344415|NCT00267111|13147893|P2|NOT COMPLETED|Overall Study||0
5344416|NCT00267111|13147894|P1|NOT COMPLETED|Overall Study||0
5344417|NCT00267111|13147893|P2|COMPLETED|Overall Study||55
5344418|NCT00267111|13147894|P1|COMPLETED|Overall Study||55
5344419|NCT00267111|13147893|P2|STARTED|Overall Study||55
5344420|NCT00267111|13147894|P1|STARTED|Overall Study||55
5344421|NCT00267098|13147910|P8|NOT COMPLETED|Overall Study||15
5344422|NCT00267098|13147911|P7|NOT COMPLETED|Overall Study||46
5344423|NCT00267098|13147912|P6|NOT COMPLETED|Overall Study||40
5344424|NCT00267098|13147913|P5|NOT COMPLETED|Overall Study||37
5344425|NCT00267098|13147914|P4|NOT COMPLETED|Overall Study||106
5344426|NCT00267098|13147915|P3|NOT COMPLETED|Overall Study||94
5344427|NCT00267098|13147916|P2|NOT COMPLETED|Overall Study||51
5344428|NCT00267098|13147917|P1|NOT COMPLETED|Overall Study||109
5344429|NCT00267098|13147910|P8|COMPLETED|Overall Study||5
5344430|NCT00267098|13147911|P7|COMPLETED|Overall Study||55
5344431|NCT00267098|13147912|P6|COMPLETED|Overall Study||66
5344432|NCT00267098|13147913|P5|COMPLETED|Overall Study||10
5344433|NCT00267098|13147914|P4|COMPLETED|Overall Study||135
5344434|NCT00267098|13147915|P3|COMPLETED|Overall Study||149
5344435|NCT00267098|13147916|P2|COMPLETED|Overall Study||0
5344436|NCT00267098|13147917|P1|COMPLETED|Overall Study||0
5344437|NCT00267098|13147910|P8|STARTED|Overall Study||20
5344438|NCT00267098|13147911|P7|STARTED|Overall Study||101
5344439|NCT00267098|13147912|P6|STARTED|Overall Study||106
5344440|NCT00267098|13147913|P5|STARTED|Overall Study||47
5344441|NCT00267098|13147914|P4|STARTED|Overall Study||241
5344442|NCT00267098|13147915|P3|STARTED|Overall Study||243
5344443|NCT00267098|13147916|P2|STARTED|Overall Study||51
5344444|NCT00267098|13147917|P1|STARTED|Overall Study||109
5344445|NCT00267085|13148050|P1|NOT COMPLETED|Overall Study||0
5344446|NCT00267085|13148050|P1|COMPLETED|Overall Study||10
5344447|NCT00267085|13148050|P1|STARTED|Overall Study||10
5344448|NCT00267059|13148054|P1|NOT COMPLETED|Overall Study||0
5344449|NCT00267059|13148054|P1|COMPLETED|Overall Study||44
5344450|NCT00267059|13148054|P1|STARTED|Overall Study||44
5344451|NCT00267046|13148060|P2|NOT COMPLETED|Overall Study||11
5344452|NCT00267046|13148061|P1|NOT COMPLETED|Overall Study||12
5344453|NCT00267046|13148060|P2|COMPLETED|Overall Study||5
5344454|NCT00267046|13148061|P1|COMPLETED|Overall Study||20
5344455|NCT00267046|13148060|P2|STARTED|Overall Study||16
5344456|NCT00267046|13148061|P1|STARTED|Overall Study||32
5344457|NCT00267007|13148071|P2|NOT COMPLETED|Overall Study||1
5344458|NCT00267007|13148072|P1|NOT COMPLETED|Overall Study||8
5344459|NCT00267007|13148071|P2|COMPLETED|Overall Study||10
5344460|NCT00267007|13148072|P1|COMPLETED|Overall Study||11
5344461|NCT00267007|13148071|P2|STARTED|Overall Study||11
5344462|NCT00267007|13148072|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
5344463|NCT00266877|13148083|P3|NOT COMPLETED|Overall Study||28
5344464|NCT00266877|13148084|P2|NOT COMPLETED|Overall Study||48
5344465|NCT00266877|13148085|P1|NOT COMPLETED|Overall Study||91
5344466|NCT00266877|13148083|P3|COMPLETED|Overall Study||0
5344467|NCT00266877|13148084|P2|COMPLETED|Overall Study||0
5344468|NCT00266877|13148085|P1|COMPLETED|Overall Study||0
5344469|NCT00266877|13148083|P3|STARTED|Overall Study||28
5344470|NCT00266877|13148084|P2|STARTED|Overall Study||48
5344471|NCT00266877|13148085|P1|STARTED|Overall Study||91
5344472|NCT00266864|13148104|P2|NOT COMPLETED|Overall Study||2
5344473|NCT00266864|13148105|P1|NOT COMPLETED|Overall Study||5
5344474|NCT00266864|13148104|P2|COMPLETED|Overall Study||11
5344475|NCT00266864|13148105|P1|COMPLETED|Overall Study||13
5344476|NCT00266864|13148104|P2|STARTED|Overall Study||13
5344477|NCT00266864|13148105|P1|STARTED|Overall Study||18
5344478|NCT00266851|13148115|P3|NOT COMPLETED|Overall Study||0
5344479|NCT00266851|13148116|P2|NOT COMPLETED|Overall Study||0
5344480|NCT00266851|13148117|P1|NOT COMPLETED|Overall Study||0
5344481|NCT00266851|13148115|P3|COMPLETED|Overall Study||22
5344482|NCT00266851|13148116|P2|COMPLETED|Overall Study||38
5344483|NCT00266851|13148117|P1|COMPLETED|Overall Study||37
5344484|NCT00266851|13148115|P3|Completed 12 Month Follow up|Overall Study||13
5344485|NCT00266851|13148116|P2|Completed 12 Month Follow up|Overall Study||19
5344486|NCT00266851|13148117|P1|Completed 12 Month Follow up|Overall Study||25
5344487|NCT00266851|13148115|P3|Completed 9 Month Follow up|Overall Study||15
5344488|NCT00266851|13148116|P2|Completed 9 Month Follow up|Overall Study||23
5344489|NCT00266851|13148117|P1|Completed 9 Month Follow up|Overall Study||22
5344490|NCT00266851|13148115|P3|Completed 6 Month Follow up|Overall Study||17
5344491|NCT00266851|13148116|P2|Completed 6 Month Follow up|Overall Study||22
5344492|NCT00266851|13148117|P1|Completed 6 Month Follow up|Overall Study||27
5344493|NCT00266851|13148115|P3|Completed 3 Month Follow up|Overall Study||15
5344494|NCT00266851|13148116|P2|Completed 3 Month Follow up|Overall Study||22
5344495|NCT00266851|13148117|P1|Completed 3 Month Follow up|Overall Study||26
5344496|NCT00266851|13148115|P3|STARTED|Overall Study||22
5344497|NCT00266851|13148116|P2|STARTED|Overall Study||38
5344498|NCT00266851|13148117|P1|STARTED|Overall Study||37
5344499|NCT00266825|13148136|P2|NOT COMPLETED|Completed Follow-Up||24
5344500|NCT00266825|13148137|P1|NOT COMPLETED|Completed Follow-Up||25
5344501|NCT00266825|13148136|P2|COMPLETED|Completed Follow-Up||154
5344502|NCT00266825|13148137|P1|COMPLETED|Completed Follow-Up||147
5344503|NCT00266825|13148136|P2|STARTED|Completed Follow-Up||178
5344504|NCT00266825|13148137|P1|STARTED|Completed Follow-Up||172
5344505|NCT00266825|13148136|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
5344506|NCT00266825|13148137|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
5344507|NCT00266825|13148136|P2|COMPLETED|Enrolled and Allocated Intervention||178
5344508|NCT00266825|13148137|P1|COMPLETED|Enrolled and Allocated Intervention||172
5344509|NCT00266825|13148136|P2|STARTED|Enrolled and Allocated Intervention||178
5344510|NCT00266825|13148137|P1|STARTED|Enrolled and Allocated Intervention||172
5344511|NCT00266812|13148163|P2|NOT COMPLETED|Overall Study||11
5344512|NCT00266812|13148164|P1|NOT COMPLETED|Overall Study||21
5344513|NCT00266812|13148163|P2|COMPLETED|Overall Study||2
5344514|NCT00266812|13148164|P1|COMPLETED|Overall Study||1
5344515|NCT00266812|13148163|P2|STARTED|Overall Study||13
5344516|NCT00266812|13148164|P1|STARTED|Overall Study||22
5344517|NCT00266799|13148172|P2|NOT COMPLETED|Overall Study||34
5344518|NCT00266799|13148173|P1|NOT COMPLETED|Overall Study||36
5344519|NCT00266799|13148172|P2|COMPLETED|Overall Study||68
5344520|NCT00266799|13148173|P1|COMPLETED|Overall Study||62
5344521|NCT00266799|13148172|P2|STARTED|Overall Study||102
5344522|NCT00266799|13148173|P1|STARTED|Overall Study||98
5344523|NCT00266708|13148189|P2|NOT COMPLETED|Overall Study||9
5344524|NCT00266708|13148190|P1|NOT COMPLETED|Overall Study||4
5344525|NCT00266708|13148189|P2|COMPLETED|Overall Study||13
5344526|NCT00266708|13148190|P1|COMPLETED|Overall Study||16
5344527|NCT00266708|13148189|P2|STARTED|Overall Study||22
5344528|NCT00266708|13148190|P1|STARTED|Overall Study||20
5344529|NCT00266695|13148230|P1|NOT COMPLETED|Overall Study||29
5344530|NCT00266695|13148230|P1|COMPLETED|Overall Study||174
5344531|NCT00266695|13148230|P1|STARTED|Overall Study||203
5344532|NCT00266656|13148242|P2|NOT COMPLETED|Overall Study||13
5344533|NCT00266656|13148243|P1|NOT COMPLETED|Overall Study||14
5344534|NCT00266656|13148242|P2|COMPLETED|Overall Study||20
5344535|NCT00266656|13148243|P1|COMPLETED|Overall Study||22
5344536|NCT00266656|13148242|P2|STARTED|Overall Study||33
5344537|NCT00266656|13148243|P1|STARTED|Overall Study||36
5344538|NCT00266630|13148267|P2|NOT COMPLETED|Overall Study||28
5344539|NCT00266630|13148268|P1|NOT COMPLETED|Overall Study||42
5344540|NCT00266630|13148267|P2|COMPLETED|Overall Study||11
5344541|NCT00266630|13148268|P1|COMPLETED|Overall Study||58
5344542|NCT00266630|13148267|P2|STARTED|Overall Study||39
5344543|NCT00266630|13148268|P1|STARTED|Overall Study||100
5344544|NCT00266409|13148310|P4|NOT COMPLETED|Overall Study||22
5344545|NCT00266409|13148311|P3|NOT COMPLETED|Overall Study||17
5344546|NCT00266409|13148312|P2|NOT COMPLETED|Overall Study||46
5344547|NCT00266409|13148313|P1|NOT COMPLETED|Overall Study||45
5344548|NCT00266409|13148310|P4|COMPLETED|Overall Study||49
5344549|NCT00266409|13148311|P3|COMPLETED|Overall Study||55
5344550|NCT00266409|13148312|P2|COMPLETED|Overall Study||92
5344551|NCT00266409|13148313|P1|COMPLETED|Overall Study||92
5344552|NCT00266409|13148310|P4|STARTED|Overall Study||71
5344553|NCT00266409|13148311|P3|STARTED|Overall Study||72
5344554|NCT00266409|13148312|P2|STARTED|Overall Study||138
5344555|NCT00266409|13148313|P1|STARTED|Overall Study||137
5344556|NCT00266279|13148595|P1|NOT COMPLETED|Overall Study||2
5344557|NCT00266279|13148595|P1|COMPLETED|Overall Study||15
5344558|NCT00266279|13148595|P1|STARTED|Overall Study||17
5344559|NCT00266227|13148601|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
5344560|NCT00266227|13148602|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
5344561|NCT00266227|13148603|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
5344562|NCT00266227|13148601|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
5344563|NCT00266227|13148602|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
5344564|NCT00266227|13148603|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
5344565|NCT00266227|13148601|P3|STARTED|Retreatment: Week 48 to Week 72||0
5344566|NCT00266227|13148602|P2|STARTED|Retreatment: Week 48 to Week 72||134
5344567|NCT00266227|13148603|P1|STARTED|Retreatment: Week 48 to Week 72||291
5344568|NCT00266227|13148601|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
5344569|NCT00266227|13148602|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
5344570|NCT00266227|13148603|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
5344571|NCT00266227|13148601|P3|COMPLETED|Retreatment: Up to Week 48||0
5344572|NCT00266227|13148602|P2|COMPLETED|Retreatment: Up to Week 48||134
5344573|NCT00266227|13148603|P1|COMPLETED|Retreatment: Up to Week 48||291
5344574|NCT00266227|13148601|P3|STARTED|Retreatment: Up to Week 48||0
5344575|NCT00266227|13148602|P2|STARTED|Retreatment: Up to Week 48||157
5344576|NCT00266227|13148603|P1|STARTED|Retreatment: Up to Week 48||318
5344577|NCT00266227|13148601|P3|NOT COMPLETED|Initial Treatment||77
5344578|NCT00266227|13148602|P2|NOT COMPLETED|Initial Treatment||0
5344579|NCT00266227|13148603|P1|NOT COMPLETED|Initial Treatment||0
5344580|NCT00266227|13148601|P3|COMPLETED|Initial Treatment||482
5344581|NCT00266227|13148602|P2|COMPLETED|Initial Treatment||0
5344582|NCT00266227|13148603|P1|COMPLETED|Initial Treatment||0
5344583|NCT00266227|13148601|P3|STARTED|Initial Treatment||559
5344584|NCT00266227|13148602|P2|STARTED|Initial Treatment||0
5344585|NCT00266227|13148603|P1|STARTED|Initial Treatment||0
5344586|NCT00266110|13148648|P1|NOT COMPLETED|Overall Study||7
5344587|NCT00266110|13148648|P1|COMPLETED|Overall Study||10
5344588|NCT00266110|13148648|P1|STARTED|Overall Study||17
5344589|NCT00266032|13148657|P3|NOT COMPLETED|Open-label Safety Extension||25
5344590|NCT00266032|13148658|P2|NOT COMPLETED|Open-label Safety Extension||14
5344591|NCT00266032|13148659|P1|NOT COMPLETED|Open-label Safety Extension||41
5344592|NCT00266032|13148657|P3|COMPLETED|Open-label Safety Extension||140
5344593|NCT00266032|13148658|P2|COMPLETED|Open-label Safety Extension||115
5344594|NCT00266032|13148659|P1|COMPLETED|Open-label Safety Extension||448
5344595|NCT00266032|13148657|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
5344596|NCT00266032|13148658|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
5344597|NCT00266032|13148659|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
5344598|NCT00266032|13148657|P3|NOT COMPLETED|Treatment||47
5344599|NCT00266032|13148658|P2|NOT COMPLETED|Treatment||64
5344600|NCT00266032|13148659|P1|NOT COMPLETED|Treatment||111
5344601|NCT00266032|13148657|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
5344602|NCT00266032|13148658|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
5344603|NCT00266032|13148659|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
5344604|NCT00266032|13148657|P3|Patients Treated and in FAS|Treatment|FAS|216
5344605|NCT00266032|13148658|P2|Patients Treated and in FAS|Treatment|FAS|209
5344606|NCT00266032|13148659|P1|Patients Treated and in FAS|Treatment|FAS|642
5344607|NCT00266032|13148657|P3|Patients Treated|Treatment||229
5344608|NCT00266032|13148658|P2|Patients Treated|Treatment||221
5344609|NCT00266032|13148659|P1|Patients Treated|Treatment||684
5344610|NCT00266032|13148657|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
5344611|NCT00266032|13148658|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
5344612|NCT00266032|13148659|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
5344613|NCT00265980|13148687|P1|NOT COMPLETED|Overall Study||0
5344614|NCT00265980|13148687|P1|COMPLETED|Overall Study||22
5344615|NCT00265980|13148687|P1|Weight -10% Leptin|Overall Study||22
5344616|NCT00265980|13148687|P1|Weight -10% Placebo|Overall Study||22
5344617|NCT00265980|13148687|P1|Weight Initial|Overall Study||22
5344618|NCT00265980|13148687|P1|STARTED|Overall Study||22
5344619|NCT00265941|13148694|P2|NOT COMPLETED|Overall Study||26
5344620|NCT00265941|13148695|P1|NOT COMPLETED|Overall Study||23
5344621|NCT00265941|13148694|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
5344622|NCT00265941|13148695|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
5344623|NCT00265941|13148694|P2|STARTED|Overall Study||470
5344624|NCT00265941|13148695|P1|STARTED|Overall Study||470
5344625|NCT00265889|13148727|P1|NOT COMPLETED|Overall Study||5
5344626|NCT00265889|13148727|P1|COMPLETED|Overall Study||37
5344627|NCT00265889|13148727|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
5344628|NCT00265889|13148727|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
5344629|NCT00265889|13148727|P1|STARTED|Overall Study||42
5344630|NCT00265850|13148736|P3|NOT COMPLETED|Overall Study||0
5344631|NCT00265850|13148737|P2|NOT COMPLETED|Overall Study||0
5344632|NCT00265850|13148738|P1|NOT COMPLETED|Overall Study||0
5344633|NCT00265850|13148736|P3|COMPLETED|Overall Study||533
5344634|NCT00265850|13148737|P2|COMPLETED|Overall Study||902
5344635|NCT00265850|13148738|P1|COMPLETED|Overall Study||899
5344636|NCT00265850|13148736|P3|STARTED|Overall Study||533
5344637|NCT00265850|13148737|P2|STARTED|Overall Study||902
5344638|NCT00265850|13148738|P1|STARTED|Overall Study||899
5344639|NCT00265798|13148748|P1|NOT COMPLETED|Overall Study||0
5344640|NCT00265798|13148748|P1|COMPLETED|Overall Study||38
5344641|NCT00265798|13148748|P1|STARTED|Overall Study||38
5344642|NCT00265785|13148754|P1|NOT COMPLETED|Overall Study||27
5344643|NCT00265785|13148754|P1|COMPLETED|Overall Study||0
5344644|NCT00265785|13148754|P1|Eligible and Began Protocol Treatment|Overall Study||24
5344645|NCT00265785|13148754|P1|Eligible|Overall Study||26
5344646|NCT00265785|13148754|P1|STARTED|Overall Study||27
5344647|NCT00265759|13148767|P4|NOT COMPLETED|Overall Study||9
5344648|NCT00265759|13148768|P3|NOT COMPLETED|Overall Study||2
5344649|NCT00265759|13148769|P2|NOT COMPLETED|Overall Study||1
5344650|NCT00265759|13148770|P1|NOT COMPLETED|Overall Study||0
5344651|NCT00265759|13148767|P4|COMPLETED|Overall Study||236
5344652|NCT00265759|13148768|P3|COMPLETED|Overall Study||123
5344653|NCT00265759|13148769|P2|COMPLETED|Overall Study||127
5344654|NCT00265759|13148770|P1|COMPLETED|Overall Study||124
5344655|NCT00265759|13148767|P4|STARTED|Overall Study||245
5344656|NCT00265759|13148768|P3|STARTED|Overall Study||125
5344657|NCT00265759|13148769|P2|STARTED|Overall Study||128
5344658|NCT00265759|13148770|P1|STARTED|Overall Study||124
5344659|NCT00265616|13148801|P2|NOT COMPLETED|Overall Study||0
5344660|NCT00265616|13148802|P1|NOT COMPLETED|Overall Study||0
5344661|NCT00265616|13148801|P2|COMPLETED|Overall Study||9
5344662|NCT00265616|13148802|P1|COMPLETED|Overall Study||14
5344663|NCT00265616|13148801|P2|STARTED|Overall Study||9
5344664|NCT00265616|13148802|P1|STARTED|Overall Study||14
5344665|NCT00265538|13148820|P4|NOT COMPLETED|Overall Study||19
5344666|NCT00265538|13148821|P3|NOT COMPLETED|Overall Study||11
5344667|NCT00265538|13148822|P2|NOT COMPLETED|Overall Study||9
5344668|NCT00265538|13148823|P1|NOT COMPLETED|Overall Study||10
5344669|NCT00265538|13148820|P4|COMPLETED|Overall Study||267
5344670|NCT00265538|13148821|P3|COMPLETED|Overall Study||171
5344671|NCT00265538|13148822|P2|COMPLETED|Overall Study||161
5344672|NCT00265538|13148823|P1|COMPLETED|Overall Study||186
5344673|NCT00265538|13148820|P4|STARTED|Overall Study||286
5344674|NCT00265538|13148821|P3|STARTED|Overall Study||182
5344675|NCT00265538|13148822|P2|STARTED|Overall Study||170
5344676|NCT00265538|13148823|P1|STARTED|Overall Study||196
5344677|NCT00265512|13148837|P2|NOT COMPLETED|Overall Study||95
5344678|NCT00265512|13148838|P1|NOT COMPLETED|Overall Study||45
5344679|NCT00265512|13148837|P2|COMPLETED|Overall Study||359
5344680|NCT00265512|13148838|P1|COMPLETED|Overall Study||168
5344681|NCT00265512|13148837|P2|STARTED|Overall Study||454
5344682|NCT00265512|13148838|P1|STARTED|Overall Study||213
5344683|NCT00265473|13148848|P1|NOT COMPLETED|Overall Study||0
5344684|NCT00265473|13148848|P1|COMPLETED|Overall Study||5
5344685|NCT00265473|13148848|P1|STARTED|Overall Study||5
5344686|NCT00265395|13148858|P2|NOT COMPLETED|Overall Study||17
5344687|NCT00265395|13148859|P1|NOT COMPLETED|Overall Study||8
5344688|NCT00265395|13148858|P2|COMPLETED|Overall Study||56
5344689|NCT00265395|13148859|P1|COMPLETED|Overall Study||78
5344690|NCT00265395|13148858|P2|STARTED|Overall Study||73
5344691|NCT00265395|13148859|P1|STARTED|Overall Study||86
5344692|NCT00265382|13148864|P1|NOT COMPLETED|Overall Study||145
5344693|NCT00265382|13148864|P1|COMPLETED|Overall Study||76
5344694|NCT00265382|13148864|P1|STARTED|Overall Study||221
5344695|NCT00265343|13148884|P2|NOT COMPLETED|Overall Study||19
5344696|NCT00265343|13148885|P1|NOT COMPLETED|Overall Study||21
5344697|NCT00265343|13148884|P2|COMPLETED|Overall Study||153
5344698|NCT00265343|13148885|P1|COMPLETED|Overall Study||113
5344699|NCT00265343|13148884|P2|STARTED|Overall Study||172
5344700|NCT00265343|13148885|P1|STARTED|Overall Study||134
5344701|NCT00265330|13148893|P1|NOT COMPLETED|Overall Study||95
5344702|NCT00265330|13148893|P1|COMPLETED|Overall Study||67
5344703|NCT00265330|13148893|P1|STARTED|Overall Study||162
5344704|NCT00265317|13148919|P4|NOT COMPLETED|Phase 2||65
5344705|NCT00265317|13148920|P3|NOT COMPLETED|Phase 2||64
5344706|NCT00265317|13148921|P2|NOT COMPLETED|Phase 2||0
5344707|NCT00265317|13148922|P1|NOT COMPLETED|Phase 2||0
5344708|NCT00265317|13148919|P4|COMPLETED|Phase 2||2
5344709|NCT00265317|13148920|P3|COMPLETED|Phase 2||1
5344710|NCT00265317|13148921|P2|COMPLETED|Phase 2||0
5344711|NCT00265317|13148922|P1|COMPLETED|Phase 2||0
5344712|NCT00265317|13148919|P4|STARTED|Phase 2||67
5344713|NCT00265317|13148920|P3|STARTED|Phase 2||65
5344714|NCT00265317|13148921|P2|STARTED|Phase 2||0
5344715|NCT00265317|13148922|P1|STARTED|Phase 2||0
5344716|NCT00265317|13148919|P4|NOT COMPLETED|Lead-In||0
5344717|NCT00265317|13148920|P3|NOT COMPLETED|Lead-In||0
5344718|NCT00265317|13148921|P2|NOT COMPLETED|Lead-In||17
5344719|NCT00265317|13148922|P1|NOT COMPLETED|Lead-In||12
5344720|NCT00265317|13148919|P4|COMPLETED|Lead-In||0
5344721|NCT00265317|13148920|P3|COMPLETED|Lead-In||0
5344722|NCT00265317|13148921|P2|COMPLETED|Lead-In||0
5344723|NCT00265317|13148922|P1|COMPLETED|Lead-In||1
5344724|NCT00265317|13148919|P4|STARTED|Lead-In||0
5344725|NCT00265317|13148920|P3|STARTED|Lead-In||0
5344726|NCT00265317|13148921|P2|STARTED|Lead-In||17
5344727|NCT00265317|13148922|P1|STARTED|Lead-In||13
5344728|NCT00265239|13149037|P2|NOT COMPLETED|Overall Study||1
5344729|NCT00265239|13149038|P1|NOT COMPLETED|Overall Study||2
5344730|NCT00265239|13149037|P2|COMPLETED|Overall Study||51
5344731|NCT00265239|13149038|P1|COMPLETED|Overall Study||50
5344732|NCT00265239|13149037|P2|STARTED|Overall Study||52
5344733|NCT00265239|13149038|P1|STARTED|Overall Study||52
5344734|NCT00265200|13149050|P1|NOT COMPLETED|Overall Study||4
5344735|NCT00265200|13149050|P1|COMPLETED|Overall Study||24
5344736|NCT00265200|13149050|P1|STARTED|Overall Study||28
5344737|NCT00265122|13149060|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
5344738|NCT00265122|13149061|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
5344739|NCT00265122|13149062|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
5344740|NCT00265122|13149063|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
5344741|NCT00265122|13149064|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
5344742|NCT00265122|13149065|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
5344743|NCT00265122|13149060|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
5344744|NCT00265122|13149061|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
5344745|NCT00265122|13149062|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
5344746|NCT00265122|13149063|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
5344747|NCT00265122|13149064|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
5344748|NCT00265122|13149065|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
5344749|NCT00265122|13149060|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
5344750|NCT00265122|13149061|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
5344751|NCT00265122|13149062|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
5344752|NCT00265122|13149063|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
5344753|NCT00265122|13149064|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
5344754|NCT00265122|13149065|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
5344755|NCT00265122|13149060|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
5344756|NCT00265122|13149061|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
5344757|NCT00265122|13149062|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
5344758|NCT00265122|13149063|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
5344759|NCT00265122|13149064|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
5344760|NCT00265122|13149065|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
5344761|NCT00265122|13149060|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
5344762|NCT00265122|13149061|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
5344763|NCT00265122|13149062|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
5344764|NCT00265122|13149063|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
5344765|NCT00265122|13149064|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
5344766|NCT00265122|13149065|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
5344767|NCT00265122|13149060|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
5344768|NCT00265122|13149061|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
5344769|NCT00265122|13149062|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
5344770|NCT00265122|13149063|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
5344771|NCT00265122|13149064|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
5344772|NCT00265122|13149065|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
5344773|NCT00265109|13149087|P1|NOT COMPLETED|Overall Study||6
5344774|NCT00265109|13149087|P1|COMPLETED|Overall Study||11
5344775|NCT00265109|13149087|P1|STARTED|Overall Study||17
5344776|NCT00265096|13149106|P3|NOT COMPLETED|Overall Study||39
5344777|NCT00265096|13149107|P2|NOT COMPLETED|Overall Study||51
5344778|NCT00265096|13149108|P1|NOT COMPLETED|Overall Study||36
5344779|NCT00265096|13149106|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
5344780|NCT00265096|13149107|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
5344781|NCT00265096|13149108|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
5344782|NCT00265096|13149106|P3|STARTED|Overall Study||146
5344783|NCT00265096|13149107|P2|STARTED|Overall Study||146
5344784|NCT00265096|13149108|P1|STARTED|Overall Study||113
5344785|NCT00265083|13149140|P3|NOT COMPLETED|Overall Study||42
5344786|NCT00265083|13149141|P2|NOT COMPLETED|Overall Study||42
5344787|NCT00265083|13149142|P1|NOT COMPLETED|Overall Study||17
5344788|NCT00265083|13149140|P3|COMPLETED|Overall Study||98
5344789|NCT00265083|13149141|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
5344790|NCT00265083|13149142|P1|COMPLETED|Overall Study||61
5344791|NCT00265083|13149140|P3|STARTED|Overall Study||140
5344792|NCT00265083|13149141|P2|STARTED|Overall Study|One patient did not receive study agent.|138
5344793|NCT00265083|13149142|P1|STARTED|Overall Study||78
5344794|NCT00264875|13149163|P1|NOT COMPLETED|Overall Study||30
5344795|NCT00264875|13149163|P1|COMPLETED|Overall Study||190
5344796|NCT00264875|13149163|P1|STARTED|Overall Study||220
5344797|NCT00264849|13149169|P2|NOT COMPLETED|Overall Study||25
5344798|NCT00264849|13149170|P1|NOT COMPLETED|Overall Study||22
5344799|NCT00264849|13149169|P2|COMPLETED|Overall Study||106
5344800|NCT00264849|13149170|P1|COMPLETED|Overall Study||253
5344801|NCT00264849|13149169|P2|STARTED|Overall Study||131
5344802|NCT00264849|13149170|P1|STARTED|Overall Study||275
5344803|NCT00264810|13149204|P2|NOT COMPLETED|Open Label Evaluation Period||6
5344804|NCT00264810|13149205|P1|NOT COMPLETED|Open Label Evaluation Period||6
5344805|NCT00264810|13149204|P2|COMPLETED|Open Label Evaluation Period||86
5344806|NCT00264810|13149205|P1|COMPLETED|Open Label Evaluation Period||89
5344807|NCT00264810|13149204|P2|1-year Post-implant|Open Label Evaluation Period||90
5344808|NCT00264810|13149205|P1|1-year Post-implant|Open Label Evaluation Period||92
5344809|NCT00264810|13149204|P2|STARTED|Open Label Evaluation Period||92
5344810|NCT00264810|13149205|P1|STARTED|Open Label Evaluation Period||95
5344811|NCT00264810|13149204|P2|NOT COMPLETED|Blinded Evaluation Period||1
5344812|NCT00264810|13149205|P1|NOT COMPLETED|Blinded Evaluation Period||1
5344813|NCT00264810|13149204|P2|COMPLETED|Blinded Evaluation Period||92
5344814|NCT00264810|13149205|P1|COMPLETED|Blinded Evaluation Period||95
5344815|NCT00264810|13149204|P2|STARTED|Blinded Evaluation Period||93
5344816|NCT00264810|13149205|P1|STARTED|Blinded Evaluation Period||96
5344817|NCT00264810|13149204|P2|NOT COMPLETED|Stimulation Optimization Period||1
5344818|NCT00264810|13149205|P1|NOT COMPLETED|Stimulation Optimization Period||1
5344819|NCT00264810|13149204|P2|COMPLETED|Stimulation Optimization Period||93
5344820|NCT00264810|13149205|P1|COMPLETED|Stimulation Optimization Period||96
5344821|NCT00264810|13149204|P2|STARTED|Stimulation Optimization Period||94
5344822|NCT00264810|13149205|P1|STARTED|Stimulation Optimization Period||97
5344823|NCT00264810|13149204|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
5344824|NCT00264810|13149205|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
5344825|NCT00264810|13149204|P2|COMPLETED|Post-Operative Stabilization Period||94
5344826|NCT00264810|13149205|P1|COMPLETED|Post-Operative Stabilization Period||97
5344827|NCT00264810|13149204|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
5344828|NCT00264810|13149205|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
5344829|NCT00264810|13149204|P2|NOT COMPLETED|Baseline||26
5344830|NCT00264810|13149205|P1|NOT COMPLETED|Baseline||23
5344831|NCT00264810|13149204|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
5344832|NCT00264810|13149205|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
5344833|NCT00264810|13149204|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
5344834|NCT00264810|13149205|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
5344835|NCT00264797|13149215|P2|NOT COMPLETED|Overall Study||43
5344836|NCT00264797|13149216|P1|NOT COMPLETED|Overall Study||33
5344837|NCT00264797|13149215|P2|COMPLETED|Overall Study||109
5344838|NCT00264797|13149216|P1|COMPLETED|Overall Study||118
5344839|NCT00264797|13149215|P2|STARTED|Overall Study||152
5344840|NCT00264797|13149216|P1|STARTED|Overall Study||151
5344841|NCT00264641|13149230|P2|NOT COMPLETED|Overall Study||0
5344842|NCT00264641|13149231|P1|NOT COMPLETED|Overall Study||0
5344843|NCT00264641|13149230|P2|COMPLETED|Overall Study||10
5344844|NCT00264641|13149231|P1|COMPLETED|Overall Study||10
5344845|NCT00264641|13149230|P2|Initiation of the Study|Overall Study||10
5344846|NCT00264641|13149231|P1|Initiation of the Study|Overall Study||10
5344847|NCT00264641|13149230|P2|STARTED|Overall Study||10
5344848|NCT00264641|13149231|P1|STARTED|Overall Study||10
5344849|NCT00264576|13149238|P2|NOT COMPLETED|Overall Study||1
5344850|NCT00264576|13149239|P1|NOT COMPLETED|Overall Study||1
5344851|NCT00264576|13149238|P2|COMPLETED|Overall Study||304
5344852|NCT00264576|13149239|P1|COMPLETED|Overall Study||307
5344853|NCT00264576|13149238|P2|STARTED|Overall Study||305
5344854|NCT00264576|13149239|P1|STARTED|Overall Study||308
5344855|NCT00264550|13149263|P4|NOT COMPLETED|Overall Study||30
5344856|NCT00264550|13149264|P3|NOT COMPLETED|Overall Study||17
5344857|NCT00264550|13149265|P2|NOT COMPLETED|Overall Study||41
5344858|NCT00264550|13149266|P1|NOT COMPLETED|Overall Study||43
5344859|NCT00264550|13149263|P4|COMPLETED|Overall Study||59
5344860|NCT00264550|13149264|P3|COMPLETED|Overall Study||72
5344861|NCT00264550|13149265|P2|COMPLETED|Overall Study||92
5344862|NCT00264550|13149266|P1|COMPLETED|Overall Study||90
5344863|NCT00264550|13149263|P4|STARTED|Overall Study||89
5344864|NCT00264550|13149264|P3|STARTED|Overall Study||89
5344865|NCT00264550|13149265|P2|STARTED|Overall Study||133
5344866|NCT00264550|13149266|P1|STARTED|Overall Study||133
5344867|NCT00264537|13149305|P4|NOT COMPLETED|Overall Study||60
5344868|NCT00264537|13149306|P3|NOT COMPLETED|Overall Study||50
5344869|NCT00264537|13149307|P2|NOT COMPLETED|Overall Study||58
5344870|NCT00264537|13149308|P1|NOT COMPLETED|Overall Study||50
5344871|NCT00264537|13149305|P4|COMPLETED|Overall Study||99
5344872|NCT00264537|13149306|P3|COMPLETED|Overall Study||109
5344873|NCT00264537|13149307|P2|COMPLETED|Overall Study||101
5344874|NCT00264537|13149308|P1|COMPLETED|Overall Study||110
5344875|NCT00264537|13149305|P4|STARTED|Overall Study||159
5344876|NCT00264537|13149306|P3|STARTED|Overall Study||159
5344877|NCT00264537|13149307|P2|STARTED|Overall Study||159
5344878|NCT00264537|13149308|P1|STARTED|Overall Study||160
5344879|NCT00264498|13149340|P2|NOT COMPLETED|Crossover Treatment||9
5344880|NCT00264498|13149341|P1|NOT COMPLETED|Crossover Treatment||6
5344881|NCT00264498|13149340|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
5344882|NCT00264498|13149341|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
5344883|NCT00264498|13149340|P2|STARTED|Crossover Treatment||9
5344884|NCT00264498|13149341|P1|STARTED|Crossover Treatment||6
5344885|NCT00264498|13149340|P2|NOT COMPLETED|Randomized Treatment||18
5344886|NCT00264498|13149341|P1|NOT COMPLETED|Randomized Treatment||17
5344887|NCT00264498|13149340|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
5344888|NCT00264498|13149341|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
5344889|NCT00264498|13149340|P2|STARTED|Randomized Treatment||18
5344890|NCT00264498|13149341|P1|STARTED|Randomized Treatment||17
5344891|NCT00264381|13149349|P2|NOT COMPLETED|Overall Study||0
5344892|NCT00264381|13149350|P1|NOT COMPLETED|Overall Study||0
5344893|NCT00264381|13149349|P2|COMPLETED|Overall Study||37
5344894|NCT00264381|13149350|P1|COMPLETED|Overall Study||35
5344895|NCT00264381|13149349|P2|STARTED|Overall Study||37
5344896|NCT00264381|13149350|P1|STARTED|Overall Study||35
5344897|NCT00264303|13149364|P2|NOT COMPLETED|Overall Study||29
5344898|NCT00264303|13149365|P1|NOT COMPLETED|Overall Study||25
5344899|NCT00264303|13149364|P2|COMPLETED|Overall Study||419
5344900|NCT00264303|13149365|P1|COMPLETED|Overall Study||413
5344901|NCT00264303|13149364|P2|STARTED|Overall Study||448
5344902|NCT00264303|13149365|P1|STARTED|Overall Study||438
5344903|NCT00264290|13149383|P2|NOT COMPLETED|Observation (4 Weeks)||0
5344904|NCT00264290|13149384|P1|NOT COMPLETED|Observation (4 Weeks)||0
5344905|NCT00264290|13149383|P2|COMPLETED|Observation (4 Weeks)||14
5344906|NCT00264290|13149384|P1|COMPLETED|Observation (4 Weeks)||15
5344907|NCT00264290|13149383|P2|STARTED|Observation (4 Weeks)||14
5344908|NCT00264290|13149384|P1|STARTED|Observation (4 Weeks)||15
5344909|NCT00264290|13149383|P2|NOT COMPLETED|Intervention (8 Weeks)||0
5344910|NCT00264290|13149384|P1|NOT COMPLETED|Intervention (8 Weeks)||1
5344911|NCT00264290|13149383|P2|COMPLETED|Intervention (8 Weeks)||14
5344912|NCT00264290|13149384|P1|COMPLETED|Intervention (8 Weeks)||15
5344913|NCT00264290|13149383|P2|STARTED|Intervention (8 Weeks)||14
5344914|NCT00264290|13149384|P1|STARTED|Intervention (8 Weeks)||16
5344915|NCT00264238|13149400|P1|NOT COMPLETED|Overall Study||1
5344916|NCT00264238|13149400|P1|COMPLETED|Overall Study||14
5344917|NCT00264238|13149400|P1|STARTED|Overall Study||15
5344918|NCT00264147|13149412|P6|NOT COMPLETED|Treatment II Period||33
5344919|NCT00264147|13149413|P5|NOT COMPLETED|Treatment II Period||33
5344920|NCT00264147|13149414|P4|NOT COMPLETED|Treatment II Period||0
5344921|NCT00264147|13149415|P3|NOT COMPLETED|Treatment II Period||0
5344922|NCT00264147|13149416|P2|NOT COMPLETED|Treatment II Period||0
5344923|NCT00264147|13149417|P1|NOT COMPLETED|Treatment II Period||0
5344924|NCT00264147|13149412|P6|COMPLETED|Treatment II Period||116
5344925|NCT00264147|13149413|P5|COMPLETED|Treatment II Period||147
5344926|NCT00264147|13149414|P4|COMPLETED|Treatment II Period||0
5344927|NCT00264147|13149415|P3|COMPLETED|Treatment II Period||0
5344928|NCT00264147|13149416|P2|COMPLETED|Treatment II Period||0
5344929|NCT00264147|13149417|P1|COMPLETED|Treatment II Period||0
5344930|NCT00264147|13149412|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
5344931|NCT00264147|13149413|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
5344932|NCT00264147|13149414|P4|STARTED|Treatment II Period||0
5344933|NCT00264147|13149415|P3|STARTED|Treatment II Period||0
5344934|NCT00264147|13149416|P2|STARTED|Treatment II Period||0
5344935|NCT00264147|13149417|P1|STARTED|Treatment II Period||0
5344936|NCT00264147|13149412|P6|NOT COMPLETED|Treatment I Period||0
5344937|NCT00264147|13149413|P5|NOT COMPLETED|Treatment I Period||56
5344938|NCT00264147|13149414|P4|NOT COMPLETED|Treatment I Period||72
5344939|NCT00264147|13149415|P3|NOT COMPLETED|Treatment I Period||77
5344940|NCT00264147|13149416|P2|NOT COMPLETED|Treatment I Period||83
5344941|NCT00264147|13149417|P1|NOT COMPLETED|Treatment I Period||98
5344942|NCT00264147|13149412|P6|COMPLETED|Treatment I Period||0
5344943|NCT00264147|13149413|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
5344944|NCT00264147|13149414|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
5344945|NCT00264147|13149415|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
5344946|NCT00264147|13149416|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
5344947|NCT00264147|13149417|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
5344948|NCT00264147|13149412|P6|STARTED|Treatment I Period||0
5344949|NCT00264147|13149413|P5|STARTED|Treatment I Period||155
5344950|NCT00264147|13149414|P4|STARTED|Treatment I Period||140
5344951|NCT00264147|13149415|P3|STARTED|Treatment I Period||151
5344952|NCT00264147|13149416|P2|STARTED|Treatment I Period||154
5344953|NCT00264147|13149417|P1|STARTED|Treatment I Period||161
5344954|NCT00264004|13149460|P4|NOT COMPLETED|Overall Study||15
5344955|NCT00264004|13149461|P3|NOT COMPLETED|Overall Study||14
5344956|NCT00264004|13149462|P2|NOT COMPLETED|Overall Study||11
5344957|NCT00264004|13149463|P1|NOT COMPLETED|Overall Study||17
5344958|NCT00264004|13149460|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
5344959|NCT00264004|13149461|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
5344960|NCT00264004|13149462|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
5344961|NCT00264004|13149463|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
5344962|NCT00264004|13149460|P4|STARTED|Overall Study|Randomised|34
5344963|NCT00264004|13149461|P3|STARTED|Overall Study|Randomised|30
5344964|NCT00264004|13149462|P2|STARTED|Overall Study|Randomised|32
5344965|NCT00264004|13149463|P1|STARTED|Overall Study|Randomised|30
5344966|NCT00263887|13149491|P2|NOT COMPLETED|Overall Study||7
5344967|NCT00263887|13149492|P1|NOT COMPLETED|Overall Study||3
5344968|NCT00263887|13149491|P2|COMPLETED|Overall Study||32
5344969|NCT00263887|13149492|P1|COMPLETED|Overall Study||35
5344970|NCT00263887|13149491|P2|STARTED|Overall Study||39
5344971|NCT00263887|13149492|P1|STARTED|Overall Study||38
5344972|NCT00263757|13149500|P2|NOT COMPLETED|Overall Study||8
5344973|NCT00263757|13149501|P1|NOT COMPLETED|Overall Study||8
5344974|NCT00263757|13149500|P2|COMPLETED|Overall Study||5
5344975|NCT00263757|13149501|P1|COMPLETED|Overall Study||4
5344976|NCT00263757|13149500|P2|STARTED|Overall Study||13
5344977|NCT00263757|13149501|P1|STARTED|Overall Study||12
5344978|NCT00263666|13149513|P2|NOT COMPLETED|Overall Study||11
5344979|NCT00263666|13149514|P1|NOT COMPLETED|Overall Study||7
5344980|NCT00263666|13149513|P2|COMPLETED|Overall Study||39
5344981|NCT00263666|13149514|P1|COMPLETED|Overall Study||43
5344982|NCT00263666|13149513|P2|STARTED|Overall Study||50
5344983|NCT00263666|13149514|P1|STARTED|Overall Study||50
5344984|NCT00263588|13149567|P2|NOT COMPLETED|Overall Study||132
5344985|NCT00263588|13149568|P1|NOT COMPLETED|Overall Study||81
5344986|NCT00263588|13149567|P2|COMPLETED|Overall Study||15
5344987|NCT00263588|13149568|P1|COMPLETED|Overall Study||14
5344988|NCT00263588|13149567|P2|STARTED|Overall Study||147
5344989|NCT00263588|13149568|P1|STARTED|Overall Study||95
5344990|NCT00263562|13149593|P2|NOT COMPLETED|Overall Study||0
5344991|NCT00263562|13149594|P1|NOT COMPLETED|Overall Study||3
5344992|NCT00263562|13149593|P2|COMPLETED|Overall Study||9
5344993|NCT00263562|13149594|P1|COMPLETED|Overall Study||6
5344994|NCT00263562|13149593|P2|STARTED|Overall Study||9
5344995|NCT00263562|13149594|P1|STARTED|Overall Study||9
5344996|NCT00263328|13149611|P3|NOT COMPLETED|Overall Study||7
5344997|NCT00263328|13149612|P2|NOT COMPLETED|Overall Study||2
5344998|NCT00263328|13149613|P1|NOT COMPLETED|Overall Study||8
5344999|NCT00263328|13149611|P3|COMPLETED|Overall Study||6
5345000|NCT00263328|13149612|P2|COMPLETED|Overall Study||12
5345001|NCT00263328|13149613|P1|COMPLETED|Overall Study||10
5345002|NCT00263328|13149611|P3|STARTED|Overall Study||13
5345003|NCT00263328|13149612|P2|STARTED|Overall Study||14
5345004|NCT00263328|13149613|P1|STARTED|Overall Study||18
5345005|NCT00263211|13149771|P2|NOT COMPLETED|Overall Study||1
5345006|NCT00263211|13149772|P1|NOT COMPLETED|Overall Study||5
5345007|NCT00263211|13149771|P2|COMPLETED|Overall Study||23
5345008|NCT00263211|13149772|P1|COMPLETED|Overall Study||19
5345009|NCT00263211|13149771|P2|STARTED|Overall Study||24
5345010|NCT00263211|13149772|P1|STARTED|Overall Study||24
5345011|NCT00262964|13149790|P4|NOT COMPLETED|Overall Study||0
5345012|NCT00262964|13149791|P3|NOT COMPLETED|Overall Study||0
5345013|NCT00262964|13149792|P2|NOT COMPLETED|Overall Study||0
5345014|NCT00262964|13149793|P1|NOT COMPLETED|Overall Study||0
5345015|NCT00262964|13149790|P4|COMPLETED|Overall Study||12
5345016|NCT00262964|13149791|P3|COMPLETED|Overall Study||17
5345017|NCT00262964|13149792|P2|COMPLETED|Overall Study||11
5345018|NCT00262964|13149793|P1|COMPLETED|Overall Study||11
5345019|NCT00262964|13149790|P4|STARTED|Overall Study||12
5345020|NCT00262964|13149791|P3|STARTED|Overall Study||17
5345021|NCT00262964|13149792|P2|STARTED|Overall Study||11
5345022|NCT00262964|13149793|P1|STARTED|Overall Study||11
5345023|NCT00262951|13149823|P1|NOT COMPLETED|Overall Study||16
5345024|NCT00262951|13149823|P1|COMPLETED|Overall Study||7
5345025|NCT00262951|13149823|P1|STARTED|Overall Study||23
5345026|NCT00262925|13149828|P1|NOT COMPLETED|Overall Study||11
5345027|NCT00262925|13149828|P1|COMPLETED|Overall Study||1
5345028|NCT00262925|13149828|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
5345029|NCT00262873|13149834|P1|NOT COMPLETED|Overall Study||8
5345030|NCT00262873|13149834|P1|COMPLETED|Overall Study||0
5345031|NCT00262873|13149834|P1|STARTED|Overall Study||8
5345032|NCT00262860|13149845|P1|NOT COMPLETED|Overall Study||2
5345033|NCT00262860|13149845|P1|COMPLETED|Overall Study||16
5345034|NCT00262860|13149845|P1|STARTED|Overall Study||18
5345035|NCT00262847|13149854|P3|NOT COMPLETED|Overall Study||396
5345036|NCT00262847|13149855|P2|NOT COMPLETED|Overall Study||513
5345037|NCT00262847|13149856|P1|NOT COMPLETED|Overall Study||518
5345038|NCT00262847|13149854|P3|COMPLETED|Overall Study||227
5345039|NCT00262847|13149855|P2|COMPLETED|Overall Study||112
5345040|NCT00262847|13149856|P1|COMPLETED|Overall Study||107
5345041|NCT00262847|13149854|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
5345042|NCT00262847|13149855|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
5345043|NCT00262847|13149856|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
5345044|NCT00262834|13149875|P2|NOT COMPLETED|Overall Study||4
5345045|NCT00262834|13149876|P1|NOT COMPLETED|Overall Study||1
5345046|NCT00262834|13149875|P2|COMPLETED|Overall Study||25
5345047|NCT00262834|13149876|P1|COMPLETED|Overall Study||24
5345048|NCT00262834|13149875|P2|STARTED|Overall Study||29
5345049|NCT00262834|13149876|P1|STARTED|Overall Study||25
5345050|NCT00262821|13149889|P2|NOT COMPLETED|Overall Study||19
5345051|NCT00262821|13149890|P1|NOT COMPLETED|Overall Study||4
5345052|NCT00262821|13149889|P2|COMPLETED|Overall Study||185
5345053|NCT00262821|13149890|P1|COMPLETED|Overall Study||194
5345054|NCT00262821|13149889|P2|STARTED|Overall Study||204
5345055|NCT00262821|13149890|P1|STARTED|Overall Study||198
5345056|NCT00262743|13149902|P2|NOT COMPLETED|Overall Study||12
5345057|NCT00262743|13149903|P1|NOT COMPLETED|Overall Study||0
5345058|NCT00262743|13149902|P2|COMPLETED|Overall Study||30
5345059|NCT00262743|13149903|P1|COMPLETED|Overall Study||27
5345060|NCT00262743|13149902|P2|STARTED|Overall Study||42
5345061|NCT00262743|13149903|P1|STARTED|Overall Study||27
5345062|NCT00262730|13149910|P1|NOT COMPLETED|Overall Study||0
5345063|NCT00262730|13149910|P1|COMPLETED|Overall Study||97
5345064|NCT00262730|13149910|P1|STARTED|Overall Study||97
5345065|NCT00262639|13149918|P4|NOT COMPLETED|Overall Study||0
5345066|NCT00262639|13149919|P3|NOT COMPLETED|Overall Study||0
5345067|NCT00262639|13149920|P2|NOT COMPLETED|Overall Study||0
5345068|NCT00262639|13149921|P1|NOT COMPLETED|Overall Study||0
5345069|NCT00262639|13149918|P4|COMPLETED|Overall Study||7
5345070|NCT00262639|13149919|P3|COMPLETED|Overall Study||9
5345071|NCT00262639|13149920|P2|COMPLETED|Overall Study||26
5345072|NCT00262639|13149921|P1|COMPLETED|Overall Study||18
5345073|NCT00262639|13149918|P4|STARTED|Overall Study||7
5345074|NCT00262639|13149919|P3|STARTED|Overall Study||9
5345075|NCT00262639|13149920|P2|STARTED|Overall Study||26
5345076|NCT00262639|13149921|P1|STARTED|Overall Study||18
5345077|NCT00262600|13149938|P3|NOT COMPLETED|Overall Study||266
5345078|NCT00262600|13149939|P2|NOT COMPLETED|Overall Study||252
5345079|NCT00262600|13149940|P1|NOT COMPLETED|Overall Study||235
5345080|NCT00262600|13149938|P3|COMPLETED|Overall Study||5756
5345081|NCT00262600|13149939|P2|COMPLETED|Overall Study||5824
5345082|NCT00262600|13149940|P1|COMPLETED|Overall Study||5780
5345083|NCT00262600|13149938|P3|STARTED|Overall Study||6022
5345084|NCT00262600|13149939|P2|STARTED|Overall Study||6076
5345085|NCT00262600|13149940|P1|STARTED|Overall Study||6015
5345086|NCT00262522|13149967|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
5345087|NCT00262522|13149968|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
5345088|NCT00262522|13149969|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
5345089|NCT00262522|13149970|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
5345090|NCT00262522|13149967|P4|COMPLETED|Study Start Through 96 Weeks||0
5345091|NCT00262522|13149968|P3|COMPLETED|Study Start Through 96 Weeks||254
5345092|NCT00262522|13149969|P2|COMPLETED|Study Start Through 96 Weeks||0
5345093|NCT00262522|13149970|P1|COMPLETED|Study Start Through 96 Weeks||256
5345094|NCT00262522|13149967|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
5345095|NCT00262522|13149968|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
5345169|NCT00262223|13150032|P2|COMPLETED|Treatment Phase||29
5345096|NCT00262522|13149969|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
5345097|NCT00262522|13149970|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
5345098|NCT00262522|13149967|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
5345099|NCT00262522|13149968|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
5345100|NCT00262522|13149969|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
5345101|NCT00262522|13149970|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
5345102|NCT00262522|13149967|P4|COMPLETED|Study Start Through 48 Weeks||0
5345103|NCT00262522|13149968|P3|COMPLETED|Study Start Through 48 Weeks||276
5345104|NCT00262522|13149969|P2|COMPLETED|Study Start Through 48 Weeks||0
5345105|NCT00262522|13149970|P1|COMPLETED|Study Start Through 48 Weeks||284
5345106|NCT00262522|13149967|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
5345107|NCT00262522|13149968|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
5345108|NCT00262522|13149969|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
5345109|NCT00262522|13149970|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
5345110|NCT00262522|13149967|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
5345111|NCT00262522|13149968|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
5345112|NCT00262522|13149969|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
5345113|NCT00262522|13149970|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
5345114|NCT00262522|13149967|P4|COMPLETED|Study Start Through 8 Weeks||160
5345115|NCT00262522|13149968|P3|COMPLETED|Study Start Through 8 Weeks||155
5345116|NCT00262522|13149969|P2|COMPLETED|Study Start Through 8 Weeks||161
5345117|NCT00262522|13149970|P1|COMPLETED|Study Start Through 8 Weeks||163
5345118|NCT00262522|13149967|P4|STARTED|Study Start Through 8 Weeks||165
5345119|NCT00262522|13149968|P3|STARTED|Study Start Through 8 Weeks||166
5345120|NCT00262522|13149969|P2|STARTED|Study Start Through 8 Weeks||166
5345121|NCT00262522|13149970|P1|STARTED|Study Start Through 8 Weeks||167
5345122|NCT00262509|13149992|P2|NOT COMPLETED|Overall Study||0
5345123|NCT00262509|13149993|P1|NOT COMPLETED|Overall Study||0
5345124|NCT00262509|13149992|P2|COMPLETED|Overall Study||9
5345125|NCT00262509|13149993|P1|COMPLETED|Overall Study||8
5345126|NCT00262509|13149992|P2|STARTED|Overall Study||9
5345127|NCT00262509|13149993|P1|STARTED|Overall Study||8
5345128|NCT00262314|13149999|P1|NOT COMPLETED|Overall Study||337
5345129|NCT00262314|13149999|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
5345130|NCT00262314|13149999|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
5345131|NCT00262301|13150017|P3|NOT COMPLETED|Open-label Phase||0
5345132|NCT00262301|13150018|P2|NOT COMPLETED|Open-label Phase||0
5345133|NCT00262301|13150019|P1|NOT COMPLETED|Open-label Phase||0
5345134|NCT00262301|13150017|P3|COMPLETED|Open-label Phase||57
5345135|NCT00262301|13150018|P2|COMPLETED|Open-label Phase||0
5345136|NCT00262301|13150019|P1|COMPLETED|Open-label Phase||0
5345137|NCT00262301|13150017|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
5345138|NCT00262301|13150018|P2|STARTED|Open-label Phase||0
5345139|NCT00262301|13150019|P1|STARTED|Open-label Phase||0
5345140|NCT00262301|13150017|P3|NOT COMPLETED|Double-blind Phase||0
5345141|NCT00262301|13150018|P2|NOT COMPLETED|Double-blind Phase||1
5345142|NCT00262301|13150019|P1|NOT COMPLETED|Double-blind Phase||1
5345143|NCT00262301|13150017|P3|COMPLETED|Double-blind Phase||0
5345144|NCT00262301|13150018|P2|COMPLETED|Double-blind Phase||15
5345145|NCT00262301|13150019|P1|COMPLETED|Double-blind Phase||15
5345146|NCT00262301|13150017|P3|STARTED|Double-blind Phase||0
5345147|NCT00262301|13150018|P2|STARTED|Double-blind Phase||16
5345148|NCT00262301|13150019|P1|STARTED|Double-blind Phase||16
5345149|NCT00262223|13150032|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
5345150|NCT00262223|13150033|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
5345151|NCT00262223|13150032|P2|COMPLETED|12-month Post-treatment Follow-up||22
5345152|NCT00262223|13150033|P1|COMPLETED|12-month Post-treatment Follow-up||21
5345153|NCT00262223|13150032|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
5345154|NCT00262223|13150033|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
5345155|NCT00262223|13150032|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
5345156|NCT00262223|13150033|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
5345157|NCT00262223|13150032|P2|COMPLETED|6-month Post-treatment Follow-up||28
5345158|NCT00262223|13150033|P1|COMPLETED|6-month Post-treatment Follow-up||22
5345159|NCT00262223|13150032|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
5345160|NCT00262223|13150033|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
5345161|NCT00262223|13150032|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
5345162|NCT00262223|13150033|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
5345163|NCT00262223|13150032|P2|COMPLETED|1-week Post-treatment Follow-up||25
5345164|NCT00262223|13150033|P1|COMPLETED|1-week Post-treatment Follow-up||24
5345165|NCT00262223|13150032|P2|STARTED|1-week Post-treatment Follow-up||29
5345166|NCT00262223|13150033|P1|STARTED|1-week Post-treatment Follow-up||28
5345167|NCT00262223|13150032|P2|NOT COMPLETED|Treatment Phase||8
5345168|NCT00262223|13150033|P1|NOT COMPLETED|Treatment Phase||4
5345170|NCT00262223|13150033|P1|COMPLETED|Treatment Phase||28
5345171|NCT00262223|13150032|P2|STARTED|Treatment Phase||37
5345172|NCT00262223|13150033|P1|STARTED|Treatment Phase||32
5345173|NCT00262119|13150044|P3|NOT COMPLETED|Overall Study||58
5345174|NCT00262119|13150045|P2|NOT COMPLETED|Overall Study||70
5345175|NCT00262119|13150046|P1|NOT COMPLETED|Overall Study||58
5345176|NCT00262119|13150044|P3|COMPLETED|Overall Study||325
5345177|NCT00262119|13150045|P2|COMPLETED|Overall Study||328
5345178|NCT00262119|13150046|P1|COMPLETED|Overall Study||327
5345179|NCT00262119|13150044|P3|STARTED|Overall Study||383
5345180|NCT00262119|13150045|P2|STARTED|Overall Study||398
5345181|NCT00262119|13150046|P1|STARTED|Overall Study||385
5345182|NCT00262080|13150066|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
5345183|NCT00262080|13150067|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
5345184|NCT00262080|13150068|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
5345185|NCT00262080|13150066|P3|COMPLETED|Repeat Dose Treatment Period||14
5345186|NCT00262080|13150067|P2|COMPLETED|Repeat Dose Treatment Period||25
5345187|NCT00262080|13150068|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
5345188|NCT00262080|13150066|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
5345189|NCT00262080|13150067|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
5345190|NCT00262080|13150068|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
5345191|NCT00262080|13150066|P3|NOT COMPLETED|Double Blind Treatment Period||0
5345192|NCT00262080|13150067|P2|NOT COMPLETED|Double Blind Treatment Period||0
5345193|NCT00262080|13150068|P1|NOT COMPLETED|Double Blind Treatment Period||1
5345194|NCT00262080|13150066|P3|COMPLETED|Double Blind Treatment Period||0
5345195|NCT00262080|13150067|P2|COMPLETED|Double Blind Treatment Period||36
5345196|NCT00262080|13150068|P1|COMPLETED|Double Blind Treatment Period||35
5345197|NCT00262080|13150066|P3|STARTED|Double Blind Treatment Period||0
5345198|NCT00262080|13150067|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
5345199|NCT00262080|13150068|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
5345200|NCT00262067|13150088|P4|NOT COMPLETED|Overall Study||113
5345201|NCT00262067|13150089|P3|NOT COMPLETED|Overall Study||216
5345202|NCT00262067|13150090|P2|NOT COMPLETED|Overall Study||100
5345203|NCT00262067|13150091|P1|NOT COMPLETED|Overall Study||219
5345204|NCT00262067|13150088|P4|COMPLETED|Overall Study||93
5345205|NCT00262067|13150089|P3|COMPLETED|Overall Study||193
5345206|NCT00262067|13150090|P2|COMPLETED|Overall Study||107
5345207|NCT00262067|13150091|P1|COMPLETED|Overall Study||196
5345208|NCT00262067|13150088|P4|STARTED|Overall Study||206
5345209|NCT00262067|13150089|P3|STARTED|Overall Study||409
5345210|NCT00262067|13150090|P2|STARTED|Overall Study||207
5345211|NCT00262067|13150091|P1|STARTED|Overall Study||415
5345212|NCT00262041|13150125|P3|NOT COMPLETED|Overall Study||6
5345213|NCT00262041|13150126|P2|NOT COMPLETED|Overall Study||4
5345214|NCT00262041|13150127|P1|NOT COMPLETED|Overall Study||2
5345215|NCT00262041|13150125|P3|COMPLETED|Overall Study||203
5345216|NCT00262041|13150126|P2|COMPLETED|Overall Study||147
5345217|NCT00262041|13150127|P1|COMPLETED|Overall Study||162
5345218|NCT00262041|13150125|P3|STARTED|Overall Study||209
5345219|NCT00262041|13150126|P2|STARTED|Overall Study||151
5345220|NCT00262041|13150127|P1|STARTED|Overall Study||164
5345221|NCT00262028|13150156|P9|NOT COMPLETED|Overall Study||19
5345222|NCT00262028|13150157|P8|NOT COMPLETED|Overall Study||18
5345223|NCT00262028|13150158|P7|NOT COMPLETED|Overall Study||12
5345224|NCT00262028|13150159|P6|NOT COMPLETED|Overall Study||13
5345225|NCT00262028|13150160|P5|NOT COMPLETED|Overall Study||12
5345226|NCT00262028|13150161|P4|NOT COMPLETED|Overall Study||23
5345227|NCT00262028|13150162|P3|NOT COMPLETED|Overall Study||20
5345228|NCT00262028|13150163|P2|NOT COMPLETED|Overall Study||27
5345229|NCT00262028|13150164|P1|NOT COMPLETED|Overall Study||24
5345230|NCT00262028|13150156|P9|COMPLETED|Overall Study||81
5345231|NCT00262028|13150157|P8|COMPLETED|Overall Study||55
5345232|NCT00262028|13150158|P7|COMPLETED|Overall Study||59
5345233|NCT00262028|13150159|P6|COMPLETED|Overall Study||60
5345234|NCT00262028|13150160|P5|COMPLETED|Overall Study||62
5345235|NCT00262028|13150161|P4|COMPLETED|Overall Study||134
5345236|NCT00262028|13150162|P3|COMPLETED|Overall Study||137
5345237|NCT00262028|13150163|P2|COMPLETED|Overall Study||126
5345238|NCT00262028|13150164|P1|COMPLETED|Overall Study||128
5345239|NCT00262028|13150156|P9|STARTED|Overall Study||100
5345240|NCT00262028|13150157|P8|STARTED|Overall Study||73
5345241|NCT00262028|13150158|P7|STARTED|Overall Study||71
5345242|NCT00262028|13150159|P6|STARTED|Overall Study||73
5345243|NCT00262028|13150160|P5|STARTED|Overall Study||74
5345244|NCT00262028|13150161|P4|STARTED|Overall Study||157
5345245|NCT00262028|13150162|P3|STARTED|Overall Study||157
5345246|NCT00262028|13150163|P2|STARTED|Overall Study||153
5345247|NCT00262028|13150164|P1|STARTED|Overall Study||152
5345248|NCT00262002|13150226|P7|NOT COMPLETED|Overall Study||6
5345249|NCT00262002|13150227|P6|NOT COMPLETED|Overall Study||7
5345250|NCT00262002|13150228|P5|NOT COMPLETED|Overall Study||7
5345251|NCT00262002|13150229|P4|NOT COMPLETED|Overall Study||5
5345252|NCT00262002|13150230|P3|NOT COMPLETED|Overall Study||0
5345253|NCT00262002|13150231|P2|NOT COMPLETED|Overall Study||6
5345254|NCT00262002|13150232|P1|NOT COMPLETED|Overall Study||11
5345255|NCT00262002|13150226|P7|COMPLETED|Overall Study||84
5345256|NCT00262002|13150227|P6|COMPLETED|Overall Study||83
5345257|NCT00262002|13150228|P5|COMPLETED|Overall Study||91
5345258|NCT00262002|13150229|P4|COMPLETED|Overall Study||93
5345259|NCT00262002|13150230|P3|COMPLETED|Overall Study||45
5345260|NCT00262002|13150231|P2|COMPLETED|Overall Study||84
5345261|NCT00262002|13150232|P1|COMPLETED|Overall Study||79
5345262|NCT00262002|13150226|P7|STARTED|Overall Study||90
5345263|NCT00262002|13150227|P6|STARTED|Overall Study||90
5345264|NCT00262002|13150228|P5|STARTED|Overall Study||98
5345265|NCT00262002|13150229|P4|STARTED|Overall Study||98
5345266|NCT00262002|13150230|P3|STARTED|Overall Study||45
5345267|NCT00262002|13150231|P2|STARTED|Overall Study||90
5345268|NCT00262002|13150232|P1|STARTED|Overall Study||90
5345269|NCT00261950|13150325|P1|NOT COMPLETED|Overall Study||26
5345270|NCT00261950|13150325|P1|COMPLETED|Overall Study||84
5345271|NCT00261950|13150325|P1|STARTED|Overall Study||110
5345272|NCT00261846|13150350|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
5345273|NCT00261846|13150351|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
5345274|NCT00261846|13150352|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
5345275|NCT00261846|13150353|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
5345276|NCT00261846|13150354|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
5345277|NCT00261846|13150355|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
5345278|NCT00261846|13150356|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
5345279|NCT00261846|13150357|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
5345280|NCT00261846|13150358|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
5345281|NCT00261846|13150359|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
5345282|NCT00261846|13150360|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
5345283|NCT00261846|13150361|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
5345284|NCT00261846|13150350|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
5345285|NCT00261846|13150351|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
5345286|NCT00261846|13150352|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
5345287|NCT00261846|13150353|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
5345288|NCT00261846|13150354|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
5345289|NCT00261846|13150355|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
5345290|NCT00261846|13150356|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
5345291|NCT00261846|13150357|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
5345292|NCT00261846|13150358|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
5345293|NCT00261846|13150359|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
5345294|NCT00261846|13150360|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
5345295|NCT00261846|13150361|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
5345296|NCT00261846|13150350|P12|STARTED|Period 2: Part 2 (Efficacy)||24
5345297|NCT00261846|13150351|P11|STARTED|Period 2: Part 2 (Efficacy)||64
5345298|NCT00261846|13150352|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
5345299|NCT00261846|13150353|P9|STARTED|Period 2: Part 2 (Efficacy)||26
5345300|NCT00261846|13150354|P8|STARTED|Period 2: Part 2 (Efficacy)||50
5345301|NCT00261846|13150355|P7|STARTED|Period 2: Part 2 (Efficacy)||38
5345302|NCT00261846|13150356|P6|STARTED|Period 2: Part 2 (Efficacy)||5
5345303|NCT00261846|13150357|P5|STARTED|Period 2: Part 2 (Efficacy)||89
5345304|NCT00261846|13150358|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
5345305|NCT00261846|13150359|P3|STARTED|Period 2: Part 2 (Efficacy)||0
5345306|NCT00261846|13150360|P2|STARTED|Period 2: Part 2 (Efficacy)||0
5345307|NCT00261846|13150361|P1|STARTED|Period 2: Part 2 (Efficacy)||0
5345308|NCT00261846|13150350|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345309|NCT00261846|13150351|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345310|NCT00261846|13150352|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345311|NCT00261846|13150353|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345312|NCT00261846|13150354|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345313|NCT00261846|13150355|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345314|NCT00261846|13150356|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345315|NCT00261846|13150357|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345316|NCT00261846|13150358|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345317|NCT00261846|13150359|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
5345318|NCT00261846|13150360|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
5345319|NCT00261846|13150361|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
5345320|NCT00261846|13150350|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345321|NCT00261846|13150351|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345322|NCT00261846|13150352|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345323|NCT00261846|13150353|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345324|NCT00261846|13150354|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345325|NCT00261846|13150355|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345326|NCT00261846|13150356|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345327|NCT00261846|13150357|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345328|NCT00261846|13150358|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345329|NCT00261846|13150359|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345330|NCT00261846|13150360|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345331|NCT00261846|13150361|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
5345332|NCT00261846|13150350|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345333|NCT00261846|13150351|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345334|NCT00261846|13150352|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345335|NCT00261846|13150353|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345336|NCT00261846|13150354|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345337|NCT00261846|13150355|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345338|NCT00261846|13150356|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345339|NCT00261846|13150357|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345340|NCT00261846|13150358|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
5345341|NCT00261846|13150359|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
5345342|NCT00261846|13150360|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
5345343|NCT00261846|13150361|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
5345344|NCT00261833|13150620|P2|NOT COMPLETED|Overall Study||18
5345345|NCT00261833|13150621|P1|NOT COMPLETED|Overall Study||9
5345346|NCT00261833|13150620|P2|COMPLETED|Overall Study||69
5345347|NCT00261833|13150621|P1|COMPLETED|Overall Study||84
5345348|NCT00261833|13150620|P2|STARTED|Overall Study||87
5345349|NCT00261833|13150621|P1|STARTED|Overall Study||93
5345350|NCT00261716|13150655|P2|NOT COMPLETED|Overall Study||10
5345351|NCT00261716|13150656|P1|NOT COMPLETED|Overall Study||6
5345352|NCT00261716|13150655|P2|COMPLETED|Overall Study||11
5345353|NCT00261716|13150656|P1|COMPLETED|Overall Study||11
5345354|NCT00261716|13150655|P2|STARTED|Overall Study||21
5345355|NCT00261716|13150656|P1|STARTED|Overall Study||17
5345356|NCT00261495|13150676|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
5345357|NCT00261495|13150677|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
5345358|NCT00261495|13150676|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
5345359|NCT00261495|13150677|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
5345360|NCT00261495|13150676|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
5345361|NCT00261495|13150677|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
5345362|NCT00261495|13150676|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
5345363|NCT00261495|13150677|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
5345364|NCT00261495|13150676|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
5345365|NCT00261495|13150677|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
5345366|NCT00261495|13150676|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
5345367|NCT00261495|13150677|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
5345368|NCT00261495|13150676|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
5345369|NCT00261495|13150677|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
5345370|NCT00261495|13150676|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
5345371|NCT00261495|13150677|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
5345372|NCT00261495|13150676|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
5345373|NCT00261495|13150677|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
5345374|NCT00261443|13150841|P3|NOT COMPLETED|4: Extension Phase||2
5345375|NCT00261443|13150842|P2|NOT COMPLETED|4: Extension Phase||3
5345376|NCT00261443|13150843|P1|NOT COMPLETED|4: Extension Phase||0
5345377|NCT00261443|13150841|P3|COMPLETED|4: Extension Phase||21
5345378|NCT00261443|13150842|P2|COMPLETED|4: Extension Phase||16
5345379|NCT00261443|13150843|P1|COMPLETED|4: Extension Phase||0
5345380|NCT00261443|13150841|P3|STARTED|4: Extension Phase||23
5345381|NCT00261443|13150842|P2|STARTED|4: Extension Phase||19
5345382|NCT00261443|13150843|P1|STARTED|4: Extension Phase||0
5345383|NCT00261443|13150841|P3|NOT COMPLETED|3: Assessment of Relapse||65
5345384|NCT00261443|13150842|P2|NOT COMPLETED|3: Assessment of Relapse||80
5345385|NCT00261443|13150843|P1|NOT COMPLETED|3: Assessment of Relapse||0
5345386|NCT00261443|13150841|P3|COMPLETED|3: Assessment of Relapse||103
5345387|NCT00261443|13150842|P2|COMPLETED|3: Assessment of Relapse||89
5345388|NCT00261443|13150843|P1|COMPLETED|3: Assessment of Relapse||0
5345389|NCT00261443|13150841|P3|STARTED|3: Assessment of Relapse||168
5345390|NCT00261443|13150842|P2|STARTED|3: Assessment of Relapse||169
5345391|NCT00261443|13150843|P1|STARTED|3: Assessment of Relapse||0
5345392|NCT00261443|13150841|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
5345393|NCT00261443|13150842|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
5345394|NCT00261443|13150843|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
5345395|NCT00261443|13150841|P3|COMPLETED|2: Stability & Maintenance of Stability||0
5345396|NCT00261443|13150842|P2|COMPLETED|2: Stability & Maintenance of Stability||0
5345397|NCT00261443|13150843|P1|COMPLETED|2: Stability & Maintenance of Stability||346
5345398|NCT00261443|13150841|P3|STARTED|2: Stability & Maintenance of Stability||0
5345399|NCT00261443|13150842|P2|STARTED|2: Stability & Maintenance of Stability||0
5345400|NCT00261443|13150843|P1|STARTED|2: Stability & Maintenance of Stability||686
5345401|NCT00261443|13150841|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
5345402|NCT00261443|13150842|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
5345403|NCT00261443|13150843|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
5345404|NCT00261443|13150841|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
5345405|NCT00261443|13150842|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
5345406|NCT00261443|13150843|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
5345407|NCT00261443|13150841|P3|STARTED|1: Confirmation of Partial Nonresponse||0
5345408|NCT00261443|13150842|P2|STARTED|1: Confirmation of Partial Nonresponse||0
5345409|NCT00261443|13150843|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
5345410|NCT00261040|13151100|P2|NOT COMPLETED|Overall Study||0
5345411|NCT00261040|13151101|P1|NOT COMPLETED|Overall Study||1
5345412|NCT00261040|13151100|P2|COMPLETED|Overall Study||20
5345413|NCT00261040|13151101|P1|COMPLETED|Overall Study||19
5345414|NCT00261040|13151100|P2|STARTED|Overall Study||20
5345415|NCT00261040|13151101|P1|STARTED|Overall Study||20
5345416|NCT00260962|13151117|P2|NOT COMPLETED|Overall Study||2
5345417|NCT00260962|13151118|P1|NOT COMPLETED|Overall Study||4
5345418|NCT00260962|13151117|P2|COMPLETED|Overall Study||14
5345419|NCT00260962|13151118|P1|COMPLETED|Overall Study||14
5345420|NCT00260962|13151117|P2|STARTED|Overall Study||16
5345421|NCT00260962|13151118|P1|STARTED|Overall Study||18
5345422|NCT00260832|13151128|P2|NOT COMPLETED|Overall Study||211
5345423|NCT00260832|13151129|P1|NOT COMPLETED|Overall Study||228
5345424|NCT00260832|13151128|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
5345425|NCT00260832|13151129|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
5345426|NCT00260832|13151128|P2|STARTED|Overall Study||242
5345427|NCT00260832|13151129|P1|STARTED|Overall Study||243
5345428|NCT00260689|13151140|P3|NOT COMPLETED|Overall Study||15
5345429|NCT00260689|13151141|P2|NOT COMPLETED|Overall Study||49
5345430|NCT00260689|13151142|P1|NOT COMPLETED|Overall Study||41
5345431|NCT00260689|13151140|P3|COMPLETED|Overall Study||1
5345432|NCT00260689|13151141|P2|COMPLETED|Overall Study||11
5345433|NCT00260689|13151142|P1|COMPLETED|Overall Study||19
5345434|NCT00260689|13151140|P3|STARTED|Overall Study||16
5345435|NCT00260689|13151141|P2|STARTED|Overall Study||60
5345436|NCT00260689|13151142|P1|STARTED|Overall Study||60
5345437|NCT00260533|13151158|P2|NOT COMPLETED|Overall Study||3
5345438|NCT00260533|13151159|P1|NOT COMPLETED|Overall Study||3
5345439|NCT00260533|13151158|P2|COMPLETED|Overall Study||10
5345440|NCT00260533|13151159|P1|COMPLETED|Overall Study||11
5345441|NCT00260533|13151158|P2|STARTED|Overall Study||13
5345442|NCT00260533|13151159|P1|STARTED|Overall Study||14
5345443|NCT00260429|13151167|P2|NOT COMPLETED|Overall Study||0
5345444|NCT00260429|13151168|P1|NOT COMPLETED|Overall Study||2
5345445|NCT00260429|13151167|P2|COMPLETED|Overall Study||12
5345446|NCT00260429|13151168|P1|COMPLETED|Overall Study||21
5345447|NCT00260429|13151167|P2|STARTED|Overall Study||12
5345448|NCT00260429|13151168|P1|STARTED|Overall Study||23
5345449|NCT00260208|13151176|P2|NOT COMPLETED|Overall Study||34
5345450|NCT00260208|13151177|P1|NOT COMPLETED|Overall Study||47
5345451|NCT00260208|13151176|P2|COMPLETED|Overall Study||138
5345452|NCT00260208|13151177|P1|COMPLETED|Overall Study||137
5345453|NCT00260208|13151176|P2|Modified ITT|Overall Study||96
5345454|NCT00260208|13151177|P1|Modified ITT|Overall Study||101
5345455|NCT00260208|13151176|P2|Intent to Treat (ITT) Population|Overall Study||169
5345456|NCT00260208|13151177|P1|Intent to Treat (ITT) Population|Overall Study||182
5345457|NCT00260208|13151176|P2|STARTED|Overall Study||172
5345458|NCT00260208|13151177|P1|STARTED|Overall Study|"Started indicates safety population."|184
5345459|NCT00260195|13151207|P2|NOT COMPLETED|Overall Study||0
5345460|NCT00260195|13151208|P1|NOT COMPLETED|Overall Study||0
5345461|NCT00260195|13151207|P2|COMPLETED|Overall Study||37
5345462|NCT00260195|13151208|P1|COMPLETED|Overall Study||39
5345463|NCT00260195|13151207|P2|STARTED|Overall Study||37
5345464|NCT00260195|13151208|P1|STARTED|Overall Study||39
5345465|NCT00260065|13151220|P1|NOT COMPLETED|Overall Study||93
5345466|NCT00260065|13151220|P1|COMPLETED|Overall Study||6
5345467|NCT00260065|13151220|P1|STARTED|Overall Study||99
5345468|NCT00259857|13151227|P2|NOT COMPLETED|24 Months Treatment||3
5345469|NCT00259857|13151228|P1|NOT COMPLETED|24 Months Treatment||0
5345470|NCT00259857|13151227|P2|COMPLETED|24 Months Treatment||6
5345471|NCT00259857|13151228|P1|COMPLETED|24 Months Treatment||10
5345472|NCT00259857|13151227|P2|STARTED|24 Months Treatment||9
5345473|NCT00259857|13151228|P1|STARTED|24 Months Treatment||10
5345474|NCT00259857|13151227|P2|NOT COMPLETED|12 Months Treatment||2
5345475|NCT00259857|13151228|P1|NOT COMPLETED|12 Months Treatment||1
5345476|NCT00259857|13151227|P2|COMPLETED|12 Months Treatment||9
5345477|NCT00259857|13151228|P1|COMPLETED|12 Months Treatment||10
5345478|NCT00259857|13151227|P2|STARTED|12 Months Treatment||11
5345479|NCT00259857|13151228|P1|STARTED|12 Months Treatment||11
5345480|NCT00259740|13151246|P2|NOT COMPLETED|Overall Study||53
5345481|NCT00259740|13151247|P1|NOT COMPLETED|Overall Study||43
5345482|NCT00259740|13151246|P2|COMPLETED|Overall Study||0
5345483|NCT00259740|13151247|P1|COMPLETED|Overall Study||0
5345484|NCT00259740|13151246|P2|Received Study Medication|Overall Study||53
5345485|NCT00259740|13151247|P1|Received Study Medication|Overall Study||42
5345486|NCT00259740|13151246|P2|STARTED|Overall Study||53
5345487|NCT00259740|13151247|P1|STARTED|Overall Study||43
5345488|NCT00259649|13151257|P1|NOT COMPLETED|Overall Study||10
5345489|NCT00259649|13151257|P1|COMPLETED|Overall Study||61
5345490|NCT00259649|13151257|P1|STARTED|Overall Study||71
5345491|NCT00259610|13151265|P4|NOT COMPLETED|Overall Study||43
5345492|NCT00259610|13151266|P3|NOT COMPLETED|Overall Study||73
5345493|NCT00259610|13151267|P2|NOT COMPLETED|Overall Study||46
5345494|NCT00259610|13151268|P1|NOT COMPLETED|Overall Study||76
5345495|NCT00259610|13151265|P4|COMPLETED|Overall Study||81
5345496|NCT00259610|13151266|P3|COMPLETED|Overall Study||182
5345497|NCT00259610|13151267|P2|COMPLETED|Overall Study||86
5345498|NCT00259610|13151268|P1|COMPLETED|Overall Study||168
5345499|NCT00259610|13151265|P4|STARTED|Overall Study||124
5345500|NCT00259610|13151266|P3|STARTED|Overall Study||255
5345501|NCT00259610|13151267|P2|STARTED|Overall Study||132
5345502|NCT00259610|13151268|P1|STARTED|Overall Study||244
5345503|NCT00259298|13151282|P1|NOT COMPLETED|Overall Study||3
5345504|NCT00259298|13151282|P1|COMPLETED|Overall Study||9
5345505|NCT00259298|13151282|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
5345506|NCT00259298|13151282|P1|STARTED|Overall Study||12
5345507|NCT00259285|13151290|P1|NOT COMPLETED|Overall Study||0
5345508|NCT00259285|13151290|P1|COMPLETED|Overall Study||10
5345509|NCT00259285|13151290|P1|STARTED|Overall Study||10
5345510|NCT00259272|13151300|P4|NOT COMPLETED|Overall Study||21
5345511|NCT00259272|13151301|P3|NOT COMPLETED|Overall Study||5
5345512|NCT00259272|13151302|P2|NOT COMPLETED|Overall Study||7
5345513|NCT00259272|13151303|P1|NOT COMPLETED|Overall Study||15
5345514|NCT00259272|13151300|P4|COMPLETED|Overall Study||27
5345515|NCT00259272|13151301|P3|COMPLETED|Overall Study||21
5345516|NCT00259272|13151302|P2|COMPLETED|Overall Study||24
5345517|NCT00259272|13151303|P1|COMPLETED|Overall Study||21
5345518|NCT00259272|13151300|P4|STARTED|Overall Study||48
5345519|NCT00259272|13151301|P3|STARTED|Overall Study||26
5345520|NCT00259272|13151302|P2|STARTED|Overall Study||31
5345521|NCT00259272|13151303|P1|STARTED|Overall Study||36
5345522|NCT00259090|13151381|P3|NOT COMPLETED|Overall Study||0
5345523|NCT00259090|13151382|P2|NOT COMPLETED|Overall Study||0
5345524|NCT00259090|13151383|P1|NOT COMPLETED|Overall Study||0
5345525|NCT00259090|13151381|P3|COMPLETED|Overall Study||37
5345526|NCT00259090|13151382|P2|COMPLETED|Overall Study||31
5345527|NCT00259090|13151383|P1|COMPLETED|Overall Study||35
5345528|NCT00259090|13151381|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
5345529|NCT00259090|13151382|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
5345530|NCT00259090|13151383|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
5345531|NCT00259012|13151399|P2|NOT COMPLETED|Overall Study||4
5345532|NCT00259012|13151400|P1|NOT COMPLETED|Overall Study||2
5345533|NCT00259012|13151399|P2|COMPLETED|Overall Study||30
5345534|NCT00259012|13151400|P1|COMPLETED|Overall Study||31
5345535|NCT00259012|13151399|P2|STARTED|Overall Study||34
5345536|NCT00259012|13151400|P1|STARTED|Overall Study||33
5345537|NCT00258960|13151432|P1|NOT COMPLETED|Overall Study||17
5345538|NCT00258960|13151432|P1|COMPLETED|Overall Study||32
5345539|NCT00258960|13151432|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
5345540|NCT00258908|13151440|P1|NOT COMPLETED|Overall Study||0
5345541|NCT00258908|13151440|P1|COMPLETED|Overall Study||112
5345542|NCT00258908|13151440|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
5345543|NCT00258895|13151448|P2|NOT COMPLETED|Overall Study||3
5345544|NCT00258895|13151449|P1|NOT COMPLETED|Overall Study||10
5345545|NCT00258895|13151448|P2|COMPLETED|Overall Study||159
5345546|NCT00258895|13151449|P1|COMPLETED|Overall Study||477
5345547|NCT00258895|13151448|P2|STARTED|Overall Study||162
5345548|NCT00258895|13151449|P1|STARTED|Overall Study||487
5345549|NCT00258882|13151465|P2|NOT COMPLETED|Pregnancy Surveillance||0
5345550|NCT00258882|13151466|P1|NOT COMPLETED|Pregnancy Surveillance||0
5345551|NCT00258882|13151465|P2|COMPLETED|Pregnancy Surveillance||675
5345552|NCT00258882|13151466|P1|COMPLETED|Pregnancy Surveillance||225
5345553|NCT00258882|13151465|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
5345554|NCT00258882|13151466|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
5345555|NCT00258882|13151465|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
5345556|NCT00258882|13151466|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
5345557|NCT00258882|13151465|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
5345558|NCT00258882|13151466|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
5345559|NCT00258882|13151465|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
5345560|NCT00258882|13151466|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
5345561|NCT00258882|13151465|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
5345562|NCT00258882|13151466|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
5345563|NCT00258882|13151465|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
5345564|NCT00258882|13151466|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
5345565|NCT00258882|13151465|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
5345566|NCT00258882|13151466|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
5345567|NCT00258856|13151485|P4|NOT COMPLETED|Overall Study||1
5345568|NCT00258856|13151486|P3|NOT COMPLETED|Overall Study||2
5345569|NCT00258856|13151487|P2|NOT COMPLETED|Overall Study||0
5345570|NCT00258856|13151488|P1|NOT COMPLETED|Overall Study||3
5345571|NCT00258856|13151485|P4|COMPLETED|Overall Study||58
5345572|NCT00258856|13151486|P3|COMPLETED|Overall Study||56
5345573|NCT00258856|13151487|P2|COMPLETED|Overall Study||58
5345574|NCT00258856|13151488|P1|COMPLETED|Overall Study||56
5345575|NCT00258856|13151485|P4|STARTED|Overall Study||59
5345576|NCT00258856|13151486|P3|STARTED|Overall Study||58
5345577|NCT00258856|13151487|P2|STARTED|Overall Study||58
5345578|NCT00258856|13151488|P1|STARTED|Overall Study||59
5345579|NCT00258830|13151500|P2|NOT COMPLETED|Overall Study||0
5345580|NCT00258830|13151501|P1|NOT COMPLETED|Overall Study||0
5345581|NCT00258830|13151500|P2|COMPLETED|Overall Study||60
5345582|NCT00258830|13151501|P1|COMPLETED|Overall Study||60
5345583|NCT00258830|13151500|P2|STARTED|Overall Study||60
5345584|NCT00258830|13151501|P1|STARTED|Overall Study||60
5345585|NCT00258817|13151515|P2|NOT COMPLETED|Overall Study||0
5345586|NCT00258817|13151516|P1|NOT COMPLETED|Overall Study||0
5345587|NCT00258817|13151515|P2|COMPLETED|Overall Study||15
5345588|NCT00258817|13151516|P1|COMPLETED|Overall Study||15
5345589|NCT00258817|13151515|P2|STARTED|Overall Study||15
5345590|NCT00258817|13151516|P1|STARTED|Overall Study||15
5345591|NCT00258674|13151529|P3|NOT COMPLETED|Overall Study||34
5345592|NCT00258674|13151530|P2|NOT COMPLETED|Overall Study||53
5345593|NCT00258674|13151531|P1|NOT COMPLETED|Overall Study||32
5345594|NCT00258674|13151529|P3|COMPLETED|Overall Study||568
5345595|NCT00258674|13151530|P2|COMPLETED|Overall Study||758
5345596|NCT00258674|13151531|P1|COMPLETED|Overall Study||565
5345597|NCT00258674|13151529|P3|STARTED|Overall Study||602
5345598|NCT00258674|13151530|P2|STARTED|Overall Study||811
5345599|NCT00258674|13151531|P1|STARTED|Overall Study||597
5345600|NCT00258440|13151590|P3|NOT COMPLETED|Overall Study||1
5345601|NCT00258440|13151591|P2|NOT COMPLETED|Overall Study||0
5345602|NCT00258440|13151592|P1|NOT COMPLETED|Overall Study||0
5345603|NCT00258440|13151590|P3|COMPLETED|Overall Study||5
5345604|NCT00258440|13151591|P2|COMPLETED|Overall Study||0
5345605|NCT00258440|13151592|P1|COMPLETED|Overall Study||1
5345606|NCT00258440|13151590|P3|STARTED|Overall Study||6
5345607|NCT00258440|13151591|P2|STARTED|Overall Study||0
5345608|NCT00258440|13151592|P1|STARTED|Overall Study||1
5345609|NCT00258362|13151603|P1|NOT COMPLETED|Overall Study||0
5345610|NCT00258362|13151603|P1|COMPLETED|Overall Study||41
5345611|NCT00258362|13151603|P1|STARTED|Overall Study||41
5345612|NCT00258349|13151608|P1|NOT COMPLETED|Overall Study||0
5345613|NCT00258349|13151608|P1|COMPLETED|Overall Study||16
5345614|NCT00258349|13151608|P1|HER2-positive by Central Review|Overall Study||10
5345615|NCT00258349|13151608|P1|STARTED|Overall Study||16
5345616|NCT00258310|13151615|P1|NOT COMPLETED|Overall Study||0
5345617|NCT00258310|13151615|P1|COMPLETED|Overall Study||35
5345618|NCT00258310|13151615|P1|STARTED|Overall Study||35
5345619|NCT00258206|13151619|P1|NOT COMPLETED|Overall Study||0
5345620|NCT00258206|13151619|P1|COMPLETED|Overall Study||21
5345621|NCT00258206|13151619|P1|STARTED|Overall Study||21
5345622|NCT00258180|13151623|P1|NOT COMPLETED|Overall Study||0
5345623|NCT00258180|13151623|P1|COMPLETED|Overall Study||2
5345624|NCT00258180|13151623|P1|STARTED|Overall Study||2
5345625|NCT00258154|13151630|P2|NOT COMPLETED|Overall Study||7
5345626|NCT00258154|13151631|P1|NOT COMPLETED|Overall Study||9
5345627|NCT00258154|13151630|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
5345628|NCT00258154|13151631|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
5345629|NCT00258154|13151630|P2|Vaccinated at Visit 3|Overall Study||197
5345630|NCT00258154|13151631|P1|Vaccinated at Visit 3|Overall Study||195
5345631|NCT00258154|13151630|P2|Vaccinated at Visit 2|Overall Study||198
5345632|NCT00258154|13151631|P1|Vaccinated at Visit 2|Overall Study||198
5345633|NCT00258154|13151630|P2|Vaccinated at Visit 1|Overall Study||202
5345634|NCT00258154|13151631|P1|Vaccinated at Visit 1|Overall Study||201
5345635|NCT00258154|13151630|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
5345636|NCT00258154|13151631|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
5345637|NCT00258128|13151701|P2|NOT COMPLETED|Overall Study||0
5345638|NCT00258128|13151702|P1|NOT COMPLETED|Overall Study||0
5345639|NCT00258128|13151701|P2|COMPLETED|Overall Study||9
5345640|NCT00258128|13151702|P1|COMPLETED|Overall Study||8
5345641|NCT00258128|13151701|P2|STARTED|Overall Study||9
5345642|NCT00258128|13151702|P1|STARTED|Overall Study||8
5345643|NCT00258011|13151710|P1|NOT COMPLETED|Overall Study||0
5345644|NCT00258011|13151710|P1|COMPLETED|Overall Study||3
5345645|NCT00258011|13151710|P1|STARTED|Overall Study||3
5345646|NCT00257933|13151717|P2|NOT COMPLETED|Overall Study||0
5345647|NCT00257933|13151718|P1|NOT COMPLETED|Overall Study||0
5345648|NCT00257933|13151717|P2|COMPLETED|Overall Study||78
5345649|NCT00257933|13151718|P1|COMPLETED|Overall Study||74
5345650|NCT00257933|13151717|P2|STARTED|Overall Study||78
5345651|NCT00257933|13151718|P1|STARTED|Overall Study||74
5345652|NCT00257920|13151726|P2|NOT COMPLETED|Period: Second Intervention||1
5345653|NCT00257920|13151727|P1|NOT COMPLETED|Period: Second Intervention||2
5345654|NCT00257920|13151726|P2|COMPLETED|Period: Second Intervention||18
5345655|NCT00257920|13151727|P1|COMPLETED|Period: Second Intervention||19
5345656|NCT00257920|13151726|P2|STARTED|Period: Second Intervention||19
5345657|NCT00257920|13151727|P1|STARTED|Period: Second Intervention||21
5345658|NCT00257920|13151726|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
5345659|NCT00257920|13151727|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
5345660|NCT00257920|13151726|P2|COMPLETED|Period: Washout Period of Two Weeks||19
5345661|NCT00257920|13151727|P1|COMPLETED|Period: Washout Period of Two Weeks||21
5345662|NCT00257920|13151726|P2|STARTED|Period: Washout Period of Two Weeks||20
5345663|NCT00257920|13151727|P1|STARTED|Period: Washout Period of Two Weeks||21
5345664|NCT00257920|13151726|P2|NOT COMPLETED|Period: First Intervention||0
5345665|NCT00257920|13151727|P1|NOT COMPLETED|Period: First Intervention||0
5345666|NCT00257920|13151726|P2|COMPLETED|Period: First Intervention||20
5345667|NCT00257920|13151727|P1|COMPLETED|Period: First Intervention||21
5345668|NCT00257920|13151726|P2|STARTED|Period: First Intervention||20
5345669|NCT00257920|13151727|P1|STARTED|Period: First Intervention||21
5345670|NCT00257894|13151737|P2|NOT COMPLETED|Overall Study||5
5345671|NCT00257894|13151738|P1|NOT COMPLETED|Overall Study||4
5345672|NCT00257894|13151737|P2|COMPLETED|Overall Study||15
5345673|NCT00257894|13151738|P1|COMPLETED|Overall Study||17
5345674|NCT00257894|13151737|P2|STARTED|Overall Study||20
5345675|NCT00257894|13151738|P1|STARTED|Overall Study||21
5345676|NCT00257686|13151756|P6|NOT COMPLETED|Overall Study||9
5345677|NCT00257686|13151757|P5|NOT COMPLETED|Overall Study||22
5345678|NCT00257686|13151758|P4|NOT COMPLETED|Overall Study||11
5345679|NCT00257686|13151759|P3|NOT COMPLETED|Overall Study||18
5345680|NCT00257686|13151760|P2|NOT COMPLETED|Overall Study||19
5345681|NCT00257686|13151761|P1|NOT COMPLETED|Overall Study||21
5345682|NCT00257686|13151756|P6|COMPLETED|Overall Study||95
5345683|NCT00257686|13151757|P5|COMPLETED|Overall Study||194
5345684|NCT00257686|13151758|P4|COMPLETED|Overall Study||88
5345685|NCT00257686|13151759|P3|COMPLETED|Overall Study||208
5345686|NCT00257686|13151760|P2|COMPLETED|Overall Study||89
5345687|NCT00257686|13151761|P1|COMPLETED|Overall Study||188
5345688|NCT00257686|13151756|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
5345689|NCT00257686|13151757|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
5345690|NCT00257686|13151758|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
5345691|NCT00257686|13151759|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
5345692|NCT00257686|13151760|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
5345693|NCT00257686|13151761|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
5345694|NCT00257686|13151756|P6|STARTED|Overall Study||104
5345695|NCT00257686|13151757|P5|STARTED|Overall Study||216
5345696|NCT00257686|13151758|P4|STARTED|Overall Study||99
5345697|NCT00257686|13151759|P3|STARTED|Overall Study||226
5345698|NCT00257686|13151760|P2|STARTED|Overall Study||108
5345699|NCT00257686|13151761|P1|STARTED|Overall Study||209
5345700|NCT00257660|13151783|P2|NOT COMPLETED|Overall Study||23
5345701|NCT00257660|13151784|P1|NOT COMPLETED|Overall Study||10
5345702|NCT00257660|13151783|P2|COMPLETED|Overall Study||38
5345703|NCT00257660|13151784|P1|COMPLETED|Overall Study||45
5345704|NCT00257660|13151783|P2|STARTED|Overall Study||61
5345705|NCT00257660|13151784|P1|STARTED|Overall Study||55
5345706|NCT00257608|13151814|P3|NOT COMPLETED|Post Chemotherapy Phase||244
5345707|NCT00257608|13151815|P2|NOT COMPLETED|Post Chemotherapy Phase||264
5345708|NCT00257608|13151816|P1|NOT COMPLETED|Post Chemotherapy Phase||0
5345709|NCT00257608|13151814|P3|COMPLETED|Post Chemotherapy Phase||126
5345710|NCT00257608|13151815|P2|COMPLETED|Post Chemotherapy Phase||109
5345711|NCT00257608|13151816|P1|COMPLETED|Post Chemotherapy Phase||0
5345712|NCT00257608|13151814|P3|STARTED|Post Chemotherapy Phase||370
5345713|NCT00257608|13151815|P2|STARTED|Post Chemotherapy Phase||373
5345714|NCT00257608|13151816|P1|STARTED|Post Chemotherapy Phase||0
5345715|NCT00257608|13151814|P3|NOT COMPLETED|Chemotherapy Phase||0
5345716|NCT00257608|13151815|P2|NOT COMPLETED|Chemotherapy Phase||0
5345717|NCT00257608|13151816|P1|NOT COMPLETED|Chemotherapy Phase||376
5345718|NCT00257608|13151814|P3|COMPLETED|Chemotherapy Phase||0
5345719|NCT00257608|13151815|P2|COMPLETED|Chemotherapy Phase||0
5345720|NCT00257608|13151816|P1|COMPLETED|Chemotherapy Phase||769
5345721|NCT00257608|13151814|P3|STARTED|Chemotherapy Phase||0
5345722|NCT00257608|13151815|P2|STARTED|Chemotherapy Phase||0
5345723|NCT00257608|13151816|P1|STARTED|Chemotherapy Phase||1145
5345724|NCT00257556|13151842|P2|NOT COMPLETED|Overall Study||10
5345725|NCT00257556|13151843|P1|NOT COMPLETED|Overall Study||14
5345726|NCT00257556|13151842|P2|COMPLETED|Overall Study||32
5345727|NCT00257556|13151843|P1|COMPLETED|Overall Study||24
5345728|NCT00257556|13151842|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
5345729|NCT00257556|13151843|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
5345730|NCT00257556|13151842|P2|STARTED|Overall Study||42
5345731|NCT00257556|13151843|P1|STARTED|Overall Study||38
5345732|NCT00257322|13151869|P1|NOT COMPLETED|Overall Study||4
5345733|NCT00257322|13151869|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
5345734|NCT00257322|13151869|P1|STARTED|Overall Study|20 subjects accrued.|20
5345735|NCT00257309|13151876|P2|NOT COMPLETED|Overall Study||2
5345736|NCT00257309|13151877|P1|NOT COMPLETED|Overall Study||2
5345737|NCT00257309|13151876|P2|COMPLETED|Overall Study||130
5345738|NCT00257309|13151877|P1|COMPLETED|Overall Study||132
5345739|NCT00257309|13151876|P2|STARTED|Overall Study||132
5345740|NCT00257309|13151877|P1|STARTED|Overall Study||134
5345741|NCT00257192|13151887|P2|NOT COMPLETED|Overall Study||39
5345742|NCT00257192|13151888|P1|NOT COMPLETED|Overall Study||58
5345743|NCT00257192|13151887|P2|COMPLETED|Overall Study||52
5345744|NCT00257192|13151888|P1|COMPLETED|Overall Study||135
5345745|NCT00257192|13151887|P2|Received Study Treatment|Overall Study||90
5345746|NCT00257192|13151888|P1|Received Study Treatment|Overall Study||193
5345747|NCT00257192|13151887|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
5345748|NCT00257192|13151888|P1|STARTED|Overall Study||193
5345749|NCT00257166|13151932|P2|NOT COMPLETED|Overall Study||37
5345750|NCT00257166|13151933|P1|NOT COMPLETED|Overall Study||53
5345751|NCT00257166|13151932|P2|COMPLETED|Overall Study||51
5345752|NCT00257166|13151933|P1|COMPLETED|Overall Study||97
5345753|NCT00257166|13151932|P2|Treated|Overall Study||88
5345754|NCT00257166|13151933|P1|Treated|Overall Study||149
5345755|NCT00257166|13151932|P2|STARTED|Overall Study||88
5345756|NCT00257166|13151933|P1|STARTED|Overall Study||150
5345757|NCT00257010|13151945|P1|NOT COMPLETED|Overall Study||128
5345758|NCT00257010|13151945|P1|COMPLETED|Overall Study||319
5345759|NCT00257010|13151945|P1|STARTED|Overall Study||447
5345760|NCT00256997|13151956|P2|NOT COMPLETED|Overall Study||55
5345761|NCT00256997|13151957|P1|NOT COMPLETED|Overall Study||48
5345762|NCT00256997|13151956|P2|COMPLETED|Overall Study||31
5345763|NCT00256997|13151957|P1|COMPLETED|Overall Study||33
5345764|NCT00256997|13151956|P2|Treated|Overall Study||86
5345765|NCT00256997|13151957|P1|Treated|Overall Study||79
5345766|NCT00256997|13151956|P2|STARTED|Overall Study||86
5345767|NCT00256997|13151957|P1|STARTED|Overall Study||81
5345768|NCT00256984|13151981|P1|NOT COMPLETED|Overall Study||16
5345769|NCT00256984|13151981|P1|COMPLETED|Overall Study||59
5345770|NCT00256984|13151981|P1|STARTED|Overall Study||75
5345771|NCT00256867|13151999|P8|NOT COMPLETED|Overall Study||11
5345772|NCT00256867|13152000|P7|NOT COMPLETED|Overall Study||5
5345773|NCT00256867|13152001|P6|NOT COMPLETED|Overall Study||6
5345774|NCT00256867|13152002|P5|NOT COMPLETED|Overall Study||7
5345775|NCT00256867|13152003|P4|NOT COMPLETED|Overall Study||6
5345776|NCT00256867|13152004|P3|NOT COMPLETED|Overall Study||5
5345777|NCT00256867|13152005|P2|NOT COMPLETED|Overall Study||5
5345778|NCT00256867|13152006|P1|NOT COMPLETED|Overall Study||2
5345779|NCT00256867|13151999|P8|COMPLETED|Overall Study||36
5345780|NCT00256867|13152000|P7|COMPLETED|Overall Study||41
5345781|NCT00256867|13152001|P6|COMPLETED|Overall Study||40
5345782|NCT00256867|13152002|P5|COMPLETED|Overall Study||41
5345783|NCT00256867|13152003|P4|COMPLETED|Overall Study||40
5345784|NCT00256867|13152004|P3|COMPLETED|Overall Study||40
5345785|NCT00256867|13152005|P2|COMPLETED|Overall Study||39
5345786|NCT00256867|13152006|P1|COMPLETED|Overall Study||45
5345787|NCT00256867|13151999|P8|STARTED|Overall Study||47
5345788|NCT00256867|13152000|P7|STARTED|Overall Study||46
5345789|NCT00256867|13152001|P6|STARTED|Overall Study||46
5345790|NCT00256867|13152002|P5|STARTED|Overall Study||48
5345791|NCT00256867|13152003|P4|STARTED|Overall Study||46
5345792|NCT00256867|13152004|P3|STARTED|Overall Study||45
5345793|NCT00256867|13152005|P2|STARTED|Overall Study||44
5345794|NCT00256867|13152006|P1|STARTED|Overall Study||47
5345795|NCT00256854|13152096|P6|NOT COMPLETED|Overall Study||1
5345796|NCT00256854|13152097|P5|NOT COMPLETED|Overall Study||1
5345797|NCT00256854|13152098|P4|NOT COMPLETED|Overall Study||3
5345798|NCT00256854|13152099|P3|NOT COMPLETED|Overall Study||3
5345799|NCT00256854|13152100|P2|NOT COMPLETED|Overall Study||4
5345800|NCT00256854|13152101|P1|NOT COMPLETED|Overall Study||3
5345801|NCT00256854|13152096|P6|COMPLETED|Overall Study||13
5345802|NCT00256854|13152097|P5|COMPLETED|Overall Study||15
5345803|NCT00256854|13152098|P4|COMPLETED|Overall Study||24
5345804|NCT00256854|13152099|P3|COMPLETED|Overall Study||23
5345805|NCT00256854|13152100|P2|COMPLETED|Overall Study||22
5345806|NCT00256854|13152101|P1|COMPLETED|Overall Study||23
5345807|NCT00256854|13152096|P6|STARTED|Overall Study||14
5345808|NCT00256854|13152097|P5|STARTED|Overall Study||16
5345809|NCT00256854|13152098|P4|STARTED|Overall Study||27
5345810|NCT00256854|13152099|P3|STARTED|Overall Study||26
5345811|NCT00256854|13152100|P2|STARTED|Overall Study||26
5345812|NCT00256854|13152101|P1|STARTED|Overall Study||26
5345813|NCT00256750|13152160|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
5345814|NCT00256750|13152161|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
5345815|NCT00256750|13152162|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
5345816|NCT00256750|13152160|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
5345817|NCT00256750|13152161|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
5345818|NCT00256750|13152162|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
5345819|NCT00256750|13152160|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
5345820|NCT00256750|13152161|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
5345821|NCT00256750|13152162|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
5345822|NCT00256750|13152160|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
5345823|NCT00256750|13152161|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
5345824|NCT00256750|13152162|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
5345825|NCT00256750|13152160|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
5345826|NCT00256750|13152161|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
5345827|NCT00256750|13152162|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
5345828|NCT00256750|13152160|P3|STARTED|Post-Transplant Treated (36 Months)||164
5345829|NCT00256750|13152161|P2|STARTED|Post-Transplant Treated (36 Months)||176
5345830|NCT00256750|13152162|P1|STARTED|Post-Transplant Treated (36 Months)||153
5345831|NCT00256750|13152160|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
5345832|NCT00256750|13152161|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
5345833|NCT00256750|13152162|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
5345834|NCT00256750|13152160|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
5345835|NCT00256750|13152161|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
5345836|NCT00256750|13152162|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
5345837|NCT00256750|13152160|P3|STARTED|Post-Transplant Treated (24 Months)||173
5345838|NCT00256750|13152161|P2|STARTED|Post-Transplant Treated (24 Months)||183
5345839|NCT00256750|13152162|P1|STARTED|Post-Transplant Treated (24 Months)||174
5345840|NCT00256750|13152160|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
5345841|NCT00256750|13152161|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
5345842|NCT00256750|13152162|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
5345843|NCT00256750|13152160|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
5345844|NCT00256750|13152161|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
5345845|NCT00256750|13152162|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
5345846|NCT00256750|13152160|P3|STARTED|Post-Transplant Treated (12 Months)||219
5345847|NCT00256750|13152161|P2|STARTED|Post-Transplant Treated (12 Months)||226
5345848|NCT00256750|13152162|P1|STARTED|Post-Transplant Treated (12 Months)||215
5345849|NCT00256750|13152160|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
5345850|NCT00256750|13152161|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
5345851|NCT00256750|13152162|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
5345852|NCT00256750|13152160|P3|COMPLETED|Transplanted Pre-Treatment||219
5345853|NCT00256750|13152161|P2|COMPLETED|Transplanted Pre-Treatment||226
5345854|NCT00256750|13152162|P1|COMPLETED|Transplanted Pre-Treatment||215
5345855|NCT00256750|13152160|P3|STARTED|Transplanted Pre-Treatment||219
5345856|NCT00256750|13152161|P2|STARTED|Transplanted Pre-Treatment||226
5345857|NCT00256750|13152162|P1|STARTED|Transplanted Pre-Treatment||221
5345858|NCT00256724|13152298|P2|NOT COMPLETED|Overall Study||8
5345859|NCT00256724|13152299|P1|NOT COMPLETED|Overall Study||5
5345860|NCT00256724|13152298|P2|COMPLETED|Overall Study||16
5345861|NCT00256724|13152299|P1|COMPLETED|Overall Study||18
5345862|NCT00256724|13152298|P2|STARTED|Overall Study||24
5345863|NCT00256724|13152299|P1|STARTED|Overall Study||23
5345864|NCT00256698|13152309|P2|NOT COMPLETED|Overall Study||172
5345865|NCT00256698|13152310|P1|NOT COMPLETED|Overall Study||167
5345866|NCT00256698|13152309|P2|COMPLETED|Overall Study||84
5345867|NCT00256698|13152310|P1|COMPLETED|Overall Study||91
5345868|NCT00256698|13152309|P2|STARTED|Overall Study||256
5345869|NCT00256698|13152310|P1|STARTED|Overall Study||258
5345870|NCT00256451|13152328|P4|NOT COMPLETED|Session4||0
5345871|NCT00256451|13152329|P3|NOT COMPLETED|Session4||0
5345872|NCT00256451|13152330|P2|NOT COMPLETED|Session4||0
5345873|NCT00256451|13152331|P1|NOT COMPLETED|Session4||0
5345874|NCT00256451|13152328|P4|COMPLETED|Session4||8
5345875|NCT00256451|13152329|P3|COMPLETED|Session4||10
5345876|NCT00256451|13152330|P2|COMPLETED|Session4||8
5345877|NCT00256451|13152331|P1|COMPLETED|Session4||9
5345878|NCT00256451|13152328|P4|STARTED|Session4||8
5345879|NCT00256451|13152329|P3|STARTED|Session4||10
5345880|NCT00256451|13152330|P2|STARTED|Session4||8
5345881|NCT00256451|13152331|P1|STARTED|Session4||9
5345882|NCT00256451|13152328|P4|NOT COMPLETED|Session3||0
5345883|NCT00256451|13152329|P3|NOT COMPLETED|Session3||0
5345884|NCT00256451|13152330|P2|NOT COMPLETED|Session3||0
5345885|NCT00256451|13152331|P1|NOT COMPLETED|Session3||0
5345886|NCT00256451|13152328|P4|COMPLETED|Session3||9
5345887|NCT00256451|13152329|P3|COMPLETED|Session3||10
5345888|NCT00256451|13152330|P2|COMPLETED|Session3||9
5345889|NCT00256451|13152331|P1|COMPLETED|Session3||9
5345890|NCT00256451|13152328|P4|STARTED|Session3||9
5345891|NCT00256451|13152329|P3|STARTED|Session3||10
5345892|NCT00256451|13152330|P2|STARTED|Session3||9
5345893|NCT00256451|13152331|P1|STARTED|Session3||9
5345894|NCT00256451|13152328|P4|NOT COMPLETED|Session2||0
5345895|NCT00256451|13152329|P3|NOT COMPLETED|Session2||0
5345896|NCT00256451|13152330|P2|NOT COMPLETED|Session2||0
5345897|NCT00256451|13152331|P1|NOT COMPLETED|Session2||0
5345898|NCT00256451|13152328|P4|COMPLETED|Session2||10
5345899|NCT00256451|13152329|P3|COMPLETED|Session2||10
5345900|NCT00256451|13152330|P2|COMPLETED|Session2||11
5345901|NCT00256451|13152331|P1|COMPLETED|Session2||9
5345902|NCT00256451|13152328|P4|STARTED|Session2||10
5345903|NCT00256451|13152329|P3|STARTED|Session2||10
5345904|NCT00256451|13152330|P2|STARTED|Session2||11
5345905|NCT00256451|13152331|P1|STARTED|Session2||9
5345906|NCT00256451|13152328|P4|NOT COMPLETED|Session1||0
5345907|NCT00256451|13152329|P3|NOT COMPLETED|Session1||0
5345908|NCT00256451|13152330|P2|NOT COMPLETED|Session1||0
5345909|NCT00256451|13152331|P1|NOT COMPLETED|Session1||0
5345910|NCT00256451|13152328|P4|COMPLETED|Session1||11
5345911|NCT00256451|13152329|P3|COMPLETED|Session1||11
5345912|NCT00256451|13152330|P2|COMPLETED|Session1||11
5345913|NCT00256451|13152331|P1|COMPLETED|Session1||10
5345914|NCT00256451|13152328|P4|STARTED|Session1||11
5345915|NCT00256451|13152329|P3|STARTED|Session1||11
5345916|NCT00256451|13152330|P2|STARTED|Session1||11
5345917|NCT00256451|13152331|P1|STARTED|Session1||10
5345918|NCT00256308|13152357|P1|NOT COMPLETED|Overall Study||2
5345919|NCT00256308|13152357|P1|COMPLETED|Overall Study||4
5345920|NCT00256308|13152357|P1|STARTED|Overall Study||6
5345921|NCT00256295|13152365|P1|NOT COMPLETED|Overall Study||4
5345922|NCT00256295|13152365|P1|COMPLETED|Overall Study||3
5345923|NCT00256295|13152365|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
5345924|NCT00256282|13152371|P1|NOT COMPLETED|Overall Study||16
5345925|NCT00256282|13152371|P1|COMPLETED|Overall Study||36
5345926|NCT00256282|13152371|P1|STARTED|Overall Study||52
5345927|NCT00256243|13152376|P1|NOT COMPLETED|Overall Study||10
5345928|NCT00256243|13152376|P1|COMPLETED|Overall Study||38
5345929|NCT00256243|13152376|P1|STARTED|Overall Study||48
5345930|NCT00256204|13152385|P4|NOT COMPLETED|Overall Study||49
5345931|NCT00256204|13152386|P3|NOT COMPLETED|Overall Study||54
5345932|NCT00256204|13152387|P2|NOT COMPLETED|Overall Study||50
5345933|NCT00256204|13152388|P1|NOT COMPLETED|Overall Study||67
5345934|NCT00256204|13152385|P4|COMPLETED|Overall Study||244
5345935|NCT00256204|13152386|P3|COMPLETED|Overall Study||241
5345936|NCT00256204|13152387|P2|COMPLETED|Overall Study||238
5345937|NCT00256204|13152388|P1|COMPLETED|Overall Study||231
5345938|NCT00256204|13152385|P4|STARTED|Overall Study||293
5345939|NCT00256204|13152386|P3|STARTED|Overall Study||295
5345940|NCT00256204|13152387|P2|STARTED|Overall Study||288
5345941|NCT00256204|13152388|P1|STARTED|Overall Study||298
5345942|NCT00256126|13152403|P2|NOT COMPLETED|Overall Study||2
5345943|NCT00256126|13152404|P1|NOT COMPLETED|Overall Study||2
5345944|NCT00256126|13152403|P2|COMPLETED|Overall Study||167
5345945|NCT00256126|13152404|P1|COMPLETED|Overall Study||147
5345946|NCT00256126|13152403|P2|STARTED|Overall Study||169
5345947|NCT00256126|13152404|P1|STARTED|Overall Study||149
5345948|NCT00255970|13152422|P2|NOT COMPLETED|Overall Study||0
5345949|NCT00255970|13152423|P1|NOT COMPLETED|Overall Study||0
5345950|NCT00255970|13152422|P2|COMPLETED|Overall Study||19
5345951|NCT00255970|13152423|P1|COMPLETED|Overall Study||21
5345952|NCT00255970|13152422|P2|Final Visit Week 24|Overall Study||19
5345953|NCT00255970|13152423|P1|Final Visit Week 24|Overall Study||21
5345954|NCT00255970|13152422|P2|Screening Visit|Overall Study||19
5345955|NCT00255970|13152423|P1|Screening Visit|Overall Study||21
5345956|NCT00255970|13152422|P2|STARTED|Overall Study||19
5345957|NCT00255970|13152423|P1|STARTED|Overall Study||21
5345958|NCT00255840|13152443|P2|NOT COMPLETED|Overall Study||70
5345959|NCT00255840|13152444|P1|NOT COMPLETED|Overall Study||63
5345960|NCT00255840|13152443|P2|COMPLETED|Overall Study||334
5345961|NCT00255840|13152444|P1|COMPLETED|Overall Study||345
5345962|NCT00255840|13152443|P2|STARTED|Overall Study||404
5345963|NCT00255840|13152444|P1|STARTED|Overall Study||408
5345964|NCT00255801|13152450|P1|NOT COMPLETED|Overall Study||0
5345965|NCT00255801|13152450|P1|COMPLETED|Overall Study||37
5345966|NCT00255801|13152450|P1|STARTED|Overall Study||37
5345967|NCT00255723|13152457|P2|NOT COMPLETED|Overall Study||2
5345968|NCT00255723|13152458|P1|NOT COMPLETED|Overall Study||2
5345969|NCT00255723|13152457|P2|COMPLETED|Overall Study||39
5345970|NCT00255723|13152458|P1|COMPLETED|Overall Study||54
5345971|NCT00255723|13152457|P2|STARTED|Overall Study||41
5345972|NCT00255723|13152458|P1|STARTED|Overall Study||56
5345973|NCT00255684|13152464|P1|NOT COMPLETED|Overall Study||0
5345974|NCT00255684|13152464|P1|COMPLETED|Overall Study||16
5345975|NCT00255684|13152464|P1|STARTED|Overall Study||16
5345976|NCT00255346|13152474|P5|NOT COMPLETED|Overall Study||0
5345977|NCT00255346|13152475|P4|NOT COMPLETED|Overall Study||0
5345978|NCT00255346|13152476|P3|NOT COMPLETED|Overall Study||0
5345979|NCT00255346|13152477|P2|NOT COMPLETED|Overall Study||0
5345980|NCT00255346|13152478|P1|NOT COMPLETED|Overall Study||1
5345981|NCT00255346|13152474|P5|COMPLETED|Overall Study||33
5345982|NCT00255346|13152475|P4|COMPLETED|Overall Study||11
5345983|NCT00255346|13152476|P3|COMPLETED|Overall Study||8
5345984|NCT00255346|13152477|P2|COMPLETED|Overall Study||6
5345985|NCT00255346|13152478|P1|COMPLETED|Overall Study||9
5345986|NCT00255346|13152474|P5|STARTED|Overall Study||33
5345987|NCT00255346|13152475|P4|STARTED|Overall Study||11
5345988|NCT00255346|13152476|P3|STARTED|Overall Study||8
5345989|NCT00255346|13152477|P2|STARTED|Overall Study||6
5345990|NCT00255346|13152478|P1|STARTED|Overall Study||10
5345991|NCT00255190|13152493|P2|NOT COMPLETED|Overall Study||157
5345992|NCT00255190|13152494|P1|NOT COMPLETED|Overall Study||50
5345993|NCT00255190|13152493|P2|COMPLETED|Overall Study||281
5345994|NCT00255190|13152494|P1|COMPLETED|Overall Study||103
5345995|NCT00255190|13152493|P2|STARTED|Overall Study||438
5345996|NCT00255190|13152494|P1|STARTED|Overall Study||153
5345997|NCT00255177|13152562|P4|NOT COMPLETED|Overall Study||2
5345998|NCT00255177|13152563|P3|NOT COMPLETED|Overall Study||1
5345999|NCT00255177|13152564|P2|NOT COMPLETED|Overall Study||1
5346000|NCT00255177|13152565|P1|NOT COMPLETED|Overall Study||2
5346001|NCT00255177|13152562|P4|COMPLETED|Overall Study||4
5346002|NCT00255177|13152563|P3|COMPLETED|Overall Study||12
5346003|NCT00255177|13152564|P2|COMPLETED|Overall Study||13
5346004|NCT00255177|13152565|P1|COMPLETED|Overall Study||9
5346005|NCT00255177|13152562|P4|STARTED|Overall Study||6
5346006|NCT00255177|13152563|P3|STARTED|Overall Study||13
5346007|NCT00255177|13152564|P2|STARTED|Overall Study||14
5346008|NCT00255177|13152565|P1|STARTED|Overall Study||11
5346009|NCT00255164|13152578|P3|NOT COMPLETED|Overall Study||49
5346010|NCT00255164|13152579|P2|NOT COMPLETED|Overall Study||49
5346011|NCT00255164|13152580|P1|NOT COMPLETED|Overall Study||123
5346012|NCT00255164|13152578|P3|COMPLETED|Overall Study||103
5346013|NCT00255164|13152579|P2|COMPLETED|Overall Study||110
5346014|NCT00255164|13152580|P1|COMPLETED|Overall Study||17
5346015|NCT00255164|13152578|P3|STARTED|Overall Study||152
5346016|NCT00255164|13152579|P2|STARTED|Overall Study||159
5346017|NCT00255164|13152580|P1|STARTED|Overall Study||140
5346018|NCT00255151|13152606|P3|NOT COMPLETED|Overall Study||49
5346019|NCT00255151|13152607|P2|NOT COMPLETED|Overall Study||49
5346020|NCT00255151|13152608|P1|NOT COMPLETED|Overall Study||123
5346021|NCT00255151|13152606|P3|COMPLETED|Overall Study||103
5346022|NCT00255151|13152607|P2|COMPLETED|Overall Study||110
5346023|NCT00255151|13152608|P1|COMPLETED|Overall Study||17
5346024|NCT00255151|13152606|P3|STARTED|Overall Study||152
5346025|NCT00255151|13152607|P2|STARTED|Overall Study||159
5346026|NCT00255151|13152608|P1|STARTED|Overall Study||140
5346027|NCT00255125|13152633|P2|NOT COMPLETED|Overall Study||0
5346028|NCT00255125|13152634|P1|NOT COMPLETED|Overall Study||0
5346029|NCT00255125|13152633|P2|COMPLETED|Overall Study||44
5346030|NCT00255125|13152634|P1|COMPLETED|Overall Study||42
5346031|NCT00255125|13152633|P2|STARTED|Overall Study||44
5346032|NCT00255125|13152634|P1|STARTED|Overall Study||42
5346033|NCT00255086|13152646|P2|NOT COMPLETED|Overall Study||2
5346034|NCT00255086|13152647|P1|NOT COMPLETED|Overall Study||2
5346035|NCT00255086|13152646|P2|COMPLETED|Overall Study||6
5346036|NCT00255086|13152647|P1|COMPLETED|Overall Study||7
5346037|NCT00255086|13152646|P2|STARTED|Overall Study||8
5346038|NCT00255086|13152647|P1|STARTED|Overall Study||9
5346039|NCT00255047|13152659|P4|NOT COMPLETED|Overall Study||46
5346040|NCT00255047|13152660|P3|NOT COMPLETED|Overall Study||50
5346041|NCT00255047|13152661|P2|NOT COMPLETED|Overall Study||48
5346042|NCT00255047|13152662|P1|NOT COMPLETED|Overall Study||48
5346043|NCT00255047|13152659|P4|COMPLETED|Overall Study||502
5346044|NCT00255047|13152660|P3|COMPLETED|Overall Study||496
5346045|NCT00255047|13152661|P2|COMPLETED|Overall Study||487
5346046|NCT00255047|13152662|P1|COMPLETED|Overall Study||490
5346047|NCT00255047|13152659|P4|STARTED|Overall Study||548
5346048|NCT00255047|13152660|P3|STARTED|Overall Study||546
5346049|NCT00255047|13152661|P2|STARTED|Overall Study||535
5346050|NCT00255047|13152662|P1|STARTED|Overall Study||538
5346051|NCT00255034|13152686|P2|NOT COMPLETED|Overall Study||38
5346052|NCT00255034|13152687|P1|NOT COMPLETED|Overall Study||15
5346053|NCT00255034|13152686|P2|COMPLETED|Overall Study||26
5346054|NCT00255034|13152687|P1|COMPLETED|Overall Study||64
5346055|NCT00255034|13152686|P2|STARTED|Overall Study||64
5346056|NCT00255034|13152687|P1|STARTED|Overall Study||79
5346057|NCT00255008|13152697|P4|NOT COMPLETED|Overall Study||22
5346058|NCT00255008|13152698|P3|NOT COMPLETED|Overall Study||16
5346059|NCT00255008|13152699|P2|NOT COMPLETED|Overall Study||9
5346060|NCT00255008|13152700|P1|NOT COMPLETED|Overall Study||32
5346061|NCT00255008|13152697|P4|COMPLETED|Overall Study||12
5346062|NCT00255008|13152698|P3|COMPLETED|Overall Study||17
5346063|NCT00255008|13152699|P2|COMPLETED|Overall Study||0
5346064|NCT00255008|13152700|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
5346065|NCT00255008|13152697|P4|STARTED|Overall Study||34
5346066|NCT00255008|13152698|P3|STARTED|Overall Study||33
5346067|NCT00255008|13152699|P2|STARTED|Overall Study||9
5346068|NCT00255008|13152700|P1|STARTED|Overall Study||45
5346069|NCT00254995|13152712|P2|NOT COMPLETED|Overall Study||0
5346070|NCT00254995|13152713|P1|NOT COMPLETED|Overall Study||0
5346071|NCT00254995|13152712|P2|COMPLETED|Overall Study||31065
5346072|NCT00254995|13152713|P1|COMPLETED|Overall Study||31561
5346073|NCT00254995|13152712|P2|STARTED|Overall Study||31065
5346074|NCT00254995|13152713|P1|STARTED|Overall Study||31561
5346075|NCT00254982|13152736|P2|NOT COMPLETED|Overall Study||31
5346076|NCT00254982|13152737|P1|NOT COMPLETED|Overall Study||36
5346077|NCT00254982|13152736|P2|COMPLETED|Overall Study||265
5346078|NCT00254982|13152737|P1|COMPLETED|Overall Study||261
5346079|NCT00254982|13152736|P2|STARTED|Overall Study||296
5346080|NCT00254982|13152737|P1|STARTED|Overall Study||297
5346081|NCT00254592|13152743|P1|NOT COMPLETED|Overall Study||2
5346082|NCT00254592|13152743|P1|COMPLETED|Overall Study||41
5346083|NCT00254592|13152743|P1|STARTED|Overall Study||43
5346084|NCT00254566|13152749|P2|NOT COMPLETED|Overall Study||26
5346085|NCT00254566|13152750|P1|NOT COMPLETED|Overall Study||31
5346086|NCT00254566|13152749|P2|COMPLETED|Overall Study||172
5346087|NCT00254566|13152750|P1|COMPLETED|Overall Study||167
5346088|NCT00254566|13152749|P2|STARTED|Overall Study||198
5346089|NCT00254566|13152750|P1|STARTED|Overall Study||198
5346090|NCT00254540|13152774|P2|NOT COMPLETED|Overall Study||22
5346091|NCT00254540|13152775|P1|NOT COMPLETED|Overall Study||19
5346092|NCT00254540|13152774|P2|COMPLETED|Overall Study||4
5346093|NCT00254540|13152775|P1|COMPLETED|Overall Study||6
5346094|NCT00254540|13152774|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
5346095|NCT00254540|13152775|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
5346096|NCT00254501|13152804|P2|NOT COMPLETED|Overall Study||1
5346097|NCT00254501|13152805|P1|NOT COMPLETED|Overall Study||1
5346098|NCT00254501|13152804|P2|COMPLETED|Overall Study||36
5346099|NCT00254501|13152805|P1|COMPLETED|Overall Study||31
5346100|NCT00254501|13152804|P2|STARTED|Overall Study||37
5346101|NCT00254501|13152805|P1|STARTED|Overall Study||32
5346102|NCT00254488|13152819|P2|NOT COMPLETED|Overall Study||49
5346103|NCT00254488|13152820|P1|NOT COMPLETED|Overall Study||57
5346104|NCT00254488|13152819|P2|COMPLETED|Overall Study||63
5346105|NCT00254488|13152820|P1|COMPLETED|Overall Study||55
5346106|NCT00254488|13152819|P2|STARTED|Overall Study||112
5346107|NCT00254488|13152820|P1|STARTED|Overall Study||112
5346108|NCT00254462|13152830|P2|NOT COMPLETED|Overall Study||10
5346109|NCT00254462|13152831|P1|NOT COMPLETED|Overall Study||8
5346110|NCT00254462|13152830|P2|COMPLETED|Overall Study||39
5346111|NCT00254462|13152831|P1|COMPLETED|Overall Study||36
5346112|NCT00254462|13152830|P2|STARTED|Overall Study||49
5346113|NCT00254462|13152831|P1|STARTED|Overall Study||44
5346114|NCT00254410|13152839|P1|NOT COMPLETED|Overall Study||0
5346115|NCT00254410|13152839|P1|COMPLETED|Overall Study||30
5346116|NCT00254410|13152839|P1|STARTED|Overall Study||30
5346117|NCT00254397|13152850|P4|NOT COMPLETED|Overall Study||25
5346118|NCT00254397|13152851|P3|NOT COMPLETED|Overall Study||19
5346119|NCT00254397|13152852|P2|NOT COMPLETED|Overall Study||1
5346120|NCT00254397|13152853|P1|NOT COMPLETED|Overall Study||6
5346121|NCT00254397|13152850|P4|COMPLETED|Overall Study||20
5346122|NCT00254397|13152851|P3|COMPLETED|Overall Study||18
5346123|NCT00254397|13152852|P2|COMPLETED|Overall Study||5
5346124|NCT00254397|13152853|P1|COMPLETED|Overall Study||4
5346125|NCT00254397|13152850|P4|STARTED|Overall Study||45
5346126|NCT00254397|13152851|P3|STARTED|Overall Study||37
5346127|NCT00254397|13152852|P2|STARTED|Overall Study||6
5346128|NCT00254397|13152853|P1|STARTED|Overall Study||10
5346129|NCT00254293|13152877|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
5346130|NCT00254293|13152878|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346131|NCT00254293|13152879|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346132|NCT00254293|13152880|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346133|NCT00254293|13152881|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346134|NCT00254293|13152882|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346135|NCT00254293|13152883|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
5346136|NCT00254293|13152877|P7|COMPLETED|LTE Open Label Fixed Dosing||35
5346137|NCT00254293|13152878|P6|COMPLETED|LTE Open Label Fixed Dosing||0
5346138|NCT00254293|13152879|P5|COMPLETED|LTE Open Label Fixed Dosing||0
5346139|NCT00254293|13152880|P4|COMPLETED|LTE Open Label Fixed Dosing||0
5346140|NCT00254293|13152881|P3|COMPLETED|LTE Open Label Fixed Dosing||0
5346141|NCT00254293|13152882|P2|COMPLETED|LTE Open Label Fixed Dosing||0
5346142|NCT00254293|13152883|P1|COMPLETED|LTE Open Label Fixed Dosing||0
5346143|NCT00254293|13152877|P7|STARTED|LTE Open Label Fixed Dosing||48
5346144|NCT00254293|13152878|P6|STARTED|LTE Open Label Fixed Dosing||0
5346145|NCT00254293|13152879|P5|STARTED|LTE Open Label Fixed Dosing||0
5346146|NCT00254293|13152880|P4|STARTED|LTE Open Label Fixed Dosing||0
5346147|NCT00254293|13152881|P3|STARTED|LTE Open Label Fixed Dosing||0
5346148|NCT00254293|13152882|P2|STARTED|LTE Open Label Fixed Dosing||0
5346149|NCT00254293|13152883|P1|STARTED|LTE Open Label Fixed Dosing||0
5346150|NCT00254293|13152877|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
5346151|NCT00254293|13152878|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
5346152|NCT00254293|13152879|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
5346153|NCT00254293|13152880|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
5346154|NCT00254293|13152881|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
5346155|NCT00254293|13152882|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
5346156|NCT00254293|13152883|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
5346157|NCT00254293|13152877|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
5346158|NCT00254293|13152878|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
5346159|NCT00254293|13152879|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
5346160|NCT00254293|13152880|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
5346161|NCT00254293|13152881|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
5346162|NCT00254293|13152882|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
5346163|NCT00254293|13152883|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
5346164|NCT00254293|13152877|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
5346165|NCT00254293|13152878|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
5346166|NCT00254293|13152879|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
5346167|NCT00254293|13152880|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
5346168|NCT00254293|13152881|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
5346169|NCT00254293|13152882|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
5346170|NCT00254293|13152883|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
5346171|NCT00254293|13152877|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
5346172|NCT00254293|13152878|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
5346173|NCT00254293|13152879|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
5346174|NCT00254293|13152880|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
5346175|NCT00254293|13152881|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
5346176|NCT00254293|13152882|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
5346177|NCT00254293|13152883|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
5346178|NCT00254293|13152877|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
5346179|NCT00254293|13152878|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
5346180|NCT00254293|13152879|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
5346181|NCT00254293|13152880|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
5346182|NCT00254293|13152881|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
5346183|NCT00254293|13152882|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
5346184|NCT00254293|13152883|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
5346185|NCT00254293|13152877|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
5346186|NCT00254293|13152878|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
5346187|NCT00254293|13152879|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
5346188|NCT00254293|13152880|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
5346189|NCT00254293|13152881|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
5346190|NCT00254293|13152882|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
5346191|NCT00254293|13152883|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
5346192|NCT00254163|13152966|P2|NOT COMPLETED|Overall Study||46
5346193|NCT00254163|13152967|P1|NOT COMPLETED|Overall Study||45
5346194|NCT00254163|13152966|P2|COMPLETED|Overall Study||46
5346195|NCT00254163|13152967|P1|COMPLETED|Overall Study||47
5346196|NCT00254163|13152966|P2|STARTED|Overall Study||92
5346197|NCT00254163|13152967|P1|STARTED|Overall Study||92
5346198|NCT00254072|13152991|P2|NOT COMPLETED|Overall Study||0
5346199|NCT00254072|13152992|P1|NOT COMPLETED|Overall Study||0
5346200|NCT00254072|13152991|P2|COMPLETED|Overall Study||175
5346201|NCT00254072|13152992|P1|COMPLETED|Overall Study||180
5346202|NCT00254072|13152991|P2|STARTED|Overall Study||175
5346203|NCT00254072|13152992|P1|STARTED|Overall Study||180
5346204|NCT00253981|13153000|P2|NOT COMPLETED|Overall Study||0
5346205|NCT00253981|13153001|P1|NOT COMPLETED|Overall Study||0
5346206|NCT00253981|13153000|P2|COMPLETED|Overall Study||14
5346207|NCT00253981|13153001|P1|COMPLETED|Overall Study||16
5346208|NCT00253981|13153000|P2|STARTED|Overall Study||14
5346209|NCT00253981|13153001|P1|STARTED|Overall Study||16
5346210|NCT00253890|13153009|P2|NOT COMPLETED|Overall Study||7
5346211|NCT00253890|13153010|P1|NOT COMPLETED|Overall Study||7
5346212|NCT00253890|13153009|P2|COMPLETED|Overall Study||61
5346213|NCT00253890|13153010|P1|COMPLETED|Overall Study||62
5346214|NCT00253890|13153009|P2|STARTED|Overall Study||68
5346215|NCT00253890|13153010|P1|STARTED|Overall Study||69
5346216|NCT00253747|13153018|P2|NOT COMPLETED|Overall Study||27
5346217|NCT00253747|13153019|P1|NOT COMPLETED|Overall Study||24
5346218|NCT00253747|13153018|P2|COMPLETED|Overall Study||101
5346219|NCT00253747|13153019|P1|COMPLETED|Overall Study||103
5346220|NCT00253747|13153018|P2|STARTED|Overall Study||128
5346221|NCT00253747|13153019|P1|STARTED|Overall Study||127
5346222|NCT00253708|13153040|P3|NOT COMPLETED|Overall Study||1
5346223|NCT00253708|13153041|P2|NOT COMPLETED|Overall Study||0
5346224|NCT00253708|13153042|P1|NOT COMPLETED|Overall Study||0
5346225|NCT00253708|13153040|P3|COMPLETED|Overall Study||8
5346226|NCT00253708|13153041|P2|COMPLETED|Overall Study||10
5346227|NCT00253708|13153042|P1|COMPLETED|Overall Study||20
5346228|NCT00253708|13153040|P3|STARTED|Overall Study||9
5346229|NCT00253708|13153041|P2|STARTED|Overall Study||10
5346230|NCT00253708|13153042|P1|STARTED|Overall Study||20
5346231|NCT00253643|13153072|P4|NOT COMPLETED|Overall Study||3
5346232|NCT00253643|13153073|P3|NOT COMPLETED|Overall Study||1
5346233|NCT00253643|13153074|P2|NOT COMPLETED|Overall Study||0
5346234|NCT00253643|13153075|P1|NOT COMPLETED|Overall Study||0
5346235|NCT00253643|13153072|P4|COMPLETED|Overall Study||28
5346236|NCT00253643|13153073|P3|COMPLETED|Overall Study||28
5346237|NCT00253643|13153074|P2|COMPLETED|Overall Study||15
5346238|NCT00253643|13153075|P1|COMPLETED|Overall Study||14
5346239|NCT00253643|13153072|P4|STARTED|Overall Study||31
5346240|NCT00253643|13153073|P3|STARTED|Overall Study||29
5346241|NCT00253643|13153074|P2|STARTED|Overall Study||15
5346242|NCT00253643|13153075|P1|STARTED|Overall Study||14
5346243|NCT00253630|13153089|P1|NOT COMPLETED|Overall Study||2
5346244|NCT00253630|13153089|P1|COMPLETED|Overall Study||35
5346245|NCT00253630|13153089|P1|STARTED|Overall Study||37
5346246|NCT00253513|13153098|P1|NOT COMPLETED|Overall Study||0
5346247|NCT00253513|13153098|P1|COMPLETED|Overall Study||60
5346248|NCT00253513|13153098|P1|STARTED|Overall Study||60
5346249|NCT00253448|13153105|P1|NOT COMPLETED|Overall Study||1
5346250|NCT00253448|13153105|P1|COMPLETED|Overall Study||34
5346251|NCT00253448|13153105|P1|STARTED|Overall Study||35
5346252|NCT00253435|13153111|P2|NOT COMPLETED|Overall Study||0
5346253|NCT00253435|13153112|P1|NOT COMPLETED|Overall Study||0
5346254|NCT00253435|13153111|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
5346255|NCT00253435|13153112|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
5346256|NCT00253435|13153111|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
5346257|NCT00253435|13153112|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
5346258|NCT00253435|13153111|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
5346259|NCT00253435|13153112|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
5346260|NCT00253435|13153111|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
5346261|NCT00253435|13153112|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
5346262|NCT00253435|13153111|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
5346263|NCT00253435|13153112|P1|STARTED|Overall Study|Total number is 42|42
5346264|NCT00253370|13153124|P1|NOT COMPLETED|Overall Study||43
5346265|NCT00253370|13153124|P1|COMPLETED|Overall Study||1
5346266|NCT00253370|13153124|P1|STARTED|Overall Study||44
5346267|NCT00253019|13153133|P3|NOT COMPLETED|Overall Study||18
5346268|NCT00253019|13153134|P2|NOT COMPLETED|Overall Study||31
5346269|NCT00253019|13153135|P1|NOT COMPLETED|Overall Study||29
5346270|NCT00253019|13153133|P3|COMPLETED|Overall Study||83
5346271|NCT00253019|13153134|P2|COMPLETED|Overall Study||78
5346272|NCT00253019|13153135|P1|COMPLETED|Overall Study||82
5346273|NCT00253019|13153133|P3|STARTED|Overall Study||101
5346274|NCT00253019|13153134|P2|STARTED|Overall Study||109
5346275|NCT00253019|13153135|P1|STARTED|Overall Study||111
5346276|NCT00252967|13153145|P2|NOT COMPLETED|Overall Study||0
5346277|NCT00252967|13153146|P1|NOT COMPLETED|Overall Study||0
5346278|NCT00252967|13153145|P2|COMPLETED|Overall Study||33
5346279|NCT00252967|13153146|P1|COMPLETED|Overall Study||31
5346280|NCT00252967|13153145|P2|STARTED|Overall Study||33
5346281|NCT00252967|13153146|P1|STARTED|Overall Study||31
5346282|NCT00252733|13153170|P2|NOT COMPLETED|Overall Study||92
5346283|NCT00252733|13153171|P1|NOT COMPLETED|Overall Study||106
5346284|NCT00252733|13153170|P2|COMPLETED|Overall Study||618
5346285|NCT00252733|13153171|P1|COMPLETED|Overall Study||605
5346286|NCT00252733|13153170|P2|STARTED|Overall Study||710
5346287|NCT00252733|13153171|P1|STARTED|Overall Study||711
5346288|NCT00252720|13153181|P2|NOT COMPLETED|Overall Study||165
5346289|NCT00252720|13153182|P1|NOT COMPLETED|Overall Study||132
5346290|NCT00252720|13153181|P2|COMPLETED|Overall Study||789
5346291|NCT00252720|13153182|P1|COMPLETED|Overall Study||819
5346292|NCT00252720|13153181|P2|STARTED|Overall Study||954
5346293|NCT00252720|13153182|P1|STARTED|Overall Study||951
5346294|NCT00252694|13153196|P2|NOT COMPLETED|Overall Study||154
5346295|NCT00252694|13153197|P1|NOT COMPLETED|Overall Study||144
5346296|NCT00252694|13153196|P2|COMPLETED|Overall Study||800
5346297|NCT00252694|13153197|P1|COMPLETED|Overall Study||807
5346298|NCT00252694|13153196|P2|STARTED|Overall Study||954
5346299|NCT00252694|13153197|P1|STARTED|Overall Study||951
5346300|NCT00252629|13153212|P3|NOT COMPLETED|Overall Study||0
5346301|NCT00252629|13153213|P2|NOT COMPLETED|Overall Study||0
5346302|NCT00252629|13153214|P1|NOT COMPLETED|Overall Study||1
5346303|NCT00252629|13153212|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
5346304|NCT00252629|13153213|P2|COMPLETED|Overall Study||9
5346305|NCT00252629|13153214|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
5346306|NCT00252629|13153212|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
5346307|NCT00252629|13153213|P2|STARTED|Overall Study||9
5346308|NCT00252629|13153214|P1|STARTED|Overall Study||9
5346309|NCT00252590|13153230|P3|NOT COMPLETED|Overall Study||3
5346310|NCT00252590|13153231|P2|NOT COMPLETED|Overall Study||2
5346311|NCT00252590|13153232|P1|NOT COMPLETED|Overall Study||2
5346312|NCT00252590|13153230|P3|COMPLETED|Overall Study||31
5346313|NCT00252590|13153231|P2|COMPLETED|Overall Study||28
5346314|NCT00252590|13153232|P1|COMPLETED|Overall Study||33
5346315|NCT00252590|13153230|P3|STARTED|Overall Study||34
5346316|NCT00252590|13153231|P2|STARTED|Overall Study||30
5346317|NCT00252590|13153232|P1|STARTED|Overall Study||35
5346318|NCT00252577|13153243|P1|NOT COMPLETED|Overall Study||20
5346319|NCT00252577|13153243|P1|COMPLETED|Overall Study||110
5346320|NCT00252577|13153243|P1|STARTED|Overall Study||130
5346321|NCT00252564|13153249|P2|NOT COMPLETED|Overall Study||44
5346322|NCT00252564|13153250|P1|NOT COMPLETED|Overall Study||39
5346323|NCT00252564|13153249|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
5346324|NCT00252564|13153250|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
5346325|NCT00252564|13153249|P2|STARTED|Overall Study|From randomization|123
5346326|NCT00252564|13153250|P1|STARTED|Overall Study|From randomization|124
5346327|NCT00252538|13153262|P2|NOT COMPLETED|Overall Study||0
5346328|NCT00252538|13153263|P1|NOT COMPLETED|Overall Study||0
5346329|NCT00252538|13153262|P2|COMPLETED|Overall Study||114
5346330|NCT00252538|13153263|P1|COMPLETED|Overall Study||19
5346331|NCT00252538|13153262|P2|STARTED|Overall Study||114
5346332|NCT00252538|13153263|P1|STARTED|Overall Study||19
5346333|NCT00252512|13153270|P2|NOT COMPLETED|12 Month Follow up||1
5346334|NCT00252512|13153271|P1|NOT COMPLETED|12 Month Follow up||9
5346335|NCT00252512|13153270|P2|COMPLETED|12 Month Follow up||121
5346336|NCT00252512|13153271|P1|COMPLETED|12 Month Follow up||123
5346337|NCT00252512|13153270|P2|STARTED|12 Month Follow up||122
5346338|NCT00252512|13153271|P1|STARTED|12 Month Follow up||132
5346339|NCT00252512|13153270|P2|NOT COMPLETED|Six Month Follow up||12
5346340|NCT00252512|13153271|P1|NOT COMPLETED|Six Month Follow up||4
5346341|NCT00252512|13153270|P2|COMPLETED|Six Month Follow up||122
5346342|NCT00252512|13153271|P1|COMPLETED|Six Month Follow up||132
5346343|NCT00252512|13153270|P2|STARTED|Six Month Follow up||134
5346344|NCT00252512|13153271|P1|STARTED|Six Month Follow up||136
5346345|NCT00252512|13153270|P2|NOT COMPLETED|Intervention||31
5346346|NCT00252512|13153271|P1|NOT COMPLETED|Intervention||29
5346347|NCT00252512|13153270|P2|COMPLETED|Intervention||134
5346348|NCT00252512|13153271|P1|COMPLETED|Intervention||136
5346349|NCT00252512|13153270|P2|STARTED|Intervention||165
5346350|NCT00252512|13153271|P1|STARTED|Intervention||165
5346351|NCT00252499|13153290|P3|NOT COMPLETED|Overall Study||0
5346352|NCT00252499|13153291|P2|NOT COMPLETED|Overall Study||0
5346353|NCT00252499|13153292|P1|NOT COMPLETED|Overall Study||1
5346354|NCT00252499|13153290|P3|COMPLETED|Overall Study||6
5346355|NCT00252499|13153291|P2|COMPLETED|Overall Study||2
5346356|NCT00252499|13153292|P1|COMPLETED|Overall Study||4
5346357|NCT00252499|13153290|P3|STARTED|Overall Study||6
5346358|NCT00252499|13153291|P2|STARTED|Overall Study||2
5346359|NCT00252499|13153292|P1|STARTED|Overall Study||5
5346360|NCT00252382|13153315|P1|NOT COMPLETED|Overall Study||26
5346361|NCT00252382|13153315|P1|COMPLETED|Overall Study||5
5346362|NCT00252382|13153315|P1|STARTED|Overall Study||31
5346363|NCT00252239|13153324|P4|NOT COMPLETED|Overall Study||1
5346364|NCT00252239|13153325|P3|NOT COMPLETED|Overall Study||2
5346365|NCT00252239|13153326|P2|NOT COMPLETED|Overall Study||0
5346366|NCT00252239|13153327|P1|NOT COMPLETED|Overall Study||1
5346367|NCT00252239|13153324|P4|COMPLETED|Overall Study||30
5346368|NCT00252239|13153325|P3|COMPLETED|Overall Study||17
5346369|NCT00252239|13153326|P2|COMPLETED|Overall Study||31
5346370|NCT00252239|13153327|P1|COMPLETED|Overall Study||30
5346371|NCT00252239|13153324|P4|STARTED|Overall Study||31
5346372|NCT00252239|13153325|P3|STARTED|Overall Study||19
5346373|NCT00252239|13153326|P2|STARTED|Overall Study||31
5346374|NCT00252239|13153327|P1|STARTED|Overall Study||31
5346375|NCT00252187|13153339|P2|NOT COMPLETED|Overall Study||1
5346376|NCT00252187|13153340|P1|NOT COMPLETED|Overall Study||4
5346377|NCT00252187|13153339|P2|COMPLETED|Overall Study||20
5346378|NCT00252187|13153340|P1|COMPLETED|Overall Study||20
5346379|NCT00252187|13153339|P2|STARTED|Overall Study||21
5346380|NCT00252187|13153340|P1|STARTED|Overall Study||24
5346381|NCT00252174|13153363|P3|NOT COMPLETED|Overall Study||0
5346382|NCT00252174|13153364|P2|NOT COMPLETED|Overall Study||1
5346383|NCT00252174|13153365|P1|NOT COMPLETED|Overall Study||0
5346384|NCT00252174|13153363|P3|COMPLETED|Overall Study||0
5346385|NCT00252174|13153364|P2|COMPLETED|Overall Study||1
5346386|NCT00252174|13153365|P1|COMPLETED|Overall Study||0
5346387|NCT00252174|13153363|P3|STARTED|Overall Study|No subjects entered Stage 2|0
5346388|NCT00252174|13153364|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
5346389|NCT00252174|13153365|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
5346390|NCT00252057|13153405|P2|NOT COMPLETED|Overall Study||8
5346391|NCT00252057|13153406|P1|NOT COMPLETED|Overall Study||3
5346392|NCT00252057|13153405|P2|COMPLETED|Overall Study||368
5346393|NCT00252057|13153406|P1|COMPLETED|Overall Study||370
5346394|NCT00252057|13153405|P2|STARTED|Overall Study||376
5346395|NCT00252057|13153406|P1|STARTED|Overall Study||373
5346396|NCT00251979|13153414|P2|NOT COMPLETED|Overall Study||40
5346397|NCT00251979|13153415|P1|NOT COMPLETED|Overall Study||38
5346398|NCT00251979|13153414|P2|COMPLETED|Overall Study||349
5346399|NCT00251979|13153415|P1|COMPLETED|Overall Study||337
5346400|NCT00251979|13153414|P2|STARTED|Overall Study|ITT population|389
5346401|NCT00251979|13153415|P1|STARTED|Overall Study|ITT population|375
5346402|NCT00251927|13153447|P2|NOT COMPLETED|Overall Study||74
5346403|NCT00251927|13153448|P1|NOT COMPLETED|Overall Study||108
5346404|NCT00251927|13153447|P2|COMPLETED|Overall Study|Completed 5 year visit|192
5346405|NCT00251927|13153448|P1|COMPLETED|Overall Study|Completed 5 year visit|180
5346406|NCT00251927|13153447|P2|STARTED|Overall Study|Randomised|266
5346407|NCT00251927|13153448|P1|STARTED|Overall Study|Randomised|288
5346408|NCT00251862|13153478|P3|NOT COMPLETED|Overall Study||0
5346409|NCT00251862|13153479|P2|NOT COMPLETED|Overall Study||0
5346410|NCT00251862|13153480|P1|NOT COMPLETED|Overall Study||0
5346411|NCT00251862|13153478|P3|COMPLETED|Overall Study||276
5346412|NCT00251862|13153479|P2|COMPLETED|Overall Study||269
5346413|NCT00251862|13153480|P1|COMPLETED|Overall Study||280
5346414|NCT00251862|13153478|P3|STARTED|Overall Study||276
5346415|NCT00251862|13153479|P2|STARTED|Overall Study||269
5346416|NCT00251862|13153480|P1|STARTED|Overall Study||280
5346417|NCT00251758|13153500|P3|NOT COMPLETED|Overall Study||27
5346418|NCT00251758|13153501|P2|NOT COMPLETED|Overall Study||27
5346419|NCT00251758|13153502|P1|NOT COMPLETED|Overall Study||28
5346420|NCT00251758|13153500|P3|COMPLETED|Overall Study||277
5346421|NCT00251758|13153501|P2|COMPLETED|Overall Study||285
5346422|NCT00251758|13153502|P1|COMPLETED|Overall Study||264
5346423|NCT00251758|13153500|P3|STARTED|Overall Study||304
5346424|NCT00251758|13153501|P2|STARTED|Overall Study||312
5346425|NCT00251758|13153502|P1|STARTED|Overall Study||292
5346426|NCT00251745|13153522|P3|NOT COMPLETED|Overall Study||27
5346427|NCT00251745|13153523|P2|NOT COMPLETED|Overall Study||27
5346428|NCT00251745|13153524|P1|NOT COMPLETED|Overall Study||28
5346429|NCT00251745|13153522|P3|COMPLETED|Overall Study||277
5346430|NCT00251745|13153523|P2|COMPLETED|Overall Study||285
5346431|NCT00251745|13153524|P1|COMPLETED|Overall Study||264
5346432|NCT00251745|13153522|P3|STARTED|Overall Study||304
5346433|NCT00251745|13153523|P2|STARTED|Overall Study||312
5346434|NCT00251745|13153524|P1|STARTED|Overall Study||292
5346435|NCT00251719|13153544|P3|NOT COMPLETED|Overall Study||30
5346436|NCT00251719|13153545|P2|NOT COMPLETED|Overall Study||45
5346437|NCT00251719|13153546|P1|NOT COMPLETED|Overall Study||53
5346438|NCT00251719|13153544|P3|COMPLETED|Overall Study||643
5346439|NCT00251719|13153545|P2|COMPLETED|Overall Study||642
5346440|NCT00251719|13153546|P1|COMPLETED|Overall Study||641
5346441|NCT00251719|13153544|P3|STARTED|Overall Study||673
5346442|NCT00251719|13153545|P2|STARTED|Overall Study||687
5346443|NCT00251719|13153546|P1|STARTED|Overall Study||694
5346444|NCT00251693|13153572|P3|NOT COMPLETED|Overall Study||46
5346445|NCT00251693|13153573|P2|NOT COMPLETED|Overall Study||44
5346446|NCT00251693|13153574|P1|NOT COMPLETED|Overall Study||51
5346447|NCT00251693|13153572|P3|COMPLETED|Overall Study||644
5346448|NCT00251693|13153573|P2|COMPLETED|Overall Study||624
5346449|NCT00251693|13153574|P1|COMPLETED|Overall Study||629
5346450|NCT00251693|13153572|P3|STARTED|Overall Study||690
5346451|NCT00251693|13153573|P2|STARTED|Overall Study||668
5346452|NCT00251693|13153574|P1|STARTED|Overall Study||680
5346453|NCT00251641|13153599|P2|NOT COMPLETED|Overall Study||88
5346454|NCT00251641|13153600|P1|NOT COMPLETED|Overall Study||112
5346455|NCT00251641|13153599|P2|COMPLETED|Overall Study||127
5346456|NCT00251641|13153600|P1|COMPLETED|Overall Study||541
5346457|NCT00251641|13153599|P2|STARTED|Overall Study||215
5346458|NCT00251641|13153600|P1|STARTED|Overall Study||653
5346459|NCT00251589|13153618|P4|NOT COMPLETED|Overall Study||2
5346460|NCT00251589|13153619|P3|NOT COMPLETED|Overall Study||2
5346461|NCT00251589|13153620|P2|NOT COMPLETED|Overall Study||3
5346462|NCT00251589|13153621|P1|NOT COMPLETED|Overall Study||15
5346463|NCT00251589|13153618|P4|COMPLETED|Overall Study||0
5346464|NCT00251589|13153619|P3|COMPLETED|Overall Study||0
5346465|NCT00251589|13153620|P2|COMPLETED|Overall Study||0
5346466|NCT00251589|13153621|P1|COMPLETED|Overall Study||1
5346467|NCT00251589|13153618|P4|STARTED|Overall Study||2
5346468|NCT00251589|13153619|P3|STARTED|Overall Study||2
5346469|NCT00251589|13153620|P2|STARTED|Overall Study||3
5346470|NCT00251589|13153621|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
5346471|NCT00251316|13153658|P2|NOT COMPLETED|Overall Study||3
5346472|NCT00251316|13153659|P1|NOT COMPLETED|Overall Study||2
5346473|NCT00251316|13153658|P2|COMPLETED|Overall Study||14
5346474|NCT00251316|13153659|P1|COMPLETED|Overall Study||15
5346475|NCT00251316|13153658|P2|STARTED|Overall Study||17
5346476|NCT00251316|13153659|P1|STARTED|Overall Study||17
5346477|NCT00251303|13153667|P2|NOT COMPLETED|Overall Study||1
5346478|NCT00251303|13153668|P1|NOT COMPLETED|Overall Study||8
5346479|NCT00251303|13153667|P2|COMPLETED|Overall Study||29
5346480|NCT00251303|13153668|P1|COMPLETED|Overall Study||22
5346481|NCT00251303|13153667|P2|STARTED|Overall Study||30
5346482|NCT00251303|13153668|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
5346483|NCT00251238|13153678|P2|NOT COMPLETED|Overall Study||0
5346484|NCT00251238|13153679|P1|NOT COMPLETED|Overall Study||0
5346485|NCT00251238|13153678|P2|COMPLETED|Overall Study||20
5346486|NCT00251238|13153679|P1|COMPLETED|Overall Study||21
5346487|NCT00251238|13153678|P2|STARTED|Overall Study||20
5346488|NCT00251238|13153679|P1|STARTED|Overall Study||21
5346489|NCT00251225|13153689|P1|NOT COMPLETED|Overall Study||0
5346490|NCT00251225|13153689|P1|COMPLETED|Overall Study||49
5346491|NCT00251225|13153689|P1|STARTED|Overall Study||49
5346492|NCT00251004|13153698|P3|NOT COMPLETED|Overall Study||31
5346493|NCT00251004|13153699|P2|NOT COMPLETED|Overall Study||41
5346494|NCT00251004|13153700|P1|NOT COMPLETED|Overall Study||45
5346495|NCT00251004|13153698|P3|COMPLETED|Overall Study||246
5346496|NCT00251004|13153699|P2|COMPLETED|Overall Study||238
5346497|NCT00251004|13153700|P1|COMPLETED|Overall Study||232
5346498|NCT00251004|13153698|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
5346499|NCT00251004|13153699|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
5346500|NCT00251004|13153700|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
5346501|NCT00251004|13153698|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
5346502|NCT00251004|13153699|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
5346503|NCT00251004|13153700|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
5346504|NCT00251004|13153698|P3|STARTED|Overall Study||277
5346505|NCT00251004|13153699|P2|STARTED|Overall Study||279
5346506|NCT00251004|13153700|P1|STARTED|Overall Study||277
5346507|NCT00250926|13153717|P1|NOT COMPLETED|Overall Study||0
5346508|NCT00250926|13153717|P1|COMPLETED|Overall Study||23
5346509|NCT00250926|13153717|P1|STARTED|Overall Study||23
5346510|NCT00250835|13153724|P1|NOT COMPLETED|Overall Study||1
5346511|NCT00250835|13153724|P1|COMPLETED|Overall Study||37
5346512|NCT00250835|13153724|P1|STARTED|Overall Study||38
5346513|NCT00250718|13153733|P1|NOT COMPLETED|Overall Study||3
5346514|NCT00250718|13153733|P1|COMPLETED|Overall Study||14
5346515|NCT00250718|13153733|P1|Received Treatment|Overall Study||16
5346516|NCT00250718|13153733|P1|STARTED|Overall Study||17
5346517|NCT00250705|13153738|P1|NOT COMPLETED|Overall Study||2
5346518|NCT00250705|13153738|P1|COMPLETED|Overall Study||10
5346519|NCT00250705|13153738|P1|STARTED|Overall Study||12
5346520|NCT00250679|13153749|P3|NOT COMPLETED|Overall Study||44
5346521|NCT00250679|13153750|P2|NOT COMPLETED|Overall Study||49
5346522|NCT00250679|13153751|P1|NOT COMPLETED|Overall Study||39
5346523|NCT00250679|13153749|P3|COMPLETED|Overall Study||103
5346524|NCT00250679|13153750|P2|COMPLETED|Overall Study||100
5346525|NCT00250679|13153751|P1|COMPLETED|Overall Study||108
5346526|NCT00250679|13153749|P3|STARTED|Overall Study||147
5346527|NCT00250679|13153750|P2|STARTED|Overall Study||149
5346528|NCT00250679|13153751|P1|STARTED|Overall Study||147
5346529|NCT00250588|13153852|P3|NOT COMPLETED|Overall Study||13
5346530|NCT00250588|13153853|P2|NOT COMPLETED|Overall Study||19
5346531|NCT00250588|13153854|P1|NOT COMPLETED|Overall Study||9
5346532|NCT00250588|13153852|P3|COMPLETED|Overall Study||74
5346533|NCT00250588|13153853|P2|COMPLETED|Overall Study||65
5346534|NCT00250588|13153854|P1|COMPLETED|Overall Study||72
5346535|NCT00250588|13153852|P3|STARTED|Overall Study||87
5346536|NCT00250588|13153853|P2|STARTED|Overall Study||84
5346537|NCT00250588|13153854|P1|STARTED|Overall Study||81
5346538|NCT00250497|13153870|P2|NOT COMPLETED|Overall Study||15
5346539|NCT00250497|13153871|P1|NOT COMPLETED|Overall Study||5
5346540|NCT00250497|13153870|P2|COMPLETED|Overall Study||159
5346541|NCT00250497|13153871|P1|COMPLETED|Overall Study||177
5346542|NCT00250497|13153870|P2|STARTED|Overall Study||174
5346543|NCT00250497|13153871|P1|STARTED|Overall Study||182
5346544|NCT00250484|13153889|P2|NOT COMPLETED|Overall Study||0
5346545|NCT00250484|13153890|P1|NOT COMPLETED|Overall Study||0
5346546|NCT00250484|13153889|P2|COMPLETED|Overall Study||8
5346547|NCT00250484|13153890|P1|COMPLETED|Overall Study||9
5346548|NCT00250484|13153889|P2|STARTED|Overall Study||8
5346549|NCT00250484|13153890|P1|STARTED|Overall Study||9
5346550|NCT00250458|13153902|P2|NOT COMPLETED|Overall Study||17
5346551|NCT00250458|13153903|P1|NOT COMPLETED|Overall Study||32
5346552|NCT00250458|13153902|P2|COMPLETED|Overall Study||97
5346553|NCT00250458|13153903|P1|COMPLETED|Overall Study||200
5346554|NCT00250458|13153902|P2|STARTED|Overall Study||114
5346555|NCT00250458|13153903|P1|STARTED|Overall Study||232
5346556|NCT00250432|13153913|P2|NOT COMPLETED|Overall Study||47
5346557|NCT00250432|13153914|P1|NOT COMPLETED|Overall Study||45
5346558|NCT00250432|13153913|P2|COMPLETED|Overall Study||53
5346559|NCT00250432|13153914|P1|COMPLETED|Overall Study||59
5346560|NCT00250432|13153913|P2|STARTED|Overall Study||100
5346561|NCT00250432|13153914|P1|STARTED|Overall Study||104
5346562|NCT00250276|13153926|P4|NOT COMPLETED|Overall Study||19
5346563|NCT00250276|13153927|P3|NOT COMPLETED|Overall Study||19
5346564|NCT00250276|13153928|P2|NOT COMPLETED|Overall Study||21
5346565|NCT00250276|13153929|P1|NOT COMPLETED|Overall Study||17
5346566|NCT00250276|13153926|P4|COMPLETED|Overall Study||181
5346567|NCT00250276|13153927|P3|COMPLETED|Overall Study||182
5346568|NCT00250276|13153928|P2|COMPLETED|Overall Study||177
5346569|NCT00250276|13153929|P1|COMPLETED|Overall Study||182
5346570|NCT00250276|13153926|P4|STARTED|Overall Study||200
5346571|NCT00250276|13153927|P3|STARTED|Overall Study||201
5346572|NCT00250276|13153928|P2|STARTED|Overall Study||198
5346573|NCT00250276|13153929|P1|STARTED|Overall Study||199
5346574|NCT00249873|13154009|P2|NOT COMPLETED|Overall Study||1254
5346575|NCT00249873|13154010|P1|NOT COMPLETED|Overall Study||1330
5346576|NCT00249873|13154009|P2|COMPLETED|Overall Study|started and completed study drug|2528
5346577|NCT00249873|13154010|P1|COMPLETED|Overall Study|started and completed study drug|2442
5346578|NCT00249873|13154009|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
5346671|NCT00249288|13154236|P1|NOT COMPLETED|Overall Study||5
5346579|NCT00249873|13154010|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
5346580|NCT00249834|13154030|P8|NOT COMPLETED|Overall Study||0
5346581|NCT00249834|13154031|P7|NOT COMPLETED|Overall Study||1
5346582|NCT00249834|13154032|P6|NOT COMPLETED|Overall Study||2
5346583|NCT00249834|13154033|P5|NOT COMPLETED|Overall Study||5
5346584|NCT00249834|13154034|P4|NOT COMPLETED|Overall Study||8
5346585|NCT00249834|13154035|P3|NOT COMPLETED|Overall Study||14
5346586|NCT00249834|13154036|P2|NOT COMPLETED|Overall Study||19
5346587|NCT00249834|13154037|P1|NOT COMPLETED|Overall Study||1
5346588|NCT00249834|13154030|P8|COMPLETED|Overall Study||2
5346589|NCT00249834|13154031|P7|COMPLETED|Overall Study||1
5346590|NCT00249834|13154032|P6|COMPLETED|Overall Study||8
5346591|NCT00249834|13154033|P5|COMPLETED|Overall Study||19
5346592|NCT00249834|13154034|P4|COMPLETED|Overall Study||26
5346593|NCT00249834|13154035|P3|COMPLETED|Overall Study||31
5346594|NCT00249834|13154036|P2|COMPLETED|Overall Study||29
5346595|NCT00249834|13154037|P1|COMPLETED|Overall Study||0
5346596|NCT00249834|13154030|P8|STARTED|Overall Study||2
5346597|NCT00249834|13154031|P7|STARTED|Overall Study||2
5346598|NCT00249834|13154032|P6|STARTED|Overall Study||10
5346599|NCT00249834|13154033|P5|STARTED|Overall Study||24
5346600|NCT00249834|13154034|P4|STARTED|Overall Study||34
5346601|NCT00249834|13154035|P3|STARTED|Overall Study||45
5346602|NCT00249834|13154036|P2|STARTED|Overall Study||48
5346603|NCT00249834|13154037|P1|STARTED|Overall Study||1
5346604|NCT00249821|13154086|P2|NOT COMPLETED|Overall Study||1
5346605|NCT00249821|13154087|P1|NOT COMPLETED|Overall Study||0
5346606|NCT00249821|13154086|P2|COMPLETED|Overall Study||11
5346607|NCT00249821|13154087|P1|COMPLETED|Overall Study||10
5346608|NCT00249821|13154086|P2|STARTED|Overall Study||12
5346609|NCT00249821|13154087|P1|STARTED|Overall Study||10
5346610|NCT00249808|13154107|P1|NOT COMPLETED|Overall Study||182
5346611|NCT00249808|13154107|P1|COMPLETED|Overall Study||1084
5346612|NCT00249808|13154107|P1|STARTED|Overall Study||1266
5346613|NCT00249795|13154115|P2|NOT COMPLETED|Overall Study||1390
5346614|NCT00249795|13154116|P1|NOT COMPLETED|Overall Study||1394
5346615|NCT00249795|13154115|P2|COMPLETED|Overall Study|started and completed study drug|3108
5346616|NCT00249795|13154116|P1|COMPLETED|Overall Study|started and completed study drug|3124
5346617|NCT00249795|13154115|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
5346618|NCT00249795|13154116|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
5346619|NCT00249769|13154137|P3|NOT COMPLETED|Overall Study||28
5346620|NCT00249769|13154138|P2|NOT COMPLETED|Overall Study||15
5346621|NCT00249769|13154139|P1|NOT COMPLETED|Overall Study||2
5346622|NCT00249769|13154137|P3|COMPLETED|Overall Study||222
5346623|NCT00249769|13154138|P2|COMPLETED|Overall Study||235
5346624|NCT00249769|13154139|P1|COMPLETED|Overall Study||98
5346625|NCT00249769|13154137|P3|Received Measles Vaccine|Overall Study||235
5346626|NCT00249769|13154138|P2|Received Measles Vaccine|Overall Study||236
5346627|NCT00249769|13154139|P1|Received Measles Vaccine|Overall Study||97
5346628|NCT00249769|13154137|P3|Received LJEV|Overall Study||224
5346629|NCT00249769|13154138|P2|Received LJEV|Overall Study||236
5346630|NCT00249769|13154139|P1|Received LJEV|Overall Study||100
5346631|NCT00249769|13154137|P3|STARTED|Overall Study||250
5346632|NCT00249769|13154138|P2|STARTED|Overall Study||250
5346633|NCT00249769|13154139|P1|STARTED|Overall Study||100
5346634|NCT00249613|13154167|P2|NOT COMPLETED|12 Month Follow-up||15
5346635|NCT00249613|13154168|P1|NOT COMPLETED|12 Month Follow-up||17
5346636|NCT00249613|13154167|P2|COMPLETED|12 Month Follow-up||124
5346637|NCT00249613|13154168|P1|COMPLETED|12 Month Follow-up||135
5346638|NCT00249613|13154167|P2|STARTED|12 Month Follow-up||139
5346639|NCT00249613|13154168|P1|STARTED|12 Month Follow-up||152
5346640|NCT00249613|13154167|P2|NOT COMPLETED|Baseline||0
5346641|NCT00249613|13154168|P1|NOT COMPLETED|Baseline||0
5346642|NCT00249613|13154167|P2|COMPLETED|Baseline||139
5346643|NCT00249613|13154168|P1|COMPLETED|Baseline||152
5346644|NCT00249613|13154167|P2|STARTED|Baseline||139
5346645|NCT00249613|13154168|P1|STARTED|Baseline||152
5346646|NCT00249496|13154179|P2|NOT COMPLETED|Overall Study||1
5346647|NCT00249496|13154180|P1|NOT COMPLETED|Overall Study||0
5346648|NCT00249496|13154179|P2|COMPLETED|Overall Study||26
5346649|NCT00249496|13154180|P1|COMPLETED|Overall Study||24
5346650|NCT00249496|13154179|P2|STARTED|Overall Study||27
5346651|NCT00249496|13154180|P1|STARTED|Overall Study||24
5346652|NCT00249470|13154196|P2|NOT COMPLETED|Overall Study||0
5346653|NCT00249470|13154197|P1|NOT COMPLETED|Overall Study||0
5346654|NCT00249470|13154196|P2|COMPLETED|Overall Study||28
5346655|NCT00249470|13154197|P1|COMPLETED|Overall Study||28
5346656|NCT00249470|13154196|P2|STARTED|Overall Study||28
5346657|NCT00249470|13154197|P1|STARTED|Overall Study||28
5346658|NCT00249444|13154209|P2|NOT COMPLETED|Overall Study||15
5346659|NCT00249444|13154210|P1|NOT COMPLETED|Overall Study||12
5346660|NCT00249444|13154209|P2|COMPLETED|Overall Study||29
5346661|NCT00249444|13154210|P1|COMPLETED|Overall Study||30
5346662|NCT00249444|13154209|P2|STARTED|Overall Study||44
5346663|NCT00249444|13154210|P1|STARTED|Overall Study||42
5346664|NCT00249379|13154220|P2|NOT COMPLETED|Overall Study||8
5346665|NCT00249379|13154221|P1|NOT COMPLETED|Overall Study||8
5346666|NCT00249379|13154220|P2|COMPLETED|Overall Study||4
5346667|NCT00249379|13154221|P1|COMPLETED|Overall Study||6
5346668|NCT00249379|13154220|P2|STARTED|Overall Study||12
5346669|NCT00249379|13154221|P1|STARTED|Overall Study||14
5346670|NCT00249288|13154235|P2|NOT COMPLETED|Overall Study||5
5346672|NCT00249288|13154235|P2|COMPLETED|Overall Study||14
5346673|NCT00249288|13154236|P1|COMPLETED|Overall Study||14
5346674|NCT00249288|13154235|P2|Initiated Treatment|Overall Study||15
5346675|NCT00249288|13154236|P1|Initiated Treatment|Overall Study||17
5346676|NCT00249288|13154235|P2|STARTED|Overall Study||19
5346677|NCT00249288|13154236|P1|STARTED|Overall Study||19
5346678|NCT00249249|13154271|P4|NOT COMPLETED|Overall Study||3
5346679|NCT00249249|13154272|P3|NOT COMPLETED|Overall Study||15
5346680|NCT00249249|13154273|P2|NOT COMPLETED|Overall Study||5
5346681|NCT00249249|13154274|P1|NOT COMPLETED|Overall Study||20
5346682|NCT00249249|13154271|P4|COMPLETED|Overall Study||100
5346683|NCT00249249|13154272|P3|COMPLETED|Overall Study||288
5346684|NCT00249249|13154273|P2|COMPLETED|Overall Study||98
5346685|NCT00249249|13154274|P1|COMPLETED|Overall Study||301
5346686|NCT00249249|13154271|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
5346687|NCT00249249|13154272|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
5346688|NCT00249249|13154273|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
5346689|NCT00249249|13154274|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
5346690|NCT00249249|13154271|P4|STARTED|Overall Study||103
5346691|NCT00249249|13154272|P3|STARTED|Overall Study||303
5346692|NCT00249249|13154273|P2|STARTED|Overall Study||103
5346693|NCT00249249|13154274|P1|STARTED|Overall Study||321
5346694|NCT00249002|13154328|P1|NOT COMPLETED|Overall Study||7
5346695|NCT00249002|13154328|P1|COMPLETED|Overall Study||2
5346696|NCT00249002|13154328|P1|STARTED|Overall Study||9
5346697|NCT00248833|13154347|P3|NOT COMPLETED|Overall Study||2
5346698|NCT00248833|13154348|P2|NOT COMPLETED|Overall Study||3
5346699|NCT00248833|13154349|P1|NOT COMPLETED|Overall Study||3
5346700|NCT00248833|13154347|P3|COMPLETED|Overall Study||9
5346701|NCT00248833|13154348|P2|COMPLETED|Overall Study||8
5346702|NCT00248833|13154349|P1|COMPLETED|Overall Study||9
5346703|NCT00248833|13154347|P3|STARTED|Overall Study||11
5346704|NCT00248833|13154348|P2|STARTED|Overall Study||11
5346705|NCT00248833|13154349|P1|STARTED|Overall Study||12
5346706|NCT00248807|13154367|P2|NOT COMPLETED|Overall Study||0
5346707|NCT00248807|13154368|P1|NOT COMPLETED|Overall Study||0
5346708|NCT00248807|13154367|P2|COMPLETED|Overall Study||11
5346709|NCT00248807|13154368|P1|COMPLETED|Overall Study||19
5346710|NCT00248807|13154367|P2|STARTED|Overall Study||11
5346711|NCT00248807|13154368|P1|STARTED|Overall Study||19
5346712|NCT00248794|13154385|P3|NOT COMPLETED|Overall Study||3
5346713|NCT00248794|13154386|P2|NOT COMPLETED|Overall Study||8
5346714|NCT00248794|13154387|P1|NOT COMPLETED|Overall Study||6
5346715|NCT00248794|13154385|P3|COMPLETED|Overall Study||7
5346716|NCT00248794|13154386|P2|COMPLETED|Overall Study||16
5346717|NCT00248794|13154387|P1|COMPLETED|Overall Study||19
5346718|NCT00248794|13154385|P3|STARTED|Overall Study||10
5346719|NCT00248794|13154386|P2|STARTED|Overall Study||24
5346720|NCT00248794|13154387|P1|STARTED|Overall Study||25
5346721|NCT00248781|13154409|P2|NOT COMPLETED|Overall Study||4
5346722|NCT00248781|13154410|P1|NOT COMPLETED|Overall Study||10
5346723|NCT00248781|13154409|P2|COMPLETED|Overall Study||47
5346724|NCT00248781|13154410|P1|COMPLETED|Overall Study||42
5346725|NCT00248781|13154409|P2|STARTED|Overall Study||51
5346726|NCT00248781|13154410|P1|STARTED|Overall Study||52
5346727|NCT00248651|13154437|P3|NOT COMPLETED|Overall Study||32
5346728|NCT00248651|13154438|P2|NOT COMPLETED|Overall Study||40
5346729|NCT00248651|13154439|P1|NOT COMPLETED|Overall Study||28
5346730|NCT00248651|13154437|P3|COMPLETED|Overall Study||65
5346731|NCT00248651|13154438|P2|COMPLETED|Overall Study||58
5346732|NCT00248651|13154439|P1|COMPLETED|Overall Study||69
5346733|NCT00248651|13154437|P3|Completed 12 Weeks of Treatment|Overall Study||75
5346734|NCT00248651|13154438|P2|Completed 12 Weeks of Treatment|Overall Study||66
5346735|NCT00248651|13154439|P1|Completed 12 Weeks of Treatment|Overall Study||78
5346736|NCT00248651|13154437|P3|STARTED|Overall Study||97
5346737|NCT00248651|13154438|P2|STARTED|Overall Study||98
5346738|NCT00248651|13154439|P1|STARTED|Overall Study||97
5346739|NCT00248638|13154458|P2|NOT COMPLETED|Overall Study||0
5346740|NCT00248638|13154459|P1|NOT COMPLETED|Overall Study||0
5346741|NCT00248638|13154458|P2|COMPLETED|Overall Study||75
5346742|NCT00248638|13154459|P1|COMPLETED|Overall Study||75
5346743|NCT00248638|13154458|P2|STARTED|Overall Study||75
5346744|NCT00248638|13154459|P1|STARTED|Overall Study||75
5346745|NCT00248625|13154475|P2|NOT COMPLETED|Overall Study||2
5346746|NCT00248625|13154476|P1|NOT COMPLETED|Overall Study||0
5346747|NCT00248625|13154475|P2|COMPLETED|Overall Study||90
5346748|NCT00248625|13154476|P1|COMPLETED|Overall Study||92
5346749|NCT00248625|13154475|P2|STARTED|Overall Study||92
5346750|NCT00248625|13154476|P1|STARTED|Overall Study||92
5346751|NCT00248612|13154500|P4|NOT COMPLETED|Overall Study||0
5346752|NCT00248612|13154501|P3|NOT COMPLETED|Overall Study||0
5346753|NCT00248612|13154502|P2|NOT COMPLETED|Overall Study||0
5346754|NCT00248612|13154503|P1|NOT COMPLETED|Overall Study||0
5346755|NCT00248612|13154500|P4|COMPLETED|Overall Study||22
5346756|NCT00248612|13154501|P3|COMPLETED|Overall Study||14
5346757|NCT00248612|13154502|P2|COMPLETED|Overall Study||21
5346758|NCT00248612|13154503|P1|COMPLETED|Overall Study||24
5346759|NCT00248612|13154500|P4|STARTED|Overall Study||22
5346760|NCT00248612|13154501|P3|STARTED|Overall Study||14
5346761|NCT00248612|13154502|P2|STARTED|Overall Study||21
5346762|NCT00248612|13154503|P1|STARTED|Overall Study||24
5346763|NCT00248560|13154545|P1|NOT COMPLETED|Overall Study||0
5346764|NCT00248560|13154545|P1|COMPLETED|Overall Study||36
5346765|NCT00248560|13154545|P1|STARTED|Overall Study||36
5346766|NCT00248547|13154554|P2|NOT COMPLETED|Overall Study||0
5346767|NCT00248547|13154555|P1|NOT COMPLETED|Overall Study||0
5346768|NCT00248547|13154554|P2|COMPLETED|Overall Study||20
5346769|NCT00248547|13154555|P1|COMPLETED|Overall Study||20
5346770|NCT00248547|13154554|P2|STARTED|Overall Study||20
5346771|NCT00248547|13154555|P1|STARTED|Overall Study||20
5346772|NCT00248534|13154561|P1|NOT COMPLETED|Overall Study||0
5346773|NCT00248534|13154561|P1|COMPLETED|Overall Study||16
5346774|NCT00248534|13154561|P1|STARTED|Overall Study||16
5346775|NCT00248495|13154568|P1|NOT COMPLETED|Overall Study||1
5346776|NCT00248495|13154568|P1|COMPLETED|Overall Study||37
5346777|NCT00248495|13154568|P1|STARTED|Overall Study||38
5346778|NCT00248287|13154579|P2|NOT COMPLETED|Overall Study||19
5346779|NCT00248287|13154580|P1|NOT COMPLETED|Overall Study||24
5346780|NCT00248287|13154579|P2|COMPLETED|Overall Study||60
5346781|NCT00248287|13154580|P1|COMPLETED|Overall Study||51
5346782|NCT00248287|13154579|P2|STARTED|Overall Study||79
5346783|NCT00248287|13154580|P1|STARTED|Overall Study||75
5346784|NCT00248170|13154594|P2|NOT COMPLETED|Overall Study||808
5346785|NCT00248170|13154595|P1|NOT COMPLETED|Overall Study||761
5346786|NCT00248170|13154594|P2|COMPLETED|Overall Study||1286
5346787|NCT00248170|13154595|P1|COMPLETED|Overall Study||1317
5346788|NCT00248170|13154594|P2|Safety Set|Overall Study||2062
5346789|NCT00248170|13154595|P1|Safety Set|Overall Study||2049
5346790|NCT00248170|13154594|P2|Intent-to-treat (ITT)|Overall Study||2075
5346791|NCT00248170|13154595|P1|Intent-to-treat (ITT)|Overall Study||2061
5346792|NCT00248170|13154594|P2|STARTED|Overall Study||2094
5346793|NCT00248170|13154595|P1|STARTED|Overall Study||2078
5346794|NCT00248040|13154618|P3|NOT COMPLETED|Overall Study||4
5346795|NCT00248040|13154619|P2|NOT COMPLETED|Overall Study||1
5346796|NCT00248040|13154620|P1|NOT COMPLETED|Overall Study||3
5346797|NCT00248040|13154618|P3|COMPLETED|Overall Study||22
5346798|NCT00248040|13154619|P2|COMPLETED|Overall Study||22
5346799|NCT00248040|13154620|P1|COMPLETED|Overall Study||22
5346800|NCT00248040|13154618|P3|STARTED|Overall Study||26
5346801|NCT00248040|13154619|P2|STARTED|Overall Study||23
5346802|NCT00248040|13154620|P1|STARTED|Overall Study||25
5346803|NCT00247962|13154669|P2|NOT COMPLETED|Overall Study||19
5346804|NCT00247962|13154670|P1|NOT COMPLETED|Overall Study||26
5346805|NCT00247962|13154669|P2|COMPLETED|Overall Study||168
5346806|NCT00247962|13154670|P1|COMPLETED|Overall Study||353
5346807|NCT00247962|13154669|P2|STARTED|Overall Study||187
5346808|NCT00247962|13154670|P1|STARTED|Overall Study||379
5346809|NCT00247676|13154678|P1|NOT COMPLETED|Overall Study||36
5346810|NCT00247676|13154678|P1|COMPLETED|Overall Study||1
5346811|NCT00247676|13154678|P1|STARTED|Overall Study||37
5346812|NCT00247624|13154708|P2|NOT COMPLETED|Overall Study||4
5346813|NCT00247624|13154709|P1|NOT COMPLETED|Overall Study||5
5346814|NCT00247624|13154708|P2|COMPLETED|Overall Study||26
5346815|NCT00247624|13154709|P1|COMPLETED|Overall Study||25
5346816|NCT00247624|13154708|P2|STARTED|Overall Study||30
5346817|NCT00247624|13154709|P1|STARTED|Overall Study||30
5346818|NCT00247611|13154723|P2|NOT COMPLETED|On Protocol Sample||125
5346819|NCT00247611|13154724|P1|NOT COMPLETED|On Protocol Sample||111
5346820|NCT00247611|13154723|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
5346821|NCT00247611|13154724|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
5346822|NCT00247611|13154723|P2|STARTED|On Protocol Sample|ITT sample participants|277
5346823|NCT00247611|13154724|P1|STARTED|On Protocol Sample|ITT sample participants|287
5346824|NCT00247611|13154723|P2|NOT COMPLETED|Intention to Treat Sample||13
5346825|NCT00247611|13154724|P1|NOT COMPLETED|Intention to Treat Sample||17
5346826|NCT00247611|13154723|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
5346827|NCT00247611|13154724|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
5346828|NCT00247611|13154723|P2|STARTED|Intention to Treat Sample|Participants randomized|290
5346829|NCT00247611|13154724|P1|STARTED|Intention to Treat Sample|Participants randomized|304
5346830|NCT00247611|13154723|P2|NOT COMPLETED|Baselined||13
5346831|NCT00247611|13154724|P1|NOT COMPLETED|Baselined||17
5346832|NCT00247611|13154723|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
5346833|NCT00247611|13154724|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
5346834|NCT00247611|13154723|P2|STARTED|Baselined|Participants randomized|290
5346835|NCT00247611|13154724|P1|STARTED|Baselined|Participants randomized|304
5346836|NCT00247416|13154742|P2|NOT COMPLETED|Overall Study||2
5346837|NCT00247416|13154743|P1|NOT COMPLETED|Overall Study||1
5346838|NCT00247416|13154742|P2|COMPLETED|Overall Study||31
5346839|NCT00247416|13154743|P1|COMPLETED|Overall Study||25
5346840|NCT00247416|13154742|P2|STARTED|Overall Study||33
5346841|NCT00247416|13154743|P1|STARTED|Overall Study||26
5346842|NCT00247377|13154757|P2|NOT COMPLETED|Overall Study||0
5346843|NCT00247377|13154758|P1|NOT COMPLETED|Overall Study||0
5346844|NCT00247377|13154757|P2|COMPLETED|Overall Study||86
5346845|NCT00247377|13154758|P1|COMPLETED|Overall Study||111
5346846|NCT00247377|13154757|P2|STARTED|Overall Study||86
5346847|NCT00247377|13154758|P1|STARTED|Overall Study||111
5346848|NCT00247273|13154784|P2|NOT COMPLETED|Overall Study||137
5346849|NCT00247273|13154785|P1|NOT COMPLETED|Overall Study||146
5346850|NCT00247273|13154784|P2|COMPLETED|Overall Study||513
5346851|NCT00247273|13154785|P1|COMPLETED|Overall Study||498
5346852|NCT00247273|13154784|P2|Intent to Treat Population|Overall Study||650
5346853|NCT00247273|13154785|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
5346854|NCT00247273|13154784|P2|STARTED|Overall Study||650
5346855|NCT00247273|13154785|P1|STARTED|Overall Study||644
5346856|NCT00246805|13154831|P2|NOT COMPLETED|Phase 2||0
5346857|NCT00246805|13154832|P1|NOT COMPLETED|Phase 2||0
5346858|NCT00246805|13154831|P2|COMPLETED|Phase 2||33
5346859|NCT00246805|13154832|P1|COMPLETED|Phase 2||33
5346860|NCT00246805|13154831|P2|STARTED|Phase 2||33
5346861|NCT00246805|13154832|P1|STARTED|Phase 2||33
5346862|NCT00246805|13154831|P2|NOT COMPLETED|Phase 1||0
5346863|NCT00246805|13154832|P1|NOT COMPLETED|Phase 1||1
5346864|NCT00246805|13154831|P2|COMPLETED|Phase 1||33
5346865|NCT00246805|13154832|P1|COMPLETED|Phase 1||33
5346866|NCT00246805|13154831|P2|STARTED|Phase 1||33
5346867|NCT00246805|13154832|P1|STARTED|Phase 1||34
5346868|NCT00246753|13154838|P1|NOT COMPLETED|Overall Study||8
5346869|NCT00246753|13154838|P1|COMPLETED|Overall Study||21
5346870|NCT00246753|13154838|P1|STARTED|Overall Study||29
5346871|NCT00246740|13154846|P2|NOT COMPLETED|Experimental Phase||0
5346872|NCT00246740|13154847|P1|NOT COMPLETED|Experimental Phase||0
5346873|NCT00246740|13154846|P2|COMPLETED|Experimental Phase||20
5346874|NCT00246740|13154847|P1|COMPLETED|Experimental Phase||22
5346875|NCT00246740|13154846|P2|STARTED|Experimental Phase||20
5346876|NCT00246740|13154847|P1|STARTED|Experimental Phase||22
5346877|NCT00246740|13154846|P2|NOT COMPLETED|Initial Enrollment||8
5346878|NCT00246740|13154847|P1|NOT COMPLETED|Initial Enrollment||6
5346879|NCT00246740|13154846|P2|COMPLETED|Initial Enrollment||20
5346880|NCT00246740|13154847|P1|COMPLETED|Initial Enrollment||22
5346881|NCT00246740|13154846|P2|STARTED|Initial Enrollment||28
5346882|NCT00246740|13154847|P1|STARTED|Initial Enrollment||28
5346883|NCT00246571|13154871|P2|NOT COMPLETED|Overall Study||104
5346884|NCT00246571|13154872|P1|NOT COMPLETED|Overall Study||113
5346885|NCT00246571|13154871|P2|COMPLETED|Overall Study||0
5346886|NCT00246571|13154872|P1|COMPLETED|Overall Study||0
5346887|NCT00246571|13154871|P2|Randomized But Not Treated|Overall Study||1
5346888|NCT00246571|13154872|P1|Randomized But Not Treated|Overall Study||3
5346889|NCT00246571|13154871|P2|STARTED|Overall Study||104
5346890|NCT00246571|13154872|P1|STARTED|Overall Study||113
5346891|NCT00246519|13154912|P2|NOT COMPLETED|Overall Study||64
5346892|NCT00246519|13154913|P1|NOT COMPLETED|Overall Study||56
5346893|NCT00246519|13154912|P2|COMPLETED|Overall Study||382
5346894|NCT00246519|13154913|P1|COMPLETED|Overall Study||386
5346895|NCT00246519|13154912|P2|STARTED|Overall Study||446
5346896|NCT00246519|13154913|P1|STARTED|Overall Study||442
5346897|NCT00246441|13154921|P2|NOT COMPLETED|Overall Study||0
5346898|NCT00246441|13154922|P1|NOT COMPLETED|Overall Study||1
5346899|NCT00246441|13154921|P2|COMPLETED|Overall Study||22
5346900|NCT00246441|13154922|P1|COMPLETED|Overall Study||19
5346901|NCT00246441|13154921|P2|STARTED|Overall Study||22
5346902|NCT00246441|13154922|P1|STARTED|Overall Study||20
5346903|NCT00246376|13154937|P5|NOT COMPLETED|Overall Study||17
5346904|NCT00246376|13154938|P4|NOT COMPLETED|Overall Study||26
5346905|NCT00246376|13154939|P3|NOT COMPLETED|Overall Study||16
5346906|NCT00246376|13154940|P2|NOT COMPLETED|Overall Study||19
5346907|NCT00246376|13154941|P1|NOT COMPLETED|Overall Study||15
5346908|NCT00246376|13154937|P5|COMPLETED|Overall Study||28
5346909|NCT00246376|13154938|P4|COMPLETED|Overall Study||21
5346910|NCT00246376|13154939|P3|COMPLETED|Overall Study||29
5346911|NCT00246376|13154940|P2|COMPLETED|Overall Study||24
5346912|NCT00246376|13154941|P1|COMPLETED|Overall Study||26
5346913|NCT00246376|13154937|P5|After Dietary run-in at Two Weeks|Overall Study||42
5346914|NCT00246376|13154938|P4|After Dietary run-in at Two Weeks|Overall Study||40
5346915|NCT00246376|13154939|P3|After Dietary run-in at Two Weeks|Overall Study||41
5346916|NCT00246376|13154940|P2|After Dietary run-in at Two Weeks|Overall Study||38
5346917|NCT00246376|13154941|P1|After Dietary run-in at Two Weeks|Overall Study||30
5346918|NCT00246376|13154937|P5|STARTED|Overall Study||45
5346919|NCT00246376|13154938|P4|STARTED|Overall Study||47
5346920|NCT00246376|13154939|P3|STARTED|Overall Study||45
5346921|NCT00246376|13154940|P2|STARTED|Overall Study||43
5346922|NCT00246376|13154941|P1|STARTED|Overall Study||41
5346923|NCT00246337|13154992|P9|NOT COMPLETED|Overall Study||11
5346924|NCT00246337|13154993|P8|NOT COMPLETED|Overall Study||13
5346925|NCT00246337|13154994|P7|NOT COMPLETED|Overall Study||9
5346926|NCT00246337|13154995|P6|NOT COMPLETED|Overall Study||15
5346927|NCT00246337|13154996|P5|NOT COMPLETED|Overall Study||4
5346928|NCT00246337|13154997|P4|NOT COMPLETED|Overall Study||1
5346929|NCT00246337|13154998|P3|NOT COMPLETED|Overall Study||3
5346930|NCT00246337|13154999|P2|NOT COMPLETED|Overall Study||2
5346931|NCT00246337|13155000|P1|NOT COMPLETED|Overall Study||32
5346932|NCT00246337|13154992|P9|COMPLETED|Overall Study||34
5346933|NCT00246337|13154993|P8|COMPLETED|Overall Study||40
5346934|NCT00246337|13154994|P7|COMPLETED|Overall Study||45
5346935|NCT00246337|13154995|P6|COMPLETED|Overall Study||39
5346936|NCT00246337|13154996|P5|COMPLETED|Overall Study||12
5346937|NCT00246337|13154997|P4|COMPLETED|Overall Study||16
5346938|NCT00246337|13154998|P3|COMPLETED|Overall Study||15
5346939|NCT00246337|13154999|P2|COMPLETED|Overall Study||14
5346940|NCT00246337|13155000|P1|COMPLETED|Overall Study||115
5346941|NCT00246337|13154992|P9|Completed Period (Both Doses)|Overall Study||15
5346942|NCT00246337|13154993|P8|Completed Period (Both Doses)|Overall Study||13
5346943|NCT00246337|13154994|P7|Completed Period (Both Doses)|Overall Study||16
5346944|NCT00246337|13154995|P6|Completed Period (Both Doses)|Overall Study||10
5346945|NCT00246337|13154996|P5|Completed Period (Both Doses)|Overall Study||4
5346946|NCT00246337|13154997|P4|Completed Period (Both Doses)|Overall Study||11
5346947|NCT00246337|13154998|P3|Completed Period (Both Doses)|Overall Study||6
5346948|NCT00246337|13154999|P2|Completed Period (Both Doses)|Overall Study||10
5346949|NCT00246337|13155000|P1|Completed Period (Both Doses)|Overall Study||69
5346950|NCT00246337|13154992|P9|Completed Period (Initial Dose)|Overall Study||19
5346951|NCT00246337|13154993|P8|Completed Period (Initial Dose)|Overall Study||27
5346952|NCT00246337|13154994|P7|Completed Period (Initial Dose)|Overall Study||29
5346953|NCT00246337|13154995|P6|Completed Period (Initial Dose)|Overall Study||29
5346954|NCT00246337|13154996|P5|Completed Period (Initial Dose)|Overall Study||8
5346955|NCT00246337|13154997|P4|Completed Period (Initial Dose)|Overall Study||5
5346956|NCT00246337|13154998|P3|Completed Period (Initial Dose)|Overall Study||9
5346957|NCT00246337|13154999|P2|Completed Period (Initial Dose)|Overall Study||4
5346958|NCT00246337|13155000|P1|Completed Period (Initial Dose)|Overall Study||46
5346959|NCT00246337|13154992|P9|STARTED|Overall Study||45
5346960|NCT00246337|13154993|P8|STARTED|Overall Study||53
5346961|NCT00246337|13154994|P7|STARTED|Overall Study||54
5346962|NCT00246337|13154995|P6|STARTED|Overall Study||54
5346963|NCT00246337|13154996|P5|STARTED|Overall Study||16
5346964|NCT00246337|13154997|P4|STARTED|Overall Study||17
5346965|NCT00246337|13154998|P3|STARTED|Overall Study||18
5346966|NCT00246337|13154999|P2|STARTED|Overall Study||16
5346967|NCT00246337|13155000|P1|STARTED|Overall Study||147
5346968|NCT00246324|13155047|P1|NOT COMPLETED|Overall Study||1
5346969|NCT00246324|13155047|P1|COMPLETED|Overall Study||15
5346970|NCT00246324|13155047|P1|STARTED|Overall Study||16
5346971|NCT00246259|13155054|P2|NOT COMPLETED|Overall Study||26
5346972|NCT00246259|13155055|P1|NOT COMPLETED|Overall Study||28
5346973|NCT00246259|13155054|P2|COMPLETED|Overall Study||15
5346974|NCT00246259|13155055|P1|COMPLETED|Overall Study||16
5346975|NCT00246259|13155054|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
5346976|NCT00246259|13155055|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
5346977|NCT00246259|13155054|P2|STARTED|Overall Study||41
5346978|NCT00246259|13155055|P1|STARTED|Overall Study||44
5346979|NCT00246090|13155089|P1|NOT COMPLETED|Overall Study||295
5346980|NCT00246090|13155089|P1|COMPLETED|Overall Study||3
5346981|NCT00246090|13155089|P1|STARTED|Overall Study||298
5346982|NCT00246025|13155098|P4|NOT COMPLETED|Overall Study||13
5346983|NCT00246025|13155099|P3|NOT COMPLETED|Overall Study||10
5346984|NCT00246025|13155100|P2|NOT COMPLETED|Overall Study||9
5346985|NCT00246025|13155101|P1|NOT COMPLETED|Overall Study||10
5346986|NCT00246025|13155098|P4|COMPLETED|Overall Study||116
5346987|NCT00246025|13155099|P3|COMPLETED|Overall Study||116
5346988|NCT00246025|13155100|P2|COMPLETED|Overall Study||124
5346989|NCT00246025|13155101|P1|COMPLETED|Overall Study||114
5346990|NCT00246025|13155098|P4|STARTED|Overall Study||129
5346991|NCT00246025|13155099|P3|STARTED|Overall Study||126
5346992|NCT00246025|13155100|P2|STARTED|Overall Study||133
5346993|NCT00246025|13155101|P1|STARTED|Overall Study||124
5346994|NCT00246012|13155160|P9|NOT COMPLETED|Overall Study||28
5346995|NCT00246012|13155161|P8|NOT COMPLETED|Overall Study||28
5346996|NCT00246012|13155162|P7|NOT COMPLETED|Overall Study||31
5346997|NCT00246012|13155163|P6|NOT COMPLETED|Overall Study||28
5346998|NCT00246012|13155164|P5|NOT COMPLETED|Overall Study||3
5346999|NCT00246012|13155165|P4|NOT COMPLETED|Overall Study||3
5347000|NCT00246012|13155166|P3|NOT COMPLETED|Overall Study||2
5347001|NCT00246012|13155167|P2|NOT COMPLETED|Overall Study||1
5347002|NCT00246012|13155168|P1|NOT COMPLETED|Overall Study||3
5347003|NCT00246012|13155160|P9|COMPLETED|Overall Study||4
5347004|NCT00246012|13155161|P8|COMPLETED|Overall Study||5
5347005|NCT00246012|13155162|P7|COMPLETED|Overall Study||1
5347006|NCT00246012|13155163|P6|COMPLETED|Overall Study||4
5347007|NCT00246012|13155164|P5|COMPLETED|Overall Study||0
5347008|NCT00246012|13155165|P4|COMPLETED|Overall Study||0
5347009|NCT00246012|13155166|P3|COMPLETED|Overall Study||1
5347010|NCT00246012|13155167|P2|COMPLETED|Overall Study||2
5347011|NCT00246012|13155168|P1|COMPLETED|Overall Study||0
5347012|NCT00246012|13155160|P9|Treated|Overall Study||32
5347013|NCT00246012|13155161|P8|Treated|Overall Study||33
5347014|NCT00246012|13155162|P7|Treated|Overall Study||31
5347015|NCT00246012|13155163|P6|Treated|Overall Study||31
5347016|NCT00246012|13155164|P5|Treated|Overall Study||3
5347017|NCT00246012|13155165|P4|Treated|Overall Study||3
5347018|NCT00246012|13155166|P3|Treated|Overall Study||3
5347019|NCT00246012|13155167|P2|Treated|Overall Study||3
5347020|NCT00246012|13155168|P1|Treated|Overall Study||3
5347021|NCT00246012|13155160|P9|STARTED|Overall Study||32
5347022|NCT00246012|13155161|P8|STARTED|Overall Study||33
5347023|NCT00246012|13155162|P7|STARTED|Overall Study||32
5347024|NCT00246012|13155163|P6|STARTED|Overall Study||32
5347025|NCT00246012|13155164|P5|STARTED|Overall Study||3
5347026|NCT00246012|13155165|P4|STARTED|Overall Study||3
5347027|NCT00246012|13155166|P3|STARTED|Overall Study||3
5347028|NCT00246012|13155167|P2|STARTED|Overall Study||3
5347029|NCT00246012|13155168|P1|STARTED|Overall Study||3
5347030|NCT00245960|13155263|P2|NOT COMPLETED|Overall Study||28
5347031|NCT00245960|13155264|P1|NOT COMPLETED|Overall Study||29
5347032|NCT00245960|13155263|P2|COMPLETED|Overall Study||345
5347033|NCT00245960|13155264|P1|COMPLETED|Overall Study||350
5347034|NCT00245960|13155263|P2|STARTED|Overall Study||373
5347035|NCT00245960|13155264|P1|STARTED|Overall Study||379
5347036|NCT00245856|13155272|P2|NOT COMPLETED|Period Two||1
5347037|NCT00245856|13155273|P1|NOT COMPLETED|Period Two||0
5347038|NCT00245856|13155272|P2|COMPLETED|Period Two||38
5347039|NCT00245856|13155273|P1|COMPLETED|Period Two||0
5347040|NCT00245856|13155272|P2|STARTED|Period Two||39
5347041|NCT00245856|13155273|P1|STARTED|Period Two||0
5347042|NCT00245856|13155272|P2|NOT COMPLETED|Period One||0
5347043|NCT00245856|13155273|P1|NOT COMPLETED|Period One||0
5347044|NCT00245856|13155272|P2|COMPLETED|Period One||0
5347045|NCT00245856|13155273|P1|COMPLETED|Period One||28
5347046|NCT00245856|13155272|P2|STARTED|Period One||0
5347047|NCT00245856|13155273|P1|STARTED|Period One||28
5347048|NCT00245765|13155283|P3|NOT COMPLETED|Overall Study||8
5347049|NCT00245765|13155284|P2|NOT COMPLETED|Overall Study||14
5347050|NCT00245765|13155285|P1|NOT COMPLETED|Overall Study||32
5347051|NCT00245765|13155283|P3|COMPLETED|Overall Study||50
5347052|NCT00245765|13155284|P2|COMPLETED|Overall Study||45
5347053|NCT00245765|13155285|P1|COMPLETED|Overall Study||27
5347054|NCT00245765|13155283|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
5347055|NCT00245765|13155284|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
5347056|NCT00245765|13155285|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
5347057|NCT00245765|13155283|P3|STARTED|Overall Study||58
5347058|NCT00245765|13155284|P2|STARTED|Overall Study||59
5347059|NCT00245765|13155285|P1|STARTED|Overall Study||59
5347060|NCT00245635|13155325|P2|NOT COMPLETED|Overall Study||0
5347061|NCT00245635|13155326|P1|NOT COMPLETED|Overall Study||0
5347062|NCT00245635|13155325|P2|COMPLETED|Overall Study||18
5347063|NCT00245635|13155326|P1|COMPLETED|Overall Study||25
5347064|NCT00245635|13155325|P2|STARTED|Overall Study||18
5347065|NCT00245635|13155326|P1|STARTED|Overall Study||25
5347066|NCT00245583|13155334|P2|NOT COMPLETED|Overall Study||9
5347067|NCT00245583|13155335|P1|NOT COMPLETED|Overall Study||6
5347068|NCT00245583|13155334|P2|COMPLETED|Overall Study||13
5347069|NCT00245583|13155335|P1|COMPLETED|Overall Study||14
5347070|NCT00245583|13155334|P2|STARTED|Overall Study||22
5347071|NCT00245583|13155335|P1|STARTED|Overall Study||20
5347072|NCT00245570|13155355|P6|NOT COMPLETED|Treatment Period IV||0
5347073|NCT00245570|13155356|P5|NOT COMPLETED|Treatment Period IV||0
5347074|NCT00245570|13155357|P4|NOT COMPLETED|Treatment Period IV||0
5347075|NCT00245570|13155358|P3|NOT COMPLETED|Treatment Period IV||0
5347076|NCT00245570|13155359|P2|NOT COMPLETED|Treatment Period IV||0
5347077|NCT00245570|13155360|P1|NOT COMPLETED|Treatment Period IV||0
5347078|NCT00245570|13155355|P6|COMPLETED|Treatment Period IV||8
5347079|NCT00245570|13155356|P5|COMPLETED|Treatment Period IV||8
5347080|NCT00245570|13155357|P4|COMPLETED|Treatment Period IV||8
5347081|NCT00245570|13155358|P3|COMPLETED|Treatment Period IV||8
5347082|NCT00245570|13155359|P2|COMPLETED|Treatment Period IV||7
5347083|NCT00245570|13155360|P1|COMPLETED|Treatment Period IV||7
5347084|NCT00245570|13155355|P6|STARTED|Treatment Period IV||8
5347085|NCT00245570|13155356|P5|STARTED|Treatment Period IV||8
5347086|NCT00245570|13155357|P4|STARTED|Treatment Period IV||8
5347087|NCT00245570|13155358|P3|STARTED|Treatment Period IV||8
5347088|NCT00245570|13155359|P2|STARTED|Treatment Period IV||7
5347089|NCT00245570|13155360|P1|STARTED|Treatment Period IV||7
5347090|NCT00245570|13155355|P6|NOT COMPLETED|Washout Between Periods III and IV||0
5347091|NCT00245570|13155356|P5|NOT COMPLETED|Washout Between Periods III and IV||0
5347092|NCT00245570|13155357|P4|NOT COMPLETED|Washout Between Periods III and IV||0
5347093|NCT00245570|13155358|P3|NOT COMPLETED|Washout Between Periods III and IV||0
5347094|NCT00245570|13155359|P2|NOT COMPLETED|Washout Between Periods III and IV||1
5347095|NCT00245570|13155360|P1|NOT COMPLETED|Washout Between Periods III and IV||0
5347096|NCT00245570|13155355|P6|COMPLETED|Washout Between Periods III and IV||8
5347097|NCT00245570|13155356|P5|COMPLETED|Washout Between Periods III and IV||8
5347098|NCT00245570|13155357|P4|COMPLETED|Washout Between Periods III and IV||8
5347099|NCT00245570|13155358|P3|COMPLETED|Washout Between Periods III and IV||8
5347100|NCT00245570|13155359|P2|COMPLETED|Washout Between Periods III and IV||7
5347101|NCT00245570|13155360|P1|COMPLETED|Washout Between Periods III and IV||7
5347102|NCT00245570|13155355|P6|STARTED|Washout Between Periods III and IV||8
5347103|NCT00245570|13155356|P5|STARTED|Washout Between Periods III and IV||8
5347104|NCT00245570|13155357|P4|STARTED|Washout Between Periods III and IV||8
5347105|NCT00245570|13155358|P3|STARTED|Washout Between Periods III and IV||8
5347106|NCT00245570|13155359|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
5347107|NCT00245570|13155360|P1|STARTED|Washout Between Periods III and IV||7
5347108|NCT00245570|13155355|P6|NOT COMPLETED|Treatment Period III||0
5347109|NCT00245570|13155356|P5|NOT COMPLETED|Treatment Period III||0
5347110|NCT00245570|13155357|P4|NOT COMPLETED|Treatment Period III||0
5347111|NCT00245570|13155358|P3|NOT COMPLETED|Treatment Period III||0
5347112|NCT00245570|13155359|P2|NOT COMPLETED|Treatment Period III||0
5347113|NCT00245570|13155360|P1|NOT COMPLETED|Treatment Period III||0
5347114|NCT00245570|13155355|P6|COMPLETED|Treatment Period III||8
5347115|NCT00245570|13155356|P5|COMPLETED|Treatment Period III||8
5347116|NCT00245570|13155357|P4|COMPLETED|Treatment Period III||8
5347117|NCT00245570|13155358|P3|COMPLETED|Treatment Period III||8
5347118|NCT00245570|13155359|P2|COMPLETED|Treatment Period III||8
5347119|NCT00245570|13155360|P1|COMPLETED|Treatment Period III||7
5347120|NCT00245570|13155355|P6|STARTED|Treatment Period III||8
5347121|NCT00245570|13155356|P5|STARTED|Treatment Period III||8
5347122|NCT00245570|13155357|P4|STARTED|Treatment Period III||8
5347123|NCT00245570|13155358|P3|STARTED|Treatment Period III||8
5347124|NCT00245570|13155359|P2|STARTED|Treatment Period III||8
5347125|NCT00245570|13155360|P1|STARTED|Treatment Period III||7
5347126|NCT00245570|13155355|P6|NOT COMPLETED|Washout Between Periods II and III||0
5347127|NCT00245570|13155356|P5|NOT COMPLETED|Washout Between Periods II and III||0
5347128|NCT00245570|13155357|P4|NOT COMPLETED|Washout Between Periods II and III||0
5347129|NCT00245570|13155358|P3|NOT COMPLETED|Washout Between Periods II and III||0
5347130|NCT00245570|13155359|P2|NOT COMPLETED|Washout Between Periods II and III||0
5347131|NCT00245570|13155360|P1|NOT COMPLETED|Washout Between Periods II and III||0
5347132|NCT00245570|13155355|P6|COMPLETED|Washout Between Periods II and III||8
5347133|NCT00245570|13155356|P5|COMPLETED|Washout Between Periods II and III||8
5347134|NCT00245570|13155357|P4|COMPLETED|Washout Between Periods II and III||8
5347135|NCT00245570|13155358|P3|COMPLETED|Washout Between Periods II and III||8
5347136|NCT00245570|13155359|P2|COMPLETED|Washout Between Periods II and III||8
5347137|NCT00245570|13155360|P1|COMPLETED|Washout Between Periods II and III||7
5347138|NCT00245570|13155355|P6|STARTED|Washout Between Periods II and III||8
5347139|NCT00245570|13155356|P5|STARTED|Washout Between Periods II and III||8
5347140|NCT00245570|13155357|P4|STARTED|Washout Between Periods II and III||8
5347141|NCT00245570|13155358|P3|STARTED|Washout Between Periods II and III||8
5347142|NCT00245570|13155359|P2|STARTED|Washout Between Periods II and III||8
5347143|NCT00245570|13155360|P1|STARTED|Washout Between Periods II and III||7
5347144|NCT00245570|13155355|P6|NOT COMPLETED|Treatment Period II||0
5347145|NCT00245570|13155356|P5|NOT COMPLETED|Treatment Period II||0
5347146|NCT00245570|13155357|P4|NOT COMPLETED|Treatment Period II||0
5347147|NCT00245570|13155358|P3|NOT COMPLETED|Treatment Period II||0
5347148|NCT00245570|13155359|P2|NOT COMPLETED|Treatment Period II||0
5347149|NCT00245570|13155360|P1|NOT COMPLETED|Treatment Period II||0
5347150|NCT00245570|13155355|P6|COMPLETED|Treatment Period II||8
5347151|NCT00245570|13155356|P5|COMPLETED|Treatment Period II||8
5347152|NCT00245570|13155357|P4|COMPLETED|Treatment Period II||8
5347153|NCT00245570|13155358|P3|COMPLETED|Treatment Period II||8
5347154|NCT00245570|13155359|P2|COMPLETED|Treatment Period II||8
5347155|NCT00245570|13155360|P1|COMPLETED|Treatment Period II||7
5347156|NCT00245570|13155355|P6|STARTED|Treatment Period II||8
5347157|NCT00245570|13155356|P5|STARTED|Treatment Period II||8
5347158|NCT00245570|13155357|P4|STARTED|Treatment Period II||8
5347159|NCT00245570|13155358|P3|STARTED|Treatment Period II||8
5347160|NCT00245570|13155359|P2|STARTED|Treatment Period II||8
5347161|NCT00245570|13155360|P1|STARTED|Treatment Period II||7
5347162|NCT00245557|13155406|P2|NOT COMPLETED|Overall Study||16
5347163|NCT00245557|13155407|P1|NOT COMPLETED|Overall Study||6
5347164|NCT00245557|13155406|P2|COMPLETED|Overall Study||10
5347165|NCT00245557|13155407|P1|COMPLETED|Overall Study||11
5347166|NCT00245557|13155406|P2|STARTED|Overall Study||26
5347167|NCT00245557|13155407|P1|STARTED|Overall Study||17
5347168|NCT00245518|13155420|P2|NOT COMPLETED|Overall Study||0
5347169|NCT00245518|13155421|P1|NOT COMPLETED|Overall Study||0
5347170|NCT00245518|13155420|P2|COMPLETED|Overall Study||16
5347171|NCT00245518|13155421|P1|COMPLETED|Overall Study||17
5347172|NCT00245518|13155420|P2|STARTED|Overall Study||16
5347173|NCT00245518|13155421|P1|STARTED|Overall Study||17
5347174|NCT00245466|13155494|P3|NOT COMPLETED|Overall Study||37
5347175|NCT00245466|13155495|P2|NOT COMPLETED|Overall Study||44
5347176|NCT00245466|13155496|P1|NOT COMPLETED|Overall Study||36
5347177|NCT00245466|13155494|P3|COMPLETED|Overall Study||3
5347178|NCT00245466|13155495|P2|COMPLETED|Overall Study||2
5347179|NCT00245466|13155496|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
5347180|NCT00245466|13155494|P3|Started FE200486 CS02A|Overall Study||26
5347181|NCT00245466|13155495|P2|Started FE200486 CS02A|Overall Study||30
5347182|NCT00245466|13155496|P1|Started FE200486 CS02A|Overall Study||32
5347183|NCT00245466|13155494|P3|STARTED|Overall Study||40
5347184|NCT00245466|13155495|P2|STARTED|Overall Study||46
5347185|NCT00245466|13155496|P1|STARTED|Overall Study||43
5347186|NCT00245219|13155513|P3|NOT COMPLETED|Overall Study||2
5347187|NCT00245219|13155514|P2|NOT COMPLETED|Overall Study||6
5347188|NCT00245219|13155515|P1|NOT COMPLETED|Overall Study||6
5347189|NCT00245219|13155513|P3|COMPLETED|Overall Study||58
5347190|NCT00245219|13155514|P2|COMPLETED|Overall Study||88
5347191|NCT00245219|13155515|P1|COMPLETED|Overall Study||85
5347192|NCT00245219|13155513|P3|STARTED|Overall Study||60
5347193|NCT00245219|13155514|P2|STARTED|Overall Study||94
5347194|NCT00245219|13155515|P1|STARTED|Overall Study||91
5347195|NCT00245128|13155529|P1|NOT COMPLETED|Overall Study||10
5347196|NCT00245128|13155529|P1|COMPLETED|Overall Study||0
5347197|NCT00245128|13155529|P1|STARTED|Overall Study||10
5347198|NCT00245102|13155539|P6|NOT COMPLETED|Overall Study||4
5347199|NCT00245102|13155540|P5|NOT COMPLETED|Overall Study||0
5347200|NCT00245102|13155541|P4|NOT COMPLETED|Overall Study||3
5347201|NCT00245102|13155542|P3|NOT COMPLETED|Overall Study||7
5347202|NCT00245102|13155543|P2|NOT COMPLETED|Overall Study||4
5347203|NCT00245102|13155544|P1|NOT COMPLETED|Overall Study||7
5347204|NCT00245102|13155539|P6|COMPLETED|Overall Study||19
5347205|NCT00245102|13155540|P5|COMPLETED|Overall Study||5
5347206|NCT00245102|13155541|P4|COMPLETED|Overall Study||10
5347207|NCT00245102|13155542|P3|COMPLETED|Overall Study||39
5347208|NCT00245102|13155543|P2|COMPLETED|Overall Study||12
5347209|NCT00245102|13155544|P1|COMPLETED|Overall Study||37
5347210|NCT00245102|13155539|P6|STARTED|Overall Study||23
5347211|NCT00245102|13155540|P5|STARTED|Overall Study||5
5347212|NCT00245102|13155541|P4|STARTED|Overall Study||13
5347213|NCT00245102|13155542|P3|STARTED|Overall Study||46
5347214|NCT00245102|13155543|P2|STARTED|Overall Study||16
5347215|NCT00245102|13155544|P1|STARTED|Overall Study||44
5347216|NCT00245063|13155560|P2|NOT COMPLETED|Overall Study||5
5347217|NCT00245063|13155561|P1|NOT COMPLETED|Overall Study||7
5347218|NCT00245063|13155560|P2|COMPLETED|Overall Study||8
5347219|NCT00245063|13155561|P1|COMPLETED|Overall Study||5
5347220|NCT00245063|13155560|P2|STARTED|Overall Study||13
5347221|NCT00245063|13155561|P1|STARTED|Overall Study||12
5347222|NCT00245050|13155569|P2|NOT COMPLETED|Overall Study||2
5347223|NCT00245050|13155570|P1|NOT COMPLETED|Overall Study||3
5347224|NCT00245050|13155569|P2|COMPLETED|Overall Study||14
5347225|NCT00245050|13155570|P1|COMPLETED|Overall Study||15
5347226|NCT00245050|13155569|P2|STARTED|Overall Study||16
5347227|NCT00245050|13155570|P1|STARTED|Overall Study||18
5347228|NCT00245037|13155578|P1|NOT COMPLETED|Overall Study||17
5347229|NCT00245037|13155578|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
5347230|NCT00245037|13155578|P1|STARTED|Overall Study||147
5347231|NCT00245011|13155588|P1|NOT COMPLETED|Overall Study||1
5347232|NCT00245011|13155588|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
5347233|NCT00245011|13155588|P1|STARTED|Overall Study||11
5347234|NCT00244985|13155597|P1|NOT COMPLETED|Overall Study||0
5347235|NCT00244985|13155597|P1|COMPLETED|Overall Study||42
5347236|NCT00244985|13155597|P1|STARTED|Overall Study||42
5347237|NCT00244933|13155605|P1|NOT COMPLETED|Overall Study||2
5347238|NCT00244933|13155605|P1|COMPLETED|Overall Study||17
5347239|NCT00244933|13155605|P1|STARTED|Overall Study||19
5347240|NCT00244881|13155609|P1|NOT COMPLETED|Overall Study||3
5347241|NCT00244881|13155609|P1|COMPLETED|Overall Study||23
5347242|NCT00244881|13155609|P1|STARTED|Overall Study||26
5347243|NCT00244855|13155617|P2|NOT COMPLETED|Overall Study||1
5347244|NCT00244855|13155618|P1|NOT COMPLETED|Overall Study||0
5347245|NCT00244855|13155617|P2|COMPLETED|Overall Study||24
5347246|NCT00244855|13155618|P1|COMPLETED|Overall Study||7
5347247|NCT00244855|13155617|P2|STARTED|Overall Study||25
5347248|NCT00244855|13155618|P1|STARTED|Overall Study||7
5347249|NCT00244764|13155626|P1|NOT COMPLETED|Overall Study||96
5347250|NCT00244764|13155626|P1|COMPLETED|Overall Study||129
5347251|NCT00244764|13155626|P1|STARTED|Overall Study||225
5347252|NCT00244751|13155636|P3|NOT COMPLETED|Overall Study||10
5347253|NCT00244751|13155637|P2|NOT COMPLETED|Overall Study||15
5347254|NCT00244751|13155638|P1|NOT COMPLETED|Overall Study||16
5347255|NCT00244751|13155636|P3|COMPLETED|Overall Study||78
5347256|NCT00244751|13155637|P2|COMPLETED|Overall Study||74
5347257|NCT00244751|13155638|P1|COMPLETED|Overall Study||72
5347258|NCT00244751|13155636|P3|STARTED|Overall Study||88
5347259|NCT00244751|13155637|P2|STARTED|Overall Study||89
5347260|NCT00244751|13155638|P1|STARTED|Overall Study||88
5347261|NCT00244725|13155739|P4|NOT COMPLETED|Overall Study||21
5347262|NCT00244725|13155740|P3|NOT COMPLETED|Overall Study||24
5347263|NCT00244725|13155741|P2|NOT COMPLETED|Overall Study||19
5347264|NCT00244725|13155742|P1|NOT COMPLETED|Overall Study||23
5347265|NCT00244725|13155739|P4|COMPLETED|Overall Study||216
5347266|NCT00244725|13155740|P3|COMPLETED|Overall Study||215
5347267|NCT00244725|13155741|P2|COMPLETED|Overall Study||226
5347268|NCT00244725|13155742|P1|COMPLETED|Overall Study||214
5347269|NCT00244725|13155739|P4|STARTED|Overall Study||237
5347270|NCT00244725|13155740|P3|STARTED|Overall Study||239
5347271|NCT00244725|13155741|P2|STARTED|Overall Study||245
5347272|NCT00244725|13155742|P1|STARTED|Overall Study||237
5347273|NCT00244712|13155798|P2|NOT COMPLETED|Overall Study||124
5347274|NCT00244712|13155799|P1|NOT COMPLETED|Overall Study||109
5347275|NCT00244712|13155798|P2|COMPLETED|Overall Study||221
5347276|NCT00244712|13155799|P1|COMPLETED|Overall Study||234
5347277|NCT00244712|13155798|P2|STARTED|Overall Study||345
5347278|NCT00244712|13155799|P1|STARTED|Overall Study||343
5347279|NCT00244621|13155834|P3|NOT COMPLETED|Open-label Treatment Period||2
5347280|NCT00244621|13155835|P2|NOT COMPLETED|Open-label Treatment Period||1
5347281|NCT00244621|13155836|P1|NOT COMPLETED|Open-label Treatment Period||1
5347282|NCT00244621|13155834|P3|COMPLETED|Open-label Treatment Period||28
5347283|NCT00244621|13155835|P2|COMPLETED|Open-label Treatment Period||28
5347284|NCT00244621|13155836|P1|COMPLETED|Open-label Treatment Period||25
5347285|NCT00244621|13155834|P3|STARTED|Open-label Treatment Period||30
5347286|NCT00244621|13155835|P2|STARTED|Open-label Treatment Period||29
5347287|NCT00244621|13155836|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
5347288|NCT00244621|13155834|P3|NOT COMPLETED|Double-blind Treatment Period||2
5347289|NCT00244621|13155835|P2|NOT COMPLETED|Double-blind Treatment Period||3
5347290|NCT00244621|13155836|P1|NOT COMPLETED|Double-blind Treatment Period||2
5347291|NCT00244621|13155834|P3|COMPLETED|Double-blind Treatment Period||30
5347292|NCT00244621|13155835|P2|COMPLETED|Double-blind Treatment Period||29
5347293|NCT00244621|13155836|P1|COMPLETED|Double-blind Treatment Period||27
5347294|NCT00244621|13155834|P3|STARTED|Double-blind Treatment Period||32
5347295|NCT00244621|13155835|P2|STARTED|Double-blind Treatment Period||32
5347296|NCT00244621|13155836|P1|STARTED|Double-blind Treatment Period||29
5347297|NCT00244374|13155853|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
5347298|NCT00244374|13155854|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
5347299|NCT00244374|13155855|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
5347300|NCT00244374|13155856|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
5347301|NCT00244374|13155857|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
5347302|NCT00244374|13155853|P5|COMPLETED|Vaccine Adherence Cohort||41
5347303|NCT00244374|13155854|P4|COMPLETED|Vaccine Adherence Cohort||36
5347304|NCT00244374|13155855|P3|COMPLETED|Vaccine Adherence Cohort||43
5347305|NCT00244374|13155856|P2|COMPLETED|Vaccine Adherence Cohort||47
5347306|NCT00244374|13155857|P1|COMPLETED|Vaccine Adherence Cohort||0
5347307|NCT00244374|13155853|P5|STARTED|Vaccine Adherence Cohort||41
5347308|NCT00244374|13155854|P4|STARTED|Vaccine Adherence Cohort||36
5347309|NCT00244374|13155855|P3|STARTED|Vaccine Adherence Cohort||43
5347310|NCT00244374|13155856|P2|STARTED|Vaccine Adherence Cohort||47
5347311|NCT00244374|13155857|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
5347312|NCT00244374|13155853|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347313|NCT00244374|13155854|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347314|NCT00244374|13155855|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347315|NCT00244374|13155856|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347316|NCT00244374|13155857|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
5347317|NCT00244374|13155853|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347318|NCT00244374|13155854|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347319|NCT00244374|13155855|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347320|NCT00244374|13155856|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
5347321|NCT00244374|13155857|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
5347322|NCT00244374|13155853|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
5347323|NCT00244374|13155854|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
5347324|NCT00244374|13155855|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
5347325|NCT00244374|13155856|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
5347326|NCT00244374|13155857|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
5347327|NCT00244374|13155853|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
5347328|NCT00244374|13155854|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
5347329|NCT00244374|13155855|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
5347330|NCT00244374|13155856|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
5347331|NCT00244374|13155857|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
5347332|NCT00244374|13155853|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
5347333|NCT00244374|13155854|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
5347334|NCT00244374|13155855|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
5347335|NCT00244374|13155856|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
5347336|NCT00244374|13155857|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
5347337|NCT00244374|13155853|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
5347338|NCT00244374|13155854|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
5347339|NCT00244374|13155855|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
5347340|NCT00244374|13155856|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
5347341|NCT00244374|13155857|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
5347342|NCT00244374|13155853|P5|STARTED|Pre-Randomization Cross-sectional Study||0
5347343|NCT00244374|13155854|P4|STARTED|Pre-Randomization Cross-sectional Study||0
5347344|NCT00244374|13155855|P3|STARTED|Pre-Randomization Cross-sectional Study||0
5347345|NCT00244374|13155856|P2|STARTED|Pre-Randomization Cross-sectional Study||0
5347346|NCT00244374|13155857|P1|STARTED|Pre-Randomization Cross-sectional Study||546
5347347|NCT00244140|13155875|P2|NOT COMPLETED|Overall Study||0
5347348|NCT00244140|13155876|P1|NOT COMPLETED|Overall Study||0
5347349|NCT00244140|13155875|P2|COMPLETED|Overall Study||22
5347350|NCT00244140|13155876|P1|COMPLETED|Overall Study||412
5347351|NCT00244140|13155875|P2|STARTED|Overall Study||22
5347352|NCT00244140|13155876|P1|STARTED|Overall Study||412
5347353|NCT00244101|13155891|P3|NOT COMPLETED|Overall Study||0
5347354|NCT00244101|13155892|P2|NOT COMPLETED|Overall Study||0
5347355|NCT00244101|13155893|P1|NOT COMPLETED|Overall Study||0
5347356|NCT00244101|13155891|P3|COMPLETED|Overall Study||216
5347357|NCT00244101|13155892|P2|COMPLETED|Overall Study||223
5347358|NCT00244101|13155893|P1|COMPLETED|Overall Study||209
5347359|NCT00244101|13155891|P3|STARTED|Overall Study||216
5347360|NCT00244101|13155892|P2|STARTED|Overall Study||223
5347361|NCT00244101|13155893|P1|STARTED|Overall Study||209
5347362|NCT00244010|13155903|P2|NOT COMPLETED|Overall Study||0
5347363|NCT00244010|13155904|P1|NOT COMPLETED|Overall Study||0
5347364|NCT00244010|13155903|P2|COMPLETED|Overall Study||2
5347365|NCT00244010|13155904|P1|COMPLETED|Overall Study||2
5347366|NCT00244010|13155903|P2|STARTED|Overall Study||2
5347367|NCT00244010|13155904|P1|STARTED|Overall Study||2
5347368|NCT00243932|13155913|P3|NOT COMPLETED|Stage 2: Efficacy||0
5347369|NCT00243932|13155914|P2|NOT COMPLETED|Stage 2: Efficacy||0
5347370|NCT00243932|13155915|P1|NOT COMPLETED|Stage 2: Efficacy||0
5347371|NCT00243932|13155913|P3|COMPLETED|Stage 2: Efficacy||0
5347372|NCT00243932|13155914|P2|COMPLETED|Stage 2: Efficacy||40
5347373|NCT00243932|13155915|P1|COMPLETED|Stage 2: Efficacy||40
5347374|NCT00243932|13155913|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
5347375|NCT00243932|13155914|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
5347376|NCT00243932|13155915|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
5347377|NCT00243932|13155913|P3|NOT COMPLETED|Stage 1: Dose Selection||0
5347378|NCT00243932|13155914|P2|NOT COMPLETED|Stage 1: Dose Selection||0
5347379|NCT00243932|13155915|P1|NOT COMPLETED|Stage 1: Dose Selection||2
5347380|NCT00243932|13155913|P3|COMPLETED|Stage 1: Dose Selection||35
5347381|NCT00243932|13155914|P2|COMPLETED|Stage 1: Dose Selection||35
5347382|NCT00243932|13155915|P1|COMPLETED|Stage 1: Dose Selection||33
5347383|NCT00243932|13155913|P3|STARTED|Stage 1: Dose Selection||35
5347384|NCT00243932|13155914|P2|STARTED|Stage 1: Dose Selection||35
5347385|NCT00243932|13155915|P1|STARTED|Stage 1: Dose Selection||35
5347386|NCT00243919|13155926|P3|NOT COMPLETED|Overall Study||11
5347387|NCT00243919|13155927|P2|NOT COMPLETED|Overall Study||18
5347388|NCT00243919|13155928|P1|NOT COMPLETED|Overall Study||17
5347389|NCT00243919|13155926|P3|COMPLETED|Overall Study||115
5347390|NCT00243919|13155927|P2|COMPLETED|Overall Study||125
5347391|NCT00243919|13155928|P1|COMPLETED|Overall Study||122
5347392|NCT00243919|13155926|P3|STARTED|Overall Study||126
5347393|NCT00243919|13155927|P2|STARTED|Overall Study||143
5347394|NCT00243919|13155928|P1|STARTED|Overall Study||139
5347395|NCT00243841|13155972|P6|NOT COMPLETED|Overall Study||2
5347396|NCT00243841|13155973|P5|NOT COMPLETED|Overall Study||0
5347397|NCT00243841|13155974|P4|NOT COMPLETED|Overall Study||0
5347398|NCT00243841|13155975|P3|NOT COMPLETED|Overall Study||1
5347399|NCT00243841|13155976|P2|NOT COMPLETED|Overall Study||0
5347400|NCT00243841|13155977|P1|NOT COMPLETED|Overall Study||0
5347401|NCT00243841|13155972|P6|COMPLETED|Overall Study||19
5347402|NCT00243841|13155973|P5|COMPLETED|Overall Study||39
5347403|NCT00243841|13155974|P4|COMPLETED|Overall Study||3
5347404|NCT00243841|13155975|P3|COMPLETED|Overall Study||4
5347405|NCT00243841|13155976|P2|COMPLETED|Overall Study||6
5347406|NCT00243841|13155977|P1|COMPLETED|Overall Study||3
5347407|NCT00243841|13155972|P6|STARTED|Overall Study||21
5347408|NCT00243841|13155973|P5|STARTED|Overall Study||39
5347409|NCT00243841|13155974|P4|STARTED|Overall Study||3
5347410|NCT00243841|13155975|P3|STARTED|Overall Study||5
5347411|NCT00243841|13155976|P2|STARTED|Overall Study||6
5347412|NCT00243841|13155977|P1|STARTED|Overall Study||3
5347413|NCT00243659|13155999|P2|NOT COMPLETED|Overall Study||3
5347414|NCT00243659|13156000|P1|NOT COMPLETED|Overall Study||2
5347415|NCT00243659|13155999|P2|COMPLETED|Overall Study||5
5347416|NCT00243659|13156000|P1|COMPLETED|Overall Study||20
5347417|NCT00243659|13155999|P2|STARTED|Overall Study||8
5347418|NCT00243659|13156000|P1|STARTED|Overall Study||22
5347419|NCT00243503|13156008|P1|NOT COMPLETED|Overall Study||58
5347420|NCT00243503|13156008|P1|COMPLETED|Overall Study||2
5347421|NCT00243503|13156008|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
5347422|NCT00243412|13156025|P2|NOT COMPLETED|Overall Study||11
5347423|NCT00243412|13156026|P1|NOT COMPLETED|Overall Study||10
5347424|NCT00243412|13156025|P2|COMPLETED|Overall Study|Completed Week 104|10
5347425|NCT00243412|13156026|P1|COMPLETED|Overall Study|Completed Week 104|11
5347426|NCT00243412|13156025|P2|Safety Evaluable|Overall Study||20
5347427|NCT00243412|13156026|P1|Safety Evaluable|Overall Study||21
5347428|NCT00243412|13156025|P2|STARTED|Overall Study|Intent to treat|21
5347429|NCT00243412|13156026|P1|STARTED|Overall Study|Intent to treat|21
5347430|NCT00243386|13156052|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
5347431|NCT00243386|13156053|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
5347432|NCT00243386|13156054|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
5347433|NCT00243386|13156052|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
5347434|NCT00243386|13156053|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
5347435|NCT00243386|13156054|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
5347436|NCT00243386|13156052|P3|STARTED|PK-Driven or Standard Prophylaxis||32
5347437|NCT00243386|13156053|P2|STARTED|PK-Driven or Standard Prophylaxis||34
5347438|NCT00243386|13156054|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
5347439|NCT00243386|13156052|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
5347440|NCT00243386|13156053|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
5347441|NCT00243386|13156054|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
5347442|NCT00243386|13156052|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
5347443|NCT00243386|13156053|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
5347444|NCT00243386|13156054|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
5347445|NCT00243386|13156052|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
5347446|NCT00243386|13156053|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
5347447|NCT00243386|13156054|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
5347448|NCT00243386|13156052|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
5347449|NCT00243386|13156053|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
5347450|NCT00243386|13156054|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
5347451|NCT00243386|13156052|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
5347452|NCT00243386|13156053|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
5347453|NCT00243386|13156054|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
5347454|NCT00243386|13156052|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
5347455|NCT00243386|13156053|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
5347456|NCT00243386|13156054|P1|STARTED|On-Demand Regimen (Study Part 1)||73
5347457|NCT00243347|13156119|P1|NOT COMPLETED|Overall Study||19
5347458|NCT00243347|13156119|P1|COMPLETED|Overall Study|Completed study|0
5347459|NCT00243347|13156119|P1|STARTED|Overall Study|Treated|19
5347460|NCT00243269|13156128|P4|NOT COMPLETED|Overall Study||4
5347461|NCT00243269|13156129|P3|NOT COMPLETED|Overall Study||1
5347462|NCT00243269|13156130|P2|NOT COMPLETED|Overall Study||1
5347463|NCT00243269|13156131|P1|NOT COMPLETED|Overall Study||3
5347464|NCT00243269|13156128|P4|COMPLETED|Overall Study||25
5347465|NCT00243269|13156129|P3|COMPLETED|Overall Study||11
5347466|NCT00243269|13156130|P2|COMPLETED|Overall Study||10
5347467|NCT00243269|13156131|P1|COMPLETED|Overall Study||28
5347468|NCT00243269|13156128|P4|STARTED|Overall Study||29
5347469|NCT00243269|13156129|P3|STARTED|Overall Study||12
5347470|NCT00243269|13156130|P2|STARTED|Overall Study||11
5347471|NCT00243269|13156131|P1|STARTED|Overall Study||31
5347472|NCT00243243|13156147|P2|NOT COMPLETED|Overall Study||0
5347473|NCT00243243|13156148|P1|NOT COMPLETED|Overall Study||0
5347474|NCT00243243|13156147|P2|COMPLETED|Overall Study||10
5347475|NCT00243243|13156148|P1|COMPLETED|Overall Study||10
5347476|NCT00243243|13156147|P2|STARTED|Overall Study||10
5347477|NCT00243243|13156148|P1|STARTED|Overall Study||10
5347478|NCT00243191|13156154|P1|NOT COMPLETED|Overall Study||0
5347479|NCT00243191|13156154|P1|COMPLETED|Overall Study||18
5347480|NCT00243191|13156154|P1|STARTED|Overall Study||18
5347481|NCT00243152|13156158|P2|NOT COMPLETED|Overall Study||0
5347482|NCT00243152|13156159|P1|NOT COMPLETED|Overall Study||0
5347483|NCT00243152|13156158|P2|COMPLETED|Overall Study||3
5347484|NCT00243152|13156159|P1|COMPLETED|Overall Study||3
5347485|NCT00243152|13156158|P2|Scan 2: Placebo or Drug|Overall Study||3
5347486|NCT00243152|13156159|P1|Scan 2: Placebo or Drug|Overall Study||3
5347487|NCT00243152|13156158|P2|Scan 1: Drug or Placebo|Overall Study||3
5347488|NCT00243152|13156159|P1|Scan 1: Drug or Placebo|Overall Study||3
5347489|NCT00243152|13156158|P2|STARTED|Overall Study||3
5347490|NCT00243152|13156159|P1|STARTED|Overall Study||3
5347491|NCT00243074|13156166|P1|NOT COMPLETED|Overall Study||54
5347492|NCT00243074|13156166|P1|COMPLETED|Overall Study||0
5347493|NCT00243074|13156166|P1|STARTED|Overall Study||54
5347494|NCT00243061|13156176|P1|NOT COMPLETED|Overall Study||0
5347495|NCT00243061|13156176|P1|COMPLETED|Overall Study||24
5347496|NCT00243061|13156176|P1|STARTED|Overall Study||24
5347497|NCT00243022|13156192|P2|NOT COMPLETED|Overall Study||1
5347498|NCT00243022|13156193|P1|NOT COMPLETED|Overall Study||2
5347499|NCT00243022|13156192|P2|COMPLETED|Overall Study||4
5347500|NCT00243022|13156193|P1|COMPLETED|Overall Study||5
5347501|NCT00243022|13156192|P2|STARTED|Overall Study||5
5347502|NCT00243022|13156193|P1|STARTED|Overall Study||7
5347503|NCT00242710|13156217|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
5347504|NCT00242710|13156218|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
5347505|NCT00242710|13156219|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
5347506|NCT00242710|13156220|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
5347507|NCT00242710|13156217|P4|COMPLETED|Study Extension (up to Year 2)||84
5347508|NCT00242710|13156218|P3|COMPLETED|Study Extension (up to Year 2)||69
5347509|NCT00242710|13156219|P2|COMPLETED|Study Extension (up to Year 2)||148
5347510|NCT00242710|13156220|P1|COMPLETED|Study Extension (up to Year 2)||141
5347511|NCT00242710|13156217|P4|STARTED|Study Extension (up to Year 2)||94
5347512|NCT00242710|13156218|P3|STARTED|Study Extension (up to Year 2)||84
5347513|NCT00242710|13156219|P2|STARTED|Study Extension (up to Year 2)||177
5347514|NCT00242710|13156220|P1|STARTED|Study Extension (up to Year 2)||168
5347515|NCT00242710|13156217|P4|NOT COMPLETED|Period Between Core Study and Extension||49
5347516|NCT00242710|13156218|P3|NOT COMPLETED|Period Between Core Study and Extension||48
5347517|NCT00242710|13156219|P2|NOT COMPLETED|Period Between Core Study and Extension||112
5347518|NCT00242710|13156220|P1|NOT COMPLETED|Period Between Core Study and Extension||119
5347519|NCT00242710|13156217|P4|COMPLETED|Period Between Core Study and Extension||94
5347520|NCT00242710|13156218|P3|COMPLETED|Period Between Core Study and Extension||84
5347521|NCT00242710|13156219|P2|COMPLETED|Period Between Core Study and Extension||177
5347522|NCT00242710|13156220|P1|COMPLETED|Period Between Core Study and Extension||168
5347523|NCT00242710|13156217|P4|STARTED|Period Between Core Study and Extension||143
5347524|NCT00242710|13156218|P3|STARTED|Period Between Core Study and Extension||132
5347525|NCT00242710|13156219|P2|STARTED|Period Between Core Study and Extension||289
5347526|NCT00242710|13156220|P1|STARTED|Period Between Core Study and Extension||287
5347527|NCT00242710|13156217|P4|NOT COMPLETED|Core Study (up to Year 1)||31
5347528|NCT00242710|13156218|P3|NOT COMPLETED|Core Study (up to Year 1)||51
5347529|NCT00242710|13156219|P2|NOT COMPLETED|Core Study (up to Year 1)||64
5347530|NCT00242710|13156220|P1|NOT COMPLETED|Core Study (up to Year 1)||86
5347531|NCT00242710|13156217|P4|COMPLETED|Core Study (up to Year 1)||143
5347532|NCT00242710|13156218|P3|COMPLETED|Core Study (up to Year 1)||132
5347533|NCT00242710|13156219|P2|COMPLETED|Core Study (up to Year 1)||289
5347534|NCT00242710|13156220|P1|COMPLETED|Core Study (up to Year 1)||287
5347535|NCT00242710|13156217|P4|Treated|Core Study (up to Year 1)||172
5347536|NCT00242710|13156218|P3|Treated|Core Study (up to Year 1)||179
5347537|NCT00242710|13156219|P2|Treated|Core Study (up to Year 1)||349
5347538|NCT00242710|13156220|P1|Treated|Core Study (up to Year 1)||361
5347539|NCT00242710|13156217|P4|STARTED|Core Study (up to Year 1)||174
5347540|NCT00242710|13156218|P3|STARTED|Core Study (up to Year 1)||183
5347541|NCT00242710|13156219|P2|STARTED|Core Study (up to Year 1)||353
5347542|NCT00242710|13156220|P1|STARTED|Core Study (up to Year 1)||373
5347543|NCT00242684|13156270|P1|NOT COMPLETED|Overall Study||0
5347544|NCT00242684|13156270|P1|COMPLETED|Overall Study||446
5347545|NCT00242684|13156270|P1|STARTED|Overall Study||446
5347546|NCT00242658|13156277|P2|NOT COMPLETED|Overall Study||19
5347547|NCT00242658|13156278|P1|NOT COMPLETED|Overall Study||22
5347548|NCT00242658|13156277|P2|COMPLETED|Overall Study||188
5347549|NCT00242658|13156278|P1|COMPLETED|Overall Study||165
5347550|NCT00242658|13156277|P2|STARTED|Overall Study||207
5347551|NCT00242658|13156278|P1|STARTED|Overall Study||187
5347552|NCT00242632|13156288|P2|NOT COMPLETED|Overall Study||0
5347553|NCT00242632|13156289|P1|NOT COMPLETED|Overall Study||0
5347554|NCT00242632|13156288|P2|COMPLETED|Overall Study||11
5347555|NCT00242632|13156289|P1|COMPLETED|Overall Study||11
5347556|NCT00242632|13156288|P2|STARTED|Overall Study||11
5347557|NCT00242632|13156289|P1|STARTED|Overall Study||11
5347558|NCT00242619|13156297|P2|NOT COMPLETED|Overall Study||0
5347559|NCT00242619|13156298|P1|NOT COMPLETED|Overall Study||0
5347560|NCT00242619|13156297|P2|COMPLETED|Overall Study||4
5347561|NCT00242619|13156298|P1|COMPLETED|Overall Study||8
5347562|NCT00242619|13156297|P2|STARTED|Overall Study||4
5347563|NCT00242619|13156298|P1|STARTED|Overall Study||8
5347564|NCT00242580|13156309|P3|NOT COMPLETED|Overall Study||14
5347565|NCT00242580|13156310|P2|NOT COMPLETED|Overall Study||12
5347566|NCT00242580|13156311|P1|NOT COMPLETED|Overall Study||10
5347567|NCT00242580|13156309|P3|COMPLETED|Overall Study||24
5347568|NCT00242580|13156310|P2|COMPLETED|Overall Study||29
5347569|NCT00242580|13156311|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
5347570|NCT00242580|13156309|P3|STARTED|Overall Study||38
5347571|NCT00242580|13156310|P2|STARTED|Overall Study||41
5347572|NCT00242580|13156311|P1|STARTED|Overall Study||32
5347573|NCT00242567|13156336|P2|NOT COMPLETED|Overall Study||140
5347574|NCT00242567|13156337|P1|NOT COMPLETED|Overall Study||166
5347575|NCT00242567|13156336|P2|COMPLETED|Overall Study||123
5347576|NCT00242567|13156337|P1|COMPLETED|Overall Study||93
5347577|NCT00242567|13156336|P2|Never Received Study Drug|Overall Study||191
5347578|NCT00242567|13156337|P1|Never Received Study Drug|Overall Study||0
5347579|NCT00242567|13156336|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
5347580|NCT00242567|13156337|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
5347581|NCT00242567|13156336|P2|STARTED|Overall Study||263
5347582|NCT00242567|13156337|P1|STARTED|Overall Study||259
5347583|NCT00242502|13156353|P1|NOT COMPLETED|Overall Study||0
5347584|NCT00242502|13156353|P1|COMPLETED|Overall Study||59
5347585|NCT00242502|13156353|P1|STARTED|Overall Study||59
5347586|NCT00242385|13156357|P2|NOT COMPLETED|Period 2||0
5347587|NCT00242385|13156358|P1|NOT COMPLETED|Period 2||0
5347588|NCT00242385|13156357|P2|COMPLETED|Period 2||11
5347589|NCT00242385|13156358|P1|COMPLETED|Period 2||14
5347590|NCT00242385|13156357|P2|STARTED|Period 2||11
5347591|NCT00242385|13156358|P1|STARTED|Period 2||14
5347592|NCT00242385|13156357|P2|NOT COMPLETED|Period 1||0
5347593|NCT00242385|13156358|P1|NOT COMPLETED|Period 1||0
5347594|NCT00242385|13156357|P2|COMPLETED|Period 1||11
5347595|NCT00242385|13156358|P1|COMPLETED|Period 1||14
5347596|NCT00242385|13156357|P2|STARTED|Period 1||11
5347597|NCT00242385|13156358|P1|STARTED|Period 1||14
5347598|NCT00242216|13156384|P2|NOT COMPLETED|Overall Study||22
5347599|NCT00242216|13156385|P1|NOT COMPLETED|Overall Study||18
5347600|NCT00242216|13156384|P2|COMPLETED|Overall Study||15
5347601|NCT00242216|13156385|P1|COMPLETED|Overall Study||21
5347602|NCT00242216|13156384|P2|STARTED|Overall Study||37
5347603|NCT00242216|13156385|P1|STARTED|Overall Study||39
5347604|NCT00241969|13156395|P2|NOT COMPLETED|Overall Study||0
5347605|NCT00241969|13156396|P1|NOT COMPLETED|Overall Study||0
5347606|NCT00241969|13156395|P2|COMPLETED|Overall Study||42
5347607|NCT00241969|13156396|P1|COMPLETED|Overall Study||36
5347608|NCT00241969|13156395|P2|STARTED|Overall Study||42
5347609|NCT00241969|13156396|P1|STARTED|Overall Study||36
5347610|NCT00241904|13156408|P2|NOT COMPLETED|Overall Study||24
5347611|NCT00241904|13156409|P1|NOT COMPLETED|Overall Study||34
5347612|NCT00241904|13156408|P2|COMPLETED|Overall Study||240
5347613|NCT00241904|13156409|P1|COMPLETED|Overall Study||227
5347614|NCT00241904|13156408|P2|STARTED|Overall Study||264
5347615|NCT00241904|13156409|P1|STARTED|Overall Study||261
5347616|NCT00241839|13156423|P2|NOT COMPLETED|Overall Study||18
5347617|NCT00241839|13156424|P1|NOT COMPLETED|Overall Study||19
5347618|NCT00241839|13156423|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
5347619|NCT00241839|13156424|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
5347620|NCT00241839|13156423|P2|STARTED|Overall Study||71
5347621|NCT00241839|13156424|P1|STARTED|Overall Study||71
5347622|NCT00241644|13156440|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
5347623|NCT00241644|13156441|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
5347624|NCT00241644|13156442|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
5347625|NCT00241644|13156443|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
5347626|NCT00241644|13156440|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
5347627|NCT00241644|13156441|P3|COMPLETED|Second Efficacy Period (Year 2)||682
5347628|NCT00241644|13156442|P2|COMPLETED|Second Efficacy Period (Year 2)||697
5347629|NCT00241644|13156443|P1|COMPLETED|Second Efficacy Period (Year 2)||710
5347630|NCT00241644|13156440|P4|STARTED|Second Efficacy Period (Year 2)||1525
5347631|NCT00241644|13156441|P3|STARTED|Second Efficacy Period (Year 2)||746
5347632|NCT00241644|13156442|P2|STARTED|Second Efficacy Period (Year 2)||754
5347633|NCT00241644|13156443|P1|STARTED|Second Efficacy Period (Year 2)||771
5347634|NCT00241644|13156440|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
5347635|NCT00241644|13156441|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
5347636|NCT00241644|13156442|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
5347637|NCT00241644|13156443|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
5347638|NCT00241644|13156440|P4|COMPLETED|First Efficacy Period (Year 1)||2803
5347639|NCT00241644|13156441|P3|COMPLETED|First Efficacy Period (Year 1)||1392
5347640|NCT00241644|13156442|P2|COMPLETED|First Efficacy Period (Year 1)||1383
5347641|NCT00241644|13156443|P1|COMPLETED|First Efficacy Period (Year 1)||1420
5347642|NCT00241644|13156440|P4|STARTED|First Efficacy Period (Year 1)||3298
5347643|NCT00241644|13156441|P3|STARTED|First Efficacy Period (Year 1)||1641
5347644|NCT00241644|13156442|P2|STARTED|First Efficacy Period (Year 1)||1651
5347645|NCT00241644|13156443|P1|STARTED|First Efficacy Period (Year 1)||1647
5347646|NCT00241631|13156527|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
5347647|NCT00241631|13156528|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
5347648|NCT00241631|13156527|P2|COMPLETED|Phase 2 (4 Weeks)||16
5347649|NCT00241631|13156528|P1|COMPLETED|Phase 2 (4 Weeks)||14
5347650|NCT00241631|13156527|P2|STARTED|Phase 2 (4 Weeks)||16
5347651|NCT00241631|13156528|P1|STARTED|Phase 2 (4 Weeks)||14
5347652|NCT00241631|13156527|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
5347653|NCT00241631|13156528|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
5347654|NCT00241631|13156527|P2|COMPLETED|Wash Out (2 Weeks)||16
5347655|NCT00241631|13156528|P1|COMPLETED|Wash Out (2 Weeks)||14
5347656|NCT00241631|13156527|P2|STARTED|Wash Out (2 Weeks)||16
5347657|NCT00241631|13156528|P1|STARTED|Wash Out (2 Weeks)||14
5347658|NCT00241631|13156527|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
5347659|NCT00241631|13156528|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
5347660|NCT00241631|13156527|P2|COMPLETED|Phase 1 (4 Weeks)||16
5347661|NCT00241631|13156528|P1|COMPLETED|Phase 1 (4 Weeks)||14
5347662|NCT00241631|13156527|P2|STARTED|Phase 1 (4 Weeks)||21
5347663|NCT00241631|13156528|P1|STARTED|Phase 1 (4 Weeks)||22
5347664|NCT00241631|13156527|P2|NOT COMPLETED|Run in (2 Weeks)||3
5347665|NCT00241631|13156528|P1|NOT COMPLETED|Run in (2 Weeks)||3
5347666|NCT00241631|13156527|P2|COMPLETED|Run in (2 Weeks)||21
5347667|NCT00241631|13156528|P1|COMPLETED|Run in (2 Weeks)||22
5347668|NCT00241631|13156527|P2|STARTED|Run in (2 Weeks)||24
5347669|NCT00241631|13156528|P1|STARTED|Run in (2 Weeks)||25
5347670|NCT00241358|13156541|P3|NOT COMPLETED|Overall Study||1
5347671|NCT00241358|13156542|P2|NOT COMPLETED|Overall Study||1
5347672|NCT00241358|13156543|P1|NOT COMPLETED|Overall Study||0
5347673|NCT00241358|13156541|P3|COMPLETED|Overall Study||20
5347674|NCT00241358|13156542|P2|COMPLETED|Overall Study||45
5347675|NCT00241358|13156543|P1|COMPLETED|Overall Study||25
5347676|NCT00241358|13156541|P3|STARTED|Overall Study||21
5347677|NCT00241358|13156542|P2|STARTED|Overall Study||46
5347678|NCT00241358|13156543|P1|STARTED|Overall Study||25
5347679|NCT00241280|13156576|P2|NOT COMPLETED|Overall Study||68
5347680|NCT00241280|13156577|P1|NOT COMPLETED|Overall Study||48
5347681|NCT00241280|13156576|P2|COMPLETED|Overall Study||186
5347682|NCT00241280|13156577|P1|COMPLETED|Overall Study||199
5347683|NCT00241280|13156576|P2|STARTED|Overall Study||254
5347684|NCT00241280|13156577|P1|STARTED|Overall Study||247
5347685|NCT00241176|13156585|P1|NOT COMPLETED|Overall Study||0
5347686|NCT00241176|13156585|P1|COMPLETED|Overall Study||11
5347687|NCT00241176|13156585|P1|STARTED|Overall Study||11
5347688|NCT00240994|13156592|P1|NOT COMPLETED|Overall Study||3
5347689|NCT00240994|13156592|P1|COMPLETED|Overall Study||32
5347690|NCT00240994|13156592|P1|STARTED|Overall Study||35
5347691|NCT00240981|13156598|P2|NOT COMPLETED|Overall Study||33
5347692|NCT00240981|13156599|P1|NOT COMPLETED|Overall Study||38
5347693|NCT00240981|13156598|P2|COMPLETED|Overall Study||70
5347694|NCT00240981|13156599|P1|COMPLETED|Overall Study||68
5347695|NCT00240981|13156598|P2|Intent to Treat Sample|Overall Study||83
5347696|NCT00240981|13156599|P1|Intent to Treat Sample|Overall Study||82
5347697|NCT00240981|13156598|P2|STARTED|Overall Study||103
5347698|NCT00240981|13156599|P1|STARTED|Overall Study||106
5347699|NCT00240539|13156627|P4|NOT COMPLETED|Overall Study||0
5347700|NCT00240539|13156628|P3|NOT COMPLETED|Overall Study||0
5347701|NCT00240539|13156629|P2|NOT COMPLETED|Overall Study||0
5347702|NCT00240539|13156630|P1|NOT COMPLETED|Overall Study||0
5347703|NCT00240539|13156627|P4|COMPLETED|Overall Study||1
5347704|NCT00240539|13156628|P3|COMPLETED|Overall Study||31
5347705|NCT00240539|13156629|P2|COMPLETED|Overall Study||2
5347706|NCT00240539|13156630|P1|COMPLETED|Overall Study||2
5347707|NCT00240539|13156627|P4|STARTED|Overall Study||1
5347708|NCT00240539|13156628|P3|STARTED|Overall Study||31
5347709|NCT00240539|13156629|P2|STARTED|Overall Study||2
5347710|NCT00240539|13156630|P1|STARTED|Overall Study||2
5347711|NCT00240526|13156652|P4|NOT COMPLETED|Year 20||0
5347712|NCT00240526|13156653|P3|NOT COMPLETED|Year 20||0
5347713|NCT00240526|13156654|P2|NOT COMPLETED|Year 20||0
5347714|NCT00240526|13156655|P1|NOT COMPLETED|Year 20||0
5347715|NCT00240526|13156652|P4|COMPLETED|Year 20||20
5347716|NCT00240526|13156653|P3|COMPLETED|Year 20||13
5347717|NCT00240526|13156654|P2|COMPLETED|Year 20||17
5347718|NCT00240526|13156655|P1|COMPLETED|Year 20||19
5347719|NCT00240526|13156652|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
5347720|NCT00240526|13156653|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
5347721|NCT00240526|13156654|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
5347722|NCT00240526|13156655|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
5347723|NCT00240526|13156652|P4|NOT COMPLETED|Year 19||0
5347724|NCT00240526|13156653|P3|NOT COMPLETED|Year 19||0
5347725|NCT00240526|13156654|P2|NOT COMPLETED|Year 19||0
5347726|NCT00240526|13156655|P1|NOT COMPLETED|Year 19||0
5347727|NCT00240526|13156652|P4|COMPLETED|Year 19||18
5347728|NCT00240526|13156653|P3|COMPLETED|Year 19||12
5347729|NCT00240526|13156654|P2|COMPLETED|Year 19||16
5347730|NCT00240526|13156655|P1|COMPLETED|Year 19||17
5347731|NCT00240526|13156652|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
5347732|NCT00240526|13156653|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
5347733|NCT00240526|13156654|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
5347734|NCT00240526|13156655|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
5347735|NCT00240526|13156652|P4|NOT COMPLETED|Year 18||0
5347736|NCT00240526|13156653|P3|NOT COMPLETED|Year 18||0
5347737|NCT00240526|13156654|P2|NOT COMPLETED|Year 18||0
5347738|NCT00240526|13156655|P1|NOT COMPLETED|Year 18||0
5347739|NCT00240526|13156652|P4|COMPLETED|Year 18||20
5347740|NCT00240526|13156653|P3|COMPLETED|Year 18||14
5347741|NCT00240526|13156654|P2|COMPLETED|Year 18||17
5347742|NCT00240526|13156655|P1|COMPLETED|Year 18||16
5347743|NCT00240526|13156652|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
5347744|NCT00240526|13156653|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
5347745|NCT00240526|13156654|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
5347746|NCT00240526|13156655|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
5347747|NCT00240526|13156652|P4|NOT COMPLETED|Year 17||0
5347748|NCT00240526|13156653|P3|NOT COMPLETED|Year 17||0
5347749|NCT00240526|13156654|P2|NOT COMPLETED|Year 17||0
5347750|NCT00240526|13156655|P1|NOT COMPLETED|Year 17||0
5347751|NCT00240526|13156652|P4|COMPLETED|Year 17||20
5347752|NCT00240526|13156653|P3|COMPLETED|Year 17||13
5347753|NCT00240526|13156654|P2|COMPLETED|Year 17||17
5347754|NCT00240526|13156655|P1|COMPLETED|Year 17||19
5347755|NCT00240526|13156652|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
5347756|NCT00240526|13156653|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
5347757|NCT00240526|13156654|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
5347758|NCT00240526|13156655|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
5347759|NCT00240526|13156652|P4|NOT COMPLETED|Year 16||0
5347760|NCT00240526|13156653|P3|NOT COMPLETED|Year 16||0
5347761|NCT00240526|13156654|P2|NOT COMPLETED|Year 16||0
5347762|NCT00240526|13156655|P1|NOT COMPLETED|Year 16||0
5347763|NCT00240526|13156652|P4|COMPLETED|Year 16||22
5347764|NCT00240526|13156653|P3|COMPLETED|Year 16||16
5347765|NCT00240526|13156654|P2|COMPLETED|Year 16||19
5347766|NCT00240526|13156655|P1|COMPLETED|Year 16||17
5347767|NCT00240526|13156652|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
5347768|NCT00240526|13156653|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
5347769|NCT00240526|13156654|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
5347770|NCT00240526|13156655|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
5347771|NCT00240526|13156652|P4|NOT COMPLETED|Year 15||0
5347772|NCT00240526|13156653|P3|NOT COMPLETED|Year 15||0
5347773|NCT00240526|13156654|P2|NOT COMPLETED|Year 15||0
5347774|NCT00240526|13156655|P1|NOT COMPLETED|Year 15||0
5347775|NCT00240526|13156652|P4|COMPLETED|Year 15||21
5347776|NCT00240526|13156653|P3|COMPLETED|Year 15||14
5347777|NCT00240526|13156654|P2|COMPLETED|Year 15||19
5347778|NCT00240526|13156655|P1|COMPLETED|Year 15||19
5347779|NCT00240526|13156652|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
5347780|NCT00240526|13156653|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
5347781|NCT00240526|13156654|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
5347782|NCT00240526|13156655|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
5347783|NCT00240500|13156691|P6|NOT COMPLETED|Overall Study||1
5347784|NCT00240500|13156692|P5|NOT COMPLETED|Overall Study||3
5347785|NCT00240500|13156693|P4|NOT COMPLETED|Overall Study||4
5347786|NCT00240500|13156694|P3|NOT COMPLETED|Overall Study||3
5347787|NCT00240500|13156695|P2|NOT COMPLETED|Overall Study||3
5347788|NCT00240500|13156696|P1|NOT COMPLETED|Overall Study||1
5347789|NCT00240500|13156691|P6|COMPLETED|Overall Study||2
5347790|NCT00240500|13156692|P5|COMPLETED|Overall Study||26
5347791|NCT00240500|13156693|P4|COMPLETED|Overall Study||19
5347792|NCT00240500|13156694|P3|COMPLETED|Overall Study||14
5347793|NCT00240500|13156695|P2|COMPLETED|Overall Study||17
5347794|NCT00240500|13156696|P1|COMPLETED|Overall Study||16
5347795|NCT00240500|13156691|P6|STARTED|Overall Study||3
5347796|NCT00240500|13156692|P5|STARTED|Overall Study||29
5347797|NCT00240500|13156693|P4|STARTED|Overall Study||23
5347798|NCT00240500|13156694|P3|STARTED|Overall Study||17
5347799|NCT00240500|13156695|P2|STARTED|Overall Study||20
5347800|NCT00240500|13156696|P1|STARTED|Overall Study||17
5347801|NCT00240487|13156718|P2|NOT COMPLETED|Overall Study||0
5347802|NCT00240487|13156719|P1|NOT COMPLETED|Overall Study||0
5347803|NCT00240487|13156718|P2|COMPLETED|Overall Study||28
5347804|NCT00240487|13156719|P1|COMPLETED|Overall Study||24
5347805|NCT00240487|13156718|P2|STARTED|Overall Study||28
5347806|NCT00240487|13156719|P1|STARTED|Overall Study||24
5347807|NCT00240331|13156727|P2|NOT COMPLETED|Overall Study||134
5347808|NCT00240331|13156728|P1|NOT COMPLETED|Overall Study||126
5347809|NCT00240331|13156727|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
5347810|NCT00240331|13156728|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
5347811|NCT00240331|13156727|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
5347993|NCT00237809|13157174|P2|COMPLETED|Overall Study||17
5347812|NCT00240331|13156728|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
5347813|NCT00240227|13156746|P1|NOT COMPLETED|Overall Study||0
5347814|NCT00240227|13156746|P1|COMPLETED|Overall Study||8
5347815|NCT00240227|13156746|P1|STARTED|Overall Study||8
5347816|NCT00240162|13156762|P1|NOT COMPLETED|Overall Study||0
5347817|NCT00240162|13156762|P1|COMPLETED|Overall Study||21
5347818|NCT00240162|13156762|P1|STARTED|Overall Study||21
5347819|NCT00240110|13156771|P2|NOT COMPLETED|Overall Study||7
5347820|NCT00240110|13156772|P1|NOT COMPLETED|Overall Study||6
5347821|NCT00240110|13156771|P2|COMPLETED|Overall Study||6
5347822|NCT00240110|13156772|P1|COMPLETED|Overall Study||7
5347823|NCT00240110|13156771|P2|STARTED|Overall Study||13
5347824|NCT00240110|13156772|P1|STARTED|Overall Study||13
5347825|NCT00240097|13156780|P1|NOT COMPLETED|Part II||23
5347826|NCT00240097|13156780|P1|COMPLETED|Part II||3
5347827|NCT00240097|13156780|P1|STARTED|Part II||26
5347828|NCT00240097|13156780|P1|NOT COMPLETED|Part I||4
5347829|NCT00240097|13156780|P1|COMPLETED|Part I||26
5347830|NCT00240097|13156780|P1|STARTED|Part I||30
5347831|NCT00240071|13156790|P1|NOT COMPLETED|Overall Study||3
5347832|NCT00240071|13156790|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
5347833|NCT00240071|13156790|P1|STARTED|Overall Study||30
5347834|NCT00239928|13156795|P1|NOT COMPLETED|Overall Study||10
5347835|NCT00239928|13156795|P1|COMPLETED|Overall Study||51
5347836|NCT00239928|13156795|P1|STARTED|Overall Study||61
5347837|NCT00239837|13156807|P2|NOT COMPLETED|Overall Study||7
5347838|NCT00239837|13156808|P1|NOT COMPLETED|Overall Study||3
5347839|NCT00239837|13156807|P2|COMPLETED|Overall Study|3-year follow-up|45
5347840|NCT00239837|13156808|P1|COMPLETED|Overall Study|3-year follow-up|45
5347841|NCT00239837|13156807|P2|6 Months|Overall Study||50
5347842|NCT00239837|13156808|P1|6 Months|Overall Study||48
5347843|NCT00239837|13156807|P2|STARTED|Overall Study||52
5347844|NCT00239837|13156808|P1|STARTED|Overall Study||48
5347845|NCT00239733|13156828|P1|NOT COMPLETED|Overall Study||0
5347846|NCT00239733|13156828|P1|COMPLETED|Overall Study||6
5347847|NCT00239733|13156828|P1|STARTED|Overall Study||6
5347848|NCT00239720|13156835|P2|NOT COMPLETED|Overall Study||1
5347849|NCT00239720|13156836|P1|NOT COMPLETED|Overall Study||1
5347850|NCT00239720|13156835|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
5347851|NCT00239720|13156836|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
5347852|NCT00239720|13156835|P2|STARTED|Overall Study||1
5347853|NCT00239720|13156836|P1|STARTED|Overall Study||3
5347854|NCT00239681|13156844|P2|NOT COMPLETED|Overall Study||715
5347855|NCT00239681|13156845|P1|NOT COMPLETED|Overall Study||693
5347856|NCT00239681|13156844|P2|COMPLETED|Overall Study||8186
5347857|NCT00239681|13156845|P1|COMPLETED|Overall Study||8208
5347858|NCT00239681|13156844|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
5347859|NCT00239681|13156845|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
5347860|NCT00239681|13156844|P2|STARTED|Overall Study||8901
5347861|NCT00239681|13156845|P1|STARTED|Overall Study||8901
5347862|NCT00239642|13156864|P3|NOT COMPLETED|Overall Study||2
5347863|NCT00239642|13156865|P2|NOT COMPLETED|Overall Study||0
5347864|NCT00239642|13156866|P1|NOT COMPLETED|Overall Study||2
5347865|NCT00239642|13156864|P3|COMPLETED|Overall Study||47
5347866|NCT00239642|13156865|P2|COMPLETED|Overall Study||47
5347867|NCT00239642|13156866|P1|COMPLETED|Overall Study||47
5347868|NCT00239642|13156864|P3|STARTED|Overall Study||49
5347869|NCT00239642|13156865|P2|STARTED|Overall Study||47
5347870|NCT00239642|13156866|P1|STARTED|Overall Study||49
5347871|NCT00239590|13156898|P2|NOT COMPLETED|Completed Study Protocol||2
5347872|NCT00239590|13156899|P1|NOT COMPLETED|Completed Study Protocol||1
5347873|NCT00239590|13156898|P2|COMPLETED|Completed Study Protocol||10
5347874|NCT00239590|13156899|P1|COMPLETED|Completed Study Protocol||13
5347875|NCT00239590|13156898|P2|STARTED|Completed Study Protocol||12
5347876|NCT00239590|13156899|P1|STARTED|Completed Study Protocol||14
5347877|NCT00239590|13156898|P2|NOT COMPLETED|Started Intervention After Randomization||0
5347878|NCT00239590|13156899|P1|NOT COMPLETED|Started Intervention After Randomization||0
5347879|NCT00239590|13156898|P2|COMPLETED|Started Intervention After Randomization||12
5347880|NCT00239590|13156899|P1|COMPLETED|Started Intervention After Randomization||14
5347881|NCT00239590|13156898|P2|STARTED|Started Intervention After Randomization||12
5347882|NCT00239590|13156899|P1|STARTED|Started Intervention After Randomization||14
5347883|NCT00239590|13156898|P2|NOT COMPLETED|Randomized||2
5347884|NCT00239590|13156899|P1|NOT COMPLETED|Randomized||0
5347885|NCT00239590|13156898|P2|COMPLETED|Randomized||12
5347886|NCT00239590|13156899|P1|COMPLETED|Randomized||14
5347887|NCT00239590|13156898|P2|STARTED|Randomized||14
5347888|NCT00239590|13156899|P1|STARTED|Randomized||14
5347889|NCT00239577|13156911|P4|NOT COMPLETED|Booster Phase||0
5347890|NCT00239577|13156912|P3|NOT COMPLETED|Booster Phase||0
5347891|NCT00239577|13156913|P2|NOT COMPLETED|Booster Phase||0
5347892|NCT00239577|13156914|P1|NOT COMPLETED|Booster Phase||0
5347893|NCT00239577|13156911|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
5347894|NCT00239577|13156912|P3|COMPLETED|Booster Phase||12
5347895|NCT00239577|13156913|P2|COMPLETED|Booster Phase||9
5347896|NCT00239577|13156914|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
5347897|NCT00239577|13156911|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
5347898|NCT00239577|13156912|P3|STARTED|Booster Phase||12
5347899|NCT00239577|13156913|P2|STARTED|Booster Phase||9
5347900|NCT00239577|13156914|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
5347901|NCT00239577|13156911|P4|NOT COMPLETED|Primary Phase||0
5347902|NCT00239577|13156912|P3|NOT COMPLETED|Primary Phase||3
5347903|NCT00239577|13156913|P2|NOT COMPLETED|Primary Phase||3
5347904|NCT00239577|13156914|P1|NOT COMPLETED|Primary Phase||5
5347905|NCT00239577|13156911|P4|COMPLETED|Primary Phase||21
5347906|NCT00239577|13156912|P3|COMPLETED|Primary Phase||18
5347907|NCT00239577|13156913|P2|COMPLETED|Primary Phase||19
5347908|NCT00239577|13156914|P1|COMPLETED|Primary Phase||17
5347909|NCT00239577|13156911|P4|STARTED|Primary Phase||21
5347910|NCT00239577|13156912|P3|STARTED|Primary Phase||21
5347911|NCT00239577|13156913|P2|STARTED|Primary Phase||22
5347912|NCT00239577|13156914|P1|STARTED|Primary Phase||22
5347913|NCT00239356|13157018|P2|NOT COMPLETED|Overall Study||9
5347914|NCT00239356|13157019|P1|NOT COMPLETED|Overall Study||39
5347915|NCT00239356|13157018|P2|COMPLETED|Overall Study||11
5347916|NCT00239356|13157019|P1|COMPLETED|Overall Study||58
5347917|NCT00239356|13157018|P2|STARTED|Overall Study||20
5347918|NCT00239356|13157019|P1|STARTED|Overall Study||97
5347919|NCT00239226|13157041|P4|NOT COMPLETED|Overall Study||3
5347920|NCT00239226|13157042|P3|NOT COMPLETED|Overall Study||1
5347921|NCT00239226|13157043|P2|NOT COMPLETED|Overall Study||0
5347922|NCT00239226|13157044|P1|NOT COMPLETED|Overall Study||1
5347923|NCT00239226|13157041|P4|COMPLETED|Overall Study||14
5347924|NCT00239226|13157042|P3|COMPLETED|Overall Study||36
5347925|NCT00239226|13157043|P2|COMPLETED|Overall Study||18
5347926|NCT00239226|13157044|P1|COMPLETED|Overall Study||29
5347927|NCT00239226|13157041|P4|STARTED|Overall Study||17
5347928|NCT00239226|13157042|P3|STARTED|Overall Study||37
5347929|NCT00239226|13157043|P2|STARTED|Overall Study||18
5347930|NCT00239226|13157044|P1|STARTED|Overall Study||30
5347931|NCT00239005|13157056|P2|NOT COMPLETED|Overall Study||12
5347932|NCT00239005|13157057|P1|NOT COMPLETED|Overall Study||12
5347933|NCT00239005|13157056|P2|COMPLETED|Overall Study||53
5347934|NCT00239005|13157057|P1|COMPLETED|Overall Study||57
5347935|NCT00239005|13157056|P2|Intention-to-treat Population (ITT)|Overall Study||61
5347936|NCT00239005|13157057|P1|Intention-to-treat Population (ITT)|Overall Study||68
5347937|NCT00239005|13157056|P2|STARTED|Overall Study||65
5347938|NCT00239005|13157057|P1|STARTED|Overall Study||69
5347939|NCT00238615|13157067|P1|NOT COMPLETED|Overall Study||0
5347940|NCT00238615|13157067|P1|COMPLETED|Overall Study||13
5347941|NCT00238615|13157067|P1|STARTED|Overall Study||13
5347942|NCT00238433|13157073|P1|NOT COMPLETED|Overall Study||3
5347943|NCT00238433|13157073|P1|COMPLETED|Overall Study||34
5347944|NCT00238433|13157073|P1|STARTED|Overall Study||37
5347945|NCT00238420|13157080|P2|NOT COMPLETED|Overall Study||1
5347946|NCT00238420|13157081|P1|NOT COMPLETED|Overall Study||1
5347947|NCT00238420|13157080|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
5347948|NCT00238420|13157081|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
5347949|NCT00238420|13157080|P2|STARTED|Overall Study||48
5347950|NCT00238420|13157081|P1|STARTED|Overall Study||22
5347951|NCT00238355|13157091|P1|NOT COMPLETED|Overall Study||3
5347952|NCT00238355|13157091|P1|COMPLETED|Overall Study||10
5347953|NCT00238355|13157091|P1|STARTED|Overall Study||13
5347954|NCT00238303|13157098|P3|NOT COMPLETED|Overall Study||9
5347955|NCT00238303|13157099|P2|NOT COMPLETED|Overall Study||2
5347956|NCT00238303|13157100|P1|NOT COMPLETED|Overall Study||15
5347957|NCT00238303|13157098|P3|COMPLETED|Overall Study||11
5347958|NCT00238303|13157099|P2|COMPLETED|Overall Study||13
5347959|NCT00238303|13157100|P1|COMPLETED|Overall Study||53
5347960|NCT00238303|13157098|P3|STARTED|Overall Study||20
5347961|NCT00238303|13157099|P2|STARTED|Overall Study||15
5347962|NCT00238303|13157100|P1|STARTED|Overall Study||68
5347963|NCT00238264|13157117|P1|NOT COMPLETED|Overall Study||36
5347964|NCT00238264|13157117|P1|COMPLETED|Overall Study||56
5347965|NCT00238264|13157117|P1|STARTED|Overall Study||92
5347966|NCT00238238|13157130|P3|NOT COMPLETED|Overall Study||0
5347967|NCT00238238|13157131|P2|NOT COMPLETED|Overall Study||3
5347968|NCT00238238|13157132|P1|NOT COMPLETED|Overall Study||0
5347969|NCT00238238|13157130|P3|COMPLETED|Overall Study||46
5347970|NCT00238238|13157131|P2|COMPLETED|Overall Study||45
5347971|NCT00238238|13157132|P1|COMPLETED|Overall Study||3
5347972|NCT00238238|13157130|P3|STARTED|Overall Study||46
5347973|NCT00238238|13157131|P2|STARTED|Overall Study||48
5347974|NCT00238238|13157132|P1|STARTED|Overall Study||3
5347975|NCT00238121|13157145|P2|NOT COMPLETED|Overall Study||2
5347976|NCT00238121|13157146|P1|NOT COMPLETED|Overall Study||3
5347977|NCT00238121|13157145|P2|COMPLETED|Overall Study||14
5347978|NCT00238121|13157146|P1|COMPLETED|Overall Study||37
5347979|NCT00238121|13157145|P2|STARTED|Overall Study||16
5347980|NCT00238121|13157146|P1|STARTED|Overall Study||40
5347981|NCT00238108|13157159|P2|NOT COMPLETED|Overall Study||0
5347982|NCT00238108|13157160|P1|NOT COMPLETED|Overall Study||0
5347983|NCT00238108|13157159|P2|COMPLETED|Overall Study||8
5347984|NCT00238108|13157160|P1|COMPLETED|Overall Study||8
5347985|NCT00238108|13157159|P2|STARTED|Overall Study||8
5347986|NCT00238108|13157160|P1|STARTED|Overall Study||8
5347987|NCT00237809|13157172|P4|NOT COMPLETED|Overall Study||9
5347988|NCT00237809|13157173|P3|NOT COMPLETED|Overall Study||9
5347989|NCT00237809|13157174|P2|NOT COMPLETED|Overall Study||10
5347990|NCT00237809|13157175|P1|NOT COMPLETED|Overall Study||11
5347991|NCT00237809|13157172|P4|COMPLETED|Overall Study||17
5347992|NCT00237809|13157173|P3|COMPLETED|Overall Study||15
5347994|NCT00237809|13157175|P1|COMPLETED|Overall Study||16
5347995|NCT00237809|13157172|P4|STARTED|Overall Study||26
5347996|NCT00237809|13157173|P3|STARTED|Overall Study||24
5347997|NCT00237809|13157174|P2|STARTED|Overall Study||27
5347998|NCT00237809|13157175|P1|STARTED|Overall Study||27
5347999|NCT00237796|13157211|P2|NOT COMPLETED|Overall Study||5
5348000|NCT00237796|13157212|P1|NOT COMPLETED|Overall Study||10
5348001|NCT00237796|13157211|P2|COMPLETED|Overall Study||33
5348002|NCT00237796|13157212|P1|COMPLETED|Overall Study||31
5348003|NCT00237796|13157211|P2|STARTED|Overall Study||38
5348004|NCT00237796|13157212|P1|STARTED|Overall Study||41
5348005|NCT00237770|13157232|P2|NOT COMPLETED|Overall Study||0
5348006|NCT00237770|13157233|P1|NOT COMPLETED|Overall Study||0
5348007|NCT00237770|13157232|P2|COMPLETED|Overall Study||7
5348008|NCT00237770|13157233|P1|COMPLETED|Overall Study||9
5348009|NCT00237770|13157232|P2|STARTED|Overall Study||7
5348010|NCT00237770|13157233|P1|STARTED|Overall Study||9
5348011|NCT00237744|13157246|P3|NOT COMPLETED|Overall Study||0
5348012|NCT00237744|13157247|P2|NOT COMPLETED|Overall Study||1
5348013|NCT00237744|13157248|P1|NOT COMPLETED|Overall Study||3
5348014|NCT00237744|13157246|P3|COMPLETED|Overall Study||18
5348015|NCT00237744|13157247|P2|COMPLETED|Overall Study||10
5348016|NCT00237744|13157248|P1|COMPLETED|Overall Study||8
5348017|NCT00237744|13157246|P3|STARTED|Overall Study||18
5348018|NCT00237744|13157247|P2|STARTED|Overall Study||11
5348019|NCT00237744|13157248|P1|STARTED|Overall Study||11
5348020|NCT00237718|13157261|P2|NOT COMPLETED|Overall Study||41
5348021|NCT00237718|13157262|P1|NOT COMPLETED|Overall Study||46
5348022|NCT00237718|13157261|P2|COMPLETED|Overall Study||124
5348023|NCT00237718|13157262|P1|COMPLETED|Overall Study||114
5348024|NCT00237718|13157261|P2|STARTED|Overall Study||165
5348025|NCT00237718|13157262|P1|STARTED|Overall Study||160
5348026|NCT00237692|13157274|P4|NOT COMPLETED|Overall Study||19
5348027|NCT00237692|13157275|P3|NOT COMPLETED|Overall Study||22
5348028|NCT00237692|13157276|P2|NOT COMPLETED|Overall Study||14
5348029|NCT00237692|13157277|P1|NOT COMPLETED|Overall Study||18
5348030|NCT00237692|13157274|P4|COMPLETED|Overall Study||128
5348031|NCT00237692|13157275|P3|COMPLETED|Overall Study||127
5348032|NCT00237692|13157276|P2|COMPLETED|Overall Study||134
5348033|NCT00237692|13157277|P1|COMPLETED|Overall Study||129
5348034|NCT00237692|13157274|P4|18 Month f/u|Overall Study||122
5348035|NCT00237692|13157275|P3|18 Month f/u|Overall Study||126
5348036|NCT00237692|13157276|P2|18 Month f/u|Overall Study||131
5348037|NCT00237692|13157277|P1|18 Month f/u|Overall Study||124
5348038|NCT00237692|13157274|P4|12 Month f/u|Overall Study||127
5348039|NCT00237692|13157275|P3|12 Month f/u|Overall Study||132
5348040|NCT00237692|13157276|P2|12 Month f/u|Overall Study||127
5348041|NCT00237692|13157277|P1|12 Month f/u|Overall Study||137
5348042|NCT00237692|13157274|P4|6 Month f/u|Overall Study||134
5348043|NCT00237692|13157275|P3|6 Month f/u|Overall Study||135
5348044|NCT00237692|13157276|P2|6 Month f/u|Overall Study||134
5348045|NCT00237692|13157277|P1|6 Month f/u|Overall Study||132
5348046|NCT00237692|13157274|P4|STARTED|Overall Study||147
5348047|NCT00237692|13157275|P3|STARTED|Overall Study||149
5348048|NCT00237692|13157276|P2|STARTED|Overall Study||148
5348049|NCT00237692|13157277|P1|STARTED|Overall Study||147
5348050|NCT00237666|13157307|P1|NOT COMPLETED|Overall Study||6
5348051|NCT00237666|13157307|P1|COMPLETED|Overall Study||24
5348052|NCT00237666|13157307|P1|STARTED|Overall Study||30
5348053|NCT00237458|13157317|P1|NOT COMPLETED|Overall Study||3
5348054|NCT00237458|13157317|P1|COMPLETED|Overall Study||4
5348055|NCT00237458|13157317|P1|STARTED|Overall Study||7
5348056|NCT00237185|13157335|P2|NOT COMPLETED|Extension||19
5348057|NCT00237185|13157336|P1|NOT COMPLETED|Extension||16
5348058|NCT00237185|13157335|P2|COMPLETED|Extension||13
5348059|NCT00237185|13157336|P1|COMPLETED|Extension||8
5348060|NCT00237185|13157335|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
5348061|NCT00237185|13157336|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
5348062|NCT00237185|13157335|P2|NOT COMPLETED|Core||37
5348063|NCT00237185|13157336|P1|NOT COMPLETED|Core||44
5348064|NCT00237185|13157335|P2|COMPLETED|Core||37
5348065|NCT00237185|13157336|P1|COMPLETED|Core||30
5348066|NCT00237185|13157335|P2|Treated Participants|Core||74
5348067|NCT00237185|13157336|P1|Treated Participants|Core||73
5348068|NCT00237185|13157335|P2|STARTED|Core||74
5348069|NCT00237185|13157336|P1|STARTED|Core||74
5348070|NCT00237042|13157367|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
5348071|NCT00237042|13157368|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
5348072|NCT00237042|13157369|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
5348073|NCT00237042|13157367|P3|COMPLETED|Long Term (12 Month) Follow up||48
5348074|NCT00237042|13157368|P2|COMPLETED|Long Term (12 Month) Follow up||46
5348075|NCT00237042|13157369|P1|COMPLETED|Long Term (12 Month) Follow up||48
5348076|NCT00237042|13157367|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
5348077|NCT00237042|13157368|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
5348078|NCT00237042|13157369|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
5348079|NCT00237042|13157367|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
5348080|NCT00237042|13157368|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
5348081|NCT00237042|13157369|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
5348082|NCT00237042|13157367|P3|COMPLETED|Short Term (6 Month) Follow up||46
5348083|NCT00237042|13157368|P2|COMPLETED|Short Term (6 Month) Follow up||47
5348084|NCT00237042|13157369|P1|COMPLETED|Short Term (6 Month) Follow up||50
5348085|NCT00237042|13157367|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
5348086|NCT00237042|13157368|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
5348087|NCT00237042|13157369|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
5348088|NCT00237042|13157367|P3|NOT COMPLETED|Treatment||38
5348089|NCT00237042|13157368|P2|NOT COMPLETED|Treatment||7
5348090|NCT00237042|13157369|P1|NOT COMPLETED|Treatment||6
5348091|NCT00237042|13157367|P3|COMPLETED|Treatment||36
5348092|NCT00237042|13157368|P2|COMPLETED|Treatment||50
5348093|NCT00237042|13157369|P1|COMPLETED|Treatment||54
5348094|NCT00237042|13157367|P3|STARTED|Treatment||74
5348095|NCT00237042|13157368|P2|STARTED|Treatment||57
5348096|NCT00237042|13157369|P1|STARTED|Treatment||60
5348097|NCT00236977|13157388|P2|NOT COMPLETED|Overall Study||19
5348098|NCT00236977|13157389|P1|NOT COMPLETED|Overall Study||21
5348099|NCT00236977|13157388|P2|COMPLETED|Overall Study||72
5348100|NCT00236977|13157389|P1|COMPLETED|Overall Study||70
5348101|NCT00236977|13157388|P2|STARTED|Overall Study||91
5348102|NCT00236977|13157389|P1|STARTED|Overall Study||91
5348103|NCT00236951|13157411|P4|NOT COMPLETED|Overall Study||31
5348104|NCT00236951|13157412|P3|NOT COMPLETED|Overall Study||19
5348105|NCT00236951|13157413|P2|NOT COMPLETED|Overall Study||31
5348106|NCT00236951|13157414|P1|NOT COMPLETED|Overall Study||26
5348107|NCT00236951|13157411|P4|COMPLETED|Overall Study||17
5348108|NCT00236951|13157412|P3|COMPLETED|Overall Study||21
5348109|NCT00236951|13157413|P2|COMPLETED|Overall Study||46
5348110|NCT00236951|13157414|P1|COMPLETED|Overall Study||33
5348111|NCT00236951|13157411|P4|STARTED|Overall Study||48
5348112|NCT00236951|13157412|P3|STARTED|Overall Study||40
5348113|NCT00236951|13157413|P2|STARTED|Overall Study||77
5348114|NCT00236951|13157414|P1|STARTED|Overall Study||59
5348115|NCT00236938|13157426|P2|NOT COMPLETED|Overall Study||20
5348116|NCT00236938|13157427|P1|NOT COMPLETED|Overall Study||13
5348117|NCT00236938|13157426|P2|COMPLETED|Overall Study||26
5348118|NCT00236938|13157427|P1|COMPLETED|Overall Study||62
5348119|NCT00236938|13157426|P2|STARTED|Overall Study||46
5348120|NCT00236938|13157427|P1|STARTED|Overall Study||75
5348121|NCT00236899|13157443|P4|NOT COMPLETED|Overall Study||40
5348122|NCT00236899|13157444|P3|NOT COMPLETED|Overall Study||44
5348123|NCT00236899|13157445|P2|NOT COMPLETED|Overall Study||40
5348124|NCT00236899|13157446|P1|NOT COMPLETED|Overall Study||42
5348125|NCT00236899|13157443|P4|COMPLETED|Overall Study||19
5348126|NCT00236899|13157444|P3|COMPLETED|Overall Study||14
5348127|NCT00236899|13157445|P2|COMPLETED|Overall Study||24
5348128|NCT00236899|13157446|P1|COMPLETED|Overall Study||18
5348129|NCT00236899|13157443|P4|STARTED|Overall Study||59
5348130|NCT00236899|13157444|P3|STARTED|Overall Study||58
5348131|NCT00236899|13157445|P2|STARTED|Overall Study||64
5348132|NCT00236899|13157446|P1|STARTED|Overall Study||60
5348133|NCT00236197|13157478|P2|NOT COMPLETED|Overall Study||14
5348134|NCT00236197|13157479|P1|NOT COMPLETED|Overall Study||5
5348135|NCT00236197|13157478|P2|COMPLETED|Overall Study||293
5348136|NCT00236197|13157479|P1|COMPLETED|Overall Study||307
5348137|NCT00236197|13157478|P2|STARTED|Overall Study||307
5348138|NCT00236197|13157479|P1|STARTED|Overall Study||312
5348139|NCT00236184|13157487|P2|NOT COMPLETED|Overall Study||11
5348140|NCT00236184|13157488|P1|NOT COMPLETED|Overall Study||18
5348141|NCT00236184|13157487|P2|COMPLETED|Overall Study||308
5348142|NCT00236184|13157488|P1|COMPLETED|Overall Study||292
5348143|NCT00236184|13157487|P2|STARTED|Overall Study||319
5348144|NCT00236184|13157488|P1|STARTED|Overall Study||310
5348145|NCT00236080|13157499|P5|NOT COMPLETED|Overall Study||1
5348146|NCT00236080|13157500|P4|NOT COMPLETED|Overall Study||2
5348147|NCT00236080|13157501|P3|NOT COMPLETED|Overall Study||5
5348148|NCT00236080|13157502|P2|NOT COMPLETED|Overall Study||1
5348149|NCT00236080|13157503|P1|NOT COMPLETED|Overall Study||2
5348150|NCT00236080|13157499|P5|COMPLETED|Overall Study||26
5348151|NCT00236080|13157500|P4|COMPLETED|Overall Study||23
5348152|NCT00236080|13157501|P3|COMPLETED|Overall Study||22
5348153|NCT00236080|13157502|P2|COMPLETED|Overall Study||27
5348154|NCT00236080|13157503|P1|COMPLETED|Overall Study||27
5348155|NCT00236080|13157499|P5|STARTED|Overall Study||27
5348156|NCT00236080|13157500|P4|STARTED|Overall Study||25
5348157|NCT00236080|13157501|P3|STARTED|Overall Study||27
5348158|NCT00236080|13157502|P2|STARTED|Overall Study||28
5348159|NCT00236080|13157503|P1|STARTED|Overall Study||29
5348160|NCT00235989|13157524|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
5348161|NCT00235989|13157525|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
5348162|NCT00235989|13157526|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
5348163|NCT00235989|13157527|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
5348164|NCT00235989|13157528|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
5348165|NCT00235989|13157529|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
5348166|NCT00235989|13157524|P6|COMPLETED|Extension Treatment Period (ET)||0
5348167|NCT00235989|13157525|P5|COMPLETED|Extension Treatment Period (ET)||0
5348168|NCT00235989|13157526|P4|COMPLETED|Extension Treatment Period (ET)||14
5348169|NCT00235989|13157527|P3|COMPLETED|Extension Treatment Period (ET)||14
5348170|NCT00235989|13157528|P2|COMPLETED|Extension Treatment Period (ET)||2
5348171|NCT00235989|13157529|P1|COMPLETED|Extension Treatment Period (ET)||8
5348172|NCT00235989|13157524|P6|STARTED|Extension Treatment Period (ET)||0
5348173|NCT00235989|13157525|P5|STARTED|Extension Treatment Period (ET)||0
5348174|NCT00235989|13157526|P4|STARTED|Extension Treatment Period (ET)||20
5348175|NCT00235989|13157527|P3|STARTED|Extension Treatment Period (ET)||19
5348176|NCT00235989|13157528|P2|STARTED|Extension Treatment Period (ET)||6
5348177|NCT00235989|13157529|P1|STARTED|Extension Treatment Period (ET)||16
5348178|NCT00235989|13157524|P6|NOT COMPLETED|Core Treatment Period (CT)||2
5348179|NCT00235989|13157525|P5|NOT COMPLETED|Core Treatment Period (CT)||0
5348180|NCT00235989|13157526|P4|NOT COMPLETED|Core Treatment Period (CT)||0
5348181|NCT00235989|13157527|P3|NOT COMPLETED|Core Treatment Period (CT)||0
5348182|NCT00235989|13157528|P2|NOT COMPLETED|Core Treatment Period (CT)||0
5348183|NCT00235989|13157529|P1|NOT COMPLETED|Core Treatment Period (CT)||0
5348184|NCT00235989|13157524|P6|COMPLETED|Core Treatment Period (CT)||25
5348185|NCT00235989|13157525|P5|COMPLETED|Core Treatment Period (CT)||36
5348186|NCT00235989|13157526|P4|COMPLETED|Core Treatment Period (CT)||0
5348187|NCT00235989|13157527|P3|COMPLETED|Core Treatment Period (CT)||0
5348188|NCT00235989|13157528|P2|COMPLETED|Core Treatment Period (CT)||0
5348189|NCT00235989|13157529|P1|COMPLETED|Core Treatment Period (CT)||0
5348190|NCT00235989|13157524|P6|STARTED|Core Treatment Period (CT)||27
5348191|NCT00235989|13157525|P5|STARTED|Core Treatment Period (CT)||36
5348192|NCT00235989|13157526|P4|STARTED|Core Treatment Period (CT)||0
5348193|NCT00235989|13157527|P3|STARTED|Core Treatment Period (CT)||0
5348194|NCT00235989|13157528|P2|STARTED|Core Treatment Period (CT)||0
5348195|NCT00235989|13157529|P1|STARTED|Core Treatment Period (CT)||0
5348196|NCT00235872|13157543|P1|NOT COMPLETED|Overall Study||147
5348197|NCT00235872|13157543|P1|COMPLETED|Overall Study||162
5348198|NCT00235872|13157543|P1|STARTED|Overall Study||309
5348199|NCT00235833|13157558|P1|NOT COMPLETED|Overall Study||16
5348200|NCT00235833|13157558|P1|COMPLETED|Overall Study||9
5348201|NCT00235833|13157558|P1|STARTED|Overall Study||25
5348202|NCT00235755|13157574|P3|NOT COMPLETED|12-Week Maintenance Phase||31
5348203|NCT00235755|13157575|P2|NOT COMPLETED|12-Week Maintenance Phase||27
5348204|NCT00235755|13157576|P1|NOT COMPLETED|12-Week Maintenance Phase||16
5348205|NCT00235755|13157574|P3|COMPLETED|12-Week Maintenance Phase||122
5348206|NCT00235755|13157575|P2|COMPLETED|12-Week Maintenance Phase||135
5348207|NCT00235755|13157576|P1|COMPLETED|12-Week Maintenance Phase||152
5348208|NCT00235755|13157574|P3|STARTED|12-Week Maintenance Phase||153
5348209|NCT00235755|13157575|P2|STARTED|12-Week Maintenance Phase||162
5348210|NCT00235755|13157576|P1|STARTED|12-Week Maintenance Phase||168
5348211|NCT00235755|13157574|P3|NOT COMPLETED|4-Week Titration Phase||26
5348212|NCT00235755|13157575|P2|NOT COMPLETED|4-Week Titration Phase||19
5348213|NCT00235755|13157576|P1|NOT COMPLETED|4-Week Titration Phase||11
5348214|NCT00235755|13157574|P3|COMPLETED|4-Week Titration Phase||153
5348215|NCT00235755|13157575|P2|COMPLETED|4-Week Titration Phase||162
5348216|NCT00235755|13157576|P1|COMPLETED|4-Week Titration Phase||168
5348217|NCT00235755|13157574|P3|STARTED|4-Week Titration Phase||179
5348218|NCT00235755|13157575|P2|STARTED|4-Week Titration Phase||181
5348219|NCT00235755|13157576|P1|STARTED|4-Week Titration Phase||179
5348220|NCT00235716|13157654|P4|NOT COMPLETED|Overall Study||62
5348221|NCT00235716|13157655|P3|NOT COMPLETED|Overall Study||65
5348222|NCT00235716|13157656|P2|NOT COMPLETED|Overall Study||67
5348223|NCT00235716|13157657|P1|NOT COMPLETED|Overall Study||62
5348224|NCT00235716|13157654|P4|COMPLETED|Overall Study||90
5348225|NCT00235716|13157655|P3|COMPLETED|Overall Study||89
5348226|NCT00235716|13157656|P2|COMPLETED|Overall Study||88
5348227|NCT00235716|13157657|P1|COMPLETED|Overall Study||90
5348228|NCT00235716|13157654|P4|STARTED|Overall Study||152
5348229|NCT00235716|13157655|P3|STARTED|Overall Study||154
5348230|NCT00235716|13157656|P2|STARTED|Overall Study||155
5348231|NCT00235716|13157657|P1|STARTED|Overall Study||152
5348232|NCT00235573|13157691|P1|NOT COMPLETED|Overall Study||0
5348233|NCT00235573|13157691|P1|COMPLETED|Overall Study||21
5348234|NCT00235573|13157691|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
5348235|NCT00235547|13157697|P2|NOT COMPLETED|6 Month Follow-up Survey||68
5348236|NCT00235547|13157698|P1|NOT COMPLETED|6 Month Follow-up Survey||71
5348237|NCT00235547|13157697|P2|COMPLETED|6 Month Follow-up Survey||76
5348238|NCT00235547|13157698|P1|COMPLETED|6 Month Follow-up Survey||83
5348239|NCT00235547|13157697|P2|STARTED|6 Month Follow-up Survey||144
5348240|NCT00235547|13157698|P1|STARTED|6 Month Follow-up Survey||154
5348241|NCT00235547|13157697|P2|NOT COMPLETED|2 Month Follow-up Survey||40
5348242|NCT00235547|13157698|P1|NOT COMPLETED|2 Month Follow-up Survey||46
5348243|NCT00235547|13157697|P2|COMPLETED|2 Month Follow-up Survey||104
5348244|NCT00235547|13157698|P1|COMPLETED|2 Month Follow-up Survey||108
5348245|NCT00235547|13157697|P2|STARTED|2 Month Follow-up Survey||144
5348246|NCT00235547|13157698|P1|STARTED|2 Month Follow-up Survey||154
5348247|NCT00235495|13157708|P2|NOT COMPLETED|Overall Study||68
5348248|NCT00235495|13157709|P1|NOT COMPLETED|Overall Study||68
5348249|NCT00235495|13157708|P2|COMPLETED|Overall Study||351
5348250|NCT00235495|13157709|P1|COMPLETED|Overall Study||354
5348251|NCT00235495|13157708|P2|STARTED|Overall Study||419
5348252|NCT00235495|13157709|P1|STARTED|Overall Study||422
5348253|NCT00235456|13157759|P2|NOT COMPLETED|Overall Study||7
5348254|NCT00235456|13157760|P1|NOT COMPLETED|Overall Study||2
5348255|NCT00235456|13157759|P2|COMPLETED|Overall Study||143
5348256|NCT00235456|13157760|P1|COMPLETED|Overall Study||148
5348257|NCT00235456|13157759|P2|STARTED|Overall Study||150
5348258|NCT00235456|13157760|P1|STARTED|Overall Study||150
5348259|NCT00235443|13157782|P6|NOT COMPLETED|Overall Study||45
5348260|NCT00235443|13157783|P5|NOT COMPLETED|Overall Study||30
5348261|NCT00235443|13157784|P4|NOT COMPLETED|Overall Study||97
5348262|NCT00235443|13157785|P3|NOT COMPLETED|Overall Study||62
5348263|NCT00235443|13157786|P2|NOT COMPLETED|Overall Study||38
5348264|NCT00235443|13157787|P1|NOT COMPLETED|Overall Study||8
5348265|NCT00235443|13157782|P6|COMPLETED|Overall Study||9
5348266|NCT00235443|13157783|P5|COMPLETED|Overall Study||9
5348267|NCT00235443|13157784|P4|COMPLETED|Overall Study||108
5348268|NCT00235443|13157785|P3|COMPLETED|Overall Study||23
5348269|NCT00235443|13157786|P2|COMPLETED|Overall Study||19
5348270|NCT00235443|13157787|P1|COMPLETED|Overall Study||3
5348271|NCT00235443|13157782|P6|STARTED|Overall Study||54
5348272|NCT00235443|13157783|P5|STARTED|Overall Study||39
5348273|NCT00235443|13157784|P4|STARTED|Overall Study||205
5348274|NCT00235443|13157785|P3|STARTED|Overall Study||85
5348275|NCT00235443|13157786|P2|STARTED|Overall Study||57
5348276|NCT00235443|13157787|P1|STARTED|Overall Study||11
5348277|NCT00235391|13157928|P6|NOT COMPLETED|Overall Study||4
5348278|NCT00235391|13157929|P5|NOT COMPLETED|Overall Study||12
5348279|NCT00235391|13157930|P4|NOT COMPLETED|Overall Study||220
5348280|NCT00235391|13157931|P3|NOT COMPLETED|Overall Study||24
5348281|NCT00235391|13157932|P2|NOT COMPLETED|Overall Study||18
5348282|NCT00235391|13157933|P1|NOT COMPLETED|Overall Study||12
5348283|NCT00235391|13157928|P6|COMPLETED|Overall Study||3
5348284|NCT00235391|13157929|P5|COMPLETED|Overall Study||31
5348285|NCT00235391|13157930|P4|COMPLETED|Overall Study||944
5348286|NCT00235391|13157931|P3|COMPLETED|Overall Study||148
5348287|NCT00235391|13157932|P2|COMPLETED|Overall Study||182
5348288|NCT00235391|13157933|P1|COMPLETED|Overall Study||85
5348289|NCT00235391|13157928|P6|Deferasirox Treatment|Overall Study||7
5348290|NCT00235391|13157929|P5|Deferasirox Treatment|Overall Study||43
5348291|NCT00235391|13157930|P4|Deferasirox Treatment|Overall Study||1164
5348292|NCT00235391|13157931|P3|Deferasirox Treatment|Overall Study||172
5348293|NCT00235391|13157932|P2|Deferasirox Treatment|Overall Study||200
5348294|NCT00235391|13157933|P1|Deferasirox Treatment|Overall Study||97
5348295|NCT00235391|13157928|P6|STARTED|Overall Study||7
5348296|NCT00235391|13157929|P5|STARTED|Overall Study||43
5348297|NCT00235391|13157930|P4|STARTED|Overall Study||1164
5348298|NCT00235391|13157931|P3|STARTED|Overall Study||172
5348299|NCT00235391|13157932|P2|STARTED|Overall Study||200
5348300|NCT00235391|13157933|P1|STARTED|Overall Study||97
5348301|NCT00235326|13157950|P2|NOT COMPLETED|Overall Study||1400
5348302|NCT00235326|13157951|P1|NOT COMPLETED|Overall Study||746
5348303|NCT00235326|13157950|P2|COMPLETED|Overall Study||1586
5348304|NCT00235326|13157951|P1|COMPLETED|Overall Study||829
5348305|NCT00235326|13157950|P2|STARTED|Overall Study||2986
5348306|NCT00235326|13157951|P1|STARTED|Overall Study||1575
5348307|NCT00234884|13157955|P1|NOT COMPLETED|Overall Study||1630
5348308|NCT00234884|13157955|P1|COMPLETED|Overall Study||1805
5348309|NCT00234884|13157955|P1|STARTED|Overall Study||3435
5348310|NCT00234832|13157965|P2|NOT COMPLETED|Overall Study||996
5348311|NCT00234832|13157966|P1|NOT COMPLETED|Overall Study||1016
5348312|NCT00234832|13157965|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
5348313|NCT00234832|13157966|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
5348314|NCT00234832|13157965|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
5348315|NCT00234832|13157966|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
5348316|NCT00234533|13157991|P1|NOT COMPLETED|Overall Study||11
5348317|NCT00234533|13157991|P1|COMPLETED|Overall Study||240
5348318|NCT00234533|13157991|P1|STARTED|Overall Study||251
5348319|NCT00234494|13158010|P1|NOT COMPLETED|Overall Study||2
5348320|NCT00234494|13158010|P1|COMPLETED|Overall Study||43
5348321|NCT00234494|13158010|P1|STARTED|Overall Study||45
5348322|NCT00234286|13158017|P1|NOT COMPLETED|Overall Study||0
5348323|NCT00234286|13158017|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
5348324|NCT00234286|13158017|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
5348325|NCT00234104|13158056|P4|NOT COMPLETED|Overall Study||8
5348326|NCT00234104|13158057|P3|NOT COMPLETED|Overall Study||5
5348327|NCT00234104|13158058|P2|NOT COMPLETED|Overall Study||1
5348328|NCT00234104|13158059|P1|NOT COMPLETED|Overall Study||4
5348329|NCT00234104|13158056|P4|COMPLETED|Overall Study||21
5348330|NCT00234104|13158057|P3|COMPLETED|Overall Study||29
5348331|NCT00234104|13158058|P2|COMPLETED|Overall Study||28
5348332|NCT00234104|13158059|P1|COMPLETED|Overall Study||26
5348333|NCT00234104|13158056|P4|STARTED|Overall Study||29
5348334|NCT00234104|13158057|P3|STARTED|Overall Study||34
5348335|NCT00234104|13158058|P2|STARTED|Overall Study||29
5348336|NCT00234104|13158059|P1|STARTED|Overall Study||30
5348337|NCT00234078|13158073|P4|NOT COMPLETED|Overall Study||4
5348338|NCT00234078|13158074|P3|NOT COMPLETED|Overall Study||10
5348339|NCT00234078|13158075|P2|NOT COMPLETED|Overall Study||9
5348340|NCT00234078|13158076|P1|NOT COMPLETED|Overall Study||6
5348341|NCT00234078|13158073|P4|COMPLETED|Overall Study||68
5348342|NCT00234078|13158074|P3|COMPLETED|Overall Study||64
5348343|NCT00234078|13158075|P2|COMPLETED|Overall Study||63
5348344|NCT00234078|13158076|P1|COMPLETED|Overall Study||66
5348345|NCT00234078|13158073|P4|STARTED|Overall Study||72
5348346|NCT00234078|13158074|P3|STARTED|Overall Study||74
5348347|NCT00234078|13158075|P2|STARTED|Overall Study||72
5348348|NCT00234078|13158076|P1|STARTED|Overall Study||72
5348349|NCT00234065|13158100|P2|NOT COMPLETED|Overall Study||356
5348350|NCT00234065|13158101|P1|NOT COMPLETED|Overall Study||475
5348351|NCT00234065|13158100|P2|COMPLETED|Overall Study||1004
5348352|NCT00234065|13158101|P1|COMPLETED|Overall Study||881
5348353|NCT00234065|13158100|P2|STARTED|Overall Study||1360
5348354|NCT00234065|13158101|P1|STARTED|Overall Study||1356
5348355|NCT00234052|13158117|P1|NOT COMPLETED|Follow-up for 5 Years||49
5348356|NCT00234052|13158117|P1|COMPLETED|Follow-up for 5 Years||1
5348357|NCT00234052|13158117|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
5348358|NCT00234052|13158117|P1|NOT COMPLETED|Treatment||21
5348359|NCT00234052|13158117|P1|COMPLETED|Treatment||30
5348360|NCT00234052|13158117|P1|Went Into Maintenance Phase|Treatment||30
5348361|NCT00234052|13158117|P1|Completed 6 Cycles|Treatment||33
5348362|NCT00234052|13158117|P1|Started Treatment|Treatment||50
5348363|NCT00234052|13158117|P1|STARTED|Treatment||51
5348364|NCT00234039|13158127|P1|NOT COMPLETED|Overall Study||50
5348365|NCT00234039|13158127|P1|COMPLETED|Overall Study||8
5348366|NCT00234039|13158127|P1|Eligible and Began Protocol Therapy|Overall Study||47
5348367|NCT00234039|13158127|P1|Eligible|Overall Study||49
5348368|NCT00234039|13158127|P1|STARTED|Overall Study||58
5348369|NCT00233987|13158134|P1|NOT COMPLETED|Overall Study||15
5348370|NCT00233987|13158134|P1|COMPLETED|Overall Study||83
5348371|NCT00233987|13158134|P1|Eligible and Treated|Overall Study||92
5348372|NCT00233987|13158134|P1|Eligible|Overall Study||94
5348373|NCT00233987|13158134|P1|STARTED|Overall Study||98
5348374|NCT00233948|13158143|P6|NOT COMPLETED|Overall Study||0
5348375|NCT00233948|13158144|P5|NOT COMPLETED|Overall Study||0
5348376|NCT00233948|13158145|P4|NOT COMPLETED|Overall Study||0
5348377|NCT00233948|13158146|P3|NOT COMPLETED|Overall Study||0
5348378|NCT00233948|13158147|P2|NOT COMPLETED|Overall Study||0
5348379|NCT00233948|13158148|P1|NOT COMPLETED|Overall Study||1
5348380|NCT00233948|13158143|P6|COMPLETED|Overall Study||12
5348381|NCT00233948|13158144|P5|COMPLETED|Overall Study||4
5348382|NCT00233948|13158145|P4|COMPLETED|Overall Study||3
5348383|NCT00233948|13158146|P3|COMPLETED|Overall Study||3
5348384|NCT00233948|13158147|P2|COMPLETED|Overall Study||3
5348385|NCT00233948|13158148|P1|COMPLETED|Overall Study||3
5348386|NCT00233948|13158143|P6|STARTED|Overall Study||12
5348387|NCT00233948|13158144|P5|STARTED|Overall Study||4
5348388|NCT00233948|13158145|P4|STARTED|Overall Study||3
5348389|NCT00233948|13158146|P3|STARTED|Overall Study||3
5348390|NCT00233948|13158147|P2|STARTED|Overall Study||3
5348391|NCT00233948|13158148|P1|STARTED|Overall Study||4
5348392|NCT00233519|13158165|P2|NOT COMPLETED|Overall Study||1
5348393|NCT00233519|13158166|P1|NOT COMPLETED|Overall Study||1
5348394|NCT00233519|13158165|P2|COMPLETED|Overall Study||9
5348395|NCT00233519|13158166|P1|COMPLETED|Overall Study||6
5348396|NCT00233519|13158165|P2|STARTED|Overall Study||10
5348397|NCT00233519|13158166|P1|STARTED|Overall Study||7
5348398|NCT00233480|13158174|P2|NOT COMPLETED|Overall Study||1
5348399|NCT00233480|13158175|P1|NOT COMPLETED|Overall Study||0
5348400|NCT00233480|13158174|P2|COMPLETED|Overall Study||12
5348401|NCT00233480|13158175|P1|COMPLETED|Overall Study||14
5348402|NCT00233480|13158174|P2|STARTED|Overall Study||13
5348403|NCT00233480|13158175|P1|STARTED|Overall Study||14
5348404|NCT00233454|13158191|P1|NOT COMPLETED|Overall Study||6
5348405|NCT00233454|13158191|P1|COMPLETED|Overall Study||20
5348406|NCT00233454|13158191|P1|2 Months (for Response Rate)|Overall Study||26
5348407|NCT00233454|13158191|P1|STARTED|Overall Study||26
5348408|NCT00233402|13158199|P2|NOT COMPLETED|Overall Study||124
5348409|NCT00233402|13158200|P1|NOT COMPLETED|Overall Study||104
5348410|NCT00233402|13158199|P2|COMPLETED|Overall Study||271
5348411|NCT00233402|13158200|P1|COMPLETED|Overall Study||280
5348412|NCT00233402|13158199|P2|STARTED|Overall Study||395
5348413|NCT00233402|13158200|P1|STARTED|Overall Study||384
5348414|NCT00233324|13158215|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
5348415|NCT00233324|13158216|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
5348416|NCT00233324|13158217|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
5348417|NCT00233324|13158218|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
5348418|NCT00233324|13158215|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
5348419|NCT00233324|13158216|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
5348420|NCT00233324|13158217|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
5348421|NCT00233324|13158218|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
5348422|NCT00233324|13158215|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
5348423|NCT00233324|13158216|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
5348424|NCT00233324|13158217|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
5348425|NCT00233324|13158218|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
5348426|NCT00233324|13158215|P4|NOT COMPLETED|Main Study||47
5348427|NCT00233324|13158216|P3|NOT COMPLETED|Main Study||62
5348428|NCT00233324|13158217|P2|NOT COMPLETED|Main Study||60
5348429|NCT00233324|13158218|P1|NOT COMPLETED|Main Study||68
5348430|NCT00233324|13158215|P4|COMPLETED|Main Study||280
5348431|NCT00233324|13158216|P3|COMPLETED|Main Study||274
5348432|NCT00233324|13158217|P2|COMPLETED|Main Study||275
5348433|NCT00233324|13158218|P1|COMPLETED|Main Study||250
5348434|NCT00233324|13158215|P4|STARTED|Main Study||327
5348435|NCT00233324|13158216|P3|STARTED|Main Study||336
5348436|NCT00233324|13158217|P2|STARTED|Main Study||335
5348437|NCT00233324|13158218|P1|STARTED|Main Study||318
5348438|NCT00233103|13158302|P2|NOT COMPLETED|Overall Study||6
5348439|NCT00233103|13158303|P1|NOT COMPLETED|Overall Study||5
5348440|NCT00233103|13158302|P2|COMPLETED|Overall Study||19
5348441|NCT00233103|13158303|P1|COMPLETED|Overall Study||22
5348442|NCT00233103|13158302|P2|STARTED|Overall Study||25
5348443|NCT00233103|13158303|P1|STARTED|Overall Study||27
5348444|NCT00233090|13158317|P2|NOT COMPLETED|Overall Study||0
5348445|NCT00233090|13158318|P1|NOT COMPLETED|Overall Study||0
5348446|NCT00233090|13158317|P2|COMPLETED|Overall Study||9
5348447|NCT00233090|13158318|P1|COMPLETED|Overall Study||12
5348448|NCT00233090|13158317|P2|STARTED|Overall Study||9
5348449|NCT00233090|13158318|P1|STARTED|Overall Study||12
5348450|NCT00233064|13158340|P2|NOT COMPLETED|Overall Study||12
5348451|NCT00233064|13158341|P1|NOT COMPLETED|Overall Study||14
5348452|NCT00233064|13158340|P2|COMPLETED|Overall Study||190
5348453|NCT00233064|13158341|P1|COMPLETED|Overall Study||197
5348454|NCT00233064|13158340|P2|STARTED|Overall Study||202
5348455|NCT00233064|13158341|P1|STARTED|Overall Study||211
5348456|NCT00232739|13158348|P1|NOT COMPLETED|Overall Study||9
5348457|NCT00232739|13158348|P1|COMPLETED|Overall Study||91
5348458|NCT00232739|13158348|P1|STARTED|Overall Study||100
5348459|NCT00232596|13158367|P2|NOT COMPLETED|12-Week Maintenance Phase||28
5348460|NCT00232596|13158368|P1|NOT COMPLETED|12-Week Maintenance Phase||12
5348461|NCT00232596|13158367|P2|COMPLETED|12-Week Maintenance Phase||97
5348462|NCT00232596|13158368|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
5348463|NCT00232596|13158367|P2|STARTED|12-Week Maintenance Phase||125
5348464|NCT00232596|13158368|P1|STARTED|12-Week Maintenance Phase||138
5348465|NCT00232596|13158367|P2|NOT COMPLETED|6-Week Titration Phase||29
5348466|NCT00232596|13158368|P1|NOT COMPLETED|6-Week Titration Phase||14
5348467|NCT00232596|13158367|P2|COMPLETED|6-Week Titration Phase||125
5348468|NCT00232596|13158368|P1|COMPLETED|6-Week Titration Phase||138
5348469|NCT00232596|13158367|P2|STARTED|6-Week Titration Phase||154
5348470|NCT00232596|13158368|P1|STARTED|6-Week Titration Phase||152
5348471|NCT00232583|13158420|P2|NOT COMPLETED|Overall Study||13
5348472|NCT00232583|13158421|P1|NOT COMPLETED|Overall Study||10
5348473|NCT00232583|13158420|P2|COMPLETED|Overall Study||16
5348474|NCT00232583|13158421|P1|COMPLETED|Overall Study||19
5348475|NCT00232583|13158420|P2|STARTED|Overall Study||29
5348476|NCT00232583|13158421|P1|STARTED|Overall Study||29
5348477|NCT00232557|13158459|P2|NOT COMPLETED|Overall Study||5
5348478|NCT00232557|13158460|P1|NOT COMPLETED|Overall Study||3
5348479|NCT00232557|13158459|P2|COMPLETED|Overall Study||60
5348480|NCT00232557|13158460|P1|COMPLETED|Overall Study||68
5348481|NCT00232557|13158459|P2|STARTED|Overall Study||65
5348482|NCT00232557|13158460|P1|STARTED|Overall Study||71
5348483|NCT00232544|13158470|P2|NOT COMPLETED|Overall Study||15
5348484|NCT00232544|13158471|P1|NOT COMPLETED|Overall Study||20
5348485|NCT00232544|13158470|P2|COMPLETED|Overall Study||111
5348486|NCT00232544|13158471|P1|COMPLETED|Overall Study||104
5348487|NCT00232544|13158470|P2|STARTED|Overall Study||126
5348488|NCT00232544|13158471|P1|STARTED|Overall Study||124
5348489|NCT00232505|13158481|P2|NOT COMPLETED|Overall Study||11
5348490|NCT00232505|13158482|P1|NOT COMPLETED|Overall Study||5
5348491|NCT00232505|13158481|P2|COMPLETED|Overall Study||60
5348492|NCT00232505|13158482|P1|COMPLETED|Overall Study||26
5348493|NCT00232505|13158481|P2|Off Protocol|Overall Study||0
5348494|NCT00232505|13158482|P1|Off Protocol|Overall Study||5
5348495|NCT00232505|13158481|P2|Early Progressors|Overall Study||5
5348496|NCT00232505|13158482|P1|Early Progressors|Overall Study||2
5348497|NCT00232505|13158481|P2|Not Evaluable|Overall Study||6
5348498|NCT00232505|13158482|P1|Not Evaluable|Overall Study||0
5348499|NCT00232505|13158481|P2|STARTED|Overall Study||71
5348500|NCT00232505|13158482|P1|STARTED|Overall Study||31
5348501|NCT00232479|13158495|P1|NOT COMPLETED|Overall Study||0
5348502|NCT00232479|13158495|P1|COMPLETED|Overall Study||44
5348503|NCT00232479|13158495|P1|STARTED|Overall Study||44
5348504|NCT00232180|13158502|P3|NOT COMPLETED|Open Label Phase||148
5348505|NCT00232180|13158503|P2|NOT COMPLETED|Open Label Phase||0
5348506|NCT00232180|13158504|P1|NOT COMPLETED|Open Label Phase||0
5348507|NCT00232180|13158502|P3|COMPLETED|Open Label Phase||1098
5348508|NCT00232180|13158503|P2|COMPLETED|Open Label Phase||0
5348509|NCT00232180|13158504|P1|COMPLETED|Open Label Phase||0
5348510|NCT00232180|13158502|P3|Treated|Open Label Phase||1245
5348511|NCT00232180|13158503|P2|Treated|Open Label Phase||0
5348512|NCT00232180|13158504|P1|Treated|Open Label Phase||0
5348513|NCT00232180|13158502|P3|STARTED|Open Label Phase||1246
5348514|NCT00232180|13158503|P2|STARTED|Open Label Phase||0
5348515|NCT00232180|13158504|P1|STARTED|Open Label Phase||0
5348516|NCT00232180|13158502|P3|NOT COMPLETED|Double-blind (DB) Phase||0
5348517|NCT00232180|13158503|P2|NOT COMPLETED|Double-blind (DB) Phase||605
5348518|NCT00232180|13158504|P1|NOT COMPLETED|Double-blind (DB) Phase||541
5348519|NCT00232180|13158502|P3|COMPLETED|Double-blind (DB) Phase||0
5348520|NCT00232180|13158503|P2|COMPLETED|Double-blind (DB) Phase||771
5348521|NCT00232180|13158504|P1|COMPLETED|Double-blind (DB) Phase||826
5348522|NCT00232180|13158502|P3|Treated|Double-blind (DB) Phase||0
5348523|NCT00232180|13158503|P2|Treated|Double-blind (DB) Phase||1372
5348524|NCT00232180|13158504|P1|Treated|Double-blind (DB) Phase||1364
5348525|NCT00232180|13158502|P3|STARTED|Double-blind (DB) Phase||0
5348526|NCT00232180|13158503|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
5348527|NCT00232180|13158504|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
5348528|NCT00232141|13158549|P2|NOT COMPLETED|Overall Study||26
5348529|NCT00232141|13158550|P1|NOT COMPLETED|Overall Study||31
5348530|NCT00232141|13158549|P2|COMPLETED|Overall Study||125
5348531|NCT00232141|13158550|P1|COMPLETED|Overall Study||120
5348532|NCT00232141|13158549|P2|STARTED|Overall Study||151
5348533|NCT00232141|13158550|P1|STARTED|Overall Study||151
5348534|NCT00231894|13158620|P2|NOT COMPLETED|Overall Study||1
5348535|NCT00231894|13158621|P1|NOT COMPLETED|Overall Study||1
5348536|NCT00231894|13158620|P2|COMPLETED|Overall Study||24
5348537|NCT00231894|13158621|P1|COMPLETED|Overall Study||30
5348538|NCT00231894|13158620|P2|STARTED|Overall Study||25
5348539|NCT00231894|13158621|P1|STARTED|Overall Study||31
5348540|NCT00231842|13158643|P1|NOT COMPLETED|Overall Study||11
5348541|NCT00231842|13158643|P1|COMPLETED|Overall Study||19
5348542|NCT00231842|13158643|P1|Completed Full Prescribed Therapy|Overall Study||19
5348543|NCT00231842|13158643|P1|Completed Prescribed RT|Overall Study||27
5348544|NCT00231842|13158643|P1|Completed First 3 Cycles|Overall Study||27
5348545|NCT00231842|13158643|P1|Initiated Therapy|Overall Study||27
5348546|NCT00231842|13158643|P1|STARTED|Overall Study||30
5348547|NCT00231816|13158650|P2|NOT COMPLETED|Overall Study||12
5348548|NCT00231816|13158651|P1|NOT COMPLETED|Overall Study||16
5348549|NCT00231816|13158650|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
5348550|NCT00231816|13158651|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
5348551|NCT00231816|13158650|P2|Vaccinated at Visit 2|Overall Study||371
5348552|NCT00231816|13158651|P1|Vaccinated at Visit 2|Overall Study||369
5348553|NCT00231816|13158650|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
5348554|NCT00231816|13158651|P1|Vaccinated at Visit 1|Overall Study||382
5348555|NCT00231816|13158650|P2|STARTED|Overall Study||381
5348556|NCT00231816|13158651|P1|STARTED|Overall Study||382
5348557|NCT00231777|13158666|P2|NOT COMPLETED|Overall Study||2
5348558|NCT00231777|13158667|P1|NOT COMPLETED|Overall Study||6
5348559|NCT00231777|13158666|P2|COMPLETED|Overall Study||44
5348560|NCT00231777|13158667|P1|COMPLETED|Overall Study||164
5348561|NCT00231777|13158666|P2|STARTED|Overall Study||46
5348562|NCT00231777|13158667|P1|STARTED|Overall Study||170
5348563|NCT00231478|13158681|P2|NOT COMPLETED|Overall Study||6
5348564|NCT00231478|13158682|P1|NOT COMPLETED|Overall Study||8
5348565|NCT00231478|13158681|P2|COMPLETED|Overall Study||78
5348566|NCT00231478|13158682|P1|COMPLETED|Overall Study||79
5348567|NCT00231478|13158681|P2|STARTED|Overall Study||84
5348568|NCT00231478|13158682|P1|STARTED|Overall Study||87
5348569|NCT00231465|13158694|P1|NOT COMPLETED|Overall Study||2
5348570|NCT00231465|13158694|P1|COMPLETED|Overall Study||42
5348571|NCT00231465|13158694|P1|STARTED|Overall Study||44
5348572|NCT00231413|13158707|P7|NOT COMPLETED|Overall Study||4
5348573|NCT00231413|13158708|P6|NOT COMPLETED|Overall Study||5
5348574|NCT00231413|13158709|P5|NOT COMPLETED|Overall Study||3
5348575|NCT00231413|13158710|P4|NOT COMPLETED|Overall Study||3
5348576|NCT00231413|13158711|P3|NOT COMPLETED|Overall Study||7
5348577|NCT00231413|13158712|P2|NOT COMPLETED|Overall Study||5
5348578|NCT00231413|13158713|P1|NOT COMPLETED|Overall Study||8
5348579|NCT00231413|13158707|P7|COMPLETED|Overall Study||46
5348580|NCT00231413|13158708|P6|COMPLETED|Overall Study||45
5348581|NCT00231413|13158709|P5|COMPLETED|Overall Study||45
5348582|NCT00231413|13158710|P4|COMPLETED|Overall Study||45
5348583|NCT00231413|13158711|P3|COMPLETED|Overall Study||42
5348584|NCT00231413|13158712|P2|COMPLETED|Overall Study||45
5348585|NCT00231413|13158713|P1|COMPLETED|Overall Study||80
5348586|NCT00231413|13158707|P7|STARTED|Overall Study||50
5348587|NCT00231413|13158708|P6|STARTED|Overall Study||50
5348588|NCT00231413|13158709|P5|STARTED|Overall Study||48
5348589|NCT00231413|13158710|P4|STARTED|Overall Study||48
5348590|NCT00231413|13158711|P3|STARTED|Overall Study||49
5348591|NCT00231413|13158712|P2|STARTED|Overall Study||50
5348592|NCT00231413|13158713|P1|STARTED|Overall Study||88
5348593|NCT00231309|13158869|P1|NOT COMPLETED|Overall Study||0
5348594|NCT00231309|13158869|P1|COMPLETED|Overall Study||10
5348595|NCT00231309|13158869|P1|STARTED|Overall Study||10
5348596|NCT00231283|13158874|P1|NOT COMPLETED|Overall Study||5
5348597|NCT00231283|13158874|P1|COMPLETED|Overall Study||95
5348598|NCT00231283|13158874|P1|STARTED|Overall Study||100
5348599|NCT00231179|13158883|P2|NOT COMPLETED|Overall Study||24
5348600|NCT00231179|13158884|P1|NOT COMPLETED|Overall Study||24
5348601|NCT00231179|13158883|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
5348602|NCT00231179|13158884|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
5348603|NCT00231179|13158883|P2|STARTED|Overall Study||150
5348604|NCT00231179|13158884|P1|STARTED|Overall Study||152
5348605|NCT00231153|13158900|P2|NOT COMPLETED|Overall Study||188
5348606|NCT00231153|13158901|P1|NOT COMPLETED|Overall Study||217
5348607|NCT00231153|13158900|P2|COMPLETED|Overall Study||720
5348608|NCT00231153|13158901|P1|COMPLETED|Overall Study||690
5348609|NCT00231153|13158900|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
5348610|NCT00231153|13158901|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
5348611|NCT00231114|13158911|P2|NOT COMPLETED|Post-Treatment Period||1
5348612|NCT00231114|13158912|P1|NOT COMPLETED|Post-Treatment Period||8
5348613|NCT00231114|13158911|P2|COMPLETED|Post-Treatment Period||97
5348614|NCT00231114|13158912|P1|COMPLETED|Post-Treatment Period||181
5348615|NCT00231114|13158911|P2|STARTED|Post-Treatment Period||98
5348616|NCT00231114|13158912|P1|STARTED|Post-Treatment Period||189
5348617|NCT00231114|13158911|P2|NOT COMPLETED|Treatment Period||0
5348618|NCT00231114|13158912|P1|NOT COMPLETED|Treatment Period||1
5348619|NCT00231114|13158911|P2|COMPLETED|Treatment Period||98
5348620|NCT00231114|13158912|P1|COMPLETED|Treatment Period||189
5348621|NCT00231114|13158911|P2|STARTED|Treatment Period||98
5348622|NCT00231114|13158912|P1|STARTED|Treatment Period||190
5348623|NCT00231114|13158911|P2|NOT COMPLETED|Randomized||3
5348624|NCT00231114|13158912|P1|NOT COMPLETED|Randomized||6
5348625|NCT00231114|13158911|P2|COMPLETED|Randomized||98
5348626|NCT00231114|13158912|P1|COMPLETED|Randomized||190
5348627|NCT00231114|13158911|P2|STARTED|Randomized||101
5348628|NCT00231114|13158912|P1|STARTED|Randomized||196
5348629|NCT00231062|13158948|P1|NOT COMPLETED|Overall Study||6
5348630|NCT00231062|13158948|P1|COMPLETED|Overall Study||109
5348631|NCT00231062|13158948|P1|STARTED|Overall Study||115
5348632|NCT00230971|13158956|P2|NOT COMPLETED|Baseline Participants||19
5348633|NCT00230971|13158957|P1|NOT COMPLETED|Baseline Participants||22
5348634|NCT00230971|13158956|P2|COMPLETED|Baseline Participants||216
5348635|NCT00230971|13158957|P1|COMPLETED|Baseline Participants||210
5348636|NCT00230971|13158956|P2|STARTED|Baseline Participants||235
5348637|NCT00230971|13158957|P1|STARTED|Baseline Participants||232
5348638|NCT00230971|13158956|P2|NOT COMPLETED|Randomization||3
5348639|NCT00230971|13158957|P1|NOT COMPLETED|Randomization||3
5348640|NCT00230971|13158956|P2|COMPLETED|Randomization||235
5348641|NCT00230971|13158957|P1|COMPLETED|Randomization||232
5348642|NCT00230971|13158956|P2|STARTED|Randomization||238
5348643|NCT00230971|13158957|P1|STARTED|Randomization||235
5348644|NCT00230802|13158971|P2|NOT COMPLETED|Overall Study||0
5348645|NCT00230802|13158972|P1|NOT COMPLETED|Overall Study||0
5348646|NCT00230802|13158971|P2|COMPLETED|Overall Study||23
5348647|NCT00230802|13158972|P1|COMPLETED|Overall Study||25
5348648|NCT00230802|13158971|P2|STARTED|Overall Study||23
5348649|NCT00230802|13158972|P1|STARTED|Overall Study||25
5348650|NCT00230737|13158985|P3|NOT COMPLETED|Overall Study||0
5348651|NCT00230737|13158986|P2|NOT COMPLETED|Overall Study||0
5348652|NCT00230737|13158987|P1|NOT COMPLETED|Overall Study||0
5348653|NCT00230737|13158985|P3|COMPLETED|Overall Study||8
5348654|NCT00230737|13158986|P2|COMPLETED|Overall Study||10
5348655|NCT00230737|13158987|P1|COMPLETED|Overall Study||9
5348656|NCT00230737|13158985|P3|STARTED|Overall Study||8
5348657|NCT00230737|13158986|P2|STARTED|Overall Study||10
5348658|NCT00230737|13158987|P1|STARTED|Overall Study||9
5348659|NCT00230282|13158995|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
5348660|NCT00230282|13158995|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
5348661|NCT00230282|13158995|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
5348662|NCT00230282|13158995|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
5348663|NCT00230282|13158995|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
5348664|NCT00230282|13158995|P1|STARTED|Fludarabine + Cyclophosphamide||25
5348665|NCT00230178|13159003|P3|NOT COMPLETED|Overall Study||7
5348666|NCT00230178|13159004|P2|NOT COMPLETED|Overall Study||7
5348667|NCT00230178|13159005|P1|NOT COMPLETED|Overall Study||4
5348668|NCT00230178|13159003|P3|COMPLETED|Overall Study||86
5348669|NCT00230178|13159004|P2|COMPLETED|Overall Study||86
5348670|NCT00230178|13159005|P1|COMPLETED|Overall Study||90
5348671|NCT00230178|13159003|P3|Treated|Overall Study||91
5348672|NCT00230178|13159004|P2|Treated|Overall Study||92
5348673|NCT00230178|13159005|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
5348674|NCT00230178|13159003|P3|STARTED|Overall Study||93
5348675|NCT00230178|13159004|P2|STARTED|Overall Study||93
5348676|NCT00230178|13159005|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
5348677|NCT00230126|13159021|P2|NOT COMPLETED|Overall Study||1
5348678|NCT00230126|13159022|P1|NOT COMPLETED|Overall Study||2
5348679|NCT00230126|13159021|P2|COMPLETED|Overall Study||27
5348680|NCT00230126|13159022|P1|COMPLETED|Overall Study||28
5348681|NCT00230126|13159021|P2|STARTED|Overall Study||28
5348682|NCT00230126|13159022|P1|STARTED|Overall Study||30
5348683|NCT00230100|13159034|P2|NOT COMPLETED|Overall Study||0
5348684|NCT00230100|13159035|P1|NOT COMPLETED|Overall Study||0
5348685|NCT00230100|13159034|P2|COMPLETED|Overall Study||17
5348686|NCT00230100|13159035|P1|COMPLETED|Overall Study||29
5348687|NCT00230100|13159034|P2|STARTED|Overall Study||17
5348688|NCT00230100|13159035|P1|STARTED|Overall Study||29
5348689|NCT00230048|13159057|P2|NOT COMPLETED|Overall Study||18
5348690|NCT00230048|13159058|P1|NOT COMPLETED|Overall Study||13
5348691|NCT00230048|13159057|P2|COMPLETED|Overall Study||37
5348692|NCT00230048|13159058|P1|COMPLETED|Overall Study||39
5348693|NCT00230048|13159057|P2|Completed Intervention/Control Session|Overall Study||55
5348694|NCT00230048|13159058|P1|Completed Intervention/Control Session|Overall Study||52
5348695|NCT00230048|13159057|P2|STARTED|Overall Study||55
5348696|NCT00230048|13159058|P1|STARTED|Overall Study||52
5348697|NCT00230022|13159068|P2|NOT COMPLETED|Overall Study||0
5348698|NCT00230022|13159069|P1|NOT COMPLETED|Overall Study||0
5348699|NCT00230022|13159068|P2|COMPLETED|Overall Study||15
5348700|NCT00230022|13159069|P1|COMPLETED|Overall Study||15
5348701|NCT00230022|13159068|P2|STARTED|Overall Study||15
5348702|NCT00230022|13159069|P1|STARTED|Overall Study||15
5348703|NCT00230009|13159077|P2|NOT COMPLETED|Follow-up||26
5348704|NCT00230009|13159078|P1|NOT COMPLETED|Follow-up||31
5348705|NCT00230009|13159077|P2|COMPLETED|Follow-up||24
5348706|NCT00230009|13159078|P1|COMPLETED|Follow-up||19
5348707|NCT00230009|13159077|P2|STARTED|Follow-up||50
5348708|NCT00230009|13159078|P1|STARTED|Follow-up||50
5348709|NCT00230009|13159077|P2|NOT COMPLETED|Single Session Intervention/Control||0
5348710|NCT00230009|13159078|P1|NOT COMPLETED|Single Session Intervention/Control||0
5348711|NCT00230009|13159077|P2|COMPLETED|Single Session Intervention/Control||50
5348712|NCT00230009|13159078|P1|COMPLETED|Single Session Intervention/Control||50
5348713|NCT00230009|13159077|P2|STARTED|Single Session Intervention/Control||50
5348714|NCT00230009|13159078|P1|STARTED|Single Session Intervention/Control||50
5348715|NCT00229970|13159095|P3|NOT COMPLETED|Overall Study||0
5348716|NCT00229970|13159096|P2|NOT COMPLETED|Overall Study||0
5348717|NCT00229970|13159097|P1|NOT COMPLETED|Overall Study||0
5348718|NCT00229970|13159095|P3|COMPLETED|Overall Study||75
5348719|NCT00229970|13159096|P2|COMPLETED|Overall Study||72
5348720|NCT00229970|13159097|P1|COMPLETED|Overall Study||78
5348721|NCT00229970|13159095|P3|STARTED|Overall Study||75
5348722|NCT00229970|13159096|P2|STARTED|Overall Study||72
5348723|NCT00229970|13159097|P1|STARTED|Overall Study||78
5348724|NCT00229957|13159107|P2|NOT COMPLETED|Overall Study||12
5348725|NCT00229957|13159108|P1|NOT COMPLETED|Overall Study||20
5348726|NCT00229957|13159107|P2|COMPLETED|Overall Study||139
5348727|NCT00229957|13159108|P1|COMPLETED|Overall Study||132
5348728|NCT00229957|13159107|P2|STARTED|Overall Study||151
5348729|NCT00229957|13159108|P1|STARTED|Overall Study||152
5348730|NCT00229931|13159116|P2|NOT COMPLETED|Overall Study||2
5348731|NCT00229931|13159117|P1|NOT COMPLETED|Overall Study||4
5348732|NCT00229931|13159116|P2|COMPLETED|Overall Study||3
5348733|NCT00229931|13159117|P1|COMPLETED|Overall Study||2
5348734|NCT00229931|13159116|P2|STARTED|Overall Study||5
5348735|NCT00229931|13159117|P1|STARTED|Overall Study||6
5348736|NCT00229723|13159132|P7|NOT COMPLETED|Maintenance Phase||10
5348737|NCT00229723|13159133|P6|NOT COMPLETED|Maintenance Phase||19
5348738|NCT00229723|13159134|P5|NOT COMPLETED|Maintenance Phase||15
5348739|NCT00229723|13159135|P4|NOT COMPLETED|Maintenance Phase||17
5348740|NCT00229723|13159136|P3|NOT COMPLETED|Maintenance Phase||9
5348741|NCT00229723|13159137|P2|NOT COMPLETED|Maintenance Phase||14
5348742|NCT00229723|13159138|P1|NOT COMPLETED|Maintenance Phase||25
5348743|NCT00229723|13159132|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
5348744|NCT00229723|13159133|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
5348745|NCT00229723|13159134|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
5348746|NCT00229723|13159135|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
5348747|NCT00229723|13159136|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
5348748|NCT00229723|13159137|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
5348749|NCT00229723|13159138|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
5348750|NCT00229723|13159132|P7|STARTED|Maintenance Phase||19
5348751|NCT00229723|13159133|P6|STARTED|Maintenance Phase||31
5348752|NCT00229723|13159134|P5|STARTED|Maintenance Phase||22
5348753|NCT00229723|13159135|P4|STARTED|Maintenance Phase||26
5348754|NCT00229723|13159136|P3|STARTED|Maintenance Phase||25
5348755|NCT00229723|13159137|P2|STARTED|Maintenance Phase||19
5348756|NCT00229723|13159138|P1|STARTED|Maintenance Phase||50
5348757|NCT00229723|13159132|P7|NOT COMPLETED|Concomitant Phase||3
5348758|NCT00229723|13159133|P6|NOT COMPLETED|Concomitant Phase||3
5348759|NCT00229723|13159134|P5|NOT COMPLETED|Concomitant Phase||2
5348760|NCT00229723|13159135|P4|NOT COMPLETED|Concomitant Phase||5
5348761|NCT00229723|13159136|P3|NOT COMPLETED|Concomitant Phase||6
5348762|NCT00229723|13159137|P2|NOT COMPLETED|Concomitant Phase||5
5348763|NCT00229723|13159138|P1|NOT COMPLETED|Concomitant Phase||10
5348764|NCT00229723|13159132|P7|COMPLETED|Concomitant Phase||19
5348765|NCT00229723|13159133|P6|COMPLETED|Concomitant Phase||31
5348766|NCT00229723|13159134|P5|COMPLETED|Concomitant Phase||22
5348767|NCT00229723|13159135|P4|COMPLETED|Concomitant Phase||26
5348768|NCT00229723|13159136|P3|COMPLETED|Concomitant Phase||25
5348769|NCT00229723|13159137|P2|COMPLETED|Concomitant Phase||19
5348770|NCT00229723|13159138|P1|COMPLETED|Concomitant Phase||50
5348771|NCT00229723|13159132|P7|STARTED|Concomitant Phase|Received randomized treatment|22
5348772|NCT00229723|13159133|P6|STARTED|Concomitant Phase|Received randomized treatment|34
5348773|NCT00229723|13159134|P5|STARTED|Concomitant Phase|Received randomized treatment|24
5348774|NCT00229723|13159135|P4|STARTED|Concomitant Phase|Received randomized treatment|31
5348775|NCT00229723|13159136|P3|STARTED|Concomitant Phase|Received randomized treatment|31
5348776|NCT00229723|13159137|P2|STARTED|Concomitant Phase|Received randomized treatment|24
5348777|NCT00229723|13159138|P1|STARTED|Concomitant Phase|Received randomized treatment|60
5348778|NCT00229658|13159191|P2|NOT COMPLETED|Overall Study||167
5348779|NCT00229658|13159192|P1|NOT COMPLETED|Overall Study||225
5348780|NCT00229658|13159191|P2|COMPLETED|Overall Study||364
5348781|NCT00229658|13159192|P1|COMPLETED|Overall Study||541
5348782|NCT00229658|13159191|P2|STARTED|Overall Study||531
5348783|NCT00229658|13159192|P1|STARTED|Overall Study||766
5348784|NCT00229619|13159220|P1|NOT COMPLETED|Overall Study||0
5348785|NCT00229619|13159220|P1|COMPLETED|Overall Study||11
5348786|NCT00229619|13159220|P1|STARTED|Overall Study||11
5348787|NCT00229203|13159228|P2|NOT COMPLETED|Overall Study||19
5348788|NCT00229203|13159229|P1|NOT COMPLETED|Overall Study||32
5348789|NCT00229203|13159228|P2|COMPLETED|Overall Study||0
5348790|NCT00229203|13159229|P1|COMPLETED|Overall Study||0
5348791|NCT00229203|13159228|P2|STARTED|Overall Study||19
5348792|NCT00229203|13159229|P1|STARTED|Overall Study||32
5348793|NCT00228943|13159241|P1|NOT COMPLETED|Week 2||1
5348794|NCT00228943|13159241|P1|COMPLETED|Week 2||27
5348795|NCT00228943|13159241|P1|STARTED|Week 2||28
5348796|NCT00228943|13159241|P1|NOT COMPLETED|Week 1||0
5348797|NCT00228943|13159241|P1|COMPLETED|Week 1||28
5348798|NCT00228943|13159241|P1|STARTED|Week 1||28
5348799|NCT00228917|13159257|P8|NOT COMPLETED|Overall Study||0
5348800|NCT00228917|13159258|P7|NOT COMPLETED|Overall Study||0
5348801|NCT00228917|13159259|P6|NOT COMPLETED|Overall Study||2
5348802|NCT00228917|13159260|P5|NOT COMPLETED|Overall Study||0
5348803|NCT00228917|13159261|P4|NOT COMPLETED|Overall Study||0
5348804|NCT00228917|13159262|P3|NOT COMPLETED|Overall Study||0
5348805|NCT00228917|13159263|P2|NOT COMPLETED|Overall Study||0
5348806|NCT00228917|13159264|P1|NOT COMPLETED|Overall Study||0
5348807|NCT00228917|13159257|P8|COMPLETED|Overall Study||33
5348808|NCT00228917|13159258|P7|COMPLETED|Overall Study||69
5348809|NCT00228917|13159259|P6|COMPLETED|Overall Study||102
5348810|NCT00228917|13159260|P5|COMPLETED|Overall Study||205
5348811|NCT00228917|13159261|P4|COMPLETED|Overall Study||33
5348812|NCT00228917|13159262|P3|COMPLETED|Overall Study||65
5348813|NCT00228917|13159263|P2|COMPLETED|Overall Study||96
5348814|NCT00228917|13159264|P1|COMPLETED|Overall Study||193
5348815|NCT00228917|13159257|P8|STARTED|Overall Study||33
5348816|NCT00228917|13159258|P7|STARTED|Overall Study||69
5348817|NCT00228917|13159259|P6|STARTED|Overall Study||104
5348818|NCT00228917|13159260|P5|STARTED|Overall Study||205
5348819|NCT00228917|13159261|P4|STARTED|Overall Study||33
5348820|NCT00228917|13159262|P3|STARTED|Overall Study||65
5348821|NCT00228917|13159263|P2|STARTED|Overall Study||96
5348822|NCT00228917|13159264|P1|STARTED|Overall Study||193
5348823|NCT00228813|13159310|P1|NOT COMPLETED|Overall Study||4
5348824|NCT00228813|13159310|P1|COMPLETED|Overall Study||4
5348825|NCT00228813|13159310|P1|STARTED|Overall Study||8
5348826|NCT00228566|13159316|P1|NOT COMPLETED|Overall Study||71
5348827|NCT00228566|13159316|P1|COMPLETED|Overall Study||176
5348828|NCT00228566|13159316|P1|STARTED|Overall Study||247
5348829|NCT00228553|13159320|P1|NOT COMPLETED|Overall Study||430
5348830|NCT00228553|13159320|P1|COMPLETED|Overall Study||313
5348831|NCT00228553|13159320|P1|STARTED|Overall Study||743
5348832|NCT00228384|13159326|P2|NOT COMPLETED|Overall Study||29
5348833|NCT00228384|13159327|P1|NOT COMPLETED|Overall Study||29
5348834|NCT00228384|13159326|P2|COMPLETED|Overall Study||47
5348835|NCT00228384|13159327|P1|COMPLETED|Overall Study||43
5348836|NCT00228384|13159326|P2|Three Year Follow-up (Final)|Overall Study||47
5348837|NCT00228384|13159327|P1|Three Year Follow-up (Final)|Overall Study||43
5348838|NCT00228384|13159326|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
5348839|NCT00228384|13159327|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
5348840|NCT00228384|13159326|P2|Baseline|Overall Study||76
5348841|NCT00228384|13159327|P1|Baseline|Overall Study||72
5348842|NCT00228384|13159326|P2|STARTED|Overall Study||76
5348843|NCT00228384|13159327|P1|STARTED|Overall Study||72
5348844|NCT00227994|13159367|P2|NOT COMPLETED|Overall Study||7
5348845|NCT00227994|13159368|P1|NOT COMPLETED|Overall Study||7
5348846|NCT00227994|13159367|P2|COMPLETED|Overall Study||13
5348847|NCT00227994|13159368|P1|COMPLETED|Overall Study||13
5348848|NCT00227994|13159367|P2|STARTED|Overall Study||20
5348849|NCT00227994|13159368|P1|STARTED|Overall Study||20
5348850|NCT00227903|13159378|P2|NOT COMPLETED|Overall Study||10
5348851|NCT00227903|13159379|P1|NOT COMPLETED|Overall Study||5
5348852|NCT00227903|13159378|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
5348853|NCT00227903|13159379|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
5348854|NCT00227903|13159378|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
5348855|NCT00227903|13159379|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
5348856|NCT00227903|13159378|P2|STARTED|Overall Study||92
5348857|NCT00227903|13159379|P1|STARTED|Overall Study||91
5348858|NCT00227877|13159443|P4|NOT COMPLETED|12-months Follow-up||26
5348859|NCT00227877|13159444|P3|NOT COMPLETED|12-months Follow-up||31
5348860|NCT00227877|13159445|P2|NOT COMPLETED|12-months Follow-up||263
5348861|NCT00227877|13159446|P1|NOT COMPLETED|12-months Follow-up||310
5348862|NCT00227877|13159443|P4|COMPLETED|12-months Follow-up||266
5348863|NCT00227877|13159444|P3|COMPLETED|12-months Follow-up||266
5348864|NCT00227877|13159445|P2|COMPLETED|12-months Follow-up||765
5348865|NCT00227877|13159446|P1|COMPLETED|12-months Follow-up||758
5348866|NCT00227877|13159443|P4|STARTED|12-months Follow-up||292
5348867|NCT00227877|13159444|P3|STARTED|12-months Follow-up||297
5348868|NCT00227877|13159445|P2|STARTED|12-months Follow-up||1028
5348869|NCT00227877|13159446|P1|STARTED|12-months Follow-up||1068
5348870|NCT00227877|13159443|P4|NOT COMPLETED|3-months Follow-up||21
5348871|NCT00227877|13159444|P3|NOT COMPLETED|3-months Follow-up||52
5348872|NCT00227877|13159445|P2|NOT COMPLETED|3-months Follow-up||267
5348873|NCT00227877|13159446|P1|NOT COMPLETED|3-months Follow-up||313
5348874|NCT00227877|13159443|P4|COMPLETED|3-months Follow-up||271
5348875|NCT00227877|13159444|P3|COMPLETED|3-months Follow-up||245
5348876|NCT00227877|13159445|P2|COMPLETED|3-months Follow-up||761
5348877|NCT00227877|13159446|P1|COMPLETED|3-months Follow-up||755
5348878|NCT00227877|13159443|P4|STARTED|3-months Follow-up||292
5348879|NCT00227877|13159444|P3|STARTED|3-months Follow-up||297
5348880|NCT00227877|13159445|P2|STARTED|3-months Follow-up||1028
5348881|NCT00227877|13159446|P1|STARTED|3-months Follow-up||1068
5348882|NCT00227877|13159443|P4|NOT COMPLETED|Post-visit Checklist||0
5348883|NCT00227877|13159444|P3|NOT COMPLETED|Post-visit Checklist||1
5348884|NCT00227877|13159445|P2|NOT COMPLETED|Post-visit Checklist||13
5348885|NCT00227877|13159446|P1|NOT COMPLETED|Post-visit Checklist||24
5348886|NCT00227877|13159443|P4|COMPLETED|Post-visit Checklist||292
5348887|NCT00227877|13159444|P3|COMPLETED|Post-visit Checklist||296
5348888|NCT00227877|13159445|P2|COMPLETED|Post-visit Checklist||1015
5348889|NCT00227877|13159446|P1|COMPLETED|Post-visit Checklist||1044
5348890|NCT00227877|13159443|P4|STARTED|Post-visit Checklist||292
5348891|NCT00227877|13159444|P3|STARTED|Post-visit Checklist||297
5348892|NCT00227877|13159445|P2|STARTED|Post-visit Checklist||1028
5348893|NCT00227877|13159446|P1|STARTED|Post-visit Checklist||1068
5348894|NCT00227877|13159443|P4|NOT COMPLETED|Pre-visit Assessment||0
5348895|NCT00227877|13159444|P3|NOT COMPLETED|Pre-visit Assessment||0
5348896|NCT00227877|13159445|P2|NOT COMPLETED|Pre-visit Assessment||3
5348897|NCT00227877|13159446|P1|NOT COMPLETED|Pre-visit Assessment||7
5348898|NCT00227877|13159443|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
5348899|NCT00227877|13159444|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
5348900|NCT00227877|13159445|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
5348901|NCT00227877|13159446|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
5348902|NCT00227877|13159443|P4|STARTED|Pre-visit Assessment||292
5348903|NCT00227877|13159444|P3|STARTED|Pre-visit Assessment||297
5348904|NCT00227877|13159445|P2|STARTED|Pre-visit Assessment||1031
5348905|NCT00227877|13159446|P1|STARTED|Pre-visit Assessment||1075
5348906|NCT00227760|13159476|P1|NOT COMPLETED|Overall Study||0
5348907|NCT00227760|13159476|P1|COMPLETED|Overall Study||44
5348908|NCT00227760|13159476|P1|STARTED|Overall Study||44
5348909|NCT00227721|13159482|P1|NOT COMPLETED|Overall Study||1
5348910|NCT00227721|13159482|P1|COMPLETED|Overall Study||29
5348911|NCT00227721|13159482|P1|STARTED|Overall Study||30
5348912|NCT00227617|13159486|P3|NOT COMPLETED|Stage 2||0
5348913|NCT00227617|13159487|P2|NOT COMPLETED|Stage 2||0
5348914|NCT00227617|13159488|P1|NOT COMPLETED|Stage 2||0
5348915|NCT00227617|13159486|P3|COMPLETED|Stage 2||0
5348916|NCT00227617|13159487|P2|COMPLETED|Stage 2||0
5348917|NCT00227617|13159488|P1|COMPLETED|Stage 2||0
5348918|NCT00227617|13159486|P3|STARTED|Stage 2||0
5348919|NCT00227617|13159487|P2|STARTED|Stage 2||0
5348920|NCT00227617|13159488|P1|STARTED|Stage 2||0
5348921|NCT00227617|13159486|P3|NOT COMPLETED|Stage 1||0
5348922|NCT00227617|13159487|P2|NOT COMPLETED|Stage 1||0
5348923|NCT00227617|13159488|P1|NOT COMPLETED|Stage 1||0
5348924|NCT00227617|13159486|P3|COMPLETED|Stage 1||2
5348925|NCT00227617|13159487|P2|COMPLETED|Stage 1||12
5348926|NCT00227617|13159488|P1|COMPLETED|Stage 1||22
5348927|NCT00227617|13159486|P3|STARTED|Stage 1||2
5348928|NCT00227617|13159487|P2|STARTED|Stage 1||12
5348929|NCT00227617|13159488|P1|STARTED|Stage 1||22
5348930|NCT00227591|13159504|P1|NOT COMPLETED|Overall Study||1
5348931|NCT00227591|13159504|P1|COMPLETED|Overall Study||47
5348932|NCT00227591|13159504|P1|Began Treatment|Overall Study||47
5348933|NCT00227591|13159504|P1|STARTED|Overall Study|48 pts registered to the study|48
5348934|NCT00227539|13159508|P1|NOT COMPLETED|Overall Study||1
5348935|NCT00227539|13159508|P1|COMPLETED|Overall Study||24
5348936|NCT00227539|13159508|P1|STARTED|Overall Study||25
5348937|NCT00227370|13159516|P2|NOT COMPLETED|Overall Study||24
5348938|NCT00227370|13159517|P1|NOT COMPLETED|Overall Study||21
5348939|NCT00227370|13159516|P2|COMPLETED|Overall Study||46
5348940|NCT00227370|13159517|P1|COMPLETED|Overall Study||45
5348941|NCT00227370|13159516|P2|STARTED|Overall Study|Treatment Group|70
5348942|NCT00227370|13159517|P1|STARTED|Overall Study|Placebo Group|66
5348943|NCT00227344|13159537|P2|NOT COMPLETED|Overall Study||5
5348944|NCT00227344|13159538|P1|NOT COMPLETED|Overall Study||12
5348945|NCT00227344|13159537|P2|COMPLETED|Overall Study||37
5348946|NCT00227344|13159538|P1|COMPLETED|Overall Study||75
5348947|NCT00227344|13159537|P2|STARTED|Overall Study||42
5348948|NCT00227344|13159538|P1|STARTED|Overall Study||87
5348949|NCT00227305|13159558|P1|NOT COMPLETED|Overall Study||144
5348950|NCT00227305|13159558|P1|COMPLETED|Overall Study|Completed 26 weeks|237
5348951|NCT00227305|13159558|P1|Drug Received|Overall Study|safety population|380
5348952|NCT00227305|13159558|P1|STARTED|Overall Study|enrolled|381
5348953|NCT00227266|13159575|P3|NOT COMPLETED|Overall Study||4
5348954|NCT00227266|13159576|P2|NOT COMPLETED|Overall Study||0
5348955|NCT00227266|13159577|P1|NOT COMPLETED|Overall Study||1
5348956|NCT00227266|13159575|P3|COMPLETED|Overall Study||29
5348957|NCT00227266|13159576|P2|COMPLETED|Overall Study||30
5348958|NCT00227266|13159577|P1|COMPLETED|Overall Study||30
5348959|NCT00227266|13159575|P3|STARTED|Overall Study||33
5348960|NCT00227266|13159576|P2|STARTED|Overall Study||30
5348961|NCT00227266|13159577|P1|STARTED|Overall Study||31
5348962|NCT00227019|13159597|P1|NOT COMPLETED|Overall Study||0
5348963|NCT00227019|13159597|P1|COMPLETED|Overall Study||16
5348964|NCT00227019|13159597|P1|STARTED|Overall Study||16
5348965|NCT00226941|13159607|P4|NOT COMPLETED|Overall Study||2
5348966|NCT00226941|13159608|P3|NOT COMPLETED|Overall Study||0
5348967|NCT00226941|13159609|P2|NOT COMPLETED|Overall Study||0
5348968|NCT00226941|13159610|P1|NOT COMPLETED|Overall Study||0
5348969|NCT00226941|13159607|P4|COMPLETED|Overall Study||5
5348970|NCT00226941|13159608|P3|COMPLETED|Overall Study||4
5348971|NCT00226941|13159609|P2|COMPLETED|Overall Study||6
5348972|NCT00226941|13159610|P1|COMPLETED|Overall Study||6
5348973|NCT00226941|13159607|P4|STARTED|Overall Study||7
5348974|NCT00226941|13159608|P3|STARTED|Overall Study||4
5348975|NCT00226941|13159609|P2|STARTED|Overall Study||6
5348976|NCT00226941|13159610|P1|STARTED|Overall Study||6
5348977|NCT00226811|13159644|P1|NOT COMPLETED|Overall Study||76
5348978|NCT00226811|13159644|P1|COMPLETED|Overall Study||2
5348979|NCT00226811|13159644|P1|STARTED|Overall Study||78
5348980|NCT00226655|13159654|P1|NOT COMPLETED|Overall Study||79
5348981|NCT00226655|13159654|P1|COMPLETED|Overall Study||33
5348982|NCT00226655|13159654|P1|STARTED|Overall Study||112
5348983|NCT00226590|13159658|P1|NOT COMPLETED|Overall Study||0
5348984|NCT00226590|13159658|P1|COMPLETED|Overall Study||39
5348985|NCT00226590|13159658|P1|STARTED|Overall Study||39
5348986|NCT00226577|13159665|P1|NOT COMPLETED|Overall Study||0
5348987|NCT00226577|13159665|P1|COMPLETED|Overall Study||52
5348988|NCT00226577|13159665|P1|STARTED|Overall Study||52
5348989|NCT00226499|13159676|P3|NOT COMPLETED|Overall Study||359
5348990|NCT00226499|13159677|P2|NOT COMPLETED|Overall Study||1072
5348991|NCT00226499|13159678|P1|NOT COMPLETED|Overall Study||1074
5348992|NCT00226499|13159676|P3|COMPLETED|Overall Study||468
5348993|NCT00226499|13159677|P2|COMPLETED|Overall Study||1415
5348994|NCT00226499|13159678|P1|COMPLETED|Overall Study||1415
5348995|NCT00226499|13159676|P3|STARTED|Overall Study||827
5348996|NCT00226499|13159677|P2|STARTED|Overall Study||2487
5348997|NCT00226499|13159678|P1|STARTED|Overall Study||2489
5348998|NCT00226239|13159793|P1|NOT COMPLETED|Maintenance Cetuximab||14
5348999|NCT00226239|13159793|P1|COMPLETED|Maintenance Cetuximab||17
5349000|NCT00226239|13159793|P1|STARTED|Maintenance Cetuximab||31
5349001|NCT00226239|13159793|P1|NOT COMPLETED|XPE, Definitive Therapy||4
5349002|NCT00226239|13159793|P1|COMPLETED|XPE, Definitive Therapy||33
5349003|NCT00226239|13159793|P1|STARTED|XPE, Definitive Therapy||37
5349004|NCT00226239|13159793|P1|NOT COMPLETED|TPE, Induction Therapy||2
5349005|NCT00226239|13159793|P1|COMPLETED|TPE, Induction Therapy||37
5349006|NCT00226239|13159793|P1|STARTED|TPE, Induction Therapy||39
5349007|NCT00225784|13159802|P1|NOT COMPLETED|Overall Study||4
5349008|NCT00225784|13159802|P1|COMPLETED|Overall Study||33
5349009|NCT00225784|13159802|P1|STARTED|Overall Study||37
5349010|NCT00225758|13159813|P1|NOT COMPLETED|Overall Study||4
5349011|NCT00225758|13159813|P1|COMPLETED|Overall Study||23
5349012|NCT00225758|13159813|P1|STARTED|Overall Study||27
5349013|NCT00225732|13159823|P2|NOT COMPLETED|Overall Study||0
5349014|NCT00225732|13159824|P1|NOT COMPLETED|Overall Study||0
5349015|NCT00225732|13159823|P2|COMPLETED|Overall Study||166
5349016|NCT00225732|13159824|P1|COMPLETED|Overall Study||153
5349017|NCT00225732|13159823|P2|STARTED|Overall Study||166
5349018|NCT00225732|13159824|P1|STARTED|Overall Study||153
5349019|NCT00225498|13159830|P1|NOT COMPLETED|Overall Study||0
5349020|NCT00225498|13159830|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
5349021|NCT00225498|13159830|P1|STARTED|Overall Study||10
5349022|NCT00225420|13159834|P3|NOT COMPLETED|Overall Study||0
5349023|NCT00225420|13159835|P2|NOT COMPLETED|Overall Study||0
5349024|NCT00225420|13159836|P1|NOT COMPLETED|Overall Study||0
5349025|NCT00225420|13159834|P3|COMPLETED|Overall Study||3
5349026|NCT00225420|13159835|P2|COMPLETED|Overall Study||6
5349027|NCT00225420|13159836|P1|COMPLETED|Overall Study||9
5349028|NCT00225420|13159834|P3|STARTED|Overall Study||3
5349029|NCT00225420|13159835|P2|STARTED|Overall Study||6
5349030|NCT00225420|13159836|P1|STARTED|Overall Study||9
5349031|NCT00225277|13159845|P2|NOT COMPLETED|Overall Study||95
5349032|NCT00225277|13159846|P1|NOT COMPLETED|Overall Study||97
5349033|NCT00225277|13159845|P2|COMPLETED|Overall Study||178
5349034|NCT00225277|13159846|P1|COMPLETED|Overall Study||177
5349035|NCT00225277|13159845|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
5349036|NCT00225277|13159846|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
5349037|NCT00225251|13159864|P2|NOT COMPLETED|Overall Study||1
5349038|NCT00225251|13159865|P1|NOT COMPLETED|Overall Study||1
5349039|NCT00225251|13159864|P2|COMPLETED|Overall Study||6
5349040|NCT00225251|13159865|P1|COMPLETED|Overall Study||10
5349041|NCT00225251|13159864|P2|STARTED|Overall Study||7
5349042|NCT00225251|13159865|P1|STARTED|Overall Study||11
5349043|NCT00225212|13159879|P1|NOT COMPLETED|Overall Study||6
5349044|NCT00225212|13159879|P1|COMPLETED|Overall Study||29
5349045|NCT00225212|13159879|P1|STARTED|Overall Study||35
5349046|NCT00225147|13159888|P4|NOT COMPLETED|Open-label Phase||10
5349047|NCT00225147|13159889|P3|NOT COMPLETED|Open-label Phase||0
5349048|NCT00225147|13159890|P2|NOT COMPLETED|Open-label Phase||0
5349049|NCT00225147|13159891|P1|NOT COMPLETED|Open-label Phase||0
5349050|NCT00225147|13159888|P4|COMPLETED|Open-label Phase||52
5349051|NCT00225147|13159889|P3|COMPLETED|Open-label Phase||0
5349052|NCT00225147|13159890|P2|COMPLETED|Open-label Phase||0
5349053|NCT00225147|13159891|P1|COMPLETED|Open-label Phase||0
5349054|NCT00225147|13159888|P4|STARTED|Open-label Phase||62
5349055|NCT00225147|13159889|P3|STARTED|Open-label Phase||0
5349056|NCT00225147|13159890|P2|STARTED|Open-label Phase||0
5349057|NCT00225147|13159891|P1|STARTED|Open-label Phase||0
5349058|NCT00225147|13159888|P4|NOT COMPLETED|Double-blind Phase||0
5349059|NCT00225147|13159889|P3|NOT COMPLETED|Double-blind Phase||0
5349060|NCT00225147|13159890|P2|NOT COMPLETED|Double-blind Phase||0
5349061|NCT00225147|13159891|P1|NOT COMPLETED|Double-blind Phase||0
5349062|NCT00225147|13159888|P4|COMPLETED|Double-blind Phase||0
5349063|NCT00225147|13159889|P3|COMPLETED|Double-blind Phase||13
5349064|NCT00225147|13159890|P2|COMPLETED|Double-blind Phase||12
5349065|NCT00225147|13159891|P1|COMPLETED|Double-blind Phase||13
5349066|NCT00225147|13159888|P4|STARTED|Double-blind Phase||0
5349067|NCT00225147|13159889|P3|STARTED|Double-blind Phase||13
5349068|NCT00225147|13159890|P2|STARTED|Double-blind Phase||12
5349069|NCT00225147|13159891|P1|STARTED|Double-blind Phase||13
5349070|NCT00225017|13159907|P2|NOT COMPLETED|Overall Study||1
5349071|NCT00225017|13159908|P1|NOT COMPLETED|Overall Study||0
5349072|NCT00225017|13159907|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
5349073|NCT00225017|13159908|P1|COMPLETED|Overall Study||26
5349074|NCT00225017|13159907|P2|STARTED|Overall Study||24
5349075|NCT00225017|13159908|P1|STARTED|Overall Study||26
5349076|NCT00224952|13159921|P3|NOT COMPLETED|Overall Study||0
5349077|NCT00224952|13159922|P2|NOT COMPLETED|Overall Study||0
5349078|NCT00224952|13159923|P1|NOT COMPLETED|Overall Study||0
5349079|NCT00224952|13159921|P3|COMPLETED|Overall Study||134
5349080|NCT00224952|13159922|P2|COMPLETED|Overall Study||87
5349081|NCT00224952|13159923|P1|COMPLETED|Overall Study||53
5349082|NCT00224952|13159921|P3|STARTED|Overall Study||134
5349083|NCT00224952|13159922|P2|STARTED|Overall Study||87
5349084|NCT00224952|13159923|P1|STARTED|Overall Study||53
5349085|NCT00224874|13159938|P4|NOT COMPLETED|Overall Study||0
5349086|NCT00224874|13159939|P3|NOT COMPLETED|Overall Study||1
5349087|NCT00224874|13159940|P2|NOT COMPLETED|Overall Study||0
5349088|NCT00224874|13159941|P1|NOT COMPLETED|Overall Study||0
5349089|NCT00224874|13159938|P4|COMPLETED|Overall Study||42
5349090|NCT00224874|13159939|P3|COMPLETED|Overall Study||46
5349091|NCT00224874|13159940|P2|COMPLETED|Overall Study||45
5349092|NCT00224874|13159941|P1|COMPLETED|Overall Study||46
5349093|NCT00224874|13159938|P4|STARTED|Overall Study||42
5349094|NCT00224874|13159939|P3|STARTED|Overall Study||47
5349095|NCT00224874|13159940|P2|STARTED|Overall Study||45
5349096|NCT00224874|13159941|P1|STARTED|Overall Study||46
5349097|NCT00224770|13159986|P3|NOT COMPLETED|Overall Study||0
5349098|NCT00224770|13159987|P2|NOT COMPLETED|Overall Study||2
5349099|NCT00224770|13159988|P1|NOT COMPLETED|Overall Study||4
5349100|NCT00224770|13159986|P3|COMPLETED|Overall Study||14
5349101|NCT00224770|13159987|P2|COMPLETED|Overall Study||52
5349102|NCT00224770|13159988|P1|COMPLETED|Overall Study||38
5349103|NCT00224770|13159986|P3|STARTED|Overall Study||14
5349104|NCT00224770|13159987|P2|STARTED|Overall Study||54
5349105|NCT00224770|13159988|P1|STARTED|Overall Study||42
5349106|NCT00224484|13160023|P3|NOT COMPLETED|Overall Study||62
5349107|NCT00224484|13160024|P2|NOT COMPLETED|Overall Study||65
5349108|NCT00224484|13160025|P1|NOT COMPLETED|Overall Study||146
5349109|NCT00224484|13160023|P3|COMPLETED|Overall Study||1425
5349110|NCT00224484|13160024|P2|COMPLETED|Overall Study||1426
5349111|NCT00224484|13160025|P1|COMPLETED|Overall Study||2831
5349112|NCT00224484|13160023|P3|STARTED|Overall Study||1487
5349113|NCT00224484|13160024|P2|STARTED|Overall Study||1491
5349114|NCT00224484|13160025|P1|STARTED|Overall Study||2977
5349115|NCT00224289|13160084|P1|NOT COMPLETED|Overall Study||0
5349116|NCT00224289|13160084|P1|COMPLETED|Overall Study||17
5349117|NCT00224289|13160084|P1|STARTED|Overall Study||17
5349118|NCT00224133|13160089|P1|NOT COMPLETED|Overall Study||226
5349119|NCT00224133|13160089|P1|COMPLETED|Overall Study||435
5349120|NCT00224133|13160089|P1|STARTED|Overall Study||661
5349121|NCT00224120|13160095|P2|NOT COMPLETED|Overall Study||24
5349122|NCT00224120|13160096|P1|NOT COMPLETED|Overall Study||22
5349123|NCT00224120|13160095|P2|COMPLETED|Overall Study||205
5349124|NCT00224120|13160096|P1|COMPLETED|Overall Study||211
5349125|NCT00224120|13160095|P2|STARTED|Overall Study||229
5349126|NCT00224120|13160096|P1|STARTED|Overall Study||233
5349127|NCT00224107|13160106|P2|NOT COMPLETED|Overall Study||14
5349128|NCT00224107|13160107|P1|NOT COMPLETED|Overall Study||31
5349129|NCT00224107|13160106|P2|COMPLETED|Overall Study||214
5349130|NCT00224107|13160107|P1|COMPLETED|Overall Study||202
5349131|NCT00224107|13160106|P2|STARTED|Overall Study||228
5349132|NCT00224107|13160107|P1|STARTED|Overall Study||233
5349133|NCT00224055|13160117|P2|NOT COMPLETED|Overall Study||14
5349134|NCT00224055|13160118|P1|NOT COMPLETED|Overall Study||15
5349135|NCT00224055|13160117|P2|COMPLETED|Overall Study||31
5349136|NCT00224055|13160118|P1|COMPLETED|Overall Study||29
5349137|NCT00224055|13160117|P2|STARTED|Overall Study||45
5349138|NCT00224055|13160118|P1|STARTED|Overall Study||44
5349139|NCT00224042|13160128|P2|NOT COMPLETED|Overall Study||6
5349140|NCT00224042|13160129|P1|NOT COMPLETED|Overall Study||6
5349141|NCT00224042|13160128|P2|COMPLETED|Overall Study||20
5349142|NCT00224042|13160129|P1|COMPLETED|Overall Study||20
5349143|NCT00224042|13160128|P2|STARTED|Overall Study||26
5349144|NCT00224042|13160129|P1|STARTED|Overall Study||26
5349145|NCT00224029|13160141|P1|NOT COMPLETED|Overall Study||6
5349146|NCT00224029|13160141|P1|COMPLETED|Overall Study||18
5349147|NCT00224029|13160141|P1|STARTED|Overall Study||24
5349148|NCT00224016|13160147|P2|NOT COMPLETED|Follow-Up Period||0
5349149|NCT00224016|13160148|P1|NOT COMPLETED|Follow-Up Period||0
5349150|NCT00224016|13160147|P2|COMPLETED|Follow-Up Period||0
5349151|NCT00224016|13160148|P1|COMPLETED|Follow-Up Period||35
5349152|NCT00224016|13160147|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
5349153|NCT00224016|13160148|P1|STARTED|Follow-Up Period||35
5349154|NCT00224016|13160147|P2|NOT COMPLETED|Maintenance Period||1
5349155|NCT00224016|13160148|P1|NOT COMPLETED|Maintenance Period||2
5349156|NCT00224016|13160147|P2|COMPLETED|Maintenance Period||14
5349157|NCT00224016|13160148|P1|COMPLETED|Maintenance Period||36
5349158|NCT00224016|13160147|P2|STARTED|Maintenance Period||15
5349159|NCT00224016|13160148|P1|STARTED|Maintenance Period||38
5349160|NCT00224016|13160147|P2|NOT COMPLETED|Titration Period||1
5349161|NCT00224016|13160148|P1|NOT COMPLETED|Titration Period||1
5349162|NCT00224016|13160147|P2|COMPLETED|Titration Period||15
5349163|NCT00224016|13160148|P1|COMPLETED|Titration Period||38
5349164|NCT00224016|13160147|P2|STARTED|Titration Period||16
5349165|NCT00224016|13160148|P1|STARTED|Titration Period||39
5349166|NCT00224003|13160156|P1|NOT COMPLETED|Overall Study||7
5349167|NCT00224003|13160156|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
5349168|NCT00224003|13160156|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
5349169|NCT00223990|13160162|P2|NOT COMPLETED|Overall Study||9
5349170|NCT00223990|13160163|P1|NOT COMPLETED|Overall Study||7
5349171|NCT00223990|13160162|P2|COMPLETED|Overall Study||191
5349172|NCT00223990|13160163|P1|COMPLETED|Overall Study||193
5349173|NCT00223990|13160162|P2|STARTED|Overall Study||200
5349174|NCT00223990|13160163|P1|STARTED|Overall Study||200
5349175|NCT00223977|13160188|P3|NOT COMPLETED|Overall Study||3
5349176|NCT00223977|13160189|P2|NOT COMPLETED|Overall Study||11
5349177|NCT00223977|13160190|P1|NOT COMPLETED|Overall Study||9
5349178|NCT00223977|13160188|P3|COMPLETED|Overall Study||39
5349179|NCT00223977|13160189|P2|COMPLETED|Overall Study||47
5349180|NCT00223977|13160190|P1|COMPLETED|Overall Study||37
5349181|NCT00223977|13160188|P3|STARTED|Overall Study||42
5349182|NCT00223977|13160189|P2|STARTED|Overall Study||58
5349183|NCT00223977|13160190|P1|STARTED|Overall Study||46
5349184|NCT00223821|13160212|P2|NOT COMPLETED|Overall Study||10
5349185|NCT00223821|13160213|P1|NOT COMPLETED|Overall Study||4
5349186|NCT00223821|13160212|P2|COMPLETED|Overall Study||22
5349187|NCT00223821|13160213|P1|COMPLETED|Overall Study||28
5349188|NCT00223821|13160212|P2|Completed 6-month Follow-up|Overall Study||25
5349189|NCT00223821|13160213|P1|Completed 6-month Follow-up|Overall Study||28
5349190|NCT00223821|13160212|P2|Completed Post-treatment Assessment|Overall Study||27
5349191|NCT00223821|13160213|P1|Completed Post-treatment Assessment|Overall Study||31
5349192|NCT00223821|13160212|P2|Completed Therapy|Overall Study||28
5349193|NCT00223821|13160213|P1|Completed Therapy|Overall Study||31
5349194|NCT00223821|13160212|P2|STARTED|Overall Study||32
5349195|NCT00223821|13160213|P1|STARTED|Overall Study||32
5349196|NCT00223808|13160224|P3|NOT COMPLETED|Overall Study||5
5349197|NCT00223808|13160225|P2|NOT COMPLETED|Overall Study||5
5349198|NCT00223808|13160226|P1|NOT COMPLETED|Overall Study||3
5349199|NCT00223808|13160224|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
5349200|NCT00223808|13160225|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
5349201|NCT00223808|13160226|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
5349202|NCT00223808|13160224|P3|STARTED|Overall Study||23
5349203|NCT00223808|13160225|P2|STARTED|Overall Study||22
5349204|NCT00223808|13160226|P1|STARTED|Overall Study||22
5349205|NCT00223795|13160243|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
5349206|NCT00223795|13160244|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
5349207|NCT00223795|13160243|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
5349208|NCT00223795|13160244|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
5349209|NCT00223795|13160243|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
5349210|NCT00223795|13160244|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
5349211|NCT00223795|13160243|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
5349212|NCT00223795|13160244|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
5349213|NCT00223795|13160243|P2|COMPLETED|First Intervention - Eight Weeks||18
5349214|NCT00223795|13160244|P1|COMPLETED|First Intervention - Eight Weeks||19
5349215|NCT00223795|13160243|P2|STARTED|First Intervention - Eight Weeks||27
5349216|NCT00223795|13160244|P1|STARTED|First Intervention - Eight Weeks||26
5349217|NCT00223704|13160254|P3|NOT COMPLETED|Overall Study||0
5349218|NCT00223704|13160255|P2|NOT COMPLETED|Overall Study||0
5349219|NCT00223704|13160256|P1|NOT COMPLETED|Overall Study||0
5349220|NCT00223704|13160254|P3|COMPLETED|Overall Study||40
5349221|NCT00223704|13160255|P2|COMPLETED|Overall Study||37
5349222|NCT00223704|13160256|P1|COMPLETED|Overall Study||38
5349223|NCT00223704|13160254|P3|STARTED|Overall Study||40
5349224|NCT00223704|13160255|P2|STARTED|Overall Study||37
5349225|NCT00223704|13160256|P1|STARTED|Overall Study||38
5349226|NCT00223678|13160278|P2|NOT COMPLETED|Overall Study||0
5349227|NCT00223678|13160279|P1|NOT COMPLETED|Overall Study||0
5349228|NCT00223678|13160278|P2|COMPLETED|Overall Study||7
5349229|NCT00223678|13160279|P1|COMPLETED|Overall Study||13
5349230|NCT00223678|13160278|P2|STARTED|Overall Study||7
5349231|NCT00223678|13160279|P1|STARTED|Overall Study||13
5349232|NCT00223665|13160285|P1|NOT COMPLETED|Overall Study||0
5349233|NCT00223665|13160285|P1|COMPLETED|Overall Study||102
5349234|NCT00223665|13160285|P1|STARTED|Overall Study||102
5349235|NCT00223652|13160305|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
5349236|NCT00223652|13160306|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
5349237|NCT00223652|13160305|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
5349238|NCT00223652|13160306|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
5349239|NCT00223652|13160305|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
5349240|NCT00223652|13160306|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
5349241|NCT00223652|13160305|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
5349242|NCT00223652|13160306|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
5349243|NCT00223652|13160305|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
5349244|NCT00223652|13160306|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
5349245|NCT00223652|13160305|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
5349246|NCT00223652|13160306|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
5349247|NCT00223652|13160305|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
5349248|NCT00223652|13160306|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
5349249|NCT00223652|13160305|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
5349250|NCT00223652|13160306|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
5349251|NCT00223652|13160305|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
5349252|NCT00223652|13160306|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
5349253|NCT00223496|13160322|P1|NOT COMPLETED|Overall Study||22
5349254|NCT00223496|13160322|P1|COMPLETED|Overall Study||10
5349255|NCT00223496|13160322|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
5349256|NCT00223262|13160328|P2|NOT COMPLETED|Overall Study||1
5349257|NCT00223262|13160329|P1|NOT COMPLETED|Overall Study||8
5349258|NCT00223262|13160328|P2|COMPLETED|Overall Study||11
5349259|NCT00223262|13160329|P1|COMPLETED|Overall Study||8
5349260|NCT00223262|13160328|P2|STARTED|Overall Study||12
5349261|NCT00223262|13160329|P1|STARTED|Overall Study||16
5349262|NCT00223236|13160337|P2|NOT COMPLETED|Overall Study||14
5349263|NCT00223236|13160338|P1|NOT COMPLETED|Overall Study||7
5349264|NCT00223236|13160337|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
5349265|NCT00223236|13160338|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
5349266|NCT00223236|13160337|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
5349267|NCT00223236|13160338|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
5349268|NCT00223080|13160352|P2|NOT COMPLETED|Overall Study||797
5349269|NCT00223080|13160353|P1|NOT COMPLETED|Overall Study||796
5349270|NCT00223080|13160352|P2|COMPLETED|Overall Study||7401
5349271|NCT00223080|13160353|P1|COMPLETED|Overall Study||7401
5349272|NCT00223080|13160352|P2|STARTED|Overall Study||8198
5349273|NCT00223080|13160353|P1|STARTED|Overall Study||8197
5349274|NCT00222729|13160371|P1|NOT COMPLETED|Overall Study||3
5349275|NCT00222729|13160371|P1|COMPLETED|Overall Study||37
5349276|NCT00222729|13160371|P1|STARTED|Overall Study||40
5349277|NCT00222131|13160380|P2|NOT COMPLETED|Overall Study||0
5349278|NCT00222131|13160381|P1|NOT COMPLETED|Overall Study||0
5349279|NCT00222131|13160380|P2|COMPLETED|Overall Study||35
5349280|NCT00222131|13160381|P1|COMPLETED|Overall Study||38
5349281|NCT00222131|13160380|P2|STARTED|Overall Study||35
5349282|NCT00222131|13160381|P1|STARTED|Overall Study||38
5349283|NCT00222105|13160389|P1|NOT COMPLETED|Overall Study||14
5349284|NCT00222105|13160389|P1|COMPLETED|Overall Study||11
5349285|NCT00222105|13160389|P1|STARTED|Overall Study||25
5349286|NCT00221299|13160397|P4|NOT COMPLETED|Overall Study||1
5349287|NCT00221299|13160398|P3|NOT COMPLETED|Overall Study||0
5349288|NCT00221299|13160399|P2|NOT COMPLETED|Overall Study||2
5349289|NCT00221299|13160400|P1|NOT COMPLETED|Overall Study||1
5349290|NCT00221299|13160397|P4|COMPLETED|Overall Study||10
5349291|NCT00221299|13160398|P3|COMPLETED|Overall Study||14
5349292|NCT00221299|13160399|P2|COMPLETED|Overall Study||11
5349293|NCT00221299|13160400|P1|COMPLETED|Overall Study||10
5349294|NCT00221299|13160397|P4|STARTED|Overall Study||11
5349295|NCT00221299|13160398|P3|STARTED|Overall Study||14
5349296|NCT00221299|13160399|P2|STARTED|Overall Study||13
5349297|NCT00221299|13160400|P1|STARTED|Overall Study||11
5349298|NCT00221195|13160410|P2|NOT COMPLETED|Therapy 2 (Months 10-15)||0
5349299|NCT00221195|13160411|P1|NOT COMPLETED|Therapy 2 (Months 10-15)||2
5349300|NCT00221195|13160410|P2|COMPLETED|Therapy 2 (Months 10-15)||14
5349301|NCT00221195|13160411|P1|COMPLETED|Therapy 2 (Months 10-15)||12
5349302|NCT00221195|13160410|P2|STARTED|Therapy 2 (Months 10-15)||14
5349303|NCT00221195|13160411|P1|STARTED|Therapy 2 (Months 10-15)||14
5349304|NCT00221195|13160410|P2|NOT COMPLETED|Washout Period (Months 7-9)||1
5349305|NCT00221195|13160411|P1|NOT COMPLETED|Washout Period (Months 7-9)||0
5349306|NCT00221195|13160410|P2|COMPLETED|Washout Period (Months 7-9)||14
5349307|NCT00221195|13160411|P1|COMPLETED|Washout Period (Months 7-9)||14
5349308|NCT00221195|13160410|P2|STARTED|Washout Period (Months 7-9)||15
5349309|NCT00221195|13160411|P1|STARTED|Washout Period (Months 7-9)||14
5349310|NCT00221195|13160410|P2|NOT COMPLETED|Therapy 1 (Months 1-6)||2
5349311|NCT00221195|13160411|P1|NOT COMPLETED|Therapy 1 (Months 1-6)||3
5349312|NCT00221195|13160410|P2|COMPLETED|Therapy 1 (Months 1-6)||15
5349313|NCT00221195|13160411|P1|COMPLETED|Therapy 1 (Months 1-6)||14
5349314|NCT00221195|13160410|P2|STARTED|Therapy 1 (Months 1-6)||17
5349315|NCT00221195|13160411|P1|STARTED|Therapy 1 (Months 1-6)||17
5349316|NCT00221117|13160420|P2|NOT COMPLETED|Overall Study||0
5349317|NCT00221117|13160421|P1|NOT COMPLETED|Overall Study||0
5349318|NCT00221117|13160420|P2|COMPLETED|Overall Study||9
5349319|NCT00221117|13160421|P1|COMPLETED|Overall Study||12
5349320|NCT00221117|13160420|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
5349321|NCT00221117|13160421|P1|STARTED|Overall Study||12
5349322|NCT00221104|13160433|P2|NOT COMPLETED|Overall Study||76
5349323|NCT00221104|13160434|P1|NOT COMPLETED|Overall Study||83
5349324|NCT00221104|13160433|P2|COMPLETED|Overall Study||709
5349325|NCT00221104|13160434|P1|COMPLETED|Overall Study||710
5349326|NCT00221104|13160433|P2|STARTED|Overall Study||785
5349327|NCT00221104|13160434|P1|STARTED|Overall Study||793
5349328|NCT00220961|13160450|P2|NOT COMPLETED|Overall Study||90
5349329|NCT00220961|13160451|P1|NOT COMPLETED|Overall Study||71
5349330|NCT00220961|13160450|P2|COMPLETED|Overall Study||213
5349331|NCT00220961|13160451|P1|COMPLETED|Overall Study||228
5349332|NCT00220961|13160450|P2|STARTED|Overall Study||303
5349333|NCT00220961|13160451|P1|STARTED|Overall Study||299
5349334|NCT00220805|13160467|P2|NOT COMPLETED|Overall Study||11
5349335|NCT00220805|13160468|P1|NOT COMPLETED|Overall Study||8
5349336|NCT00220805|13160467|P2|COMPLETED|Overall Study||16
5349337|NCT00220805|13160468|P1|COMPLETED|Overall Study||22
5349338|NCT00220805|13160467|P2|STARTED|Overall Study||27
5349339|NCT00220805|13160468|P1|STARTED|Overall Study||30
5349340|NCT00220779|13160489|P3|NOT COMPLETED|Overall Study||4
5349341|NCT00220779|13160490|P2|NOT COMPLETED|Overall Study||4
5349342|NCT00220779|13160491|P1|NOT COMPLETED|Overall Study||7
5349343|NCT00220779|13160489|P3|COMPLETED|Overall Study||37
5349344|NCT00220779|13160490|P2|COMPLETED|Overall Study||38
5349345|NCT00220779|13160491|P1|COMPLETED|Overall Study||38
5349346|NCT00220779|13160489|P3|STARTED|Overall Study||41
5349347|NCT00220779|13160490|P2|STARTED|Overall Study||42
5349348|NCT00220779|13160491|P1|STARTED|Overall Study||45
5349349|NCT00220740|13160501|P2|NOT COMPLETED|Withdrawal Period||15
5349350|NCT00220740|13160502|P1|NOT COMPLETED|Withdrawal Period||6
5349351|NCT00220740|13160501|P2|COMPLETED|Withdrawal Period||16
5349352|NCT00220740|13160502|P1|COMPLETED|Withdrawal Period||37
5349353|NCT00220740|13160501|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
5349354|NCT00220740|13160502|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
5349355|NCT00220740|13160501|P2|NOT COMPLETED|Rescue Treatment||18
5349356|NCT00220740|13160502|P1|NOT COMPLETED|Rescue Treatment||19
5349357|NCT00220740|13160501|P2|COMPLETED|Rescue Treatment||5
5349358|NCT00220740|13160502|P1|COMPLETED|Rescue Treatment||26
5349359|NCT00220740|13160501|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
5349360|NCT00220740|13160502|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
5349361|NCT00220740|13160501|P2|NOT COMPLETED|Efficacy Period||46
5349362|NCT00220740|13160502|P1|NOT COMPLETED|Efficacy Period||26
5349363|NCT00220740|13160501|P2|COMPLETED|Efficacy Period||12
5349364|NCT00220740|13160502|P1|COMPLETED|Efficacy Period||33
5349365|NCT00220740|13160501|P2|STARTED|Efficacy Period||58
5349366|NCT00220740|13160502|P1|STARTED|Efficacy Period||59
5349367|NCT00220727|13160516|P2|NOT COMPLETED|Second Infusion (Week <6)||0
5349368|NCT00220727|13160517|P1|NOT COMPLETED|Second Infusion (Week <6)||1
5349369|NCT00220727|13160516|P2|COMPLETED|Second Infusion (Week <6)||4
5349370|NCT00220727|13160517|P1|COMPLETED|Second Infusion (Week <6)||3
5349371|NCT00220727|13160516|P2|STARTED|Second Infusion (Week <6)||4
5349372|NCT00220727|13160517|P1|STARTED|Second Infusion (Week <6)||4
5349373|NCT00220727|13160516|P2|NOT COMPLETED|First Infusion (Week 0)||0
5349374|NCT00220727|13160517|P1|NOT COMPLETED|First Infusion (Week 0)||0
5349375|NCT00220727|13160516|P2|COMPLETED|First Infusion (Week 0)||4
5349376|NCT00220727|13160517|P1|COMPLETED|First Infusion (Week 0)||4
5349377|NCT00220727|13160516|P2|STARTED|First Infusion (Week 0)||4
5349378|NCT00220727|13160517|P1|STARTED|First Infusion (Week 0)||4
5349379|NCT00220701|13160533|P2|NOT COMPLETED|Overall Study||4
5349380|NCT00220701|13160534|P1|NOT COMPLETED|Overall Study||5
5349381|NCT00220701|13160533|P2|COMPLETED|Overall Study||13
5349382|NCT00220701|13160534|P1|COMPLETED|Overall Study||12
5349383|NCT00220701|13160533|P2|STARTED|Overall Study||17
5349384|NCT00220701|13160534|P1|STARTED|Overall Study||17
5349385|NCT00220636|13160550|P1|NOT COMPLETED|Overall Study||4
5349386|NCT00220636|13160550|P1|COMPLETED|Overall Study||11
5349387|NCT00220636|13160550|P1|STARTED|Overall Study||15
5349388|NCT00219557|13160560|P3|NOT COMPLETED|Phase 2||33
5349389|NCT00219557|13160561|P2|NOT COMPLETED|Phase 2||69
5349390|NCT00219557|13160562|P1|NOT COMPLETED|Phase 2||0
5349391|NCT00219557|13160560|P3|COMPLETED|Phase 2||1
5349392|NCT00219557|13160561|P2|COMPLETED|Phase 2||0
5349393|NCT00219557|13160562|P1|COMPLETED|Phase 2||0
5349394|NCT00219557|13160560|P3|Treated|Phase 2||31
5349395|NCT00219557|13160561|P2|Treated|Phase 2||68
5349396|NCT00219557|13160562|P1|Treated|Phase 2||0
5349397|NCT00219557|13160560|P3|STARTED|Phase 2||34
5349398|NCT00219557|13160561|P2|STARTED|Phase 2||69
5349399|NCT00219557|13160562|P1|STARTED|Phase 2||0
5349400|NCT00219557|13160560|P3|NOT COMPLETED|Phase 1||0
5349401|NCT00219557|13160561|P2|NOT COMPLETED|Phase 1||0
5349402|NCT00219557|13160562|P1|NOT COMPLETED|Phase 1||7
5349403|NCT00219557|13160560|P3|COMPLETED|Phase 1||0
5349404|NCT00219557|13160561|P2|COMPLETED|Phase 1||0
5349405|NCT00219557|13160562|P1|COMPLETED|Phase 1||1
5349406|NCT00219557|13160560|P3|STARTED|Phase 1||0
5349407|NCT00219557|13160561|P2|STARTED|Phase 1||0
5349408|NCT00219557|13160562|P1|STARTED|Phase 1||8
5349409|NCT00219544|13160590|P2|NOT COMPLETED|Double Blind Treatment Period||0
5349410|NCT00219544|13160591|P1|NOT COMPLETED|Double Blind Treatment Period||0
5349411|NCT00219544|13160590|P2|COMPLETED|Double Blind Treatment Period||77
5349412|NCT00219544|13160591|P1|COMPLETED|Double Blind Treatment Period||80
5349413|NCT00219544|13160590|P2|STARTED|Double Blind Treatment Period||77
5349414|NCT00219544|13160591|P1|STARTED|Double Blind Treatment Period||80
5349415|NCT00219544|13160590|P2|NOT COMPLETED|Single Blind Treatment Period||0
5349416|NCT00219544|13160591|P1|NOT COMPLETED|Single Blind Treatment Period||22
5349417|NCT00219544|13160590|P2|COMPLETED|Single Blind Treatment Period||0
5349418|NCT00219544|13160591|P1|COMPLETED|Single Blind Treatment Period||234
5349419|NCT00219544|13160590|P2|STARTED|Single Blind Treatment Period||0
5349420|NCT00219544|13160591|P1|STARTED|Single Blind Treatment Period||256
5349421|NCT00219349|13160629|P1|NOT COMPLETED|Escitalopram Phase||3
5349422|NCT00219349|13160629|P1|COMPLETED|Escitalopram Phase||4
5349423|NCT00219349|13160629|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
5349424|NCT00219349|13160629|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
5349425|NCT00219349|13160629|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
5349426|NCT00219349|13160629|P1|STARTED|Cognitive Behavioral Therapy Phase||25
5349427|NCT00219284|13160642|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
5349428|NCT00219284|13160643|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
5349429|NCT00219284|13160642|P2|COMPLETED|Extension Phase - 8 Weeks||99
5349430|NCT00219284|13160643|P1|COMPLETED|Extension Phase - 8 Weeks||112
5349431|NCT00219284|13160642|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
5349432|NCT00219284|13160643|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
5349433|NCT00219284|13160642|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
5349434|NCT00219284|13160643|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
5349435|NCT00219284|13160642|P2|COMPLETED|Treatment Phase - 16 Weeks||128
5349436|NCT00219284|13160643|P1|COMPLETED|Treatment Phase - 16 Weeks||136
5349437|NCT00219284|13160642|P2|STARTED|Treatment Phase - 16 Weeks||179
5349438|NCT00219284|13160643|P1|STARTED|Treatment Phase - 16 Weeks||180
5349439|NCT00219141|13160668|P3|NOT COMPLETED|Overall Study||12
5349440|NCT00219141|13160669|P2|NOT COMPLETED|Overall Study||21
5349441|NCT00219141|13160670|P1|NOT COMPLETED|Overall Study||14
5349442|NCT00219141|13160668|P3|COMPLETED|Overall Study||142
5349443|NCT00219141|13160669|P2|COMPLETED|Overall Study||131
5349444|NCT00219141|13160670|P1|COMPLETED|Overall Study||140
5349445|NCT00219141|13160668|P3|STARTED|Overall Study||154
5349446|NCT00219141|13160669|P2|STARTED|Overall Study||152
5349447|NCT00219141|13160670|P1|STARTED|Overall Study||154
5349448|NCT00218634|13160716|P2|NOT COMPLETED|Overall Study||15
5349449|NCT00218634|13160717|P1|NOT COMPLETED|Overall Study||8
5349450|NCT00218634|13160716|P2|COMPLETED|Overall Study||30
5349451|NCT00218634|13160717|P1|COMPLETED|Overall Study||36
5349452|NCT00218634|13160716|P2|STARTED|Overall Study||45
5349453|NCT00218634|13160717|P1|STARTED|Overall Study||44
5349454|NCT00218543|13160737|P1|NOT COMPLETED|Overall Study||15
5349455|NCT00218543|13160737|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
5349456|NCT00218543|13160737|P1|STARTED|Overall Study||20
5349457|NCT00218491|13160745|P3|NOT COMPLETED|Overall Study||0
5349458|NCT00218491|13160746|P2|NOT COMPLETED|Overall Study||0
5349459|NCT00218491|13160747|P1|NOT COMPLETED|Overall Study||0
5349460|NCT00218491|13160745|P3|COMPLETED|Overall Study||38
5349461|NCT00218491|13160746|P2|COMPLETED|Overall Study||33
5349462|NCT00218491|13160747|P1|COMPLETED|Overall Study||40
5349463|NCT00218491|13160745|P3|STARTED|Overall Study||38
5349464|NCT00218491|13160746|P2|STARTED|Overall Study||33
5349465|NCT00218491|13160747|P1|STARTED|Overall Study||40
5349466|NCT00218465|13160757|P2|NOT COMPLETED|Overall Study||18
5349467|NCT00218465|13160758|P1|NOT COMPLETED|Overall Study||17
5349468|NCT00218465|13160757|P2|COMPLETED|Overall Study||30
5349469|NCT00218465|13160758|P1|COMPLETED|Overall Study||33
5349470|NCT00218465|13160757|P2|STARTED|Overall Study||48
5349471|NCT00218465|13160758|P1|STARTED|Overall Study||50
5349472|NCT00218439|13160770|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
5349473|NCT00218439|13160771|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
5349474|NCT00218439|13160770|P2|COMPLETED|Second Intervention (4 Weeks)||30
5349475|NCT00218439|13160771|P1|COMPLETED|Second Intervention (4 Weeks)||33
5349476|NCT00218439|13160770|P2|STARTED|Second Intervention (4 Weeks)||35
5349477|NCT00218439|13160771|P1|STARTED|Second Intervention (4 Weeks)||40
5349478|NCT00218439|13160770|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
5349479|NCT00218439|13160771|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
5349480|NCT00218439|13160770|P2|COMPLETED|First Intervention (4 Weeks)||35
5349481|NCT00218439|13160771|P1|COMPLETED|First Intervention (4 Weeks)||40
5349482|NCT00218439|13160770|P2|STARTED|First Intervention (4 Weeks)||47
5349483|NCT00218439|13160771|P1|STARTED|First Intervention (4 Weeks)||58
5349484|NCT00218426|13160788|P3|NOT COMPLETED|Overall Study||91
5349485|NCT00218426|13160789|P2|NOT COMPLETED|Overall Study||86
5349486|NCT00218426|13160790|P1|NOT COMPLETED|Overall Study||48
5349487|NCT00218426|13160788|P3|COMPLETED|Overall Study||11
5349488|NCT00218426|13160789|P2|COMPLETED|Overall Study||16
5349489|NCT00218426|13160790|P1|COMPLETED|Overall Study||54
5349490|NCT00218426|13160788|P3|STARTED|Overall Study||102
5349491|NCT00218426|13160789|P2|STARTED|Overall Study||102
5349492|NCT00218426|13160790|P1|STARTED|Overall Study||102
5349493|NCT00218387|13160831|P3|NOT COMPLETED|Overall Study||23
5349494|NCT00218387|13160832|P2|NOT COMPLETED|Overall Study||18
5349495|NCT00218387|13160833|P1|NOT COMPLETED|Overall Study||15
5349496|NCT00218387|13160831|P3|COMPLETED|Overall Study||17
5349497|NCT00218387|13160832|P2|COMPLETED|Overall Study||25
5349498|NCT00218387|13160833|P1|COMPLETED|Overall Study||25
5349499|NCT00218387|13160831|P3|STARTED|Overall Study||40
5349500|NCT00218387|13160832|P2|STARTED|Overall Study||43
5349501|NCT00218387|13160833|P1|STARTED|Overall Study||40
5349502|NCT00218335|13160848|P4|NOT COMPLETED|Overall Study||36
5349503|NCT00218335|13160849|P3|NOT COMPLETED|Overall Study||54
5349504|NCT00218335|13160850|P2|NOT COMPLETED|Overall Study||3
5349505|NCT00218335|13160851|P1|NOT COMPLETED|Overall Study||6
5349506|NCT00218335|13160848|P4|COMPLETED|Overall Study||388
5349507|NCT00218335|13160849|P3|COMPLETED|Overall Study||319
5349508|NCT00218335|13160850|P2|COMPLETED|Overall Study||110
5349509|NCT00218335|13160851|P1|COMPLETED|Overall Study||108
5349510|NCT00218335|13160848|P4|18 Month Follow-up|Overall Study||368
5349511|NCT00218335|13160849|P3|18 Month Follow-up|Overall Study||296
5349512|NCT00218335|13160850|P2|18 Month Follow-up|Overall Study||108
5349513|NCT00218335|13160851|P1|18 Month Follow-up|Overall Study||101
5349514|NCT00218335|13160848|P4|12 Month Follow-up|Overall Study||303
5349515|NCT00218335|13160849|P3|12 Month Follow-up|Overall Study||244
5349516|NCT00218335|13160850|P2|12 Month Follow-up|Overall Study||102
5349517|NCT00218335|13160851|P1|12 Month Follow-up|Overall Study||95
5349518|NCT00218335|13160848|P4|6 Month Follow-up|Overall Study||301
5349519|NCT00218335|13160849|P3|6 Month Follow-up|Overall Study||219
5349520|NCT00218335|13160850|P2|6 Month Follow-up|Overall Study||99
5349521|NCT00218335|13160851|P1|6 Month Follow-up|Overall Study||103
5349522|NCT00218335|13160848|P4|STARTED|Overall Study||424
5349523|NCT00218335|13160849|P3|STARTED|Overall Study||373
5349524|NCT00218335|13160850|P2|STARTED|Overall Study||113
5349525|NCT00218335|13160851|P1|STARTED|Overall Study||114
5349526|NCT00218296|13160915|P2|NOT COMPLETED|Overall Study||121
5349527|NCT00218296|13160916|P1|NOT COMPLETED|Overall Study||111
5349528|NCT00218296|13160915|P2|COMPLETED|Overall Study||48
5349529|NCT00218296|13160916|P1|COMPLETED|Overall Study||52
5349530|NCT00218296|13160915|P2|Attended Visti|Overall Study||102
5349531|NCT00218296|13160916|P1|Attended Visti|Overall Study||97
5349532|NCT00218296|13160915|P2|STARTED|Overall Study||169
5349533|NCT00218296|13160916|P1|STARTED|Overall Study||163
5349534|NCT00218062|13160936|P4|NOT COMPLETED|Overall Study||13
5349535|NCT00218062|13160937|P3|NOT COMPLETED|Overall Study||12
5349536|NCT00218062|13160938|P2|NOT COMPLETED|Overall Study||16
5349537|NCT00218062|13160939|P1|NOT COMPLETED|Overall Study||15
5349538|NCT00218062|13160936|P4|COMPLETED|Overall Study||3
5349539|NCT00218062|13160937|P3|COMPLETED|Overall Study||3
5349540|NCT00218062|13160938|P2|COMPLETED|Overall Study||4
5349541|NCT00218062|13160939|P1|COMPLETED|Overall Study||7
5349542|NCT00218062|13160936|P4|Received First Dose of Study Medication|Overall Study||12
5349543|NCT00218062|13160937|P3|Received First Dose of Study Medication|Overall Study||10
5349544|NCT00218062|13160938|P2|Received First Dose of Study Medication|Overall Study||11
5349545|NCT00218062|13160939|P1|Received First Dose of Study Medication|Overall Study||16
5349546|NCT00218062|13160936|P4|STARTED|Overall Study||16
5349547|NCT00218062|13160937|P3|STARTED|Overall Study||15
5349548|NCT00218062|13160938|P2|STARTED|Overall Study||20
5349549|NCT00218062|13160939|P1|STARTED|Overall Study||22
5349550|NCT00218036|13160970|P5|NOT COMPLETED|Overall Study||6
5349551|NCT00218036|13160971|P4|NOT COMPLETED|Overall Study||6
5349552|NCT00218036|13160972|P3|NOT COMPLETED|Overall Study||8
5349553|NCT00218036|13160973|P2|NOT COMPLETED|Overall Study||3
5349554|NCT00218036|13160974|P1|NOT COMPLETED|Overall Study||5
5349555|NCT00218036|13160970|P5|COMPLETED|Overall Study||3
5349556|NCT00218036|13160971|P4|COMPLETED|Overall Study||6
5349557|NCT00218036|13160972|P3|COMPLETED|Overall Study||5
5349558|NCT00218036|13160973|P2|COMPLETED|Overall Study||3
5349559|NCT00218036|13160974|P1|COMPLETED|Overall Study||6
5349560|NCT00218036|13160970|P5|STARTED|Overall Study||9
5349561|NCT00218036|13160971|P4|STARTED|Overall Study||12
5349562|NCT00218036|13160972|P3|STARTED|Overall Study||13
5349563|NCT00218036|13160973|P2|STARTED|Overall Study||6
5349564|NCT00218036|13160974|P1|STARTED|Overall Study||11
5349565|NCT00218023|13161000|P4|NOT COMPLETED|Overall Study||7
5349566|NCT00218023|13161001|P3|NOT COMPLETED|Overall Study||10
5349567|NCT00218023|13161002|P2|NOT COMPLETED|Overall Study||15
5349568|NCT00218023|13161003|P1|NOT COMPLETED|Overall Study||13
5349569|NCT00218023|13161000|P4|COMPLETED|Overall Study||11
5349570|NCT00218023|13161001|P3|COMPLETED|Overall Study||6
5349571|NCT00218023|13161002|P2|COMPLETED|Overall Study||10
5349572|NCT00218023|13161003|P1|COMPLETED|Overall Study||9
5349573|NCT00218023|13161000|P4|Received Drug or Placebo in Phase II|Overall Study||18
5349574|NCT00218023|13161001|P3|Received Drug or Placebo in Phase II|Overall Study||15
5349575|NCT00218023|13161002|P2|Received Drug or Placebo in Phase II|Overall Study||24
5349576|NCT00218023|13161003|P1|Received Drug or Placebo in Phase II|Overall Study||18
5349577|NCT00218023|13161000|P4|STARTED|Overall Study||18
5349578|NCT00218023|13161001|P3|STARTED|Overall Study||16
5349579|NCT00218023|13161002|P2|STARTED|Overall Study||25
5349580|NCT00218023|13161003|P1|STARTED|Overall Study||22
5349581|NCT00217971|13161019|P2|NOT COMPLETED|Overall Study||33
5349582|NCT00217971|13161020|P1|NOT COMPLETED|Overall Study||24
5349583|NCT00217971|13161019|P2|COMPLETED|Overall Study||44
5349584|NCT00217971|13161020|P1|COMPLETED|Overall Study||55
5349585|NCT00217971|13161019|P2|STARTED|Overall Study||77
5349586|NCT00217971|13161020|P1|STARTED|Overall Study||79
5349587|NCT00217724|13161026|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
5349588|NCT00217724|13161027|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
5349589|NCT00217724|13161026|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
5349590|NCT00217724|13161027|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
5349591|NCT00217724|13161026|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
5349592|NCT00217724|13161027|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
5349593|NCT00217724|13161026|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
5349594|NCT00217724|13161027|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
5349595|NCT00217724|13161026|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
5349596|NCT00217724|13161027|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
5349597|NCT00217724|13161026|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
5349598|NCT00217724|13161027|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
5349599|NCT00217672|13161035|P2|NOT COMPLETED|Follow-up||0
5349600|NCT00217672|13161036|P1|NOT COMPLETED|Follow-up||5
5349601|NCT00217672|13161035|P2|COMPLETED|Follow-up||0
5349602|NCT00217672|13161036|P1|COMPLETED|Follow-up||69
5349603|NCT00217672|13161035|P2|STARTED|Follow-up||0
5349604|NCT00217672|13161036|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
5349605|NCT00217672|13161035|P2|NOT COMPLETED|Treatment||7
5349606|NCT00217672|13161036|P1|NOT COMPLETED|Treatment||67
5349607|NCT00217672|13161035|P2|COMPLETED|Treatment||0
5349608|NCT00217672|13161036|P1|COMPLETED|Treatment||0
5349609|NCT00217672|13161035|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
5349610|NCT00217672|13161036|P1|STARTED|Treatment||67
5349611|NCT00217672|13161035|P2|NOT COMPLETED|Allocation||0
5349612|NCT00217672|13161036|P1|NOT COMPLETED|Allocation||2
5349613|NCT00217672|13161035|P2|COMPLETED|Allocation||7
5349614|NCT00217672|13161036|P1|COMPLETED|Allocation||67
5349615|NCT00217672|13161035|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
5349616|NCT00217672|13161036|P1|STARTED|Allocation||69
5349617|NCT00217620|13161042|P1|NOT COMPLETED|Overall Study||51
5349618|NCT00217620|13161042|P1|COMPLETED|Overall Study||0
5349619|NCT00217620|13161042|P1|Eligible and Began Protocol Therapy|Overall Study||37
5349620|NCT00217620|13161042|P1|Eligible|Overall Study||38
5349621|NCT00217620|13161042|P1|STARTED|Overall Study||51
5349622|NCT00217594|13161053|P1|NOT COMPLETED|Overall Study||0
5349623|NCT00217594|13161053|P1|COMPLETED|Overall Study||31
5349624|NCT00217594|13161053|P1|STARTED|Overall Study||31
5349625|NCT00217581|13161057|P1|NOT COMPLETED|Overall Study||1
5349626|NCT00217581|13161057|P1|COMPLETED|Overall Study||38
5349627|NCT00217581|13161057|P1|STARTED|Overall Study||39
5349628|NCT00217490|13161069|P4|NOT COMPLETED|Overall Study||23
5349629|NCT00217490|13161070|P3|NOT COMPLETED|Overall Study||24
5349630|NCT00217490|13161071|P2|NOT COMPLETED|Overall Study||25
5349631|NCT00217490|13161072|P1|NOT COMPLETED|Overall Study||17
5349632|NCT00217490|13161069|P4|COMPLETED|Overall Study||130
5349633|NCT00217490|13161070|P3|COMPLETED|Overall Study||131
5349634|NCT00217490|13161071|P2|COMPLETED|Overall Study||128
5349635|NCT00217490|13161072|P1|COMPLETED|Overall Study||137
5349636|NCT00217490|13161069|P4|STARTED|Overall Study||153
5349637|NCT00217490|13161070|P3|STARTED|Overall Study||155
5349638|NCT00217490|13161071|P2|STARTED|Overall Study||153
5349639|NCT00217490|13161072|P1|STARTED|Overall Study||154
5349640|NCT00217464|13161086|P1|NOT COMPLETED|Overall Study||17
5349641|NCT00217464|13161086|P1|COMPLETED|Overall Study||0
5349642|NCT00217464|13161086|P1|STARTED|Overall Study||17
5349643|NCT00217438|13161093|P2|NOT COMPLETED|Overall Study||1
5349644|NCT00217438|13161094|P1|NOT COMPLETED|Overall Study||0
5349645|NCT00217438|13161093|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
5349646|NCT00217438|13161094|P1|COMPLETED|Overall Study||66
5349647|NCT00217438|13161093|P2|STARTED|Overall Study||64
5349648|NCT00217438|13161094|P1|STARTED|Overall Study||66
5349649|NCT00217425|13161102|P1|NOT COMPLETED|Overall Study||37
5349650|NCT00217425|13161102|P1|COMPLETED|Overall Study||9
5349651|NCT00217425|13161102|P1|Eligible and Treated|Overall Study||39
5349652|NCT00217425|13161102|P1|Treated|Overall Study||44
5349653|NCT00217425|13161102|P1|STARTED|Overall Study||46
5349654|NCT00217399|13161108|P1|NOT COMPLETED|Overall Study||0
5349655|NCT00217399|13161108|P1|COMPLETED|Overall Study||35
5349656|NCT00217399|13161108|P1|STARTED|Overall Study||35
5349657|NCT00217087|13161116|P2|NOT COMPLETED|Overall Study||20
5349658|NCT00217087|13161117|P1|NOT COMPLETED|Overall Study||11
5349659|NCT00217087|13161116|P2|COMPLETED|Overall Study||17
5349660|NCT00217087|13161117|P1|COMPLETED|Overall Study||25
5349661|NCT00217087|13161116|P2|STARTED|Overall Study||37
5349662|NCT00217087|13161117|P1|STARTED|Overall Study||36
5349663|NCT00217022|13161131|P2|NOT COMPLETED|Overall Study||1
5349664|NCT00217022|13161132|P1|NOT COMPLETED|Overall Study||1
5349665|NCT00217022|13161131|P2|COMPLETED|Overall Study||3
5349666|NCT00217022|13161132|P1|COMPLETED|Overall Study||11
5349667|NCT00217022|13161131|P2|STARTED|Overall Study||4
5349668|NCT00217022|13161132|P1|STARTED|Overall Study||12
5349669|NCT00216736|13161142|P2|NOT COMPLETED|Overall Study||1
5349670|NCT00216736|13161143|P1|NOT COMPLETED|Overall Study||1
5349671|NCT00216736|13161142|P2|COMPLETED|Overall Study||30
5349672|NCT00216736|13161143|P1|COMPLETED|Overall Study||31
5349673|NCT00216736|13161142|P2|STARTED|Overall Study||31
5349674|NCT00216736|13161143|P1|STARTED|Overall Study||32
5349675|NCT00216671|13161157|P2|NOT COMPLETED|Overall Study||50
5349676|NCT00216671|13161158|P1|NOT COMPLETED|Overall Study||35
5349677|NCT00216671|13161157|P2|COMPLETED|Overall Study||60
5349678|NCT00216671|13161158|P1|COMPLETED|Overall Study||75
5349679|NCT00216671|13161157|P2|STARTED|Overall Study||110
5349680|NCT00216671|13161158|P1|STARTED|Overall Study||110
5349681|NCT00216476|13161176|P3|NOT COMPLETED|Overall Study||17
5349682|NCT00216476|13161177|P2|NOT COMPLETED|Overall Study||107
5349683|NCT00216476|13161178|P1|NOT COMPLETED|Overall Study||105
5349684|NCT00216476|13161176|P3|COMPLETED|Overall Study||28
5349685|NCT00216476|13161177|P2|COMPLETED|Overall Study||230
5349686|NCT00216476|13161178|P1|COMPLETED|Overall Study||224
5349687|NCT00216476|13161176|P3|STARTED|Overall Study||45
5349688|NCT00216476|13161177|P2|STARTED|Overall Study||337
5349689|NCT00216476|13161178|P1|STARTED|Overall Study||329
5349690|NCT00216320|13161198|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
5349691|NCT00216320|13161199|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
5349692|NCT00216320|13161200|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
5349693|NCT00216320|13161198|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
5349694|NCT00216320|13161199|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
5349695|NCT00216320|13161200|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
5349696|NCT00216320|13161198|P3|STARTED|Phase 2 (Weeks 6 -12)||25
5349697|NCT00216320|13161199|P2|STARTED|Phase 2 (Weeks 6 -12)||35
5349698|NCT00216320|13161200|P1|STARTED|Phase 2 (Weeks 6 -12)||43
5349699|NCT00216320|13161198|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
5349700|NCT00216320|13161199|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
5349701|NCT00216320|13161200|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
5349702|NCT00216320|13161198|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
5349703|NCT00216320|13161199|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
5349704|NCT00216320|13161200|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
5349705|NCT00216320|13161198|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
5349706|NCT00216320|13161199|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
5349707|NCT00216320|13161200|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
5349708|NCT00216203|13161215|P1|NOT COMPLETED|Overall Study||2
5349709|NCT00216203|13161215|P1|COMPLETED|Overall Study||34
5349710|NCT00216203|13161215|P1|STARTED|Overall Study||36
5349711|NCT00216125|13161223|P3|NOT COMPLETED|Randomization Phase||8
5349712|NCT00216125|13161224|P2|NOT COMPLETED|Randomization Phase||11
5349713|NCT00216125|13161225|P1|NOT COMPLETED|Randomization Phase||0
5349714|NCT00216125|13161223|P3|COMPLETED|Randomization Phase||74
5349715|NCT00216125|13161224|P2|COMPLETED|Randomization Phase||73
5349716|NCT00216125|13161225|P1|COMPLETED|Randomization Phase||0
5349717|NCT00216125|13161223|P3|DSMB Cohort for Futility|Randomization Phase||74
5349718|NCT00216125|13161224|P2|DSMB Cohort for Futility|Randomization Phase||73
5349719|NCT00216125|13161225|P1|DSMB Cohort for Futility|Randomization Phase||0
5349720|NCT00216125|13161223|P3|STARTED|Randomization Phase||82
5349721|NCT00216125|13161224|P2|STARTED|Randomization Phase||84
5349722|NCT00216125|13161225|P1|STARTED|Randomization Phase||0
5349723|NCT00216125|13161223|P3|NOT COMPLETED|Pre-Randomization Phase||0
5349724|NCT00216125|13161224|P2|NOT COMPLETED|Pre-Randomization Phase||0
5349725|NCT00216125|13161225|P1|NOT COMPLETED|Pre-Randomization Phase||77
5349726|NCT00216125|13161223|P3|COMPLETED|Pre-Randomization Phase||0
5349727|NCT00216125|13161224|P2|COMPLETED|Pre-Randomization Phase||0
5349728|NCT00216125|13161225|P1|COMPLETED|Pre-Randomization Phase||166
5349729|NCT00216125|13161223|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
5349730|NCT00216125|13161224|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
5349731|NCT00216125|13161225|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
5349732|NCT00216125|13161223|P3|STARTED|Pre-Randomization Phase||0
5349733|NCT00216125|13161224|P2|STARTED|Pre-Randomization Phase||0
5349734|NCT00216125|13161225|P1|STARTED|Pre-Randomization Phase||243
5349735|NCT00216099|13161234|P1|NOT COMPLETED|Overall Study||1
5349736|NCT00216099|13161234|P1|COMPLETED|Overall Study||48
5349737|NCT00216099|13161234|P1|Response Analysis|Overall Study||48
5349738|NCT00216099|13161234|P1|Toxicity Analysis|Overall Study||49
5349739|NCT00216099|13161234|P1|STARTED|Overall Study||49
5349740|NCT00216086|13161245|P1|NOT COMPLETED|Overall Study||4
5349741|NCT00216086|13161245|P1|COMPLETED|Overall Study||18
5349742|NCT00216086|13161245|P1|STARTED|Overall Study||22
5349743|NCT00216060|13161254|P2|NOT COMPLETED|Overall Study||0
5349744|NCT00216060|13161255|P1|NOT COMPLETED|Overall Study||0
5349745|NCT00216060|13161254|P2|COMPLETED|Overall Study||31
5349746|NCT00216060|13161255|P1|COMPLETED|Overall Study||32
5349747|NCT00216060|13161254|P2|STARTED|Overall Study||31
5349748|NCT00216060|13161255|P1|STARTED|Overall Study||32
5349749|NCT00215943|13161277|P2|NOT COMPLETED|Overall Study||14
5349750|NCT00215943|13161278|P1|NOT COMPLETED|Overall Study||9
5349751|NCT00215943|13161277|P2|COMPLETED|Overall Study||23
5349752|NCT00215943|13161278|P1|COMPLETED|Overall Study||27
5349753|NCT00215943|13161277|P2|STARTED|Overall Study||37
5349754|NCT00215943|13161278|P1|STARTED|Overall Study||36
5349755|NCT00215930|13161290|P1|NOT COMPLETED|Overall Study||0
5349756|NCT00215930|13161290|P1|COMPLETED|Overall Study||53
5349757|NCT00215930|13161290|P1|STARTED|Overall Study||53
5349758|NCT00215787|13161296|P1|NOT COMPLETED|Overall Study||0
5349759|NCT00215787|13161296|P1|COMPLETED|Overall Study||20
5349760|NCT00215787|13161296|P1|STARTED|Overall Study||20
5349761|NCT00215683|13161303|P3|NOT COMPLETED|Overall Study||32
5349762|NCT00215683|13161304|P2|NOT COMPLETED|Overall Study||26
5349763|NCT00215683|13161305|P1|NOT COMPLETED|Overall Study||29
5349764|NCT00215683|13161303|P3|COMPLETED|Overall Study||12
5349765|NCT00215683|13161304|P2|COMPLETED|Overall Study||22
5349766|NCT00215683|13161305|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
5349767|NCT00215683|13161303|P3|Switched to 160 mg|Overall Study||36
5349768|NCT00215683|13161304|P2|Switched to 160 mg|Overall Study||41
5349769|NCT00215683|13161305|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
5349770|NCT00215683|13161303|P3|STARTED|Overall Study||44
5349771|NCT00215683|13161304|P2|STARTED|Overall Study||48
5349772|NCT00215683|13161305|P1|STARTED|Overall Study|Safety analysis set|45
5349773|NCT00215657|13161324|P8|NOT COMPLETED|Overall Study||16
5349774|NCT00215657|13161325|P7|NOT COMPLETED|Overall Study||23
5349775|NCT00215657|13161326|P6|NOT COMPLETED|Overall Study||20
5349776|NCT00215657|13161327|P5|NOT COMPLETED|Overall Study||23
5349777|NCT00215657|13161328|P4|NOT COMPLETED|Overall Study||18
5349778|NCT00215657|13161329|P3|NOT COMPLETED|Overall Study||11
5349779|NCT00215657|13161330|P2|NOT COMPLETED|Overall Study||11
5349780|NCT00215657|13161331|P1|NOT COMPLETED|Overall Study||22
5349781|NCT00215657|13161324|P8|COMPLETED|Overall Study||11
5349782|NCT00215657|13161325|P7|COMPLETED|Overall Study||4
5349783|NCT00215657|13161326|P6|COMPLETED|Overall Study||4
5349784|NCT00215657|13161327|P5|COMPLETED|Overall Study||4
5349785|NCT00215657|13161328|P4|COMPLETED|Overall Study||6
5349786|NCT00215657|13161329|P3|COMPLETED|Overall Study||2
5349787|NCT00215657|13161330|P2|COMPLETED|Overall Study||1
5349788|NCT00215657|13161331|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
5349789|NCT00215657|13161324|P8|Started FE200486 CS07A|Overall Study||23
5349790|NCT00215657|13161325|P7|Started FE200486 CS07A|Overall Study||14
5349791|NCT00215657|13161326|P6|Started FE200486 CS07A|Overall Study||20
5349792|NCT00215657|13161327|P5|Started FE200486 CS07A|Overall Study||17
5349793|NCT00215657|13161328|P4|Started FE200486 CS07A|Overall Study||24
5349794|NCT00215657|13161329|P3|Started FE200486 CS07A|Overall Study||7
5349795|NCT00215657|13161330|P2|Started FE200486 CS07A|Overall Study||6
5349796|NCT00215657|13161331|P1|Started FE200486 CS07A|Overall Study||20
5349797|NCT00215657|13161324|P8|Intention-to-treat Population|Overall Study||27
5349798|NCT00215657|13161325|P7|Intention-to-treat Population|Overall Study||24
5349799|NCT00215657|13161326|P6|Intention-to-treat Population|Overall Study||24
5349800|NCT00215657|13161327|P5|Intention-to-treat Population|Overall Study||24
5349801|NCT00215657|13161328|P4|Intention-to-treat Population|Overall Study||24
5349802|NCT00215657|13161329|P3|Intention-to-treat Population|Overall Study||12
5349803|NCT00215657|13161330|P2|Intention-to-treat Population|Overall Study||12
5349804|NCT00215657|13161331|P1|Intention-to-treat Population|Overall Study||25
5349805|NCT00215657|13161324|P8|STARTED|Overall Study||27
5349806|NCT00215657|13161325|P7|STARTED|Overall Study||27
5349807|NCT00215657|13161326|P6|STARTED|Overall Study||24
5349808|NCT00215657|13161327|P5|STARTED|Overall Study||27
5349809|NCT00215657|13161328|P4|STARTED|Overall Study||24
5349810|NCT00215657|13161329|P3|STARTED|Overall Study||13
5349811|NCT00215657|13161330|P2|STARTED|Overall Study||12
5349812|NCT00215657|13161331|P1|STARTED|Overall Study||26
5349813|NCT00215644|13161359|P2|NOT COMPLETED|Overall Study||36
5349814|NCT00215644|13161360|P1|NOT COMPLETED|Overall Study||36
5349815|NCT00215644|13161359|P2|COMPLETED|Overall Study||0
5349816|NCT00215644|13161360|P1|COMPLETED|Overall Study||0
5349817|NCT00215644|13161359|P2|Treated|Overall Study||36
5349818|NCT00215644|13161360|P1|Treated|Overall Study||35
5349819|NCT00215644|13161359|P2|STARTED|Overall Study||36
5349820|NCT00215644|13161360|P1|STARTED|Overall Study||36
5349821|NCT00215553|13161387|P7|NOT COMPLETED|Overall Study||0
5349822|NCT00215553|13161388|P6|NOT COMPLETED|Overall Study||6
5349823|NCT00215553|13161389|P5|NOT COMPLETED|Overall Study||2
5349824|NCT00215553|13161390|P4|NOT COMPLETED|Overall Study||1
5349825|NCT00215553|13161391|P3|NOT COMPLETED|Overall Study||2
5349826|NCT00215553|13161392|P2|NOT COMPLETED|Overall Study||1
5349827|NCT00215553|13161393|P1|NOT COMPLETED|Overall Study||0
5349828|NCT00215553|13161387|P7|COMPLETED|Overall Study||36
5349829|NCT00215553|13161388|P6|COMPLETED|Overall Study||32
5349830|NCT00215553|13161389|P5|COMPLETED|Overall Study||26
5349831|NCT00215553|13161390|P4|COMPLETED|Overall Study||4
5349832|NCT00215553|13161391|P3|COMPLETED|Overall Study||4
5349833|NCT00215553|13161392|P2|COMPLETED|Overall Study||5
5349834|NCT00215553|13161393|P1|COMPLETED|Overall Study||5
5349835|NCT00215553|13161387|P7|STARTED|Overall Study||36
5349836|NCT00215553|13161388|P6|STARTED|Overall Study||38
5349837|NCT00215553|13161389|P5|STARTED|Overall Study||28
5349838|NCT00215553|13161390|P4|STARTED|Overall Study||5
5349839|NCT00215553|13161391|P3|STARTED|Overall Study||6
5349840|NCT00215553|13161392|P2|STARTED|Overall Study||6
5349841|NCT00215553|13161393|P1|STARTED|Overall Study||5
5349842|NCT00215540|13161426|P3|NOT COMPLETED|Overall Study||0
5349843|NCT00215540|13161427|P2|NOT COMPLETED|Overall Study||0
5349844|NCT00215540|13161428|P1|NOT COMPLETED|Overall Study||1
5349845|NCT00215540|13161426|P3|COMPLETED|Overall Study||44
5349846|NCT00215540|13161427|P2|COMPLETED|Overall Study||47
5349847|NCT00215540|13161428|P1|COMPLETED|Overall Study||44
5349848|NCT00215540|13161426|P3|STARTED|Overall Study||44
5349849|NCT00215540|13161427|P2|STARTED|Overall Study||47
5349850|NCT00215540|13161428|P1|STARTED|Overall Study||45
5349851|NCT00215150|13161463|P1|NOT COMPLETED|Randomization Phase Placebo||1
5349852|NCT00215150|13161463|P1|COMPLETED|Randomization Phase Placebo||10
5349853|NCT00215150|13161463|P1|STARTED|Randomization Phase Placebo||11
5349854|NCT00215150|13161463|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
5349855|NCT00215150|13161463|P1|COMPLETED|Randomization Phase Ziprasidone||7
5349856|NCT00215150|13161463|P1|STARTED|Randomization Phase Ziprasidone||10
5349857|NCT00215150|13161463|P1|NOT COMPLETED|Open Label Phase||30
5349858|NCT00215150|13161463|P1|COMPLETED|Open Label Phase||21
5349859|NCT00215150|13161463|P1|STARTED|Open Label Phase|Number of subjects consented|51
5349860|NCT00215137|13161471|P3|NOT COMPLETED|Randomization Period||0
5349861|NCT00215137|13161472|P2|NOT COMPLETED|Randomization Period||2
5349862|NCT00215137|13161473|P1|NOT COMPLETED|Randomization Period||0
5349863|NCT00215137|13161471|P3|COMPLETED|Randomization Period||5
5349864|NCT00215137|13161472|P2|COMPLETED|Randomization Period||5
5349865|NCT00215137|13161473|P1|COMPLETED|Randomization Period||0
5349866|NCT00215137|13161471|P3|STARTED|Randomization Period||5
5349867|NCT00215137|13161472|P2|STARTED|Randomization Period||7
5349868|NCT00215137|13161473|P1|STARTED|Randomization Period||0
5349869|NCT00215137|13161471|P3|NOT COMPLETED|Open Label Escitalopram||0
5349870|NCT00215137|13161472|P2|NOT COMPLETED|Open Label Escitalopram||0
5349871|NCT00215137|13161473|P1|NOT COMPLETED|Open Label Escitalopram||1
5349872|NCT00215137|13161471|P3|COMPLETED|Open Label Escitalopram||0
5349873|NCT00215137|13161472|P2|COMPLETED|Open Label Escitalopram||0
5349874|NCT00215137|13161473|P1|COMPLETED|Open Label Escitalopram||13
5349875|NCT00215137|13161471|P3|STARTED|Open Label Escitalopram||0
5349876|NCT00215137|13161472|P2|STARTED|Open Label Escitalopram||0
5349877|NCT00215137|13161473|P1|STARTED|Open Label Escitalopram||14
5349878|NCT00214903|13161485|P4|NOT COMPLETED|Overall Study||0
5349879|NCT00214903|13161486|P3|NOT COMPLETED|Overall Study||0
5349880|NCT00214903|13161487|P2|NOT COMPLETED|Overall Study||0
5349881|NCT00214903|13161488|P1|NOT COMPLETED|Overall Study||0
5349882|NCT00214903|13161485|P4|COMPLETED|Overall Study||3057
5349883|NCT00214903|13161486|P3|COMPLETED|Overall Study||4113
5349884|NCT00214903|13161487|P2|COMPLETED|Overall Study||13384
5349885|NCT00214903|13161488|P1|COMPLETED|Overall Study||10043
5349886|NCT00214903|13161485|P4|STARTED|Overall Study||3057
5349887|NCT00214903|13161486|P3|STARTED|Overall Study||4113
5349888|NCT00214903|13161487|P2|STARTED|Overall Study||13384
5349889|NCT00214903|13161488|P1|STARTED|Overall Study||10043
5349890|NCT00214786|13161502|P1|NOT COMPLETED|Overall Study||3
5349891|NCT00214786|13161502|P1|COMPLETED|Overall Study||1
5349892|NCT00214786|13161502|P1|STARTED|Overall Study||4
5349893|NCT00214539|13161517|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
5349894|NCT00214539|13161518|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
5349895|NCT00214539|13161517|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
5349896|NCT00214539|13161518|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
5349897|NCT00214539|13161517|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
5349898|NCT00214539|13161518|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
5349899|NCT00214539|13161517|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
5349900|NCT00214539|13161518|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
5349901|NCT00214539|13161517|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
5349902|NCT00214539|13161518|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
5349903|NCT00214539|13161517|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
5349904|NCT00214539|13161518|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
5349905|NCT00214539|13161517|P2|NOT COMPLETED|Treatment Period||0
5349906|NCT00214539|13161518|P1|NOT COMPLETED|Treatment Period||0
5349907|NCT00214539|13161517|P2|COMPLETED|Treatment Period||17
5349908|NCT00214539|13161518|P1|COMPLETED|Treatment Period||15
5349909|NCT00214539|13161517|P2|STARTED|Treatment Period||17
5349910|NCT00214539|13161518|P1|STARTED|Treatment Period||15
5349911|NCT00214539|13161517|P2|NOT COMPLETED|Randomized||0
5349912|NCT00214539|13161518|P1|NOT COMPLETED|Randomized||2
5349913|NCT00214539|13161517|P2|COMPLETED|Randomized||17
5349914|NCT00214539|13161518|P1|COMPLETED|Randomized||15
5349915|NCT00214539|13161517|P2|STARTED|Randomized||17
5349916|NCT00214539|13161518|P1|STARTED|Randomized||17
5349917|NCT00214526|13161544|P2|NOT COMPLETED|Post-Treatment Period||0
5349918|NCT00214526|13161545|P1|NOT COMPLETED|Post-Treatment Period||1
5349919|NCT00214526|13161544|P2|COMPLETED|Post-Treatment Period||49
5349920|NCT00214526|13161545|P1|COMPLETED|Post-Treatment Period||52
5349921|NCT00214526|13161544|P2|STARTED|Post-Treatment Period||49
5349922|NCT00214526|13161545|P1|STARTED|Post-Treatment Period||53
5349923|NCT00214526|13161544|P2|NOT COMPLETED|Treatment Period||5
5349924|NCT00214526|13161545|P1|NOT COMPLETED|Treatment Period||2
5349925|NCT00214526|13161544|P2|COMPLETED|Treatment Period||49
5349926|NCT00214526|13161545|P1|COMPLETED|Treatment Period||53
5349927|NCT00214526|13161544|P2|STARTED|Treatment Period||54
5349928|NCT00214526|13161545|P1|STARTED|Treatment Period||55
5349929|NCT00214526|13161544|P2|NOT COMPLETED|Randomized||2
5349930|NCT00214526|13161545|P1|NOT COMPLETED|Randomized||1
5349931|NCT00214526|13161544|P2|COMPLETED|Randomized||54
5349932|NCT00214526|13161545|P1|COMPLETED|Randomized||55
5349933|NCT00214526|13161544|P2|STARTED|Randomized||56
5349934|NCT00214526|13161545|P1|STARTED|Randomized||56
5349935|NCT00214500|13161571|P1|NOT COMPLETED|Extension Period||2
5349936|NCT00214500|13161571|P1|COMPLETED|Extension Period||6
5349937|NCT00214500|13161571|P1|STARTED|Extension Period||8
5349938|NCT00214500|13161571|P1|NOT COMPLETED|Treatment Period||1
5349939|NCT00214500|13161571|P1|COMPLETED|Treatment Period||8
5349940|NCT00214500|13161571|P1|Pharmacodynamic (PD) Population|Treatment Period||9
5349941|NCT00214500|13161571|P1|Pharmacokinetic (PK) Population|Treatment Period||9
5349942|NCT00214500|13161571|P1|Safety Population|Treatment Period||9
5349943|NCT00214500|13161571|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
5349944|NCT00214487|13161581|P2|NOT COMPLETED|Overall Study||3
5349945|NCT00214487|13161582|P1|NOT COMPLETED|Overall Study||5
5349946|NCT00214487|13161581|P2|COMPLETED|Overall Study||40
5349947|NCT00214487|13161582|P1|COMPLETED|Overall Study||38
5349948|NCT00214487|13161581|P2|STARTED|Overall Study||43
5349949|NCT00214487|13161582|P1|STARTED|Overall Study||43
5349950|NCT00214461|13161592|P4|NOT COMPLETED|Overall Study||1
5349951|NCT00214461|13161593|P3|NOT COMPLETED|Overall Study||2
5349952|NCT00214461|13161594|P2|NOT COMPLETED|Overall Study||0
5349953|NCT00214461|13161595|P1|NOT COMPLETED|Overall Study||0
5349954|NCT00214461|13161592|P4|COMPLETED|Overall Study||11
5349955|NCT00214461|13161593|P3|COMPLETED|Overall Study||10
5349956|NCT00214461|13161594|P2|COMPLETED|Overall Study||12
5349957|NCT00214461|13161595|P1|COMPLETED|Overall Study||12
5349958|NCT00214461|13161592|P4|STARTED|Overall Study||12
5349959|NCT00214461|13161593|P3|STARTED|Overall Study||12
5349960|NCT00214461|13161594|P2|STARTED|Overall Study||12
5349961|NCT00214461|13161595|P1|STARTED|Overall Study||12
5349962|NCT00214422|13161612|P3|NOT COMPLETED|Overall Study||1
5349963|NCT00214422|13161613|P2|NOT COMPLETED|Overall Study||1
5349964|NCT00214422|13161614|P1|NOT COMPLETED|Overall Study||5
5349965|NCT00214422|13161612|P3|COMPLETED|Overall Study||3
5349966|NCT00214422|13161613|P2|COMPLETED|Overall Study||2
5349967|NCT00214422|13161614|P1|COMPLETED|Overall Study||7
5349968|NCT00214422|13161612|P3|STARTED|Overall Study||4
5349969|NCT00214422|13161613|P2|STARTED|Overall Study||3
5349970|NCT00214422|13161614|P1|STARTED|Overall Study||12
5349971|NCT00214383|13161637|P2|NOT COMPLETED|Overall Study||26
5349972|NCT00214383|13161638|P1|NOT COMPLETED|Overall Study||16
5349973|NCT00214383|13161637|P2|COMPLETED|Overall Study||127
5349974|NCT00214383|13161638|P1|COMPLETED|Overall Study||132
5349975|NCT00214383|13161637|P2|STARTED|Overall Study||153
5349976|NCT00214383|13161638|P1|STARTED|Overall Study||148
5349977|NCT00214201|13161650|P2|NOT COMPLETED|Overall Study||2
5349978|NCT00214201|13161651|P1|NOT COMPLETED|Overall Study||2
5349979|NCT00214201|13161650|P2|COMPLETED|Overall Study||18
5349980|NCT00214201|13161651|P1|COMPLETED|Overall Study||18
5349981|NCT00214201|13161650|P2|STARTED|Overall Study||20
5349982|NCT00214201|13161651|P1|STARTED|Overall Study||20
5349983|NCT00214149|13161661|P1|NOT COMPLETED|Overall Study||127
5349984|NCT00214149|13161661|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
5349985|NCT00214149|13161661|P1|STARTED|Overall Study||127
5349986|NCT00214136|13161666|P1|NOT COMPLETED|Overall Study||5
5349987|NCT00214136|13161666|P1|COMPLETED|Overall Study||25
5349988|NCT00214136|13161666|P1|STARTED|Overall Study||30
5349989|NCT00214097|13161674|P3|NOT COMPLETED|Overall Study||0
5349990|NCT00214097|13161675|P2|NOT COMPLETED|Overall Study||0
5349991|NCT00214097|13161676|P1|NOT COMPLETED|Overall Study||0
5349992|NCT00214097|13161674|P3|COMPLETED|Overall Study||135
5349993|NCT00214097|13161675|P2|COMPLETED|Overall Study||111
5349994|NCT00214097|13161676|P1|COMPLETED|Overall Study||101
5349995|NCT00214097|13161674|P3|STARTED|Overall Study||135
5349996|NCT00214097|13161675|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
5349997|NCT00214097|13161676|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
5349998|NCT00214045|13161704|P2|NOT COMPLETED|Overall Study||0
5349999|NCT00214045|13161705|P1|NOT COMPLETED|Overall Study||0
5350000|NCT00214045|13161704|P2|COMPLETED|Overall Study||18
5350001|NCT00214045|13161705|P1|COMPLETED|Overall Study||18
5350002|NCT00214045|13161704|P2|STARTED|Overall Study||18
5350003|NCT00214045|13161705|P1|STARTED|Overall Study||18
5350004|NCT00214019|13161711|P1|NOT COMPLETED|Overall Study||30
5350005|NCT00214019|13161711|P1|COMPLETED|Overall Study||6
5350006|NCT00214019|13161711|P1|Fluticason/Salmeterol Arm|Overall Study||6
5350007|NCT00214019|13161711|P1|Fluticasone/Placebo Arm|Overall Study||6
5350008|NCT00214019|13161711|P1|Placebo/Salmeterol Arm|Overall Study||6
5350009|NCT00214019|13161711|P1|Placebo/Placebo Arm|Overall Study||6
5350010|NCT00214019|13161711|P1|STARTED|Overall Study||36
5350011|NCT00213980|13161720|P2|NOT COMPLETED|Overall Study||7
5350012|NCT00213980|13161721|P1|NOT COMPLETED|Overall Study||6
5350013|NCT00213980|13161720|P2|COMPLETED|Overall Study||29
5350014|NCT00213980|13161721|P1|COMPLETED|Overall Study||26
5350015|NCT00213980|13161720|P2|STARTED|Overall Study||36
5350016|NCT00213980|13161721|P1|STARTED|Overall Study||32
5350017|NCT00213239|13161735|P2|NOT COMPLETED|Overall Study||0
5350018|NCT00213239|13161736|P1|NOT COMPLETED|Overall Study||0
5350019|NCT00213239|13161735|P2|COMPLETED|Overall Study||32
5350020|NCT00213239|13161736|P1|COMPLETED|Overall Study||32
5350021|NCT00213239|13161735|P2|STARTED|Overall Study||32
5350022|NCT00213239|13161736|P1|STARTED|Overall Study||32
5350023|NCT00213148|13161748|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
5350024|NCT00213148|13161749|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
5350025|NCT00213148|13161750|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
5350026|NCT00213148|13161751|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
5350027|NCT00213148|13161752|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
5350028|NCT00213148|13161748|P5|COMPLETED|Cycle 3 (1 Month)||21
5350029|NCT00213148|13161749|P4|COMPLETED|Cycle 3 (1 Month)||23
5350030|NCT00213148|13161750|P3|COMPLETED|Cycle 3 (1 Month)||25
5350031|NCT00213148|13161751|P2|COMPLETED|Cycle 3 (1 Month)||8
5350032|NCT00213148|13161752|P1|COMPLETED|Cycle 3 (1 Month)||23
5350033|NCT00213148|13161748|P5|STARTED|Cycle 3 (1 Month)||22
5350034|NCT00213148|13161749|P4|STARTED|Cycle 3 (1 Month)||24
5350035|NCT00213148|13161750|P3|STARTED|Cycle 3 (1 Month)||26
5350036|NCT00213148|13161751|P2|STARTED|Cycle 3 (1 Month)||10
5350037|NCT00213148|13161752|P1|STARTED|Cycle 3 (1 Month)||23
5350038|NCT00213148|13161748|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
5350039|NCT00213148|13161749|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
5350040|NCT00213148|13161750|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
5350041|NCT00213148|13161751|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
5350042|NCT00213148|13161752|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
5350043|NCT00213148|13161748|P5|COMPLETED|Cycle 2 (1 Month)||11
5350044|NCT00213148|13161749|P4|COMPLETED|Cycle 2 (1 Month)||33
5350045|NCT00213148|13161750|P3|COMPLETED|Cycle 2 (1 Month)||28
5350046|NCT00213148|13161751|P2|COMPLETED|Cycle 2 (1 Month)||4
5350047|NCT00213148|13161752|P1|COMPLETED|Cycle 2 (1 Month)||29
5350048|NCT00213148|13161748|P5|STARTED|Cycle 2 (1 Month)||41
5350049|NCT00213148|13161749|P4|STARTED|Cycle 2 (1 Month)||52
5350050|NCT00213148|13161750|P3|STARTED|Cycle 2 (1 Month)||42
5350051|NCT00213148|13161751|P2|STARTED|Cycle 2 (1 Month)||10
5350052|NCT00213148|13161752|P1|STARTED|Cycle 2 (1 Month)||43
5350053|NCT00213148|13161748|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
5350054|NCT00213148|13161749|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
5350055|NCT00213148|13161750|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
5350056|NCT00213148|13161751|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
5350057|NCT00213148|13161752|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
5350058|NCT00213148|13161748|P5|COMPLETED|Cycle 1 (1 Month)||17
5350059|NCT00213148|13161749|P4|COMPLETED|Cycle 1 (1 Month)||58
5350060|NCT00213148|13161750|P3|COMPLETED|Cycle 1 (1 Month)||60
5350061|NCT00213148|13161751|P2|COMPLETED|Cycle 1 (1 Month)||0
5350062|NCT00213148|13161752|P1|COMPLETED|Cycle 1 (1 Month)||53
5350063|NCT00213148|13161748|P5|STARTED|Cycle 1 (1 Month)||39
5350064|NCT00213148|13161749|P4|STARTED|Cycle 1 (1 Month)||76
5350065|NCT00213148|13161750|P3|STARTED|Cycle 1 (1 Month)||79
5350066|NCT00213148|13161751|P2|STARTED|Cycle 1 (1 Month)||0
5350067|NCT00213148|13161752|P1|STARTED|Cycle 1 (1 Month)||77
5350068|NCT00213135|13161779|P3|NOT COMPLETED|Overall Study||57
5350069|NCT00213135|13161780|P2|NOT COMPLETED|Overall Study||35
5350070|NCT00213135|13161781|P1|NOT COMPLETED|Overall Study||50
5350071|NCT00213135|13161779|P3|COMPLETED|Overall Study||380
5350072|NCT00213135|13161780|P2|COMPLETED|Overall Study||398
5350073|NCT00213135|13161781|P1|COMPLETED|Overall Study||406
5350074|NCT00213135|13161779|P3|STARTED|Overall Study||437
5350075|NCT00213135|13161780|P2|STARTED|Overall Study||433
5350076|NCT00213135|13161781|P1|STARTED|Overall Study||456
5350077|NCT00212888|13161801|P3|NOT COMPLETED|Overall Study||1
5350078|NCT00212888|13161802|P2|NOT COMPLETED|Overall Study||0
5350079|NCT00212888|13161803|P1|NOT COMPLETED|Overall Study||3
5350080|NCT00212888|13161801|P3|COMPLETED|Overall Study||14
5350081|NCT00212888|13161802|P2|COMPLETED|Overall Study||18
5350082|NCT00212888|13161803|P1|COMPLETED|Overall Study||16
5350083|NCT00212888|13161801|P3|STARTED|Overall Study||15
5350084|NCT00212888|13161802|P2|STARTED|Overall Study||18
5350085|NCT00212888|13161803|P1|STARTED|Overall Study||19
5350086|NCT00212758|13161824|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
5350087|NCT00212758|13161825|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
5350088|NCT00212758|13161824|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
5350089|NCT00212758|13161825|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
5350090|NCT00212758|13161824|P2|STARTED|Standard Therapy of GH (12 Months)||9
5350091|NCT00212758|13161825|P1|STARTED|Standard Therapy of GH (12 Months)||8
5350092|NCT00212758|13161824|P2|NOT COMPLETED|Second Intervention (7 Days)||0
5350093|NCT00212758|13161825|P1|NOT COMPLETED|Second Intervention (7 Days)||0
5350094|NCT00212758|13161824|P2|COMPLETED|Second Intervention (7 Days)||9
5350095|NCT00212758|13161825|P1|COMPLETED|Second Intervention (7 Days)||8
5350096|NCT00212758|13161824|P2|STARTED|Second Intervention (7 Days)||9
5350097|NCT00212758|13161825|P1|STARTED|Second Intervention (7 Days)||8
5350098|NCT00212758|13161824|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
5350099|NCT00212758|13161825|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
5350100|NCT00212758|13161824|P2|COMPLETED|Wash Out Period (2 Weeks)||9
5350101|NCT00212758|13161825|P1|COMPLETED|Wash Out Period (2 Weeks)||8
5350102|NCT00212758|13161824|P2|STARTED|Wash Out Period (2 Weeks)||9
5350103|NCT00212758|13161825|P1|STARTED|Wash Out Period (2 Weeks)||8
5350104|NCT00212758|13161824|P2|NOT COMPLETED|First Intervention (7 Days)||0
5350105|NCT00212758|13161825|P1|NOT COMPLETED|First Intervention (7 Days)||0
5350106|NCT00212758|13161824|P2|COMPLETED|First Intervention (7 Days)||9
5350107|NCT00212758|13161825|P1|COMPLETED|First Intervention (7 Days)||8
5350108|NCT00212758|13161824|P2|STARTED|First Intervention (7 Days)||9
5350109|NCT00212758|13161825|P1|STARTED|First Intervention (7 Days)||8
5350110|NCT00212446|13161831|P1|NOT COMPLETED|Overall Study||0
5350111|NCT00212446|13161831|P1|COMPLETED|Overall Study||8
5350112|NCT00212446|13161831|P1|STARTED|Overall Study||8
5350113|NCT00212355|13161841|P1|NOT COMPLETED|Overall Study||3
5350114|NCT00212355|13161841|P1|COMPLETED|Overall Study||34
5350115|NCT00212355|13161841|P1|STARTED|Overall Study||37
5350116|NCT00212264|13161848|P3|NOT COMPLETED|Overall Study||4
5350117|NCT00212264|13161849|P2|NOT COMPLETED|Overall Study||16
5350118|NCT00212264|13161850|P1|NOT COMPLETED|Overall Study||12
5350119|NCT00212264|13161848|P3|COMPLETED|Overall Study||64
5350120|NCT00212264|13161849|P2|COMPLETED|Overall Study||54
5350121|NCT00212264|13161850|P1|COMPLETED|Overall Study||58
5350122|NCT00212264|13161848|P3|STARTED|Overall Study||68
5350123|NCT00212264|13161849|P2|STARTED|Overall Study||70
5350124|NCT00212264|13161850|P1|STARTED|Overall Study||70
5350125|NCT00212134|13161862|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
5350126|NCT00212134|13161863|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
5350127|NCT00212134|13161862|P2|COMPLETED|Phase 3 (Age 10 Years)||35
5350128|NCT00212134|13161863|P1|COMPLETED|Phase 3 (Age 10 Years)||36
5350129|NCT00212134|13161862|P2|STARTED|Phase 3 (Age 10 Years)||56
5350130|NCT00212134|13161863|P1|STARTED|Phase 3 (Age 10 Years)||57
5350131|NCT00212134|13161862|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
5350132|NCT00212134|13161863|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
5350133|NCT00212134|13161862|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
5350134|NCT00212134|13161863|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
5350135|NCT00212134|13161862|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
5350136|NCT00212134|13161863|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
5350137|NCT00212134|13161862|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
5350138|NCT00212134|13161863|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
5350139|NCT00212134|13161862|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
5350140|NCT00212134|13161863|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
5350141|NCT00212134|13161862|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
5350142|NCT00212134|13161863|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
5350143|NCT00212134|13161862|P2|STARTED|Phase 1 (to Age 1 Year)||57
5350144|NCT00212134|13161863|P1|STARTED|Phase 1 (to Age 1 Year)||57
5350145|NCT00211887|13161884|P3|NOT COMPLETED|Overall Study||36
5350146|NCT00211887|13161885|P2|NOT COMPLETED|Overall Study||56
5350147|NCT00211887|13161886|P1|NOT COMPLETED|Overall Study||102
5350148|NCT00211887|13161884|P3|COMPLETED|Overall Study||223
5350149|NCT00211887|13161885|P2|COMPLETED|Overall Study||194
5350150|NCT00211887|13161886|P1|COMPLETED|Overall Study||397
5350151|NCT00211887|13161884|P3|STARTED|Overall Study||259
5350152|NCT00211887|13161885|P2|STARTED|Overall Study||250
5350153|NCT00211887|13161886|P1|STARTED|Overall Study||499
5350154|NCT00211809|13161903|P1|NOT COMPLETED|Overall Study||6
5350155|NCT00211809|13161903|P1|COMPLETED|Overall Study||11
5350156|NCT00211809|13161903|P1|STARTED|Overall Study||17
5350157|NCT00211757|13161919|P2|NOT COMPLETED|Overall Study||2
5350158|NCT00211757|13161920|P1|NOT COMPLETED|Overall Study||1
5350159|NCT00211757|13161919|P2|COMPLETED|Overall Study||14
5350160|NCT00211757|13161920|P1|COMPLETED|Overall Study||10
5350161|NCT00211757|13161919|P2|STARTED|Overall Study||16
5350162|NCT00211757|13161920|P1|STARTED|Overall Study||11
5350163|NCT00211692|13161930|P2|NOT COMPLETED|Overall Study||0
5350164|NCT00211692|13161931|P1|NOT COMPLETED|Overall Study||0
5350165|NCT00211692|13161930|P2|COMPLETED|Overall Study||31
5350166|NCT00211692|13161931|P1|COMPLETED|Overall Study||33
5350167|NCT00211692|13161930|P2|STARTED|Overall Study||31
5350168|NCT00211692|13161931|P1|STARTED|Overall Study||33
5350169|NCT00211536|13161941|P2|NOT COMPLETED|Overall Study||7
5350170|NCT00211536|13161942|P1|NOT COMPLETED|Overall Study||4
5350171|NCT00211536|13161941|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
5350172|NCT00211536|13161942|P1|COMPLETED|Overall Study||49
5350173|NCT00211536|13161941|P2|As Treated Data Analysis Set|Overall Study||48
5350174|NCT00211536|13161942|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
5350175|NCT00211536|13161941|P2|STARTED|Overall Study||54
5350176|NCT00211536|13161942|P1|STARTED|Overall Study||53
5350177|NCT00211510|13161958|P2|NOT COMPLETED|Overall Study||2
5350178|NCT00211510|13161959|P1|NOT COMPLETED|Overall Study||6
5350179|NCT00211510|13161958|P2|COMPLETED|Overall Study||72
5350180|NCT00211510|13161959|P1|COMPLETED|Overall Study||66
5350181|NCT00211510|13161958|P2|STARTED|Overall Study||74
5350182|NCT00211510|13161959|P1|STARTED|Overall Study||72
5350183|NCT00211237|13161977|P3|NOT COMPLETED|12 Months||6
5350184|NCT00211237|13161978|P2|NOT COMPLETED|12 Months||2
5350185|NCT00211237|13161979|P1|NOT COMPLETED|12 Months||9
5350186|NCT00211237|13161977|P3|COMPLETED|12 Months||28
5350187|NCT00211237|13161978|P2|COMPLETED|12 Months||6
5350188|NCT00211237|13161979|P1|COMPLETED|12 Months||40
5350189|NCT00211237|13161977|P3|STARTED|12 Months||34
5350190|NCT00211237|13161978|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
5350191|NCT00211237|13161979|P1|STARTED|12 Months||49
5350192|NCT00211237|13161977|P3|NOT COMPLETED|6 Months||3
5350193|NCT00211237|13161978|P2|NOT COMPLETED|6 Months||2
5350194|NCT00211237|13161979|P1|NOT COMPLETED|6 Months||8
5350195|NCT00211237|13161977|P3|COMPLETED|6 Months||33
5350196|NCT00211237|13161978|P2|COMPLETED|6 Months||9
5350197|NCT00211237|13161979|P1|COMPLETED|6 Months||49
5350198|NCT00211237|13161977|P3|STARTED|6 Months||36
5350199|NCT00211237|13161978|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
5350200|NCT00211237|13161979|P1|STARTED|6 Months||57
5350201|NCT00211237|13161977|P3|NOT COMPLETED|3 Months||1
5350202|NCT00211237|13161978|P2|NOT COMPLETED|3 Months||4
5350203|NCT00211237|13161979|P1|NOT COMPLETED|3 Months||8
5350204|NCT00211237|13161977|P3|COMPLETED|3 Months||33
5350205|NCT00211237|13161978|P2|COMPLETED|3 Months||14
5350206|NCT00211237|13161979|P1|COMPLETED|3 Months||57
5350207|NCT00211237|13161977|P3|STARTED|3 Months||34
5350208|NCT00211237|13161978|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
5350209|NCT00211237|13161979|P1|STARTED|3 Months||65
5350210|NCT00211237|13161977|P3|NOT COMPLETED|1 Month||0
5350211|NCT00211237|13161978|P2|NOT COMPLETED|1 Month||9
5350212|NCT00211237|13161979|P1|NOT COMPLETED|1 Month||3
5350213|NCT00211237|13161977|P3|COMPLETED|1 Month||0
5350214|NCT00211237|13161978|P2|COMPLETED|1 Month||52
5350215|NCT00211237|13161979|P1|COMPLETED|1 Month||65
5350216|NCT00211237|13161977|P3|STARTED|1 Month||0
5350217|NCT00211237|13161978|P2|STARTED|1 Month||61
5350218|NCT00211237|13161979|P1|STARTED|1 Month||68
5350219|NCT00211237|13161977|P3|NOT COMPLETED|Baseline||0
5350220|NCT00211237|13161978|P2|NOT COMPLETED|Baseline||3
5350221|NCT00211237|13161979|P1|NOT COMPLETED|Baseline||2
5350222|NCT00211237|13161977|P3|COMPLETED|Baseline||0
5350223|NCT00211237|13161978|P2|COMPLETED|Baseline||61
5350224|NCT00211237|13161979|P1|COMPLETED|Baseline||68
5350225|NCT00211237|13161977|P3|STARTED|Baseline||0
5350226|NCT00211237|13161978|P2|STARTED|Baseline||64
5350227|NCT00211237|13161979|P1|STARTED|Baseline||70
5350228|NCT00211185|13162069|P1|NOT COMPLETED|Overall Study||20
5350229|NCT00211185|13162069|P1|COMPLETED|Overall Study||29
5350230|NCT00211185|13162069|P1|STARTED|Overall Study||49
5350231|NCT00211172|13162083|P2|NOT COMPLETED|Overall Study||32
5350232|NCT00211172|13162084|P1|NOT COMPLETED|Overall Study||39
5350233|NCT00211172|13162083|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
5350234|NCT00211172|13162084|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
5350235|NCT00211172|13162083|P2|STARTED|Overall Study||458
5350236|NCT00211172|13162084|P1|STARTED|Overall Study||449
5350237|NCT00211081|13162090|P1|NOT COMPLETED|Overall Study||2
5350238|NCT00211081|13162090|P1|COMPLETED|Overall Study||10
5350239|NCT00211081|13162090|P1|STARTED|Overall Study||12
5350240|NCT00210639|13162102|P2|NOT COMPLETED|Overall Study||42
5350241|NCT00210639|13162103|P1|NOT COMPLETED|Overall Study||63
5350242|NCT00210639|13162102|P2|COMPLETED|Overall Study||41
5350243|NCT00210639|13162103|P1|COMPLETED|Overall Study||61
5350244|NCT00210639|13162102|P2|STARTED|Overall Study||83
5350245|NCT00210639|13162103|P1|STARTED|Overall Study||124
5350246|NCT00210626|13162111|P2|NOT COMPLETED|Overall Study||45
5350247|NCT00210626|13162112|P1|NOT COMPLETED|Overall Study||48
5350248|NCT00210626|13162111|P2|COMPLETED|Overall Study||50
5350249|NCT00210626|13162112|P1|COMPLETED|Overall Study||49
5350250|NCT00210626|13162111|P2|STARTED|Overall Study||95
5350251|NCT00210626|13162112|P1|STARTED|Overall Study||97
5350252|NCT00210470|13162120|P1|NOT COMPLETED|Overall Study||1
5350253|NCT00210470|13162120|P1|COMPLETED|Overall Study||26
5350254|NCT00210470|13162120|P1|STARTED|Overall Study||27
5350255|NCT00210353|13162127|P3|NOT COMPLETED|Overall Study||26
5350256|NCT00210353|13162128|P2|NOT COMPLETED|Overall Study||45
5350257|NCT00210353|13162129|P1|NOT COMPLETED|Overall Study||38
5350258|NCT00210353|13162127|P3|COMPLETED|Overall Study||125
5350259|NCT00210353|13162128|P2|COMPLETED|Overall Study||107
5350260|NCT00210353|13162129|P1|COMPLETED|Overall Study||113
5350261|NCT00210353|13162127|P3|STARTED|Overall Study||151
5350262|NCT00210353|13162128|P2|STARTED|Overall Study||152
5350263|NCT00210353|13162129|P1|STARTED|Overall Study||151
5350264|NCT00209560|13162151|P2|NOT COMPLETED|Overall Study||0
5350265|NCT00209560|13162152|P1|NOT COMPLETED|Overall Study||1
5350266|NCT00209560|13162151|P2|COMPLETED|Overall Study||42
5350267|NCT00209560|13162152|P1|COMPLETED|Overall Study||120
5350268|NCT00209560|13162151|P2|STARTED|Overall Study||42
5350269|NCT00209560|13162152|P1|STARTED|Overall Study||121
5350270|NCT00209417|13162162|P2|NOT COMPLETED|Overall Study||0
5350271|NCT00209417|13162163|P1|NOT COMPLETED|Overall Study||0
5350272|NCT00209417|13162162|P2|COMPLETED|Overall Study||327
5350273|NCT00209417|13162163|P1|COMPLETED|Overall Study||321
5350274|NCT00209417|13162162|P2|STARTED|Overall Study||327
5350275|NCT00209417|13162163|P1|STARTED|Overall Study||321
5350276|NCT00209339|13162171|P1|NOT COMPLETED|At 5 Years Follow-up||8
5350277|NCT00209339|13162171|P1|COMPLETED|At 5 Years Follow-up||15
5350278|NCT00209339|13162171|P1|STARTED|At 5 Years Follow-up||23
5350279|NCT00209339|13162171|P1|NOT COMPLETED|At 4 Years Follow-up||5
5350280|NCT00209339|13162171|P1|COMPLETED|At 4 Years Follow-up||23
5350281|NCT00209339|13162171|P1|STARTED|At 4 Years Follow-up||28
5350282|NCT00209339|13162171|P1|NOT COMPLETED|At 3 Years Follow-up||1
5350283|NCT00209339|13162171|P1|COMPLETED|At 3 Years Follow-up||28
5350284|NCT00209339|13162171|P1|STARTED|At 3 Years Follow-up||29
5350285|NCT00209339|13162171|P1|NOT COMPLETED|At 24 Months Follow-up||11
5350286|NCT00209339|13162171|P1|COMPLETED|At 24 Months Follow-up||29
5350287|NCT00209339|13162171|P1|STARTED|At 24 Months Follow-up||40
5350288|NCT00209339|13162171|P1|NOT COMPLETED|At 12 Months Follow-up||15
5350289|NCT00209339|13162171|P1|COMPLETED|At 12 Months Follow-up||40
5350290|NCT00209339|13162171|P1|STARTED|At 12 Months Follow-up||55
5350291|NCT00209274|13162255|P2|NOT COMPLETED|Overall Study||47
5350292|NCT00209274|13162256|P1|NOT COMPLETED|Overall Study||71
5350293|NCT00209274|13162255|P2|COMPLETED|Overall Study||48
5350294|NCT00209274|13162256|P1|COMPLETED|Overall Study||113
5350295|NCT00209274|13162255|P2|STARTED|Overall Study||95
5350296|NCT00209274|13162256|P1|STARTED|Overall Study||184
5350297|NCT00209170|13162576|P2|NOT COMPLETED|Overall Study||3
5350298|NCT00209170|13162577|P1|NOT COMPLETED|Overall Study||2
5350299|NCT00209170|13162576|P2|COMPLETED|Overall Study||4
5350300|NCT00209170|13162577|P1|COMPLETED|Overall Study||5
5350301|NCT00209170|13162576|P2|STARTED|Overall Study||7
5350302|NCT00209170|13162577|P1|STARTED|Overall Study||7
5350303|NCT00209131|13162585|P2|NOT COMPLETED|Overall Study||11
5350304|NCT00209131|13162586|P1|NOT COMPLETED|Overall Study||15
5350305|NCT00209131|13162585|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
5350306|NCT00209131|13162586|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
5350307|NCT00209131|13162585|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
5350308|NCT00209131|13162586|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
5350309|NCT00209092|13162596|P2|NOT COMPLETED|Overall Study||2
5350310|NCT00209092|13162597|P1|NOT COMPLETED|Overall Study||8
5350311|NCT00209092|13162596|P2|COMPLETED|Overall Study||24
5350312|NCT00209092|13162597|P1|COMPLETED|Overall Study||17
5350313|NCT00209092|13162596|P2|STARTED|Overall Study||26
5350314|NCT00209092|13162597|P1|STARTED|Overall Study||25
5350315|NCT00209027|13162607|P2|NOT COMPLETED|Overall Study||0
5350316|NCT00209027|13162608|P1|NOT COMPLETED|Overall Study||10
5350317|NCT00209027|13162607|P2|COMPLETED|Overall Study||10
5350318|NCT00209027|13162608|P1|COMPLETED|Overall Study||0
5350319|NCT00209027|13162607|P2|STARTED|Overall Study||10
5350320|NCT00209027|13162608|P1|STARTED|Overall Study||10
5350321|NCT00208975|13162614|P1|NOT COMPLETED|Overall Study||0
5350322|NCT00208975|13162614|P1|COMPLETED|Overall Study||15
5350323|NCT00208975|13162614|P1|STARTED|Overall Study||15
5350324|NCT00208949|13162621|P2|NOT COMPLETED|Overall Study||0
5350325|NCT00208949|13162622|P1|NOT COMPLETED|Overall Study||0
5350326|NCT00208949|13162621|P2|COMPLETED|Overall Study||25
5350327|NCT00208949|13162622|P1|COMPLETED|Overall Study||25
5350328|NCT00208949|13162621|P2|STARTED|Overall Study||25
5350329|NCT00208949|13162622|P1|STARTED|Overall Study||25
5350330|NCT00208767|13162632|P2|NOT COMPLETED|Overall Study||7
5350331|NCT00208767|13162633|P1|NOT COMPLETED|Overall Study||27
5350332|NCT00208767|13162632|P2|COMPLETED|Overall Study||33
5350333|NCT00208767|13162633|P1|COMPLETED|Overall Study||53
5350334|NCT00208767|13162632|P2|STARTED|Overall Study||40
5350335|NCT00208767|13162633|P1|STARTED|Overall Study||80
5350336|NCT00208507|13162641|P2|NOT COMPLETED|Overall Study||8
5350337|NCT00208507|13162642|P1|NOT COMPLETED|Overall Study||14
5350338|NCT00208507|13162641|P2|COMPLETED|Overall Study||79
5350339|NCT00208507|13162642|P1|COMPLETED|Overall Study||163
5350340|NCT00208507|13162641|P2|STARTED|Overall Study||87
5350341|NCT00208507|13162642|P1|STARTED|Overall Study||177
5350342|NCT00208494|13162650|P2|NOT COMPLETED|Overall Study||34
5350343|NCT00208494|13162651|P1|NOT COMPLETED|Overall Study||30
5350344|NCT00208494|13162650|P2|COMPLETED|Overall Study||162
5350345|NCT00208494|13162651|P1|COMPLETED|Overall Study||164
5350346|NCT00208494|13162650|P2|STARTED|Overall Study||196
5350347|NCT00208494|13162651|P1|STARTED|Overall Study||194
5350348|NCT00208325|13162661|P4|NOT COMPLETED|Overall Study||14
5350349|NCT00208325|13162662|P3|NOT COMPLETED|Overall Study||14
5350350|NCT00208325|13162663|P2|NOT COMPLETED|Overall Study||54
5350351|NCT00208325|13162664|P1|NOT COMPLETED|Overall Study||51
5350352|NCT00208325|13162661|P4|COMPLETED|Overall Study||147
5350353|NCT00208325|13162662|P3|COMPLETED|Overall Study||156
5350354|NCT00208325|13162663|P2|COMPLETED|Overall Study||142
5350355|NCT00208325|13162664|P1|COMPLETED|Overall Study||142
5350356|NCT00208325|13162661|P4|STARTED|Overall Study||161
5350357|NCT00208325|13162662|P3|STARTED|Overall Study||170
5350358|NCT00208325|13162663|P2|STARTED|Overall Study||196
5350359|NCT00208325|13162664|P1|STARTED|Overall Study||193
5350360|NCT00208091|13162772|P1|NOT COMPLETED|Overall Study||0
5350361|NCT00208091|13162772|P1|COMPLETED|Overall Study||16
5350362|NCT00208091|13162772|P1|STARTED|Overall Study||16
5350363|NCT00208026|13162780|P1|NOT COMPLETED|Overall Study||0
5350364|NCT00208026|13162780|P1|COMPLETED|Overall Study||3
5350365|NCT00208026|13162780|P1|STARTED|Overall Study||3
5350366|NCT00207883|13162788|P2|NOT COMPLETED|Overall Study||0
5350367|NCT00207883|13162789|P1|NOT COMPLETED|Overall Study||0
5350368|NCT00207883|13162788|P2|COMPLETED|Overall Study||119
5350369|NCT00207883|13162789|P1|COMPLETED|Overall Study||93
5350370|NCT00207883|13162788|P2|STARTED|Overall Study||119
5350371|NCT00207883|13162789|P1|STARTED|Overall Study||93
5350372|NCT00207740|13162801|P4|NOT COMPLETED|Overall Study||43
5350373|NCT00207740|13162802|P3|NOT COMPLETED|Overall Study||40
5350374|NCT00207740|13162803|P2|NOT COMPLETED|Overall Study||41
5350375|NCT00207740|13162804|P1|NOT COMPLETED|Overall Study||29
5350376|NCT00207740|13162801|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
5350377|NCT00207740|13162802|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
5350378|NCT00207740|13162803|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
5350379|NCT00207740|13162804|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
5350380|NCT00207740|13162801|P4|STARTED|Overall Study||78
5350381|NCT00207740|13162802|P3|STARTED|Overall Study||76
5350382|NCT00207740|13162803|P2|STARTED|Overall Study||77
5350383|NCT00207740|13162804|P1|STARTED|Overall Study||78
5350384|NCT00207727|13162850|P5|NOT COMPLETED|Overall Study||34
5350385|NCT00207727|13162851|P4|NOT COMPLETED|Overall Study||37
5350386|NCT00207727|13162852|P3|NOT COMPLETED|Overall Study||41
5350387|NCT00207727|13162853|P2|NOT COMPLETED|Overall Study||42
5350388|NCT00207727|13162854|P1|NOT COMPLETED|Overall Study||38
5350389|NCT00207727|13162850|P5|COMPLETED|Overall Study||16
5350390|NCT00207727|13162851|P4|COMPLETED|Overall Study||13
5350391|NCT00207727|13162852|P3|COMPLETED|Overall Study||9
5350392|NCT00207727|13162853|P2|COMPLETED|Overall Study||8
5350393|NCT00207727|13162854|P1|COMPLETED|Overall Study||11
5350394|NCT00207727|13162850|P5|STARTED|Overall Study||50
5350395|NCT00207727|13162851|P4|STARTED|Overall Study||50
5350396|NCT00207727|13162852|P3|STARTED|Overall Study||50
5350397|NCT00207727|13162853|P2|STARTED|Overall Study||50
5350398|NCT00207727|13162854|P1|STARTED|Overall Study||49
5350399|NCT00207714|13162881|P5|NOT COMPLETED|Overall Study||5
5350400|NCT00207714|13162882|P4|NOT COMPLETED|Overall Study||8
5350401|NCT00207714|13162883|P3|NOT COMPLETED|Overall Study||10
5350402|NCT00207714|13162884|P2|NOT COMPLETED|Overall Study||7
5350403|NCT00207714|13162885|P1|NOT COMPLETED|Overall Study||14
5350404|NCT00207714|13162881|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
5350405|NCT00207714|13162882|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
5350406|NCT00207714|13162883|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
5350407|NCT00207714|13162884|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
5350408|NCT00207714|13162885|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
5350409|NCT00207714|13162881|P5|STARTED|Overall Study||34
5350410|NCT00207714|13162882|P4|STARTED|Overall Study||34
5350411|NCT00207714|13162883|P3|STARTED|Overall Study||34
5350412|NCT00207714|13162884|P2|STARTED|Overall Study||35
5350413|NCT00207714|13162885|P1|STARTED|Overall Study||35
5350414|NCT00207142|13162907|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
5350415|NCT00207142|13162908|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
5350416|NCT00207142|13162909|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
5350417|NCT00207142|13162910|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
5350418|NCT00207142|13162907|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
5350419|NCT00207142|13162908|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
5350420|NCT00207142|13162909|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
5350421|NCT00207142|13162910|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
5350422|NCT00207142|13162907|P4|STARTED|Maintenance Phase/Rescue Phase||50
5350423|NCT00207142|13162908|P3|STARTED|Maintenance Phase/Rescue Phase||85
5350424|NCT00207142|13162909|P2|STARTED|Maintenance Phase/Rescue Phase||87
5350425|NCT00207142|13162910|P1|STARTED|Maintenance Phase/Rescue Phase||0
5350426|NCT00207142|13162907|P4|NOT COMPLETED|Induction Phase||0
5350427|NCT00207142|13162908|P3|NOT COMPLETED|Induction Phase||0
5350428|NCT00207142|13162909|P2|NOT COMPLETED|Induction Phase||0
5350429|NCT00207142|13162910|P1|NOT COMPLETED|Induction Phase||30
5350430|NCT00207142|13162907|P4|COMPLETED|Induction Phase||0
5350431|NCT00207142|13162908|P3|COMPLETED|Induction Phase||0
5350432|NCT00207142|13162909|P2|COMPLETED|Induction Phase||0
5350433|NCT00207142|13162910|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
5350434|NCT00207142|13162907|P4|STARTED|Induction Phase||0
5350435|NCT00207142|13162908|P3|STARTED|Induction Phase||0
5350436|NCT00207142|13162909|P2|STARTED|Induction Phase||0
5350437|NCT00207142|13162910|P1|STARTED|Induction Phase||252
5350438|NCT00207090|13162947|P1|NOT COMPLETED|Overall Study||7
5350439|NCT00207090|13162947|P1|COMPLETED|Overall Study||8
5350440|NCT00207090|13162947|P1|STARTED|Overall Study|Number of participants treated|15
5350441|NCT00206726|13162976|P1|NOT COMPLETED|Overall Study||51
5350442|NCT00206726|13162976|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
5350443|NCT00206726|13162976|P1|4 Cycles Completed|Overall Study|per protocol population|41
5350444|NCT00206726|13162976|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
5350445|NCT00206726|13162976|P1|STARTED|Overall Study||60
5350446|NCT00206518|13162987|P2|NOT COMPLETED|Overall Study||6
5350447|NCT00206518|13162988|P1|NOT COMPLETED|Overall Study||10
5350448|NCT00206518|13162987|P2|COMPLETED|Overall Study||78
5350449|NCT00206518|13162988|P1|COMPLETED|Overall Study||73
5350450|NCT00206518|13162987|P2|STARTED|Overall Study||84
5350451|NCT00206518|13162988|P1|STARTED|Overall Study||83
5350452|NCT00206440|13163000|P2|NOT COMPLETED|Overall Study||4
5350453|NCT00206440|13163001|P1|NOT COMPLETED|Overall Study||5
5350454|NCT00206440|13163000|P2|COMPLETED|Overall Study||18
5350455|NCT00206440|13163001|P1|COMPLETED|Overall Study||16
5350456|NCT00206440|13163000|P2|STARTED|Overall Study||22
5350457|NCT00206440|13163001|P1|STARTED|Overall Study||21
5350458|NCT00206427|13163007|P1|NOT COMPLETED|Overall Study||2
5350459|NCT00206427|13163007|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
5350460|NCT00206427|13163007|P1|STARTED|Overall Study|Received First Dose|49
5350461|NCT00206336|13163011|P1|NOT COMPLETED|Overall Study||0
5350462|NCT00206336|13163011|P1|COMPLETED|Overall Study||20
5350463|NCT00206336|13163011|P1|STARTED|Overall Study||20
5350464|NCT00206323|13163017|P2|NOT COMPLETED|Overall Study||3
5350465|NCT00206323|13163018|P1|NOT COMPLETED|Overall Study||6
5350466|NCT00206323|13163017|P2|COMPLETED|Overall Study||12
5350467|NCT00206323|13163018|P1|COMPLETED|Overall Study||8
5350468|NCT00206323|13163017|P2|STARTED|Overall Study||15
5350469|NCT00206323|13163018|P1|STARTED|Overall Study||14
5350470|NCT00206102|13163026|P2|NOT COMPLETED|Overall Study||315
5350471|NCT00206102|13163027|P1|NOT COMPLETED|Overall Study||408
5350472|NCT00206102|13163026|P2|COMPLETED|Overall Study||187
5350473|NCT00206102|13163027|P1|COMPLETED|Overall Study||188
5350474|NCT00206102|13163026|P2|STARTED|Overall Study||502
5350475|NCT00206102|13163027|P1|STARTED|Overall Study||596
5350476|NCT00206076|13163063|P2|NOT COMPLETED|Overall Study||1
5350477|NCT00206076|13163064|P1|NOT COMPLETED|Overall Study||3
5350478|NCT00206076|13163063|P2|COMPLETED|Overall Study||9
5350479|NCT00206076|13163064|P1|COMPLETED|Overall Study||6
5350480|NCT00206076|13163063|P2|STARTED|Overall Study||10
5350481|NCT00206076|13163064|P1|STARTED|Overall Study||9
5350482|NCT00205881|13163074|P1|NOT COMPLETED|Overall Study||16
5350483|NCT00205881|13163074|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
5350484|NCT00205881|13163074|P1|STARTED|Overall Study||32
5350485|NCT00205855|13163079|P1|NOT COMPLETED|Overall Study||21
5350486|NCT00205855|13163079|P1|COMPLETED|Overall Study||44
5350487|NCT00205855|13163079|P1|STARTED|Overall Study||65
5350488|NCT00205803|13163085|P2|NOT COMPLETED|Toddler Dose||3
5350489|NCT00205803|13163086|P1|NOT COMPLETED|Toddler Dose||2
5350490|NCT00205803|13163085|P2|COMPLETED|Toddler Dose||100
5350491|NCT00205803|13163086|P1|COMPLETED|Toddler Dose||84
5350492|NCT00205803|13163085|P2|STARTED|Toddler Dose||103
5350493|NCT00205803|13163086|P1|STARTED|Toddler Dose||86
5350494|NCT00205803|13163085|P2|NOT COMPLETED|After Infant Series||13
5350495|NCT00205803|13163086|P1|NOT COMPLETED|After Infant Series||18
5350496|NCT00205803|13163085|P2|COMPLETED|After Infant Series||103
5350497|NCT00205803|13163086|P1|COMPLETED|After Infant Series||86
5350498|NCT00205803|13163085|P2|STARTED|After Infant Series||116
5350499|NCT00205803|13163086|P1|STARTED|After Infant Series||104
5350500|NCT00205803|13163085|P2|NOT COMPLETED|Infant Series||11
5350501|NCT00205803|13163086|P1|NOT COMPLETED|Infant Series||18
5350502|NCT00205803|13163085|P2|COMPLETED|Infant Series||116
5350503|NCT00205803|13163086|P1|COMPLETED|Infant Series||104
5350504|NCT00205803|13163085|P2|Vaccinated Dose 3|Infant Series||118
5350505|NCT00205803|13163086|P1|Vaccinated Dose 3|Infant Series||110
5350506|NCT00205803|13163085|P2|Vaccinated Dose 2|Infant Series||122
5350507|NCT00205803|13163086|P1|Vaccinated Dose 2|Infant Series||115
5350508|NCT00205803|13163085|P2|Vaccinated Dose 1|Infant Series||126
5350509|NCT00205803|13163086|P1|Vaccinated Dose 1|Infant Series||121
5350510|NCT00205803|13163085|P2|STARTED|Infant Series||127
5350511|NCT00205803|13163086|P1|STARTED|Infant Series||122
5350512|NCT00205777|13163142|P6|NOT COMPLETED|Study Extension II||282
5350513|NCT00205777|13163143|P5|NOT COMPLETED|Study Extension II||0
5350514|NCT00205777|13163144|P4|NOT COMPLETED|Study Extension II||149
5350515|NCT00205777|13163145|P3|NOT COMPLETED|Study Extension II||0
5350516|NCT00205777|13163146|P2|NOT COMPLETED|Study Extension II||0
5350517|NCT00205777|13163147|P1|NOT COMPLETED|Study Extension II||0
5350518|NCT00205777|13163142|P6|COMPLETED|Study Extension II||860
5350519|NCT00205777|13163143|P5|COMPLETED|Study Extension II||0
5350520|NCT00205777|13163144|P4|COMPLETED|Study Extension II||441
5350521|NCT00205777|13163145|P3|COMPLETED|Study Extension II||0
5350522|NCT00205777|13163146|P2|COMPLETED|Study Extension II||0
5350523|NCT00205777|13163147|P1|COMPLETED|Study Extension II||0
5350524|NCT00205777|13163142|P6|TREATED|Study Extension II||1011
5350525|NCT00205777|13163143|P5|TREATED|Study Extension II||0
5350526|NCT00205777|13163144|P4|TREATED|Study Extension II||519
5350527|NCT00205777|13163145|P3|TREATED|Study Extension II||0
5350528|NCT00205777|13163146|P2|TREATED|Study Extension II||0
5350529|NCT00205777|13163147|P1|TREATED|Study Extension II||0
5350530|NCT00205777|13163142|P6|STARTED|Study Extension II||1142
5350531|NCT00205777|13163143|P5|STARTED|Study Extension II||0
5350532|NCT00205777|13163144|P4|STARTED|Study Extension II||590
5350533|NCT00205777|13163145|P3|STARTED|Study Extension II||0
5350534|NCT00205777|13163146|P2|STARTED|Study Extension II||0
5350535|NCT00205777|13163147|P1|STARTED|Study Extension II||0
5350536|NCT00205777|13163142|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
5350537|NCT00205777|13163143|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
5350538|NCT00205777|13163144|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
5350539|NCT00205777|13163145|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
5350540|NCT00205777|13163146|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
5350541|NCT00205777|13163147|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
5350542|NCT00205777|13163142|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
5350543|NCT00205777|13163143|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
5350544|NCT00205777|13163144|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
5350545|NCT00205777|13163145|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
5350546|NCT00205777|13163146|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
5350547|NCT00205777|13163147|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
5350548|NCT00205777|13163142|P6|STARTED|Completed SE I, Entered Extension SE II||0
5350549|NCT00205777|13163143|P5|STARTED|Completed SE I, Entered Extension SE II||840
5350550|NCT00205777|13163144|P4|STARTED|Completed SE I, Entered Extension SE II||830
5350551|NCT00205777|13163145|P3|STARTED|Completed SE I, Entered Extension SE II||0
5350552|NCT00205777|13163146|P2|STARTED|Completed SE I, Entered Extension SE II||0
5350553|NCT00205777|13163147|P1|STARTED|Completed SE I, Entered Extension SE II||833
5350554|NCT00205777|13163142|P6|NOT COMPLETED|Study Extension I||0
5350555|NCT00205777|13163143|P5|NOT COMPLETED|Study Extension I||201
5350556|NCT00205777|13163144|P4|NOT COMPLETED|Study Extension I||228
5350557|NCT00205777|13163145|P3|NOT COMPLETED|Study Extension I||1070
5350558|NCT00205777|13163146|P2|NOT COMPLETED|Study Extension I||0
5350559|NCT00205777|13163147|P1|NOT COMPLETED|Study Extension I||214
5350560|NCT00205777|13163142|P6|COMPLETED|Study Extension I||0
5350561|NCT00205777|13163143|P5|COMPLETED|Study Extension I||840
5350562|NCT00205777|13163144|P4|COMPLETED|Study Extension I||830
5350563|NCT00205777|13163145|P3|COMPLETED|Study Extension I||0
5350564|NCT00205777|13163146|P2|COMPLETED|Study Extension I||0
5350565|NCT00205777|13163147|P1|COMPLETED|Study Extension I||833
5350566|NCT00205777|13163142|P6|STARTED|Study Extension I||0
5350567|NCT00205777|13163143|P5|STARTED|Study Extension I||1041
5350568|NCT00205777|13163144|P4|STARTED|Study Extension I||1058
5350569|NCT00205777|13163145|P3|STARTED|Study Extension I||1070
5350570|NCT00205777|13163146|P2|STARTED|Study Extension I||0
5350571|NCT00205777|13163147|P1|STARTED|Study Extension I||1047
5350572|NCT00205777|13163142|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
5350573|NCT00205777|13163143|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
5350574|NCT00205777|13163144|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
5350575|NCT00205777|13163145|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
5350576|NCT00205777|13163146|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
5350577|NCT00205777|13163147|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
5350578|NCT00205777|13163142|P6|COMPLETED|Completed Core Study, Entered SE I||0
5350579|NCT00205777|13163143|P5|COMPLETED|Completed Core Study, Entered SE I||0
5350580|NCT00205777|13163144|P4|COMPLETED|Completed Core Study, Entered SE I||1058
5350581|NCT00205777|13163145|P3|COMPLETED|Completed Core Study, Entered SE I||1070
5350582|NCT00205777|13163146|P2|COMPLETED|Completed Core Study, Entered SE I||1041
5350583|NCT00205777|13163147|P1|COMPLETED|Completed Core Study, Entered SE I||1047
5350584|NCT00205777|13163142|P6|STARTED|Completed Core Study, Entered SE I||0
5350585|NCT00205777|13163143|P5|STARTED|Completed Core Study, Entered SE I||0
5350586|NCT00205777|13163144|P4|STARTED|Completed Core Study, Entered SE I||1282
5350587|NCT00205777|13163145|P3|STARTED|Completed Core Study, Entered SE I||1277
5350588|NCT00205777|13163146|P2|STARTED|Completed Core Study, Entered SE I||1245
5350589|NCT00205777|13163147|P1|STARTED|Completed Core Study, Entered SE I||1279
5350590|NCT00205777|13163142|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
5350591|NCT00205777|13163143|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
5350592|NCT00205777|13163144|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
5350593|NCT00205777|13163145|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
5350594|NCT00205777|13163146|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
5350595|NCT00205777|13163147|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
5350596|NCT00205777|13163142|P6|COMPLETED|Core Study (Up to 3 Years)||0
5350597|NCT00205777|13163143|P5|COMPLETED|Core Study (Up to 3 Years)||0
5350598|NCT00205777|13163144|P4|COMPLETED|Core Study (Up to 3 Years)||1282
5350599|NCT00205777|13163145|P3|COMPLETED|Core Study (Up to 3 Years)||1277
5350600|NCT00205777|13163146|P2|COMPLETED|Core Study (Up to 3 Years)||1245
5350601|NCT00205777|13163147|P1|COMPLETED|Core Study (Up to 3 Years)||1279
5350602|NCT00205777|13163142|P6|TREATED|Core Study (Up to 3 Years)||0
5350603|NCT00205777|13163143|P5|TREATED|Core Study (Up to 3 Years)||0
5350604|NCT00205777|13163144|P4|TREATED|Core Study (Up to 3 Years)||1885
5350605|NCT00205777|13163145|P3|TREATED|Core Study (Up to 3 Years)||1849
5350606|NCT00205777|13163146|P2|TREATED|Core Study (Up to 3 Years)||1872
5350607|NCT00205777|13163147|P1|TREATED|Core Study (Up to 3 Years)||1886
5350608|NCT00205777|13163142|P6|STARTED|Core Study (Up to 3 Years)||0
5350609|NCT00205777|13163143|P5|STARTED|Core Study (Up to 3 Years)||0
5350610|NCT00205777|13163144|P4|STARTED|Core Study (Up to 3 Years)||1914
5350611|NCT00205777|13163145|P3|STARTED|Core Study (Up to 3 Years)||1884
5350612|NCT00205777|13163146|P2|STARTED|Core Study (Up to 3 Years)||1904
5350613|NCT00205777|13163147|P1|STARTED|Core Study (Up to 3 Years)||1907
5350614|NCT00205712|13163356|P2|NOT COMPLETED|Overall Study||1
5350615|NCT00205712|13163357|P1|NOT COMPLETED|Overall Study||0
5350616|NCT00205712|13163356|P2|COMPLETED|Overall Study||19
5350617|NCT00205712|13163357|P1|COMPLETED|Overall Study||20
5350618|NCT00205712|13163356|P2|STARTED|Overall Study||20
5350619|NCT00205712|13163357|P1|STARTED|Overall Study||20
5350620|NCT00205699|13163370|P3|NOT COMPLETED|Overall Study||6
5350621|NCT00205699|13163371|P2|NOT COMPLETED|Overall Study||6
5350622|NCT00205699|13163372|P1|NOT COMPLETED|Overall Study||3
5350623|NCT00205699|13163370|P3|COMPLETED|Overall Study||43
5350624|NCT00205699|13163371|P2|COMPLETED|Overall Study||40
5350625|NCT00205699|13163372|P1|COMPLETED|Overall Study||46
5350626|NCT00205699|13163370|P3|STARTED|Overall Study||49
5350627|NCT00205699|13163371|P2|STARTED|Overall Study||46
5350628|NCT00205699|13163372|P1|STARTED|Overall Study||49
5350629|NCT00205660|13163397|P2|NOT COMPLETED|Overall Study||2
5350630|NCT00205660|13163398|P1|NOT COMPLETED|Overall Study||2
5350631|NCT00205660|13163397|P2|COMPLETED|Overall Study||35
5350632|NCT00205660|13163398|P1|COMPLETED|Overall Study||12
5350633|NCT00205660|13163397|P2|STARTED|Overall Study||37
5350634|NCT00205660|13163398|P1|STARTED|Overall Study||14
5350635|NCT00205504|13163410|P2|NOT COMPLETED|Overall Study||0
5350636|NCT00205504|13163411|P1|NOT COMPLETED|Overall Study||7
5350637|NCT00205504|13163410|P2|COMPLETED|Overall Study||15
5350638|NCT00205504|13163411|P1|COMPLETED|Overall Study||14
5350639|NCT00205504|13163410|P2|STARTED|Overall Study||15
5350640|NCT00205504|13163411|P1|STARTED|Overall Study||21
5350641|NCT00205374|13163437|P2|NOT COMPLETED|Overall Study||0
5350642|NCT00205374|13163438|P1|NOT COMPLETED|Overall Study||0
5350643|NCT00205374|13163437|P2|COMPLETED|Overall Study||9
5350644|NCT00205374|13163438|P1|COMPLETED|Overall Study||10
5350645|NCT00205374|13163437|P2|STARTED|Overall Study||9
5350646|NCT00205374|13163438|P1|STARTED|Overall Study||10
5350647|NCT00205348|13163446|P1|NOT COMPLETED|Overall Study||30
5350648|NCT00205348|13163446|P1|COMPLETED|Overall Study||116
5350649|NCT00205348|13163446|P1|STARTED|Overall Study||146
5350650|NCT00205179|13163452|P2|NOT COMPLETED|Overall Study||4
5350651|NCT00205179|13163453|P1|NOT COMPLETED|Overall Study||2
5350652|NCT00205179|13163452|P2|COMPLETED|Overall Study||29
5350653|NCT00205179|13163453|P1|COMPLETED|Overall Study||30
5350654|NCT00205179|13163452|P2|STARTED|Overall Study||33
5350655|NCT00205179|13163453|P1|STARTED|Overall Study||32
5350656|NCT00205049|13163517|P2|NOT COMPLETED|Overall Study||0
5350657|NCT00205049|13163518|P1|NOT COMPLETED|Overall Study||0
5350658|NCT00205049|13163517|P2|COMPLETED|Overall Study||0
5350659|NCT00205049|13163518|P1|COMPLETED|Overall Study||0
5350660|NCT00205049|13163517|P2|STARTED|Overall Study||0
5350661|NCT00205049|13163518|P1|STARTED|Overall Study||0
5350662|NCT00204932|13163526|P2|NOT COMPLETED|Overall Study||6
5350663|NCT00204932|13163527|P1|NOT COMPLETED|Overall Study||2
5350664|NCT00204932|13163526|P2|COMPLETED|Overall Study||18
5350665|NCT00204932|13163527|P1|COMPLETED|Overall Study||22
5350666|NCT00204932|13163526|P2|STARTED|Overall Study||24
5350667|NCT00204932|13163527|P1|STARTED|Overall Study||24
5350668|NCT00204737|13163535|P2|NOT COMPLETED|Overall Study||0
5350669|NCT00204737|13163536|P1|NOT COMPLETED|Overall Study||0
5350670|NCT00204737|13163535|P2|COMPLETED|Overall Study||6
5350671|NCT00204737|13163536|P1|COMPLETED|Overall Study||6
5350672|NCT00204737|13163535|P2|STARTED|Overall Study||6
5350673|NCT00204737|13163536|P1|STARTED|Overall Study||6
5350674|NCT00204373|13163560|P1|NOT COMPLETED|Overall Study||0
5350675|NCT00204373|13163560|P1|COMPLETED|Overall Study||72
5350676|NCT00204373|13163560|P1|STARTED|Overall Study||72
5350677|NCT00203996|13163571|P10|NOT COMPLETED|Overall Study||1
5350678|NCT00203996|13163572|P9|NOT COMPLETED|Overall Study||0
5350679|NCT00203996|13163573|P8|NOT COMPLETED|Overall Study||2
5350680|NCT00203996|13163574|P7|NOT COMPLETED|Overall Study||0
5350681|NCT00203996|13163575|P6|NOT COMPLETED|Overall Study||0
5350682|NCT00203996|13163576|P5|NOT COMPLETED|Overall Study||1
5350683|NCT00203996|13163577|P4|NOT COMPLETED|Overall Study||10
5350684|NCT00203996|13163578|P3|NOT COMPLETED|Overall Study||0
5350685|NCT00203996|13163579|P2|NOT COMPLETED|Overall Study||0
5350686|NCT00203996|13163580|P1|NOT COMPLETED|Overall Study||0
5350687|NCT00203996|13163571|P10|COMPLETED|Overall Study||2
5350688|NCT00203996|13163572|P9|COMPLETED|Overall Study||2
5350689|NCT00203996|13163573|P8|COMPLETED|Overall Study||2
5350690|NCT00203996|13163574|P7|COMPLETED|Overall Study||2
5350691|NCT00203996|13163575|P6|COMPLETED|Overall Study||3
5350692|NCT00203996|13163576|P5|COMPLETED|Overall Study||3
5350693|NCT00203996|13163577|P4|COMPLETED|Overall Study||9
5350694|NCT00203996|13163578|P3|COMPLETED|Overall Study||0
5350695|NCT00203996|13163579|P2|COMPLETED|Overall Study||0
5350696|NCT00203996|13163580|P1|COMPLETED|Overall Study||0
5350697|NCT00203996|13163571|P10|Aim 3 Only: Third Intervention|Overall Study||2
5350698|NCT00203996|13163572|P9|Aim 3 Only: Third Intervention|Overall Study||2
5350699|NCT00203996|13163573|P8|Aim 3 Only: Third Intervention|Overall Study||2
5350700|NCT00203996|13163574|P7|Aim 3 Only: Third Intervention|Overall Study||2
5350701|NCT00203996|13163575|P6|Aim 3 Only: Third Intervention|Overall Study||3
5350702|NCT00203996|13163576|P5|Aim 3 Only: Third Intervention|Overall Study||0
5350703|NCT00203996|13163577|P4|Aim 3 Only: Third Intervention|Overall Study||0
5350704|NCT00203996|13163578|P3|Aim 3 Only: Third Intervention|Overall Study||0
5350705|NCT00203996|13163579|P2|Aim 3 Only: Third Intervention|Overall Study||0
5350706|NCT00203996|13163580|P1|Aim 3 Only: Third Intervention|Overall Study||0
5350707|NCT00203996|13163571|P10|Aim 3 Only: Second Washout|Overall Study||2
5350708|NCT00203996|13163572|P9|Aim 3 Only: Second Washout|Overall Study||2
5350709|NCT00203996|13163573|P8|Aim 3 Only: Second Washout|Overall Study||2
5350710|NCT00203996|13163574|P7|Aim 3 Only: Second Washout|Overall Study||2
5350711|NCT00203996|13163575|P6|Aim 3 Only: Second Washout|Overall Study||3
5350712|NCT00203996|13163576|P5|Aim 3 Only: Second Washout|Overall Study||0
5350713|NCT00203996|13163577|P4|Aim 3 Only: Second Washout|Overall Study||0
5350714|NCT00203996|13163578|P3|Aim 3 Only: Second Washout|Overall Study||0
5350715|NCT00203996|13163579|P2|Aim 3 Only: Second Washout|Overall Study||0
5350716|NCT00203996|13163580|P1|Aim 3 Only: Second Washout|Overall Study||0
5350717|NCT00203996|13163571|P10|Aim 3 Only: Second Intervention|Overall Study||2
5350718|NCT00203996|13163572|P9|Aim 3 Only: Second Intervention|Overall Study||2
5350719|NCT00203996|13163573|P8|Aim 3 Only: Second Intervention|Overall Study||2
5350720|NCT00203996|13163574|P7|Aim 3 Only: Second Intervention|Overall Study||2
5350721|NCT00203996|13163575|P6|Aim 3 Only: Second Intervention|Overall Study||3
5350722|NCT00203996|13163576|P5|Aim 3 Only: Second Intervention|Overall Study||0
5350723|NCT00203996|13163577|P4|Aim 3 Only: Second Intervention|Overall Study||0
5350724|NCT00203996|13163578|P3|Aim 3 Only: Second Intervention|Overall Study||0
5350725|NCT00203996|13163579|P2|Aim 3 Only: Second Intervention|Overall Study||0
5350726|NCT00203996|13163580|P1|Aim 3 Only: Second Intervention|Overall Study||0
5350727|NCT00203996|13163571|P10|Aim 3 Only: Washout|Overall Study||2
5350728|NCT00203996|13163572|P9|Aim 3 Only: Washout|Overall Study||2
5350729|NCT00203996|13163573|P8|Aim 3 Only: Washout|Overall Study||2
5350730|NCT00203996|13163574|P7|Aim 3 Only: Washout|Overall Study||2
5350731|NCT00203996|13163575|P6|Aim 3 Only: Washout|Overall Study||3
5350732|NCT00203996|13163576|P5|Aim 3 Only: Washout|Overall Study||0
5350733|NCT00203996|13163577|P4|Aim 3 Only: Washout|Overall Study||0
5350734|NCT00203996|13163578|P3|Aim 3 Only: Washout|Overall Study||0
5350735|NCT00203996|13163579|P2|Aim 3 Only: Washout|Overall Study||0
5350736|NCT00203996|13163580|P1|Aim 3 Only: Washout|Overall Study||0
5350737|NCT00203996|13163571|P10|Aim 3 Only: First Intervention|Overall Study||3
5350738|NCT00203996|13163572|P9|Aim 3 Only: First Intervention|Overall Study||2
5350739|NCT00203996|13163573|P8|Aim 3 Only: First Intervention|Overall Study||4
5350740|NCT00203996|13163574|P7|Aim 3 Only: First Intervention|Overall Study||2
5350741|NCT00203996|13163575|P6|Aim 3 Only: First Intervention|Overall Study||3
5350742|NCT00203996|13163576|P5|Aim 3 Only: First Intervention|Overall Study||0
5350743|NCT00203996|13163577|P4|Aim 3 Only: First Intervention|Overall Study||0
5350744|NCT00203996|13163578|P3|Aim 3 Only: First Intervention|Overall Study||0
5350745|NCT00203996|13163579|P2|Aim 3 Only: First Intervention|Overall Study||0
5350746|NCT00203996|13163580|P1|Aim 3 Only: First Intervention|Overall Study||0
5350747|NCT00203996|13163571|P10|STARTED|Overall Study||3
5350748|NCT00203996|13163572|P9|STARTED|Overall Study||2
5350749|NCT00203996|13163573|P8|STARTED|Overall Study||4
5350750|NCT00203996|13163574|P7|STARTED|Overall Study||2
5350751|NCT00203996|13163575|P6|STARTED|Overall Study||3
5350752|NCT00203996|13163576|P5|STARTED|Overall Study||4
5350753|NCT00203996|13163577|P4|STARTED|Overall Study||19
5350754|NCT00203996|13163578|P3|STARTED|Overall Study||0
5350755|NCT00203996|13163579|P2|STARTED|Overall Study||0
5350756|NCT00203996|13163580|P1|STARTED|Overall Study||0
5350757|NCT00203931|13163629|P2|NOT COMPLETED|Overall Study||5
5350758|NCT00203931|13163630|P1|NOT COMPLETED|Overall Study||7
5350759|NCT00203931|13163629|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
5350760|NCT00203931|13163630|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
5350761|NCT00203931|13163629|P2|STARTED|Overall Study||28
5350762|NCT00203931|13163630|P1|STARTED|Overall Study||27
5350763|NCT00203892|13163647|P3|NOT COMPLETED|Overall Study||0
5350764|NCT00203892|13163648|P2|NOT COMPLETED|Overall Study||2
5350765|NCT00203892|13163649|P1|NOT COMPLETED|Overall Study||2
5350766|NCT00203892|13163647|P3|COMPLETED|Overall Study||6
5350767|NCT00203892|13163648|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
5350768|NCT00203892|13163649|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
5350769|NCT00203892|13163647|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
5350770|NCT00203892|13163648|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
5350771|NCT00203892|13163649|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
5350772|NCT00203892|13163647|P3|STARTED|Overall Study||6
5350773|NCT00203892|13163648|P2|STARTED|Overall Study||10
5350774|NCT00203892|13163649|P1|STARTED|Overall Study||7
5350775|NCT00203502|13163660|P1|NOT COMPLETED|Overall Study||1
5350776|NCT00203502|13163660|P1|COMPLETED|Overall Study||39
5350777|NCT00203502|13163660|P1|STARTED|Overall Study||40
5350778|NCT00203476|13163671|P3|NOT COMPLETED|Overall Study||0
5350779|NCT00203476|13163672|P2|NOT COMPLETED|Overall Study||1
5350780|NCT00203476|13163673|P1|NOT COMPLETED|Overall Study||1
5350781|NCT00203476|13163671|P3|COMPLETED|Overall Study||10
5350782|NCT00203476|13163672|P2|COMPLETED|Overall Study||9
5350783|NCT00203476|13163673|P1|COMPLETED|Overall Study||9
5350784|NCT00203476|13163671|P3|STARTED|Overall Study||10
5350785|NCT00203476|13163672|P2|STARTED|Overall Study||10
5350786|NCT00203476|13163673|P1|STARTED|Overall Study||10
5350787|NCT00203424|13163690|P1|NOT COMPLETED|Follow-up Period||6
5350788|NCT00203424|13163690|P1|COMPLETED|Follow-up Period||10
5350789|NCT00203424|13163690|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
5350790|NCT00203424|13163690|P1|NOT COMPLETED|Treatment Period||11
5350791|NCT00203424|13163690|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
5350792|NCT00203424|13163690|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
5350793|NCT00203411|13163697|P1|NOT COMPLETED|Follow-up||4
5350794|NCT00203411|13163697|P1|COMPLETED|Follow-up||41
5350795|NCT00203411|13163697|P1|STARTED|Follow-up||45
5350796|NCT00203411|13163697|P1|NOT COMPLETED|Treatment Period||0
5350797|NCT00203411|13163697|P1|COMPLETED|Treatment Period||45
5350798|NCT00203411|13163697|P1|STARTED|Treatment Period||45
5350799|NCT00203307|13163706|P2|NOT COMPLETED|Second Intervention||0
5350800|NCT00203307|13163707|P1|NOT COMPLETED|Second Intervention||0
5350801|NCT00203307|13163706|P2|COMPLETED|Second Intervention||0
5350802|NCT00203307|13163707|P1|COMPLETED|Second Intervention||1
5350803|NCT00203307|13163706|P2|STARTED|Second Intervention||0
5350804|NCT00203307|13163707|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
5350805|NCT00203307|13163706|P2|NOT COMPLETED|First Intervention||0
5350806|NCT00203307|13163707|P1|NOT COMPLETED|First Intervention||2
5350807|NCT00203307|13163706|P2|COMPLETED|First Intervention||0
5350808|NCT00203307|13163707|P1|COMPLETED|First Intervention||1
5350809|NCT00203307|13163706|P2|STARTED|First Intervention||0
5350810|NCT00203307|13163707|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
5350811|NCT00203294|13163715|P2|NOT COMPLETED|Overall Study||13
5350812|NCT00203294|13163716|P1|NOT COMPLETED|Overall Study||8
5350813|NCT00203294|13163715|P2|COMPLETED|Overall Study||10
5350814|NCT00203294|13163716|P1|COMPLETED|Overall Study||14
5350815|NCT00203294|13163715|P2|STARTED|Overall Study||23
5350816|NCT00203294|13163716|P1|STARTED|Overall Study||22
5350817|NCT00203268|13163722|P1|NOT COMPLETED|Late Treatment||0
5350818|NCT00203268|13163722|P1|COMPLETED|Late Treatment||9
5350819|NCT00203268|13163722|P1|STARTED|Late Treatment||9
5350820|NCT00203268|13163722|P1|NOT COMPLETED|Early Treatment||4
5350821|NCT00203268|13163722|P1|COMPLETED|Early Treatment||9
5350822|NCT00203268|13163722|P1|STARTED|Early Treatment||13
5350823|NCT00203242|13163728|P1|NOT COMPLETED|Overall Study||1
5350824|NCT00203242|13163728|P1|COMPLETED|Overall Study||14
5350825|NCT00203242|13163728|P1|STARTED|Overall Study||15
5350826|NCT00203229|13163734|P2|NOT COMPLETED|Overall Study||3
5350827|NCT00203229|13163735|P1|NOT COMPLETED|Overall Study||3
5350828|NCT00203229|13163734|P2|COMPLETED|Overall Study||7
5350829|NCT00203229|13163735|P1|COMPLETED|Overall Study||7
5350830|NCT00203229|13163734|P2|STARTED|Overall Study||10
5350831|NCT00203229|13163735|P1|STARTED|Overall Study||10
5350832|NCT00203216|13163741|P1|NOT COMPLETED|Overall Study||4
5350833|NCT00203216|13163741|P1|COMPLETED|Overall Study||27
5350834|NCT00203216|13163741|P1|STARTED|Overall Study||31
5350835|NCT00203203|13163747|P2|NOT COMPLETED|Overall Study||0
5350836|NCT00203203|13163748|P1|NOT COMPLETED|Overall Study||1
5350837|NCT00203203|13163747|P2|COMPLETED|Overall Study||20
5350838|NCT00203203|13163748|P1|COMPLETED|Overall Study||9
5350839|NCT00203203|13163747|P2|STARTED|Overall Study||20
5350840|NCT00203203|13163748|P1|STARTED|Overall Study||10
5350841|NCT00203047|13163780|P2|NOT COMPLETED|Overall Study||203
5350842|NCT00203047|13163781|P1|NOT COMPLETED|Overall Study||191
5350843|NCT00203047|13163780|P2|COMPLETED|Overall Study||7
5350844|NCT00203047|13163781|P1|COMPLETED|Overall Study||13
5350845|NCT00203047|13163780|P2|In Database as of January 29, 2009|Overall Study||209
5350846|NCT00203047|13163781|P1|In Database as of January 29, 2009|Overall Study||199
5350847|NCT00203047|13163780|P2|STARTED|Overall Study||210
5350848|NCT00203047|13163781|P1|STARTED|Overall Study||204
5350849|NCT00203021|13163795|P2|NOT COMPLETED|Overall Study||77
5350850|NCT00203021|13163796|P1|NOT COMPLETED|Overall Study||79
5350851|NCT00203021|13163795|P2|COMPLETED|Overall Study||24
5350852|NCT00203021|13163796|P1|COMPLETED|Overall Study||28
5350853|NCT00203021|13163795|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
5350854|NCT00203021|13163796|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
5350855|NCT00203021|13163795|P2|STARTED|Overall Study||101
5350856|NCT00203021|13163796|P1|STARTED|Overall Study||107
5350857|NCT00202878|13163806|P2|NOT COMPLETED|Overall Study||2217
5350858|NCT00202878|13163807|P1|NOT COMPLETED|Overall Study||2199
5350859|NCT00202878|13163806|P2|COMPLETED|Overall Study||6860
5350860|NCT00202878|13163807|P1|COMPLETED|Overall Study||6868
5350861|NCT00202878|13163806|P2|STARTED|Overall Study||9077
5350862|NCT00202878|13163807|P1|STARTED|Overall Study||9067
5350863|NCT00202839|13163821|P2|NOT COMPLETED|Overall Study||10
5350864|NCT00202839|13163822|P1|NOT COMPLETED|Overall Study||24
5350865|NCT00202839|13163821|P2|COMPLETED|Overall Study||72
5350866|NCT00202839|13163822|P1|COMPLETED|Overall Study||54
5350867|NCT00202839|13163821|P2|STARTED|Overall Study||82
5350868|NCT00202839|13163822|P1|STARTED|Overall Study||78
5350869|NCT00202722|13163830|P1|NOT COMPLETED|Overall Study||0
5350870|NCT00202722|13163830|P1|COMPLETED|Overall Study||41
5350871|NCT00202722|13163830|P1|STARTED|Overall Study||41
5350872|NCT00202644|13163837|P2|NOT COMPLETED|Overall Study||27
5350873|NCT00202644|13163838|P1|NOT COMPLETED|Overall Study||35
5350874|NCT00202644|13163837|P2|COMPLETED|Overall Study||43
5350875|NCT00202644|13163838|P1|COMPLETED|Overall Study||41
5350876|NCT00202644|13163837|P2|STARTED|Overall Study||70
5350877|NCT00202644|13163838|P1|STARTED|Overall Study|One participant not randomized but treated.|76
5350878|NCT00202449|13163865|P3|NOT COMPLETED|Overall Study||12
5350879|NCT00202449|13163866|P2|NOT COMPLETED|Overall Study||11
5350880|NCT00202449|13163867|P1|NOT COMPLETED|Overall Study||11
5350881|NCT00202449|13163865|P3|COMPLETED|Overall Study||9
5350882|NCT00202449|13163866|P2|COMPLETED|Overall Study||9
5350883|NCT00202449|13163867|P1|COMPLETED|Overall Study||7
5350884|NCT00202449|13163865|P3|STARTED|Overall Study||21
5350885|NCT00202449|13163866|P2|STARTED|Overall Study||20
5350886|NCT00202449|13163867|P1|STARTED|Overall Study||18
5350887|NCT00201877|13163881|P1|NOT COMPLETED|Overall Study||0
5350888|NCT00201877|13163881|P1|COMPLETED|Overall Study||25
5350889|NCT00201877|13163881|P1|STARTED|Overall Study||25
5350890|NCT00201864|13163888|P1|NOT COMPLETED|Overall Study||0
5350891|NCT00201864|13163888|P1|COMPLETED|Overall Study||40
5350892|NCT00201864|13163888|P1|STARTED|Overall Study||40
5350893|NCT00201851|13163899|P3|NOT COMPLETED|Overall Study||1
5350894|NCT00201851|13163900|P2|NOT COMPLETED|Overall Study||2
5350895|NCT00201851|13163901|P1|NOT COMPLETED|Overall Study||8
5350896|NCT00201851|13163899|P3|COMPLETED|Overall Study||230
5350897|NCT00201851|13163900|P2|COMPLETED|Overall Study||255
5350898|NCT00201851|13163901|P1|COMPLETED|Overall Study||244
5350899|NCT00201851|13163899|P3|STARTED|Overall Study||231
5350900|NCT00201851|13163900|P2|STARTED|Overall Study||257
5350901|NCT00201851|13163901|P1|STARTED|Overall Study||252
5350902|NCT00201838|13163911|P2|NOT COMPLETED|Overall Study||0
5350903|NCT00201838|13163912|P1|NOT COMPLETED|Overall Study||0
5350904|NCT00201838|13163911|P2|COMPLETED|Overall Study||8
5350905|NCT00201838|13163912|P1|COMPLETED|Overall Study||30
5350906|NCT00201838|13163911|P2|Treatment Cohort|Overall Study||8
5350907|NCT00201838|13163912|P1|Treatment Cohort|Overall Study||30
5350908|NCT00201838|13163911|P2|STARTED|Overall Study||8
5350909|NCT00201838|13163912|P1|STARTED|Overall Study||30
5350910|NCT00201825|13163926|P1|NOT COMPLETED|Overall Study||0
5350911|NCT00201825|13163926|P1|COMPLETED|Overall Study||29
5350912|NCT00201825|13163926|P1|STARTED|Overall Study||29
5350913|NCT00201773|13163933|P1|NOT COMPLETED|Overall Study||6
5350914|NCT00201773|13163933|P1|COMPLETED|Overall Study||16
5350915|NCT00201773|13163933|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
5350916|NCT00201773|13163933|P1|Received All Exemestane Therapy|Overall Study||5
5350917|NCT00201773|13163933|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
5350918|NCT00201773|13163933|P1|STARTED|Overall Study||22
5350919|NCT00201760|13163942|P2|NOT COMPLETED|Overall Study||0
5350920|NCT00201760|13163943|P1|NOT COMPLETED|Overall Study||0
5350921|NCT00201760|13163942|P2|COMPLETED|Overall Study||5
5350922|NCT00201760|13163943|P1|COMPLETED|Overall Study||5
5350923|NCT00201760|13163942|P2|STARTED|Overall Study||5
5350924|NCT00201760|13163943|P1|STARTED|Overall Study||5
5350925|NCT00201734|13163955|P2|NOT COMPLETED|Overall Study||0
5350926|NCT00201734|13163956|P1|NOT COMPLETED|Overall Study||3
5350927|NCT00201734|13163955|P2|COMPLETED|Overall Study||25
5350928|NCT00201734|13163956|P1|COMPLETED|Overall Study||29
5350929|NCT00201734|13163955|P2|Patients Not Evaluable|Overall Study||0
5350930|NCT00201734|13163956|P1|Patients Not Evaluable|Overall Study||3
5350931|NCT00201734|13163955|P2|STARTED|Overall Study||25
5350932|NCT00201734|13163956|P1|STARTED|Overall Study||32
5350933|NCT00201643|13163973|P2|NOT COMPLETED|Overall Study||4
5350934|NCT00201643|13163974|P1|NOT COMPLETED|Overall Study||5
5350935|NCT00201643|13163973|P2|COMPLETED|Overall Study||210
5350936|NCT00201643|13163974|P1|COMPLETED|Overall Study||218
5350937|NCT00201643|13163973|P2|STARTED|Overall Study||214
5350938|NCT00201643|13163974|P1|STARTED|Overall Study||223
5350939|NCT00201448|13163998|P2|NOT COMPLETED|Overall Study||0
5350940|NCT00201448|13163999|P1|NOT COMPLETED|Overall Study||0
5350941|NCT00201448|13163998|P2|COMPLETED|Overall Study||40
5350942|NCT00201448|13163999|P1|COMPLETED|Overall Study||42
5350943|NCT00201448|13163998|P2|STARTED|Overall Study||40
5350944|NCT00201448|13163999|P1|STARTED|Overall Study||42
5350945|NCT00201409|13164009|P2|NOT COMPLETED|Overall Study||1
5350946|NCT00201409|13164010|P1|NOT COMPLETED|Overall Study||1
5350947|NCT00201409|13164009|P2|COMPLETED|Overall Study||66
5350948|NCT00201409|13164010|P1|COMPLETED|Overall Study||64
5350949|NCT00201409|13164009|P2|STARTED|Overall Study||67
5350950|NCT00201409|13164010|P1|STARTED|Overall Study||65
5350951|NCT00201240|13164020|P1|NOT COMPLETED|Overall Study||3
5350952|NCT00201240|13164020|P1|COMPLETED|Overall Study||44
5350953|NCT00201240|13164020|P1|STARTED|Overall Study||47
5350954|NCT00201201|13164038|P2|NOT COMPLETED|Overall Study||7
5350955|NCT00201201|13164039|P1|NOT COMPLETED|Overall Study||5
5350956|NCT00201201|13164038|P2|COMPLETED|Overall Study||66
5350957|NCT00201201|13164039|P1|COMPLETED|Overall Study||82
5350958|NCT00201201|13164038|P2|STARTED|Overall Study||73
5350959|NCT00201201|13164039|P1|STARTED|Overall Study||87
5350960|NCT00201123|13164058|P3|NOT COMPLETED|Overall Study||9
5350961|NCT00201123|13164059|P2|NOT COMPLETED|Overall Study||4
5350962|NCT00201123|13164060|P1|NOT COMPLETED|Overall Study||6
5350963|NCT00201123|13164058|P3|COMPLETED|Overall Study||23
5350964|NCT00201123|13164059|P2|COMPLETED|Overall Study||28
5350965|NCT00201123|13164060|P1|COMPLETED|Overall Study||26
5350966|NCT00201123|13164058|P3|Did Not Meet Continuation Criteria|Overall Study||5
5350967|NCT00201123|13164059|P2|Did Not Meet Continuation Criteria|Overall Study||0
5350968|NCT00201123|13164060|P1|Did Not Meet Continuation Criteria|Overall Study||2
5350969|NCT00201123|13164058|P3|STARTED|Overall Study||32
5350970|NCT00201123|13164059|P2|STARTED|Overall Study||32
5350971|NCT00201123|13164060|P1|STARTED|Overall Study||32
5350972|NCT00201006|13164077|P3|NOT COMPLETED|Overall Study||4
5350973|NCT00201006|13164078|P2|NOT COMPLETED|Overall Study||2
5350974|NCT00201006|13164079|P1|NOT COMPLETED|Overall Study||8
5350975|NCT00201006|13164077|P3|COMPLETED|Overall Study||75
5350976|NCT00201006|13164078|P2|COMPLETED|Overall Study||70
5350977|NCT00201006|13164079|P1|COMPLETED|Overall Study||75
5350978|NCT00201006|13164077|P3|STARTED|Overall Study||79
5350979|NCT00201006|13164078|P2|STARTED|Overall Study||72
5350980|NCT00201006|13164079|P1|STARTED|Overall Study||83
5350981|NCT00200967|13164089|P2|NOT COMPLETED|Run-out Period||0
5350982|NCT00200967|13164090|P1|NOT COMPLETED|Run-out Period||1
5350983|NCT00200967|13164089|P2|COMPLETED|Run-out Period||41
5350984|NCT00200967|13164090|P1|COMPLETED|Run-out Period||34
5350985|NCT00200967|13164089|P2|STARTED|Run-out Period||41
5350986|NCT00200967|13164090|P1|STARTED|Run-out Period||35
5350987|NCT00200967|13164089|P2|NOT COMPLETED|Second Treatment Period||2
5350988|NCT00200967|13164090|P1|NOT COMPLETED|Second Treatment Period||1
5350989|NCT00200967|13164089|P2|COMPLETED|Second Treatment Period||41
5350990|NCT00200967|13164090|P1|COMPLETED|Second Treatment Period||35
5350991|NCT00200967|13164089|P2|STARTED|Second Treatment Period||43
5350992|NCT00200967|13164090|P1|STARTED|Second Treatment Period||36
5350993|NCT00200967|13164089|P2|NOT COMPLETED|Wash-out Period||1
5350994|NCT00200967|13164090|P1|NOT COMPLETED|Wash-out Period||0
5350995|NCT00200967|13164089|P2|COMPLETED|Wash-out Period||43
5350996|NCT00200967|13164090|P1|COMPLETED|Wash-out Period||36
5350997|NCT00200967|13164089|P2|STARTED|Wash-out Period||44
5350998|NCT00200967|13164090|P1|STARTED|Wash-out Period||36
5350999|NCT00200967|13164089|P2|NOT COMPLETED|First Treatment Period||1
5351000|NCT00200967|13164090|P1|NOT COMPLETED|First Treatment Period||6
5351001|NCT00200967|13164089|P2|COMPLETED|First Treatment Period||44
5351002|NCT00200967|13164090|P1|COMPLETED|First Treatment Period||36
5351003|NCT00200967|13164089|P2|First Treatment Period|First Treatment Period||45
5351004|NCT00200967|13164090|P1|First Treatment Period|First Treatment Period||42
5351005|NCT00200967|13164089|P2|STARTED|First Treatment Period||45
5351006|NCT00200967|13164090|P1|STARTED|First Treatment Period||42
5351007|NCT00200902|13164121|P3|NOT COMPLETED|Overall Study||8
5351008|NCT00200902|13164122|P2|NOT COMPLETED|Overall Study||3
5351009|NCT00200902|13164123|P1|NOT COMPLETED|Overall Study||10
5351010|NCT00200902|13164121|P3|COMPLETED|Overall Study||12
5351011|NCT00200902|13164122|P2|COMPLETED|Overall Study||26
5351012|NCT00200902|13164123|P1|COMPLETED|Overall Study||29
5351013|NCT00200902|13164121|P3|STARTED|Overall Study||20
5351014|NCT00200902|13164122|P2|STARTED|Overall Study||29
5351015|NCT00200902|13164123|P1|STARTED|Overall Study||39
5351016|NCT00200850|13164140|P3|NOT COMPLETED|Overall Study||6
5351017|NCT00200850|13164141|P2|NOT COMPLETED|Overall Study||1
5351018|NCT00200850|13164142|P1|NOT COMPLETED|Overall Study||3
5351019|NCT00200850|13164140|P3|COMPLETED|Overall Study||5
5351020|NCT00200850|13164141|P2|COMPLETED|Overall Study||9
5351021|NCT00200850|13164142|P1|COMPLETED|Overall Study||7
5351022|NCT00200850|13164140|P3|STARTED|Overall Study||11
5351023|NCT00200850|13164141|P2|STARTED|Overall Study||10
5351024|NCT00200850|13164142|P1|STARTED|Overall Study||10
5351025|NCT00200785|13164152|P2|NOT COMPLETED|Second Intervention||0
5351026|NCT00200785|13164153|P1|NOT COMPLETED|Second Intervention||0
5351027|NCT00200785|13164152|P2|COMPLETED|Second Intervention||6
5351028|NCT00200785|13164153|P1|COMPLETED|Second Intervention||9
5351029|NCT00200785|13164152|P2|STARTED|Second Intervention||6
5351030|NCT00200785|13164153|P1|STARTED|Second Intervention||9
5351031|NCT00200785|13164152|P2|NOT COMPLETED|Washout Period of 1 Week||0
5351032|NCT00200785|13164153|P1|NOT COMPLETED|Washout Period of 1 Week||0
5351033|NCT00200785|13164152|P2|COMPLETED|Washout Period of 1 Week||6
5351034|NCT00200785|13164153|P1|COMPLETED|Washout Period of 1 Week||9
5351035|NCT00200785|13164152|P2|STARTED|Washout Period of 1 Week||6
5351036|NCT00200785|13164153|P1|STARTED|Washout Period of 1 Week||9
5351037|NCT00200785|13164152|P2|NOT COMPLETED|First Intervention||0
5351038|NCT00200785|13164153|P1|NOT COMPLETED|First Intervention||0
5351039|NCT00200785|13164152|P2|COMPLETED|First Intervention||6
5351040|NCT00200785|13164153|P1|COMPLETED|First Intervention||9
5351041|NCT00200785|13164152|P2|STARTED|First Intervention||6
5351042|NCT00200785|13164153|P1|STARTED|First Intervention||9
5351043|NCT00200356|13164163|P2|NOT COMPLETED|Overall Study||7
5351044|NCT00200356|13164164|P1|NOT COMPLETED|Overall Study||8
5351045|NCT00200356|13164163|P2|COMPLETED|Overall Study||195
5351046|NCT00200356|13164164|P1|COMPLETED|Overall Study||191
5351047|NCT00200356|13164163|P2|Safety Analysis Set|Overall Study||198
5351048|NCT00200356|13164164|P1|Safety Analysis Set|Overall Study||194
5351049|NCT00200356|13164163|P2|STARTED|Overall Study||202
5351050|NCT00200356|13164164|P1|STARTED|Overall Study||199
5351051|NCT00200343|13164191|P3|NOT COMPLETED|Overall Study||13
5351052|NCT00200343|13164192|P2|NOT COMPLETED|Overall Study||8
5351053|NCT00200343|13164193|P1|NOT COMPLETED|Overall Study||16
5351054|NCT00200343|13164191|P3|COMPLETED|Overall Study||184
5351055|NCT00200343|13164192|P2|COMPLETED|Overall Study||192
5351056|NCT00200343|13164193|P1|COMPLETED|Overall Study||183
5351057|NCT00200343|13164191|P3|STARTED|Overall Study||197
5351058|NCT00200343|13164192|P2|STARTED|Overall Study||200
5351059|NCT00200343|13164193|P1|STARTED|Overall Study||199
5351060|NCT00200161|13164218|P2|NOT COMPLETED|Overall Study||0
5351061|NCT00200161|13164219|P1|NOT COMPLETED|Overall Study||0
5351062|NCT00200161|13164218|P2|COMPLETED|Overall Study||42
5351063|NCT00200161|13164219|P1|COMPLETED|Overall Study||43
5351064|NCT00200161|13164218|P2|STARTED|Overall Study||42
5351065|NCT00200161|13164219|P1|STARTED|Overall Study||43
5351066|NCT00200057|13164231|P1|NOT COMPLETED|Overall Study||9
5351067|NCT00200057|13164231|P1|COMPLETED|Overall Study||111
5351068|NCT00200057|13164231|P1|12 Month Follow-up|Overall Study||111
5351069|NCT00200057|13164231|P1|6 Month Follow-up|Overall Study||114
5351070|NCT00200057|13164231|P1|3 Month Follow-up|Overall Study||116
5351071|NCT00200057|13164231|P1|1 Month Follow-up|Overall Study||117
5351072|NCT00200057|13164231|P1|STARTED|Overall Study||120
5351073|NCT00199914|13164243|P2|NOT COMPLETED|Overall Study||6
5351074|NCT00199914|13164244|P1|NOT COMPLETED|Overall Study||3
5351075|NCT00199914|13164243|P2|COMPLETED|Overall Study||54
5351076|NCT00199914|13164244|P1|COMPLETED|Overall Study||50
5351077|NCT00199914|13164243|P2|STARTED|Overall Study||60
5351078|NCT00199914|13164244|P1|STARTED|Overall Study||53
5351079|NCT00199875|13164255|P5|NOT COMPLETED|Overall Study||1
5351080|NCT00199875|13164256|P4|NOT COMPLETED|Overall Study||0
5351081|NCT00199875|13164257|P3|NOT COMPLETED|Overall Study||0
5351082|NCT00199875|13164258|P2|NOT COMPLETED|Overall Study||0
5351083|NCT00199875|13164259|P1|NOT COMPLETED|Overall Study||0
5351084|NCT00199875|13164255|P5|COMPLETED|Overall Study||2
5351085|NCT00199875|13164256|P4|COMPLETED|Overall Study||3
5351086|NCT00199875|13164257|P3|COMPLETED|Overall Study||6
5351087|NCT00199875|13164258|P2|COMPLETED|Overall Study||3
5351088|NCT00199875|13164259|P1|COMPLETED|Overall Study||3
5351089|NCT00199875|13164255|P5|STARTED|Overall Study||3
5351090|NCT00199875|13164256|P4|STARTED|Overall Study||3
5351091|NCT00199875|13164257|P3|STARTED|Overall Study||6
5351092|NCT00199875|13164258|P2|STARTED|Overall Study||3
5351093|NCT00199875|13164259|P1|STARTED|Overall Study||3
5351094|NCT00199381|13164281|P1|NOT COMPLETED|Overall Study||504
5351095|NCT00199381|13164281|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
5351096|NCT00199381|13164281|P1|STARTED|Overall Study||504
5351097|NCT00198822|13164288|P3|NOT COMPLETED|Overall Study||21
5351098|NCT00198822|13164289|P2|NOT COMPLETED|Overall Study||20
5351099|NCT00198822|13164290|P1|NOT COMPLETED|Overall Study||14
5351100|NCT00198822|13164288|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
5351101|NCT00198822|13164289|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
5351102|NCT00198822|13164290|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
5351103|NCT00198822|13164288|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
5351104|NCT00198822|13164289|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
5351105|NCT00198822|13164290|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
5351106|NCT00198133|13164309|P2|NOT COMPLETED|Overall Study||8
5351107|NCT00198133|13164310|P1|NOT COMPLETED|Overall Study||5
5351108|NCT00198133|13164309|P2|COMPLETED|Overall Study||3
5351109|NCT00198133|13164310|P1|COMPLETED|Overall Study||11
5351110|NCT00198133|13164309|P2|STARTED|Overall Study||11
5351111|NCT00198133|13164310|P1|STARTED|Overall Study||16
5351112|NCT00198107|13164322|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
5351113|NCT00198107|13164323|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351114|NCT00198107|13164324|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351115|NCT00198107|13164322|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
5351116|NCT00198107|13164323|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351117|NCT00198107|13164324|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351118|NCT00198107|13164322|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
5351119|NCT00198107|13164323|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351120|NCT00198107|13164324|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
5351121|NCT00198107|13164322|P3|NOT COMPLETED|Double-Blind Period||0
5351122|NCT00198107|13164323|P2|NOT COMPLETED|Double-Blind Period||3
5351123|NCT00198107|13164324|P1|NOT COMPLETED|Double-Blind Period||6
5351124|NCT00198107|13164322|P3|COMPLETED|Double-Blind Period||0
5351125|NCT00198107|13164323|P2|COMPLETED|Double-Blind Period||37
5351126|NCT00198107|13164324|P1|COMPLETED|Double-Blind Period||35
5351127|NCT00198107|13164322|P3|1 or More Follow-up Visits|Double-Blind Period||0
5351128|NCT00198107|13164323|P2|1 or More Follow-up Visits|Double-Blind Period||38
5351129|NCT00198107|13164324|P1|1 or More Follow-up Visits|Double-Blind Period||40
5351130|NCT00198107|13164322|P3|STARTED|Double-Blind Period||0
5351131|NCT00198107|13164323|P2|STARTED|Double-Blind Period||40
5351132|NCT00198107|13164324|P1|STARTED|Double-Blind Period||41
5351133|NCT00198081|13164361|P2|NOT COMPLETED|Overall Study||0
5351134|NCT00198081|13164362|P1|NOT COMPLETED|Overall Study||1
5351135|NCT00198081|13164361|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
5351136|NCT00198081|13164362|P1|COMPLETED|Overall Study||4
5351137|NCT00198081|13164361|P2|STARTED|Overall Study|No enrollment on this arm.|0
5351138|NCT00198081|13164362|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
5351139|NCT00198042|13164388|P1|NOT COMPLETED|Overall Study||0
5351140|NCT00198042|13164388|P1|COMPLETED|Overall Study||18
5351141|NCT00198042|13164388|P1|STARTED|Overall Study||18
5351142|NCT00198029|13164392|P1|NOT COMPLETED|Overall Study||4
5351143|NCT00198029|13164392|P1|COMPLETED|Overall Study||28
5351144|NCT00198029|13164392|P1|STARTED|Overall Study||32
5351145|NCT00197496|13164399|P2|NOT COMPLETED|Follow-up||1
5351146|NCT00197496|13164400|P1|NOT COMPLETED|Follow-up||2
5351147|NCT00197496|13164399|P2|COMPLETED|Follow-up||4
5351148|NCT00197496|13164400|P1|COMPLETED|Follow-up||10
5351149|NCT00197496|13164399|P2|STARTED|Follow-up||5
5351150|NCT00197496|13164400|P1|STARTED|Follow-up||12
5351151|NCT00197496|13164399|P2|NOT COMPLETED|Baseline to Discharge||2
5351152|NCT00197496|13164400|P1|NOT COMPLETED|Baseline to Discharge||2
5351153|NCT00197496|13164399|P2|COMPLETED|Baseline to Discharge||5
5351154|NCT00197496|13164400|P1|COMPLETED|Baseline to Discharge||12
5351155|NCT00197496|13164399|P2|STARTED|Baseline to Discharge||7
5351156|NCT00197496|13164400|P1|STARTED|Baseline to Discharge||14
5351157|NCT00197392|13164415|P2|NOT COMPLETED|Overall Study||86
5351158|NCT00197392|13164416|P1|NOT COMPLETED|Overall Study||88
5351159|NCT00197392|13164415|P2|COMPLETED|Overall Study||134
5351160|NCT00197392|13164416|P1|COMPLETED|Overall Study||126
5351161|NCT00197392|13164415|P2|Per Protocol|Overall Study||134
5351162|NCT00197392|13164416|P1|Per Protocol|Overall Study||126
5351163|NCT00197392|13164415|P2|Evaluable|Overall Study||181
5351164|NCT00197392|13164416|P1|Evaluable|Overall Study||176
5351165|NCT00197392|13164415|P2|Modified Intent to Treat|Overall Study||210
5351166|NCT00197392|13164416|P1|Modified Intent to Treat|Overall Study||209
5351167|NCT00197392|13164415|P2|Safety Population|Overall Study||220
5351168|NCT00197392|13164416|P1|Safety Population|Overall Study||214
5351169|NCT00197392|13164415|P2|STARTED|Overall Study||220
5351170|NCT00197392|13164416|P1|STARTED|Overall Study||214
5351171|NCT00197236|13164448|P3|NOT COMPLETED|Overall Study||23
5351172|NCT00197236|13164449|P2|NOT COMPLETED|Overall Study||17
5351173|NCT00197236|13164450|P1|NOT COMPLETED|Overall Study||14
5351174|NCT00197236|13164448|P3|COMPLETED|Overall Study||109
5351175|NCT00197236|13164449|P2|COMPLETED|Overall Study||110
5351176|NCT00197236|13164450|P1|COMPLETED|Overall Study||121
5351177|NCT00197236|13164448|P3|STARTED|Overall Study||132
5351178|NCT00197236|13164449|P2|STARTED|Overall Study||127
5351179|NCT00197236|13164450|P1|STARTED|Overall Study||135
5351180|NCT00197184|13164499|P2|NOT COMPLETED|Overall Study||0
5351181|NCT00197184|13164500|P1|NOT COMPLETED|Overall Study||0
5351182|NCT00197184|13164499|P2|COMPLETED|Overall Study||137
5351183|NCT00197184|13164500|P1|COMPLETED|Overall Study||139
5351184|NCT00197184|13164499|P2|STARTED|Overall Study||137
5351185|NCT00197184|13164500|P1|STARTED|Overall Study||139
5351186|NCT00197145|13164524|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
5351187|NCT00197145|13164525|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
5351188|NCT00197145|13164524|P2|COMPLETED|Period 2 : Open Label Phase||0
5351189|NCT00197145|13164525|P1|COMPLETED|Period 2 : Open Label Phase||0
5351190|NCT00197145|13164524|P2|STARTED|Period 2 : Open Label Phase||0
5351191|NCT00197145|13164525|P1|STARTED|Period 2 : Open Label Phase||10
5351192|NCT00197145|13164524|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
5351193|NCT00197145|13164525|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
5351194|NCT00197145|13164524|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
5351195|NCT00197145|13164525|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
5351196|NCT00197145|13164524|P2|STARTED|Period 1: Randomized Treatment Phase||11
5351197|NCT00197145|13164525|P1|STARTED|Period 1: Randomized Treatment Phase||13
5351198|NCT00197119|13164583|P2|NOT COMPLETED|Year 10||0
5351199|NCT00197119|13164584|P1|NOT COMPLETED|Year 10||0
5351200|NCT00197119|13164583|P2|COMPLETED|Year 10||108
5351201|NCT00197119|13164584|P1|COMPLETED|Year 10||120
5351202|NCT00197119|13164583|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
5351203|NCT00197119|13164584|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
5351204|NCT00197119|13164583|P2|NOT COMPLETED|Year 9||0
5351205|NCT00197119|13164584|P1|NOT COMPLETED|Year 9||0
5351206|NCT00197119|13164583|P2|COMPLETED|Year 9||114
5351207|NCT00197119|13164584|P1|COMPLETED|Year 9||121
5351208|NCT00197119|13164583|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
5351209|NCT00197119|13164584|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
5351210|NCT00197119|13164583|P2|NOT COMPLETED|Year 8||0
5351211|NCT00197119|13164584|P1|NOT COMPLETED|Year 8||0
5351212|NCT00197119|13164583|P2|COMPLETED|Year 8||115
5351213|NCT00197119|13164584|P1|COMPLETED|Year 8||122
5351214|NCT00197119|13164583|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
5351215|NCT00197119|13164584|P1|STARTED|Year 8||122
5351216|NCT00197119|13164583|P2|NOT COMPLETED|Year 7||0
5351217|NCT00197119|13164584|P1|NOT COMPLETED|Year 7||0
5351218|NCT00197119|13164583|P2|COMPLETED|Year 7||114
5351219|NCT00197119|13164584|P1|COMPLETED|Year 7||122
5351220|NCT00197119|13164583|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
5351221|NCT00197119|13164584|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
5351222|NCT00197119|13164583|P2|NOT COMPLETED|Year 6||0
5351223|NCT00197119|13164584|P1|NOT COMPLETED|Year 6||0
5351224|NCT00197119|13164583|P2|COMPLETED|Year 6||118
5351225|NCT00197119|13164584|P1|COMPLETED|Year 6||126
5351226|NCT00197119|13164583|P2|STARTED|Year 6||118
5351227|NCT00197119|13164584|P1|STARTED|Year 6||126
5351228|NCT00197106|13164596|P3|NOT COMPLETED|Overall Treatment Period||6
5351229|NCT00197106|13164597|P2|NOT COMPLETED|Overall Treatment Period||1
5351230|NCT00197106|13164598|P1|NOT COMPLETED|Overall Treatment Period||0
5351231|NCT00197106|13164596|P3|COMPLETED|Overall Treatment Period||74
5351232|NCT00197106|13164597|P2|COMPLETED|Overall Treatment Period||77
5351233|NCT00197106|13164598|P1|COMPLETED|Overall Treatment Period||0
5351234|NCT00197106|13164596|P3|STARTED|Overall Treatment Period||80
5351235|NCT00197106|13164597|P2|STARTED|Overall Treatment Period||78
5351236|NCT00197106|13164598|P1|STARTED|Overall Treatment Period||0
5351237|NCT00197106|13164596|P3|NOT COMPLETED|4-Week Run-In Period||0
5351238|NCT00197106|13164597|P2|NOT COMPLETED|4-Week Run-In Period||0
5351239|NCT00197106|13164598|P1|NOT COMPLETED|4-Week Run-In Period||99
5351240|NCT00197106|13164596|P3|COMPLETED|4-Week Run-In Period||0
5351241|NCT00197106|13164597|P2|COMPLETED|4-Week Run-In Period||0
5351242|NCT00197106|13164598|P1|COMPLETED|4-Week Run-In Period||158
5351243|NCT00197106|13164596|P3|STARTED|4-Week Run-In Period||0
5351244|NCT00197106|13164597|P2|STARTED|4-Week Run-In Period||0
5351245|NCT00197106|13164598|P1|STARTED|4-Week Run-In Period||257
5351246|NCT00197028|13164634|P2|NOT COMPLETED|Overall Study||21
5351247|NCT00197028|13164635|P1|NOT COMPLETED|Overall Study||16
5351248|NCT00197028|13164634|P2|COMPLETED|Overall Study||86
5351249|NCT00197028|13164635|P1|COMPLETED|Overall Study||91
5351250|NCT00197028|13164634|P2|STARTED|Overall Study||107
5351251|NCT00197028|13164635|P1|STARTED|Overall Study||107
5351252|NCT00197015|13164678|P3|NOT COMPLETED|Overall Study||77
5351253|NCT00197015|13164679|P2|NOT COMPLETED|Overall Study||89
5351254|NCT00197015|13164680|P1|NOT COMPLETED|Overall Study||50
5351255|NCT00197015|13164678|P3|COMPLETED|Overall Study||385
5351256|NCT00197015|13164679|P2|COMPLETED|Overall Study||366
5351257|NCT00197015|13164680|P1|COMPLETED|Overall Study||274
5351258|NCT00197015|13164678|P3|STARTED|Overall Study||462
5351259|NCT00197015|13164679|P2|STARTED|Overall Study||455
5351260|NCT00197015|13164680|P1|STARTED|Overall Study||324
5351261|NCT00197002|13164739|P3|NOT COMPLETED|Overall Study||17
5351262|NCT00197002|13164740|P2|NOT COMPLETED|Overall Study||18
5351263|NCT00197002|13164741|P1|NOT COMPLETED|Overall Study||22
5351264|NCT00197002|13164739|P3|COMPLETED|Overall Study||132
5351265|NCT00197002|13164740|P2|COMPLETED|Overall Study||119
5351266|NCT00197002|13164741|P1|COMPLETED|Overall Study||125
5351267|NCT00197002|13164739|P3|STARTED|Overall Study||149
5351268|NCT00197002|13164740|P2|STARTED|Overall Study||137
5351269|NCT00197002|13164741|P1|STARTED|Overall Study||147
5351270|NCT00196976|13164792|P14|NOT COMPLETED|Booster Study||0
5351271|NCT00196976|13164793|P13|NOT COMPLETED|Booster Study||0
5351272|NCT00196976|13164794|P12|NOT COMPLETED|Booster Study||2
5351273|NCT00196976|13164795|P11|NOT COMPLETED|Booster Study||2
5351274|NCT00196976|13164796|P10|NOT COMPLETED|Booster Study||0
5351275|NCT00196976|13164797|P9|NOT COMPLETED|Booster Study||0
5351276|NCT00196976|13164798|P8|NOT COMPLETED|Booster Study||0
5351277|NCT00196976|13164799|P7|NOT COMPLETED|Booster Study||0
5351278|NCT00196976|13164800|P6|NOT COMPLETED|Booster Study||0
5351279|NCT00196976|13164801|P5|NOT COMPLETED|Booster Study||0
5351280|NCT00196976|13164802|P4|NOT COMPLETED|Booster Study||0
5351281|NCT00196976|13164803|P3|NOT COMPLETED|Booster Study||0
5351282|NCT00196976|13164804|P2|NOT COMPLETED|Booster Study||0
5351283|NCT00196976|13164805|P1|NOT COMPLETED|Booster Study||0
5351284|NCT00196976|13164792|P14|COMPLETED|Booster Study||43
5351285|NCT00196976|13164793|P13|COMPLETED|Booster Study||45
5351286|NCT00196976|13164794|P12|COMPLETED|Booster Study||30
5351287|NCT00196976|13164795|P11|COMPLETED|Booster Study||31
5351288|NCT00196976|13164796|P10|COMPLETED|Booster Study||0
5351289|NCT00196976|13164797|P9|COMPLETED|Booster Study||0
5351290|NCT00196976|13164798|P8|COMPLETED|Booster Study||0
5351291|NCT00196976|13164799|P7|COMPLETED|Booster Study||0
5351292|NCT00196976|13164800|P6|COMPLETED|Booster Study||0
5351293|NCT00196976|13164801|P5|COMPLETED|Booster Study||0
5351294|NCT00196976|13164802|P4|COMPLETED|Booster Study||0
5351295|NCT00196976|13164803|P3|COMPLETED|Booster Study||0
5351296|NCT00196976|13164804|P2|COMPLETED|Booster Study||0
5351297|NCT00196976|13164805|P1|COMPLETED|Booster Study||0
5351298|NCT00196976|13164792|P14|STARTED|Booster Study||43
5351299|NCT00196976|13164793|P13|STARTED|Booster Study||45
5351300|NCT00196976|13164794|P12|STARTED|Booster Study||32
5351301|NCT00196976|13164795|P11|STARTED|Booster Study||33
5351302|NCT00196976|13164796|P10|STARTED|Booster Study||0
5351303|NCT00196976|13164797|P9|STARTED|Booster Study||0
5351304|NCT00196976|13164798|P8|STARTED|Booster Study||0
5351305|NCT00196976|13164799|P7|STARTED|Booster Study||0
5351306|NCT00196976|13164800|P6|STARTED|Booster Study||0
5351307|NCT00196976|13164801|P5|STARTED|Booster Study||0
5351308|NCT00196976|13164802|P4|STARTED|Booster Study||0
5351309|NCT00196976|13164803|P3|STARTED|Booster Study||0
5351310|NCT00196976|13164804|P2|STARTED|Booster Study||0
5351311|NCT00196976|13164805|P1|STARTED|Booster Study||0
5351312|NCT00196976|13164792|P14|NOT COMPLETED|Primary Study||0
5351313|NCT00196976|13164793|P13|NOT COMPLETED|Primary Study||0
5351314|NCT00196976|13164794|P12|NOT COMPLETED|Primary Study||0
5351315|NCT00196976|13164795|P11|NOT COMPLETED|Primary Study||0
5351316|NCT00196976|13164796|P10|NOT COMPLETED|Primary Study||1
5351317|NCT00196976|13164797|P9|NOT COMPLETED|Primary Study||0
5351318|NCT00196976|13164798|P8|NOT COMPLETED|Primary Study||3
5351319|NCT00196976|13164799|P7|NOT COMPLETED|Primary Study||0
5351320|NCT00196976|13164800|P6|NOT COMPLETED|Primary Study||2
5351321|NCT00196976|13164801|P5|NOT COMPLETED|Primary Study||3
5351322|NCT00196976|13164802|P4|NOT COMPLETED|Primary Study||1
5351323|NCT00196976|13164803|P3|NOT COMPLETED|Primary Study||4
5351324|NCT00196976|13164804|P2|NOT COMPLETED|Primary Study||1
5351325|NCT00196976|13164805|P1|NOT COMPLETED|Primary Study||1
5351326|NCT00196976|13164792|P14|COMPLETED|Primary Study||0
5351327|NCT00196976|13164793|P13|COMPLETED|Primary Study||0
5351328|NCT00196976|13164794|P12|COMPLETED|Primary Study||0
5351329|NCT00196976|13164795|P11|COMPLETED|Primary Study||0
5351330|NCT00196976|13164796|P10|COMPLETED|Primary Study||51
5351331|NCT00196976|13164797|P9|COMPLETED|Primary Study||52
5351332|NCT00196976|13164798|P8|COMPLETED|Primary Study||49
5351333|NCT00196976|13164799|P7|COMPLETED|Primary Study||50
5351334|NCT00196976|13164800|P6|COMPLETED|Primary Study||52
5351335|NCT00196976|13164801|P5|COMPLETED|Primary Study||37
5351336|NCT00196976|13164802|P4|COMPLETED|Primary Study||39
5351337|NCT00196976|13164803|P3|COMPLETED|Primary Study||37
5351338|NCT00196976|13164804|P2|COMPLETED|Primary Study||40
5351339|NCT00196976|13164805|P1|COMPLETED|Primary Study||38
5351340|NCT00196976|13164792|P14|STARTED|Primary Study||0
5351341|NCT00196976|13164793|P13|STARTED|Primary Study||0
5351342|NCT00196976|13164794|P12|STARTED|Primary Study||0
5351343|NCT00196976|13164795|P11|STARTED|Primary Study||0
5351344|NCT00196976|13164796|P10|STARTED|Primary Study||52
5351345|NCT00196976|13164797|P9|STARTED|Primary Study||52
5351346|NCT00196976|13164798|P8|STARTED|Primary Study||52
5351347|NCT00196976|13164799|P7|STARTED|Primary Study||50
5351348|NCT00196976|13164800|P6|STARTED|Primary Study||54
5351349|NCT00196976|13164801|P5|STARTED|Primary Study||40
5351350|NCT00196976|13164802|P4|STARTED|Primary Study||40
5351351|NCT00196976|13164803|P3|STARTED|Primary Study||41
5351352|NCT00196976|13164804|P2|STARTED|Primary Study||41
5351353|NCT00196976|13164805|P1|STARTED|Primary Study||39
5351354|NCT00196937|13165001|P3|NOT COMPLETED|Overall Study||7
5351355|NCT00196937|13165002|P2|NOT COMPLETED|Overall Study||5
5351356|NCT00196937|13165003|P1|NOT COMPLETED|Overall Study||9
5351357|NCT00196937|13165001|P3|COMPLETED|Overall Study||204
5351358|NCT00196937|13165002|P2|COMPLETED|Overall Study||221
5351359|NCT00196937|13165003|P1|COMPLETED|Overall Study||220
5351360|NCT00196937|13165001|P3|STARTED|Overall Study||211
5351361|NCT00196937|13165002|P2|STARTED|Overall Study||226
5351362|NCT00196937|13165003|P1|STARTED|Overall Study||229
5351363|NCT00196716|13165047|P1|NOT COMPLETED|0.3 mg/kg Period||0
5351364|NCT00196716|13165047|P1|COMPLETED|0.3 mg/kg Period||21
5351365|NCT00196716|13165047|P1|STARTED|0.3 mg/kg Period||21
5351366|NCT00196716|13165047|P1|NOT COMPLETED|1.0 mg/kg Period||0
5351367|NCT00196716|13165047|P1|COMPLETED|1.0 mg/kg Period||21
5351368|NCT00196716|13165047|P1|STARTED|1.0 mg/kg Period||21
5351369|NCT00196326|13165057|P1|NOT COMPLETED|Overall Study||986
5351370|NCT00196326|13165057|P1|COMPLETED|Overall Study||1249
5351371|NCT00196326|13165057|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
5351372|NCT00196326|13165057|P1|Safety Population|Overall Study|Treated participants|2185
5351373|NCT00196326|13165057|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
5351374|NCT00196313|13165065|P2|NOT COMPLETED|Overall Study||8
5351375|NCT00196313|13165066|P1|NOT COMPLETED|Overall Study||11
5351376|NCT00196313|13165065|P2|COMPLETED|Overall Study||40
5351377|NCT00196313|13165066|P1|COMPLETED|Overall Study||36
5351378|NCT00196313|13165065|P2|STARTED|Overall Study||48
5351379|NCT00196313|13165066|P1|STARTED|Overall Study||47
5351380|NCT00196196|13165080|P1|NOT COMPLETED|Overall Study||7
5351381|NCT00196196|13165080|P1|COMPLETED|Overall Study||267
5351382|NCT00196196|13165080|P1|STARTED|Overall Study||274
5351383|NCT00196105|13165088|P3|NOT COMPLETED|Overall Study||7
5351384|NCT00196105|13165089|P2|NOT COMPLETED|Overall Study||5
5351385|NCT00196105|13165090|P1|NOT COMPLETED|Overall Study||4
5351386|NCT00196105|13165088|P3|COMPLETED|Overall Study||82
5351387|NCT00196105|13165089|P2|COMPLETED|Overall Study||83
5351388|NCT00196105|13165090|P1|COMPLETED|Overall Study||60
5351389|NCT00196105|13165088|P3|STARTED|Overall Study||89
5351390|NCT00196105|13165089|P2|STARTED|Overall Study||88
5351391|NCT00196105|13165090|P1|STARTED|Overall Study||64
5351392|NCT00195819|13165110|P2|NOT COMPLETED|Open-label||20
5351393|NCT00195819|13165111|P1|NOT COMPLETED|Open-label||0
5351394|NCT00195819|13165110|P2|COMPLETED|Open-label||62
5351395|NCT00195819|13165111|P1|COMPLETED|Open-label||0
5351396|NCT00195819|13165110|P2|STARTED|Open-label||82
5351397|NCT00195819|13165111|P1|STARTED|Open-label||0
5351398|NCT00195819|13165110|P2|NOT COMPLETED|Double-Blind||0
5351399|NCT00195819|13165111|P1|NOT COMPLETED|Double-Blind||2
5351400|NCT00195819|13165110|P2|COMPLETED|Double-Blind||38
5351401|NCT00195819|13165111|P1|COMPLETED|Double-Blind||42
5351402|NCT00195819|13165110|P2|STARTED|Double-Blind||38
5351403|NCT00195819|13165111|P1|STARTED|Double-Blind||44
5351404|NCT00195715|13165161|P1|NOT COMPLETED|Overall Study||377
5351405|NCT00195715|13165161|P1|COMPLETED|Overall Study||400
5351406|NCT00195715|13165161|P1|STARTED|Overall Study||777
5351407|NCT00195702|13165192|P6|NOT COMPLETED|Open-label Extension Phase||78
5351408|NCT00195702|13165193|P5|NOT COMPLETED|Open-label Extension Phase||78
5351409|NCT00195702|13165194|P4|NOT COMPLETED|Open-label Extension Phase||99
5351410|NCT00195702|13165195|P3|NOT COMPLETED|Open-label Extension Phase||0
5351411|NCT00195702|13165196|P2|NOT COMPLETED|Open-label Extension Phase||0
5351412|NCT00195702|13165197|P1|NOT COMPLETED|Open-label Extension Phase||0
5351413|NCT00195702|13165192|P6|COMPLETED|Open-label Extension Phase||56
5351414|NCT00195702|13165193|P5|COMPLETED|Open-label Extension Phase||80
5351415|NCT00195702|13165194|P4|COMPLETED|Open-label Extension Phase||66
5351416|NCT00195702|13165195|P3|COMPLETED|Open-label Extension Phase||0
5351417|NCT00195702|13165196|P2|COMPLETED|Open-label Extension Phase||0
5351418|NCT00195702|13165197|P1|COMPLETED|Open-label Extension Phase||0
5351419|NCT00195702|13165192|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
5351420|NCT00195702|13165193|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
5351421|NCT00195702|13165194|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
5351422|NCT00195702|13165195|P3|STARTED|Open-label Extension Phase||0
5351423|NCT00195702|13165196|P2|STARTED|Open-label Extension Phase||0
5351424|NCT00195702|13165197|P1|STARTED|Open-label Extension Phase||0
5351425|NCT00195702|13165192|P6|NOT COMPLETED|Double-blind Phase||0
5351426|NCT00195702|13165193|P5|NOT COMPLETED|Double-blind Phase||0
5351427|NCT00195702|13165194|P4|NOT COMPLETED|Double-blind Phase||0
5351428|NCT00195702|13165195|P3|NOT COMPLETED|Double-blind Phase||60
5351429|NCT00195702|13165196|P2|NOT COMPLETED|Double-blind Phase||48
5351430|NCT00195702|13165197|P1|NOT COMPLETED|Double-blind Phase||44
5351431|NCT00195702|13165192|P6|COMPLETED|Double-blind Phase||0
5351432|NCT00195702|13165193|P5|COMPLETED|Double-blind Phase||0
5351433|NCT00195702|13165194|P4|COMPLETED|Double-blind Phase||0
5351434|NCT00195702|13165195|P3|COMPLETED|Double-blind Phase||140
5351435|NCT00195702|13165196|P2|COMPLETED|Double-blind Phase||159
5351436|NCT00195702|13165197|P1|COMPLETED|Double-blind Phase||168
5351437|NCT00195702|13165192|P6|STARTED|Double-blind Phase||0
5351438|NCT00195702|13165193|P5|STARTED|Double-blind Phase||0
5351439|NCT00195702|13165194|P4|STARTED|Double-blind Phase||0
5351440|NCT00195702|13165195|P3|STARTED|Double-blind Phase||200
5351441|NCT00195702|13165196|P2|STARTED|Double-blind Phase||207
5351442|NCT00195702|13165197|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
5351443|NCT00195676|13165261|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
5351444|NCT00195676|13165261|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
5351445|NCT00195676|13165261|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
5351446|NCT00195676|13165261|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
5351447|NCT00195676|13165261|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
5351448|NCT00195676|13165261|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
5351449|NCT00195676|13165261|P1|NOT COMPLETED|Period O - Open-label Treatment||606
5351450|NCT00195676|13165261|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
5351451|NCT00195676|13165261|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
5351452|NCT00195663|13165275|P3|NOT COMPLETED|Open-Label Extension Period||97
5351453|NCT00195663|13165276|P2|NOT COMPLETED|Open-Label Extension Period||74
5351454|NCT00195663|13165277|P1|NOT COMPLETED|Open-Label Extension Period||76
5351455|NCT00195663|13165275|P3|COMPLETED|Open-Label Extension Period||86
5351456|NCT00195663|13165276|P2|COMPLETED|Open-Label Extension Period||85
5351457|NCT00195663|13165277|P1|COMPLETED|Open-Label Extension Period||79
5351458|NCT00195663|13165275|P3|STARTED|Open-Label Extension Period||183
5351459|NCT00195663|13165276|P2|STARTED|Open-Label Extension Period||159
5351460|NCT00195663|13165277|P1|STARTED|Open-Label Extension Period||155
5351461|NCT00195663|13165275|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
5351462|NCT00195663|13165276|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
5351463|NCT00195663|13165277|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
5351464|NCT00195663|13165275|P3|COMPLETED|2-year Double-blind Treatment Period||196
5351465|NCT00195663|13165276|P2|COMPLETED|2-year Double-blind Treatment Period||166
5351466|NCT00195663|13165277|P1|COMPLETED|2-year Double-blind Treatment Period||164
5351467|NCT00195663|13165275|P3|STARTED|2-year Double-blind Treatment Period||268
5351468|NCT00195663|13165276|P2|STARTED|2-year Double-blind Treatment Period||274
5351469|NCT00195663|13165277|P1|STARTED|2-year Double-blind Treatment Period||257
5351470|NCT00195650|13165371|P1|NOT COMPLETED|Overall Study||525
5351471|NCT00195650|13165371|P1|COMPLETED|Overall Study||321
5351472|NCT00195650|13165371|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
5351473|NCT00195624|13165387|P2|NOT COMPLETED|Overall Study||0
5351474|NCT00195624|13165388|P1|NOT COMPLETED|Overall Study||0
5351475|NCT00195624|13165387|P2|COMPLETED|Overall Study||42
5351476|NCT00195624|13165388|P1|COMPLETED|Overall Study||5
5351477|NCT00195624|13165387|P2|STARTED|Overall Study||42
5351478|NCT00195624|13165388|P1|STARTED|Overall Study||5
5351479|NCT00195507|13165396|P2|NOT COMPLETED|Overall Study||118
5351480|NCT00195507|13165397|P1|NOT COMPLETED|Overall Study||99
5351481|NCT00195507|13165396|P2|COMPLETED|Overall Study||245
5351482|NCT00195507|13165397|P1|COMPLETED|Overall Study||258
5351483|NCT00195507|13165396|P2|STARTED|Overall Study||363
5351484|NCT00195507|13165397|P1|STARTED|Overall Study||357
5351485|NCT00195494|13165411|P6|NOT COMPLETED|Year 2||0
5351486|NCT00195494|13165412|P5|NOT COMPLETED|Year 2||0
5351487|NCT00195494|13165413|P4|NOT COMPLETED|Year 2||23
5351488|NCT00195494|13165414|P3|NOT COMPLETED|Year 2||18
5351489|NCT00195494|13165415|P2|NOT COMPLETED|Year 2||16
5351490|NCT00195494|13165416|P1|NOT COMPLETED|Year 2||7
5351491|NCT00195494|13165411|P6|COMPLETED|Year 2||0
5351492|NCT00195494|13165412|P5|COMPLETED|Year 2||0
5351493|NCT00195494|13165413|P4|COMPLETED|Year 2||76
5351494|NCT00195494|13165414|P3|COMPLETED|Year 2||93
5351495|NCT00195494|13165415|P2|COMPLETED|Year 2||74
5351496|NCT00195494|13165416|P1|COMPLETED|Year 2||104
5351497|NCT00195494|13165411|P6|STARTED|Year 2||0
5351498|NCT00195494|13165412|P5|STARTED|Year 2||0
5351499|NCT00195494|13165413|P4|STARTED|Year 2||99
5351500|NCT00195494|13165414|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
5351501|NCT00195494|13165415|P2|STARTED|Year 2||90
5351502|NCT00195494|13165416|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
5351503|NCT00195494|13165411|P6|NOT COMPLETED|Year 1||53
5351504|NCT00195494|13165412|P5|NOT COMPLETED|Year 1||79
5351505|NCT00195494|13165413|P4|NOT COMPLETED|Year 1||0
5351506|NCT00195494|13165414|P3|NOT COMPLETED|Year 1||0
5351507|NCT00195494|13165415|P2|NOT COMPLETED|Year 1||0
5351508|NCT00195494|13165416|P1|NOT COMPLETED|Year 1||0
5351509|NCT00195494|13165411|P6|COMPLETED|Year 1||221
5351510|NCT00195494|13165412|P5|COMPLETED|Year 1||189
5351511|NCT00195494|13165413|P4|COMPLETED|Year 1||0
5351512|NCT00195494|13165414|P3|COMPLETED|Year 1||0
5351513|NCT00195494|13165415|P2|COMPLETED|Year 1||0
5351514|NCT00195494|13165416|P1|COMPLETED|Year 1||0
5351515|NCT00195494|13165411|P6|STARTED|Year 1||274
5351516|NCT00195494|13165412|P5|STARTED|Year 1||268
5351517|NCT00195494|13165413|P4|STARTED|Year 1||0
5351518|NCT00195494|13165414|P3|STARTED|Year 1||0
5351519|NCT00195494|13165415|P2|STARTED|Year 1||0
5351520|NCT00195494|13165416|P1|STARTED|Year 1||0
5351521|NCT00195442|13165434|P1|NOT COMPLETED|Overall Study||136
5351522|NCT00195442|13165434|P1|COMPLETED|Overall Study||152
5351523|NCT00195442|13165434|P1|STARTED|Overall Study||288
5351524|NCT00195429|13165453|P2|NOT COMPLETED|Overall Study||5
5351525|NCT00195429|13165454|P1|NOT COMPLETED|Overall Study||5
5351526|NCT00195429|13165453|P2|COMPLETED|Overall Study||18
5351527|NCT00195429|13165454|P1|COMPLETED|Overall Study||19
5351528|NCT00195429|13165453|P2|STARTED|Overall Study||23
5351529|NCT00195429|13165454|P1|STARTED|Overall Study||24
5351530|NCT00195403|13165462|P1|NOT COMPLETED|Overall Study||0
5351531|NCT00195403|13165462|P1|COMPLETED|Overall Study||1014
5351532|NCT00195403|13165462|P1|STARTED|Overall Study||1014
5351533|NCT00195351|13165470|P2|NOT COMPLETED|Overall Study||16
5351534|NCT00195351|13165471|P1|NOT COMPLETED|Overall Study||21
5351535|NCT00195351|13165470|P2|COMPLETED|Overall Study||215
5351536|NCT00195351|13165471|P1|COMPLETED|Overall Study||215
5351537|NCT00195351|13165470|P2|STARTED|Overall Study||231
5351538|NCT00195351|13165471|P1|STARTED|Overall Study||236
5351539|NCT00195338|13165481|P1|NOT COMPLETED|Overall Study||12
5351540|NCT00195338|13165481|P1|COMPLETED|Overall Study||13
5351541|NCT00195338|13165481|P1|STARTED|Overall Study||25
5351542|NCT00195273|13165491|P2|NOT COMPLETED|Overall Study||14
5351543|NCT00195273|13165492|P1|NOT COMPLETED|Overall Study||21
5351544|NCT00195273|13165491|P2|COMPLETED|Overall Study||16
5351545|NCT00195273|13165492|P1|COMPLETED|Overall Study||10
5351546|NCT00195273|13165491|P2|STARTED|Overall Study||30
5351547|NCT00195273|13165492|P1|STARTED|Overall Study||31
5351548|NCT00195260|13165506|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
5351549|NCT00195260|13165507|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
5351550|NCT00195260|13165508|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
5351551|NCT00195260|13165509|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351552|NCT00195260|13165510|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351553|NCT00195260|13165511|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351554|NCT00195260|13165512|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351555|NCT00195260|13165513|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351556|NCT00195260|13165514|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351557|NCT00195260|13165515|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351558|NCT00195260|13165516|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351559|NCT00195260|13165506|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
5351560|NCT00195260|13165507|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351561|NCT00195260|13165508|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
5351562|NCT00195260|13165509|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351563|NCT00195260|13165510|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351564|NCT00195260|13165511|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351565|NCT00195260|13165512|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351566|NCT00195260|13165513|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351567|NCT00195260|13165514|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351568|NCT00195260|13165515|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351569|NCT00195260|13165516|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351570|NCT00195260|13165506|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
5351571|NCT00195260|13165507|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
5351572|NCT00195260|13165508|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
5351573|NCT00195260|13165509|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351574|NCT00195260|13165510|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351575|NCT00195260|13165511|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351576|NCT00195260|13165512|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351577|NCT00195260|13165513|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351578|NCT00195260|13165514|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351579|NCT00195260|13165515|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351580|NCT00195260|13165516|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
5351581|NCT00195260|13165506|P11|NOT COMPLETED|Part 1: Dose Escalation||0
5351582|NCT00195260|13165507|P10|NOT COMPLETED|Part 1: Dose Escalation||0
5351583|NCT00195260|13165508|P9|NOT COMPLETED|Part 1: Dose Escalation||0
5351584|NCT00195260|13165509|P8|NOT COMPLETED|Part 1: Dose Escalation||6
5351585|NCT00195260|13165510|P7|NOT COMPLETED|Part 1: Dose Escalation||10
5351586|NCT00195260|13165511|P6|NOT COMPLETED|Part 1: Dose Escalation||7
5351587|NCT00195260|13165512|P5|NOT COMPLETED|Part 1: Dose Escalation||7
5351588|NCT00195260|13165513|P4|NOT COMPLETED|Part 1: Dose Escalation||7
5351589|NCT00195260|13165514|P3|NOT COMPLETED|Part 1: Dose Escalation||6
5351590|NCT00195260|13165515|P2|NOT COMPLETED|Part 1: Dose Escalation||4
5351591|NCT00195260|13165516|P1|NOT COMPLETED|Part 1: Dose Escalation||4
5351592|NCT00195260|13165506|P11|COMPLETED|Part 1: Dose Escalation||0
5351593|NCT00195260|13165507|P10|COMPLETED|Part 1: Dose Escalation||0
5351594|NCT00195260|13165508|P9|COMPLETED|Part 1: Dose Escalation||0
5351595|NCT00195260|13165509|P8|COMPLETED|Part 1: Dose Escalation||0
5351596|NCT00195260|13165510|P7|COMPLETED|Part 1: Dose Escalation||0
5351597|NCT00195260|13165511|P6|COMPLETED|Part 1: Dose Escalation||0
5351598|NCT00195260|13165512|P5|COMPLETED|Part 1: Dose Escalation||0
5351599|NCT00195260|13165513|P4|COMPLETED|Part 1: Dose Escalation||0
5351600|NCT00195260|13165514|P3|COMPLETED|Part 1: Dose Escalation||0
5351601|NCT00195260|13165515|P2|COMPLETED|Part 1: Dose Escalation||0
5351602|NCT00195260|13165516|P1|COMPLETED|Part 1: Dose Escalation||0
5351603|NCT00195260|13165506|P11|STARTED|Part 1: Dose Escalation||0
5351604|NCT00195260|13165507|P10|STARTED|Part 1: Dose Escalation||0
5351605|NCT00195260|13165508|P9|STARTED|Part 1: Dose Escalation||0
5351606|NCT00195260|13165509|P8|STARTED|Part 1: Dose Escalation||6
5351607|NCT00195260|13165510|P7|STARTED|Part 1: Dose Escalation||10
5351608|NCT00195260|13165511|P6|STARTED|Part 1: Dose Escalation||7
5351609|NCT00195260|13165512|P5|STARTED|Part 1: Dose Escalation||7
5351610|NCT00195260|13165513|P4|STARTED|Part 1: Dose Escalation||7
5351611|NCT00195260|13165514|P3|STARTED|Part 1: Dose Escalation||6
5351612|NCT00195260|13165515|P2|STARTED|Part 1: Dose Escalation||4
5351613|NCT00195260|13165516|P1|STARTED|Part 1: Dose Escalation||4
5351614|NCT00195039|13165662|P1|NOT COMPLETED|Overall Study||0
5351615|NCT00195039|13165662|P1|COMPLETED|Overall Study||47
5351616|NCT00195039|13165662|P1|STARTED|Overall Study||47
5351617|NCT00195013|13165675|P2|NOT COMPLETED|Overall Study||1
5351618|NCT00195013|13165676|P1|NOT COMPLETED|Overall Study||2
5351619|NCT00195013|13165675|P2|COMPLETED|Overall Study||15
5351620|NCT00195013|13165676|P1|COMPLETED|Overall Study||12
5351621|NCT00195013|13165675|P2|STARTED|Overall Study||16
5351622|NCT00195013|13165676|P1|STARTED|Overall Study||14
5351623|NCT00194987|13165684|P2|NOT COMPLETED|Overall Study||3
5351624|NCT00194987|13165685|P1|NOT COMPLETED|Overall Study||0
5351625|NCT00194987|13165684|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
5351626|NCT00194987|13165685|P1|COMPLETED|Overall Study||51
5351627|NCT00194987|13165684|P2|STARTED|Overall Study||51
5351628|NCT00194987|13165685|P1|STARTED|Overall Study||51
5351629|NCT00194896|13165701|P4|NOT COMPLETED|Overall Study||12
5351630|NCT00194896|13165702|P3|NOT COMPLETED|Overall Study||6
5351631|NCT00194896|13165703|P2|NOT COMPLETED|Overall Study||5
5351632|NCT00194896|13165704|P1|NOT COMPLETED|Overall Study||11
5351633|NCT00194896|13165701|P4|COMPLETED|Overall Study||9
5351634|NCT00194896|13165702|P3|COMPLETED|Overall Study||7
5351635|NCT00194896|13165703|P2|COMPLETED|Overall Study||10
5351636|NCT00194896|13165704|P1|COMPLETED|Overall Study||4
5351637|NCT00194896|13165701|P4|STARTED|Overall Study||21
5351638|NCT00194896|13165702|P3|STARTED|Overall Study||13
5351639|NCT00194896|13165703|P2|STARTED|Overall Study||15
5351640|NCT00194896|13165704|P1|STARTED|Overall Study||15
5351641|NCT00194792|13165718|P1|NOT COMPLETED|Overall Study||1
5351642|NCT00194792|13165718|P1|COMPLETED|Overall Study||27
5351643|NCT00194792|13165718|P1|STARTED|Overall Study||28
5351644|NCT00194779|13165728|P1|NOT COMPLETED|Overall Study||0
5351645|NCT00194779|13165728|P1|COMPLETED|Overall Study||50
5351646|NCT00194779|13165728|P1|STARTED|Overall Study||50
5351647|NCT00194675|13165742|P2|NOT COMPLETED|Overall Study||2
5351648|NCT00194675|13165743|P1|NOT COMPLETED|Overall Study||5
5351649|NCT00194675|13165742|P2|COMPLETED|Overall Study||24
5351650|NCT00194675|13165743|P1|COMPLETED|Overall Study||22
5351651|NCT00194675|13165742|P2|STARTED|Overall Study||26
5351652|NCT00194675|13165743|P1|STARTED|Overall Study||27
5351653|NCT00194610|13165761|P2|NOT COMPLETED|Overall Study||0
5351654|NCT00194610|13165762|P1|NOT COMPLETED|Overall Study||0
5351655|NCT00194610|13165761|P2|COMPLETED|Overall Study||9
5351656|NCT00194610|13165762|P1|COMPLETED|Overall Study||11
5351657|NCT00194610|13165761|P2|STARTED|Overall Study||9
5351658|NCT00194610|13165762|P1|STARTED|Overall Study||11
5351659|NCT00194532|13165770|P2|NOT COMPLETED|Overall Study||0
5351660|NCT00194532|13165771|P1|NOT COMPLETED|Overall Study||0
5351661|NCT00194532|13165770|P2|COMPLETED|Overall Study||150
5351662|NCT00194532|13165771|P1|COMPLETED|Overall Study||150
5351663|NCT00194532|13165770|P2|STARTED|Overall Study||150
5351664|NCT00194532|13165771|P1|STARTED|Overall Study||150
5351665|NCT00194129|13165781|P2|NOT COMPLETED|Overall Study||13
5351666|NCT00194129|13165782|P1|NOT COMPLETED|Overall Study||10
5351667|NCT00194129|13165781|P2|COMPLETED|Overall Study||3
5351668|NCT00194129|13165782|P1|COMPLETED|Overall Study||5
5351669|NCT00194129|13165781|P2|STARTED|Overall Study||16
5351670|NCT00194129|13165782|P1|STARTED|Overall Study||15
5351671|NCT00194116|13165797|P2|NOT COMPLETED|Overall Study||15
5351672|NCT00194116|13165798|P1|NOT COMPLETED|Overall Study||13
5351673|NCT00194116|13165797|P2|COMPLETED|Overall Study||13
5351674|NCT00194116|13165798|P1|COMPLETED|Overall Study||13
5351675|NCT00194116|13165797|P2|STARTED|Overall Study||28
5351676|NCT00194116|13165798|P1|STARTED|Overall Study||26
5351677|NCT00194077|13165818|P2|NOT COMPLETED|Overall Study||30
5351678|NCT00194077|13165819|P1|NOT COMPLETED|Overall Study||24
5351679|NCT00194077|13165818|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
5351680|NCT00194077|13165819|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
5351681|NCT00194077|13165818|P2|STARTED|Overall Study||30
5351682|NCT00194077|13165819|P1|STARTED|Overall Study||30
5351683|NCT00194025|13165825|P1|NOT COMPLETED|Overall Study||5
5351684|NCT00194025|13165825|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
5351685|NCT00194025|13165825|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
5351686|NCT00194012|13165840|P2|NOT COMPLETED|Open Label Extension (OLE)||6
5351687|NCT00194012|13165841|P1|NOT COMPLETED|Open Label Extension (OLE)||5
5351688|NCT00194012|13165840|P2|COMPLETED|Open Label Extension (OLE)||15
5351689|NCT00194012|13165841|P1|COMPLETED|Open Label Extension (OLE)||17
5351690|NCT00194012|13165840|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
5351691|NCT00194012|13165841|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
5351692|NCT00194012|13165840|P2|NOT COMPLETED|Randomized Phase||25
5351693|NCT00194012|13165841|P1|NOT COMPLETED|Randomized Phase||16
5351694|NCT00194012|13165840|P2|COMPLETED|Randomized Phase||6
5351695|NCT00194012|13165841|P1|COMPLETED|Randomized Phase||15
5351696|NCT00194012|13165840|P2|Received More Than One Dose|Randomized Phase||29
5351697|NCT00194012|13165841|P1|Received More Than One Dose|Randomized Phase||30
5351698|NCT00194012|13165840|P2|STARTED|Randomized Phase||31
5351699|NCT00194012|13165841|P1|STARTED|Randomized Phase||31
5351700|NCT00193609|13165877|P1|NOT COMPLETED|Overall Study||4
5351701|NCT00193609|13165877|P1|COMPLETED|Overall Study||44
5351702|NCT00193609|13165877|P1|STARTED|Overall Study||48
5351703|NCT00193596|13165884|P2|NOT COMPLETED|Overall Study||66
5351704|NCT00193596|13165885|P1|NOT COMPLETED|Overall Study||56
5351705|NCT00193596|13165884|P2|COMPLETED|Overall Study||39
5351706|NCT00193596|13165885|P1|COMPLETED|Overall Study||37
5351707|NCT00193596|13165884|P2|STARTED|Overall Study||105
5351708|NCT00193596|13165885|P1|STARTED|Overall Study||93
5351709|NCT00193492|13165895|P2|NOT COMPLETED|Overall Study||15
5351710|NCT00193492|13165896|P1|NOT COMPLETED|Overall Study||17
5351711|NCT00193492|13165895|P2|COMPLETED|Overall Study||14
5351712|NCT00193492|13165896|P1|COMPLETED|Overall Study||14
5351713|NCT00193492|13165895|P2|STARTED|Overall Study||29
5351714|NCT00193492|13165896|P1|STARTED|Overall Study||31
5351715|NCT00193479|13165904|P1|NOT COMPLETED|Maintenance Rituximab||0
5351716|NCT00193479|13165904|P1|COMPLETED|Maintenance Rituximab||44
5351717|NCT00193479|13165904|P1|STARTED|Maintenance Rituximab||44
5351718|NCT00193479|13165904|P1|NOT COMPLETED|Induction Chemotherapy||3
5351719|NCT00193479|13165904|P1|COMPLETED|Induction Chemotherapy||48
5351720|NCT00193479|13165904|P1|STARTED|Induction Chemotherapy||51
5351721|NCT00193453|13165908|P1|NOT COMPLETED|Overall Study||48
5351722|NCT00193453|13165908|P1|COMPLETED|Overall Study||21
5351723|NCT00193453|13165908|P1|STARTED|Overall Study||69
5351724|NCT00193427|13165914|P1|NOT COMPLETED|Overall Study||49
5351725|NCT00193427|13165914|P1|COMPLETED|Overall Study||26
5351726|NCT00193427|13165914|P1|STARTED|Overall Study||75
5351727|NCT00193414|13165921|P1|NOT COMPLETED|Overall Study||58
5351728|NCT00193414|13165921|P1|COMPLETED|Overall Study||14
5351729|NCT00193414|13165921|P1|STARTED|Overall Study||72
5351730|NCT00193375|13165927|P1|NOT COMPLETED|Overall Study||19
5351731|NCT00193375|13165927|P1|COMPLETED|Overall Study||41
5351732|NCT00193375|13165927|P1|STARTED|Overall Study||60
5351733|NCT00193258|13165933|P1|NOT COMPLETED|Overall Study||0
5351734|NCT00193258|13165933|P1|COMPLETED|Overall Study||94
5351735|NCT00193258|13165933|P1|STARTED|Overall Study||94
5351736|NCT00193219|13165939|P1|NOT COMPLETED|Overall Study||30
5351737|NCT00193219|13165939|P1|COMPLETED|Overall Study||6
5351738|NCT00193219|13165939|P1|STARTED|Overall Study||36
5351739|NCT00193206|13165945|P1|NOT COMPLETED|Postoperative Therapy||14
5351740|NCT00193206|13165945|P1|COMPLETED|Postoperative Therapy||102
5351741|NCT00193206|13165945|P1|STARTED|Postoperative Therapy||116
5351742|NCT00193206|13165945|P1|NOT COMPLETED|Surgery||0
5351743|NCT00193206|13165945|P1|COMPLETED|Surgery||116
5351744|NCT00193206|13165945|P1|STARTED|Surgery||116
5351745|NCT00193206|13165945|P1|NOT COMPLETED|Preoperative Therapy||7
5351746|NCT00193206|13165945|P1|COMPLETED|Preoperative Therapy||116
5351747|NCT00193206|13165945|P1|STARTED|Preoperative Therapy||123
5351748|NCT00193180|13165949|P1|NOT COMPLETED|Overall Study||10
5351749|NCT00193180|13165949|P1|COMPLETED|Overall Study||27
5351750|NCT00193180|13165949|P1|STARTED|Overall Study||37
5351751|NCT00193128|13165957|P2|NOT COMPLETED|Overall Study||10
5351752|NCT00193128|13165958|P1|NOT COMPLETED|Overall Study||0
5351753|NCT00193128|13165957|P2|COMPLETED|Overall Study||39
5351754|NCT00193128|13165958|P1|COMPLETED|Overall Study||10
5351755|NCT00193128|13165957|P2|STARTED|Overall Study||49
5351756|NCT00193128|13165958|P1|STARTED|Overall Study||10
5351757|NCT00193063|13165964|P1|NOT COMPLETED|Overall Study||4
5351758|NCT00193063|13165964|P1|COMPLETED|Overall Study||37
5351759|NCT00193063|13165964|P1|STARTED|Overall Study||41
5351760|NCT00193050|13165970|P1|NOT COMPLETED|Adjuvant||10
5351761|NCT00193050|13165970|P1|COMPLETED|Adjuvant||77
5351762|NCT00193050|13165970|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
5351763|NCT00193050|13165970|P1|NOT COMPLETED|Surgery||0
5351764|NCT00193050|13165970|P1|COMPLETED|Surgery||103
5351765|NCT00193050|13165970|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
5351766|NCT00193050|13165970|P1|NOT COMPLETED|Neoadjuvant Treatment||9
5351767|NCT00193050|13165970|P1|COMPLETED|Neoadjuvant Treatment||101
5351768|NCT00193050|13165970|P1|STARTED|Neoadjuvant Treatment||110
5351769|NCT00193037|13165976|P2|NOT COMPLETED|Crossover Treatment||0
5351770|NCT00193037|13165977|P1|NOT COMPLETED|Crossover Treatment||0
5351771|NCT00193037|13165976|P2|COMPLETED|Crossover Treatment||24
5351772|NCT00193037|13165977|P1|COMPLETED|Crossover Treatment||32
5351773|NCT00193037|13165976|P2|STARTED|Crossover Treatment||24
5351774|NCT00193037|13165977|P1|STARTED|Crossover Treatment||32
5351775|NCT00193037|13165976|P2|NOT COMPLETED|Randomized Treatment||28
5351776|NCT00193037|13165977|P1|NOT COMPLETED|Randomized Treatment||18
5351777|NCT00193037|13165976|P2|COMPLETED|Randomized Treatment||24
5351778|NCT00193037|13165977|P1|COMPLETED|Randomized Treatment||32
5351779|NCT00193037|13165976|P2|STARTED|Randomized Treatment||52
5351780|NCT00193037|13165977|P1|STARTED|Randomized Treatment||50
5351781|NCT00192647|13165987|P2|NOT COMPLETED|Overall Study||146
5351782|NCT00192647|13165988|P1|NOT COMPLETED|Overall Study||128
5351783|NCT00192647|13165987|P2|COMPLETED|Overall Study||302
5351784|NCT00192647|13165988|P1|COMPLETED|Overall Study||320
5351785|NCT00192647|13165987|P2|Treated|Overall Study||438
5351786|NCT00192647|13165988|P1|Treated|Overall Study||433
5351787|NCT00192647|13165987|P2|STARTED|Overall Study||448
5351788|NCT00192647|13165988|P1|STARTED|Overall Study||448
5351789|NCT00192296|13166008|P4|NOT COMPLETED|Overall Study||0
5351790|NCT00192296|13166009|P3|NOT COMPLETED|Overall Study||0
5351791|NCT00192296|13166010|P2|NOT COMPLETED|Overall Study||1
5351792|NCT00192296|13166011|P1|NOT COMPLETED|Overall Study||0
5351793|NCT00192296|13166008|P4|COMPLETED|Overall Study||6
5351794|NCT00192296|13166009|P3|COMPLETED|Overall Study||6
5351795|NCT00192296|13166010|P2|COMPLETED|Overall Study||5
5351796|NCT00192296|13166011|P1|COMPLETED|Overall Study||6
5351797|NCT00192296|13166008|P4|STARTED|Overall Study||6
5351798|NCT00192296|13166009|P3|STARTED|Overall Study||6
5351799|NCT00192296|13166010|P2|STARTED|Overall Study||6
5351800|NCT00192296|13166011|P1|STARTED|Overall Study||6
5351801|NCT00192075|13166067|P2|NOT COMPLETED|Overall Study||19
5351802|NCT00192075|13166068|P1|NOT COMPLETED|Overall Study||39
5351803|NCT00192075|13166067|P2|COMPLETED|Overall Study||23
5351804|NCT00192075|13166068|P1|COMPLETED|Overall Study||3
5351805|NCT00192075|13166067|P2|STARTED|Overall Study||42
5351806|NCT00192075|13166068|P1|STARTED|Overall Study||42
5351807|NCT00192036|13166093|P1|NOT COMPLETED|Overall Study||21
5351808|NCT00192036|13166093|P1|COMPLETED|Overall Study||28
5351809|NCT00192036|13166093|P1|STARTED|Overall Study||49
5351810|NCT00192023|13166103|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
5351811|NCT00192023|13166104|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
5351812|NCT00192023|13166103|P2|COMPLETED|Period IV - Optional Open-Label||0
5351813|NCT00192023|13166104|P1|COMPLETED|Period IV - Optional Open-Label||49
5351814|NCT00192023|13166103|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
5351815|NCT00192023|13166104|P1|STARTED|Period IV - Optional Open-Label||124
5351816|NCT00192023|13166103|P2|NOT COMPLETED|Period III - Double-Blind||0
5351817|NCT00192023|13166104|P1|NOT COMPLETED|Period III - Double-Blind||7
5351818|NCT00192023|13166103|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
5351819|NCT00192023|13166104|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
5351820|NCT00192023|13166103|P2|STARTED|Period III - Double-Blind||32
5351821|NCT00192023|13166104|P1|STARTED|Period III - Double-Blind||107
5351822|NCT00191984|13166126|P1|NOT COMPLETED|Overall Study||39
5351823|NCT00191984|13166126|P1|COMPLETED|Overall Study||7
5351824|NCT00191984|13166126|P1|STARTED|Overall Study||46
5351825|NCT00191945|13166136|P2|NOT COMPLETED|Open-Label Treatment Extension||0
5351826|NCT00191945|13166137|P1|NOT COMPLETED|Open-Label Treatment Extension||0
5351827|NCT00191945|13166136|P2|COMPLETED|Open-Label Treatment Extension||48
5351828|NCT00191945|13166137|P1|COMPLETED|Open-Label Treatment Extension||94
5351829|NCT00191945|13166136|P2|STARTED|Open-Label Treatment Extension||48
5351830|NCT00191945|13166137|P1|STARTED|Open-Label Treatment Extension||94
5351831|NCT00191945|13166136|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
5351832|NCT00191945|13166137|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
5351833|NCT00191945|13166136|P2|COMPLETED|Double-Blind Acute Treatment||48
5351834|NCT00191945|13166137|P1|COMPLETED|Double-Blind Acute Treatment||94
5351835|NCT00191945|13166136|P2|STARTED|Double-Blind Acute Treatment||51
5351836|NCT00191945|13166137|P1|STARTED|Double-Blind Acute Treatment||100
5351837|NCT00191906|13166173|P4|NOT COMPLETED|Study Period III||0
5351838|NCT00191906|13166174|P3|NOT COMPLETED|Study Period III||0
5351839|NCT00191906|13166175|P2|NOT COMPLETED|Study Period III||4
5351840|NCT00191906|13166176|P1|NOT COMPLETED|Study Period III||5
5351841|NCT00191906|13166173|P4|COMPLETED|Study Period III||0
5351842|NCT00191906|13166174|P3|COMPLETED|Study Period III||0
5351843|NCT00191906|13166175|P2|COMPLETED|Study Period III||7
5351844|NCT00191906|13166176|P1|COMPLETED|Study Period III||9
5351845|NCT00191906|13166173|P4|STARTED|Study Period III||0
5351846|NCT00191906|13166174|P3|STARTED|Study Period III||0
5351847|NCT00191906|13166175|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
5351848|NCT00191906|13166176|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
5351849|NCT00191906|13166173|P4|NOT COMPLETED|Study Period II||0
5351850|NCT00191906|13166174|P3|NOT COMPLETED|Study Period II||1
5351851|NCT00191906|13166175|P2|NOT COMPLETED|Study Period II||5
5351852|NCT00191906|13166176|P1|NOT COMPLETED|Study Period II||0
5351853|NCT00191906|13166173|P4|COMPLETED|Study Period II||18
5351854|NCT00191906|13166174|P3|COMPLETED|Study Period II||26
5351855|NCT00191906|13166175|P2|COMPLETED|Study Period II||32
5351856|NCT00191906|13166176|P1|COMPLETED|Study Period II||39
5351857|NCT00191906|13166173|P4|STARTED|Study Period II||18
5351858|NCT00191906|13166174|P3|STARTED|Study Period II||27
5351859|NCT00191906|13166175|P2|STARTED|Study Period II||37
5351860|NCT00191906|13166176|P1|STARTED|Study Period II||39
5351861|NCT00191854|13166219|P3|NOT COMPLETED|Overall Study||39
5351862|NCT00191854|13166220|P2|NOT COMPLETED|Overall Study||30
5351863|NCT00191854|13166221|P1|NOT COMPLETED|Overall Study||37
5351864|NCT00191854|13166219|P3|COMPLETED|Overall Study||12
5351865|NCT00191854|13166220|P2|COMPLETED|Overall Study||17
5351866|NCT00191854|13166221|P1|COMPLETED|Overall Study||12
5351867|NCT00191854|13166219|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
5351868|NCT00191854|13166220|P2|Received at Least One Dose of Study Drug|Overall Study||47
5351869|NCT00191854|13166221|P1|Received at Least One Dose of Study Drug|Overall Study||49
5351870|NCT00191854|13166219|P3|STARTED|Overall Study||51
5351871|NCT00191854|13166220|P2|STARTED|Overall Study||47
5351872|NCT00191854|13166221|P1|STARTED|Overall Study||49
5351873|NCT00191815|13166241|P1|NOT COMPLETED|Overall Study||40
5351874|NCT00191815|13166241|P1|COMPLETED|Overall Study||30
5351875|NCT00191815|13166241|P1|Treated|Overall Study||67
5351876|NCT00191815|13166241|P1|STARTED|Overall Study||70
5351877|NCT00191789|13166253|P1|NOT COMPLETED|Overall Study||25
5351878|NCT00191789|13166253|P1|COMPLETED|Overall Study||40
5351879|NCT00191789|13166253|P1|STARTED|Overall Study||65
5351880|NCT00191724|13166270|P5|NOT COMPLETED|Overall Study||3
5351881|NCT00191724|13166271|P4|NOT COMPLETED|Overall Study||3
5351882|NCT00191724|13166272|P3|NOT COMPLETED|Overall Study||1
5351883|NCT00191724|13166273|P2|NOT COMPLETED|Overall Study||1
5351884|NCT00191724|13166274|P1|NOT COMPLETED|Overall Study||1
5351885|NCT00191724|13166270|P5|COMPLETED|Overall Study||12
5351886|NCT00191724|13166271|P4|COMPLETED|Overall Study||5
5351887|NCT00191724|13166272|P3|COMPLETED|Overall Study||8
5351888|NCT00191724|13166273|P2|COMPLETED|Overall Study||8
5351889|NCT00191724|13166274|P1|COMPLETED|Overall Study||5
5351890|NCT00191724|13166270|P5|STARTED|Overall Study||15
5351891|NCT00191724|13166271|P4|STARTED|Overall Study||8
5351892|NCT00191724|13166272|P3|STARTED|Overall Study||9
5351893|NCT00191724|13166273|P2|STARTED|Overall Study||9
5351894|NCT00191724|13166274|P1|STARTED|Overall Study||6
5351895|NCT00191646|13166303|P2|NOT COMPLETED|Overall Study||153
5351896|NCT00191646|13166304|P1|NOT COMPLETED|Overall Study||171
5351897|NCT00191646|13166303|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
5351898|NCT00191646|13166304|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
5351899|NCT00191646|13166303|P2|Received Crossover Therapy|Overall Study||78
5351900|NCT00191646|13166304|P1|Received Crossover Therapy|Overall Study||77
5351901|NCT00191646|13166303|P2|Received Consolidation Therapy|Overall Study||183
5351902|NCT00191646|13166304|P1|Received Consolidation Therapy|Overall Study||169
5351903|NCT00191646|13166303|P2|Received Induction Therapy|Overall Study||409
5351904|NCT00191646|13166304|P1|Received Induction Therapy|Overall Study||411
5351905|NCT00191646|13166303|P2|STARTED|Overall Study||414
5351906|NCT00191646|13166304|P1|STARTED|Overall Study||417
5351907|NCT00191477|13166324|P2|NOT COMPLETED|Overall Study||129
5351908|NCT00191477|13166325|P1|NOT COMPLETED|Overall Study||138
5351909|NCT00191477|13166324|P2|COMPLETED|Overall Study||47
5351910|NCT00191477|13166325|P1|COMPLETED|Overall Study||41
5351911|NCT00191477|13166324|P2|Received Study Drug|Overall Study||162
5351912|NCT00191477|13166325|P1|Received Study Drug|Overall Study||166
5351913|NCT00191477|13166324|P2|STARTED|Overall Study||176
5351914|NCT00191477|13166325|P1|STARTED|Overall Study||179
5351915|NCT00191451|13166344|P3|NOT COMPLETED|Overall Study||14
5351916|NCT00191451|13166345|P2|NOT COMPLETED|Overall Study||14
5351917|NCT00191451|13166346|P1|NOT COMPLETED|Overall Study||7
5351918|NCT00191451|13166344|P3|COMPLETED|Overall Study||35
5351919|NCT00191451|13166345|P2|COMPLETED|Overall Study||37
5351920|NCT00191451|13166346|P1|COMPLETED|Overall Study||43
5351921|NCT00191451|13166344|P3|Received at Least One Dose of Study Drug|Overall Study||47
5351922|NCT00191451|13166345|P2|Received at Least One Dose of Study Drug|Overall Study||48
5351923|NCT00191451|13166346|P1|Received at Least One Dose of Study Drug|Overall Study||50
5351924|NCT00191451|13166344|P3|STARTED|Overall Study||49
5351925|NCT00191451|13166345|P2|STARTED|Overall Study||51
5351926|NCT00191451|13166346|P1|STARTED|Overall Study||50
5351927|NCT00191386|13166366|P1|NOT COMPLETED|Overall Study||160
5351928|NCT00191386|13166366|P1|COMPLETED|Overall Study||68
5351929|NCT00191386|13166366|P1|3 Years|Overall Study||65
5351930|NCT00191386|13166366|P1|2 Years|Overall Study||105
5351931|NCT00191386|13166366|P1|12 Months|Overall Study||149
5351932|NCT00191386|13166366|P1|6 Months|Overall Study||183
5351933|NCT00191386|13166366|P1|STARTED|Overall Study||228
5351934|NCT00191334|13166373|P1|NOT COMPLETED|Overall Study||17
5351935|NCT00191334|13166373|P1|COMPLETED|Overall Study||33
5351936|NCT00191334|13166373|P1|STARTED|Overall Study||50
5351937|NCT00191308|13166381|P1|NOT COMPLETED|Overall Study||1
5351938|NCT00191308|13166381|P1|COMPLETED|Overall Study||29
5351939|NCT00191308|13166381|P1|STARTED|Overall Study||30
5351940|NCT00191282|13166391|P2|NOT COMPLETED|Overall Study||212
5351941|NCT00191282|13166392|P1|NOT COMPLETED|Overall Study||220
5351942|NCT00191282|13166391|P2|COMPLETED|Overall Study||346
5351943|NCT00191282|13166392|P1|COMPLETED|Overall Study||338
5351944|NCT00191282|13166391|P2|STARTED|Overall Study||558
5351945|NCT00191282|13166392|P1|STARTED|Overall Study||558
5351946|NCT00191269|13166452|P2|NOT COMPLETED|Overall Study||58
5351947|NCT00191269|13166453|P1|NOT COMPLETED|Overall Study||6
5351948|NCT00191269|13166452|P2|COMPLETED|Overall Study||4
5351949|NCT00191269|13166453|P1|COMPLETED|Overall Study||0
5351950|NCT00191269|13166452|P2|STARTED|Overall Study||62
5351951|NCT00191269|13166453|P1|STARTED|Overall Study||6
5351952|NCT00191191|13166469|P2|NOT COMPLETED|Overall Study||112
5351953|NCT00191191|13166470|P1|NOT COMPLETED|Overall Study||114
5351954|NCT00191191|13166469|P2|COMPLETED|Overall Study||0
5351955|NCT00191191|13166470|P1|COMPLETED|Overall Study||0
5351956|NCT00191191|13166469|P2|Full Analysis Set Population|Overall Study||108
5351957|NCT00191191|13166470|P1|Full Analysis Set Population|Overall Study||108
5351958|NCT00191191|13166469|P2|Safety Analysis Population|Overall Study||111
5351959|NCT00191191|13166470|P1|Safety Analysis Population|Overall Study||114
5351960|NCT00191191|13166469|P2|STARTED|Overall Study||112
5351961|NCT00191191|13166470|P1|STARTED|Overall Study||114
5351962|NCT00191165|13166486|P2|NOT COMPLETED|Overall Study||2
5351963|NCT00191165|13166487|P1|NOT COMPLETED|Overall Study||2
5351964|NCT00191165|13166486|P2|COMPLETED|Overall Study||11
5351965|NCT00191165|13166487|P1|COMPLETED|Overall Study||12
5351966|NCT00191165|13166486|P2|STARTED|Overall Study||13
5351967|NCT00191165|13166487|P1|STARTED|Overall Study||14
5351968|NCT00191152|13166499|P2|NOT COMPLETED|Crossover Treatment||28
5351969|NCT00191152|13166500|P1|NOT COMPLETED|Crossover Treatment||27
5351970|NCT00191152|13166499|P2|COMPLETED|Crossover Treatment||53
5351971|NCT00191152|13166500|P1|COMPLETED|Crossover Treatment||50
5351972|NCT00191152|13166499|P2|Received Treatment|Crossover Treatment||80
5351973|NCT00191152|13166500|P1|Received Treatment|Crossover Treatment||76
5351974|NCT00191152|13166499|P2|STARTED|Crossover Treatment||81
5351975|NCT00191152|13166500|P1|STARTED|Crossover Treatment||77
5351976|NCT00191152|13166499|P2|NOT COMPLETED|Initial Treatment||153
5351977|NCT00191152|13166500|P1|NOT COMPLETED|Initial Treatment||141
5351978|NCT00191152|13166499|P2|COMPLETED|Initial Treatment||83
5351979|NCT00191152|13166500|P1|COMPLETED|Initial Treatment||98
5351980|NCT00191152|13166499|P2|Received Initial Treatment|Initial Treatment||227
5351981|NCT00191152|13166500|P1|Received Initial Treatment|Initial Treatment||236
5351982|NCT00191152|13166499|P2|STARTED|Initial Treatment||236
5351983|NCT00191152|13166500|P1|STARTED|Initial Treatment||239
5351984|NCT00191139|13166532|P2|NOT COMPLETED|Overall Study||12
5351985|NCT00191139|13166533|P1|NOT COMPLETED|Overall Study||5
5351986|NCT00191139|13166532|P2|COMPLETED|Overall Study||20
5351987|NCT00191139|13166533|P1|COMPLETED|Overall Study||27
5351988|NCT00191139|13166532|P2|STARTED|Overall Study||32
5351989|NCT00191139|13166533|P1|STARTED|Overall Study||32
5351990|NCT00191113|13166549|P2|NOT COMPLETED|Addendum 3||0
5351991|NCT00191113|13166550|P1|NOT COMPLETED|Addendum 3||0
5351992|NCT00191113|13166549|P2|COMPLETED|Addendum 3||37
5351993|NCT00191113|13166550|P1|COMPLETED|Addendum 3||20
5351994|NCT00191113|13166549|P2|STARTED|Addendum 3||37
5351995|NCT00191113|13166550|P1|STARTED|Addendum 3||20
5351996|NCT00191113|13166549|P2|NOT COMPLETED|Addendum 2||17
5351997|NCT00191113|13166550|P1|NOT COMPLETED|Addendum 2||10
5351998|NCT00191113|13166549|P2|COMPLETED|Addendum 2||31
5351999|NCT00191113|13166550|P1|COMPLETED|Addendum 2||18
5352000|NCT00191113|13166549|P2|STARTED|Addendum 2||48
5352001|NCT00191113|13166550|P1|STARTED|Addendum 2||28
5352002|NCT00191113|13166549|P2|NOT COMPLETED|Addendum 1||0
5352003|NCT00191113|13166550|P1|NOT COMPLETED|Addendum 1||0
5352004|NCT00191113|13166549|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
5352005|NCT00191113|13166550|P1|COMPLETED|Addendum 1||2
5352006|NCT00191113|13166549|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
5352007|NCT00191113|13166550|P1|STARTED|Addendum 1||2
5352008|NCT00191113|13166549|P2|NOT COMPLETED|Core Study||15
5352009|NCT00191113|13166550|P1|NOT COMPLETED|Core Study||35
5352010|NCT00191113|13166549|P2|COMPLETED|Core Study||61
5352011|NCT00191113|13166550|P1|COMPLETED|Core Study||43
5352012|NCT00191113|13166549|P2|STARTED|Core Study||76
5352013|NCT00191113|13166550|P1|STARTED|Core Study||78
5352014|NCT00191100|13166592|P2|NOT COMPLETED|Overall Study||12
5352015|NCT00191100|13166593|P1|NOT COMPLETED|Overall Study||42
5352016|NCT00191100|13166592|P2|COMPLETED|Overall Study||244
5352017|NCT00191100|13166593|P1|COMPLETED|Overall Study||217
5352018|NCT00191100|13166592|P2|STARTED|Overall Study||256
5352019|NCT00191100|13166593|P1|STARTED|Overall Study||259
5352020|NCT00190983|13166609|P1|NOT COMPLETED|Overall Study||2
5352021|NCT00190983|13166609|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
5352022|NCT00190983|13166609|P1|STARTED|Overall Study||29
5352023|NCT00190775|13166618|P2|NOT COMPLETED|Overall Study||100
5352024|NCT00190775|13166619|P1|NOT COMPLETED|Overall Study||149
5352025|NCT00190775|13166618|P2|COMPLETED|Overall Study||134
5352026|NCT00190775|13166619|P1|COMPLETED|Overall Study||119
5352027|NCT00190775|13166618|P2|Received Study Drug|Overall Study||234
5352028|NCT00190775|13166619|P1|Received Study Drug|Overall Study||266
5352029|NCT00190775|13166618|P2|STARTED|Overall Study||234
5352030|NCT00190775|13166619|P1|STARTED|Overall Study||268
5352031|NCT00190749|13166690|P2|NOT COMPLETED|Overall Study||31
5352032|NCT00190749|13166691|P1|NOT COMPLETED|Overall Study||26
5352033|NCT00190749|13166690|P2|COMPLETED|Overall Study||31
5352034|NCT00190749|13166691|P1|COMPLETED|Overall Study||42
5352035|NCT00190749|13166690|P2|STARTED|Overall Study||62
5352036|NCT00190749|13166691|P1|STARTED|Overall Study||68
5352037|NCT00190684|13166755|P1|NOT COMPLETED|Overall Study||1489
5352038|NCT00190684|13166755|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
5352039|NCT00190684|13166755|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
5352040|NCT00190684|13166755|P1|STARTED|Overall Study||1553
5352041|NCT00190671|13166776|P2|NOT COMPLETED|Overall Study||42
5352042|NCT00190671|13166777|P1|NOT COMPLETED|Overall Study||27
5352043|NCT00190671|13166776|P2|COMPLETED|Overall Study||19
5352044|NCT00190671|13166777|P1|COMPLETED|Overall Study||15
5352045|NCT00190671|13166776|P2|STARTED|Overall Study||61
5352046|NCT00190671|13166777|P1|STARTED|Overall Study||42
5352047|NCT00189540|13166797|P2|NOT COMPLETED|Overall Study||1
5352048|NCT00189540|13166798|P1|NOT COMPLETED|Overall Study||7
5352049|NCT00189540|13166797|P2|COMPLETED|Overall Study||5
5352050|NCT00189540|13166798|P1|COMPLETED|Overall Study||14
5352051|NCT00189540|13166797|P2|STARTED|Overall Study||6
5352052|NCT00189540|13166798|P1|STARTED|Overall Study||21
5352053|NCT00189488|13166816|P2|NOT COMPLETED|Overall Study||22
5352054|NCT00189488|13166817|P1|NOT COMPLETED|Overall Study||15
5352055|NCT00189488|13166816|P2|COMPLETED|Overall Study||55
5352056|NCT00189488|13166817|P1|COMPLETED|Overall Study||63
5352057|NCT00189488|13166816|P2|Received Palifermin/Placebo|Overall Study||76
5352058|NCT00189488|13166817|P1|Received Palifermin/Placebo|Overall Study||75
5352059|NCT00189488|13166816|P2|STARTED|Overall Study||77
5352060|NCT00189488|13166817|P1|STARTED|Overall Study||78
5352061|NCT00189475|13166839|P2|NOT COMPLETED|Overall Study||0
5352062|NCT00189475|13166840|P1|NOT COMPLETED|Overall Study||0
5352063|NCT00189475|13166839|P2|COMPLETED|Overall Study||42
5352064|NCT00189475|13166840|P1|COMPLETED|Overall Study||42
5352065|NCT00189475|13166839|P2|STARTED|Overall Study||42
5352066|NCT00189475|13166840|P1|STARTED|Overall Study||42
5352067|NCT00189462|13166848|P2|NOT COMPLETED|Overall Study||21
5352068|NCT00189462|13166849|P1|NOT COMPLETED|Overall Study||23
5352069|NCT00189462|13166848|P2|COMPLETED|Overall Study||28
5352070|NCT00189462|13166849|P1|COMPLETED|Overall Study||27
5352071|NCT00189462|13166848|P2|STARTED|Overall Study||49
5352072|NCT00189462|13166849|P1|STARTED|Overall Study||50
5352073|NCT00189436|13166857|P2|NOT COMPLETED|Overall Study||5
5352074|NCT00189436|13166858|P1|NOT COMPLETED|Overall Study||8
5352075|NCT00189436|13166857|P2|COMPLETED|Overall Study||25
5352076|NCT00189436|13166858|P1|COMPLETED|Overall Study||23
5352077|NCT00189436|13166857|P2|STARTED|Overall Study||30
5352078|NCT00189436|13166858|P1|STARTED|Overall Study||31
5352079|NCT00189423|13166866|P2|NOT COMPLETED|Overall Study||766
5352080|NCT00189423|13166867|P1|NOT COMPLETED|Overall Study||765
5352081|NCT00189423|13166866|P2|COMPLETED|Overall Study||74
5352082|NCT00189423|13166867|P1|COMPLETED|Overall Study||48
5352083|NCT00189423|13166866|P2|STARTED|Overall Study||840
5352084|NCT00189423|13166867|P1|STARTED|Overall Study||813
5352085|NCT00189306|13166889|P1|NOT COMPLETED|Long-Term Follow-up||38
5352086|NCT00189306|13166889|P1|COMPLETED|Long-Term Follow-up||119
5352087|NCT00189306|13166889|P1|STARTED|Long-Term Follow-up||157
5352088|NCT00189306|13166889|P1|NOT COMPLETED|Posttreatment Period||12
5352089|NCT00189306|13166889|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
5352090|NCT00189306|13166889|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
5352091|NCT00189306|13166889|P1|NOT COMPLETED|Treatment Period||5
5352092|NCT00189306|13166889|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
5352093|NCT00189306|13166889|P1|STARTED|Treatment Period||169
5352094|NCT00189228|13166894|P1|NOT COMPLETED|Overall Study||0
5352095|NCT00189228|13166894|P1|COMPLETED|Overall Study||18
5352096|NCT00189228|13166894|P1|STARTED|Overall Study||18
5352097|NCT00189202|13166898|P1|NOT COMPLETED|Overall Study||5
5352098|NCT00189202|13166898|P1|COMPLETED|Overall Study||44
5352099|NCT00189202|13166898|P1|STARTED|Overall Study||49
5352100|NCT00189137|13166909|P2|NOT COMPLETED|Overall Study||0
5352101|NCT00189137|13166910|P1|NOT COMPLETED|Overall Study||0
5352102|NCT00189137|13166909|P2|COMPLETED|Overall Study||43
5352103|NCT00189137|13166910|P1|COMPLETED|Overall Study||37
5352104|NCT00189137|13166909|P2|STARTED|Overall Study||43
5352105|NCT00189137|13166910|P1|STARTED|Overall Study||37
5352106|NCT00189098|13166920|P2|NOT COMPLETED|Overall Study||6
5352107|NCT00189098|13166921|P1|NOT COMPLETED|Overall Study||5
5352108|NCT00189098|13166920|P2|COMPLETED|Overall Study||44
5352109|NCT00189098|13166921|P1|COMPLETED|Overall Study||46
5352110|NCT00189098|13166920|P2|STARTED|Overall Study||50
5352111|NCT00189098|13166921|P1|STARTED|Overall Study||51
5352112|NCT00187889|13166939|P2|NOT COMPLETED|Overall Study||4
5352113|NCT00187889|13166940|P1|NOT COMPLETED|Overall Study||6
5352114|NCT00187889|13166939|P2|COMPLETED|Overall Study||22
5352115|NCT00187889|13166940|P1|COMPLETED|Overall Study||19
5352116|NCT00187889|13166939|P2|STARTED|Overall Study||26
5352117|NCT00187889|13166940|P1|STARTED|Overall Study||25
5352118|NCT00187876|13166950|P2|NOT COMPLETED|Overall Study||0
5352119|NCT00187876|13166951|P1|NOT COMPLETED|Overall Study||0
5352120|NCT00187876|13166950|P2|COMPLETED|Overall Study||43
5352121|NCT00187876|13166951|P1|COMPLETED|Overall Study||24
5352122|NCT00187876|13166950|P2|STARTED|Overall Study||43
5352123|NCT00187876|13166951|P1|STARTED|Overall Study||24
5352124|NCT00187720|13166959|P2|NOT COMPLETED|Overall Study||0
5352125|NCT00187720|13166960|P1|NOT COMPLETED|Overall Study||0
5352126|NCT00187720|13166959|P2|COMPLETED|Overall Study||14
5352127|NCT00187720|13166960|P1|COMPLETED|Overall Study||9
5352128|NCT00187720|13166959|P2|STARTED|Overall Study||14
5352129|NCT00187720|13166960|P1|STARTED|Overall Study||9
5352130|NCT00187681|13166968|P2|NOT COMPLETED|Overall Study||0
5352131|NCT00187681|13166969|P1|NOT COMPLETED|Overall Study||0
5352132|NCT00187681|13166968|P2|COMPLETED|Overall Study||8
5352133|NCT00187681|13166969|P1|COMPLETED|Overall Study||12
5352134|NCT00187681|13166968|P2|STARTED|Overall Study||8
5352135|NCT00187681|13166969|P1|STARTED|Overall Study||12
5352136|NCT00187655|13166977|P1|NOT COMPLETED|Overall Study||0
5352137|NCT00187655|13166977|P1|COMPLETED|Overall Study||24
5352138|NCT00187655|13166977|P1|STARTED|Overall Study||24
5352139|NCT00187486|13166982|P1|NOT COMPLETED|Overall Study||1
5352140|NCT00187486|13166982|P1|COMPLETED|Overall Study||65
5352141|NCT00187486|13166982|P1|STARTED|Overall Study||66
5352142|NCT00187369|13166989|P2|NOT COMPLETED|Fetuses or Infants||30
5352143|NCT00187369|13166990|P1|NOT COMPLETED|Fetuses or Infants||12
5352144|NCT00187369|13166989|P2|COMPLETED|Fetuses or Infants||2782
5352145|NCT00187369|13166990|P1|COMPLETED|Fetuses or Infants||2783
5352146|NCT00187369|13166989|P2|Included in the Study|Fetuses or Infants||2786
5352147|NCT00187369|13166990|P1|Included in the Study|Fetuses or Infants||2785
5352148|NCT00187369|13166989|P2|STARTED|Fetuses or Infants||2812
5352149|NCT00187369|13166990|P1|STARTED|Fetuses or Infants||2795
5352150|NCT00187369|13166989|P2|NOT COMPLETED|Mothers||14
5352151|NCT00187369|13166990|P1|NOT COMPLETED|Mothers||6
5352152|NCT00187369|13166989|P2|COMPLETED|Mothers||1392
5352153|NCT00187369|13166990|P1|COMPLETED|Mothers||1392
5352154|NCT00187369|13166989|P2|Included in the Study|Mothers||1393
5352155|NCT00187369|13166990|P1|Included in the Study|Mothers||1393
5352156|NCT00187369|13166989|P2|STARTED|Mothers||1406
5352157|NCT00187369|13166990|P1|STARTED|Mothers||1398
5352158|NCT00187226|13167022|P6|NOT COMPLETED|Overall Study||0
5352159|NCT00187226|13167023|P5|NOT COMPLETED|Overall Study||0
5352160|NCT00187226|13167024|P4|NOT COMPLETED|Overall Study||0
5352161|NCT00187226|13167025|P3|NOT COMPLETED|Overall Study||0
5352162|NCT00187226|13167026|P2|NOT COMPLETED|Overall Study||0
5352163|NCT00187226|13167027|P1|NOT COMPLETED|Overall Study||0
5352164|NCT00187226|13167022|P6|COMPLETED|Overall Study||1
5352165|NCT00187226|13167023|P5|COMPLETED|Overall Study||34
5352166|NCT00187226|13167024|P4|COMPLETED|Overall Study||2
5352167|NCT00187226|13167025|P3|COMPLETED|Overall Study||28
5352168|NCT00187226|13167026|P2|COMPLETED|Overall Study||49
5352169|NCT00187226|13167027|P1|COMPLETED|Overall Study||88
5352170|NCT00187226|13167022|P6|STARTED|Overall Study||1
5352171|NCT00187226|13167023|P5|STARTED|Overall Study||34
5352172|NCT00187226|13167024|P4|STARTED|Overall Study||2
5352173|NCT00187226|13167025|P3|STARTED|Overall Study||28
5352174|NCT00187226|13167026|P2|STARTED|Overall Study||49
5352175|NCT00187226|13167027|P1|STARTED|Overall Study||88
5352176|NCT00187200|13167043|P2|NOT COMPLETED|Overall Study||18
5352177|NCT00187200|13167044|P1|NOT COMPLETED|Overall Study||18
5352178|NCT00187200|13167043|P2|COMPLETED|Overall Study||26
5352179|NCT00187200|13167044|P1|COMPLETED|Overall Study||31
5352180|NCT00187200|13167043|P2|STARTED|Overall Study||44
5352181|NCT00187200|13167044|P1|STARTED|Overall Study||49
5352182|NCT00187135|13167062|P6|NOT COMPLETED|Visit Three||6
5352183|NCT00187135|13167063|P5|NOT COMPLETED|Visit Three||8
5352184|NCT00187135|13167064|P4|NOT COMPLETED|Visit Three||9
5352185|NCT00187135|13167065|P3|NOT COMPLETED|Visit Three||9
5352186|NCT00187135|13167066|P2|NOT COMPLETED|Visit Three||7
5352187|NCT00187135|13167067|P1|NOT COMPLETED|Visit Three||7
5352188|NCT00187135|13167062|P6|COMPLETED|Visit Three||12
5352189|NCT00187135|13167063|P5|COMPLETED|Visit Three||11
5352190|NCT00187135|13167064|P4|COMPLETED|Visit Three||9
5352191|NCT00187135|13167065|P3|COMPLETED|Visit Three||14
5352192|NCT00187135|13167066|P2|COMPLETED|Visit Three||17
5352193|NCT00187135|13167067|P1|COMPLETED|Visit Three||14
5352194|NCT00187135|13167062|P6|STARTED|Visit Three||18
5352195|NCT00187135|13167063|P5|STARTED|Visit Three||19
5352196|NCT00187135|13167064|P4|STARTED|Visit Three||18
5352197|NCT00187135|13167065|P3|STARTED|Visit Three||23
5352198|NCT00187135|13167066|P2|STARTED|Visit Three||24
5352199|NCT00187135|13167067|P1|STARTED|Visit Three||21
5352200|NCT00187135|13167062|P6|NOT COMPLETED|Visit Two||8
5352201|NCT00187135|13167063|P5|NOT COMPLETED|Visit Two||6
5352202|NCT00187135|13167064|P4|NOT COMPLETED|Visit Two||8
5352203|NCT00187135|13167065|P3|NOT COMPLETED|Visit Two||2
5352204|NCT00187135|13167066|P2|NOT COMPLETED|Visit Two||3
5352205|NCT00187135|13167067|P1|NOT COMPLETED|Visit Two||5
5352206|NCT00187135|13167062|P6|COMPLETED|Visit Two||18
5352207|NCT00187135|13167063|P5|COMPLETED|Visit Two||19
5352208|NCT00187135|13167064|P4|COMPLETED|Visit Two||18
5352209|NCT00187135|13167065|P3|COMPLETED|Visit Two||23
5352210|NCT00187135|13167066|P2|COMPLETED|Visit Two||24
5352211|NCT00187135|13167067|P1|COMPLETED|Visit Two||21
5352212|NCT00187135|13167062|P6|STARTED|Visit Two||26
5352213|NCT00187135|13167063|P5|STARTED|Visit Two||25
5352214|NCT00187135|13167064|P4|STARTED|Visit Two||26
5352215|NCT00187135|13167065|P3|STARTED|Visit Two||25
5352216|NCT00187135|13167066|P2|STARTED|Visit Two||27
5352217|NCT00187135|13167067|P1|STARTED|Visit Two||26
5352218|NCT00187135|13167062|P6|NOT COMPLETED|Visit One||2
5352219|NCT00187135|13167063|P5|NOT COMPLETED|Visit One||0
5352220|NCT00187135|13167064|P4|NOT COMPLETED|Visit One||0
5352221|NCT00187135|13167065|P3|NOT COMPLETED|Visit One||0
5352222|NCT00187135|13167066|P2|NOT COMPLETED|Visit One||1
5352223|NCT00187135|13167067|P1|NOT COMPLETED|Visit One||4
5352224|NCT00187135|13167062|P6|COMPLETED|Visit One||26
5352225|NCT00187135|13167063|P5|COMPLETED|Visit One||25
5352226|NCT00187135|13167064|P4|COMPLETED|Visit One||26
5352227|NCT00187135|13167065|P3|COMPLETED|Visit One||25
5352228|NCT00187135|13167066|P2|COMPLETED|Visit One||27
5352229|NCT00187135|13167067|P1|COMPLETED|Visit One||26
5352230|NCT00187135|13167062|P6|STARTED|Visit One||28
5352231|NCT00187135|13167063|P5|STARTED|Visit One||25
5352232|NCT00187135|13167064|P4|STARTED|Visit One||26
5352233|NCT00187135|13167065|P3|STARTED|Visit One||25
5352234|NCT00187135|13167066|P2|STARTED|Visit One||28
5352235|NCT00187135|13167067|P1|STARTED|Visit One||30
5352236|NCT00187096|13167090|P3|NOT COMPLETED|Overall Study||1
5352237|NCT00187096|13167091|P2|NOT COMPLETED|Overall Study||0
5352238|NCT00187096|13167092|P1|NOT COMPLETED|Overall Study||0
5352239|NCT00187096|13167090|P3|COMPLETED|Overall Study||11
5352240|NCT00187096|13167091|P2|COMPLETED|Overall Study||3
5352241|NCT00187096|13167092|P1|COMPLETED|Overall Study||10
5352242|NCT00187096|13167090|P3|STARTED|Overall Study||12
5352243|NCT00187096|13167091|P2|STARTED|Overall Study||3
5352244|NCT00187096|13167092|P1|STARTED|Overall Study||10
5352245|NCT00186901|13167130|P3|NOT COMPLETED|Overall Study||149
5352246|NCT00186901|13167131|P2|NOT COMPLETED|Overall Study||45
5352247|NCT00186901|13167132|P1|NOT COMPLETED|Overall Study||49
5352248|NCT00186901|13167130|P3|COMPLETED|Overall Study||0
5352249|NCT00186901|13167131|P2|COMPLETED|Overall Study||96
5352250|NCT00186901|13167132|P1|COMPLETED|Overall Study||85
5352251|NCT00186901|13167130|P3|24 Month Follow-up|Overall Study||0
5352252|NCT00186901|13167131|P2|24 Month Follow-up|Overall Study||107
5352253|NCT00186901|13167132|P1|24 Month Follow-up|Overall Study||106
5352254|NCT00186901|13167130|P3|12 Month Follow-up|Overall Study||0
5352255|NCT00186901|13167131|P2|12 Month Follow-up|Overall Study||122
5352256|NCT00186901|13167132|P1|12 Month Follow-up|Overall Study||117
5352257|NCT00186901|13167130|P3|Baseline|Overall Study||0
5352258|NCT00186901|13167131|P2|Baseline|Overall Study||141
5352259|NCT00186901|13167132|P1|Baseline|Overall Study||134
5352260|NCT00186901|13167130|P3|STARTED|Overall Study||149
5352261|NCT00186901|13167131|P2|STARTED|Overall Study||141
5352262|NCT00186901|13167132|P1|STARTED|Overall Study||134
5352263|NCT00186888|13167172|P3|NOT COMPLETED|Overall Study||0
5352264|NCT00186888|13167173|P2|NOT COMPLETED|Overall Study||3
5352265|NCT00186888|13167174|P1|NOT COMPLETED|Overall Study||4
5352266|NCT00186888|13167172|P3|COMPLETED|Overall Study||55
5352267|NCT00186888|13167173|P2|COMPLETED|Overall Study||24
5352268|NCT00186888|13167174|P1|COMPLETED|Overall Study||19
5352269|NCT00186888|13167172|P3|Window Therapy|Overall Study||0
5352270|NCT00186888|13167173|P2|Window Therapy|Overall Study||27
5352271|NCT00186888|13167174|P1|Window Therapy|Overall Study||0
5352272|NCT00186888|13167172|P3|STARTED|Overall Study||55
5352273|NCT00186888|13167173|P2|STARTED|Overall Study||27
5352274|NCT00186888|13167174|P1|STARTED|Overall Study||23
5352275|NCT00186875|13167251|P2|NOT COMPLETED|Overall Study||0
5352276|NCT00186875|13167252|P1|NOT COMPLETED|Overall Study||0
5352277|NCT00186875|13167251|P2|COMPLETED|Overall Study||14
5352278|NCT00186875|13167252|P1|COMPLETED|Overall Study||26
5352279|NCT00186875|13167251|P2|STARTED|Overall Study||14
5352280|NCT00186875|13167252|P1|STARTED|Overall Study||26
5352281|NCT00186628|13167266|P1|NOT COMPLETED|Overall Study||3
5352282|NCT00186628|13167266|P1|COMPLETED|Overall Study||33
5352283|NCT00186628|13167266|P1|STARTED|Overall Study||36
5352284|NCT00186537|13167277|P3|NOT COMPLETED|Overall Study||3
5352285|NCT00186537|13167278|P2|NOT COMPLETED|Overall Study||0
5352286|NCT00186537|13167279|P1|NOT COMPLETED|Overall Study||7
5352287|NCT00186537|13167277|P3|COMPLETED|Overall Study||13
5352288|NCT00186537|13167278|P2|COMPLETED|Overall Study||12
5352289|NCT00186537|13167279|P1|COMPLETED|Overall Study||12
5352290|NCT00186537|13167277|P3|STARTED|Overall Study||16
5352291|NCT00186537|13167278|P2|STARTED|Overall Study||12
5352292|NCT00186537|13167279|P1|STARTED|Overall Study||19
5352293|NCT00186498|13167295|P2|NOT COMPLETED|Overall Study||2
5352294|NCT00186498|13167296|P1|NOT COMPLETED|Overall Study||2
5352295|NCT00186498|13167295|P2|COMPLETED|Overall Study||3
5352296|NCT00186498|13167296|P1|COMPLETED|Overall Study||4
5352297|NCT00186498|13167295|P2|STARTED|Overall Study||5
5352298|NCT00186498|13167296|P1|STARTED|Overall Study||6
5352299|NCT00186485|13167302|P1|NOT COMPLETED|Overall Study||3
5352300|NCT00186485|13167302|P1|COMPLETED|Overall Study||25
5352301|NCT00186485|13167302|P1|STARTED|Overall Study||28
5352302|NCT00186446|13167308|P1|NOT COMPLETED|Overall Study||9
5352303|NCT00186446|13167308|P1|COMPLETED|Overall Study||11
5352304|NCT00186446|13167308|P1|STARTED|Overall Study||20
5352305|NCT00186186|13167314|P1|NOT COMPLETED|Overall Study||8
5352306|NCT00186186|13167314|P1|COMPLETED|Overall Study||20
5352307|NCT00186186|13167314|P1|STARTED|Overall Study||28
5352308|NCT00186121|13167319|P1|NOT COMPLETED|Overall Study||3
5352309|NCT00186121|13167319|P1|COMPLETED|Overall Study||32
5352310|NCT00186121|13167319|P1|STARTED|Overall Study||35
5352311|NCT00186069|13167331|P2|NOT COMPLETED|Overall Study||0
5352312|NCT00186069|13167332|P1|NOT COMPLETED|Overall Study||0
5352313|NCT00186069|13167331|P2|COMPLETED|Overall Study||15
5352314|NCT00186069|13167332|P1|COMPLETED|Overall Study||15
5352315|NCT00186069|13167331|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
5352316|NCT00186069|13167332|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
5352317|NCT00186056|13167344|P2|NOT COMPLETED|Overall Study||1
5352318|NCT00186056|13167345|P1|NOT COMPLETED|Overall Study||2
5352319|NCT00186056|13167344|P2|COMPLETED|Overall Study||16
5352320|NCT00186056|13167345|P1|COMPLETED|Overall Study||12
5352321|NCT00186056|13167344|P2|STARTED|Overall Study||17
5352322|NCT00186056|13167345|P1|STARTED|Overall Study||14
5352323|NCT00186043|13167353|P2|NOT COMPLETED|Overall Study||13
5352324|NCT00186043|13167354|P1|NOT COMPLETED|Overall Study||15
5352325|NCT00186043|13167353|P2|COMPLETED|Overall Study||12
5352326|NCT00186043|13167354|P1|COMPLETED|Overall Study||15
5352327|NCT00186043|13167353|P2|STARTED|Overall Study||25
5352328|NCT00186043|13167354|P1|STARTED|Overall Study||30
5352329|NCT00186017|13167366|P2|NOT COMPLETED|Overall Study||3
5352330|NCT00186017|13167367|P1|NOT COMPLETED|Overall Study||2
5352331|NCT00186017|13167366|P2|COMPLETED|Overall Study||22
5352332|NCT00186017|13167367|P1|COMPLETED|Overall Study||23
5352333|NCT00186017|13167366|P2|STARTED|Overall Study||25
5352334|NCT00186017|13167367|P1|STARTED|Overall Study||25
5352335|NCT00185965|13167381|P2|NOT COMPLETED|Overall Study||1
5352336|NCT00185965|13167382|P1|NOT COMPLETED|Overall Study||0
5352337|NCT00185965|13167381|P2|COMPLETED|Overall Study||14
5352338|NCT00185965|13167382|P1|COMPLETED|Overall Study||15
5352339|NCT00185965|13167381|P2|STARTED|Overall Study||15
5352340|NCT00185965|13167382|P1|STARTED|Overall Study||15
5352341|NCT00185900|13167390|P2|NOT COMPLETED|Overall Study||0
5352342|NCT00185900|13167391|P1|NOT COMPLETED|Overall Study||0
5352343|NCT00185900|13167390|P2|COMPLETED|Overall Study||100
5352344|NCT00185900|13167391|P1|COMPLETED|Overall Study||92
5352345|NCT00185900|13167390|P2|STARTED|Overall Study||100
5352346|NCT00185900|13167391|P1|STARTED|Overall Study||92
5352347|NCT00185731|13167407|P1|NOT COMPLETED|Overall Study||2
5352348|NCT00185731|13167407|P1|COMPLETED|Overall Study||23
5352349|NCT00185731|13167407|P1|STARTED|Overall Study||25
5352350|NCT00185692|13167413|P1|NOT COMPLETED|Overall Study||16
5352351|NCT00185692|13167413|P1|COMPLETED|Overall Study||0
5352352|NCT00185692|13167413|P1|STARTED|Overall Study||16
5352353|NCT00185679|13167418|P1|NOT COMPLETED|Overall Study||0
5352354|NCT00185679|13167418|P1|COMPLETED|Overall Study||13
5352355|NCT00185679|13167418|P1|STARTED|Overall Study||13
5352356|NCT00185640|13167424|P1|NOT COMPLETED|Overall Study||145
5352357|NCT00185640|13167424|P1|COMPLETED|Overall Study||158
5352358|NCT00185640|13167424|P1|90 Days Post-transplant|Overall Study||161
5352359|NCT00185640|13167424|P1|Transplanted|Overall Study||296
5352360|NCT00185640|13167424|P1|STARTED|Overall Study||303
5352361|NCT00185614|13167433|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
5352362|NCT00185614|13167433|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
5352363|NCT00185614|13167433|P1|STARTED|Allogenic HCT (Allo-HCT)||59
5352364|NCT00185614|13167433|P1|NOT COMPLETED|Inter-treatment Period||4
5352365|NCT00185614|13167433|P1|COMPLETED|Inter-treatment Period||59
5352366|NCT00185614|13167433|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
5352367|NCT00185614|13167433|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
5352368|NCT00185614|13167433|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
5352369|NCT00185614|13167433|P1|STARTED|Autologous HCT (Auto-HCT)||63
5352370|NCT00185588|13167445|P4|NOT COMPLETED|Overall Study||4
5352371|NCT00185588|13167446|P3|NOT COMPLETED|Overall Study||6
5352372|NCT00185588|13167447|P2|NOT COMPLETED|Overall Study||2
5352373|NCT00185588|13167448|P1|NOT COMPLETED|Overall Study||3
5352374|NCT00185588|13167445|P4|COMPLETED|Overall Study||13
5352375|NCT00185588|13167446|P3|COMPLETED|Overall Study||0
5352376|NCT00185588|13167447|P2|COMPLETED|Overall Study||2
5352377|NCT00185588|13167448|P1|COMPLETED|Overall Study||3
5352378|NCT00185588|13167445|P4|STARTED|Overall Study||17
5352379|NCT00185588|13167446|P3|STARTED|Overall Study||6
5352380|NCT00185588|13167447|P2|STARTED|Overall Study||4
5352381|NCT00185588|13167448|P1|STARTED|Overall Study||6
5352382|NCT00185458|13167462|P1|NOT COMPLETED|HRT Phase||27
5352383|NCT00185458|13167462|P1|COMPLETED|HRT Phase||141
5352384|NCT00185458|13167462|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
5352385|NCT00185458|13167462|P1|NOT COMPLETED|Contraception Phase||58
5352386|NCT00185458|13167462|P1|COMPLETED|Contraception Phase||336
5352387|NCT00185458|13167462|P1|STARTED|Contraception Phase||394
5352388|NCT00185380|13167525|P3|NOT COMPLETED|Overall Study||74
5352389|NCT00185380|13167526|P2|NOT COMPLETED|Overall Study||72
5352390|NCT00185380|13167527|P1|NOT COMPLETED|Overall Study||66
5352391|NCT00185380|13167525|P3|COMPLETED|Overall Study||182
5352392|NCT00185380|13167526|P2|COMPLETED|Overall Study||174
5352393|NCT00185380|13167527|P1|COMPLETED|Overall Study||174
5352394|NCT00185380|13167525|P3|Subjects Received Treatment|Overall Study||254
5352395|NCT00185380|13167526|P2|Subjects Received Treatment|Overall Study||245
5352396|NCT00185380|13167527|P1|Subjects Received Treatment|Overall Study||239
5352397|NCT00185380|13167525|P3|STARTED|Overall Study||256
5352398|NCT00185380|13167526|P2|STARTED|Overall Study||246
5352399|NCT00185380|13167527|P1|STARTED|Overall Study||240
5352400|NCT00185211|13167555|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
5352401|NCT00185211|13167556|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
5352402|NCT00185211|13167555|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
5352403|NCT00185211|13167556|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
5352404|NCT00185211|13167555|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
5352405|NCT00185211|13167556|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
5352406|NCT00185211|13167555|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
5352407|NCT00185211|13167556|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
5352408|NCT00185211|13167555|P2|COMPLETED|Placebo-controlled Study (92012)||166
5352409|NCT00185211|13167556|P1|COMPLETED|Placebo-controlled Study (92012)||271
5352410|NCT00185211|13167555|P2|STARTED|Placebo-controlled Study (92012)||176
5352411|NCT00185211|13167556|P1|STARTED|Placebo-controlled Study (92012)||292
5352412|NCT00184717|13167584|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
5352413|NCT00184717|13167585|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
5352414|NCT00184717|13167586|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
5352415|NCT00184717|13167587|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
5352416|NCT00184717|13167588|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
5352417|NCT00184717|13167584|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
5352418|NCT00184717|13167585|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
5352419|NCT00184717|13167586|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
5352420|NCT00184717|13167587|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
5352421|NCT00184717|13167588|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
5352422|NCT00184717|13167584|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
5352423|NCT00184717|13167585|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
5352424|NCT00184717|13167586|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
5352425|NCT00184717|13167587|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
5352426|NCT00184717|13167588|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
5352427|NCT00184717|13167584|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
5352428|NCT00184717|13167585|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
5352429|NCT00184717|13167586|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
5352430|NCT00184717|13167587|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
5352431|NCT00184717|13167588|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
5352432|NCT00184717|13167584|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
5352433|NCT00184717|13167585|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
5352434|NCT00184717|13167586|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
5352435|NCT00184717|13167587|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
5352436|NCT00184717|13167588|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
5352437|NCT00184717|13167584|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
5352438|NCT00184717|13167585|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
5352439|NCT00184717|13167586|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
5352440|NCT00184717|13167587|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
5352441|NCT00184717|13167588|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
5352442|NCT00184717|13167584|P5|STARTED|Main Period (GHLIQUID-1516)||0
5352443|NCT00184717|13167585|P4|STARTED|Main Period (GHLIQUID-1516)||0
5352444|NCT00184717|13167586|P3|STARTED|Main Period (GHLIQUID-1516)||21
5352445|NCT00184717|13167587|P2|STARTED|Main Period (GHLIQUID-1516)||38
5352446|NCT00184717|13167588|P1|STARTED|Main Period (GHLIQUID-1516)||39
5352447|NCT00184600|13167629|P3|NOT COMPLETED|Overall Study||34
5352448|NCT00184600|13167630|P2|NOT COMPLETED|Overall Study||51
5352449|NCT00184600|13167631|P1|NOT COMPLETED|Overall Study||45
5352450|NCT00184600|13167629|P3|COMPLETED|Overall Study||201
5352451|NCT00184600|13167630|P2|COMPLETED|Overall Study||188
5352452|NCT00184600|13167631|P1|COMPLETED|Overall Study||189
5352453|NCT00184600|13167629|P3|STARTED|Overall Study||235
5352454|NCT00184600|13167630|P2|STARTED|Overall Study||239
5352455|NCT00184600|13167631|P1|STARTED|Overall Study||234
5352456|NCT00184548|13167685|P4|NOT COMPLETED|Overall Study||7
5352457|NCT00184548|13167686|P3|NOT COMPLETED|Overall Study||3
5352458|NCT00184548|13167687|P2|NOT COMPLETED|Overall Study||13
5352459|NCT00184548|13167688|P1|NOT COMPLETED|Overall Study||8
5352460|NCT00184548|13167685|P4|COMPLETED|Overall Study||38
5352461|NCT00184548|13167686|P3|COMPLETED|Overall Study||44
5352462|NCT00184548|13167687|P2|COMPLETED|Overall Study||242
5352463|NCT00184548|13167688|P1|COMPLETED|Overall Study||218
5352464|NCT00184548|13167685|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
5352465|NCT00184548|13167686|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
5352466|NCT00184548|13167687|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
5352467|NCT00184548|13167688|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
5352468|NCT00184548|13167685|P4|STARTED|Overall Study||45
5352469|NCT00184548|13167686|P3|STARTED|Overall Study||47
5352470|NCT00184548|13167687|P2|STARTED|Overall Study||255
5352471|NCT00184548|13167688|P1|STARTED|Overall Study||226
5352472|NCT00184093|13167722|P1|NOT COMPLETED|Overall Study||9
5352473|NCT00184093|13167722|P1|COMPLETED|Overall Study||26
5352474|NCT00184093|13167722|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
5352475|NCT00184054|13167727|P1|NOT COMPLETED|Overall Study||1
5352476|NCT00184054|13167727|P1|COMPLETED|Overall Study||10
5352477|NCT00184054|13167727|P1|STARTED|Overall Study||11
5352478|NCT00184028|13167732|P1|NOT COMPLETED|Overall Study||10
5352479|NCT00184028|13167732|P1|COMPLETED|Overall Study||2
5352480|NCT00184028|13167732|P1|STARTED|Overall Study||12
5352481|NCT00184002|13167737|P1|NOT COMPLETED|Overall Study||17
5352482|NCT00184002|13167737|P1|COMPLETED|Overall Study||51
5352483|NCT00184002|13167737|P1|STARTED|Overall Study||68
5352484|NCT00183963|13167746|P4|NOT COMPLETED|Overall Study||1
5352485|NCT00183963|13167747|P3|NOT COMPLETED|Overall Study||1
5352486|NCT00183963|13167748|P2|NOT COMPLETED|Overall Study||1
5352487|NCT00183963|13167749|P1|NOT COMPLETED|Overall Study||1
5352488|NCT00183963|13167746|P4|COMPLETED|Overall Study||0
5352489|NCT00183963|13167747|P3|COMPLETED|Overall Study||0
5352490|NCT00183963|13167748|P2|COMPLETED|Overall Study||0
5352491|NCT00183963|13167749|P1|COMPLETED|Overall Study||0
5352492|NCT00183963|13167746|P4|STARTED|Overall Study||1
5352493|NCT00183963|13167747|P3|STARTED|Overall Study||1
5352494|NCT00183963|13167748|P2|STARTED|Overall Study||1
5352495|NCT00183963|13167749|P1|STARTED|Overall Study||1
5352496|NCT00183872|13167763|P1|NOT COMPLETED|Overall Study||16
5352497|NCT00183872|13167763|P1|COMPLETED|Overall Study||24
5352498|NCT00183872|13167763|P1|STARTED|Overall Study||40
5352499|NCT00183794|13167768|P1|NOT COMPLETED|Overall Study||0
5352500|NCT00183794|13167768|P1|COMPLETED|Overall Study||20
5352501|NCT00183794|13167768|P1|STARTED|Overall Study||20
5352502|NCT00183729|13167775|P2|NOT COMPLETED|Overall Study||5
5352503|NCT00183729|13167776|P1|NOT COMPLETED|Overall Study||3
5352504|NCT00183729|13167775|P2|COMPLETED|Overall Study||13
5352505|NCT00183729|13167776|P1|COMPLETED|Overall Study||14
5352506|NCT00183729|13167775|P2|STARTED|Overall Study||18
5352507|NCT00183729|13167776|P1|STARTED|Overall Study||17
5352508|NCT00183677|13167786|P1|NOT COMPLETED|Overall Study||44
5352509|NCT00183677|13167786|P1|COMPLETED|Overall Study||53
5352510|NCT00183677|13167786|P1|STARTED|Overall Study||97
5352511|NCT00183625|13167792|P4|NOT COMPLETED|Overall Study||14
5352512|NCT00183625|13167793|P3|NOT COMPLETED|Overall Study||19
5352513|NCT00183625|13167794|P2|NOT COMPLETED|Overall Study||18
5352514|NCT00183625|13167795|P1|NOT COMPLETED|Overall Study||18
5352515|NCT00183625|13167792|P4|COMPLETED|Overall Study||10
5352516|NCT00183625|13167793|P3|COMPLETED|Overall Study||9
5352517|NCT00183625|13167794|P2|COMPLETED|Overall Study||10
5352518|NCT00183625|13167795|P1|COMPLETED|Overall Study||9
5352519|NCT00183625|13167792|P4|Obtained Employment|Overall Study||14
5352520|NCT00183625|13167793|P3|Obtained Employment|Overall Study||14
5352521|NCT00183625|13167794|P2|Obtained Employment|Overall Study||18
5352522|NCT00183625|13167795|P1|Obtained Employment|Overall Study||21
5352523|NCT00183625|13167792|P4|STARTED|Overall Study||24
5352524|NCT00183625|13167793|P3|STARTED|Overall Study||28
5352525|NCT00183625|13167794|P2|STARTED|Overall Study||28
5352526|NCT00183625|13167795|P1|STARTED|Overall Study||27
5352527|NCT00183469|13167805|P2|NOT COMPLETED|Overall Study||29
5352528|NCT00183469|13167806|P1|NOT COMPLETED|Overall Study||28
5352529|NCT00183469|13167805|P2|COMPLETED|Overall Study||16
5352530|NCT00183469|13167806|P1|COMPLETED|Overall Study||13
5352531|NCT00183469|13167805|P2|STARTED|Overall Study||45
5352532|NCT00183469|13167806|P1|STARTED|Overall Study||41
5352533|NCT00183456|13167816|P4|NOT COMPLETED|Overall Study||28
5352534|NCT00183456|13167817|P3|NOT COMPLETED|Overall Study||16
5352535|NCT00183456|13167818|P2|NOT COMPLETED|Overall Study||1
5352536|NCT00183456|13167819|P1|NOT COMPLETED|Overall Study||3
5352537|NCT00183456|13167816|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
5352538|NCT00183456|13167817|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
5352539|NCT00183456|13167818|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
5352540|NCT00183456|13167819|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
5352541|NCT00183456|13167816|P4|18 Month Follow-up|Overall Study||207
5352542|NCT00183456|13167817|P3|18 Month Follow-up|Overall Study||303
5352543|NCT00183456|13167818|P2|18 Month Follow-up|Overall Study||81
5352544|NCT00183456|13167819|P1|18 Month Follow-up|Overall Study||80
5352545|NCT00183456|13167816|P4|12 Month Follow-up|Overall Study||186
5352546|NCT00183456|13167817|P3|12 Month Follow-up|Overall Study||267
5352547|NCT00183456|13167818|P2|12 Month Follow-up|Overall Study||74
5352548|NCT00183456|13167819|P1|12 Month Follow-up|Overall Study||76
5352549|NCT00183456|13167816|P4|6 Month Follow-up|Overall Study||175
5352550|NCT00183456|13167817|P3|6 Month Follow-up|Overall Study||278
5352551|NCT00183456|13167818|P2|6 Month Follow-up|Overall Study||77
5352552|NCT00183456|13167819|P1|6 Month Follow-up|Overall Study||74
5352553|NCT00183456|13167816|P4|STARTED|Overall Study||248
5352554|NCT00183456|13167817|P3|STARTED|Overall Study||329
5352555|NCT00183456|13167818|P2|STARTED|Overall Study||84
5352556|NCT00183456|13167819|P1|STARTED|Overall Study||85
5352557|NCT00183443|13167868|P3|NOT COMPLETED|Overall Study||0
5352558|NCT00183443|13167869|P2|NOT COMPLETED|Overall Study||0
5352559|NCT00183443|13167870|P1|NOT COMPLETED|Overall Study||0
5352560|NCT00183443|13167868|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
5352561|NCT00183443|13167869|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
5352562|NCT00183443|13167870|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
5352563|NCT00183443|13167868|P3|STARTED|Overall Study||25
5352564|NCT00183443|13167869|P2|STARTED|Overall Study||26
5352565|NCT00183443|13167870|P1|STARTED|Overall Study||24
5352566|NCT00183430|13167892|P2|NOT COMPLETED|Overall Study||0
5352567|NCT00183430|13167893|P1|NOT COMPLETED|Overall Study||6
5352568|NCT00183430|13167892|P2|COMPLETED|Overall Study||11
5352569|NCT00183430|13167893|P1|COMPLETED|Overall Study||3
5352570|NCT00183430|13167892|P2|STARTED|Overall Study||11
5352571|NCT00183430|13167893|P1|STARTED|Overall Study||9
5352572|NCT00183391|13167905|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
5352573|NCT00183391|13167906|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
5352574|NCT00183391|13167905|P2|COMPLETED|Block 2 - 5 Weeks||108
5352575|NCT00183391|13167906|P1|COMPLETED|Block 2 - 5 Weeks||91
5352576|NCT00183391|13167905|P2|STARTED|Block 2 - 5 Weeks||110
5352577|NCT00183391|13167906|P1|STARTED|Block 2 - 5 Weeks||95
5352578|NCT00183391|13167905|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
5352579|NCT00183391|13167906|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
5352580|NCT00183391|13167905|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
5352581|NCT00183391|13167906|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
5352582|NCT00183391|13167905|P2|STARTED|Crossover Placebo - 2 Weeks||110
5352583|NCT00183391|13167906|P1|STARTED|Crossover Placebo - 2 Weeks||95
5352584|NCT00183391|13167905|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
5352585|NCT00183391|13167906|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
5352586|NCT00183391|13167905|P2|COMPLETED|Block 1 - 5 Weeks||110
5352587|NCT00183391|13167906|P1|COMPLETED|Block 1 - 5 Weeks||95
5352588|NCT00183391|13167905|P2|STARTED|Block 1 - 5 Weeks||124
5352589|NCT00183391|13167906|P1|STARTED|Block 1 - 5 Weeks||108
5352590|NCT00183339|13167966|P2|NOT COMPLETED|Overall Study||4
5352591|NCT00183339|13167967|P1|NOT COMPLETED|Overall Study||6
5352592|NCT00183339|13167966|P2|COMPLETED|Overall Study||4
5352593|NCT00183339|13167967|P1|COMPLETED|Overall Study||4
5352594|NCT00183339|13167966|P2|STARTED|Overall Study||8
5352595|NCT00183339|13167967|P1|STARTED|Overall Study||10
5352596|NCT00183274|13167979|P6|NOT COMPLETED|Phase 3: Double-Blind||4
5352597|NCT00183274|13167980|P5|NOT COMPLETED|Phase 3: Double-Blind||20
5352598|NCT00183274|13167981|P4|NOT COMPLETED|Phase 3: Double-Blind||2
5352599|NCT00183274|13167982|P3|NOT COMPLETED|Phase 3: Double-Blind||0
5352600|NCT00183274|13167983|P2|NOT COMPLETED|Phase 3: Double-Blind||0
5352601|NCT00183274|13167984|P1|NOT COMPLETED|Phase 3: Double-Blind||0
5352602|NCT00183274|13167979|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
5352603|NCT00183274|13167980|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
5352604|NCT00183274|13167981|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
5352605|NCT00183274|13167982|P3|COMPLETED|Phase 3: Double-Blind||0
5352606|NCT00183274|13167983|P2|COMPLETED|Phase 3: Double-Blind||0
5352607|NCT00183274|13167984|P1|COMPLETED|Phase 3: Double-Blind||0
5352608|NCT00183274|13167979|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
5352609|NCT00183274|13167980|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
5352610|NCT00183274|13167981|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
5352611|NCT00183274|13167982|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
5352612|NCT00183274|13167983|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
5352613|NCT00183274|13167984|P1|STARTED|Phase 3: Double-Blind||0
5352614|NCT00183274|13167979|P6|NOT COMPLETED|Phase 2: Double-Blind||0
5352615|NCT00183274|13167980|P5|NOT COMPLETED|Phase 2: Double-Blind||0
5352616|NCT00183274|13167981|P4|NOT COMPLETED|Phase 2: Double-Blind||0
5352617|NCT00183274|13167982|P3|NOT COMPLETED|Phase 2: Double-Blind||43
5352618|NCT00183274|13167983|P2|NOT COMPLETED|Phase 2: Double-Blind||26
5352619|NCT00183274|13167984|P1|NOT COMPLETED|Phase 2: Double-Blind||0
5352620|NCT00183274|13167979|P6|COMPLETED|Phase 2: Double-Blind||0
5352621|NCT00183274|13167980|P5|COMPLETED|Phase 2: Double-Blind||0
5352622|NCT00183274|13167981|P4|COMPLETED|Phase 2: Double-Blind||0
5352623|NCT00183274|13167982|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
5352624|NCT00183274|13167983|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
5352625|NCT00183274|13167984|P1|COMPLETED|Phase 2: Double-Blind||0
5352626|NCT00183274|13167979|P6|STARTED|Phase 2: Double-Blind||0
5352627|NCT00183274|13167980|P5|STARTED|Phase 2: Double-Blind||0
5352628|NCT00183274|13167981|P4|STARTED|Phase 2: Double-Blind||0
5352629|NCT00183274|13167982|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
5352630|NCT00183274|13167983|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
5352631|NCT00183274|13167984|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
5352632|NCT00183274|13167979|P6|NOT COMPLETED|Phase 1: Open-Label||0
5352633|NCT00183274|13167980|P5|NOT COMPLETED|Phase 1: Open-Label||0
5352634|NCT00183274|13167981|P4|NOT COMPLETED|Phase 1: Open-Label||0
5352635|NCT00183274|13167982|P3|NOT COMPLETED|Phase 1: Open-Label||0
5352636|NCT00183274|13167983|P2|NOT COMPLETED|Phase 1: Open-Label||0
5352637|NCT00183274|13167984|P1|NOT COMPLETED|Phase 1: Open-Label||110
5352638|NCT00183274|13167979|P6|COMPLETED|Phase 1: Open-Label||0
5352639|NCT00183274|13167980|P5|COMPLETED|Phase 1: Open-Label||0
5352640|NCT00183274|13167981|P4|COMPLETED|Phase 1: Open-Label||0
5352641|NCT00183274|13167982|P3|COMPLETED|Phase 1: Open-Label||0
5352642|NCT00183274|13167983|P2|COMPLETED|Phase 1: Open-Label||0
5352643|NCT00183274|13167984|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
5352644|NCT00183274|13167979|P6|STARTED|Phase 1: Open-Label||0
5352645|NCT00183274|13167980|P5|STARTED|Phase 1: Open-Label||0
5352646|NCT00183274|13167981|P4|STARTED|Phase 1: Open-Label||0
5352647|NCT00183274|13167982|P3|STARTED|Phase 1: Open-Label||0
5352648|NCT00183274|13167983|P2|STARTED|Phase 1: Open-Label||0
5352649|NCT00183274|13167984|P1|STARTED|Phase 1: Open-Label||268
5352650|NCT00183248|13168001|P2|NOT COMPLETED|Overall Study||1
5352651|NCT00183248|13168002|P1|NOT COMPLETED|Overall Study||1
5352652|NCT00183248|13168001|P2|COMPLETED|Overall Study||4
5352653|NCT00183248|13168002|P1|COMPLETED|Overall Study||3
5352654|NCT00183248|13168001|P2|STARTED|Overall Study||5
5352655|NCT00183248|13168002|P1|STARTED|Overall Study||4
5352656|NCT00183196|13168023|P3|NOT COMPLETED|Overall Study||18
5352657|NCT00183196|13168024|P2|NOT COMPLETED|Overall Study||15
5352658|NCT00183196|13168025|P1|NOT COMPLETED|Overall Study||20
5352659|NCT00183196|13168023|P3|COMPLETED|Overall Study||32
5352660|NCT00183196|13168024|P2|COMPLETED|Overall Study||35
5352661|NCT00183196|13168025|P1|COMPLETED|Overall Study||30
5352662|NCT00183196|13168023|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
5352663|NCT00183196|13168024|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
5352664|NCT00183196|13168025|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
5352665|NCT00183092|13168035|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
5352666|NCT00183092|13168036|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
5352667|NCT00183092|13168037|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
5352668|NCT00183092|13168038|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
5352669|NCT00183092|13168035|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
5352670|NCT00183092|13168036|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
5352671|NCT00183092|13168037|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
5352672|NCT00183092|13168038|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
5352673|NCT00183092|13168035|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
5352674|NCT00183092|13168036|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
5352675|NCT00183092|13168037|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
5352676|NCT00183092|13168038|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
5352677|NCT00183092|13168035|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
5352678|NCT00183092|13168036|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
5352679|NCT00183092|13168037|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
5352680|NCT00183092|13168038|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
5352681|NCT00183092|13168035|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
5352682|NCT00183092|13168036|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
5352683|NCT00183092|13168037|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
5352684|NCT00183092|13168038|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
5352685|NCT00183092|13168035|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
5352686|NCT00183092|13168036|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
5352687|NCT00183092|13168037|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
5352688|NCT00183092|13168038|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
5352689|NCT00183092|13168035|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
5352690|NCT00183092|13168036|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
5352691|NCT00183092|13168037|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
5352692|NCT00183092|13168038|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
5352693|NCT00183092|13168035|P4|STARTED|Double-blind (Baseline - Month 2)||0
5352694|NCT00183092|13168036|P3|STARTED|Double-blind (Baseline - Month 2)||0
5352695|NCT00183092|13168037|P2|STARTED|Double-blind (Baseline - Month 2)||28
5352696|NCT00183092|13168038|P1|STARTED|Double-blind (Baseline - Month 2)||23
5352697|NCT00182793|13168059|P1|NOT COMPLETED|Overall Study||0
5352698|NCT00182793|13168059|P1|COMPLETED|Overall Study||32
5352699|NCT00182793|13168059|P1|STARTED|Overall Study||32
5352700|NCT00182767|13168064|P5|NOT COMPLETED|Overall Study||0
5352701|NCT00182767|13168065|P4|NOT COMPLETED|Overall Study||0
5352702|NCT00182767|13168066|P3|NOT COMPLETED|Overall Study||0
5352703|NCT00182767|13168067|P2|NOT COMPLETED|Overall Study||0
5352704|NCT00182767|13168068|P1|NOT COMPLETED|Overall Study||0
5352705|NCT00182767|13168064|P5|COMPLETED|Overall Study||24
5352706|NCT00182767|13168065|P4|COMPLETED|Overall Study||3
5352707|NCT00182767|13168066|P3|COMPLETED|Overall Study||6
5352708|NCT00182767|13168067|P2|COMPLETED|Overall Study||6
5352709|NCT00182767|13168068|P1|COMPLETED|Overall Study||6
5352710|NCT00182767|13168064|P5|STARTED|Overall Study||24
5352711|NCT00182767|13168065|P4|STARTED|Overall Study||3
5352712|NCT00182767|13168066|P3|STARTED|Overall Study||6
5352713|NCT00182767|13168067|P2|STARTED|Overall Study||6
5352714|NCT00182767|13168068|P1|STARTED|Overall Study||6
5352715|NCT00182754|13168085|P2|NOT COMPLETED|Overall Study||0
5352716|NCT00182754|13168086|P1|NOT COMPLETED|Overall Study||0
5352717|NCT00182754|13168085|P2|COMPLETED|Overall Study||17
5352718|NCT00182754|13168086|P1|COMPLETED|Overall Study||16
5352719|NCT00182754|13168085|P2|STARTED|Overall Study||17
5352720|NCT00182754|13168086|P1|STARTED|Overall Study||16
5352721|NCT00182728|13168096|P1|NOT COMPLETED|Overall Study||0
5352722|NCT00182728|13168096|P1|COMPLETED|Overall Study||71
5352723|NCT00182728|13168096|P1|STARTED|Overall Study||71
5352724|NCT00182689|13168108|P2|NOT COMPLETED|Overall Study||49
5352725|NCT00182689|13168109|P1|NOT COMPLETED|Overall Study||40
5352726|NCT00182689|13168108|P2|COMPLETED|Overall Study||0
5352727|NCT00182689|13168109|P1|COMPLETED|Overall Study||0
5352728|NCT00182689|13168108|P2|Eligible and Began Protocol Therapy|Overall Study||45
5352729|NCT00182689|13168109|P1|Eligible and Began Protocol Therapy|Overall Study||38
5352730|NCT00182689|13168108|P2|Eligible|Overall Study||45
5352731|NCT00182689|13168109|P1|Eligible|Overall Study||39
5352732|NCT00182689|13168108|P2|STARTED|Overall Study||49
5352733|NCT00182689|13168109|P1|STARTED|Overall Study||40
5352734|NCT00182637|13168119|P1|NOT COMPLETED|Overall Study||3
5352735|NCT00182637|13168119|P1|COMPLETED|Overall Study|off study date|2
5352736|NCT00182637|13168119|P1|STARTED|Overall Study|active/on treatment date|5
5352737|NCT00182325|13168127|P2|NOT COMPLETED|Overall Study||53
5352738|NCT00182325|13168128|P1|NOT COMPLETED|Overall Study||34
5352739|NCT00182325|13168127|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
5352740|NCT00182325|13168128|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
5352741|NCT00182325|13168127|P2|STARTED|Overall Study||96
5352742|NCT00182325|13168128|P1|STARTED|Overall Study||97
5352743|NCT00182091|13168156|P4|NOT COMPLETED|Overall Study||0
5352744|NCT00182091|13168157|P3|NOT COMPLETED|Overall Study||0
5352745|NCT00182091|13168158|P2|NOT COMPLETED|Overall Study||0
5352746|NCT00182091|13168159|P1|NOT COMPLETED|Overall Study||1
5352747|NCT00182091|13168156|P4|COMPLETED|Overall Study||20
5352748|NCT00182091|13168157|P3|COMPLETED|Overall Study||25
5352749|NCT00182091|13168158|P2|COMPLETED|Overall Study||15
5352750|NCT00182091|13168159|P1|COMPLETED|Overall Study||14
5352751|NCT00182091|13168156|P4|STARTED|Overall Study||20
5352752|NCT00182091|13168157|P3|STARTED|Overall Study||25
5352753|NCT00182091|13168158|P2|STARTED|Overall Study||15
5352754|NCT00182091|13168159|P1|STARTED|Overall Study||15
5352755|NCT00182078|13168175|P2|NOT COMPLETED|Overall Study||0
5352756|NCT00182078|13168176|P1|NOT COMPLETED|Overall Study||1
5352757|NCT00182078|13168175|P2|COMPLETED|Overall Study||17
5352758|NCT00182078|13168176|P1|COMPLETED|Overall Study||8
5352759|NCT00182078|13168175|P2|STARTED|Overall Study||17
5352760|NCT00182078|13168176|P1|STARTED|Overall Study||9
5352761|NCT00182000|13168188|P2|NOT COMPLETED|Overall Study||2
5352762|NCT00182000|13168189|P1|NOT COMPLETED|Overall Study||5
5352763|NCT00182000|13168188|P2|COMPLETED|Overall Study||13
5352764|NCT00182000|13168189|P1|COMPLETED|Overall Study||9
5352765|NCT00182000|13168188|P2|STARTED|Overall Study||15
5352766|NCT00182000|13168189|P1|STARTED|Overall Study||14
5352767|NCT00181961|13168197|P2|NOT COMPLETED|Overall Study||5
5352768|NCT00181961|13168198|P1|NOT COMPLETED|Overall Study||1
5352769|NCT00181961|13168197|P2|COMPLETED|Overall Study||4
5352770|NCT00181961|13168198|P1|COMPLETED|Overall Study||6
5352771|NCT00181961|13168197|P2|STARTED|Overall Study||9
5352772|NCT00181961|13168198|P1|STARTED|Overall Study||7
5352773|NCT00181883|13168204|P1|NOT COMPLETED|Overall Study||10
5352774|NCT00181883|13168204|P1|COMPLETED|Overall Study||20
5352775|NCT00181883|13168204|P1|STARTED|Overall Study||30
5352776|NCT00181844|13168208|P1|NOT COMPLETED|Exposed to Study Medication||17
5352777|NCT00181844|13168208|P1|COMPLETED|Exposed to Study Medication||22
5352778|NCT00181844|13168208|P1|STARTED|Exposed to Study Medication||39
5352779|NCT00181844|13168208|P1|NOT COMPLETED|Signed Consent||12
5352780|NCT00181844|13168208|P1|COMPLETED|Signed Consent||39
5352781|NCT00181844|13168208|P1|STARTED|Signed Consent||51
5352782|NCT00181766|13168212|P1|NOT COMPLETED|Overall Study||12
5352783|NCT00181766|13168212|P1|COMPLETED|Overall Study|Completed the trial.|33
5352784|NCT00181766|13168212|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
5352785|NCT00181714|13168217|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
5352786|NCT00181714|13168217|P1|COMPLETED|Began Treatment With OROS-MPH||30
5352787|NCT00181714|13168217|P1|STARTED|Began Treatment With OROS-MPH||154
5352788|NCT00181714|13168217|P1|NOT COMPLETED|Signed Consent/Enrolled||49
5352789|NCT00181714|13168217|P1|COMPLETED|Signed Consent/Enrolled||154
5352790|NCT00181714|13168217|P1|STARTED|Signed Consent/Enrolled||203
5352791|NCT00181623|13168221|P1|NOT COMPLETED|Overall Study||1
5352792|NCT00181623|13168221|P1|COMPLETED|Overall Study||5
5352793|NCT00181623|13168221|P1|STARTED|Overall Study||6
5352794|NCT00181610|13168229|P3|NOT COMPLETED|Overall Study||0
5352795|NCT00181610|13168230|P2|NOT COMPLETED|Overall Study||1
5352796|NCT00181610|13168231|P1|NOT COMPLETED|Overall Study||0
5352797|NCT00181610|13168229|P3|COMPLETED|Overall Study||3
5352798|NCT00181610|13168230|P2|COMPLETED|Overall Study||3
5352799|NCT00181610|13168231|P1|COMPLETED|Overall Study||4
5352800|NCT00181610|13168229|P3|STARTED|Overall Study||3
5352801|NCT00181610|13168230|P2|STARTED|Overall Study||4
5352802|NCT00181610|13168231|P1|STARTED|Overall Study||4
5352803|NCT00181363|13168242|P1|NOT COMPLETED|Overall Study||0
5352804|NCT00181363|13168242|P1|COMPLETED|Overall Study||10
5352805|NCT00181363|13168242|P1|STARTED|Overall Study|10|10
5352806|NCT00181285|13168257|P2|NOT COMPLETED|Overall Study||0
5352807|NCT00181285|13168258|P1|NOT COMPLETED|Overall Study||0
5352808|NCT00181285|13168257|P2|COMPLETED|Overall Study||25
5352809|NCT00181285|13168258|P1|COMPLETED|Overall Study||27
5352810|NCT00181285|13168257|P2|STARTED|Overall Study||25
5352811|NCT00181285|13168258|P1|STARTED|Overall Study||27
5352812|NCT00181207|13168268|P2|NOT COMPLETED|Overall Study||0
5352813|NCT00181207|13168269|P1|NOT COMPLETED|Overall Study||0
5352814|NCT00181207|13168268|P2|COMPLETED|Overall Study||26
5352815|NCT00181207|13168269|P1|COMPLETED|Overall Study||24
5352816|NCT00181207|13168268|P2|STARTED|Overall Study||26
5352817|NCT00181207|13168269|P1|STARTED|Overall Study||24
5352818|NCT00181168|13168279|P2|NOT COMPLETED|Overall Study||0
5352819|NCT00181168|13168280|P1|NOT COMPLETED|Overall Study||0
5352820|NCT00181168|13168279|P2|COMPLETED|Overall Study||33
5352821|NCT00181168|13168280|P1|COMPLETED|Overall Study||30
5352822|NCT00181168|13168279|P2|STARTED|Overall Study||33
5352823|NCT00181168|13168280|P1|STARTED|Overall Study||30
5352824|NCT00181155|13168286|P2|NOT COMPLETED|Overall Study||0
5352825|NCT00181155|13168287|P1|NOT COMPLETED|Overall Study||2
5352826|NCT00181155|13168286|P2|COMPLETED|Overall Study||3
5352827|NCT00181155|13168287|P1|COMPLETED|Overall Study||13
5352828|NCT00181155|13168286|P2|STARTED|Overall Study||3
5352829|NCT00181155|13168287|P1|STARTED|Overall Study||15
5352830|NCT00180713|13168297|P2|NOT COMPLETED|Overall Study||3
5352831|NCT00180713|13168298|P1|NOT COMPLETED|Overall Study||5
5352832|NCT00180713|13168297|P2|COMPLETED|Overall Study||16
5352833|NCT00180713|13168298|P1|COMPLETED|Overall Study||18
5352834|NCT00180713|13168297|P2|STARTED|Overall Study||19
5352835|NCT00180713|13168298|P1|STARTED|Overall Study||23
5352836|NCT00180687|13168316|P4|NOT COMPLETED|Overall Study||0
5352837|NCT00180687|13168317|P3|NOT COMPLETED|Overall Study||0
5352838|NCT00180687|13168318|P2|NOT COMPLETED|Overall Study||0
5352839|NCT00180687|13168319|P1|NOT COMPLETED|Overall Study||0
5352840|NCT00180687|13168316|P4|COMPLETED|Overall Study||20
5352841|NCT00180687|13168317|P3|COMPLETED|Overall Study||20
5352842|NCT00180687|13168318|P2|COMPLETED|Overall Study||20
5352843|NCT00180687|13168319|P1|COMPLETED|Overall Study||20
5352844|NCT00180687|13168316|P4|STARTED|Overall Study||20
5352845|NCT00180687|13168317|P3|STARTED|Overall Study||20
5352846|NCT00180687|13168318|P2|STARTED|Overall Study||20
5352847|NCT00180687|13168319|P1|STARTED|Overall Study||20
5352848|NCT00180661|13168343|P2|NOT COMPLETED|Overall Study||0
5352849|NCT00180661|13168344|P1|NOT COMPLETED|Overall Study||0
5352850|NCT00180661|13168343|P2|COMPLETED|Overall Study||20
5352851|NCT00180661|13168344|P1|COMPLETED|Overall Study||19
5352852|NCT00180661|13168343|P2|STARTED|Overall Study||20
5352853|NCT00180661|13168344|P1|STARTED|Overall Study||19
5352854|NCT00180479|13168362|P2|NOT COMPLETED|Overall Study||13
5352855|NCT00180479|13168363|P1|NOT COMPLETED|Overall Study||16
5352856|NCT00180479|13168362|P2|COMPLETED|Overall Study||320
5352857|NCT00180479|13168363|P1|COMPLETED|Overall Study||653
5352858|NCT00180479|13168362|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
5352859|NCT00180479|13168363|P1|STARTED|Overall Study||669
5352860|NCT00180323|13168455|P1|NOT COMPLETED|Overall Study||0
5352861|NCT00180323|13168455|P1|COMPLETED|Overall Study||43
5352862|NCT00180323|13168455|P1|STARTED|Overall Study||43
5352863|NCT00180271|13168464|P2|NOT COMPLETED|Overall Study||0
5352864|NCT00180271|13168465|P1|NOT COMPLETED|Overall Study||0
5352865|NCT00180271|13168464|P2|COMPLETED|Overall Study||731
5352866|NCT00180271|13168465|P1|COMPLETED|Overall Study||1089
5352867|NCT00180271|13168464|P2|STARTED|Overall Study||731
5352868|NCT00180271|13168465|P1|STARTED|Overall Study||1089
5352869|NCT00179998|13168475|P2|NOT COMPLETED|Crossover Period - 6 Months||2
5352870|NCT00179998|13168476|P1|NOT COMPLETED|Crossover Period - 6 Months||0
5352871|NCT00179998|13168475|P2|COMPLETED|Crossover Period - 6 Months||10
5352872|NCT00179998|13168476|P1|COMPLETED|Crossover Period - 6 Months||12
5352873|NCT00179998|13168475|P2|STARTED|Crossover Period - 6 Months||12
5352874|NCT00179998|13168476|P1|STARTED|Crossover Period - 6 Months||12
5352875|NCT00179998|13168475|P2|NOT COMPLETED|Initial Period - 6 Months||0
5352876|NCT00179998|13168476|P1|NOT COMPLETED|Initial Period - 6 Months||0
5352877|NCT00179998|13168475|P2|COMPLETED|Initial Period - 6 Months||12
5352878|NCT00179998|13168476|P1|COMPLETED|Initial Period - 6 Months||12
5352879|NCT00179998|13168475|P2|STARTED|Initial Period - 6 Months||12
5352880|NCT00179998|13168476|P1|STARTED|Initial Period - 6 Months||12
5352881|NCT00179959|13168488|P2|NOT COMPLETED|Overall Study||3
5352882|NCT00179959|13168489|P1|NOT COMPLETED|Overall Study||6
5352883|NCT00179959|13168488|P2|COMPLETED|Overall Study||13
5352884|NCT00179959|13168489|P1|COMPLETED|Overall Study||9
5352885|NCT00179959|13168488|P2|STARTED|Overall Study||16
5352886|NCT00179959|13168489|P1|STARTED|Overall Study||15
5352887|NCT00179673|13168495|P1|NOT COMPLETED|Overall Study||43
5352888|NCT00179673|13168495|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
5352889|NCT00179673|13168495|P1|Received Study Drug|Overall Study||43
5352890|NCT00179673|13168495|P1|STARTED|Overall Study||43
5352891|NCT00179660|13168503|P1|NOT COMPLETED|Overall Study||50
5352892|NCT00179660|13168503|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
5352893|NCT00179660|13168503|P1|Completed 12 Cycles of Treatment|Overall Study||12
5352894|NCT00179660|13168503|P1|Received Study Drug|Overall Study||49
5352895|NCT00179660|13168503|P1|STARTED|Overall Study||50
5352896|NCT00179647|13168512|P1|NOT COMPLETED|Overall Study||1913
5352897|NCT00179647|13168512|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
5352898|NCT00179647|13168512|P1|STARTED|Overall Study||1913
5352899|NCT00179621|13168519|P4|NOT COMPLETED|Open-Label Period||43
5352900|NCT00179621|13168520|P3|NOT COMPLETED|Open-Label Period||28
5352901|NCT00179621|13168521|P2|NOT COMPLETED|Open-Label Period||28
5352902|NCT00179621|13168522|P1|NOT COMPLETED|Open-Label Period||0
5352903|NCT00179621|13168519|P4|COMPLETED|Open-Label Period||13
5352904|NCT00179621|13168520|P3|COMPLETED|Open-Label Period||19
5352905|NCT00179621|13168521|P2|COMPLETED|Open-Label Period||14
5352906|NCT00179621|13168522|P1|COMPLETED|Open-Label Period||0
5352907|NCT00179621|13168519|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
5353001|NCT00178503|13168712|P1|NOT COMPLETED|MPH Trial: Placebo||0
5352908|NCT00179621|13168520|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
5352909|NCT00179621|13168521|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
5352910|NCT00179621|13168522|P1|STARTED|Open-Label Period||0
5352911|NCT00179621|13168519|P4|NOT COMPLETED|Double-Blind Period||0
5352912|NCT00179621|13168520|P3|NOT COMPLETED|Double-Blind Period||30
5352913|NCT00179621|13168521|P2|NOT COMPLETED|Double-Blind Period||46
5352914|NCT00179621|13168522|P1|NOT COMPLETED|Double-Blind Period||64
5352915|NCT00179621|13168519|P4|COMPLETED|Double-Blind Period||0
5352916|NCT00179621|13168520|P3|COMPLETED|Double-Blind Period||39
5352917|NCT00179621|13168521|P2|COMPLETED|Double-Blind Period||23
5352918|NCT00179621|13168522|P1|COMPLETED|Double-Blind Period||3
5352919|NCT00179621|13168519|P4|STARTED|Double-Blind Period||0
5352920|NCT00179621|13168520|P3|STARTED|Double-Blind Period||69
5352921|NCT00179621|13168521|P2|STARTED|Double-Blind Period||69
5352922|NCT00179621|13168522|P1|STARTED|Double-Blind Period||67
5352923|NCT00179517|13168575|P2|NOT COMPLETED|Overall Study||1
5352924|NCT00179517|13168576|P1|NOT COMPLETED|Overall Study||2
5352925|NCT00179517|13168575|P2|COMPLETED|Overall Study||19
5352926|NCT00179517|13168576|P1|COMPLETED|Overall Study||18
5352927|NCT00179517|13168575|P2|STARTED|Overall Study||20
5352928|NCT00179517|13168576|P1|STARTED|Overall Study||20
5352929|NCT00179478|13168600|P2|NOT COMPLETED|Overall Study||15
5352930|NCT00179478|13168601|P1|NOT COMPLETED|Overall Study||13
5352931|NCT00179478|13168600|P2|COMPLETED|Overall Study||59
5352932|NCT00179478|13168601|P1|COMPLETED|Overall Study||68
5352933|NCT00179478|13168600|P2|STARTED|Overall Study||74
5352934|NCT00179478|13168601|P1|STARTED|Overall Study||81
5352935|NCT00179413|13168614|P2|NOT COMPLETED|Overall Study||115
5352936|NCT00179413|13168615|P1|NOT COMPLETED|Overall Study||125
5352937|NCT00179413|13168614|P2|COMPLETED|Overall Study||152
5352938|NCT00179413|13168615|P1|COMPLETED|Overall Study||157
5352939|NCT00179413|13168614|P2|STARTED|Overall Study||267
5352940|NCT00179413|13168615|P1|STARTED|Overall Study||282
5352941|NCT00179309|13168627|P2|NOT COMPLETED|Crossover||0
5352942|NCT00179309|13168628|P1|NOT COMPLETED|Crossover||0
5352943|NCT00179309|13168627|P2|COMPLETED|Crossover||3
5352944|NCT00179309|13168628|P1|COMPLETED|Crossover||0
5352945|NCT00179309|13168627|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
5352946|NCT00179309|13168628|P1|STARTED|Crossover||0
5352947|NCT00179309|13168627|P2|NOT COMPLETED|Treatment||5
5352948|NCT00179309|13168628|P1|NOT COMPLETED|Treatment||4
5352949|NCT00179309|13168627|P2|COMPLETED|Treatment||18
5352950|NCT00179309|13168628|P1|COMPLETED|Treatment||21
5352951|NCT00179309|13168627|P2|STARTED|Treatment||23
5352952|NCT00179309|13168628|P1|STARTED|Treatment||25
5352953|NCT00179127|13168638|P2|NOT COMPLETED|Overall Study||0
5352954|NCT00179127|13168639|P1|NOT COMPLETED|Overall Study||0
5352955|NCT00179127|13168638|P2|COMPLETED|Overall Study||0
5352956|NCT00179127|13168639|P1|COMPLETED|Overall Study||0
5352957|NCT00179127|13168638|P2|STARTED|Overall Study||0
5352958|NCT00179127|13168639|P1|STARTED|Overall Study||0
5352959|NCT00179010|13168651|P2|NOT COMPLETED|Overall Study||2
5352960|NCT00179010|13168652|P1|NOT COMPLETED|Overall Study||1
5352961|NCT00179010|13168651|P2|COMPLETED|Overall Study||5
5352962|NCT00179010|13168652|P1|COMPLETED|Overall Study||5
5352963|NCT00179010|13168651|P2|STARTED|Overall Study||7
5352964|NCT00179010|13168652|P1|STARTED|Overall Study||6
5352965|NCT00178919|13168662|P2|NOT COMPLETED|Overall Study||25
5352966|NCT00178919|13168663|P1|NOT COMPLETED|Overall Study||0
5352967|NCT00178919|13168662|P2|COMPLETED|Overall Study||68
5352968|NCT00178919|13168663|P1|COMPLETED|Overall Study||19
5352969|NCT00178919|13168662|P2|STARTED|Overall Study||93
5352970|NCT00178919|13168663|P1|STARTED|Overall Study||19
5352971|NCT00178841|13168671|P1|NOT COMPLETED|Overall Study||0
5352972|NCT00178841|13168671|P1|COMPLETED|Overall Study||4
5352973|NCT00178841|13168671|P1|STARTED|Overall Study||4
5352974|NCT00178711|13168679|P2|NOT COMPLETED|Overall Study||0
5352975|NCT00178711|13168680|P1|NOT COMPLETED|Overall Study||0
5352976|NCT00178711|13168679|P2|COMPLETED|Overall Study||45
5352977|NCT00178711|13168680|P1|COMPLETED|Overall Study||52
5352978|NCT00178711|13168679|P2|STARTED|Overall Study||45
5352979|NCT00178711|13168680|P1|STARTED|Overall Study||52
5352980|NCT00178685|13168691|P3|NOT COMPLETED|Overall Study||196
5352981|NCT00178685|13168692|P2|NOT COMPLETED|Overall Study||204
5352982|NCT00178685|13168693|P1|NOT COMPLETED|Overall Study||111
5352983|NCT00178685|13168691|P3|COMPLETED|Overall Study||128
5352984|NCT00178685|13168692|P2|COMPLETED|Overall Study||120
5352985|NCT00178685|13168693|P1|COMPLETED|Overall Study||61
5352986|NCT00178685|13168691|P3|STARTED|Overall Study||324
5352987|NCT00178685|13168692|P2|STARTED|Overall Study||324
5352988|NCT00178685|13168693|P1|STARTED|Overall Study||172
5352989|NCT00178633|13168704|P1|NOT COMPLETED|Overall Study||6
5352990|NCT00178633|13168704|P1|COMPLETED|Overall Study||37
5352991|NCT00178633|13168704|P1|STARTED|Overall Study||43
5352992|NCT00178503|13168712|P1|NOT COMPLETED|MPH Trial: High Dose||0
5352993|NCT00178503|13168712|P1|COMPLETED|MPH Trial: High Dose||24
5352994|NCT00178503|13168712|P1|STARTED|MPH Trial: High Dose||24
5352995|NCT00178503|13168712|P1|NOT COMPLETED|MPH Trial: Med Dose||0
5352996|NCT00178503|13168712|P1|COMPLETED|MPH Trial: Med Dose||24
5352997|NCT00178503|13168712|P1|STARTED|MPH Trial: Med Dose||24
5352998|NCT00178503|13168712|P1|NOT COMPLETED|MPH Trial: Low Dose||0
5352999|NCT00178503|13168712|P1|COMPLETED|MPH Trial: Low Dose||24
5353000|NCT00178503|13168712|P1|STARTED|MPH Trial: Low Dose||24
5353002|NCT00178503|13168712|P1|COMPLETED|MPH Trial: Placebo||24
5353003|NCT00178503|13168712|P1|STARTED|MPH Trial: Placebo||24
5353004|NCT00178477|13168730|P1|NOT COMPLETED|Overall Study||5
5353005|NCT00178477|13168730|P1|COMPLETED|Overall Study||5
5353006|NCT00178477|13168730|P1|STARTED|Overall Study||10
5353007|NCT00178464|13168734|P1|NOT COMPLETED|Overall Study||2
5353008|NCT00178464|13168734|P1|COMPLETED|Overall Study||9
5353009|NCT00178464|13168734|P1|STARTED|Overall Study||11
5353010|NCT00178399|13168739|P1|NOT COMPLETED|Overall Study||13
5353011|NCT00178399|13168739|P1|COMPLETED|Overall Study||115
5353012|NCT00178399|13168739|P1|STARTED|Overall Study||128
5353013|NCT00178256|13168746|P4|NOT COMPLETED|Overall Study||2
5353014|NCT00178256|13168747|P3|NOT COMPLETED|Overall Study||0
5353015|NCT00178256|13168748|P2|NOT COMPLETED|Overall Study||1
5353016|NCT00178256|13168749|P1|NOT COMPLETED|Overall Study||4
5353017|NCT00178256|13168746|P4|COMPLETED|Overall Study||16
5353018|NCT00178256|13168747|P3|COMPLETED|Overall Study||6
5353019|NCT00178256|13168748|P2|COMPLETED|Overall Study||6
5353020|NCT00178256|13168749|P1|COMPLETED|Overall Study||6
5353021|NCT00178256|13168746|P4|STARTED|Overall Study||18
5353022|NCT00178256|13168747|P3|STARTED|Overall Study||6
5353023|NCT00178256|13168748|P2|STARTED|Overall Study||7
5353024|NCT00178256|13168749|P1|STARTED|Overall Study||10
5353025|NCT00178191|13168759|P3|NOT COMPLETED|Overall Study||0
5353026|NCT00178191|13168760|P2|NOT COMPLETED|Overall Study||0
5353027|NCT00178191|13168761|P1|NOT COMPLETED|Overall Study||0
5353028|NCT00178191|13168759|P3|COMPLETED|Overall Study||7
5353029|NCT00178191|13168760|P2|COMPLETED|Overall Study||10
5353030|NCT00178191|13168761|P1|COMPLETED|Overall Study||11
5353031|NCT00178191|13168759|P3|STARTED|Overall Study||7
5353032|NCT00178191|13168760|P2|STARTED|Overall Study||10
5353033|NCT00178191|13168761|P1|STARTED|Overall Study||11
5353034|NCT00178178|13168773|P4|NOT COMPLETED|Overall Study||0
5353035|NCT00178178|13168774|P3|NOT COMPLETED|Overall Study||0
5353036|NCT00178178|13168775|P2|NOT COMPLETED|Overall Study||0
5353037|NCT00178178|13168776|P1|NOT COMPLETED|Overall Study||0
5353038|NCT00178178|13168773|P4|COMPLETED|Overall Study||24
5353039|NCT00178178|13168774|P3|COMPLETED|Overall Study||24
5353040|NCT00178178|13168775|P2|COMPLETED|Overall Study||24
5353041|NCT00178178|13168776|P1|COMPLETED|Overall Study||24
5353042|NCT00178178|13168773|P4|STARTED|Overall Study||24
5353043|NCT00178178|13168774|P3|STARTED|Overall Study||24
5353044|NCT00178178|13168775|P2|STARTED|Overall Study||24
5353045|NCT00178178|13168776|P1|STARTED|Overall Study||24
5353046|NCT00178126|13168788|P2|NOT COMPLETED|Overall Study||27
5353047|NCT00178126|13168789|P1|NOT COMPLETED|Overall Study||25
5353048|NCT00178126|13168788|P2|COMPLETED|Overall Study||86
5353049|NCT00178126|13168789|P1|COMPLETED|Overall Study||94
5353050|NCT00178126|13168788|P2|STARTED|Overall Study||113
5353051|NCT00178126|13168789|P1|STARTED|Overall Study||119
5353052|NCT00177970|13168797|P2|NOT COMPLETED|Overall Study||0
5353053|NCT00177970|13168798|P1|NOT COMPLETED|Overall Study||0
5353054|NCT00177970|13168797|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
5353055|NCT00177970|13168798|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
5353056|NCT00177970|13168797|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
5353057|NCT00177970|13168798|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
5353058|NCT00177866|13168820|P2|NOT COMPLETED|Overall Study||0
5353059|NCT00177866|13168821|P1|NOT COMPLETED|Overall Study||0
5353060|NCT00177866|13168820|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
5353061|NCT00177866|13168821|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
5353062|NCT00177866|13168820|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
5353063|NCT00177866|13168821|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
5353064|NCT00177671|13168831|P2|NOT COMPLETED|Overall Study||14
5353065|NCT00177671|13168832|P1|NOT COMPLETED|Overall Study||25
5353066|NCT00177671|13168831|P2|COMPLETED|Overall Study||49
5353067|NCT00177671|13168832|P1|COMPLETED|Overall Study||42
5353068|NCT00177671|13168831|P2|Month 24|Overall Study||49
5353069|NCT00177671|13168832|P1|Month 24|Overall Study||42
5353070|NCT00177671|13168831|P2|Month 12|Overall Study||57
5353071|NCT00177671|13168832|P1|Month 12|Overall Study||45
5353072|NCT00177671|13168831|P2|STARTED|Overall Study||63
5353073|NCT00177671|13168832|P1|STARTED|Overall Study||67
5353074|NCT00177307|13168844|P1|NOT COMPLETED|Overall Study||1
5353075|NCT00177307|13168844|P1|COMPLETED|Overall Study||39
5353076|NCT00177307|13168844|P1|STARTED|Overall Study||40
5353077|NCT00177294|13168853|P2|NOT COMPLETED|Overall Study||5
5353078|NCT00177294|13168854|P1|NOT COMPLETED|Overall Study||7
5353079|NCT00177294|13168853|P2|COMPLETED|Overall Study||59
5353080|NCT00177294|13168854|P1|COMPLETED|Overall Study||53
5353081|NCT00177294|13168853|P2|STARTED|Overall Study||64
5353082|NCT00177294|13168854|P1|STARTED|Overall Study||60
5353083|NCT00177255|13168860|P1|NOT COMPLETED|Overall Study||0
5353084|NCT00177255|13168860|P1|COMPLETED|Overall Study||39
5353085|NCT00177255|13168860|P1|STARTED|Overall Study||39
5353086|NCT00177216|13168868|P3|NOT COMPLETED|Overall Study||1
5353087|NCT00177216|13168869|P2|NOT COMPLETED|Overall Study||3
5353088|NCT00177216|13168870|P1|NOT COMPLETED|Overall Study||6
5353089|NCT00177216|13168868|P3|COMPLETED|Overall Study||19
5353090|NCT00177216|13168869|P2|COMPLETED|Overall Study||20
5353091|NCT00177216|13168870|P1|COMPLETED|Overall Study||20
5353092|NCT00177216|13168868|P3|STARTED|Overall Study||20
5353093|NCT00177216|13168869|P2|STARTED|Overall Study||23
5353094|NCT00177216|13168870|P1|STARTED|Overall Study||26
5353095|NCT00177164|13168886|P2|NOT COMPLETED|Overall Study||16
5353096|NCT00177164|13168887|P1|NOT COMPLETED|Overall Study||9
5353097|NCT00177164|13168886|P2|COMPLETED|Overall Study||9
5353098|NCT00177164|13168887|P1|COMPLETED|Overall Study||14
5353099|NCT00177164|13168886|P2|STARTED|Overall Study||25
5353100|NCT00177164|13168887|P1|STARTED|Overall Study||23
5353101|NCT00176917|13168899|P1|NOT COMPLETED|Overall Study||0
5353102|NCT00176917|13168899|P1|COMPLETED|Overall Study||41
5353103|NCT00176917|13168899|P1|STARTED|Overall Study||41
5353104|NCT00176904|13168906|P1|NOT COMPLETED|Overall Study||0
5353105|NCT00176904|13168906|P1|COMPLETED|Overall Study||135
5353106|NCT00176904|13168906|P1|STARTED|Overall Study||135
5353107|NCT00176891|13168914|P1|NOT COMPLETED|Overall Study||3
5353108|NCT00176891|13168914|P1|COMPLETED|Overall Study||22
5353109|NCT00176891|13168914|P1|STARTED|Overall Study||25
5353110|NCT00176878|13168925|P1|NOT COMPLETED|Overall Study||0
5353111|NCT00176878|13168925|P1|COMPLETED|Overall Study||10
5353112|NCT00176878|13168925|P1|STARTED|Overall Study||10
5353113|NCT00176865|13168937|P3|NOT COMPLETED|Overall Study||0
5353114|NCT00176865|13168938|P2|NOT COMPLETED|Overall Study||0
5353115|NCT00176865|13168939|P1|NOT COMPLETED|Overall Study||0
5353116|NCT00176865|13168937|P3|COMPLETED|Overall Study||6
5353117|NCT00176865|13168938|P2|COMPLETED|Overall Study||10
5353118|NCT00176865|13168939|P1|COMPLETED|Overall Study||3
5353119|NCT00176865|13168937|P3|STARTED|Overall Study||6
5353120|NCT00176865|13168938|P2|STARTED|Overall Study||10
5353121|NCT00176865|13168939|P1|STARTED|Overall Study||3
5353122|NCT00176852|13168977|P3|NOT COMPLETED|Overall Study||0
5353123|NCT00176852|13168978|P2|NOT COMPLETED|Overall Study||0
5353124|NCT00176852|13168979|P1|NOT COMPLETED|Overall Study||0
5353125|NCT00176852|13168977|P3|COMPLETED|Overall Study||14
5353126|NCT00176852|13168978|P2|COMPLETED|Overall Study||5
5353127|NCT00176852|13168979|P1|COMPLETED|Overall Study||3
5353128|NCT00176852|13168977|P3|STARTED|Overall Study||14
5353129|NCT00176852|13168978|P2|STARTED|Overall Study||5
5353130|NCT00176852|13168979|P1|STARTED|Overall Study||3
5353131|NCT00176839|13169035|P1|NOT COMPLETED|Overall Study||0
5353132|NCT00176839|13169035|P1|COMPLETED|Overall Study||11
5353133|NCT00176839|13169035|P1|STARTED|Overall Study||11
5353134|NCT00176826|13169044|P1|NOT COMPLETED|Overall Study||0
5353135|NCT00176826|13169044|P1|COMPLETED|Overall Study||22
5353136|NCT00176826|13169044|P1|STARTED|Overall Study||22
5353137|NCT00176800|13169054|P1|NOT COMPLETED|Overall Study||0
5353138|NCT00176800|13169054|P1|COMPLETED|Overall Study||69
5353139|NCT00176800|13169054|P1|STARTED|Overall Study||69
5353140|NCT00176644|13169060|P1|NOT COMPLETED|Overall Study||1
5353141|NCT00176644|13169060|P1|COMPLETED|Overall Study||22
5353142|NCT00176644|13169060|P1|STARTED|Overall Study||23
5353143|NCT00176631|13169068|P1|NOT COMPLETED|Overall Study||0
5353144|NCT00176631|13169068|P1|COMPLETED|Overall Study||10
5353145|NCT00176631|13169068|P1|STARTED|Overall Study||10
5353146|NCT00176605|13169073|P1|NOT COMPLETED|Overall Study||2
5353147|NCT00176605|13169073|P1|COMPLETED|Overall Study||13
5353148|NCT00176605|13169073|P1|STARTED|Overall Study||15
5353149|NCT00176501|13169078|P1|NOT COMPLETED|Overall Study||0
5353150|NCT00176501|13169078|P1|COMPLETED|Overall Study||3
5353151|NCT00176501|13169078|P1|STARTED|Overall Study||3
5353152|NCT00176488|13169084|P1|NOT COMPLETED|Overall Study||1
5353153|NCT00176488|13169084|P1|COMPLETED|Overall Study||30
5353154|NCT00176488|13169084|P1|STARTED|Overall Study||31
5353155|NCT00176462|13169092|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
5353156|NCT00176462|13169093|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
5353157|NCT00176462|13169092|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
5353158|NCT00176462|13169093|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
5353159|NCT00176462|13169092|P2|STARTED|Continuation -up to 30mos Post Remission||26
5353160|NCT00176462|13169093|P1|STARTED|Continuation -up to 30mos Post Remission||19
5353161|NCT00176462|13169092|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
5353162|NCT00176462|13169093|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
5353163|NCT00176462|13169092|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
5353164|NCT00176462|13169093|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
5353165|NCT00176462|13169092|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
5353166|NCT00176462|13169093|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
5353167|NCT00176462|13169092|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
5353168|NCT00176462|13169093|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
5353169|NCT00176462|13169092|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
5353170|NCT00176462|13169093|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
5353171|NCT00176462|13169092|P2|STARTED|Delayed Intensification (8 Weeks)||29
5353172|NCT00176462|13169093|P1|STARTED|Delayed Intensification (8 Weeks)||20
5353173|NCT00176462|13169092|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
5353174|NCT00176462|13169093|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
5353175|NCT00176462|13169092|P2|COMPLETED|Consolidation (12 Weeks)||29
5353176|NCT00176462|13169093|P1|COMPLETED|Consolidation (12 Weeks)||20
5353177|NCT00176462|13169092|P2|STARTED|Consolidation (12 Weeks)||34
5353178|NCT00176462|13169093|P1|STARTED|Consolidation (12 Weeks)||20
5353179|NCT00176462|13169092|P2|NOT COMPLETED|Induction (4 Weeks)||5
5353180|NCT00176462|13169093|P1|NOT COMPLETED|Induction (4 Weeks)||1
5353181|NCT00176462|13169092|P2|COMPLETED|Induction (4 Weeks)||34
5353182|NCT00176462|13169093|P1|COMPLETED|Induction (4 Weeks)||20
5353183|NCT00176462|13169092|P2|STARTED|Induction (4 Weeks)||39
5353184|NCT00176462|13169093|P1|STARTED|Induction (4 Weeks)||21
5353185|NCT00176436|13169102|P2|NOT COMPLETED|Overall Study||5
5353186|NCT00176436|13169103|P1|NOT COMPLETED|Overall Study||6
5353187|NCT00176436|13169102|P2|COMPLETED|Overall Study||12
5353188|NCT00176436|13169103|P1|COMPLETED|Overall Study||14
5353189|NCT00176436|13169102|P2|STARTED|Overall Study||17
5353190|NCT00176436|13169103|P1|STARTED|Overall Study||20
5353191|NCT00176306|13169109|P1|NOT COMPLETED|Overall Study||0
5353192|NCT00176306|13169109|P1|COMPLETED|Overall Study||15
5353193|NCT00176306|13169109|P1|STARTED|Overall Study||15
5353194|NCT00176254|13169113|P1|NOT COMPLETED|Overall Study||1
5353195|NCT00176254|13169113|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
5353196|NCT00176254|13169113|P1|STARTED|Overall Study||40
5353197|NCT00176228|13169121|P1|NOT COMPLETED|Overall Study||2
5353198|NCT00176228|13169121|P1|COMPLETED|Overall Study|Study ended|46
5353199|NCT00176228|13169121|P1|STARTED|Overall Study|When study began|48
5353200|NCT00176202|13169128|P2|NOT COMPLETED|Overall Study||16
5353201|NCT00176202|13169129|P1|NOT COMPLETED|Overall Study||5
5353202|NCT00176202|13169128|P2|COMPLETED|Overall Study||17
5353203|NCT00176202|13169129|P1|COMPLETED|Overall Study||27
5353204|NCT00176202|13169128|P2|STARTED|Overall Study||33
5353205|NCT00176202|13169129|P1|STARTED|Overall Study||32
5353206|NCT00175916|13169141|P1|NOT COMPLETED|Overall Study||619
5353207|NCT00175916|13169141|P1|COMPLETED|Overall Study||234
5353208|NCT00175916|13169141|P1|STARTED|Overall Study||853
5353209|NCT00175877|13169150|P1|NOT COMPLETED|Overall Study||349
5353210|NCT00175877|13169150|P1|COMPLETED|Overall Study||497
5353211|NCT00175877|13169150|P1|STARTED|Overall Study||846
5353212|NCT00175825|13169185|P4|NOT COMPLETED|Overall Study||1
5353213|NCT00175825|13169186|P3|NOT COMPLETED|Overall Study||1
5353214|NCT00175825|13169187|P2|NOT COMPLETED|Overall Study||4
5353215|NCT00175825|13169188|P1|NOT COMPLETED|Overall Study||5
5353216|NCT00175825|13169185|P4|COMPLETED|Overall Study||51
5353217|NCT00175825|13169186|P3|COMPLETED|Overall Study||51
5353218|NCT00175825|13169187|P2|COMPLETED|Overall Study||46
5353219|NCT00175825|13169188|P1|COMPLETED|Overall Study||49
5353220|NCT00175825|13169185|P4|STARTED|Overall Study||52
5353221|NCT00175825|13169186|P3|STARTED|Overall Study||52
5353222|NCT00175825|13169187|P2|STARTED|Overall Study||50
5353223|NCT00175825|13169188|P1|STARTED|Overall Study||54
5353224|NCT00175019|13169241|P3|NOT COMPLETED|Overall Study||57
5353225|NCT00175019|13169242|P2|NOT COMPLETED|Overall Study||171
5353226|NCT00175019|13169243|P1|NOT COMPLETED|Overall Study||194
5353227|NCT00175019|13169241|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
5353228|NCT00175019|13169242|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
5353229|NCT00175019|13169243|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
5353230|NCT00175019|13169241|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
5353231|NCT00175019|13169242|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
5353232|NCT00175019|13169243|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
5353233|NCT00175006|13169287|P1|NOT COMPLETED|Overall Study||0
5353234|NCT00175006|13169287|P1|COMPLETED|Overall Study||13
5353235|NCT00175006|13169287|P1|STARTED|Overall Study||13
5353236|NCT00174967|13169296|P4|NOT COMPLETED|Overall Study||2
5353237|NCT00174967|13169297|P3|NOT COMPLETED|Overall Study||2
5353238|NCT00174967|13169298|P2|NOT COMPLETED|Overall Study||3
5353239|NCT00174967|13169299|P1|NOT COMPLETED|Overall Study||1
5353240|NCT00174967|13169296|P4|COMPLETED|Overall Study||36
5353241|NCT00174967|13169297|P3|COMPLETED|Overall Study||36
5353242|NCT00174967|13169298|P2|COMPLETED|Overall Study||37
5353243|NCT00174967|13169299|P1|COMPLETED|Overall Study||36
5353244|NCT00174967|13169296|P4|STARTED|Overall Study||38
5353245|NCT00174967|13169297|P3|STARTED|Overall Study||38
5353246|NCT00174967|13169298|P2|STARTED|Overall Study||40
5353247|NCT00174967|13169299|P1|STARTED|Overall Study||37
5353248|NCT00174954|13169345|P1|NOT COMPLETED|Overall Study||4
5353249|NCT00174954|13169345|P1|COMPLETED|Overall Study||28
5353250|NCT00174954|13169345|P1|STARTED|Overall Study||32
5353251|NCT00174941|13169353|P4|NOT COMPLETED|Overall Study||58
5353252|NCT00174941|13169354|P3|NOT COMPLETED|Overall Study||18
5353253|NCT00174941|13169355|P2|NOT COMPLETED|Overall Study||38
5353254|NCT00174941|13169356|P1|NOT COMPLETED|Overall Study||2
5353255|NCT00174941|13169353|P4|COMPLETED|Overall Study||58
5353256|NCT00174941|13169354|P3|COMPLETED|Overall Study||11
5353257|NCT00174941|13169355|P2|COMPLETED|Overall Study||41
5353258|NCT00174941|13169356|P1|COMPLETED|Overall Study||6
5353259|NCT00174941|13169353|P4|STARTED|Overall Study||116
5353260|NCT00174941|13169354|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
5353261|NCT00174941|13169355|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
5353262|NCT00174941|13169356|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
5353263|NCT00174915|13169431|P5|NOT COMPLETED|Overall Study||33
5353264|NCT00174915|13169432|P4|NOT COMPLETED|Overall Study||57
5353265|NCT00174915|13169433|P3|NOT COMPLETED|Overall Study||48
5353266|NCT00174915|13169434|P2|NOT COMPLETED|Overall Study||69
5353267|NCT00174915|13169435|P1|NOT COMPLETED|Overall Study||93
5353268|NCT00174915|13169431|P5|COMPLETED|Overall Study||101
5353269|NCT00174915|13169432|P4|COMPLETED|Overall Study||211
5353270|NCT00174915|13169433|P3|COMPLETED|Overall Study||86
5353271|NCT00174915|13169434|P2|COMPLETED|Overall Study||200
5353272|NCT00174915|13169435|P1|COMPLETED|Overall Study||174
5353273|NCT00174915|13169431|P5|STARTED|Overall Study||134
5353274|NCT00174915|13169432|P4|STARTED|Overall Study||268
5353275|NCT00174915|13169433|P3|STARTED|Overall Study||134
5353276|NCT00174915|13169434|P2|STARTED|Overall Study||269
5353277|NCT00174915|13169435|P1|STARTED|Overall Study||267
5353278|NCT00174785|13169494|P2|NOT COMPLETED|Overall Study||716
5353279|NCT00174785|13169495|P1|NOT COMPLETED|Overall Study||696
5353280|NCT00174785|13169494|P2|COMPLETED|Overall Study|completed study drug|1611
5353281|NCT00174785|13169495|P1|COMPLETED|Overall Study|completed study drug|1605
5353282|NCT00174785|13169494|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
5353283|NCT00174785|13169495|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
5353284|NCT00174460|13169511|P2|NOT COMPLETED|Overall Study||1
5353285|NCT00174460|13169512|P1|NOT COMPLETED|Overall Study||0
5353286|NCT00174460|13169511|P2|COMPLETED|Overall Study||14
5353287|NCT00174460|13169512|P1|COMPLETED|Overall Study||18
5353288|NCT00174460|13169511|P2|Received Study Treatment|Overall Study||14
5353289|NCT00174460|13169512|P1|Received Study Treatment|Overall Study||18
5353290|NCT00174460|13169511|P2|STARTED|Overall Study||15
5353291|NCT00174460|13169512|P1|STARTED|Overall Study||18
5353292|NCT00174447|13169558|P1|NOT COMPLETED|Overall Study||38
5353293|NCT00174447|13169558|P1|COMPLETED|Overall Study||5
5353294|NCT00174447|13169558|P1|STARTED|Overall Study||43
5353295|NCT00174382|13169567|P1|NOT COMPLETED|Overall Study||33
5353296|NCT00174382|13169567|P1|COMPLETED|Overall Study||116
5353297|NCT00174382|13169567|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
5353298|NCT00174291|13169586|P2|NOT COMPLETED|Overall Study||6
5353299|NCT00174291|13169587|P1|NOT COMPLETED|Overall Study||5
5353300|NCT00174291|13169586|P2|COMPLETED|Overall Study||4
5353301|NCT00174291|13169587|P1|COMPLETED|Overall Study||6
5353302|NCT00174291|13169586|P2|STARTED|Overall Study||10
5353303|NCT00174291|13169587|P1|STARTED|Overall Study||11
5353304|NCT00174265|13169617|P2|NOT COMPLETED|Overall Study||21
5353305|NCT00174265|13169618|P1|NOT COMPLETED|Overall Study||29
5353306|NCT00174265|13169617|P2|COMPLETED|Overall Study||89
5353307|NCT00174265|13169618|P1|COMPLETED|Overall Study||57
5353308|NCT00174265|13169617|P2|STARTED|Overall Study||110
5353309|NCT00174265|13169618|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
5353310|NCT00174252|13169626|P1|NOT COMPLETED|Overall Study||2
5353311|NCT00174252|13169626|P1|COMPLETED|Overall Study||55
5353312|NCT00174252|13169626|P1|STARTED|Overall Study||57
5353313|NCT00174187|13169661|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
5353314|NCT00174187|13169662|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
5353315|NCT00174187|13169663|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
5353316|NCT00174187|13169661|P3|COMPLETED|Period 2 (After 3 Years)||13
5353317|NCT00174187|13169662|P2|COMPLETED|Period 2 (After 3 Years)||0
5353318|NCT00174187|13169663|P1|COMPLETED|Period 2 (After 3 Years)||0
5353319|NCT00174187|13169661|P3|STARTED|Period 2 (After 3 Years)||21
5353320|NCT00174187|13169662|P2|STARTED|Period 2 (After 3 Years)||0
5353321|NCT00174187|13169663|P1|STARTED|Period 2 (After 3 Years)||0
5353322|NCT00174187|13169661|P3|NOT COMPLETED|Between Period 1 and Period 2||5
5353323|NCT00174187|13169662|P2|NOT COMPLETED|Between Period 1 and Period 2||0
5353324|NCT00174187|13169663|P1|NOT COMPLETED|Between Period 1 and Period 2||0
5353325|NCT00174187|13169661|P3|COMPLETED|Between Period 1 and Period 2||21
5353326|NCT00174187|13169662|P2|COMPLETED|Between Period 1 and Period 2||0
5353327|NCT00174187|13169663|P1|COMPLETED|Between Period 1 and Period 2||0
5353328|NCT00174187|13169661|P3|Consented|Between Period 1 and Period 2||24
5353329|NCT00174187|13169662|P2|Consented|Between Period 1 and Period 2||0
5353330|NCT00174187|13169663|P1|Consented|Between Period 1 and Period 2||0
5353331|NCT00174187|13169661|P3|STARTED|Between Period 1 and Period 2||26
5353332|NCT00174187|13169662|P2|STARTED|Between Period 1 and Period 2||0
5353333|NCT00174187|13169663|P1|STARTED|Between Period 1 and Period 2||0
5353334|NCT00174187|13169661|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
5353335|NCT00174187|13169662|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
5353336|NCT00174187|13169663|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
5353337|NCT00174187|13169661|P3|COMPLETED|Period 1 (up to 3 Years)||0
5353338|NCT00174187|13169662|P2|COMPLETED|Period 1 (up to 3 Years)||11
5353339|NCT00174187|13169663|P1|COMPLETED|Period 1 (up to 3 Years)||15
5353340|NCT00174187|13169661|P3|STARTED|Period 1 (up to 3 Years)||0
5353341|NCT00174187|13169662|P2|STARTED|Period 1 (up to 3 Years)||15
5353342|NCT00174187|13169663|P1|STARTED|Period 1 (up to 3 Years)||15
5353343|NCT00172185|13169728|P4|NOT COMPLETED|Overall Study||4
5353344|NCT00172185|13169729|P3|NOT COMPLETED|Overall Study||5
5353345|NCT00172185|13169730|P2|NOT COMPLETED|Overall Study||2
5353346|NCT00172185|13169731|P1|NOT COMPLETED|Overall Study||0
5353347|NCT00172185|13169728|P4|COMPLETED|Overall Study||23
5353348|NCT00172185|13169729|P3|COMPLETED|Overall Study||20
5353349|NCT00172185|13169730|P2|COMPLETED|Overall Study||5
5353350|NCT00172185|13169731|P1|COMPLETED|Overall Study||6
5353351|NCT00172185|13169728|P4|STARTED|Overall Study||27
5353352|NCT00172185|13169729|P3|STARTED|Overall Study||25
5353353|NCT00172185|13169730|P2|STARTED|Overall Study||7
5353354|NCT00172185|13169731|P1|STARTED|Overall Study||6
5353355|NCT00172042|13169747|P2|NOT COMPLETED|Overall Study||125
5353356|NCT00172042|13169748|P1|NOT COMPLETED|Overall Study||158
5353357|NCT00172042|13169747|P2|COMPLETED|Overall Study||86
5353358|NCT00172042|13169748|P1|COMPLETED|Overall Study||68
5353359|NCT00172042|13169747|P2|STARTED|Overall Study||211
5353360|NCT00172042|13169748|P1|STARTED|Overall Study||226
5353361|NCT00171925|13169770|P2|NOT COMPLETED|Overall Study||31
5353362|NCT00171925|13169771|P1|NOT COMPLETED|Overall Study||30
5353363|NCT00171925|13169770|P2|COMPLETED|Overall Study||40
5353364|NCT00171925|13169771|P1|COMPLETED|Overall Study||42
5353365|NCT00171925|13169770|P2|STARTED|Overall Study||71
5353366|NCT00171925|13169771|P1|STARTED|Overall Study||72
5353367|NCT00171873|13169783|P2|NOT COMPLETED|Overall Study||3
5353368|NCT00171873|13169784|P1|NOT COMPLETED|Overall Study||9
5353369|NCT00171873|13169783|P2|COMPLETED|Overall Study||40
5353370|NCT00171873|13169784|P1|COMPLETED|Overall Study||33
5353371|NCT00171873|13169783|P2|STARTED|Overall Study||43
5353372|NCT00171873|13169784|P1|STARTED|Overall Study||42
5353373|NCT00171834|13169797|P7|NOT COMPLETED|Overall Study||4
5353374|NCT00171834|13169798|P6|NOT COMPLETED|Overall Study||35
5353375|NCT00171834|13169799|P5|NOT COMPLETED|Overall Study||8
5353376|NCT00171834|13169800|P4|NOT COMPLETED|Overall Study||12
5353377|NCT00171834|13169801|P3|NOT COMPLETED|Overall Study||12
5353378|NCT00171834|13169802|P2|NOT COMPLETED|Overall Study||12
5353379|NCT00171834|13169803|P1|NOT COMPLETED|Overall Study||6
5353380|NCT00171834|13169797|P7|COMPLETED|Overall Study||0
5353381|NCT00171834|13169798|P6|COMPLETED|Overall Study||0
5353382|NCT00171834|13169799|P5|COMPLETED|Overall Study||0
5353383|NCT00171834|13169800|P4|COMPLETED|Overall Study||0
5353384|NCT00171834|13169801|P3|COMPLETED|Overall Study||0
5353385|NCT00171834|13169802|P2|COMPLETED|Overall Study||0
5353386|NCT00171834|13169803|P1|COMPLETED|Overall Study||0
5353387|NCT00171834|13169797|P7|Completed 6 Cycles of Treatment|Overall Study||0
5353388|NCT00171834|13169798|P6|Completed 6 Cycles of Treatment|Overall Study||1
5353389|NCT00171834|13169799|P5|Completed 6 Cycles of Treatment|Overall Study||2
5353390|NCT00171834|13169800|P4|Completed 6 Cycles of Treatment|Overall Study||0
5353391|NCT00171834|13169801|P3|Completed 6 Cycles of Treatment|Overall Study||1
5353392|NCT00171834|13169802|P2|Completed 6 Cycles of Treatment|Overall Study||0
5353393|NCT00171834|13169803|P1|Completed 6 Cycles of Treatment|Overall Study||0
5353394|NCT00171834|13169797|P7|STARTED|Overall Study||4
5353395|NCT00171834|13169798|P6|STARTED|Overall Study||35
5353396|NCT00171834|13169799|P5|STARTED|Overall Study||8
5353397|NCT00171834|13169800|P4|STARTED|Overall Study||12
5353398|NCT00171834|13169801|P3|STARTED|Overall Study||12
5353399|NCT00171834|13169802|P2|STARTED|Overall Study||12
5353400|NCT00171834|13169803|P1|STARTED|Overall Study||6
5353401|NCT00171704|13169843|P2|NOT COMPLETED|Overall Study||49
5353402|NCT00171704|13169844|P1|NOT COMPLETED|Overall Study||44
5353403|NCT00171704|13169843|P2|COMPLETED|Overall Study||81
5353404|NCT00171704|13169844|P1|COMPLETED|Overall Study||89
5353405|NCT00171704|13169843|P2|STARTED|Overall Study||130
5353406|NCT00171704|13169844|P1|STARTED|Overall Study||133
5353407|NCT00171340|13169866|P2|NOT COMPLETED|Overall Study||135
5353408|NCT00171340|13169867|P1|NOT COMPLETED|Overall Study||124
5353409|NCT00171340|13169866|P2|COMPLETED|Overall Study||398
5353410|NCT00171340|13169867|P1|COMPLETED|Overall Study||408
5353411|NCT00171340|13169866|P2|STARTED|Overall Study||533
5353412|NCT00171340|13169867|P1|STARTED|Overall Study||532
5353413|NCT00171314|13169883|P2|NOT COMPLETED|Overall Study||78
5353414|NCT00171314|13169884|P1|NOT COMPLETED|Overall Study||91
5353415|NCT00171314|13169883|P2|COMPLETED|Overall Study||186
5353416|NCT00171314|13169884|P1|COMPLETED|Overall Study||172
5353417|NCT00171314|13169883|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
5353418|NCT00171314|13169884|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
5353419|NCT00171314|13169883|P2|STARTED|Overall Study||264
5353420|NCT00171314|13169884|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
5353421|NCT00171301|13169900|P2|NOT COMPLETED|Overall Study||9
5353422|NCT00171301|13169901|P1|NOT COMPLETED|Overall Study||8
5353423|NCT00171301|13169900|P2|COMPLETED|Overall Study||62
5353424|NCT00171301|13169901|P1|COMPLETED|Overall Study||154
5353425|NCT00171301|13169900|P2|Received Deferasirox|Overall Study||69
5353426|NCT00171301|13169901|P1|Received Deferasirox|Overall Study||162
5353427|NCT00171301|13169900|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
5353428|NCT00171301|13169901|P1|STARTED|Overall Study||162
5353429|NCT00171210|13169914|P2|NOT COMPLETED|Overall Study||115
5353430|NCT00171210|13169915|P1|NOT COMPLETED|Overall Study||69
5353431|NCT00171210|13169914|P2|COMPLETED|Overall Study||181
5353432|NCT00171210|13169915|P1|COMPLETED|Overall Study||190
5353433|NCT00171210|13169914|P2|STARTED EXTENSION STUDY|Overall Study||247
5353434|NCT00171210|13169915|P1|STARTED EXTENSION STUDY|Overall Study||259
5353435|NCT00171210|13169914|P2|STARTED|Overall Study||296
5353436|NCT00171210|13169915|P1|STARTED|Overall Study||259
5353437|NCT00171054|13169945|P2|NOT COMPLETED|Overall Study||12
5353438|NCT00171054|13169946|P1|NOT COMPLETED|Overall Study||10
5353439|NCT00171054|13169945|P2|COMPLETED|Overall Study||50
5353440|NCT00171054|13169946|P1|COMPLETED|Overall Study||53
5353441|NCT00171054|13169945|P2|STARTED|Overall Study||62
5353442|NCT00171054|13169946|P1|STARTED|Overall Study||63
5353443|NCT00170950|13169978|P2|NOT COMPLETED|Overall Study||910
5353444|NCT00170950|13169979|P1|NOT COMPLETED|Overall Study||885
5353445|NCT00170950|13169978|P2|COMPLETED|Overall Study||4852
5353446|NCT00170950|13169979|P1|COMPLETED|Overall Study||4859
5353447|NCT00170950|13169978|P2|STARTED|Overall Study||5762
5353448|NCT00170950|13169979|P1|STARTED|Overall Study||5744
5353449|NCT00170846|13169992|P3|NOT COMPLETED|Overall Study||13
5353450|NCT00170846|13169993|P2|NOT COMPLETED|Overall Study||19
5353451|NCT00170846|13169994|P1|NOT COMPLETED|Overall Study||11
5353452|NCT00170846|13169992|P3|COMPLETED|Overall Study||131
5353453|NCT00170846|13169993|P2|COMPLETED|Overall Study||108
5353454|NCT00170846|13169994|P1|COMPLETED|Overall Study||112
5353455|NCT00170846|13169992|P3|STARTED|Overall Study||144
5353456|NCT00170846|13169993|P2|STARTED|Overall Study||127
5353457|NCT00170846|13169994|P1|STARTED|Overall Study||123
5353458|NCT00170625|13170008|P1|NOT COMPLETED|Overall Study||0
5353459|NCT00170625|13170008|P1|COMPLETED|Overall Study||26
5353460|NCT00170625|13170008|P1|STARTED|Overall Study||26
5353461|NCT00170157|13170013|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
5353462|NCT00170157|13170014|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
5353463|NCT00170157|13170013|P2|COMPLETED|Treatment Period 2 Crossover||41
5353464|NCT00170157|13170014|P1|COMPLETED|Treatment Period 2 Crossover||0
5353465|NCT00170157|13170013|P2|STARTED|Treatment Period 2 Crossover||41
5353466|NCT00170157|13170014|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
5353467|NCT00170157|13170013|P2|NOT COMPLETED|Washout Period of 14 Days||17
5353468|NCT00170157|13170014|P1|NOT COMPLETED|Washout Period of 14 Days||0
5353469|NCT00170157|13170013|P2|COMPLETED|Washout Period of 14 Days||41
5353470|NCT00170157|13170014|P1|COMPLETED|Washout Period of 14 Days||0
5353471|NCT00170157|13170013|P2|STARTED|Washout Period of 14 Days||58
5353472|NCT00170157|13170014|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
5353473|NCT00170157|13170013|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
5353474|NCT00170157|13170014|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
5353475|NCT00170157|13170013|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
5353476|NCT00170157|13170014|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
5353477|NCT00170157|13170013|P2|STARTED|Treatment Period 1 Initial Randomization||58
5353478|NCT00170157|13170014|P1|STARTED|Treatment Period 1 Initial Randomization||54
5353479|NCT00169442|13170026|P6|NOT COMPLETED|Overall Study||2
5353480|NCT00169442|13170027|P5|NOT COMPLETED|Overall Study||1
5353481|NCT00169442|13170028|P4|NOT COMPLETED|Overall Study||0
5353482|NCT00169442|13170029|P3|NOT COMPLETED|Overall Study||1
5353483|NCT00169442|13170030|P2|NOT COMPLETED|Overall Study||1
5353484|NCT00169442|13170031|P1|NOT COMPLETED|Overall Study||0
5353485|NCT00169442|13170026|P6|COMPLETED|Overall Study||41
5353486|NCT00169442|13170027|P5|COMPLETED|Overall Study||41
5353487|NCT00169442|13170028|P4|COMPLETED|Overall Study||250
5353488|NCT00169442|13170029|P3|COMPLETED|Overall Study||166
5353489|NCT00169442|13170030|P2|COMPLETED|Overall Study||123
5353490|NCT00169442|13170031|P1|COMPLETED|Overall Study||119
5353491|NCT00169442|13170026|P6|STARTED|Overall Study||43
5353492|NCT00169442|13170027|P5|STARTED|Overall Study||42
5353493|NCT00169442|13170028|P4|STARTED|Overall Study||250
5353494|NCT00169442|13170029|P3|STARTED|Overall Study||167
5353495|NCT00169442|13170030|P2|STARTED|Overall Study||124
5353496|NCT00169442|13170031|P1|STARTED|Overall Study||119
5353497|NCT00169104|13170140|P2|NOT COMPLETED|Overall Study||2
5353498|NCT00169104|13170141|P1|NOT COMPLETED|Overall Study||2
5353499|NCT00169104|13170140|P2|COMPLETED|Overall Study||8
5353500|NCT00169104|13170141|P1|COMPLETED|Overall Study||11
5353501|NCT00169104|13170140|P2|STARTED|Overall Study||10
5353502|NCT00169104|13170141|P1|STARTED|Overall Study||13
5353503|NCT00168844|13170155|P3|NOT COMPLETED|Overall Study||91
5353504|NCT00168844|13170156|P2|NOT COMPLETED|Overall Study||55
5353505|NCT00168844|13170157|P1|NOT COMPLETED|Overall Study||55
5353506|NCT00168844|13170155|P3|COMPLETED|Overall Study||228
5353507|NCT00168844|13170156|P2|COMPLETED|Overall Study||277
5353508|NCT00168844|13170157|P1|COMPLETED|Overall Study||277
5353509|NCT00168844|13170155|P3|STARTED|Overall Study||319
5353510|NCT00168844|13170156|P2|STARTED|Overall Study||332
5353511|NCT00168844|13170157|P1|STARTED|Overall Study||332
5353512|NCT00168831|13170339|P3|NOT COMPLETED|Overall Study||114
5353513|NCT00168831|13170340|P2|NOT COMPLETED|Overall Study||81
5353514|NCT00168831|13170341|P1|NOT COMPLETED|Overall Study||60
5353515|NCT00168831|13170339|P3|COMPLETED|Overall Study||220
5353516|NCT00168831|13170340|P2|COMPLETED|Overall Study||254
5353517|NCT00168831|13170341|P1|COMPLETED|Overall Study||278
5353518|NCT00168831|13170339|P3|STARTED|Overall Study||334
5353519|NCT00168831|13170340|P2|STARTED|Overall Study||335
5353520|NCT00168831|13170341|P1|STARTED|Overall Study||338
5353521|NCT00168818|13170523|P3|NOT COMPLETED|Treatment||133
5353522|NCT00168818|13170524|P2|NOT COMPLETED|Treatment||151
5353523|NCT00168818|13170525|P1|NOT COMPLETED|Treatment||133
5353524|NCT00168818|13170523|P3|COMPLETED|Treatment||1021
5353525|NCT00168818|13170524|P2|COMPLETED|Treatment||1012
5353526|NCT00168818|13170525|P1|COMPLETED|Treatment||1013
5353527|NCT00168818|13170523|P3|STARTED|Treatment||1154
5353528|NCT00168818|13170524|P2|STARTED|Treatment||1163
5353529|NCT00168818|13170525|P1|STARTED|Treatment||1146
5353530|NCT00168818|13170523|P3|NOT COMPLETED|Overall Study||124
5353531|NCT00168818|13170524|P2|NOT COMPLETED|Overall Study||109
5353532|NCT00168818|13170525|P1|NOT COMPLETED|Overall Study||117
5353533|NCT00168818|13170523|P3|COMPLETED|Overall Study||1030
5353534|NCT00168818|13170524|P2|COMPLETED|Overall Study||1054
5353535|NCT00168818|13170525|P1|COMPLETED|Overall Study||1029
5353536|NCT00168818|13170523|P3|STARTED|Overall Study||1154
5353537|NCT00168818|13170524|P2|STARTED|Overall Study||1163
5353538|NCT00168818|13170525|P1|STARTED|Overall Study||1146
5353539|NCT00168805|13170569|P3|NOT COMPLETED|Treatment||62
5353540|NCT00168805|13170570|P2|NOT COMPLETED|Treatment||56
5353541|NCT00168805|13170571|P1|NOT COMPLETED|Treatment||49
5353542|NCT00168805|13170569|P3|COMPLETED|Treatment||632
5353543|NCT00168805|13170570|P2|COMPLETED|Treatment||647
5353544|NCT00168805|13170571|P1|COMPLETED|Treatment||630
5353545|NCT00168805|13170569|P3|STARTED|Treatment||694
5353546|NCT00168805|13170570|P2|STARTED|Treatment||703
5353547|NCT00168805|13170571|P1|STARTED|Treatment||679
5353548|NCT00168805|13170569|P3|NOT COMPLETED|Overall Study||78
5353549|NCT00168805|13170570|P2|NOT COMPLETED|Overall Study||78
5353550|NCT00168805|13170571|P1|NOT COMPLETED|Overall Study||71
5353551|NCT00168805|13170569|P3|COMPLETED|Overall Study||616
5353552|NCT00168805|13170570|P2|COMPLETED|Overall Study||625
5353553|NCT00168805|13170571|P1|COMPLETED|Overall Study||608
5353554|NCT00168805|13170569|P3|STARTED|Overall Study||694
5353555|NCT00168805|13170570|P2|STARTED|Overall Study||703
5353556|NCT00168805|13170571|P1|STARTED|Overall Study||679
5353557|NCT00168454|13170618|P6|NOT COMPLETED|Overall Study||6
5353558|NCT00168454|13170619|P5|NOT COMPLETED|Overall Study||6
5353559|NCT00168454|13170620|P4|NOT COMPLETED|Overall Study||9
5353560|NCT00168454|13170621|P3|NOT COMPLETED|Overall Study||6
5353561|NCT00168454|13170622|P2|NOT COMPLETED|Overall Study||7
5353562|NCT00168454|13170623|P1|NOT COMPLETED|Overall Study||7
5353563|NCT00168454|13170618|P6|COMPLETED|Overall Study||50
5353564|NCT00168454|13170619|P5|COMPLETED|Overall Study||47
5353565|NCT00168454|13170620|P4|COMPLETED|Overall Study||40
5353566|NCT00168454|13170621|P3|COMPLETED|Overall Study||48
5353567|NCT00168454|13170622|P2|COMPLETED|Overall Study||50
5353568|NCT00168454|13170623|P1|COMPLETED|Overall Study||37
5353569|NCT00168454|13170618|P6|STARTED|Overall Study||56
5353570|NCT00168454|13170619|P5|STARTED|Overall Study||53
5353571|NCT00168454|13170620|P4|STARTED|Overall Study||49
5353572|NCT00168454|13170621|P3|STARTED|Overall Study||54
5353573|NCT00168454|13170622|P2|STARTED|Overall Study||57
5353574|NCT00168454|13170623|P1|STARTED|Overall Study||44
5353575|NCT00168428|13170669|P2|NOT COMPLETED|Open-Label Phase (OL)||68
5353576|NCT00168428|13170670|P1|NOT COMPLETED|Open-Label Phase (OL)||44
5353577|NCT00168428|13170669|P2|COMPLETED|Open-Label Phase (OL)||261
5353578|NCT00168428|13170670|P1|COMPLETED|Open-Label Phase (OL)||261
5353579|NCT00168428|13170669|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
5353580|NCT00168428|13170670|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
5353581|NCT00168428|13170669|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
5353582|NCT00168428|13170670|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
5353583|NCT00168428|13170669|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
5353584|NCT00168428|13170670|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
5353585|NCT00168428|13170669|P2|STARTED|Double-Blind Phase (DB)||358
5353586|NCT00168428|13170670|P1|STARTED|Double-Blind Phase (DB)||347
5353587|NCT00168389|13170689|P3|NOT COMPLETED|Overall Study||95
5353588|NCT00168389|13170690|P2|NOT COMPLETED|Overall Study||48
5353589|NCT00168389|13170691|P1|NOT COMPLETED|Overall Study||56
5353590|NCT00168389|13170689|P3|COMPLETED|Overall Study||70
5353591|NCT00168389|13170690|P2|COMPLETED|Overall Study||118
5353592|NCT00168389|13170691|P1|COMPLETED|Overall Study||107
5353593|NCT00168389|13170689|P3|STARTED|Overall Study||165
5353594|NCT00168389|13170690|P2|STARTED|Overall Study||166
5353595|NCT00168389|13170691|P1|STARTED|Overall Study||163
5353596|NCT00168337|13170720|P3|NOT COMPLETED|Overall Study||103
5353597|NCT00168337|13170721|P2|NOT COMPLETED|Overall Study||69
5353598|NCT00168337|13170722|P1|NOT COMPLETED|Overall Study||70
5353599|NCT00168337|13170720|P3|COMPLETED|Overall Study||82
5353600|NCT00168337|13170721|P2|COMPLETED|Overall Study||112
5353601|NCT00168337|13170722|P1|COMPLETED|Overall Study||118
5353602|NCT00168337|13170720|P3|STARTED|Overall Study||185
5353603|NCT00168337|13170721|P2|STARTED|Overall Study||181
5353604|NCT00168337|13170722|P1|STARTED|Overall Study||188
5353605|NCT00168324|13170751|P3|NOT COMPLETED|Open-Label Period||6
5353606|NCT00168324|13170752|P2|NOT COMPLETED|Open-Label Period||8
5353607|NCT00168324|13170753|P1|NOT COMPLETED|Open-Label Period||4
5353608|NCT00168324|13170751|P3|COMPLETED|Open-Label Period||152
5353609|NCT00168324|13170752|P2|COMPLETED|Open-Label Period||147
5353610|NCT00168324|13170753|P1|COMPLETED|Open-Label Period||160
5353611|NCT00168324|13170751|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
5353612|NCT00168324|13170752|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
5353613|NCT00168324|13170753|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
5353614|NCT00168324|13170751|P3|NOT COMPLETED|Double-Blind Period||13
5353615|NCT00168324|13170752|P2|NOT COMPLETED|Double-Blind Period||7
5353616|NCT00168324|13170753|P1|NOT COMPLETED|Double-Blind Period||12
5353617|NCT00168324|13170751|P3|COMPLETED|Double-Blind Period||189
5353618|NCT00168324|13170752|P2|COMPLETED|Double-Blind Period||189
5353619|NCT00168324|13170753|P1|COMPLETED|Double-Blind Period||189
5353620|NCT00168324|13170751|P3|STARTED|Double-Blind Period||202
5353621|NCT00168324|13170752|P2|STARTED|Double-Blind Period||196
5353622|NCT00168324|13170753|P1|STARTED|Double-Blind Period||201
5353623|NCT00168311|13170775|P2|NOT COMPLETED|Overall Study||2
5353624|NCT00168311|13170776|P1|NOT COMPLETED|Overall Study||0
5353625|NCT00168311|13170775|P2|COMPLETED|Overall Study||8
5353626|NCT00168311|13170776|P1|COMPLETED|Overall Study||12
5353627|NCT00168311|13170775|P2|STARTED|Overall Study||10
5353628|NCT00168311|13170776|P1|STARTED|Overall Study||12
5353629|NCT00168298|13170785|P3|NOT COMPLETED|Open-Label Period||8
5353630|NCT00168298|13170786|P2|NOT COMPLETED|Open-Label Period||5
5353631|NCT00168298|13170787|P1|NOT COMPLETED|Open-Label Period||7
5353632|NCT00168298|13170785|P3|COMPLETED|Open-Label Period||160
5353633|NCT00168298|13170786|P2|COMPLETED|Open-Label Period||168
5353634|NCT00168298|13170787|P1|COMPLETED|Open-Label Period||172
5353635|NCT00168298|13170785|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
5353636|NCT00168298|13170786|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
5353637|NCT00168298|13170787|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
5353638|NCT00168298|13170785|P3|NOT COMPLETED|Double-Blind Period||15
5353639|NCT00168298|13170786|P2|NOT COMPLETED|Double-Blind Period||12
5353640|NCT00168298|13170787|P1|NOT COMPLETED|Double-Blind Period||12
5353641|NCT00168298|13170785|P3|COMPLETED|Double-Blind Period||209
5353642|NCT00168298|13170786|P2|COMPLETED|Double-Blind Period||206
5353643|NCT00168298|13170787|P1|COMPLETED|Double-Blind Period||214
5353644|NCT00168298|13170785|P3|STARTED|Double-Blind Period||224
5353645|NCT00168298|13170786|P2|STARTED|Double-Blind Period||218
5353646|NCT00168298|13170787|P1|STARTED|Double-Blind Period||226
5353647|NCT00168103|13170807|P4|NOT COMPLETED|Overall Study||0
5353648|NCT00168103|13170808|P3|NOT COMPLETED|Overall Study||1
5353649|NCT00168103|13170809|P2|NOT COMPLETED|Overall Study||5
5353650|NCT00168103|13170810|P1|NOT COMPLETED|Overall Study||2
5353651|NCT00168103|13170807|P4|COMPLETED|Overall Study||1
5353652|NCT00168103|13170808|P3|COMPLETED|Overall Study||41
5353653|NCT00168103|13170809|P2|COMPLETED|Overall Study||38
5353654|NCT00168103|13170810|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
5353655|NCT00168103|13170807|P4|STARTED|Overall Study||1
5353656|NCT00168103|13170808|P3|STARTED|Overall Study||42
5353657|NCT00168103|13170809|P2|STARTED|Overall Study||43
5353658|NCT00168103|13170810|P1|STARTED|Overall Study||40
5353659|NCT00168064|13170832|P2|NOT COMPLETED|Overall Study||44
5353660|NCT00168064|13170833|P1|NOT COMPLETED|Overall Study||49
5353661|NCT00168064|13170832|P2|COMPLETED|Overall Study||86
5353662|NCT00168064|13170833|P1|COMPLETED|Overall Study||81
5353663|NCT00168064|13170832|P2|STARTED|Overall Study|127 participants received AP formulation|130
5353664|NCT00168064|13170833|P1|STARTED|Overall Study|128 participants received PG formulation|130
5353665|NCT00168038|13170841|P1|NOT COMPLETED|Overall Study||2
5353666|NCT00168038|13170841|P1|COMPLETED|Overall Study||55
5353667|NCT00168038|13170841|P1|STARTED|Overall Study||57
5353668|NCT00167934|13170855|P2|NOT COMPLETED|Overall Study||0
5353669|NCT00167934|13170856|P1|NOT COMPLETED|Overall Study||0
5353670|NCT00167934|13170855|P2|COMPLETED|Overall Study||82
5353671|NCT00167934|13170856|P1|COMPLETED|Overall Study||82
5353672|NCT00167934|13170855|P2|STARTED|Overall Study||82
5353673|NCT00167934|13170856|P1|STARTED|Overall Study||82
5353674|NCT00167778|13170864|P1|NOT COMPLETED|Overall Study||1
5353675|NCT00167778|13170864|P1|COMPLETED|Overall Study||10
5353676|NCT00167778|13170864|P1|STARTED|Overall Study||11
5353677|NCT00167544|13170915|P2|NOT COMPLETED|Overall Study||0
5353678|NCT00167544|13170916|P1|NOT COMPLETED|Overall Study||1
5353679|NCT00167544|13170915|P2|COMPLETED|Overall Study||33
5353680|NCT00167544|13170916|P1|COMPLETED|Overall Study||30
5353681|NCT00167544|13170915|P2|STARTED|Overall Study||33
5353682|NCT00167544|13170916|P1|STARTED|Overall Study||31
5353683|NCT00167414|13170930|P1|NOT COMPLETED|Overall Study||10
5353684|NCT00167414|13170930|P1|COMPLETED|Overall Study||39
5353685|NCT00167414|13170930|P1|STARTED|Overall Study||49
5353686|NCT00167388|13170942|P4|NOT COMPLETED|Overall Study||0
5353687|NCT00167388|13170943|P3|NOT COMPLETED|Overall Study||0
5353688|NCT00167388|13170944|P2|NOT COMPLETED|Overall Study||0
5353689|NCT00167388|13170945|P1|NOT COMPLETED|Overall Study||0
5353690|NCT00167388|13170942|P4|COMPLETED|Overall Study||6
5353691|NCT00167388|13170943|P3|COMPLETED|Overall Study||6
5353692|NCT00167388|13170944|P2|COMPLETED|Overall Study||5
5353693|NCT00167388|13170945|P1|COMPLETED|Overall Study||5
5353694|NCT00167388|13170942|P4|Completed Doppler Study|Overall Study||6
5353695|NCT00167388|13170943|P3|Completed Doppler Study|Overall Study||6
5353696|NCT00167388|13170944|P2|Completed Doppler Study|Overall Study||5
5353697|NCT00167388|13170945|P1|Completed Doppler Study|Overall Study||5
5353698|NCT00167388|13170942|P4|STARTED|Overall Study||6
5353699|NCT00167388|13170943|P3|STARTED|Overall Study||6
5353700|NCT00167388|13170944|P2|STARTED|Overall Study||5
5353701|NCT00167388|13170945|P1|STARTED|Overall Study||5
5353702|NCT00167310|13170955|P2|NOT COMPLETED|Overall Study||10
5353703|NCT00167310|13170956|P1|NOT COMPLETED|Overall Study||8
5353704|NCT00167310|13170955|P2|COMPLETED|Overall Study||18
5353705|NCT00167310|13170956|P1|COMPLETED|Overall Study||21
5353706|NCT00167310|13170955|P2|STARTED|Overall Study||28
5353707|NCT00167310|13170956|P1|STARTED|Overall Study||29
5353708|NCT00167245|13170966|P2|NOT COMPLETED|Overall Study||41
5353709|NCT00167245|13170967|P1|NOT COMPLETED|Overall Study||29
5353710|NCT00167245|13170966|P2|COMPLETED|Overall Study||46
5353711|NCT00167245|13170967|P1|COMPLETED|Overall Study||54
5353712|NCT00167245|13170966|P2|STARTED|Overall Study||87
5353713|NCT00167245|13170967|P1|STARTED|Overall Study||83
5353714|NCT00167206|13170979|P1|NOT COMPLETED|Overall Study||0
5353715|NCT00167206|13170979|P1|COMPLETED|Overall Study||16
5353716|NCT00167206|13170979|P1|STARTED|Overall Study||16
5353717|NCT00167180|13170993|P2|NOT COMPLETED|Overall Study||0
5353718|NCT00167180|13170994|P1|NOT COMPLETED|Overall Study||0
5353719|NCT00167180|13170993|P2|COMPLETED|Overall Study||57
5353720|NCT00167180|13170994|P1|COMPLETED|Overall Study||0
5353721|NCT00167180|13170993|P2|STARTED|Overall Study||57
5353722|NCT00167180|13170994|P1|STARTED|Overall Study||0
5353723|NCT00167102|13171010|P2|NOT COMPLETED|Overall Study||0
5353724|NCT00167102|13171011|P1|NOT COMPLETED|Overall Study||0
5353725|NCT00167102|13171010|P2|COMPLETED|Overall Study||22
5353726|NCT00167102|13171011|P1|COMPLETED|Overall Study||23
5353727|NCT00167102|13171010|P2|STARTED|Overall Study||22
5353728|NCT00167102|13171011|P1|STARTED|Overall Study||23
5353729|NCT00166712|13171021|P2|NOT COMPLETED|Overall Study||5
5353730|NCT00166712|13171022|P1|NOT COMPLETED|Overall Study||2
5353731|NCT00166712|13171021|P2|COMPLETED|Overall Study|Completed study participation.|11
5353732|NCT00166712|13171022|P1|COMPLETED|Overall Study|Completed study participation.|22
5353733|NCT00166712|13171021|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
5353734|NCT00166712|13171022|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
5353735|NCT00166712|13171021|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
5353736|NCT00166712|13171022|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
5353737|NCT00166712|13171021|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
5353738|NCT00166712|13171022|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
5353739|NCT00166712|13171021|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
5353740|NCT00166712|13171022|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
5353741|NCT00166712|13171021|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
5353742|NCT00166712|13171022|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
5353743|NCT00166517|13171039|P2|NOT COMPLETED|Overall Study||2
5353744|NCT00166517|13171040|P1|NOT COMPLETED|Overall Study||5
5353745|NCT00166517|13171039|P2|COMPLETED|Overall Study||61
5353746|NCT00166517|13171040|P1|COMPLETED|Overall Study||110
5353747|NCT00166517|13171039|P2|Vaccinated at Visit 3|Overall Study||61
5353748|NCT00166517|13171040|P1|Vaccinated at Visit 3|Overall Study||110
5353749|NCT00166517|13171039|P2|Vaccinated at Visit 2|Overall Study||61
5353750|NCT00166517|13171040|P1|Vaccinated at Visit 2|Overall Study||112
5353751|NCT00166517|13171039|P2|Vaccinated at Visit 1|Overall Study||63
5353752|NCT00166517|13171040|P1|Vaccinated at Visit 1|Overall Study||115
5353753|NCT00166517|13171039|P2|STARTED|Overall Study||63
5353754|NCT00166517|13171040|P1|STARTED|Overall Study||115
5353755|NCT00166504|13171050|P2|NOT COMPLETED|Overall Study||4
5353756|NCT00166504|13171051|P1|NOT COMPLETED|Overall Study||5
5353757|NCT00166504|13171050|P2|COMPLETED|Overall Study||91
5353758|NCT00166504|13171051|P1|COMPLETED|Overall Study||103
5353759|NCT00166504|13171050|P2|STARTED|Overall Study||95
5353760|NCT00166504|13171051|P1|STARTED|Overall Study||108
5353761|NCT00166439|13171057|P1|NOT COMPLETED|Overall Study||5
5353762|NCT00166439|13171057|P1|COMPLETED|Overall Study||45
5353763|NCT00166439|13171057|P1|STARTED|Overall Study||50
5353764|NCT00166361|13171065|P2|NOT COMPLETED|Overall Study||0
5353765|NCT00166361|13171066|P1|NOT COMPLETED|Overall Study||0
5353766|NCT00166361|13171065|P2|COMPLETED|Overall Study||10
5353767|NCT00166361|13171066|P1|COMPLETED|Overall Study||14
5353768|NCT00166361|13171065|P2|STARTED|Overall Study||10
5353769|NCT00166361|13171066|P1|STARTED|Overall Study||14
5353770|NCT00166296|13171074|P2|NOT COMPLETED|Overall Study||9
5353771|NCT00166296|13171075|P1|NOT COMPLETED|Overall Study||7
5353772|NCT00166296|13171074|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
5353773|NCT00166296|13171075|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
5353774|NCT00166296|13171074|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
5353775|NCT00166296|13171075|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
5353776|NCT00166296|13171074|P2|STARTED|Overall Study|Randomized patients|66
5353777|NCT00166296|13171075|P1|STARTED|Overall Study|Randomized patients|67
5353778|NCT00166205|13171087|P1|NOT COMPLETED|Overall Study||48
5353779|NCT00166205|13171087|P1|COMPLETED|Overall Study||228
5353780|NCT00166205|13171087|P1|Intervention - SAGB Surgery|Overall Study||276
5353781|NCT00166205|13171087|P1|STARTED|Overall Study||276
5353782|NCT00166166|13171103|P2|NOT COMPLETED|Overall Study||0
5353783|NCT00166166|13171104|P1|NOT COMPLETED|Overall Study||0
5353784|NCT00166166|13171103|P2|COMPLETED|Overall Study||71
5353785|NCT00166166|13171104|P1|COMPLETED|Overall Study||103
5353786|NCT00166166|13171103|P2|STARTED|Overall Study||71
5353787|NCT00166166|13171104|P1|STARTED|Overall Study||103
5353788|NCT00166114|13171127|P2|NOT COMPLETED|Overall Study||6
5353789|NCT00166114|13171128|P1|NOT COMPLETED|Overall Study||14
5353790|NCT00166114|13171127|P2|COMPLETED|Overall Study||13
5353791|NCT00166114|13171128|P1|COMPLETED|Overall Study||7
5353792|NCT00166114|13171127|P2|STARTED|Overall Study||19
5353793|NCT00166114|13171128|P1|STARTED|Overall Study||21
5353794|NCT00166036|13171136|P2|NOT COMPLETED|Overall Study||0
5353795|NCT00166036|13171137|P1|NOT COMPLETED|Overall Study||0
5353796|NCT00166036|13171136|P2|COMPLETED|Overall Study||19
5353797|NCT00166036|13171137|P1|COMPLETED|Overall Study||17
5353798|NCT00166036|13171136|P2|STARTED|Overall Study||19
5353799|NCT00166036|13171137|P1|STARTED|Overall Study||17
5353800|NCT00165984|13171145|P1|NOT COMPLETED|Overall Study||15
5353801|NCT00165984|13171145|P1|COMPLETED|Overall Study||150
5353802|NCT00165984|13171145|P1|STARTED|Overall Study||165
5353803|NCT00165958|13171154|P2|NOT COMPLETED|Overall Study||2
5353804|NCT00165958|13171155|P1|NOT COMPLETED|Overall Study||1
5353805|NCT00165958|13171154|P2|COMPLETED|Overall Study||19
5353806|NCT00165958|13171155|P1|COMPLETED|Overall Study||18
5353807|NCT00165958|13171154|P2|STARTED|Overall Study||21
5353808|NCT00165958|13171155|P1|STARTED|Overall Study||19
5353809|NCT00165841|13171163|P2|NOT COMPLETED|Overall Study||62
5353810|NCT00165841|13171164|P1|NOT COMPLETED|Overall Study||30
5353811|NCT00165841|13171163|P2|COMPLETED|Overall Study||35
5353812|NCT00165841|13171164|P1|COMPLETED|Overall Study||73
5353813|NCT00165841|13171163|P2|STARTED|Overall Study||97
5353814|NCT00165841|13171164|P1|STARTED|Overall Study||103
5353815|NCT00165789|13171174|P4|NOT COMPLETED|Overall Study||14
5353816|NCT00165789|13171175|P3|NOT COMPLETED|Overall Study||1
5353817|NCT00165789|13171176|P2|NOT COMPLETED|Overall Study||4
5353818|NCT00165789|13171177|P1|NOT COMPLETED|Overall Study||0
5353819|NCT00165789|13171174|P4|COMPLETED|Overall Study||21
5353820|NCT00165789|13171175|P3|COMPLETED|Overall Study||11
5353821|NCT00165789|13171176|P2|COMPLETED|Overall Study||16
5353822|NCT00165789|13171177|P1|COMPLETED|Overall Study||8
5353823|NCT00165789|13171174|P4|STARTED|Overall Study||35
5353824|NCT00165789|13171175|P3|STARTED|Overall Study||12
5353825|NCT00165789|13171176|P2|STARTED|Overall Study||20
5353826|NCT00165789|13171177|P1|STARTED|Overall Study||8
5353827|NCT00165776|13171231|P4|NOT COMPLETED|Overall Study||2
5353828|NCT00165776|13171232|P3|NOT COMPLETED|Overall Study||2
5353829|NCT00165776|13171233|P2|NOT COMPLETED|Overall Study||1
5353830|NCT00165776|13171234|P1|NOT COMPLETED|Overall Study||4
5353831|NCT00165776|13171231|P4|COMPLETED|Overall Study||29
5353832|NCT00165776|13171232|P3|COMPLETED|Overall Study||31
5353833|NCT00165776|13171233|P2|COMPLETED|Overall Study||33
5353834|NCT00165776|13171234|P1|COMPLETED|Overall Study||31
5353835|NCT00165776|13171231|P4|STARTED|Overall Study||31
5353836|NCT00165776|13171232|P3|STARTED|Overall Study||33
5353837|NCT00165776|13171233|P2|STARTED|Overall Study||34
5353838|NCT00165776|13171234|P1|STARTED|Overall Study||35
5353839|NCT00165698|13171270|P2|NOT COMPLETED|Overall Study||15
5353840|NCT00165698|13171271|P1|NOT COMPLETED|Overall Study||8
5353841|NCT00165698|13171270|P2|COMPLETED|Overall Study||105
5353842|NCT00165698|13171271|P1|COMPLETED|Overall Study||112
5353843|NCT00165698|13171270|P2|STARTED|Overall Study||120
5353844|NCT00165698|13171271|P1|STARTED|Overall Study||120
5353845|NCT00165672|13171297|P2|NOT COMPLETED|Overall Study||1
5353846|NCT00165672|13171298|P1|NOT COMPLETED|Overall Study||0
5353847|NCT00165672|13171297|P2|COMPLETED|Overall Study||12
5353848|NCT00165672|13171298|P1|COMPLETED|Overall Study||13
5353849|NCT00165672|13171297|P2|STARTED|Overall Study||13
5353850|NCT00165672|13171298|P1|STARTED|Overall Study||13
5353851|NCT00165646|13171307|P3|NOT COMPLETED|Overall Study||4
5353852|NCT00165646|13171308|P2|NOT COMPLETED|Overall Study||5
5353853|NCT00165646|13171309|P1|NOT COMPLETED|Overall Study||5
5353854|NCT00165646|13171307|P3|COMPLETED|Overall Study||98
5353855|NCT00165646|13171308|P2|COMPLETED|Overall Study||88
5353856|NCT00165646|13171309|P1|COMPLETED|Overall Study||88
5353857|NCT00165646|13171307|P3|STARTED|Overall Study||102
5353858|NCT00165646|13171308|P2|STARTED|Overall Study||93
5353859|NCT00165646|13171309|P1|STARTED|Overall Study||93
5353860|NCT00165503|13171317|P1|NOT COMPLETED|Overall Study||16
5353861|NCT00165503|13171317|P1|COMPLETED|Overall Study||0
5353862|NCT00165503|13171317|P1|STARTED|Overall Study||16
5353863|NCT00163657|13171324|P3|NOT COMPLETED|Overall Study||37
5353864|NCT00163657|13171325|P2|NOT COMPLETED|Overall Study||23
5353865|NCT00163657|13171326|P1|NOT COMPLETED|Overall Study||20
5353866|NCT00163657|13171324|P3|COMPLETED|Overall Study||116
5353867|NCT00163657|13171325|P2|COMPLETED|Overall Study||56
5353868|NCT00163657|13171326|P1|COMPLETED|Overall Study||60
5353869|NCT00163657|13171324|P3|STARTED|Overall Study||153
5353870|NCT00163657|13171325|P2|STARTED|Overall Study||79
5353871|NCT00163657|13171326|P1|STARTED|Overall Study||80
5353872|NCT00163293|13171340|P3|NOT COMPLETED|Overall Study||19
5353873|NCT00163293|13171341|P2|NOT COMPLETED|Overall Study||7
5353874|NCT00163293|13171342|P1|NOT COMPLETED|Overall Study||13
5353875|NCT00163293|13171340|P3|COMPLETED|Overall Study||66
5353876|NCT00163293|13171341|P2|COMPLETED|Overall Study||69
5353877|NCT00163293|13171342|P1|COMPLETED|Overall Study||66
5353878|NCT00163293|13171340|P3|STARTED|Overall Study||85
5353879|NCT00163293|13171341|P2|STARTED|Overall Study||76
5353880|NCT00163293|13171342|P1|STARTED|Overall Study||79
5353881|NCT00163215|13171416|P1|NOT COMPLETED|Overall Study||15
5353882|NCT00163215|13171416|P1|COMPLETED|Overall Study||31
5353883|NCT00163215|13171416|P1|STARTED|Overall Study||46
5353884|NCT00163189|13171436|P1|NOT COMPLETED|Overall Study||63
5353885|NCT00163189|13171436|P1|COMPLETED|Overall Study||35
5353886|NCT00163189|13171436|P1|STARTED|Overall Study||98
5353887|NCT00163020|13171460|P2|NOT COMPLETED|Overall Study||2
5353888|NCT00163020|13171461|P1|NOT COMPLETED|Overall Study||0
5353889|NCT00163020|13171460|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
5353890|NCT00163020|13171461|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
5353891|NCT00163020|13171460|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
5353892|NCT00163020|13171461|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
5353893|NCT00162981|13171501|P2|NOT COMPLETED|Overall Study||6
5353894|NCT00162981|13171502|P1|NOT COMPLETED|Overall Study||4
5353895|NCT00162981|13171501|P2|COMPLETED|Overall Study||30
5353896|NCT00162981|13171502|P1|COMPLETED|Overall Study||28
5353897|NCT00162981|13171501|P2|STARTED|Overall Study||36
5353898|NCT00162981|13171502|P1|STARTED|Overall Study||32
5353899|NCT00162942|13171518|P2|NOT COMPLETED|Overall Study||52
5353900|NCT00162942|13171519|P1|NOT COMPLETED|Overall Study||106
5353901|NCT00162942|13171518|P2|COMPLETED|Overall Study||26
5353902|NCT00162942|13171519|P1|COMPLETED|Overall Study||51
5353903|NCT00162942|13171518|P2|Week 12|Overall Study||61
5353904|NCT00162942|13171519|P1|Week 12|Overall Study||127
5353905|NCT00162942|13171518|P2|STARTED|Overall Study||78
5353906|NCT00162942|13171519|P1|STARTED|Overall Study||157
5353907|NCT00162773|13171567|P1|NOT COMPLETED|Overall Study||22
5353908|NCT00162773|13171567|P1|COMPLETED|Overall Study||7
5353909|NCT00162773|13171567|P1|STARTED|Overall Study||29
5353910|NCT00162370|13171571|P1|NOT COMPLETED|Efficacy Population||51
5353911|NCT00162370|13171571|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
5353912|NCT00162370|13171571|P1|STARTED|Efficacy Population||366
5353913|NCT00162370|13171571|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
5353914|NCT00162370|13171571|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
5353915|NCT00162370|13171571|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
5353916|NCT00162266|13171579|P4|NOT COMPLETED|Open-Label Period||137
5353917|NCT00162266|13171580|P3|NOT COMPLETED|Open-Label Period||0
5353918|NCT00162266|13171581|P2|NOT COMPLETED|Open-Label Period||0
5353919|NCT00162266|13171582|P1|NOT COMPLETED|Open-Label Period||0
5353920|NCT00162266|13171579|P4|COMPLETED|Open-Label Period||82
5353921|NCT00162266|13171580|P3|COMPLETED|Open-Label Period||0
5353922|NCT00162266|13171581|P2|COMPLETED|Open-Label Period||0
5353923|NCT00162266|13171582|P1|COMPLETED|Open-Label Period||0
5353924|NCT00162266|13171579|P4|STARTED|Open-Label Period||219
5353925|NCT00162266|13171580|P3|STARTED|Open-Label Period||0
5353926|NCT00162266|13171581|P2|STARTED|Open-Label Period||0
5353927|NCT00162266|13171582|P1|STARTED|Open-Label Period||0
5353928|NCT00162266|13171579|P4|NOT COMPLETED|Double-Blind Period||0
5353929|NCT00162266|13171580|P3|NOT COMPLETED|Double-Blind Period||48
5353930|NCT00162266|13171581|P2|NOT COMPLETED|Double-Blind Period||31
5353931|NCT00162266|13171582|P1|NOT COMPLETED|Double-Blind Period||25
5353932|NCT00162266|13171579|P4|COMPLETED|Double-Blind Period||0
5353933|NCT00162266|13171580|P3|COMPLETED|Double-Blind Period||71
5353934|NCT00162266|13171581|P2|COMPLETED|Double-Blind Period||74
5353935|NCT00162266|13171582|P1|COMPLETED|Double-Blind Period||90
5353936|NCT00162266|13171579|P4|Completed Day 1 to Day 181|Double-Blind Period||0
5353937|NCT00162266|13171580|P3|Completed Day 1 to Day 181|Double-Blind Period||78
5353938|NCT00162266|13171581|P2|Completed Day 1 to Day 181|Double-Blind Period||80
5353939|NCT00162266|13171582|P1|Completed Day 1 to Day 181|Double-Blind Period||98
5353940|NCT00162266|13171579|P4|STARTED|Double-Blind Period||0
5353941|NCT00162266|13171580|P3|STARTED|Double-Blind Period||119
5353942|NCT00162266|13171581|P2|STARTED|Double-Blind Period||105
5353943|NCT00162266|13171582|P1|STARTED|Double-Blind Period||115
5353944|NCT00162136|13171783|P1|NOT COMPLETED|Overall Study||35
5353945|NCT00162136|13171783|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
5353946|NCT00162136|13171783|P1|STARTED|Overall Study||35
5353947|NCT00162123|13171815|P8|NOT COMPLETED|Overall Study||58
5353948|NCT00162123|13171816|P7|NOT COMPLETED|Overall Study||4
5353949|NCT00162123|13171817|P6|NOT COMPLETED|Overall Study||9
5353950|NCT00162123|13171818|P5|NOT COMPLETED|Overall Study||31
5353951|NCT00162123|13171819|P4|NOT COMPLETED|Overall Study||8
5353952|NCT00162123|13171820|P3|NOT COMPLETED|Overall Study||21
5353953|NCT00162123|13171821|P2|NOT COMPLETED|Overall Study||29
5353954|NCT00162123|13171822|P1|NOT COMPLETED|Overall Study||44
5353955|NCT00162123|13171815|P8|COMPLETED|Overall Study|Still on treatment|0
5353956|NCT00162123|13171816|P7|COMPLETED|Overall Study|Still on treatment|0
5353957|NCT00162123|13171817|P6|COMPLETED|Overall Study|Still on treatment|4
5353958|NCT00162123|13171818|P5|COMPLETED|Overall Study|Still on treatment|14
5353959|NCT00162123|13171819|P4|COMPLETED|Overall Study|Still on treatment|3
5353960|NCT00162123|13171820|P3|COMPLETED|Overall Study|Still on treatment|3
5353961|NCT00162123|13171821|P2|COMPLETED|Overall Study|Still on treatment|5
5353962|NCT00162123|13171822|P1|COMPLETED|Overall Study|Still on treatment|9
5353963|NCT00162123|13171815|P8|Received Treatment|Overall Study||0
5353964|NCT00162123|13171816|P7|Received Treatment|Overall Study||4
5353965|NCT00162123|13171817|P6|Received Treatment|Overall Study||12
5353966|NCT00162123|13171818|P5|Received Treatment|Overall Study||33
5353967|NCT00162123|13171819|P4|Received Treatment|Overall Study||11
5353968|NCT00162123|13171820|P3|Received Treatment|Overall Study||24
5353969|NCT00162123|13171821|P2|Received Treatment|Overall Study||34
5353970|NCT00162123|13171822|P1|Received Treatment|Overall Study||53
5353971|NCT00162123|13171815|P8|STARTED|Overall Study|Enrolled|58
5353972|NCT00162123|13171816|P7|STARTED|Overall Study|Enrolled|4
5353973|NCT00162123|13171817|P6|STARTED|Overall Study|Enrolled|13
5353974|NCT00162123|13171818|P5|STARTED|Overall Study|Enrolled|45
5353975|NCT00162123|13171819|P4|STARTED|Overall Study|Enrolled|11
5353976|NCT00162123|13171820|P3|STARTED|Overall Study|Enrolled|24
5353977|NCT00162123|13171821|P2|STARTED|Overall Study|Enrolled|34
5353978|NCT00162123|13171822|P1|STARTED|Overall Study|Enrolled|53
5353979|NCT00162097|13171855|P4|NOT COMPLETED|Overall Study||1
5353980|NCT00162097|13171856|P3|NOT COMPLETED|Overall Study||0
5353981|NCT00162097|13171857|P2|NOT COMPLETED|Overall Study||0
5353982|NCT00162097|13171858|P1|NOT COMPLETED|Overall Study||0
5353983|NCT00162097|13171855|P4|COMPLETED|Overall Study||6
5353984|NCT00162097|13171856|P3|COMPLETED|Overall Study||1
5353985|NCT00162097|13171857|P2|COMPLETED|Overall Study||2
5353986|NCT00162097|13171858|P1|COMPLETED|Overall Study||6
5353987|NCT00162097|13171855|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
5353988|NCT00162097|13171856|P3|STARTED|Overall Study|Treated on Day 1|1
5353989|NCT00162097|13171857|P2|STARTED|Overall Study|Treated on Day 1|2
5353990|NCT00162097|13171858|P1|STARTED|Overall Study|Treated on Day 1|6
5353991|NCT00162032|13171920|P2|NOT COMPLETED|Overall Study||2
5353992|NCT00162032|13171921|P1|NOT COMPLETED|Overall Study||5
5353993|NCT00162032|13171920|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
5353994|NCT00162032|13171921|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
5353995|NCT00162032|13171920|P2|STARTED|Overall Study||116
5353996|NCT00162032|13171921|P1|STARTED|Overall Study||329
5353997|NCT00161616|13171942|P2|NOT COMPLETED|Overall Study||19
5353998|NCT00161616|13171943|P1|NOT COMPLETED|Overall Study||26
5353999|NCT00161616|13171942|P2|COMPLETED|Overall Study||119
5354000|NCT00161616|13171943|P1|COMPLETED|Overall Study||113
5354001|NCT00161616|13171942|P2|STARTED|Overall Study||138
5354002|NCT00161616|13171943|P1|STARTED|Overall Study||139
5354003|NCT00161473|13171953|P2|NOT COMPLETED|Overall Study||6
5354004|NCT00161473|13171954|P1|NOT COMPLETED|Overall Study||5
5354005|NCT00161473|13171953|P2|COMPLETED|Overall Study||6
5354006|NCT00161473|13171954|P1|COMPLETED|Overall Study||7
5354007|NCT00161473|13171953|P2|STARTED|Overall Study||12
5354008|NCT00161473|13171954|P1|STARTED|Overall Study||12
5354009|NCT00161382|13171968|P2|NOT COMPLETED|Overall Study||289
5354010|NCT00161382|13171969|P1|NOT COMPLETED|Overall Study||249
5354011|NCT00161382|13171968|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
5354012|NCT00161382|13171969|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
5354013|NCT00161382|13171968|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
5354014|NCT00161382|13171969|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
5354015|NCT00161213|13171975|P1|NOT COMPLETED|Overall Study||2
5354016|NCT00161213|13171975|P1|COMPLETED|Overall Study||42
5354017|NCT00161213|13171975|P1|STARTED|Overall Study||44
5354018|NCT00160706|13171982|P1|NOT COMPLETED|Overall Study||286
5354019|NCT00160706|13171982|P1|COMPLETED|Overall Study||24
5354020|NCT00160706|13171982|P1|STARTED|Overall Study||310
5354021|NCT00160693|13171994|P1|NOT COMPLETED|Overall Study||235
5354022|NCT00160693|13171994|P1|COMPLETED|Overall Study||167
5354023|NCT00160693|13171994|P1|STARTED|Overall Study||402
5354024|NCT00160680|13172013|P2|NOT COMPLETED|Overall Study||13
5354025|NCT00160680|13172014|P1|NOT COMPLETED|Overall Study||9
5354026|NCT00160680|13172013|P2|COMPLETED|Overall Study||18
5354027|NCT00160680|13172014|P1|COMPLETED|Overall Study||22
5354028|NCT00160680|13172013|P2|STARTED|Overall Study||31
5354029|NCT00160680|13172014|P1|STARTED|Overall Study||31
5354030|NCT00160667|13172049|P3|NOT COMPLETED|Overall Study||6
5354031|NCT00160667|13172050|P2|NOT COMPLETED|Overall Study||3
5354032|NCT00160667|13172051|P1|NOT COMPLETED|Overall Study||5
5354033|NCT00160667|13172049|P3|COMPLETED|Overall Study||45
5354034|NCT00160667|13172050|P2|COMPLETED|Overall Study||48
5354035|NCT00160667|13172051|P1|COMPLETED|Overall Study||45
5354036|NCT00160667|13172049|P3|STARTED|Overall Study||51
5354037|NCT00160667|13172050|P2|STARTED|Overall Study||51
5354038|NCT00160667|13172051|P1|STARTED|Overall Study||50
5354039|NCT00160641|13172098|P1|NOT COMPLETED|Overall Study||221
5354040|NCT00160641|13172098|P1|COMPLETED|Overall Study||346
5354041|NCT00160641|13172098|P1|STARTED|Overall Study||567
5354042|NCT00160615|13172131|P2|NOT COMPLETED|Overall Study||45
5354043|NCT00160615|13172132|P1|NOT COMPLETED|Overall Study||18
5354044|NCT00160615|13172131|P2|COMPLETED|Overall Study||56
5354045|NCT00160615|13172132|P1|COMPLETED|Overall Study||32
5354046|NCT00160615|13172131|P2|STARTED|Overall Study||101
5354047|NCT00160615|13172132|P1|STARTED|Overall Study||50
5354048|NCT00160563|13172155|P3|NOT COMPLETED|Overall Study||90
5354049|NCT00160563|13172156|P2|NOT COMPLETED|Overall Study||45
5354050|NCT00160563|13172157|P1|NOT COMPLETED|Overall Study||51
5354051|NCT00160563|13172155|P3|COMPLETED|Overall Study||11
5354052|NCT00160563|13172156|P2|COMPLETED|Overall Study||2
5354053|NCT00160563|13172157|P1|COMPLETED|Overall Study||8
5354054|NCT00160563|13172155|P3|STARTED|Overall Study||101
5354055|NCT00160563|13172156|P2|STARTED|Overall Study||47
5354056|NCT00160563|13172157|P1|STARTED|Overall Study||59
5354057|NCT00160524|13172169|P1|NOT COMPLETED|Overall Study||478
5354058|NCT00160524|13172169|P1|COMPLETED|Overall Study||117
5354059|NCT00160524|13172169|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
5354060|NCT00160251|13172186|P8|NOT COMPLETED|Post-amendment 2||55
5354061|NCT00160251|13172187|P7|NOT COMPLETED|Post-amendment 2||0
5354062|NCT00160251|13172188|P6|NOT COMPLETED|Post-amendment 2||0
5354063|NCT00160251|13172189|P5|NOT COMPLETED|Post-amendment 2||0
5354064|NCT00160251|13172190|P4|NOT COMPLETED|Post-amendment 2||0
5354065|NCT00160251|13172191|P3|NOT COMPLETED|Post-amendment 2||0
5354066|NCT00160251|13172192|P2|NOT COMPLETED|Post-amendment 2||0
5354067|NCT00160251|13172193|P1|NOT COMPLETED|Post-amendment 2||0
5354068|NCT00160251|13172186|P8|COMPLETED|Post-amendment 2||88
5354069|NCT00160251|13172187|P7|COMPLETED|Post-amendment 2||0
5354070|NCT00160251|13172188|P6|COMPLETED|Post-amendment 2||0
5354071|NCT00160251|13172189|P5|COMPLETED|Post-amendment 2||0
5354072|NCT00160251|13172190|P4|COMPLETED|Post-amendment 2||0
5354073|NCT00160251|13172191|P3|COMPLETED|Post-amendment 2||0
5354074|NCT00160251|13172192|P2|COMPLETED|Post-amendment 2||0
5354075|NCT00160251|13172193|P1|COMPLETED|Post-amendment 2||0
5354076|NCT00160251|13172186|P8|STARTED|Post-amendment 2||143
5354077|NCT00160251|13172187|P7|STARTED|Post-amendment 2||0
5354078|NCT00160251|13172188|P6|STARTED|Post-amendment 2||0
5354079|NCT00160251|13172189|P5|STARTED|Post-amendment 2||0
5354080|NCT00160251|13172190|P4|STARTED|Post-amendment 2||0
5354081|NCT00160251|13172191|P3|STARTED|Post-amendment 2||0
5354082|NCT00160251|13172192|P2|STARTED|Post-amendment 2||0
5354083|NCT00160251|13172193|P1|STARTED|Post-amendment 2||0
5354084|NCT00160251|13172186|P8|NOT COMPLETED|Prior to Amendment 2||0
5354085|NCT00160251|13172187|P7|NOT COMPLETED|Prior to Amendment 2||4
5354086|NCT00160251|13172188|P6|NOT COMPLETED|Prior to Amendment 2||83
5354087|NCT00160251|13172189|P5|NOT COMPLETED|Prior to Amendment 2||28
5354088|NCT00160251|13172190|P4|NOT COMPLETED|Prior to Amendment 2||40
5354089|NCT00160251|13172191|P3|NOT COMPLETED|Prior to Amendment 2||44
5354090|NCT00160251|13172192|P2|NOT COMPLETED|Prior to Amendment 2||6
5354091|NCT00160251|13172193|P1|NOT COMPLETED|Prior to Amendment 2||9
5354092|NCT00160251|13172186|P8|COMPLETED|Prior to Amendment 2||0
5354093|NCT00160251|13172187|P7|COMPLETED|Prior to Amendment 2||61
5354094|NCT00160251|13172188|P6|COMPLETED|Prior to Amendment 2||14
5354095|NCT00160251|13172189|P5|COMPLETED|Prior to Amendment 2||21
5354096|NCT00160251|13172190|P4|COMPLETED|Prior to Amendment 2||9
5354097|NCT00160251|13172191|P3|COMPLETED|Prior to Amendment 2||4
5354098|NCT00160251|13172192|P2|COMPLETED|Prior to Amendment 2||28
5354099|NCT00160251|13172193|P1|COMPLETED|Prior to Amendment 2||6
5354100|NCT00160251|13172186|P8|STARTED|Prior to Amendment 2||0
5354101|NCT00160251|13172187|P7|STARTED|Prior to Amendment 2||65
5354102|NCT00160251|13172188|P6|STARTED|Prior to Amendment 2||97
5354103|NCT00160251|13172189|P5|STARTED|Prior to Amendment 2||49
5354104|NCT00160251|13172190|P4|STARTED|Prior to Amendment 2||49
5354105|NCT00160251|13172191|P3|STARTED|Prior to Amendment 2||48
5354106|NCT00160251|13172192|P2|STARTED|Prior to Amendment 2||34
5354107|NCT00160251|13172193|P1|STARTED|Prior to Amendment 2||15
5354108|NCT00160199|13172269|P2|NOT COMPLETED|Overall Study||37
5354109|NCT00160199|13172270|P1|NOT COMPLETED|Overall Study||24
5354110|NCT00160199|13172269|P2|COMPLETED|Overall Study||81
5354111|NCT00160199|13172270|P1|COMPLETED|Overall Study||98
5354112|NCT00160199|13172269|P2|STARTED|Overall Study||118
5354113|NCT00160199|13172270|P1|STARTED|Overall Study||122
5354114|NCT00159965|13172290|P2|NOT COMPLETED|Overall Study||5
5354115|NCT00159965|13172291|P1|NOT COMPLETED|Overall Study||7
5354116|NCT00159965|13172290|P2|COMPLETED|Overall Study||14
5354117|NCT00159965|13172291|P1|COMPLETED|Overall Study||12
5354118|NCT00159965|13172290|P2|STARTED|Overall Study||19
5354119|NCT00159965|13172291|P1|STARTED|Overall Study||19
5354120|NCT00159913|13172327|P4|NOT COMPLETED|Overall Study||2
5354121|NCT00159913|13172328|P3|NOT COMPLETED|Overall Study||2
5354122|NCT00159913|13172329|P2|NOT COMPLETED|Overall Study||0
5354123|NCT00159913|13172330|P1|NOT COMPLETED|Overall Study||2
5354124|NCT00159913|13172327|P4|COMPLETED|Overall Study||58
5354125|NCT00159913|13172328|P3|COMPLETED|Overall Study||75
5354126|NCT00159913|13172329|P2|COMPLETED|Overall Study||55
5354127|NCT00159913|13172330|P1|COMPLETED|Overall Study||40
5354128|NCT00159913|13172327|P4|STARTED|Overall Study||60
5354129|NCT00159913|13172328|P3|STARTED|Overall Study||77
5354130|NCT00159913|13172329|P2|STARTED|Overall Study||55
5354131|NCT00159913|13172330|P1|STARTED|Overall Study||42
5354132|NCT00159874|13172404|P7|NOT COMPLETED|Overall Study||5
5354133|NCT00159874|13172405|P6|NOT COMPLETED|Overall Study||12
5354134|NCT00159874|13172406|P5|NOT COMPLETED|Overall Study||8
5354135|NCT00159874|13172407|P4|NOT COMPLETED|Overall Study||6
5354136|NCT00159874|13172408|P3|NOT COMPLETED|Overall Study||43
5354137|NCT00159874|13172409|P2|NOT COMPLETED|Overall Study||30
5354138|NCT00159874|13172410|P1|NOT COMPLETED|Overall Study||20
5354139|NCT00159874|13172404|P7|COMPLETED|Overall Study||0
5354140|NCT00159874|13172405|P6|COMPLETED|Overall Study||11
5354141|NCT00159874|13172406|P5|COMPLETED|Overall Study||11
5354142|NCT00159874|13172407|P4|COMPLETED|Overall Study||7
5354143|NCT00159874|13172408|P3|COMPLETED|Overall Study||34
5354144|NCT00159874|13172409|P2|COMPLETED|Overall Study||25
5354145|NCT00159874|13172410|P1|COMPLETED|Overall Study||22
5354146|NCT00159874|13172404|P7|Treated|Overall Study||5
5354147|NCT00159874|13172405|P6|Treated|Overall Study||23
5354148|NCT00159874|13172406|P5|Treated|Overall Study||19
5354149|NCT00159874|13172407|P4|Treated|Overall Study||13
5354150|NCT00159874|13172408|P3|Treated|Overall Study||77
5354151|NCT00159874|13172409|P2|Treated|Overall Study||55
5354152|NCT00159874|13172410|P1|Treated|Overall Study||42
5354153|NCT00159874|13172404|P7|STARTED|Overall Study||5
5354154|NCT00159874|13172405|P6|STARTED|Overall Study||23
5354155|NCT00159874|13172406|P5|STARTED|Overall Study||19
5354156|NCT00159874|13172407|P4|STARTED|Overall Study||13
5354157|NCT00159874|13172408|P3|STARTED|Overall Study||77
5354158|NCT00159874|13172409|P2|STARTED|Overall Study||55
5354159|NCT00159874|13172410|P1|STARTED|Overall Study||42
5354160|NCT00159861|13172580|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
5354161|NCT00159861|13172581|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
5354162|NCT00159861|13172580|P2|COMPLETED|Extension Study - up to 3 Years||56
5354163|NCT00159861|13172581|P1|COMPLETED|Extension Study - up to 3 Years||53
5354164|NCT00159861|13172580|P2|Treated|Extension Study - up to 3 Years||127
5354165|NCT00159861|13172581|P1|Treated|Extension Study - up to 3 Years||115
5354166|NCT00159861|13172580|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
5354167|NCT00159861|13172581|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
5354168|NCT00159861|13172580|P2|NOT COMPLETED|Core Study - 16 Weeks||12
5354169|NCT00159861|13172581|P1|NOT COMPLETED|Core Study - 16 Weeks||25
5354170|NCT00159861|13172580|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
5354171|NCT00159861|13172581|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
5354172|NCT00159861|13172580|P2|Treated|Core Study - 16 Weeks||134
5354173|NCT00159861|13172581|P1|Treated|Core Study - 16 Weeks||131
5354174|NCT00159861|13172580|P2|STARTED|Core Study - 16 Weeks||134
5354175|NCT00159861|13172581|P1|STARTED|Core Study - 16 Weeks||133
5354176|NCT00159822|13172602|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
5354177|NCT00159822|13172602|P1|COMPLETED|Post-treatment Follow-up Period||23
5354178|NCT00159822|13172602|P1|STARTED|Post-treatment Follow-up Period||26
5354179|NCT00159822|13172602|P1|NOT COMPLETED|Voriconazole Treatment Period||22
5354180|NCT00159822|13172602|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
5354181|NCT00159822|13172602|P1|STARTED|Voriconazole Treatment Period||48
5354182|NCT00159783|13172620|P3|NOT COMPLETED|Overall Study||39
5354183|NCT00159783|13172621|P2|NOT COMPLETED|Overall Study||27
5354184|NCT00159783|13172622|P1|NOT COMPLETED|Overall Study||19
5354185|NCT00159783|13172620|P3|COMPLETED|Overall Study||68
5354186|NCT00159783|13172621|P2|COMPLETED|Overall Study||52
5354187|NCT00159783|13172622|P1|COMPLETED|Overall Study||13
5354188|NCT00159783|13172620|P3|STARTED|Overall Study||107
5354189|NCT00159783|13172621|P2|STARTED|Overall Study||79
5354190|NCT00159783|13172622|P1|STARTED|Overall Study||32
5354191|NCT00159432|13172652|P1|NOT COMPLETED|Overall Study||10
5354192|NCT00159432|13172652|P1|COMPLETED|Overall Study||53
5354193|NCT00159432|13172652|P1|STARTED|Overall Study||63
5354194|NCT00159419|13172659|P2|NOT COMPLETED|Overall Study||0
5354195|NCT00159419|13172660|P1|NOT COMPLETED|Overall Study||0
5354196|NCT00159419|13172659|P2|COMPLETED|Overall Study||9
5354197|NCT00159419|13172660|P1|COMPLETED|Overall Study||9
5354198|NCT00159419|13172659|P2|STARTED|Overall Study||9
5354199|NCT00159419|13172660|P1|STARTED|Overall Study||9
5354200|NCT00159263|13172666|P6|NOT COMPLETED|Sixth Intervention||0
5354201|NCT00159263|13172667|P5|NOT COMPLETED|Sixth Intervention||0
5354202|NCT00159263|13172668|P4|NOT COMPLETED|Sixth Intervention||0
5354203|NCT00159263|13172669|P3|NOT COMPLETED|Sixth Intervention||0
5354204|NCT00159263|13172670|P2|NOT COMPLETED|Sixth Intervention||0
5354205|NCT00159263|13172671|P1|NOT COMPLETED|Sixth Intervention||0
5354206|NCT00159263|13172666|P6|COMPLETED|Sixth Intervention||2
5354207|NCT00159263|13172667|P5|COMPLETED|Sixth Intervention||2
5354208|NCT00159263|13172668|P4|COMPLETED|Sixth Intervention||2
5354209|NCT00159263|13172669|P3|COMPLETED|Sixth Intervention||2
5354210|NCT00159263|13172670|P2|COMPLETED|Sixth Intervention||1
5354211|NCT00159263|13172671|P1|COMPLETED|Sixth Intervention||1
5354212|NCT00159263|13172666|P6|STARTED|Sixth Intervention||2
5354213|NCT00159263|13172667|P5|STARTED|Sixth Intervention||2
5354214|NCT00159263|13172668|P4|STARTED|Sixth Intervention||2
5354215|NCT00159263|13172669|P3|STARTED|Sixth Intervention||2
5354216|NCT00159263|13172670|P2|STARTED|Sixth Intervention||1
5354217|NCT00159263|13172671|P1|STARTED|Sixth Intervention||1
5354218|NCT00159263|13172666|P6|NOT COMPLETED|Washout||0
5354219|NCT00159263|13172667|P5|NOT COMPLETED|Washout||0
5354220|NCT00159263|13172668|P4|NOT COMPLETED|Washout||0
5354221|NCT00159263|13172669|P3|NOT COMPLETED|Washout||0
5354222|NCT00159263|13172670|P2|NOT COMPLETED|Washout||0
5354223|NCT00159263|13172671|P1|NOT COMPLETED|Washout||0
5354224|NCT00159263|13172666|P6|COMPLETED|Washout||2
5354225|NCT00159263|13172667|P5|COMPLETED|Washout||2
5354226|NCT00159263|13172668|P4|COMPLETED|Washout||2
5354227|NCT00159263|13172669|P3|COMPLETED|Washout||2
5354228|NCT00159263|13172670|P2|COMPLETED|Washout||1
5354229|NCT00159263|13172671|P1|COMPLETED|Washout||1
5354230|NCT00159263|13172666|P6|STARTED|Washout||2
5354231|NCT00159263|13172667|P5|STARTED|Washout||2
5354232|NCT00159263|13172668|P4|STARTED|Washout||2
5354233|NCT00159263|13172669|P3|STARTED|Washout||2
5354234|NCT00159263|13172670|P2|STARTED|Washout||1
5354235|NCT00159263|13172671|P1|STARTED|Washout||1
5354236|NCT00159263|13172666|P6|NOT COMPLETED|Fifth Intervention||0
5354237|NCT00159263|13172667|P5|NOT COMPLETED|Fifth Intervention||0
5354238|NCT00159263|13172668|P4|NOT COMPLETED|Fifth Intervention||0
5354239|NCT00159263|13172669|P3|NOT COMPLETED|Fifth Intervention||0
5354240|NCT00159263|13172670|P2|NOT COMPLETED|Fifth Intervention||0
5354241|NCT00159263|13172671|P1|NOT COMPLETED|Fifth Intervention||0
5354242|NCT00159263|13172666|P6|COMPLETED|Fifth Intervention||2
5354243|NCT00159263|13172667|P5|COMPLETED|Fifth Intervention||2
5354244|NCT00159263|13172668|P4|COMPLETED|Fifth Intervention||2
5354245|NCT00159263|13172669|P3|COMPLETED|Fifth Intervention||2
5354246|NCT00159263|13172670|P2|COMPLETED|Fifth Intervention||1
5354247|NCT00159263|13172671|P1|COMPLETED|Fifth Intervention||1
5354248|NCT00159263|13172666|P6|STARTED|Fifth Intervention||2
5354249|NCT00159263|13172667|P5|STARTED|Fifth Intervention||2
5354250|NCT00159263|13172668|P4|STARTED|Fifth Intervention||2
5354251|NCT00159263|13172669|P3|STARTED|Fifth Intervention||2
5354252|NCT00159263|13172670|P2|STARTED|Fifth Intervention||1
5354253|NCT00159263|13172671|P1|STARTED|Fifth Intervention||1
5354254|NCT00159263|13172666|P6|NOT COMPLETED|Washout||0
5354255|NCT00159263|13172667|P5|NOT COMPLETED|Washout||0
5354256|NCT00159263|13172668|P4|NOT COMPLETED|Washout||0
5354257|NCT00159263|13172669|P3|NOT COMPLETED|Washout||0
5354258|NCT00159263|13172670|P2|NOT COMPLETED|Washout||0
5354259|NCT00159263|13172671|P1|NOT COMPLETED|Washout||0
5354260|NCT00159263|13172666|P6|COMPLETED|Washout||2
5354261|NCT00159263|13172667|P5|COMPLETED|Washout||2
5354262|NCT00159263|13172668|P4|COMPLETED|Washout||2
5354263|NCT00159263|13172669|P3|COMPLETED|Washout||2
5354264|NCT00159263|13172670|P2|COMPLETED|Washout||1
5354265|NCT00159263|13172671|P1|COMPLETED|Washout||1
5354266|NCT00159263|13172666|P6|STARTED|Washout||2
5354267|NCT00159263|13172667|P5|STARTED|Washout||2
5354268|NCT00159263|13172668|P4|STARTED|Washout||2
5354269|NCT00159263|13172669|P3|STARTED|Washout||2
5354270|NCT00159263|13172670|P2|STARTED|Washout||1
5354271|NCT00159263|13172671|P1|STARTED|Washout||1
5354272|NCT00159263|13172666|P6|NOT COMPLETED|Fourth Intervention||0
5354273|NCT00159263|13172667|P5|NOT COMPLETED|Fourth Intervention||0
5354274|NCT00159263|13172668|P4|NOT COMPLETED|Fourth Intervention||0
5354275|NCT00159263|13172669|P3|NOT COMPLETED|Fourth Intervention||0
5354276|NCT00159263|13172670|P2|NOT COMPLETED|Fourth Intervention||0
5354277|NCT00159263|13172671|P1|NOT COMPLETED|Fourth Intervention||0
5354278|NCT00159263|13172666|P6|COMPLETED|Fourth Intervention||2
5354279|NCT00159263|13172667|P5|COMPLETED|Fourth Intervention||2
5354280|NCT00159263|13172668|P4|COMPLETED|Fourth Intervention||2
5354281|NCT00159263|13172669|P3|COMPLETED|Fourth Intervention||2
5354282|NCT00159263|13172670|P2|COMPLETED|Fourth Intervention||1
5354283|NCT00159263|13172671|P1|COMPLETED|Fourth Intervention||1
5354284|NCT00159263|13172666|P6|STARTED|Fourth Intervention||2
5354285|NCT00159263|13172667|P5|STARTED|Fourth Intervention||2
5354286|NCT00159263|13172668|P4|STARTED|Fourth Intervention||2
5354287|NCT00159263|13172669|P3|STARTED|Fourth Intervention||2
5354288|NCT00159263|13172670|P2|STARTED|Fourth Intervention||1
5354289|NCT00159263|13172671|P1|STARTED|Fourth Intervention||1
5354290|NCT00159263|13172666|P6|NOT COMPLETED|Washout||0
5354291|NCT00159263|13172667|P5|NOT COMPLETED|Washout||0
5354292|NCT00159263|13172668|P4|NOT COMPLETED|Washout||0
5354293|NCT00159263|13172669|P3|NOT COMPLETED|Washout||0
5354294|NCT00159263|13172670|P2|NOT COMPLETED|Washout||0
5354295|NCT00159263|13172671|P1|NOT COMPLETED|Washout||0
5354296|NCT00159263|13172666|P6|COMPLETED|Washout||2
5354297|NCT00159263|13172667|P5|COMPLETED|Washout||2
5354298|NCT00159263|13172668|P4|COMPLETED|Washout||2
5354299|NCT00159263|13172669|P3|COMPLETED|Washout||2
5354300|NCT00159263|13172670|P2|COMPLETED|Washout||1
5354301|NCT00159263|13172671|P1|COMPLETED|Washout||1
5354302|NCT00159263|13172666|P6|STARTED|Washout||2
5354303|NCT00159263|13172667|P5|STARTED|Washout||2
5354304|NCT00159263|13172668|P4|STARTED|Washout||2
5354305|NCT00159263|13172669|P3|STARTED|Washout||2
5354306|NCT00159263|13172670|P2|STARTED|Washout||1
5354307|NCT00159263|13172671|P1|STARTED|Washout||1
5354308|NCT00159263|13172666|P6|NOT COMPLETED|Third Intervention||0
5354309|NCT00159263|13172667|P5|NOT COMPLETED|Third Intervention||0
5354310|NCT00159263|13172668|P4|NOT COMPLETED|Third Intervention||0
5354311|NCT00159263|13172669|P3|NOT COMPLETED|Third Intervention||0
5354312|NCT00159263|13172670|P2|NOT COMPLETED|Third Intervention||0
5354313|NCT00159263|13172671|P1|NOT COMPLETED|Third Intervention||0
5354314|NCT00159263|13172666|P6|COMPLETED|Third Intervention||2
5354315|NCT00159263|13172667|P5|COMPLETED|Third Intervention||2
5354316|NCT00159263|13172668|P4|COMPLETED|Third Intervention||2
5354317|NCT00159263|13172669|P3|COMPLETED|Third Intervention||2
5354318|NCT00159263|13172670|P2|COMPLETED|Third Intervention||1
5354319|NCT00159263|13172671|P1|COMPLETED|Third Intervention||1
5354320|NCT00159263|13172666|P6|STARTED|Third Intervention||2
5354321|NCT00159263|13172667|P5|STARTED|Third Intervention||2
5354322|NCT00159263|13172668|P4|STARTED|Third Intervention||2
5354323|NCT00159263|13172669|P3|STARTED|Third Intervention||2
5354324|NCT00159263|13172670|P2|STARTED|Third Intervention||1
5354325|NCT00159263|13172671|P1|STARTED|Third Intervention||1
5354326|NCT00159263|13172666|P6|NOT COMPLETED|Washout||0
5354327|NCT00159263|13172667|P5|NOT COMPLETED|Washout||0
5354328|NCT00159263|13172668|P4|NOT COMPLETED|Washout||0
5354329|NCT00159263|13172669|P3|NOT COMPLETED|Washout||0
5354330|NCT00159263|13172670|P2|NOT COMPLETED|Washout||0
5354331|NCT00159263|13172671|P1|NOT COMPLETED|Washout||0
5354332|NCT00159263|13172666|P6|COMPLETED|Washout||2
5354333|NCT00159263|13172667|P5|COMPLETED|Washout||2
5354334|NCT00159263|13172668|P4|COMPLETED|Washout||2
5354335|NCT00159263|13172669|P3|COMPLETED|Washout||2
5354336|NCT00159263|13172670|P2|COMPLETED|Washout||1
5354337|NCT00159263|13172671|P1|COMPLETED|Washout||1
5354338|NCT00159263|13172666|P6|STARTED|Washout||2
5354339|NCT00159263|13172667|P5|STARTED|Washout||2
5354340|NCT00159263|13172668|P4|STARTED|Washout||2
5354341|NCT00159263|13172669|P3|STARTED|Washout||2
5354342|NCT00159263|13172670|P2|STARTED|Washout||1
5354343|NCT00159263|13172671|P1|STARTED|Washout||1
5354344|NCT00159263|13172666|P6|NOT COMPLETED|Second Intervention||0
5354345|NCT00159263|13172667|P5|NOT COMPLETED|Second Intervention||0
5354346|NCT00159263|13172668|P4|NOT COMPLETED|Second Intervention||0
5354347|NCT00159263|13172669|P3|NOT COMPLETED|Second Intervention||0
5354348|NCT00159263|13172670|P2|NOT COMPLETED|Second Intervention||0
5354349|NCT00159263|13172671|P1|NOT COMPLETED|Second Intervention||0
5354350|NCT00159263|13172666|P6|COMPLETED|Second Intervention||2
5354351|NCT00159263|13172667|P5|COMPLETED|Second Intervention||2
5354352|NCT00159263|13172668|P4|COMPLETED|Second Intervention||2
5354353|NCT00159263|13172669|P3|COMPLETED|Second Intervention||2
5354354|NCT00159263|13172670|P2|COMPLETED|Second Intervention||1
5354355|NCT00159263|13172671|P1|COMPLETED|Second Intervention||1
5354356|NCT00159263|13172666|P6|STARTED|Second Intervention||2
5354357|NCT00159263|13172667|P5|STARTED|Second Intervention||2
5354358|NCT00159263|13172668|P4|STARTED|Second Intervention||2
5354359|NCT00159263|13172669|P3|STARTED|Second Intervention||2
5354360|NCT00159263|13172670|P2|STARTED|Second Intervention||1
5354361|NCT00159263|13172671|P1|STARTED|Second Intervention||1
5354362|NCT00159263|13172666|P6|NOT COMPLETED|Washout||0
5354363|NCT00159263|13172667|P5|NOT COMPLETED|Washout||0
5354364|NCT00159263|13172668|P4|NOT COMPLETED|Washout||0
5354365|NCT00159263|13172669|P3|NOT COMPLETED|Washout||0
5354366|NCT00159263|13172670|P2|NOT COMPLETED|Washout||0
5354367|NCT00159263|13172671|P1|NOT COMPLETED|Washout||0
5354368|NCT00159263|13172666|P6|COMPLETED|Washout||2
5354369|NCT00159263|13172667|P5|COMPLETED|Washout||2
5354370|NCT00159263|13172668|P4|COMPLETED|Washout||2
5354371|NCT00159263|13172669|P3|COMPLETED|Washout||2
5354372|NCT00159263|13172670|P2|COMPLETED|Washout||1
5354373|NCT00159263|13172671|P1|COMPLETED|Washout||1
5354374|NCT00159263|13172666|P6|STARTED|Washout||2
5354375|NCT00159263|13172667|P5|STARTED|Washout||2
5354376|NCT00159263|13172668|P4|STARTED|Washout||2
5354377|NCT00159263|13172669|P3|STARTED|Washout||2
5354378|NCT00159263|13172670|P2|STARTED|Washout||1
5354379|NCT00159263|13172671|P1|STARTED|Washout||1
5354380|NCT00159263|13172666|P6|NOT COMPLETED|First Intervention||0
5354381|NCT00159263|13172667|P5|NOT COMPLETED|First Intervention||0
5354382|NCT00159263|13172668|P4|NOT COMPLETED|First Intervention||0
5354383|NCT00159263|13172669|P3|NOT COMPLETED|First Intervention||0
5354384|NCT00159263|13172670|P2|NOT COMPLETED|First Intervention||0
5354385|NCT00159263|13172671|P1|NOT COMPLETED|First Intervention||0
5354386|NCT00159263|13172666|P6|COMPLETED|First Intervention||2
5354387|NCT00159263|13172667|P5|COMPLETED|First Intervention||2
5354388|NCT00159263|13172668|P4|COMPLETED|First Intervention||2
5354389|NCT00159263|13172669|P3|COMPLETED|First Intervention||2
5354390|NCT00159263|13172670|P2|COMPLETED|First Intervention||1
5354391|NCT00159263|13172671|P1|COMPLETED|First Intervention||1
5354392|NCT00159263|13172666|P6|STARTED|First Intervention||2
5354393|NCT00159263|13172667|P5|STARTED|First Intervention||2
5354394|NCT00159263|13172668|P4|STARTED|First Intervention||2
5354395|NCT00159263|13172669|P3|STARTED|First Intervention||2
5354396|NCT00159263|13172670|P2|STARTED|First Intervention||1
5354397|NCT00159263|13172671|P1|STARTED|First Intervention||1
5354398|NCT00159250|13172699|P2|NOT COMPLETED|Overall Study||0
5354399|NCT00159250|13172700|P1|NOT COMPLETED|Overall Study||0
5354400|NCT00159250|13172699|P2|COMPLETED|Overall Study||5
5354401|NCT00159250|13172700|P1|COMPLETED|Overall Study||2
5354402|NCT00159250|13172699|P2|STARTED|Overall Study||5
5354403|NCT00159250|13172700|P1|STARTED|Overall Study||2
5354404|NCT00158925|13172716|P1|NOT COMPLETED|Overall Study||12
5354405|NCT00158925|13172716|P1|COMPLETED|Overall Study||84
5354406|NCT00158925|13172716|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
5354407|NCT00158860|13172726|P2|NOT COMPLETED|Overall Study||71
5354408|NCT00158860|13172727|P1|NOT COMPLETED|Overall Study||35
5354409|NCT00158860|13172726|P2|COMPLETED|Overall Study||184
5354410|NCT00158860|13172727|P1|COMPLETED|Overall Study||93
5354411|NCT00158860|13172726|P2|STARTED|Overall Study||255
5354412|NCT00158860|13172727|P1|STARTED|Overall Study||128
5354413|NCT00158756|13172746|P5|NOT COMPLETED|Overall Study||3
5354414|NCT00158756|13172747|P4|NOT COMPLETED|Overall Study||1
5354415|NCT00158756|13172748|P3|NOT COMPLETED|Overall Study||8
5354416|NCT00158756|13172749|P2|NOT COMPLETED|Overall Study||0
5354417|NCT00158756|13172750|P1|NOT COMPLETED|Overall Study||5
5354418|NCT00158756|13172746|P5|COMPLETED|Overall Study||96
5354419|NCT00158756|13172747|P4|COMPLETED|Overall Study||22
5354420|NCT00158756|13172748|P3|COMPLETED|Overall Study||73
5354421|NCT00158756|13172749|P2|COMPLETED|Overall Study||25
5354422|NCT00158756|13172750|P1|COMPLETED|Overall Study||75
5354423|NCT00158756|13172746|P5|STARTED|Overall Study||99
5354424|NCT00158756|13172747|P4|STARTED|Overall Study||23
5354425|NCT00158756|13172748|P3|STARTED|Overall Study||81
5354426|NCT00158756|13172749|P2|STARTED|Overall Study||25
5354427|NCT00158756|13172750|P1|STARTED|Overall Study||80
5354428|NCT00158743|13172847|P2|NOT COMPLETED|Overall Study||7
5354429|NCT00158743|13172848|P1|NOT COMPLETED|Overall Study||9
5354430|NCT00158743|13172847|P2|COMPLETED|Overall Study||20
5354431|NCT00158743|13172848|P1|COMPLETED|Overall Study||15
5354432|NCT00158743|13172847|P2|STARTED|Overall Study||27
5354433|NCT00158743|13172848|P1|STARTED|Overall Study||24
5354434|NCT00158600|13172856|P2|NOT COMPLETED|Overall Study||4
5354435|NCT00158600|13172857|P1|NOT COMPLETED|Overall Study||5
5354436|NCT00158600|13172856|P2|COMPLETED|Overall Study||26
5354437|NCT00158600|13172857|P1|COMPLETED|Overall Study||55
5354438|NCT00158600|13172856|P2|STARTED|Overall Study||30
5354439|NCT00158600|13172857|P1|STARTED|Overall Study||60
5354440|NCT00158379|13172875|P1|NOT COMPLETED|Overall Study||0
5354441|NCT00158379|13172875|P1|COMPLETED|Overall Study||105
5354442|NCT00158379|13172875|P1|STARTED|Overall Study||105
5354443|NCT00158262|13172882|P2|NOT COMPLETED|Overall Study||1
5354444|NCT00158262|13172883|P1|NOT COMPLETED|Overall Study||1
5354445|NCT00158262|13172882|P2|COMPLETED|Overall Study||21
5354446|NCT00158262|13172883|P1|COMPLETED|Overall Study||20
5354447|NCT00158262|13172882|P2|STARTED|Overall Study||22
5354448|NCT00158262|13172883|P1|STARTED|Overall Study||21
5354449|NCT00158249|13172895|P2|NOT COMPLETED|Overall Study||0
5354450|NCT00158249|13172896|P1|NOT COMPLETED|Overall Study||2
5354451|NCT00158249|13172895|P2|COMPLETED|Overall Study||10
5354452|NCT00158249|13172896|P1|COMPLETED|Overall Study||9
5354453|NCT00158249|13172895|P2|STARTED|Overall Study||10
5354454|NCT00158249|13172896|P1|STARTED|Overall Study||11
5354455|NCT00158223|13172906|P2|NOT COMPLETED|Overall Study||3
5354456|NCT00158223|13172907|P1|NOT COMPLETED|Overall Study||5
5354457|NCT00158223|13172906|P2|COMPLETED|Overall Study||22
5354458|NCT00158223|13172907|P1|COMPLETED|Overall Study||23
5354459|NCT00158223|13172906|P2|STARTED|Overall Study||25
5354460|NCT00158223|13172907|P1|STARTED|Overall Study||28
5354461|NCT00158197|13172921|P4|NOT COMPLETED|Overall Study||0
5354462|NCT00158197|13172922|P3|NOT COMPLETED|Overall Study||0
5354463|NCT00158197|13172923|P2|NOT COMPLETED|Overall Study||0
5354464|NCT00158197|13172924|P1|NOT COMPLETED|Overall Study||0
5354465|NCT00158197|13172921|P4|COMPLETED|Overall Study||29
5354466|NCT00158197|13172922|P3|COMPLETED|Overall Study||28
5354467|NCT00158197|13172923|P2|COMPLETED|Overall Study||30
5354468|NCT00158197|13172924|P1|COMPLETED|Overall Study||32
5354469|NCT00158197|13172921|P4|STARTED|Overall Study||29
5354470|NCT00158197|13172922|P3|STARTED|Overall Study||28
5354471|NCT00158197|13172923|P2|STARTED|Overall Study||30
5354472|NCT00158197|13172924|P1|STARTED|Overall Study||32
5354473|NCT00158184|13172944|P2|NOT COMPLETED|Overall Study||2
5354474|NCT00158184|13172945|P1|NOT COMPLETED|Overall Study||6
5354475|NCT00158184|13172944|P2|COMPLETED|Overall Study||9
5354476|NCT00158184|13172945|P1|COMPLETED|Overall Study||10
5354477|NCT00158184|13172944|P2|STARTED|Overall Study||11
5354478|NCT00158184|13172945|P1|STARTED|Overall Study||16
5354479|NCT00158054|13172955|P2|NOT COMPLETED|Overall Study||3
5354480|NCT00158054|13172956|P1|NOT COMPLETED|Overall Study||10
5354481|NCT00158054|13172955|P2|COMPLETED|Overall Study||74
5354482|NCT00158054|13172956|P1|COMPLETED|Overall Study||70
5354483|NCT00158054|13172955|P2|STARTED|Overall Study||77
5354484|NCT00158054|13172956|P1|STARTED|Overall Study||80
5354485|NCT00157950|13172970|P2|NOT COMPLETED|Overall Study||0
5354486|NCT00157950|13172971|P1|NOT COMPLETED|Overall Study||1
5354487|NCT00157950|13172970|P2|COMPLETED|Overall Study||59
5354488|NCT00157950|13172971|P1|COMPLETED|Overall Study||116
5354489|NCT00157950|13172970|P2|Vaccinated at Dose 3|Overall Study||59
5354490|NCT00157950|13172971|P1|Vaccinated at Dose 3|Overall Study||116
5354491|NCT00157950|13172970|P2|Vaccinated at Dose 2|Overall Study||59
5354492|NCT00157950|13172971|P1|Vaccinated at Dose 2|Overall Study||117
5354493|NCT00157950|13172970|P2|Vaccinated at Dose 1|Overall Study||59
5354494|NCT00157950|13172971|P1|Vaccinated at Dose 1|Overall Study||117
5354495|NCT00157950|13172970|P2|STARTED|Overall Study||59
5354496|NCT00157950|13172971|P1|STARTED|Overall Study||117
5354497|NCT00157820|13172988|P3|NOT COMPLETED|2nd 8 Months||14
5354498|NCT00157820|13172989|P2|NOT COMPLETED|2nd 8 Months||13
5354499|NCT00157820|13172990|P1|NOT COMPLETED|2nd 8 Months||5
5354500|NCT00157820|13172988|P3|COMPLETED|2nd 8 Months||94
5354501|NCT00157820|13172989|P2|COMPLETED|2nd 8 Months||88
5354502|NCT00157820|13172990|P1|COMPLETED|2nd 8 Months||98
5354503|NCT00157820|13172988|P3|STARTED|2nd 8 Months||108
5354504|NCT00157820|13172989|P2|STARTED|2nd 8 Months||101
5354505|NCT00157820|13172990|P1|STARTED|2nd 8 Months||103
5354506|NCT00157820|13172988|P3|NOT COMPLETED|1 Month Wash Out Period||0
5354507|NCT00157820|13172989|P2|NOT COMPLETED|1 Month Wash Out Period||0
5354508|NCT00157820|13172990|P1|NOT COMPLETED|1 Month Wash Out Period||0
5354509|NCT00157820|13172988|P3|COMPLETED|1 Month Wash Out Period||108
5354510|NCT00157820|13172989|P2|COMPLETED|1 Month Wash Out Period||101
5354511|NCT00157820|13172990|P1|COMPLETED|1 Month Wash Out Period||103
5354512|NCT00157820|13172988|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
5354513|NCT00157820|13172989|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
5354514|NCT00157820|13172990|P1|STARTED|1 Month Wash Out Period||103
5354515|NCT00157820|13172988|P3|NOT COMPLETED|1st 8 Month||6
5354516|NCT00157820|13172989|P2|NOT COMPLETED|1st 8 Month||12
5354517|NCT00157820|13172990|P1|NOT COMPLETED|1st 8 Month||8
5354518|NCT00157820|13172988|P3|COMPLETED|1st 8 Month||106
5354519|NCT00157820|13172989|P2|COMPLETED|1st 8 Month||99
5354520|NCT00157820|13172990|P1|COMPLETED|1st 8 Month||103
5354521|NCT00157820|13172988|P3|STARTED|1st 8 Month||112
5354522|NCT00157820|13172989|P2|STARTED|1st 8 Month||111
5354523|NCT00157820|13172990|P1|STARTED|1st 8 Month||111
5354524|NCT00157820|13172988|P3|NOT COMPLETED|Randomized||8
5354525|NCT00157820|13172989|P2|NOT COMPLETED|Randomized||5
5354526|NCT00157820|13172990|P1|NOT COMPLETED|Randomized||7
5354527|NCT00157820|13172988|P3|COMPLETED|Randomized||112
5354528|NCT00157820|13172989|P2|COMPLETED|Randomized||111
5354529|NCT00157820|13172990|P1|COMPLETED|Randomized||111
5354530|NCT00157820|13172988|P3|STARTED|Randomized||120
5354531|NCT00157820|13172989|P2|STARTED|Randomized||116
5354532|NCT00157820|13172990|P1|STARTED|Randomized||118
5354533|NCT00157755|13173003|P6|NOT COMPLETED|Overall Study||5
5354534|NCT00157755|13173004|P5|NOT COMPLETED|Overall Study||2
5354535|NCT00157755|13173005|P4|NOT COMPLETED|Overall Study||4
5354536|NCT00157755|13173006|P3|NOT COMPLETED|Overall Study||7
5354537|NCT00157755|13173007|P2|NOT COMPLETED|Overall Study||4
5354538|NCT00157755|13173008|P1|NOT COMPLETED|Overall Study||2
5354539|NCT00157755|13173003|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
5354540|NCT00157755|13173004|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
5354541|NCT00157755|13173005|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
5354542|NCT00157755|13173006|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
5354543|NCT00157755|13173007|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
5354544|NCT00157755|13173008|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
5354545|NCT00157755|13173003|P6|STARTED|Overall Study||5
5354546|NCT00157755|13173004|P5|STARTED|Overall Study||12
5354547|NCT00157755|13173005|P4|STARTED|Overall Study||15
5354548|NCT00157755|13173006|P3|STARTED|Overall Study||10
5354549|NCT00157755|13173007|P2|STARTED|Overall Study||19
5354550|NCT00157755|13173008|P1|STARTED|Overall Study||26
5354551|NCT00157573|13173030|P2|NOT COMPLETED|Overall Study||0
5354552|NCT00157573|13173031|P1|NOT COMPLETED|Overall Study||0
5354553|NCT00157573|13173030|P2|COMPLETED|Overall Study||37
5354554|NCT00157573|13173031|P1|COMPLETED|Overall Study||35
5354555|NCT00157573|13173030|P2|STARTED|Overall Study||37
5354556|NCT00157573|13173031|P1|STARTED|Overall Study||35
5354557|NCT00157248|13173044|P4|NOT COMPLETED|Overall Study||47
5354558|NCT00157248|13173045|P3|NOT COMPLETED|Overall Study||21
5354559|NCT00157248|13173046|P2|NOT COMPLETED|Overall Study||37
5354560|NCT00157248|13173047|P1|NOT COMPLETED|Overall Study||48
5354561|NCT00157248|13173044|P4|COMPLETED|Overall Study||77
5354562|NCT00157248|13173045|P3|COMPLETED|Overall Study||29
5354563|NCT00157248|13173046|P2|COMPLETED|Overall Study||52
5354564|NCT00157248|13173047|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
5354565|NCT00157248|13173044|P4|STARTED|Overall Study||124
5354566|NCT00157248|13173045|P3|STARTED|Overall Study||50
5354567|NCT00157248|13173046|P2|STARTED|Overall Study||89
5354568|NCT00157248|13173047|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
5354569|NCT00157209|13173153|P2|NOT COMPLETED|Overall Study||0
5354570|NCT00157209|13173154|P1|NOT COMPLETED|Overall Study||10
5354571|NCT00157209|13173153|P2|COMPLETED|Overall Study||83
5354572|NCT00157209|13173154|P1|COMPLETED|Overall Study||78
5354573|NCT00157209|13173153|P2|STARTED|Overall Study||83
5354574|NCT00157209|13173154|P1|STARTED|Overall Study||88
5354575|NCT00157196|13173168|P1|NOT COMPLETED|Overall Study||9
5354576|NCT00157196|13173168|P1|COMPLETED|Overall Study||13
5354577|NCT00157196|13173168|P1|STARTED|Overall Study||22
5354578|NCT00157157|13173174|P1|NOT COMPLETED|Overall Study||11
5354579|NCT00157157|13173174|P1|COMPLETED|Overall Study||44
5354580|NCT00157157|13173174|P1|STARTED|Overall Study||55
5354581|NCT00157014|13173201|P4|NOT COMPLETED|Overall Study||1
5354582|NCT00157014|13173202|P3|NOT COMPLETED|Overall Study||1
5354583|NCT00157014|13173203|P2|NOT COMPLETED|Overall Study||5
5354584|NCT00157014|13173204|P1|NOT COMPLETED|Overall Study||7
5354585|NCT00157014|13173201|P4|COMPLETED|Overall Study||5
5354586|NCT00157014|13173202|P3|COMPLETED|Overall Study||4
5354587|NCT00157014|13173203|P2|COMPLETED|Overall Study||41
5354588|NCT00157014|13173204|P1|COMPLETED|Overall Study||45
5354589|NCT00157014|13173201|P4|STARTED|Overall Study||6
5354590|NCT00157014|13173202|P3|STARTED|Overall Study||5
5354591|NCT00157014|13173203|P2|STARTED|Overall Study||46
5354592|NCT00157014|13173204|P1|STARTED|Overall Study||52
5354593|NCT00156936|13173284|P2|NOT COMPLETED|Overall Study||11
5354594|NCT00156936|13173285|P1|NOT COMPLETED|Overall Study||72
5354595|NCT00156936|13173284|P2|COMPLETED|Overall Study||5
5354596|NCT00156936|13173285|P1|COMPLETED|Overall Study||20
5354597|NCT00156936|13173284|P2|STARTED|Overall Study||16
5354598|NCT00156936|13173285|P1|STARTED|Overall Study||92
5354599|NCT00156923|13173293|P2|NOT COMPLETED|Overall Study||32
5354600|NCT00156923|13173294|P1|NOT COMPLETED|Overall Study||34
5354601|NCT00156923|13173293|P2|COMPLETED|Overall Study||20
5354602|NCT00156923|13173294|P1|COMPLETED|Overall Study||22
5354603|NCT00156923|13173293|P2|STARTED|Overall Study||52
5354604|NCT00156923|13173294|P1|STARTED|Overall Study||56
5354605|NCT00156910|13173302|P2|NOT COMPLETED|Open-Label Phase (OL)||55
5354606|NCT00156910|13173303|P1|NOT COMPLETED|Open-Label Phase (OL)||33
5354607|NCT00156910|13173302|P2|COMPLETED|Open-Label Phase (OL)||231
5354608|NCT00156910|13173303|P1|COMPLETED|Open-Label Phase (OL)||252
5354609|NCT00156910|13173302|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
5354610|NCT00156910|13173303|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
5354611|NCT00156910|13173302|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
5354612|NCT00156910|13173303|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
5354613|NCT00156910|13173302|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
5354614|NCT00156910|13173303|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
5354615|NCT00156910|13173302|P2|STARTED|Double-Blind Phase (DB)||338
5354616|NCT00156910|13173303|P1|STARTED|Double-Blind Phase (DB)||341
5354617|NCT00156819|13173320|P3|NOT COMPLETED|Overall Study||3
5354618|NCT00156819|13173321|P2|NOT COMPLETED|Overall Study||1
5354619|NCT00156819|13173322|P1|NOT COMPLETED|Overall Study||1
5354620|NCT00156819|13173320|P3|COMPLETED|Overall Study||162
5354621|NCT00156819|13173321|P2|COMPLETED|Overall Study||165
5354622|NCT00156819|13173322|P1|COMPLETED|Overall Study||168
5354623|NCT00156819|13173320|P3|STARTED|Overall Study||165
5354624|NCT00156819|13173321|P2|STARTED|Overall Study||166
5354625|NCT00156819|13173322|P1|STARTED|Overall Study||169
5354626|NCT00156715|13173330|P1|NOT COMPLETED|Overall Study||7
5354627|NCT00156715|13173330|P1|COMPLETED|Overall Study||16
5354628|NCT00156715|13173330|P1|STARTED|Overall Study||23
5354629|NCT00156533|13173339|P4|NOT COMPLETED|Overall Study||2
5354630|NCT00156533|13173340|P3|NOT COMPLETED|Overall Study||2
5354631|NCT00156533|13173341|P2|NOT COMPLETED|Overall Study||2
5354632|NCT00156533|13173342|P1|NOT COMPLETED|Overall Study||2
5354633|NCT00156533|13173339|P4|COMPLETED|Overall Study||3
5354634|NCT00156533|13173340|P3|COMPLETED|Overall Study||3
5354635|NCT00156533|13173341|P2|COMPLETED|Overall Study||3
5354636|NCT00156533|13173342|P1|COMPLETED|Overall Study||3
5354637|NCT00156533|13173339|P4|STARTED|Overall Study||5
5354638|NCT00156533|13173340|P3|STARTED|Overall Study||5
5354639|NCT00156533|13173341|P2|STARTED|Overall Study||5
5354640|NCT00156533|13173342|P1|STARTED|Overall Study||5
5354641|NCT00156390|13173358|P2|NOT COMPLETED|Overall Study||8
5354642|NCT00156390|13173359|P1|NOT COMPLETED|Overall Study||14
5354643|NCT00156390|13173358|P2|COMPLETED|Overall Study||69
5354644|NCT00156390|13173359|P1|COMPLETED|Overall Study||96
5354645|NCT00156390|13173358|P2|STARTED|Overall Study||77
5354646|NCT00156390|13173359|P1|STARTED|Overall Study||110
5354647|NCT00156247|13173367|P1|NOT COMPLETED|Overall Study||4
5354648|NCT00156247|13173367|P1|COMPLETED|Overall Study||5
5354649|NCT00156247|13173367|P1|STARTED|Overall Study||9
5354650|NCT00156065|13173376|P3|NOT COMPLETED|Overall Study||27
5354651|NCT00156065|13173377|P2|NOT COMPLETED|Overall Study||63
5354652|NCT00156065|13173378|P1|NOT COMPLETED|Overall Study||31
5354653|NCT00156065|13173376|P3|COMPLETED|Overall Study||16
5354654|NCT00156065|13173377|P2|COMPLETED|Overall Study||30
5354655|NCT00156065|13173378|P1|COMPLETED|Overall Study||20
5354656|NCT00156065|13173376|P3|STARTED|Overall Study||43
5354657|NCT00156065|13173377|P2|STARTED|Overall Study||93
5354658|NCT00156065|13173378|P1|STARTED|Overall Study||51
5354659|NCT00156013|13173389|P1|NOT COMPLETED|Overall Study||2
5354660|NCT00156013|13173389|P1|COMPLETED|Overall Study||31
5354661|NCT00156013|13173389|P1|STARTED|Overall Study||33
5354662|NCT00154466|13173398|P3|NOT COMPLETED|Overall Study||0
5354663|NCT00154466|13173399|P2|NOT COMPLETED|Overall Study||0
5354664|NCT00154466|13173400|P1|NOT COMPLETED|Overall Study||0
5354665|NCT00154466|13173398|P3|COMPLETED|Overall Study||19
5354666|NCT00154466|13173399|P2|COMPLETED|Overall Study||19
5354667|NCT00154466|13173400|P1|COMPLETED|Overall Study||20
5354668|NCT00154466|13173398|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
5354669|NCT00154466|13173399|P2|STARTED|Overall Study||19
5354670|NCT00154466|13173400|P1|STARTED|Overall Study||20
5354671|NCT00154375|13173412|P2|NOT COMPLETED|Overall Study||106
5354672|NCT00154375|13173413|P1|NOT COMPLETED|Overall Study||113
5354673|NCT00154375|13173412|P2|COMPLETED|Overall Study||14
5354674|NCT00154375|13173413|P1|COMPLETED|Overall Study||7
5354675|NCT00154375|13173412|P2|Not Exposed to Study Treatment|Overall Study||2
5354676|NCT00154375|13173413|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
5354677|NCT00154375|13173412|P2|Discontinued Study Treatment|Overall Study||104
5354678|NCT00154375|13173413|P1|Discontinued Study Treatment|Overall Study||111
5354679|NCT00154375|13173412|P2|STARTED|Overall Study||120
5354680|NCT00154375|13173413|P1|STARTED|Overall Study||120
5354681|NCT00154310|13173424|P2|NOT COMPLETED|Overall Study||28
5354682|NCT00154310|13173425|P1|NOT COMPLETED|Overall Study||37
5354683|NCT00154310|13173424|P2|COMPLETED|Overall Study||117
5354684|NCT00154310|13173425|P1|COMPLETED|Overall Study||118
5354685|NCT00154310|13173424|P2|STARTED|Overall Study||145
5354686|NCT00154310|13173425|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
5354687|NCT00154297|13173441|P2|NOT COMPLETED|Overall Study||7
5354688|NCT00154297|13173442|P1|NOT COMPLETED|Overall Study||8
5354689|NCT00154297|13173441|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
5354690|NCT00154297|13173442|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
5354691|NCT00154297|13173441|P2|STARTED|Overall Study|Randomized population.|74
5354692|NCT00154297|13173442|P1|STARTED|Overall Study|Randomized population.|65
5354693|NCT00154284|13173460|P2|NOT COMPLETED|Overall Study||13
5354694|NCT00154284|13173461|P1|NOT COMPLETED|Overall Study||7
5354695|NCT00154284|13173460|P2|COMPLETED|Overall Study||42
5354696|NCT00154284|13173461|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
5354697|NCT00154284|13173460|P2|Intent to Treat (ITT) Population|Overall Study||53
5354698|NCT00154284|13173461|P1|Intent to Treat (ITT) Population|Overall Study||57
5354699|NCT00154284|13173460|P2|STARTED|Overall Study||55
5354700|NCT00154284|13173461|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
5354701|NCT00154102|13173475|P2|NOT COMPLETED|Overall Study||2
5354702|NCT00154102|13173476|P1|NOT COMPLETED|Overall Study||7
5354703|NCT00154102|13173475|P2|COMPLETED|Overall Study||597
5354704|NCT00154102|13173476|P1|COMPLETED|Overall Study||592
5354705|NCT00154102|13173475|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
5354706|NCT00154102|13173476|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
5354707|NCT00154063|13173512|P2|NOT COMPLETED|Overall Study||22
5354708|NCT00154063|13173513|P1|NOT COMPLETED|Overall Study||12
5354709|NCT00154063|13173512|P2|COMPLETED|Overall Study||80
5354710|NCT00154063|13173513|P1|COMPLETED|Overall Study||92
5354711|NCT00154063|13173512|P2|STARTED|Overall Study||102
5354712|NCT00154063|13173513|P1|STARTED|Overall Study||104
5354713|NCT00153985|13173569|P1|NOT COMPLETED|Overall Study||0
5354714|NCT00153985|13173569|P1|COMPLETED|Overall Study||2
5354715|NCT00153985|13173569|P1|STARTED|Overall Study||2
5354716|NCT00153920|13173575|P1|NOT COMPLETED|Overall Study||30
5354717|NCT00153920|13173575|P1|COMPLETED|Overall Study||36
5354718|NCT00153920|13173575|P1|Eligible and Treated|Overall Study||64
5354719|NCT00153920|13173575|P1|STARTED|Overall Study||66
5354720|NCT00153842|13173586|P2|NOT COMPLETED|Overall Study||0
5354721|NCT00153842|13173587|P1|NOT COMPLETED|Overall Study||0
5354722|NCT00153842|13173586|P2|COMPLETED|Overall Study||7
5354723|NCT00153842|13173587|P1|COMPLETED|Overall Study||26
5354724|NCT00153842|13173586|P2|STARTED|Overall Study||7
5354725|NCT00153842|13173587|P1|STARTED|Overall Study||26
5354726|NCT00153816|13173601|P6|NOT COMPLETED|Overall Study||27
5354727|NCT00153816|13173602|P5|NOT COMPLETED|Overall Study||17
5354728|NCT00153816|13173603|P4|NOT COMPLETED|Overall Study||31
5354729|NCT00153816|13173604|P3|NOT COMPLETED|Overall Study||32
5354730|NCT00153816|13173605|P2|NOT COMPLETED|Overall Study||32
5354731|NCT00153816|13173606|P1|NOT COMPLETED|Overall Study||32
5354732|NCT00153816|13173601|P6|COMPLETED|Overall Study||262
5354733|NCT00153816|13173602|P5|COMPLETED|Overall Study||278
5354734|NCT00153816|13173603|P4|COMPLETED|Overall Study||390
5354735|NCT00153816|13173604|P3|COMPLETED|Overall Study||388
5354736|NCT00153816|13173605|P2|COMPLETED|Overall Study||387
5354737|NCT00153816|13173606|P1|COMPLETED|Overall Study||383
5354738|NCT00153816|13173601|P6|STARTED|Overall Study||289
5354739|NCT00153816|13173602|P5|STARTED|Overall Study||295
5354740|NCT00153816|13173603|P4|STARTED|Overall Study||421
5354741|NCT00153816|13173604|P3|STARTED|Overall Study||420
5354742|NCT00153816|13173605|P2|STARTED|Overall Study||419
5354743|NCT00153816|13173606|P1|STARTED|Overall Study||415
5354744|NCT00153803|13173628|P2|NOT COMPLETED|Investigational Drug||42
5354745|NCT00153803|13173629|P1|NOT COMPLETED|Investigational Drug||41
5354746|NCT00153803|13173628|P2|COMPLETED|Investigational Drug||75
5354747|NCT00153803|13173629|P1|COMPLETED|Investigational Drug||77
5354748|NCT00153803|13173628|P2|Investigational Drug Dispensed|Investigational Drug||75
5354749|NCT00153803|13173629|P1|Investigational Drug Dispensed|Investigational Drug||77
5354750|NCT00153803|13173628|P2|STARTED|Investigational Drug||117
5354751|NCT00153803|13173629|P1|STARTED|Investigational Drug||118
5354752|NCT00153803|13173628|P2|NOT COMPLETED|Concurrent Chemoradiation||5
5354753|NCT00153803|13173629|P1|NOT COMPLETED|Concurrent Chemoradiation||5
5354754|NCT00153803|13173628|P2|COMPLETED|Concurrent Chemoradiation||117
5354755|NCT00153803|13173629|P1|COMPLETED|Concurrent Chemoradiation||118
5354756|NCT00153803|13173628|P2|Received Chemoradiation|Concurrent Chemoradiation||117
5354757|NCT00153803|13173629|P1|Received Chemoradiation|Concurrent Chemoradiation||118
5354758|NCT00153803|13173628|P2|STARTED|Concurrent Chemoradiation||122
5354759|NCT00153803|13173629|P1|STARTED|Concurrent Chemoradiation||123
5354760|NCT00153179|13173647|P4|NOT COMPLETED|Study Visit Day 2||2
5354761|NCT00153179|13173648|P3|NOT COMPLETED|Study Visit Day 2||2
5354762|NCT00153179|13173649|P2|NOT COMPLETED|Study Visit Day 2||0
5354763|NCT00153179|13173650|P1|NOT COMPLETED|Study Visit Day 2||1
5354764|NCT00153179|13173647|P4|COMPLETED|Study Visit Day 2||7
5354765|NCT00153179|13173648|P3|COMPLETED|Study Visit Day 2||11
5354766|NCT00153179|13173649|P2|COMPLETED|Study Visit Day 2||8
5354767|NCT00153179|13173650|P1|COMPLETED|Study Visit Day 2||9
5354768|NCT00153179|13173647|P4|STARTED|Study Visit Day 2||9
5354769|NCT00153179|13173648|P3|STARTED|Study Visit Day 2||13
5354770|NCT00153179|13173649|P2|STARTED|Study Visit Day 2||8
5354771|NCT00153179|13173650|P1|STARTED|Study Visit Day 2||10
5354772|NCT00153179|13173647|P4|NOT COMPLETED|Study Visit Day 1||0
5354773|NCT00153179|13173648|P3|NOT COMPLETED|Study Visit Day 1||0
5354774|NCT00153179|13173649|P2|NOT COMPLETED|Study Visit Day 1||0
5354775|NCT00153179|13173650|P1|NOT COMPLETED|Study Visit Day 1||0
5354776|NCT00153179|13173647|P4|COMPLETED|Study Visit Day 1||9
5354777|NCT00153179|13173648|P3|COMPLETED|Study Visit Day 1||13
5354778|NCT00153179|13173649|P2|COMPLETED|Study Visit Day 1||8
5354779|NCT00153179|13173650|P1|COMPLETED|Study Visit Day 1||10
5354780|NCT00153179|13173647|P4|STARTED|Study Visit Day 1||9
5354781|NCT00153179|13173648|P3|STARTED|Study Visit Day 1||13
5354782|NCT00153179|13173649|P2|STARTED|Study Visit Day 1||8
5354783|NCT00153179|13173650|P1|STARTED|Study Visit Day 1||10
5354784|NCT00153166|13173663|P3|NOT COMPLETED|Overall Study||0
5354785|NCT00153166|13173664|P2|NOT COMPLETED|Overall Study||0
5354786|NCT00153166|13173665|P1|NOT COMPLETED|Overall Study||0
5354787|NCT00153166|13173663|P3|COMPLETED|Overall Study||28
5354788|NCT00153166|13173664|P2|COMPLETED|Overall Study||37
5354789|NCT00153166|13173665|P1|COMPLETED|Overall Study||11
5354790|NCT00153166|13173663|P3|Received Placebo and Placebo|Overall Study||7
5354791|NCT00153166|13173664|P2|Received Placebo and Placebo|Overall Study||9
5354792|NCT00153166|13173665|P1|Received Placebo and Placebo|Overall Study||3
5354793|NCT00153166|13173663|P3|Received Placebo and Pioglitazone|Overall Study||7
5354794|NCT00153166|13173664|P2|Received Placebo and Pioglitazone|Overall Study||10
5354795|NCT00153166|13173665|P1|Received Placebo and Pioglitazone|Overall Study||3
5354796|NCT00153166|13173663|P3|Received Atorvastatin and Placebo|Overall Study||7
5354797|NCT00153166|13173664|P2|Received Atorvastatin and Placebo|Overall Study||9
5354798|NCT00153166|13173665|P1|Received Atorvastatin and Placebo|Overall Study||2
5354799|NCT00153166|13173663|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
5354800|NCT00153166|13173664|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
5354801|NCT00153166|13173665|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
5354802|NCT00153166|13173663|P3|STARTED|Overall Study||28
5354803|NCT00153166|13173664|P2|STARTED|Overall Study||37
5354804|NCT00153166|13173665|P1|STARTED|Overall Study||11
5354805|NCT00153101|13173682|P5|NOT COMPLETED|Overall Study||10
5354806|NCT00153101|13173683|P4|NOT COMPLETED|Overall Study||8
5354807|NCT00153101|13173684|P3|NOT COMPLETED|Overall Study||15
5354808|NCT00153101|13173685|P2|NOT COMPLETED|Overall Study||18
5354809|NCT00153101|13173686|P1|NOT COMPLETED|Overall Study||17
5354810|NCT00153101|13173682|P5|COMPLETED|Overall Study||2962
5354811|NCT00153101|13173683|P4|COMPLETED|Overall Study||2946
5354812|NCT00153101|13173684|P3|COMPLETED|Overall Study||8561
5354813|NCT00153101|13173685|P2|COMPLETED|Overall Study||8524
5354814|NCT00153101|13173686|P1|COMPLETED|Overall Study||8485
5354815|NCT00153101|13173682|P5|STARTED|Overall Study||2972
5354816|NCT00153101|13173683|P4|STARTED|Overall Study||2954
5354817|NCT00153101|13173684|P3|STARTED|Overall Study||8576
5354818|NCT00153101|13173685|P2|STARTED|Overall Study||8542
5354819|NCT00153101|13173686|P1|STARTED|Overall Study||8502
5354820|NCT00153062|13173794|P4|NOT COMPLETED|Overall Study||411
5354821|NCT00153062|13173795|P3|NOT COMPLETED|Overall Study||415
5354822|NCT00153062|13173796|P2|NOT COMPLETED|Overall Study||406
5354823|NCT00153062|13173797|P1|NOT COMPLETED|Overall Study||387
5354824|NCT00153062|13173794|P4|COMPLETED|Overall Study||4680
5354825|NCT00153062|13173795|P3|COMPLETED|Overall Study||4645
5354826|NCT00153062|13173796|P2|COMPLETED|Overall Study||4689
5354827|NCT00153062|13173797|P1|COMPLETED|Overall Study||4699
5354828|NCT00153062|13173794|P4|STARTED|Overall Study||5091
5354829|NCT00153062|13173795|P3|STARTED|Overall Study||5060
5354830|NCT00153062|13173796|P2|STARTED|Overall Study||5095
5354831|NCT00153062|13173797|P1|STARTED|Overall Study||5086
5354832|NCT00152971|13173816|P3|NOT COMPLETED|Treatment||80
5354833|NCT00152971|13173817|P2|NOT COMPLETED|Treatment||63
5354834|NCT00152971|13173818|P1|NOT COMPLETED|Treatment||71
5354835|NCT00152971|13173816|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
5354836|NCT00152971|13173817|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
5354837|NCT00152971|13173818|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
5354838|NCT00152971|13173816|P3|STARTED|Treatment||868
5354839|NCT00152971|13173817|P2|STARTED|Treatment||871
5354840|NCT00152971|13173818|P1|STARTED|Treatment||857
5354841|NCT00152971|13173816|P3|NOT COMPLETED|Overall Study||49
5354842|NCT00152971|13173817|P2|NOT COMPLETED|Overall Study||48
5354843|NCT00152971|13173818|P1|NOT COMPLETED|Overall Study||51
5354844|NCT00152971|13173816|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
5354845|NCT00152971|13173817|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
5354846|NCT00152971|13173818|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
5354847|NCT00152971|13173816|P3|STARTED|Overall Study||868
5354848|NCT00152971|13173817|P2|STARTED|Overall Study||871
5354849|NCT00152971|13173818|P1|STARTED|Overall Study||857
5354850|NCT00152763|13173854|P4|NOT COMPLETED|Overall Study||14
5354851|NCT00152763|13173855|P3|NOT COMPLETED|Overall Study||4
5354852|NCT00152763|13173856|P2|NOT COMPLETED|Overall Study||5
5354853|NCT00152763|13173857|P1|NOT COMPLETED|Overall Study||10
5354854|NCT00152763|13173854|P4|COMPLETED|Overall Study||63
5354855|NCT00152763|13173855|P3|COMPLETED|Overall Study||16
5354856|NCT00152763|13173856|P2|COMPLETED|Overall Study||14
5354857|NCT00152763|13173857|P1|COMPLETED|Overall Study||67
5354858|NCT00152763|13173854|P4|STARTED|Overall Study||77
5354859|NCT00152763|13173855|P3|STARTED|Overall Study||20
5354860|NCT00152763|13173856|P2|STARTED|Overall Study||19
5354861|NCT00152763|13173857|P1|STARTED|Overall Study||77
5354862|NCT00152516|13173973|P1|NOT COMPLETED|Overall Study||75
5354863|NCT00152516|13173973|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
5354864|NCT00152516|13173973|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
5354865|NCT00152464|13173999|P2|NOT COMPLETED|Overall Study||36
5354866|NCT00152464|13174000|P1|NOT COMPLETED|Overall Study||40
5354867|NCT00152464|13173999|P2|COMPLETED|Overall Study||219
5354868|NCT00152464|13174000|P1|COMPLETED|Overall Study||215
5354869|NCT00152464|13173999|P2|STARTED|Overall Study||255
5354870|NCT00152464|13174000|P1|STARTED|Overall Study||255
5354871|NCT00152009|13174028|P4|NOT COMPLETED|Overall Study||33
5354872|NCT00152009|13174029|P3|NOT COMPLETED|Overall Study||37
5354873|NCT00152009|13174030|P2|NOT COMPLETED|Overall Study||31
5354874|NCT00152009|13174031|P1|NOT COMPLETED|Overall Study||29
5354875|NCT00152009|13174028|P4|COMPLETED|Overall Study||53
5354876|NCT00152009|13174029|P3|COMPLETED|Overall Study||49
5354877|NCT00152009|13174030|P2|COMPLETED|Overall Study||55
5354878|NCT00152009|13174031|P1|COMPLETED|Overall Study||58
5354879|NCT00152009|13174028|P4|STARTED|Overall Study||86
5354880|NCT00152009|13174029|P3|STARTED|Overall Study||86
5354881|NCT00152009|13174030|P2|STARTED|Overall Study||86
5354882|NCT00152009|13174031|P1|STARTED|Overall Study||87
5354883|NCT00151996|13174063|P2|NOT COMPLETED|Overall Study||7
5354884|NCT00151996|13174064|P1|NOT COMPLETED|Overall Study||5
5354885|NCT00151996|13174063|P2|COMPLETED|Overall Study||26
5354886|NCT00151996|13174064|P1|COMPLETED|Overall Study||37
5354887|NCT00151996|13174063|P2|STARTED|Overall Study||33
5354888|NCT00151996|13174064|P1|STARTED|Overall Study||42
5354889|NCT00151892|13174080|P2|NOT COMPLETED|Overall Study||83
5354890|NCT00151892|13174081|P1|NOT COMPLETED|Overall Study||76
5354891|NCT00151892|13174080|P2|COMPLETED|Overall Study||330
5354892|NCT00151892|13174081|P1|COMPLETED|Overall Study||340
5354893|NCT00151892|13174080|P2|STARTED|Overall Study||413
5354894|NCT00151892|13174081|P1|STARTED|Overall Study||416
5354895|NCT00151814|13174098|P3|NOT COMPLETED|Overall Study||0
5354896|NCT00151814|13174099|P2|NOT COMPLETED|Overall Study||0
5354897|NCT00151814|13174100|P1|NOT COMPLETED|Overall Study||0
5354898|NCT00151814|13174098|P3|COMPLETED|Overall Study||10
5354899|NCT00151814|13174099|P2|COMPLETED|Overall Study||10
5354900|NCT00151814|13174100|P1|COMPLETED|Overall Study||4
5354901|NCT00151814|13174098|P3|STARTED|Overall Study||10
5354902|NCT00151814|13174099|P2|STARTED|Overall Study||10
5354903|NCT00151814|13174100|P1|STARTED|Overall Study||4
5354904|NCT00151775|13174126|P12|NOT COMPLETED|Period 4: Open Label||0
5354905|NCT00151775|13174127|P11|NOT COMPLETED|Period 4: Open Label||0
5354906|NCT00151775|13174128|P10|NOT COMPLETED|Period 4: Open Label||21
5354907|NCT00151775|13174129|P9|NOT COMPLETED|Period 4: Open Label||0
5354908|NCT00151775|13174130|P8|NOT COMPLETED|Period 4: Open Label||0
5354909|NCT00151775|13174131|P7|NOT COMPLETED|Period 4: Open Label||0
5354910|NCT00151775|13174132|P6|NOT COMPLETED|Period 4: Open Label||0
5354911|NCT00151775|13174133|P5|NOT COMPLETED|Period 4: Open Label||30
5354912|NCT00151775|13174134|P4|NOT COMPLETED|Period 4: Open Label||0
5354913|NCT00151775|13174135|P3|NOT COMPLETED|Period 4: Open Label||0
5354914|NCT00151775|13174136|P2|NOT COMPLETED|Period 4: Open Label||0
5354915|NCT00151775|13174137|P1|NOT COMPLETED|Period 4: Open Label||0
5354916|NCT00151775|13174126|P12|COMPLETED|Period 4: Open Label||0
5354917|NCT00151775|13174127|P11|COMPLETED|Period 4: Open Label||57
5354918|NCT00151775|13174128|P10|COMPLETED|Period 4: Open Label||83
5354919|NCT00151775|13174129|P9|COMPLETED|Period 4: Open Label||0
5354920|NCT00151775|13174130|P8|COMPLETED|Period 4: Open Label||0
5354921|NCT00151775|13174131|P7|COMPLETED|Period 4: Open Label||0
5354922|NCT00151775|13174132|P6|COMPLETED|Period 4: Open Label||0
5354923|NCT00151775|13174133|P5|COMPLETED|Period 4: Open Label||149
5354924|NCT00151775|13174134|P4|COMPLETED|Period 4: Open Label||0
5354925|NCT00151775|13174135|P3|COMPLETED|Period 4: Open Label||0
5354926|NCT00151775|13174136|P2|COMPLETED|Period 4: Open Label||0
5354927|NCT00151775|13174137|P1|COMPLETED|Period 4: Open Label||0
5354928|NCT00151775|13174126|P12|STARTED|Period 4: Open Label||0
5354929|NCT00151775|13174127|P11|STARTED|Period 4: Open Label||57
5354930|NCT00151775|13174128|P10|STARTED|Period 4: Open Label||104
5354931|NCT00151775|13174129|P9|STARTED|Period 4: Open Label||0
5354932|NCT00151775|13174130|P8|STARTED|Period 4: Open Label||0
5354933|NCT00151775|13174131|P7|STARTED|Period 4: Open Label||0
5354934|NCT00151775|13174132|P6|STARTED|Period 4: Open Label||0
5354935|NCT00151775|13174133|P5|STARTED|Period 4: Open Label||179
5354936|NCT00151775|13174134|P4|STARTED|Period 4: Open Label||0
5354937|NCT00151775|13174135|P3|STARTED|Period 4: Open Label||0
5354938|NCT00151775|13174136|P2|STARTED|Period 4: Open Label||0
5354939|NCT00151775|13174137|P1|STARTED|Period 4: Open Label||0
5354940|NCT00151775|13174126|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
5354941|NCT00151775|13174127|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354942|NCT00151775|13174128|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354943|NCT00151775|13174129|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354944|NCT00151775|13174130|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
5354945|NCT00151775|13174131|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
5354946|NCT00151775|13174132|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
5354947|NCT00151775|13174133|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354948|NCT00151775|13174134|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354949|NCT00151775|13174135|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
5354950|NCT00151775|13174136|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354951|NCT00151775|13174137|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
5354952|NCT00151775|13174126|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
5354953|NCT00151775|13174127|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
5354954|NCT00151775|13174128|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
5354955|NCT00151775|13174129|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
5354956|NCT00151775|13174130|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
5354957|NCT00151775|13174131|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
5354958|NCT00151775|13174132|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
5354959|NCT00151775|13174133|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
5354960|NCT00151775|13174134|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
5354961|NCT00151775|13174135|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
5354962|NCT00151775|13174136|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
5354963|NCT00151775|13174137|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
5354964|NCT00151775|13174126|P12|STARTED|Period 3: Double-blind, Withdrawal||29
5354965|NCT00151775|13174127|P11|STARTED|Period 3: Double-blind, Withdrawal||29
5354966|NCT00151775|13174128|P10|STARTED|Period 3: Double-blind, Withdrawal||0
5354967|NCT00151775|13174129|P9|STARTED|Period 3: Double-blind, Withdrawal||26
5354968|NCT00151775|13174130|P8|STARTED|Period 3: Double-blind, Withdrawal||28
5354969|NCT00151775|13174131|P7|STARTED|Period 3: Double-blind, Withdrawal||27
5354970|NCT00151775|13174132|P6|STARTED|Period 3: Double-blind, Withdrawal||26
5354971|NCT00151775|13174133|P5|STARTED|Period 3: Double-blind, Withdrawal||0
5354972|NCT00151775|13174134|P4|STARTED|Period 3: Double-blind, Withdrawal||44
5354973|NCT00151775|13174135|P3|STARTED|Period 3: Double-blind, Withdrawal||45
5354974|NCT00151775|13174136|P2|STARTED|Period 3: Double-blind, Withdrawal||45
5354975|NCT00151775|13174137|P1|STARTED|Period 3: Double-blind, Withdrawal||48
5354976|NCT00151775|13174126|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354977|NCT00151775|13174127|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
5354978|NCT00151775|13174128|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354979|NCT00151775|13174129|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354980|NCT00151775|13174130|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354981|NCT00151775|13174131|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
5354982|NCT00151775|13174132|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
5354983|NCT00151775|13174133|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354984|NCT00151775|13174134|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354985|NCT00151775|13174135|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
5354986|NCT00151775|13174136|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
5354987|NCT00151775|13174137|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
5354988|NCT00151775|13174126|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354989|NCT00151775|13174127|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
5354990|NCT00151775|13174128|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354991|NCT00151775|13174129|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354992|NCT00151775|13174130|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354993|NCT00151775|13174131|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
5354994|NCT00151775|13174132|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
5354995|NCT00151775|13174133|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354996|NCT00151775|13174134|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354997|NCT00151775|13174135|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
5354998|NCT00151775|13174136|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
5354999|NCT00151775|13174137|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
5355000|NCT00151775|13174126|P12|STARTED|Period 2 - Double-Blind Dose Response||0
5355001|NCT00151775|13174127|P11|STARTED|Period 2 - Double-Blind Dose Response||60
5355002|NCT00151775|13174128|P10|STARTED|Period 2 - Double-Blind Dose Response||0
5355003|NCT00151775|13174129|P9|STARTED|Period 2 - Double-Blind Dose Response||0
5355004|NCT00151775|13174130|P8|STARTED|Period 2 - Double-Blind Dose Response||0
5355005|NCT00151775|13174131|P7|STARTED|Period 2 - Double-Blind Dose Response||56
5355006|NCT00151775|13174132|P6|STARTED|Period 2 - Double-Blind Dose Response||56
5355007|NCT00151775|13174133|P5|STARTED|Period 2 - Double-Blind Dose Response||0
5355008|NCT00151775|13174134|P4|STARTED|Period 2 - Double-Blind Dose Response||0
5355009|NCT00151775|13174135|P3|STARTED|Period 2 - Double-Blind Dose Response||0
5355010|NCT00151775|13174136|P2|STARTED|Period 2 - Double-Blind Dose Response||95
5355011|NCT00151775|13174137|P1|STARTED|Period 2 - Double-Blind Dose Response||95
5355012|NCT00151476|13174181|P2|NOT COMPLETED|FAP Analyzed Subjects||3
5355013|NCT00151476|13174182|P1|NOT COMPLETED|FAP Analyzed Subjects||0
5355014|NCT00151476|13174181|P2|COMPLETED|FAP Analyzed Subjects||51
5355015|NCT00151476|13174182|P1|COMPLETED|FAP Analyzed Subjects||13
5355016|NCT00151476|13174181|P2|STARTED|FAP Analyzed Subjects||54
5355017|NCT00151476|13174182|P1|STARTED|FAP Analyzed Subjects||13
5355018|NCT00151476|13174181|P2|NOT COMPLETED|FAP Identified Subjects||1
5355019|NCT00151476|13174182|P1|NOT COMPLETED|FAP Identified Subjects||0
5355020|NCT00151476|13174181|P2|COMPLETED|FAP Identified Subjects||54
5355021|NCT00151476|13174182|P1|COMPLETED|FAP Identified Subjects||13
5355022|NCT00151476|13174181|P2|STARTED|FAP Identified Subjects||55
5355023|NCT00151476|13174182|P1|STARTED|FAP Identified Subjects||13
5355024|NCT00151411|13174239|P2|NOT COMPLETED|Overall Study||43
5355025|NCT00151411|13174240|P1|NOT COMPLETED|Overall Study||33
5355026|NCT00151411|13174239|P2|COMPLETED|Overall Study||16
5355027|NCT00151411|13174240|P1|COMPLETED|Overall Study||22
5355028|NCT00151411|13174239|P2|STARTED|Overall Study||59
5355029|NCT00151411|13174240|P1|STARTED|Overall Study||55
5355030|NCT00151372|13174252|P2|NOT COMPLETED|Overall Study||29
5355031|NCT00151372|13174253|P1|NOT COMPLETED|Overall Study||29
5355032|NCT00151372|13174252|P2|COMPLETED|Overall Study||45
5355033|NCT00151372|13174253|P1|COMPLETED|Overall Study||38
5355034|NCT00151372|13174252|P2|STARTED|Overall Study||74
5355035|NCT00151372|13174253|P1|STARTED|Overall Study||67
5355036|NCT00151320|13174263|P1|NOT COMPLETED|Overall Study||0
5355037|NCT00151320|13174263|P1|COMPLETED|Overall Study||76
5355038|NCT00151320|13174263|P1|STARTED|Overall Study||76
5355039|NCT00151281|13174268|P1|NOT COMPLETED|Overall Study||3
5355040|NCT00151281|13174268|P1|COMPLETED|Overall Study||22
5355041|NCT00151281|13174268|P1|STARTED|Overall Study||25
5355042|NCT00150969|13174277|P2|NOT COMPLETED|24-48 Month Extension||100
5355043|NCT00150969|13174278|P1|NOT COMPLETED|24-48 Month Extension||88
5355044|NCT00150969|13174277|P2|COMPLETED|24-48 Month Extension||40
5355045|NCT00150969|13174278|P1|COMPLETED|24-48 Month Extension||33
5355046|NCT00150969|13174277|P2|STARTED|24-48 Month Extension||140
5355047|NCT00150969|13174278|P1|STARTED|24-48 Month Extension||121
5355048|NCT00150969|13174277|P2|NOT COMPLETED|24 Month Main Study||21
5355049|NCT00150969|13174278|P1|NOT COMPLETED|24 Month Main Study||19
5355050|NCT00150969|13174277|P2|COMPLETED|24 Month Main Study||202
5355051|NCT00150969|13174278|P1|COMPLETED|24 Month Main Study||198
5355052|NCT00150969|13174277|P2|STARTED|24 Month Main Study||223
5355053|NCT00150969|13174278|P1|STARTED|24 Month Main Study||217
5355054|NCT00150813|13174310|P1|NOT COMPLETED|Overall Study||18
5355055|NCT00150813|13174310|P1|COMPLETED|Overall Study||48
5355056|NCT00150813|13174310|P1|STARTED|Overall Study||66
5355057|NCT00150800|13174314|P1|NOT COMPLETED|Overall Study||496
5355058|NCT00150800|13174314|P1|COMPLETED|Overall Study||171
5355059|NCT00150800|13174314|P1|STARTED|Overall Study||667
5355060|NCT00150618|13174328|P5|NOT COMPLETED|Overall Study||25
5355061|NCT00150618|13174329|P4|NOT COMPLETED|Overall Study||26
5355062|NCT00150618|13174330|P3|NOT COMPLETED|Overall Study||27
5355063|NCT00150618|13174331|P2|NOT COMPLETED|Overall Study||18
5355064|NCT00150618|13174332|P1|NOT COMPLETED|Overall Study||17
5355065|NCT00150618|13174328|P5|COMPLETED|Overall Study||41
5355066|NCT00150618|13174329|P4|COMPLETED|Overall Study||40
5355067|NCT00150618|13174330|P3|COMPLETED|Overall Study||38
5355068|NCT00150618|13174331|P2|COMPLETED|Overall Study||47
5355069|NCT00150618|13174332|P1|COMPLETED|Overall Study||45
5355070|NCT00150618|13174328|P5|STARTED|Overall Study||66
5355071|NCT00150618|13174329|P4|STARTED|Overall Study||66
5355072|NCT00150618|13174330|P3|STARTED|Overall Study||65
5355073|NCT00150618|13174331|P2|STARTED|Overall Study||65
5355074|NCT00150618|13174332|P1|STARTED|Overall Study||62
5355075|NCT00150592|13174366|P2|NOT COMPLETED|Overall Study||3
5355076|NCT00150592|13174367|P1|NOT COMPLETED|Overall Study||7
5355077|NCT00150592|13174366|P2|COMPLETED|Overall Study||54
5355078|NCT00150592|13174367|P1|COMPLETED|Overall Study||114
5355079|NCT00150592|13174366|P2|STARTED|Overall Study||57
5355080|NCT00150592|13174367|P1|STARTED|Overall Study||121
5355081|NCT00150462|13174398|P11|NOT COMPLETED|Overall Study||3
5355082|NCT00150462|13174399|P10|NOT COMPLETED|Overall Study||6
5355083|NCT00150462|13174400|P9|NOT COMPLETED|Overall Study||6
5355084|NCT00150462|13174401|P8|NOT COMPLETED|Overall Study||8
5355085|NCT00150462|13174402|P7|NOT COMPLETED|Overall Study||3
5355086|NCT00150462|13174403|P6|NOT COMPLETED|Overall Study||4
5355087|NCT00150462|13174404|P5|NOT COMPLETED|Overall Study||3
5355088|NCT00150462|13174405|P4|NOT COMPLETED|Overall Study||3
5355089|NCT00150462|13174406|P3|NOT COMPLETED|Overall Study||4
5355090|NCT00150462|13174407|P2|NOT COMPLETED|Overall Study||3
5355091|NCT00150462|13174408|P1|NOT COMPLETED|Overall Study||3
5355092|NCT00150462|13174398|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
5355093|NCT00150462|13174399|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
5355094|NCT00150462|13174400|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355095|NCT00150462|13174401|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355096|NCT00150462|13174402|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355097|NCT00150462|13174403|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355098|NCT00150462|13174404|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355099|NCT00150462|13174405|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355100|NCT00150462|13174406|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355101|NCT00150462|13174407|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355102|NCT00150462|13174408|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
5355103|NCT00150462|13174398|P11|STARTED|Overall Study||4
5355104|NCT00150462|13174399|P10|STARTED|Overall Study||7
5355105|NCT00150462|13174400|P9|STARTED|Overall Study||6
5355106|NCT00150462|13174401|P8|STARTED|Overall Study||8
5355107|NCT00150462|13174402|P7|STARTED|Overall Study||3
5355108|NCT00150462|13174403|P6|STARTED|Overall Study||4
5355109|NCT00150462|13174404|P5|STARTED|Overall Study||3
5355110|NCT00150462|13174405|P4|STARTED|Overall Study||3
5355111|NCT00150462|13174406|P3|STARTED|Overall Study||4
5355112|NCT00150462|13174407|P2|STARTED|Overall Study||3
5355113|NCT00150462|13174408|P1|STARTED|Overall Study||3
5355114|NCT00150345|13174518|P2|NOT COMPLETED|Overall Study||32
5355115|NCT00150345|13174519|P1|NOT COMPLETED|Overall Study||34
5355116|NCT00150345|13174518|P2|COMPLETED|Overall Study||34
5355117|NCT00150345|13174519|P1|COMPLETED|Overall Study||47
5355118|NCT00150345|13174518|P2|STARTED|Overall Study||66
5355119|NCT00150345|13174519|P1|STARTED|Overall Study||81
5355120|NCT00150176|13174583|P2|NOT COMPLETED|Overall Study||120
5355121|NCT00150176|13174584|P1|NOT COMPLETED|Overall Study||59
5355122|NCT00150176|13174583|P2|COMPLETED|Overall Study||72
5355123|NCT00150176|13174584|P1|COMPLETED|Overall Study||135
5355124|NCT00150176|13174583|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
5355125|NCT00150176|13174584|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
5355126|NCT00149994|13174595|P2|NOT COMPLETED|Overall Study||1
5355127|NCT00149994|13174596|P1|NOT COMPLETED|Overall Study||1
5355128|NCT00149994|13174595|P2|COMPLETED|Overall Study||85
5355129|NCT00149994|13174596|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
5355130|NCT00149994|13174595|P2|STARTED|Overall Study||86
5355131|NCT00149994|13174596|P1|STARTED|Overall Study|"Started indicates Safety population."|85
5355132|NCT00149890|13174604|P2|NOT COMPLETED|Overall Study||18
5355133|NCT00149890|13174605|P1|NOT COMPLETED|Overall Study||13
5355134|NCT00149890|13174604|P2|COMPLETED|Overall Study||20
5355135|NCT00149890|13174605|P1|COMPLETED|Overall Study||26
5355136|NCT00149890|13174604|P2|STARTED|Overall Study||38
5355137|NCT00149890|13174605|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
5355138|NCT00149838|13174625|P4|NOT COMPLETED|Phase III||24
5355139|NCT00149838|13174626|P3|NOT COMPLETED|Phase III||0
5355140|NCT00149838|13174627|P2|NOT COMPLETED|Phase III||0
5355141|NCT00149838|13174628|P1|NOT COMPLETED|Phase III||0
5355142|NCT00149838|13174625|P4|COMPLETED|Phase III||37
5355143|NCT00149838|13174626|P3|COMPLETED|Phase III||0
5355144|NCT00149838|13174627|P2|COMPLETED|Phase III||0
5355145|NCT00149838|13174628|P1|COMPLETED|Phase III||0
5355146|NCT00149838|13174625|P4|STARTED|Phase III||61
5355147|NCT00149838|13174626|P3|STARTED|Phase III||0
5355148|NCT00149838|13174627|P2|STARTED|Phase III||0
5355149|NCT00149838|13174628|P1|STARTED|Phase III||0
5355150|NCT00149838|13174625|P4|NOT COMPLETED|Phase II||0
5355151|NCT00149838|13174626|P3|NOT COMPLETED|Phase II||0
5355152|NCT00149838|13174627|P2|NOT COMPLETED|Phase II||0
5355153|NCT00149838|13174628|P1|NOT COMPLETED|Phase II||0
5355154|NCT00149838|13174625|P4|COMPLETED|Phase II||0
5355155|NCT00149838|13174626|P3|COMPLETED|Phase II||144
5355156|NCT00149838|13174627|P2|COMPLETED|Phase II||0
5355157|NCT00149838|13174628|P1|COMPLETED|Phase II||0
5355158|NCT00149838|13174625|P4|STARTED|Phase II||0
5355159|NCT00149838|13174626|P3|STARTED|Phase II||144
5355160|NCT00149838|13174627|P2|STARTED|Phase II||0
5355161|NCT00149838|13174628|P1|STARTED|Phase II||0
5355162|NCT00149838|13174625|P4|NOT COMPLETED|Phase I||0
5355163|NCT00149838|13174626|P3|NOT COMPLETED|Phase I||0
5355164|NCT00149838|13174627|P2|NOT COMPLETED|Phase I||16
5355165|NCT00149838|13174628|P1|NOT COMPLETED|Phase I||20
5355166|NCT00149838|13174625|P4|COMPLETED|Phase I||0
5355167|NCT00149838|13174626|P3|COMPLETED|Phase I||0
5355168|NCT00149838|13174627|P2|COMPLETED|Phase I||82
5355169|NCT00149838|13174628|P1|COMPLETED|Phase I||72
5355170|NCT00149838|13174625|P4|STARTED|Phase I||0
5355171|NCT00149838|13174626|P3|STARTED|Phase I||0
5355172|NCT00149838|13174627|P2|STARTED|Phase I||98
5355173|NCT00149838|13174628|P1|STARTED|Phase I||92
5355174|NCT00149825|13174640|P2|NOT COMPLETED|Overall Study||3
5355175|NCT00149825|13174641|P1|NOT COMPLETED|Overall Study||5
5355176|NCT00149825|13174640|P2|COMPLETED|Overall Study||12
5355177|NCT00149825|13174641|P1|COMPLETED|Overall Study||10
5355178|NCT00149825|13174640|P2|STARTED|Overall Study||15
5355179|NCT00149825|13174641|P1|STARTED|Overall Study||15
5355180|NCT00149799|13174651|P3|NOT COMPLETED|Discontinuation (Phase II)||9
5355181|NCT00149799|13174652|P2|NOT COMPLETED|Discontinuation (Phase II)||3
5355182|NCT00149799|13174653|P1|NOT COMPLETED|Discontinuation (Phase II)||0
5355183|NCT00149799|13174651|P3|COMPLETED|Discontinuation (Phase II)||21
5355184|NCT00149799|13174652|P2|COMPLETED|Discontinuation (Phase II)||25
5355185|NCT00149799|13174653|P1|COMPLETED|Discontinuation (Phase II)||0
5355186|NCT00149799|13174651|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
5355187|NCT00149799|13174652|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
5355188|NCT00149799|13174653|P1|STARTED|Discontinuation (Phase II)||0
5355189|NCT00149799|13174651|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
5355190|NCT00149799|13174652|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
5355191|NCT00149799|13174653|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
5355192|NCT00149799|13174651|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
5355193|NCT00149799|13174652|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
5355194|NCT00149799|13174653|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
5355195|NCT00149799|13174651|P3|STARTED|Open Label Escitalopram (Phase I)||0
5355196|NCT00149799|13174652|P2|STARTED|Open Label Escitalopram (Phase I)||0
5355197|NCT00149799|13174653|P1|STARTED|Open Label Escitalopram (Phase I)||100
5355198|NCT00149747|13174669|P2|NOT COMPLETED|Overall Study||3
5355199|NCT00149747|13174670|P1|NOT COMPLETED|Overall Study||4
5355200|NCT00149747|13174669|P2|COMPLETED|Overall Study||27
5355201|NCT00149747|13174670|P1|COMPLETED|Overall Study||32
5355202|NCT00149747|13174669|P2|STARTED|Overall Study||30
5355203|NCT00149747|13174670|P1|STARTED|Overall Study||36
5355204|NCT00149669|13174682|P2|NOT COMPLETED|Overall Study||5
5355205|NCT00149669|13174683|P1|NOT COMPLETED|Overall Study||3
5355206|NCT00149669|13174682|P2|COMPLETED|Overall Study||30
5355207|NCT00149669|13174683|P1|COMPLETED|Overall Study||29
5355208|NCT00149669|13174682|P2|STARTED|Overall Study||35
5355209|NCT00149669|13174683|P1|STARTED|Overall Study||32
5355210|NCT00149643|13174703|P2|NOT COMPLETED|Overall Study||36
5355211|NCT00149643|13174704|P1|NOT COMPLETED|Overall Study||34
5355212|NCT00149643|13174703|P2|COMPLETED|Overall Study||0
5355213|NCT00149643|13174704|P1|COMPLETED|Overall Study||0
5355214|NCT00149643|13174703|P2|STARTED|Overall Study||36
5355215|NCT00149643|13174704|P1|STARTED|Overall Study||34
5355216|NCT00149630|13174716|P2|NOT COMPLETED|Overall Study||5
5355217|NCT00149630|13174717|P1|NOT COMPLETED|Overall Study||8
5355218|NCT00149630|13174716|P2|COMPLETED|Overall Study||35
5355219|NCT00149630|13174717|P1|COMPLETED|Overall Study||26
5355220|NCT00149630|13174716|P2|STARTED|Overall Study||40
5355221|NCT00149630|13174717|P1|STARTED|Overall Study||34
5355222|NCT00149396|13174727|P1|NOT COMPLETED|Overall Study||23
5355223|NCT00149396|13174727|P1|COMPLETED|Overall Study||9
5355224|NCT00149396|13174727|P1|Completed NV1020 and Chemotherapy|Overall Study||9
5355225|NCT00149396|13174727|P1|Completed NV1020 Therapy|Overall Study||29
5355226|NCT00149396|13174727|P1|STARTED|Overall Study||32
5355227|NCT00149227|13174770|P2|NOT COMPLETED|Overall Study||0
5355228|NCT00149227|13174771|P1|NOT COMPLETED|Overall Study||0
5355229|NCT00149227|13174770|P2|COMPLETED|Overall Study||1514
5355230|NCT00149227|13174771|P1|COMPLETED|Overall Study||1517
5355231|NCT00149227|13174770|P2|STARTED|Overall Study||1514
5355232|NCT00149227|13174771|P1|STARTED|Overall Study||1517
5355233|NCT00149214|13174797|P2|NOT COMPLETED|Overall Study||17
5355234|NCT00149214|13174798|P1|NOT COMPLETED|Overall Study||26
5355235|NCT00149214|13174797|P2|COMPLETED|Overall Study||105
5355236|NCT00149214|13174798|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
5355237|NCT00149214|13174797|P2|STARTED|Overall Study||122
5355238|NCT00149214|13174798|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
5355239|NCT00148954|13174814|P2|NOT COMPLETED|Overall Study||300
5355240|NCT00148954|13174815|P1|NOT COMPLETED|Overall Study||307
5355241|NCT00148954|13174814|P2|COMPLETED|Overall Study||677
5355242|NCT00148954|13174815|P1|COMPLETED|Overall Study||678
5355243|NCT00148954|13174814|P2|STARTED|Overall Study||977
5355244|NCT00148954|13174815|P1|STARTED|Overall Study||985
5355245|NCT00148941|13174825|P4|NOT COMPLETED|Overall Study||24
5355246|NCT00148941|13174826|P3|NOT COMPLETED|Overall Study||20
5355247|NCT00148941|13174827|P2|NOT COMPLETED|Overall Study||24
5355248|NCT00148941|13174828|P1|NOT COMPLETED|Overall Study||18
5355249|NCT00148941|13174825|P4|COMPLETED|Overall Study||1029
5355250|NCT00148941|13174826|P3|COMPLETED|Overall Study||1032
5355251|NCT00148941|13174827|P2|COMPLETED|Overall Study||1027
5355252|NCT00148941|13174828|P1|COMPLETED|Overall Study||1035
5355253|NCT00148941|13174825|P4|STARTED|Overall Study||1053
5355254|NCT00148941|13174826|P3|STARTED|Overall Study||1052
5355255|NCT00148941|13174827|P2|STARTED|Overall Study||1051
5355256|NCT00148941|13174828|P1|STARTED|Overall Study||1053
5355257|NCT00148798|13174920|P2|NOT COMPLETED|Overall Study||0
5355258|NCT00148798|13174921|P1|NOT COMPLETED|Overall Study||0
5355259|NCT00148798|13174920|P2|COMPLETED|Overall Study||568
5355260|NCT00148798|13174921|P1|COMPLETED|Overall Study||557
5355261|NCT00148798|13174920|P2|STARTED|Overall Study|ITT Population|568
5355262|NCT00148798|13174921|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
5355263|NCT00148759|13174943|P2|NOT COMPLETED|Overall Study||1
5355264|NCT00148759|13174944|P1|NOT COMPLETED|Overall Study||2
5355265|NCT00148759|13174943|P2|COMPLETED|Overall Study||11
5355266|NCT00148759|13174944|P1|COMPLETED|Overall Study||9
5355267|NCT00148759|13174943|P2|24-hr PK Sampling|Overall Study||11
5355268|NCT00148759|13174944|P1|24-hr PK Sampling|Overall Study||9
5355269|NCT00148759|13174943|P2|STARTED|Overall Study||12
5355270|NCT00148759|13174944|P1|STARTED|Overall Study||11
5355271|NCT00148733|13174954|P2|NOT COMPLETED|Overall Study||15
5355272|NCT00148733|13174955|P1|NOT COMPLETED|Overall Study||14
5355273|NCT00148733|13174954|P2|COMPLETED|Overall Study||1299
5355274|NCT00148733|13174955|P1|COMPLETED|Overall Study||1300
5355275|NCT00148733|13174954|P2|STARTED|Overall Study||1314
5355276|NCT00148733|13174955|P1|STARTED|Overall Study||1314
5355277|NCT00148668|13174963|P2|NOT COMPLETED|Overall Study||0
5355278|NCT00148668|13174964|P1|NOT COMPLETED|Overall Study||0
5355279|NCT00148668|13174963|P2|COMPLETED|Overall Study||40
5355280|NCT00148668|13174964|P1|COMPLETED|Overall Study||41
5355281|NCT00148668|13174963|P2|STARTED|Overall Study||40
5355282|NCT00148668|13174964|P1|STARTED|Overall Study||41
5355283|NCT00148343|13174972|P2|NOT COMPLETED|Overall Study||11
5355284|NCT00148343|13174973|P1|NOT COMPLETED|Overall Study||15
5355285|NCT00148343|13174972|P2|COMPLETED|Overall Study||45
5355286|NCT00148343|13174973|P1|COMPLETED|Overall Study||39
5355287|NCT00148343|13174972|P2|STARTED|Overall Study||56
5355288|NCT00148343|13174973|P1|STARTED|Overall Study||54
5355289|NCT00148317|13174987|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
5355290|NCT00148317|13174987|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
5355291|NCT00148317|13174987|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
5355292|NCT00148317|13174987|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
5355293|NCT00148317|13174987|P1|COMPLETED|Consolidation (VEL + DEX)||38
5355294|NCT00148317|13174987|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
5355295|NCT00148317|13174987|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
5355296|NCT00148317|13174987|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
5355297|NCT00148317|13174987|P1|STARTED|Consolidation (VEL + DEX)||38
5355298|NCT00148122|13174994|P1|NOT COMPLETED|Overall Study||2
5355299|NCT00148122|13174994|P1|COMPLETED|Overall Study||38
5355300|NCT00148122|13174994|P1|STARTED|Overall Study||40
5355301|NCT00148109|13175002|P2|NOT COMPLETED|Overall Study||20
5355302|NCT00148109|13175003|P1|NOT COMPLETED|Overall Study||12
5355303|NCT00148109|13175002|P2|COMPLETED|Overall Study||1
5355304|NCT00148109|13175003|P1|COMPLETED|Overall Study||3
5355305|NCT00148109|13175002|P2|STARTED|Overall Study||21
5355306|NCT00148109|13175003|P1|STARTED|Overall Study||15
5355307|NCT00147966|13175013|P1|NOT COMPLETED|Overall Study||0
5355308|NCT00147966|13175013|P1|COMPLETED|Overall Study||24
5355309|NCT00147966|13175013|P1|STARTED|Overall Study||24
5355310|NCT00147823|13175019|P2|NOT COMPLETED|Overall Study||15
5355311|NCT00147823|13175020|P1|NOT COMPLETED|Overall Study||13
5355312|NCT00147823|13175019|P2|COMPLETED|Overall Study||16
5355313|NCT00147823|13175020|P1|COMPLETED|Overall Study||19
5355314|NCT00147823|13175019|P2|Month 24 Visit|Overall Study||18
5355315|NCT00147823|13175020|P1|Month 24 Visit|Overall Study||21
5355316|NCT00147823|13175019|P2|Month 18 Visit|Overall Study||20
5355317|NCT00147823|13175020|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
5355318|NCT00147823|13175019|P2|Month 12 CT Scan|Overall Study||25
5355319|NCT00147823|13175020|P1|Month 12 CT Scan|Overall Study||20
5355320|NCT00147823|13175019|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
5355321|NCT00147823|13175020|P1|Month 12 Visit|Overall Study||21
5355322|NCT00147823|13175019|P2|Month 6 Visit|Overall Study||21
5355323|NCT00147823|13175020|P1|Month 6 Visit|Overall Study||25
5355324|NCT00147823|13175019|P2|Month 3 Visit|Overall Study||24
5355325|NCT00147823|13175020|P1|Month 3 Visit|Overall Study||25
5355326|NCT00147823|13175019|P2|Week 6 Visit|Overall Study||28
5355327|NCT00147823|13175020|P1|Week 6 Visit|Overall Study||26
5355328|NCT00147823|13175019|P2|STARTED|Overall Study||31
5355329|NCT00147823|13175020|P1|STARTED|Overall Study||32
5355330|NCT00147745|13175051|P3|NOT COMPLETED|Overall Study||0
5355331|NCT00147745|13175052|P2|NOT COMPLETED|Overall Study||0
5355332|NCT00147745|13175053|P1|NOT COMPLETED|Overall Study||1
5355333|NCT00147745|13175051|P3|COMPLETED|Overall Study||6
5355334|NCT00147745|13175052|P2|COMPLETED|Overall Study||14
5355335|NCT00147745|13175053|P1|COMPLETED|Overall Study||15
5355336|NCT00147745|13175051|P3|STARTED|Overall Study||6
5355337|NCT00147745|13175052|P2|STARTED|Overall Study||14
5355338|NCT00147745|13175053|P1|STARTED|Overall Study||16
5355339|NCT00147537|13175075|P11|NOT COMPLETED|Phase 2||52
5355340|NCT00147537|13175076|P10|NOT COMPLETED|Phase 2||161
5355341|NCT00147537|13175077|P9|NOT COMPLETED|Phase 2||0
5355342|NCT00147537|13175078|P8|NOT COMPLETED|Phase 2||0
5355343|NCT00147537|13175079|P7|NOT COMPLETED|Phase 2||0
5355344|NCT00147537|13175080|P6|NOT COMPLETED|Phase 2||0
5355345|NCT00147537|13175081|P5|NOT COMPLETED|Phase 2||0
5355346|NCT00147537|13175082|P4|NOT COMPLETED|Phase 2||0
5355347|NCT00147537|13175083|P3|NOT COMPLETED|Phase 2||0
5355348|NCT00147537|13175084|P2|NOT COMPLETED|Phase 2||0
5355349|NCT00147537|13175085|P1|NOT COMPLETED|Phase 2||0
5355350|NCT00147537|13175075|P11|COMPLETED|Phase 2||3
5355351|NCT00147537|13175076|P10|COMPLETED|Phase 2||5
5355352|NCT00147537|13175077|P9|COMPLETED|Phase 2||0
5355353|NCT00147537|13175078|P8|COMPLETED|Phase 2||0
5355354|NCT00147537|13175079|P7|COMPLETED|Phase 2||0
5355355|NCT00147537|13175080|P6|COMPLETED|Phase 2||0
5355356|NCT00147537|13175081|P5|COMPLETED|Phase 2||0
5355357|NCT00147537|13175082|P4|COMPLETED|Phase 2||0
5355358|NCT00147537|13175083|P3|COMPLETED|Phase 2||0
5355359|NCT00147537|13175084|P2|COMPLETED|Phase 2||0
5355360|NCT00147537|13175085|P1|COMPLETED|Phase 2||0
5355361|NCT00147537|13175075|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
5355362|NCT00147537|13175076|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
5355363|NCT00147537|13175077|P9|STARTED|Phase 2||0
5355364|NCT00147537|13175078|P8|STARTED|Phase 2||0
5355365|NCT00147537|13175079|P7|STARTED|Phase 2||0
5355366|NCT00147537|13175080|P6|STARTED|Phase 2||0
5355367|NCT00147537|13175081|P5|STARTED|Phase 2||0
5355368|NCT00147537|13175082|P4|STARTED|Phase 2||0
5355369|NCT00147537|13175083|P3|STARTED|Phase 2||0
5355370|NCT00147537|13175084|P2|STARTED|Phase 2||0
5355371|NCT00147537|13175085|P1|STARTED|Phase 2||0
5355372|NCT00147537|13175075|P11|NOT COMPLETED|Phase 1b||0
5355373|NCT00147537|13175076|P10|NOT COMPLETED|Phase 1b||0
5355374|NCT00147537|13175077|P9|NOT COMPLETED|Phase 1b||17
5355375|NCT00147537|13175078|P8|NOT COMPLETED|Phase 1b||7
5355376|NCT00147537|13175079|P7|NOT COMPLETED|Phase 1b||18
5355377|NCT00147537|13175080|P6|NOT COMPLETED|Phase 1b||3
5355378|NCT00147537|13175081|P5|NOT COMPLETED|Phase 1b||3
5355379|NCT00147537|13175082|P4|NOT COMPLETED|Phase 1b||2
5355380|NCT00147537|13175083|P3|NOT COMPLETED|Phase 1b||4
5355381|NCT00147537|13175084|P2|NOT COMPLETED|Phase 1b||2
5355382|NCT00147537|13175085|P1|NOT COMPLETED|Phase 1b||2
5355383|NCT00147537|13175075|P11|COMPLETED|Phase 1b||0
5355384|NCT00147537|13175076|P10|COMPLETED|Phase 1b||0
5355385|NCT00147537|13175077|P9|COMPLETED|Phase 1b||1
5355386|NCT00147537|13175078|P8|COMPLETED|Phase 1b||0
5355387|NCT00147537|13175079|P7|COMPLETED|Phase 1b||0
5355388|NCT00147537|13175080|P6|COMPLETED|Phase 1b||0
5355389|NCT00147537|13175081|P5|COMPLETED|Phase 1b||0
5355390|NCT00147537|13175082|P4|COMPLETED|Phase 1b||1
5355391|NCT00147537|13175083|P3|COMPLETED|Phase 1b||0
5355392|NCT00147537|13175084|P2|COMPLETED|Phase 1b||0
5355393|NCT00147537|13175085|P1|COMPLETED|Phase 1b||1
5355394|NCT00147537|13175075|P11|STARTED|Phase 1b||0
5355395|NCT00147537|13175076|P10|STARTED|Phase 1b||0
5355396|NCT00147537|13175077|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
5355397|NCT00147537|13175078|P8|STARTED|Phase 1b||7
5355398|NCT00147537|13175079|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
5355399|NCT00147537|13175080|P6|STARTED|Phase 1b||3
5355400|NCT00147537|13175081|P5|STARTED|Phase 1b||3
5355401|NCT00147537|13175082|P4|STARTED|Phase 1b||3
5355402|NCT00147537|13175083|P3|STARTED|Phase 1b||4
5355403|NCT00147537|13175084|P2|STARTED|Phase 1b||2
5355404|NCT00147537|13175085|P1|STARTED|Phase 1b||3
5355405|NCT00147498|13175268|P4|NOT COMPLETED|Overall Study||17
5355406|NCT00147498|13175269|P3|NOT COMPLETED|Overall Study||17
5355407|NCT00147498|13175270|P2|NOT COMPLETED|Overall Study||9
5355408|NCT00147498|13175271|P1|NOT COMPLETED|Overall Study||3
5355409|NCT00147498|13175268|P4|COMPLETED|Overall Study||48
5355410|NCT00147498|13175269|P3|COMPLETED|Overall Study||52
5355411|NCT00147498|13175270|P2|COMPLETED|Overall Study||60
5355412|NCT00147498|13175271|P1|COMPLETED|Overall Study||58
5355413|NCT00147498|13175268|P4|STARTED|Overall Study||65
5355414|NCT00147498|13175269|P3|STARTED|Overall Study||69
5355415|NCT00147498|13175270|P2|STARTED|Overall Study||69
5355416|NCT00147498|13175271|P1|STARTED|Overall Study||61
5355417|NCT00147446|13175367|P2|NOT COMPLETED|Overall Study||0
5355418|NCT00147446|13175368|P1|NOT COMPLETED|Overall Study||0
5355419|NCT00147446|13175367|P2|COMPLETED|Overall Study||61
5355420|NCT00147446|13175368|P1|COMPLETED|Overall Study||60
5355421|NCT00147446|13175367|P2|STARTED|Overall Study||61
5355422|NCT00147446|13175368|P1|STARTED|Overall Study||60
5355423|NCT00147316|13175376|P1|NOT COMPLETED|Overall Study||0
5355424|NCT00147316|13175376|P1|COMPLETED|Overall Study||103
5355425|NCT00147316|13175376|P1|STARTED|Overall Study||103
5355426|NCT00147290|13175383|P2|NOT COMPLETED|Overall Study||0
5355427|NCT00147290|13175384|P1|NOT COMPLETED|Overall Study||0
5355428|NCT00147290|13175383|P2|COMPLETED|Overall Study||260
5355429|NCT00147290|13175384|P1|COMPLETED|Overall Study||266
5355430|NCT00147290|13175383|P2|STARTED|Overall Study||260
5355431|NCT00147290|13175384|P1|STARTED|Overall Study||266
5355432|NCT00147277|13175390|P2|NOT COMPLETED|Overall Study||0
5355433|NCT00147277|13175391|P1|NOT COMPLETED|Overall Study||0
5355434|NCT00147277|13175390|P2|COMPLETED|Overall Study||450
5355435|NCT00147277|13175391|P1|COMPLETED|Overall Study||475
5355436|NCT00147277|13175390|P2|STARTED|Overall Study||450
5355437|NCT00147277|13175391|P1|STARTED|Overall Study||475
5355438|NCT00147238|13175395|P1|NOT COMPLETED|Overall Study||8
5355439|NCT00147238|13175395|P1|COMPLETED|Overall Study||2
5355440|NCT00147238|13175395|P1|STARTED|Overall Study||10
5355441|NCT00147225|13175405|P6|NOT COMPLETED|Overall Study||2
5355442|NCT00147225|13175406|P5|NOT COMPLETED|Overall Study||1
5355443|NCT00147225|13175407|P4|NOT COMPLETED|Overall Study||1
5355444|NCT00147225|13175408|P3|NOT COMPLETED|Overall Study||2
5355445|NCT00147225|13175409|P2|NOT COMPLETED|Overall Study||0
5355446|NCT00147225|13175410|P1|NOT COMPLETED|Overall Study||1
5355447|NCT00147225|13175405|P6|COMPLETED|Overall Study||10
5355448|NCT00147225|13175406|P5|COMPLETED|Overall Study||10
5355449|NCT00147225|13175407|P4|COMPLETED|Overall Study||10
5355450|NCT00147225|13175408|P3|COMPLETED|Overall Study||6
5355451|NCT00147225|13175409|P2|COMPLETED|Overall Study||6
5355452|NCT00147225|13175410|P1|COMPLETED|Overall Study||6
5355453|NCT00147225|13175405|P6|STARTED|Overall Study||12
5355454|NCT00147225|13175406|P5|STARTED|Overall Study||11
5355455|NCT00147225|13175407|P4|STARTED|Overall Study||11
5355456|NCT00147225|13175408|P3|STARTED|Overall Study||8
5355457|NCT00147225|13175409|P2|STARTED|Overall Study||6
5355458|NCT00147225|13175410|P1|STARTED|Overall Study||7
5355459|NCT00147212|13175430|P1|NOT COMPLETED|Overall Study||0
5355460|NCT00147212|13175430|P1|COMPLETED|Overall Study||50
5355461|NCT00147212|13175430|P1|STARTED|Overall Study||50
5355462|NCT00147199|13175436|P2|NOT COMPLETED|Overall Study||10
5355463|NCT00147199|13175437|P1|NOT COMPLETED|Overall Study||13
5355464|NCT00147199|13175436|P2|COMPLETED|Overall Study||110
5355465|NCT00147199|13175437|P1|COMPLETED|Overall Study||102
5355466|NCT00147199|13175436|P2|STARTED|Overall Study||120
5355467|NCT00147199|13175437|P1|STARTED|Overall Study||115
5355468|NCT00147082|13175462|P3|NOT COMPLETED|Overall Study||0
5355469|NCT00147082|13175463|P2|NOT COMPLETED|Overall Study||0
5355470|NCT00147082|13175464|P1|NOT COMPLETED|Overall Study||0
5355471|NCT00147082|13175462|P3|COMPLETED|Overall Study||30
5355472|NCT00147082|13175463|P2|COMPLETED|Overall Study||33
5355473|NCT00147082|13175464|P1|COMPLETED|Overall Study||37
5355474|NCT00147082|13175462|P3|STARTED|Overall Study||30
5355475|NCT00147082|13175463|P2|STARTED|Overall Study||33
5355476|NCT00147082|13175464|P1|STARTED|Overall Study||37
5355477|NCT00147069|13175482|P4|NOT COMPLETED|Overall Study||0
5355478|NCT00147069|13175483|P3|NOT COMPLETED|Overall Study||0
5355479|NCT00147069|13175484|P2|NOT COMPLETED|Overall Study||0
5355480|NCT00147069|13175485|P1|NOT COMPLETED|Overall Study||0
5355481|NCT00147069|13175482|P4|COMPLETED|Overall Study||15
5355482|NCT00147069|13175483|P3|COMPLETED|Overall Study||15
5355483|NCT00147069|13175484|P2|COMPLETED|Overall Study||15
5355484|NCT00147069|13175485|P1|COMPLETED|Overall Study||15
5355485|NCT00147069|13175482|P4|STARTED|Overall Study||15
5355486|NCT00147069|13175483|P3|STARTED|Overall Study||15
5355487|NCT00147069|13175484|P2|STARTED|Overall Study||15
5355488|NCT00147069|13175485|P1|STARTED|Overall Study||15
5355489|NCT00147043|13175507|P1|NOT COMPLETED|Overall Study||0
5355490|NCT00147043|13175507|P1|COMPLETED|Overall Study||5
5355491|NCT00147043|13175507|P1|STARTED|Overall Study||5
5355492|NCT00147030|13175514|P2|NOT COMPLETED|Overall Study||0
5355493|NCT00147030|13175515|P1|NOT COMPLETED|Overall Study||0
5355494|NCT00147030|13175514|P2|COMPLETED|Overall Study||162
5355495|NCT00147030|13175515|P1|COMPLETED|Overall Study||163
5355496|NCT00147030|13175514|P2|STARTED|Overall Study||162
5355497|NCT00147030|13175515|P1|STARTED|Overall Study||163
5355498|NCT00147017|13175566|P3|NOT COMPLETED|Overall Study||0
5355499|NCT00147017|13175567|P2|NOT COMPLETED|Overall Study||0
5355500|NCT00147017|13175568|P1|NOT COMPLETED|Overall Study||0
5355501|NCT00147017|13175566|P3|COMPLETED|Overall Study||4
5355502|NCT00147017|13175567|P2|COMPLETED|Overall Study||7
5355503|NCT00147017|13175568|P1|COMPLETED|Overall Study||6
5355504|NCT00147017|13175566|P3|STARTED|Overall Study||4
5355505|NCT00147017|13175567|P2|STARTED|Overall Study||7
5355506|NCT00147017|13175568|P1|STARTED|Overall Study||6
5355507|NCT00146848|13175585|P3|NOT COMPLETED|Post-randomization||39
5355508|NCT00146848|13175586|P2|NOT COMPLETED|Post-randomization||47
5355509|NCT00146848|13175587|P1|NOT COMPLETED|Post-randomization||38
5355510|NCT00146848|13175585|P3|COMPLETED|Post-randomization||431
5355511|NCT00146848|13175586|P2|COMPLETED|Post-randomization||441
5355512|NCT00146848|13175587|P1|COMPLETED|Post-randomization||437
5355513|NCT00146848|13175585|P3|STARTED|Post-randomization||470
5355514|NCT00146848|13175586|P2|STARTED|Post-randomization||488
5355515|NCT00146848|13175587|P1|STARTED|Post-randomization||475
5355516|NCT00146848|13175585|P3|NOT COMPLETED|Pre-randomization||0
5355517|NCT00146848|13175586|P2|NOT COMPLETED|Pre-randomization||0
5355518|NCT00146848|13175587|P1|NOT COMPLETED|Pre-randomization||309
5355519|NCT00146848|13175585|P3|COMPLETED|Pre-randomization||0
5355520|NCT00146848|13175586|P2|COMPLETED|Pre-randomization||0
5355521|NCT00146848|13175587|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
5355522|NCT00146848|13175585|P3|STARTED|Pre-randomization||0
5355523|NCT00146848|13175586|P2|STARTED|Pre-randomization||0
5355524|NCT00146848|13175587|P1|STARTED|Pre-randomization|Registered|1742
5355525|NCT00146770|13175603|P2|NOT COMPLETED|Overall Study||0
5355526|NCT00146770|13175604|P1|NOT COMPLETED|Overall Study||5
5355527|NCT00146770|13175603|P2|COMPLETED|Overall Study||22
5355528|NCT00146770|13175604|P1|COMPLETED|Overall Study||18
5355529|NCT00146770|13175603|P2|STARTED|Overall Study||22
5355530|NCT00146770|13175604|P1|STARTED|Overall Study||23
5355531|NCT00146757|13175622|P2|NOT COMPLETED|Overall Study||0
5355532|NCT00146757|13175623|P1|NOT COMPLETED|Overall Study||2
5355533|NCT00146757|13175622|P2|COMPLETED|Overall Study||4
5355534|NCT00146757|13175623|P1|COMPLETED|Overall Study||14
5355535|NCT00146757|13175622|P2|STARTED|Overall Study||4
5355536|NCT00146757|13175623|P1|STARTED|Overall Study||16
5355537|NCT00146640|13175642|P2|NOT COMPLETED|Overall Study||14
5355538|NCT00146640|13175643|P1|NOT COMPLETED|Overall Study||23
5355539|NCT00146640|13175642|P2|COMPLETED|Overall Study||130
5355540|NCT00146640|13175643|P1|COMPLETED|Overall Study||121
5355541|NCT00146640|13175642|P2|STARTED|Overall Study||144
5355542|NCT00146640|13175643|P1|STARTED|Overall Study||144
5355543|NCT00146328|13175666|P3|NOT COMPLETED|Overall Study||291
5355544|NCT00146328|13175667|P2|NOT COMPLETED|Overall Study||154
5355545|NCT00146328|13175668|P1|NOT COMPLETED|Overall Study||141
5355546|NCT00146328|13175666|P3|COMPLETED|Overall Study||158
5355547|NCT00146328|13175667|P2|COMPLETED|Overall Study||101
5355548|NCT00146328|13175668|P1|COMPLETED|Overall Study||150
5355549|NCT00146328|13175666|P3|STARTED|Overall Study||449
5355550|NCT00146328|13175667|P2|STARTED|Overall Study||255
5355551|NCT00146328|13175668|P1|STARTED|Overall Study||291
5355552|NCT00146172|13175759|P8|NOT COMPLETED|Overall Study||40
5355553|NCT00146172|13175760|P7|NOT COMPLETED|Overall Study||6
5355554|NCT00146172|13175761|P6|NOT COMPLETED|Overall Study||7
5355555|NCT00146172|13175762|P5|NOT COMPLETED|Overall Study||3
5355556|NCT00146172|13175763|P4|NOT COMPLETED|Overall Study||6
5355557|NCT00146172|13175764|P3|NOT COMPLETED|Overall Study||4
5355558|NCT00146172|13175765|P2|NOT COMPLETED|Overall Study||4
5355559|NCT00146172|13175766|P1|NOT COMPLETED|Overall Study||3
5355560|NCT00146172|13175759|P8|COMPLETED|Overall Study||0
5355561|NCT00146172|13175760|P7|COMPLETED|Overall Study||0
5355562|NCT00146172|13175761|P6|COMPLETED|Overall Study||0
5355563|NCT00146172|13175762|P5|COMPLETED|Overall Study||0
5355564|NCT00146172|13175763|P4|COMPLETED|Overall Study||0
5355565|NCT00146172|13175764|P3|COMPLETED|Overall Study||0
5355566|NCT00146172|13175765|P2|COMPLETED|Overall Study||0
5355567|NCT00146172|13175766|P1|COMPLETED|Overall Study||0
5355568|NCT00146172|13175759|P8|Received Drug|Overall Study||39
5355569|NCT00146172|13175760|P7|Received Drug|Overall Study||6
5355570|NCT00146172|13175761|P6|Received Drug|Overall Study||7
5355571|NCT00146172|13175762|P5|Received Drug|Overall Study||3
5355572|NCT00146172|13175763|P4|Received Drug|Overall Study||6
5355573|NCT00146172|13175764|P3|Received Drug|Overall Study||4
5355574|NCT00146172|13175765|P2|Received Drug|Overall Study||4
5355575|NCT00146172|13175766|P1|Received Drug|Overall Study||3
5355576|NCT00146172|13175759|P8|STARTED|Overall Study||40
5355577|NCT00146172|13175760|P7|STARTED|Overall Study||6
5355578|NCT00146172|13175761|P6|STARTED|Overall Study||7
5355579|NCT00146172|13175762|P5|STARTED|Overall Study||3
5355580|NCT00146172|13175763|P4|STARTED|Overall Study||6
5355581|NCT00146172|13175764|P3|STARTED|Overall Study||4
5355582|NCT00146172|13175765|P2|STARTED|Overall Study||4
5355583|NCT00146172|13175766|P1|STARTED|Overall Study||3
5355584|NCT00145977|13175801|P2|NOT COMPLETED|Overall Study||4
5355585|NCT00145977|13175802|P1|NOT COMPLETED|Overall Study||2
5355586|NCT00145977|13175801|P2|COMPLETED|Overall Study||13
5355587|NCT00145977|13175802|P1|COMPLETED|Overall Study||17
5355588|NCT00145977|13175801|P2|STARTED|Overall Study||17
5355589|NCT00145977|13175802|P1|STARTED|Overall Study||19
5355590|NCT00145795|13175828|P2|NOT COMPLETED|Overall Study||0
5355591|NCT00145795|13175829|P1|NOT COMPLETED|Overall Study||1
5355592|NCT00145795|13175828|P2|COMPLETED|Overall Study||10
5355593|NCT00145795|13175829|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
5355594|NCT00145795|13175828|P2|STARTED|Overall Study||10
5355595|NCT00145795|13175829|P1|STARTED|Overall Study||10
5355596|NCT00145704|13175855|P2|NOT COMPLETED|Overall Study||3
5355597|NCT00145704|13175856|P1|NOT COMPLETED|Overall Study||3
5355598|NCT00145704|13175855|P2|COMPLETED|Overall Study||0
5355599|NCT00145704|13175856|P1|COMPLETED|Overall Study||0
5355600|NCT00145704|13175855|P2|STARTED|Overall Study||3
5355601|NCT00145704|13175856|P1|STARTED|Overall Study||3
5355602|NCT00145626|13175864|P1|NOT COMPLETED|Overall Study||5
5355603|NCT00145626|13175864|P1|COMPLETED|Overall Study||14
5355604|NCT00145626|13175864|P1|STARTED|Overall Study||19
5355605|NCT00145600|13175910|P4|NOT COMPLETED|Overall Study||16
5355606|NCT00145600|13175911|P3|NOT COMPLETED|Overall Study||5
5355607|NCT00145600|13175912|P2|NOT COMPLETED|Overall Study||10
5355608|NCT00145600|13175913|P1|NOT COMPLETED|Overall Study||8
5355609|NCT00145600|13175910|P4|COMPLETED|Overall Study||130
5355610|NCT00145600|13175911|P3|COMPLETED|Overall Study||8
5355611|NCT00145600|13175912|P2|COMPLETED|Overall Study||36
5355612|NCT00145600|13175913|P1|COMPLETED|Overall Study||83
5355613|NCT00145600|13175910|P4|STARTED|Overall Study||146
5355614|NCT00145600|13175911|P3|STARTED|Overall Study||13
5355615|NCT00145600|13175912|P2|STARTED|Overall Study||46
5355616|NCT00145600|13175913|P1|STARTED|Overall Study||91
5355617|NCT00145587|13176027|P2|NOT COMPLETED|Overall Study||0
5355618|NCT00145587|13176028|P1|NOT COMPLETED|Overall Study||0
5355619|NCT00145587|13176027|P2|COMPLETED|Overall Study||1
5355620|NCT00145587|13176028|P1|COMPLETED|Overall Study||5
5355621|NCT00145587|13176027|P2|STARTED|Overall Study||1
5355622|NCT00145587|13176028|P1|STARTED|Overall Study||5
5355623|NCT00145574|13176037|P3|NOT COMPLETED|Open Label Long-term Extension||11
5355624|NCT00145574|13176038|P2|NOT COMPLETED|Open Label Long-term Extension||0
5355625|NCT00145574|13176039|P1|NOT COMPLETED|Open Label Long-term Extension||0
5355626|NCT00145574|13176037|P3|COMPLETED|Open Label Long-term Extension||173
5355627|NCT00145574|13176038|P2|COMPLETED|Open Label Long-term Extension||0
5355628|NCT00145574|13176039|P1|COMPLETED|Open Label Long-term Extension||0
5355629|NCT00145574|13176037|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
5355630|NCT00145574|13176038|P2|STARTED|Open Label Long-term Extension||0
5355631|NCT00145574|13176039|P1|STARTED|Open Label Long-term Extension||0
5355632|NCT00145574|13176037|P3|NOT COMPLETED|Double Blind||2
5355633|NCT00145574|13176038|P2|NOT COMPLETED|Double Blind||5
5355634|NCT00145574|13176039|P1|NOT COMPLETED|Double Blind||1
5355635|NCT00145574|13176037|P3|COMPLETED|Double Blind||62
5355636|NCT00145574|13176038|P2|COMPLETED|Double Blind||60
5355637|NCT00145574|13176039|P1|COMPLETED|Double Blind||64
5355638|NCT00145574|13176037|P3|STARTED|Double Blind||64
5355639|NCT00145574|13176038|P2|STARTED|Double Blind||65
5355640|NCT00145574|13176039|P1|STARTED|Double Blind||65
5355641|NCT00145509|13176096|P2|NOT COMPLETED|Overall Study||21
5355642|NCT00145509|13176097|P1|NOT COMPLETED|Overall Study||22
5355643|NCT00145509|13176096|P2|COMPLETED|Overall Study||15
5355644|NCT00145509|13176097|P1|COMPLETED|Overall Study||19
5355645|NCT00145509|13176096|P2|STARTED|Overall Study||36
5355646|NCT00145509|13176097|P1|STARTED|Overall Study||41
5355647|NCT00145496|13176111|P2|NOT COMPLETED|Overall Study||81
5355648|NCT00145496|13176112|P1|NOT COMPLETED|Overall Study||123
5355649|NCT00145496|13176111|P2|COMPLETED|Overall Study||143
5355650|NCT00145496|13176112|P1|COMPLETED|Overall Study||121
5355651|NCT00145496|13176111|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
5355652|NCT00145496|13176112|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
5355653|NCT00145470|13176124|P2|NOT COMPLETED|Overall Study||98
5355654|NCT00145470|13176125|P1|NOT COMPLETED|Overall Study||112
5355655|NCT00145470|13176124|P2|COMPLETED|Overall Study||61
5355656|NCT00145470|13176125|P1|COMPLETED|Overall Study||55
5355657|NCT00145470|13176124|P2|Treated|Overall Study||158
5355658|NCT00145470|13176125|P1|Treated|Overall Study||166
5355659|NCT00145470|13176124|P2|STARTED|Overall Study||159
5355660|NCT00145470|13176125|P1|STARTED|Overall Study||167
5355661|NCT00145418|13176185|P1|NOT COMPLETED|Overall Study||0
5355662|NCT00145418|13176185|P1|COMPLETED|Overall Study||15
5355663|NCT00145418|13176185|P1|STARTED|Overall Study||15
5355664|NCT00145327|13176195|P3|NOT COMPLETED|Overall Study||248
5355665|NCT00145327|13176196|P2|NOT COMPLETED|Overall Study||124
5355666|NCT00145327|13176197|P1|NOT COMPLETED|Overall Study||142
5355667|NCT00145327|13176195|P3|COMPLETED|Overall Study||975
5355668|NCT00145327|13176196|P2|COMPLETED|Overall Study||493
5355669|NCT00145327|13176197|P1|COMPLETED|Overall Study||474
5355670|NCT00145327|13176195|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
5355671|NCT00145327|13176196|P2|STARTED|Overall Study||617
5355672|NCT00145327|13176197|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
5355673|NCT00145249|13176253|P3|NOT COMPLETED|Overall Study||17
5355674|NCT00145249|13176254|P2|NOT COMPLETED|Overall Study||15
5355675|NCT00145249|13176255|P1|NOT COMPLETED|Overall Study||11
5355676|NCT00145249|13176253|P3|COMPLETED|Overall Study||31
5355677|NCT00145249|13176254|P2|COMPLETED|Overall Study||33
5355678|NCT00145249|13176255|P1|COMPLETED|Overall Study||36
5355679|NCT00145249|13176253|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
5355680|NCT00145249|13176254|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
5355681|NCT00145249|13176255|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
5355682|NCT00145119|13176296|P1|NOT COMPLETED|Overall Study||45
5355683|NCT00145119|13176296|P1|COMPLETED|Overall Study||267
5355684|NCT00145119|13176296|P1|STARTED|Overall Study||312
5355685|NCT00145041|13176300|P1|NOT COMPLETED|Overall Study||0
5355686|NCT00145041|13176300|P1|COMPLETED|Overall Study||7
5355687|NCT00145041|13176300|P1|STARTED|Overall Study||7
5355688|NCT00144963|13176306|P1|NOT COMPLETED|Overall Study||0
5355689|NCT00144963|13176306|P1|COMPLETED|Overall Study||36
5355690|NCT00144963|13176306|P1|STARTED|Overall Study||36
5355691|NCT00144781|13176314|P4|NOT COMPLETED|Overall Study||0
5355692|NCT00144781|13176315|P3|NOT COMPLETED|Overall Study||0
5355693|NCT00144781|13176316|P2|NOT COMPLETED|Overall Study||2
5355694|NCT00144781|13176317|P1|NOT COMPLETED|Overall Study||0
5355695|NCT00144781|13176314|P4|COMPLETED|Overall Study||9
5355696|NCT00144781|13176315|P3|COMPLETED|Overall Study||8
5355697|NCT00144781|13176316|P2|COMPLETED|Overall Study||7
5355698|NCT00144781|13176317|P1|COMPLETED|Overall Study||8
5355699|NCT00144781|13176314|P4|STARTED|Overall Study||9
5355700|NCT00144781|13176315|P3|STARTED|Overall Study||8
5355701|NCT00144781|13176316|P2|STARTED|Overall Study||9
5355702|NCT00144781|13176317|P1|STARTED|Overall Study||8
5355703|NCT00144391|13176337|P2|NOT COMPLETED|Overall Study||0
5355704|NCT00144391|13176338|P1|NOT COMPLETED|Overall Study||0
5355705|NCT00144391|13176337|P2|COMPLETED|Overall Study||9
5355706|NCT00144391|13176338|P1|COMPLETED|Overall Study||11
5355707|NCT00144391|13176337|P2|STARTED|Overall Study||9
5355708|NCT00144391|13176338|P1|STARTED|Overall Study||11
5355709|NCT00144339|13176346|P2|NOT COMPLETED|Overall Study||1099
5355710|NCT00144339|13176347|P1|NOT COMPLETED|Overall Study||1358
5355711|NCT00144339|13176346|P2|COMPLETED|Overall Study||1887
5355712|NCT00144339|13176347|P1|COMPLETED|Overall Study||1648
5355713|NCT00144339|13176346|P2|STARTED|Overall Study||2986
5355714|NCT00144339|13176347|P1|STARTED|Overall Study||3006
5355715|NCT00144300|13176555|P2|NOT COMPLETED|Overall Study||28
5355716|NCT00144300|13176556|P1|NOT COMPLETED|Overall Study||29
5355717|NCT00144300|13176555|P2|COMPLETED|Overall Study||97
5355718|NCT00144300|13176556|P1|COMPLETED|Overall Study||92
5355719|NCT00144300|13176555|P2|STARTED|Overall Study||125
5355720|NCT00144300|13176556|P1|STARTED|Overall Study||121
5355721|NCT00144170|13176604|P2|NOT COMPLETED|Overall Study||396
5355722|NCT00144170|13176605|P1|NOT COMPLETED|Overall Study||352
5355723|NCT00144170|13176604|P2|COMPLETED|Overall Study||32
5355724|NCT00144170|13176605|P1|COMPLETED|Overall Study||86
5355725|NCT00144170|13176604|P2|STARTED|Overall Study||428
5355726|NCT00144170|13176605|P1|STARTED|Overall Study||438
5355727|NCT00144027|13176795|P2|NOT COMPLETED|Overall Study||11
5355728|NCT00144027|13176796|P1|NOT COMPLETED|Overall Study||3
5355729|NCT00144027|13176795|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
5355730|NCT00144027|13176796|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
5355731|NCT00144027|13176795|P2|Completed 6 Month Assessment|Overall Study||24
5355732|NCT00144027|13176796|P1|Completed 6 Month Assessment|Overall Study||37
5355733|NCT00144027|13176795|P2|Completed Baseline Assessment|Overall Study||29
5355734|NCT00144027|13176796|P1|Completed Baseline Assessment|Overall Study||39
5355735|NCT00144027|13176795|P2|STARTED|Overall Study|participants who consented|36
5355736|NCT00144027|13176796|P1|STARTED|Overall Study|participants who consented|39
5355737|NCT00143845|13176802|P1|NOT COMPLETED|Overall Study||0
5355738|NCT00143845|13176802|P1|COMPLETED|Overall Study||54
5355739|NCT00143845|13176802|P1|STARTED|Overall Study||54
5355740|NCT00143819|13176810|P2|NOT COMPLETED|Overall Study||3
5355741|NCT00143819|13176811|P1|NOT COMPLETED|Overall Study||2
5355742|NCT00143819|13176810|P2|COMPLETED|Overall Study||5
5355743|NCT00143819|13176811|P1|COMPLETED|Overall Study||3
5355744|NCT00143819|13176810|P2|STARTED|Overall Study||8
5355745|NCT00143819|13176811|P1|STARTED|Overall Study||5
5355746|NCT00143598|13176826|P2|NOT COMPLETED|Overall Study||94
5355747|NCT00143598|13176827|P1|NOT COMPLETED|Overall Study||92
5355748|NCT00143598|13176826|P2|COMPLETED|Overall Study||302
5355749|NCT00143598|13176827|P1|COMPLETED|Overall Study||318
5355750|NCT00143598|13176826|P2|STARTED|Overall Study||396
5355751|NCT00143598|13176827|P1|STARTED|Overall Study||410
5355752|NCT00143507|13176841|P2|NOT COMPLETED|Overall Study||652
5355753|NCT00143507|13176842|P1|NOT COMPLETED|Overall Study||687
5355754|NCT00143507|13176841|P2|COMPLETED|Overall Study||4786
5355755|NCT00143507|13176842|P1|COMPLETED|Overall Study||4792
5355756|NCT00143507|13176841|P2|STARTED|Overall Study||5438
5355757|NCT00143507|13176842|P1|STARTED|Overall Study||5479
5355758|NCT00143455|13176876|P4|NOT COMPLETED|Cohort 2||93
5355759|NCT00143455|13176877|P3|NOT COMPLETED|Cohort 2||106
5355760|NCT00143455|13176878|P2|NOT COMPLETED|Cohort 2||0
5355761|NCT00143455|13176879|P1|NOT COMPLETED|Cohort 2||0
5355762|NCT00143455|13176876|P4|COMPLETED|Cohort 2||111
5355763|NCT00143455|13176877|P3|COMPLETED|Cohort 2||97
5355764|NCT00143455|13176878|P2|COMPLETED|Cohort 2||0
5355765|NCT00143455|13176879|P1|COMPLETED|Cohort 2||0
5355766|NCT00143455|13176876|P4|Received Treatment|Cohort 2||203
5355767|NCT00143455|13176877|P3|Received Treatment|Cohort 2||202
5355768|NCT00143455|13176878|P2|Received Treatment|Cohort 2||0
5355769|NCT00143455|13176879|P1|Received Treatment|Cohort 2||0
5355770|NCT00143455|13176876|P4|STARTED|Cohort 2||204
5355771|NCT00143455|13176877|P3|STARTED|Cohort 2||203
5355772|NCT00143455|13176878|P2|STARTED|Cohort 2||0
5355773|NCT00143455|13176879|P1|STARTED|Cohort 2||0
5355774|NCT00143455|13176876|P4|NOT COMPLETED|Cohort 1||0
5355775|NCT00143455|13176877|P3|NOT COMPLETED|Cohort 1||0
5355776|NCT00143455|13176878|P2|NOT COMPLETED|Cohort 1||17
5355777|NCT00143455|13176879|P1|NOT COMPLETED|Cohort 1||14
5355778|NCT00143455|13176876|P4|COMPLETED|Cohort 1||0
5355779|NCT00143455|13176877|P3|COMPLETED|Cohort 1||0
5355780|NCT00143455|13176878|P2|COMPLETED|Cohort 1||22
5355781|NCT00143455|13176879|P1|COMPLETED|Cohort 1||25
5355782|NCT00143455|13176876|P4|Received Treatment|Cohort 1||0
5355783|NCT00143455|13176877|P3|Received Treatment|Cohort 1||0
5355784|NCT00143455|13176878|P2|Received Treatment|Cohort 1||38
5355785|NCT00143455|13176879|P1|Received Treatment|Cohort 1||39
5355786|NCT00143455|13176876|P4|STARTED|Cohort 1||0
5355787|NCT00143455|13176877|P3|STARTED|Cohort 1||0
5355788|NCT00143455|13176878|P2|STARTED|Cohort 1||39
5355789|NCT00143455|13176879|P1|STARTED|Cohort 1||39
5355790|NCT00143403|13176913|P2|NOT COMPLETED|Overall Study||46
5355791|NCT00143403|13176914|P1|NOT COMPLETED|Overall Study||35
5355792|NCT00143403|13176913|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
5355793|NCT00143403|13176914|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
5355794|NCT00143403|13176913|P2|Treated|Overall Study||153
5355795|NCT00143403|13176914|P1|Treated|Overall Study||153
5355796|NCT00143403|13176913|P2|STARTED|Overall Study||161
5355797|NCT00143403|13176914|P1|STARTED|Overall Study||160
5355798|NCT00143390|13176924|P2|NOT COMPLETED|Overall Study||149
5355799|NCT00143390|13176925|P1|NOT COMPLETED|Overall Study||149
5355800|NCT00143390|13176924|P2|COMPLETED|Overall Study||0
5355801|NCT00143390|13176925|P1|COMPLETED|Overall Study||0
5355802|NCT00143390|13176924|P2|STARTED|Overall Study||149
5355803|NCT00143390|13176925|P1|STARTED|Overall Study||149
5355804|NCT00143312|13176941|P1|NOT COMPLETED|Overall Study||16
5355805|NCT00143312|13176941|P1|COMPLETED|Overall Study||29
5355806|NCT00143312|13176941|P1|STARTED|Overall Study||45
5355807|NCT00143247|13176951|P1|NOT COMPLETED|Overall Study||156
5355808|NCT00143247|13176951|P1|COMPLETED|Overall Study||17
5355809|NCT00143247|13176951|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
5355810|NCT00142935|13176968|P3|NOT COMPLETED|Overall Study||7
5355811|NCT00142935|13176969|P2|NOT COMPLETED|Overall Study||8
5355812|NCT00142935|13176970|P1|NOT COMPLETED|Overall Study||3
5355813|NCT00142935|13176968|P3|COMPLETED|Overall Study||23
5355814|NCT00142935|13176969|P2|COMPLETED|Overall Study||20
5355815|NCT00142935|13176970|P1|COMPLETED|Overall Study||26
5355816|NCT00142935|13176968|P3|STARTED|Overall Study||30
5355817|NCT00142935|13176969|P2|STARTED|Overall Study||28
5355818|NCT00142935|13176970|P1|STARTED|Overall Study||29
5355819|NCT00142909|13176995|P2|NOT COMPLETED|Medications Begin||3
5355820|NCT00142909|13176996|P1|NOT COMPLETED|Medications Begin||9
5355821|NCT00142909|13176995|P2|COMPLETED|Medications Begin||31
5355822|NCT00142909|13176996|P1|COMPLETED|Medications Begin||26
5355823|NCT00142909|13176995|P2|STARTED|Medications Begin||34
5355824|NCT00142909|13176996|P1|STARTED|Medications Begin||35
5355825|NCT00142909|13176995|P2|NOT COMPLETED|Randomization||10
5355826|NCT00142909|13176996|P1|NOT COMPLETED|Randomization||7
5355827|NCT00142909|13176995|P2|COMPLETED|Randomization||34
5355828|NCT00142909|13176996|P1|COMPLETED|Randomization||35
5355829|NCT00142909|13176995|P2|STARTED|Randomization||44
5355830|NCT00142909|13176996|P1|STARTED|Randomization||42
5355831|NCT00142818|13177016|P4|NOT COMPLETED|Overall Study||22
5355832|NCT00142818|13177017|P3|NOT COMPLETED|Overall Study||13
5355833|NCT00142818|13177018|P2|NOT COMPLETED|Overall Study||21
5355834|NCT00142818|13177019|P1|NOT COMPLETED|Overall Study||17
5355835|NCT00142818|13177016|P4|COMPLETED|Overall Study||20
5355836|NCT00142818|13177017|P3|COMPLETED|Overall Study||24
5355837|NCT00142818|13177018|P2|COMPLETED|Overall Study||19
5355838|NCT00142818|13177019|P1|COMPLETED|Overall Study||28
5355839|NCT00142818|13177016|P4|STARTED|Overall Study||42
5355840|NCT00142818|13177017|P3|STARTED|Overall Study||37
5355841|NCT00142818|13177018|P2|STARTED|Overall Study||40
5355842|NCT00142818|13177019|P1|STARTED|Overall Study||45
5355843|NCT00142792|13177036|P3|NOT COMPLETED|Overall Study||12
5355844|NCT00142792|13177037|P2|NOT COMPLETED|Overall Study||15
5355845|NCT00142792|13177038|P1|NOT COMPLETED|Overall Study||12
5355846|NCT00142792|13177036|P3|COMPLETED|Overall Study||30
5355847|NCT00142792|13177037|P2|COMPLETED|Overall Study||26
5355848|NCT00142792|13177038|P1|COMPLETED|Overall Study||27
5355849|NCT00142792|13177036|P3|Completed Intervention|Overall Study||37
5355850|NCT00142792|13177037|P2|Completed Intervention|Overall Study||37
5355851|NCT00142792|13177038|P1|Completed Intervention|Overall Study||35
5355852|NCT00142792|13177036|P3|STARTED|Overall Study||42
5355853|NCT00142792|13177037|P2|STARTED|Overall Study||41
5355854|NCT00142792|13177038|P1|STARTED|Overall Study||39
5355855|NCT00142597|13177051|P2|NOT COMPLETED|Overall Study||1
5355856|NCT00142597|13177052|P1|NOT COMPLETED|Overall Study||3
5355857|NCT00142597|13177051|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
5355858|NCT00142597|13177052|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
5355859|NCT00142597|13177051|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
5355860|NCT00142597|13177052|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
5355861|NCT00142519|13177060|P2|NOT COMPLETED|Overall Study||16
5355862|NCT00142519|13177061|P1|NOT COMPLETED|Overall Study||18
5355863|NCT00142519|13177060|P2|COMPLETED|Overall Study||9
5355864|NCT00142519|13177061|P1|COMPLETED|Overall Study||7
5355865|NCT00142519|13177060|P2|STARTED|Overall Study||25
5355866|NCT00142519|13177061|P1|STARTED|Overall Study||25
5355867|NCT00142506|13177071|P2|NOT COMPLETED|Overall Study||29
5355868|NCT00142506|13177072|P1|NOT COMPLETED|Overall Study||72
5355869|NCT00142506|13177071|P2|COMPLETED|Overall Study||77
5355870|NCT00142506|13177072|P1|COMPLETED|Overall Study||112
5355871|NCT00142506|13177071|P2|STARTED|Overall Study||106
5355872|NCT00142506|13177072|P1|STARTED|Overall Study||184
5355873|NCT00142415|13177084|P6|NOT COMPLETED|Overall Study||2
5355874|NCT00142415|13177085|P5|NOT COMPLETED|Overall Study||1
5355875|NCT00142415|13177086|P4|NOT COMPLETED|Overall Study||0
5355876|NCT00142415|13177087|P3|NOT COMPLETED|Overall Study||0
5355877|NCT00142415|13177088|P2|NOT COMPLETED|Overall Study||0
5355878|NCT00142415|13177089|P1|NOT COMPLETED|Overall Study||0
5355879|NCT00142415|13177084|P6|COMPLETED|Overall Study||6
5355880|NCT00142415|13177085|P5|COMPLETED|Overall Study||2
5355881|NCT00142415|13177086|P4|COMPLETED|Overall Study||3
5355882|NCT00142415|13177087|P3|COMPLETED|Overall Study||6
5355883|NCT00142415|13177088|P2|COMPLETED|Overall Study||3
5355884|NCT00142415|13177089|P1|COMPLETED|Overall Study||3
5355885|NCT00142415|13177084|P6|STARTED|Overall Study||8
5355886|NCT00142415|13177085|P5|STARTED|Overall Study||3
5355887|NCT00142415|13177086|P4|STARTED|Overall Study||3
5355888|NCT00142415|13177087|P3|STARTED|Overall Study||6
5355889|NCT00142415|13177088|P2|STARTED|Overall Study||3
5355890|NCT00142415|13177089|P1|STARTED|Overall Study||3
5355891|NCT00142298|13177127|P10|NOT COMPLETED|Overall Study||0
5355892|NCT00142298|13177128|P9|NOT COMPLETED|Overall Study||5
5355893|NCT00142298|13177129|P8|NOT COMPLETED|Overall Study||8
5355894|NCT00142298|13177130|P7|NOT COMPLETED|Overall Study||8
5355895|NCT00142298|13177131|P6|NOT COMPLETED|Overall Study||16
5355896|NCT00142298|13177132|P5|NOT COMPLETED|Overall Study||10
5355897|NCT00142298|13177133|P4|NOT COMPLETED|Overall Study||85
5355898|NCT00142298|13177134|P3|NOT COMPLETED|Overall Study||33
5355899|NCT00142298|13177135|P2|NOT COMPLETED|Overall Study||176
5355900|NCT00142298|13177136|P1|NOT COMPLETED|Overall Study||160
5355901|NCT00142298|13177127|P10|COMPLETED|Overall Study||13
5355902|NCT00142298|13177128|P9|COMPLETED|Overall Study||52
5355903|NCT00142298|13177129|P8|COMPLETED|Overall Study||58
5355904|NCT00142298|13177130|P7|COMPLETED|Overall Study||15
5355905|NCT00142298|13177131|P6|COMPLETED|Overall Study||10
5355906|NCT00142298|13177132|P5|COMPLETED|Overall Study||46
5355907|NCT00142298|13177133|P4|COMPLETED|Overall Study||121
5355908|NCT00142298|13177134|P3|COMPLETED|Overall Study||90
5355909|NCT00142298|13177135|P2|COMPLETED|Overall Study||456
5355910|NCT00142298|13177136|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
5355911|NCT00142298|13177127|P10|Per Protocol Population|Overall Study||13
5355912|NCT00142298|13177128|P9|Per Protocol Population|Overall Study||56
5355913|NCT00142298|13177129|P8|Per Protocol Population|Overall Study||64
5355914|NCT00142298|13177130|P7|Per Protocol Population|Overall Study||19
5355915|NCT00142298|13177131|P6|Per Protocol Population|Overall Study||25
5355916|NCT00142298|13177132|P5|Per Protocol Population|Overall Study||50
5355917|NCT00142298|13177133|P4|Per Protocol Population|Overall Study||202
5355918|NCT00142298|13177134|P3|Per Protocol Population|Overall Study||120
5355919|NCT00142298|13177135|P2|Per Protocol Population|Overall Study||606
5355920|NCT00142298|13177136|P1|Per Protocol Population|Overall Study||635
5355921|NCT00142298|13177127|P10|Safety Population|Overall Study||13
5355922|NCT00142298|13177128|P9|Safety Population|Overall Study||57
5355923|NCT00142298|13177129|P8|Safety Population|Overall Study||66
5355924|NCT00142298|13177130|P7|Safety Population|Overall Study||23
5355925|NCT00142298|13177131|P6|Safety Population|Overall Study||26
5355926|NCT00142298|13177132|P5|Safety Population|Overall Study||50
5355927|NCT00142298|13177133|P4|Safety Population|Overall Study||206
5355928|NCT00142298|13177134|P3|Safety Population|Overall Study||122
5355929|NCT00142298|13177135|P2|Safety Population|Overall Study||626
5355930|NCT00142298|13177136|P1|Safety Population|Overall Study||655
5355931|NCT00142298|13177127|P10|STARTED|Overall Study||13
5355932|NCT00142298|13177128|P9|STARTED|Overall Study||57
5355933|NCT00142298|13177129|P8|STARTED|Overall Study||66
5355934|NCT00142298|13177130|P7|STARTED|Overall Study||23
5355935|NCT00142298|13177131|P6|STARTED|Overall Study||26
5355936|NCT00142298|13177132|P5|STARTED|Overall Study||56
5355937|NCT00142298|13177133|P4|STARTED|Overall Study||206
5355938|NCT00142298|13177134|P3|STARTED|Overall Study||123
5355939|NCT00142298|13177135|P2|STARTED|Overall Study||632
5355940|NCT00142298|13177136|P1|STARTED|Overall Study||667
5355941|NCT00142168|13177158|P1|NOT COMPLETED|Overall Study||0
5355942|NCT00142168|13177158|P1|COMPLETED|Overall Study||16
5355943|NCT00142168|13177158|P1|STARTED|Overall Study||16
5355944|NCT00142116|13177165|P1|NOT COMPLETED|Overall Study||0
5355945|NCT00142116|13177165|P1|COMPLETED|Overall Study||25
5355946|NCT00142116|13177165|P1|STARTED|Overall Study||25
5355947|NCT00141921|13177170|P1|NOT COMPLETED|Overall Study||141
5355948|NCT00141921|13177170|P1|COMPLETED|Overall Study||41
5355949|NCT00141921|13177170|P1|Received Treatment|Overall Study||181
5355950|NCT00141921|13177170|P1|STARTED|Overall Study||182
5355951|NCT00141817|13177196|P4|NOT COMPLETED|Overall Study||0
5355952|NCT00141817|13177197|P3|NOT COMPLETED|Overall Study||1
5355953|NCT00141817|13177198|P2|NOT COMPLETED|Overall Study||0
5355954|NCT00141817|13177199|P1|NOT COMPLETED|Overall Study||1
5355955|NCT00141817|13177196|P4|COMPLETED|Overall Study||13
5355956|NCT00141817|13177197|P3|COMPLETED|Overall Study||10
5355957|NCT00141817|13177198|P2|COMPLETED|Overall Study||10
5355958|NCT00141817|13177199|P1|COMPLETED|Overall Study||6
5355959|NCT00141817|13177196|P4|STARTED|Overall Study||13
5355960|NCT00141817|13177197|P3|STARTED|Overall Study||11
5355961|NCT00141817|13177198|P2|STARTED|Overall Study||10
5355962|NCT00141817|13177199|P1|STARTED|Overall Study||7
5355963|NCT00141778|13177240|P3|NOT COMPLETED|Started Study Medication||4
5355964|NCT00141778|13177241|P2|NOT COMPLETED|Started Study Medication||7
5355965|NCT00141778|13177242|P1|NOT COMPLETED|Started Study Medication||2
5355966|NCT00141778|13177240|P3|COMPLETED|Started Study Medication||143
5355967|NCT00141778|13177241|P2|COMPLETED|Started Study Medication||144
5355968|NCT00141778|13177242|P1|COMPLETED|Started Study Medication||145
5355969|NCT00141778|13177240|P3|STARTED|Started Study Medication||147
5355970|NCT00141778|13177241|P2|STARTED|Started Study Medication||151
5355971|NCT00141778|13177242|P1|STARTED|Started Study Medication||147
5355972|NCT00141778|13177240|P3|NOT COMPLETED|Randomization Prior to Study Med||6
5355973|NCT00141778|13177241|P2|NOT COMPLETED|Randomization Prior to Study Med||2
5355974|NCT00141778|13177242|P1|NOT COMPLETED|Randomization Prior to Study Med||5
5355975|NCT00141778|13177240|P3|COMPLETED|Randomization Prior to Study Med||147
5355976|NCT00141778|13177241|P2|COMPLETED|Randomization Prior to Study Med||151
5355977|NCT00141778|13177242|P1|COMPLETED|Randomization Prior to Study Med||147
5355978|NCT00141778|13177240|P3|STARTED|Randomization Prior to Study Med||153
5355979|NCT00141778|13177241|P2|STARTED|Randomization Prior to Study Med||153
5355980|NCT00141778|13177242|P1|STARTED|Randomization Prior to Study Med||152
5355981|NCT00141765|13177280|P1|NOT COMPLETED|Overall Study||0
5355982|NCT00141765|13177280|P1|COMPLETED|Overall Study||25
5355983|NCT00141765|13177280|P1|STARTED|Overall Study||25
5355984|NCT00141739|13177284|P1|NOT COMPLETED|Overall Study||0
5355985|NCT00141739|13177284|P1|COMPLETED|Overall Study||100
5355986|NCT00141739|13177284|P1|STARTED|Overall Study|Number of evaluable patients|100
5355987|NCT00141726|13177295|P1|NOT COMPLETED|Overall Study||3
5355988|NCT00141726|13177295|P1|COMPLETED|Overall Study||31
5355989|NCT00141726|13177295|P1|STARTED|Overall Study||34
5355990|NCT00141518|13177303|P3|NOT COMPLETED|Overall Study||6
5355991|NCT00141518|13177304|P2|NOT COMPLETED|Overall Study||6
5355992|NCT00141518|13177305|P1|NOT COMPLETED|Overall Study||16
5355993|NCT00141518|13177303|P3|COMPLETED|Overall Study||12
5355994|NCT00141518|13177304|P2|COMPLETED|Overall Study||16
5355995|NCT00141518|13177305|P1|COMPLETED|Overall Study||21
5355996|NCT00141518|13177303|P3|Full Analysis Sample|Overall Study||18
5355997|NCT00141518|13177304|P2|Full Analysis Sample|Overall Study||22
5355998|NCT00141518|13177305|P1|Full Analysis Sample|Overall Study||27
5355999|NCT00141518|13177303|P3|Safety Sample|Overall Study||18
5356000|NCT00141518|13177304|P2|Safety Sample|Overall Study||22
5356001|NCT00141518|13177305|P1|Safety Sample|Overall Study||36
5356002|NCT00141518|13177303|P3|STARTED|Overall Study||18
5356003|NCT00141518|13177304|P2|STARTED|Overall Study||22
5356004|NCT00141518|13177305|P1|STARTED|Overall Study||37
5356005|NCT00141453|13177494|P2|NOT COMPLETED|Overall Study||5
5356006|NCT00141453|13177495|P1|NOT COMPLETED|Overall Study||6
5356007|NCT00141453|13177494|P2|COMPLETED|Overall Study||284
5356008|NCT00141453|13177495|P1|COMPLETED|Overall Study||282
5356009|NCT00141453|13177494|P2|STARTED|Overall Study||289
5356010|NCT00141453|13177495|P1|STARTED|Overall Study||288
5356011|NCT00141297|13177509|P10|NOT COMPLETED|Overall Study||6
5356012|NCT00141297|13177510|P9|NOT COMPLETED|Overall Study||20
5356013|NCT00141297|13177511|P8|NOT COMPLETED|Overall Study||4
5356014|NCT00141297|13177512|P7|NOT COMPLETED|Overall Study||3
5356015|NCT00141297|13177513|P6|NOT COMPLETED|Overall Study||3
5356016|NCT00141297|13177514|P5|NOT COMPLETED|Overall Study||22
5356017|NCT00141297|13177515|P4|NOT COMPLETED|Overall Study||3
5356018|NCT00141297|13177516|P3|NOT COMPLETED|Overall Study||7
5356019|NCT00141297|13177517|P2|NOT COMPLETED|Overall Study||3
5356020|NCT00141297|13177518|P1|NOT COMPLETED|Overall Study||3
5356021|NCT00141297|13177509|P10|COMPLETED|Overall Study||0
5356022|NCT00141297|13177510|P9|COMPLETED|Overall Study||0
5356023|NCT00141297|13177511|P8|COMPLETED|Overall Study||0
5356024|NCT00141297|13177512|P7|COMPLETED|Overall Study||0
5356025|NCT00141297|13177513|P6|COMPLETED|Overall Study||0
5356026|NCT00141297|13177514|P5|COMPLETED|Overall Study||0
5356027|NCT00141297|13177515|P4|COMPLETED|Overall Study||0
5356028|NCT00141297|13177516|P3|COMPLETED|Overall Study||0
5356029|NCT00141297|13177517|P2|COMPLETED|Overall Study||0
5356030|NCT00141297|13177518|P1|COMPLETED|Overall Study||0
5356031|NCT00141297|13177509|P10|STARTED|Overall Study||6
5356032|NCT00141297|13177510|P9|STARTED|Overall Study||20
5356033|NCT00141297|13177511|P8|STARTED|Overall Study||4
5356034|NCT00141297|13177512|P7|STARTED|Overall Study||3
5356035|NCT00141297|13177513|P6|STARTED|Overall Study||3
5356036|NCT00141297|13177514|P5|STARTED|Overall Study||22
5356037|NCT00141297|13177515|P4|STARTED|Overall Study||3
5356038|NCT00141297|13177516|P3|STARTED|Overall Study||7
5356039|NCT00141297|13177517|P2|STARTED|Overall Study||3
5356040|NCT00141297|13177518|P1|STARTED|Overall Study||3
5356041|NCT00141271|13177796|P3|NOT COMPLETED|Overall Study||57
5356042|NCT00141271|13177797|P2|NOT COMPLETED|Overall Study||63
5356043|NCT00141271|13177798|P1|NOT COMPLETED|Overall Study||80
5356044|NCT00141271|13177796|P3|COMPLETED|Overall Study||111
5356045|NCT00141271|13177797|P2|COMPLETED|Overall Study||102
5356046|NCT00141271|13177798|P1|COMPLETED|Overall Study||91
5356047|NCT00141271|13177796|P3|STARTED|Overall Study||168
5356048|NCT00141271|13177797|P2|STARTED|Overall Study||165
5356049|NCT00141271|13177798|P1|STARTED|Overall Study||171
5356050|NCT00141219|13177919|P2|NOT COMPLETED|Overall Study||16
5356051|NCT00141219|13177920|P1|NOT COMPLETED|Overall Study||24
5356052|NCT00141219|13177919|P2|COMPLETED|Overall Study||62
5356053|NCT00141219|13177920|P1|COMPLETED|Overall Study||138
5356054|NCT00141219|13177919|P2|STARTED|Overall Study||78
5356055|NCT00141219|13177920|P1|STARTED|Overall Study||162
5356056|NCT00141115|13177970|P1|NOT COMPLETED|Overall Study||1
5356057|NCT00141115|13177970|P1|COMPLETED|Overall Study||2
5356058|NCT00141115|13177970|P1|STARTED|Overall Study||3
5356059|NCT00141102|13177977|P2|NOT COMPLETED|Overall Study||625
5356060|NCT00141102|13177978|P1|NOT COMPLETED|Overall Study||508
5356061|NCT00141102|13177977|P2|COMPLETED|Overall Study||1621
5356062|NCT00141102|13177978|P1|COMPLETED|Overall Study||1730
5356063|NCT00141102|13177977|P2|Received Treatment|Overall Study||2237
5356064|NCT00141102|13177978|P1|Received Treatment|Overall Study||2223
5356065|NCT00141102|13177977|P2|STARTED|Overall Study||2246
5356066|NCT00141102|13177978|P1|STARTED|Overall Study||2238
5356067|NCT00141037|13178018|P2|NOT COMPLETED|Overall Study||18
5356068|NCT00141037|13178019|P1|NOT COMPLETED|Overall Study||10
5356069|NCT00141037|13178018|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
5356070|NCT00141037|13178019|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
5356071|NCT00141037|13178018|P2|STARTED|Overall Study||70
5356072|NCT00141037|13178019|P1|STARTED|Overall Study||60
5356073|NCT00140842|13178029|P2|NOT COMPLETED|Overall Study||0
5356074|NCT00140842|13178030|P1|NOT COMPLETED|Overall Study||0
5356075|NCT00140842|13178029|P2|COMPLETED|Overall Study||15
5356076|NCT00140842|13178030|P1|COMPLETED|Overall Study||15
5356077|NCT00140842|13178029|P2|STARTED|Overall Study||15
5356078|NCT00140842|13178030|P1|STARTED|Overall Study||15
5356079|NCT00140621|13178038|P1|NOT COMPLETED|Overall Study||0
5356080|NCT00140621|13178038|P1|COMPLETED|Overall Study||6
5356081|NCT00140621|13178038|P1|STARTED|Overall Study||6
5356082|NCT00140556|13178048|P1|NOT COMPLETED|Chemoradiotherapy Period||0
5356083|NCT00140556|13178048|P1|COMPLETED|Chemoradiotherapy Period||28
5356084|NCT00140556|13178048|P1|STARTED|Chemoradiotherapy Period||28
5356085|NCT00140556|13178048|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
5356086|NCT00140556|13178048|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
5356087|NCT00140556|13178048|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
5356088|NCT00140426|13178054|P2|NOT COMPLETED|Overall Study||3
5356089|NCT00140426|13178055|P1|NOT COMPLETED|Overall Study||0
5356090|NCT00140426|13178054|P2|COMPLETED|Overall Study||16
5356091|NCT00140426|13178055|P1|COMPLETED|Overall Study||22
5356092|NCT00140426|13178054|P2|STARTED|Overall Study||19
5356093|NCT00140426|13178055|P1|STARTED|Overall Study||22
5356094|NCT00140413|13178088|P2|NOT COMPLETED|Overall Study||0
5356095|NCT00140413|13178089|P1|NOT COMPLETED|Overall Study||3
5356096|NCT00140413|13178088|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
5356097|NCT00140413|13178089|P1|COMPLETED|Overall Study||10
5356098|NCT00140413|13178088|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
5356099|NCT00140413|13178089|P1|Received at Least One Dose of GH|Overall Study||13
5356100|NCT00140413|13178088|P2|STARTED|Overall Study||7
5356101|NCT00140413|13178089|P1|STARTED|Overall Study||13
5356102|NCT00140244|13178096|P2|NOT COMPLETED|Intervention 2||2
5356103|NCT00140244|13178097|P1|NOT COMPLETED|Intervention 2||0
5356104|NCT00140244|13178096|P2|COMPLETED|Intervention 2||2
5356105|NCT00140244|13178097|P1|COMPLETED|Intervention 2||3
5356106|NCT00140244|13178096|P2|STARTED|Intervention 2||4
5356107|NCT00140244|13178097|P1|STARTED|Intervention 2||3
5356108|NCT00140244|13178096|P2|NOT COMPLETED|Washout||0
5356109|NCT00140244|13178097|P1|NOT COMPLETED|Washout||0
5356110|NCT00140244|13178096|P2|COMPLETED|Washout||4
5356111|NCT00140244|13178097|P1|COMPLETED|Washout||3
5356112|NCT00140244|13178096|P2|STARTED|Washout||4
5356113|NCT00140244|13178097|P1|STARTED|Washout||3
5356114|NCT00140244|13178096|P2|NOT COMPLETED|Intervention 1||0
5356115|NCT00140244|13178097|P1|NOT COMPLETED|Intervention 1||0
5356116|NCT00140244|13178096|P2|COMPLETED|Intervention 1||4
5356117|NCT00140244|13178097|P1|COMPLETED|Intervention 1||3
5356118|NCT00140244|13178096|P2|STARTED|Intervention 1||4
5356119|NCT00140244|13178097|P1|STARTED|Intervention 1||3
5356120|NCT00140231|13178129|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
5356121|NCT00140231|13178130|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
5356122|NCT00140231|13178129|P2|COMPLETED|Fasting State With Leptin and Crossover||6
5356123|NCT00140231|13178130|P1|COMPLETED|Fasting State With Leptin and Crossover||7
5356124|NCT00140231|13178129|P2|STARTED|Fasting State With Leptin and Crossover||6
5356125|NCT00140231|13178130|P1|STARTED|Fasting State With Leptin and Crossover||7
5356126|NCT00140231|13178129|P2|NOT COMPLETED|Washout 8 Weeks||0
5356127|NCT00140231|13178130|P1|NOT COMPLETED|Washout 8 Weeks||0
5356128|NCT00140231|13178129|P2|COMPLETED|Washout 8 Weeks||6
5356129|NCT00140231|13178130|P1|COMPLETED|Washout 8 Weeks||7
5356130|NCT00140231|13178129|P2|STARTED|Washout 8 Weeks||6
5356131|NCT00140231|13178130|P1|STARTED|Washout 8 Weeks||7
5356132|NCT00140231|13178129|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
5356133|NCT00140231|13178130|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
5356134|NCT00140231|13178129|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
5356135|NCT00140231|13178130|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
5356136|NCT00140231|13178129|P2|STARTED|First Fasting State 3 Days With Placebo||6
5356137|NCT00140231|13178130|P1|STARTED|First Fasting State 3 Days With Placebo||7
5356138|NCT00140231|13178129|P2|NOT COMPLETED|Washout 8weeks||0
5356139|NCT00140231|13178130|P1|NOT COMPLETED|Washout 8weeks||0
5356140|NCT00140231|13178129|P2|COMPLETED|Washout 8weeks||6
5356141|NCT00140231|13178130|P1|COMPLETED|Washout 8weeks||7
5356142|NCT00140231|13178129|P2|STARTED|Washout 8weeks||6
5356143|NCT00140231|13178130|P1|STARTED|Washout 8weeks||7
5356144|NCT00140231|13178129|P2|NOT COMPLETED|Fed State 1 Day- day5||0
5356145|NCT00140231|13178130|P1|NOT COMPLETED|Fed State 1 Day- day5||0
5356146|NCT00140231|13178129|P2|COMPLETED|Fed State 1 Day- day5||6
5356147|NCT00140231|13178130|P1|COMPLETED|Fed State 1 Day- day5||7
5356148|NCT00140231|13178129|P2|STARTED|Fed State 1 Day- day5||6
5356149|NCT00140231|13178130|P1|STARTED|Fed State 1 Day- day5||7
5356150|NCT00140205|13178149|P3|NOT COMPLETED|Overall Study||0
5356151|NCT00140205|13178150|P2|NOT COMPLETED|Overall Study||0
5356152|NCT00140205|13178151|P1|NOT COMPLETED|Overall Study||0
5356153|NCT00140205|13178149|P3|COMPLETED|Overall Study||5
5356154|NCT00140205|13178150|P2|COMPLETED|Overall Study||5
5356155|NCT00140205|13178151|P1|COMPLETED|Overall Study||5
5356156|NCT00140205|13178149|P3|STARTED|Overall Study||5
5356157|NCT00140205|13178150|P2|STARTED|Overall Study||5
5356158|NCT00140205|13178151|P1|STARTED|Overall Study||5
5356159|NCT00140140|13178220|P3|NOT COMPLETED|Overall Study||2
5356160|NCT00140140|13178221|P2|NOT COMPLETED|Overall Study||2
5356161|NCT00140140|13178222|P1|NOT COMPLETED|Overall Study||2
5356162|NCT00140140|13178220|P3|COMPLETED|Overall Study|Progressive disease|4
5356163|NCT00140140|13178221|P2|COMPLETED|Overall Study|Progressive disease|4
5356164|NCT00140140|13178222|P1|COMPLETED|Overall Study|Progressive disease|2
5356165|NCT00140140|13178220|P3|STARTED|Overall Study||6
5356166|NCT00140140|13178221|P2|STARTED|Overall Study||6
5356167|NCT00140140|13178222|P1|STARTED|Overall Study||4
5356168|NCT00139997|13178261|P2|NOT COMPLETED|Overall Study||2
5356169|NCT00139997|13178262|P1|NOT COMPLETED|Overall Study||1
5356170|NCT00139997|13178261|P2|COMPLETED|Overall Study||9
5356171|NCT00139997|13178262|P1|COMPLETED|Overall Study||14
5356172|NCT00139997|13178261|P2|STARTED|Overall Study||11
5356173|NCT00139997|13178262|P1|STARTED|Overall Study||15
5356174|NCT00139776|13178272|P4|NOT COMPLETED|Period III||106
5356175|NCT00139776|13178273|P3|NOT COMPLETED|Period III||76
5356176|NCT00139776|13178274|P2|NOT COMPLETED|Period III||0
5356177|NCT00139776|13178275|P1|NOT COMPLETED|Period III||0
5356178|NCT00139776|13178272|P4|COMPLETED|Period III||321
5356179|NCT00139776|13178273|P3|COMPLETED|Period III||355
5356180|NCT00139776|13178274|P2|COMPLETED|Period III||0
5356181|NCT00139776|13178275|P1|COMPLETED|Period III||0
5356182|NCT00139776|13178272|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
5356183|NCT00139776|13178273|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
5356184|NCT00139776|13178274|P2|STARTED|Period III||0
5356185|NCT00139776|13178275|P1|STARTED|Period III||0
5356186|NCT00139776|13178272|P4|NOT COMPLETED|Period II||0
5356187|NCT00139776|13178273|P3|NOT COMPLETED|Period II||0
5356188|NCT00139776|13178274|P2|NOT COMPLETED|Period II||322
5356189|NCT00139776|13178275|P1|NOT COMPLETED|Period II||0
5356190|NCT00139776|13178272|P4|COMPLETED|Period II||0
5356191|NCT00139776|13178273|P3|COMPLETED|Period II||0
5356192|NCT00139776|13178274|P2|COMPLETED|Period II||875
5356193|NCT00139776|13178275|P1|COMPLETED|Period II||0
5356194|NCT00139776|13178272|P4|STARTED|Period II||0
5356195|NCT00139776|13178273|P3|STARTED|Period II||0
5356196|NCT00139776|13178274|P2|STARTED|Period II||1197
5356197|NCT00139776|13178275|P1|STARTED|Period II||0
5356198|NCT00139776|13178272|P4|NOT COMPLETED|Period I||0
5356199|NCT00139776|13178273|P3|NOT COMPLETED|Period I||0
5356200|NCT00139776|13178274|P2|NOT COMPLETED|Period I||0
5356201|NCT00139776|13178275|P1|NOT COMPLETED|Period I||575
5356202|NCT00139776|13178272|P4|COMPLETED|Period I||0
5356203|NCT00139776|13178273|P3|COMPLETED|Period I||0
5356204|NCT00139776|13178274|P2|COMPLETED|Period I||0
5356205|NCT00139776|13178275|P1|COMPLETED|Period I||1197
5356206|NCT00139776|13178272|P4|STARTED|Period I||0
5356207|NCT00139776|13178273|P3|STARTED|Period I||0
5356208|NCT00139776|13178274|P2|STARTED|Period I||0
5356209|NCT00139776|13178275|P1|STARTED|Period I||1772
5356210|NCT00139737|13178310|P1|NOT COMPLETED|Overall Study||341
5356211|NCT00139737|13178310|P1|COMPLETED|Overall Study||3
5356212|NCT00139737|13178310|P1|Received Treatment|Overall Study||331
5356213|NCT00139737|13178310|P1|STARTED|Overall Study||344
5356214|NCT00139659|13178316|P2|NOT COMPLETED|Overall Study||18
5356215|NCT00139659|13178317|P1|NOT COMPLETED|Overall Study||40
5356216|NCT00139659|13178316|P2|COMPLETED|Overall Study||123
5356217|NCT00139659|13178317|P1|COMPLETED|Overall Study||106
5356218|NCT00139659|13178316|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
5356219|NCT00139659|13178317|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
5356220|NCT00139477|13178395|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
5356221|NCT00139477|13178396|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
5356222|NCT00139477|13178395|P2|COMPLETED|Second Intervention -6Months to 12Months||18
5356223|NCT00139477|13178396|P1|COMPLETED|Second Intervention -6Months to 12Months||14
5356224|NCT00139477|13178395|P2|STARTED|Second Intervention -6Months to 12Months||23
5356225|NCT00139477|13178396|P1|STARTED|Second Intervention -6Months to 12Months||19
5356226|NCT00139477|13178395|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
5356227|NCT00139477|13178396|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
5356228|NCT00139477|13178395|P2|COMPLETED|First Intervention -Baseline to 6Months||23
5356229|NCT00139477|13178396|P1|COMPLETED|First Intervention -Baseline to 6Months||19
5356230|NCT00139477|13178395|P2|STARTED|First Intervention -Baseline to 6Months||35
5356231|NCT00139477|13178396|P1|STARTED|First Intervention -Baseline to 6Months||31
5356232|NCT00139399|13178418|P2|NOT COMPLETED|Overall Study||23
5356233|NCT00139399|13178419|P1|NOT COMPLETED|Overall Study||16
5356234|NCT00139399|13178418|P2|COMPLETED|Overall Study||59
5356235|NCT00139399|13178419|P1|COMPLETED|Overall Study||44
5356236|NCT00139399|13178418|P2|STARTED|Overall Study||82
5356237|NCT00139399|13178419|P1|STARTED|Overall Study||60
5356238|NCT00138671|13178431|P2|NOT COMPLETED|Overall Study||16
5356239|NCT00138671|13178432|P1|NOT COMPLETED|Overall Study||13
5356240|NCT00138671|13178431|P2|COMPLETED|Overall Study||30
5356241|NCT00138671|13178432|P1|COMPLETED|Overall Study||46
5356242|NCT00138671|13178431|P2|STARTED|Overall Study||46
5356243|NCT00138671|13178432|P1|STARTED|Overall Study||59
5356244|NCT00138658|13178482|P1|NOT COMPLETED|Overall Study||61
5356245|NCT00138658|13178482|P1|COMPLETED|Overall Study||20
5356246|NCT00138658|13178482|P1|STARTED|Overall Study||81
5356247|NCT00138645|13178494|P2|NOT COMPLETED|Overall Study||7
5356248|NCT00138645|13178495|P1|NOT COMPLETED|Overall Study||6
5356249|NCT00138645|13178494|P2|COMPLETED|Overall Study||23
5356250|NCT00138645|13178495|P1|COMPLETED|Overall Study||24
5356251|NCT00138645|13178494|P2|STARTED|Overall Study||30
5356252|NCT00138645|13178495|P1|STARTED|Overall Study||30
5356253|NCT00138424|13178505|P4|NOT COMPLETED|Overall Study||0
5356254|NCT00138424|13178506|P3|NOT COMPLETED|Overall Study||0
5356255|NCT00138424|13178507|P2|NOT COMPLETED|Overall Study||1
5356256|NCT00138424|13178508|P1|NOT COMPLETED|Overall Study||0
5356257|NCT00138424|13178505|P4|COMPLETED|Overall Study||3
5356258|NCT00138424|13178506|P3|COMPLETED|Overall Study||5
5356259|NCT00138424|13178507|P2|COMPLETED|Overall Study||4
5356260|NCT00138424|13178508|P1|COMPLETED|Overall Study||9
5356261|NCT00138424|13178505|P4|STARTED|Overall Study||3
5356262|NCT00138424|13178506|P3|STARTED|Overall Study||5
5356263|NCT00138424|13178507|P2|STARTED|Overall Study||5
5356264|NCT00138424|13178508|P1|STARTED|Overall Study||9
5356265|NCT00138294|13178574|P1|NOT COMPLETED|Overall Study||0
5356266|NCT00138294|13178574|P1|COMPLETED|Overall Study||29255
5356267|NCT00138294|13178574|P1|STARTED|Overall Study||29255
5356268|NCT00138203|13178584|P1|NOT COMPLETED|Overall Study||0
5356269|NCT00138203|13178584|P1|COMPLETED|Overall Study||16
5356270|NCT00138203|13178584|P1|STARTED|Overall Study||16
5356271|NCT00138151|13178591|P1|NOT COMPLETED|Overall Study||4
5356272|NCT00138151|13178591|P1|COMPLETED|Overall Study||29
5356273|NCT00138151|13178591|P1|STARTED|Overall Study||33
5356274|NCT00138125|13178597|P1|NOT COMPLETED|Overall Study||0
5356275|NCT00138125|13178597|P1|COMPLETED|Overall Study||2
5356276|NCT00138125|13178597|P1|STARTED|Overall Study||2
5356277|NCT00138073|13178601|P1|NOT COMPLETED|Overall Study||55
5356278|NCT00138073|13178601|P1|COMPLETED|Overall Study||0
5356279|NCT00138073|13178601|P1|Pre-intervention Testing|Overall Study||55
5356280|NCT00138073|13178601|P1|STARTED|Overall Study||55
5356281|NCT00138034|13178608|P2|NOT COMPLETED|Overall Study||3
5356282|NCT00138034|13178609|P1|NOT COMPLETED|Overall Study||3
5356283|NCT00138034|13178608|P2|COMPLETED|Overall Study||20
5356284|NCT00138034|13178609|P1|COMPLETED|Overall Study||23
5356285|NCT00138034|13178608|P2|STARTED|Overall Study||23
5356286|NCT00138034|13178609|P1|STARTED|Overall Study||26
5356287|NCT00137969|13178619|P2|NOT COMPLETED|Overall Study||21
5356288|NCT00137969|13178620|P1|NOT COMPLETED|Overall Study||67
5356289|NCT00137969|13178619|P2|COMPLETED|Overall Study||67
5356290|NCT00137969|13178620|P1|COMPLETED|Overall Study||107
5356291|NCT00137969|13178619|P2|Received Study Drug|Overall Study||88
5356292|NCT00137969|13178620|P1|Received Study Drug|Overall Study||169
5356293|NCT00137969|13178619|P2|STARTED|Overall Study||88
5356294|NCT00137969|13178620|P1|STARTED|Overall Study||174
5356295|NCT00137839|13178640|P1|NOT COMPLETED|Overall Study||84
5356296|NCT00137839|13178640|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
5356297|NCT00137839|13178640|P1|Treated|Overall Study||83
5356298|NCT00137839|13178640|P1|STARTED|Overall Study||84
5356299|NCT00137631|13178653|P2|NOT COMPLETED|Overall Study||41
5356300|NCT00137631|13178654|P1|NOT COMPLETED|Overall Study||37
5356301|NCT00137631|13178653|P2|COMPLETED|Overall Study||133
5356302|NCT00137631|13178654|P1|COMPLETED|Overall Study||127
5356303|NCT00137631|13178653|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
5356304|NCT00137631|13178654|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
5356305|NCT00137631|13178653|P2|Complete 3-month Follow-up|Overall Study||125
5356306|NCT00137631|13178654|P1|Complete 3-month Follow-up|Overall Study||120
5356307|NCT00137631|13178653|P2|STARTED|Overall Study||174
5356308|NCT00137631|13178654|P1|STARTED|Overall Study||164
5356309|NCT00137449|13178670|P2|NOT COMPLETED|Overall Study||18
5356310|NCT00137449|13178671|P1|NOT COMPLETED|Overall Study||16
5356311|NCT00137449|13178670|P2|COMPLETED|Overall Study||12
5356312|NCT00137449|13178671|P1|COMPLETED|Overall Study||14
5356313|NCT00137449|13178670|P2|STARTED|Overall Study||30
5356314|NCT00137449|13178671|P1|STARTED|Overall Study||30
5356315|NCT00137436|13178708|P1|NOT COMPLETED|Overall Study||43
5356316|NCT00137436|13178708|P1|COMPLETED|Overall Study||12
5356317|NCT00137436|13178708|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
5356318|NCT00137423|13178727|P2|NOT COMPLETED|Overall Study||44
5356319|NCT00137423|13178728|P1|NOT COMPLETED|Overall Study||39
5356320|NCT00137423|13178727|P2|COMPLETED|Overall Study||9
5356321|NCT00137423|13178728|P1|COMPLETED|Overall Study||15
5356322|NCT00137423|13178727|P2|STARTED|Overall Study||53
5356323|NCT00137423|13178728|P1|STARTED|Overall Study||54
5356324|NCT00137280|13178750|P2|NOT COMPLETED|Overall Study||55
5356325|NCT00137280|13178751|P1|NOT COMPLETED|Overall Study||84
5356326|NCT00137280|13178750|P2|COMPLETED|Overall Study||357
5356327|NCT00137280|13178751|P1|COMPLETED|Overall Study||305
5356328|NCT00137280|13178750|P2|STARTED|Overall Study||412
5356329|NCT00137280|13178751|P1|STARTED|Overall Study||389
5356330|NCT00137267|13178765|P2|NOT COMPLETED|Overall Study||21
5356331|NCT00137267|13178766|P1|NOT COMPLETED|Overall Study||15
5356332|NCT00137267|13178765|P2|COMPLETED|Overall Study||26
5356333|NCT00137267|13178766|P1|COMPLETED|Overall Study||40
5356334|NCT00137267|13178765|P2|STARTED|Overall Study||47
5356335|NCT00137267|13178766|P1|STARTED|Overall Study||55
5356336|NCT00137111|13178778|P4|NOT COMPLETED|Total Therapy||0
5356337|NCT00137111|13178779|P3|NOT COMPLETED|Total Therapy||0
5356338|NCT00137111|13178780|P2|NOT COMPLETED|Total Therapy||0
5356339|NCT00137111|13178781|P1|NOT COMPLETED|Total Therapy||40
5356340|NCT00137111|13178778|P4|COMPLETED|Total Therapy||0
5356341|NCT00137111|13178779|P3|COMPLETED|Total Therapy||0
5356342|NCT00137111|13178780|P2|COMPLETED|Total Therapy||0
5356343|NCT00137111|13178781|P1|COMPLETED|Total Therapy||458
5356344|NCT00137111|13178778|P4|STARTED|Total Therapy||0
5356345|NCT00137111|13178779|P3|STARTED|Total Therapy||0
5356346|NCT00137111|13178780|P2|STARTED|Total Therapy||0
5356347|NCT00137111|13178781|P1|STARTED|Total Therapy||498
5356348|NCT00137111|13178778|P4|NOT COMPLETED|Window Therapy||0
5356349|NCT00137111|13178779|P3|NOT COMPLETED|Window Therapy||0
5356350|NCT00137111|13178780|P2|NOT COMPLETED|Window Therapy||0
5356351|NCT00137111|13178781|P1|NOT COMPLETED|Window Therapy||0
5356352|NCT00137111|13178778|P4|COMPLETED|Window Therapy||142
5356353|NCT00137111|13178779|P3|COMPLETED|Window Therapy||180
5356354|NCT00137111|13178780|P2|COMPLETED|Window Therapy||176
5356355|NCT00137111|13178781|P1|COMPLETED|Window Therapy||0
5356356|NCT00137111|13178778|P4|STARTED|Window Therapy||142
5356357|NCT00137111|13178779|P3|STARTED|Window Therapy||180
5356358|NCT00137111|13178780|P2|STARTED|Window Therapy||176
5356359|NCT00137111|13178781|P1|STARTED|Window Therapy||0
5356360|NCT00137046|13178795|P2|NOT COMPLETED|Overall Study||93
5356361|NCT00137046|13178796|P1|NOT COMPLETED|Overall Study||99
5356362|NCT00137046|13178795|P2|COMPLETED|Overall Study||198
5356363|NCT00137046|13178796|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
5356364|NCT00137046|13178795|P2|Received Study Treatment|Overall Study||290
5356365|NCT00137046|13178796|P1|Received Study Treatment|Overall Study||290
5356366|NCT00137046|13178795|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
5356367|NCT00137046|13178796|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
5356368|NCT00136955|13178844|P1|NOT COMPLETED|Overall Study||23
5356369|NCT00136955|13178844|P1|COMPLETED|Overall Study||18
5356370|NCT00136955|13178844|P1|STARTED|Overall Study||41
5356371|NCT00136916|13178853|P2|NOT COMPLETED|Overall Study||104
5356372|NCT00136916|13178854|P1|NOT COMPLETED|Overall Study||125
5356373|NCT00136916|13178853|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
5356374|NCT00136916|13178854|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
5356375|NCT00136916|13178853|P2|Received Treatment|Overall Study||311
5356376|NCT00136916|13178854|P1|Received Treatment|Overall Study||316
5356377|NCT00136916|13178853|P2|STARTED|Overall Study||316
5356378|NCT00136916|13178854|P1|STARTED|Overall Study||319
5356379|NCT00136838|13178908|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
5356380|NCT00136838|13178909|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
5356381|NCT00136838|13178908|P2|COMPLETED|Second Intervention ( 5 Days)||6
5356382|NCT00136838|13178909|P1|COMPLETED|Second Intervention ( 5 Days)||6
5356383|NCT00136838|13178908|P2|STARTED|Second Intervention ( 5 Days)||6
5356384|NCT00136838|13178909|P1|STARTED|Second Intervention ( 5 Days)||6
5356385|NCT00136838|13178908|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
5356386|NCT00136838|13178909|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
5356387|NCT00136838|13178908|P2|COMPLETED|First Intervention ( 5 Days)||6
5356388|NCT00136838|13178909|P1|COMPLETED|First Intervention ( 5 Days)||6
5356389|NCT00136838|13178908|P2|STARTED|First Intervention ( 5 Days)||6
5356390|NCT00136838|13178909|P1|STARTED|First Intervention ( 5 Days)||6
5356391|NCT00136812|13178919|P2|NOT COMPLETED|Overall Study||0
5356392|NCT00136812|13178920|P1|NOT COMPLETED|Overall Study||0
5356393|NCT00136812|13178919|P2|COMPLETED|Overall Study||113
5356394|NCT00136812|13178920|P1|COMPLETED|Overall Study||111
5356395|NCT00136812|13178919|P2|STARTED|Overall Study||113
5356396|NCT00136812|13178920|P1|STARTED|Overall Study||111
5356397|NCT00136760|13178930|P4|NOT COMPLETED|Overall Study||0
5356398|NCT00136760|13178931|P3|NOT COMPLETED|Overall Study||0
5356399|NCT00136760|13178932|P2|NOT COMPLETED|Overall Study||0
5356400|NCT00136760|13178933|P1|NOT COMPLETED|Overall Study||0
5356401|NCT00136760|13178930|P4|COMPLETED|Overall Study||13
5356402|NCT00136760|13178931|P3|COMPLETED|Overall Study||11
5356403|NCT00136760|13178932|P2|COMPLETED|Overall Study||16
5356404|NCT00136760|13178933|P1|COMPLETED|Overall Study||12
5356405|NCT00136760|13178930|P4|STARTED|Overall Study||13
5356406|NCT00136760|13178931|P3|STARTED|Overall Study||11
5356407|NCT00136760|13178932|P2|STARTED|Overall Study||16
5356408|NCT00136760|13178933|P1|STARTED|Overall Study||12
5356409|NCT00136695|13178949|P2|NOT COMPLETED|Overall Study||8
5356410|NCT00136695|13178950|P1|NOT COMPLETED|Overall Study||11
5356411|NCT00136695|13178949|P2|COMPLETED|Overall Study||35
5356412|NCT00136695|13178950|P1|COMPLETED|Overall Study||34
5356413|NCT00136695|13178949|P2|STARTED|Overall Study||43
5356414|NCT00136695|13178950|P1|STARTED|Overall Study||45
5356415|NCT00136604|13178961|P5|NOT COMPLETED|Overall Study||1
5356416|NCT00136604|13178962|P4|NOT COMPLETED|Overall Study||0
5356417|NCT00136604|13178963|P3|NOT COMPLETED|Overall Study||0
5356418|NCT00136604|13178964|P2|NOT COMPLETED|Overall Study||1
5356419|NCT00136604|13178965|P1|NOT COMPLETED|Overall Study||1
5356420|NCT00136604|13178961|P5|COMPLETED|Overall Study||124
5356421|NCT00136604|13178962|P4|COMPLETED|Overall Study||41
5356422|NCT00136604|13178963|P3|COMPLETED|Overall Study||79
5356423|NCT00136604|13178964|P2|COMPLETED|Overall Study||122
5356424|NCT00136604|13178965|P1|COMPLETED|Overall Study||248
5356425|NCT00136604|13178961|P5|STARTED|Overall Study||125
5356426|NCT00136604|13178962|P4|STARTED|Overall Study||41
5356427|NCT00136604|13178963|P3|STARTED|Overall Study||79
5356428|NCT00136604|13178964|P2|STARTED|Overall Study||123
5356429|NCT00136604|13178965|P1|STARTED|Overall Study||249
5356430|NCT00136357|13179073|P2|NOT COMPLETED|Overall Study||2
5356431|NCT00136357|13179074|P1|NOT COMPLETED|Overall Study||3
5356432|NCT00136357|13179073|P2|COMPLETED|Overall Study||39
5356433|NCT00136357|13179074|P1|COMPLETED|Overall Study||38
5356434|NCT00136357|13179073|P2|STARTED|Overall Study||41
5356435|NCT00136357|13179074|P1|STARTED|Overall Study||41
5356436|NCT00136318|13179082|P2|NOT COMPLETED|Overall Study||7
5356437|NCT00136318|13179083|P1|NOT COMPLETED|Overall Study||7
5356438|NCT00136318|13179082|P2|COMPLETED|Overall Study||84
5356531|NCT00134784|13179522|P2|STARTED|Overall Study||38
5356439|NCT00136318|13179083|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
5356440|NCT00136318|13179082|P2|STARTED|Overall Study|Took first dose of study medication|91
5356441|NCT00136318|13179083|P1|STARTED|Overall Study|Took first dose of study medication|90
5356442|NCT00136214|13179099|P2|NOT COMPLETED|Overall Study||0
5356443|NCT00136214|13179100|P1|NOT COMPLETED|Overall Study||0
5356444|NCT00136214|13179099|P2|COMPLETED|Overall Study||7
5356445|NCT00136214|13179100|P1|COMPLETED|Overall Study||15
5356446|NCT00136214|13179099|P2|STARTED|Overall Study||7
5356447|NCT00136214|13179100|P1|STARTED|Overall Study||15
5356448|NCT00136084|13179110|P2|NOT COMPLETED|Overall Study||42
5356449|NCT00136084|13179111|P1|NOT COMPLETED|Overall Study||48
5356450|NCT00136084|13179110|P2|COMPLETED|Overall Study||72
5356451|NCT00136084|13179111|P1|COMPLETED|Overall Study||61
5356452|NCT00136084|13179110|P2|STARTED|Overall Study||114
5356453|NCT00136084|13179111|P1|STARTED|Overall Study||109
5356454|NCT00135798|13179127|P3|NOT COMPLETED|Overall Study||0
5356455|NCT00135798|13179128|P2|NOT COMPLETED|Overall Study||0
5356456|NCT00135798|13179129|P1|NOT COMPLETED|Overall Study||0
5356457|NCT00135798|13179127|P3|COMPLETED|Overall Study||32
5356458|NCT00135798|13179128|P2|COMPLETED|Overall Study||31
5356459|NCT00135798|13179129|P1|COMPLETED|Overall Study||16
5356460|NCT00135798|13179127|P3|STARTED|Overall Study||32
5356461|NCT00135798|13179128|P2|STARTED|Overall Study||31
5356462|NCT00135798|13179129|P1|STARTED|Overall Study||16
5356463|NCT00135707|13179147|P2|NOT COMPLETED|Overall Study||90
5356464|NCT00135707|13179148|P1|NOT COMPLETED|Overall Study||95
5356465|NCT00135707|13179147|P2|COMPLETED|Overall Study||4976
5356466|NCT00135707|13179148|P1|COMPLETED|Overall Study||4993
5356467|NCT00135707|13179147|P2|STARTED|Overall Study||5066
5356468|NCT00135707|13179148|P1|STARTED|Overall Study||5088
5356469|NCT00135694|13179231|P3|NOT COMPLETED|Overall Study||7
5356470|NCT00135694|13179232|P2|NOT COMPLETED|Overall Study||21
5356471|NCT00135694|13179233|P1|NOT COMPLETED|Overall Study||180
5356472|NCT00135694|13179231|P3|COMPLETED|Overall Study||11
5356473|NCT00135694|13179232|P2|COMPLETED|Overall Study||56
5356474|NCT00135694|13179233|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
5356475|NCT00135694|13179231|P3|STARTED|Overall Study||18
5356476|NCT00135694|13179232|P2|STARTED|Overall Study||77
5356477|NCT00135694|13179233|P1|STARTED|Overall Study||180
5356478|NCT00135512|13179251|P1|NOT COMPLETED|Overall Study||123
5356479|NCT00135512|13179251|P1|COMPLETED|Overall Study||111
5356480|NCT00135512|13179251|P1|STARTED|Overall Study||234
5356481|NCT00135356|13179263|P2|NOT COMPLETED|Overall Study||9
5356482|NCT00135356|13179264|P1|NOT COMPLETED|Overall Study||17
5356483|NCT00135356|13179263|P2|COMPLETED|Overall Study||60
5356484|NCT00135356|13179264|P1|COMPLETED|Overall Study||114
5356485|NCT00135356|13179263|P2|Discontinued on or After Week 96 Visit|Overall Study||0
5356486|NCT00135356|13179264|P1|Discontinued on or After Week 96 Visit|Overall Study||1
5356487|NCT00135356|13179263|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
5356488|NCT00135356|13179264|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
5356489|NCT00135356|13179263|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
5356490|NCT00135356|13179264|P1|STARTED|Overall Study|Number randomized and treated|131
5356491|NCT00135330|13179307|P3|NOT COMPLETED|Overall Study||11
5356492|NCT00135330|13179308|P2|NOT COMPLETED|Overall Study||13
5356493|NCT00135330|13179309|P1|NOT COMPLETED|Overall Study||12
5356494|NCT00135330|13179307|P3|COMPLETED|Overall Study||34
5356495|NCT00135330|13179308|P2|COMPLETED|Overall Study||34
5356496|NCT00135330|13179309|P1|COMPLETED|Overall Study||33
5356497|NCT00135330|13179307|P3|STARTED|Overall Study||45
5356498|NCT00135330|13179308|P2|STARTED|Overall Study||47
5356499|NCT00135330|13179309|P1|STARTED|Overall Study||45
5356500|NCT00135226|13179405|P4|NOT COMPLETED|Overall Study||36
5356501|NCT00135226|13179406|P3|NOT COMPLETED|Overall Study||34
5356502|NCT00135226|13179407|P2|NOT COMPLETED|Overall Study||35
5356503|NCT00135226|13179408|P1|NOT COMPLETED|Overall Study||34
5356504|NCT00135226|13179405|P4|COMPLETED|Overall Study||3834
5356505|NCT00135226|13179406|P3|COMPLETED|Overall Study||3836
5356506|NCT00135226|13179407|P2|COMPLETED|Overall Study||3835
5356507|NCT00135226|13179408|P1|COMPLETED|Overall Study||3836
5356508|NCT00135226|13179405|P4|STARTED|Overall Study||3870
5356509|NCT00135226|13179406|P3|STARTED|Overall Study||3870
5356510|NCT00135226|13179407|P2|STARTED|Overall Study||3870
5356511|NCT00135226|13179408|P1|STARTED|Overall Study||3870
5356512|NCT00135200|13179500|P1|NOT COMPLETED|Overall Study||0
5356513|NCT00135200|13179500|P1|COMPLETED|Overall Study||16
5356514|NCT00135200|13179500|P1|STARTED|Overall Study||16
5356515|NCT00134901|13179507|P2|NOT COMPLETED|Overall Study||15
5356516|NCT00134901|13179508|P1|NOT COMPLETED|Overall Study||17
5356517|NCT00134901|13179507|P2|COMPLETED|Overall Study||27
5356518|NCT00134901|13179508|P1|COMPLETED|Overall Study||22
5356519|NCT00134901|13179507|P2|STARTED|Overall Study||42
5356520|NCT00134901|13179508|P1|STARTED|Overall Study||39
5356521|NCT00134784|13179520|P4|NOT COMPLETED|Overall Study||1
5356522|NCT00134784|13179521|P3|NOT COMPLETED|Overall Study||2
5356523|NCT00134784|13179522|P2|NOT COMPLETED|Overall Study||2
5356524|NCT00134784|13179523|P1|NOT COMPLETED|Overall Study||2
5356525|NCT00134784|13179520|P4|COMPLETED|Overall Study||37
5356526|NCT00134784|13179521|P3|COMPLETED|Overall Study||35
5356527|NCT00134784|13179522|P2|COMPLETED|Overall Study||36
5356528|NCT00134784|13179523|P1|COMPLETED|Overall Study||27
5356529|NCT00134784|13179520|P4|STARTED|Overall Study||38
5356530|NCT00134784|13179521|P3|STARTED|Overall Study||37
5356532|NCT00134784|13179523|P1|STARTED|Overall Study||29
5356533|NCT00134719|13179533|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
5356534|NCT00134719|13179534|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
5356535|NCT00134719|13179535|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
5356536|NCT00134719|13179533|P3|COMPLETED|Fourth Dose Vaccination Phase||203
5356537|NCT00134719|13179534|P2|COMPLETED|Fourth Dose Vaccination Phase||203
5356538|NCT00134719|13179535|P1|COMPLETED|Fourth Dose Vaccination Phase||623
5356539|NCT00134719|13179533|P3|STARTED|Fourth Dose Vaccination Phase||204
5356540|NCT00134719|13179534|P2|STARTED|Fourth Dose Vaccination Phase||206
5356541|NCT00134719|13179535|P1|STARTED|Fourth Dose Vaccination Phase||625
5356542|NCT00134719|13179533|P3|NOT COMPLETED|Primary Vaccination Phase||5
5356543|NCT00134719|13179534|P2|NOT COMPLETED|Primary Vaccination Phase||6
5356544|NCT00134719|13179535|P1|NOT COMPLETED|Primary Vaccination Phase||14
5356545|NCT00134719|13179533|P3|COMPLETED|Primary Vaccination Phase||216
5356546|NCT00134719|13179534|P2|COMPLETED|Primary Vaccination Phase||215
5356547|NCT00134719|13179535|P1|COMPLETED|Primary Vaccination Phase||647
5356548|NCT00134719|13179533|P3|STARTED|Primary Vaccination Phase||221
5356549|NCT00134719|13179534|P2|STARTED|Primary Vaccination Phase||221
5356550|NCT00134719|13179535|P1|STARTED|Primary Vaccination Phase||661
5356551|NCT00134563|13179666|P3|NOT COMPLETED|Overall Study||96
5356552|NCT00134563|13179667|P2|NOT COMPLETED|Overall Study||92
5356553|NCT00134563|13179668|P1|NOT COMPLETED|Overall Study||104
5356554|NCT00134563|13179666|P3|COMPLETED|Overall Study|completed treatment period|263
5356555|NCT00134563|13179667|P2|COMPLETED|Overall Study|completed treatment period|274
5356556|NCT00134563|13179668|P1|COMPLETED|Overall Study|completed treatment period|259
5356557|NCT00134563|13179666|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
5356558|NCT00134563|13179667|P2|Treated|Overall Study||365
5356559|NCT00134563|13179668|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
5356560|NCT00134563|13179666|P3|STARTED|Overall Study|Randomized|359
5356561|NCT00134563|13179667|P2|STARTED|Overall Study|Randomized|366
5356562|NCT00134563|13179668|P1|STARTED|Overall Study|Randomized|363
5356563|NCT00134381|13179691|P6|NOT COMPLETED|Overall Study||2
5356564|NCT00134381|13179692|P5|NOT COMPLETED|Overall Study||0
5356565|NCT00134381|13179693|P4|NOT COMPLETED|Overall Study||0
5356566|NCT00134381|13179694|P3|NOT COMPLETED|Overall Study||0
5356567|NCT00134381|13179695|P2|NOT COMPLETED|Overall Study||0
5356568|NCT00134381|13179696|P1|NOT COMPLETED|Overall Study||0
5356569|NCT00134381|13179691|P6|COMPLETED|Overall Study||29
5356570|NCT00134381|13179692|P5|COMPLETED|Overall Study||31
5356571|NCT00134381|13179693|P4|COMPLETED|Overall Study||2
5356572|NCT00134381|13179694|P3|COMPLETED|Overall Study||1
5356573|NCT00134381|13179695|P2|COMPLETED|Overall Study||2
5356574|NCT00134381|13179696|P1|COMPLETED|Overall Study||1
5356575|NCT00134381|13179691|P6|STARTED|Overall Study||31
5356576|NCT00134381|13179692|P5|STARTED|Overall Study||31
5356577|NCT00134381|13179693|P4|STARTED|Overall Study||2
5356578|NCT00134381|13179694|P3|STARTED|Overall Study||1
5356579|NCT00134381|13179695|P2|STARTED|Overall Study||2
5356580|NCT00134381|13179696|P1|STARTED|Overall Study||1
5356581|NCT00134082|13179729|P1|NOT COMPLETED|Overall Study||3
5356582|NCT00134082|13179729|P1|COMPLETED|Overall Study||27
5356583|NCT00134082|13179729|P1|STARTED|Overall Study||30
5356584|NCT00134056|13179738|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
5356585|NCT00134056|13179739|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
5356586|NCT00134056|13179738|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
5356587|NCT00134056|13179739|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
5356588|NCT00134056|13179738|P2|STARTED|Eligible for Protocol Assigned Treatment||500
5356589|NCT00134056|13179739|P1|STARTED|Eligible for Protocol Assigned Treatment||496
5356590|NCT00134056|13179738|P2|NOT COMPLETED|Randomization||20
5356591|NCT00134056|13179739|P1|NOT COMPLETED|Randomization||22
5356592|NCT00134056|13179738|P2|COMPLETED|Randomization||500
5356593|NCT00134056|13179739|P1|COMPLETED|Randomization||496
5356594|NCT00134056|13179738|P2|STARTED|Randomization||520
5356595|NCT00134056|13179739|P1|STARTED|Randomization||518
5356596|NCT00134043|13179761|P2|NOT COMPLETED|Overall Study||0
5356597|NCT00134043|13179762|P1|NOT COMPLETED|Overall Study||0
5356598|NCT00134043|13179761|P2|COMPLETED|Overall Study||3
5356599|NCT00134043|13179762|P1|COMPLETED|Overall Study||16
5356600|NCT00134043|13179761|P2|STARTED|Overall Study||3
5356601|NCT00134043|13179762|P1|STARTED|Overall Study||16
5356602|NCT00134017|13179767|P1|NOT COMPLETED|Overall Study||0
5356603|NCT00134017|13179767|P1|COMPLETED|Overall Study||142
5356604|NCT00134017|13179767|P1|STARTED|Overall Study||142
5356605|NCT00134004|13179775|P1|NOT COMPLETED|Overall Study||0
5356606|NCT00134004|13179775|P1|COMPLETED|Overall Study||210
5356607|NCT00134004|13179775|P1|STARTED|Overall Study||210
5356608|NCT00133991|13179783|P1|NOT COMPLETED|Overall Study||4
5356609|NCT00133991|13179783|P1|COMPLETED|Overall Study||17
5356610|NCT00133991|13179783|P1|STARTED|Overall Study||21
5356611|NCT00133978|13179795|P4|NOT COMPLETED|Overall Study||2
5356612|NCT00133978|13179796|P3|NOT COMPLETED|Overall Study||0
5356613|NCT00133978|13179797|P2|NOT COMPLETED|Overall Study||1
5356614|NCT00133978|13179798|P1|NOT COMPLETED|Overall Study||2
5356615|NCT00133978|13179795|P4|COMPLETED|Overall Study||300
5356616|NCT00133978|13179796|P3|COMPLETED|Overall Study||310
5356617|NCT00133978|13179797|P2|COMPLETED|Overall Study||307
5356618|NCT00133978|13179798|P1|COMPLETED|Overall Study||301
5356619|NCT00133978|13179795|P4|STARTED|Overall Study||302
5356620|NCT00133978|13179796|P3|STARTED|Overall Study||310
5356621|NCT00133978|13179797|P2|STARTED|Overall Study||308
5356622|NCT00133978|13179798|P1|STARTED|Overall Study||303
5356623|NCT00133952|13179822|P2|NOT COMPLETED|Overall Study||28
5356624|NCT00133952|13179823|P1|NOT COMPLETED|Overall Study||42
5356625|NCT00133952|13179822|P2|COMPLETED|Overall Study||124
5356626|NCT00133952|13179823|P1|COMPLETED|Overall Study||115
5356627|NCT00133952|13179822|P2|Received at Least One Dose of Study Drug|Overall Study||149
5356628|NCT00133952|13179823|P1|Received at Least One Dose of Study Drug|Overall Study||153
5356629|NCT00133952|13179822|P2|STARTED|Overall Study||152
5356630|NCT00133952|13179823|P1|STARTED|Overall Study||157
5356631|NCT00133809|13179845|P1|NOT COMPLETED|Overall Study||0
5356632|NCT00133809|13179845|P1|COMPLETED|Overall Study||8
5356633|NCT00133809|13179845|P1|STARTED|Overall Study||8
5356634|NCT00133705|13179854|P2|NOT COMPLETED|Overall Study||3
5356635|NCT00133705|13179855|P1|NOT COMPLETED|Overall Study||2
5356636|NCT00133705|13179854|P2|COMPLETED|Overall Study||17
5356637|NCT00133705|13179855|P1|COMPLETED|Overall Study||20
5356638|NCT00133705|13179854|P2|STARTED|Overall Study||20
5356639|NCT00133705|13179855|P1|STARTED|Overall Study||22
5356640|NCT00133575|13179868|P7|NOT COMPLETED|Overall Study||3
5356641|NCT00133575|13179869|P6|NOT COMPLETED|Overall Study||1
5356642|NCT00133575|13179870|P5|NOT COMPLETED|Overall Study||4
5356643|NCT00133575|13179871|P4|NOT COMPLETED|Overall Study||1
5356644|NCT00133575|13179872|P3|NOT COMPLETED|Overall Study||2
5356645|NCT00133575|13179873|P2|NOT COMPLETED|Overall Study||0
5356646|NCT00133575|13179874|P1|NOT COMPLETED|Overall Study||0
5356647|NCT00133575|13179868|P7|COMPLETED|Overall Study||9
5356648|NCT00133575|13179869|P6|COMPLETED|Overall Study||9
5356649|NCT00133575|13179870|P5|COMPLETED|Overall Study||6
5356650|NCT00133575|13179871|P4|COMPLETED|Overall Study||9
5356651|NCT00133575|13179872|P3|COMPLETED|Overall Study||8
5356652|NCT00133575|13179873|P2|COMPLETED|Overall Study||10
5356653|NCT00133575|13179874|P1|COMPLETED|Overall Study||10
5356654|NCT00133575|13179868|P7|STARTED|Overall Study||12
5356655|NCT00133575|13179869|P6|STARTED|Overall Study||10
5356656|NCT00133575|13179870|P5|STARTED|Overall Study||10
5356657|NCT00133575|13179871|P4|STARTED|Overall Study||10
5356658|NCT00133575|13179872|P3|STARTED|Overall Study||10
5356659|NCT00133575|13179873|P2|STARTED|Overall Study||10
5356660|NCT00133575|13179874|P1|STARTED|Overall Study||10
5356661|NCT00132964|13179983|P2|NOT COMPLETED|Overall Study||3
5356662|NCT00132964|13179984|P1|NOT COMPLETED|Overall Study||4
5356663|NCT00132964|13179983|P2|COMPLETED|Overall Study||54
5356664|NCT00132964|13179984|P1|COMPLETED|Overall Study||50
5356665|NCT00132964|13179983|P2|STARTED|Overall Study||57
5356666|NCT00132964|13179984|P1|STARTED|Overall Study||54
5356667|NCT00132873|13179990|P1|NOT COMPLETED|Overall Study||9
5356668|NCT00132873|13179990|P1|COMPLETED|Overall Study||50
5356669|NCT00132873|13179990|P1|STARTED|Overall Study||59
5356670|NCT00132808|13179998|P3|NOT COMPLETED|Stratum II||9
5356671|NCT00132808|13179999|P2|NOT COMPLETED|Stratum II||15
5356672|NCT00132808|13180000|P1|NOT COMPLETED|Stratum II||8
5356673|NCT00132808|13179998|P3|COMPLETED|Stratum II||116
5356674|NCT00132808|13179999|P2|COMPLETED|Stratum II||96
5356675|NCT00132808|13180000|P1|COMPLETED|Stratum II||113
5356676|NCT00132808|13179998|P3|STARTED|Stratum II||125
5356677|NCT00132808|13179999|P2|STARTED|Stratum II||111
5356678|NCT00132808|13180000|P1|STARTED|Stratum II||121
5356679|NCT00132808|13179998|P3|NOT COMPLETED|Stratum I||5
5356680|NCT00132808|13179999|P2|NOT COMPLETED|Stratum I||12
5356681|NCT00132808|13180000|P1|NOT COMPLETED|Stratum I||9
5356682|NCT00132808|13179998|P3|COMPLETED|Stratum I||72
5356683|NCT00132808|13179999|P2|COMPLETED|Stratum I||58
5356684|NCT00132808|13180000|P1|COMPLETED|Stratum I||68
5356685|NCT00132808|13179998|P3|STARTED|Stratum I||77
5356686|NCT00132808|13179999|P2|STARTED|Stratum I||70
5356687|NCT00132808|13180000|P1|STARTED|Stratum I||77
5356688|NCT00132769|13180025|P2|NOT COMPLETED|Overall Study||11
5356689|NCT00132769|13180026|P1|NOT COMPLETED|Overall Study||11
5356690|NCT00132769|13180025|P2|COMPLETED|Overall Study||42
5356691|NCT00132769|13180026|P1|COMPLETED|Overall Study||42
5356692|NCT00132769|13180025|P2|STARTED|Overall Study||53
5356693|NCT00132769|13180026|P1|STARTED|Overall Study||53
5356694|NCT00132730|13180052|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
5356695|NCT00132730|13180053|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
5356696|NCT00132730|13180054|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
5356697|NCT00132730|13180055|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
5356698|NCT00132730|13180056|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
5356699|NCT00132730|13180057|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
5356700|NCT00132730|13180052|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356701|NCT00132730|13180053|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356702|NCT00132730|13180054|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356703|NCT00132730|13180055|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356704|NCT00132730|13180056|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356705|NCT00132730|13180057|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
5356706|NCT00132730|13180052|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
5356707|NCT00132730|13180053|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
5356708|NCT00132730|13180054|P4|STARTED|Period V - Open-label Extension (EXT2)||0
5356709|NCT00132730|13180055|P3|STARTED|Period V - Open-label Extension (EXT2)||0
5356710|NCT00132730|13180056|P2|STARTED|Period V - Open-label Extension (EXT2)||0
5356711|NCT00132730|13180057|P1|STARTED|Period V - Open-label Extension (EXT2)||0
5356712|NCT00132730|13180052|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
5356713|NCT00132730|13180053|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
5356714|NCT00132730|13180054|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356715|NCT00132730|13180055|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356716|NCT00132730|13180056|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356717|NCT00132730|13180057|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356718|NCT00132730|13180052|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
5356719|NCT00132730|13180053|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
5356720|NCT00132730|13180054|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356721|NCT00132730|13180055|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356722|NCT00132730|13180056|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356723|NCT00132730|13180057|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
5356724|NCT00132730|13180052|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
5356725|NCT00132730|13180053|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
5356726|NCT00132730|13180054|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
5356727|NCT00132730|13180055|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
5356728|NCT00132730|13180056|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
5356729|NCT00132730|13180057|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
5356730|NCT00132730|13180052|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
5356731|NCT00132730|13180053|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
5356732|NCT00132730|13180054|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
5356733|NCT00132730|13180055|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
5356734|NCT00132730|13180056|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
5356735|NCT00132730|13180057|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
5356736|NCT00132730|13180052|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
5356737|NCT00132730|13180053|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
5356738|NCT00132730|13180054|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
5356739|NCT00132730|13180055|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
5356740|NCT00132730|13180056|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
5356741|NCT00132730|13180057|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
5356742|NCT00132730|13180052|P6|STARTED|Period III - Blinded Extension (EXT1)||0
5356743|NCT00132730|13180053|P5|STARTED|Period III - Blinded Extension (EXT1)||0
5356744|NCT00132730|13180054|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
5356745|NCT00132730|13180055|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
5356746|NCT00132730|13180056|P2|STARTED|Period III - Blinded Extension (EXT1)||0
5356747|NCT00132730|13180057|P1|STARTED|Period III - Blinded Extension (EXT1)||0
5356748|NCT00132730|13180052|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
5356749|NCT00132730|13180053|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
5356750|NCT00132730|13180054|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
5356751|NCT00132730|13180055|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
5356752|NCT00132730|13180056|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
5356753|NCT00132730|13180057|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
5356754|NCT00132730|13180052|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
5356755|NCT00132730|13180053|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
5356756|NCT00132730|13180054|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
5356757|NCT00132730|13180055|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
5356758|NCT00132730|13180056|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
5356759|NCT00132730|13180057|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
5356760|NCT00132730|13180052|P6|STARTED|Period II - 12-week Treatment (Base)||0
5356761|NCT00132730|13180053|P5|STARTED|Period II - 12-week Treatment (Base)||0
5356762|NCT00132730|13180054|P4|STARTED|Period II - 12-week Treatment (Base)||153
5356763|NCT00132730|13180055|P3|STARTED|Period II - 12-week Treatment (Base)||153
5356764|NCT00132730|13180056|P2|STARTED|Period II - 12-week Treatment (Base)||148
5356765|NCT00132730|13180057|P1|STARTED|Period II - 12-week Treatment (Base)||150
5356766|NCT00132730|13180052|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356767|NCT00132730|13180053|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356768|NCT00132730|13180054|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356769|NCT00132730|13180055|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356770|NCT00132730|13180056|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356771|NCT00132730|13180057|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
5356772|NCT00132730|13180052|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
5356773|NCT00132730|13180053|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
5356774|NCT00132730|13180054|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
5356775|NCT00132730|13180055|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
5356776|NCT00132730|13180056|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
5356777|NCT00132730|13180057|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
5356778|NCT00132730|13180052|P6|STARTED|Period I - Placebo Run-in (Base)||0
5356779|NCT00132730|13180053|P5|STARTED|Period I - Placebo Run-in (Base)||0
5356780|NCT00132730|13180054|P4|STARTED|Period I - Placebo Run-in (Base)||153
5356781|NCT00132730|13180055|P3|STARTED|Period I - Placebo Run-in (Base)||153
5356782|NCT00132730|13180056|P2|STARTED|Period I - Placebo Run-in (Base)||148
5356783|NCT00132730|13180057|P1|STARTED|Period I - Placebo Run-in (Base)||150
5356784|NCT00132691|13180101|P2|NOT COMPLETED|Overall Study||12
5356785|NCT00132691|13180102|P1|NOT COMPLETED|Overall Study||11
5356786|NCT00132691|13180101|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
5356787|NCT00132691|13180102|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
5356788|NCT00132691|13180101|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
5356789|NCT00132691|13180102|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
5356790|NCT00132678|13180142|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
5356791|NCT00132678|13180143|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
5356792|NCT00132678|13180144|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
5356793|NCT00132678|13180142|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
5356794|NCT00132678|13180143|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
5356795|NCT00132678|13180144|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
5356796|NCT00132678|13180142|P3|STARTED|Period IV (Double-Blind Treatment)||0
5356797|NCT00132678|13180143|P2|STARTED|Period IV (Double-Blind Treatment)||149
5356798|NCT00132678|13180144|P1|STARTED|Period IV (Double-Blind Treatment)||154
5356799|NCT00132678|13180142|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
5356800|NCT00132678|13180143|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
5356801|NCT00132678|13180144|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
5356802|NCT00132678|13180142|P3|COMPLETED|Period III (Open-Label Stabilization)||0
5356803|NCT00132678|13180143|P2|COMPLETED|Period III (Open-Label Stabilization)||0
5356804|NCT00132678|13180144|P1|COMPLETED|Period III (Open-Label Stabilization)||303
5356805|NCT00132678|13180142|P3|STARTED|Period III (Open-Label Stabilization)||0
5356806|NCT00132678|13180143|P2|STARTED|Period III (Open-Label Stabilization)||0
5356807|NCT00132678|13180144|P1|STARTED|Period III (Open-Label Stabilization)||501
5356808|NCT00132678|13180142|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
5356809|NCT00132678|13180143|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
5356810|NCT00132678|13180144|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
5356811|NCT00132678|13180142|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
5356812|NCT00132678|13180143|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
5356813|NCT00132678|13180144|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
5356814|NCT00132678|13180142|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
5356815|NCT00132678|13180143|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
5356816|NCT00132678|13180144|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
5356817|NCT00132496|13180158|P2|NOT COMPLETED|Overall Study||2
5356818|NCT00132496|13180159|P1|NOT COMPLETED|Overall Study||2
5356819|NCT00132496|13180158|P2|COMPLETED|Overall Study||55
5356820|NCT00132496|13180159|P1|COMPLETED|Overall Study||52
5356821|NCT00132496|13180158|P2|STARTED|Overall Study||57
5356822|NCT00132496|13180159|P1|STARTED|Overall Study||54
5356823|NCT00132314|13180167|P2|NOT COMPLETED|Overall Study||72
5356824|NCT00132314|13180168|P1|NOT COMPLETED|Overall Study||73
5356825|NCT00132314|13180167|P2|COMPLETED|Overall Study||120
5356826|NCT00132314|13180168|P1|COMPLETED|Overall Study||117
5356827|NCT00132314|13180167|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
5356828|NCT00132314|13180168|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
5356829|NCT00132314|13180167|P2|Received Treatment|Overall Study||185
5356830|NCT00132314|13180168|P1|Received Treatment|Overall Study||188
5356831|NCT00132314|13180167|P2|STARTED|Overall Study||192
5356832|NCT00132314|13180168|P1|STARTED|Overall Study||190
5356833|NCT00132301|13180178|P2|NOT COMPLETED|Overall Study||13
5356834|NCT00132301|13180179|P1|NOT COMPLETED|Overall Study||20
5356835|NCT00132301|13180178|P2|COMPLETED|Overall Study||144
5356836|NCT00132301|13180179|P1|COMPLETED|Overall Study||121
5356837|NCT00132301|13180178|P2|STARTED|Overall Study||157
5356838|NCT00132301|13180179|P1|STARTED|Overall Study||141
5356839|NCT00132132|13180187|P2|NOT COMPLETED|Overall Study||2
5356840|NCT00132132|13180188|P1|NOT COMPLETED|Overall Study||7
5356841|NCT00132132|13180187|P2|COMPLETED|Overall Study||13
5356842|NCT00132132|13180188|P1|COMPLETED|Overall Study||8
5356843|NCT00132132|13180187|P2|STARTED|Overall Study||15
5356844|NCT00132132|13180188|P1|STARTED|Overall Study||15
5356845|NCT00132028|13180196|P1|NOT COMPLETED|Overall Study||27
5356846|NCT00132028|13180196|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
5356847|NCT00132028|13180196|P1|Eligible and Began Protocol Therapy|Overall Study||25
5356848|NCT00132028|13180196|P1|Eligible|Overall Study||25
5356849|NCT00132028|13180196|P1|STARTED|Overall Study||27
5356850|NCT00132002|13180202|P1|NOT COMPLETED|Overall Study||0
5356851|NCT00132002|13180202|P1|COMPLETED|Overall Study||14
5356852|NCT00132002|13180202|P1|STARTED|Overall Study||14
5356853|NCT00131937|13180208|P1|NOT COMPLETED|Overall Study||14
5356854|NCT00131937|13180208|P1|COMPLETED|Overall Study||0
5356855|NCT00131937|13180208|P1|STARTED|Overall Study||14
5356856|NCT00131911|13180216|P2|NOT COMPLETED|Overall Study||0
5356857|NCT00131911|13180217|P1|NOT COMPLETED|Overall Study||1
5356858|NCT00131911|13180216|P2|COMPLETED|Overall Study||42
5356859|NCT00131911|13180217|P1|COMPLETED|Overall Study||50
5356860|NCT00131911|13180216|P2|STARTED|Overall Study||42
5356861|NCT00131911|13180217|P1|STARTED|Overall Study||51
5356862|NCT00131885|13180234|P4|NOT COMPLETED|Time 2: Second Intervention||0
5356863|NCT00131885|13180235|P3|NOT COMPLETED|Time 2: Second Intervention||0
5356864|NCT00131885|13180236|P2|NOT COMPLETED|Time 2: Second Intervention||0
5356865|NCT00131885|13180237|P1|NOT COMPLETED|Time 2: Second Intervention||0
5356866|NCT00131885|13180234|P4|COMPLETED|Time 2: Second Intervention||9
5356867|NCT00131885|13180235|P3|COMPLETED|Time 2: Second Intervention||9
5356868|NCT00131885|13180236|P2|COMPLETED|Time 2: Second Intervention||9
5356869|NCT00131885|13180237|P1|COMPLETED|Time 2: Second Intervention||9
5356870|NCT00131885|13180234|P4|STARTED|Time 2: Second Intervention||9
5356871|NCT00131885|13180235|P3|STARTED|Time 2: Second Intervention||9
5356872|NCT00131885|13180236|P2|STARTED|Time 2: Second Intervention||9
5356873|NCT00131885|13180237|P1|STARTED|Time 2: Second Intervention||9
5356874|NCT00131885|13180234|P4|NOT COMPLETED|Time 1: First Intervention||0
5356875|NCT00131885|13180235|P3|NOT COMPLETED|Time 1: First Intervention||0
5356876|NCT00131885|13180236|P2|NOT COMPLETED|Time 1: First Intervention||0
5356877|NCT00131885|13180237|P1|NOT COMPLETED|Time 1: First Intervention||0
5356878|NCT00131885|13180234|P4|COMPLETED|Time 1: First Intervention||9
5356879|NCT00131885|13180235|P3|COMPLETED|Time 1: First Intervention||9
5356880|NCT00131885|13180236|P2|COMPLETED|Time 1: First Intervention||9
5356881|NCT00131885|13180237|P1|COMPLETED|Time 1: First Intervention||9
5356882|NCT00131885|13180234|P4|STARTED|Time 1: First Intervention||9
5356883|NCT00131885|13180235|P3|STARTED|Time 1: First Intervention||9
5356884|NCT00131885|13180236|P2|STARTED|Time 1: First Intervention||9
5356885|NCT00131885|13180237|P1|STARTED|Time 1: First Intervention||9
5356886|NCT00131677|13180269|P2|NOT COMPLETED|Overall Study||39
5356887|NCT00131677|13180270|P1|NOT COMPLETED|Overall Study||30
5356888|NCT00131677|13180269|P2|COMPLETED|Overall Study||160
5356889|NCT00131677|13180270|P1|COMPLETED|Overall Study||171
5356890|NCT00131677|13180269|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
5356891|NCT00131677|13180270|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
5356892|NCT00131664|13180287|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
5356893|NCT00131664|13180288|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
5356894|NCT00131664|13180289|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
5356895|NCT00131664|13180290|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
5356896|NCT00131664|13180291|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
5356897|NCT00131664|13180292|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
5356898|NCT00131664|13180287|P6|COMPLETED|Second Period (Additional Drug Added)||22
5356899|NCT00131664|13180288|P5|COMPLETED|Second Period (Additional Drug Added)||15
5356900|NCT00131664|13180289|P4|COMPLETED|Second Period (Additional Drug Added)||19
5356901|NCT00131664|13180290|P3|COMPLETED|Second Period (Additional Drug Added)||76
5356902|NCT00131664|13180291|P2|COMPLETED|Second Period (Additional Drug Added)||97
5356903|NCT00131664|13180292|P1|COMPLETED|Second Period (Additional Drug Added)||81
5356904|NCT00131664|13180287|P6|STARTED|Second Period (Additional Drug Added)||25
5356905|NCT00131664|13180288|P5|STARTED|Second Period (Additional Drug Added)||16
5356906|NCT00131664|13180289|P4|STARTED|Second Period (Additional Drug Added)||21
5356907|NCT00131664|13180290|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
5356908|NCT00131664|13180291|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
5356909|NCT00131664|13180292|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
5356910|NCT00131664|13180287|P6|NOT COMPLETED|First Period (First 6 Months)||0
5356911|NCT00131664|13180288|P5|NOT COMPLETED|First Period (First 6 Months)||0
5356912|NCT00131664|13180289|P4|NOT COMPLETED|First Period (First 6 Months)||0
5356913|NCT00131664|13180290|P3|NOT COMPLETED|First Period (First 6 Months)||16
5356914|NCT00131664|13180291|P2|NOT COMPLETED|First Period (First 6 Months)||18
5356915|NCT00131664|13180292|P1|NOT COMPLETED|First Period (First 6 Months)||25
5356916|NCT00131664|13180287|P6|COMPLETED|First Period (First 6 Months)||0
5356917|NCT00131664|13180288|P5|COMPLETED|First Period (First 6 Months)||0
5356918|NCT00131664|13180289|P4|COMPLETED|First Period (First 6 Months)||0
5356919|NCT00131664|13180290|P3|COMPLETED|First Period (First 6 Months)||104
5356920|NCT00131664|13180291|P2|COMPLETED|First Period (First 6 Months)||117
5356921|NCT00131664|13180292|P1|COMPLETED|First Period (First 6 Months)||111
5356922|NCT00131664|13180287|P6|STARTED|First Period (First 6 Months)||0
5356923|NCT00131664|13180288|P5|STARTED|First Period (First 6 Months)||0
5356924|NCT00131664|13180289|P4|STARTED|First Period (First 6 Months)||0
5356925|NCT00131664|13180290|P3|STARTED|First Period (First 6 Months)||120
5356926|NCT00131664|13180291|P2|STARTED|First Period (First 6 Months)||135
5356927|NCT00131664|13180292|P1|STARTED|First Period (First 6 Months)||136
5356928|NCT00131573|13180353|P2|NOT COMPLETED|Overall Study||26
5356929|NCT00131573|13180354|P1|NOT COMPLETED|Overall Study||33
5356930|NCT00131573|13180353|P2|COMPLETED|Overall Study||13
5356931|NCT00131573|13180354|P1|COMPLETED|Overall Study||13
5356932|NCT00131573|13180353|P2|STARTED|Overall Study||39
5356933|NCT00131573|13180354|P1|STARTED|Overall Study||46
5356934|NCT00131508|13180364|P2|NOT COMPLETED|Overall Study||8
5356935|NCT00131508|13180365|P1|NOT COMPLETED|Overall Study||3
5356936|NCT00131508|13180364|P2|COMPLETED|Overall Study||5
5356937|NCT00131508|13180365|P1|COMPLETED|Overall Study||9
5356938|NCT00131508|13180364|P2|STARTED|Overall Study||13
5356939|NCT00131508|13180365|P1|STARTED|Overall Study||12
5356940|NCT00131469|13180389|P2|NOT COMPLETED|Overall Study||13
5356941|NCT00131469|13180390|P1|NOT COMPLETED|Overall Study||9
5356942|NCT00131469|13180389|P2|COMPLETED|Overall Study||27
5356943|NCT00131469|13180390|P1|COMPLETED|Overall Study||29
5356944|NCT00131469|13180389|P2|STARTED|Overall Study||40
5356945|NCT00131469|13180390|P1|STARTED|Overall Study||38
5356946|NCT00131456|13180400|P2|NOT COMPLETED|Overall Study||20
5356947|NCT00131456|13180401|P1|NOT COMPLETED|Overall Study||19
5356948|NCT00131456|13180400|P2|COMPLETED|Overall Study||31
5356949|NCT00131456|13180401|P1|COMPLETED|Overall Study||33
5356950|NCT00131456|13180400|P2|STARTED|Overall Study||51
5356951|NCT00131456|13180401|P1|STARTED|Overall Study||52
5356952|NCT00131378|13180411|P4|NOT COMPLETED|Overall Study||9
5356953|NCT00131378|13180412|P3|NOT COMPLETED|Overall Study||10
5356954|NCT00131378|13180413|P2|NOT COMPLETED|Overall Study||18
5356955|NCT00131378|13180414|P1|NOT COMPLETED|Overall Study||11
5356956|NCT00131378|13180411|P4|COMPLETED|Overall Study||21
5356957|NCT00131378|13180412|P3|COMPLETED|Overall Study||22
5356958|NCT00131378|13180413|P2|COMPLETED|Overall Study||22
5356959|NCT00131378|13180414|P1|COMPLETED|Overall Study||29
5356960|NCT00131378|13180411|P4|STARTED|Overall Study||30
5356961|NCT00131378|13180412|P3|STARTED|Overall Study||32
5356962|NCT00131378|13180413|P2|STARTED|Overall Study||40
5356963|NCT00131378|13180414|P1|STARTED|Overall Study||40
5356964|NCT00131365|13180436|P1|NOT COMPLETED|Overall Study||4
5356965|NCT00131365|13180436|P1|COMPLETED|Overall Study||5
5356966|NCT00131365|13180436|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
5356967|NCT00131352|13180443|P2|NOT COMPLETED|Repeat Treatment Period||0
5356968|NCT00131352|13180444|P1|NOT COMPLETED|Repeat Treatment Period||2
5356969|NCT00131352|13180443|P2|COMPLETED|Repeat Treatment Period||0
5356970|NCT00131352|13180444|P1|COMPLETED|Repeat Treatment Period||158
5356971|NCT00131352|13180443|P2|STARTED|Repeat Treatment Period||0
5356972|NCT00131352|13180444|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
5356973|NCT00131352|13180443|P2|NOT COMPLETED|Initial Treatment Period||12
5356974|NCT00131352|13180444|P1|NOT COMPLETED|Initial Treatment Period||9
5356975|NCT00131352|13180443|P2|COMPLETED|Initial Treatment Period||118
5356976|NCT00131352|13180444|P1|COMPLETED|Initial Treatment Period||114
5356977|NCT00131352|13180443|P2|Intent to Treat Population|Initial Treatment Period||129
5356978|NCT00131352|13180444|P1|Intent to Treat Population|Initial Treatment Period||124
5356979|NCT00131352|13180443|P2|STARTED|Initial Treatment Period|Safety population|130
5356980|NCT00131352|13180444|P1|STARTED|Initial Treatment Period|Safety population|123
5356981|NCT00131248|13180466|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
5356982|NCT00131248|13180467|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
5356983|NCT00131248|13180466|P2|COMPLETED|Intervention 3 (4-day Course)||9
5356984|NCT00131248|13180467|P1|COMPLETED|Intervention 3 (4-day Course)||8
5356985|NCT00131248|13180466|P2|STARTED|Intervention 3 (4-day Course)||9
5356986|NCT00131248|13180467|P1|STARTED|Intervention 3 (4-day Course)||8
5356987|NCT00131248|13180466|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
5356988|NCT00131248|13180467|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
5356989|NCT00131248|13180466|P2|COMPLETED|Washout 2 (24 Hours)||9
5356990|NCT00131248|13180467|P1|COMPLETED|Washout 2 (24 Hours)||8
5356991|NCT00131248|13180466|P2|STARTED|Washout 2 (24 Hours)||9
5356992|NCT00131248|13180467|P1|STARTED|Washout 2 (24 Hours)||8
5356993|NCT00131248|13180466|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
5356994|NCT00131248|13180467|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
5356995|NCT00131248|13180466|P2|COMPLETED|Intervention 2 (7-day Course)||9
5356996|NCT00131248|13180467|P1|COMPLETED|Intervention 2 (7-day Course)||8
5356997|NCT00131248|13180466|P2|STARTED|Intervention 2 (7-day Course)||9
5356998|NCT00131248|13180467|P1|STARTED|Intervention 2 (7-day Course)||8
5356999|NCT00131248|13180466|P2|NOT COMPLETED|Washout (24 Hour)||0
5357000|NCT00131248|13180467|P1|NOT COMPLETED|Washout (24 Hour)||0
5357001|NCT00131248|13180466|P2|COMPLETED|Washout (24 Hour)||9
5357002|NCT00131248|13180467|P1|COMPLETED|Washout (24 Hour)||8
5357003|NCT00131248|13180466|P2|STARTED|Washout (24 Hour)||9
5357004|NCT00131248|13180467|P1|STARTED|Washout (24 Hour)||8
5357005|NCT00131248|13180466|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
5357006|NCT00131248|13180467|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
5357007|NCT00131248|13180466|P2|COMPLETED|Intervention 1 (3-day Course)||9
5357008|NCT00131248|13180467|P1|COMPLETED|Intervention 1 (3-day Course)||8
5357009|NCT00131248|13180466|P2|STARTED|Intervention 1 (3-day Course)||9
5357010|NCT00131248|13180467|P1|STARTED|Intervention 1 (3-day Course)||9
5357011|NCT00130923|13180475|P2|NOT COMPLETED|Overall Study||14
5357012|NCT00130923|13180476|P1|NOT COMPLETED|Overall Study||13
5357013|NCT00130923|13180475|P2|COMPLETED|Overall Study||32
5357014|NCT00130923|13180476|P1|COMPLETED|Overall Study||36
5357015|NCT00130923|13180475|P2|STARTED|Overall Study||46
5357016|NCT00130923|13180476|P1|STARTED|Overall Study||49
5357017|NCT00130832|13180494|P2|NOT COMPLETED|Overall Study||17
5357018|NCT00130832|13180495|P1|NOT COMPLETED|Overall Study||16
5357019|NCT00130832|13180494|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
5357020|NCT00130832|13180495|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
5357021|NCT00130832|13180494|P2|STARTED|Overall Study||363
5357022|NCT00130832|13180495|P1|STARTED|Overall Study||372
5357023|NCT00130793|13180507|P2|NOT COMPLETED|Overall Study||4
5357024|NCT00130793|13180508|P1|NOT COMPLETED|Overall Study||3
5357025|NCT00130793|13180507|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
5357026|NCT00130793|13180508|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
5357027|NCT00130793|13180507|P2|Vaccinated|Overall Study||185
5357028|NCT00130793|13180508|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
5357029|NCT00130793|13180507|P2|STARTED|Overall Study||185
5357030|NCT00130793|13180508|P1|STARTED|Overall Study||183
5357031|NCT00130780|13180520|P2|NOT COMPLETED|Overall Study||0
5357032|NCT00130780|13180521|P1|NOT COMPLETED|Overall Study||0
5357033|NCT00130780|13180520|P2|COMPLETED|Overall Study||20
5357034|NCT00130780|13180521|P1|COMPLETED|Overall Study||51
5357035|NCT00130780|13180520|P2|STARTED|Overall Study||20
5357036|NCT00130780|13180521|P1|STARTED|Overall Study||51
5357037|NCT00130728|13180529|P2|NOT COMPLETED|Overall Study||213
5357038|NCT00130728|13180530|P1|NOT COMPLETED|Overall Study||211
5357039|NCT00130728|13180529|P2|COMPLETED|Overall Study||104
5357040|NCT00130728|13180530|P1|COMPLETED|Overall Study||108
5357041|NCT00130728|13180529|P2|Received Study Drug (Safety Population)|Overall Study||313
5357042|NCT00130728|13180530|P1|Received Study Drug (Safety Population)|Overall Study||313
5357043|NCT00130728|13180529|P2|STARTED|Overall Study||317
5357044|NCT00130728|13180530|P1|STARTED|Overall Study||319
5357045|NCT00130689|13180542|P1|NOT COMPLETED|Overall Study||43
5357046|NCT00130689|13180542|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
5357047|NCT00130689|13180542|P1|Treated|Overall Study||35
5357048|NCT00130689|13180542|P1|Eligible|Overall Study||37
5357049|NCT00130689|13180542|P1|STARTED|Overall Study||43
5357050|NCT00130637|13180546|P1|NOT COMPLETED|Overall Study||3
5357051|NCT00130637|13180546|P1|COMPLETED|Overall Study||3
5357052|NCT00130637|13180546|P1|STARTED|Overall Study||6
5357053|NCT00130533|13180553|P2|NOT COMPLETED|Overall Study||30
5357054|NCT00130533|13180554|P1|NOT COMPLETED|Overall Study||111
5357055|NCT00130533|13180553|P2|COMPLETED|Overall Study||398
5357056|NCT00130533|13180554|P1|COMPLETED|Overall Study||337
5357057|NCT00130533|13180553|P2|STARTED|Overall Study||428
5357058|NCT00130533|13180554|P1|STARTED|Overall Study||448
5357059|NCT00130520|13180566|P1|NOT COMPLETED|Overall Study||39
5357060|NCT00130520|13180566|P1|COMPLETED|Overall Study||1
5357061|NCT00130520|13180566|P1|Completion of at Least One Cycle|Overall Study||39
5357062|NCT00130520|13180566|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
5357063|NCT00130286|13180576|P4|NOT COMPLETED|Overall Study||2
5357064|NCT00130286|13180577|P3|NOT COMPLETED|Overall Study||4
5357065|NCT00130286|13180578|P2|NOT COMPLETED|Overall Study||3
5357066|NCT00130286|13180579|P1|NOT COMPLETED|Overall Study||0
5357067|NCT00130286|13180576|P4|COMPLETED|Overall Study||17
5357068|NCT00130286|13180577|P3|COMPLETED|Overall Study||13
5357069|NCT00130286|13180578|P2|COMPLETED|Overall Study||16
5357070|NCT00130286|13180579|P1|COMPLETED|Overall Study||22
5357071|NCT00130286|13180576|P4|STARTED|Overall Study||19
5357072|NCT00130286|13180577|P3|STARTED|Overall Study||17
5357073|NCT00130286|13180578|P2|STARTED|Overall Study||19
5357074|NCT00130286|13180579|P1|STARTED|Overall Study||22
5357075|NCT00130247|13180599|P2|NOT COMPLETED|Overall Study||4
5357076|NCT00130247|13180600|P1|NOT COMPLETED|Overall Study||2
5357077|NCT00130247|13180599|P2|COMPLETED|Overall Study||194
5357078|NCT00130247|13180600|P1|COMPLETED|Overall Study||194
5357079|NCT00130247|13180599|P2|STARTED|Overall Study||198
5357080|NCT00130247|13180600|P1|STARTED|Overall Study||196
5357081|NCT00130208|13180618|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
5357082|NCT00130208|13180619|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
5357083|NCT00130208|13180618|P2|COMPLETED|Washout Period (8 Weeks)||490
5357084|NCT00130208|13180619|P1|COMPLETED|Washout Period (8 Weeks)||494
5357085|NCT00130208|13180618|P2|STARTED|Washout Period (8 Weeks)||502
5357086|NCT00130208|13180619|P1|STARTED|Washout Period (8 Weeks)||500
5357087|NCT00130208|13180618|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
5357088|NCT00130208|13180619|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
5357089|NCT00130208|13180618|P2|COMPLETED|Maintenance Period (26 Weeks)||502
5357090|NCT00130208|13180619|P1|COMPLETED|Maintenance Period (26 Weeks)||500
5357091|NCT00130208|13180618|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
5357092|NCT00130208|13180619|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
5357093|NCT00130208|13180618|P2|STARTED|Maintenance Period (26 Weeks)||532
5357094|NCT00130208|13180619|P1|STARTED|Maintenance Period (26 Weeks)||524
5357095|NCT00130117|13180631|P2|NOT COMPLETED|Overall Study||3
5357096|NCT00130117|13180632|P1|NOT COMPLETED|Overall Study||4
5357097|NCT00130117|13180631|P2|COMPLETED|Overall Study||6
5357098|NCT00130117|13180632|P1|COMPLETED|Overall Study||7
5357099|NCT00130117|13180631|P2|STARTED|Overall Study||9
5357100|NCT00130117|13180632|P1|STARTED|Overall Study||11
5357101|NCT00130039|13180655|P2|NOT COMPLETED|Overall Study||18
5357102|NCT00130039|13180656|P1|NOT COMPLETED|Overall Study||30
5357103|NCT00130039|13180655|P2|COMPLETED|Overall Study|full analysis set|207
5357104|NCT00130039|13180656|P1|COMPLETED|Overall Study|full analysis set|202
5357105|NCT00130039|13180655|P2|STARTED|Overall Study||225
5357106|NCT00130039|13180656|P1|STARTED|Overall Study||232
5357107|NCT00129987|13180674|P2|NOT COMPLETED|1 Year||21
5357108|NCT00129987|13180675|P1|NOT COMPLETED|1 Year||32
5357109|NCT00129987|13180674|P2|COMPLETED|1 Year||150
5357110|NCT00129987|13180675|P1|COMPLETED|1 Year||114
5357111|NCT00129987|13180674|P2|STARTED|1 Year||171
5357112|NCT00129987|13180675|P1|STARTED|1 Year||146
5357113|NCT00129987|13180674|P2|NOT COMPLETED|1st Educational Session||109
5357114|NCT00129987|13180675|P1|NOT COMPLETED|1st Educational Session||141
5357115|NCT00129987|13180674|P2|COMPLETED|1st Educational Session||171
5357116|NCT00129987|13180675|P1|COMPLETED|1st Educational Session||146
5357117|NCT00129987|13180674|P2|STARTED|1st Educational Session||280
5357118|NCT00129987|13180675|P1|STARTED|1st Educational Session||287
5357119|NCT00129974|13180687|P1|NOT COMPLETED|Overall Study||1
5357120|NCT00129974|13180687|P1|COMPLETED|Overall Study||0
5357121|NCT00129974|13180687|P1|STARTED|Overall Study||1
5357122|NCT00129961|13180694|P2|NOT COMPLETED|Overall Study||23
5357123|NCT00129961|13180695|P1|NOT COMPLETED|Overall Study||19
5357124|NCT00129961|13180694|P2|COMPLETED|Overall Study||24
5357125|NCT00129961|13180695|P1|COMPLETED|Overall Study||20
5357126|NCT00129961|13180694|P2|STARTED|Overall Study||47
5357127|NCT00129961|13180695|P1|STARTED|Overall Study||39
5357128|NCT00129935|13180731|P2|NOT COMPLETED|Overall Study||92
5357129|NCT00129935|13180732|P1|NOT COMPLETED|Overall Study||36
5357130|NCT00129935|13180731|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
5357131|NCT00129935|13180732|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
5357132|NCT00129935|13180731|P2|STARTED|Overall Study||715
5357133|NCT00129935|13180732|P1|STARTED|Overall Study||669
5357134|NCT00129766|13180750|P2|NOT COMPLETED|Overall Study||59
5357135|NCT00129766|13180751|P1|NOT COMPLETED|Overall Study||60
5357136|NCT00129766|13180750|P2|COMPLETED|Overall Study||3270
5357137|NCT00129766|13180751|P1|COMPLETED|Overall Study||3246
5357138|NCT00129766|13180750|P2|STARTED|Overall Study||3329
5357139|NCT00129766|13180751|P1|STARTED|Overall Study||3306
5357140|NCT00129740|13180789|P1|NOT COMPLETED|Overall Study||0
5357141|NCT00129740|13180789|P1|COMPLETED|Overall Study||148
5357142|NCT00129740|13180789|P1|STARTED|Overall Study||148
5357143|NCT00129727|13180794|P1|NOT COMPLETED|Overall Study||5
5357144|NCT00129727|13180794|P1|COMPLETED|Overall Study||57
5357145|NCT00129727|13180794|P1|STARTED|Overall Study||62
5357146|NCT00129701|13180800|P1|NOT COMPLETED|Overall Study||33
5357147|NCT00129701|13180800|P1|COMPLETED|Overall Study||71
5357148|NCT00129701|13180800|P1|STARTED|Overall Study||104
5357149|NCT00129649|13180809|P2|NOT COMPLETED|Overall Study||65
5357150|NCT00129649|13180810|P1|NOT COMPLETED|Overall Study||76
5357151|NCT00129649|13180809|P2|COMPLETED|Overall Study||181
5357152|NCT00129649|13180810|P1|COMPLETED|Overall Study||182
5357153|NCT00129649|13180809|P2|STARTED|Overall Study||246
5357154|NCT00129649|13180810|P1|STARTED|Overall Study||258
5357155|NCT00129623|13180818|P2|NOT COMPLETED|Overall Study||12
5357156|NCT00129623|13180819|P1|NOT COMPLETED|Overall Study||10
5357157|NCT00129623|13180818|P2|COMPLETED|Overall Study||65
5357158|NCT00129623|13180819|P1|COMPLETED|Overall Study||73
5357159|NCT00129623|13180818|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
5357160|NCT00129623|13180819|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
5357161|NCT00129623|13180818|P2|STARTED|Overall Study||77
5357162|NCT00129623|13180819|P1|STARTED|Overall Study||83
5357163|NCT00129545|13180844|P3|NOT COMPLETED|Overall Study||111
5357164|NCT00129545|13180845|P2|NOT COMPLETED|Overall Study||164
5357165|NCT00129545|13180846|P1|NOT COMPLETED|Overall Study||26
5357166|NCT00129545|13180844|P3|COMPLETED|Overall Study||133
5357167|NCT00129545|13180845|P2|COMPLETED|Overall Study||299
5357168|NCT00129545|13180846|P1|COMPLETED|Overall Study||67
5357169|NCT00129545|13180844|P3|STARTED|Overall Study||244
5357170|NCT00129545|13180845|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
5357171|NCT00129545|13180846|P1|STARTED|Overall Study||93
5357172|NCT00129480|13180858|P2|NOT COMPLETED|Overall Study||0
5357173|NCT00129480|13180859|P1|NOT COMPLETED|Overall Study||0
5357174|NCT00129480|13180858|P2|COMPLETED|Overall Study||214
5357175|NCT00129480|13180859|P1|COMPLETED|Overall Study||187
5357176|NCT00129480|13180858|P2|STARTED|Overall Study||214
5357177|NCT00129480|13180859|P1|STARTED|Overall Study||187
5357178|NCT00129467|13180875|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
5357179|NCT00129467|13180876|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
5357180|NCT00129467|13180875|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
5357181|NCT00129467|13180876|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
5357182|NCT00129467|13180875|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
5357183|NCT00129467|13180876|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
5357184|NCT00129467|13180875|P2|NOT COMPLETED|Received Intervention||4
5357185|NCT00129467|13180876|P1|NOT COMPLETED|Received Intervention||6
5357186|NCT00129467|13180875|P2|COMPLETED|Received Intervention||13
5357187|NCT00129467|13180876|P1|COMPLETED|Received Intervention||9
5357188|NCT00129467|13180875|P2|STARTED|Received Intervention||17
5357189|NCT00129467|13180876|P1|STARTED|Received Intervention||15
5357190|NCT00129441|13180884|P2|NOT COMPLETED|Overall Study||0
5357191|NCT00129441|13180885|P1|NOT COMPLETED|Overall Study||0
5357192|NCT00129441|13180884|P2|COMPLETED|Overall Study||6
5357193|NCT00129441|13180885|P1|COMPLETED|Overall Study||9
5357194|NCT00129441|13180884|P2|Year 1, Visit 8|Overall Study||6
5357195|NCT00129441|13180885|P1|Year 1, Visit 8|Overall Study||9
5357196|NCT00129441|13180884|P2|Week 26, Visit 7|Overall Study||6
5357197|NCT00129441|13180885|P1|Week 26, Visit 7|Overall Study||9
5357198|NCT00129441|13180884|P2|Week 5, Visit 6|Overall Study||6
5357199|NCT00129441|13180885|P1|Week 5, Visit 6|Overall Study||9
5357200|NCT00129441|13180884|P2|Week 4, Visit 5|Overall Study||6
5357201|NCT00129441|13180885|P1|Week 4, Visit 5|Overall Study||9
5357202|NCT00129441|13180884|P2|Week 3, Visit 4|Overall Study||6
5357203|NCT00129441|13180885|P1|Week 3, Visit 4|Overall Study||9
5357204|NCT00129441|13180884|P2|Week 2, Visit 3|Overall Study||6
5357205|NCT00129441|13180885|P1|Week 2, Visit 3|Overall Study||9
5357206|NCT00129441|13180884|P2|Week 1, Visit 2|Overall Study||6
5357207|NCT00129441|13180885|P1|Week 1, Visit 2|Overall Study||9
5357208|NCT00129441|13180884|P2|Baseline, Visit 1|Overall Study||6
5357366|NCT00129129|13181067|P1|COMPLETED|Primary Phase||262
5357209|NCT00129441|13180885|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
5357210|NCT00129441|13180884|P2|STARTED|Overall Study||6
5357211|NCT00129441|13180885|P1|STARTED|Overall Study||9
5357212|NCT00129402|13180907|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
5357213|NCT00129402|13180908|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357214|NCT00129402|13180909|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357215|NCT00129402|13180910|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357216|NCT00129402|13180911|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357217|NCT00129402|13180912|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357218|NCT00129402|13180913|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357219|NCT00129402|13180907|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
5357220|NCT00129402|13180908|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357221|NCT00129402|13180909|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357222|NCT00129402|13180910|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357223|NCT00129402|13180911|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357224|NCT00129402|13180912|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357225|NCT00129402|13180913|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
5357226|NCT00129402|13180907|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
5357227|NCT00129402|13180908|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357228|NCT00129402|13180909|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357229|NCT00129402|13180910|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357230|NCT00129402|13180911|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357231|NCT00129402|13180912|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357232|NCT00129402|13180913|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
5357233|NCT00129402|13180907|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357234|NCT00129402|13180908|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
5357235|NCT00129402|13180909|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357236|NCT00129402|13180910|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357237|NCT00129402|13180911|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
5357238|NCT00129402|13180912|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357239|NCT00129402|13180913|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357240|NCT00129402|13180907|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357241|NCT00129402|13180908|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
5357242|NCT00129402|13180909|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357243|NCT00129402|13180910|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357244|NCT00129402|13180911|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
5357245|NCT00129402|13180912|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357246|NCT00129402|13180913|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
5357247|NCT00129402|13180907|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
5357248|NCT00129402|13180908|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
5357249|NCT00129402|13180909|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
5357250|NCT00129402|13180910|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
5357251|NCT00129402|13180911|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
5357252|NCT00129402|13180912|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
5357253|NCT00129402|13180913|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
5357254|NCT00129402|13180907|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
5357255|NCT00129402|13180908|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
5357256|NCT00129402|13180909|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
5357257|NCT00129402|13180910|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
5357258|NCT00129402|13180911|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
5357259|NCT00129402|13180912|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
5357260|NCT00129402|13180913|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
5357261|NCT00129402|13180907|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
5357262|NCT00129402|13180908|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
5357263|NCT00129402|13180909|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
5357264|NCT00129402|13180910|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
5357265|NCT00129402|13180911|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
5357266|NCT00129402|13180912|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
5357267|NCT00129402|13180913|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
5357268|NCT00129402|13180907|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
5357269|NCT00129402|13180908|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
5357270|NCT00129402|13180909|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
5357271|NCT00129402|13180910|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
5357272|NCT00129402|13180911|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
5357273|NCT00129402|13180912|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
5357274|NCT00129402|13180913|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
5357275|NCT00129389|13180932|P2|NOT COMPLETED|Overall Study||140
5357276|NCT00129389|13180933|P1|NOT COMPLETED|Overall Study||33
5357277|NCT00129389|13180932|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
5357278|NCT00129389|13180933|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
5357279|NCT00129389|13180932|P2|STARTED|Overall Study||951
5357280|NCT00129389|13180933|P1|STARTED|Overall Study||974
5357281|NCT00129376|13180941|P1|NOT COMPLETED|Overall Study||2
5357282|NCT00129376|13180941|P1|COMPLETED|Overall Study||61
5357283|NCT00129376|13180941|P1|STARTED|Overall Study||63
5357284|NCT00129311|13180951|P2|NOT COMPLETED|Overall Study||19
5357285|NCT00129311|13180952|P1|NOT COMPLETED|Overall Study||12
5357286|NCT00129311|13180951|P2|COMPLETED|Overall Study||31
5357287|NCT00129311|13180952|P1|COMPLETED|Overall Study||39
5357288|NCT00129311|13180951|P2|STARTED|Overall Study||50
5357289|NCT00129311|13180952|P1|STARTED|Overall Study||51
5357290|NCT00129285|13180963|P3|NOT COMPLETED|Overall Study||38
5357291|NCT00129285|13180964|P2|NOT COMPLETED|Overall Study||27
5357292|NCT00129285|13180965|P1|NOT COMPLETED|Overall Study||25
5357293|NCT00129285|13180963|P3|COMPLETED|Overall Study||37
5357294|NCT00129285|13180964|P2|COMPLETED|Overall Study||43
5357295|NCT00129285|13180965|P1|COMPLETED|Overall Study||40
5357296|NCT00129285|13180963|P3|STARTED|Overall Study||75
5357297|NCT00129285|13180964|P2|STARTED|Overall Study||70
5357298|NCT00129285|13180965|P1|STARTED|Overall Study||65
5357299|NCT00129272|13180981|P2|NOT COMPLETED|Overall Study||22
5357300|NCT00129272|13180982|P1|NOT COMPLETED|Overall Study||17
5357301|NCT00129272|13180981|P2|COMPLETED|Overall Study||51
5357302|NCT00129272|13180982|P1|COMPLETED|Overall Study||54
5357303|NCT00129272|13180981|P2|STARTED|Overall Study||73
5357304|NCT00129272|13180982|P1|STARTED|Overall Study||71
5357305|NCT00129259|13180992|P2|NOT COMPLETED|Overall Study||3
5357306|NCT00129259|13180993|P1|NOT COMPLETED|Overall Study||3
5357307|NCT00129259|13180992|P2|COMPLETED|Overall Study||22
5357308|NCT00129259|13180993|P1|COMPLETED|Overall Study||49
5357309|NCT00129259|13180992|P2|Received All or Part of Cycle 2|Overall Study||0
5357310|NCT00129259|13180993|P1|Received All or Part of Cycle 2|Overall Study||40
5357311|NCT00129259|13180992|P2|Received All or Part of Cycle 1|Overall Study||0
5357312|NCT00129259|13180993|P1|Received All or Part of Cycle 1|Overall Study||52
5357313|NCT00129259|13180992|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
5357314|NCT00129259|13180993|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
5357315|NCT00129246|13181005|P2|NOT COMPLETED|Overall Study||0
5357316|NCT00129246|13181006|P1|NOT COMPLETED|Overall Study||0
5357317|NCT00129246|13181005|P2|COMPLETED|Overall Study||20
5357318|NCT00129246|13181006|P1|COMPLETED|Overall Study||20
5357319|NCT00129246|13181005|P2|STARTED|Overall Study||20
5357320|NCT00129246|13181006|P1|STARTED|Overall Study||20
5357321|NCT00129220|13181021|P3|NOT COMPLETED|Study Period III||10
5357322|NCT00129220|13181022|P2|NOT COMPLETED|Study Period III||1
5357323|NCT00129220|13181023|P1|NOT COMPLETED|Study Period III||13
5357324|NCT00129220|13181021|P3|COMPLETED|Study Period III||42
5357325|NCT00129220|13181022|P2|COMPLETED|Study Period III||7
5357326|NCT00129220|13181023|P1|COMPLETED|Study Period III||59
5357327|NCT00129220|13181021|P3|STARTED|Study Period III||52
5357328|NCT00129220|13181022|P2|STARTED|Study Period III||8
5357329|NCT00129220|13181023|P1|STARTED|Study Period III||72
5357330|NCT00129220|13181021|P3|NOT COMPLETED|Study Period II||47
5357331|NCT00129220|13181022|P2|NOT COMPLETED|Study Period II||12
5357332|NCT00129220|13181023|P1|NOT COMPLETED|Study Period II||33
5357333|NCT00129220|13181021|P3|COMPLETED|Study Period II||52
5357334|NCT00129220|13181022|P2|COMPLETED|Study Period II||8
5357335|NCT00129220|13181023|P1|COMPLETED|Study Period II||72
5357336|NCT00129220|13181021|P3|Received at Least One Dose of Study Drug|Study Period II||97
5357337|NCT00129220|13181022|P2|Received at Least One Dose of Study Drug|Study Period II||20
5357338|NCT00129220|13181023|P1|Received at Least One Dose of Study Drug|Study Period II||104
5357339|NCT00129220|13181021|P3|STARTED|Study Period II||99
5357340|NCT00129220|13181022|P2|STARTED|Study Period II||20
5357341|NCT00129220|13181023|P1|STARTED|Study Period II||105
5357342|NCT00129129|13181063|P5|NOT COMPLETED|Fourth Dose Phase||6
5357343|NCT00129129|13181064|P4|NOT COMPLETED|Fourth Dose Phase||4
5357344|NCT00129129|13181065|P3|NOT COMPLETED|Fourth Dose Phase||0
5357345|NCT00129129|13181066|P2|NOT COMPLETED|Fourth Dose Phase||0
5357346|NCT00129129|13181067|P1|NOT COMPLETED|Fourth Dose Phase||4
5357347|NCT00129129|13181063|P5|COMPLETED|Fourth Dose Phase||124
5357348|NCT00129129|13181064|P4|COMPLETED|Fourth Dose Phase||128
5357349|NCT00129129|13181065|P3|COMPLETED|Fourth Dose Phase||0
5357350|NCT00129129|13181066|P2|COMPLETED|Fourth Dose Phase||0
5357351|NCT00129129|13181067|P1|COMPLETED|Fourth Dose Phase||232
5357352|NCT00129129|13181063|P5|STARTED|Fourth Dose Phase||130
5357353|NCT00129129|13181064|P4|STARTED|Fourth Dose Phase||132
5357354|NCT00129129|13181065|P3|STARTED|Fourth Dose Phase||0
5357355|NCT00129129|13181066|P2|STARTED|Fourth Dose Phase||0
5357356|NCT00129129|13181067|P1|STARTED|Fourth Dose Phase||236
5357357|NCT00129129|13181063|P5|NOT COMPLETED|Primary Phase||0
5357358|NCT00129129|13181064|P4|NOT COMPLETED|Primary Phase||0
5357359|NCT00129129|13181065|P3|NOT COMPLETED|Primary Phase||0
5357360|NCT00129129|13181066|P2|NOT COMPLETED|Primary Phase||25
5357361|NCT00129129|13181067|P1|NOT COMPLETED|Primary Phase||25
5357362|NCT00129129|13181063|P5|COMPLETED|Primary Phase||0
5357363|NCT00129129|13181064|P4|COMPLETED|Primary Phase||0
5357364|NCT00129129|13181065|P3|COMPLETED|Primary Phase||150
5357365|NCT00129129|13181066|P2|COMPLETED|Primary Phase||294
5357367|NCT00129129|13181063|P5|STARTED|Primary Phase||0
5357368|NCT00129129|13181064|P4|STARTED|Primary Phase||0
5357369|NCT00129129|13181065|P3|STARTED|Primary Phase||150
5357370|NCT00129129|13181066|P2|STARTED|Primary Phase||319
5357371|NCT00129129|13181067|P1|STARTED|Primary Phase||287
5357372|NCT00129116|13181274|P5|NOT COMPLETED|Booster Phase||1
5357373|NCT00129116|13181275|P4|NOT COMPLETED|Booster Phase||0
5357374|NCT00129116|13181276|P3|NOT COMPLETED|Booster Phase||0
5357375|NCT00129116|13181277|P2|NOT COMPLETED|Booster Phase||0
5357376|NCT00129116|13181278|P1|NOT COMPLETED|Booster Phase||2
5357377|NCT00129116|13181274|P5|COMPLETED|Booster Phase||43
5357378|NCT00129116|13181275|P4|COMPLETED|Booster Phase||44
5357379|NCT00129116|13181276|P3|COMPLETED|Booster Phase||44
5357380|NCT00129116|13181277|P2|COMPLETED|Booster Phase||42
5357381|NCT00129116|13181278|P1|COMPLETED|Booster Phase||45
5357382|NCT00129116|13181274|P5|STARTED|Booster Phase||44
5357383|NCT00129116|13181275|P4|STARTED|Booster Phase||44
5357384|NCT00129116|13181276|P3|STARTED|Booster Phase||44
5357385|NCT00129116|13181277|P2|STARTED|Booster Phase||42
5357386|NCT00129116|13181278|P1|STARTED|Booster Phase||47
5357387|NCT00129116|13181274|P5|NOT COMPLETED|Primary Phase||1
5357388|NCT00129116|13181275|P4|NOT COMPLETED|Primary Phase||1
5357389|NCT00129116|13181276|P3|NOT COMPLETED|Primary Phase||1
5357390|NCT00129116|13181277|P2|NOT COMPLETED|Primary Phase||4
5357391|NCT00129116|13181278|P1|NOT COMPLETED|Primary Phase||2
5357392|NCT00129116|13181274|P5|COMPLETED|Primary Phase||76
5357393|NCT00129116|13181275|P4|COMPLETED|Primary Phase||77
5357394|NCT00129116|13181276|P3|COMPLETED|Primary Phase||77
5357395|NCT00129116|13181277|P2|COMPLETED|Primary Phase||73
5357396|NCT00129116|13181278|P1|COMPLETED|Primary Phase||76
5357397|NCT00129116|13181274|P5|STARTED|Primary Phase||77
5357398|NCT00129116|13181275|P4|STARTED|Primary Phase||78
5357399|NCT00129116|13181276|P3|STARTED|Primary Phase||78
5357400|NCT00129116|13181277|P2|STARTED|Primary Phase||77
5357401|NCT00129116|13181278|P1|STARTED|Primary Phase||78
5357402|NCT00128921|13181543|P3|NOT COMPLETED|Overall Study||0
5357403|NCT00128921|13181544|P2|NOT COMPLETED|Overall Study||5
5357404|NCT00128921|13181545|P1|NOT COMPLETED|Overall Study||5
5357405|NCT00128921|13181543|P3|COMPLETED|Overall Study||0
5357406|NCT00128921|13181544|P2|COMPLETED|Overall Study||3
5357407|NCT00128921|13181545|P1|COMPLETED|Overall Study||5
5357408|NCT00128921|13181543|P3|Received Bortezomib|Overall Study||0
5357409|NCT00128921|13181544|P2|Received Bortezomib|Overall Study||6
5357410|NCT00128921|13181545|P1|Received Bortezomib|Overall Study||10
5357411|NCT00128921|13181543|P3|STARTED|Overall Study||0
5357412|NCT00128921|13181544|P2|STARTED|Overall Study||8
5357413|NCT00128921|13181545|P1|STARTED|Overall Study||10
5357414|NCT00128830|13181562|P1|NOT COMPLETED|Overall Study||72
5357415|NCT00128830|13181562|P1|COMPLETED|Overall Study||139
5357416|NCT00128830|13181562|P1|STARTED|Overall Study||211
5357417|NCT00128713|13181580|P3|NOT COMPLETED|Overall Study||0
5357418|NCT00128713|13181581|P2|NOT COMPLETED|Overall Study||0
5357419|NCT00128713|13181582|P1|NOT COMPLETED|Overall Study||0
5357420|NCT00128713|13181580|P3|COMPLETED|Overall Study||449
5357421|NCT00128713|13181581|P2|COMPLETED|Overall Study||449
5357422|NCT00128713|13181582|P1|COMPLETED|Overall Study||453
5357423|NCT00128713|13181580|P3|STARTED|Overall Study||449
5357424|NCT00128713|13181581|P2|STARTED|Overall Study||449
5357425|NCT00128713|13181582|P1|STARTED|Overall Study||453
5357426|NCT00128661|13181604|P2|NOT COMPLETED|Overall Study||258
5357427|NCT00128661|13181605|P1|NOT COMPLETED|Overall Study||274
5357428|NCT00128661|13181604|P2|COMPLETED|Overall Study||3481
5357429|NCT00128661|13181605|P1|COMPLETED|Overall Study||3453
5357430|NCT00128661|13181604|P2|STARTED|Overall Study||3739
5357431|NCT00128661|13181605|P1|STARTED|Overall Study||3727
5357432|NCT00128492|13181651|P2|NOT COMPLETED|Overall Study||59
5357433|NCT00128492|13181652|P1|NOT COMPLETED|Overall Study||20
5357434|NCT00128492|13181651|P2|COMPLETED|Overall Study||130
5357435|NCT00128492|13181652|P1|COMPLETED|Overall Study||65
5357436|NCT00128492|13181651|P2|STARTED|Overall Study||189
5357437|NCT00128492|13181652|P1|STARTED|Overall Study||85
5357438|NCT00128401|13181712|P2|NOT COMPLETED|Overall Study||4
5357439|NCT00128401|13181713|P1|NOT COMPLETED|Overall Study||6
5357440|NCT00128401|13181712|P2|COMPLETED|Overall Study||15
5357441|NCT00128401|13181713|P1|COMPLETED|Overall Study||14
5357442|NCT00128401|13181712|P2|STARTED|Overall Study||19
5357443|NCT00128401|13181713|P1|STARTED|Overall Study||20
5357444|NCT00128219|13181724|P2|NOT COMPLETED|Overall Study||71
5357445|NCT00128219|13181725|P1|NOT COMPLETED|Overall Study||69
5357446|NCT00128219|13181724|P2|COMPLETED|Overall Study||263
5357447|NCT00128219|13181725|P1|COMPLETED|Overall Study||264
5357448|NCT00128219|13181724|P2|STARTED|Overall Study||334
5357449|NCT00128219|13181725|P1|STARTED|Overall Study||333
5357450|NCT00128206|13181809|P2|NOT COMPLETED|Overall Study||120
5357451|NCT00128206|13181810|P1|NOT COMPLETED|Overall Study||137
5357452|NCT00128206|13181809|P2|COMPLETED|Overall Study||60
5357453|NCT00128206|13181810|P1|COMPLETED|Overall Study||47
5357454|NCT00128206|13181809|P2|STARTED|Overall Study||180
5357455|NCT00128206|13181810|P1|STARTED|Overall Study||184
5357456|NCT00128193|13181832|P12|NOT COMPLETED|Overall Study||2
5357457|NCT00128193|13181833|P11|NOT COMPLETED|Overall Study||3
5357458|NCT00128193|13181834|P10|NOT COMPLETED|Overall Study||2
5357459|NCT00128193|13181835|P9|NOT COMPLETED|Overall Study||2
5357460|NCT00128193|13181836|P8|NOT COMPLETED|Overall Study||0
5357461|NCT00128193|13181837|P7|NOT COMPLETED|Overall Study||4
5357462|NCT00128193|13181838|P6|NOT COMPLETED|Overall Study||3
5357463|NCT00128193|13181839|P5|NOT COMPLETED|Overall Study||2
5357464|NCT00128193|13181840|P4|NOT COMPLETED|Overall Study||1
5357465|NCT00128193|13181841|P3|NOT COMPLETED|Overall Study||3
5357466|NCT00128193|13181842|P2|NOT COMPLETED|Overall Study||0
5357467|NCT00128193|13181843|P1|NOT COMPLETED|Overall Study||0
5357468|NCT00128193|13181832|P12|COMPLETED|Overall Study||18
5357469|NCT00128193|13181833|P11|COMPLETED|Overall Study||17
5357470|NCT00128193|13181834|P10|COMPLETED|Overall Study||18
5357471|NCT00128193|13181835|P9|COMPLETED|Overall Study||18
5357472|NCT00128193|13181836|P8|COMPLETED|Overall Study||20
5357473|NCT00128193|13181837|P7|COMPLETED|Overall Study||16
5357474|NCT00128193|13181838|P6|COMPLETED|Overall Study||17
5357475|NCT00128193|13181839|P5|COMPLETED|Overall Study||18
5357476|NCT00128193|13181840|P4|COMPLETED|Overall Study||44
5357477|NCT00128193|13181841|P3|COMPLETED|Overall Study||42
5357478|NCT00128193|13181842|P2|COMPLETED|Overall Study||5
5357479|NCT00128193|13181843|P1|COMPLETED|Overall Study||5
5357480|NCT00128193|13181832|P12|STARTED|Overall Study||20
5357481|NCT00128193|13181833|P11|STARTED|Overall Study||20
5357482|NCT00128193|13181834|P10|STARTED|Overall Study||20
5357483|NCT00128193|13181835|P9|STARTED|Overall Study||20
5357484|NCT00128193|13181836|P8|STARTED|Overall Study||20
5357485|NCT00128193|13181837|P7|STARTED|Overall Study||20
5357486|NCT00128193|13181838|P6|STARTED|Overall Study||20
5357487|NCT00128193|13181839|P5|STARTED|Overall Study||20
5357488|NCT00128193|13181840|P4|STARTED|Overall Study||45
5357489|NCT00128193|13181841|P3|STARTED|Overall Study||45
5357490|NCT00128193|13181842|P2|STARTED|Overall Study||5
5357491|NCT00128193|13181843|P1|STARTED|Overall Study||5
5357492|NCT00128180|13182079|P2|NOT COMPLETED|Overall Study||0
5357493|NCT00128180|13182080|P1|NOT COMPLETED|Overall Study||0
5357494|NCT00128180|13182079|P2|COMPLETED|Overall Study||34
5357495|NCT00128180|13182080|P1|COMPLETED|Overall Study||32
5357496|NCT00128180|13182079|P2|STARTED|Overall Study||34
5357497|NCT00128180|13182080|P1|STARTED|Overall Study||32
5357498|NCT00127933|13182106|P2|NOT COMPLETED|Overall Study||0
5357499|NCT00127933|13182107|P1|NOT COMPLETED|Overall Study||1
5357500|NCT00127933|13182106|P2|COMPLETED|Overall Study||34
5357501|NCT00127933|13182107|P1|COMPLETED|Overall Study||122
5357502|NCT00127933|13182106|P2|Postoperative|Overall Study||27
5357503|NCT00127933|13182107|P1|Postoperative|Overall Study||98
5357504|NCT00127933|13182106|P2|Quality of Life Population|Overall Study||33
5357505|NCT00127933|13182107|P1|Quality of Life Population|Overall Study||118
5357506|NCT00127933|13182106|P2|Safety Population|Overall Study||34
5357507|NCT00127933|13182107|P1|Safety Population|Overall Study||122
5357508|NCT00127933|13182106|P2|Clinical Response|Overall Study||34
5357509|NCT00127933|13182107|P1|Clinical Response|Overall Study||122
5357510|NCT00127933|13182106|P2|Pathological Response|Overall Study||28
5357511|NCT00127933|13182107|P1|Pathological Response|Overall Study||101
5357512|NCT00127933|13182106|P2|STARTED|Overall Study||34
5357513|NCT00127933|13182107|P1|STARTED|Overall Study||123
5357514|NCT00127855|13182128|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
5357515|NCT00127855|13182129|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
5357516|NCT00127855|13182130|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
5357517|NCT00127855|13182131|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
5357518|NCT00127855|13182132|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
5357519|NCT00127855|13182128|P5|COMPLETED|Polysaccharide Challenge Dose||77
5357520|NCT00127855|13182129|P4|COMPLETED|Polysaccharide Challenge Dose||81
5357521|NCT00127855|13182130|P3|COMPLETED|Polysaccharide Challenge Dose||77
5357522|NCT00127855|13182131|P2|COMPLETED|Polysaccharide Challenge Dose||79
5357523|NCT00127855|13182132|P1|COMPLETED|Polysaccharide Challenge Dose||80
5357524|NCT00127855|13182128|P5|STARTED|Polysaccharide Challenge Dose||77
5357525|NCT00127855|13182129|P4|STARTED|Polysaccharide Challenge Dose||81
5357526|NCT00127855|13182130|P3|STARTED|Polysaccharide Challenge Dose||77
5357527|NCT00127855|13182131|P2|STARTED|Polysaccharide Challenge Dose||79
5357528|NCT00127855|13182132|P1|STARTED|Polysaccharide Challenge Dose||80
5357529|NCT00127855|13182128|P5|NOT COMPLETED|Primary Vaccination Course||4
5357530|NCT00127855|13182129|P4|NOT COMPLETED|Primary Vaccination Course||0
5357531|NCT00127855|13182130|P3|NOT COMPLETED|Primary Vaccination Course||2
5357532|NCT00127855|13182131|P2|NOT COMPLETED|Primary Vaccination Course||1
5357533|NCT00127855|13182132|P1|NOT COMPLETED|Primary Vaccination Course||2
5357534|NCT00127855|13182128|P5|COMPLETED|Primary Vaccination Course||78
5357535|NCT00127855|13182129|P4|COMPLETED|Primary Vaccination Course||81
5357536|NCT00127855|13182130|P3|COMPLETED|Primary Vaccination Course||78
5357537|NCT00127855|13182131|P2|COMPLETED|Primary Vaccination Course||81
5357538|NCT00127855|13182132|P1|COMPLETED|Primary Vaccination Course||80
5357539|NCT00127855|13182128|P5|STARTED|Primary Vaccination Course||82
5357540|NCT00127855|13182129|P4|STARTED|Primary Vaccination Course||81
5357541|NCT00127855|13182130|P3|STARTED|Primary Vaccination Course||80
5357542|NCT00127855|13182131|P2|STARTED|Primary Vaccination Course||82
5357543|NCT00127855|13182132|P1|STARTED|Primary Vaccination Course||82
5357544|NCT00127842|13182314|P1|NOT COMPLETED|Overall Study||39
5357545|NCT00127842|13182314|P1|COMPLETED|Overall Study||71
5357546|NCT00127842|13182314|P1|STARTED|Overall Study||110
5357547|NCT00127803|13182332|P4|NOT COMPLETED|Overall Study||1
5357548|NCT00127803|13182333|P3|NOT COMPLETED|Overall Study||0
5357549|NCT00127803|13182334|P2|NOT COMPLETED|Overall Study||0
5357550|NCT00127803|13182335|P1|NOT COMPLETED|Overall Study||3
5357551|NCT00127803|13182332|P4|COMPLETED|Overall Study||11
5357552|NCT00127803|13182333|P3|COMPLETED|Overall Study||12
5357553|NCT00127803|13182334|P2|COMPLETED|Overall Study||13
5357554|NCT00127803|13182335|P1|COMPLETED|Overall Study||10
5357555|NCT00127803|13182332|P4|STARTED|Overall Study||12
5357556|NCT00127803|13182333|P3|STARTED|Overall Study||12
5357557|NCT00127803|13182334|P2|STARTED|Overall Study||13
5357558|NCT00127803|13182335|P1|STARTED|Overall Study||13
5357559|NCT00127790|13182357|P4|NOT COMPLETED|Post-Treatment||0
5357560|NCT00127790|13182358|P3|NOT COMPLETED|Post-Treatment||0
5357561|NCT00127790|13182359|P2|NOT COMPLETED|Post-Treatment||0
5357562|NCT00127790|13182360|P1|NOT COMPLETED|Post-Treatment||0
5357563|NCT00127790|13182357|P4|COMPLETED|Post-Treatment||4
5357564|NCT00127790|13182358|P3|COMPLETED|Post-Treatment||6
5357565|NCT00127790|13182359|P2|COMPLETED|Post-Treatment||5
5357566|NCT00127790|13182360|P1|COMPLETED|Post-Treatment||6
5357567|NCT00127790|13182357|P4|STARTED|Post-Treatment||4
5357568|NCT00127790|13182358|P3|STARTED|Post-Treatment||6
5357569|NCT00127790|13182359|P2|STARTED|Post-Treatment||5
5357570|NCT00127790|13182360|P1|STARTED|Post-Treatment||6
5357571|NCT00127790|13182357|P4|NOT COMPLETED|Pre-Treatment||0
5357572|NCT00127790|13182358|P3|NOT COMPLETED|Pre-Treatment||0
5357573|NCT00127790|13182359|P2|NOT COMPLETED|Pre-Treatment||0
5357574|NCT00127790|13182360|P1|NOT COMPLETED|Pre-Treatment||0
5357575|NCT00127790|13182357|P4|COMPLETED|Pre-Treatment||4
5357576|NCT00127790|13182358|P3|COMPLETED|Pre-Treatment||6
5357577|NCT00127790|13182359|P2|COMPLETED|Pre-Treatment||5
5357578|NCT00127790|13182360|P1|COMPLETED|Pre-Treatment||6
5357579|NCT00127790|13182357|P4|STARTED|Pre-Treatment||4
5357580|NCT00127790|13182358|P3|STARTED|Pre-Treatment||6
5357581|NCT00127790|13182359|P2|STARTED|Pre-Treatment||5
5357582|NCT00127790|13182360|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
5357583|NCT00127712|13182384|P2|NOT COMPLETED|Overall Study||0
5357584|NCT00127712|13182385|P1|NOT COMPLETED|Overall Study||5
5357585|NCT00127712|13182384|P2|COMPLETED|Overall Study||65
5357586|NCT00127712|13182385|P1|COMPLETED|Overall Study||60
5357587|NCT00127712|13182384|P2|STARTED|Overall Study||65
5357588|NCT00127712|13182385|P1|STARTED|Overall Study||65
5357589|NCT00127660|13182401|P4|NOT COMPLETED|Overall Study||0
5357590|NCT00127660|13182402|P3|NOT COMPLETED|Overall Study||5
5357591|NCT00127660|13182403|P2|NOT COMPLETED|Overall Study||3
5357592|NCT00127660|13182404|P1|NOT COMPLETED|Overall Study||3
5357593|NCT00127660|13182401|P4|COMPLETED|Overall Study||150
5357594|NCT00127660|13182402|P3|COMPLETED|Overall Study||143
5357595|NCT00127660|13182403|P2|COMPLETED|Overall Study||151
5357596|NCT00127660|13182404|P1|COMPLETED|Overall Study||150
5357597|NCT00127660|13182401|P4|STARTED|Overall Study||150
5357598|NCT00127660|13182402|P3|STARTED|Overall Study||148
5357599|NCT00127660|13182403|P2|STARTED|Overall Study||154
5357600|NCT00127660|13182404|P1|STARTED|Overall Study||153
5357601|NCT00127608|13182414|P1|NOT COMPLETED|Overall Study||1
5357602|NCT00127608|13182414|P1|COMPLETED|Overall Study||35
5357603|NCT00127608|13182414|P1|STARTED|Overall Study||36
5357604|NCT00127530|13182422|P2|NOT COMPLETED|Overall Study||21
5357605|NCT00127530|13182423|P1|NOT COMPLETED|Overall Study||1
5357606|NCT00127530|13182422|P2|COMPLETED|Overall Study||207
5357607|NCT00127530|13182423|P1|COMPLETED|Overall Study||71
5357608|NCT00127530|13182422|P2|STARTED|Overall Study||228
5357609|NCT00127530|13182423|P1|STARTED|Overall Study||72
5357610|NCT00127439|13182431|P2|NOT COMPLETED|Overall Study||0
5357611|NCT00127439|13182432|P1|NOT COMPLETED|Overall Study||0
5357612|NCT00127439|13182431|P2|COMPLETED|Overall Study||10
5357613|NCT00127439|13182432|P1|COMPLETED|Overall Study||9
5357614|NCT00127439|13182431|P2|STARTED|Overall Study||10
5357615|NCT00127439|13182432|P1|STARTED|Overall Study||9
5357616|NCT00127413|13182458|P4|NOT COMPLETED|Overall Study||2
5357617|NCT00127413|13182459|P3|NOT COMPLETED|Overall Study||8
5357618|NCT00127413|13182460|P2|NOT COMPLETED|Overall Study||4
5357619|NCT00127413|13182461|P1|NOT COMPLETED|Overall Study||6
5357620|NCT00127413|13182458|P4|COMPLETED|Overall Study||5
5357621|NCT00127413|13182459|P3|COMPLETED|Overall Study||5
5357622|NCT00127413|13182460|P2|COMPLETED|Overall Study||6
5357623|NCT00127413|13182461|P1|COMPLETED|Overall Study||6
5357624|NCT00127413|13182458|P4|STARTED|Overall Study||7
5357625|NCT00127413|13182459|P3|STARTED|Overall Study||13
5357626|NCT00127413|13182460|P2|STARTED|Overall Study||10
5357627|NCT00127413|13182461|P1|STARTED|Overall Study||12
5357628|NCT00127231|13182473|P2|NOT COMPLETED|Overall Study||6
5357629|NCT00127231|13182474|P1|NOT COMPLETED|Overall Study||6
5357630|NCT00127231|13182473|P2|COMPLETED|Overall Study||68
5357631|NCT00127231|13182474|P1|COMPLETED|Overall Study||68
5357632|NCT00127231|13182473|P2|STARTED|Overall Study||74
5357633|NCT00127231|13182474|P1|STARTED|Overall Study||74
5357634|NCT00127218|13182490|P2|NOT COMPLETED|Overall Study||15
5357635|NCT00127218|13182491|P1|NOT COMPLETED|Overall Study||13
5357636|NCT00127218|13182490|P2|COMPLETED|Overall Study||58
5357637|NCT00127218|13182491|P1|COMPLETED|Overall Study||59
5357638|NCT00127218|13182490|P2|STARTED|Overall Study||73
5357639|NCT00127218|13182491|P1|STARTED|Overall Study||72
5357640|NCT00127205|13182502|P3|NOT COMPLETED|Overall Study||617
5357641|NCT00127205|13182503|P2|NOT COMPLETED|Overall Study||980
5357642|NCT00127205|13182504|P1|NOT COMPLETED|Overall Study||835
5357643|NCT00127205|13182502|P3|COMPLETED|Overall Study||950
5357644|NCT00127205|13182503|P2|COMPLETED|Overall Study||1288
5357645|NCT00127205|13182504|P1|COMPLETED|Overall Study||1427
5357646|NCT00127205|13182502|P3|STARTED|Overall Study||1567
5357647|NCT00127205|13182503|P2|STARTED|Overall Study||2268
5357648|NCT00127205|13182504|P1|STARTED|Overall Study||2262
5357649|NCT00127192|13182526|P5|NOT COMPLETED|Overall Study||5
5357650|NCT00127192|13182527|P4|NOT COMPLETED|Overall Study||1
5357651|NCT00127192|13182528|P3|NOT COMPLETED|Overall Study||2
5357652|NCT00127192|13182529|P2|NOT COMPLETED|Overall Study||1
5357653|NCT00127192|13182530|P1|NOT COMPLETED|Overall Study||3
5357654|NCT00127192|13182526|P5|COMPLETED|Overall Study||68
5357655|NCT00127192|13182527|P4|COMPLETED|Overall Study||67
5357656|NCT00127192|13182528|P3|COMPLETED|Overall Study||68
5357657|NCT00127192|13182529|P2|COMPLETED|Overall Study||71
5357658|NCT00127192|13182530|P1|COMPLETED|Overall Study||77
5357659|NCT00127192|13182526|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
5357660|NCT00127192|13182527|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
5357661|NCT00127192|13182528|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
5357662|NCT00127192|13182529|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
5357663|NCT00127192|13182530|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
5357664|NCT00127166|13182554|P2|NOT COMPLETED|Period II||0
5357665|NCT00127166|13182555|P1|NOT COMPLETED|Period II||3
5357666|NCT00127166|13182554|P2|COMPLETED|Period II||73
5357667|NCT00127166|13182555|P1|COMPLETED|Period II||72
5357668|NCT00127166|13182554|P2|STARTED|Period II||73
5357669|NCT00127166|13182555|P1|STARTED|Period II||75
5357670|NCT00127166|13182554|P2|NOT COMPLETED|Washout Period||1
5357671|NCT00127166|13182555|P1|NOT COMPLETED|Washout Period||0
5357672|NCT00127166|13182554|P2|COMPLETED|Washout Period||73
5357673|NCT00127166|13182555|P1|COMPLETED|Washout Period||75
5357674|NCT00127166|13182554|P2|STARTED|Washout Period||74
5357675|NCT00127166|13182555|P1|STARTED|Washout Period||75
5357676|NCT00127166|13182554|P2|NOT COMPLETED|Period I||2
5357677|NCT00127166|13182555|P1|NOT COMPLETED|Period I||3
5357678|NCT00127166|13182554|P2|COMPLETED|Period I||74
5357679|NCT00127166|13182555|P1|COMPLETED|Period I||75
5357680|NCT00127166|13182554|P2|STARTED|Period I||76
5357681|NCT00127166|13182555|P1|STARTED|Period I||78
5357682|NCT00127101|13182575|P6|NOT COMPLETED|Continuation Phase||3
5357683|NCT00127101|13182576|P5|NOT COMPLETED|Continuation Phase||3
5357684|NCT00127101|13182577|P4|NOT COMPLETED|Continuation Phase||0
5357685|NCT00127101|13182578|P3|NOT COMPLETED|Continuation Phase||1
5357686|NCT00127101|13182579|P2|NOT COMPLETED|Continuation Phase||0
5357687|NCT00127101|13182580|P1|NOT COMPLETED|Continuation Phase||0
5357688|NCT00127101|13182575|P6|COMPLETED|Continuation Phase||0
5357689|NCT00127101|13182576|P5|COMPLETED|Continuation Phase||0
5357690|NCT00127101|13182577|P4|COMPLETED|Continuation Phase||0
5357691|NCT00127101|13182578|P3|COMPLETED|Continuation Phase||0
5357692|NCT00127101|13182579|P2|COMPLETED|Continuation Phase||0
5357693|NCT00127101|13182580|P1|COMPLETED|Continuation Phase||0
5357694|NCT00127101|13182575|P6|STARTED|Continuation Phase||3
5357695|NCT00127101|13182576|P5|STARTED|Continuation Phase||3
5357696|NCT00127101|13182577|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
5357697|NCT00127101|13182578|P3|STARTED|Continuation Phase||1
5357698|NCT00127101|13182579|P2|STARTED|Continuation Phase||0
5357699|NCT00127101|13182580|P1|STARTED|Continuation Phase||0
5357700|NCT00127101|13182575|P6|NOT COMPLETED|Base Protocol||1
5357701|NCT00127101|13182576|P5|NOT COMPLETED|Base Protocol||2
5357702|NCT00127101|13182577|P4|NOT COMPLETED|Base Protocol||0
5357703|NCT00127101|13182578|P3|NOT COMPLETED|Base Protocol||2
5357704|NCT00127101|13182579|P2|NOT COMPLETED|Base Protocol||4
5357705|NCT00127101|13182580|P1|NOT COMPLETED|Base Protocol||2
5357706|NCT00127101|13182575|P6|COMPLETED|Base Protocol||3
5357707|NCT00127101|13182576|P5|COMPLETED|Base Protocol||3
5357708|NCT00127101|13182577|P4|COMPLETED|Base Protocol||3
5357709|NCT00127101|13182578|P3|COMPLETED|Base Protocol||1
5357710|NCT00127101|13182579|P2|COMPLETED|Base Protocol||1
5357711|NCT00127101|13182580|P1|COMPLETED|Base Protocol||1
5357712|NCT00127101|13182575|P6|STARTED|Base Protocol||4
5357713|NCT00127101|13182576|P5|STARTED|Base Protocol||5
5357714|NCT00127101|13182577|P4|STARTED|Base Protocol||3
5357715|NCT00127101|13182578|P3|STARTED|Base Protocol||3
5357716|NCT00127101|13182579|P2|STARTED|Base Protocol||5
5357717|NCT00127101|13182580|P1|STARTED|Base Protocol||3
5357718|NCT00127062|13182602|P2|NOT COMPLETED|Second intervention_Hyde Park||0
5357719|NCT00127062|13182603|P1|NOT COMPLETED|Second intervention_Hyde Park||0
5357720|NCT00127062|13182602|P2|COMPLETED|Second intervention_Hyde Park||29
5357721|NCT00127062|13182603|P1|COMPLETED|Second intervention_Hyde Park||31
5357722|NCT00127062|13182602|P2|STARTED|Second intervention_Hyde Park||29
5357723|NCT00127062|13182603|P1|STARTED|Second intervention_Hyde Park||31
5357724|NCT00127062|13182602|P2|NOT COMPLETED|First intervention_Oxford Street||0
5357725|NCT00127062|13182603|P1|NOT COMPLETED|First intervention_Oxford Street||0
5357726|NCT00127062|13182602|P2|COMPLETED|First intervention_Oxford Street||29
5357727|NCT00127062|13182603|P1|COMPLETED|First intervention_Oxford Street||31
5357728|NCT00127062|13182602|P2|STARTED|First intervention_Oxford Street||29
5357729|NCT00127062|13182603|P1|STARTED|First intervention_Oxford Street||31
5357730|NCT00127036|13182615|P2|NOT COMPLETED|Overall Study||11
5357731|NCT00127036|13182616|P1|NOT COMPLETED|Overall Study||8
5357732|NCT00127036|13182615|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
5357733|NCT00127036|13182616|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
5357734|NCT00127036|13182615|P2|STARTED|Overall Study||31
5357735|NCT00127036|13182616|P1|STARTED|Overall Study||34
5357736|NCT00126776|13182628|P2|NOT COMPLETED|Overall Study||0
5357737|NCT00126776|13182629|P1|NOT COMPLETED|Overall Study||0
5357738|NCT00126776|13182628|P2|COMPLETED|Overall Study||371
5357739|NCT00126776|13182629|P1|COMPLETED|Overall Study||372
5357740|NCT00126776|13182628|P2|STARTED|Overall Study||371
5357741|NCT00126776|13182629|P1|STARTED|Overall Study||372
5357742|NCT00126750|13182635|P2|NOT COMPLETED|Overall Study||266
5357743|NCT00126750|13182636|P1|NOT COMPLETED|Overall Study||180
5357744|NCT00126750|13182635|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
5357745|NCT00126750|13182636|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
5357746|NCT00126750|13182635|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
5357747|NCT00126750|13182636|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
5357748|NCT00126737|13182646|P4|NOT COMPLETED|Overall Study||7
5357749|NCT00126737|13182647|P3|NOT COMPLETED|Overall Study||6
5357750|NCT00126737|13182648|P2|NOT COMPLETED|Overall Study||3
5357751|NCT00126737|13182649|P1|NOT COMPLETED|Overall Study||6
5357752|NCT00126737|13182646|P4|COMPLETED|Overall Study||18
5357753|NCT00126737|13182647|P3|COMPLETED|Overall Study||24
5357754|NCT00126737|13182648|P2|COMPLETED|Overall Study||24
5357755|NCT00126737|13182649|P1|COMPLETED|Overall Study||22
5357756|NCT00126737|13182646|P4|STARTED|Overall Study||25
5357757|NCT00126737|13182647|P3|STARTED|Overall Study||30
5357758|NCT00126737|13182648|P2|STARTED|Overall Study||27
5357759|NCT00126737|13182649|P1|STARTED|Overall Study||28
5357760|NCT00126659|13182678|P3|NOT COMPLETED|Overall Study||2
5357761|NCT00126659|13182679|P2|NOT COMPLETED|Overall Study||0
5357762|NCT00126659|13182680|P1|NOT COMPLETED|Overall Study||0
5357763|NCT00126659|13182678|P3|COMPLETED|Overall Study||2
5357764|NCT00126659|13182679|P2|COMPLETED|Overall Study||3
5357765|NCT00126659|13182680|P1|COMPLETED|Overall Study||3
5357766|NCT00126659|13182678|P3|STARTED|Overall Study||4
5357767|NCT00126659|13182679|P2|STARTED|Overall Study||3
5357768|NCT00126659|13182680|P1|STARTED|Overall Study||3
5357769|NCT00126594|13182688|P2|NOT COMPLETED|Overall Study||37
5357770|NCT00126594|13182689|P1|NOT COMPLETED|Overall Study||39
5357771|NCT00126594|13182688|P2|COMPLETED|Overall Study||3
5357772|NCT00126594|13182689|P1|COMPLETED|Overall Study||1
5357773|NCT00126594|13182688|P2|STARTED|Overall Study||40
5357774|NCT00126594|13182689|P1|STARTED|Overall Study||40
5357775|NCT00126581|13182706|P2|NOT COMPLETED|Overall Study||20
5357776|NCT00126581|13182707|P1|NOT COMPLETED|Overall Study||13
5357777|NCT00126581|13182706|P2|COMPLETED|Overall Study||80
5357778|NCT00126581|13182707|P1|COMPLETED|Overall Study||68
5357779|NCT00126581|13182706|P2|STARTED|Overall Study||100
5357780|NCT00126581|13182707|P1|STARTED|Overall Study||81
5357781|NCT00126568|13182727|P1|NOT COMPLETED|Overall Study||2
5357782|NCT00126568|13182727|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
5357783|NCT00126568|13182727|P1|STARTED|Overall Study||20
5357784|NCT00126555|13182734|P1|NOT COMPLETED|Overall Study||6
5357785|NCT00126555|13182734|P1|COMPLETED|Overall Study||17
5357786|NCT00126555|13182734|P1|Stratum 2- Unresectable|Overall Study||4
5357787|NCT00126555|13182734|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
5357788|NCT00126555|13182734|P1|STARTED|Overall Study||23
5357789|NCT00126503|13182756|P2|NOT COMPLETED|Overall Study||21
5357790|NCT00126503|13182757|P1|NOT COMPLETED|Overall Study||47
5357791|NCT00126503|13182756|P2|COMPLETED|Overall Study||0
5357792|NCT00126503|13182757|P1|COMPLETED|Overall Study||1
5357793|NCT00126503|13182756|P2|STARTED|Overall Study||21
5357794|NCT00126503|13182757|P1|STARTED|Overall Study||48
5357795|NCT00126490|13182769|P1|NOT COMPLETED|Overall Study||1
5357796|NCT00126490|13182769|P1|COMPLETED|Overall Study||18
5357797|NCT00126490|13182769|P1|STARTED|Overall Study||19
5357798|NCT00126438|13182779|P2|NOT COMPLETED|Overall Study||10
5357799|NCT00126438|13182780|P1|NOT COMPLETED|Overall Study||34
5357800|NCT00126438|13182779|P2|COMPLETED|Overall Study||52
5357801|NCT00126438|13182780|P1|COMPLETED|Overall Study||419
5357802|NCT00126438|13182779|P2|STARTED|Overall Study||62
5357803|NCT00126438|13182780|P1|STARTED|Overall Study||453
5357804|NCT00126425|13182788|P2|NOT COMPLETED|Overall Study||11
5357805|NCT00126425|13182789|P1|NOT COMPLETED|Overall Study||41
5357806|NCT00126425|13182788|P2|COMPLETED|Overall Study||37
5357807|NCT00126425|13182789|P1|COMPLETED|Overall Study||498
5357808|NCT00126425|13182788|P2|STARTED|Overall Study||48
5357809|NCT00126425|13182789|P1|STARTED|Overall Study||539
5357810|NCT00126191|13182797|P2|NOT COMPLETED|Overall Study||2
5357811|NCT00126191|13182798|P1|NOT COMPLETED|Overall Study||0
5357812|NCT00126191|13182797|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
5357813|NCT00126191|13182798|P1|COMPLETED|Overall Study||2
5357814|NCT00126191|13182797|P2|STARTED|Overall Study||8
5357815|NCT00126191|13182798|P1|STARTED|Overall Study||2
5357816|NCT00126126|13182808|P2|NOT COMPLETED|Overall Study||2
5357817|NCT00126126|13182809|P1|NOT COMPLETED|Overall Study||0
5357818|NCT00126126|13182808|P2|COMPLETED|Overall Study||7
5357819|NCT00126126|13182809|P1|COMPLETED|Overall Study||9
5357820|NCT00126126|13182808|P2|STARTED|Overall Study||9
5357821|NCT00126126|13182809|P1|STARTED|Overall Study||9
5357822|NCT00126113|13182819|P2|NOT COMPLETED|Overall Study||2
5357823|NCT00126113|13182820|P1|NOT COMPLETED|Overall Study||3
5357824|NCT00126113|13182819|P2|COMPLETED|Overall Study||35
5357825|NCT00126113|13182820|P1|COMPLETED|Overall Study||34
5357826|NCT00126113|13182819|P2|STARTED|Overall Study||37
5357827|NCT00126113|13182820|P1|STARTED|Overall Study||37
5357828|NCT00125957|13182834|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
5357829|NCT00125957|13182835|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
5357830|NCT00125957|13182834|P2|COMPLETED|Second Intervention (3 Weeks)||17
5357831|NCT00125957|13182835|P1|COMPLETED|Second Intervention (3 Weeks)||15
5357832|NCT00125957|13182834|P2|STARTED|Second Intervention (3 Weeks)||17
5357833|NCT00125957|13182835|P1|STARTED|Second Intervention (3 Weeks)||15
5357834|NCT00125957|13182834|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
5357835|NCT00125957|13182835|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
5357836|NCT00125957|13182834|P2|COMPLETED|First Intervention (3 Weeks)||17
5357837|NCT00125957|13182835|P1|COMPLETED|First Intervention (3 Weeks)||15
5357838|NCT00125957|13182834|P2|STARTED|First Intervention (3 Weeks)||17
5357839|NCT00125957|13182835|P1|STARTED|First Intervention (3 Weeks)||15
5357840|NCT00125931|13182843|P1|NOT COMPLETED|Overall Study||0
5357841|NCT00125931|13182843|P1|COMPLETED|Overall Study||10
5357842|NCT00125931|13182843|P1|STARTED|Overall Study||10
5357843|NCT00125853|13182848|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
5357844|NCT00125853|13182849|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
5357845|NCT00125853|13182848|P2|COMPLETED|Second Intervention (8 Weeks)||20
5357846|NCT00125853|13182849|P1|COMPLETED|Second Intervention (8 Weeks)||24
5357847|NCT00125853|13182848|P2|STARTED|Second Intervention (8 Weeks)||20
5357848|NCT00125853|13182849|P1|STARTED|Second Intervention (8 Weeks)||24
5357849|NCT00125853|13182848|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
5357850|NCT00125853|13182849|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
5357851|NCT00125853|13182848|P2|COMPLETED|Wash-out (4 Weeks)||20
5357852|NCT00125853|13182849|P1|COMPLETED|Wash-out (4 Weeks)||24
5357853|NCT00125853|13182848|P2|STARTED|Wash-out (4 Weeks)||27
5357854|NCT00125853|13182849|P1|STARTED|Wash-out (4 Weeks)||27
5357855|NCT00125853|13182848|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
5357856|NCT00125853|13182849|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
5357857|NCT00125853|13182848|P2|COMPLETED|First Intervention (8 Weeks)||27
5357858|NCT00125853|13182849|P1|COMPLETED|First Intervention (8 Weeks)||27
5357859|NCT00125853|13182848|P2|STARTED|First Intervention (8 Weeks)||27
5357860|NCT00125853|13182849|P1|STARTED|First Intervention (8 Weeks)||27
5357861|NCT00125853|13182848|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
5357862|NCT00125853|13182849|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
5357863|NCT00125853|13182848|P2|COMPLETED|Wash-out (4 Weeks)||27
5357864|NCT00125853|13182849|P1|COMPLETED|Wash-out (4 Weeks)||27
5357865|NCT00125853|13182848|P2|STARTED|Wash-out (4 Weeks)||27
5357866|NCT00125853|13182849|P1|STARTED|Wash-out (4 Weeks)||27
5357867|NCT00125762|13182863|P1|NOT COMPLETED|Overall Study||159
5357868|NCT00125762|13182863|P1|COMPLETED|Overall Study||748
5357869|NCT00125762|13182863|P1|STARTED|Overall Study||907
5357870|NCT00125658|13182870|P2|NOT COMPLETED|Overall Study||0
5357871|NCT00125658|13182871|P1|NOT COMPLETED|Overall Study||0
5357872|NCT00125658|13182870|P2|COMPLETED|Overall Study||6
5357873|NCT00125658|13182871|P1|COMPLETED|Overall Study||8
5357874|NCT00125658|13182870|P2|STARTED|Overall Study||6
5357875|NCT00125658|13182871|P1|STARTED|Overall Study||8
5357876|NCT00125619|13182891|P2|NOT COMPLETED|Overall Study||0
5357877|NCT00125619|13182892|P1|NOT COMPLETED|Overall Study||0
5357878|NCT00125619|13182891|P2|COMPLETED|Overall Study||8
5357879|NCT00125619|13182892|P1|COMPLETED|Overall Study||8
5357880|NCT00125619|13182891|P2|STARTED|Overall Study||8
5357881|NCT00125619|13182892|P1|STARTED|Overall Study||8
5357882|NCT00125593|13182912|P2|NOT COMPLETED|Overall Study||103
5357883|NCT00125593|13182913|P1|NOT COMPLETED|Overall Study||101
5357884|NCT00125593|13182912|P2|COMPLETED|Overall Study||4517
5357885|NCT00125593|13182913|P1|COMPLETED|Overall Study||4549
5357886|NCT00125593|13182912|P2|STARTED|Overall Study||4620
5357887|NCT00125593|13182913|P1|STARTED|Overall Study||4650
5357888|NCT00125528|13182933|P2|NOT COMPLETED|Overall Study||1
5357889|NCT00125528|13182934|P1|NOT COMPLETED|Overall Study||2
5357890|NCT00125528|13182933|P2|COMPLETED|Overall Study||20
5357891|NCT00125528|13182934|P1|COMPLETED|Overall Study||18
5357892|NCT00125528|13182933|P2|STARTED|Overall Study||21
5357893|NCT00125528|13182934|P1|STARTED|Overall Study||20
5357894|NCT00125515|13182945|P3|NOT COMPLETED|Overall Study||21
5357895|NCT00125515|13182946|P2|NOT COMPLETED|Overall Study||20
5357896|NCT00125515|13182947|P1|NOT COMPLETED|Overall Study||20
5357897|NCT00125515|13182945|P3|COMPLETED|Overall Study||6
5357898|NCT00125515|13182946|P2|COMPLETED|Overall Study||7
5357899|NCT00125515|13182947|P1|COMPLETED|Overall Study||7
5357900|NCT00125515|13182945|P3|STARTED|Overall Study||27
5357901|NCT00125515|13182946|P2|STARTED|Overall Study||27
5357902|NCT00125515|13182947|P1|STARTED|Overall Study||27
5357903|NCT00125372|13182955|P1|NOT COMPLETED|Overall Study||2
5357904|NCT00125372|13182955|P1|COMPLETED|Overall Study||10
5357905|NCT00125372|13182955|P1|STARTED|Overall Study||12
5357906|NCT00125359|13182963|P1|NOT COMPLETED|Overall Study||23
5357907|NCT00125359|13182963|P1|COMPLETED|Overall Study||19
5357908|NCT00125359|13182963|P1|STARTED|Overall Study||42
5357909|NCT00125268|13182972|P2|NOT COMPLETED|Overall Study||1
5357910|NCT00125268|13182973|P1|NOT COMPLETED|Overall Study||1
5357911|NCT00125268|13182972|P2|COMPLETED|Overall Study||13
5357912|NCT00125268|13182973|P1|COMPLETED|Overall Study||15
5357913|NCT00125268|13182972|P2|STARTED|Overall Study||14
5357914|NCT00125268|13182973|P1|STARTED|Overall Study||16
5357915|NCT00125242|13182985|P2|NOT COMPLETED|Overall Study||2
5357916|NCT00125242|13182986|P1|NOT COMPLETED|Overall Study||7
5357917|NCT00125242|13182985|P2|COMPLETED|Overall Study||14
5357918|NCT00125242|13182986|P1|COMPLETED|Overall Study||87
5357919|NCT00125242|13182985|P2|STARTED|Overall Study||16
5357920|NCT00125242|13182986|P1|STARTED|Overall Study||94
5357921|NCT00125190|13182991|P1|NOT COMPLETED|Overall Study||15
5357922|NCT00125190|13182991|P1|COMPLETED|Overall Study||30
5357923|NCT00125190|13182991|P1|Completed 34 Weeks of Study|Overall Study||43
5357924|NCT00125190|13182991|P1|STARTED|Overall Study||45
5357925|NCT00125164|13183007|P4|NOT COMPLETED|Overall Study||6
5357926|NCT00125164|13183008|P3|NOT COMPLETED|Overall Study||4
5357927|NCT00125164|13183009|P2|NOT COMPLETED|Overall Study||0
5357928|NCT00125164|13183010|P1|NOT COMPLETED|Overall Study||2
5357929|NCT00125164|13183007|P4|COMPLETED|Overall Study||45
5357930|NCT00125164|13183008|P3|COMPLETED|Overall Study||40
5357931|NCT00125164|13183009|P2|COMPLETED|Overall Study||16
5357932|NCT00125164|13183010|P1|COMPLETED|Overall Study||23
5357933|NCT00125164|13183007|P4|STARTED|Overall Study||51
5357934|NCT00125164|13183008|P3|STARTED|Overall Study||44
5357935|NCT00125164|13183009|P2|STARTED|Overall Study||16
5357936|NCT00125164|13183010|P1|STARTED|Overall Study||25
5357937|NCT00125138|13183064|P4|NOT COMPLETED|Overall Study||5
5357938|NCT00125138|13183065|P3|NOT COMPLETED|Overall Study||4
5357939|NCT00125138|13183066|P2|NOT COMPLETED|Overall Study||3
5357940|NCT00125138|13183067|P1|NOT COMPLETED|Overall Study||3
5357941|NCT00125138|13183064|P4|COMPLETED|Overall Study||25
5357942|NCT00125138|13183065|P3|COMPLETED|Overall Study||21
5357943|NCT00125138|13183066|P2|COMPLETED|Overall Study||17
5357944|NCT00125138|13183067|P1|COMPLETED|Overall Study||12
5357945|NCT00125138|13183064|P4|STARTED|Overall Study||30
5357946|NCT00125138|13183065|P3|STARTED|Overall Study||25
5357947|NCT00125138|13183066|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
5357948|NCT00125138|13183067|P1|STARTED|Overall Study||15
5357949|NCT00125034|13183083|P2|NOT COMPLETED|Overall Study||0
5357950|NCT00125034|13183084|P1|NOT COMPLETED|Overall Study||0
5357951|NCT00125034|13183083|P2|COMPLETED|Overall Study||168
5357952|NCT00125034|13183084|P1|COMPLETED|Overall Study||170
5357953|NCT00125034|13183083|P2|STARTED|Overall Study|Randomized & treated|168
5357954|NCT00125034|13183084|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
5357955|NCT00124982|13183116|P3|NOT COMPLETED|Long-term Period||89
5357956|NCT00124982|13183117|P2|NOT COMPLETED|Long-term Period||0
5357957|NCT00124982|13183118|P1|NOT COMPLETED|Long-term Period||0
5357958|NCT00124982|13183116|P3|COMPLETED|Long-term Period||441
5357959|NCT00124982|13183117|P2|COMPLETED|Long-term Period||0
5357960|NCT00124982|13183118|P1|COMPLETED|Long-term Period||0
5357961|NCT00124982|13183116|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
5357962|NCT00124982|13183117|P2|STARTED|Long-term Period||0
5357963|NCT00124982|13183118|P1|STARTED|Long-term Period||0
5357964|NCT00124982|13183116|P3|NOT COMPLETED|Short-term Period||0
5357965|NCT00124982|13183117|P2|NOT COMPLETED|Short-term Period||114
5357966|NCT00124982|13183118|P1|NOT COMPLETED|Short-term Period||72
5357967|NCT00124982|13183116|P3|COMPLETED|Short-term Period||0
5357968|NCT00124982|13183117|P2|COMPLETED|Short-term Period||483
5357969|NCT00124982|13183118|P1|COMPLETED|Short-term Period||377
5357970|NCT00124982|13183116|P3|STARTED|Short-term Period||0
5357971|NCT00124982|13183117|P2|STARTED|Short-term Period||597
5357972|NCT00124982|13183118|P1|STARTED|Short-term Period||449
5357973|NCT00124943|13183200|P4|NOT COMPLETED|Phase II||5
5357974|NCT00124943|13183201|P3|NOT COMPLETED|Phase II||0
5357975|NCT00124943|13183202|P2|NOT COMPLETED|Phase II||2
5357976|NCT00124943|13183203|P1|NOT COMPLETED|Phase II||0
5357977|NCT00124943|13183200|P4|COMPLETED|Phase II||50
5357978|NCT00124943|13183201|P3|COMPLETED|Phase II||3
5357979|NCT00124943|13183202|P2|COMPLETED|Phase II||49
5357980|NCT00124943|13183203|P1|COMPLETED|Phase II||3
5357981|NCT00124943|13183200|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
5357982|NCT00124943|13183201|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
5357983|NCT00124943|13183202|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
5357984|NCT00124943|13183203|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
5357985|NCT00124943|13183200|P4|NOT COMPLETED|Phase I||0
5357986|NCT00124943|13183201|P3|NOT COMPLETED|Phase I||0
5357987|NCT00124943|13183202|P2|NOT COMPLETED|Phase I||0
5357988|NCT00124943|13183203|P1|NOT COMPLETED|Phase I||0
5357989|NCT00124943|13183200|P4|COMPLETED|Phase I||3
5357990|NCT00124943|13183201|P3|COMPLETED|Phase I||3
5357991|NCT00124943|13183202|P2|COMPLETED|Phase I||3
5357992|NCT00124943|13183203|P1|COMPLETED|Phase I||3
5357993|NCT00124943|13183200|P4|STARTED|Phase I||3
5357994|NCT00124943|13183201|P3|STARTED|Phase I||3
5357995|NCT00124943|13183202|P2|STARTED|Phase I||3
5357996|NCT00124943|13183203|P1|STARTED|Phase I||3
5357997|NCT00124917|13183241|P1|NOT COMPLETED|Overall Study||3
5357998|NCT00124917|13183241|P1|COMPLETED|Overall Study||3
5357999|NCT00124917|13183241|P1|STARTED|Overall Study||6
5358000|NCT00124748|13183251|P2|NOT COMPLETED|Overall Study||284
5358001|NCT00124748|13183252|P1|NOT COMPLETED|Overall Study||143
5358002|NCT00124748|13183251|P2|COMPLETED|Overall Study||35
5358003|NCT00124748|13183252|P1|COMPLETED|Overall Study||14
5358004|NCT00124748|13183251|P2|Safety Population|Overall Study||316
5358005|NCT00124748|13183252|P1|Safety Population|Overall Study||157
5358006|NCT00124748|13183251|P2|STARTED|Overall Study||319
5358007|NCT00124748|13183252|P1|STARTED|Overall Study||157
5358008|NCT00124735|13183304|P10|NOT COMPLETED|Overall Study||2
5358009|NCT00124735|13183305|P9|NOT COMPLETED|Overall Study||3
5358010|NCT00124735|13183306|P8|NOT COMPLETED|Overall Study||1
5358011|NCT00124735|13183307|P7|NOT COMPLETED|Overall Study||0
5358012|NCT00124735|13183308|P6|NOT COMPLETED|Overall Study||2
5358013|NCT00124735|13183309|P5|NOT COMPLETED|Overall Study||2
5358014|NCT00124735|13183310|P4|NOT COMPLETED|Overall Study||3
5358015|NCT00124735|13183311|P3|NOT COMPLETED|Overall Study||0
5358016|NCT00124735|13183312|P2|NOT COMPLETED|Overall Study||2
5358017|NCT00124735|13183313|P1|NOT COMPLETED|Overall Study||1
5358018|NCT00124735|13183304|P10|COMPLETED|Overall Study||18
5358019|NCT00124735|13183305|P9|COMPLETED|Overall Study||22
5358020|NCT00124735|13183306|P8|COMPLETED|Overall Study||19
5358021|NCT00124735|13183307|P7|COMPLETED|Overall Study||6
5358022|NCT00124735|13183308|P6|COMPLETED|Overall Study||5
5358023|NCT00124735|13183309|P5|COMPLETED|Overall Study||17
5358024|NCT00124735|13183310|P4|COMPLETED|Overall Study||18
5358025|NCT00124735|13183311|P3|COMPLETED|Overall Study||18
5358026|NCT00124735|13183312|P2|COMPLETED|Overall Study||6
5358027|NCT00124735|13183313|P1|COMPLETED|Overall Study||4
5358028|NCT00124735|13183304|P10|STARTED|Overall Study||20
5358029|NCT00124735|13183305|P9|STARTED|Overall Study||25
5358030|NCT00124735|13183306|P8|STARTED|Overall Study||20
5358031|NCT00124735|13183307|P7|STARTED|Overall Study||6
5358032|NCT00124735|13183308|P6|STARTED|Overall Study||7
5358033|NCT00124735|13183309|P5|STARTED|Overall Study||19
5358034|NCT00124735|13183310|P4|STARTED|Overall Study||21
5358035|NCT00124735|13183311|P3|STARTED|Overall Study||18
5358036|NCT00124735|13183312|P2|STARTED|Overall Study||8
5358037|NCT00124735|13183313|P1|STARTED|Overall Study||5
5358038|NCT00124709|13183359|P2|NOT COMPLETED|Overall Study||272
5358039|NCT00124709|13183360|P1|NOT COMPLETED|Overall Study||255
5358040|NCT00124709|13183359|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
5358041|NCT00124709|13183360|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
5358042|NCT00124709|13183359|P2|Patients Who Received Study Medication|Overall Study||544
5358043|NCT00124709|13183360|P1|Patients Who Received Study Medication|Overall Study||543
5358044|NCT00124709|13183359|P2|STARTED|Overall Study||545
5358045|NCT00124709|13183360|P1|STARTED|Overall Study||546
5358046|NCT00124657|13183377|P3|NOT COMPLETED|Overall Study||32
5358047|NCT00124657|13183378|P2|NOT COMPLETED|Overall Study||5
5358048|NCT00124657|13183379|P1|NOT COMPLETED|Overall Study||16
5358049|NCT00124657|13183377|P3|COMPLETED|Overall Study||7
5358050|NCT00124657|13183378|P2|COMPLETED|Overall Study||0
5358051|NCT00124657|13183379|P1|COMPLETED|Overall Study||2
5358052|NCT00124657|13183377|P3|STARTED|Overall Study||39
5358053|NCT00124657|13183378|P2|STARTED|Overall Study||5
5358054|NCT00124657|13183379|P1|STARTED|Overall Study||18
5358055|NCT00124618|13183414|P1|NOT COMPLETED|Overall Study||1
5358056|NCT00124618|13183414|P1|COMPLETED|Overall Study||57
5358057|NCT00124618|13183414|P1|STARTED|Overall Study||58
5358058|NCT00124579|13183421|P1|NOT COMPLETED|Maintenance||2
5358059|NCT00124579|13183421|P1|COMPLETED|Maintenance||0
5358060|NCT00124579|13183421|P1|STARTED|Maintenance||2
5358061|NCT00124579|13183421|P1|NOT COMPLETED|Induction||5
5358062|NCT00124579|13183421|P1|COMPLETED|Induction||2
5358063|NCT00124579|13183421|P1|STARTED|Induction||7
5358064|NCT00124462|13183429|P2|NOT COMPLETED|Overall Study||13
5358065|NCT00124462|13183430|P1|NOT COMPLETED|Overall Study||11
5358066|NCT00124462|13183429|P2|COMPLETED|Overall Study||27
5358067|NCT00124462|13183430|P1|COMPLETED|Overall Study||29
5358068|NCT00124462|13183429|P2|STARTED|Overall Study||40
5358069|NCT00124462|13183430|P1|STARTED|Overall Study||40
5358070|NCT00124449|13183440|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
5358071|NCT00124449|13183441|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
5358072|NCT00124449|13183440|P2|COMPLETED|18-Month Untreated Observation Period||4
5358073|NCT00124449|13183441|P1|COMPLETED|18-Month Untreated Observation Period||7
5358074|NCT00124449|13183440|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
5358075|NCT00124449|13183441|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
5358076|NCT00124449|13183440|P2|STARTED|18-Month Untreated Observation Period||17
5358077|NCT00124449|13183441|P1|STARTED|18-Month Untreated Observation Period||22
5358078|NCT00124449|13183440|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
5358079|NCT00124449|13183441|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
5358080|NCT00124449|13183440|P2|COMPLETED|6-month Double-Blind Treatment Period||17
5358081|NCT00124449|13183441|P1|COMPLETED|6-month Double-Blind Treatment Period||22
5358082|NCT00124449|13183440|P2|STARTED|6-month Double-Blind Treatment Period||28
5358083|NCT00124449|13183441|P1|STARTED|6-month Double-Blind Treatment Period||28
5358084|NCT00124176|13183476|P2|NOT COMPLETED|Overall Study||0
5358085|NCT00124176|13183477|P1|NOT COMPLETED|Overall Study||0
5358086|NCT00124176|13183476|P2|COMPLETED|Overall Study||41
5358087|NCT00124176|13183477|P1|COMPLETED|Overall Study||40
5358088|NCT00124176|13183476|P2|Received Study Drug|Overall Study||41
5358089|NCT00124176|13183477|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
5358090|NCT00124176|13183476|P2|STARTED|Overall Study||41
5358091|NCT00124176|13183477|P1|STARTED|Overall Study||40
5358092|NCT00124072|13183495|P4|NOT COMPLETED|Overall Study||500
5358093|NCT00124072|13183496|P3|NOT COMPLETED|Overall Study||492
5358094|NCT00124072|13183497|P2|NOT COMPLETED|Overall Study||512
5358095|NCT00124072|13183498|P1|NOT COMPLETED|Overall Study||514
5358096|NCT00124072|13183495|P4|COMPLETED|Overall Study||2515
5358097|NCT00124072|13183496|P3|COMPLETED|Overall Study||2524
5358098|NCT00124072|13183497|P2|COMPLETED|Overall Study||2504
5358099|NCT00124072|13183498|P1|COMPLETED|Overall Study||2503
5358100|NCT00124072|13183495|P4|STARTED|Overall Study||3015
5358101|NCT00124072|13183496|P3|STARTED|Overall Study||3016
5358102|NCT00124072|13183497|P2|STARTED|Overall Study||3016
5358103|NCT00124072|13183498|P1|STARTED|Overall Study||3017
5358104|NCT00124020|13183510|P2|NOT COMPLETED|Overall Study||91
5358105|NCT00124020|13183511|P1|NOT COMPLETED|Overall Study||88
5358106|NCT00124020|13183510|P2|COMPLETED|Overall Study||289
5358107|NCT00124020|13183511|P1|COMPLETED|Overall Study||289
5358108|NCT00124020|13183510|P2|STARTED|Overall Study||380
5358109|NCT00124020|13183511|P1|STARTED|Overall Study||377
5358110|NCT00123955|13183519|P2|NOT COMPLETED|Overall Study||4
5358111|NCT00123955|13183520|P1|NOT COMPLETED|Overall Study||5
5358112|NCT00123955|13183519|P2|COMPLETED|Overall Study||34
5358113|NCT00123955|13183520|P1|COMPLETED|Overall Study||37
5358114|NCT00123955|13183519|P2|STARTED|Overall Study||38
5358115|NCT00123955|13183520|P1|STARTED|Overall Study||42
5358116|NCT00123734|13183532|P1|NOT COMPLETED|Overall Study||8
5358117|NCT00123734|13183532|P1|COMPLETED|Overall Study||74
5358118|NCT00123734|13183532|P1|STARTED|Overall Study||82
5358119|NCT00123682|13183567|P4|NOT COMPLETED|Overall Study||95
5358120|NCT00123682|13183568|P3|NOT COMPLETED|Overall Study||154
5358121|NCT00123682|13183569|P2|NOT COMPLETED|Overall Study||203
5358122|NCT00123682|13183570|P1|NOT COMPLETED|Overall Study||320
5358123|NCT00123682|13183567|P4|COMPLETED|Overall Study||430
5358124|NCT00123682|13183568|P3|COMPLETED|Overall Study||438
5358125|NCT00123682|13183569|P2|COMPLETED|Overall Study||731
5358126|NCT00123682|13183570|P1|COMPLETED|Overall Study||749
5358127|NCT00123682|13183567|P4|STARTED|Overall Study||525
5358128|NCT00123682|13183568|P3|STARTED|Overall Study||592
5358129|NCT00123682|13183569|P2|STARTED|Overall Study||934
5358130|NCT00123682|13183570|P1|STARTED|Overall Study||1069
5358131|NCT00123643|13183590|P2|NOT COMPLETED|Overall Study||0
5358132|NCT00123643|13183591|P1|NOT COMPLETED|Overall Study||0
5358133|NCT00123643|13183590|P2|COMPLETED|Overall Study||16
5358134|NCT00123643|13183591|P1|COMPLETED|Overall Study||20
5358135|NCT00123643|13183590|P2|STARTED|Overall Study||16
5358136|NCT00123643|13183591|P1|STARTED|Overall Study||20
5358137|NCT00123630|13183599|P2|NOT COMPLETED|Overall Study||0
5358138|NCT00123630|13183600|P1|NOT COMPLETED|Overall Study||0
5358139|NCT00123630|13183599|P2|COMPLETED|Overall Study||15
5358140|NCT00123630|13183600|P1|COMPLETED|Overall Study||15
5358141|NCT00123630|13183599|P2|STARTED|Overall Study||15
5358142|NCT00123630|13183600|P1|STARTED|Overall Study||15
5358143|NCT00123604|13183608|P2|NOT COMPLETED|Overall Study||1
5358144|NCT00123604|13183609|P1|NOT COMPLETED|Overall Study||1
5358145|NCT00123604|13183608|P2|COMPLETED|Overall Study||16
5358146|NCT00123604|13183609|P1|COMPLETED|Overall Study||18
5358147|NCT00123604|13183608|P2|STARTED|Overall Study||17
5358148|NCT00123604|13183609|P1|STARTED|Overall Study||19
5358149|NCT00123487|13183617|P2|NOT COMPLETED|Treated With Study Drug||305
5358150|NCT00123487|13183618|P1|NOT COMPLETED|Treated With Study Drug||304
5358151|NCT00123487|13183617|P2|COMPLETED|Treated With Study Drug||0
5358152|NCT00123487|13183618|P1|COMPLETED|Treated With Study Drug||0
5358153|NCT00123487|13183617|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
5358154|NCT00123487|13183618|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
5358155|NCT00123487|13183617|P2|NOT COMPLETED|Randomized||1
5358156|NCT00123487|13183618|P1|NOT COMPLETED|Randomized||1
5358157|NCT00123487|13183617|P2|COMPLETED|Randomized||304
5358158|NCT00123487|13183618|P1|COMPLETED|Randomized||305
5358159|NCT00123487|13183617|P2|STARTED|Randomized||305
5358160|NCT00123487|13183618|P1|STARTED|Randomized||306
5358161|NCT00123474|13183662|P4|NOT COMPLETED|As Treated at Study Closure||167
5358162|NCT00123474|13183663|P3|NOT COMPLETED|As Treated at Study Closure||167
5358163|NCT00123474|13183664|P2|NOT COMPLETED|As Treated at Study Closure||163
5358164|NCT00123474|13183665|P1|NOT COMPLETED|As Treated at Study Closure||165
5358165|NCT00123474|13183662|P4|COMPLETED|As Treated at Study Closure||0
5358166|NCT00123474|13183663|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
5358167|NCT00123474|13183664|P2|COMPLETED|As Treated at Study Closure||0
5358168|NCT00123474|13183665|P1|COMPLETED|As Treated at Study Closure||0
5358169|NCT00123474|13183662|P4|STARTED|As Treated at Study Closure||167
5358170|NCT00123474|13183663|P3|STARTED|As Treated at Study Closure||167
5358171|NCT00123474|13183664|P2|STARTED|As Treated at Study Closure||163
5358172|NCT00123474|13183665|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
5358173|NCT00123474|13183662|P4|NOT COMPLETED|Randomized to Treatment||1
5358174|NCT00123474|13183663|P3|NOT COMPLETED|Randomized to Treatment||2
5358175|NCT00123474|13183664|P2|NOT COMPLETED|Randomized to Treatment||4
5358176|NCT00123474|13183665|P1|NOT COMPLETED|Randomized to Treatment||1
5358177|NCT00123474|13183662|P4|COMPLETED|Randomized to Treatment||167
5358178|NCT00123474|13183663|P3|COMPLETED|Randomized to Treatment||166
5358179|NCT00123474|13183664|P2|COMPLETED|Randomized to Treatment||163
5358180|NCT00123474|13183665|P1|COMPLETED|Randomized to Treatment||166
5358181|NCT00123474|13183662|P4|STARTED|Randomized to Treatment||168
5358182|NCT00123474|13183663|P3|STARTED|Randomized to Treatment||168
5358183|NCT00123474|13183664|P2|STARTED|Randomized to Treatment||167
5358184|NCT00123474|13183665|P1|STARTED|Randomized to Treatment||167
5358185|NCT00123422|13183759|P3|NOT COMPLETED|Overall Study||10
5358186|NCT00123422|13183760|P2|NOT COMPLETED|Overall Study||6
5358187|NCT00123422|13183761|P1|NOT COMPLETED|Overall Study||4
5358188|NCT00123422|13183759|P3|COMPLETED|Overall Study||25
5358189|NCT00123422|13183760|P2|COMPLETED|Overall Study||27
5358190|NCT00123422|13183761|P1|COMPLETED|Overall Study||31
5358191|NCT00123422|13183759|P3|8-week Testing|Overall Study||27
5358192|NCT00123422|13183760|P2|8-week Testing|Overall Study||30
5358193|NCT00123422|13183761|P1|8-week Testing|Overall Study||32
5358194|NCT00123422|13183759|P3|STARTED|Overall Study||35
5358195|NCT00123422|13183760|P2|STARTED|Overall Study||33
5358196|NCT00123422|13183761|P1|STARTED|Overall Study||35
5358197|NCT00123409|13183774|P2|NOT COMPLETED|Overall Study||3
5358198|NCT00123409|13183775|P1|NOT COMPLETED|Overall Study||4
5358199|NCT00123409|13183774|P2|COMPLETED|Overall Study||71
5358200|NCT00123409|13183775|P1|COMPLETED|Overall Study||68
5358201|NCT00123409|13183774|P2|STARTED|Overall Study||74
5358202|NCT00123409|13183775|P1|STARTED|Overall Study||72
5358203|NCT00123162|13183785|P2|NOT COMPLETED|Overall Study||0
5358204|NCT00123162|13183786|P1|NOT COMPLETED|Overall Study||0
5358205|NCT00123162|13183785|P2|COMPLETED|Overall Study||12
5358206|NCT00123162|13183786|P1|COMPLETED|Overall Study||13
5358207|NCT00123162|13183785|P2|STARTED|Overall Study||12
5358208|NCT00123162|13183786|P1|STARTED|Overall Study||13
5358209|NCT00123123|13183797|P3|NOT COMPLETED|Overall Study||0
5358210|NCT00123123|13183798|P2|NOT COMPLETED|Overall Study||0
5358211|NCT00123123|13183799|P1|NOT COMPLETED|Overall Study||0
5358212|NCT00123123|13183797|P3|COMPLETED|Overall Study||58
5358213|NCT00123123|13183798|P2|COMPLETED|Overall Study||58
5358214|NCT00123123|13183799|P1|COMPLETED|Overall Study||59
5358215|NCT00123123|13183797|P3|STARTED|Overall Study||58
5358216|NCT00123123|13183798|P2|STARTED|Overall Study||58
5358217|NCT00123123|13183799|P1|STARTED|Overall Study||59
5358218|NCT00123110|13183813|P3|NOT COMPLETED|Overall Study||0
5358219|NCT00123110|13183814|P2|NOT COMPLETED|Overall Study||0
5358220|NCT00123110|13183815|P1|NOT COMPLETED|Overall Study||0
5358221|NCT00123110|13183813|P3|COMPLETED|Overall Study||11
5358222|NCT00123110|13183814|P2|COMPLETED|Overall Study||12
5358223|NCT00123110|13183815|P1|COMPLETED|Overall Study||12
5358224|NCT00123110|13183813|P3|STARTED|Overall Study||11
5358225|NCT00123110|13183814|P2|STARTED|Overall Study||12
5358226|NCT00123110|13183815|P1|STARTED|Overall Study||12
5358227|NCT00122980|13183849|P2|NOT COMPLETED|Overall Study||40
5358228|NCT00122980|13183850|P1|NOT COMPLETED|Overall Study||43
5358229|NCT00122980|13183849|P2|COMPLETED|Overall Study|Study terminated early|26
5358230|NCT00122980|13183850|P1|COMPLETED|Overall Study|Study terminated early|24
5358231|NCT00122980|13183849|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
5358232|NCT00122980|13183850|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
5358233|NCT00122954|13183874|P2|NOT COMPLETED|Overall Study||3
5358234|NCT00122954|13183875|P1|NOT COMPLETED|Overall Study||2
5358235|NCT00122954|13183874|P2|COMPLETED|Overall Study||18
5358236|NCT00122954|13183875|P1|COMPLETED|Overall Study||16
5358237|NCT00122954|13183874|P2|STARTED|Overall Study||21
5358238|NCT00122954|13183875|P1|STARTED|Overall Study||18
5358239|NCT00122681|13183885|P2|NOT COMPLETED|Overall Study||1521
5358240|NCT00122681|13183886|P1|NOT COMPLETED|Overall Study||1514
5358241|NCT00122681|13183885|P2|COMPLETED|Overall Study||7798
5358242|NCT00122681|13183886|P1|COMPLETED|Overall Study||7811
5358243|NCT00122681|13183885|P2|STARTED|Overall Study||9319
5358244|NCT00122681|13183886|P1|STARTED|Overall Study||9325
5358245|NCT00122460|13183960|P2|NOT COMPLETED|Overall Study||1
5358246|NCT00122460|13183961|P1|NOT COMPLETED|Overall Study||7
5358247|NCT00122460|13183960|P2|COMPLETED|Overall Study||219
5358248|NCT00122460|13183961|P1|COMPLETED|Overall Study||215
5358249|NCT00122460|13183960|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
5358250|NCT00122460|13183961|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
5358251|NCT00122447|13183987|P4|NOT COMPLETED|Overall Study||3
5358252|NCT00122447|13183988|P3|NOT COMPLETED|Overall Study||1
5358253|NCT00122447|13183989|P2|NOT COMPLETED|Overall Study||5
5358254|NCT00122447|13183990|P1|NOT COMPLETED|Overall Study||1
5358255|NCT00122447|13183987|P4|COMPLETED|Overall Study||14
5358256|NCT00122447|13183988|P3|COMPLETED|Overall Study||16
5358257|NCT00122447|13183989|P2|COMPLETED|Overall Study||13
5358258|NCT00122447|13183990|P1|COMPLETED|Overall Study||17
5358259|NCT00122447|13183987|P4|STARTED|Overall Study||17
5358260|NCT00122447|13183988|P3|STARTED|Overall Study||17
5358261|NCT00122447|13183989|P2|STARTED|Overall Study||18
5358262|NCT00122447|13183990|P1|STARTED|Overall Study||18
5358263|NCT00122382|13184010|P3|NOT COMPLETED|Open-Label Study||26
5358264|NCT00122382|13184011|P2|NOT COMPLETED|Open-Label Study||0
5358265|NCT00122382|13184012|P1|NOT COMPLETED|Open-Label Study||0
5358266|NCT00122382|13184010|P3|COMPLETED|Open-Label Study||433
5358267|NCT00122382|13184011|P2|COMPLETED|Open-Label Study||0
5358268|NCT00122382|13184012|P1|COMPLETED|Open-Label Study||0
5358269|NCT00122382|13184010|P3|STARTED|Open-Label Study||459
5358270|NCT00122382|13184011|P2|STARTED|Open-Label Study||0
5358271|NCT00122382|13184012|P1|STARTED|Open-Label Study||0
5358272|NCT00122382|13184010|P3|NOT COMPLETED|Double-Blind Study||0
5358273|NCT00122382|13184011|P2|NOT COMPLETED|Double-Blind Study||28
5358274|NCT00122382|13184012|P1|NOT COMPLETED|Double-Blind Study||24
5358275|NCT00122382|13184010|P3|COMPLETED|Double-Blind Study||0
5358276|NCT00122382|13184011|P2|COMPLETED|Double-Blind Study||227
5358277|NCT00122382|13184012|P1|COMPLETED|Double-Blind Study||232
5358278|NCT00122382|13184010|P3|Treated|Double-Blind Study||0
5358279|NCT00122382|13184011|P2|Treated|Double-Blind Study||253
5358280|NCT00122382|13184012|P1|Treated|Double-Blind Study||256
5358281|NCT00122382|13184010|P3|STARTED|Double-Blind Study||0
5358282|NCT00122382|13184011|P2|STARTED|Double-Blind Study|participants randomized|255
5358283|NCT00122382|13184012|P1|STARTED|Double-Blind Study|participants randomized|256
5358284|NCT00122369|13184065|P3|NOT COMPLETED|Overall Study||0
5358285|NCT00122369|13184066|P2|NOT COMPLETED|Overall Study||0
5358286|NCT00122369|13184067|P1|NOT COMPLETED|Overall Study||0
5358287|NCT00122369|13184065|P3|COMPLETED|Overall Study||78
5358288|NCT00122369|13184066|P2|COMPLETED|Overall Study||82
5358289|NCT00122369|13184067|P1|COMPLETED|Overall Study||76
5358290|NCT00122369|13184065|P3|STARTED|Overall Study||78
5358291|NCT00122369|13184066|P2|STARTED|Overall Study||82
5358292|NCT00122369|13184067|P1|STARTED|Overall Study||76
5358293|NCT00122317|13184156|P1|NOT COMPLETED|Overall Study||11
5358294|NCT00122317|13184156|P1|COMPLETED|Overall Study||176
5358295|NCT00122317|13184156|P1|STARTED|Overall Study||187
5358296|NCT00122278|13184165|P2|NOT COMPLETED|Overall Study||0
5358297|NCT00122278|13184166|P1|NOT COMPLETED|Overall Study||2
5358298|NCT00122278|13184165|P2|COMPLETED|Overall Study||99
5358299|NCT00122278|13184166|P1|COMPLETED|Overall Study||104
5358300|NCT00122278|13184165|P2|STARTED|Overall Study||99
5358301|NCT00122278|13184166|P1|STARTED|Overall Study||106
5358302|NCT00122187|13184176|P2|NOT COMPLETED|Overall Study||2
5358303|NCT00122187|13184177|P1|NOT COMPLETED|Overall Study||2
5358304|NCT00122187|13184176|P2|COMPLETED|Overall Study||2
5358305|NCT00122187|13184177|P1|COMPLETED|Overall Study||2
5358306|NCT00122187|13184176|P2|Post-intervention Data Collection|Overall Study||2
5358307|NCT00122187|13184177|P1|Post-intervention Data Collection|Overall Study||2
5358308|NCT00122187|13184176|P2|Intervention Implemented|Overall Study||4
5358309|NCT00122187|13184177|P1|Intervention Implemented|Overall Study||3
5358310|NCT00122187|13184176|P2|Randomized to Intervention or Usual Care|Overall Study||4
5358311|NCT00122187|13184177|P1|Randomized to Intervention or Usual Care|Overall Study||4
5358312|NCT00122187|13184176|P2|Matched by Colonoscopy Volume|Overall Study||4
5358313|NCT00122187|13184177|P1|Matched by Colonoscopy Volume|Overall Study||4
5358314|NCT00122187|13184176|P2|STARTED|Overall Study||4
5358315|NCT00122187|13184177|P1|STARTED|Overall Study||4
5358316|NCT00122135|13184191|P2|NOT COMPLETED|Overall Study||0
5358317|NCT00122135|13184192|P1|NOT COMPLETED|Overall Study||3
5358318|NCT00122135|13184191|P2|COMPLETED|Overall Study||60
5358319|NCT00122135|13184192|P1|COMPLETED|Overall Study||57
5358320|NCT00122135|13184191|P2|STARTED|Overall Study||60
5358321|NCT00122135|13184192|P1|STARTED|Overall Study||60
5358322|NCT00122109|13184200|P2|NOT COMPLETED|Overall Study||7
5358323|NCT00122109|13184201|P1|NOT COMPLETED|Overall Study||6
5358324|NCT00122109|13184200|P2|COMPLETED|Overall Study||57
5358325|NCT00122109|13184201|P1|COMPLETED|Overall Study||55
5358326|NCT00122109|13184200|P2|STARTED|Overall Study|ITT|64
5358327|NCT00122109|13184201|P1|STARTED|Overall Study|ITT|61
5358328|NCT00121836|13184225|P1|NOT COMPLETED|Overall Study||55
5358329|NCT00121836|13184225|P1|COMPLETED|Overall Study||54
5358330|NCT00121836|13184225|P1|STARTED|Overall Study||109
5358331|NCT00121810|13184236|P2|NOT COMPLETED|Overall Study||39
5358332|NCT00121810|13184237|P1|NOT COMPLETED|Overall Study||30
5358333|NCT00121810|13184236|P2|COMPLETED|Overall Study||115
5358334|NCT00121810|13184237|P1|COMPLETED|Overall Study||121
5358335|NCT00121810|13184236|P2|Intent-to-Treat (ITT) Population|Overall Study||151
5358336|NCT00121810|13184237|P1|Intent-to-Treat (ITT) Population|Overall Study||148
5358337|NCT00121810|13184236|P2|Safety Population|Overall Study||153
5358338|NCT00121810|13184237|P1|Safety Population|Overall Study||148
5358339|NCT00121810|13184236|P2|STARTED|Overall Study||154
5358340|NCT00121810|13184237|P1|STARTED|Overall Study||151
5358341|NCT00121719|13184263|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358342|NCT00121719|13184264|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358343|NCT00121719|13184265|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358344|NCT00121719|13184266|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358345|NCT00121719|13184267|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358346|NCT00121719|13184268|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358347|NCT00121719|13184269|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358348|NCT00121719|13184270|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358349|NCT00121719|13184271|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358350|NCT00121719|13184272|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358351|NCT00121719|13184273|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358352|NCT00121719|13184274|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358353|NCT00121719|13184275|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358354|NCT00121719|13184276|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358355|NCT00121719|13184263|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358356|NCT00121719|13184264|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358357|NCT00121719|13184265|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
5358358|NCT00121719|13184266|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
5358359|NCT00121719|13184267|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358360|NCT00121719|13184268|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358361|NCT00121719|13184269|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358362|NCT00121719|13184270|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358363|NCT00121719|13184271|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358364|NCT00121719|13184272|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358365|NCT00121719|13184273|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358366|NCT00121719|13184274|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358367|NCT00121719|13184275|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358368|NCT00121719|13184276|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
5358369|NCT00121719|13184263|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358370|NCT00121719|13184264|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358371|NCT00121719|13184265|P12|STARTED|Food-Effect Pilot Study (4 Weeks)||5
5358372|NCT00121719|13184266|P11|STARTED|Food-Effect Pilot Study (4 Weeks)||6
5358373|NCT00121719|13184267|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358374|NCT00121719|13184268|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358375|NCT00121719|13184269|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358376|NCT00121719|13184270|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358377|NCT00121719|13184271|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358378|NCT00121719|13184272|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358379|NCT00121719|13184273|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358380|NCT00121719|13184274|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358381|NCT00121719|13184275|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358382|NCT00121719|13184276|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
5358383|NCT00121719|13184263|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358384|NCT00121719|13184264|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358385|NCT00121719|13184265|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358386|NCT00121719|13184266|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358387|NCT00121719|13184267|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358388|NCT00121719|13184268|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358389|NCT00121719|13184269|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358390|NCT00121719|13184270|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358391|NCT00121719|13184271|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358392|NCT00121719|13184272|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358393|NCT00121719|13184273|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358394|NCT00121719|13184274|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358395|NCT00121719|13184275|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358396|NCT00121719|13184276|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||0
5358397|NCT00121719|13184263|P14|COMPLETED|Dose Escalation (4 Weeks)||7
5358398|NCT00121719|13184264|P13|COMPLETED|Dose Escalation (4 Weeks)||24
5358399|NCT00121719|13184265|P12|COMPLETED|Dose Escalation (4 Weeks)||0
5358400|NCT00121719|13184266|P11|COMPLETED|Dose Escalation (4 Weeks)||0
5358401|NCT00121719|13184267|P10|COMPLETED|Dose Escalation (4 Weeks)||3
5358402|NCT00121719|13184268|P9|COMPLETED|Dose Escalation (4 Weeks)||6
5358403|NCT00121719|13184269|P8|COMPLETED|Dose Escalation (4 Weeks)||9
5358404|NCT00121719|13184270|P7|COMPLETED|Dose Escalation (4 Weeks)||12
5358405|NCT00121719|13184271|P6|COMPLETED|Dose Escalation (4 Weeks)||3
5358406|NCT00121719|13184272|P5|COMPLETED|Dose Escalation (4 Weeks)||3
5358407|NCT00121719|13184273|P4|COMPLETED|Dose Escalation (4 Weeks)||3
5358408|NCT00121719|13184274|P3|COMPLETED|Dose Escalation (4 Weeks)||4
5358409|NCT00121719|13184275|P2|COMPLETED|Dose Escalation (4 Weeks)||4
5358410|NCT00121719|13184276|P1|COMPLETED|Dose Escalation (4 Weeks)||4
5358411|NCT00121719|13184263|P14|STARTED|Dose Escalation (4 Weeks)||7
5358412|NCT00121719|13184264|P13|STARTED|Dose Escalation (4 Weeks)||24
5358413|NCT00121719|13184265|P12|STARTED|Dose Escalation (4 Weeks)||0
5358414|NCT00121719|13184266|P11|STARTED|Dose Escalation (4 Weeks)||0
5358415|NCT00121719|13184267|P10|STARTED|Dose Escalation (4 Weeks)||3
5358416|NCT00121719|13184268|P9|STARTED|Dose Escalation (4 Weeks)||6
5358417|NCT00121719|13184269|P8|STARTED|Dose Escalation (4 Weeks)||9
5358418|NCT00121719|13184270|P7|STARTED|Dose Escalation (4 Weeks)||12
5358419|NCT00121719|13184271|P6|STARTED|Dose Escalation (4 Weeks)||3
5358420|NCT00121719|13184272|P5|STARTED|Dose Escalation (4 Weeks)||3
5358421|NCT00121719|13184273|P4|STARTED|Dose Escalation (4 Weeks)||3
5358422|NCT00121719|13184274|P3|STARTED|Dose Escalation (4 Weeks)||4
5358423|NCT00121719|13184275|P2|STARTED|Dose Escalation (4 Weeks)||4
5358424|NCT00121719|13184276|P1|STARTED|Dose Escalation (4 Weeks)||4
5358425|NCT00121667|13184467|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
5358426|NCT00121667|13184468|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
5358427|NCT00121667|13184469|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
5358428|NCT00121667|13184470|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
5358429|NCT00121667|13184467|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
5358430|NCT00121667|13184468|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
5358431|NCT00121667|13184469|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
5358432|NCT00121667|13184470|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
5358433|NCT00121667|13184467|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
5358434|NCT00121667|13184468|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
5358435|NCT00121667|13184469|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
5358436|NCT00121667|13184470|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
5358437|NCT00121667|13184467|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
5358438|NCT00121667|13184468|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
5358439|NCT00121667|13184469|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
5358440|NCT00121667|13184470|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
5358441|NCT00121667|13184467|P4|NOT COMPLETED|Short Term (ST) Period||67
5358442|NCT00121667|13184468|P3|NOT COMPLETED|Short Term (ST) Period||41
5358443|NCT00121667|13184469|P2|NOT COMPLETED|Short Term (ST) Period||48
5358444|NCT00121667|13184470|P1|NOT COMPLETED|Short Term (ST) Period||44
5358445|NCT00121667|13184467|P4|COMPLETED|Short Term (ST) Period||112
5358446|NCT00121667|13184468|P3|COMPLETED|Short Term (ST) Period||140
5358447|NCT00121667|13184469|P2|COMPLETED|Short Term (ST) Period||143
5358448|NCT00121667|13184470|P1|COMPLETED|Short Term (ST) Period||148
5358449|NCT00121667|13184467|P4|STARTED|Short Term (ST) Period||179
5358450|NCT00121667|13184468|P3|STARTED|Short Term (ST) Period||181
5358451|NCT00121667|13184469|P2|STARTED|Short Term (ST) Period||191
5358452|NCT00121667|13184470|P1|STARTED|Short Term (ST) Period||192
5358453|NCT00121641|13184568|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
5358454|NCT00121641|13184569|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
5358455|NCT00121641|13184570|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
5358456|NCT00121641|13184571|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
5358457|NCT00121641|13184572|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
5358458|NCT00121641|13184568|P5|COMPLETED|48-month Short Term + Long Term Period||8
5358459|NCT00121641|13184569|P4|COMPLETED|48-month Short Term + Long Term Period||24
5358460|NCT00121641|13184570|P3|COMPLETED|48-month Short Term + Long Term Period||28
5358461|NCT00121641|13184571|P2|COMPLETED|48-month Short Term + Long Term Period||24
5358462|NCT00121641|13184572|P1|COMPLETED|48-month Short Term + Long Term Period||23
5358463|NCT00121641|13184568|P5|STARTED|48-month Short Term + Long Term Period||66
5358464|NCT00121641|13184569|P4|STARTED|48-month Short Term + Long Term Period||95
5358465|NCT00121641|13184570|P3|STARTED|48-month Short Term + Long Term Period||98
5358466|NCT00121641|13184571|P2|STARTED|48-month Short Term + Long Term Period||106
5358467|NCT00121641|13184572|P1|STARTED|48-month Short Term + Long Term Period||102
5358468|NCT00121641|13184568|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
5358469|NCT00121641|13184569|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
5358470|NCT00121641|13184570|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
5358471|NCT00121641|13184571|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
5358472|NCT00121641|13184572|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
5358473|NCT00121641|13184568|P5|COMPLETED|24-week Short-term Treatment Period||25
5358474|NCT00121641|13184569|P4|COMPLETED|24-week Short-term Treatment Period||55
5358475|NCT00121641|13184570|P3|COMPLETED|24-week Short-term Treatment Period||69
5358476|NCT00121641|13184571|P2|COMPLETED|24-week Short-term Treatment Period||68
5358477|NCT00121641|13184572|P1|COMPLETED|24-week Short-term Treatment Period||73
5358478|NCT00121641|13184568|P5|STARTED|24-week Short-term Treatment Period||66
5358479|NCT00121641|13184569|P4|STARTED|24-week Short-term Treatment Period||95
5358480|NCT00121641|13184570|P3|STARTED|24-week Short-term Treatment Period||98
5358481|NCT00121641|13184571|P2|STARTED|24-week Short-term Treatment Period||106
5358482|NCT00121641|13184572|P1|STARTED|24-week Short-term Treatment Period||102
5358483|NCT00121485|13184685|P2|NOT COMPLETED|Overall Study||7
5358484|NCT00121485|13184686|P1|NOT COMPLETED|Overall Study||1
5358485|NCT00121485|13184685|P2|COMPLETED|Overall Study||59
5358486|NCT00121485|13184686|P1|COMPLETED|Overall Study||133
5358487|NCT00121485|13184685|P2|STARTED|Overall Study||66
5358488|NCT00121485|13184686|P1|STARTED|Overall Study||134
5358489|NCT00121472|13184720|P1|NOT COMPLETED|Overall Study||0
5358490|NCT00121472|13184720|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
5358491|NCT00121472|13184720|P1|STARTED|Overall Study||194
5358492|NCT00121238|13184731|P1|NOT COMPLETED|Overall Study||3
5358493|NCT00121238|13184731|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
5358494|NCT00121238|13184731|P1|STARTED|Overall Study||16
5358495|NCT00121225|13184739|P1|NOT COMPLETED|Overall Study||0
5358496|NCT00121225|13184739|P1|COMPLETED|Overall Study||32
5358497|NCT00121225|13184739|P1|STARTED|Overall Study||32
5358498|NCT00121199|13184747|P1|NOT COMPLETED|Overall Study||28
5358499|NCT00121199|13184747|P1|COMPLETED|Overall Study||45
5358500|NCT00121199|13184747|P1|Eligible and Began Protocol Therapy|Overall Study||64
5358501|NCT00121199|13184747|P1|Eligible|Overall Study||64
5358502|NCT00121199|13184747|P1|STARTED|Overall Study||73
5358503|NCT00121186|13184754|P1|NOT COMPLETED|Overall Study||0
5358504|NCT00121186|13184754|P1|COMPLETED|Overall Study||1
5358505|NCT00121186|13184754|P1|STARTED|Overall Study||1
5358506|NCT00121173|13184762|P3|NOT COMPLETED|Overall Study||0
5358507|NCT00121173|13184763|P2|NOT COMPLETED|Overall Study||0
5358508|NCT00121173|13184764|P1|NOT COMPLETED|Overall Study||1
5358509|NCT00121173|13184762|P3|COMPLETED|Overall Study||9
5358510|NCT00121173|13184763|P2|COMPLETED|Overall Study||3
5358511|NCT00121173|13184764|P1|COMPLETED|Overall Study||3
5358512|NCT00121173|13184762|P3|STARTED|Overall Study||9
5358513|NCT00121173|13184763|P2|STARTED|Overall Study||3
5358514|NCT00121173|13184764|P1|STARTED|Overall Study||4
5358515|NCT00121134|13184791|P4|NOT COMPLETED|Overall Study||9
5358516|NCT00121134|13184792|P3|NOT COMPLETED|Overall Study||21
5358517|NCT00121134|13184793|P2|NOT COMPLETED|Overall Study||15
5358518|NCT00121134|13184794|P1|NOT COMPLETED|Overall Study||16
5358519|NCT00121134|13184791|P4|COMPLETED|Overall Study||31
5358520|NCT00121134|13184792|P3|COMPLETED|Overall Study||20
5358521|NCT00121134|13184793|P2|COMPLETED|Overall Study||26
5358522|NCT00121134|13184794|P1|COMPLETED|Overall Study||24
5358523|NCT00121134|13184791|P4|STARTED|Overall Study||40
5358524|NCT00121134|13184792|P3|STARTED|Overall Study||41
5358525|NCT00121134|13184793|P2|STARTED|Overall Study||41
5358526|NCT00121134|13184794|P1|STARTED|Overall Study||40
5358527|NCT00120874|13184806|P2|NOT COMPLETED|Overall Study||1
5358528|NCT00120874|13184807|P1|NOT COMPLETED|Overall Study||0
5358529|NCT00120874|13184806|P2|COMPLETED|Overall Study||9
5358530|NCT00120874|13184807|P1|COMPLETED|Overall Study||10
5358531|NCT00120874|13184806|P2|Completed Study; Started Extension Study|Overall Study||10
5358532|NCT00120874|13184807|P1|Completed Study; Started Extension Study|Overall Study||10
5358533|NCT00120874|13184806|P2|STARTED|Overall Study||10
5358534|NCT00120874|13184807|P1|STARTED|Overall Study||10
5358535|NCT00120627|13184845|P2|NOT COMPLETED|Overall Study||5
5358536|NCT00120627|13184846|P1|NOT COMPLETED|Overall Study||5
5358537|NCT00120627|13184845|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
5358538|NCT00120627|13184846|P1|COMPLETED|Overall Study||66
5358539|NCT00120627|13184845|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
5358540|NCT00120627|13184846|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
5358541|NCT00120627|13184845|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
5358542|NCT00120627|13184846|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
5358543|NCT00120627|13184845|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
5358544|NCT00120627|13184846|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
5358545|NCT00120523|13184872|P2|NOT COMPLETED|Follow-Up Period||24
5358546|NCT00120523|13184873|P1|NOT COMPLETED|Follow-Up Period||30
5358547|NCT00120523|13184872|P2|COMPLETED|Follow-Up Period||46
5358548|NCT00120523|13184873|P1|COMPLETED|Follow-Up Period||90
5358549|NCT00120523|13184872|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
5358550|NCT00120523|13184873|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
5358551|NCT00120523|13184872|P2|NOT COMPLETED|Treatment Period||339
5358552|NCT00120523|13184873|P1|NOT COMPLETED|Treatment Period||369
5358553|NCT00120523|13184872|P2|COMPLETED|Treatment Period||874
5358554|NCT00120523|13184873|P1|COMPLETED|Treatment Period||836
5358555|NCT00120523|13184872|P2|STARTED|Treatment Period||1213
5358556|NCT00120523|13184873|P1|STARTED|Treatment Period||1205
5358557|NCT00120406|13184897|P2|NOT COMPLETED|Overall Study||16
5358558|NCT00120406|13184898|P1|NOT COMPLETED|Overall Study||19
5358559|NCT00120406|13184897|P2|COMPLETED|Overall Study||222
5358560|NCT00120406|13184898|P1|COMPLETED|Overall Study||217
5358561|NCT00120406|13184897|P2|STARTED|Overall Study||238
5358562|NCT00120406|13184898|P1|STARTED|Overall Study||236
5358563|NCT00120289|13184908|P2|NOT COMPLETED|Overall Study||109
5358564|NCT00120289|13184909|P1|NOT COMPLETED|Overall Study||121
5358565|NCT00120289|13184908|P2|COMPLETED|Overall Study||1587
5358566|NCT00120289|13184909|P1|COMPLETED|Overall Study||1597
5358567|NCT00120289|13184908|P2|STARTED|Overall Study||1696
5358568|NCT00120289|13184909|P1|STARTED|Overall Study||1718
5358569|NCT00120250|13184921|P2|NOT COMPLETED|Overall Study||2
5358570|NCT00120250|13184922|P1|NOT COMPLETED|Overall Study||1
5358571|NCT00120250|13184921|P2|COMPLETED|Overall Study||12
5358572|NCT00120250|13184922|P1|COMPLETED|Overall Study||12
5358573|NCT00120250|13184921|P2|STARTED|Overall Study||14
5358574|NCT00120250|13184922|P1|STARTED|Overall Study||13
5358575|NCT00120042|13184938|P3|NOT COMPLETED|Overall Study||0
5358576|NCT00120042|13184939|P2|NOT COMPLETED|Overall Study||0
5358577|NCT00120042|13184940|P1|NOT COMPLETED|Overall Study||0
5358578|NCT00120042|13184938|P3|COMPLETED|Overall Study||83
5358579|NCT00120042|13184939|P2|COMPLETED|Overall Study||83
5358580|NCT00120042|13184940|P1|COMPLETED|Overall Study||85
5358581|NCT00120042|13184938|P3|STARTED|Overall Study||83
5358582|NCT00120042|13184939|P2|STARTED|Overall Study||83
5358583|NCT00120042|13184940|P1|STARTED|Overall Study||85
5358584|NCT00119847|13184950|P2|NOT COMPLETED|Overall Study||32
5358585|NCT00119847|13184951|P1|NOT COMPLETED|Overall Study||31
5358586|NCT00119847|13184950|P2|COMPLETED|Overall Study||119
5358587|NCT00119847|13184951|P1|COMPLETED|Overall Study||118
5358588|NCT00119847|13184950|P2|STARTED|Overall Study||151
5358589|NCT00119847|13184951|P1|STARTED|Overall Study||149
5358590|NCT00119678|13184963|P2|NOT COMPLETED|Open-label Treatment Period||0
5358591|NCT00119678|13184964|P1|NOT COMPLETED|Open-label Treatment Period||110
5358592|NCT00119678|13184963|P2|COMPLETED|Open-label Treatment Period||0
5358593|NCT00119678|13184964|P1|COMPLETED|Open-label Treatment Period||0
5358594|NCT00119678|13184963|P2|STARTED|Open-label Treatment Period||0
5358595|NCT00119678|13184964|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
5358596|NCT00119678|13184963|P2|NOT COMPLETED|Double-blind Treatment Period||26
5358597|NCT00119678|13184964|P1|NOT COMPLETED|Double-blind Treatment Period||41
5358598|NCT00119678|13184963|P2|COMPLETED|Double-blind Treatment Period||35
5358599|NCT00119678|13184964|P1|COMPLETED|Double-blind Treatment Period||81
5358600|NCT00119678|13184963|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
5358601|NCT00119678|13184964|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
5358602|NCT00119678|13184963|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
5358603|NCT00119678|13184964|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
5358604|NCT00119678|13184963|P2|STARTED|Double-blind Treatment Period||61
5358605|NCT00119678|13184964|P1|STARTED|Double-blind Treatment Period||122
5358606|NCT00119405|13185010|P1|NOT COMPLETED|Overall Study||1
5358607|NCT00119405|13185010|P1|COMPLETED|Overall Study||17
5358608|NCT00119405|13185010|P1|STARTED|Overall Study||18
5358609|NCT00119392|13185014|P1|NOT COMPLETED|Overall Study||5
5358610|NCT00119392|13185014|P1|COMPLETED|Overall Study||40
5358611|NCT00119392|13185014|P1|STARTED|Overall Study||45
5358612|NCT00119379|13185024|P2|NOT COMPLETED|Overall Study||1
5358613|NCT00119379|13185025|P1|NOT COMPLETED|Overall Study||4
5358614|NCT00119379|13185024|P2|COMPLETED|Overall Study||23
5358615|NCT00119379|13185025|P1|COMPLETED|Overall Study||22
5358616|NCT00119379|13185024|P2|STARTED|Overall Study||24
5358617|NCT00119379|13185025|P1|STARTED|Overall Study||26
5358618|NCT00119262|13185043|P2|NOT COMPLETED|Overall Study||58
5358619|NCT00119262|13185044|P1|NOT COMPLETED|Overall Study||46
5358620|NCT00119262|13185043|P2|COMPLETED|Overall Study||64
5358621|NCT00119262|13185044|P1|COMPLETED|Overall Study||58
5358622|NCT00119262|13185043|P2|Eligible and Treated|Overall Study||119
5358623|NCT00119262|13185044|P1|Eligible and Treated|Overall Study||102
5358624|NCT00119262|13185043|P2|Treated|Overall Study||120
5358625|NCT00119262|13185044|P1|Treated|Overall Study||103
5358626|NCT00119262|13185043|P2|Eligible|Overall Study||120
5358627|NCT00119262|13185044|P1|Eligible|Overall Study||103
5358628|NCT00119262|13185043|P2|STARTED|Overall Study||122
5358629|NCT00119262|13185044|P1|STARTED|Overall Study||104
5358630|NCT00119158|13185056|P2|NOT COMPLETED|Placebo Treatment||0
5358631|NCT00119158|13185057|P1|NOT COMPLETED|Placebo Treatment||0
5358632|NCT00119158|13185056|P2|COMPLETED|Placebo Treatment||45
5358633|NCT00119158|13185057|P1|COMPLETED|Placebo Treatment||45
5358634|NCT00119158|13185056|P2|STARTED|Placebo Treatment||45
5358635|NCT00119158|13185057|P1|STARTED|Placebo Treatment||45
5358636|NCT00119158|13185056|P2|NOT COMPLETED|Active Treatment||0
5358637|NCT00119158|13185057|P1|NOT COMPLETED|Active Treatment||0
5358638|NCT00119158|13185056|P2|COMPLETED|Active Treatment||45
5358639|NCT00119158|13185057|P1|COMPLETED|Active Treatment||45
5358640|NCT00119158|13185056|P2|STARTED|Active Treatment||45
5358641|NCT00119158|13185057|P1|STARTED|Active Treatment|patients are self controls|45
5358642|NCT00119041|13185068|P3|NOT COMPLETED|Overall Study||0
5358643|NCT00119041|13185069|P2|NOT COMPLETED|Overall Study||0
5358644|NCT00119041|13185070|P1|NOT COMPLETED|Overall Study||0
5358645|NCT00119041|13185068|P3|COMPLETED|Overall Study||22
5358646|NCT00119041|13185069|P2|COMPLETED|Overall Study||83
5358647|NCT00119041|13185070|P1|COMPLETED|Overall Study||199
5358648|NCT00119041|13185068|P3|STARTED|Overall Study||22
5358649|NCT00119041|13185069|P2|STARTED|Overall Study||83
5358650|NCT00119041|13185070|P1|STARTED|Overall Study||199
5358651|NCT00119015|13185081|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
5358652|NCT00119015|13185082|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
5358653|NCT00119015|13185083|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
5358654|NCT00119015|13185081|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
5358655|NCT00119015|13185082|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
5358656|NCT00119015|13185083|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
5358657|NCT00119015|13185081|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
5358658|NCT00119015|13185082|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
5358659|NCT00119015|13185083|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
5358660|NCT00119015|13185081|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
5358661|NCT00119015|13185082|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
5358662|NCT00119015|13185083|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
5358663|NCT00119015|13185081|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
5358664|NCT00119015|13185082|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
5358665|NCT00119015|13185083|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
5358666|NCT00119015|13185081|P3|STARTED|Open-Label Phase (2 Weeks)||0
5358667|NCT00119015|13185082|P2|STARTED|Open-Label Phase (2 Weeks)||0
5358668|NCT00119015|13185083|P1|STARTED|Open-Label Phase (2 Weeks)||102
5358669|NCT00118911|13185099|P2|NOT COMPLETED|Overall Study||5
5358670|NCT00118911|13185100|P1|NOT COMPLETED|Overall Study||2
5358671|NCT00118911|13185099|P2|COMPLETED|Overall Study||38
5358672|NCT00118911|13185100|P1|COMPLETED|Overall Study||41
5358673|NCT00118911|13185099|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
5358674|NCT00118911|13185100|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
5358675|NCT00118911|13185099|P2|6 Month Follow-up|Overall Study||30
5358676|NCT00118911|13185100|P1|6 Month Follow-up|Overall Study||37
5358677|NCT00118911|13185099|P2|Completed Post-Treatment Assessment|Overall Study||37
5358678|NCT00118911|13185100|P1|Completed Post-Treatment Assessment|Overall Study||41
5358679|NCT00118911|13185099|P2|Received Intervention as Assigned|Overall Study||38
5358680|NCT00118911|13185100|P1|Received Intervention as Assigned|Overall Study||41
5358681|NCT00118911|13185099|P2|STARTED|Overall Study||43
5358682|NCT00118911|13185100|P1|STARTED|Overall Study||43
5358683|NCT00118898|13185112|P4|NOT COMPLETED|Overall Study||141
5358684|NCT00118898|13185113|P3|NOT COMPLETED|Overall Study||123
5358685|NCT00118898|13185114|P2|NOT COMPLETED|Overall Study||141
5358686|NCT00118898|13185115|P1|NOT COMPLETED|Overall Study||121
5358687|NCT00118898|13185112|P4|COMPLETED|Overall Study||322
5358688|NCT00118898|13185113|P3|COMPLETED|Overall Study||342
5358689|NCT00118898|13185114|P2|COMPLETED|Overall Study||324
5358690|NCT00118898|13185115|P1|COMPLETED|Overall Study||343
5358691|NCT00118898|13185112|P4|Initiated Treatment|Overall Study||462
5358692|NCT00118898|13185113|P3|Initiated Treatment|Overall Study||464
5358693|NCT00118898|13185114|P2|Initiated Treatment|Overall Study||461
5358694|NCT00118898|13185115|P1|Initiated Treatment|Overall Study||461
5358695|NCT00118898|13185112|P4|STARTED|Overall Study||463
5358696|NCT00118898|13185113|P3|STARTED|Overall Study||465
5358697|NCT00118898|13185114|P2|STARTED|Overall Study||465
5358698|NCT00118898|13185115|P1|STARTED|Overall Study||464
5358699|NCT00118755|13185211|P2|NOT COMPLETED|Overall Study||215
5358700|NCT00118755|13185212|P1|NOT COMPLETED|Overall Study||210
5358701|NCT00118755|13185211|P2|COMPLETED|Overall Study||3
5358702|NCT00118755|13185212|P1|COMPLETED|Overall Study||7
5358703|NCT00118755|13185211|P2|Safety Population|Overall Study||211
5358704|NCT00118755|13185212|P1|Safety Population|Overall Study||208
5358705|NCT00118755|13185211|P2|STARTED|Overall Study||218
5358706|NCT00118755|13185212|P1|STARTED|Overall Study||217
5358707|NCT00118742|13185226|P2|NOT COMPLETED|Overall Study||66
5358708|NCT00118742|13185227|P1|NOT COMPLETED|Overall Study||49
5358709|NCT00118742|13185226|P2|COMPLETED|Overall Study||82
5358710|NCT00118742|13185227|P1|COMPLETED|Overall Study||96
5358711|NCT00118742|13185226|P2|STARTED|Overall Study||148
5358712|NCT00118742|13185227|P1|STARTED|Overall Study||145
5358713|NCT00118716|13185241|P2|NOT COMPLETED|Overall Study||22
5358714|NCT00118716|13185242|P1|NOT COMPLETED|Overall Study||13
5358715|NCT00118716|13185241|P2|COMPLETED|Overall Study||102
5358716|NCT00118716|13185242|P1|COMPLETED|Overall Study||111
5358717|NCT00118716|13185241|P2|STARTED|Overall Study||124
5358718|NCT00118716|13185242|P1|STARTED|Overall Study||124
5358719|NCT00118703|13185262|P2|NOT COMPLETED|Overall Study||9
5358720|NCT00118703|13185263|P1|NOT COMPLETED|Overall Study||5
5358721|NCT00118703|13185262|P2|COMPLETED|Overall Study||165
5358722|NCT00118703|13185263|P1|COMPLETED|Overall Study||168
5358723|NCT00118703|13185262|P2|STARTED|Overall Study||174
5358724|NCT00118703|13185263|P1|STARTED|Overall Study||173
5358725|NCT00118534|13185275|P2|NOT COMPLETED|Overall Study||0
5358726|NCT00118534|13185276|P1|NOT COMPLETED|Overall Study||0
5358727|NCT00118534|13185275|P2|COMPLETED|Overall Study||471
5358728|NCT00118534|13185276|P1|COMPLETED|Overall Study||472
5358729|NCT00118534|13185275|P2|STARTED|Overall Study||471
5358730|NCT00118534|13185276|P1|STARTED|Overall Study||472
5358731|NCT00118482|13185360|P2|NOT COMPLETED|Overall Study||29
5358732|NCT00118482|13185361|P1|NOT COMPLETED|Overall Study||30
5358733|NCT00118482|13185360|P2|COMPLETED|Overall Study||76
5358734|NCT00118482|13185361|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
5358735|NCT00118482|13185360|P2|STARTED|Overall Study||105
5358736|NCT00118482|13185361|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
5358737|NCT00118430|13185376|P3|NOT COMPLETED|Overall Study||28
5358738|NCT00118430|13185377|P2|NOT COMPLETED|Overall Study||24
5358739|NCT00118430|13185378|P1|NOT COMPLETED|Overall Study||21
5358740|NCT00118430|13185376|P3|COMPLETED|Overall Study||222
5358741|NCT00118430|13185377|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
5358742|NCT00118430|13185378|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
5358743|NCT00118430|13185376|P3|STARTED|Overall Study||250
5358744|NCT00118430|13185377|P2|STARTED|Overall Study||127
5358745|NCT00118430|13185378|P1|STARTED|Overall Study||123
5358746|NCT00118417|13185393|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
5358747|NCT00118417|13185394|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
5358748|NCT00118417|13185393|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
5358749|NCT00118417|13185394|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
5358750|NCT00118417|13185393|P2|STARTED|Phase III (Weeks 12 to 24)||10
5358751|NCT00118417|13185394|P1|STARTED|Phase III (Weeks 12 to 24)||9
5358752|NCT00118417|13185393|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
5358753|NCT00118417|13185394|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
5358754|NCT00118417|13185393|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
5358755|NCT00118417|13185394|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
5358756|NCT00118417|13185393|P2|STARTED|Phase II (Weeks 6 to 12)||13
5358757|NCT00118417|13185394|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
5358758|NCT00118417|13185393|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
5358759|NCT00118417|13185394|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
5358760|NCT00118417|13185393|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
5358761|NCT00118417|13185394|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
5358762|NCT00118417|13185393|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
5358763|NCT00118417|13185394|P1|STARTED|Phase I (Weeks 0 to 6)||39
5358764|NCT00118404|13185407|P3|NOT COMPLETED|Overall Study||20
5358765|NCT00118404|13185408|P2|NOT COMPLETED|Overall Study||16
5358766|NCT00118404|13185409|P1|NOT COMPLETED|Overall Study||24
5358767|NCT00118404|13185407|P3|COMPLETED|Overall Study||49
5358768|NCT00118404|13185408|P2|COMPLETED|Overall Study||70
5358769|NCT00118404|13185409|P1|COMPLETED|Overall Study||62
5358770|NCT00118404|13185407|P3|STARTED|Overall Study||69
5358771|NCT00118404|13185408|P2|STARTED|Overall Study||86
5358772|NCT00118404|13185409|P1|STARTED|Overall Study||86
5358773|NCT00118378|13185425|P2|NOT COMPLETED|Overall Study||8
5358774|NCT00118378|13185426|P1|NOT COMPLETED|Overall Study||2
5358775|NCT00118378|13185425|P2|COMPLETED|Overall Study||45
5358776|NCT00118378|13185426|P1|COMPLETED|Overall Study||60
5358777|NCT00118378|13185425|P2|STARTED|Overall Study||53
5358778|NCT00118378|13185426|P1|STARTED|Overall Study||62
5358779|NCT00118365|13185440|P2|NOT COMPLETED|Overall Study||60
5358780|NCT00118365|13185441|P1|NOT COMPLETED|Overall Study||59
5358781|NCT00118365|13185440|P2|COMPLETED|Overall Study||124
5358782|NCT00118365|13185441|P1|COMPLETED|Overall Study||132
5358783|NCT00118365|13185440|P2|STARTED|Overall Study||184
5358784|NCT00118365|13185441|P1|STARTED|Overall Study||191
5358785|NCT00118352|13185510|P3|NOT COMPLETED|Overall Study||0
5358786|NCT00118352|13185511|P2|NOT COMPLETED|Overall Study||0
5358787|NCT00118352|13185512|P1|NOT COMPLETED|Overall Study||0
5358788|NCT00118352|13185510|P3|COMPLETED|Overall Study||0
5358789|NCT00118352|13185511|P2|COMPLETED|Overall Study||0
5358790|NCT00118352|13185512|P1|COMPLETED|Overall Study||12
5358791|NCT00118352|13185510|P3|STARTED|Overall Study||0
5358792|NCT00118352|13185511|P2|STARTED|Overall Study||0
5358793|NCT00118352|13185512|P1|STARTED|Overall Study||12
5358794|NCT00118287|13185538|P1|NOT COMPLETED|Overall Study||2
5358795|NCT00118287|13185538|P1|COMPLETED|Overall Study||30
5358796|NCT00118287|13185538|P1|STARTED|Overall Study||32
5358797|NCT00118248|13185544|P2|NOT COMPLETED|Overall Study||0
5358798|NCT00118248|13185545|P1|NOT COMPLETED|Overall Study||0
5358799|NCT00118248|13185544|P2|COMPLETED|Overall Study||24
5358800|NCT00118248|13185545|P1|COMPLETED|Overall Study||17
5358801|NCT00118248|13185544|P2|STARTED|Overall Study||24
5358802|NCT00118248|13185545|P1|STARTED|Overall Study||17
5358803|NCT00118209|13185560|P2|NOT COMPLETED|Overall Study||21
5358804|NCT00118209|13185561|P1|NOT COMPLETED|Overall Study||12
5358805|NCT00118209|13185560|P2|COMPLETED|Overall Study||241
5358806|NCT00118209|13185561|P1|COMPLETED|Overall Study||250
5358807|NCT00118209|13185560|P2|Evaluable for Safety Analysis|Overall Study||237
5358808|NCT00118209|13185561|P1|Evaluable for Safety Analysis|Overall Study||243
5358809|NCT00118209|13185560|P2|Evaluable for Primary Endpoint|Overall Study||241
5358810|NCT00118209|13185561|P1|Evaluable for Primary Endpoint|Overall Study||250
5358811|NCT00118209|13185560|P2|STARTED|Overall Study||262
5358812|NCT00118209|13185561|P1|STARTED|Overall Study||262
5358813|NCT00118157|13185571|P1|NOT COMPLETED|Overall Study||12
5358814|NCT00118157|13185571|P1|COMPLETED|Overall Study||7
5358815|NCT00118157|13185571|P1|STARTED|Overall Study||19
5358816|NCT00118144|13185576|P1|NOT COMPLETED|Overall Study||1
5358817|NCT00118144|13185576|P1|COMPLETED|Overall Study||41
5358818|NCT00118144|13185576|P1|STARTED|Overall Study||42
5358819|NCT00118131|13185582|P1|NOT COMPLETED|Overall Study||0
5358820|NCT00118131|13185582|P1|COMPLETED|Overall Study||49
5358821|NCT00118131|13185582|P1|STARTED|Overall Study||49
5358822|NCT00118092|13185589|P1|NOT COMPLETED|Overall Study||2
5358823|NCT00118092|13185589|P1|COMPLETED|Overall Study||15
5358824|NCT00118092|13185589|P1|STARTED|Overall Study||17
5358825|NCT00118053|13185597|P1|NOT COMPLETED|Overall Study||0
5358826|NCT00118053|13185597|P1|COMPLETED|Overall Study||5
5358827|NCT00118053|13185597|P1|STARTED|Overall Study||5
5358828|NCT00118040|13185607|P3|NOT COMPLETED|Overall Study||6
5358829|NCT00118040|13185608|P2|NOT COMPLETED|Overall Study||2
5358830|NCT00118040|13185609|P1|NOT COMPLETED|Overall Study||1
5358831|NCT00118040|13185607|P3|COMPLETED|Overall Study||14
5358832|NCT00118040|13185608|P2|COMPLETED|Overall Study||18
5358833|NCT00118040|13185609|P1|COMPLETED|Overall Study||19
5358834|NCT00118040|13185607|P3|STARTED|Overall Study||20
5358835|NCT00118040|13185608|P2|STARTED|Overall Study||20
5358836|NCT00118040|13185609|P1|STARTED|Overall Study||20
5358837|NCT00117988|13185670|P1|NOT COMPLETED|Overall Study||4
5358838|NCT00117988|13185670|P1|COMPLETED|Overall Study||18
5358839|NCT00117988|13185670|P1|STARTED|Overall Study||22
5358840|NCT00117962|13185676|P2|NOT COMPLETED|Overall Study||25
5358841|NCT00117962|13185677|P1|NOT COMPLETED|Overall Study||22
5358842|NCT00117962|13185676|P2|COMPLETED|Overall Study||28
5358843|NCT00117962|13185677|P1|COMPLETED|Overall Study||26
5358844|NCT00117962|13185676|P2|STARTED|Overall Study||53
5358845|NCT00117962|13185677|P1|STARTED|Overall Study||48
5358846|NCT00117949|13185693|P4|NOT COMPLETED|Overall Study||24
5358847|NCT00117949|13185694|P3|NOT COMPLETED|Overall Study||24
5358848|NCT00117949|13185695|P2|NOT COMPLETED|Overall Study||24
5358849|NCT00117949|13185696|P1|NOT COMPLETED|Overall Study||10
5358850|NCT00117949|13185693|P4|COMPLETED|Overall Study||0
5358851|NCT00117949|13185694|P3|COMPLETED|Overall Study||0
5358852|NCT00117949|13185695|P2|COMPLETED|Overall Study||0
5358853|NCT00117949|13185696|P1|COMPLETED|Overall Study||0
5358854|NCT00117949|13185693|P4|STARTED|Overall Study||24
5358855|NCT00117949|13185694|P3|STARTED|Overall Study||24
5358856|NCT00117949|13185695|P2|STARTED|Overall Study||24
5358857|NCT00117949|13185696|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
5358858|NCT00117845|13185730|P1|NOT COMPLETED|Overall Study||1
5358859|NCT00117845|13185730|P1|COMPLETED|Overall Study||16
5358860|NCT00117845|13185730|P1|STARTED|Overall Study||17
5358861|NCT00117806|13185737|P2|NOT COMPLETED|Overall Study||16
5358862|NCT00117806|13185738|P1|NOT COMPLETED|Overall Study||38
5358863|NCT00117806|13185737|P2|COMPLETED|Overall Study||60
5358864|NCT00117806|13185738|P1|COMPLETED|Overall Study||43
5358865|NCT00117806|13185737|P2|STARTED|Overall Study||76
5358866|NCT00117806|13185738|P1|STARTED|Overall Study||81
5358867|NCT00117793|13185748|P1|NOT COMPLETED|Overall Study||12
5358868|NCT00117793|13185748|P1|COMPLETED|Overall Study||5
5358869|NCT00117793|13185748|P1|STARTED|Overall Study||17
5358870|NCT00117715|13185763|P1|NOT COMPLETED|Overall Study||72
5358871|NCT00117715|13185763|P1|COMPLETED|Overall Study||49
5358872|NCT00117715|13185763|P1|5 Year|Overall Study||49
5358873|NCT00117715|13185763|P1|4.5 Year|Overall Study||55
5358874|NCT00117715|13185763|P1|4 Year|Overall Study||58
5358875|NCT00117715|13185763|P1|3.5 Year|Overall Study||60
5358876|NCT00117715|13185763|P1|3 Year|Overall Study||61
5358877|NCT00117715|13185763|P1|2.5 Year|Overall Study||70
5358878|NCT00117715|13185763|P1|2 Year|Overall Study||76
5358879|NCT00117715|13185763|P1|1.5 Year|Overall Study||85
5358880|NCT00117715|13185763|P1|1 Year|Overall Study||88
5358881|NCT00117715|13185763|P1|STARTED|Overall Study||121
5358882|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
5358883|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
5358884|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
5358885|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
5358886|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
5358887|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 433 - 480||82
5358888|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
5358889|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
5358890|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
5358891|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
5358892|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
5358893|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
5358894|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
5358895|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
5358896|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
5358897|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
5358898|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 337 - 384||93
5358899|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 337 - 384||183
5358900|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
5358901|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
5358902|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
5358903|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
5358904|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 289 - 336||100
5358905|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 289 - 336||192
5358906|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
5358907|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
5358908|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
5358909|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
5358910|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 241 - 288||103
5358911|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 241 - 288||202
5358912|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
5358913|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
5358914|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
5358915|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
5358916|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 193 - 240||106
5358917|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 193 - 240||209
5358918|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
5358919|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
5358920|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
5358921|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
5358922|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 145 - 192||109
5358923|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 145 - 192||219
5358924|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
5358925|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
5358926|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
5358927|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
5358928|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 97 - 144||110
5358929|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 97 - 144||225
5358930|NCT00117676|13185771|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
5358931|NCT00117676|13185772|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
5358932|NCT00117676|13185771|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
5358933|NCT00117676|13185772|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
5358934|NCT00117676|13185771|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
5358935|NCT00117676|13185772|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
5358936|NCT00117676|13185771|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
5358937|NCT00117676|13185772|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
5358938|NCT00117676|13185771|P2|COMPLETED|Double-blind Period Through Week 48||121
5358939|NCT00117676|13185772|P1|COMPLETED|Double-blind Period Through Week 48||244
5358940|NCT00117676|13185771|P2|STARTED|Double-blind Period Through Week 48||128
5358941|NCT00117676|13185772|P1|STARTED|Double-blind Period Through Week 48||254
5358942|NCT00117637|13185861|P2|NOT COMPLETED|Second Intervention (Period 2)||22
5358943|NCT00117637|13185862|P1|NOT COMPLETED|Second Intervention (Period 2)||10
5358944|NCT00117637|13185861|P2|COMPLETED|Second Intervention (Period 2)||39
5358945|NCT00117637|13185862|P1|COMPLETED|Second Intervention (Period 2)||39
5358946|NCT00117637|13185861|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
5358947|NCT00117637|13185862|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
5358948|NCT00117637|13185861|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
5358949|NCT00117637|13185862|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
5358950|NCT00117637|13185861|P2|NOT COMPLETED|First Intervention (Period 1)||25
5358951|NCT00117637|13185862|P1|NOT COMPLETED|First Intervention (Period 1)||18
5358952|NCT00117637|13185861|P2|COMPLETED|First Intervention (Period 1)||67
5358953|NCT00117637|13185862|P1|COMPLETED|First Intervention (Period 1)||79
5358954|NCT00117637|13185861|P2|Subjects Received Treatment|First Intervention (Period 1)||90
5358955|NCT00117637|13185862|P1|Subjects Received Treatment|First Intervention (Period 1)||97
5358956|NCT00117637|13185861|P2|STARTED|First Intervention (Period 1)||92
5358957|NCT00117637|13185862|P1|STARTED|First Intervention (Period 1)||97
5358958|NCT00117598|13185937|P5|NOT COMPLETED|After Treament Cross Over||4
5358959|NCT00117598|13185938|P4|NOT COMPLETED|After Treament Cross Over||3
5358960|NCT00117598|13185939|P3|NOT COMPLETED|After Treament Cross Over||0
5358961|NCT00117598|13185940|P2|NOT COMPLETED|After Treament Cross Over||0
5358962|NCT00117598|13185941|P1|NOT COMPLETED|After Treament Cross Over||0
5358963|NCT00117598|13185937|P5|COMPLETED|After Treament Cross Over||0
5358964|NCT00117598|13185938|P4|COMPLETED|After Treament Cross Over||0
5358965|NCT00117598|13185939|P3|COMPLETED|After Treament Cross Over||0
5358966|NCT00117598|13185940|P2|COMPLETED|After Treament Cross Over||0
5358967|NCT00117598|13185941|P1|COMPLETED|After Treament Cross Over||0
5358968|NCT00117598|13185937|P5|STARTED|After Treament Cross Over||4
5358969|NCT00117598|13185938|P4|STARTED|After Treament Cross Over||3
5358970|NCT00117598|13185939|P3|STARTED|After Treament Cross Over||0
5358971|NCT00117598|13185940|P2|STARTED|After Treament Cross Over||0
5358972|NCT00117598|13185941|P1|STARTED|After Treament Cross Over||0
5358973|NCT00117598|13185937|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
5358974|NCT00117598|13185938|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
5358975|NCT00117598|13185939|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
5358976|NCT00117598|13185940|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
5358977|NCT00117598|13185941|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
5358978|NCT00117598|13185937|P5|COMPLETED|Prior to Treatment Cross Over||0
5358979|NCT00117598|13185938|P4|COMPLETED|Prior to Treatment Cross Over||0
5358980|NCT00117598|13185939|P3|COMPLETED|Prior to Treatment Cross Over||4
5358981|NCT00117598|13185940|P2|COMPLETED|Prior to Treatment Cross Over||3
5358982|NCT00117598|13185941|P1|COMPLETED|Prior to Treatment Cross Over||0
5358983|NCT00117598|13185937|P5|STARTED|Prior to Treatment Cross Over||0
5358984|NCT00117598|13185938|P4|STARTED|Prior to Treatment Cross Over||0
5358985|NCT00117598|13185939|P3|STARTED|Prior to Treatment Cross Over||56
5358986|NCT00117598|13185940|P2|STARTED|Prior to Treatment Cross Over||56
5358987|NCT00117598|13185941|P1|STARTED|Prior to Treatment Cross Over||57
5358988|NCT00117585|13185969|P1|NOT COMPLETED|Overall Study||0
5358989|NCT00117585|13185969|P1|COMPLETED|Overall Study||341
5358990|NCT00117585|13185969|P1|STARTED|Overall Study||341
5358991|NCT00117572|13185975|P2|NOT COMPLETED|Overall Study||6
5358992|NCT00117572|13185976|P1|NOT COMPLETED|Overall Study||6
5358993|NCT00117572|13185975|P2|COMPLETED|Overall Study||135
5358994|NCT00117572|13185976|P1|COMPLETED|Overall Study||138
5358995|NCT00117572|13185975|P2|STARTED|Overall Study||141
5358996|NCT00117572|13185976|P1|STARTED|Overall Study||144
5358997|NCT00117559|13186008|P2|NOT COMPLETED|Overall Study||1
5358998|NCT00117559|13186009|P1|NOT COMPLETED|Overall Study||1
5358999|NCT00117559|13186008|P2|COMPLETED|Overall Study||9
5359000|NCT00117559|13186009|P1|COMPLETED|Overall Study||8
5359001|NCT00117559|13186008|P2|STARTED|Overall Study||10
5359002|NCT00117559|13186009|P1|STARTED|Overall Study||9
5359003|NCT00117338|13186017|P2|NOT COMPLETED|Overall Study||4
5359004|NCT00117338|13186018|P1|NOT COMPLETED|Overall Study||5
5359005|NCT00117338|13186017|P2|COMPLETED|Overall Study||127
5359006|NCT00117338|13186018|P1|COMPLETED|Overall Study||140
5359007|NCT00117338|13186017|P2|STARTED|Overall Study||131
5359008|NCT00117338|13186018|P1|STARTED|Overall Study||145
5359009|NCT00117325|13186038|P2|NOT COMPLETED|Overall Study||12
5359010|NCT00117325|13186039|P1|NOT COMPLETED|Overall Study||13
5359011|NCT00117325|13186038|P2|COMPLETED|Overall Study||167
5359012|NCT00117325|13186039|P1|COMPLETED|Overall Study||160
5359013|NCT00117325|13186038|P2|STARTED|Overall Study||179
5359014|NCT00117325|13186039|P1|STARTED|Overall Study||173
5359015|NCT00117312|13186071|P4|NOT COMPLETED|Overall Study||21
5359016|NCT00117312|13186072|P3|NOT COMPLETED|Overall Study||24
5359017|NCT00117312|13186073|P2|NOT COMPLETED|Overall Study||20
5359018|NCT00117312|13186074|P1|NOT COMPLETED|Overall Study||10
5359019|NCT00117312|13186071|P4|COMPLETED|Overall Study||3
5359020|NCT00117312|13186072|P3|COMPLETED|Overall Study||0
5359021|NCT00117312|13186073|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
5359022|NCT00117312|13186074|P1|COMPLETED|Overall Study||0
5359023|NCT00117312|13186071|P4|Started FE200486 CS06A|Overall Study||9
5359024|NCT00117312|13186072|P3|Started FE200486 CS06A|Overall Study||16
5359025|NCT00117312|13186073|P2|Started FE200486 CS06A|Overall Study||11
5359026|NCT00117312|13186074|P1|Started FE200486 CS06A|Overall Study||1
5359027|NCT00117312|13186071|P4|STARTED|Overall Study||24
5359028|NCT00117312|13186072|P3|STARTED|Overall Study||24
5359029|NCT00117312|13186073|P2|STARTED|Overall Study||24
5359030|NCT00117312|13186074|P1|STARTED|Overall Study||10
5359031|NCT00117286|13186090|P2|NOT COMPLETED|Overall Study||21
5359032|NCT00117286|13186091|P1|NOT COMPLETED|Overall Study||28
5359033|NCT00117286|13186090|P2|COMPLETED|Overall Study||6
5359034|NCT00117286|13186091|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
5359035|NCT00117286|13186090|P2|Switched to Higher Dose|Overall Study||17
5359036|NCT00117286|13186091|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
5359037|NCT00117286|13186090|P2|STARTED|Overall Study||27
5359038|NCT00117286|13186091|P1|STARTED|Overall Study|Safety analysis set|30
5359039|NCT00117156|13186099|P1|NOT COMPLETED|Overall Study||11
5359040|NCT00117156|13186099|P1|COMPLETED|Overall Study||15
5359041|NCT00117156|13186099|P1|STARTED|Overall Study||26
5359042|NCT00117143|13186111|P4|NOT COMPLETED|Overall Study||0
5359043|NCT00117143|13186112|P3|NOT COMPLETED|Overall Study||0
5359044|NCT00117143|13186113|P2|NOT COMPLETED|Overall Study||0
5359045|NCT00117143|13186114|P1|NOT COMPLETED|Overall Study||0
5359046|NCT00117143|13186111|P4|COMPLETED|Overall Study||1
5359047|NCT00117143|13186112|P3|COMPLETED|Overall Study||7
5359048|NCT00117143|13186113|P2|COMPLETED|Overall Study||4
5359049|NCT00117143|13186114|P1|COMPLETED|Overall Study||4
5359050|NCT00117143|13186111|P4|Received Second Dose|Overall Study||0
5359051|NCT00117143|13186112|P3|Received Second Dose|Overall Study||6
5359052|NCT00117143|13186113|P2|Received Second Dose|Overall Study||4
5359053|NCT00117143|13186114|P1|Received Second Dose|Overall Study||4
5359054|NCT00117143|13186111|P4|Received First Dose|Overall Study||1
5359055|NCT00117143|13186112|P3|Received First Dose|Overall Study||7
5359056|NCT00117143|13186113|P2|Received First Dose|Overall Study||4
5359057|NCT00117143|13186114|P1|Received First Dose|Overall Study||4
5359058|NCT00117143|13186111|P4|STARTED|Overall Study||1
5359059|NCT00117143|13186112|P3|STARTED|Overall Study||7
5359060|NCT00117143|13186113|P2|STARTED|Overall Study||4
5359061|NCT00117143|13186114|P1|STARTED|Overall Study||4
5359062|NCT00116857|13186158|P2|NOT COMPLETED|Overall Study||4
5359063|NCT00116857|13186159|P1|NOT COMPLETED|Overall Study||3
5359064|NCT00116857|13186158|P2|COMPLETED|Overall Study||56
5359065|NCT00116857|13186159|P1|COMPLETED|Overall Study||59
5359066|NCT00116857|13186158|P2|STARTED|Overall Study||60
5359067|NCT00116857|13186159|P1|STARTED|Overall Study||62
5359068|NCT00116844|13186167|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
5359069|NCT00116844|13186168|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
5359070|NCT00116844|13186167|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
5359071|NCT00116844|13186168|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
5359072|NCT00116844|13186167|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
5359073|NCT00116844|13186168|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
5359074|NCT00116844|13186167|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5359075|NCT00116844|13186168|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5359076|NCT00116844|13186167|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
5359077|NCT00116844|13186168|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
5359078|NCT00116844|13186167|P2|STARTED|Period 2: Washout Period (7 Days)||33
5359079|NCT00116844|13186168|P1|STARTED|Period 2: Washout Period (7 Days)||28
5359080|NCT00116844|13186167|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
5359081|NCT00116844|13186168|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
5359082|NCT00116844|13186167|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
5359083|NCT00116844|13186168|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
5359084|NCT00116844|13186167|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
5359085|NCT00116844|13186168|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
5359086|NCT00116831|13186186|P2|NOT COMPLETED|Overall Study||72
5359087|NCT00116831|13186187|P1|NOT COMPLETED|Overall Study||73
5359088|NCT00116831|13186186|P2|COMPLETED|Overall Study||259
5359089|NCT00116831|13186187|P1|COMPLETED|Overall Study||264
5359090|NCT00116831|13186186|P2|STARTED|Overall Study||331
5359091|NCT00116831|13186187|P1|STARTED|Overall Study||337
5359092|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
5359093|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
5359094|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
5359095|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
5359096|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
5359097|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 433 - 480||57
5359098|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
5359099|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
5359100|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
5359101|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
5359102|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
5359103|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
5359104|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
5359105|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
5359106|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
5359107|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
5359108|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 337 - 384||57
5359109|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 337 - 384||98
5359110|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
5359111|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
5359112|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
5359113|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
5359114|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 289 - 336||64
5359115|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 289 - 336||104
5359116|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
5359117|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
5359118|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
5359119|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
5359120|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 241 - 288||64
5359121|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 241 - 288||110
5359122|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
5359123|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
5359124|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
5359125|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
5359126|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 193 - 240||68
5359127|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 193 - 240||123
5359128|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
5359129|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
5359130|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
5359131|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
5359132|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 145 - 192||74
5359133|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 145 - 192||133
5359134|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
5359135|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
5359136|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
5359137|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
5359138|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 97 - 144||83
5359139|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 97 - 144||144
5359140|NCT00116805|13186265|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
5359141|NCT00116805|13186266|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
5359142|NCT00116805|13186265|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
5359143|NCT00116805|13186266|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
5359144|NCT00116805|13186265|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
5359145|NCT00116805|13186266|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
5359146|NCT00116805|13186265|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
5359147|NCT00116805|13186266|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
5359148|NCT00116805|13186265|P2|COMPLETED|Double-blind Period Through Week 48||85
5359149|NCT00116805|13186266|P1|COMPLETED|Double-blind Period Through Week 48||165
5359150|NCT00116805|13186265|P2|STARTED|Double-blind Period Through Week 48||90
5359151|NCT00116805|13186266|P1|STARTED|Double-blind Period Through Week 48||176
5359152|NCT00116779|13186359|P2|NOT COMPLETED|Overall Study||19
5359153|NCT00116779|13186360|P1|NOT COMPLETED|Overall Study||21
5359154|NCT00116779|13186359|P2|COMPLETED|Overall Study||45
5359155|NCT00116779|13186360|P1|COMPLETED|Overall Study||42
5359156|NCT00116779|13186359|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
5359157|NCT00116779|13186360|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
5359158|NCT00116753|13186393|P3|NOT COMPLETED|Overall Study||24
5359159|NCT00116753|13186394|P2|NOT COMPLETED|Overall Study||30
5359160|NCT00116753|13186395|P1|NOT COMPLETED|Overall Study||32
5359161|NCT00116753|13186393|P3|COMPLETED|Overall Study||128
5359162|NCT00116753|13186394|P2|COMPLETED|Overall Study||125
5359163|NCT00116753|13186395|P1|COMPLETED|Overall Study||121
5359164|NCT00116753|13186393|P3|ITT Population|Overall Study||147
5359165|NCT00116753|13186394|P2|ITT Population|Overall Study||150
5359166|NCT00116753|13186395|P1|ITT Population|Overall Study||150
5359167|NCT00116753|13186393|P3|STARTED|Overall Study||152
5359168|NCT00116753|13186394|P2|STARTED|Overall Study||155
5359169|NCT00116753|13186395|P1|STARTED|Overall Study|Randomised.|153
5359170|NCT00116688|13186417|P2|NOT COMPLETED|Overall Study||4
5359171|NCT00116688|13186418|P1|NOT COMPLETED|Overall Study||92
5359172|NCT00116688|13186417|P2|COMPLETED|Overall Study||17
5359173|NCT00116688|13186418|P1|COMPLETED|Overall Study||200
5359174|NCT00116688|13186417|P2|Received Study Medication|Overall Study||20
5359175|NCT00116688|13186418|P1|Received Study Medication|Overall Study||291
5359176|NCT00116688|13186417|P2|STARTED|Overall Study||21
5359177|NCT00116688|13186418|P1|STARTED|Overall Study||292
5359178|NCT00116649|13186433|P1|NOT COMPLETED|Overall Study||155
5359179|NCT00116649|13186433|P1|COMPLETED|Overall Study||396
5359180|NCT00116649|13186433|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
5359181|NCT00116584|13186440|P2|NOT COMPLETED|Overall Study||1
5359182|NCT00116584|13186441|P1|NOT COMPLETED|Overall Study||2
5359183|NCT00116584|13186440|P2|COMPLETED|Overall Study||35
5359184|NCT00116584|13186441|P1|COMPLETED|Overall Study||34
5359185|NCT00116584|13186440|P2|STARTED|Overall Study||36
5359186|NCT00116584|13186441|P1|STARTED|Overall Study||36
5359187|NCT00116558|13186454|P3|NOT COMPLETED|Overall Study||33
5359188|NCT00116558|13186455|P2|NOT COMPLETED|Overall Study||15
5359189|NCT00116558|13186456|P1|NOT COMPLETED|Overall Study||31
5359190|NCT00116558|13186454|P3|COMPLETED|Overall Study||14
5359191|NCT00116558|13186455|P2|COMPLETED|Overall Study||11
5359192|NCT00116558|13186456|P1|COMPLETED|Overall Study||49
5359193|NCT00116558|13186454|P3|STARTED|Overall Study||47
5359194|NCT00116558|13186455|P2|STARTED|Overall Study||26
5359195|NCT00116558|13186456|P1|STARTED|Overall Study||80
5359196|NCT00116428|13186467|P2|NOT COMPLETED|Overall Study||5
5359197|NCT00116428|13186468|P1|NOT COMPLETED|Overall Study||3
5359198|NCT00116428|13186467|P2|COMPLETED|Overall Study||56
5359199|NCT00116428|13186468|P1|COMPLETED|Overall Study||103
5359200|NCT00116428|13186467|P2|Underwent Study Ablation Procedure|Overall Study||36
5359201|NCT00116428|13186468|P1|Underwent Study Ablation Procedure|Overall Study||103
5359202|NCT00116428|13186467|P2|STARTED|Overall Study||61
5359203|NCT00116428|13186468|P1|STARTED|Overall Study||106
5359204|NCT00116337|13186484|P1|NOT COMPLETED|Overall Study||0
5359205|NCT00116337|13186484|P1|COMPLETED|Overall Study||17
5359206|NCT00116337|13186484|P1|STARTED|Overall Study||17
5359207|NCT00116272|13186497|P2|NOT COMPLETED|Overall Study||6
5359208|NCT00116272|13186498|P1|NOT COMPLETED|Overall Study||11
5359209|NCT00116272|13186497|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
5359210|NCT00116272|13186498|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
5359211|NCT00116272|13186497|P2|STARTED|Overall Study||164
5359212|NCT00116272|13186498|P1|STARTED|Overall Study||370
5359213|NCT00116207|13186550|P2|NOT COMPLETED|Overall Study||4
5359214|NCT00116207|13186551|P1|NOT COMPLETED|Overall Study||9
5359215|NCT00116207|13186550|P2|COMPLETED|Overall Study||18
5359216|NCT00116207|13186551|P1|COMPLETED|Overall Study||13
5359217|NCT00116207|13186550|P2|STARTED|Overall Study||22
5359218|NCT00116207|13186551|P1|STARTED|Overall Study||22
5359219|NCT00116168|13186567|P4|NOT COMPLETED|Overall Study||0
5359220|NCT00116168|13186568|P3|NOT COMPLETED|Overall Study||0
5359221|NCT00116168|13186569|P2|NOT COMPLETED|Overall Study||5
5359222|NCT00116168|13186570|P1|NOT COMPLETED|Overall Study||6
5359223|NCT00116168|13186567|P4|COMPLETED|Overall Study||6
5359224|NCT00116168|13186568|P3|COMPLETED|Overall Study||6
5359225|NCT00116168|13186569|P2|COMPLETED|Overall Study||6
5359226|NCT00116168|13186570|P1|COMPLETED|Overall Study||0
5359227|NCT00116168|13186567|P4|STARTED|Overall Study||6
5359228|NCT00116168|13186568|P3|STARTED|Overall Study||6
5359229|NCT00116168|13186569|P2|STARTED|Overall Study||11
5359230|NCT00116168|13186570|P1|STARTED|Overall Study||6
5359231|NCT00115934|13186634|P2|NOT COMPLETED|Overall Study||2
5359232|NCT00115934|13186635|P1|NOT COMPLETED|Overall Study||4
5359233|NCT00115934|13186634|P2|COMPLETED|Overall Study||274
5359234|NCT00115934|13186635|P1|COMPLETED|Overall Study||275
5359235|NCT00115934|13186634|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
5359236|NCT00115934|13186635|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
5359237|NCT00115869|13186675|P2|NOT COMPLETED|Overall Study||296
5359238|NCT00115869|13186676|P1|NOT COMPLETED|Overall Study||317
5359239|NCT00115869|13186675|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
5359240|NCT00115869|13186676|P1|COMPLETED|Overall Study||3894
5359241|NCT00115869|13186675|P2|Completed Data Collection at 12th Grade|Overall Study||3847
5359242|NCT00115869|13186676|P1|Completed Data Collection at 12th Grade|Overall Study||3876
5359243|NCT00115869|13186675|P2|STARTED|Overall Study||4177
5359244|NCT00115869|13186676|P1|STARTED|Overall Study||4211
5359245|NCT00115804|13186684|P1|NOT COMPLETED|Overall Study||2
5359246|NCT00115804|13186684|P1|COMPLETED|Overall Study||4
5359247|NCT00115804|13186684|P1|STARTED|Overall Study||6
5359248|NCT00115778|13186695|P2|NOT COMPLETED|Overall Study||1
5359249|NCT00115778|13186696|P1|NOT COMPLETED|Overall Study||0
5359250|NCT00115778|13186695|P2|COMPLETED|Overall Study||4
5359251|NCT00115778|13186696|P1|COMPLETED|Overall Study||6
5359252|NCT00115778|13186695|P2|STARTED|Overall Study||5
5359253|NCT00115778|13186696|P1|STARTED|Overall Study||6
5359254|NCT00115765|13186716|P4|NOT COMPLETED|Overall Study||31
5359255|NCT00115765|13186717|P3|NOT COMPLETED|Overall Study||121
5359256|NCT00115765|13186718|P2|NOT COMPLETED|Overall Study||100
5359257|NCT00115765|13186719|P1|NOT COMPLETED|Overall Study||35
5359258|NCT00115765|13186716|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
5359259|NCT00115765|13186717|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
5359260|NCT00115765|13186718|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
5359261|NCT00115765|13186719|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
5359262|NCT00115765|13186716|P4|STARTED|Overall Study||115
5359263|NCT00115765|13186717|P3|STARTED|Overall Study||410
5359264|NCT00115765|13186718|P2|STARTED|Overall Study||413
5359265|NCT00115765|13186719|P1|STARTED|Overall Study||115
5359266|NCT00115739|13186757|P1|NOT COMPLETED|Overall Study||3
5359267|NCT00115739|13186757|P1|COMPLETED|Overall Study||8
5359268|NCT00115739|13186757|P1|STARTED|Overall Study||11
5359269|NCT00115349|13186766|P2|NOT COMPLETED|Overall Study||9
5359270|NCT00115349|13186767|P1|NOT COMPLETED|Overall Study||11
5359271|NCT00115349|13186766|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
5359272|NCT00115349|13186767|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
5359273|NCT00115349|13186766|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
5359274|NCT00115349|13186767|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
5359275|NCT00115297|13186775|P2|NOT COMPLETED|Overall Study||0
5359276|NCT00115297|13186776|P1|NOT COMPLETED|Overall Study||0
5359277|NCT00115297|13186775|P2|COMPLETED|Overall Study||32
5359278|NCT00115297|13186776|P1|COMPLETED|Overall Study||30
5359279|NCT00115297|13186775|P2|STARTED|Overall Study||32
5359280|NCT00115297|13186776|P1|STARTED|Overall Study||30
5359281|NCT00115063|13186788|P2|NOT COMPLETED|Overall Study||104
5359282|NCT00115063|13186789|P1|NOT COMPLETED|Overall Study||99
5359283|NCT00115063|13186788|P2|COMPLETED|Overall Study||86
5359284|NCT00115063|13186789|P1|COMPLETED|Overall Study||101
5359285|NCT00115063|13186788|P2|STARTED|Overall Study||190
5359286|NCT00115063|13186789|P1|STARTED|Overall Study||200
5359287|NCT00115037|13186807|P6|NOT COMPLETED|Phase2||12
5359288|NCT00115037|13186808|P5|NOT COMPLETED|Phase2||6
5359289|NCT00115037|13186809|P4|NOT COMPLETED|Phase2||15
5359290|NCT00115037|13186810|P3|NOT COMPLETED|Phase2||15
5359291|NCT00115037|13186811|P2|NOT COMPLETED|Phase2||0
5359292|NCT00115037|13186812|P1|NOT COMPLETED|Phase2||0
5359293|NCT00115037|13186807|P6|COMPLETED|Phase2||21
5359294|NCT00115037|13186808|P5|COMPLETED|Phase2||28
5359295|NCT00115037|13186809|P4|COMPLETED|Phase2||77
5359296|NCT00115037|13186810|P3|COMPLETED|Phase2||76
5359297|NCT00115037|13186811|P2|COMPLETED|Phase2||0
5359298|NCT00115037|13186812|P1|COMPLETED|Phase2||0
5359299|NCT00115037|13186807|P6|STARTED|Phase2||33
5359300|NCT00115037|13186808|P5|STARTED|Phase2||34
5359301|NCT00115037|13186809|P4|STARTED|Phase2||92
5359302|NCT00115037|13186810|P3|STARTED|Phase2||91
5359303|NCT00115037|13186811|P2|STARTED|Phase2||0
5359304|NCT00115037|13186812|P1|STARTED|Phase2||0
5359305|NCT00115037|13186807|P6|NOT COMPLETED|Phase1||0
5359306|NCT00115037|13186808|P5|NOT COMPLETED|Phase1||0
5359307|NCT00115037|13186809|P4|NOT COMPLETED|Phase1||0
5359308|NCT00115037|13186810|P3|NOT COMPLETED|Phase1||0
5359309|NCT00115037|13186811|P2|NOT COMPLETED|Phase1||27
5359310|NCT00115037|13186812|P1|NOT COMPLETED|Phase1||25
5359311|NCT00115037|13186807|P6|COMPLETED|Phase1||0
5359312|NCT00115037|13186808|P5|COMPLETED|Phase1||0
5359313|NCT00115037|13186809|P4|COMPLETED|Phase1||0
5359314|NCT00115037|13186810|P3|COMPLETED|Phase1||0
5359315|NCT00115037|13186811|P2|COMPLETED|Phase1||123
5359316|NCT00115037|13186812|P1|COMPLETED|Phase1||127
5359317|NCT00115037|13186807|P6|STARTED|Phase1||0
5359318|NCT00115037|13186808|P5|STARTED|Phase1||0
5359319|NCT00115037|13186809|P4|STARTED|Phase1||0
5359320|NCT00115037|13186810|P3|STARTED|Phase1||0
5359321|NCT00115037|13186811|P2|STARTED|Phase1||150
5359322|NCT00115037|13186812|P1|STARTED|Phase1||152
5359323|NCT00114972|13186828|P2|NOT COMPLETED|Overall Study||12
5359324|NCT00114972|13186829|P1|NOT COMPLETED|Overall Study||48
5359325|NCT00114972|13186828|P2|COMPLETED|Overall Study||891
5359326|NCT00114972|13186829|P1|COMPLETED|Overall Study||849
5359327|NCT00114972|13186828|P2|STARTED|Overall Study||903
5359328|NCT00114972|13186829|P1|STARTED|Overall Study||897
5359329|NCT00114959|13186849|P1|NOT COMPLETED|Overall Study||8
5359330|NCT00114959|13186849|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
5359331|NCT00114959|13186849|P1|STARTED|Overall Study||15
5359332|NCT00114777|13186859|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
5359333|NCT00114777|13186860|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
5359334|NCT00114777|13186861|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
5359335|NCT00114777|13186859|P3|COMPLETED|Long-Term Extension to Month 84||57
5359336|NCT00114777|13186860|P2|COMPLETED|Long-Term Extension to Month 84||84
5359337|NCT00114777|13186861|P1|COMPLETED|Long-Term Extension to Month 84||74
5359338|NCT00114777|13186859|P3|STARTED|Long-Term Extension to Month 84||87
5359339|NCT00114777|13186860|P2|STARTED|Long-Term Extension to Month 84||113
5359340|NCT00114777|13186861|P1|STARTED|Long-Term Extension to Month 84||104
5359341|NCT00114777|13186859|P3|NOT COMPLETED|Randomization to Month 36||84
5359342|NCT00114777|13186860|P2|NOT COMPLETED|Randomization to Month 36||61
5359343|NCT00114777|13186861|P1|NOT COMPLETED|Randomization to Month 36||75
5359344|NCT00114777|13186859|P3|COMPLETED|Randomization to Month 36||100
5359345|NCT00114777|13186860|P2|COMPLETED|Randomization to Month 36||114
5359346|NCT00114777|13186861|P1|COMPLETED|Randomization to Month 36||109
5359347|NCT00114777|13186859|P3|STARTED|Randomization to Month 36||184
5359348|NCT00114777|13186860|P2|STARTED|Randomization to Month 36||175
5359349|NCT00114777|13186861|P1|STARTED|Randomization to Month 36||184
5359350|NCT00114738|13186935|P3|NOT COMPLETED|Randomization||0
5359351|NCT00114738|13186936|P2|NOT COMPLETED|Randomization||0
5359352|NCT00114738|13186937|P1|NOT COMPLETED|Randomization||0
5359353|NCT00114738|13186935|P3|COMPLETED|Randomization||16
5359354|NCT00114738|13186936|P2|COMPLETED|Randomization||14
5359355|NCT00114738|13186937|P1|COMPLETED|Randomization||0
5359356|NCT00114738|13186935|P3|STARTED|Randomization||16
5359357|NCT00114738|13186936|P2|STARTED|Randomization||14
5359358|NCT00114738|13186937|P1|STARTED|Randomization||0
5359359|NCT00114738|13186935|P3|NOT COMPLETED|Screening for Randomization||0
5359360|NCT00114738|13186936|P2|NOT COMPLETED|Screening for Randomization||0
5359361|NCT00114738|13186937|P1|NOT COMPLETED|Screening for Randomization||21
5359362|NCT00114738|13186935|P3|COMPLETED|Screening for Randomization||0
5359363|NCT00114738|13186936|P2|COMPLETED|Screening for Randomization||0
5359364|NCT00114738|13186937|P1|COMPLETED|Screening for Randomization||30
5359365|NCT00114738|13186935|P3|STARTED|Screening for Randomization||0
5359366|NCT00114738|13186936|P2|STARTED|Screening for Randomization||0
5359367|NCT00114738|13186937|P1|STARTED|Screening for Randomization||51
5359368|NCT00114738|13186935|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
5359369|NCT00114738|13186936|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
5359370|NCT00114738|13186937|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
5359371|NCT00114738|13186935|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
5359372|NCT00114738|13186936|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
5359373|NCT00114738|13186937|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
5359374|NCT00114738|13186935|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
5359375|NCT00114738|13186936|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
5359376|NCT00114738|13186937|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
5359377|NCT00114738|13186935|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
5359378|NCT00114738|13186936|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
5359379|NCT00114738|13186937|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
5359380|NCT00114738|13186935|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
5359381|NCT00114738|13186936|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
5359382|NCT00114738|13186937|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
5359383|NCT00114634|13186950|P1|NOT COMPLETED|Overall Study||3
5359384|NCT00114634|13186950|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
5359385|NCT00114634|13186950|P1|STARTED|Overall Study||13
5359386|NCT00114530|13186966|P2|NOT COMPLETED|Overall Study||20
5359387|NCT00114530|13186967|P1|NOT COMPLETED|Overall Study||9
5359481|NCT00113841|13187301|P1|STARTED|Overall Study||16
5359482|NCT00113763|13187309|P2|NOT COMPLETED|Overall Study||26
5359388|NCT00114530|13186966|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
5359389|NCT00114530|13186967|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
5359390|NCT00114530|13186966|P2|STARTED|Overall Study||39
5359391|NCT00114530|13186967|P1|STARTED|Overall Study||36
5359392|NCT00114517|13187076|P4|NOT COMPLETED|Overall Study||10
5359393|NCT00114517|13187077|P3|NOT COMPLETED|Overall Study||14
5359394|NCT00114517|13187078|P2|NOT COMPLETED|Overall Study||11
5359395|NCT00114517|13187079|P1|NOT COMPLETED|Overall Study||12
5359396|NCT00114517|13187076|P4|COMPLETED|Overall Study||176
5359397|NCT00114517|13187077|P3|COMPLETED|Overall Study||172
5359398|NCT00114517|13187078|P2|COMPLETED|Overall Study||123
5359399|NCT00114517|13187079|P1|COMPLETED|Overall Study||125
5359400|NCT00114517|13187076|P4|STARTED|Overall Study||186
5359401|NCT00114517|13187077|P3|STARTED|Overall Study||186
5359402|NCT00114517|13187078|P2|STARTED|Overall Study||134
5359403|NCT00114517|13187079|P1|STARTED|Overall Study||137
5359404|NCT00114504|13187091|P2|NOT COMPLETED|Overall Study||0
5359405|NCT00114504|13187092|P1|NOT COMPLETED|Overall Study||0
5359406|NCT00114504|13187091|P2|COMPLETED|Overall Study||22
5359407|NCT00114504|13187092|P1|COMPLETED|Overall Study||21
5359408|NCT00114504|13187091|P2|STARTED|Overall Study||22
5359409|NCT00114504|13187092|P1|STARTED|Overall Study||21
5359410|NCT00114244|13187104|P2|NOT COMPLETED|Overall Study||7
5359411|NCT00114244|13187105|P1|NOT COMPLETED|Overall Study||2
5359412|NCT00114244|13187104|P2|COMPLETED|Overall Study||30
5359413|NCT00114244|13187105|P1|COMPLETED|Overall Study||13
5359414|NCT00114244|13187104|P2|STARTED|Overall Study||37
5359415|NCT00114244|13187105|P1|STARTED|Overall Study||15
5359416|NCT00114231|13187117|P2|NOT COMPLETED|Overall Study||2
5359417|NCT00114231|13187118|P1|NOT COMPLETED|Overall Study||9
5359418|NCT00114231|13187117|P2|COMPLETED|Overall Study||26
5359419|NCT00114231|13187118|P1|COMPLETED|Overall Study||53
5359420|NCT00114231|13187117|P2|STARTED|Overall Study||28
5359421|NCT00114231|13187118|P1|STARTED|Overall Study||62
5359422|NCT00114218|13187127|P1|NOT COMPLETED|Overall Study||4
5359423|NCT00114218|13187127|P1|COMPLETED|Overall Study||24
5359424|NCT00114218|13187127|P1|STARTED|Overall Study||28
5359425|NCT00114166|13187134|P2|NOT COMPLETED|Overall Study||1
5359426|NCT00114166|13187135|P1|NOT COMPLETED|Overall Study||0
5359427|NCT00114166|13187134|P2|COMPLETED|Overall Study||65
5359428|NCT00114166|13187135|P1|COMPLETED|Overall Study||15
5359429|NCT00114166|13187134|P2|STARTED|Overall Study||66
5359430|NCT00114166|13187135|P1|STARTED|Overall Study||15
5359431|NCT00114140|13187145|P1|NOT COMPLETED|Overall Study||7
5359432|NCT00114140|13187145|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
5359433|NCT00114140|13187145|P1|STARTED|Overall Study||136
5359434|NCT00114127|13187159|P2|NOT COMPLETED|Overall Study||4
5359435|NCT00114127|13187160|P1|NOT COMPLETED|Overall Study||4
5359436|NCT00114127|13187159|P2|COMPLETED|Overall Study||11
5359437|NCT00114127|13187160|P1|COMPLETED|Overall Study||9
5359438|NCT00114127|13187159|P2|STARTED|Overall Study||15
5359439|NCT00114127|13187160|P1|STARTED|Overall Study||13
5359440|NCT00114114|13187174|P6|NOT COMPLETED|Overall Study||1
5359441|NCT00114114|13187175|P5|NOT COMPLETED|Overall Study||2
5359442|NCT00114114|13187176|P4|NOT COMPLETED|Overall Study||4
5359443|NCT00114114|13187177|P3|NOT COMPLETED|Overall Study||1
5359444|NCT00114114|13187178|P2|NOT COMPLETED|Overall Study||1
5359445|NCT00114114|13187179|P1|NOT COMPLETED|Overall Study||5
5359446|NCT00114114|13187174|P6|COMPLETED|Overall Study||30
5359447|NCT00114114|13187175|P5|COMPLETED|Overall Study||27
5359448|NCT00114114|13187176|P4|COMPLETED|Overall Study||31
5359449|NCT00114114|13187177|P3|COMPLETED|Overall Study||30
5359450|NCT00114114|13187178|P2|COMPLETED|Overall Study||24
5359451|NCT00114114|13187179|P1|COMPLETED|Overall Study||21
5359452|NCT00114114|13187174|P6|STARTED|Overall Study||31
5359453|NCT00114114|13187175|P5|STARTED|Overall Study||29
5359454|NCT00114114|13187176|P4|STARTED|Overall Study||35
5359455|NCT00114114|13187177|P3|STARTED|Overall Study||31
5359456|NCT00114114|13187178|P2|STARTED|Overall Study||25
5359457|NCT00114114|13187179|P1|STARTED|Overall Study||26
5359458|NCT00114101|13187219|P2|NOT COMPLETED|Overall Study||0
5359459|NCT00114101|13187220|P1|NOT COMPLETED|Overall Study||0
5359460|NCT00114101|13187219|P2|COMPLETED|Overall Study||229
5359461|NCT00114101|13187220|P1|COMPLETED|Overall Study||231
5359462|NCT00114101|13187219|P2|STARTED|Overall Study||229
5359463|NCT00114101|13187220|P1|STARTED|Overall Study||231
5359464|NCT00113919|13187232|P1|NOT COMPLETED|Overall Study||14
5359465|NCT00113919|13187232|P1|COMPLETED|Overall Study||0
5359466|NCT00113919|13187232|P1|STARTED|Overall Study||14
5359467|NCT00113880|13187239|P3|NOT COMPLETED|Overall Study||0
5359468|NCT00113880|13187240|P2|NOT COMPLETED|Overall Study||0
5359469|NCT00113880|13187241|P1|NOT COMPLETED|Overall Study||0
5359470|NCT00113880|13187239|P3|COMPLETED|Overall Study||62492
5359471|NCT00113880|13187240|P2|COMPLETED|Overall Study||71949
5359472|NCT00113880|13187241|P1|COMPLETED|Overall Study||63061
5359473|NCT00113880|13187239|P3|STARTED|Overall Study||62492
5359474|NCT00113880|13187240|P2|STARTED|Overall Study||71949
5359475|NCT00113880|13187241|P1|STARTED|Overall Study||63061
5359476|NCT00113841|13187300|P2|NOT COMPLETED|Overall Study||2
5359477|NCT00113841|13187301|P1|NOT COMPLETED|Overall Study||1
5359478|NCT00113841|13187300|P2|COMPLETED|Overall Study||15
5359479|NCT00113841|13187301|P1|COMPLETED|Overall Study||15
5359480|NCT00113841|13187300|P2|STARTED|Overall Study||17
5359483|NCT00113763|13187310|P1|NOT COMPLETED|Overall Study||73
5359484|NCT00113763|13187309|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
5359485|NCT00113763|13187310|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
5359486|NCT00113763|13187309|P2|Received Study Drug|Overall Study||0
5359487|NCT00113763|13187310|P1|Received Study Drug|Overall Study||229
5359488|NCT00113763|13187309|P2|STARTED|Overall Study||232
5359489|NCT00113763|13187310|P1|STARTED|Overall Study||231
5359490|NCT00113607|13187336|P2|NOT COMPLETED|Overall Study||337
5359491|NCT00113607|13187337|P1|NOT COMPLETED|Overall Study||335
5359492|NCT00113607|13187336|P2|COMPLETED|Overall Study||0
5359493|NCT00113607|13187337|P1|COMPLETED|Overall Study||0
5359494|NCT00113607|13187336|P2|STARTED|Overall Study|Number of randomized participants|337
5359495|NCT00113607|13187337|P1|STARTED|Overall Study|Number of randomized participants|335
5359496|NCT00113568|13187351|P1|NOT COMPLETED|Overall Study||545
5359497|NCT00113568|13187351|P1|COMPLETED|Overall Study||239
5359498|NCT00113568|13187351|P1|Intent to Treat Population|Overall Study||723
5359499|NCT00113568|13187351|P1|STARTED|Overall Study||784
5359500|NCT00113555|13187363|P1|NOT COMPLETED|Overall Study||79
5359501|NCT00113555|13187363|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
5359502|NCT00113555|13187363|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
5359503|NCT00113555|13187363|P1|STARTED|Overall Study||221
5359504|NCT00113529|13187373|P1|NOT COMPLETED|Overall Study||34
5359505|NCT00113529|13187373|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
5359506|NCT00113529|13187373|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
5359507|NCT00113516|13187406|P2|NOT COMPLETED|Part 2||66
5359508|NCT00113516|13187407|P1|NOT COMPLETED|Part 2||0
5359509|NCT00113516|13187406|P2|COMPLETED|Part 2||0
5359510|NCT00113516|13187407|P1|COMPLETED|Part 2||0
5359511|NCT00113516|13187406|P2|STARTED|Part 2||66
5359512|NCT00113516|13187407|P1|STARTED|Part 2||0
5359513|NCT00113516|13187406|P2|NOT COMPLETED|Part 1||0
5359514|NCT00113516|13187407|P1|NOT COMPLETED|Part 1||84
5359515|NCT00113516|13187406|P2|COMPLETED|Part 1||0
5359516|NCT00113516|13187407|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
5359517|NCT00113516|13187406|P2|STARTED|Part 1||0
5359518|NCT00113516|13187407|P1|STARTED|Part 1||84
5359519|NCT00113490|13187450|P2|NOT COMPLETED|Overall Study||3
5359520|NCT00113490|13187451|P1|NOT COMPLETED|Overall Study||2
5359521|NCT00113490|13187450|P2|COMPLETED|Overall Study||67
5359522|NCT00113490|13187451|P1|COMPLETED|Overall Study||64
5359523|NCT00113490|13187450|P2|STARTED|Overall Study||70
5359524|NCT00113490|13187451|P1|STARTED|Overall Study||66
5359525|NCT00113425|13187464|P1|NOT COMPLETED|Overall Study||15
5359526|NCT00113425|13187464|P1|COMPLETED|Overall Study||29
5359527|NCT00113425|13187464|P1|STARTED|Overall Study||44
5359528|NCT00113399|13187484|P2|NOT COMPLETED|Overall Study||5
5359529|NCT00113399|13187485|P1|NOT COMPLETED|Overall Study||2
5359530|NCT00113399|13187484|P2|COMPLETED|Overall Study||3
5359531|NCT00113399|13187485|P1|COMPLETED|Overall Study||5
5359532|NCT00113399|13187484|P2|STARTED|Overall Study||8
5359533|NCT00113399|13187485|P1|STARTED|Overall Study||7
5359534|NCT00113386|13187493|P2|NOT COMPLETED|Overall Study||4
5359535|NCT00113386|13187494|P1|NOT COMPLETED|Overall Study||7
5359536|NCT00113386|13187493|P2|COMPLETED|Overall Study||5
5359537|NCT00113386|13187494|P1|COMPLETED|Overall Study||3
5359538|NCT00113386|13187493|P2|STARTED|Overall Study||9
5359539|NCT00113386|13187494|P1|STARTED|Overall Study||10
5359540|NCT00113373|13187500|P1|NOT COMPLETED|Overall Study||3
5359541|NCT00113373|13187500|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
5359542|NCT00113373|13187500|P1|STARTED|Overall Study||28
5359543|NCT00113360|13187515|P1|NOT COMPLETED|Overall Study||7
5359544|NCT00113360|13187515|P1|COMPLETED|Overall Study||60
5359545|NCT00113360|13187515|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
5359546|NCT00113334|13187519|P1|NOT COMPLETED|Overall Study||0
5359547|NCT00113334|13187519|P1|COMPLETED|Overall Study||6
5359548|NCT00113334|13187519|P1|STARTED|Overall Study||6
5359549|NCT00113321|13187523|P1|NOT COMPLETED|Overall Study||0
5359550|NCT00113321|13187523|P1|COMPLETED|Overall Study||16
5359551|NCT00113321|13187523|P1|STARTED|Overall Study||16
5359552|NCT00113295|13187529|P2|NOT COMPLETED|Overall Study||1
5359553|NCT00113295|13187530|P1|NOT COMPLETED|Overall Study||5
5359554|NCT00113295|13187529|P2|COMPLETED|Overall Study||10
5359555|NCT00113295|13187530|P1|COMPLETED|Overall Study||6
5359556|NCT00113295|13187529|P2|STARTED|Overall Study||11
5359557|NCT00113295|13187530|P1|STARTED|Overall Study||11
5359558|NCT00113269|13187549|P4|NOT COMPLETED|Overall Study||40
5359559|NCT00113269|13187550|P3|NOT COMPLETED|Overall Study||41
5359560|NCT00113269|13187551|P2|NOT COMPLETED|Overall Study||22
5359561|NCT00113269|13187552|P1|NOT COMPLETED|Overall Study||25
5359562|NCT00113269|13187549|P4|COMPLETED|Overall Study||140
5359563|NCT00113269|13187550|P3|COMPLETED|Overall Study||134
5359564|NCT00113269|13187551|P2|COMPLETED|Overall Study||48
5359565|NCT00113269|13187552|P1|COMPLETED|Overall Study||51
5359566|NCT00113269|13187549|P4|Received Treatment|Overall Study||171
5359567|NCT00113269|13187550|P3|Received Treatment|Overall Study||164
5359568|NCT00113269|13187551|P2|Received Treatment|Overall Study||69
5359569|NCT00113269|13187552|P1|Received Treatment|Overall Study||70
5359570|NCT00113269|13187549|P4|STARTED|Overall Study||180
5359571|NCT00113269|13187550|P3|STARTED|Overall Study||175
5359572|NCT00113269|13187551|P2|STARTED|Overall Study||70
5359573|NCT00113269|13187552|P1|STARTED|Overall Study||76
5359574|NCT00113230|13187602|P1|NOT COMPLETED|Overall Study||0
5359575|NCT00113230|13187602|P1|COMPLETED|Overall Study||25
5359576|NCT00113230|13187602|P1|STARTED|Overall Study||25
5359577|NCT00113217|13187606|P1|NOT COMPLETED|Overall Study||0
5359578|NCT00113217|13187606|P1|COMPLETED|Overall Study||50
5359579|NCT00113217|13187606|P1|STARTED|Overall Study||50
5359580|NCT00113087|13187612|P2|NOT COMPLETED|Overall Study||21
5359581|NCT00113087|13187613|P1|NOT COMPLETED|Overall Study||24
5359582|NCT00113087|13187612|P2|COMPLETED|Overall Study||94
5359583|NCT00113087|13187613|P1|COMPLETED|Overall Study||91
5359584|NCT00113087|13187612|P2|STARTED|Overall Study||115
5359585|NCT00113087|13187613|P1|STARTED|Overall Study||115
5359586|NCT00113022|13187677|P2|NOT COMPLETED|Overall Study||2
5359587|NCT00113022|13187678|P1|NOT COMPLETED|Overall Study||3
5359588|NCT00113022|13187677|P2|COMPLETED|Overall Study||2
5359589|NCT00113022|13187678|P1|COMPLETED|Overall Study||2
5359590|NCT00113022|13187677|P2|STARTED|Overall Study||4
5359591|NCT00113022|13187678|P1|STARTED|Overall Study||5
5359592|NCT00112957|13187684|P1|NOT COMPLETED|Overall Study||19
5359593|NCT00112957|13187684|P1|COMPLETED|Overall Study||4
5359594|NCT00112957|13187684|P1|STARTED|Overall Study||23
5359595|NCT00112918|13187699|P3|NOT COMPLETED|Overall Study||299
5359596|NCT00112918|13187700|P2|NOT COMPLETED|Overall Study||345
5359597|NCT00112918|13187701|P1|NOT COMPLETED|Overall Study||297
5359598|NCT00112918|13187699|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
5359599|NCT00112918|13187700|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
5359600|NCT00112918|13187701|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
5359601|NCT00112918|13187699|P3|Stage III Disease Population|Overall Study||952
5359602|NCT00112918|13187700|P2|Stage III Disease Population|Overall Study||960
5359603|NCT00112918|13187701|P1|Stage III Disease Population|Overall Study||955
5359604|NCT00112918|13187699|P3|Received Treatment|Overall Study||1135
5359605|NCT00112918|13187700|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
5359606|NCT00112918|13187701|P1|Received Treatment|Overall Study||1126
5359607|NCT00112918|13187699|P3|STARTED|Overall Study||1145
5359608|NCT00112918|13187700|P2|STARTED|Overall Study||1155
5359609|NCT00112918|13187701|P1|STARTED|Overall Study||1151
5359610|NCT00112905|13187724|P1|NOT COMPLETED|Overall Study||12
5359611|NCT00112905|13187724|P1|COMPLETED|Overall Study||15
5359612|NCT00112905|13187724|P1|Eligible and Treated|Overall Study||22
5359613|NCT00112905|13187724|P1|STARTED|Overall Study||27
5359614|NCT00112866|13187733|P2|NOT COMPLETED|Overall Study||2
5359615|NCT00112866|13187734|P1|NOT COMPLETED|Overall Study||2
5359616|NCT00112866|13187733|P2|COMPLETED|Overall Study||13
5359617|NCT00112866|13187734|P1|COMPLETED|Overall Study||13
5359618|NCT00112866|13187733|P2|STARTED|Overall Study||15
5359619|NCT00112866|13187734|P1|STARTED|Overall Study||15
5359620|NCT00112840|13187756|P3|NOT COMPLETED|Overall Study||6
5359621|NCT00112840|13187757|P2|NOT COMPLETED|Overall Study||0
5359622|NCT00112840|13187758|P1|NOT COMPLETED|Overall Study||2
5359623|NCT00112840|13187756|P3|COMPLETED|Overall Study||40
5359624|NCT00112840|13187757|P2|COMPLETED|Overall Study||6
5359625|NCT00112840|13187758|P1|COMPLETED|Overall Study||6
5359626|NCT00112840|13187756|P3|STARTED|Overall Study||46
5359627|NCT00112840|13187757|P2|STARTED|Overall Study||6
5359628|NCT00112840|13187758|P1|STARTED|Overall Study||8
5359629|NCT00112736|13187777|P2|NOT COMPLETED|Overall Study||0
5359630|NCT00112736|13187778|P1|NOT COMPLETED|Overall Study||1
5359631|NCT00112736|13187777|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
5359632|NCT00112736|13187778|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
5359633|NCT00112736|13187777|P2|STARTED|Overall Study||47
5359634|NCT00112736|13187778|P1|STARTED|Overall Study||22
5359635|NCT00112723|13187791|P3|NOT COMPLETED|Overall Study||2
5359636|NCT00112723|13187792|P2|NOT COMPLETED|Overall Study||7
5359637|NCT00112723|13187793|P1|NOT COMPLETED|Overall Study||2
5359638|NCT00112723|13187791|P3|COMPLETED|Overall Study||12
5359639|NCT00112723|13187792|P2|COMPLETED|Overall Study||12
5359640|NCT00112723|13187793|P1|COMPLETED|Overall Study||11
5359641|NCT00112723|13187791|P3|Patients Evaluable for Toxicity|Overall Study||12
5359642|NCT00112723|13187792|P2|Patients Evaluable for Toxicity|Overall Study||12
5359643|NCT00112723|13187793|P1|Patients Evaluable for Toxicity|Overall Study||11
5359644|NCT00112723|13187791|P3|STARTED|Overall Study||14
5359645|NCT00112723|13187792|P2|STARTED|Overall Study||19
5359646|NCT00112723|13187793|P1|STARTED|Overall Study||13
5359647|NCT00112671|13187818|P1|NOT COMPLETED|Overall Study||0
5359648|NCT00112671|13187818|P1|COMPLETED|Overall Study||17
5359649|NCT00112671|13187818|P1|STARTED|Overall Study||17
5359650|NCT00112593|13187826|P1|NOT COMPLETED|Overall Study||0
5359651|NCT00112593|13187826|P1|COMPLETED|Overall Study||5
5359652|NCT00112593|13187826|P1|STARTED|Overall Study||5
5359653|NCT00112489|13187835|P1|NOT COMPLETED|Overall Study||40
5359654|NCT00112489|13187835|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
5359655|NCT00112489|13187835|P1|STARTED|Overall Study|All patients enrolled on study|55
5359656|NCT00112463|13187845|P1|NOT COMPLETED|Overall Study||39
5359657|NCT00112463|13187845|P1|COMPLETED|Overall Study||1
5359658|NCT00112463|13187845|P1|STARTED|Overall Study||40
5359659|NCT00112437|13187857|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
5359660|NCT00112437|13187858|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
5359661|NCT00112437|13187859|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
5359662|NCT00112437|13187860|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
5359663|NCT00112437|13187861|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359664|NCT00112437|13187862|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359665|NCT00112437|13187863|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359666|NCT00112437|13187864|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359667|NCT00112437|13187865|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359668|NCT00112437|13187866|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359669|NCT00112437|13187867|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359670|NCT00112437|13187868|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359671|NCT00112437|13187869|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359672|NCT00112437|13187870|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359673|NCT00112437|13187871|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359674|NCT00112437|13187872|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359675|NCT00112437|13187873|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359676|NCT00112437|13187874|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359677|NCT00112437|13187875|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359678|NCT00112437|13187876|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359679|NCT00112437|13187877|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359680|NCT00112437|13187878|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359681|NCT00112437|13187879|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359682|NCT00112437|13187880|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359683|NCT00112437|13187881|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359684|NCT00112437|13187882|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
5359685|NCT00112437|13187857|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
5359686|NCT00112437|13187858|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
5359687|NCT00112437|13187859|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
5359688|NCT00112437|13187860|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
5359689|NCT00112437|13187861|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
5359690|NCT00112437|13187862|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
5359691|NCT00112437|13187863|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
5359692|NCT00112437|13187864|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
5359693|NCT00112437|13187865|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
5359694|NCT00112437|13187866|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
5359695|NCT00112437|13187867|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
5359696|NCT00112437|13187868|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
5359697|NCT00112437|13187869|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
5359698|NCT00112437|13187870|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
5359699|NCT00112437|13187871|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
5359700|NCT00112437|13187872|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
5359701|NCT00112437|13187873|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
5359702|NCT00112437|13187874|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
5359703|NCT00112437|13187875|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
5359704|NCT00112437|13187876|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
5359705|NCT00112437|13187877|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
5359706|NCT00112437|13187878|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
5359707|NCT00112437|13187879|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
5359708|NCT00112437|13187880|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
5359709|NCT00112437|13187881|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
5359710|NCT00112437|13187882|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
5359711|NCT00112437|13187857|P26|STARTED|Years 6-10 (60-Month Extension)||32
5359712|NCT00112437|13187858|P25|STARTED|Years 6-10 (60-Month Extension)||23
5359713|NCT00112437|13187859|P24|STARTED|Years 6-10 (60-Month Extension)||34
5359714|NCT00112437|13187860|P23|STARTED|Years 6-10 (60-Month Extension)||28
5359715|NCT00112437|13187861|P22|STARTED|Years 6-10 (60-Month Extension)||0
5359716|NCT00112437|13187862|P21|STARTED|Years 6-10 (60-Month Extension)||0
5359717|NCT00112437|13187863|P20|STARTED|Years 6-10 (60-Month Extension)||0
5359718|NCT00112437|13187864|P19|STARTED|Years 6-10 (60-Month Extension)||0
5359719|NCT00112437|13187865|P18|STARTED|Years 6-10 (60-Month Extension)||0
5359720|NCT00112437|13187866|P17|STARTED|Years 6-10 (60-Month Extension)||0
5359721|NCT00112437|13187867|P16|STARTED|Years 6-10 (60-Month Extension)||0
5359722|NCT00112437|13187868|P15|STARTED|Years 6-10 (60-Month Extension)||0
5359723|NCT00112437|13187869|P14|STARTED|Years 6-10 (60-Month Extension)||0
5359724|NCT00112437|13187870|P13|STARTED|Years 6-10 (60-Month Extension)||0
5359725|NCT00112437|13187871|P12|STARTED|Years 6-10 (60-Month Extension)||0
5359726|NCT00112437|13187872|P11|STARTED|Years 6-10 (60-Month Extension)||0
5359727|NCT00112437|13187873|P10|STARTED|Years 6-10 (60-Month Extension)||0
5359728|NCT00112437|13187874|P9|STARTED|Years 6-10 (60-Month Extension)||0
5359729|NCT00112437|13187875|P8|STARTED|Years 6-10 (60-Month Extension)||0
5359730|NCT00112437|13187876|P7|STARTED|Years 6-10 (60-Month Extension)||0
5359731|NCT00112437|13187877|P6|STARTED|Years 6-10 (60-Month Extension)||0
5359732|NCT00112437|13187878|P5|STARTED|Years 6-10 (60-Month Extension)||0
5359733|NCT00112437|13187879|P4|STARTED|Years 6-10 (60-Month Extension)||0
5359734|NCT00112437|13187880|P3|STARTED|Years 6-10 (60-Month Extension)||0
5359735|NCT00112437|13187881|P2|STARTED|Years 6-10 (60-Month Extension)||0
5359736|NCT00112437|13187882|P1|STARTED|Years 6-10 (60-Month Extension)||0
5359737|NCT00112437|13187857|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359738|NCT00112437|13187858|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359739|NCT00112437|13187859|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359740|NCT00112437|13187860|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359741|NCT00112437|13187861|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
5359742|NCT00112437|13187862|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
5359743|NCT00112437|13187863|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359744|NCT00112437|13187864|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359745|NCT00112437|13187865|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359746|NCT00112437|13187866|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359747|NCT00112437|13187867|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359748|NCT00112437|13187868|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359749|NCT00112437|13187869|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359750|NCT00112437|13187870|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359751|NCT00112437|13187871|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359752|NCT00112437|13187872|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359753|NCT00112437|13187873|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359754|NCT00112437|13187874|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359755|NCT00112437|13187875|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359756|NCT00112437|13187876|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359757|NCT00112437|13187877|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359758|NCT00112437|13187878|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359759|NCT00112437|13187879|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359760|NCT00112437|13187880|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359761|NCT00112437|13187881|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359762|NCT00112437|13187882|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
5359763|NCT00112437|13187857|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
5359764|NCT00112437|13187858|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
5359765|NCT00112437|13187859|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
5359766|NCT00112437|13187860|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
5359767|NCT00112437|13187861|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
5359768|NCT00112437|13187862|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
5359769|NCT00112437|13187863|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
5359770|NCT00112437|13187864|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
5359771|NCT00112437|13187865|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
5359772|NCT00112437|13187866|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
5359773|NCT00112437|13187867|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
5359774|NCT00112437|13187868|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
5359775|NCT00112437|13187869|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
5359776|NCT00112437|13187870|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
5359777|NCT00112437|13187871|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
5359778|NCT00112437|13187872|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
5359779|NCT00112437|13187873|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
5359780|NCT00112437|13187874|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
5359781|NCT00112437|13187875|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
5359782|NCT00112437|13187876|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
5359783|NCT00112437|13187877|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
5359784|NCT00112437|13187878|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
5359785|NCT00112437|13187879|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
5359786|NCT00112437|13187880|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
5359787|NCT00112437|13187881|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
5359788|NCT00112437|13187882|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
5359789|NCT00112437|13187857|P26|STARTED|Years 4-5 (24-Month Extension)||0
5359790|NCT00112437|13187858|P25|STARTED|Years 4-5 (24-Month Extension)||0
5359791|NCT00112437|13187859|P24|STARTED|Years 4-5 (24-Month Extension)||0
5359792|NCT00112437|13187860|P23|STARTED|Years 4-5 (24-Month Extension)||0
5359793|NCT00112437|13187861|P22|STARTED|Years 4-5 (24-Month Extension)||100
5359794|NCT00112437|13187862|P21|STARTED|Years 4-5 (24-Month Extension)||41
5359795|NCT00112437|13187863|P20|STARTED|Years 4-5 (24-Month Extension)||0
5359796|NCT00112437|13187864|P19|STARTED|Years 4-5 (24-Month Extension)||0
5359797|NCT00112437|13187865|P18|STARTED|Years 4-5 (24-Month Extension)||0
5359798|NCT00112437|13187866|P17|STARTED|Years 4-5 (24-Month Extension)||0
5359799|NCT00112437|13187867|P16|STARTED|Years 4-5 (24-Month Extension)||0
5359800|NCT00112437|13187868|P15|STARTED|Years 4-5 (24-Month Extension)||0
5359801|NCT00112437|13187869|P14|STARTED|Years 4-5 (24-Month Extension)||0
5359802|NCT00112437|13187870|P13|STARTED|Years 4-5 (24-Month Extension)||0
5359803|NCT00112437|13187871|P12|STARTED|Years 4-5 (24-Month Extension)||0
5359804|NCT00112437|13187872|P11|STARTED|Years 4-5 (24-Month Extension)||0
5359805|NCT00112437|13187873|P10|STARTED|Years 4-5 (24-Month Extension)||0
5359806|NCT00112437|13187874|P9|STARTED|Years 4-5 (24-Month Extension)||0
5359807|NCT00112437|13187875|P8|STARTED|Years 4-5 (24-Month Extension)||0
5359808|NCT00112437|13187876|P7|STARTED|Years 4-5 (24-Month Extension)||0
5359809|NCT00112437|13187877|P6|STARTED|Years 4-5 (24-Month Extension)||0
5359810|NCT00112437|13187878|P5|STARTED|Years 4-5 (24-Month Extension)||0
5359811|NCT00112437|13187879|P4|STARTED|Years 4-5 (24-Month Extension)||0
5359812|NCT00112437|13187880|P3|STARTED|Years 4-5 (24-Month Extension)||0
5359813|NCT00112437|13187881|P2|STARTED|Years 4-5 (24-Month Extension)||0
5359814|NCT00112437|13187882|P1|STARTED|Years 4-5 (24-Month Extension)||0
5359815|NCT00112437|13187857|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359816|NCT00112437|13187858|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359817|NCT00112437|13187859|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359818|NCT00112437|13187860|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359819|NCT00112437|13187861|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359820|NCT00112437|13187862|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359821|NCT00112437|13187863|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
5359822|NCT00112437|13187864|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
5359823|NCT00112437|13187865|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
5359824|NCT00112437|13187866|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
5359825|NCT00112437|13187867|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
5359826|NCT00112437|13187868|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
5359827|NCT00112437|13187869|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
5359828|NCT00112437|13187870|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359829|NCT00112437|13187871|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
5359830|NCT00112437|13187872|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
5359831|NCT00112437|13187873|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359832|NCT00112437|13187874|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359833|NCT00112437|13187875|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359834|NCT00112437|13187876|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359835|NCT00112437|13187877|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359836|NCT00112437|13187878|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359837|NCT00112437|13187879|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359838|NCT00112437|13187880|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359839|NCT00112437|13187881|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359840|NCT00112437|13187882|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
5359841|NCT00112437|13187857|P26|COMPLETED|Year 3 (12-Month Extension)||0
5359842|NCT00112437|13187858|P25|COMPLETED|Year 3 (12-Month Extension)||0
5359843|NCT00112437|13187859|P24|COMPLETED|Year 3 (12-Month Extension)||0
5359844|NCT00112437|13187860|P23|COMPLETED|Year 3 (12-Month Extension)||0
5359845|NCT00112437|13187861|P22|COMPLETED|Year 3 (12-Month Extension)||0
5359846|NCT00112437|13187862|P21|COMPLETED|Year 3 (12-Month Extension)||0
5359847|NCT00112437|13187863|P20|COMPLETED|Year 3 (12-Month Extension)||19
5359848|NCT00112437|13187864|P19|COMPLETED|Year 3 (12-Month Extension)||16
5359849|NCT00112437|13187865|P18|COMPLETED|Year 3 (12-Month Extension)||20
5359850|NCT00112437|13187866|P17|COMPLETED|Year 3 (12-Month Extension)||16
5359851|NCT00112437|13187867|P16|COMPLETED|Year 3 (12-Month Extension)||13
5359852|NCT00112437|13187868|P15|COMPLETED|Year 3 (12-Month Extension)||17
5359853|NCT00112437|13187869|P14|COMPLETED|Year 3 (12-Month Extension)||16
5359854|NCT00112437|13187870|P13|COMPLETED|Year 3 (12-Month Extension)||18
5359855|NCT00112437|13187871|P12|COMPLETED|Year 3 (12-Month Extension)||17
5359856|NCT00112437|13187872|P11|COMPLETED|Year 3 (12-Month Extension)||17
5359857|NCT00112437|13187873|P10|COMPLETED|Year 3 (12-Month Extension)||0
5359858|NCT00112437|13187874|P9|COMPLETED|Year 3 (12-Month Extension)||0
5359859|NCT00112437|13187875|P8|COMPLETED|Year 3 (12-Month Extension)||0
5359860|NCT00112437|13187876|P7|COMPLETED|Year 3 (12-Month Extension)||0
5359861|NCT00112437|13187877|P6|COMPLETED|Year 3 (12-Month Extension)||0
5359862|NCT00112437|13187878|P5|COMPLETED|Year 3 (12-Month Extension)||0
5359863|NCT00112437|13187879|P4|COMPLETED|Year 3 (12-Month Extension)||0
5359864|NCT00112437|13187880|P3|COMPLETED|Year 3 (12-Month Extension)||0
5359865|NCT00112437|13187881|P2|COMPLETED|Year 3 (12-Month Extension)||0
5359866|NCT00112437|13187882|P1|COMPLETED|Year 3 (12-Month Extension)||0
5359867|NCT00112437|13187857|P26|STARTED|Year 3 (12-Month Extension)||0
5359868|NCT00112437|13187858|P25|STARTED|Year 3 (12-Month Extension)||0
5359869|NCT00112437|13187859|P24|STARTED|Year 3 (12-Month Extension)||0
5359870|NCT00112437|13187860|P23|STARTED|Year 3 (12-Month Extension)||0
5359871|NCT00112437|13187861|P22|STARTED|Year 3 (12-Month Extension)||0
5359872|NCT00112437|13187862|P21|STARTED|Year 3 (12-Month Extension)||0
5359873|NCT00112437|13187863|P20|STARTED|Year 3 (12-Month Extension)||20
5359874|NCT00112437|13187864|P19|STARTED|Year 3 (12-Month Extension)||18
5359875|NCT00112437|13187865|P18|STARTED|Year 3 (12-Month Extension)||21
5359876|NCT00112437|13187866|P17|STARTED|Year 3 (12-Month Extension)||19
5359877|NCT00112437|13187867|P16|STARTED|Year 3 (12-Month Extension)||17
5359878|NCT00112437|13187868|P15|STARTED|Year 3 (12-Month Extension)||18
5359879|NCT00112437|13187869|P14|STARTED|Year 3 (12-Month Extension)||17
5359880|NCT00112437|13187870|P13|STARTED|Year 3 (12-Month Extension)||18
5359881|NCT00112437|13187871|P12|STARTED|Year 3 (12-Month Extension)||22
5359882|NCT00112437|13187872|P11|STARTED|Year 3 (12-Month Extension)||19
5359883|NCT00112437|13187873|P10|STARTED|Year 3 (12-Month Extension)||0
5359884|NCT00112437|13187874|P9|STARTED|Year 3 (12-Month Extension)||0
5359885|NCT00112437|13187875|P8|STARTED|Year 3 (12-Month Extension)||0
5359886|NCT00112437|13187876|P7|STARTED|Year 3 (12-Month Extension)||0
5359887|NCT00112437|13187877|P6|STARTED|Year 3 (12-Month Extension)||0
5359888|NCT00112437|13187878|P5|STARTED|Year 3 (12-Month Extension)||0
5359889|NCT00112437|13187879|P4|STARTED|Year 3 (12-Month Extension)||0
5359890|NCT00112437|13187880|P3|STARTED|Year 3 (12-Month Extension)||0
5359891|NCT00112437|13187881|P2|STARTED|Year 3 (12-Month Extension)||0
5359892|NCT00112437|13187882|P1|STARTED|Year 3 (12-Month Extension)||0
5359893|NCT00112437|13187857|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359894|NCT00112437|13187858|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359895|NCT00112437|13187859|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359896|NCT00112437|13187860|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359897|NCT00112437|13187861|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359898|NCT00112437|13187862|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359899|NCT00112437|13187863|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359900|NCT00112437|13187864|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359901|NCT00112437|13187865|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359902|NCT00112437|13187866|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359903|NCT00112437|13187867|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359904|NCT00112437|13187868|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359905|NCT00112437|13187869|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359906|NCT00112437|13187870|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359907|NCT00112437|13187871|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359908|NCT00112437|13187872|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359909|NCT00112437|13187873|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
5359910|NCT00112437|13187874|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
5359911|NCT00112437|13187875|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
5359912|NCT00112437|13187876|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
5359913|NCT00112437|13187877|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
5359914|NCT00112437|13187878|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359915|NCT00112437|13187879|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359916|NCT00112437|13187880|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359917|NCT00112437|13187881|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359918|NCT00112437|13187882|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
5359919|NCT00112437|13187857|P26|COMPLETED|Year 2 (12-Month Extension)||0
5359920|NCT00112437|13187858|P25|COMPLETED|Year 2 (12-Month Extension)||0
5359921|NCT00112437|13187859|P24|COMPLETED|Year 2 (12-Month Extension)||0
5359922|NCT00112437|13187860|P23|COMPLETED|Year 2 (12-Month Extension)||0
5359923|NCT00112437|13187861|P22|COMPLETED|Year 2 (12-Month Extension)||0
5359924|NCT00112437|13187862|P21|COMPLETED|Year 2 (12-Month Extension)||0
5359925|NCT00112437|13187863|P20|COMPLETED|Year 2 (12-Month Extension)||0
5359926|NCT00112437|13187864|P19|COMPLETED|Year 2 (12-Month Extension)||0
5359927|NCT00112437|13187865|P18|COMPLETED|Year 2 (12-Month Extension)||0
5359928|NCT00112437|13187866|P17|COMPLETED|Year 2 (12-Month Extension)||0
5359929|NCT00112437|13187867|P16|COMPLETED|Year 2 (12-Month Extension)||0
5359930|NCT00112437|13187868|P15|COMPLETED|Year 2 (12-Month Extension)||0
5359931|NCT00112437|13187869|P14|COMPLETED|Year 2 (12-Month Extension)||0
5359932|NCT00112437|13187870|P13|COMPLETED|Year 2 (12-Month Extension)||0
5359933|NCT00112437|13187871|P12|COMPLETED|Year 2 (12-Month Extension)||0
5359934|NCT00112437|13187872|P11|COMPLETED|Year 2 (12-Month Extension)||0
5359935|NCT00112437|13187873|P10|COMPLETED|Year 2 (12-Month Extension)||50
5359936|NCT00112437|13187874|P9|COMPLETED|Year 2 (12-Month Extension)||62
5359937|NCT00112437|13187875|P8|COMPLETED|Year 2 (12-Month Extension)||55
5359938|NCT00112437|13187876|P7|COMPLETED|Year 2 (12-Month Extension)||53
5359939|NCT00112437|13187877|P6|COMPLETED|Year 2 (12-Month Extension)||60
5359940|NCT00112437|13187878|P5|COMPLETED|Year 2 (12-Month Extension)||0
5359941|NCT00112437|13187879|P4|COMPLETED|Year 2 (12-Month Extension)||0
5359942|NCT00112437|13187880|P3|COMPLETED|Year 2 (12-Month Extension)||0
5359943|NCT00112437|13187881|P2|COMPLETED|Year 2 (12-Month Extension)||0
5359944|NCT00112437|13187882|P1|COMPLETED|Year 2 (12-Month Extension)||0
5359945|NCT00112437|13187857|P26|STARTED|Year 2 (12-Month Extension)||0
5359946|NCT00112437|13187858|P25|STARTED|Year 2 (12-Month Extension)||0
5359947|NCT00112437|13187859|P24|STARTED|Year 2 (12-Month Extension)||0
5359948|NCT00112437|13187860|P23|STARTED|Year 2 (12-Month Extension)||0
5359949|NCT00112437|13187861|P22|STARTED|Year 2 (12-Month Extension)||0
5359950|NCT00112437|13187862|P21|STARTED|Year 2 (12-Month Extension)||0
5359951|NCT00112437|13187863|P20|STARTED|Year 2 (12-Month Extension)||0
5359952|NCT00112437|13187864|P19|STARTED|Year 2 (12-Month Extension)||0
5359953|NCT00112437|13187865|P18|STARTED|Year 2 (12-Month Extension)||0
5359954|NCT00112437|13187866|P17|STARTED|Year 2 (12-Month Extension)||0
5359955|NCT00112437|13187867|P16|STARTED|Year 2 (12-Month Extension)||0
5359956|NCT00112437|13187868|P15|STARTED|Year 2 (12-Month Extension)||0
5359957|NCT00112437|13187869|P14|STARTED|Year 2 (12-Month Extension)||0
5359958|NCT00112437|13187870|P13|STARTED|Year 2 (12-Month Extension)||0
5359959|NCT00112437|13187871|P12|STARTED|Year 2 (12-Month Extension)||0
5359960|NCT00112437|13187872|P11|STARTED|Year 2 (12-Month Extension)||0
5359961|NCT00112437|13187873|P10|STARTED|Year 2 (12-Month Extension)||63
5359962|NCT00112437|13187874|P9|STARTED|Year 2 (12-Month Extension)||69
5359963|NCT00112437|13187875|P8|STARTED|Year 2 (12-Month Extension)||63
5359964|NCT00112437|13187876|P7|STARTED|Year 2 (12-Month Extension)||62
5359965|NCT00112437|13187877|P6|STARTED|Year 2 (12-Month Extension)||63
5359966|NCT00112437|13187878|P5|STARTED|Year 2 (12-Month Extension)||0
5359967|NCT00112437|13187879|P4|STARTED|Year 2 (12-Month Extension)||0
5359968|NCT00112437|13187880|P3|STARTED|Year 2 (12-Month Extension)||0
5359969|NCT00112437|13187881|P2|STARTED|Year 2 (12-Month Extension)||0
5359970|NCT00112437|13187882|P1|STARTED|Year 2 (12-Month Extension)||0
5359971|NCT00112437|13187857|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359972|NCT00112437|13187858|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359973|NCT00112437|13187859|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359974|NCT00112437|13187860|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359975|NCT00112437|13187861|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359976|NCT00112437|13187862|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359977|NCT00112437|13187863|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359978|NCT00112437|13187864|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359979|NCT00112437|13187865|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359980|NCT00112437|13187866|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359981|NCT00112437|13187867|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359982|NCT00112437|13187868|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359983|NCT00112437|13187869|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359984|NCT00112437|13187870|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359985|NCT00112437|13187871|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359986|NCT00112437|13187872|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359987|NCT00112437|13187873|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359988|NCT00112437|13187874|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359989|NCT00112437|13187875|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359990|NCT00112437|13187876|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359991|NCT00112437|13187877|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
5359992|NCT00112437|13187878|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
5359993|NCT00112437|13187879|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
5359994|NCT00112437|13187880|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
5359995|NCT00112437|13187881|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
5359996|NCT00112437|13187882|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
5359997|NCT00112437|13187857|P26|COMPLETED|Year 1 (12-Month Base Study)||0
5359998|NCT00112437|13187858|P25|COMPLETED|Year 1 (12-Month Base Study)||0
5359999|NCT00112437|13187859|P24|COMPLETED|Year 1 (12-Month Base Study)||0
5360000|NCT00112437|13187860|P23|COMPLETED|Year 1 (12-Month Base Study)||0
5360001|NCT00112437|13187861|P22|COMPLETED|Year 1 (12-Month Base Study)||0
5360002|NCT00112437|13187862|P21|COMPLETED|Year 1 (12-Month Base Study)||0
5360003|NCT00112437|13187863|P20|COMPLETED|Year 1 (12-Month Base Study)||0
5360004|NCT00112437|13187864|P19|COMPLETED|Year 1 (12-Month Base Study)||0
5360005|NCT00112437|13187865|P18|COMPLETED|Year 1 (12-Month Base Study)||0
5360006|NCT00112437|13187866|P17|COMPLETED|Year 1 (12-Month Base Study)||0
5360007|NCT00112437|13187867|P16|COMPLETED|Year 1 (12-Month Base Study)||0
5360008|NCT00112437|13187868|P15|COMPLETED|Year 1 (12-Month Base Study)||0
5360009|NCT00112437|13187869|P14|COMPLETED|Year 1 (12-Month Base Study)||0
5360010|NCT00112437|13187870|P13|COMPLETED|Year 1 (12-Month Base Study)||0
5360011|NCT00112437|13187871|P12|COMPLETED|Year 1 (12-Month Base Study)||0
5360012|NCT00112437|13187872|P11|COMPLETED|Year 1 (12-Month Base Study)||0
5360013|NCT00112437|13187873|P10|COMPLETED|Year 1 (12-Month Base Study)||0
5360014|NCT00112437|13187874|P9|COMPLETED|Year 1 (12-Month Base Study)||0
5360015|NCT00112437|13187875|P8|COMPLETED|Year 1 (12-Month Base Study)||0
5360016|NCT00112437|13187876|P7|COMPLETED|Year 1 (12-Month Base Study)||0
5360017|NCT00112437|13187877|P6|COMPLETED|Year 1 (12-Month Base Study)||0
5360018|NCT00112437|13187878|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
5360019|NCT00112437|13187879|P4|COMPLETED|Year 1 (12-Month Base Study)||71
5360020|NCT00112437|13187880|P3|COMPLETED|Year 1 (12-Month Base Study)||65
5360021|NCT00112437|13187881|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
5360022|NCT00112437|13187882|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
5360023|NCT00112437|13187857|P26|STARTED|Year 1 (12-Month Base Study)||0
5360024|NCT00112437|13187858|P25|STARTED|Year 1 (12-Month Base Study)||0
5360025|NCT00112437|13187859|P24|STARTED|Year 1 (12-Month Base Study)||0
5360026|NCT00112437|13187860|P23|STARTED|Year 1 (12-Month Base Study)||0
5360027|NCT00112437|13187861|P22|STARTED|Year 1 (12-Month Base Study)||0
5360028|NCT00112437|13187862|P21|STARTED|Year 1 (12-Month Base Study)||0
5360029|NCT00112437|13187863|P20|STARTED|Year 1 (12-Month Base Study)||0
5360030|NCT00112437|13187864|P19|STARTED|Year 1 (12-Month Base Study)||0
5360031|NCT00112437|13187865|P18|STARTED|Year 1 (12-Month Base Study)||0
5360032|NCT00112437|13187866|P17|STARTED|Year 1 (12-Month Base Study)||0
5360033|NCT00112437|13187867|P16|STARTED|Year 1 (12-Month Base Study)||0
5360034|NCT00112437|13187868|P15|STARTED|Year 1 (12-Month Base Study)||0
5360035|NCT00112437|13187869|P14|STARTED|Year 1 (12-Month Base Study)||0
5360036|NCT00112437|13187870|P13|STARTED|Year 1 (12-Month Base Study)||0
5360037|NCT00112437|13187871|P12|STARTED|Year 1 (12-Month Base Study)||0
5360038|NCT00112437|13187872|P11|STARTED|Year 1 (12-Month Base Study)||0
5360039|NCT00112437|13187873|P10|STARTED|Year 1 (12-Month Base Study)||0
5360040|NCT00112437|13187874|P9|STARTED|Year 1 (12-Month Base Study)||0
5360041|NCT00112437|13187875|P8|STARTED|Year 1 (12-Month Base Study)||0
5360042|NCT00112437|13187876|P7|STARTED|Year 1 (12-Month Base Study)||0
5360043|NCT00112437|13187877|P6|STARTED|Year 1 (12-Month Base Study)||0
5360044|NCT00112437|13187878|P5|STARTED|Year 1 (12-Month Base Study)||78
5360045|NCT00112437|13187879|P4|STARTED|Year 1 (12-Month Base Study)||79
5360046|NCT00112437|13187880|P3|STARTED|Year 1 (12-Month Base Study)||77
5360047|NCT00112437|13187881|P2|STARTED|Year 1 (12-Month Base Study)||82
5360048|NCT00112437|13187882|P1|STARTED|Year 1 (12-Month Base Study)||83
5360049|NCT00112385|13188162|P2|NOT COMPLETED|Overall Study||1
5360050|NCT00112385|13188163|P1|NOT COMPLETED|Overall Study||1
5360051|NCT00112385|13188162|P2|COMPLETED|Overall Study||4
5360052|NCT00112385|13188163|P1|COMPLETED|Overall Study||10
5360053|NCT00112385|13188162|P2|STARTED|Overall Study||5
5360054|NCT00112385|13188163|P1|STARTED|Overall Study||11
5360055|NCT00112359|13188253|P2|NOT COMPLETED|Overall Study||13
5360056|NCT00112359|13188254|P1|NOT COMPLETED|Overall Study||27
5360057|NCT00112359|13188253|P2|COMPLETED|Overall Study||67
5360058|NCT00112359|13188254|P1|COMPLETED|Overall Study||57
5360059|NCT00112359|13188253|P2|STARTED|Overall Study||80
5360060|NCT00112359|13188254|P1|STARTED|Overall Study||84
5360061|NCT00112294|13188280|P2|NOT COMPLETED|Overall Study||0
5360062|NCT00112294|13188281|P1|NOT COMPLETED|Overall Study||5
5360063|NCT00112294|13188280|P2|COMPLETED|Overall Study|Off all study therapies.|320
5360064|NCT00112294|13188281|P1|COMPLETED|Overall Study|Off all study therapies.|320
5360065|NCT00112294|13188280|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
5360066|NCT00112294|13188281|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
5360067|NCT00112294|13188280|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
5360068|NCT00112294|13188281|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
5360069|NCT00112242|13188324|P5|NOT COMPLETED|Overall Study||7
5360070|NCT00112242|13188325|P4|NOT COMPLETED|Overall Study||6
5360071|NCT00112242|13188326|P3|NOT COMPLETED|Overall Study||1
5360072|NCT00112242|13188327|P2|NOT COMPLETED|Overall Study||2
5360073|NCT00112242|13188328|P1|NOT COMPLETED|Overall Study||5
5360074|NCT00112242|13188324|P5|COMPLETED|Overall Study||2
5360075|NCT00112242|13188325|P4|COMPLETED|Overall Study||4
5360076|NCT00112242|13188326|P3|COMPLETED|Overall Study||4
5360077|NCT00112242|13188327|P2|COMPLETED|Overall Study||3
5360078|NCT00112242|13188328|P1|COMPLETED|Overall Study||5
5360079|NCT00112242|13188324|P5|Cycle 3 Completed|Overall Study||2
5360080|NCT00112242|13188325|P4|Cycle 3 Completed|Overall Study||4
5360081|NCT00112242|13188326|P3|Cycle 3 Completed|Overall Study||4
5360082|NCT00112242|13188327|P2|Cycle 3 Completed|Overall Study||3
5360083|NCT00112242|13188328|P1|Cycle 3 Completed|Overall Study||5
5360084|NCT00112242|13188324|P5|Cycle 2 Completed|Overall Study||4
5360085|NCT00112242|13188325|P4|Cycle 2 Completed|Overall Study||8
5360086|NCT00112242|13188326|P3|Cycle 2 Completed|Overall Study||4
5360087|NCT00112242|13188327|P2|Cycle 2 Completed|Overall Study||3
5360088|NCT00112242|13188328|P1|Cycle 2 Completed|Overall Study||8
5360089|NCT00112242|13188324|P5|Cycle 1 Completed|Overall Study||7
5360090|NCT00112242|13188325|P4|Cycle 1 Completed|Overall Study||9
5360091|NCT00112242|13188326|P3|Cycle 1 Completed|Overall Study||5
5360092|NCT00112242|13188327|P2|Cycle 1 Completed|Overall Study||5
5360093|NCT00112242|13188328|P1|Cycle 1 Completed|Overall Study||10
5360094|NCT00112242|13188324|P5|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
5360095|NCT00112242|13188325|P4|STARTED|Overall Study||10
5360096|NCT00112242|13188326|P3|STARTED|Overall Study||5
5360097|NCT00112242|13188327|P2|STARTED|Overall Study||5
5360098|NCT00112242|13188328|P1|STARTED|Overall Study||10
5360099|NCT00112151|13188391|P6|NOT COMPLETED|Overall Study||3
5360100|NCT00112151|13188392|P5|NOT COMPLETED|Overall Study||6
5360101|NCT00112151|13188393|P4|NOT COMPLETED|Overall Study||3
5360102|NCT00112151|13188394|P3|NOT COMPLETED|Overall Study||3
5360103|NCT00112151|13188395|P2|NOT COMPLETED|Overall Study||5
5360104|NCT00112151|13188396|P1|NOT COMPLETED|Overall Study||4
5360105|NCT00112151|13188391|P6|COMPLETED|Overall Study||25
5360106|NCT00112151|13188392|P5|COMPLETED|Overall Study||22
5360107|NCT00112151|13188393|P4|COMPLETED|Overall Study||24
5360108|NCT00112151|13188394|P3|COMPLETED|Overall Study||25
5360109|NCT00112151|13188395|P2|COMPLETED|Overall Study||23
5360110|NCT00112151|13188396|P1|COMPLETED|Overall Study||24
5360111|NCT00112151|13188391|P6|STARTED|Overall Study||28
5360112|NCT00112151|13188392|P5|STARTED|Overall Study||28
5360113|NCT00112151|13188393|P4|STARTED|Overall Study||27
5360114|NCT00112151|13188394|P3|STARTED|Overall Study||28
5360115|NCT00112151|13188395|P2|STARTED|Overall Study||28
5360116|NCT00112151|13188396|P1|STARTED|Overall Study||28
5360117|NCT00112112|13188427|P2|NOT COMPLETED|Overall Study||0
5360118|NCT00112112|13188428|P1|NOT COMPLETED|Overall Study||0
5360119|NCT00112112|13188427|P2|COMPLETED|Overall Study||10
5360120|NCT00112112|13188428|P1|COMPLETED|Overall Study||10
5360121|NCT00112112|13188427|P2|STARTED|Overall Study||10
5360122|NCT00112112|13188428|P1|STARTED|Overall Study||10
5360123|NCT00112047|13188570|P2|NOT COMPLETED|Atripla Phase||20
5360124|NCT00112047|13188571|P1|NOT COMPLETED|Atripla Phase||18
5360125|NCT00112047|13188570|P2|COMPLETED|Atripla Phase||106
5360126|NCT00112047|13188571|P1|COMPLETED|Atripla Phase||142
5360127|NCT00112047|13188570|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
5360128|NCT00112047|13188571|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
5360129|NCT00112047|13188570|P2|NOT COMPLETED|Randomized Phase||88
5360130|NCT00112047|13188571|P1|NOT COMPLETED|Randomized Phase||70
5360131|NCT00112047|13188570|P2|COMPLETED|Randomized Phase||166
5360132|NCT00112047|13188571|P1|COMPLETED|Randomized Phase||187
5360133|NCT00112047|13188570|P2|STARTED|Randomized Phase|ITT analysis population|254
5360134|NCT00112047|13188571|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
5360135|NCT00111917|13188671|P2|NOT COMPLETED|Overall Study||1
5360136|NCT00111917|13188672|P1|NOT COMPLETED|Overall Study||1
5360137|NCT00111917|13188671|P2|COMPLETED|Overall Study||3
5360138|NCT00111917|13188672|P1|COMPLETED|Overall Study||8
5360139|NCT00111917|13188671|P2|STARTED|Overall Study||4
5360140|NCT00111917|13188672|P1|STARTED|Overall Study||9
5360141|NCT00111839|13188687|P3|NOT COMPLETED|Overall Study||49
5360142|NCT00111839|13188688|P2|NOT COMPLETED|Overall Study||46
5360143|NCT00111839|13188689|P1|NOT COMPLETED|Overall Study||48
5360144|NCT00111839|13188687|P3|COMPLETED|Overall Study||0
5360145|NCT00111839|13188688|P2|COMPLETED|Overall Study||5
5360146|NCT00111839|13188689|P1|COMPLETED|Overall Study||2
5360147|NCT00111839|13188687|P3|Treated|Overall Study||47
5360148|NCT00111839|13188688|P2|Treated|Overall Study||51
5360149|NCT00111839|13188689|P1|Treated|Overall Study||50
5360150|NCT00111839|13188687|P3|STARTED|Overall Study||49
5360151|NCT00111839|13188688|P2|STARTED|Overall Study||51
5360152|NCT00111839|13188689|P1|STARTED|Overall Study||50
5360153|NCT00111813|13188709|P6|NOT COMPLETED|Overall Study||6
5360154|NCT00111813|13188710|P5|NOT COMPLETED|Overall Study||6
5360155|NCT00111813|13188711|P4|NOT COMPLETED|Overall Study||5
5360156|NCT00111813|13188712|P3|NOT COMPLETED|Overall Study||10
5360157|NCT00111813|13188713|P2|NOT COMPLETED|Overall Study||3
5360158|NCT00111813|13188714|P1|NOT COMPLETED|Overall Study||3
5360159|NCT00111813|13188709|P6|COMPLETED|Overall Study||0
5360160|NCT00111813|13188710|P5|COMPLETED|Overall Study||0
5360161|NCT00111813|13188711|P4|COMPLETED|Overall Study||1
5360162|NCT00111813|13188712|P3|COMPLETED|Overall Study||0
5360163|NCT00111813|13188713|P2|COMPLETED|Overall Study||0
5360164|NCT00111813|13188714|P1|COMPLETED|Overall Study||0
5360165|NCT00111813|13188709|P6|STARTED|Overall Study||6
5360166|NCT00111813|13188710|P5|STARTED|Overall Study||6
5360167|NCT00111813|13188711|P4|STARTED|Overall Study||6
5360168|NCT00111813|13188712|P3|STARTED|Overall Study||10
5360169|NCT00111813|13188713|P2|STARTED|Overall Study||3
5360170|NCT00111813|13188714|P1|STARTED|Overall Study||3
5360171|NCT00111800|13188753|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
5360172|NCT00111800|13188754|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
5360173|NCT00111800|13188755|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
5360174|NCT00111800|13188756|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
5360175|NCT00111800|13188757|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
5360176|NCT00111800|13188758|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
5360177|NCT00111800|13188753|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
5360178|NCT00111800|13188754|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
5360179|NCT00111800|13188755|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
5360180|NCT00111800|13188756|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
5360181|NCT00111800|13188757|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
5360182|NCT00111800|13188758|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
5360183|NCT00111800|13188753|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
5360184|NCT00111800|13188754|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
5360185|NCT00111800|13188755|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
5360186|NCT00111800|13188756|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
5360187|NCT00111800|13188757|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
5360188|NCT00111800|13188758|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
5360189|NCT00111800|13188753|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
5360190|NCT00111800|13188754|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
5360191|NCT00111800|13188755|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
5360192|NCT00111800|13188756|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
5360193|NCT00111800|13188757|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
5360194|NCT00111800|13188758|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
5360195|NCT00111800|13188753|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
5360196|NCT00111800|13188754|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
5360197|NCT00111800|13188755|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
5360198|NCT00111800|13188756|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
5360199|NCT00111800|13188757|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
5360200|NCT00111800|13188758|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
5360201|NCT00111800|13188753|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
5360202|NCT00111800|13188754|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
5360203|NCT00111800|13188755|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
5360204|NCT00111800|13188756|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
5360205|NCT00111800|13188757|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
5360206|NCT00111800|13188758|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
5360207|NCT00111761|13188928|P2|NOT COMPLETED|Part 2||0
5360208|NCT00111761|13188929|P1|NOT COMPLETED|Part 2||8
5360209|NCT00111761|13188928|P2|COMPLETED|Part 2||0
5360210|NCT00111761|13188929|P1|COMPLETED|Part 2||16
5360211|NCT00111761|13188928|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
5360212|NCT00111761|13188929|P1|STARTED|Part 2||24
5360213|NCT00111761|13188928|P2|NOT COMPLETED|Part 1||5
5360214|NCT00111761|13188929|P1|NOT COMPLETED|Part 1||0
5360215|NCT00111761|13188928|P2|COMPLETED|Part 1|Completed through safety followup|14
5360216|NCT00111761|13188929|P1|COMPLETED|Part 1||0
5360217|NCT00111761|13188928|P2|STARTED|Part 1||19
5360218|NCT00111761|13188929|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
5360219|NCT00111657|13188946|P1|NOT COMPLETED|Overall Study||16
5360220|NCT00111657|13188946|P1|COMPLETED|Overall Study|Completed all intended doses.|21
5360221|NCT00111657|13188946|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
5360222|NCT00111475|13188966|P10|NOT COMPLETED|Overall Study||0
5360223|NCT00111475|13188967|P9|NOT COMPLETED|Overall Study||0
5360224|NCT00111475|13188968|P8|NOT COMPLETED|Overall Study||0
5360225|NCT00111475|13188969|P7|NOT COMPLETED|Overall Study||0
5360226|NCT00111475|13188970|P6|NOT COMPLETED|Overall Study||1
5360227|NCT00111475|13188971|P5|NOT COMPLETED|Overall Study||0
5360228|NCT00111475|13188972|P4|NOT COMPLETED|Overall Study||0
5360229|NCT00111475|13188973|P3|NOT COMPLETED|Overall Study||0
5360230|NCT00111475|13188974|P2|NOT COMPLETED|Overall Study||0
5360231|NCT00111475|13188975|P1|NOT COMPLETED|Overall Study||0
5360232|NCT00111475|13188966|P10|COMPLETED|Overall Study||1
5360233|NCT00111475|13188967|P9|COMPLETED|Overall Study||8
5360234|NCT00111475|13188968|P8|COMPLETED|Overall Study||8
5360235|NCT00111475|13188969|P7|COMPLETED|Overall Study||4
5360236|NCT00111475|13188970|P6|COMPLETED|Overall Study||3
5360237|NCT00111475|13188971|P5|COMPLETED|Overall Study||4
5360238|NCT00111475|13188972|P4|COMPLETED|Overall Study||4
5360239|NCT00111475|13188973|P3|COMPLETED|Overall Study||4
5360240|NCT00111475|13188974|P2|COMPLETED|Overall Study||4
5360241|NCT00111475|13188975|P1|COMPLETED|Overall Study||4
5360242|NCT00111475|13188966|P10|STARTED|Overall Study||1
5360243|NCT00111475|13188967|P9|STARTED|Overall Study||8
5360244|NCT00111475|13188968|P8|STARTED|Overall Study||8
5360245|NCT00111475|13188969|P7|STARTED|Overall Study||4
5360246|NCT00111475|13188970|P6|STARTED|Overall Study||4
5360247|NCT00111475|13188971|P5|STARTED|Overall Study||4
5360248|NCT00111475|13188972|P4|STARTED|Overall Study||4
5360249|NCT00111475|13188973|P3|STARTED|Overall Study||4
5360250|NCT00111475|13188974|P2|STARTED|Overall Study||4
5360251|NCT00111475|13188975|P1|STARTED|Overall Study||4
5360252|NCT00111241|13189093|P2|NOT COMPLETED|Overall Study||8
5360253|NCT00111241|13189094|P1|NOT COMPLETED|Overall Study||15
5360254|NCT00111241|13189093|P2|COMPLETED|Overall Study||62
5360255|NCT00111241|13189094|P1|COMPLETED|Overall Study||30
5360256|NCT00111241|13189093|P2|STARTED|Overall Study||70
5360257|NCT00111241|13189094|P1|STARTED|Overall Study||45
5360258|NCT00111228|13189105|P3|NOT COMPLETED|Overall Study||0
5360259|NCT00111228|13189106|P2|NOT COMPLETED|Overall Study||1
5360260|NCT00111228|13189107|P1|NOT COMPLETED|Overall Study||5
5360261|NCT00111228|13189105|P3|COMPLETED|Overall Study||54
5360262|NCT00111228|13189106|P2|COMPLETED|Overall Study||53
5360263|NCT00111228|13189107|P1|COMPLETED|Overall Study||49
5360264|NCT00111228|13189105|P3|STARTED|Overall Study||54
5360265|NCT00111228|13189106|P2|STARTED|Overall Study||54
5360266|NCT00111228|13189107|P1|STARTED|Overall Study||54
5360267|NCT00111007|13189120|P2|NOT COMPLETED|Long Term Follow-up||45
5360268|NCT00111007|13189121|P1|NOT COMPLETED|Long Term Follow-up||47
5360269|NCT00111007|13189120|P2|COMPLETED|Long Term Follow-up||62
5360270|NCT00111007|13189121|P1|COMPLETED|Long Term Follow-up||54
5360271|NCT00111007|13189120|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
5360272|NCT00111007|13189121|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
5360273|NCT00111007|13189120|P2|NOT COMPLETED|Active Follow-up||2
5360274|NCT00111007|13189121|P1|NOT COMPLETED|Active Follow-up||6
5360275|NCT00111007|13189120|P2|COMPLETED|Active Follow-up||2
5360276|NCT00111007|13189121|P1|COMPLETED|Active Follow-up||0
5360277|NCT00111007|13189120|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
5360278|NCT00111007|13189121|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
5360279|NCT00111007|13189120|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
5360280|NCT00111007|13189121|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
5360281|NCT00111007|13189120|P2|COMPLETED|Double-blind (DB) Treatment||24
5360282|NCT00111007|13189121|P1|COMPLETED|Double-blind (DB) Treatment||27
5360283|NCT00111007|13189120|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
5360284|NCT00111007|13189121|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
5360285|NCT00111007|13189120|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
5360286|NCT00111007|13189121|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
5360287|NCT00110994|13189137|P2|NOT COMPLETED|Long Term Follow-up||17
5360288|NCT00110994|13189138|P1|NOT COMPLETED|Long Term Follow-up||19
5360289|NCT00110994|13189137|P2|COMPLETED|Long Term Follow-up||30
5360290|NCT00110994|13189138|P1|COMPLETED|Long Term Follow-up||22
5360291|NCT00110994|13189137|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
5360292|NCT00110994|13189138|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
5360293|NCT00110994|13189137|P2|NOT COMPLETED|Active Follow-up||2
5360294|NCT00110994|13189138|P1|NOT COMPLETED|Active Follow-up||1
5360295|NCT00110994|13189137|P2|COMPLETED|Active Follow-up||0
5360296|NCT00110994|13189138|P1|COMPLETED|Active Follow-up||0
5360297|NCT00110994|13189137|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
5360298|NCT00110994|13189138|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
5360299|NCT00110994|13189137|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
5360300|NCT00110994|13189138|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
5360301|NCT00110994|13189137|P2|COMPLETED|Double-blind (DB) Treatment||3
5360302|NCT00110994|13189138|P1|COMPLETED|Double-blind (DB) Treatment||9
5360303|NCT00110994|13189137|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
5360304|NCT00110994|13189138|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
5360305|NCT00110994|13189137|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
5360306|NCT00110994|13189138|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
5360307|NCT00110890|13189164|P2|NOT COMPLETED|Overall Study||179
5360308|NCT00110890|13189165|P1|NOT COMPLETED|Overall Study||361
5360309|NCT00110890|13189164|P2|COMPLETED|Overall Study|Follow-up Phase|5
5360310|NCT00110890|13189165|P1|COMPLETED|Overall Study|Follow-up Phase|7
5360311|NCT00110890|13189164|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
5360312|NCT00110890|13189165|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
5360313|NCT00110890|13189164|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
5360314|NCT00110890|13189165|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
5360315|NCT00110890|13189164|P2|STARTED|Overall Study||184
5360316|NCT00110890|13189165|P1|STARTED|Overall Study||368
5360317|NCT00110812|13189182|P3|NOT COMPLETED|Extended Follow-up||4
5360318|NCT00110812|13189183|P2|NOT COMPLETED|Extended Follow-up||4
5360319|NCT00110812|13189184|P1|NOT COMPLETED|Extended Follow-up||2
5360320|NCT00110812|13189182|P3|COMPLETED|Extended Follow-up||69
5360321|NCT00110812|13189183|P2|COMPLETED|Extended Follow-up||65
5360322|NCT00110812|13189184|P1|COMPLETED|Extended Follow-up||78
5360323|NCT00110812|13189182|P3|STARTED|Extended Follow-up||73
5360324|NCT00110812|13189183|P2|STARTED|Extended Follow-up||69
5360325|NCT00110812|13189184|P1|STARTED|Extended Follow-up||80
5360326|NCT00110812|13189182|P3|NOT COMPLETED|Main Study||13
5360327|NCT00110812|13189183|P2|NOT COMPLETED|Main Study||11
5360328|NCT00110812|13189184|P1|NOT COMPLETED|Main Study||8
5360329|NCT00110812|13189182|P3|COMPLETED|Main Study||74
5360330|NCT00110812|13189183|P2|COMPLETED|Main Study||78
5360331|NCT00110812|13189184|P1|COMPLETED|Main Study||83
5360332|NCT00110812|13189182|P3|STARTED|Main Study||87
5360333|NCT00110812|13189183|P2|STARTED|Main Study||89
5360334|NCT00110812|13189184|P1|STARTED|Main Study||91
5360335|NCT00110617|13189229|P2|NOT COMPLETED|Overall Study||29
5360336|NCT00110617|13189230|P1|NOT COMPLETED|Overall Study||39
5360337|NCT00110617|13189229|P2|COMPLETED|Overall Study||39
5360338|NCT00110617|13189230|P1|COMPLETED|Overall Study||96
5360339|NCT00110617|13189229|P2|On Going at Week 24|Overall Study||53
5360340|NCT00110617|13189230|P1|On Going at Week 24|Overall Study||126
5360341|NCT00110617|13189229|P2|Full Analysis 2; Received ICL670|Overall Study||53
5360342|NCT00110617|13189230|P1|Full Analysis 2; Received ICL670|Overall Study||135
5360343|NCT00110617|13189229|P2|Safety Set 1; Received Study Drug|Overall Study||56
5360344|NCT00110617|13189230|P1|Safety Set 1; Received Study Drug|Overall Study||135
5360345|NCT00110617|13189229|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
5360346|NCT00110617|13189230|P1|STARTED|Overall Study||135
5360347|NCT00110513|13189243|P1|NOT COMPLETED|Overall Study||0
5360348|NCT00110513|13189243|P1|COMPLETED|Overall Study||18
5360349|NCT00110513|13189243|P1|STARTED|Overall Study||18
5360350|NCT00110461|13189250|P3|NOT COMPLETED|Acute Phase||23
5360351|NCT00110461|13189251|P2|NOT COMPLETED|Acute Phase||22
5360352|NCT00110461|13189252|P1|NOT COMPLETED|Acute Phase||14
5360353|NCT00110461|13189250|P3|COMPLETED|Acute Phase||76
5360354|NCT00110461|13189251|P2|COMPLETED|Acute Phase||77
5360355|NCT00110461|13189252|P1|COMPLETED|Acute Phase||84
5360356|NCT00110461|13189250|P3|STARTED|Acute Phase||99
5360357|NCT00110461|13189251|P2|STARTED|Acute Phase||99
5360358|NCT00110461|13189252|P1|STARTED|Acute Phase||98
5360359|NCT00110461|13189250|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
5360360|NCT00110461|13189251|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
5360361|NCT00110461|13189252|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
5360362|NCT00110461|13189250|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
5360363|NCT00110461|13189251|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
5360364|NCT00110461|13189252|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
5360365|NCT00110461|13189250|P3|STARTED|30-Week, Double-blind Treatment Phase||99
5360366|NCT00110461|13189251|P2|STARTED|30-Week, Double-blind Treatment Phase||99
5360367|NCT00110461|13189252|P1|STARTED|30-Week, Double-blind Treatment Phase||98
5360368|NCT00110396|13189347|P1|NOT COMPLETED|Overall Study||36
5360369|NCT00110396|13189347|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
5360370|NCT00110396|13189347|P1|STARTED|Overall Study||260
5360371|NCT00110357|13189355|P2|NOT COMPLETED|Overall Study||19
5360372|NCT00110357|13189356|P1|NOT COMPLETED|Overall Study||27
5360373|NCT00110357|13189355|P2|COMPLETED|Overall Study|Number Still on Study|0
5360374|NCT00110357|13189356|P1|COMPLETED|Overall Study|Number Still on Study|0
5360375|NCT00110357|13189355|P2|STARTED|Overall Study||19
5360376|NCT00110357|13189356|P1|STARTED|Overall Study||27
5360377|NCT00110305|13189444|P2|NOT COMPLETED|Overall Study||32
5360378|NCT00110305|13189445|P1|NOT COMPLETED|Overall Study||114
5360379|NCT00110305|13189444|P2|COMPLETED|Overall Study||57
5360380|NCT00110305|13189445|P1|COMPLETED|Overall Study||165
5360381|NCT00110305|13189444|P2|STARTED|Overall Study||89
5360382|NCT00110305|13189445|P1|STARTED|Overall Study||279
5360383|NCT00110214|13189498|P2|NOT COMPLETED|Overall Study||503
5360384|NCT00110214|13189499|P1|NOT COMPLETED|Overall Study||509
5360385|NCT00110214|13189498|P2|COMPLETED|Overall Study||21
5360386|NCT00110214|13189499|P1|COMPLETED|Overall Study||17
5360387|NCT00110214|13189498|P2|STARTED|Overall Study||524
5360388|NCT00110214|13189499|P1|STARTED|Overall Study||526
5360389|NCT00110149|13189511|P1|NOT COMPLETED|Overall Study||3
5360390|NCT00110149|13189511|P1|COMPLETED|Overall Study||9
5360391|NCT00110149|13189511|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
5360392|NCT00110149|13189511|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
5360393|NCT00110136|13189516|P1|NOT COMPLETED|Overall Study||0
5360394|NCT00110136|13189516|P1|COMPLETED|Overall Study||9
5360395|NCT00110136|13189516|P1|STARTED|Overall Study||9
5360396|NCT00110084|13189525|P1|NOT COMPLETED|Overall Study||28
5360397|NCT00110084|13189525|P1|COMPLETED|Overall Study||22
5360398|NCT00110084|13189525|P1|STARTED|Overall Study||50
5360399|NCT00110019|13189534|P2|NOT COMPLETED|Overall Study||413
5360400|NCT00110019|13189535|P1|NOT COMPLETED|Overall Study||406
5360401|NCT00110019|13189534|P2|COMPLETED|Overall Study||0
5360402|NCT00110019|13189535|P1|COMPLETED|Overall Study||4
5360403|NCT00110019|13189534|P2|Treated|Overall Study||397
5360404|NCT00110019|13189535|P1|Treated|Overall Study||393
5360405|NCT00110019|13189534|P2|Eligible|Overall Study||398
5360406|NCT00110019|13189535|P1|Eligible|Overall Study||395
5360407|NCT00110019|13189534|P2|STARTED|Overall Study||413
5360408|NCT00110019|13189535|P1|STARTED|Overall Study||410
5360409|NCT00109967|13189547|P2|NOT COMPLETED|Overall Study||6
5360410|NCT00109967|13189548|P1|NOT COMPLETED|Overall Study||20
5360411|NCT00109967|13189547|P2|COMPLETED|Overall Study||15
5360412|NCT00109967|13189548|P1|COMPLETED|Overall Study||30
5360413|NCT00109967|13189547|P2|STARTED|Overall Study||21
5360414|NCT00109967|13189548|P1|STARTED|Overall Study||50
5360415|NCT00109928|13189562|P1|NOT COMPLETED|Overall Study||13
5360416|NCT00109928|13189562|P1|COMPLETED|Overall Study||21
5360417|NCT00109928|13189562|P1|Eligible and Began Protocol Therapy|Overall Study||33
5360418|NCT00109928|13189562|P1|Eligible|Overall Study||33
5360419|NCT00109928|13189562|P1|STARTED|Overall Study||34
5360420|NCT00109876|13189569|P1|NOT COMPLETED|Overall Study||0
5360421|NCT00109876|13189569|P1|COMPLETED|Overall Study||51
5360422|NCT00109876|13189569|P1|STARTED|Overall Study||51
5360423|NCT00109850|13189579|P1|NOT COMPLETED|Overall Study||4
5360424|NCT00109850|13189579|P1|COMPLETED|Overall Study||18
5360425|NCT00109850|13189579|P1|Eligible and Began Protocol Therapy|Overall Study||21
5360426|NCT00109850|13189579|P1|Eligible|Overall Study||21
5360427|NCT00109850|13189579|P1|STARTED|Overall Study||22
5360428|NCT00109837|13189586|P1|NOT COMPLETED|Overall Study||23
5360429|NCT00109837|13189586|P1|COMPLETED|Overall Study||56
5360430|NCT00109837|13189586|P1|Eligible and Ph- and Treated|Overall Study||60
5360431|NCT00109837|13189586|P1|Eligible and Ph-|Overall Study||61
5360432|NCT00109837|13189586|P1|Eligible|Overall Study||78
5360433|NCT00109837|13189586|P1|STARTED|Overall Study||79
5360434|NCT00109772|13189596|P2|NOT COMPLETED|Open-label Extension||49
5360435|NCT00109772|13189597|P1|NOT COMPLETED|Open-label Extension||45
5360436|NCT00109772|13189596|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
5360437|NCT00109772|13189597|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
5360438|NCT00109772|13189596|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
5360439|NCT00109772|13189597|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
5360440|NCT00109772|13189596|P2|NOT COMPLETED|Double-blind Treatment||15
5360441|NCT00109772|13189597|P1|NOT COMPLETED|Double-blind Treatment||22
5360442|NCT00109772|13189596|P2|COMPLETED|Double-blind Treatment||79
5360443|NCT00109772|13189597|P1|COMPLETED|Double-blind Treatment||68
5360444|NCT00109772|13189596|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
5360445|NCT00109772|13189597|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
5360446|NCT00109772|13189596|P2|STARTED|Double-blind Treatment||94
5360447|NCT00109772|13189597|P1|STARTED|Double-blind Treatment||90
5360448|NCT00109733|13189637|P2|NOT COMPLETED|Overall Study||4
5360449|NCT00109733|13189638|P1|NOT COMPLETED|Overall Study||2
5360450|NCT00109733|13189637|P2|COMPLETED|Overall Study||12
5360451|NCT00109733|13189638|P1|COMPLETED|Overall Study||13
5360452|NCT00109733|13189637|P2|STARTED|Overall Study||16
5360453|NCT00109733|13189638|P1|STARTED|Overall Study||15
5360454|NCT00109590|13189655|P3|NOT COMPLETED|Overall Study||4
5360455|NCT00109590|13189656|P2|NOT COMPLETED|Overall Study||2
5360456|NCT00109590|13189657|P1|NOT COMPLETED|Overall Study||2
5360457|NCT00109590|13189655|P3|COMPLETED|Overall Study||56
5360458|NCT00109590|13189656|P2|COMPLETED|Overall Study||56
5360459|NCT00109590|13189657|P1|COMPLETED|Overall Study||55
5360460|NCT00109590|13189655|P3|RECEIVED TREATMENT|Overall Study||57
5360461|NCT00109590|13189656|P2|RECEIVED TREATMENT|Overall Study||56
5360462|NCT00109590|13189657|P1|RECEIVED TREATMENT|Overall Study||56
5360463|NCT00109590|13189655|P3|STARTED|Overall Study||60
5360464|NCT00109590|13189656|P2|STARTED|Overall Study||58
5360465|NCT00109590|13189657|P1|STARTED|Overall Study||57
5360466|NCT00109577|13189699|P2|NOT COMPLETED|Overall Study||3
5360467|NCT00109577|13189700|P1|NOT COMPLETED|Overall Study||3
5360468|NCT00109577|13189699|P2|COMPLETED|Overall Study||17
5360469|NCT00109577|13189700|P1|COMPLETED|Overall Study||17
5360470|NCT00109577|13189699|P2|STARTED|Overall Study||20
5360471|NCT00109577|13189700|P1|STARTED|Overall Study||20
5360472|NCT00109473|13189708|P2|NOT COMPLETED|52 Week Extension Phase||5
5360473|NCT00109473|13189709|P1|NOT COMPLETED|52 Week Extension Phase||4
5360474|NCT00109473|13189708|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
5360475|NCT00109473|13189709|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
5360476|NCT00109473|13189708|P2|Analyzed|52 Week Extension Phase||8
5360477|NCT00109473|13189709|P1|Analyzed|52 Week Extension Phase||9
5360478|NCT00109473|13189708|P2|STARTED|52 Week Extension Phase||8
5360479|NCT00109473|13189709|P1|STARTED|52 Week Extension Phase||9
5360480|NCT00109473|13189708|P2|NOT COMPLETED|Week 12 to Week 24||0
5360481|NCT00109473|13189709|P1|NOT COMPLETED|Week 12 to Week 24||1
5360482|NCT00109473|13189708|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
5360483|NCT00109473|13189709|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
5360484|NCT00109473|13189708|P2|Analyzed|Week 12 to Week 24||9
5360485|NCT00109473|13189709|P1|Analyzed|Week 12 to Week 24||9
5360486|NCT00109473|13189708|P2|STARTED|Week 12 to Week 24||9
5360487|NCT00109473|13189709|P1|STARTED|Week 12 to Week 24||10
5360488|NCT00109473|13189708|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
5360489|NCT00109473|13189709|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
5360490|NCT00109473|13189708|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
5360491|NCT00109473|13189709|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
5360492|NCT00109473|13189708|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
5360493|NCT00109473|13189709|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
5360494|NCT00109473|13189708|P2|STARTED|Baseline (0 Through 12 Weeks)||10
5360495|NCT00109473|13189709|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
5360496|NCT00109343|13189731|P3|NOT COMPLETED|Overall Study||30
5360497|NCT00109343|13189732|P2|NOT COMPLETED|Overall Study||37
5360498|NCT00109343|13189733|P1|NOT COMPLETED|Overall Study||64
5360499|NCT00109343|13189731|P3|COMPLETED|Overall Study||229
5360500|NCT00109343|13189732|P2|COMPLETED|Overall Study||221
5360501|NCT00109343|13189733|P1|COMPLETED|Overall Study||446
5360502|NCT00109343|13189731|P3|Vaccinated at Visit 4|Overall Study||240
5360503|NCT00109343|13189732|P2|Vaccinated at Visit 4|Overall Study||235
5360504|NCT00109343|13189733|P1|Vaccinated at Visit 4|Overall Study||466
5360505|NCT00109343|13189731|P3|Vaccinated at Visit 2|Overall Study||246
5360506|NCT00109343|13189732|P2|Vaccinated at Visit 2|Overall Study||246
5360507|NCT00109343|13189733|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
5360508|NCT00109343|13189731|P3|Vaccinated at Visit 1|Overall Study||259
5360509|NCT00109343|13189732|P2|Vaccinated at Visit 1|Overall Study||258
5360510|NCT00109343|13189733|P1|Vaccinated at Visit 1|Overall Study||510
5360511|NCT00109343|13189731|P3|STARTED|Overall Study||259
5360512|NCT00109343|13189732|P2|STARTED|Overall Study||258
5360513|NCT00109343|13189733|P1|STARTED|Overall Study||510
5360514|NCT00109031|13189778|P4|NOT COMPLETED|Overall Study||0
5360515|NCT00109031|13189779|P3|NOT COMPLETED|Overall Study||2
5360516|NCT00109031|13189780|P2|NOT COMPLETED|Overall Study||2
5360517|NCT00109031|13189781|P1|NOT COMPLETED|Overall Study||0
5360518|NCT00109031|13189778|P4|COMPLETED|Overall Study||12
5360519|NCT00109031|13189779|P3|COMPLETED|Overall Study||12
5360520|NCT00109031|13189780|P2|COMPLETED|Overall Study||8
5360521|NCT00109031|13189781|P1|COMPLETED|Overall Study||11
5360522|NCT00109031|13189778|P4|STARTED|Overall Study||12
5360523|NCT00109031|13189779|P3|STARTED|Overall Study||14
5360524|NCT00109031|13189780|P2|STARTED|Overall Study||10
5360525|NCT00109031|13189781|P1|STARTED|Overall Study||11
5360526|NCT00109005|13189817|P2|NOT COMPLETED|Overall Study||0
5360527|NCT00109005|13189818|P1|NOT COMPLETED|Overall Study||0
5360528|NCT00109005|13189817|P2|COMPLETED|Overall Study||9
5360529|NCT00109005|13189818|P1|COMPLETED|Overall Study||8
5360530|NCT00109005|13189817|P2|STARTED|Overall Study||9
5360531|NCT00109005|13189818|P1|STARTED|Overall Study||8
5360532|NCT00108953|13189832|P2|NOT COMPLETED|Follow-up||33
5360533|NCT00108953|13189833|P1|NOT COMPLETED|Follow-up||29
5360534|NCT00108953|13189832|P2|COMPLETED|Follow-up||12
5360535|NCT00108953|13189833|P1|COMPLETED|Follow-up||11
5360536|NCT00108953|13189832|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
5360537|NCT00108953|13189833|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
5360538|NCT00108953|13189832|P2|NOT COMPLETED|Treatment Period||0
5360539|NCT00108953|13189833|P1|NOT COMPLETED|Treatment Period||0
5360540|NCT00108953|13189832|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
5360541|NCT00108953|13189833|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
5360542|NCT00108953|13189832|P2|STARTED|Treatment Period|ITT population|49
5360543|NCT00108953|13189833|P1|STARTED|Treatment Period|ITT population|47
5360544|NCT00108862|13189855|P2|NOT COMPLETED|Overall Study||62
5360545|NCT00108862|13189856|P1|NOT COMPLETED|Overall Study||68
5360546|NCT00108862|13189855|P2|COMPLETED|Overall Study||339
5360547|NCT00108862|13189856|P1|COMPLETED|Overall Study||337
5360548|NCT00108862|13189855|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
5360549|NCT00108862|13189856|P1|STARTED|Overall Study||405
5360550|NCT00108732|13189884|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
5360551|NCT00108732|13189884|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
5360552|NCT00108732|13189884|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
5360553|NCT00108732|13189884|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
5360554|NCT00108732|13189884|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
5360555|NCT00108732|13189884|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
5360556|NCT00108732|13189884|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
5360557|NCT00108628|13189893|P2|NOT COMPLETED|Overall Study||10
5360558|NCT00108628|13189894|P1|NOT COMPLETED|Overall Study||20
5360559|NCT00108628|13189893|P2|COMPLETED|Overall Study||53
5360560|NCT00108628|13189894|P1|COMPLETED|Overall Study||41
5360561|NCT00108628|13189893|P2|Completed Treatment|Overall Study||57
5360562|NCT00108628|13189894|P1|Completed Treatment|Overall Study||42
5360563|NCT00108628|13189893|P2|Received One or More Sessions|Overall Study||58
5360564|NCT00108628|13189894|P1|Received One or More Sessions|Overall Study||53
5360565|NCT00108628|13189893|P2|STARTED|Overall Study||63
5360566|NCT00108628|13189894|P1|STARTED|Overall Study||61
5360567|NCT00108550|13189920|P2|NOT COMPLETED|Overall Study||16
5360568|NCT00108550|13189921|P1|NOT COMPLETED|Overall Study||16
5360569|NCT00108550|13189920|P2|COMPLETED|Overall Study||37
5360570|NCT00108550|13189921|P1|COMPLETED|Overall Study||39
5360571|NCT00108550|13189920|P2|STARTED|Overall Study||53
5360572|NCT00108550|13189921|P1|STARTED|Overall Study||55
5360573|NCT00108524|13189931|P2|NOT COMPLETED|Overall Study||18
5360574|NCT00108524|13189932|P1|NOT COMPLETED|Overall Study||29
5360575|NCT00108524|13189931|P2|COMPLETED|Overall Study||61
5360576|NCT00108524|13189932|P1|COMPLETED|Overall Study||52
5360577|NCT00108524|13189931|P2|STARTED|Overall Study||79
5360578|NCT00108524|13189932|P1|STARTED|Overall Study||81
5360579|NCT00108485|13189944|P2|NOT COMPLETED|Overall Study||2
5360580|NCT00108485|13189945|P1|NOT COMPLETED|Overall Study||3
5360581|NCT00108485|13189944|P2|COMPLETED|Overall Study||2
5360582|NCT00108485|13189945|P1|COMPLETED|Overall Study||2
5360583|NCT00108485|13189944|P2|STARTED|Overall Study||4
5360584|NCT00108485|13189945|P1|STARTED|Overall Study||5
5360585|NCT00108433|13189953|P2|NOT COMPLETED|Overall Study||17
5360586|NCT00108433|13189954|P1|NOT COMPLETED|Overall Study||21
5360587|NCT00108433|13189953|P2|COMPLETED|Overall Study||14
5360588|NCT00108433|13189954|P1|COMPLETED|Overall Study||9
5360589|NCT00108433|13189953|P2|STARTED|Overall Study||31
5360590|NCT00108433|13189954|P1|STARTED|Overall Study||30
5360591|NCT00108355|13189970|P2|NOT COMPLETED|Overall Study||2
5360592|NCT00108355|13189971|P1|NOT COMPLETED|Overall Study||2
5360593|NCT00108355|13189970|P2|COMPLETED|Overall Study||12
5360594|NCT00108355|13189971|P1|COMPLETED|Overall Study||13
5360595|NCT00108355|13189970|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
5360596|NCT00108355|13189971|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
5360597|NCT00108342|13189981|P2|NOT COMPLETED|Overall Study||0
5360598|NCT00108342|13189982|P1|NOT COMPLETED|Overall Study||1
5360599|NCT00108342|13189981|P2|COMPLETED|Overall Study||9
5360600|NCT00108342|13189982|P1|COMPLETED|Overall Study||7
5360601|NCT00108342|13189981|P2|STARTED|Overall Study||9
5360602|NCT00108342|13189982|P1|STARTED|Overall Study||8
5360603|NCT00108303|13189991|P3|NOT COMPLETED|Overall Study||0
5360604|NCT00108303|13189992|P2|NOT COMPLETED|Overall Study||0
5360605|NCT00108303|13189993|P1|NOT COMPLETED|Overall Study||0
5360606|NCT00108303|13189991|P3|COMPLETED|Overall Study||180
5360607|NCT00108303|13189992|P2|COMPLETED|Overall Study||179
5360608|NCT00108303|13189993|P1|COMPLETED|Overall Study||179
5360609|NCT00108303|13189991|P3|STARTED|Overall Study||180
5360610|NCT00108303|13189992|P2|STARTED|Overall Study||179
5360611|NCT00108303|13189993|P1|STARTED|Overall Study||179
5360612|NCT00108277|13190008|P3|NOT COMPLETED|Overall Study||16
5360613|NCT00108277|13190009|P2|NOT COMPLETED|Overall Study||12
5360614|NCT00108277|13190010|P1|NOT COMPLETED|Overall Study||10
5360615|NCT00108277|13190008|P3|COMPLETED|Overall Study||19
5360616|NCT00108277|13190009|P2|COMPLETED|Overall Study||16
5360617|NCT00108277|13190010|P1|COMPLETED|Overall Study||19
5360618|NCT00108277|13190008|P3|STARTED|Overall Study||35
5360619|NCT00108277|13190009|P2|STARTED|Overall Study||28
5360620|NCT00108277|13190010|P1|STARTED|Overall Study||29
5360621|NCT00108160|13190020|P2|NOT COMPLETED|Overall Study||21
5360622|NCT00108160|13190021|P1|NOT COMPLETED|Overall Study||39
5360623|NCT00108160|13190020|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
5360624|NCT00108160|13190021|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
5360625|NCT00108160|13190020|P2|Completed Visit 7 (18 mo)|Overall Study||31
5360626|NCT00108160|13190021|P1|Completed Visit 7 (18 mo)|Overall Study||34
5360627|NCT00108160|13190020|P2|Completed Visit 6 (15 mo)|Overall Study||33
5360628|NCT00108160|13190021|P1|Completed Visit 6 (15 mo)|Overall Study||36
5360629|NCT00108160|13190020|P2|Completed Visit 5 (12 mo)|Overall Study||37
5360630|NCT00108160|13190021|P1|Completed Visit 5 (12 mo)|Overall Study||37
5360631|NCT00108160|13190020|P2|Completed Visit 4 (9 mo)|Overall Study||37
5360632|NCT00108160|13190021|P1|Completed Visit 4 (9 mo)|Overall Study||38
5360633|NCT00108160|13190020|P2|Completed Visit 3 (6 mo)|Overall Study||38
5360634|NCT00108160|13190021|P1|Completed Visit 3 (6 mo)|Overall Study||44
5360635|NCT00108160|13190020|P2|Completed Visit 2 (3 mo)|Overall Study||46
5360636|NCT00108160|13190021|P1|Completed Visit 2 (3 mo)|Overall Study||54
5360637|NCT00108160|13190020|P2|Completed Visit 1 (2 Wks)|Overall Study||54
5360638|NCT00108160|13190021|P1|Completed Visit 1 (2 Wks)|Overall Study||72
5360639|NCT00108160|13190020|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
5360640|NCT00108160|13190021|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
5360641|NCT00108160|13190020|P2|STARTED|Overall Study||63
5360642|NCT00108160|13190021|P1|STARTED|Overall Study||83
5360643|NCT00108082|13190034|P3|NOT COMPLETED|Overall Study||43
5360644|NCT00108082|13190035|P2|NOT COMPLETED|Overall Study||32
5360645|NCT00108082|13190036|P1|NOT COMPLETED|Overall Study||38
5360646|NCT00108082|13190034|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
5360647|NCT00108082|13190035|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
5360648|NCT00108082|13190036|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
5360649|NCT00108082|13190034|P3|STARTED|Overall Study||96
5360650|NCT00108082|13190035|P2|STARTED|Overall Study||100
5360651|NCT00108082|13190036|P1|STARTED|Overall Study||91
5360652|NCT00108069|13190085|P2|NOT COMPLETED|Overall Study||13
5360653|NCT00108069|13190086|P1|NOT COMPLETED|Overall Study||30
5360654|NCT00108069|13190085|P2|COMPLETED|Overall Study||0
5360655|NCT00108069|13190086|P1|COMPLETED|Overall Study||0
5360656|NCT00108069|13190085|P2|STARTED|Overall Study||13
5360657|NCT00108069|13190086|P1|STARTED|Overall Study||30
5360658|NCT00107991|13190100|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
5360659|NCT00107991|13190100|P1|COMPLETED|18-Week Post Treatment Assessment||8
5360660|NCT00107991|13190100|P1|STARTED|18-Week Post Treatment Assessment||10
5360661|NCT00107991|13190100|P1|NOT COMPLETED|12 Week Treatment Period||5
5360662|NCT00107991|13190100|P1|COMPLETED|12 Week Treatment Period||10
5360663|NCT00107991|13190100|P1|STARTED|12 Week Treatment Period||15
5360664|NCT00107991|13190100|P1|NOT COMPLETED|Eligibility Assessment||23
5360665|NCT00107991|13190100|P1|COMPLETED|Eligibility Assessment||15
5360666|NCT00107991|13190100|P1|STARTED|Eligibility Assessment||38
5360667|NCT00107978|13190110|P2|NOT COMPLETED|Overall Study||50
5360668|NCT00107978|13190111|P1|NOT COMPLETED|Overall Study||33
5360669|NCT00107978|13190110|P2|COMPLETED|Overall Study||431
5360670|NCT00107978|13190111|P1|COMPLETED|Overall Study||425
5360671|NCT00107978|13190110|P2|STARTED|Overall Study||481
5360672|NCT00107978|13190111|P1|STARTED|Overall Study||458
5360673|NCT00107952|13190119|P2|NOT COMPLETED|Overall Study||81
5360674|NCT00107952|13190120|P1|NOT COMPLETED|Overall Study||95
5360675|NCT00107952|13190119|P2|COMPLETED|Overall Study||299
5360676|NCT00107952|13190120|P1|COMPLETED|Overall Study||286
5360677|NCT00107952|13190119|P2|STARTED|Overall Study||380
5360678|NCT00107952|13190120|P1|STARTED|Overall Study||381
5360679|NCT00107900|13190132|P6|NOT COMPLETED|Overall Study||9
5360680|NCT00107900|13190133|P5|NOT COMPLETED|Overall Study||21
5360681|NCT00107900|13190134|P4|NOT COMPLETED|Overall Study||12
5360682|NCT00107900|13190135|P3|NOT COMPLETED|Overall Study||25
5360683|NCT00107900|13190136|P2|NOT COMPLETED|Overall Study||3
5360684|NCT00107900|13190137|P1|NOT COMPLETED|Overall Study||10
5360685|NCT00107900|13190132|P6|COMPLETED|Overall Study||94
5360686|NCT00107900|13190133|P5|COMPLETED|Overall Study||94
5360687|NCT00107900|13190134|P4|COMPLETED|Overall Study||87
5360688|NCT00107900|13190135|P3|COMPLETED|Overall Study||104
5360689|NCT00107900|13190136|P2|COMPLETED|Overall Study||72
5360690|NCT00107900|13190137|P1|COMPLETED|Overall Study||75
5360691|NCT00107900|13190132|P6|STARTED|Overall Study||103
5360692|NCT00107900|13190133|P5|STARTED|Overall Study||115
5360693|NCT00107900|13190134|P4|STARTED|Overall Study||99
5360694|NCT00107900|13190135|P3|STARTED|Overall Study||129
5360695|NCT00107900|13190136|P2|STARTED|Overall Study||75
5360696|NCT00107900|13190137|P1|STARTED|Overall Study||85
5360697|NCT00107783|13190171|P2|NOT COMPLETED|Overall Study||4
5360698|NCT00107783|13190172|P1|NOT COMPLETED|Overall Study||3
5360699|NCT00107783|13190171|P2|COMPLETED|Overall Study||16
5360700|NCT00107783|13190172|P1|COMPLETED|Overall Study||17
5360701|NCT00107783|13190171|P2|STARTED|Overall Study||20
5360702|NCT00107783|13190172|P1|STARTED|Overall Study||20
5360703|NCT00107744|13190189|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5360704|NCT00107744|13190190|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5360705|NCT00107744|13190191|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5360706|NCT00107744|13190189|P3|COMPLETED|Intervention 3 (8 Weeks)||88
5360707|NCT00107744|13190190|P2|COMPLETED|Intervention 3 (8 Weeks)||92
5360708|NCT00107744|13190191|P1|COMPLETED|Intervention 3 (8 Weeks)||93
5360709|NCT00107744|13190189|P3|STARTED|Intervention 3 (8 Weeks)||88
5360710|NCT00107744|13190190|P2|STARTED|Intervention 3 (8 Weeks)||92
5360711|NCT00107744|13190191|P1|STARTED|Intervention 3 (8 Weeks)||93
5360712|NCT00107744|13190189|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
5360713|NCT00107744|13190190|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
5360714|NCT00107744|13190191|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
5360715|NCT00107744|13190189|P3|COMPLETED|Intervention 2 (8 Weeks)||88
5360716|NCT00107744|13190190|P2|COMPLETED|Intervention 2 (8 Weeks)||92
5360717|NCT00107744|13190191|P1|COMPLETED|Intervention 2 (8 Weeks)||93
5360718|NCT00107744|13190189|P3|STARTED|Intervention 2 (8 Weeks)||101
5360719|NCT00107744|13190190|P2|STARTED|Intervention 2 (8 Weeks)||104
5360720|NCT00107744|13190191|P1|STARTED|Intervention 2 (8 Weeks)||101
5360721|NCT00107744|13190189|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
5360722|NCT00107744|13190190|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
5360723|NCT00107744|13190191|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
5360724|NCT00107744|13190189|P3|COMPLETED|Intervention 1 (8 Weeks)||101
5360725|NCT00107744|13190190|P2|COMPLETED|Intervention 1 (8 Weeks)||104
5360726|NCT00107744|13190191|P1|COMPLETED|Intervention 1 (8 Weeks)||101
5360727|NCT00107744|13190189|P3|STARTED|Intervention 1 (8 Weeks)||118
5360728|NCT00107744|13190190|P2|STARTED|Intervention 1 (8 Weeks)||117
5360729|NCT00107744|13190191|P1|STARTED|Intervention 1 (8 Weeks)||117
5360730|NCT00107653|13190207|P2|NOT COMPLETED|Overall Study||76
5360731|NCT00107653|13190208|P1|NOT COMPLETED|Overall Study||79
5360732|NCT00107653|13190207|P2|COMPLETED|Overall Study||224
5360733|NCT00107653|13190208|P1|COMPLETED|Overall Study||190
5360734|NCT00107653|13190207|P2|STARTED|Overall Study||300
5360735|NCT00107653|13190208|P1|STARTED|Overall Study||269
5360736|NCT00107614|13190254|P1|NOT COMPLETED|Overall Study||12
5360737|NCT00107614|13190254|P1|COMPLETED|Overall Study||0
5360738|NCT00107614|13190254|P1|STARTED|Overall Study||12
5360739|NCT00107575|13190260|P2|NOT COMPLETED|Overall Study||10
5360740|NCT00107575|13190261|P1|NOT COMPLETED|Overall Study||11
5360741|NCT00107575|13190260|P2|COMPLETED|Overall Study||107
5360742|NCT00107575|13190261|P1|COMPLETED|Overall Study||108
5360743|NCT00107575|13190260|P2|STARTED|Overall Study||117
5360744|NCT00107575|13190261|P1|STARTED|Overall Study||119
5360745|NCT00107536|13190275|P1|NOT COMPLETED|Overall Study||0
5360746|NCT00107536|13190275|P1|COMPLETED|Overall Study||26
5360747|NCT00107536|13190275|P1|STARTED|Overall Study||26
5360748|NCT00107380|13190285|P1|NOT COMPLETED|Overall Study||30
5360749|NCT00107380|13190285|P1|COMPLETED|Overall Study||56
5360750|NCT00107380|13190285|P1|Eligible|Overall Study||84
5360751|NCT00107380|13190285|P1|STARTED|Overall Study||86
5360752|NCT00107315|13190291|P1|NOT COMPLETED|Overall Study||15
5360753|NCT00107315|13190291|P1|COMPLETED|Overall Study||1
5360754|NCT00107315|13190291|P1|STARTED|Overall Study||16
5360755|NCT00107276|13190298|P1|NOT COMPLETED|Overall Study||72
5360756|NCT00107276|13190298|P1|COMPLETED|Overall Study||40
5360757|NCT00107276|13190298|P1|Eligible|Overall Study||96
5360758|NCT00107276|13190298|P1|STARTED|Overall Study||112
5360759|NCT00107198|13190304|P1|NOT COMPLETED|Overall Study||52
5360760|NCT00107198|13190304|P1|COMPLETED|Overall Study||136
5360761|NCT00107198|13190304|P1|STARTED|Overall Study||188
5360762|NCT00107172|13190314|P2|NOT COMPLETED|Overall Study||5
5360763|NCT00107172|13190315|P1|NOT COMPLETED|Overall Study||5
5360764|NCT00107172|13190314|P2|COMPLETED|Overall Study||103
5360765|NCT00107172|13190315|P1|COMPLETED|Overall Study||109
5360766|NCT00107172|13190314|P2|STARTED|Overall Study||108
5360767|NCT00107172|13190315|P1|STARTED|Overall Study||114
5360768|NCT00107120|13190345|P2|NOT COMPLETED|Overall Study||24
5360769|NCT00107120|13190346|P1|NOT COMPLETED|Overall Study||29
5360770|NCT00107120|13190345|P2|COMPLETED|Overall Study||133
5360771|NCT00107120|13190346|P1|COMPLETED|Overall Study||126
5360772|NCT00107120|13190345|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
5360773|NCT00107120|13190346|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
5360774|NCT00107042|13190358|P2|NOT COMPLETED|Overall Study||16
5360775|NCT00107042|13190359|P1|NOT COMPLETED|Overall Study||22
5360776|NCT00107042|13190358|P2|COMPLETED|Overall Study||47
5360777|NCT00107042|13190359|P1|COMPLETED|Overall Study||38
5360778|NCT00107042|13190358|P2|STARTED|Overall Study||63
5360779|NCT00107042|13190359|P1|STARTED|Overall Study||60
5360780|NCT00106964|13190425|P3|NOT COMPLETED|Overall Study||7
5360781|NCT00106964|13190426|P2|NOT COMPLETED|Overall Study||15
5360782|NCT00106964|13190427|P1|NOT COMPLETED|Overall Study||13
5360783|NCT00106964|13190425|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
5360784|NCT00106964|13190426|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
5360785|NCT00106964|13190427|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
5360786|NCT00106964|13190425|P3|STARTED|Overall Study||127
5360787|NCT00106964|13190426|P2|STARTED|Overall Study||126
5360788|NCT00106964|13190427|P1|STARTED|Overall Study||118
5360789|NCT00106938|13190452|P2|NOT COMPLETED|Overall Study||71
5360790|NCT00106938|13190453|P1|NOT COMPLETED|Overall Study||176
5360791|NCT00106938|13190452|P2|COMPLETED|Overall Study||293
5360792|NCT00106938|13190453|P1|COMPLETED|Overall Study||913
5360793|NCT00106938|13190452|P2|STARTED|Overall Study||364
5360794|NCT00106938|13190453|P1|STARTED|Overall Study||1089
5360795|NCT00106704|13190522|P2|NOT COMPLETED|Overall Study||151
5360796|NCT00106704|13190523|P1|NOT COMPLETED|Overall Study||131
5360797|NCT00106704|13190522|P2|COMPLETED|Overall Study||68
5360798|NCT00106704|13190523|P1|COMPLETED|Overall Study||91
5360799|NCT00106704|13190522|P2|STARTED|Overall Study||219
5360800|NCT00106704|13190523|P1|STARTED|Overall Study||222
5360801|NCT00106639|13190534|P3|NOT COMPLETED|Overall Study||2
5360802|NCT00106639|13190535|P2|NOT COMPLETED|Overall Study||7
5360803|NCT00106639|13190536|P1|NOT COMPLETED|Overall Study||3
5360804|NCT00106639|13190534|P3|COMPLETED|Overall Study||19
5360805|NCT00106639|13190535|P2|COMPLETED|Overall Study||13
5360806|NCT00106639|13190536|P1|COMPLETED|Overall Study||17
5360807|NCT00106639|13190534|P3|STARTED|Overall Study||21
5360808|NCT00106639|13190535|P2|STARTED|Overall Study||20
5360809|NCT00106639|13190536|P1|STARTED|Overall Study||20
5360810|NCT00106626|13190663|P4|NOT COMPLETED|Overall Study||13
5360811|NCT00106626|13190664|P3|NOT COMPLETED|Overall Study||12
5360812|NCT00106626|13190665|P2|NOT COMPLETED|Overall Study||6
5360813|NCT00106626|13190666|P1|NOT COMPLETED|Overall Study||10
5360814|NCT00106626|13190663|P4|COMPLETED|Overall Study||3
5360815|NCT00106626|13190664|P3|COMPLETED|Overall Study||2
5360816|NCT00106626|13190665|P2|COMPLETED|Overall Study||3
5360817|NCT00106626|13190666|P1|COMPLETED|Overall Study||3
5360818|NCT00106626|13190663|P4|STARTED|Overall Study||16
5360819|NCT00106626|13190664|P3|STARTED|Overall Study||14
5360820|NCT00106626|13190665|P2|STARTED|Overall Study||9
5360821|NCT00106626|13190666|P1|STARTED|Overall Study||13
5360822|NCT00106535|13190684|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
5360823|NCT00106535|13190685|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360824|NCT00106535|13190686|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360825|NCT00106535|13190687|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360826|NCT00106535|13190684|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
5360827|NCT00106535|13190685|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360828|NCT00106535|13190686|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360829|NCT00106535|13190687|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
5360830|NCT00106535|13190684|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
5360831|NCT00106535|13190685|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
5360832|NCT00106535|13190686|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
5360833|NCT00106535|13190687|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
5360834|NCT00106535|13190684|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
5360835|NCT00106535|13190685|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
5360836|NCT00106535|13190686|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
5360837|NCT00106535|13190687|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
5360838|NCT00106535|13190684|P4|COMPLETED|2-year Placebo Controlled Period||0
5360839|NCT00106535|13190685|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
5360840|NCT00106535|13190686|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
5360841|NCT00106535|13190687|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
5360842|NCT00106535|13190684|P4|Completed Week 52|2-year Placebo Controlled Period||0
5360843|NCT00106535|13190685|P3|Completed Week 52|2-year Placebo Controlled Period||338
5360844|NCT00106535|13190686|P2|Completed Week 52|2-year Placebo Controlled Period||342
5360845|NCT00106535|13190687|P1|Completed Week 52|2-year Placebo Controlled Period||326
5360846|NCT00106535|13190684|P4|Completed Week 24|2-year Placebo Controlled Period||0
5360847|NCT00106535|13190685|P3|Completed Week 24|2-year Placebo Controlled Period||366
5360848|NCT00106535|13190686|P2|Completed Week 24|2-year Placebo Controlled Period||373
5360849|NCT00106535|13190687|P1|Completed Week 24|2-year Placebo Controlled Period||356
5360850|NCT00106535|13190684|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
5360851|NCT00106535|13190685|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
5360852|NCT00106535|13190686|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
5360853|NCT00106535|13190687|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
5360854|NCT00106535|13190684|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
5360855|NCT00106535|13190685|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
5360856|NCT00106535|13190686|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
5360857|NCT00106535|13190687|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
5360858|NCT00106535|13190684|P4|STARTED|2-year Placebo Controlled Period||0
5360859|NCT00106535|13190685|P3|STARTED|2-year Placebo Controlled Period||401
5360860|NCT00106535|13190686|P2|STARTED|2-year Placebo Controlled Period||401
5360861|NCT00106535|13190687|P1|STARTED|2-year Placebo Controlled Period||394
5360862|NCT00106431|13190980|P1|NOT COMPLETED|Overall Study||65
5360863|NCT00106431|13190980|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
5360864|NCT00106431|13190980|P1|STARTED|Overall Study||102
5360865|NCT00106392|13190992|P2|NOT COMPLETED|Overall Study||27
5360866|NCT00106392|13190993|P1|NOT COMPLETED|Overall Study||26
5360867|NCT00106392|13190992|P2|COMPLETED|Overall Study||42
5360868|NCT00106392|13190993|P1|COMPLETED|Overall Study||36
5360869|NCT00106392|13190992|P2|Full Analysis Set (FAS)|Overall Study||61
5360870|NCT00106392|13190993|P1|Full Analysis Set (FAS)|Overall Study||53
5360871|NCT00106392|13190992|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
5360872|NCT00106392|13190993|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
5360873|NCT00106392|13190992|P2|STARTED|Overall Study||69
5360874|NCT00106392|13190993|P1|STARTED|Overall Study||62
5360875|NCT00106353|13191011|P7|NOT COMPLETED|Part 2||16
5360876|NCT00106353|13191012|P6|NOT COMPLETED|Part 2||18
5360877|NCT00106353|13191013|P5|NOT COMPLETED|Part 2||16
5360878|NCT00106353|13191014|P4|NOT COMPLETED|Part 2||0
5360879|NCT00106353|13191015|P3|NOT COMPLETED|Part 2||0
5360880|NCT00106353|13191016|P2|NOT COMPLETED|Part 2||0
5360881|NCT00106353|13191017|P1|NOT COMPLETED|Part 2||0
5360882|NCT00106353|13191011|P7|COMPLETED|Part 2||0
5360883|NCT00106353|13191012|P6|COMPLETED|Part 2||1
5360884|NCT00106353|13191013|P5|COMPLETED|Part 2||1
5360885|NCT00106353|13191014|P4|COMPLETED|Part 2||0
5360886|NCT00106353|13191015|P3|COMPLETED|Part 2||0
5360887|NCT00106353|13191016|P2|COMPLETED|Part 2||0
5360888|NCT00106353|13191017|P1|COMPLETED|Part 2||0
5360889|NCT00106353|13191011|P7|STARTED|Part 2||16
5360890|NCT00106353|13191012|P6|STARTED|Part 2||19
5360891|NCT00106353|13191013|P5|STARTED|Part 2||17
5360892|NCT00106353|13191014|P4|STARTED|Part 2||0
5360893|NCT00106353|13191015|P3|STARTED|Part 2||0
5360894|NCT00106353|13191016|P2|STARTED|Part 2||0
5360895|NCT00106353|13191017|P1|STARTED|Part 2||0
5360896|NCT00106353|13191011|P7|NOT COMPLETED|Part 1||0
5360897|NCT00106353|13191012|P6|NOT COMPLETED|Part 1||0
5360898|NCT00106353|13191013|P5|NOT COMPLETED|Part 1||0
5360899|NCT00106353|13191014|P4|NOT COMPLETED|Part 1||7
5360900|NCT00106353|13191015|P3|NOT COMPLETED|Part 1||3
5360901|NCT00106353|13191016|P2|NOT COMPLETED|Part 1||5
5360902|NCT00106353|13191017|P1|NOT COMPLETED|Part 1||4
5360903|NCT00106353|13191011|P7|COMPLETED|Part 1||0
5360904|NCT00106353|13191012|P6|COMPLETED|Part 1||0
5360905|NCT00106353|13191013|P5|COMPLETED|Part 1||0
5360906|NCT00106353|13191014|P4|COMPLETED|Part 1||0
5360907|NCT00106353|13191015|P3|COMPLETED|Part 1||0
5360908|NCT00106353|13191016|P2|COMPLETED|Part 1||0
5360909|NCT00106353|13191017|P1|COMPLETED|Part 1||0
5360910|NCT00106353|13191011|P7|STARTED|Part 1||0
5360911|NCT00106353|13191012|P6|STARTED|Part 1||0
5360912|NCT00106353|13191013|P5|STARTED|Part 1||0
5360913|NCT00106353|13191014|P4|STARTED|Part 1||7
5360914|NCT00106353|13191015|P3|STARTED|Part 1||3
5360915|NCT00106353|13191016|P2|STARTED|Part 1||5
5360916|NCT00106353|13191017|P1|STARTED|Part 1||4
5360917|NCT00106249|13191144|P2|NOT COMPLETED|Overall Study||2
5360918|NCT00106249|13191145|P1|NOT COMPLETED|Overall Study||3
5360919|NCT00106249|13191144|P2|COMPLETED|Overall Study||11
5360920|NCT00106249|13191145|P1|COMPLETED|Overall Study||11
5360921|NCT00106249|13191144|P2|STARTED|Overall Study||13
5360922|NCT00106249|13191145|P1|STARTED|Overall Study||14
5360923|NCT00106184|13191157|P2|NOT COMPLETED|Overall Study||2
5360924|NCT00106184|13191158|P1|NOT COMPLETED|Overall Study||3
5360925|NCT00106184|13191157|P2|COMPLETED|Overall Study||102
5360926|NCT00106184|13191158|P1|COMPLETED|Overall Study||93
5360927|NCT00106184|13191157|P2|Treated|Overall Study|104 subjects were randomized.|102
5360928|NCT00106184|13191158|P1|Treated|Overall Study|96 subjects were randomized.|93
5360929|NCT00106184|13191157|P2|STARTED|Overall Study||104
5360930|NCT00106184|13191158|P1|STARTED|Overall Study||96
5360931|NCT00106119|13191168|P2|NOT COMPLETED|Second Intervention||0
5360932|NCT00106119|13191169|P1|NOT COMPLETED|Second Intervention||0
5360933|NCT00106119|13191168|P2|COMPLETED|Second Intervention||7
5360934|NCT00106119|13191169|P1|COMPLETED|Second Intervention||7
5360935|NCT00106119|13191168|P2|STARTED|Second Intervention||7
5360936|NCT00106119|13191169|P1|STARTED|Second Intervention||7
5360937|NCT00106119|13191168|P2|NOT COMPLETED|Washout Period of 30 Days||0
5360938|NCT00106119|13191169|P1|NOT COMPLETED|Washout Period of 30 Days||0
5360939|NCT00106119|13191168|P2|COMPLETED|Washout Period of 30 Days||7
5360940|NCT00106119|13191169|P1|COMPLETED|Washout Period of 30 Days||7
5360941|NCT00106119|13191168|P2|STARTED|Washout Period of 30 Days||7
5360942|NCT00106119|13191169|P1|STARTED|Washout Period of 30 Days||7
5360943|NCT00106119|13191168|P2|NOT COMPLETED|First Intervention||0
5360944|NCT00106119|13191169|P1|NOT COMPLETED|First Intervention||0
5360945|NCT00106119|13191168|P2|COMPLETED|First Intervention||7
5360946|NCT00106119|13191169|P1|COMPLETED|First Intervention||7
5360947|NCT00106119|13191168|P2|STARTED|First Intervention||7
5360948|NCT00106119|13191169|P1|STARTED|First Intervention||7
5360949|NCT00106106|13191189|P2|NOT COMPLETED|Overall Study||4
5360950|NCT00106106|13191190|P1|NOT COMPLETED|Overall Study||4
5360951|NCT00106106|13191189|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
5360952|NCT00106106|13191190|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
5360953|NCT00106106|13191189|P2|Completed Both MRS Scans|Overall Study||15
5360954|NCT00106106|13191190|P1|Completed Both MRS Scans|Overall Study||18
5360955|NCT00106106|13191189|P2|STARTED|Overall Study||23
5360956|NCT00106106|13191190|P1|STARTED|Overall Study||26
5360957|NCT00106080|13191200|P2|NOT COMPLETED|Overall Study||27
5360958|NCT00106080|13191201|P1|NOT COMPLETED|Overall Study||43
5360959|NCT00106080|13191200|P2|COMPLETED|Overall Study||155
5360960|NCT00106080|13191201|P1|COMPLETED|Overall Study||151
5360961|NCT00106080|13191200|P2|STARTED|Overall Study||182
5360962|NCT00106080|13191201|P1|STARTED|Overall Study||194
5360963|NCT00106028|13191211|P2|NOT COMPLETED|Overall Study||12
5360964|NCT00106028|13191212|P1|NOT COMPLETED|Overall Study||6
5360965|NCT00106028|13191211|P2|COMPLETED|Overall Study|Completed Month 36|82
5360966|NCT00106028|13191212|P1|COMPLETED|Overall Study|Completed Month 36|43
5360967|NCT00106028|13191211|P2|Month 12 Completed/Started Open Label|Overall Study||87
5360968|NCT00106028|13191212|P1|Month 12 Completed/Started Open Label|Overall Study||49
5360969|NCT00106028|13191211|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
5360970|NCT00106028|13191212|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
5360971|NCT00106002|13191306|P1|NOT COMPLETED|Overall Study||2
5360972|NCT00106002|13191306|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
5360973|NCT00106002|13191306|P1|STARTED|Overall Study||37
5360974|NCT00105989|13191314|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
5360975|NCT00105989|13191315|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
5360976|NCT00105989|13191314|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
5360977|NCT00105989|13191315|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
5360978|NCT00105989|13191314|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
5360979|NCT00105989|13191315|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
5360980|NCT00105989|13191314|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
5360981|NCT00105989|13191315|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
5360982|NCT00105989|13191314|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
5360983|NCT00105989|13191315|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
5360984|NCT00105989|13191314|P2|STARTED|Continuation - Open Label:Week 10-34||0
5360985|NCT00105989|13191315|P1|STARTED|Continuation - Open Label:Week 10-34||413
5360986|NCT00105989|13191314|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
5360987|NCT00105989|13191315|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
5360988|NCT00105989|13191314|P2|COMPLETED|Acute - Open Label: Week 0-10||0
5360989|NCT00105989|13191315|P1|COMPLETED|Acute - Open Label: Week 0-10||413
5360990|NCT00105989|13191314|P2|STARTED|Acute - Open Label: Week 0-10||0
5360991|NCT00105989|13191315|P1|STARTED|Acute - Open Label: Week 0-10||514
5360992|NCT00105586|13191431|P2|NOT COMPLETED|Overall Study||16
5360993|NCT00105586|13191432|P1|NOT COMPLETED|Overall Study||17
5360994|NCT00105586|13191431|P2|COMPLETED|Overall Study||69
5360995|NCT00105586|13191432|P1|COMPLETED|Overall Study||75
5360996|NCT00105586|13191431|P2|STARTED|Overall Study||85
5360997|NCT00105586|13191432|P1|STARTED|Overall Study||92
5360998|NCT00105560|13191440|P1|NOT COMPLETED|Overall Study||1
5360999|NCT00105560|13191440|P1|COMPLETED|Overall Study||58
5361000|NCT00105560|13191440|P1|STARTED|Overall Study||59
5361001|NCT00105534|13191462|P2|NOT COMPLETED|Overall Study||33
5361002|NCT00105534|13191463|P1|NOT COMPLETED|Overall Study||22
5361003|NCT00105534|13191462|P2|COMPLETED|Overall Study||317
5361004|NCT00105534|13191463|P1|COMPLETED|Overall Study||313
5361005|NCT00105534|13191462|P2|STARTED|Overall Study||350
5361006|NCT00105534|13191463|P1|STARTED|Overall Study||335
5361007|NCT00105521|13191475|P4|NOT COMPLETED|Overall Study||17
5361008|NCT00105521|13191476|P3|NOT COMPLETED|Overall Study||17
5361009|NCT00105521|13191477|P2|NOT COMPLETED|Overall Study||11
5361010|NCT00105521|13191478|P1|NOT COMPLETED|Overall Study||15
5361011|NCT00105521|13191475|P4|COMPLETED|Overall Study||85
5361012|NCT00105521|13191476|P3|COMPLETED|Overall Study||80
5361013|NCT00105521|13191477|P2|COMPLETED|Overall Study||90
5361014|NCT00105521|13191478|P1|COMPLETED|Overall Study||83
5361015|NCT00105521|13191475|P4|STARTED|Overall Study||102
5361016|NCT00105521|13191476|P3|STARTED|Overall Study||97
5361017|NCT00105521|13191477|P2|STARTED|Overall Study||101
5361018|NCT00105521|13191478|P1|STARTED|Overall Study||98
5361019|NCT00105508|13191502|P2|NOT COMPLETED|Overall Study||36
5361020|NCT00105508|13191503|P1|NOT COMPLETED|Overall Study||40
5361021|NCT00105508|13191502|P2|COMPLETED|Overall Study||217
5361022|NCT00105508|13191503|P1|COMPLETED|Overall Study||213
5361023|NCT00105508|13191502|P2|STARTED|Overall Study||253
5361024|NCT00105508|13191503|P1|STARTED|Overall Study||253
5361025|NCT00105482|13191517|P2|NOT COMPLETED|Overall Study||55
5361026|NCT00105482|13191518|P1|NOT COMPLETED|Overall Study||59
5361027|NCT00105482|13191517|P2|COMPLETED|Overall Study||30
5361028|NCT00105482|13191518|P1|COMPLETED|Overall Study||28
5361029|NCT00105482|13191517|P2|STARTED|Overall Study||85
5361030|NCT00105482|13191518|P1|STARTED|Overall Study||87
5361031|NCT00105469|13191534|P2|NOT COMPLETED|Overall Study||11
5361032|NCT00105469|13191535|P1|NOT COMPLETED|Overall Study||22
5361033|NCT00105469|13191534|P2|COMPLETED|Overall Study||367
5361034|NCT00105469|13191535|P1|COMPLETED|Overall Study||343
5361035|NCT00105469|13191534|P2|STARTED|Overall Study||378
5361036|NCT00105469|13191535|P1|STARTED|Overall Study||365
5361037|NCT00105443|13191545|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
5361038|NCT00105443|13191546|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
5361039|NCT00105443|13191547|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
5361040|NCT00105443|13191548|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
5361041|NCT00105443|13191545|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
5361042|NCT00105443|13191546|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
5361043|NCT00105443|13191547|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
5361044|NCT00105443|13191548|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
5361045|NCT00105443|13191545|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
5361046|NCT00105443|13191546|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
5361047|NCT00105443|13191547|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
5361048|NCT00105443|13191548|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
5361049|NCT00105443|13191545|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
5361050|NCT00105443|13191546|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
5361051|NCT00105443|13191547|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
5361052|NCT00105443|13191548|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
5361053|NCT00105443|13191545|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
5361054|NCT00105443|13191546|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
5361055|NCT00105443|13191547|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
5361056|NCT00105443|13191548|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
5361057|NCT00105443|13191545|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
5361058|NCT00105443|13191546|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
5361059|NCT00105443|13191547|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
5361060|NCT00105443|13191548|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
5361061|NCT00105443|13191545|P4|NOT COMPLETED|Double-Blind Treatment||0
5361062|NCT00105443|13191546|P3|NOT COMPLETED|Double-Blind Treatment||11
5361063|NCT00105443|13191547|P2|NOT COMPLETED|Double-Blind Treatment||0
5361064|NCT00105443|13191548|P1|NOT COMPLETED|Double-Blind Treatment||14
5361065|NCT00105443|13191545|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
5361066|NCT00105443|13191546|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
5361067|NCT00105443|13191547|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
5361068|NCT00105443|13191548|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
5361069|NCT00105443|13191545|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
5361070|NCT00105443|13191546|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
5361071|NCT00105443|13191547|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
5361155|NCT00105027|13191883|P6|COMPLETED|Overall Study||125
5361072|NCT00105443|13191548|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
5361073|NCT00105443|13191545|P4|STARTED|Double-Blind Treatment||47
5361074|NCT00105443|13191546|P3|STARTED|Double-Blind Treatment||256
5361075|NCT00105443|13191547|P2|STARTED|Double-Blind Treatment||57
5361076|NCT00105443|13191548|P1|STARTED|Double-Blind Treatment||242
5361077|NCT00105235|13191575|P1|NOT COMPLETED|Overall Study||7
5361078|NCT00105235|13191575|P1|COMPLETED|Overall Study||20
5361079|NCT00105235|13191575|P1|STARTED|Overall Study||27
5361080|NCT00105196|13191588|P2|NOT COMPLETED|Overall Study||23
5361081|NCT00105196|13191589|P1|NOT COMPLETED|Overall Study||30
5361082|NCT00105196|13191588|P2|COMPLETED|Overall Study||149
5361083|NCT00105196|13191589|P1|COMPLETED|Overall Study||147
5361084|NCT00105196|13191588|P2|STARTED|Overall Study||172
5361085|NCT00105196|13191589|P1|STARTED|Overall Study||177
5361086|NCT00105183|13191612|P3|NOT COMPLETED|Overall Study||23
5361087|NCT00105183|13191613|P2|NOT COMPLETED|Overall Study||19
5361088|NCT00105183|13191614|P1|NOT COMPLETED|Overall Study||22
5361089|NCT00105183|13191612|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
5361090|NCT00105183|13191613|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
5361091|NCT00105183|13191614|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
5361092|NCT00105183|13191612|P3|STARTED|Overall Study|Randomized|62
5361093|NCT00105183|13191613|P2|STARTED|Overall Study|Randomized|79
5361094|NCT00105183|13191614|P1|STARTED|Overall Study|Randomized|82
5361095|NCT00105157|13191650|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
5361096|NCT00105157|13191651|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
5361097|NCT00105157|13191652|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
5361098|NCT00105157|13191653|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
5361099|NCT00105157|13191650|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
5361100|NCT00105157|13191651|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
5361101|NCT00105157|13191652|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
5361102|NCT00105157|13191653|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
5361103|NCT00105157|13191650|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
5361104|NCT00105157|13191651|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
5361105|NCT00105157|13191652|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
5361106|NCT00105157|13191653|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
5361107|NCT00105157|13191650|P4|NOT COMPLETED|Open-Label Continuation of DB||1
5361108|NCT00105157|13191651|P3|NOT COMPLETED|Open-Label Continuation of DB||9
5361109|NCT00105157|13191652|P2|NOT COMPLETED|Open-Label Continuation of DB||10
5361110|NCT00105157|13191653|P1|NOT COMPLETED|Open-Label Continuation of DB||7
5361111|NCT00105157|13191650|P4|COMPLETED|Open-Label Continuation of DB||5
5361112|NCT00105157|13191651|P3|COMPLETED|Open-Label Continuation of DB||24
5361113|NCT00105157|13191652|P2|COMPLETED|Open-Label Continuation of DB||21
5361114|NCT00105157|13191653|P1|COMPLETED|Open-Label Continuation of DB||23
5361115|NCT00105157|13191650|P4|STARTED|Open-Label Continuation of DB||6
5361116|NCT00105157|13191651|P3|STARTED|Open-Label Continuation of DB||33
5361117|NCT00105157|13191652|P2|STARTED|Open-Label Continuation of DB||31
5361118|NCT00105157|13191653|P1|STARTED|Open-Label Continuation of DB||30
5361119|NCT00105157|13191650|P4|NOT COMPLETED|Double-Blind (DB)||39
5361120|NCT00105157|13191651|P3|NOT COMPLETED|Double-Blind (DB)||12
5361121|NCT00105157|13191652|P2|NOT COMPLETED|Double-Blind (DB)||14
5361122|NCT00105157|13191653|P1|NOT COMPLETED|Double-Blind (DB)||14
5361123|NCT00105157|13191650|P4|COMPLETED|Double-Blind (DB)||6
5361124|NCT00105157|13191651|P3|COMPLETED|Double-Blind (DB)||33
5361125|NCT00105157|13191652|P2|COMPLETED|Double-Blind (DB)||31
5361126|NCT00105157|13191653|P1|COMPLETED|Double-Blind (DB)||30
5361127|NCT00105157|13191650|P4|Treated|Double-Blind (DB)||45
5361128|NCT00105157|13191651|P3|Treated|Double-Blind (DB)||45
5361129|NCT00105157|13191652|P2|Treated|Double-Blind (DB)||45
5361130|NCT00105157|13191653|P1|Treated|Double-Blind (DB)||43
5361131|NCT00105157|13191650|P4|STARTED|Double-Blind (DB)||45
5361132|NCT00105157|13191651|P3|STARTED|Double-Blind (DB)||45
5361133|NCT00105157|13191652|P2|STARTED|Double-Blind (DB)||45
5361134|NCT00105157|13191653|P1|STARTED|Double-Blind (DB)||44
5361135|NCT00105079|13191847|P2|NOT COMPLETED|Overall Study||35
5361136|NCT00105079|13191848|P1|NOT COMPLETED|Overall Study||39
5361137|NCT00105079|13191847|P2|COMPLETED|Overall Study||135
5361138|NCT00105079|13191848|P1|COMPLETED|Overall Study||128
5361139|NCT00105079|13191847|P2|Safety Population|Overall Study||168
5361140|NCT00105079|13191848|P1|Safety Population|Overall Study||163
5361141|NCT00105079|13191847|P2|STARTED|Overall Study||170
5361142|NCT00105079|13191848|P1|STARTED|Overall Study||167
5361143|NCT00105066|13191866|P2|NOT COMPLETED|Overall Study||5
5361144|NCT00105066|13191867|P1|NOT COMPLETED|Overall Study||2
5361145|NCT00105066|13191866|P2|COMPLETED|Overall Study||45
5361146|NCT00105066|13191867|P1|COMPLETED|Overall Study||25
5361147|NCT00105066|13191866|P2|STARTED|Overall Study||50
5361148|NCT00105066|13191867|P1|STARTED|Overall Study||27
5361149|NCT00105027|13191883|P6|NOT COMPLETED|Overall Study||13
5361150|NCT00105027|13191884|P5|NOT COMPLETED|Overall Study||15
5361151|NCT00105027|13191885|P4|NOT COMPLETED|Overall Study||16
5361152|NCT00105027|13191886|P3|NOT COMPLETED|Overall Study||9
5361153|NCT00105027|13191887|P2|NOT COMPLETED|Overall Study||9
5361154|NCT00105027|13191888|P1|NOT COMPLETED|Overall Study||15
5361156|NCT00105027|13191884|P5|COMPLETED|Overall Study||121
5361157|NCT00105027|13191885|P4|COMPLETED|Overall Study||121
5361158|NCT00105027|13191886|P3|COMPLETED|Overall Study||82
5361159|NCT00105027|13191887|P2|COMPLETED|Overall Study||83
5361160|NCT00105027|13191888|P1|COMPLETED|Overall Study||73
5361161|NCT00105027|13191883|P6|STARTED|Overall Study||138
5361162|NCT00105027|13191884|P5|STARTED|Overall Study||136
5361163|NCT00105027|13191885|P4|STARTED|Overall Study||137
5361164|NCT00105027|13191886|P3|STARTED|Overall Study||91
5361165|NCT00105027|13191887|P2|STARTED|Overall Study||92
5361166|NCT00105027|13191888|P1|STARTED|Overall Study||88
5361167|NCT00105001|13191923|P3|NOT COMPLETED|Overall Study||0
5361168|NCT00105001|13191924|P2|NOT COMPLETED|Overall Study||0
5361169|NCT00105001|13191925|P1|NOT COMPLETED|Overall Study||0
5361170|NCT00105001|13191923|P3|COMPLETED|Overall Study||69
5361171|NCT00105001|13191924|P2|COMPLETED|Overall Study||71
5361172|NCT00105001|13191925|P1|COMPLETED|Overall Study||70
5361173|NCT00105001|13191923|P3|STARTED|Overall Study||69
5361174|NCT00105001|13191924|P2|STARTED|Overall Study||71
5361175|NCT00105001|13191925|P1|STARTED|Overall Study||70
5361176|NCT00104884|13191945|P1|NOT COMPLETED|Overall Study||4
5361177|NCT00104884|13191945|P1|COMPLETED|Overall Study||0
5361178|NCT00104884|13191945|P1|STARTED|Overall Study||4
5361179|NCT00104871|13191949|P1|NOT COMPLETED|Overall Study||1
5361180|NCT00104871|13191949|P1|COMPLETED|Overall Study||21
5361181|NCT00104871|13191949|P1|STARTED|Overall Study||22
5361182|NCT00104858|13191955|P1|NOT COMPLETED|Overall Study||0
5361183|NCT00104858|13191955|P1|COMPLETED|Overall Study||52
5361184|NCT00104858|13191955|P1|STARTED|Overall Study||52
5361185|NCT00104728|13191970|P1|NOT COMPLETED|Overall Study||19
5361186|NCT00104728|13191970|P1|COMPLETED|Overall Study||23
5361187|NCT00104728|13191970|P1|STARTED|Overall Study|42 consented on study|42
5361188|NCT00104650|13191978|P3|NOT COMPLETED|Follow-up Period||10
5361189|NCT00104650|13191979|P2|NOT COMPLETED|Follow-up Period||13
5361190|NCT00104650|13191980|P1|NOT COMPLETED|Follow-up Period||11
5361191|NCT00104650|13191978|P3|COMPLETED|Follow-up Period||18
5361192|NCT00104650|13191979|P2|COMPLETED|Follow-up Period||12
5361193|NCT00104650|13191980|P1|COMPLETED|Follow-up Period||14
5361194|NCT00104650|13191978|P3|STARTED|Follow-up Period||28
5361195|NCT00104650|13191979|P2|STARTED|Follow-up Period||25
5361196|NCT00104650|13191980|P1|STARTED|Follow-up Period||25
5361197|NCT00104650|13191978|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
5361198|NCT00104650|13191979|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
5361199|NCT00104650|13191980|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
5361200|NCT00104650|13191978|P3|COMPLETED|Treatment Period (25 Weeks)||28
5361201|NCT00104650|13191979|P2|COMPLETED|Treatment Period (25 Weeks)||25
5361202|NCT00104650|13191980|P1|COMPLETED|Treatment Period (25 Weeks)||25
5361203|NCT00104650|13191978|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
5361204|NCT00104650|13191979|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
5361205|NCT00104650|13191980|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
5361206|NCT00104650|13191978|P3|STARTED|Treatment Period (25 Weeks)||38
5361207|NCT00104650|13191979|P2|STARTED|Treatment Period (25 Weeks)||36
5361208|NCT00104650|13191980|P1|STARTED|Treatment Period (25 Weeks)||37
5361209|NCT00104637|13192012|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
5361210|NCT00104637|13192013|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
5361211|NCT00104637|13192012|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
5361212|NCT00104637|13192013|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
5361213|NCT00104637|13192012|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
5361214|NCT00104637|13192013|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
5361215|NCT00104637|13192012|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
5361216|NCT00104637|13192013|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
5361217|NCT00104637|13192012|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
5361218|NCT00104637|13192013|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
5361219|NCT00104637|13192012|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
5361220|NCT00104637|13192013|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
5361221|NCT00104637|13192012|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
5361222|NCT00104637|13192013|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
5361223|NCT00104637|13192012|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
5361224|NCT00104637|13192013|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
5361225|NCT00104637|13192012|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
5361226|NCT00104637|13192013|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
5361227|NCT00104572|13192042|P3|NOT COMPLETED|Overall Study||0
5361228|NCT00104572|13192043|P2|NOT COMPLETED|Overall Study||3
5361229|NCT00104572|13192044|P1|NOT COMPLETED|Overall Study||3
5361230|NCT00104572|13192042|P3|COMPLETED|Overall Study||9
5361231|NCT00104572|13192043|P2|COMPLETED|Overall Study||10
5361232|NCT00104572|13192044|P1|COMPLETED|Overall Study||10
5361233|NCT00104572|13192042|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
5361234|NCT00104572|13192043|P2|STARTED|Overall Study|These are the analysed subjects|13
5361235|NCT00104572|13192044|P1|STARTED|Overall Study|These are the analysed subjects|13
5361236|NCT00104520|13192063|P2|NOT COMPLETED|Overall Study||71
5361237|NCT00104520|13192064|P1|NOT COMPLETED|Overall Study||50
5361238|NCT00104520|13192063|P2|COMPLETED|Overall Study||64
5361239|NCT00104520|13192064|P1|COMPLETED|Overall Study||26
5361240|NCT00104520|13192063|P2|STARTED|Overall Study||135
5361241|NCT00104520|13192064|P1|STARTED|Overall Study||76
5361242|NCT00104416|13192084|P5|NOT COMPLETED|Continuation Phase||5
5361243|NCT00104416|13192085|P4|NOT COMPLETED|Continuation Phase||2
5361244|NCT00104416|13192086|P3|NOT COMPLETED|Continuation Phase||6
5361245|NCT00104416|13192087|P2|NOT COMPLETED|Continuation Phase||0
5361246|NCT00104416|13192088|P1|NOT COMPLETED|Continuation Phase||0
5361247|NCT00104416|13192084|P5|COMPLETED|Continuation Phase||27
5361248|NCT00104416|13192085|P4|COMPLETED|Continuation Phase||65
5361249|NCT00104416|13192086|P3|COMPLETED|Continuation Phase||63
5361250|NCT00104416|13192087|P2|COMPLETED|Continuation Phase||0
5361251|NCT00104416|13192088|P1|COMPLETED|Continuation Phase||0
5361252|NCT00104416|13192084|P5|STARTED|Continuation Phase||32
5361253|NCT00104416|13192085|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
5361254|NCT00104416|13192086|P3|STARTED|Continuation Phase||69
5361255|NCT00104416|13192087|P2|STARTED|Continuation Phase||0
5361256|NCT00104416|13192088|P1|STARTED|Continuation Phase||0
5361257|NCT00104416|13192084|P5|NOT COMPLETED|Double-Blind Phase||0
5361258|NCT00104416|13192085|P4|NOT COMPLETED|Double-Blind Phase||0
5361259|NCT00104416|13192086|P3|NOT COMPLETED|Double-Blind Phase||0
5361260|NCT00104416|13192087|P2|NOT COMPLETED|Double-Blind Phase||10
5361261|NCT00104416|13192088|P1|NOT COMPLETED|Double-Blind Phase||8
5361262|NCT00104416|13192084|P5|COMPLETED|Double-Blind Phase||0
5361263|NCT00104416|13192085|P4|COMPLETED|Double-Blind Phase||0
5361264|NCT00104416|13192086|P3|COMPLETED|Double-Blind Phase||0
5361265|NCT00104416|13192087|P2|COMPLETED|Double-Blind Phase||66
5361266|NCT00104416|13192088|P1|COMPLETED|Double-Blind Phase||69
5361267|NCT00104416|13192084|P5|STARTED|Double-Blind Phase||0
5361268|NCT00104416|13192085|P4|STARTED|Double-Blind Phase||0
5361269|NCT00104416|13192086|P3|STARTED|Double-Blind Phase||0
5361270|NCT00104416|13192087|P2|STARTED|Double-Blind Phase||76
5361271|NCT00104416|13192088|P1|STARTED|Double-Blind Phase||77
5361272|NCT00104299|13192133|P2|NOT COMPLETED|Overall Study||10
5361273|NCT00104299|13192134|P1|NOT COMPLETED|Overall Study||9
5361274|NCT00104299|13192133|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
5361275|NCT00104299|13192134|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
5361276|NCT00104299|13192133|P2|STARTED|Overall Study||98
5361277|NCT00104299|13192134|P1|STARTED|Overall Study||99
5361278|NCT00104247|13192156|P2|NOT COMPLETED|Overall Study||1
5361279|NCT00104247|13192157|P1|NOT COMPLETED|Overall Study||1
5361280|NCT00104247|13192156|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
5361281|NCT00104247|13192157|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
5361282|NCT00104247|13192156|P2|STARTED|Overall Study||47
5361283|NCT00104247|13192157|P1|STARTED|Overall Study||42
5361284|NCT00104234|13192165|P2|NOT COMPLETED|Overall Study||1
5361285|NCT00104234|13192166|P1|NOT COMPLETED|Overall Study||0
5361286|NCT00104234|13192165|P2|COMPLETED|Overall Study||19
5361287|NCT00104234|13192166|P1|COMPLETED|Overall Study||19
5361288|NCT00104234|13192165|P2|STARTED|Overall Study||20
5361289|NCT00104234|13192166|P1|STARTED|Overall Study||19
5361290|NCT00104104|13192176|P2|NOT COMPLETED|Overall Study||72
5361291|NCT00104104|13192177|P1|NOT COMPLETED|Overall Study||75
5361292|NCT00104104|13192176|P2|COMPLETED|Overall Study||17
5361293|NCT00104104|13192177|P1|COMPLETED|Overall Study||15
5361294|NCT00104104|13192176|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
5361295|NCT00104104|13192177|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
5361296|NCT00104104|13192176|P2|Safety Population (Including Site 74)|Overall Study||88
5361297|NCT00104104|13192177|P1|Safety Population (Including Site 74)|Overall Study||88
5361298|NCT00104104|13192176|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
5361299|NCT00104104|13192177|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
5361300|NCT00104052|13192191|P1|NOT COMPLETED|Overall Study||29
5361301|NCT00104052|13192191|P1|COMPLETED|Overall Study||78
5361302|NCT00104052|13192191|P1|STARTED|Overall Study||107
5361303|NCT00103857|13192202|P7|NOT COMPLETED|50-Week Extension Study||0
5361304|NCT00103857|13192203|P6|NOT COMPLETED|50-Week Extension Study||20
5361305|NCT00103857|13192204|P5|NOT COMPLETED|50-Week Extension Study||21
5361306|NCT00103857|13192205|P4|NOT COMPLETED|50-Week Extension Study||36
5361307|NCT00103857|13192206|P3|NOT COMPLETED|50-Week Extension Study||26
5361308|NCT00103857|13192207|P2|NOT COMPLETED|50-Week Extension Study||27
5361309|NCT00103857|13192208|P1|NOT COMPLETED|50-Week Extension Study||38
5361310|NCT00103857|13192202|P7|COMPLETED|50-Week Extension Study||0
5361311|NCT00103857|13192203|P6|COMPLETED|50-Week Extension Study||78
5361312|NCT00103857|13192204|P5|COMPLETED|50-Week Extension Study||101
5361313|NCT00103857|13192205|P4|COMPLETED|50-Week Extension Study||98
5361314|NCT00103857|13192206|P3|COMPLETED|50-Week Extension Study||95
5361315|NCT00103857|13192207|P2|COMPLETED|50-Week Extension Study||80
5361316|NCT00103857|13192208|P1|COMPLETED|50-Week Extension Study||65
5361317|NCT00103857|13192202|P7|STARTED|50-Week Extension Study||0
5361318|NCT00103857|13192203|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
5361319|NCT00103857|13192204|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
5361320|NCT00103857|13192205|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
5361321|NCT00103857|13192206|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
5361322|NCT00103857|13192207|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
5361323|NCT00103857|13192208|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
5361324|NCT00103857|13192202|P7|NOT COMPLETED|54-Week Base Study||38
5361325|NCT00103857|13192203|P6|NOT COMPLETED|54-Week Base Study||61
5361326|NCT00103857|13192204|P5|NOT COMPLETED|54-Week Base Study||41
5361327|NCT00103857|13192205|P4|NOT COMPLETED|54-Week Base Study||42
5361328|NCT00103857|13192206|P3|NOT COMPLETED|54-Week Base Study||47
5361329|NCT00103857|13192207|P2|NOT COMPLETED|54-Week Base Study||56
5361330|NCT00103857|13192208|P1|NOT COMPLETED|54-Week Base Study||57
5361331|NCT00103857|13192202|P7|COMPLETED|54-Week Base Study||79
5361332|NCT00103857|13192203|P6|COMPLETED|54-Week Base Study||115
5361333|NCT00103857|13192204|P5|COMPLETED|54-Week Base Study||141
5361334|NCT00103857|13192205|P4|COMPLETED|54-Week Base Study||148
5361335|NCT00103857|13192206|P3|COMPLETED|54-Week Base Study||135
5361336|NCT00103857|13192207|P2|COMPLETED|54-Week Base Study||126
5361337|NCT00103857|13192208|P1|COMPLETED|54-Week Base Study||122
5361338|NCT00103857|13192202|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
5361339|NCT00103857|13192203|P6|STARTED|54-Week Base Study||176
5361340|NCT00103857|13192204|P5|STARTED|54-Week Base Study||182
5361341|NCT00103857|13192205|P4|STARTED|54-Week Base Study||190
5361342|NCT00103857|13192206|P3|STARTED|54-Week Base Study||182
5361343|NCT00103857|13192207|P2|STARTED|54-Week Base Study||182
5361344|NCT00103857|13192208|P1|STARTED|54-Week Base Study||179
5361345|NCT00103844|13192273|P2|NOT COMPLETED|Overall Study||0
5361346|NCT00103844|13192274|P1|NOT COMPLETED|Overall Study||0
5361347|NCT00103844|13192273|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
5361348|NCT00103844|13192274|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
5361349|NCT00103844|13192273|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
5361350|NCT00103844|13192274|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
5361351|NCT00103844|13192273|P2|STARTED|Overall Study||49
5361352|NCT00103844|13192274|P1|STARTED|Overall Study||101
5361353|NCT00103740|13192307|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
5361354|NCT00103740|13192308|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
5361355|NCT00103740|13192307|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
5361356|NCT00103740|13192308|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
5361357|NCT00103740|13192307|P2|STARTED|Period 2 - Extended Observation Period||63
5361358|NCT00103740|13192308|P1|STARTED|Period 2 - Extended Observation Period||78
5361359|NCT00103740|13192307|P2|NOT COMPLETED|Period 1 - Core||4
5361360|NCT00103740|13192308|P1|NOT COMPLETED|Period 1 - Core||7
5361361|NCT00103740|13192307|P2|COMPLETED|Period 1 - Core||89
5361362|NCT00103740|13192308|P1|COMPLETED|Period 1 - Core||85
5361363|NCT00103740|13192307|P2|STARTED|Period 1 - Core||93
5361364|NCT00103740|13192308|P1|STARTED|Period 1 - Core||92
5361365|NCT00103662|13192336|P2|NOT COMPLETED|Overall Study||33
5361366|NCT00103662|13192337|P1|NOT COMPLETED|Overall Study||19
5361367|NCT00103662|13192336|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
5361368|NCT00103662|13192337|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
5361369|NCT00103662|13192336|P2|STARTED|Overall Study||154
5361370|NCT00103662|13192337|P1|STARTED|Overall Study||148
5361371|NCT00103610|13192363|P2|NOT COMPLETED|Overall Study||80
5361372|NCT00103610|13192364|P1|NOT COMPLETED|Overall Study||38
5361373|NCT00103610|13192363|P2|COMPLETED|Overall Study||68
5361374|NCT00103610|13192364|P1|COMPLETED|Overall Study||112
5361375|NCT00103610|13192363|P2|STARTED|Overall Study||148
5361376|NCT00103610|13192364|P1|STARTED|Overall Study||150
5361377|NCT00103506|13192388|P2|NOT COMPLETED|Overall Study||324
5361378|NCT00103506|13192389|P1|NOT COMPLETED|Overall Study||322
5361379|NCT00103506|13192388|P2|COMPLETED|Overall Study||0
5361380|NCT00103506|13192389|P1|COMPLETED|Overall Study||0
5361381|NCT00103506|13192388|P2|STARTED|Overall Study||324
5361382|NCT00103506|13192389|P1|STARTED|Overall Study||322
5361383|NCT00103402|13192401|P2|NOT COMPLETED|Overall Study||17
5361384|NCT00103402|13192402|P1|NOT COMPLETED|Overall Study||22
5361385|NCT00103402|13192401|P2|COMPLETED|Overall Study||117
5361386|NCT00103402|13192402|P1|COMPLETED|Overall Study||116
5361387|NCT00103402|13192401|P2|STARTED|Overall Study||134
5361388|NCT00103402|13192402|P1|STARTED|Overall Study||138
5361389|NCT00103376|13192425|P3|NOT COMPLETED|Overall Study||0
5361390|NCT00103376|13192426|P2|NOT COMPLETED|Overall Study||0
5361391|NCT00103376|13192427|P1|NOT COMPLETED|Overall Study||0
5361392|NCT00103376|13192425|P3|COMPLETED|Overall Study||8
5361393|NCT00103376|13192426|P2|COMPLETED|Overall Study||7
5361394|NCT00103376|13192427|P1|COMPLETED|Overall Study||8
5361395|NCT00103376|13192425|P3|STARTED|Overall Study||8
5361396|NCT00103376|13192426|P2|STARTED|Overall Study||7
5361397|NCT00103376|13192427|P1|STARTED|Overall Study||8
5361398|NCT00103311|13192443|P2|NOT COMPLETED|Overall Study||1
5361399|NCT00103311|13192444|P1|NOT COMPLETED|Overall Study||4
5361400|NCT00103311|13192443|P2|COMPLETED|Overall Study||30
5361401|NCT00103311|13192444|P1|COMPLETED|Overall Study||29
5361402|NCT00103311|13192443|P2|STARTED|Overall Study||31
5361403|NCT00103311|13192444|P1|STARTED|Overall Study||33
5361404|NCT00103285|13192454|P8|NOT COMPLETED|Response Assignment||120
5361405|NCT00103285|13192455|P7|NOT COMPLETED|Response Assignment||49
5361406|NCT00103285|13192456|P6|NOT COMPLETED|Response Assignment||48
5361407|NCT00103285|13192457|P5|NOT COMPLETED|Response Assignment||84
5361408|NCT00103285|13192458|P4|NOT COMPLETED|Response Assignment||62
5361409|NCT00103285|13192459|P3|NOT COMPLETED|Response Assignment||84
5361410|NCT00103285|13192460|P2|NOT COMPLETED|Response Assignment||132
5361411|NCT00103285|13192461|P1|NOT COMPLETED|Response Assignment||0
5361412|NCT00103285|13192454|P8|COMPLETED|Response Assignment||523
5361413|NCT00103285|13192455|P7|COMPLETED|Response Assignment||199
5361414|NCT00103285|13192456|P6|COMPLETED|Response Assignment||201
5361415|NCT00103285|13192457|P5|COMPLETED|Response Assignment||425
5361416|NCT00103285|13192458|P4|COMPLETED|Response Assignment||441
5361417|NCT00103285|13192459|P3|COMPLETED|Response Assignment||853
5361418|NCT00103285|13192460|P2|COMPLETED|Response Assignment||807
5361419|NCT00103285|13192461|P1|COMPLETED|Response Assignment||0
5361420|NCT00103285|13192454|P8|STARTED|Response Assignment||643
5361421|NCT00103285|13192455|P7|STARTED|Response Assignment||248
5361422|NCT00103285|13192456|P6|STARTED|Response Assignment||249
5361423|NCT00103285|13192457|P5|STARTED|Response Assignment||509
5361424|NCT00103285|13192458|P4|STARTED|Response Assignment||503
5361425|NCT00103285|13192459|P3|STARTED|Response Assignment||937
5361426|NCT00103285|13192460|P2|STARTED|Response Assignment||939
5361427|NCT00103285|13192461|P1|STARTED|Response Assignment||0
5361428|NCT00103285|13192454|P8|NOT COMPLETED|Induction||0
5361429|NCT00103285|13192455|P7|NOT COMPLETED|Induction||0
5361430|NCT00103285|13192456|P6|NOT COMPLETED|Induction||0
5361431|NCT00103285|13192457|P5|NOT COMPLETED|Induction||0
5361432|NCT00103285|13192458|P4|NOT COMPLETED|Induction||0
5361433|NCT00103285|13192459|P3|NOT COMPLETED|Induction||0
5361434|NCT00103285|13192460|P2|NOT COMPLETED|Induction||0
5361435|NCT00103285|13192461|P1|NOT COMPLETED|Induction||1349
5361436|NCT00103285|13192454|P8|COMPLETED|Induction||0
5361437|NCT00103285|13192455|P7|COMPLETED|Induction||0
5361438|NCT00103285|13192456|P6|COMPLETED|Induction||0
5361439|NCT00103285|13192457|P5|COMPLETED|Induction||0
5361440|NCT00103285|13192458|P4|COMPLETED|Induction||0
5361441|NCT00103285|13192459|P3|COMPLETED|Induction||0
5361442|NCT00103285|13192460|P2|COMPLETED|Induction||0
5361443|NCT00103285|13192461|P1|COMPLETED|Induction||4028
5361444|NCT00103285|13192454|P8|STARTED|Induction||0
5361445|NCT00103285|13192455|P7|STARTED|Induction||0
5361446|NCT00103285|13192456|P6|STARTED|Induction||0
5361447|NCT00103285|13192457|P5|STARTED|Induction||0
5361448|NCT00103285|13192458|P4|STARTED|Induction||0
5361449|NCT00103285|13192459|P3|STARTED|Induction||0
5361450|NCT00103285|13192460|P2|STARTED|Induction||0
5361451|NCT00103285|13192461|P1|STARTED|Induction||5377
5361452|NCT00103259|13192490|P2|NOT COMPLETED|Overall Study||12
5361453|NCT00103259|13192491|P1|NOT COMPLETED|Overall Study||12
5361454|NCT00103259|13192490|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
5361455|NCT00103259|13192491|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
5361456|NCT00103259|13192490|P2|Eligible Patients Who Cross Over|Overall Study||10
5361457|NCT00103259|13192491|P1|Eligible Patients Who Cross Over|Overall Study||0
5361458|NCT00103259|13192490|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
5361459|NCT00103259|13192491|P1|Cross Over to the Other Arm|Overall Study||0
5361460|NCT00103259|13192490|P2|Eligible and Treated|Overall Study||38
5361461|NCT00103259|13192491|P1|Eligible and Treated|Overall Study||23
5361462|NCT00103259|13192490|P2|Treated|Overall Study||41
5361463|NCT00103259|13192491|P1|Treated|Overall Study||23
5361464|NCT00103259|13192490|P2|Eligible|Overall Study||41
5361465|NCT00103259|13192491|P1|Eligible|Overall Study||27
5361466|NCT00103259|13192490|P2|STARTED|Overall Study||44
5361467|NCT00103259|13192491|P1|STARTED|Overall Study||27
5361468|NCT00103207|13192503|P1|NOT COMPLETED|Overall Study||38
5361469|NCT00103207|13192503|P1|COMPLETED|Overall Study||34
5361470|NCT00103207|13192503|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
5361471|NCT00103207|13192503|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
5361472|NCT00103207|13192503|P1|STARTED|Overall Study||72
5361473|NCT00103194|13192513|P1|NOT COMPLETED|Overall Study||31
5361474|NCT00103194|13192513|P1|COMPLETED|Overall Study||18
5361475|NCT00103194|13192513|P1|Eligible and Treated|Overall Study||35
5361476|NCT00103194|13192513|P1|Eligible|Overall Study||35
5361477|NCT00103194|13192513|P1|Treated|Overall Study||49
5361478|NCT00103194|13192513|P1|STARTED|Overall Study||49
5361479|NCT00103142|13192522|P2|NOT COMPLETED|Overall Study||1
5361480|NCT00103142|13192523|P1|NOT COMPLETED|Overall Study||3
5361481|NCT00103142|13192522|P2|COMPLETED|Overall Study||36
5361482|NCT00103142|13192523|P1|COMPLETED|Overall Study||33
5361483|NCT00103142|13192522|P2|STARTED|Overall Study||37
5361484|NCT00103142|13192523|P1|STARTED|Overall Study||36
5361485|NCT00103116|13192531|P1|NOT COMPLETED|Overall Study||0
5361486|NCT00103116|13192531|P1|COMPLETED|Overall Study||32
5361487|NCT00103116|13192531|P1|STARTED|Overall Study||32
5361488|NCT00103012|13192539|P3|NOT COMPLETED|Overall Study||4
5361489|NCT00103012|13192540|P2|NOT COMPLETED|Overall Study||1
5361490|NCT00103012|13192541|P1|NOT COMPLETED|Overall Study||3
5361491|NCT00103012|13192539|P3|COMPLETED|Overall Study||12
5361492|NCT00103012|13192540|P2|COMPLETED|Overall Study||13
5361493|NCT00103012|13192541|P1|COMPLETED|Overall Study||14
5361494|NCT00103012|13192539|P3|STARTED|Overall Study||16
5361495|NCT00103012|13192540|P2|STARTED|Overall Study||14
5361496|NCT00103012|13192541|P1|STARTED|Overall Study||17
5361497|NCT00102960|13192552|P3|NOT COMPLETED|Overall Study||28
5361498|NCT00102960|13192553|P2|NOT COMPLETED|Overall Study||23
5361499|NCT00102960|13192554|P1|NOT COMPLETED|Overall Study||30
5361500|NCT00102960|13192552|P3|COMPLETED|Overall Study||98
5361501|NCT00102960|13192553|P2|COMPLETED|Overall Study||103
5361502|NCT00102960|13192554|P1|COMPLETED|Overall Study||95
5361503|NCT00102960|13192552|P3|STARTED|Overall Study||126
5361504|NCT00102960|13192553|P2|STARTED|Overall Study||126
5361505|NCT00102960|13192554|P1|STARTED|Overall Study||125
5361506|NCT00102804|13192603|P2|NOT COMPLETED|Overall Study||222
5361507|NCT00102804|13192604|P1|NOT COMPLETED|Overall Study||441
5361508|NCT00102804|13192603|P2|COMPLETED|Overall Study||0
5361509|NCT00102804|13192604|P1|COMPLETED|Overall Study||0
5361510|NCT00102804|13192603|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
5361511|NCT00102804|13192604|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
5361512|NCT00102804|13192603|P2|STARTED|Overall Study||222
5361513|NCT00102804|13192604|P1|STARTED|Overall Study||441
5361514|NCT00102687|13192625|P5|NOT COMPLETED|Maintenance Period||13
5361515|NCT00102687|13192626|P4|NOT COMPLETED|Maintenance Period||10
5361516|NCT00102687|13192627|P3|NOT COMPLETED|Maintenance Period||6
5361517|NCT00102687|13192628|P2|NOT COMPLETED|Maintenance Period||4
5361518|NCT00102687|13192629|P1|NOT COMPLETED|Maintenance Period||7
5361519|NCT00102687|13192625|P5|COMPLETED|Maintenance Period||8
5361520|NCT00102687|13192626|P4|COMPLETED|Maintenance Period||12
5361521|NCT00102687|13192627|P3|COMPLETED|Maintenance Period||2
5361522|NCT00102687|13192628|P2|COMPLETED|Maintenance Period||2
5361523|NCT00102687|13192629|P1|COMPLETED|Maintenance Period||6
5361524|NCT00102687|13192625|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
5361525|NCT00102687|13192626|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
5361526|NCT00102687|13192627|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
5361527|NCT00102687|13192628|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
5361528|NCT00102687|13192629|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
5361529|NCT00102687|13192625|P5|NOT COMPLETED|Initial Period||0
5361530|NCT00102687|13192626|P4|NOT COMPLETED|Initial Period||0
5361531|NCT00102687|13192627|P3|NOT COMPLETED|Initial Period||26
5361532|NCT00102687|13192628|P2|NOT COMPLETED|Initial Period||28
5361533|NCT00102687|13192629|P1|NOT COMPLETED|Initial Period||18
5361534|NCT00102687|13192625|P5|COMPLETED|Initial Period||0
5361535|NCT00102687|13192626|P4|COMPLETED|Initial Period||0
5361536|NCT00102687|13192627|P3|COMPLETED|Initial Period||25
5361537|NCT00102687|13192628|P2|COMPLETED|Initial Period||22
5361538|NCT00102687|13192629|P1|COMPLETED|Initial Period||32
5361539|NCT00102687|13192625|P5|STARTED|Initial Period||0
5361540|NCT00102687|13192626|P4|STARTED|Initial Period||0
5361541|NCT00102687|13192627|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
5361542|NCT00102687|13192628|P2|STARTED|Initial Period||50
5361543|NCT00102687|13192629|P1|STARTED|Initial Period||50
5361544|NCT00102596|13192693|P2|NOT COMPLETED|Part C||0
5361545|NCT00102596|13192694|P1|NOT COMPLETED|Part C||0
5361546|NCT00102596|13192693|P2|COMPLETED|Part C||2
5361547|NCT00102596|13192694|P1|COMPLETED|Part C||0
5361548|NCT00102596|13192693|P2|STARTED|Part C|Only 2 patients participated in Part C|2
5361549|NCT00102596|13192694|P1|STARTED|Part C||0
5361550|NCT00102596|13192693|P2|NOT COMPLETED|Part B||0
5361551|NCT00102596|13192694|P1|NOT COMPLETED|Part B||0
5361552|NCT00102596|13192693|P2|COMPLETED|Part B||10
5361553|NCT00102596|13192694|P1|COMPLETED|Part B||0
5361554|NCT00102596|13192693|P2|STARTED|Part B||10
5361555|NCT00102596|13192694|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
5361556|NCT00102596|13192693|P2|NOT COMPLETED|Part A||0
5361557|NCT00102596|13192694|P1|NOT COMPLETED|Part A||7
5361558|NCT00102596|13192693|P2|COMPLETED|Part A||0
5361559|NCT00102596|13192694|P1|COMPLETED|Part A||4
5361560|NCT00102596|13192693|P2|Participants Assigned Treatment|Part A||0
5361561|NCT00102596|13192694|P1|Participants Assigned Treatment|Part A||5
5361562|NCT00102596|13192693|P2|STARTED|Part A||0
5361563|NCT00102596|13192694|P1|STARTED|Part A||11
5361564|NCT00102531|13192705|P2|NOT COMPLETED|Overall Study||11
5361565|NCT00102531|13192706|P1|NOT COMPLETED|Overall Study||5
5361566|NCT00102531|13192705|P2|COMPLETED|Overall Study||1
5361567|NCT00102531|13192706|P1|COMPLETED|Overall Study||2
5361568|NCT00102531|13192705|P2|STARTED|Overall Study||12
5361569|NCT00102531|13192706|P1|STARTED|Overall Study||7
5361570|NCT00102518|13192712|P1|NOT COMPLETED|Overall Study||87
5361571|NCT00102518|13192712|P1|COMPLETED|Overall Study||238
5361572|NCT00102518|13192712|P1|STARTED|Overall Study||325
5361573|NCT00102440|13192721|P3|NOT COMPLETED|Overall Study||66
5361574|NCT00102440|13192722|P2|NOT COMPLETED|Overall Study||98
5361575|NCT00102440|13192723|P1|NOT COMPLETED|Overall Study||88
5361576|NCT00102440|13192721|P3|COMPLETED|Overall Study||187
5361577|NCT00102440|13192722|P2|COMPLETED|Overall Study||153
5361578|NCT00102440|13192723|P1|COMPLETED|Overall Study||168
5361579|NCT00102440|13192721|P3|STARTED|Overall Study||253
5361580|NCT00102440|13192722|P2|STARTED|Overall Study||251
5361581|NCT00102440|13192723|P1|STARTED|Overall Study||256
5361582|NCT00102063|13192773|P3|NOT COMPLETED|Overall Study||10
5361583|NCT00102063|13192774|P2|NOT COMPLETED|Overall Study||18
5361584|NCT00102063|13192775|P1|NOT COMPLETED|Overall Study||16
5361585|NCT00102063|13192773|P3|COMPLETED|Overall Study||90
5361586|NCT00102063|13192774|P2|COMPLETED|Overall Study||84
5361587|NCT00102063|13192775|P1|COMPLETED|Overall Study||84
5361588|NCT00102063|13192773|P3|STARTED|Overall Study||100
5361589|NCT00102063|13192774|P2|STARTED|Overall Study||102
5361590|NCT00102063|13192775|P1|STARTED|Overall Study||100
5361591|NCT00101933|13192806|P2|NOT COMPLETED|Overall Study||0
5361592|NCT00101933|13192807|P1|NOT COMPLETED|Overall Study||0
5361593|NCT00101933|13192806|P2|COMPLETED|Overall Study||55
5361594|NCT00101933|13192807|P1|COMPLETED|Overall Study||54
5361595|NCT00101933|13192806|P2|STARTED|Overall Study||55
5361596|NCT00101933|13192807|P1|STARTED|Overall Study||54
5361597|NCT00101907|13192833|P6|NOT COMPLETED|Overall Study||0
5361598|NCT00101907|13192834|P5|NOT COMPLETED|Overall Study||5
5361599|NCT00101907|13192835|P4|NOT COMPLETED|Overall Study||1
5361600|NCT00101907|13192836|P3|NOT COMPLETED|Overall Study||1
5361601|NCT00101907|13192837|P2|NOT COMPLETED|Overall Study||1
5361602|NCT00101907|13192838|P1|NOT COMPLETED|Overall Study||2
5361603|NCT00101907|13192833|P6|COMPLETED|Overall Study||2
5361604|NCT00101907|13192834|P5|COMPLETED|Overall Study||6
5361605|NCT00101907|13192835|P4|COMPLETED|Overall Study||5
5361606|NCT00101907|13192836|P3|COMPLETED|Overall Study||5
5361607|NCT00101907|13192837|P2|COMPLETED|Overall Study||7
5361608|NCT00101907|13192838|P1|COMPLETED|Overall Study||6
5361609|NCT00101907|13192833|P6|STARTED|Overall Study||2
5361610|NCT00101907|13192834|P5|STARTED|Overall Study||11
5361611|NCT00101907|13192835|P4|STARTED|Overall Study||6
5361612|NCT00101907|13192836|P3|STARTED|Overall Study||6
5361613|NCT00101907|13192837|P2|STARTED|Overall Study||8
5361614|NCT00101907|13192838|P1|STARTED|Overall Study||8
5361615|NCT00101868|13192880|P2|NOT COMPLETED|Overall Study||32
5361616|NCT00101868|13192881|P1|NOT COMPLETED|Overall Study||29
5361617|NCT00101868|13192880|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
5361618|NCT00101868|13192881|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
5361619|NCT00101868|13192880|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
5361620|NCT00101868|13192881|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
5361621|NCT00101816|13192893|P2|NOT COMPLETED|Overall Study||0
5361622|NCT00101816|13192894|P1|NOT COMPLETED|Overall Study||0
5361623|NCT00101816|13192893|P2|COMPLETED|Overall Study||99
5361624|NCT00101816|13192894|P1|COMPLETED|Overall Study||10
5361625|NCT00101816|13192893|P2|STARTED|Overall Study||99
5361626|NCT00101816|13192894|P1|STARTED|Overall Study||10
5361627|NCT00101686|13192951|P10|NOT COMPLETED|Overall Study||30
5361628|NCT00101686|13192952|P9|NOT COMPLETED|Overall Study||30
5361629|NCT00101686|13192953|P8|NOT COMPLETED|Overall Study||30
5361630|NCT00101686|13192954|P7|NOT COMPLETED|Overall Study||27
5361631|NCT00101686|13192955|P6|NOT COMPLETED|Overall Study||72
5361632|NCT00101686|13192956|P5|NOT COMPLETED|Overall Study||73
5361633|NCT00101686|13192957|P4|NOT COMPLETED|Overall Study||72
5361634|NCT00101686|13192958|P3|NOT COMPLETED|Overall Study||69
5361635|NCT00101686|13192959|P2|NOT COMPLETED|Overall Study||73
5361636|NCT00101686|13192960|P1|NOT COMPLETED|Overall Study||71
5361637|NCT00101686|13192951|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361638|NCT00101686|13192952|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361639|NCT00101686|13192953|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361640|NCT00101686|13192954|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361641|NCT00101686|13192955|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361642|NCT00101686|13192956|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361643|NCT00101686|13192957|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361644|NCT00101686|13192958|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361645|NCT00101686|13192959|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361646|NCT00101686|13192960|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
5361647|NCT00101686|13192951|P10|Received Treatment|Overall Study||29
5361648|NCT00101686|13192952|P9|Received Treatment|Overall Study||30
5361649|NCT00101686|13192953|P8|Received Treatment|Overall Study||29
5361650|NCT00101686|13192954|P7|Received Treatment|Overall Study||27
5361651|NCT00101686|13192955|P6|Received Treatment|Overall Study||70
5361652|NCT00101686|13192956|P5|Received Treatment|Overall Study||71
5361653|NCT00101686|13192957|P4|Received Treatment|Overall Study||70
5361654|NCT00101686|13192958|P3|Received Treatment|Overall Study||67
5361655|NCT00101686|13192959|P2|Received Treatment|Overall Study||67
5361656|NCT00101686|13192960|P1|Received Treatment|Overall Study||70
5361657|NCT00101686|13192951|P10|STARTED|Overall Study||30
5361658|NCT00101686|13192952|P9|STARTED|Overall Study||30
5361659|NCT00101686|13192953|P8|STARTED|Overall Study||30
5361660|NCT00101686|13192954|P7|STARTED|Overall Study||27
5361661|NCT00101686|13192955|P6|STARTED|Overall Study||72
5361662|NCT00101686|13192956|P5|STARTED|Overall Study||73
5361663|NCT00101686|13192957|P4|STARTED|Overall Study||72
5361664|NCT00101686|13192958|P3|STARTED|Overall Study||69
5361665|NCT00101686|13192959|P2|STARTED|Overall Study||73
5361666|NCT00101686|13192960|P1|STARTED|Overall Study||71
5361667|NCT00101660|13193007|P2|NOT COMPLETED|Overall Study||0
5361668|NCT00101660|13193008|P1|NOT COMPLETED|Overall Study||0
5361669|NCT00101660|13193007|P2|COMPLETED|Overall Study||288
5361670|NCT00101660|13193008|P1|COMPLETED|Overall Study||99
5361671|NCT00101660|13193007|P2|STARTED|Overall Study||288
5361672|NCT00101660|13193008|P1|STARTED|Overall Study||99
5361673|NCT00101647|13193026|P2|NOT COMPLETED|Overall Study||0
5361674|NCT00101647|13193027|P1|NOT COMPLETED|Overall Study||0
5361675|NCT00101647|13193026|P2|COMPLETED|Overall Study||161
5361676|NCT00101647|13193027|P1|COMPLETED|Overall Study||13
5361677|NCT00101647|13193026|P2|STARTED|Overall Study|Randomized|161
5361678|NCT00101647|13193027|P1|STARTED|Overall Study|Randomized|13
5361679|NCT00101582|13193077|P2|NOT COMPLETED|Overall Study||15
5361680|NCT00101582|13193078|P1|NOT COMPLETED|Overall Study||11
5361681|NCT00101582|13193077|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
5361682|NCT00101582|13193078|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
5361683|NCT00101582|13193077|P2|Received Study Drug|Overall Study||94
5361684|NCT00101582|13193078|P1|Received Study Drug|Overall Study||91
5361685|NCT00101582|13193077|P2|STARTED|Overall Study||94
5361686|NCT00101582|13193078|P1|STARTED|Overall Study||94
5361687|NCT00101452|13193101|P3|NOT COMPLETED|Overall Study||43
5361688|NCT00101452|13193102|P2|NOT COMPLETED|Overall Study||43
5361689|NCT00101452|13193103|P1|NOT COMPLETED|Overall Study||44
5361690|NCT00101452|13193101|P3|COMPLETED|Overall Study||22
5361691|NCT00101452|13193102|P2|COMPLETED|Overall Study||26
5361692|NCT00101452|13193103|P1|COMPLETED|Overall Study||21
5361693|NCT00101452|13193101|P3|STARTED|Overall Study||65
5361694|NCT00101452|13193102|P2|STARTED|Overall Study||69
5361695|NCT00101452|13193103|P1|STARTED|Overall Study||65
5361696|NCT00101439|13193117|P2|NOT COMPLETED|Period 2||2
5361697|NCT00101439|13193118|P1|NOT COMPLETED|Period 2||0
5361698|NCT00101439|13193117|P2|COMPLETED|Period 2||28
5361699|NCT00101439|13193118|P1|COMPLETED|Period 2||28
5361700|NCT00101439|13193117|P2|STARTED|Period 2||30
5361701|NCT00101439|13193118|P1|STARTED|Period 2||28
5361702|NCT00101439|13193117|P2|NOT COMPLETED|Period 1||0
5361703|NCT00101439|13193118|P1|NOT COMPLETED|Period 1||0
5361704|NCT00101439|13193117|P2|COMPLETED|Period 1||30
5361705|NCT00101439|13193118|P1|COMPLETED|Period 1||28
5361706|NCT00101439|13193117|P2|STARTED|Period 1||30
5361707|NCT00101439|13193118|P1|STARTED|Period 1||28
5361708|NCT00101413|13193126|P1|NOT COMPLETED|Overall Study||0
5361709|NCT00101413|13193126|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
5361710|NCT00101413|13193126|P1|STARTED|Overall Study||52
5361711|NCT00101400|13193134|P1|NOT COMPLETED|Survival Follow-Up||7
5361712|NCT00101400|13193134|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
5361713|NCT00101400|13193134|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
5361714|NCT00101400|13193134|P1|NOT COMPLETED|Treatment||0
5361715|NCT00101400|13193134|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
5361716|NCT00101400|13193134|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
5361717|NCT00101361|13193145|P2|NOT COMPLETED|Overall Study||0
5361718|NCT00101361|13193146|P1|NOT COMPLETED|Overall Study||0
5361719|NCT00101361|13193145|P2|COMPLETED|Overall Study||104
5361720|NCT00101361|13193146|P1|COMPLETED|Overall Study||108
5361721|NCT00101361|13193145|P2|STARTED|Overall Study||104
5361722|NCT00101361|13193146|P1|STARTED|Overall Study||108
5361723|NCT00101283|13193154|P2|NOT COMPLETED|Overall Study||3
5361724|NCT00101283|13193155|P1|NOT COMPLETED|Overall Study||0
5361725|NCT00101283|13193154|P2|COMPLETED|Overall Study||13
5361726|NCT00101283|13193155|P1|COMPLETED|Overall Study||16
5361727|NCT00101283|13193154|P2|Began Treatment|Overall Study||13
5361728|NCT00101283|13193155|P1|Began Treatment|Overall Study||16
5361729|NCT00101283|13193154|P2|STARTED|Overall Study||16
5361730|NCT00101283|13193155|P1|STARTED|Overall Study||16
5361731|NCT00101192|13193165|P1|NOT COMPLETED|Overall Study||7
5361732|NCT00101192|13193165|P1|COMPLETED|Overall Study||69
5361733|NCT00101192|13193165|P1|STARTED|Overall Study||76
5361734|NCT00101166|13193169|P1|NOT COMPLETED|Overall Study||10
5361735|NCT00101166|13193169|P1|COMPLETED|Overall Study||18
5361736|NCT00101166|13193169|P1|STARTED|Overall Study||28
5361737|NCT00101101|13193177|P1|NOT COMPLETED|Overall Study||20
5361738|NCT00101101|13193177|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
5361739|NCT00101101|13193177|P1|STARTED|Overall Study||43
5361740|NCT00101036|13193185|P2|NOT COMPLETED|Overall Study||0
5361741|NCT00101036|13193186|P1|NOT COMPLETED|Overall Study||0
5361742|NCT00101036|13193185|P2|COMPLETED|Overall Study||40
5361743|NCT00101036|13193186|P1|COMPLETED|Overall Study||17
5361744|NCT00101036|13193185|P2|STARTED|Overall Study||40
5361745|NCT00101036|13193186|P1|STARTED|Overall Study||17
5361746|NCT00100932|13193200|P2|NOT COMPLETED|Overall Study||27
5361747|NCT00100932|13193201|P1|NOT COMPLETED|Overall Study||73
5361748|NCT00100932|13193200|P2|COMPLETED|Overall Study||1
5361749|NCT00100932|13193201|P1|COMPLETED|Overall Study||5
5361750|NCT00100932|13193200|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
5361751|NCT00100932|13193201|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
5361752|NCT00100841|13193211|P1|NOT COMPLETED|Overall Study||0
5361753|NCT00100841|13193211|P1|COMPLETED|Overall Study||66
5361754|NCT00100841|13193211|P1|STARTED|Overall Study||66
5361755|NCT00100828|13193216|P1|NOT COMPLETED|Overall Study||6
5361756|NCT00100828|13193216|P1|COMPLETED|Overall Study||0
5361757|NCT00100828|13193216|P1|STARTED|Overall Study||6
5361758|NCT00100815|13193220|P1|NOT COMPLETED|Overall Study||49
5361759|NCT00100815|13193220|P1|COMPLETED|Overall Study||1
5361760|NCT00100815|13193220|P1|STARTED|Overall Study||50
5361761|NCT00100802|13193228|P1|NOT COMPLETED|Overall Study||80
5361762|NCT00100802|13193228|P1|COMPLETED|Overall Study||38
5361763|NCT00100802|13193228|P1|STARTED|Overall Study||118
5361764|NCT00100789|13193233|P1|NOT COMPLETED|Overall Study||64
5361765|NCT00100789|13193233|P1|COMPLETED|Overall Study||3
5361766|NCT00100789|13193233|P1|Eligible and Began Protocol Therapy|Overall Study||63
5361767|NCT00100789|13193233|P1|Eligible|Overall Study||64
5361768|NCT00100789|13193233|P1|STARTED|Overall Study||67
5361769|NCT00100698|13193242|P2|NOT COMPLETED|Overall Study||2
5361770|NCT00100698|13193243|P1|NOT COMPLETED|Overall Study||6
5361771|NCT00100698|13193242|P2|COMPLETED|Overall Study||27
5361772|NCT00100698|13193243|P1|COMPLETED|Overall Study||21
5361773|NCT00100698|13193242|P2|STARTED|Overall Study||29
5361774|NCT00100698|13193243|P1|STARTED|Overall Study||27
5361775|NCT00100659|13193285|P2|NOT COMPLETED|Overall Study||2
5361776|NCT00100659|13193286|P1|NOT COMPLETED|Overall Study||3
5361777|NCT00100659|13193285|P2|COMPLETED|Overall Study||57
5361778|NCT00100659|13193286|P1|COMPLETED|Overall Study||52
5361779|NCT00100659|13193285|P2|STARTED|Overall Study||59
5361780|NCT00100659|13193286|P1|STARTED|Overall Study||55
5361781|NCT00100230|13193296|P2|NOT COMPLETED|Overall Study||15
5361782|NCT00100230|13193297|P1|NOT COMPLETED|Overall Study||12
5361783|NCT00100230|13193296|P2|COMPLETED|Overall Study||22
5361784|NCT00100230|13193297|P1|COMPLETED|Overall Study||29
5361785|NCT00100230|13193296|P2|STARTED|Overall Study||37
5361786|NCT00100230|13193297|P1|STARTED|Overall Study||41
5361787|NCT00100178|13193310|P3|NOT COMPLETED|Overall Study||10
5361788|NCT00100178|13193311|P2|NOT COMPLETED|Overall Study||10
5361789|NCT00100178|13193312|P1|NOT COMPLETED|Overall Study||9
5361790|NCT00100178|13193310|P3|COMPLETED|Overall Study||32
5361791|NCT00100178|13193311|P2|COMPLETED|Overall Study||21
5361792|NCT00100178|13193312|P1|COMPLETED|Overall Study||32
5361793|NCT00100178|13193310|P3|STARTED|Overall Study||42
5361794|NCT00100178|13193311|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
5361795|NCT00100178|13193312|P1|STARTED|Overall Study||41
5361796|NCT00100165|13193323|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
5361797|NCT00100165|13193324|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
5361798|NCT00100165|13193325|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
5361799|NCT00100165|13193323|P3|COMPLETED|Third Intervention (4 Weeks)||9
5361800|NCT00100165|13193324|P2|COMPLETED|Third Intervention (4 Weeks)||10
5361801|NCT00100165|13193325|P1|COMPLETED|Third Intervention (4 Weeks)||10
5361802|NCT00100165|13193323|P3|STARTED|Third Intervention (4 Weeks)||9
5361803|NCT00100165|13193324|P2|STARTED|Third Intervention (4 Weeks)||10
5361804|NCT00100165|13193325|P1|STARTED|Third Intervention (4 Weeks)||10
5361805|NCT00100165|13193323|P3|NOT COMPLETED|Washout (1 Week)||0
5361806|NCT00100165|13193324|P2|NOT COMPLETED|Washout (1 Week)||0
5361807|NCT00100165|13193325|P1|NOT COMPLETED|Washout (1 Week)||0
5361808|NCT00100165|13193323|P3|COMPLETED|Washout (1 Week)||9
5361809|NCT00100165|13193324|P2|COMPLETED|Washout (1 Week)||10
5361810|NCT00100165|13193325|P1|COMPLETED|Washout (1 Week)||10
5361811|NCT00100165|13193323|P3|STARTED|Washout (1 Week)||9
5361812|NCT00100165|13193324|P2|STARTED|Washout (1 Week)||10
5361813|NCT00100165|13193325|P1|STARTED|Washout (1 Week)||10
5361814|NCT00100165|13193323|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
5361815|NCT00100165|13193324|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
5361816|NCT00100165|13193325|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
5361817|NCT00100165|13193323|P3|COMPLETED|Second Intervention (4 Weeks)||9
5361818|NCT00100165|13193324|P2|COMPLETED|Second Intervention (4 Weeks)||10
5361819|NCT00100165|13193325|P1|COMPLETED|Second Intervention (4 Weeks)||10
5361820|NCT00100165|13193323|P3|STARTED|Second Intervention (4 Weeks)||9
5361821|NCT00100165|13193324|P2|STARTED|Second Intervention (4 Weeks)||10
5361822|NCT00100165|13193325|P1|STARTED|Second Intervention (4 Weeks)||10
5361823|NCT00100165|13193323|P3|NOT COMPLETED|Washout (1 Week)||0
5361824|NCT00100165|13193324|P2|NOT COMPLETED|Washout (1 Week)||0
5361825|NCT00100165|13193325|P1|NOT COMPLETED|Washout (1 Week)||0
5361826|NCT00100165|13193323|P3|COMPLETED|Washout (1 Week)||9
5361827|NCT00100165|13193324|P2|COMPLETED|Washout (1 Week)||10
5361828|NCT00100165|13193325|P1|COMPLETED|Washout (1 Week)||10
5361829|NCT00100165|13193323|P3|STARTED|Washout (1 Week)||9
5361830|NCT00100165|13193324|P2|STARTED|Washout (1 Week)||10
5361831|NCT00100165|13193325|P1|STARTED|Washout (1 Week)||10
5361832|NCT00100165|13193323|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
5361833|NCT00100165|13193324|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
5361834|NCT00100165|13193325|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
5361835|NCT00100165|13193323|P3|COMPLETED|First Intervention (4 Weeks)||9
5361836|NCT00100165|13193324|P2|COMPLETED|First Intervention (4 Weeks)||10
5361837|NCT00100165|13193325|P1|COMPLETED|First Intervention (4 Weeks)||10
5361838|NCT00100165|13193323|P3|STARTED|First Intervention (4 Weeks)||9
5361839|NCT00100165|13193324|P2|STARTED|First Intervention (4 Weeks)||10
5361840|NCT00100165|13193325|P1|STARTED|First Intervention (4 Weeks)||10
5361841|NCT00100165|13193323|P3|NOT COMPLETED|Baseline||0
5361842|NCT00100165|13193324|P2|NOT COMPLETED|Baseline||0
5361843|NCT00100165|13193325|P1|NOT COMPLETED|Baseline||0
5361844|NCT00100165|13193323|P3|COMPLETED|Baseline||9
5361845|NCT00100165|13193324|P2|COMPLETED|Baseline||10
5361846|NCT00100165|13193325|P1|COMPLETED|Baseline||10
5361847|NCT00100165|13193323|P3|STARTED|Baseline||9
5361848|NCT00100165|13193324|P2|STARTED|Baseline||10
5361849|NCT00100165|13193325|P1|STARTED|Baseline||10
5361850|NCT00100048|13193341|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
5361851|NCT00100048|13193342|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
5361852|NCT00100048|13193343|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
5361853|NCT00100048|13193344|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
5361854|NCT00100048|13193345|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
5361855|NCT00100048|13193346|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
5361856|NCT00100048|13193341|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
5361857|NCT00100048|13193342|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
5361858|NCT00100048|13193343|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
5361859|NCT00100048|13193344|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
5361860|NCT00100048|13193345|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
5361861|NCT00100048|13193346|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
5361862|NCT00100048|13193341|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
5361863|NCT00100048|13193342|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
5361864|NCT00100048|13193343|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
5361865|NCT00100048|13193344|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
5361866|NCT00100048|13193345|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
5361867|NCT00100048|13193346|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
5361868|NCT00100048|13193341|P6|Treated|Cohort I & II-Combination Therapy Phase||38
5361869|NCT00100048|13193342|P5|Treated|Cohort I & II-Combination Therapy Phase||0
5361870|NCT00100048|13193343|P4|Treated|Cohort I & II-Combination Therapy Phase||40
5361871|NCT00100048|13193344|P3|Treated|Cohort I & II-Combination Therapy Phase||41
5361872|NCT00100048|13193345|P2|Treated|Cohort I & II-Combination Therapy Phase||40
5361873|NCT00100048|13193346|P1|Treated|Cohort I & II-Combination Therapy Phase||39
5361874|NCT00100048|13193341|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
5361875|NCT00100048|13193342|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
5361876|NCT00100048|13193343|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
5361877|NCT00100048|13193344|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
5361878|NCT00100048|13193345|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
5361879|NCT00100048|13193346|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
5361880|NCT00100048|13193341|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361881|NCT00100048|13193342|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361882|NCT00100048|13193343|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361883|NCT00100048|13193344|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361884|NCT00100048|13193345|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361885|NCT00100048|13193346|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361886|NCT00100048|13193341|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
5361887|NCT00100048|13193342|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
5361888|NCT00100048|13193343|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
5361889|NCT00100048|13193344|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
5361890|NCT00100048|13193345|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
5361891|NCT00100048|13193346|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
5361892|NCT00100048|13193341|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
5361893|NCT00100048|13193342|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
5361894|NCT00100048|13193343|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
5361895|NCT00100048|13193344|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
5361896|NCT00100048|13193345|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
5361897|NCT00100048|13193346|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
5361898|NCT00100048|13193341|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
5361899|NCT00100048|13193342|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
5361900|NCT00100048|13193343|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
5361901|NCT00100048|13193344|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
5361902|NCT00100048|13193345|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
5361903|NCT00100048|13193346|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
5361904|NCT00099983|13193455|P2|NOT COMPLETED|Overall Study||25
5361905|NCT00099983|13193456|P1|NOT COMPLETED|Overall Study||24
5361906|NCT00099983|13193455|P2|COMPLETED|Overall Study||124
5361907|NCT00099983|13193456|P1|COMPLETED|Overall Study||123
5361908|NCT00099983|13193455|P2|STARTED|Overall Study||149
5361909|NCT00099983|13193456|P1|STARTED|Overall Study||147
5361910|NCT00099632|13193468|P6|NOT COMPLETED|Overall Study||2
5361911|NCT00099632|13193469|P5|NOT COMPLETED|Overall Study||1
5361912|NCT00099632|13193470|P4|NOT COMPLETED|Overall Study||1
5361913|NCT00099632|13193471|P3|NOT COMPLETED|Overall Study||3
5361914|NCT00099632|13193472|P2|NOT COMPLETED|Overall Study||1
5361915|NCT00099632|13193473|P1|NOT COMPLETED|Overall Study||1
5361916|NCT00099632|13193468|P6|COMPLETED|Overall Study||66
5361917|NCT00099632|13193469|P5|COMPLETED|Overall Study||70
5361918|NCT00099632|13193470|P4|COMPLETED|Overall Study||66
5361919|NCT00099632|13193471|P3|COMPLETED|Overall Study||72
5361920|NCT00099632|13193472|P2|COMPLETED|Overall Study||67
5361921|NCT00099632|13193473|P1|COMPLETED|Overall Study||72
5361922|NCT00099632|13193468|P6|STARTED|Overall Study||68
5361923|NCT00099632|13193469|P5|STARTED|Overall Study||71
5361924|NCT00099632|13193470|P4|STARTED|Overall Study||67
5361925|NCT00099632|13193471|P3|STARTED|Overall Study||75
5361926|NCT00099632|13193472|P2|STARTED|Overall Study||68
5361927|NCT00099632|13193473|P1|STARTED|Overall Study||73
5361928|NCT00099437|13193513|P2|NOT COMPLETED|Overall Study||349
5361929|NCT00099437|13193514|P1|NOT COMPLETED|Overall Study||366
5361930|NCT00099437|13193513|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
5361931|NCT00099437|13193514|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
5361932|NCT00099437|13193513|P2|STARTED|Overall Study|randomised patients|362
5361933|NCT00099437|13193514|P1|STARTED|Overall Study|randomised patients|374
5361934|NCT00099359|13193537|P3|NOT COMPLETED|Overall Study||68
5361935|NCT00099359|13193538|P2|NOT COMPLETED|Overall Study||65
5361936|NCT00099359|13193539|P1|NOT COMPLETED|Overall Study||54
5361937|NCT00099359|13193537|P3|COMPLETED|Overall Study||506
5361938|NCT00099359|13193538|P2|COMPLETED|Overall Study||515
5361939|NCT00099359|13193539|P1|COMPLETED|Overall Study||527
5361940|NCT00099359|13193537|P3|STARTED|Overall Study||574
5361941|NCT00099359|13193538|P2|STARTED|Overall Study||580
5361942|NCT00099359|13193539|P1|STARTED|Overall Study||581
5361943|NCT00099268|13193562|P2|NOT COMPLETED|Overall Study||82
5361944|NCT00099268|13193563|P1|NOT COMPLETED|Overall Study||92
5361945|NCT00099268|13193562|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
5361946|NCT00099268|13193563|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
5361947|NCT00099268|13193562|P2|Intent-to-Treat|Overall Study||372
5361948|NCT00099268|13193563|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
5361949|NCT00099268|13193562|P2|STARTED|Overall Study||373
5361950|NCT00099268|13193563|P1|STARTED|Overall Study||374
5361951|NCT00099047|13193581|P2|NOT COMPLETED|Overall Study||0
5361952|NCT00099047|13193582|P1|NOT COMPLETED|Overall Study||0
5361953|NCT00099047|13193581|P2|COMPLETED|Overall Study||12
5361954|NCT00099047|13193582|P1|COMPLETED|Overall Study||11
5361955|NCT00099047|13193581|P2|STARTED|Overall Study||12
5361956|NCT00099047|13193582|P1|STARTED|Overall Study||11
5361957|NCT00099021|13193588|P1|NOT COMPLETED|Overall Study||0
5361958|NCT00099021|13193588|P1|COMPLETED|Overall Study||21
5361959|NCT00099021|13193588|P1|STARTED|Overall Study||21
5361960|NCT00098956|13193594|P1|NOT COMPLETED|Overall Study||0
5361961|NCT00098956|13193594|P1|COMPLETED|Overall Study||19
5361962|NCT00098956|13193594|P1|STARTED|Overall Study||19
5361963|NCT00098865|13193603|P1|NOT COMPLETED|Overall Study||9
5361964|NCT00098865|13193603|P1|COMPLETED|Overall Study||6
5361965|NCT00098865|13193603|P1|STARTED|Overall Study||15
5361966|NCT00098839|13193611|P2|NOT COMPLETED|Overall Study||33
5361967|NCT00098839|13193612|P1|NOT COMPLETED|Overall Study||32
5361968|NCT00098839|13193611|P2|COMPLETED|Overall Study||27
5361969|NCT00098839|13193612|P1|COMPLETED|Overall Study||24
5361970|NCT00098839|13193611|P2|STARTED|Overall Study||60
5361971|NCT00098839|13193612|P1|STARTED|Overall Study||56
5361972|NCT00098813|13193623|P1|NOT COMPLETED|Overall Study||19
5361973|NCT00098813|13193623|P1|COMPLETED|Overall Study||1
5361974|NCT00098813|13193623|P1|STARTED|Overall Study||20
5361975|NCT00098787|13193630|P3|NOT COMPLETED|Overall Study||63
5361976|NCT00098787|13193631|P2|NOT COMPLETED|Overall Study||75
5361977|NCT00098787|13193632|P1|NOT COMPLETED|Overall Study||73
5361978|NCT00098787|13193630|P3|COMPLETED|Overall Study||0
5361979|NCT00098787|13193631|P2|COMPLETED|Overall Study||0
5361980|NCT00098787|13193632|P1|COMPLETED|Overall Study||0
5361981|NCT00098787|13193630|P3|Eligible and Treated|Overall Study||59
5361982|NCT00098787|13193631|P2|Eligible and Treated|Overall Study||66
5361983|NCT00098787|13193632|P1|Eligible and Treated|Overall Study||61
5361984|NCT00098787|13193630|P3|Treated|Overall Study||62
5361985|NCT00098787|13193631|P2|Treated|Overall Study||73
5361986|NCT00098787|13193632|P1|Treated|Overall Study||70
5361987|NCT00098787|13193630|P3|STARTED|Overall Study||63
5361988|NCT00098787|13193631|P2|STARTED|Overall Study||75
5361989|NCT00098787|13193632|P1|STARTED|Overall Study||73
5361990|NCT00098774|13193646|P1|NOT COMPLETED|Overall Study||18
5361991|NCT00098774|13193646|P1|COMPLETED|Overall Study||26
5361992|NCT00098774|13193646|P1|STARTED|Overall Study||44
5361993|NCT00098748|13193656|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
5361994|NCT00098748|13193657|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
5361995|NCT00098748|13193658|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
5361996|NCT00098748|13193656|P3|COMPLETED|Continued on Open-Label Treatment||0
5361997|NCT00098748|13193657|P2|COMPLETED|Continued on Open-Label Treatment||10
5361998|NCT00098748|13193658|P1|COMPLETED|Continued on Open-Label Treatment||7
5361999|NCT00098748|13193656|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
5362000|NCT00098748|13193657|P2|STARTED|Continued on Open-Label Treatment||25
5362001|NCT00098748|13193658|P1|STARTED|Continued on Open-Label Treatment||15
5362002|NCT00098748|13193656|P3|NOT COMPLETED|Received Study Treatment||44
5362003|NCT00098748|13193657|P2|NOT COMPLETED|Received Study Treatment||36
5362004|NCT00098748|13193658|P1|NOT COMPLETED|Received Study Treatment||48
5362005|NCT00098748|13193656|P3|COMPLETED|Received Study Treatment||18
5362006|NCT00098748|13193657|P2|COMPLETED|Received Study Treatment||25
5362007|NCT00098748|13193658|P1|COMPLETED|Received Study Treatment||15
5362008|NCT00098748|13193656|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
5362009|NCT00098748|13193657|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
5362099|NCT00098475|13193797|P1|NOT COMPLETED|Step 2||5
5362010|NCT00098748|13193658|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
5362011|NCT00098748|13193656|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
5362012|NCT00098748|13193657|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
5362013|NCT00098748|13193658|P1|STARTED|Received Study Treatment||63
5362014|NCT00098748|13193656|P3|NOT COMPLETED|Assigned to Study Treatment||2
5362015|NCT00098748|13193657|P2|NOT COMPLETED|Assigned to Study Treatment||2
5362016|NCT00098748|13193658|P1|NOT COMPLETED|Assigned to Study Treatment||0
5362017|NCT00098748|13193656|P3|COMPLETED|Assigned to Study Treatment||62
5362018|NCT00098748|13193657|P2|COMPLETED|Assigned to Study Treatment||61
5362019|NCT00098748|13193658|P1|COMPLETED|Assigned to Study Treatment||63
5362020|NCT00098748|13193656|P3|STARTED|Assigned to Study Treatment||64
5362021|NCT00098748|13193657|P2|STARTED|Assigned to Study Treatment||63
5362022|NCT00098748|13193658|P1|STARTED|Assigned to Study Treatment||63
5362023|NCT00098722|13193714|P7|NOT COMPLETED|Observation Phase||17
5362024|NCT00098722|13193715|P6|NOT COMPLETED|Observation Phase||45
5362025|NCT00098722|13193716|P5|NOT COMPLETED|Observation Phase||0
5362026|NCT00098722|13193717|P4|NOT COMPLETED|Observation Phase||0
5362027|NCT00098722|13193718|P3|NOT COMPLETED|Observation Phase||0
5362028|NCT00098722|13193719|P2|NOT COMPLETED|Observation Phase||0
5362029|NCT00098722|13193720|P1|NOT COMPLETED|Observation Phase||0
5362030|NCT00098722|13193714|P7|COMPLETED|Observation Phase||48
5362031|NCT00098722|13193715|P6|COMPLETED|Observation Phase||160
5362032|NCT00098722|13193716|P5|COMPLETED|Observation Phase||0
5362033|NCT00098722|13193717|P4|COMPLETED|Observation Phase||0
5362034|NCT00098722|13193718|P3|COMPLETED|Observation Phase||0
5362035|NCT00098722|13193719|P2|COMPLETED|Observation Phase||0
5362036|NCT00098722|13193720|P1|COMPLETED|Observation Phase||0
5362037|NCT00098722|13193714|P7|STARTED|Observation Phase||65
5362038|NCT00098722|13193715|P6|STARTED|Observation Phase||205
5362039|NCT00098722|13193716|P5|STARTED|Observation Phase||0
5362040|NCT00098722|13193717|P4|STARTED|Observation Phase||0
5362041|NCT00098722|13193718|P3|STARTED|Observation Phase||0
5362042|NCT00098722|13193719|P2|STARTED|Observation Phase||0
5362043|NCT00098722|13193720|P1|STARTED|Observation Phase||0
5362044|NCT00098722|13193714|P7|NOT COMPLETED|Open Label Phase||0
5362045|NCT00098722|13193715|P6|NOT COMPLETED|Open Label Phase||0
5362046|NCT00098722|13193716|P5|NOT COMPLETED|Open Label Phase||50
5362047|NCT00098722|13193717|P4|NOT COMPLETED|Open Label Phase||272
5362048|NCT00098722|13193718|P3|NOT COMPLETED|Open Label Phase||0
5362049|NCT00098722|13193719|P2|NOT COMPLETED|Open Label Phase||0
5362050|NCT00098722|13193720|P1|NOT COMPLETED|Open Label Phase||0
5362051|NCT00098722|13193714|P7|COMPLETED|Open Label Phase||0
5362052|NCT00098722|13193715|P6|COMPLETED|Open Label Phase||0
5362053|NCT00098722|13193716|P5|COMPLETED|Open Label Phase||0
5362054|NCT00098722|13193717|P4|COMPLETED|Open Label Phase||0
5362055|NCT00098722|13193718|P3|COMPLETED|Open Label Phase||0
5362056|NCT00098722|13193719|P2|COMPLETED|Open Label Phase||0
5362057|NCT00098722|13193720|P1|COMPLETED|Open Label Phase||0
5362058|NCT00098722|13193714|P7|STARTED|Open Label Phase||0
5362059|NCT00098722|13193715|P6|STARTED|Open Label Phase||0
5362060|NCT00098722|13193716|P5|STARTED|Open Label Phase||50
5362061|NCT00098722|13193717|P4|STARTED|Open Label Phase||272
5362062|NCT00098722|13193718|P3|STARTED|Open Label Phase||0
5362063|NCT00098722|13193719|P2|STARTED|Open Label Phase||0
5362064|NCT00098722|13193720|P1|STARTED|Open Label Phase||0
5362065|NCT00098722|13193714|P7|NOT COMPLETED|Double Blind Phase||0
5362066|NCT00098722|13193715|P6|NOT COMPLETED|Double Blind Phase||0
5362067|NCT00098722|13193716|P5|NOT COMPLETED|Double Blind Phase||0
5362068|NCT00098722|13193717|P4|NOT COMPLETED|Double Blind Phase||0
5362069|NCT00098722|13193718|P3|NOT COMPLETED|Double Blind Phase||94
5362070|NCT00098722|13193719|P2|NOT COMPLETED|Double Blind Phase||194
5362071|NCT00098722|13193720|P1|NOT COMPLETED|Double Blind Phase||186
5362072|NCT00098722|13193714|P7|COMPLETED|Double Blind Phase||0
5362073|NCT00098722|13193715|P6|COMPLETED|Double Blind Phase||0
5362074|NCT00098722|13193716|P5|COMPLETED|Double Blind Phase||0
5362075|NCT00098722|13193717|P4|COMPLETED|Double Blind Phase||0
5362076|NCT00098722|13193718|P3|COMPLETED|Double Blind Phase||0
5362077|NCT00098722|13193719|P2|COMPLETED|Double Blind Phase||0
5362078|NCT00098722|13193720|P1|COMPLETED|Double Blind Phase||0
5362079|NCT00098722|13193714|P7|Treated|Double Blind Phase||0
5362080|NCT00098722|13193715|P6|Treated|Double Blind Phase||0
5362081|NCT00098722|13193716|P5|Treated|Double Blind Phase||0
5362082|NCT00098722|13193717|P4|Treated|Double Blind Phase||0
5362083|NCT00098722|13193718|P3|Treated|Double Blind Phase||91
5362084|NCT00098722|13193719|P2|Treated|Double Blind Phase||191
5362085|NCT00098722|13193720|P1|Treated|Double Blind Phase||182
5362086|NCT00098722|13193714|P7|STARTED|Double Blind Phase||0
5362087|NCT00098722|13193715|P6|STARTED|Double Blind Phase||0
5362088|NCT00098722|13193716|P5|STARTED|Double Blind Phase||0
5362089|NCT00098722|13193717|P4|STARTED|Double Blind Phase||0
5362090|NCT00098722|13193718|P3|STARTED|Double Blind Phase||94
5362091|NCT00098722|13193719|P2|STARTED|Double Blind Phase||194
5362092|NCT00098722|13193720|P1|STARTED|Double Blind Phase||186
5362093|NCT00098670|13193783|P1|NOT COMPLETED|Overall Study||0
5362094|NCT00098670|13193783|P1|COMPLETED|Overall Study||102
5362095|NCT00098670|13193783|P1|STARTED|Overall Study||102
5362096|NCT00098475|13193794|P4|NOT COMPLETED|Step 2||0
5362097|NCT00098475|13193795|P3|NOT COMPLETED|Step 2||0
5362098|NCT00098475|13193796|P2|NOT COMPLETED|Step 2||10
5362100|NCT00098475|13193794|P4|COMPLETED|Step 2||0
5362101|NCT00098475|13193795|P3|COMPLETED|Step 2||0
5362102|NCT00098475|13193796|P2|COMPLETED|Step 2||5
5362103|NCT00098475|13193797|P1|COMPLETED|Step 2||0
5362104|NCT00098475|13193794|P4|Eligible|Step 2||0
5362105|NCT00098475|13193795|P3|Eligible|Step 2||0
5362106|NCT00098475|13193796|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
5362107|NCT00098475|13193797|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
5362108|NCT00098475|13193794|P4|Treated|Step 2||0
5362109|NCT00098475|13193795|P3|Treated|Step 2||0
5362110|NCT00098475|13193796|P2|Treated|Step 2||14
5362111|NCT00098475|13193797|P1|Treated|Step 2||4
5362112|NCT00098475|13193794|P4|STARTED|Step 2||0
5362113|NCT00098475|13193795|P3|STARTED|Step 2||0
5362114|NCT00098475|13193796|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
5362115|NCT00098475|13193797|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
5362116|NCT00098475|13193794|P4|NOT COMPLETED|Step 1||3
5362117|NCT00098475|13193795|P3|NOT COMPLETED|Step 1||4
5362118|NCT00098475|13193796|P2|NOT COMPLETED|Step 1||173
5362119|NCT00098475|13193797|P1|NOT COMPLETED|Step 1||171
5362120|NCT00098475|13193794|P4|COMPLETED|Step 1||0
5362121|NCT00098475|13193795|P3|COMPLETED|Step 1||0
5362122|NCT00098475|13193796|P2|COMPLETED|Step 1||49
5362123|NCT00098475|13193797|P1|COMPLETED|Step 1||52
5362124|NCT00098475|13193794|P4|Eligible|Step 1||3
5362125|NCT00098475|13193795|P3|Eligible|Step 1||4
5362126|NCT00098475|13193796|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
5362127|NCT00098475|13193797|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
5362128|NCT00098475|13193794|P4|Treated|Step 1||3
5362129|NCT00098475|13193795|P3|Treated|Step 1||4
5362130|NCT00098475|13193796|P2|Treated|Step 1||220
5362131|NCT00098475|13193797|P1|Treated|Step 1||223
5362132|NCT00098475|13193794|P4|STARTED|Step 1||3
5362133|NCT00098475|13193795|P3|STARTED|Step 1||4
5362134|NCT00098475|13193796|P2|STARTED|Step 1||222
5362135|NCT00098475|13193797|P1|STARTED|Step 1||223
5362136|NCT00098371|13193809|P1|NOT COMPLETED|Overall Study||0
5362137|NCT00098371|13193809|P1|COMPLETED|Overall Study||64
5362138|NCT00098371|13193809|P1|STARTED|Overall Study||64
5362139|NCT00098345|13193834|P1|NOT COMPLETED|Overall Study||13
5362140|NCT00098345|13193834|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
5362141|NCT00098345|13193834|P1|STARTED|Overall Study||30
5362142|NCT00098306|13193847|P7|NOT COMPLETED|Observational Phase||26
5362143|NCT00098306|13193848|P6|NOT COMPLETED|Observational Phase||46
5362144|NCT00098306|13193849|P5|NOT COMPLETED|Observational Phase||0
5362145|NCT00098306|13193850|P4|NOT COMPLETED|Observational Phase||0
5362146|NCT00098306|13193851|P3|NOT COMPLETED|Observational Phase||0
5362147|NCT00098306|13193852|P2|NOT COMPLETED|Observational Phase||0
5362148|NCT00098306|13193853|P1|NOT COMPLETED|Observational Phase||0
5362149|NCT00098306|13193847|P7|COMPLETED|Observational Phase||55
5362150|NCT00098306|13193848|P6|COMPLETED|Observational Phase||204
5362151|NCT00098306|13193849|P5|COMPLETED|Observational Phase||0
5362152|NCT00098306|13193850|P4|COMPLETED|Observational Phase||0
5362153|NCT00098306|13193851|P3|COMPLETED|Observational Phase||0
5362154|NCT00098306|13193852|P2|COMPLETED|Observational Phase||0
5362155|NCT00098306|13193853|P1|COMPLETED|Observational Phase||0
5362156|NCT00098306|13193847|P7|STARTED|Observational Phase||81
5362157|NCT00098306|13193848|P6|STARTED|Observational Phase||250
5362158|NCT00098306|13193849|P5|STARTED|Observational Phase||0
5362159|NCT00098306|13193850|P4|STARTED|Observational Phase||0
5362160|NCT00098306|13193851|P3|STARTED|Observational Phase||0
5362161|NCT00098306|13193852|P2|STARTED|Observational Phase||0
5362162|NCT00098306|13193853|P1|STARTED|Observational Phase||0
5362163|NCT00098306|13193847|P7|NOT COMPLETED|Open Label||0
5362164|NCT00098306|13193848|P6|NOT COMPLETED|Open Label||0
5362165|NCT00098306|13193849|P5|NOT COMPLETED|Open Label||62
5362166|NCT00098306|13193850|P4|NOT COMPLETED|Open Label||327
5362167|NCT00098306|13193851|P3|NOT COMPLETED|Open Label||0
5362168|NCT00098306|13193852|P2|NOT COMPLETED|Open Label||0
5362169|NCT00098306|13193853|P1|NOT COMPLETED|Open Label||0
5362170|NCT00098306|13193847|P7|COMPLETED|Open Label||0
5362171|NCT00098306|13193848|P6|COMPLETED|Open Label||0
5362172|NCT00098306|13193849|P5|COMPLETED|Open Label||0
5362173|NCT00098306|13193850|P4|COMPLETED|Open Label||0
5362174|NCT00098306|13193851|P3|COMPLETED|Open Label||0
5362175|NCT00098306|13193852|P2|COMPLETED|Open Label||0
5362176|NCT00098306|13193853|P1|COMPLETED|Open Label||0
5362177|NCT00098306|13193847|P7|STARTED|Open Label||0
5362178|NCT00098306|13193848|P6|STARTED|Open Label||0
5362179|NCT00098306|13193849|P5|STARTED|Open Label||62
5362180|NCT00098306|13193850|P4|STARTED|Open Label||327
5362181|NCT00098306|13193851|P3|STARTED|Open Label||0
5362182|NCT00098306|13193852|P2|STARTED|Open Label||0
5362183|NCT00098306|13193853|P1|STARTED|Open Label||0
5362184|NCT00098306|13193847|P7|NOT COMPLETED|Double Blind||0
5362185|NCT00098306|13193848|P6|NOT COMPLETED|Double Blind||0
5362186|NCT00098306|13193849|P5|NOT COMPLETED|Double Blind||0
5362187|NCT00098306|13193850|P4|NOT COMPLETED|Double Blind||0
5362188|NCT00098306|13193851|P3|NOT COMPLETED|Double Blind||120
5362189|NCT00098306|13193852|P2|NOT COMPLETED|Double Blind||240
5362190|NCT00098306|13193853|P1|NOT COMPLETED|Double Blind||241
5362191|NCT00098306|13193847|P7|COMPLETED|Double Blind||0
5362192|NCT00098306|13193848|P6|COMPLETED|Double Blind||0
5362193|NCT00098306|13193849|P5|COMPLETED|Double Blind||0
5362194|NCT00098306|13193850|P4|COMPLETED|Double Blind||0
5362195|NCT00098306|13193851|P3|COMPLETED|Double Blind||0
5362196|NCT00098306|13193852|P2|COMPLETED|Double Blind||0
5362197|NCT00098306|13193853|P1|COMPLETED|Double Blind||0
5362198|NCT00098306|13193847|P7|Treated|Double Blind||0
5362199|NCT00098306|13193848|P6|Treated|Double Blind||0
5362200|NCT00098306|13193849|P5|Treated|Double Blind||0
5362201|NCT00098306|13193850|P4|Treated|Double Blind||0
5362202|NCT00098306|13193851|P3|Treated|Double Blind||118
5362203|NCT00098306|13193852|P2|Treated|Double Blind||235
5362204|NCT00098306|13193853|P1|Treated|Double Blind||232
5362205|NCT00098306|13193847|P7|STARTED|Double Blind||0
5362206|NCT00098306|13193848|P6|STARTED|Double Blind||0
5362207|NCT00098306|13193849|P5|STARTED|Double Blind||0
5362208|NCT00098306|13193850|P4|STARTED|Double Blind||0
5362209|NCT00098306|13193851|P3|STARTED|Double Blind||120
5362210|NCT00098306|13193852|P2|STARTED|Double Blind||240
5362211|NCT00098306|13193853|P1|STARTED|Double Blind||241
5362212|NCT00098293|13193919|P5|NOT COMPLETED|Supplemental Phase (SP)||33
5362213|NCT00098293|13193920|P4|NOT COMPLETED|Supplemental Phase (SP)||0
5362214|NCT00098293|13193921|P3|NOT COMPLETED|Supplemental Phase (SP)||0
5362215|NCT00098293|13193922|P2|NOT COMPLETED|Supplemental Phase (SP)||0
5362216|NCT00098293|13193923|P1|NOT COMPLETED|Supplemental Phase (SP)||0
5362217|NCT00098293|13193919|P5|COMPLETED|Supplemental Phase (SP)||94
5362218|NCT00098293|13193920|P4|COMPLETED|Supplemental Phase (SP)||0
5362219|NCT00098293|13193921|P3|COMPLETED|Supplemental Phase (SP)||0
5362220|NCT00098293|13193922|P2|COMPLETED|Supplemental Phase (SP)||0
5362221|NCT00098293|13193923|P1|COMPLETED|Supplemental Phase (SP)||0
5362222|NCT00098293|13193919|P5|STARTED|Supplemental Phase (SP)||127
5362223|NCT00098293|13193920|P4|STARTED|Supplemental Phase (SP)||0
5362224|NCT00098293|13193921|P3|STARTED|Supplemental Phase (SP)||0
5362225|NCT00098293|13193922|P2|STARTED|Supplemental Phase (SP)||0
5362226|NCT00098293|13193923|P1|STARTED|Supplemental Phase (SP)||0
5362227|NCT00098293|13193919|P5|NOT COMPLETED|Open-label (OL) Phase||0
5362228|NCT00098293|13193920|P4|NOT COMPLETED|Open-label (OL) Phase||65
5362229|NCT00098293|13193921|P3|NOT COMPLETED|Open-label (OL) Phase||41
5362230|NCT00098293|13193922|P2|NOT COMPLETED|Open-label (OL) Phase||25
5362231|NCT00098293|13193923|P1|NOT COMPLETED|Open-label (OL) Phase||0
5362232|NCT00098293|13193919|P5|COMPLETED|Open-label (OL) Phase||0
5362233|NCT00098293|13193920|P4|COMPLETED|Open-label (OL) Phase||65
5362234|NCT00098293|13193921|P3|COMPLETED|Open-label (OL) Phase||158
5362235|NCT00098293|13193922|P2|COMPLETED|Open-label (OL) Phase||177
5362236|NCT00098293|13193923|P1|COMPLETED|Open-label (OL) Phase||0
5362237|NCT00098293|13193919|P5|STARTED|Open-label (OL) Phase||0
5362238|NCT00098293|13193920|P4|STARTED|Open-label (OL) Phase||130
5362239|NCT00098293|13193921|P3|STARTED|Open-label (OL) Phase||199
5362240|NCT00098293|13193922|P2|STARTED|Open-label (OL) Phase||202
5362241|NCT00098293|13193923|P1|STARTED|Open-label (OL) Phase||0
5362242|NCT00098293|13193919|P5|NOT COMPLETED|Between DB and OL Phase||0
5362243|NCT00098293|13193920|P4|NOT COMPLETED|Between DB and OL Phase||0
5362244|NCT00098293|13193921|P3|NOT COMPLETED|Between DB and OL Phase||3
5362245|NCT00098293|13193922|P2|NOT COMPLETED|Between DB and OL Phase||0
5362246|NCT00098293|13193923|P1|NOT COMPLETED|Between DB and OL Phase||0
5362247|NCT00098293|13193919|P5|COMPLETED|Between DB and OL Phase||0
5362248|NCT00098293|13193920|P4|COMPLETED|Between DB and OL Phase||0
5362249|NCT00098293|13193921|P3|COMPLETED|Between DB and OL Phase||199
5362250|NCT00098293|13193922|P2|COMPLETED|Between DB and OL Phase||202
5362251|NCT00098293|13193923|P1|COMPLETED|Between DB and OL Phase||0
5362252|NCT00098293|13193919|P5|STARTED|Between DB and OL Phase||0
5362253|NCT00098293|13193920|P4|STARTED|Between DB and OL Phase||0
5362254|NCT00098293|13193921|P3|STARTED|Between DB and OL Phase||202
5362255|NCT00098293|13193922|P2|STARTED|Between DB and OL Phase||202
5362256|NCT00098293|13193923|P1|STARTED|Between DB and OL Phase||0
5362257|NCT00098293|13193919|P5|NOT COMPLETED|Double-blind (DB) Phase||0
5362258|NCT00098293|13193920|P4|NOT COMPLETED|Double-blind (DB) Phase||0
5362259|NCT00098293|13193921|P3|NOT COMPLETED|Double-blind (DB) Phase||170
5362260|NCT00098293|13193922|P2|NOT COMPLETED|Double-blind (DB) Phase||166
5362261|NCT00098293|13193923|P1|NOT COMPLETED|Double-blind (DB) Phase||177
5362262|NCT00098293|13193919|P5|COMPLETED|Double-blind (DB) Phase||0
5362263|NCT00098293|13193920|P4|COMPLETED|Double-blind (DB) Phase||0
5362264|NCT00098293|13193921|P3|COMPLETED|Double-blind (DB) Phase||202
5362265|NCT00098293|13193922|P2|COMPLETED|Double-blind (DB) Phase||202
5362266|NCT00098293|13193923|P1|COMPLETED|Double-blind (DB) Phase||0
5362267|NCT00098293|13193919|P5|Treated|Double-blind (DB) Phase||0
5362268|NCT00098293|13193920|P4|Treated|Double-blind (DB) Phase||0
5362269|NCT00098293|13193921|P3|Treated|Double-blind (DB) Phase||361
5362270|NCT00098293|13193922|P2|Treated|Double-blind (DB) Phase||360
5362271|NCT00098293|13193923|P1|Treated|Double-blind (DB) Phase||174
5362272|NCT00098293|13193919|P5|STARTED|Double-blind (DB) Phase||0
5362273|NCT00098293|13193920|P4|STARTED|Double-blind (DB) Phase||0
5362274|NCT00098293|13193921|P3|STARTED|Double-blind (DB) Phase||372
5362275|NCT00098293|13193922|P2|STARTED|Double-blind (DB) Phase||368
5362276|NCT00098293|13193923|P1|STARTED|Double-blind (DB) Phase||177
5362277|NCT00098254|13193976|P1|NOT COMPLETED|Overall Study||3
5362278|NCT00098254|13193976|P1|COMPLETED|Overall Study||34
5362279|NCT00098254|13193976|P1|STARTED|Overall Study||37
5362280|NCT00098059|13193997|P2|NOT COMPLETED|Overall Study||1
5362281|NCT00098059|13193998|P1|NOT COMPLETED|Overall Study||0
5362282|NCT00098059|13193997|P2|COMPLETED|Overall Study||46
5362283|NCT00098059|13193998|P1|COMPLETED|Overall Study||27
5362284|NCT00098059|13193997|P2|STARTED|Overall Study||47
5362285|NCT00098059|13193998|P1|STARTED|Overall Study||27
5362286|NCT00098020|13194042|P1|NOT COMPLETED|Overall Study||6
5362287|NCT00098020|13194042|P1|COMPLETED|Overall Study||6
5362288|NCT00098020|13194042|P1|Started Isotretinoin|Overall Study||8
5362289|NCT00098020|13194042|P1|STARTED|Overall Study||12
5362290|NCT00097981|13194049|P2|NOT COMPLETED|Overall Study||100
5362291|NCT00097981|13194050|P1|NOT COMPLETED|Overall Study||106
5362292|NCT00097981|13194049|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
5362293|NCT00097981|13194050|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
5362294|NCT00097981|13194049|P2|Received Study Medication|Overall Study||106
5362295|NCT00097981|13194050|P1|Received Study Medication|Overall Study||110
5362296|NCT00097981|13194049|P2|STARTED|Overall Study|Enrollment at randomization|112
5362297|NCT00097981|13194050|P1|STARTED|Overall Study|Enrollment at randomization|113
5362298|NCT00097786|13194072|P4|NOT COMPLETED|Overall Study||310
5362299|NCT00097786|13194073|P3|NOT COMPLETED|Overall Study||313
5362300|NCT00097786|13194074|P2|NOT COMPLETED|Overall Study||292
5362301|NCT00097786|13194075|P1|NOT COMPLETED|Overall Study||296
5362302|NCT00097786|13194072|P4|COMPLETED|Overall Study||2036
5362303|NCT00097786|13194073|P3|COMPLETED|Overall Study||2016
5362304|NCT00097786|13194074|P2|COMPLETED|Overall Study||2023
5362305|NCT00097786|13194075|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
5362306|NCT00097786|13194072|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
5362307|NCT00097786|13194073|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
5362308|NCT00097786|13194074|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
5362309|NCT00097786|13194075|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
5362310|NCT00097786|13194072|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
5362311|NCT00097786|13194073|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
5362312|NCT00097786|13194074|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
5362313|NCT00097786|13194075|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
5362314|NCT00097786|13194072|P4|Complete FU for Progression to Diabetes|Overall Study||1762
5362315|NCT00097786|13194073|P3|Complete FU for Progression to Diabetes|Overall Study||1734
5362316|NCT00097786|13194074|P2|Complete FU for Progression to Diabetes|Overall Study||1712
5362317|NCT00097786|13194075|P1|Complete FU for Progression to Diabetes|Overall Study||1709
5362318|NCT00097786|13194072|P4|STARTED|Overall Study||2346
5362319|NCT00097786|13194073|P3|STARTED|Overall Study||2329
5362320|NCT00097786|13194074|P2|STARTED|Overall Study||2315
5362321|NCT00097786|13194075|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
5362322|NCT00097773|13194097|P4|NOT COMPLETED|Overall Study||3
5362323|NCT00097773|13194098|P3|NOT COMPLETED|Overall Study||8
5362324|NCT00097773|13194099|P2|NOT COMPLETED|Overall Study||8
5362325|NCT00097773|13194100|P1|NOT COMPLETED|Overall Study||8
5362326|NCT00097773|13194097|P4|COMPLETED|Overall Study||73
5362327|NCT00097773|13194098|P3|COMPLETED|Overall Study||68
5362328|NCT00097773|13194099|P2|COMPLETED|Overall Study||68
5362329|NCT00097773|13194100|P1|COMPLETED|Overall Study||68
5362330|NCT00097773|13194097|P4|STARTED|Overall Study||76
5362331|NCT00097773|13194098|P3|STARTED|Overall Study||76
5362332|NCT00097773|13194099|P2|STARTED|Overall Study||76
5362333|NCT00097773|13194100|P1|STARTED|Overall Study||76
5362334|NCT00097721|13194120|P2|NOT COMPLETED|Overall Study||33
5362335|NCT00097721|13194121|P1|NOT COMPLETED|Overall Study||71
5362336|NCT00097721|13194120|P2|COMPLETED|Overall Study||0
5362337|NCT00097721|13194121|P1|COMPLETED|Overall Study||0
5362338|NCT00097721|13194120|P2|STARTED|Overall Study||33
5362339|NCT00097721|13194121|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
5362340|NCT00097708|13194138|P3|NOT COMPLETED|Overall Study||65
5362341|NCT00097708|13194139|P2|NOT COMPLETED|Overall Study||56
5362342|NCT00097708|13194140|P1|NOT COMPLETED|Overall Study||64
5362343|NCT00097708|13194138|P3|COMPLETED|Overall Study||97
5362344|NCT00097708|13194139|P2|COMPLETED|Overall Study||120
5362345|NCT00097708|13194140|P1|COMPLETED|Overall Study||109
5362346|NCT00097708|13194138|P3|Treated|Overall Study||160
5362347|NCT00097708|13194139|P2|Treated|Overall Study||176
5362348|NCT00097708|13194140|P1|Treated|Overall Study||171
5362349|NCT00097708|13194138|P3|Intent-to-Treat (ITT)|Overall Study||149
5362350|NCT00097708|13194139|P2|Intent-to-Treat (ITT)|Overall Study||169
5362351|NCT00097708|13194140|P1|Intent-to-Treat (ITT)|Overall Study||165
5362352|NCT00097708|13194138|P3|STARTED|Overall Study||162
5362353|NCT00097708|13194139|P2|STARTED|Overall Study||176
5362354|NCT00097708|13194140|P1|STARTED|Overall Study||173
5362355|NCT00097695|13194152|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
5362356|NCT00097695|13194153|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
5362357|NCT00097695|13194154|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
5362358|NCT00097695|13194155|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
5362359|NCT00097695|13194152|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
5362360|NCT00097695|13194153|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
5362361|NCT00097695|13194154|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
5362362|NCT00097695|13194155|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
5362363|NCT00097695|13194152|P4|STARTED|The Open Label Extension (OLE) Phase||20
5362364|NCT00097695|13194153|P3|STARTED|The Open Label Extension (OLE) Phase||3
5362365|NCT00097695|13194154|P2|STARTED|The Open Label Extension (OLE) Phase||26
5362366|NCT00097695|13194155|P1|STARTED|The Open Label Extension (OLE) Phase||23
5362367|NCT00097695|13194152|P4|NOT COMPLETED|The Controlled Phase||20
5362368|NCT00097695|13194153|P3|NOT COMPLETED|The Controlled Phase||5
5362369|NCT00097695|13194154|P2|NOT COMPLETED|The Controlled Phase||3
5362370|NCT00097695|13194155|P1|NOT COMPLETED|The Controlled Phase||4
5362371|NCT00097695|13194152|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
5362372|NCT00097695|13194153|P3|COMPLETED|The Controlled Phase||3
5362373|NCT00097695|13194154|P2|COMPLETED|The Controlled Phase||26
5362374|NCT00097695|13194155|P1|COMPLETED|The Controlled Phase||23
5362375|NCT00097695|13194152|P4|STARTED|The Controlled Phase||20
5362376|NCT00097695|13194153|P3|STARTED|The Controlled Phase||8
5362377|NCT00097695|13194154|P2|STARTED|The Controlled Phase||29
5362378|NCT00097695|13194155|P1|STARTED|The Controlled Phase||27
5362379|NCT00097591|13194171|P2|NOT COMPLETED|Overall Study||394
5362380|NCT00097591|13194172|P1|NOT COMPLETED|Overall Study||410
5362381|NCT00097591|13194171|P2|COMPLETED|Overall Study||6401
5362382|NCT00097591|13194172|P1|COMPLETED|Overall Study||6403
5362383|NCT00097591|13194171|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
5362384|NCT00097591|13194172|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
5362385|NCT00097539|13194195|P7|NOT COMPLETED|Overall Study||171
5362386|NCT00097539|13194196|P6|NOT COMPLETED|Overall Study||5892
5362387|NCT00097539|13194197|P5|NOT COMPLETED|Overall Study||1758
5362388|NCT00097539|13194198|P4|NOT COMPLETED|Overall Study||3585
5362389|NCT00097539|13194199|P3|NOT COMPLETED|Overall Study||9108
5362390|NCT00097539|13194200|P2|NOT COMPLETED|Overall Study||6531
5362391|NCT00097539|13194201|P1|NOT COMPLETED|Overall Study||19066
5362392|NCT00097539|13194195|P7|COMPLETED|Overall Study||68
5362393|NCT00097539|13194196|P6|COMPLETED|Overall Study||2118
5362394|NCT00097539|13194197|P5|COMPLETED|Overall Study||386
5362395|NCT00097539|13194198|P4|COMPLETED|Overall Study||2066
5362396|NCT00097539|13194199|P3|COMPLETED|Overall Study||3411
5362397|NCT00097539|13194200|P2|COMPLETED|Overall Study||2825
5362398|NCT00097539|13194201|P1|COMPLETED|Overall Study||8220
5362399|NCT00097539|13194195|P7|STARTED|Overall Study||239
5362400|NCT00097539|13194196|P6|STARTED|Overall Study||8010
5362401|NCT00097539|13194197|P5|STARTED|Overall Study||2144
5362402|NCT00097539|13194198|P4|STARTED|Overall Study||5651
5362403|NCT00097539|13194199|P3|STARTED|Overall Study||12519
5362404|NCT00097539|13194200|P2|STARTED|Overall Study||9356
5362405|NCT00097539|13194201|P1|STARTED|Overall Study||27286
5362406|NCT00097500|13194247|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
5362407|NCT00097500|13194248|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
5362408|NCT00097500|13194247|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
5362409|NCT00097500|13194248|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
5362410|NCT00097500|13194247|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
5362411|NCT00097500|13194248|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
5362412|NCT00097500|13194247|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
5362413|NCT00097500|13194248|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
5362414|NCT00097500|13194247|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
5362415|NCT00097500|13194248|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
5362416|NCT00097500|13194247|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
5362417|NCT00097500|13194248|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
5362418|NCT00097448|13194272|P2|NOT COMPLETED|Overall Study||1
5362419|NCT00097448|13194273|P1|NOT COMPLETED|Overall Study||4
5362420|NCT00097448|13194272|P2|COMPLETED|Overall Study||129
5362421|NCT00097448|13194273|P1|COMPLETED|Overall Study||121
5362422|NCT00097448|13194272|P2|STARTED|Overall Study||130
5362423|NCT00097448|13194273|P1|STARTED|Overall Study||125
5362424|NCT00097370|13194279|P1|NOT COMPLETED|Stage 3||59
5362425|NCT00097370|13194279|P1|COMPLETED|Stage 3||0
5362426|NCT00097370|13194279|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
5362427|NCT00097370|13194279|P1|NOT COMPLETED|Stage 2||13
5362428|NCT00097370|13194279|P1|COMPLETED|Stage 2||59
5362429|NCT00097370|13194279|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
5362430|NCT00097370|13194279|P1|NOT COMPLETED|Stage 1||6
5362431|NCT00097370|13194279|P1|COMPLETED|Stage 1||31
5362432|NCT00097370|13194279|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
5362433|NCT00097253|13194296|P1|NOT COMPLETED|Water (Control)||0
5362434|NCT00097253|13194296|P1|COMPLETED|Water (Control)||56
5362435|NCT00097253|13194296|P1|STARTED|Water (Control)||56
5362436|NCT00097253|13194296|P1|NOT COMPLETED|Lemon||0
5362437|NCT00097253|13194296|P1|COMPLETED|Lemon||56
5362438|NCT00097253|13194296|P1|STARTED|Lemon||56
5362439|NCT00097253|13194296|P1|NOT COMPLETED|Lavender||0
5362440|NCT00097253|13194296|P1|COMPLETED|Lavender||56
5362441|NCT00097253|13194296|P1|STARTED|Lavender||56
5362442|NCT00096993|13194313|P2|NOT COMPLETED|Overall Study||65
5362443|NCT00096993|13194314|P1|NOT COMPLETED|Overall Study||65
5362444|NCT00096993|13194313|P2|COMPLETED|Overall Study||0
5362445|NCT00096993|13194314|P1|COMPLETED|Overall Study||1
5362446|NCT00096993|13194313|P2|STARTED|Overall Study||65
5362447|NCT00096993|13194314|P1|STARTED|Overall Study||66
5362448|NCT00096954|13194330|P2|NOT COMPLETED|Overall Study||20
5362449|NCT00096954|13194331|P1|NOT COMPLETED|Overall Study||24
5362450|NCT00096954|13194330|P2|COMPLETED|Overall Study||154
5362451|NCT00096954|13194331|P1|COMPLETED|Overall Study||135
5362452|NCT00096954|13194330|P2|Received Study Drug|Overall Study||171
5362453|NCT00096954|13194331|P1|Received Study Drug|Overall Study||157
5362454|NCT00096954|13194330|P2|STARTED|Overall Study||174
5362455|NCT00096954|13194331|P1|STARTED|Overall Study||159
5362456|NCT00096941|13194343|P1|NOT COMPLETED|Overall Study||3
5362457|NCT00096941|13194343|P1|COMPLETED|Overall Study||0
5362458|NCT00096941|13194343|P1|STARTED|Overall Study||3
5362459|NCT00096785|13194350|P2|NOT COMPLETED|Overall Study||1
5362460|NCT00096785|13194351|P1|NOT COMPLETED|Overall Study||2
5362461|NCT00096785|13194350|P2|COMPLETED|Overall Study|As randomized cohort|33
5362462|NCT00096785|13194351|P1|COMPLETED|Overall Study|As randomized cohort|33
5362463|NCT00096785|13194350|P2|As-Treated Population|Overall Study||33
5362464|NCT00096785|13194351|P1|As-Treated Population|Overall Study||36
5362465|NCT00096785|13194350|P2|As-Randomized Population|Overall Study||34
5362466|NCT00096785|13194351|P1|As-Randomized Population|Overall Study||35
5362467|NCT00096785|13194350|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
5362468|NCT00096785|13194351|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
5362469|NCT00096681|13194375|P1|NOT COMPLETED|Overall Study||0
5362470|NCT00096681|13194375|P1|COMPLETED|Overall Study||762
5362471|NCT00096681|13194375|P1|STARTED|Overall Study||762
5362472|NCT00096538|13194380|P1|NOT COMPLETED|Overall Study||1
5362473|NCT00096538|13194380|P1|COMPLETED|Overall Study||5
5362474|NCT00096538|13194380|P1|STARTED|Overall Study||6
5362475|NCT00096486|13194388|P4|NOT COMPLETED|Overall Study||2
5362476|NCT00096486|13194389|P3|NOT COMPLETED|Overall Study||2
5362477|NCT00096486|13194390|P2|NOT COMPLETED|Overall Study||0
5362478|NCT00096486|13194391|P1|NOT COMPLETED|Overall Study||0
5362479|NCT00096486|13194388|P4|COMPLETED|Overall Study||36
5362480|NCT00096486|13194389|P3|COMPLETED|Overall Study||24
5362481|NCT00096486|13194390|P2|COMPLETED|Overall Study||6
5362482|NCT00096486|13194391|P1|COMPLETED|Overall Study||4
5362483|NCT00096486|13194388|P4|STARTED|Overall Study||38
5362484|NCT00096486|13194389|P3|STARTED|Overall Study||26
5362485|NCT00096486|13194390|P2|STARTED|Overall Study||6
5362486|NCT00096486|13194391|P1|STARTED|Overall Study||4
5362487|NCT00096460|13194403|P2|NOT COMPLETED|Overall Study||1
5362488|NCT00096460|13194404|P1|NOT COMPLETED|Overall Study||7
5362489|NCT00096460|13194403|P2|COMPLETED|Overall Study||7
5362490|NCT00096460|13194404|P1|COMPLETED|Overall Study||15
5362491|NCT00096460|13194403|P2|STARTED|Overall Study||8
5362492|NCT00096460|13194404|P1|STARTED|Overall Study||22
5362493|NCT00096447|13194410|P1|NOT COMPLETED|Overall Study||1
5362494|NCT00096447|13194410|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
5362495|NCT00096447|13194410|P1|STARTED|Overall Study||31
5362496|NCT00096382|13194426|P2|NOT COMPLETED|Overall Study||0
5362497|NCT00096382|13194427|P1|NOT COMPLETED|Overall Study||2
5362498|NCT00096382|13194426|P2|COMPLETED|Overall Study||3
5362499|NCT00096382|13194427|P1|COMPLETED|Overall Study||21
5362500|NCT00096382|13194426|P2|STARTED|Overall Study||3
5362501|NCT00096382|13194427|P1|STARTED|Overall Study||23
5362502|NCT00096356|13194437|P2|NOT COMPLETED|Overall Study||53
5362503|NCT00096356|13194438|P1|NOT COMPLETED|Overall Study||44
5362504|NCT00096356|13194437|P2|COMPLETED|Overall Study||61
5362505|NCT00096356|13194438|P1|COMPLETED|Overall Study||78
5362506|NCT00096356|13194437|P2|STARTED|Overall Study||114
5362507|NCT00096356|13194438|P1|STARTED|Overall Study||122
5362508|NCT00096278|13194450|P2|NOT COMPLETED|Overall Study||20
5362509|NCT00096278|13194451|P1|NOT COMPLETED|Overall Study||18
5362510|NCT00096278|13194450|P2|COMPLETED|Overall Study||1334
5362511|NCT00096278|13194451|P1|COMPLETED|Overall Study||1338
5362512|NCT00096278|13194450|P2|STARTED|Overall Study||1354
5362513|NCT00096278|13194451|P1|STARTED|Overall Study||1356
5362514|NCT00096265|13194470|P3|NOT COMPLETED|Overall Study||0
5362515|NCT00096265|13194471|P2|NOT COMPLETED|Overall Study||0
5362516|NCT00096265|13194472|P1|NOT COMPLETED|Overall Study||1
5362517|NCT00096265|13194470|P3|COMPLETED|Overall Study||41
5362518|NCT00096265|13194471|P2|COMPLETED|Overall Study||40
5362519|NCT00096265|13194472|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
5362520|NCT00096265|13194470|P3|STARTED|Overall Study||41
5362521|NCT00096265|13194471|P2|STARTED|Overall Study||40
5362522|NCT00096265|13194472|P1|STARTED|Overall Study||45
5362523|NCT00096226|13194498|P1|NOT COMPLETED|Overall Study||3
5362524|NCT00096226|13194498|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
5362525|NCT00096226|13194498|P1|Eligible and Underwent Surgery|Overall Study||37
5362526|NCT00096226|13194498|P1|Eligible|Overall Study||57
5362527|NCT00096226|13194498|P1|STARTED|Overall Study||60
5362528|NCT00096200|13194512|P3|NOT COMPLETED|Overall Study||0
5362529|NCT00096200|13194513|P2|NOT COMPLETED|Overall Study||7
5362530|NCT00096200|13194514|P1|NOT COMPLETED|Overall Study||1
5362531|NCT00096200|13194512|P3|COMPLETED|Overall Study||5
5362532|NCT00096200|13194513|P2|COMPLETED|Overall Study||23
5362533|NCT00096200|13194514|P1|COMPLETED|Overall Study||8
5362534|NCT00096200|13194512|P3|STARTED|Overall Study||5
5362535|NCT00096200|13194513|P2|STARTED|Overall Study||30
5362536|NCT00096200|13194514|P1|STARTED|Overall Study||9
5362537|NCT00096174|13194528|P1|NOT COMPLETED|Overall Study||62
5362538|NCT00096174|13194528|P1|COMPLETED|Overall Study||7
5362622|NCT00095940|13194635|P8|COMPLETED|Molecular Biology Phase||2
5362539|NCT00096174|13194528|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
5362540|NCT00096174|13194528|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
5362541|NCT00096174|13194528|P1|STARTED|Overall Study||69
5362542|NCT00096161|13194538|P4|NOT COMPLETED|Overall Study||0
5362543|NCT00096161|13194539|P3|NOT COMPLETED|Overall Study||0
5362544|NCT00096161|13194540|P2|NOT COMPLETED|Overall Study||0
5362545|NCT00096161|13194541|P1|NOT COMPLETED|Overall Study||0
5362546|NCT00096161|13194538|P4|COMPLETED|Overall Study||0
5362547|NCT00096161|13194539|P3|COMPLETED|Overall Study||6
5362548|NCT00096161|13194540|P2|COMPLETED|Overall Study||10
5362549|NCT00096161|13194541|P1|COMPLETED|Overall Study||20
5362550|NCT00096161|13194538|P4|STARTED|Overall Study||0
5362551|NCT00096161|13194539|P3|STARTED|Overall Study||6
5362552|NCT00096161|13194540|P2|STARTED|Overall Study||10
5362553|NCT00096161|13194541|P1|STARTED|Overall Study||20
5362554|NCT00096135|13194573|P2|NOT COMPLETED|Overall Study||15
5362555|NCT00096135|13194574|P1|NOT COMPLETED|Overall Study||63
5362556|NCT00096135|13194573|P2|COMPLETED|Overall Study||27
5362557|NCT00096135|13194574|P1|COMPLETED|Overall Study||63
5362558|NCT00096135|13194573|P2|STARTED|Overall Study||42
5362559|NCT00096135|13194574|P1|STARTED|Overall Study||126
5362560|NCT00096122|13194580|P1|NOT COMPLETED|Overall Study||0
5362561|NCT00096122|13194580|P1|COMPLETED|Overall Study||95
5362562|NCT00096122|13194580|P1|STARTED|Overall Study||95
5362563|NCT00096109|13194584|P1|NOT COMPLETED|Overall Study||0
5362564|NCT00096109|13194584|P1|COMPLETED|Overall Study||11
5362565|NCT00096109|13194584|P1|STARTED|Overall Study||11
5362566|NCT00096044|13194590|P1|NOT COMPLETED|Overall Study||34
5362567|NCT00096044|13194590|P1|COMPLETED|Overall Study||11
5362568|NCT00096044|13194590|P1|STARTED|Overall Study||45
5362569|NCT00096031|13194599|P1|NOT COMPLETED|Overall Study||63
5362570|NCT00096031|13194599|P1|COMPLETED|Overall Study||0
5362571|NCT00096031|13194599|P1|Eligible and Began Protocol Therapy|Overall Study||55
5362572|NCT00096031|13194599|P1|Eligible|Overall Study||57
5362573|NCT00096031|13194599|P1|STARTED|Overall Study||63
5362574|NCT00096018|13194607|P2|NOT COMPLETED|Overall Study||14
5362575|NCT00096018|13194608|P1|NOT COMPLETED|Overall Study||2
5362576|NCT00096018|13194607|P2|COMPLETED|Overall Study||16
5362577|NCT00096018|13194608|P1|COMPLETED|Overall Study||11
5362578|NCT00096018|13194607|P2|Treated With Study Therapy|Overall Study||25
5362579|NCT00096018|13194608|P1|Treated With Study Therapy|Overall Study||13
5362580|NCT00096018|13194607|P2|STARTED|Overall Study||30
5362581|NCT00096018|13194608|P1|STARTED|Overall Study||13
5362582|NCT00095979|13194616|P1|NOT COMPLETED|Overall Study||2
5362583|NCT00095979|13194616|P1|COMPLETED|Overall Study||50
5362584|NCT00095979|13194616|P1|STARTED|Overall Study||52
5362585|NCT00095940|13194634|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
5362586|NCT00095940|13194635|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
5362587|NCT00095940|13194636|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
5362588|NCT00095940|13194637|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
5362589|NCT00095940|13194638|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
5362590|NCT00095940|13194639|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
5362591|NCT00095940|13194640|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
5362592|NCT00095940|13194641|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
5362593|NCT00095940|13194642|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
5362594|NCT00095940|13194634|P9|COMPLETED|Lapatinib Continuation/Phase II||1
5362595|NCT00095940|13194635|P8|COMPLETED|Lapatinib Continuation/Phase II||0
5362596|NCT00095940|13194636|P7|COMPLETED|Lapatinib Continuation/Phase II||0
5362597|NCT00095940|13194637|P6|COMPLETED|Lapatinib Continuation/Phase II||0
5362598|NCT00095940|13194638|P5|COMPLETED|Lapatinib Continuation/Phase II||0
5362599|NCT00095940|13194639|P4|COMPLETED|Lapatinib Continuation/Phase II||0
5362600|NCT00095940|13194640|P3|COMPLETED|Lapatinib Continuation/Phase II||1
5362601|NCT00095940|13194641|P2|COMPLETED|Lapatinib Continuation/Phase II||0
5362602|NCT00095940|13194642|P1|COMPLETED|Lapatinib Continuation/Phase II||0
5362603|NCT00095940|13194634|P9|STARTED|Lapatinib Continuation/Phase II||14
5362604|NCT00095940|13194635|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
5362605|NCT00095940|13194636|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
5362606|NCT00095940|13194637|P6|STARTED|Lapatinib Continuation/Phase II||13
5362607|NCT00095940|13194638|P5|STARTED|Lapatinib Continuation/Phase II||0
5362608|NCT00095940|13194639|P4|STARTED|Lapatinib Continuation/Phase II||0
5362609|NCT00095940|13194640|P3|STARTED|Lapatinib Continuation/Phase II||17
5362610|NCT00095940|13194641|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
5362611|NCT00095940|13194642|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
5362612|NCT00095940|13194634|P9|NOT COMPLETED|Molecular Biology Phase||0
5362613|NCT00095940|13194635|P8|NOT COMPLETED|Molecular Biology Phase||0
5362614|NCT00095940|13194636|P7|NOT COMPLETED|Molecular Biology Phase||0
5362615|NCT00095940|13194637|P6|NOT COMPLETED|Molecular Biology Phase||0
5362616|NCT00095940|13194638|P5|NOT COMPLETED|Molecular Biology Phase||0
5362617|NCT00095940|13194639|P4|NOT COMPLETED|Molecular Biology Phase||0
5362618|NCT00095940|13194640|P3|NOT COMPLETED|Molecular Biology Phase||0
5362619|NCT00095940|13194641|P2|NOT COMPLETED|Molecular Biology Phase||0
5362620|NCT00095940|13194642|P1|NOT COMPLETED|Molecular Biology Phase||0
5362621|NCT00095940|13194634|P9|COMPLETED|Molecular Biology Phase||0
5362623|NCT00095940|13194636|P7|COMPLETED|Molecular Biology Phase||2
5362624|NCT00095940|13194637|P6|COMPLETED|Molecular Biology Phase||0
5362625|NCT00095940|13194638|P5|COMPLETED|Molecular Biology Phase||0
5362626|NCT00095940|13194639|P4|COMPLETED|Molecular Biology Phase||0
5362627|NCT00095940|13194640|P3|COMPLETED|Molecular Biology Phase||0
5362628|NCT00095940|13194641|P2|COMPLETED|Molecular Biology Phase||2
5362629|NCT00095940|13194642|P1|COMPLETED|Molecular Biology Phase||2
5362630|NCT00095940|13194634|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
5362631|NCT00095940|13194635|P8|STARTED|Molecular Biology Phase||2
5362632|NCT00095940|13194636|P7|STARTED|Molecular Biology Phase||2
5362633|NCT00095940|13194637|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
5362634|NCT00095940|13194638|P5|STARTED|Molecular Biology Phase||0
5362635|NCT00095940|13194639|P4|STARTED|Molecular Biology Phase||0
5362636|NCT00095940|13194640|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
5362637|NCT00095940|13194641|P2|STARTED|Molecular Biology Phase||2
5362638|NCT00095940|13194642|P1|STARTED|Molecular Biology Phase||2
5362639|NCT00095875|13194666|P2|NOT COMPLETED|Overall Study||9
5362640|NCT00095875|13194667|P1|NOT COMPLETED|Overall Study||14
5362641|NCT00095875|13194666|P2|COMPLETED|Overall Study||66
5362642|NCT00095875|13194667|P1|COMPLETED|Overall Study||56
5362643|NCT00095875|13194666|P2|STARTED|Overall Study||75
5362644|NCT00095875|13194667|P1|STARTED|Overall Study||70
5362645|NCT00095836|13194675|P1|NOT COMPLETED|Overall Study||4
5362646|NCT00095836|13194675|P1|COMPLETED|Overall Study||23
5362647|NCT00095836|13194675|P1|STARTED|Overall Study||27
5362648|NCT00095784|13194682|P1|NOT COMPLETED|Overall Study||0
5362649|NCT00095784|13194682|P1|COMPLETED|Overall Study||21
5362650|NCT00095784|13194682|P1|STARTED|Overall Study||21
5362651|NCT00095628|13194705|P1|NOT COMPLETED|Overall Study||1
5362652|NCT00095628|13194705|P1|COMPLETED|Overall Study||20
5362653|NCT00095628|13194705|P1|STARTED|Overall Study||21
5362654|NCT00095576|13194716|P2|NOT COMPLETED|Overall Study||1481
5362655|NCT00095576|13194717|P1|NOT COMPLETED|Overall Study||1475
5362656|NCT00095576|13194716|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
5362657|NCT00095576|13194717|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
5362658|NCT00095576|13194716|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
5362659|NCT00095576|13194717|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
5362660|NCT00095576|13194716|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
5362661|NCT00095576|13194717|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
5362662|NCT00095576|13194716|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
5362663|NCT00095576|13194717|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
5362664|NCT00095576|13194716|P2|STARTED|Overall Study||1495
5362665|NCT00095576|13194717|P1|STARTED|Overall Study||1484
5362666|NCT00095563|13194729|P1|NOT COMPLETED|Overall Study||0
5362667|NCT00095563|13194729|P1|COMPLETED|Overall Study||39
5362668|NCT00095563|13194729|P1|STARTED|Overall Study||39
5362669|NCT00095498|13194741|P3|NOT COMPLETED|Overall Study||39
5362670|NCT00095498|13194742|P2|NOT COMPLETED|Overall Study||35
5362671|NCT00095498|13194743|P1|NOT COMPLETED|Overall Study||37
5362672|NCT00095498|13194741|P3|COMPLETED|Overall Study||39
5362673|NCT00095498|13194742|P2|COMPLETED|Overall Study||38
5362674|NCT00095498|13194743|P1|COMPLETED|Overall Study||39
5362675|NCT00095498|13194741|P3|Received Investigational Product|Overall Study||75
5362676|NCT00095498|13194742|P2|Received Investigational Product|Overall Study||71
5362677|NCT00095498|13194743|P1|Received Investigational Product|Overall Study||72
5362678|NCT00095498|13194741|P3|STARTED|Overall Study||78
5362679|NCT00095498|13194742|P2|STARTED|Overall Study||73
5362680|NCT00095498|13194743|P1|STARTED|Overall Study||76
5362681|NCT00095303|13195170|P2|NOT COMPLETED|Follow Up Study||58
5362682|NCT00095303|13195171|P1|NOT COMPLETED|Follow Up Study||59
5362683|NCT00095303|13195170|P2|COMPLETED|Follow Up Study||121
5362684|NCT00095303|13195171|P1|COMPLETED|Follow Up Study||140
5362685|NCT00095303|13195170|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
5362686|NCT00095303|13195171|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
5362687|NCT00095303|13195170|P2|NOT COMPLETED|Main Study||87
5362688|NCT00095303|13195171|P1|NOT COMPLETED|Main Study||91
5362689|NCT00095303|13195170|P2|COMPLETED|Main Study||148
5362690|NCT00095303|13195171|P1|COMPLETED|Main Study||154
5362691|NCT00095303|13195170|P2|STARTED|Main Study||235
5362692|NCT00095303|13195171|P1|STARTED|Main Study||245
5362693|NCT00095238|13195239|P2|NOT COMPLETED|Overall Study||852
5362694|NCT00095238|13195240|P1|NOT COMPLETED|Overall Study||857
5362695|NCT00095238|13195239|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
5362696|NCT00095238|13195240|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
5362697|NCT00095238|13195239|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
5362698|NCT00095238|13195240|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
5362699|NCT00095238|13195239|P2|STARTED|Overall Study|number randomized|2061
5362700|NCT00095238|13195240|P1|STARTED|Overall Study|number randomized|2067
5362701|NCT00095212|13195302|P2|NOT COMPLETED|Overall Study||3
5362702|NCT00095212|13195303|P1|NOT COMPLETED|Overall Study||1
5362703|NCT00095212|13195302|P2|COMPLETED|Overall Study||9
5362704|NCT00095212|13195303|P1|COMPLETED|Overall Study||12
5362705|NCT00095212|13195302|P2|STARTED|Overall Study||12
5362706|NCT00095212|13195303|P1|STARTED|Overall Study||13
5362707|NCT00095199|13195333|P4|NOT COMPLETED|Overall Study||143
5362708|NCT00095199|13195334|P3|NOT COMPLETED|Overall Study||160
5362709|NCT00095199|13195335|P2|NOT COMPLETED|Overall Study||242
5362710|NCT00095199|13195336|P1|NOT COMPLETED|Overall Study||296
5362711|NCT00095199|13195333|P4|COMPLETED|Overall Study||23
5362712|NCT00095199|13195334|P3|COMPLETED|Overall Study||7
5362713|NCT00095199|13195335|P2|COMPLETED|Overall Study||62
5362714|NCT00095199|13195336|P1|COMPLETED|Overall Study||6
5362715|NCT00095199|13195333|P4|STARTED|Overall Study||166
5362716|NCT00095199|13195334|P3|STARTED|Overall Study||167
5362717|NCT00095199|13195335|P2|STARTED|Overall Study||304
5362718|NCT00095199|13195336|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
5362719|NCT00095173|13195374|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
5362720|NCT00095173|13195375|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
5362721|NCT00095173|13195376|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
5362722|NCT00095173|13195377|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
5362723|NCT00095173|13195378|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
5362724|NCT00095173|13195379|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
5362725|NCT00095173|13195374|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
5362726|NCT00095173|13195375|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
5362727|NCT00095173|13195376|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
5362728|NCT00095173|13195377|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
5362729|NCT00095173|13195378|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
5362730|NCT00095173|13195379|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
5362731|NCT00095173|13195374|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
5362732|NCT00095173|13195375|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
5362733|NCT00095173|13195376|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
5362734|NCT00095173|13195377|P3|STARTED|Open-Label Extension Phase (Period C)||0
5362735|NCT00095173|13195378|P2|STARTED|Open-Label Extension Phase (Period C)||0
5362736|NCT00095173|13195379|P1|STARTED|Open-Label Extension Phase (Period C)||0
5362737|NCT00095173|13195374|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
5362738|NCT00095173|13195375|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
5362739|NCT00095173|13195376|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
5362740|NCT00095173|13195377|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
5362741|NCT00095173|13195378|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
5362742|NCT00095173|13195379|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
5362743|NCT00095173|13195374|P6|COMPLETED|Double-Blind Phase (Period B)||0
5362744|NCT00095173|13195375|P5|COMPLETED|Double-Blind Phase (Period B)||0
5362745|NCT00095173|13195376|P4|COMPLETED|Double-Blind Phase (Period B)||0
5362746|NCT00095173|13195377|P3|COMPLETED|Double-Blind Phase (Period B)||31
5362747|NCT00095173|13195378|P2|COMPLETED|Double-Blind Phase (Period B)||49
5362748|NCT00095173|13195379|P1|COMPLETED|Double-Blind Phase (Period B)||0
5362749|NCT00095173|13195374|P6|STARTED|Double-Blind Phase (Period B)||0
5362750|NCT00095173|13195375|P5|STARTED|Double-Blind Phase (Period B)||0
5362751|NCT00095173|13195376|P4|STARTED|Double-Blind Phase (Period B)||0
5362752|NCT00095173|13195377|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
5362753|NCT00095173|13195378|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
5362754|NCT00095173|13195379|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
5362755|NCT00095173|13195374|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362756|NCT00095173|13195375|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362757|NCT00095173|13195376|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362758|NCT00095173|13195377|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362759|NCT00095173|13195378|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362760|NCT00095173|13195379|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
5362761|NCT00095173|13195374|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362762|NCT00095173|13195375|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362763|NCT00095173|13195376|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362764|NCT00095173|13195377|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362765|NCT00095173|13195378|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
5362766|NCT00095173|13195379|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
5362767|NCT00095173|13195374|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
5362768|NCT00095173|13195375|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
5362769|NCT00095173|13195376|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
5362770|NCT00095173|13195377|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
5362771|NCT00095173|13195378|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
5362772|NCT00095173|13195379|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
5362773|NCT00095147|13195417|P5|NOT COMPLETED|Long-term Extension Period||45
5362774|NCT00095147|13195418|P4|NOT COMPLETED|Long-term Extension Period||0
5362775|NCT00095147|13195419|P3|NOT COMPLETED|Long-term Extension Period||0
5362776|NCT00095147|13195420|P2|NOT COMPLETED|Long-term Extension Period||0
5362777|NCT00095147|13195421|P1|NOT COMPLETED|Long-term Extension Period||0
5362778|NCT00095147|13195417|P5|COMPLETED|Long-term Extension Period||327
5362779|NCT00095147|13195418|P4|COMPLETED|Long-term Extension Period||0
5362780|NCT00095147|13195419|P3|COMPLETED|Long-term Extension Period||0
5362781|NCT00095147|13195420|P2|COMPLETED|Long-term Extension Period||0
5362782|NCT00095147|13195421|P1|COMPLETED|Long-term Extension Period||0
5362783|NCT00095147|13195417|P5|STARTED|Long-term Extension Period||372
5362784|NCT00095147|13195418|P4|STARTED|Long-term Extension Period||0
5362785|NCT00095147|13195419|P3|STARTED|Long-term Extension Period||0
5362786|NCT00095147|13195420|P2|STARTED|Long-term Extension Period||0
5362787|NCT00095147|13195421|P1|STARTED|Long-term Extension Period||0
5362788|NCT00095147|13195417|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
5362789|NCT00095147|13195418|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
5362790|NCT00095147|13195419|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
5362791|NCT00095147|13195420|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
5362792|NCT00095147|13195421|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
5362793|NCT00095147|13195417|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
5362794|NCT00095147|13195418|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
5362795|NCT00095147|13195419|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
5362796|NCT00095147|13195420|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
5362797|NCT00095147|13195421|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
5362798|NCT00095147|13195417|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
5362799|NCT00095147|13195418|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
5362800|NCT00095147|13195419|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
5362801|NCT00095147|13195420|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
5362802|NCT00095147|13195421|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
5362803|NCT00095147|13195417|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
5362804|NCT00095147|13195418|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
5362805|NCT00095147|13195419|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
5362806|NCT00095147|13195420|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
5362807|NCT00095147|13195421|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
5362808|NCT00095147|13195417|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
5362809|NCT00095147|13195418|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
5362810|NCT00095147|13195419|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
5362811|NCT00095147|13195420|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
5362812|NCT00095147|13195421|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
5362813|NCT00095147|13195417|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
5362814|NCT00095147|13195418|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
5362815|NCT00095147|13195419|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
5362816|NCT00095147|13195420|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
5362817|NCT00095147|13195421|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
5362818|NCT00095121|13195616|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
5362819|NCT00095121|13195617|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
5362820|NCT00095121|13195616|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
5362821|NCT00095121|13195617|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
5362822|NCT00095121|13195616|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
5362823|NCT00095121|13195617|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
5362824|NCT00095121|13195616|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
5362825|NCT00095121|13195617|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
5362826|NCT00095121|13195616|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
5362827|NCT00095121|13195617|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
5362828|NCT00095121|13195616|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
5362829|NCT00095121|13195617|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
5362830|NCT00095121|13195616|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
5362831|NCT00095121|13195617|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
5362832|NCT00095056|13195663|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
5362833|NCT00095056|13195664|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
5362834|NCT00095056|13195663|P2|COMPLETED|Phase B (Weeks 12-54)||20
5362835|NCT00095056|13195664|P1|COMPLETED|Phase B (Weeks 12-54)||46
5362836|NCT00095056|13195663|P2|STARTED|Phase B (Weeks 12-54)||25
5362837|NCT00095056|13195664|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
5362838|NCT00095056|13195663|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
5362839|NCT00095056|13195664|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
5362840|NCT00095056|13195663|P2|COMPLETED|Phase A (Weeks 0-12)||25
5362841|NCT00095056|13195664|P1|COMPLETED|Phase A (Weeks 0-12)||58
5362842|NCT00095056|13195663|P2|STARTED|Phase A (Weeks 0-12)||26
5362843|NCT00095056|13195664|P1|STARTED|Phase A (Weeks 0-12)||65
5362844|NCT00094900|13195672|P1|NOT COMPLETED|Overall Study||1
5362845|NCT00094900|13195672|P1|COMPLETED|Overall Study||10
5362846|NCT00094900|13195672|P1|STARTED|Overall Study||11
5362847|NCT00094887|13195774|P2|NOT COMPLETED|Overall Study||4
5362848|NCT00094887|13195775|P1|NOT COMPLETED|Overall Study||4
5362849|NCT00094887|13195774|P2|COMPLETED|Overall Study||71
5362850|NCT00094887|13195775|P1|COMPLETED|Overall Study||71
5362851|NCT00094887|13195774|P2|Primary Efficacy Population|Overall Study||64
5362852|NCT00094887|13195775|P1|Primary Efficacy Population|Overall Study||65
5362853|NCT00094887|13195774|P2|Per Protocol Analysis Set|Overall Study||71
5362854|NCT00094887|13195775|P1|Per Protocol Analysis Set|Overall Study||71
5362855|NCT00094887|13195774|P2|Intent to Treat Population|Overall Study||75
5362856|NCT00094887|13195775|P1|Intent to Treat Population|Overall Study||75
5362857|NCT00094887|13195774|P2|Safety Population|Overall Study||75
5362858|NCT00094887|13195775|P1|Safety Population|Overall Study||75
5362859|NCT00094887|13195774|P2|STARTED|Overall Study||75
5362860|NCT00094887|13195775|P1|STARTED|Overall Study||75
5362861|NCT00094861|13195793|P2|NOT COMPLETED|Overall Study||9
5362862|NCT00094861|13195794|P1|NOT COMPLETED|Overall Study||18
5362863|NCT00094861|13195793|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
5362864|NCT00094861|13195794|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
5362865|NCT00094861|13195793|P2|Participants Treated|Overall Study||48
5362866|NCT00094861|13195794|P1|Participants Treated|Overall Study||46
5362867|NCT00094861|13195793|P2|STARTED|Overall Study||49
5362868|NCT00094861|13195794|P1|STARTED|Overall Study||46
5362869|NCT00094835|13195821|P7|NOT COMPLETED|Overall Study||2
5362870|NCT00094835|13195822|P6|NOT COMPLETED|Overall Study||3
5362871|NCT00094835|13195823|P5|NOT COMPLETED|Overall Study||4
5362872|NCT00094835|13195824|P4|NOT COMPLETED|Overall Study||1
5362873|NCT00094835|13195825|P3|NOT COMPLETED|Overall Study||3
5362874|NCT00094835|13195826|P2|NOT COMPLETED|Overall Study||3
5362875|NCT00094835|13195827|P1|NOT COMPLETED|Overall Study||4
5362876|NCT00094835|13195821|P7|COMPLETED|Overall Study||4
5362877|NCT00094835|13195822|P6|COMPLETED|Overall Study||3
5362878|NCT00094835|13195823|P5|COMPLETED|Overall Study||3
5362879|NCT00094835|13195824|P4|COMPLETED|Overall Study||4
5362880|NCT00094835|13195825|P3|COMPLETED|Overall Study||4
5362881|NCT00094835|13195826|P2|COMPLETED|Overall Study||8
5362882|NCT00094835|13195827|P1|COMPLETED|Overall Study||5
5362883|NCT00094835|13195821|P7|Treated With Motesanib|Overall Study||6
5362884|NCT00094835|13195822|P6|Treated With Motesanib|Overall Study||5
5362885|NCT00094835|13195823|P5|Treated With Motesanib|Overall Study||7
5362886|NCT00094835|13195824|P4|Treated With Motesanib|Overall Study||4
5362887|NCT00094835|13195825|P3|Treated With Motesanib|Overall Study||6
5362888|NCT00094835|13195826|P2|Treated With Motesanib|Overall Study||11
5362889|NCT00094835|13195827|P1|Treated With Motesanib|Overall Study||6
5362890|NCT00094835|13195821|P7|STARTED|Overall Study||6
5362891|NCT00094835|13195822|P6|STARTED|Overall Study||6
5362892|NCT00094835|13195823|P5|STARTED|Overall Study||7
5362893|NCT00094835|13195824|P4|STARTED|Overall Study||5
5362894|NCT00094835|13195825|P3|STARTED|Overall Study||7
5362895|NCT00094835|13195826|P2|STARTED|Overall Study||11
5362896|NCT00094835|13195827|P1|STARTED|Overall Study||9
5362897|NCT00094809|13195905|P2|NOT COMPLETED|Overall Study||65
5362898|NCT00094809|13195906|P1|NOT COMPLETED|Overall Study||52
5362899|NCT00094809|13195905|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
5362900|NCT00094809|13195906|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
5362901|NCT00094809|13195905|P2|Completed All 4 Cycles of Treatment|Overall Study||90
5362902|NCT00094809|13195906|P1|Completed All 4 Cycles of Treatment|Overall Study||98
5362903|NCT00094809|13195905|P2|Properly Consented; Received Study Drug|Overall Study||118
5362904|NCT00094809|13195906|P1|Properly Consented; Received Study Drug|Overall Study||123
5362905|NCT00094809|13195905|P2|Received Study Drug|Overall Study||118
5362906|NCT00094809|13195906|P1|Received Study Drug|Overall Study||124
5362907|NCT00094809|13195905|P2|STARTED|Overall Study||126
5362908|NCT00094809|13195906|P1|STARTED|Overall Study||126
5362909|NCT00094770|13195932|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
5362910|NCT00094770|13195933|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
5362911|NCT00094770|13195932|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
5362912|NCT00094770|13195933|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
5362913|NCT00094770|13195932|P2|STARTED|Year 2 (Week 0 to Week 104)||584
5362914|NCT00094770|13195933|P1|STARTED|Year 2 (Week 0 to Week 104)||588
5362915|NCT00094770|13195932|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
5362916|NCT00094770|13195933|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
5362917|NCT00094770|13195932|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
5362918|NCT00094770|13195933|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
5362919|NCT00094770|13195932|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
5362920|NCT00094770|13195933|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
5362921|NCT00094757|13195964|P3|NOT COMPLETED|Overall Study||30
5362922|NCT00094757|13195965|P2|NOT COMPLETED|Overall Study||62
5362923|NCT00094757|13195966|P1|NOT COMPLETED|Overall Study||53
5362924|NCT00094757|13195964|P3|COMPLETED|Overall Study||80
5362925|NCT00094757|13195965|P2|COMPLETED|Overall Study||144
5362926|NCT00094757|13195966|P1|COMPLETED|Overall Study||152
5362927|NCT00094757|13195964|P3|STARTED|Overall Study||110
5362928|NCT00094757|13195965|P2|STARTED|Overall Study||206
5362929|NCT00094757|13195966|P1|STARTED|Overall Study||205
5362930|NCT00094653|13195986|P3|NOT COMPLETED|Overall Study||126
5362931|NCT00094653|13195987|P2|NOT COMPLETED|Overall Study||106
5362932|NCT00094653|13195988|P1|NOT COMPLETED|Overall Study||321
5362933|NCT00094653|13195986|P3|COMPLETED|Overall Study||10
5362934|NCT00094653|13195987|P2|COMPLETED|Overall Study||31
5362935|NCT00094653|13195988|P1|COMPLETED|Overall Study||82
5362936|NCT00094653|13195986|P3|Treated|Overall Study||131
5362937|NCT00094653|13195987|P2|Treated|Overall Study||131
5362938|NCT00094653|13195988|P1|Treated|Overall Study||381
5362939|NCT00094653|13195986|P3|STARTED|Overall Study||136
5362940|NCT00094653|13195987|P2|STARTED|Overall Study||137
5362941|NCT00094653|13195988|P1|STARTED|Overall Study||403
5362942|NCT00094575|13196051|P2|NOT COMPLETED|Overall Study||146
5362943|NCT00094575|13196052|P1|NOT COMPLETED|Overall Study||146
5362944|NCT00094575|13196051|P2|COMPLETED|Overall Study||291
5362945|NCT00094575|13196052|P1|COMPLETED|Overall Study||298
5362946|NCT00094575|13196051|P2|STARTED|Overall Study||437
5362947|NCT00094575|13196052|P1|STARTED|Overall Study||444
5362948|NCT00094536|13196072|P1|NOT COMPLETED|Treatment and Follow-up||31
5362949|NCT00094536|13196072|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
5362950|NCT00094536|13196072|P1|36 Month Follow-up|Treatment and Follow-up||51
5362951|NCT00094536|13196072|P1|24 Month Follow-up|Treatment and Follow-up||53
5362952|NCT00094536|13196072|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
5362953|NCT00094536|13196072|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
5362954|NCT00094536|13196072|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
5362955|NCT00094536|13196072|P1|COMPLETED|Inclusion Exclusion Evaluation||82
5362956|NCT00094536|13196072|P1|STARTED|Inclusion Exclusion Evaluation||106
5362957|NCT00094497|13196078|P2|NOT COMPLETED|Overall Study||0
5362958|NCT00094497|13196079|P1|NOT COMPLETED|Overall Study||0
5362959|NCT00094497|13196078|P2|COMPLETED|Overall Study||153
5362960|NCT00094497|13196079|P1|COMPLETED|Overall Study||151
5362961|NCT00094497|13196078|P2|Received Second Line Therapy|Overall Study||101
5362962|NCT00094497|13196079|P1|Received Second Line Therapy|Overall Study||84
5362963|NCT00094497|13196078|P2|Treated|Overall Study||149
5362964|NCT00094497|13196079|P1|Treated|Overall Study||148
5362965|NCT00094497|13196078|P2|STARTED|Overall Study||153
5362966|NCT00094497|13196079|P1|STARTED|Overall Study||151
5362967|NCT00094458|13196096|P6|NOT COMPLETED|OLE: Open-Label Extension||4
5362968|NCT00094458|13196097|P5|NOT COMPLETED|OLE: Open-Label Extension||5
5362969|NCT00094458|13196098|P4|NOT COMPLETED|OLE: Open-Label Extension||1
5362970|NCT00094458|13196099|P3|NOT COMPLETED|OLE: Open-Label Extension||0
5362971|NCT00094458|13196100|P2|NOT COMPLETED|OLE: Open-Label Extension||0
5362972|NCT00094458|13196101|P1|NOT COMPLETED|OLE: Open-Label Extension||0
5362973|NCT00094458|13196096|P6|COMPLETED|OLE: Open-Label Extension||13
5362974|NCT00094458|13196097|P5|COMPLETED|OLE: Open-Label Extension||13
5362975|NCT00094458|13196098|P4|COMPLETED|OLE: Open-Label Extension||7
5362976|NCT00094458|13196099|P3|COMPLETED|OLE: Open-Label Extension||0
5362977|NCT00094458|13196100|P2|COMPLETED|OLE: Open-Label Extension||0
5362978|NCT00094458|13196101|P1|COMPLETED|OLE: Open-Label Extension||0
5362979|NCT00094458|13196096|P6|STARTED|OLE: Open-Label Extension||17
5362980|NCT00094458|13196097|P5|STARTED|OLE: Open-Label Extension||18
5362981|NCT00094458|13196098|P4|STARTED|OLE: Open-Label Extension||8
5362982|NCT00094458|13196099|P3|STARTED|OLE: Open-Label Extension||0
5362983|NCT00094458|13196100|P2|STARTED|OLE: Open-Label Extension||0
5362984|NCT00094458|13196101|P1|STARTED|OLE: Open-Label Extension||0
5362985|NCT00094458|13196096|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
5362986|NCT00094458|13196097|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
5362987|NCT00094458|13196098|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
5362988|NCT00094458|13196099|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
5362989|NCT00094458|13196100|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
5362990|NCT00094458|13196101|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
5362991|NCT00094458|13196096|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
5362992|NCT00094458|13196097|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
5362993|NCT00094458|13196098|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
5362994|NCT00094458|13196099|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
5362995|NCT00094458|13196100|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
5362996|NCT00094458|13196101|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
5362997|NCT00094458|13196096|P6|STARTED|Study Extension: Week 30 Through Week 50||0
5362998|NCT00094458|13196097|P5|STARTED|Study Extension: Week 30 Through Week 50||0
5362999|NCT00094458|13196098|P4|STARTED|Study Extension: Week 30 Through Week 50||0
5363000|NCT00094458|13196099|P3|STARTED|Study Extension: Week 30 Through Week 50||108
5363001|NCT00094458|13196100|P2|STARTED|Study Extension: Week 30 Through Week 50||97
5363002|NCT00094458|13196101|P1|STARTED|Study Extension: Week 30 Through Week 50||75
5363003|NCT00094458|13196096|P6|NOT COMPLETED|Main Study: Through Week 30||0
5363004|NCT00094458|13196097|P5|NOT COMPLETED|Main Study: Through Week 30||0
5363005|NCT00094458|13196098|P4|NOT COMPLETED|Main Study: Through Week 30||0
5363006|NCT00094458|13196099|P3|NOT COMPLETED|Main Study: Through Week 30||48
5363007|NCT00094458|13196100|P2|NOT COMPLETED|Main Study: Through Week 30||58
5363008|NCT00094458|13196101|P1|NOT COMPLETED|Main Study: Through Week 30||84
5363009|NCT00094458|13196096|P6|COMPLETED|Main Study: Through Week 30||0
5363010|NCT00094458|13196097|P5|COMPLETED|Main Study: Through Week 30||0
5363011|NCT00094458|13196098|P4|COMPLETED|Main Study: Through Week 30||0
5363012|NCT00094458|13196099|P3|COMPLETED|Main Study: Through Week 30||121
5363013|NCT00094458|13196100|P2|COMPLETED|Main Study: Through Week 30||111
5363014|NCT00094458|13196101|P1|COMPLETED|Main Study: Through Week 30||86
5363015|NCT00094458|13196096|P6|STARTED|Main Study: Through Week 30||0
5363016|NCT00094458|13196097|P5|STARTED|Main Study: Through Week 30||0
5363017|NCT00094458|13196098|P4|STARTED|Main Study: Through Week 30||0
5363018|NCT00094458|13196099|P3|STARTED|Main Study: Through Week 30||169
5363019|NCT00094458|13196100|P2|STARTED|Main Study: Through Week 30||169
5363020|NCT00094458|13196101|P1|STARTED|Main Study: Through Week 30||170
5363021|NCT00094328|13196139|P1|NOT COMPLETED|Overall Study||1
5363022|NCT00094328|13196139|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
5363023|NCT00094328|13196139|P1|STARTED|Overall Study|Received treatment|14
5363024|NCT00094302|13196153|P2|NOT COMPLETED|Overall Study||406
5363025|NCT00094302|13196154|P1|NOT COMPLETED|Overall Study||417
5363026|NCT00094302|13196153|P2|COMPLETED|Overall Study||1316
5363027|NCT00094302|13196154|P1|COMPLETED|Overall Study||1306
5363028|NCT00094302|13196153|P2|STARTED|Overall Study||1722
5363029|NCT00094302|13196154|P1|STARTED|Overall Study||1723
5363030|NCT00094211|13196212|P4|NOT COMPLETED|Overall Study||7
5363031|NCT00094211|13196213|P3|NOT COMPLETED|Overall Study||10
5363032|NCT00094211|13196214|P2|NOT COMPLETED|Overall Study||8
5363033|NCT00094211|13196215|P1|NOT COMPLETED|Overall Study||9
5363034|NCT00094211|13196212|P4|COMPLETED|Overall Study||179
5363035|NCT00094211|13196213|P3|COMPLETED|Overall Study||220
5363036|NCT00094211|13196214|P2|COMPLETED|Overall Study||251
5363037|NCT00094211|13196215|P1|COMPLETED|Overall Study||212
5363038|NCT00094211|13196212|P4|STARTED|Overall Study||186
5363039|NCT00094211|13196213|P3|STARTED|Overall Study||230
5363040|NCT00094211|13196214|P2|STARTED|Overall Study||259
5363041|NCT00094211|13196215|P1|STARTED|Overall Study||221
5363042|NCT00094172|13196243|P2|NOT COMPLETED|Overall Study||7
5363043|NCT00094172|13196244|P1|NOT COMPLETED|Overall Study||14
5363044|NCT00094172|13196243|P2|COMPLETED|Overall Study||25
5363045|NCT00094172|13196244|P1|COMPLETED|Overall Study||36
5363046|NCT00094172|13196243|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
5363047|NCT00094172|13196244|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
5363048|NCT00094107|13196254|P1|NOT COMPLETED|Overall Study||32
5363049|NCT00094107|13196254|P1|COMPLETED|Overall Study||0
5363050|NCT00094107|13196254|P1|STARTED|Overall Study||32
5363051|NCT00094094|13196263|P1|NOT COMPLETED|Overall Study||32
5363052|NCT00094094|13196263|P1|COMPLETED|Overall Study||0
5363053|NCT00094094|13196263|P1|STARTED|Overall Study||32
5363054|NCT00094055|13196272|P1|NOT COMPLETED|Overall Study||60
5363055|NCT00094055|13196272|P1|COMPLETED|Overall Study||0
5363056|NCT00094055|13196272|P1|STARTED|Overall Study||60
5363057|NCT00093964|13196283|P2|NOT COMPLETED|Overall Study||0
5363058|NCT00093964|13196284|P1|NOT COMPLETED|Overall Study||0
5363059|NCT00093964|13196283|P2|COMPLETED|Overall Study||40
5363060|NCT00093964|13196284|P1|COMPLETED|Overall Study||41
5363061|NCT00093964|13196283|P2|STARTED|Overall Study||40
5363062|NCT00093964|13196284|P1|STARTED|Overall Study||41
5363063|NCT00093847|13196320|P2|NOT COMPLETED|Overall Study||10
5363064|NCT00093847|13196321|P1|NOT COMPLETED|Overall Study||8
5363065|NCT00093847|13196320|P2|COMPLETED|Overall Study||24
5363066|NCT00093847|13196321|P1|COMPLETED|Overall Study||31
5363067|NCT00093847|13196320|P2|STARTED|Overall Study||34
5363068|NCT00093847|13196321|P1|STARTED|Overall Study||39
5363069|NCT00093808|13196329|P1|NOT COMPLETED|Overall Study||2
5363070|NCT00093808|13196329|P1|COMPLETED|Overall Study||45
5363071|NCT00093808|13196329|P1|STARTED|Overall Study||47
5363072|NCT00093795|13196339|P3|NOT COMPLETED|Overall Study||17
5363073|NCT00093795|13196340|P2|NOT COMPLETED|Overall Study||16
5363074|NCT00093795|13196341|P1|NOT COMPLETED|Overall Study||20
5363075|NCT00093795|13196339|P3|COMPLETED|Overall Study||1613
5363076|NCT00093795|13196340|P2|COMPLETED|Overall Study||1618
5363077|NCT00093795|13196341|P1|COMPLETED|Overall Study||1610
5363078|NCT00093795|13196339|P3|STARTED|Overall Study||1630
5363079|NCT00093795|13196340|P2|STARTED|Overall Study||1634
5363080|NCT00093795|13196341|P1|STARTED|Overall Study||1630
5363081|NCT00093782|13196361|P1|NOT COMPLETED|Overall Study||0
5363082|NCT00093782|13196361|P1|COMPLETED|Overall Study||36
5363083|NCT00093782|13196361|P1|STARTED|Overall Study||36
5363084|NCT00093756|13196373|P2|NOT COMPLETED|Overall Study||0
5363085|NCT00093756|13196374|P1|NOT COMPLETED|Overall Study||0
5363086|NCT00093756|13196373|P2|COMPLETED|Overall Study||21
5363087|NCT00093756|13196374|P1|COMPLETED|Overall Study||27
5363088|NCT00093756|13196373|P2|STARTED|Overall Study||21
5363089|NCT00093756|13196374|P1|STARTED|Overall Study||27
5363090|NCT00093496|13196386|P2|NOT COMPLETED|Overall Study||3
5363091|NCT00093496|13196387|P1|NOT COMPLETED|Overall Study||1
5363092|NCT00093496|13196386|P2|COMPLETED|Overall Study||11
5363093|NCT00093496|13196387|P1|COMPLETED|Overall Study||14
5363094|NCT00093496|13196386|P2|STARTED|Overall Study||14
5363095|NCT00093496|13196387|P1|STARTED|Overall Study||15
5363096|NCT00093470|13196400|P2|NOT COMPLETED|Overall Study||0
5363097|NCT00093470|13196401|P1|NOT COMPLETED|Overall Study||73
5363098|NCT00093470|13196400|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
5363099|NCT00093470|13196401|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
5363100|NCT00093470|13196400|P2|Patients With Toxicity Assessment|Overall Study||69
5363101|NCT00093470|13196401|P1|Patients With Toxicity Assessment|Overall Study||72
5363102|NCT00093470|13196400|P2|Treated|Overall Study||71
5363103|NCT00093470|13196401|P1|Treated|Overall Study||72
5363104|NCT00093470|13196400|P2|STARTED|Overall Study||71
5363105|NCT00093470|13196401|P1|STARTED|Overall Study||73
5363106|NCT00093379|13196409|P1|NOT COMPLETED|Overall Study||0
5363107|NCT00093379|13196409|P1|COMPLETED|Overall Study||20
5363108|NCT00093379|13196409|P1|STARTED|Overall Study||20
5363109|NCT00093145|13196415|P1|NOT COMPLETED|Overall Study||17
5363110|NCT00093145|13196415|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
5363111|NCT00093145|13196415|P1|At Least One Response Assessment|Overall Study||31
5363112|NCT00093145|13196415|P1|STARTED|Overall Study||32
5363113|NCT00093041|13196430|P6|NOT COMPLETED|Overall Study||3
5363114|NCT00093041|13196431|P5|NOT COMPLETED|Overall Study||1
5363115|NCT00093041|13196432|P4|NOT COMPLETED|Overall Study||1
5363116|NCT00093041|13196433|P3|NOT COMPLETED|Overall Study||2
5363117|NCT00093041|13196434|P2|NOT COMPLETED|Overall Study||3
5363118|NCT00093041|13196435|P1|NOT COMPLETED|Overall Study||2
5363119|NCT00093041|13196430|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
5363120|NCT00093041|13196431|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
5363121|NCT00093041|13196432|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
5363122|NCT00093041|13196433|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
5363123|NCT00093041|13196434|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
5363124|NCT00093041|13196435|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
5363125|NCT00093041|13196430|P6|STARTED|Overall Study||7
5363126|NCT00093041|13196431|P5|STARTED|Overall Study||4
5363127|NCT00093041|13196432|P4|STARTED|Overall Study||4
5363128|NCT00093041|13196433|P3|STARTED|Overall Study||5
5363129|NCT00093041|13196434|P2|STARTED|Overall Study||4
5363130|NCT00093041|13196435|P1|STARTED|Overall Study||4
5363131|NCT00093015|13196457|P2|NOT COMPLETED|Overall Study||664
5363132|NCT00093015|13196458|P1|NOT COMPLETED|Overall Study||665
5363133|NCT00093015|13196457|P2|COMPLETED|Overall Study||1348
5363134|NCT00093015|13196458|P1|COMPLETED|Overall Study||1361
5363135|NCT00093015|13196457|P2|Received Study Medication|Overall Study||2004
5363136|NCT00093015|13196458|P1|Received Study Medication|Overall Study||2019
5363137|NCT00093015|13196457|P2|STARTED|Overall Study||2012
5363138|NCT00093015|13196458|P1|STARTED|Overall Study||2026
5363139|NCT00092677|13196486|P2|NOT COMPLETED|Overall Study||11
5363140|NCT00092677|13196487|P1|NOT COMPLETED|Overall Study||5
5363141|NCT00092677|13196486|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
5363142|NCT00092677|13196487|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
5363143|NCT00092677|13196486|P2|STARTED|Overall Study||929
5363144|NCT00092677|13196487|P1|STARTED|Overall Study||944
5363145|NCT00092547|13196531|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
5363146|NCT00092547|13196532|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
5363147|NCT00092547|13196533|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
5363148|NCT00092547|13196531|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
5363149|NCT00092547|13196532|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
5363150|NCT00092547|13196533|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
5363151|NCT00092547|13196531|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
5363152|NCT00092547|13196532|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
5363153|NCT00092547|13196533|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
5363154|NCT00092547|13196531|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
5363155|NCT00092547|13196532|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
5363156|NCT00092547|13196533|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
5363157|NCT00092547|13196531|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
5363158|NCT00092547|13196532|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
5363159|NCT00092547|13196533|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
5363160|NCT00092547|13196531|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
5363161|NCT00092547|13196532|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
5363162|NCT00092547|13196533|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
5363163|NCT00092547|13196531|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
5363164|NCT00092547|13196532|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
5363165|NCT00092547|13196533|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
5363166|NCT00092547|13196531|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
5363167|NCT00092547|13196532|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
5363168|NCT00092547|13196533|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
5363169|NCT00092547|13196531|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
5363170|NCT00092547|13196532|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
5363171|NCT00092547|13196533|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
5363172|NCT00092547|13196531|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
5363173|NCT00092547|13196532|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
5363174|NCT00092547|13196533|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
5363175|NCT00092547|13196531|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
5363176|NCT00092547|13196532|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
5363177|NCT00092547|13196533|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
5363178|NCT00092547|13196531|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
5363179|NCT00092547|13196532|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
5363180|NCT00092547|13196533|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
5363181|NCT00092547|13196531|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
5363182|NCT00092547|13196532|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
5363183|NCT00092547|13196533|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
5363184|NCT00092547|13196531|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
5363185|NCT00092547|13196532|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
5363186|NCT00092547|13196533|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
5363187|NCT00092547|13196531|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
5363188|NCT00092547|13196532|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
5363256|NCT00092534|13196580|P2|NOT COMPLETED|Base Study EXT||0
5363189|NCT00092547|13196533|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
5363190|NCT00092547|13196531|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
5363191|NCT00092547|13196532|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
5363192|NCT00092547|13196533|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
5363193|NCT00092547|13196531|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
5363194|NCT00092547|13196532|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
5363195|NCT00092547|13196533|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
5363196|NCT00092547|13196531|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
5363197|NCT00092547|13196532|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
5363198|NCT00092547|13196533|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
5363199|NCT00092547|13196531|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
5363200|NCT00092547|13196532|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
5363201|NCT00092547|13196533|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
5363202|NCT00092547|13196531|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
5363203|NCT00092547|13196532|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
5363204|NCT00092547|13196533|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
5363205|NCT00092547|13196531|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
5363206|NCT00092547|13196532|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
5363207|NCT00092547|13196533|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
5363208|NCT00092547|13196531|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
5363209|NCT00092547|13196532|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
5363210|NCT00092547|13196533|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
5363211|NCT00092547|13196531|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
5363212|NCT00092547|13196532|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
5363213|NCT00092547|13196533|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
5363214|NCT00092547|13196531|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
5363215|NCT00092547|13196532|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
5363216|NCT00092547|13196533|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
5363217|NCT00092547|13196531|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
5363218|NCT00092547|13196532|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
5363219|NCT00092547|13196533|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
5363220|NCT00092547|13196531|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
5363221|NCT00092547|13196532|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
5363222|NCT00092547|13196533|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
5363223|NCT00092534|13196577|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363224|NCT00092534|13196578|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
5363225|NCT00092534|13196579|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363226|NCT00092534|13196580|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363227|NCT00092534|13196581|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363228|NCT00092534|13196577|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
5363229|NCT00092534|13196578|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
5363230|NCT00092534|13196579|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363231|NCT00092534|13196580|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363232|NCT00092534|13196581|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
5363233|NCT00092534|13196577|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
5363234|NCT00092534|13196578|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
5363235|NCT00092534|13196579|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
5363236|NCT00092534|13196580|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
5363237|NCT00092534|13196581|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
5363238|NCT00092534|13196577|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
5363239|NCT00092534|13196578|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
5363240|NCT00092534|13196579|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
5363241|NCT00092534|13196580|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
5363242|NCT00092534|13196581|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
5363243|NCT00092534|13196577|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
5363244|NCT00092534|13196578|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
5363245|NCT00092534|13196579|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
5363246|NCT00092534|13196580|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
5363247|NCT00092534|13196581|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
5363248|NCT00092534|13196577|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
5363249|NCT00092534|13196578|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
5363250|NCT00092534|13196579|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
5363251|NCT00092534|13196580|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
5363252|NCT00092534|13196581|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
5363253|NCT00092534|13196577|P5|NOT COMPLETED|Base Study EXT||0
5363254|NCT00092534|13196578|P4|NOT COMPLETED|Base Study EXT||0
5363255|NCT00092534|13196579|P3|NOT COMPLETED|Base Study EXT||145
5363257|NCT00092534|13196581|P1|NOT COMPLETED|Base Study EXT||0
5363258|NCT00092534|13196577|P5|COMPLETED|Base Study EXT||0
5363259|NCT00092534|13196578|P4|COMPLETED|Base Study EXT||0
5363260|NCT00092534|13196579|P3|COMPLETED|Base Study EXT||449
5363261|NCT00092534|13196580|P2|COMPLETED|Base Study EXT||0
5363262|NCT00092534|13196581|P1|COMPLETED|Base Study EXT||0
5363263|NCT00092534|13196577|P5|STARTED|Base Study EXT||0
5363264|NCT00092534|13196578|P4|STARTED|Base Study EXT||0
5363265|NCT00092534|13196579|P3|STARTED|Base Study EXT||594
5363266|NCT00092534|13196580|P2|STARTED|Base Study EXT||0
5363267|NCT00092534|13196581|P1|STARTED|Base Study EXT||0
5363268|NCT00092534|13196577|P5|NOT COMPLETED|Base Study Follow-Up Period||0
5363269|NCT00092534|13196578|P4|NOT COMPLETED|Base Study Follow-Up Period||0
5363270|NCT00092534|13196579|P3|NOT COMPLETED|Base Study Follow-Up Period||0
5363271|NCT00092534|13196580|P2|NOT COMPLETED|Base Study Follow-Up Period||694
5363272|NCT00092534|13196581|P1|NOT COMPLETED|Base Study Follow-Up Period||316
5363273|NCT00092534|13196577|P5|COMPLETED|Base Study Follow-Up Period||0
5363274|NCT00092534|13196578|P4|COMPLETED|Base Study Follow-Up Period||0
5363275|NCT00092534|13196579|P3|COMPLETED|Base Study Follow-Up Period||0
5363276|NCT00092534|13196580|P2|COMPLETED|Base Study Follow-Up Period||5277
5363277|NCT00092534|13196581|P1|COMPLETED|Base Study Follow-Up Period||5626
5363278|NCT00092534|13196577|P5|STARTED|Base Study Follow-Up Period||0
5363279|NCT00092534|13196578|P4|STARTED|Base Study Follow-Up Period||0
5363280|NCT00092534|13196579|P3|STARTED|Base Study Follow-Up Period||0
5363281|NCT00092534|13196580|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
5363282|NCT00092534|13196581|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
5363283|NCT00092534|13196577|P5|NOT COMPLETED|Base Study Vaccination Period||0
5363284|NCT00092534|13196578|P4|NOT COMPLETED|Base Study Vaccination Period||0
5363285|NCT00092534|13196579|P3|NOT COMPLETED|Base Study Vaccination Period||0
5363286|NCT00092534|13196580|P2|NOT COMPLETED|Base Study Vaccination Period||126
5363287|NCT00092534|13196581|P1|NOT COMPLETED|Base Study Vaccination Period||171
5363288|NCT00092534|13196577|P5|COMPLETED|Base Study Vaccination Period||0
5363289|NCT00092534|13196578|P4|COMPLETED|Base Study Vaccination Period||0
5363290|NCT00092534|13196579|P3|COMPLETED|Base Study Vaccination Period||0
5363291|NCT00092534|13196580|P2|COMPLETED|Base Study Vaccination Period||5954
5363292|NCT00092534|13196581|P1|COMPLETED|Base Study Vaccination Period||5916
5363293|NCT00092534|13196577|P5|STARTED|Base Study Vaccination Period||0
5363294|NCT00092534|13196578|P4|STARTED|Base Study Vaccination Period||0
5363295|NCT00092534|13196579|P3|STARTED|Base Study Vaccination Period||0
5363296|NCT00092534|13196580|P2|STARTED|Base Study Vaccination Period||6080
5363297|NCT00092534|13196581|P1|STARTED|Base Study Vaccination Period||6087
5363298|NCT00092521|13196612|P4|NOT COMPLETED|Extension Study (Group 4)||209
5363299|NCT00092521|13196613|P3|NOT COMPLETED|Extension Study (Group 4)||0
5363300|NCT00092521|13196614|P2|NOT COMPLETED|Extension Study (Group 4)||0
5363301|NCT00092521|13196615|P1|NOT COMPLETED|Extension Study (Group 4)||0
5363302|NCT00092521|13196612|P4|COMPLETED|Extension Study (Group 4)||635
5363303|NCT00092521|13196613|P3|COMPLETED|Extension Study (Group 4)||0
5363304|NCT00092521|13196614|P2|COMPLETED|Extension Study (Group 4)||0
5363305|NCT00092521|13196615|P1|COMPLETED|Extension Study (Group 4)||0
5363306|NCT00092521|13196612|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
5363307|NCT00092521|13196613|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
5363308|NCT00092521|13196614|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
5363309|NCT00092521|13196615|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
5363310|NCT00092521|13196612|P4|Initiated Extension Study|Extension Study (Group 4)||829
5363311|NCT00092521|13196613|P3|Initiated Extension Study|Extension Study (Group 4)||0
5363312|NCT00092521|13196614|P2|Initiated Extension Study|Extension Study (Group 4)||0
5363313|NCT00092521|13196615|P1|Initiated Extension Study|Extension Study (Group 4)||0
5363314|NCT00092521|13196612|P4|STARTED|Extension Study (Group 4)||844
5363315|NCT00092521|13196613|P3|STARTED|Extension Study (Group 4)||0
5363316|NCT00092521|13196614|P2|STARTED|Extension Study (Group 4)||0
5363317|NCT00092521|13196615|P1|STARTED|Extension Study (Group 4)||0
5363318|NCT00092521|13196612|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
5363319|NCT00092521|13196613|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
5363320|NCT00092521|13196614|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
5363321|NCT00092521|13196615|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
5363322|NCT00092521|13196612|P4|COMPLETED|Follow-Up (After Month 7)||0
5363323|NCT00092521|13196613|P3|COMPLETED|Follow-Up (After Month 7)||1959
5363324|NCT00092521|13196614|P2|COMPLETED|Follow-Up (After Month 7)||155
5363325|NCT00092521|13196615|P1|COMPLETED|Follow-Up (After Month 7)||2353
5363326|NCT00092521|13196612|P4|STARTED|Follow-Up (After Month 7)||0
5363327|NCT00092521|13196613|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
5363328|NCT00092521|13196614|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
5363329|NCT00092521|13196615|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
5363330|NCT00092521|13196612|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
5363331|NCT00092521|13196613|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
5363332|NCT00092521|13196614|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
5363333|NCT00092521|13196615|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
5363334|NCT00092521|13196612|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
5363335|NCT00092521|13196613|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
5363336|NCT00092521|13196614|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
5363337|NCT00092521|13196615|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
5363338|NCT00092521|13196612|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
5363339|NCT00092521|13196613|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
5363340|NCT00092521|13196614|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
5363341|NCT00092521|13196615|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
5363342|NCT00092495|13196629|P5|NOT COMPLETED|Extension Study||0
5363343|NCT00092495|13196630|P4|NOT COMPLETED|Extension Study||0
5363344|NCT00092495|13196631|P3|NOT COMPLETED|Extension Study||0
5363345|NCT00092495|13196632|P2|NOT COMPLETED|Extension Study||0
5363346|NCT00092495|13196633|P1|NOT COMPLETED|Extension Study||0
5363347|NCT00092495|13196629|P5|COMPLETED|Extension Study||12
5363348|NCT00092495|13196630|P4|COMPLETED|Extension Study||0
5363349|NCT00092495|13196631|P3|COMPLETED|Extension Study||0
5363350|NCT00092495|13196632|P2|COMPLETED|Extension Study||0
5363351|NCT00092495|13196633|P1|COMPLETED|Extension Study||0
5363352|NCT00092495|13196629|P5|STARTED|Extension Study||12
5363353|NCT00092495|13196630|P4|STARTED|Extension Study||0
5363354|NCT00092495|13196631|P3|STARTED|Extension Study||0
5363355|NCT00092495|13196632|P2|STARTED|Extension Study||0
5363356|NCT00092495|13196633|P1|STARTED|Extension Study||0
5363357|NCT00092495|13196629|P5|NOT COMPLETED|Base Study Follow-up Period||0
5363358|NCT00092495|13196630|P4|NOT COMPLETED|Base Study Follow-up Period||14
5363359|NCT00092495|13196631|P3|NOT COMPLETED|Base Study Follow-up Period||4
5363360|NCT00092495|13196632|P2|NOT COMPLETED|Base Study Follow-up Period||3
5363361|NCT00092495|13196633|P1|NOT COMPLETED|Base Study Follow-up Period||3
5363362|NCT00092495|13196629|P5|COMPLETED|Base Study Follow-up Period||0
5363363|NCT00092495|13196630|P4|COMPLETED|Base Study Follow-up Period||446
5363364|NCT00092495|13196631|P3|COMPLETED|Base Study Follow-up Period||126
5363365|NCT00092495|13196632|P2|COMPLETED|Base Study Follow-up Period||122
5363366|NCT00092495|13196633|P1|COMPLETED|Base Study Follow-up Period||112
5363367|NCT00092495|13196629|P5|STARTED|Base Study Follow-up Period||0
5363368|NCT00092495|13196630|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
5363369|NCT00092495|13196631|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
5363370|NCT00092495|13196632|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
5363371|NCT00092495|13196633|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
5363372|NCT00092495|13196629|P5|NOT COMPLETED|Base Study Vaccination Period||0
5363373|NCT00092495|13196630|P4|NOT COMPLETED|Base Study Vaccination Period||88
5363374|NCT00092495|13196631|P3|NOT COMPLETED|Base Study Vaccination Period||34
5363375|NCT00092495|13196632|P2|NOT COMPLETED|Base Study Vaccination Period||22
5363376|NCT00092495|13196633|P1|NOT COMPLETED|Base Study Vaccination Period||37
5363377|NCT00092495|13196629|P5|COMPLETED|Base Study Vaccination Period||0
5363378|NCT00092495|13196630|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
5363379|NCT00092495|13196631|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
5363380|NCT00092495|13196632|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
5363381|NCT00092495|13196633|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
5363382|NCT00092495|13196629|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
5363383|NCT00092495|13196630|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
5363384|NCT00092495|13196631|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
5363385|NCT00092495|13196632|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
5363386|NCT00092495|13196633|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
5363387|NCT00092495|13196629|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
5363388|NCT00092495|13196630|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
5363389|NCT00092495|13196631|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
5363390|NCT00092495|13196632|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
5363391|NCT00092495|13196633|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
5363392|NCT00092495|13196629|P5|STARTED|Base Study Vaccination Period||0
5363393|NCT00092495|13196630|P4|STARTED|Base Study Vaccination Period||1529
5363394|NCT00092495|13196631|P3|STARTED|Base Study Vaccination Period||508
5363395|NCT00092495|13196632|P2|STARTED|Base Study Vaccination Period||514
5363396|NCT00092495|13196633|P1|STARTED|Base Study Vaccination Period||504
5363397|NCT00092456|13196699|P4|NOT COMPLETED|Overall Study||16
5363398|NCT00092456|13196700|P3|NOT COMPLETED|Overall Study||29
5363399|NCT00092456|13196701|P2|NOT COMPLETED|Overall Study||17
5363400|NCT00092456|13196702|P1|NOT COMPLETED|Overall Study||25
5363476|NCT00091832|13196877|P4|NOT COMPLETED|Overall Study||14
5363401|NCT00092456|13196699|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
5363402|NCT00092456|13196700|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
5363403|NCT00092456|13196701|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
5363404|NCT00092456|13196702|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
5363405|NCT00092456|13196699|P4|Vaccinated at Visit 3|Overall Study||98
5363406|NCT00092456|13196700|P3|Vaccinated at Visit 3|Overall Study||200
5363407|NCT00092456|13196701|P2|Vaccinated at Visit 3|Overall Study||210
5363408|NCT00092456|13196702|P1|Vaccinated at Visit 3|Overall Study||202
5363409|NCT00092456|13196699|P4|Vaccinated at Visit 2|Overall Study||104
5363410|NCT00092456|13196700|P3|Vaccinated at Visit 2|Overall Study||210
5363411|NCT00092456|13196701|P2|Vaccinated at Visit 2|Overall Study||217
5363412|NCT00092456|13196702|P1|Vaccinated at Visit 2|Overall Study||208
5363413|NCT00092456|13196699|P4|Vaccinated at Visit 1|Overall Study||113
5363414|NCT00092456|13196700|P3|Vaccinated at Visit 1|Overall Study||229
5363415|NCT00092456|13196701|P2|Vaccinated at Visit 1|Overall Study||225
5363416|NCT00092456|13196702|P1|Vaccinated at Visit 1|Overall Study||226
5363417|NCT00092456|13196699|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
5363418|NCT00092456|13196700|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
5363419|NCT00092456|13196701|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
5363420|NCT00092456|13196702|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
5363421|NCT00092443|13196750|P2|NOT COMPLETED|Overall Study||54
5363422|NCT00092443|13196751|P1|NOT COMPLETED|Overall Study||58
5363423|NCT00092443|13196750|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
5363424|NCT00092443|13196751|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
5363425|NCT00092443|13196750|P2|Vaccinated at Visit 3|Overall Study||608
5363426|NCT00092443|13196751|P1|Vaccinated at Visit 3|Overall Study||593
5363427|NCT00092443|13196750|P2|Vaccinated at Visit 2|Overall Study||627
5363428|NCT00092443|13196751|P1|Vaccinated at Visit 2|Overall Study||618
5363429|NCT00092443|13196750|P2|Vaccinated at Visit 1|Overall Study||660
5363430|NCT00092443|13196751|P1|Vaccinated at Visit 1|Overall Study||650
5363431|NCT00092443|13196750|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
5363432|NCT00092443|13196751|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
5363433|NCT00092417|13196769|P2|NOT COMPLETED|Overall Study||1
5363434|NCT00092417|13196770|P1|NOT COMPLETED|Overall Study||5
5363435|NCT00092417|13196769|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
5363436|NCT00092417|13196770|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
5363437|NCT00092417|13196769|P2|Vaccinated|Overall Study||234
5363438|NCT00092417|13196770|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
5363439|NCT00092417|13196769|P2|STARTED|Overall Study|Started Period Group 2|234
5363440|NCT00092417|13196770|P1|STARTED|Overall Study|Started Period Group 1|464
5363441|NCT00092131|13196784|P2|NOT COMPLETED|Treatment Period II||1
5363442|NCT00092131|13196785|P1|NOT COMPLETED|Treatment Period II||0
5363443|NCT00092131|13196784|P2|COMPLETED|Treatment Period II||25
5363444|NCT00092131|13196785|P1|COMPLETED|Treatment Period II||24
5363445|NCT00092131|13196784|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
5363446|NCT00092131|13196785|P1|STARTED|Treatment Period II||24
5363447|NCT00092131|13196784|P2|NOT COMPLETED|Treatment Period I||0
5363448|NCT00092131|13196785|P1|NOT COMPLETED|Treatment Period I||1
5363449|NCT00092131|13196784|P2|COMPLETED|Treatment Period I||26
5363450|NCT00092131|13196785|P1|COMPLETED|Treatment Period I||24
5363451|NCT00092131|13196784|P2|STARTED|Treatment Period I||26
5363452|NCT00092131|13196785|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
5363453|NCT00092118|13196815|P2|NOT COMPLETED|Overall Study||89
5363454|NCT00092118|13196816|P1|NOT COMPLETED|Overall Study||84
5363455|NCT00092118|13196815|P2|COMPLETED|Overall Study||913
5363456|NCT00092118|13196816|P1|COMPLETED|Overall Study||906
5363457|NCT00092118|13196815|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
5363458|NCT00092118|13196816|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
5363459|NCT00091962|13196829|P3|NOT COMPLETED|Overall Study||0
5363460|NCT00091962|13196830|P2|NOT COMPLETED|Overall Study||0
5363461|NCT00091962|13196831|P1|NOT COMPLETED|Overall Study||0
5363462|NCT00091962|13196829|P3|COMPLETED|Overall Study||151
5363463|NCT00091962|13196830|P2|COMPLETED|Overall Study||152
5363464|NCT00091962|13196831|P1|COMPLETED|Overall Study||150
5363465|NCT00091962|13196829|P3|STARTED|Overall Study||151
5363466|NCT00091962|13196830|P2|STARTED|Overall Study||152
5363467|NCT00091962|13196831|P1|STARTED|Overall Study||150
5363468|NCT00091949|13196850|P2|NOT COMPLETED|Overall Study||151
5363469|NCT00091949|13196851|P1|NOT COMPLETED|Overall Study||175
5363470|NCT00091949|13196850|P2|COMPLETED|Overall Study||1786
5363471|NCT00091949|13196851|P1|COMPLETED|Overall Study||1764
5363472|NCT00091949|13196850|P2|STARTED|Overall Study||1937
5363473|NCT00091949|13196851|P1|STARTED|Overall Study||1939
5363474|NCT00091832|13196875|P6|NOT COMPLETED|Overall Study||11
5363475|NCT00091832|13196876|P5|NOT COMPLETED|Overall Study||15
5363477|NCT00091832|13196878|P3|NOT COMPLETED|Overall Study||12
5363478|NCT00091832|13196879|P2|NOT COMPLETED|Overall Study||11
5363479|NCT00091832|13196880|P1|NOT COMPLETED|Overall Study||14
5363480|NCT00091832|13196875|P6|COMPLETED|Overall Study||32
5363481|NCT00091832|13196876|P5|COMPLETED|Overall Study||27
5363482|NCT00091832|13196877|P4|COMPLETED|Overall Study||29
5363483|NCT00091832|13196878|P3|COMPLETED|Overall Study||30
5363484|NCT00091832|13196879|P2|COMPLETED|Overall Study||31
5363485|NCT00091832|13196880|P1|COMPLETED|Overall Study||29
5363486|NCT00091832|13196875|P6|Received Study Medication|Overall Study||43
5363487|NCT00091832|13196876|P5|Received Study Medication|Overall Study||42
5363488|NCT00091832|13196877|P4|Received Study Medication|Overall Study||43
5363489|NCT00091832|13196878|P3|Received Study Medication|Overall Study||41
5363490|NCT00091832|13196879|P2|Received Study Medication|Overall Study||42
5363491|NCT00091832|13196880|P1|Received Study Medication|Overall Study||43
5363492|NCT00091832|13196875|P6|STARTED|Overall Study||43
5363493|NCT00091832|13196876|P5|STARTED|Overall Study||42
5363494|NCT00091832|13196877|P4|STARTED|Overall Study||43
5363495|NCT00091832|13196878|P3|STARTED|Overall Study||42
5363496|NCT00091832|13196879|P2|STARTED|Overall Study||42
5363497|NCT00091832|13196880|P1|STARTED|Overall Study||43
5363498|NCT00091819|13196998|P2|NOT COMPLETED|Overall Study||46
5363499|NCT00091819|13196999|P1|NOT COMPLETED|Overall Study||42
5363500|NCT00091819|13196998|P2|COMPLETED|Overall Study||387
5363501|NCT00091819|13196999|P1|COMPLETED|Overall Study||387
5363502|NCT00091819|13196998|P2|STARTED|Overall Study||433
5363503|NCT00091819|13196999|P1|STARTED|Overall Study||429
5363504|NCT00091793|13197007|P2|NOT COMPLETED|Overall Study||22
5363505|NCT00091793|13197008|P1|NOT COMPLETED|Overall Study||24
5363506|NCT00091793|13197007|P2|COMPLETED|Overall Study||144
5363507|NCT00091793|13197008|P1|COMPLETED|Overall Study||142
5363508|NCT00091793|13197007|P2|STARTED|Overall Study||166
5363509|NCT00091793|13197008|P1|STARTED|Overall Study||166
5363510|NCT00091572|13197032|P2|NOT COMPLETED|Overall Study||82
5363511|NCT00091572|13197033|P1|NOT COMPLETED|Overall Study||95
5363512|NCT00091572|13197032|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
5363513|NCT00091572|13197033|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
5363514|NCT00091572|13197032|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
5363515|NCT00091572|13197033|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
5363516|NCT00091507|13197047|P2|NOT COMPLETED|Overall Study||19
5363517|NCT00091507|13197048|P1|NOT COMPLETED|Overall Study||21
5363518|NCT00091507|13197047|P2|COMPLETED|Overall Study||460
5363519|NCT00091507|13197048|P1|COMPLETED|Overall Study||411
5363520|NCT00091507|13197047|P2|STARTED|Overall Study||479
5363521|NCT00091507|13197048|P1|STARTED|Overall Study||432
5363522|NCT00091442|13197064|P2|NOT COMPLETED|Overall Study||373
5363523|NCT00091442|13197065|P1|NOT COMPLETED|Overall Study||369
5363524|NCT00091442|13197064|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
5363525|NCT00091442|13197065|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
5363526|NCT00091442|13197064|P2|STARTED|Overall Study||378
5363527|NCT00091442|13197065|P1|STARTED|Overall Study||373
5363528|NCT00091390|13197075|P1|NOT COMPLETED|Overall Study||4
5363529|NCT00091390|13197075|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
5363530|NCT00091390|13197075|P1|STARTED|Overall Study||129
5363531|NCT00091273|13197079|P1|NOT COMPLETED|Overall Study||0
5363532|NCT00091273|13197079|P1|COMPLETED|Overall Study||9
5363533|NCT00091273|13197079|P1|STARTED|Overall Study||9
5363534|NCT00091260|13197085|P1|NOT COMPLETED|Overall Study||0
5363535|NCT00091260|13197085|P1|COMPLETED|Overall Study||82
5363536|NCT00091260|13197085|P1|STARTED|Overall Study||82
5363537|NCT00091169|13197093|P2|NOT COMPLETED|Overall Study||53
5363538|NCT00091169|13197094|P1|NOT COMPLETED|Overall Study||57
5363539|NCT00091169|13197093|P2|COMPLETED|Overall Study||134
5363540|NCT00091169|13197094|P1|COMPLETED|Overall Study||132
5363541|NCT00091169|13197093|P2|Treated|Overall Study||170
5363542|NCT00091169|13197094|P1|Treated|Overall Study||163
5363543|NCT00091169|13197093|P2|STARTED|Overall Study||187
5363544|NCT00091169|13197094|P1|STARTED|Overall Study||189
5363545|NCT00091026|13197112|P2|NOT COMPLETED|Overall Study||3
5363546|NCT00091026|13197113|P1|NOT COMPLETED|Overall Study||1
5363547|NCT00091026|13197112|P2|COMPLETED|Overall Study||68
5363548|NCT00091026|13197113|P1|COMPLETED|Overall Study||71
5363549|NCT00091026|13197112|P2|STARTED|Overall Study||71
5363550|NCT00091026|13197113|P1|STARTED|Overall Study||72
5363551|NCT00090987|13197123|P1|NOT COMPLETED|Overall Study||21
5363552|NCT00090987|13197123|P1|COMPLETED|Overall Study||9
5363553|NCT00090987|13197123|P1|STARTED|Overall Study||30
5363554|NCT00090870|13197127|P1|NOT COMPLETED|Overall Study||0
5363555|NCT00090870|13197127|P1|COMPLETED|Overall Study||10
5363556|NCT00090870|13197127|P1|STARTED|Overall Study||10
5363557|NCT00090857|13197136|P2|NOT COMPLETED|Overall Study||3
5363558|NCT00090857|13197137|P1|NOT COMPLETED|Overall Study||4
5363559|NCT00090857|13197136|P2|COMPLETED|Overall Study||13
5363560|NCT00090857|13197137|P1|COMPLETED|Overall Study||29
5363561|NCT00090857|13197136|P2|STARTED|Overall Study||16
5363562|NCT00090857|13197137|P1|STARTED|Overall Study||33
5363563|NCT00090844|13197167|P2|NOT COMPLETED|Overall Study||1
5363564|NCT00090844|13197168|P1|NOT COMPLETED|Overall Study||1
5363565|NCT00090844|13197167|P2|COMPLETED|Overall Study||21
5363566|NCT00090844|13197168|P1|COMPLETED|Overall Study||26
5363567|NCT00090844|13197167|P2|STARTED|Overall Study||22
5363568|NCT00090844|13197168|P1|STARTED|Overall Study||27
5363569|NCT00090779|13197176|P2|NOT COMPLETED|Step 3||5
5363570|NCT00090779|13197177|P1|NOT COMPLETED|Step 3||7
5363571|NCT00090779|13197176|P2|COMPLETED|Step 3||0
5363572|NCT00090779|13197177|P1|COMPLETED|Step 3||0
5363573|NCT00090779|13197176|P2|STARTED|Step 3||5
5363574|NCT00090779|13197177|P1|STARTED|Step 3||7
5363575|NCT00090779|13197176|P2|NOT COMPLETED|Step 2||18
5363576|NCT00090779|13197177|P1|NOT COMPLETED|Step 2||6
5363577|NCT00090779|13197176|P2|COMPLETED|Step 2||1
5363578|NCT00090779|13197177|P1|COMPLETED|Step 2||0
5363579|NCT00090779|13197176|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
5363580|NCT00090779|13197177|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
5363581|NCT00090779|13197176|P2|NOT COMPLETED|Step 1||15
5363582|NCT00090779|13197177|P1|NOT COMPLETED|Step 1||11
5363583|NCT00090779|13197176|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
5363584|NCT00090779|13197177|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
5363585|NCT00090779|13197176|P2|STARTED|Step 1||64
5363586|NCT00090779|13197177|P1|STARTED|Step 1||66
5363587|NCT00090766|13197201|P3|NOT COMPLETED|Overall Study||3
5363588|NCT00090766|13197202|P2|NOT COMPLETED|Overall Study||2
5363589|NCT00090766|13197203|P1|NOT COMPLETED|Overall Study||3
5363590|NCT00090766|13197201|P3|COMPLETED|Overall Study||22
5363591|NCT00090766|13197202|P2|COMPLETED|Overall Study||19
5363592|NCT00090766|13197203|P1|COMPLETED|Overall Study||14
5363593|NCT00090766|13197201|P3|STARTED|Overall Study||25
5363594|NCT00090766|13197202|P2|STARTED|Overall Study||21
5363595|NCT00090766|13197203|P1|STARTED|Overall Study||17
5363596|NCT00090753|13197245|P2|NOT COMPLETED|Extended Treatment Period||191
5363597|NCT00090753|13197246|P1|NOT COMPLETED|Extended Treatment Period||359
5363598|NCT00090753|13197245|P2|COMPLETED|Extended Treatment Period||59
5363599|NCT00090753|13197246|P1|COMPLETED|Extended Treatment Period||94
5363600|NCT00090753|13197245|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
5363601|NCT00090753|13197246|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
5363602|NCT00090753|13197245|P2|NOT COMPLETED|First Treatment Period||178
5363603|NCT00090753|13197246|P1|NOT COMPLETED|First Treatment Period||256
5363604|NCT00090753|13197245|P2|COMPLETED|First Treatment Period||302
5363605|NCT00090753|13197246|P1|COMPLETED|First Treatment Period||492
5363606|NCT00090753|13197245|P2|STARTED|First Treatment Period||480
5363607|NCT00090753|13197246|P1|STARTED|First Treatment Period||748
5363608|NCT00090610|13197256|P2|NOT COMPLETED|Overall Study||1
5363609|NCT00090610|13197257|P1|NOT COMPLETED|Overall Study||1
5363610|NCT00090610|13197256|P2|COMPLETED|Overall Study||74
5363611|NCT00090610|13197257|P1|COMPLETED|Overall Study||74
5363612|NCT00090610|13197256|P2|STARTED|Overall Study||75
5363613|NCT00090610|13197257|P1|STARTED|Overall Study||75
5363614|NCT00090584|13197273|P2|NOT COMPLETED|Baseline to 8 Months||41
5363615|NCT00090584|13197274|P1|NOT COMPLETED|Baseline to 8 Months||44
5363616|NCT00090584|13197273|P2|COMPLETED|Baseline to 8 Months||112
5363617|NCT00090584|13197274|P1|COMPLETED|Baseline to 8 Months||110
5363618|NCT00090584|13197273|P2|STARTED|Baseline to 8 Months||153
5363619|NCT00090584|13197274|P1|STARTED|Baseline to 8 Months||154
5363620|NCT00090584|13197273|P2|NOT COMPLETED|Baseline to 10 Weeks||12
5363621|NCT00090584|13197274|P1|NOT COMPLETED|Baseline to 10 Weeks||15
5363622|NCT00090584|13197273|P2|COMPLETED|Baseline to 10 Weeks||141
5363623|NCT00090584|13197274|P1|COMPLETED|Baseline to 10 Weeks||139
5363624|NCT00090584|13197273|P2|STARTED|Baseline to 10 Weeks||153
5363625|NCT00090584|13197274|P1|STARTED|Baseline to 10 Weeks||154
5363626|NCT00090519|13197306|P2|NOT COMPLETED|Overall Study||75
5363627|NCT00090519|13197307|P1|NOT COMPLETED|Overall Study||73
5363628|NCT00090519|13197306|P2|COMPLETED|Overall Study||285
5363629|NCT00090519|13197307|P1|COMPLETED|Overall Study||298
5363630|NCT00090519|13197306|P2|STARTED|Overall Study||360
5363631|NCT00090519|13197307|P1|STARTED|Overall Study||371
5363632|NCT00090493|13197331|P1|NOT COMPLETED|Overall Study||2
5363633|NCT00090493|13197331|P1|COMPLETED|Overall Study||2
5363634|NCT00090493|13197331|P1|STARTED|Overall Study||4
5363635|NCT00090363|13197338|P3|NOT COMPLETED|Overall Study||96
5363636|NCT00090363|13197339|P2|NOT COMPLETED|Overall Study||107
5363637|NCT00090363|13197340|P1|NOT COMPLETED|Overall Study||106
5363638|NCT00090363|13197338|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
5363639|NCT00090363|13197339|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
5363640|NCT00090363|13197340|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
5363641|NCT00090363|13197338|P3|Received Study Treatment.|Overall Study||98
5363642|NCT00090363|13197339|P2|Received Study Treatment.|Overall Study||107
5363643|NCT00090363|13197340|P1|Received Study Treatment.|Overall Study||107
5363644|NCT00090363|13197338|P3|STARTED|Overall Study||98
5363645|NCT00090363|13197339|P2|STARTED|Overall Study||107
5363646|NCT00090363|13197340|P1|STARTED|Overall Study||107
5363647|NCT00090545|13197362|P2|NOT COMPLETED|Overall Study||24
5363648|NCT00090545|13197363|P1|NOT COMPLETED|Overall Study||22
5363649|NCT00090545|13197362|P2|COMPLETED|Overall Study||0
5363650|NCT00090545|13197363|P1|COMPLETED|Overall Study||0
5363651|NCT00090545|13197362|P2|STARTED|Overall Study||24
5363652|NCT00090545|13197363|P1|STARTED|Overall Study||22
5363653|NCT00090285|13197383|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
5363654|NCT00090285|13197384|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
5363655|NCT00090285|13197385|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363656|NCT00090285|13197386|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363657|NCT00090285|13197387|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363658|NCT00090285|13197388|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363659|NCT00090285|13197383|P6|COMPLETED|Long-term Follow-up (EXT2)||664
5363660|NCT00090285|13197384|P5|COMPLETED|Long-term Follow-up (EXT2)||709
5363661|NCT00090285|13197385|P4|COMPLETED|Long-term Follow-up (EXT2)||0
5363662|NCT00090285|13197386|P3|COMPLETED|Long-term Follow-up (EXT2)||0
5363663|NCT00090285|13197387|P2|COMPLETED|Long-term Follow-up (EXT2)||0
5363664|NCT00090285|13197388|P1|COMPLETED|Long-term Follow-up (EXT2)||0
5363665|NCT00090285|13197383|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
5363666|NCT00090285|13197384|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
5363667|NCT00090285|13197385|P4|STARTED|Long-term Follow-up (EXT2)||0
5363668|NCT00090285|13197386|P3|STARTED|Long-term Follow-up (EXT2)||0
5363669|NCT00090285|13197387|P2|STARTED|Long-term Follow-up (EXT2)||0
5363670|NCT00090285|13197388|P1|STARTED|Long-term Follow-up (EXT2)||0
5363671|NCT00090285|13197383|P6|NOT COMPLETED|Extension 1||0
5363672|NCT00090285|13197384|P5|NOT COMPLETED|Extension 1||0
5363673|NCT00090285|13197385|P4|NOT COMPLETED|Extension 1||1
5363674|NCT00090285|13197386|P3|NOT COMPLETED|Extension 1||57
5363675|NCT00090285|13197387|P2|NOT COMPLETED|Extension 1||0
5363676|NCT00090285|13197388|P1|NOT COMPLETED|Extension 1||0
5363677|NCT00090285|13197383|P6|COMPLETED|Extension 1||0
5363678|NCT00090285|13197384|P5|COMPLETED|Extension 1||0
5363679|NCT00090285|13197385|P4|COMPLETED|Extension 1||15
5363680|NCT00090285|13197386|P3|COMPLETED|Extension 1||1041
5363681|NCT00090285|13197387|P2|COMPLETED|Extension 1||0
5363682|NCT00090285|13197388|P1|COMPLETED|Extension 1||0
5363683|NCT00090285|13197383|P6|STARTED|Extension 1||0
5363684|NCT00090285|13197384|P5|STARTED|Extension 1||0
5363685|NCT00090285|13197385|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
5363686|NCT00090285|13197386|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
5363687|NCT00090285|13197387|P2|STARTED|Extension 1||0
5363688|NCT00090285|13197388|P1|STARTED|Extension 1||0
5363689|NCT00090285|13197383|P6|NOT COMPLETED|Base Study Follow-up Period||0
5363690|NCT00090285|13197384|P5|NOT COMPLETED|Base Study Follow-up Period||0
5363691|NCT00090285|13197385|P4|NOT COMPLETED|Base Study Follow-up Period||0
5363692|NCT00090285|13197386|P3|NOT COMPLETED|Base Study Follow-up Period||0
5363693|NCT00090285|13197387|P2|NOT COMPLETED|Base Study Follow-up Period||342
5363694|NCT00090285|13197388|P1|NOT COMPLETED|Base Study Follow-up Period||335
5363695|NCT00090285|13197383|P6|COMPLETED|Base Study Follow-up Period||0
5363696|NCT00090285|13197384|P5|COMPLETED|Base Study Follow-up Period||0
5363697|NCT00090285|13197385|P4|COMPLETED|Base Study Follow-up Period||0
5363698|NCT00090285|13197386|P3|COMPLETED|Base Study Follow-up Period||0
5363699|NCT00090285|13197387|P2|COMPLETED|Base Study Follow-up Period||1479
5363700|NCT00090285|13197388|P1|COMPLETED|Base Study Follow-up Period||1487
5363701|NCT00090285|13197383|P6|STARTED|Base Study Follow-up Period||0
5363702|NCT00090285|13197384|P5|STARTED|Base Study Follow-up Period||0
5363703|NCT00090285|13197385|P4|STARTED|Base Study Follow-up Period||0
5363704|NCT00090285|13197386|P3|STARTED|Base Study Follow-up Period||0
5363705|NCT00090285|13197387|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
5363706|NCT00090285|13197388|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
5363707|NCT00090285|13197383|P6|NOT COMPLETED|Base Study Vaccination Period||0
5363708|NCT00090285|13197384|P5|NOT COMPLETED|Base Study Vaccination Period||0
5363709|NCT00090285|13197385|P4|NOT COMPLETED|Base Study Vaccination Period||0
5363710|NCT00090285|13197386|P3|NOT COMPLETED|Base Study Vaccination Period||0
5363711|NCT00090285|13197387|P2|NOT COMPLETED|Base Study Vaccination Period||219
5363712|NCT00090285|13197388|P1|NOT COMPLETED|Base Study Vaccination Period||214
5363713|NCT00090285|13197383|P6|COMPLETED|Base Study Vaccination Period||0
5363714|NCT00090285|13197384|P5|COMPLETED|Base Study Vaccination Period||0
5363715|NCT00090285|13197385|P4|COMPLETED|Base Study Vaccination Period||0
5363716|NCT00090285|13197386|P3|COMPLETED|Base Study Vaccination Period||0
5363717|NCT00090285|13197387|P2|COMPLETED|Base Study Vaccination Period||1814
5363718|NCT00090285|13197388|P1|COMPLETED|Base Study Vaccination Period||1818
5363719|NCT00090285|13197383|P6|Vaccinated|Base Study Vaccination Period||0
5363720|NCT00090285|13197384|P5|Vaccinated|Base Study Vaccination Period||0
5363721|NCT00090285|13197385|P4|Vaccinated|Base Study Vaccination Period||0
5363722|NCT00090285|13197386|P3|Vaccinated|Base Study Vaccination Period||0
5363723|NCT00090285|13197387|P2|Vaccinated|Base Study Vaccination Period||2030
5363724|NCT00090285|13197388|P1|Vaccinated|Base Study Vaccination Period||2025
5363725|NCT00090285|13197383|P6|STARTED|Base Study Vaccination Period||0
5363726|NCT00090285|13197384|P5|STARTED|Base Study Vaccination Period||0
5363727|NCT00090285|13197385|P4|STARTED|Base Study Vaccination Period||0
5363728|NCT00090285|13197386|P3|STARTED|Base Study Vaccination Period||0
5363729|NCT00090285|13197387|P2|STARTED|Base Study Vaccination Period||2033
5363730|NCT00090285|13197388|P1|STARTED|Base Study Vaccination Period||2032
5363731|NCT00090259|13197425|P2|NOT COMPLETED|Overall Study||48
5363732|NCT00090259|13197426|P1|NOT COMPLETED|Overall Study||62
5363733|NCT00090259|13197425|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
5363734|NCT00090259|13197426|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
5363735|NCT00090259|13197425|P2|STARTED|Overall Study||1921
5363736|NCT00090259|13197426|P1|STARTED|Overall Study||1913
5363737|NCT00090233|13197442|P2|NOT COMPLETED|Overall Study||5065
5363738|NCT00090233|13197443|P1|NOT COMPLETED|Overall Study||4999
5363739|NCT00090233|13197442|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
5363740|NCT00090233|13197443|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
5363741|NCT00090233|13197442|P2|Vaccinated at Visit 3|Overall Study||29598
5363742|NCT00090233|13197443|P1|Vaccinated at Visit 3|Overall Study||29667
5363743|NCT00090233|13197442|P2|Vaccinated at Visit 2|Overall Study||31066
5363744|NCT00090233|13197443|P1|Vaccinated at Visit 2|Overall Study||31052
5363745|NCT00090233|13197442|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
5363746|NCT00090233|13197443|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
5363747|NCT00090233|13197442|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
5363748|NCT00090233|13197443|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
5363749|NCT00090220|13197467|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
5363750|NCT00090220|13197468|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
5363751|NCT00090220|13197469|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363752|NCT00090220|13197470|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363753|NCT00090220|13197471|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363754|NCT00090220|13197472|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
5363755|NCT00090220|13197467|P6|COMPLETED|Long-term Follow-up (EXT2)||623
5363756|NCT00090220|13197468|P5|COMPLETED|Long-term Follow-up (EXT2)||641
5363757|NCT00090220|13197469|P4|COMPLETED|Long-term Follow-up (EXT2)||0
5363758|NCT00090220|13197470|P3|COMPLETED|Long-term Follow-up (EXT2)||0
5363759|NCT00090220|13197471|P2|COMPLETED|Long-term Follow-up (EXT2)||0
5363760|NCT00090220|13197472|P1|COMPLETED|Long-term Follow-up (EXT2)||0
5363761|NCT00090220|13197467|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
5363762|NCT00090220|13197468|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
5363763|NCT00090220|13197469|P4|STARTED|Long-term Follow-up (EXT2)||0
5363764|NCT00090220|13197470|P3|STARTED|Long-term Follow-up (EXT2)||0
5363765|NCT00090220|13197471|P2|STARTED|Long-term Follow-up (EXT2)||0
5363766|NCT00090220|13197472|P1|STARTED|Long-term Follow-up (EXT2)||0
5363767|NCT00090220|13197467|P6|NOT COMPLETED|Extension 1 (EXT1)||0
5363768|NCT00090220|13197468|P5|NOT COMPLETED|Extension 1 (EXT1)||0
5363769|NCT00090220|13197469|P4|NOT COMPLETED|Extension 1 (EXT1)||2
5363770|NCT00090220|13197470|P3|NOT COMPLETED|Extension 1 (EXT1)||55
5363771|NCT00090220|13197471|P2|NOT COMPLETED|Extension 1 (EXT1)||0
5363772|NCT00090220|13197472|P1|NOT COMPLETED|Extension 1 (EXT1)||0
5363773|NCT00090220|13197467|P6|COMPLETED|Extension 1 (EXT1)||0
5363774|NCT00090220|13197468|P5|COMPLETED|Extension 1 (EXT1)||0
5363775|NCT00090220|13197469|P4|COMPLETED|Extension 1 (EXT1)||5
5363776|NCT00090220|13197470|P3|COMPLETED|Extension 1 (EXT1)||1267
5363777|NCT00090220|13197471|P2|COMPLETED|Extension 1 (EXT1)||0
5363778|NCT00090220|13197472|P1|COMPLETED|Extension 1 (EXT1)||0
5363779|NCT00090220|13197467|P6|Vaccinated|Extension 1 (EXT1)||0
5363780|NCT00090220|13197468|P5|Vaccinated|Extension 1 (EXT1)||0
5363781|NCT00090220|13197469|P4|Vaccinated|Extension 1 (EXT1)||7
5363782|NCT00090220|13197470|P3|Vaccinated|Extension 1 (EXT1)||1321
5363783|NCT00090220|13197471|P2|Vaccinated|Extension 1 (EXT1)||0
5363784|NCT00090220|13197472|P1|Vaccinated|Extension 1 (EXT1)||0
5363785|NCT00090220|13197467|P6|STARTED|Extension 1 (EXT1)||0
5363786|NCT00090220|13197468|P5|STARTED|Extension 1 (EXT1)||0
5363787|NCT00090220|13197469|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
5363788|NCT00090220|13197470|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
5363789|NCT00090220|13197471|P2|STARTED|Extension 1 (EXT1)||0
5363790|NCT00090220|13197472|P1|STARTED|Extension 1 (EXT1)||0
5363791|NCT00090220|13197467|P6|NOT COMPLETED|Base Study Follow-up Period||0
5363792|NCT00090220|13197468|P5|NOT COMPLETED|Base Study Follow-up Period||0
5363793|NCT00090220|13197469|P4|NOT COMPLETED|Base Study Follow-up Period||0
5363794|NCT00090220|13197470|P3|NOT COMPLETED|Base Study Follow-up Period||0
5363795|NCT00090220|13197471|P2|NOT COMPLETED|Base Study Follow-up Period||164
5363796|NCT00090220|13197472|P1|NOT COMPLETED|Base Study Follow-up Period||160
5363797|NCT00090220|13197467|P6|COMPLETED|Base Study Follow-up Period||0
5363798|NCT00090220|13197468|P5|COMPLETED|Base Study Follow-up Period||0
5363799|NCT00090220|13197469|P4|COMPLETED|Base Study Follow-up Period||0
5363800|NCT00090220|13197470|P3|COMPLETED|Base Study Follow-up Period||0
5363801|NCT00090220|13197471|P2|COMPLETED|Base Study Follow-up Period||1687
5363802|NCT00090220|13197472|P1|COMPLETED|Base Study Follow-up Period||1695
5363803|NCT00090220|13197467|P6|STARTED|Base Study Follow-up Period||0
5363804|NCT00090220|13197468|P5|STARTED|Base Study Follow-up Period||0
5363805|NCT00090220|13197469|P4|STARTED|Base Study Follow-up Period||0
5363806|NCT00090220|13197470|P3|STARTED|Base Study Follow-up Period||0
5363807|NCT00090220|13197471|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
5363808|NCT00090220|13197472|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
5363809|NCT00090220|13197467|P6|NOT COMPLETED|Base Study Vaccination Period||0
5363810|NCT00090220|13197468|P5|NOT COMPLETED|Base Study Vaccination Period||0
5363811|NCT00090220|13197469|P4|NOT COMPLETED|Base Study Vaccination Period||0
5363812|NCT00090220|13197470|P3|NOT COMPLETED|Base Study Vaccination Period||0
5363813|NCT00090220|13197471|P2|NOT COMPLETED|Base Study Vaccination Period||63
5363814|NCT00090220|13197472|P1|NOT COMPLETED|Base Study Vaccination Period||64
5363815|NCT00090220|13197467|P6|COMPLETED|Base Study Vaccination Period||0
5363816|NCT00090220|13197468|P5|COMPLETED|Base Study Vaccination Period||0
5363817|NCT00090220|13197469|P4|COMPLETED|Base Study Vaccination Period||0
5363818|NCT00090220|13197470|P3|COMPLETED|Base Study Vaccination Period||0
5363819|NCT00090220|13197471|P2|COMPLETED|Base Study Vaccination Period||1845
5363820|NCT00090220|13197472|P1|COMPLETED|Base Study Vaccination Period||1847
5363821|NCT00090220|13197467|P6|Vaccinated|Base Study Vaccination Period||0
5363822|NCT00090220|13197468|P5|Vaccinated|Base Study Vaccination Period||0
5363823|NCT00090220|13197469|P4|Vaccinated|Base Study Vaccination Period||0
5363824|NCT00090220|13197470|P3|Vaccinated|Base Study Vaccination Period||0
5363825|NCT00090220|13197471|P2|Vaccinated|Base Study Vaccination Period||1907
5363826|NCT00090220|13197472|P1|Vaccinated|Base Study Vaccination Period||1910
5363827|NCT00090220|13197467|P6|STARTED|Base Study Vaccination Period||0
5363828|NCT00090220|13197468|P5|STARTED|Base Study Vaccination Period||0
5363829|NCT00090220|13197469|P4|STARTED|Base Study Vaccination Period||0
5363830|NCT00090220|13197470|P3|STARTED|Base Study Vaccination Period||0
5363831|NCT00090220|13197471|P2|STARTED|Base Study Vaccination Period||1908
5363832|NCT00090220|13197472|P1|STARTED|Base Study Vaccination Period||1911
5363833|NCT00090402|13197567|P3|NOT COMPLETED|Overall Study||1
5363834|NCT00090402|13197568|P2|NOT COMPLETED|Overall Study||2
5363835|NCT00090402|13197569|P1|NOT COMPLETED|Overall Study||2
5363836|NCT00090402|13197567|P3|COMPLETED|Overall Study||12
5363837|NCT00090402|13197568|P2|COMPLETED|Overall Study||11
5363838|NCT00090402|13197569|P1|COMPLETED|Overall Study||11
5363839|NCT00090402|13197567|P3|STARTED|Overall Study||13
5363840|NCT00090402|13197568|P2|STARTED|Overall Study||13
5363841|NCT00090402|13197569|P1|STARTED|Overall Study||13
5363842|NCT00090142|13197583|P2|NOT COMPLETED|Treatment Period II||0
5363843|NCT00090142|13197584|P1|NOT COMPLETED|Treatment Period II||1
5363844|NCT00090142|13197583|P2|COMPLETED|Treatment Period II||28
5363845|NCT00090142|13197584|P1|COMPLETED|Treatment Period II||25
5363846|NCT00090142|13197583|P2|STARTED|Treatment Period II||28
5363847|NCT00090142|13197584|P1|STARTED|Treatment Period II||26
5363848|NCT00090142|13197583|P2|NOT COMPLETED|Treatment Period I||3
5363849|NCT00090142|13197584|P1|NOT COMPLETED|Treatment Period I||5
5363850|NCT00090142|13197583|P2|COMPLETED|Treatment Period I||28
5363851|NCT00090142|13197584|P1|COMPLETED|Treatment Period I||26
5363852|NCT00090142|13197583|P2|STARTED|Treatment Period I||31
5363853|NCT00090142|13197584|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
5363854|NCT00090103|13197615|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
5363855|NCT00090103|13197616|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
5363856|NCT00090103|13197617|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
5363857|NCT00090103|13197615|P3|COMPLETED|16-Week Safety Follow-up Period||1143
5363858|NCT00090103|13197616|P2|COMPLETED|16-Week Safety Follow-up Period||1205
5363859|NCT00090103|13197617|P1|COMPLETED|16-Week Safety Follow-up Period||1224
5363860|NCT00090103|13197615|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
5363861|NCT00090103|13197616|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
5363862|NCT00090103|13197617|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
5363863|NCT00090103|13197615|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
5363864|NCT00090103|13197616|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
5363865|NCT00090103|13197617|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
5363866|NCT00090103|13197615|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
5363867|NCT00090103|13197616|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
5363868|NCT00090103|13197617|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
5363869|NCT00090103|13197615|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
5363870|NCT00090103|13197616|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
5363871|NCT00090103|13197617|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
5363872|NCT00090051|13197717|P2|NOT COMPLETED|Overall Study||95
5363873|NCT00090051|13197718|P1|NOT COMPLETED|Overall Study||109
5363874|NCT00090051|13197717|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
5363875|NCT00090051|13197718|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
5363876|NCT00090051|13197717|P2|Safety Population; Received Study Drug|Overall Study||274
5363877|NCT00090051|13197718|P1|Safety Population; Received Study Drug|Overall Study||272
5363878|NCT00090051|13197717|P2|STARTED|Overall Study||276
5363879|NCT00090051|13197718|P1|STARTED|Overall Study||276
5363880|NCT00003224|13197758|P6|NOT COMPLETED|Overall Study||0
5363881|NCT00003224|13197759|P5|NOT COMPLETED|Overall Study||0
5363882|NCT00003224|13197760|P4|NOT COMPLETED|Overall Study||0
5363883|NCT00003224|13197761|P3|NOT COMPLETED|Overall Study||0
5363884|NCT00003224|13197762|P2|NOT COMPLETED|Overall Study||0
5363885|NCT00003224|13197763|P1|NOT COMPLETED|Overall Study||0
5363886|NCT00003224|13197758|P6|COMPLETED|Overall Study||3
5363887|NCT00003224|13197759|P5|COMPLETED|Overall Study||4
5363888|NCT00003224|13197760|P4|COMPLETED|Overall Study||2
5363889|NCT00003224|13197761|P3|COMPLETED|Overall Study||4
5363890|NCT00003224|13197762|P2|COMPLETED|Overall Study||5
5363891|NCT00003224|13197763|P1|COMPLETED|Overall Study||4
5363892|NCT00003224|13197758|P6|STARTED|Overall Study||3
5363893|NCT00003224|13197759|P5|STARTED|Overall Study||4
5363894|NCT00003224|13197760|P4|STARTED|Overall Study||2
5363895|NCT00003224|13197761|P3|STARTED|Overall Study||4
5363896|NCT00003224|13197762|P2|STARTED|Overall Study||5
5363897|NCT00003224|13197763|P1|STARTED|Overall Study||4
5363898|NCT00089999|13197783|P2|NOT COMPLETED|Overall Study||69
5363899|NCT00089999|13197784|P1|NOT COMPLETED|Overall Study||69
5363900|NCT00089999|13197783|P2|COMPLETED|Overall Study||0
5363901|NCT00089999|13197784|P1|COMPLETED|Overall Study||0
5363902|NCT00089999|13197783|P2|STARTED|Overall Study||69
5363903|NCT00089999|13197784|P1|STARTED|Overall Study||69
5363904|NCT00089986|13197807|P3|NOT COMPLETED|Overall Study||10
5363905|NCT00089986|13197808|P2|NOT COMPLETED|Overall Study||24
5363906|NCT00089986|13197809|P1|NOT COMPLETED|Overall Study||15
5363907|NCT00089986|13197807|P3|COMPLETED|Overall Study||172
5363908|NCT00089986|13197808|P2|COMPLETED|Overall Study||574
5363909|NCT00089986|13197809|P1|COMPLETED|Overall Study||584
5363910|NCT00089986|13197807|P3|STARTED|Overall Study||182
5363911|NCT00089986|13197808|P2|STARTED|Overall Study||598
5363912|NCT00089986|13197809|P1|STARTED|Overall Study||599
5363913|NCT00089973|13197826|P1|NOT COMPLETED|Overall Study||50
5363914|NCT00089973|13197826|P1|COMPLETED|Overall Study||0
5363915|NCT00089973|13197826|P1|STARTED|Overall Study||50
5363916|NCT00089895|13197841|P2|NOT COMPLETED|Overall Study||42
5363917|NCT00089895|13197842|P1|NOT COMPLETED|Overall Study||35
5363918|NCT00089895|13197841|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
5363919|NCT00089895|13197842|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
5363920|NCT00089895|13197841|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
5363921|NCT00089895|13197842|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
5363922|NCT00089843|13197854|P4|NOT COMPLETED|Overall Study||7
5363923|NCT00089843|13197855|P3|NOT COMPLETED|Overall Study||5
5363924|NCT00089843|13197856|P2|NOT COMPLETED|Overall Study||4
5363925|NCT00089843|13197857|P1|NOT COMPLETED|Overall Study||2
5363926|NCT00089843|13197854|P4|COMPLETED|Overall Study||11
5363927|NCT00089843|13197855|P3|COMPLETED|Overall Study||15
5363928|NCT00089843|13197856|P2|COMPLETED|Overall Study||16
5363929|NCT00089843|13197857|P1|COMPLETED|Overall Study||17
5363930|NCT00089843|13197854|P4|STARTED|Overall Study||18
5363931|NCT00089843|13197855|P3|STARTED|Overall Study||20
5363932|NCT00089843|13197856|P2|STARTED|Overall Study||20
5363933|NCT00089843|13197857|P1|STARTED|Overall Study||19
5363934|NCT00089791|13197869|P2|NOT COMPLETED|Overall Study||630
5363935|NCT00089791|13197870|P1|NOT COMPLETED|Overall Study||700
5363936|NCT00089791|13197869|P2|COMPLETED|Overall Study||3272
5363937|NCT00089791|13197870|P1|COMPLETED|Overall Study||3206
5363938|NCT00089791|13197869|P2|Safety Analysis Set|Overall Study||3886
5363939|NCT00089791|13197870|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
5363940|NCT00089791|13197869|P2|Received Study Medication|Overall Study||3879
5363941|NCT00089791|13197870|P1|Received Study Medication|Overall Study||3883
5363942|NCT00089791|13197869|P2|STARTED|Overall Study||3902
5363943|NCT00089791|13197870|P1|STARTED|Overall Study||3906
5363944|NCT00089752|13197882|P2|NOT COMPLETED|Overall Study||22
5363945|NCT00089752|13197883|P1|NOT COMPLETED|Overall Study||20
5363946|NCT00089752|13197882|P2|COMPLETED|Overall Study||118
5363947|NCT00089752|13197883|P1|COMPLETED|Overall Study||121
5363948|NCT00089752|13197882|P2|STARTED|Overall Study||140
5363949|NCT00089752|13197883|P1|STARTED|Overall Study||141
5363950|NCT00089778|13197904|P3|NOT COMPLETED|Overall Study||1
5363951|NCT00089778|13197905|P2|NOT COMPLETED|Overall Study||0
5363952|NCT00089778|13197906|P1|NOT COMPLETED|Overall Study||0
5363953|NCT00089778|13197904|P3|COMPLETED|Overall Study||7
5363954|NCT00089778|13197905|P2|COMPLETED|Overall Study||1
5363955|NCT00089778|13197906|P1|COMPLETED|Overall Study||2
5363956|NCT00089778|13197904|P3|STARTED|Overall Study||8
5363957|NCT00089778|13197905|P2|STARTED|Overall Study||1
5363958|NCT00089778|13197906|P1|STARTED|Overall Study||2
5363959|NCT00089674|13197919|P2|NOT COMPLETED|Overall Study||267
5363960|NCT00089674|13197920|P1|NOT COMPLETED|Overall Study||289
5363961|NCT00089674|13197919|P2|COMPLETED|Overall Study||467
5363962|NCT00089674|13197920|P1|COMPLETED|Overall Study||445
5363963|NCT00089674|13197919|P2|Received Study Drug|Overall Study||726
5363964|NCT00089674|13197920|P1|Received Study Drug|Overall Study||730
5363965|NCT00089674|13197919|P2|STARTED|Overall Study||734
5363966|NCT00089674|13197920|P1|STARTED|Overall Study||734
5363967|NCT00089661|13197946|P2|NOT COMPLETED|Overall Study||26
5363968|NCT00089661|13197947|P1|NOT COMPLETED|Overall Study||21
5363969|NCT00089661|13197946|P2|COMPLETED|Overall Study||99
5363970|NCT00089661|13197947|P1|COMPLETED|Overall Study||106
5363971|NCT00089661|13197946|P2|STARTED|Overall Study||125
5363972|NCT00089661|13197947|P1|STARTED|Overall Study||127
5363973|NCT00089648|13197963|P1|NOT COMPLETED|Overall Study||41
5363974|NCT00089648|13197963|P1|COMPLETED|Overall Study||20
5363975|NCT00089648|13197963|P1|STARTED|Overall Study||61
5363976|NCT00089635|13197979|P1|NOT COMPLETED|Overall Study||43
5363977|NCT00089635|13197979|P1|COMPLETED|Overall Study||160
5363978|NCT00089635|13197979|P1|STARTED|Overall Study||203
5363979|NCT00089583|13197993|P2|NOT COMPLETED|Overall Study||38
5363980|NCT00089583|13197994|P1|NOT COMPLETED|Overall Study||7
5363981|NCT00089583|13197993|P2|COMPLETED|Overall Study||51
5363982|NCT00089583|13197994|P1|COMPLETED|Overall Study||13
5363983|NCT00089583|13197993|P2|STARTED|Overall Study||89
5363984|NCT00089583|13197994|P1|STARTED|Overall Study||20
5363985|NCT00089609|13198088|P2|NOT COMPLETED|Overall Study||1
5363986|NCT00089609|13198089|P1|NOT COMPLETED|Overall Study||3
5363987|NCT00089609|13198088|P2|COMPLETED|Overall Study||12
5363988|NCT00089609|13198089|P1|COMPLETED|Overall Study||57
5363989|NCT00089609|13198088|P2|STARTED|Overall Study||13
5363990|NCT00089609|13198089|P1|STARTED|Overall Study||60
5363991|NCT00089544|13198108|P2|NOT COMPLETED|Overall Study||0
5363992|NCT00089544|13198109|P1|NOT COMPLETED|Overall Study||1
5363993|NCT00089544|13198108|P2|COMPLETED|Overall Study||7
5363994|NCT00089544|13198109|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
5363995|NCT00089544|13198108|P2|STARTED|Overall Study||7
5363996|NCT00089544|13198109|P1|STARTED|Overall Study||16
5363997|NCT00089505|13198123|P4|NOT COMPLETED|Overall Study||21
5363998|NCT00089505|13198124|P3|NOT COMPLETED|Overall Study||21
5363999|NCT00089505|13198125|P2|NOT COMPLETED|Overall Study||2
5364000|NCT00089505|13198126|P1|NOT COMPLETED|Overall Study||9
5364001|NCT00089505|13198123|P4|COMPLETED|Overall Study||230
5364002|NCT00089505|13198124|P3|COMPLETED|Overall Study||228
5364003|NCT00089505|13198125|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
5364004|NCT00089505|13198126|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
5364005|NCT00089505|13198123|P4|STARTED|Overall Study||251
5364006|NCT00089505|13198124|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
5364007|NCT00089505|13198125|P2|STARTED|Overall Study||120
5364008|NCT00089505|13198126|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
5364009|NCT00089479|13198170|P2|NOT COMPLETED|Overall Study||289
5364010|NCT00089479|13198171|P1|NOT COMPLETED|Overall Study||331
5364011|NCT00089479|13198170|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
5364012|NCT00089479|13198171|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
5364013|NCT00089479|13198170|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
5364014|NCT00089479|13198171|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
5364015|NCT00089479|13198170|P2|STARTED|Overall Study||1307
5364016|NCT00089479|13198171|P1|STARTED|Overall Study||1304
5364017|NCT00089414|13198198|P3|NOT COMPLETED|Overall Study||0
5364018|NCT00089414|13198199|P2|NOT COMPLETED|Overall Study||0
5364019|NCT00089414|13198200|P1|NOT COMPLETED|Overall Study||0
5364020|NCT00089414|13198198|P3|COMPLETED|Overall Study||2
5364021|NCT00089414|13198199|P2|COMPLETED|Overall Study||1
5364022|NCT00089414|13198200|P1|COMPLETED|Overall Study||2
5364023|NCT00089414|13198198|P3|STARTED|Overall Study||2
5364024|NCT00089414|13198199|P2|STARTED|Overall Study||1
5364025|NCT00089414|13198200|P1|STARTED|Overall Study||2
5364026|NCT00089297|13198214|P1|NOT COMPLETED|Overall Study||38
5364027|NCT00089297|13198214|P1|COMPLETED|Overall Study||36
5364028|NCT00089297|13198214|P1|Eligible|Overall Study||63
5364029|NCT00089297|13198214|P1|Treated|Overall Study||70
5364030|NCT00089297|13198214|P1|STARTED|Overall Study||74
5364031|NCT00089284|13198226|P7|NOT COMPLETED|Overall Study||1
5364032|NCT00089284|13198227|P6|NOT COMPLETED|Overall Study||0
5364033|NCT00089284|13198228|P5|NOT COMPLETED|Overall Study||0
5364034|NCT00089284|13198229|P4|NOT COMPLETED|Overall Study||0
5364035|NCT00089284|13198230|P3|NOT COMPLETED|Overall Study||0
5364036|NCT00089284|13198231|P2|NOT COMPLETED|Overall Study||0
5364037|NCT00089284|13198232|P1|NOT COMPLETED|Overall Study||0
5364038|NCT00089284|13198226|P7|COMPLETED|Overall Study||7
5364039|NCT00089284|13198227|P6|COMPLETED|Overall Study||0
5364040|NCT00089284|13198228|P5|COMPLETED|Overall Study||0
5364041|NCT00089284|13198229|P4|COMPLETED|Overall Study||6
5364042|NCT00089284|13198230|P3|COMPLETED|Overall Study||6
5364043|NCT00089284|13198231|P2|COMPLETED|Overall Study||3
5364044|NCT00089284|13198232|P1|COMPLETED|Overall Study||7
5364045|NCT00089284|13198226|P7|STARTED|Overall Study||8
5364046|NCT00089284|13198227|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
5364047|NCT00089284|13198228|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
5364048|NCT00089284|13198229|P4|STARTED|Overall Study||6
5364049|NCT00089284|13198230|P3|STARTED|Overall Study||6
5364050|NCT00089284|13198231|P2|STARTED|Overall Study||3
5364051|NCT00089284|13198232|P1|STARTED|Overall Study||7
5364052|NCT00089141|13198269|P2|NOT COMPLETED|Overall Study||24
5364053|NCT00089141|13198270|P1|NOT COMPLETED|Overall Study||18
5364054|NCT00089141|13198269|P2|COMPLETED|Overall Study||53
5364055|NCT00089141|13198270|P1|COMPLETED|Overall Study||56
5364056|NCT00089141|13198269|P2|STARTED|Overall Study||77
5364057|NCT00089141|13198270|P1|STARTED|Overall Study||74
5364058|NCT00089128|13198292|P1|NOT COMPLETED|Overall Study||0
5364059|NCT00089128|13198292|P1|COMPLETED|Overall Study||16
5364060|NCT00089128|13198292|P1|STARTED|Overall Study||16
5364061|NCT00089102|13198299|P1|NOT COMPLETED|Overall Study||0
5364062|NCT00089102|13198299|P1|COMPLETED|Overall Study||9
5364063|NCT00089102|13198299|P1|STARTED|Overall Study||9
5364064|NCT00089076|13198306|P1|NOT COMPLETED|Overall Study||10
5364065|NCT00089076|13198306|P1|COMPLETED|Overall Study||8
5364066|NCT00089076|13198306|P1|STARTED|Overall Study||18
5364067|NCT00089024|13198317|P1|NOT COMPLETED|Overall Study||5
5364068|NCT00089024|13198317|P1|COMPLETED|Overall Study||24
5364069|NCT00089024|13198317|P1|Treated Subjects|Overall Study||29
5364070|NCT00089024|13198317|P1|STARTED|Overall Study||29
5364071|NCT00089011|13198324|P2|NOT COMPLETED|Overall Study||0
5364072|NCT00089011|13198325|P1|NOT COMPLETED|Overall Study||0
5364073|NCT00089011|13198324|P2|COMPLETED|Overall Study||50
5364074|NCT00089011|13198325|P1|COMPLETED|Overall Study||100
5364075|NCT00089011|13198324|P2|STARTED|Overall Study||50
5364076|NCT00089011|13198325|P1|STARTED|Overall Study||100
5364077|NCT00088985|13198345|P1|NOT COMPLETED|Overall Study||3
5364078|NCT00088985|13198345|P1|COMPLETED|Overall Study||4
5364079|NCT00088985|13198345|P1|STARTED|Overall Study||7
5364080|NCT00088972|13198352|P2|NOT COMPLETED|Overall Study||4
5364081|NCT00088972|13198353|P1|NOT COMPLETED|Overall Study||2
5364082|NCT00088972|13198352|P2|COMPLETED|Overall Study||1
5364083|NCT00088972|13198353|P1|COMPLETED|Overall Study||1
5364084|NCT00088972|13198352|P2|STARTED|Overall Study||5
5364085|NCT00088972|13198353|P1|STARTED|Overall Study||3
5364086|NCT00088907|13198363|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
5364087|NCT00088907|13198364|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
5364088|NCT00088907|13198363|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
5364089|NCT00088907|13198364|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
5364090|NCT00088907|13198363|P2|Treated|Single Gefitinib Treatment (Step 2)||0
5364091|NCT00088907|13198364|P1|Treated|Single Gefitinib Treatment (Step 2)||19
5364092|NCT00088907|13198363|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
5364093|NCT00088907|13198364|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
5364094|NCT00088907|13198363|P2|NOT COMPLETED|Randomized Study (Step 1)||134
5364095|NCT00088907|13198364|P1|NOT COMPLETED|Randomized Study (Step 1)||136
5364096|NCT00088907|13198363|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
5364097|NCT00088907|13198364|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
5364098|NCT00088907|13198363|P2|Eligible and Treated|Randomized Study (Step 1)||122
5364099|NCT00088907|13198364|P1|Eligible and Treated|Randomized Study (Step 1)||117
5364100|NCT00088907|13198363|P2|Eligible|Randomized Study (Step 1)||122
5364101|NCT00088907|13198364|P1|Eligible|Randomized Study (Step 1)||117
5364102|NCT00088907|13198363|P2|Treated|Randomized Study (Step 1)||124
5364103|NCT00088907|13198364|P1|Treated|Randomized Study (Step 1)||129
5364104|NCT00088907|13198363|P2|STARTED|Randomized Study (Step 1)||134
5364105|NCT00088907|13198364|P1|STARTED|Randomized Study (Step 1)||136
5364106|NCT00088881|13198375|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
5364107|NCT00088881|13198375|P1|COMPLETED|Step 3 - Radiation Therapy||1
5364108|NCT00088881|13198375|P1|STARTED|Step 3 - Radiation Therapy||1
5364109|NCT00088881|13198375|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
5364110|NCT00088881|13198375|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
5364111|NCT00088881|13198375|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
5364112|NCT00088881|13198375|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
5364113|NCT00088881|13198375|P1|NOT COMPLETED|Step 1 - R-CHOP||14
5364114|NCT00088881|13198375|P1|COMPLETED|Step 1 - R-CHOP||48
5364115|NCT00088881|13198375|P1|Eligible and Treated|Step 1 - R-CHOP||53
5364116|NCT00088881|13198375|P1|STARTED|Step 1 - R-CHOP||62
5364117|NCT00088829|13198384|P1|NOT COMPLETED|Overall Study||22
5364118|NCT00088829|13198384|P1|COMPLETED|Overall Study||0
5364119|NCT00088829|13198384|P1|STARTED|Overall Study||22
5364120|NCT00088699|13198390|P4|NOT COMPLETED|Infusion 2||1
5364121|NCT00088699|13198391|P3|NOT COMPLETED|Infusion 2||0
5364122|NCT00088699|13198392|P2|NOT COMPLETED|Infusion 2||0
5364123|NCT00088699|13198393|P1|NOT COMPLETED|Infusion 2||0
5364124|NCT00088699|13198390|P4|COMPLETED|Infusion 2||10
5364125|NCT00088699|13198391|P3|COMPLETED|Infusion 2||11
5364126|NCT00088699|13198392|P2|COMPLETED|Infusion 2||18
5364127|NCT00088699|13198393|P1|COMPLETED|Infusion 2||19
5364128|NCT00088699|13198390|P4|STARTED|Infusion 2||11
5364129|NCT00088699|13198391|P3|STARTED|Infusion 2||11
5364130|NCT00088699|13198392|P2|STARTED|Infusion 2||18
5364131|NCT00088699|13198393|P1|STARTED|Infusion 2||19
5364132|NCT00088699|13198390|P4|NOT COMPLETED|Infusion 1||2
5364133|NCT00088699|13198391|P3|NOT COMPLETED|Infusion 1||1
5364134|NCT00088699|13198392|P2|NOT COMPLETED|Infusion 1||0
5364135|NCT00088699|13198393|P1|NOT COMPLETED|Infusion 1||1
5364136|NCT00088699|13198390|P4|COMPLETED|Infusion 1||10
5364137|NCT00088699|13198391|P3|COMPLETED|Infusion 1||12
5364138|NCT00088699|13198392|P2|COMPLETED|Infusion 1||19
5364139|NCT00088699|13198393|P1|COMPLETED|Infusion 1||22
5364140|NCT00088699|13198390|P4|STARTED|Infusion 1||12
5364141|NCT00088699|13198391|P3|STARTED|Infusion 1||13
5364142|NCT00088699|13198392|P2|STARTED|Infusion 1||19
5364143|NCT00088699|13198393|P1|STARTED|Infusion 1||23
5364144|NCT00088634|13198409|P2|NOT COMPLETED|Overall Study||43
5364145|NCT00088634|13198410|P1|NOT COMPLETED|Overall Study||38
5364146|NCT00088634|13198409|P2|COMPLETED|Overall Study||47
5364147|NCT00088634|13198410|P1|COMPLETED|Overall Study||52
5364148|NCT00088634|13198409|P2|STARTED|Overall Study||90
5364149|NCT00088634|13198410|P1|STARTED|Overall Study||90
5364150|NCT00088621|13198422|P1|NOT COMPLETED|Overall Study||54
5364151|NCT00088621|13198422|P1|COMPLETED|Overall Study||7
5364152|NCT00088621|13198422|P1|STARTED|Overall Study||61
5364153|NCT00088595|13198426|P1|NOT COMPLETED|Overall Study||28
5364154|NCT00088595|13198426|P1|COMPLETED|Overall Study||17
5364155|NCT00088595|13198426|P1|STARTED|Overall Study||45
5364156|NCT00088530|13198444|P2|NOT COMPLETED|Overall Study||54
5364157|NCT00088530|13198445|P1|NOT COMPLETED|Overall Study||50
5364158|NCT00088530|13198444|P2|COMPLETED|Overall Study||16
5364159|NCT00088530|13198445|P1|COMPLETED|Overall Study||20
5364160|NCT00088530|13198444|P2|STARTED|Overall Study||70
5364161|NCT00088530|13198445|P1|STARTED|Overall Study||70
5364162|NCT00088465|13198457|P1|NOT COMPLETED|Overall Study||561
5364163|NCT00088465|13198457|P1|COMPLETED|Overall Study||370
5364164|NCT00088465|13198457|P1|STARTED|Overall Study||931
5364165|NCT00088413|13198484|P4|NOT COMPLETED|Overall Study||14
5364166|NCT00088413|13198485|P3|NOT COMPLETED|Overall Study||12
5364167|NCT00088413|13198486|P2|NOT COMPLETED|Overall Study||15
5364168|NCT00088413|13198487|P1|NOT COMPLETED|Overall Study||10
5364169|NCT00088413|13198484|P4|COMPLETED|Overall Study||0
5364170|NCT00088413|13198485|P3|COMPLETED|Overall Study||0
5364171|NCT00088413|13198486|P2|COMPLETED|Overall Study||0
5364172|NCT00088413|13198487|P1|COMPLETED|Overall Study||0
5364173|NCT00088413|13198484|P4|STARTED|Overall Study||14
5364174|NCT00088413|13198485|P3|STARTED|Overall Study||12
5364175|NCT00088413|13198486|P2|STARTED|Overall Study||15
5364176|NCT00088413|13198487|P1|STARTED|Overall Study||10
5364177|NCT00088374|13198501|P1|NOT COMPLETED|Overall Study||2
5364178|NCT00088374|13198501|P1|COMPLETED|Overall Study||7
5364179|NCT00088374|13198501|P1|STARTED|Overall Study||9
5364180|NCT00088218|13198512|P2|NOT COMPLETED|Overall Study||0
5364181|NCT00088218|13198513|P1|NOT COMPLETED|Overall Study||0
5364182|NCT00088218|13198512|P2|COMPLETED|Overall Study||79
5364183|NCT00088218|13198513|P1|COMPLETED|Overall Study||16
5364184|NCT00088218|13198512|P2|STARTED|Overall Study||79
5364185|NCT00088218|13198513|P1|STARTED|Overall Study||16
5364186|NCT00088205|13198519|P1|NOT COMPLETED|Overall Study||60
5364187|NCT00088205|13198519|P1|COMPLETED|Overall Study||0
5364188|NCT00088205|13198519|P1|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
5364189|NCT00088205|13198519|P1|Received at Least 1 Dose of Study Drug|Overall Study||60
5364190|NCT00088205|13198519|P1|STARTED|Overall Study||60
5364191|NCT00088166|13198536|P2|NOT COMPLETED|Overall Study||61
5364192|NCT00088166|13198537|P1|NOT COMPLETED|Overall Study||53
5364193|NCT00088166|13198536|P2|COMPLETED|Overall Study||39
5364194|NCT00088166|13198537|P1|COMPLETED|Overall Study||47
5364195|NCT00088166|13198536|P2|STARTED|Overall Study||100
5364196|NCT00088166|13198537|P1|STARTED|Overall Study||100
5364197|NCT00088153|13198561|P2|NOT COMPLETED|Overall Study||25
5364198|NCT00088153|13198562|P1|NOT COMPLETED|Overall Study||24
5364199|NCT00088153|13198561|P2|COMPLETED|Overall Study||30
5364200|NCT00088153|13198562|P1|COMPLETED|Overall Study||31
5364201|NCT00088153|13198561|P2|STARTED|Overall Study||55
5364202|NCT00088153|13198562|P1|STARTED|Overall Study||55
5364203|NCT00087698|13198572|P1|NOT COMPLETED|Overall Study||36
5364204|NCT00087698|13198572|P1|COMPLETED|Overall Study||41
5364205|NCT00087698|13198572|P1|STARTED|Overall Study||77
5364206|NCT00087685|13198581|P1|NOT COMPLETED|Overall Study||14
5364207|NCT00087685|13198581|P1|COMPLETED|Overall Study||21
5364208|NCT00087685|13198581|P1|STARTED|Overall Study||35
5364209|NCT00087672|13198586|P1|NOT COMPLETED|Overall Study||0
5364210|NCT00087672|13198586|P1|COMPLETED|Overall Study||41
5364211|NCT00087672|13198586|P1|STARTED|Overall Study||41
5364212|NCT00087646|13198594|P4|NOT COMPLETED|Overall Study||84
5364213|NCT00087646|13198595|P3|NOT COMPLETED|Overall Study||65
5364214|NCT00087646|13198596|P2|NOT COMPLETED|Overall Study||42
5364215|NCT00087646|13198597|P1|NOT COMPLETED|Overall Study||135
5364216|NCT00087646|13198594|P4|COMPLETED|Overall Study||229
5364217|NCT00087646|13198595|P3|COMPLETED|Overall Study||91
5364218|NCT00087646|13198596|P2|COMPLETED|Overall Study||114
5364219|NCT00087646|13198597|P1|COMPLETED|Overall Study||182
5364220|NCT00087646|13198594|P4|STARTED|Overall Study||313
5364221|NCT00087646|13198595|P3|STARTED|Overall Study||156
5364222|NCT00087646|13198596|P2|STARTED|Overall Study||156
5364223|NCT00087646|13198597|P1|STARTED|Overall Study||317
5364224|NCT00087633|13198625|P2|NOT COMPLETED|Overall Study||17
5364225|NCT00087633|13198626|P1|NOT COMPLETED|Overall Study||24
5364226|NCT00087633|13198625|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
5364227|NCT00087633|13198626|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
5364228|NCT00087633|13198625|P2|STARTED|Overall Study|Randomized|60
5364229|NCT00087633|13198626|P1|STARTED|Overall Study|Randomized|55
5364230|NCT00087607|13198636|P2|NOT COMPLETED|Overall Study||122
5364231|NCT00087607|13198637|P1|NOT COMPLETED|Overall Study||122
5364232|NCT00087607|13198636|P2|COMPLETED|Overall Study||71
5364233|NCT00087607|13198637|P1|COMPLETED|Overall Study||70
5364234|NCT00087607|13198636|P2|STARTED|Overall Study||193
5364235|NCT00087607|13198637|P1|STARTED|Overall Study||192
5364236|NCT00087594|13198677|P2|NOT COMPLETED|Overall Study||12
5364237|NCT00087594|13198678|P1|NOT COMPLETED|Overall Study||8
5364238|NCT00087594|13198677|P2|COMPLETED|Overall Study||12
5364239|NCT00087594|13198678|P1|COMPLETED|Overall Study||16
5364240|NCT00087594|13198677|P2|STARTED|Overall Study||24
5364241|NCT00087594|13198678|P1|STARTED|Overall Study||24
5364242|NCT00087568|13198712|P2|NOT COMPLETED|Overall Study||2
5364243|NCT00087568|13198713|P1|NOT COMPLETED|Overall Study||30
5364244|NCT00087568|13198712|P2|COMPLETED|Overall Study||23
5364245|NCT00087568|13198713|P1|COMPLETED|Overall Study||2
5364246|NCT00087568|13198712|P2|STARTED|Overall Study||25
5364247|NCT00087568|13198713|P1|STARTED|Overall Study||32
5364248|NCT00087555|13198740|P3|NOT COMPLETED|Overall Study||21
5364249|NCT00087555|13198741|P2|NOT COMPLETED|Overall Study||11
5364250|NCT00087555|13198742|P1|NOT COMPLETED|Overall Study||12
5364251|NCT00087555|13198740|P3|COMPLETED|Overall Study||46
5364252|NCT00087555|13198741|P2|COMPLETED|Overall Study||51
5364253|NCT00087555|13198742|P1|COMPLETED|Overall Study||54
5364254|NCT00087555|13198740|P3|Treated|Overall Study||67
5364255|NCT00087555|13198741|P2|Treated|Overall Study||60
5364256|NCT00087555|13198742|P1|Treated|Overall Study||65
5364257|NCT00087555|13198740|P3|STARTED|Overall Study||67
5364258|NCT00087555|13198741|P2|STARTED|Overall Study||62
5364259|NCT00087555|13198742|P1|STARTED|Overall Study||66
5364260|NCT00087529|13198752|P2|NOT COMPLETED|Overall Study||68
5364261|NCT00087529|13198753|P1|NOT COMPLETED|Overall Study||31
5364262|NCT00087529|13198752|P2|COMPLETED|Overall Study||224
5364263|NCT00087529|13198753|P1|COMPLETED|Overall Study||116
5364264|NCT00087529|13198752|P2|STARTED|Overall Study||292
5364265|NCT00087529|13198753|P1|STARTED|Overall Study||147
5364266|NCT00087516|13198768|P4|NOT COMPLETED|Overall Study||85
5364267|NCT00087516|13198769|P3|NOT COMPLETED|Overall Study||97
5364268|NCT00087516|13198770|P2|NOT COMPLETED|Overall Study||169
5364269|NCT00087516|13198771|P1|NOT COMPLETED|Overall Study||161
5364270|NCT00087516|13198768|P4|COMPLETED|Overall Study||38
5364271|NCT00087516|13198769|P3|COMPLETED|Overall Study||33
5364272|NCT00087516|13198770|P2|COMPLETED|Overall Study||81
5364273|NCT00087516|13198771|P1|COMPLETED|Overall Study||77
5364274|NCT00087516|13198768|P4|STARTED|Overall Study||123
5364275|NCT00087516|13198769|P3|STARTED|Overall Study||130
5364276|NCT00087516|13198770|P2|STARTED|Overall Study||250
5364277|NCT00087516|13198771|P1|STARTED|Overall Study||238
5364278|NCT00087490|13198800|P2|NOT COMPLETED|Overall Study||269
5364279|NCT00087490|13198801|P1|NOT COMPLETED|Overall Study||258
5364280|NCT00087490|13198800|P2|COMPLETED|Overall Study||264
5364281|NCT00087490|13198801|P1|COMPLETED|Overall Study||286
5364282|NCT00087490|13198800|P2|Treated|Overall Study||515
5364283|NCT00087490|13198801|P1|Treated|Overall Study||537
5364284|NCT00087490|13198800|P2|STARTED|Overall Study||533
5364285|NCT00087490|13198801|P1|STARTED|Overall Study||544
5364286|NCT00087438|13198835|P1|NOT COMPLETED|Overall Study||4
5364287|NCT00087438|13198835|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
5364288|NCT00087438|13198835|P1|STARTED|Overall Study||59
5364289|NCT00087152|13198845|P1|NOT COMPLETED|Overall Study||6
5364290|NCT00087152|13198845|P1|COMPLETED|Overall Study||21
5364291|NCT00087152|13198845|P1|STARTED|Overall Study||27
5364292|NCT00087139|13198854|P3|NOT COMPLETED|Overall Study||36
5364293|NCT00087139|13198855|P2|NOT COMPLETED|Overall Study||49
5364294|NCT00087139|13198856|P1|NOT COMPLETED|Overall Study||39
5364295|NCT00087139|13198854|P3|COMPLETED|Overall Study||0
5364296|NCT00087139|13198855|P2|COMPLETED|Overall Study||0
5364297|NCT00087139|13198856|P1|COMPLETED|Overall Study||0
5364298|NCT00087139|13198854|P3|Patients w/ Measurable Disease Response|Overall Study||0
5364299|NCT00087139|13198855|P2|Patients w/ Measurable Disease Response|Overall Study||2
5364300|NCT00087139|13198856|P1|Patients w/ Measurable Disease Response|Overall Study||5
5364301|NCT00087139|13198854|P3|Patients With PSA Response|Overall Study||4
5364302|NCT00087139|13198855|P2|Patients With PSA Response|Overall Study||8
5364303|NCT00087139|13198856|P1|Patients With PSA Response|Overall Study||10
5364304|NCT00087139|13198854|P3|Patients With Measurable Disease|Overall Study||24
5364305|NCT00087139|13198855|P2|Patients With Measurable Disease|Overall Study||25
5364306|NCT00087139|13198856|P1|Patients With Measurable Disease|Overall Study||22
5364307|NCT00087139|13198854|P3|Patients for the Analysis of PSA Respons|Overall Study||22
5364308|NCT00087139|13198855|P2|Patients for the Analysis of PSA Respons|Overall Study||34
5364309|NCT00087139|13198856|P1|Patients for the Analysis of PSA Respons|Overall Study||30
5364310|NCT00087139|13198854|P3|Eligible and Treated|Overall Study||32
5364311|NCT00087139|13198855|P2|Eligible and Treated|Overall Study||42
5364312|NCT00087139|13198856|P1|Eligible and Treated|Overall Study||35
5364313|NCT00087139|13198854|P3|Treated|Overall Study||36
5364314|NCT00087139|13198855|P2|Treated|Overall Study||48
5364315|NCT00087139|13198856|P1|Treated|Overall Study||39
5364316|NCT00087139|13198854|P3|STARTED|Overall Study||36
5364317|NCT00087139|13198855|P2|STARTED|Overall Study||49
5364318|NCT00087139|13198856|P1|STARTED|Overall Study||39
5364319|NCT00087126|13198871|P1|NOT COMPLETED|Overall Study||2
5364320|NCT00087126|13198871|P1|COMPLETED|Overall Study||25
5364321|NCT00087126|13198871|P1|STARTED|Overall Study||27
5364322|NCT00087022|13198882|P2|NOT COMPLETED|Overall Study||55
5364323|NCT00087022|13198883|P1|NOT COMPLETED|Overall Study||54
5364324|NCT00087022|13198882|P2|COMPLETED|Overall Study||376
5364325|NCT00087022|13198883|P1|COMPLETED|Overall Study||379
5364326|NCT00087022|13198882|P2|Treated (Safety Population)|Overall Study||424
5364327|NCT00087022|13198883|P1|Treated (Safety Population)|Overall Study||431
5364328|NCT00087022|13198882|P2|STARTED|Overall Study||431
5364329|NCT00087022|13198883|P1|STARTED|Overall Study||433
5364330|NCT00086996|13198896|P1|NOT COMPLETED|Overall Study||64
5364331|NCT00086996|13198896|P1|COMPLETED|Overall Study||34
5364332|NCT00086996|13198896|P1|Eligible and Began Protocol Therapy|Overall Study||93
5364333|NCT00086996|13198896|P1|Eligible|Overall Study||93
5364334|NCT00086996|13198896|P1|STARTED|Overall Study||98
5364335|NCT00086957|13198903|P3|NOT COMPLETED|Overall Study||0
5364336|NCT00086957|13198904|P2|NOT COMPLETED|Overall Study||0
5364337|NCT00086957|13198905|P1|NOT COMPLETED|Overall Study||0
5364338|NCT00086957|13198903|P3|COMPLETED|Overall Study||22
5364339|NCT00086957|13198904|P2|COMPLETED|Overall Study||7
5364340|NCT00086957|13198905|P1|COMPLETED|Overall Study||2
5364341|NCT00086957|13198903|P3|STARTED|Overall Study||22
5364342|NCT00086957|13198904|P2|STARTED|Overall Study||7
5364343|NCT00086957|13198905|P1|STARTED|Overall Study||2
5364344|NCT00086684|13198918|P3|NOT COMPLETED|Overall Study||53
5364345|NCT00086684|13198919|P2|NOT COMPLETED|Overall Study||55
5364346|NCT00086684|13198920|P1|NOT COMPLETED|Overall Study||55
5364347|NCT00086684|13198918|P3|COMPLETED|Overall Study||69
5364348|NCT00086684|13198919|P2|COMPLETED|Overall Study||74
5364349|NCT00086684|13198920|P1|COMPLETED|Overall Study||63
5364350|NCT00086684|13198918|P3|STARTED|Overall Study||122
5364351|NCT00086684|13198919|P2|STARTED|Overall Study||129
5364352|NCT00086684|13198920|P1|STARTED|Overall Study||118
5364353|NCT00086619|13198933|P2|NOT COMPLETED|Overall Study||17
5364354|NCT00086619|13198934|P1|NOT COMPLETED|Overall Study||15
5364355|NCT00086619|13198933|P2|COMPLETED|Overall Study||23
5364356|NCT00086619|13198934|P1|COMPLETED|Overall Study||25
5364357|NCT00086619|13198933|P2|Completed 12 Month Visit|Overall Study||26
5364358|NCT00086619|13198934|P1|Completed 12 Month Visit|Overall Study||26
5364359|NCT00086619|13198933|P2|Completed Baseline Visit|Overall Study||36
5364360|NCT00086619|13198934|P1|Completed Baseline Visit|Overall Study||34
5364361|NCT00086619|13198933|P2|STARTED|Overall Study||40
5364362|NCT00086619|13198934|P1|STARTED|Overall Study||40
5364363|NCT00086580|13198944|P2|NOT COMPLETED|Observation Period||65
5364364|NCT00086580|13198945|P1|NOT COMPLETED|Observation Period||46
5364365|NCT00086580|13198944|P2|COMPLETED|Observation Period||56
5364366|NCT00086580|13198945|P1|COMPLETED|Observation Period||49
5364367|NCT00086580|13198944|P2|STARTED|Observation Period||121
5364368|NCT00086580|13198945|P1|STARTED|Observation Period||95
5364369|NCT00086580|13198944|P2|NOT COMPLETED|Follow-up Period||119
5364370|NCT00086580|13198945|P1|NOT COMPLETED|Follow-up Period||104
5364371|NCT00086580|13198944|P2|COMPLETED|Follow-up Period||18
5364372|NCT00086580|13198945|P1|COMPLETED|Follow-up Period||37
5364373|NCT00086580|13198944|P2|STARTED|Follow-up Period||137
5364374|NCT00086580|13198945|P1|STARTED|Follow-up Period||141
5364375|NCT00086580|13198944|P2|NOT COMPLETED|Treatment Period||60
5364376|NCT00086580|13198945|P1|NOT COMPLETED|Treatment Period||65
5364377|NCT00086580|13198944|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
5364378|NCT00086580|13198945|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
5364379|NCT00086580|13198944|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
5364380|NCT00086580|13198945|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
5364381|NCT00086580|13198944|P2|STARTED|Treatment Period||167
5364382|NCT00086580|13198945|P1|STARTED|Treatment Period||168
5364383|NCT00086411|13198993|P4|NOT COMPLETED|Overall Study||12
5364384|NCT00086411|13198994|P3|NOT COMPLETED|Overall Study||13
5364385|NCT00086411|13198995|P2|NOT COMPLETED|Overall Study||11
5364386|NCT00086411|13198996|P1|NOT COMPLETED|Overall Study||11
5364387|NCT00086411|13198993|P4|COMPLETED|Overall Study||53
5364388|NCT00086411|13198994|P3|COMPLETED|Overall Study||49
5364389|NCT00086411|13198995|P2|COMPLETED|Overall Study||52
5364390|NCT00086411|13198996|P1|COMPLETED|Overall Study||59
5364391|NCT00086411|13198993|P4|STARTED|Overall Study||65
5364392|NCT00086411|13198994|P3|STARTED|Overall Study||62
5364393|NCT00086411|13198995|P2|STARTED|Overall Study||63
5364394|NCT00086411|13198996|P1|STARTED|Overall Study||70
5364395|NCT00086385|13199014|P4|NOT COMPLETED|Overall Study||1
5364396|NCT00086385|13199015|P3|NOT COMPLETED|Overall Study||1
5364397|NCT00086385|13199016|P2|NOT COMPLETED|Overall Study||2
5364398|NCT00086385|13199017|P1|NOT COMPLETED|Overall Study||2
5364399|NCT00086385|13199014|P4|COMPLETED|Overall Study||98
5364400|NCT00086385|13199015|P3|COMPLETED|Overall Study||103
5364401|NCT00086385|13199016|P2|COMPLETED|Overall Study||97
5364402|NCT00086385|13199017|P1|COMPLETED|Overall Study||98
5364403|NCT00086385|13199014|P4|STARTED|Overall Study||99
5364404|NCT00086385|13199015|P3|STARTED|Overall Study||104
5364405|NCT00086385|13199016|P2|STARTED|Overall Study||99
5364406|NCT00086385|13199017|P1|STARTED|Overall Study||100
5364407|NCT00086515|13199029|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
5364408|NCT00086515|13199030|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
5364409|NCT00086515|13199029|P2|COMPLETED|Phase B (Weeks 24-104)||109
5364410|NCT00086515|13199030|P1|COMPLETED|Phase B (Weeks 24-104)||201
5364411|NCT00086515|13199029|P2|STARTED|Phase B (Weeks 24-104)||164
5364412|NCT00086515|13199030|P1|STARTED|Phase B (Weeks 24-104)||391
5364413|NCT00086515|13199029|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
5364414|NCT00086515|13199030|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
5364415|NCT00086515|13199029|P2|COMPLETED|Phase A to Phase B Transition Period||164
5364416|NCT00086515|13199030|P1|COMPLETED|Phase A to Phase B Transition Period||391
5364417|NCT00086515|13199029|P2|STARTED|Phase A to Phase B Transition Period||192
5364418|NCT00086515|13199030|P1|STARTED|Phase A to Phase B Transition Period||415
5364419|NCT00086515|13199029|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
5364420|NCT00086515|13199030|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
5364421|NCT00086515|13199029|P2|COMPLETED|Phase A (Weeks 0-24)||192
5364422|NCT00086515|13199030|P1|COMPLETED|Phase A (Weeks 0-24)||415
5364423|NCT00086515|13199029|P2|STARTED|Phase A (Weeks 0-24)||237
5364424|NCT00086515|13199030|P1|STARTED|Phase A (Weeks 0-24)||464
5364425|NCT00086502|13199042|P2|NOT COMPLETED|Overall Study||20
5364426|NCT00086502|13199043|P1|NOT COMPLETED|Overall Study||26
5364427|NCT00086502|13199042|P2|COMPLETED|Overall Study||158
5364428|NCT00086502|13199043|P1|COMPLETED|Overall Study||149
5364429|NCT00086502|13199042|P2|STARTED|Overall Study||178
5364430|NCT00086502|13199043|P1|STARTED|Overall Study||175
5364431|NCT00086450|13199053|P2|NOT COMPLETED|Overall Study||0
5364432|NCT00086450|13199054|P1|NOT COMPLETED|Overall Study||0
5364433|NCT00086450|13199053|P2|COMPLETED|Overall Study||947
5364434|NCT00086450|13199054|P1|COMPLETED|Overall Study||953
5364435|NCT00086450|13199053|P2|STARTED|Overall Study||947
5364436|NCT00086450|13199054|P1|STARTED|Overall Study||953
5364437|NCT00086346|13199068|P2|NOT COMPLETED|Patients Dosed With Test Article||23
5364438|NCT00086346|13199069|P1|NOT COMPLETED|Patients Dosed With Test Article||140
5364439|NCT00086346|13199068|P2|COMPLETED|Patients Dosed With Test Article||187
5364440|NCT00086346|13199069|P1|COMPLETED|Patients Dosed With Test Article||249
5364441|NCT00086346|13199068|P2|STARTED|Patients Dosed With Test Article||210
5364442|NCT00086346|13199069|P1|STARTED|Patients Dosed With Test Article||389
5364443|NCT00086346|13199068|P2|NOT COMPLETED|Randomization||4
5364444|NCT00086346|13199069|P1|NOT COMPLETED|Randomization||4
5364445|NCT00086346|13199068|P2|COMPLETED|Randomization||210
5364446|NCT00086346|13199069|P1|COMPLETED|Randomization||389
5364447|NCT00086346|13199068|P2|STARTED|Randomization||214
5364448|NCT00086346|13199069|P1|STARTED|Randomization||393
5364449|NCT00086281|13199096|P15|NOT COMPLETED|Phase 2||0
5364450|NCT00086281|13199097|P14|NOT COMPLETED|Phase 2||1
5364451|NCT00086281|13199098|P13|NOT COMPLETED|Phase 2||1
5364452|NCT00086281|13199099|P12|NOT COMPLETED|Phase 2||0
5364453|NCT00086281|13199100|P11|NOT COMPLETED|Phase 2||0
5364454|NCT00086281|13199101|P10|NOT COMPLETED|Phase 2||0
5364455|NCT00086281|13199102|P9|NOT COMPLETED|Phase 2||0
5364456|NCT00086281|13199103|P8|NOT COMPLETED|Phase 2||0
5364457|NCT00086281|13199104|P7|NOT COMPLETED|Phase 2||0
5364458|NCT00086281|13199105|P6|NOT COMPLETED|Phase 2||0
5364459|NCT00086281|13199106|P5|NOT COMPLETED|Phase 2||0
5364460|NCT00086281|13199107|P4|NOT COMPLETED|Phase 2||0
5364461|NCT00086281|13199108|P3|NOT COMPLETED|Phase 2||0
5364462|NCT00086281|13199109|P2|NOT COMPLETED|Phase 2||0
5364463|NCT00086281|13199110|P1|NOT COMPLETED|Phase 2||0
5364464|NCT00086281|13199096|P15|COMPLETED|Phase 2||0
5364465|NCT00086281|13199097|P14|COMPLETED|Phase 2||26
5364466|NCT00086281|13199098|P13|COMPLETED|Phase 2||22
5364467|NCT00086281|13199099|P12|COMPLETED|Phase 2||0
5364468|NCT00086281|13199100|P11|COMPLETED|Phase 2||0
5364469|NCT00086281|13199101|P10|COMPLETED|Phase 2||0
5364470|NCT00086281|13199102|P9|COMPLETED|Phase 2||0
5364471|NCT00086281|13199103|P8|COMPLETED|Phase 2||0
5364472|NCT00086281|13199104|P7|COMPLETED|Phase 2||0
5364473|NCT00086281|13199105|P6|COMPLETED|Phase 2||0
5364474|NCT00086281|13199106|P5|COMPLETED|Phase 2||0
5364475|NCT00086281|13199107|P4|COMPLETED|Phase 2||0
5364476|NCT00086281|13199108|P3|COMPLETED|Phase 2||0
5364477|NCT00086281|13199109|P2|COMPLETED|Phase 2||0
5364478|NCT00086281|13199110|P1|COMPLETED|Phase 2||0
5364479|NCT00086281|13199096|P15|STARTED|Phase 2||0
5364480|NCT00086281|13199097|P14|STARTED|Phase 2||27
5364481|NCT00086281|13199098|P13|STARTED|Phase 2||23
5364482|NCT00086281|13199099|P12|STARTED|Phase 2||0
5364483|NCT00086281|13199100|P11|STARTED|Phase 2||0
5364484|NCT00086281|13199101|P10|STARTED|Phase 2||0
5364485|NCT00086281|13199102|P9|STARTED|Phase 2||0
5364486|NCT00086281|13199103|P8|STARTED|Phase 2||0
5364487|NCT00086281|13199104|P7|STARTED|Phase 2||0
5364488|NCT00086281|13199105|P6|STARTED|Phase 2||0
5364489|NCT00086281|13199106|P5|STARTED|Phase 2||0
5364490|NCT00086281|13199107|P4|STARTED|Phase 2||0
5364491|NCT00086281|13199108|P3|STARTED|Phase 2||0
5364492|NCT00086281|13199109|P2|STARTED|Phase 2||0
5364493|NCT00086281|13199110|P1|STARTED|Phase 2||0
5364494|NCT00086281|13199096|P15|NOT COMPLETED|Phase 1||3
5364495|NCT00086281|13199097|P14|NOT COMPLETED|Phase 1||1
5364496|NCT00086281|13199098|P13|NOT COMPLETED|Phase 1||1
5364497|NCT00086281|13199099|P12|NOT COMPLETED|Phase 1||1
5364498|NCT00086281|13199100|P11|NOT COMPLETED|Phase 1||3
5364499|NCT00086281|13199101|P10|NOT COMPLETED|Phase 1||1
5364500|NCT00086281|13199102|P9|NOT COMPLETED|Phase 1||0
5364501|NCT00086281|13199103|P8|NOT COMPLETED|Phase 1||0
5364502|NCT00086281|13199104|P7|NOT COMPLETED|Phase 1||0
5364503|NCT00086281|13199105|P6|NOT COMPLETED|Phase 1||0
5364504|NCT00086281|13199106|P5|NOT COMPLETED|Phase 1||0
5364505|NCT00086281|13199107|P4|NOT COMPLETED|Phase 1||0
5364506|NCT00086281|13199108|P3|NOT COMPLETED|Phase 1||0
5364507|NCT00086281|13199109|P2|NOT COMPLETED|Phase 1||0
5364508|NCT00086281|13199110|P1|NOT COMPLETED|Phase 1||0
5364509|NCT00086281|13199096|P15|COMPLETED|Phase 1||0
5364510|NCT00086281|13199097|P14|COMPLETED|Phase 1||0
5364511|NCT00086281|13199098|P13|COMPLETED|Phase 1||0
5364512|NCT00086281|13199099|P12|COMPLETED|Phase 1||0
5364513|NCT00086281|13199100|P11|COMPLETED|Phase 1||0
5364514|NCT00086281|13199101|P10|COMPLETED|Phase 1||0
5364515|NCT00086281|13199102|P9|COMPLETED|Phase 1||2
5364516|NCT00086281|13199103|P8|COMPLETED|Phase 1||1
5364517|NCT00086281|13199104|P7|COMPLETED|Phase 1||1
5364518|NCT00086281|13199105|P6|COMPLETED|Phase 1||3
5364519|NCT00086281|13199106|P5|COMPLETED|Phase 1||1
5364520|NCT00086281|13199107|P4|COMPLETED|Phase 1||11
5364521|NCT00086281|13199108|P3|COMPLETED|Phase 1||8
5364522|NCT00086281|13199109|P2|COMPLETED|Phase 1||12
5364523|NCT00086281|13199110|P1|COMPLETED|Phase 1||11
5364524|NCT00086281|13199096|P15|STARTED|Phase 1||3
5364525|NCT00086281|13199097|P14|STARTED|Phase 1||1
5364526|NCT00086281|13199098|P13|STARTED|Phase 1||1
5364527|NCT00086281|13199099|P12|STARTED|Phase 1||1
5364528|NCT00086281|13199100|P11|STARTED|Phase 1||3
5364529|NCT00086281|13199101|P10|STARTED|Phase 1||1
5364530|NCT00086281|13199102|P9|STARTED|Phase 1||2
5364531|NCT00086281|13199103|P8|STARTED|Phase 1||1
5364532|NCT00086281|13199104|P7|STARTED|Phase 1||1
5364533|NCT00086281|13199105|P6|STARTED|Phase 1||3
5364534|NCT00086281|13199106|P5|STARTED|Phase 1||1
5364535|NCT00086281|13199107|P4|STARTED|Phase 1||11
5364536|NCT00086281|13199108|P3|STARTED|Phase 1||8
5364537|NCT00086281|13199109|P2|STARTED|Phase 1||12
5364538|NCT00086281|13199110|P1|STARTED|Phase 1||11
5364539|NCT00086307|13199123|P3|NOT COMPLETED|Overall Study||8
5364540|NCT00086307|13199124|P2|NOT COMPLETED|Overall Study||1
5364541|NCT00086307|13199125|P1|NOT COMPLETED|Overall Study||2
5364542|NCT00086307|13199123|P3|COMPLETED|Overall Study||5
5364543|NCT00086307|13199124|P2|COMPLETED|Overall Study||12
5364544|NCT00086307|13199125|P1|COMPLETED|Overall Study||11
5364545|NCT00086307|13199123|P3|STARTED|Overall Study||13
5364546|NCT00086307|13199124|P2|STARTED|Overall Study||13
5364547|NCT00086307|13199125|P1|STARTED|Overall Study||13
5364548|NCT00086190|13199136|P3|NOT COMPLETED|Overall Study||6
5364549|NCT00086190|13199137|P2|NOT COMPLETED|Overall Study||4
5364550|NCT00086190|13199138|P1|NOT COMPLETED|Overall Study||8
5364551|NCT00086190|13199136|P3|COMPLETED|Overall Study||33
5364552|NCT00086190|13199137|P2|COMPLETED|Overall Study||30
5364553|NCT00086190|13199138|P1|COMPLETED|Overall Study||34
5364554|NCT00086190|13199136|P3|STARTED|Overall Study||39
5364555|NCT00086190|13199137|P2|STARTED|Overall Study||34
5364556|NCT00086190|13199138|P1|STARTED|Overall Study||42
5364557|NCT00086138|13199196|P2|NOT COMPLETED|Overall Study||3
5364558|NCT00086138|13199197|P1|NOT COMPLETED|Overall Study||4
5364559|NCT00086138|13199196|P2|COMPLETED|Overall Study||64
5364560|NCT00086138|13199197|P1|COMPLETED|Overall Study||60
5364561|NCT00086138|13199196|P2|STARTED|Overall Study||67
5364562|NCT00086138|13199197|P1|STARTED|Overall Study||64
5364563|NCT00086047|13199207|P2|NOT COMPLETED|Overall Study||7
5364564|NCT00086047|13199208|P1|NOT COMPLETED|Overall Study||7
5364565|NCT00086047|13199207|P2|COMPLETED|Overall Study||50
5364566|NCT00086047|13199208|P1|COMPLETED|Overall Study||50
5364567|NCT00086047|13199207|P2|STARTED|Overall Study||57
5364568|NCT00086047|13199208|P1|STARTED|Overall Study||57
5364569|NCT00085917|13199216|P2|NOT COMPLETED|Overall Study||3
5364570|NCT00085917|13199217|P1|NOT COMPLETED|Overall Study||4
5364571|NCT00085917|13199216|P2|COMPLETED|Overall Study||11
5364572|NCT00085917|13199217|P1|COMPLETED|Overall Study||11
5364573|NCT00085917|13199216|P2|STARTED|Overall Study||14
5364574|NCT00085917|13199217|P1|STARTED|Overall Study||15
5364575|NCT00085839|13199229|P2|NOT COMPLETED|Overall Study||0
5364576|NCT00085839|13199230|P1|NOT COMPLETED|Overall Study||0
5364577|NCT00085839|13199229|P2|COMPLETED|Overall Study||51
5364578|NCT00085839|13199230|P1|COMPLETED|Overall Study||52
5364579|NCT00085839|13199229|P2|STARTED|Overall Study||51
5364580|NCT00085839|13199230|P1|STARTED|Overall Study||52
5364581|NCT00085735|13199246|P6|NOT COMPLETED|Overall Study||31
5364582|NCT00085735|13199247|P5|NOT COMPLETED|Overall Study||42
5364583|NCT00085735|13199248|P4|NOT COMPLETED|Overall Study||19
5364584|NCT00085735|13199249|P3|NOT COMPLETED|Overall Study||17
5364585|NCT00085735|13199250|P2|NOT COMPLETED|Overall Study||10
5364586|NCT00085735|13199251|P1|NOT COMPLETED|Overall Study||12
5364587|NCT00085735|13199246|P6|COMPLETED|Overall Study||115
5364588|NCT00085735|13199247|P5|COMPLETED|Overall Study||105
5364589|NCT00085735|13199248|P4|COMPLETED|Overall Study||46
5364590|NCT00085735|13199249|P3|COMPLETED|Overall Study||46
5364591|NCT00085735|13199250|P2|COMPLETED|Overall Study||54
5364592|NCT00085735|13199251|P1|COMPLETED|Overall Study||52
5364593|NCT00085735|13199246|P6|STARTED|Overall Study||146
5364594|NCT00085735|13199247|P5|STARTED|Overall Study||147
5364595|NCT00085735|13199248|P4|STARTED|Overall Study||65
5364596|NCT00085735|13199249|P3|STARTED|Overall Study||63
5364597|NCT00085735|13199250|P2|STARTED|Overall Study||64
5364598|NCT00085735|13199251|P1|STARTED|Overall Study||64
5364599|NCT00085709|13199306|P2|NOT COMPLETED|Overall Study||50
5364600|NCT00085709|13199307|P1|NOT COMPLETED|Overall Study||53
5364601|NCT00085709|13199306|P2|COMPLETED|Overall Study||270
5364602|NCT00085709|13199307|P1|COMPLETED|Overall Study||264
5364603|NCT00085709|13199306|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
5364604|NCT00085709|13199307|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
5364605|NCT00085709|13199306|P2|Eligible|Overall Study||301
5364606|NCT00085709|13199307|P1|Eligible|Overall Study||298
5364607|NCT00085709|13199306|P2|STARTED|Overall Study||320
5364608|NCT00085709|13199307|P1|STARTED|Overall Study||317
5364609|NCT00085644|13199323|P3|NOT COMPLETED|Open-Label Period||109
5364610|NCT00085644|13199324|P2|NOT COMPLETED|Open-Label Period||0
5364611|NCT00085644|13199325|P1|NOT COMPLETED|Open-Label Period||0
5364612|NCT00085644|13199323|P3|COMPLETED|Open-Label Period||202
5364613|NCT00085644|13199324|P2|COMPLETED|Open-Label Period||0
5364614|NCT00085644|13199325|P1|COMPLETED|Open-Label Period||0
5364615|NCT00085644|13199323|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
5364616|NCT00085644|13199324|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
5364617|NCT00085644|13199325|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
5364618|NCT00085644|13199323|P3|NOT COMPLETED|Double-Blind Period||0
5364619|NCT00085644|13199324|P2|NOT COMPLETED|Double-Blind Period||6
5364620|NCT00085644|13199325|P1|NOT COMPLETED|Double-Blind Period||13
5364621|NCT00085644|13199323|P3|COMPLETED|Double-Blind Period||0
5364622|NCT00085644|13199324|P2|COMPLETED|Double-Blind Period||101
5364623|NCT00085644|13199325|P1|COMPLETED|Double-Blind Period||195
5364624|NCT00085644|13199323|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
5364625|NCT00085644|13199324|P2|STARTED|Double-Blind Period||107
5364626|NCT00085644|13199325|P1|STARTED|Double-Blind Period||208
5364627|NCT00085631|13199366|P3|NOT COMPLETED|Overall Study||7
5364628|NCT00085631|13199367|P2|NOT COMPLETED|Overall Study||11
5364629|NCT00085631|13199368|P1|NOT COMPLETED|Overall Study||4
5364630|NCT00085631|13199366|P3|COMPLETED|Overall Study||32
5364631|NCT00085631|13199367|P2|COMPLETED|Overall Study||38
5364632|NCT00085631|13199368|P1|COMPLETED|Overall Study||9
5364633|NCT00085631|13199366|P3|STARTED|Overall Study||39
5364634|NCT00085631|13199367|P2|STARTED|Overall Study||49
5364635|NCT00085631|13199368|P1|STARTED|Overall Study||13
5364636|NCT00085566|13199378|P3|NOT COMPLETED|Overall Study||14
5364637|NCT00085566|13199379|P2|NOT COMPLETED|Overall Study||0
5364638|NCT00085566|13199380|P1|NOT COMPLETED|Overall Study||0
5364639|NCT00085566|13199378|P3|COMPLETED|Overall Study||43
5364640|NCT00085566|13199379|P2|COMPLETED|Overall Study||3
5364641|NCT00085566|13199380|P1|COMPLETED|Overall Study||3
5364642|NCT00085566|13199378|P3|STARTED|Overall Study||57
5364643|NCT00085566|13199379|P2|STARTED|Overall Study||3
5364644|NCT00085566|13199380|P1|STARTED|Overall Study||3
5364645|NCT00085540|13199390|P2|NOT COMPLETED|Overall Study||2
5364646|NCT00085540|13199391|P1|NOT COMPLETED|Overall Study||0
5364647|NCT00085540|13199390|P2|COMPLETED|Overall Study||40
5364648|NCT00085540|13199391|P1|COMPLETED|Overall Study||8
5364649|NCT00085540|13199390|P2|STARTED|Overall Study||42
5364650|NCT00085540|13199391|P1|STARTED|Overall Study||8
5364651|NCT00085436|13199398|P1|NOT COMPLETED|Overall Study||0
5364652|NCT00085436|13199398|P1|COMPLETED|Overall Study||18
5364653|NCT00085436|13199398|P1|STARTED|Overall Study||18
5364654|NCT00085423|13199403|P1|NOT COMPLETED|Overall Study||2
5364655|NCT00085423|13199403|P1|COMPLETED|Overall Study||18
5364656|NCT00085423|13199403|P1|STARTED|Overall Study||20
5364657|NCT00085410|13199409|P1|NOT COMPLETED|Overall Study||0
5364658|NCT00085410|13199409|P1|COMPLETED|Overall Study||20
5364659|NCT00085410|13199409|P1|STARTED|Overall Study||20
5364660|NCT00085293|13199423|P1|NOT COMPLETED|Overall Study||0
5364661|NCT00085293|13199423|P1|COMPLETED|Overall Study||12
5364662|NCT00085293|13199423|P1|STARTED|Overall Study||12
5364663|NCT00085254|13199436|P3|NOT COMPLETED|Overall Study||0
5364664|NCT00085254|13199437|P2|NOT COMPLETED|Overall Study||0
5364665|NCT00085254|13199438|P1|NOT COMPLETED|Overall Study||0
5364666|NCT00085254|13199436|P3|COMPLETED|Overall Study||48
5364667|NCT00085254|13199437|P2|COMPLETED|Overall Study||46
5364668|NCT00085254|13199438|P1|COMPLETED|Overall Study||18
5364669|NCT00085254|13199436|P3|STARTED|Overall Study||48
5364670|NCT00085254|13199437|P2|STARTED|Overall Study||46
5364671|NCT00085254|13199438|P1|STARTED|Overall Study||18
5364672|NCT00085202|13199454|P2|NOT COMPLETED|Overall Study||24
5364673|NCT00085202|13199455|P1|NOT COMPLETED|Overall Study||18
5364674|NCT00085202|13199454|P2|COMPLETED|Overall Study||120
5364675|NCT00085202|13199455|P1|COMPLETED|Overall Study||251
5364676|NCT00085202|13199454|P2|STARTED|Overall Study||144
5364677|NCT00085202|13199455|P1|STARTED|Overall Study||269
5364678|NCT00085098|13199476|P2|NOT COMPLETED|Overall Study||2
5364679|NCT00085098|13199477|P1|NOT COMPLETED|Overall Study||1
5364680|NCT00085098|13199476|P2|COMPLETED|Overall Study||11
5364681|NCT00085098|13199477|P1|COMPLETED|Overall Study||10
5364682|NCT00085098|13199476|P2|STARTED|Overall Study||13
5364683|NCT00085098|13199477|P1|STARTED|Overall Study||11
5364684|NCT00084864|13199491|P4|NOT COMPLETED|Overall Study||0
5364685|NCT00084864|13199492|P3|NOT COMPLETED|Overall Study||0
5364686|NCT00084864|13199493|P2|NOT COMPLETED|Overall Study||0
5364687|NCT00084864|13199494|P1|NOT COMPLETED|Overall Study||1
5364688|NCT00084864|13199491|P4|COMPLETED|Overall Study||4
5364689|NCT00084864|13199492|P3|COMPLETED|Overall Study||4
5364690|NCT00084864|13199493|P2|COMPLETED|Overall Study||7
5364691|NCT00084864|13199494|P1|COMPLETED|Overall Study||9
5364692|NCT00084864|13199491|P4|STARTED|Overall Study||4
5364693|NCT00084864|13199492|P3|STARTED|Overall Study||4
5364694|NCT00084864|13199493|P2|STARTED|Overall Study||7
5364695|NCT00084864|13199494|P1|STARTED|Overall Study||10
5364696|NCT00084838|13199520|P1|NOT COMPLETED|Overall Study||13
5364697|NCT00084838|13199520|P1|COMPLETED|Overall Study||12
5364698|NCT00084838|13199520|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
5364699|NCT00084838|13199520|P1|STARTED|Overall Study||25
5364700|NCT00084747|13199542|P1|NOT COMPLETED|Overall Study||13
5364701|NCT00084747|13199542|P1|COMPLETED|Overall Study||17
5364702|NCT00084747|13199542|P1|STARTED|Overall Study||30
5364703|NCT00084682|13199547|P1|NOT COMPLETED|Overall Study||1
5364704|NCT00084682|13199547|P1|COMPLETED|Overall Study||13
5364705|NCT00084682|13199547|P1|STARTED|Overall Study||14
5364706|NCT00084617|13199551|P1|NOT COMPLETED|Overall Study||9
5364707|NCT00084617|13199551|P1|COMPLETED|Overall Study||30
5364708|NCT00084617|13199551|P1|STARTED|Overall Study||39
5364709|NCT00084487|13199557|P1|NOT COMPLETED|Overall Study||1
5364710|NCT00084487|13199557|P1|COMPLETED|Overall Study||20
5364711|NCT00084487|13199557|P1|STARTED|Overall Study||21
5364712|NCT00084409|13199567|P2|NOT COMPLETED|Overall Study||12
5364713|NCT00084409|13199568|P1|NOT COMPLETED|Overall Study||15
5364714|NCT00084409|13199567|P2|COMPLETED|Overall Study|4 Current, 8 former|65
5364715|NCT00084409|13199568|P1|COMPLETED|Overall Study|9 current, 6 former|60
5364716|NCT00084409|13199567|P2|STARTED|Overall Study|41 current, 36 former|77
5364717|NCT00084409|13199568|P1|STARTED|Overall Study|40 Current, 35 former|75
5364718|NCT00084383|13199594|P1|NOT COMPLETED|Overall Study||47
5364719|NCT00084383|13199594|P1|COMPLETED|Overall Study||13
5364720|NCT00084383|13199594|P1|STARTED|Overall Study||60
5364721|NCT00084318|13199601|P2|NOT COMPLETED|Overall Study||13
5364722|NCT00084318|13199602|P1|NOT COMPLETED|Overall Study||22
5364723|NCT00084318|13199601|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
5364724|NCT00084318|13199602|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
5364725|NCT00084318|13199601|P2|STARTED|Overall Study||119
5364726|NCT00084318|13199602|P1|STARTED|Overall Study||119
5364727|NCT00084266|13199622|P2|NOT COMPLETED|Overall Study||423
5364728|NCT00084266|13199623|P1|NOT COMPLETED|Overall Study||441
5364729|NCT00084266|13199622|P2|COMPLETED|Overall Study||184
5364730|NCT00084266|13199623|P1|COMPLETED|Overall Study||177
5364731|NCT00084266|13199622|P2|Treated|Overall Study||587
5364732|NCT00084266|13199623|P1|Treated|Overall Study||597
5364733|NCT00084266|13199622|P2|STARTED|Overall Study||607
5364734|NCT00084266|13199623|P1|STARTED|Overall Study||618
5364735|NCT00084149|13199659|P2|NOT COMPLETED|Overall Study||5
5364736|NCT00084149|13199660|P1|NOT COMPLETED|Overall Study||8
5364737|NCT00084149|13199659|P2|COMPLETED|Overall Study||13
5364738|NCT00084149|13199660|P1|COMPLETED|Overall Study||28
5364739|NCT00084149|13199659|P2|STARTED|Overall Study||18
5364740|NCT00084149|13199660|P1|STARTED|Overall Study||36
5364741|NCT00084136|13199681|P3|NOT COMPLETED|NRTI Comparison||82
5364742|NCT00084136|13199682|P2|NOT COMPLETED|NRTI Comparison||0
5364743|NCT00084136|13199683|P1|NOT COMPLETED|NRTI Comparison||101
5364744|NCT00084136|13199681|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
5364745|NCT00084136|13199682|P2|COMPLETED|NRTI Comparison||0
5364746|NCT00084136|13199683|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
5364747|NCT00084136|13199681|P3|STARTED|NRTI Comparison||526
5364748|NCT00084136|13199682|P2|STARTED|NRTI Comparison||0
5364749|NCT00084136|13199683|P1|STARTED|NRTI Comparison||519
5364750|NCT00084136|13199681|P3|NOT COMPLETED|PI Comparison||0
5364751|NCT00084136|13199682|P2|NOT COMPLETED|PI Comparison||47
5364752|NCT00084136|13199683|P1|NOT COMPLETED|PI Comparison||55
5364753|NCT00084136|13199681|P3|COMPLETED|PI Comparison||0
5364754|NCT00084136|13199682|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
5364755|NCT00084136|13199683|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
5364756|NCT00084136|13199681|P3|STARTED|PI Comparison||0
5364757|NCT00084136|13199682|P2|STARTED|PI Comparison||526
5364758|NCT00084136|13199683|P1|STARTED|PI Comparison||519
5364759|NCT00084084|13199742|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
5364760|NCT00084084|13199742|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
5364761|NCT00084084|13199742|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
5364762|NCT00084084|13199742|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
5364763|NCT00084084|13199742|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
5364764|NCT00084084|13199742|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
5364765|NCT00083915|13199752|P2|NOT COMPLETED|Overall Study||37
5364766|NCT00083915|13199753|P1|NOT COMPLETED|Overall Study||50
5364767|NCT00083915|13199752|P2|COMPLETED|Overall Study||8
5364768|NCT00083915|13199753|P1|COMPLETED|Overall Study||2
5364769|NCT00083915|13199752|P2|STARTED|Overall Study||45
5364770|NCT00083915|13199753|P1|STARTED|Overall Study||52
5364771|NCT00083889|13199761|P2|NOT COMPLETED|Overall Study||375
5364772|NCT00083889|13199762|P1|NOT COMPLETED|Overall Study||375
5364773|NCT00083889|13199761|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
5364774|NCT00083889|13199762|P1|COMPLETED|Overall Study||0
5364775|NCT00083889|13199761|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
5364776|NCT00083889|13199762|P1|Received Treatment|Overall Study||375
5364777|NCT00083889|13199761|P2|STARTED|Overall Study||375
5364778|NCT00083889|13199762|P1|STARTED|Overall Study||375
5364779|NCT00004146|13199811|P1|NOT COMPLETED|Overall Study||0
5364780|NCT00004146|13199811|P1|COMPLETED|Overall Study||55
5364781|NCT00004146|13199811|P1|STARTED|Overall Study||55
5364782|NCT00083759|13199820|P2|NOT COMPLETED|Overall Study||83
5364783|NCT00083759|13199821|P1|NOT COMPLETED|Overall Study||84
5364784|NCT00083759|13199820|P2|COMPLETED|Overall Study||66
5364785|NCT00083759|13199821|P1|COMPLETED|Overall Study||66
5364786|NCT00083759|13199820|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
5364787|NCT00083759|13199821|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
5364788|NCT00083720|13199829|P1|NOT COMPLETED|Overall Study||0
5364789|NCT00083720|13199829|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
5364790|NCT00083720|13199829|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
5364791|NCT00083616|13199839|P1|NOT COMPLETED|Overall Study||31
5364792|NCT00083616|13199839|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
5364793|NCT00083616|13199839|P1|Received Study Medication|Overall Study||182
5364794|NCT00083616|13199839|P1|STARTED|Overall Study||185
5364795|NCT00083551|13199853|P2|NOT COMPLETED|Overall Study||0
5364796|NCT00083551|13199854|P1|NOT COMPLETED|Overall Study||0
5364797|NCT00083551|13199853|P2|COMPLETED|Overall Study||345
5364798|NCT00083551|13199854|P1|COMPLETED|Overall Study||323
5364799|NCT00083551|13199853|P2|STARTED|Overall Study||345
5364800|NCT00083551|13199854|P1|STARTED|Overall Study||323
5364801|NCT00083382|13199860|P1|NOT COMPLETED|Overall Study||0
5364802|NCT00083382|13199860|P1|COMPLETED|Overall Study||83
5364803|NCT00083382|13199860|P1|STARTED|Overall Study||83
5364804|NCT00082888|13199867|P3|NOT COMPLETED|Overall Study||0
5364805|NCT00082888|13199868|P2|NOT COMPLETED|Overall Study||0
5364806|NCT00082888|13199869|P1|NOT COMPLETED|Overall Study||1
5364807|NCT00082888|13199867|P3|COMPLETED|Overall Study||36
5364808|NCT00082888|13199868|P2|COMPLETED|Overall Study||15
5364809|NCT00082888|13199869|P1|COMPLETED|Overall Study||41
5364810|NCT00082888|13199867|P3|STARTED|Overall Study||36
5364811|NCT00082888|13199868|P2|STARTED|Overall Study||15
5364812|NCT00082888|13199869|P1|STARTED|Overall Study||42
5364813|NCT00082810|13199889|P1|NOT COMPLETED|Overall Study||31
5364814|NCT00082810|13199889|P1|COMPLETED|Overall Study||2
5364815|NCT00082810|13199889|P1|STARTED|Overall Study||33
5364816|NCT00082758|13199900|P3|NOT COMPLETED|Overall Study||0
5364817|NCT00082758|13199901|P2|NOT COMPLETED|Overall Study||17
5364818|NCT00082758|13199902|P1|NOT COMPLETED|Overall Study||15
5364819|NCT00082758|13199900|P3|COMPLETED|Overall Study||0
5364820|NCT00082758|13199901|P2|COMPLETED|Overall Study||7
5364821|NCT00082758|13199902|P1|COMPLETED|Overall Study||0
5364822|NCT00082758|13199900|P3|STARTED|Overall Study||0
5364823|NCT00082758|13199901|P2|STARTED|Overall Study||24
5364824|NCT00082758|13199902|P1|STARTED|Overall Study||15
5364825|NCT00082641|13199912|P2|NOT COMPLETED|Overall Study||0
5364826|NCT00082641|13199913|P1|NOT COMPLETED|Overall Study||0
5364827|NCT00082641|13199912|P2|COMPLETED|Overall Study||12
5364828|NCT00082641|13199913|P1|COMPLETED|Overall Study||11
5364829|NCT00082641|13199912|P2|STARTED|Overall Study||12
5364830|NCT00082641|13199913|P1|STARTED|Overall Study||11
5364831|NCT00083226|13199922|P1|NOT COMPLETED|Overall Study||42
5364832|NCT00083226|13199922|P1|COMPLETED|Overall Study||0
5364833|NCT00083226|13199922|P1|STARTED|Overall Study||42
5364834|NCT00083174|13199930|P3|NOT COMPLETED|Open-label Extension||0
5364835|NCT00083174|13199931|P2|NOT COMPLETED|Open-label Extension||0
5364836|NCT00083174|13199932|P1|NOT COMPLETED|Open-label Extension||0
5364837|NCT00083174|13199930|P3|COMPLETED|Open-label Extension||2831
5364838|NCT00083174|13199931|P2|COMPLETED|Open-label Extension||0
5364839|NCT00083174|13199932|P1|COMPLETED|Open-label Extension||0
5364840|NCT00083174|13199930|P3|STARTED|Open-label Extension||2831
5364841|NCT00083174|13199931|P2|STARTED|Open-label Extension||0
5364842|NCT00083174|13199932|P1|STARTED|Open-label Extension||0
5364843|NCT00083174|13199930|P3|NOT COMPLETED|Randomization Period||0
5364844|NCT00083174|13199931|P2|NOT COMPLETED|Randomization Period||0
5364845|NCT00083174|13199932|P1|NOT COMPLETED|Randomization Period||0
5364846|NCT00083174|13199930|P3|COMPLETED|Randomization Period||0
5364847|NCT00083174|13199931|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
5364848|NCT00083174|13199932|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
5364849|NCT00083174|13199930|P3|STARTED|Randomization Period||0
5364850|NCT00083174|13199931|P2|STARTED|Randomization Period||2275
5364851|NCT00083174|13199932|P1|STARTED|Randomization Period||2285
5364852|NCT00083122|13199954|P2|NOT COMPLETED|Overall Study||0
5364853|NCT00083122|13199955|P1|NOT COMPLETED|Overall Study||0
5364854|NCT00083122|13199954|P2|COMPLETED|Overall Study||5
5364855|NCT00083122|13199955|P1|COMPLETED|Overall Study||40
5364856|NCT00083122|13199954|P2|STARTED|Overall Study||5
5364857|NCT00083122|13199955|P1|STARTED|Overall Study||40
5364858|NCT00082628|13199966|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
5364859|NCT00082628|13199967|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
5364860|NCT00082628|13199968|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
5364861|NCT00082628|13199969|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
5364862|NCT00082628|13199970|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
5364863|NCT00082628|13199966|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
5364864|NCT00082628|13199967|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
5364865|NCT00082628|13199968|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
5364866|NCT00082628|13199969|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
5364867|NCT00082628|13199970|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
5364868|NCT00082628|13199966|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
5364869|NCT00082628|13199967|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
5364870|NCT00082628|13199968|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
5364871|NCT00082628|13199969|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
5364872|NCT00082628|13199970|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
5364873|NCT00082628|13199966|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364874|NCT00082628|13199967|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364875|NCT00082628|13199968|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364876|NCT00082628|13199969|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
5364877|NCT00082628|13199970|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
5364878|NCT00082628|13199966|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364879|NCT00082628|13199967|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364880|NCT00082628|13199968|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
5364881|NCT00082628|13199969|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
5364882|NCT00082628|13199970|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
5364883|NCT00082628|13199966|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
5364884|NCT00082628|13199967|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
5364885|NCT00082628|13199968|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
5364886|NCT00082628|13199969|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
5364887|NCT00082628|13199970|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
5364888|NCT00082433|13199990|P2|NOT COMPLETED|Overall Study||597
5364889|NCT00082433|13199991|P1|NOT COMPLETED|Overall Study||594
5364890|NCT00082433|13199990|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
5364891|NCT00082433|13199991|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
5364892|NCT00082433|13199990|P2|STARTED|Overall Study||612
5364893|NCT00082433|13199991|P1|STARTED|Overall Study||609
5364894|NCT00082381|13200011|P2|NOT COMPLETED|Overall Study||26
5364895|NCT00082381|13200012|P1|NOT COMPLETED|Overall Study||55
5364896|NCT00082381|13200011|P2|COMPLETED|Overall Study||242
5364897|NCT00082381|13200012|P1|COMPLETED|Overall Study||228
5364898|NCT00082381|13200011|P2|Received Treatment (Intent to Treat)|Overall Study||267
5364899|NCT00082381|13200012|P1|Received Treatment (Intent to Treat)|Overall Study||282
5364900|NCT00082381|13200011|P2|STARTED|Overall Study||268
5364901|NCT00082381|13200012|P1|STARTED|Overall Study||283
5364902|NCT00082407|13200032|P2|NOT COMPLETED|Overall Study||27
5364903|NCT00082407|13200033|P1|NOT COMPLETED|Overall Study||56
5364904|NCT00082407|13200032|P2|COMPLETED|Overall Study||223
5364905|NCT00082407|13200033|P1|COMPLETED|Overall Study||199
5364906|NCT00082407|13200032|P2|Received Treatment (Intent to Treat)|Overall Study||248
5364907|NCT00082407|13200033|P1|Received Treatment (Intent to Treat)|Overall Study||253
5364908|NCT00082407|13200032|P2|STARTED|Overall Study||250
5364909|NCT00082407|13200033|P1|STARTED|Overall Study||255
5364910|NCT00082368|13200051|P1|NOT COMPLETED|Overall Study||1
5364911|NCT00082368|13200051|P1|COMPLETED|Overall Study||11
5364912|NCT00082368|13200051|P1|STARTED|Overall Study||12
5364913|NCT00082355|13200056|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
5364914|NCT00082355|13200056|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
5364915|NCT00082355|13200056|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
5364916|NCT00082355|13200056|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
5364917|NCT00082355|13200056|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
5364918|NCT00082355|13200056|P1|STARTED|Initial Results of Thrombolytic Therapy||30
5364919|NCT00082342|13200063|P2|NOT COMPLETED|Overall Study||0
5364920|NCT00082342|13200064|P1|NOT COMPLETED|Overall Study||0
5364921|NCT00082342|13200063|P2|COMPLETED|Overall Study||12
5364922|NCT00082342|13200064|P1|COMPLETED|Overall Study||13
5364923|NCT00082342|13200063|P2|STARTED|Overall Study||12
5364924|NCT00082342|13200064|P1|STARTED|Overall Study||13
5364925|NCT00082329|13200084|P1|NOT COMPLETED|Overall Study||0
5364926|NCT00082329|13200084|P1|COMPLETED|Overall Study||9
5364927|NCT00082329|13200084|P1|STARTED|Overall Study||9
5364928|NCT00082173|13200090|P2|NOT COMPLETED|Overall Study||11
5364929|NCT00082173|13200091|P1|NOT COMPLETED|Overall Study||10
5364930|NCT00082173|13200090|P2|COMPLETED|Overall Study||61
5364931|NCT00082173|13200091|P1|COMPLETED|Overall Study||64
5364932|NCT00082173|13200090|P2|STARTED|Overall Study||72
5364933|NCT00082173|13200091|P1|STARTED|Overall Study||74
5364934|NCT00003726|13200099|P1|NOT COMPLETED|Overall Study||1
5364935|NCT00003726|13200099|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
5364936|NCT00003726|13200099|P1|STARTED|Overall Study||1
5364937|NCT00081939|13200103|P1|NOT COMPLETED|Overall Study||0
5364938|NCT00081939|13200103|P1|COMPLETED|Overall Study||303
5364939|NCT00081939|13200103|P1|STARTED|Overall Study||303
5364940|NCT00082017|13200107|P2|NOT COMPLETED|Overall Study||0
5364941|NCT00082017|13200108|P1|NOT COMPLETED|Overall Study||0
5364942|NCT00082017|13200107|P2|COMPLETED|Overall Study||9
5364943|NCT00082017|13200108|P1|COMPLETED|Overall Study||11
5364944|NCT00082017|13200107|P2|STARTED|Overall Study||9
5364945|NCT00082017|13200108|P1|STARTED|Overall Study||11
5364946|NCT00081861|13200124|P1|NOT COMPLETED|Overall Study||0
5364947|NCT00081861|13200124|P1|COMPLETED|Overall Study||13
5364948|NCT00081861|13200124|P1|STARTED|Overall Study||13
5364949|NCT00003270|13200128|P1|NOT COMPLETED|Overall Study||0
5364950|NCT00003270|13200128|P1|COMPLETED|Overall Study||20
5364951|NCT00003270|13200128|P1|STARTED|Overall Study||20
5364952|NCT00081770|13200136|P3|NOT COMPLETED|Overall Study||456
5364953|NCT00081770|13200137|P2|NOT COMPLETED|Overall Study||546
5364954|NCT00081770|13200138|P1|NOT COMPLETED|Overall Study||502
5364955|NCT00081770|13200136|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
5364956|NCT00081770|13200137|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
5364957|NCT00081770|13200138|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
5364958|NCT00081770|13200136|P3|STARTED|Overall Study||1035
5364959|NCT00081770|13200137|P2|STARTED|Overall Study||1016
5364960|NCT00081770|13200138|P1|STARTED|Overall Study||1019
5364961|NCT00081731|13200157|P2|NOT COMPLETED|Overall Study||8
5364962|NCT00081731|13200158|P1|NOT COMPLETED|Overall Study||8
5364963|NCT00081731|13200157|P2|COMPLETED|Overall Study||459
5364964|NCT00081731|13200158|P1|COMPLETED|Overall Study||472
5364965|NCT00081731|13200157|P2|STARTED|Overall Study||467
5364966|NCT00081731|13200158|P1|STARTED|Overall Study||480
5364967|NCT00081653|13200178|P2|NOT COMPLETED|Overall Study||37
5364968|NCT00081653|13200179|P1|NOT COMPLETED|Overall Study||47
5364969|NCT00081653|13200178|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
5364970|NCT00081653|13200179|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
5364971|NCT00081653|13200178|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
5364972|NCT00081653|13200179|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
5364973|NCT00081497|13200197|P2|NOT COMPLETED|Overall Study||2
5364974|NCT00081497|13200198|P1|NOT COMPLETED|Overall Study||3
5364975|NCT00081497|13200197|P2|COMPLETED|Overall Study||37
5364976|NCT00081497|13200198|P1|COMPLETED|Overall Study||25
5364977|NCT00081497|13200197|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
5364978|NCT00081497|13200198|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
5364979|NCT00081458|13200216|P3|NOT COMPLETED|Overall Study||4
5364980|NCT00081458|13200217|P2|NOT COMPLETED|Overall Study||8
5364981|NCT00081458|13200218|P1|NOT COMPLETED|Overall Study||1
5364982|NCT00081458|13200216|P3|COMPLETED|Overall Study||29
5364983|NCT00081458|13200217|P2|COMPLETED|Overall Study||27
5364984|NCT00081458|13200218|P1|COMPLETED|Overall Study||15
5364985|NCT00081458|13200216|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
5364986|NCT00081458|13200217|P2|Received Treatment|Overall Study||35
5364987|NCT00081458|13200218|P1|Received Treatment|Overall Study||16
5364988|NCT00081458|13200216|P3|STARTED|Overall Study||33
5364989|NCT00081458|13200217|P2|STARTED|Overall Study||35
5364990|NCT00081458|13200218|P1|STARTED|Overall Study||16
5364991|NCT00081328|13200232|P3|NOT COMPLETED|Overall Study||0
5364992|NCT00081328|13200233|P2|NOT COMPLETED|Overall Study||0
5364993|NCT00081328|13200234|P1|NOT COMPLETED|Overall Study||0
5364994|NCT00081328|13200232|P3|COMPLETED|Overall Study||234
5364995|NCT00081328|13200233|P2|COMPLETED|Overall Study||233
5364996|NCT00081328|13200234|P1|COMPLETED|Overall Study||232
5364997|NCT00081328|13200232|P3|STARTED|Overall Study||234
5364998|NCT00081328|13200233|P2|STARTED|Overall Study||233
5364999|NCT00081328|13200234|P1|STARTED|Overall Study||232
5365000|NCT00081289|13200274|P2|NOT COMPLETED|Overall Study||21
5365001|NCT00081289|13200275|P1|NOT COMPLETED|Overall Study||21
5365002|NCT00081289|13200274|P2|COMPLETED|Overall Study||52
5365003|NCT00081289|13200275|P1|COMPLETED|Overall Study||52
5365004|NCT00081289|13200274|P2|Defecation Symptom Score at Two Years|Overall Study||15
5365005|NCT00081289|13200275|P1|Defecation Symptom Score at Two Years|Overall Study||13
5365006|NCT00081289|13200274|P2|DS Score at End of Post-op CT|Overall Study||14
5365007|NCT00081289|13200275|P1|DS Score at End of Post-op CT|Overall Study||12
5365008|NCT00081289|13200274|P2|Defecation Symptom Score at End of CR|Overall Study||32
5365009|NCT00081289|13200275|P1|Defecation Symptom Score at End of CR|Overall Study||32
5365010|NCT00081289|13200274|P2|GI Symptom Score at Two Years|Overall Study||20
5365011|NCT00081289|13200275|P1|GI Symptom Score at Two Years|Overall Study||21
5365012|NCT00081289|13200274|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
5365013|NCT00081289|13200275|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
5365014|NCT00081289|13200274|P2|GI Symptom Score at End of CR|Overall Study||33
5365015|NCT00081289|13200275|P1|GI Symptom Score at End of CR|Overall Study||34
5365016|NCT00081289|13200274|P2|GHS at Two Years|Overall Study||20
5365017|NCT00081289|13200275|P1|GHS at Two Years|Overall Study||21
5365018|NCT00081289|13200274|P2|GHS at End of Post-op CT|Overall Study||28
5365019|NCT00081289|13200275|P1|GHS at End of Post-op CT|Overall Study||20
5365020|NCT00081289|13200274|P2|Global Health Status Score at End of CR|Overall Study||32
5365021|NCT00081289|13200275|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
5365022|NCT00081289|13200274|P2|Surgery|Overall Study||51
5365023|NCT00081289|13200275|P1|Surgery|Overall Study||47
5365024|NCT00081289|13200274|P2|Full AE Population|Overall Study||68
5365025|NCT00081289|13200275|P1|Full AE Population|Overall Study||70
5365026|NCT00081289|13200274|P2|General Analysis Population|Overall Study||52
5365027|NCT00081289|13200275|P1|General Analysis Population|Overall Study||52
5365028|NCT00081289|13200274|P2|Primary Endpoint Population|Overall Study||48
5365029|NCT00081289|13200275|P1|Primary Endpoint Population|Overall Study||48
5365030|NCT00081289|13200274|P2|STARTED|Overall Study||73
5365031|NCT00081289|13200275|P1|STARTED|Overall Study||73
5365032|NCT00081263|13200319|P2|NOT COMPLETED|Overall Study||22
5365033|NCT00081263|13200320|P1|NOT COMPLETED|Overall Study||17
5365034|NCT00081263|13200319|P2|COMPLETED|Overall Study||41
5365035|NCT00081263|13200320|P1|COMPLETED|Overall Study||50
5365036|NCT00081263|13200319|P2|STARTED|Overall Study||63
5365037|NCT00081263|13200320|P1|STARTED|Overall Study||67
5365038|NCT00081159|13200330|P2|NOT COMPLETED|Overall Study||5
5365039|NCT00081159|13200331|P1|NOT COMPLETED|Overall Study||2
5365040|NCT00081159|13200330|P2|COMPLETED|Overall Study||35
5365041|NCT00081159|13200331|P1|COMPLETED|Overall Study||37
5365042|NCT00081159|13200330|P2|STARTED|Overall Study||40
5365043|NCT00081159|13200331|P1|STARTED|Overall Study||39
5365044|NCT00080938|13200341|P1|NOT COMPLETED|Overall Study||24
5365045|NCT00080938|13200341|P1|COMPLETED|Overall Study||2
5365046|NCT00080938|13200341|P1|Eligible and Treated|Overall Study||21
5365047|NCT00080938|13200341|P1|Began Protocol Therapy|Overall Study||25
5365048|NCT00080938|13200341|P1|STARTED|Overall Study||26
5365049|NCT00080912|13200350|P2|NOT COMPLETED|Overall Study||0
5365050|NCT00080912|13200351|P1|NOT COMPLETED|Overall Study||0
5365051|NCT00080912|13200350|P2|COMPLETED|Overall Study||425
5365052|NCT00080912|13200351|P1|COMPLETED|Overall Study||425
5365053|NCT00080912|13200350|P2|STARTED|Overall Study||425
5365054|NCT00080912|13200351|P1|STARTED|Overall Study||425
5365055|NCT00080899|13200357|P1|NOT COMPLETED|Overall Study||1
5365056|NCT00080899|13200357|P1|COMPLETED|Overall Study||22
5365057|NCT00080899|13200357|P1|STARTED|Overall Study||23
5365058|NCT00080535|13200362|P1|NOT COMPLETED|Overall Study||0
5365059|NCT00080535|13200362|P1|COMPLETED|Overall Study||10
5365060|NCT00080535|13200362|P1|STARTED|Overall Study||10
5365061|NCT00080483|13200369|P2|NOT COMPLETED|Overall Study||2
5365062|NCT00080483|13200370|P1|NOT COMPLETED|Overall Study||2
5365063|NCT00080483|13200369|P2|COMPLETED|Overall Study||16
5365064|NCT00080483|13200370|P1|COMPLETED|Overall Study||15
5365065|NCT00080483|13200369|P2|STARTED|Overall Study||18
5365066|NCT00080483|13200370|P1|STARTED|Overall Study||17
5365067|NCT00002525|13200378|P2|NOT COMPLETED|Overall Study||0
5365068|NCT00002525|13200379|P1|NOT COMPLETED|Overall Study||186
5365069|NCT00002525|13200378|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
5365070|NCT00002525|13200379|P1|COMPLETED|Overall Study||241
5365071|NCT00002525|13200378|P2|Dukes' B2 Stage|Overall Study||139
5365072|NCT00002525|13200379|P1|Dukes' B2 Stage|Overall Study||150
5365073|NCT00002525|13200378|P2|Dukes' B3 or C Stage|Overall Study||158
5365074|NCT00002525|13200379|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
5365075|NCT00002525|13200378|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
5365076|NCT00002525|13200379|P1|Treated|Overall Study||419
5365077|NCT00002525|13200378|P2|STARTED|Overall Study||428
5365078|NCT00002525|13200379|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
5365079|NCT00080470|13200395|P2|NOT COMPLETED|Overall Study||28
5365080|NCT00080470|13200396|P1|NOT COMPLETED|Overall Study||34
5365081|NCT00080470|13200395|P2|COMPLETED|Overall Study||14
5365082|NCT00080470|13200396|P1|COMPLETED|Overall Study||11
5365083|NCT00080470|13200395|P2|STARTED|Overall Study||42
5365084|NCT00080470|13200396|P1|STARTED|Overall Study||45
5365085|NCT00080301|13200406|P2|NOT COMPLETED|Overall Study||11
5365086|NCT00080301|13200407|P1|NOT COMPLETED|Overall Study||5
5365087|NCT00080301|13200406|P2|COMPLETED|Overall Study|Participants who are off treatment|366
5365088|NCT00080301|13200407|P1|COMPLETED|Overall Study|Participants who are off treatment|370
5365089|NCT00080301|13200406|P2|Still on Treatment|Overall Study||1
5365090|NCT00080301|13200407|P1|Still on Treatment|Overall Study||0
5365091|NCT00080301|13200406|P2|Never Treated|Overall Study||10
5365092|NCT00080301|13200407|P1|Never Treated|Overall Study||5
5365093|NCT00080301|13200406|P2|STARTED|Overall Study||377
5365094|NCT00080301|13200407|P1|STARTED|Overall Study||375
5365095|NCT00080288|13200427|P2|NOT COMPLETED|Overall Study||38
5365096|NCT00080288|13200428|P1|NOT COMPLETED|Overall Study||30
5365097|NCT00080288|13200427|P2|COMPLETED|Overall Study||89
5365098|NCT00080288|13200428|P1|COMPLETED|Overall Study||97
5365099|NCT00080288|13200427|P2|STARTED|Overall Study||127
5365100|NCT00080288|13200428|P1|STARTED|Overall Study||127
5365101|NCT00080223|13200436|P1|NOT COMPLETED|Overall Study||76
5365102|NCT00080223|13200436|P1|COMPLETED|Overall Study||7
5365103|NCT00080223|13200436|P1|STARTED|Overall Study||83
5365104|NCT00002540|13200446|P2|NOT COMPLETED|Overall Study||2464
5365105|NCT00002540|13200447|P1|NOT COMPLETED|Overall Study||801
5365106|NCT00002540|13200446|P2|COMPLETED|Overall Study||35876
5365107|NCT00002540|13200447|P1|COMPLETED|Overall Study||37544
5365108|NCT00002540|13200446|P2|STARTED|Overall Study||38340
5365109|NCT00002540|13200447|P1|STARTED|Overall Study||38345
5365110|NCT00080119|13200477|P4|NOT COMPLETED|Overall Study||163
5365111|NCT00080119|13200478|P3|NOT COMPLETED|Overall Study||165
5365112|NCT00080119|13200479|P2|NOT COMPLETED|Overall Study||62
5365113|NCT00080119|13200480|P1|NOT COMPLETED|Overall Study||56
5365114|NCT00080119|13200477|P4|COMPLETED|Overall Study||111
5365115|NCT00080119|13200478|P3|COMPLETED|Overall Study||108
5365116|NCT00080119|13200479|P2|COMPLETED|Overall Study||339
5365117|NCT00080119|13200480|P1|COMPLETED|Overall Study||347
5365118|NCT00080119|13200477|P4|STARTED|Overall Study||274
5365119|NCT00080119|13200478|P3|STARTED|Overall Study||273
5365120|NCT00080119|13200479|P2|STARTED|Overall Study||401
5365121|NCT00080119|13200480|P1|STARTED|Overall Study||403
5365122|NCT00079937|13200514|P2|NOT COMPLETED|Overall Study||32
5365123|NCT00079937|13200515|P1|NOT COMPLETED|Overall Study||69
5365124|NCT00079937|13200514|P2|COMPLETED|Overall Study||175
5365125|NCT00079937|13200515|P1|COMPLETED|Overall Study||352
5365126|NCT00079937|13200514|P2|STARTED|Overall Study||207
5365127|NCT00079937|13200515|P1|STARTED|Overall Study||421
5365128|NCT00009737|13200533|P2|NOT COMPLETED|Overall Study||123
5365129|NCT00009737|13200534|P1|NOT COMPLETED|Overall Study||170
5365130|NCT00009737|13200533|P2|COMPLETED|Overall Study||860
5365131|NCT00009737|13200534|P1|COMPLETED|Overall Study||834
5365132|NCT00009737|13200533|P2|STARTED|Overall Study||983
5365133|NCT00009737|13200534|P1|STARTED|Overall Study||1004
5365134|NCT00079781|13200553|P3|NOT COMPLETED|Follow-up Period||2
5365135|NCT00079781|13200554|P2|NOT COMPLETED|Follow-up Period||0
5365136|NCT00079781|13200555|P1|NOT COMPLETED|Follow-up Period||4
5365137|NCT00079781|13200553|P3|COMPLETED|Follow-up Period||12
5365138|NCT00079781|13200554|P2|COMPLETED|Follow-up Period||9
5365139|NCT00079781|13200555|P1|COMPLETED|Follow-up Period||38
5365140|NCT00079781|13200553|P3|STARTED|Follow-up Period||14
5365141|NCT00079781|13200554|P2|STARTED|Follow-up Period||9
5365142|NCT00079781|13200555|P1|STARTED|Follow-up Period||42
5365143|NCT00079781|13200553|P3|NOT COMPLETED|Evaluation Period||0
5365144|NCT00079781|13200554|P2|NOT COMPLETED|Evaluation Period||0
5365145|NCT00079781|13200555|P1|NOT COMPLETED|Evaluation Period||0
5365146|NCT00079781|13200553|P3|COMPLETED|Evaluation Period||14
5365147|NCT00079781|13200554|P2|COMPLETED|Evaluation Period||9
5365148|NCT00079781|13200555|P1|COMPLETED|Evaluation Period||42
5365149|NCT00079781|13200553|P3|STARTED|Evaluation Period||14
5365150|NCT00079781|13200554|P2|STARTED|Evaluation Period||9
5365151|NCT00079781|13200555|P1|STARTED|Evaluation Period||42
5365152|NCT00079781|13200553|P3|NOT COMPLETED|Pre-implant Period||1
5365153|NCT00079781|13200554|P2|NOT COMPLETED|Pre-implant Period||1
5365154|NCT00079781|13200555|P1|NOT COMPLETED|Pre-implant Period||3
5365155|NCT00079781|13200553|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
5365156|NCT00079781|13200554|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
5365157|NCT00079781|13200555|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
5365158|NCT00079781|13200553|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
5365159|NCT00079781|13200554|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
5365160|NCT00079781|13200555|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
5365161|NCT00079677|13200564|P2|NOT COMPLETED|Overall Study||14
5365162|NCT00079677|13200565|P1|NOT COMPLETED|Overall Study||20
5365163|NCT00079677|13200564|P2|COMPLETED|Overall Study||118
5365164|NCT00079677|13200565|P1|COMPLETED|Overall Study||111
5365165|NCT00079677|13200564|P2|STARTED|Overall Study||132
5365166|NCT00079677|13200565|P1|STARTED|Overall Study||131
5365167|NCT00002601|13200573|P1|NOT COMPLETED|Overall Study||0
5365168|NCT00002601|13200573|P1|COMPLETED|Overall Study||13
5365169|NCT00002601|13200573|P1|STARTED|Overall Study||13
5365170|NCT00079417|13200581|P1|NOT COMPLETED|Overall Study||9
5365171|NCT00079417|13200581|P1|COMPLETED|Overall Study||19
5365172|NCT00079417|13200581|P1|STARTED|Overall Study||28
5365173|NCT00079391|13200589|P1|NOT COMPLETED|Overall Study||1
5365174|NCT00079391|13200589|P1|COMPLETED|Overall Study||49
5365175|NCT00079391|13200589|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
5365176|NCT00079339|13200601|P3|NOT COMPLETED|Overall Study||6
5365177|NCT00079339|13200602|P2|NOT COMPLETED|Overall Study||39
5365178|NCT00079339|13200603|P1|NOT COMPLETED|Overall Study||5
5365179|NCT00079339|13200601|P3|COMPLETED|Overall Study||0
5365180|NCT00079339|13200602|P2|COMPLETED|Overall Study||1
5365181|NCT00079339|13200603|P1|COMPLETED|Overall Study||0
5365182|NCT00079339|13200601|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
5365183|NCT00079339|13200602|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
5365184|NCT00079339|13200603|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
5365185|NCT00079339|13200601|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
5365186|NCT00079339|13200602|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
5365187|NCT00079339|13200603|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
5365188|NCT00079339|13200601|P3|Enrolled in Phase I|Overall Study||6
5365189|NCT00079339|13200602|P2|Enrolled in Phase I|Overall Study||6
5365190|NCT00079339|13200603|P1|Enrolled in Phase I|Overall Study||5
5365191|NCT00079339|13200601|P3|STARTED|Overall Study||6
5365192|NCT00079339|13200602|P2|STARTED|Overall Study||40
5365193|NCT00079339|13200603|P1|STARTED|Overall Study||5
5365194|NCT00079326|13200619|P2|NOT COMPLETED|Overall Study||0
5365195|NCT00079326|13200620|P1|NOT COMPLETED|Overall Study||0
5365196|NCT00079326|13200619|P2|COMPLETED|Overall Study||24
5365197|NCT00079326|13200620|P1|COMPLETED|Overall Study||15
5365198|NCT00079326|13200619|P2|STARTED|Overall Study||24
5365199|NCT00079326|13200620|P1|STARTED|Overall Study||15
5365200|NCT00079274|13200634|P7|NOT COMPLETED|Overall Study||0
5365201|NCT00079274|13200635|P6|NOT COMPLETED|Overall Study||20
5365202|NCT00079274|13200636|P5|NOT COMPLETED|Overall Study||15
5365203|NCT00079274|13200637|P4|NOT COMPLETED|Overall Study||444
5365204|NCT00079274|13200638|P3|NOT COMPLETED|Overall Study||27
5365205|NCT00079274|13200639|P2|NOT COMPLETED|Overall Study||27
5365206|NCT00079274|13200640|P1|NOT COMPLETED|Overall Study||321
5365207|NCT00079274|13200634|P7|COMPLETED|Overall Study||332
5365208|NCT00079274|13200635|P6|COMPLETED|Overall Study||26
5365209|NCT00079274|13200636|P5|COMPLETED|Overall Study||30
5365210|NCT00079274|13200637|P4|COMPLETED|Overall Study||906
5365211|NCT00079274|13200638|P3|COMPLETED|Overall Study||84
5365212|NCT00079274|13200639|P2|COMPLETED|Overall Study||84
5365213|NCT00079274|13200640|P1|COMPLETED|Overall Study||1081
5365214|NCT00079274|13200634|P7|STARTED|Overall Study||332
5365215|NCT00079274|13200635|P6|STARTED|Overall Study||46
5365216|NCT00079274|13200636|P5|STARTED|Overall Study||45
5365217|NCT00079274|13200637|P4|STARTED|Overall Study||1350
5365218|NCT00079274|13200638|P3|STARTED|Overall Study||111
5365219|NCT00079274|13200639|P2|STARTED|Overall Study||111
5365220|NCT00079274|13200640|P1|STARTED|Overall Study||1402
5365221|NCT00079183|13200661|P1|NOT COMPLETED|Overall Study||7
5365222|NCT00079183|13200661|P1|COMPLETED|Overall Study||37
5365223|NCT00079183|13200661|P1|Drop Outs|Overall Study||7
5365224|NCT00079183|13200661|P1|STARTED|Overall Study||44
5365225|NCT00079040|13200676|P1|NOT COMPLETED|Overall Study||2
5365226|NCT00079040|13200676|P1|COMPLETED|Overall Study||63
5365227|NCT00079040|13200676|P1|STARTED|Overall Study||65
5365228|NCT00079001|13200684|P2|NOT COMPLETED|Overall Study||0
5365229|NCT00079001|13200685|P1|NOT COMPLETED|Overall Study||0
5365230|NCT00079001|13200684|P2|COMPLETED|Overall Study||322
5365231|NCT00079001|13200685|P1|COMPLETED|Overall Study||323
5365232|NCT00079001|13200684|P2|STARTED|Overall Study||322
5365233|NCT00079001|13200685|P1|STARTED|Overall Study||323
5365234|NCT00078949|13200699|P4|NOT COMPLETED|Overall Study||3
5365235|NCT00078949|13200700|P3|NOT COMPLETED|Overall Study||3
5365236|NCT00078949|13200701|P2|NOT COMPLETED|Overall Study||5
5365237|NCT00078949|13200702|P1|NOT COMPLETED|Overall Study||4
5365238|NCT00078949|13200699|P4|COMPLETED|Overall Study||112
5365239|NCT00078949|13200700|P3|COMPLETED|Overall Study||112
5365240|NCT00078949|13200701|P2|COMPLETED|Overall Study||304
5365241|NCT00078949|13200702|P1|COMPLETED|Overall Study||306
5365242|NCT00078949|13200699|P4|STARTED|Overall Study||115
5365243|NCT00078949|13200700|P3|STARTED|Overall Study||115
5365244|NCT00078949|13200701|P2|STARTED|Overall Study||309
5365245|NCT00078949|13200702|P1|STARTED|Overall Study||310
5365246|NCT00078897|13200720|P2|NOT COMPLETED|Overall Study||123
5365247|NCT00078897|13200721|P1|NOT COMPLETED|Overall Study||124
5365248|NCT00078897|13200720|P2|COMPLETED|Overall Study||689
5365249|NCT00078897|13200721|P1|COMPLETED|Overall Study||685
5365250|NCT00078897|13200720|P2|STARTED|Overall Study||812
5365251|NCT00078897|13200721|P1|STARTED|Overall Study||809
5365252|NCT00078819|13200731|P4|NOT COMPLETED|Re-treatment Period||0
5365253|NCT00078819|13200732|P3|NOT COMPLETED|Re-treatment Period||0
5365254|NCT00078819|13200733|P2|NOT COMPLETED|Re-treatment Period||0
5365255|NCT00078819|13200734|P1|NOT COMPLETED|Re-treatment Period||0
5365256|NCT00078819|13200731|P4|COMPLETED|Re-treatment Period||13
5365257|NCT00078819|13200732|P3|COMPLETED|Re-treatment Period||29
5365258|NCT00078819|13200733|P2|COMPLETED|Re-treatment Period||0
5365259|NCT00078819|13200734|P1|COMPLETED|Re-treatment Period||0
5365260|NCT00078819|13200731|P4|Received Study Drug|Re-treatment Period||12
5365261|NCT00078819|13200732|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
5365262|NCT00078819|13200733|P2|Received Study Drug|Re-treatment Period||0
5365263|NCT00078819|13200734|P1|Received Study Drug|Re-treatment Period||0
5365264|NCT00078819|13200731|P4|STARTED|Re-treatment Period||13
5365265|NCT00078819|13200732|P3|STARTED|Re-treatment Period||29
5365266|NCT00078819|13200733|P2|STARTED|Re-treatment Period||0
5365267|NCT00078819|13200734|P1|STARTED|Re-treatment Period||0
5365268|NCT00078819|13200731|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
5365269|NCT00078819|13200732|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
5365270|NCT00078819|13200733|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
5365271|NCT00078819|13200734|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
5365272|NCT00078819|13200731|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
5365273|NCT00078819|13200732|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
5365274|NCT00078819|13200733|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
5365275|NCT00078819|13200734|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
5365276|NCT00078819|13200731|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
5365277|NCT00078819|13200732|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
5365278|NCT00078819|13200733|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
5365279|NCT00078819|13200734|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
5365280|NCT00078819|13200731|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
5365281|NCT00078819|13200732|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
5365282|NCT00078819|13200733|P2|STARTED|Withdrawal Period: Weeks 37-48||0
5365283|NCT00078819|13200734|P1|STARTED|Withdrawal Period: Weeks 37-48||0
5365284|NCT00078819|13200731|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
5365285|NCT00078819|13200732|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
5365286|NCT00078819|13200733|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
5365287|NCT00078819|13200734|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
5365288|NCT00078819|13200731|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
5365289|NCT00078819|13200732|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
5365290|NCT00078819|13200733|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
5365291|NCT00078819|13200734|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
5365292|NCT00078819|13200731|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
5365293|NCT00078819|13200732|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
5365294|NCT00078819|13200733|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
5365295|NCT00078819|13200734|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
5365296|NCT00078819|13200731|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
5365297|NCT00078819|13200732|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
5365298|NCT00078819|13200733|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
5365299|NCT00078819|13200734|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
5365300|NCT00078819|13200731|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
5365301|NCT00078819|13200732|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
5365302|NCT00078819|13200733|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
5365303|NCT00078819|13200734|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
5365304|NCT00078819|13200731|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
5365305|NCT00078819|13200732|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
5365306|NCT00078819|13200733|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
5365307|NCT00078819|13200734|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
5365308|NCT00078819|13200731|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
5365309|NCT00078819|13200732|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
5365310|NCT00078819|13200733|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
5365311|NCT00078819|13200734|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
5365312|NCT00078806|13200759|P4|NOT COMPLETED|Part 3||0
5365313|NCT00078806|13200760|P3|NOT COMPLETED|Part 3||0
5365314|NCT00078806|13200761|P2|NOT COMPLETED|Part 3||0
5365315|NCT00078806|13200762|P1|NOT COMPLETED|Part 3||0
5365316|NCT00078806|13200759|P4|COMPLETED|Part 3||9
5365317|NCT00078806|13200760|P3|COMPLETED|Part 3||0
5365318|NCT00078806|13200761|P2|COMPLETED|Part 3||0
5365319|NCT00078806|13200762|P1|COMPLETED|Part 3||0
5365320|NCT00078806|13200759|P4|STARTED|Part 3||9
5365321|NCT00078806|13200760|P3|STARTED|Part 3||0
5365322|NCT00078806|13200761|P2|STARTED|Part 3||0
5365323|NCT00078806|13200762|P1|STARTED|Part 3||0
5365324|NCT00078806|13200759|P4|NOT COMPLETED|Part 2||0
5365325|NCT00078806|13200760|P3|NOT COMPLETED|Part 2||0
5365326|NCT00078806|13200761|P2|NOT COMPLETED|Part 2||1
5365327|NCT00078806|13200762|P1|NOT COMPLETED|Part 2||0
5365328|NCT00078806|13200759|P4|COMPLETED|Part 2||0
5365329|NCT00078806|13200760|P3|COMPLETED|Part 2||4
5365330|NCT00078806|13200761|P2|COMPLETED|Part 2||5
5365331|NCT00078806|13200762|P1|COMPLETED|Part 2||0
5365332|NCT00078806|13200759|P4|Received Study Drug|Part 2||0
5365333|NCT00078806|13200760|P3|Received Study Drug|Part 2||4
5365334|NCT00078806|13200761|P2|Received Study Drug|Part 2||5
5365335|NCT00078806|13200762|P1|Received Study Drug|Part 2||0
5365336|NCT00078806|13200759|P4|STARTED|Part 2||0
5365337|NCT00078806|13200760|P3|STARTED|Part 2||4
5365338|NCT00078806|13200761|P2|STARTED|Part 2||6
5365339|NCT00078806|13200762|P1|STARTED|Part 2||0
5365340|NCT00078806|13200759|P4|NOT COMPLETED|Part 1B||0
5365341|NCT00078806|13200760|P3|NOT COMPLETED|Part 1B||0
5365342|NCT00078806|13200761|P2|NOT COMPLETED|Part 1B||0
5365343|NCT00078806|13200762|P1|NOT COMPLETED|Part 1B||8
5365344|NCT00078806|13200759|P4|COMPLETED|Part 1B||0
5365345|NCT00078806|13200760|P3|COMPLETED|Part 1B||0
5365346|NCT00078806|13200761|P2|COMPLETED|Part 1B||0
5365347|NCT00078806|13200762|P1|COMPLETED|Part 1B||2
5365348|NCT00078806|13200759|P4|STARTED|Part 1B||0
5365349|NCT00078806|13200760|P3|STARTED|Part 1B||0
5365350|NCT00078806|13200761|P2|STARTED|Part 1B||0
5365351|NCT00078806|13200762|P1|STARTED|Part 1B||10
5365352|NCT00078806|13200759|P4|NOT COMPLETED|Part 1A||0
5365353|NCT00078806|13200760|P3|NOT COMPLETED|Part 1A||0
5365354|NCT00078806|13200761|P2|NOT COMPLETED|Part 1A||0
5365355|NCT00078806|13200762|P1|NOT COMPLETED|Part 1A||10
5365356|NCT00078806|13200759|P4|COMPLETED|Part 1A||0
5365357|NCT00078806|13200760|P3|COMPLETED|Part 1A||0
5365358|NCT00078806|13200761|P2|COMPLETED|Part 1A||0
5365359|NCT00078806|13200762|P1|COMPLETED|Part 1A||9
5365360|NCT00078806|13200759|P4|STARTED|Part 1A||0
5365361|NCT00078806|13200760|P3|STARTED|Part 1A||0
5365362|NCT00078806|13200761|P2|STARTED|Part 1A||0
5365363|NCT00078806|13200762|P1|STARTED|Part 1A||19
5365364|NCT00078767|13200798|P2|NOT COMPLETED|Overall Study||1
5365365|NCT00078767|13200799|P1|NOT COMPLETED|Overall Study||1
5365366|NCT00078767|13200798|P2|COMPLETED|Overall Study||11
5365367|NCT00078767|13200799|P1|COMPLETED|Overall Study||11
5365368|NCT00078767|13200798|P2|STARTED|Overall Study||12
5365369|NCT00078767|13200799|P1|STARTED|Overall Study||12
5365370|NCT00078754|13200816|P3|NOT COMPLETED|Overall Study||15
5365371|NCT00078754|13200817|P2|NOT COMPLETED|Overall Study||19
5365372|NCT00078754|13200818|P1|NOT COMPLETED|Overall Study||15
5365373|NCT00078754|13200816|P3|COMPLETED|Overall Study||16
5365374|NCT00078754|13200817|P2|COMPLETED|Overall Study||11
5365375|NCT00078754|13200818|P1|COMPLETED|Overall Study||14
5365376|NCT00078754|13200816|P3|STARTED|Overall Study||31
5365377|NCT00078754|13200817|P2|STARTED|Overall Study||30
5365378|NCT00078754|13200818|P1|STARTED|Overall Study||29
5365379|NCT00078728|13200828|P2|NOT COMPLETED|Overall Study||3
5365380|NCT00078728|13200829|P1|NOT COMPLETED|Overall Study||4
5365381|NCT00078728|13200828|P2|COMPLETED|Overall Study||17
5365382|NCT00078728|13200829|P1|COMPLETED|Overall Study||16
5365383|NCT00078728|13200828|P2|STARTED|Overall Study||20
5365384|NCT00078728|13200829|P1|STARTED|Overall Study||20
5365385|NCT00078715|13200837|P2|NOT COMPLETED|Second Intervention||0
5365386|NCT00078715|13200838|P1|NOT COMPLETED|Second Intervention||0
5365387|NCT00078715|13200837|P2|COMPLETED|Second Intervention||4
5365388|NCT00078715|13200838|P1|COMPLETED|Second Intervention||2
5365389|NCT00078715|13200837|P2|STARTED|Second Intervention||4
5365390|NCT00078715|13200838|P1|STARTED|Second Intervention||2
5365391|NCT00078715|13200837|P2|NOT COMPLETED|First Intervention||0
5365392|NCT00078715|13200838|P1|NOT COMPLETED|First Intervention||0
5365393|NCT00078715|13200837|P2|COMPLETED|First Intervention||4
5365394|NCT00078715|13200838|P1|COMPLETED|First Intervention||2
5365395|NCT00078715|13200837|P2|STARTED|First Intervention||4
5365396|NCT00078715|13200838|P1|STARTED|First Intervention||2
5365397|NCT00005947|13200846|P2|NOT COMPLETED|Overall Study||41
5365398|NCT00005947|13200847|P1|NOT COMPLETED|Overall Study||57
5365399|NCT00005947|13200846|P2|COMPLETED|Overall Study||4
5365400|NCT00005947|13200847|P1|COMPLETED|Overall Study||25
5365401|NCT00005947|13200846|P2|STARTED|Overall Study||45
5365402|NCT00005947|13200847|P1|STARTED|Overall Study||82
5365403|NCT00078559|13200855|P1|NOT COMPLETED|Overall Study||0
5365404|NCT00078559|13200855|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
5365405|NCT00078559|13200855|P1|STARTED|Overall Study||10
5365406|NCT00002597|13200883|P2|NOT COMPLETED|Overall Study||23
5365407|NCT00002597|13200884|P1|NOT COMPLETED|Overall Study||26
5365408|NCT00002597|13200883|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
5365409|NCT00002597|13200884|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
5365410|NCT00002597|13200883|P2|STARTED|Overall Study||1015
5365411|NCT00002597|13200884|P1|STARTED|Overall Study||1013
5365412|NCT00078377|13200909|P3|NOT COMPLETED|Overall Study||9
5365413|NCT00078377|13200910|P2|NOT COMPLETED|Overall Study||16
5365414|NCT00078377|13200911|P1|NOT COMPLETED|Overall Study||11
5365415|NCT00078377|13200909|P3|COMPLETED|Overall Study||55
5365416|NCT00078377|13200910|P2|COMPLETED|Overall Study||49
5365417|NCT00078377|13200911|P1|COMPLETED|Overall Study||56
5365418|NCT00078377|13200909|P3|STARTED|Overall Study||64
5365419|NCT00078377|13200910|P2|STARTED|Overall Study||65
5365420|NCT00078377|13200911|P1|STARTED|Overall Study||67
5365421|NCT00078338|13200926|P2|NOT COMPLETED|Overall Study||54
5365422|NCT00078338|13200927|P1|NOT COMPLETED|Overall Study||85
5365423|NCT00078338|13200926|P2|COMPLETED|Overall Study||324
5365424|NCT00078338|13200927|P1|COMPLETED|Overall Study||301
5365425|NCT00078338|13200926|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
5365426|NCT00078338|13200927|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
5365427|NCT00078338|13200926|P2|STARTED|Overall Study||378
5365428|NCT00078338|13200927|P1|STARTED|Overall Study||386
5365429|NCT00076687|13200936|P3|NOT COMPLETED|Overall Study||4
5365430|NCT00076687|13200937|P2|NOT COMPLETED|Overall Study||5
5365431|NCT00076687|13200938|P1|NOT COMPLETED|Overall Study||6
5365432|NCT00076687|13200936|P3|COMPLETED|Overall Study||51
5365433|NCT00076687|13200937|P2|COMPLETED|Overall Study||47
5365434|NCT00076687|13200938|P1|COMPLETED|Overall Study||42
5365435|NCT00076687|13200936|P3|STARTED|Overall Study||55
5365436|NCT00076687|13200937|P2|STARTED|Overall Study||52
5365437|NCT00076687|13200938|P1|STARTED|Overall Study||48
5365438|NCT00078403|13200958|P3|NOT COMPLETED|Overall Study||28
5365439|NCT00078403|13200959|P2|NOT COMPLETED|Overall Study||16
5365440|NCT00078403|13200960|P1|NOT COMPLETED|Overall Study||18
5365441|NCT00078403|13200958|P3|COMPLETED|Overall Study||141
5365442|NCT00078403|13200959|P2|COMPLETED|Overall Study||26
5365443|NCT00078403|13200960|P1|COMPLETED|Overall Study||26
5365444|NCT00078403|13200958|P3|STARTED|Overall Study||169
5365445|NCT00078403|13200959|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
5365446|NCT00078403|13200960|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
5365447|NCT00078325|13201020|P3|NOT COMPLETED|Overall Study||11
5365448|NCT00078325|13201021|P2|NOT COMPLETED|Overall Study||19
5365449|NCT00078325|13201022|P1|NOT COMPLETED|Overall Study||21
5365450|NCT00078325|13201020|P3|COMPLETED|Overall Study||120
5365451|NCT00078325|13201021|P2|COMPLETED|Overall Study||114
5365452|NCT00078325|13201022|P1|COMPLETED|Overall Study||110
5365453|NCT00078325|13201020|P3|STARTED|Overall Study||131
5365454|NCT00078325|13201021|P2|STARTED|Overall Study||133
5365455|NCT00078325|13201022|P1|STARTED|Overall Study||131
5365456|NCT00078312|13201033|P1|NOT COMPLETED|Overall Study||177
5365457|NCT00078312|13201033|P1|COMPLETED|Overall Study||151
5365458|NCT00078312|13201033|P1|STARTED|Overall Study||328
5365459|NCT00078286|13201039|P2|NOT COMPLETED|Overall Study||83
5365460|NCT00078286|13201040|P1|NOT COMPLETED|Overall Study||96
5365461|NCT00078286|13201039|P2|COMPLETED|Overall Study||152
5365462|NCT00078286|13201040|P1|COMPLETED|Overall Study||138
5365463|NCT00078286|13201039|P2|STARTED|Overall Study||235
5365464|NCT00078286|13201040|P1|STARTED|Overall Study||234
5365465|NCT00077974|13201048|P1|NOT COMPLETED|Overall Study||104
5365466|NCT00077974|13201048|P1|COMPLETED|Overall Study||2
5365467|NCT00077974|13201048|P1|STARTED|Overall Study||106
5365468|NCT00077857|13201065|P2|NOT COMPLETED|Overall Study||204
5365469|NCT00077857|13201066|P1|NOT COMPLETED|Overall Study||201
5365470|NCT00077857|13201065|P2|COMPLETED|Overall Study||31
5365471|NCT00077857|13201066|P1|COMPLETED|Overall Study||34
5365472|NCT00077857|13201065|P2|Safety Population: Actual Dose Received|Overall Study||248
5365473|NCT00077857|13201066|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
5365474|NCT00077857|13201065|P2|Received Study Drug|Overall Study||234
5365475|NCT00077857|13201066|P1|Received Study Drug|Overall Study||231
5365476|NCT00077857|13201065|P2|STARTED|Overall Study||235
5365477|NCT00077857|13201066|P1|STARTED|Overall Study||235
5365478|NCT00077766|13201086|P2|NOT COMPLETED|Overall Study||25
5365479|NCT00077766|13201087|P1|NOT COMPLETED|Overall Study||39
5365480|NCT00077766|13201086|P2|COMPLETED|Overall Study||131
5365481|NCT00077766|13201087|P1|COMPLETED|Overall Study||118
5365482|NCT00077766|13201086|P2|STARTED|Overall Study||156
5365483|NCT00077766|13201087|P1|STARTED|Overall Study||157
5365484|NCT00077922|13201105|P1|NOT COMPLETED|Overall Study||0
5365485|NCT00077922|13201105|P1|COMPLETED|Overall Study||15
5365486|NCT00077922|13201105|P1|STARTED|Overall Study||15
5365487|NCT00077675|13201112|P2|NOT COMPLETED|Overall Study||9
5365488|NCT00077675|13201113|P1|NOT COMPLETED|Overall Study||11
5365489|NCT00077675|13201112|P2|COMPLETED|Overall Study||89
5365490|NCT00077675|13201113|P1|COMPLETED|Overall Study||92
5365491|NCT00077675|13201112|P2|STARTED|Overall Study||98
5365492|NCT00077675|13201113|P1|STARTED|Overall Study||103
5365493|NCT00077649|13201123|P4|NOT COMPLETED|Overall Study||17
5365494|NCT00077649|13201124|P3|NOT COMPLETED|Overall Study||15
5365495|NCT00077649|13201125|P2|NOT COMPLETED|Overall Study||9
5365496|NCT00077649|13201126|P1|NOT COMPLETED|Overall Study||14
5365497|NCT00077649|13201123|P4|COMPLETED|Overall Study||30
5365498|NCT00077649|13201124|P3|COMPLETED|Overall Study||32
5365499|NCT00077649|13201125|P2|COMPLETED|Overall Study||38
5365500|NCT00077649|13201126|P1|COMPLETED|Overall Study||33
5365501|NCT00077649|13201123|P4|Completed 24 Weeks of Follow-up|Overall Study||31
5365502|NCT00077649|13201124|P3|Completed 24 Weeks of Follow-up|Overall Study||36
5365503|NCT00077649|13201125|P2|Completed 24 Weeks of Follow-up|Overall Study||40
5365504|NCT00077649|13201126|P1|Completed 24 Weeks of Follow-up|Overall Study||36
5365505|NCT00077649|13201123|P4|STARTED|Overall Study||47
5365506|NCT00077649|13201124|P3|STARTED|Overall Study||47
5365507|NCT00077649|13201125|P2|STARTED|Overall Study||47
5365508|NCT00077649|13201126|P1|STARTED|Overall Study||47
5365509|NCT00077636|13201174|P2|NOT COMPLETED|Overall Study||92
5365510|NCT00077636|13201175|P1|NOT COMPLETED|Overall Study||44
5365511|NCT00077636|13201174|P2|COMPLETED|Overall Study||641
5365512|NCT00077636|13201175|P1|COMPLETED|Overall Study||692
5365513|NCT00077636|13201174|P2|STARTED|Overall Study||733
5365514|NCT00077636|13201175|P1|STARTED|Overall Study||736
5365515|NCT00077623|13201196|P3|NOT COMPLETED|Overall Study||32
5365516|NCT00077623|13201197|P2|NOT COMPLETED|Overall Study||43
5365517|NCT00077623|13201198|P1|NOT COMPLETED|Overall Study||36
5365518|NCT00077623|13201196|P3|COMPLETED|Overall Study||159
5365519|NCT00077623|13201197|P2|COMPLETED|Overall Study||148
5365520|NCT00077623|13201198|P1|COMPLETED|Overall Study||154
5365521|NCT00077623|13201196|P3|STARTED|Overall Study||191
5365522|NCT00077623|13201197|P2|STARTED|Overall Study||191
5365523|NCT00077623|13201198|P1|STARTED|Overall Study||190
5365524|NCT00077610|13201233|P3|NOT COMPLETED|Overall Study||46
5365525|NCT00077610|13201234|P2|NOT COMPLETED|Overall Study||56
5365526|NCT00077610|13201235|P1|NOT COMPLETED|Overall Study||54
5365527|NCT00077610|13201233|P3|COMPLETED|Overall Study||180
5365528|NCT00077610|13201234|P2|COMPLETED|Overall Study||168
5365529|NCT00077610|13201235|P1|COMPLETED|Overall Study||169
5365530|NCT00077610|13201233|P3|Started Treatment|Overall Study||225
5365531|NCT00077610|13201234|P2|Started Treatment|Overall Study||220
5365532|NCT00077610|13201235|P1|Started Treatment|Overall Study||221
5365533|NCT00077610|13201233|P3|STARTED|Overall Study||226
5365534|NCT00077610|13201234|P2|STARTED|Overall Study||224
5365535|NCT00077610|13201235|P1|STARTED|Overall Study||223
5365536|NCT00077376|13201264|P1|NOT COMPLETED|Overall Study||22
5365537|NCT00077376|13201264|P1|COMPLETED|Overall Study||39
5365538|NCT00077376|13201264|P1|HER2+ in Central Testing|Overall Study||39
5365539|NCT00077376|13201264|P1|Treated|Overall Study||59
5365540|NCT00077376|13201264|P1|STARTED|Overall Study||61
5365541|NCT00077207|13201275|P1|NOT COMPLETED|Overall Study||30
5365542|NCT00077207|13201275|P1|COMPLETED|Overall Study||36
5365543|NCT00077207|13201275|P1|STARTED|Overall Study||66
5365544|NCT00077064|13201287|P2|NOT COMPLETED|Overall Study||6
5365545|NCT00077064|13201288|P1|NOT COMPLETED|Overall Study||0
5365546|NCT00077064|13201287|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
5365547|NCT00077064|13201288|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
5365548|NCT00077064|13201287|P2|STARTED|Overall Study||16
5365549|NCT00077064|13201288|P1|STARTED|Overall Study||17
5365550|NCT00076999|13201304|P5|NOT COMPLETED|Overall Study||25
5365551|NCT00076999|13201305|P4|NOT COMPLETED|Overall Study||1
5365552|NCT00076999|13201306|P3|NOT COMPLETED|Overall Study||17
5365553|NCT00076999|13201307|P2|NOT COMPLETED|Overall Study||24
5365554|NCT00076999|13201308|P1|NOT COMPLETED|Overall Study||12
5365555|NCT00076999|13201304|P5|COMPLETED|Overall Study||9
5365556|NCT00076999|13201305|P4|COMPLETED|Overall Study||5
5365557|NCT00076999|13201306|P3|COMPLETED|Overall Study||2
5365558|NCT00076999|13201307|P2|COMPLETED|Overall Study||7
5365559|NCT00076999|13201308|P1|COMPLETED|Overall Study||13
5365560|NCT00076999|13201304|P5|STARTED|Overall Study||34
5365561|NCT00076999|13201305|P4|STARTED|Overall Study||6
5365562|NCT00076999|13201306|P3|STARTED|Overall Study||19
5365563|NCT00076999|13201307|P2|STARTED|Overall Study||31
5365564|NCT00076999|13201308|P1|STARTED|Overall Study||25
5365565|NCT00003222|13201427|P2|NOT COMPLETED|Overall Study||1
5365566|NCT00003222|13201428|P1|NOT COMPLETED|Overall Study||0
5365567|NCT00003222|13201427|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
5365568|NCT00003222|13201428|P1|COMPLETED|Overall Study||13
5365569|NCT00003222|13201427|P2|STARTED|Overall Study||28
5365570|NCT00003222|13201428|P1|STARTED|Overall Study||13
5365571|NCT00076804|13201440|P2|NOT COMPLETED|Overall Study||69
5365572|NCT00076804|13201441|P1|NOT COMPLETED|Overall Study||60
5365573|NCT00076804|13201440|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
5365574|NCT00076804|13201441|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
5365575|NCT00076804|13201440|P2|STARTED|Overall Study||137
5365576|NCT00076804|13201441|P1|STARTED|Overall Study||137
5365577|NCT00076752|13201453|P1|NOT COMPLETED|Overall Study||3
5365578|NCT00076752|13201453|P1|COMPLETED|Overall Study||6
5365579|NCT00076752|13201453|P1|STARTED|Overall Study||9
5365580|NCT00076622|13201476|P4|NOT COMPLETED|Overall Study||0
5365581|NCT00076622|13201477|P3|NOT COMPLETED|Overall Study||0
5365582|NCT00076622|13201478|P2|NOT COMPLETED|Overall Study||0
5365583|NCT00076622|13201479|P1|NOT COMPLETED|Overall Study||0
5365584|NCT00076622|13201476|P4|COMPLETED|Overall Study||18
5365585|NCT00076622|13201477|P3|COMPLETED|Overall Study||40
5365586|NCT00076622|13201478|P2|COMPLETED|Overall Study||13
5365587|NCT00076622|13201479|P1|COMPLETED|Overall Study||23
5365588|NCT00076622|13201476|P4|STARTED|Overall Study||18
5365589|NCT00076622|13201477|P3|STARTED|Overall Study||40
5365590|NCT00076622|13201478|P2|STARTED|Overall Study||13
5365591|NCT00076622|13201479|P1|STARTED|Overall Study||23
5365592|NCT00076570|13201499|P2|NOT COMPLETED|Overall Study||8
5365593|NCT00076570|13201500|P1|NOT COMPLETED|Overall Study||8
5365594|NCT00076570|13201499|P2|COMPLETED|Overall Study||8
5365595|NCT00076570|13201500|P1|COMPLETED|Overall Study||7
5365596|NCT00076570|13201499|P2|STARTED|Overall Study||16
5365597|NCT00076570|13201500|P1|STARTED|Overall Study||15
5365598|NCT00003298|13201508|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
5365599|NCT00003298|13201508|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
5365600|NCT00003298|13201508|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
5365601|NCT00003298|13201508|P1|STARTED|Step 2 (Adjuvant Therapy)||10
5365602|NCT00003298|13201508|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
5365603|NCT00003298|13201508|P1|COMPLETED|Re-register to Step 2 After Surgery||10
5365604|NCT00003298|13201508|P1|STARTED|Re-register to Step 2 After Surgery||28
5365605|NCT00003298|13201508|P1|NOT COMPLETED|Surgery||7
5365606|NCT00003298|13201508|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
5365607|NCT00003298|13201508|P1|STARTED|Surgery||35
5365608|NCT00003298|13201508|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
5365609|NCT00003298|13201508|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
5365610|NCT00003298|13201508|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
5365611|NCT00003298|13201508|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
5365612|NCT00003298|13201508|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
5365613|NCT00076336|13201518|P2|NOT COMPLETED|Overall Study||56
5365614|NCT00076336|13201519|P1|NOT COMPLETED|Overall Study||52
5365615|NCT00076336|13201518|P2|COMPLETED|Overall Study||60
5365616|NCT00076336|13201519|P1|COMPLETED|Overall Study||64
5365617|NCT00076336|13201518|P2|Completed Week 104|Overall Study||62
5365618|NCT00076336|13201519|P1|Completed Week 104|Overall Study||70
5365619|NCT00076336|13201518|P2|Completed Week 52|Overall Study||94
5365620|NCT00076336|13201519|P1|Completed Week 52|Overall Study||97
5365621|NCT00076336|13201518|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
5365622|NCT00076336|13201519|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
5365623|NCT00076336|13201518|P2|Safety Population|Overall Study||116
5365624|NCT00076336|13201519|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
5365625|NCT00076336|13201518|P2|STARTED|Overall Study||116
5365626|NCT00076336|13201519|P1|STARTED|Overall Study||116
5365627|NCT00076258|13201535|P2|NOT COMPLETED|Overall Study||3
5365628|NCT00076258|13201536|P1|NOT COMPLETED|Overall Study||1
5365629|NCT00076258|13201535|P2|COMPLETED|Overall Study||61
5365630|NCT00076258|13201536|P1|COMPLETED|Overall Study||61
5365631|NCT00076258|13201535|P2|STARTED|Overall Study||64
5365632|NCT00076258|13201536|P1|STARTED|Overall Study||62
5365633|NCT00076245|13201546|P4|NOT COMPLETED|Overall Study||1
5365634|NCT00076245|13201547|P3|NOT COMPLETED|Overall Study||0
5365635|NCT00076245|13201548|P2|NOT COMPLETED|Overall Study||0
5365636|NCT00076245|13201549|P1|NOT COMPLETED|Overall Study||0
5365637|NCT00076245|13201546|P4|COMPLETED|Overall Study||14
5365638|NCT00076245|13201547|P3|COMPLETED|Overall Study||15
5365639|NCT00076245|13201548|P2|COMPLETED|Overall Study||15
5365640|NCT00076245|13201549|P1|COMPLETED|Overall Study||16
5365641|NCT00076245|13201546|P4|STARTED|Overall Study||15
5365642|NCT00076245|13201547|P3|STARTED|Overall Study||15
5365643|NCT00076245|13201548|P2|STARTED|Overall Study||15
5365644|NCT00076245|13201549|P1|STARTED|Overall Study||16
5365645|NCT00076219|13201565|P2|NOT COMPLETED|Overall Study||11
5365646|NCT00076219|13201566|P1|NOT COMPLETED|Overall Study||18
5365647|NCT00076219|13201565|P2|COMPLETED|Overall Study||550
5365648|NCT00076219|13201566|P1|COMPLETED|Overall Study||545
5365649|NCT00076219|13201565|P2|STARTED|Overall Study||561
5365650|NCT00076219|13201566|P1|STARTED|Overall Study||563
5365651|NCT00076102|13201572|P1|NOT COMPLETED|Overall Study||5
5365652|NCT00076102|13201572|P1|COMPLETED|Overall Study||31
5365653|NCT00076102|13201572|P1|STARTED|Overall Study||36
5365654|NCT00076050|13201586|P2|NOT COMPLETED|Overall Study||43
5365655|NCT00076050|13201587|P1|NOT COMPLETED|Overall Study||23
5365656|NCT00076050|13201586|P2|COMPLETED|Overall Study||83
5365657|NCT00076050|13201587|P1|COMPLETED|Overall Study||99
5365658|NCT00076050|13201586|P2|STARTED|Overall Study||126
5365659|NCT00076050|13201587|P1|STARTED|Overall Study||122
5365660|NCT00076024|13201600|P4|NOT COMPLETED|Phase 2, Open-label||16
5365661|NCT00076024|13201601|P3|NOT COMPLETED|Phase 2, Open-label||0
5365662|NCT00076024|13201602|P2|NOT COMPLETED|Phase 2, Open-label||0
5365663|NCT00076024|13201603|P1|NOT COMPLETED|Phase 2, Open-label||0
5365664|NCT00076024|13201600|P4|COMPLETED|Phase 2, Open-label||0
5365665|NCT00076024|13201601|P3|COMPLETED|Phase 2, Open-label||0
5365666|NCT00076024|13201602|P2|COMPLETED|Phase 2, Open-label||0
5365667|NCT00076024|13201603|P1|COMPLETED|Phase 2, Open-label||0
5365668|NCT00076024|13201600|P4|STARTED|Phase 2, Open-label||16
5365669|NCT00076024|13201601|P3|STARTED|Phase 2, Open-label||0
5365670|NCT00076024|13201602|P2|STARTED|Phase 2, Open-label||0
5365671|NCT00076024|13201603|P1|STARTED|Phase 2, Open-label||0
5365672|NCT00076024|13201600|P4|NOT COMPLETED|Phase 2, Double-blind||0
5365673|NCT00076024|13201601|P3|NOT COMPLETED|Phase 2, Double-blind||56
5365674|NCT00076024|13201602|P2|NOT COMPLETED|Phase 2, Double-blind||112
5365675|NCT00076024|13201603|P1|NOT COMPLETED|Phase 2, Double-blind||0
5365676|NCT00076024|13201600|P4|COMPLETED|Phase 2, Double-blind||0
5365677|NCT00076024|13201601|P3|COMPLETED|Phase 2, Double-blind||0
5365678|NCT00076024|13201602|P2|COMPLETED|Phase 2, Double-blind||0
5365679|NCT00076024|13201603|P1|COMPLETED|Phase 2, Double-blind||0
5365680|NCT00076024|13201600|P4|Treated|Phase 2, Double-blind||0
5365681|NCT00076024|13201601|P3|Treated|Phase 2, Double-blind||56
5365682|NCT00076024|13201602|P2|Treated|Phase 2, Double-blind||111
5365683|NCT00076024|13201603|P1|Treated|Phase 2, Double-blind||0
5365684|NCT00076024|13201600|P4|STARTED|Phase 2, Double-blind||0
5365685|NCT00076024|13201601|P3|STARTED|Phase 2, Double-blind||56
5365686|NCT00076024|13201602|P2|STARTED|Phase 2, Double-blind||112
5365687|NCT00076024|13201603|P1|STARTED|Phase 2, Double-blind||0
5365688|NCT00076024|13201600|P4|NOT COMPLETED|Phase 1, Lead-in||0
5365689|NCT00076024|13201601|P3|NOT COMPLETED|Phase 1, Lead-in||0
5365690|NCT00076024|13201602|P2|NOT COMPLETED|Phase 1, Lead-in||0
5365691|NCT00076024|13201603|P1|NOT COMPLETED|Phase 1, Lead-in||6
5365692|NCT00076024|13201600|P4|COMPLETED|Phase 1, Lead-in||0
5365693|NCT00076024|13201601|P3|COMPLETED|Phase 1, Lead-in||0
5365694|NCT00076024|13201602|P2|COMPLETED|Phase 1, Lead-in||0
5365695|NCT00076024|13201603|P1|COMPLETED|Phase 1, Lead-in||0
5365696|NCT00076024|13201600|P4|STARTED|Phase 1, Lead-in||0
5365697|NCT00076024|13201601|P3|STARTED|Phase 1, Lead-in||0
5365698|NCT00076024|13201602|P2|STARTED|Phase 1, Lead-in||0
5365699|NCT00076024|13201603|P1|STARTED|Phase 1, Lead-in||6
5365700|NCT00076011|13201617|P1|NOT COMPLETED|Overall Study||52
5365701|NCT00076011|13201617|P1|COMPLETED|Overall Study||0
5365702|NCT00076011|13201617|P1|STARTED|Overall Study||52
5365703|NCT00075946|13201629|P5|NOT COMPLETED|Overall Study||188
5365704|NCT00075946|13201630|P4|NOT COMPLETED|Overall Study||30
5365705|NCT00075946|13201631|P3|NOT COMPLETED|Overall Study||28
5365706|NCT00075946|13201632|P2|NOT COMPLETED|Overall Study||151
5365707|NCT00075946|13201633|P1|NOT COMPLETED|Overall Study||148
5365708|NCT00075946|13201629|P5|COMPLETED|Overall Study||0
5365709|NCT00075946|13201630|P4|COMPLETED|Overall Study||0
5365710|NCT00075946|13201631|P3|COMPLETED|Overall Study||0
5365711|NCT00075946|13201632|P2|COMPLETED|Overall Study||0
5365712|NCT00075946|13201633|P1|COMPLETED|Overall Study||0
5365713|NCT00075946|13201629|P5|Included in Primary Analysis|Overall Study||0
5365714|NCT00075946|13201630|P4|Included in Primary Analysis|Overall Study||29
5365715|NCT00075946|13201631|P3|Included in Primary Analysis|Overall Study||23
5365716|NCT00075946|13201632|P2|Included in Primary Analysis|Overall Study||146
5365717|NCT00075946|13201633|P1|Included in Primary Analysis|Overall Study||143
5365718|NCT00075946|13201629|P5|Treated and With Toxicity Data Available|Overall Study||154
5365719|NCT00075946|13201630|P4|Treated and With Toxicity Data Available|Overall Study||29
5365720|NCT00075946|13201631|P3|Treated and With Toxicity Data Available|Overall Study||27
5365721|NCT00075946|13201632|P2|Treated and With Toxicity Data Available|Overall Study||148
5365722|NCT00075946|13201633|P1|Treated and With Toxicity Data Available|Overall Study||142
5365723|NCT00075946|13201629|P5|STARTED|Overall Study||188
5365724|NCT00075946|13201630|P4|STARTED|Overall Study||30
5365725|NCT00075946|13201631|P3|STARTED|Overall Study||28
5365726|NCT00075946|13201632|P2|STARTED|Overall Study||151
5365727|NCT00075946|13201633|P1|STARTED|Overall Study||148
5365728|NCT00075881|13201648|P1|NOT COMPLETED|Overall Study||43
5365729|NCT00075881|13201648|P1|COMPLETED|Overall Study||1
5365730|NCT00075881|13201648|P1|Reinduction Treatment|Overall Study||7
5365731|NCT00075881|13201648|P1|Maintenance Treatment|Overall Study||15
5365732|NCT00075881|13201648|P1|Induction Treatment|Overall Study||42
5365733|NCT00075881|13201648|P1|Treated|Overall Study||42
5365734|NCT00075881|13201648|P1|Eligible|Overall Study||43
5365735|NCT00075881|13201648|P1|STARTED|Overall Study||44
5365736|NCT00075829|13201659|P4|NOT COMPLETED|Overall Study||24
5365737|NCT00075829|13201660|P3|NOT COMPLETED|Overall Study||34
5365738|NCT00075829|13201661|P2|NOT COMPLETED|Overall Study||118
5365739|NCT00075829|13201662|P1|NOT COMPLETED|Overall Study||258
5365740|NCT00075829|13201659|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
5365741|NCT00075829|13201660|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
5365742|NCT00075829|13201661|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
5365743|NCT00075829|13201662|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
5365744|NCT00075829|13201659|P4|STARTED|Overall Study||37
5365745|NCT00075829|13201660|P3|STARTED|Overall Study||48
5365746|NCT00075829|13201661|P2|STARTED|Overall Study||189
5365747|NCT00075829|13201662|P1|STARTED|Overall Study||436
5365748|NCT00075816|13201692|P2|NOT COMPLETED|Overall Study||11
5365749|NCT00075816|13201693|P1|NOT COMPLETED|Overall Study||14
5365750|NCT00075816|13201692|P2|COMPLETED|Overall Study||262
5365751|NCT00075816|13201693|P1|COMPLETED|Overall Study||264
5365752|NCT00075816|13201692|P2|STARTED|Overall Study||273
5365753|NCT00075816|13201693|P1|STARTED|Overall Study||278
5365754|NCT00075803|13201733|P2|NOT COMPLETED|Overall Study||0
5365755|NCT00075803|13201734|P1|NOT COMPLETED|Overall Study||0
5365756|NCT00075803|13201733|P2|COMPLETED|Overall Study||305
5365757|NCT00075803|13201734|P1|COMPLETED|Overall Study||295
5365758|NCT00075803|13201733|P2|STARTED|Overall Study||305
5365759|NCT00075803|13201734|P1|STARTED|Overall Study||295
5365760|NCT00075764|13201762|P2|NOT COMPLETED|Overall Study||349
5365761|NCT00075764|13201763|P1|NOT COMPLETED|Overall Study||345
5365762|NCT00075764|13201762|P2|COMPLETED|Overall Study||0
5365763|NCT00075764|13201763|P1|COMPLETED|Overall Study||0
5365764|NCT00075764|13201762|P2|STARTED|Overall Study||349
5365765|NCT00075764|13201763|P1|STARTED|Overall Study||345
5365766|NCT00075725|13201787|P12|NOT COMPLETED|Overall Study||18
5365767|NCT00075725|13201788|P11|NOT COMPLETED|Overall Study||9
5365768|NCT00075725|13201789|P10|NOT COMPLETED|Overall Study||18
5365769|NCT00075725|13201790|P9|NOT COMPLETED|Overall Study||117
5365770|NCT00075725|13201791|P8|NOT COMPLETED|Overall Study||295
5365771|NCT00075725|13201792|P7|NOT COMPLETED|Overall Study||75
5365772|NCT00075725|13201793|P6|NOT COMPLETED|Overall Study||313
5365773|NCT00075725|13201794|P5|NOT COMPLETED|Overall Study||66
5365774|NCT00075725|13201795|P4|NOT COMPLETED|Overall Study||78
5365775|NCT00075725|13201796|P3|NOT COMPLETED|Overall Study||121
5365776|NCT00075725|13201797|P2|NOT COMPLETED|Overall Study||49
5365777|NCT00075725|13201798|P1|NOT COMPLETED|Overall Study||74
5365778|NCT00075725|13201787|P12|COMPLETED|Overall Study||10
5365779|NCT00075725|13201788|P11|COMPLETED|Overall Study||3
5365780|NCT00075725|13201789|P10|COMPLETED|Overall Study||16
5365781|NCT00075725|13201790|P9|COMPLETED|Overall Study||185
5365782|NCT00075725|13201791|P8|COMPLETED|Overall Study||401
5365783|NCT00075725|13201792|P7|COMPLETED|Overall Study||171
5365784|NCT00075725|13201793|P6|COMPLETED|Overall Study||397
5365785|NCT00075725|13201794|P5|COMPLETED|Overall Study||166
5365786|NCT00075725|13201795|P4|COMPLETED|Overall Study||168
5365787|NCT00075725|13201796|P3|COMPLETED|Overall Study||175
5365788|NCT00075725|13201797|P2|COMPLETED|Overall Study||57
5365789|NCT00075725|13201798|P1|COMPLETED|Overall Study||172
5365790|NCT00075725|13201787|P12|STARTED|Overall Study||28
5365791|NCT00075725|13201788|P11|STARTED|Overall Study||12
5365792|NCT00075725|13201789|P10|STARTED|Overall Study||34
5365793|NCT00075725|13201790|P9|STARTED|Overall Study||302
5365794|NCT00075725|13201791|P8|STARTED|Overall Study||696
5365795|NCT00075725|13201792|P7|STARTED|Overall Study||246
5365796|NCT00075725|13201793|P6|STARTED|Overall Study||710
5365797|NCT00075725|13201794|P5|STARTED|Overall Study||232
5365798|NCT00075725|13201795|P4|STARTED|Overall Study||246
5365799|NCT00075725|13201796|P3|STARTED|Overall Study||296
5365800|NCT00075725|13201797|P2|STARTED|Overall Study||106
5365801|NCT00075725|13201798|P1|STARTED|Overall Study||246
5365802|NCT00075608|13201887|P1|NOT COMPLETED|Overall Study||0
5365803|NCT00075608|13201887|P1|COMPLETED|Overall Study||12
5365804|NCT00075608|13201887|P1|STARTED|Overall Study||12
5365805|NCT00075582|13201895|P2|NOT COMPLETED|Overall Study||35
5365806|NCT00075582|13201896|P1|NOT COMPLETED|Overall Study||50
5365807|NCT00075582|13201895|P2|COMPLETED|Overall Study||50
5365808|NCT00075582|13201896|P1|COMPLETED|Overall Study||255
5365809|NCT00075582|13201895|P2|STARTED|Overall Study||85
5365810|NCT00075582|13201896|P1|STARTED|Overall Study||305
5365811|NCT00075504|13201910|P2|NOT COMPLETED|Overall Study||7
5365812|NCT00075504|13201911|P1|NOT COMPLETED|Overall Study||9
5365813|NCT00075504|13201910|P2|COMPLETED|Overall Study||3
5365814|NCT00075504|13201911|P1|COMPLETED|Overall Study||14
5365815|NCT00075504|13201910|P2|STARTED|Overall Study||10
5365816|NCT00075504|13201911|P1|STARTED|Overall Study||23
5365817|NCT00075478|13201923|P2|NOT COMPLETED|Overall Study||1
5365818|NCT00075478|13201924|P1|NOT COMPLETED|Overall Study||1
5365819|NCT00075478|13201923|P2|COMPLETED|Overall Study||44
5365820|NCT00075478|13201924|P1|COMPLETED|Overall Study||41
5365821|NCT00075478|13201923|P2|STARTED|Overall Study||45
5365822|NCT00075478|13201924|P1|STARTED|Overall Study||42
5365823|NCT00075400|13201944|P1|NOT COMPLETED|Overall Study||3
5365824|NCT00075400|13201944|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
5365825|NCT00075400|13201944|P1|STARTED|Overall Study||26
5365826|NCT00075335|13201958|P1|NOT COMPLETED|Overall Study||0
5365827|NCT00075335|13201958|P1|COMPLETED|Overall Study||8
5365828|NCT00075335|13201958|P1|STARTED|Overall Study||8
5365829|NCT00075270|13201965|P2|NOT COMPLETED|Overall Study||284
5365830|NCT00075270|13201966|P1|NOT COMPLETED|Overall Study||286
5365831|NCT00075270|13201965|P2|COMPLETED|Overall Study||4
5365832|NCT00075270|13201966|P1|COMPLETED|Overall Study||5
5365833|NCT00075270|13201965|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
5365834|NCT00075270|13201966|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
5365835|NCT00075270|13201965|P2|STARTED|Overall Study||288
5365836|NCT00075270|13201966|P1|STARTED|Overall Study||291
5365837|NCT00075218|13202012|P3|NOT COMPLETED|Open-Label Treatment||255
5365838|NCT00075218|13202013|P2|NOT COMPLETED|Open-Label Treatment||0
5365839|NCT00075218|13202014|P1|NOT COMPLETED|Open-Label Treatment||0
5365840|NCT00075218|13202012|P3|COMPLETED|Open-Label Treatment||0
5365841|NCT00075218|13202013|P2|COMPLETED|Open-Label Treatment||0
5365842|NCT00075218|13202014|P1|COMPLETED|Open-Label Treatment||0
5365843|NCT00075218|13202012|P3|STARTED|Open-Label Treatment||255
5365844|NCT00075218|13202013|P2|STARTED|Open-Label Treatment||0
5365845|NCT00075218|13202014|P1|STARTED|Open-Label Treatment||0
5365846|NCT00075218|13202012|P3|NOT COMPLETED|Double-Blind Treatment||0
5365847|NCT00075218|13202013|P2|NOT COMPLETED|Double-Blind Treatment||15
5365848|NCT00075218|13202014|P1|NOT COMPLETED|Double-Blind Treatment||91
5365849|NCT00075218|13202012|P3|COMPLETED|Double-Blind Treatment||0
5365850|NCT00075218|13202013|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
5365851|NCT00075218|13202014|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
5365852|NCT00075218|13202012|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
5365853|NCT00075218|13202013|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
5365854|NCT00075218|13202014|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
5365855|NCT00075218|13202012|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
5365856|NCT00075218|13202013|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
5365857|NCT00075218|13202014|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
5365858|NCT00075218|13202012|P3|STARTED|Double-Blind Treatment||0
5365859|NCT00075218|13202013|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
5365860|NCT00075218|13202014|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
5365861|NCT00075088|13202049|P2|NOT COMPLETED|Overall Study||0
5365862|NCT00075088|13202050|P1|NOT COMPLETED|Overall Study||0
5365863|NCT00075088|13202049|P2|COMPLETED|Overall Study||391
5365864|NCT00075088|13202050|P1|COMPLETED|Overall Study||403
5365865|NCT00075088|13202049|P2|STARTED|Overall Study||391
5365866|NCT00075088|13202050|P1|STARTED|Overall Study||403
5365867|NCT00075023|13202063|P2|NOT COMPLETED|Part Two||0
5365868|NCT00075023|13202064|P1|NOT COMPLETED|Part Two||0
5365869|NCT00075023|13202063|P2|COMPLETED|Part Two||0
5365870|NCT00075023|13202064|P1|COMPLETED|Part Two||0
5365871|NCT00075023|13202063|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
5365872|NCT00075023|13202064|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
5365873|NCT00075023|13202063|P2|NOT COMPLETED|Pilot Study||2
5365874|NCT00075023|13202064|P1|NOT COMPLETED|Pilot Study||2
5365875|NCT00075023|13202063|P2|COMPLETED|Pilot Study||3
5365876|NCT00075023|13202064|P1|COMPLETED|Pilot Study||3
5365877|NCT00075023|13202063|P2|STARTED|Pilot Study||5
5365878|NCT00075023|13202064|P1|STARTED|Pilot Study||5
5365879|NCT00074984|13202073|P2|NOT COMPLETED|Overall Study||8
5365880|NCT00074984|13202074|P1|NOT COMPLETED|Overall Study||3
5365881|NCT00074984|13202073|P2|COMPLETED|Overall Study||43
5365882|NCT00074984|13202074|P1|COMPLETED|Overall Study||28
5365883|NCT00074984|13202073|P2|STARTED|Overall Study||51
5365884|NCT00074984|13202074|P1|STARTED|Overall Study||31
5365885|NCT00074958|13202089|P1|NOT COMPLETED|Overall Study||1
5365886|NCT00074958|13202089|P1|COMPLETED|Overall Study||15
5365887|NCT00074958|13202089|P1|STARTED|Overall Study||16
5365888|NCT00074815|13202097|P3|NOT COMPLETED|Overall Study||12
5365889|NCT00074815|13202098|P2|NOT COMPLETED|Overall Study||6
5365890|NCT00074815|13202099|P1|NOT COMPLETED|Overall Study||5
5365891|NCT00074815|13202097|P3|COMPLETED|Overall Study||30
5365892|NCT00074815|13202098|P2|COMPLETED|Overall Study||34
5365893|NCT00074815|13202099|P1|COMPLETED|Overall Study||37
5365894|NCT00074815|13202097|P3|STARTED|Overall Study||42
5365895|NCT00074815|13202098|P2|STARTED|Overall Study||40
5365896|NCT00074815|13202099|P1|STARTED|Overall Study||42
5365897|NCT00074802|13202109|P2|NOT COMPLETED|Overall Study||7
5365898|NCT00074802|13202110|P1|NOT COMPLETED|Overall Study||9
5365899|NCT00074802|13202109|P2|COMPLETED|Overall Study||25
5365900|NCT00074802|13202110|P1|COMPLETED|Overall Study||20
5365901|NCT00074802|13202109|P2|STARTED|Overall Study||32
5365902|NCT00074802|13202110|P1|STARTED|Overall Study||29
5365903|NCT00074711|13202130|P2|NOT COMPLETED|Overall Study||15
5365904|NCT00074711|13202131|P1|NOT COMPLETED|Overall Study||15
5365905|NCT00074711|13202130|P2|COMPLETED|Overall Study||106
5365906|NCT00074711|13202131|P1|COMPLETED|Overall Study||105
5365907|NCT00074711|13202130|P2|STARTED|Overall Study||121
5365908|NCT00074711|13202131|P1|STARTED|Overall Study||120
5365909|NCT00074581|13202149|P2|NOT COMPLETED|Overall Study||226
5365910|NCT00074581|13202150|P1|NOT COMPLETED|Overall Study||244
5365911|NCT00074581|13202149|P2|COMPLETED|Overall Study||1541
5365912|NCT00074581|13202150|P1|COMPLETED|Overall Study||1545
5365913|NCT00074581|13202149|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
5365914|NCT00074581|13202150|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
5365915|NCT00074490|13202163|P6|NOT COMPLETED|Overall Study||0
5365916|NCT00074490|13202164|P5|NOT COMPLETED|Overall Study||3
5365917|NCT00074490|13202165|P4|NOT COMPLETED|Overall Study||0
5365918|NCT00074490|13202166|P3|NOT COMPLETED|Overall Study||0
5365919|NCT00074490|13202167|P2|NOT COMPLETED|Overall Study||7
5365920|NCT00074490|13202168|P1|NOT COMPLETED|Overall Study||0
5365921|NCT00074490|13202163|P6|COMPLETED|Overall Study||221
5365922|NCT00074490|13202164|P5|COMPLETED|Overall Study||42
5365923|NCT00074490|13202165|P4|COMPLETED|Overall Study||44
5365924|NCT00074490|13202166|P3|COMPLETED|Overall Study||40
5365925|NCT00074490|13202167|P2|COMPLETED|Overall Study||27
5365926|NCT00074490|13202168|P1|COMPLETED|Overall Study||1
5365927|NCT00074490|13202163|P6|STARTED|Overall Study||221
5365928|NCT00074490|13202164|P5|STARTED|Overall Study||45
5365929|NCT00074490|13202165|P4|STARTED|Overall Study||44
5365930|NCT00074490|13202166|P3|STARTED|Overall Study||40
5365931|NCT00074490|13202167|P2|STARTED|Overall Study||34
5365932|NCT00074490|13202168|P1|STARTED|Overall Study||1
5365933|NCT00074412|13202202|P2|NOT COMPLETED|Overall Study||84
5365934|NCT00074412|13202203|P1|NOT COMPLETED|Overall Study||82
5365935|NCT00074412|13202202|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
5365936|NCT00074412|13202203|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
5365937|NCT00074412|13202202|P2|Month 12 Visit|Overall Study||735
5365938|NCT00074412|13202203|P1|Month 12 Visit|Overall Study||733
5365939|NCT00074412|13202202|P2|Month 9 Visit|Overall Study||741
5365940|NCT00074412|13202203|P1|Month 9 Visit|Overall Study||741
5365941|NCT00074412|13202202|P2|Month 6 Visit|Overall Study||748
5365942|NCT00074412|13202203|P1|Month 6 Visit|Overall Study||748
5365943|NCT00074412|13202202|P2|Month 5 Visit|Overall Study||750
5365944|NCT00074412|13202203|P1|Month 5 Visit|Overall Study||756
5365945|NCT00074412|13202202|P2|Month 4 Visit|Overall Study||752
5365946|NCT00074412|13202203|P1|Month 4 Visit|Overall Study||758
5365947|NCT00074412|13202202|P2|Month 3 Visit|Overall Study||755
5365948|NCT00074412|13202203|P1|Month 3 Visit|Overall Study||759
5365949|NCT00074412|13202202|P2|Week 8 Visit|Overall Study||759
5365950|NCT00074412|13202203|P1|Week 8 Visit|Overall Study||759
5365951|NCT00074412|13202202|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
5365952|NCT00074412|13202203|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
5365953|NCT00074308|13202219|P5|NOT COMPLETED|Overall Study||0
5365954|NCT00074308|13202220|P4|NOT COMPLETED|Overall Study||0
5365955|NCT00074308|13202221|P3|NOT COMPLETED|Overall Study||0
5365956|NCT00074308|13202222|P2|NOT COMPLETED|Overall Study||0
5365957|NCT00074308|13202223|P1|NOT COMPLETED|Overall Study||0
5365958|NCT00074308|13202219|P5|COMPLETED|Overall Study||23
5365959|NCT00074308|13202220|P4|COMPLETED|Overall Study||8
5365960|NCT00074308|13202221|P3|COMPLETED|Overall Study||3
5365961|NCT00074308|13202222|P2|COMPLETED|Overall Study||3
5365962|NCT00074308|13202223|P1|COMPLETED|Overall Study||3
5365963|NCT00074308|13202219|P5|STARTED|Overall Study||23
5365964|NCT00074308|13202220|P4|STARTED|Overall Study||8
5365965|NCT00074308|13202221|P3|STARTED|Overall Study||3
5365966|NCT00074308|13202222|P2|STARTED|Overall Study||3
5365967|NCT00074308|13202223|P1|STARTED|Overall Study||3
5365968|NCT00074282|13202234|P3|NOT COMPLETED|Step 2||24
5365969|NCT00074282|13202235|P2|NOT COMPLETED|Step 2||2
5365970|NCT00074282|13202236|P1|NOT COMPLETED|Step 2||0
5365971|NCT00074282|13202234|P3|COMPLETED|Step 2||7
5365972|NCT00074282|13202235|P2|COMPLETED|Step 2||7
5365973|NCT00074282|13202236|P1|COMPLETED|Step 2||0
5365974|NCT00074282|13202234|P3|STARTED|Step 2||31
5365975|NCT00074282|13202235|P2|STARTED|Step 2||9
5365976|NCT00074282|13202236|P1|STARTED|Step 2||0
5365977|NCT00074282|13202234|P3|NOT COMPLETED|Step 1||0
5365978|NCT00074282|13202235|P2|NOT COMPLETED|Step 1||0
5365979|NCT00074282|13202236|P1|NOT COMPLETED|Step 1||58
5365980|NCT00074282|13202234|P3|COMPLETED|Step 1||0
5365981|NCT00074282|13202235|P2|COMPLETED|Step 1||0
5365982|NCT00074282|13202236|P1|COMPLETED|Step 1||44
5365983|NCT00074282|13202234|P3|Started Treatment|Step 1||0
5365984|NCT00074282|13202235|P2|Started Treatment|Step 1||0
5365985|NCT00074282|13202236|P1|Started Treatment|Step 1||96
5365986|NCT00074282|13202234|P3|Eligible|Step 1||0
5365987|NCT00074282|13202235|P2|Eligible|Step 1||0
5365988|NCT00074282|13202236|P1|Eligible|Step 1||98
5365989|NCT00074282|13202234|P3|STARTED|Step 1||0
5365990|NCT00074282|13202235|P2|STARTED|Step 1||0
5365991|NCT00074282|13202236|P1|STARTED|Step 1||102
5365992|NCT00074269|13202245|P1|NOT COMPLETED|Overall Study||0
5365993|NCT00074269|13202245|P1|COMPLETED|Overall Study||5
5365994|NCT00074269|13202245|P1|STARTED|Overall Study||5
5365995|NCT00074165|13202255|P1|NOT COMPLETED|Overall Study||0
5365996|NCT00074165|13202255|P1|COMPLETED|Overall Study||17
5365997|NCT00074165|13202255|P1|STARTED|Overall Study||17
5365998|NCT00074152|13202262|P2|NOT COMPLETED|Overall Study||33
5365999|NCT00074152|13202263|P1|NOT COMPLETED|Overall Study||55
5366000|NCT00074152|13202262|P2|COMPLETED|Overall Study||52
5366001|NCT00074152|13202263|P1|COMPLETED|Overall Study||22
5366002|NCT00074152|13202262|P2|STARTED|Overall Study||85
5366003|NCT00074152|13202263|P1|STARTED|Overall Study||77
5366004|NCT00074035|13202273|P1|NOT COMPLETED|Overall Study||0
5366005|NCT00074035|13202273|P1|COMPLETED|Overall Study||38
5366006|NCT00074035|13202273|P1|STARTED|Overall Study||38
5366007|NCT00073983|13202280|P1|NOT COMPLETED|Overall Study||1
5366008|NCT00073983|13202280|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
5366009|NCT00073983|13202280|P1|STARTED|Overall Study||54
5366010|NCT00073957|13202295|P1|NOT COMPLETED|Overall Study||0
5366011|NCT00073957|13202295|P1|COMPLETED|Overall Study||25
5366012|NCT00073957|13202295|P1|STARTED|Overall Study||25
5366013|NCT00073918|13202301|P1|NOT COMPLETED|Overall Study||4
5366014|NCT00073918|13202301|P1|COMPLETED|Overall Study||107
5366015|NCT00073918|13202301|P1|STARTED|Overall Study||111
5366016|NCT00073749|13202315|P7|NOT COMPLETED|Overall Study||40
5366017|NCT00073749|13202316|P6|NOT COMPLETED|Overall Study||6
5366018|NCT00073749|13202317|P5|NOT COMPLETED|Overall Study||6
5366019|NCT00073749|13202318|P4|NOT COMPLETED|Overall Study||6
5366020|NCT00073749|13202319|P3|NOT COMPLETED|Overall Study||11
5366021|NCT00073749|13202320|P2|NOT COMPLETED|Overall Study||5
5366022|NCT00073749|13202321|P1|NOT COMPLETED|Overall Study||2
5366023|NCT00073749|13202315|P7|COMPLETED|Overall Study||3
5366024|NCT00073749|13202316|P6|COMPLETED|Overall Study||0
5366025|NCT00073749|13202317|P5|COMPLETED|Overall Study||0
5366026|NCT00073749|13202318|P4|COMPLETED|Overall Study||0
5366027|NCT00073749|13202319|P3|COMPLETED|Overall Study||0
5366028|NCT00073749|13202320|P2|COMPLETED|Overall Study||0
5366029|NCT00073749|13202321|P1|COMPLETED|Overall Study||0
5366030|NCT00073749|13202315|P7|STARTED|Overall Study||43
5366031|NCT00073749|13202316|P6|STARTED|Overall Study||6
5366032|NCT00073749|13202317|P5|STARTED|Overall Study||6
5366033|NCT00073749|13202318|P4|STARTED|Overall Study||6
5366034|NCT00073749|13202319|P3|STARTED|Overall Study||11
5366035|NCT00073749|13202320|P2|STARTED|Overall Study||5
5366036|NCT00073749|13202321|P1|STARTED|Overall Study||2
5366037|NCT00073528|13202352|P2|NOT COMPLETED|Overall Study||642
5366038|NCT00073528|13202353|P1|NOT COMPLETED|Overall Study||644
5366039|NCT00073528|13202352|P2|COMPLETED|Overall Study||0
5366040|NCT00073528|13202353|P1|COMPLETED|Overall Study||0
5366041|NCT00073528|13202352|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
5366042|NCT00073528|13202353|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
5366043|NCT00073528|13202352|P2|STARTED|Overall Study||642
5366044|NCT00073528|13202353|P1|STARTED|Overall Study||644
5366045|NCT00073333|13202430|P3|NOT COMPLETED|Overall Study||0
5366046|NCT00073333|13202431|P2|NOT COMPLETED|Overall Study||14
5366047|NCT00073333|13202432|P1|NOT COMPLETED|Overall Study||14
5366048|NCT00073333|13202430|P3|COMPLETED|Overall Study||19
5366049|NCT00073333|13202431|P2|COMPLETED|Overall Study||27
5366050|NCT00073333|13202432|P1|COMPLETED|Overall Study||32
5366051|NCT00073333|13202430|P3|STARTED|Overall Study||19
5366052|NCT00073333|13202431|P2|STARTED|Overall Study||41
5366053|NCT00073333|13202432|P1|STARTED|Overall Study||46
5366054|NCT00073307|13202442|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
5366055|NCT00073307|13202443|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
5366056|NCT00073307|13202444|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
5366057|NCT00073307|13202442|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
5366058|NCT00073307|13202443|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
5366059|NCT00073307|13202444|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
5366060|NCT00073307|13202442|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
5366061|NCT00073307|13202443|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
5366062|NCT00073307|13202444|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
5366063|NCT00073307|13202442|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
5366064|NCT00073307|13202443|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
5366065|NCT00073307|13202444|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
5366066|NCT00073307|13202442|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
5366067|NCT00073307|13202443|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
5366068|NCT00073307|13202444|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
5366069|NCT00073307|13202442|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
5366070|NCT00073307|13202443|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
5366071|NCT00073307|13202444|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
5366072|NCT00073307|13202442|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
5366073|NCT00073307|13202443|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
5366074|NCT00073307|13202444|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
5366075|NCT00073307|13202442|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
5366076|NCT00073307|13202443|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
5366077|NCT00073307|13202444|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
5366078|NCT00073073|13202462|P1|NOT COMPLETED|Overall Study||4
5366079|NCT00073073|13202462|P1|COMPLETED|Overall Study||42
5366080|NCT00073073|13202462|P1|STARTED|Overall Study||46
5366081|NCT00073021|13202475|P2|NOT COMPLETED|Overall Study||16
5366082|NCT00073021|13202476|P1|NOT COMPLETED|Overall Study||26
5366083|NCT00073021|13202475|P2|COMPLETED|Overall Study||113
5366084|NCT00073021|13202476|P1|COMPLETED|Overall Study||113
5366085|NCT00073021|13202475|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
5366086|NCT00073021|13202476|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
5366087|NCT00073008|13202506|P2|NOT COMPLETED|Overall Study||63
5366088|NCT00073008|13202507|P1|NOT COMPLETED|Overall Study||62
5366089|NCT00073008|13202506|P2|COMPLETED|Overall Study||3
5366090|NCT00073008|13202507|P1|COMPLETED|Overall Study||3
5366091|NCT00073008|13202506|P2|STARTED|Overall Study||66
5366092|NCT00073008|13202507|P1|STARTED|Overall Study||65
5366093|NCT00072761|13202539|P2|NOT COMPLETED|Overall Study||2
5366094|NCT00072761|13202540|P1|NOT COMPLETED|Overall Study||9
5366095|NCT00072761|13202539|P2|COMPLETED|Overall Study||95
5366096|NCT00072761|13202540|P1|COMPLETED|Overall Study||90
5366097|NCT00072761|13202539|P2|STARTED|Overall Study||97
5366098|NCT00072761|13202540|P1|STARTED|Overall Study||99
5366099|NCT00072475|13202546|P1|NOT COMPLETED|Overall Study||97
5366100|NCT00072475|13202546|P1|COMPLETED|Overall Study||45
5366101|NCT00072475|13202546|P1|STARTED|Overall Study||142
5366102|NCT00072449|13202554|P1|NOT COMPLETED|Overall Study||0
5366103|NCT00072449|13202554|P1|COMPLETED|Overall Study||12
5366104|NCT00072449|13202554|P1|STARTED|Overall Study||12
5366105|NCT00072384|13202561|P1|NOT COMPLETED|Overall Study||9
5366106|NCT00072384|13202561|P1|COMPLETED|Overall Study||21
5366107|NCT00072384|13202561|P1|STARTED|Overall Study||30
5366108|NCT00072293|13202574|P2|NOT COMPLETED|Overall Study||2
5366109|NCT00072293|13202575|P1|NOT COMPLETED|Overall Study||1
5366110|NCT00072293|13202574|P2|COMPLETED|Overall Study||467
5366111|NCT00072293|13202575|P1|COMPLETED|Overall Study||464
5366112|NCT00072293|13202574|P2|STARTED|Overall Study||469
5366113|NCT00072293|13202575|P1|STARTED|Overall Study||465
5366114|NCT00072280|13202587|P2|NOT COMPLETED|Follow-up||2
5366115|NCT00072280|13202588|P1|NOT COMPLETED|Follow-up||2
5366116|NCT00072280|13202587|P2|COMPLETED|Follow-up||0
5366117|NCT00072280|13202588|P1|COMPLETED|Follow-up||0
5366118|NCT00072280|13202587|P2|STARTED|Follow-up||2
5366119|NCT00072280|13202588|P1|STARTED|Follow-up||2
5366120|NCT00072280|13202587|P2|NOT COMPLETED|Treatment||2
5366121|NCT00072280|13202588|P1|NOT COMPLETED|Treatment||1
5366122|NCT00072280|13202587|P2|COMPLETED|Treatment||2
5366123|NCT00072280|13202588|P1|COMPLETED|Treatment||2
5366124|NCT00072280|13202587|P2|STARTED|Treatment||4
5366125|NCT00072280|13202588|P1|STARTED|Treatment||3
5366126|NCT00072189|13202593|P1|NOT COMPLETED|Overall Study||1
5366127|NCT00072189|13202593|P1|COMPLETED|Overall Study||16
5366128|NCT00072189|13202593|P1|STARTED|Overall Study||17
5366129|NCT00072176|13202601|P2|NOT COMPLETED|Overall Study||1
5366130|NCT00072176|13202602|P1|NOT COMPLETED|Overall Study||1
5366131|NCT00072176|13202601|P2|COMPLETED|Overall Study||27
5366132|NCT00072176|13202602|P1|COMPLETED|Overall Study||33
5366133|NCT00072176|13202601|P2|STARTED|Overall Study||28
5366134|NCT00072176|13202602|P1|STARTED|Overall Study||34
5366135|NCT00071981|13202614|P4|NOT COMPLETED|Overall Study||45
5366136|NCT00071981|13202615|P3|NOT COMPLETED|Overall Study||37
5366137|NCT00071981|13202616|P2|NOT COMPLETED|Overall Study||41
5366138|NCT00071981|13202617|P1|NOT COMPLETED|Overall Study||46
5366139|NCT00071981|13202614|P4|COMPLETED|Overall Study||3
5366140|NCT00071981|13202615|P3|COMPLETED|Overall Study||0
5366141|NCT00071981|13202616|P2|COMPLETED|Overall Study||2
5366142|NCT00071981|13202617|P1|COMPLETED|Overall Study||1
5366143|NCT00071981|13202614|P4|Have Helper T Cell Response Data|Overall Study||39
5366144|NCT00071981|13202615|P3|Have Helper T Cell Response Data|Overall Study||25
5366145|NCT00071981|13202616|P2|Have Helper T Cell Response Data|Overall Study||27
5366146|NCT00071981|13202617|P1|Have Helper T Cell Response Data|Overall Study||37
5366147|NCT00071981|13202614|P4|Have CTL Response Data|Overall Study||41
5366148|NCT00071981|13202615|P3|Have CTL Response Data|Overall Study||29
5366149|NCT00071981|13202616|P2|Have CTL Response Data|Overall Study||30
5366150|NCT00071981|13202617|P1|Have CTL Response Data|Overall Study||40
5366151|NCT00071981|13202614|P4|Eligible and Treated|Overall Study||42
5366152|NCT00071981|13202615|P3|Eligible and Treated|Overall Study||32
5366153|NCT00071981|13202616|P2|Eligible and Treated|Overall Study||33
5366154|NCT00071981|13202617|P1|Eligible and Treated|Overall Study||41
5366155|NCT00071981|13202614|P4|Treated|Overall Study||48
5366156|NCT00071981|13202615|P3|Treated|Overall Study||36
5366157|NCT00071981|13202616|P2|Treated|Overall Study||38
5366158|NCT00071981|13202617|P1|Treated|Overall Study||45
5366159|NCT00071981|13202614|P4|Eligible|Overall Study||42
5366160|NCT00071981|13202615|P3|Eligible|Overall Study||33
5366161|NCT00071981|13202616|P2|Eligible|Overall Study||36
5366162|NCT00071981|13202617|P1|Eligible|Overall Study||43
5366163|NCT00071981|13202614|P4|STARTED|Overall Study||48
5366164|NCT00071981|13202615|P3|STARTED|Overall Study||37
5366165|NCT00071981|13202616|P2|STARTED|Overall Study||43
5366166|NCT00071981|13202617|P1|STARTED|Overall Study||47
5366167|NCT00072566|13202643|P1|NOT COMPLETED|Overall Study||0
5366168|NCT00072566|13202643|P1|COMPLETED|Overall Study||70
5366169|NCT00072566|13202643|P1|STARTED|Overall Study||70
5366170|NCT00072514|13202649|P1|NOT COMPLETED|Overall Study||4
5366171|NCT00072514|13202649|P1|COMPLETED|Overall Study||51
5366172|NCT00072514|13202649|P1|STARTED|Overall Study||55
5366173|NCT00071812|13202660|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
5366174|NCT00071812|13202661|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
5366175|NCT00071812|13202662|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
5366176|NCT00071812|13202663|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
5366177|NCT00071812|13202660|P4|COMPLETED|24-Week Open-Label Extension Period||178
5366178|NCT00071812|13202661|P3|COMPLETED|24-Week Open-Label Extension Period||7
5366179|NCT00071812|13202662|P2|COMPLETED|24-Week Open-Label Extension Period||11
5366180|NCT00071812|13202663|P1|COMPLETED|24-Week Open-Label Extension Period||0
5366181|NCT00071812|13202660|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
5366182|NCT00071812|13202661|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
5366183|NCT00071812|13202662|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
5366184|NCT00071812|13202663|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
5366185|NCT00071812|13202660|P4|NOT COMPLETED|24-Week Double-Blind Period||11
5366186|NCT00071812|13202661|P3|NOT COMPLETED|24-Week Double-Blind Period||8
5366187|NCT00071812|13202662|P2|NOT COMPLETED|24-Week Double-Blind Period||6
5366188|NCT00071812|13202663|P1|NOT COMPLETED|24-Week Double-Blind Period||10
5366189|NCT00071812|13202660|P4|COMPLETED|24-Week Double-Blind Period||60
5366190|NCT00071812|13202661|P3|COMPLETED|24-Week Double-Blind Period||63
5366191|NCT00071812|13202662|P2|COMPLETED|24-Week Double-Blind Period||66
5366192|NCT00071812|13202663|P1|COMPLETED|24-Week Double-Blind Period||59
5366193|NCT00071812|13202660|P4|STARTED|24-Week Double-Blind Period||71
5366194|NCT00071812|13202661|P3|STARTED|24-Week Double-Blind Period||71
5366195|NCT00071812|13202662|P2|STARTED|24-Week Double-Blind Period||72
5366196|NCT00071812|13202663|P1|STARTED|24-Week Double-Blind Period||69
5366197|NCT00071799|13202705|P2|NOT COMPLETED|Overall Study||98
5366198|NCT00071799|13202706|P1|NOT COMPLETED|Overall Study||70
5366199|NCT00071799|13202705|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
5366200|NCT00071799|13202706|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
5366284|NCT00071058|13202952|P1|STARTED|Overall Study||50
5366201|NCT00071799|13202705|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
5366202|NCT00071799|13202706|P1|STARTED|Overall Study||179
5366203|NCT00071890|13202748|P2|NOT COMPLETED|Overall Study||0
5366204|NCT00071890|13202749|P1|NOT COMPLETED|Overall Study||0
5366205|NCT00071890|13202748|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
5366206|NCT00071890|13202749|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
5366207|NCT00071890|13202748|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
5366208|NCT00071890|13202749|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
5366209|NCT00071760|13202759|P1|NOT COMPLETED|Overall Study||54
5366210|NCT00071760|13202759|P1|COMPLETED|Overall Study||0
5366211|NCT00071760|13202759|P1|Ongoing|Overall Study||25
5366212|NCT00071760|13202759|P1|STARTED|Overall Study||54
5366213|NCT00071721|13202820|P2|NOT COMPLETED|Overall Study||91
5366214|NCT00071721|13202821|P1|NOT COMPLETED|Overall Study||72
5366215|NCT00071721|13202820|P2|COMPLETED|Overall Study||69
5366216|NCT00071721|13202821|P1|COMPLETED|Overall Study||81
5366217|NCT00071721|13202820|P2|STARTED|Overall Study||160
5366218|NCT00071721|13202821|P1|STARTED|Overall Study||153
5366219|NCT00071513|13202839|P2|NOT COMPLETED|Follow-up Assessment||6
5366220|NCT00071513|13202840|P1|NOT COMPLETED|Follow-up Assessment||6
5366221|NCT00071513|13202839|P2|COMPLETED|Follow-up Assessment||247
5366222|NCT00071513|13202840|P1|COMPLETED|Follow-up Assessment||233
5366223|NCT00071513|13202839|P2|STARTED|Follow-up Assessment||253
5366224|NCT00071513|13202840|P1|STARTED|Follow-up Assessment||239
5366225|NCT00071513|13202839|P2|NOT COMPLETED|Intervention Component||3
5366226|NCT00071513|13202840|P1|NOT COMPLETED|Intervention Component||2
5366227|NCT00071513|13202839|P2|COMPLETED|Intervention Component||253
5366228|NCT00071513|13202840|P1|COMPLETED|Intervention Component||239
5366229|NCT00071513|13202839|P2|STARTED|Intervention Component||256
5366230|NCT00071513|13202840|P1|STARTED|Intervention Component||241
5366231|NCT00071487|13202852|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
5366232|NCT00071487|13202853|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
5366233|NCT00071487|13202854|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
5366234|NCT00071487|13202855|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
5366235|NCT00071487|13202852|P4|COMPLETED|24-Week Open-Label Extension Period||279
5366236|NCT00071487|13202853|P3|COMPLETED|24-Week Open-Label Extension Period||23
5366237|NCT00071487|13202854|P2|COMPLETED|24-Week Open-Label Extension Period||19
5366238|NCT00071487|13202855|P1|COMPLETED|24-Week Open-Label Extension Period||0
5366239|NCT00071487|13202852|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
5366240|NCT00071487|13202853|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
5366241|NCT00071487|13202854|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
5366242|NCT00071487|13202855|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
5366243|NCT00071487|13202852|P4|NOT COMPLETED|52-Week Double-Blind Period||21
5366244|NCT00071487|13202853|P3|NOT COMPLETED|52-Week Double-Blind Period||17
5366245|NCT00071487|13202854|P2|NOT COMPLETED|52-Week Double-Blind Period||27
5366246|NCT00071487|13202855|P1|NOT COMPLETED|52-Week Double-Blind Period||20
5366247|NCT00071487|13202852|P4|COMPLETED|52-Week Double-Blind Period||90
5366248|NCT00071487|13202853|P3|COMPLETED|52-Week Double-Blind Period||94
5366249|NCT00071487|13202854|P2|COMPLETED|52-Week Double-Blind Period||87
5366250|NCT00071487|13202855|P1|COMPLETED|52-Week Double-Blind Period||93
5366251|NCT00071487|13202852|P4|STARTED|52-Week Double-Blind Period||111
5366252|NCT00071487|13202853|P3|STARTED|52-Week Double-Blind Period||111
5366253|NCT00071487|13202854|P2|STARTED|52-Week Double-Blind Period||114
5366254|NCT00071487|13202855|P1|STARTED|52-Week Double-Blind Period||113
5366255|NCT00071396|13202899|P1|NOT COMPLETED|Overall Study||3
5366256|NCT00071396|13202899|P1|COMPLETED|Overall Study|Evaluable for response.|41
5366257|NCT00071396|13202899|P1|STARTED|Overall Study||44
5366258|NCT00071110|13202905|P2|NOT COMPLETED|Overall Study||4
5366259|NCT00071110|13202906|P1|NOT COMPLETED|Overall Study||0
5366260|NCT00071110|13202905|P2|COMPLETED|Overall Study||25
5366261|NCT00071110|13202906|P1|COMPLETED|Overall Study||28
5366262|NCT00071110|13202905|P2|STARTED|Overall Study||29
5366263|NCT00071110|13202906|P1|STARTED|Overall Study||28
5366264|NCT00071032|13202920|P2|NOT COMPLETED|Overall Study||8
5366265|NCT00071032|13202921|P1|NOT COMPLETED|Overall Study||9
5366266|NCT00071032|13202920|P2|COMPLETED|Overall Study||1001
5366267|NCT00071032|13202921|P1|COMPLETED|Overall Study||998
5366268|NCT00071032|13202920|P2|STARTED|Overall Study||1009
5366269|NCT00071032|13202921|P1|STARTED|Overall Study||1007
5366270|NCT00071006|13202929|P1|NOT COMPLETED|Overall Study||12
5366271|NCT00071006|13202929|P1|COMPLETED|Overall Study||0
5366272|NCT00071006|13202929|P1|STARTED|Overall Study||12
5366273|NCT00070941|13202942|P3|NOT COMPLETED|Overall Study||4
5366274|NCT00070941|13202943|P2|NOT COMPLETED|Overall Study||8
5366275|NCT00070941|13202944|P1|NOT COMPLETED|Overall Study||10
5366276|NCT00070941|13202942|P3|COMPLETED|Overall Study||2
5366277|NCT00070941|13202943|P2|COMPLETED|Overall Study||3
5366278|NCT00070941|13202944|P1|COMPLETED|Overall Study||2
5366279|NCT00070941|13202942|P3|STARTED|Overall Study||6
5366280|NCT00070941|13202943|P2|STARTED|Overall Study||11
5366281|NCT00070941|13202944|P1|STARTED|Overall Study||12
5366282|NCT00071058|13202952|P1|NOT COMPLETED|Overall Study||1
5366283|NCT00071058|13202952|P1|COMPLETED|Overall Study||49
5366285|NCT00070707|13202959|P2|NOT COMPLETED|Overall Study||7
5366286|NCT00070707|13202960|P1|NOT COMPLETED|Overall Study||14
5366287|NCT00070707|13202959|P2|COMPLETED|Overall Study||68
5366288|NCT00070707|13202960|P1|COMPLETED|Overall Study||99
5366289|NCT00070707|13202959|P2|STARTED|Overall Study||75
5366290|NCT00070707|13202960|P1|STARTED|Overall Study||113
5366291|NCT00003907|13203008|P2|NOT COMPLETED|Overall Study||23
5366292|NCT00003907|13203009|P1|NOT COMPLETED|Overall Study||13
5366293|NCT00003907|13203008|P2|COMPLETED|Overall Study||8
5366294|NCT00003907|13203009|P1|COMPLETED|Overall Study||6
5366295|NCT00003907|13203008|P2|Eligible and Treated|Overall Study||29
5366296|NCT00003907|13203009|P1|Eligible and Treated|Overall Study||17
5366297|NCT00003907|13203008|P2|Received Protocol Therapy (Treated)|Overall Study||31
5366298|NCT00003907|13203009|P1|Received Protocol Therapy (Treated)|Overall Study||18
5366299|NCT00003907|13203008|P2|Eligible|Overall Study||29
5366300|NCT00003907|13203009|P1|Eligible|Overall Study||18
5366301|NCT00003907|13203008|P2|STARTED|Overall Study||31
5366302|NCT00003907|13203009|P1|STARTED|Overall Study||19
5366303|NCT00070564|13203025|P6|NOT COMPLETED|Overall Study||52
5366304|NCT00070564|13203026|P5|NOT COMPLETED|Overall Study||79
5366305|NCT00070564|13203027|P4|NOT COMPLETED|Overall Study||167
5366306|NCT00070564|13203028|P3|NOT COMPLETED|Overall Study||171
5366307|NCT00070564|13203029|P2|NOT COMPLETED|Overall Study||203
5366308|NCT00070564|13203030|P1|NOT COMPLETED|Overall Study||200
5366309|NCT00070564|13203025|P6|COMPLETED|Overall Study||244
5366310|NCT00070564|13203026|P5|COMPLETED|Overall Study||203
5366311|NCT00070564|13203027|P4|COMPLETED|Overall Study||481
5366312|NCT00070564|13203028|P3|COMPLETED|Overall Study||526
5366313|NCT00070564|13203029|P2|COMPLETED|Overall Study||490
5366314|NCT00070564|13203030|P1|COMPLETED|Overall Study||478
5366315|NCT00070564|13203025|P6|STARTED|Overall Study||296
5366316|NCT00070564|13203026|P5|STARTED|Overall Study||282
5366317|NCT00070564|13203027|P4|STARTED|Overall Study||648
5366318|NCT00070564|13203028|P3|STARTED|Overall Study||697
5366319|NCT00070564|13203029|P2|STARTED|Overall Study||693
5366320|NCT00070564|13203030|P1|STARTED|Overall Study||678
5366321|NCT00070499|13203084|P4|NOT COMPLETED|Overall Study||110
5366322|NCT00070499|13203085|P3|NOT COMPLETED|Overall Study||120
5366323|NCT00070499|13203086|P2|NOT COMPLETED|Overall Study||26
5366324|NCT00070499|13203087|P1|NOT COMPLETED|Overall Study||38
5366325|NCT00070499|13203084|P4|COMPLETED|Overall Study||17
5366326|NCT00070499|13203085|P3|COMPLETED|Overall Study||6
5366327|NCT00070499|13203086|P2|COMPLETED|Overall Study||52
5366328|NCT00070499|13203087|P1|COMPLETED|Overall Study||37
5366329|NCT00070499|13203084|P4|Eligible and Treated|Overall Study||123
5366330|NCT00070499|13203085|P3|Eligible and Treated|Overall Study||123
5366331|NCT00070499|13203086|P2|Eligible and Treated|Overall Study||73
5366332|NCT00070499|13203087|P1|Eligible and Treated|Overall Study||72
5366333|NCT00070499|13203084|P4|Eligible|Overall Study||125
5366334|NCT00070499|13203085|P3|Eligible|Overall Study||123
5366335|NCT00070499|13203086|P2|Eligible|Overall Study||73
5366336|NCT00070499|13203087|P1|Eligible|Overall Study||73
5366337|NCT00070499|13203084|P4|STARTED|Overall Study||127
5366338|NCT00070499|13203085|P3|STARTED|Overall Study||126
5366339|NCT00070499|13203086|P2|STARTED|Overall Study||78
5366340|NCT00070499|13203087|P1|STARTED|Overall Study||75
5366341|NCT00070317|13203113|P1|NOT COMPLETED|Overall Study||13
5366342|NCT00070317|13203113|P1|COMPLETED|Overall Study||89
5366343|NCT00070317|13203113|P1|STARTED|Overall Study||102
5366344|NCT00070291|13203118|P1|NOT COMPLETED|Step 2||1
5366345|NCT00070291|13203118|P1|COMPLETED|Step 2||0
5366346|NCT00070291|13203118|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
5366347|NCT00070291|13203118|P1|NOT COMPLETED|Step 1||2
5366348|NCT00070291|13203118|P1|COMPLETED|Step 1||2
5366349|NCT00070291|13203118|P1|Treated|Step 1||3
5366350|NCT00070291|13203118|P1|STARTED|Step 1||4
5366351|NCT00070135|13203123|P1|NOT COMPLETED|Overall Study||0
5366352|NCT00070135|13203123|P1|COMPLETED|Overall Study||114
5366353|NCT00070135|13203123|P1|STARTED|Overall Study||114
5366354|NCT00070109|13203134|P5|NOT COMPLETED|Overall Study||8
5366355|NCT00070109|13203135|P4|NOT COMPLETED|Overall Study||20
5366356|NCT00070109|13203136|P3|NOT COMPLETED|Overall Study||8
5366357|NCT00070109|13203137|P2|NOT COMPLETED|Overall Study||6
5366358|NCT00070109|13203138|P1|NOT COMPLETED|Overall Study||8
5366359|NCT00070109|13203134|P5|COMPLETED|Overall Study||0
5366360|NCT00070109|13203135|P4|COMPLETED|Overall Study||0
5366361|NCT00070109|13203136|P3|COMPLETED|Overall Study||0
5366362|NCT00070109|13203137|P2|COMPLETED|Overall Study||0
5366363|NCT00070109|13203138|P1|COMPLETED|Overall Study||0
5366364|NCT00070109|13203134|P5|STARTED|Overall Study||8
5366365|NCT00070109|13203135|P4|STARTED|Overall Study||20
5366366|NCT00070109|13203136|P3|STARTED|Overall Study||8
5366367|NCT00070109|13203137|P2|STARTED|Overall Study||6
5366368|NCT00070109|13203138|P1|STARTED|Overall Study||8
5366369|NCT00070018|13203166|P1|NOT COMPLETED|Overall Study||4
5366370|NCT00070018|13203166|P1|COMPLETED|Overall Study||42
5366371|NCT00070018|13203166|P1|Eligible and Began Protocol Therapy|Overall Study||46
5366372|NCT00070018|13203166|P1|Eligible|Overall Study||46
5366373|NCT00070018|13203166|P1|STARTED|Overall Study||46
5366374|NCT00069953|13203170|P1|NOT COMPLETED|Overall Study||2
5366375|NCT00069953|13203170|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
5366376|NCT00069953|13203170|P1|STARTED|Overall Study||43
5366377|NCT00069784|13203176|P2|NOT COMPLETED|Overall Study||0
5366378|NCT00069784|13203177|P1|NOT COMPLETED|Overall Study||1212
5366379|NCT00069784|13203176|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
5366380|NCT00069784|13203177|P1|COMPLETED|Overall Study|completed study treatment|5052
5366381|NCT00069784|13203176|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
5366382|NCT00069784|13203177|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
5366383|NCT00069784|13203176|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
5366384|NCT00069784|13203177|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
5366385|NCT00069823|13203197|P2|NOT COMPLETED|Overall Study||3
5366386|NCT00069823|13203198|P1|NOT COMPLETED|Overall Study||6
5366387|NCT00069823|13203197|P2|COMPLETED|Overall Study||200
5366388|NCT00069823|13203198|P1|COMPLETED|Overall Study||193
5366389|NCT00069823|13203197|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
5366390|NCT00069823|13203198|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
5366391|NCT00069641|13203241|P3|NOT COMPLETED|Overall Study||1
5366392|NCT00069641|13203242|P2|NOT COMPLETED|Overall Study||0
5366393|NCT00069641|13203243|P1|NOT COMPLETED|Overall Study||1
5366394|NCT00069641|13203241|P3|COMPLETED|Overall Study||31
5366395|NCT00069641|13203242|P2|COMPLETED|Overall Study||32
5366396|NCT00069641|13203243|P1|COMPLETED|Overall Study||31
5366397|NCT00069641|13203241|P3|STARTED|Overall Study||32
5366398|NCT00069641|13203242|P2|STARTED|Overall Study||32
5366399|NCT00069641|13203243|P1|STARTED|Overall Study||32
5366400|NCT00069576|13203270|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
5366401|NCT00069576|13203271|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
5366402|NCT00069576|13203270|P2|COMPLETED|Follow-up Study at 5-10 Years||236
5366403|NCT00069576|13203271|P1|COMPLETED|Follow-up Study at 5-10 Years||264
5366404|NCT00069576|13203270|P2|STARTED|Follow-up Study at 5-10 Years||440
5366405|NCT00069576|13203271|P1|STARTED|Follow-up Study at 5-10 Years||460
5366406|NCT00069576|13203270|P2|NOT COMPLETED|Original Trial||33
5366407|NCT00069576|13203271|P1|NOT COMPLETED|Original Trial||25
5366408|NCT00069576|13203270|P2|COMPLETED|Original Trial||440
5366409|NCT00069576|13203271|P1|COMPLETED|Original Trial||460
5366410|NCT00069576|13203270|P2|STARTED|Original Trial||473
5366411|NCT00069576|13203271|P1|STARTED|Original Trial||485
5366412|NCT00069277|13203321|P1|NOT COMPLETED|Overall Study||21
5366413|NCT00069277|13203321|P1|COMPLETED|Overall Study||0
5366414|NCT00069277|13203321|P1|STARTED|Overall Study||21
5366415|NCT00069264|13203325|P1|NOT COMPLETED|Overall Study||32
5366416|NCT00069264|13203325|P1|COMPLETED|Overall Study||0
5366417|NCT00069264|13203325|P1|STARTED|Overall Study||32
5366418|NCT00069329|13203329|P1|NOT COMPLETED|Overall Study||2
5366419|NCT00069329|13203329|P1|COMPLETED|Overall Study||41
5366420|NCT00069329|13203329|P1|STARTED|Overall Study||43
5366421|NCT00069238|13203353|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
5366422|NCT00069238|13203354|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366423|NCT00069238|13203355|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366424|NCT00069238|13203353|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
5366425|NCT00069238|13203354|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366426|NCT00069238|13203355|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366427|NCT00069238|13203353|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
5366428|NCT00069238|13203354|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366429|NCT00069238|13203355|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
5366430|NCT00069238|13203353|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366431|NCT00069238|13203354|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
5366432|NCT00069238|13203355|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366433|NCT00069238|13203353|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366434|NCT00069238|13203354|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
5366435|NCT00069238|13203355|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366436|NCT00069238|13203353|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366437|NCT00069238|13203354|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
5366438|NCT00069238|13203355|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
5366439|NCT00069238|13203353|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366440|NCT00069238|13203354|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366441|NCT00069238|13203355|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
5366442|NCT00069238|13203353|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366443|NCT00069238|13203354|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366444|NCT00069238|13203355|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
5366445|NCT00069238|13203353|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366446|NCT00069238|13203354|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
5366447|NCT00069238|13203355|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
5366448|NCT00069121|13203363|P2|NOT COMPLETED|Overall Study||325
5366449|NCT00069121|13203364|P1|NOT COMPLETED|Overall Study||367
5366450|NCT00069121|13203363|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
5366451|NCT00069121|13203364|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
5366452|NCT00069121|13203363|P2|Received Treatment|Overall Study|Safety Population|938
5366453|NCT00069121|13203364|P1|Received Treatment|Overall Study|Safety Population|926
5366454|NCT00069121|13203363|P2|STARTED|Overall Study||944
5366455|NCT00069121|13203364|P1|STARTED|Overall Study||942
5366456|NCT00069108|13203386|P2|NOT COMPLETED|Overall Study||219
5366457|NCT00069108|13203387|P1|NOT COMPLETED|Overall Study||213
5366458|NCT00069108|13203386|P2|COMPLETED|Overall Study||95
5366459|NCT00069108|13203387|P1|COMPLETED|Overall Study||100
5366460|NCT00069108|13203386|P2|STARTED|Overall Study||314
5366461|NCT00069108|13203387|P1|STARTED|Overall Study||313
5366462|NCT00069095|13203419|P6|NOT COMPLETED|Follow-up Phase||101
5366463|NCT00069095|13203420|P5|NOT COMPLETED|Follow-up Phase||92
5366464|NCT00069095|13203421|P4|NOT COMPLETED|Follow-up Phase||112
5366465|NCT00069095|13203422|P3|NOT COMPLETED|Follow-up Phase||120
5366466|NCT00069095|13203423|P2|NOT COMPLETED|Follow-up Phase||206
5366467|NCT00069095|13203424|P1|NOT COMPLETED|Follow-up Phase||174
5366468|NCT00069095|13203419|P6|COMPLETED|Follow-up Phase||171
5366469|NCT00069095|13203420|P5|COMPLETED|Follow-up Phase||186
5366470|NCT00069095|13203421|P4|COMPLETED|Follow-up Phase||187
5366471|NCT00069095|13203422|P3|COMPLETED|Follow-up Phase||178
5366472|NCT00069095|13203423|P2|COMPLETED|Follow-up Phase||93
5366473|NCT00069095|13203424|P1|COMPLETED|Follow-up Phase||110
5366474|NCT00069095|13203419|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
5366475|NCT00069095|13203420|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
5366476|NCT00069095|13203421|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
5366477|NCT00069095|13203422|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
5366478|NCT00069095|13203423|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
5366479|NCT00069095|13203424|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
5366480|NCT00069095|13203419|P6|NOT COMPLETED|Post-study Treatment Phase||29
5366481|NCT00069095|13203420|P5|NOT COMPLETED|Post-study Treatment Phase||36
5366482|NCT00069095|13203421|P4|NOT COMPLETED|Post-study Treatment Phase||17
5366483|NCT00069095|13203422|P3|NOT COMPLETED|Post-study Treatment Phase||21
5366484|NCT00069095|13203423|P2|NOT COMPLETED|Post-study Treatment Phase||13
5366485|NCT00069095|13203424|P1|NOT COMPLETED|Post-study Treatment Phase||8
5366486|NCT00069095|13203419|P6|COMPLETED|Post-study Treatment Phase||0
5366487|NCT00069095|13203420|P5|COMPLETED|Post-study Treatment Phase||0
5366488|NCT00069095|13203421|P4|COMPLETED|Post-study Treatment Phase||0
5366489|NCT00069095|13203422|P3|COMPLETED|Post-study Treatment Phase||0
5366490|NCT00069095|13203423|P2|COMPLETED|Post-study Treatment Phase||0
5366491|NCT00069095|13203424|P1|COMPLETED|Post-study Treatment Phase||0
5366492|NCT00069095|13203419|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
5366493|NCT00069095|13203420|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
5366494|NCT00069095|13203421|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
5366495|NCT00069095|13203422|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
5366496|NCT00069095|13203423|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
5366497|NCT00069095|13203424|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
5366498|NCT00069095|13203419|P6|NOT COMPLETED|Primary Treatment Phase||301
5366499|NCT00069095|13203420|P5|NOT COMPLETED|Primary Treatment Phase||302
5366500|NCT00069095|13203421|P4|NOT COMPLETED|Primary Treatment Phase||320
5366501|NCT00069095|13203422|P3|NOT COMPLETED|Primary Treatment Phase||314
5366502|NCT00069095|13203423|P2|NOT COMPLETED|Primary Treatment Phase||302
5366503|NCT00069095|13203424|P1|NOT COMPLETED|Primary Treatment Phase||295
5366504|NCT00069095|13203419|P6|COMPLETED|Primary Treatment Phase||48
5366505|NCT00069095|13203420|P5|COMPLETED|Primary Treatment Phase||48
5366506|NCT00069095|13203421|P4|COMPLETED|Primary Treatment Phase||31
5366507|NCT00069095|13203422|P3|COMPLETED|Primary Treatment Phase||36
5366508|NCT00069095|13203423|P2|COMPLETED|Primary Treatment Phase||15
5366509|NCT00069095|13203424|P1|COMPLETED|Primary Treatment Phase||22
5366510|NCT00069095|13203419|P6|STARTED|Primary Treatment Phase||349
5366511|NCT00069095|13203420|P5|STARTED|Primary Treatment Phase||350
5366512|NCT00069095|13203421|P4|STARTED|Primary Treatment Phase||351
5366513|NCT00069095|13203422|P3|STARTED|Primary Treatment Phase||350
5366514|NCT00069095|13203423|P2|STARTED|Primary Treatment Phase||317
5366515|NCT00069095|13203424|P1|STARTED|Primary Treatment Phase||317
5366516|NCT00069160|13203478|P2|NOT COMPLETED|Overall Study||0
5366517|NCT00069160|13203479|P1|NOT COMPLETED|Overall Study||0
5366518|NCT00069160|13203478|P2|COMPLETED|Overall Study||25
5366519|NCT00069160|13203479|P1|COMPLETED|Overall Study||23
5366520|NCT00069160|13203478|P2|STARTED|Overall Study||25
5366521|NCT00069160|13203479|P1|STARTED|Overall Study||23
5366522|NCT00068822|13203494|P2|NOT COMPLETED|Optional Crossover Intervention||0
5366523|NCT00068822|13203495|P1|NOT COMPLETED|Optional Crossover Intervention||0
5366524|NCT00068822|13203494|P2|COMPLETED|Optional Crossover Intervention||29
5366525|NCT00068822|13203495|P1|COMPLETED|Optional Crossover Intervention||9
5366526|NCT00068822|13203494|P2|Crossover at Month 3|Optional Crossover Intervention||27
5366527|NCT00068822|13203495|P1|Crossover at Month 3|Optional Crossover Intervention||8
5366528|NCT00068822|13203494|P2|Crossover at Month 1|Optional Crossover Intervention||2
5366529|NCT00068822|13203495|P1|Crossover at Month 1|Optional Crossover Intervention||1
5366530|NCT00068822|13203494|P2|STARTED|Optional Crossover Intervention||29
5366531|NCT00068822|13203495|P1|STARTED|Optional Crossover Intervention||9
5366532|NCT00068822|13203494|P2|NOT COMPLETED|First Randomized Intervention||2
5366533|NCT00068822|13203495|P1|NOT COMPLETED|First Randomized Intervention||1
5366534|NCT00068822|13203494|P2|COMPLETED|First Randomized Intervention||61
5366535|NCT00068822|13203495|P1|COMPLETED|First Randomized Intervention||67
5366536|NCT00068822|13203494|P2|STARTED|First Randomized Intervention||63
5366537|NCT00068822|13203495|P1|STARTED|First Randomized Intervention||68
5366538|NCT00068770|13203507|P2|NOT COMPLETED|Overall Study||0
5366539|NCT00068770|13203508|P1|NOT COMPLETED|Overall Study||0
5366540|NCT00068770|13203507|P2|COMPLETED|Overall Study||22
5366541|NCT00068770|13203508|P1|COMPLETED|Overall Study||13
5366542|NCT00068770|13203507|P2|STARTED|Overall Study||22
5366543|NCT00068770|13203508|P1|STARTED|Overall Study||13
5366544|NCT00068718|13203516|P1|NOT COMPLETED|Overall Study||0
5366545|NCT00068718|13203516|P1|COMPLETED|Overall Study||35
5366546|NCT00068718|13203516|P1|STARTED|Overall Study||35
5366547|NCT00068692|13203529|P8|NOT COMPLETED|Step 2: Randomization||8
5366548|NCT00068692|13203530|P7|NOT COMPLETED|Step 2: Randomization||4
5366549|NCT00068692|13203531|P6|NOT COMPLETED|Step 2: Randomization||6
5366550|NCT00068692|13203532|P5|NOT COMPLETED|Step 2: Randomization||9
5366551|NCT00068692|13203533|P4|NOT COMPLETED|Step 2: Randomization||12
5366552|NCT00068692|13203534|P3|NOT COMPLETED|Step 2: Randomization||10
5366553|NCT00068692|13203535|P2|NOT COMPLETED|Step 2: Randomization||0
5366554|NCT00068692|13203536|P1|NOT COMPLETED|Step 2: Randomization||0
5366555|NCT00068692|13203529|P8|COMPLETED|Step 2: Randomization||24
5366556|NCT00068692|13203530|P7|COMPLETED|Step 2: Randomization||29
5366557|NCT00068692|13203531|P6|COMPLETED|Step 2: Randomization||25
5366558|NCT00068692|13203532|P5|COMPLETED|Step 2: Randomization||21
5366559|NCT00068692|13203533|P4|COMPLETED|Step 2: Randomization||13
5366560|NCT00068692|13203534|P3|COMPLETED|Step 2: Randomization||18
5366561|NCT00068692|13203535|P2|COMPLETED|Step 2: Randomization||0
5366562|NCT00068692|13203536|P1|COMPLETED|Step 2: Randomization||0
5366563|NCT00068692|13203529|P8|Reported AE Data|Step 2: Randomization||32
5366564|NCT00068692|13203530|P7|Reported AE Data|Step 2: Randomization||33
5366565|NCT00068692|13203531|P6|Reported AE Data|Step 2: Randomization||31
5366566|NCT00068692|13203532|P5|Reported AE Data|Step 2: Randomization||28
5366567|NCT00068692|13203533|P4|Reported AE Data|Step 2: Randomization||22
5366568|NCT00068692|13203534|P3|Reported AE Data|Step 2: Randomization||27
5366569|NCT00068692|13203535|P2|Reported AE Data|Step 2: Randomization||0
5366570|NCT00068692|13203536|P1|Reported AE Data|Step 2: Randomization||0
5366571|NCT00068692|13203529|P8|Had Sphincter Preservation|Step 2: Randomization||30
5366572|NCT00068692|13203530|P7|Had Sphincter Preservation|Step 2: Randomization||33
5366573|NCT00068692|13203531|P6|Had Sphincter Preservation|Step 2: Randomization||31
5366574|NCT00068692|13203532|P5|Had Sphincter Preservation|Step 2: Randomization||28
5366575|NCT00068692|13203533|P4|Had Sphincter Preservation|Step 2: Randomization||25
5366576|NCT00068692|13203534|P3|Had Sphincter Preservation|Step 2: Randomization||28
5366577|NCT00068692|13203535|P2|Had Sphincter Preservation|Step 2: Randomization||0
5366578|NCT00068692|13203536|P1|Had Sphincter Preservation|Step 2: Randomization||0
5366579|NCT00068692|13203529|P8|Treated|Step 2: Randomization||32
5366580|NCT00068692|13203530|P7|Treated|Step 2: Randomization||33
5366581|NCT00068692|13203531|P6|Treated|Step 2: Randomization||31
5366582|NCT00068692|13203532|P5|Treated|Step 2: Randomization||29
5366583|NCT00068692|13203533|P4|Treated|Step 2: Randomization||25
5366584|NCT00068692|13203534|P3|Treated|Step 2: Randomization||27
5366585|NCT00068692|13203535|P2|Treated|Step 2: Randomization||0
5366586|NCT00068692|13203536|P1|Treated|Step 2: Randomization||0
5366587|NCT00068692|13203529|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
5366588|NCT00068692|13203530|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
5366589|NCT00068692|13203531|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
5366590|NCT00068692|13203532|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
5366591|NCT00068692|13203533|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
5366592|NCT00068692|13203534|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
5366593|NCT00068692|13203535|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
5366594|NCT00068692|13203536|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
5366595|NCT00068692|13203529|P8|NOT COMPLETED|Step 1: Registration||0
5366596|NCT00068692|13203530|P7|NOT COMPLETED|Step 1: Registration||0
5366597|NCT00068692|13203531|P6|NOT COMPLETED|Step 1: Registration||0
5366598|NCT00068692|13203532|P5|NOT COMPLETED|Step 1: Registration||0
5366599|NCT00068692|13203533|P4|NOT COMPLETED|Step 1: Registration||0
5366600|NCT00068692|13203534|P3|NOT COMPLETED|Step 1: Registration||0
5366601|NCT00068692|13203535|P2|NOT COMPLETED|Step 1: Registration||1
5366602|NCT00068692|13203536|P1|NOT COMPLETED|Step 1: Registration||40
5366603|NCT00068692|13203529|P8|COMPLETED|Step 1: Registration||0
5366604|NCT00068692|13203530|P7|COMPLETED|Step 1: Registration||0
5366605|NCT00068692|13203531|P6|COMPLETED|Step 1: Registration||0
5366606|NCT00068692|13203532|P5|COMPLETED|Step 1: Registration||0
5366607|NCT00068692|13203533|P4|COMPLETED|Step 1: Registration||0
5366608|NCT00068692|13203534|P3|COMPLETED|Step 1: Registration||0
5366609|NCT00068692|13203535|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
5366610|NCT00068692|13203536|P1|COMPLETED|Step 1: Registration||88
5366611|NCT00068692|13203529|P8|Reported AE Data|Step 1: Registration||0
5366612|NCT00068692|13203530|P7|Reported AE Data|Step 1: Registration||0
5366613|NCT00068692|13203531|P6|Reported AE Data|Step 1: Registration||0
5366614|NCT00068692|13203532|P5|Reported AE Data|Step 1: Registration||0
5366615|NCT00068692|13203533|P4|Reported AE Data|Step 1: Registration||0
5366616|NCT00068692|13203534|P3|Reported AE Data|Step 1: Registration||0
5366617|NCT00068692|13203535|P2|Reported AE Data|Step 1: Registration||0
5366618|NCT00068692|13203536|P1|Reported AE Data|Step 1: Registration||123
5366619|NCT00068692|13203529|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366620|NCT00068692|13203530|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366621|NCT00068692|13203531|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366622|NCT00068692|13203532|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366623|NCT00068692|13203533|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366624|NCT00068692|13203534|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
5366625|NCT00068692|13203535|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
5366626|NCT00068692|13203536|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
5366627|NCT00068692|13203529|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
5366628|NCT00068692|13203530|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
5366629|NCT00068692|13203531|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
5366630|NCT00068692|13203532|P5|STARTED|Step 1: Registration||0
5366631|NCT00068692|13203533|P4|STARTED|Step 1: Registration||0
5366632|NCT00068692|13203534|P3|STARTED|Step 1: Registration||0
5366633|NCT00068692|13203535|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
5366634|NCT00068692|13203536|P1|STARTED|Step 1: Registration||128
5366635|NCT00068601|13203559|P2|NOT COMPLETED|Overall Study||60
5366636|NCT00068601|13203560|P1|NOT COMPLETED|Overall Study||62
5366637|NCT00068601|13203559|P2|COMPLETED|Overall Study||66
5366638|NCT00068601|13203560|P1|COMPLETED|Overall Study||69
5366639|NCT00068601|13203559|P2|STARTED|Overall Study||126
5366640|NCT00068601|13203560|P1|STARTED|Overall Study||131
5366641|NCT00068588|13203573|P3|NOT COMPLETED|Overall Study||4
5366642|NCT00068588|13203574|P2|NOT COMPLETED|Overall Study||0
5366643|NCT00068588|13203575|P1|NOT COMPLETED|Overall Study||0
5366644|NCT00068588|13203573|P3|COMPLETED|Overall Study||17
5366645|NCT00068588|13203574|P2|COMPLETED|Overall Study||3
5366646|NCT00068588|13203575|P1|COMPLETED|Overall Study||0
5366647|NCT00068588|13203573|P3|STARTED|Overall Study||21
5366648|NCT00068588|13203574|P2|STARTED|Overall Study||3
5366649|NCT00068588|13203575|P1|STARTED|Overall Study||0
5366650|NCT00068575|13203585|P1|NOT COMPLETED|Overall Study||0
5366651|NCT00068575|13203585|P1|COMPLETED|Overall Study||28
5366652|NCT00068575|13203585|P1|STARTED|Overall Study||28
5366653|NCT00068445|13203591|P2|NOT COMPLETED|Treatment||16
5366654|NCT00068445|13203592|P1|NOT COMPLETED|Treatment||29
5366655|NCT00068445|13203591|P2|COMPLETED|Treatment||46
5366656|NCT00068445|13203592|P1|COMPLETED|Treatment||34
5366657|NCT00068445|13203591|P2|STARTED|Treatment||62
5366658|NCT00068445|13203592|P1|STARTED|Treatment||63
5366659|NCT00068445|13203591|P2|NOT COMPLETED|Randomization||4
5366660|NCT00068445|13203592|P1|NOT COMPLETED|Randomization||2
5366661|NCT00068445|13203591|P2|COMPLETED|Randomization||62
5366662|NCT00068445|13203592|P1|COMPLETED|Randomization||63
5366663|NCT00068445|13203591|P2|STARTED|Randomization||66
5366664|NCT00068445|13203592|P1|STARTED|Randomization||65
5366665|NCT00068419|13203616|P1|NOT COMPLETED|Overall Study||60
5366666|NCT00068419|13203616|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
5366667|NCT00068419|13203616|P1|STARTED|Overall Study||70
5366668|NCT00068406|13203625|P1|NOT COMPLETED|Overall Study||3
5366669|NCT00068406|13203625|P1|COMPLETED|Overall Study||58
5366670|NCT00068406|13203625|P1|STARTED|Overall Study||61
5366671|NCT00068393|13203630|P1|NOT COMPLETED|Overall Study||10
5366672|NCT00068393|13203630|P1|COMPLETED|Overall Study||29
5366673|NCT00068393|13203630|P1|Eligible and Treated|Overall Study||38
5366674|NCT00068393|13203630|P1|STARTED|Overall Study||39
5366675|NCT00068380|13203636|P1|NOT COMPLETED|Overall Study||5
5366676|NCT00068380|13203636|P1|COMPLETED|Overall Study||12
5366677|NCT00068380|13203636|P1|STARTED|Overall Study||17
5366678|NCT00068367|13203645|P1|NOT COMPLETED|Overall Study||0
5366679|NCT00068367|13203645|P1|COMPLETED|Overall Study||20
5366680|NCT00068367|13203645|P1|STARTED|Overall Study||20
5366681|NCT00068341|13203654|P3|NOT COMPLETED|Overall Study||0
5366682|NCT00068341|13203655|P2|NOT COMPLETED|Overall Study||0
5366683|NCT00068341|13203656|P1|NOT COMPLETED|Overall Study||0
5366684|NCT00068341|13203654|P3|COMPLETED|Overall Study||44
5366685|NCT00068341|13203655|P2|COMPLETED|Overall Study||15
5366686|NCT00068341|13203656|P1|COMPLETED|Overall Study||15
5366687|NCT00068341|13203654|P3|STARTED|Overall Study||44
5366688|NCT00068341|13203655|P2|STARTED|Overall Study||15
5366689|NCT00068341|13203656|P1|STARTED|Overall Study||15
5366690|NCT00068250|13203680|P4|NOT COMPLETED|Phase II: Dose Level 2||0
5366691|NCT00068250|13203681|P3|NOT COMPLETED|Phase II: Dose Level 2||0
5366692|NCT00068250|13203682|P2|NOT COMPLETED|Phase II: Dose Level 2||0
5366693|NCT00068250|13203683|P1|NOT COMPLETED|Phase II: Dose Level 2||0
5366694|NCT00068250|13203680|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
5366695|NCT00068250|13203681|P3|COMPLETED|Phase II: Dose Level 2||0
5366696|NCT00068250|13203682|P2|COMPLETED|Phase II: Dose Level 2||0
5366697|NCT00068250|13203683|P1|COMPLETED|Phase II: Dose Level 2||0
5366698|NCT00068250|13203680|P4|STARTED|Phase II: Dose Level 2||47
5366699|NCT00068250|13203681|P3|STARTED|Phase II: Dose Level 2||0
5366700|NCT00068250|13203682|P2|STARTED|Phase II: Dose Level 2||0
5366701|NCT00068250|13203683|P1|STARTED|Phase II: Dose Level 2||0
5366702|NCT00068250|13203680|P4|NOT COMPLETED|Phase I: Dose Level 2||0
5366703|NCT00068250|13203681|P3|NOT COMPLETED|Phase I: Dose Level 2||0
5366704|NCT00068250|13203682|P2|NOT COMPLETED|Phase I: Dose Level 2||1
5366705|NCT00068250|13203683|P1|NOT COMPLETED|Phase I: Dose Level 2||0
5366706|NCT00068250|13203680|P4|COMPLETED|Phase I: Dose Level 2||0
5366707|NCT00068250|13203681|P3|COMPLETED|Phase I: Dose Level 2||0
5366708|NCT00068250|13203682|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
5366709|NCT00068250|13203683|P1|COMPLETED|Phase I: Dose Level 2||0
5366710|NCT00068250|13203680|P4|STARTED|Phase I: Dose Level 2||0
5366711|NCT00068250|13203681|P3|STARTED|Phase I: Dose Level 2||0
5366712|NCT00068250|13203682|P2|STARTED|Phase I: Dose Level 2||7
5366713|NCT00068250|13203683|P1|STARTED|Phase I: Dose Level 2||0
5366714|NCT00068250|13203680|P4|NOT COMPLETED|Phase I: Dose Level 1||0
5366715|NCT00068250|13203681|P3|NOT COMPLETED|Phase I: Dose Level 1||0
5366716|NCT00068250|13203682|P2|NOT COMPLETED|Phase I: Dose Level 1||0
5366717|NCT00068250|13203683|P1|NOT COMPLETED|Phase I: Dose Level 1||0
5366718|NCT00068250|13203680|P4|COMPLETED|Phase I: Dose Level 1||0
5366719|NCT00068250|13203681|P3|COMPLETED|Phase I: Dose Level 1||0
5366720|NCT00068250|13203682|P2|COMPLETED|Phase I: Dose Level 1||0
5366721|NCT00068250|13203683|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
5366722|NCT00068250|13203680|P4|STARTED|Phase I: Dose Level 1||0
5366723|NCT00068250|13203681|P3|STARTED|Phase I: Dose Level 1||0
5366724|NCT00068250|13203682|P2|STARTED|Phase I: Dose Level 1||0
5366725|NCT00068250|13203683|P1|STARTED|Phase I: Dose Level 1||6
5366726|NCT00068237|13203693|P1|NOT COMPLETED|Overall Study||5
5366727|NCT00068237|13203693|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
5366728|NCT00068237|13203693|P1|STARTED|Overall Study||49
5366729|NCT00068107|13203705|P1|NOT COMPLETED|Overall Study||9
5366730|NCT00068107|13203705|P1|COMPLETED|Overall Study||3
5366731|NCT00068107|13203705|P1|STARTED|Overall Study||12
5366732|NCT00067990|13203718|P2|NOT COMPLETED|Overall Study||22
5366733|NCT00067990|13203719|P1|NOT COMPLETED|Overall Study||10
5366734|NCT00067990|13203718|P2|COMPLETED|Overall Study||54
5366735|NCT00067990|13203719|P1|COMPLETED|Overall Study||67
5366736|NCT00067990|13203718|P2|STARTED|Overall Study||76
5366737|NCT00067990|13203719|P1|STARTED|Overall Study||77
5366738|NCT00067808|13203730|P3|NOT COMPLETED|Overall Study||0
5366739|NCT00067808|13203731|P2|NOT COMPLETED|Overall Study||0
5366740|NCT00067808|13203732|P1|NOT COMPLETED|Overall Study||0
5366741|NCT00067808|13203730|P3|COMPLETED|Overall Study||14
5366742|NCT00067808|13203731|P2|COMPLETED|Overall Study||93
5366743|NCT00067808|13203732|P1|COMPLETED|Overall Study||17
5366744|NCT00067808|13203730|P3|STARTED|Overall Study||14
5366745|NCT00067808|13203731|P2|STARTED|Overall Study||93
5366746|NCT00067808|13203732|P1|STARTED|Overall Study||17
5366747|NCT00067470|13203742|P2|NOT COMPLETED|Overall Study||1
5366748|NCT00067470|13203743|P1|NOT COMPLETED|Overall Study||0
5366749|NCT00067470|13203742|P2|COMPLETED|Overall Study||19
5366750|NCT00067470|13203743|P1|COMPLETED|Overall Study||19
5366751|NCT00067470|13203742|P2|STARTED|Overall Study||20
5366752|NCT00067470|13203743|P1|STARTED|Overall Study||19
5366753|NCT00067236|13203755|P2|NOT COMPLETED|Overall Study||26
5366754|NCT00067236|13203756|P1|NOT COMPLETED|Overall Study||20
5366755|NCT00067236|13203755|P2|COMPLETED|Overall Study||99
5366756|NCT00067236|13203756|P1|COMPLETED|Overall Study||108
5366757|NCT00067236|13203755|P2|STARTED|Overall Study||125
5366758|NCT00067236|13203756|P1|STARTED|Overall Study||128
5366759|NCT00067002|13203764|P2|NOT COMPLETED|Overall Study||9
5366760|NCT00067002|13203765|P1|NOT COMPLETED|Overall Study||7
5366761|NCT00067002|13203764|P2|COMPLETED|Overall Study||44
5366762|NCT00067002|13203765|P1|COMPLETED|Overall Study||45
5366763|NCT00067002|13203764|P2|STARTED|Overall Study||53
5366764|NCT00067002|13203765|P1|STARTED|Overall Study||52
5366765|NCT00066963|13203782|P3|NOT COMPLETED|Overall Study||39
5366766|NCT00066963|13203783|P2|NOT COMPLETED|Overall Study||31
5366767|NCT00066963|13203784|P1|NOT COMPLETED|Overall Study||26
5366768|NCT00066963|13203782|P3|COMPLETED|Overall Study||87
5366769|NCT00066963|13203783|P2|COMPLETED|Overall Study||93
5366770|NCT00066963|13203784|P1|COMPLETED|Overall Study|any follow-up|100
5366771|NCT00066963|13203782|P3|STARTED|Overall Study||126
5366772|NCT00066963|13203783|P2|STARTED|Overall Study||124
5366773|NCT00066963|13203784|P1|STARTED|Overall Study||126
5366774|NCT00066937|13203796|P4|NOT COMPLETED|6 Month Follow-up||1
5366775|NCT00066937|13203797|P3|NOT COMPLETED|6 Month Follow-up||3
5366776|NCT00066937|13203798|P2|NOT COMPLETED|6 Month Follow-up||3
5366777|NCT00066937|13203799|P1|NOT COMPLETED|6 Month Follow-up||7
5366778|NCT00066937|13203796|P4|COMPLETED|6 Month Follow-up||14
5366779|NCT00066937|13203797|P3|COMPLETED|6 Month Follow-up||22
5366780|NCT00066937|13203798|P2|COMPLETED|6 Month Follow-up||29
5366781|NCT00066937|13203799|P1|COMPLETED|6 Month Follow-up||26
5366782|NCT00066937|13203796|P4|STARTED|6 Month Follow-up||15
5366783|NCT00066937|13203797|P3|STARTED|6 Month Follow-up||25
5366784|NCT00066937|13203798|P2|STARTED|6 Month Follow-up||32
5366785|NCT00066937|13203799|P1|STARTED|6 Month Follow-up||33
5366786|NCT00066937|13203796|P4|NOT COMPLETED|3 Month Follow-up||4
5366787|NCT00066937|13203797|P3|NOT COMPLETED|3 Month Follow-up||1
5366788|NCT00066937|13203798|P2|NOT COMPLETED|3 Month Follow-up||1
5366789|NCT00066937|13203799|P1|NOT COMPLETED|3 Month Follow-up||5
5366790|NCT00066937|13203796|P4|COMPLETED|3 Month Follow-up||15
5366791|NCT00066937|13203797|P3|COMPLETED|3 Month Follow-up||25
5366792|NCT00066937|13203798|P2|COMPLETED|3 Month Follow-up||32
5366793|NCT00066937|13203799|P1|COMPLETED|3 Month Follow-up||33
5366794|NCT00066937|13203796|P4|STARTED|3 Month Follow-up||19
5366795|NCT00066937|13203797|P3|STARTED|3 Month Follow-up||26
5366796|NCT00066937|13203798|P2|STARTED|3 Month Follow-up||33
5366797|NCT00066937|13203799|P1|STARTED|3 Month Follow-up||38
5366798|NCT00066937|13203796|P4|NOT COMPLETED|Treatment Phase||5
5366799|NCT00066937|13203797|P3|NOT COMPLETED|Treatment Phase||11
5366800|NCT00066937|13203798|P2|NOT COMPLETED|Treatment Phase||5
5366801|NCT00066937|13203799|P1|NOT COMPLETED|Treatment Phase||3
5366802|NCT00066937|13203796|P4|COMPLETED|Treatment Phase||19
5366803|NCT00066937|13203797|P3|COMPLETED|Treatment Phase||26
5366804|NCT00066937|13203798|P2|COMPLETED|Treatment Phase||33
5366805|NCT00066937|13203799|P1|COMPLETED|Treatment Phase||38
5366806|NCT00066937|13203796|P4|STARTED|Treatment Phase||24
5366807|NCT00066937|13203797|P3|STARTED|Treatment Phase||37
5366808|NCT00066937|13203798|P2|STARTED|Treatment Phase||38
5366809|NCT00066937|13203799|P1|STARTED|Treatment Phase||41
5366810|NCT00066807|13203823|P2|NOT COMPLETED|Overall Study||15
5366811|NCT00066807|13203824|P1|NOT COMPLETED|Overall Study||14
5366812|NCT00066807|13203823|P2|COMPLETED|Overall Study||0
5366813|NCT00066807|13203824|P1|COMPLETED|Overall Study||0
5366814|NCT00066807|13203823|P2|STARTED|Overall Study||15
5366815|NCT00066807|13203824|P1|STARTED|Overall Study||14
5366816|NCT00066781|13203838|P2|NOT COMPLETED|Overall Study||0
5366817|NCT00066781|13203839|P1|NOT COMPLETED|Overall Study||0
5366818|NCT00066781|13203838|P2|COMPLETED|Overall Study||17
5366819|NCT00066781|13203839|P1|COMPLETED|Overall Study||14
5366820|NCT00066781|13203838|P2|STARTED|Overall Study||17
5366821|NCT00066781|13203839|P1|STARTED|Overall Study||14
5366822|NCT00066742|13203849|P1|NOT COMPLETED|Consolidation Chemotherapy||3
5366823|NCT00066742|13203849|P1|COMPLETED|Consolidation Chemotherapy||39
5366824|NCT00066742|13203849|P1|Eligible|Consolidation Chemotherapy||40
5366825|NCT00066742|13203849|P1|STARTED|Consolidation Chemotherapy||42
5366826|NCT00066742|13203849|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
5366827|NCT00066742|13203849|P1|COMPLETED|Induction Chemoradiotherapy||43
5366828|NCT00066742|13203849|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
5366829|NCT00066742|13203849|P1|Eligible|Induction Chemoradiotherapy||69
5366830|NCT00066742|13203849|P1|STARTED|Induction Chemoradiotherapy||72
5366831|NCT00066703|13203858|P2|NOT COMPLETED|Overall Study||582
5366832|NCT00066703|13203859|P1|NOT COMPLETED|Overall Study||612
5366833|NCT00066703|13203858|P2|COMPLETED|Overall Study||756
5366834|NCT00066703|13203859|P1|COMPLETED|Overall Study||722
5366835|NCT00066703|13203858|P2|STARTED|Overall Study||1338
5366836|NCT00066703|13203859|P1|STARTED|Overall Study||1334
5366837|NCT00066690|13203874|P3|NOT COMPLETED|Overall Study||564
5366838|NCT00066690|13203875|P2|NOT COMPLETED|Overall Study||522
5366839|NCT00066690|13203876|P1|NOT COMPLETED|Overall Study||598
5366840|NCT00066690|13203874|P3|COMPLETED|Overall Study||457
5366841|NCT00066690|13203875|P2|COMPLETED|Overall Study||502
5366842|NCT00066690|13203876|P1|COMPLETED|Overall Study||423
5366843|NCT00066690|13203874|P3|STARTED|Overall Study||1021
5366844|NCT00066690|13203875|P2|STARTED|Overall Study||1024
5366845|NCT00066690|13203876|P1|STARTED|Overall Study||1021
5366846|NCT00066573|13203895|P2|NOT COMPLETED|Overall Study||28
5366847|NCT00066573|13203896|P1|NOT COMPLETED|Overall Study||28
5366848|NCT00066573|13203895|P2|COMPLETED|Overall Study||3759
5366849|NCT00066573|13203896|P1|COMPLETED|Overall Study||3761
5366850|NCT00066573|13203895|P2|STARTED|Overall Study||3787
5366851|NCT00066573|13203896|P1|STARTED|Overall Study||3789
5366852|NCT00066469|13203908|P1|NOT COMPLETED|Overall Study||16
5366853|NCT00066469|13203908|P1|COMPLETED|Overall Study||39
5366854|NCT00066469|13203908|P1|STARTED|Overall Study||55
5366855|NCT00066365|13203914|P2|NOT COMPLETED|Overall Study||14
5366856|NCT00066365|13203915|P1|NOT COMPLETED|Overall Study||23
5366857|NCT00066365|13203914|P2|COMPLETED|Overall Study||4
5366858|NCT00066365|13203915|P1|COMPLETED|Overall Study||8
5366859|NCT00066365|13203914|P2|STARTED|Overall Study||18
5366860|NCT00066365|13203915|P1|STARTED|Overall Study||31
5366861|NCT00066222|13203943|P1|NOT COMPLETED|Overall Study||1
5366862|NCT00066222|13203943|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
5366863|NCT00066222|13203943|P1|STARTED|Overall Study||72
5366864|NCT00066170|13203956|P4|NOT COMPLETED|Overall Study||9
5366865|NCT00066170|13203957|P3|NOT COMPLETED|Overall Study||4
5366866|NCT00066170|13203958|P2|NOT COMPLETED|Overall Study||10
5366867|NCT00066170|13203959|P1|NOT COMPLETED|Overall Study||7
5366868|NCT00066170|13203956|P4|COMPLETED|Overall Study||48
5366869|NCT00066170|13203957|P3|COMPLETED|Overall Study||59
5366870|NCT00066170|13203958|P2|COMPLETED|Overall Study||45
5366871|NCT00066170|13203959|P1|COMPLETED|Overall Study||49
5366872|NCT00066170|13203956|P4|Intent to Treat|Overall Study||54
5366873|NCT00066170|13203957|P3|Intent to Treat|Overall Study||63
5366874|NCT00066170|13203958|P2|Intent to Treat|Overall Study||50
5366875|NCT00066170|13203959|P1|Intent to Treat|Overall Study||55
5366876|NCT00066170|13203956|P4|STARTED|Overall Study||57
5366877|NCT00066170|13203957|P3|STARTED|Overall Study||63
5366878|NCT00066170|13203958|P2|STARTED|Overall Study||55
5366879|NCT00066170|13203959|P1|STARTED|Overall Study||56
5366880|NCT00066066|13203972|P6|NOT COMPLETED|Overall Study||5
5366881|NCT00066066|13203973|P5|NOT COMPLETED|Overall Study||3
5366882|NCT00066066|13203974|P4|NOT COMPLETED|Overall Study||4
5366883|NCT00066066|13203975|P3|NOT COMPLETED|Overall Study||7
5366884|NCT00066066|13203976|P2|NOT COMPLETED|Overall Study||4
5366885|NCT00066066|13203977|P1|NOT COMPLETED|Overall Study||6
5366886|NCT00066066|13203972|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
5366887|NCT00066066|13203973|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
5366888|NCT00066066|13203974|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
5366889|NCT00066066|13203975|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
5366890|NCT00066066|13203976|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
5366891|NCT00066066|13203977|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
5366892|NCT00066066|13203972|P6|12 Month|Overall Study||9
5366893|NCT00066066|13203973|P5|12 Month|Overall Study||19
5366894|NCT00066066|13203974|P4|12 Month|Overall Study||11
5366895|NCT00066066|13203975|P3|12 Month|Overall Study||21
5366896|NCT00066066|13203976|P2|12 Month|Overall Study||11
5366897|NCT00066066|13203977|P1|12 Month|Overall Study||18
5366898|NCT00066066|13203972|P6|6 Month|Overall Study||14
5366899|NCT00066066|13203973|P5|6 Month|Overall Study||21
5366900|NCT00066066|13203974|P4|6 Month|Overall Study||13
5366901|NCT00066066|13203975|P3|6 Month|Overall Study||23
5366902|NCT00066066|13203976|P2|6 Month|Overall Study||13
5366903|NCT00066066|13203977|P1|6 Month|Overall Study||19
5366904|NCT00066066|13203972|P6|3 Month|Overall Study||15
5366905|NCT00066066|13203973|P5|3 Month|Overall Study||22
5366906|NCT00066066|13203974|P4|3 Month|Overall Study||16
5366907|NCT00066066|13203975|P3|3 Month|Overall Study||23
5366908|NCT00066066|13203976|P2|3 Month|Overall Study||17
5366909|NCT00066066|13203977|P1|3 Month|Overall Study||21
5366910|NCT00066066|13203972|P6|Baseline|Overall Study||20
5366911|NCT00066066|13203973|P5|Baseline|Overall Study||27
5366912|NCT00066066|13203974|P4|Baseline|Overall Study||20
5366913|NCT00066066|13203975|P3|Baseline|Overall Study||30
5366914|NCT00066066|13203976|P2|Baseline|Overall Study||22
5366915|NCT00066066|13203977|P1|Baseline|Overall Study||27
5366916|NCT00066066|13203972|P6|STARTED|Overall Study||20
5366917|NCT00066066|13203973|P5|STARTED|Overall Study||27
5366918|NCT00066066|13203974|P4|STARTED|Overall Study||20
5366919|NCT00066066|13203975|P3|STARTED|Overall Study||30
5366920|NCT00066066|13203976|P2|STARTED|Overall Study||22
5366921|NCT00066066|13203977|P1|STARTED|Overall Study||27
5366922|NCT00065806|13203993|P2|NOT COMPLETED|Overall Study||19
5366923|NCT00065806|13203994|P1|NOT COMPLETED|Overall Study||20
5366924|NCT00065806|13203993|P2|COMPLETED|Overall Study||89
5366925|NCT00065806|13203994|P1|COMPLETED|Overall Study||93
5366926|NCT00065806|13203993|P2|STARTED|Overall Study||108
5366927|NCT00065806|13203994|P1|STARTED|Overall Study||113
5366928|NCT00014560|13204036|P1|NOT COMPLETED|Overall Study||3
5366929|NCT00014560|13204036|P1|COMPLETED|Overall Study||0
5366930|NCT00014560|13204036|P1|STARTED|Overall Study||3
5366931|NCT00065611|13204042|P2|NOT COMPLETED|Overall Study||1
5366932|NCT00065611|13204043|P1|NOT COMPLETED|Overall Study||0
5366933|NCT00065611|13204042|P2|COMPLETED|Overall Study||3
5366934|NCT00065611|13204043|P1|COMPLETED|Overall Study||4
5366935|NCT00065611|13204042|P2|STARTED|Overall Study||4
5366936|NCT00065611|13204043|P1|STARTED|Overall Study||4
5366937|NCT00065507|13204055|P2|NOT COMPLETED|Overall Study||29
5366938|NCT00065507|13204056|P1|NOT COMPLETED|Overall Study||29
5366939|NCT00065507|13204055|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
5366940|NCT00065507|13204056|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
5366941|NCT00065507|13204055|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
5366942|NCT00065507|13204056|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
5366943|NCT00065507|13204055|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
5366944|NCT00065507|13204056|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
5366945|NCT00065507|13204055|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
5366946|NCT00065507|13204056|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
5366947|NCT00065507|13204055|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
5366948|NCT00065507|13204056|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
5366949|NCT00065507|13204055|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
5366950|NCT00065507|13204056|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
5366951|NCT00065468|13204121|P3|NOT COMPLETED|Overall Study||210
5366952|NCT00065468|13204122|P2|NOT COMPLETED|Overall Study||209
5366953|NCT00065468|13204123|P1|NOT COMPLETED|Overall Study||207
5366954|NCT00065468|13204121|P3|COMPLETED|Overall Study||0
5366955|NCT00065468|13204122|P2|COMPLETED|Overall Study||0
5366956|NCT00065468|13204123|P1|COMPLETED|Overall Study||0
5366957|NCT00065468|13204121|P3|Received Treatment|Overall Study||208
5366958|NCT00065468|13204122|P2|Received Treatment|Overall Study||208
5366959|NCT00065468|13204123|P1|Received Treatment|Overall Study||200
5366960|NCT00065468|13204121|P3|STARTED|Overall Study||210
5366961|NCT00065468|13204122|P2|STARTED|Overall Study||209
5366962|NCT00065468|13204123|P1|STARTED|Overall Study||207
5366963|NCT00065442|13204154|P2|NOT COMPLETED|Overall Study||220
5366964|NCT00065442|13204155|P1|NOT COMPLETED|Overall Study||125
5366965|NCT00065442|13204154|P2|COMPLETED|Overall Study||121
5366966|NCT00065442|13204155|P1|COMPLETED|Overall Study||46
5366967|NCT00065442|13204154|P2|STARTED|Overall Study||341
5366968|NCT00065442|13204155|P1|STARTED|Overall Study||171
5366969|NCT00065429|13204170|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366970|NCT00065429|13204171|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366971|NCT00065429|13204172|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
5366972|NCT00065429|13204173|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366973|NCT00065429|13204174|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366974|NCT00065429|13204175|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366975|NCT00065429|13204176|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366976|NCT00065429|13204170|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366977|NCT00065429|13204171|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366978|NCT00065429|13204172|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
5366979|NCT00065429|13204173|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366980|NCT00065429|13204174|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366981|NCT00065429|13204175|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366982|NCT00065429|13204176|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
5366983|NCT00065429|13204170|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366984|NCT00065429|13204171|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366985|NCT00065429|13204172|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
5366986|NCT00065429|13204173|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366987|NCT00065429|13204174|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366988|NCT00065429|13204175|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366989|NCT00065429|13204176|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
5366990|NCT00065429|13204170|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
5366991|NCT00065429|13204171|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
5366992|NCT00065429|13204172|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
5366993|NCT00065429|13204173|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
5366994|NCT00065429|13204174|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
5366995|NCT00065429|13204175|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
5366996|NCT00065429|13204176|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
5366997|NCT00065429|13204170|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
5366998|NCT00065429|13204171|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
5366999|NCT00065429|13204172|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
5367000|NCT00065429|13204173|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
5367001|NCT00065429|13204174|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
5367002|NCT00065429|13204175|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
5367003|NCT00065429|13204176|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
5367004|NCT00065429|13204170|P7|STARTED|Phase I - May 2001 - Oct 2002||4
5367005|NCT00065429|13204171|P6|STARTED|Phase I - May 2001 - Oct 2002||4
5367006|NCT00065429|13204172|P5|STARTED|Phase I - May 2001 - Oct 2002||9
5367007|NCT00065429|13204173|P4|STARTED|Phase I - May 2001 - Oct 2002||4
5367008|NCT00065429|13204174|P3|STARTED|Phase I - May 2001 - Oct 2002||4
5367009|NCT00065429|13204175|P2|STARTED|Phase I - May 2001 - Oct 2002||3
5367010|NCT00065429|13204176|P1|STARTED|Phase I - May 2001 - Oct 2002||4
5367011|NCT00065260|13204190|P2|NOT COMPLETED|Overall Study||1
5367012|NCT00065260|13204191|P1|NOT COMPLETED|Overall Study||0
5367013|NCT00065260|13204190|P2|COMPLETED|Overall Study||26
5367014|NCT00065260|13204191|P1|COMPLETED|Overall Study||27
5367015|NCT00065260|13204190|P2|STARTED|Overall Study||27
5367016|NCT00065260|13204191|P1|STARTED|Overall Study||27
5367017|NCT00065182|13204199|P2|NOT COMPLETED|Overall Study||37
5367018|NCT00065182|13204200|P1|NOT COMPLETED|Overall Study||48
5367019|NCT00065182|13204199|P2|COMPLETED|Overall Study||160
5367020|NCT00065182|13204200|P1|COMPLETED|Overall Study||154
5367021|NCT00065182|13204199|P2|STARTED|Overall Study||197
5367022|NCT00065182|13204200|P1|STARTED|Overall Study||202
5367023|NCT00065156|13204226|P1|NOT COMPLETED|Overall Study||124
5367024|NCT00065156|13204226|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
5367025|NCT00065156|13204226|P1|Modified Intent to Treat Population|Overall Study||94
5367026|NCT00065156|13204226|P1|STARTED|Overall Study||148
5367027|NCT00065065|13204243|P2|NOT COMPLETED|Overall Study||20
5367028|NCT00065065|13204244|P1|NOT COMPLETED|Overall Study||10
5367029|NCT00065065|13204243|P2|COMPLETED|Overall Study||33
5367030|NCT00065065|13204244|P1|COMPLETED|Overall Study||42
5367031|NCT00065065|13204243|P2|STARTED|Overall Study||53
5367032|NCT00065065|13204244|P1|STARTED|Overall Study||52
5367033|NCT00003895|13204256|P2|NOT COMPLETED|Overall Study||4
5367034|NCT00003895|13204257|P1|NOT COMPLETED|Overall Study||7
5367035|NCT00003895|13204256|P2|COMPLETED|Overall Study||14
5367036|NCT00003895|13204257|P1|COMPLETED|Overall Study||11
5367037|NCT00003895|13204256|P2|STARTED|Overall Study||18
5367038|NCT00003895|13204257|P1|STARTED|Overall Study||18
5367039|NCT00064987|13204265|P2|NOT COMPLETED|Overall Study||0
5367040|NCT00064987|13204266|P1|NOT COMPLETED|Overall Study||3
5367041|NCT00064987|13204265|P2|COMPLETED|Overall Study||6
5367042|NCT00064987|13204266|P1|COMPLETED|Overall Study||7
5367043|NCT00064987|13204265|P2|STARTED|Overall Study||6
5367044|NCT00064987|13204266|P1|STARTED|Overall Study||10
5367045|NCT00064844|13204286|P2|NOT COMPLETED|Overall Study||19
5367046|NCT00064844|13204287|P1|NOT COMPLETED|Overall Study||8
5367047|NCT00064844|13204286|P2|COMPLETED|Overall Study||32
5367048|NCT00064844|13204287|P1|COMPLETED|Overall Study||37
5367049|NCT00064844|13204286|P2|12 Month Follow-up|Overall Study||32
5367050|NCT00064844|13204287|P1|12 Month Follow-up|Overall Study||37
5367051|NCT00064844|13204286|P2|6 Month Follow-up|Overall Study||40
5367052|NCT00064844|13204287|P1|6 Month Follow-up|Overall Study||39
5367053|NCT00064844|13204286|P2|3 Month Follow-up|Overall Study||47
5367054|NCT00064844|13204287|P1|3 Month Follow-up|Overall Study||40
5367055|NCT00064844|13204286|P2|2 Week Follow-up|Overall Study||51
5367056|NCT00064844|13204287|P1|2 Week Follow-up|Overall Study||45
5367057|NCT00064844|13204286|P2|STARTED|Overall Study||51
5367058|NCT00064844|13204287|P1|STARTED|Overall Study||45
5367059|NCT00064753|13204297|P2|NOT COMPLETED|Overall Study||648
5367060|NCT00064753|13204298|P1|NOT COMPLETED|Overall Study||674
5367061|NCT00064753|13204297|P2|COMPLETED|Overall Study||1406
5367062|NCT00064753|13204298|P1|COMPLETED|Overall Study||1382
5367063|NCT00064753|13204297|P2|STARTED|Overall Study||2054
5367064|NCT00064753|13204298|P1|STARTED|Overall Study||2056
5367065|NCT00003645|13204328|P2|NOT COMPLETED|Overall Study||12
5367066|NCT00003645|13204329|P1|NOT COMPLETED|Overall Study||12
5367067|NCT00003645|13204328|P2|COMPLETED|Overall Study||22
5367068|NCT00003645|13204329|P1|COMPLETED|Overall Study||18
5367069|NCT00003645|13204328|P2|STARTED|Overall Study||34
5367070|NCT00003645|13204329|P1|STARTED|Overall Study||30
5367071|NCT00064792|13204343|P2|NOT COMPLETED|Overall Study||0
5367072|NCT00064792|13204344|P1|NOT COMPLETED|Overall Study||5
5367073|NCT00064792|13204343|P2|COMPLETED|Overall Study||10
5367074|NCT00064792|13204344|P1|COMPLETED|Overall Study||8
5367075|NCT00064792|13204343|P2|STARTED|Overall Study||10
5367076|NCT00064792|13204344|P1|STARTED|Overall Study||13
5367077|NCT00064701|13204355|P3|NOT COMPLETED|Clinical Continuation Phase||140
5367078|NCT00064701|13204356|P2|NOT COMPLETED|Clinical Continuation Phase||178
5367079|NCT00064701|13204357|P1|NOT COMPLETED|Clinical Continuation Phase||170
5367080|NCT00064701|13204355|P3|COMPLETED|Clinical Continuation Phase||11
5367081|NCT00064701|13204356|P2|COMPLETED|Clinical Continuation Phase||4
5367082|NCT00064701|13204357|P1|COMPLETED|Clinical Continuation Phase||9
5367083|NCT00064701|13204355|P3|STARTED|Clinical Continuation Phase||151
5367084|NCT00064701|13204356|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
5367085|NCT00064701|13204357|P1|STARTED|Clinical Continuation Phase||179
5367086|NCT00064701|13204355|P3|NOT COMPLETED|One Year Post-transplant||72
5367087|NCT00064701|13204356|P2|NOT COMPLETED|One Year Post-transplant||43
5367088|NCT00064701|13204357|P1|NOT COMPLETED|One Year Post-transplant||40
5367089|NCT00064701|13204355|P3|COMPLETED|One Year Post-transplant||151
5367090|NCT00064701|13204356|P2|COMPLETED|One Year Post-transplant||183
5367091|NCT00064701|13204357|P1|COMPLETED|One Year Post-transplant||179
5367092|NCT00064701|13204355|P3|Received Study Drug|One Year Post-transplant||212
5367093|NCT00064701|13204356|P2|Received Study Drug|One Year Post-transplant||214
5367094|NCT00064701|13204357|P1|Received Study Drug|One Year Post-transplant||212
5367095|NCT00064701|13204355|P3|STARTED|One Year Post-transplant||223
5367096|NCT00064701|13204356|P2|STARTED|One Year Post-transplant||226
5367097|NCT00064701|13204357|P1|STARTED|One Year Post-transplant||219
5367098|NCT00064662|13204409|P2|NOT COMPLETED|Overall Study||61
5367099|NCT00064662|13204410|P1|NOT COMPLETED|Overall Study||74
5367100|NCT00064662|13204409|P2|COMPLETED|Overall Study||265
5367101|NCT00064662|13204410|P1|COMPLETED|Overall Study||255
5367102|NCT00064662|13204409|P2|STARTED|Overall Study||326
5367103|NCT00064662|13204410|P1|STARTED|Overall Study||329
5367104|NCT00064350|13204421|P3|NOT COMPLETED|Cross-Over||0
5367105|NCT00064350|13204422|P2|NOT COMPLETED|Cross-Over||14
5367106|NCT00064350|13204423|P1|NOT COMPLETED|Cross-Over||6
5367107|NCT00064350|13204421|P3|COMPLETED|Cross-Over||0
5367108|NCT00064350|13204422|P2|COMPLETED|Cross-Over||13
5367109|NCT00064350|13204423|P1|COMPLETED|Cross-Over||4
5367110|NCT00064350|13204421|P3|Eligible and Treated|Cross-Over||0
5367111|NCT00064350|13204422|P2|Eligible and Treated|Cross-Over||21
5367112|NCT00064350|13204423|P1|Eligible and Treated|Cross-Over||7
5367113|NCT00064350|13204421|P3|Treated|Cross-Over||0
5367114|NCT00064350|13204422|P2|Treated|Cross-Over||26
5367115|NCT00064350|13204423|P1|Treated|Cross-Over||9
5367116|NCT00064350|13204421|P3|STARTED|Cross-Over||0
5367117|NCT00064350|13204422|P2|STARTED|Cross-Over||27
5367118|NCT00064350|13204423|P1|STARTED|Cross-Over||10
5367119|NCT00064350|13204421|P3|NOT COMPLETED|Randomization||0
5367120|NCT00064350|13204422|P2|NOT COMPLETED|Randomization||18
5367121|NCT00064350|13204423|P1|NOT COMPLETED|Randomization||26
5367122|NCT00064350|13204421|P3|COMPLETED|Randomization||0
5367123|NCT00064350|13204422|P2|COMPLETED|Randomization||28
5367124|NCT00064350|13204423|P1|COMPLETED|Randomization||33
5367125|NCT00064350|13204421|P3|Eligible and Treated|Randomization||0
5367126|NCT00064350|13204422|P2|Eligible and Treated|Randomization||31
5367127|NCT00064350|13204423|P1|Eligible and Treated|Randomization||50
5367128|NCT00064350|13204421|P3|Treated|Randomization||0
5367129|NCT00064350|13204422|P2|Treated|Randomization||40
5367130|NCT00064350|13204423|P1|Treated|Randomization||55
5367131|NCT00064350|13204421|P3|STARTED|Randomization||0
5367132|NCT00064350|13204422|P2|STARTED|Randomization||46
5367133|NCT00064350|13204423|P1|STARTED|Randomization||59
5367134|NCT00064350|13204421|P3|NOT COMPLETED|Induction Treatment||236
5367135|NCT00064350|13204422|P2|NOT COMPLETED|Induction Treatment||9
5367136|NCT00064350|13204423|P1|NOT COMPLETED|Induction Treatment||8
5367137|NCT00064350|13204421|P3|COMPLETED|Induction Treatment||1
5367138|NCT00064350|13204422|P2|COMPLETED|Induction Treatment||37
5367139|NCT00064350|13204423|P1|COMPLETED|Induction Treatment||51
5367140|NCT00064350|13204421|P3|Eligible and Treated|Induction Treatment||194
5367141|NCT00064350|13204422|P2|Eligible and Treated|Induction Treatment||46
5367142|NCT00064350|13204423|P1|Eligible and Treated|Induction Treatment||59
5367143|NCT00064350|13204421|P3|Treated|Induction Treatment||228
5367144|NCT00064350|13204422|P2|Treated|Induction Treatment||46
5367145|NCT00064350|13204423|P1|Treated|Induction Treatment||59
5367146|NCT00064350|13204421|P3|STARTED|Induction Treatment||237
5367147|NCT00064350|13204422|P2|STARTED|Induction Treatment||46
5367148|NCT00064350|13204423|P1|STARTED|Induction Treatment||59
5367149|NCT00064337|13204438|P1|NOT COMPLETED|Maintenance||10
5367150|NCT00064337|13204438|P1|COMPLETED|Maintenance||3
5367151|NCT00064337|13204438|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
5367152|NCT00064337|13204438|P1|NOT COMPLETED|Transplant||21
5367153|NCT00064337|13204438|P1|COMPLETED|Transplant||46
5367154|NCT00064337|13204438|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
5367155|NCT00064337|13204438|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
5367156|NCT00064337|13204438|P1|COMPLETED|PBSCC or Induction/PBSCC||73
5367157|NCT00064337|13204438|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
5367158|NCT00064298|13204447|P2|NOT COMPLETED|Overall Study||5
5367159|NCT00064298|13204448|P1|NOT COMPLETED|Overall Study||6
5367160|NCT00064298|13204447|P2|COMPLETED|Overall Study||57
5367161|NCT00064298|13204448|P1|COMPLETED|Overall Study||66
5367162|NCT00064298|13204447|P2|STARTED|Overall Study||62
5367163|NCT00064298|13204448|P1|STARTED|Overall Study||72
5367164|NCT00064259|13204456|P4|NOT COMPLETED|Overall Study||1
5367165|NCT00064259|13204457|P3|NOT COMPLETED|Overall Study||0
5367166|NCT00064259|13204458|P2|NOT COMPLETED|Overall Study||0
5367167|NCT00064259|13204459|P1|NOT COMPLETED|Overall Study||1
5367168|NCT00064259|13204456|P4|COMPLETED|Overall Study||0
5367169|NCT00064259|13204457|P3|COMPLETED|Overall Study||6
5367170|NCT00064259|13204458|P2|COMPLETED|Overall Study||4
5367171|NCT00064259|13204459|P1|COMPLETED|Overall Study||3
5367172|NCT00064259|13204456|P4|STARTED|Overall Study||1
5367173|NCT00064259|13204457|P3|STARTED|Overall Study||6
5367174|NCT00064259|13204458|P2|STARTED|Overall Study||4
5367175|NCT00064259|13204459|P1|STARTED|Overall Study||4
5367176|NCT00064077|13204467|P4|NOT COMPLETED|Overall Study||7
5367177|NCT00064077|13204468|P3|NOT COMPLETED|Overall Study||7
5367178|NCT00064077|13204469|P2|NOT COMPLETED|Overall Study||9
5367179|NCT00064077|13204470|P1|NOT COMPLETED|Overall Study||15
5367180|NCT00064077|13204467|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
5367181|NCT00064077|13204468|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
5367182|NCT00064077|13204469|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
5367183|NCT00064077|13204470|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
5367184|NCT00064077|13204467|P4|STARTED|Overall Study||118
5367185|NCT00064077|13204468|P3|STARTED|Overall Study||119
5367186|NCT00064077|13204469|P2|STARTED|Overall Study||117
5367187|NCT00064077|13204470|P1|STARTED|Overall Study||118
5367188|NCT00064038|13204502|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
5367189|NCT00064038|13204503|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
5367190|NCT00064038|13204504|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
5367191|NCT00064038|13204502|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
5367192|NCT00064038|13204503|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
5367193|NCT00064038|13204504|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
5367194|NCT00064038|13204502|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
5367195|NCT00064038|13204503|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
5367196|NCT00064038|13204504|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
5367197|NCT00064038|13204502|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
5367198|NCT00064038|13204503|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
5367199|NCT00064038|13204504|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
5367200|NCT00064038|13204502|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
5367201|NCT00064038|13204503|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
5367202|NCT00064038|13204504|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
5367203|NCT00064038|13204502|P3|NOT COMPLETED|Initial Randomization||0
5367204|NCT00064038|13204503|P2|NOT COMPLETED|Initial Randomization||98
5367205|NCT00064038|13204504|P1|NOT COMPLETED|Initial Randomization||100
5367206|NCT00064038|13204502|P3|COMPLETED|Initial Randomization||0
5367207|NCT00064038|13204503|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
5367208|NCT00064038|13204504|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
5367209|NCT00064038|13204502|P3|Safety Population|Initial Randomization||0
5367210|NCT00064038|13204503|P2|Safety Population|Initial Randomization||94
5367211|NCT00064038|13204504|P1|Safety Population|Initial Randomization||96
5367212|NCT00064038|13204502|P3|Eligible and Analyzable|Initial Randomization||0
5367213|NCT00064038|13204503|P2|Eligible and Analyzable|Initial Randomization||95
5367214|NCT00064038|13204504|P1|Eligible and Analyzable|Initial Randomization||97
5367215|NCT00064038|13204502|P3|STARTED|Initial Randomization||0
5367216|NCT00064038|13204503|P2|STARTED|Initial Randomization||98
5367217|NCT00064038|13204504|P1|STARTED|Initial Randomization||100
5367218|NCT00064025|13204514|P1|NOT COMPLETED|Overall Study||7
5367219|NCT00064025|13204514|P1|COMPLETED|Overall Study||68
5367220|NCT00064025|13204514|P1|STARTED|Overall Study||75
5367221|NCT00063999|13204523|P2|NOT COMPLETED|Overall Study||24
5367222|NCT00063999|13204524|P1|NOT COMPLETED|Overall Study||45
5367223|NCT00063999|13204523|P2|COMPLETED|Overall Study||665
5367224|NCT00063999|13204524|P1|COMPLETED|Overall Study||647
5367225|NCT00063999|13204523|P2|STARTED|Overall Study||689
5367226|NCT00063999|13204524|P1|STARTED|Overall Study||692
5367227|NCT00063986|13204540|P1|NOT COMPLETED|Overall Study||6
5367228|NCT00063986|13204540|P1|COMPLETED|Overall Study||104
5367229|NCT00063986|13204540|P1|Eligible and Treated|Overall Study||104
5367230|NCT00063986|13204540|P1|Treated|Overall Study||105
5367231|NCT00063986|13204540|P1|STARTED|Overall Study||110
5367232|NCT00063934|13204552|P1|NOT COMPLETED|Overall Study||1
5367233|NCT00063934|13204552|P1|COMPLETED|Overall Study||30
5367234|NCT00063934|13204552|P1|STARTED|Overall Study||31
5367235|NCT00063882|13204561|P2|NOT COMPLETED|Overall Study||4
5367236|NCT00063882|13204562|P1|NOT COMPLETED|Overall Study||5
5367237|NCT00063882|13204561|P2|COMPLETED|Overall Study||292
5367238|NCT00063882|13204562|P1|COMPLETED|Overall Study||287
5367239|NCT00063882|13204561|P2|Eligible Patients|Overall Study||292
5367240|NCT00063882|13204562|P1|Eligible Patients|Overall Study||287
5367241|NCT00063882|13204561|P2|Has Baseline/24-month EPIC Data|Overall Study||219
5367242|NCT00063882|13204562|P1|Has Baseline/24-month EPIC Data|Overall Study||201
5367243|NCT00063882|13204561|P2|Has Baseline/4-month EPIC Data|Overall Study||241
5367244|NCT00063882|13204562|P1|Has Baseline/4-month EPIC Data|Overall Study||222
5367245|NCT00063882|13204561|P2|Has Late Adverse Event Data|Overall Study||287
5367246|NCT00063882|13204562|P1|Has Late Adverse Event Data|Overall Study||282
5367247|NCT00063882|13204561|P2|Has Acute Adverse Event Data|Overall Study||288
5367248|NCT00063882|13204562|P1|Has Acute Adverse Event Data|Overall Study||282
5367249|NCT00063882|13204561|P2|STARTED|Overall Study||296
5367250|NCT00063882|13204562|P1|STARTED|Overall Study||292
5367251|NCT00063635|13204593|P3|NOT COMPLETED|Overall Study||9
5367252|NCT00063635|13204594|P2|NOT COMPLETED|Overall Study||8
5367253|NCT00063635|13204595|P1|NOT COMPLETED|Overall Study||6
5367254|NCT00063635|13204593|P3|COMPLETED|Overall Study||49
5367255|NCT00063635|13204594|P2|COMPLETED|Overall Study||50
5367256|NCT00063635|13204595|P1|COMPLETED|Overall Study||51
5367257|NCT00063635|13204593|P3|STARTED|Overall Study||58
5367258|NCT00063635|13204594|P2|STARTED|Overall Study||58
5367259|NCT00063635|13204595|P1|STARTED|Overall Study||57
5367260|NCT00063622|13204636|P3|NOT COMPLETED|Overall Study||11
5367261|NCT00063622|13204637|P2|NOT COMPLETED|Overall Study||4
5367262|NCT00063622|13204638|P1|NOT COMPLETED|Overall Study||10
5367263|NCT00063622|13204636|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
5367264|NCT00063622|13204637|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
5367265|NCT00063622|13204638|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
5367266|NCT00063622|13204636|P3|STARTED|Overall Study||83
5367267|NCT00063622|13204637|P2|STARTED|Overall Study||84
5367268|NCT00063622|13204638|P1|STARTED|Overall Study||80
5367269|NCT00063570|13204663|P2|NOT COMPLETED|Overall Study||0
5367270|NCT00063570|13204664|P1|NOT COMPLETED|Overall Study||0
5367271|NCT00063570|13204663|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
5367272|NCT00063570|13204664|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
5367273|NCT00063570|13204663|P2|STARTED|Overall Study||21
5367274|NCT00063570|13204664|P1|STARTED|Overall Study||52
5367275|NCT00063362|13204680|P2|NOT COMPLETED|Overall Study||4
5367276|NCT00063362|13204681|P1|NOT COMPLETED|Overall Study||4
5367277|NCT00063362|13204680|P2|COMPLETED|Overall Study||22
5367278|NCT00063362|13204681|P1|COMPLETED|Overall Study||19
5367279|NCT00063362|13204680|P2|STARTED|Overall Study||26
5367280|NCT00063362|13204681|P1|STARTED|Overall Study||23
5367281|NCT00063258|13204689|P2|NOT COMPLETED|Overall Study||0
5367282|NCT00063258|13204690|P1|NOT COMPLETED|Overall Study||4
5367283|NCT00063258|13204689|P2|COMPLETED|Overall Study||0
5367284|NCT00063258|13204690|P1|COMPLETED|Overall Study||1
5367285|NCT00063258|13204689|P2|STARTED|Overall Study||0
5367286|NCT00063258|13204690|P1|STARTED|Overall Study||5
5367287|NCT00063154|13204696|P1|NOT COMPLETED|Overall Study||51
5367288|NCT00063154|13204696|P1|COMPLETED|Overall Study||0
5367289|NCT00063154|13204696|P1|STARTED|Overall Study||51
5367290|NCT00063232|13204703|P1|NOT COMPLETED|Overall Study||0
5367291|NCT00063232|13204703|P1|COMPLETED|Overall Study||26
5367292|NCT00063232|13204703|P1|STARTED|Overall Study||26
5367293|NCT00062868|13204730|P21|NOT COMPLETED|Dose Level 3||0
5367294|NCT00062868|13204731|P20|NOT COMPLETED|Dose Level 3||0
5367295|NCT00062868|13204732|P19|NOT COMPLETED|Dose Level 3||0
5367296|NCT00062868|13204733|P18|NOT COMPLETED|Dose Level 3||1
5367297|NCT00062868|13204734|P17|NOT COMPLETED|Dose Level 3||0
5367298|NCT00062868|13204735|P16|NOT COMPLETED|Dose Level 3||0
5367299|NCT00062868|13204736|P15|NOT COMPLETED|Dose Level 3||1
5367300|NCT00062868|13204737|P14|NOT COMPLETED|Dose Level 3||0
5367301|NCT00062868|13204738|P13|NOT COMPLETED|Dose Level 3||0
5367302|NCT00062868|13204739|P12|NOT COMPLETED|Dose Level 3||1
5367303|NCT00062868|13204740|P11|NOT COMPLETED|Dose Level 3||0
5367304|NCT00062868|13204741|P10|NOT COMPLETED|Dose Level 3||0
5367305|NCT00062868|13204742|P9|NOT COMPLETED|Dose Level 3||0
5367306|NCT00062868|13204743|P8|NOT COMPLETED|Dose Level 3||0
5367307|NCT00062868|13204744|P7|NOT COMPLETED|Dose Level 3||0
5367308|NCT00062868|13204745|P6|NOT COMPLETED|Dose Level 3||0
5367309|NCT00062868|13204746|P5|NOT COMPLETED|Dose Level 3||0
5367310|NCT00062868|13204747|P4|NOT COMPLETED|Dose Level 3||0
5367311|NCT00062868|13204748|P3|NOT COMPLETED|Dose Level 3||2
5367312|NCT00062868|13204749|P2|NOT COMPLETED|Dose Level 3||0
5367313|NCT00062868|13204750|P1|NOT COMPLETED|Dose Level 3||0
5367314|NCT00062868|13204730|P21|COMPLETED|Dose Level 3||0
5367315|NCT00062868|13204731|P20|COMPLETED|Dose Level 3||0
5367316|NCT00062868|13204732|P19|COMPLETED|Dose Level 3||0
5367317|NCT00062868|13204733|P18|COMPLETED|Dose Level 3||3
5367318|NCT00062868|13204734|P17|COMPLETED|Dose Level 3||0
5367319|NCT00062868|13204735|P16|COMPLETED|Dose Level 3||0
5367320|NCT00062868|13204736|P15|COMPLETED|Dose Level 3||2
5367321|NCT00062868|13204737|P14|COMPLETED|Dose Level 3||0
5367322|NCT00062868|13204738|P13|COMPLETED|Dose Level 3||0
5367323|NCT00062868|13204739|P12|COMPLETED|Dose Level 3||4
5367324|NCT00062868|13204740|P11|COMPLETED|Dose Level 3||0
5367325|NCT00062868|13204741|P10|COMPLETED|Dose Level 3||0
5367326|NCT00062868|13204742|P9|COMPLETED|Dose Level 3||0
5367327|NCT00062868|13204743|P8|COMPLETED|Dose Level 3||0
5367328|NCT00062868|13204744|P7|COMPLETED|Dose Level 3||0
5367329|NCT00062868|13204745|P6|COMPLETED|Dose Level 3||0
5367330|NCT00062868|13204746|P5|COMPLETED|Dose Level 3||0
5367331|NCT00062868|13204747|P4|COMPLETED|Dose Level 3||0
5367332|NCT00062868|13204748|P3|COMPLETED|Dose Level 3||1
5367333|NCT00062868|13204749|P2|COMPLETED|Dose Level 3||0
5367334|NCT00062868|13204750|P1|COMPLETED|Dose Level 3||0
5367335|NCT00062868|13204730|P21|STARTED|Dose Level 3||0
5367336|NCT00062868|13204731|P20|STARTED|Dose Level 3||0
5367337|NCT00062868|13204732|P19|STARTED|Dose Level 3||0
5367338|NCT00062868|13204733|P18|STARTED|Dose Level 3||4
5367339|NCT00062868|13204734|P17|STARTED|Dose Level 3||0
5367340|NCT00062868|13204735|P16|STARTED|Dose Level 3||0
5367341|NCT00062868|13204736|P15|STARTED|Dose Level 3||3
5367342|NCT00062868|13204737|P14|STARTED|Dose Level 3||0
5367343|NCT00062868|13204738|P13|STARTED|Dose Level 3||0
5367344|NCT00062868|13204739|P12|STARTED|Dose Level 3||5
5367345|NCT00062868|13204740|P11|STARTED|Dose Level 3||0
5367346|NCT00062868|13204741|P10|STARTED|Dose Level 3||0
5367347|NCT00062868|13204742|P9|STARTED|Dose Level 3||0
5367348|NCT00062868|13204743|P8|STARTED|Dose Level 3||0
5367349|NCT00062868|13204744|P7|STARTED|Dose Level 3||0
5367350|NCT00062868|13204745|P6|STARTED|Dose Level 3||0
5367351|NCT00062868|13204746|P5|STARTED|Dose Level 3||0
5367352|NCT00062868|13204747|P4|STARTED|Dose Level 3||0
5367353|NCT00062868|13204748|P3|STARTED|Dose Level 3||3
5367354|NCT00062868|13204749|P2|STARTED|Dose Level 3||0
5367355|NCT00062868|13204750|P1|STARTED|Dose Level 3||0
5367356|NCT00062868|13204730|P21|NOT COMPLETED|Dose Level 2||0
5367357|NCT00062868|13204731|P20|NOT COMPLETED|Dose Level 2||0
5367358|NCT00062868|13204732|P19|NOT COMPLETED|Dose Level 2||0
5367359|NCT00062868|13204733|P18|NOT COMPLETED|Dose Level 2||0
5367360|NCT00062868|13204734|P17|NOT COMPLETED|Dose Level 2||3
5367361|NCT00062868|13204735|P16|NOT COMPLETED|Dose Level 2||0
5367362|NCT00062868|13204736|P15|NOT COMPLETED|Dose Level 2||0
5367363|NCT00062868|13204737|P14|NOT COMPLETED|Dose Level 2||1
5367364|NCT00062868|13204738|P13|NOT COMPLETED|Dose Level 2||0
5367365|NCT00062868|13204739|P12|NOT COMPLETED|Dose Level 2||0
5367366|NCT00062868|13204740|P11|NOT COMPLETED|Dose Level 2||1
5367367|NCT00062868|13204741|P10|NOT COMPLETED|Dose Level 2||0
5367368|NCT00062868|13204742|P9|NOT COMPLETED|Dose Level 2||0
5367369|NCT00062868|13204743|P8|NOT COMPLETED|Dose Level 2||0
5367370|NCT00062868|13204744|P7|NOT COMPLETED|Dose Level 2||0
5367371|NCT00062868|13204745|P6|NOT COMPLETED|Dose Level 2||0
5367372|NCT00062868|13204746|P5|NOT COMPLETED|Dose Level 2||2
5367373|NCT00062868|13204747|P4|NOT COMPLETED|Dose Level 2||0
5367374|NCT00062868|13204748|P3|NOT COMPLETED|Dose Level 2||0
5367375|NCT00062868|13204749|P2|NOT COMPLETED|Dose Level 2||3
5367376|NCT00062868|13204750|P1|NOT COMPLETED|Dose Level 2||0
5367377|NCT00062868|13204730|P21|COMPLETED|Dose Level 2||0
5367378|NCT00062868|13204731|P20|COMPLETED|Dose Level 2||0
5367379|NCT00062868|13204732|P19|COMPLETED|Dose Level 2||0
5367380|NCT00062868|13204733|P18|COMPLETED|Dose Level 2||0
5367381|NCT00062868|13204734|P17|COMPLETED|Dose Level 2||0
5367382|NCT00062868|13204735|P16|COMPLETED|Dose Level 2||0
5367383|NCT00062868|13204736|P15|COMPLETED|Dose Level 2||0
5367384|NCT00062868|13204737|P14|COMPLETED|Dose Level 2||2
5367385|NCT00062868|13204738|P13|COMPLETED|Dose Level 2||0
5367386|NCT00062868|13204739|P12|COMPLETED|Dose Level 2||0
5367387|NCT00062868|13204740|P11|COMPLETED|Dose Level 2||3
5367388|NCT00062868|13204741|P10|COMPLETED|Dose Level 2||0
5367389|NCT00062868|13204742|P9|COMPLETED|Dose Level 2||0
5367390|NCT00062868|13204743|P8|COMPLETED|Dose Level 2||0
5367391|NCT00062868|13204744|P7|COMPLETED|Dose Level 2||0
5367392|NCT00062868|13204745|P6|COMPLETED|Dose Level 2||0
5367393|NCT00062868|13204746|P5|COMPLETED|Dose Level 2||1
5367394|NCT00062868|13204747|P4|COMPLETED|Dose Level 2||0
5367395|NCT00062868|13204748|P3|COMPLETED|Dose Level 2||0
5367396|NCT00062868|13204749|P2|COMPLETED|Dose Level 2||3
5367397|NCT00062868|13204750|P1|COMPLETED|Dose Level 2||0
5367398|NCT00062868|13204730|P21|STARTED|Dose Level 2||0
5367399|NCT00062868|13204731|P20|STARTED|Dose Level 2||0
5367400|NCT00062868|13204732|P19|STARTED|Dose Level 2||0
5367401|NCT00062868|13204733|P18|STARTED|Dose Level 2||0
5367402|NCT00062868|13204734|P17|STARTED|Dose Level 2||3
5367403|NCT00062868|13204735|P16|STARTED|Dose Level 2||0
5367404|NCT00062868|13204736|P15|STARTED|Dose Level 2||0
5367405|NCT00062868|13204737|P14|STARTED|Dose Level 2||3
5367406|NCT00062868|13204738|P13|STARTED|Dose Level 2||0
5367407|NCT00062868|13204739|P12|STARTED|Dose Level 2||0
5367408|NCT00062868|13204740|P11|STARTED|Dose Level 2||4
5367409|NCT00062868|13204741|P10|STARTED|Dose Level 2||0
5367410|NCT00062868|13204742|P9|STARTED|Dose Level 2||0
5367411|NCT00062868|13204743|P8|STARTED|Dose Level 2||0
5367412|NCT00062868|13204744|P7|STARTED|Dose Level 2||0
5367413|NCT00062868|13204745|P6|STARTED|Dose Level 2||0
5367414|NCT00062868|13204746|P5|STARTED|Dose Level 2||3
5367415|NCT00062868|13204747|P4|STARTED|Dose Level 2||0
5367416|NCT00062868|13204748|P3|STARTED|Dose Level 2||0
5367417|NCT00062868|13204749|P2|STARTED|Dose Level 2||6
5367418|NCT00062868|13204750|P1|STARTED|Dose Level 2||0
5367419|NCT00062868|13204730|P21|NOT COMPLETED|Dose Level 1||2
5367420|NCT00062868|13204731|P20|NOT COMPLETED|Dose Level 1||0
5367421|NCT00062868|13204732|P19|NOT COMPLETED|Dose Level 1||9
5367422|NCT00062868|13204733|P18|NOT COMPLETED|Dose Level 1||0
5367423|NCT00062868|13204734|P17|NOT COMPLETED|Dose Level 1||0
5367424|NCT00062868|13204735|P16|NOT COMPLETED|Dose Level 1||0
5367425|NCT00062868|13204736|P15|NOT COMPLETED|Dose Level 1||0
5367426|NCT00062868|13204737|P14|NOT COMPLETED|Dose Level 1||0
5367427|NCT00062868|13204738|P13|NOT COMPLETED|Dose Level 1||1
5367428|NCT00062868|13204739|P12|NOT COMPLETED|Dose Level 1||0
5367429|NCT00062868|13204740|P11|NOT COMPLETED|Dose Level 1||0
5367430|NCT00062868|13204741|P10|NOT COMPLETED|Dose Level 1||0
5367431|NCT00062868|13204742|P9|NOT COMPLETED|Dose Level 1||0
5367432|NCT00062868|13204743|P8|NOT COMPLETED|Dose Level 1||0
5367433|NCT00062868|13204744|P7|NOT COMPLETED|Dose Level 1||3
5367434|NCT00062868|13204745|P6|NOT COMPLETED|Dose Level 1||0
5367435|NCT00062868|13204746|P5|NOT COMPLETED|Dose Level 1||0
5367436|NCT00062868|13204747|P4|NOT COMPLETED|Dose Level 1||2
5367437|NCT00062868|13204748|P3|NOT COMPLETED|Dose Level 1||0
5367438|NCT00062868|13204749|P2|NOT COMPLETED|Dose Level 1||0
5367439|NCT00062868|13204750|P1|NOT COMPLETED|Dose Level 1||2
5367440|NCT00062868|13204730|P21|COMPLETED|Dose Level 1||1
5367441|NCT00062868|13204731|P20|COMPLETED|Dose Level 1||2
5367442|NCT00062868|13204732|P19|COMPLETED|Dose Level 1||7
5367443|NCT00062868|13204733|P18|COMPLETED|Dose Level 1||0
5367444|NCT00062868|13204734|P17|COMPLETED|Dose Level 1||0
5367445|NCT00062868|13204735|P16|COMPLETED|Dose Level 1||3
5367446|NCT00062868|13204736|P15|COMPLETED|Dose Level 1||0
5367447|NCT00062868|13204737|P14|COMPLETED|Dose Level 1||0
5367448|NCT00062868|13204738|P13|COMPLETED|Dose Level 1||2
5367449|NCT00062868|13204739|P12|COMPLETED|Dose Level 1||0
5367450|NCT00062868|13204740|P11|COMPLETED|Dose Level 1||0
5367451|NCT00062868|13204741|P10|COMPLETED|Dose Level 1||3
5367452|NCT00062868|13204742|P9|COMPLETED|Dose Level 1||0
5367453|NCT00062868|13204743|P8|COMPLETED|Dose Level 1||0
5367454|NCT00062868|13204744|P7|COMPLETED|Dose Level 1||1
5367455|NCT00062868|13204745|P6|COMPLETED|Dose Level 1||0
5367456|NCT00062868|13204746|P5|COMPLETED|Dose Level 1||0
5367457|NCT00062868|13204747|P4|COMPLETED|Dose Level 1||1
5367458|NCT00062868|13204748|P3|COMPLETED|Dose Level 1||0
5367459|NCT00062868|13204749|P2|COMPLETED|Dose Level 1||0
5367460|NCT00062868|13204750|P1|COMPLETED|Dose Level 1||1
5367461|NCT00062868|13204730|P21|STARTED|Dose Level 1||3
5367462|NCT00062868|13204731|P20|STARTED|Dose Level 1||2
5367463|NCT00062868|13204732|P19|STARTED|Dose Level 1||16
5367464|NCT00062868|13204733|P18|STARTED|Dose Level 1||0
5367465|NCT00062868|13204734|P17|STARTED|Dose Level 1||0
5367466|NCT00062868|13204735|P16|STARTED|Dose Level 1||3
5367467|NCT00062868|13204736|P15|STARTED|Dose Level 1||0
5367468|NCT00062868|13204737|P14|STARTED|Dose Level 1||0
5367469|NCT00062868|13204738|P13|STARTED|Dose Level 1||3
5367470|NCT00062868|13204739|P12|STARTED|Dose Level 1||0
5367471|NCT00062868|13204740|P11|STARTED|Dose Level 1||0
5367472|NCT00062868|13204741|P10|STARTED|Dose Level 1||3
5367473|NCT00062868|13204742|P9|STARTED|Dose Level 1||0
5367474|NCT00062868|13204743|P8|STARTED|Dose Level 1||0
5367475|NCT00062868|13204744|P7|STARTED|Dose Level 1||4
5367476|NCT00062868|13204745|P6|STARTED|Dose Level 1||0
5367477|NCT00062868|13204746|P5|STARTED|Dose Level 1||0
5367478|NCT00062868|13204747|P4|STARTED|Dose Level 1||3
5367479|NCT00062868|13204748|P3|STARTED|Dose Level 1||0
5367480|NCT00062868|13204749|P2|STARTED|Dose Level 1||0
5367481|NCT00062868|13204750|P1|STARTED|Dose Level 1||3
5367482|NCT00062764|13204836|P1|NOT COMPLETED|Overall Study||0
5367483|NCT00062764|13204836|P1|COMPLETED|Overall Study||18
5367484|NCT00062764|13204836|P1|STARTED|Overall Study||18
5367485|NCT00062751|13204849|P5|NOT COMPLETED|Overall Study||6
5367486|NCT00062751|13204850|P4|NOT COMPLETED|Overall Study||5
5367487|NCT00062751|13204851|P3|NOT COMPLETED|Overall Study||30
5367488|NCT00062751|13204852|P2|NOT COMPLETED|Overall Study||30
5367489|NCT00062751|13204853|P1|NOT COMPLETED|Overall Study||33
5367490|NCT00062751|13204849|P5|COMPLETED|Overall Study||0
5367491|NCT00062751|13204850|P4|COMPLETED|Overall Study||1
5367492|NCT00062751|13204851|P3|COMPLETED|Overall Study||3
5367493|NCT00062751|13204852|P2|COMPLETED|Overall Study||0
5367494|NCT00062751|13204853|P1|COMPLETED|Overall Study||0
5367495|NCT00062751|13204849|P5|STARTED|Overall Study||6
5367496|NCT00062751|13204850|P4|STARTED|Overall Study||6
5367497|NCT00062751|13204851|P3|STARTED|Overall Study||33
5367498|NCT00062751|13204852|P2|STARTED|Overall Study||30
5367499|NCT00062751|13204853|P1|STARTED|Overall Study||33
5367500|NCT00062738|13204924|P3|NOT COMPLETED|Overall Study||0
5367501|NCT00062738|13204925|P2|NOT COMPLETED|Overall Study||0
5367502|NCT00062738|13204926|P1|NOT COMPLETED|Overall Study||0
5367503|NCT00062738|13204924|P3|COMPLETED|Overall Study||17
5367504|NCT00062738|13204925|P2|COMPLETED|Overall Study||18
5367505|NCT00062738|13204926|P1|COMPLETED|Overall Study||17
5367506|NCT00062738|13204924|P3|STARTED|Overall Study||17
5367507|NCT00062738|13204925|P2|STARTED|Overall Study||18
5367508|NCT00062738|13204926|P1|STARTED|Overall Study||17
5367509|NCT00062647|13204939|P2|NOT COMPLETED|Overall Study||13
5367510|NCT00062647|13204940|P1|NOT COMPLETED|Overall Study||16
5367511|NCT00062647|13204939|P2|COMPLETED|Overall Study||17
5367512|NCT00062647|13204940|P1|COMPLETED|Overall Study||14
5367513|NCT00062647|13204939|P2|STARTED|Overall Study||30
5367514|NCT00062647|13204940|P1|STARTED|Overall Study||30
5367515|NCT00062439|13204946|P1|NOT COMPLETED|Consolidation Chemotherapy||2
5367516|NCT00062439|13204946|P1|COMPLETED|Consolidation Chemotherapy||20
5367517|NCT00062439|13204946|P1|STARTED|Consolidation Chemotherapy||22
5367518|NCT00062439|13204946|P1|NOT COMPLETED|Surgery||7
5367519|NCT00062439|13204946|P1|COMPLETED|Surgery||22
5367520|NCT00062439|13204946|P1|STARTED|Surgery||29
5367521|NCT00062439|13204946|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
5367522|NCT00062439|13204946|P1|COMPLETED|Post Chemoradiation Assessment||29
5367523|NCT00062439|13204946|P1|STARTED|Post Chemoradiation Assessment||38
5367524|NCT00062439|13204946|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
5367525|NCT00062439|13204946|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
5367526|NCT00062439|13204946|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
5367527|NCT00062374|13204958|P1|NOT COMPLETED|Overall Study||12
5367528|NCT00062374|13204958|P1|COMPLETED|Overall Study||43
5367529|NCT00062374|13204958|P1|STARTED|Overall Study||55
5367530|NCT00062166|13204963|P1|NOT COMPLETED|Overall Study||6
5367531|NCT00062166|13204963|P1|COMPLETED|Overall Study||334
5367532|NCT00062166|13204963|P1|STARTED|Overall Study||340
5367533|NCT00062010|13204971|P1|NOT COMPLETED|Overall Study||3
5367534|NCT00062010|13204971|P1|COMPLETED|Overall Study||34
5367535|NCT00062010|13204971|P1|Eligible and Treated|Overall Study||34
5367536|NCT00062010|13204971|P1|STARTED|Overall Study||37
5367537|NCT00061945|13204979|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
5367538|NCT00061945|13204980|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
5367539|NCT00061945|13204979|P2|COMPLETED|Course IV: Alemtuzumab||50
5367540|NCT00061945|13204980|P1|COMPLETED|Course IV: Alemtuzumab||18
5367541|NCT00061945|13204979|P2|STARTED|Course IV: Alemtuzumab||66
5367542|NCT00061945|13204980|P1|STARTED|Course IV: Alemtuzumab||25
5367543|NCT00061945|13204979|P2|NOT COMPLETED|Registration Through Course 3||115
5367544|NCT00061945|13204980|P1|NOT COMPLETED|Registration Through Course 3||94
5367545|NCT00061945|13204979|P2|COMPLETED|Registration Through Course 3||66
5367546|NCT00061945|13204980|P1|COMPLETED|Registration Through Course 3||25
5367547|NCT00061945|13204979|P2|STARTED|Registration Through Course 3||181
5367548|NCT00061945|13204980|P1|STARTED|Registration Through Course 3||119
5367549|NCT00061932|13204990|P2|NOT COMPLETED|Overall Study||4
5367550|NCT00061932|13204991|P1|NOT COMPLETED|Overall Study||13
5367551|NCT00061932|13204990|P2|COMPLETED|Overall Study||8
5367552|NCT00061932|13204991|P1|COMPLETED|Overall Study||16
5367553|NCT00061932|13204990|P2|STARTED|Overall Study||12
5367554|NCT00061932|13204991|P1|STARTED|Overall Study||29
5367555|NCT00061893|13204997|P1|NOT COMPLETED|Overall Study||18
5367556|NCT00061893|13204997|P1|COMPLETED|Overall Study||20
5367557|NCT00061893|13204997|P1|STARTED|Overall Study||38
5367558|NCT00061633|13205004|P2|NOT COMPLETED|Overall Study||11
5367559|NCT00061633|13205005|P1|NOT COMPLETED|Overall Study||5
5367560|NCT00061633|13205004|P2|COMPLETED|Overall Study||74
5367561|NCT00061633|13205005|P1|COMPLETED|Overall Study||79
5367562|NCT00061633|13205004|P2|STARTED|Overall Study||85
5367563|NCT00061633|13205005|P1|STARTED|Overall Study||84
5367564|NCT00061373|13205013|P2|NOT COMPLETED|Overall Study||0
5367565|NCT00061373|13205014|P1|NOT COMPLETED|Overall Study||0
5367566|NCT00061373|13205013|P2|COMPLETED|Overall Study||3
5367567|NCT00061373|13205014|P1|COMPLETED|Overall Study||15
5367568|NCT00061373|13205013|P2|Aspirin and Tinzaparin|Overall Study||3
5367569|NCT00061373|13205014|P1|Aspirin and Tinzaparin|Overall Study||15
5367570|NCT00061373|13205013|P2|STARTED|Overall Study||3
5367571|NCT00061373|13205014|P1|STARTED|Overall Study||15
5367572|NCT00061048|13205030|P1|NOT COMPLETED|Overall Study||22
5367573|NCT00061048|13205030|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
5367574|NCT00061048|13205030|P1|STARTED|Overall Study||29
5367575|NCT00060944|13205040|P2|NOT COMPLETED|Overall Study||134
5367576|NCT00060944|13205041|P1|NOT COMPLETED|Overall Study||136
5367577|NCT00060944|13205040|P2|COMPLETED|Overall Study||0
5367578|NCT00060944|13205041|P1|COMPLETED|Overall Study||0
5367579|NCT00060944|13205040|P2|Treated|Overall Study||130
5367580|NCT00060944|13205041|P1|Treated|Overall Study||130
5367581|NCT00060944|13205040|P2|STARTED|Overall Study||134
5367582|NCT00060944|13205041|P1|STARTED|Overall Study||136
5367583|NCT00060840|13205057|P2|NOT COMPLETED|Overall Study||9
5367584|NCT00060840|13205058|P1|NOT COMPLETED|Overall Study||4
5367585|NCT00060840|13205057|P2|COMPLETED|Overall Study||68
5367586|NCT00060840|13205058|P1|COMPLETED|Overall Study||69
5367587|NCT00060840|13205057|P2|STARTED|Overall Study||77
5367588|NCT00060840|13205058|P1|STARTED|Overall Study||73
5367589|NCT00060606|13205066|P2|NOT COMPLETED|Overall Study||1
5367590|NCT00060606|13205067|P1|NOT COMPLETED|Overall Study||0
5367591|NCT00060606|13205066|P2|COMPLETED|Overall Study||91
5367592|NCT00060606|13205067|P1|COMPLETED|Overall Study||91
5367593|NCT00060606|13205066|P2|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
5367594|NCT00060606|13205067|P1|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
5367595|NCT00060606|13205066|P2|STARTED|Overall Study||92
5367596|NCT00060606|13205067|P1|STARTED|Overall Study||91
5367597|NCT00060528|13205077|P4|NOT COMPLETED|Overall Study||0
5367598|NCT00060528|13205078|P3|NOT COMPLETED|Overall Study||0
5367599|NCT00060528|13205079|P2|NOT COMPLETED|Overall Study||0
5367600|NCT00060528|13205080|P1|NOT COMPLETED|Overall Study||0
5367601|NCT00060528|13205077|P4|COMPLETED|Overall Study||8
5367602|NCT00060528|13205078|P3|COMPLETED|Overall Study||7
5367603|NCT00060528|13205079|P2|COMPLETED|Overall Study||9
5367604|NCT00060528|13205080|P1|COMPLETED|Overall Study||8
5367605|NCT00060528|13205077|P4|STARTED|Overall Study||8
5367606|NCT00060528|13205078|P3|STARTED|Overall Study||7
5367607|NCT00060528|13205079|P2|STARTED|Overall Study||9
5367608|NCT00060528|13205080|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
5367609|NCT00060424|13205094|P1|NOT COMPLETED|Overall Study||0
5367610|NCT00060424|13205094|P1|COMPLETED|Overall Study||21
5367611|NCT00060424|13205094|P1|STARTED|Overall Study||21
5367612|NCT00060346|13205102|P1|NOT COMPLETED|Overall Study||0
5367613|NCT00060346|13205102|P1|COMPLETED|Overall Study||16
5367614|NCT00060346|13205102|P1|Eligible and Treated|Overall Study||16
5367615|NCT00060346|13205102|P1|STARTED|Overall Study||16
5367616|NCT00060333|13205106|P1|NOT COMPLETED|Overall Study||0
5367617|NCT00060333|13205106|P1|COMPLETED|Overall Study||20
5367618|NCT00060333|13205106|P1|STARTED|Overall Study||20
5367619|NCT00060008|13205117|P1|NOT COMPLETED|Overall Study||0
5367620|NCT00060008|13205117|P1|COMPLETED|Overall Study||18
5367621|NCT00060008|13205117|P1|STARTED|Overall Study||18
5367622|NCT00059839|13205124|P2|NOT COMPLETED|Overall Study||17
5367623|NCT00059839|13205125|P1|NOT COMPLETED|Overall Study||12
5367624|NCT00059839|13205124|P2|COMPLETED|Overall Study||47
5367625|NCT00059839|13205125|P1|COMPLETED|Overall Study||53
5367626|NCT00059839|13205124|P2|STARTED|Overall Study||64
5367627|NCT00059839|13205125|P1|STARTED|Overall Study||65
5367628|NCT00059787|13205131|P1|NOT COMPLETED|Overall Study||20
5367629|NCT00059787|13205131|P1|COMPLETED|Overall Study||36
5367630|NCT00059787|13205131|P1|STARTED|Overall Study||56
5367631|NCT00059475|13205147|P8|NOT COMPLETED|Overall Study||0
5367632|NCT00059475|13205148|P7|NOT COMPLETED|Overall Study||0
5367633|NCT00059475|13205149|P6|NOT COMPLETED|Overall Study||0
5367634|NCT00059475|13205150|P5|NOT COMPLETED|Overall Study||0
5367635|NCT00059475|13205151|P4|NOT COMPLETED|Overall Study||0
5367636|NCT00059475|13205152|P3|NOT COMPLETED|Overall Study||0
5367637|NCT00059475|13205153|P2|NOT COMPLETED|Overall Study||0
5367638|NCT00059475|13205154|P1|NOT COMPLETED|Overall Study||0
5367639|NCT00059475|13205147|P8|COMPLETED|Overall Study||7
5367640|NCT00059475|13205148|P7|COMPLETED|Overall Study||34
5367641|NCT00059475|13205149|P6|COMPLETED|Overall Study||2
5367642|NCT00059475|13205150|P5|COMPLETED|Overall Study||33
5367643|NCT00059475|13205151|P4|COMPLETED|Overall Study||3
5367644|NCT00059475|13205152|P3|COMPLETED|Overall Study||24
5367645|NCT00059475|13205153|P2|COMPLETED|Overall Study||2
5367646|NCT00059475|13205154|P1|COMPLETED|Overall Study||33
5367647|NCT00059475|13205147|P8|STARTED|Overall Study||7
5367648|NCT00059475|13205148|P7|STARTED|Overall Study||34
5367649|NCT00059475|13205149|P6|STARTED|Overall Study||2
5367650|NCT00059475|13205150|P5|STARTED|Overall Study||33
5367651|NCT00059475|13205151|P4|STARTED|Overall Study||3
5367652|NCT00059475|13205152|P3|STARTED|Overall Study||24
5367653|NCT00059475|13205153|P2|STARTED|Overall Study||2
5367654|NCT00059475|13205154|P1|STARTED|Overall Study||33
5367655|NCT00059332|13205182|P2|NOT COMPLETED|Overall Study||2
5367656|NCT00059332|13205183|P1|NOT COMPLETED|Overall Study||3
5367657|NCT00059332|13205182|P2|COMPLETED|Overall Study||855
5367658|NCT00059332|13205183|P1|COMPLETED|Overall Study||840
5367659|NCT00059332|13205182|P2|STARTED|Overall Study||857
5367660|NCT00059332|13205183|P1|STARTED|Overall Study||843
5367661|NCT00059215|13205209|P4|NOT COMPLETED|Overall Study||15
5367662|NCT00059215|13205210|P3|NOT COMPLETED|Overall Study||15
5367663|NCT00059215|13205211|P2|NOT COMPLETED|Overall Study||14
5367664|NCT00059215|13205212|P1|NOT COMPLETED|Overall Study||13
5367665|NCT00059215|13205209|P4|COMPLETED|Overall Study||239
5367666|NCT00059215|13205210|P3|COMPLETED|Overall Study||236
5367667|NCT00059215|13205211|P2|COMPLETED|Overall Study||186
5367668|NCT00059215|13205212|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
5367669|NCT00059215|13205209|P4|STARTED|Overall Study||254
5367670|NCT00059215|13205210|P3|STARTED|Overall Study||251
5367671|NCT00059215|13205211|P2|STARTED|Overall Study||200
5367672|NCT00059215|13205212|P1|STARTED|Overall Study||200
5367673|NCT00059228|13205240|P2|NOT COMPLETED|Overall Study||1
5367674|NCT00059228|13205241|P1|NOT COMPLETED|Overall Study||0
5367675|NCT00059228|13205240|P2|COMPLETED|Overall Study||5
5367676|NCT00059228|13205241|P1|COMPLETED|Overall Study||6
5367677|NCT00059228|13205240|P2|STARTED|Overall Study||6
5367678|NCT00059228|13205241|P1|STARTED|Overall Study||6
5367679|NCT00058825|13205249|P1|NOT COMPLETED|Overall Study||22
5367680|NCT00058825|13205249|P1|COMPLETED|Overall Study||5
5367681|NCT00058825|13205249|P1|STARTED|Overall Study||27
5367682|NCT00058552|13205265|P2|NOT COMPLETED|Overall Study||62
5367683|NCT00058552|13205266|P1|NOT COMPLETED|Overall Study||65
5367684|NCT00058552|13205265|P2|COMPLETED|Overall Study||2
5367685|NCT00058552|13205266|P1|COMPLETED|Overall Study||0
5367686|NCT00058552|13205265|P2|STARTED|Overall Study||64
5367687|NCT00058552|13205266|P1|STARTED|Overall Study||65
5367688|NCT00058539|13205284|P1|NOT COMPLETED|Overall Study||42
5367689|NCT00058539|13205284|P1|COMPLETED|Overall Study||0
5367690|NCT00058539|13205284|P1|STARTED|Overall Study||42
5367691|NCT00058370|13205294|P1|NOT COMPLETED|Overall Study||0
5367692|NCT00058370|13205294|P1|COMPLETED|Overall Study||6
5367693|NCT00058370|13205294|P1|STARTED|Overall Study||6
5367694|NCT00058240|13205304|P4|NOT COMPLETED|Second Dose Level||0
5367695|NCT00058240|13205305|P3|NOT COMPLETED|Second Dose Level||0
5367696|NCT00058240|13205306|P2|NOT COMPLETED|Second Dose Level||0
5367697|NCT00058240|13205307|P1|NOT COMPLETED|Second Dose Level||0
5367698|NCT00058240|13205304|P4|COMPLETED|Second Dose Level||4
5367699|NCT00058240|13205305|P3|COMPLETED|Second Dose Level||2
5367700|NCT00058240|13205306|P2|COMPLETED|Second Dose Level||0
5367701|NCT00058240|13205307|P1|COMPLETED|Second Dose Level||0
5367702|NCT00058240|13205304|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
5367703|NCT00058240|13205305|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
5367704|NCT00058240|13205306|P2|STARTED|Second Dose Level||0
5367705|NCT00058240|13205307|P1|STARTED|Second Dose Level||0
5367706|NCT00058240|13205304|P4|NOT COMPLETED|First Dose Level||0
5367707|NCT00058240|13205305|P3|NOT COMPLETED|First Dose Level||0
5367708|NCT00058240|13205306|P2|NOT COMPLETED|First Dose Level||0
5367709|NCT00058240|13205307|P1|NOT COMPLETED|First Dose Level||0
5367710|NCT00058240|13205304|P4|COMPLETED|First Dose Level||12
5367711|NCT00058240|13205305|P3|COMPLETED|First Dose Level||17
5367712|NCT00058240|13205306|P2|COMPLETED|First Dose Level||3
5367713|NCT00058240|13205307|P1|COMPLETED|First Dose Level||20
5367714|NCT00058240|13205304|P4|Treated|First Dose Level||12
5367715|NCT00058240|13205305|P3|Treated|First Dose Level||17
5367716|NCT00058240|13205306|P2|Treated|First Dose Level||3
5367717|NCT00058240|13205307|P1|Treated|First Dose Level||20
5367718|NCT00058240|13205304|P4|STARTED|First Dose Level||12
5367719|NCT00058240|13205305|P3|STARTED|First Dose Level||17
5367720|NCT00058240|13205306|P2|STARTED|First Dose Level||3
5367721|NCT00058240|13205307|P1|STARTED|First Dose Level||20
5367722|NCT00058214|13205317|P1|NOT COMPLETED|Overall Study||1
5367723|NCT00058214|13205317|P1|COMPLETED|Overall Study||24
5367724|NCT00058214|13205317|P1|STARTED|Overall Study||25
5367725|NCT00058123|13205322|P1|NOT COMPLETED|Overall Study||10
5367726|NCT00058123|13205322|P1|COMPLETED|Overall Study||45
5367727|NCT00058123|13205322|P1|STARTED|Overall Study||55
5367728|NCT00058058|13205329|P1|NOT COMPLETED|Overall Study||38
5367729|NCT00058058|13205329|P1|COMPLETED|Overall Study||969
5367730|NCT00058058|13205329|P1|STARTED|Overall Study||1007
5367731|NCT00058019|13205340|P2|NOT COMPLETED|Overall Study||0
5367732|NCT00058019|13205341|P1|NOT COMPLETED|Overall Study||0
5367733|NCT00058019|13205340|P2|COMPLETED|Overall Study||12
5367734|NCT00058019|13205341|P1|COMPLETED|Overall Study||39
5367735|NCT00058019|13205340|P2|STARTED|Overall Study||12
5367736|NCT00058019|13205341|P1|STARTED|Overall Study||39
5367737|NCT00057954|13205354|P1|NOT COMPLETED|Overall Study||2
5367738|NCT00057954|13205354|P1|COMPLETED|Overall Study||4
5367739|NCT00057954|13205354|P1|STARTED|Overall Study||6
5367740|NCT00057941|13205362|P2|NOT COMPLETED|Overall Study||74
5367741|NCT00057941|13205363|P1|NOT COMPLETED|Overall Study||74
5367742|NCT00057941|13205362|P2|COMPLETED|Overall Study||0
5367743|NCT00057941|13205363|P1|COMPLETED|Overall Study||0
5367744|NCT00057941|13205362|P2|Eligible|Overall Study||69
5367745|NCT00057941|13205363|P1|Eligible|Overall Study||72
5367746|NCT00057941|13205362|P2|Treated|Overall Study||74
5367747|NCT00057941|13205363|P1|Treated|Overall Study||74
5367748|NCT00057941|13205362|P2|STARTED|Overall Study||74
5367749|NCT00057941|13205363|P1|STARTED|Overall Study||74
5367750|NCT00057876|13205371|P2|NOT COMPLETED|Overall Study||27
5367751|NCT00057876|13205372|P1|NOT COMPLETED|Overall Study||29
5367752|NCT00057876|13205371|P2|COMPLETED|Overall Study||9
5367753|NCT00057876|13205372|P1|COMPLETED|Overall Study||9
5367754|NCT00057876|13205371|P2|Eligible and Treated|Overall Study||34
5367755|NCT00057876|13205372|P1|Eligible and Treated|Overall Study||34
5367756|NCT00057876|13205371|P2|Began Protocol Therapy|Overall Study||34
5367757|NCT00057876|13205372|P1|Began Protocol Therapy|Overall Study||35
5367758|NCT00057876|13205371|P2|Eligible|Overall Study||34
5367759|NCT00057876|13205372|P1|Eligible|Overall Study||37
5367760|NCT00057876|13205371|P2|STARTED|Overall Study||36
5367761|NCT00057876|13205372|P1|STARTED|Overall Study||38
5367762|NCT00057863|13205382|P1|NOT COMPLETED|Overall Study||3
5367763|NCT00057863|13205382|P1|COMPLETED|Overall Study||32
5367764|NCT00057863|13205382|P1|STARTED|Overall Study||35
5367765|NCT00057837|13205391|P2|NOT COMPLETED|Overall Study||39
5367766|NCT00057837|13205392|P1|NOT COMPLETED|Overall Study||31
5367767|NCT00057837|13205391|P2|COMPLETED|Overall Study||31
5367768|NCT00057837|13205392|P1|COMPLETED|Overall Study||39
5367769|NCT00057837|13205391|P2|Patients With Response|Overall Study||38
5367770|NCT00057837|13205392|P1|Patients With Response|Overall Study||46
5367771|NCT00057837|13205391|P2|Eligible and Treated|Overall Study||66
5367772|NCT00057837|13205392|P1|Eligible and Treated|Overall Study||66
5367773|NCT00057837|13205391|P2|Treated|Overall Study||68
5367774|NCT00057837|13205392|P1|Treated|Overall Study||69
5367775|NCT00057837|13205391|P2|STARTED|Overall Study||70
5367776|NCT00057837|13205392|P1|STARTED|Overall Study||70
5367777|NCT00057811|13205404|P2|NOT COMPLETED|Overall Study||12
5367778|NCT00057811|13205405|P1|NOT COMPLETED|Overall Study||10
5367779|NCT00057811|13205404|P2|COMPLETED|Overall Study||34
5367780|NCT00057811|13205405|P1|COMPLETED|Overall Study||41
5367781|NCT00057811|13205404|P2|STARTED|Overall Study||46
5367782|NCT00057811|13205405|P1|STARTED|Overall Study||51
5367783|NCT00057785|13205417|P1|NOT COMPLETED|Overall Study||0
5367784|NCT00057785|13205417|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
5367785|NCT00057785|13205417|P1|STARTED|Overall Study||68
5367786|NCT00057746|13205424|P3|NOT COMPLETED|Overall Study||1
5367787|NCT00057746|13205425|P2|NOT COMPLETED|Overall Study||0
5367788|NCT00057746|13205426|P1|NOT COMPLETED|Overall Study||0
5367789|NCT00057746|13205424|P3|COMPLETED|Overall Study||66
5367790|NCT00057746|13205425|P2|COMPLETED|Overall Study||67
5367791|NCT00057746|13205426|P1|COMPLETED|Overall Study||131
5367792|NCT00057746|13205424|P3|STARTED|Overall Study||67
5367793|NCT00057746|13205425|P2|STARTED|Overall Study||67
5367794|NCT00057746|13205426|P1|STARTED|Overall Study||131
5367795|NCT00023673|13205437|P4|NOT COMPLETED|Overall Study||2
5367796|NCT00023673|13205438|P3|NOT COMPLETED|Overall Study||0
5367797|NCT00023673|13205439|P2|NOT COMPLETED|Overall Study||0
5367798|NCT00023673|13205440|P1|NOT COMPLETED|Overall Study||0
5367799|NCT00023673|13205437|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
5367800|NCT00023673|13205438|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
5367801|NCT00023673|13205439|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
5367802|NCT00023673|13205440|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
5367803|NCT00023673|13205437|P4|STARTED|Overall Study||46
5367804|NCT00023673|13205438|P3|STARTED|Overall Study||0
5367805|NCT00023673|13205439|P2|STARTED|Overall Study||9
5367806|NCT00023673|13205440|P1|STARTED|Overall Study||8
5367807|NCT00057681|13205456|P3|NOT COMPLETED|Overall Study||34
5367808|NCT00057681|13205457|P2|NOT COMPLETED|Overall Study||72
5367809|NCT00057681|13205458|P1|NOT COMPLETED|Overall Study||65
5367810|NCT00057681|13205456|P3|COMPLETED|Overall Study||69
5367811|NCT00057681|13205457|P2|COMPLETED|Overall Study||67
5367812|NCT00057681|13205458|P1|COMPLETED|Overall Study||72
5367813|NCT00057681|13205456|P3|STARTED|Overall Study||103
5367814|NCT00057681|13205457|P2|STARTED|Overall Study||139
5367815|NCT00057681|13205458|P1|STARTED|Overall Study||137
5367816|NCT00057577|13205474|P2|NOT COMPLETED|Overall Study||0
5367817|NCT00057577|13205475|P1|NOT COMPLETED|Overall Study||0
5367818|NCT00057577|13205474|P2|COMPLETED|Overall Study||225
5367819|NCT00057577|13205475|P1|COMPLETED|Overall Study||227
5367820|NCT00057577|13205474|P2|STARTED|Overall Study||225
5367821|NCT00057577|13205475|P1|STARTED|Overall Study||227
5367822|NCT00057551|13205492|P3|NOT COMPLETED|Overall Study||16
5367823|NCT00057551|13205493|P2|NOT COMPLETED|Overall Study||27
5367824|NCT00057551|13205494|P1|NOT COMPLETED|Overall Study||25
5367825|NCT00057551|13205492|P3|COMPLETED|Overall Study||80
5367826|NCT00057551|13205493|P2|COMPLETED|Overall Study||168
5367827|NCT00057551|13205494|P1|COMPLETED|Overall Study||175
5367828|NCT00057551|13205492|P3|STARTED|Overall Study||96
5367829|NCT00057551|13205493|P2|STARTED|Overall Study||195
5367830|NCT00057551|13205494|P1|STARTED|Overall Study||200
5367831|NCT00057330|13205504|P2|NOT COMPLETED|Overall Study||920
5367832|NCT00057330|13205505|P1|NOT COMPLETED|Overall Study||1132
5367833|NCT00057330|13205504|P2|COMPLETED|Overall Study||2826
5367834|NCT00057330|13205505|P1|COMPLETED|Overall Study||3445
5367835|NCT00057330|13205504|P2|STARTED|Overall Study||3746
5367836|NCT00057330|13205505|P1|STARTED|Overall Study||4577
5367837|NCT00056862|13205535|P2|NOT COMPLETED|Overall Study||0
5367838|NCT00056862|13205536|P1|NOT COMPLETED|Overall Study||1
5367839|NCT00056862|13205535|P2|COMPLETED|Overall Study||27
5367840|NCT00056862|13205536|P1|COMPLETED|Overall Study||30
5367841|NCT00056862|13205535|P2|STARTED|Overall Study||27
5367842|NCT00056862|13205536|P1|STARTED|Overall Study||31
5367843|NCT00056563|13205552|P2|NOT COMPLETED|Overall Study||0
5367844|NCT00056563|13205553|P1|NOT COMPLETED|Overall Study||0
5367845|NCT00056563|13205552|P2|COMPLETED|Overall Study||134
5367846|NCT00056563|13205553|P1|COMPLETED|Overall Study||121
5367847|NCT00056563|13205552|P2|STARTED|Overall Study||134
5367848|NCT00056563|13205553|P1|STARTED|Overall Study||121
5367849|NCT00056550|13205561|P1|NOT COMPLETED|Overall Study||0
5367850|NCT00056550|13205561|P1|COMPLETED|Overall Study||14
5367851|NCT00056550|13205561|P1|STARTED|Overall Study||14
5367852|NCT00056498|13205568|P2|NOT COMPLETED|Overall Study||7
5367853|NCT00056498|13205569|P1|NOT COMPLETED|Overall Study||5
5367854|NCT00056498|13205568|P2|COMPLETED|Overall Study||28
5367855|NCT00056498|13205569|P1|COMPLETED|Overall Study||25
5367856|NCT00056498|13205568|P2|STARTED|Overall Study||35
5367857|NCT00056498|13205569|P1|STARTED|Overall Study||30
5367858|NCT00056472|13205581|P2|NOT COMPLETED|Overall Study||69
5367859|NCT00056472|13205582|P1|NOT COMPLETED|Overall Study||48
5367860|NCT00056472|13205581|P2|COMPLETED|Overall Study||61
5367861|NCT00056472|13205582|P1|COMPLETED|Overall Study||81
5367862|NCT00056472|13205581|P2|STARTED|Overall Study||130
5367863|NCT00056472|13205582|P1|STARTED|Overall Study||129
5367864|NCT00056407|13205594|P2|NOT COMPLETED|Overall Study||1193
5367865|NCT00056407|13205595|P1|NOT COMPLETED|Overall Study||1211
5367866|NCT00056407|13205594|P2|COMPLETED|Overall Study||2912
5367867|NCT00056407|13205595|P1|COMPLETED|Overall Study||2915
5367868|NCT00056407|13205594|P2|STARTED|Overall Study||4105
5367869|NCT00056407|13205595|P1|STARTED|Overall Study||4126
5367870|NCT00056316|13205653|P2|NOT COMPLETED|Overall Study||3
5367871|NCT00056316|13205654|P1|NOT COMPLETED|Overall Study||3
5367872|NCT00056316|13205653|P2|COMPLETED|Overall Study||38
5367873|NCT00056316|13205654|P1|COMPLETED|Overall Study||30
5367874|NCT00056316|13205653|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
5367875|NCT00056316|13205654|P1|STARTED|Overall Study||33
5367876|NCT00056160|13205668|P2|NOT COMPLETED|Final Follow-up||0
5367877|NCT00056160|13205669|P1|NOT COMPLETED|Final Follow-up||6
5367878|NCT00056160|13205668|P2|COMPLETED|Final Follow-up||0
5367879|NCT00056160|13205669|P1|COMPLETED|Final Follow-up||0
5367880|NCT00056160|13205668|P2|STARTED|Final Follow-up||0
5367881|NCT00056160|13205669|P1|STARTED|Final Follow-up||6
5367882|NCT00056160|13205668|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
5367883|NCT00056160|13205669|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
5367884|NCT00056160|13205668|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
5367885|NCT00056160|13205669|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
5367886|NCT00056160|13205668|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
5367887|NCT00056160|13205669|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
5367888|NCT00056160|13205668|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
5367889|NCT00056160|13205669|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
5367890|NCT00056160|13205668|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
5367891|NCT00056160|13205669|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
5367892|NCT00056160|13205668|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
5367893|NCT00056160|13205669|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
5367894|NCT00055692|13205681|P1|NOT COMPLETED|Overall Study||0
5367895|NCT00055692|13205681|P1|COMPLETED|Overall Study||46
5367896|NCT00055692|13205681|P1|STARTED|Overall Study||46
5367897|NCT00055601|13205692|P2|NOT COMPLETED|Overall Study||2
5367898|NCT00055601|13205693|P1|NOT COMPLETED|Overall Study||2
5367899|NCT00055601|13205692|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
5367900|NCT00055601|13205693|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
5367901|NCT00055601|13205692|P2|STARTED|Overall Study||49
5367902|NCT00055601|13205693|P1|STARTED|Overall Study||48
5367903|NCT00055497|13205707|P4|NOT COMPLETED|Overall Study||90
5367904|NCT00055497|13205708|P3|NOT COMPLETED|Overall Study||2
5367905|NCT00055497|13205709|P2|NOT COMPLETED|Overall Study||3
5367906|NCT00055497|13205710|P1|NOT COMPLETED|Overall Study||5
5367907|NCT00055497|13205707|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
5367908|NCT00055497|13205708|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
5367909|NCT00055497|13205709|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
5367910|NCT00055497|13205710|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
5367911|NCT00055497|13205707|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
5367912|NCT00055497|13205708|P3|STARTED|Overall Study||18
5367913|NCT00055497|13205709|P2|STARTED|Overall Study||19
5367914|NCT00055497|13205710|P1|STARTED|Overall Study||18
5367915|NCT00055471|13205755|P3|NOT COMPLETED|Period 2: Extension Period||0
5367916|NCT00055471|13205756|P2|NOT COMPLETED|Period 2: Extension Period||0
5367917|NCT00055471|13205757|P1|NOT COMPLETED|Period 2: Extension Period||0
5367918|NCT00055471|13205755|P3|COMPLETED|Period 2: Extension Period||0
5367919|NCT00055471|13205756|P2|COMPLETED|Period 2: Extension Period||6
5367920|NCT00055471|13205757|P1|COMPLETED|Period 2: Extension Period||3
5367921|NCT00055471|13205755|P3|STARTED|Period 2: Extension Period||0
5367922|NCT00055471|13205756|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
5367923|NCT00055471|13205757|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
5367924|NCT00055471|13205755|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
5367925|NCT00055471|13205756|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
5367926|NCT00055471|13205757|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
5367927|NCT00055471|13205755|P3|COMPLETED|Period 1: Dose Escalation Period||0
5367928|NCT00055471|13205756|P2|COMPLETED|Period 1: Dose Escalation Period||8
5367929|NCT00055471|13205757|P1|COMPLETED|Period 1: Dose Escalation Period||3
5367930|NCT00055471|13205755|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
5367931|NCT00055471|13205756|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
5367932|NCT00055471|13205757|P1|STARTED|Period 1: Dose Escalation Period||3
5367933|NCT00055237|13205785|P2|NOT COMPLETED|Overall Study||0
5367934|NCT00055237|13205786|P1|NOT COMPLETED|Overall Study||0
5367935|NCT00055237|13205785|P2|COMPLETED|Overall Study||2
5367936|NCT00055237|13205786|P1|COMPLETED|Overall Study||17
5367937|NCT00055237|13205785|P2|STARTED|Overall Study||2
5367938|NCT00055237|13205786|P1|STARTED|Overall Study||17
5367939|NCT00054847|13205793|P2|NOT COMPLETED|Overall Study||100
5367940|NCT00054847|13205794|P1|NOT COMPLETED|Overall Study||98
5367941|NCT00054847|13205793|P2|COMPLETED|Overall Study||266
5367942|NCT00054847|13205794|P1|COMPLETED|Overall Study||269
5367943|NCT00054847|13205793|P2|STARTED|Overall Study||366
5367944|NCT00054847|13205794|P1|STARTED|Overall Study||367
5367945|NCT00054756|13205806|P1|NOT COMPLETED|Overall Study||2
5367946|NCT00054756|13205806|P1|COMPLETED|Overall Study||94
5367947|NCT00054756|13205806|P1|STARTED|Overall Study||96
5367948|NCT00054717|13205812|P2|NOT COMPLETED|Overall Study||299
5367949|NCT00054717|13205813|P1|NOT COMPLETED|Overall Study||262
5367950|NCT00054717|13205812|P2|COMPLETED|Overall Study||18
5367951|NCT00054717|13205813|P1|COMPLETED|Overall Study||51
5367952|NCT00054717|13205812|P2|STARTED|Overall Study||317
5367953|NCT00054717|13205813|P1|STARTED|Overall Study||313
5367954|NCT00054704|13206001|P2|NOT COMPLETED|Overall Study||5
5367955|NCT00054704|13206002|P1|NOT COMPLETED|Overall Study||5
5367956|NCT00054704|13206001|P2|COMPLETED|Overall Study||6
5367957|NCT00054704|13206002|P1|COMPLETED|Overall Study||3
5367958|NCT00054704|13206001|P2|STARTED|Overall Study||11
5367959|NCT00054704|13206002|P1|STARTED|Overall Study||8
5367960|NCT00054691|13206008|P1|NOT COMPLETED|Overall Study||3
5367961|NCT00054691|13206008|P1|COMPLETED|Overall Study||37
5367962|NCT00054691|13206008|P1|STARTED|Overall Study||40
5367963|NCT00054665|13206013|P2|NOT COMPLETED|Part B||0
5367964|NCT00054665|13206014|P1|NOT COMPLETED|Part B||0
5367965|NCT00054665|13206013|P2|COMPLETED|Part B||44
5367966|NCT00054665|13206014|P1|COMPLETED|Part B||0
5367967|NCT00054665|13206013|P2|STARTED|Part B|26 participants received only Part B|44
5367968|NCT00054665|13206014|P1|STARTED|Part B||0
5367969|NCT00054665|13206013|P2|NOT COMPLETED|Part A||0
5367970|NCT00054665|13206014|P1|NOT COMPLETED|Part A||0
5367971|NCT00054665|13206013|P2|COMPLETED|Part A||0
5367972|NCT00054665|13206014|P1|COMPLETED|Part A||23
5367973|NCT00054665|13206013|P2|STARTED|Part A||0
5367974|NCT00054665|13206014|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
5367975|NCT00054639|13206022|P1|NOT COMPLETED|Overall Study||2
5367976|NCT00054639|13206022|P1|COMPLETED|Overall Study||46
5367977|NCT00054639|13206022|P1|STARTED|Overall Study||48
5367978|NCT00054353|13206028|P2|NOT COMPLETED|Overall Study||0
5367979|NCT00054353|13206029|P1|NOT COMPLETED|Overall Study||0
5367980|NCT00054353|13206028|P2|COMPLETED|Overall Study||4
5367981|NCT00054353|13206029|P1|COMPLETED|Overall Study||12
5367982|NCT00054353|13206028|P2|STARTED|Overall Study||4
5367983|NCT00054353|13206029|P1|STARTED|Overall Study||12
5367984|NCT00054327|13206055|P6|NOT COMPLETED|Overall Study||0
5367985|NCT00054327|13206056|P5|NOT COMPLETED|Overall Study||0
5367986|NCT00054327|13206057|P4|NOT COMPLETED|Overall Study||0
5367987|NCT00054327|13206058|P3|NOT COMPLETED|Overall Study||0
5367988|NCT00054327|13206059|P2|NOT COMPLETED|Overall Study||0
5367989|NCT00054327|13206060|P1|NOT COMPLETED|Overall Study||1
5367990|NCT00054327|13206055|P6|COMPLETED|Overall Study||2
5367991|NCT00054327|13206056|P5|COMPLETED|Overall Study||10
5367992|NCT00054327|13206057|P4|COMPLETED|Overall Study||4
5367993|NCT00054327|13206058|P3|COMPLETED|Overall Study||3
5367994|NCT00054327|13206059|P2|COMPLETED|Overall Study||4
5367995|NCT00054327|13206060|P1|COMPLETED|Overall Study||10
5367996|NCT00054327|13206055|P6|STARTED|Overall Study||2
5367997|NCT00054327|13206056|P5|STARTED|Overall Study||10
5367998|NCT00054327|13206057|P4|STARTED|Overall Study||4
5367999|NCT00054327|13206058|P3|STARTED|Overall Study||3
5368000|NCT00054327|13206059|P2|STARTED|Overall Study||4
5368001|NCT00054327|13206060|P1|STARTED|Overall Study||11
5368002|NCT00054275|13206098|P1|NOT COMPLETED|Overall Study||11
5368003|NCT00054275|13206098|P1|COMPLETED|Overall Study||28
5368004|NCT00054275|13206098|P1|STARTED|Overall Study||39
5368005|NCT00054132|13206104|P1|NOT COMPLETED|Overall Study||1
5368006|NCT00054132|13206104|P1|COMPLETED|Overall Study||37
5368007|NCT00054132|13206104|P1|STARTED|Overall Study||38
5368008|NCT00054028|13206115|P1|NOT COMPLETED|Overall Study||0
5368009|NCT00054028|13206115|P1|COMPLETED|Overall Study||31
5368010|NCT00054028|13206115|P1|Phase II|Overall Study||22
5368011|NCT00054028|13206115|P1|Phase I|Overall Study||9
5368012|NCT00054028|13206115|P1|STARTED|Overall Study||31
5368013|NCT00053989|13206121|P1|NOT COMPLETED|Overall Study||0
5368014|NCT00053989|13206121|P1|COMPLETED|Overall Study||41
5368015|NCT00053989|13206121|P1|STARTED|Overall Study||41
5368016|NCT00053898|13206131|P2|NOT COMPLETED|Overall Study||13
5368017|NCT00053898|13206132|P1|NOT COMPLETED|Overall Study||14
5368018|NCT00053898|13206131|P2|COMPLETED|Overall Study||1539
5368019|NCT00053898|13206132|P1|COMPLETED|Overall Study||1538
5368020|NCT00053898|13206131|P2|STARTED|Overall Study||1552
5368021|NCT00053898|13206132|P1|STARTED|Overall Study||1552
5368022|NCT00053846|13206158|P2|NOT COMPLETED|Overall Study||27
5368023|NCT00053846|13206159|P1|NOT COMPLETED|Overall Study||26
5368024|NCT00053846|13206158|P2|COMPLETED|Overall Study||192
5368025|NCT00053846|13206159|P1|COMPLETED|Overall Study||187
5368026|NCT00053846|13206158|P2|STARTED|Overall Study||219
5368027|NCT00053846|13206159|P1|STARTED|Overall Study||213
5368028|NCT00053703|13206168|P3|NOT COMPLETED|Overall Study||15
5368029|NCT00053703|13206169|P2|NOT COMPLETED|Overall Study||13
5368030|NCT00053703|13206170|P1|NOT COMPLETED|Overall Study||18
5368031|NCT00053703|13206168|P3|COMPLETED|Overall Study||25
5368032|NCT00053703|13206169|P2|COMPLETED|Overall Study||28
5368033|NCT00053703|13206170|P1|COMPLETED|Overall Study||17
5368034|NCT00053703|13206168|P3|STARTED|Overall Study||40
5368035|NCT00053703|13206169|P2|STARTED|Overall Study||41
5368036|NCT00053703|13206170|P1|STARTED|Overall Study||35
5368037|NCT00053677|13206195|P2|NOT COMPLETED|Overall Study||6
5368038|NCT00053677|13206196|P1|NOT COMPLETED|Overall Study||22
5368039|NCT00053677|13206195|P2|COMPLETED|Overall Study||13
5368040|NCT00053677|13206196|P1|COMPLETED|Overall Study||36
5368041|NCT00053677|13206195|P2|STARTED|Overall Study||19
5368042|NCT00053677|13206196|P1|STARTED|Overall Study||58
5368043|NCT00053495|13206207|P5|NOT COMPLETED|Overall Study||0
5368044|NCT00053495|13206208|P4|NOT COMPLETED|Overall Study||0
5368045|NCT00053495|13206209|P3|NOT COMPLETED|Overall Study||0
5368046|NCT00053495|13206210|P2|NOT COMPLETED|Overall Study||0
5368047|NCT00053495|13206211|P1|NOT COMPLETED|Overall Study||0
5368048|NCT00053495|13206207|P5|COMPLETED|Overall Study||49
5368049|NCT00053495|13206208|P4|COMPLETED|Overall Study||51
5368050|NCT00053495|13206209|P3|COMPLETED|Overall Study||101
5368051|NCT00053495|13206210|P2|COMPLETED|Overall Study||101
5368052|NCT00053495|13206211|P1|COMPLETED|Overall Study||51
5368053|NCT00053495|13206207|P5|STARTED|Overall Study||49
5368054|NCT00053495|13206208|P4|STARTED|Overall Study||51
5368055|NCT00053495|13206209|P3|STARTED|Overall Study||101
5368056|NCT00053495|13206210|P2|STARTED|Overall Study||101
5368057|NCT00053495|13206211|P1|STARTED|Overall Study||51
5368058|NCT00053482|13206263|P5|NOT COMPLETED|Overall Study||0
5368059|NCT00053482|13206264|P4|NOT COMPLETED|Overall Study||0
5368060|NCT00053482|13206265|P3|NOT COMPLETED|Overall Study||0
5368061|NCT00053482|13206266|P2|NOT COMPLETED|Overall Study||0
5368062|NCT00053482|13206267|P1|NOT COMPLETED|Overall Study||0
5368063|NCT00053482|13206263|P5|COMPLETED|Overall Study||52
5368064|NCT00053482|13206264|P4|COMPLETED|Overall Study||50
5368065|NCT00053482|13206265|P3|COMPLETED|Overall Study||102
5368066|NCT00053482|13206266|P2|COMPLETED|Overall Study||102
5368067|NCT00053482|13206267|P1|COMPLETED|Overall Study||51
5368068|NCT00053482|13206263|P5|STARTED|Overall Study||52
5368069|NCT00053482|13206264|P4|STARTED|Overall Study||50
5368070|NCT00053482|13206265|P3|STARTED|Overall Study||102
5368071|NCT00053482|13206266|P2|STARTED|Overall Study||102
5368072|NCT00053482|13206267|P1|STARTED|Overall Study||51
5368073|NCT00053417|13206318|P4|NOT COMPLETED|Overall Study||6
5368074|NCT00053417|13206319|P3|NOT COMPLETED|Overall Study||1
5368075|NCT00053417|13206320|P2|NOT COMPLETED|Overall Study||2
5368076|NCT00053417|13206321|P1|NOT COMPLETED|Overall Study||2
5368077|NCT00053417|13206318|P4|COMPLETED|Overall Study||51
5368078|NCT00053417|13206319|P3|COMPLETED|Overall Study||49
5368079|NCT00053417|13206320|P2|COMPLETED|Overall Study||50
5368080|NCT00053417|13206321|P1|COMPLETED|Overall Study||45
5368081|NCT00053417|13206318|P4|STARTED|Overall Study||57
5368082|NCT00053417|13206319|P3|STARTED|Overall Study||50
5368083|NCT00053417|13206320|P2|STARTED|Overall Study||52
5368084|NCT00053417|13206321|P1|STARTED|Overall Study||47
5368085|NCT00053365|13206331|P1|NOT COMPLETED|Overall Study||6
5368086|NCT00053365|13206331|P1|COMPLETED|Overall Study||55
5368087|NCT00053365|13206331|P1|STARTED|Overall Study||61
5368088|NCT00053352|13206340|P2|NOT COMPLETED|Overall Study||10
5368089|NCT00053352|13206341|P1|NOT COMPLETED|Overall Study||21
5368090|NCT00053352|13206340|P2|COMPLETED|Overall Study||102
5368091|NCT00053352|13206341|P1|COMPLETED|Overall Study||169
5368092|NCT00053352|13206340|P2|STARTED|Overall Study||112
5368093|NCT00053352|13206341|P1|STARTED|Overall Study||190
5368094|NCT00053014|13206350|P1|NOT COMPLETED|Overall Study||0
5368095|NCT00053014|13206350|P1|COMPLETED|Overall Study||5
5368096|NCT00053014|13206350|P1|STARTED|Overall Study||5
5368097|NCT00003830|13206357|P2|NOT COMPLETED|Overall Study||793
5368098|NCT00003830|13206358|P1|NOT COMPLETED|Overall Study||832
5368099|NCT00003830|13206357|P2|COMPLETED|Overall Study||2011
5368100|NCT00003830|13206358|P1|COMPLETED|Overall Study||1975
5368101|NCT00003830|13206357|P2|STARTED|Overall Study||2804
5368102|NCT00003830|13206358|P1|STARTED|Overall Study||2807
5368103|NCT00052962|13206384|P2|NOT COMPLETED|Overall Study||2
5368104|NCT00052962|13206385|P1|NOT COMPLETED|Overall Study||1
5368105|NCT00052962|13206384|P2|COMPLETED|Overall Study||15
5368106|NCT00052962|13206385|P1|COMPLETED|Overall Study||12
5368107|NCT00052962|13206384|P2|STARTED|Overall Study||17
5368108|NCT00052962|13206385|P1|STARTED|Overall Study||13
5368109|NCT00052910|13206395|P2|NOT COMPLETED|Overall Study||0
5368110|NCT00052910|13206396|P1|NOT COMPLETED|Overall Study||0
5368111|NCT00052910|13206395|P2|COMPLETED|Overall Study||266
5368112|NCT00052910|13206396|P1|COMPLETED|Overall Study||280
5368113|NCT00052910|13206395|P2|STARTED|Overall Study||266
5368114|NCT00052910|13206396|P1|STARTED|Overall Study||280
5368115|NCT00052715|13206404|P1|NOT COMPLETED|Overall Study||1
5368116|NCT00052715|13206404|P1|COMPLETED|Overall Study||30
5368117|NCT00052715|13206404|P1|STARTED|Overall Study||31
5368118|NCT00052429|13206413|P1|NOT COMPLETED|Overall Study||0
5368119|NCT00052429|13206413|P1|COMPLETED|Overall Study||25
5368120|NCT00052429|13206413|P1|STARTED|Overall Study||25
5368121|NCT00049543|13206420|P2|NOT COMPLETED|Overall Study||9
5368122|NCT00049543|13206421|P1|NOT COMPLETED|Overall Study||2
5368123|NCT00049543|13206420|P2|COMPLETED|Overall Study||243
5368124|NCT00049543|13206421|P1|COMPLETED|Overall Study||249
5368125|NCT00049543|13206420|P2|STARTED|Overall Study||252
5368126|NCT00049543|13206421|P1|STARTED|Overall Study||251
5368127|NCT00049530|13206431|P1|NOT COMPLETED|Overall Study||32
5368128|NCT00049530|13206431|P1|COMPLETED|Overall Study||0
5368129|NCT00049530|13206431|P1|Eligible and Treated|Overall Study||29
5368130|NCT00049530|13206431|P1|STARTED|Overall Study||32
5368131|NCT00049517|13206440|P6|NOT COMPLETED|Conditioning/Transplant||6
5368132|NCT00049517|13206441|P5|NOT COMPLETED|Conditioning/Transplant||6
5368133|NCT00049517|13206442|P4|NOT COMPLETED|Conditioning/Transplant||43
5368134|NCT00049517|13206443|P3|NOT COMPLETED|Conditioning/Transplant||38
5368135|NCT00049517|13206444|P2|NOT COMPLETED|Conditioning/Transplant||50
5368136|NCT00049517|13206445|P1|NOT COMPLETED|Conditioning/Transplant||52
5368137|NCT00049517|13206440|P6|COMPLETED|Conditioning/Transplant||18
5368138|NCT00049517|13206441|P5|COMPLETED|Conditioning/Transplant||15
5368139|NCT00049517|13206442|P4|COMPLETED|Conditioning/Transplant||32
5368140|NCT00049517|13206443|P3|COMPLETED|Conditioning/Transplant||25
5368141|NCT00049517|13206444|P2|COMPLETED|Conditioning/Transplant||40
5368142|NCT00049517|13206445|P1|COMPLETED|Conditioning/Transplant||27
5368143|NCT00049517|13206440|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
5368144|NCT00049517|13206441|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
5368145|NCT00049517|13206442|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
5368146|NCT00049517|13206443|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
5368147|NCT00049517|13206444|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
5368148|NCT00049517|13206445|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
5368149|NCT00049517|13206440|P6|STARTED|Conditioning/Transplant||24
5368150|NCT00049517|13206441|P5|STARTED|Conditioning/Transplant||21
5368151|NCT00049517|13206442|P4|STARTED|Conditioning/Transplant||75
5368152|NCT00049517|13206443|P3|STARTED|Conditioning/Transplant||63
5368153|NCT00049517|13206444|P2|STARTED|Conditioning/Transplant||90
5368154|NCT00049517|13206445|P1|STARTED|Conditioning/Transplant||79
5368155|NCT00049517|13206440|P6|NOT COMPLETED|Induction||54
5368156|NCT00049517|13206441|P5|NOT COMPLETED|Induction||60
5368157|NCT00049517|13206442|P4|NOT COMPLETED|Induction||0
5368158|NCT00049517|13206443|P3|NOT COMPLETED|Induction||0
5368159|NCT00049517|13206444|P2|NOT COMPLETED|Induction||0
5368160|NCT00049517|13206445|P1|NOT COMPLETED|Induction||0
5368161|NCT00049517|13206440|P6|COMPLETED|Induction||108
5368162|NCT00049517|13206441|P5|COMPLETED|Induction||128
5368163|NCT00049517|13206442|P4|COMPLETED|Induction||75
5368164|NCT00049517|13206443|P3|COMPLETED|Induction||63
5368165|NCT00049517|13206444|P2|COMPLETED|Induction||90
5368166|NCT00049517|13206445|P1|COMPLETED|Induction||79
5368167|NCT00049517|13206440|P6|Treated|Induction||160
5368168|NCT00049517|13206441|P5|Treated|Induction||186
5368169|NCT00049517|13206442|P4|Treated|Induction||75
5368170|NCT00049517|13206443|P3|Treated|Induction||63
5368171|NCT00049517|13206444|P2|Treated|Induction||90
5368172|NCT00049517|13206445|P1|Treated|Induction||79
5368173|NCT00049517|13206440|P6|STARTED|Induction||162
5368174|NCT00049517|13206441|P5|STARTED|Induction||188
5368175|NCT00049517|13206442|P4|STARTED|Induction||75
5368176|NCT00049517|13206443|P3|STARTED|Induction||63
5368177|NCT00049517|13206444|P2|STARTED|Induction||90
5368178|NCT00049517|13206445|P1|STARTED|Induction||79
5368179|NCT00049504|13206455|P1|NOT COMPLETED|Overall Study||0
5368180|NCT00049504|13206455|P1|COMPLETED|Overall Study||55
5368181|NCT00049504|13206455|P1|STARTED|Overall Study||55
5368182|NCT00049322|13206463|P2|NOT COMPLETED|Overall Study||6
5368183|NCT00049322|13206464|P1|NOT COMPLETED|Overall Study||1
5368184|NCT00049322|13206463|P2|COMPLETED|Overall Study||9
5368185|NCT00049322|13206464|P1|COMPLETED|Overall Study||14
5368186|NCT00049322|13206463|P2|STARTED|Overall Study||15
5368187|NCT00049322|13206464|P1|STARTED|Overall Study||15
5368188|NCT00049257|13206476|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
5368189|NCT00049257|13206476|P1|COMPLETED|Follow-up Period for Survival Status||41
5368190|NCT00049257|13206476|P1|STARTED|Follow-up Period for Survival Status||45
5368191|NCT00049257|13206476|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
5368192|NCT00049257|13206476|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
5368193|NCT00049257|13206476|P1|STARTED|Carboplatin, Paclitaxel||58
5368194|NCT00049127|13206488|P5|NOT COMPLETED|Overall Study||0
5368195|NCT00049127|13206489|P4|NOT COMPLETED|Overall Study||0
5368196|NCT00049127|13206490|P3|NOT COMPLETED|Overall Study||1
5368197|NCT00049127|13206491|P2|NOT COMPLETED|Overall Study||0
5368198|NCT00049127|13206492|P1|NOT COMPLETED|Overall Study||0
5368199|NCT00049127|13206488|P5|COMPLETED|Overall Study||12
5368200|NCT00049127|13206489|P4|COMPLETED|Overall Study||0
5368201|NCT00049127|13206490|P3|COMPLETED|Overall Study||39
5368202|NCT00049127|13206491|P2|COMPLETED|Overall Study||0
5368203|NCT00049127|13206492|P1|COMPLETED|Overall Study||12
5368204|NCT00049127|13206488|P5|STARTED|Overall Study||12
5368205|NCT00049127|13206489|P4|STARTED|Overall Study||0
5368206|NCT00049127|13206490|P3|STARTED|Overall Study||40
5368207|NCT00049127|13206491|P2|STARTED|Overall Study||0
5368208|NCT00049127|13206492|P1|STARTED|Overall Study||12
5368209|NCT00049036|13206521|P2|NOT COMPLETED|Overall Study||0
5368210|NCT00049036|13206522|P1|NOT COMPLETED|Overall Study||0
5368211|NCT00049036|13206521|P2|COMPLETED|Overall Study||55
5368212|NCT00049036|13206522|P1|COMPLETED|Overall Study||51
5368213|NCT00049036|13206521|P2|STARTED|Overall Study||55
5368214|NCT00049036|13206522|P1|STARTED|Overall Study||51
5368215|NCT00048997|13206530|P2|NOT COMPLETED|Overall Study||3
5368216|NCT00048997|13206531|P1|NOT COMPLETED|Overall Study||13
5368217|NCT00048997|13206530|P2|COMPLETED|Overall Study||177
5368218|NCT00048997|13206531|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
5368219|NCT00048997|13206530|P2|STARTED|Overall Study||180
5368220|NCT00048997|13206531|P1|STARTED|Overall Study||176
5368221|NCT00047385|13206554|P2|NOT COMPLETED|Overall Study||500
5368222|NCT00047385|13206555|P1|NOT COMPLETED|Overall Study||267
5368223|NCT00047385|13206554|P2|COMPLETED|Overall Study||26232
5368224|NCT00047385|13206555|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
5368225|NCT00047385|13206554|P2|STARTED|Overall Study||26732
5368226|NCT00047385|13206555|P1|STARTED|Overall Study||26722
5368227|NCT00047320|13206573|P1|NOT COMPLETED|Overall Study||28
5368228|NCT00047320|13206573|P1|COMPLETED|Overall Study||76
5368229|NCT00047320|13206573|P1|STARTED|Overall Study||104
5368230|NCT00047060|13206582|P1|NOT COMPLETED|Overall Study||2
5368231|NCT00047060|13206582|P1|COMPLETED|Overall Study||3
5368232|NCT00047060|13206582|P1|STARTED|Overall Study||5
5368233|NCT00047008|13206588|P2|NOT COMPLETED|Overall Study||11
5368234|NCT00047008|13206589|P1|NOT COMPLETED|Overall Study||11
5368235|NCT00047008|13206588|P2|COMPLETED|Overall Study||360
5368236|NCT00047008|13206589|P1|COMPLETED|Overall Study||361
5368237|NCT00047008|13206588|P2|STARTED|Overall Study||371
5368238|NCT00047008|13206589|P1|STARTED|Overall Study||372
5368239|NCT00046930|13206597|P2|NOT COMPLETED|Overall Study||4
5368240|NCT00046930|13206598|P1|NOT COMPLETED|Overall Study||12
5368241|NCT00046930|13206597|P2|COMPLETED|Overall Study||221
5368242|NCT00046930|13206598|P1|COMPLETED|Overall Study||212
5368243|NCT00046930|13206597|P2|STARTED|Overall Study||225
5368244|NCT00046930|13206598|P1|STARTED|Overall Study||224
5368245|NCT00046891|13206613|P2|NOT COMPLETED|Overall Study||30
5368246|NCT00046891|13206614|P1|NOT COMPLETED|Overall Study||29
5368247|NCT00046891|13206613|P2|COMPLETED|Overall Study||83
5368248|NCT00046891|13206614|P1|COMPLETED|Overall Study||84
5368249|NCT00046891|13206613|P2|STARTED|Overall Study||113
5368250|NCT00046891|13206614|P1|STARTED|Overall Study||113
5368251|NCT00046839|13206634|P2|NOT COMPLETED|Overall Study||2
5368252|NCT00046839|13206635|P1|NOT COMPLETED|Overall Study||1
5368253|NCT00046839|13206634|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
5368254|NCT00046839|13206635|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
5368255|NCT00046839|13206634|P2|STARTED|Overall Study||13
5368256|NCT00046839|13206635|P1|STARTED|Overall Study||8
5368257|NCT00045734|13206642|P1|NOT COMPLETED|Overall Study||1
5368258|NCT00045734|13206642|P1|COMPLETED|Overall Study||22
5368259|NCT00045734|13206642|P1|STARTED|Overall Study||23
5368260|NCT00045708|13206657|P3|NOT COMPLETED|Phase 2||0
5368261|NCT00045708|13206658|P2|NOT COMPLETED|Phase 2||0
5368262|NCT00045708|13206659|P1|NOT COMPLETED|Phase 2||0
5368263|NCT00045708|13206657|P3|COMPLETED|Phase 2||19
5368264|NCT00045708|13206658|P2|COMPLETED|Phase 2||0
5368265|NCT00045708|13206659|P1|COMPLETED|Phase 2||0
5368266|NCT00045708|13206657|P3|STARTED|Phase 2||19
5368267|NCT00045708|13206658|P2|STARTED|Phase 2||0
5368268|NCT00045708|13206659|P1|STARTED|Phase 2||0
5368269|NCT00045708|13206657|P3|NOT COMPLETED|Phase 1||0
5368270|NCT00045708|13206658|P2|NOT COMPLETED|Phase 1||1
5368271|NCT00045708|13206659|P1|NOT COMPLETED|Phase 1||0
5368272|NCT00045708|13206657|P3|COMPLETED|Phase 1||0
5368273|NCT00045708|13206658|P2|COMPLETED|Phase 1||16
5368274|NCT00045708|13206659|P1|COMPLETED|Phase 1||21
5368275|NCT00045708|13206657|P3|STARTED|Phase 1||0
5368276|NCT00045708|13206658|P2|STARTED|Phase 1||17
5368277|NCT00045708|13206659|P1|STARTED|Phase 1||21
5368278|NCT00045630|13206684|P1|NOT COMPLETED|Overall Study||6
5368279|NCT00045630|13206684|P1|COMPLETED|Overall Study||71
5368280|NCT00045630|13206684|P1|Eligible and Began Protocol Therapy|Overall Study||74
5368281|NCT00045630|13206684|P1|Eligible|Overall Study||75
5368282|NCT00045630|13206684|P1|STARTED|Overall Study||77
5368283|NCT00045487|13206690|P1|NOT COMPLETED|Overall Study||11
5368284|NCT00045487|13206690|P1|COMPLETED|Overall Study||30
5368285|NCT00045487|13206690|P1|STARTED|Overall Study||41
5368286|NCT00045435|13206694|P1|NOT COMPLETED|Overall Study||0
5368287|NCT00045435|13206694|P1|COMPLETED|Overall Study||17
5368288|NCT00045435|13206694|P1|STARTED|Overall Study||17
5368289|NCT00045305|13206703|P1|NOT COMPLETED|Overall Study||14
5368290|NCT00045305|13206703|P1|COMPLETED|Overall Study||3
5368291|NCT00045305|13206703|P1|Eligible and Treated|Overall Study||17
5368292|NCT00045305|13206703|P1|STARTED|Overall Study||17
5368293|NCT00045162|13206714|P2|NOT COMPLETED|Overall Study||118
5368294|NCT00045162|13206715|P1|NOT COMPLETED|Overall Study||142
5368295|NCT00045162|13206714|P2|COMPLETED|Overall Study||217
5368296|NCT00045162|13206715|P1|COMPLETED|Overall Study||194
5368297|NCT00045162|13206714|P2|STARTED|Overall Study||335
5368298|NCT00045162|13206715|P1|STARTED|Overall Study||336
5368299|NCT00045110|13206730|P3|NOT COMPLETED|775mg Dose Escalation||0
5368300|NCT00045110|13206731|P2|NOT COMPLETED|775mg Dose Escalation||0
5368301|NCT00045110|13206732|P1|NOT COMPLETED|775mg Dose Escalation||0
5368302|NCT00045110|13206730|P3|COMPLETED|775mg Dose Escalation||0
5368303|NCT00045110|13206731|P2|COMPLETED|775mg Dose Escalation||0
5368304|NCT00045110|13206732|P1|COMPLETED|775mg Dose Escalation||7
5368305|NCT00045110|13206730|P3|STARTED|775mg Dose Escalation||0
5368306|NCT00045110|13206731|P2|STARTED|775mg Dose Escalation||0
5368307|NCT00045110|13206732|P1|STARTED|775mg Dose Escalation||7
5368308|NCT00045110|13206730|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
5368309|NCT00045110|13206731|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
5368310|NCT00045110|13206732|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
5368311|NCT00045110|13206730|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
5368312|NCT00045110|13206731|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
5368313|NCT00045110|13206732|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
5368314|NCT00045110|13206730|P3|STARTED|650mg Phase 1 Dose Escalation||0
5368315|NCT00045110|13206731|P2|STARTED|650mg Phase 1 Dose Escalation||0
5368316|NCT00045110|13206732|P1|STARTED|650mg Phase 1 Dose Escalation||6
5368317|NCT00045110|13206730|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
5368318|NCT00045110|13206731|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
5368319|NCT00045110|13206732|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
5368320|NCT00045110|13206730|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
5368321|NCT00045110|13206731|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
5368322|NCT00045110|13206732|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
5368323|NCT00045110|13206730|P3|STARTED|525mg Phase 1 Dose Escalation||0
5368324|NCT00045110|13206731|P2|STARTED|525mg Phase 1 Dose Escalation||0
5368325|NCT00045110|13206732|P1|STARTED|525mg Phase 1 Dose Escalation||3
5368326|NCT00045110|13206730|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
5368327|NCT00045110|13206731|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
5368328|NCT00045110|13206732|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
5368329|NCT00045110|13206730|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
5368330|NCT00045110|13206731|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
5368331|NCT00045110|13206732|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
5368332|NCT00045110|13206730|P3|STARTED|400mg Phase 1 Dose Escalation||0
5368333|NCT00045110|13206731|P2|STARTED|400mg Phase 1 Dose Escalation||0
5368334|NCT00045110|13206732|P1|STARTED|400mg Phase 1 Dose Escalation||3
5368335|NCT00045110|13206730|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
5368336|NCT00045110|13206731|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
5368337|NCT00045110|13206732|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
5368338|NCT00045110|13206730|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
5368339|NCT00045110|13206731|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
5368340|NCT00045110|13206732|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
5368341|NCT00045110|13206730|P3|STARTED|275mg Phase 1 Dose Escalation||0
5368342|NCT00045110|13206731|P2|STARTED|275mg Phase 1 Dose Escalation||0
5368343|NCT00045110|13206732|P1|STARTED|275mg Phase 1 Dose Escalation||3
5368344|NCT00045110|13206730|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
5368345|NCT00045110|13206731|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
5368346|NCT00045110|13206732|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
5368347|NCT00045110|13206730|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
5368348|NCT00045110|13206731|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
5368349|NCT00045110|13206732|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
5368350|NCT00045110|13206730|P3|STARTED|200mg Phase 1 Dose Escalation||0
5368351|NCT00045110|13206731|P2|STARTED|200mg Phase 1 Dose Escalation||0
5368352|NCT00045110|13206732|P1|STARTED|200mg Phase 1 Dose Escalation||4
5368353|NCT00045110|13206730|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
5368354|NCT00045110|13206731|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
5368355|NCT00045110|13206732|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
5368356|NCT00045110|13206730|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
5368357|NCT00045110|13206731|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
5368358|NCT00045110|13206732|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
5368359|NCT00045110|13206730|P3|STARTED|100mg Phase 1 Dose Escalalation||45
5368360|NCT00045110|13206731|P2|STARTED|100mg Phase 1 Dose Escalalation||59
5368361|NCT00045110|13206732|P1|STARTED|100mg Phase 1 Dose Escalalation||6
5368362|NCT00045032|13206781|P3|NOT COMPLETED|Overall Study||726
5368363|NCT00045032|13206782|P2|NOT COMPLETED|Overall Study||708
5368364|NCT00045032|13206783|P1|NOT COMPLETED|Overall Study||863
5368365|NCT00045032|13206781|P3|COMPLETED|Overall Study||974
5368366|NCT00045032|13206782|P2|COMPLETED|Overall Study||994
5368367|NCT00045032|13206783|P1|COMPLETED|Overall Study||834
5368368|NCT00045032|13206781|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
5368369|NCT00045032|13206782|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
5368370|NCT00045032|13206783|P1|Crossover to Adjuvant Herceptin|Overall Study||888
5368371|NCT00045032|13206781|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
5368372|NCT00045032|13206782|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
5368373|NCT00045032|13206783|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
5368374|NCT00042991|13206917|P7|NOT COMPLETED|Overall Study||2
5368375|NCT00042991|13206918|P6|NOT COMPLETED|Overall Study||5
5368376|NCT00042991|13206919|P5|NOT COMPLETED|Overall Study||3
5368377|NCT00042991|13206920|P4|NOT COMPLETED|Overall Study||2
5368378|NCT00042991|13206921|P3|NOT COMPLETED|Overall Study||6
5368379|NCT00042991|13206922|P2|NOT COMPLETED|Overall Study||40
5368380|NCT00042991|13206923|P1|NOT COMPLETED|Overall Study||6
5368381|NCT00042991|13206917|P7|COMPLETED|Overall Study||1
5368382|NCT00042991|13206918|P6|COMPLETED|Overall Study||0
5368383|NCT00042991|13206919|P5|COMPLETED|Overall Study||0
5368384|NCT00042991|13206920|P4|COMPLETED|Overall Study||0
5368385|NCT00042991|13206921|P3|COMPLETED|Overall Study||1
5368386|NCT00042991|13206922|P2|COMPLETED|Overall Study||3
5368387|NCT00042991|13206923|P1|COMPLETED|Overall Study||0
5368388|NCT00042991|13206917|P7|Phase-II Trial|Overall Study||0
5368389|NCT00042991|13206918|P6|Phase-II Trial|Overall Study||0
5368390|NCT00042991|13206919|P5|Phase-II Trial|Overall Study||0
5368391|NCT00042991|13206920|P4|Phase-II Trial|Overall Study||0
5368392|NCT00042991|13206921|P3|Phase-II Trial|Overall Study||0
5368393|NCT00042991|13206922|P2|Phase-II Trial|Overall Study||36
5368394|NCT00042991|13206923|P1|Phase-II Trial|Overall Study||0
5368395|NCT00042991|13206917|P7|Phase-I Trial|Overall Study||3
5368396|NCT00042991|13206918|P6|Phase-I Trial|Overall Study||5
5368397|NCT00042991|13206919|P5|Phase-I Trial|Overall Study||3
5368398|NCT00042991|13206920|P4|Phase-I Trial|Overall Study||2
5368399|NCT00042991|13206921|P3|Phase-I Trial|Overall Study||7
5368400|NCT00042991|13206922|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
5368401|NCT00042991|13206923|P1|Phase-I Trial|Overall Study||6
5368402|NCT00042991|13206917|P7|STARTED|Overall Study||3
5368403|NCT00042991|13206918|P6|STARTED|Overall Study||5
5368404|NCT00042991|13206919|P5|STARTED|Overall Study||3
5368405|NCT00042991|13206920|P4|STARTED|Overall Study||2
5368406|NCT00042991|13206921|P3|STARTED|Overall Study||7
5368407|NCT00042991|13206922|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
5368408|NCT00042991|13206923|P1|STARTED|Overall Study||6
5368409|NCT00042939|13206966|P2|NOT COMPLETED|Overall Study||21
5368410|NCT00042939|13206967|P1|NOT COMPLETED|Overall Study||24
5368411|NCT00042939|13206966|P2|COMPLETED|Overall Study||25
5368412|NCT00042939|13206967|P1|COMPLETED|Overall Study||24
5368413|NCT00042939|13206966|P2|Patients With EGFR Results Available|Overall Study||31
5368414|NCT00042939|13206967|P1|Patients With EGFR Results Available|Overall Study||30
5368415|NCT00042939|13206966|P2|Eligible and Began Protocol Therapy|Overall Study||43
5368416|NCT00042939|13206967|P1|Eligible and Began Protocol Therapy|Overall Study||44
5368417|NCT00042939|13206966|P2|Treated|Overall Study||45
5368418|NCT00042939|13206967|P1|Treated|Overall Study||46
5368419|NCT00042939|13206966|P2|STARTED|Overall Study||46
5368420|NCT00042939|13206967|P1|STARTED|Overall Study||48
5368421|NCT00041132|13206981|P1|NOT COMPLETED|Overall Study||30
5368422|NCT00041132|13206981|P1|COMPLETED|Overall Study||26
5368423|NCT00041132|13206981|P1|Eligible and Began Protocol Therapy|Overall Study||49
5368424|NCT00041132|13206981|P1|Eligible|Overall Study||49
5368425|NCT00041132|13206981|P1|STARTED|Overall Study||56
5368426|NCT00041119|13206991|P4|NOT COMPLETED|Overall Study||0
5368427|NCT00041119|13206992|P3|NOT COMPLETED|Overall Study||0
5368428|NCT00041119|13206993|P2|NOT COMPLETED|Overall Study||0
5368429|NCT00041119|13206994|P1|NOT COMPLETED|Overall Study||0
5368430|NCT00041119|13206991|P4|COMPLETED|Overall Study||789
5368431|NCT00041119|13206992|P3|COMPLETED|Overall Study||1151
5368432|NCT00041119|13206993|P2|COMPLETED|Overall Study||789
5368433|NCT00041119|13206994|P1|COMPLETED|Overall Study||1142
5368434|NCT00041119|13206991|P4|STARTED|Overall Study||789
5368435|NCT00041119|13206992|P3|STARTED|Overall Study||1151
5368436|NCT00041119|13206993|P2|STARTED|Overall Study||789
5368437|NCT00041119|13206994|P1|STARTED|Overall Study||1142
5368438|NCT00041080|13207016|P2|NOT COMPLETED|Overall Study||10
5368439|NCT00041080|13207017|P1|NOT COMPLETED|Overall Study||30
5368440|NCT00041080|13207016|P2|COMPLETED|Overall Study||60
5368441|NCT00041080|13207017|P1|COMPLETED|Overall Study||39
5368442|NCT00041080|13207016|P2|STARTED|Overall Study|number patients enrolled on study|70
5368443|NCT00041080|13207017|P1|STARTED|Overall Study|number patients enrolled on study|69
5368444|NCT00041067|13207023|P1|NOT COMPLETED|Overall Study||76
5368445|NCT00041067|13207023|P1|COMPLETED|Overall Study||0
5368446|NCT00041067|13207023|P1|Eligible|Overall Study||74
5368447|NCT00041067|13207023|P1|STARTED|Overall Study||76
5368448|NCT00040937|13207030|P1|NOT COMPLETED|Maintenance||0
5368449|NCT00040937|13207030|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
5368450|NCT00040937|13207030|P1|STARTED|Maintenance||76
5368451|NCT00040937|13207030|P1|NOT COMPLETED|Autologous PBSCT||31
5368452|NCT00040937|13207030|P1|COMPLETED|Autologous PBSCT||77
5368453|NCT00040937|13207030|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
5368454|NCT00040937|13207030|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
5368455|NCT00040937|13207030|P1|COMPLETED|Induction/PBSC Mobilization||110
5368456|NCT00040937|13207030|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
5368457|NCT00040846|13207043|P6|NOT COMPLETED|Overall Study||0
5368458|NCT00040846|13207044|P5|NOT COMPLETED|Overall Study||0
5368459|NCT00040846|13207045|P4|NOT COMPLETED|Overall Study||0
5368460|NCT00040846|13207046|P3|NOT COMPLETED|Overall Study||0
5368461|NCT00040846|13207047|P2|NOT COMPLETED|Overall Study||0
5368462|NCT00040846|13207048|P1|NOT COMPLETED|Overall Study||0
5368463|NCT00040846|13207043|P6|COMPLETED|Overall Study||0
5368464|NCT00040846|13207044|P5|COMPLETED|Overall Study||0
5368465|NCT00040846|13207045|P4|COMPLETED|Overall Study||0
5368466|NCT00040846|13207046|P3|COMPLETED|Overall Study||0
5368467|NCT00040846|13207047|P2|COMPLETED|Overall Study||0
5368468|NCT00040846|13207048|P1|COMPLETED|Overall Study||60
5368469|NCT00040846|13207043|P6|STARTED|Overall Study||0
5368470|NCT00040846|13207044|P5|STARTED|Overall Study||0
5368471|NCT00040846|13207045|P4|STARTED|Overall Study||0
5368472|NCT00040846|13207046|P3|STARTED|Overall Study||0
5368473|NCT00040846|13207047|P2|STARTED|Overall Study||0
5368474|NCT00040846|13207048|P1|STARTED|Overall Study||60
5368475|NCT00040742|13207090|P4|NOT COMPLETED|Overall Study||34
5368476|NCT00040742|13207091|P3|NOT COMPLETED|Overall Study||46
5368477|NCT00040742|13207092|P2|NOT COMPLETED|Overall Study||49
5368478|NCT00040742|13207093|P1|NOT COMPLETED|Overall Study||39
5368479|NCT00040742|13207090|P4|COMPLETED|Overall Study||152
5368480|NCT00040742|13207091|P3|COMPLETED|Overall Study||141
5368481|NCT00040742|13207092|P2|COMPLETED|Overall Study||134
5368482|NCT00040742|13207093|P1|COMPLETED|Overall Study||149
5368483|NCT00040742|13207090|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
5368484|NCT00040742|13207091|P3|STARTED|Overall Study||187
5368485|NCT00040742|13207092|P2|STARTED|Overall Study||183
5368486|NCT00040742|13207093|P1|STARTED|Overall Study||188
5368487|NCT00039377|13207107|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
5368488|NCT00039377|13207108|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
5368489|NCT00039377|13207109|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
5368490|NCT00039377|13207110|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
5368491|NCT00039377|13207107|P4|COMPLETED|Course 5 (Transplant Assignments)||1
5368492|NCT00039377|13207108|P3|COMPLETED|Course 5 (Transplant Assignments)||19
5368493|NCT00039377|13207109|P2|COMPLETED|Course 5 (Transplant Assignments)||15
5368494|NCT00039377|13207110|P1|COMPLETED|Course 5 (Transplant Assignments)||0
5368495|NCT00039377|13207107|P4|STARTED|Course 5 (Transplant Assignments)||1
5368496|NCT00039377|13207108|P3|STARTED|Course 5 (Transplant Assignments)||19
5368497|NCT00039377|13207109|P2|STARTED|Course 5 (Transplant Assignments)||15
5368498|NCT00039377|13207110|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
5368499|NCT00039377|13207107|P4|NOT COMPLETED|Initial Registration||0
5368500|NCT00039377|13207108|P3|NOT COMPLETED|Initial Registration||0
5368501|NCT00039377|13207109|P2|NOT COMPLETED|Initial Registration||0
5368502|NCT00039377|13207110|P1|NOT COMPLETED|Initial Registration||22
5368503|NCT00039377|13207107|P4|COMPLETED|Initial Registration||0
5368504|NCT00039377|13207108|P3|COMPLETED|Initial Registration||0
5368505|NCT00039377|13207109|P2|COMPLETED|Initial Registration||0
5368506|NCT00039377|13207110|P1|COMPLETED|Initial Registration||35
5368507|NCT00039377|13207107|P4|STARTED|Initial Registration||0
5368508|NCT00039377|13207108|P3|STARTED|Initial Registration||0
5368509|NCT00039377|13207109|P2|STARTED|Initial Registration||0
5368510|NCT00039377|13207110|P1|STARTED|Initial Registration||57
5368511|NCT00039195|13207122|P1|NOT COMPLETED|Overall Study||0
5368512|NCT00039195|13207122|P1|COMPLETED|Overall Study||98
5368513|NCT00039195|13207122|P1|STARTED|Overall Study||98
5368514|NCT00039130|13207126|P1|NOT COMPLETED|Overall Study||30
5368515|NCT00039130|13207126|P1|COMPLETED|Overall Study||75
5368516|NCT00039130|13207126|P1|STARTED|Overall Study||105
5368517|NCT00036738|13207132|P1|NOT COMPLETED|Overall Study||0
5368518|NCT00036738|13207132|P1|COMPLETED|Overall Study||28
5368519|NCT00036738|13207132|P1|STARTED|Overall Study||28
5368520|NCT00033657|13207142|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
5368521|NCT00033657|13207143|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
5368522|NCT00033657|13207142|P2|COMPLETED|Adjuvant Chemotherapy||16
5368523|NCT00033657|13207143|P1|COMPLETED|Adjuvant Chemotherapy||18
5368524|NCT00033657|13207142|P2|STARTED|Adjuvant Chemotherapy||33
5368525|NCT00033657|13207143|P1|STARTED|Adjuvant Chemotherapy||36
5368526|NCT00033657|13207142|P2|NOT COMPLETED|Surgical Resection||3
5368527|NCT00033657|13207143|P1|NOT COMPLETED|Surgical Resection||0
5368528|NCT00033657|13207142|P2|COMPLETED|Surgical Resection||33
5368529|NCT00033657|13207143|P1|COMPLETED|Surgical Resection||36
5368530|NCT00033657|13207142|P2|STARTED|Surgical Resection||36
5368531|NCT00033657|13207143|P1|STARTED|Surgical Resection||36
5368532|NCT00033657|13207142|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
5368533|NCT00033657|13207143|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
5368534|NCT00033657|13207142|P2|COMPLETED|Neoadjuvant Chemotherapy||36
5368535|NCT00033657|13207143|P1|COMPLETED|Neoadjuvant Chemotherapy||36
5368536|NCT00033657|13207142|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
5368537|NCT00033657|13207143|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
5368538|NCT00033657|13207142|P2|Eligible|Neoadjuvant Chemotherapy||43
5368539|NCT00033657|13207143|P1|Eligible|Neoadjuvant Chemotherapy||42
5368540|NCT00033657|13207142|P2|STARTED|Neoadjuvant Chemotherapy||47
5368541|NCT00033657|13207143|P1|STARTED|Neoadjuvant Chemotherapy||50
5368542|NCT00033631|13207157|P2|NOT COMPLETED|Overall Study||15
5368543|NCT00033631|13207158|P1|NOT COMPLETED|Overall Study||18
5368544|NCT00033631|13207157|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
5368545|NCT00033631|13207158|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
5368546|NCT00033631|13207157|P2|STARTED|Overall Study||763
5368547|NCT00033631|13207158|P1|STARTED|Overall Study||769
5368548|NCT00033540|13207176|P1|NOT COMPLETED|Overall Study||57
5368549|NCT00033540|13207176|P1|COMPLETED|Overall Study||0
5368550|NCT00033540|13207176|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
5368551|NCT00033540|13207176|P1|Eligible|Overall Study||54
5368552|NCT00033540|13207176|P1|STARTED|Overall Study||57
5368553|NCT00033514|13207186|P2|NOT COMPLETED|Overall Study||4
5368554|NCT00033514|13207187|P1|NOT COMPLETED|Overall Study||1
5368555|NCT00033514|13207186|P2|COMPLETED|Overall Study||7
5368556|NCT00033514|13207187|P1|COMPLETED|Overall Study||15
5368557|NCT00033514|13207186|P2|STARTED|Overall Study||11
5368558|NCT00033514|13207187|P1|STARTED|Overall Study||16
5368559|NCT00033371|13207197|P2|NOT COMPLETED|Overall Study||10
5368560|NCT00033371|13207198|P1|NOT COMPLETED|Overall Study||6
5368561|NCT00033371|13207197|P2|COMPLETED|Overall Study||47
5368562|NCT00033371|13207198|P1|COMPLETED|Overall Study||49
5368563|NCT00033371|13207197|P2|STARTED|Overall Study||57
5368564|NCT00033371|13207198|P1|STARTED|Overall Study||55
5368565|NCT00033293|13207206|P2|NOT COMPLETED|Overall Study||18
5368566|NCT00033293|13207207|P1|NOT COMPLETED|Overall Study||10
5368567|NCT00033293|13207206|P2|COMPLETED|Overall Study||9
5368568|NCT00033293|13207207|P1|COMPLETED|Overall Study||16
5368569|NCT00033293|13207206|P2|STARTED|Overall Study||27
5368570|NCT00033293|13207207|P1|STARTED|Overall Study||26
5368571|NCT00031694|13207225|P1|NOT COMPLETED|Overall Study||19
5368572|NCT00031694|13207225|P1|COMPLETED|Overall Study||0
5368573|NCT00031694|13207225|P1|STARTED|Overall Study||19
5368574|NCT00031590|13207229|P1|NOT COMPLETED|Overall Study||3
5368575|NCT00031590|13207229|P1|COMPLETED|Overall Study||25
5368576|NCT00031590|13207229|P1|STARTED|Overall Study||28
5368577|NCT00030901|13207236|P3|NOT COMPLETED|Randomization||88
5368578|NCT00030901|13207237|P2|NOT COMPLETED|Randomization||101
5368579|NCT00030901|13207238|P1|NOT COMPLETED|Randomization||0
5368580|NCT00030901|13207236|P3|COMPLETED|Randomization||137
5368581|NCT00030901|13207237|P2|COMPLETED|Randomization||126
5368582|NCT00030901|13207238|P1|COMPLETED|Randomization||0
5368583|NCT00030901|13207236|P3|Eligible|Randomization||211
5368584|NCT00030901|13207237|P2|Eligible|Randomization||212
5368585|NCT00030901|13207238|P1|Eligible|Randomization||0
5368586|NCT00030901|13207236|P3|STARTED|Randomization||225
5368587|NCT00030901|13207237|P2|STARTED|Randomization||227
5368588|NCT00030901|13207238|P1|STARTED|Randomization||0
5368589|NCT00030901|13207236|P3|NOT COMPLETED|Initial Registration||0
5368590|NCT00030901|13207237|P2|NOT COMPLETED|Initial Registration||0
5368591|NCT00030901|13207238|P1|NOT COMPLETED|Initial Registration||167
5368592|NCT00030901|13207236|P3|COMPLETED|Initial Registration||0
5368593|NCT00030901|13207237|P2|COMPLETED|Initial Registration||0
5368594|NCT00030901|13207238|P1|COMPLETED|Initial Registration||452
5368595|NCT00030901|13207236|P3|STARTED|Initial Registration||0
5368596|NCT00030901|13207237|P2|STARTED|Initial Registration||0
5368597|NCT00030901|13207238|P1|STARTED|Initial Registration||619
5368598|NCT00030823|13207246|P1|NOT COMPLETED|Overall Study||1
5368599|NCT00030823|13207246|P1|COMPLETED|Overall Study||13
5368600|NCT00030823|13207246|P1|STARTED|Overall Study||14
5368601|NCT00030264|13207250|P1|NOT COMPLETED|Overall Study||0
5368602|NCT00030264|13207250|P1|COMPLETED|Overall Study||23
5368603|NCT00030264|13207250|P1|STARTED|Overall Study||23
5368604|NCT00028769|13207254|P1|NOT COMPLETED|Overall Study||41
5368605|NCT00028769|13207254|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
5368606|NCT00028769|13207254|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
5368607|NCT00028769|13207254|P1|Eligible|Overall Study||36
5368608|NCT00028769|13207254|P1|STARTED|Overall Study||41
5368609|NCT00028002|13207260|P1|NOT COMPLETED|Overall Study||11
5368610|NCT00028002|13207260|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
5368611|NCT00028002|13207260|P1|STARTED|Overall Study||63
5368612|NCT00027846|13207270|P3|NOT COMPLETED|Overall Study||37
5368613|NCT00027846|13207271|P2|NOT COMPLETED|Overall Study||68
5368614|NCT00027846|13207272|P1|NOT COMPLETED|Overall Study||2
5368615|NCT00027846|13207270|P3|COMPLETED|Overall Study||41
5368616|NCT00027846|13207271|P2|COMPLETED|Overall Study||219
5368617|NCT00027846|13207272|P1|COMPLETED|Overall Study||11
5368618|NCT00027846|13207270|P3|STARTED|Overall Study||78
5368619|NCT00027846|13207271|P2|STARTED|Overall Study||287
5368620|NCT00027846|13207272|P1|STARTED|Overall Study||13
5368621|NCT00027560|13207290|P1|NOT COMPLETED|Overall Study||1
5368622|NCT00027560|13207290|P1|COMPLETED|Overall Study||50
5368623|NCT00027560|13207290|P1|STARTED|Overall Study||51
5368624|NCT00026494|13207303|P4|NOT COMPLETED|Overall Study||0
5368625|NCT00026494|13207304|P3|NOT COMPLETED|Overall Study||6
5368626|NCT00026494|13207305|P2|NOT COMPLETED|Overall Study||0
5368627|NCT00026494|13207306|P1|NOT COMPLETED|Overall Study||2
5368628|NCT00026494|13207303|P4|COMPLETED|Overall Study||16
5368629|NCT00026494|13207304|P3|COMPLETED|Overall Study||16
5368630|NCT00026494|13207305|P2|COMPLETED|Overall Study||4
5368631|NCT00026494|13207306|P1|COMPLETED|Overall Study||5
5368632|NCT00026494|13207303|P4|STARTED|Overall Study||16
5368633|NCT00026494|13207304|P3|STARTED|Overall Study||22
5368634|NCT00026494|13207305|P2|STARTED|Overall Study||4
5368635|NCT00026494|13207306|P1|STARTED|Overall Study||7
5368636|NCT00026312|13207318|P2|NOT COMPLETED|Overall Study||269
5368637|NCT00026312|13207319|P1|NOT COMPLETED|Overall Study||34
5368638|NCT00026312|13207318|P2|COMPLETED|Overall Study||1064
5368639|NCT00026312|13207319|P1|COMPLETED|Overall Study||82
5368640|NCT00026312|13207318|P2|STARTED|Overall Study||1333
5368641|NCT00026312|13207319|P1|STARTED|Overall Study||116
5368642|NCT00026221|13207337|P3|NOT COMPLETED|Overall Study||0
5368643|NCT00026221|13207338|P2|NOT COMPLETED|Overall Study||0
5368644|NCT00026221|13207339|P1|NOT COMPLETED|Overall Study||0
5368645|NCT00026221|13207337|P3|COMPLETED|Overall Study||25
5368646|NCT00026221|13207338|P2|COMPLETED|Overall Study||16
5368647|NCT00026221|13207339|P1|COMPLETED|Overall Study||16
5368648|NCT00026221|13207337|P3|STARTED|Overall Study||25
5368649|NCT00026221|13207338|P2|STARTED|Overall Study||16
5368650|NCT00026221|13207339|P1|STARTED|Overall Study||16
5368651|NCT00026208|13207358|P2|NOT COMPLETED|Overall Study||0
5368652|NCT00026208|13207359|P1|NOT COMPLETED|Overall Study||1
5368653|NCT00026208|13207358|P2|COMPLETED|Overall Study||4
5368654|NCT00026208|13207359|P1|COMPLETED|Overall Study||71
5368655|NCT00026208|13207358|P2|STARTED|Overall Study||4
5368656|NCT00026208|13207359|P1|STARTED|Overall Study||72
5368657|NCT00025662|13207377|P1|NOT COMPLETED|Overall Study||3
5368658|NCT00025662|13207377|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
5368659|NCT00025662|13207377|P1|STARTED|Overall Study||25
5368660|NCT00025506|13207385|P1|NOT COMPLETED|Overall Study||10
5368661|NCT00025506|13207385|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
5368662|NCT00025506|13207385|P1|STARTED|Overall Study||55
5368663|NCT00025259|13207406|P7|NOT COMPLETED|Overall Study||51
5368664|NCT00025259|13207407|P6|NOT COMPLETED|Overall Study||52
5368665|NCT00025259|13207408|P5|NOT COMPLETED|Overall Study||36
5368666|NCT00025259|13207409|P4|NOT COMPLETED|Overall Study||114
5368667|NCT00025259|13207410|P3|NOT COMPLETED|Overall Study||81
5368668|NCT00025259|13207411|P2|NOT COMPLETED|Overall Study||89
5368669|NCT00025259|13207412|P1|NOT COMPLETED|Overall Study||45
5368670|NCT00025259|13207406|P7|COMPLETED|Overall Study||102
5368671|NCT00025259|13207407|P6|COMPLETED|Overall Study||101
5368672|NCT00025259|13207408|P5|COMPLETED|Overall Study||6
5368673|NCT00025259|13207409|P4|COMPLETED|Overall Study||457
5368674|NCT00025259|13207410|P3|COMPLETED|Overall Study||301
5368675|NCT00025259|13207411|P2|COMPLETED|Overall Study||292
5368676|NCT00025259|13207412|P1|COMPLETED|Overall Study||7
5368677|NCT00025259|13207406|P7|STARTED|Overall Study||153
5368678|NCT00025259|13207407|P6|STARTED|Overall Study||153
5368679|NCT00025259|13207408|P5|STARTED|Overall Study||42
5368680|NCT00025259|13207409|P4|STARTED|Overall Study||571
5368681|NCT00025259|13207410|P3|STARTED|Overall Study||382
5368682|NCT00025259|13207411|P2|STARTED|Overall Study||381
5368683|NCT00025259|13207412|P1|STARTED|Overall Study||52
5368684|NCT00025233|13207448|P1|NOT COMPLETED|Overall Study||4
5368685|NCT00025233|13207448|P1|COMPLETED|Overall Study||46
5368686|NCT00025233|13207448|P1|STARTED|Overall Study||50
5368687|NCT00025155|13207463|P1|NOT COMPLETED|Overall Study||2
5368688|NCT00025155|13207463|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
5368689|NCT00025155|13207463|P1|STARTED|Overall Study||51
5368690|NCT00024258|13207474|P1|NOT COMPLETED|Overall Study||9
5368691|NCT00024258|13207474|P1|COMPLETED|Overall Study||13
5368692|NCT00024258|13207474|P1|STARTED|Overall Study||22
5368693|NCT00024167|13207481|P2|NOT COMPLETED|Overall Study||47
5368694|NCT00024167|13207482|P1|NOT COMPLETED|Overall Study||53
5368695|NCT00024167|13207481|P2|COMPLETED|Overall Study||15
5368696|NCT00024167|13207482|P1|COMPLETED|Overall Study||12
5368697|NCT00024167|13207481|P2|Induction Treatment Option 2 Completed|Overall Study||41
5368698|NCT00024167|13207482|P1|Induction Treatment Option 2 Completed|Overall Study||43
5368699|NCT00024167|13207481|P2|Induction Treatment Option 1 Completed|Overall Study||21
5368700|NCT00024167|13207482|P1|Induction Treatment Option 1 Completed|Overall Study||22
5368701|NCT00024167|13207481|P2|STARTED|Overall Study||62
5368702|NCT00024167|13207482|P1|STARTED|Overall Study||65
5368703|NCT00024102|13207493|P2|NOT COMPLETED|Overall Study||0
5368704|NCT00024102|13207494|P1|NOT COMPLETED|Overall Study||0
5368705|NCT00024102|13207493|P2|COMPLETED|Overall Study||307
5368706|NCT00024102|13207494|P1|COMPLETED|Overall Study||326
5368707|NCT00024102|13207493|P2|STARTED|Overall Study||307
5368708|NCT00024102|13207494|P1|STARTED|Overall Study||326
5368709|NCT00023764|13207506|P1|NOT COMPLETED|Overall Study||14
5368710|NCT00023764|13207506|P1|COMPLETED|Overall Study||89
5368711|NCT00023764|13207506|P1|STARTED|Overall Study||103
5368712|NCT00023712|13207513|P2|NOT COMPLETED|Overall Study||1
5368713|NCT00023712|13207514|P1|NOT COMPLETED|Overall Study||2
5368714|NCT00023712|13207513|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
5368715|NCT00023712|13207514|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
5368716|NCT00023712|13207513|P2|STARTED|Overall Study|total number of participants enrolled on study|30
5368717|NCT00023712|13207514|P1|STARTED|Overall Study|total number of participants enrolled on study|28
5368718|NCT00022698|13207538|P2|NOT COMPLETED|Overall Study||35
5368719|NCT00022698|13207539|P1|NOT COMPLETED|Overall Study||8
5368720|NCT00022698|13207538|P2|COMPLETED|Overall Study||17
5368721|NCT00022698|13207539|P1|COMPLETED|Overall Study||7
5368722|NCT00022698|13207538|P2|STARTED|Overall Study||52
5368723|NCT00022698|13207539|P1|STARTED|Overall Study||15
5368724|NCT00022672|13207564|P2|NOT COMPLETED|Extension Phase||51
5368725|NCT00022672|13207565|P1|NOT COMPLETED|Extension Phase||3
5368726|NCT00022672|13207564|P2|COMPLETED|Extension Phase||7
5368727|NCT00022672|13207565|P1|COMPLETED|Extension Phase||11
5368728|NCT00022672|13207564|P2|Safety Set: Received Study Drug|Extension Phase||58
5368729|NCT00022672|13207565|P1|Safety Set: Received Study Drug|Extension Phase||14
5368730|NCT00022672|13207564|P2|STARTED|Extension Phase||58
5368731|NCT00022672|13207565|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
5368732|NCT00022672|13207564|P2|NOT COMPLETED|Main Phase: 24 Months||100
5368733|NCT00022672|13207565|P1|NOT COMPLETED|Main Phase: 24 Months||87
5368734|NCT00022672|13207564|P2|COMPLETED|Main Phase: 24 Months||4
5368735|NCT00022672|13207565|P1|COMPLETED|Main Phase: 24 Months||16
5368736|NCT00022672|13207564|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
5368737|NCT00022672|13207565|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
5368738|NCT00022672|13207564|P2|STARTED|Main Phase: 24 Months||104
5368739|NCT00022672|13207565|P1|STARTED|Main Phase: 24 Months||103
5368740|NCT00022659|13207598|P1|NOT COMPLETED|Overall Study||2
5368741|NCT00022659|13207598|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
5368742|NCT00022659|13207598|P1|STARTED|Overall Study||64
5368743|NCT00022633|13207611|P2|NOT COMPLETED|Overall Study||5
5368744|NCT00022633|13207612|P1|NOT COMPLETED|Overall Study||32
5368745|NCT00022633|13207611|P2|COMPLETED|Overall Study||5
5368746|NCT00022633|13207612|P1|COMPLETED|Overall Study||23
5368747|NCT00022633|13207611|P2|Eligible|Overall Study||10
5368748|NCT00022633|13207612|P1|Eligible|Overall Study||51
5368749|NCT00022633|13207611|P2|STARTED|Overall Study||10
5368750|NCT00022633|13207612|P1|STARTED|Overall Study||55
5368751|NCT00022516|13207625|P2|NOT COMPLETED|Overall Study||230
5368752|NCT00022516|13207626|P1|NOT COMPLETED|Overall Study||3
5368753|NCT00022516|13207625|P2|COMPLETED|Overall Study||314
5368754|NCT00022516|13207626|P1|COMPLETED|Overall Study||539
5368755|NCT00022516|13207625|P2|STARTED|Overall Study||544
5368756|NCT00022516|13207626|P1|STARTED|Overall Study||542
5368757|NCT00022490|13207638|P1|NOT COMPLETED|Overall Study||0
5368758|NCT00022490|13207638|P1|COMPLETED|Overall Study||24
5368759|NCT00022490|13207638|P1|STARTED|Overall Study||24
5368760|NCT00021255|13207645|P3|NOT COMPLETED|Overall Study||149
5368761|NCT00021255|13207646|P2|NOT COMPLETED|Overall Study||270
5368762|NCT00021255|13207647|P1|NOT COMPLETED|Overall Study||121
5368763|NCT00021255|13207645|P3|COMPLETED|Overall Study||926
5368764|NCT00021255|13207646|P2|COMPLETED|Overall Study||804
5368765|NCT00021255|13207647|P1|COMPLETED|Overall Study||952
5368766|NCT00021255|13207645|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
5368767|NCT00021255|13207646|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
5368768|NCT00021255|13207647|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
5368769|NCT00021255|13207645|P3|Treated|Overall Study||1057
5368770|NCT00021255|13207646|P2|Treated|Overall Study||1072
5368771|NCT00021255|13207647|P1|Treated|Overall Study||1045
5368772|NCT00021255|13207645|P3|STARTED|Overall Study|Randomized|1075
5368773|NCT00021255|13207646|P2|STARTED|Overall Study|Randomized|1074
5368774|NCT00021255|13207647|P1|STARTED|Overall Study|Randomized|1073
5368775|NCT00021229|13207664|P3|NOT COMPLETED|Overall Study||16
5368776|NCT00021229|13207665|P2|NOT COMPLETED|Overall Study||33
5368777|NCT00021229|13207666|P1|NOT COMPLETED|Overall Study||35
5368778|NCT00021229|13207664|P3|COMPLETED|Overall Study||0
5368779|NCT00021229|13207665|P2|COMPLETED|Overall Study||0
5368780|NCT00021229|13207666|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
5368781|NCT00021229|13207664|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
5368782|NCT00021229|13207665|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
5368783|NCT00021229|13207666|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
5368784|NCT00021229|13207664|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
5368785|NCT00021229|13207665|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
5368786|NCT00021229|13207666|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
5368787|NCT00021229|13207664|P3|Enrolled in Phase I|Overall Study||16
5368788|NCT00021229|13207665|P2|Enrolled in Phase I|Overall Study||33
5368789|NCT00021229|13207666|P1|Enrolled in Phase I|Overall Study||35
5368790|NCT00021229|13207664|P3|STARTED|Overall Study||16
5368791|NCT00021229|13207665|P2|STARTED|Overall Study||33
5368792|NCT00021229|13207666|P1|STARTED|Overall Study||36
5368793|NCT00020722|13207692|P1|NOT COMPLETED|Overall Study||0
5368794|NCT00020722|13207692|P1|COMPLETED|Overall Study||7
5368795|NCT00020722|13207692|P1|STARTED|Overall Study||7
5368796|NCT00019747|13207699|P2|NOT COMPLETED|Overall Study||0
5368797|NCT00019747|13207700|P1|NOT COMPLETED|Overall Study||0
5368798|NCT00019747|13207699|P2|COMPLETED|Overall Study||16
5368799|NCT00019747|13207700|P1|COMPLETED|Overall Study||23
5368800|NCT00019747|13207699|P2|STARTED|Overall Study||16
5368801|NCT00019747|13207700|P1|STARTED|Overall Study||23
5368802|NCT00019682|13207708|P2|NOT COMPLETED|Overall Study||6
5368803|NCT00019682|13207709|P1|NOT COMPLETED|Overall Study||1
5368804|NCT00019682|13207708|P2|COMPLETED|Overall Study||85
5368805|NCT00019682|13207709|P1|COMPLETED|Overall Study||93
5368806|NCT00019682|13207708|P2|STARTED|Overall Study||91
5368807|NCT00019682|13207709|P1|STARTED|Overall Study||94
5368808|NCT00019604|13207721|P1|NOT COMPLETED|Overall Study||39
5368809|NCT00019604|13207721|P1|COMPLETED|Overall Study||5
5368810|NCT00019604|13207721|P1|STARTED|Overall Study||44
5368811|NCT00017563|13207734|P1|NOT COMPLETED|Overall Study||1
5368812|NCT00017563|13207734|P1|COMPLETED|Overall Study||56
5368813|NCT00017563|13207734|P1|STARTED|Overall Study||57
5368814|NCT00016913|13207738|P1|NOT COMPLETED|Overall Study||0
5368815|NCT00016913|13207738|P1|COMPLETED|Overall Study||27
5368816|NCT00016913|13207738|P1|STARTED|Overall Study||27
5368817|NCT00016354|13207744|P8|NOT COMPLETED|Overall Study||1
5368818|NCT00016354|13207745|P7|NOT COMPLETED|Overall Study||0
5368819|NCT00016354|13207746|P6|NOT COMPLETED|Overall Study||0
5368820|NCT00016354|13207747|P5|NOT COMPLETED|Overall Study||0
5368821|NCT00016354|13207748|P4|NOT COMPLETED|Overall Study||0
5368822|NCT00016354|13207749|P3|NOT COMPLETED|Overall Study||0
5368823|NCT00016354|13207750|P2|NOT COMPLETED|Overall Study||0
5368824|NCT00016354|13207751|P1|NOT COMPLETED|Overall Study||0
5368825|NCT00016354|13207744|P8|COMPLETED|Overall Study||6
5368826|NCT00016354|13207745|P7|COMPLETED|Overall Study||6
5368827|NCT00016354|13207746|P6|COMPLETED|Overall Study||1
5368828|NCT00016354|13207747|P5|COMPLETED|Overall Study||1
5368829|NCT00016354|13207748|P4|COMPLETED|Overall Study||1
5368830|NCT00016354|13207749|P3|COMPLETED|Overall Study||1
5368831|NCT00016354|13207750|P2|COMPLETED|Overall Study||1
5368832|NCT00016354|13207751|P1|COMPLETED|Overall Study||1
5368833|NCT00016354|13207744|P8|STARTED|Overall Study||7
5368834|NCT00016354|13207745|P7|STARTED|Overall Study||6
5368835|NCT00016354|13207746|P6|STARTED|Overall Study||1
5368836|NCT00016354|13207747|P5|STARTED|Overall Study||1
5368837|NCT00016354|13207748|P4|STARTED|Overall Study||1
5368838|NCT00016354|13207749|P3|STARTED|Overall Study||1
5368839|NCT00016354|13207750|P2|STARTED|Overall Study||1
5368840|NCT00016354|13207751|P1|STARTED|Overall Study||1
5368841|NCT00015847|13207755|P1|NOT COMPLETED|Overall Study||0
5368842|NCT00015847|13207755|P1|COMPLETED|Overall Study||25
5368843|NCT00015847|13207755|P1|STARTED|Overall Study||25
5368844|NCT00014495|13207765|P4|NOT COMPLETED|Overall Study||1
5368845|NCT00014495|13207766|P3|NOT COMPLETED|Overall Study||1
5368846|NCT00014495|13207767|P2|NOT COMPLETED|Overall Study||0
5368847|NCT00014495|13207768|P1|NOT COMPLETED|Overall Study||0
5368848|NCT00014495|13207765|P4|COMPLETED|Overall Study||5
5368849|NCT00014495|13207766|P3|COMPLETED|Overall Study||19
5368850|NCT00014495|13207767|P2|COMPLETED|Overall Study||3
5368851|NCT00014495|13207768|P1|COMPLETED|Overall Study||3
5368852|NCT00014495|13207765|P4|STARTED|Overall Study||6
5368853|NCT00014495|13207766|P3|STARTED|Overall Study||20
5368854|NCT00014495|13207767|P2|STARTED|Overall Study||3
5368855|NCT00014495|13207768|P1|STARTED|Overall Study||3
5368856|NCT00014222|13207778|P3|NOT COMPLETED|Overall Study||27
5368857|NCT00014222|13207779|P2|NOT COMPLETED|Overall Study||13
5368858|NCT00014222|13207780|P1|NOT COMPLETED|Overall Study||21
5368859|NCT00014222|13207778|P3|COMPLETED|Overall Study||675
5368860|NCT00014222|13207779|P2|COMPLETED|Overall Study||688
5368861|NCT00014222|13207780|P1|COMPLETED|Overall Study||680
5368862|NCT00014222|13207778|P3|STARTED|Overall Study||702
5368863|NCT00014222|13207779|P2|STARTED|Overall Study||701
5368864|NCT00014222|13207780|P1|STARTED|Overall Study||701
5368865|NCT00012298|13207798|P7|NOT COMPLETED|Overall Study||0
5368866|NCT00012298|13207799|P6|NOT COMPLETED|Overall Study||0
5368867|NCT00012298|13207800|P5|NOT COMPLETED|Overall Study||0
5368868|NCT00012298|13207801|P4|NOT COMPLETED|Overall Study||0
5368869|NCT00012298|13207802|P3|NOT COMPLETED|Overall Study||0
5368870|NCT00012298|13207803|P2|NOT COMPLETED|Overall Study||0
5368871|NCT00012298|13207804|P1|NOT COMPLETED|Overall Study||0
5368872|NCT00012298|13207798|P7|COMPLETED|Overall Study||39
5368873|NCT00012298|13207799|P6|COMPLETED|Overall Study||6
5368874|NCT00012298|13207800|P5|COMPLETED|Overall Study||5
5368875|NCT00012298|13207801|P4|COMPLETED|Overall Study||4
5368876|NCT00012298|13207802|P3|COMPLETED|Overall Study||9
5368877|NCT00012298|13207803|P2|COMPLETED|Overall Study||7
5368878|NCT00012298|13207804|P1|COMPLETED|Overall Study||11
5368879|NCT00012298|13207798|P7|STARTED|Overall Study||39
5368880|NCT00012298|13207799|P6|STARTED|Overall Study||6
5368881|NCT00012298|13207800|P5|STARTED|Overall Study||5
5368882|NCT00012298|13207801|P4|STARTED|Overall Study||4
5368883|NCT00012298|13207802|P3|STARTED|Overall Study||9
5368884|NCT00012298|13207803|P2|STARTED|Overall Study||7
5368885|NCT00012298|13207804|P1|STARTED|Overall Study||11
5368886|NCT00012012|13207834|P2|NOT COMPLETED|Overall Study||3
5368887|NCT00012012|13207835|P1|NOT COMPLETED|Overall Study||1
5368888|NCT00012012|13207834|P2|COMPLETED|Overall Study||15
5368889|NCT00012012|13207835|P1|COMPLETED|Overall Study||26
5368890|NCT00012012|13207834|P2|STARTED|Overall Study||18
5368891|NCT00012012|13207835|P1|STARTED|Overall Study||27
5368892|NCT00011986|13207846|P5|NOT COMPLETED|Overall Study||0
5368893|NCT00011986|13207847|P4|NOT COMPLETED|Overall Study||0
5368894|NCT00011986|13207848|P3|NOT COMPLETED|Overall Study||0
5368895|NCT00011986|13207849|P2|NOT COMPLETED|Overall Study||0
5368896|NCT00011986|13207850|P1|NOT COMPLETED|Overall Study||0
5368897|NCT00011986|13207846|P5|COMPLETED|Overall Study||861
5368898|NCT00011986|13207847|P4|COMPLETED|Overall Study||861
5368899|NCT00011986|13207848|P3|COMPLETED|Overall Study||862
5368900|NCT00011986|13207849|P2|COMPLETED|Overall Study||864
5368901|NCT00011986|13207850|P1|COMPLETED|Overall Study||864
5368902|NCT00011986|13207846|P5|Initiated Treatment|Overall Study||851
5368903|NCT00011986|13207847|P4|Initiated Treatment|Overall Study||846
5368904|NCT00011986|13207848|P3|Initiated Treatment|Overall Study||854
5368905|NCT00011986|13207849|P2|Initiated Treatment|Overall Study||860
5368906|NCT00011986|13207850|P1|Initiated Treatment|Overall Study||862
5368907|NCT00011986|13207846|P5|STARTED|Overall Study||861
5368908|NCT00011986|13207847|P4|STARTED|Overall Study||861
5368909|NCT00011986|13207848|P3|STARTED|Overall Study||862
5368910|NCT00011986|13207849|P2|STARTED|Overall Study||864
5368911|NCT00011986|13207850|P1|STARTED|Overall Study||864
5368912|NCT00010257|13207874|P2|NOT COMPLETED|Overall Study||0
5368913|NCT00010257|13207875|P1|NOT COMPLETED|Overall Study||1
5368914|NCT00010257|13207874|P2|COMPLETED|Overall Study||21
5368915|NCT00010257|13207875|P1|COMPLETED|Overall Study||24
5368916|NCT00010257|13207874|P2|STARTED|Overall Study||21
5368917|NCT00010257|13207875|P1|STARTED|Overall Study||25
5368918|NCT00009945|13207885|P2|NOT COMPLETED|Overall Study||5
5368919|NCT00009945|13207886|P1|NOT COMPLETED|Overall Study||7
5368920|NCT00009945|13207885|P2|COMPLETED|Overall Study||1656
5368921|NCT00009945|13207886|P1|COMPLETED|Overall Study||1655
5368922|NCT00009945|13207885|P2|STARTED|Overall Study||1661
5368923|NCT00009945|13207886|P1|STARTED|Overall Study||1662
5368924|NCT00008385|13207902|P2|NOT COMPLETED|Overall Study||802
5368925|NCT00008385|13207903|P1|NOT COMPLETED|Overall Study||387
5368926|NCT00008385|13207902|P2|COMPLETED|Overall Study||238
5368927|NCT00008385|13207903|P1|COMPLETED|Overall Study||134
5368928|NCT00008385|13207902|P2|Off Treatment Reasons Reported|Overall Study||795
5368929|NCT00008385|13207903|P1|Off Treatment Reasons Reported|Overall Study||398
5368930|NCT00008385|13207902|P2|Treated|Overall Study||865
5368931|NCT00008385|13207903|P1|Treated|Overall Study||477
5368932|NCT00008385|13207902|P2|STARTED|Overall Study||1040
5368933|NCT00008385|13207903|P1|STARTED|Overall Study||521
5368934|NCT00008138|13207913|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
5368935|NCT00008138|13207913|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
5368936|NCT00008138|13207913|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
5368937|NCT00008138|13207913|P1|NOT COMPLETED|Interval Debulking||2
5368938|NCT00008138|13207913|P1|COMPLETED|Interval Debulking||36
5368939|NCT00008138|13207913|P1|Received Protocol Surgery|Interval Debulking||36
5368940|NCT00008138|13207913|P1|STARTED|Interval Debulking||38
5368941|NCT00008138|13207913|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
5368942|NCT00008138|13207913|P1|COMPLETED|Neoadjuvant Chemotherapy||38
5368943|NCT00008138|13207913|P1|Eligible|Neoadjuvant Chemotherapy||58
5368944|NCT00008138|13207913|P1|STARTED|Neoadjuvant Chemotherapy||58
5368945|NCT00006916|13207919|P1|NOT COMPLETED|Overall Study||5
5368946|NCT00006916|13207919|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
5368947|NCT00006916|13207919|P1|STARTED|Overall Study||19
5368948|NCT00006903|13207925|P3|NOT COMPLETED|Overall Study||6
5368949|NCT00006903|13207926|P2|NOT COMPLETED|Overall Study||4
5368950|NCT00006903|13207927|P1|NOT COMPLETED|Overall Study||10
5368951|NCT00006903|13207925|P3|COMPLETED|Overall Study||27
5368952|NCT00006903|13207926|P2|COMPLETED|Overall Study||20
5368953|NCT00006903|13207927|P1|COMPLETED|Overall Study||0
5368954|NCT00006903|13207925|P3|STARTED|Overall Study||33
5368955|NCT00006903|13207926|P2|STARTED|Overall Study||24
5368956|NCT00006903|13207927|P1|STARTED|Overall Study||10
5368957|NCT00006721|13207940|P3|NOT COMPLETED|Overall Study||33
5368958|NCT00006721|13207941|P2|NOT COMPLETED|Overall Study||25
5368959|NCT00006721|13207942|P1|NOT COMPLETED|Overall Study||4
5368960|NCT00006721|13207940|P3|COMPLETED|Overall Study||242
5368961|NCT00006721|13207941|P2|COMPLETED|Overall Study||254
5368962|NCT00006721|13207942|P1|COMPLETED|Overall Study||13
5368963|NCT00006721|13207940|P3|Eligible and Began Protocol Therapy|Overall Study||265
5368964|NCT00006721|13207941|P2|Eligible and Began Protocol Therapy|Overall Study||267
5368965|NCT00006721|13207942|P1|Eligible and Began Protocol Therapy|Overall Study||14
5368966|NCT00006721|13207940|P3|Eligible|Overall Study||265
5368967|NCT00006721|13207941|P2|Eligible|Overall Study||267
5368968|NCT00006721|13207942|P1|Eligible|Overall Study||15
5368969|NCT00006721|13207940|P3|STARTED|Overall Study||275
5368970|NCT00006721|13207941|P2|STARTED|Overall Study||279
5368971|NCT00006721|13207942|P1|STARTED|Overall Study||17
5368972|NCT00006478|13207960|P1|NOT COMPLETED|Overall Study||7
5368973|NCT00006478|13207960|P1|COMPLETED|Overall Study||12
5368974|NCT00006478|13207960|P1|STARTED|Overall Study||19
5368975|NCT00006392|13207971|P4|NOT COMPLETED|Overall Study||160
5368976|NCT00006392|13207972|P3|NOT COMPLETED|Overall Study||160
5368977|NCT00006392|13207973|P2|NOT COMPLETED|Overall Study||158
5368978|NCT00006392|13207974|P1|NOT COMPLETED|Overall Study||167
5368979|NCT00006392|13207971|P4|COMPLETED|Overall Study||8696
5368980|NCT00006392|13207972|P3|COMPLETED|Overall Study||8703
5368981|NCT00006392|13207973|P2|COMPLETED|Overall Study||8752
5368982|NCT00006392|13207974|P1|COMPLETED|Overall Study||8737
5368983|NCT00006392|13207971|P4|STARTED|Overall Study||8856
5368984|NCT00006392|13207972|P3|STARTED|Overall Study||8863
5368985|NCT00006392|13207973|P2|STARTED|Overall Study||8910
5368986|NCT00006392|13207974|P1|STARTED|Overall Study||8904
5368987|NCT00006389|13208004|P1|NOT COMPLETED|Overall Study||1
5368988|NCT00006389|13208004|P1|COMPLETED|Overall Study||11
5368989|NCT00006389|13208004|P1|STARTED|Overall Study||12
5368990|NCT00006244|13208010|P1|NOT COMPLETED|Overall Study||0
5368991|NCT00006244|13208010|P1|COMPLETED|Overall Study||36
5368992|NCT00006244|13208010|P1|STARTED|Overall Study||36
5368993|NCT00006237|13208021|P2|NOT COMPLETED|Overall Study||61
5368994|NCT00006237|13208022|P1|NOT COMPLETED|Overall Study||125
5368995|NCT00006237|13208021|P2|COMPLETED|Overall Study||159
5368996|NCT00006237|13208022|P1|COMPLETED|Overall Study||87
5368997|NCT00006237|13208021|P2|Eligible and Treated|Overall Study||199
5368998|NCT00006237|13208022|P1|Eligible and Treated|Overall Study||203
5368999|NCT00006237|13208021|P2|Eligible|Overall Study||200
5369000|NCT00006237|13208022|P1|Eligible|Overall Study||203
5369001|NCT00006237|13208021|P2|STARTED|Overall Study||220
5369002|NCT00006237|13208022|P1|STARTED|Overall Study||212
5369003|NCT00006227|13208032|P1|NOT COMPLETED|Overall Study||0
5369004|NCT00006227|13208032|P1|COMPLETED|Overall Study||31
5369005|NCT00006227|13208032|P1|STARTED|Overall Study||31
5369006|NCT00006110|13208040|P2|NOT COMPLETED|Overall Study||0
5369007|NCT00006110|13208041|P1|NOT COMPLETED|Overall Study||0
5369008|NCT00006110|13208040|P2|COMPLETED|Overall Study||30
5369009|NCT00006110|13208041|P1|COMPLETED|Overall Study||52
5369010|NCT00006110|13208040|P2|STARTED|Overall Study||30
5369011|NCT00006110|13208041|P1|STARTED|Overall Study||52
5369012|NCT00006101|13208055|P2|NOT COMPLETED|Overall Study||5
5369013|NCT00006101|13208056|P1|NOT COMPLETED|Overall Study||5
5369014|NCT00006101|13208055|P2|COMPLETED|Overall Study||33
5369015|NCT00006101|13208056|P1|COMPLETED|Overall Study||33
5369016|NCT00006101|13208055|P2|STARTED|Overall Study||38
5369017|NCT00006101|13208056|P1|STARTED|Overall Study||38
5369018|NCT00006011|13208065|P3|NOT COMPLETED|Overall Study||73
5369019|NCT00006011|13208066|P2|NOT COMPLETED|Overall Study||77
5369020|NCT00006011|13208067|P1|NOT COMPLETED|Overall Study||65
5369021|NCT00006011|13208065|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
5369022|NCT00006011|13208066|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
5369023|NCT00006011|13208067|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
5369024|NCT00006011|13208065|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
5369025|NCT00006011|13208066|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
5369026|NCT00006011|13208067|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
5369027|NCT00005957|13208075|P2|NOT COMPLETED|Overall Study||28
5369028|NCT00005957|13208076|P1|NOT COMPLETED|Overall Study||8
5369029|NCT00005957|13208075|P2|COMPLETED|Overall Study||888
5369030|NCT00005957|13208076|P1|COMPLETED|Overall Study||908
5369031|NCT00005957|13208075|P2|STARTED|Overall Study||916
5369032|NCT00005957|13208076|P1|STARTED|Overall Study||916
5369033|NCT00005879|13208086|P2|NOT COMPLETED|Overall Study||10
5369034|NCT00005879|13208087|P1|NOT COMPLETED|Overall Study||8
5369035|NCT00005879|13208086|P2|COMPLETED|Overall Study||88
5369036|NCT00005879|13208087|P1|COMPLETED|Overall Study||93
5369037|NCT00005879|13208086|P2|STARTED|Overall Study||98
5369038|NCT00005879|13208087|P1|STARTED|Overall Study||101
5369039|NCT00005803|13208095|P1|NOT COMPLETED|Overall Study||22
5369040|NCT00005803|13208095|P1|COMPLETED|Overall Study||54
5369041|NCT00005803|13208095|P1|STARTED|Overall Study||76
5369042|NCT00005047|13208110|P4|NOT COMPLETED|Overall Study||0
5369043|NCT00005047|13208111|P3|NOT COMPLETED|Overall Study||0
5369044|NCT00005047|13208112|P2|NOT COMPLETED|Overall Study||0
5369045|NCT00005047|13208113|P1|NOT COMPLETED|Overall Study||19
5369046|NCT00005047|13208110|P4|COMPLETED|Overall Study||158
5369047|NCT00005047|13208111|P3|COMPLETED|Overall Study||227
5369048|NCT00005047|13208112|P2|COMPLETED|Overall Study||56
5369049|NCT00005047|13208113|P1|COMPLETED|Overall Study||39
5369050|NCT00005047|13208110|P4|STARTED|Overall Study||158
5369051|NCT00005047|13208111|P3|STARTED|Overall Study||227
5369052|NCT00005047|13208112|P2|STARTED|Overall Study||56
5369053|NCT00005047|13208113|P1|STARTED|Overall Study||58
5369054|NCT00005044|13208129|P2|NOT COMPLETED|Overall Study||52
5369055|NCT00005044|13208130|P1|NOT COMPLETED|Overall Study||38
5369056|NCT00005044|13208129|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
5369057|NCT00005044|13208130|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
5369058|NCT00005044|13208129|P2|STARTED|Overall Study||789
5369059|NCT00005044|13208130|P1|STARTED|Overall Study||790
5369060|NCT00004888|13208150|P2|NOT COMPLETED|Overall Study||24
5369061|NCT00004888|13208151|P1|NOT COMPLETED|Overall Study||11
5369062|NCT00004888|13208150|P2|COMPLETED|Overall Study||22
5369063|NCT00004888|13208151|P1|COMPLETED|Overall Study||27
5369064|NCT00004888|13208150|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
5369065|NCT00004888|13208151|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
5369066|NCT00004859|13208169|P2|NOT COMPLETED|Overall Study||282
5369067|NCT00004859|13208170|P1|NOT COMPLETED|Overall Study||118
5369068|NCT00004859|13208169|P2|COMPLETED|Overall Study||12
5369069|NCT00004859|13208170|P1|COMPLETED|Overall Study||177
5369070|NCT00004859|13208169|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
5369071|NCT00004859|13208170|P1|Treated and Having Toxicity Data|Overall Study||289
5369072|NCT00004859|13208169|P2|Treated|Overall Study||289
5369073|NCT00004859|13208170|P1|Treated|Overall Study||289
5369074|NCT00004859|13208169|P2|Eligible|Overall Study||271
5369075|NCT00004859|13208170|P1|Eligible|Overall Study||275
5369076|NCT00004859|13208169|P2|STARTED|Overall Study||294
5369077|NCT00004859|13208170|P1|STARTED|Overall Study||295
5369078|NCT00004259|13208184|P4|NOT COMPLETED|Overall Study||0
5369079|NCT00004259|13208185|P3|NOT COMPLETED|Overall Study||0
5369080|NCT00004259|13208186|P2|NOT COMPLETED|Overall Study||4
5369081|NCT00004259|13208187|P1|NOT COMPLETED|Overall Study||1
5369082|NCT00004259|13208184|P4|COMPLETED|Overall Study||14
5369083|NCT00004259|13208185|P3|COMPLETED|Overall Study||15
5369084|NCT00004259|13208186|P2|COMPLETED|Overall Study||99
5369085|NCT00004259|13208187|P1|COMPLETED|Overall Study||97
5369086|NCT00004259|13208184|P4|STARTED|Overall Study||14
5369087|NCT00004259|13208185|P3|STARTED|Overall Study||15
5369088|NCT00004259|13208186|P2|STARTED|Overall Study||103
5369089|NCT00004259|13208187|P1|STARTED|Overall Study||98
5369090|NCT00004228|13208212|P7|NOT COMPLETED|Overall Study||12
5369091|NCT00004228|13208213|P6|NOT COMPLETED|Overall Study||14
5369092|NCT00004228|13208214|P5|NOT COMPLETED|Overall Study||16
5369093|NCT00004228|13208215|P4|NOT COMPLETED|Overall Study||7
5369094|NCT00004228|13208216|P3|NOT COMPLETED|Overall Study||19
5369095|NCT00004228|13208217|P2|NOT COMPLETED|Overall Study||15
5369096|NCT00004228|13208218|P1|NOT COMPLETED|Overall Study||9
5369097|NCT00004228|13208212|P7|COMPLETED|Overall Study||45
5369098|NCT00004228|13208213|P6|COMPLETED|Overall Study||51
5369099|NCT00004228|13208214|P5|COMPLETED|Overall Study||51
5369100|NCT00004228|13208215|P4|COMPLETED|Overall Study||6
5369101|NCT00004228|13208216|P3|COMPLETED|Overall Study||46
5369102|NCT00004228|13208217|P2|COMPLETED|Overall Study||51
5369103|NCT00004228|13208218|P1|COMPLETED|Overall Study||51
5369104|NCT00004228|13208212|P7|STARTED|Overall Study||57
5369105|NCT00004228|13208213|P6|STARTED|Overall Study||65
5369106|NCT00004228|13208214|P5|STARTED|Overall Study||67
5369107|NCT00004228|13208215|P4|STARTED|Overall Study||13
5369108|NCT00004228|13208216|P3|STARTED|Overall Study||65
5369109|NCT00004228|13208217|P2|STARTED|Overall Study||66
5369110|NCT00004228|13208218|P1|STARTED|Overall Study||60
5369111|NCT00004143|13208241|P1|NOT COMPLETED|Overall Study||0
5369112|NCT00004143|13208241|P1|COMPLETED|Overall Study||2
5369113|NCT00004143|13208241|P1|STARTED|Overall Study||2
5369114|NCT00004124|13208252|P2|NOT COMPLETED|Overall Study||20
5369115|NCT00004124|13208253|P1|NOT COMPLETED|Overall Study||12
5369116|NCT00004124|13208252|P2|COMPLETED|Overall Study||460
5369117|NCT00004124|13208253|P1|COMPLETED|Overall Study||469
5369118|NCT00004124|13208252|P2|STARTED|Overall Study||480
5369119|NCT00004124|13208253|P1|STARTED|Overall Study||481
5369120|NCT00004092|13208269|P2|NOT COMPLETED|Overall Study||0
5369121|NCT00004092|13208270|P1|NOT COMPLETED|Overall Study||0
5369122|NCT00004092|13208269|P2|COMPLETED|Overall Study||51
5369123|NCT00004092|13208270|P1|COMPLETED|Overall Study||21
5369124|NCT00004092|13208269|P2|STARTED|Overall Study||51
5369125|NCT00004092|13208270|P1|STARTED|Overall Study||21
5369126|NCT00004088|13208278|P1|NOT COMPLETED|Overall Study||9
5369127|NCT00004088|13208278|P1|COMPLETED|Overall Study||68
5369128|NCT00004088|13208278|P1|STARTED|Overall Study||77
5369129|NCT00004054|13208289|P2|NOT COMPLETED|Overall Study||0
5369130|NCT00004054|13208290|P1|NOT COMPLETED|Overall Study||0
5369131|NCT00004054|13208289|P2|COMPLETED|Overall Study||200
5369132|NCT00004054|13208290|P1|COMPLETED|Overall Study||197
5369133|NCT00004054|13208289|P2|STARTED|Overall Study||200
5369134|NCT00004054|13208290|P1|STARTED|Overall Study||197
5369135|NCT00003910|13208304|P2|NOT COMPLETED|Step 2||0
5369136|NCT00003910|13208305|P1|NOT COMPLETED|Step 2||0
5369137|NCT00003910|13208304|P2|COMPLETED|Step 2||16
5369138|NCT00003910|13208305|P1|COMPLETED|Step 2||0
5369139|NCT00003910|13208304|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
5369140|NCT00003910|13208305|P1|STARTED|Step 2||0
5369141|NCT00003910|13208304|P2|NOT COMPLETED|Step 1||0
5369142|NCT00003910|13208305|P1|NOT COMPLETED|Step 1||0
5369143|NCT00003910|13208304|P2|COMPLETED|Step 1||0
5369144|NCT00003910|13208305|P1|COMPLETED|Step 1||55
5369145|NCT00003910|13208304|P2|STARTED|Step 1||0
5369146|NCT00003910|13208305|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
5369147|NCT00003901|13208311|P1|NOT COMPLETED|Overall Study||17
5369148|NCT00003901|13208311|P1|COMPLETED|Overall Study||1030
5369149|NCT00003901|13208311|P1|STARTED|Overall Study||1047
5369150|NCT00003896|13208322|P1|NOT COMPLETED|Overall Study||29
5369151|NCT00003896|13208322|P1|COMPLETED|Overall Study||39
5369152|NCT00003896|13208322|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
5369153|NCT00003896|13208322|P1|STARTED|Overall Study||68
5369154|NCT00003875|13208328|P1|NOT COMPLETED|Overall Study||1
5369155|NCT00003875|13208328|P1|COMPLETED|Overall Study||29
5369156|NCT00003875|13208328|P1|STARTED|Overall Study||30
5369157|NCT00003869|13208337|P2|NOT COMPLETED|Overall Study||12
5369158|NCT00003869|13208338|P1|NOT COMPLETED|Overall Study||41
5369159|NCT00003869|13208337|P2|COMPLETED|Overall Study||80
5369160|NCT00003869|13208338|P1|COMPLETED|Overall Study||53
5369161|NCT00003869|13208337|P2|STARTED|Overall Study||92
5369162|NCT00003869|13208338|P1|STARTED|Overall Study||94
5369163|NCT00003820|13208354|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
5369164|NCT00003820|13208355|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
5369165|NCT00003820|13208354|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
5369166|NCT00003820|13208355|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
5369167|NCT00003820|13208354|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
5369168|NCT00003820|13208355|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
5369169|NCT00003820|13208354|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
5369170|NCT00003820|13208355|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
5369171|NCT00003820|13208354|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
5369172|NCT00003820|13208355|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
5369173|NCT00003820|13208354|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
5369174|NCT00003820|13208355|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
5369175|NCT00003820|13208354|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
5369176|NCT00003820|13208355|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
5369177|NCT00003820|13208354|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
5369178|NCT00003820|13208355|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
5369179|NCT00003820|13208354|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
5369180|NCT00003820|13208355|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
5369181|NCT00003820|13208354|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
5369182|NCT00003820|13208355|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
5369183|NCT00003820|13208354|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
5369184|NCT00003820|13208355|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
5369185|NCT00003820|13208354|P2|STARTED|Cycle 1 (Initial Treatment)||16
5369186|NCT00003820|13208355|P1|STARTED|Cycle 1 (Initial Treatment)||23
5369187|NCT00003782|13208364|P3|NOT COMPLETED|Overall Study||26
5369188|NCT00003782|13208365|P2|NOT COMPLETED|Overall Study||31
5369189|NCT00003782|13208366|P1|NOT COMPLETED|Overall Study||30
5369190|NCT00003782|13208364|P3|COMPLETED|Overall Study||1758
5369191|NCT00003782|13208365|P2|COMPLETED|Overall Study||1753
5369192|NCT00003782|13208366|P1|COMPLETED|Overall Study||1753
5369193|NCT00003782|13208364|P3|STARTED|Overall Study||1784
5369194|NCT00003782|13208365|P2|STARTED|Overall Study||1784
5369195|NCT00003782|13208366|P1|STARTED|Overall Study||1783
5369196|NCT00003702|13208376|P2|NOT COMPLETED|Overall Study||11
5369197|NCT00003702|13208377|P1|NOT COMPLETED|Overall Study||13
5369198|NCT00003702|13208376|P2|COMPLETED|Overall Study||109
5369199|NCT00003702|13208377|P1|COMPLETED|Overall Study||107
5369200|NCT00003702|13208376|P2|STARTED|Overall Study||120
5369201|NCT00003702|13208377|P1|STARTED|Overall Study||120
5369202|NCT00003659|13208386|P1|NOT COMPLETED|Overall Study||3
5369203|NCT00003659|13208386|P1|COMPLETED|Overall Study||36
5369204|NCT00003659|13208386|P1|STARTED|Overall Study||39
5369205|NCT00003644|13208394|P2|NOT COMPLETED|Overall Study||14
5369206|NCT00003644|13208395|P1|NOT COMPLETED|Overall Study||15
5369207|NCT00003644|13208394|P2|COMPLETED|Overall Study||268
5369208|NCT00003644|13208395|P1|COMPLETED|Overall Study||274
5369209|NCT00003644|13208394|P2|STARTED|Overall Study||282
5369210|NCT00003644|13208395|P1|STARTED|Overall Study||289
5369211|NCT00003641|13208407|P2|NOT COMPLETED|Overall Study||174
5369212|NCT00003641|13208408|P1|NOT COMPLETED|Overall Study||569
5369213|NCT00003641|13208407|P2|COMPLETED|Overall Study||407
5369214|NCT00003641|13208408|P1|COMPLETED|Overall Study||0
5369215|NCT00003641|13208407|P2|Toxicity Assessed|Overall Study||568
5369216|NCT00003641|13208408|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
5369217|NCT00003641|13208407|P2|Treated|Overall Study||569
5369218|NCT00003641|13208408|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
5369219|NCT00003641|13208407|P2|STARTED|Overall Study||581
5369220|NCT00003641|13208408|P1|STARTED|Overall Study||569
5369221|NCT00003631|13208419|P3|NOT COMPLETED|Overall Study||9
5369222|NCT00003631|13208420|P2|NOT COMPLETED|Overall Study||1
5369223|NCT00003631|13208421|P1|NOT COMPLETED|Overall Study||3
5369224|NCT00003631|13208419|P3|COMPLETED|Overall Study||15
5369225|NCT00003631|13208420|P2|COMPLETED|Overall Study||43
5369226|NCT00003631|13208421|P1|COMPLETED|Overall Study||47
5369227|NCT00003631|13208419|P3|STARTED|Overall Study||24
5369228|NCT00003631|13208420|P2|STARTED|Overall Study||44
5369229|NCT00003631|13208421|P1|STARTED|Overall Study||50
5369230|NCT00003590|13208429|P1|NOT COMPLETED|Overall Study||22
5369231|NCT00003590|13208429|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
5369232|NCT00003590|13208429|P1|Eligible and Began Protocol Therapy|Overall Study||28
5369233|NCT00003590|13208429|P1|Eligible|Overall Study||28
5369234|NCT00003590|13208429|P1|STARTED|Overall Study||29
5369235|NCT00003537|13208434|P1|NOT COMPLETED|Overall Study||1
5369236|NCT00003537|13208434|P1|COMPLETED|Overall Study||18
5369237|NCT00003537|13208434|P1|STARTED|Overall Study||19
5369238|NCT00003535|13208439|P1|NOT COMPLETED|Overall Study||5
5369239|NCT00003535|13208439|P1|COMPLETED|Overall Study||4
5369240|NCT00003535|13208439|P1|STARTED|Overall Study||9
5369241|NCT00003499|13208444|P1|NOT COMPLETED|Overall Study||8
5369242|NCT00003499|13208444|P1|COMPLETED|Overall Study||23
5369243|NCT00003499|13208444|P1|STARTED|Overall Study||31
5369244|NCT00003483|13208449|P1|NOT COMPLETED|Overall Study||1
5369245|NCT00003483|13208449|P1|COMPLETED|Overall Study||2
5369246|NCT00003483|13208449|P1|STARTED|Overall Study||3
5369247|NCT00003479|13208454|P1|NOT COMPLETED|Overall Study||3
5369248|NCT00003479|13208454|P1|COMPLETED|Overall Study||6
5369249|NCT00003479|13208454|P1|STARTED|Overall Study||9
5369250|NCT00003477|13208459|P1|NOT COMPLETED|Overall Study||4
5369251|NCT00003477|13208459|P1|COMPLETED|Overall Study||8
5369252|NCT00003477|13208459|P1|STARTED|Overall Study||12
5369253|NCT00003476|13208464|P1|NOT COMPLETED|Overall Study||1
5369254|NCT00003476|13208464|P1|COMPLETED|Overall Study||7
5369255|NCT00003476|13208464|P1|STARTED|Overall Study||8
5369256|NCT00003475|13208469|P1|NOT COMPLETED|Overall Study||13
5369257|NCT00003475|13208469|P1|COMPLETED|Overall Study||27
5369258|NCT00003475|13208469|P1|STARTED|Overall Study||40
5369259|NCT00003474|13208474|P1|NOT COMPLETED|Overall Study||14
5369260|NCT00003474|13208474|P1|COMPLETED|Overall Study||26
5369261|NCT00003474|13208474|P1|STARTED|Overall Study||40
5369262|NCT00003473|13208479|P1|NOT COMPLETED|Overall Study||3
5369263|NCT00003473|13208479|P1|COMPLETED|Overall Study||17
5369264|NCT00003473|13208479|P1|STARTED|Overall Study||20
5369265|NCT00003472|13208484|P1|NOT COMPLETED|Overall Study||3
5369266|NCT00003472|13208484|P1|COMPLETED|Overall Study||10
5369267|NCT00003472|13208484|P1|STARTED|Overall Study||13
5369268|NCT00003471|13208489|P1|NOT COMPLETED|Overall Study||4
5369269|NCT00003471|13208489|P1|COMPLETED|Overall Study||3
5369270|NCT00003471|13208489|P1|STARTED|Overall Study||7
5369271|NCT00003470|13208494|P1|NOT COMPLETED|Overall Study||6
5369272|NCT00003470|13208494|P1|COMPLETED|Overall Study||21
5369273|NCT00003470|13208494|P1|STARTED|Overall Study||27
5369274|NCT00003469|13208499|P1|NOT COMPLETED|Overall Study||0
5369275|NCT00003469|13208499|P1|COMPLETED|Overall Study||4
5369276|NCT00003469|13208499|P1|STARTED|Overall Study||4
5369277|NCT00003468|13208504|P1|NOT COMPLETED|Overall Study||2
5369278|NCT00003468|13208504|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
5369279|NCT00003468|13208504|P1|STARTED|Overall Study||11
5369280|NCT00003460|13208509|P1|NOT COMPLETED|Overall Study||1
5369281|NCT00003460|13208509|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
5369282|NCT00003460|13208509|P1|STARTED|Overall Study||13
5369283|NCT00003459|13208514|P1|NOT COMPLETED|Overall Study||9
5369284|NCT00003459|13208514|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
5369285|NCT00003459|13208514|P1|STARTED|Overall Study||40
5369286|NCT00003458|13208519|P1|NOT COMPLETED|Overall Study||4
5369287|NCT00003458|13208519|P1|COMPLETED|Overall Study||30
5369288|NCT00003458|13208519|P1|STARTED|Overall Study||34
5369289|NCT00003457|13208524|P1|NOT COMPLETED|Overall Study||9
5369290|NCT00003457|13208524|P1|COMPLETED|Overall Study||31
5369291|NCT00003457|13208524|P1|STARTED|Overall Study||40
5369292|NCT00003456|13208529|P1|NOT COMPLETED|Overall Study||8
5369293|NCT00003456|13208529|P1|COMPLETED|Overall Study||32
5369294|NCT00003456|13208529|P1|STARTED|Overall Study||40
5369295|NCT00003453|13208534|P1|NOT COMPLETED|Overall Study||1
5369296|NCT00003453|13208534|P1|COMPLETED|Overall Study|One patient was not evaluable|5
5369297|NCT00003453|13208534|P1|STARTED|Overall Study||6
5369298|NCT00003404|13208539|P1|NOT COMPLETED|Overall Study||0
5369299|NCT00003404|13208539|P1|COMPLETED|Overall Study||46
5369300|NCT00003404|13208539|P1|STARTED|Overall Study||46
5369301|NCT00003389|13208546|P2|NOT COMPLETED|Overall Study||60
5369302|NCT00003389|13208547|P1|NOT COMPLETED|Overall Study||98
5369303|NCT00003389|13208546|P2|COMPLETED|Overall Study||366
5369304|NCT00003389|13208547|P1|COMPLETED|Overall Study||330
5369305|NCT00003389|13208546|P2|Eligible Patients|Overall Study||399
5369306|NCT00003389|13208547|P1|Eligible Patients|Overall Study||395
5369307|NCT00003389|13208546|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
5369308|NCT00003389|13208547|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
5369309|NCT00003389|13208546|P2|STARTED|Overall Study||426
5369310|NCT00003389|13208547|P1|STARTED|Overall Study||428
5369311|NCT00003377|13208562|P5|NOT COMPLETED|Period II||1
5369312|NCT00003377|13208563|P4|NOT COMPLETED|Period II||0
5369313|NCT00003377|13208564|P3|NOT COMPLETED|Period II||0
5369314|NCT00003377|13208565|P2|NOT COMPLETED|Period II||0
5369315|NCT00003377|13208566|P1|NOT COMPLETED|Period II||0
5369316|NCT00003377|13208562|P5|COMPLETED|Period II||16
5369317|NCT00003377|13208563|P4|COMPLETED|Period II||0
5369318|NCT00003377|13208564|P3|COMPLETED|Period II||0
5369319|NCT00003377|13208565|P2|COMPLETED|Period II||0
5369320|NCT00003377|13208566|P1|COMPLETED|Period II||0
5369321|NCT00003377|13208562|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
5369322|NCT00003377|13208563|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
5369323|NCT00003377|13208564|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
5369324|NCT00003377|13208565|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
5369325|NCT00003377|13208566|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
5369326|NCT00003377|13208562|P5|NOT COMPLETED|Period I||0
5369327|NCT00003377|13208563|P4|NOT COMPLETED|Period I||1
5369328|NCT00003377|13208564|P3|NOT COMPLETED|Period I||1
5369329|NCT00003377|13208565|P2|NOT COMPLETED|Period I||0
5369330|NCT00003377|13208566|P1|NOT COMPLETED|Period I||0
5369331|NCT00003377|13208562|P5|COMPLETED|Period I||0
5369332|NCT00003377|13208563|P4|COMPLETED|Period I||2
5369333|NCT00003377|13208564|P3|COMPLETED|Period I||2
5369334|NCT00003377|13208565|P2|COMPLETED|Period I||3
5369335|NCT00003377|13208566|P1|COMPLETED|Period I||3
5369336|NCT00003377|13208562|P5|STARTED|Period I||0
5369337|NCT00003377|13208563|P4|STARTED|Period I||3
5369338|NCT00003377|13208564|P3|STARTED|Period I||3
5369339|NCT00003377|13208565|P2|STARTED|Period I||3
5369340|NCT00003377|13208566|P1|STARTED|Period I||3
5369341|NCT00003199|13208580|P1|NOT COMPLETED|Overall Study||22
5369342|NCT00003199|13208580|P1|COMPLETED|Overall Study||28
5369343|NCT00003199|13208580|P1|STARTED|Overall Study||50
5369344|NCT00003138|13208588|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
5369345|NCT00003138|13208589|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
5369346|NCT00003138|13208588|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
5369347|NCT00003138|13208589|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
5369348|NCT00003138|13208588|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
5369349|NCT00003138|13208589|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
5369350|NCT00003138|13208588|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
5369351|NCT00003138|13208589|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
5369352|NCT00003138|13208588|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
5369353|NCT00003138|13208589|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
5369354|NCT00003138|13208588|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
5369355|NCT00003138|13208589|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
5369356|NCT00003138|13208588|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
5369357|NCT00003138|13208589|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
5369358|NCT00003138|13208588|P2|NOT COMPLETED|Step 2 (Cross Over)||0
5369359|NCT00003138|13208589|P1|NOT COMPLETED|Step 2 (Cross Over)||26
5369360|NCT00003138|13208588|P2|COMPLETED|Step 2 (Cross Over)||0
5369361|NCT00003138|13208589|P1|COMPLETED|Step 2 (Cross Over)||0
5369362|NCT00003138|13208588|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
5369363|NCT00003138|13208589|P1|STARTED|Step 2 (Cross Over)||26
5369364|NCT00003138|13208588|P2|NOT COMPLETED|Step 1||57
5369365|NCT00003138|13208589|P1|NOT COMPLETED|Step 1||61
5369366|NCT00003138|13208588|P2|COMPLETED|Step 1||0
5369367|NCT00003138|13208589|P1|COMPLETED|Step 1||0
5369368|NCT00003138|13208588|P2|Patients With Transfusion Data|Step 1||42
5369369|NCT00003138|13208589|P1|Patients With Transfusion Data|Step 1||37
5369370|NCT00003138|13208588|P2|Patients With QOL Data at 4 Months|Step 1||42
5369371|NCT00003138|13208589|P1|Patients With QOL Data at 4 Months|Step 1||42
5369372|NCT00003138|13208588|P2|Eligible and Treated|Step 1||50
5369373|NCT00003138|13208589|P1|Eligible and Treated|Step 1||52
5369374|NCT00003138|13208588|P2|Treated|Step 1||53
5369375|NCT00003138|13208589|P1|Treated|Step 1||56
5369376|NCT00003138|13208588|P2|Patients With Complete Data|Step 1||53
5369377|NCT00003138|13208589|P1|Patients With Complete Data|Step 1||57
5369378|NCT00003138|13208588|P2|STARTED|Step 1||57
5369379|NCT00003138|13208589|P1|STARTED|Step 1||61
5369380|NCT00002975|13208602|P1|NOT COMPLETED|Overall Study||5
5369381|NCT00002975|13208602|P1|COMPLETED|Overall Study||175
5369382|NCT00002975|13208602|P1|Treated With Study Therapy|Overall Study||175
5369383|NCT00002975|13208602|P1|STARTED|Overall Study||180
5369384|NCT00002931|13208606|P1|NOT COMPLETED|Overall Study||2
5369385|NCT00002931|13208606|P1|COMPLETED|Overall Study||46
5369386|NCT00002931|13208606|P1|STARTED|Overall Study||48
5369387|NCT00002874|13208614|P2|NOT COMPLETED|Overall Study||35
5369388|NCT00002874|13208615|P1|NOT COMPLETED|Overall Study||45
5369389|NCT00002874|13208614|P2|COMPLETED|Overall Study||384
5369390|NCT00002874|13208615|P1|COMPLETED|Overall Study||376
5369391|NCT00002874|13208614|P2|STARTED|Overall Study||419
5369392|NCT00002874|13208615|P1|STARTED|Overall Study||421
5369393|NCT00002850|13208640|P3|NOT COMPLETED|Overall Study||4
5369394|NCT00002850|13208641|P2|NOT COMPLETED|Overall Study||2
5369395|NCT00002850|13208642|P1|NOT COMPLETED|Overall Study||5
5369396|NCT00002850|13208640|P3|COMPLETED|Overall Study||63
5369397|NCT00002850|13208641|P2|COMPLETED|Overall Study||74
5369398|NCT00002850|13208642|P1|COMPLETED|Overall Study||64
5369399|NCT00002850|13208640|P3|STARTED|Overall Study||67
5369400|NCT00002850|13208641|P2|STARTED|Overall Study||76
5369401|NCT00002850|13208642|P1|STARTED|Overall Study||69
5369402|NCT00002842|13208650|P1|NOT COMPLETED|Overall Study||27
5369403|NCT00002842|13208650|P1|COMPLETED|Overall Study||22
5369404|NCT00002842|13208650|P1|STARTED|Overall Study||49
5369405|NCT00002766|13208656|P2|NOT COMPLETED|Overall Study||4
5369406|NCT00002766|13208657|P1|NOT COMPLETED|Overall Study||3
5369407|NCT00002766|13208656|P2|COMPLETED|Overall Study||85
5369408|NCT00002766|13208657|P1|COMPLETED|Overall Study||78
5369409|NCT00002766|13208656|P2|STARTED|Overall Study||89
5369410|NCT00002766|13208657|P1|STARTED|Overall Study||81
5369411|NCT00002651|13208665|P3|NOT COMPLETED|Consolidation and Randomization||860
5369412|NCT00002651|13208666|P2|NOT COMPLETED|Consolidation and Randomization||838
5369413|NCT00002651|13208667|P1|NOT COMPLETED|Consolidation and Randomization||0
5369414|NCT00002651|13208665|P3|COMPLETED|Consolidation and Randomization||22
5369415|NCT00002651|13208666|P2|COMPLETED|Consolidation and Randomization||29
5369416|NCT00002651|13208667|P1|COMPLETED|Consolidation and Randomization||0
5369417|NCT00002651|13208665|P3|Assessable for Toxicity|Consolidation and Randomization||702
5369418|NCT00002651|13208666|P2|Assessable for Toxicity|Consolidation and Randomization||732
5369419|NCT00002651|13208667|P1|Assessable for Toxicity|Consolidation and Randomization||0
5369420|NCT00002651|13208665|P3|Eligible|Consolidation and Randomization||770
5369421|NCT00002651|13208666|P2|Eligible|Consolidation and Randomization||765
5369422|NCT00002651|13208667|P1|Eligible|Consolidation and Randomization||0
5369423|NCT00002651|13208665|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
5369424|NCT00002651|13208666|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
5369425|NCT00002651|13208667|P1|STARTED|Consolidation and Randomization||0
5369426|NCT00002651|13208665|P3|NOT COMPLETED|Induction||0
5369427|NCT00002651|13208666|P2|NOT COMPLETED|Induction||0
5369428|NCT00002651|13208667|P1|NOT COMPLETED|Induction||1343
5369429|NCT00002651|13208665|P3|COMPLETED|Induction||0
5369430|NCT00002651|13208666|P2|COMPLETED|Induction||0
5369431|NCT00002651|13208667|P1|COMPLETED|Induction||1697
5369432|NCT00002651|13208665|P3|Eligible and Began Protocol Therapy|Induction||0
5369433|NCT00002651|13208666|P2|Eligible and Began Protocol Therapy|Induction||0
5369434|NCT00002651|13208667|P1|Eligible and Began Protocol Therapy|Induction||2950
5369435|NCT00002651|13208665|P3|Eligible|Induction||0
5369436|NCT00002651|13208666|P2|Eligible|Induction||0
5369437|NCT00002651|13208667|P1|Eligible|Induction||2950
5369438|NCT00002651|13208665|P3|STARTED|Induction||0
5369439|NCT00002651|13208666|P2|STARTED|Induction||0
5369440|NCT00002651|13208667|P1|STARTED|Induction||3040
5369441|NCT00002558|13208685|P2|NOT COMPLETED|Overall Study||1
5369442|NCT00002558|13208686|P1|NOT COMPLETED|Overall Study||0
5369443|NCT00002558|13208685|P2|COMPLETED|Overall Study||15
5369444|NCT00002558|13208686|P1|COMPLETED|Overall Study||92
5369445|NCT00002558|13208685|P2|STARTED|Overall Study||16
5369446|NCT00002558|13208686|P1|STARTED|Overall Study||92
5369447|NCT00052078|13208696|P4|NOT COMPLETED|Overall Study||15
5369448|NCT00052078|13208697|P3|NOT COMPLETED|Overall Study||13
5369449|NCT00052078|13208698|P2|NOT COMPLETED|Overall Study||6
5369450|NCT00052078|13208699|P1|NOT COMPLETED|Overall Study||23
5369451|NCT00052078|13208696|P4|COMPLETED|Overall Study||61
5369452|NCT00052078|13208697|P3|COMPLETED|Overall Study||127
5369453|NCT00052078|13208698|P2|COMPLETED|Overall Study||133
5369454|NCT00052078|13208699|P1|COMPLETED|Overall Study||110
5369455|NCT00052078|13208696|P4|STARTED|Overall Study||76
5369456|NCT00052078|13208697|P3|STARTED|Overall Study||140
5369457|NCT00052078|13208698|P2|STARTED|Overall Study||139
5369458|NCT00052078|13208699|P1|STARTED|Overall Study||133
5369459|NCT00051636|13208711|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
5369460|NCT00051636|13208712|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
5369461|NCT00051636|13208711|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
5369462|NCT00051636|13208712|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
5369463|NCT00051636|13208711|P2|STARTED|Period 2- Extended Observation Period||52
5369464|NCT00051636|13208712|P1|STARTED|Period 2- Extended Observation Period||75
5369465|NCT00051636|13208711|P2|NOT COMPLETED|Period 1 - Core||6
5369466|NCT00051636|13208712|P1|NOT COMPLETED|Period 1 - Core||4
5369467|NCT00051636|13208711|P2|COMPLETED|Period 1 - Core||76
5369468|NCT00051636|13208712|P1|COMPLETED|Period 1 - Core||86
5369469|NCT00051636|13208711|P2|STARTED|Period 1 - Core||82
5369470|NCT00051636|13208712|P1|STARTED|Period 1 - Core||90
5369471|NCT00051558|13208740|P2|NOT COMPLETED|Overall Study||96
5369472|NCT00051558|13208741|P1|NOT COMPLETED|Overall Study||91
5369473|NCT00051558|13208740|P2|COMPLETED|Overall Study||118
5369474|NCT00051558|13208741|P1|COMPLETED|Overall Study||123
5369475|NCT00051558|13208740|P2|STARTED|Overall Study||214
5369476|NCT00051558|13208741|P1|STARTED|Overall Study||214
5369477|NCT00051363|13208777|P2|NOT COMPLETED|Overall Study||144
5369478|NCT00051363|13208778|P1|NOT COMPLETED|Overall Study||115
5369479|NCT00051363|13208777|P2|COMPLETED|Overall Study||403
5369480|NCT00051363|13208778|P1|COMPLETED|Overall Study||443
5369481|NCT00051363|13208777|P2|Completed 6M Vist On-Study|Overall Study||403
5369482|NCT00051363|13208778|P1|Completed 6M Vist On-Study|Overall Study||443
5369483|NCT00051363|13208777|P2|Completed 6M Visit On-Treatment|Overall Study||372
5369484|NCT00051363|13208778|P1|Completed 6M Visit On-Treatment|Overall Study||427
5369485|NCT00051363|13208777|P2|Completed 2M Visit On-Study|Overall Study||432
5369486|NCT00051363|13208778|P1|Completed 2M Visit On-Study|Overall Study||468
5369487|NCT00051363|13208777|P2|Completed 2M Visit On-Treatment|Overall Study||417
5369488|NCT00051363|13208778|P1|Completed 2M Visit On-Treatment|Overall Study||456
5369489|NCT00051363|13208777|P2|Randomized & Analyzed|Overall Study||542
5369490|NCT00051363|13208778|P1|Randomized & Analyzed|Overall Study||556
5369491|NCT00051363|13208777|P2|STARTED|Overall Study||547
5369492|NCT00051363|13208778|P1|STARTED|Overall Study||558
5369493|NCT00051168|13208812|P1|NOT COMPLETED|Overall Study||135
5369494|NCT00051168|13208812|P1|COMPLETED|Overall Study||367
5369495|NCT00051168|13208812|P1|STARTED|Overall Study||502
5369496|NCT00051025|13208818|P2|NOT COMPLETED|Overall Study||4
5369497|NCT00051025|13208819|P1|NOT COMPLETED|Overall Study||2
5369498|NCT00051025|13208818|P2|COMPLETED|Overall Study||0
5369499|NCT00051025|13208819|P1|COMPLETED|Overall Study||3
5369500|NCT00051025|13208818|P2|STARTED|Overall Study||4
5369501|NCT00051025|13208819|P1|STARTED|Overall Study||5
5369502|NCT00050986|13208827|P1|NOT COMPLETED|Overall Study||2
5369503|NCT00050986|13208827|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
5369504|NCT00050986|13208827|P1|STARTED|Overall Study||55
5369505|NCT00050960|13208833|P2|NOT COMPLETED|Overall Study||304
5369506|NCT00050960|13208834|P1|NOT COMPLETED|Overall Study||302
5369507|NCT00050960|13208833|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
5369508|NCT00050960|13208834|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
5369509|NCT00050960|13208833|P2|STARTED|Overall Study||306
5369510|NCT00050960|13208834|P1|STARTED|Overall Study||306
5369511|NCT00050778|13208843|P3|NOT COMPLETED|Overall Study||18
5369512|NCT00050778|13208844|P2|NOT COMPLETED|Overall Study||21
5369513|NCT00050778|13208845|P1|NOT COMPLETED|Overall Study||45
5369514|NCT00050778|13208843|P3|COMPLETED|Overall Study||92
5369515|NCT00050778|13208844|P2|COMPLETED|Overall Study||92
5369516|NCT00050778|13208845|P1|COMPLETED|Overall Study||66
5369517|NCT00050778|13208843|P3|Treated|Overall Study||108
5369518|NCT00050778|13208844|P2|Treated|Overall Study||108
5369519|NCT00050778|13208845|P1|Treated|Overall Study||107
5369520|NCT00050778|13208843|P3|STARTED|Overall Study||110
5369521|NCT00050778|13208844|P2|STARTED|Overall Study||113
5369522|NCT00050778|13208845|P1|STARTED|Overall Study|Randomized.|111
5369523|NCT00050622|13208871|P1|NOT COMPLETED|Overall Study||1
5369524|NCT00050622|13208871|P1|COMPLETED|Overall Study||153
5369525|NCT00050622|13208871|P1|STARTED|Overall Study||154
5369526|NCT00050167|13208909|P2|NOT COMPLETED|Overall Study||1
5369527|NCT00050167|13208910|P1|NOT COMPLETED|Overall Study||1
5369528|NCT00050167|13208909|P2|COMPLETED|Overall Study||300
5369529|NCT00050167|13208910|P1|COMPLETED|Overall Study||301
5369530|NCT00050167|13208909|P2|STARTED|Overall Study||301
5369531|NCT00050167|13208910|P1|STARTED|Overall Study||302
5369532|NCT00050089|13208920|P4|NOT COMPLETED|Overall Study||0
5369533|NCT00050089|13208921|P3|NOT COMPLETED|Overall Study||0
5369534|NCT00050089|13208922|P2|NOT COMPLETED|Overall Study||0
5369535|NCT00050089|13208923|P1|NOT COMPLETED|Overall Study||0
5369536|NCT00050089|13208920|P4|COMPLETED|Overall Study|For primary outcome assessment|78
5369537|NCT00050089|13208921|P3|COMPLETED|Overall Study|For primary outcome assessment|86
5369538|NCT00050089|13208922|P2|COMPLETED|Overall Study|For primary outcome assessment|98
5369539|NCT00050089|13208923|P1|COMPLETED|Overall Study|For primary outcome assessment|106
5369540|NCT00050089|13208920|P4|Baseline|Overall Study||78
5369541|NCT00050089|13208921|P3|Baseline|Overall Study||86
5369542|NCT00050089|13208922|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
5369543|NCT00050089|13208923|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
5369544|NCT00050089|13208920|P4|STARTED|Overall Study||78
5369545|NCT00050089|13208921|P3|STARTED|Overall Study||86
5369546|NCT00050089|13208922|P2|STARTED|Overall Study||98
5369547|NCT00050089|13208923|P1|STARTED|Overall Study||106
5369548|NCT00050011|13208943|P2|NOT COMPLETED|Overall Study||126
5369549|NCT00050011|13208944|P1|NOT COMPLETED|Overall Study||121
5369550|NCT00050011|13208943|P2|COMPLETED|Overall Study||175
5369551|NCT00050011|13208944|P1|COMPLETED|Overall Study||180
5369552|NCT00050011|13208943|P2|Intent-to-treat Population|Overall Study||300
5369553|NCT00050011|13208944|P1|Intent-to-treat Population|Overall Study||300
5369554|NCT00050011|13208943|P2|STARTED|Overall Study||301
5369555|NCT00050011|13208944|P1|STARTED|Overall Study||301
5369556|NCT00049842|13208966|P2|NOT COMPLETED|Follow-up Phase||5
5369557|NCT00049842|13208967|P1|NOT COMPLETED|Follow-up Phase||7
5369558|NCT00049842|13208966|P2|COMPLETED|Follow-up Phase||189
5369559|NCT00049842|13208967|P1|COMPLETED|Follow-up Phase||211
5369560|NCT00049842|13208966|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
5369561|NCT00049842|13208967|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
5369562|NCT00049842|13208966|P2|NOT COMPLETED|Treatment Phase||78
5369563|NCT00049842|13208967|P1|NOT COMPLETED|Treatment Phase||93
5369564|NCT00049842|13208966|P2|COMPLETED|Treatment Phase||192
5369565|NCT00049842|13208967|P1|COMPLETED|Treatment Phase||177
5369566|NCT00049842|13208966|P2|STARTED|Treatment Phase||270
5369567|NCT00049842|13208967|P1|STARTED|Treatment Phase||270
5369568|NCT00048932|13208985|P3|NOT COMPLETED|Open Label Period (OL)||441
5369569|NCT00048932|13208986|P2|NOT COMPLETED|Open Label Period (OL)||0
5369570|NCT00048932|13208987|P1|NOT COMPLETED|Open Label Period (OL)||0
5369571|NCT00048932|13208985|P3|COMPLETED|Open Label Period (OL)||743
5369572|NCT00048932|13208986|P2|COMPLETED|Open Label Period (OL)||0
5369573|NCT00048932|13208987|P1|COMPLETED|Open Label Period (OL)||0
5369574|NCT00048932|13208985|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
5369575|NCT00048932|13208986|P2|STARTED|Open Label Period (OL)||0
5369576|NCT00048932|13208987|P1|STARTED|Open Label Period (OL)||0
5369577|NCT00048932|13208985|P3|NOT COMPLETED|Double Blind Period (DB)||0
5369578|NCT00048932|13208986|P2|NOT COMPLETED|Double Blind Period (DB)||87
5369579|NCT00048932|13208987|P1|NOT COMPLETED|Double Blind Period (DB)||123
5369580|NCT00048932|13208985|P3|COMPLETED|Double Blind Period (DB)||0
5369581|NCT00048932|13208986|P2|COMPLETED|Double Blind Period (DB)||395
5369582|NCT00048932|13208987|P1|COMPLETED|Double Blind Period (DB)||836
5369583|NCT00048932|13208985|P3|STARTED|Double Blind Period (DB)||0
5369584|NCT00048932|13208986|P2|STARTED|Double Blind Period (DB)|Number Treated|482
5369585|NCT00048932|13208987|P1|STARTED|Double Blind Period (DB)|Number Treated|959
5369586|NCT00048815|13209014|P3|NOT COMPLETED|Overall Study||4
5369587|NCT00048815|13209015|P2|NOT COMPLETED|Overall Study||4
5369588|NCT00048815|13209016|P1|NOT COMPLETED|Overall Study||6
5369589|NCT00048815|13209014|P3|COMPLETED|Overall Study||19
5369590|NCT00048815|13209015|P2|COMPLETED|Overall Study||22
5369591|NCT00048815|13209016|P1|COMPLETED|Overall Study||18
5369592|NCT00048815|13209014|P3|STARTED|Overall Study||23
5369593|NCT00048815|13209015|P2|STARTED|Overall Study||26
5369594|NCT00048815|13209016|P1|STARTED|Overall Study||24
5369595|NCT00048581|13209029|P3|NOT COMPLETED|Open-Label Period||167
5369596|NCT00048581|13209030|P2|NOT COMPLETED|Open-Label Period||0
5369597|NCT00048581|13209031|P1|NOT COMPLETED|Open-Label Period||0
5369598|NCT00048581|13209029|P3|COMPLETED|Open-Label Period||150
5369599|NCT00048581|13209030|P2|COMPLETED|Open-Label Period||0
5369600|NCT00048581|13209031|P1|COMPLETED|Open-Label Period||0
5369601|NCT00048581|13209029|P3|STARTED|Open-Label Period||317
5369602|NCT00048581|13209030|P2|STARTED|Open-Label Period||0
5369603|NCT00048581|13209031|P1|STARTED|Open-Label Period||0
5369604|NCT00048581|13209029|P3|NOT COMPLETED|Double-Blind Period||0
5369605|NCT00048581|13209030|P2|NOT COMPLETED|Double-Blind Period||34
5369606|NCT00048581|13209031|P1|NOT COMPLETED|Double-Blind Period||35
5369607|NCT00048581|13209029|P3|COMPLETED|Double-Blind Period||0
5369608|NCT00048581|13209030|P2|COMPLETED|Double-Blind Period||99
5369609|NCT00048581|13209031|P1|COMPLETED|Double-Blind Period||223
5369610|NCT00048581|13209029|P3|STARTED|Double-Blind Period||0
5369611|NCT00048581|13209030|P2|STARTED|Double-Blind Period||133
5369612|NCT00048581|13209031|P1|STARTED|Double-Blind Period||258
5369613|NCT00048568|13209198|P3|NOT COMPLETED|Open-Label Period||160
5369614|NCT00048568|13209199|P2|NOT COMPLETED|Open-Label Period||0
5369615|NCT00048568|13209200|P1|NOT COMPLETED|Open-Label Period||0
5369616|NCT00048568|13209198|P3|COMPLETED|Open-Label Period||379
5369617|NCT00048568|13209199|P2|COMPLETED|Open-Label Period||0
5369618|NCT00048568|13209200|P1|COMPLETED|Open-Label Period||0
5369619|NCT00048568|13209198|P3|STARTED|Open-Label Period||539
5369620|NCT00048568|13209199|P2|STARTED|Open-Label Period||0
5369621|NCT00048568|13209200|P1|STARTED|Open-Label Period||0
5369622|NCT00048568|13209198|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
5369623|NCT00048568|13209199|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
5369624|NCT00048568|13209200|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
5369625|NCT00048568|13209198|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
5369626|NCT00048568|13209199|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
5369627|NCT00048568|13209200|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
5369628|NCT00048568|13209198|P3|STARTED|Double-Blind Period Days 170 to 365||0
5369629|NCT00048568|13209199|P2|STARTED|Double-Blind Period Days 170 to 365||174
5369630|NCT00048568|13209200|P1|STARTED|Double-Blind Period Days 170 to 365||401
5369631|NCT00048568|13209198|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
5369632|NCT00048568|13209199|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
5369633|NCT00048568|13209200|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
5369634|NCT00048568|13209198|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
5369635|NCT00048568|13209199|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
5369636|NCT00048568|13209200|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
5369637|NCT00048568|13209198|P3|STARTED|Double-Blind Period Days 1 to 169||0
5369638|NCT00048568|13209199|P2|STARTED|Double-Blind Period Days 1 to 169||219
5369639|NCT00048568|13209200|P1|STARTED|Double-Blind Period Days 1 to 169||433
5369640|NCT00048893|13209488|P1|NOT COMPLETED|Overall Study||0
5369641|NCT00048893|13209488|P1|COMPLETED|Overall Study||37
5369642|NCT00048893|13209488|P1|STARTED|Overall Study||37
5369643|NCT00048737|13209499|P1|NOT COMPLETED|Overall Study||0
5369644|NCT00048737|13209499|P1|COMPLETED|Overall Study||70
5369645|NCT00048737|13209499|P1|STARTED|Overall Study||70
5369646|NCT00048724|13209505|P2|NOT COMPLETED|Overall Study||118
5369647|NCT00048724|13209506|P1|NOT COMPLETED|Overall Study||116
5369648|NCT00048724|13209505|P2|COMPLETED|Overall Study||197
5369649|NCT00048724|13209506|P1|COMPLETED|Overall Study||195
5369650|NCT00048724|13209505|P2|STARTED|Overall Study||315
5369651|NCT00048724|13209506|P1|STARTED|Overall Study||311
5369652|NCT00048542|13209518|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
5369653|NCT00048542|13209519|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
5369654|NCT00048542|13209520|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369655|NCT00048542|13209521|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369656|NCT00048542|13209522|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369657|NCT00048542|13209523|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369658|NCT00048542|13209524|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369659|NCT00048542|13209525|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369660|NCT00048542|13209518|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
5369661|NCT00048542|13209519|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
5369662|NCT00048542|13209520|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369663|NCT00048542|13209521|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369664|NCT00048542|13209522|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369665|NCT00048542|13209523|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369666|NCT00048542|13209524|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369667|NCT00048542|13209525|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
5369668|NCT00048542|13209518|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
5369669|NCT00048542|13209519|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
5369670|NCT00048542|13209520|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
5369671|NCT00048542|13209521|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
5369672|NCT00048542|13209522|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
5369673|NCT00048542|13209523|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
5369674|NCT00048542|13209524|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
5369675|NCT00048542|13209525|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
5369676|NCT00048542|13209518|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369677|NCT00048542|13209519|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369678|NCT00048542|13209520|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
5369679|NCT00048542|13209521|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
5369680|NCT00048542|13209522|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369681|NCT00048542|13209523|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369682|NCT00048542|13209524|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369683|NCT00048542|13209525|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
5369684|NCT00048542|13209518|P8|COMPLETED|Open-Label Extension BSA Phase||0
5369685|NCT00048542|13209519|P7|COMPLETED|Open-Label Extension BSA Phase||0
5369686|NCT00048542|13209520|P6|COMPLETED|Open-Label Extension BSA Phase||47
5369687|NCT00048542|13209521|P5|COMPLETED|Open-Label Extension BSA Phase||59
5369688|NCT00048542|13209522|P4|COMPLETED|Open-Label Extension BSA Phase||0
5369689|NCT00048542|13209523|P3|COMPLETED|Open-Label Extension BSA Phase||0
5369690|NCT00048542|13209524|P2|COMPLETED|Open-Label Extension BSA Phase||0
5369691|NCT00048542|13209525|P1|COMPLETED|Open-Label Extension BSA Phase||0
5369692|NCT00048542|13209518|P8|STARTED|Open-Label Extension BSA Phase||0
5369693|NCT00048542|13209519|P7|STARTED|Open-Label Extension BSA Phase||0
5369694|NCT00048542|13209520|P6|STARTED|Open-Label Extension BSA Phase||57
5369695|NCT00048542|13209521|P5|STARTED|Open-Label Extension BSA Phase||71
5369696|NCT00048542|13209522|P4|STARTED|Open-Label Extension BSA Phase||0
5369697|NCT00048542|13209523|P3|STARTED|Open-Label Extension BSA Phase||0
5369698|NCT00048542|13209524|P2|STARTED|Open-Label Extension BSA Phase||0
5369699|NCT00048542|13209525|P1|STARTED|Open-Label Extension BSA Phase||0
5369700|NCT00048542|13209518|P8|NOT COMPLETED|Double-Blind Phase||0
5369701|NCT00048542|13209519|P7|NOT COMPLETED|Double-Blind Phase||0
5369702|NCT00048542|13209520|P6|NOT COMPLETED|Double-Blind Phase||0
5369703|NCT00048542|13209521|P5|NOT COMPLETED|Double-Blind Phase||0
5369704|NCT00048542|13209522|P4|NOT COMPLETED|Double-Blind Phase||0
5369705|NCT00048542|13209523|P3|NOT COMPLETED|Double-Blind Phase||1
5369706|NCT00048542|13209524|P2|NOT COMPLETED|Double-Blind Phase||1
5369707|NCT00048542|13209525|P1|NOT COMPLETED|Double-Blind Phase||3
5369708|NCT00048542|13209518|P8|COMPLETED|Double-Blind Phase||0
5369709|NCT00048542|13209519|P7|COMPLETED|Double-Blind Phase||0
5369710|NCT00048542|13209520|P6|COMPLETED|Double-Blind Phase||0
5369711|NCT00048542|13209521|P5|COMPLETED|Double-Blind Phase||0
5369712|NCT00048542|13209522|P4|COMPLETED|Double-Blind Phase||28
5369713|NCT00048542|13209523|P3|COMPLETED|Double-Blind Phase||29
5369714|NCT00048542|13209524|P2|COMPLETED|Double-Blind Phase||36
5369715|NCT00048542|13209525|P1|COMPLETED|Double-Blind Phase||35
5369716|NCT00048542|13209518|P8|STARTED|Double-Blind Phase||0
5369717|NCT00048542|13209519|P7|STARTED|Double-Blind Phase||0
5369718|NCT00048542|13209520|P6|STARTED|Double-Blind Phase||0
5369719|NCT00048542|13209521|P5|STARTED|Double-Blind Phase||0
5369720|NCT00048542|13209522|P4|STARTED|Double-Blind Phase||28
5369721|NCT00048542|13209523|P3|STARTED|Double-Blind Phase||30
5369722|NCT00048542|13209524|P2|STARTED|Double-Blind Phase||37
5369723|NCT00048542|13209525|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
5369724|NCT00048347|13209591|P1|NOT COMPLETED|Overall Study||2
5369725|NCT00048347|13209591|P1|COMPLETED|Overall Study||16
5369726|NCT00048347|13209591|P1|STARTED|Overall Study||18
5369727|NCT00048165|13209597|P2|NOT COMPLETED|Completed 12 Months Study||3
5369728|NCT00048165|13209598|P1|NOT COMPLETED|Completed 12 Months Study||3
5369729|NCT00048165|13209597|P2|COMPLETED|Completed 12 Months Study||167
5369730|NCT00048165|13209598|P1|COMPLETED|Completed 12 Months Study||162
5369731|NCT00048165|13209597|P2|STARTED|Completed 12 Months Study||170
5369732|NCT00048165|13209598|P1|STARTED|Completed 12 Months Study||165
5369733|NCT00048165|13209597|P2|NOT COMPLETED|Completed 6 Months Study||48
5369734|NCT00048165|13209598|P1|NOT COMPLETED|Completed 6 Months Study||51
5369735|NCT00048165|13209597|P2|COMPLETED|Completed 6 Months Study||170
5369736|NCT00048165|13209598|P1|COMPLETED|Completed 6 Months Study||165
5369737|NCT00048165|13209597|P2|STARTED|Completed 6 Months Study||218
5369738|NCT00048165|13209598|P1|STARTED|Completed 6 Months Study||216
5369739|NCT00048074|13209633|P3|NOT COMPLETED|Overall Study||97
5369740|NCT00048074|13209634|P2|NOT COMPLETED|Overall Study||87
5369741|NCT00048074|13209635|P1|NOT COMPLETED|Overall Study||81
5369742|NCT00048074|13209633|P3|COMPLETED|Overall Study||372
5369743|NCT00048074|13209634|P2|COMPLETED|Overall Study||361
5369744|NCT00048074|13209635|P1|COMPLETED|Overall Study||384
5369745|NCT00048074|13209633|P3|STARTED|Overall Study||469
5369746|NCT00048074|13209634|P2|STARTED|Overall Study||448
5369747|NCT00048074|13209635|P1|STARTED|Overall Study||465
5369748|NCT00048061|13209692|P4|NOT COMPLETED|Overall Study||79
5369749|NCT00048061|13209693|P3|NOT COMPLETED|Overall Study||84
5369750|NCT00048061|13209694|P2|NOT COMPLETED|Overall Study||73
5369751|NCT00048061|13209695|P1|NOT COMPLETED|Overall Study||75
5369752|NCT00048061|13209692|P4|COMPLETED|Overall Study||322
5369753|NCT00048061|13209693|P3|COMPLETED|Overall Study||316
5369754|NCT00048061|13209694|P2|COMPLETED|Overall Study||328
5369755|NCT00048061|13209695|P1|COMPLETED|Overall Study||325
5369756|NCT00048061|13209692|P4|STARTED|Overall Study||401
5369757|NCT00048061|13209693|P3|STARTED|Overall Study||400
5369758|NCT00048061|13209694|P2|STARTED|Overall Study||401
5369759|NCT00048061|13209695|P1|STARTED|Overall Study||400
5369760|NCT00048048|13209774|P12|NOT COMPLETED|Extension Year 2||2
5369761|NCT00048048|13209775|P11|NOT COMPLETED|Extension Year 2||4
5369762|NCT00048048|13209776|P10|NOT COMPLETED|Extension Year 2||0
5369763|NCT00048048|13209777|P9|NOT COMPLETED|Extension Year 2||0
5369764|NCT00048048|13209778|P8|NOT COMPLETED|Extension Year 2||0
5369765|NCT00048048|13209779|P7|NOT COMPLETED|Extension Year 2||0
5369766|NCT00048048|13209780|P6|NOT COMPLETED|Extension Year 2||0
5369767|NCT00048048|13209781|P5|NOT COMPLETED|Extension Year 2||0
5369768|NCT00048048|13209782|P4|NOT COMPLETED|Extension Year 2||0
5369769|NCT00048048|13209783|P3|NOT COMPLETED|Extension Year 2||0
5369770|NCT00048048|13209784|P2|NOT COMPLETED|Extension Year 2||0
5369771|NCT00048048|13209785|P1|NOT COMPLETED|Extension Year 2||0
5369772|NCT00048048|13209774|P12|COMPLETED|Extension Year 2||13
5369773|NCT00048048|13209775|P11|COMPLETED|Extension Year 2||19
5369774|NCT00048048|13209776|P10|COMPLETED|Extension Year 2||2
5369775|NCT00048048|13209777|P9|COMPLETED|Extension Year 2||0
5369776|NCT00048048|13209778|P8|COMPLETED|Extension Year 2||0
5369777|NCT00048048|13209779|P7|COMPLETED|Extension Year 2||0
5369778|NCT00048048|13209780|P6|COMPLETED|Extension Year 2||0
5369779|NCT00048048|13209781|P5|COMPLETED|Extension Year 2||0
5369780|NCT00048048|13209782|P4|COMPLETED|Extension Year 2||0
5369781|NCT00048048|13209783|P3|COMPLETED|Extension Year 2||0
5369782|NCT00048048|13209784|P2|COMPLETED|Extension Year 2||0
5369783|NCT00048048|13209785|P1|COMPLETED|Extension Year 2||0
5369784|NCT00048048|13209774|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
5369785|NCT00048048|13209775|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
5369786|NCT00048048|13209776|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
5369787|NCT00048048|13209777|P9|STARTED|Extension Year 2||0
5369788|NCT00048048|13209778|P8|STARTED|Extension Year 2||0
5369789|NCT00048048|13209779|P7|STARTED|Extension Year 2||0
5369790|NCT00048048|13209780|P6|STARTED|Extension Year 2||0
5369791|NCT00048048|13209781|P5|STARTED|Extension Year 2||0
5369792|NCT00048048|13209782|P4|STARTED|Extension Year 2||0
5369793|NCT00048048|13209783|P3|STARTED|Extension Year 2||0
5369794|NCT00048048|13209784|P2|STARTED|Extension Year 2||0
5369795|NCT00048048|13209785|P1|STARTED|Extension Year 2||0
5369796|NCT00048048|13209774|P12|NOT COMPLETED|Extension Year 1||4
5369797|NCT00048048|13209775|P11|NOT COMPLETED|Extension Year 1||2
5369798|NCT00048048|13209776|P10|NOT COMPLETED|Extension Year 1||2
5369799|NCT00048048|13209777|P9|NOT COMPLETED|Extension Year 1||0
5369800|NCT00048048|13209778|P8|NOT COMPLETED|Extension Year 1||0
5369801|NCT00048048|13209779|P7|NOT COMPLETED|Extension Year 1||0
5369802|NCT00048048|13209780|P6|NOT COMPLETED|Extension Year 1||0
5369803|NCT00048048|13209781|P5|NOT COMPLETED|Extension Year 1||0
5369804|NCT00048048|13209782|P4|NOT COMPLETED|Extension Year 1||0
5369805|NCT00048048|13209783|P3|NOT COMPLETED|Extension Year 1||0
5369806|NCT00048048|13209784|P2|NOT COMPLETED|Extension Year 1||0
5369807|NCT00048048|13209785|P1|NOT COMPLETED|Extension Year 1||0
5369808|NCT00048048|13209774|P12|COMPLETED|Extension Year 1||15
5369809|NCT00048048|13209775|P11|COMPLETED|Extension Year 1||14
5369810|NCT00048048|13209776|P10|COMPLETED|Extension Year 1||14
5369811|NCT00048048|13209777|P9|COMPLETED|Extension Year 1||0
5369812|NCT00048048|13209778|P8|COMPLETED|Extension Year 1||0
5369813|NCT00048048|13209779|P7|COMPLETED|Extension Year 1||0
5369814|NCT00048048|13209780|P6|COMPLETED|Extension Year 1||0
5369815|NCT00048048|13209781|P5|COMPLETED|Extension Year 1||0
5369816|NCT00048048|13209782|P4|COMPLETED|Extension Year 1||0
5369817|NCT00048048|13209783|P3|COMPLETED|Extension Year 1||0
5369818|NCT00048048|13209784|P2|COMPLETED|Extension Year 1||0
5369819|NCT00048048|13209785|P1|COMPLETED|Extension Year 1||0
5369820|NCT00048048|13209774|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
5369821|NCT00048048|13209775|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
5369822|NCT00048048|13209776|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
5369823|NCT00048048|13209777|P9|STARTED|Extension Year 1||0
5369824|NCT00048048|13209778|P8|STARTED|Extension Year 1||0
5369825|NCT00048048|13209779|P7|STARTED|Extension Year 1||0
5369826|NCT00048048|13209780|P6|STARTED|Extension Year 1||0
5369827|NCT00048048|13209781|P5|STARTED|Extension Year 1||0
5369828|NCT00048048|13209782|P4|STARTED|Extension Year 1||0
5369829|NCT00048048|13209783|P3|STARTED|Extension Year 1||0
5369830|NCT00048048|13209784|P2|STARTED|Extension Year 1||0
5369831|NCT00048048|13209785|P1|STARTED|Extension Year 1||0
5369832|NCT00048048|13209774|P12|NOT COMPLETED|Core Treatment||0
5369833|NCT00048048|13209775|P11|NOT COMPLETED|Core Treatment||0
5369834|NCT00048048|13209776|P10|NOT COMPLETED|Core Treatment||0
5369835|NCT00048048|13209777|P9|NOT COMPLETED|Core Treatment||0
5369836|NCT00048048|13209778|P8|NOT COMPLETED|Core Treatment||1
5369837|NCT00048048|13209779|P7|NOT COMPLETED|Core Treatment||0
5369838|NCT00048048|13209780|P6|NOT COMPLETED|Core Treatment||0
5369839|NCT00048048|13209781|P5|NOT COMPLETED|Core Treatment||0
5369840|NCT00048048|13209782|P4|NOT COMPLETED|Core Treatment||0
5369841|NCT00048048|13209783|P3|NOT COMPLETED|Core Treatment||1
5369842|NCT00048048|13209784|P2|NOT COMPLETED|Core Treatment||0
5369843|NCT00048048|13209785|P1|NOT COMPLETED|Core Treatment||0
5369844|NCT00048048|13209774|P12|COMPLETED|Core Treatment||0
5369845|NCT00048048|13209775|P11|COMPLETED|Core Treatment||0
5369846|NCT00048048|13209776|P10|COMPLETED|Core Treatment||0
5369847|NCT00048048|13209777|P9|COMPLETED|Core Treatment||10
5369848|NCT00048048|13209778|P8|COMPLETED|Core Treatment||5
5369849|NCT00048048|13209779|P7|COMPLETED|Core Treatment||6
5369850|NCT00048048|13209780|P6|COMPLETED|Core Treatment||9
5369851|NCT00048048|13209781|P5|COMPLETED|Core Treatment||6
5369852|NCT00048048|13209782|P4|COMPLETED|Core Treatment||6
5369853|NCT00048048|13209783|P3|COMPLETED|Core Treatment||9
5369854|NCT00048048|13209784|P2|COMPLETED|Core Treatment||6
5369855|NCT00048048|13209785|P1|COMPLETED|Core Treatment||6
5369856|NCT00048048|13209774|P12|STARTED|Core Treatment||0
5369857|NCT00048048|13209775|P11|STARTED|Core Treatment||0
5369858|NCT00048048|13209776|P10|STARTED|Core Treatment||0
5369859|NCT00048048|13209777|P9|STARTED|Core Treatment||10
5369860|NCT00048048|13209778|P8|STARTED|Core Treatment||6
5369861|NCT00048048|13209779|P7|STARTED|Core Treatment||6
5369862|NCT00048048|13209780|P6|STARTED|Core Treatment||9
5369863|NCT00048048|13209781|P5|STARTED|Core Treatment||6
5369864|NCT00048048|13209782|P4|STARTED|Core Treatment||6
5369865|NCT00048048|13209783|P3|STARTED|Core Treatment||10
5369866|NCT00048048|13209784|P2|STARTED|Core Treatment||6
5369867|NCT00048048|13209785|P1|STARTED|Core Treatment||6
5369868|NCT00048035|13209841|P8|NOT COMPLETED|Extension Year 2||3
5369869|NCT00048035|13209842|P7|NOT COMPLETED|Extension Year 2||3
5369870|NCT00048035|13209843|P6|NOT COMPLETED|Extension Year 2||0
5369871|NCT00048035|13209844|P5|NOT COMPLETED|Extension Year 2||0
5369872|NCT00048035|13209845|P4|NOT COMPLETED|Extension Year 2||0
5369873|NCT00048035|13209846|P3|NOT COMPLETED|Extension Year 2||0
5369874|NCT00048035|13209847|P2|NOT COMPLETED|Extension Year 2||0
5369875|NCT00048035|13209848|P1|NOT COMPLETED|Extension Year 2||0
5369876|NCT00048035|13209841|P8|COMPLETED|Extension Year 2||10
5369877|NCT00048035|13209842|P7|COMPLETED|Extension Year 2||11
5369878|NCT00048035|13209843|P6|COMPLETED|Extension Year 2||0
5369879|NCT00048035|13209844|P5|COMPLETED|Extension Year 2||0
5369880|NCT00048035|13209845|P4|COMPLETED|Extension Year 2||0
5369881|NCT00048035|13209846|P3|COMPLETED|Extension Year 2||0
5369882|NCT00048035|13209847|P2|COMPLETED|Extension Year 2||0
5369883|NCT00048035|13209848|P1|COMPLETED|Extension Year 2||0
5369884|NCT00048035|13209841|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
5369885|NCT00048035|13209842|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
5369886|NCT00048035|13209843|P6|STARTED|Extension Year 2||0
5369887|NCT00048035|13209844|P5|STARTED|Extension Year 2||0
5369888|NCT00048035|13209845|P4|STARTED|Extension Year 2||0
5369889|NCT00048035|13209846|P3|STARTED|Extension Year 2||0
5369890|NCT00048035|13209847|P2|STARTED|Extension Year 2||0
5369891|NCT00048035|13209848|P1|STARTED|Extension Year 2||0
5369892|NCT00048035|13209841|P8|NOT COMPLETED|Extension Year 1||11
5369893|NCT00048035|13209842|P7|NOT COMPLETED|Extension Year 1||11
5369894|NCT00048035|13209843|P6|NOT COMPLETED|Extension Year 1||0
5369895|NCT00048035|13209844|P5|NOT COMPLETED|Extension Year 1||0
5369896|NCT00048035|13209845|P4|NOT COMPLETED|Extension Year 1||0
5369897|NCT00048035|13209846|P3|NOT COMPLETED|Extension Year 1||0
5369898|NCT00048035|13209847|P2|NOT COMPLETED|Extension Year 1||0
5369899|NCT00048035|13209848|P1|NOT COMPLETED|Extension Year 1||0
5369900|NCT00048035|13209841|P8|COMPLETED|Extension Year 1||15
5369901|NCT00048035|13209842|P7|COMPLETED|Extension Year 1||16
5369902|NCT00048035|13209843|P6|COMPLETED|Extension Year 1||0
5369903|NCT00048035|13209844|P5|COMPLETED|Extension Year 1||0
5369904|NCT00048035|13209845|P4|COMPLETED|Extension Year 1||0
5369905|NCT00048035|13209846|P3|COMPLETED|Extension Year 1||0
5369906|NCT00048035|13209847|P2|COMPLETED|Extension Year 1||0
5369907|NCT00048035|13209848|P1|COMPLETED|Extension Year 1||0
5369908|NCT00048035|13209841|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
5369909|NCT00048035|13209842|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
5369910|NCT00048035|13209843|P6|STARTED|Extension Year 1||0
5369911|NCT00048035|13209844|P5|STARTED|Extension Year 1||0
5369912|NCT00048035|13209845|P4|STARTED|Extension Year 1||0
5369913|NCT00048035|13209846|P3|STARTED|Extension Year 1||0
5369914|NCT00048035|13209847|P2|STARTED|Extension Year 1||0
5369915|NCT00048035|13209848|P1|STARTED|Extension Year 1||0
5369916|NCT00048035|13209841|P8|NOT COMPLETED|Core Period||0
5369917|NCT00048035|13209842|P7|NOT COMPLETED|Core Period||0
5369918|NCT00048035|13209843|P6|NOT COMPLETED|Core Period||1
5369919|NCT00048035|13209844|P5|NOT COMPLETED|Core Period||1
5369920|NCT00048035|13209845|P4|NOT COMPLETED|Core Period||1
5369921|NCT00048035|13209846|P3|NOT COMPLETED|Core Period||1
5369922|NCT00048035|13209847|P2|NOT COMPLETED|Core Period||2
5369923|NCT00048035|13209848|P1|NOT COMPLETED|Core Period||4
5369924|NCT00048035|13209841|P8|COMPLETED|Core Period||0
5369925|NCT00048035|13209842|P7|COMPLETED|Core Period||0
5369926|NCT00048035|13209843|P6|COMPLETED|Core Period||14
5369927|NCT00048035|13209844|P5|COMPLETED|Core Period||15
5369928|NCT00048035|13209845|P4|COMPLETED|Core Period||14
5369929|NCT00048035|13209846|P3|COMPLETED|Core Period||14
5369930|NCT00048035|13209847|P2|COMPLETED|Core Period||13
5369931|NCT00048035|13209848|P1|COMPLETED|Core Period||11
5369932|NCT00048035|13209841|P8|STARTED|Core Period||0
5369933|NCT00048035|13209842|P7|STARTED|Core Period||0
5369934|NCT00048035|13209843|P6|STARTED|Core Period||15
5369935|NCT00048035|13209844|P5|STARTED|Core Period||16
5369936|NCT00048035|13209845|P4|STARTED|Core Period||15
5369937|NCT00048035|13209846|P3|STARTED|Core Period||15
5369938|NCT00048035|13209847|P2|STARTED|Core Period||15
5369939|NCT00048035|13209848|P1|STARTED|Core Period||15
5369940|NCT00047879|13209886|P2|NOT COMPLETED|Overall Study||3
5369941|NCT00047879|13209887|P1|NOT COMPLETED|Overall Study||4
5369942|NCT00047879|13209886|P2|COMPLETED|Overall Study||0
5369943|NCT00047879|13209887|P1|COMPLETED|Overall Study||0
5369944|NCT00047879|13209886|P2|STARTED|Overall Study||3
5369945|NCT00047879|13209887|P1|STARTED|Overall Study||4
5369946|NCT00047697|13209899|P2|NOT COMPLETED|Overall Study||2
5369947|NCT00047697|13209900|P1|NOT COMPLETED|Overall Study||0
5369948|NCT00047697|13209899|P2|COMPLETED|Overall Study||14
5369949|NCT00047697|13209900|P1|COMPLETED|Overall Study||18
5369950|NCT00047697|13209899|P2|STARTED|Overall Study||16
5369951|NCT00047697|13209900|P1|STARTED|Overall Study||18
5369952|NCT00047619|13209912|P2|NOT COMPLETED|Overall Study||0
5369953|NCT00047619|13209913|P1|NOT COMPLETED|Overall Study||0
5369954|NCT00047619|13209912|P2|COMPLETED|Overall Study||14
5369955|NCT00047619|13209913|P1|COMPLETED|Overall Study||14
5369956|NCT00047619|13209912|P2|STARTED|Overall Study||14
5369957|NCT00047619|13209913|P1|STARTED|Overall Study||14
5369958|NCT00047463|13209923|P2|NOT COMPLETED|Overall Study||3
5369959|NCT00047463|13209924|P1|NOT COMPLETED|Overall Study||0
5369960|NCT00047463|13209923|P2|COMPLETED|Overall Study||19
5369961|NCT00047463|13209924|P1|COMPLETED|Overall Study||13
5369962|NCT00047463|13209923|P2|STARTED|Overall Study||22
5369963|NCT00047463|13209924|P1|STARTED|Overall Study||13
5369964|NCT00046475|13209935|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
5369965|NCT00046475|13209936|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
5369966|NCT00046475|13209937|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
5369967|NCT00046475|13209935|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
5369968|NCT00046475|13209936|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
5369969|NCT00046475|13209937|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
5369970|NCT00046475|13209935|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
5369971|NCT00046475|13209936|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
5369972|NCT00046475|13209937|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
5369973|NCT00046475|13209935|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
5369974|NCT00046475|13209936|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
5369975|NCT00046475|13209937|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
5369976|NCT00046475|13209935|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
5369977|NCT00046475|13209936|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
5369978|NCT00046475|13209937|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
5369979|NCT00046475|13209935|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
5369980|NCT00046475|13209936|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
5369981|NCT00046475|13209937|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
5369982|NCT00046475|13209935|P3|NOT COMPLETED|Titration (1 Week)||0
5369983|NCT00046475|13209936|P2|NOT COMPLETED|Titration (1 Week)||0
5369984|NCT00046475|13209937|P1|NOT COMPLETED|Titration (1 Week)||0
5369985|NCT00046475|13209935|P3|COMPLETED|Titration (1 Week)||0
5369986|NCT00046475|13209936|P2|COMPLETED|Titration (1 Week)||0
5369987|NCT00046475|13209937|P1|COMPLETED|Titration (1 Week)||136
5369988|NCT00046475|13209935|P3|STARTED|Titration (1 Week)||0
5369989|NCT00046475|13209936|P2|STARTED|Titration (1 Week)||0
5369990|NCT00046475|13209937|P1|STARTED|Titration (1 Week)||136
5369991|NCT00046475|13209935|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
5369992|NCT00046475|13209936|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
5369993|NCT00046475|13209937|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
5369994|NCT00046475|13209935|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
5369995|NCT00046475|13209936|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
5369996|NCT00046475|13209937|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
5369997|NCT00046475|13209935|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
5369998|NCT00046475|13209936|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
5369999|NCT00046475|13209937|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
5370000|NCT00046566|13209976|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5370001|NCT00046566|13209977|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5370002|NCT00046566|13209978|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
5370003|NCT00046566|13209976|P3|COMPLETED|Intervention 3 (8 Weeks)||88
5370004|NCT00046566|13209977|P2|COMPLETED|Intervention 3 (8 Weeks)||92
5370005|NCT00046566|13209978|P1|COMPLETED|Intervention 3 (8 Weeks)||93
5370006|NCT00046566|13209976|P3|STARTED|Intervention 3 (8 Weeks)||88
5370007|NCT00046566|13209977|P2|STARTED|Intervention 3 (8 Weeks)||92
5370008|NCT00046566|13209978|P1|STARTED|Intervention 3 (8 Weeks)||93
5370009|NCT00046566|13209976|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
5370010|NCT00046566|13209977|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
5370011|NCT00046566|13209978|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
5370012|NCT00046566|13209976|P3|COMPLETED|Intervention 2 (8 Weeks)||88
5370013|NCT00046566|13209977|P2|COMPLETED|Intervention 2 (8 Weeks)||92
5370014|NCT00046566|13209978|P1|COMPLETED|Intervention 2 (8 Weeks)||93
5370015|NCT00046566|13209976|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
5370016|NCT00046566|13209977|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
5370017|NCT00046566|13209978|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
5370018|NCT00046566|13209976|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
5370019|NCT00046566|13209977|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
5370020|NCT00046566|13209978|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
5370021|NCT00046566|13209976|P3|COMPLETED|Intervention 1 (8 Weeks)||101
5370022|NCT00046566|13209977|P2|COMPLETED|Intervention 1 (8 Weeks)||104
5370023|NCT00046566|13209978|P1|COMPLETED|Intervention 1 (8 Weeks)||101
5370024|NCT00046566|13209976|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
5370025|NCT00046566|13209977|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
5370026|NCT00046566|13209978|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
5370027|NCT00046228|13209995|P3|NOT COMPLETED|1 Year||12
5370028|NCT00046228|13209996|P2|NOT COMPLETED|1 Year||14
5370029|NCT00046228|13209997|P1|NOT COMPLETED|1 Year||19
5370030|NCT00046228|13209995|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
5370031|NCT00046228|13209996|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
5370032|NCT00046228|13209997|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
5370033|NCT00046228|13209995|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
5370034|NCT00046228|13209996|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
5370035|NCT00046228|13209997|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
5370036|NCT00046228|13209995|P3|NOT COMPLETED|90 Days||15
5370037|NCT00046228|13209996|P2|NOT COMPLETED|90 Days||8
5370038|NCT00046228|13209997|P1|NOT COMPLETED|90 Days||13
5370039|NCT00046228|13209995|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
5370040|NCT00046228|13209996|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
5370041|NCT00046228|13209997|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
5370042|NCT00046228|13209995|P3|STARTED|90 Days||828
5370043|NCT00046228|13209996|P2|STARTED|90 Days||818
5370044|NCT00046228|13209997|P1|STARTED|90 Days||806
5370045|NCT00045942|13210041|P9|NOT COMPLETED|PKC412A2104E2||6
5370046|NCT00045942|13210042|P8|NOT COMPLETED|PKC412A2104E2||7
5370047|NCT00045942|13210043|P7|NOT COMPLETED|PKC412A2104E2||7
5370048|NCT00045942|13210044|P6|NOT COMPLETED|PKC412A2104E2||9
5370049|NCT00045942|13210045|P5|NOT COMPLETED|PKC412A2104E2||0
5370050|NCT00045942|13210046|P4|NOT COMPLETED|PKC412A2104E2||0
5370051|NCT00045942|13210047|P3|NOT COMPLETED|PKC412A2104E2||0
5370052|NCT00045942|13210048|P2|NOT COMPLETED|PKC412A2104E2||0
5370053|NCT00045942|13210049|P1|NOT COMPLETED|PKC412A2104E2||0
5370054|NCT00045942|13210041|P9|COMPLETED|PKC412A2104E2||0
5370055|NCT00045942|13210042|P8|COMPLETED|PKC412A2104E2||0
5370056|NCT00045942|13210043|P7|COMPLETED|PKC412A2104E2||0
5370057|NCT00045942|13210044|P6|COMPLETED|PKC412A2104E2||0
5370058|NCT00045942|13210045|P5|COMPLETED|PKC412A2104E2||0
5370059|NCT00045942|13210046|P4|COMPLETED|PKC412A2104E2||0
5370060|NCT00045942|13210047|P3|COMPLETED|PKC412A2104E2||0
5370061|NCT00045942|13210048|P2|COMPLETED|PKC412A2104E2||0
5370062|NCT00045942|13210049|P1|COMPLETED|PKC412A2104E2||0
5370063|NCT00045942|13210041|P9|Primary Efficacy|PKC412A2104E2||6
5370064|NCT00045942|13210042|P8|Primary Efficacy|PKC412A2104E2||7
5370065|NCT00045942|13210043|P7|Primary Efficacy|PKC412A2104E2||7
5370066|NCT00045942|13210044|P6|Primary Efficacy|PKC412A2104E2||9
5370067|NCT00045942|13210045|P5|Primary Efficacy|PKC412A2104E2||0
5370068|NCT00045942|13210046|P4|Primary Efficacy|PKC412A2104E2||0
5370069|NCT00045942|13210047|P3|Primary Efficacy|PKC412A2104E2||0
5370070|NCT00045942|13210048|P2|Primary Efficacy|PKC412A2104E2||0
5370071|NCT00045942|13210049|P1|Primary Efficacy|PKC412A2104E2||0
5370072|NCT00045942|13210041|P9|STARTED|PKC412A2104E2||6
5370073|NCT00045942|13210042|P8|STARTED|PKC412A2104E2||7
5370074|NCT00045942|13210043|P7|STARTED|PKC412A2104E2||7
5370075|NCT00045942|13210044|P6|STARTED|PKC412A2104E2||9
5370076|NCT00045942|13210045|P5|STARTED|PKC412A2104E2||0
5370077|NCT00045942|13210046|P4|STARTED|PKC412A2104E2||0
5370078|NCT00045942|13210047|P3|STARTED|PKC412A2104E2||0
5370079|NCT00045942|13210048|P2|STARTED|PKC412A2104E2||0
5370080|NCT00045942|13210049|P1|STARTED|PKC412A2104E2||0
5370081|NCT00045942|13210041|P9|NOT COMPLETED|PKC412A2104E1||0
5370082|NCT00045942|13210042|P8|NOT COMPLETED|PKC412A2104E1||0
5370083|NCT00045942|13210043|P7|NOT COMPLETED|PKC412A2104E1||0
5370084|NCT00045942|13210044|P6|NOT COMPLETED|PKC412A2104E1||0
5370085|NCT00045942|13210045|P5|NOT COMPLETED|PKC412A2104E1||27
5370086|NCT00045942|13210046|P4|NOT COMPLETED|PKC412A2104E1||33
5370087|NCT00045942|13210047|P3|NOT COMPLETED|PKC412A2104E1||17
5370088|NCT00045942|13210048|P2|NOT COMPLETED|PKC412A2104E1||18
5370089|NCT00045942|13210049|P1|NOT COMPLETED|PKC412A2104E1||0
5370090|NCT00045942|13210041|P9|COMPLETED|PKC412A2104E1||0
5370091|NCT00045942|13210042|P8|COMPLETED|PKC412A2104E1||0
5370092|NCT00045942|13210043|P7|COMPLETED|PKC412A2104E1||0
5370093|NCT00045942|13210044|P6|COMPLETED|PKC412A2104E1||0
5370094|NCT00045942|13210045|P5|COMPLETED|PKC412A2104E1||0
5370095|NCT00045942|13210046|P4|COMPLETED|PKC412A2104E1||0
5370096|NCT00045942|13210047|P3|COMPLETED|PKC412A2104E1||0
5370097|NCT00045942|13210048|P2|COMPLETED|PKC412A2104E1||0
5370098|NCT00045942|13210049|P1|COMPLETED|PKC412A2104E1||0
5370099|NCT00045942|13210041|P9|Primary Efficacy|PKC412A2104E1||0
5370100|NCT00045942|13210042|P8|Primary Efficacy|PKC412A2104E1||0
5370101|NCT00045942|13210043|P7|Primary Efficacy|PKC412A2104E1||0
5370102|NCT00045942|13210044|P6|Primary Efficacy|PKC412A2104E1||0
5370103|NCT00045942|13210045|P5|Primary Efficacy|PKC412A2104E1||25
5370104|NCT00045942|13210046|P4|Primary Efficacy|PKC412A2104E1||32
5370105|NCT00045942|13210047|P3|Primary Efficacy|PKC412A2104E1||17
5370106|NCT00045942|13210048|P2|Primary Efficacy|PKC412A2104E1||18
5370107|NCT00045942|13210049|P1|Primary Efficacy|PKC412A2104E1||0
5370108|NCT00045942|13210041|P9|STARTED|PKC412A2104E1||0
5370109|NCT00045942|13210042|P8|STARTED|PKC412A2104E1||0
5370110|NCT00045942|13210043|P7|STARTED|PKC412A2104E1||0
5370111|NCT00045942|13210044|P6|STARTED|PKC412A2104E1||0
5370112|NCT00045942|13210045|P5|STARTED|PKC412A2104E1||27
5370113|NCT00045942|13210046|P4|STARTED|PKC412A2104E1||33
5370114|NCT00045942|13210047|P3|STARTED|PKC412A2104E1||17
5370115|NCT00045942|13210048|P2|STARTED|PKC412A2104E1||18
5370116|NCT00045942|13210049|P1|STARTED|PKC412A2104E1||0
5370117|NCT00045942|13210041|P9|NOT COMPLETED|PKC412A2104 (Core)||0
5370118|NCT00045942|13210042|P8|NOT COMPLETED|PKC412A2104 (Core)||0
5370119|NCT00045942|13210043|P7|NOT COMPLETED|PKC412A2104 (Core)||0
5370120|NCT00045942|13210044|P6|NOT COMPLETED|PKC412A2104 (Core)||0
5370121|NCT00045942|13210045|P5|NOT COMPLETED|PKC412A2104 (Core)||0
5370122|NCT00045942|13210046|P4|NOT COMPLETED|PKC412A2104 (Core)||0
5370123|NCT00045942|13210047|P3|NOT COMPLETED|PKC412A2104 (Core)||0
5370124|NCT00045942|13210048|P2|NOT COMPLETED|PKC412A2104 (Core)||0
5370125|NCT00045942|13210049|P1|NOT COMPLETED|PKC412A2104 (Core)||20
5370126|NCT00045942|13210041|P9|COMPLETED|PKC412A2104 (Core)||0
5370127|NCT00045942|13210042|P8|COMPLETED|PKC412A2104 (Core)||0
5370128|NCT00045942|13210043|P7|COMPLETED|PKC412A2104 (Core)||0
5370129|NCT00045942|13210044|P6|COMPLETED|PKC412A2104 (Core)||0
5370130|NCT00045942|13210045|P5|COMPLETED|PKC412A2104 (Core)||0
5370131|NCT00045942|13210046|P4|COMPLETED|PKC412A2104 (Core)||0
5370132|NCT00045942|13210047|P3|COMPLETED|PKC412A2104 (Core)||0
5370133|NCT00045942|13210048|P2|COMPLETED|PKC412A2104 (Core)||0
5370134|NCT00045942|13210049|P1|COMPLETED|PKC412A2104 (Core)||0
5370135|NCT00045942|13210041|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
5370136|NCT00045942|13210042|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
5370137|NCT00045942|13210043|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
5370138|NCT00045942|13210044|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
5370139|NCT00045942|13210045|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
5370140|NCT00045942|13210046|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
5370141|NCT00045942|13210047|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
5370142|NCT00045942|13210048|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
5370143|NCT00045942|13210049|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
5370144|NCT00045942|13210041|P9|STARTED|PKC412A2104 (Core)||0
5370145|NCT00045942|13210042|P8|STARTED|PKC412A2104 (Core)||0
5370146|NCT00045942|13210043|P7|STARTED|PKC412A2104 (Core)||0
5370147|NCT00045942|13210044|P6|STARTED|PKC412A2104 (Core)||0
5370148|NCT00045942|13210045|P5|STARTED|PKC412A2104 (Core)||0
5370149|NCT00045942|13210046|P4|STARTED|PKC412A2104 (Core)||0
5370150|NCT00045942|13210047|P3|STARTED|PKC412A2104 (Core)||0
5370151|NCT00045942|13210048|P2|STARTED|PKC412A2104 (Core)||0
5370152|NCT00045942|13210049|P1|STARTED|PKC412A2104 (Core)||20
5370153|NCT00044655|13210131|P2|NOT COMPLETED|Overall Study||38
5370154|NCT00044655|13210132|P1|NOT COMPLETED|Overall Study||20
5370155|NCT00044655|13210131|P2|COMPLETED|Overall Study||79
5370156|NCT00044655|13210132|P1|COMPLETED|Overall Study||82
5370157|NCT00044655|13210131|P2|STARTED|Overall Study||117
5370158|NCT00044655|13210132|P1|STARTED|Overall Study||102
5370159|NCT00044512|13210138|P1|NOT COMPLETED|Follow Up||2
5370160|NCT00044512|13210138|P1|COMPLETED|Follow Up||135
5370161|NCT00044512|13210138|P1|STARTED|Follow Up||137
5370162|NCT00044512|13210138|P1|NOT COMPLETED|Treatment||0
5370163|NCT00044512|13210138|P1|COMPLETED|Treatment||137
5370164|NCT00044512|13210138|P1|STARTED|Treatment||137
5370165|NCT00044213|13210153|P4|NOT COMPLETED|Overall Study||136
5370166|NCT00044213|13210154|P3|NOT COMPLETED|Overall Study||138
5370167|NCT00044213|13210155|P2|NOT COMPLETED|Overall Study||112
5370168|NCT00044213|13210156|P1|NOT COMPLETED|Overall Study||100
5370169|NCT00044213|13210153|P4|COMPLETED|Overall Study||301
5370170|NCT00044213|13210154|P3|COMPLETED|Overall Study||294
5370171|NCT00044213|13210155|P2|COMPLETED|Overall Study||306
5370172|NCT00044213|13210156|P1|COMPLETED|Overall Study||321
5370173|NCT00044213|13210153|P4|STARTED|Overall Study||437
5370174|NCT00044213|13210154|P3|STARTED|Overall Study||432
5370175|NCT00044213|13210155|P2|STARTED|Overall Study||418
5370176|NCT00044213|13210156|P1|STARTED|Overall Study||421
5370177|NCT00044044|13210175|P5|NOT COMPLETED|Overall Study||36
5370178|NCT00044044|13210176|P4|NOT COMPLETED|Overall Study||44
5370179|NCT00044044|13210177|P3|NOT COMPLETED|Overall Study||40
5370180|NCT00044044|13210178|P2|NOT COMPLETED|Overall Study||41
5370181|NCT00044044|13210179|P1|NOT COMPLETED|Overall Study||44
5370182|NCT00044044|13210175|P5|COMPLETED|Overall Study||36
5370183|NCT00044044|13210176|P4|COMPLETED|Overall Study||29
5370184|NCT00044044|13210177|P3|COMPLETED|Overall Study||31
5370185|NCT00044044|13210178|P2|COMPLETED|Overall Study||28
5370186|NCT00044044|13210179|P1|COMPLETED|Overall Study||27
5370187|NCT00044044|13210175|P5|STARTED|Overall Study||72
5370188|NCT00044044|13210176|P4|STARTED|Overall Study||73
5370189|NCT00044044|13210177|P3|STARTED|Overall Study||71
5370190|NCT00044044|13210178|P2|STARTED|Overall Study||69
5370191|NCT00044044|13210179|P1|STARTED|Overall Study||71
5370192|NCT00044005|13210209|P3|NOT COMPLETED|Overall Study||22
5370193|NCT00044005|13210210|P2|NOT COMPLETED|Overall Study||14
5370194|NCT00044005|13210211|P1|NOT COMPLETED|Overall Study||19
5370195|NCT00044005|13210209|P3|COMPLETED|Overall Study||11
5370196|NCT00044005|13210210|P2|COMPLETED|Overall Study||19
5370197|NCT00044005|13210211|P1|COMPLETED|Overall Study||13
5370198|NCT00044005|13210209|P3|STARTED|Overall Study||33
5370199|NCT00044005|13210210|P2|STARTED|Overall Study||33
5370200|NCT00044005|13210211|P1|STARTED|Overall Study||32
5370201|NCT00044083|13210221|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
5370202|NCT00044083|13210222|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
5370203|NCT00044083|13210221|P2|COMPLETED|Second Intervention (One Week) Patients||29
5370204|NCT00044083|13210222|P1|COMPLETED|Second Intervention (One Week) Patients||30
5370205|NCT00044083|13210221|P2|STARTED|Second Intervention (One Week) Patients||30
5370206|NCT00044083|13210222|P1|STARTED|Second Intervention (One Week) Patients||30
5370207|NCT00044083|13210221|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
5370208|NCT00044083|13210222|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
5370209|NCT00044083|13210221|P2|COMPLETED|First Intervention (One Week) Patients||30
5370210|NCT00044083|13210222|P1|COMPLETED|First Intervention (One Week) Patients||30
5370211|NCT00044083|13210221|P2|STARTED|First Intervention (One Week) Patients||32
5370212|NCT00044083|13210222|P1|STARTED|First Intervention (One Week) Patients||31
5370213|NCT00044083|13210221|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
5370214|NCT00044083|13210222|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
5370215|NCT00044083|13210221|P2|COMPLETED|Second Intervention (One Week) HV's||66
5370216|NCT00044083|13210222|P1|COMPLETED|Second Intervention (One Week) HV's||64
5370217|NCT00044083|13210221|P2|STARTED|Second Intervention (One Week) HV's||66
5370218|NCT00044083|13210222|P1|STARTED|Second Intervention (One Week) HV's||64
5370219|NCT00044083|13210221|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
5370220|NCT00044083|13210222|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
5370221|NCT00044083|13210221|P2|COMPLETED|First Intervention (One Week)- HV's||66
5370222|NCT00044083|13210222|P1|COMPLETED|First Intervention (One Week)- HV's||64
5370223|NCT00044083|13210221|P2|STARTED|First Intervention (One Week)- HV's||73
5370224|NCT00044083|13210222|P1|STARTED|First Intervention (One Week)- HV's||74
5370225|NCT00043979|13210260|P3|NOT COMPLETED|Period 2||0
5370226|NCT00043979|13210261|P2|NOT COMPLETED|Period 2||0
5370227|NCT00043979|13210262|P1|NOT COMPLETED|Period 2||0
5370228|NCT00043979|13210260|P3|COMPLETED|Period 2||10
5370229|NCT00043979|13210261|P2|COMPLETED|Period 2||13
5370230|NCT00043979|13210262|P1|COMPLETED|Period 2||0
5370231|NCT00043979|13210260|P3|STARTED|Period 2||10
5370232|NCT00043979|13210261|P2|STARTED|Period 2||13
5370233|NCT00043979|13210262|P1|STARTED|Period 2||0
5370234|NCT00043979|13210260|P3|NOT COMPLETED|Period 1||3
5370235|NCT00043979|13210261|P2|NOT COMPLETED|Period 1||4
5370236|NCT00043979|13210262|P1|NOT COMPLETED|Period 1||7
5370237|NCT00043979|13210260|P3|COMPLETED|Period 1||10
5370238|NCT00043979|13210261|P2|COMPLETED|Period 1||13
5370239|NCT00043979|13210262|P1|COMPLETED|Period 1||23
5370240|NCT00043979|13210260|P3|STARTED|Period 1||13
5370241|NCT00043979|13210261|P2|STARTED|Period 1||17
5370242|NCT00043979|13210262|P1|STARTED|Period 1||30
5370243|NCT00043550|13210283|P3|NOT COMPLETED|Overall Study||20
5370244|NCT00043550|13210284|P2|NOT COMPLETED|Overall Study||12
5370245|NCT00043550|13210285|P1|NOT COMPLETED|Overall Study||22
5370246|NCT00043550|13210283|P3|COMPLETED|Overall Study||30
5370247|NCT00043550|13210284|P2|COMPLETED|Overall Study||39
5370248|NCT00043550|13210285|P1|COMPLETED|Overall Study||33
5370249|NCT00043550|13210283|P3|Week 8 Completed|Overall Study||35
5370250|NCT00043550|13210284|P2|Week 8 Completed|Overall Study||40
5370251|NCT00043550|13210285|P1|Week 8 Completed|Overall Study||35
5370252|NCT00043550|13210283|P3|STARTED|Overall Study||50
5370253|NCT00043550|13210284|P2|STARTED|Overall Study||51
5370254|NCT00043550|13210285|P1|STARTED|Overall Study||55
5370255|NCT00043186|13210302|P9|NOT COMPLETED|Overall Study||17
5370256|NCT00043186|13210303|P8|NOT COMPLETED|Overall Study||16
5370257|NCT00043186|13210304|P7|NOT COMPLETED|Overall Study||17
5370258|NCT00043186|13210305|P6|NOT COMPLETED|Overall Study||8
5370259|NCT00043186|13210306|P5|NOT COMPLETED|Overall Study||18
5370260|NCT00043186|13210307|P4|NOT COMPLETED|Overall Study||22
5370261|NCT00043186|13210308|P3|NOT COMPLETED|Overall Study||20
5370262|NCT00043186|13210309|P2|NOT COMPLETED|Overall Study||15
5370263|NCT00043186|13210310|P1|NOT COMPLETED|Overall Study||17
5370264|NCT00043186|13210302|P9|COMPLETED|Overall Study||30
5370265|NCT00043186|13210303|P8|COMPLETED|Overall Study||31
5370266|NCT00043186|13210304|P7|COMPLETED|Overall Study||25
5370267|NCT00043186|13210305|P6|COMPLETED|Overall Study||39
5370268|NCT00043186|13210306|P5|COMPLETED|Overall Study||36
5370269|NCT00043186|13210307|P4|COMPLETED|Overall Study||19
5370270|NCT00043186|13210308|P3|COMPLETED|Overall Study||24
5370271|NCT00043186|13210309|P2|COMPLETED|Overall Study||29
5370272|NCT00043186|13210310|P1|COMPLETED|Overall Study||29
5370273|NCT00043186|13210302|P9|STARTED|Overall Study||47
5370274|NCT00043186|13210303|P8|STARTED|Overall Study||47
5370275|NCT00043186|13210304|P7|STARTED|Overall Study||42
5370276|NCT00043186|13210305|P6|STARTED|Overall Study||47
5370277|NCT00043186|13210306|P5|STARTED|Overall Study||54
5370278|NCT00043186|13210307|P4|STARTED|Overall Study||41
5370279|NCT00043186|13210308|P3|STARTED|Overall Study||44
5370280|NCT00043186|13210309|P2|STARTED|Overall Study||44
5370281|NCT00043186|13210310|P1|STARTED|Overall Study||46
5370282|NCT00042432|13210638|P2|NOT COMPLETED|Overall Study||7
5370283|NCT00042432|13210639|P1|NOT COMPLETED|Overall Study||9
5370284|NCT00042432|13210638|P2|COMPLETED|Overall Study||20
5370285|NCT00042432|13210639|P1|COMPLETED|Overall Study||18
5370286|NCT00042432|13210638|P2|STARTED|Overall Study||27
5370287|NCT00042432|13210639|P1|STARTED|Overall Study||27
5370288|NCT00042224|13210649|P2|NOT COMPLETED|Overall Study||3
5370289|NCT00042224|13210650|P1|NOT COMPLETED|Overall Study||3
5370290|NCT00042224|13210649|P2|COMPLETED|Overall Study||16
5370291|NCT00042224|13210650|P1|COMPLETED|Overall Study||17
5370292|NCT00042224|13210649|P2|STARTED|Overall Study||19
5370293|NCT00042224|13210650|P1|STARTED|Overall Study||20
5370294|NCT00041938|13210658|P2|NOT COMPLETED|Overall Study||31
5370295|NCT00041938|13210659|P1|NOT COMPLETED|Overall Study||38
5370296|NCT00041938|13210658|P2|COMPLETED|Overall Study||1111
5370297|NCT00041938|13210659|P1|COMPLETED|Overall Study||1125
5370298|NCT00041938|13210658|P2|Withdrew Consent|Overall Study||14
5370299|NCT00041938|13210659|P1|Withdrew Consent|Overall Study||20
5370300|NCT00041938|13210658|P2|Lost to Follow-up|Overall Study||17
5370301|NCT00041938|13210659|P1|Lost to Follow-up|Overall Study||18
5370302|NCT00041938|13210658|P2|Only Vital Status Known|Overall Study||46
5370303|NCT00041938|13210659|P1|Only Vital Status Known|Overall Study||44
5370304|NCT00041938|13210658|P2|Primary Endpoint|Overall Study||302
5370305|NCT00041938|13210659|P1|Primary Endpoint|Overall Study||320
5370306|NCT00041938|13210658|P2|Completed Follow-up|Overall Study||745
5370307|NCT00041938|13210659|P1|Completed Follow-up|Overall Study||761
5370308|NCT00041938|13210658|P2|STARTED|Overall Study||1142
5370309|NCT00041938|13210659|P1|STARTED|Overall Study||1163
5370310|NCT00041756|13210692|P5|NOT COMPLETED|Overall Study||60
5370311|NCT00041756|13210693|P4|NOT COMPLETED|Overall Study||16
5370312|NCT00041756|13210694|P3|NOT COMPLETED|Overall Study||13
5370313|NCT00041756|13210695|P2|NOT COMPLETED|Overall Study||15
5370314|NCT00041756|13210696|P1|NOT COMPLETED|Overall Study||8
5370315|NCT00041756|13210692|P5|COMPLETED|Overall Study||19
5370316|NCT00041756|13210693|P4|COMPLETED|Overall Study||64
5370317|NCT00041756|13210694|P3|COMPLETED|Overall Study||66
5370318|NCT00041756|13210695|P2|COMPLETED|Overall Study||65
5370319|NCT00041756|13210696|P1|COMPLETED|Overall Study||69
5370320|NCT00041756|13210692|P5|STARTED|Overall Study||79
5370321|NCT00041756|13210693|P4|STARTED|Overall Study||80
5370322|NCT00041756|13210694|P3|STARTED|Overall Study||79
5370323|NCT00041756|13210695|P2|STARTED|Overall Study||80
5370324|NCT00041756|13210696|P1|STARTED|Overall Study||77
5370325|NCT00041717|13210715|P2|NOT COMPLETED|Overall Study||12
5370326|NCT00041717|13210716|P1|NOT COMPLETED|Overall Study||33
5370327|NCT00041717|13210715|P2|COMPLETED|Overall Study||86
5370328|NCT00041717|13210716|P1|COMPLETED|Overall Study||81
5370329|NCT00041717|13210715|P2|STARTED|Overall Study||98
5370330|NCT00041717|13210716|P1|STARTED|Overall Study||114
5370331|NCT00041470|13210724|P1|NOT COMPLETED|Overall Study||38
5370332|NCT00041470|13210724|P1|COMPLETED|Overall Study||0
5370333|NCT00041470|13210724|P1|STARTED|Overall Study||38
5370334|NCT00040664|13210729|P4|NOT COMPLETED|Overall Study||27
5370335|NCT00040664|13210730|P3|NOT COMPLETED|Overall Study||13
5370336|NCT00040664|13210731|P2|NOT COMPLETED|Overall Study||13
5370337|NCT00040664|13210732|P1|NOT COMPLETED|Overall Study||53
5370338|NCT00040664|13210729|P4|COMPLETED|Overall Study||8
5370339|NCT00040664|13210730|P3|COMPLETED|Overall Study||4
5370340|NCT00040664|13210731|P2|COMPLETED|Overall Study||4
5370341|NCT00040664|13210732|P1|COMPLETED|Overall Study||16
5370342|NCT00040664|13210729|P4|STARTED|Overall Study||35
5370343|NCT00040664|13210730|P3|STARTED|Overall Study||17
5370344|NCT00040664|13210731|P2|STARTED|Overall Study||17
5370345|NCT00040664|13210732|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
5370346|NCT00041392|13210782|P2|NOT COMPLETED|Overall Study||0
5370347|NCT00041392|13210783|P1|NOT COMPLETED|Overall Study||0
5370348|NCT00041392|13210782|P2|COMPLETED|Overall Study||191
5370349|NCT00041392|13210783|P1|COMPLETED|Overall Study||198
5370350|NCT00041392|13210782|P2|STARTED|Overall Study||191
5370351|NCT00041392|13210783|P1|STARTED|Overall Study||198
5370352|NCT00040443|13210791|P2|NOT COMPLETED|Overall Study||0
5370353|NCT00040443|13210792|P1|NOT COMPLETED|Overall Study||0
5370354|NCT00040443|13210791|P2|COMPLETED|Overall Study||91
5370355|NCT00040443|13210792|P1|COMPLETED|Overall Study||84
5370356|NCT00040443|13210791|P2|STARTED|Overall Study||91
5370357|NCT00040443|13210792|P1|STARTED|Overall Study||84
5370358|NCT00040365|13210798|P1|NOT COMPLETED|Overall Study||11
5370359|NCT00040365|13210798|P1|COMPLETED|Overall Study||19
5370360|NCT00040365|13210798|P1|Completed Follow Up Phase|Overall Study||19
5370361|NCT00040365|13210798|P1|STARTED|Overall Study||30
5370362|NCT00039871|13210807|P1|NOT COMPLETED|Overall Study||1384
5370363|NCT00039871|13210807|P1|COMPLETED|Overall Study||928
5370364|NCT00039871|13210807|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
5370365|NCT00039741|13210817|P4|NOT COMPLETED|Overall Study||14
5370366|NCT00039741|13210818|P3|NOT COMPLETED|Overall Study||11
5370367|NCT00039741|13210819|P2|NOT COMPLETED|Overall Study||12
5370368|NCT00039741|13210820|P1|NOT COMPLETED|Overall Study||15
5370369|NCT00039741|13210817|P4|COMPLETED|Overall Study||50
5370370|NCT00039741|13210818|P3|COMPLETED|Overall Study||54
5370371|NCT00039741|13210819|P2|COMPLETED|Overall Study||56
5370372|NCT00039741|13210820|P1|COMPLETED|Overall Study||51
5370373|NCT00039741|13210817|P4|Death|Overall Study||0
5370374|NCT00039741|13210818|P3|Death|Overall Study||0
5370375|NCT00039741|13210819|P2|Death|Overall Study||1
5370376|NCT00039741|13210820|P1|Death|Overall Study||0
5370377|NCT00039741|13210817|P4|STARTED|Overall Study||64
5370378|NCT00039741|13210818|P3|STARTED|Overall Study||65
5370379|NCT00039741|13210819|P2|STARTED|Overall Study||68
5370380|NCT00039741|13210820|P1|STARTED|Overall Study||66
5370381|NCT00038948|13210864|P2|NOT COMPLETED|Overall Study||77
5370382|NCT00038948|13210865|P1|NOT COMPLETED|Overall Study||169
5370383|NCT00038948|13210864|P2|COMPLETED|Overall Study||198
5370384|NCT00038948|13210865|P1|COMPLETED|Overall Study||386
5370385|NCT00038948|13210864|P2|STARTED|Overall Study||275
5370386|NCT00038948|13210865|P1|STARTED|Overall Study||555
5370387|NCT00038857|13210877|P1|NOT COMPLETED|Overall Study||1
5370388|NCT00038857|13210877|P1|COMPLETED|Overall Study||28
5370389|NCT00038857|13210877|P1|STARTED|Overall Study||29
5370390|NCT00038727|13210884|P3|NOT COMPLETED|Overall Study||0
5370391|NCT00038727|13210885|P2|NOT COMPLETED|Overall Study||0
5370392|NCT00038727|13210886|P1|NOT COMPLETED|Overall Study||0
5370393|NCT00038727|13210884|P3|COMPLETED|Overall Study||936
5370394|NCT00038727|13210885|P2|COMPLETED|Overall Study||927
5370395|NCT00038727|13210886|P1|COMPLETED|Overall Study||916
5370396|NCT00038727|13210884|P3|DPPOS Phase 3 Enrolled|Overall Study||936
5370397|NCT00038727|13210885|P2|DPPOS Phase 3 Enrolled|Overall Study||927
5370398|NCT00038727|13210886|P1|DPPOS Phase 3 Enrolled|Overall Study||916
5370399|NCT00038727|13210884|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
5370400|NCT00038727|13210885|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
5370401|NCT00038727|13210886|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
5370402|NCT00038727|13210884|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
5370403|NCT00038727|13210885|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
5370404|NCT00038727|13210886|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
5370405|NCT00038727|13210884|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
5370406|NCT00038727|13210885|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
5370407|NCT00038727|13210886|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
5370408|NCT00038727|13210884|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
5370409|NCT00038727|13210885|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
5370410|NCT00038727|13210886|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
5370411|NCT00038649|13210900|P1|NOT COMPLETED|Overall Study||9
5370412|NCT00038649|13210900|P1|COMPLETED|Overall Study||105
5370413|NCT00038649|13210900|P1|STARTED|Overall Study||114
5370414|NCT00038610|13210905|P1|NOT COMPLETED|Overall Study||0
5370415|NCT00038610|13210905|P1|COMPLETED|Overall Study||54
5370416|NCT00038610|13210905|P1|STARTED|Overall Study||54
5370417|NCT00038467|13210913|P2|NOT COMPLETED|Overall Study||542
5370418|NCT00038467|13210914|P1|NOT COMPLETED|Overall Study||542
5370419|NCT00038467|13210913|P2|COMPLETED|Overall Study||1830
5370420|NCT00038467|13210914|P1|COMPLETED|Overall Study||1810
5370421|NCT00038467|13210913|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
5370422|NCT00038467|13210914|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
5370423|NCT00038467|13210913|P2|STARTED|Overall Study||2372
5370424|NCT00038467|13210914|P1|STARTED|Overall Study||2352
5370425|NCT00038142|13210976|P2|NOT COMPLETED|Overall Study||7
5370426|NCT00038142|13210977|P1|NOT COMPLETED|Overall Study||22
5370427|NCT00038142|13210976|P2|COMPLETED|Overall Study||7
5370428|NCT00038142|13210977|P1|COMPLETED|Overall Study||10
5370429|NCT00038142|13210976|P2|STARTED|Overall Study||14
5370430|NCT00038142|13210977|P1|STARTED|Overall Study||32
5370431|NCT00038103|13210985|P2|NOT COMPLETED|Overall Study||56
5370432|NCT00038103|13210986|P1|NOT COMPLETED|Overall Study||55
5370433|NCT00038103|13210985|P2|COMPLETED|Overall Study||0
5370434|NCT00038103|13210986|P1|COMPLETED|Overall Study||0
5370435|NCT00038103|13210985|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
5370436|NCT00038103|13210986|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
5370437|NCT00038103|13210985|P2|STARTED|Overall Study||56
5370438|NCT00038103|13210986|P1|STARTED|Overall Study||55
5370439|NCT00037830|13211009|P3|NOT COMPLETED|Overall Study||1
5370440|NCT00037830|13211010|P2|NOT COMPLETED|Overall Study||7
5370441|NCT00037830|13211011|P1|NOT COMPLETED|Overall Study||10
5370442|NCT00037830|13211009|P3|COMPLETED|Overall Study||16
5370443|NCT00037830|13211010|P2|COMPLETED|Overall Study||31
5370444|NCT00037830|13211011|P1|COMPLETED|Overall Study||29
5370445|NCT00037830|13211009|P3|STARTED|Overall Study||17
5370446|NCT00037830|13211010|P2|STARTED|Overall Study||38
5370447|NCT00037830|13211011|P1|STARTED|Overall Study||39
5370448|NCT00036569|13211032|P1|NOT COMPLETED|Overall Study||0
5370449|NCT00036569|13211032|P1|COMPLETED|Overall Study||32
5370450|NCT00036569|13211032|P1|STARTED|Overall Study||32
5370451|NCT00036270|13211043|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
5370452|NCT00036270|13211044|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
5370453|NCT00036270|13211043|P2|COMPLETED|Study Treatment to 5 Year Report||1380
5370454|NCT00036270|13211044|P1|COMPLETED|Study Treatment to 5 Year Report||2333
5370455|NCT00036270|13211043|P2|Treated|Study Treatment to 5 Year Report||4814
5370456|NCT00036270|13211044|P1|Treated|Study Treatment to 5 Year Report||4852
5370457|NCT00036270|13211043|P2|STARTED|Study Treatment to 5 Year Report||4868
5370458|NCT00036270|13211044|P1|STARTED|Study Treatment to 5 Year Report||4898
5370459|NCT00036270|13211043|P2|NOT COMPLETED|Randomized to Study Treatment||7
5370460|NCT00036270|13211044|P1|NOT COMPLETED|Randomized to Study Treatment||6
5370461|NCT00036270|13211043|P2|COMPLETED|Randomized to Study Treatment||4868
5370462|NCT00036270|13211044|P1|COMPLETED|Randomized to Study Treatment||4898
5370463|NCT00036270|13211043|P2|STARTED|Randomized to Study Treatment||4875
5370464|NCT00036270|13211044|P1|STARTED|Randomized to Study Treatment||4904
5370465|NCT00035932|13211063|P3|NOT COMPLETED|Overall Study||49
5370466|NCT00035932|13211064|P2|NOT COMPLETED|Overall Study||60
5370467|NCT00035932|13211065|P1|NOT COMPLETED|Overall Study||56
5370468|NCT00035932|13211063|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
5370469|NCT00035932|13211064|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
5370470|NCT00035932|13211065|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
5370471|NCT00035932|13211063|P3|Discontinued on or After Week 96|Overall Study||6
5370472|NCT00035932|13211064|P2|Discontinued on or After Week 96|Overall Study||4
5370473|NCT00035932|13211065|P1|Discontinued on or After Week 96|Overall Study||4
5370474|NCT00035932|13211063|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
5370475|NCT00035932|13211064|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
5370476|NCT00035932|13211065|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
5370477|NCT00035932|13211063|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
5370478|NCT00035932|13211064|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
5370479|NCT00035932|13211065|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
5370480|NCT00035932|13211063|P3|STARTED|Overall Study|123 randomized, 118 treated|118
5370481|NCT00035932|13211064|P2|STARTED|Overall Study|115 randomized, 110 treated|110
5370482|NCT00035932|13211065|P1|STARTED|Overall Study|120 randomized, 119 treated|119
5370483|NCT00035815|13211191|P2|NOT COMPLETED|Overall Study||11
5370484|NCT00035815|13211192|P1|NOT COMPLETED|Overall Study||17
5370485|NCT00035815|13211191|P2|COMPLETED|Overall Study||152
5370486|NCT00035815|13211192|P1|COMPLETED|Overall Study||150
5370487|NCT00035815|13211191|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
5370488|NCT00035815|13211192|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
5370489|NCT00035555|13211205|P3|NOT COMPLETED|Overall Study||22
5370490|NCT00035555|13211206|P2|NOT COMPLETED|Overall Study||16
5370491|NCT00035555|13211207|P1|NOT COMPLETED|Overall Study||16
5370492|NCT00035555|13211205|P3|COMPLETED|Overall Study||51
5370493|NCT00035555|13211206|P2|COMPLETED|Overall Study||55
5370494|NCT00035555|13211207|P1|COMPLETED|Overall Study||58
5370495|NCT00035555|13211205|P3|Number Who Received Study Drug|Overall Study||71
5370496|NCT00035555|13211206|P2|Number Who Received Study Drug|Overall Study||71
5370497|NCT00035555|13211207|P1|Number Who Received Study Drug|Overall Study||74
5370498|NCT00035555|13211205|P3|Number Who Had Undergone Transplantation|Overall Study||73
5370499|NCT00035555|13211206|P2|Number Who Had Undergone Transplantation|Overall Study||71
5370500|NCT00035555|13211207|P1|Number Who Had Undergone Transplantation|Overall Study||74
5370501|NCT00035555|13211205|P3|STARTED|Overall Study|Randomized patients|73
5370502|NCT00035555|13211206|P2|STARTED|Overall Study|Randomized patients|71
5370503|NCT00035555|13211207|P1|STARTED|Overall Study|Randomized patients|74
5370504|NCT00033917|13211250|P2|NOT COMPLETED|Overall Study||0
5370505|NCT00033917|13211251|P1|NOT COMPLETED|Overall Study||0
5370506|NCT00033917|13211250|P2|COMPLETED|Overall Study||222
5370507|NCT00033917|13211251|P1|COMPLETED|Overall Study||209
5370508|NCT00033917|13211250|P2|STARTED|Overall Study||222
5370509|NCT00033917|13211251|P1|STARTED|Overall Study||209
5370510|NCT00032630|13211263|P2|NOT COMPLETED|Overall Study||43
5370511|NCT00032630|13211264|P1|NOT COMPLETED|Overall Study||49
5370512|NCT00032630|13211263|P2|COMPLETED|Overall Study||1061
5370513|NCT00032630|13211264|P1|COMPLETED|Overall Study||1050
5370514|NCT00032630|13211263|P2|STARTED|Overall Study||1104
5370515|NCT00032630|13211264|P1|STARTED|Overall Study||1099
5370516|NCT00032591|13211274|P2|NOT COMPLETED|Follow-up||5
5370517|NCT00032591|13211275|P1|NOT COMPLETED|Follow-up||2
5370518|NCT00032591|13211274|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
5370519|NCT00032591|13211275|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
5370520|NCT00032591|13211274|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
5370521|NCT00032591|13211275|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
5370522|NCT00032591|13211274|P2|NOT COMPLETED|Randomization||0
5370523|NCT00032591|13211275|P1|NOT COMPLETED|Randomization||0
5370524|NCT00032591|13211274|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
5370525|NCT00032591|13211275|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
5370526|NCT00032591|13211274|P2|STARTED|Randomization||1457
5370527|NCT00032591|13211275|P1|STARTED|Randomization|2922 underwent randomization|1465
5370528|NCT00032591|13211274|P2|NOT COMPLETED|Screening||415
5370529|NCT00032591|13211275|P1|NOT COMPLETED|Screening||408
5370530|NCT00032591|13211274|P2|COMPLETED|Screening||1457
5370531|NCT00032591|13211275|P1|COMPLETED|Screening|823 were excluded from the study|1465
5370532|NCT00032591|13211274|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
5370533|NCT00032591|13211275|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
5370534|NCT00032487|13211291|P2|NOT COMPLETED|Overall Study||120
5370535|NCT00032487|13211292|P1|NOT COMPLETED|Overall Study||139
5370536|NCT00032487|13211291|P2|COMPLETED|Overall Study||772
5370537|NCT00032487|13211292|P1|COMPLETED|Overall Study||760
5370538|NCT00032487|13211291|P2|STARTED|Overall Study||892
5370539|NCT00032487|13211292|P1|STARTED|Overall Study||899
5370540|NCT00031551|13211302|P2|NOT COMPLETED|Overall Study||0
5370541|NCT00031551|13211303|P1|NOT COMPLETED|Overall Study||2
5370542|NCT00031551|13211302|P2|COMPLETED|Overall Study||25
5370543|NCT00031551|13211303|P1|COMPLETED|Overall Study||0
5370544|NCT00031551|13211302|P2|STARTED|Overall Study||25
5370545|NCT00031551|13211303|P1|STARTED|Overall Study||2
5370546|NCT00031486|13211315|P2|NOT COMPLETED|Overall Study||12
5370547|NCT00031486|13211316|P1|NOT COMPLETED|Overall Study||7
5370548|NCT00031486|13211315|P2|COMPLETED|Overall Study||35
5370549|NCT00031486|13211316|P1|COMPLETED|Overall Study||33
5370550|NCT00031486|13211315|P2|STARTED|Overall Study||47
5370551|NCT00031486|13211316|P1|STARTED|Overall Study||40
5370552|NCT00031460|13211342|P2|NOT COMPLETED|Overall Study||14
5370553|NCT00031460|13211343|P1|NOT COMPLETED|Overall Study||9
5370554|NCT00031460|13211342|P2|COMPLETED|Overall Study||8
5370555|NCT00031460|13211343|P1|COMPLETED|Overall Study||15
5370556|NCT00031460|13211342|P2|STARTED|Overall Study||22
5370557|NCT00031460|13211343|P1|STARTED|Overall Study||24
5370558|NCT00031447|13211357|P2|NOT COMPLETED|Overall Study||7
5370559|NCT00031447|13211358|P1|NOT COMPLETED|Overall Study||10
5370560|NCT00031447|13211357|P2|COMPLETED|Overall Study||8
5370561|NCT00031447|13211358|P1|COMPLETED|Overall Study||4
5370562|NCT00031447|13211357|P2|STARTED|Overall Study||15
5370563|NCT00031447|13211358|P1|STARTED|Overall Study||14
5370564|NCT00030992|13211370|P1|NOT COMPLETED|Overall Study||0
5370565|NCT00030992|13211370|P1|COMPLETED|Overall Study||102
5370566|NCT00030992|13211370|P1|STARTED|Overall Study||102
5370567|NCT00030147|13211379|P4|NOT COMPLETED|Overall Study||0
5370568|NCT00030147|13211380|P3|NOT COMPLETED|Overall Study||0
5370569|NCT00030147|13211381|P2|NOT COMPLETED|Overall Study||1
5370570|NCT00030147|13211382|P1|NOT COMPLETED|Overall Study||0
5370571|NCT00030147|13211379|P4|COMPLETED|Overall Study||11
5370572|NCT00030147|13211380|P3|COMPLETED|Overall Study||16
5370573|NCT00030147|13211381|P2|COMPLETED|Overall Study||18
5370574|NCT00030147|13211382|P1|COMPLETED|Overall Study||17
5370575|NCT00030147|13211379|P4|STARTED|Overall Study||11
5370576|NCT00030147|13211380|P3|STARTED|Overall Study||16
5370577|NCT00030147|13211381|P2|STARTED|Overall Study||19
5370578|NCT00030147|13211382|P1|STARTED|Overall Study||17
5370579|NCT00029536|13211400|P4|NOT COMPLETED|Overall Study||0
5370580|NCT00029536|13211401|P3|NOT COMPLETED|Overall Study||0
5370581|NCT00029536|13211402|P2|NOT COMPLETED|Overall Study||0
5370582|NCT00029536|13211403|P1|NOT COMPLETED|Overall Study||0
5370583|NCT00029536|13211400|P4|COMPLETED|Overall Study||59
5370584|NCT00029536|13211401|P3|COMPLETED|Overall Study||105
5370585|NCT00029536|13211402|P2|COMPLETED|Overall Study||45
5370586|NCT00029536|13211403|P1|COMPLETED|Overall Study||85
5370587|NCT00029536|13211400|P4|STARTED|Overall Study||59
5370588|NCT00029536|13211401|P3|STARTED|Overall Study||105
5370589|NCT00029536|13211402|P2|STARTED|Overall Study||45
5370590|NCT00029536|13211403|P1|STARTED|Overall Study||85
5370591|NCT00029172|13211427|P1|NOT COMPLETED|Overall Study||6
5370592|NCT00029172|13211427|P1|COMPLETED|Overall Study||182
5370593|NCT00029172|13211427|P1|STARTED|Overall Study||188
5370594|NCT00029146|13211433|P2|NOT COMPLETED|Overall Study||1
5370595|NCT00029146|13211434|P1|NOT COMPLETED|Overall Study||2
5370596|NCT00029146|13211433|P2|COMPLETED|Overall Study||97
5370597|NCT00029146|13211434|P1|COMPLETED|Overall Study||95
5370598|NCT00029146|13211433|P2|STARTED|Overall Study||98
5370599|NCT00029146|13211434|P1|STARTED|Overall Study||97
5370600|NCT00029107|13211463|P2|NOT COMPLETED|Overall Study||0
5370601|NCT00029107|13211464|P1|NOT COMPLETED|Overall Study||0
5370602|NCT00029107|13211463|P2|COMPLETED|Overall Study||12
5370603|NCT00029107|13211464|P1|COMPLETED|Overall Study||12
5370604|NCT00029107|13211463|P2|STARTED|Overall Study||12
5370605|NCT00029107|13211464|P1|STARTED|Overall Study||12
5370606|NCT00028262|13211470|P1|NOT COMPLETED|Overall Study||1
5370607|NCT00028262|13211470|P1|COMPLETED|Overall Study||9
5370608|NCT00028262|13211470|P1|STARTED|Overall Study||10
5370609|NCT00028093|13211476|P2|NOT COMPLETED|Overall Study||0
5370610|NCT00028093|13211477|P1|NOT COMPLETED|Overall Study||0
5370611|NCT00028093|13211476|P2|COMPLETED|Overall Study||25
5370612|NCT00028093|13211477|P1|COMPLETED|Overall Study||25
5370613|NCT00028093|13211476|P2|STARTED|Overall Study||25
5370614|NCT00028093|13211477|P1|STARTED|Overall Study||25
5370615|NCT00027378|13211485|P2|NOT COMPLETED|Overall Study||3
5370616|NCT00027378|13211486|P1|NOT COMPLETED|Overall Study||0
5370617|NCT00027378|13211485|P2|COMPLETED|Overall Study||23
5370618|NCT00027378|13211486|P1|COMPLETED|Overall Study||24
5370619|NCT00027378|13211485|P2|STARTED|Overall Study||26
5370620|NCT00027378|13211486|P1|STARTED|Overall Study||24
5370621|NCT00027027|13211499|P5|NOT COMPLETED|Overall Study||8
5370622|NCT00027027|13211500|P4|NOT COMPLETED|Overall Study||3
5370623|NCT00027027|13211501|P3|NOT COMPLETED|Overall Study||4
5370624|NCT00027027|13211502|P2|NOT COMPLETED|Overall Study||3
5370625|NCT00027027|13211503|P1|NOT COMPLETED|Overall Study||3
5370626|NCT00027027|13211499|P5|COMPLETED|Overall Study||0
5370627|NCT00027027|13211500|P4|COMPLETED|Overall Study||0
5370628|NCT00027027|13211501|P3|COMPLETED|Overall Study||0
5370629|NCT00027027|13211502|P2|COMPLETED|Overall Study||0
5370630|NCT00027027|13211503|P1|COMPLETED|Overall Study||0
5370631|NCT00027027|13211499|P5|Treated Beyond Cycle 2|Overall Study||4
5370632|NCT00027027|13211500|P4|Treated Beyond Cycle 2|Overall Study||2
5370633|NCT00027027|13211501|P3|Treated Beyond Cycle 2|Overall Study||2
5370634|NCT00027027|13211502|P2|Treated Beyond Cycle 2|Overall Study||1
5370635|NCT00027027|13211503|P1|Treated Beyond Cycle 2|Overall Study||1
5370636|NCT00027027|13211499|P5|Discontinued at Cycle 2|Overall Study||3
5370637|NCT00027027|13211500|P4|Discontinued at Cycle 2|Overall Study||1
5370638|NCT00027027|13211501|P3|Discontinued at Cycle 2|Overall Study||1
5370639|NCT00027027|13211502|P2|Discontinued at Cycle 2|Overall Study||2
5370640|NCT00027027|13211503|P1|Discontinued at Cycle 2|Overall Study||2
5370641|NCT00027027|13211499|P5|Completed 2 Cycles of Treatment|Overall Study||7
5370642|NCT00027027|13211500|P4|Completed 2 Cycles of Treatment|Overall Study||3
5370643|NCT00027027|13211501|P3|Completed 2 Cycles of Treatment|Overall Study||3
5370644|NCT00027027|13211502|P2|Completed 2 Cycles of Treatment|Overall Study||3
5370645|NCT00027027|13211503|P1|Completed 2 Cycles of Treatment|Overall Study||3
5370646|NCT00027027|13211499|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
5370647|NCT00027027|13211500|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
5370648|NCT00027027|13211501|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
5370649|NCT00027027|13211502|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
5370650|NCT00027027|13211503|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
5370651|NCT00027027|13211499|P5|STARTED|Overall Study||8
5370652|NCT00027027|13211500|P4|STARTED|Overall Study||3
5370653|NCT00027027|13211501|P3|STARTED|Overall Study||4
5370654|NCT00027027|13211502|P2|STARTED|Overall Study||3
5370655|NCT00027027|13211503|P1|STARTED|Overall Study||3
5370656|NCT00026793|13211548|P1|NOT COMPLETED|Overall Study||8
5370657|NCT00026793|13211548|P1|COMPLETED|Overall Study||21
5370658|NCT00026793|13211548|P1|STARTED|Overall Study||29
5370659|NCT00025883|13211558|P1|NOT COMPLETED|Overall Study||17
5370660|NCT00025883|13211558|P1|COMPLETED|Overall Study||86
5370661|NCT00025883|13211558|P1|Partial Lipodystrophy|Overall Study||40
5370662|NCT00025883|13211558|P1|Generalized Lipodystrophy|Overall Study||63
5370663|NCT00025883|13211558|P1|STARTED|Overall Study||103
5370664|NCT00023595|13211570|P5|NOT COMPLETED|10 Year Follow up||0
5370665|NCT00023595|13211571|P4|NOT COMPLETED|10 Year Follow up||0
5370666|NCT00023595|13211572|P3|NOT COMPLETED|10 Year Follow up||3
5370667|NCT00023595|13211573|P2|NOT COMPLETED|10 Year Follow up||10
5370668|NCT00023595|13211574|P1|NOT COMPLETED|10 Year Follow up||12
5370669|NCT00023595|13211570|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
5370670|NCT00023595|13211571|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
5370671|NCT00023595|13211572|P3|COMPLETED|10 Year Follow up||73
5370672|NCT00023595|13211573|P2|COMPLETED|10 Year Follow up||524
5370673|NCT00023595|13211574|P1|COMPLETED|10 Year Follow up||590
5370674|NCT00023595|13211570|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
5370675|NCT00023595|13211571|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
5370676|NCT00023595|13211572|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
5370677|NCT00023595|13211573|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
5370678|NCT00023595|13211574|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
5370679|NCT00023595|13211570|P5|NOT COMPLETED|5 Year Follow up||3
5370680|NCT00023595|13211571|P4|NOT COMPLETED|5 Year Follow up||7
5370681|NCT00023595|13211572|P3|NOT COMPLETED|5 Year Follow up||1
5370682|NCT00023595|13211573|P2|NOT COMPLETED|5 Year Follow up||2
5370683|NCT00023595|13211574|P1|NOT COMPLETED|5 Year Follow up||2
5370684|NCT00023595|13211570|P5|COMPLETED|5 Year Follow up||498
5370685|NCT00023595|13211571|P4|COMPLETED|5 Year Follow up||416
5370686|NCT00023595|13211572|P3|COMPLETED|5 Year Follow up||75
5370687|NCT00023595|13211573|P2|COMPLETED|5 Year Follow up||532
5370688|NCT00023595|13211574|P1|COMPLETED|5 Year Follow up||600
5370689|NCT00023595|13211570|P5|STARTED|5 Year Follow up||501
5370690|NCT00023595|13211571|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
5370691|NCT00023595|13211572|P3|STARTED|5 Year Follow up||76
5370692|NCT00023595|13211573|P2|STARTED|5 Year Follow up||534
5370693|NCT00023595|13211574|P1|STARTED|5 Year Follow up||602
5370694|NCT00023452|13211785|P2|NOT COMPLETED|Overall Study||872
5370695|NCT00023452|13211786|P1|NOT COMPLETED|Overall Study||1323
5370696|NCT00023452|13211785|P2|COMPLETED|Overall Study||3273
5370697|NCT00023452|13211786|P1|COMPLETED|Overall Study||2585
5370698|NCT00023452|13211785|P2|Completed Study|Overall Study||3475
5370699|NCT00023452|13211786|P1|Completed Study|Overall Study||3174
5370700|NCT00023452|13211785|P2|Not Treated|Overall Study||105
5370701|NCT00023452|13211786|P1|Not Treated|Overall Study||149
5370702|NCT00023452|13211785|P2|Completed Treatment|Overall Study||3273
5370703|NCT00023452|13211786|P1|Completed Treatment|Overall Study||2585
5370704|NCT00023452|13211785|P2|Enrolled as Part of a Cluster|Overall Study||971
5370705|NCT00023452|13211786|P1|Enrolled as Part of a Cluster|Overall Study||718
5370706|NCT00023452|13211785|P2|Randomized|Overall Study||3174
5370707|NCT00023452|13211786|P1|Randomized|Overall Study||3190
5370708|NCT00023452|13211785|P2|STARTED|Overall Study||4145
5370709|NCT00023452|13211786|P1|STARTED|Overall Study||3908
5370710|NCT00023322|13211810|P1|NOT COMPLETED|Overall Study||1
5370711|NCT00023322|13211810|P1|COMPLETED|Overall Study||12
5370712|NCT00023322|13211810|P1|STARTED|Overall Study||13
5370713|NCT00023309|13211817|P2|NOT COMPLETED|Overall Study||0
5370714|NCT00023309|13211818|P1|NOT COMPLETED|Overall Study||0
5370715|NCT00023309|13211817|P2|COMPLETED|Overall Study||19
5370716|NCT00023309|13211818|P1|COMPLETED|Overall Study||22
5370717|NCT00023309|13211817|P2|STARTED|Overall Study||19
5370718|NCT00023309|13211818|P1|STARTED|Overall Study||22
5370719|NCT00022763|13211834|P2|NOT COMPLETED|Overall Study||17
5370720|NCT00022763|13211835|P1|NOT COMPLETED|Overall Study||9
5370721|NCT00022763|13211834|P2|COMPLETED|Overall Study||11
5370722|NCT00022763|13211835|P1|COMPLETED|Overall Study||15
5370723|NCT00022763|13211834|P2|STARTED|Overall Study||28
5370724|NCT00022763|13211835|P1|STARTED|Overall Study||24
5370725|NCT00016718|13211861|P3|NOT COMPLETED|Overall Study||0
5370726|NCT00016718|13211862|P2|NOT COMPLETED|Overall Study||0
5370727|NCT00016718|13211863|P1|NOT COMPLETED|Overall Study||0
5370728|NCT00016718|13211861|P3|COMPLETED|Overall Study||16
5370729|NCT00016718|13211862|P2|COMPLETED|Overall Study||21
5370730|NCT00016718|13211863|P1|COMPLETED|Overall Study||6
5370731|NCT00016718|13211861|P3|STARTED|Overall Study||16
5370732|NCT00016718|13211862|P2|STARTED|Overall Study||21
5370733|NCT00016718|13211863|P1|STARTED|Overall Study||6
5370734|NCT00014911|13211877|P1|NOT COMPLETED|Overall Study||11
5370735|NCT00014911|13211877|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
5370736|NCT00014911|13211877|P1|STARTED|Overall Study||36
5370737|NCT00006604|13211893|P17|NOT COMPLETED|Overall Study||9
5370738|NCT00006604|13211894|P16|NOT COMPLETED|Overall Study||5
5370739|NCT00006604|13211895|P15|NOT COMPLETED|Overall Study||10
5370740|NCT00006604|13211896|P14|NOT COMPLETED|Overall Study||6
5370741|NCT00006604|13211897|P13|NOT COMPLETED|Overall Study||4
5370742|NCT00006604|13211898|P12|NOT COMPLETED|Overall Study||6
5370743|NCT00006604|13211899|P11|NOT COMPLETED|Overall Study||8
5370744|NCT00006604|13211900|P10|NOT COMPLETED|Overall Study||19
5370745|NCT00006604|13211901|P9|NOT COMPLETED|Overall Study||1
5370746|NCT00006604|13211902|P8|NOT COMPLETED|Overall Study||3
5370747|NCT00006604|13211903|P7|NOT COMPLETED|Overall Study||9
5370748|NCT00006604|13211904|P6|NOT COMPLETED|Overall Study||3
5370749|NCT00006604|13211905|P5|NOT COMPLETED|Overall Study||2
5370750|NCT00006604|13211906|P4|NOT COMPLETED|Overall Study||5
5370751|NCT00006604|13211907|P3|NOT COMPLETED|Overall Study||4
5370752|NCT00006604|13211908|P2|NOT COMPLETED|Overall Study||0
5370753|NCT00006604|13211909|P1|NOT COMPLETED|Overall Study||2
5370754|NCT00006604|13211893|P17|COMPLETED|Overall Study||6
5370755|NCT00006604|13211894|P16|COMPLETED|Overall Study||1
5370756|NCT00006604|13211895|P15|COMPLETED|Overall Study||14
5370757|NCT00006604|13211896|P14|COMPLETED|Overall Study||0
5370758|NCT00006604|13211897|P13|COMPLETED|Overall Study||22
5370759|NCT00006604|13211898|P12|COMPLETED|Overall Study||6
5370760|NCT00006604|13211899|P11|COMPLETED|Overall Study||13
5370761|NCT00006604|13211900|P10|COMPLETED|Overall Study||6
5370762|NCT00006604|13211901|P9|COMPLETED|Overall Study||4
5370763|NCT00006604|13211902|P8|COMPLETED|Overall Study||2
5370764|NCT00006604|13211903|P7|COMPLETED|Overall Study||12
5370765|NCT00006604|13211904|P6|COMPLETED|Overall Study||2
5370766|NCT00006604|13211905|P5|COMPLETED|Overall Study||3
5370767|NCT00006604|13211906|P4|COMPLETED|Overall Study||1
5370768|NCT00006604|13211907|P3|COMPLETED|Overall Study||1
5370769|NCT00006604|13211908|P2|COMPLETED|Overall Study||2
5370770|NCT00006604|13211909|P1|COMPLETED|Overall Study||4
5370771|NCT00006604|13211893|P17|STARTED|Overall Study||15
5370772|NCT00006604|13211894|P16|STARTED|Overall Study||6
5370773|NCT00006604|13211895|P15|STARTED|Overall Study||24
5370774|NCT00006604|13211896|P14|STARTED|Overall Study||6
5370775|NCT00006604|13211897|P13|STARTED|Overall Study||26
5370776|NCT00006604|13211898|P12|STARTED|Overall Study||12
5370777|NCT00006604|13211899|P11|STARTED|Overall Study||21
5370778|NCT00006604|13211900|P10|STARTED|Overall Study||25
5370779|NCT00006604|13211901|P9|STARTED|Overall Study||5
5370780|NCT00006604|13211902|P8|STARTED|Overall Study||5
5370781|NCT00006604|13211903|P7|STARTED|Overall Study||21
5370782|NCT00006604|13211904|P6|STARTED|Overall Study||5
5370783|NCT00006604|13211905|P5|STARTED|Overall Study||5
5370784|NCT00006604|13211906|P4|STARTED|Overall Study||6
5370785|NCT00006604|13211907|P3|STARTED|Overall Study||5
5370786|NCT00006604|13211908|P2|STARTED|Overall Study||2
5370787|NCT00006604|13211909|P1|STARTED|Overall Study||6
5370788|NCT00004978|13212025|P2|NOT COMPLETED|Overall Study||270
5370789|NCT00004978|13212026|P1|NOT COMPLETED|Overall Study||244
5370790|NCT00004978|13212025|P2|COMPLETED|Overall Study||1790
5370791|NCT00004978|13212026|P1|COMPLETED|Overall Study||1846
5370792|NCT00004978|13212025|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
5370793|NCT00004978|13212026|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
5370794|NCT00021541|13212052|P2|NOT COMPLETED|Period 2-crossover||11
5370795|NCT00021541|13212053|P1|NOT COMPLETED|Period 2-crossover||10
5370796|NCT00021541|13212052|P2|COMPLETED|Period 2-crossover||12
5370797|NCT00021541|13212053|P1|COMPLETED|Period 2-crossover||10
5370798|NCT00021541|13212052|P2|STARTED|Period 2-crossover||23
5370799|NCT00021541|13212053|P1|STARTED|Period 2-crossover||20
5370800|NCT00021541|13212052|P2|NOT COMPLETED|Period 1-First Treatment||8
5370801|NCT00021541|13212053|P1|NOT COMPLETED|Period 1-First Treatment||11
5370802|NCT00021541|13212052|P2|COMPLETED|Period 1-First Treatment||23
5370803|NCT00021541|13212053|P1|COMPLETED|Period 1-First Treatment||20
5370804|NCT00021541|13212052|P2|Ineligible Patients|Period 1-First Treatment||2
5370805|NCT00021541|13212053|P1|Ineligible Patients|Period 1-First Treatment||0
5370806|NCT00021541|13212052|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
5370807|NCT00021541|13212053|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
5370808|NCT00021541|13212052|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
5370809|NCT00021541|13212053|P1|STARTED|Period 1-First Treatment||31
5370810|NCT00018031|13212063|P1|NOT COMPLETED|Overall Study||0
5370811|NCT00018031|13212063|P1|COMPLETED|Overall Study||36
5370812|NCT00018031|13212063|P1|STARTED|Overall Study||36
5370813|NCT00015457|13212067|P2|NOT COMPLETED|Second Intervention||0
5370814|NCT00015457|13212068|P1|NOT COMPLETED|Second Intervention||1
5370815|NCT00015457|13212067|P2|COMPLETED|Second Intervention||5
5370816|NCT00015457|13212068|P1|COMPLETED|Second Intervention||7
5370817|NCT00015457|13212067|P2|STARTED|Second Intervention||5
5370818|NCT00015457|13212068|P1|STARTED|Second Intervention||8
5370819|NCT00015457|13212067|P2|NOT COMPLETED|First Intervention||3
5370820|NCT00015457|13212068|P1|NOT COMPLETED|First Intervention||0
5370821|NCT00015457|13212067|P2|COMPLETED|First Intervention||5
5370822|NCT00015457|13212068|P1|COMPLETED|First Intervention||8
5370823|NCT00015457|13212067|P2|STARTED|First Intervention||8
5370824|NCT00015457|13212068|P1|STARTED|First Intervention||8
5370825|NCT00013611|13212078|P2|NOT COMPLETED|Overall Study||100
5370826|NCT00013611|13212079|P1|NOT COMPLETED|Overall Study||91
5370827|NCT00013611|13212078|P2|COMPLETED|Overall Study||746
5370828|NCT00013611|13212079|P1|COMPLETED|Overall Study||758
5370829|NCT00013611|13212078|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
5370830|NCT00013611|13212079|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
5370831|NCT00010803|13212097|P2|NOT COMPLETED|Overall Study||98
5370832|NCT00010803|13212098|P1|NOT COMPLETED|Overall Study||97
5370833|NCT00010803|13212097|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
5370834|NCT00010803|13212098|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
5370835|NCT00010803|13212097|P2|STARTED|Overall Study|Randomized|1524
5370836|NCT00010803|13212098|P1|STARTED|Overall Study|Randomized|1545
5370837|NCT00010439|13212108|P1|NOT COMPLETED|Overall Study||0
5370838|NCT00010439|13212108|P1|COMPLETED|Overall Study||10
5370839|NCT00010439|13212108|P1|6 Months|Overall Study||10
5370840|NCT00010439|13212108|P1|STARTED|Overall Study||10
5370841|NCT00010374|13212113|P1|NOT COMPLETED|Overall Study||1
5370842|NCT00010374|13212113|P1|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
5370843|NCT00010374|13212113|P1|STARTED|Overall Study||54
5370844|NCT00007644|13212121|P2|NOT COMPLETED|Overall Study||0
5370845|NCT00007644|13212122|P1|NOT COMPLETED|Overall Study||0
5370846|NCT00007644|13212121|P2|COMPLETED|Overall Study||367
5370847|NCT00007644|13212122|P1|COMPLETED|Overall Study||364
5370848|NCT00007644|13212121|P2|STARTED|Overall Study||367
5370849|NCT00007644|13212122|P1|STARTED|Overall Study||364
5370850|NCT00007475|13212131|P4|NOT COMPLETED|Overall Study||0
5370851|NCT00007475|13212132|P3|NOT COMPLETED|Overall Study||0
5370852|NCT00007475|13212133|P2|NOT COMPLETED|Overall Study||0
5370853|NCT00007475|13212134|P1|NOT COMPLETED|Overall Study||4
5370854|NCT00007475|13212131|P4|COMPLETED|Overall Study||0
5370855|NCT00007475|13212132|P3|COMPLETED|Overall Study||2
5370856|NCT00007475|13212133|P2|COMPLETED|Overall Study||1
5370857|NCT00007475|13212134|P1|COMPLETED|Overall Study||8
5370858|NCT00007475|13212131|P4|Initiate Cyclophosphamide|Overall Study||0
5370859|NCT00007475|13212132|P3|Initiate Cyclophosphamide|Overall Study||2
5370860|NCT00007475|13212133|P2|Initiate Cyclophosphamide|Overall Study||1
5370861|NCT00007475|13212134|P1|Initiate Cyclophosphamide|Overall Study||12
5370862|NCT00007475|13212131|P4|Initial Plasma Exchange|Overall Study||0
5370863|NCT00007475|13212132|P3|Initial Plasma Exchange|Overall Study||2
5370864|NCT00007475|13212133|P2|Initial Plasma Exchange|Overall Study||1
5370865|NCT00007475|13212134|P1|Initial Plasma Exchange|Overall Study||12
5370866|NCT00007475|13212131|P4|Post-initial Transplant Proteinuria|Overall Study||0
5370867|NCT00007475|13212132|P3|Post-initial Transplant Proteinuria|Overall Study||2
5370868|NCT00007475|13212133|P2|Post-initial Transplant Proteinuria|Overall Study||1
5370869|NCT00007475|13212134|P1|Post-initial Transplant Proteinuria|Overall Study||12
5370870|NCT00007475|13212131|P4|Initial Transplant|Overall Study||0
5370871|NCT00007475|13212132|P3|Initial Transplant|Overall Study||2
5370872|NCT00007475|13212133|P2|Initial Transplant|Overall Study||1
5370873|NCT00007475|13212134|P1|Initial Transplant|Overall Study||12
5370874|NCT00007475|13212131|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
5370875|NCT00007475|13212132|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
5370876|NCT00007475|13212133|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
5370877|NCT00007475|13212134|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
5370878|NCT00007475|13212131|P4|STARTED|Overall Study||0
5370879|NCT00007475|13212132|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
5370880|NCT00007475|13212133|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
5370881|NCT00007475|13212134|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
5370882|NCT00007345|13212156|P2|NOT COMPLETED|Overall Study||11
5370883|NCT00007345|13212157|P1|NOT COMPLETED|Overall Study||2
5370884|NCT00007345|13212156|P2|COMPLETED|Overall Study||73
5370885|NCT00007345|13212157|P1|COMPLETED|Overall Study||45
5370886|NCT00007345|13212156|P2|STARTED|Overall Study||84
5370887|NCT00007345|13212157|P1|STARTED|Overall Study||47
5370888|NCT00007020|13212175|P1|NOT COMPLETED|Overall Study||44
5370889|NCT00007020|13212175|P1|COMPLETED|Overall Study||41
5370890|NCT00007020|13212175|P1|STARTED|Overall Study||85
5370891|NCT00006489|13212188|P4|NOT COMPLETED|Overall Study||11
5370892|NCT00006489|13212189|P3|NOT COMPLETED|Overall Study||15
5370893|NCT00006489|13212190|P2|NOT COMPLETED|Overall Study||14
5370894|NCT00006489|13212191|P1|NOT COMPLETED|Overall Study||13
5370895|NCT00006489|13212188|P4|COMPLETED|Overall Study||32
5370896|NCT00006489|13212189|P3|COMPLETED|Overall Study||25
5370897|NCT00006489|13212190|P2|COMPLETED|Overall Study||26
5370898|NCT00006489|13212191|P1|COMPLETED|Overall Study||29
5370899|NCT00006489|13212188|P4|STARTED|Overall Study||43
5370900|NCT00006489|13212189|P3|STARTED|Overall Study||40
5370901|NCT00006489|13212190|P2|STARTED|Overall Study||40
5370902|NCT00006489|13212191|P1|STARTED|Overall Study||42
5370903|NCT00006411|13212211|P2|NOT COMPLETED|Overall Study||0
5370904|NCT00006411|13212212|P1|NOT COMPLETED|Overall Study||0
5370905|NCT00006411|13212211|P2|COMPLETED|Overall Study||383
5370906|NCT00006411|13212212|P1|COMPLETED|Overall Study||707
5370907|NCT00006411|13212211|P2|STARTED|Overall Study||383
5370908|NCT00006411|13212212|P1|STARTED|Overall Study||707
5370909|NCT00006409|13212226|P6|NOT COMPLETED|Post-3 Year Intervention||62
5370910|NCT00006409|13212227|P5|NOT COMPLETED|Post-3 Year Intervention||62
5370911|NCT00006409|13212228|P4|NOT COMPLETED|Post-3 Year Intervention||0
5370912|NCT00006409|13212229|P3|NOT COMPLETED|Post-3 Year Intervention||0
5370913|NCT00006409|13212230|P2|NOT COMPLETED|Post-3 Year Intervention||0
5370914|NCT00006409|13212231|P1|NOT COMPLETED|Post-3 Year Intervention||0
5370915|NCT00006409|13212226|P6|COMPLETED|Post-3 Year Intervention||1714
5370916|NCT00006409|13212227|P5|COMPLETED|Post-3 Year Intervention||1664
5370917|NCT00006409|13212228|P4|COMPLETED|Post-3 Year Intervention||0
5370918|NCT00006409|13212229|P3|COMPLETED|Post-3 Year Intervention||0
5370919|NCT00006409|13212230|P2|COMPLETED|Post-3 Year Intervention||0
5370920|NCT00006409|13212231|P1|COMPLETED|Post-3 Year Intervention||0
5370921|NCT00006409|13212226|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
5370922|NCT00006409|13212227|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
5370923|NCT00006409|13212228|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
5370924|NCT00006409|13212229|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
5370925|NCT00006409|13212230|P2|STARTED|Post-3 Year Intervention||0
5370926|NCT00006409|13212231|P1|STARTED|Post-3 Year Intervention||0
5370927|NCT00006409|13212226|P6|NOT COMPLETED|Post-2 Year Intervention||0
5370928|NCT00006409|13212227|P5|NOT COMPLETED|Post-2 Year Intervention||0
5370929|NCT00006409|13212228|P4|NOT COMPLETED|Post-2 Year Intervention||168
5370930|NCT00006409|13212229|P3|NOT COMPLETED|Post-2 Year Intervention||251
5370931|NCT00006409|13212230|P2|NOT COMPLETED|Post-2 Year Intervention||0
5370932|NCT00006409|13212231|P1|NOT COMPLETED|Post-2 Year Intervention||0
5370933|NCT00006409|13212226|P6|COMPLETED|Post-2 Year Intervention||0
5370934|NCT00006409|13212227|P5|COMPLETED|Post-2 Year Intervention||0
5370935|NCT00006409|13212228|P4|COMPLETED|Post-2 Year Intervention||1545
5370936|NCT00006409|13212229|P3|COMPLETED|Post-2 Year Intervention||1540
5370937|NCT00006409|13212230|P2|COMPLETED|Post-2 Year Intervention||0
5370938|NCT00006409|13212231|P1|COMPLETED|Post-2 Year Intervention||0
5370939|NCT00006409|13212226|P6|STARTED|Post-2 Year Intervention||0
5370940|NCT00006409|13212227|P5|STARTED|Post-2 Year Intervention||0
5370941|NCT00006409|13212228|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
5370942|NCT00006409|13212229|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
5370943|NCT00006409|13212230|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
5370944|NCT00006409|13212231|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
5370945|NCT00006409|13212226|P6|NOT COMPLETED|Baseline||0
5370946|NCT00006409|13212227|P5|NOT COMPLETED|Baseline||0
5370947|NCT00006409|13212228|P4|NOT COMPLETED|Baseline||0
5370948|NCT00006409|13212229|P3|NOT COMPLETED|Baseline||0
5370949|NCT00006409|13212230|P2|NOT COMPLETED|Baseline||70
5370950|NCT00006409|13212231|P1|NOT COMPLETED|Baseline||48
5370951|NCT00006409|13212226|P6|COMPLETED|Baseline||0
5370952|NCT00006409|13212227|P5|COMPLETED|Baseline||0
5370953|NCT00006409|13212228|P4|COMPLETED|Baseline||0
5370954|NCT00006409|13212229|P3|COMPLETED|Baseline||0
5370955|NCT00006409|13212230|P2|COMPLETED|Baseline||786
5370956|NCT00006409|13212231|P1|COMPLETED|Baseline||817
5370957|NCT00006409|13212226|P6|STARTED|Baseline||0
5370958|NCT00006409|13212227|P5|STARTED|Baseline||0
5370959|NCT00006409|13212228|P4|STARTED|Baseline||0
5370960|NCT00006409|13212229|P3|STARTED|Baseline||0
5370961|NCT00006409|13212230|P2|STARTED|Baseline||856
5370962|NCT00006409|13212231|P1|STARTED|Baseline||865
5370963|NCT00006305|13212255|P4|NOT COMPLETED|Overall Study||14
5370964|NCT00006305|13212256|P3|NOT COMPLETED|Overall Study||15
5370965|NCT00006305|13212257|P2|NOT COMPLETED|Overall Study||10
5370966|NCT00006305|13212258|P1|NOT COMPLETED|Overall Study||17
5370967|NCT00006305|13212255|P4|COMPLETED|Overall Study||585
5370968|NCT00006305|13212256|P3|COMPLETED|Overall Study||578
5370969|NCT00006305|13212257|P2|COMPLETED|Overall Study||574
5370970|NCT00006305|13212258|P1|COMPLETED|Overall Study||575
5370971|NCT00006305|13212255|P4|STARTED|Overall Study||599
5370972|NCT00006305|13212256|P3|STARTED|Overall Study||593
5370973|NCT00006305|13212257|P2|STARTED|Overall Study||584
5370974|NCT00006305|13212258|P1|STARTED|Overall Study||592
5370975|NCT00006289|13212274|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
5370976|NCT00006289|13212275|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
5370977|NCT00006289|13212274|P2|COMPLETED|Second Intervention (5 Weeks)||9
5370978|NCT00006289|13212275|P1|COMPLETED|Second Intervention (5 Weeks)||9
5370979|NCT00006289|13212274|P2|STARTED|Second Intervention (5 Weeks)||10
5370980|NCT00006289|13212275|P1|STARTED|Second Intervention (5 Weeks)||10
5370981|NCT00006289|13212274|P2|NOT COMPLETED|Washout (>= 1 Week)||0
5370982|NCT00006289|13212275|P1|NOT COMPLETED|Washout (>= 1 Week)||0
5370983|NCT00006289|13212274|P2|COMPLETED|Washout (>= 1 Week)||10
5370984|NCT00006289|13212275|P1|COMPLETED|Washout (>= 1 Week)||10
5370985|NCT00006289|13212274|P2|STARTED|Washout (>= 1 Week)||10
5370986|NCT00006289|13212275|P1|STARTED|Washout (>= 1 Week)||10
5370987|NCT00006289|13212274|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
5370988|NCT00006289|13212275|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
5370989|NCT00006289|13212274|P2|COMPLETED|First Intervention (5 Weeks)||10
5370990|NCT00006289|13212275|P1|COMPLETED|First Intervention (5 Weeks)||10
5370991|NCT00006289|13212274|P2|STARTED|First Intervention (5 Weeks)||10
5370992|NCT00006289|13212275|P1|STARTED|First Intervention (5 Weeks)||11
5370993|NCT00006184|13212293|P2|NOT COMPLETED|Overall Study||0
5370994|NCT00006184|13212294|P1|NOT COMPLETED|Overall Study||1
5370995|NCT00006184|13212293|P2|COMPLETED|Overall Study||10
5370996|NCT00006184|13212294|P1|COMPLETED|Overall Study||9
5370997|NCT00006184|13212293|P2|STARTED|Overall Study||10
5370998|NCT00006184|13212294|P1|STARTED|Overall Study||10
5370999|NCT00006178|13212301|P1|NOT COMPLETED|Overall Study||0
5371000|NCT00006178|13212301|P1|COMPLETED|Overall Study||12
5371001|NCT00006178|13212301|P1|STARTED|Overall Study||12
5371002|NCT00006170|13212312|P4|NOT COMPLETED|Overall Study||39
5371003|NCT00006170|13212313|P3|NOT COMPLETED|Overall Study||43
5371004|NCT00006170|13212314|P2|NOT COMPLETED|Overall Study||50
5371005|NCT00006170|13212315|P1|NOT COMPLETED|Overall Study||49
5371006|NCT00006170|13212312|P4|COMPLETED|Overall Study||28
5371007|NCT00006170|13212313|P3|COMPLETED|Overall Study||46
5371008|NCT00006170|13212314|P2|COMPLETED|Overall Study||37
5371009|NCT00006170|13212315|P1|COMPLETED|Overall Study||57
5371010|NCT00006170|13212312|P4|STARTED|Overall Study||67
5371011|NCT00006170|13212313|P3|STARTED|Overall Study||89
5371012|NCT00006170|13212314|P2|STARTED|Overall Study||87
5371013|NCT00006170|13212315|P1|STARTED|Overall Study||106
5371014|NCT00006156|13212335|P2|NOT COMPLETED|Overall Study||0
5371015|NCT00006156|13212336|P1|NOT COMPLETED|Overall Study||0
5371016|NCT00006156|13212335|P2|COMPLETED|Overall Study||7
5371017|NCT00006156|13212336|P1|COMPLETED|Overall Study||42
5371018|NCT00006156|13212335|P2|STARTED|Overall Study||7
5371019|NCT00006156|13212336|P1|STARTED|Overall Study||42
5371020|NCT00006164|13212345|P2|NOT COMPLETED|Overall Study||81
5371021|NCT00006164|13212346|P1|NOT COMPLETED|Overall Study||70
5371022|NCT00006164|13212345|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
5371023|NCT00006164|13212346|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
5371024|NCT00006164|13212345|P2|STARTED|Overall Study||533
5371025|NCT00006164|13212346|P1|STARTED|Overall Study||517
5371026|NCT00006151|13212382|P2|NOT COMPLETED|Overall Study||14
5371027|NCT00006151|13212383|P1|NOT COMPLETED|Overall Study||13
5371028|NCT00006151|13212382|P2|COMPLETED|Overall Study||16
5371029|NCT00006151|13212383|P1|COMPLETED|Overall Study||17
5371030|NCT00006151|13212382|P2|STARTED|Overall Study||30
5371031|NCT00006151|13212383|P1|STARTED|Overall Study||30
5371032|NCT00005937|13212389|P1|NOT COMPLETED|Overall Study||5
5371033|NCT00005937|13212389|P1|COMPLETED|Overall Study||37
5371034|NCT00005937|13212389|P1|STARTED|Overall Study||42
5371035|NCT00005908|13212393|P2|NOT COMPLETED|Overall Study||0
5371036|NCT00005908|13212394|P1|NOT COMPLETED|Overall Study||1
5371037|NCT00005908|13212393|P2|COMPLETED|Overall Study||20
5371038|NCT00005908|13212394|P1|COMPLETED|Overall Study||9
5371039|NCT00005908|13212393|P2|STARTED|Overall Study||20
5371040|NCT00005908|13212394|P1|STARTED|Overall Study||10
5371041|NCT00005906|13212403|P1|NOT COMPLETED|Overall Study||3
5371042|NCT00005906|13212403|P1|COMPLETED|Overall Study||1
5371043|NCT00005906|13212403|P1|STARTED|Overall Study||4
5371044|NCT00005901|13212411|P2|NOT COMPLETED|Overall Study||0
5371045|NCT00005901|13212412|P1|NOT COMPLETED|Overall Study||0
5371046|NCT00005901|13212411|P2|COMPLETED|Overall Study||15
5371047|NCT00005901|13212412|P1|COMPLETED|Overall Study||19
5371048|NCT00005901|13212411|P2|STARTED|Overall Study||15
5371049|NCT00005901|13212412|P1|STARTED|Overall Study||19
5371050|NCT00005669|13212430|P2|NOT COMPLETED|Overall Study||7
5371051|NCT00005669|13212431|P1|NOT COMPLETED|Overall Study||8
5371052|NCT00005669|13212430|P2|COMPLETED|Overall Study||40
5371053|NCT00005669|13212431|P1|COMPLETED|Overall Study||45
5371054|NCT00005669|13212430|P2|STARTED|Overall Study||47
5371055|NCT00005669|13212431|P1|STARTED|Overall Study||53
5371056|NCT00004980|13212447|P2|NOT COMPLETED|Overall Study||2
5371057|NCT00004980|13212448|P1|NOT COMPLETED|Overall Study||2
5371058|NCT00004980|13212447|P2|COMPLETED|Overall Study||21
5371059|NCT00004980|13212448|P1|COMPLETED|Overall Study||25
5371060|NCT00004980|13212447|P2|STARTED|Overall Study||23
5371061|NCT00004980|13212448|P1|STARTED|Overall Study||27
5371062|NCT00004732|13212462|P2|NOT COMPLETED|Overall Study||111
5371063|NCT00004732|13212463|P1|NOT COMPLETED|Overall Study||69
5371064|NCT00004732|13212462|P2|COMPLETED|Overall Study||1129
5371065|NCT00004732|13212463|P1|COMPLETED|Overall Study||1193
5371066|NCT00004732|13212462|P2|STARTED|Overall Study||1240
5371067|NCT00004732|13212463|P1|STARTED|Overall Study||1262
5371068|NCT00004635|13212473|P2|NOT COMPLETED|Period Two||9
5371069|NCT00004635|13212474|P1|NOT COMPLETED|Period Two||6
5371070|NCT00004635|13212473|P2|COMPLETED|Period Two||50
5371071|NCT00004635|13212474|P1|COMPLETED|Period Two||38
5371072|NCT00004635|13212473|P2|STARTED|Period Two||59
5371073|NCT00004635|13212474|P1|STARTED|Period Two||44
5371074|NCT00004635|13212473|P2|NOT COMPLETED|Period One||6
5371075|NCT00004635|13212474|P1|NOT COMPLETED|Period One||6
5371076|NCT00004635|13212473|P2|COMPLETED|Period One||74
5371077|NCT00004635|13212474|P1|COMPLETED|Period One||73
5371078|NCT00004635|13212473|P2|Received Treatment|Period One||75
5371079|NCT00004635|13212474|P1|Received Treatment|Period One||73
5371080|NCT00004635|13212473|P2|STARTED|Period One||80
5371081|NCT00004635|13212474|P1|STARTED|Period One||79
5371082|NCT00004563|13212486|P2|NOT COMPLETED|Overall Study||24
5371083|NCT00004563|13212487|P1|NOT COMPLETED|Overall Study||25
5371084|NCT00004563|13212486|P2|COMPLETED|Overall Study||55
5371085|NCT00004563|13212487|P1|COMPLETED|Overall Study||54
5371086|NCT00004563|13212486|P2|STARTED|Overall Study||79
5371087|NCT00004563|13212487|P1|STARTED|Overall Study||79
5371088|NCT00004562|13212499|P2|NOT COMPLETED|Overall Study||91
5371089|NCT00004562|13212500|P1|NOT COMPLETED|Overall Study||102
5371090|NCT00004562|13212499|P2|COMPLETED|Overall Study||1009
5371091|NCT00004562|13212500|P1|COMPLETED|Overall Study||999
5371092|NCT00004562|13212499|P2|STARTED|Overall Study||1100
5371093|NCT00004562|13212500|P1|STARTED|Overall Study||1101
5371094|NCT00004547|13212511|P3|NOT COMPLETED|Overall Study||22
5371095|NCT00004547|13212512|P2|NOT COMPLETED|Overall Study||9
5371096|NCT00004547|13212513|P1|NOT COMPLETED|Overall Study||22
5371097|NCT00004547|13212511|P3|COMPLETED|Overall Study||35
5371098|NCT00004547|13212512|P2|COMPLETED|Overall Study||39
5371099|NCT00004547|13212513|P1|COMPLETED|Overall Study||61
5371100|NCT00004547|13212511|P3|Not Evaluable|Overall Study||23
5371101|NCT00004547|13212512|P2|Not Evaluable|Overall Study||9
5371102|NCT00004547|13212513|P1|Not Evaluable|Overall Study||21
5371103|NCT00004547|13212511|P3|STARTED|Overall Study||57
5371104|NCT00004547|13212512|P2|STARTED|Overall Study||48
5371105|NCT00004547|13212513|P1|STARTED|Overall Study||83
5371106|NCT00001984|13212531|P1|NOT COMPLETED|Overall Study||0
5371107|NCT00001984|13212531|P1|COMPLETED|Overall Study||5
5371108|NCT00001984|13212531|P1|STARTED|Overall Study||5
5371109|NCT00001962|13212541|P1|NOT COMPLETED|Overall Study||28
5371110|NCT00001962|13212541|P1|COMPLETED|Overall Study||72
5371111|NCT00001962|13212541|P1|STARTED|Overall Study||100
5371112|NCT00001959|13212545|P1|NOT COMPLETED|Overall Study||3
5371113|NCT00001959|13212545|P1|COMPLETED|Overall Study||18
5371114|NCT00001959|13212545|P1|STARTED|Overall Study||21
5371115|NCT00001941|13212551|P5|NOT COMPLETED|Overall Study||1
5371116|NCT00001941|13212552|P4|NOT COMPLETED|Overall Study||0
5371117|NCT00001941|13212553|P3|NOT COMPLETED|Overall Study||0
5371118|NCT00001941|13212554|P2|NOT COMPLETED|Overall Study||0
5371119|NCT00001941|13212555|P1|NOT COMPLETED|Overall Study||0
5371120|NCT00001941|13212551|P5|COMPLETED|Overall Study||19
5371121|NCT00001941|13212552|P4|COMPLETED|Overall Study||3
5371122|NCT00001941|13212553|P3|COMPLETED|Overall Study||3
5371123|NCT00001941|13212554|P2|COMPLETED|Overall Study||5
5371124|NCT00001941|13212555|P1|COMPLETED|Overall Study||3
5371125|NCT00001941|13212551|P5|STARTED|Overall Study||20
5371126|NCT00001941|13212552|P4|STARTED|Overall Study||3
5371127|NCT00001941|13212553|P3|STARTED|Overall Study||3
5371128|NCT00001941|13212554|P2|STARTED|Overall Study||5
5371129|NCT00001941|13212555|P1|STARTED|Overall Study||3
5371130|NCT00000392|13212564|P2|NOT COMPLETED|Overall Study||32
5371131|NCT00000392|13212565|P1|NOT COMPLETED|Overall Study||40
5371132|NCT00000392|13212564|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
5371133|NCT00000392|13212565|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
5371134|NCT00000392|13212564|P2|STARTED|Overall Study||109
5371135|NCT00000392|13212565|P1|STARTED|Overall Study||106
5371136|NCT00001832|13212587|P15|NOT COMPLETED|Treatment Period||0
5371137|NCT00001832|13212588|P14|NOT COMPLETED|Treatment Period||0
5371138|NCT00001832|13212589|P13|NOT COMPLETED|Treatment Period||0
5371139|NCT00001832|13212590|P12|NOT COMPLETED|Treatment Period||0
5371140|NCT00001832|13212591|P11|NOT COMPLETED|Treatment Period||0
5371141|NCT00001832|13212592|P10|NOT COMPLETED|Treatment Period||0
5371142|NCT00001832|13212593|P9|NOT COMPLETED|Treatment Period||0
5371143|NCT00001832|13212594|P8|NOT COMPLETED|Treatment Period||1
5371144|NCT00001832|13212595|P7|NOT COMPLETED|Treatment Period||0
5371145|NCT00001832|13212596|P6|NOT COMPLETED|Treatment Period||1
5371146|NCT00001832|13212597|P5|NOT COMPLETED|Treatment Period||0
5371147|NCT00001832|13212598|P4|NOT COMPLETED|Treatment Period||0
5371148|NCT00001832|13212599|P3|NOT COMPLETED|Treatment Period||0
5371149|NCT00001832|13212600|P2|NOT COMPLETED|Treatment Period||0
5371150|NCT00001832|13212601|P1|NOT COMPLETED|Treatment Period||0
5371151|NCT00001832|13212587|P15|COMPLETED|Treatment Period||2
5371152|NCT00001832|13212588|P14|COMPLETED|Treatment Period||3
5371153|NCT00001832|13212589|P13|COMPLETED|Treatment Period||6
5371154|NCT00001832|13212590|P12|COMPLETED|Treatment Period||7
5371155|NCT00001832|13212591|P11|COMPLETED|Treatment Period||1
5371156|NCT00001832|13212592|P10|COMPLETED|Treatment Period||6
5371157|NCT00001832|13212593|P9|COMPLETED|Treatment Period||8
5371158|NCT00001832|13212594|P8|COMPLETED|Treatment Period||6
5371159|NCT00001832|13212595|P7|COMPLETED|Treatment Period||4
5371160|NCT00001832|13212596|P6|COMPLETED|Treatment Period||50
5371161|NCT00001832|13212597|P5|COMPLETED|Treatment Period||6
5371162|NCT00001832|13212598|P4|COMPLETED|Treatment Period||3
5371163|NCT00001832|13212599|P3|COMPLETED|Treatment Period||3
5371164|NCT00001832|13212600|P2|COMPLETED|Treatment Period||3
5371165|NCT00001832|13212601|P1|COMPLETED|Treatment Period||0
5371166|NCT00001832|13212587|P15|STARTED|Treatment Period||2
5371167|NCT00001832|13212588|P14|STARTED|Treatment Period||3
5371168|NCT00001832|13212589|P13|STARTED|Treatment Period||6
5371169|NCT00001832|13212590|P12|STARTED|Treatment Period||7
5371170|NCT00001832|13212591|P11|STARTED|Treatment Period||1
5371171|NCT00001832|13212592|P10|STARTED|Treatment Period||6
5371172|NCT00001832|13212593|P9|STARTED|Treatment Period||8
5371173|NCT00001832|13212594|P8|STARTED|Treatment Period||7
5371174|NCT00001832|13212595|P7|STARTED|Treatment Period||4
5371175|NCT00001832|13212596|P6|STARTED|Treatment Period||51
5371176|NCT00001832|13212597|P5|STARTED|Treatment Period||6
5371177|NCT00001832|13212598|P4|STARTED|Treatment Period||3
5371178|NCT00001832|13212599|P3|STARTED|Treatment Period||3
5371179|NCT00001832|13212600|P2|STARTED|Treatment Period||3
5371180|NCT00001832|13212601|P1|STARTED|Treatment Period||0
5371181|NCT00001832|13212587|P15|NOT COMPLETED|Apheresis Period||0
5371182|NCT00001832|13212588|P14|NOT COMPLETED|Apheresis Period||0
5371183|NCT00001832|13212589|P13|NOT COMPLETED|Apheresis Period||0
5371184|NCT00001832|13212590|P12|NOT COMPLETED|Apheresis Period||0
5371185|NCT00001832|13212591|P11|NOT COMPLETED|Apheresis Period||0
5371186|NCT00001832|13212592|P10|NOT COMPLETED|Apheresis Period||0
5371187|NCT00001832|13212593|P9|NOT COMPLETED|Apheresis Period||0
5371188|NCT00001832|13212594|P8|NOT COMPLETED|Apheresis Period||0
5371189|NCT00001832|13212595|P7|NOT COMPLETED|Apheresis Period||0
5371190|NCT00001832|13212596|P6|NOT COMPLETED|Apheresis Period||0
5371191|NCT00001832|13212597|P5|NOT COMPLETED|Apheresis Period||0
5371192|NCT00001832|13212598|P4|NOT COMPLETED|Apheresis Period||0
5371193|NCT00001832|13212599|P3|NOT COMPLETED|Apheresis Period||0
5371194|NCT00001832|13212600|P2|NOT COMPLETED|Apheresis Period||0
5371195|NCT00001832|13212601|P1|NOT COMPLETED|Apheresis Period||60
5371196|NCT00001832|13212587|P15|COMPLETED|Apheresis Period||0
5371197|NCT00001832|13212588|P14|COMPLETED|Apheresis Period||0
5371198|NCT00001832|13212589|P13|COMPLETED|Apheresis Period||0
5371199|NCT00001832|13212590|P12|COMPLETED|Apheresis Period||0
5371200|NCT00001832|13212591|P11|COMPLETED|Apheresis Period||0
5371201|NCT00001832|13212592|P10|COMPLETED|Apheresis Period||0
5371202|NCT00001832|13212593|P9|COMPLETED|Apheresis Period||0
5371203|NCT00001832|13212594|P8|COMPLETED|Apheresis Period||0
5371204|NCT00001832|13212595|P7|COMPLETED|Apheresis Period||0
5371205|NCT00001832|13212596|P6|COMPLETED|Apheresis Period||0
5371206|NCT00001832|13212597|P5|COMPLETED|Apheresis Period||0
5371207|NCT00001832|13212598|P4|COMPLETED|Apheresis Period||0
5371208|NCT00001832|13212599|P3|COMPLETED|Apheresis Period||0
5371209|NCT00001832|13212600|P2|COMPLETED|Apheresis Period||0
5371210|NCT00001832|13212601|P1|COMPLETED|Apheresis Period||110
5371211|NCT00001832|13212587|P15|STARTED|Apheresis Period||0
5371212|NCT00001832|13212588|P14|STARTED|Apheresis Period||0
5371213|NCT00001832|13212589|P13|STARTED|Apheresis Period||0
5371214|NCT00001832|13212590|P12|STARTED|Apheresis Period||0
5371215|NCT00001832|13212591|P11|STARTED|Apheresis Period||0
5371216|NCT00001832|13212592|P10|STARTED|Apheresis Period||0
5371217|NCT00001832|13212593|P9|STARTED|Apheresis Period||0
5371218|NCT00001832|13212594|P8|STARTED|Apheresis Period||0
5371219|NCT00001832|13212595|P7|STARTED|Apheresis Period||0
5371220|NCT00001832|13212596|P6|STARTED|Apheresis Period||0
5371221|NCT00001832|13212597|P5|STARTED|Apheresis Period||0
5371222|NCT00001832|13212598|P4|STARTED|Apheresis Period||0
5371223|NCT00001832|13212599|P3|STARTED|Apheresis Period||0
5371224|NCT00001832|13212600|P2|STARTED|Apheresis Period||0
5371225|NCT00001832|13212601|P1|STARTED|Apheresis Period||170
5371226|NCT00001723|13212647|P2|NOT COMPLETED|Overall Study||16
5371227|NCT00001723|13212648|P1|NOT COMPLETED|Overall Study||13
5371228|NCT00001723|13212647|P2|COMPLETED|Overall Study||84
5371229|NCT00001723|13212648|P1|COMPLETED|Overall Study||87
5371230|NCT00001723|13212647|P2|STARTED|Overall Study||100
5371231|NCT00001723|13212648|P1|STARTED|Overall Study||100
5371232|NCT00001703|13212664|P1|NOT COMPLETED|Overall Study||5
5371233|NCT00001703|13212664|P1|COMPLETED|Overall Study||1
5371234|NCT00001703|13212664|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
5371235|NCT00001703|13212664|P1|STARTED|Overall Study||6
5371236|NCT00001656|13212671|P2|NOT COMPLETED|Overall Study||0
5371237|NCT00001656|13212672|P1|NOT COMPLETED|Overall Study||1
5371238|NCT00001656|13212671|P2|COMPLETED|Overall Study||12
5371239|NCT00001656|13212672|P1|COMPLETED|Overall Study||12
5371240|NCT00001656|13212671|P2|STARTED|Overall Study||12
5371241|NCT00001656|13212672|P1|STARTED|Overall Study||13
5371242|NCT00001596|13212702|P2|NOT COMPLETED|Overall Study||10
5371243|NCT00001596|13212703|P1|NOT COMPLETED|Overall Study||17
5371244|NCT00001596|13212702|P2|COMPLETED|Overall Study||2
5371245|NCT00001596|13212703|P1|COMPLETED|Overall Study||6
5371246|NCT00001596|13212702|P2|STARTED|Overall Study||12
5371247|NCT00001596|13212703|P1|STARTED|Overall Study||23
5371248|NCT00001586|13212725|P2|NOT COMPLETED|Overall Study||0
5371249|NCT00001586|13212726|P1|NOT COMPLETED|Overall Study||0
5371250|NCT00001586|13212725|P2|COMPLETED|Overall Study||56
5371251|NCT00001586|13212726|P1|COMPLETED|Overall Study||49
5371252|NCT00001586|13212725|P2|STARTED|Overall Study||56
5371253|NCT00001586|13212726|P1|STARTED|Overall Study||49
5371254|NCT00001575|13212734|P1|NOT COMPLETED|Overall Study||45
5371255|NCT00001575|13212734|P1|COMPLETED|Overall Study||42
5371256|NCT00001575|13212734|P1|Treated|Overall Study||65
5371257|NCT00001575|13212734|P1|STARTED|Overall Study||87
5371258|NCT00001566|13212740|P1|NOT COMPLETED|Overall Study||19
5371259|NCT00001566|13212740|P1|COMPLETED|Overall Study||23
5371260|NCT00001566|13212740|P1|Completed Immunotherapy|Overall Study||23
5371261|NCT00001566|13212740|P1|STARTED|Overall Study||42
5371262|NCT00001305|13212752|P1|NOT COMPLETED|Overall Study||0
5371263|NCT00001305|13212752|P1|COMPLETED|Overall Study||42
5371264|NCT00001305|13212752|P1|STARTED|Overall Study||42
5371265|NCT00001304|13212758|P2|NOT COMPLETED|Overall Study||0
5371266|NCT00001304|13212759|P1|NOT COMPLETED|Overall Study||0
5371267|NCT00001304|13212758|P2|COMPLETED|Overall Study||14
5371268|NCT00001304|13212759|P1|COMPLETED|Overall Study||13
5371269|NCT00001304|13212758|P2|STARTED|Overall Study||14
5371270|NCT00001304|13212759|P1|STARTED|Overall Study||13
5371271|NCT00001262|13212780|P3|NOT COMPLETED|Overall Study||0
5371272|NCT00001262|13212781|P2|NOT COMPLETED|Overall Study||14
5371273|NCT00001262|13212782|P1|NOT COMPLETED|Overall Study||10
5371274|NCT00001262|13212780|P3|COMPLETED|Overall Study||3
5371275|NCT00001262|13212781|P2|COMPLETED|Overall Study||8
5371276|NCT00001262|13212782|P1|COMPLETED|Overall Study||25
5371277|NCT00001262|13212780|P3|STARTED|Overall Study||3
5371278|NCT00001262|13212781|P2|STARTED|Overall Study||22
5371279|NCT00001262|13212782|P1|STARTED|Overall Study||35
5371280|NCT00001213|13212808|P1|NOT COMPLETED|Overall Study||18
5371281|NCT00001213|13212808|P1|COMPLETED|Overall Study||310
5371282|NCT00001213|13212808|P1|STARTED|Overall Study||328
5371283|NCT00001151|13212813|P1|NOT COMPLETED|Overall Study||5
5371284|NCT00001151|13212813|P1|COMPLETED|Overall Study||1
5371285|NCT00001151|13212813|P1|STARTED|Overall Study||6
5371286|NCT00000378|13212819|P2|NOT COMPLETED|Overall Study||14
5371287|NCT00000378|13212820|P1|NOT COMPLETED|Overall Study||16
5371288|NCT00000378|13212819|P2|COMPLETED|Overall Study||38
5371289|NCT00000378|13212820|P1|COMPLETED|Overall Study||42
5371290|NCT00000378|13212819|P2|STARTED|Overall Study||52
5371291|NCT00000378|13212820|P1|STARTED|Overall Study||58
5371292|NCT00000371|13212828|P2|NOT COMPLETED|Overall Study||16
5371293|NCT00000371|13212829|P1|NOT COMPLETED|Overall Study||13
5371294|NCT00000371|13212828|P2|COMPLETED|Overall Study||12
5371295|NCT00000371|13212829|P1|COMPLETED|Overall Study||14
5371296|NCT00000371|13212828|P2|STARTED|Overall Study||28
5371297|NCT00000371|13212829|P1|STARTED|Overall Study||27
5371298|NCT00000620|13212837|P8|NOT COMPLETED|Overall Study||146
5371299|NCT00000620|13212838|P7|NOT COMPLETED|Overall Study||149
5371300|NCT00000620|13212839|P6|NOT COMPLETED|Overall Study||152
5371301|NCT00000620|13212840|P5|NOT COMPLETED|Overall Study||135
5371302|NCT00000620|13212841|P4|NOT COMPLETED|Overall Study||178
5371303|NCT00000620|13212842|P3|NOT COMPLETED|Overall Study||170
5371304|NCT00000620|13212843|P2|NOT COMPLETED|Overall Study||136
5371305|NCT00000620|13212844|P1|NOT COMPLETED|Overall Study||162
5371306|NCT00000620|13212837|P8|COMPLETED|Overall Study||1224
5371307|NCT00000620|13212838|P7|COMPLETED|Overall Study||1242
5371308|NCT00000620|13212839|P6|COMPLETED|Overall Study||1026
5371309|NCT00000620|13212840|P5|COMPLETED|Overall Study||1049
5371310|NCT00000620|13212841|P4|COMPLETED|Overall Study||1205
5371311|NCT00000620|13212842|P3|COMPLETED|Overall Study||1204
5371312|NCT00000620|13212843|P2|COMPLETED|Overall Study||1057
5371313|NCT00000620|13212844|P1|COMPLETED|Overall Study||1016
5371314|NCT00000620|13212837|P8|STARTED|Overall Study||1370
5371315|NCT00000620|13212838|P7|STARTED|Overall Study||1391
5371316|NCT00000620|13212839|P6|STARTED|Overall Study||1178
5371317|NCT00000620|13212840|P5|STARTED|Overall Study||1184
5371318|NCT00000620|13212841|P4|STARTED|Overall Study||1383
5371319|NCT00000620|13212842|P3|STARTED|Overall Study||1374
5371320|NCT00000620|13212843|P2|STARTED|Overall Study||1193
5371321|NCT00000620|13212844|P1|STARTED|Overall Study||1178
5371322|NCT00000575|13212863|P3|NOT COMPLETED|Overall Study||0
5371323|NCT00000575|13212864|P2|NOT COMPLETED|Overall Study||0
5371324|NCT00000575|13212865|P1|NOT COMPLETED|Overall Study||0
5371325|NCT00000575|13212863|P3|COMPLETED|Overall Study||418
5371326|NCT00000575|13212864|P2|COMPLETED|Overall Study||312
5371327|NCT00000575|13212865|P1|COMPLETED|Overall Study||311
5371328|NCT00000575|13212863|P3|STARTED|Overall Study||418
5371329|NCT00000575|13212864|P2|STARTED|Overall Study||312
5371330|NCT00000575|13212865|P1|STARTED|Overall Study||311
5371331|NCT00000479|13212895|P4|NOT COMPLETED|Overall Study||0
5371332|NCT00000479|13212896|P3|NOT COMPLETED|Overall Study||0
5371333|NCT00000479|13212897|P2|NOT COMPLETED|Overall Study||0
5371334|NCT00000479|13212898|P1|NOT COMPLETED|Overall Study||0
5371335|NCT00000479|13212895|P4|COMPLETED|Overall Study||9971
5371336|NCT00000479|13212896|P3|COMPLETED|Overall Study||9966
5371337|NCT00000479|13212897|P2|COMPLETED|Overall Study||9971
5371338|NCT00000479|13212898|P1|COMPLETED|Overall Study||9968
5371339|NCT00000479|13212895|P4|STARTED|Overall Study||9971
5371340|NCT00000479|13212896|P3|STARTED|Overall Study||9966
5371341|NCT00000479|13212897|P2|STARTED|Overall Study||9971
5371342|NCT00000479|13212898|P1|STARTED|Overall Study||9968
5371343|NCT00004500|13212914|P2|NOT COMPLETED|Overall Study||0
5371344|NCT00004500|13212915|P1|NOT COMPLETED|Overall Study||0
5371345|NCT00004500|13212914|P2|COMPLETED|Overall Study||31
5371346|NCT00004500|13212915|P1|COMPLETED|Overall Study||38
5371347|NCT00004500|13212914|P2|1 Year Follow-Up|Overall Study||24
5371348|NCT00004500|13212915|P1|1 Year Follow-Up|Overall Study||24
5371349|NCT00004500|13212914|P2|STARTED|Overall Study||31
5371350|NCT00004500|13212915|P1|STARTED|Overall Study||38
5371351|NCT00004445|13212925|P1|NOT COMPLETED|Overall Study||3
5371352|NCT00004445|13212925|P1|COMPLETED|Overall Study||15
5371353|NCT00004445|13212925|P1|STARTED|Overall Study||18
5371354|NCT00004412|13212933|P3|NOT COMPLETED|Crossover Period||0
5371355|NCT00004412|13212934|P2|NOT COMPLETED|Crossover Period||0
5371356|NCT00004412|13212935|P1|NOT COMPLETED|Crossover Period||0
5371357|NCT00004412|13212933|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
5371358|NCT00004412|13212934|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
5371359|NCT00004412|13212935|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
5371360|NCT00004412|13212933|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
5371361|NCT00004412|13212934|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
5371362|NCT00004412|13212935|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
5371363|NCT00004412|13212933|P3|NOT COMPLETED|Randomized Period||0
5371364|NCT00004412|13212934|P2|NOT COMPLETED|Randomized Period||0
5371365|NCT00004412|13212935|P1|NOT COMPLETED|Randomized Period||3
5371366|NCT00004412|13212933|P3|COMPLETED|Randomized Period||0
5371367|NCT00004412|13212934|P2|COMPLETED|Randomized Period||12
5371368|NCT00004412|13212935|P1|COMPLETED|Randomized Period||8
5371369|NCT00004412|13212933|P3|STARTED|Randomized Period||0
5371370|NCT00004412|13212934|P2|STARTED|Randomized Period||12
5371371|NCT00004412|13212935|P1|STARTED|Randomized Period||11
5371372|NCT00000143|13212945|P2|NOT COMPLETED|Overall Study||0
5371373|NCT00000143|13212946|P1|NOT COMPLETED|Overall Study||0
5371374|NCT00000143|13212945|P2|COMPLETED|Overall Study||30
5371375|NCT00000143|13212946|P1|COMPLETED|Overall Study||31
5371376|NCT00000143|13212945|P2|STARTED|Overall Study||30
5371377|NCT00000143|13212946|P1|STARTED|Overall Study||31
5371378|NCT00000142|13212955|P3|NOT COMPLETED|Overall Study||0
5371379|NCT00000142|13212956|P2|NOT COMPLETED|Overall Study||0
5371380|NCT00000142|13212957|P1|NOT COMPLETED|Overall Study||0
5371381|NCT00000142|13212955|P3|COMPLETED|Overall Study||12
5371382|NCT00000142|13212956|P2|COMPLETED|Overall Study||26
5371383|NCT00000142|13212957|P1|COMPLETED|Overall Study||26
5371384|NCT00000142|13212955|P3|STARTED|Overall Study||12
5371385|NCT00000142|13212956|P2|STARTED|Overall Study||26
5371386|NCT00000142|13212957|P1|STARTED|Overall Study||26
5371387|NCT00000136|13212967|P2|NOT COMPLETED|Overall Study||0
5371388|NCT00000136|13212968|P1|NOT COMPLETED|Overall Study||0
5371389|NCT00000136|13212967|P2|COMPLETED|Overall Study||127
5371390|NCT00000136|13212968|P1|COMPLETED|Overall Study||107
5371391|NCT00000136|13212967|P2|STARTED|Overall Study||127
5371392|NCT00000136|13212968|P1|STARTED|Overall Study||107
5371393|NCT00000135|13212976|P2|NOT COMPLETED|Overall Study||14
5371394|NCT00000135|13212977|P1|NOT COMPLETED|Overall Study||27
5371395|NCT00000135|13212976|P2|COMPLETED|Overall Study||91
5371396|NCT00000135|13212977|P1|COMPLETED|Overall Study||77
5371397|NCT00000135|13212976|P2|STARTED|Overall Study||105
5371398|NCT00000135|13212977|P1|STARTED|Overall Study||104
5371399|NCT00000134|13212986|P3|NOT COMPLETED|Overall Study||0
5371400|NCT00000134|13212987|P2|NOT COMPLETED|Overall Study||0
5371401|NCT00000134|13212988|P1|NOT COMPLETED|Overall Study||0
5371402|NCT00000134|13212986|P3|COMPLETED|Overall Study||96
5371403|NCT00000134|13212987|P2|COMPLETED|Overall Study||94
5371404|NCT00000134|13212988|P1|COMPLETED|Overall Study||89
5371405|NCT00000134|13212986|P3|STARTED|Overall Study||96
5371406|NCT00000134|13212987|P2|STARTED|Overall Study||94
5371407|NCT00000134|13212988|P1|STARTED|Overall Study||89
5371408|NCT00000125|13212998|P2|NOT COMPLETED|Overall Study||238
5371409|NCT00000125|13212999|P1|NOT COMPLETED|Overall Study||239
5371410|NCT00000125|13212998|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
5371411|NCT00000125|13212999|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
5371412|NCT00000125|13212998|P2|Completed OHTS Phase I, June 2002|Overall Study||702
5371413|NCT00000125|13212999|P1|Completed OHTS Phase I, June 2002|Overall Study||706
5371414|NCT00000125|13212998|P2|STARTED|Overall Study||817
5371415|NCT00000125|13212999|P1|STARTED|Overall Study||819
